PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Nonomura, M				Nonomura, Makiko			Study on Multicellular Systems Using a Phase Field Model	PLOS ONE			English	Article							COMPUTER-SIMULATION; CELL BEHAVIOR; GROWTH; REARRANGEMENT; MORPHOGENESIS	A model of multicellular systems with several types of cells is developed from the phase field model. The model is presented as a set of partial differential equations of the field variables, each of which expresses the shape of one cell. The dynamics of each cell is based on the criteria for minimizing the surface area and retaining a certain volume. The effects of cell adhesion and excluded volume are also taken into account. The proposed model can be used to find the position of the membrane and/or the cortex of each cell without the need to adopt extra variables. This model is suitable for numerical simulations of a system having a large number of cells. The two-dimensional results of cell division, cell adhesion, rearrangement of a cell cluster, chemotaxis, and cell sorting as well as the three-dimensional results of cell clusters on the substrate are presented.	[Nonomura, Makiko] Nihon Univ, Coll Ind Technol, Dept Math Informat Engn, Narashino, Chiba 275, Japan; [Nonomura, Makiko] PRESTO, Japan Sci & Technol Agcy, Kawaguchi, Saitama, Japan	Nihon University; Japan Science & Technology Agency (JST)	Nonomura, M (corresponding author), Nihon Univ, Coll Ind Technol, Dept Math Informat Engn, Narashino, Chiba 275, Japan.	nonomura.makiko@nihon-u.ac.jp			Japan Science and Technology Agency, PRESTO	Japan Science and Technology Agency, PRESTO(Japan Science & Technology Agency (JST))	This work was supported by the Japan Science and Technology Agency, PRESTO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama M, 2010, J THEOR BIOL, V264, P84, DOI 10.1016/j.jtbi.2009.12.016; Folch R, 1999, PHYS REV E, V60, P1724, DOI 10.1103/PhysRevE.60.1724; GLAZIER JA, 1993, PHYS REV E, V47, P2128, DOI 10.1103/PhysRevE.47.2128; GRANER F, 1992, PHYS REV LETT, V69, P2013, DOI 10.1103/PhysRevLett.69.2013; GRANER F, 1993, J THEOR BIOL, V164, P477, DOI 10.1006/jtbi.1993.1168; Grill SW, 2003, SCIENCE, V301, P518, DOI 10.1126/science.1086560; HONDA H, 1978, J THEOR BIOL, V72, P523, DOI 10.1016/0022-5193(78)90315-6; Honda H, 2004, J THEOR BIOL, V226, P439, DOI 10.1016/j.jtbi.2003.10.001; HONDA H, 1979, J THEOR BIOL, V81, P745, DOI 10.1016/0022-5193(79)90279-0; HONDA H, 1984, J THEOR BIOL, V106, P423, DOI 10.1016/0022-5193(84)90039-0; Kafer J, 2006, PLOS COMPUT BIOL, V2, P518, DOI 10.1371/journal.pcbi.0020056; Karma A, 1998, PHYS REV E, V57, P4323, DOI 10.1103/PhysRevE.57.4323; Karma A, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.045501; KOBAYASHI R, 1993, PHYSICA D, V63, P410, DOI 10.1016/0167-2789(93)90120-P; Kockelkoren J, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.037702; Morishita Y, 2008, B MATH BIOL, V70, P1957, DOI 10.1007/s11538-008-9334-1; Nagai T, 2001, PHILOS MAG B, V81, P699, DOI 10.1080/13642810110055328; NEWMAN T. J, 2007, SINGLE CELL BASED MO, P221; Poplawski NJ, 2008, MATH BIOSCI ENG, V5, P355; Shao DY, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.108104; Thery M, 2007, NATURE, V447, P493, DOI 10.1038/nature05786; WELIKY M, 1991, DEVELOPMENT, V113, P1231	22	53	53	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e33501	10.1371/journal.pone.0033501	http://dx.doi.org/10.1371/journal.pone.0033501			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22539943	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341000006
J	Janowski, M; Kunert, P				Janowski, Miroslaw; Kunert, Przemyslaw			Intravenous Fluid Administration May Improve Post-Operative Course of Patients with Chronic Subdural Hematoma: A Retrospective Study	PLOS ONE			English	Article							BURR-HOLE CRANIOSTOMY; INDEPENDENT PREDICTORS; BLOOD-VOLUME; RECURRENCE	Background: The treatment of chronic subdural hematoma (cSDH) is still charged of significant risk of hematoma recurrence. Patient-related predictors and the surgical procedures themselves have been addressed in many studies. In contrast, postoperative management has infrequently been subjected to detailed analysis. Moreover variable intravenous fluid administration (IFA) was not reported in literature till now in the context of cSDH treatment. Methodology/Principal Findings: A total of 45 patients with cSDH were operated in our department via two burr hole craniostomy within one calendar year. Downward drainage was routinely left in hematoma cavity for a one day. Independent variables selected for the analysis were related to various aspects of patient management, including IFA. Two dependent variables were chosen as measure of clinical course: the rate of hematoma recurrence (RHR) and neurological status at discharge from hospital expressed in points of Glasgow Outcome Scale (GOS). Univariate and multivariate regression analyses were performed. Hematoma recurrence with subsequent evacuation occurred in 7 (15%) patients. Univariate regression analysis revealed that length of IFA after surgery influenced both dependent variables: RHR (p = 0.045) and GOS (p = 0.023). Multivariate regression performed by backward elimination method confirmed that IFA is a sole independent factor influencing RHR. Post hoc dichotomous division of patients revealed that those receiving at least 2000 ml/day over 3 day period revealed lower RHR than the group with less intensive IFA. (p = 0.031). Conclusions/Significance: IFA has been found to be a sole factor influencing both: RHR and GOS. Based on those results we may recommend administration of at least 2000 ml per 3 days post-operatively to decrease the risk of hematoma recurrence.	[Janowski, Miroslaw; Kunert, Przemyslaw] Med Univ Warsaw, Dept Neurosurg, Warsaw, Poland; [Janowski, Miroslaw] Polish Acad Sci, NeuroRepair Dept, Mossakowski Med Res Ctr, Warsaw, Poland	Medical University of Warsaw; Polish Academy of Sciences; Mossakowski Medical Research Institute of the Polish Academy of Sciences	Janowski, M (corresponding author), Med Univ Warsaw, Dept Neurosurg, Warsaw, Poland.	mjanows1@jhmi.edu		Kunert, Przemyslaw/0000-0002-0583-9505; Janowski, Miroslaw/0000-0001-5261-7975				Abouzari M, 2007, NEUROSURGERY, V61, P794, DOI 10.1227/01.NEU.0000298908.94129.67; Gastone P, 2004, NEUROL INDIA, V52, P475; Han HJ, 2009, J KOREAN NEUROSURG S, V46, P87, DOI 10.3340/jkns.2009.46.2.87; Hoff R, 2009, STROKE, V40, P2575, DOI 10.1161/STROKEAHA.108.538116; Horn EM, 2006, SURG NEUROL, V65, P150, DOI 10.1016/j.surneu.2005.05.030; Ishfaq A, 2009, JCPSP-J COLL PHYSICI, V19, P492, DOI 08.2009/JCPSP.492495; Kasuya H, 2003, STROKE, V34, P956, DOI 10.1161/01.STR.0000064321.10700.63; Ko BS, 2008, J KOREAN NEUROSURG S, V43, P11, DOI 10.3340/jkns.2008.43.1.11; Komotar RJ, 2010, NEUROSURGERY, V66, pN15, DOI 10.1227/01.neu.0000367840.82764.3a; Kurabe S, 2010, ACTA NEUROCHIR WIEN; Lee JY, 2004, SURG NEUROL, V61, P523, DOI 10.1016/j.surneu.2003.10.026; Lega BC, 2009, J NEUROSURG; Mondorf Y, 2009, BRIT J NEUROSURG, V23, P612, DOI 10.3109/02688690903370297; Moskala M, 2007, MICROSC MICROANAL, V13, P211, DOI 10.1017/S1431927607070286; Santarius T, 2008, BRIT J NEUROSURG, V22, P529, DOI 10.1080/02688690802195381; Stanisic M, 2005, ACTA NEUROCHIR, V147, P1249, DOI 10.1007/s00701-005-0616-1; Taussky P, 2008, BRIT J NEUROSURG, V22, P279, DOI 10.1080/02688690701818885; Torihashi K, 2008, NEUROSURGERY, V63, P1125, DOI 10.1227/01.NEU.0000335782.60059.17; Weigel R, 2003, J NEUROL NEUROSUR PS, V74, P937, DOI 10.1136/jnnp.74.7.937; Yamamoto H, 2003, J NEUROSURG, V98, P1217, DOI 10.3171/jns.2003.98.6.1217	20	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35634	10.1371/journal.pone.0035634	http://dx.doi.org/10.1371/journal.pone.0035634			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22532865	Green Submitted, gold, Green Published			2022-12-27	WOS:000305339200089
J	Kaliuzhna, M; Chambon, V; Franck, N; Testud, B; Van der Henst, JB				Kaliuzhna, Mariia; Chambon, Valerian; Franck, Nicolas; Testud, Berangere; Van der Henst, Jean-Baptiste			Belief Revision and Delusions: How Do Patients with Schizophrenia Take Advice?	PLOS ONE			English	Article							DISCONFIRMATORY EVIDENCE BADE; IMPROVING JUDGMENT; DECISION-MAKING; COGNITIVE BIAS; EXPERT ADVICE; EXPLANATIONS; EXPERIENCES; PEOPLE; SELF	The dominant cognitive model that accounts for the persistence of delusional beliefs in schizophrenia postulates that patients suffer from a general deficit in belief revision. It is generally assumed that this deficit is a consequence of impaired reasoning skills. However, the possibility that such inflexibility affects the entire system of a patient's beliefs has rarely been empirically tested. Using delusion-neutral material in a well-documented advice-taking task, the present study reports that patients with schizophrenia: 1) revise their beliefs, 2) take into account socially provided information to do so, 3) are not overconfident about their judgments, and 4) show less egocentric advice-discounting than controls. This study thus shows that delusional patients' difficulty in revising beliefs is more selective than had been previously assumed. The specificities of the task and the implications for a theory of delusion formation are discussed.	[Kaliuzhna, Mariia; Van der Henst, Jean-Baptiste] Univ Lyon, Lab Langage Cerveau & Cognit L2C2, CNRS, Bron, France; [Kaliuzhna, Mariia] Ecole Polytech Fed Lausanne, Brain Mind Inst, Cognit Neurosci Lab, Lausanne, Switzerland; [Chambon, Valerian; Franck, Nicolas] Univ Lyon, Ctr Neurosci Cognit, CNRS, Bron, France; [Franck, Nicolas] Ctr Hosp Le Vinatier, Bron, France; [Testud, Berangere] Univ Lyon 2, Bron, France	Centre National de la Recherche Scientifique (CNRS); Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Centre National de la Recherche Scientifique (CNRS); Universite Lyon 2	Kaliuzhna, M (corresponding author), Univ Lyon, Lab Langage Cerveau & Cognit L2C2, CNRS, Bron, France.	mariia.kaliuzhna@epfl.ch; vanderhenst@isc.cnrs.fr	Franck, Nicolas/GWZ-4383-2022; Chambon, Valerian/AAF-5482-2019	Franck, Nicolas/0000-0002-2894-5108; Chambon, Valerian/0000-0002-2401-1906; Kaliuzhna, Mariia/0000-0002-0954-961X	Swiss National Science Foundation (SINERGIA) [CRSII1-125135]; French National Research Agency [ANR-07-BLAN-0024-01]	Swiss National Science Foundation (SINERGIA)(Swiss National Science Foundation (SNSF)); French National Research Agency(French National Research Agency (ANR))	MK was supported by the Swiss National Science Foundation (SINERGIA project 'Balancing Self and Body': CRSII1-125135) and JBVDH by the French National Research Agency (ANR-07-BLAN-0024-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Andreasen N. C., 1984, SCALE ASSESSMENT POS; Andreasen NC, 1983, SCALE ASSESSMENT NEG; Anselmetti S, 2007, PSYCHIAT RES, V150, P51, DOI 10.1016/j.psychres.2005.12.004; Beck AT, 2004, SCHIZOPHR RES, V68, P319, DOI 10.1016/s0920-9964(03)00189-0; Bonaccio S, 2006, ORGAN BEHAV HUM DEC, V101, P127, DOI 10.1016/j.obhdp.2006.07.001; BRETTJONES J, 1987, BRIT J CLIN PSYCHOL, V26, P257, DOI 10.1111/j.2044-8260.1987.tb01359.x; Buchy L, 2007, SCHIZOPHR RES, V90, P334, DOI 10.1016/j.schres.2006.11.012; CHAPMAN L J, 1964, Prog Exp Pers Res, V72, P49; Coltheart M, 2011, ANNU REV PSYCHOL, V62, P271, DOI 10.1146/annurev.psych.121208.131622; CORNBLATT BA, 1994, SCHIZOPHRENIA BULL, V20, P31, DOI 10.1093/schbul/20.1.31; Davies M., 2001, PHILOS PSYCHIAT PSYC, V8, P133, DOI [10.1353/ppp.2001.0007, DOI 10.1353/PPP.2001.0007]; Elio R, 1997, COGNITIVE SCI, V21, P419, DOI 10.1207/s15516709cog2104_2; Fowler D, 1995, COGNITIVE BEHAV THER; Freeman D, 2004, J CONSULT CLIN PSYCH, V72, P671, DOI 10.1037/0022-006X.72.4.671; FRICKER E, 1995, MIND, V104, P393, DOI 10.1093/mind/104.414.393; Gallagher S, 2000, TRENDS COGN SCI, V4, P14, DOI 10.1016/S1364-6613(99)01417-5; GARDNER PH, 1995, APPL COGNITIVE PSYCH, V9, pS55, DOI 10.1002/acp.2350090706; GARETY P. A., 1994, DELUSIONS INVESTIGAT; Garety PA, 2005, J ABNORM PSYCHOL, V114, P373, DOI 10.1037/0021-843X.114.3.373; GARETY PA, 1991, J NERV MENT DIS, V179, P194, DOI 10.1097/00005053-199104000-00003; Gaweda L, PSYCHIAT RE IN PRESS; Hardy-Bayle MC, 2003, SCHIZOPHRENIA BULL, V29, P459, DOI 10.1093/oxfordjournals.schbul.a007019; Harvey N, 1997, ORGAN BEHAV HUM DEC, V70, P117, DOI 10.1006/obhd.1997.2697; Heinrichs RW, 1998, NEUROPSYCHOLOGY, V12, P426, DOI 10.1037/0894-4105.12.3.426; HUQ SF, 1988, Q J EXP PSYCHOL-A, V40, P801, DOI 10.1080/14640748808402300; Langdon R, 2000, MIND LANG, V15, P184, DOI 10.1111/1468-0017.00129; McCabe R, 2004, THEOR PSYCHOL, V14, P738, DOI 10.1177/0959354304046187; McGuire PK, 1996, BRIT J PSYCHIAT, V169, P148, DOI 10.1192/bjp.169.2.148; McKay R, MIND LANGUA IN PRESS; Moritz S, 2006, PSYCHIAT RES, V142, P157, DOI 10.1016/j.psychres.2005.08.016; Parnas J, 2003, COMPR PSYCHIAT, V44, P121, DOI 10.1053/comp.2003.50017; Riggs SE, 2010, SCHIZOPHRENIA B; SALZINGER K, 1964, ANN NY ACAD SCI, V105, P845, DOI 10.1111/j.1749-6632.1964.tb42967.x; Salzinger K, 1984, NEBR S MOT THEOR SCH, P231; Schneider K., 1959, CLIN PSYCHOPATHOLOGY; Serper M. R., 2004, INT J PSYCHOL PSYCHO, V4, P397; Sniezek JA, 2004, J BEHAV DECIS MAKING, V17, P173, DOI 10.1002/bdm.468; Soll JB, 2009, J EXP PSYCHOL LEARN, V35, P780, DOI 10.1037/a0015145; Speechley WJ, 2010, J PSYCHIATR NEUROSCI, V35, P7, DOI 10.1503/jpn.090025; Sperber D, 2010, MIND LANG, V25, P359, DOI 10.1111/j.1468-0017.2010.01394.x; Van Swol LM, 2005, BRIT J SOC PSYCHOL, V44, P443, DOI 10.1348/014466604X17092; Wang LA, 2011, SCHIZOPHR RES, V125, P136, DOI 10.1016/j.schres.2010.11.012; WESSELY S, 1993, BRIT J PSYCHIAT, V163, P69, DOI 10.1192/bjp.163.1.69; Woodward TS, 2007, SCHIZOPHRENIA BULL, V33, P1023, DOI 10.1093/schbul/sbm013; Woodward Todd S, 2008, Cogn Neuropsychiatry, V13, P267, DOI 10.1080/13546800802099033; Woodward TS, 2006, J CLIN EXP NEUROPSYC, V28, P605, DOI 10.1080/13803390590949511; Yaniv I, 2000, ORGAN BEHAV HUM DEC, V83, P260, DOI 10.1006/obhd.2000.2909; Yaniv I, 2007, ORGAN BEHAV HUM DEC, V103, P104, DOI 10.1016/j.obhdp.2006.05.006	50	17	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e34771	10.1371/journal.pone.0034771	http://dx.doi.org/10.1371/journal.pone.0034771			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UD	22536329	Green Published, gold, Green Submitted			2022-12-27	WOS:000305339200018
J	Orgiazzi, A; Lumini, E; Nilsson, RH; Girlanda, M; Vizzini, A; Bonfante, P; Bianciotto, V				Orgiazzi, Alberto; Lumini, Erica; Nilsson, R. Henrik; Girlanda, Mariangela; Vizzini, Alfredo; Bonfante, Paola; Bianciotto, Valeria			Unravelling Soil Fungal Communities from Different Mediterranean Land-Use Backgrounds	PLOS ONE			English	Article							DNA BARCODE; BIODIVERSITY; DIVERSITY; IDENTIFICATION; INDICATOR; GRADIENT; DATABASE; ECOLOGY; REVEAL; YEASTS	Background: Fungi strongly influence ecosystem structure and functioning, playing a key role in many ecological services as decomposers, plant mutualists and pathogens. The Mediterranean area is a biodiversity hotspot that is increasingly threatened by intense land use. Therefore, to achieve a balance between conservation and human development, a better understanding of the impact of land use on the underlying fungal communities is needed. Methodology/Principal Findings: We used parallel pyrosequencing of the nuclear ribosomal ITS regions to characterize the fungal communities in five soils subjected to different anthropogenic impact in a typical Mediterranean landscape: a natural cork-oak forest, a pasture, a managed meadow, and two vineyards. Marked differences in the distribution of taxon assemblages among the different sites and communities were found. Data analyses consistently indicated a sharp distinction of the fungal community of the cork oak forest soil from those described in the other soils. Each soil showed features of the fungal assemblages retrieved which can be easily related to the above-ground settings: ectomycorrhizal phylotypes were numerous in natural sites covered by trees, but were nearly completely missing from the anthropogenic and grass-covered sites; similarly, coprophilous fungi were common in grazed sites. Conclusions/Significance: Data suggest that investigation on the below-ground fungal community may provide useful elements on the above-ground features such as vegetation coverage and agronomic procedures, allowing to assess the cost of anthropogenic land use to hidden diversity in soil. Datasets provided in this study may contribute to future searches for fungal bio-indicators as biodiversity markers of a specific site or a land-use degree.	[Orgiazzi, Alberto; Lumini, Erica; Bonfante, Paola; Bianciotto, Valeria] Natl Res Council CNR, Plant Protect Inst Turin UOS, Turin, Italy; [Orgiazzi, Alberto; Girlanda, Mariangela; Vizzini, Alfredo; Bonfante, Paola] Univ Turin, Dept Life Sci & Syst Biol, Turin, Italy; [Nilsson, R. Henrik] Univ Gothenburg, Dept Biol & Environm Sci, Gothenburg, Sweden	University of Turin; University of Gothenburg	Bianciotto, V (corresponding author), Natl Res Council CNR, Plant Protect Inst Turin UOS, Turin, Italy.	v.bianciotto@ipp.cnr.it	Bonfante, Paola/ABE-6733-2020; Nilsson, R. Henrik/A-6062-2009; LUMINI, Erica/AAR-7802-2021; LUMINI, Erica/F-8901-2013	Nilsson, R. Henrik/0000-0002-8052-0107; LUMINI, Erica/0000-0001-5864-8561; LUMINI, Erica/0000-0001-5864-8561; Vizzini, Alfredo/0000-0001-8390-6446; Bonfante, Paola/0000-0003-3576-8530; BIANCIOTTO, VALERIA/0000-0002-7409-5538	ENDURE (European Network for the Durable Exploitation of Crop Protection Strategies); IPP-CNR (Plant Protection Institute - National Research Council); SOILSINK Project (Fondo Integrativo Speciale Ricerca - FISR); FORMAS [215-2011-498]; Ministero dell'Istruzione, dell'Universita della Ricerca (MIUR); IPP-CNR	ENDURE (European Network for the Durable Exploitation of Crop Protection Strategies); IPP-CNR (Plant Protection Institute - National Research Council); SOILSINK Project (Fondo Integrativo Speciale Ricerca - FISR); FORMAS(Swedish Research Council Formas); Ministero dell'Istruzione, dell'Universita della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR)); IPP-CNR	VB's research was funded by ENDURE (European Network for the Durable Exploitation of Crop Protection Strategies) Project and IPP-CNR (Plant Protection Institute - National Research Council) (Biodiversity Projects-Torino). PB's research was funded by the SOILSINK Project (Fondo Integrativo Speciale Ricerca - FISR). Financial support to RHN from FORMAS (grant no. 215-2011-498) is gratefully acknowledged. AO was supported by Ministero dell'Istruzione, dell'Universita della Ricerca (MIUR) and IPP-CNR grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarenkov K, 2010, NEW PHYTOL, V186, P281, DOI 10.1111/j.1469-8137.2009.03160.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 1994, BIODIVERSITY UK ACTI; Arnolds E, 2010, FUNGAL ECOL, V3, P81, DOI 10.1016/j.funeco.2009.05.005; BACCHETTA, 2004, FITOSOCIOLOGIA, V41, P29; Barrios E, 2007, ECOL ECON, V64, P269, DOI 10.1016/j.ecolecon.2007.03.004; Bellemain E, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-189; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Blaalid R, 2012, MOL ECOL, V21, P1897, DOI 10.1111/j.1365-294X.2011.05214.x; Blaxter M, 2005, PHILOS T R SOC B, V360, P1935, DOI 10.1098/rstb.2005.1725; Boddy L., 2007, ECOLOGY SAPROTROPHIC; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Buee M, 2009, NEW PHYTOL, V184, P449, DOI 10.1111/j.1469-8137.2009.03003.x; Coleman M, 2010, ANOTHER KINGDOM AMAZ; Council of Europe, 2001, O J EUR COMM; Council of Europe, 1992, O J EUR COMM; Cox RL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014508; Curtis TP, 2005, SCIENCE, V309, P1331, DOI 10.1126/science.1118176; Dance A, 2008, NATURE, V455, P724, DOI 10.1038/455724a; Dumbrell AJ, 2011, NEW PHYTOL, V190, P794, DOI 10.1111/j.1469-8137.2010.03636.x; Egli S, 2011, ANN FOREST SCI, V68, P81, DOI 10.1007/s13595-010-0009-3; FELLNER R, 1990, AGR ECOSYST ENVIRON, V28, P115, DOI 10.1016/0167-8809(90)90025-9; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Hartmann M, 2010, J MICROBIOL METH, V83, P250, DOI 10.1016/j.mimet.2010.08.008; Hawksworth DL, 2001, MYCOL RES, V105, P1422, DOI 10.1017/S0953756201004725; Hibbett David S., 2011, Fungal Biology Reviews, V25, P38, DOI 10.1016/j.fbr.2011.01.001; Hibbett DS, 2009, NEW PHYTOL, V184, P279, DOI 10.1111/j.1469-8137.2009.03042.x; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Jolly N. P., 2006, SOUTH AFRICAN JOURNAL OF ENOLOGY AND VITICULTURE, V27, P15; Jonsson BG, 1999, BIODIVERS CONSERV, V8, P1417, DOI 10.1023/A:1008900309571; Jumpponen A, 2010, MOL ECOL, V19, P41, DOI 10.1111/j.1365-294X.2009.04483.x; Kirk PM., 2008, DICT FUNGI, V10th ed; Lagomarsino A, 2011, BIOL FERT SOILS, V47, P283, DOI 10.1007/s00374-010-0530-4; Lilleskov EA, 2001, ECOL APPL, V11, P397, DOI 10.1890/1051-0761(2001)011[0397:EFACCO]2.0.CO;2; Loureiro V, 2003, INT J FOOD MICROBIOL, V86, P23, DOI 10.1016/S0168-1605(03)00246-0; Lumini E, 2010, ENVIRON MICROBIOL, V12, P2165, DOI 10.1111/j.1462-2920.2009.02099.x; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Martin F, 2011, NEW PHYTOL, V190, P818, DOI 10.1111/j.1469-8137.2011.03688.x; Medail F, 1999, CONSERV BIOL, V13, P1510, DOI 10.1046/j.1523-1739.1999.98467.x; Mello A, 2011, MYCOLOGIA, V103, P1184, DOI 10.3852/11-027; Mueller GM, 2007, BIODIVERS CONSERV, V16, P1, DOI 10.1007/s10531-006-9117-7; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nacke H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017000; Newton AC, 2003, BIOL CONSERV, V111, P11, DOI 10.1016/S0006-3207(02)00243-4; Nilsson RH, 2010, FUNGAL ECOL, V3, P284, DOI 10.1016/j.funeco.2010.05.002; Novacek MJ, 2001, P NATL ACAD SCI USA, V98, P5466, DOI 10.1073/pnas.091093698; O'Brien HE, 2005, APPL ENVIRON MICROB, V71, P5544, DOI 10.1128/AEM.71.9.5544-5550.2005; Parmasto E, 2001, BR MYCOL SY, V22, P81, DOI 10.1017/CBO9780511565168.006; Pastorelli R, 2009, AGROCHIMICA, V53, P386; Podani J., 2001, SYNTAX 2000 COMPUTER; Rotheroe M, 2001, BR MYCOL SY, V22, P120, DOI 10.1017/CBO9780511565168.011; Schwarze F.W.M.R., 2004, FUNGAL STRATEGIES WO; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Tedersoo L, 2010, NEW PHYTOL, V188, P291, DOI 10.1111/j.1469-8137.2010.03373.x; ter Braak C.J.F., 2012, CANOCO REFERENCE MAN; Unterseher M, 2011, MOL ECOL, V20, P275, DOI 10.1111/j.1365-294X.2010.04948.x; Wang Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019039; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Xu LH, 2012, SOIL BIOL BIOCHEM, V46, P26, DOI 10.1016/j.soilbio.2011.11.010	60	129	137	8	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e34847	10.1371/journal.pone.0034847	http://dx.doi.org/10.1371/journal.pone.0034847			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536336	Green Submitted, Green Published, gold			2022-12-27	WOS:000305339200024
J	Ouna, BA; Nyambega, B; Manful, T; Helbig, C; Males, M; Fadda, A; Clayton, C				Ouna, Benard A.; Nyambega, Benson; Manful, Theresa; Helbig, Claudia; Males, Matilda; Fadda, Abeer; Clayton, Christine			Depletion of Trypanosome CTR9 Leads to Gene Expression Defects	PLOS ONE			English	Article							RNA-POLYMERASE-I; PAF1 COMPLEX; MESSENGER-RNA; TRANSCRIPTION ELONGATION; H2B UBIQUITYLATION; TUMOR-SUPPRESSOR; HISTONE H3; POLYADENYLATION; IDENTIFICATION; BRUCEI	The Paf complex of Opisthokonts and plants contains at least five subunits: Paf1, Cdc73, Rtf1, Ctr9, and Leo1. Mutations in, or loss of Paf complex subunits have been shown to cause defects in histone modification, mRNA polyadenylation, and transcription by RNA polymerase I and RNA polymerase II. We here investigated trypanosome CTR9, which is essential for trypanosome survival. The results of tandem affinity purification suggested that trypanosome CTR9 associates with homologues of Leo1 and Cdc73; genes encoding homologues of Rtf1 and Paf1 were not found. RNAi targeting CTR9 resulted in at least ten-fold decreases in 131 essential mRNAs: they included several that are required for gene expression and its control, such as those encoding subunits of RNA polymerases, exoribonucleases that target mRNA, RNA helicases and RNA-binding proteins. Simultaneously, some genes from regions subject to chromatin silencing were derepressed, possibly as a secondary effect of the loss of two proteins that are required for silencing, ISWI and NLP1.	[Ouna, Benard A.; Nyambega, Benson; Manful, Theresa; Helbig, Claudia; Males, Matilda; Fadda, Abeer; Clayton, Christine] Heidelberg Univ, Zentrum Mol Biol, DKFZ ZMBH Alliance, D-6900 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Clayton, C (corresponding author), Heidelberg Univ, Zentrum Mol Biol, DKFZ ZMBH Alliance, D-6900 Heidelberg, Germany.	cclayon@zmbh.uni-heidelberg.de	Nyambega, Benson/GOH-3417-2022; Clayton, Christine/K-7700-2019	Nyambega, Benson/0000-0002-0947-0354; Clayton, Christine/0000-0002-6384-0731; Fadda, Abeer/0000-0002-8489-1335	Deutsche Forschungsgemeinschaft (German Research Foundation) [SFB544, Cl112/9]; Bundesministerium fur Bildung und Forschung (BMBF, Federal Ministry of Education and Research); Deutsches Akademisches Austauschdienst (German Academic Exchange Service)	Deutsche Forschungsgemeinschaft (German Research Foundation)(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung (BMBF, Federal Ministry of Education and Research)(Federal Ministry of Education & Research (BMBF)); Deutsches Akademisches Austauschdienst (German Academic Exchange Service)	This work was supported by Deutsche Forschungsgemeinschaft (German Research Foundation), SFB544 and Cl112/9; Bundesministerium fur Bildung und Forschung (BMBF, Federal Ministry of Education and Research), Sysmo project "The silicon trypanosome"; and Deutsches Akademisches Austauschdienst (German Academic Exchange Service). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alibu VP, 2005, MOL BIOCHEM PARASIT, V139, P75, DOI 10.1016/j.molbiopara.2004.10.002; Alsford S, 2011, GENOME RES, V21, P915, DOI 10.1101/gr.115089.110; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Biebinger S, 1996, NUCLEIC ACIDS RES, V24, P1202, DOI 10.1093/nar/24.7.1202; Colasante C, 2006, EUKARYOT CELL, V5, P1194, DOI 10.1128/EC.00096-06; Crisucci EM, 2011, EUKARYOT CELL, V10, P712, DOI 10.1128/EC.05013-11; Das A, 2005, MOL CELL BIOL, V25, P7314, DOI 10.1128/MCB.25.16.7314-7322.2005; Das A, 2008, EUKARYOT CELL, V7, P429, DOI 10.1128/EC.00297-07; Das A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006959; Dermody JL, 2010, J BIOL CHEM, V285, P33671, DOI 10.1074/jbc.M110.140764; Estevez AM, 2003, J BIOL CHEM, V278, P34943, DOI 10.1074/jbc.M305333200; Estevez AM, 2001, EMBO J, V20, P3831, DOI 10.1093/emboj/20.14.3831; Fernandez-Moya SM, 2010, WIRES RNA, V1, P34, DOI 10.1002/wrna.6; Gunzl A, 2003, EUKARYOT CELL, V2, P542, DOI 10.1128/EC.2.3.542-551.2003; Haanstra JR, 2011, MOL MICROBIOL, V79, P94, DOI 10.1111/j.1365-2958.2010.07435.x; Ip JY, 2011, GENOME RES, V21, P390, DOI 10.1101/gr.111070.110; Jaehning JA, 2010, BBA-GENE REGUL MECH, V1799, P379, DOI 10.1016/j.bbagrm.2010.01.001; Kim J, 2011, METHODS, V54, P331, DOI 10.1016/j.ymeth.2011.03.009; Kim J, 2010, CELL, V140, P491, DOI 10.1016/j.cell.2009.12.050; Kolev NG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001090; Kramer S, 2011, TRENDS PARASITOL, V27, P23, DOI 10.1016/j.pt.2010.06.011; Langenbacher AD, 2011, DEV BIOL, V353, P19, DOI 10.1016/j.ydbio.2011.02.011; Lee JH, 2010, MOL CELL BIOL, V30, P5502, DOI 10.1128/MCB.00966-10; Manful T, 2011, RNA, V17, P2039, DOI 10.1261/rna.2837311; MATTHEWS KR, 1994, GENE DEV, V8, P491, DOI 10.1101/gad.8.4.491; Mayer A, 2010, NAT STRUCT MOL BIOL, V17, P1272, DOI 10.1038/nsmb.1903; Michaeli S, 2011, FUTURE MICROBIOL, V6, P459, DOI [10.2217/fmb.11.20, 10.2217/FMB.11.20]; Mueller CL, 2002, MOL CELL BIOL, V22, P1971, DOI 10.1128/MCB.22.7.1971-1980.2002; Mueller JE, 2006, GENETICS, V173, P557, DOI 10.1534/genetics.106.055400; Narayanan MS, 2011, NUCLEIC ACIDS RES, V39, P2018, DOI 10.1093/nar/gkq950; Nguyen CT, 2010, DEV BIOL, V341, P167, DOI 10.1016/j.ydbio.2010.02.020; Nordick K, 2008, EUKARYOT CELL, V7, P1158, DOI 10.1128/EC.00434-07; Oesterreich FC, 2011, TRENDS CELL BIOL, V21, P328, DOI 10.1016/j.tcb.2011.03.002; Oh S, 2004, PLANT CELL, V16, P2940, DOI 10.1105/tpc.104.026062; Panicker LM, 2010, ENDOCR-RELAT CANCER, V17, P513, DOI 10.1677/ERC-09-0272; Park SH, 2012, MOL BIOCHEM PARASIT, V181, P29, DOI 10.1016/j.molbiopara.2011.09.009; Penheiter KL, 2005, MOL CELL, V20, P213, DOI 10.1016/j.molcel.2005.08.023; Peterson ML, 2011, WIRES RNA, V2, P92, DOI 10.1002/wrna.36; Pinto PAB, 2011, EMBO J, V30, P2431, DOI 10.1038/emboj.2011.156; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Rigbolt KTG, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001570; Rozenblatt-Rosen O, 2009, P NATL ACAD SCI USA, V106, P755, DOI 10.1073/pnas.0812023106; Rudenko G, 2010, ESSAYS BIOCHEM, V48, P201, DOI [10.1042/BSE0480201, 10.1042/bse0480201]; Schwede A, 2009, NUCLEIC ACIDS RES, V37, P5511, DOI 10.1093/nar/gkp571; Siegel TN, 2009, GENE DEV, V23, P1063, DOI 10.1101/gad.1790409; Siegel TN, 2010, NUCLEIC ACIDS RES, V38, P4946, DOI 10.1093/nar/gkq237; Solnoki K, 2011, MOL BIOCH P IN PRESS; Squazzo SL, 2002, EMBO J, V21, P1764, DOI 10.1093/emboj/21.7.1764; Stanne TM, 2011, EUKARYOT CELL, V10, P964, DOI 10.1128/EC.05048-11; Tomson BN, 2011, GENETICS, V188, P273, DOI 10.1534/genetics.111.128645; ULLU E, 1993, MOL CELL BIOL, V13, P720, DOI 10.1128/MCB.13.1.720; Warner MH, 2007, MOL CELL BIOL, V27, P6103, DOI 10.1128/MCB.00772-07; Wurst M, 2012, MOL MICROBI IN PRESS; Yang YJ, 2010, NUCLEIC ACIDS RES, V38, P382, DOI 10.1093/nar/gkp991; Zeiner GM, 2003, EUKARYOT CELL, V2, P222, DOI 10.1128/EC.2.2.222-230.2003; Zhang YF, 2010, J BIOL CHEM, V285, P14152, DOI 10.1074/jbc.M110.115220; Zhang YF, 2009, P NATL ACAD SCI USA, V106, P2153, DOI 10.1073/pnas.0812939106	57	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e34256	10.1371/journal.pone.0034256	http://dx.doi.org/10.1371/journal.pone.0034256			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22532828	gold, Green Published, Green Submitted			2022-12-27	WOS:000305339200011
J	Latka, MH; Fielding, K; Gray, GE; Bekker, LG; Nchabeleng, M; Mlisana, K; Nielson, T; Roux, S; Mkhize, B; Mathebula, M; Naicker, N; de Bruyn, G; Kublin, J; Churchyard, GJ				Latka, Mary H.; Fielding, Katherine; Gray, Glenda E.; Bekker, Linda-Gail; Nchabeleng, Maphoshane; Mlisana, Koleka; Nielson, Tanya; Roux, Surita; Mkhize, Baningi; Mathebula, Matsontso; Naicker, Nivashnee; de Bruyn, Guy; Kublin, James; Churchyard, Gavin J.		HVTN 503 Phambili Study Team	Pregnancy Incidence and Correlates during the HVTN 503 Phambili HIV Vaccine Trial Conducted among South African Women	PLOS ONE			English	Article							DOUBLE-BLIND; PREVENTION TRIALS; EFFICACY; ACQUISITION; OUTCOMES	Background: HIV prevention trials are increasingly being conducted in sub-Saharan Africa. Women at risk for HIV are also at risk of pregnancy. To maximize safety, women agree to avoid pregnancy during trials, yet pregnancies occur. Using data from the HVTN 503/"Phambili" vaccine trial, we report pregnancy incidence during and after the vaccination period and identify factors, measured at screening, associated with incident pregnancy. Methods: To enrol in the trial, women agreed and were supported to avoid pregnancy until 1 month after their third and final vaccination ("vaccination period"), corresponding to the first 7 months of follow-up. Unsterilized women, pooled across study arms, were analyzed. Poisson regression compared pregnancy rates during and after the vaccination period. Cox proportional hazards regression identified associations with first pregnancy. Results: Among 352 women (median age 23 yrs; median follow-up 1.5 yrs), pregnancy incidence was 9.6/100 women-years overall and 6.8/100 w-yrs and 11.3/100 w-yrs during and after the vaccination period, respectively [Rate Ratio = 0.60 (0.32-1.14), p = 0.10]. In multivariable analysis, pregnancy was reduced among women who: enrolled at sites providing contraception on-site [HR = 0.43, 95% CI (0.22-0.86)]; entered the trial as injectable contraceptive users [HR = 0.37 (0.21-0.67)] or as consistent condom users (trend) [HR = 0.54 (0.28-1.04)]. Compared with women with a single partner of HIV-unknown status, pregnancy rates were increased among women with: a single partner whose status was HIV-negative [HR = 2.34(1.16-4.73)] and; 2 partners both of HIV-unknown status [HR = 4.42(1.59-12.29)]. Women with 2 more of these risk factors: marijuana use, heavy drinking, or use of either during sex, had increased pregnancy incidence [HR = 2.66 (1.24-5.72)]. Conclusions: It is possible to screen South African women for pregnancy risk at trial entry. Providing injectable contraception for free on-site and supporting consistent condom use may reduce incident pregnancy. Screening should determine the substance use, partnering, and HIV status of both members of the couple for both pregnancy and HIV prevention.	[Latka, Mary H.; Nielson, Tanya; Churchyard, Gavin J.] Aurum Inst, Johannesburg, South Africa; [Fielding, Katherine] London Sch Hyg & Trop Med, London WC1, England; [Gray, Glenda E.; Mkhize, Baningi; de Bruyn, Guy] Univ Witwatersrand, Perinatal HIV Res Unit, Johannesburg, South Africa; [Bekker, Linda-Gail; Roux, Surita] Univ Cape Town, Desmond Tutu HIV Fdn, ZA-7925 Cape Town, South Africa; [Nchabeleng, Maphoshane; Mathebula, Matsontso] Univ Limpopo, Med Univ S Africa Medunsa HIV Clin Res Unit, Pretoria, South Africa; [Mlisana, Koleka; Naicker, Nivashnee] Univ KwaZulu Natal, Ctr AIDS Programme Res S Africa CAPRISA, Durban, South Africa; [Kublin, James] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98104 USA	University of London; London School of Hygiene & Tropical Medicine; University of Witwatersrand; University of Cape Town; Sefako Makgatho Health Sciences University; University of Limpopo; University of Kwazulu Natal; Fred Hutchinson Cancer Center	Latka, MH (corresponding author), Aurum Inst, Johannesburg, South Africa.	mlatka@auruminstitute.org	Bekker, Linda-Gail/AAZ-8929-2020; Mlisana, Koleka/N-6204-2013	de Bruyn, Guy/0000-0002-8028-4474; BEKKER, LINDA-GAIL/0000-0002-0755-4386; Mlisana, Koleka/0000-0002-8436-3268; Churchyard, Gavin/0000-0002-4269-3699	National Institute of Allergy and Infectious Diseases; HVTN Foundation; South African AIDS Vaccine initiative (SAAVI); HVTN Leadership Core at the Fred Hutchinson Cancer Research Center [U01AI068614]; MRC [G0700837] Funding Source: UKRI; Medical Research Council [G0700837] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI068614, UM1AI068614, UM1AI069519] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); HVTN Foundation; South African AIDS Vaccine initiative (SAAVI); HVTN Leadership Core at the Fred Hutchinson Cancer Research Center; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	HVTN 503 is supported by grants from the National Institute of Allergy and Infectious Diseases, http://www.niaid.nih.gov, to the sites and HVTN Leadership Core based at the Fred Hutchinson Cancer Research Center (U01AI068614). Clinical care was supported through non-Federal sources, via the HVTN Foundation. The South African AIDS Vaccine initiative (SAAVI) provided support to the clinical trial sites. This study was conducted as a cooperative agreement where NIAID was involved in the development of the study design and reviewed drafts of this manuscript prior to publication. However, the opinions expressed in this article are those of the authors and do not represent the official views of the National Institute of Allergy and Infectious Diseases (NIAID).	Bello B, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-565; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Cao H, 2003, J INFECT DIS, V187, P887, DOI 10.1086/368020; Gray GE, 2011, LANCET INFECT DIS, V11, P507, DOI 10.1016/S1473-3099(11)70098-6; Halpern V, 2011, CONTRACEPTION, V83, P436, DOI 10.1016/j.contraception.2010.08.018; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Kibuuka H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005164; Padian NS, 2007, LANCET, V370, P251, DOI 10.1016/S0140-6736(07)60950-7; Peterson L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001312; Pitisuttithum P, 2009, THAIL AIDS VACC C PA; Ramjee G, 2008, JAIDS-J ACQ IMM DEF, V47, P93, DOI 10.1097/QAI.0b013e31815c71f7; Raymond EG, 2007, SEX TRANSM DIS, V34, P1035, DOI 10.1097/OLQ.0b013e3180e90586; Reid SE, 2010, JAIDS-J ACQ IMM DEF, V53, P606, DOI 10.1097/QAI.0b013e3181bc4869; Rerks-Ngarm S, 2009, THAILAND NEW ENG J M, V361, P1; Shisana O, 2009, S AFRICAN NATL HIV P; Sibeko S, 2011, OBSTET GYNECOL, V118, P895, DOI 10.1097/AOG.0b013e31822be512; Skoler S, 2006, MICROBICIDE Q, V1, P1; Skoler-Karpoff S, 2008, LANCET, V372, P1977, DOI 10.1016/S0140-6736(08)61842-5; Vallely A, 2010, PLOS ONE, V5, P1	19	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e31387	10.1371/journal.pone.0031387	http://dx.doi.org/10.1371/journal.pone.0031387			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22532824	gold, Green Published			2022-12-27	WOS:000305336200001
J	Monk, J; Ierodiaconou, D; Harvey, E; Rattray, A; Versace, VL				Monk, Jacquomo; Ierodiaconou, Daniel; Harvey, Euan; Rattray, Alex; Versace, Vincent L.			Are We Predicting the Actual or Apparent Distribution of Temperate Marine Fishes?	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; UNDERWATER VIDEO STATIONS; HABITAT-SUITABILITY; RELATIVE DENSITY; REEF FISHES; PERFORMANCE; BIODIVERSITY; BEHAVIOR; SYSTEM; DETECTABILITY	Planning for resilience is the focus of many marine conservation programs and initiatives. These efforts aim to inform conservation strategies for marine regions to ensure they have inbuilt capacity to retain biological diversity and ecological function in the face of global environmental change - particularly changes in climate and resource exploitation. In the absence of direct biological and ecological information for many marine species, scientists are increasingly using spatially-explicit, predictive-modeling approaches. Through the improved access to multibeam sonar and underwater video technology these models provide spatial predictions of the most suitable regions for an organism at resolutions previously not possible. However, sensible-looking, well-performing models can provide very different predictions of distribution depending on which occurrence dataset is used. To examine this, we construct species distribution models for nine temperate marine sedentary fishes for a 25.7 km(2) study region off the coast of southeastern Australia. We use generalized linear model (GLM), generalized additive model (GAM) and maximum entropy (MAXENT) to build models based on co-located occurrence datasets derived from two underwater video methods (i.e. baited and towed video) and fine-scale multibeam sonar based seafloor habitat variables. Overall, this study found that the choice of modeling approach did not considerably influence the prediction of distributions based on the same occurrence dataset. However, greater dissimilarity between model predictions was observed across the nine fish taxa when the two occurrence datasets were compared (relative to models based on the same dataset). Based on these results it is difficult to draw any general trends in regards to which video method provides more reliable occurrence datasets. Nonetheless, we suggest predictions reflecting the species apparent distribution (i.e. a combination of species distribution and the probability of detecting it). Consequently, we also encourage researchers and marine managers to carefully interpret model predictions.	[Monk, Jacquomo; Ierodiaconou, Daniel; Rattray, Alex] Deakin Univ, Fac Sci & Technol, Sch Life & Environm Sci, Warrnambool, Vic, Australia; [Harvey, Euan] Univ Western Australia, Sch Plant Biol, Oceans Inst M470, Crawley, WA, Australia; [Versace, Vincent L.] Deakin Univ, Sch Informat Syst, Fac Business & Law, Warrnambool, Vic, Australia	Deakin University; University of Western Australia; Deakin University	Monk, J (corresponding author), Deakin Univ, Fac Sci & Technol, Sch Life & Environm Sci, Warrnambool, Vic, Australia.	jacquomo.monk@deakin.edu.au	Ierodiaconou, Daniel A/B-9915-2008; Rattray, Alex J/I-8172-2012; Harvey, Euan/B-2896-2011; Monk, Jacquomo/C-6856-2011; Versace, Vincent/AAL-6418-2021	Harvey, Euan/0000-0002-9069-4581; Monk, Jacquomo/0000-0002-1874-0619; Versace, Vincent/0000-0002-8514-1763; Ierodiaconou, Daniel/0000-0002-7832-4801; Rattray, Alex/0000-0002-8591-6688	National Heritage Trust/Caring for our Country and Parks Victoria as part of the Victorian Marine Habitat Mapping Project	National Heritage Trust/Caring for our Country and Parks Victoria as part of the Victorian Marine Habitat Mapping Project	This work was supported by the National Heritage Trust/Caring for our Country and Parks Victoria as part of the Victorian Marine Habitat Mapping Project. The funders had no role in data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Aswani S, 2006, ENVIRON CONSERV, V33, P263, DOI 10.1017/S0376892906003183; Austin M, 2007, ECOL MODEL, V200, P1, DOI 10.1016/j.ecolmodel.2006.07.005; BARRETT NS, 1995, MAR FRESHWATER RES, V46, P853, DOI 10.1071/MF9950853; Bozec YM, 2011, MAR BIOL, V158, P969, DOI 10.1007/s00227-011-1623-9; Breiman L, 2001, STAT SCI, V16, P199, DOI 10.1214/ss/1009213726; Cappo M, 2004, J EXP MAR BIOL ECOL, V302, P123, DOI 10.1016/j.jembe.2003.10.006; Cappo M, 2001, USE BAITED REMOTE UN, P63; Colton MA, 2010, MAR ECOL PROG SER, V400, P19, DOI 10.3354/meps08377; Dormann CF, 2007, GLOBAL ECOL BIOGEOGR, V16, P774, DOI 10.1111/j.1466-8238.2007.00344.x; Edgar G, 2000, AUSTR MARINE LIFE PL; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Engler R, 2004, J APPL ECOL, V41, P263, DOI 10.1111/j.0021-8901.2004.00881.x; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Gibson L, 2007, DIVERS DISTRIB, V13, P704, DOI 10.1111/j.1472-4642.2007.00365.x; Godo OR, 1997, ICES J MAR SCI, V54, P273, DOI 10.1006/jmsc.1996.0167; Gomon M., 2008, FISHES AUSTR S COAST; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Harris PT, 2009, OCEAN COAST MANAGE, V52, P22, DOI 10.1016/j.ocecoaman.2008.09.009; Harvey E, 1995, MAR TECHNOL SOC J, V29, P10; Harvey ES, 1998, MAR TECHNOL SOC J, V32, P3; Harvey ES, 2007, MAR ECOL PROG SER, V350, P245, DOI 10.3354/meps07192; HASTIE T, 2008, GAM GEN ADDITIVE MOD; Hirzel AH, 2001, ECOL MODEL, V145, P111, DOI 10.1016/S0304-3800(01)00396-9; Ierodiaconou D, 2007, J SPAT SCI, V52, P93, DOI 10.1080/14498596.2007.9635105; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jordan A, 2005, AQUAT CONSERV, V15, P51, DOI 10.1002/aqc.657; Kadmon R, 2003, ECOL APPL, V13, P853, DOI 10.1890/1051-0761(2003)013[0853:ASAOFA]2.0.CO;2; Kery M, 2008, COMMUNITY ECOL, V9, P207, DOI 10.1556/ComEc.9.2008.2.10; Kery M, 2010, J BIOGEOGR, V37, P1851, DOI 10.1111/j.1365-2699.2010.02345.x; Kulbicki M, 1999, AQUAT LIVING RESOUR, V12, P315, DOI 10.1016/S0990-7440(99)00116-3; Langlois TJ, 2012, GLOBAL ECOL BIOGEOGR, V21, P886, DOI 10.1111/j.1466-8238.2011.00734.x; Leathwick JR, 2006, ECOL MODEL, V199, P188, DOI 10.1016/j.ecolmodel.2006.05.022; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; MacNeill MA, 2008, MAR ECOL PROG SER, V367, P249, DOI 10.3354/meps07580; Moisen GG, 2002, ECOL MODEL, V157, P209, DOI 10.1016/S0304-3800(02)00197-7; Monk J, 2011, CONT SHELF RES, V31, pS17, DOI 10.1016/j.csr.2010.02.012; Monk J, 2010, MAR ECOL PROG SER, V420, P157, DOI 10.3354/meps08858; Moore CH, 2010, MAR BIOL, V157, P2717, DOI 10.1007/s00227-010-1531-4; Moore CH, 2009, ICES J MAR SCI, V66, P2068, DOI 10.1093/icesjms/fsp205; Murphy HM, 2010, MAR FRESHWATER RES, V61, P236, DOI 10.1071/MF09068; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pittman SJ, 2009, J COASTAL RES, V25, P27, DOI [10.2112/SI53-004.1, 10.2112/S153-004.1]; Popper AN, 2009, J FISH BIOL, V75, P455, DOI 10.1111/j.1095-8649.2009.02319.x; R Core Development Team, 2008, R LANG ENV STAT COMP; Ready J, 2010, ECOL MODEL, V221, P467, DOI 10.1016/j.ecolmodel.2009.10.025; Roubicek AJ, 2010, ECOL MODEL, V221, P2280, DOI 10.1016/j.ecolmodel.2010.06.021; Sara G, 2007, MAR ECOL PROG SER, V331, P243, DOI 10.3354/meps331243; Segurado P, 2004, J BIOGEOGR, V31, P1555, DOI 10.1111/j.1365-2699.2004.01076.x; Sergio C, 2007, BIOL CONSERV, V135, P341, DOI 10.1016/j.biocon.2006.10.018; Stoner AW, 2008, CAN J FISH AQUAT SCI, V65, P1230, DOI 10.1139/F08-032; Stoner AW, 2007, J SEA RES, V57, P137, DOI 10.1016/j.seares.2006.08.005; Thomsen Bjarti, 2010, P143, DOI 10.1002/9780813810966.ch6; Tsoar A, 2007, DIVERS DISTRIB, V13, P397, DOI 10.1111/j.1472-4642.2007.00346.x; Tyre AJ, 2003, ECOL APPL, V13, P1790, DOI 10.1890/02-5078; Vanderklift M. A., 2000, Pacific Conservation Biology, V6, P152; VanDerWal J, 2009, ECOL MODEL, V220, P589, DOI 10.1016/j.ecolmodel.2008.11.010; Ward G, 2009, BIOMETRICS, V65, P554, DOI 10.1111/j.1541-0420.2008.01116.x; Ward TJ, 1999, ECOL APPL, V9, P691; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Watson D.L, 2006, THESIS U W AUSTR; Watson DL, 2010, MAR BIOL, V157, P1237, DOI 10.1007/s00227-010-1404-x; Watson DL, 2005, MAR BIOL, V148, P415, DOI 10.1007/s00227-005-0090-6; Willis TJ, 2000, MAR FRESHWATER RES, V51, P755, DOI 10.1071/MF00010; Willis TJ, 2006, J EXP MAR BIOL ECOL, V331, P108, DOI 10.1016/j.jembe.2005.10.003; Willis TJ, 2000, MAR ECOL PROG SER, V198, P249, DOI 10.3354/meps198249; Wilson MFJ, 2007, MAR GEOD, V30, P3, DOI 10.1080/01490410701295962; Wintle BA, 2005, J WILDLIFE MANAGE, V69, P905, DOI 10.2193/0022-541X(2005)069[0905:EADWDI]2.0.CO;2; Wisz Mary S., 2009, BMC Ecology, V9, P8, DOI 10.1186/1472-6785-9-8; Zacharias MA, 2005, CONSERV BIOL, V19, P86, DOI 10.1111/j.1523-1739.2005.00148.x	74	33	33	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e34558	10.1371/journal.pone.0034558	http://dx.doi.org/10.1371/journal.pone.0034558			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22536325	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336200007
J	Nel, A; Mabude, Z; Smit, J; Kotze, P; Arbuckle, D; Wu, J; van Niekerk, N; van de Wijgert, J				Nel, Annalene; Mabude, Zonke; Smit, Jenni; Kotze, Philip; Arbuckle, Derek; Wu, Jian; van Niekerk, Neliette; van de Wijgert, Janneke			HIV Incidence Remains High in KwaZulu-Natal, South Africa: Evidence from Three Districts	PLOS ONE			English	Article							PREVALENCE; SURVEILLANCE; INFECTION; ASSAY	Background: HIV prevalence and incidence among sexually active women in peri-urban areas of Ladysmith, Edendale, and Pinetown, KwaZulu-Natal, South Africa, were assessed between October 2007 and February 2010 in preparation for vaginal microbicide trials. Methodology/Principal Findings: Sexually active women 18-35 years, not known to be HIV-positive or pregnant were tested cross-sectionally to determine HIV and pregnancy prevalence (798 in Ladysmith, 1,084 in Edendale, and 891 in Pinetown). Out of these, approximately 300 confirmed non-pregnant, HIV-negative women were subsequently enrolled at each clinical research center (CRC) in a 12-month cohort study with quarterly study visits. Women in the cohort studies were required to use a condom plus a hormonal contraceptive method. HIV prevalence rates in the baseline cross-sectional surveys were high: 42% in Ladysmith, 46% in Edendale and 41% in Pinetown. Around 90% of study participants at each CRC reported one sex partner in the last 3 months, but only 14-30% stated that they were sure that none of their sex partners were HIV-positive. HIV incidence rates based on seroconversions over 12 months were 14.8/100 person-years (PY) (95% CI 9.7, 19.8) in Ladysmith, 6.3/100 PY (95% CI 3.2, 9.4) in Edendale, and 7.2/100 PY (95% CI 3.7, 10.7) in Pinetown. The 12-month pregnancy incidence rates (in the context of high reported contraceptive use) were: 5.7/100 PY (95% CI 2.6, 8.7) in Ladysmith, 3.1/100 PY (95% CI 0.9, 5.2) in Edendale and 6.3/100 PY (95% CI 3.0, 9.6) in Pinetown. Conclusions/Significance: HIV prevalence and incidence remain high in peri-urban areas of KwaZulu-Natal.	[Nel, Annalene] Int Partnership Microbicides, Silver Spring, MD USA; [Mabude, Zonke; Smit, Jenni] Univ Witwatersrand Durban, MatCH, Dept Obstet & Gynecol, Kwa Zulu, South Africa; [Kotze, Philip] Qhakaza Mbokodo Res Clin, Ladysmith, Kwazulu Natal, South Africa; [Arbuckle, Derek] PHIVA Project, Pinetown, Kwazulu Natal, South Africa; [Wu, Jian] JW Consulting, Hurstville Grove, NSW, Australia; [Mabude, Zonke; Smit, Jenni; van Niekerk, Neliette] Int Partnership Microbicides, Paarl, Western Cape, South Africa; [van de Wijgert, Janneke] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [van de Wijgert, Janneke] Amsterdam Inst Global Hlth & Dev, Amsterdam, Netherlands	University of Witwatersrand; University of Amsterdam; Academic Medical Center Amsterdam	Nel, A (corresponding author), Int Partnership Microbicides, Silver Spring, MD USA.	j.vandewijgert@amc-cpcd.org		van de Wijgert, Janneke H.H.M./0000-0003-2728-4560; kotze, Paulo Gustavo/0000-0002-2053-5315; Kotze, Philip/0000-0003-1346-7833				[Anonymous], 2011, US ASS REC INF EST H; [Anonymous], 2009, S AFRICAN NATL HIV P; Barnighausen T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003640; Braunstein SL, 2009, AIDS REV, V11, P140; Department of Health, 2011, 2010 NAT ANT SENT HI; Department of Health, 2010, NAT ANT SENT HIV SYP; Ghys PD, 2006, SEX TRANSM INFECT, V82, pI52, DOI 10.1136/sti.2005.016428; Hargrove JW, 2008, AIDS, V22, P511, DOI 10.1097/QAD.0b013e3282f2a960; Karim QA, 2011, INT J EPIDEMIOL, V40, P922, DOI 10.1093/ije/dyq176; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; McWalter TA, 2010, J MATH BIOL, V60, P687, DOI 10.1007/s00285-009-0282-7; National Department of Health, 2008, 1 LIN COMPR MAN CONT, P1; Parekh BS, 2002, AIDS RES HUM RETROV, V18, P295, DOI 10.1089/088922202753472874; Pettifor AE, 2005, AIDS, V19, P1525, DOI 10.1097/01.aids.0000183129.16830.06; Tanser F, 2011, LANCET, V378, P247, DOI 10.1016/S0140-6736(11)60779-4; UNAIDS, 2010, UNAIDS REP GLOB AIDS; Welz T, 2007, CONTINUED VERY HIGH; WHO Department of Reproductive Health, 2010, MED EL CRIT CONTR US	18	38	38	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e35278	10.1371/journal.pone.0035278	http://dx.doi.org/10.1371/journal.pone.0035278			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22536364	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336200031
J	Perry, LE; Pannell, JR; Dorken, ME				Perry, Laura E.; Pannell, John R.; Dorken, Marcel E.			Two's Company, Three's a Crowd: Experimental Evaluation of the Evolutionary Maintenance of Trioecy in Mercurialis annua (Euphorbiaceae)	PLOS ONE			English	Article							PACHYCEREUS-PRINGLEI CACTACEAE; INBREEDING DEPRESSION; POLLEN LIMITATION; SEXUAL SYSTEMS; ANNUAL PLANT; ANDRODIOECY; DIOECY; POPULATION; GYNODIOECY; ALLOCATION	Trioecy is an uncommon sexual system in which males, females, and hermaphrodites co-occur as three clearly different gender classes. The evolutionary stability of trioecy is unclear, but would depend on factors such as hermaphroditic sex allocation and rates of outcrossing vs. selfing. Here, trioecious populations of Mercurialis annua are described for the first time. We examined the frequencies of females, males and hermaphrodites across ten natural populations and evaluated the association between the frequency of females and plant densities. Previous studies have shown that selfing rates in this species are density-dependent and are reduced in the presence of males, which produce substantially more pollen than hermaphrodites. Accordingly, we examined the evolutionary stability of trioecy using an experiment in which we (a) indirectly manipulated selfing rates by altering plant densities and the frequency of males in a fully factorial manner across 20 experimental plots and (b) examined the effect of these manipulations on the frequency of the three sex phenotypes in the next generation of plants. In the parental generation, we measured the seed and pollen allocations of hermaphrodites and compared them with allocations by unisexual plants. In natural populations, females occurred at higher frequencies in denser patches, a finding consistent with our expectations. Under our experimental conditions, however, no combination of plant densities and male frequencies was associated with increased frequencies of females. Our results suggest that the factors that regulate female frequencies in trioecious populations of M. annua are independent of those regulating male frequencies (density), and that the stable co-existence of all three sex phenotypes within populations is unlikely.	[Perry, Laura E.; Dorken, Marcel E.] Trent Univ, Dept Biol, Peterborough, ON K9J 7B8, Canada; [Pannell, John R.] Univ Oxford, Dept Plant Sci, Oxford, England; [Pannell, John R.] Univ Lausanne, Dept Ecol & Evolut, Lausanne, Switzerland	Trent University; University of Oxford; University of Lausanne	Perry, LE (corresponding author), Trent Univ, Dept Biol, Peterborough, ON K9J 7B8, Canada.	marceldorken@trentu.ca		Pannell, John/0000-0002-0098-7074	Natural Sciences and Engineering Research Council of Canada (NSERC)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	The work was funded by the Natural Sciences and Engineering Research Council of Canada (NSERC) through a Discovery Grant to MED. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashman T. L., 2006, ECOLOGY EVOLUTION FL, P204; Bailey MF, 2007, OIKOS, V116, P1609, DOI 10.1111/j.0030-1299.2007.15315.x; Bates D., 2011, PACKAGE LME4 LINEAR, V1; CHARLESWORTH B, 1978, AM NAT, V112, P975, DOI 10.1086/283342; Charlesworth D, 2002, HEREDITY, V88, P94, DOI 10.1038/sj.hdy.6800016; Charlesworth D., 1999, GENDER SEXUAL DIMORP, P33, DOI [10.1007/978-3-662-03908-3_2, DOI 10.1007/978-3-662-03908-3_2]; CHARNOV E L, 1982; Crawley M.J., 2007, R BOOK; Darwin C, 1877, EFFECTS CROSS SELF F; DELPH LF, 1990, ECOLOGY, V71, P1342, DOI 10.2307/1938271; Delph LF, 2007, TRENDS ECOL EVOL, V22, P17, DOI 10.1016/j.tree.2006.09.013; Dorken ME, 2008, AM NAT, V171, P824, DOI 10.1086/587524; Dorken ME, 2008, EVOLUTION, V62, P971, DOI 10.1111/j.1558-5646.2008.00336.x; Dorken ME, 2009, CURR BIOL, V19, P620, DOI 10.1016/j.cub.2009.03.042; Durand B, 1963, ANN SCI NAT BOT BIOL, V12, P579, DOI DOI 10.1080/01811797.1992.10824974; Eppley SM, 2009, HEREDITY, V102, P600, DOI 10.1038/hdy.2009.21; Eppley SM, 2007, EVOLUTION, V61, P2349, DOI 10.1111/j.1558-5646.2007.00195.x; Fleming TH, 1998, EVOL ECOL, V12, P279, DOI 10.1023/A:1006548132606; FLEMING TH, 1994, AM J BOT, V81, P858, DOI 10.2307/2445767; Hesse E, 2011, J ECOL, V99, P1531, DOI 10.1111/j.1365-2745.2011.01880.x; LLOYD DG, 1975, GENETICA, V45, P325, DOI 10.1007/BF01508307; LLOYD DG, 1974, HEREDITY, V32, P11, DOI 10.1038/hdy.1974.2; Lopez S, 2003, J EVOLUTION BIOL, V16, P1177, DOI 10.1046/j.1420-9101.2003.00622.x; MAURICE S, 1995, OIKOS, V74, P55, DOI 10.2307/3545674; Obbard DJ, 2006, AM NAT, V167, P354, DOI 10.1086/499546; Pannell J, 1997, BIOL J LINN SOC, V61, P95, DOI 10.1006/bijl.1996.0117; Pannell J, 1997, HEREDITY, V78, P50, DOI 10.1038/hdy.1997.6; Pannell J, 1997, J ECOL, V85, P57, DOI 10.2307/2960627; Pannell JR, 2008, GENET RES, V90, P73, DOI 10.1017/S0016672307008981; Pannell JR, 2008, INT J PLANT SCI, V169, P129, DOI 10.1086/523360; Pannell JR, 2002, ANNU REV ECOL SYST, V33, P397, DOI 10.1146/annurev.ecolsys.33.010802.150419; Pannell JR, 2004, BIOL J LINN SOC, V82, P547, DOI 10.1111/j.1095-8312.2004.00340.x; Pannell JR, 2000, PHILOS T R SOC B, V355, P1851, DOI 10.1098/rstb.2000.0740; PINHEIRO JC, 2011, NLME LINEAR NONLINEA, V3, P1, DOI DOI 10.1371/J0URNAL.P0NE.0018860; Pujol B, 2009, P NATL ACAD SCI USA, V106, P15379, DOI 10.1073/pnas.0902257106; R Core Team, 2020, R LANG ENV STAT COMP; RENNER SS, 1995, AM J BOT, V82, P596, DOI 10.2307/2445418; Sokal RR, 1995, BIOMETRY; Tutin T.G., 1968, FLORA EUROPAEA, V2, P368; Venables WN., 2002, MODERN APPL STAT S 4; Webb C.J., 1999, GENDER SEXUAL DIMORP, P61, DOI DOI 10.1007/978-3-662-03908-3_3; Weiblen GD, 2000, AM NAT, V155, P46, DOI 10.1086/303303; Whitlock MC, 1997, GENETICS, V146, P427; Wolf DE, 2004, AM NAT, V163, P122, DOI 10.1086/380493; Wright S, 1940, AM NAT, V74, P232, DOI 10.1086/280891	45	7	7	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e35597	10.1371/journal.pone.0035597	http://dx.doi.org/10.1371/journal.pone.0035597			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22532862	gold, Green Published, Green Submitted			2022-12-27	WOS:000305336200061
J	Emmert-Streib, F				Emmert-Streib, Frank			Limitations of Gene Duplication Models: Evolution of Modules in Protein Interaction Networks	PLOS ONE			English	Article							TRANSCRIPTIONAL REGULATORY NETWORK; COMMUNITY STRUCTURE; GENOME DUPLICATION; MODULARITY; DYNAMICS; BIOLOGY; IDENTIFICATION; COMPLEXITY; EMERGENCE; ALGORITHM	It has been generally acknowledged that the module structure of protein interaction networks plays a crucial role with respect to the functional understanding of these networks. In this paper, we study evolutionary aspects of the module structure of protein interaction networks, which forms a mesoscopic level of description with respect to the architectural principles of networks. The purpose of this paper is to investigate limitations of well known gene duplication models by showing that these models are lacking crucial structural features present in protein interaction networks on a mesoscopic scale. This observation reveals our incomplete understanding of the structural evolution of protein networks on the module level.	Queens Univ Belfast, Sch Med Dent & Biomed Sci, Computat Biol & Machine Learning Lab, Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland	Queens University Belfast	Emmert-Streib, F (corresponding author), Queens Univ Belfast, Sch Med Dent & Biomed Sci, Computat Biol & Machine Learning Lab, Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland.	v@bio-complexity.com	Emmert-Streib, Frank/G-8099-2011; Emmert-Streib, Frank/AAF-2878-2020	Emmert-Streib, Frank/0000-0003-0745-5641; Emmert-Streib, Frank/0000-0003-0745-5641	Department for Employment and Learning through its "Strengthening the all-Island Research Base" initiative	Department for Employment and Learning through its "Strengthening the all-Island Research Base" initiative	Parts of this project are supported by the Department for Employment and Learning through its "Strengthening the all-Island Research Base" initiative. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], ANAL COMPLEX NETWORK; [Anonymous], HDB GRAPHS NETWORKS; [Anonymous], TAXONOMY NETWORKS AR; [Anonymous], [No title captured]; [Anonymous], NUCL ACIDS RES; [Anonymous], MULTIVARIATE ANAL; Babu MM, 2004, CURR OPIN STRUC BIOL, V14, P283, DOI 10.1016/j.sbi.2004.05.004; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Berg J, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-51; Breitkreutz BJ, 2008, NUCLEIC ACIDS RES, V36, pD637, DOI 10.1093/nar/gkm1001; Cerami E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008918; Chung F, 2003, J COMPUT BIOL, V10, P677, DOI 10.1089/106652703322539024; Ciliberti S, 2007, PLOS COMPUT BIOL, V3, P164, DOI 10.1371/journal.pcbi.0030015; Csardi G, 2008, IGRAPH PACKAGE; Danon L, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/09/P09008; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Dehmer M, 2011, INFORM SCIENCES, V181, P57, DOI 10.1016/j.ins.2010.08.041; Dehmer M, 2009, J CHEM INF MODEL, V49, P1655, DOI 10.1021/ci900060x; del Sol A, 2007, PLOS COMPUT BIOL, V3, P2446, DOI 10.1371/journal.pcbi.0030239; Dobzhansky T., 1937; Durrett R, 2006, RANDOM GRAPH DYNAMIC; Emmert-Streib F, 2006, J COMPUT BIOL, V13, P1503, DOI 10.1089/cmb.2006.13.1503; Emmert-Streib F, 2011, WIRES SYST BIOL MED, V3, P379, DOI 10.1002/wsbm.134; Emmert-Streib F, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-35; Emmert-Streib F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-237; Evlampiev K, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-49; Felsenstein J, 2004, INFERRING PHYLOGENIE; Fernandez E, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.27; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Futuyma D. J., 2005, EVOLUTION; Gould SJ, 2002, STRUCTURE EVOLUTIONA; Hallinan J, 2004, BIOSYSTEMS, V74, P51, DOI 10.1016/j.biosystems.2004.02.004; HIGGINS DG, 1988, GENE, V73, P237, DOI 10.1016/0378-1119(88)90330-7; Hoaglin D.C., 1983, UNDERSTANDING ROBUST; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; Ispolatov I, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.061911; Ispolatov I, 2006, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2006/09/P09014; Izenman AJ, 2008, SPRINGER TEXTS STAT, P1, DOI 10.1007/978-0-387-78189-1_1; Kim WK, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000232; Klebanov L, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-9; Koonin EV, 2006, CURR OPIN BIOTECH, V17, P481, DOI 10.1016/j.copbio.2006.08.003; Koonin EV, 2003, SEQUENCE EVOLUTION F; Lancichinetti A, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.046110; Lehman E. L., 2005, TESTING STAT HYPOTHE, V3rd; Levy ED, 2008, CURR OPIN STRUC BIOL, V18, P349, DOI 10.1016/j.sbi.2008.03.003; Lozano S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001892; Lynch M, 2001, GENETICS, V159, P1789; Lynch M, 2007, ORIGINS GENOME ARCHI; Ma HW, 2004, NUCLEIC ACIDS RES, V32, P6643, DOI 10.1093/nar/gkh1009; Mayr E, 1976, EVOLUTION DIVERSITY; MCQUITTY LL, 1966, EDUC PSYCHOL MEAS, V26, P825, DOI 10.1177/001316446602600402; Middendorf M., 2005, P NATL ACAD SCI USA, V102, p3192 3197, DOI DOI 10.1073/pnas.0409515102; MOWSHOWITZ A, 1968, B MATH BIOPHYS, V30, P175, DOI 10.1007/BF02476948; MOWSHOWITZ A, 1968, B MATH BIOPHYS, V30, P225, DOI 10.1007/BF02476692; MUSHEGIAN A, 2007, FDN COMP GENOMICS; Newman MEJ, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036104; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066133; Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898; Otto SP, 2000, ANNU REV GENET, V34, P401, DOI 10.1146/annurev.genet.34.1.401; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Plachetzki DC, 2007, INTEGR COMP BIOL, V47, P759, DOI 10.1093/icb/icm050; Popper K.R., 1959, LOGIC SCI DISCOVERY; Przulj N, 2004, BIOINFORMATICS, V20, P3508, DOI 10.1093/bioinformatics/bth436; R Core Team, 2018, R LANG ENV STAT COMP; Ratmann O, 2009, HFSP J, V3, P290, DOI 10.2976/1.3167215; Rosvall M, 2007, P NATL ACAD SCI USA, V104, P7327, DOI 10.1073/pnas.0611034104; Shannon C. E., 1949, MATH THEORY COMMUNIC; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Sole RV, 2008, J R SOC INTERFACE, V5, P129, DOI 10.1098/rsif.2007.1108; SOLOMONOFF RAY, 1951, BULL MATH BIOPHYS, V13, P107, DOI 10.1007/BF02478357; Stouffer DB, 2011, P NATL ACAD SCI USA, V108, P3648, DOI 10.1073/pnas.1014353108; Thorne T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-467; Todeschini R., 2002, HDB MOL DESCRIPTORS; Vazquez Alexei, 2003, ComPlexUs, V1, P38, DOI 10.1159/000067642; Wagner A, 2003, P ROY SOC B-BIOL SCI, V270, P457, DOI 10.1098/rspb.2002.2269; Wagner A, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-231; Wagner GP., 2005, ROBUSTNESS EVOLVABIL; Wagner GP, 2007, NAT REV GENET, V8, P921, DOI 10.1038/nrg2267; Wang XW, 2008, CURR OPIN BIOTECH, V19, P482, DOI 10.1016/j.copbio.2008.07.011; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Yoon J, 2006, BIOINFORMATICS, V22, P3106, DOI 10.1093/bioinformatics/btl533; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Ziv E, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.046117	86	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35531	10.1371/journal.pone.0035531	http://dx.doi.org/10.1371/journal.pone.0035531			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22530042	Green Published, Green Submitted, gold			2022-12-27	WOS:000305350600095
J	Kabgani, N; Grigoleit, T; Schulte, K; Sechi, A; Sauer-Lehnen, S; Tag, C; Boor, P; Kuppe, C; Warsow, G; Schordan, S; Mostertz, J; Chilukoti, RK; Homuth, G; Endlich, N; Tacke, F; Weiskirchen, R; Fuellen, G; Endlich, K; Floege, J; Smeets, B; Moeller, MJ				Kabgani, Nazanin; Grigoleit, Tamara; Schulte, Kevin; Sechi, Antonio; Sauer-Lehnen, Sibille; Tag, Carmen; Boor, Peter; Kuppe, Christoph; Warsow, Gregor; Schordan, Sandra; Mostertz, Joerg; Chilukoti, Ravi Kumar; Homuth, Georg; Endlich, Nicole; Tacke, Frank; Weiskirchen, Ralf; Fuellen, Georg; Endlich, Karlhans; Floege, Juergen; Smeets, Bart; Moeller, Marcus J.			Primary Cultures of Glomerular Parietal Epithelial Cells or Podocytes with Proven Origin	PLOS ONE			English	Article							FOCAL SEGMENTAL GLOMERULOSCLEROSIS; TRANSGENIC MICE; MURINE MODEL; EXPRESSION; GLOMERULONEPHRITIS; CRESCENTS; MOUSE; RATS	Parietal epithelial cells (PECs) are crucially involved in the pathogenesis of rapidly progressive glomerulonephritis (RPGN) as well as in focal and segmental glomerulosclerosis (FSGS). In this study, transgenic mouse lines were used to isolate pure, genetically tagged primary cultures of PECs or podocytes using FACsorting. By this approach, the morphology of primary glomerular epithelial cells in culture could be resolved: Primary podocytes formed either large cells with intracytoplasmatic extensions or smaller spindle shaped cells, depending on specific culture conditions. Primary PECs were small and exhibited a spindle-shaped or polygonal morphology. In the very early phases of primary culture, rapid changes in gene expression (e. g. of WT-1 and Pax-2) were observed. However, after prolonged culture primary PECs and podocytes still segregated clearly in a transcriptome analysis - demonstrating that the origin of primary cell cultures is important. Of the classical markers, synaptopodin and podoplanin expression were differentially regulated the most in primary PEC and podocyte cultures. However, no expression of any endogenous gene allowed to differentiate between the two cell types in culture. Finally, we show that the transcription factor WT1 is also expressed by PECs. In summary, genetic tagging of PECs and podocytes is a novel and necessary tool to derive pure primary cultures with proven origin. These cultures will be a powerful tool for the emerging field of parietal epithelial cell biology.	[Kabgani, Nazanin; Grigoleit, Tamara; Schulte, Kevin; Kuppe, Christoph; Floege, Juergen; Smeets, Bart; Moeller, Marcus J.] Aachen Univ Technol RWTH, Univ Hosp, Div Nephrol & Immunol, Aachen, Germany; [Sechi, Antonio] Aachen Univ Technol RWTH, Univ Hosp, Dept Cell Biol, Aachen, Germany; [Sauer-Lehnen, Sibille; Tag, Carmen; Tacke, Frank] Aachen Univ Technol RWTH, Univ Hosp, Div Gastroenterol, Aachen, Germany; [Sauer-Lehnen, Sibille; Tag, Carmen; Weiskirchen, Ralf] Comenius Univ, Inst Clin Chem & Pathobiochem, Bratislava, Slovakia; [Boor, Peter] Comenius Univ, Inst Pathol, Bratislava, Slovakia; [Boor, Peter] Comenius Univ, Inst Mol Biomed, Bratislava, Slovakia; [Warsow, Gregor; Fuellen, Georg] Univ Rostock, Inst Biostat & Informat Med & Ageing Res, Rostock, Germany; [Warsow, Gregor] Ernst Moritz Arndt Univ Greifswald, Dept Math & Informat, Greifswald, Germany; [Warsow, Gregor; Schordan, Sandra; Endlich, Nicole; Endlich, Karlhans] Univ Med Greifswald, Dept Anat & Cell Biol, Greifswald, Germany; [Mostertz, Joerg; Chilukoti, Ravi Kumar; Homuth, Georg] Ernst Moritz Arndt Univ Greifswald, Dept Funct Genom, Interfac Inst Genet, Greifswald, Germany	RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; RWTH Aachen University Hospital; Comenius University Bratislava; Comenius University Bratislava; Comenius University Bratislava; University of Rostock; Ernst Moritz Arndt Universitat Greifswald; Greifswald Medical School; Ernst Moritz Arndt Universitat Greifswald	Kabgani, N (corresponding author), Aachen Univ Technol RWTH, Univ Hosp, Div Nephrol & Immunol, Aachen, Germany.	mmoeller@ukaachen.de	Boor, Peter/C-7707-2011; Weiskirchen, Ralf/O-1734-2018; Endlich, Karlhans/G-5485-2013; Moeller, Marcus J/L-1836-2015; Smeets, Bart/D-5179-2014; Kuppe, Christoph/ABF-8873-2020; Kuppe, Christoph/ABD-4882-2021; Tacke, Frank/ABF-2212-2020; Sechi, Antonio S/A-5595-2009	Boor, Peter/0000-0001-9921-4284; Weiskirchen, Ralf/0000-0003-3888-0931; Smeets, Bart/0000-0002-8466-3367; Kuppe, Christoph/0000-0003-4597-9833; Sechi, Antonio S/0000-0002-1374-1794; Endlich, Karlhans/0000-0001-6052-6061	German Research Foundation (DFG) [TP17, SFB/Transregio 57]; German Ministry for Science and Education (BMBF) [01 GN 0805, 01 GN 0901, 01 GN 0804]; Genzyme Renal Innovation Program (GRIP); Netherlands Organization for Scientific Research (NWO) [2007/09196/ALW]; NephCure Foundation [F001]	German Research Foundation (DFG)(German Research Foundation (DFG)); German Ministry for Science and Education (BMBF)(Federal Ministry of Education & Research (BMBF)); Genzyme Renal Innovation Program (GRIP); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); NephCure Foundation	This work was supported by TP17 and the Q3 central platform SFB/Transregio 57 of the German Research Foundation (DFG to MJM, FT, RW), the German Ministry for Science and Education (BMBF, 01 GN 0805, 01 GN 0901 and 01 GN 0804 to KE, GF and MJM), the Genzyme Renal Innovation Program (GRIP, to BS), and the Netherlands Organization for Scientific Research (NWO) (2007/09196/ALW, to BS). Furthermore, this work received support from the NephCure Foundation (F001 to MJM and BS). FT, RW, JF, MJM are members of the SFB/Transregio 57 DFG consortium "Mechanisms of organ fibrosis.'' The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appel D, 2009, J AM SOC NEPHROL, V20, P333, DOI 10.1681/ASN.2008070795; Brinkkoetter PT, 2010, CELL CYCLE, V9, P1729, DOI 10.4161/cc.9.9.11471; Chittiprol S, 2011, AM J PHYSL RENAL PHY; Dijkman H, 2005, KIDNEY INT, V68, P1562, DOI 10.1111/j.1523-1755.2005.00568.x; Ding M, 2006, NAT MED, V12, P1081, DOI 10.1038/nm1460; KRIZ W, 1995, KIDNEY INT, V48, P1435, DOI 10.1038/ki.1995.433; Krtil J, 2007, KIDNEY BLOOD PRESS R, V30, P162, DOI 10.1159/000102520; Le Hir M, 2003, KIDNEY INT, V63, P591, DOI 10.1046/j.1523-1755.2003.00782.x; Matsusaka T, 2005, J AM SOC NEPHROL, V16, P1013, DOI 10.1681/ASN.2004080720; Moeller MJ, 2004, J AM SOC NEPHROL, V15, P61, DOI 10.1097/01.ASN.0000102468.37809.C6; Moeller MJ, 2003, GENESIS, V35, P39, DOI 10.1002/gene.10164; Moeller MJ, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000015614.68893.0B; Mundel P, 1997, J AM SOC NEPHROL, V8, P697; Ohse T, 2008, J AM SOC NEPHROL, V19, P1879, DOI 10.1681/ASN.2007101087; PABST R, 1983, KIDNEY INT, V24, P626, DOI 10.1038/ki.1983.203; Reidy KJ, 2009, SEMIN NEPHROL, V29, P321, DOI 10.1016/j.semnephrol.2009.03.009; Ronconi E, 2009, J AM SOC NEPHROL, V20, P322, DOI 10.1681/ASN.2008070709; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Sasaki Tamaki, 1994, Medical Electron Microscopy, V27, P49, DOI 10.1007/BF02348228; Shigehara T, 2003, J AM SOC NEPHROL, V14, P1998, DOI 10.1681/ASN.V1481998; Smeets B, 2011, J AM SOC NEPHROL, V22, P1262, DOI 10.1681/ASN.2010090970; Smeets B, 2009, J AM SOC NEPHROL, V20, P2604, DOI 10.1681/ASN.2009010122; Thorner PS, 2008, J AM SOC NEPHROL, V19, P495, DOI 10.1681/ASN.2006101115; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; WEINSTEIN T, 1992, J AM SOC NEPHROL, V3, P1279; Yaoita E, 2002, MICROSC RES TECHNIQ, V57, P212, DOI 10.1002/jemt.10075; Yaoita E, 2001, CELL TISSUE RES, V304, P339; Yu DH, 2005, J AM SOC NEPHROL, V16, P1733, DOI 10.1681/ASN.2005020159	29	46	50	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e34907	10.1371/journal.pone.0034907	http://dx.doi.org/10.1371/journal.pone.0034907			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529955	Green Published, Green Submitted, gold			2022-12-27	WOS:000305350600041
J	Muller, P; Chikkaballi, D; Hensel, M				Muller, Petra; Chikkaballi, Deepak; Hensel, Michael			Functional Dissection of SseF, a Membrane-Integral Effector Protein of Intracellular Salmonella enterica	PLOS ONE			English	Article							III SECRETION SYSTEM; HOST-CELLS; EPITHELIAL-CELLS; PATHOGENICITY ISLAND-2; FILAMENTOUS STRUCTURES; CONTAINING VACUOLES; VIRULENCE; TYPHIMURIUM; IDENTIFICATION; SIFA	During intracellular life, the bacterial pathogen Salmonella enterica translocates a complex cocktail of effector proteins by means of the SPI2-encoded type III secretions system. The effectors jointly modify the endosomal system and vesicular transport in host cells. SseF and SseG are two effectors encoded by genes within Salmonella Pathogenicity Island 2 and both effector associate with endosomal membranes and microtubules and are involved in the formation of Salmonella-induced filaments. Our previous deletional analyses identified protein domains of SseF required for the effector function. Here we present a detailed mutational analysis that identifies a short hydrophobic motif as functionally essential. We demonstrate that SseF and SseG are still functional if translocated as a single fusion protein, but also mediate effector function if translocated in cells co-infected with sseF and sseG strains. SseF has characteristics of an integral membrane protein after translocation into host cells.	[Muller, Petra; Chikkaballi, Deepak; Hensel, Michael] Univ Klinikum Erlangen, Inst Mikrobiol, Erlangen, Germany; [Chikkaballi, Deepak; Hensel, Michael] Univ Osnabruck, Abt Mikrobiol, Osnabruck, Germany	University of Erlangen Nuremberg; University Osnabruck	Muller, P (corresponding author), Univ Klinikum Erlangen, Inst Mikrobiol, Erlangen, Germany.	Michael.Hensel@biologie.uni-osnabrueck.de	Chikkaballi, Deepak/AAB-2775-2021	Hensel, Michael/0000-0001-6604-6253; C A, Deepak/0000-0001-7835-5790	DFG [SPP1150]; DFG collaborative research center [SFB796, C1]	DFG(German Research Foundation (DFG)); DFG collaborative research center(German Research Foundation (DFG))	This work was supported by the DFG through priority program SPP1150 'Signaling pathways to the cytoskeleton and bacterial pathogenesis' and the DFG collaborative research center SFB796, project C1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams GL, 2006, TRAFFIC, V7, P950, DOI 10.1111/j.1600-0854.2006.00454.x; Abrahams GL, 2006, CELL MICROBIOL, V8, P728, DOI 10.1111/j.1462-5822.2006.00706.x; Aleman A, 2009, FEMS MICROBIOL LETT, V296, P167, DOI 10.1111/j.1574-6968.2009.01630.x; Betts HJ, 2004, TRENDS MICROBIOL, V12, P476, DOI 10.1016/j.tim.2004.09.010; Beuzon CR, 2000, EMBO J, V19, P3235, DOI 10.1093/emboj/19.13.3235; Boucrot E, 2003, J BIOL CHEM, V278, P14196, DOI 10.1074/jbc.M207901200; Brumell JH, 2002, TRAFFIC, V3, P407, DOI 10.1034/j.1600-0854.2002.30604.x; Dai SP, 2004, J BACTERIOL, V186, P5078, DOI 10.1128/jb.186.15.5078-5086.2004; Deiwick J, 2006, INFECT IMMUN, V74, P6965, DOI 10.1128/IAI.00648-06; Drecktrah D, 2008, TRAFFIC, V9, P2117, DOI 10.1111/j.1600-0854.2008.00830.x; GARCIADELPORTILLO F, 1993, P NATL ACAD SCI USA, V90, P10544, DOI 10.1073/pnas.90.22.10544; Halici S, 2008, INFECT IMMUN, V76, P4924, DOI 10.1128/IAI.00531-08; Haraga A, 2008, NAT REV MICROBIOL, V6, P53, DOI 10.1038/nrmicro1788; Henry T, 2006, CELL MICROBIOL, V8, P23, DOI 10.1111/j.1462-5822.2005.00649.x; Henry T, 2006, P NATL ACAD SCI USA, V103, P13497, DOI 10.1073/pnas.0605443103; Hensel M, 1998, MOL MICROBIOL, V30, P163, DOI 10.1046/j.1365-2958.1998.01047.x; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Husseiny MI, 2007, VACCINE, V25, P185, DOI 10.1016/j.vaccine.2005.11.020; Ibarra JA, 2009, CELL MICROBIOL, V11, P1579, DOI 10.1111/j.1462-5822.2009.01368.x; Jordan M, 2004, METHODS, V33, P136, DOI 10.1016/j.ymeth.2003.11.011; Knodler LA, 2005, MOL BIOL CELL, V16, P4108, DOI 10.1091/mbc.e05-04-0367; Kuhle V, 2004, CELL MOL LIFE SCI, V61, P2812, DOI 10.1007/s00018-004-4248-z; Kuhle V, 2004, TRAFFIC, V5, P356, DOI 10.1111/j.1398-9219.2004.00179.x; Kuhle V, 2002, CELL MICROBIOL, V4, P813, DOI 10.1046/j.1462-5822.2002.00234.x; Marcus SL, 2002, CELL MICROBIOL, V4, P435, DOI 10.1046/j.1462-5822.2002.00202.x; Miao EA, 2000, P NATL ACAD SCI USA, V97, P7539, DOI 10.1073/pnas.97.13.7539; PLUTNER H, 1992, J CELL BIOL, V119, P1097, DOI 10.1083/jcb.119.5.1097; Rajashekar R, 2008, TRAFFIC, V9, P2100, DOI 10.1111/j.1600-0854.2008.00821.x; Ramsden AE, 2007, TRENDS MICROBIOL, V15, P516, DOI 10.1016/j.tim.2007.10.002; Ramsden AE, 2007, CELL MICROBIOL, V9, P2517, DOI 10.1111/j.1462-5822.2007.00977.x; Salcedo SP, 2003, EMBO J, V22, P5003, DOI 10.1093/emboj/cdg517; SCHMIEGER H, 1972, MOL GEN GENET, V119, P75, DOI 10.1007/BF00270447; Shea JE, 1996, P NATL ACAD SCI USA, V93, P2593, DOI 10.1073/pnas.93.6.2593; Stein MA, 1996, MOL MICROBIOL, V20, P151, DOI 10.1111/j.1365-2958.1996.tb02497.x; Tan YP, 2005, MICROBIOL-SGM, V151, P2301, DOI 10.1099/mic.0.28005-0; Ustun S, 2012, NEW PHYTOL IN PRESS; Zhao YX, 2004, ANAL CHEM, V76, P1817, DOI 10.1021/ac0354037	37	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35004	10.1371/journal.pone.0035004	http://dx.doi.org/10.1371/journal.pone.0035004			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529968	Green Submitted, gold, Green Published			2022-12-27	WOS:000305350600051
J	Psouni, E; Janke, A; Garwicz, M				Psouni, Elia; Janke, Axel; Garwicz, Martin			Impact of Carnivory on Human Development and Evolution Revealed by a New Unifying Model of Weaning in Mammals	PLOS ONE			English	Article							LIFE-HISTORY; PROTEIN EVOLUTION; BRAIN-DEVELOPMENT; HYPOTHESIS; PATTERNS; WEIGHT; SPAN; TIME; APES	Our large brain, long life span and high fertility are key elements of human evolutionary success and are often thought to have evolved in interplay with tool use, carnivory and hunting. However, the specific impact of carnivory on human evolution, life history and development remains controversial. Here we show in quantitative terms that dietary profile is a key factor influencing time to weaning across a wide taxonomic range of mammals, including humans. In a model encompassing a total of 67 species and genera from 12 mammalian orders, adult brain mass and two dichotomous variables reflecting species differences regarding limb biomechanics and dietary profile, accounted for 75.5%, 10.3% and 3.4% of variance in time to weaning, respectively, together capturing 89.2% of total variance. Crucially, carnivory predicted the time point of early weaning in humans with remarkable precision, yielding a prediction error of less than 5% with a sample of forty-six human natural fertility societies as reference. Hence, carnivory appears to provide both a necessary and sufficient explanation as to why humans wean so much earlier than the great apes. While early weaning is regarded as essentially differentiating the genus Homo from the great apes, its timing seems to be determined by the same limited set of factors in humans as in mammals in general, despite some 90 million years of evolution. Our analysis emphasizes the high degree of similarity of relative time scales in mammalian development and life history across 67 genera from 12 mammalian orders and shows that the impact of carnivory on time to weaning in humans is quantifiable, and critical. Since early weaning yields shorter interbirth intervals and higher rates of reproduction, with profound effects on population dynamics, our findings highlight the emergence of carnivory as a process fundamentally determining human evolution.	[Psouni, Elia] Lund Univ, Dept Psychol, Lund, Sweden; [Psouni, Elia] Kristianstad Univ, Ctr Psychol, Kristianstad, Sweden; [Janke, Axel] LOEWE Biodivers & Climate Res Ctr BiK F, Frankfurt, Germany; [Janke, Axel] Goethe Univ, Inst Ecol Evolut & Divers, Frankfurt, Germany; [Garwicz, Martin] Lund Univ, Neuronano Res Ctr, BMC F10, Lund, Sweden	Lund University; Kristianstad University; Goethe University Frankfurt; Lund University	Psouni, E (corresponding author), Lund Univ, Dept Psychol, Lund, Sweden.	Elia.Psouni@med.lu.se	Janke, Axel/M-2135-2013	Janke, Axel/0000-0002-9394-1904; Garwicz-Psouni, Elia/0000-0003-2758-5785	Swedish Research Council [2009-1273, 14015, 60012701]; Knut and Alice Wallenberg Foundation [KAW 2004.0119]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	EP was supported by the Swedish Research Council (2009-1273). MG was supported by the Swedish Research Council, projects 14015 and 60012701 (a Linnaeus Grant to the Neuronano Research Center) and the Knut and Alice Wallenberg Foundation (project number: KAW 2004.0119). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; AIELLO LC, 1995, CURR ANTHROPOL, V36, P199, DOI 10.1086/204350; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; ALLMAN J, 1993, P NATL ACAD SCI USA, V90, P118, DOI 10.1073/pnas.90.1.118; Ardrey R, AFRICAN GENESIS PERS; Arnason U, 2002, P NATL ACAD SCI USA, V99, P8151, DOI 10.1073/pnas.102164299; Benton Michael J., 2009, P35; Binford L.R., 1981, BONES ANCIENT MEN MO; Bunn HT, 2001, MEAT EATING HUMAN EV, P350; Cao Y, 1998, J MOL EVOL, V47, P307, DOI 10.1007/PL00006389; Carmody RN, 2009, J HUM EVOL, V57, P379, DOI 10.1016/j.jhevol.2009.02.011; Charnov Eric L., 1993, Evolutionary Anthropology, V1, P191, DOI 10.1002/evan.1360010604; Clancy B, 2001, NEUROSCIENCE, V105, P7, DOI 10.1016/S0306-4522(01)00171-3; Clancy B, 2007, NEUROTOXICOLOGY, V28, P931, DOI 10.1016/j.neuro.2007.01.014; de Magalhaes JP, 2009, J EVOLUTION BIOL, V22, P1770, DOI 10.1111/j.1420-9101.2009.01783.x; Deaner Robert O., 2003, P233; Dettwyler Katherine A., 1995, BREASTFEEDING, P39, DOI [10.4324/9781315081984-2, DOI 10.4324/9781315081984-2]; Ernest SKM, 2003, ECOLOGY, V84, P3402, DOI 10.1890/02-9002; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Finch CE, 2010, P NATL ACAD SCI USA, V107, P1718, DOI 10.1073/pnas.0909606106; FINLAY BL, 1995, SCIENCE, V268, P1578, DOI 10.1126/science.7777856; Foley Robert, 2001, P305; GALDIKAS BMF, 1990, AM J PHYS ANTHROPOL, V83, P185, DOI 10.1002/ajpa.1330830207; Garwicz M, 2009, P NATL ACAD SCI USA, V106, P21889, DOI 10.1073/pnas.0905777106; HARVEY PH, 1985, EVOLUTION, V39, P559, DOI 10.1111/j.1558-5646.1985.tb00395.x; Hawkes K, 2006, SCH AM RES, P95; Hawkes K, 2006, SCH AM RES, P45; Hutchins M, 2003, GRZIMEKS ANIMAL LIFE, V13- 16; Isler K, 2009, J HUM EVOL, V57, P392, DOI 10.1016/j.jhevol.2009.04.009; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; Kennedy GE, 2005, J HUM EVOL, V48, P123, DOI 10.1016/j.jhevol.2004.09.005; Lefebvre L, 2006, BRAIN BEHAV EVOLUT, V68, P218, DOI 10.1159/000094359; Maddison D.R., 2007, MESQUITE 2 MODULAR S; Martin R.D., 1983, HUMAN BRAIN EVOLUTIO; Martin RD, 2007, YEARB PHYS ANTHROPOL, V50, P59, DOI 10.1002/ajpa.20734; MAYR E, 1961, SCIENCE, V134, P1501, DOI 10.1126/science.134.3489.1501; Midford P. E., 2008, PDAP PDTREE PACKAGE; Milton K, 1999, EVOL ANTHROPOL, V8, P11, DOI 10.1002/(SICI)1520-6505(1999)8:1<11::AID-EVAN6>3.3.CO;2-D; PASSINGHAM RE, 1985, BRAIN BEHAV EVOLUT, V26, P167, DOI 10.1159/000118773; Robson SL, 2008, J ANAT, V212, P394, DOI 10.1111/j.1469-7580.2008.00867.x; Robson SL, 2006, SCH AM RES, P17; SACHER GA, 1974, AM NAT, V108, P593, DOI 10.1086/282938; Sellen DW, 2009, ADV EXP MED BIOL, V639, P253, DOI 10.1007/978-1-4020-8749-3_18; Sellen DW, 2001, J NUTR, V131, P2707, DOI 10.1093/jn/131.10.2707; SHERMAN PW, 1988, ANIM BEHAV, V36, P616, DOI 10.1016/S0003-3472(88)80039-3; Smith BH, 1992, EVOL ANTHROPOL, V1, P134, DOI DOI 10.1002/EVAN.1360010406; Stanford Craig B., 2001, P122; Taylor HW, 1999, J BIOSOC SCI, V31, P289, DOI 10.1017/S0021932099002898; van Schaik CP, 2006, SCH AM RES, P127; Yang ZH, 1998, MOL BIOL EVOL, V15, P1600, DOI 10.1093/oxfordjournals.molbev.a025888	51	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e32452	10.1371/journal.pone.0032452	http://dx.doi.org/10.1371/journal.pone.0032452			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959XD	22536316	Green Published, gold			2022-12-27	WOS:000305350600003
J	Yeang, CH; Ma, GC; Shih, JC; Yang, YS; Chen, CP; Chang, SP; Wu, SH; Liu, CS; Kuo, SJ; Chou, HC; Hwu, WL; Cameron, AD; Ginsberg, NA; Lin, YS; Chen, M				Yeang, Chen-Hsiang; Ma, Gwo-Chin; Shih, Jin-Chung; Yang, Yu-Shih; Chen, Chih-Ping; Chang, Shun-Ping; Wu, Sheng-Hai; Liu, Chin-San; Kuo, Shou-Jen; Chou, Hung-Chieh; Hwu, Wuh-Liang; Cameron, Alan D.; Ginsberg, Norman A.; Lin, Yi-Shing; Chen, Ming			Genome-Wide Gene Expression Analysis Implicates the Immune Response and Lymphangiogenesis in the Pathogenesis of Fetal Chylothorax	PLOS ONE			English	Article							PLEURAL EFFUSION; HUMAN FETUSES; OK-432	Fetal chylothorax (FC) is a rare condition characterized by lymphocyte-rich pleural effusion. Although its pathogenesis remains elusive, it may involve inflammation, since there are increased concentrations of proinflammatory mediators in pleural fluids. Only a few hereditary lymphedema-associated gene loci, e. g. VEGFR3, ITGA9 and PTPN11, were detected in human fetuses with this condition; these cases had a poorer prognosis, due to defective lymphangiogenesis. In the present study, genome-wide gene expression analysis was conducted, comparing pleural and ascitic fluids in three hydropic fetuses, one with and two without the ITGA9 mutation. One fetus (the index case), from a dizygotic pregnancy (the cotwin was unaffected), received antenatal OK-432 pleurodesis and survived beyond the neonatal stage, despite having the ITGA9 mutation. Genes and pathways involved in the immune response were universally up-regulated in fetal pleural fluids compared to those in ascitic fluids. Furthermore, genes involved in the lymphangiogenesis pathway were down-regulated in fetal pleural fluids (compared to ascitic fluid), but following OK-432 pleurodesis, they were up-regulated. Expression of ITGA9 was concordant with overall trends of lymphangiogenesis. In conclusion, we inferred that both the immune response and lymphangiogenesis were implicated in the pathogenesis of fetal chylothorax. Furthermore, genome-wide gene expression microarray analysis may facilitate personalized medicine by selecting the most appropriate treatment, according to the specific circumstances of the patient, for this rare, but heterogeneous disease.	[Yeang, Chen-Hsiang] Acad Sinica, Inst Stat Sci, Taipei 11529, Taiwan; [Ma, Gwo-Chin; Chang, Shun-Ping; Chen, Ming] Changhua Christian Hosp, Dept Genom Med, Changhua, Taiwan; [Ma, Gwo-Chin; Chang, Shun-Ping; Chen, Ming] Changhua Christian Hosp, Ctr Med Genet, Changhua, Taiwan; [Ma, Gwo-Chin] Chung Shan Med Univ, Inst Biochem & Biotechnol, Taichung, Taiwan; [Shih, Jin-Chung; Yang, Yu-Shih; Chen, Ming] Natl Taiwan Univ, Dept Obstet & Gynecol, Taipei 10764, Taiwan; [Chen, Chih-Ping] Mackay Mem Hosp, Dept Obstet & Gynecol, Taipei, Taiwan; [Chen, Chih-Ping] Mackay Mem Hosp, Dept Med Res, Taipei, Taiwan; [Chang, Shun-Ping; Wu, Sheng-Hai; Chen, Ming] Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan; [Liu, Chin-San] Changhua Christian Hosp, Dept Med Res, Vasc & Genom Ctr, Changhua, Taiwan; [Kuo, Shou-Jen] Changhua Christian Hosp, Dept Surg, Changhua, Taiwan; [Chou, Hung-Chieh; Hwu, Wuh-Liang; Chen, Ming] Natl Taiwan Univ, Coll Med & Hosp, Dept Pediat, Taipei 10764, Taiwan; [Chou, Hung-Chieh; Hwu, Wuh-Liang; Chen, Ming] Natl Taiwan Univ, Coll Med & Hosp, Dept Med Genet, Taipei 10764, Taiwan; [Cameron, Alan D.] So Gen Hosp, Ian Donald Foetal Med Unit, Glasgow G51 4TF, Lanark, Scotland; [Cameron, Alan D.] Univ Glasgow, Glasgow, Lanark, Scotland; [Ginsberg, Norman A.] Northwestern Univ, Feinberg Sch Med, Dept Obstet & Gynecol, Chicago, IL 60611 USA; [Lin, Yi-Shing] Welgene Biotechnol Co, Taipei, Taiwan; [Chen, Ming] Tunghai Univ, Dept Life Sci, Taichung 40704, Taiwan; [Chen, Ming] Chung Shan Med Univ, Coll Med, Taichung, Taiwan	Academia Sinica - Taiwan; Changhua Christian Hospital; Changhua Christian Hospital; Chung Shan Medical University; National Taiwan University; Mackay Memorial Hospital; Mackay Memorial Hospital; National Chung Hsing University; Changhua Christian Hospital; Changhua Christian Hospital; National Taiwan University; National Taiwan University; University of Glasgow; University of Glasgow; Northwestern University; Feinberg School of Medicine; Tunghai University; Chung Shan Medical University	Yeang, CH (corresponding author), Acad Sinica, Inst Stat Sci, Taipei 11529, Taiwan.	mchen_cch@yahoo.com	Yeang, Chen-Hsiang/AAP-2962-2021; Chou, Hung-Chieh/AGZ-5161-2022; SHIH, JIN-CHUNG/AAQ-8651-2021	SHIH, JIN-CHUNG/0000-0002-0296-4327; YANG, YU-SHIH/0000-0002-8633-0873; Chen, Ming/0000-0001-5076-2917; HWU, WUH-LIANG/0000-0001-6690-4879; CHOU, HUNG-CHIEH/0000-0002-8932-9472	National Science Council, Taiwan [NSC-99-2314-B371-001-MY2]; Changhua Christian Hospital [100-CCH-ICO04]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Changhua Christian Hospital	This research was funded by grants from the National Science Council, Taiwan (NSC-99-2314-B371-001-MY2) to Ming Chen and Wuh-Liang Hwu, and from Changhua Christian Hospital (100-CCH-ICO04) to Ming Chen. The funders had no role in study design, data collection and analysis, decision to publish, or manuscript preparation.	Bazigou E, 2009, DEV CELL, V17, P175, DOI 10.1016/j.devcel.2009.06.017; Bennet L, 2010, AM J PHYSIOL-REG I, V299, pR664, DOI 10.1152/ajpregu.00116.2010; Chao AS, 2010, EUR J OBSTET GYN R B, V151, P112, DOI 10.1016/j.ejogrb.2010.03.027; Chen CH, 2009, LYMPHOLOGY, V42, P134; Chen M, 2005, ULTRASOUND OBST GYN, V26, P791, DOI 10.1002/uog.2634; Chen M, 2007, PRENATAL DIAG, V27, P435, DOI 10.1002/pd.1704; Cowie RV, 2009, FETAL DIAGN THER, V25, P304, DOI 10.1159/000235876; Deurloo KL, 2007, PRENATAL DIAG, V27, P893, DOI 10.1002/pd.1808; Huang XZ, 2000, MOL CELL BIOL, V20, P5208, DOI 10.1128/MCB.20.14.5208-5215.2000; Joshi-Tope G, 2005, NUCLEIC ACIDS RES, V33, pD428, DOI 10.1093/nar/gki072; Ma GC, 2010, AM J MED GENET A, V152A, P784, DOI 10.1002/ajmg.a.33157; Ma GC, 2008, PRENATAL DIAG, V28, P1057, DOI 10.1002/pd.2130; Matsukuma Eiji, 2009, J Pediatr Surg, V44, pe37, DOI 10.1016/j.jpedsurg.2008.12.008; Nygaard U, 2007, OBSTET GYNECOL, V109, P1088, DOI 10.1097/01.AOG.0000259907.91973.69; Ono S, 2010, J PEDIATR SURG, V45, pE7, DOI 10.1016/j.jpedsurg.2010.06.010; PEMBLE SE, 1992, BIOCHEM J, V287, P957, DOI 10.1042/bj2870957; Ruano R, 2011, PRENATAL DIAG, V31, P496, DOI 10.1002/pd.2726; Saharinen P, 2004, TRENDS IMMUNOL, V25, P387, DOI 10.1016/j.it.2004.05.003; Samuel M, 2000, FETAL DIAGN THER, V15, P93, DOI 10.1159/000020983; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tammela T, 2010, CELL, V140, P460, DOI 10.1016/j.cell.2010.01.045; Tartaglia M, 2002, AM J HUM GENET, V70, P1555, DOI 10.1086/340847; Yang YS, 2012, ULTRASOUND OBST GYN, V39, P56, DOI 10.1002/uog.9048; Yinon Y, 2008, BEST PRACT RES CL OB, V22, P77, DOI 10.1016/j.bpobgyn.2007.09.004; Zheng DY, 2007, GENOME RES, V17, P839, DOI 10.1101/gr.5586307	26	5	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e34901	10.1371/journal.pone.0034901	http://dx.doi.org/10.1371/journal.pone.0034901			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529953	Green Published, gold, Green Submitted			2022-12-27	WOS:000305350600040
J	Zimmer, J; Doelken, SC; Horn, D; Groppe, JC; Shore, EM; Kaplan, FS; Seemann, P				Zimmer, Julia; Doelken, Sandra C.; Horn, Denise; Groppe, Jay C.; Shore, Eileen M.; Kaplan, Frederick S.; Seemann, Petra			Functional Analysis of Alleged NOGGIN Mutation G92E Disproves Its Pathogenic Relevance	PLOS ONE			English	Article							FIBRODYSPLASIA-OSSIFICANS-PROGRESSIVA; BONE MORPHOGENETIC PROTEINS; I RECEPTOR GENES; SPEMANN ORGANIZER; NATURAL-HISTORY; FOP; EXPRESSION; OVEREXPRESSION; IDENTIFICATION; INHIBITION	We identified an amino acid change (p.G92E) in the Bone Morphogenetic Protein antagonist NOGGIN in a 22-month-old boy who presented with a unilateral brachydactyly type B phenotype. Brachydactyly type B is a skeletal malformation that has been associated with increased Bone Morphogenetic Protein pathway activation in other patients. Previously, the amino acid change p.G92E in NOGGIN was described as causing fibrodysplasia ossificans progressiva, a rare genetic disorder characterized by limb malformations and progressive heterotopic bone formation in soft tissues that, like Brachydactyly type B, is caused by increased activation of Bone Morphogenetic Protein signaling. To determine whether G92E-NOGGIN shows impaired antagonism that could lead to increased Bone Morphogenetic Protein signaling, we performed functional assays to evaluate inhibition of BMP signaling. Interestingly, wt-NOGGIN shows different inhibition efficacies towards various Bone Morphogenetic Proteins that are known to be essential in limb development. However, comparing the biological activity of G92E-NOGGIN with wt-NOGGIN, we observed that G92E-NOGGIN inhibits activation of bone morphogenetic protein signaling with equal efficiency as wt-NOGGIN, supporting that G92E-NOGGIN does not cause pathological effects. Genetic testing of the child's parents revealed the same amino acid change in the healthy father, further supporting that p.G92E is a neutral amino acid substitution in NOGGIN. We conclude that p.G92E represents a rare polymorphism of the NOGGIN gene - causing neither brachydactyly nor fibrodysplasia ossificans progressiva. This study highlights that a given genetic variation should not be considered pathogenic unless supported by functional analyses.	[Zimmer, Julia; Seemann, Petra] Charite Univ Med Berlin, Berlin Brandenburg Ctr Regenerat Therapies, Berlin, Germany; [Zimmer, Julia; Seemann, Petra] Charite Univ Med Berlin, Berlin Brandenburg Sch Regenerat Therapies, Berlin, Germany; [Doelken, Sandra C.; Horn, Denise] Charite Univ Med Berlin, Inst Med Genet & Humangenet, Berlin, Germany; [Groppe, Jay C.] Texas A&M Hlth Sci Ctr, Baylor Coll Dent, Dept Biomed Sci, Dallas, TX USA; [Shore, Eileen M.; Kaplan, Frederick S.] Univ Penn, Perelman Sch Med, Dept Orthopaed Surg, Philadelphia, PA 19104 USA; [Kaplan, Frederick S.; Seemann, Petra] Univ Penn, Perelman Sch Med, Ctr Res FOP & Related Disorders, Philadelphia, PA 19104 USA	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Zimmer, J (corresponding author), Charite Univ Med Berlin, Berlin Brandenburg Ctr Regenerat Therapies, Berlin, Germany.	petra.seemann@charite.de	Seemann, Petra/G-3606-2011	Seemann, Petra/0000-0002-6056-6669	Ian Cali Fund of the Center for Research in FOP and Related Disorders at the Perelman School of Medicine at the University of Pennsylvania; German FOPe.V.; Deutsche Forschungsgemeinschaft [SFB760-A2]; Isaac & Rose Nassau Professorship of Orthopaedic Molecular Medicine; National Institutes of Health [R01-AR41916]; DFG through the Berlin-Brandenburg School for Regenerative Therapies [GSC 203]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR041916] Funding Source: NIH RePORTER	Ian Cali Fund of the Center for Research in FOP and Related Disorders at the Perelman School of Medicine at the University of Pennsylvania; German FOPe.V.; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Isaac & Rose Nassau Professorship of Orthopaedic Molecular Medicine; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DFG through the Berlin-Brandenburg School for Regenerative Therapies; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported in part by a Developmental Grant from the Ian Cali Fund of the Center for Research in FOP and Related Disorders at the Perelman School of Medicine at the University of Pennsylvania (to PS and JCG), the German FOPe.V. (to PS), the Deutsche Forschungsgemeinschaft (SFB760-A2 to PS), the Isaac & Rose Nassau Professorship of Orthopaedic Molecular Medicine and a grant from the National Institutes of Health (R01-AR41916) (to FSK and EMS). Contributions were made possible by DFG funding through the Berlin-Brandenburg School for Regenerative Therapies GSC 203. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht AN, 2002, MECH DEVELOP, V112, P53, DOI 10.1016/S0925-4773(01)00639-6; Beck HN, 2001, BMC NEUROSCI, V2, DOI 10.1186/1471-2202-2-12; Bell J, 1951, BRACHYDACTYLY SYMPHA; Brunet LJ, 1998, SCIENCE, V280, P1455, DOI 10.1126/science.280.5368.1455; Cohen MM, 2002, AM J MED GENET, V109, P87, DOI 10.1002/ajmg.10289; COHEN RB, 1993, J BONE JOINT SURG AM, V75A, P215, DOI 10.2106/00004623-199302000-00008; CONNOR JM, 1982, J BONE JOINT SURG BR, V64, P76, DOI 10.1302/0301-620X.64B1.7068725; CONNOR JM, 1993, J MED GENET, V30, P687, DOI 10.1136/jmg.30.8.687; Duprez D, 1996, MECH DEVELOP, V57, P145, DOI 10.1016/0925-4773(96)00540-0; Fontaine K, 2005, GENET COUNSEL, V16, P149; Gannon FH, 1997, HUM PATHOL, V28, P339, DOI 10.1016/S0046-8177(97)90133-7; Gazzerro E, 1998, J CLIN INVEST, V102, P2106, DOI 10.1172/JCI3459; Gong YQ, 1999, NAT GENET, V21, P302, DOI 10.1038/6821; Groppe J, 2002, NATURE, V420, P636, DOI 10.1038/nature01245; Huang N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001154; Ishii Y, 2011, BIOCH GENET; Kaplan FS, 2008, GENET COUNSEL, V19, P357; Kaplan Frederick S, 2009, Hum Mutat, V30, P379, DOI 10.1002/humu.20868; KAPLAN FS, 1990, CALCIFIED TISSUE INT, V47, P117, DOI 10.1007/BF02555995; KAPLAN FS, 1993, J BONE JOINT SURG AM, V75A, P220, DOI 10.2106/00004623-199302000-00009; Lanchoney TF, 1998, CLIN ORTHOP RELAT R, P38; Lehmann K, 2007, AM J HUM GENET, V81, P388, DOI 10.1086/519697; Lucotte G, 2000, DEV DYNAM, V219, P459; Lucotte G, 2007, GENET COUNSEL, V18, P349; Lucotte G, 1999, CLIN GENET, V56, P469, DOI 10.1034/j.1399-0004.1999.560613.x; Lucotte G, 2009, GENET COUNSEL, V20, P53; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; Miyazono K, 2010, J BIOCHEM, V147, P35, DOI 10.1093/jb/mvp148; Morgan BA, 1996, METHOD CELL BIOL, V51, P185, DOI 10.1016/S0091-679X(08)60629-9; NHLBI Exome Sequencing Project (ESP) S WA, 2012, NHLBI EX SEQ PROJ ES; Ploger F, 2008, HUM MOL GENET, V17, P1222, DOI 10.1093/hmg/ddn012; Potti TA, 2011, HUM MUTAT, V32, P877, DOI 10.1002/humu.21515; ROSEN V, 1992, TRENDS GENET, V8, P97, DOI 10.1016/0168-9525(92)90063-A; Schwabe G C, 2004, Handchir Mikrochir Plast Chir, V36, P85; Schwabe GC, 2000, AM J HUM GENET, V67, P822, DOI 10.1086/303084; Seemann P, 2008, GENET COUNSEL, V19, P353; Seemann P, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000747; Seemann Petra, 2008, P141, DOI 10.1007/978-3-7643-8552-1_8; Semonin O, 2001, AM J MED GENET, V102, P314, DOI 10.1002/ajmg.1504; Shafritz AB, 1996, NEW ENGL J MED, V335, P555, DOI 10.1056/NEJM199608223350804; Shen Q, 2009, J CLIN INVEST, V119, P3462, DOI 10.1172/JCI37412; Shore EM, 2006, NAT GENET, V38, P525, DOI 10.1038/ng1783; SMITH WC, 1992, CELL, V70, P829, DOI 10.1016/0092-8674(92)90316-5; Song KN, 2010, J BIOL CHEM, V285, P12169, DOI 10.1074/jbc.M109.087197; TABAS JA, 1993, CLIN ORTHOP RELAT R, P310; URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893; Wadman M, 2008, NATURE, V452, P788, DOI 10.1038/452788b; Warman ML, 2002, AM J MED GENET, V109, P162, DOI 10.1002/ajmg.10290; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Xu MQ, 1998, CLIN ORTHOP RELAT R, P53; Xu MQ, 2000, CLIN GENET, V58, P291, DOI 10.1034/j.1399-0004.2000.580407.x; Xu MQ, 2002, AM J MED GENET, V109, P161, DOI 10.1002/ajmg.10288; Zimmerman LB, 1996, CELL, V86, P599, DOI 10.1016/S0092-8674(00)80133-6	53	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35062	10.1371/journal.pone.0035062	http://dx.doi.org/10.1371/journal.pone.0035062			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529972	Green Published, gold, Green Submitted			2022-12-27	WOS:000305350600054
J	Sabiiti, W; May, RC				Sabiiti, Wilber; May, Robin C.			Capsule Independent Uptake of the Fungal Pathogen Cryptococcus neoformans into Brain Microvascular Endothelial Cells	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; IN-VITRO; MOUSE-BRAIN; MENINGITIS; BARRIER; DISSEMINATION; AIDS; PHAGOCYTOSIS; MACROPHAGES; EXPRESSION	Cryptococcosis is a life-threatening fungal disease with a high rate of mortality among HIV/AIDS patients across the world. The ability to penetrate the blood-brain barrier (BBB) is central to the pathogenesis of cryptococcosis, but the way in which this occurs remains unclear. Here we use both mouse and human brain derived endothelial cells (bEnd3 and hCMEC/D3) to accurately quantify fungal uptake and survival within brain endothelial cells. Our data indicate that the adherence and internalisation of cryptococci by brain microvascular endothelial cells is an infrequent event involving small numbers of cryptococcal yeast cells. Interestingly, this process requires neither active signalling from the fungus nor the presence of the fungal capsule. Thus entry into brain microvascular endothelial cells is most likely a passive event that occurs following 'trapping' within capillary beds of the BBB.	[Sabiiti, Wilber; May, Robin C.] Univ Birmingham, Coll Life & Environm Sci, Sch Biosci, Inst Microbiol & Infect, Birmingham, W Midlands, England	University of Birmingham	Sabiiti, W (corresponding author), Univ Birmingham, Coll Life & Environm Sci, Sch Biosci, Inst Microbiol & Infect, Birmingham, W Midlands, England.	r.c.may@bham.ac.uk	May, Robin Charles/ABA-9266-2021; Sabiiti, Wilber/AAH-7921-2021	May, Robin Charles/0000-0001-5364-1838; Sabiiti, Wilber/0000-0002-4742-2791	Wellcome Trust [088148MF]; Lister Institute of Preventive Medicine	Wellcome Trust(Wellcome TrustEuropean Commission); Lister Institute of Preventive Medicine	The work was funded by the Wellcome Trust (http://www.wellcome.ac.uk) grant (088148MF), the Lister Institute of Preventive Medicine (http://www.lister-institute.org.uk/) to Dr. May, and Darwin Trust doctoral scholarship to Dr. Sabiiti. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bicanic T, 2005, BRIT MED BULL, V72, P99, DOI 10.1093/bmb/ldh043; BOLANOS B, 1989, J LEUKOCYTE BIOL, V46, P521, DOI 10.1002/jlb.46.6.521; Boulware DR, 2010, J INFECT DIS, V202, P962, DOI 10.1086/655785; Brown RC, 2007, BRAIN RES, V1130, P17, DOI 10.1016/j.brainres.2006.10.083; Byrnes Edmond J, 2009, F1000 Biol Rep, V1, DOI 10.3410/B1-62; Byrnes EJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000850; Byrnes EJ, 2009, J INFECT DIS, V199, P1081, DOI 10.1086/597306; Casadevall A, 1998, CRYPTOCOCCUS NEOFORM; Chang YC, 2004, INFECT IMMUN, V72, P4985, DOI 10.1128/IAI.72.9.4985-4995.2004; Charlier C, 2005, AM J PATHOL, V166, P421, DOI 10.1016/S0002-9440(10)62265-1; Charlier C, 2009, INFECT IMMUN, V77, P120, DOI 10.1128/IAI.01065-08; Chen SHM, 2003, J MED MICROBIOL, V52, P961, DOI 10.1099/jmm.0.05230-0; Correale J, 2009, NEUROCHEM RES; Datta K, 2009, EMERG INFECT DIS, V15, P1185, DOI 10.3201/eid1508.081384; De Jesus M, 2010, EUKARYOT CELL, V9, P1018, DOI 10.1128/EC.00268-09; Eisenman Helene C, 2007, Curr Infect Dis Rep, V9, P457, DOI 10.1007/s11908-007-0070-8; Fries BC, 2001, J CLIN INVEST, V108, P1639, DOI 10.1172/JCI13407; Goldman DL, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.5.e66; Guerrero A, 2006, MICROBIOL-SGM, V152, P3, DOI 10.1099/mic.0.28451-0; Heitman J., CRYPTOCOCCUS HUMAN P; Huang SH, 2011, J BIOL CHEM, V286, P34761, DOI 10.1074/jbc.M111.219378; Huffnagle GB, 1999, J NEUROVIROL, V5, P76, DOI 10.3109/13550289909029748; IBRAHIM AS, 1995, INFECT IMMUN, V63, P4368, DOI 10.1128/IAI.63.11.4368-4374.1995; Jain N, 2006, FEMS YEAST RES, V6, P480, DOI 10.1111/j.1567-1364.2006.00039.x; Jong AY, 2001, INFECT IMMUN, V69, P4536, DOI 10.1128/IAI.69.7.4536-4544.2001; Kambugu A, 2008, CLIN INFECT DIS, V46, P1694, DOI 10.1086/587667; Kidd SE, 2004, P NATL ACAD SCI USA, V101, P17258, DOI 10.1073/pnas.0402981101; Kim KS, 2008, NAT REV MICROBIOL, V6, P625, DOI 10.1038/nrmicro1952; Lin XR, 2009, INFECT GENET EVOL, V9, P401, DOI 10.1016/j.meegid.2009.01.013; Lortholary O, 2007, CLIN INFECT DIS, V45, P81, DOI 10.1086/518583; Ma HS, 2009, ADV APPL MICROBIOL, V67, P131, DOI 10.1016/S0065-2164(08)01005-8; MITCHELL TG, 1995, CLIN MICROBIOL REV, V8, P515, DOI 10.1128/CMR.8.4.515; MUKHERJEE S, 1995, INFECT IMMUN, V63, P573, DOI 10.1128/IAI.63.2.573-579.1995; Mwaba P, 2001, POSTGRAD MED J, V77, P769, DOI 10.1136/pmj.77.914.769; Neofytos D, 2010, TRANSPL INFECT DIS, V12, P220, DOI 10.1111/j.1399-3062.2010.00492.x; Nussbaum JC, 2010, CLIN INFECT DIS, V50, P338, DOI 10.1086/649861; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Santangelo R, 2004, INFECT IMMUN, V72, P2229, DOI 10.1128/IAI.72.4.2229-2239.2004; Shi MQ, 2010, J CLIN INVEST, V120, P1683, DOI 10.1172/JCI41963; Syme RM, 1999, INFECT IMMUN, V67, P4620, DOI 10.1128/IAI.67.9.4620-4627.1999; Vecchiarelli A, 2002, IMMUNOLOGY, V106, P267, DOI 10.1046/j.1365-2567.2002.01419.x; Zaragoza O, 2008, CELL MICROBIOL, V10, P2043, DOI 10.1111/j.1462-5822.2008.01186.x	42	23	26	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e35455	10.1371/journal.pone.0035455	http://dx.doi.org/10.1371/journal.pone.0035455			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22530025	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000305347400052
J	Wu, MZ; Nissen, JC; Chen, EI; Tsirka, SE				Wu, Muzhou; Nissen, Jillian C.; Chen, Emily I.; Tsirka, Stella E.			Tuftsin Promotes an Anti-Inflammatory Switch and Attenuates Symptoms in Experimental Autoimmune Encephalomyelitis	PLOS ONE			English	Article							EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; TISSUE-PLASMINOGEN ACTIVATOR; CENTRAL-NERVOUS-SYSTEM; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; REGULATORY T-CELLS; SPINAL-CORD-INJURY; MULTIPLE-SCLEROSIS; ANIMAL-MODELS; CUTTING EDGE; MICROGLIA	Multiple sclerosis (MS) is a demyelinating autoimmune disease mediated by infiltration of T cells into the central nervous system after compromise of the blood-brain barrier. We have previously shown that administration of tuftsin, a macrophage/microglial activator, dramatically improves the clinical course of experimental autoimmune encephalomyelitis (EAE), a well-established animal model for MS. Tuftsin administration correlates with upregulation of the immunosuppressive Helper-2 Tcell (Th2) cytokine transcription factor GATA-3. We now show that tuftsin-mediated microglial activation results in shifting microglia to an anti-inflammatory phenotype. Moreover, the T cell phenotype is shifted towards immunoprotection after exposure to tuftsin-treated activated microglia; specifically, downregulation of pro-inflammatory Th1 responses is triggered in conjunction with upregulation of Th2-specific responses and expansion of immunosuppressive regulatory T cells (Tregs). Finally, tuftsin-shifted T cells, delivered into animals via adoptive transfer, reverse the pathology observed in mice with established EAE. Taken together, our findings demonstrate that tuftsin decreases the proinflammatory environment of EAE and may represent a therapeutic opportunity for treatment of MS.	[Wu, Muzhou; Nissen, Jillian C.; Chen, Emily I.; Tsirka, Stella E.] SUNY Stony Brook, Sch Med, Dept Pharmacol Sci, Stony Brook, NY 11794 USA; [Wu, Muzhou; Tsirka, Stella E.] SUNY Stony Brook, Sch Med, Program Neurosci, Stony Brook, NY 11794 USA; [Nissen, Jillian C.; Tsirka, Stella E.] SUNY Stony Brook, Sch Med, Program Mol & Cellular Pharmacol, Stony Brook, NY 11794 USA; [Chen, Emily I.] SUNY Stony Brook, Sch Med, Prote Ctr, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Wu, MZ (corresponding author), SUNY Stony Brook, Sch Med, Dept Pharmacol Sci, Stony Brook, NY 11794 USA.	stella@pharm.stonybrook.edu	Tsirka, Stella/AAD-4018-2019		National Institutes of Health (NIH) [R01NS42168]; National Multiple Sclerosis Society (NMSS) [CA1044A1]; National Science Foundation (NSF) 3MT IGERT; NIH/NCRR [1 S10 RR023680-1]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023680] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007518] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042168] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society (NMSS)(National Multiple Sclerosis Society); National Science Foundation (NSF) 3MT IGERT(National Science Foundation (NSF)); NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health (NIH) R01NS42168, National Multiple Sclerosis Society (NMSS) CA1044A1 and National Science Foundation (NSF) 3MT IGERT. The mass spectrometer used in this study was funded by the shared instrument grant (NIH/NCRR 1 S10 RR023680-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2003, J NEUROTRAUM, V20, P43, DOI 10.1089/08977150360517173; Benveniste EN, 1997, J MOL MED-JMM, V75, P165, DOI 10.1007/s001090050101; Bernard CCA, 1997, J MOL MED-JMM, V75, P77, DOI 10.1007/s001090050092; Bhasin M, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-10; Bonecchi R, 1998, J EXP MED, V187, P129, DOI 10.1084/jem.187.1.129; Bukhari N, 2011, J NEUROSCI, V31, P14931, DOI 10.1523/JNEUROSCI.3339-11.2011; Carvalho PC, 2008, GENET MOL RES, V7, P342, DOI 10.4238/vol7-2gmr426; CHAO CC, 1992, J IMMUNOL, V149, P2736; Crawford HC, 2009, CURR PHARM DESIGN, V15, P2288, DOI 10.2174/138161209788682442; Diemel LT, 1998, NEUROCHEM RES, V23, P341, DOI 10.1023/A:1022405516630; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Ferber IA, 1996, J IMMUNOL, V156, P5; FRIDKIN M, 1989, CRIT REV BIOCHEM MOL, V24, P1, DOI 10.3109/10409238909082550; Funderburg N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001915; Gavazzi I, 2001, CELL TISSUE RES, V305, P275, DOI 10.1007/s004410100365; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; HERMAN ZS, 1981, EXPERIENTIA, V37, P76, DOI 10.1007/BF01965580; Hjelmstrom P, 1998, J IMMUNOL, V161, P4480; Jee Y, 2001, J NEUROIMMUNOL, V114, P40, DOI 10.1016/S0165-5728(00)00446-X; Kersey PJ, 2004, PROTEOMICS, V4, P1985, DOI 10.1002/pmic.200300721; Kigerl K, 2009, J NEUROSCI; Kim S, 2007, J NEUROCHEM, V103, P2640, DOI 10.1111/j.1471-4159.2007.04995.x; Kohm AP, 2002, J IMMUNOL, V169, P4712, DOI 10.4049/jimmunol.169.9.4712; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Lai AY, 2008, GLIA, V56, P259, DOI 10.1002/glia.20610; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Liu YW, 2006, NAT MED, V12, P518, DOI 10.1038/nm1402; Lloyd CM, 2000, J EXP MED, V191, P265, DOI 10.1084/jem.191.2.265; Lock C, 2002, NAT MED, V8, P500, DOI 10.1038/nm0502-500; Lohr J, 2006, J EXP MED, V203, P2785, DOI 10.1084/jem.20061341; Lu WQ, 2002, J NEUROSCI, V22, P10781; McGeachy MJ, 2005, J IMMUNOL, V175, P3025, DOI 10.4049/jimmunol.175.5.3025; Michelucci A, 2009, J NEUROIMMUNOL, V210, P3, DOI 10.1016/j.jneuroim.2009.02.003; MIKITA J, 2010, MULT SCLER; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Nieuwenhuis EES, 2002, P NATL ACAD SCI USA, V99, P16951, DOI 10.1073/pnas.252648899; NISHIOKA K, 1973, BIOCHIM BIOPHYS ACTA, V310, P230, DOI 10.1016/0005-2795(73)90025-1; Olah M, 2012, GLIA, V60, P306, DOI 10.1002/glia.21266; Olivares-Villagomez D, 1998, J EXP MED, V188, P1883, DOI 10.1084/jem.188.10.1883; Paul C, 2000, J NEUROSCI METH, V98, P83, DOI 10.1016/S0165-0270(00)00201-6; Pitt D, 2000, NAT MED, V6, P67, DOI 10.1038/71555; Rabchevsky AG, 1998, MENT RETARD DEV D R, V4, P187, DOI 10.1002/(SICI)1098-2779(1998)4:3<187::AID-MRDD6>3.0.CO;2-L; Raivich G, 2004, BRAIN RES REV, V46, P261, DOI 10.1016/j.brainresrev.2004.06.006; Rogove AD, 1998, CURR BIOL, V8, P19, DOI 10.1016/S0960-9822(98)70016-8; ROTT O, 1994, EUR J IMMUNOL, V24, P1434, DOI 10.1002/eji.1830240629; Siao CJ, 2002, J NEUROSCI, V22, P3352; Siddiq MM, 2004, MOL CELL NEUROSCI, V25, P162, DOI 10.1016/j.mcn.2003.10.007; Siemion IZ, 1999, PEPTIDES, V20, P645, DOI 10.1016/S0196-9781(99)00019-4; Smith T, 2000, NAT MED, V6, P62, DOI 10.1038/71548; Stanislaus Romesh, 2005, J Autoimmune Dis, V2, P4, DOI 10.1186/1740-2557-2-4; STEVENS DB, 1994, J NEUROIMMUNOL, V51, P77, DOI 10.1016/0165-5728(94)90131-7; SWANBORG RH, 1995, CLIN IMMUNOL IMMUNOP, V77, P4, DOI 10.1016/0090-1229(95)90130-2; THANOS S, 1993, J NEUROSCI, V13, P455; Tordjman R, 2002, NAT IMMUNOL, V3, P477, DOI 10.1038/ni789; Veeravalli KK, 2009, NEUROCHEM RES, V34, P1183, DOI 10.1007/s11064-008-9894-3; von Wronski MA, 2006, J BIOL CHEM, V281, P5702, DOI 10.1074/jbc.M511941200; Wang L, 2003, J BIOL CHEM, V278, P48848, DOI 10.1074/jbc.M310047200; Wei JC, 2007, INT ELECTRON J ALGEB, V2, P1; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Wu M, 2009, GLIA; Yao Y, 2010, J BIOL CHEM, V285, P31509, DOI 10.1074/jbc.M110.124891; Ye BH, 1997, NAT GENET, V16, P161, DOI 10.1038/ng0697-161; Zhai HY, 2011, GLIA, V59, P472, DOI 10.1002/glia.21117	65	29	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e34933	10.1371/journal.pone.0034933	http://dx.doi.org/10.1371/journal.pone.0034933			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22529957	Green Published, gold, Green Submitted			2022-12-27	WOS:000305347400026
J	McIver, SC; Stanger, SJ; Santarelli, DM; Roman, SD; Nixon, B; McLaughlin, EA				McIver, Skye C.; Stanger, Simone J.; Santarelli, Danielle M.; Roman, Shaun D.; Nixon, Brett; McLaughlin, Eileen A.			A Unique Combination of Male Germ Cell miRNAs Coordinates Gonocyte Differentiation	PLOS ONE			English	Article							SPERMATOGONIAL STEM-CELLS; TESTICULAR EMBRYONAL CARCINOMA; MOUSE SPERMATOGENESIS; SELF-RENEWAL; MICRORNA EXPRESSION; TESTIS TISSUES; UP-REGULATION; TUMORS; PROLIFERATION; TRANSITION	The last 100 years have seen a concerning decline in male reproductive health associated with decreased sperm production, sperm function and male fertility. Concomitantly, the incidence of defects in reproductive development, such as undescended testes, hypospadias and testicular cancer has increased. Indeed testicular cancer is now recognised as the most common malignancy in young men. Such cancers develop from the pre-invasive lesion Carcinoma in Situ (CIS), a dysfunctional precursor germ cell or gonocyte which has failed to successfully differentiate into a spermatogonium. It is therefore essential to understand the cellular transition from gonocytes to spermatogonia, in order to gain a better understanding of the aetiology of testicular germ cell tumours. MicroRNA (miRNA) are important regulators of gene expression in differentiation and development and thus highly likely to play a role in the differentiation of gonocytes. In this study we have examined the miRNA profiles of highly enriched populations of gonocytes and spermatogonia, using microarray technology. We identified seven differentially expressed miRNAs between gonocytes and spermatogonia (down-regulated: miR-293, 291a-5p, 290-5p and 294*, up-regulated: miR-136, 743a and 463*). Target prediction software identified many potential targets of several differentially expressed miRNA implicated in germ cell development, including members of the PTEN, and Wnt signalling pathways. These targets converge on the key downstream cell cycle regulator Cyclin D1, indicating that a unique combination of male germ cell miRNAs coordinate the differentiation and maintenance of pluripotency in germ cells.	[McIver, Skye C.; Stanger, Simone J.; Roman, Shaun D.; Nixon, Brett; McLaughlin, Eileen A.] Univ Newcastle, ARC Ctr Excellence Biotechnol & Dev, Discipline Biol Sci, Sch Environm & Life Sci, Callaghan, NSW 2308, Australia; [Santarelli, Danielle M.] Univ Newcastle, Sch Biomed Sci & Pharm, Callaghan, NSW 2308, Australia	University of Newcastle; University of Newcastle	McLaughlin, EA (corresponding author), Univ Newcastle, ARC Ctr Excellence Biotechnol & Dev, Discipline Biol Sci, Sch Environm & Life Sci, Callaghan, NSW 2308, Australia.	eileen.mclaughlin@newcastle.edu.au	McLaughlin, Eileen A/G-7620-2013; Roman, Shaun/AFR-5087-2022; Nixon, Brett/B-5121-2012; McLaughlin, Eileen/AAF-5588-2021; ROMAN, SHAUN/G-7047-2013	Nixon, Brett/0000-0003-2745-8188; McLaughlin, Eileen/0000-0002-5837-3876; Santarelli, Danielle/0000-0002-2756-3327; ROMAN, SHAUN/0000-0002-7758-7757	Australian Research Council; National Health and Medical Research Council; University of Newcastle; Australian Postgraduate Award PhD scholarship; Australian Research Council Centre of Excellence in Biotechnology and Development [CE0348239]; University of Newcastle Vice Chancellors Post Graduate Award	Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); University of Newcastle; Australian Postgraduate Award PhD scholarship; Australian Research Council Centre of Excellence in Biotechnology and Development(Australian Research Council); University of Newcastle Vice Chancellors Post Graduate Award	The authors gratefully acknowledge the financial assistance to EAM, SDR and BN by the Australian Research Council, National Health and Medical Research Council and the University of Newcastle. SCM is the recipient of an Australian Postgraduate Award PhD scholarship and a University of Newcastle Vice Chancellors Post Graduate Award. This work was supported by the Australian Research Council Centre of Excellence in Biotechnology and Development (CE0348239) to EAM and SDR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baleato RM, 2005, DEV BIOL, V286, P78, DOI 10.1016/j.ydbio.2005.07.009; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Beumer TL, 2000, BIOL REPROD, V63, P1893, DOI 10.1095/biolreprod63.6.1893; Buchold GM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015317; Cao X, 2011, MED ONCOLOGY; Conrotto P, 2011, MOL ONCOLOGY; Corney DC, 2007, CANCER RES, V67, P8433, DOI 10.1158/0008-5472.CAN-07-1585; Cui Y, 2011, J CELL PHYSL; Culty M, 2009, BIRTH DEFECTS RES C, V87, P1, DOI 10.1002/bdrc.20142; Dai L, 2011, J BIOL CHEM; Dalgaard MD, 2011, J MED GENETICS; de Jong Jeroen, 2006, Critical Reviews in Oncogenesis, V12, P171; Di Vizio D, 2005, ONCOGENE, V24, P1882, DOI 10.1038/sj.onc.1208368; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Feng M, 2011, ONCOGENE, V30, P2242, DOI 10.1038/onc.2010.602; Freemantle SJ, 2007, INT J ONCOL, V30, P333; Gilbert D, 2011, NAT REV CANCER, V11, P278, DOI 10.1038/nrc3021; Gilbert DC, 2011, GENE CHROMOSOME CANC, V50, P186, DOI 10.1002/gcc.20843; Gillis AJM, 2007, J PATHOL, V213, P319, DOI 10.1002/path.2230; Giwercman A, 2011, BEST PRACT RES CL EN, V25, P391, DOI 10.1016/j.beem.2010.09.011; Goddard NC, 2007, INT J ANDROL, V30, P337, DOI 10.1111/j.1365-2605.2007.00769.x; Golestaneh N, 2009, REPRODUCTION, V138, P151, DOI 10.1530/REP-08-0510; Hayashi K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001738; Huang Y, 2011, CELL BIOL INT, V35, P905, DOI 10.1042/CBI20110161; Jin X, 2011, CANCER RES, V71, P3066, DOI 10.1158/0008-5472.CAN-10-1495; Joffe M, 2010, HUM REPROD, V25, P295, DOI 10.1093/humrep/dep390; Kocer A, 2009, MOL HUM REPROD, V15, P205, DOI 10.1093/molehr/gap008; Kotlabova K, 2011, J REPROD IMMUNOL, V89, P185, DOI 10.1016/j.jri.2011.02.006; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Larson BL, 2010, TISSUE ENG PT A, V16, P3385, DOI 10.1089/ten.tea.2010.0085; Lee J, 2007, DEVELOPMENT, V134, P1853, DOI 10.1242/dev.003004; Lee TL, 2009, BIRTH DEFECTS RES C, V87, P43, DOI 10.1002/bdrc.20147; Li Q, 2005, J BIOL CHEM, V280, P2831, DOI 10.1074/jbc.M405680200; Lian J, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.70; Lian J, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-13; Linsen SEV, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-249; Liu X, 2010, J CLIN INVEST, V120, P1298, DOI 10.1172/JCI39566; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lize M, 2010, CELL DEATH DIFFER, V17, P452, DOI 10.1038/cdd.2009.188; Luo JP, 2009, J CELL PHYSIOL, V220, P460, DOI 10.1002/jcp.21789; Luo LF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011744; Ma PP, 2006, MOL REPROD DEV, V73, P774, DOI 10.1002/mrd.20468; Maatouk DM, 2008, BIOL REPROD, V79, P696, DOI 10.1095/biolreprod.108.067827; Marcon E, 2008, CHROMOSOME RES, V16, P243, DOI 10.1007/s10577-007-1190-6; McIver SC, 2012, HUM REPROD UPDATE, V18, P44, DOI 10.1093/humupd/dmr041; Medeiros LA, 2011, P NATL ACAD SCI USA, V108, P14163, DOI 10.1073/pnas.1111241108; Meyts ERD, 2007, ANN NY ACAD SCI, V1120, P168, DOI 10.1196/annals.1411.013; Niu ZY, 2011, P NATL ACAD SCI USA, V108, P12740, DOI 10.1073/pnas.1109987108; Noel EE, 2010, AM J PATHOL, V176, P2607, DOI 10.2353/ajpath.2010.090780; Nusse R, 2008, CELL RES, V18, P523, DOI 10.1038/cr.2008.47; Oatley JM, 2006, METHOD ENZYMOL, V419, P259, DOI 10.1016/S0076-6879(06)19011-4; Papaioannou MD, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M900587-MCP200; Papaioannou MD, 2010, J ANDROL, V31, P26, DOI 10.2164/jandrol.109.008128; Pode-Shakked N, 2011, ONCOGENE, V30, P1664, DOI 10.1038/onc.2010.549; Povey AC, 2010, HUM FERTIL, V13, P182, DOI 10.3109/14647273.2010.515700; Ro S, 2007, DEV BIOL, V311, P592, DOI 10.1016/j.ydbio.2007.09.009; Ruprecht-Karles-Universitat, 2010, MIRWALK DAT PRED VAL; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Shi QL, 2011, J NEUROCHEM, V118, P440, DOI 10.1111/j.1471-4159.2011.07333.x; Skakkebek NE, 2007, INT J ANDROL, V30, P198, DOI 10.1111/j.1365-2605.2007.00776.x; Sonne SB, 2009, CANCER RES, V69, P5241, DOI 10.1158/0008-5472.CAN-08-4554; Suzuki H, 2011, DEV BIOL; Tanwar PS, 2010, BIOL REPROD, V82, P422, DOI 10.1095/biolreprod.109.079335; Tong MH, 2011, BIOL REPROD; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vasudevan S, 2007, CELL, V128, P1105, DOI 10.1016/j.cell.2007.01.038; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Wang Y, 2008, NAT GENET, V40, P1478, DOI 10.1038/ng.250; Wu X, 2011, BIOL REPROD, V85, P1114, DOI 10.1095/biolreprod.111.091793; Yan NH, 2007, REPRODUCTION, V134, P73, DOI 10.1530/REP-07-0056; Yan NH, 2009, J ASSIST REPROD GEN, V26, P179, DOI 10.1007/s10815-009-9305-y; Yang L, 2011, ONCOGENE; Yu ZR, 2005, BIOL REPROD, V73, P427, DOI 10.1095/biolreprod.105.040998; Zhang BH, 2009, ENVIRON HEALTH PERSP, V117, P231, DOI 10.1289/ehp.11841; Zheng GXY, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002054; Zovoilis A, 2008, MOL HUM REPROD, V14, P521, DOI 10.1093/molehr/gan044; Zovoilis A, 2010, MOL HUM REPROD, V16, P793, DOI 10.1093/molehr/gaq053	77	59	62	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35553	10.1371/journal.pone.0035553	http://dx.doi.org/10.1371/journal.pone.0035553			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536405	Green Published, gold			2022-12-27	WOS:000305339200078
J	Momke, S; Sickinger, M; Rehage, J; Doll, K; Distl, O				Moemke, Stefanie; Sickinger, Marlene; Rehage, Juergen; Doll, Klaus; Distl, Ottmar			Transcription Factor Binding Site Polymorphism in the Motilin Gene Associated with Left-Sided Displacement of the Abomasum in German Holstein Cattle	PLOS ONE			English	Article							GASTRIC DILATATION; MILK-PRODUCTION	Left-sided displacement of the abomasum (LDA) is a common disease in many dairy cattle breeds. A genome-wide screen for QTL for LDA in German Holstein (GH) cows indicated motilin (MLN) as a candidate gene on bovine chromosome 23. Genomic DNA sequence analysis of MLN revealed a total of 32 polymorphisms. All informative polymorphisms used for association analyses in a random sample of 1,136 GH cows confirmed MLN as a candidate for LDA. A single nucleotide polymorphism (FN298674:g.90T>C) located within the first non-coding exon of bovine MLN affects a NKX2-5 transcription factor binding site and showed significant associations (ORallele = 0.64; -log(10)P(allele) = 6.8, -log(10)P(genotype) = 7.0) with LDA. An expression study gave evidence of a significantly decreased MLN expression in cows carrying the mutant allele (C). In individuals heterozygous or homozygous for the mutation, MLN expression was decreased by 89% relative to the wildtype. FN298674:g.90T>C may therefore play a role in bovine LDA via the motility of the abomasum. This MLN SNP appears useful to reduce the incidence of LDA in German Holstein cattle and provides a first step towards a deeper understanding of the genetics of LDA.	[Moemke, Stefanie; Distl, Ottmar] Univ Vet Med Hannover, Inst Anim Breeding & Genet, Hannover, Germany; [Sickinger, Marlene; Doll, Klaus] Univ Giessen, Fac Vet Med, Clin Ruminants & Swine, Giessen, Germany; [Rehage, Juergen] Univ Vet Med Hannover, Clin Cattle, Hannover, Germany	University of Veterinary Medicine Hannover, Foundation; Justus Liebig University Giessen; University of Veterinary Medicine Hannover, Foundation	Distl, O (corresponding author), Univ Vet Med Hannover, Inst Anim Breeding & Genet, Hannover, Germany.	ottmar.distl@tiho-hannover.de			German Research Foundation (Deutsche Forschungsgemeinschaft, DFG), Bonn [MO1691/1-2, MO1691/2-1]	German Research Foundation (Deutsche Forschungsgemeinschaft, DFG), Bonn(German Research Foundation (DFG))	The project and SM were supported by the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG), Bonn (MO1691/1-2 and 2-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; BETHLEHEM M, 1987, TIJDSCHR DIERGENEESK, V112, P1101; Bredal WP, 1996, ACTA VET SCAND, V37, P445; Doll K, 2009, VET J, V181, P90, DOI 10.1016/j.tvjl.2008.01.013; Geishauser T, 1998, NEUROGASTROENT MOTIL, V10, P395; GRYMER J, 1982, NORD VET MED, V34, P412; Hamann H, 2004, J VET MED A, V51, P203, DOI 10.1111/j.1439-0442.2004.00626.x; Hudson NPH, 2008, EQUINE VET J, V40, P422, DOI 10.2746/042516408X312932; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McCallum RW, 2007, ALIMENT PHARM THER, V26, P1121, DOI 10.1111/j.1365-2036.2007.03461.x; McCallum RW, 2007, ALIMENT PHARM THER, V26, P107, DOI 10.1111/j.1365-2036.2007.03346.x; Momke S, 2008, J DAIRY SCI, V91, P4383, DOI 10.3168/jds.2008-1260; Monnet E, 2003, VET CLIN N AM-SMALL, V33, P987, DOI 10.1016/S0195-5616(03)00059-7; Oishi T, 2008, J HUM GENET, V53, P151, DOI 10.1007/s10038-007-0233-3; Poitras P, 2008, CURR OPIN ENDOCRINOL, V15, P54, DOI 10.1097/MED.0b013e3282f370af; Riazi AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005698; Rohrbach BW, 1999, J AM VET MED ASSOC, V214, P1660; Tsai JJ, 2009, J GASTROEN HEPATOL, V24, P1306, DOI 10.1111/j.1440-1746.2009.05956.x; Tsutsui C, 2009, PEPTIDES, V30, P318, DOI 10.1016/j.peptides.2008.10.006; Wierup N, 2007, J CLIN ENDOCR METAB, V92, P3573, DOI 10.1210/jc.2006-2756; Willemse A, 1975, Tijdschr Diergeneeskd, V100, P840; Wittek T, 2008, VET SURG, V37, P537, DOI 10.1111/j.1532-950X.2008.00401.x; Wolf V, 2001, DEUT TIERARZTL WOCH, V108, P403; Zhang ZH, 2008, HEPATOB PANCREAT DIS, V7, P58	26	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35562	10.1371/journal.pone.0035562	http://dx.doi.org/10.1371/journal.pone.0035562			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536407	Green Published, gold, Green Submitted			2022-12-27	WOS:000305339200080
J	de Hevia, MD; Vanderslice, M; Spelke, ES				de Hevia, Maria Dolores; Vanderslice, Monica; Spelke, Elizabeth S.			Cross-Dimensional Mapping of Number, Length and Brightness by Preschool Children	PLOS ONE			English	Article							MENTAL REPRESENTATION; DISCRIMINATION; MAGNITUDE; SPACE; DISTANCE; QUANTITY; DISCRETE; MODEL; TIME; PROXIMITIES	Human adults in diverse cultures, children, infants, and non-human primates relate number to space, but it is not clear whether this ability reflects a specific and privileged number-space mapping. To investigate this possibility, we tested preschool children in matching tasks where the dimensions of number and length were mapped both to one another and to a third dimension, brightness. Children detected variation on all three dimensions, and they reliably performed mappings between number and length, and partially between brightness and length, but not between number and brightness. Moreover, children showed reliably better mapping of number onto the dimension of length than onto the dimension of brightness. These findings suggest that number establishes a privileged mapping with the dimension of length, and that other dimensions, including brightness, can be mapped onto length, although less efficiently. Children's adeptness at number-length mappings suggests that these two dimensions are intuitively related by the end of the preschool years.	[de Hevia, Maria Dolores] Univ Paris 05, Lab Psychol Percept, CNRS, UMR 8158, Paris, France; [Vanderslice, Monica; Spelke, Elizabeth S.] Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Harvard University	de Hevia, MD (corresponding author), Univ Paris 05, Lab Psychol Percept, CNRS, UMR 8158, Paris, France.	dehevialola@gmail.com			ESS from NIH [HD23103]; Harvard Mind, Brain and Behavior; Jacobs Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD023103] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD023103] Funding Source: NIH RePORTER	ESS from NIH; Harvard Mind, Brain and Behavior; Jacobs Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research has been supported by a grant to ESS from NIH (HD23103), and by a Harvard Mind, Brain and Behavior Postdoctoral Fellowship, and a Jacobs Foundation grant to MDdH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres M, 2004, NEUROREPORT, V15, P2773; Bachtold D, 1998, NEUROPSYCHOLOGIA, V36, P731, DOI 10.1016/S0028-3932(98)00002-5; BAIRD JC, 1980, J EXP PSYCHOL HUMAN, V6, P277, DOI 10.1037/0096-1523.6.2.277; BANKS WP, 1977, J EXP PSYCHOL HUMAN, V3, P278, DOI 10.1037/0096-1523.3.2.278; Berch DB, 1999, J EXP CHILD PSYCHOL, V74, P286, DOI 10.1006/jecp.1999.2518; Brannon EM, 2007, DEVELOPMENTAL SCI, V10, P770, DOI 10.1111/j.1467-7687.2007.00635.x; Brannon EM, 2006, DEVELOPMENTAL SCI, V9, pF59, DOI 10.1111/j.1467-7687.2006.00530.x; Brannon EM, 2004, COGNITION, V93, pB59, DOI 10.1016/j.cognition.2004.01.004; Casasanto D, 2008, COGNITION, V106, P579, DOI 10.1016/j.cognition.2007.03.004; Castelli F, 2006, P NATL ACAD SCI USA, V103, P4693, DOI 10.1073/pnas.0600444103; Kadosh RC, 2006, EXP PSYCHOL, V53, P87, DOI 10.1027/1618-3769.53.2.87; Cordes S, 2009, DEVELOPMENTAL SCI, V12, P453, DOI 10.1111/j.1467-7687.2008.00781.x; de Hevia MD, 2010, PSYCHOL SCI, V21, P653, DOI 10.1177/0956797610366091; de Hevia MD, 2008, Q J EXP PSYCHOL, V61, P1496, DOI 10.1080/17470210701560674; de Hevia MD, 2009, COGNITION, V110, P198, DOI 10.1016/j.cognition.2008.11.003; de Hevia MD, 2006, EXP BRAIN RES, V168, P254, DOI 10.1007/s00221-005-0084-0; Dehaene S, 2003, COGN NEUROPSYCHOL, V20, P487, DOI 10.1080/02643290244000239; DEHAENE S, 1993, J EXP PSYCHOL GEN, V122, P371, DOI 10.1037/0278-7393.21.2.314; Dehaene S, 2008, SCIENCE, V320, P1217, DOI 10.1126/science.1156540; Fias W, 2001, PSYCHOL RES-PSYCH FO, V65, P250, DOI 10.1007/s004260100065; Fias W., 1996, MATH COGNITION, V2, P95, DOI [DOI 10.1080/135467996387552, 10.1080/135467996387552]; Fischer MH, 2010, BRAIN COGNITION, V72, P333, DOI 10.1016/j.bandc.2009.10.010; Fischer MH, 2003, NAT NEUROSCI, V6, P555, DOI 10.1038/nn1066; Galton F., 1880, NATURE, V21, P252, DOI [10.1038/021252a0, DOI 10.1038/021252A0]; Gebuis T, 2011, ATTEN PERCEPT PSYCHO, V73, P259, DOI 10.3758/s13414-010-0002-9; Gevers W, 2003, COGNITION, V87, pB87, DOI 10.1016/S0010-0277(02)00234-2; Gevers Wim, 2004, Cortex, V40, P171, DOI 10.1016/S0010-9452(08)70938-9; Holloway ID, 2008, DEVELOPMENTAL SCI, V11, P644, DOI 10.1111/j.1467-7687.2008.00712.x; Holloway ID, 2009, J EXP CHILD PSYCHOL, V103, P17, DOI 10.1016/j.jecp.2008.04.001; Izard V, 2009, P NATL ACAD SCI USA, V106, P10382, DOI 10.1073/pnas.0812142106; JOHNSON DM, 1939, ARCH PSYCHOL, V34, P1; Kadosh RC, 2008, CEREB CORTEX, V18, P337, DOI 10.1093/cercor/bhm058; Knops A, 2009, SCIENCE, V324, P1583, DOI 10.1126/science.1171599; Kotovsky L, 1996, CHILD DEV, V67, P2797, DOI 10.1111/j.1467-8624.1996.tb01889.x; Lipton JS, 2003, PSYCHOL SCI, V14, P396, DOI 10.1111/1467-9280.01453; Lourenco SF, 2010, PSYCHOL SCI, V21, P873, DOI 10.1177/0956797610370158; MECK WH, 1983, J EXP PSYCHOL ANIM B, V9, P320, DOI 10.1037/0097-7403.9.3.320; MOYER RS, 1973, PERCEPT PSYCHOPHYS, V13, P180, DOI 10.3758/BF03214124; Munshell AH, 1912, AM J PSYCHOL, V23, P236, DOI 10.2307/1412843; Opfer JE, 2008, CHILD DEV, V79, P788, DOI 10.1111/j.1467-8624.2008.01158.x; Opfer JE, 2007, COGNITIVE PSYCHOL, V55, P169, DOI 10.1016/j.cogpsych.2006.09.002; Opfer JE, 2010, DEVELOPMENTAL SCI, V13, P761, DOI 10.1111/j.1467-7687.2009.00934.x; PAIVIO A, 1975, MEM COGNITION, V3, P635, DOI 10.3758/BF03198229; Pinel P, 2004, NEURON, V41, P983, DOI 10.1016/S0896-6273(04)00107-2; Previtali P, 2010, EXP BRAIN RES, V201, P599, DOI 10.1007/s00221-009-2063-3; Roitman JD, 2007, ACTA PSYCHOL, V124, P296, DOI 10.1016/j.actpsy.2006.03.008; Rusconi E, 2006, COGNITION, V99, P113, DOI 10.1016/j.cognition.2005.01.004; SHEPARD RN, 1982, PSYCHOL REV, V89, P305, DOI 10.1037/0033-295X.89.4.305; SHEPARD RN, 1958, J EXP PSYCHOL, V55, P509, DOI 10.1037/h0042354; SHEPARD RN, 1962, PSYCHOMETRIKA, V27, P125, DOI 10.1007/BF02289630; SHEPARD RN, 1962, PSYCHOMETRIKA, V27, P219, DOI 10.1007/BF02289621; SHEPARD RN, 1987, SCIENCE, V237, P1317, DOI 10.1126/science.3629243; Siegler RS, 2003, PSYCHOL SCI, V14, P237, DOI 10.1111/1467-9280.02438; Srinivasan M, 2010, COGNITION, V116, P217, DOI 10.1016/j.cognition.2010.05.005; STEVENS JC, 1965, P NATL ACAD SCI USA, V54, P407, DOI 10.1073/pnas.54.2.407; STEVENS SS, 1957, PSYCHOL REV, V64, P153, DOI 10.1037/h0046162; Tudusciuc O, 2007, P NATL ACAD SCI USA, V104, P14513, DOI 10.1073/pnas.0705495104; TVERSKY A, 1977, PSYCHOL REV, V84, P327, DOI 10.1037/h0026750; VALENTINE T, 1991, Q J EXP PSYCHOL-A, V43, P161, DOI 10.1080/14640749108400966; van Galen MS, 2008, J EXP CHILD PSYCHOL, V101, P99, DOI 10.1016/j.jecp.2008.05.001; Vanmarle K, 2006, DEVELOPMENTAL SCI, V9, pF41, DOI 10.1111/j.1467-7687.2006.00508.x; VANOEFFELEN MP, 1982, PERCEPT PSYCHOPHYS, V32, P163, DOI 10.3758/BF03204275; Vuilleumier P, 2004, CORTEX, V40, P399, DOI 10.1016/S0010-9452(08)70134-5; Walker P, 2010, PSYCHOL SCI, V21, P21, DOI 10.1177/0956797609354734; Walsh V, 2003, TRENDS COGN SCI, V7, P483, DOI 10.1016/j.tics.2003.09.002; Xu F, 2000, COGNITION, V74, pB1, DOI 10.1016/S0010-0277(99)00066-9; Zebian S, 2005, J COGN CULT, V5, P165, DOI 10.1163/1568537054068660; Zorzi M, 2002, NATURE, V417, P138, DOI 10.1038/417138a	68	27	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e35530	10.1371/journal.pone.0035530	http://dx.doi.org/10.1371/journal.pone.0035530			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TL	22536399	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336200051
J	DeAndrade, MP; Zhang, L; Doroodchi, A; Yokoi, F; Cheetham, CC; Chen, HX; Roper, SN; Sweatt, JD; Li, YQ				DeAndrade, Mark P.; Zhang, Li; Doroodchi, Atbin; Yokoi, Fumiaki; Cheetham, Chad C.; Chen, Huan-Xin; Roper, Steven N.; Sweatt, J. David; Li, Yuqing			Enhanced Hippocampal Long-Term Potentiation and Fear Memory in Btbd9 Mutant Mice	PLOS ONE			English	Article							SYNAPTIC PLASTICITY; DEFICITS; PROTEIN; DOMAIN; INHIBITOR	Polymorphisms in BTBD9 have recently been associated with higher risk of restless legs syndrome (RLS), a neurological disorder characterized by uncomfortable sensations in the legs at rest that are relieved by movement. The BTBD9 protein contains a BTB/POZ domain and a BACK domain, but its function is unknown. To elucidate its function and potential role in the pathophysiology of RLS, we generated a line of mutant Btbd9 mice derived from a commercial gene-trap embryonic stem cell clone. Btbd9 is the mouse homolog of the human BTBD9. Proteins that contain a BTB/POZ domain have been reported to be associated with synaptic transmission and plasticity. We found that Btbd9 is naturally expressed in the hippocampus of our mutant mice, a region critical for learning and memory. As electrophysiological characteristics of CA3-CA1 synapses of the hippocampus are well characterized, we performed electrophysiological recordings in this region. The mutant mice showed normal input-output relationship, a significant impairment in pre-synaptic activity, and an enhanced long-term potentiation. We further performed an analysis of fear memory and found the mutant mice had an enhanced cued and contextual fear memory. To elucidate a possible molecular basis for these enhancements, we analyzed proteins that have been associated with synaptic plasticity. We found an elevated level of dynamin 1, an enzyme associated with endocytosis, in the mutant mice. These results suggest the first identified function of Btbd9 as being involved in regulating synaptic plasticity and memory. Recent studies have suggested that enhanced synaptic plasticity, analogous to what we have observed, in other regions of the brain could enhance sensory perception similar to what is seen in RLS patients. Further analyses of the mutant mice will help shine light on the function of BTBD9 and its role in RLS.	[DeAndrade, Mark P.] Univ Florida, Coll Med, Interdisciplinary Program Biomed Sci, Gainesville, FL 32610 USA; [DeAndrade, Mark P.; Yokoi, Fumiaki; Li, Yuqing] Univ Florida, Coll Med, Dept Neurol, Gainesville, FL 32611 USA; [Zhang, Li; Doroodchi, Atbin; Cheetham, Chad C.] Univ Alabama Birmingham, Dept Neurol, Sch Med, Ctr Neurodegenerat & Expt Therapeut, Birmingham, AL 35294 USA; [Chen, Huan-Xin; Roper, Steven N.] Univ Florida, Coll Med, Dept Neurosurg, Gainesville, FL USA; [Sweatt, J. David] Univ Alabama Birmingham, Sch Med, Dept Neurobiol, Birmingham, AL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Alabama System; University of Alabama Birmingham; State University System of Florida; University of Florida; University of Alabama System; University of Alabama Birmingham	Li, YQ (corresponding author), Univ Florida, Coll Med, Dept Neurol, Gainesville, FL 32611 USA.	yuqing.li@neurology.ufl.edu	Li, Yuqing/G-1596-2011; Li, Yuqing/AAR-9383-2021; DeAndrade, Mark/G-4930-2011	Li, Yuqing/0000-0003-1211-5529; Li, Yuqing/0000-0003-1211-5529; Tilahin, Shimelis/0000-0001-8975-8026; Sweatt, J. David/0000-0003-3567-485X; DeAndrade, Mark/0000-0003-3610-6459	National Institutes of Health [NS37409, NS47466, NS47692, NS54246, NS57098, NS65273, NS72872, NS74423]; Department of Neurology (University of Alabama at Birmingham); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS037409, P30NS047466, R01NS054246, R21NS065273, R21NS072872, R21NS047692, P50NS037409, R03NS074423, P30NS057098] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Neurology (University of Alabama at Birmingham); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health (grants NS37409, NS47466, NS47692, NS54246, NS57098, NS65273, NS72872, and NS74423) and the Department of Neurology (University of Alabama at Birmingham). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acheson DT, 2011, NEUROPHARMACOLOGY; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Chen Y, 2002, J BIOL CHEM, V277, P30495, DOI 10.1074/jbc.M202076200; Dang MT, 2012, BEHAV BRAIN RES, V226, P465, DOI 10.1016/j.bbr.2011.10.002; Djagaeva I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007598; Edwards RR, 2011, SLEEP MED, V12, P603, DOI 10.1016/j.sleep.2010.09.018; Ferguson SM, 2007, SCIENCE, V316, P570, DOI 10.1126/science.1140621; Flicek P, 2008, NUCLEIC ACIDS RES, V36, pD707, DOI 10.1093/nar/gkm988; FREY U, 1988, BRAIN RES, V452, P57, DOI 10.1016/0006-8993(88)90008-X; Frey U, 1996, J PHYSIOL-LONDON, V490, P703, DOI 10.1113/jphysiol.1996.sp021179; Gong QJ, 2010, BRAIN RES, V1361, P23, DOI 10.1016/j.brainres.2010.09.034; Goosens KA, 2011, CURR OPIN NEUROBIOL; Hallett Penelope J, 2008, Curr Protoc Neurosci, VChapter 1, DOI 10.1002/0471142301.ns0116s42; Hornyak M, 2007, SLEEP MED, V9, P22, DOI 10.1016/j.sleep.2006.09.010; HU S, 1995, GENE DEV, V9, P2936, DOI 10.1101/gad.9.23.2936; Ikeda H, 2003, SCIENCE, V299, P1237, DOI 10.1126/science.1080659; Ito Y, 2001, PHARMACOL BIOCHEM BE, V70, P353, DOI 10.1016/S0091-3057(01)00618-9; Jellen LC, 2009, BIOCHIMIE, V91, P1255, DOI 10.1016/j.biochi.2009.04.009; Kavalali ET, 2011, PHYSIOLOGY, V26, P45, DOI 10.1152/physiol.00040.2010; Kelleher RJ, 2004, NEURON, V44, P59, DOI 10.1016/j.neuron.2004.09.013; Kothapalli KSD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000370; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Levenson JM, 2004, J BIOL CHEM, V279, P40545, DOI 10.1074/jbc.M402229200; Li WJ, 2004, NEURON, V43, P823, DOI 10.1016/j.neuron.2004.08.040; Lukiw WJ, 2005, J CLIN INVEST, V115, P2774, DOI 10.1172/JCI25420; Martin SJ, 2002, HIPPOCAMPUS, V12, P609, DOI 10.1002/hipo.10107; Molinaro P, 2011, J NEUROSCI, V31, P7312, DOI 10.1523/JNEUROSCI.6296-10.2011; Nakamura H, 2010, BMC NEUROSCI ENGLAND; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Pohlack ST, 2011, HUM BRAIN MAPP; Polter A, 2010, NEUROPSYCHOPHARMACOL, V35, P1761, DOI 10.1038/npp.2010.43; Priller C, 2006, J NEUROSCI, V26, P7212, DOI 10.1523/JNEUROSCI.1450-06.2006; Ruscheweyh R, 2011, MOL PAIN ENGLAND; Salinas GD, 2006, J BIOL CHEM, V281, P40164, DOI 10.1074/jbc.M608194200; Schaefer H, 2006, MOL BIOL CELL, V17, P1250, DOI 10.1091/mbc.E05-08-0794; Schrenk-Siemens K, 2008, STEM CELLS; Shalin SC, 2006, NEURON, V50, P765, DOI 10.1016/j.neuron.2006.04.029; Song S, 2007, MOL THER, V15, P1432, DOI 10.1038/sj.mt.6300199; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Stefansson H, 2007, NEW ENGL J MED, V357, P639, DOI 10.1056/NEJMoa072743; Stogios PJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r82; Stogios PJ, 2004, TRENDS BIOCHEM SCI, V29, P634, DOI 10.1016/j.tibs.2004.10.003; Sweitzer SM, 1998, CELL, V93, P1021, DOI 10.1016/S0092-8674(00)81207-6; Walters AS, 2003, SLEEP MED, V4, P121, DOI 10.1016/S1389-9457(02)00258-7; Watanabe T, 2010, J NEUROSCI RES, V88, P1908, DOI 10.1002/jnr.22346; Winkelmann J, 2007, NAT GENET, V39, P1000, DOI 10.1038/ng2099; Yokoi F, 2012, HUM MOL GENET, V21, P916, DOI 10.1093/hmg/ddr528; Yokoi F, 2010, J BIOCHEM, V148, P459, DOI 10.1093/jb/mvq078; Yokoi F, 2009, NEUROSCI RES, V65, P228, DOI 10.1016/j.neures.2009.07.004; Youdim KA, 2000, INT J DEV NEUROSCI, V18, P383, DOI 10.1016/S0736-5748(00)00013-7	50	27	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e35518	10.1371/journal.pone.0035518	http://dx.doi.org/10.1371/journal.pone.0035518			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22536397	Green Submitted, Green Published, gold			2022-12-27	WOS:000305336200050
J	Ramilo, DW; Diaz, S; da Fonseca, IP; Delecolle, JC; Wilson, A; Meireles, J; Lucientes, J; Ribeiro, R; Boinas, F				Ramilo, David W.; Diaz, Suraya; da Fonseca, Isabel Pereira; Delecolle, Jean-Claude; Wilson, Anthony; Meireles, Jose; Lucientes, Javier; Ribeiro, Rita; Boinas, Fernando			First Report of 13 Species of Culicoides (Diptera: Ceratopogonidae) in Mainland Portugal and Azores by Morphological and Molecular Characterization	PLOS ONE			English	Article							AFRICAN HORSE SICKNESS; BITING MIDGES; BLUETONGUE; EPIDEMIOLOGY; VECTORS	The genus Culicoides (Diptera: Ceratopogonidae) contains important vectors of animal and human diseases, including bluetongue, African horse sickness and filariosis. A major outbreak of bluetongue occurred in mainland Portugal in 2004, forty eight years after the last recorded case. A national Entomological Surveillance Plan was initiated in mainland Portugal, Azores and the Madeira archipelagos in 2005 in order to better understand the disease and facilitate policy decisions. During the survey, the most prevalent Culicoides species in mainland Portugal was C. imicola (75.3%) and species belonging to the Obsoletus group (6.5%). The latter were the most prevalent in Azores archipelago, accounting for 96.7% of the total species identified. The Obsoletus group was further characterized by multiplex Polymerase Chain Reaction to species level showing that only two species of this group were present: C. obsoletus sensu strictu (69.6%) and C. scoticus (30.4%). Nine species of Culicoides were detected for the first time in mainland Portugal: C. alazanicus, C. bahrainensis, C. deltus, C. lupicaris, C. picturatus, C. santonicus, C. semimaculatus, C. simulator and C. subfagineus. In the Azores, C. newsteadi and C. circumscriptus were identified for the first time from some islands, and bluetongue vectors belonging to the Obsoletus group (C. obsoletus and C. scoticus) were found to be widespread.	[Ramilo, David W.; Diaz, Suraya; da Fonseca, Isabel Pereira; Meireles, Jose; Ribeiro, Rita; Boinas, Fernando] Univ Tecn Lisboa, Fac Vet Med, Interdisciplinary Ctr Res Anim Hlth CIISA, Lisbon, Portugal; [Delecolle, Jean-Claude] Fac Med, Inst Parasitol & Trop Pathol, Entomol Lab, Strasbourg, France; [Wilson, Anthony] AFRC, Inst Anim Hlth, Pirbright Lab, Woking GU24 0NF, Surrey, England; [Lucientes, Javier] Univ Zaragoza, Fac Vet, Dept Anim Pathol Anim Hlth, Zaragoza, Spain	Universidade de Lisboa; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Pirbright Institute; University of Zaragoza	Ramilo, DW (corresponding author), Univ Tecn Lisboa, Fac Vet Med, Interdisciplinary Ctr Res Anim Hlth CIISA, Lisbon, Portugal.	ifonseca@fmv.utl.pt	Boinas, Fernando/AAD-9779-2022; Pereira da Fonseca, I/AAR-2441-2021; da Fonseca, Isabel Pereira/AAY-1828-2021	Boinas, Fernando/0000-0001-6259-4404; Pereira da Fonseca, I/0000-0002-6632-1224; Wilson, Anthony/0000-0002-2000-2914; Ramilo, David/0000-0003-4096-2581; Meireles, Jose/0000-0002-3001-2809; Ribeiro, Rita/0000-0002-9976-3731	Direccao-Geral de Veterinaria of Portugal; Faculty of Veterinary Medicine of the Technical University of Lisbon; Biotechnology and Biological Sciences Research Council [BBS/E/I/00001409] Funding Source: researchfish; BBSRC [BBS/E/I/00001409] Funding Source: UKRI	Direccao-Geral de Veterinaria of Portugal; Faculty of Veterinary Medicine of the Technical University of Lisbon; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Sources of funding include Direccao-Geral de Veterinaria of Portugal and Faculty of Veterinary Medicine of the Technical University of Lisbon. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alahmed A. M., 2010, Journal of Entomology, V7, P227; Barros SC, 2007, VET MICROBIOL, V124, P25, DOI 10.1016/j.vetmic.2007.04.014; Borkent A, 2011, NUMBERS EXTANT FOSSI; Capela R, 2003, MED VET ENTOMOL, V17, P165, DOI 10.1046/j.1365-2915.2003.00419.x; da Silva VNRB, 2008, SURVEILLANCE VECTOR; Delecolle J-C, 1985, NOUVELLE CONTRIBUITI; Diaz S., 2005, LIST TERRESTRIAL FAU; Guis H, 2007, GEOMATIQUE EPIDEMIOL; Haubruge E., 2008, ECOLOGY CULICOIDES B; LINLEY JR, 1983, J MED ENTOMOL, V20, P347, DOI 10.1093/jmedent/20.4.347; Mathieu B, 2010, INTERACTIVE IDENTIFI, P201; Mellor PS, 2000, ANNU REV ENTOMOL, V45, P307, DOI 10.1146/annurev.ento.45.1.307; Nolan DV, 2007, VET MICROBIOL, V124, P82, DOI 10.1016/j.vetmic.2007.03.019; Pages N, 2009, CULICOIDES SPECIES S; Pena I, 2003, CONTRIBUICAO ESTUDO; Portas M, 1999, EPIDEMIOL INFECT, V123, P337, DOI 10.1017/S0950268899002897; Purse BV, 2005, NAT REV MICROBIOL, V3, P171, DOI 10.1038/nrmicro1090; Rawlings Peter, 1996, Graellsia, V52, P57; Saegerman C, 2008, EMERG INFECT DIS, V14, P539, DOI 10.3201/eid1404.071441; Venter GJ, 2009, VET PARASITOL, V166, P299, DOI 10.1016/j.vetpar.2009.08.020; Vila-Vicosa MJM, 2009, GENERO CULICOIDES LA; Wilson A, 2008, PARASITOL RES, V103, pS69, DOI 10.1007/s00436-008-1053-x	22	16	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e34896	10.1371/journal.pone.0034896	http://dx.doi.org/10.1371/journal.pone.0034896			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22536340	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336200012
J	Sinha, S; Redfield, RJ				Sinha, Sunita; Redfield, Rosemary J.			Natural DNA Uptake by Escherichia coli	PLOS ONE			English	Article							COMPETENCE GENE HOMOLOGS; HAEMOPHILUS-INFLUENZAE; VIBRIO-CHOLERAE; PLASMID TRANSFORMATION; BINDING; PROTEIN; STRAINS; K-12; CELLS; IDENTIFICATION	Escherichia coli has homologues of the competence genes other species use for DNA uptake and processing, but natural competence and transformation have never been detected. Although we previously showed that these genes are induced by the competence regulator Sxy as in other gamma-proteobacteria, no conditions are known that naturally induce sxy expression. We have now tested whether the competence gene homologues encode a functional DNA uptake machinery and whether DNA uptake leads to recombination, by investigating the effects of plasmid-borne sxy expression on natural competence in a wide variety of E. coli strains. High-and low-level sxy expression alone did not induce transformation in any of the strains tested, despite varying the transforming DNA, its concentration, and the incubation conditions used. Direct measurements of uptake of radiolabelled DNA were below the limit of detection, however transformants were readily detected when recombination functions were provided by the lambda Red recombinase. This is the first demonstration that E. coli sxy expression can induce natural DNA uptake and that E. coli's competence genes do encode a functional uptake machinery. However, the amount of transformation cells undergo is limited both by low levels of DNA uptake and by inefficient DNA processing/recombination.	[Sinha, Sunita; Redfield, Rosemary J.] Univ British Columbia, Dept Zool, Vancouver, BC, Canada	University of British Columbia	Sinha, S (corresponding author), Univ British Columbia, Dept Zool, Vancouver, BC, Canada.	sinha@zoology.ubc.ca	Redfield, Rosemary/K-5633-2012	Redfield, Rosemary/0000-0001-8940-587X	Canadian Institute of Health Research	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	This study was funded by a research grant from the Canadian Institute of Health Research to RJR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APPLEYARD RK, 1954, GENETICS, V39, P440; Archer CT, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-9; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BACHMANN BJ, 1972, BACTERIOL REV, V36, P525, DOI 10.1128/MMBR.36.4.525-557.1972; BARTOLOME B, 1991, GENE, V102, P75, DOI 10.1016/0378-1119(91)90541-I; Bauer F, 1999, SYST APPL MICROBIOL, V22, P161, DOI 10.1016/S0723-2020(99)80061-7; Baur B, 1996, APPL ENVIRON MICROB, V62, P3673, DOI 10.1128/AEM.62.10.3673-3678.1996; BERGMANS HEN, 1981, J BACTERIOL, V146, P564, DOI 10.1128/JB.146.2.564-570.1981; Blokesch M, 2012, ENV MICROBIOL; Bosse JT, 2009, FEMS MICROBIOL LETT, V298, P124, DOI 10.1111/j.1574-6968.2009.01706.x; BUKAU B, 1985, J BACTERIOL, V163, P61, DOI 10.1128/JB.163.1.61-68.1985; Cameron ADS, 2008, NUCLEIC ACIDS RES, V36, P10, DOI 10.1093/nar/gkm915; Cameron ADS, 2006, NUCLEIC ACIDS RES, V34, P6001, DOI 10.1093/nar/gkl734; Chen SF, 2001, J MOL BIOL, V314, P75, DOI 10.1006/jmbi.2001.5090; COSLOY SD, 1973, P NATL ACAD SCI USA, V70, P84, DOI 10.1073/pnas.70.1.84; DAGERT M, 1979, GENE, V6, P23, DOI 10.1016/0378-1119(79)90082-9; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dubnau D, 1999, ANNU REV MICROBIOL, V53, P217, DOI 10.1146/annurev.micro.53.1.217; Etchuuya R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016355; Finkel SE, 2001, J BACTERIOL, V183, P6288, DOI 10.1128/JB.183.21.6288-6293.2001; Grainger DC, 2005, P NATL ACAD SCI USA, V102, P17693, DOI 10.1073/pnas.0506687102; GUTTERSON NI, 1983, P NATL ACAD SCI-BIOL, V80, P4894, DOI 10.1073/pnas.80.16.4894; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; INOUE H, 1990, GENE, V96, P23, DOI 10.1016/0378-1119(90)90336-P; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; KOOISTRA J, 1976, J BACTERIOL, V128, P549, DOI 10.1128/JB.128.2.549-556.1976; Lawson CL, 2004, CURR OPIN STRUC BIOL, V14, P10, DOI 10.1016/j.sbi.2004.01.012; Maeda S, 2006, FEMS MICROBIOL LETT, V255, P115, DOI 10.1111/j.1574-6968.2005.00072.x; Maeda S, 2004, FEMS MICROBIOL LETT, V236, P61, DOI 10.1111/j.1574-6968.2004.tb09627.x; Marvig RL, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-155; Maughan H, 2009, EVOLUTION, V63, P1852, DOI 10.1111/j.1558-5646.2009.00658.x; Meibom KL, 2005, SCIENCE, V310, P1824, DOI 10.1126/science.1120096; OCHMAN H, 1984, J BACTERIOL, V157, P690, DOI 10.1128/JB.157.2.690-693.1984; Palchevskiy V, 2006, J BACTERIOL, V188, P3902, DOI 10.1128/JB.01974-05; Pollack-Berti A, 2010, ENVIRON MICROBIOL, DOI [10.1111/j.1462-2920.2011.02689.x, DOI 10.1111/J.1462-2920.2011.02689.X]; REDFIELD RJ, 1991, J BACTERIOL, V173, P5612, DOI 10.1128/jb.173.18.5612-5618.1991; Redfield RJ, 2005, J MOL BIOL, V347, P735, DOI 10.1016/j.jmb.2005.01.012; SABELNIKOV AG, 1979, MOL GEN GENET, V172, P313, DOI 10.1007/BF00271731; SABELNIKOV AG, 1975, MOL GEN GENET, V138, P351, DOI 10.1007/BF00264805; Sauvonnet N, 2000, EMBO J, V19, P2221, DOI 10.1093/emboj/19.10.2221; Sauvonnet N, 2000, J BACTERIOL, V182, P848, DOI 10.1128/JB.182.3.848-854.2000; Sinha S, 2009, J BACTERIOL, V191, P5180, DOI 10.1128/JB.00476-09; Sobue R, 2011, FEBS LETT, V585, P2223, DOI 10.1016/j.febslet.2011.05.040; Suckow G, 2011, J BACTERIOL, V193, P4914, DOI 10.1128/JB.05396-11; Sun DC, 2006, FEMS MICROBIOL LETT, V265, P249, DOI 10.1111/j.1574-6968.2006.00503.x; Sun DC, 2009, J BACTERIOL, V191, P713, DOI 10.1128/JB.01130-08; Tarry M, 2011, J MOL BIOL, V409, P642, DOI 10.1016/j.jmb.2011.04.034; Tracy E, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-101; Tsen SD, 2002, J BIOMED SCI, V9, P246, DOI 10.1159/000059425; VANDIE IM, 1983, J GEN MICROBIOL, V129, P663; VanWagoner TM, 2004, J BACTERIOL, V186, P6409, DOI 10.1128/JB.186.19.6409-6421.2004; WACKERNAGEL W, 1973, BIOCHEM BIOPH RES CO, V51, P306, DOI 10.1016/0006-291X(73)91257-6; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; WESTON A, 1981, J BACTERIOL, V145, P780, DOI 10.1128/JB.145.2.780-787.1981; WILCOX KW, 1975, J BACTERIOL, V122, P443, DOI 10.1128/JB.122.2.443-453.1975; Woegerbauer M, 2002, APPL ENVIRON MICROB, V68, P440, DOI 10.1128/AEM.68.1.440-443.2002; Yamamoto S, 2011, J BACTERIOL, V193, P1953, DOI 10.1128/JB.01340-10; Yamamoto S, 2010, GENE, V457, P42, DOI 10.1016/j.gene.2010.03.003; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597; ZULTY JJ, 1995, P NATL ACAD SCI USA, V92, P3616, DOI 10.1073/pnas.92.8.3616	60	29	31	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e35620	10.1371/journal.pone.0035620	http://dx.doi.org/10.1371/journal.pone.0035620			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22532864	Green Submitted, Green Published, gold			2022-12-27	WOS:000305336200063
J	de Biase, D; Visani, M; Morandi, L; Marucci, G; Taccioli, C; Cerasoli, S; Baruzzi, A; Pession, A				de Biase, Dario; Visani, Michela; Morandi, Luca; Marucci, Gianluca; Taccioli, Cristian; Cerasoli, Serenella; Baruzzi, Agostino; Pession, Annalisa		PERNO Study Grp	miRNAs Expression Analysis in Paired Fresh/Frozen and Dissected Formalin Fixed and Paraffin Embedded Glioblastoma Using Real-Time PCR	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; MICRORNA EXPRESSION; PATHOLOGY ARCHIVES; CANCER; PROLIFERATION; FROZEN; CELLS; GLIOMA	miRNAs are small molecules involved in gene regulation. Each tissue shows a characteristic miRNAs epression profile that could be altered during neoplastic transformation. Glioblastoma is the most aggressive brain tumour of the adult with a high rate of mortality. Recognizing a specific pattern of miRNAs for GBM could provide further boost for target therapy. The availability of fresh tissue for brain specimens is often limited and for this reason the possibility of starting from formalin fixed and paraffin embedded tissue (FFPE) could very helpful even in miRNAs expression analysis. We analysed a panel of 19 miRNAs in 30 paired samples starting both from FFPE and Fresh/Frozen material. Our data revealed that there is a good correlation in results obtained from FFPE in comparison with those obtained analysing miRNAs extracted from Fresh/Frozen specimen. In the few cases with a not good correlation value we noticed that the discrepancy could be due to dissection performed in FFPE samples. To the best of our knowledge this is the first paper demonstrating that the results obtained in miRNAs analysis using Real-Time PCR starting from FFPE specimens of glioblastoma are comparable with those obtained in Fresh/Frozen samples.	[de Biase, Dario; Visani, Michela; Pession, Annalisa] Univ Bologna, Dept Patol Sperimentale, Bologna, Italy; [de Biase, Dario; Morandi, Luca; Marucci, Gianluca] Univ Bologna, Dept Ematol & Sci Oncol, Bologna, Italy; [Taccioli, Cristian] UCL, Paul OGorman Canc Inst, Dept Canc Biol, London, England; [Cerasoli, Serenella] Anat Pathol Bufalini Hosp, Cesena, Italy; [Baruzzi, Agostino] Univ Bologna, IRCCS, Ist Sci Neurol Bologna, Bologna, Italy; [Baruzzi, Agostino] Univ Bologna, Dept Biomed & Neuromotor Sci, Bologna, Italy	University of Bologna; University of Bologna; University of London; University College London; IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB); University of Bologna; University of Bologna	de Biase, D (corresponding author), Univ Bologna, Dept Patol Sperimentale, Bologna, Italy.	dario.debiase@unibo.it	Meletti, Stefano/O-3622-2015; Immovilli, Paolo/AAC-8360-2021; Taccioli, Cristian/ABC-3379-2020; SILINI, ENRICO MARIA/AAB-8747-2019; bertolini, francesco/AAC-9780-2019; Franceschi, Claudio/L-4484-2017; Marucci, Gianluca/F-1426-2019; Rizzi, Romana/R-7051-2016; Morandi, Luca/A-3191-2016; fiorica, francesco/K-8036-2016; Leonardi, Marco/B-2961-2013; Baldin, Elisa/AAC-1311-2020; Nichelli, Paolo/F-7336-2015; Visani, Michela/K-5597-2016; Taccioli, Cristian/F-8801-2010; Iaccarino, Corrado/L-3190-2013; cenni, patrizia/AAL-3588-2020; pisanello, anna/AAM-4486-2020; de Biase, Dario/B-9274-2012; Servadei, Franco/ABX-4656-2022; Rinaldi, Rita/K-7004-2016	Meletti, Stefano/0000-0003-0334-539X; Immovilli, Paolo/0000-0001-9417-3903; Taccioli, Cristian/0000-0003-2995-5612; SILINI, ENRICO MARIA/0000-0003-2578-3059; bertolini, francesco/0000-0001-5660-3255; Franceschi, Claudio/0000-0001-9841-6386; Marucci, Gianluca/0000-0003-4508-3359; Rizzi, Romana/0000-0002-0875-8575; Morandi, Luca/0000-0002-3810-9760; fiorica, francesco/0000-0002-9404-3655; Baldin, Elisa/0000-0002-3277-5623; Nichelli, Paolo/0000-0001-9756-6796; Visani, Michela/0000-0002-9051-2231; Taccioli, Cristian/0000-0003-2995-5612; Iaccarino, Corrado/0000-0002-5133-6327; cenni, patrizia/0000-0001-7911-8500; de Biase, Dario/0000-0002-0609-8817; CARELLI, VALERIO/0000-0003-4923-6404; Pasini, Elena/0000-0001-6298-455X; Brandes, Alba/0000-0002-2503-9089; Bisulli, Francesca/0000-0002-1109-7296; Michelucci, Roberto/0000-0002-9655-7940; Dall'Agata, Monia/0000-0002-2270-5269; Granieri, Enrico/0000-0003-4038-3192; Bonora, Elena/0000-0001-6132-7734; tinuper, paolo/0000-0002-0588-3063; Servadei, Franco/0000-0002-3595-3464; Bigliardi, Guido/0000-0001-5312-7206; morelli, nicola/0000-0003-3787-2243; Palandri, Giorgio/0000-0002-9306-0242; Pession, Annalisa/0000-0001-9035-9698; /0000-0001-9734-8035; Giorgi, Carlotta/0000-0002-2494-7405; Rinaldi, Rita/0000-0002-4564-7284; Casmiro, Mario/0000-0003-0283-5987; franceschi, enrico/0000-0001-9332-4677; Mostacci, Barbara/0000-0002-6994-0821	Progetto Emiliano-Romagnolo di Neuro-Oncologia (PERNO); C.I.R.C. (Centro Interdipartimentale di Ricerche sul Cancro 'G.Prodi', University of Bologna)	Progetto Emiliano-Romagnolo di Neuro-Oncologia (PERNO); C.I.R.C. (Centro Interdipartimentale di Ricerche sul Cancro 'G.Prodi', University of Bologna)	This study was funded by Progetto Emiliano-Romagnolo di Neuro-Oncologia (PERNO) (Emilia-Romagna region project). Dr. de Biase was funded by C.I.R.C. (Centro Interdipartimentale di Ricerche sul Cancro 'G.Prodi', University of Bologna). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Carlsson J, 2011, CANCER CELL INT, V11, DOI 10.1186/1475-2867-11-14; Chen Y, 2008, CANCER LETT, V272, P197, DOI 10.1016/j.canlet.2008.06.034; Ciafre SA, 2005, BIOCHEM BIOPH RES CO, V334, P1351, DOI 10.1016/j.bbrc.2005.07.030; Conti A, 2009, J NEURO-ONCOL, V93, P325, DOI 10.1007/s11060-009-9797-4; Dalmay T, 2008, J INTERN MED, V263, P366, DOI 10.1111/j.1365-2796.2008.01926.x; Gabriely G, 2011, CANCER RES, V71, P3563, DOI 10.1158/0008-5472.CAN-10-3568; Glud M, 2009, J INVEST DERMATOL, V129, P1219, DOI 10.1038/jid.2008.347; Godlewski J, 2008, CANCER RES, V68, P9125, DOI 10.1158/0008-5472.CAN-08-2629; Hasemeier B, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-90; Henriksson R, 2011, J NEURO-ONCOL, V104, P639, DOI 10.1007/s11060-011-0565-x; Hoefig KP, 2008, ANTICANCER RES, V28, P119; Hui ABY, 2009, LAB INVEST, V89, P597, DOI 10.1038/labinvest.2009.12; Huse JT, 2009, GENE DEV, V23, P1327, DOI 10.1101/gad.1777409; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Kefas B, 2008, CANCER RES, V68, P3566, DOI 10.1158/0008-5472.CAN-07-6639; Lawrie CH, 2007, EXPERT OPIN BIOL TH, V7, P1363, DOI 10.1517/14712598.7.9.1363; Leite KRM, 2011, UROL ONCOL-SEMIN ORI, V29, P533, DOI 10.1016/j.urolonc.2009.05.008; Li JH, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-36; Li WB, 2011, CANCER BIOL THER, V12, P477, DOI 10.4161/cbt.12.6.16300; Li YQ, 2009, CANCER RES, V69, P7569, DOI 10.1158/0008-5472.CAN-09-0529; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lukiw WJ, 2009, J NEURO-ONCOL, V91, P27, DOI 10.1007/s11060-009-0077-0; Malzkorn B, 2010, BRAIN PATHOL, V20, P539, DOI 10.1111/j.1750-3639.2009.00328.x; Michael MZ, 2003, MOL CANCER RES, V1, P882; Nass D, 2009, BRAIN PATHOL, V19, P375, DOI 10.1111/j.1750-3639.2008.00184.x; Nelson PT, 2004, NAT METHODS, V1, P155, DOI 10.1038/NMETH717; Nonn L, 2010, EXP MOL PATHOL, V88, P45, DOI 10.1016/j.yexmp.2009.10.005; Pang JCS, 2009, ACTA NEUROPATHOL, V117, P599, DOI 10.1007/s00401-009-0525-0; Quintavalle C, 2011, ONCOGENE; Roa W, 2010, CLIN INVEST MED, V33, pE124; Siebolts U, 2009, J CLIN PATHOL, V62, P84, DOI 10.1136/jcp.2008.058339; Silber J, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-14; Skalsky RL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024248; Smits M, 2010, ONCOTARGET, V1, P710, DOI 10.18632/oncotarget.205; Sozzi G, 2011, CELL CYCLE, V10, P2045, DOI 10.4161/cc.10.13.15712; The WHO, 2020, CLASSIFICATION TUMOU; Ujifuku K, 2010, CANCER LETT, V296, P241, DOI 10.1016/j.canlet.2010.04.013; Wang H, 2007, RNA, V13, P151, DOI 10.1261/rna.234507; Webster RJ, 2009, J BIOL CHEM, V284, P5731, DOI 10.1074/jbc.M804280200; Weng LH, 2010, J PATHOL, V222, P41, DOI 10.1002/path.2736; Xi YG, 2007, RNA, V13, P1668, DOI 10.1261/rna.642907; Zhang X, 2008, J MOL DIAGN, V10, P513, DOI 10.2353/jmoldx.2008.080077	43	27	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35596	10.1371/journal.pone.0035596	http://dx.doi.org/10.1371/journal.pone.0035596			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22530056	Green Published, gold, Green Submitted			2022-12-27	WOS:000305350600102
J	de Cima, S; Gil-Ortiz, F; Crabeel, M; Fita, I; Rubio, V				de Cima, Sergio; Gil-Ortiz, Fernando; Crabeel, Marjolaine; Fita, Ignacio; Rubio, Vicente			Insight on an Arginine Synthesis Metabolon from the Tetrameric Structure of Yeast Acetylglutamate Kinase	PLOS ONE			English	Article							L-GLUTAMATE KINASE; N-ACETYLGLUTAMATE; CRYSTAL-STRUCTURE; THERMOTOGA-MARITIMA; P-II; BIOSYNTHESIS; SYNTHASE; COMPLEX; PURIFICATION; ACETYLTRANSFERASES	N-acetyl-L-glutamate kinase (NAGK) catalyzes the second, generally controlling, step of arginine biosynthesis. In yeasts, NAGK exists either alone or forming a metabolon with N-acetyl-L-glutamate synthase (NAGS), which catalyzes the first step and exists only within the metabolon. Yeast NAGK (yNAGK) has, in addition to the amino acid kinase (AAK) domain found in other NAGKs, a similar to 150-residue C-terminal domain of unclear significance belonging to the DUF619 domain family. We deleted this domain, proving that it stabilizes yNAGK, slows catalysis and modulates feed-back inhibition by arginine. We determined the crystal structures of both the DUF619 domain-lacking yNAGK, ligand-free as well as complexed with acetylglutamate or acetylglutamate and arginine, and of complete mature yNAGK. While all other known arginine-inhibitable NAGKs are doughnut-like hexameric trimers of dimers of AAK domains, yNAGK has as central structure a flat tetramer formed by two dimers of AAK domains. These dimers differ from canonical AAK dimers in the -110 degrees rotation of one subunit with respect to the other. In the hexameric enzymes, an N-terminal extension, found in all arginine-inhibitable NAGKs, forms a protruding helix that interlaces the dimers. In yNAGK, however, it conforms a two-helix platform that mediates interdimeric interactions. Arginine appears to freeze an open inactive AAK domain conformation. In the complete yNAGK structure, two pairs of DUF619 domains flank the AAK domain tetramer, providing a mechanism for the DUF619 domain modulatory functions. The DUF619 domain exhibits the histone acetyltransferase fold, resembling the catalytic domain of bacterial NAGS. However, the putative acetyl CoA site is blocked, explaining the lack of NAGS activity of yNAGK. We conclude that the tetrameric architecture is an adaptation to metabolon formation and propose an organization for this metabolon, suggesting that yNAGK may be a good model also for yeast and human NAGSs.	[de Cima, Sergio; Gil-Ortiz, Fernando; Rubio, Vicente] Ctr Invest Biomed Red Enfermedades Rasas CIBERER, Inst Biomed Valencia Consejo Super Invest Cientif, Valencia, Spain; [Crabeel, Marjolaine] Vrije Univ, Dept Genet & Microbiol Emeritus, Brussels, Belgium; [Fita, Ignacio] Inst Res Biomed IRB Barcelona, Inst Biol Mol Barcelona IBMB CSIC, Barcelona, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biomedicina de Valencia (IBV); Vrije Universiteit Brussel; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB)	de Cima, S (corresponding author), Ctr Invest Biomed Red Enfermedades Rasas CIBERER, Inst Biomed Valencia Consejo Super Invest Cientif, Valencia, Spain.	ifrcri@ibmb.csic.es; rubio@ibv.csic.es	Fita, Ignasi/R-4515-2019; de Cima, Sergio/K-7982-2014; Rubio, Vicente/K-7919-2014	Fita, Ignasi/0000-0002-7521-2679; de Cima, Sergio/0000-0001-9341-5042; Rubio, Vicente/0000-0001-8124-1196; Gil-Ortiz, Fernando/0000-0001-5897-2724	Spanish Ministry for Science (MICINN) [BFU2008-05021]; Valencian Government [Prometeo/2009/051]; CIBERER-ISCIII; Valencian Government; CIBERER; EU (European Union); EMBL (European Molecular Biology Laboratory)	Spanish Ministry for Science (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Valencian Government; CIBERER-ISCIII(Instituto de Salud Carlos III); Valencian Government; CIBERER; EU (European Union)(European Commission); EMBL (European Molecular Biology Laboratory)	This work was supported by the Spanish Ministry for Science (MICINN) (http://www.micinn.es/) [grant number BFU2008-05021], the Valencian Government (http://www.gva.es/) [grant number Prometeo/2009/051], and CIBERER-ISCIII (http://www.ciberer.es/). Dr. de Cima had postdoctoral contracts of the Valencian Government and CIBERER. Dr. Gil-Ortiz was a CSIC-JAE-Doc fellow (http://www.csic.es/web/guest/programa-jae). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the ESRF synchrotron staff for assisting in the data collection, the EU (European Union) and the EMBL (European Molecular Biology Laboratory) for funding synchrotron visits, Nadine Gougeard (CIBERER) for technical help, Drs. A. Abadjieva and K. Pauwels for discussions and for sending plasmid pYB3, Clara Marco for initial expression and crystallization trials, Mariano Polo (IBV-CSIC) for yNAGK crystal 1 data collection, Helen Warburton for English correction, and the crystallization service at the IBV (Dr. F. Gallego) for robotized crystallization trials.	Abadjieva A, 2001, J BIOL CHEM, V276, P42869, DOI 10.1074/jbc.M103732200; BACHMANN C, 1982, BIOCHEM J, V205, P123, DOI 10.1042/bj2050123; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BOONCHIRD C, 1991, EUR J BIOCHEM, V199, P325, DOI 10.1111/j.1432-1033.1991.tb16128.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Caldovic L, 2003, BIOCHEM J, V372, P279, DOI 10.1042/BJ20030002; Caldovic L, 2002, BIOCHEM BIOPH RES CO, V299, P581, DOI 10.1016/S0006-291X(02)02696-7; Caldovic L, 2010, MOL GENET METAB, V100, pS13, DOI 10.1016/j.ymgme.2010.02.018; Cowtan K, JOINT CCP4 ESF EACBM, V31, P34; CUNIN R, 1986, MICROBIOL REV, V50, P314, DOI 10.1128/MMBR.50.3.314-352.1986; Dixon M., 1979, ENZYMES, Vthird; Doublie Sylvie, 2007, Methods Mol Biol, V363, P91, DOI 10.1007/978-1-59745-209-0_5; Dyda F, 2000, ANNU REV BIOPH BIOM, V29, P81, DOI 10.1146/annurev.biophys.29.1.81; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Errey JC, 2005, J BACTERIOL, V187, P3039, DOI 10.1128/JB.187.9.3039-3044.2005; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fernandez-Murga ML, 2004, J BACTERIOL, V186, P6142, DOI 10.1128/JB.186.18.6142-6149.2004; Forchhammer K, 2008, TRENDS MICROBIOL, V16, P65, DOI 10.1016/j.tim.2007.11.004; FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114; Gil-Ortiz F, 2003, J MOL BIOL, V331, P231, DOI 10.1016/S0022-2836(03)00716-2; Gil-Ortiz F, 2010, J MOL BIOL, V399, P476, DOI 10.1016/j.jmb.2010.04.025; HAAS D, 1975, EUR J BIOCHEM, V52, P365, DOI 10.1111/j.1432-1033.1975.tb04004.x; Haberle J, 2003, HUM MUTAT, V21, P593, DOI 10.1002/humu.10216; Hayward S, 2002, J MOL GRAPH MODEL, V21, P181, DOI 10.1016/S1093-3263(02)00140-7; JANCARIK J, 1991, J APPL CRYSTALLOGR, V24, P409, DOI 10.1107/S0021889891004430; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Llacer JL, 2007, P NATL ACAD SCI USA, V104, P17644, DOI 10.1073/pnas.0705987104; Llacer JL, 2008, CURR OPIN STRUC BIOL, V18, P673, DOI 10.1016/j.sbi.2008.11.002; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Min L, 2009, J BIOL CHEM, V284, P4873, DOI 10.1074/jbc.M805348200; Mizuno Y, 2007, J BIOL CHEM, V282, P35733, DOI 10.1074/jbc.M707127200; Neuwald AF, 1997, TRENDS BIOCHEM SCI, V22, P154, DOI 10.1016/S0968-0004(97)01034-7; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Parra-Gessert L, 1998, J BIOL CHEM, V273, P7972, DOI 10.1074/jbc.273.14.7972; Pauwels K, 2003, EUR J BIOCHEM, V270, P1014, DOI 10.1046/j.1432-1033.2003.03477.x; Qu Qiuhao, 2007, BMC Biochemistry, V8, DOI 10.1186/1471-2091-8-4; Ramon-Maiques S, 2006, J MOL BIOL, V356, P695, DOI 10.1016/j.jmb.2005.11.079; Ramon-Maiques S, 2002, STRUCTURE, V10, P329, DOI 10.1016/S0969-2126(02)00721-9; REGLERO A, 1977, FEBS LETT, V81, P13, DOI 10.1016/0014-5793(77)80917-4; Sancho-Vaello E, 2009, FEBS LETT, V583, P202, DOI 10.1016/j.febslet.2008.12.001; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Shi D, 2008, J BIOL CHEM, V283, P7176, DOI 10.1074/jbc.M707678200; SONODA T, 1983, J BIOL CHEM, V258, P9839; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vedadi M, 2006, P NATL ACAD SCI USA, V103, P15835, DOI 10.1073/pnas.0605224103; Walter TS, 2006, STRUCTURE, V14, P1617, DOI 10.1016/j.str.2006.09.005; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Xu Y, 2007, MICROBIOL MOL BIOL R, V71, P36, DOI 10.1128/MMBR.00032-06	54	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e34734	10.1371/journal.pone.0034734	http://dx.doi.org/10.1371/journal.pone.0034734			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529931	Green Published, gold, Green Submitted			2022-12-27	WOS:000305350600024
J	Greenwald, JW; Greenwald, CJ; Philmus, BJ; Begley, TP; Gross, DC				Greenwald, Jessica W.; Greenwald, Charles J.; Philmus, Benjamin J.; Begley, Tadhg P.; Gross, Dennis C.			RNA-seq Analysis Reveals That an ECF sigma Factor, AcsS, Regulates Achromobactin Biosynthesis in Pseudomonas syringae pv. syringae B728a	PLOS ONE			English	Article							OUTER-MEMBRANE; EPIPHYTIC FITNESS; EFFLUX PUMPS; IRON; IDENTIFICATION; VIRULENCE; FLAGELLAR; GENES; SIDEROPHORES; BIOGENESIS	Iron is an essential micronutrient for Pseudomonas syringae pv. syringae strain B728a and many other microorganisms; therefore, B728a has evolved methods of iron acquirement including the use of iron-chelating siderophores. In this study an extracytoplasmic function (ECF) sigma factor, AcsS, encoded within the achromobactin gene cluster is shown to be a major regulator of genes involved in the biosynthesis and secretion of this siderophore. However, production of achromobactin was not completely abrogated in the deletion mutant, implying that other regulators may be involved such as PvdS, the sigma factor that regulates pyoverdine biosynthesis. RNA-seq analysis identified 287 genes that are differentially expressed between the AcsS deletion mutant and the wild type strain. These genes are involved in iron response, secretion, extracellular polysaccharide production, and cell motility. Thus, the transcriptome analysis supports a role for AcsS in the regulation of achromobactin production and the potential activity of both AcsS and achromobactin in the plant-associated lifestyle of strain B728a.	[Greenwald, Jessica W.; Greenwald, Charles J.; Gross, Dennis C.] Texas A&M Univ, Dept Plant Pathol & Microbiol, College Stn, TX 77843 USA; [Philmus, Benjamin J.; Begley, Tadhg P.] Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Greenwald, JW (corresponding author), Texas A&M Univ, Dept Plant Pathol & Microbiol, College Stn, TX 77843 USA.	d-gross@tamu.edu	Begley, Tadhg/B-5801-2015	Philmus, Benjamin/0000-0003-2085-0873	Texas A&M AgriLife Research project [H-8832]	Texas A&M AgriLife Research project	This work was supported by Texas A&M AgriLife Research project no. H-8832. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen C, 2003, REV PHYSIOL BIOCH P, V147, P122, DOI 10.1007/s10254-003-0008-y; Arrebola E, 2007, MOL PLANT MICROBE IN, V20, P500, DOI 10.1094/MPMI-20-5-0500; Arrebola E, 2009, INT MICROBIOL, V12, P87, DOI 10.2436/20.1501.01.85; Banin E, 2005, P NATL ACAD SCI USA, V102, P11076, DOI 10.1073/pnas.0504266102; BERNARD P, 1992, J MOL BIOL, V226, P735, DOI 10.1016/0022-2836(92)90629-X; Berti AD, 2007, J BACTERIOL, V189, P6312, DOI 10.1128/JB.00725-07; Berti AD, 2009, J BACTERIOL, V191, P4594, DOI 10.1128/JB.00457-09; Blair JMA, 2009, CURR OPIN MICROBIOL, V12, P512, DOI 10.1016/j.mib.2009.07.003; Bleuel C, 2005, J BACTERIOL, V187, P6701, DOI 10.1128/JB.187.19.6701-6707.2005; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cornelis P, 2009, ENV MICROBIOL REP, V1, P256, DOI 10.1111/j.1758-2229.2009.00041.x; Croucher NJ, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp811; Dasgupta N, 2003, MOL MICROBIOL, V50, P809, DOI 10.1046/j.1365-2958.2003.03740.x; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Feil H, 2005, P NATL ACAD SCI USA, V102, P11064, DOI 10.1073/pnas.0504930102; Filiatrault MJ, 2010, J BACTERIOL, V192, P2359, DOI 10.1128/JB.01445-09; Franza T, 2005, MOL MICROBIOL, V55, P261, DOI 10.1111/j.1365-2958.2004.04383.x; Friedman L, 2004, J BACTERIOL, V186, P4457, DOI 10.1128/JB.186.14.4457-4465.2004; Goel AK, 2002, J BACTERIOL, V184, P3539, DOI 10.1128/JB.184.13.3539-3548.2002; GRANT SGN, 1990, P NATL ACAD SCI USA, V87, P4645, DOI 10.1073/pnas.87.12.4645; GROSS DC, 1985, J APPL BACTERIOL, V58, P167, DOI 10.1111/j.1365-2672.1985.tb01444.x; GUERINOT ML, 1994, ANNU REV MICROBIOL, V48, P743, DOI 10.1146/annurev.micro.48.1.743; HIRANO SS, 1990, ANNU REV PHYTOPATHOL, V28, P155, DOI 10.1146/annurev.py.28.090190.001103; HUYNH TV, 1989, SCIENCE, V245, P1374, DOI 10.1126/science.2781284; Jackson KD, 2004, J BACTERIOL, V186, P4466, DOI 10.1128/JB.186.14.4466-4475.2004; Jahn CE, 2008, J MICROBIOL METH, V75, P318, DOI 10.1016/j.mimet.2008.07.004; Jones AM, 2011, J BACTERIOL, V193, P2767, DOI 10.1128/JB.00069-10; Joyner DC, 2000, MICROBIOL-UK, V146, P2435, DOI 10.1099/00221287-146-10-2435; KADURUGAMUWA JL, 1987, J CLIN MICROBIOL, V25, P849, DOI 10.1128/JCM.25.5.849-855.1987; Kang HJ, 2005, APPL ENVIRON MICROB, V71, P5056, DOI 10.1128/AEM.71.9.5056-5065.2005; Kendziorski C, 2005, P NATL ACAD SCI USA, V102, P4252, DOI 10.1073/pnas.0500607102; KING EO, 1954, J LAB CLIN MED, V44, P301; Koorts A. M., 2007, Archives of Physiology and Biochemistry, V113, P30, DOI 10.1080/13813450701318583; LANDY A, 1989, ANNU REV BIOCHEM, V58, P913, DOI 10.1146/annurev.biochem.58.1.913; LEONG SA, 1982, J BIOL CHEM, V257, P8724; Liu F, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-153; Liu RY, 2007, P NATL ACAD SCI USA, V104, P7116, DOI 10.1073/pnas.0700266104; LOPER JE, 1987, PHYTOPATHOLOGY, V77, P1449, DOI 10.1094/Phyto-77-1449; Lu SE, 2005, MOL PLANT MICROBE IN, V18, P324, DOI 10.1094/MPMI-18-0324; Ma LY, 2007, J BACTERIOL, V189, P8353, DOI 10.1128/JB.00620-07; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Miethke M, 2007, MICROBIOL MOL BIOL R, V71, P413, DOI 10.1128/MMBR.00012-07; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mossialos D, 2007, FUTURE MICROBIOL, V2, P387, DOI 10.2217/17460913.2.4.387; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; Owen JG, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-218; Peng XJ, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-26; Perkins TT, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000569; Piddock LJV, 2006, NAT REV MICROBIOL, V4, P629, DOI 10.1038/nrmicro1464; Records AR, 2010, J BACTERIOL, V192, P3584, DOI 10.1128/JB.00114-10; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SAWAHEL W, 1993, BIOTECHNOL TECH, V7, P261, DOI 10.1007/BF00150895; Sorek R, 2010, NAT REV GENET, V11, P9, DOI 10.1038/nrg2695; Visca P, 2007, TRENDS MICROBIOL, V15, P22, DOI 10.1016/j.tim.2006.11.004; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Weber KA, 2006, NAT REV MICROBIOL, V4, P752, DOI 10.1038/nrmicro1490; Wensing A, 2010, APPL ENVIRON MICROB, V76, P2704, DOI 10.1128/AEM.02979-09; Yang CH, 2002, MOL PLANT MICROBE IN, V15, P472, DOI 10.1094/MPMI.2002.15.5.472	59	14	14	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e34804	10.1371/journal.pone.0034804	http://dx.doi.org/10.1371/journal.pone.0034804			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529937	Green Published, Green Submitted, gold			2022-12-27	WOS:000305350600029
J	Hayashino, Y; Utsugi-Ozaki, M; Feldman, MD; Fukuhara, S				Hayashino, Yasuaki; Utsugi-Ozaki, Makiko; Feldman, Mitchell D.; Fukuhara, Shunichi			Hope Modified the Association between Distress and Incidence of Self-Perceived Medical Errors among Practicing Physicians: Prospective Cohort Study	PLOS ONE			English	Article							ADVERSE DRUG EVENTS; HOSPITALIZED-PATIENTS; CANCER-PATIENTS; INTENSIVE-CARE; EXCESS LENGTH; DEPRESSION; PERFORMANCE; SAFETY; SATISFACTION; SURGERY	The presence of hope has been found to influence an individual's ability to cope with stressful situations. The objective of this study is to evaluate the relationship between medical errors, hope and burnout among practicing physicians using validated metrics. Prospective cohort study was conducted among hospital based physicians practicing in Japan (N = 836). Measures included the validated Burnout Scale, self-assessment of medical errors and Herth Hope Index (HHI). The main outcome measure was the frequency of self-perceived medical errors, and Poisson regression analysis was used to evaluate the association between hope and medical error. A total of 361 errors were reported in 836 physician-years. We observed a significant association between hope and self-report of medical errors. Compared with the lowest tertile category of HHI, incidence rate ratios (IRRs) of self-perceived medical errors of physicians in the highest category were 0.44 (95% CI, 0.34 to 0.58) and 0.54 (95% CI, 0.42 to 0.70) respectively, for the 2nd and 3rd tertile. In stratified analysis by hope score, among physicians with a low hope score, those who experienced higher burnout reported higher incidence of errors; physicians with high hope scores did not report high incidences of errors, even if they experienced high burnout. Self-perceived medical errors showed a strong association with physicians' hope, and hope modified the association between physicians' burnout and self-perceived medical errors.	[Hayashino, Yasuaki; Fukuhara, Shunichi] Kyoto Univ, Grad Sch Med & Publ Hlth, Dept Epidemiol & Healthcare Res, Kyoto, Japan; [Feldman, Mitchell D.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Utsugi-Ozaki, Makiko] Horikawa Hosp, Kyoto, Japan	Kyoto University; University of California System; University of California San Francisco	Hayashino, Y (corresponding author), Kyoto Univ, Grad Sch Med & Publ Hlth, Dept Epidemiol & Healthcare Res, Kyoto, Japan.	hayasino-y@umin.net	Hayashino, Yasuaki/AAA-8637-2022	Hayashino, Yasuaki/0000-0002-2932-8478	Ministry of Education, Science and Culture of Japan [21790580]; Fulbright Research Fellowship	Ministry of Education, Science and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Fulbright Research Fellowship	This study was funded by research grants from the Ministry of Education, Science and Culture of Japan (No. 21790580). MDF was supported by a Fulbright Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apatira L, 2008, ANN INTERN MED, V149, P861, DOI 10.7326/0003-4819-149-12-200812160-00005; Awata S, 2007, PSYCHIAT CLIN NEUROS, V61, P112, DOI 10.1111/j.1440-1819.2007.01619.x; Baker GR, 2004, CAN MED ASSOC J, V170, P1678, DOI 10.1503/cmaj.1040498; Bates DW, 1997, JAMA-J AM MED ASSOC, V277, P307, DOI 10.1001/jama.277.4.307; Bech P, 2003, INT J METH PSYCH RES, V12, P85, DOI 10.1002/mpr.145; Bumpus Lisa, 2003, J Cardiovasc Manag, V14, P11; Chen ML, 2003, CANCER NURS, V26, P61, DOI 10.1097/00002820-200302000-00009; Chi GCHL, 2007, ONCOL NURS FORUM, V34, P415, DOI 10.1188/07.ONF.415-424; Classen DC, 1997, JAMA-J AM MED ASSOC, V277, P301, DOI 10.1001/jama.277.4.301; Davison SN, 2006, BRIT MED J, V333, P886, DOI 10.1136/bmj.38965.626250.55; DUFAULT K, 1985, NURS CLIN N AM, V20, P379; Duggleby W, 2009, J ADV NURS, V65, P2376, DOI 10.1111/j.1365-2648.2009.05094.x; Fahrenkopf AM, 2008, BRIT MED J, V336, P488, DOI 10.1136/bmj.39469.763218.BE; Greenberg CC, 2008, ANN SURG, V248, P337, DOI 10.1097/SLA.0b013e318181c9a3; Groopman Jerome., 2004, ANATOMY HOPE; Henkel V, 2004, GEN HOSP PSYCHIAT, V26, P190, DOI 10.1016/j.genhosppsych.2004.02.003; Henkel V, 2003, BRIT MED J, V326, P200, DOI 10.1136/bmj.326.7382.200; Herth K, 1991, Sch Inq Nurs Pract, V5, P39; HERTH K, 1992, J ADV NURS, V17, P1251, DOI 10.1111/j.1365-2648.1992.tb01843.x; Kalish R L, 1995, Am J Med Qual, V10, P48, DOI 10.1177/0885713X9501000108; Kataoka M, 2008, JAPANESE SOC NURSING, V31, P67; Kazandjian VA, 2004, QUAL SAF HEALTH CARE, V13, P9, DOI 10.1136/qshc.2003.008698; Kleinbaum D, 1988, APPL REGRESSION ANAL; Kohn L.T., 2000, ERR IS HUMAN BUILDIN, VVolume 600; Koizumi M, 1999, ANN GUNMA HLTH SCI, V20, P103; Kubo M., 2007, Journal of Science of Labour, V83, P39; Kubo M, 2004, PSYCHOL BURNOUT; LEAPE LL, 1991, NEW ENGL J MED, V324, P377, DOI 10.1056/NEJM199102073240605; Leimkuhler AMM, 2007, J AFFECT DISORDERS, V98, P65, DOI 10.1016/j.jad.2006.07.007; Lin CC, 2003, J PAIN SYMPTOM MANAG, V25, P29, DOI 10.1016/S0885-3924(02)00542-0; Lynch W. F., 1974, IMAGES HOPE IMAGINAT; Makary MA, 2006, ANN SURG, V243, P628, DOI 10.1097/01.sla.0000216410.74062.0f; Makary MA, 2007, J AM COLL SURGEONS, V204, P236, DOI 10.1016/j.jamcollsurg.2006.10.018; Matsuda S, 1997, JAPANESE J HLTH PSYC, V10, P44; McClement SE, 2008, EUR J CANCER, V44, P1169, DOI 10.1016/j.ejca.2008.02.031; Mitsumoto H, 2007, JAMA-J AM MED ASSOC, V298, P207, DOI 10.1001/jama.298.2.207; Morimoto T, 2011, J GEN INTERN MED, V26, P148, DOI 10.1007/s11606-010-1518-3; Mutter Michael, 2003, Jt Comm J Qual Saf, V29, P279; Rothschild JM, 2005, CRIT CARE MED, V33, P1694, DOI 10.1097/01.CCM.0000171609.91035.BD; Rustoen T, 2004, HEART LUNG, V33, P111, DOI 10.1016/j.hrtlng.2003.12.003; Rustoen T, 2010, CANCER NURS, V33, P258, DOI 10.1097/NCC.0b013e3181d6fb61; Sand L, 2009, J PAIN SYMPTOM MANAG, V37, P13, DOI 10.1016/j.jpainsymman.2008.01.013; Shively EH, 2004, ANN SURG, V239, P752, DOI 10.1097/01.sla.0000128301.67780.d7; SHORTELL SM, 1994, MED CARE, V32, P508, DOI 10.1097/00005650-199405000-00009; Tao M, 1996, THEORY RES BURNOUT B, P129; Thomas NK, 2004, JAMA-J AM MED ASSOC, V292, P2880, DOI 10.1001/jama.292.23.2880; Ueno T, 1996, JPN J HLTH PSYCHOL, V9, P9; West CP, 2006, JAMA-J AM MED ASSOC, V296, P1071, DOI 10.1001/jama.296.9.1071; West CP, 2009, JAMA-J AM MED ASSOC, V302, P1294, DOI 10.1001/jama.2009.1389; Wonghongkul T, 2000, CANCER NURS, V23, P422, DOI 10.1097/00002820-200012000-00004; Zhan CL, 2003, JAMA-J AM MED ASSOC, V290, P1868, DOI 10.1001/jama.290.14.1868	51	37	39	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35585	10.1371/journal.pone.0035585	http://dx.doi.org/10.1371/journal.pone.0035585			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959XD	22530055	Green Submitted, Green Published, gold			2022-12-27	WOS:000305350600101
J	Liu, JH; Rotkirch, A; Lummaa, V				Liu, Jianghua; Rotkirch, Anna; Lummaa, Virpi			Maternal Risk of Breeding Failure Remained Low throughout the Demographic Transitions in Fertility and Age at First Reproduction in Finland	PLOS ONE			English	Article							LIFE-HISTORY TRAITS; NATURAL-SELECTION; INVESTMENT; POPULATION; PLASTICITY; EXPECTANCY; MORTALITY; BIRTH; MODEL; SIZE	Radical declines in fertility and postponement of first reproduction during the recent human demographic transitions have posed a challenge to interpreting human behaviour in evolutionary terms. This challenge has stemmed from insufficient evolutionary insight into individual reproductive decision-making and the rarity of datasets recording individual long-term reproductive success throughout the transitions. We use such data from about 2,000 Finnish mothers (first births: 1880s to 1970s) to show that changes in the maternal risk of breeding failure (no offspring raised to adulthood) underlay shifts in both fertility and first reproduction. With steady improvements in offspring survival, the expected fertility required to satisfy a low risk of breeding failure became lower and observed maternal fertility subsequently declined through an earlier age at last reproduction. Postponement of the age at first reproduction began when this risk approximated zero-even for mothers starting reproduction late. Interestingly, despite vastly differing fertility rates at different stages of the transitions, the number of offspring successfully raised to breeding per mother remained relatively constant over the period. Our results stress the importance of assessing the long-term success of reproductive strategies by including measures of offspring quality and suggest that avoidance of breeding failure may explain several key features of recent life-history shifts in industrialized societies.	[Liu, Jianghua; Lummaa, Virpi] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; [Rotkirch, Anna] Univ Oxford, Dept Social Policy & Intervent, Oxford Ctr Populat Studies, Oxford, England; [Lummaa, Virpi] Inst Adv Study, Berlin, Germany	University of Sheffield; University of Oxford	Liu, JH (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England.	jh1980.liu@gmail.com	Lummaa, Virpi/AHB-0181-2022	Liu, Jianghua/0000-0003-1143-0535	University of Sheffield; Kone Foundation; European Research Council; Royal Society of London	University of Sheffield; Kone Foundation; European Research Council(European Research Council (ERC)European Commission); Royal Society of London(Royal Society of London)	The research was supported by the University of Sheffield (JL), Kone Foundation (VL, AR, and JL), European Research Council (VL) and the Royal Society of London (VL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allal N, 2004, P ROY SOC B-BIOL SCI, V271, P465, DOI 10.1098/rspb.2003.2623; Alvergne A, 2008, PHYSIOL BEHAV, V95, P625, DOI 10.1016/j.physbeh.2008.09.005; Anderson KG, 2010, HUM NATURE-INT BIOS, V21, P103, DOI 10.1007/s12110-010-9087-z; ANGERBJORN A, 1995, ANN ZOOL FENN, V32, P55; [Anonymous], 2010, R LANG ENV STAT COMP; Bates D, LME4 LINEAR MIXED EF; Boyd R., 1985, CULTURE EVOLUTIONARY; Chesnais J-C, 1986, DEMOGRAPHIC TRANSITI; Coale AJ, 1986, DECLINE FERTILITY EU, P1; Council of Europe, 2003, REC DEM DEV EUR; Crawley M. J, 2002, STAT COMPUTING INTRO; Faraway J, 2006, EXTENDING LINEAR MOD; Frejka T, 2006, DEMOGR RES, V15, P147, DOI 10.4054/DemRes.2006.15.6; Gant L, 2009, SOC WORK PUBLIC HLTH, V24, P39, DOI 10.1080/19371910802569435; Geronimus AT, 1996, HUM NATURE-INT BIOS, V7, P323, DOI 10.1007/BF02732898; Gillespie DOS, 2008, P ROY SOC B-BIOL SCI, V275, P713, DOI 10.1098/rspb.2007.1000; HAMILTON WD, 1966, J THEOR BIOL, V12, P12, DOI 10.1016/0022-5193(66)90184-6; HASHIMOTO M, 1981, ECON DEV CULT CHANGE, V29, P781, DOI 10.1086/451291; Hill K., 1996, ACHE LIFE HIST ECOLO, DOI 10.4324/9781351329248; Kaplan H, 2002, AM J HUM BIOL, V14, P233, DOI 10.1002/ajhb.10041; Kaplan H, 1995, HUMAN REPROD DECISIO, P96; KLINDWORTH H, 1995, HUM NATURE-INT BIOS, V6, P221, DOI 10.1007/BF02734140; Lawson DW, 2011, PHILOS T R SOC B, V366, P333, DOI 10.1098/rstb.2010.0297; Lenni-Taattola H, 2002, KOTOISIN IKAALISISTA; Liu JH, 2011, EVOL HUM BEHAV, V32, P433, DOI 10.1016/j.evolhumbehav.2010.10.007; Low BS, 2008, CROSS-CULT RES, V42, P201, DOI 10.1177/1069397108317669; Low BS, 2002, AM J HUM BIOL, V14, P149, DOI 10.1002/ajhb.10043; Lumia M., 2010, IKAAALISTEN ISOROYHI; Lumia M, 2008, IKAALISTEN LEUTOLAN; Lumia M, 2003, IKAALISTEN HEITTOLAN; Lummaa V, 1998, NATURE, V394, P533, DOI 10.1038/28977; Lummaa V, 2001, P ROY SOC B-BIOL SCI, V268, P1977, DOI 10.1098/rspb.2001.1786; LUTTBEG B, 2000, ADAPTATION HUMAN BEH, P345; Lutz W., 1987, FINNISH FERTILITY 17; Mace R, 1996, ETHOL SOCIOBIOL, V17, P263, DOI 10.1016/0162-3095(96)00044-1; Mace R, 2008, SCIENCE, V319, P764, DOI 10.1126/science.1153960; Malthus Thomas Robert, 1803, ESSAY PRINCIPLE POPU, V2nd; MAY DA, 1968, POP STUD-J DEMOG, V22, P199, DOI 10.1080/00324728.1968.10405535; Mowat G, 1996, J WILDLIFE MANAGE, V60, P441, DOI 10.2307/3802247; Mulder MB, 1998, TRENDS ECOL EVOL, V13, P266, DOI 10.1016/S0169-5347(98)01357-3; Nettle D, 2011, PHILOS T R SOC B, V366, P357, DOI 10.1098/rstb.2010.0073; NEWTON I, 1981, ORNIS SCAND, V12, P224, DOI 10.2307/3676082; Organisation for Economic Co-operation and Development (OECD), OECD FAM DAT; Pettay JE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000606; Sarkar D, LATTICE LATTICE GRAP; Singleton F, 1998, SHORT HIST FINLAND; Sobotka T., 2004, THESIS U GRONINGEN; Sobotka T, 2008, DEMOGR RES, V19, P171, DOI 10.4054/DemRes.2008.19.8; Statistics Finland, 2009, TOT FERT RAT 1900 20; Stearns S., 1992, EVOLUTION LIFE HIST; STEARNS SC, 1986, EVOLUTION, V40, P893, DOI 10.1111/j.1558-5646.1986.tb00560.x; SYDEMAN WJ, 1991, J ANIM ECOL, V60, P135, DOI 10.2307/5450; TAYLOR CE, 1976, POP STUD-J DEMOG, V30, P263, DOI 10.1080/00324728.1976.10412734; van de Walle Francine, 1986, DECLINE FERTILITY EU, P201; Wilson M, 1997, BRIT MED J, V314, P1271, DOI 10.1136/bmj.314.7089.1271; Winterhalder B, 2002, EVOL HUM BEHAV, V23, P59, DOI 10.1016/S1090-5138(01)00089-7; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; [No title captured]	58	18	18	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e34898	10.1371/journal.pone.0034898	http://dx.doi.org/10.1371/journal.pone.0034898			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529952	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000305350600039
J	Arocena, GM; Zorreguieta, A; Sieira, R				Arocena, Gaston M.; Zorreguieta, Angeles; Sieira, Rodrigo			Expression of VjbR under Nutrient Limitation Conditions Is Regulated at the Post-Transcriptional Level by Specific Acidic pH Values and Urocanic Acid	PLOS ONE			English	Article							IV SECRETION SYSTEM; PATHOGEN BRUCELLA-MELITENSIS; INTRACELLULAR SURVIVAL; ENDOPLASMIC-RETICULUM; VIRB OPERON; ABORTUS; SUIS; IDENTIFICATION; MACROPHAGES; HOMOLOG	VjbR is a LuxR homolog that regulates transcription of many genes including important virulence determinants of the facultative intracellular pathogen Brucella abortus. This transcription factor belongs to a family of regulators that participate in a cell-cell communication process called quorum sensing, which enables bacteria to respond to changes in cell population density by monitoring concentration of self produced autoinducer molecules. Unlike almost all other LuxR-type proteins, VjbR binds to DNA and activates transcription in the absence of any autoinducer signal. To investigate the mechanisms by which Brucella induces VjbR-mediated transcriptional activation, and to determine how inappropriate spatio-temporal expression of the VjbR target genes is prevented, we focused on the study of expression of vjbR itself. By assaying different parameters related to the intracellular lifestyle of Brucella, we identified a restricted set of conditions that triggers VjbR protein expression. Such conditions required the convergence of two signals of different nature: a specific pH value of 5.5 and the presence of urocanic acid, a metabolite involved in the connection between virulence and metabolism of Brucella. In addition, we also observed an urocanic acid, pH-dependent expression of RibH2 and VirB7, two additional intracellular survival-related proteins of Brucella. Analysis of promoter activities and determination of mRNA levels demonstrated that the urocanic acid-dependent mechanisms that induced expression of VjbR, RibH2, and VirB7 act at the post-transcriptional level. Taken together, our findings support a model whereby Brucella induces VjbR-mediated transcription by modulating expression of VjbR in response to specific signals related to the changing environment encountered within the host.	[Arocena, Gaston M.; Zorreguieta, Angeles; Sieira, Rodrigo] Consejo Nacl Invest Cient & Tecn, IBBA, Fdn Inst Leloir, RA-1033 Buenos Aires, DF, Argentina; [Zorreguieta, Angeles] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Leloir Institute; University of Buenos Aires	Arocena, GM (corresponding author), Consejo Nacl Invest Cient & Tecn, IBBA, Fdn Inst Leloir, RA-1033 Buenos Aires, DF, Argentina.	rsieira@leloir.org.ar			Argentinian Council of Research (CONICET) [PIP2011-00336]; University of Buenos Aires, Argentina [UBACyT X240]	Argentinian Council of Research (CONICET); University of Buenos Aires, Argentina(University of Buenos Aires)	This work was supported by grant PIP2011-00336 to Rodrigo Sieira from the Argentinian Council of Research (CONICET) (http://www.conicet.gov.ar/web/conicet/inicio), and grant UBACyT X240 (http://secinves.com.ar/guias/ubacyt) to Angeles Zorreguieta from the University of Buenos Aires, Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arocena GM, 2010, J BACTERIOL, V192, P3434, DOI 10.1128/JB.00232-10; BECKER A, 1995, GENE, V162, P37, DOI 10.1016/0378-1119(95)00313-U; Boschiroli ML, 2002, P NATL ACAD SCI USA, V99, P1544, DOI 10.1073/pnas.032514299; Broughton ES, 1997, VET MICROBIOL, V57, P253, DOI 10.1016/S0378-1135(97)00135-1; Celli J, 2003, J EXP MED, V198, P545, DOI 10.1084/jem.20030088; Corbel MJ, 1997, EMERG INFECT DIS, V3, P213, DOI 10.3201/eid0302.970219; de Barsy M, 2011, CELL MICROBIOL, V13, P1044, DOI 10.1111/j.1462-5822.2011.01601.x; de Jong MF, 2008, MOL MICROBIOL, V70, P1378, DOI 10.1111/j.1365-2958.2008.06487.x; Delrue RM, 2005, CELL MICROBIOL, V7, P1151, DOI 10.1111/j.1462-5822.2005.00543.x; Dorrell N, 1999, MICROB PATHOGENESIS, V27, P1, DOI 10.1006/mpat.1999.0278; Marchesini MI, 2011, CELL MICROBIOL, V13, P1261, DOI 10.1111/j.1462-5822.2011.01618.x; Kohler S, 2002, P NATL ACAD SCI USA, V99, P15711, DOI 10.1073/pnas.232454299; Martinez-Nunez C, 2010, J BACTERIOL, V192, P5603, DOI 10.1128/JB.00567-10; McAnulla C, 2007, MICROBIOL-SGM, V153, P2074, DOI 10.1099/mic.0.2007/007153-0; O'Callaghan D, 1999, MOL MICROBIOL, V33, P1210, DOI 10.1046/j.1365-2958.1999.01569.x; Patankar AV, 2009, FEMS MICROBIOL REV, V33, P739, DOI 10.1111/j.1574-6976.2009.00163.x; Patey G, 2006, INFECT IMMUN, V74, P4945, DOI 10.1128/IAI.00584-06; Pizarro-Cerda J, 1998, INFECT IMMUN, V66, P5711; Porte F, 1999, INFECT IMMUN, V67, P4041, DOI 10.1128/IAI.67.8.4041-4047.1999; Rambow-Larsen AA, 2009, TRENDS MICROBIOL, V17, P371, DOI 10.1016/j.tim.2009.05.006; Rarnbow-Larsen AA, 2008, J BACTERIOL, V190, P3274, DOI 10.1128/JB.01915-07; Rouot B, 2003, INFECT IMMUN, V71, P1075, DOI 10.1128/IAI.71.3.1075-1082.2003; Bonomi HR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009435; Sambrook J., MOL CLONING LAB MANU; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Sieira R, 2004, MOL MICROBIOL, V54, P808, DOI 10.1111/j.1365-2958.2004.04316.x; Sieira R, 2010, J BACTERIOL, V192, P217, DOI 10.1128/JB.01124-09; Starr T, 2008, TRAFFIC, V9, P678, DOI 10.1111/j.1600-0854.2008.00718.x; Taminiau B, 2002, INFECT IMMUN, V70, P3004, DOI 10.1128/IAI.70.6.3004-3011.2002; Tsai CS, 2010, MOL MICROBIOL, V77, P1072, DOI 10.1111/j.1365-2958.2010.07279.x; Uzureau S, 2007, J BACTERIOL, V189, P6035, DOI 10.1128/JB.00265-07; Uzureau S, 2010, J PROTEOME RES, V9, P3200, DOI 10.1021/pr100068p; Weeks JN, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-167; Yang MH, 2009, J BACTERIOL, V191, P434, DOI 10.1128/JB.01247-08; Zhang XX, 2007, GENETICS, V176, P2165, DOI 10.1534/genetics.107.075713	35	16	19	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e35394	10.1371/journal.pone.0035394	http://dx.doi.org/10.1371/journal.pone.0035394			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22530016	Green Published, Green Submitted, gold			2022-12-27	WOS:000305347400048
J	Kwan, JY; Jeong, SY; Van Gelderen, P; Deng, HX; Quezado, MM; Danielian, LE; Butman, JA; Chen, LY; Bayat, E; Russell, J; Siddique, T; Duyn, JH; Rouault, TA; Floeter, MK				Kwan, Justin Y.; Jeong, Suh Young; Van Gelderen, Peter; Deng, Han-Xiang; Quezado, Martha M.; Danielian, Laura E.; Butman, John A.; Chen, Lingye; Bayat, Elham; Russell, James; Siddique, Teepu; Duyn, Jeff H.; Rouault, Tracey A.; Floeter, Mary Kay			Iron Accumulation in Deep Cortical Layers Accounts for MRI Signal Abnormalities in ALS: Correlating 7 Tesla MRI and Pathology	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; HIGH-FIELD MRI; PRECENTRAL GYRUS; CORTICOSPINAL TRACT; MAGNETIC-RESONANCE; PARKINSONS-DISEASE; BRAIN IRON; CELLULAR-DISTRIBUTION; MOTOR CORTEX; WHITE-MATTER	Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by cortical and spinal motor neuron dysfunction. Routine magnetic resonance imaging (MRI) studies have previously shown hypointense signal in the motor cortex on T-2-weighted images in some ALS patients, however, the cause of this finding is unknown. To investigate the utility of this MR signal change as a marker of cortical motor neuron degeneration, signal abnormalities on 3T and 7T MR images of the brain were compared, and pathology was obtained in two ALS patients to determine the origin of the motor cortex hypointensity. Nineteen patients with clinically probable or definite ALS by El Escorial criteria and 19 healthy controls underwent 3T MRI. A 7T MRI scan was carried out on five ALS patients who had motor cortex hypointensity on the 3T FLAIR sequence and on three healthy controls. Postmortem 7T MRI of the brain was performed in one ALS patient and histological studies of the brains and spinal cords were obtained post-mortem in two patients. The motor cortex hypointensity on 3T FLAIR images was present in greater frequency in ALS patients. Increased hypointensity correlated with greater severity of upper motor neuron impairment. Analysis of 7T T-2*-weighted gradient echo imaging localized the signal alteration to the deeper layers of the motor cortex in both ALS patients. Pathological studies showed increased iron accumulation in microglial cells in areas corresponding to the location of the signal changes on the 3T and 7T MRI of the motor cortex. These findings indicate that the motor cortex hypointensity on 3T MRI FLAIR images in ALS is due to increased iron accumulation by microglia.	[Kwan, Justin Y.; Danielian, Laura E.; Chen, Lingye; Floeter, Mary Kay] NINDS, NIH, Bethesda, MD 20892 USA; [Jeong, Suh Young; Rouault, Tracey A.] NICHHD, Program Mol Med, NIH, Bethesda, MD 20892 USA; [Van Gelderen, Peter; Duyn, Jeff H.] NINDS, Adv MRI Sect, Lab Funct & Mol Imaging, NIH, Bethesda, MD 20892 USA; [Deng, Han-Xiang; Siddique, Teepu] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Quezado, Martha M.] NCI, NIH, Bethesda, MD 20892 USA; [Butman, John A.] NIH, Ctr Clin, Bethesda, MD 20892 USA; [Bayat, Elham] George Washington Univ, Dept Neurol, Washington, DC USA; [Russell, James] Univ Maryland, Dept Neurol, Baltimore, MD 21201 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Northwestern University; Feinberg School of Medicine; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); George Washington University; University System of Maryland; University of Maryland Baltimore	Kwan, JY (corresponding author), NINDS, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.	kwanjy@ninds.nih.gov	Butman, John/J-2780-2013; Siddique, Teepu/AAT-8166-2021; Butman, John A/A-2694-2008; van Gelderen, Peter/U-4535-2019	Butman, John/0000-0002-1547-9195; Siddique, Teepu/0000-0001-7293-9146; Jeong, Suh Young/0000-0002-6376-7001; Deng, Han-Xiang/0000-0002-0030-8465	National Institute of Neurological Disorders and Stroke, National Institutes of Health [1ZIANS002976-12]; National Institute of Aging [P01-AG07232, R37-AG15473, P50-AG08702]; Hereditary Disease Foundation; Iseman Fund; Louis and Rachel Rudin Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001602] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003027, ZIANS002976] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG007232, R37AG015473, P50AG008702] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Hereditary Disease Foundation; Iseman Fund; Louis and Rachel Rudin Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the Intramural Research Program of the National Institute of Neurological Disorders and Stroke, National Institutes of Health (1ZIANS002976-12). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The control tissue was provided by the New York Brain Bank - The Taub Institute, Columbia University (NYBB), which is supported by the National Institute of Aging (P01-AG07232, R37-AG15473, and P50-AG08702), the Hereditary Disease Foundation, the Iseman Fund, and the Louis and Rachel Rudin Foundation. We gratefully acknowledge the assistance of Dr. Tian-Xia Wu with statistics and Dr. Esther Mayron-Holtz for providing the ferritin antibody. The protocol is registered on clinicaltrials.gov as NCT00334516.	Anderson LJ, 2001, EUR HEART J, V22, P2171, DOI 10.1053/euhj.2001.2822; Bartzokis G, 1999, MAGN RESON IMAGING, V17, P213, DOI 10.1016/S0730-725X(98)00155-6; Benarroch EE, 2009, NEUROLOGY, V72, P1436, DOI 10.1212/WNL.0b013e3181a26b30; BOHANNON RW, 1987, PHYS THER, V67, P206, DOI 10.1093/ptj/67.2.206; Bowen BC, 2000, AM J NEURORADIOL, V21, P647; Braak H, 2004, CELL TISSUE RES, V318, P121, DOI 10.1007/s00441-004-0956-9; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Carri MT, 2003, BRAIN RES BULL, V61, P365, DOI 10.1016/S0361-9230(03)00179-5; Cass WA, 2007, NEUROBIOL AGING, V28, P258, DOI 10.1016/j.neurobiolaging.2005.12.010; CONNOR JR, 1994, J NEUROSCI RES, V37, P461, DOI 10.1002/jnr.490370405; CONNOR JR, 1990, J NEUROSCI RES, V27, P595, DOI 10.1002/jnr.490270421; Deng HX, 2010, ANN NEUROL, V67, P739, DOI 10.1002/ana.22051; DEXTER DT, 1987, LANCET, V2, P1219; DUARA R, 1983, BRAIN, V106, P761, DOI 10.1093/brain/106.3.761; Duyn JH, 2007, P NATL ACAD SCI USA, V104, P11796, DOI 10.1073/pnas.0610821104; Duyn JH, 2011, METHODS MOL BIOL, V711, P239, DOI 10.1007/978-1-61737-992-5_11; Ellis CM, 1999, NEUROLOGY, V53, P1051, DOI 10.1212/WNL.53.5.1051; Goodall EF, 2005, NEUROLOGY, V65, P934, DOI 10.1212/01.wnl.0000176032.94434.d4; Goodall EF, 2008, J NEUROL, V255, P1652, DOI 10.1007/s00415-008-0945-0; GRAEBER MB, 1989, J NEUROSCI RES, V23, P342, DOI 10.1002/jnr.490230315; HALLGREN B, 1958, J NEUROCHEM, V3, P41, DOI 10.1111/j.1471-4159.1958.tb12607.x; Hecht MJ, 2005, NEURORADIOLOGY, V47, P805, DOI 10.1007/s00234-005-1421-5; Hecht MJ, 2002, J NEUROL SCI, V199, P59, DOI 10.1016/S0022-510X(02)00104-1; Henkel JS, 2009, J NEUROIMMUNE PHARM, V4, P389, DOI 10.1007/s11481-009-9171-5; Imon Y, 1995, J NEUROL SCI, V134, P27, DOI 10.1016/0022-510X(95)00205-G; Ince PG, 2003, NEUROLOGY, V60, P1252, DOI 10.1212/01.WNL.0000058901.75728.4E; Iwata NK, 2011, BRAIN, V134, P2642, DOI 10.1093/brain/awr178; Jellinger KA, 1999, DRUG AGING, V14, P115, DOI 10.2165/00002512-199914020-00004; Jeong SY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025404; Jeong SY, 2009, J NEUROSCI, V29, P570, DOI 10.1523/JNEUROSCI.5443-08.2009; JONES EG, 1979, J COMP NEUROL, V188, P113, DOI 10.1002/cne.901880110; KASARSKIS EJ, 1995, J NEUROL SCI, V130, P203, DOI 10.1016/0022-510X(95)00037-3; KONIJN AM, 1981, BRIT J HAEMATOL, V49, P361, DOI 10.1111/j.1365-2141.1981.tb07238.x; Litvan I, 1996, NEUROLOGY, V47, P969, DOI 10.1212/WNL.47.4.969; Mitchell RM, 2008, NEUROLOGY; Mitchell RM, 2010, MUSCLE NERVE, V42, P95, DOI 10.1002/mus.21625; Mitsumoto H, 2007, NEUROLOGY, V68, P1402, DOI 10.1212/01.wnl.0000260065.57832.87; Miwa H, 2003, J NEUROL SCI, V211, P85, DOI 10.1016/S0022-510X(03)00061-3; Mizuno Y, 2006, ACTA NEUROPATHOL, V112, P597, DOI 10.1007/s00401-006-0122-4; MORRIS CM, 1992, ACTA ANAT, V144, P235; Nandar W, 2011, J NUTR, V141, p729S, DOI 10.3945/jn.110.130351; Neumann H, 2009, BRAIN, V132, P288, DOI 10.1093/brain/awn109; Ngai S, 2007, AM J NEURORADIOL, V28, P250; OBA H, 1993, RADIOLOGY, V189, P843, DOI 10.1148/radiology.189.3.8234713; Olsen MK, 2001, ANN NEUROL, V50, P730, DOI 10.1002/ana.1252; Pitt D, 2010, ARCH NEUROL-CHICAGO, V67, P812, DOI 10.1001/archneurol.2010.148; Restagno G, 2007, J NEUROL NEUROSUR PS, V78, P327, DOI 10.1136/jnnp.2006.092338; Rouault Tracey A, 2006, Semin Pediatr Neurol, V13, P142, DOI 10.1016/j.spen.2006.08.002; Schymick JC, 2007, HUM MOL GENET, V16, pR233, DOI 10.1093/hmg/ddm215; Simmons DA, 2007, GLIA, V55, P1074, DOI 10.1002/glia.20526; Smith MA, 1997, P NATL ACAD SCI USA, V94, P9866, DOI 10.1073/pnas.94.18.9866; STARK DD, 1991, RADIOLOGY, V179, P333, DOI 10.1148/radiology.179.2.2014271; Sutedja NA, 2007, ARCH NEUROL-CHICAGO, V64, P63, DOI 10.1001/archneur.64.1.63; Tsushima Y, 2006, CURR PROBL DIAGN RAD, V35, P140, DOI 10.1067/j.cpradiol.2006.04.002; UDAKA F, 1986, ACTA NEUROPATHOL, V70, P289, DOI 10.1007/BF00686086; van Es MA, 2008, NAT GENET, V40, P29, DOI 10.1038/ng.2007.52; Wang Q, 2011, NEURODEGENER DIS, V8, P310, DOI 10.1159/000323469; Wang XS, 2004, J NEUROL SCI, V227, P27, DOI 10.1016/j.jns.2004.08.003; Ward RJ, 2011, J NEURAL TRANSM, V118, P315, DOI 10.1007/s00702-010-0479-3; Wijesekera LC, 2009, ORPHANET J RARE DIS, V4, DOI 10.1186/1750-1172-4-3; Williams R, 2012, J NEUROCHEM, V120, P7, DOI 10.1111/j.1471-4159.2011.07536.x; Yousry TA, 1997, BRAIN, V120, P141, DOI 10.1093/brain/120.1.141; Zecca L, 2004, NAT REV NEUROSCI, V5, P863, DOI 10.1038/nrn1537; Zhang LJ, 2003, J MAGN RESON IMAGING, V17, P521, DOI 10.1002/jmri.10293	64	178	178	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e35241	10.1371/journal.pone.0035241	http://dx.doi.org/10.1371/journal.pone.0035241			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22529995	Green Published, Green Submitted, gold			2022-12-27	WOS:000305347400037
J	Hippert, C; Ibanes, S; Serratrice, N; Court, F; Malecaze, F; Kremer, EJ; Kalatzis, V				Hippert, Claire; Ibanes, Sandy; Serratrice, Nicolas; Court, Franck; Malecaze, Francois; Kremer, Eric J.; Kalatzis, Vasiliki			Corneal Transduction by Intra-Stromal Injection of AAV Vectors In Vivo in the Mouse and Ex Vivo in Human Explants	PLOS ONE			English	Article							LEBERS CONGENITAL AMAUROSIS; GENE-THERAPY; ADENOASSOCIATED VIRUS; IGF2 GENE; EXPRESSION; CELLS; TISSUE; KERATOCYTES; CYSTINOSIS; DELIVERY	The cornea is a transparent, avascular tissue that acts as the major refractive surface of the eye. Corneal transparency, assured by the inner stroma, is vital for this role. Disruption in stromal transparency can occur in some inherited or acquired diseases. As a consequence, light entering the eye is blocked or distorted, leading to decreased visual acuity. Possible treatment for restoring transparency could be via viral-based gene therapy. The stroma is particularly amenable to this strategy due to its immunoprivileged nature and low turnover rate. We assayed the potential of AAV vectors to transduce keratocytes following intra-stromal injection in vivo in the mouse cornea and ex vivo in human explants. In murine and human corneas, we transduced the entire stroma using a single injection, preferentially targeted keratocytes and achieved long-term gene transfer (up to 17 months in vivo in mice). Of the serotypes tested, AAV2/8 was the most promising for gene transfer in both mouse and man. Furthermore, transgene expression could be transiently increased following aggression to the cornea.	[Hippert, Claire; Ibanes, Sandy; Serratrice, Nicolas; Court, Franck; Kremer, Eric J.; Kalatzis, Vasiliki] CNRS, Inst Genet Mol Montpellier, Montpellier, France; [Hippert, Claire; Ibanes, Sandy; Serratrice, Nicolas; Court, Franck; Kremer, Eric J.; Kalatzis, Vasiliki] Univ Montpellier I, Montpellier, France; [Hippert, Claire; Ibanes, Sandy; Serratrice, Nicolas; Court, Franck; Kremer, Eric J.; Kalatzis, Vasiliki] Univ Montpellier 2, Montpellier, France; [Malecaze, Francois] Fac Med Toulouse, INSERM, U563, F-31073 Toulouse, France; [Malecaze, Francois] Hop Purpan, Dept Ophtalmol, Toulouse, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Universite de Montpellier; Universite de Montpellier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Toulouse	Hippert, C (corresponding author), Inst Ophthalmol, Div Mol Therapy, London, England.	vasiliki.kalatzis@inserm.fr	Kremer, Eric J/D-3734-2013; Kremer, EJ/P-9838-2019; Kalatzis, Vasiliki/F-6170-2019	Kremer, EJ/0000-0001-6114-7530; Kalatzis, Vasiliki/0000-0002-9626-8807; court, franck/0000-0003-0327-9708; Serratrice, Nicolas/0000-0002-9419-1463	Cystinosis Research Foundation (CRF; Irvine, CA); Cystinosis Research Network (CRN; Lake Forest, IL); Association Francaise contre les Myopathies (Paris, France) [11960]; Region Languedoc Roussillon-CTP (Communaute de travail des Pyrenees) [115277]; CRN	Cystinosis Research Foundation (CRF; Irvine, CA); Cystinosis Research Network (CRN; Lake Forest, IL); Association Francaise contre les Myopathies (Paris, France)(Association Francaise contre les Myopathies); Region Languedoc Roussillon-CTP (Communaute de travail des Pyrenees)(Region Occitanie); CRN	This work was funded by the Cystinosis Research Foundation (CRF; Irvine, CA; http://www.natalieswish.org/), the Cystinosis Research Network (CRN; Lake Forest, IL; http://www.cystinosis.org/), the Association Francaise contre les Myopathies (Paris, France; http://www.afm-telethon.fr/; grant number 11960) and the Region Languedoc Roussillon-CTP (Communaute de travail des Pyrenees; http://www.transferts-lr.org/transferts_lr/europe/; grant number 115277). C. H. was a CRF fellow. S. I. was supported by the CRN. V. K. and E.J.K. are Inserm fellows. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER IE, 1994, J VIROL, V68, P8282, DOI 10.1128/JVI.68.12.8282-8287.1994; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Beck M, 2007, HUM GENET, V121, P1, DOI 10.1007/s00439-006-0280-4; Bemelmans AP, 2009, GENE THER, V16, P933, DOI 10.1038/gt.2009.41; Borras T, 1996, INVEST OPHTH VIS SCI, V37, P1282; Brissette-Storkus CS, 2002, INVEST OPHTH VIS SCI, V43, P2264; Carlson EC, 2004, INVEST OPHTH VIS SCI, V45, P2194, DOI 10.1167/iovs.03-1224; Chintakuntlawar AV, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000841; Du YD, 2005, STEM CELLS, V23, P1266, DOI 10.1634/stemcells.2004-0256; Du YQ, 2009, STEM CELLS, V27, P1635, DOI 10.1002/stem.91; Duan DS, 1998, J VIROL, V72, P8568, DOI 10.1128/JVI.72.11.8568-8577.1998; Espana EM, 2004, INVEST OPHTH VIS SCI, V45, P2985, DOI 10.1167/iovs.04-0201; Fini ME, 2005, CORNEA, V24, pS2, DOI 10.1097/01.ico.0000178743.06340.2c; Galiacy SD, 2011, GENE THER, V18, P462, DOI 10.1038/gt.2010.159; George AJT, 2000, AM J RESP CRIT CARE, V162, pS194, DOI 10.1164/ajrccm.162.supplement_3.15tac11; Hagege H, 2006, CYTOGENET GENOME RES, V113, P230, DOI 10.1159/000090837; Hao J, 2010, BRAIN RES BULL, V81, P256, DOI 10.1016/j.brainresbull.2009.06.011; Jhanji V, 2010, CURR OPIN OPHTHALMOL, V21, P301, DOI 10.1097/ICU.0b013e32833a8dd3; Johnson JS, 2009, J VIROL, V83, P2632, DOI 10.1128/JVI.02309-08; Joseph A, 2003, INVEST OPHTH VIS SCI, V44, P4689, DOI 10.1167/iovs.02-0999; Kalatzis V, 2001, EMBO J, V20, P5940, DOI 10.1093/emboj/20.21.5940; Kalatzis V, 2007, PEDIATR RES, V62, P156, DOI 10.1203/PDR.0b013e31809fda89; Kamata Y, 2001, MOL THER, V4, P307, DOI 10.1006/mthe.2001.0461; Klausner EA, 2007, J CONTROL RELEASE, V124, P107, DOI 10.1016/j.jconrel.2007.05.041; Kremer EJ, 2000, J VIROL, V74, P505, DOI 10.1128/JVI.74.1.505-512.2000; Lai LJ, 2007, J BIOMED SCI, V14, P313, DOI 10.1007/s11373-007-9153-7; Liu J, 2008, MOL VIS, V14, P2087; Lutfalla G, 2006, METHOD ENZYMOL, V410, P386, DOI 10.1016/S0076-6879(06)10019-1; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Mohan RR, 2005, PROG RETIN EYE RES, V24, P537, DOI 10.1016/j.preteyeres.2005.04.001; Mohan RR, 2003, EXP EYE RES, V76, P373, DOI 10.1016/S0014-4835(02)00275-0; Nesterova G, 2008, PEDIATR NEPHROL, V23, P863, DOI 10.1007/s00467-007-0650-8; NEUFELD EF, 1991, ANNU REV BIOCHEM, V60, P257, DOI 10.1146/annurev.biochem.60.1.257; Nilsson EC, 2011, NAT MED, V17, P105, DOI 10.1038/nm.2267; Prydal JI, 1998, EYE, V12, P337, DOI 10.1038/eye.1998.82; Saika S, 2005, AM J PATHOL, V166, P1405, DOI 10.1016/S0002-9440(10)62358-9; Sharma A, 2010, EXP EYE RES, V91, P440, DOI 10.1016/j.exer.2010.06.020; Smith RH, 2008, GENE THER, V15, P817, DOI 10.1038/gt.2008.55; Sosnova M, 2005, STEM CELLS, V23, P507, DOI 10.1634/stemcells.2004-0291; Stieger K, 2009, MOL THER, V17, P516, DOI 10.1038/mt.2008.283; Toti P, 2002, OPHTHALMOLOGY, V109, P1167, DOI 10.1016/S0161-6420(02)01042-4; Tsai ML, 2002, INVEST OPHTH VIS SCI, V43, P751; Weber M, 2001, MECH DEVELOP, V101, P133, DOI 10.1016/S0925-4773(00)00573-6; Weber ML, 2003, ANAL BIOCHEM, V320, P252, DOI 10.1016/S0003-2697(03)00396-8; West-Mays JA, 2006, INT J BIOCHEM CELL B, V38, P1625, DOI 10.1016/j.biocel.2006.03.010; Williams KA, 2010, CLIN EXP OPHTHALMOL, V38, P93, DOI 10.1111/j.1442-9071.2009.02179.x; Yu H, 2007, BIOCHEM BIOPH RES CO, V361, P946, DOI 10.1016/j.bbrc.2007.07.114	47	29	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e35318	10.1371/journal.pone.0035318	http://dx.doi.org/10.1371/journal.pone.0035318			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523585	Green Published, Green Submitted, gold			2022-12-27	WOS:000305345000057
J	Paul, G; Ozen, I; Christophersen, NS; Reinbothe, T; Bengzon, J; Visse, E; Jansson, K; Dannaeus, K; Henriques-Oliveira, C; Roybon, L; Anisimov, SV; Renstrom, E; Svensson, M; Haegerstrand, A; Brundin, P				Paul, Gesine; Ozen, Ilknur; Christophersen, Nicolaj S.; Reinbothe, Thomas; Bengzon, Johan; Visse, Edward; Jansson, Katarina; Dannaeus, Karin; Henriques-Oliveira, Catarina; Roybon, Laurent; Anisimov, Sergey V.; Renstrom, Erik; Svensson, Mikael; Haegerstrand, Anders; Brundin, Patrik			The Adult Human Brain Harbors Multipotent Perivascular Mesenchymal Stem Cells	PLOS ONE			English	Article							MARROW STROMAL CELLS; NEURAL PROGENITOR CELLS; IN-VITRO; MICROVASCULAR PERICYTES; DIFFERENTIATE; EXPRESSION; MUSCLE; MOUSE; TISSUES; NICHES	Blood vessels and adjacent cells form perivascular stem cell niches in adult tissues. In this perivascular niche, a stem cell with mesenchymal characteristics was recently identified in some adult somatic tissues. These cells are pericytes that line the microvasculature, express mesenchymal markers and differentiate into mesodermal lineages but might even have the capacity to generate tissue-specific cell types. Here, we isolated, purified and characterized a previously unrecognized progenitor population from two different regions in the adult human brain, the ventricular wall and the neocortex. We show that these cells co-express markers for mesenchymal stem cells and pericytes in vivo and in vitro, but do not express glial, neuronal progenitor, hematopoietic, endothelial or microglial markers in their native state. Furthermore, we demonstrate at a clonal level that these progenitors have true multilineage potential towards both, the mesodermal and neuroectodermal phenotype. They can be epigenetically induced in vitro into adipocytes, chondroblasts and osteoblasts but also into glial cells and immature neurons. This progenitor population exhibits long-term proliferation, karyotype stability and retention of phenotype and multipotency following extensive propagation. Thus, we provide evidence that the vascular niche in the adult human brain harbors a novel progenitor with multilineage capacity that appears to represent mesenchymal stem cells and is different from any previously described human neural stem cell. Future studies will elucidate whether these cells may play a role for disease or may represent a reservoir that can be exploited in efforts to repair the diseased human brain.	[Paul, Gesine; Ozen, Ilknur; Christophersen, Nicolaj S.; Henriques-Oliveira, Catarina; Roybon, Laurent; Anisimov, Sergey V.; Brundin, Patrik] Lund Univ, Wallenberg Neurosci Ctr, Dept Expt Med Sci, Neuronal Survival Unit, Lund, Sweden; [Paul, Gesine] Scania Univ Hosp, Dept Neurol, Lund, Sweden; [Reinbothe, Thomas; Renstrom, Erik] Lund Univ, Ctr Diabet, Scania Univ Hosp, Malmo, Sweden; [Bengzon, Johan] Lund Univ, Lund Stem Cell Ctr, Lund, Sweden; [Bengzon, Johan] Scania Univ Hosp, Dept Neurosurg, Lund, Sweden; [Visse, Edward] Lund Univ, Dept Clin Med, Rausing Lab, Lund, Sweden; [Jansson, Katarina; Dannaeus, Karin; Haegerstrand, Anders] NeuroNova AB, Stockholm, Sweden; [Svensson, Mikael] Karolinska Hosp, Dept Neurosurg, S-10401 Stockholm, Sweden; [Paul, Gesine; Ozen, Ilknur] Lund Univ, Wallenberg Neurosci Ctr, Dept Clin Sci, Translat Neurol Grp, Lund, Sweden; [Brundin, Patrik] Van Andel Res Inst, Ctr Neurodegenerat Sci, Grand Rapids, MI USA	Lund University; Lund University; Lund University; Lund University; Karolinska Institutet; Karolinska University Hospital; Lund University; Van Andel Institute	Paul, G (corresponding author), Lund Univ, Wallenberg Neurosci Ctr, Dept Expt Med Sci, Neuronal Survival Unit, Lund, Sweden.	gesine.paul@med.lu.se	Svensson, Mikael/F-8662-2012; Reinbothe, Thomas M./N-1532-2014	Svensson, Mikael/0000-0003-1179-7003; Reinbothe, Thomas M./0000-0002-8934-6109; Bengzon, Johan/0000-0001-6536-2107	Swedish Research Council; EuroStemCell (EU Framework 6 project) [LHSB-CT-2003-503005]; EU FP6 project STEMS [LHSB-CT-2006-037328]; Lundbeckfonden [R7-A686]	Swedish Research Council(Swedish Research CouncilEuropean Commission); EuroStemCell (EU Framework 6 project); EU FP6 project STEMS; Lundbeckfonden(Lundbeckfonden)	This study was supported by the Swedish Research Council, the EuroStemCell (EU Framework 6 project LHSB-CT-2003-503005), the EU FP6 project STEMS (LHSB-CT-2006-037328). G. P. is supported by a grant according to the "Agreement on doctor's training and research''. L. R. and I.O. are supported by the EU (FP6 project STEMS (LHSB-CT-2006-037328) and Multipark. N.S.C. was sponsored by a grant from Lundbeckfonden (#R7-A686). The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alliot F, 1999, J NEUROSCI RES, V58, P367; Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7; Bianco P, 2008, CELL STEM CELL, V2, P313, DOI 10.1016/j.stem.2008.03.002; Bondjers C, 2003, AM J PATHOL, V162, P721, DOI 10.1016/S0002-9440(10)63868-0; Bondjers C, 2006, FASEB J, V20, P1703, DOI 10.1096/fj.05-4944fje; Brachvogel B, 2005, DEVELOPMENT, V132, P2657, DOI 10.1242/dev.01846; Canfield AE, 1996, J CELL SCI, V109, P343; CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504; Caplan AI, 2008, CELL STEM CELL, V3, P229, DOI 10.1016/j.stem.2008.08.008; Conti L, 2010, NAT REV NEUROSCI, V11, P176, DOI 10.1038/nrn2761; Covas DT, 2008, EXP HEMATOL, V36, P642, DOI 10.1016/j.exphem.2007.12.015; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Meirelles LDS, 2006, J CELL SCI, V119, P2204, DOI 10.1242/jcs.02932; Davidoff MS, 2004, J CELL BIOL, V167, P935, DOI 10.1083/jcb.200409107; Dellavalle A, 2007, NAT CELL BIOL, V9, P255, DOI 10.1038/ncb1542; Dezawa M, 2004, J CLIN INVEST, V113, P1701, DOI 10.1172/JCI200420935; Doherty MJ, 1998, J BONE MINER RES, V13, P828, DOI 10.1359/jbmr.1998.13.5.828; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Dore-Duffy P, 2006, J CEREBR BLOOD F MET, V26, P613, DOI 10.1038/sj.jcbfm.9600272; EHLER E, 1995, CELL TISSUE RES, V279, P393, DOI 10.1007/BF00318497; Farrington-Rock C, 2004, CIRCULATION, V110, P2226, DOI 10.1161/01.CIR.0000144457.55518.E5; Fox LE, 2010, STEM CELLS DEV; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gerhardt H, 2003, CELL TISSUE RES, V314, P15, DOI 10.1007/s00441-003-0745-x; Goritz C, 2011, SCIENCE, V333, P238, DOI 10.1126/science.1203165; Gould E, 2007, NAT REV NEUROSCI, V8, P481, DOI 10.1038/nrn2147; Hayase M, 2009, J CEREBR BLOOD F MET, V29, P1409, DOI 10.1038/jcbfm.2009.62; Hermann A, 2004, J CELL SCI, V117, P4411, DOI 10.1242/jcs.01307; Huang FJ, 2010, DEV BIOL, V344, P1035, DOI 10.1016/j.ydbio.2010.06.023; Johansson CB, 1999, EXP CELL RES, V253, P733, DOI 10.1006/excr.1999.4678; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; Lotharius J, 2002, J BIOL CHEM, V277, P38884, DOI 10.1074/jbc.M205518200; Meirelles LD, 2008, STEM CELLS, V26, P2287, DOI 10.1634/stemcells.2007-1122; Miller FD, 2009, CELL STEM CELL, V4, P507, DOI 10.1016/j.stem.2009.05.008; Nunes MC, 2003, NAT MED, V9, P439, DOI 10.1038/nm837; Ozerdem U, 2002, MICROVASC RES, V63, P129, DOI 10.1006/mvre.2001.2376; Palmer TD, 2001, NATURE, V411, P42, DOI 10.1038/35075141; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; RICHARDSON RL, 1982, ACTA ANAT, V114, P41; Sanchez-Ramos J, 2000, EXP NEUROL, V164, P247, DOI 10.1006/exnr.2000.7389; SIMS DE, 1991, CAN J CARDIOL, V7, P431; Walton NM, 2006, DEVELOPMENT, V133, P3671, DOI 10.1242/dev.02541; Winkler EA, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-32; Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C; Yamashima T, 2004, HIPPOCAMPUS, V14, P861, DOI 10.1002/hipo.20001	47	158	161	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e35577	10.1371/journal.pone.0035577	http://dx.doi.org/10.1371/journal.pone.0035577			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523602	Green Published, Green Submitted, gold			2022-12-27	WOS:000305345000076
J	Lacruz, RS; Nakayama, Y; Holcroft, J; Nguyen, V; Somogyi-Ganss, E; Snead, ML; White, SN; Paine, ML; Ganss, B				Lacruz, Rodrigo S.; Nakayama, Yohei; Holcroft, James; Van Nguyen; Somogyi-Ganss, Eszter; Snead, Malcolm L.; White, Shane N.; Paine, Michael L.; Ganss, Bernhard			Targeted Overexpression of Amelotin Disrupts the Microstructure of Dental Enamel	PLOS ONE			English	Article							AMELOGENESIS IMPERFECTA; PROTEIN; EXPRESSION; SIALOPROTEIN; BINDING; MATRIX; HYDROXYAPATITE; AMELOBLASTS; GENE; MICE	We have previously identified amelotin (AMTN) as a novel protein expressed predominantly during the late stages of dental enamel formation, but its role during amelogenesis remains to be determined. In this study we generated transgenic mice that produce AMTN under the amelogenin (Amel) gene promoter to study the effect of AMTN overexpression on enamel formation in vivo. The specific overexpression of AMTN in secretory stage ameloblasts was confirmed by Western blot and immunohistochemistry. The gross histological appearance of ameloblasts or supporting cellular structures as well as the expression of the enamel proteins amelogenin (AMEL) and ameloblastin (AMBN) was not altered by AMTN overexpression, suggesting that protein production, processing and secretion occurred normally in transgenic mice. The expression of Odontogenic, Ameloblast-Associated (ODAM) was slightly increased in secretory stage ameloblasts of transgenic animals. The enamel in AMTN-overexpressing mice was much thinner and displayed a highly irregular surface structure compared to wild type littermates. Teeth of transgenic animals underwent rapid attrition due to the brittleness of the enamel layer. The microstructure of enamel, normally a highly ordered arrangement of hydroxyapatite crystals, was completely disorganized. Tomes' process, the hallmark of secretory stage ameloblasts, did not form in transgenic mice. Collectively our data demonstrate that the overexpression of amelotin has a profound effect on enamel structure by disrupting the formation of Tomes' process and the orderly growth of enamel prisms.	[Lacruz, Rodrigo S.; Snead, Malcolm L.; Paine, Michael L.] Univ So Calif, Ctr Craniofacial Mol Biol, Sch Dent, Los Angeles, CA 90033 USA; [Nakayama, Yohei; Holcroft, James; Van Nguyen; Somogyi-Ganss, Eszter; Ganss, Bernhard] Univ Toronto, Fac Dent, Matrix Dynam Grp, Toronto, ON, Canada; [White, Shane N.] Univ Calif Los Angeles, Sch Dent, Los Angeles, CA 90024 USA	University of Southern California; University of Toronto; University of California System; University of California Los Angeles	Lacruz, RS (corresponding author), Univ So Calif, Ctr Craniofacial Mol Biol, Sch Dent, 2250 Alcazar St, Los Angeles, CA 90033 USA.	b.ganss@utoronto.ca	Lacruz, Rodrigo/AGY-8090-2022	LACRUZ, RODRIGO/0000-0002-0776-6143	NIDCR, National Institutes of Health [DE006988, DE013045, DE013404, DE019629, DE014189]; Canadian Institutes of Health Research (CIHR) [MOP-79449]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE006988, R01DE013045, R01DE019629] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R37DE013045, R01DE013404, K22DE014189] Funding Source: NIH RePORTER	NIDCR, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by Grants DE006988 and DE013045 (MLS), DE013404 and DE019629 (MLP) and DE014189 (SNW) from the NIDCR, National Institutes of Health and by an Operating Grant MOP-79449 (BG) from the Canadian Institutes of Health Research (CIHR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Fong CD, 1998, EUR J ORAL SCI, V106, P324, DOI 10.1111/j.1600-0722.1998.tb02193.x; Goldberg HA, 2001, CONNECT TISSUE RES, V42, P25, DOI 10.3109/03008200109014246; Hu JCC, 2007, CELLS TISSUES ORGANS, V186, P78, DOI 10.1159/000102683; IGNELZI MA, 1995, CRIT REV ORAL BIOL M, V6, P181, DOI 10.1177/10454411950060030201; INAGE T, 1990, Journal of Nihon University School of Dentistry, V32, P259; Iwasaki K, 2005, J DENT RES, V84, P1127, DOI 10.1177/154405910508401207; KALLENBACH E, 1973, TISSUE CELL, V5, P501, DOI 10.1016/S0040-8166(73)80041-2; Kestler DP, 2008, MOL MED, V14, P318, DOI 10.2119/2008-00010.Kestler; Lacruz RS, 2011, J DENT RES, V90, P1228, DOI 10.1177/0022034511418231; Lu Y, 2008, BIOL CHEM, V389, P695, DOI 10.1515/BC.2008.080; Luo W, 2004, CELLS TISSUES ORGANS, V177, P212, DOI 10.1159/000080134; Moffatt P, 2008, J CELL BIOCHEM, V103, P941, DOI 10.1002/jcb.21465; Moffatt P, 2006, BIOCHEM J, V399, P37, DOI 10.1042/BJ20060662; Moinichen CB, 1996, J ANAT, V189, P325; Nagy A., 2003, MANIPULATING MOUSE E; Nanci A, 2008, 10 CATES ORAL HISTOL, P141; Paine ML, 2003, J BIOL CHEM, V278, P19447, DOI 10.1074/jbc.M300445200; Paine ML, 2005, J BIOL CHEM, V280, P31991, DOI 10.1074/jbc.M502991200; Paine ML, 2004, CELLS TISSUES ORGANS, V176, P7, DOI 10.1159/000075023; Sire JY, 2007, CELLS TISSUES ORGANS, V186, P25, DOI 10.1159/000102679; Snead ML, 1996, CONNECT TISSUE RES, V35, P41, DOI 10.3109/03008209609029173; Somogyi E, 2003, MATRIX BIOL, V22, P179, DOI 10.1016/S0945-053X(02)00117-8; Somogyi-Ganss E., 2011, CELLS TISSUES ORGANS; WEILE V, 1993, CALCIFIED TISSUE INT, V52, P318, DOI 10.1007/BF00296658; Wen X, 2008, ANAT REC, V291, P1246, DOI 10.1002/ar.20751; White SN, 2007, J BIOL CHEM, V282, P5340, DOI 10.1074/jbc.M604814200; White SN, 2001, J DENT RES, V80, P321, DOI 10.1177/00220345010800010501; Zhou YL, 2000, J BIOL CHEM, V275, P12273, DOI 10.1074/jbc.275.16.12273	28	53	54	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35200	10.1371/journal.pone.0035200	http://dx.doi.org/10.1371/journal.pone.0035200			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22539960	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341000024
J	Ramasamy, S; Wahab, NA; Abidin, NZ; Manickam, S; Zakaria, Z				Ramasamy, Sujatha; Wahab, Norhanom Abdul; Abidin, Nurhayati Zainal; Manickam, Sugumaran; Zakaria, Zubaidah			Growth Inhibition of Human Gynecologic and Colon Cancer Cells by Phyllanthus watsonii through Apoptosis Induction	PLOS ONE			English	Article							ELLAGIC ACID; BETULINIC ACID; CYCLE ARREST; IN-VITRO; PHENOLIC-COMPOUNDS; PROLIFERATION; ANTITUMOR; AMARUS; LUNG; CHEMOPREVENTION	Phyllanthus watsonii Airy Shaw is an endemic plant found in Peninsular Malaysia. Although there are numerous reports on the anti cancer properties of other Phyllanthus species, published information on the cytotoxicity of P. watsonii are very limited. The present study was carried out with bioassay-guided fractionation approach to evaluate the cytotoxicity and apoptosis induction capability of the P. watsonii extracts and fractions on human gynecologic (SKOV-3 and Ca Ski) and colon (HT-29) cancer cells. P. watsonii extracts exhibited strong cytotoxicity on all the cancer cells studied with IC50 values of <= 20.0 mu g/mL. Hexane extract of P. watsonii was further subjected to bioassay-guided fractionation and yielded 10 fractions (PW-1 -> PW-10). PW-4 -> PW-8 portrayed stronger cytotoxic activity and was further subjected to bioassay-guided fractionation and resulted with 8 sub-fractions (PPWH-1 -> PPWH-8). PPWH-7 possessed greatest cytotoxicity (IC50 values ranged from 0.66 - 0.83 mu g/mL) and was selective on the cancer cells studied. LC-MS/MS analysis of PPWH-7 revealed the presence of ellagic acid, geranic acid, glochidone, betulin, phyllanthin and sterol glucoside. Marked morphological changes, ladder-like appearance of DNA and increment in caspase-3 activity indicating apoptosis were clearly observed in both human gynecologic and colon cancer cells treated with P. watsonii especially with PPWH-7. The study also indicated that P. watsonii extracts arrested cell cycle at different growth phases in SKOV-3, Ca Ski and HT-29 cells. Cytotoxic and apoptotic potential of the endemic P. watsonii was investigated for the first time by bioassay-guided approach. These results demonstrated that P. watsonii selectively inhibits the growth of SKOV-3, Ca Ski and HT-29 cells through apoptosis induction and cell cycle modulation. Hence, P. watsonii has the potential to be further exploited for the discovery and development of new anti cancer drugs.	[Ramasamy, Sujatha; Abidin, Nurhayati Zainal; Manickam, Sugumaran] Univ Malaya, Fac Sci, Inst Biol Sci, Kuala Lumpur, Malaysia; [Wahab, Norhanom Abdul] Univ Malaya, Ctr Fdn Studies Sci, Kuala Lumpur, Malaysia; [Zakaria, Zubaidah] Inst Med Res, Canc Res Ctr, Hematol Unit, Kuala Lumpur 50588, Malaysia	Universiti Malaya; Universiti Malaya; Kementerian Kesihatan Malaysia	Ramasamy, S (corresponding author), Univ Malaya, Fac Sci, Inst Biol Sci, Kuala Lumpur, Malaysia.	sujatha@um.edu.my	ABIDIN, NURHAYATI ZAINAL/B-9429-2010; Manickam, Sugumaran/B-5268-2010; RAMASAMY, SUJATHA/B-9854-2010; ABDUL WAHAB, NORHANOM/B-5207-2010	Manickam, Sugumaran/0000-0003-3125-767X; 	Postgraduate Research Fund (PPP) [UM 524 PS130/2008A, UM PS307/2010A]; University of Malaya	Postgraduate Research Fund (PPP); University of Malaya(Universiti Malaya)	This study was supported by Postgraduate Research Fund (PPP) Grants UM 524 PS130/2008A and UM PS307/2010A, funded by University of Malaya. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaby K, 2007, J AGR FOOD CHEM, V55, P4395, DOI 10.1021/jf0702592; Abu Bakal MF, 2010, FOOD CHEM TOXICOL, V48, P1688, DOI 10.1016/j.fct.2010.03.046; Aggarwal BB, 2006, BIOCHEM PHARMACOL, V71, P1397, DOI 10.1016/j.bcp.2006.02.009; AVATO P, 1995, PHYTOCHEMISTRY, V40, P141, DOI 10.1016/0031-9422(95)00183-8; Balunas MJ, 2005, LIFE SCI, V78, P431, DOI 10.1016/j.lfs.2005.09.012; Bardon S, 2002, CANCER LETT, V181, P187, DOI 10.1016/S0304-3835(02)00047-2; Besson A, 2008, DEV CELL, V14, P159, DOI 10.1016/j.devcel.2008.01.013; Boik J, 2001, NATURAL COMPOUNDS CA; BORENFREUND E, 1985, TOXICOL LETT, V24, P119, DOI 10.1016/0378-4274(85)90046-3; Boyle P, 2008, 1260 INT AG RES CANC, P1; BURKILL I. H., 1966, A Dictionary of the Economic Products of the Malay Peninsula., V2; Cain K, 1999, J BIOL CHEM, V274, P22686, DOI 10.1074/jbc.274.32.22686; Cheng YL, 2004, LIFE SCI, V75, P1579, DOI 10.1016/j.lfs.2004.03.009; Chien SC, 2007, TETRAHEDRON LETT, V48, P1567, DOI 10.1016/j.tetlet.2007.01.011; Cragg GM, 2005, J ETHNOPHARMACOL, V100, P72, DOI 10.1016/j.jep.2005.05.011; Darison GWH, 1988, ENDAU ROMPIN MALAYSI; DAS M, 1985, CARCINOGENESIS, V6, P1409, DOI 10.1093/carcin/6.10.1409; Fjaeraa C, 2009, BIOMED PHARMACOTHER, V63, P254, DOI 10.1016/j.biopha.2008.07.093; GERAN RI, 1972, CANC CHEMOTHER REP, V3, P1; Gosslau A, 2004, NUTRITION, V20, P95, DOI 10.1016/j.nut.2003.09.017; Gurib-Fakim A., 2006, MOL ASPECTS MED, V27, P1, DOI [10.1016/j.mam.2005.07.008, DOI 10.1016/J.MAM.2005.07.008]; Hail N, 2008, FREE RADICAL BIO MED, V45, P97, DOI 10.1016/j.freeradbiomed.2008.04.004; Hansakul P., 2009, Songklanakarin Journal of Science and Technology, V31, P273; Harada H, 2002, ANTICANCER RES, V22, P2587; Hu XL, 2010, BIOCHEM BIOPH RES CO, V398, P62, DOI 10.1016/j.bbrc.2010.06.033; Hu YW, 2009, J ETHNOPHARMACOL, V123, P293, DOI 10.1016/j.jep.2009.03.016; Huang ST, 2006, INT IMMUNOPHARMACOL, V6, P870, DOI 10.1016/j.intimp.2005.12.010; Huang ST, 2003, LIFE SCI, V72, P1705, DOI 10.1016/S0024-3205(03)00016-X; Jeena KJ, 1999, CANCER LETT, V136, P11, DOI 10.1016/S0304-3835(98)00294-8; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kajdzanoska M, 2010, MACED J CHEM CHEM EN, V29, P181; Kiemer AK, 2003, J HEPATOL, V38, P289, DOI 10.1016/S0168-8278(02)00417-8; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Krithika R, 2009, CHEM-BIOL INTERACT, V181, P351, DOI 10.1016/j.cbi.2009.06.014; Lai CS, 2008, J ETHNOPHARMACOL, V118, P14, DOI 10.1016/j.jep.2008.02.034; Le NTV, 2002, BBA-REV CANCER, V1603, P31, DOI 10.1016/S0304-419X(02)00068-9; Liu J, 2006, CANCER LETT, V242, P133, DOI 10.1016/j.canlet.2005.11.023; Losso JN, 2004, J NUTR BIOCHEM, V15, P672, DOI 10.1016/j.jnutbio.2004.06.004; Mahavorasirikul W, 2010, BMC COMPLEM ALTERN M, V10, DOI 10.1186/1472-6882-10-55; Maia LF, 2000, J NAT PROD, V63, P1427, DOI 10.1021/np9906323; Malek SNA, 2009, MOLECULES, V14, P1713, DOI 10.3390/molecules14051713; Marston A, 2007, PHYTOCHEMISTRY, V68, P2786, DOI 10.1016/j.phytochem.2007.08.004; MATSUNAGA S, 1993, PHYTOCHEMISTRY, V32, P165, DOI 10.1016/0031-9422(92)80125-X; MILLS JJ, 1995, CANCER RES, V55, P979; Moongkarndi P, 2004, J ETHNOPHARMACOL, V90, P161, DOI 10.1016/j.jep.2003.09.048; Narayanan BA, 1999, CANCER LETT, V136, P215, DOI 10.1016/S0304-3835(98)00323-1; Nayak PS, 2010, B LATINOAM CARIBE PL, V9, P353; Nhan TQ, 2006, AM J PATHOL, V169, P729, DOI 10.2353/ajpath.2006.060105; Nieves-Neira W, 1999, INT J CANCER, V82, P396, DOI 10.1002/(SICI)1097-0215(19990730)82:3<396::AID-IJC13>3.0.CO;2-Z; Panchal RG, 1998, BIOCHEM PHARMACOL, V55, P247, DOI 10.1016/S0006-2952(97)00240-2; PERCHELLET JP, 1992, BASIC LIFE SCI, V59, P783; Popov B, 2005, BIOCHEM BIOPH RES CO, V336, P762, DOI 10.1016/j.bbrc.2005.08.163; Prasanna R, 2009, CELL BIOL INT, V33, P127, DOI 10.1016/j.cellbi.2008.10.006; Rajkapoor B, 2007, BIOSCI BIOTECH BIOCH, V71, P2177, DOI 10.1271/bbb.70149; Ramasamy S, 2011, J MED PLANTS RES, V5, P2267; Reddy BS, 1997, CANCER RES, V57, P420; Santafe G, 2002, J NAT PROD, V65, P1161, DOI 10.1021/np0200459; Schmidt ML, 1997, EUR J CANCER, V33, P2007, DOI 10.1016/S0959-8049(97)00294-3; Schwartz GK, 2005, J CLIN ONCOL, V23, P9408, DOI 10.1200/JCO.2005.01.5594; Shakya R, 2008, J AGR FOOD CHEM, V56, P6949, DOI 10.1021/jf8006618; Sherr CJ, 2000, CANCER RES, V60, P3689; Sheu JH, 2000, J NAT PROD, V63, P149, DOI 10.1021/np9903954; STARK MJ, 1995, CANCER LETT, V96, P15, DOI 10.1016/0304-3835(95)03912-G; Stoner GD, 1997, CANCER LETT, V114, P113, DOI 10.1016/S0304-3835(97)04639-9; Su NW, 2005, J AGR FOOD CHEM, V53, P1949, DOI 10.1021/jf048310e; Sun J, 2006, CANCER LETT, V241, P124, DOI 10.1016/j.canlet.2005.10.027; Tanaka R, 1998, PHYTOCHEMISTRY, V21, P3563; Tang YQ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0012644, 10.1371/journal.pone.0015631]; Taraphdar AK, 2001, CURR SCI INDIA, V80, P1387; TEEL RW, 1986, CANCER LETT, V30, P329, DOI 10.1016/0304-3835(86)90058-3; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Tokarska-Schlattner M, 2006, CR BIOL, V329, P657, DOI 10.1016/j.crvi.2005.08.007; Wang W, 2009, PROG NEUROBIOL, V89, P1, DOI 10.1016/j.pneurobio.2009.01.007; Wang ZB, 2005, CELL BIOL INT, V29, P489, DOI 10.1016/j.cellbi.2005.04.001; Wick W, 1999, J PHARMACOL EXP THER, V289, P1306; WYLLIE AH, 1984, J PATHOL, V142, P67, DOI 10.1002/path.1711420112; Yang Y, 2010, MOLECULES, V15, P7075, DOI 10.3390/molecules15107075; Zhang JH, 2002, TRENDS CELL BIOL, V12, P84, DOI 10.1016/S0962-8924(01)02206-1; Zhang YJ, 2004, BIOL PHARM BULL, V27, P251, DOI 10.1248/bpb.27.251; Zuco V, 2002, CANCER LETT, V175, P17, DOI 10.1016/S0304-3835(01)00718-2	80	27	29	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e34793	10.1371/journal.pone.0034793	http://dx.doi.org/10.1371/journal.pone.0034793			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536331	gold, Green Published			2022-12-27	WOS:000305339200020
J	Zhang, J; Lazarenko, OP; Wu, XL; Tong, YD; Blackburn, ML; Gomez-Acevedo, H; Shankar, K; Badger, TM; Ronis, MJJ; Chen, JR				Zhang, Jian; Lazarenko, Oxana P.; Wu, Xianli; Tong, Yudong; Blackburn, Michael L.; Gomez-Acevedo, Horatio; Shankar, Kartik; Badger, Thomas M.; Ronis, Martin J. J.; Chen, Jin-Ran			Differential Effects of Short Term Feeding of a Soy Protein Isolate Diet and Estrogen Treatment on Bone in the Pre-Pubertal Rat	PLOS ONE			English	Article							FEMALE RATS; CONSUMPTION; ISOFLAVONES; EXPRESSION; DIFFERS; HEALTH; WOMEN; BETA; SIZE; MASS	Background: Previous reports suggest that beneficial effects of soy on bone quality are due to the estrogenic actions of isoflavone phytochemicals associated with the protein. However, mechanistic studies comparing the effects of soy diet and estrogens on bone, particularly in rapidly growing animals are lacking. Methodology and Principal Findings: We studied the effects of short term feeding of soy protein isolate (SPI) on bone in comparison to the effects of 17 beta-estradiol (E2) in pre-pubertal rats. Female rats were weaned to one of 4 treatments: 1) a control casein-based diet (CAS); 2) CAS with subcutaneous E2 (10 mg/kg/d) (CAS+E2); 3) a SPI-containing diet (SPI); or 4) SPI with subcutaneous E2 (SPI) or SPI with 10 mu g/kg/d E2 (SPI+E2) for 14 days beginning on postnatal day 20. SPI increased while E2 decreased bone turnover compared to CAS. In contrast, both treatments decreased serum sclerostin levels. Microarray analysis of RNA isolated from bone revealed 652 genes regulated by SPI, 491 genes regulated by E2, and 266 genes regulated by both SPI diet and E2 compared to CAS. The expression of caveolin-1, a protein localized in the cell membrane, was down-regulated (p < 0.05) in rats fed SPI, but not by E2 compared to rats fed casein. Down-regulation of caveolin-1 by SPI was associated with increased BMP2, Smad and Runx2 expression in bone and osteoblasts (p < 0.05). Conclusions/Significance: These results suggest SPI and E2 have different effects on bone turnover prior to puberty. Approximately half of the genes are regulated in the same direction by E2 or SPI, but in combination, SPI blocks the estrogen effects and returns the profile towards control levels. In addition, there are E2 specific and SPI-specific gene changes related to regulation of bone formation.	[Zhang, Jian; Lazarenko, Oxana P.; Wu, Xianli; Tong, Yudong; Blackburn, Michael L.; Gomez-Acevedo, Horatio; Shankar, Kartik; Badger, Thomas M.; Ronis, Martin J. J.; Chen, Jin-Ran] Arkansas Childrens Nutr Ctr, Little Rock, AR USA; [Zhang, Jian; Shankar, Kartik; Badger, Thomas M.; Ronis, Martin J. J.; Chen, Jin-Ran] Univ Arkansas Med Sci, Dept Pediat, Little Rock, AR 72205 USA; [Lazarenko, Oxana P.; Wu, Xianli; Blackburn, Michael L.; Badger, Thomas M.] Univ Arkansas Med Sci, Dept Physiol & Biophys, Little Rock, AR 72205 USA; [Ronis, Martin J. J.] Univ Arkansas Med Sci, Dept Pharmacol & Toxicol, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences	Chen, JR (corresponding author), Arkansas Childrens Nutr Ctr, Little Rock, AR USA.	chenjinran@uams.edu	Gomez-Acevedo, Horacio/AAR-8783-2021	Gomez-Acevedo, Horacio/0000-0002-1570-1606; Shankar, Kartik/0000-0002-7964-9026	United States Department of Agriculture/Agriculture Research Service (USDA/ARS) [6251-51000-005-03S]	United States Department of Agriculture/Agriculture Research Service (USDA/ARS)(United States Department of Agriculture (USDA))	This work was supported by United States Department of Agriculture/Agriculture Research Service (USDA/ARS) #6251-51000-005-03S to the Arkansas Children's Nutrition Center (JRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arjmandi BH, 1996, J NUTR, V126, P161, DOI 10.1093/jn/126.1.161; Badger TM, 2002, J NUTR, V132, p559S, DOI 10.1093/jn/132.3.559S; Bhangu PS, 2001, BONE, V29, P16, DOI 10.1016/S8756-3282(01)00482-3; Bitto A, 2010, CURR MED CHEM, V17, P3007, DOI 10.2174/092986710791959738; Chen JR, 2008, EXP BIOL MED, V233, P1348, DOI 10.3181/0802-RM-63; Chen JR, 2009, J NUTR, V139, P1839, DOI 10.3945/jn.109.109041; Gallea S, 2001, BONE, V28, P491, DOI 10.1016/S8756-3282(01)00415-X; Gu LW, 2006, J NUTR, V136, P1215, DOI 10.1093/jn/136.5.1215; Ho SC, 2001, J BONE MINER RES, V16, P1363, DOI 10.1359/jbmr.2001.16.7.1363; Kaludjerovic J, 2010, J NUTR, V140, P766, DOI 10.3945/jn.109.116343; Kousteni S, 2001, CELL, V104, P719, DOI 10.1016/S0092-8674(01)00268-9; Kuiper GGJM, 1998, ENDOCRINOLOGY, V139, P4252, DOI 10.1210/en.139.10.4252; Kurzer M. S., 2008, Inflammopharmacology, V16, P227, DOI 10.1007/s10787-008-8021-z; Meksem K., 2001, Journal of Biomedicine and Biotechnology, V1, P38, DOI 10.1155/S1110724301000110; Messina M, 2010, J NUTR, V140, p2289S, DOI 10.3945/jn.110.124107; Mughal MZ, 2011, CURR OPIN ENDOCRINOL, V18, P28, DOI 10.1097/MED.0b013e3283416441; Okamoto T, 1998, J BIOL CHEM, V273, P5419, DOI 10.1074/jbc.273.10.5419; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Reinwald S, 2006, J NAT PROD, V69, P450, DOI 10.1021/np058104g; Ronis MJ, 2001, J NUTR, V131, P1180, DOI 10.1093/jn/131.4.1180; Rubin J, 2007, J BONE MINER RES, V22, P1408, DOI 10.1359/jbmr.070601; Sacco SM, 2009, MENOPAUSE, V16, P545, DOI 10.1097/gme.0b013e31818fc00a; Setchell KDR, 2001, J AM COLL NUTR, V20, p354S, DOI 10.1080/07315724.2001.10719168; Shankar K, 2010, ENDOCRINOLOGY, V151, P153, DOI 10.1210/en.2009-0840; Shupnik MA, 1998, J CLIN ENDOCR METAB, V83, P3965, DOI 10.1210/jc.83.11.3965; Singhal R, 2009, J ENDOCRINOL, V202, P141, DOI 10.1677/JOE-09-0059; Tylavsky FA, 2004, AM J CLIN NUTR, V79, P311; Warri A, 2008, BRIT J CANCER, V98, P1485, DOI 10.1038/sj.bjc.6604321; Wrana JL, 2000, CELL, V100, P189, DOI 10.1016/S0092-8674(00)81556-1	29	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35736	10.1371/journal.pone.0035736	http://dx.doi.org/10.1371/journal.pone.0035736			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536432	Green Published, gold, Green Submitted			2022-12-27	WOS:000305339200104
J	O'Sullivan, VJ; Barrette-Ng, I; Hommema, E; Hermanson, GT; Schofield, M; Wu, SC; Honetschlaeger, C; Ng, KKS; Wong, SL				O'Sullivan, Valerie J.; Barrette-Ng, Isabelle; Hommema, Eric; Hermanson, Greg T.; Schofield, Mark; Wu, Sau-Ching; Honetschlaeger, Claudia; Ng, Kenneth K. -S.; Wong, Sui-Lam			Development of a Tetrameric Streptavidin Mutein with Reversible Biotin Binding Capability: Engineering a Mobile Loop as an Exit Door for Biotin	PLOS ONE			English	Article							MONOMERIC STREPTAVIDIN; SECRETORY PRODUCTION; BACILLUS-SUBTILIS; AVIDIN; DISSOCIATION; DIFFRACTION; COMPLEX; TOOLS	A novel form of tetrameric streptavidin has been engineered to have reversible biotin binding capability. In wild-type streptavidin, loop(3-4) functions as a lid for the entry and exit of biotin. When biotin is bound, interactions between biotin and key residues in loop(3-4) keep this lid in the closed state. In the engineered mutein, a second biotin exit door is created by changing the amino acid sequence of loop(7-8). This door is mobile even in the presence of the bound biotin and can facilitate the release of biotin from the mutein. Since loop(7-8) is involved in subunit interactions, alteration of this loop in the engineered mutein results in an 11 degrees rotation between the two dimers in reference to wild-type streptavidin. The tetrameric state of the engineered mutein is stabilized by a H127C mutation, which leads to the formation of inter-subunit disulfide bonds. The biotin binding kinetic parameters (k(off) of 4.28 x 10(-4) s(-1) and K-d of 1.9 x 10(-8) M) make this engineered mutein a superb affinity agent for the purification of biotinylated biomolecules. Affinity matrices can be regenerated using gentle procedures, and regenerated matrices can be reused at least ten times without any observable reduction in binding capacity. With the combination of both the engineered mutein and wild-type streptavidin, biotinylated biomolecules can easily be affinity purified to high purity and immobilized to desirable platforms without any leakage concerns. Other potential biotechnological applications, such as development of an automated high-throughput protein purification system, are feasible.	[O'Sullivan, Valerie J.; Hommema, Eric; Hermanson, Greg T.; Schofield, Mark] Thermo Fisher Sci Inc, Pierce Prot Res, Rockford, IL USA; [Barrette-Ng, Isabelle; Wu, Sau-Ching; Honetschlaeger, Claudia; Ng, Kenneth K. -S.; Wong, Sui-Lam] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada	Thermo Fisher Scientific; University of Calgary	O'Sullivan, VJ (corresponding author), Thermo Fisher Sci Inc, Pierce Prot Res, Rockford, IL USA.	slwong@ucalgary.ca		Ng, Kenneth K.S./0000-0001-7280-8445	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	The work was supported by Natural Sciences and Engineering Research Council of Canada, http://www.nserc-crsng.gc.ca/Index_eng.asp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayer EA, 1996, ELECTROPHORESIS, V17, P1319, DOI 10.1002/elps.1150170808; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; CHILKOTI A, 1995, P NATL ACAD SCI USA, V92, P1754, DOI 10.1073/pnas.92.5.1754; CHILKOTI A, 1995, BIO-TECHNOL, V13, P1198, DOI 10.1038/nbt1195-1198; Chivers CE, 2011, BIOCHEM J, V435, P55, DOI 10.1042/BJ20101593; Chivers CE, 2010, NAT METHODS, V7, P391, DOI [10.1038/nmeth.1450, 10.1038/NMETH.1450]; Chu V, 1998, PROTEIN SCI, V7, P848; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Freitag S, 1998, J MOL BIOL, V279, P211, DOI 10.1006/jmbi.1998.1735; Freitag S, 1999, P NATL ACAD SCI USA, V96, P8384, DOI 10.1073/pnas.96.15.8384; Freitag S, 1997, PROTEIN SCI, V6, P1157, DOI 10.1002/pro.5560060604; GREEN NM, 1990, METHOD ENZYMOL, V184, P51; HENDRICKSON WA, 1989, P NATL ACAD SCI USA, V86, P2190, DOI 10.1073/pnas.86.7.2190; Huang W, 1997, ANAL CHEM, V69, P4601, DOI 10.1021/ac970390g; Katz BA, 1997, J MOL BIOL, V274, P776, DOI 10.1006/jmbi.1997.1444; KOHANSKI RA, 1990, METHOD ENZYMOL, V184, P194; Kopetzki E, 2001, US, Patent No. [6312916 B1, 6312916]; Krebs WG, 2000, NUCLEIC ACIDS RES, V28, P1665, DOI 10.1093/nar/28.8.1665; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Laitinen OH, 2007, TRENDS BIOTECHNOL, V25, P269, DOI 10.1016/j.tibtech.2007.04.001; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Le Trong I, 2011, ACTA CRYSTALLOGR D, V67, P813, DOI 10.1107/S0907444911027806; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Qureshi MH, 2001, J BIOL CHEM, V276, P46422, DOI 10.1074/jbc.M107398200; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Reznik GO, 1996, NAT BIOTECHNOL, V14, P1007, DOI 10.1038/nbt0896-1007; Reznik GO, 2001, BIOCONJUGATE CHEM, V12, P1000, DOI 10.1021/bc015507t; SANO T, 1995, P NATL ACAD SCI USA, V92, P3180, DOI 10.1073/pnas.92.8.3180; Stayton PS, 1999, BIOMOL ENG, V16, P39, DOI 10.1016/S1050-3862(99)00042-X; Thomsen R, 2006, J MED CHEM, V49, P3315, DOI 10.1021/jm051197e; Waner MJ, 2004, BIOPHYS J, V87, P2701, DOI 10.1529/biophysj.104.047266; WEBER PC, 1989, SCIENCE, V243, P85, DOI 10.1126/science.2911722; WILCHEK M, 1990, METHOD ENZYMOL, V184, P5; WILMOT CM, 1988, J MOL BIOL, V203, P221, DOI 10.1016/0022-2836(88)90103-9; Wu SC, 2006, PROTEIN EXPRES PURIF, V46, P268, DOI 10.1016/j.pep.2005.10.006; Wu SC, 2005, J BIOL CHEM, V280, P23225, DOI 10.1074/jbc.M501733200; Wu SC, 2002, APPL ENVIRON MICROB, V68, P3261, DOI 10.1128/AEM.68.7.3261-3269.2002; Wu SC, 2002, PROTEIN EXPRES PURIF, V24, P348, DOI 10.1006/prep.2001.1582; Wu SC, 2002, APPL ENVIRON MICROB, V68, P1102, DOI 10.1128/AEM.68.3.1102-1108.2002	41	20	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e35203	10.1371/journal.pone.0035203	http://dx.doi.org/10.1371/journal.pone.0035203			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22536357	Green Submitted, Green Published, gold			2022-12-27	WOS:000305336200028
J	Jin, MY; Kumar, A; Kumar, S				Jin, Mengyao; Kumar, Anil; Kumar, Santosh			Ethanol-Mediated Regulation of Cytochrome P450 2A6 Expression in Monocytes: Role of Oxidative Stress-Mediated PKC/MEK/Nrf2 Pathway	PLOS ONE			English	Article							DRUG-METABOLISM; PHENETHYL ISOTHIOCYANATE; ANTIOXIDANT RESPONSE; SMOKING-BEHAVIOR; HUMAN CYP2A6; ACTIVATION; INDUCTION; NICOTINE; ALCOHOL; ENZYMES	Cytochrome P450 2A6 (CYP2A6) is known to metabolize nicotine, the major constituent of tobacco, leading to the production of toxic metabolites and induction of oxidative stress that result in liver damage and lung cancer. Recently, we have shown that CYP2A6 is induced by ethanol and metabolizes nicotine into cotinine and other metabolites leading to generation of reactive oxygen species (ROS) in U937 monocytes. However, the mechanism by which CYP2A6 is induced by ethanol is unknown. In this study, we have examined the role of the PKC/Nrf2 pathway (protein kinase C-mediated phosphorylation and translocation of nuclear erythroid 2-related factor 2 to the nucleus) in ethanol-mediated CYP2A6 induction. Our results showed that 100 mM ethanol significantly induced CYP2A6 mRNA and protein (similar to 150%) and increased ROS formation, and induction of gene expression and ROS were both completely blocked by treatment with either a CYP2E1 inhibitor (diallyl sulfide) or an antioxidant (vitamin C). The results suggest the role of oxidative stress in the regulation of CYP2A6 expression. Subsequently, we investigated the role of Nrf2 pathway in oxidative stress-mediated regulation of CYP2A6 expression in U937 monocytes. Our results showed that butylated hydroxyanisole, a stabilizer of nuclear Nrf2, increased CYP2A6 levels >200%. Staurosporine, an inhibitor of PKC, completely abolished ethanol-induced CYP2A6 expression. Furthermore, our results showed that a specific inhibitor of mitogen-activated protein kinase kinase (MEK) (U0126) completely abolished ethanol-mediated CYP2A6 induction and Nrf2 translocation. Overall, these results suggest that CYP2E1-mediated oxidative stress produced as a result of ethanol metabolism translocates Nrf2 into the nucleus through PKC/MEK pathway, resulting in the induction of CYP2A6 in monocytes. An increased level of CYP2A6 in monocytes is expected to further increase oxidative stress in smokers through CYP2A6-mediated nicotine metabolism. Thus, this study has clinical relevance because of the high incidence of alcohol use among smokers, especially in HIV-infected individuals.	[Jin, Mengyao; Kumar, Anil; Kumar, Santosh] Univ Missouri, Sch Pharm, Div Pharmacol & Toxicol, Kansas City, MO 64110 USA	University of Missouri System; University of Missouri Kansas City	Jin, MY (corresponding author), Univ Missouri, Sch Pharm, Div Pharmacol & Toxicol, Kansas City, MO 64110 USA.	kumarsa@umkc.edu	Boothapati, Anil Kumar/HHS-1813-2022; KUMAR, ANIL/ACD-8340-2022		National Institutes of Health [DA031616-01, AA015045]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA015045] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA031616] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The work was supported by National Institutes of Health grants (DA031616-01) to Santosh Kumar and (AA015045) to Anil Kumar. The funders provided salary support and costs for supplies to carry out this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBUD RA, 1995, J INFECT DIS, V172, P859, DOI 10.1093/infdis/172.3.859; Achur RN, 2010, J NEUROIMMUNE PHARM, V5, P83, DOI 10.1007/s11481-009-9185-z; Andrieux L, 2004, MOL PHARMACOL, V65, P934, DOI 10.1124/mol.65.4.934; Bloom DA, 2003, J BIOL CHEM, V278, P44675, DOI 10.1074/jbc.M307633200; Boelaert JR, 1996, INFECT AGENT DIS, V5, P36; Boelaert JR, 1996, J INFECT DIS, V173, P1045, DOI 10.1093/infdis/173.4.1045a; BRADY JF, 1991, CHEM RES TOXICOL, V4, P642, DOI 10.1021/tx00024a008; Buckner CM, 2011, CELL IMMUNOL, V267, P109, DOI 10.1016/j.cellimm.2010.12.004; Burkhalter JE, 2005, NICOTINE TOB RES, V7, P511, DOI 10.1080/14622200500186064; Carayol N, 2006, J BIOL CHEM, V281, P31142, DOI 10.1074/jbc.M603417200; Cassol E, 2006, J LEUKOCYTE BIOL, V80, P1018, DOI 10.1189/jlb.0306150; Coleman CM, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-51; Correa F, 2011, GLIA, V59, P785, DOI 10.1002/glia.21151; Di YM, 2009, CURR DRUG METAB, V10, P754, DOI 10.2174/138920009789895507; Ferguson CS, 2011, DRUG METAB DISPOS, V39, P2233, DOI 10.1124/dmd.111.040378; Gescher A, 1998, GEN PHARMACOL, V31, P721, DOI 10.1016/S0306-3623(98)00069-X; Gilmore WJ, 2003, TOXICOLOGY, V184, P211, DOI 10.1016/S0300-483X(02)00581-4; Guo XQ, 2011, TOXICOL IND HEALTH, V27, P341, DOI 10.1177/0748233710387007; Haorah J, 2008, FREE RADICAL BIO MED, V45, P1542, DOI 10.1016/j.freeradbiomed.2008.08.030; Hennig M, 2009, J SURG RES, V154, P187, DOI 10.1016/j.jss.2008.11.836; Howard LA, 2003, BRIT J PHARMACOL, V138, P1376, DOI 10.1038/sj.bjp.0705146; HUANG K-P, 1990, Biofactors, V2, P171; Itoh M, 2006, J PHARMACOL EXP THER, V319, P693, DOI 10.1124/jpet.106.107573; Jin MY, 2012, J NEUROIMMUNE PHARM, V7, P289, DOI 10.1007/s11481-011-9283-6; Jin MY, 2011, ALCOHOL CLIN EXP RES, V35, P132, DOI 10.1111/j.1530-0277.2010.01330.x; Keum YS, 2006, PHARM RES, V23, P2586, DOI 10.1007/s11095-006-9094-2; Kim KC, 2010, INT J BIOCHEM CELL B, V42, P297, DOI 10.1016/j.biocel.2009.11.009; Kirby GM, 2011, CURR DRUG METAB, V12, P186; Kong SY, 2009, PHARMACOGENOMICS, V10, P1147, DOI 10.2217/PGS.09.48; Lamle J, 2008, GASTROENTEROLOGY, V134, P1159, DOI 10.1053/j.gastro.2008.01.011; Lee SE, 2011, J CELL BIOCHEM, V112, P2352, DOI 10.1002/jcb.23158; Lu YK, 2011, DRUG METAB DISPOS, V39, P330, DOI 10.1124/dmd.110.035691; Maicas N, 2011, ANTIOXID REDOX SIGN, V15, P889, DOI 10.1089/ars.2010.3835; Manda VK, 2010, J NEUROCHEM, V115, P1495, DOI 10.1111/j.1471-4159.2010.07054.x; Meyer RP, 2007, CURR DRUG METAB, V8, P297, DOI 10.2174/138920007780655478; Moon HJ, 2011, MOL CELL BIOCHEM, V349, P179, DOI 10.1007/s11010-010-0672-6; Morris CR, 2004, NUTR CANCER, V48, P54, DOI 10.1207/s15327914nc4801_8; Nakajima M, 2007, CURR OPIN MOL THER, V9, P538; Narasimhan M, 2011, MOL PHARMACOL, V80, P988, DOI 10.1124/mol.111.073262; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Nitti M, 2008, MOL ASPECTS MED, V29, P36, DOI 10.1016/j.mam.2007.09.001; Niture SK, 2010, TOXICOL APPL PHARM, V244, P37, DOI 10.1016/j.taap.2009.06.009; Orlicky DJ, 2011, ALCOHOL CLIN EXP RES, V35, P1020, DOI 10.1111/j.1530-0277.2011.01434.x; Peterhans E, 1997, J NUTR, V127, pS962, DOI 10.1093/jn/127.5.962S; Pichette V, 2003, CURR DRUG METAB, V4, P91, DOI 10.2174/1389200033489532; Prandota Joseph, 2005, Am J Ther, V12, P254; PROCHASKA HJ, 1988, CANCER RES, V48, P4776; Rock RB, 2008, J NEUROIMMUNE PHARM, V3, P143, DOI 10.1007/s11481-007-9098-7; Schlaepfer Isabel R, 2008, Curr Drug Abuse Rev, V1, P124; Sellers EM, 2003, DRUG DISCOV TODAY, V8, P487, DOI 10.1016/S1359-6446(03)02704-1; Solodova E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018543; Sonoda J, 2003, CURR DRUG METAB, V4, P59, DOI 10.2174/1389200033336739; Tang W, 2005, CURR DRUG METAB, V6, P503, DOI 10.2174/138920005774330602; Tkachev VO, 2011, BIOCHEMISTRY-MOSCOW+, V76, P407, DOI 10.1134/S0006297911040031; Venugopal SK, 2007, J BIOL CHEM, V282, P31900, DOI 10.1074/jbc.M703729200; Villeneuve NF, 2010, ANTIOXID REDOX SIGN, V13, P1699, DOI 10.1089/ars.2010.3211; von Weymarn LB, 2006, CARCINOGENESIS, V27, P782, DOI 10.1093/carcin/bgi301; Williams J F, 1991, J Fla Med Assoc, V78, P517; YAMAZAKI H, 1992, CARCINOGENESIS, V13, P1789, DOI 10.1093/carcin/13.10.1789; Yokota S, 2011, BIOCHEM PHARMACOL, V81, P289, DOI 10.1016/j.bcp.2010.09.020; Zhang JY, 2006, CURR DRUG METAB, V7, P939, DOI 10.2174/138920006779010575	61	37	40	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35505	10.1371/journal.pone.0035505	http://dx.doi.org/10.1371/journal.pone.0035505			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22530035	Green Published, gold, Green Submitted			2022-12-27	WOS:000305350600090
J	Lakshmanan, LN; Gruber, J; Halliwell, B; Gunawan, R				Lakshmanan, Lakshmi Narayanan; Gruber, Jan; Halliwell, Barry; Gunawan, Rudiyanto			Role of Direct Repeat and Stem-Loop Motifs in mtDNA Deletions: Cause or Coincidence?	PLOS ONE			English	Article							MITOCHONDRIAL-DNA DELETIONS; SUBSTANTIA-NIGRA NEURONS; SKELETAL-MUSCLE FIBERS; RHESUS-MONKEYS; LIFE-SPAN; MUTATIONS; REGIONS; REPLICATION; SEQUENCES; MODEL	Deletion mutations within mitochondrial DNA (mtDNA) have been implicated in degenerative and aging related conditions, such as sarcopenia and neuro-degeneration. While the precise molecular mechanism of deletion formation in mtDNA is still not completely understood, genome motifs such as direct repeat (DR) and stem-loop (SL) have been observed in the neighborhood of deletion breakpoints and thus have been postulated to take part in mutagenesis. In this study, we have analyzed the mitochondrial genomes from four different mammals: human, rhesus monkey, mouse and rat, and compared them to randomly generated sequences to further elucidate the role of direct repeat and stem-loop motifs in aging associated mtDNA deletions. Our analysis revealed that in the four species, DR and SL structures are abundant and that their distributions in mtDNA are not statistically different from randomized sequences. However, the average distance between the reported age associated mtDNA breakpoints and their respective nearest DR motifs is significantly shorter than what is expected of random chance in human (p < 10(-4)) and rhesus monkey (p = 0.0034), but not in mouse (p = 0.0719) and rat (p = 0.0437), indicating the existence of species specific difference in the relationship between DR motifs and deletion breakpoints. In addition, the frequencies of large DRs (> 10 bp) tend to decrease with increasing lifespan among the four mammals studied here, further suggesting an evolutionary selection against stable mtDNA misalignments associated with long DRs in long-living animals. In contrast to the results on DR, the probability of finding SL motifs near a deletion breakpoint does not differ from random in any of the four mtDNA sequences considered. Taken together, the findings in this study give support for the importance of stable mtDNA misalignments, aided by long DRs, as a major mechanism of deletion formation in long-living, but not in short-living mammals.	[Lakshmanan, Lakshmi Narayanan; Gunawan, Rudiyanto] Swiss Fed Inst Technol, Inst Chem & Bioengn, Zurich, Switzerland; [Lakshmanan, Lakshmi Narayanan] Natl Univ Singapore, Dept Chem & Biomol Engn, Singapore 117548, Singapore; [Gruber, Jan; Halliwell, Barry] Natl Univ Singapore, Ctr Life Sci CeLS, Dept Biochem Neurobiol & Ageing Program, Singapore 117548, Singapore	Swiss Federal Institutes of Technology Domain; ETH Zurich; National University of Singapore; National University of Singapore	Lakshmanan, LN (corresponding author), Swiss Fed Inst Technol, Inst Chem & Bioengn, Zurich, Switzerland.	rudi.gunawan@chem.ethz.ch	Gunawan, Rudiyanto/D-4650-2009; Halliwell, Barry/C-8318-2009	Gunawan, Rudiyanto/0000-0002-6480-7976; Halliwell, Barry/0000-0002-3560-7123; Lakshmanan, Lakshmi Narayanan/0000-0002-2892-1931	ETH Zurich; Ministry of Education Singapore [MOE2010-T2-2-048]	ETH Zurich(ETH Zurich); Ministry of Education Singapore(Ministry of Education, Singapore)	LNL and RG were supported by funding from ETH Zurich. JG and BH were supported by funding from the Ministry of Education Singapore under grant MOE2010-T2-2-048. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERTINI AM, 1982, CELL, V29, P319, DOI 10.1016/0092-8674(82)90148-9; BAUMER A, 1994, AM J HUM GENET, V54, P618; Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769; Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132; Cao ZJ, 2001, NUCLEIC ACIDS RES, V29, P4502, DOI 10.1093/nar/29.21.4502; Chung SS, 1996, AGE, V19, P117, DOI 10.1007/BF02434081; CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6; EDRIS W, 1994, MUTAT RES-DNAGING G, V316, P69, DOI 10.1016/0921-8734(94)90009-4; Eimon PM, 1996, DEV GENET, V18, P107, DOI 10.1002/(SICI)1520-6408(1996)18:2&lt;107::AID-DVG3&gt;3.0.CO;2-D; GLICKMAN BW, 1984, P NATL ACAD SCI-BIOL, V81, P512, DOI 10.1073/pnas.81.2.512; Gokey NG, 2004, AGING CELL, V3, P319, DOI 10.1111/j.1474-9728.2004.00122.x; Gruber J, 2008, FRONT BIOSCI-LANDMRK, V13, P6554, DOI 10.2741/3174; Guo XH, 2010, TRENDS GENET, V26, P340, DOI 10.1016/j.tig.2010.05.006; Herbst A, 2007, J GERONTOL A-BIOL, V62, P235, DOI 10.1093/gerona/62.3.235; Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778; Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94; LEE CM, 1994, MECH AGEING DEV, V75, P69, DOI 10.1016/0047-6374(94)90029-9; Markham Nicholas R., 2008, V453, P3, DOI 10.1007/978-1-60327-429-6_1; McKiernan SH, 2009, EXP GERONTOL, V44, P170, DOI 10.1016/j.exger.2008.09.014; Mita S, 1998, MUSCLE NERVE, V21, P490, DOI 10.1002/(SICI)1097-4598(199804)21:4<490::AID-MUS7>3.0.CO;2-4; Reeve AK, 2008, AM J HUM GENET, V82, P228, DOI 10.1016/j.ajhg.2007.09.018; Sadikovic B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015687; Samuels DC, 2005, MECH AGEING DEV, V126, P1123, DOI 10.1016/j.mad.2005.05.003; Samuels DC, 2004, TRENDS GENET, V20, P393, DOI 10.1016/j.tig.2004.07.003; Samuels DC, 2004, TRENDS GENET, V20, P226, DOI 10.1016/j.tig.2004.03.003; SHOFFNER JM, 1989, P NATL ACAD SCI USA, V86, P7952, DOI 10.1073/pnas.86.20.7952; Solano A, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.7.e86; VanTuyle GC, 1996, MUTAT RES-FUND MOL M, V349, P95, DOI 10.1016/0027-5107(95)00165-4	28	18	19	4	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35271	10.1371/journal.pone.0035271	http://dx.doi.org/10.1371/journal.pone.0035271			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529999	Green Published, Green Submitted, gold			2022-12-27	WOS:000305350600071
J	Bai, YL; Yang, J; Zhou, X; Ding, XX; Eisele, LE; Bai, GC				Bai, Yinlan; Yang, Jun; Zhou, Xin; Ding, Xinxin; Eisele, Leslie E.; Bai, Guangchun			Mycobacterium tuberculosis Rv3586 (DacA) Is a Diadenylate Cyclase That Converts ATP or ADP into c-di-AMP	PLOS ONE			English	Article							DNA-BINDING PROTEIN; CYCLIC-AMP; ADENYLYL CYCLASES; GMP; BACTERIA; CAMP; BCG; PHOSPHODIESTERASE; BIOCHEMISTRY; DIGUANYLATE	Cyclic diguanosine monophosphate (c-di-GMP) and cyclic diadenosine monophosphate (c-di-AMP) are recently identified signaling molecules. c-di-GMP has been shown to play important roles in bacterial pathogenesis, whereas information about c-di-AMP remains very limited. Mycobacterium tuberculosis Rv3586 (DacA), which is an ortholog of Bacillus subtilis DisA, is a putative diadenylate cyclase. In this study, we determined the enzymatic activity of DacA in vitro using high-performance liquid chromatography (HPLC), mass spectrometry (MS) and thin layer chromatography (TLC). Our results showed that DacA was mainly a diadenylate cyclase, which resembles DisA. In addition, DacA also exhibited residual ATPase and ADPase in vitro. Among the potential substrates tested, DacA was able to utilize both ATP and ADP, but not AMP, pApA, c-di-AMP or GTP. By using gel filtration and analytical ultracentrifugation, we further demonstrated that DacA existed as an octamer, with the N-terminal domain contributing to tetramerization and the C-terminal domain providing additional dimerization. Both the N-terminal and the C-terminal domains were essential for the DacA's enzymatically active conformation. The diadenylate cyclase activity of DacA was dependent on divalent metal ions such as Mg2+, Mn2+ or Co2+. DacA was more active at a basic pH rather than at an acidic pH. The conserved RHR motif in DacA was essential for interacting with ATP, and mutation of this motif to AAA completely abolished DacA's diadenylate cyclase activity. These results provide the molecular basis for designating DacA as a diadenylate cyclase. Our future studies will explore the biological function of this enzyme in M. tuberculosis.	[Bai, Yinlan; Yang, Jun; Bai, Guangchun] Albany Med Coll, Ctr Immunol & Microbial Dis, Albany, NY 12208 USA; [Zhou, Xin; Ding, Xinxin; Eisele, Leslie E.] New York State Dept Hlth, Wadsworth Ctr, Albany, NY USA; [Zhou, Xin; Ding, Xinxin] SUNY Albany, Sch Publ Hlth, Albany, NY USA	Albany Medical College; State University of New York (SUNY) System; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Bai, YL (corresponding author), Albany Med Coll, Ctr Immunol & Microbial Dis, Albany, NY 12208 USA.	baig@mail.amc.edu		Bai, Guangchun/0000-0002-2086-4020	Potts Memorial Foundation; National Cancer Institute, National Institutes of Health [CA092596]; NATIONAL CANCER INSTITUTE [R01CA092596] Funding Source: NIH RePORTER	Potts Memorial Foundation; National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the Potts Memorial Foundation (to GB) and by grant CA092596 from the National Cancer Institute, National Institutes of Health (to XD) (http://www.cancer.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal N, 2009, NATURE, V460, P98, DOI 10.1038/nature08123; Aziz MA, 2005, CLIN INFECT DIS, V41, pS258, DOI 10.1086/430786; Bai GC, 2005, J BACTERIOL, V187, P7795, DOI 10.1128/JB.187.22.7795-7804.2005; Bai GC, 2007, INFECT IMMUN, V75, P5509, DOI 10.1128/IAI.00658-07; Bai G, 2011, MOL MICROBIOL, V82, P180, DOI 10.1111/j.1365-2958.2011.07806.x; Bai G, 2011, CELL MICROBIOL, V13, P349, DOI 10.1111/j.1462-5822.2010.01562.x; Bai GC, 2009, FEMS IMMUNOL MED MIC, V55, P68, DOI 10.1111/j.1574-695X.2008.00500.x; BOTSFORD JL, 1992, MICROBIOL REV, V56, P100, DOI 10.1128/MMBR.56.1.100-122.1992; Camilli A, 2006, SCIENCE, V311, P1113, DOI 10.1126/science.1121357; Christen M, 2005, J BIOL CHEM, V280, P30829, DOI 10.1074/jbc.M504429200; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Corrigan RM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002217; Cotter PA, 2007, CURR OPIN MICROBIOL, V10, P17, DOI 10.1016/j.mib.2006.12.006; Dam J, 2004, METHOD ENZYMOL, V384, P185; Ebensen T, 2011, VACCINE, V29, P5210, DOI 10.1016/j.vaccine.2011.05.026; Eisele LE, 2006, BBA-PROTEINS PROTEOM, V1764, P1479, DOI 10.1016/j.bbapap.2006.06.008; Espinal MA, 2003, TUBERCULOSIS, V83, P44, DOI 10.1016/S1472-9792(02)00058-6; FINE PEM, 1995, LANCET, V346, P1339, DOI 10.1016/S0140-6736(95)92348-9; Florczyk MA, 2003, INFECT IMMUN, V71, P5332, DOI 10.1128/IAI.71.9.5332-5343.2003; Gomelsky M, 2011, MOL MICROBIOL, V79, P562, DOI 10.1111/j.1365-2958.2010.07514.x; Guo YL, 2001, EMBO J, V20, P3667, DOI 10.1093/emboj/20.14.3667; Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109; Jenal U, 2006, ANNU REV GENET, V40, P385, DOI 10.1146/annurev.genet.40.110405.090423; Jin L, 2011, J IMMUNOL, V187, P2595, DOI 10.4049/jimmunol.1100088; Kamegaya T, 2011, NAGOYA J MED SCI, V73, P49; Keppetipola Niroshika, 2008, J Biol Chem, V283, P30942, DOI 10.1074/jbc.M805064200; Linder JU, 2002, J BIOL CHEM, V277, P15271, DOI 10.1074/jbc.M200235200; LOWRIE DB, 1975, NATURE, V254, P600, DOI 10.1038/254600a0; McCue LA, 2000, GENOME RES, V10, P204, DOI 10.1101/gr.10.2.204; Oppenheimer-Shaanan Y, 2011, EMBO REP, V12, P594, DOI 10.1038/embor.2011.77; Pesavento C, 2009, CURR OPIN MICROBIOL, V12, P170, DOI 10.1016/j.mib.2009.01.007; Rao F, 2010, J BIOL CHEM, V285, P473, DOI 10.1074/jbc.M109.040238; Romling U, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.133pe39; Ryjenkov DA, 2005, J BACTERIOL, V187, P1792, DOI 10.1128/JB.187.5.1792-1798.2005; Sauer JD, 2011, INFECT IMMUN, V79, P688, DOI 10.1128/IAI.00999-10; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shenoy AR, 2005, BIOCHEMISTRY-US, V44, P15695, DOI 10.1021/bi0512391; Shenoy AR, 2006, FEBS LETT, V580, P3344, DOI 10.1016/j.febslet.2006.05.034; Shenoy AR, 2006, TRENDS MICROBIOL, V14, P543, DOI 10.1016/j.tim.2006.10.005; Tamayo R, 2007, ANNU REV MICROBIOL, V61, P131, DOI 10.1146/annurev.micro.61.080706.093426; Witte G, 2008, MOL CELL, V30, P167, DOI 10.1016/j.molcel.2008.02.020; Woodward JJ, 2010, SCIENCE, V328, P1703, DOI 10.1126/science.1189801	42	55	68	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e35206	10.1371/journal.pone.0035206	http://dx.doi.org/10.1371/journal.pone.0035206			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22529992	Green Published, gold, Green Submitted			2022-12-27	WOS:000305347400036
J	Laillou, A; Pham, TV; Tran, NT; Le, HP; Wieringa, F; Rohner, F; Fortin, S; Le, MB; Tran, DT; Moench-Pfanner, R; Berger, J				Laillou, Arnaud; Thuy Van Pham; Nga Thuy Tran; Hop Thi Le; Wieringa, Frank; Rohner, Fabian; Fortin, Sonia; Mai Bach Le; Do Thanh Tran; Moench-Pfanner, Regina; Berger, Jacques			Micronutrient Deficits Are Still Public Health Issues among Women and Young Children in Vietnam	PLOS ONE			English	Article							FOLIC-ACID SUPPLEMENTATION; FORTIFIED FISH SAUCE; IRON-DEFICIENCY; VITAMIN-B-12 STATUS; REPRODUCTIVE AGE; ZINC STATUS; MALNUTRITION; POPULATION; INDICATORS; ANEMIA	Background: The 2000 Vietnamese National Nutrition Survey showed that the population's dietary intake had improved since 1987. However, inequalities were found in food consumption between socioeconomic groups. As no national data exist on the prevalence of micronutrient deficiencies, a survey was conducted in 2010 to assess the micronutrient status of randomly selected 1526 women of reproductive age and 586 children aged 6-75 mo. Principal Findings: In women, according to international thresholds, prevalence of zinc deficiency (ZnD, 67.2 +/- 2.6%) and vitamin B12 deficiency (11.7 +/- 1.7%) represented public health problems, whereas prevalence of anemia (11.6 +/- 1.0%) and iron deficiency (ID, 13.7 +/- 1.1%) were considered low, and folate (<3%) and vitamin A (VAD, <2%) deficiencies were considered negligible. However, many women had marginal folate (25.1%) and vitamin A status (13.6%). Moreover, overweight (BMI >= 23 kg/m(2) for Asian population) or underweight occurred in 20% of women respectively highlighting the double burden of malnutrition. In children, a similar pattern was observed for ZnD (51.9 +/- 3.5%), anemia (9.1 +/- 1.4%) and ID (12.9 +/- 1.5%) whereas prevalence of marginal vitamin A status was also high (47.3 +/- 2.2%). There was a significant effect of age on anemia and ID prevalence, with the youngest age group (6-17 mo) having the highest risk for anemia, ID, ZnD and marginal vitamin A status as compared to other groups. Moreover, the poorest groups of population had a higher risk for zinc, anemia and ID. Conclusion: The prevalence of anemia and ID in Vietnam has been markedly reduced over the last decade, but a large part of the population is still at risk for other deficiencies such as zinc, vitamin A, folate and vitamin B12 especially the youngest children aged 6-17 mo. Consequently specific interventions to improve food diversity and quality should be implemented, among them food fortification of staple foods and condiments and improvement of complementary feeding.	[Laillou, Arnaud; Rohner, Fabian; Moench-Pfanner, Regina] GAIN, Geneva, Switzerland; [Thuy Van Pham; Nga Thuy Tran; Hop Thi Le; Mai Bach Le; Do Thanh Tran] NIN, Hanoi, Vietnam; [Wieringa, Frank; Fortin, Sonia; Berger, Jacques] IRD, UMR Nutripass IRD UM2 UM1, Montpellier, France	Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Laillou, A (corresponding author), GAIN, Geneva, Switzerland.	alaillou@gainhealth.org	Wieringa, Frank Tammo/K-7565-2017; Rohner, Fabian/I-5088-2019	Wieringa, Frank Tammo/0000-0002-6010-355X; Rohner, Fabian/0000-0003-0579-6952	Bill and Melinda Gates Foundation	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	The survey was funded by the Bill and Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aekplakorn Wichai, 2004, Journal of the Medical Association of Thailand, V87, P685; Allen L, 2006, GUIDELINES FOOD FORT; Allen LH, 2005, AM J CLIN NUTR, V81, p1206S; [Anonymous], SAS STAT INTR SURV S; AOAC International, 1995, OFF METH AN AOAC INT, P95; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Barton-Wright EC, 1952, PRACTICAL METHODS MI; Berger J, 2005, NUTR REV, V63, pS95, DOI 10.1301/nr.2005.dec.S95-S108; Berger Jacques, 2002, Sante, V12, P22; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Bui MH, 1999, INT J VITAM NUTR RES, V69, P362, DOI 10.1024/0300-9831.69.5.362; Casey GJ, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-261; de Benoist B, 2007, FOOD NUTR BULL, V28, pS480, DOI 10.1177/15648265070283S306; de Onis M, 2006, PUBLIC HEALTH NUTR, V9, P942, DOI 10.1017/PHN20062005; de Pee S, 2002, J NUTR, V132, p2895S, DOI 10.1093/jn/132.9.2895S; Dien LN, 2004, ASIA PAC J CLIN NUTR, V13, P40; Do TKL, 2009, ASIA PAC J CLIN NUTR, V18, P326; Ecker O, 2011, 10 USAID; European Committee for Standardization (CEN), 2003, FOODST DET FOL MICR; FerroLuzzi A, 1995, WHO TECH REP SER, V854, P1; FSS, 2010, DAT FOOD AGR ORG UN; Gibson RS, 2008, BRIT J NUTR, V99, pS14, DOI 10.1017/S0007114508006818; Gibson RS, 2006, P NUTR SOC, V65, P51, DOI 10.1079/PNS2005474; GSO, 2008, SUMM RES VIETN HOUS; GSO, 2010, RES SURV HOUS LIV ST; Ha do TP, 2011, BMC PUBLIC HEALTH, V11, P62; Hess SY, 2007, FOOD NUTR BULL, V28, pS403, DOI 10.1177/15648265070283S303; Hoang LV, 2009, ANAL CALORIE MICRONU; Hop LT, 2005, J NUTR, V135, p660S, DOI 10.1093/jn/135.3.660S; Hop LT, 2003, J NUTR, V133, p4006S, DOI 10.1093/jn/133.11.4006S; Hotz C, 2004, FOOD NUTR BULL, V25, pS189; Hung Le Q., 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P816; Huy ND, 2009, FOOD NUTR BULL, V30, pS506, DOI 10.1177/15648265090304S405; International Zinc Nutrition Consultative Group (IZiNCG), 2004, Food Nutr Bull, V25, pS99; IVACG, 1982, BIOCH METH ASS VIT S; Jones KM, 2007, J NUTR, V137, P1307, DOI 10.1093/jn/137.5.1307; Khan NC, 2008, ASIA PAC J CLIN NUTR, V17, P116; Khan NC, 2007, ASIA PAC J CLIN NUTR, V16, P274; Khoury C., 2008, Sight and Life Magazine, P40; Kim Y, 2004, OBES RES, V12, P445, DOI 10.1038/oby.2004.50; KIRKE PN, 1993, Q J MED, V86, P703; Ko GTC, 2001, ANN ACAD MED SINGAP, V30, P393; Le HT, 2007, BRIT J NUTR, V97, P955, DOI 10.1017/S0007114507659029; Le HT, 2007, FOOD NUTR BULL, V28, P291, DOI 10.1177/156482650702800305; Mai TT, 2003, ASIA PAC J CLIN NUTR, V12, P178; McLean E, 2008, FOOD NUTR BULL, V29, pS38, DOI 10.1177/15648265080292S107; MOH/ NIN, 2000, NAT PLAN ACT NUTR NP; Molloy AM, 2009, PEDIATRICS, V123, P917, DOI 10.1542/peds.2008-1173; National Institute of Nutrition, 2001, REP NAT SUBCL VIT A; Nguyen MD, 2007, PUBLIC HEALTH NUTR, V10, P115, DOI 10.1017/S1368980007224085; NIN NIoN, 2010, PREV UND CHIILDR 5 Y; Ninh N, 2001, MICRONUTRIENT DEFICI, P24; Oanh THT, 2009, ASIA PAC J CLIN NUTR, V18, P226; Organization WH, 1996, IND ASS VIT DEF THEI; PEREIRA SM, 1969, AM J CLIN NUTR, V22, P858; Perlas Leah A., 1996, Southeast Asian Journal of Tropical Medicine and Public Health, V27, P785; Pham VP, 2010, J NUTR, V140, P2241, DOI 10.3945/jn.110.123711; Nguyen PH, 2011, ASIA PAC J CLIN NUTR, V20, P359; Rustein SO, 2004, DHS COMPERATIVE REPO; Rutstein S.O., DHS WEALTH INDEX APP; Solomons NW, 2008, ASIA PAC J CLIN NUTR, V17, P20; Tagny CT, 2008, ANN BIOL CLIN-PARIS, V66, P90, DOI 10.1684/abc.2008.0195; Thurnham DI, 2010, AM J CLIN NUTR, V92, P546, DOI 10.3945/ajcn.2010.29284; Thurnham DI, 2003, LANCET, V362, P2052, DOI 10.1016/S0140-6736(03)15099-4; Thuy PV, 2003, AM J CLIN NUTR, V78, P284, DOI 10.1093/ajcn/78.2.284; Tran TN, 2009, J NUTR, V139, P1013, DOI 10.3945/jn.108.099754; Van Thuy P, 2005, J NUTR, V135, P2596, DOI 10.1093/jn/135.11.2596; Vietnam Academy of Social Science, 2006, VIETN POV UPD POV PO; Viteri FE, 2005, NUTR REV, V63, pS65, DOI 10.1301/nr.2005.dec.S65-S76; Vu TTH, 2009, PUBLIC HEALTH NUTR, V12, P941, DOI 10.1017/S1368980008003479; Wang Y, 2007, INT J OBESITY, V31, P177, DOI 10.1038/sj.ijo.0803354; WDI, 2010, DAT WORLD BANK; WHO, 2001, IRON DEFICIENCY ANAE; Wiss O, 1950, HYG, P225; World Health Organization, 2000, COMPL FEED FAM FOODS	75	61	62	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e34906	10.1371/journal.pone.0034906	http://dx.doi.org/10.1371/journal.pone.0034906			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22529954	gold, Green Published, Green Submitted			2022-12-27	WOS:000305347400024
J	Wang, CC; Lin, SY; Lai, YH; Liu, YJ; Hsu, YL; Chen, JJW				Wang, Chi-Chung; Lin, Sheng-Yi; Lai, Yi-Hua; Liu, Ya-Jung; Hsu, Yuan-Lin; Chen, Jeremy J. W.			Dimethyl Sulfoxide Promotes the Multiple Functions of the Tumor Suppressor HLJ1 through Activator Protein-1 Activation in NSCLC Cells	PLOS ONE			English	Article							FREE-RADICAL SCAVENGERS; LUNG-CARCINOMA CELLS; COMPLEX NAMI-A; FACTOR-KAPPA-B; INTERSTITIAL CYSTITIS; GENE-EXPRESSION; INDUCED APOPTOSIS; UP-REGULATION; DIMETHYLSULFOXIDE; CANCER	Background: Dimethyl sulfoxide (DMSO) is an amphipathic molecule that displays a diversity of antitumor activities. Previous studies have demonstrated that DMSO can modulate AP-1 activity and lead to cell cycle arrest at the G1 phase. HLJ1 is a newly identified tumor and invasion suppressor that inhibits tumorigenesis and cancer metastasis. Its transcriptional activity is regulated by the transcription factor AP-1. However, the effects of DMSO on HLJ1 are still unknown. In the present study, we investigate the antitumor effects of DMSO through HLJ1 induction and demonstrate the mechanisms involved. Methods and Findings: Low-HLJ1-expressing highly invasive CL1-5 lung adenocarcinoma cells were treated with various concentrations of DMSO. We found that DMSO can significantly inhibit cancer cell invasion, migration, proliferation, and colony formation capabilities through upregulation of HLJ1 in a concentration-dependent manner, whereas ethanol has no effect. In addition, the HLJ1 promoter and enhancer reporter assay revealed that DMSO transcriptionally upregulates HLJ1 expression through an AP-1 site within the HLJ1 enhancer. The AP-1 subfamily members JunD and JunB were significantly upregulated by DMSO in a concentration-dependent manner. Furthermore, pretreatment with DMSO led to a significant increase in the percentage of UV-induced apoptotic cells. Conclusions: Our results suggest that DMSO may be an important stimulator of the tumor suppressor protein HLJ1 through AP-1 activation in highly invasive lung adenocarcinoma cells. Targeted induction of HLJ1 represents a promising approach for cancer therapy, which also implied that DMSO may serve as a potential lead compound or coordinated ligand for the development of novel anticancer drugs.	[Wang, Chi-Chung; Liu, Ya-Jung; Hsu, Yuan-Lin] Fu Jen Cathol Univ, Grad Inst Basic Med, Taipei, Taiwan; [Lin, Sheng-Yi; Lai, Yi-Hua; Chen, Jeremy J. W.] Natl Chung Hsing Univ, Inst Biomed Sci, Taichung 40227, Taiwan; [Lin, Sheng-Yi; Lai, Yi-Hua; Chen, Jeremy J. W.] Natl Chung Hsing Univ, Inst Mol Biol, Taichung 40227, Taiwan	Fu Jen Catholic University; National Chung Hsing University; National Chung Hsing University	Wang, CC (corresponding author), Fu Jen Cathol Univ, Grad Inst Basic Med, Taipei, Taiwan.	075006@mail.fju.edu.tw; jwchen@dragon.nchu.edu.tw		Chen, Jeremy J.W./0000-0003-1049-3825	National Science Council (NSC), Taiwan, R.O.C. [NSC 97-2314-B-039-028-MY2, NSC 100-2325-B-005-001]; Ministry of Education, Taiwan, R.O.C. under the ATU; Fu Jen Catholic University, Taiwan, R.O.C. [9991A08, 9991A01-409931034019]	National Science Council (NSC), Taiwan, R.O.C.(Ministry of Science and Technology, Taiwan); Ministry of Education, Taiwan, R.O.C. under the ATU; Fu Jen Catholic University, Taiwan, R.O.C.	This study was supported by grants from the National Science Council (NSC), Taiwan, R.O.C. (NSC 97-2314-B-039-028-MY2 and NSC 100-2325-B-005-001 to Dr. Wang and Dr. Chen), as well as in part by the Ministry of Education, Taiwan, R.O.C. under the ATU plan (to Dr. Chen) and in part by grants from the Fu Jen Catholic University, Taiwan, R.O.C. (9991A08 and 9991A01-409931034019 to Dr. Wang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albini A, 2006, J NATL CANCER I, V98, P825; Antonarakis ES, 2010, CANCER CHEMOTH PHARM, V66, P1, DOI 10.1007/s00280-010-1293-1; Bacac M, 2004, J INORG BIOCHEM, V98, P402, DOI 10.1016/j.jinorgbio.2003.12.003; BERTELLI G, 1995, J CLIN ONCOL, V13, P2851, DOI 10.1200/JCO.1995.13.11.2851; Bouma M, 2002, INT J PHARMACEUT, V248, P239, DOI 10.1016/S0378-5173(02)00460-X; Camici GG, 2006, CIRCULATION, V114, P1512, DOI 10.1161/CIRCULATIONAHA.106.638460; CEROSALETTI KM, 1990, CELL IMMUNOL, V127, P299, DOI 10.1016/0008-8749(90)90134-D; Chang CK, 2001, J SURG RES, V95, P181, DOI 10.1006/jsre.2000.6033; Chen HW, 2008, CANCER RES, V68, P7428, DOI 10.1158/0008-5472.CAN-07-6734; Chen JJW, 2003, CLIN CANCER RES, V9, P729; Chen JJW, 2001, CANCER RES, V61, P5223; Chu YW, 1997, AM J RESP CELL MOL, V17, P353, DOI 10.1165/ajrcmb.17.3.2837; COLLINS SJ, 1978, P NATL ACAD SCI USA, V75, P2458, DOI 10.1073/pnas.75.5.2458; Curado MP, 2007, CANC INCIDENCE 5 CON, VIX; Eter N, 2002, BRIT J OPHTHALMOL, V86, P1303, DOI 10.1136/bjo.86.11.1303; Goto I, 1996, BRIT J CANCER, V74, P546, DOI 10.1038/bjc.1996.399; Hanslick JL, 2009, NEUROBIOL DIS, V34, P1, DOI 10.1016/j.nbd.2008.11.006; IKEDA Y, 1990, ACT NEUR S, V51, P74; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kami D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002407; Koizumi K, 2003, BIOL PHARM BULL, V26, P1295; Lee YR, 2005, LEUKEMIA RES, V29, P401, DOI 10.1016/j.leukres.2004.09.010; Lin SY, 2010, NUCLEIC ACIDS RES, V38, P6148, DOI 10.1093/nar/gkq412; Liu J, 2001, INT IMMUNOPHARMACOL, V1, P63, DOI 10.1016/S1567-5769(00)00016-3; Mastronarde JG, 1998, J INFECT DIS, V177, P1275, DOI 10.1086/515279; Metts JF, 2001, AM FAM PHYSICIAN, V64, P1199; Moldwin RM, 2002, CLIN OBSTET GYNECOL, V45, P259, DOI 10.1097/00003081-200203000-00027; Morassi P, 1989, Minerva Med, V80, P65; Murav'ev Iu V, 1986, Ter Arkh, V58, P104; Parkin J, 1997, UROLOGY, V49, P105, DOI 10.1016/S0090-4295(97)00181-7; Pegg David E, 2007, Methods Mol Biol, V368, P39; Reddy SPM, 2002, AM J PHYSIOL-LUNG C, V283, pL1161, DOI 10.1152/ajplung.00140.2002; Rosenstein ED, 1999, RHEUM DIS CLIN N AM, V25, P899, DOI 10.1016/S0889-857X(05)70109-5; SALIM AS, 1992, J LAB CLIN MED, V119, P710; SALIM AS, 1991, INTENS CARE MED, V17, P455, DOI 10.1007/BF01690766; Santos NC, 2005, LEUKEMIA RES, V29, P361, DOI 10.1016/j.leukres.2004.09.009; Santos NC, 2003, BIOCHEM PHARMACOL, V65, P1035, DOI 10.1016/S0006-2952(03)00002-9; SHIRLEY S W, 1978, Urology, V11, P215, DOI 10.1016/0090-4295(78)90118-8; SMITH RS, 1992, MED HYPOTHESES, V39, P248, DOI 10.1016/0306-9877(92)90117-U; TAKASE K, 1992, CELL GROWTH DIFFER, V3, P515; TAKENAGA K, 1984, CANCER RES, V44, P1122; Teraoka H, 1996, EXP CELL RES, V222, P218, DOI 10.1006/excr.1996.0027; Tsai MF, 2006, JNCI-J NATL CANCER I, V98, P825, DOI 10.1093/jnci/djj229; Vondracek J, 2006, LEUKEMIA RES, V30, P81, DOI 10.1016/j.leukres.2005.05.016; Wang CC, 2005, ONCOGENE, V24, P4081, DOI 10.1038/sj.onc.1208573; Wang CC, 2007, CANCER RES, V67, P4816, DOI 10.1158/0008-5472.CAN-07-0504	46	21	23	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e33772	10.1371/journal.pone.0033772	http://dx.doi.org/10.1371/journal.pone.0033772			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22529897	Green Submitted, gold, Green Published			2022-12-27	WOS:000305347400004
J	Wilke, M				Wilke, Marko			An Iterative Jackknife Approach for Assessing Reliability and Power of fMRI Group Analyses	PLOS ONE			English	Article							FALSE DISCOVERY RATE; EVENT-RELATED FMRI; TIME-SERIES; PERMUTATION TESTS; OUTLIER DETECTION; INFERENCE; CONJUNCTION; ACTIVATION; LANGUAGE; MAPS	For functional magnetic resonance imaging (fMRI) group activation maps, so-called second-level random effect approaches are commonly used, which are intended to be generalizable to the population as a whole. However, reliability of a certain activation focus as a function of group composition or group size cannot directly be deduced from such maps. This question is of particular relevance when examining smaller groups (<20-27 subjects). The approach presented here tries to address this issue by iteratively excluding each subject from a group study and presenting the overlap of the resulting (reduced) second-level maps in a group percent overlap map. This allows to judge where activation is reliable even upon excluding one, two, or three (or more) subjects, thereby also demonstrating the inherent variability that is still present in second-level analyses. Moreover, when progressively decreasing group size, foci of activation will become smaller and/or disappear; hence, the group size at which a given activation disappears can be considered to reflect the power necessary to detect this particular activation. Systematically exploiting this effect allows to rank clusters according to their observable effect size. The approach is tested using different scenarios from a recent fMRI study (children performing a "dual-use" fMRI task, n = 39), and the implications of this approach are discussed.	[Wilke, Marko] Univ Tubingen, Childrens Hosp, Dept Pediat Neurol & Dev Med, Tubingen, Germany; [Wilke, Marko] Univ Tubingen, Dept Neuroradiol, D-7400 Tubingen, Germany	Eberhard Karls University of Tubingen; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL; Eberhard Karls University of Tubingen	Wilke, M (corresponding author), Univ Tubingen, Childrens Hosp, Dept Pediat Neurol & Dev Med, Tubingen, Germany.	Marko.Wilke@med.uni-tuebingen.de		Hess, Christopher/0000-0002-5132-5302	Deutsche Forschungsgemeinschaft DFG [WI 3630/1-1]	Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG))	This work has been supported by the Deutsche Forschungsgemeinschaft DFG (WI 3630/1-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson JLR, 2001, NEUROIMAGE, V13, P903, DOI 10.1006/nimg.2001.0746; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Biswal BB, 2001, J COMPUT ASSIST TOMO, V25, P113, DOI 10.1097/00004728-200101000-00021; COOK RD, 1977, TECHNOMETRICS, V19, P15, DOI 10.2307/1268249; Davison AC, 1997, BOOTSTRAP METHODS TH; Desmond JE, 2002, J NEUROSCI METH, V118, P115, DOI 10.1016/S0165-0270(02)00121-8; Diedrichsen J, 2005, NEUROIMAGE, V27, P624, DOI 10.1016/j.neuroimage.2005.04.039; Ebner K, 2011, NEUROIMAGE, V58, P923, DOI 10.1016/j.neuroimage.2011.06.048; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Esterman M, 2010, NEUROIMAGE, V50, P572, DOI 10.1016/j.neuroimage.2009.10.092; Friston KJ, 2002, NEUROIMAGE, V16, P484, DOI 10.1006/nimg.2002.1091; Friston KJ, 1999, NEUROIMAGE, V10, P1, DOI 10.1006/nimg.1999.0439; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Glass G.V., 1976, ED RES, V5, P3, DOI [10.2307/1174772, DOI 10.3102/0013189X005010003, 10.2307/1174772ISSN0536-1036]; Gountouna VE, 2010, NEUROIMAGE, V49, P552, DOI 10.1016/j.neuroimage.2009.07.026; Heller R, 2007, NEUROIMAGE, V37, P1178, DOI 10.1016/j.neuroimage.2007.05.051; Hodge VJ, 2004, ARTIF INTELL REV, V22, P85, DOI 10.1023/B:AIRE.0000045502.10941.a9; Hoenig JM, 2001, AM STAT, V55, P19, DOI 10.1198/000313001300339897; Kherif F, 2003, NEUROIMAGE, V20, P2197, DOI 10.1016/j.neuroimage.2003.08.018; Liu TT, 2001, NEUROIMAGE, V13, P759, DOI 10.1006/nimg.2000.0728; Logothetis NK, 2004, MAGN RESON IMAGING, V22, P1517, DOI 10.1016/j.mri.2004.10.018; Luo WL, 2003, NEUROIMAGE, V19, P1014, DOI 10.1016/S1053-8119(03)00149-6; Macey PM, 2004, NEUROIMAGE, V22, P360, DOI 10.1016/j.neuroimage.2003.12.042; Maitra R, 2010, NEUROIMAGE, V50, P124, DOI 10.1016/j.neuroimage.2009.11.070; Martin MA, 2010, AUST NZ J STAT, V52, P45, DOI 10.1111/j.1467-842X.2009.00565.x; Mazziotta JC, 2009, NEUROIMAGE, V44, P914, DOI 10.1016/j.neuroimage.2008.07.062; Mbwana J, 2009, BRAIN, V132, P347, DOI 10.1093/brain/awn329; McGonigle DJ, 2000, NEUROIMAGE, V11, P708, DOI 10.1006/nimg.2000.0562; McNamee RL, 2004, NEUROIMAGE, V22, P920, DOI 10.1016/j.neuroimage.2004.02.016; Mehta S, 2003, NEUROIMAGE, V20, P1438, DOI 10.1016/S1053-8119(03)00377-X; Mumford JA, 2008, NEUROIMAGE, V39, P261, DOI 10.1016/j.neuroimage.2007.07.061; Murphy K, 2004, NEUROIMAGE, V22, P879, DOI 10.1016/j.neuroimage.2004.02.005; Nadeau SE, 1998, NEUROPSY NEUROPSY BE, V11, P83; Nichols T, 2005, NEUROIMAGE, V25, P653, DOI 10.1016/j.neuroimage.2004.12.005; Nichols T, 2003, STAT METHODS MED RES, V12, P419, DOI 10.1191/0962280203sm341ra; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Onwuegbuzie A.J., 2004, UNDERSTANDING STAT, V3, P201, DOI DOI 10.1207/S15328031US0304_1; ORR JM, 1991, PERS PSYCHOL, V44, P473; Plante E, 2006, NEUROPSYCHOLOGIA, V44, P1210, DOI 10.1016/j.neuropsychologia.2005.08.016; Price CJ, 1997, NEUROIMAGE, V5, P261, DOI 10.1006/nimg.1997.0269; SACKETT DL, 1979, J CHRON DIS, V32, P51, DOI 10.1016/0021-9681(79)90012-2; Salimi-Khorshidi G, 2011, NEUROIMAGE, V54, P2006, DOI 10.1016/j.neuroimage.2010.09.088; Schapiro MB, 2004, NEUROREPORT, V15, P2575, DOI 10.1097/00001756-200412030-00003; Seghier ML, 2007, NEUROIMAGE, V36, P594, DOI 10.1016/j.neuroimage.2007.03.021; Specht K, 2003, J MAGN RESON IMAGING, V17, P463, DOI 10.1002/jmri.10277; Suckling J, 2004, HUM BRAIN MAPP, V22, P193, DOI 10.1002/hbm.20027; Suckling J, 2010, HUM BRAIN MAPP, V31, P1183, DOI 10.1002/hbm.20927; Thirion B, 2007, NEUROIMAGE, V35, P105, DOI 10.1016/j.neuroimage.2006.11.054; Wilke M, 2003, NEUROPEDIATRICS, V34, P225; Wilke M, 2008, NEUROIMAGE, V41, P903, DOI 10.1016/j.neuroimage.2008.02.056; Wilke M, 2011, HUM BRAIN MAPP, V32, P1882, DOI 10.1002/hbm.21156; Wink AM, 2004, IEEE T MED IMAGING, V23, P374, DOI 10.1109/TMI.2004.824234; Woolrich M, 2008, NEUROIMAGE, V41, P286, DOI 10.1016/j.neuroimage.2008.02.042; Zarahn E, 2001, NEUROIMAGE, V14, P768, DOI 10.1006/nimg.2001.0852; Zou KH, 2004, ACAD RADIOL, V11, P178, DOI 10.1016/S1076-6332(03)00671-8	57	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e35578	10.1371/journal.pone.0035578	http://dx.doi.org/10.1371/journal.pone.0035578			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22530053	Green Published, gold, Green Submitted			2022-12-27	WOS:000305347400063
J	Yang, M; Wang, XY; Chen, DY; Wang, YA; Zhang, AY; Zhou, H				Yang, Mu; Wang, Xinyan; Chen, Danyan; Wang, Yanan; Zhang, Anying; Zhou, Hong			TGF-beta 1 Exerts Opposing Effects on Grass Carp Leukocytes: Implication in Teleost Immunity, Receptor Signaling and Potential Self-Regulatory Mechanisms	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; TGF-BETA; FUNCTIONAL-CHARACTERIZATION; RAINBOW-TROUT; GENES; CELLS; EXPRESSION; KIDNEY	In fish immunity, the regulatory role of transforming growth factor-beta 1 (TGF-beta 1) has not been fully characterized. Here we examined the immunoregulatory effects of TGF-beta 1 in grass carp peripheral blood leukocytes (PBL) and head kidney leukocytes (HKL). It is interesting that TGF-beta 1 consistently stimulated the cell viability and the mRNA levels of pro-inflammatory cytokines (Tnf alpha and Ifn gamma) and T/B cell markers [Cd4-like (Cd4l), Cd8 alpha, Cd8 beta and Ig mu] in PBL, which contrasted with its inhibitory tone in HKL. Further studies showed that grass carp TGF-beta 1 type I receptor, activin receptor-like kinase 5 (ALK5), was indispensable for the immunoregulatory effects of TGF-beta 1 in PBL and HKL. Notably, TGF-beta 1 persistently attenuated ALK5 expression, whereas immunoneutralization of endogenous grass carp TGF-beta 1 could increase ALK5 mRNA and protein levels. It is consistent with the observation that TGF-beta 1 decreased the number of ALK5(+) leukocytes in PBL and HKL, revealing a negative regulation of TGF-beta 1 signaling at the receptor level. Moreover, transient treatment with TGF-beta 1 for 24 h was sufficient to induce similar cellular responses compared with the continuous treatment. This indicated a possible mechanism by which TGF-beta 1 triggered the down-regulation of ALK5 mRNA and protein, leading to the desensitization of grass carp leukocytes toward TGF-beta 1. Accordingly, our data revealed a dual role of TGF-beta 1 in teleost immunity in which it can serve as a positive or negative control device and provided additional mechanistic insights as to how TGF-beta 1 controls its signaling in vertebrate leukocytes.	[Yang, Mu; Wang, Xinyan; Chen, Danyan; Wang, Yanan; Zhang, Anying; Zhou, Hong] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Chengdu 610054, Peoples R China	University of Electronic Science & Technology of China	Yang, M (corresponding author), Univ Elect Sci & Technol China, Sch Life Sci & Technol, Chengdu 610054, Peoples R China.	zhouhongzh@uestc.edu.cn	Wang, Xinyan/N-7406-2019; Zhang, An/GRS-5852-2022; WANG, Xinyan/A-4819-2015		National Natural Science Foundation of China [30972280]; Science and Technology Committee of Sichuan Province [2011FZ0007]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Committee of Sichuan Province	This work was supported by grants 30972280 from the National Natural Science Foundation of China and 2011FZ0007 from the Science and Technology Committee of Sichuan Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arts JAJ, 2010, FISH SHELLFISH IMMUN, V29, P793, DOI 10.1016/j.fsi.2010.07.010; Boschi I, 2011, FISH SHELLFISH IMMUN, V31, P655, DOI 10.1016/j.fsi.2010.10.001; BRANDES ME, 1991, J BIOL CHEM, V266, P19697; Cai ZH, 2010, FISH SHELLFISH IMMUN, V28, P695, DOI 10.1016/j.fsi.2010.01.011; de Caestecker MP, 2000, JNCI-J NATL CANCER I, V92, P1388, DOI 10.1093/jnci/92.17.1388; Dijkstra JM, 2006, MOL IMMUNOL, V43, P410, DOI 10.1016/j.molimm.2005.03.005; Ebisawa T, 2001, J BIOL CHEM, V276, P12477, DOI 10.1074/jbc.C100008200; Fischer U, 2003, DEV COMP IMMUNOL, V27, P323, DOI 10.1016/S0145-305X(02)00100-3; Grayfer L, 2008, DEV COMP IMMUNOL, V32, P532, DOI 10.1016/j.dci.2007.09.009; Grayfer L, 2011, MOL IMMUNOL, V48, P563, DOI 10.1016/j.molimm.2010.10.013; Grayfer L, 2010, J BIOL CHEM, V285, P23537, DOI 10.1074/jbc.M109.096925; Haddad G, 2008, DEV COMP IMMUNOL, V32, P654, DOI 10.1016/j.dci.2007.10.003; Hetland DL, 2010, FISH SHELLFISH IMMUN, V28, P30, DOI 10.1016/j.fsi.2009.09.011; Kadowaki T, 2009, ANTICANCER RES, V29, P4871; Li B, 2006, IMMUNOL REV, V212, P99, DOI 10.1111/j.0105-2896.2006.00405.x; Li MO, 2008, CELL, V134, P392, DOI 10.1016/j.cell.2008.07.025; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Liu YZ, 2008, NAT IMMUNOL, V9, P632, DOI 10.1038/ni.1607; Lopez-Munoz A, 2009, J IMMUNOL, V182, P3440, DOI 10.4049/jimmunol.0802528; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Mitchell H, 2004, MOL BIOL CELL, V15, P4166, DOI 10.1091/mbc.E04-03-0245; Miyazono K, 2000, ADV IMMUNOL, V75, P115, DOI 10.1016/S0065-2776(00)75003-6; Pettersen EF, 2000, FISH SHELLFISH IMMUN, V10, P695, DOI 10.1006/fsim.2000.0284; Picchietti S, 2009, FISH SHELLFISH IMMUN, V27, P50, DOI 10.1016/j.fsi.2009.04.003; Rodrigues PNS, 1995, DEV COMP IMMUNOL, V19, P483, DOI 10.1016/0145-305X(95)00033-P; Ronneseth A, 2007, FISH SHELLFISH IMMUN, V23, P493, DOI 10.1016/j.fsi.2006.08.017; Saeij JPJ, 2003, DEV COMP IMMUNOL, V27, P29, DOI 10.1016/S0145-305X(02)00064-2; Saxena V, 2008, J IMMUNOL, V180, P1903, DOI 10.4049/jimmunol.180.3.1903; Scapigliati G, 2010, FISH SHELLFISH IMMUN, V28, P303, DOI 10.1016/j.fsi.2009.11.008; Sepulcre MP, 2002, CELL TISSUE RES, V308, P97, DOI 10.1007/s00441-002-0531-1; Stolte EH, 2008, DEV COMP IMMUNOL, V32, P1467, DOI 10.1016/j.dci.2008.06.012; Sun XF, 2007, FISH SHELLFISH IMMUN, V23, P1242, DOI 10.1016/j.fsi.2007.06.004; VERBURGVANKEMENADE BML, 1994, J EXP BIOL, V187, P143; Wan YY, 2007, IMMUNOL REV, V220, P199, DOI 10.1111/j.1600-065X.2007.00565.x; Wang XY, 2010, FISH SHELLFISH IMMUN, V29, P998, DOI 10.1016/j.fsi.2010.08.010; Xiao FS, 2010, FISH SHELLFISH IMMUN, V29, P594, DOI 10.1016/j.fsi.2010.06.004; Yang M, 2010, FISH SHELLFISH IMMUN, V28, P289, DOI 10.1016/j.fsi.2009.11.007; Zhang LJ, 2006, AUTOIMMUNITY, V39, P269, DOI 10.1080/08916930600753903; Zhao T, 2012, DOMEST ANIM IN PRESS; Zou J, 2003, DEV COMP IMMUNOL, V27, P813, DOI 10.1016/S0145-305X(03)00077-6; Zwollo P, 2005, J IMMUNOL, V174, P6608, DOI 10.4049/jimmunol.174.11.6608	41	19	25	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e35011	10.1371/journal.pone.0035011	http://dx.doi.org/10.1371/journal.pone.0035011			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22529969	Green Published, Green Submitted, gold			2022-12-27	WOS:000305347400029
J	Cascone, A; Bruelle, C; Lindholm, D; Bernardi, P; Eriksson, O				Cascone, Annunziata; Bruelle, Celine; Lindholm, Dan; Bernardi, Paolo; Eriksson, Ove			Destabilization of the Outer and Inner Mitochondrial Membranes by Core and Linker Histones	PLOS ONE			English	Article							CHROMATIN-STRUCTURE; APOPTOSIS; PROTEIN; ACTIVATION; P53; BINDING; ORIGIN; KINASE; H1.2; BAX	Background: Extensive DNA damage leads to apoptosis. Histones play a central role in DNA damage sensing and may mediate signals of genotoxic damage to cytosolic effectors including mitochondria. Methodology/Principal Findings: We have investigated the effects of histones on mitochondrial function and membrane integrity. We demonstrate that both linker histone H1 and core histones H2A, H2B, H3, and H4 bind strongly to isolated mitochondria. All histones caused a rapid and massive release of the pro-apoptotic intermembrane space proteins cytochrome c and Smac/Diablo, indicating that they permeabilize the outer mitochondrial membrane. In addition, linker histone H1, but not core histones, permeabilized the inner membrane with a collapse of the membrane potential, release of pyridine nucleotides, and mitochondrial fragmentation. Conclusions: We conclude that histones destabilize the mitochondrial membranes, a mechanism that may convey genotoxic signals to mitochondria and promote apoptosis following DNA damage.	[Cascone, Annunziata; Eriksson, Ove] Univ Helsinki, Res Program Unit, Helsinki, Finland; [Cascone, Annunziata; Bruelle, Celine; Lindholm, Dan; Eriksson, Ove] Univ Helsinki, Inst Biomed, Helsinki, Finland; [Bruelle, Celine; Lindholm, Dan] Minerva Med Res Inst, Helsinki, Finland; [Bernardi, Paolo] Univ Padua, Dipartimento Sci Biomed Sperimentali, Padua, Italy	University of Helsinki; University of Helsinki; University of Padua	Cascone, A (corresponding author), Univ Helsinki, Res Program Unit, Helsinki, Finland.	ove.eriksson@helsinki.fi	Bernardi, Paolo/C-3656-2008; Eriksson-Rosenberg, Ove/GVU-6692-2022; Lindholm, Dan/B-3777-2014	Bernardi, Paolo/0000-0001-9187-3736; 	Magnus Ehrnrooth Foundation; K. Albin Johansson Foundation; Swedish Culture Foundation; Italian Ministry of Education, Universities and Research (MIUR)	Magnus Ehrnrooth Foundation; K. Albin Johansson Foundation; Swedish Culture Foundation; Italian Ministry of Education, Universities and Research (MIUR)(Ministry of Education, Universities and Research (MIUR))	This study was supported by grants from the Magnus Ehrnrooth Foundation, the K. Albin Johansson Foundation, the Swedish Culture Foundation, and the Italian Ministry of Education, Universities and Research (MIUR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARENTS G, 1995, P NATL ACAD SCI USA, V92, P11170, DOI 10.1073/pnas.92.24.11170; Chen YR, 1996, J BIOL CHEM, V271, P631, DOI 10.1074/jbc.271.2.631; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Chubb JE, 2010, SUBCELL BIOCHEM, V50, P17, DOI 10.1007/978-90-481-3471-7_2; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cipolat S, 2006, CELL, V126, P163, DOI 10.1016/j.cell.2006.06.021; Cook PJ, 2009, NATURE, V458, P591, DOI 10.1038/nature07849; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Fontaine E, 1998, J BIOL CHEM, V273, P12662, DOI 10.1074/jbc.273.20.12662; Happel N, 2009, GENE, V431, P1, DOI 10.1016/j.gene.2008.11.003; Hegde R, 2002, J BIOL CHEM, V277, P432, DOI 10.1074/jbc.M109721200; Jeong SY, 2008, BMB REP, V41, P11, DOI 10.1146/annurev-genet-102108-134850; Jourdain A, 2009, INT J BIOCHEM CELL B, V41, P1884, DOI 10.1016/j.biocel.2009.05.001; Joza N, 2001, NATURE, V410, P549, DOI 10.1038/35069004; Kasinsky HE, 2001, FASEB J, V15, P34, DOI 10.1096/fj.00-0237rev; Kim MY, 2004, CELL, V119, P803, DOI 10.1016/j.cell.2004.11.002; Koh DW, 2005, PHARMACOL RES, V52, P5, DOI 10.1016/j.phrs.2005.02.011; Konishi A, 2003, CELL, V114, P673, DOI 10.1016/S0092-8674(03)00719-0; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Li LY, 2001, NATURE, V412, P95, DOI 10.1038/35083620; Lindholm D, 2004, BIOCHEM BIOPH RES CO, V321, P753, DOI 10.1016/j.bbrc.2004.06.138; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; MILNE DM, 1995, J BIOL CHEM, V270, P5511, DOI 10.1074/jbc.270.10.5511; Okamura H, 2008, J CELL BIOCHEM, V103, P1488, DOI 10.1002/jcb.21537; Polianskyte Z, 2009, P NATL ACAD SCI USA, V106, P18960, DOI 10.1073/pnas.0906734106; Postberg J, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-259; Rasola A, 2010, FEBS LETT, V584, P1989, DOI 10.1016/j.febslet.2010.02.022; Roque A, 2007, BIOPHYS J, V93, P2170, DOI 10.1529/biophysj.107.104513; Schug ZT, 2009, BBA-BIOMEMBRANES, V1788, P2022, DOI 10.1016/j.bbamem.2009.05.004; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Slesarev AI, 1998, NUCLEIC ACIDS RES, V26, P427, DOI 10.1093/nar/26.2.427; Speer O, 2003, J BIOL CHEM, V278, P34757, DOI 10.1074/jbc.M301990200; Sun MG, 2007, NAT CELL BIOL, V9, P1057, DOI 10.1038/ncb1630; Talbert PB, 2010, NAT REV MOL CELL BIO, V11, P264, DOI 10.1038/nrm2861; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Van Loo G, 2002, CELL DEATH DIFFER, V9, P301, DOI 10.1038/sj.cdd.4400966; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Verreault A, 2000, GENE DEV, V14, P1430; Wang HC, 2008, P NATL ACAD SCI USA, V105, P20758, DOI 10.1073/pnas.0811233106; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221	41	20	21	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e35357	10.1371/journal.pone.0035357	http://dx.doi.org/10.1371/journal.pone.0035357			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523586	Green Published, gold, Green Submitted			2022-12-27	WOS:000305345000058
J	Yoshino, S; Hara, T; Weng, JS; Takahashi, Y; Seiki, M; Sakamoto, T				Yoshino, Seiko; Hara, Toshiro; Weng, Jane S.; Takahashi, Yuka; Seiki, Motoharu; Sakamoto, Takeharu			Genetic Screening of New Genes Responsible for Cellular Adaptation to Hypoxia Using a Genome-Wide shRNA Library	PLOS ONE			English	Article							METABOLISM; EXPRESSION; PREVENTION; CANCERS; KINASE; RBSP3; BCL-2	Oxygen is a vital requirement for multi-cellular organisms to generate energy and cells have developed multiple compensatory mechanisms to adapt to stressful hypoxic conditions. Such adaptive mechanisms are intricately interconnected with other signaling pathways that regulate cellular functions such as cell growth. However, our understanding of the overall system governing the cellular response to the availability of oxygen remains limited. To identify new genes involved in the response to hypoxic stress, we have performed a genome-wide gene knockdown analysis in human lung carcinoma PC8 cells using an shRNA library carried by a lentiviral vector. The knockdown analysis was performed under both normoxic and hypoxic conditions to identify shRNA sequences enriched or lost in the resulting selected cell populations. Consequently, we identified 56 candidate genes that might contribute to the cellular response to hypoxia. Subsequent individual knockdown of each gene demonstrated that 13 of these have a significant effect upon oxygen-sensitive cell growth. The identification of BCL2L1, which encodes a Bcl-2 family protein that plays a role in cell survival by preventing apoptosis, validates the successful design of our screen. The other selected genes have not previously been directly implicated in the cellular response to hypoxia. Interestingly, hypoxia did not directly enhance the expression of any of the identified genes, suggesting that we have identified a new class of genes that have been missed by conventional gene expression analyses to identify hypoxia response genes. Thus, our genetic screening method using a genome-wide shRNA library and the newly-identified genes represent useful tools to analyze the cellular systems that respond to hypoxic stress.	[Yoshino, Seiko; Hara, Toshiro; Weng, Jane S.; Takahashi, Yuka; Seiki, Motoharu; Sakamoto, Takeharu] Univ Tokyo, Inst Med Sci, Div Canc Cell Res, Minato Ku, Tokyo, Japan	University of Tokyo	Yoshino, S (corresponding author), Univ Tokyo, Inst Med Sci, Div Canc Cell Res, Minato Ku, Tokyo, Japan.	mseiki@ims.u-tokyo.ac.jp	Seiki, Motoharu/K-9443-2015; Sakamoto, Takeharu/Y-6062-2019	Sakamoto, Takeharu/0000-0002-1225-1902	Ministry of Education, Culture, Sports, Science and Technology of Japan [22790846, 23112505, 22220014]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid for Young Scientists (B) (No. 22790846) and Grant-in-Aid for Scientific Research on Innovative Areas (No. 23112505) from the Ministry of Education, Culture, Sports, Science and Technology of Japan to T. S. and by a Grant-in-Aid for Scientific Research (S) (No. 22220014) from the Ministry of Education, Culture, Sports, Science and Technology of Japan to M. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson P, 2009, NAT REV MOL CELL BIO, V10, P430, DOI 10.1038/nrm2694; Arif A, 2009, MOL CELL, V35, P164, DOI 10.1016/j.molcel.2009.05.028; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Ghosh A, 2010, CANCER SCI, V101, P1511, DOI 10.1111/j.1349-7006.2010.01551.x; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Huang JH, 2002, J BIOL CHEM, V277, P39792, DOI 10.1074/jbc.M206955200; Huang WC, 2008, CURR BIOL, V18, P781, DOI 10.1016/j.cub.2008.04.049; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kashuba VI, 2004, P NATL ACAD SCI USA, V101, P4906, DOI 10.1073/pnas.0401238101; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Kunz M, 2003, J BIOL CHEM, V278, P45651, DOI 10.1074/jbc.M301373200; Ludwig MG, 2003, NATURE, V425, P93, DOI 10.1038/nature01905; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Martelange V, 2000, CANCER RES, V60, P3848; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Sakamoto T, 2011, J BIOL CHEM, V286, P14691, DOI 10.1074/jbc.M110.188714; Sakamoto T, 2010, J BIOL CHEM, V285, P29951, DOI 10.1074/jbc.M110.132704; Sakamoto T, 2009, J BIOL CHEM, V284, P30350, DOI 10.1074/jbc.M109.019216; Semenza GL, 2010, CURR OPIN GENET DEV, V20, P51, DOI 10.1016/j.gde.2009.10.009; Senchenko VN, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-75; Shimizu S, 1996, CANCER RES, V56, P2161; SHIMIZU S, 1995, NATURE, V374, P811, DOI 10.1038/374811a0; SHINMOTO H, 1990, CYTOTECHNOLOGY, V4, P121, DOI 10.1007/BF00365092; Spriggs KA, 2010, MOL CELL, V40, P228, DOI 10.1016/j.molcel.2010.09.028; Van Dijk EL, 2007, RNA, V13, P1027, DOI 10.1261/rna.575107; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wouters BG, 2008, NAT REV CANCER, V8, P851, DOI 10.1038/nrc2501; Zhang L, 2004, CANCER RES, V64, P4180, DOI 10.1158/0008-5472.CAN-03-3038; Zhou J, 2006, CANCER LETT, V237, P10, DOI 10.1016/j.canlet.2005.05.028	34	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e35590	10.1371/journal.pone.0035590	http://dx.doi.org/10.1371/journal.pone.0035590			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523603	Green Submitted, gold, Green Published			2022-12-27	WOS:000305345000077
J	Fujisawa, T; Rubin, B; Suzuki, A; Patel, PS; Gahl, WA; Joshi, BH; Puri, RK				Fujisawa, Toshio; Rubin, Benjamin; Suzuki, Akiko; Patel, Prabhudas S.; Gahl, William A.; Joshi, Bharat H.; Puri, Raj K.			Cysteamine Suppresses Invasion, Metastasis and Prolongs Survival by Inhibiting Matrix Metalloproteinases in a Mouse Model of Human Pancreatic Cancer	PLOS ONE			English	Article							INTERLEUKIN-13 RECEPTOR ALPHA-2; NEPHROPATHIC CYSTINOSIS; CELL-LINES; IN-VITRO; CHILDREN; CARCINOMA; GROWTH; RATS; ANGIOGENESIS; PROGRESSION	Background: Cysteamine, an anti-oxidant aminothiol, is the treatment of choice for nephropathic cystinosis, a rare lysosomal storage disease. Cysteamine is a chemo-sensitization and radioprotection agent and its antitumor effects have been investigated in various tumor cell lines and chemical induced carcinogenesis. Here, we investigated whether cysteamine has anti-tumor and anti-metastatic effects in transplantable human pancreatic cancer, an aggressive metastatic disease. Methodology/Principal Findings: Cysteamine's anti-invasion effects were studied by matrigel invasion and cell migration assays in 10 pancreatic cancer cell lines. To study mechanism of action, we examined cell viability and matrix metalloproteinases (MMPs) activity in the cysteamine-treated cells. We also examined cysteamine's anti-metastasis effect in two orthotopic murine models of human pancreatic cancer by measuring peritoneal metastasis and survival of animals. Cysteamine inhibited both migration and invasion of all ten pancreatic cancer cell lines at concentrations (<25 mM) that caused no toxicity to cells. It significantly decreased MMPs activity (IC50 38-460 mu M) and zymographic gelatinase activity in a dose dependent manner in vitro and in vivo; while mRNA and protein levels of MMP-9, MMP-12 and MMP-14 were slightly increased using the highest cysteamine concentration. In vivo, cysteamine significantly decreased metastasis in two established pancreatic tumor models, although it did not affect the size of primary tumors. Additionally, cysteamine prolonged survival of mice in a dose-dependent manner without causing any toxicity. Similar to the in vitro results, MMP activity was significantly decreased in animal tumors treated with cysteamine. Cysteamine had no clinical or preclinical adverse effects in the host even at the highest dose. Conclusions/Significance: Our results suggest that cysteamine, an agent with a proven safety profile, may be useful for inhibition of metastasis and prolonging the survival of a host with pancreatic cancer.	[Fujisawa, Toshio; Suzuki, Akiko; Patel, Prabhudas S.; Joshi, Bharat H.; Puri, Raj K.] Ctr Biol Evaluat & Res Food & Drug Adm, Tumor Vaccines & Biotechnol Branch, Div Cellular & Gene Therapies, Bethesda, MD USA; [Rubin, Benjamin] Johns Hopkins Sch Med, Suburban Hosp, Dept Ophthalmol, Bethesda, MD USA; [Gahl, William A.] NHGRI, Sect Human Biochem Genet, Med Genet Branch, NIH, Bethesda, MD 20892 USA	US Food & Drug Administration (FDA); Johns Hopkins University; Johns Hopkins Medicine; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Puri, RK (corresponding author), Ctr Biol Evaluat & Res Food & Drug Adm, Tumor Vaccines & Biotechnol Branch, Div Cellular & Gene Therapies, Bethesda, MD USA.	raj.puri@fda.hhs.gov	Fujisawa, Toshio/AAN-2884-2021	Fujisawa, Toshio/0000-0001-7367-0767; Patel, Prabhudas/0000-0003-1004-7024	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000215] Funding Source: NIH RePORTER	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Anderson IC, 1996, CANCER RES, V56, P715; APFFEL CA, 1975, CANCER RES, V35, P429; Basset P, 1997, MATRIX BIOL, V15, P535, DOI 10.1016/S0945-053X(97)90028-7; Besouw M, 2011, PEDIATR NEPHROL, V26, P639, DOI 10.1007/s00467-010-1680-1; Bramhall S R, 1998, J Hepatobiliary Pancreat Surg, V5, P392, DOI 10.1007/s005340050063; Brown PD, 2000, EXPERT OPIN INV DRUG, V9, P2167, DOI 10.1517/13543784.9.9.2167; Chang C, 2001, TRENDS CELL BIOL, V11, pS37, DOI 10.1016/S0962-8924(01)82222-4; D'Angelo M, 2001, J BIOL CHEM, V276, P11347, DOI 10.1074/jbc.M009725200; Dohil R, 2003, J PEDIATR-US, V143, P224, DOI 10.1067/S0022-3476(03)00281-6; Dohil R, 2006, J PEDIATR-US, V148, P764, DOI 10.1016/j.jpeds.2006.01.050; Dohil R, 2010, J PEDIATR-US, V156, P823, DOI 10.1016/j.jpeds.2009.11.059; Eccles SA, 1996, CANCER RES, V56, P2815; Fujisawa T, 2011, INT J CANCER, V128, P1221, DOI 10.1002/ijc.25437; Fujisawa T, 2009, CANCER RES, V69, P8678, DOI 10.1158/0008-5472.CAN-09-2100; Gangoiti JA, 2010, BRIT J CLIN PHARMACO, V70, P376, DOI 10.1111/j.1365-2125.2010.03721.x; Inano H, 2000, RADIAT RES, V153, P68, DOI 10.1667/0033-7587(2000)153[0068:IEOWAC]2.0.CO;2; Jeitner TM, 1996, CANCER LETT, V103, P85, DOI 10.1016/0304-3835(96)04200-0; JEITNER TM, 1990, J ENDOCRINOL, V127, P119, DOI 10.1677/joe.0.1270119; JONAS AJ, 1982, J PEDIATR-US, V100, P321, DOI 10.1016/S0022-3476(82)80665-3; Kilian M, 2006, PROSTAG LEUKOTR ESS, V75, P429, DOI 10.1016/j.plefa.2006.08.004; Kleta R, 2004, EXPERT OPIN PHARMACO, V5, P2255, DOI 10.1517/14656566.5.11.2255; MARKELLO TC, 1993, NEW ENGL J MED, V328, P1157, DOI 10.1056/NEJM199304223281604; MOLLENHAUER J, 1987, Pancreas, V2, P14, DOI 10.1097/00006676-198701000-00003; Nakashima H, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-116; Schmalfeldt B, 2001, CLIN CANCER RES, V7, P2396; Shimamura T, 2010, CLIN CANCER RES, V16, P577, DOI 10.1158/1078-0432.CCR-09-2015; Shinoda K, 2003, INT J ONCOL, V22, P281; SMOLIN LA, 1988, PEDIATR RES, V23, P616, DOI 10.1203/00006450-198806000-00018; Sparano JA, 2004, J CLIN ONCOL, V22, P4683, DOI 10.1200/JCO.2004.08.054; Steward WP, 1999, CANCER CHEMOTH PHARM, V43, pS56, DOI 10.1007/s002800051099; Tamahashi U, 2008, VIRCHOWS ARCH, V453, P79, DOI 10.1007/s00428-008-0617-6; TATSUTA M, 1988, INT J CANCER, V41, P423, DOI 10.1002/ijc.2910410318; Unak G, 2012, COLLOID SURFACE B, V90, P217, DOI 10.1016/j.colsurfb.2011.10.027; Wan XM, 2011, INT J CANCER, V129, P1087, DOI 10.1002/ijc.25771; Wang HC, 2010, J AGR FOOD CHEM, V58, P11913, DOI 10.1021/jf1022065; WATANABE H, 1988, ACTA PATHOL JAPON, V38, P1285; Wenner WJ, 1997, PEDIATR NEPHROL, V11, P600, DOI 10.1007/s004670050345; Wu C, 2011, NANOMEDICINE NANOTEC; YAMADA I, 1991, BRIT J CANCER, V63, P187, DOI 10.1038/bjc.1991.46	39	33	36	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e34437	10.1371/journal.pone.0034437	http://dx.doi.org/10.1371/journal.pone.0034437			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22532830	Green Published, gold, Green Submitted			2022-12-27	WOS:000305339200014
J	Radigan, KA; Urich, D; Misharin, AV; Chiarella, SE; Soberanes, S; Gonzalez, A; Perlman, H; Wunderink, RG; Budinger, GRS; Mutlu, GM				Radigan, Kathryn A.; Urich, Daniela; Misharin, Alexander V.; Chiarella, Sergio E.; Soberanes, Saul; Gonzalez, Angel; Perlman, Harris; Wunderink, Richard G.; Budinger, G. R. Scott; Mutlu, Goekhan M.			The Effect of Rosuvastatin in a Murine Model of Influenza A Infection	PLOS ONE			English	Article							POPULATION-BASED COHORT; CARDIOVASCULAR-DISEASE; STATIN THERAPY; PANDEMIC INFLUENZA; UNITED-STATES; SEVERE SEPSIS; PNEUMONIA; MORTALITY; VIRUS; INHIBITORS	Rationale: HMG-CoA reductase inhibitors such as rosuvastatin may have immunomodulatory and anti-inflammatory effects that may reduce the severity of influenza A infection. We hypothesized that rosuvastatin would decrease viral replication, attenuate lung injury, and improve mortality following influenza A infection in mice. Methods: C57Bl/6 mice were treated daily with rosuvastatin (10 mg/kg/day) supplemented in chow (or control chow) beginning three days prior to infection with either A//Udorn/72 [H3N2] or A/WSN/33 [H1N1] influenza A virus (1 x 10(5) pfu/mouse). Plaque assays were used to examine the effect of rosuvastatin on viral replication in vitro and in the lungs of infected mice. We measured cell count with differential, protein and cytokines in the bronchoalveolar lavage (BAL) fluid, histologic evidence of lung injury, and wet-to-dry ratio on Day 1, 2, 4, and 6. We also recorded daily weights and mortality. Results: The administration of rosuvastatin had no effect on viral clearance of influenza A after infection. Weight loss, lung inflammation and lung injury severity were similar in the rosuvastatin and control treated mice. In the mice infected with influenza A (A/WSN/33), mortality was unaffected by treatment with rosuvastatin. Conclusions: Statins did not alter the replication of influenza A in vitro or enhance its clearance from the lung in vivo. Statins neither attenuated the severity of influenza A-induced lung injury nor had an effect on influenza A-related mortality. Our data suggest that the association between HMG CoA reductase inhibitors and improved outcomes in patients with sepsis and pneumonia are not attributable to their effects on influenza A infection.	[Radigan, Kathryn A.; Urich, Daniela; Chiarella, Sergio E.; Soberanes, Saul; Gonzalez, Angel; Wunderink, Richard G.; Budinger, G. R. Scott; Mutlu, Goekhan M.] Northwestern Univ, Feinberg Sch Med, Div Pulm & Crit Care Med, Chicago, IL 60611 USA; [Misharin, Alexander V.; Perlman, Harris] Northwestern Univ, Feinberg Sch Med, Div Rheumatol, Chicago, IL 60611 USA; [Budinger, G. R. Scott] Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Radigan, KA (corresponding author), Northwestern Univ, Feinberg Sch Med, Div Pulm & Crit Care Med, Chicago, IL 60611 USA.	k-radigan@northwestern.edu	Mutlu, Gokhan/HIR-2545-2022; Misharin, Alexander/AAD-6456-2019	Chiarella, Sergio/0000-0002-0445-4929; Wunderink, Richard/0000-0002-8527-4195; Misharin, Alexander/0000-0003-2879-3789	National Institutes of Health [F32AI094976, T32HL076139, ES015024, ES013995, P01HL071643]; Veterans Administration [5I01BX000201]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025741] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL071643, T32HL076139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI094976] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015024, R01ES013995] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000201] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Administration(US Department of Veterans Affairs); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Veterans Affairs(US Department of Veterans Affairs)	Funding was provided by National Institutes of Health F32AI094976, T32HL076139, ES015024, ES013995, and P01HL071643 and Veterans Administration 5I01BX000201. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikawa M, 2001, CIRCULATION, V103, P276; Almog Y, 2004, CIRCULATION, V110, P880, DOI 10.1161/01.CIR.0000138932.17956.F1; Almog Y, 2007, CRIT CARE MED, V35, P372, DOI 10.1097/01.CCM.0000253397.42079.D5; BEUTLER B, 1987, NEW ENGL J MED, V316, P379; Blanco-Colio LM, 2003, KIDNEY INT, V63, P12, DOI 10.1046/j.1523-1755.2003.00744.x; Brammer L., 2009, Morbidity and Mortality Weekly Report, V58, P115; Catron DM, 2004, INFECT IMMUN, V72, P1036, DOI 10.1128/IAI.72.2.1036-1042.2004; Chalmers JD, 2008, AM J MED, V121, P1002, DOI 10.1016/j.amjmed.2008.06.030; del Real G, 2004, J EXP MED, V200, P541, DOI 10.1084/jem.20040061; Desjardins F, 2008, EUR HEART J, V29, P128, DOI 10.1093/eurheartj/ehm540; Fedson David S, 2007, Perm J, V11, P63; Giguere JF, 2004, J VIROL, V78, P12062, DOI 10.1128/JVI.78.21.12062-12065.2004; Guo HY, 2009, ARCH MED RES, V40, P345, DOI 10.1016/j.arcmed.2009.07.006; Gupta R, 2007, JAMA-J AM MED ASSOC, V297, P1455, DOI 10.1001/jama.297.13.1455; Hackam DG, 2006, LANCET, V367, P413, DOI 10.1016/S0140-6736(06)68041-0; Hamilton BE, 2007, PEDIATRICS, V119, P345, DOI 10.1542/peds.2006-3226; Hayden FG, 2006, J INFECT DIS, V194, pS119, DOI 10.1086/507552; Hurt A, 2011, EURO SURVEILL, V16; Jing XH, 2008, P NATL ACAD SCI USA, V105, P10967, DOI 10.1073/pnas.0804958105; Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022; Kiso M, 2004, LANCET, V364, P759, DOI 10.1016/S0140-6736(04)16934-1; Kwak B, 2000, NAT MED, V6, P1399, DOI 10.1038/82219; Liao JK, 2002, J CLIN INVEST, V110, P285, DOI 10.1172/JCI200216421; Lippi G, 2010, SEMIN THROMB HEMOST, V36, P49, DOI 10.1055/s-0030-1248724; Macreadie IG, 2006, FEMS MICROBIOL LETT, V262, P9, DOI 10.1111/j.1574-6968.2006.00370.x; Madjid M, 2004, TEX HEART I J, V31, P4; Makris D, 2011, CRIT CARE MED, V39, P2440, DOI 10.1097/CCM.0b013e318225742c; Martin CP, 2007, PHARMACOTHERAPY, V27, P20, DOI 10.1592/phco.27.1.20; Matrosovich M, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-63; Mortensen EM, 2008, EUR RESPIR J, V31, P611, DOI 10.1183/09031936.00162006; Mortensen EM, 2007, PHARMACOTHERAPY, V27, P1619, DOI 10.1592/phco.27.12.1619; Mortensen EM, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-45; Mutlu GM, 2007, J CLIN INVEST, V117, P2952, DOI 10.1172/JCI30639; Node K, 2003, CIRCULATION, V108, P839, DOI 10.1161/01.CIR.0000084539.58092.DE; Pastey MK, 2000, NAT MED, V6, P35, DOI 10.1038/71503; Puig-Barbera J, 2007, VACCINE, V25, P7313, DOI 10.1016/j.vaccine.2007.08.039; Schafer K, 2005, THROMB HAEMOSTASIS, V93, P145, DOI 10.1160/TH04-07-0415; Schlienger RG, 2007, PHARMACOTHERAPY, V27, P325, DOI 10.1592/phco.27.3.325; Schonbeck U, 2004, CIRCULATION, V109, P18, DOI 10.1161/01.CIR.0000129505.34151.23; Shrestha SS, 2011, CLIN INFECT DIS, V52, pS75, DOI 10.1093/cid/ciq012; Snelgrove RJ, 2008, NAT IMMUNOL, V9, P1074, DOI 10.1038/ni.1637; Thomsen RW, 2008, PHARMACOEPIDEM DR S, V17, pS234; van de Garde EMW, 2006, THORAX, V61, P957, DOI 10.1136/thx.2006.062885; Weitz-Schmidt G, 2001, NAT MED, V7, P687, DOI 10.1038/89058; Yeh SS, 2008, J AM MED DIR ASSOC, V9, P221, DOI 10.1016/j.jamda.2008.01.003; Zarogiannis SG, 2012, LIFE SCI	47	39	41	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35788	10.1371/journal.pone.0035788	http://dx.doi.org/10.1371/journal.pone.0035788			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536437	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339200111
J	Seibel, BA; Maas, AE; Dierssen, HM				Seibel, Brad A.; Maas, Amy E.; Dierssen, Heidi M.			Energetic Plasticity Underlies a Variable Response to Ocean Acidification in the Pteropod, Limacina helicina antarctica	PLOS ONE			English	Article							PERSPECTIVES; TEMPERATURES; METABOLISM; ANIMALS; IMPACTS; RATES; FOOD; SEA	Ocean acidification, caused by elevated seawater carbon dioxide levels, may have a deleterious impact on energetic processes in animals. Here we show that high PCO2 can suppress metabolism, measured as oxygen consumption, in the pteropod, L. helicina forma antarctica, by similar to 20%. The rates measured at 180-380 mu atm (MO2 = 1.25 M-0.25, p = 0.007) were significantly higher (ANCOVA, p = 0.004) than those measured at elevated target CO2 levels in 2007 (789-1000 mu atm, = 0.78 M-0.32, p = 0.0008; Fig. 1). However, we further demonstrate metabolic plasticity in response to regional phytoplankton concentration and that the response to CO2 is dependent on the baseline level of metabolism. We hypothesize that reduced regional Chl a levels in 2008 suppressed metabolism and masked the effect of ocean acidification. This effect of food limitation was not, we postulate, merely a result of gut clearance and specific dynamic action, but rather represents a sustained metabolic response to regional conditions. Thus, pteropod populations may be compromised by climate change, both directly via CO2-induced metabolic suppression, and indirectly via quantitative and qualitative changes to the phytoplankton community. Without the context provided by long-term observations (four seasons) and a multi-faceted laboratory analysis of the parameters affecting energetics, the complex response of polar pteropods to ocean acidification may be masked or misinterpreted.	[Seibel, Brad A.; Maas, Amy E.] Univ Rhode Isl, Kingston, RI 02881 USA; [Dierssen, Heidi M.] Univ Connecticut, Groton, CT USA	University of Rhode Island; University of Connecticut	Seibel, BA (corresponding author), Univ Rhode Isl, Kingston, RI 02881 USA.	seibel@uri.edu	Maas, Amy/AAC-1181-2022	Maas, Amy/0000-0002-3730-2876	National Science Foundation Office of Polar Programs [0538479]	National Science Foundation Office of Polar Programs(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was funded by a grant from the National Science Foundation Office of Polar Programs (0538479). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brockington S, 2001, J EXP MAR BIOL ECOL, V258, P87, DOI 10.1016/S0022-0981(00)00347-6; Cohen AL, 2009, OCEANOGRAPHY, V22, P118, DOI 10.5670/oceanog.2009.102; Comeau S, 2010, MAR BIOL, V157, P2341, DOI 10.1007/s00227-010-1493-6; Comeau S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011362; Cummings V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016069; Dierssen HM, 2010, P NATL ACAD SCI USA, V107, P17073, DOI 10.1073/pnas.0913800107; Dymowska A, J EXP BIOL IN PRESS; Falk-Petersen S, 2001, POLAR BIOL, V24, P163, DOI 10.1007/s003000000190; Feely RA, 2004, SCIENCE, V305, P362, DOI 10.1126/science.1097329; Feldman GC, 2009, OCEAN COLOR WEB SEAW; Guppy M, 1999, BIOL REV, V74, P1, DOI 10.1017/S0006323198005258; Hendriks LE, 2010, SCIENCE, V86, P157; Hofmann GE, 2010, ANNU REV ECOL EVOL S, V41, P127, DOI 10.1146/annurev.ecolsys.110308.120227; Hunt BPV, 2008, PROG OCEANOGR, V78, P193, DOI 10.1016/j.pocean.2008.06.001; Hunt BM, 2003, ANTARCT SCI, V15, P333, DOI 10.1017/S0954102003001342; Hunt BPV, 2010, PLOS ONE, V5, P1; Lischka S, 2011, BIOGEOSCIENCES, V8, P919, DOI 10.5194/bg-8-919-2011; Maas AE, 2011, MAR ECOL PROG SER, V441, P129, DOI 10.3354/meps09358; McCue MD, 2006, COMP BIOCHEM PHYS A, V144, P381, DOI 10.1016/j.cbpa.2006.03.011; McNeil B, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044597; McNeil BI, 2008, P NATL ACAD SCI USA, V105, P18860, DOI 10.1073/pnas.0806318105; Melzner F, 2009, BIOGEOSCIENCES, V6, P2313, DOI 10.5194/bg-6-2313-2009; Montes-Hugo MA, 2008, DEEP-SEA RES PT II, V55, P2106, DOI 10.1016/j.dsr2.2008.04.036; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Pierrot DEL, 2010, ORNLCDIAC105 US DEP; Portner HO, 1998, J EXP BIOL, V201, P43; Riebesell U., 2010, GUIDE BEST PRACTICES, DOI 10.2777/58454; Ries JB, 2009, GEOLOGY, V37, P1131, DOI 10.1130/G30210A.1; Rosenthal JJC, 2009, P NATL ACAD SCI USA, V106, P6192, DOI 10.1073/pnas.0901321106; Schofield O, 2010, SCIENCE, V328, P1520, DOI 10.1126/science.1185779; Seibel BA, 2003, BIOL BULL-US, V205, P93, DOI 10.2307/1543229; Seibel BA, 2003, ADV APPL BIODIVERSIT, V4, P59; Seibel BA, 2007, INTEGR COMP BIOL, V47, P880, DOI 10.1093/icb/icm089; Seibel BA, 2011, J EXP BIOL, V214, P326, DOI 10.1242/jeb.049171; Smith WO, 2011, PROG OCEANOGR, V88, P28, DOI 10.1016/j.pocean.2010.08.002; Stumpp M, 2011, COMP BIOCHEM PHYS A, V160, P331, DOI 10.1016/j.cbpa.2011.06.022; Tortell PD, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032583; Wood HL, 2008, P ROY SOC B-BIOL SCI, V275, P1767, DOI 10.1098/rspb.2008.0343	38	78	81	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e30464	10.1371/journal.pone.0030464	http://dx.doi.org/10.1371/journal.pone.0030464			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536312	Green Published, gold			2022-12-27	WOS:000305339200002
J	Wang, L; Hurley, DG; Watkins, W; Araki, H; Tamada, Y; Muthukaruppan, A; Ranjard, L; Derkac, E; Imoto, S; Miyano, S; Crampin, EJ; Print, CG				Wang, Li; Hurley, Daniel G.; Watkins, Wendy; Araki, Hiromitsu; Tamada, Yoshinori; Muthukaruppan, Anita; Ranjard, Louis; Derkac, Eliane; Imoto, Seiya; Miyano, Satoru; Crampin, Edmund J.; Print, Cristin G.			Cell Cycle Gene Networks Are Associated with Melanoma Prognosis	PLOS ONE			English	Article							EXPRESSION SIGNATURES; TRANSCRIPTION FACTOR; MALIGNANT-MELANOMA; CUTANEOUS MELANOMA; SIGNALING PATHWAYS; TUMOR PROGRESSION; CLINICAL ACTIVITY; MITF; BRAF; MUTATIONS	Background: Our understanding of the molecular pathways that underlie melanoma remains incomplete. Although several published microarray studies of clinical melanomas have provided valuable information, we found only limited concordance between these studies. Therefore, we took an in vitro functional genomics approach to understand melanoma molecular pathways. Methodology/Principal Findings: Affymetrix microarray data were generated from A375 melanoma cells treated in vitro with siRNAs against 45 transcription factors and signaling molecules. Analysis of this data using unsupervised hierarchical clustering and Bayesian gene networks identified proliferation-association RNA clusters, which were co-ordinately expressed across the A375 cells and also across melanomas from patients. The abundance in metastatic melanomas of these cellular proliferation clusters and their putative upstream regulators was significantly associated with patient prognosis. An 8-gene classifier derived from gene network hub genes correctly classified the prognosis of 23/26 metastatic melanoma patients in a cross-validation study. Unlike the RNA clusters associated with cellular proliferation described above, co-ordinately expressed RNA clusters associated with immune response were clearly identified across melanoma tumours from patients but not across the siRNA-treated A375 cells, in which immune responses are not active. Three uncharacterised genes, which the gene networks predicted to be upstream of apoptosis-or cellular proliferation-associated RNAs, were found to significantly alter apoptosis and cell number when over-expressed in vitro. Conclusions/Significance: This analysis identified co-expression of RNAs that encode functionally-related proteins, in particular, proliferation-associated RNA clusters that are linked to melanoma patient prognosis. Our analysis suggests that A375 cells in vitro may be valid models in which to study the gene expression modules that underlie some melanoma biological processes (e. g., proliferation) but not others (e. g., immune response). The gene expression modules identified here, and the RNAs predicted by Bayesian network inference to be upstream of these modules, are potential prognostic biomarkers and drug targets.	[Wang, Li; Hurley, Daniel G.; Watkins, Wendy; Araki, Hiromitsu; Muthukaruppan, Anita; Print, Cristin G.] Univ Auckland, Fac Med & Hlth Sci, Sch Med Sci, Dept Mol Med & Pathol, Auckland 1, New Zealand; [Hurley, Daniel G.; Crampin, Edmund J.] Univ Auckland, Auckland Bioengn Inst, Auckland 1, New Zealand; [Tamada, Yoshinori; Imoto, Seiya; Miyano, Satoru] Univ Tokyo, Ctr Human Genome, Inst Med Sci, Lab DNA Informat Anal, Tokyo, Japan; [Araki, Hiromitsu; Tamada, Yoshinori] GNI Ltd, Shinjuku Ku, Tokyo, Japan; [Ranjard, Louis; Derkac, Eliane; Print, Cristin G.] Univ Auckland, Bioinformat Inst, Auckland 1, New Zealand; [Crampin, Edmund J.] Univ Auckland, Dept Engn Sci, Auckland 1, New Zealand	University of Auckland; University of Auckland; University of Tokyo; University of Auckland; University of Auckland	Print, CG (corresponding author), Univ Auckland, Fac Med & Hlth Sci, Sch Med Sci, Dept Mol Med & Pathol, Auckland 1, New Zealand.	c.print@auckland.ac.nz	Tamada, Yoshinori/AAY-4542-2020; Ranjard, Louis/M-4525-2015	Tamada, Yoshinori/0000-0003-3483-9712; Ranjard, Louis/0000-0002-7622-4823; Print, Cristin/0000-0001-8345-7812; Miyano, Satoru/0000-0002-1753-6616; Hurley, Daniel Glyn/0000-0003-0171-1982; Muthukaruppan, Anitadevi/0000-0002-6330-1594	University of Auckland [23285]; Maurice Wilkins Centre for BioDiscovery Scholarship; Health Research Council of New Zealand [06/581]; Marsden Fund [06-UoA182]; University of Auckland FMHS (Faculty of Medical and Health Sciences) [8303460]	University of Auckland; Maurice Wilkins Centre for BioDiscovery Scholarship; Health Research Council of New Zealand(Health Research Council of New Zealand); Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); University of Auckland FMHS (Faculty of Medical and Health Sciences)	GNI Ltd, who provided a subset of the siRNA reagents used for this study, were shown the manuscript before submission as a matter of courtesy but played no role in its preparation. Funding for this research included University of Auckland Doctorate scholarships for DGH and LW, a Maurice Wilkins Centre for BioDiscovery Scholarship for DGH, Health Research Council of New Zealand (06/581), The Marsden Fund (06-UoA182), University of Auckland FMHS (Faculty of Medical and Health Sciences) Development Fund (8303460), and University of Auckland VCDF (Vice Chancellor Development Fund) (23285). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akslen LA, 2005, J INVEST DERMATOL, V125, P312, DOI 10.1111/j.0022-202X.2005.23788.x; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Avril MF, 2004, J CLIN ONCOL, V22, P1118, DOI 10.1200/JCO.2004.04.165; Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Bansal M, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100120; BATAILLE V, 1995, BRIT J DERMATOL, V132, P134, DOI 10.1111/j.1365-2133.1995.tb08639.x; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Berd D, 2004, J CLIN ONCOL, V22, P403, DOI 10.1200/JCO.2004.06.043; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Bilican B, 2006, EXP CELL RES, V312, P2358, DOI 10.1016/j.yexcr.2006.03.033; Bittner M, 2000, NATURE, V406, P536, DOI 10.1038/35020115; Bogunovic D, 2009, P NATL ACAD SCI USA, V106, P20429, DOI 10.1073/pnas.0905139106; Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; Bondurand N, 2000, HUM MOL GENET, V9, P1907, DOI 10.1093/hmg/9.13.1907; Brahmer JR, 2010, J CLIN ONCOL, V28, P3167, DOI 10.1200/JCO.2009.26.7609; Butte AJ, 2000, P NATL ACAD SCI USA, V97, P12182, DOI 10.1073/pnas.220392197; Carreira S, 2005, NATURE, V433, P764, DOI 10.1038/nature03269; Ch'ng S, 2009, FRONT BIOSCI-LANDMRK, V14, P918, DOI 10.2741/3286; Chang JT, 2006, BIOINFORMATICS, V22, P2926, DOI 10.1093/bioinformatics/btl483; Cheli Y, 2011, ONCOGENE, V30, P2307, DOI 10.1038/onc.2010.598; Chowdhery R, 2011, IMMUNOTHERAPY-UK, V3, P17, DOI 10.2217/IMT.10.89; Dai DL, 2005, J CLIN ONCOL, V23, P1473, DOI 10.1200/JCO.2005.07.168; Dhomen N, 2009, HEMATOL ONCOL CLIN N, V23, P529, DOI 10.1016/j.hoc.2009.04.001; Dong JL, 2003, CANCER RES, V63, P3883; Du JY, 2004, CANCER CELL, V6, P565, DOI 10.1016/j.ccr.2004.10.014; Firoz EF, 2009, CLIN CANCER RES, V15, P2573, DOI 10.1158/1078-0432.CCR-08-2678; Gajewski TF, 2010, CANCER J, V16, P399, DOI 10.1097/PPO.0b013e3181eacbd8; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; Goldstein AM, 2007, J MED GENET, V44, P99, DOI 10.1136/jmg.2006.043802; Goldstein AM, 2000, J NATL CANCER I, V92, P1006, DOI 10.1093/jnci/92.12.1006; Goodall J, 2008, CANCER RES, V68, P7788, DOI 10.1158/0008-5472.CAN-08-1053; Halaban R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004563; Haqq C, 2005, P NATL ACAD SCI USA, V102, P6092, DOI 10.1073/pnas.0501564102; Hatanaka Yosuke, 2008, Genome Inform, V20, P212; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hoek K, 2004, CANCER RES, V64, P5270, DOI 10.1158/0008-5472.CAN-04-0731; Hoek KS, 2009, GIORN ITAL DERMAT V, V144, P39; Hoek KS, 2006, PIGM CELL RES, V19, P290, DOI 10.1111/j.1600-0749.2006.00322.x; Imoto Seiya, 2006, Pac Symp Biocomput, P559; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jaeger J, 2007, CLIN CANCER RES, V13, P806, DOI 10.1158/1078-0432.CCR-06-1820; Jeffs AR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008461; John T, 2008, CLIN CANCER RES, V14, P5173, DOI 10.1158/1078-0432.CCR-07-4170; Jung CR, 2006, NAT MED, V12, P809, DOI 10.1038/nm1440; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Kaufman L., 1990, FINDING GROUPS DATA, DOI 10.1002/9780470316801; Klebanov L, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-28; Kunz M, 2008, SEMIN CUTAN MED SURG, V27, P16, DOI 10.1016/j.sder.2007.12.004; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lee HK, 2004, GENOME RES, V14, P1085, DOI 10.1101/gr.1910904; Lopez-Bergami P, 2007, CANCER CELL, V11, P447, DOI 10.1016/j.ccr.2007.03.009; Mandruzzato S, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-50; Marot G, 2009, BIOINFORMATICS, V25, P2692, DOI 10.1093/bioinformatics/btp444; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Meyle KD, 2009, HUM GENET, V126, P499, DOI 10.1007/s00439-009-0715-9; Nambiar S, 2008, CURR MOL MED, V8, P235, DOI 10.2174/156652408784221333; Neagu M, 2010, EXPERT REV MOL DIAGN, V10, P897, DOI [10.1586/erm.10.81, 10.1586/ERM.10.81]; New Zealand Ministry of Health, 2010, CANC NEW REG DEATHS; Obayashi T, 2011, NUCLEIC ACIDS RES, V39, pD1016, DOI 10.1093/nar/gkq1147; Obayashi T, 2009, DNA RES, V16, P249, DOI 10.1093/dnares/dsp016; Okoniewski MJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-276; Parman C, 2006, AFFYQCREPORT PACKAGE; Ren Suping, 2008, Cancer Control, V15, P202; Ribas A, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-89; Riker AI, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-13; RYAN RF, 1988, J SURG ONCOL, V38, P250, DOI 10.1002/jso.2930380409; Salti GI, 2000, CANCER RES, V60, P5012; Smith AP, 2005, CANCER BIOL THER, V4, P1018, DOI 10.4161/cbt.4.9.2165; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Song S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-502; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Talantov D, 2005, CLIN CANCER RES, V11, P7234, DOI 10.1158/1078-0432.CCR-05-0683; Tamada Y, 2011, IEEE ACM T COMPUT BI, V8, P683, DOI 10.1109/TCBB.2010.68; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Timar J, 2010, CLIN EXP METASTAS, V27, P371, DOI 10.1007/s10585-010-9307-2; vanElsas A, 1996, AM J PATHOL, V149, P883; Viswanathan GA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040016; Winnepenninckx VR, 2006, JNCI-J NATL CANCER I, V98, P472, DOI 10.1093/jnci/djj103; Wu H, 2003, ONCOGENE, V22, P3113, DOI 10.1038/sj.onc.1206451; Xu L, 2008, MOL CANCER RES, V6, P760, DOI 10.1158/1541-7786.MCR-07-0344	83	24	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e34247	10.1371/journal.pone.0034247	http://dx.doi.org/10.1371/journal.pone.0034247			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536322	Green Published, gold			2022-12-27	WOS:000305339200010
J	Liu, JY; Zhang, DY; Luo, WJ; Yu, JX; Li, JX; Yu, YH; Zhang, XH; Chen, JY; Wu, XR; Huang, CS				Liu, Jinyi; Zhang, Dongyun; Luo, Wenjing; Yu, Jianxiu; Li, Jingxia; Yu, Yonghui; Zhang, Xinhai; Chen, Jingyuan; Wu, Xue-Ru; Huang, Chuanshu			E3 Ligase Activity of XIAP RING Domain Is Required for XIAP-Mediated Cancer Cell Migration, but Not for Its RhoGDI Binding Activity	PLOS ONE			English	Article							X-LINKED INHIBITOR; GDP-DISSOCIATION INHIBITOR; APOPTOSIS PROTEIN XIAP; IAP FAMILY PROTEINS; EXPRESSION; MOTILITY; METASTASIS; SURVIVIN; CLEAVAGE; GROWTH	Although an increased expression level of XIAP is associated with cancer cell metastasis, the underlying molecular mechanisms remain largely unexplored. To verify the specific structural basis of XIAP for regulation of cancer cell migration, we introduced different XIAP domains into XIAP(-/-) HCT116 cells, and found that reconstitutive expression of full length HA-XIAP and HA-XIAP Delta BIR, both of which have intact RING domain, restored beta-Actin expression, actin polymerization and cancer cell motility. Whereas introduction of HA-XIAP Delta RING or H467A mutant, which abolished its E3 ligase function, did not show obvious restoration, demonstrating that E3 ligase activity of XIAP RING domain played a crucial role of XIAP in regulation of cancer cell motility. Moreover, RING domain rather than BIR domain was required for interaction with RhoGDI independent on its E3 ligase activity. To sum up, our present studies found that role of XIAP in regulating cellular motility was uncoupled from its caspase-inhibitory properties, but related to physical interaction between RhoGDI and its RING domain. Although E3 ligase activity of RING domain contributed to cell migration, it was not involved in RhoGDI binding nor its ubiquitinational modification.	[Liu, Jinyi; Zhang, Dongyun; Yu, Jianxiu; Li, Jingxia; Yu, Yonghui; Zhang, Xinhai; Huang, Chuanshu] NYU, Sch Med, Nelson Inst Environm Med, Tuxedo Pk, NY USA; [Luo, Wenjing; Chen, Jingyuan] Fourth Mil Med Univ, Dept Occupat & Environm Hlth Sci, Xian, Shanxi, Peoples R China; [Wu, Xue-Ru] NYU, Sch Med, Dept Urol & Pathol, Tuxedo Pk, NY USA	New York University; Air Force Military Medical University; New York University	Liu, JY (corresponding author), NYU, Sch Med, Nelson Inst Environm Med, Tuxedo Pk, NY USA.	chuanshu.huang@nyumc.org	Yu, Yonghui/AAZ-4093-2021	Huang, Chuanshu/0000-0003-4133-5096; Wu, Xue-Ru/0000-0001-6058-6291	United States National Institutes of Health/NCI [CA112557, CA119028-05S110]; NIH/NIEHS [ES012451, ES010344]; NATIONAL CANCER INSTITUTE [R01CA119028, R01CA112557] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012451, P42ES010344] Funding Source: NIH RePORTER	United States National Institutes of Health/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funding was provided by United States National Institutes of Health/NCI CA112557 and CA119028-05S110, NIH/NIEHS ES012451, and ES010344. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adra CN, 1997, P NATL ACAD SCI USA, V94, P4279, DOI 10.1073/pnas.94.9.4279; Akyurek N, 2006, CANCER-AM CANCER SOC, V107, P1844, DOI 10.1002/cncr.22219; Burstein E, 2004, EMBO J, V23, P244, DOI 10.1038/sj.emboj.7600031; Chan AY, 1998, J CELL SCI, V111, P199; Cummins JM, 2004, CANCER RES, V64, P3006, DOI 10.1158/0008-5472.CAN-04-0046; del Peso L, 1997, ONCOGENE, V15, P3047; DerMardirossian C, 2005, TRENDS CELL BIOL, V15, P356, DOI 10.1016/j.tcb.2005.05.001; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Dogan T, 2008, NAT CELL BIOL, V10, P1447, DOI 10.1038/ncb1804; Dovas A, 2005, BIOCHEM J, V390, P1, DOI 10.1042/BJ20050104; Duckett CS, 1996, EMBO J, V15, P2685, DOI 10.1002/j.1460-2075.1996.tb00629.x; FIDLER IJ, 1990, CANCER RES, V50, P6130; Fong WG, 2000, GENOMICS, V70, P113, DOI 10.1006/geno.2000.6364; Harlin H, 2001, MOL CELL BIOL, V21, P3604, DOI 10.1128/MCB.21.10.3604-3608.2001; Jost PJ, 2009, NATURE, V460, P1035, DOI 10.1038/nature08229; Kaur S, 2005, J BIOL CHEM, V280, P38599, DOI 10.1074/jbc.M505671200; Kjoller L, 1999, EXP CELL RES, V253, P166, DOI 10.1006/excr.1999.4674; Kleinberg L, 2007, AM J CLIN PATHOL, V128, P389, DOI 10.1309/E899BG1282M5D505; Kleinberg L, 2007, CANCER, V109, P228, DOI 10.1002/cncr.22426; Kluger HM, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-6; LEFFERS H, 1993, EXP CELL RES, V209, P165, DOI 10.1006/excr.1993.1298; Levkau B, 2001, CIRC RES, V88, P282, DOI 10.1161/01.RES.88.3.282; Lewis J, 2004, J BIOL CHEM, V279, P9023, DOI 10.1074/jbc.M312891200; Li M, 2007, CHINESE MED J-PEKING, V120, P469, DOI 10.1097/00029330-200703020-00007; Lin M, 2004, BREAST CANCER RES TR, V84, P49, DOI 10.1023/B:BREA.0000018424.43445.f3; Liston P, 1996, NATURE, V379, P349, DOI 10.1038/379349a0; Liu JY, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.176982; Mehrotra S, 2010, CANCER CELL, V17, P53, DOI 10.1016/j.ccr.2009.11.021; MIURA Y, 1993, J BIOL CHEM, V268, P510; Nagi C, 2007, ANN DIAGN PATHOL, V11, P402, DOI 10.1016/j.anndiagpath.2006.12.012; Nemoto T, 2004, EXP MOL PATHOL, V76, P253, DOI 10.1016/j.yexmp.2004.01.001; Ouyang WM, 2009, J CELL PHYSIOL, V218, P205, DOI 10.1002/jcp.21590; Schile AJ, 2008, GENE DEV, V22, P2256, DOI 10.1101/gad.1663108; Schimmer AD, 2006, CELL DEATH DIFFER, V13, P179, DOI 10.1038/sj.cdd.4401826; Schimmer AD, 2005, HEMATOL-AM SOC HEMAT, V2005, P215, DOI DOI 10.1182/asheducation.V2005.1.215.215; Shan DD, 2005, P NATL ACAD SCI USA, V102, P3772, DOI 10.1073/pnas.0500658102; Srinivasula SM, 2008, MOL CELL, V30, P123, DOI 10.1016/j.molcel.2008.03.008; Staiger CJ, 2006, CURR OPIN PLANT BIOL, V9, P554, DOI 10.1016/j.pbi.2006.09.013; Taniuchi S, 1999, PEDIATR INT, V41, P37; Wittmann T, 2001, J CELL SCI, V114, P3795; Yang L, 2003, CANCER RES, V63, P6815; Yang YL, 2000, CELL RES, V10, P169, DOI 10.1038/sj.cr.7290046; Zhang BL, 2005, CANCER RES, V65, P6054, DOI 10.1158/0008-5472.CAN-05-0175	43	32	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e35682	10.1371/journal.pone.0035682	http://dx.doi.org/10.1371/journal.pone.0035682			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22532870	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336200066
J	Morof, D; Steinauer, J; Haider, S; Liu, SN; Darney, P; Barrett, G				Morof, Diane; Steinauer, Jody; Haider, Sadia; Liu, Sonia; Darney, Philip; Barrett, Geraldine			Evaluation of the London Measure of Unplanned Pregnancy in a United States Population of Women	PLOS ONE			English	Article							UNINTENDED PREGNANCY; INTENTION; CARE; INTENDEDNESS; RATES	Objective: To evaluate the reliability and validity of the London Measure of Unplanned Pregnancy (a U.K.-developed measure of pregnancy intention), in English and Spanish translation, in a U.S. population of women. Methods: A psychometric evaluation study of the London Measure of Unplanned Pregnancy (LMUP), a six-item, self-completion paper measure was conducted with 346 women aged 15-45 who presented to San Francisco General Hospital for termination of pregnancy or antenatal care. Analyses of the two language versions were carried out separately. Reliability (internal consistency) was assessed using Cronbach's alpha and item-total correlations. Test-retest reliability (stability) was assessed using weighted Kappa. Construct validity was assessed using principal components analysis and hypothesis testing. Results: Psychometric testing demonstrated that the LMUP was reliable and valid in both U.S. English (alpha = 0.78, all item-total correlations >0.20, weighted Kappa = 0.72, unidimensionality confirmed, hypotheses met) and Spanish translation (alpha = 0.84, all item-total correlations >0.20, weighted Kappa = 0.77, unidimensionality confirmed, hypotheses met). Conclusion: The LMUP was reliable and valid in U.S. English and Spanish translation and therefore may now be used with U.S. women.	[Morof, Diane; Steinauer, Jody; Darney, Philip] Univ Calif San Francisco, San Francisco Gen Hosp, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA; [Morof, Diane; Steinauer, Jody; Darney, Philip] Univ Calif San Francisco, Bixby Ctr Global Reprod Hlth, San Francisco, CA 94143 USA; [Haider, Sadia] Beth Israel Deaconess Med Ctr, Dept Obstet & Gynecol, Boston, MA 02215 USA; [Liu, Sonia] Univ Calif Davis, Dept Family Med, Davis, CA 95616 USA; [Barrett, Geraldine] Brunel Univ, London, England	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Harvard University; Beth Israel Deaconess Medical Center; University of California System; University of California Davis; Brunel University	Morof, D (corresponding author), Univ Calif San Francisco, San Francisco Gen Hosp, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA.	dmorof@gmail.com		Barrett, Geraldine/0000-0002-9738-1051	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD055892] Funding Source: NIH RePORTER; NICHD NIH HHS [K12 HD055892] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Aaronson N, 2002, QUAL LIFE RES, V11, P193; Barrett G, 2004, J EPIDEMIOL COMMUN H, V58, P426, DOI 10.1136/jech.2003.014787; Barrett G, 2002, SOC SCI MED, V55, P545, DOI 10.1016/S0277-9536(01)00187-3; Brown S.S., 1995, BEST INTENTIONS UNIN; Canady RB, 2008, MCN-AM J MATERN-CHIL, V33, P90, DOI 10.1097/01.NMC.0000313416.59118.93; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Custer M, 2008, PAEDIATR PERINAT EP, V22, P195, DOI 10.1111/j.1365-3016.2007.00896.x; Finer LB, 2006, PERSPECT SEX REPRO H, V38, P90, DOI 10.1363/3809006; Fischer RC, 1999, J FAM PRACTICE, V48, P117; Guttmacher Institute, 2006, CONTR COUNTS RANK ST; Joyce T, 2002, DEMOGRAPHY, V39, P199, DOI 10.2307/3088371; KOST K, 1995, FAM PLANN PERSPECT, V27, P11, DOI 10.2307/2135971; Lakha F, 2006, LANCET, V368, P1782, DOI 10.1016/S0140-6736(06)69737-7; Landis J. R., 1977, BIOMETRICS, V33; Lifflander A, 2007, MATERN CHILD HLTH J, V11, P81, DOI 10.1007/s10995-006-0138-3; Lowenthal KM, 2001, INTRO PSHYCHOLOGICAL; Mohllajee AP, 2007, OBSTET GYNECOL, V109, P678, DOI 10.1097/01.AOG.0000255666.78427.c5; Mokken R. J., 1971, THEORY PROCEDURE SCA, DOI DOI 10.1515/9783110813203; Moos MK, 1997, WOMEN HEALTH ISS, V7, P385, DOI 10.1016/S1049-3867(97)00081-9; Rocca CH, 2010, DEMOGR RES, V23, P293, DOI 10.4054/DemRes.2010.23.11; Santelli J, 2003, PERSPECT SEX REPRO H, V35, P94, DOI 10.1111/j.1931-2393.2003.tb00111.x; Santelli JS, 2006, AM J PUBLIC HEALTH, V96, P2009, DOI 10.2105/AJPH.2005.064584; Santelli JS, 2009, STUD FAMILY PLANN, V40, P87, DOI 10.1111/j.1728-4465.2009.00192.x; Schwartz A, 2010, WOMEN HEALTH ISS, V20, P371, DOI 10.1016/j.whi.2010.06.005; Sijtsma K., 2002, INTRO NONPARAMETRIC, VVol. 5; Speizer IS, 2004, PERSPECT SEX REPRO H, V36, P198; STREINER DL, 1994, PERCEPT MOTOR SKILL, V78, P275, DOI 10.2466/pms.1994.78.1.275; Streiner DL., 1995, HLTH MEASUREMENT SCA, V2nd ed.; Trussell J, 1999, FAM PLANN PERSPECT, V31, P246, DOI 10.2307/2991573; U.S. Department of Health and Human Services, 2010, HEALTHYPEOPLE GOV FA; U.S Department of Health and Human Services Food and Drug Administration, 2006, HLTH QUAL LIFE OUTCO, V4; Willis GB, 2005, COGNATIVE INTERVIEWI; Zabin LS, 1999, FAM PLANN PERSPECT, V31, P250, DOI 10.2307/2991576	33	52	52	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e35381	10.1371/journal.pone.0035381	http://dx.doi.org/10.1371/journal.pone.0035381			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TL	22536377	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336200036
J	Scalliet, G; Bowler, J; Luksch, T; Kirchhofer-Allan, L; Steinhauer, D; Ward, K; Niklaus, M; Verras, A; Csukai, M; Daina, A; Fonne-Pfister, R				Scalliet, Gabriel; Bowler, Judith; Luksch, Torsten; Kirchhofer-Allan, Lucy; Steinhauer, Diana; Ward, Keith; Niklaus, Michael; Verras, Andreas; Csukai, Michael; Daina, Antoine; Fonne-Pfister, Raymonde			Mutagenesis and Functional Studies with Succinate Dehydrogenase Inhibitors in the Wheat Pathogen Mycosphaerella graminicola	PLOS ONE			English	Article							UBIQUINONE-BINDING SITE; COMPLEX-II SUCCINATE; IRON-SULFUR SUBUNIT; CARBOXIN RESISTANCE; ELECTRON-TRANSFER; ESCHERICHIA-COLI; BOSCALID RESISTANCE; OXIDATIVE STRESS; BOTRYTIS-CINEREA; OXIDOREDUCTASE	A range of novel carboxamide fungicides, inhibitors of the succinate dehydrogenase enzyme (SDH, EC 1.3.5.1) is currently being introduced to the crop protection market. The aim of this study was to explore the impact of structurally distinct carboxamides on target site resistance development and to assess possible impact on fitness. We used a UV mutagenesis approach in Mycosphaerella graminicola, a key pathogen of wheat to compare the nature, frequencies and impact of target mutations towards five subclasses of carboxamides. From this screen we identified 27 amino acid substitutions occurring at 18 different positions on the 3 subunits constituting the ubiquinone binding (Qp) site of the enzyme. The nature of substitutions and cross resistance profiles indicated significant differences in the binding interaction to the enzyme across the different inhibitors. Pharmacophore elucidation followed by docking studies in a tridimensional SDH model allowed us to propose rational hypotheses explaining some of the differential behaviors for the first time. Interestingly all the characterized substitutions had a negative impact on enzyme efficiency, however very low levels of enzyme activity appeared to be sufficient for cell survival. In order to explore the impact of mutations on pathogen fitness in vivo and in planta, homologous recombinants were generated for a selection of mutation types. In vivo, in contrast to previous studies performed in yeast and other organisms, SDH mutations did not result in a major increase of reactive oxygen species levels and did not display any significant fitness penalty. However, a number of Qp site mutations affecting enzyme efficiency were shown to have a biological impact in planta. Using the combined approaches described here, we have significantly improved our understanding of possible resistance mechanisms to carboxamides and performed preliminary fitness penalty assessment in an economically important plant pathogen years ahead of possible resistance development in the field.	[Scalliet, Gabriel; Luksch, Torsten; Kirchhofer-Allan, Lucy; Steinhauer, Diana; Niklaus, Michael; Verras, Andreas; Daina, Antoine; Fonne-Pfister, Raymonde] Syngenta Crop Protect Munchwilen AG, Stein, Switzerland; [Bowler, Judith; Ward, Keith; Csukai, Michael] Syngenta Jealotts Hill Int Res Ctr, Bracknell, Berks, England	Syngenta; Syngenta	Scalliet, G (corresponding author), Syngenta Crop Protect Munchwilen AG, Stein, Switzerland.	gabriel.scalliet@syngenta.com		Niklaus, Michael/0000-0003-4713-261X; Csukai, Michael/0000-0003-0615-7802				Amand O., 2003, Communications in Agricultural and Applied Biological Sciences, V68, P519; Anderson RF, 2005, J BIOL CHEM, V280, P33331, DOI 10.1074/jbc.M506002200; [Anonymous], 2005, PHYTOPATHOL MEDITERR, V44, P216; [Anonymous], 1995, FUNGICIDE RESISTANCE; Avenot H, 2009, PLANT PATHOL, V58, P1134, DOI 10.1111/j.1365-3059.2009.02154.x; Avenot HF, 2008, PHYTOPATHOLOGY, V98, P736, DOI 10.1094/PHYTO-98-6-0736; BAGINSKY ML, 1969, J BIOL CHEM, V244, P5313; Bowler J, 2010, MOL PLANT PATHOL, V11, P691, DOI [10.1111/J.1364-3703.2010.00629.X, 10.1111/j.1364-3703.2010.00629.x]; BROOMFIELD PLE, 1992, CURR GENET, V22, P117, DOI 10.1007/BF00351470; Cheng VWT, 2006, J BIOL CHEM, V281, P27662, DOI 10.1074/jbc.M604900200; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Eyal Z., 1987, SEPTORIA DIS WHEAT C; Fraaije BA, 2005, PHYTOPATHOLOGY, V95, P933, DOI 10.1094/PHYTO-95-0933; Fraaije BA, 2012, MOL PLANT PATHOL, V13, P263, DOI 10.1111/j.1364-3703.2011.00746.x; GERBER PR, 1995, J COMPUT AID MOL DES, V9, P251, DOI 10.1007/BF00124456; Gisi U, 2002, PEST MANAG SCI, V58, P859, DOI 10.1002/ps.565; Goodwin SB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002070; Grasso V, 2006, PEST MANAG SCI, V62, P465, DOI 10.1002/ps.1236; Guo J, 2003, J BIOL CHEM, V278, P47629, DOI 10.1074/jbc.M306312200; Hagerhall C, 1997, BBA-BIOENERGETICS, V1320, P107, DOI 10.1016/S0005-2728(97)00019-4; Hellens R, 2000, TRENDS PLANT SCI, V5, P446, DOI 10.1016/S1360-1385(00)01740-4; Heller J, 2011, ANNU REV PHYTOPATHOL, V49, P369, DOI 10.1146/annurev-phyto-072910-095355; HENDERSON PJ, 1972, BIOCHEM J, V127, P321, DOI 10.1042/bj1270321; Hobbelen PHF, 2011, PLANT PATHOL, V60, P304, DOI 10.1111/j.1365-3059.2010.02380.x; Honda Y, 2000, CURR GENET, V37, P209, DOI 10.1007/s002940050521; HOOD EE, 1993, TRANSGENIC RES, V2, P208, DOI 10.1007/BF01977351; Horsefield R, 2006, J BIOL CHEM, V281, P7309, DOI 10.1074/jbc.M508173200; Huang JZ, 2009, J MOL BIOL, V387, P559, DOI 10.1016/j.jmb.2009.02.028; Huang LS, 2006, J BIOL CHEM, V281, P5965, DOI 10.1074/jbc.M511270200; Ishii H, 2011, PEST MANAG SCI, V67, P474, DOI 10.1002/ps.2092; Ishii N, 1998, NATURE, V394, P694, DOI 10.1038/29331; Ishii T, 2005, CANCER RES, V65, P203; Ito Y, 2004, MOL GENET GENOMICS, V272, P328, DOI 10.1007/s00438-004-1060-2; Jacobson MP, 2004, PROTEINS, V55, P351, DOI 10.1002/prot.10613; Jacobson MP, 2002, J MOL BIOL, V320, P597, DOI 10.1016/S0022-2836(02)00470-9; KEARNEY EB, 1960, J BIOL CHEM, V235, P865; Keon J, 2005, FUNGAL GENET BIOL, V42, P376, DOI 10.1016/j.fgb.2004.12.005; Keon J, 2007, MOL PLANT MICROBE IN, V20, P178, DOI 10.1094/MPMI-20-2-0178; KEON JPR, 1991, CURR GENET, V19, P475, DOI 10.1007/BF00312739; Kilaru S, 2009, CURR GENET, V55, P543, DOI 10.1007/s00294-009-0266-6; KISTLER WA, 1971, J BACTERIOL, V108, P1224, DOI 10.1128/JB.108.3.1224-1234.1971; Leroux P, 2007, PEST MANAG SCI, V63, P688, DOI 10.1002/ps.1390; Leroux P, 2010, APPL ENVIRON MICROB, V76, P6615, DOI 10.1128/AEM.00931-10; Li X, 2004, PROTEINS, V55, P368, DOI 10.1002/prot.20014; Maklashina E, 2001, J BIOL CHEM, V276, P18968, DOI 10.1074/jbc.M011270200; Mehrabi R, 2006, MOL PLANT MICROBE IN, V19, P1262, DOI 10.1094/MPMI-19-1262; Newcombe G, 2000, PHYTOPATHOLOGY, V90, P179, DOI 10.1094/PHYTO.2000.90.2.179; Oyedotun KS, 2004, J BIOL CHEM, V279, P9432, DOI 10.1074/jbc.M311877200; Oyedotun KS, 1999, J BIOL CHEM, V274, P23956, DOI 10.1074/jbc.274.34.23956; Oyedotun KS, 1997, J BIOL CHEM, V272, P31382, DOI 10.1074/jbc.272.50.31382; Parnell S, 2008, PLANT PATHOL, V57, P509, DOI 10.1111/j.1365-3059.2007.01786.x; PAZOUR GJ, 1992, J BACTERIOL, V174, P4169, DOI 10.1128/jb.174.12.4169-4174.1992; Pollastri G, 2002, PROTEINS, V47, P228, DOI 10.1002/prot.10082; POLLEY RW, 1991, ANN APPL BIOL, V119, P1, DOI 10.1111/j.1744-7348.1991.tb04839.x; Ruprecht J, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.209874; Ruprecht J, 2009, J BIOL CHEM, V284, P29836, DOI 10.1074/jbc.M109.010058; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Scalliet G., 2011, Modern fungicides and antifungal compounds VI. 16th International Reinhardsbrunn Symposium, Friedrichroda, Germany, April 25-29, 2010, P171; SCHEERENGROOT EP, 1994, J BACTERIOL, V176, P6418, DOI 10.1128/JB.176.21.6418-6426.1994; Shima Y, 2009, FUNGAL GENET BIOL, V46, P67, DOI 10.1016/j.fgb.2008.10.005; Sierotzki H., 2011, Modern fungicides and antifungal compounds VI. 16th International Reinhardsbrunn Symposium, Friedrichroda, Germany, April 25-29, 2010, P179; Singer TP, 1971, METHODS ENZYMOL    B, V18, P416; Singer TP, 1980, METHOD ENZYMOL, V66, P354; Sitkin Y, 2007, BBA-BIOENERGETICS, V1767, P143, DOI 10.1016/j.bbabio.2006.11.017; Skinner T, 1998, CURR GENET, V34, P393, DOI 10.1007/s002940050412; SNEL M, 1970, PHYTOPATHOLOGY, V60, P1164, DOI [10.1094/Phyto-60-1164, 10.1094/Phyto-60-1708]; Stammler G., 2008, ABSTRACTS 18 S RES C, P30; Stergiopoulos I, 2003, MOL PLANT MICROBE IN, V16, P689, DOI 10.1094/MPMI.2003.16.8.689; Sun F, 2005, CELL, V121, P1043, DOI 10.1016/j.cell.2005.05.025; Szeto SSW, 2007, J BIOL CHEM, V282, P27518, DOI 10.1074/jbc.M700601200; Szeto SSW, 2010, J PROTEOME RES, V9, P6729, DOI 10.1021/pr100880y; Tran QM, 2006, J BIOL CHEM, V281, P32310, DOI 10.1074/jbc.M607476200; Vibat CRT, 1998, BIOCHEMISTRY-US, V37, P4148, DOI 10.1021/bi9716635; VONSCHME.B, 1966, SCIENCE, V152, P659, DOI 10.1126/science.152.3722.659; Walker DW, 2006, P NATL ACAD SCI USA, V103, P16382, DOI 10.1073/pnas.0607918103; WHITE GA, 1978, PESTIC BIOCHEM PHYS, V9, P165, DOI 10.1016/0048-3575(78)90077-9; Yankovskaya V, 2003, SCIENCE, V299, P700, DOI 10.1126/science.1079605; Yin YN, 2011, PHYTOPATHOLOGY, V101, P986, DOI 10.1094/PHYTO-01-11-0016	78	129	131	7	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e35429	10.1371/journal.pone.0035429	http://dx.doi.org/10.1371/journal.pone.0035429			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22536383	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336200040
J	Bermudez, V; Pacheco, M; Rojas, J; Cordova, E; Velazquez, R; Carrillo, D; Parra, MG; Toledo, A; Anez, R; Fonseca, E; Marcano, RP; Cano, C; Miranda, JL				Bermudez, Valmore; Pacheco, Maikol; Rojas, Joselyn; Cordova, Evelyn; Velazquez, Rossibel; Carrillo, Daniela; Parra, Maria G.; Toledo, Alexandra; Anez, Roberto; Fonseca, Eneida; Paris Marcano, Rafael; Cano, Climaco; Lopez Miranda, Jose			Epidemiologic Behavior of Obesity in the Maracaibo City Metabolic Syndrome Prevalence Study	PLOS ONE			English	Article							WAIST CIRCUMFERENCE CUTOFFS; INSULIN-RESISTANCE; BODY-COMPOSITION; LATIN-AMERICA; WEIGHT-GAIN; CARDIOVASCULAR-DISEASE; NATIONAL-HEALTH; US ADULTS; OVERWEIGHT; POVERTY	Introduction: Obesity is a worldwide public health issue. Since the epidemiological behaviour of this disease is not well established in our country, the purpose of this study was to determinate its prevalence in the Maracaibo City, Zulia State-Venezuela. Materials and Methods: A cross-sectional study was undertaken using the data set from the Maracaibo City Metabolic Syndrome Prevalence Study. The sample consists of 2108 individuals from both genders and randomly selected: 1119 (53.09%) women and 989 (46.91%) men. The participants were interrogated for a complete clinical history and anthropometric measurements. To classify obesity, the WHO criteria for Body Mass Index (BMI), and Waist Circumference (WC) from the IDF/NHLBI/AHA/WHF/IAS/IASO-2009 (IDF-2009) and ATPIII statements were applied. Results: For BMI, obesity had an overall prevalence of 33.3% (n = 701), and according to gender women had 32.4% (n = 363) and men had 34.2% (n = 338). Overweight had a prevalence of 34.8% (n = 733), Normal weight had 29.8% (n = 629), and Underweight had 2.1% (n = 45). Adding Obesity and Overweight results, the prevalence of elevated BMI (>25 Kg/m(2)) was 68.1%. Using the IDF-2009 WC's cut-off, Obesity had 74.2% prevalence, compared to 51.7% using the ATPIII parameters. Conclusions: These results show a high prevalence of abdominal obesity in our locality defined by the WHO, IDF-2009 and ATPIII criteria, which were not designed for Latin-American populations. We suggest further investigation to estimate the proper values according to ethnicity, genetic background and sociocultural aspects.	[Bermudez, Valmore; Pacheco, Maikol; Rojas, Joselyn; Velazquez, Rossibel; Carrillo, Daniela; Parra, Maria G.; Toledo, Alexandra; Anez, Roberto; Fonseca, Eneida; Paris Marcano, Rafael; Cano, Climaco] Univ Zulia, Fac Med, Endocrine & Metab Dis Res Ctr, Maracaibo 4011, Venezuela; [Cordova, Evelyn] Univ Zulia, Sch Econ, Quantitat Methods Dept, Maracaibo 4011, Venezuela; [Lopez Miranda, Jose] Univ Cordoba, Dept Med, Reina Sofia Univ Hosp, Lipid & Atherosclerosis Unit,IMIBIC, Cordoba, Spain; [Lopez Miranda, Jose] Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr CIBEROBN, Cordoba, Spain	Universidad de Cordoba; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III	Bermudez, V (corresponding author), Univ Zulia, Fac Med, Endocrine & Metab Dis Res Ctr, Maracaibo 4011, Venezuela.	valmore@gmail.com	Bermudez, Valmore/E-3517-2018; Bermudez, Valmore/K-4721-2019; Anez, Roberto/E-1049-2018	Bermudez, Valmore/0000-0003-1880-8887; Bermudez, Valmore/0000-0003-1880-8887; Rojas-Quintero, Joselyn Joanna/0000-0003-4994-075X; Anez, Roberto/0000-0001-6363-2767	Endocrine and Metabolic Diseases Research Center, The University of Zulia, Medicine Faculty, Maracaibo, Venezuela	Endocrine and Metabolic Diseases Research Center, The University of Zulia, Medicine Faculty, Maracaibo, Venezuela	The funds for the research were provided by the Endocrine and Metabolic Diseases Research Center, The University of Zulia, Medicine Faculty, Maracaibo, Venezuela. The money comes from the Clinical Practice and Clinical Laboratory income. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ades PA, 2001, NEW ENGL J MED, V345, P892, DOI 10.1056/NEJMra001529; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Banerji MA, 1999, J CLIN ENDOCR METAB, V84, P137, DOI 10.1210/jc.84.1.137; BAUMGARTNER RN, 1995, J GERONTOL A-BIOL, V50, pM307, DOI 10.1093/gerona/50A.6.M307; Bemstein A, 2008, REV PANAM SALUD PUBL, V24, P71; Bermudez Odilia I., 2003, Cad. Saúde Pública, V19, pS87, DOI 10.1590/S0102-311X2003000700010; Bermudez V, 2010, AM J THER, V17, P288, DOI 10.1097/MJT.0b013e3181c121bc; Burkhauser RV, 2008, J HEALTH ECON, V27, P519, DOI 10.1016/j.jhealeco.2007.05.005; Campos Gilberto, 2003, Invest. clín, V44, P5; Centers for Disease Control Fact Sheet, 2003, CTR DIS CONTR FACT S; Diaz J, 2005, HABITOS ALIMENTARIOS; Drewnowski A, 2004, AM J CLIN NUTR, V79, P6; Espinoza M, 2009, REV MED CHILE, V137, P1179, DOI /S0034-98872009000900006; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Gigante DP, 2009, REV SAUDE PUBL, V43, P83, DOI 10.1590/S0034-89102009000900011; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Health Statistics, 1996, NHANES 3 REF MAN REP; IBÁÑEZ A LUIS, 2007, Rev Chil Cir, V59, P399, DOI 10.4067/S0718-40262007000600001; Instituto Brasileiro de Geografia e Estatistica, 2004, PESQ ORC FAM 2002 20; Kain Juliana, 2003, Cad. Saúde Pública, V19, pS77, DOI 10.1590/S0102-311X2003000700009; KUCZMARSKI RJ, 1994, JAMA-J AM MED ASSOC, V272, P205, DOI 10.1001/jama.272.3.205; MALINA RM, 1995, INT J OBESITY, V19, P793; McLaren L, 2007, EPIDEMIOL REV, V29, P29, DOI 10.1093/epirev/mxm001; Mendez-Castellano H., 1986, VENEZUELAN ARCH CHIL, V49, P93; Misra A, 2005, NUTRITION, V21, P969, DOI 10.1016/j.nut.2005.01.007; Neufeld LM, 2008, OBESITY, V16, P714, DOI 10.1038/oby.2007.119; Novotny R, 2007, OBESITY, V15, P1565, DOI 10.1038/oby.2007.185; Núñez Roberto, 2006, AVFT, V25, P64; Okosun IS, 2000, J CLIN EPIDEMIOL, V53, P401, DOI 10.1016/S0895-4356(99)00217-6; Okosun IS, 2000, ANN EPIDEMIOL, V10, P263, DOI 10.1016/S1047-2797(00)00045-4; Omran AR, 1996, EPIDEMIOLOGIC TRANSI; Pena M, 2000, PAHO, Vxi, P3; Perez B, EFECTOS URBANIZACION; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; Raji A, 2001, J CLIN ENDOCR METAB, V86, P5366, DOI 10.1210/jc.86.11.5366; Raymond SU, 2006, CURR OPIN CLIN NUTR, V9, P111, DOI 10.1097/01.mco.0000214568.52192.91; Rojas R, 2010, SALUD PUBLICA MEXICO, V52, pS11, DOI 10.1590/s0036-36342010000700004; Rosenberg L, 2003, OBES RES, V11, P1526, DOI 10.1038/oby.2003.204; Rosengren A, 1999, EUR HEART J, V20, P269, DOI 10.1053/euhj.1998.1235; Roubenoff R, 2000, J GERONTOL A-BIOL, V55, pM716, DOI 10.1093/gerona/55.12.M716; Ruiz-Fernández Nelina, 2009, Rev. salud pública, V11, P383, DOI 10.1590/S0124-00642009000300007; Ryder Elena, 2007, Invest. clín, V48, P45; Salzano FM, 2004, REV BIOL TROP, V52, P405; Sans M, 2000, HUM BIOL, V72, P155; Seidell JC, 1997, BRIT MED BULL, V53, P238, DOI 10.1093/oxfordjournals.bmb.a011611; Tanumihardjo SA, 2007, J AM DIET ASSOC, V107, P1966, DOI 10.1016/j.jada.2007.08.007; Uauy R, 2001, J NUTR, V131, p893S, DOI 10.1093/jn/131.3.893S; Velasco-Martinez RM, 2009, NUTR HOSP, V24, P187; Villareal DT, 2004, OBES RES, V12, P913, DOI 10.1038/oby.2004.111; Wannamethee SG, 2003, AM J CLIN NUTR, V77, P1312, DOI 10.1093/ajcn/77.5.1312; *WHO, WORLD HLTH REP 2003; Wildman RP, 2004, AM J CLIN NUTR, V80, P1129, DOI 10.1093/ajcn/80.5.1129; WILLIAMSON DF, 1991, NEW ENGL J MED, V324, P739, DOI 10.1056/NEJM199103143241106; Zhu SK, 2005, AM J CLIN NUTR, V81, P409	54	19	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35392	10.1371/journal.pone.0035392	http://dx.doi.org/10.1371/journal.pone.0035392			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959XD	22530014	gold, Green Published			2022-12-27	WOS:000305350600079
J	Lee, YK; Lee, KH; Kim, SG; Melhem, R; Moon, CS; Liu, SC; Greenhalgh, DG; Cho, KH				Lee, Young-Kwan; Lee, Kang-Hoon; Kim, Seon-Gyu; Melhem, Ramzi; Moon, Chang-Suk; Liu, Sicong; Greenhalgh, David G.; Cho, Kiho			Unique Profile of Ordered Arrangements of Repetitive Elements in the C57BL/6J Mouse Genome Implicating Their Functional Roles	PLOS ONE			English	Article							DNA REPEATS; PROTEIN; SEQUENCES; GENES; ONCOGENE; FAMILY	The entirety of all protein coding sequences is reported to represent a small fraction (similar to 2%) of the mouse and human genomes; the vast majority of the rest of the genome is presumed to be repetitive elements (REs). In this study, the C57BL/6J mouse reference genome was subjected to an unbiased RE mining to establish a whole-genome profile of RE occurrence and arrangement. The C57BL/6J mouse genome was fragmented into an initial set of 5,321 units of 0.5 Mb, and surveyed for REs using unbiased self-alignment and dot-matrix protocols. The survey revealed that individual chromosomes had unique profiles of RE arrangement structures, named RE arrays. The RE populations in certain genomic regions were arranged into various forms of complexly organized structures using combinations of direct and/or inverse repeats. Some of these RE arrays spanned stretches of over 2 Mb, which may contribute to the structural configuration of the respective genomic regions. There were substantial differences in RE density among the 21 chromosomes, with chromosome Y being the most densely populated. In addition, the RE array population in the mouse chromosomes X and Y was substantially different from those of the reference human chromosomes. Conversion of the dot-matrix data pertaining to a tandem 13-repeat structure within the Ch7.032 genome unit into a line map of known REs revealed a repeat unit of similar to 11.3 Kb as a mosaic of six different RE types. The data obtained from this study allowed for a comprehensive RE profiling, including the establishment of a library of RE arrays, of the reference mouse genome. Some of these RE arrays may participate in a spectrum of normal and disease biology that are specific for mice.	[Lee, Young-Kwan; Lee, Kang-Hoon; Kim, Seon-Gyu; Melhem, Ramzi; Moon, Chang-Suk; Liu, Sicong; Greenhalgh, David G.; Cho, Kiho] Univ Calif Davis, Shriners Hosp Children No Calif, Dept Surg, Sacramento, CA 95817 USA	University of California System; University of California Davis	Lee, YK (corresponding author), Univ Calif Davis, Shriners Hosp Children No Calif, Dept Surg, Sacramento, CA 95817 USA.	kcho@ucdavis.edu			Shriners of North America [86800, 84308, 84302]; National Institutes of Health [R01 GM071360]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071360] Funding Source: NIH RePORTER	Shriners of North America; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported, in part, by grants from Shriners of North America (No. 86800 to KC, No. 84308 to Dr. Y. Lee [postdoctoral fellowship], and No. 84302 to Dr. K. Lee [postdoctoral fellowship]) and the National Institutes of Health (R01 GM071360 to Dr. Cho). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batzoglou S, 2000, GENOME RES, V10, P950, DOI 10.1101/gr.10.7.950; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Bernal A, 2001, NUCLEIC ACIDS RES, V29, P126, DOI 10.1093/nar/29.1.126; Church DM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000112; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Collins FS, 2003, NATURE, V422, P835, DOI 10.1038/nature01626; DUNNICK W, 1983, P NATL ACAD SCI-BIOL, V80, P7269, DOI 10.1073/pnas.80.23.7269; FEHON RG, 1990, CELL, V61, P523, DOI 10.1016/0092-8674(90)90534-L; Fondon JW, 2004, P NATL ACAD SCI USA, V101, P18058, DOI 10.1073/pnas.0408118101; GERONDAKIS S, 1984, CELL, V36, P973, DOI 10.1016/0092-8674(84)90047-3; Greenbaum D, 2001, GENOME RES, V11, P1463, DOI 10.1101/gr.207401; Janeway CA, 2001, IMMUNOBIOLOGY; Jin P, 2000, HUM MOL GENET, V9, P901, DOI 10.1093/hmg/9.6.901; Kim HM, 2010, FEBS LETT, V584, P605, DOI 10.1016/j.febslet.2009.12.005; KOOP BF, 1994, NAT GENET, V7, P48, DOI 10.1038/ng0594-48; Lage K, 2007, NAT BIOTECHNOL, V25, P309, DOI 10.1038/nbt1295; LAMERDIN JE, 1995, GENOMICS, V25, P547, DOI 10.1016/0888-7543(95)80056-R; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee HS, 2010, FASEB J, V24, P2314, DOI 10.1096/fj.09-147314; Lee KH, 2011, EXP MOL PATHOL, V90, P300, DOI 10.1016/j.yexmp.2011.02.007; Makalowski W, 1996, GENOME RES, V6, P846, DOI 10.1101/gr.6.9.846; Makalowski W, 1998, P NATL ACAD SCI USA, V95, P9407, DOI 10.1073/pnas.95.16.9407; Mirkin SM, 2007, NATURE, V447, P932, DOI 10.1038/nature05977; Nadeau JH, 2001, SCIENCE, V291, P1251, DOI 10.1126/science.1058244; Pennisi E, 2007, SCIENCE, V316, P1556, DOI 10.1126/science.316.5831.1556; Pruitt KD, 2009, NUCLEIC ACIDS RES, V37, pD32, DOI 10.1093/nar/gkn721; Rajkovic A, 2002, GENOMICS, V79, P711, DOI 10.1006/geno.2002.6759; Richard GF, 2008, MICROBIOL MOL BIOL R, V72, P686, DOI 10.1128/MMBR.00011-08; Smit AFA, GREEN P REPEATMASKER; Tatusova TA, 1999, FEMS MICROBIOL LETT, V174, P247, DOI 10.1016/S0378-1097(99)00149-4; Thomas M, 1999, MOL CELL BIOL, V19, P1092; Wang YH, 1996, J MOL BIOL, V263, P511, DOI 10.1006/jmbi.1996.0593; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262	33	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35156	10.1371/journal.pone.0035156	http://dx.doi.org/10.1371/journal.pone.0035156			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529984	Green Submitted, gold, Green Published			2022-12-27	WOS:000305350600062
J	Wallhausser-Franke, E; Brade, J; Balkenhol, T; D'Amelio, R; Seegmuller, A; Delb, W				Wallhaeusser-Franke, Elisabeth; Brade, Joachim; Balkenhol, Tobias; D'Amelio, Roberto; Seegmueller, Andrea; Delb, Wolfgang			Tinnitus: Distinguishing between Subjectively Perceived Loudness and Tinnitus-Related Distress	PLOS ONE			English	Article							RETRAINING THERAPY; HEARING-LOSS; SEVERITY; DEPRESSION	Objectives: Overall success of current tinnitus therapies is low, which may be due to the heterogeneity of tinnitus patients. Therefore, subclassification of tinnitus patients is expected to improve therapeutic allocation, which, in turn, is hoped to improve therapeutic success for the individual patient. The present study aims to define factors that differentially influence subjectively perceived tinnitus loudness and tinnitus-related distress. Methods: In a questionnaire-based cross-sectional survey, the data of 4705 individuals with tinnitus were analyzed. The self-report questionnaire contained items about subjective tinnitus loudness, type of onset, awareness and localization of the tinnitus, hearing impairment, chronic comorbidities, sleep quality, and psychometrically validated questionnaires addressing tinnitus-related distress, depressivity, anxiety, and somatic symptom severity. In a binary step-wise logistic regression model, we tested the predictive power of these variables on subjective tinnitus loudness and tinnitus-related distress. Results: The present data contribute to the distinction between subjective tinnitus loudness and tinnitus-related distress. Whereas subjective loudness was associated with permanent awareness and binaural localization of the tinnitus, tinnitus-related distress was associated with depressivity, anxiety, and somatic symptom severity. Conclusions: Subjective tinnitus loudness and the potential presence of severe depressivity, anxiety, and somatic symptom severity should be assessed separately from tinnitus-related distress. If loud tinnitus is the major complaint together with mild or moderate tinnitus-related distress, therapies should focus on auditory perception. If levels of depressivity, anxiety or somatic symptom severity are severe, therapies and further diagnosis should focus on these symptoms at first.	[Wallhaeusser-Franke, Elisabeth; Balkenhol, Tobias; D'Amelio, Roberto; Seegmueller, Andrea; Delb, Wolfgang] Heidelberg Univ, Med Fac Mannheim, Dept Phoniatr & Audiol, D-6800 Mannheim, Germany; [Brade, Joachim] Heidelberg Univ, Med Fac Mannheim, Dept Med Stat & Biomathemat, D-6800 Mannheim, Germany; [D'Amelio, Roberto] Univ Saarland, Univ Clin, Dept Internal Med 4, D-6650 Homburg, Germany; [D'Amelio, Roberto] Univ Saarland, Univ Clin, Neuroctr, D-6650 Homburg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Saarland University; Universitatsklinikum des Saarlandes; Saarland University; Universitatsklinikum des Saarlandes	Wallhausser-Franke, E (corresponding author), Heidelberg Univ, Med Fac Mannheim, Dept Phoniatr & Audiol, D-6800 Mannheim, Germany.	elisabeth.wallhaeusser@medma.uni-heidelberg.de			auric Horsysteme; Schaaf und Maier Horgerate	auric Horsysteme; Schaaf und Maier Horgerate	This work was partly supported by auric Horsysteme and Schaaf und Maier Horgerate. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AXELSSON A, 1989, British Journal of Audiology, V23, P53, DOI 10.3109/03005368909077819; D'Amelio R, 2004, HNO, V52, P599, DOI 10.1007/s00106-003-0944-5; DAUMAN R, 1992, TINNITUS 91, P225; Del Bo L, 2007, PROG BRAIN RES, V166, P341, DOI 10.1016/S0079-6123(07)66032-4; Delb W, 2002, HNO, V50, P997, DOI 10.1007/s00106-002-0645-5; Delb W, 1999, P 6 INT TINN SEM, P446; Dobie RA, 2003, OTOLARYNG CLIN N AM, V36, P383, DOI 10.1016/S0030-6665(02)00168-8; Frank E, 2012, J NEUROL, V259, P327, DOI 10.1007/s00415-011-6189-4; HALLAM RS, 1988, BRIT J CLIN PSYCHOL, V27, P213, DOI 10.1111/j.2044-8260.1988.tb00778.x; Henry J A, 2000, J Am Acad Audiol, V11, P138; Henry James A, 2008, Trends Amplif, V12, P188, DOI 10.1177/1084713808321184; Hiller W, 1997, J PSYCHOSOM RES, V43, P613, DOI 10.1016/S0022-3999(97)00188-8; Hiller W, 2005, BEHAV RES THER, V43, P595, DOI 10.1016/j.brat.2004.03.012; Hiller W, 2007, AUDIOL NEURO-OTOL, V12, P391, DOI 10.1159/000106482; Hiller W, 2006, ARCH OTOLARYNGOL, V132, P1323, DOI 10.1001/archotol.132.12.1323; Holgers KM, 2005, INT J AUDIOL, V44, P584, DOI 10.1080/14992020500190235; Jastreboff PJ, 2006, ORL-J OTO-RHIN-LARYN, V68, P23, DOI 10.1159/000090487; Jastreboff PJ, 1996, AM J OTOL, V17, P236; Kroenke K, 2002, PSYCHOSOM MED, V64, P258, DOI 10.1097/00006842-200203000-00008; Kroenke K, 2010, GEN HOSP PSYCHIAT, V32, P345, DOI 10.1016/j.genhosppsych.2010.03.006; Krog NH, 2010, J PSYCHOSOM RES, V69, P289, DOI 10.1016/j.jpsychores.2010.03.008; Langenbach M, 2005, GEN HOSP PSYCHIAT, V27, P73, DOI 10.1016/j.genhosppsych.2004.08.008; Langguth B, 2011, WORLD J BIOL PSYCHIA, P1; Lowe B, 2008, GEN HOSP PSYCHIAT, V30, P191, DOI 10.1016/j.genhosppsych.2008.01.001; Martinez Devesa P, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005233.pub2; Mazurek B, 2010, INT J ENV RES PUB HE, V7, P3071, DOI 10.3390/ijerph7083071; McKenna L, 1998, TINNITUS TREATMENT R, P140; Meikle Mary B, 2008, Trends Amplif, V12, P223, DOI 10.1177/1084713808319943; Newman C W, 1997, J Am Acad Audiol, V8, P143; Nondahl DM, 2011, INT J AUDIOL, V50, P313, DOI 10.3109/14992027.2010.551220; Olze H, 2012, AUDIOL NEURO-OTOL, V17, P2, DOI 10.1159/000323847; Ooms E, 2011, OTOLARYNG HEAD NECK, V145, P276, DOI 10.1177/0194599811403381; Savastano M, 2008, EUR ARCH OTO-RHINO-L, V265, P1295, DOI 10.1007/s00405-008-0630-z; Schlee W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027379; Shargorodsky J, 2010, AM J MED, V123, P711, DOI 10.1016/j.amjmed.2010.02.015; Sindhusake D, 2003, EAR HEARING, V24, P501, DOI 10.1097/01.AUD.0000100204.08771.3D; STOUFFER JL, 1990, J SPEECH HEAR DISORD, V55, P439, DOI 10.1044/jshd.5503.439; Stouffer JL, 1990, HEAR INSTR, V41, P17; VONWEDEL H, 1989, LARYNGO RHINO OTOL, V68, P259, DOI 10.1055/s-2007-998330; Wiltink J, 2011, J AFFECT DISORDERS, V130, P429, DOI 10.1016/j.jad.2010.10.041; Zoger S, 2006, PSYCHOSOMATICS, V47, P282, DOI 10.1176/appi.psy.47.4.282	41	51	53	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e34583	10.1371/journal.pone.0034583	http://dx.doi.org/10.1371/journal.pone.0034583			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959XD	22529921	Green Submitted, Green Published, gold			2022-12-27	WOS:000305350600018
J	Walther, B; Hermes, J; Cuny, C; Wieler, LH; Vincze, S; Elnaga, Y; Stamm, I; Kopp, PA; Kohn, B; Witte, W; Jansen, A; Conraths, FJ; Semmler, T; Eckmanns, T; Lubke-Becker, A				Walther, Birgit; Hermes, Julia; Cuny, Christiane; Wieler, Lothar H.; Vincze, Szilvia; Abou Elnaga, Yassmin; Stamm, Ivonne; Kopp, Peter A.; Kohn, Barbara; Witte, Wolfgang; Jansen, Andreas; Conraths, Franz J.; Semmler, Torsten; Eckmanns, Tim; Luebke-Becker, Antina			Sharing More than Friendship - Nasal Colonization with Coagulase-Positive Staphylococci (CPS) and Co-Habitation Aspects of Dogs and Their Owners	PLOS ONE			English	Article							METHICILLIN-RESISTANT; MULTIDRUG-RESISTANT; COMPANION ANIMALS; AUREUS MRSA; PET DOG; PSEUDINTERMEDIUS; INTERMEDIUS; PREVALENCE; EMERGENCE; CARRIAGE	Background: Since the relationship between dogs and their owners has changed, and dogs moved from being working dogs to family members in post-industrial countries, we hypothesized that zoonotic transmission of opportunistic pathogens like coagulase positive staphylococci (CPS) is likely between dogs and their owners. Methodology/Principal Findings: CPS- nasal carriage, different aspects of human-to-dog relationship as well as potential interspecies transmission risk factors were investigated by offering nasal swabs and a questionnaire to dog owners (108) and their dogs (108) at a dog show in 2009. S. aureus was found in swabs of 20 (18.5%) humans and two dogs (1.8%), and spa types which correspond to well known human S. aureus lineages dominated (e.g. CC45, CC30 and CC22). Multilocus sequence typing (MLST) of the two canine strains revealed ST72 and ST2065 (single locus variant of ST34). Fifteen dogs (13.9%) and six owners (5.6%) harboured S. pseudintermedius, including one mecA-positive human isolate (MRSP). Pulsed field gel electrophoresis (PFGE) revealed that one dog/owner pair harboured indistinguishable S. pseudintermedius- isolates of ST33. Ten (48%) of the 21 S. pseudintermedius-isolates showed resistance towards more than one antimicrobial class. 88.9% of the dog owners reported to allow at least one dog into the house, 68.5% allow the dog(s) to rest on the sofa, 39.8% allow their dogs to come onto the bed, 93.5% let them lick their hands and 52.8% let them lick their face. Bivariate analysis of putative risk factors revealed that dog owners who keep more than two dogs have a significantly higher chance of being colonized with S. pseudintermedius than those who keep 1-2 dogs (p < 0.05). Conclusions/Recommendations: In conclusion, CPS transmission between dog owners and their dogs is possible. Further investigation regarding interspecies transmission and the diverse adaptive pathways influencing the epidemiology of CPS (including MRSA and MRSP) in different hosts is needed.	[Walther, Birgit; Wieler, Lothar H.; Vincze, Szilvia; Abou Elnaga, Yassmin; Semmler, Torsten; Luebke-Becker, Antina] Free Univ Berlin, Fac Vet, Inst Microbiol & Epizoot, Berlin, Germany; [Hermes, Julia; Jansen, Andreas; Eckmanns, Tim] Robert Koch Inst, Dept Infect Dis Epidemiol, Berlin, Germany; [Cuny, Christiane; Witte, Wolfgang] Robert Koch Inst, Natl Reference Ctr Staphylococci, Wernigerode Branch, Wernigerode, Germany; [Stamm, Ivonne; Kopp, Peter A.] Vet Med Lab GmbH, Div IDEXX Labs, Ludwigsburg, Germany; [Kohn, Barbara] Free Univ Berlin, Fac Vet, Clin Small Anim, Berlin, Germany; [Conraths, Franz J.] Fed Res Inst Anim Hlth, Friedrich Loeffler Inst, Inst Epidemiol, Wusterhausen, Germany	Free University of Berlin; Robert Koch Institute; Robert Koch Institute; Free University of Berlin; Friedrich Loeffler Institute	Walther, B (corresponding author), Free Univ Berlin, Fac Vet, Inst Microbiol & Epizoot, Berlin, Germany.	walther.birgit@vetmed.fu-berlin.de	Semmler, Torsten/Q-7716-2018; Semmler, Torsten/O-9540-2019	Semmler, Torsten/0000-0002-2225-7267; Semmler, Torsten/0000-0002-2225-7267; Wieler, Lothar H./0000-0003-4365-3717; Conraths, Franz/0000-0002-7400-9409; Walther, Birgit/0000-0003-3112-5722	BMBF-founded interdisciplinary expert network project on zoonotic Staphylococcus aureus [MedVet- Staph: IP8, 01KI1014F]; Federal Ministry of Education and Research [01KI1014F, 01KI1012A]	BMBF-founded interdisciplinary expert network project on zoonotic Staphylococcus aureus; Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	S. Vincze is financed by the BMBF-founded interdisciplinary expert network project on zoonotic Staphylococcus aureus (MedVet- Staph: IP8, 01KI1014F:). S. Vincze and Torsten Semmler were supported by the Federal Ministry of Education and Research (MedVet- Staph, Grant no. 01KI1014F) and (FBI-Zoo, Grant no. 01KI1012A). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bannoehr J, 2007, J BACTERIOL, V189, P8685, DOI 10.1128/JB.01150-07; Bannoehr J, 2009, J CLIN MICROBIOL, V47, P469, DOI 10.1128/JCM.01915-08; Becker K., 2011, MANUAL CLIN MICROBIO; Black CC, 2009, VET MICROBIOL, V139, P333, DOI 10.1016/j.vetmic.2009.06.029; Blouin DD, 2008, THESIS INDIANA U US; Chuang CY, 2010, J CLIN MICROBIOL, V48, P1497, DOI 10.1128/JCM.02033-09; Cohn LA, 2010, J VET EMERG CRIT CAR, V20, P31, DOI 10.1111/j.1476-4431.2009.00497.x; Cuny C, 2010, INT J MED MICROBIOL, V300, P109, DOI 10.1016/j.ijmm.2009.11.002; de Sousa MA, 2003, J CLIN MICROBIOL, V41, P159, DOI [10.1128/JCM.41.1.159-163.2002, 10.1128/JCM.41.1.159-163.2003]; Engemann JJ, 2003, CLIN INFECT DIS, V36, P592, DOI 10.1086/367653; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Epley N, 2008, SOC COGNITION, V26, P143, DOI 10.1521/soco.2008.26.2.143; Fazakerley J, 2009, VET DERMATOL, V20, P179, DOI 10.1111/j.1365-3164.2009.00745.x; Frank LA, 2009, VET DERMATOL, V20, P496, DOI 10.1111/j.1365-3164.2009.00826.x; Franklin A., 1999, ANIMALS MODERN CULTU, DOI DOI 10.4135/9781446217764.N2; Futagawa-Saito K, 2004, J CLIN MICROBIOL, V42, P5324, DOI 10.1128/JCM.42.11.5324-5326.2004; Futagawa-Saito K, 2009, FEMS MICROBIOL LETT, V301, P176, DOI 10.1111/j.1574-6968.2009.01823.x; Hanselman BA, 2009, CAN VET J, V50, P954; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Ishihara K, 2010, APPL ENVIRON MICROB, V76, P5165, DOI 10.1128/AEM.02780-09; Iyori K, 2010, FEMS MICROBIOL LETT, V312, P169, DOI 10.1111/j.1574-6968.2010.02113.x; Kempker R, 2009, AM J MED SCI, V338, P425, DOI 10.1097/MAJ.0b013e3181b0baa9; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Loeffler A, 2010, J HOSP INFECT; Lozano C, 2011, INT J MED MICROBIOL, V301, P500, DOI 10.1016/j.ijmm.2011.02.004; Mahoudeau I, 1997, J CLIN MICROBIOL, V35, P2153, DOI 10.1128/JCM.35.8.2153-2154.1997; Manian FA, 2003, CLIN INFECT DIS, V36, pE26, DOI 10.1086/344772; Merlino J, 2002, J ANTIMICROB CHEMOTH, V49, P793, DOI 10.1093/jac/dkf021; Nienhoff U, 2009, J ANTIMICROB CHEMOTH, V64, P660, DOI 10.1093/jac/dkp243; Paul NC, 2011, SMALL ANIMAL VET IND; Perreten V, 2010, J ANTIMICROB CHEMOTH, V65, P1145, DOI 10.1093/jac/dkq078; Rubin JE, 2010, VET MICROBIOL, V143, P440, DOI 10.1016/j.vetmic.2009.11.012; Ruscher C, 2010, VET MICROBIOL, V144, P340, DOI 10.1016/j.vetmic.2010.01.008; Ruscher C, 2009, VET MICROBIOL, V136, P197, DOI 10.1016/j.vetmic.2008.10.023; Soedarmanto I, 2011, RES VET SCI; van Duijkeren E, 2011, VET MICROBIOL; Van Hoovels L, 2006, J CLIN MICROBIOL, V44, P4609, DOI 10.1128/JCM.01308-06; Vincze S, 2010, BERL MUNCH TIERARZTL, V123, P353, DOI 10.2376/0005-9366-123-353; Walther B, 2009, BERL MUNCH TIERARZTL, V122, P178, DOI 10.2376/0005-9366-122-178; Walther B, 2009, J CLIN MICROBIOL, V47, P704, DOI 10.1128/JCM.01626-08; Weese JS, 2006, J VET INTERN MED, V20, P182, DOI 10.1892/0891-6640(2006)20[182:MSAIHA]2.0.CO;2; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4; Wieler LH, 2011, INT J MED MICROBIOL, V301, P635, DOI 10.1016/j.ijmm.2011.09.009	43	84	86	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35197	10.1371/journal.pone.0035197	http://dx.doi.org/10.1371/journal.pone.0035197			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529990	Green Published, Green Submitted, gold			2022-12-27	WOS:000305350600066
J	Zhang, LL; Hou, R; Su, HL; Hu, XL; Wang, S; Bao, ZM				Zhang, Lingling; Hou, Rui; Su, Hailin; Hu, Xiaoli; Wang, Shi; Bao, Zhenmin			Network Analysis of Oyster Transcriptome Revealed a Cascade of Cellular Responses during Recovery after Heat Shock	PLOS ONE			English	Article							CRASSOSTREA-GIGAS; PACIFIC OYSTER; INDUCED APOPTOSIS; MOLECULAR CHARACTERIZATION; INDUCED THERMOTOLERANCE; LIPID-COMPOSITION; LEAF SENESCENCE; GENE-EXPRESSION; STRESS-RESPONSE; THERMAL-STRESS	Oysters, as a major group of marine bivalves, can tolerate a wide range of natural and anthropogenic stressors including heat stress. Recent studies have shown that oysters pretreated with heat shock can result in induced heat tolerance. A systematic study of cellular recovery from heat shock may provide insights into the mechanism of acquired thermal tolerance. In this study, we performed the first network analysis of oyster transcriptome by reanalyzing microarray data from a previous study. Network analysis revealed a cascade of cellular responses during oyster recovery after heat shock and identified responsive gene modules and key genes. Our study demonstrates the power of network analysis in a non-model organism with poor gene annotations, which can lead to new discoveries that go beyond the focus on individual genes.	[Zhang, Lingling; Hou, Rui; Su, Hailin; Hu, Xiaoli; Wang, Shi; Bao, Zhenmin] Ocean Univ China, Coll Marine Life Sci, Key Lab Marine Genet & Breeding, Qingdao, Peoples R China	Ocean University of China	Zhang, LL (corresponding author), Ocean Univ China, Coll Marine Life Sci, Key Lab Marine Genet & Breeding, Qingdao, Peoples R China.	swang@ouc.edu.cn; zmbao@ouc.edu.cn	zhang, lingling/HDM-2189-2022; Su, Hailin/D-1352-2017	Su, Hailin/0000-0002-0284-2071	National Natural Science Foundation of China [31172384]; National High Technology Research and Development Program of China [2012AA10A401]; Public Science and Technology Research Funds Projects of Ocean [201205031]; Program for New Century Excellent Talents in University [NCET-10-0761]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Public Science and Technology Research Funds Projects of Ocean; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	Financial support for this work was provided by National Natural Science Foundation of China (31172384), National High Technology Research and Development Program of China (2012AA10A401), Public Science and Technology Research Funds Projects of Ocean (201205031), and Program for New Century Excellent Talents in University (NCET-10-0761). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beere HM, 2004, J CELL SCI, V117, P2641, DOI 10.1242/jcs.01284; Berndt C, 2008, BBA-MOL CELL RES, V1783, P641, DOI 10.1016/j.bbamcr.2008.02.003; Boss K.J., 1982, P945; Chatterjee MT, 2000, MICROBIOL-UK, V146, P877, DOI 10.1099/00221287-146-4-877; Chen GH, 2002, PLANT CELL PHYSIOL, V43, P984, DOI 10.1093/pcp/pcf125; Clegg JS, 1998, MOL MAR BIOL BIOTECH, V7, P21; Dong Z, 2002, BIOCHEM J, V364, P413, DOI 10.1042/BJ20011431; Farcy E, 2009, CELL STRESS CHAPERON, V14, P371, DOI 10.1007/s12192-008-0091-8; Fulda S, 2006, RECENT PAT ANTI-CANC, V1, P81, DOI 10.2174/157489206775246539; Guerzoni ME, 1997, CAN J MICROBIOL, V43, P569, DOI 10.1139/m97-080; Guerzoni ME, 2001, MICROBIOL-SGM, V147, P2255, DOI 10.1099/00221287-147-8-2255; Hamdoun AM, 2003, BIOL BULL-US, V205, P160, DOI 10.2307/1543236; Havasi A, 2008, J BIOL CHEM, V283, P12305, DOI 10.1074/jbc.M801291200; HIDVEGI EJ, 1980, ONCOLOGY-BASEL, V37, P360, DOI 10.1159/000225470; Ivanina AV, 2009, AQUAT TOXICOL, V91, P245, DOI 10.1016/j.aquatox.2008.11.016; Jenny MJ, 2007, MAR BIOTECHNOL, V9, P577, DOI 10.1007/s10126-007-9041-1; Kamradt MC, 2005, J BIOL CHEM, V280, P11059, DOI 10.1074/jbc.M413382200; Kinne O, 1963, J TEMP OCEANOGR MAR, V1, P301; Lang RP, 2009, MAR BIOTECHNOL, V11, P650, DOI 10.1007/s10126-009-9181-6; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lee I, 2004, SCIENCE, V306, P1555, DOI 10.1126/science.1099511; Lee WP, 2009, BRIEF BIOINFORM, V10, P408, DOI 10.1093/bib/bbp028; LIU LF, 1987, P NATL ACAD SCI USA, V84, P7024, DOI 10.1073/pnas.84.20.7024; [刘涛 LIU Tao], 2010, [临床心血管病杂志, Journal of Clinical Cardiology], V26, P212; Liu WJ, 2008, CARCINOGENESIS, V29, P263, DOI 10.1093/carcin/bgm251; Meistertzheim AL, 2007, FEBS J, V274, P6392, DOI 10.1111/j.1742-4658.2007.06156.x; Oldham MC, 2008, NAT NEUROSCI, V11, P1271, DOI 10.1038/nn.2207; Pasupuleti N, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.3; Ponomarev I, 2012, J NEUROSCI, V32, P1884, DOI 10.1523/JNEUROSCI.3136-11.2012; Rebbaa A, 2003, ONCOGENE, V22, P2805, DOI 10.1038/sj.onc.1206366; Shamseldin AA, 1997, J SHELLFISH RES, V16, P487; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; TseDinh YC, 1997, TRENDS MICROBIOL, V5, P323, DOI 10.1016/S0966-842X(97)01080-9; Wang WX, 2004, TRENDS PLANT SCI, V9, P244, DOI 10.1016/j.tplants.2004.03.006; Wille A, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r92; Yap MN, 2003, PLANT MOL BIOL, V51, P471, DOI 10.1023/A:1022334820332; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128	38	18	19	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35484	10.1371/journal.pone.0035484	http://dx.doi.org/10.1371/journal.pone.0035484			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22530030	Green Submitted, gold, Green Published			2022-12-27	WOS:000305350600086
J	Cullen, MR; Cummins, C; Fuchs, VR				Cullen, Mark R.; Cummins, Clint; Fuchs, Victor R.			Geographic and Racial Variation in Premature Mortality in the US: Analyzing the Disparities	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; INCOME INEQUALITY; LIFE EXPECTANCY; UNITED-STATES; SOCIOECONOMIC INEQUALITIES; REGIONAL-VARIATION; CLIMATE-CHANGE; AIR-POLLUTION; JOB STRAIN; HEALTH	Life expectancy at birth, estimated from United States period life tables, has been shown to vary systematically and widely by region and race. We use the same tables to estimate the probability of survival from birth to age 70 (S-70), a measure of mortality more sensitive to disparities and more reliably calculated for small populations, to describe the variation and identify its sources in greater detail to assess the patterns of this variation. Examination of the unadjusted probability of S-70 for each US county with a sufficient population of whites and blacks reveals large geographic differences for each race-sex group. For example, white males born in the ten percent healthiest counties have a 77 percent probability of survival to age 70, but only a 61 percent chance if born in the ten percent least healthy counties. Similar geographical disparities face white women and blacks of each sex. Moreover, within each county, large differences in S-70 prevail between blacks and whites, on average 17 percentage points for men and 12 percentage points for women. In linear regressions for each race-sex group, nearly all of the geographic variation is accounted for by a common set of 22 socio-economic and environmental variables, selected for previously suspected impact on mortality; R-2 ranges from 0.86 for white males to 0.72 for black females. Analysis of black-white survival chances within each county reveals that the same variables account for most of the race gap in S-70 as well. When actual white male values for each explanatory variable are substituted for black in the black male prediction equation to assess the role explanatory variables play in the black-white survival difference, residual black-white differences at the county level shrink markedly to a mean of -2.4% (+/-2.4); for women the mean difference is -3.7% (+/-2.3).	[Cullen, Mark R.; Fuchs, Victor R.] Stanford Univ, Sch Med, Gen Med Disciplines, Stanford, CA 94305 USA; [Cummins, Clint; Fuchs, Victor R.] Stanford Univ, Dept Econ, Stanford, CA 94305 USA; [Cummins, Clint; Fuchs, Victor R.] Stanford Univ, Dept Hlth Res & Policy, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Cullen, MR (corresponding author), Stanford Univ, Sch Med, Gen Med Disciplines, Stanford, CA 94305 USA.	mrcullen@stanford.edu		cullen, mark/0000-0001-7996-1864				Adler NE, BIOL DISADVANTAGE; Anderson HV, 2010, CIRC-CARDIOVASC QUAL, V3, P6, DOI 10.1161/CIRCOUTCOMES.109.927103; Anenberg SC, 2010, ENVIRON HEALTH PERSP, V118, P1189, DOI 10.1289/ehp.0901220; Armstrong D, 1998, ANN EPIDEMIOL, V8, P184, DOI 10.1016/S1047-2797(97)00202-0; Backlund E, 2007, INT J EPIDEMIOL, V36, P590, DOI 10.1093/ije/dym012; Banks J, 2010, DEMOGRAPHY, V47, pS211, DOI 10.1353/dem.2010.0008; Blakely T, 2006, SOC SCI MED, V62, P2024, DOI 10.1016/j.socscimed.2005.08.059; Cooper RA, 2009, HEALTH AFFAIR, V28, pW103, DOI 10.1377/hlthaff.28.1.w103; Cooper RS, 2011, PUBLIC HLTH REPORTS, V116, P464; Deaton A, 2003, SOC SCI MED, V56, P1139, DOI 10.1016/S0277-9536(02)00115-6; Eaker ED, 2004, AM J EPIDEMIOL, V159, P950, DOI 10.1093/aje/kwh127; Ezzati M, 2008, PLOS MED, V5, P557, DOI 10.1371/journal.pmed.0050066; Fisher ES, 2003, ANN INTERN MED, V138, P273, DOI 10.7326/0003-4819-138-4-200302180-00006; Geronimus AT, 1999, J EPIDEMIOL COMMUN H, V53, P325, DOI 10.1136/jech.53.6.325; Harper S, 2007, JAMA-J AM MED ASSOC, V297, P1224, DOI 10.1001/jama.297.11.1224; Hart JE, 2011, AM J RESP CRIT CARE, V183, P73, DOI 10.1164/rccm.200912-1903OC; Jemal A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002181; Kelleher CC, 2006, SOC SCI MED, V63, P465, DOI 10.1016/j.socscimed.2005.12.017; Kivimaki M, 2002, BRIT MED J, V325, P857, DOI 10.1136/bmj.325.7369.857; Krumholz HM, 2003, AM HEART J, V146, P242, DOI 10.1016/S0002-8703(03)00237-0; Kuper H, 2003, J EPIDEMIOL COMMUN H, V57, P147, DOI 10.1136/jech.57.2.147; Laskey Warren, 2010, Crit Pathw Cardiol, V9, P1, DOI 10.1097/HPC.0b013e3181cdb5a5; Leigh A, 2007, J HEALTH ECON, V26, P1, DOI 10.1016/j.jhealeco.2006.07.003; Levine DA, 2011, HYPERTENSION, V57, P39, DOI 10.1161/HYPERTENSIONAHA.110.160341; Liu H, 2009, J MARRIAGE FAM, V71, P1158, DOI 10.1111/j.1741-3737.2009.00661.x; Lochner K, 2001, AM J PUBLIC HEALTH, V91, P385, DOI 10.2105/AJPH.91.3.385; Lopez L, 2010, ACAD EMERG MED, V17, P801, DOI 10.1111/j.1553-2712.2010.00823.x; Ly DP, 2010, J GEN INTERN MED, V25, P357, DOI 10.1007/s11606-009-1231-2; Markides KS, 2005, J GERONTOL B-PSYCHOL, V60, P68, DOI 10.1093/geronb/60.Special_Issue_2.S68; Martens WJM, 1998, SOC SCI MED, V46, P331, DOI 10.1016/S0277-9536(97)00162-7; Massing MW, 2004, SOUTH MED J, V97, P475, DOI 10.1097/00007611-200405000-00012; Meara ER, 2008, HEALTH AFFAIR, V27, P350, DOI 10.1377/hlthaff.27.2.350; Mellor JM, 2004, AM J PUBLIC HEALTH, V94, P1043, DOI 10.2105/AJPH.94.6.1043; Murray CJL, 2006, PLOS MED, V3, P1513, DOI 10.1371/journal.pmed.0030260; Neovius K, 2010, EUR J EPIDEMIOL, V25, P703, DOI 10.1007/s10654-010-9485-x; Niedhammer I, 2011, EUR J EPIDEMIOL, V26, P1, DOI 10.1007/s10654-010-9506-9; Obisesan TO, 2000, STROKE, V31, P19, DOI 10.1161/01.STR.31.1.19; Patz JA, 2005, NATURE, V438, P310, DOI 10.1038/nature04188; Pope CA, 2009, NEW ENGL J MED, V360, P376, DOI 10.1056/NEJMsa0805646; Samet JM, 2010, SALUD PUBLICA MEXICO, V52, pS98, DOI 10.1590/S0036-36342010000800005; Shi LY, 2003, J AM BOARD FAM PRACT, V16, P412, DOI 10.3122/jabfm.16.5.412; Singh GK, 2004, CAN J PUBLIC HEALTH, V95, pI14, DOI 10.1007/BF03403660; Singh GK, 2006, INT J EPIDEMIOL, V35, P903, DOI 10.1093/ije/dyl089; Smith JP, 2007, J HUM RESOUR, V42, P739; Smith JP, 2004, POPUL DEV REV, V30, P108; Stringhini S, 2010, JAMA-J AM MED ASSOC, V303, P1159, DOI 10.1001/jama.2010.297; Tagaris E, 2010, INT J ENV RES PUB HE, V7, P2222, DOI 10.3390/ijerph7052222; WILMSHURST P, 1994, BMJ-BRIT MED J, V309, P1029, DOI 10.1136/bmj.309.6961.1029	48	72	72	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e32930	10.1371/journal.pone.0032930	http://dx.doi.org/10.1371/journal.pone.0032930			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959WC	22529892	Green Published, gold			2022-12-27	WOS:000305347400001
J	Liao, LM; Zhang, X; Ren, YF; Sun, XY; Di, N; Zhou, N; Pan, RK; Ma, SH; Zhou, LX				Liao, Ling-Min; Zhang, Xin; Ren, Yu-Feng; Sun, Xiao-Ying; Di, Na; Zhou, Nan; Pan, Rui-Ke; Ma, Shu-Hua; Zhou, Li-Xue			Chromogranin A (CgA) as Poor Prognostic Factor in Patients with Small Cell Carcinoma of the Cervix: Results of a Retrospective Study of 293 Patients	PLOS ONE			English	Article							UTERINE CERVIX; NEUROENDOCRINE CARCINOMA; PROSTATE-CANCER; THERAPY; SURVIVAL	Background: Small cell carcinoma of the cervix (SCCC) is a very rare tumor. Due to its rarity and the long time period, there is a paucity of information pertaining to prognostic factors associated with survival. The objective of this study was to determine whether clinicopathologic finings or immunohistochemical presence of molecular markers predictive of clinical outcome in patients with SCCC. Methodology and Findings: We retrospectively reviewed a total of 293 patients with SCCC (47 patients from Cancer Center of Sun Yat-sen University in china, 71 patients from case report of china journal, 175 patients from case report in PubMed database). Of those 293 patients with SCCC, the median survival time is 23 months. The 3-year overall survival rates (OS) and 3-year disease-free survival rates (DFS) for all patients were 34.5% and 31.1%, respectively. Univariate and multivariate analysis showed that FIGO stage (IIb-IV VS I-IIa, Hazard Ratio (HR) = 3.08, 95% confidence interval (CI) of ratio = [2.05, 4.63], P<0.001), tumor mass size (>= 4 cm VS <4 cm, HR = 2.37, 95% CI = [1.28, 4.36], P = 0.006) and chromogranin A (CgA) (Positive VS Negative, HR = 1.81, 95% CI = [1.12, 2.91], P = 0.015) were predictive of poor prognosis. CgA stained positive was found to be highly predictive of death in early-stage (FIGO I-IIa) patient specifically. Conclusions: Patients with SCCC have poor prognosis. FIGO stage, tumor mass size and CgA stained positive may act as a surrogate for factors prognostic of survival. CgA may serve as a useful marker in prognostic evaluation for early-stage patients with SCCC.	[Liao, Ling-Min; Zhang, Xin; Di, Na; Zhou, Nan; Pan, Rui-Ke; Zhou, Li-Xue] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Gynecol & Obstet, Guangzhou, Guangdong, Peoples R China; [Ren, Yu-Feng] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Radiotherapy, Guangzhou, Guangdong, Peoples R China; [Sun, Xiao-Ying] Feng Tian Hosp, Shenyang Med Coll, Dept Gynecol & Obstet, Shenyang, Liaoning, Peoples R China; [Ma, Shu-Hua] Shantou Univ, Coll Med, Affiliated Hosp 1, Shantou, Guangdong, Peoples R China; [Ma, Shu-Hua] Guangdong Key Lab Med Mol Imaging, Shantou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Shenyang Medical College; Shantou University	Liao, LM (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Gynecol & Obstet, Guangzhou, Guangdong, Peoples R China.	shuhua6699@yahoo.com.cn; 170442370@qq.com			National Natural Science Foundation of China [81072143]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (grant 81072143). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balderston KD, 1998, GYNECOL ONCOL, V71, P128, DOI 10.1006/gyno.1998.5104; Berruti A, 2010, PROSTATE, V70, P718, DOI 10.1002/pros.21104; Chan JK, 2003, CANCER, V97, P568, DOI 10.1002/cncr.11086; Chung HH, 2006, INT J GYNECOL CANCER, V16, P1833, DOI 10.1111/j.1525-1438.2006.00708.x; Crowder S, 2007, SEMIN ONCOL, V34, P57, DOI 10.1053/j.seminoncol.2006.10.028; GERSELL DJ, 1988, AM J SURG PATHOL, V12, P684, DOI 10.1097/00000478-198809000-00005; Kim YB, 1996, GYNECOL ONCOL, V62, P411, DOI 10.1006/gyno.1996.0259; Korcum AF, 2008, ARCH GYNECOL OBSTET, V277, P367, DOI 10.1007/s00404-007-0463-9; Malaguarnera M, 2010, ARCH GERONTOL GERIAT, V51, P81, DOI 10.1016/j.archger.2009.08.004; Modlin IM, 2006, J CLIN GASTROENTEROL, V40, P572, DOI 10.1097/00004836-200608000-00003; PAZDUR R, 1981, GYNECOL ONCOL, V12, P120, DOI 10.1016/0090-8258(81)90103-7; Reis LO, 2010, J INVEST MED, V58, P957, DOI 10.231/JIM.0b013e3181f5d610; Sevin BU, 1996, CANCER-AM CANCER SOC, V77, P1489, DOI 10.1002/(SICI)1097-0142(19960415)77:8<1489::AID-CNCR10>3.0.CO;2-W; SHEETS EE, 1988, OBSTET GYNECOL, V71, P10; Straughn JM, 2001, GYNECOL ONCOL, V83, P216, DOI 10.1006/gyno.2001.6385; Tan Jun, 2009, MODERN ONCOLOGY, V17; Tsunoda S, 2005, INT J GYNECOL CANCER, V15, P295, DOI 10.1111/j.1525-1438.2005.15219.x; VANNAGELL JR, 1977, CANCER, V40, P2243, DOI 10.1002/1097-0142(197711)40:5<2243::AID-CNCR2820400534>3.0.CO;2-H; Viswanathan AN, 2004, GYNECOL ONCOL, V93, P27, DOI 10.1016/j.ygyno.2003.12.027; Zheng M, 2010, OBSTET GYNECOL, V116, P884, DOI 10.1097/AOG.0b013e3181f104ce; Zhou C, 1998, CANCER CYTOPATHOL, V84, P281, DOI 10.1002/(SICI)1097-0142(19981025)84:5<281::AID-CNCR3>3.0.CO;2-W	21	25	33	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e33674	10.1371/journal.pone.0033674	http://dx.doi.org/10.1371/journal.pone.0033674			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22529895	gold, Green Published, Green Submitted			2022-12-27	WOS:000305347400003
J	Spiliotis, M				Spiliotis, Markus			Inverse Fusion PCR Cloning	PLOS ONE			English	Article							RESTRICTION ENZYMES; LIGATION; EXTENSION; VECTOR; GENES	Inverse fusion PCR cloning (IFPC) is an easy, PCR based three-step cloning method that allows the seamless and directional insertion of PCR products into virtually all plasmids, this with a free choice of the insertion site. The PCR-derived inserts contain a vector-complementary 5'-end that allows a fusion with the vector by an overlap extension PCR, and the resulting amplified insert-vector fusions are then circularized by ligation prior transformation. A minimal amount of starting material is needed and experimental steps are reduced. Untreated circular plasmid, or alternatively bacteria containing the plasmid, can be used as templates for the insertion, and clean-up of the insert fragment is not urgently required. The whole cloning procedure can be performed within a minimal hands-on time and results in the generation of hundreds to ten-thousands of positive colonies, with a minimal background.	Univ Bern, Inst Parasitol, Bern, Switzerland	University of Bern	Spiliotis, M (corresponding author), Univ Bern, Inst Parasitol, Bern, Switzerland.	markus.spiliotis@vetsuisse.unibe.ch			Swiss National Science Foundation [NF1003A-12590-1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the Swiss National Science Foundation (grant no. NF1003A-12590-1; URL http://www.snf.ch/E/Pages/default.aspx). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BREITLING F, 1991, GENE, V104, P147, DOI 10.1016/0378-1119(91)90244-6; Bryksin AV, 2010, BIOTECHNIQUES, V48, P463, DOI 10.2144/000113418; BUBECK P, 1993, NUCLEIC ACIDS RES, V21, P3601, DOI 10.1093/nar/21.15.3601; Casali N, 2002, INFECT IMMUN, V70, P6846, DOI 10.1128/IAI.70.12.6846-6852.2002; Chen GJ, 2000, BIOTECHNIQUES, V28, P498, DOI 10.2144/00283st08; Engler C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005553; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Hoskins RA, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni184; JUNG V, 1993, METHOD ENZYMOL, V218, P357; Li CK, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-92; Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010; Lu Q, 2005, TRENDS BIOTECHNOL, V23, P199, DOI 10.1016/j.tibtech.2005.02.008; OCHMAN H, 1988, GENETICS, V120, P621; Quan JY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006441; Tillett D, 1999, NUCLEIC ACIDS RES, V27, DOI 10.1093/nar/27.19.e26; van den Ent F, 2006, J BIOCHEM BIOPH METH, V67, P67, DOI 10.1016/j.jbbm.2005.12.008; Yang J, 2010, BIOTECHNIQUES, V49, P817, DOI 10.2144/000113520; Zhang YW, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1288; Zhou M Y, 2000, Curr Issues Mol Biol, V2, P1	20	21	22	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e35407	10.1371/journal.pone.0035407	http://dx.doi.org/10.1371/journal.pone.0035407			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22530019	Green Submitted, gold, Green Published			2022-12-27	WOS:000305347400050
J	Burgess, IF; Lee, PN; Kay, K; Jones, R; Brunton, ER				Burgess, Ian F.; Lee, Peter N.; Kay, Katrina; Jones, Ruth; Brunton, Elizabeth R.			1,2-Octanediol, a Novel Surfactant, for Treating Head Louse Infestation: Identification of Activity, Formulation, and Randomised, Controlled Trials	PLOS ONE			English	Article							INSECTICIDE RESISTANCE; LICE; LOTION	Background: Interest in developing physically active pediculicides has identified new active substances. The objective was to evaluate a new treatment for clinical efficacy. Methods and Findings: We describe the selection of 1,2-octanediol as a potential pediculicide. Clinical studies were community based. The main outcome measure was no live lice, after two treatments, with follow up visits over 14 days. Study 1 was a proof of concept with 18/20 (90%) participants cured. Study 2 was a multicentre, parallel, randomised, observer-blind study (520 participants) that compared 0.5% malathion liquid with 1,2-octanediol lotion (20% alcohol) applied 2-2.5 hours or 8 hours/overnight. 1,2-octanediol lotion was significantly (p < 0.0005) more effective with success for 124/175 (70.9%) RR = 1.50 (97.5% CI, 1.22 to 1.85) for 2-2.5 hours, and 153/174 (87.9%) RR = 1.86 (97.5% CI, 1.54 to 2.26) for 8 hours/overnight compared with 81/171 (47.4%) for malathion. Study 3, a two centre, parallel, randomised, observer-blind study (121 participants), compared 1,2-octanediol lotion, 2-2.5 hours with 1,2-octanediol alcohol free mousse applied for 2-2.5 hours or 8 hours/overnight. The mousse applied for 8 hours/overnight cured 31/40 (77.5%), compared with 24/40 (60.0%) for lotion (RR = 1.29, 95% CI, 0.95 to 1.75; NNT = 5.7) but mousse applied for 2-2.5 hours 17/41 (41.5%) was less effective than lotion (RR = 0.69, 95% CI, 0.44 to 1.08). Adverse events were more common using 1,2-octanediol lotion at both 2-2.5 hours (12.0%, p = 0.001) and 8 hours/overnight (14.9%, p < 0.0005), compared with 0.5% malathion (2.3%). Similar reactions were more frequent (p < 0.045) using lotion compared with mousse. Conclusions: 1,2-octanediol was found to eliminate head louse infestation. It is believed to disrupt the insect's cuticular lipid, resulting in dehydration. The alcohol free mousse is more acceptable exhibiting significantly fewer adverse reactions.	[Burgess, Ian F.; Kay, Katrina; Jones, Ruth; Brunton, Elizabeth R.] Insect Res & Dev Ltd, Med Entomol Ctr, Cambridge, England; [Lee, Peter N.] PN Lee Stat & Comp Ltd, Sutton, Surrey, England; [Kay, Katrina] NHS Leeds, Leeds, W Yorkshire, England	PN Lee Statistics & Computing Ltd	Burgess, IF (corresponding author), Insect Res & Dev Ltd, Med Entomol Ctr, Cambridge, England.	ian@insectresearch.com	Burgess, Ian/N-2977-2013	Burgess, Ian/0000-0003-0747-3938; Lee, Peter/0000-0002-8244-1904	EctoPharma Ltd, Selkirk, Scotland; Thornton & Ross Ltd, Huddersfield, United Kingdom; Actavis A/S, Denmark; EctoPharma Ltd; Thornton Ross Ltd; Actavis A/S	EctoPharma Ltd, Selkirk, Scotland; Thornton & Ross Ltd, Huddersfield, United Kingdom; Actavis A/S, Denmark; EctoPharma Ltd; Thornton Ross Ltd; Actavis A/S	The studies described here were industry sponsored. Pre-clinical developments, proof of concept (Study 1) and the first comparative (Study 2) clinical investigations were supported financially by EctoPharma Ltd, Selkirk, Scotland. Further pre-clinical developments of the mousse formulation and the second comparative clinical investigation (Study 3) were supported by Thornton & Ross Ltd, Huddersfield, United Kingdom. Both of these industry sponsors played no active role in the design of the studies, data collection and analysis, interpretation of the results, decision to publish, or the writing of the manuscript. Actavis A/S, Denmark, sponsored the writing of the first draft of the manuscript but did not influence its content in any way. Thornton & Ross Ltd requested inclusion of all three studies in a single manuscript in order to present the product development as a continuous process.; This study was funded by EctoPharma Ltd, Thornton & Ross Ltd, and Actavis A/S. IFB and ERB are full-time employees and KK and RJ were part-time employees of Insect Research & Development Limited, and PNL is an employee of PN Lee Statistics and Computing Ltd. Neither of these companies was involved in funding the studies. The one relevant patent related to the study product was filed in the name of EctoPharma Ltd, rights to the intellectual property in the product were acquired by Thornton & Ross Ltd, and they currently market it under the name "Hedrin Treat & Go H". This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Burgess I., 1991, Pharmaceutical Journal, V247, P630; Burgess I. F., 1999, Proceedings of the 3rd International Conference on Urban Pests. Czech University of Agriculture, Prague, Czech Republic, 19-22 July 1999., P249; Burgess IF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001127; Burgess Ian F., 2009, BMC Pharmacology, V9, P3, DOI 10.1186/1471-2210-9-3; Burgess IF, 2005, BRIT MED J, V330, P1423, DOI 10.1136/bmj.38497.506481.8F; Campbell J, 2002, International Patent; WO, Patent No. [02/069707 A1, 02069707]; Cueto GM, 2002, J MED ENTOMOL, V39, P457, DOI 10.1603/0022-2585-39.3.457; Downs AMR, 2002, BRIT J DERMATOL, V146, P88, DOI 10.1046/j.1365-2133.2002.04473.x; Gibbs AG, 1998, AM ZOOL, V38, P471; GREENLAND S, 1985, BIOMETRICS, V41, P55, DOI 10.2307/2530643; Howard RW, 2003, J CHEM ECOL, V29, P615, DOI 10.1023/A:1022806922246; JACKSON LL, 1970, LIPIDS, V5, P239, DOI 10.1007/BF02532475; Lee P.N., 2008, PHARM J, V280, P371; MANTEL N, 1959, J NATL CANCER I, V22, P719; Thomas DR, 2006, ARCH DIS CHILD, V91, P777, DOI 10.1136/adc.2005.091280	15	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e35419	10.1371/journal.pone.0035419	http://dx.doi.org/10.1371/journal.pone.0035419			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523593	Green Published, gold			2022-12-27	WOS:000305345000066
J	Zaidi, S; McLaughlin, M; Bhide, SA; Eccles, SA; Workman, P; Nutting, CM; Huddart, RA; Harrington, KJ				Zaidi, Shane; McLaughlin, Martin; Bhide, Shreerang A.; Eccles, Suzanne A.; Workman, Paul; Nutting, Christopher M.; Huddart, Robert A.; Harrington, Kevin J.			The HSP90 Inhibitor NVP-AUY922 Radiosensitizes by Abrogation of Homologous Recombination Resulting in Mitotic Entry with Unresolved DNA Damage	PLOS ONE			English	Article							HEAT-SHOCK-PROTEIN; PHASE-II TRIAL; TUMOR-CELLS; MOLECULAR CHAPERONE; ANTITUMOR-ACTIVITY; MULTITARGET APPROACH; GENOTOXIC STRESSES; RADIATION RESPONSE; MULTIPLE-MYELOMA; CARCINOMA CELLS	Background: Heat shock protein 90 (HSP90) is a molecular chaperone responsible for the conformational maintenance of a number of client proteins that play key roles in cell cycle arrest, DNA damage repair and apoptosis following radiation. HSP90 inhibitors exhibit antitumor activity by modulating the stabilisation and activation of HSP90 client proteins. We sought to evaluate NVP-AUY922, the most potent HSP90 inhibitor yet reported, in preclinical radiosensitization studies. Principal Findings: NVP-AUY922 potently radiosensitized cells in vitro at low nanomolar concentrations with a concurrent depletion of radioresistance-linked client proteins. Radiosensitization by NVP-AUY922 was verified for the first time in vivo in a human head and neck squamous cell carcinoma xenograft model in athymic mice, as measured by delayed tumor growth and increased surrogate end-point survival (p =< 0.0001). NVP-AUY922 was shown to ubiquitously inhibit resolution of dsDNA damage repair correlating to delayed Rad51 foci formation in all cell lines tested. Additionally, NVP-AUY922 induced a stalled mitotic phenotype, in a cell line-dependent manner, in HeLa and HN5 cell lines irrespective of radiation exposure. Cell cycle analysis indicated that NVP-AUY922 induced aberrant mitotic entry in all cell lines tested in the presence of radiation-induced DNA damage due to ubiquitous CHK1 depletion, but resultant downstream cell cycle effects were cell line dependent. Conclusions: These results identify NVP-AUY922 as the most potent HSP90-mediated radiosensitizer yet reported in vitro, and for the first time validate it in a clinically relevant in vivo model. Mechanistic analysis at clinically achievable concentrations demonstrated that radiosensitization is mediated by the combinatorial inhibition of cell growth and survival pathways, ubiquitous delay in Rad51-mediated homologous recombination and CHK1-mediated G(2)/M arrest, but that the contribution of cell cycle perturbation to radiosensitization may be cell line specific.	[Zaidi, Shane; McLaughlin, Martin; Bhide, Shreerang A.; Harrington, Kevin J.] Inst Canc Res, Chester Beatty Labs, Targeted Therapy Team, London, England; [Eccles, Suzanne A.] Inst Canc Res, Haddow Labs, Canc Res UK Canc Therapeut Unit, Tumour Biol & Metastasis Team, Sutton, Surrey, England; [Workman, Paul] Inst Canc Res, Haddow Labs, Canc Res UK Canc Therapeut Unit, Signal Transduct & Mol Pharmacol Team, Sutton, Surrey, England; [Nutting, Christopher M.; Harrington, Kevin J.] Royal Marsden Hosp, London SW3 6JJ, England; [Huddart, Robert A.] Royal Marsden Hosp, Sutton, Surrey, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Cancer Research UK; University of London; Institute of Cancer Research - UK; Cancer Research UK; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; Royal Marsden NHS Foundation Trust	Zaidi, S (corresponding author), Inst Canc Res, Chester Beatty Labs, Targeted Therapy Team, London, England.	Martin.McLaughlin@icr.ac.uk		huddart, robert/0000-0003-3604-1990; Harrington, Kevin/0000-0002-6014-348X; McLaughlin, Martin/0000-0002-9739-7133	Cancer Research UK [C46/A10588, CA309/A2187, C309/A82741]; NHS; Cancer Research UK [10588, 11566, 13407] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); NHS; Cancer Research UK(Cancer Research UK)	SZ and MM were funded by Cancer Research UK Programme Grant C46/A10588. SAE and PW were funded by Cancer Research UK Programme Grants CA309/A2187 and C309/A82741. PW is a Cancer Research UK Life Fellow. The authors acknowledge NHS funding to the NIHR Biomedical Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; SZ, MM, SAB, SAE, PW and KJH are or have been employees or students of The Institute of Cancer Research. Intellectual property from the research collaboration with Vernalis Ltd. on HSP90 inhibitors was licensed from The Institute of Cancer Research to Vernalis Ltd. and Novartis. The Institute of Cancer Research has benefited from this and requires its employees to declare this potential conflict of interest. SAE: consultant, Vernalis Ltd. PW: commercial research grant, Vernalis Ltd. (not used for the funding of this study); consultant, Novartis. CMN and RAH declare no conflicts of interest. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guidelines for authors.	Arlander SJH, 2006, J BIOL CHEM, V281, P2989, DOI 10.1074/jbc.M508687200; Arlander SJH, 2003, J BIOL CHEM, V278, P52572, DOI 10.1074/jbc.M309054200; Banerji U, 2005, J CLIN ONCOL, V23, P4152, DOI 10.1200/JCO.2005.00.612; Banerji U, 2005, CLIN CANCER RES, V11, P7023, DOI 10.1158/1078-0432.CCR-05-0518; Bisht KS, 2003, CANCER RES, V63, P8984; Brough PA, 2008, J MED CHEM, V51, P196, DOI 10.1021/jm701018h; Bull EEA, 2004, CLIN CANCER RES, V10, P8077, DOI 10.1158/1078-0432.CCR-04-1212; Camphausen K, 2007, CLIN CANCER RES, V13, P4326, DOI 10.1158/1078-0432.CCR-07-0632; Castedo M, 2004, ONCOGENE, V23, P4362, DOI 10.1038/sj.onc.1207572; Castedo M, 2004, ONCOGENE, V23, P2825, DOI 10.1038/sj.onc.1207528; Deckbar D, 2007, J CELL BIOL, V176, P749, DOI 10.1083/jcb.200612047; Dote H, 2005, CANCER RES, V65, P6967, DOI 10.1158/0008-5472.CAN-05-1304; Dungey FA, 2009, MOL CANCER THER, V8, P2243, DOI 10.1158/1535-7163.MCT-09-0201; Eccles SA, 2008, CANCER RES, V68, P2850, DOI 10.1158/0008-5472.CAN-07-5256; Gabai VL, 2010, ONCOGENE, V29, P1952, DOI 10.1038/onc.2009.480; Gabai VL, 2008, CANCER RES, V68, P1834, DOI 10.1158/0008-5472.CAN-07-5656; Gaspar N, 2010, MOL CANCER THER, V9, P1219, DOI 10.1158/1535-7163.MCT-09-0683; Ha K, 2011, MOL CANC THER; Heath EI, 2008, CLIN CANCER RES, V14, P7940, DOI 10.1158/1078-0432.CCR-08-0221; Jensen MR, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1996; Kabakov AE, 2008, INT J RADIAT ONCOL, V71, P858, DOI 10.1016/j.ijrobp.2008.02.034; Koll TT, 2008, MOL CANCER THER, V7, P1985, DOI 10.1158/1535-7163.MCT-07-2104; Lobrich M, 2007, NAT REV CANCER, V7, P861, DOI 10.1038/nrc2248; Machida H, 2005, CANCER SCI, V96, P911, DOI 10.1111/j.1349-7006.2005.00125.x; Machida H, 2003, INT J RADIAT BIOL, V79, P973, DOI 10.1080/09553000310001626135; Massey AJ, 2010, MOL CANCER THER, V9, P906, DOI 10.1158/1535-7163.MCT-10-0055; Matsumoto Y, 2005, J RADIAT RES, V46, P215, DOI 10.1269/jrr.46.215; Merwald H, 2006, CELL STRESS CHAPERON, V11, P81, DOI 10.1379/CSC-89R.1; Moran DM, 2008, ONCOGENE, V27, P5567, DOI 10.1038/onc.2008.172; Munnink THO, 2010, EUR J CANCER, V46, P678, DOI 10.1016/j.ejca.2009.12.009; Nagengast WB, 2010, J NUCL MED; Noguchi M, 2006, BIOCHEM BIOPH RES CO, V351, P658, DOI 10.1016/j.bbrc.2006.10.094; Oda T, 2007, BLOOD, V109, P5016, DOI 10.1182/blood-2006-08-038638; Pacey S, 2012, INVEST NEW DRUG, V30, P341, DOI 10.1007/s10637-010-9493-4; Pacey S, 2011, CLIN CANCER RES, V17, P1561, DOI 10.1158/1078-0432.CCR-10-1927; Pearl LH, 2008, BIOCHEM J, V410, P439, DOI 10.1042/BJ20071640; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Richardson PG, 2010, BRIT J HAEMATOL, V150, P438, DOI 10.1111/j.1365-2141.2010.08265.x; Ronnen EA, 2006, INVEST NEW DRUG, V24, P543, DOI 10.1007/s10637-006-9208-z; Russell JS, 2003, CLIN CANCER RES, V9, P3749; Schwock J, 2008, CANCER CHEMOTH PHARM, V61, P669, DOI 10.1007/s00280-007-0522-8; Stingl L, 2010, BRIT J CANCER, V102, P1578, DOI 10.1038/sj.bjc.6605683; Stuhmer T, 2008, LEUKEMIA, V22, P1604, DOI 10.1038/leu.2008.111; Sydor JR, 2006, P NATL ACAD SCI USA, V103, P17408, DOI 10.1073/pnas.0608372103; Tao YG, 2009, CELL CYCLE, V8, P3172, DOI 10.4161/cc.8.19.9729; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; Weigel BJ, 2007, CLIN CANCER RES, V13, P1789, DOI 10.1158/1078-0432.CCR-06-2270; Workman P, 2010, BRIT J CANCER, V102, P1555, DOI 10.1038/sj.bjc.6605642; Workman P, 2007, ANN NY ACAD SCI, V1113, P202, DOI 10.1196/annals.1391.012; Yao Q, 2007, CLIN CANCER RES, V13, P1591, DOI 10.1158/1078-0432.CCR-06-1750; Yin XY, 2010, INT J CANCER, V126, P1216, DOI 10.1002/ijc.24815	51	44	44	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e35436	10.1371/journal.pone.0035436	http://dx.doi.org/10.1371/journal.pone.0035436			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523597	Green Submitted, gold, Green Published			2022-12-27	WOS:000305345000070
J	Mahla, RS; Reddy, N; Goel, S				Mahla, Ranjeet Singh; Reddy, Niranjan; Goel, Sandeep			Spermatogonial Stem Cells (SSCs) in Buffalo (Bubalus bubalis) Testis	PLOS ONE			English	Article							PRIMITIVE GERM-CELLS; NEONATAL PIG TESTIS; MOUSE TESTES; IN-VITRO; RETROVIRAL TRANSDUCTION; NUCLEAR TRANSFER; PRION PROTEIN; SELF-RENEWAL; TRANSPLANTATION; LINE	Background: Water buffalo is an economically important livestock species and about half of its total world population exists in India. Development of stem cell technology in buffalo can find application in targeted genetic modification of this species. Testis has emerged as a source of pluripotent stem cells in mice and human; however, not much information is available in buffalo. Objectives and Methods: Pou5f1 (Oct 3/4) is a transcription factor expressed by pluripotent stem cells. Therefore, in the present study, expression of POU5F1 transcript and protein was examined in testes of both young and adult buffaloes by semi-quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) and immunohistochemical analysis. Further, using the testis transplantation assay, a functional assay for spermatogonial stem cells (SSCs), stem cell potential of gonocytes/spermatogonia isolated from prepubertal buffalo testis was also determined. Results: Expression of POU5F1transcript and protein was detected in prepubertal and adult buffalo testes. Western blot analysis revealed that the POU5F1 protein in the buffalo testis exists in two isoforms; large (similar to 47 kDa) and small (similar to 21 kDa). Immunohistochemical analysis revealed that POU5F1 expression in prepubertal buffalo testis was present in gonocytes/spermatogonia and absent from somatic cells. In the adult testis, POU5F1 expression was present primarily in post-meiotic germ cells such as round spermatids, weakly in spermatogonia and spermatocytes, and absent from elongated spermatids. POU5F1 protein expression was seen both in cytoplasm and nuclei of the stained germ cells. Stem cell potential of prepubertal buffalo gonocytes/spermatogonia was confirmed by the presence of colonized DBA-stained cells in the basal membrane of seminiferous tubules of xenotransplanted mice testis. Conclusion/Significance: These findings strongly indicate that gonocytes/spermatogonia, isolated for prepubertal buffalo testis can be a potential target for establishing a germ stem cell line that would enable genetic modification of buffaloes.	[Mahla, Ranjeet Singh; Reddy, Niranjan; Goel, Sandeep] CSIR, Ctr Cellular & Mol Biol, Lab Conservat Endangered Species, Hyderabad, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Goel, S (corresponding author), CSIR, Ctr Cellular & Mol Biol, Lab Conservat Endangered Species, Hyderabad, Andhra Pradesh, India.	sandeep@ccmb.res.in	Goel, Sandeep/C-5985-2009; Mahla, Ranjeet/J-4691-2016; Mahla, Ranjeet/J-4691-2016	Goel, Sandeep/0000-0001-7485-5392; Mahla, Ranjeet/0000-0002-5525-8442; Mahla, Ranjeet/0000-0002-4351-9385	Department of Biotechnology, Ministry of Science and Technology, Government of India [BT/PR 10908/MED/31/35/2008]	Department of Biotechnology, Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India)	This work was supported by grants from Department of Biotechnology, Ministry of Science and Technology, Government of India (Grant No. BT/PR 10908/MED/31/35/2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borghese A., 2006, BUFFALO PRODUCTION R, P1; Brehm A, 1998, APMIS, V106, P114, DOI 10.1111/j.1699-0463.1998.tb01326.x; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11303, DOI 10.1073/pnas.91.24.11303; Chambers I, 2009, DEVELOPMENT, V136, P2311, DOI 10.1242/dev.024398; Clouthier DE, 1996, NATURE, V381, P418, DOI 10.1038/381418a0; Denning C, 2001, NAT BIOTECHNOL, V19, P559, DOI 10.1038/89313; Dobrinski I, 1999, BIOL REPROD, V61, P1331, DOI 10.1095/biolreprod61.5.1331; Dobrinski I, 2000, MOL REPROD DEV, V57, P270, DOI 10.1002/1098-2795(200011)57:3&lt;270::AID-MRD9&gt;3.0.CO;2-Z; Donovan PJ, 2003, CURR OPIN GENET DEV, V13, P463, DOI 10.1016/j.gde.2003.08.010; Fujihara M, 2011, J REPROD DEVELOP, V57, P355, DOI 10.1262/jrd.10-185M; Goel S, 2008, REPRODUCTION, V135, P785, DOI 10.1530/REP-07-0476; Goel S, 2011, ANIM REPROD SCI, V126, P251, DOI 10.1016/j.anireprosci.2011.05.012; Goel S, 2010, THERIOGENOLOGY, V74, P1221, DOI 10.1016/j.theriogenology.2010.05.025; Goel S, 2009, REPROD FERT DEVELOP, V21, P696, DOI 10.1071/RD08176; Guan K, 2006, NATURE, V440, P1199, DOI 10.1038/nature04697; Hamra FK, 2005, P NATL ACAD SCI USA, V102, P17430, DOI 10.1073/pnas.0508780102; Hamra FK, 2002, P NATL ACAD SCI USA, V99, P14931, DOI 10.1073/pnas.222561399; He ZP, 2010, BIOL REPROD, V82, P363, DOI 10.1095/biolreprod.109.078550; Izadyar F, 2002, REPRODUCTION, V124, P85, DOI 10.1530/rep.0.1240085; Kanatsu-Shinohara M, 2004, CELL, V119, P1001, DOI 10.1016/j.cell.2004.11.011; Kanatsu-Shinohara M, 2005, BIOL REPROD, V72, P985, DOI 10.1095/biolreprod.104.036400; Kanatsu-Shinohara M, 2004, BIOL REPROD, V71, P1202, DOI 10.1095/biolreprod.104.031294; Kanatsu-Shinohara M, 2006, P NATL ACAD SCI USA, V103, P8018, DOI 10.1073/pnas.0601139103; Kanatsu-Shinohara M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023663; Kim Y, 2006, J ANDROL, V27, P248, DOI 10.2164/jandrol.05034; Kubota H, 2004, BIOL REPROD, V71, P722, DOI 10.1095/biolreprod.104.029207; Kuroiwa Y, 2004, NAT GENET, V36, P775, DOI 10.1038/ng1373; Lai LX, 2002, SCIENCE, V295, P1089, DOI 10.1126/science.1068228; Lee J, 2011, CELL RES, V21, P1164, DOI 10.1038/cr.2011.111; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; McCreath KJ, 2000, NATURE, V405, P1066, DOI 10.1038/35016604; Mitchell RT, 2008, HUM REPROD, V23, P2755, DOI 10.1093/humrep/den295; Moore TJ, 2002, ENDOCRINOLOGY, V143, P3171, DOI 10.1210/en.143.8.3171; Nagano M, 1998, TISSUE CELL, V30, P389, DOI 10.1016/S0040-8166(98)80053-0; Nagano M, 2003, BIOL REPROD, V68, P2207, DOI 10.1095/biolreprod.102.014050; Nagano M, 2001, P NATL ACAD SCI USA, V98, P13090, DOI 10.1073/pnas.231473498; Nagano M, 2000, FEBS LETT, V475, P7, DOI 10.1016/S0014-5793(00)01606-9; Nagano M, 2001, BIOL REPROD, V64, P1409, DOI 10.1095/biolreprod64.5.1409; Ogawa T, 1997, INT J DEV BIOL, V41, P111; Ogawa T, 1999, BIOL REPROD, V60, P515, DOI 10.1095/biolreprod60.2.515; Ohbo K, 2003, DEV BIOL, V258, P209, DOI 10.1016/S0012-1606(03)00111-8; Ovitt CE, 1998, MOL HUM REPROD, V4, P1021, DOI 10.1093/molehr/4.11.1021; Perera B, 2008, REPROD DOMEST ANIM, V43, P200, DOI 10.1111/j.1439-0531.2008.01162.x; Pesce M, 1998, MECH DEVELOP, V71, P89, DOI 10.1016/S0925-4773(98)00002-1; Pesce M, 1998, BIOESSAYS, V20, P722, DOI 10.1002/(SICI)1521-1878(199809)20:9&lt;722::AID-BIES5&gt;3.0.CO;2-I; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; Shinohara T, 2003, BIOL REPROD, V68, P1064, DOI 10.1095/biolreprod.102.009977; Singh N, 2012, GENE, V491, P165, DOI 10.1016/j.gene.2011.09.036; Singh SR, 2011, J CELL MOL MED, V15, P468, DOI 10.1111/j.1582-4934.2010.01242.x; Surani MA, 2001, NATURE, V414, P122, DOI 10.1038/35102186; Tadokoro Y, 2002, MECH DEVELOP, V113, P29, DOI 10.1016/S0925-4773(02)00004-7; Yoshida S, 2010, DEV GROWTH DIFFER, V52, P311, DOI 10.1111/j.1440-169X.2010.01174.x	52	24	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e36020	10.1371/journal.pone.0036020	http://dx.doi.org/10.1371/journal.pone.0036020			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536454	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339200126
J	Dang, X; Wuthrich, C; Gordon, J; Sawa, H; Koralnik, IJ				Dang, Xin; Wuethrich, Christian; Gordon, Jennifer; Sawa, Hirofumi; Koralnik, Igor J.			JC Virus Encephalopathy Is Associated with a Novel Agnoprotein-Deletion JCV Variant	PLOS ONE			English	Article							PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; PRODUCTIVE INFECTION; GLIAL-CELLS; T-ANTIGEN; NEURONS; PROTEIN; BRAIN; SIMIAN-VIRUS-40; DISSOCIATION; NATALIZUMAB	JC virus encephalopathy (JCVE) is a newly described gray matter disease of the brain caused by productive infection of cortical pyramidal neurons. We characterized the full length sequence of JCV isolated from the brain of a JCVE patient, analyzed its distribution in various compartments by PCR, and determined viral gene expression in the brain by immunohistochemistry(IHC). We identified a novel JCV variant, JCV(CPN1), with a unique 143 bp deletion in the Agno gene encoding a truncated 10 amino acid peptide, and harboring an archetype-like regulatory region. This variant lacked one of three nuclear protein binding regions in the Agno gene. It was predominant in the brain, where it coexisted with an Agno-intact wild-type strain. Double immunostaining with anti-Agno and anti-VP1 antibodies demonstrated that the truncated JCVCPN1 Agno peptide was present in the majority of cortical cells productively infected with JCV. We then screened 68 DNA samples from 8 brain, 30 CSF and 30 PBMC samples of PML patients, HIV+and HIV-control subjects. Another JCV(CPN) strain with a different pattern of Agno-deletion was found in the CSF of an HIV+/PML patient, where it also coexisted with wildtype, Agno-intact JCV. These findings suggest that the novel tropism for cortical pyramidal neurons of JCV(CPN1,) may be associated with the Agno deletion. Productive and lytic infection of these cells, resulting in fulminant JCV encephalopathy and death may have been facilitated by the co-infection with a wild-type strain of JCV.	[Dang, Xin; Wuethrich, Christian; Koralnik, Igor J.] Beth Israel Deaconess Med Ctr, Dept Neurol, Div Neurovirol, Boston, MA 02215 USA; [Dang, Xin; Wuethrich, Christian; Koralnik, Igor J.] Beth Israel Deaconess Med Ctr, Dept Med, Div Viral Pathogenesis, Boston, MA 02215 USA; [Gordon, Jennifer] Temple Univ, Sch Med, Dept Neurosci, Philadelphia, PA 19122 USA; [Gordon, Jennifer] Temple Univ, Sch Med, Ctr Neurovirol, Philadelphia, PA 19122 USA; [Sawa, Hirofumi] Hokkaido Univ, Dept Mol Pathobiol, Res Ctr Zoonosis Control, Global COE Program Zoonosis Control, Sapporo, Hokkaido, Japan	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Hokkaido University	Dang, X (corresponding author), Beth Israel Deaconess Med Ctr, Dept Neurol, Div Neurovirol, Boston, MA 02215 USA.	ikoralni@bidmc.harvard.edu	Sawa, Hirofumi/F-6954-2012; Sawa, Hirofumi/AAW-8816-2021	Sawa, Hirofumi/0000-0003-2569-2755; 	Public Health Service [R01 NS 047029, R01 NS 074995, R56 NS 041198, K24 NS 060950]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS041198, K24NS060950, R01NS047029, R01NS074995] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by Public Health Service R01 NS 047029, R01 NS 074995, R56 NS 041198, and K24 NS 060950 to Dr. Koralnik. Funders website: www.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGOSTINI HT, 1995, J NEUROVIROL, V1, P316, DOI 10.3109/13550289509114028; Akan I, 2006, VIROLOGY, V349, P66, DOI 10.1016/j.virol.2006.01.025; Ashok A, 2003, J VIROL, V77, P1347, DOI 10.1128/JVI.77.2.1347-1356.2003; Carson KR, 2009, BLOOD, V113, P4834, DOI 10.1182/blood-2008-10-186999; Dang X, 2008, J NEUROPATH EXP NEUR, V67, P784, DOI 10.1097/NEN.0b013e318180f0d5; Dang X, 2006, J GEN VIROL, V87, P2533, DOI 10.1099/vir.0.81945-0; Del Valle L, 2002, JNCI-J NATL CANCER I, V94, P267, DOI 10.1093/jnci/94.4.267; Du Pasquier RA, 2003, NEUROLOGY, V61, P775, DOI 10.1212/01.WNL.0000081306.86961.33; Jensen PN, 2001, J NEUROVIROL, V7, P280; Kleinschmidt-DeMasters BK, 2005, NEW ENGL J MED, V353, P369, DOI 10.1056/NEJMoa051782; Koralnik IJ, 2005, ANN NEUROL, V57, P576, DOI 10.1002/ana.20431; Major EO, 2010, ANNU REV MED, V61, P35, DOI 10.1146/annurev.med.080708.082655; Okada Y, 2005, EMBO REP, V6, P452, DOI 10.1038/sj.embor.7400406; Okada Y, 2002, ACTA NEUROPATHOL, V104, P130, DOI 10.1007/s00401-002-0526-8; Okada Y, 2001, J NEUROVIROL, V7, P302; Safak M, 2001, J VIROL, V75, P1476, DOI 10.1128/JVI.75.3.1476-1486.2001; Sariyer IK, 2006, J VIROL, V80, P3893, DOI 10.1128/JVI.80.8.3893-3903.2006; Sariyer IK, 2008, VIROLOGY, V375, P464, DOI 10.1016/j.virol.2008.02.020; Suzuki T, 2005, J BIOL CHEM, V280, P24948, DOI 10.1074/jbc.M411499200; Suzuki T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000801; Tan CS, 2010, J VIROL, V84, P9200, DOI 10.1128/JVI.00609-10; Tyler KL, 2003, NEUROLOGY, V61, P734, DOI 10.1212/WNL.61.6.734; Van Assche G, 2005, NEW ENGL J MED, V353, P362, DOI 10.1056/NEJMoa051586; Weber T, 1997, J INFECT DIS, V176, P250, DOI 10.1086/514032; Wuthrich C, 2012, J NEUROPATH EXP NEUR, V71, P54, DOI 10.1097/NEN.0b013e31823ede59; Wuthrich C, 2009, ANN NEUROL, V65, P742, DOI 10.1002/ana.21619	26	35	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e35793	10.1371/journal.pone.0035793	http://dx.doi.org/10.1371/journal.pone.0035793			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22536439	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336200068
J	Kim, ASN; Binns, MA; Alain, C				Kim, Alice S. N.; Binns, Malcolm A.; Alain, Claude			Neuroelectric Evidence for Cognitive Association Formation: An Event-Related Potential Investigation	PLOS ONE			English	Article							RECOGNITION MEMORY; SLOW-WAVE; RECOLLECTION; FAMILIARITY; RETRIEVAL; ORDER; P300; INTERFERENCE; DISSOCIATION; HIPPOCAMPAL	Although many types of learning require associations to be formed, little is known about the brain mechanisms engaged in association formation. In the present study, we measured event-related potentials (ERPs) while participants studied pairs of semantically related words, with each word of a pair presented sequentially. To narrow in on the associative component of the signal, the ERP difference between the first and second words of a pair (Word2-Word1) was derived separately for subsequently recalled and subsequently not-recalled pairs. When the resulting difference waveforms were contrasted, a parietal positivity was observed for subsequently recalled pairs around 460 ms after the word presentation onset, followed by a positive slow wave that lasted until around 845 ms. Together these results suggest that associations formed between semantically related words are correlated with a specific neural signature that is reflected in scalp recordings over the parietal region.	[Kim, Alice S. N.; Binns, Malcolm A.; Alain, Claude] Rotman Res Inst Baycrest, Toronto, ON, Canada; [Kim, Alice S. N.; Alain, Claude] Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada; [Binns, Malcolm A.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Baycrest; University of Toronto; University of Toronto	Kim, ASN (corresponding author), Rotman Res Inst Baycrest, Toronto, ON, Canada.	aa.kim@utoronto.ca	Binns, Malcolm/AAQ-9195-2020	Binns, Malcolm/0000-0001-9998-6612	Canadian Institutes of Health Research [MT 13364, MOP 106619]; Natural Sciences and Engineering Research Council of Canada; Men's Service Group of Baycrest Hospital	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Men's Service Group of Baycrest Hospital	This work was supported by grants from the Canadian Institutes of Health Research to T. W. Picton (grant number MT 13364) and C. Alain (grant number MOP 106619). Additionally, this work was also supported by a Canada Graduate Scholarship from the Natural Sciences and Engineering Research Council of Canada and the Men's Service Group of Baycrest Hospital (A.S.N.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achim AM, 2005, J COGNITIVE NEUROSCI, V17, P652, DOI 10.1162/0898929053467578; Caplan JB, 2005, J MATH PSYCHOL, V49, P383, DOI 10.1016/j.jmp.2005.06.004; Caplan JB, 2009, J COGNITIVE NEUROSCI, V21, P1346, DOI 10.1162/jocn.2008.21167; DEESE J, 1957, J EXP PSYCHOL, V54, P180, DOI 10.1037/h0040536; Donaldson DI, 1998, NEUROPSYCHOLOGIA, V36, P377, DOI 10.1016/S0028-3932(97)00143-7; Donchin E., 1991, HDB COGNITIVE PSYCHO, P471; Donchin E, 1978, MULTIDISCIPLINARY PE; Duzel E, 2001, P NATL ACAD SCI USA, V98, P8101, DOI 10.1073/pnas.131205798; FABIANI M, 1990, ELECTROEN CLIN NEURO, V75, P22, DOI 10.1016/0013-4694(90)90149-E; FRIEDMAN D, 1990, BIOL PSYCHOL, V30, P61, DOI 10.1016/0301-0511(90)90091-A; Friedman D, 2000, MICROSC RES TECHNIQ, V51, P6, DOI 10.1002/1097-0029(20001001)51:1<6::AID-JEMT2>3.0.CO;2-R; Garcia-Larrea L, 1998, EVOKED POTENTIAL, V108, P260, DOI 10.1016/S0168-5597(97)00085-3; Johnson Jr R., 1995, HDB NEUROPSYCHOLOGY, V10, P135; KARIS D, 1984, COGNITIVE PSYCHOL, V16, P177, DOI 10.1016/0010-0285(84)90007-0; Kim ASN, 2009, NEUROPSYCHOLOGIA, V47, P3162, DOI 10.1016/j.neuropsychologia.2009.07.015; Kounios J, 2001, NEURON, V29, P297, DOI 10.1016/S0896-6273(01)00199-4; KUTAS M, 1977, SCIENCE, V197, P792, DOI 10.1126/science.887923; LEWANDOWSKY S, 1989, PSYCHOL REV, V96, P25, DOI 10.1037/0033-295X.96.1.25; Madan CR, 2010, J MEM LANG, V63, P46, DOI 10.1016/j.jml.2010.03.001; Mangels JA, 2001, COGNITIVE BRAIN RES, V11, P77, DOI 10.1016/S0926-6410(00)00066-5; Mecklinger A, 2006, CLIN EEG NEUROSCI, V37, P292, DOI 10.1177/155005940603700406; MORRIS CD, 1977, J VERB LEARN VERB BE, V16, P519, DOI 10.1016/S0022-5371(77)80016-9; Murdock B.B., 1974, HUMAN MEMORY THEORY; MURDOCK BB, 1962, J EXP PSYCHOL, V64, P482, DOI 10.1037/h0045106; Murray LJ, 2007, J NEUROSCI, V27, P5515, DOI 10.1523/JNEUROSCI.0406-07.2007; Norman KA, 2003, PSYCHOL REV, V110, P611, DOI 10.1037/0033-295X.110.4.611; PAIVIO A, 1965, J VERB LEARN VERB BE, V4, P32, DOI 10.1016/S0022-5371(65)80064-0; PAIVIO A, 1963, CAN J PSYCHOLOGY, V17, P370, DOI 10.1037/h0083277; PALLER KA, 1987, ELECTROEN CLIN NEURO, V67, P360, DOI 10.1016/0013-4694(87)90124-6; Paller KA, 2002, TRENDS COGN SCI, V6, P93, DOI 10.1016/S1364-6613(00)01845-3; PALLER KA, 1990, J EXP PSYCHOL LEARN, V16, P1021, DOI 10.1037/0278-7393.16.6.1021; Park H, 2008, CEREB CORTEX, V18, P868, DOI 10.1093/cercor/bhm130; Ranganath C, 2004, NEUROPSYCHOLOGIA, V42, P2, DOI 10.1016/j.neuropsychologia.2003.07.006; Rehani M, 2011, Q J EXP PSYCHOL, V64, P1409, DOI 10.1080/17470218.2010.549945; RUCHKIN DS, 1982, PSYCHOPHYSIOLOGY, V19, P629, DOI 10.1111/j.1469-8986.1982.tb02514.x; Rugg M.D., 1995, OX PSYCH S, P133; Rugg MD, 2002, PHILOS T R SOC B, V357, P1097, DOI 10.1098/rstb.2002.1102; Rugg MD, 2000, OXFORD HDB MEMORY, P521; Rugg MD, 2007, TRENDS COGN SCI, V11, P251, DOI 10.1016/j.tics.2007.04.004; Rugg MD, 2008, PROG BRAIN RES, V169, P339, DOI 10.1016/S0079-6123(07)00021-0; SANQUIST TF, 1980, PSYCHOPHYSIOLOGY, V17, P568, DOI 10.1111/j.1469-8986.1980.tb02299.x; Sikstrom S, 2006, COGNITIVE SCI, V30, P243, DOI 10.1207/s15516709cog0000_55; SOMMER W, 1991, ELECTROEN CLIN NEURO, V79, P457, DOI 10.1016/0013-4694(91)90165-Z; STUSS DT, 1978, BEHAV BIOL, V23, P135, DOI 10.1016/S0091-6773(78)91734-0; Tendolkar I, 1997, NEUROREPORT, V8, P501, DOI 10.1097/00001756-199701200-00025; TULVING E, 1973, PSYCHOL REV, V80, P352, DOI 10.1037/h0020071; Tulving E, 2006, DISTINCTIVENESS MEMO, P407, DOI [DOI 10.1093/ACPROF:OSO/9780195169669.003.0018, 10.1093/acprof:oso/9780195169669.003.0018]; Tulving E, 2007, MEMORY MIND FESTSCHR, P31; Tulving E, 2010, MEMORY, AGING AND THE BRAIN: A FESTSCHRIFT IN HONOUR OF LARS-GORAN NILSSON, P92; Wagner AD, 1999, PHILOS T R SOC B, V354, P1307, DOI 10.1098/rstb.1999.0481; Weyerts H, 1997, NEUROREPORT, V8, P1583, DOI 10.1097/00001756-199705060-00007; Woodruff CC, 2006, BRAIN RES, V1100, P125, DOI 10.1016/j.brainres.2006.05.019; Yonelinas AP, 2002, J MEM LANG, V46, P441, DOI 10.1006/jmla.2002.2864; Yu SS, 2010, BRAIN RES, V1320, P74, DOI 10.1016/j.brainres.2009.12.071	55	8	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e34856	10.1371/journal.pone.0034856	http://dx.doi.org/10.1371/journal.pone.0034856			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22536337	gold, Green Published, Green Submitted			2022-12-27	WOS:000305336200010
J	Simonov, M; Rawlings, RA; Comment, N; Reed, SE; Shi, XY; Nelson, PW				Simonov, Michael; Rawlings, Renata A.; Comment, Nick; Reed, Scott E.; Shi, Xiaoyu; Nelson, Patrick W.			Modeling Adaptive Regulatory T-Cell Dynamics during Early HIV Infection	PLOS ONE			English	Article							RESPONSES	Regulatory T-cells (Tregs) are a subset of CD4(+) T-cells that have been found to suppress the immune response. During HIV viral infection, Treg activity has been observed to have both beneficial and deleterious effects on patient recovery; however, the extent to which this is regulated is poorly understood. We hypothesize that this dichotomy in behavior is attributed to Treg dynamics changing over the course of infection through the proliferation of an 'adaptive' Treg population which targets HIV-specific immune responses. To investigate the role Tregs play in HIV infection, a delay differatial equation model was constructed to examine (1) the possible existence of two distinct Treg populations, normal (nTregs) and adaptive (aTregs), and (2) their respective effects in limiting viral load. Sensitivity analysis was performed to test parameter regimes that show the proportionality of viral load with adaptive regulatory populations and also gave insight into the importance of downregulation of CD4(+) cells by normal Tregs on viral loads. Through the inclusion of Treg populations in the model, a diverse array of viral dynamics was found. Specifically, oscillatory and steady state behaviors were both witnessed and it was seen that the model provided a more accurate depiction of the effector cell population as compared with previous models. Through further studies of adaptive and normal Tregs, improved treatments for HIV can be constructed for patients and the viral mechanisms of infection can be further elucidated.	[Simonov, Michael; Reed, Scott E.] Univ Michigan, Dept Math, Ann Arbor, MI 48109 USA; [Rawlings, Renata A.; Comment, Nick; Nelson, Patrick W.] Univ Michigan, Ctr Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Shi, Xiaoyu] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Simonov, M (corresponding author), Univ Michigan, Dept Math, Ann Arbor, MI 48109 USA.	pwn@umich.edu		Simonov, Michael/0000-0001-8032-1119	National Science Foundation, Division of Mathematical Sciences (NSF-DMS), Alliances for Graduate Education and the Professoriate (NSF-AGEP) [0634590]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM081259] Funding Source: NIH RePORTER	National Science Foundation, Division of Mathematical Sciences (NSF-DMS), Alliances for Graduate Education and the Professoriate (NSF-AGEP); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided by the National Science Foundation, Division of Mathematical Sciences (NSF-DMS) 0634590, Alliances for Graduate Education and the Professoriate (NSF-AGEP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banacloche JG, 2000, J IMMUNOL, V165, P1082; Bassingthwaighte J, 2011, JSIM SIMULATION SYST; Bluestone JA, 2003, NAT REV IMMUNOL, V3, P253, DOI 10.1038/nri1032; Ciupe MS, 2006, MATH BIOSCI, V200, P1, DOI 10.1016/j.mbs.2005.12.006; Eggena MP, 2005, J IMMUNOL, V174, P4407, DOI 10.4049/jimmunol.174.7.4407; Kinter AL, 2004, J EXP MED, V200, P331, DOI 10.1084/jem.20032069; Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011; Oswald-Richter K, 2004, PLOS BIOL, V2, P955, DOI 10.1371/journal.pbio.0020198; Perelson AS, 1999, SIAM REV, V41, P3, DOI 10.1137/S0036144598335107; Romagnani S, 2005, MICROBES INFECT, V7, P1015, DOI 10.1016/j.micinf.2005.03.017; Rouse BT, 2006, IMMUNOL REV, V212, P272, DOI 10.1111/j.0105-2896.2006.00412.x; Stafford MA, 2000, J THEOR BIOL, V203, P285, DOI 10.1006/jtbi.2000.1076; Terzieva V, 2008, VIRAL IMMUNOL, V21, P285, DOI 10.1089/vim.2008.0006; Weiss L, 2004, BLOOD, V104, P3249, DOI 10.1182/blood-2004-01-0365	14	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e33924	10.1371/journal.pone.0033924	http://dx.doi.org/10.1371/journal.pone.0033924			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22536321	gold, Green Submitted, Green Published			2022-12-27	WOS:000305336200004
J	Clapham, M; Nevin, OT; Ramsey, AD; Rosell, F				Clapham, Melanie; Nevin, Owen T.; Ramsey, Andrew D.; Rosell, Frank			A Hypothetico-Deductive Approach to Assessing the Social Function of Chemical Signalling in a Non-Territorial Solitary Carnivore	PLOS ONE			English	Article							PANDAS AILUROPODA-MELANOLEUCA; SCENT-MARKING; BROWN BEARS; REPRODUCTIVE STRATEGIES; COMPETITIVE ABILITY; SEXUAL SEGREGATION; POSITIVE IMPACTS; GRIZZLY BEARS; URINE-MARKING; DENSITY	The function of chemical signalling in non-territorial solitary carnivores is still relatively unclear. Studies on territorial solitary and social carnivores have highlighted odour capability and utility, however the social function of chemical signalling in wild carnivore populations operating dominance hierarchy social systems has received little attention. We monitored scent marking and investigatory behaviour of wild brown bears Ursus arctos, to test multiple hypotheses relating to the social function of chemical signalling. Camera traps were stationed facing bear 'marking trees' to document behaviour by different age sex classes in different seasons. We found evidence to support the hypothesis that adult males utilise chemical signalling to communicate dominance to other males throughout the non-denning period. Adult females did not appear to utilise marking trees to advertise oestrous state during the breeding season. The function of marking by subadult bears is somewhat unclear, but may be related to the behaviour of adult males. Subadults investigated trees more often than they scent marked during the breeding season, which could be a result of an increased risk from adult males. Females with young showed an increase in marking and investigation of trees outside of the breeding season. We propose the hypothesis that females engage their dependent young with marking trees from a young age, at a relatively 'safe' time of year. Memory, experience, and learning at a young age, may all contribute towards odour capabilities in adult bears.	[Clapham, Melanie; Nevin, Owen T.; Ramsey, Andrew D.] Univ Cumbria, Natl Sch Forestry, Ctr Wildlife Conservat, Penrith, Cumbria, England; [Rosell, Frank] Telemark Univ Coll, Fac Art & Sci, Dept Environm & Hlth Studies, Bo I Telemark, Norway	University of Cumbria; University College of Southeast Norway	Clapham, M (corresponding author), Univ Cumbria, Natl Sch Forestry, Ctr Wildlife Conservat, Penrith, Cumbria, England.	melanie.clapham@cumbria.ac.uk	Nevin, Owen/D-8363-2014; Nevin, Owen/AAW-5220-2020	Nevin, Owen/0000-0003-3513-8053; Nevin, Owen/0000-0003-3513-8053; Ramsey, Andrew/0000-0002-6232-5869	Knight Inlet Lodge, British Columbia, Canada	Knight Inlet Lodge, British Columbia, Canada	This work was funded in part by Knight Inlet Lodge, British Columbia, Canada (http://www.knightinletlodge.com). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Barja I, 2010, POL J ECOL, V58, P397; Bellemain E, 2006, P ROY SOC B-BIOL SCI, V273, P283, DOI 10.1098/rspb.2005.3331; Bothma JD, 2004, S AFR J WILDL RES, V34, P163; Brennan PA, 1997, PROG NEUROBIOL, V51, P457, DOI 10.1016/S0301-0082(96)00069-X; Brennan PA, 2006, PHILOS T R SOC B, V361, P2061, DOI 10.1098/rstb.2006.1931; Brown R.E., 1979, Advances in the Study of Behavior, V10, P103, DOI 10.1016/S0065-3454(08)60094-7; Burgener N, 2009, ANIM BEHAV, V77, P707, DOI 10.1016/j.anbehav.2008.11.022; Burst T. L., 1983, INT C BEAR RES MANAG, V5, P45; Can OE, 2009, ORYX, V43, P427, DOI 10.1017/S0030605308000628; CLAPPERTON BK, 1989, ANIM BEHAV, V38, P436, DOI 10.1016/S0003-3472(89)80037-5; Craighead J.J., 1995, GRIZZLY BEARS YELLOW; CRAIGHEAD L, 1995, J HERED, V86, P255, DOI 10.1093/oxfordjournals.jhered.a111578; Dahle B, 2003, J ANIM ECOL, V72, P660, DOI 10.1046/j.1365-2656.2003.00737.x; Distel H, 2001, CHEM SENSES, V26, P247, DOI 10.1093/chemse/26.3.247; DOTY RL, 1986, EXPERIENTIA, V42, P257, DOI 10.1007/BF01942506; Elsenberg J.F., 1972, Annual Rev Ecol Syst, V3, P1; Gende SM, 2004, CAN J ZOOL, V82, P75, DOI 10.1139/Z03-226; Gorman M.L., 1989, P57; GOSLING LM, 1990, BEHAV ECOL SOCIOBIOL, V26, P415; GOSLING LM, 1982, Z TIERPSYCHOL, V60, P89; GOSLING LM, 1990, CHEM SIGNAL, V5, P315; Gosling LM, 2001, ADV STUD BEHAV, V30, P169, DOI 10.1016/S0065-3454(01)80007-3; Green GI, 2003, WILDLIFE BIOL, V9, P1; GUILFORD T, 1991, ANIM BEHAV, V42, P1, DOI 10.1016/S0003-3472(05)80600-1; Hagey L, 2003, J CHEM ECOL, V29, P1479, DOI 10.1023/A:1024225806263; Harmsen BJ, 2010, J MAMMAL, V91, P1225, DOI 10.1644/09-MAMM-A-416.1; HRDY SB, 1979, ETHOL SOCIOBIOL, V1, P13, DOI 10.1016/0162-3095(79)90004-9; HURST JL, 1990, ANIM BEHAV, V40, P209, DOI 10.1016/S0003-3472(05)80916-9; Johnston RE, 2009, HORMONES, BRAIN AND BEHAVIOR, VOLS 1-5, 2ND EDITION, P395; Johnston R. E., 2008, ADV STUDY BEHAV; Jojola SM, 2011, THESIS NORWEGIAN U L; Karamanlidis AA, 2010, EUR J WILDLIFE RES, V56, P693, DOI 10.1007/s10344-010-0363-3; Kays RW, 2008, NONINVASIVE SURVEY M; Kelly MJ, 2008, NORTHEAST NAT, V15, P249, DOI 10.1656/1092-6194(2008)15[249:CTOCTS]2.0.CO;2; Kendall KC, 2008, J WILDLIFE MANAGE, V72, P1693, DOI 10.2193/2008-007; KLEIMAN DEVRA, 1966, SYMP ZOOL SOC LONDON, V18, P167; KODRICBROWN A, 1984, AM NAT, V124, P309, DOI 10.1086/284275; Liu DZ, 2005, CHEM SIGNAL, V10, P101, DOI 10.1007/0-387-25160-X_14; Lloyd HA, 1979, THESIS U BRIT COLUMB; Macdonald D.W., 1985, P619; Macdonald D.W., 1980, Symposia of the Zoological Society of London, P107; McLellan BN, 2005, URSUS, V16, P141, DOI 10.2192/1537-6176(2005)016[0141:SSIIGB]2.0.CO;2; McLellan BN, 2001, CAN J ZOOL, V79, P838, DOI 10.1139/cjz-79-5-838; Molteno AJ, 1998, J ZOOL, V245, P35, DOI 10.1017/S0952836998005044; Muller CA, 2008, ETHOLOGY, V114, P174, DOI 10.1111/j.1439-0310.2007.01455.x; Negroes N, 2010, J WILDLIFE MANAGE, V74, P1195, DOI 10.2193/2009-256; Nevin OT, 2005, BIOL CONSERV, V121, P611, DOI 10.1016/j.biocon.2004.06.011; Nevin OT, 2005, BIOL CONSERV, V123, P453, DOI 10.1016/j.biocon.2005.01.007; NEVIN OT, 2003, THESIS UTAH STATE U; Nevin OT, 2005, CAN FIELD NAT, V119, P449, DOI 10.22621/cfn.v119i3.159; PARKER GA, 1974, J THEOR BIOL, V47, P223, DOI 10.1016/0022-5193(74)90111-8; Puchkovskiy SV, 2009, CONTEMP PROBL ECOL+, V2, P260, DOI 10.1134/S1995425509030163; Rajagopal T, 2010, BEHAV PROCESS, V85, P58, DOI 10.1016/j.beproc.2010.06.007; RALLS K, 1971, SCIENCE, V171, P443, DOI 10.1126/science.171.3970.443; Rich TJ, 1999, ANIM BEHAV, V58, P1027, DOI 10.1006/anbe.1999.1217; Rich TJ, 1998, ANIM BEHAV, V56, P727, DOI 10.1006/anbe.1998.0803; Rios-Uzeda B, 2007, URSUS, V18, P124, DOI 10.2192/1537-6176(2007)18[124:APDEFA]2.0.CO;2; Roberts SC, 2001, CHEM SIGNAL, V9, P11; Rosell F, 1998, J CHEM ECOL, V24, P207, DOI 10.1023/A:1022524223435; Rosell F, 2011, J ZOOL, V283, P143, DOI 10.1111/j.1469-7998.2010.00754.x; Sanchez-Andrade G, 2009, BEHAV BRAIN RES, V200, P323, DOI 10.1016/j.bbr.2008.12.021; Schaller G.B., 1985, GIANT PANDAS WOLONG; Schaller G. C., 1967, DEER TIGER STUDY WIL; Seidensticker JC, 1973, WILDLIFE MONOGR, V35, P3; SMITH JLD, 1989, ANIM BEHAV, V37, P1; Steyaert SMJG, 2012, MAMMAL REV, V42, P12, DOI 10.1111/j.1365-2907.2011.00184.x; STIRLING I, 1990, INT C BEAR, V8, P189; Stoen OG, 2005, BEHAV ECOL SOCIOBIOL, V59, P191, DOI 10.1007/s00265-005-0024-9; Stringham S.F., 1983, BEARS BIOL MANAGE, V5, P140; Sunquist ME, 2002, WILD CATS WORLD, P413; SWAISGOOD R. R., 2004, GIANT PANDAS BIOL CO, P257; Swenson JE, 2001, URSUS-SERIES, V12, P81; Swenson JE, 2001, URSUS-SERIES, V12, P69; Swenson JE, 1998, J ANIM ECOL, V67, P819, DOI 10.1046/j.1365-2656.1998.00248.x; Trolle M, 2007, BIODIVERS CONSERV, V16, P1197, DOI 10.1007/s10531-006-9105-y; White AM, 2004, J ZOOL, V264, P231, DOI 10.1017/S095283690400562X; Wielgus RB, 2000, BIOL CONSERV, V93, P145, DOI 10.1016/S0006-3207(99)00152-4; WIELGUS RB, 1995, J WILDLIFE MANAGE, V59, P552, DOI 10.2307/3802462; WIELGUS RB, 1994, J WILDLIFE MANAGE, V58, P405, DOI 10.2307/3809310; Wilson DA, 2003, NEUROSCI BIOBEHAV R, V27, P307, DOI 10.1016/S0149-7634(03)00050-2; Wong ST, 2004, BIOL CONSERV, V119, P169, DOI 10.1016/j.biocon.2003.10.029; YAMAZAKI K, 1976, J EXP MED, V144, P1324, DOI 10.1084/jem.144.5.1324; Zar J. H., 1996, BIOSTATISTICAL ANAL	83	44	45	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35404	10.1371/journal.pone.0035404	http://dx.doi.org/10.1371/journal.pone.0035404			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22530018	Green Published, Green Accepted, gold			2022-12-27	WOS:000305350600080
J	Campbell, DD; Parra, MV; Duque, C; Gallego, N; Franco, L; Tandon, A; Hunemeier, T; Bortolini, C; Villegas, A; Bedoya, G; McCarthy, MI; Price, A; Reich, D; Ruiz-Linares, A				Campbell, Desmond D.; Parra, Maria V.; Duque, Constanza; Gallego, Natalia; Franco, Liliana; Tandon, Arti; Huenemeier, Tabita; Bortolini, Catira; Villegas, Alberto; Bedoya, Gabriel; McCarthy, Mark I.; Price, Alkes; Reich, David; Ruiz-Linares, Andres			Amerind Ancestry, Socioeconomic Status and the Genetics of Type 2 Diabetes in a Colombian Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; MEXICAN-AMERICANS; ADMIXTURE; PREVALENCE; REPLICATION; MELLITUS; KCNQ1	The "thrifty genotype" hypothesis proposes that the high prevalence of type 2 diabetes (T2D) in Native Americans and admixed Latin Americans has a genetic basis and reflects an evolutionary adaptation to a past low calorie/high exercise lifestyle. However, identification of the gene variants underpinning this hypothesis remains elusive. Here we assessed the role of Native American ancestry, socioeconomic status (SES) and 21 candidate gene loci in susceptibility to T2D in a sample of 876 T2D cases and 399 controls from Antioquia (Colombia). Although mean Native American ancestry is significantly higher in T2D cases than in controls (32% v 29%), this difference is confounded by the correlation of ancestry with SES, which is a stronger predictor of disease status. Nominally significant association (P<0.05) was observed for markers in: TCF7L2, RBMS1, CDKAL1, ZNF239, KCNQ1 and TCF1 and a significant bias (P<0.05) towards OR>1 was observed for markers selected from previous T2D genome-wide association studies, consistent with a role for Old World variants in susceptibility to T2D in Latin Americans. No association was found to the only known Native American-specific gene variant previously associated with T2D in a Mexican sample (rs9282541 in ABCA1). An admixture mapping scan with 1,536 ancestry informative markers (AIMs) did not identify genome regions with significant deviation of ancestry in Antioquia. Exclusion analysis indicates that this scan rules out similar to 95% of the genome as harboring loci with ancestry risk ratios >1.22 (at P<0.05).	[Campbell, Desmond D.; Parra, Maria V.; Duque, Constanza; Ruiz-Linares, Andres] UCL, Dept Genet Evolut & Environm, London, England; [Parra, Maria V.; Duque, Constanza; Gallego, Natalia; Franco, Liliana; Villegas, Alberto; Bedoya, Gabriel] Univ Antioquia, Lab Genet Mol, Medellin, Colombia; [Tandon, Arti; Reich, David] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Huenemeier, Tabita; Bortolini, Catira] Univ Fed Rio Grande do Sul, Dept Genet, Porto Alegre, RS, Brazil; [McCarthy, Mark I.] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Churchill Hosp, Oxford, England; [McCarthy, Mark I.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [McCarthy, Mark I.] Churchill Hosp, Oxford NIHR Biomed Res Ctr, Oxford OX3 7LJ, England; [Price, Alkes] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Reich, David] Broad Inst Harvard & MIT, Cambridge, MA USA	University of London; University College London; Universidad de Antioquia; Harvard University; Harvard Medical School; Universidade Federal do Rio Grande do Sul; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Campbell, DD (corresponding author), UCL, Dept Genet Evolut & Environm, London, England.	a.ruizlin@ucl.ac.uk	Franco, Laercio Joel/H-3814-2013; Hünemeier, Tábita/F-4181-2011; Ruiz-Linares, Andres/AAR-1104-2021; McCarthy, Mark/M-3763-2015	Franco, Laercio Joel/0000-0002-9820-3425; Ruiz-Linares, Andres/0000-0001-8372-1011; Gallego Lopera, Berta Natalia/0000-0001-8109-8473; Franco Hincapie, Liliana/0000-0001-9430-2808; Hunemeier, Tabita/0000-0002-3156-2079; Parra-Marin, Maria Victoria/0000-0002-8475-471X; Campbell, Desmond/0000-0003-1085-714X; McCarthy, Mark/0000-0002-4393-0510	Ruth Kirschstein National Research Service Award from the National Institutes of Health (NIH); Harvard Medical School; NIH grants [NS043538, DK073818]; Colciencias grants [1115-04-16451, 1115-04-012986]; Universidad de Antioquia grant [CODI/sostenibilidad 9889-E01321]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK073818] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043538] Funding Source: NIH RePORTER	Ruth Kirschstein National Research Service Award from the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Medical School; NIH grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Colciencias grants; Universidad de Antioquia grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors are very grateful to the volunteers that contributed samples for this project. AP was supported by a Ruth Kirschstein National Research Service Award from the National Institutes of Health (NIH). This work was partially funded by discretionary funding from Harvard Medical School (to DR), NIH grants NS043538 (to AR-L) and DK073818 (to DR), Colciencias grants 1115-04-16451 and 1115-04-012986 (to GB and AV), and a Universidad de Antioquia grant [CODI/sostenibilidad 9889-E01321] (to GB and AV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Aschner P, 2002, DIABETES-METAB RES, V18, pS27, DOI 10.1002/dmrr.280; Bedoya G, 2006, P NATL ACAD SCI USA, V103, P7234, DOI 10.1073/pnas.0508716103; Benyshek DC, 2006, AM J PHYS ANTHROPOL, V131, P120, DOI 10.1002/ajpa.20334; Burrows NR, 2000, DIABETES CARE, V23, P1786, DOI 10.2337/diacare.23.12.1786; Campbell DD, 2007, BEHAV GENET, V37, P408, DOI 10.1007/s10519-006-9123-2; Carvajal-Carmona LG, 2003, HUM GENET, V112, P534, DOI 10.1007/s00439-002-0899-8; Carvajal-Carmona LG, 2000, AM J HUM GENET, V67, P1287, DOI 10.1016/S0002-9297(07)62956-5; CHAKRABORTY R, 1986, GENET EPIDEMIOL, V3, P435, DOI 10.1002/gepi.1370030608; de Ferranti David, 2004, INEQUALITY LATIN AM; Diamond J, 2003, NATURE, V423, P599, DOI 10.1038/423599a; Florez JC, 2009, DIABETOLOGIA, V52, P1528, DOI 10.1007/s00125-009-1412-x; GARDNER LI, 1984, DIABETES, V33, P86, DOI 10.2337/diabetes.33.1.86; King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414; KNOWLER WC, 1978, AM J EPIDEMIOL, V108, P497, DOI 10.1093/oxfordjournals.aje.a112648; Martinez-Marignac VL, 2007, HUM GENET, V120, P807, DOI 10.1007/s00439-006-0273-3; NEEL JV, 1962, AM J HUM GENET, V14, P353; Parra EJ, 2004, J MED GENET, V41, DOI 10.1136/jmg.2004.018887; Patterson N, 2004, AM J HUM GENET, V74, P979, DOI 10.1086/420871; Pollard T.M., 2008, W DIS EVOLUTIONARY P; Price AL, 2007, AM J HUM GENET, V80, P1024, DOI 10.1086/518313; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Stumvoll M, 2005, LANCET, V365, P1333, DOI 10.1016/S0140-6736(05)61032-X; Unoki H, 2008, NAT GENET, V40, P1098, DOI 10.1038/ng.208; Villarreal-Molina MT, 2008, DIABETES, V57, P509, DOI 10.2337/db07-0484; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wang S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000037; Waters KM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001078; Williams RC, 2000, AM J HUM GENET, V66, P527, DOI 10.1086/302773; Yasuda K, 2008, NAT GENET, V40, P1092, DOI 10.1038/ng.207; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	34	41	43	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e33570	10.1371/journal.pone.0033570	http://dx.doi.org/10.1371/journal.pone.0033570			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22529894	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000305347400002
J	Eriksson, H; de la Torre-Castro, M; Olsson, P				Eriksson, Hampus; de la Torre-Castro, Maricela; Olsson, Per			Mobility, Expansion and Management of a Multi-Species Scuba Diving Fishery in East Africa	PLOS ONE			English	Article							ILLEGAL; SCALE; CONSERVATION; HOLOTHURIANS	Background: Scuba diving fishing, predominantly targeting sea cucumbers, has been documented to occur in an uncontrolled manner in the Western Indian Ocean and in other tropical regions. Although this type of fishing generally indicates a destructive activity, little attention has been directed towards this category of fishery, a major knowledge gap and barrier to management. Methodology and Principal Findings: With the aim to capture geographic scales, fishing processes and social aspects the scuba diving fishery that operate out of Zanzibar was studied using interviews, discussions, participant observations and catch monitoring. The diving fishery was resilient to resource declines and had expanded to new species, new depths and new fishing grounds, sometimes operating approximately 250 km away from Zanzibar at depths down to 50 meters, as a result of depleted easy-access stock. The diving operations were embedded in a regional and global trade network, and its actors operated in a roving manner on multiple spatial levels, taking advantage of unfair patron-client relationships and of the insufficient management in Zanzibar. Conclusions and Significance: This study illustrates that roving dynamics in fisheries, which have been predominantly addressed on a global scale, also take place at a considerably smaller spatial scale. Importantly, while proposed management of the sea cucumber fishery is often generic to a simplified fishery situation, this study illustrates a multifaceted fishery with diverse management requirements. The documented spatial scales and processes in the scuba diving fishery emphasize the need for increased regional governance partnerships to implement management that fit the spatial scales and processes of the operation.	[Eriksson, Hampus; de la Torre-Castro, Maricela] Stockholm Univ, Dept Syst Ecol, S-10691 Stockholm, Sweden; [Eriksson, Hampus] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; [de la Torre-Castro, Maricela; Olsson, Per] Stockholm Univ, Stockholm Resilience Ctr, S-10691 Stockholm, Sweden	Stockholm University; University of Sydney; Stockholm University	Eriksson, H (corresponding author), Stockholm Univ, Dept Syst Ecol, S-10691 Stockholm, Sweden.	hampus@ecology.su.se	Olsson, Per/AAE-9104-2019; Eriksson, Hampus/B-4415-2013	Olsson, Per/0000-0002-9038-4786	Western Indian Ocean Marine Science Association (WIOMSA); Swedish International Development Cooperation Agency (SIDA)	Western Indian Ocean Marine Science Association (WIOMSA); Swedish International Development Cooperation Agency (SIDA)	This work was funded by a Marine and Coastal Science for Management (MASMA) grant from the Western Indian Ocean Marine Science Association (WIOMSA) (www.wiomsa.net) and by the Swedish International Development Cooperation Agency (SIDA) (www.sida.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnew DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004570; Allison EH, 2012, FISH FISH, V13, P14, DOI 10.1111/j.1467-2979.2011.00405.x; Allison EH, 2001, MAR POLICY, V25, P377, DOI 10.1016/S0308-597X(01)00023-9; Anderson SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024368; Anderson SC, 2011, FISH FISH, V12, P317, DOI 10.1111/j.1467-2979.2010.00397.x; Baum JK, 2003, SCIENCE, V299, P389, DOI 10.1126/science.1079777; Bell JD, 2008, OCEAN COAST MANAGE, V51, P589, DOI 10.1016/j.ocecoaman.2008.06.011; Berkes F, 2006, SCIENCE, V311, P1557, DOI 10.1126/science.1122804; Bowles S, 2006, POVERTY TRAPS, DOI 10.1515/9781400841295; Bunce L., 2000, SOCIOECONOMIC MANUAL; Cash DW, 2006, ECOL SOC, V11; Cinner JE, 2011, GLOBAL ENVIRON CHANG, V21, P835, DOI 10.1016/j.gloenvcha.2011.04.012; Cinner JE, 2011, GLOBAL ENVIRON CHANG, V21, P7, DOI 10.1016/j.gloenvcha.2010.09.001; Conand C., 2008, FAO Fisheries and Aquaculture Technical Paper, P143; CONAND C, 1993, MAR BIOL, V116, P439, DOI 10.1007/BF00350061; Conand C, 1990, 2722 FAO; Conand C., 2006, SPC BECHE DE MER INF, V23, P11; Conand C., 1993, US NMFS MAR FISH REV, V55, P1; Conand C., 2007, WIOMSA BOOK SERIES, V5; de la Torre-Castro M, 2004, OCEAN COAST MANAGE, V47, P361, DOI 10.1016/j.ocecoaman.2004.07.005; De La Torre-Castro M, 2007, SPC BECHE DE MER INF, V25, P22; de la Torre-Castro M, 2006, ECOL SOC, V11; Eriksson BH, 2010, AQUAT LIVING RESOUR, V23, P387, DOI 10.1051/alr/2011002; FAO, 2010, FAO YB 2008; Folke C, 2007, ECOL SOC, V12; FRIEDMAN K, 2008, ACIAR MONOGRAPH, V135; Friedman K, 2011, FISH FISH, V12, P75, DOI 10.1111/j.1467-2979.2010.00384.x; Galaz V, 2008, I DIMENSIONS GLOBAL; Kinch J, 2008, 516 FAO; Kinch J, 2004, REV BECHE DE MER FIS; Kvale S, 1996, INTERVIEWS INTRO QUA; Le Gallic B, 2006, MAR POLICY, V30, P689, DOI 10.1016/j.marpol.2005.09.008; Logan M, 2020, BIOSTATISTICAL DESIG, DOI DOI 10.1002/9781444319620; MacKnight C. C., 1976, VOYAGE MAREGE MACASS; Maillaud C., 1999, SPC BECHE DE MER INF, V11, P23; Manez KS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011346; Marshall NT, 1999, STORMY SEAS MARINE I; Mbaga Y, 2007, WIOMSA BOOK SERIES; Muthiga N, 2007, WIOMSA BOOK SERIES; Muthiga Nyawira, 2010, Beche-de-mer Information Bulletin, V30, P3; Ochiewo J, 2010, OCEAN COAST MANAGE, V53, P192, DOI 10.1016/j.ocecoaman.2010.01.010; Olson M., 2000, POWER PROSPERITY OUT; Osterblom H, 2011, GLOBAL ENVIRON CHANG, V21, P972, DOI 10.1016/j.gloenvcha.2011.04.013; Osterblom H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012832; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; Pitcher TJ, 2002, FISH FISH, V3, P317, DOI 10.1046/j.1467-2979.2002.00093.x; Price ARG, 2010, AQUAT CONSERV, V20, P117, DOI [10.1002/aqc.1054, 10.1002/aqc.1074]; Purcell S.W., 2010, FAO FISHERIES AQUACU; Purcell SW, 2013, FISH FISH, V14, P34, DOI 10.1111/j.1467-2979.2011.00443.x; Ruffez Jean, 2008, Beche-de-mer Information Bulletin, V28, P42; Schneider K, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2011JG001755; Swartz W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015143; Swartz W, 2010, MAR POLICY, V34, P1366, DOI 10.1016/j.marpol.2010.06.011; Thorpe A., 2001, Marine Resource Economics, V16, P143; Toral-Granda V, 2008, SEA CUCUMBERS GLOBAL; Uthicke S, 1999, B MAR SCI, V64, P129; Uthicke S, 2001, J EXP MAR BIOL ECOL, V265, P153, DOI 10.1016/S0022-0981(01)00329-X; Warren C., 2010, DISCOVERING QUALITAT; Wolkenhauer SM, 2010, J MAR BIOL ASSOC UK, V90, P215, DOI 10.1017/S0025315409990518	60	36	37	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e35504	10.1371/journal.pone.0035504	http://dx.doi.org/10.1371/journal.pone.0035504			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22530034	gold, Green Published, Green Submitted			2022-12-27	WOS:000305347400055
J	Hannula, SE; de Boer, W; van Veen, J				Hannula, Silja Emilia; de Boer, Wietse; van Veen, Johannes			A 3-Year Study Reveals That Plant Growth Stage, Season and Field Site Affect Soil Fungal Communities while Cultivar and GM-Trait Have Minor Effects	PLOS ONE			English	Article							GRADIENT GEL-ELECTROPHORESIS; ACCUMULATING POTATO PLANTS; GENETICALLY-MODIFIED CROPS; 16S RIBOSOMAL-RNA; MICROBIAL COMMUNITIES; BACTERIAL COMMUNITIES; TRANSGENIC POTATOES; RHIZOSPHERE SOIL; DIVERSITY; MICROORGANISMS	In this three year field study the impact of different potato (Solanum tuberosum L.) cultivars including a genetically modified (GM) amylopectin-accumulating potato line on rhizosphere fungal communities are investigated using molecular microbiological methods. The effects of growth stage of a plant, soil type and year on the rhizosphere fungi were included in this study. To compare the effects, one GM cultivar, the parental isoline, and four non-related cultivars were planted in the fields and analysed using T-RFLP on the basis of fungal phylum specific primers combined with multivariate statistical methods. Additionally, fungal biomass and some extracellular fungal enzymes (laccases, Mn-peroxidases and cellulases) were quantified in order to gain insight into the function of the fungal communities. Plant growth stage and year (and agricultural management) had the strongest effect on both diversity and function of the fungal communities while the GM-trait studied was the least explanatory factor. The impact of cultivar and soil type was intermediate. Occasional differences between cultivars, the amylopectin-accumulating potato line, and its parental variety were detected, but these differences were mostly transient in nature and detected either only in one soil, one growth stage or one year.	[Hannula, Silja Emilia; de Boer, Wietse; van Veen, Johannes] Netherlands Inst Ecol NIOO KNAW, Dept Microbial Ecol, Wageningen, Netherlands; [van Veen, Johannes] Leiden Univ, Inst Biol, Leiden, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Leiden University; Leiden University - Excl LUMC	Hannula, SE (corresponding author), Netherlands Inst Ecol NIOO KNAW, Dept Microbial Ecol, Wageningen, Netherlands.	e.hannula@nioo.knaw.nl	van Veen, Johannes A/C-3697-2011; de Boer, Wietse/C-2737-2011; Hannula, Silja Emilia/C-7462-2012; KNAW, NIOO-KNAW/A-4320-2012	de Boer, Wietse/0000-0002-5380-2993; Hannula, Silja Emilia/0000-0003-1398-2018; KNAW, NIOO-KNAW/0000-0002-3835-159X	ERGO of the Netherlands Organization for Scientific Research [838.06.052]	ERGO of the Netherlands Organization for Scientific Research	This research was financed by ERGO grant number 838.06.052 of the Netherlands Organization for Scientific Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdo Z, 2006, ENVIRON MICROBIOL, V8, P929, DOI 10.1111/j.1462-2920.2005.00959.x; Acosta-Martinez V, 2008, SOIL BIOL BIOCHEM, V40, P2762, DOI 10.1016/j.soilbio.2008.07.022; Berg G, 2009, FEMS MICROBIOL ECOL, V68, P1, DOI 10.1111/j.1574-6941.2009.00654.x; Birch ANE, 2007, PEDOBIOLOGIA, V51, P251, DOI 10.1016/j.pedobi.2007.04.008; Bodeker ITM, 2009, ISME J, V3, P1387, DOI 10.1038/ismej.2009.77; Broeckling CD, 2008, APPL ENVIRON MICROB, V74, P738, DOI 10.1128/AEM.02188-07; Buee M, 2009, PLANT SOIL, V321, P189, DOI 10.1007/s11104-009-9991-3; Buyer JS, 2002, CAN J MICROBIOL, V48, P955, DOI [10.1139/w02-095, 10.1139/W02-095]; Carlile M, 2001, FUNGI; Culman SW, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-171; de Ridder-Duine AS, 2006, PEDOBIOLOGIA, V50, P293, DOI 10.1016/j.pedobi.2006.03.004; de Vetten N, 2003, NAT BIOTECHNOL, V21, P439, DOI 10.1038/nbt801; DONEGAN KK, 1995, APPL SOIL ECOL, V2, P111, DOI 10.1016/0929-1393(94)00043-7; Donegan KK, 1996, TRANSGENIC RES, V5, P25, DOI 10.1007/BF01979919; Donegan KK, 1999, J APPL ECOL, V36, P920, DOI 10.1046/j.1365-2664.1999.00448.x; Duineveld BM, 2001, APPL ENVIRON MICROB, V67, P172, DOI 10.1128/AEM.67.1.172-178.2001; Dunfield KE, 2003, APPL ENVIRON MICROB, V69, P7310, DOI 10.1128/AEM.69.12.7310-7318.2003; Fitzjohn RG, 2007, MOL ECOL NOTES, V7, P583, DOI 10.1111/j.1471-8286.2007.01744.x; Garbeva P, 2004, ANNU REV PHYTOPATHOL, V42, P243, DOI 10.1146/annurev.phyto.42.012604.135455; Giovannetti M, 2005, RIV BIOL-BIOL FORUM, V98, P393; Gotz M, 2006, FEMS MICROBIOL ECOL, V58, P404, DOI 10.1111/j.1574-6941.2006.00169.x; Gomes NCM, 2003, APPL ENVIRON MICROB, V69, P3758, DOI 10.1128/AEM.69.7.3758-3766.2003; Gomes NCM, 2001, PLANT SOIL, V232, P167, DOI 10.1023/A:1010350406708; Griffiths BS, 2007, PEDOBIOLOGIA, V51, P195, DOI 10.1016/j.pedobi.2007.04.002; Gschwendtner S, 2010, PLANT SOIL, V335, P413, DOI 10.1007/s11104-010-0430-2; Hack H., 2001, BBCH MONOGRAPH; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hannula SE, 2010, SOIL BIOL BIOCHEM, V42, P2211, DOI 10.1016/j.soilbio.2010.08.020; Hannula SE, 2012, NEW PHYTOLO IN PRESS, pxx; Hart MM, 2009, PEDOBIOLOGIA, V52, P253, DOI 10.1016/j.pedobi.2008.10.005; Helgason T, 1998, NATURE, V394, P431, DOI 10.1038/28764; Inceoglu O, 2010, APPL ENVIRON MICROB, V76, P3675, DOI 10.1128/AEM.00040-10; Jones DL, 2004, NEW PHYTOL, V163, P459, DOI 10.1111/j.1469-8137.2004.01130.x; Kennedy AC, 1999, AGR ECOSYST ENVIRON, V74, P65, DOI 10.1016/S0167-8809(99)00030-4; Lee SH, 2011, MICROB ECOL, V61, P646, DOI 10.1007/s00248-010-9776-5; Lottmann J, 2000, FEMS MICROBIOL ECOL, V33, P41, DOI 10.1111/j.1574-6941.2000.tb00725.x; Lottmann J, 1999, FEMS MICROBIOL ECOL, V29, P365; Lukow T, 2000, FEMS MICROBIOL ECOL, V32, P241, DOI 10.1111/j.1574-6941.2000.tb00717.x; LYNCH JM, 1990, PLANT SOIL, V129, P1, DOI 10.1007/BF00011685; Marschner P, 2003, SOIL BIOL BIOCHEM, V35, P453, DOI 10.1016/S0038-0717(02)00297-3; Marschner P, 2002, PLANT SOIL, V246, P167, DOI 10.1023/A:1020663909890; Milling A, 2004, PLANT SOIL, V266, P23; Raaijmakers JM, 2009, PLANT SOIL, V321, P341, DOI 10.1007/s11104-008-9568-6; Sessitsch A, 2004, PLANT SOIL, V266, P105; Smalla K, 2001, APPL ENVIRON MICROB, V67, P4742, DOI 10.1128/AEM.67.10.4742-4751.2001; Turrini A, 2004, PLANT SOIL, V266, P69; van der Wal A, 2006, SOIL BIOL BIOCHEM, V38, P2890, DOI 10.1016/j.soilbio.2006.04.046; van Overbeek L, 2008, FEMS MICROBIOL ECOL, V64, P283, DOI 10.1111/j.1574-6941.2008.00469.x; Verbruggen E, 2010, NEW PHYTOL, V186, P968, DOI 10.1111/j.1469-8137.2010.03230.x; Wang GH, 2009, PLANT SOIL, V317, P135, DOI 10.1007/s11104-008-9794-y; Wei XD, 2006, PLANT SOIL, V285, P347, DOI 10.1007/s11104-006-9020-8; Weinert N, 2009, APPL ENVIRON MICROB, V75, P3859, DOI 10.1128/AEM.00414-09; Wolfenbarger LL, 2000, SCIENCE, V290, P2088, DOI 10.1126/science.290.5499.2088	53	52	54	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e33819	10.1371/journal.pone.0033819	http://dx.doi.org/10.1371/journal.pone.0033819			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22529898	Green Submitted, Green Published, gold			2022-12-27	WOS:000305347400005
J	Hu, ZL; Fan, Z; Zhao, ZL; Chen, J; Li, JC				Hu, Zhangli; Fan, Zhun; Zhao, Zhonglin; Chen, Jun; Li, Jiancheng			Stable Expression of Antibiotic-Resistant Gene ble from Streptoalloteichus hindustanus in the Mitochondria of Chlamydomonas reinhardtii	PLOS ONE			English	Article							DOMINANT SELECTABLE MARKER; GREEN FLUORESCENT PROTEIN; PHLEOMYCIN-RESISTANCE; TRANSFORMATION; SACCHAROMYCES; CHLOROPLAST; FUSION; EXPORT	The mitochondrial expression of exogenous antibiotic resistance genes has not been demonstrated successfully to date, which has limited the development of antibiotic resistance genes as selectable markers for mitochondrial site-directed transformation in Chlamydomonas reinhardtii. In this work, the plasmid pBSLPNCB was constructed by inserting the gene ble of Streptoalloteichus hindustanus (Sh ble), encoding a small (14-kilodalton) protective protein into the site between TERMINVREP-Left repeats and the cob gene in a fragment of mitochondrial DNA (mtDNA) of C. reinhardtii. The fusion DNA-construct, which contained TERMINVREP-Left, Sh ble, cob, and partial nd4 sequence, were introduced into the mitochondria of the respiratory deficient dum-1 mutant CC-2654 of C. reinhardtii by biolistic particle delivery system. A large number of transformants were obtained after eight weeks in the dark. Subsequent subculture of the transformants on the selection TAP media containing 3 ig/mL Zeomycin for 12 months resulted in genetically modified transgenic algae MT-Bs. Sequencing and Southern analyses on the mitochondrial genome of the different MT-B lines revealed that Sh ble gene had been integrated into the mitochondrial genome of C. reinhardtii. Both Western blot, using the anti-BLE monoclonal antibody, and Zeomycin tolerance analysis confirmed the presence of BLE protein in the transgenic algal cells. It indicates that the Sh ble gene can be stably expressed in the mitochondria of C. reinhardtii.	[Hu, Zhangli; Fan, Zhun; Zhao, Zhonglin; Chen, Jun; Li, Jiancheng] Shenzhen Univ, Coll Life Sci, Shenzhen Key Lab Marine Bioresource & Ecoenvironm, Shenzhen, Peoples R China; [Zhao, Zhonglin] Henan Agr Univ, Coll Sci, Zhengzhou, Peoples R China	Shenzhen University; Henan Agricultural University	Hu, ZL (corresponding author), Shenzhen Univ, Coll Life Sci, Shenzhen Key Lab Marine Bioresource & Ecoenvironm, Shenzhen, Peoples R China.	huzl@szu.edu.cn			National Natural Science Foundation of China [31070323, 41176106, 31000162]; Science and Technology Planning Project of Shenzhen, China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Planning Project of Shenzhen, China	This work was supported by the National Natural Science Foundation of China (Grant No. 31070323,41176106, 31000162), Science and Technology Planning Project of Shenzhen, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KL, 2003, MOL PHYLOGENET EVOL, V29, P380, DOI 10.1016/S1055-7903(03)00194-5; BARON M, 1992, GENE, V114, P239, DOI 10.1016/0378-1119(92)90581-9; Bennett RP, 1998, BIOTECHNIQUES, V24, P478, DOI 10.2144/98243pf01; Cardol P., 2009, CHLAMYDOMONAS SOURCE, P445; Cohen JS, 2001, MITOCHONDRION, V1, P181, DOI 10.1016/S1567-7249(01)00012-5; COLLEAUX L, 1990, MOL GEN GENET, V223, P288, DOI 10.1007/BF00265065; DROCOURT D, 1990, NUCLEIC ACIDS RES, V18, P4009, DOI 10.1093/nar/18.13.4009; Franklin SE, 2004, CURR OPIN PLANT BIOL, V7, P159, DOI 10.1016/j.pbi.2004.01.012; Funes Soledad, 2007, Methods Mol Biol, V372, P137, DOI 10.1007/978-1-59745-365-3_10; GOLDSCHMIDTCLERMONT M, 1991, NUCLEIC ACIDS RES, V19, P4083, DOI 10.1093/nar/19.15.4083; Heitzer M, 2007, ADV EXP MED BIOL, V616, P46; Hu ZL, 2011, MITOCHONDRION, V11, P716, DOI 10.1016/j.mito.2011.05.012; Mireau H, 2003, MOL GENET GENOMICS, V270, P1, DOI 10.1007/s00438-003-0879-2; MULSANT P, 1988, SOMAT CELL MOLEC GEN, V14, P243, DOI 10.1007/BF01534585; NEWMAN SM, 1990, GENETICS, V126, P875; PEREZ P, 1989, PLANT MOL BIOL, V13, P365, DOI 10.1007/BF00015548; POYTON RO, 1996, ADV MOL CEL, V17, P247; RANDOLPHANDERSON BL, 1993, MOL GEN GENET, V236, P235, DOI 10.1007/BF00277118; Remacle C, 2006, P NATL ACAD SCI USA, V103, P4771, DOI 10.1073/pnas.0509501103; Remacle Claire, 1998, Advances in Photosynthesis, V7, P661; Sambrook J, 1989, MOL CLONNING LAB MAN; Soltys BJ, 2000, INT REV CYTOL, V194, P133; Stevens DR, 1996, MOL GEN GENET, V251, P23; Walker TL, 2005, PLANT CELL REP, V24, P629, DOI 10.1007/s00299-005-0004-6; Wang CG, 2004, CHINESE SCI BULL, V49, P1713, DOI 10.1360/04wc0232; Wang CG, 2010, J PHYCOL, V46, P396, DOI 10.1111/j.1529-8817.2009.00789.x; Yamasaki T, 2005, PLANT MOL BIOL, V58, P515, DOI 10.1007/s11103-005-7081-3; Yoon YG, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni140	28	28	30	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e35542	10.1371/journal.pone.0035542	http://dx.doi.org/10.1371/journal.pone.0035542			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22530046	Green Submitted, Green Published, gold			2022-12-27	WOS:000305347400059
J	Lin, P; Wang, M; Li, Y; Zhang, QL; Yang, F; Zhao, JK				Lin, Peng; Wang, Man; Li, Yan; Zhang, Qiaoli; Yang, Fang; Zhao, Jinkou			Detoxification Center-Based Sampling Missed a Subgroup of Higher Risk Drug Users, a Case from Guangdong, China	PLOS ONE			English	Article							HIV	Background: Injection drug use remains among the most important HIV transmission risk in China. Representativeness of drug users sampled from detoxification centers is questionable. A respondent driven sampling survey was conducted to compare the results with those from the detoxification center in the same city. Methods: In 2008, two independent surveys were conducted in Dongguan, China, one for community-based drug users using respondent driven sampling and the other for drug users in a compulsory detoxification center as routine sentinel surveillance. Demographic and behavioral information were collected using the same structured questionnaire. Intravenous blood samples were collected to measure antibodies to HIV-1, and syphilis. Results: Compared to those 400 drug users recruited from the detoxification center, the 303 community-based drug users had higher HIV prevalence (14.7% versus 4.0%, P = 0.04), lower syphilis prevalence (4.7% versus 10.8%, P = 0.07), higher proportion of injection drug use (83.9% versus 60.2%, P = 0.01) and syringe sharing (47.8% versus 36.3%, P = 0.10), more likely to be separated (12.4% versus 3.8%, P = 0.01) and being migrants from Guangxi province (31.4% versus 18.0%, P = 0.09), more engaging in commercial sex (64.4% versus 52.5%, P = 0.04). HIV prevalence and rate of syringe sharing were consistently higher among drug users from Guangxi. Conclusions: Detoxification center-based sampling missed a subgroup with higher HIV prevalence and higher rate of injection drug use. While detoxification center-based sampled can be used to monitor the trend of HIV prevalence and risk behaviors over time, periodic community-based sampling is still necessary to avoid possible systematic error in detoxification center-based samples.	[Lin, Peng; Li, Yan; Yang, Fang] Ctr Dis Control & Prevent Guangdong Prov, Guangzhou, Guangdong, Peoples R China; [Wang, Man] Zhongshan Municipal Ctr Dis Control & Prevent, Zhongshan, Peoples R China; [Zhang, Qiaoli] Dongguan Municipal Ctr Dis Control & Prevent, Dongguan, Peoples R China; [Zhao, Jinkou] Global Fund Fight AIDS TB & Malaria, Geneva, Switzerland		Lin, P (corresponding author), Ctr Dis Control & Prevent Guangdong Prov, Guangzhou, Guangdong, Peoples R China.	jinkou.zhao@theglobalfund.org		Zhao, Jinkou/0000-0001-9184-3385	China-U.S. Cooperation Program on HIV/AIDS Prevention and Control	China-U.S. Cooperation Program on HIV/AIDS Prevention and Control	The survey was supported by the China-U.S. Cooperation Program on HIV/AIDS Prevention and Control. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chinese Center for Disease Control and Prevention, 2002, GUID PROT HIV AIDS S; Committee of Dongguan Yearbook Compilation, 2006, DONGG YB; Committee of Guangdong Yearbook Compilation, 2006, GUANGD YB; Fu XB, 2008, AIDS BEHAV, V12, pS13, DOI 10.1007/s10461-008-9387-z; Heckathorn DD, 2002, SOC PROBL, V49, P11, DOI 10.1525/sp.2002.49.1.11; Jia YJ, 2008, HARM REDUCT J, V5, DOI 10.1186/1477-7517-5-29; Johnson T, 2005, ANN EPIDEMIOL, V15, P381, DOI 10.1016/j.annepidem.2004.09.004; Kretzschmar M, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-108; Lin P., 2009, Morbidity and Mortality Weekly Report, V58, P396; Lin P, 2003, HUA NAN YU FANG YI X, V29, P12; Liu W, 2006, ADDICTION, V101, P1493, DOI 10.1111/j.1360-0443.2006.01557.x; Lu L, 2008, CELL MOL NEUROBIOL, V28, P479, DOI 10.1007/s10571-007-9225-2; Lu Y, 2007, HARM REDUCT J; Malekinejad M, 2008, AIDS BEHAV, V12, pS105, DOI 10.1007/s10461-008-9421-1; Mathers BM, 2008, LANCET, V372, P1733, DOI 10.1016/S0140-6736(08)61311-2; Ministry of Public Health of China, 2009, EST HIV AIDS EP CHIN; Ruan YH, 2004, SEX TRANSM DIS, V31, P623; Salganik MJ, 2006, J URBAN HEALTH, V83, pI98, DOI 10.1007/s11524-006-9106-x; Salganik MJ, 2004, SOCIOL METHODOL, V34, P193, DOI 10.1111/j.0081-1750.2004.00152.x; Sun XH, 2007, AIDS, V21, pS33, DOI 10.1097/01.aids.0000304694.54884.06; Tang YL, 2006, ADDICTION, V101, P657, DOI 10.1111/j.1360-0443.2006.01367.x; Wu ZY, 2007, LANCET, V369, P679, DOI 10.1016/S0140-6736(07)60315-8; Xiong JG, 2007, YU FANG YI XUE QING, V23, P14; Xu C, 2006, ZHONGGUO AI ZI BING, V12, P409; Zhang QL, 2007, XIAN DAI YU FANG YI, V34, P4537	25	4	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e35189	10.1371/journal.pone.0035189	http://dx.doi.org/10.1371/journal.pone.0035189			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959WC	22529988	Green Published, Green Submitted, gold			2022-12-27	WOS:000305347400035
J	Libraty, DH; Makela, S; Vlk, J; Hurme, M; Vaheri, A; Ennis, FA; Mustonen, J				Libraty, Daniel H.; Makela, Satu; Vlk, Jennifer; Hurme, Mikko; Vaheri, Antti; Ennis, Francis A.; Mustonen, Jukka			The Degree of Leukocytosis and Urine GATA-3 mRNA Levels Are Risk Factors for Severe Acute Kidney Injury in Puumala Virus Nephropathia Epidemica	PLOS ONE			English	Article							HEMORRHAGIC-FEVER; HANTAVIRUS; INTERLEUKIN-6; GENE	Puumala hantavirus (PUUV) infection, also known as nephropathia epidemica, is the most common cause of hemorrhagic fever with renal syndrome (HFRS) in Europe. The pathogenesis of PUUV nephropathia epidemica is complex and multifactorial, and the risk factors for severe acute kidney injury (AKI) during acute PUUV infection are not well defined. We conducted a prospective study of hospitalized patients with PUUV infection in Tampere, Finland to identify acute illness risk factors for HFRS severity. Serial daily blood and urine samples were collected throughout acute illness and at 2 week and 6 month convalescent visits. By univariate analyses, the maximum white blood cell count during acute illness was a risk factor for severe AKI. There were no significant associations between PUUV-induced AKI severity and platelet counts, C-reactive protein, or alanine aminotransferase levels. Maximum plasma interleukin (IL)-6, urine IL-6, and urine IL-8 concentrations were positively associated with PUUV-induced AKI. Finally, the maximum urinary sediment GATA-3 mRNA level was positively correlated with the peak fold-change in serum creatinine, regardless of AKI severity classification. By multivariate analyses, we found that the maximum levels of leukocytes and urinary sediment GATA-3 mRNA during acute illness were independent risk factors for severe PUUV-induced AKI. We have identified novel acute illness risk factors for severe PUUV-induced AKI.	[Libraty, Daniel H.; Vlk, Jennifer] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01605 USA; [Makela, Satu; Mustonen, Jukka] Univ Tampere, Sch Med, Dept Med, FIN-33101 Tampere, Finland; [Hurme, Mikko] Univ Tampere, Sch Med, Dept Microbiol, FIN-33101 Tampere, Finland; [Vaheri, Antti] Univ Helsinki, Dept Virol, Haartman Inst, Helsinki, Finland; [Ennis, Francis A.] Univ Massachusetts, Sch Med, Ctr Infect Dis & Vaccine Res, Worcester, MA USA	University of Massachusetts System; University of Massachusetts Worcester; Tampere University; Tampere University; University of Helsinki; University of Massachusetts System; University of Massachusetts Worcester	Libraty, DH (corresponding author), Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01605 USA.	daniel.libraty@umassmed.edu	Vaheri, Antti/AAV-1523-2020	Hurme, Mikko/0000-0002-8614-1044; Makela, Satu/0000-0001-6967-2401	National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID) [U19 AI57319]; Pirkanmaa Hospital District; European Commission [QLK2 CT 2002-01358]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057319] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Pirkanmaa Hospital District; European Commission(European CommissionEuropean Commission Joint Research Centre); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID) (U19 AI57319), Competitive Research Funding of the Pirkanmaa Hospital District, and the European Commission (QLK2 CT 2002-01358). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chan RWY, 2007, RHEUMATOLOGY, V46, P44, DOI 10.1093/rheumatology/kel192; Hoffmann SC, 2005, AM J TRANSPLANT, V5, P573, DOI 10.1111/j.1600-6143.2005.00719.x; Hosoya T, 2010, IMMUNOL REV, V238, P110, DOI 10.1111/j.1600-065X.2010.00954.x; Komatsuda A, 2009, CLIN NEPHROL, V71, P608; LABASTIE MC, 1995, KIDNEY INT, V47, P1597, DOI 10.1038/ki.1995.223; Linderholm M, 1996, J INFECT DIS, V173, P38, DOI 10.1093/infdis/173.1.38; Liu ZW, 2008, VIRAL IMMUNOL, V21, P255, DOI 10.1089/vim.2007.0098; Makary P, EPIDEMIOL INFECT, P1; Makela S, 2004, AM J KIDNEY DIS, V43, P809, DOI 10.1053/j.ajkd.2003.12.044; Makela S, 2001, NEPHROL DIAL TRANSPL, V16, P1368, DOI 10.1093/ndt/16.7.1368; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Mustonen J, 1996, KIDNEY INT, V49, P217, DOI 10.1038/ki.1996.29; Obara N, 2008, BLOOD, V111, P5223, DOI 10.1182/blood-2007-10-115857; Outinen TK, 2011, J MED VIROL, V83, P731, DOI 10.1002/jmv.22018; Outinen TK, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-132; Sadeghi M, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-65; Temonen M, 1996, CLIN IMMUNOL IMMUNOP, V78, P47, DOI 10.1006/clin.1996.0007; Tipping PG, 2005, CLIN EXP IMMUNOL, V142, P207, DOI 10.1111/j.1365-2249.2005.02842.x; Vapalahti O, 2003, LANCET INFECT DIS, V3, P653, DOI 10.1016/S1473-3099(03)00774-6; Zhu JF, 2006, CELL RES, V16, P3, DOI 10.1038/sj.cr.7310002	20	34	37	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e35402	10.1371/journal.pone.0035402	http://dx.doi.org/10.1371/journal.pone.0035402			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523590	Green Published, Green Submitted, gold			2022-12-27	WOS:000305345000063
J	Song, HK; Hong, SE; Kim, T; Kim, DH				Song, Hong Ki; Hong, Seong-Eui; Kim, Taeyong; Kim, Do Han			Deep RNA Sequencing Reveals Novel Cardiac Transcriptomic Signatures for Physiological and Pathological Hypertrophy	PLOS ONE			English	Article							MUSCLE LIM PROTEIN-1; GENE-EXPRESSION; MICROARRAY ANALYSIS; SPLICE VARIANTS; MESSENGER-RNA; C-MYC; LOCALIZATION; SKELETAL; ISOFORM; IDENTIFICATION	Although both physiological hypertrophy (PHH) and pathological hypertrophy (PAH) of the heart have similar morphological appearances, only PAH leads to fatal heart failure. In the present study, we used RNA sequencing (RNA-Seq) to determine the transcriptomic signatures for both PHH and PAH. Approximately 13-20 million reads were obtained for both models, among which PAH showed more differentially expressed genes (DEGs) (2,041) than PHH (245). The expression of 417 genes was barely detectable in the normal heart but was suddenly activated in PAH. Among them, Foxm1 and Plk1 are of particular interest, since Ingenuity Pathway Analysis (IPA) using DEGs and upstream motif analysis showed that they are essential hub proteins that regulate the expression of downstream proteins associated with PAH. Meanwhile, 52 genes related to collagen, chemokines, and actin showed opposite expression patterns between PHH and PAH. MAZ-binding motifs were enriched in the upstream region of the participating genes. Alternative splicing (AS) of exon variants was also examined using RNA-Seq data for PAH and PHH. We found 317 and 196 exon inclusions and exon exclusions, respectively, for PAH, and 242 and 172 exon inclusions and exclusions, respectively for PHH. The AS pattern was mostly related to gains or losses of domains, changes in activity, and localization of the encoded proteins. The splicing variants of 8 genes (i.e., Fhl1, Rcan1, Ndrg2, Synpo, Ttll1, Cxxc5, Egfl7, and Tmpo) were experimentally confirmed. Multilateral pathway analysis showed that the patterns of quantitative (DEG) and qualitative (AS) changes differ depending on the type of pathway in PAH and PHH. One of the most significant changes in PHH is the severe downregulation of autoimmune pathways accompanied by significant AS. These findings revealed the unique transcriptomic signatures of PAH and PHH and also provided a more comprehensive understanding at both the quantitative and qualitative levels.	[Song, Hong Ki] Gwangju Inst Sci & Technol, Sch Life Sci, Kwangju, South Korea; Gwangju Inst Sci & Technol, Syst Biol Res Ctr, Kwangju, South Korea	Gwangju Institute of Science & Technology (GIST); Gwangju Institute of Science & Technology (GIST)	Song, HK (corresponding author), Gwangju Inst Sci & Technol, Sch Life Sci, Kwangju, South Korea.	dhkim@gist.ac.kr		Kim, Taeyong/0000-0002-4147-3635	Korea MEST NRF [20110002144]; 2011 GIST Systems Biology Infrastructure Establishment Grant	Korea MEST NRF(National Research Foundation of KoreaMinistry of Education, Science & Technology (MEST), Republic of Korea); 2011 GIST Systems Biology Infrastructure Establishment Grant	This work was supported by the Korea MEST NRF grant (20110002144) and the 2011 GIST Systems Biology Infrastructure Establishment Grant (2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja P, 2007, PHYSIOL REV, V87, P521, DOI 10.1152/physrev.00032.2006; Arndt-Maric R, 2010, CLIN LAB, V56, P519; Asanuma K, 2005, J CLIN INVEST, V115, P1188, DOI 10.1172/JCI200523371; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Beisvag V, 2009, EUR J CARDIOV PREV R, V16, P690, DOI 10.1097/HJR.0b013e32833158a2; Berger R, 1996, GENOME RES, V6, P361, DOI 10.1101/gr.6.5.361; Bolte C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022217; BOSSONE SA, 1992, P NATL ACAD SCI USA, V89, P7452, DOI 10.1073/pnas.89.16.7452; Boulkroun S, 2002, J BIOL CHEM, V277, P31506, DOI 10.1074/jbc.M200272200; Brown S, 1999, J BIOL CHEM, V274, P27083, DOI 10.1074/jbc.274.38.27083; Brown SE, 2001, MAMM GENOME, V12, P916, DOI 10.1007/s00335-001-3029-3; Casneuf T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-461; Catalucci D, 2008, FRONT BIOSCI-LANDMRK, V13, P312, DOI 10.2741/2681; Cha H, 2008, J MOL CELL CARDIOL, V45, P796, DOI 10.1016/j.yjmcc.2008.09.124; Chan DW, 2008, J PATHOL, V215, P245, DOI 10.1002/path.2355; CHIEN KR, 1991, FASEB J, V5, P3037, DOI 10.1096/fasebj.5.15.1835945; Damilano F, 2011, CIRCULATION, V123, P391, DOI 10.1161/CIRCULATIONAHA.110.950543; Davies KJA, 2007, FASEB J, V21, P3023, DOI 10.1096/fj.06-7246com; DESJARDINS E, 1993, MOL CELL BIOL, V13, P5710, DOI 10.1128/MCB.13.9.5710; Dreszer TR, 2012, NUCLEIC ACIDS RES, V40, pD918, DOI 10.1093/nar/gkr1055; Eklund AC, 2006, NAT BIOTECHNOL, V24, P1071, DOI 10.1038/nbt0906-1071; Fryknas M, 2006, TUMOR BIOL, V27, P211, DOI 10.1159/000093056; Fu Z, 2008, NAT CELL BIOL, V10, P1076, DOI 10.1038/ncb1767; Galindo Cristi L., 2009, BMC Physiology, V9, P23, DOI 10.1186/1472-6793-9-23; Gupta S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r24; Han JH, 2011, MOL CELL BIOL, V31, P793, DOI 10.1128/MCB.01117-10; Hayashi Y, 1997, BIOCHEM BIOPH RES CO, V236, P83, DOI 10.1006/bbrc.1997.6911; Henderson DM, 2007, MOL BIOL CELL, V18, P2698, DOI 10.1091/mbc.E06-09-0831; Himeda CL, 2008, MOL CELL BIOL, V28, P6521, DOI 10.1128/MCB.00306-08; Hong CS, 2008, J MOL CELL CARDIOL, V44, P672, DOI 10.1016/j.yjmcc.2008.01.012; Hunter JJ, 1999, NEW ENGL J MED, V341, P1276, DOI 10.1056/NEJM199910213411706; Iemitsu M, 2005, ACTA PHYSIOL SCAND, V185, P259, DOI 10.1111/j.1365-201X.2005.01494.x; Ikebe C, 1998, BIOCHEM BIOPH RES CO, V246, P307, DOI 10.1006/bbrc.1998.8609; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kogo H, 2004, J BIOL CHEM, V279, P25574, DOI 10.1074/jbc.M310807200; KOMURO I, 1993, ANNU REV PHYSIOL, V55, P55, DOI 10.1146/annurev.ph.55.030193.000415; Ladd AN, 2001, MOL CELL BIOL, V21, P1285, DOI 10.1128/MCB.21.4.1285-1296.2001; Lee JH, 2011, CIRC RES, V109, P1332, DOI 10.1161/CIRCRESAHA.111.249433; Lee S, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1015; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Matkovich SJ, 2010, CIRC RES, V106, P1459, DOI 10.1161/CIRCRESAHA.110.217513; McGrath MJ, 2003, AM J PHYSIOL-CELL PH, V285, pC1513, DOI 10.1152/ajpcell.00207.2003; McMullen JR, 2003, P NATL ACAD SCI USA, V100, P12355, DOI 10.1073/pnas.1934654100; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Okoniewski MJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-276; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Park JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022391; Ramakrishna S, 2007, DEV DYNAM, V236, P1000, DOI 10.1002/dvdy.21113; REYES AA, 1991, MOL CELL BIOL, V11, P1654, DOI 10.1128/MCB.11.3.1654; Rezniczek GA, 2003, HUM MOL GENET, V12, P3181, DOI 10.1093/hmg/ddg345; Soncin F, 2003, EMBO J, V22, P5700, DOI 10.1093/emboj/cdg549; Tanaka E, 2011, BIOINFORMATICS, V27, P1603, DOI 10.1093/bioinformatics/btr257; Trichet V, 2000, GENE, V257, P109, DOI 10.1016/S0378-1119(00)00383-8; U M, 2004, LEUKEMIA, V18, P1850, DOI 10.1038/sj.leu.2403516; Ueno S, 2003, BIOCHEM BIOPH RES CO, V307, P771, DOI 10.1016/S0006-291X(03)01252-X; Van den Bosch BJC, 2006, GENOMICS, V88, P480, DOI 10.1016/j.ygeno.2006.04.012; Vencio RZN, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-119; Wontakal SN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001392; Yamazaki T, 2010, CARDIOVASC RES, V86, P374, DOI 10.1093/cvr/cvq023; Yan C, 1996, J BIOL CHEM, V271, P25699, DOI 10.1074/jbc.271.41.25699; Yang J, 2000, CIRC RES, V87, pE61, DOI 10.1161/01.RES.87.12.e61; Zhang M, 2003, MOL MED, V9, P18, DOI 10.1007/BF03402103; Zhao MM, 2004, PHYSIOL GENOMICS, V19, P93, DOI 10.1152/physiolgenomics.00040.2004	64	85	86	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e35552	10.1371/journal.pone.0035552	http://dx.doi.org/10.1371/journal.pone.0035552			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523601	Green Published, gold			2022-12-27	WOS:000305345000075
J	Shih, CC; Liao, CC; Su, YC; Tsai, CC; Lin, JG				Shih, Chun-Chuan; Liao, Chien-Chang; Su, Yi-Chang; Tsai, Chin-Chuan; Lin, Jaung-Geng			Gender Differences in Traditional Chinese Medicine Use among Adults in Taiwan	PLOS ONE			English	Article							HEALTH INTERVIEW SURVEY; POPULATION-BASED SURVEY; ALTERNATIVE MEDICINE; UNITED-STATES; WESTERN MEDICINE; ACUPUNCTURE USE; NATIONAL-SURVEY; OBESE WOMEN; COMPLEMENTARY; PATTERNS	Objectives: The increasing use of complementary, alternative medicine (CAM) and traditional Chinese medicine (TCM) has attracted attention. We report on the gender difference in TCM use among the general population in Taiwan in a population-based, cross-sectional study. Methods: We collected data on socio-demographic factors, lifestyle and health behavior from the 2001 Taiwan National Health Interview Survey. The medical records of interviewees aged 20-69 years were obtained from National Health Insurance claims data with informed consent. The prevalence of TCM use and the average frequency of TCM use were compared between women and men. Results: Among 14,064 eligible participants, the one-year prevalence of TCM use for women and men was 31.8% and 22.4%, respectively. Compared with men, women had a higher average TCM use frequency (1.55 visits vs. 1.04 visits, p<0.001). This significant difference remained evident after excluding gender-specific diseases (1.43 visits vs. 1.03 visits, p<0.001). The average TCM use frequency was significantly higher in women than in men across all age groups. TCM use correlates differed for women and men. Marital status (odds ratio [OR] = 1.55, 95% confidence interval [CI] = 1.30-1.85), family income and unhealthy lifestyle (OR = 1.50, 95% CI = 1.30-1.74) were factors associated with TCM use in men but not in women. Conclusions: In Taiwan, women used more TCM services than men and the gender differences in the TCM use profile persisted across age groups.	[Shih, Chun-Chuan; Tsai, Chin-Chuan] I Shou Univ, Sch Chinese Med Postbaccalaureate, Kaohsiung Cty, Taiwan; [Shih, Chun-Chuan; Su, Yi-Chang; Lin, Jaung-Geng] China Med Univ, Coll Chinese Med, Grad Inst Chinese Med, Taichung, Taiwan; [Shih, Chun-Chuan] Taipei Chinese Med Assoc, Taipei, Taiwan; [Liao, Chien-Chang] Taipei Med Univ Hosp, Dept Anesthesiol, Taipei, Taiwan; [Liao, Chien-Chang] Taipei Med Univ, Sch Med, Taipei, Taiwan; [Liao, Chien-Chang] Taipei Med Univ Hosp, Ctr Hlth Res, Taipei, Taiwan; [Liao, Chien-Chang] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan	I Shou University; China Medical University Taiwan; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan	Shih, CC (corresponding author), I Shou Univ, Sch Chinese Med Postbaccalaureate, Kaohsiung Cty, Taiwan.	jglin@mail.cmu.edu.tw		Su, Yi-Chang/0000-0002-8765-5389	Committee on Chinese Medicine and Pharmacy, Department of Health, Taiwan [CCMP98-RD-038]; China Medical University Hospital [1MS1]; Taiwan Department of Health Clinical Trial and Research Center for Excellence [DOH100-TD-B-111-004]; Taiwan Department of Health Cancer Research Center of Excellence [DOH100-TD-C-111-005]	Committee on Chinese Medicine and Pharmacy, Department of Health, Taiwan; China Medical University Hospital; Taiwan Department of Health Clinical Trial and Research Center for Excellence; Taiwan Department of Health Cancer Research Center of Excellence	This study was supported in part by a grant from Committee on Chinese Medicine and Pharmacy, Department of Health, Taiwan (grant number CCMP98-RD-038), China Medical University Hospital (grant number 1MS1), Taiwan Department of Health Clinical Trial and Research Center for Excellence (grant number DOH100-TD-B-111-004) and Taiwan Department of Health Cancer Research Center of Excellence (grant number DOH100-TD-C-111-005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes P. M., 2008, COMPLEMENTARY ALTERN; Bishop FL, 2010, EVID-BASED COMPL ALT, V7, P11, DOI 10.1093/ecam/nen023; Buettner C, 2006, BREAST CANCER RES TR, V100, P219, DOI 10.1007/s10549-006-9239-3; Burke A, 2006, J ALTERN COMPLEM MED, V12, P639, DOI 10.1089/acm.2006.12.639; Chang LC, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-170; Chang PJ, 2010, INT J NURS STUD, V47, P13, DOI 10.1016/j.ijnurstu.2009.06.002; Chen FP, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-26; Chen JX, 2006, J ALTERN COMPLEM MED, V12, P763, DOI 10.1089/acm.2006.12.763; Chen YC, 2008, HEPATO-GASTROENTEROL, V55, P467; Chi CH, 1996, SOC SCI MED, V43, P1329, DOI 10.1016/0277-9536(95)00429-7; Chuang CH, 2007, PHARMACOEPIDEM DR S, V16, P464, DOI 10.1002/pds.1332; Chuang CH, 2006, DRUG SAFETY, V29, P537, DOI 10.2165/00002018-200629060-00006; Chuang CH, 2009, INT J NURS STUD, V46, P787, DOI 10.1016/j.ijnurstu.2008.12.015; Chung V, 2007, J ALTERN COMPLEM MED, V13, P361, DOI 10.1089/acm.2006.6152; Chung VCH, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-207; Daly M, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-10; Davis MP, 2003, ARCH PEDIAT ADOL MED, V157, P393, DOI 10.1001/archpedi.157.4.393; Dello Buono M, 2001, J PSYCHOSOM RES, V50, P147, DOI 10.1016/S0022-3999(00)00223-3; Eisenberg DM, 1998, JAMA-J AM MED ASSOC, V280, P1569, DOI 10.1001/jama.280.18.1569; Hanssen B, 2005, SCAND J PRIM HEALTH, V23, P57, DOI 10.1080/02813430510018419; Hsu CH, 2005, J WOMENS HEALTH, V14, P434, DOI 10.1089/jwh.2005.14.434; Hsu CH, 2009, J WOMENS HEALTH, V18, P813, DOI 10.1089/jwh.2008.1005; Huang N, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-18; Kim M, 2002, J COMMUN HEALTH, V27, P109, DOI 10.1023/A:1014509200352; Lai D, 2007, FAM PRACT, V24, P56, DOI 10.1093/fampra/cml058; Liao CC, 2005, TAIWAN J PUBLIC HLTH, V24, P209; Liao CC, 2006, TAIWAN J PUBLIC HLTH, V25, P223; Loh CH, 2009, SINGAP MED J, V50, P1162; MacPherson H, 2006, COMPLEMENT THER MED, V14, P20, DOI 10.1016/j.ctim.2005.07.006; Oliver MI, 2005, BRIT J PSYCHIAT, V186, P297, DOI 10.1192/bjp.186.4.297; Pu CY, 2008, EUR J CANCER CARE, V17, P340, DOI 10.1111/j.1365-2354.2007.00865.x; Shih CC, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-191; Shih CC, 2009, CHINESE MED J-PEKING, V122, P1544, DOI 10.3760/cma.j.issn.0366-6999.2009.13.013; Shih SF, 2008, SOC SCI MED, V67, P1183, DOI 10.1016/j.socscimed.2008.06.011; Shih Y-T, 2003, TAIWAN J PUBLIC HEAL, V22, P419; Shmueli A, 2004, ISRAEL MED ASSOC J, V6, P3; Sikand A, 1998, ARCH PEDIAT ADOL MED, V152, P1059; Thomas KJ, 2001, COMPLEMENT THER MED, V9, P2, DOI 10.1054/ctim.2000.0407; Tindle HA, 2005, ALTERN THER HEALTH M, V11, P42; Upchurch DM, 2008, WOMEN HEALTH ISS, V18, P62, DOI 10.1016/j.whi.2007.08.003; Wu APW, 2007, FAM MED, V39, P195; Yang YH, 2009, CLIMACTERIC, V12, P541, DOI 10.3109/13697130903060081; Yeh LLL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000719; Zhang ZJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017239	44	70	70	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e32540	10.1371/journal.pone.0032540	http://dx.doi.org/10.1371/journal.pone.0032540			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UP	22539941	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341000004
J	Firestone, SM; Cogger, N; Ward, MP; Toribio, JALML; Moloney, BJ; Dhand, NK				Firestone, Simon M.; Cogger, Naomi; Ward, Michael P.; Toribio, Jenny-Ann L. M. L.; Moloney, Barbara J.; Dhand, Navneet K.			The Influence of Meteorology on the Spread of Influenza: Survival Analysis of an Equine Influenza (A/H3N8) Outbreak	PLOS ONE			English	Article							NEW-SOUTH-WALES; ABSOLUTE-HUMIDITY; ENVIRONMENTAL-FACTORS; RELATIVE-HUMIDITY; CLINICAL SIGNS; TRANSMISSION; VIRUSES; HORSES; EPIDEMIOLOGY; INACTIVATION	The influences of relative humidity and ambient temperature on the transmission of influenza A viruses have recently been established under controlled laboratory conditions. The interplay of meteorological factors during an actual influenza epidemic is less clear, and research into the contribution of wind to epidemic spread is scarce. By applying geostatistics and survival analysis to data from a large outbreak of equine influenza (A/H3N8), we quantified the association between hazard of infection and air temperature, relative humidity, rainfall, and wind velocity, whilst controlling for premises-level covariates. The pattern of disease spread in space and time was described using extraction mapping and instantaneous hazard curves. Meteorological conditions at each premises location were estimated by kriging daily meteorological data and analysed as time-lagged time-varying predictors using generalised Cox regression. Meteorological covariates time-lagged by three days were strongly associated with hazard of influenza infection, corresponding closely with the incubation period of equine influenza. Hazard of equine influenza infection was higher when relative humidity was <60% and lowest on days when daily maximum air temperature was 20-25 degrees C. Wind speeds >30 km hour(-1) from the direction of nearby infected premises were associated with increased hazard of infection. Through combining detailed influenza outbreak and meteorological data, we provide empirical evidence for the underlying environmental mechanisms that influenced the local spread of an outbreak of influenza A. Our analysis supports, and extends, the findings of studies into influenza A transmission conducted under laboratory conditions. The relationships described are of direct importance for managing disease risk during influenza outbreaks in horses, and more generally, advance our understanding of the transmission of influenza A viruses under field conditions.	[Firestone, Simon M.; Ward, Michael P.; Toribio, Jenny-Ann L. M. L.; Dhand, Navneet K.] Univ Sydney, Fac Vet Sci, Camden, NSW, Australia; [Cogger, Naomi] Massey Univ, EpiCtr, Inst Vet Anim & Biomed Sci, Palmerston North, New Zealand; [Moloney, Barbara J.] New S Wales Govt Dept Primary Ind, Principal Dept Trade & Investment, Reg Infrastruct & Serv, Orange, NSW, Australia	University of Sydney; Massey University; NSW Department of Primary Industries	Firestone, SM (corresponding author), Univ Sydney, Fac Vet Sci, Camden, NSW, Australia.	simon.firestone@sydney.edu.au	Toribio, Jenny-Ann LML/B-5032-2011; Moloney, Barbara Jean/G-2003-2011; Dhand, Navneet K/H-5762-2019; Ward, Michael Patrick/GRX-1851-2022; Ward, Michael Patrick/W-1897-2019; Ward, Michael/C-5758-2009	Moloney, Barbara Jean/0000-0002-4416-3579; Dhand, Navneet K/0000-0002-4362-3596; Ward, Michael Patrick/0000-0002-9921-4986; Ward, Michael/0000-0002-9921-4986; Firestone, Simon/0000-0002-3239-1419	Australian Biosecurity Cooperative Research Centre for Emerging Infectious Diseases; Rural Industries Research and Development Corporation	Australian Biosecurity Cooperative Research Centre for Emerging Infectious Diseases(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Rural Industries Research and Development Corporation	This research was jointly funded by the Australian Biosecurity Cooperative Research Centre for Emerging Infectious Diseases and the Rural Industries Research and Development Corporation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DJ, 2007, VACCINE, V25, P5637, DOI 10.1016/j.vaccine.2006.10.051; Allison P. D., 2010, SURVIVAL ANAL USING, VSecond; ANDERSEN PK, 1982, ANN STAT, V10, P1100, DOI 10.1214/aos/1176345976; Animal Health Australia, 2011, DIS STRAT EQ INFL VE; Armitage P, 2001, STAT METHODS MED RES, P356; Australian Government Department of Health and Ageing, 2010, AUSTR HLTH MAN PLAN; BEAN B, 1982, J INFECT DIS, V146, P47, DOI 10.1093/infdis/146.1.47; Belser JA, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001705; Callinan I., 2008, EQUINE INFLUENZA AUG; Center for International Earth Science Information Network International Food Policy Research Institute The World Bank Centro Internacional de Agricultura Tropical, 2011, GLOB RUR URB MAPP PR; Chan T.C., 2010, PLOS ONE, V5; Charland KML, 2009, EPIDEMIOL INFECT, V137, P1377, DOI 10.1017/S0950268809002283; Cowled B, 2009, PREV VET MED, V92, P60, DOI 10.1016/j.prevetmed.2009.08.006; Daly JM, 2011, VET J, V189, P7, DOI 10.1016/j.tvjl.2010.06.026; Davies TM, 2011, J STAT SOFTW, V39, P1; Davies TM, 2010, STAT MED, V29, P2423, DOI 10.1002/sim.3995; Davis J, 2009, TRANSBOUND EMERG DIS, V56, P31, DOI 10.1111/j.1865-1682.2008.01060.x; Dhand NK, 2011, AUST VET J, V89, P73, DOI 10.1111/j.1751-0813.2011.00754.x; Diggle PJ, 2007, SPRINGER SER STAT, P1, DOI 10.1007/978-0-387-48536-2; Dohoo I., 2014, VET EPIDEMIOLOGIC RE, V2nd; du Prel JB, 2009, CLIN INFECT DIS, V49, P861, DOI 10.1086/605435; Dups JN, 2011, AUST VET J, V89, P17, DOI 10.1111/j.1751-0813.2011.00729.x; East IJ, 2011, AUST VET J, V89, P88, DOI 10.1111/j.1751-0813.2011.00756.x; Faehrmann P, 2011, AUST VET J, V89, P22, DOI 10.1111/j.1751-0813.2011.00733.x; Fang LQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002268; Firestone SM, 2012, PREV VET MED, V106, P123, DOI 10.1016/j.prevetmed.2012.01.020; Firestone SM, 2011, PREV VET MED, V102, P185, DOI 10.1016/j.prevetmed.2011.07.006; Firestone SM, 2011, PREV VET MED, V100, P53, DOI 10.1016/j.prevetmed.2011.03.002; Foord AJ, 2009, VET MICROBIOL, V137, P1, DOI 10.1016/j.vetmic.2008.12.006; Garner MG, 2011, PREV VET MED, V99, P15, DOI 10.1016/j.prevetmed.2010.02.007; Garner MG, 1995, POTENTIAL WIND BORNE; Geoscience Australia, 2008, GEODATA 9 2 DIG EL M; Geoscience Australia, 2006, GEOD TOPO 250K 3; Gloster J, 2011, REV SCI TECH OIE, V30, P457; Gloster J, 2010, VET J, V183, P278, DOI 10.1016/j.tvjl.2008.11.011; Harrell FE, 2001, REGRESSION MODELING; HEMMES JH, 1960, NATURE, V188, P430, DOI 10.1038/188430a0; Hosmer DW, 2008, APPL SURVIVAL ANAL R, V2nd; Inggs MR, 1996, IEEE T GEOSCI REMOTE, V34, P250, DOI 10.1109/36.481909; Journel A. G., 1978, MINING GEOSTATISTICS; Kedmi M, 2010, PREV VET MED, V96, P152, DOI 10.1016/j.prevetmed.2010.06.008; Lowen AC, 2008, J VIROL, V82, P5650, DOI 10.1128/JVI.00325-08; Lowen AC, 2007, PLOS PATHOG, V3, P1470, DOI 10.1371/journal.ppat.0030151; Ma E, 2010, EPIDEMIOL INFECT, V138, P1779, DOI 10.1017/S0950268810002256; Matheron G., 1963, ECON GEOL, V58, P1246, DOI [DOI 10.2113/GSECONGEO.58.8.1246, 10.2113/gsecongeo.58.8.1246]; McDevitt J, 2010, APPL ENVIRON MICROB, V76, P3943, DOI 10.1128/AEM.02674-09; MCGEADY ML, 1979, APPL ENVIRON MICROB, V37, P972, DOI 10.1128/AEM.37.5.972-977.1979; MCQUEEN JL, 1966, AM J EPIDEMIOL, V83, P280, DOI 10.1093/oxfordjournals.aje.a120584; Moloney B, 2011, AUST VET J, V89, P56, DOI 10.1111/j.1751-0813.2011.00749.x; MUMFORD JA, 1990, EQUINE VET J, V22, P93, DOI 10.1111/j.2042-3306.1990.tb04217.x; MUMFORD JA, 1994, EPIDEMIOL INFECT, V112, P421, DOI 10.1017/S0950268800057848; Murray EJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024042; Myers C., 2006, Clinical Techniques in Equine Practice, V5, P187, DOI 10.1053/j.ctep.2006.03.013; Paillot R, 2006, VACCINE, V24, P4047, DOI 10.1016/j.vaccine.2006.02.030; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; SCHAFFER FL, 1976, ARCH VIROL, V51, P263, DOI 10.1007/BF01317930; Shaman J, 2009, P NATL ACAD SCI USA, V106, P3243, DOI 10.1073/pnas.0806852106; Shoji M, 2011, TOHOKU J EXP MED, V224, P251, DOI 10.1620/tjem.224.251; Steel J, 2011, J VIROL, V85, P1400, DOI 10.1128/JVI.02186-10; Stevenson M., 2010, EPIR FUNCTIONS ANAL; Tellier R, 2006, EMERG INFECT DIS, V12, P1657, DOI 10.3201/eid1211.060426; Tellier R, 2009, J R SOC INTERFACE, V6, pS783, DOI 10.1098/rsif.2009.0302.focus; Therneau T.M., 2000, MODELING SURVIVAL DA; THERNEAU TM, 1990, BIOMETRIKA, V77, P147, DOI 10.1093/biomet/77.1.147; von Klot S, 2009, EPIDEMIOLOGY, V20, P547, DOI 10.1097/EDE.0b013e31819d9501; Ward MP, 2000, PREV VET MED, V45, P257, DOI 10.1016/S0167-5877(00)00133-1; Weber TP, 2008, J INFECTION, V57, P361, DOI 10.1016/j.jinf.2008.08.013; Wong D, 2011, AUST VET J, V89, P15, DOI 10.1111/j.1751-0813.2011.00728.x; WOOD J, 2007, EQUINE RESP MED SURG, P287; World Bank, 2011, WORLD DEV IND ONL DA; Yadav M. P., 1993, International Journal of Animal Sciences, V8, P93; Yuan JS, 2006, AM J INFECT CONTROL, V34, P234, DOI 10.1016/j.ajic.2005.12.006	72	29	29	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35284	10.1371/journal.pone.0035284	http://dx.doi.org/10.1371/journal.pone.0035284			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536366	gold, Green Published			2022-12-27	WOS:000305339200049
J	Wu, DT; Seita, Y; Zhang, X; Lu, CW; Roth, MJ				Wu, Dai-tze; Seita, Yasunari; Zhang, Xia; Lu, Chi-Wei; Roth, Monica J.			Antibody-Directed Lentiviral Gene Transduction for Live-Cell Monitoring and Selection of Human iPS and hES Cells	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; TARGETED TRANSDUCTION; EXPRESSION; DIFFERENTIATION; GENERATION; EFFICIENT; CULTURE; PROTEIN; TROPHOBLAST; FIBROBLASTS	The identification of stem cells within a mixed population of cells is a major hurdle for stem cell biology-in particular, in the identification of induced pluripotent stem (iPS) cells during the reprogramming process. Based on the selective expression of stem cell surface markers, a method to specifically infect stem cells through antibody-conjugated lentiviral particles has been developed that can deliver both visual markers for live-cell imaging as well as selectable markers to enrich for iPS cells. Antibodies recognizing SSEA4 and CD24 mediated the selective infection of the iPS cells over the parental human fibroblasts, allowing for rapid expansion of these cells by puromycin selection. Adaptation of the vector allows for the selective marking of human embryonic stem (hES) cells for their removal from a population of differentiated cells. This method has the benefit that it not only identifies stem cells, but that specific genes, including positive and negative selection markers, regulatory genes or miRNA can be delivered to the targeted stem cells. The ability to specifically target gene delivery to human pluripotent stem cells has broad applications in tissue engineering and stem cell therapies.	[Wu, Dai-tze] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA; [Zhang, Xia; Roth, Monica J.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA; [Seita, Yasunari; Lu, Chi-Wei] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Deptartment Ob Gyn, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Roth, MJ (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA.	roth@umdnj.edu	Seita, Yasunari/AAF-5173-2020; Roth, Monica/AAN-8742-2020		New Jersey Stem Cell Research Grants [HESC-08-01-00]; National Institutes of Health [RO1CA49932]; Ellison Medical Foundation [AG-NS-0628-09]; Robert Wood Johnson Foundation through Child Health Institute of New Jersey [RY1536]; NATIONAL CANCER INSTITUTE [R01CA049932, P30CA072720] Funding Source: NIH RePORTER	New Jersey Stem Cell Research Grants; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); Robert Wood Johnson Foundation through Child Health Institute of New Jersey; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by New Jersey Stem Cell Research Grants HESC-08-01-00, and National Institutes of Health RO1CA49932 to MJR. CWL is supported by the Ellison Medical Foundation award AG-NS-0628-09 and by the Robert Wood Johnson Foundation grant RY1536 through the Child Health Institute of New Jersey. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; ANDREWS PW, 1984, HYBRIDOMA, V3, P347, DOI 10.1089/hyb.1984.3.347; Apati A, 2008, BBA-BIOMEMBRANES, V1778, P2700, DOI 10.1016/j.bbamem.2008.08.010; Assou S, 2007, STEM CELLS, V25, P961, DOI 10.1634/stemcells.2006-0352; Chan EM, 2009, NAT BIOTECHNOL, V27, P1033, DOI 10.1038/nbt.1580; Chen CC, 2001, BLOOD, V97, P886, DOI 10.1182/blood.V97.4.886; COSSET FL, 1995, J VIROL, V69, P7430, DOI 10.1128/JVI.69.12.7430-7436.1995; Fouchier RAM, 1997, EMBO J, V16, P4531, DOI 10.1093/emboj/16.15.4531; Frank HG, 2001, PLACENTA, V22, pS107, DOI 10.1053/plac.2001.0644; Kamata M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011834; KANNAGI R, 1983, EMBO J, V2, P2355, DOI 10.1002/j.1460-2075.1983.tb01746.x; KAY R, 1991, J IMMUNOL, V147, P1412; Laslett AL, 2003, TRENDS CARDIOVAS MED, V13, P295, DOI 10.1016/S1050-1738(03)00125-7; Lewis JG, 2009, J IMMUNOL METHODS, V346, P71, DOI 10.1016/j.jim.2009.04.011; Liang M, 2009, J GENE MED, V11, P185, DOI 10.1002/jgm.1290; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Mazari PM, 2009, P NATL ACAD SCI USA, V106, P5848, DOI 10.1073/pnas.0809741106; Morizono K, 2005, NAT MED, V11, P346, DOI 10.1038/nm1192; Nagamatsu T, 2004, PLACENTA, V25, P153, DOI 10.1016/j.placenta.2003.08.015; Niakan KK, 2010, GENE DEV, V24, P312, DOI 10.1101/gad.1833510; Ohno K, 1997, NAT BIOTECHNOL, V15, P763, DOI 10.1038/nbt0897-763; Pariente N, 2008, J GENE MED, V10, P242, DOI 10.1002/jgm.1151; Pariente N, 2007, MOL THER, V15, P1973, DOI 10.1038/sj.mt.6300271; Park IH, 2008, NAT PROTOC, V3, P1180, DOI 10.1038/nprot.2008.92; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Potgens AJG, 2001, PLACENTA, V22, P251, DOI 10.1053/plac.2000.0597; Sarangi A, 2007, P NATL ACAD SCI USA, V104, P11032, DOI 10.1073/pnas.0704182104; Schuldiner M, 2003, STEM CELLS, V21, P257, DOI 10.1634/stemcells.21-3-257; Seguin CA, 2008, CELL STEM CELL, V3, P182, DOI 10.1016/j.stem.2008.06.018; SHEVINSKY LH, 1982, CELL, V30, P697, DOI 10.1016/0092-8674(82)90274-4; Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; Yang L, 2006, P NATL ACAD SCI USA, V103, P11479, DOI 10.1073/pnas.0604993103; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang X, 2010, J GENE MED, V12, P945, DOI 10.1002/jgm.1518	38	16	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e34778	10.1371/journal.pone.0034778	http://dx.doi.org/10.1371/journal.pone.0034778			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536330	Green Published, gold, Green Submitted			2022-12-27	WOS:000305339200019
J	Fang, G; Haznadar, M; Wang, W; Yu, HY; Steinbach, M; Church, TR; Oetting, WS; Van Ness, B; Kumar, V				Fang, Gang; Haznadar, Majda; Wang, Wen; Yu, Haoyu; Steinbach, Michael; Church, Timothy R.; Oetting, William S.; Van Ness, Brian; Kumar, Vipin			High-Order SNP Combinations Associated with Complex Diseases: Efficient Discovery, Statistical Power and Functional Interactions	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; DETECTING GENE-GENE; MULTIFACTOR DIMENSIONALITY REDUCTION; COMBINATORIAL PARTITIONING METHOD; LUNG-CANCER; ENVIRONMENT INTERACTIONS; MISSING HERITABILITY; POPULATION; CARCINOGEN; EXPRESSION	There has been increased interest in discovering combinations of single-nucleotide polymorphisms (SNPs) that are strongly associated with a phenotype even if each SNP has little individual effect. Efficient approaches have been proposed for searching two-locus combinations from genome-wide datasets. However, for high-order combinations, existing methods either adopt a brute-force search which only handles a small number of SNPs (up to few hundreds), or use heuristic search that may miss informative combinations. In addition, existing approaches lack statistical power because of the use of statistics with high degrees-of-freedom and the huge number of hypotheses tested during combinatorial search. Due to these challenges, functional interactions in high-order combinations have not been systematically explored. We leverage discriminative-pattern-mining algorithms from the data-mining community to search for high-order combinations in case-control datasets. The substantially improved efficiency and scalability demonstrated on synthetic and real datasets with several thousands of SNPs allows the study of several important mathematical and statistical properties of SNP combinations with order as high as eleven. We further explore functional interactions in high-order combinations and reveal a general connection between the increase in discriminative power of a combination over its subsets and the functional coherence among the genes comprising the combination, supported by multiple datasets. Finally, we study several significant high-order combinations discovered from a lung-cancer dataset and a kidney-transplant-rejection dataset in detail to provide novel insights on the complex diseases. Interestingly, many of these associations involve combinations of common variations that occur in small fractions of population. Thus, our approach is an alternative methodology for exploring the genetics of rare diseases for which the current focus is on individually rare variations.	[Fang, Gang; Wang, Wen; Steinbach, Michael; Kumar, Vipin] Univ Minnesota, Dept Comp Sci, Minneapolis, MN 55455 USA; [Haznadar, Majda; Van Ness, Brian] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; [Yu, Haoyu] Univ Minnesota, Minnesota Supercomp Inst, Minneapolis, MN USA; [Church, Timothy R.] Univ Minnesota, Dept Environm Hlth Sci, Minneapolis, MN 55455 USA; [Oetting, William S.] Univ Minnesota, Dept Expt & Clin Pharmacol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Fang, G (corresponding author), Univ Minnesota, Dept Comp Sci, Minneapolis, MN 55455 USA.	gangfang@cs.umn.edu; kumar@cs.umn.edu	Wang, Wen/E-6320-2012; Church, Timothy/AAH-7017-2020	Wang, Wen/0000-0002-5812-6744; Church, Timothy/0000-0003-3292-5035; Steinbach, Michael/0000-0002-7309-6395	NSF [IIS0916439]; University of Minnesota; University of Minnesota Interdisciplinary Informatics; Direct For Computer & Info Scie & Enginr [0916439] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); University of Minnesota(University of Minnesota System); University of Minnesota Interdisciplinary Informatics; Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This work was supported by NSF grants #IIS0916439, a University of Minnesota Rochester Biomedical Informatics and Computational Biology Program Traineeship Award, and a seed grant from the University of Minnesota Interdisciplinary Informatics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal R., 1994, P 20 INT C VER LARG, P487; Anastassiou D, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100124; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baranzini SE, 2009, HUM MOL GENET, V18, P2078, DOI 10.1093/hmg/ddp120; Bay SD, 2001, DATA MIN KNOWL DISC, V5, P213, DOI 10.1023/A:1011429418057; Bayardo RJ, 2000, DATA MIN KNOWL DISC, V4, P217, DOI 10.1023/A:1009895914772; Bey EA, 2007, P NATL ACAD SCI USA, V104, P11832, DOI 10.1073/pnas.0702176104; Brinza D., 2010, BIOINFORMATICS; Cantor RM, 2010, AM J HUM GENET, V86, P6, DOI 10.1016/j.ajhg.2009.11.017; Cardon LR, 2003, LANCET, V361, P598, DOI 10.1016/S0140-6736(03)12520-2; Carrasquillo MM, 2002, NAT GENET, V32, P237, DOI 10.1038/ng998; Christensen K, 2007, NEW ENGL J MED, V356, P1094, DOI 10.1056/NEJMp068126; Church TR, 2010, INT J MOL EPIDEMIOL, V1, P295; Church TR, 2009, CANCER EPIDEM BIOMAR, V18, P260, DOI 10.1158/1055-9965.EPI-08-0718; Cordell HJ, 2009, NAT REV GENET, V10, P392, DOI 10.1038/nrg2579; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Dong J.L., 1999, P 5 ACM SIGKDD INT C, P43, DOI [10.1145/312129.312191, DOI 10.1145/312129.312191]; Dowell RD, 2010, SCIENCE, V328, P469, DOI 10.1126/science.1189015; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Evans DM, 2006, PLOS GENET, V2, P1424, DOI 10.1371/journal.pgen.0020157; Fang G, 2012, IEEE T KNOWL DATA EN, V24, P279, DOI 10.1109/TKDE.2010.241; Fang G, 2010, BIOCOMPUT-PAC SYM, P145; Gao A, 2010, TOXICOL LETT, V193, P236, DOI 10.1016/j.toxlet.2010.01.017; Goldstein DB, 2009, NEW ENGL J MED, V360, P1696, DOI 10.1056/NEJMp0806284; Grahne G, 2003, WORKSH FREQ IT MIN I; Greene CS, 2010, BIOINFORMATICS, V26, P694, DOI 10.1093/bioinformatics/btq009; Greene CS, 2010, BIOCOMPUT-PAC SYM, P327; Gupta R., 2008, P 14 ACM SIGKDD INT; He H, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-127; Herold C, 2009, BIOINFORMATICS, V25, P3275, DOI 10.1093/bioinformatics/btp596; Hirschhorn JN, 2009, NEW ENGL J MED, V360, P1699, DOI 10.1056/NEJMp0808934; Howard TD, 2002, AM J HUM GENET, V70, P230, DOI 10.1086/338242; Hua X, 2010, BIOINFORMATICS, V26, P1871, DOI 10.1093/bioinformatics/btq290; Huang J, 2004, P NATL ACAD SCI USA, V101, P10529, DOI 10.1073/pnas.0403794101; Huttenhower C, 2009, GENOME RES, V19, P1093, DOI 10.1101/gr.082214.108; Kam-Thong T, 2010, EUROPEAN J IN PRESS; Kraft P, 2009, NEW ENGL J MED, V360, P1701, DOI 10.1056/NEJMp0810107; Lehar J, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.51; Lou XY, 2008, AM J HUM GENET, V83, P457, DOI 10.1016/j.ajhg.2008.09.001; Lou XY, 2007, AM J HUM GENET, V80, P1125, DOI 10.1086/518312; Ma L, 2010, GENET EPIDEMIOL, V34, P434, DOI 10.1002/gepi.20496; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marchini J, 2005, NAT GENET, V37, P413, DOI 10.1038/ng1537; Moore JH, 2010, BIOINFORMATICS, V26, P445, DOI 10.1093/bioinformatics/btp713; Motsinger-Reif AA, 2008, GENET EPIDEMIOL, V32, P767, DOI 10.1002/gepi.20345; Nelson MR, 2001, GENOME RES, V11, P458, DOI 10.1101/gr.172901; Norris MD, 2005, MOL CANCER THER, V4, P547, DOI 10.1158/1535-7163.MCT-04-0161; Oji Y, 2002, INT J CANCER, V100, P297, DOI 10.1002/ijc.10476; Pattin KA, 2009, EXPERT REV PROTEOMIC, V6, P647, DOI 10.1586/EPR.09.86; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rabinowitz D, 2000, HUM HERED, V50, P211, DOI 10.1159/000022918; RITCHIE M, 2001, AM J HUM GENET, V69, P1245; Schadt EE, 2005, NAT GENET, V37, P710, DOI 10.1038/ng1589; Small KM, 2002, NEW ENGL J MED, V347, P1135, DOI 10.1056/NEJMoa020803; Steinbach M, 2011, LECT NOTES ARTIF INT, V6634, P338, DOI 10.1007/978-3-642-20841-6_28; Storey JD, 2005, PLOS BIOL, V3, P1380, DOI 10.1371/journal.pbio.0030267; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Stram DO, 2004, GENET EPIDEMIOL, V27, P365, DOI 10.1002/gepi.20028; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tentori L, 2005, PHARMACOL RES, V52, P25, DOI 10.1016/j.phrs.2005.02.010; Thorisson GA, 2005, GENOME RES, V15, P1592, DOI 10.1101/gr.4413105; van der Deen M, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-59; Van Ness B, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-26; Van Steen K, 2011, BRIEFINGS BIOINFORMA; Varadan V, 2006, BIOINFORMATICS, V22, pE497, DOI 10.1093/bioinformatics/btl224; Varadan V, 2006, PLOS COMPUT BIOL, V2, P585, DOI 10.1371/journal.pcbi.0020068; Vicent S, 2010, J CLIN INVEST, V120, P3940, DOI 10.1172/JCI44165; Wan X, 2010, AM J HUMAN GENETICS; Wang HJ, 2009, CANCER-AM CANCER SOC, V115, P595, DOI 10.1002/cncr.24042; Wang K, 2007, AM J HUM GENET, V81, P1278, DOI 10.1086/522374; Wang K, 2010, NAT REV GENET, V11, P843, DOI 10.1038/nrg2884; Wang Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011384; Yosef N, 2007, BIOINFORMATICS, V23, pE91, DOI 10.1093/bioinformatics/btl298; Zhang W, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000642; Zhang X, 2010, BIOINFORMATICS, V26, pi217, DOI 10.1093/bioinformatics/btq186; Zhang Y, 2007, NAT GENET, V39, P1167, DOI 10.1038/ng2110	77	41	41	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e33531	10.1371/journal.pone.0033531	http://dx.doi.org/10.1371/journal.pone.0033531			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22536319	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336200003
J	Niu, KC; Schmid, B; Choler, P; Du, GZ				Niu, Kechang; Schmid, Bernhard; Choler, Philippe; Du, Guozhen			Relationship between Reproductive Allocation and Relative Abundance among 32 Species of a Tibetan Alpine Meadow: Effects of Fertilization and Grazing	PLOS ONE			English	Article							COMMUNITY STRUCTURE; FUNCTIONAL TRAITS; PLANT-COMMUNITIES; DIVERSITY LOSS; LIFE-HISTORY; TRADE-OFFS; LAND-USE; COMPETITION; COEXISTENCE; ECOLOGY	Background: Understanding the relationship between species traits and species abundance is an important goal in ecology and biodiversity science. Although theoretical studies predict that traits related to performance (e.g. reproductive allocation) are most directly linked to species abundance within a community, empirical investigations have rarely been done. It also remains unclear how environmental factors such as grazing or fertilizer application affect the predicted relationship. Methodology: We conducted a 3-year field experiment in a Tibetan alpine meadow to assess the relationship between plant reproductive allocation (RA) and species relative abundance (SRA) on control, grazed and fertilized plots. Overall, the studied plant community contained 32 common species. Principal Findings: At the treatment level, (i) RA was negatively correlated with SRA on control plots and during the first year on fertilized plots. (ii) No negative RA-SRA correlations were observed on grazed plots and during the second and third year on fertilized plots. (iii) Seed size was positively correlated with SRA on control plots. At the plot level, the correlation between SRA and RA were not affected by treatment, year or species composition. Conclusions/Significance: Our study shows that the performance-related trait RA can negatively affect SRA within communities, which is possibly due to the tradeoffs between clonal growth (for space occupancy) and sexual reproduction. We propose that if different species occupy different positions along these tradeoffs it will contribute to biodiversity maintenance in local communities or even at lager scale.	[Niu, Kechang] Nanjing Univ, Dept Biol, Nanjing 210008, Peoples R China; [Niu, Kechang; Du, Guozhen] Lanzhou Univ, MOE Key Lab Arid & Grassland Ecol, Lanzhou 730000, Peoples R China; [Schmid, Bernhard] Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland; [Choler, Philippe] Univ Grenoble, CNRS, UMR 5553, Lab Ecol Alpine, Grenoble, France; [Choler, Philippe] Univ Grenoble, CNRS, UMS 3370, Stn Alpine J Fourier, Grenoble, France	Nanjing University; Lanzhou University; University of Zurich; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite de Savoie; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA)	Niu, KC (corresponding author), Nanjing Univ, Dept Biol, Nanjing 210008, Peoples R China.	kechangniu@nju.edu.cn	Schmid, Bernhard/C-8625-2009; Choler, Philippe/A-7270-2008; Niu, Kechang/F-7648-2014	Schmid, Bernhard/0000-0002-8430-3214; Choler, Philippe/0000-0002-9062-2721; Niu, Kechang/0000-0003-4845-2930	National Science Foundation of China [31000198, 40930533]; Swiss National Science Foundation [130720]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The study was supported by the National Science Foundation of China (Grant no 31000198 to Kechang Niu and no 40930533 to Guozhen Du). B. Schmid was supported by the Swiss National Science Foundation (Grant no. 130720). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerly DD, 2006, ECOLOGY, V87, pS50, DOI 10.1890/0012-9658(2006)87[50:NEAART]2.0.CO;2; Bazzaz, 1996, PLANTS CHANGING ENV; Bazzaz Fakhri A., 1997, P1, DOI 10.1016/B978-012083490-7/50002-5; Bell G, 2001, SCIENCE, V293, P2413, DOI 10.1126/science.293.5539.2413; Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI 10.1111/boj.12385; Cadotte MW, 2007, ECOLOGY, V88, P823, DOI 10.1890/06-1117; Carson WP., 2008, TROPICAL FOREST COMM, P210; CHEPLICK GP, 1989, CAN J BOT, V67, P2514, DOI 10.1139/b89-321; CONNELL JH, 1984, ECOL MONOGR, V54, P141, DOI 10.2307/1942659; Cornwell WK, 2008, ECOL LETT, V11, P1065, DOI 10.1111/j.1461-0248.2008.01219.x; Cornwell WK, 2010, J ECOL, V98, P814, DOI 10.1111/j.1365-2745.2010.01662.x; Davies TJ, 2004, P NATL ACAD SCI USA, V101, P1904, DOI 10.1073/pnas.0308127100; Diaz S, 1998, J VEG SCI, V9, P113, DOI 10.2307/3237229; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Fakheran S, 2010, P NATL ACAD SCI USA, V107, P19120, DOI 10.1073/pnas.1010846107; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; GLEESON SK, 1990, ECOLOGY, V71, P1144, DOI 10.2307/1937382; Grime J. P., 1979, Plant strategies and vegetation processes.; GRIME JP, 1973, NATURE, V242, P344, DOI 10.1038/242344a0; Harpole WS, 2007, NATURE, V446, P791, DOI 10.1038/nature05684; Hubbell Stephen P., 2001, V32, pi; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; KEDDY PA, 1992, J VEG SCI, V3, P157, DOI 10.2307/3235676; Kelly CK, 2008, ECOLOGY, V89, P962, DOI 10.1890/07-0322.1; Kneitel JM, 2004, ECOL LETT, V7, P69, DOI 10.1046/j.1461-0248.2003.00551.x; Kraft NJB, 2008, SCIENCE, V322, P580, DOI 10.1126/science.1160662; Leishman MR, 2001, OIKOS, V94, P151, DOI 10.1034/j.1600-0706.2001.10392.x; Leishman MR, 2001, OIKOS, V93, P294, DOI 10.1034/j.1600-0706.2001.930212.x; LEVIN SA, 1974, P NATL ACAD SCI USA, V71, P2744, DOI 10.1073/pnas.71.7.2744; Levine JM, 2002, AM NAT, V160, P452, DOI 10.1086/342073; LEVINS R, 1971, P NATL ACAD SCI USA, V68, P1246, DOI 10.1073/pnas.68.6.1246; Li W, 2011, NORD J BOT, V29, P81, DOI 10.1111/j.1756-1051.2010.00954.x; Luo YJ, 2006, J VEG SCI, V17, P417, DOI 10.1658/1100-9233(2006)17[417:IOATAF]2.0.CO;2; Maechler M., 2011, LME4 LINEAR MIXED EF; Martin PH, 2010, OIKOS, V119, P807, DOI 10.1111/j.1600-0706.2009.17941.x; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; McGill BJ, 2007, ECOL LETT, V10, P995, DOI 10.1111/j.1461-0248.2007.01094.x; Murray BR, 2002, AUSTRAL ECOL, V27, P291, DOI 10.1046/j.1442-9993.2002.01181.x; NEWMAN EI, 1973, NATURE, V244, P310, DOI 10.1038/244310a0; Niu Ke-Chang, 2006, Zhiwu Shengtai Xuebao, V30, P817; Niu KC, 2008, BASIC APPL ECOL, V9, P485, DOI 10.1016/j.baae.2007.06.015; Niu KC, 2010, PLANT SOIL, V330, P215, DOI 10.1007/s11104-009-0194-8; Niu KC, 2009, FUNCT ECOL, V23, P274, DOI 10.1111/j.1365-2435.2008.01502.x; Obeso JR, 2002, NEW PHYTOL, V155, P321, DOI 10.1046/j.1469-8137.2002.00477.x; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; PINHEIRO JC, 2011, NLME LINEAR NONLINEA, V3, P1, DOI DOI 10.1371/J0URNAL.P0NE.0018860; PRESTON FW, 1948, ECOLOGY, V29, P254, DOI 10.2307/1930989; Prinzing A, 2008, ECOL LETT, V11, P809, DOI 10.1111/j.1461-0248.2008.01189.x; R Development Core Team, 2011, R LANG ENV STAT COMO; Rajaniemi TK, 2003, OIKOS, V101, P449, DOI 10.1034/j.1600-0706.2003.12128.x; Reader RJ, 1998, PLANT ECOL, V134, P43, DOI 10.1023/A:1009700100343; Reekie EG, 2005, REPROD ALLOCATION PL, P191; Shea K, 2004, ECOL LETT, V7, P491, DOI 10.1111/j.1461-0248.2004.00600.x; Shipley B, 2006, SCIENCE, V314, P812, DOI 10.1126/science.1131344; Silvertown J, 2004, TRENDS ECOL EVOL, V19, P605, DOI 10.1016/j.tree.2004.09.003; Stearns S.C., 1992, pi; Suding KN, 2005, P NATL ACAD SCI USA, V102, P4387, DOI 10.1073/pnas.0408648102; Suding KN, 2003, ECOLOGY, V84, P1; TILMAN D, 1994, ECOLOGY, V75, P2, DOI 10.2307/1939377; Tilman D, 2000, NATURE, V405, P208, DOI 10.1038/35012217; TILMAN D, 1988; Turnbull LA, 2004, J ECOL, V92, P97, DOI 10.1111/j.1365-2745.2004.00856.x; Violle C, 2007, OIKOS, V116, P882, DOI 10.1111/j.2007.0030-1299.15559.x; Vojtech E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000499; Volkov I, 2005, NATURE, V438, P658, DOI 10.1038/nature04030; Volkov I, 2003, NATURE, V424, P1035, DOI 10.1038/nature01883; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Webb CO, 2005, MOL ECOL NOTES, V5, P181, DOI 10.1111/j.1471-8286.2004.00829.x; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Westoby M, 2006, TRENDS ECOL EVOL, V21, P261, DOI 10.1016/j.tree.2006.02.004; [赵彬彬 ZHAO Bin-Bin], 2009, [生态学报, Acta Ecologica Sinica], V29, P1596	71	22	24	5	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e35448	10.1371/journal.pone.0035448	http://dx.doi.org/10.1371/journal.pone.0035448			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22536385	Green Published, Green Accepted, gold			2022-12-27	WOS:000305336200042
J	Opalinski, L; Bartoszewska, M; Fekken, S; Liu, HY; de Boer, R; van der Klei, I; Veenhuis, M; Kiel, JAKW				Opalinski, Lukasz; Bartoszewska, Magdalena; Fekken, Susan; Liu, Haiyin; de Boer, Rinse; van der Klei, Ida; Veenhuis, Marten; Kiel, Jan A. K. W.			De Novo Peroxisome Biogenesis in Penicillium Chrysogenum Is Not Dependent on the Pex11 Family Members or Pex16	PLOS ONE			English	Article							YEAST HANSENULA-POLYMORPHA; ENDOPLASMIC-RETICULUM; MEMBRANE BIOGENESIS; TARGETING SIGNALS; FILAMENTOUS FUNGI; MAMMALIAN-CELLS; FISSION; PROTEIN; BIOSYNTHESIS; DIVISION	We have analyzed the role of the three members of the Pex11 protein family in peroxisome formation in the filamentous fungus Penicillium chrysogenum. Two of these, Pex11 and Pex11C, are components of the peroxisomal membrane, while Pex11B is present at the endoplasmic reticulum. We show that Pex11 is a major factor involved in peroxisome proliferation. We also demonstrate that P. chrysogenum cells deleted for known peroxisome fission factors (all Pex11 family proteins and Vps1) still contain peroxisomes. Interestingly, we find that, unlike in mammals, Pex16 is not essential for peroxisome biogenesis in P. chrysogenum, as partially functional peroxisomes are present in a pex16 deletion strain. We also show that Pex16 is not involved in de novo biogenesis of peroxisomes, as peroxisomes were still present in quadruple Delta pex11 Delta pex11B Delta pex11C Delta pex16 mutant cells. By contrast, pex3 deletion in P. chrysogenum led to cells devoid of peroxisomes, suggesting that Pex3 may function independently of Pex16. Finally, we demonstrate that the presence of intact peroxisomes is important for the efficiency of beta-lactam antibiotics production by P. chrysogenum. Remarkably, distinct from earlier results with low penicillin producing laboratory strains, upregulation of peroxisome numbers in a high producing P. chrysogenum strain had no significant effect on penicillin production.	[Opalinski, Lukasz; Bartoszewska, Magdalena; Fekken, Susan; Liu, Haiyin; de Boer, Rinse; van der Klei, Ida; Veenhuis, Marten; Kiel, Jan A. K. W.] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst GBB, Kluyver Ctr Genom Ind Fermentat, Ag Groningen, Netherlands	University of Groningen	Opalinski, L (corresponding author), Univ Groningen, Groningen Biomol Sci & Biotechnol Inst GBB, Kluyver Ctr Genom Ind Fermentat, Ag Groningen, Netherlands.	J.A.K.W.Kiel@RUG.nl	van der Klei, Ida J/D-1919-2012	Van der Klei, Ida J./0000-0001-7165-9679; Opalinska, Magdalena/0000-0003-1449-4243; Liu, Haiyin/0000-0003-3103-6949; Opalinski, Lukasz/0000-0001-9656-8714	Kluyver Centre for Genomics of Industrial Fermentation, part of the Netherlands Genomics Initiative/Netherlands Organization for Scientific Research; Netherlands Ministry of Economic Affairs; B-Basic partner organizations through B-Basic; IBOS Programme (Integration of Biosynthesis and Organic Synthesis), part of Advanced Chemical Technologies for Sustainability (ACTS)	Kluyver Centre for Genomics of Industrial Fermentation, part of the Netherlands Genomics Initiative/Netherlands Organization for Scientific Research; Netherlands Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); B-Basic partner organizations through B-Basic; IBOS Programme (Integration of Biosynthesis and Organic Synthesis), part of Advanced Chemical Technologies for Sustainability (ACTS)	L.O. and M.B. were financially supported by the research programme of the Kluyver Centre for Genomics of Industrial Fermentation, which is part of the Netherlands Genomics Initiative/Netherlands Organization for Scientific Research. J.A.K.W.K. and S.F. were financially supported by the Netherlands Ministry of Economic Affairs and the B-Basic partner organizations (www.b-basic.nl) through B-Basic, a public-private NWO-ACTS programme (ACTS = Advanced Chemical Technologies for Sustainability). R.d.B. was supported by the IBOS Programme (Integration of Biosynthesis and Organic Synthesis), which is part of Advanced Chemical Technologies for Sustainability (ACTS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal G, 2011, P NATL ACAD SCI USA, V108, P9113, DOI 10.1073/pnas.1018749108; Aksam EB, 2009, FEMS YEAST RES, V9, P808, DOI 10.1111/j.1567-1364.2009.00534.x; Antonenkov VD, 2011, BIOCH BIOPHYS ACTA; Bartoszewska M, 2011, BIOTECHNOL LETT, V33, P1921, DOI 10.1007/s10529-011-0664-y; CANTORAL JM, 1987, BIO-TECHNOL, V5, P494, DOI 10.1038/nbt0587-494; Eitzen GA, 1997, J CELL BIOL, V137, P1265, DOI 10.1083/jcb.137.6.1265; Gandre-Babbe S, 2008, MOL BIOL CELL, V19, P2402, DOI 10.1091/mbc.E07-12-1287; Gidijala L, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-29; Guo T, 2007, J CELL BIOL, V177, P289, DOI 10.1083/jcb.200609072; Hoepfner D, 2001, J CELL BIOL, V155, P979, DOI 10.1083/jcb.200107028; Honsho M, 1998, AM J HUM GENET, V63, P1622, DOI 10.1086/302161; Honsho M, 2002, J BIOL CHEM, V277, P44513, DOI 10.1074/jbc.M206139200; Huber A, 2012, TRAFFIC, V13, P157, DOI 10.1111/j.1600-0854.2011.01290.x; Karnik SK, 2007, J EXP BOT, V58, P1677, DOI 10.1093/jxb/erm018; Karnik SK, 2005, PLANT PHYSIOL, V138, P1967, DOI [10.1104/pp.105.061291, 10.1104/PP.105.061291]; Kiel JAKW, 2005, FUNGAL GENET BIOL, V42, P154, DOI 10.1016/j.fgb.2004.10.010; Kiel JAKW, 2004, FUNGAL GENET BIOL, V41, P708, DOI 10.1016/j.fgb.2004.02.006; Kiel JAKW, 2006, TRAFFIC, V7, P1291, DOI 10.1111/j.1600-0854.2006.00479.x; Kiel JAKW, 2009, FUNCT INTEGR GENOMIC, V9, P167, DOI 10.1007/s10142-009-0110-6; Kim PK, 2006, J CELL BIOL, V173, P521, DOI 10.1083/jcb.200601036; Koch A, 2005, MOL BIOL CELL, V16, P5077, DOI 10.1091/mbc.E05-02-0159; Koch Johannes, 2011, Biomol Concepts, V2, P353; Koch J, 2010, J CELL SCI, V123, P3389, DOI 10.1242/jcs.064907; Kuravi K, 2006, J CELL SCI, V119, P3994, DOI 10.1242/jcs.03166; Lam SK, 2011, P NATL ACAD SCI USA, V108, pE51, DOI 10.1073/pnas.1103526108; Li XL, 2003, J BIOL CHEM, V278, P17012, DOI 10.1074/jbc.M212031200; Lingard MJ, 2008, PLANT CELL, V20, P1567, DOI 10.1105/tpc.107.057679; Lingard MJ, 2006, J CELL SCI, V119, P1961, DOI 10.1242/jcs.02904; Martin JF, 2012, J IND MICROBIOL BIOT, V39, P367, DOI 10.1007/s10295-011-1063-z; Matsuzaki T, 2008, J CELL BIOL, V183, P1275, DOI 10.1083/jcb.200806062; Meijer WH, 2010, APPL ENVIRON MICROB, V76, P5702, DOI 10.1128/AEM.02327-09; Motley AM, 2008, J CELL SCI, V121, P1633, DOI 10.1242/jcs.026344; Motley AM, 2007, J CELL BIOL, V178, P399, DOI 10.1083/jcb.200702167; MULLER WH, 1991, EMBO J, V10, P489, DOI 10.1002/j.1460-2075.1991.tb07971.x; Nagotu S, 2008, BBA-MOL CELL RES, V1783, P760, DOI 10.1016/j.bbamcr.2007.10.018; Nuttall JM, 2011, CURR OPIN CELL BIOL, V23, P421, DOI 10.1016/j.ceb.2011.05.005; Opalinski L, 2011, INT J BIOCHEM CELL B, V43, P847, DOI 10.1016/j.biocel.2011.03.006; Opalinski L, 2011, EMBO J, V30, P5, DOI 10.1038/emboj.2010.299; Opalinski L, 2010, FEBS J, V277, P3203, DOI 10.1111/j.1742-4658.2010.07726.x; Sambrook J., 2002, MOL CLONING LAB MANU; Saraya R, 2011, J CELL BIOL, V193, P885, DOI 10.1083/jcb.201012083; Saraya R, 2010, FEBS J, V277, P3279, DOI 10.1111/j.1742-4658.2010.07740.x; Schliebs W, 2004, CURR BIOL, V14, pR397, DOI 10.1016/j.cub.2004.05.017; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Toro AA, 2009, J CELL BIOCHEM, V107, P1083, DOI 10.1002/jcb.22210; van den Berg MA, 2008, NAT BIOTECHNOL, V26, P1161, DOI 10.1038/nbt.1498; van der Klei IJ, 2006, BBA-MOL CELL RES, V1763, P1364, DOI 10.1016/j.bbamcr.2006.09.014; VANDEPEER Y, 1994, COMPUT APPL BIOSCI, V10, P569; WATERHAM HR, 1994, J CELL BIOL, V127, P737, DOI 10.1083/jcb.127.3.737; Zhang XC, 2010, PLANT CELL, V22, P431, DOI 10.1105/tpc.109.071324	50	16	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e35490	10.1371/journal.pone.0035490	http://dx.doi.org/10.1371/journal.pone.0035490			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22536392	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336200046
J	Tang, S; Mishra, M; Frazier, DP; Moore, ML; Inoue, K; Deora, R; Sui, GC; Dubey, P				Tang, Shuai; Mishra, Meenu; Frazier, Donna P.; Moore, Miranda L.; Inoue, Kazushi; Deora, Rajendar; Sui, Guangchao; Dubey, Purnima			Positive and Negative Regulation of Prostate Stem Cell Antigen Expression by Yin Yang 1 in Prostate Epithelial Cell Lines	PLOS ONE			English	Article							TRANSCRIPTION FACTOR YY1; CANCER DEVELOPMENT; GENETIC-VARIATION; PSCA; CARCINOMA; DELETION; IDENTIFICATION; YIN-YANG-1; TUMORS; PTEN	Prostate cancer is influenced by epigenetic modification of genes involved in cancer development and progression. Increased expression of Prostate Stem Cell Antigen (PSCA) is correlated with development of malignant human prostate cancer, while studies in mouse models suggest that decreased PSCA levels promote prostate cancer metastasis. These studies suggest that PSCA has context-dependent functions, and could be differentially regulated during tumor progression. In the present study, we identified the multi-functional transcription factor Yin Yang 1 (YY1) as a modulator of PSCA expression in prostate epithelial cell lines. Increased YY1 levels are observed in prostatic intraepithelial neoplasia (PIN) and advanced disease. We show that androgen-mediated up-regulation of PSCA in prostate epithelial cell lines is dependent on YY1. We identified two direct YY1 binding sites within the PSCA promoter, and showed that the upstream site inhibited, while the downstream site, proximal to the androgen-responsive element, stimulated PSCA promoter activity. Thus, changes in PSCA expression levels in prostate cancer may at least partly be affected by cellular levels of YY1. Our results also suggest multiple roles for YY1 in prostate cancer which may contribute to disease progression by modulation of genes such as PSCA.	[Tang, Shuai; Dubey, Purnima] Wake Forest Sch Med, Mol Pathol Grad Program, Winston Salem, NC 27106 USA; [Tang, Shuai; Mishra, Meenu; Frazier, Donna P.; Moore, Miranda L.; Inoue, Kazushi; Dubey, Purnima] Wake Forest Sch Med, Dept Pathol Tumor Biol, Winston Salem, NC USA; [Inoue, Kazushi; Sui, Guangchao; Dubey, Purnima] Wake Forest Sch Med, Dept Canc Biol, Winston Salem, NC USA; [Inoue, Kazushi; Sui, Guangchao; Dubey, Purnima] Wake Forest Sch Med, Ctr Comprehens Canc, Winston Salem, NC USA; [Deora, Rajendar; Dubey, Purnima] Wake Forest Sch Med, Dept Microbiol & Immunol, Winston Salem, NC USA	Wake Forest University; Wake Forest University; Wake Forest University; Wake Forest University; Wake Forest University	Tang, S (corresponding author), Wake Forest Sch Med, Mol Pathol Grad Program, Winston Salem, NC 27106 USA.	pdubey@wakehealth.edu	Dubey, Purnima/AAY-2462-2021	Sui, Guangchao/0000-0002-8164-5585	Wake Forest School of Medicine Department of Pathology Research; American Cancer Society Research Scholar [RSG-07-196-01-LIB, R01CA106314]; American Cancer Society [RSG-07-207-01-MGO, 1R01AI075081, RSG-09-082-01-MGO]; NATIONAL CANCER INSTITUTE [R01CA106314] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075081] Funding Source: NIH RePORTER	Wake Forest School of Medicine Department of Pathology Research; American Cancer Society Research Scholar(American Cancer Society); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Wake Forest School of Medicine Department of Pathology Research Support (PD), American Cancer Society Research Scholar Grant RSG-07-196-01-LIB (PD), R01CA106314 and American Cancer Society Research Scholar Grant RSG-07-207-01-MGO (KI), 1R01AI075081 (RD), and American Cancer Society Research Scholar Grant RSG-09-082-01-MGO (GS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backman SA, 2004, P NATL ACAD SCI USA, V101, P1725, DOI 10.1073/pnas.0308217100; Bahrenberg G, 2001, CANCER LETT, V168, P37, DOI 10.1016/S0304-3835(01)00497-9; Castellano G, 2009, CELL CYCLE, V8, P1367, DOI 10.4161/cc.8.9.8314; Deng Z, 2009, ONCOGENE, V28, P3746, DOI 10.1038/onc.2009.231; Deng ZY, 2007, MOL CELL BIOL, V27, P3780, DOI 10.1128/MCB.01761-06; Deng ZY, 2010, TRANSCR-AUSTIN, V1, P81, DOI 10.4161/trns.1.2.12375; Deora R, 2001, MOL MICROBIOL, V40, P669, DOI 10.1046/j.1365-2958.2001.02415.x; Dobosy JR, 2007, J UROLOGY, V177, P822, DOI 10.1016/j.juro.2006.10.063; Dubey P, 2001, CANCER RES, V61, P3256; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Gordon S, 2006, ONCOGENE, V25, P1125, DOI 10.1038/sj.onc.1209080; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Hirai H, 1996, MOL CELL BIOL, V16, P6457; HOROSZEWICZ JS, 1983, CANCER RES, V43, P1809; HYDEDERUYSCHER RP, 1995, NUCLEIC ACIDS RES, V23, P4457, DOI 10.1093/nar/23.21.4457; Jain A, 2002, MOL ENDOCRINOL, V16, P2323, DOI 10.1210/me.2002-0004; Jiao J, 2007, CANCER RES, V67, P6083, DOI 10.1158/0008-5472.CAN-06-4202; KAIGHN ME, 1979, INVEST UROL, V17, P16; Kibel AS, 1998, CANCER RES, V58, P5652; Lepin EJ, 2010, EUR J NUCL MED MOL I, V37, P1529, DOI 10.1007/s00259-010-1433-1; Lieberthal JG, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2329; Mishra M, 2005, J BACTERIOL, V187, P6290, DOI 10.1128/JB.187.18.6290-6299.2005; Moore ML, 2008, PROSTATE, V68, P139, DOI 10.1002/pros.20686; Pilarsky C, 2004, NEOPLASIA, V6, P744, DOI 10.1593/neo.04277; Reiter RE, 1998, P NATL ACAD SCI USA, V95, P1735, DOI 10.1073/pnas.95.4.1735; Ross S, 2002, CANCER RES, V62, P2546; Ross S, 2001, AM J PATHOL, V158, P809, DOI 10.1016/S0002-9440(10)64028-X; Saffran DC, 2001, P NATL ACAD SCI USA, V98, P2658, DOI 10.1073/pnas.051624698; Sakamoto H, 2008, NAT GENET, V40, P730, DOI 10.1038/ng.152; Seligson D, 2005, INT J ONCOL, V27, P131; Shi Y, 1997, BBA-REV CANCER, V1332, pF49, DOI 10.1016/S0304-419X(96)00044-3; Sreeramaneni R, 2005, MOL CELL BIOL, V25, P220, DOI 10.1128/MCB.25.1.220-232.2005; Tan DP, 2002, NUCLEIC ACIDS RES, V30, P1213, DOI 10.1093/nar/30.5.1213; Thomas MJ, 1999, GENE, V236, P197, DOI 10.1016/S0378-1119(99)00261-9; Tran CP, 2002, MOL CANCER RES, V1, P113; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; Watabe T, 2002, P NATL ACAD SCI USA, V99, P401, DOI 10.1073/pnas.012574899; Wu XF, 2009, NAT GENET, V41, P991, DOI 10.1038/ng.421; Zhao ZG, 2007, PROSTATE, V67, P1143, DOI 10.1002/pros.20610	39	6	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e35570	10.1371/journal.pone.0035570	http://dx.doi.org/10.1371/journal.pone.0035570			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22536409	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336200056
J	Wang, Y; Ma, N; Wang, Y; Chen, GJ				Wang, Yaru; Ma, Na; Wang, Yan; Chen, Guangju			Allosteric Analysis of Glucocorticoid Receptor-DNA Interface Induced by Cyclic Py-Im Polyamide: A Molecular Dynamics Simulation Study	PLOS ONE			English	Article							AMBER FORCE-FIELD; BINDING DOMAIN; MINOR-GROOVE; UNSTRUCTURED REGION; CONTINUUM SOLVENT; STRUCTURAL BASIS; NUCLEIC-ACIDS; RECOGNITION; PROTEIN; INHIBITION	Background: It has been extensively developed in recent years that cell-permeable small molecules, such as polyamide, can be programmed to disrupt transcription factor-DNA interfaces and can silence aberrant gene expression. For example, cyclic pyrrole-imidazole polyamide that competes with glucocorticoid receptor (GR) for binding to glucocorticoid response elements could be expected to affect the DNA dependent binding by interfering with the protein-DNA interface. However, how such small molecules affect the transcription factor-DNA interfaces and gene regulatory pathways through DNA structure distortion is not fully understood so far. Methodology/Principal Findings: In the present work, we have constructed some models, especially the ternary model of polyamides+DNA+GR DNA-binding domain (GRDBD) dimer, and carried out molecular dynamics simulations and free energy calculations for them to address how polyamide molecules disrupt the GRDBD and DNA interface when polyamide and protein bind at the same sites on opposite grooves of DNA. Conclusions/Significance: We found that the cyclic polyamide binding in minor groove of DNA can induce a large structural perturbation of DNA, i.e. a >4 angstrom widening of the DNA minor groove and a compression of the major groove by more than 4 angstrom as compared with the DNA molecule in the GRDBD dimer+DNA complex. Further investigations for the ternary system of polyamides+DNA+GRDBD dimer and the binary system of allosteric DNA+GRDBD dimer revealed that the compression of DNA major groove surface causes GRDBD to move away from the DNA major groove with the initial average distance of similar to 4 angstrom to the final average distance of similar to 10 angstrom during 40 ns simulation course. Therefore, this study straightforward explores how small molecule targeting specific sites in the DNA minor groove disrupts the transcription factor-DNA interface in DNA major groove, and consequently modulates gene expression.	[Wang, Yaru; Ma, Na; Wang, Yan; Chen, Guangju] Beijing Normal Univ, Coll Chem, Beijing 100875, Peoples R China	Beijing Normal University	Wang, Y (corresponding author), Beijing Normal Univ, Coll Chem, Beijing 100875, Peoples R China.	wangy@bnu.edu.cn; wangy@bnu.edu.cn; gjchen@bnu.edu.cn			National Science Foundation of China [21073015, 21131003, 20771017, 20973024]; Major State Basic Research Development Programs [2011CB808500]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major State Basic Research Development Programs(National Basic Research Program of China)	The authors acknowledge research support from the National Science Foundation of China (No. 21073015, 21131003, 20771017 and 20973024), the Major State Basic Research Development Programs (grant No. 2011CB808500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez LD, 2008, J MED CHEM, V51, P1352, DOI 10.1021/jm800007w; Alvarez LD, 2008, CHEMMEDCHEM, V3, P1869, DOI 10.1002/cmdc.200800256; Bishop TC, 1996, PROTEINS, V24, P115; Cheatham TE, 1998, J BIOMOL STRUCT DYN, V16, P265, DOI 10.1080/07391102.1998.10508245; Chenoweth DM, 2010, J AM CHEM SOC, V132, P14521, DOI 10.1021/ja105068b; Chenoweth DM, 2009, P NATL ACAD SCI USA, V106, P13175, DOI 10.1073/pnas.0906532106; Dervan PB, 2003, CURR OPIN STRUC BIOL, V13, P284, DOI 10.1016/S0959-440X(03)00081-2; Dervan PB, 2001, BIOORGAN MED CHEM, V9, P2215, DOI 10.1016/S0968-0896(01)00262-0; Diamond MI, 2000, P NATL ACAD SCI USA, V97, P657, DOI 10.1073/pnas.97.2.657; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Fiamegos YC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018127; Goetz TL, 2000, MOL CELL BIOL, V20, P81, DOI 10.1128/MCB.20.1.81-90.2000; Green SM, 2010, J BIOL CHEM; HARRIS LF, 1993, P NATL ACAD SCI USA, V90, P5534, DOI 10.1073/pnas.90.12.5534; Harris LF, 1995, J BIOMOL STRUCT DYN, V13, P423, DOI 10.1080/07391102.1995.10508852; Hsu CF, 2008, BIOORG MED CHEM LETT, V18, P5851, DOI 10.1016/j.bmcl.2008.05.063; Huey R, 2007, J COMPUT CHEM, V28, P1145, DOI 10.1002/jcc.20634; Jayaram B, 1998, J AM CHEM SOC, V120, P10629, DOI 10.1021/ja981307p; Jensen F, 2017, INTRO COMPUTATIONAL; Kielkopf CL, 1998, SCIENCE, V282, P111, DOI 10.1126/science.282.5386.111; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Kosikov KM, 2002, J AM CHEM SOC, V124, P4838, DOI 10.1021/ja0125218; KOTTALAM J, 1990, BIOPOLYMERS, V29, P1409, DOI 10.1002/bip.360291008; LAVERY R, 1988, J BIOMOL STRUCT DYN, V6, P63, DOI 10.1080/07391102.1988.10506483; Lee GM, 2008, J MOL BIOL, V382, P1014, DOI 10.1016/j.jmb.2008.07.064; Lee MC, 2004, PROTEINS, V55, P620, DOI 10.1002/prot.10470; Leulliot N, 2001, BIOCHEMISTRY-US, V40, P7947, DOI 10.1021/bi010680y; Lonard DM, 2007, ENDOCR REV, V28, P575, DOI 10.1210/er.2007-0012; LUISI BF, 1991, NATURE, V352, P497, DOI 10.1038/352497a0; McQuarrie D. A, 2000, STAT MECH; Meijsing SH, 2009, SCIENCE, V324, P407, DOI 10.1126/science.1164265; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Muzikar KA, 2009, P NATL ACAD SCI USA, V106, P16598, DOI 10.1073/pnas.0909192106; Neidle S., 1994, DNA STRUCTURE RECOGN; Nguyen-Hackley DH, 2004, BIOCHEMISTRY-US, V43, P3880, DOI 10.1021/bi030223c; Perez A, 2007, BIOPHYS J, V92, P3817, DOI 10.1529/biophysj.106.097782; Presman DM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013279; Pufall MA, 2005, SCIENCE, V309, P142, DOI 10.1126/science.1111915; Pufall MA, 2002, ANNU REV CELL DEV BI, V18, P421, DOI 10.1146/annurev.cellbio.18.031502.133614; Rocha-Viegas L, 2006, J BIOL CHEM, V281, P33959, DOI 10.1074/jbc.M602408200; Rogatsky I, 2003, P NATL ACAD SCI USA, V100, P13845, DOI 10.1073/pnas.2336092100; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; So AYL, 2007, PLOS GENET, V3, P927, DOI 10.1371/journal.pgen.0030094; Srinivasan J, 1998, J AM CHEM SOC, V120, P9401, DOI 10.1021/ja981844+; Stockner T, 2003, J MOL BIOL, V328, P325, DOI 10.1016/S0022-2836(03)00316-4; Strahs D, 2000, J MOL BIOL, V301, P643, DOI 10.1006/jmbi.2000.3863; van Tilborg MAA, 2000, J MOL BIOL, V301, P947, DOI 10.1006/jmbi.2000.4001; van Tilborg PJA, 2000, BIOCHEMISTRY-US, V39, P8747, DOI 10.1021/bi991550g; VANTILBORG MAA, 1995, J MOL BIOL, V247, P689, DOI 10.1016/S0022-2836(05)80148-2; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Yang B, 2011, J COMPUT CHEM, V32, P416, DOI 10.1002/jcc.21630; Zhang Q, 2004, J AM CHEM SOC, V126, P7958, DOI 10.1021/ja0373622	52	11	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e35159	10.1371/journal.pone.0035159	http://dx.doi.org/10.1371/journal.pone.0035159			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22532842	Green Published, gold			2022-12-27	WOS:000305336200025
J	Votion, DM; Gnaiger, E; Lemieux, H; Mouithys-Mickalad, A; Serteyn, D				Votion, Dominique-Marie; Gnaiger, Erich; Lemieux, Helene; Mouithys-Mickalad, Ange; Serteyn, Didier			Physical Fitness and Mitochondrial Respiratory Capacity in Horse Skeletal Muscle	PLOS ONE			English	Article							AEROBIC CAPACITY; GLUTEUS MEDIUS; OXIDATIVE-PHOSPHORYLATION; CELLULAR RESPIRATION; ENDURANCE HORSES; GENE-EXPRESSION; BICEPS FEMORIS; SMALL BIOPSIES; FIBER TYPES; INHIBITION	Background: Within the animal kingdom, horses are among the most powerful aerobic athletic mammals. Determination of muscle respiratory capacity and control improves our knowledge of mitochondrial physiology in horses and high aerobic performance in general. Methodology/Principal Findings: We applied high-resolution respirometry and multiple substrate-uncoupler-inhibitor titration protocols to study mitochondrial physiology in small (1.0-2.5 mg) permeabilized muscle fibres sampled from triceps brachii of healthy horses. Oxidative phosphorylation (OXPHOS) capacity (pmol O-2.s(-2).mg(-1) wet weight) with combined Complex I and II (CI+II) substrate supply (malate+glutamate+succinate) increased from 77 +/- 18 in overweight horses to 103 +/- 18, 122 +/- 15, and 129 +/- 12 in untrained, trained and competitive horses (N = 3, 8, 16, and 5, respectively). Similar to human muscle mitochondria, equine OXPHOS capacity was limited by the phosphorylation system to 0.85 +/- 0.10 (N = 32) of electron transfer capacity, independent of fitness level. In 15 trained horses, OXPHOS capacity increased from 119 +/- 12 to 134 +/- 37 when pyruvate was included in the CI+ II substrate cocktail. Relative to this maximum OXPHOS capacity, Complex I (CI)-linked OXPHOS capacities were only 50% with glutamate+malate, 64% with pyruvate+malate, and 68% with pyruvate+malate+glutamate, and similar to 78% with CII-linked succinate+rotenone. OXPHOS capacity with glutamate+malate increased with fitness relative to CI+ II-supported ETS capacity from a flux control ratio of 0.38 to 0.40, 0.41 and 0.46 in overweight to competitive horses, whereas the CII/CI+II substrate control ratio remained constant at 0.70. Therefore, the apparent deficit of the CI- over CII-linked pathway capacity was reduced with physical fitness. Conclusions/Significance: The scope of mitochondrial density-dependent OXPHOS capacity and the density-independent (qualitative) increase of CI-linked respiratory capacity with increased fitness open up new perspectives of integrative and comparative mitochondrial respiratory physiology.	[Votion, Dominique-Marie] Univ Liege, Equine European Ctr Mont Le Soie, Vielsalm, Belgium; [Votion, Dominique-Marie; Serteyn, Didier] Univ Liege, Fac Vet Med, Equine Clin, Liege, Belgium; [Gnaiger, Erich; Lemieux, Helene] Med Univ Innsbruck, D Swarovski Res Lab, Dept Visceral Transplant & Thorac Surg, Innsbruck, Austria; [Mouithys-Mickalad, Ange; Serteyn, Didier] Univ Liege, Ctr Oxygen Res & Dev, Liege, Belgium	University of Liege; University of Liege; Medical University of Innsbruck; University of Liege	Votion, DM (corresponding author), Univ Liege, Equine European Ctr Mont Le Soie, Vielsalm, Belgium.	dominique.votion@ulg.ac.be		Mouithys Mickalad, Ange/0000-0001-9777-3023; lemieux, Helene/0000-0002-8864-6062; Votion, Dominique-Marie/0000-0003-2899-8207; Gnaiger, Erich/0000-0003-3647-5895	'Ministere de l'Agriculture et de la Ruralite de la Region Wallonne' of Belgium [06/472 10]; National Sciences and Engineering Research Council (Canada); Fonds Quebecois de la Recherche sur la Nature et les Techologies (Quebec, Canada)	'Ministere de l'Agriculture et de la Ruralite de la Region Wallonne' of Belgium; National Sciences and Engineering Research Council (Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fonds Quebecois de la Recherche sur la Nature et les Techologies (Quebec, Canada)	This study was supported by the 'Ministere de l'Agriculture et de la Ruralite de la Region Wallonne' of Belgium (subvention 06/472 10). H. Lemieux was supported by postdoctoral fellowships from the National Sciences and Engineering Research Council (Canada) and Fonds Quebecois de la Recherche sur la Nature et les Techologies (Quebec, Canada). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aragones J, 2008, NAT GENET, V40, P170, DOI 10.1038/ng.2007.62; Arnaud MG., 1997, NOTATION ETAT CORPOR, V1, P40; Barrey E, 1999, Equine Vet J Suppl, P289; Barrey E, 2009, BMC VET RES, V5, DOI 10.1186/1746-6148-5-29; Benard G, 2008, INT J BIOCHEM CELL B, V40, P1543, DOI 10.1016/j.biocel.2007.11.023; Benard G, 2010, BBA-BIOENERGETICS, V1797, P698, DOI 10.1016/j.bbabio.2010.02.030; Boushel R, 2007, DIABETOLOGIA, V50, P790, DOI 10.1007/s00125-007-0594-3; Boushel R, 2011, MITOCHONDRION, V11, P303, DOI 10.1016/j.mito.2010.12.006; Bouwman FG, 2010, COMP BIOCHEM PHYS D, V5, P55, DOI 10.1016/j.cbd.2009.11.001; Cassart D, 2007, EQUINE VET J, V39, P26, DOI 10.2746/042516407X157765; CHANCE B, 1955, J BIOL CHEM, V217, P429; Chilibeck PD, 1999, EUR J APPL PHYSIOL, V80, P604, DOI 10.1007/s004210050641; CUTMORE CMM, 1985, EQUINE VET J, V17, P354, DOI 10.1111/j.2042-3306.1985.tb02519.x; DELHUMEAU G, 1994, TOXICOL APPL PHARM, V126, P345, DOI 10.1006/taap.1994.1125; DIJESO F, 1988, CR SOC BIOL, V182, P266; Eaton M D, 1999, Equine Vet J Suppl, P521; Eivers SS, 2010, PHYSIOL GENOMICS, V40, P83, DOI 10.1152/physiolgenomics.00041.2009; Gastin PB, 2001, SPORTS MED, V31, P725, DOI 10.2165/00007256-200131100-00003; Gnaiger E, 2000, P NATL ACAD SCI USA, V97, P11080, DOI 10.1073/pnas.97.20.11080; Gnaiger E, 2003, ADV EXP MED BIOL, V543, P39; Gnaiger E, 1995, J BIOENERG BIOMEMBR, V27, P583, DOI 10.1007/BF02111656; Gnaiger E, 2009, INT J BIOCHEM CELL B, V41, P1837, DOI 10.1016/j.biocel.2009.03.013; GOLLNICK PD, 1990, PFLUG ARCH EUR J PHY, V415, P407, DOI 10.1007/BF00373617; GUY PS, 1977, J PHYSIOL-LONDON, V269, P33, DOI 10.1113/jphysiol.1977.sp011891; Hayot M, 2005, EUR RESPIR J, V25, P431, DOI 10.1183/09031936.05.00053404; Hinkle PC, 2005, BBA-BIOENERGETICS, V1706, P1, DOI 10.1016/j.bbabio.2004.09.004; Hoppeler H, 2002, J EXP BIOL, V205, P2143; HOPPELER H, 1985, J EXP BIOL, V115, P355; Hoppeler H, 1999, INT J OBESITY, V23, pS7, DOI 10.1038/sj.ijo.0800878; HOPPELER H, 1987, RESP PHYSIOL, V69, P27, DOI 10.1016/0034-5687(87)90099-5; Jeppesen TD, 2003, ANN NEUROL, V54, P86, DOI 10.1002/ana.10594; Johnson G, 2006, AM J PHYSIOL-ENDOC M, V291, pE460, DOI 10.1152/ajpendo.00258.2005; KAYAR SR, 1989, PFLUG ARCH EUR J PHY, V413, P343, DOI 10.1007/BF00584481; KLINE KH, 1988, COMP BIOCHEM PHYS A, V91, P815, DOI 10.1016/0300-9629(88)90969-3; Kuznetsov AV, 2004, AM J PHYSIOL-HEART C, V286, pH1633, DOI 10.1152/ajpheart.00701.2003; Kuznetsov AV, 2002, ANAL BIOCHEM, V305, P186, DOI 10.1006/abio.2002.5658; Lemieux H, 2011, INT J BIOCHEM CELL B, V43, P1729, DOI 10.1016/j.biocel.2011.08.008; Lenaz G, 2010, ANTIOXID REDOX SIGN, V12, P961, DOI 10.1089/ars.2009.2704; LETELLIER T, 1992, PEDIATR RES, V32, P17, DOI 10.1203/00006450-199207000-00004; LINDHOLM A, 1974, ACTA VET SCAND, V15, P287; LINDSTEDT SL, 1991, NATURE, V353, P748, DOI 10.1038/353748a0; McGivney BA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-398; Nelson D.L.C., 2005, LEHNINGER PRINCIPLES, V4th ed., P601; Nouette-Gaulain K, 2011, INT J BIOCHEM CELL B, V43, P14, DOI 10.1016/j.biocel.2010.10.005; Pesta D, 2012, METHODS MOL BIOL, V810, P25, DOI 10.1007/978-1-61779-382-0_3; Pesta D, 2011, AM J PHYSIOL-REG I, V301, pR1078, DOI 10.1152/ajpregu.00285.2011; Piercy RJ, 2004, EQUINE SPORTS MED SU, P43; Poole D. C., 2004, Equine and Comparative Exercise Physiology, V1, P5, DOI 10.1079/ECP20036; Quiroz-Rothe E, 2001, HISTOCHEM CELL BIOL, V116, P299, DOI 10.1007/s004180100319; Rasmussen UF, 2000, MOL CELL BIOCHEM, V208, P37, DOI 10.1023/A:1007046028132; Rasmussen UF, 2004, COMP BIOCHEM PHYS A, V137, P435, DOI 10.1016/j.cbpb.2003.11.002; Rasmussen UF, 2001, AM J PHYSIOL-ENDOC M, V280, pE301, DOI 10.1152/ajpendo.2001.280.2.E301; RIVERO JLL, 1995, EQUINE VET J, V27, P51, DOI 10.1111/j.2042-3306.1995.tb03033.x; RIVERO JLL, 1995, VET REC, V137, P187, DOI 10.1136/vr.137.8.187; Rivero JLL, 1996, RES VET SCI, V61, P49, DOI 10.1016/S0034-5288(96)90110-1; Rostovtseva TK, 2008, P NATL ACAD SCI USA, V105, P18746, DOI 10.1073/pnas.0806303105; SALTIN B, 1967, J APPL PHYSIOL, V23, P353, DOI 10.1152/jappl.1967.23.3.353; Scheibye-Knudsen M, 2009, EUR J APPL PHYSIOL, V105, P279, DOI 10.1007/s00421-008-0901-9; Serrano AL, 2001, J ANAT, V199, P329, DOI 10.1046/j.1469-7580.2001.19930329.x; SKLADAL D, 1994, MOD TR BIOTHERMOKIN, V3, P268; SNOW DH, 1976, EQUINE VET J, V8, P150, DOI 10.1111/j.2042-3306.1976.tb03327.x; SNOW DH, 1980, RES VET SCI, V28, P137, DOI 10.1016/S0034-5288(18)32735-8; Straub R., 1983, Equine exercise physiology. Proceedings of the first international conference, P193; TAYLOR CR, 1981, RESP PHYSIOL, V44, P25, DOI 10.1016/0034-5687(81)90075-X; TREMBLAY A, 1994, METABOLISM, V43, P814, DOI 10.1016/0026-0495(94)90259-3; Turner DL, 1997, ACTA PHYSIOL SCAND, V161, P459, DOI 10.1046/j.1365-201X.1997.00246.x; Tyler CM, 1998, PFLUG ARCH EUR J PHY, V436, P391, DOI 10.1007/s004240050648; Van Galen G, 2008, EQUINE VET EDUC, V20, P234, DOI 10.2746/095777308X299103; VANDENHOVEN R, 1985, AM J VET RES, V46, P939; VEKSLER VI, 1987, BIOCHIM BIOPHYS ACTA, V892, P191, DOI 10.1016/0005-2728(87)90174-5; Votion D. M., 2007, Equine and Comparative Exercise Physiology, V4, P105; Votion DM, 2010, EQUINE VET J, V42, P268, DOI 10.1111/j.2042-3306.2010.00271.x; Votion DM, 2009, VET J, V180, P77, DOI 10.1016/j.tvjl.2008.01.016; Weibel ER, 2004, RESP PHYSIOL NEUROBI, V140, P115, DOI 10.1016/j.resp.2004.01.006; WEIBEL ER, 1991, P NATL ACAD SCI USA, V88, P10357, DOI 10.1073/pnas.88.22.10357; Weijs W. A., 2002, European Journal of Morphology, V40, P145, DOI 10.1076/ejom.40.3.145.16687; Westermann CM, 2008, NEUROMUSCULAR DISORD, V18, P355, DOI 10.1016/j.nmd.2008.02.007; Wiswell RA, 2000, MED SCI SPORT EXER, V32, P1165, DOI 10.1097/00005768-200006000-00021; Young BL, 2002, EQUINE VET J, V34, P469, DOI 10.2746/042516402776117755	79	43	44	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e34890	10.1371/journal.pone.0034890	http://dx.doi.org/10.1371/journal.pone.0034890			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529950	gold, Green Published, Green Submitted			2022-12-27	WOS:000305350600037
J	Ren, F; Chen, XX; Hesketh, J; Gan, F; Huang, KH				Ren, Fei; Chen, Xingxiang; Hesketh, John; Gan, Fang; Huang, Kehe			Selenium Promotes T-Cell Response to TCR-Stimulation and ConA, but Not PHA in Primary Porcine Splenocytes	PLOS ONE			English	Article							MESSENGER-RNA LEVELS; GLUTATHIONE-PEROXIDASE; DIETARY SELENIUM; LYMPHOCYTE ACTIVATION; OXIDATIVE STRESS; VITAMIN-E; SELENOPROTEINS; EXPRESSION; SUPPLEMENTATION; DEFICIENCY	There is controversy in the literature over whether the selenium (Se) influences cellular immune responses, and the mechanisms possibly underlying these effects are unclear. In this study, the effects of Se on T-cell proliferation and IL-2 production were studied in primary porcine splenocytes. Splenocytes were treated with different mitogens in the presence of 0.5-4 mu mol/L sodium selenite. Se significantly promoted T-cell receptor (TCR) or concanavalin A (ConA)-induced T-cell proliferation and IL-2 production but failed to regulate T-cell response to phytohemagglutinin (PHA). In addition, Se significantly increased the levels of cytosolic glutathione peroxidase (GPx1) and thioredoxin reductase 1 (TR1) mRNA, the activity of GPx1 and the concentration of reduced glutathione (GSH) in the unstimulated, or activated splenocytes. These results indicated that Se improved the redox status in all splenocytes, including unstimulated, TCR, ConA and PHA stimulated, but only TCR and ConA-induced T-cell activation was affected by the redox status. N-acetylcysteine (NAC), a pharmacological antioxidant, increased T-cell proliferation and IL-2 production by TCR and ConA stimulated splenocytes but had no effect on the response to PHA in primary porcine splenocytes confirming that PHA-induced T-cell activation is insensitive to the redox status. We conclude that Se promotes GPx1 and TR1 expression and increases antioxidative capacity in porcine splenocytes, which enhances TCR or ConA -induced T-cell activation but not PHA-induced T-cell activation. The different susceptibilities to Se between the TCR, ConA and PHA -induced T-cell activation may help to explain the controversy in the literature over whether or not Se boosts immune responses.	[Ren, Fei; Chen, Xingxiang; Gan, Fang; Huang, Kehe] Nanjing Agr Univ, Inst Nutr & Metab Disorders Domest Anim & Fowls, Nanjing, Jiangsu, Peoples R China; [Hesketh, John] Univ Newcastle, Sch Med, Inst Cell & Mol Biosci, Newcastle Upon Tyne, Tyne & Wear, England	Nanjing Agricultural University; Newcastle University - UK	Ren, F (corresponding author), Nanjing Agr Univ, Inst Nutr & Metab Disorders Domest Anim & Fowls, Nanjing, Jiangsu, Peoples R China.	khhuang@njau.edu.cn			National Natural Science Foundation of China (NSFC) [30871892, 31011130155]; Royal Society; NSFC; Research Fund for the Doctoral Program of Higher Education of China [20110097110014]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Royal Society(Royal Society of London); NSFC(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was funded by the National Natural Science Foundation of China (NSFC) (grant numbers 30871892, 31011130155), an international collaboration grant to John Hesketh and Kehe Huang from The Royal Society and NSFC, the Research Fund for the Doctoral Program of Higher Education of China (grant number 20110097110014) and the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes KM, 2009, J NUTR, V139, P199, DOI 10.3945/jn.108.098624; Baum MK, 1997, J ACQ IMMUN DEF SYND, V15, P370, DOI 10.1097/00042560-199708150-00007; Bellinger FP, 2009, BIOCHEM J, V422, P11, DOI 10.1042/BJ20090219; Brown KM, 2000, CLIN SCI, V98, P593, DOI 10.1042/CS19990276; Butler JE, 2009, VET IMMUNOL IMMUNOP, V128, P147, DOI 10.1016/j.vetimm.2008.10.321; Carter LL, 1998, J IMMUNOTHER, V21, P181, DOI 10.1097/00002371-199805000-00003; COLLINS RJ, 1991, BIOL TRACE ELEM RES, V30, P233, DOI 10.1007/BF02991418; CURELLO S, 1987, CLIN CHEM, V33, P1448; Fairbairn L, 2011, J LEUKOCYTE BIOL, V89, P855, DOI 10.1189/jlb.1110607; Fairweather-Tait SJ, 2011, ANTIOXID REDOX SIGN, V14, P1337, DOI 10.1089/ars.2010.3275; Finch JM, 1996, RES VET SCI, V60, P97, DOI 10.1016/S0034-5288(96)90001-6; Gromer S, 2005, CELL MOL LIFE SCI, V62, P2414, DOI 10.1007/s00018-005-5143-y; Haddad JJ, 2011, CELL IMMUNOL, V270, P53, DOI 10.1016/j.cellimm.2011.04.001; Hoffmann FW, 2010, J NUTR, V140, P1155, DOI 10.3945/jn.109.120725; Hoffmann PR, 2008, ALLERGY, V63, P854, DOI 10.1111/j.1398-9995.2008.01676.x; Jariwalla RJ, 2009, BRIT J NUTR, V101, P182, DOI 10.1017/S0007114508998305; Kesherwani V, 2007, NITRIC OXIDE-BIOL CH, V16, P294, DOI 10.1016/j.niox.2006.11.001; KUCHAN MJ, 1990, J NUTR BIOCHEM, V1, P478, DOI 10.1016/0955-2863(90)90084-X; LEI XG, 1995, J NUTR, V125, P1438; LOPES MF, 1994, INFECT IMMUN, V62, P1484, DOI 10.1128/IAI.62.4.1484-1488.1994; Maquat LE, 2001, BIOFACTORS, V14, P37, DOI 10.1002/biof.5520140106; Methenitou G, 1996, VET HUM TOXICOL, V38, P274; Miao BC, 2005, INT IMMUNOPHARMACOL, V5, P1171, DOI 10.1016/j.intimp.2005.02.011; MUTH OH, 1958, SCIENCE, V128, P1090, DOI 10.1126/science.128.3331.1090; OFLYNN K, 1985, NATURE, V313, P686, DOI 10.1038/313686a0; Patterson JK, 2008, EXP BIOL MED, V233, P651, DOI 10.3181/0709-MR-262; PECANHA LT, 1989, CLIN EXP IMMUNOL, V76, P311; Qin SY, 2009, J TRACE ELEM MED BIO, V23, P29, DOI 10.1016/j.jtemb.2008.11.001; Romanowska M, 2007, LUNG CANCER, V55, P35, DOI 10.1016/j.lungcan.2006.09.007; Safir N, 2003, CLIN CHEM LAB MED, V41, P1005, DOI 10.1515/CCLM.2003.154; Sengupta A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012249; Shen HM, 2000, FREE RADICAL BIO MED, V28, P1115, DOI 10.1016/S0891-5849(00)00206-9; Shrimali RK, 2008, J BIOL CHEM, V283, P20181, DOI 10.1074/jbc.M802559200; Sunde RA, 2009, BIOSCIENCE REP, V29, P329, DOI 10.1042/BSR20080146; Ueno H, 2007, ANTIOXID REDOX SIGN, V9, P115, DOI 10.1089/ars.2007.9.115; Papp LV, 2007, ANTIOXID REDOX SIGN, V9, P775, DOI 10.1089/ars.2007.1528; Williams MS, 1996, J IMMUNOL, V157, P2395; Wu XS, 2010, BRIT J NUTR, V104, P1605, DOI 10.1017/S0007114510002643; Wu XS, 2010, J NUTR BIOCHEM, V21, P153, DOI 10.1016/j.jnutbio.2008.12.006; Zeng HW, 2008, J NUTR BIOCHEM, V19, P1, DOI 10.1016/j.jnutbio.2007.02.005; Zhang HY, 2010, CANCER LETT, V287, P91, DOI 10.1016/j.canlet.2009.06.001; Zhou JC, 2009, J NUTR, V139, P1061, DOI 10.3945/jn.109.104901	42	36	36	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e35375	10.1371/journal.pone.0035375	http://dx.doi.org/10.1371/journal.pone.0035375			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22530011	Green Submitted, gold, Green Published			2022-12-27	WOS:000305347400044
J	Garcia-Gomez, A; Ocio, EM; Crusoe, E; Santamaria, C; Hernandez-Campo, P; Blanco, JF; Sanchez-Guijo, FM; Hernandez-Iglesias, T; Brinon, JG; Fisac-Herrero, RM; Lee, FY; Pandiella, A; San Miguel, JF; Garayoa, M				Garcia-Gomez, Antonio; Ocio, Enrique M.; Crusoe, Edvan; Santamaria, Carlos; Hernandez-Campo, Pilar; Blanco, Juan F.; Sanchez-Guijo, Fermin M.; Hernandez-Iglesias, Teresa; Brinon, Jesus G.; Fisac-Herrero, Rosa M.; Lee, Francis Y.; Pandiella, Atanasio; San Miguel, Jesus F.; Garayoa, Mercedes			Dasatinib as a Bone-Modifying Agent: Anabolic and Anti-Resorptive Effects	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; MACROPHAGE INFLAMMATORY PROTEIN-1-ALPHA; MULTIPLE-MYELOMA; OSTEOBLAST DIFFERENTIATION; STROMAL CELLS; INHIBITOR; MARROW; IMATINIB; EXPRESSION; GROWTH	Background: Bone loss, in malignant or non-malignant diseases, is caused by increased osteoclast resorption and/or reduced osteoblast bone formation, and is commonly associated with skeletal complications. Thus, there is a need to identify new agents capable of influencing bone remodeling. We aimed to further pre-clinically evaluate the effects of dasatinib (BMS-354825), a multitargeted tyrosine kinase inhibitor, on osteoblast and osteoclast differentiation and function. Methods: For studies on osteoblasts, primary human bone marrow mensenchymal stem cells (hMSCs) together with the hMSC-TERT and the MG-63 cell lines were employed. Osteoclasts were generated from peripheral blood mononuclear cells (PBMC) of healthy volunteers. Skeletally-immature CD1 mice were used in the in vivo model. Results: Dasatinib inhibited the platelet derived growth factor receptor-beta (PDGFR-beta), c-Src and c-Kit phosphorylation in hMSC-TERT and MG-63 cell lines, which was associated with decreased cell proliferation and activation of canonical Wnt signaling. Treatment of MSCs from healthy donors, but also from multiple myeloma patients with low doses of dasatinib (2-5 nM), promoted its osteogenic differentiation and matrix mineralization. The bone anabolic effect of dasatinib was also observed in vivo by targeting endogenous osteoprogenitors, as assessed by elevated serum levels of bone formation markers, and increased trabecular microarchitecture and number of osteoblast-like cells. By in vitro exposure of hemopoietic progenitors to a similar range of dasatinib concentrations (1-2 nM), novel biological sequelae relative to inhibition of osteoclast formation and resorptive function were identified, including F-actin ring disruption, reduced levels of c-Fos and of nuclear factor of activated T cells 1 (NFATc1) in the nucleus, together with lowered cathepsin K, alpha V beta 3 integrin and CCR1 expression. Conclusions: Low dasatinib concentrations show convergent bone anabolic and reduced bone resorption effects, which suggests its potential use for the treatment of bone diseases such as osteoporosis, osteolytic bone metastasis and myeloma bone disease.	[Garcia-Gomez, Antonio; Ocio, Enrique M.; Crusoe, Edvan; Hernandez-Iglesias, Teresa; Pandiella, Atanasio; San Miguel, Jesus F.; Garayoa, Mercedes] Univ Salamanca, CSIC, IBMCC, Ctr Invest Canc, E-37008 Salamanca, Spain; [Garcia-Gomez, Antonio; Santamaria, Carlos; Hernandez-Campo, Pilar; Sanchez-Guijo, Fermin M.; San Miguel, Jesus F.; Garayoa, Mercedes] Ctr Red Med Regenerat & Terapia Celular Castilla, Salamanca, Spain; [Garcia-Gomez, Antonio; Ocio, Enrique M.; Crusoe, Edvan; Blanco, Juan F.; Sanchez-Guijo, Fermin M.; Pandiella, Atanasio; San Miguel, Jesus F.; Garayoa, Mercedes] Hosp Univ Salamanca IBSAL, Salamanca, Spain; [Brinon, Jesus G.] Univ Salamanca, Fac Med, Dept Biol Celular & Patol, E-37008 Salamanca, Spain; [Fisac-Herrero, Rosa M.] Hosp Gen Segovia, Serv Hematol, Segovia, Spain; [Lee, Francis Y.] Bristol Myers Squibb Pharmaceut Res Inst, Princeton, NJ USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion del Cancer (CIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; University of Salamanca; Bristol-Myers Squibb	Garcia-Gomez, A (corresponding author), Univ Salamanca, CSIC, IBMCC, Ctr Invest Canc, E-37008 Salamanca, Spain.	mgarayoa@usal.es	Garayoa, Mercedes/O-6039-2017; San-Miguel, Jesús F./V-8977-2018; Crusoe, Edvan/AAK-1497-2021; Sanchez-Guijo, Fermin/D-8542-2018; Blanco, Juan F/AAI-5787-2021; Pandiella, Atanasio/O-5180-2014; Brinon, Jesus G./L-7316-2014	Garayoa, Mercedes/0000-0003-2194-2841; San-Miguel, Jesús F./0000-0002-9183-4857; Crusoe, Edvan/0000-0002-8599-4731; Sanchez-Guijo, Fermin/0000-0002-7076-7739; Blanco, Juan F/0000-0001-7803-9149; Pandiella, Atanasio/0000-0002-4704-8971; Garcia, Antonio/0000-0003-0527-7351; Brinon, Jesus G./0000-0002-3503-0539; Ocio, Enrique M./0000-0002-5765-0085	Spanish Ministry of Science and Innovation - ISCIII [PI081825]; Mutua Madrilena Medical Research Foundation [AP27262008]; Centro en Red of Regenerative Medicine and Cellular Therapy from Castilla y Leon, Consejeria de Sanidad JCyL - ISCIII; Cooperative Research Thematic Network in Cancer (RTICC) [RD06/0020/0006, RD03/0020/0041]; Spanish FIS [PS09/01897]; Centro en Red of Regenerative Medicine and Cellular Therapy from Castilla y Leon Project	Spanish Ministry of Science and Innovation - ISCIII; Mutua Madrilena Medical Research Foundation; Centro en Red of Regenerative Medicine and Cellular Therapy from Castilla y Leon, Consejeria de Sanidad JCyL - ISCIII; Cooperative Research Thematic Network in Cancer (RTICC); Spanish FIS; Centro en Red of Regenerative Medicine and Cellular Therapy from Castilla y Leon Project	This work was supported by grants from the Spanish Ministry of Science and Innovation - ISCIII (PI081825); Mutua Madrilena Medical Research Foundation (AP27262008); Centro en Red of Regenerative Medicine and Cellular Therapy from Castilla y Leon, Consejeria de Sanidad JCyL - ISCIII; the Cooperative Research Thematic Network in Cancer (RTICC; RD06/0020/0006 and RD03/0020/0041); and Spanish FIS (PS09/01897). AG-G and CS are supported by the Centro en Red of Regenerative Medicine and Cellular Therapy from Castilla y Leon Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera Dolly G, 2009, Ther Clin Risk Manag, V5, P281; Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; Bantscheff M, 2007, NAT BIOTECHNOL, V25, P1035, DOI 10.1038/nbt1328; Basak GW, 2009, CURR PHARM BIOTECHNO, V10, P335, DOI 10.2174/138920109787847493; Boufker HI, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-298; Brownlow N, 2009, LEUKEMIA, V23, P590, DOI 10.1038/leu.2008.237; Capdeville R, 2002, NAT REV DRUG DISCOV, V1, P493, DOI 10.1038/nrd839; Charbord P, 2010, HUM GENE THER, V21, P1045, DOI 10.1089/hum.2010.115; Chaudhary LR, 2004, BONE, V34, P402, DOI 10.1016/j.bone.2003.11.014; Choi YH, 2011, BIOCHEM BIOPH RES CO, V415, P472, DOI 10.1016/j.bbrc.2011.10.097; Christopher LJ, 2008, DRUG METAB DISPOS, V36, P1357, DOI 10.1124/dmd.107.018267; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Coluccia AML, 2008, BLOOD, V112, P1346, DOI 10.1182/blood-2007-10-116590; Corre J, 2007, LEUKEMIA, V21, P1079, DOI 10.1038/sj.leu.2404621; Dewar AL, 2006, BLOOD, V107, P4334, DOI 10.1182/blood-2005-09-3568; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Fitter S, 2008, BLOOD, V111, P2538, DOI 10.1182/blood-2007-07-104281; Fowler JA, 2011, BONE, V48, P121, DOI 10.1016/j.bone.2010.06.029; Garayoa M, 2009, LEUKEMIA, V23, P1515, DOI 10.1038/leu.2009.65; Garderet L, 2007, LEUKEMIA LYMPHOMA, V48, P2032, DOI 10.1080/10428190701593644; Giuliani N, 2006, BLOOD, V108, P3992, DOI 10.1182/blood-2006-05-026112; Gregory CA, 2004, ANAL BIOCHEM, V329, P77, DOI 10.1016/j.ab.2004.02.002; GRIGORIADIS AE, 1994, SCIENCE, V266, P443, DOI 10.1126/science.7939685; Han JH, 2001, BLOOD, V97, P3349, DOI 10.1182/blood.V97.11.3349; HOCK JM, 1994, ENDOCRINOLOGY, V134, P1423, DOI 10.1210/en.134.3.1423; Jonsson S, 2010, LEUKEMIA, V24, P1357, DOI 10.1038/leu.2010.84; Kagami H, 2011, INT J BIOCHEM CELL B, V43, P286, DOI 10.1016/j.biocel.2010.12.006; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Khosla S, 2010, STEM CELLS, V28, P2124, DOI 10.1002/stem.546; Kratchmarova I, 2005, SCIENCE, V308, P1472, DOI 10.1126/science.1107627; Kulterer B, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-70; Lee YC, 2010, ONCOGENE, V29, P3196, DOI 10.1038/onc.2010.73; Lentzsch S, 2003, BLOOD, V101, P3568, DOI 10.1182/blood-2002-08-2383; Luo FR, 2006, CLIN CANCER RES, V12, P7180, DOI 10.1158/1078-0432.CCR-06-1112; Maiso P, 2006, CANCER RES, V66, P5781, DOI 10.1158/0008-5472.CAN-05-4186; Martinez-Martinez S, 2006, J BIOL CHEM, V281, P6227, DOI 10.1074/jbc.M513885200; Marzia M, 2000, J CELL BIOL, V151, P311, DOI 10.1083/jcb.151.2.311; Mazo M, 2010, CELL TRANSPLANT, V19, P313, DOI 10.3727/096368909X480323; Mihara K, 2003, BRIT J HAEMATOL, V120, P846, DOI 10.1046/j.1365-2141.2003.04217.x; Nakamura I, 2007, J BONE MINER METAB, V25, P337, DOI 10.1007/s00774-007-0773-9; Nandi SK, 2010, INDIAN J MED RES, V132, P15; O'Sullivan S, 2007, J BONE MINER RES, V22, P1679, DOI 10.1359/JBMR.070719; Olivieri A, 2007, ANN ONCOL, V18, P42, DOI 10.1093/annonc/mdm223; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Qiang YW, 2009, BLOOD, V113, P4319, DOI 10.1182/blood-2008-08-174300; Rachner TD, 2011, LANCET, V377, P1276, DOI 10.1016/S0140-6736(10)62349-5; Roodman GD, 2009, LEUKEMIA, V23, P435, DOI 10.1038/leu.2008.336; Roodman GD, 2008, CANCER TREAT REV, V34, P92, DOI 10.1016/j.ctrv.2007.09.002; Rosen Lee S, 2004, Oncology (Williston Park), V18, P26; Sambrook P, 2006, LANCET, V367, P2010, DOI 10.1016/S0140-6736(06)68891-0; Susa Mira, 2004, J Transl Med, V2, P6, DOI 10.1186/1479-5876-2-6; Takayanagi H, 2007, ANN NY ACAD SCI, V1116, P227, DOI 10.1196/annals.1402.071; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Terpos E, 2009, ANN ONCOL, V20, P1303, DOI 10.1093/annonc/mdn796; Tibullo D, 2011, HEMATOL ONCOL; Todoerti K, 2010, EXP HEMATOL, V38, P141, DOI 10.1016/j.exphem.2009.11.009; Tokunaga A, 2008, J BONE MINER RES, V23, P1519, DOI 10.1359/JBMR.080409; Vaananen HK, 2008, ARCH BIOCHEM BIOPHYS, V473, P132, DOI 10.1016/j.abb.2008.03.037; Vallet S, 2010, CLIN CANCER RES, V16, P4084, DOI 10.1158/1078-0432.CCR-10-0600; Vandyke K, 2009, LEUKEMIA, V23, P994, DOI 10.1038/leu.2008.356; Vandyke K, 2010, J BONE MINER RES, V25, P1759, DOI 10.1002/jbmr.85; Vandyke K, 2010, BLOOD, V115, P766, DOI 10.1182/blood-2009-08-237404; Veracini L, 2005, BIOCHEM SOC T, V33, P1313, DOI 10.1042/BST0331313; Voorzanger-Rousselot N, 2007, BRIT J CANCER, V97, P964, DOI 10.1038/sj.bjc.6603959; Wallace SR, 2001, CANCER-AM CANCER SOC, V91, P1219, DOI 10.1002/1097-0142(20010401)91:7<1219::AID-CNCR1122>3.0.CO;2-1; Wang LP, 2006, BIOMATERIALS, V27, P3716, DOI 10.1016/j.biomaterials.2006.02.022; Wang XY, 2007, ENDOCRINOLOGY, V148, P1629, DOI 10.1210/en.2006-1000; WANG ZQ, 1992, NATURE, V360, P741, DOI 10.1038/360741a0; Weilbaecher KN, 2011, NAT REV CANCER, V11, P411, DOI 10.1038/nrc3055; Xiao GZ, 2005, J BIOL CHEM, V280, P30689, DOI 10.1074/jbc.M500750200; Yaccoby S, 2010, BRIT J HAEMATOL, V149, P311, DOI 10.1111/j.1365-2141.2010.08141.x; Yaccoby S, 2010, LEUKEMIA LYMPHOMA, V51, P213, DOI 10.3109/10428190903503438	72	52	55	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e34914	10.1371/journal.pone.0034914	http://dx.doi.org/10.1371/journal.pone.0034914			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22539950	Green Published, gold			2022-12-27	WOS:000305341000013
J	Shen, R; Mo, QX; Schultz, N; Seshan, VE; Olshen, AB; Huse, J; Ladanyi, M; Sander, C				Shen, Ronglai; Mo, Qianxing; Schultz, Nikolaus; Seshan, Venkatraman E.; Olshen, Adam B.; Huse, Jason; Ladanyi, Marc; Sander, Chris			Integrative Subtype Discovery in Glioblastoma Using iCluster	PLOS ONE			English	Article							MODEL; SELECTION; NUMBER; CLUSTERS; BREAST	Large-scale cancer genome projects, such as the Cancer Genome Atlas (TCGA) project, are comprehensive molecular characterization efforts to accelerate our understanding of cancer biology and the discovery of new therapeutic targets. The accumulating wealth of multidimensional data provides a new paradigm for important research problems including cancer subtype discovery. The current standard approach relies on separate clustering analyses followed by manual integration. Results can be highly data type dependent, restricting the ability to discover new insights from multidimensional data. In this study, we present an integrative subtype analysis of the TCGA glioblastoma (GBM) data set. Our analysis revealed new insights through integrated subtype characterization. We found three distinct integrated tumor subtypes. Subtype 1 lacks the classical GBM events of chr 7 gain and chr 10 loss. This subclass is enriched for the G-CIMP phenotype and shows hypermethylation of genes involved in brain development and neuronal differentiation. The tumors in this subclass display a Proneural expression profile. Subtype 2 is characterized by a near complete association with EGFR amplification, overrepresentation of promoter methylation of homeobox and G-protein signaling genes, and a Classical expression profile. Subtype 3 is characterized by NF1 and PTEN alterations and exhibits a Mesenchymal-like expression profile. The data analysis workflow we propose provides a unified and computationally scalable framework to harness the full potential of large-scale integrated cancer genomic data for integrative subtype discovery.	[Shen, Ronglai; Seshan, Venkatraman E.] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; [Mo, Qianxing] Baylor Coll Med, Div Biostat, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Schultz, Nikolaus; Sander, Chris] Mem Sloan Kettering Canc Ctr, Computat Biol Program, New York, NY 10021 USA; [Olshen, Adam B.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Huse, Jason; Ladanyi, Marc] Univ Calif San Francisco, Dept Epidemiol & Biostat, Dept Pathol & Human Oncol, San Francisco, CA 94143 USA; [Huse, Jason; Ladanyi, Marc] Univ Calif San Francisco, Dept Epidemiol & Biostat, Pathogenesis Program, San Francisco, CA 94143 USA	Memorial Sloan Kettering Cancer Center; Baylor College of Medicine; Memorial Sloan Kettering Cancer Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Shen, R (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA.	shenr@mskcc.org	Ladanyi, Marc/AAG-8585-2019; Schultz, Nikolaus/ABE-6347-2020	Schultz, Nikolaus/0000-0002-0131-4904	Genome Data Analysis Center type B (GDAC-B), National Cancer Institute (NCI)/National Human Genome Research Institute (NHGRI) [U24 CA143840]; Starr Cancer Consortium; NATIONAL CANCER INSTITUTE [U24CA143840] Funding Source: NIH RePORTER	Genome Data Analysis Center type B (GDAC-B), National Cancer Institute (NCI)/National Human Genome Research Institute (NHGRI); Starr Cancer Consortium; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by a Genome Data Analysis Center type B (GDAC-B) grant (U24 CA143840) awarded as part of the National Cancer Institute (NCI)/National Human Genome Research Institute (NHGRI) funded Cancer Genome Atlas (TCGA) project. RS, QM, and VES are supported in part by a Starr Cancer Consortium grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cerami E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008918; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Dudoit S, 2002, GENOME BIOL, V3; Fang K.T., 1994, NUMBER THEORETIC MET; Friedman JH, 2004, J R STAT SOC B, V66, P815, DOI 10.1111/j.1467-9868.2004.02059.x; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Kapp AV, 2007, BIOSTATISTICS, V8, P9, DOI 10.1093/biostatistics/kxj029; Le Cao KA, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-34; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Pan W, 2007, J MACH LEARN RES, V8, P1145; Parkhomenko E, 2009, STAT APPL GENET MOL, V8, DOI 10.2202/1544-6115.1406; Pollack JR, 2002, P NATL ACAD SCI USA, V99, P12963, DOI 10.1073/pnas.162471999; Shen R, 2012, MEMORIAL SLOAN KETTE; Shen RL, 2009, BIOINFORMATICS, V25, P2906, DOI 10.1093/bioinformatics/btp543; Soneson C, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-191; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Taylor BS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003179; Tibshirani R, 2005, J COMPUT GRAPH STAT, V14, P511, DOI 10.1198/106186005X59243; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; van de Wiel MA, 2007, CANCER INFORM, V3, P55; van Wieringen WN, 2011, BIOINFORMATICS, V27, P556, DOI 10.1093/bioinformatics/btq704; Vaske CJ, 2010, BIOINFORMATICS, V26, pi237, DOI 10.1093/bioinformatics/btq182; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Waaijenborg S, 2008, STAT APPL GENET MOL, V7; Wang SJ, 2008, BIOMETRICS, V64, P440, DOI 10.1111/j.1541-0420.2007.00922.x; Witten DM, 2010, J AM STAT ASSOC, V105, P713, DOI 10.1198/jasa.2010.tm09415; Witten DM, 2009, STAT APPL GENET MOL, V8, DOI 10.2202/1544-6115.1470; Witten DM, 2009, BIOSTATISTICS, V10, P515, DOI 10.1093/biostatistics/kxp008; Xie BH, 2008, ELECTRON J STAT, V2, P168, DOI 10.1214/08-EJS194	29	152	154	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35236	10.1371/journal.pone.0035236	http://dx.doi.org/10.1371/journal.pone.0035236			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22539962	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341000026
J	Huynh, L; Kececioglu, J; Koppe, M; Tagkopoulos, I				Linh Huynh; Kececioglu, John; Koeppe, Matthias; Tagkopoulos, Ilias			Automatic Design of Synthetic Gene Circuits through Mixed Integer Non-linear Programming	PLOS ONE			English	Article							CELLULAR CONTROL PROCESSES; COMPUTATIONAL DESIGN; NETWORKS; CONSTRUCTION; MATHEMATICS; FEEDBACK; LIBRARY	Automatic design of synthetic gene circuits poses a significant challenge to synthetic biology, primarily due to the complexity of biological systems, and the lack of rigorous optimization methods that can cope with the combinatorial explosion as the number of biological parts increases. Current optimization methods for synthetic gene design rely on heuristic algorithms that are usually not deterministic, deliver sub-optimal solutions, and provide no guaranties on convergence or error bounds. Here, we introduce an optimization framework for the problem of part selection in synthetic gene circuits that is based on mixed integer non-linear programming (MINLP), which is a deterministic method that finds the globally optimal solution and guarantees convergence in finite time. Given a synthetic gene circuit, a library of characterized parts, and user-defined constraints, our method can find the optimal selection of parts that satisfy the constraints and best approximates the objective function given by the user. We evaluated the proposed method in the design of three synthetic circuits (a toggle switch, a transcriptional cascade, and a band detector), with both experimentally constructed and synthetic promoter libraries. Scalability and robustness analysis shows that the proposed framework scales well with the library size and the solution space. The work described here is a step towards a unifying, realistic framework for the automated design of biological circuits.	[Linh Huynh; Tagkopoulos, Ilias] Univ Calif Davis, Dept Comp Sci, Davis, CA 95616 USA; [Linh Huynh; Tagkopoulos, Ilias] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Kececioglu, John] Univ Arizona, Dept Comp Sci, Tucson, AZ 85721 USA; [Koeppe, Matthias] Univ Calif Davis, Dept Math, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of Arizona; University of California System; University of California Davis	Tagkopoulos, I (corresponding author), Univ Calif Davis, Dept Comp Sci, Davis, CA 95616 USA.	itagkopoulos@ucdavis.edu		Koppe, Matthias/0000-0003-2492-4139; Tagkopoulos, Ilias/0000-0003-1104-7616; HUYNH, VIET LINH/0000-0002-6736-295X	National Science Foundation [0941360, 1146926]; Vietnam Education Foundation; Direct For Computer & Info Scie & Enginr [1147844, 1146926] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Vietnam Education Foundation; Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	The authors would like to acknowledge support from grant 0941360 and 1146926 from the National Science Foundation. LH is supported by the Vietnam Education Foundation fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bansal V, 2003, COMPUT CHEM ENG, V27, P647, DOI 10.1016/S0098-1354(02)00261-2; Basu S, 2005, NATURE, V434, P1130, DOI 10.1038/nature03461; Basu S, 2002, DNA COMPUTING, P61; Beal J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022490; BELLMAN R, 1953, STABILITY THEORY DIF; Belotti P, 2009, OPTIM METHOD SOFTW, V24, P597, DOI 10.1080/10556780903087124; Berkeley 2006 iGEM Team, CONST PROM FAM; Boyce WE, 2009, ELEMENTARY DIFFERENT; Braun D, 2005, INT CONF ACOUST SPEE, P769; British-Columbia 2009 iGEM Team, PBAD PROM FAM; Dasika MS, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-24; Davis JH, 2011, NUCLEIC ACIDS RES, V39, P1131, DOI 10.1093/nar/gkq810; Densmore D, 2010, IEEE INT SYMP CIRC S, P557, DOI 10.1109/ISCAS.2010.5537540; Ellis T, 2009, NAT BIOTECHNOL, V27, P465, DOI 10.1038/nbt.1536; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Feng XJ, 2004, BIOPHYS J, V87, P2195, DOI 10.1529/biophysj.104.044131; Francois P, 2004, P NATL ACAD SCI USA, V101, P580, DOI 10.1073/pnas.0304532101; Garcia-Ojalvo J, 2004, P NATL ACAD SCI USA, V101, P10955, DOI 10.1073/pnas.0307095101; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; GOODWIN BRIAN C., 1965, ADVANCE ENZYME REGULAT, V3, P425, DOI 10.1016/0065-2571(65)90067-1; GRIFFITH JS, 1968, J THEOR BIOL, V20, P202, DOI 10.1016/0022-5193(68)90189-6; GRIFFITH JS, 1968, J THEOR BIOL, V20, P209, DOI 10.1016/0022-5193(68)90190-2; Hooshangi S, 2005, P NATL ACAD SCI USA, V102, P3581, DOI 10.1073/pnas.0408507102; Kuhlman T, 2007, P NATL ACAD SCI USA, V104, P6043, DOI 10.1073/pnas.0606717104; Lu TK, 2009, P NATL ACAD SCI USA, V106, P4629, DOI 10.1073/pnas.0800442106; Moler C, 2003, SIAM REV, V45, P3, DOI 10.1137/S00361445024180; Morgan-Kiss RM, 2002, P NATL ACAD SCI USA, V99, P7373, DOI 10.1073/pnas.122227599; Mukhopadhyay A, 2008, CURR OPIN BIOTECH, V19, P228, DOI 10.1016/j.copbio.2008.05.003; NATH K, 1970, J BIOL CHEM, V245, P2889; Pedersen M, 2009, J R SOC INTERFACE, V6, DOI 10.1098/rsif.2008.0516.focus; Rodrigo G, 2007, BIOINFORMATICS, V23, P1857, DOI 10.1093/bioinformatics/btm237; Rodrigo G, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr616; Tuttle LM, 2005, BIOPHYS J, V89, P3873, DOI 10.1529/biophysj.105.064204; Weiss JN, 1997, FASEB J, V11, P835, DOI 10.1096/fasebj.11.11.9285481; Wu CH, 2011, BIOINFORMATICS, V27, P2700, DOI 10.1093/bioinformatics/btr465	36	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35529	10.1371/journal.pone.0035529	http://dx.doi.org/10.1371/journal.pone.0035529			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536398	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339200074
J	Molina-Quiroz, RC; Munoz-Villagran, CM; de la Torre, E; Tantalean, JC; Vasquez, CC; Perez-Donoso, JM				Molina-Quiroz, Roberto C.; Munoz-Villagran, Claudia M.; de la Torre, Erick; Tantalean, Juan C.; Vasquez, Claudio C.; Perez-Donoso, Jose M.			Enhancing the Antibiotic Antibacterial Effect by Sub Lethal Tellurite Concentrations: Tellurite and Cefotaxime Act Synergistically in Escherichia coli	PLOS ONE			English	Article							POTASSIUM TELLURITE; OXIDATIVE STRESS; CELL-DEATH; RESISTANCE; MECHANISM; SURVIVAL; GROWTH; PENICILLIN; TOXICITY; BACTERIA	The emergence of antibiotic-resistant pathogenic bacteria during the last decades has become a public health concern worldwide. Aiming to explore new alternatives to treat antibiotic-resistant bacteria and given that the tellurium oxyanion tellurite is highly toxic for most microorganisms, we evaluated the ability of sub lethal tellurite concentrations to strengthen the effect of several antibiotics. Tellurite, at nM or mu M concentrations, increased importantly the toxicity of defined antibacterials. This was observed with both Gram negative and Gram positive bacteria, irrespective of the antibiotic or tellurite tolerance of the particular microorganism. The tellurite-mediated antibiotic-potentiating effect occurs in laboratory and clinical, uropathogenic Escherichia coli, especially with antibiotics disturbing the cell wall (ampicillin, cefotaxime) or protein synthesis (tetracycline, chloramphenicol, gentamicin). In particular, the effect of tellurite on the activity of the clinically-relevant, third-generation cephalosporin (cefotaxime), was evaluated. Cell viability assays showed that tellurite and cefotaxime act synergistically against E. coli. In conclusion, using tellurite like an adjuvant could be of great help to cope with several multi-resistant pathogens.	[Molina-Quiroz, Roberto C.; Munoz-Villagran, Claudia M.; Vasquez, Claudio C.; Perez-Donoso, Jose M.] Univ Santiago Chile, Mol Microbiol Lab, Dept Biol, Fac Quim & Biol, Santiago, Chile; [de la Torre, Erick; Tantalean, Juan C.] Univ San Luis Gonzaga, Lab Microbiol & Biotecnol, Fac Ciencias, Ica, Peru; [Perez-Donoso, Jose M.] Univ Chile, Fac Ciencias Quim & Farmaceut, Lab Bioquim, Santiago, Chile	Universidad de Santiago de Chile; Universidad Nacional San Luis Gonzaga; Universidad de Chile	Vasquez, CC (corresponding author), Univ Santiago Chile, Mol Microbiol Lab, Dept Biol, Fac Quim & Biol, Santiago, Chile.	claudio.vasquez@usach.cl; joseperez@ciq.uchile.cl	Molina-Quiroz, Roberto C/H-4696-2019; Pérez-Donoso, José M./G-3668-2013	Molina-Quiroz, Roberto C/0000-0003-3653-7160; Pérez-Donoso, José M./0000-0002-9506-1716; De La Torre Tarazona, Humberto Erick/0000-0003-0325-3735; TANTALEAN, JUAN/0000-0002-9541-7102	FONDECYT (Fondo Nacional de Ciencia y Tecnologia) [1090097, 3100049]; IFS (International Foundation for Science, Sweden) [4733-1]; DICYT (Direccion de Investigacion Cientifica y Tecnologica, Universidad de Santiago de Chile); CONICYT (Comision Nacional de Ciencia y Tecnologia) [24100031]	FONDECYT (Fondo Nacional de Ciencia y Tecnologia)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); IFS (International Foundation for Science, Sweden)(International Foundation for Science); DICYT (Direccion de Investigacion Cientifica y Tecnologica, Universidad de Santiago de Chile); CONICYT (Comision Nacional de Ciencia y Tecnologia)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	This work received financial support from FONDECYT (Fondo Nacional de Ciencia y Tecnologia) 1090097 (CCV) and 3100049 (JMPD); IFS (International Foundation for Science, Sweden) 4733-1 (JMPD); DICYT (Direccion de Investigacion Cientifica y Tecnologica, Universidad de Santiago de Chile) (CCV, JMPD). A doctoral fellowship and grant 24100031 from CONICYT (Comision Nacional de Ciencia y Tecnologia) to RCMQ is also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASAKURA T, 1984, BLOOD, V64, P305; Banin E, 2008, P NATL ACAD SCI USA, V105, P16761, DOI 10.1073/pnas.0808608105; Calderon IL, 2009, MICROBIOL-SGM, V155, P1840, DOI 10.1099/mic.0.026260-0; Castro ME, 2009, BIOCHEM BIOPH RES CO, V380, P148, DOI 10.1016/j.bbrc.2009.01.078; CHAPMAN PA, 1991, J MED MICROBIOL, V35, P107, DOI 10.1099/00222615-35-2-107; Chasteen TG, 2009, FEMS MICROBIOL REV, V33, P820, DOI 10.1111/j.1574-6976.2009.00177.x; Dantas G, 2008, SCIENCE, V320, P100, DOI 10.1126/science.1155157; Fleming A, 1932, J PATHOL BACTERIOL, V35, P831, DOI 10.1002/path.1700350603; Ford C. W., 2001, Current Drug Targets - Infectious Disorders, V1, P181, DOI 10.2174/1568005014606099; Guillamet E, 2008, MUTAT RES-GEN TOX EN, V654, P22, DOI 10.1016/j.mrgentox.2008.04.005; Hemaiswarya S, 2010, J MED MICROBIOL, V59, P1469, DOI 10.1099/jmm.0.022426-0; Horii T, 2002, HELICOBACTER, V7, P39, DOI 10.1046/j.1523-5378.2002.00054.x; Ison CA, 2011, EURO SURVEILL, V16; Kohanski MA, 2008, CELL, V135, P679, DOI 10.1016/j.cell.2008.09.038; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Kohanski MA, 2010, MOL CELL, V37, P311, DOI 10.1016/j.molcel.2010.01.003; Kumarasamy KK, 2010, LANCET INFECT DIS, V10, P597, DOI 10.1016/S1473-3099(10)70143-2; LaPlante KL, 2004, EXPERT OPIN PHARMACO, V5, P2321, DOI 10.1517/14656566.5.11.2321; Lepercq J, 2009, ANTIMICROB AGENTS CH, V53, P2342, DOI 10.1128/AAC.01429-08; Livermore DM, 2006, TRENDS MICROBIOL, V14, P413, DOI 10.1016/j.tim.2006.07.008; Lu TK, 2009, P NATL ACAD SCI USA, V106, P4629, DOI 10.1073/pnas.0800442106; Nicola G, 2010, BIOCHEMISTRY-US, V49, P8094, DOI 10.1021/bi100879m; NIX DE, 1995, DIAGN MICR INFEC DIS, V22, P71, DOI 10.1016/0732-8893(95)00074-K; Perez JM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000211; Perez JM, 2008, J BIOL CHEM, V283, P7346, DOI 10.1074/jbc.M708846200; Sandoval JM, 2010, BIOMETALS, V23, P623, DOI 10.1007/s10534-010-9316-2; SCHROEDE.HA, 1971, J NUTR, V101, P1531, DOI 10.1093/jn/101.11.1531; SCHROEDER HA, 1972, ARCH ENVIRON HEALTH, V24, P66, DOI 10.1080/00039896.1972.10666052; SCHROEDER HA, 1967, J NUTR, V92, P334, DOI 10.1093/jn/92.3.334; Turner RJ, 2001, CAN J MICROBIOL, V47, P33, DOI 10.1139/cjm-47-1-33; WAGNER M, 1995, J NEUROCHEM, V64, P2169; Walsh C, 2003, NAT REV MICROBIOL, V1, P65, DOI 10.1038/nrmicro727	32	22	24	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35452	10.1371/journal.pone.0035452	http://dx.doi.org/10.1371/journal.pone.0035452			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536386	Green Published, gold, Green Submitted			2022-12-27	WOS:000305339200066
J	Faty, A; Ferre, P; Commans, S				Faty, Aurelie; Ferre, Pascal; Commans, Stephane			The Acute Phase Protein Serum Amyloid A Induces Lipolysis and Inflammation in Human Adipocytes through Distinct Pathways	PLOS ONE			English	Article							LOW-GRADE INFLAMMATION; ADIPOSE-TISSUE; MESSENGER-RNA; CYTOKINE PRODUCTION; INSULIN-RESISTANCE; COUPLED RECEPTOR; LOCAL EXPRESSION; SYNOVIAL TISSUE; BINDING; GENES	Background: The acute phase response (APR) is characterized by alterations in lipid and glucose metabolism leading to an increased delivery of energy substrates. In adipocytes, there is a coordinated decrease in Free Fatty acids (FFAs) and glucose storage, in addition to an increase in FFAs mobilization. Serum Amyloid A (SAA) is an acute phase protein mainly associated with High Density Lipoproteins (HDL). We hypothesized that enrichment of HDL with SAA, during the APR, could be implicated in the metabolic changes occurring in adipocytes. Methodology/Principal Findings: In vitro differentiated human adipocytes (hMADS) were treated with SAA enriched HDL or recombinant SAA and the metabolic phenotype of the cells analyzed. In hMADS, SAA induces an increased lipolysis through an ERK dependent pathway. At the molecular level, SAA represses PPAR gamma 2, C/EBP alpha and SREBP-1c gene expression, three transcription factors involved in adipocyte differentiation or lipid synthesis. In addition, the activation of the NF-kappa B pathway by SAA leads to the induction of pro-inflammatory cytokines and chemokines, as in the case of immune cells. These latter findings were replicated in freshly isolated mature human adipocytes. Conclusions/Significance: Besides its well-characterized role in cholesterol metabolism, SAA has direct metabolic effects on human adipocytes. These metabolic changes could be at least partly responsible for alterations of adipocyte metabolism observed during the APR as well as during pathophysiological conditions such as obesity and conditions leading to insulin resistant states.	[Faty, Aurelie; Commans, Stephane] GlaxoSmithKline, Metab Pathways Ctr Excellence Drug Discovery, Les Ulis, France; [Ferre, Pascal] INSERM, Cordeliers Res Ctr, UMR S Eq 8 872, Paris, France; [Ferre, Pascal] Univ Paris 06, UMR S 872, Cordeliers Res Ctr, Paris, France	GlaxoSmithKline; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite	Faty, A (corresponding author), GlaxoSmithKline, Metab Pathways Ctr Excellence Drug Discovery, Les Ulis, France.	pascal.ferre@crc.jussieu.fr	Ferré, Pascal/K-1250-2013	Ferré, Pascal/0000-0003-0115-7045	GlaxoSmithKline	GlaxoSmithKline(GlaxoSmithKline)	Aurelie Faty and Stephane Commans had their salary paid by GlaxoSmithKline. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all Plos ONE policies on sharing data and materials.	BADOLATO R, 1995, J IMMUNOL, V155, P4004; BADOLATO R, 1994, J EXP MED, V180, P203, DOI 10.1084/jem.180.1.203; Baranova IN, 2005, J BIOL CHEM, V280, P8031, DOI 10.1074/jbc.M405009200; Cai L, 2005, J BIOL CHEM, V280, P2954, DOI 10.1074/jbc.M411555200; Chait A, 2005, J LIPID RES, V46, P389, DOI 10.1194/jlr.R400017-JLR200; Chambrier C, 2000, CLIN SCI, V99, P312; Chan ED, 1997, P NATL ACAD SCI USA, V94, P13169, DOI 10.1073/pnas.94.24.13169; Chiolero R, 1997, NUTRITION, V13, pS45, DOI 10.1016/S0899-9007(97)00205-0; Cree MG, 2008, AM J PHYSIOL-ENDOC M, V294, pE1, DOI 10.1152/ajpendo.00562.2007; Gabrielsson BG, 2005, OBES RES, V13, P649, DOI 10.1038/oby.2005.72; Gomez-Ambrosi J, 2006, OBES SURG, V16, P262, DOI 10.1381/096089206776116525; Han CY, 2007, DIABETES, V56, P2260, DOI 10.2337/db07-0218; Hatanaka E, 2004, IMMUNOL LETT, V91, P33, DOI 10.1016/j.imlet.2003.09.011; He R, 2003, BLOOD, V101, P1572, DOI 10.1182/blood-2002-05-1431; Ii M, 2006, MOL PHARMACOL, V69, P1288, DOI 10.1124/mol.105.019695; Jernas M, 2006, FASEB J, V20, P1540, DOI 10.1096/fj.05-5678fje; Khovidhunkit W, 2004, J LIPID RES, V45, P1169, DOI 10.1194/jlr.R300019-JLR200; Kumon Y, 1999, J RHEUMATOL, V26, P785; Le YY, 2001, CYTOKINE GROWTH F R, V12, P91, DOI 10.1016/S1359-6101(01)00003-X; Liu LR, 2011, OBESITY, V19, P2301, DOI 10.1038/oby.2011.176; MEEK RL, 1992, P NATL ACAD SCI USA, V89, P7949, DOI 10.1073/pnas.89.17.7949; MEEK RL, 1994, P NATL ACAD SCI USA, V91, P3186, DOI 10.1073/pnas.91.8.3186; Moutsopoulos NM, 2006, ANN NY ACAD SCI, V1088, P251, DOI 10.1196/annals.1366.032; O'Brien Kevin D, 2006, Curr Atheroscler Rep, V8, P62, DOI 10.1007/s11883-006-0066-0; O'Hara R, 2004, ARTHRITIS RHEUM-US, V50, P1788, DOI 10.1002/art.20301; Okamoto H, 2008, J RHEUMATOL, V35, P752; Patel H, 1998, SCAND J IMMUNOL, V48, P410; Poitou C, 2005, DIABETOLOGIA, V48, P519, DOI 10.1007/s00125-004-1654-6; Poitou C, 2006, OBESITY, V14, P309, DOI 10.1038/oby.2006.40; Poitou C, 2009, J CLIN ENDOCR METAB, V94, P1810, DOI 10.1210/jc.2008-2040; Rodriguez AM, 2005, J EXP MED, V201, P1397, DOI 10.1084/jem.20042224; Rodriguez AM, 2004, BIOCHEM BIOPH RES CO, V315, P255, DOI 10.1016/j.bbrc.2004.01.053; Sandri S, 2008, J LEUKOCYTE BIOL, V83, P1174, DOI 10.1189/jlb.0407203; Scheja L, 2008, EXP DIABETES RES, DOI 10.1155/2008/230837; Sjoholm K, 2005, J CLIN ENDOCR METAB, V90, P2233, DOI 10.1210/jc.2004-1830; Skurk T, 2007, J CLIN ENDOCR METAB, V92, P1023, DOI 10.1210/jc.2006-1055; Su SB, 1999, J EXP MED, V189, P395, DOI 10.1084/jem.189.2.395; Subramanian S, 2008, ARTERIOSCL THROM VAS, V28, P685, DOI 10.1161/ATVBAHA.107.157685; Theuma Pierre, 2003, Curr Diab Rep, V3, P248, DOI 10.1007/s11892-003-0072-3; Trager Karl, 2003, Curr Opin Crit Care, V9, P271; Uhlar CM, 1999, EUR J BIOCHEM, V265, P501, DOI 10.1046/j.1432-1327.1999.00657.x; Venteclef N, 2006, MOL CELL BIOL, V26, P6799, DOI 10.1128/MCB.00579-06; Walder K, 2002, DIABETES, V51, P1859, DOI 10.2337/diabetes.51.6.1859; Wang YC, 2010, J NUTR BIOCHEM, V21, P317, DOI 10.1016/j.jnutbio.2009.01.004; Wisse BE, 2004, J AM SOC NEPHROL, V15, P2792, DOI 10.1097/01.ASN.0000141966.69934.21; Wolfe RR, 1997, BAILLIERE CLIN ENDOC, V11, P645, DOI 10.1016/S0950-351X(97)80926-3; Yamada M, 2005, J MED CHEM, V48, P7457, DOI 10.1021/jm050623t; Yang RZ, 2006, PLOS MED, V3, P884, DOI 10.1371/journal.pmed.0030287; Zanetti M, 2008, J RENAL NUTR, V18, P70, DOI 10.1053/j.jrn.2007.10.015	49	25	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e34031	10.1371/journal.pone.0034031	http://dx.doi.org/10.1371/journal.pone.0034031			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22532826	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336200005
J	Kubicek, J; Schlesinger, R; Baeken, C; Buldt, G; Schafer, F; Labahn, J				Kubicek, Jan; Schlesinger, Ramona; Baeken, Christian; Bueldt, Georg; Schaefer, Frank; Labahn, Joerg			Controlled In Meso Phase Crystallization - A Method for the Structural Investigation of Membrane Proteins	PLOS ONE			English	Article							SENSORY RHODOPSIN-II; X-RAY-STRUCTURE; CRYSTAL-STRUCTURE; SOLUBLE-PROTEINS; VAPOR DIFFUSION; BACTERIORHODOPSIN; ANGSTROMS; MECHANISM; SYSTEM	We investigated in meso crystallization of membrane proteins to develop a fast screening technology which combines features of the well established classical vapor diffusion experiment with the batch meso phase crystallization, but without premixing of protein and monoolein. It inherits the advantages of both methods, namely (i) the stabilization of membrane proteins in the meso phase, (ii) the control of hydration level and additive concentration by vapor diffusion. The new technology (iii) significantly simplifies in meso crystallization experiments and allows the use of standard liquid handling robots suitable for 96 well formats. CIMP crystallization furthermore allows (iv) direct monitoring of phase transformation and crystallization events. Bacteriorhodopsin (BR) crystals of high quality and diffraction up to 1.3 angstrom resolution have been obtained in this approach. CIMP and the developed consumables and protocols have been successfully applied to obtain crystals of sensory rhodopsin II (SRII) from Halobacterium salinarum for the first time.	[Kubicek, Jan; Schaefer, Frank] QIAGEN GmbH, Hilden, Germany; [Schlesinger, Ramona; Baeken, Christian; Bueldt, Georg; Labahn, Joerg] Forschungszentrum Julich, Inst Struct Biol & Biophys, D-52425 Julich, Germany	QIAGEN GmbH; Helmholtz Association; Research Center Julich	Kubicek, J (corresponding author), QIAGEN GmbH, Hilden, Germany.	j.labahn@fz-juelich.de	Büldt, Georg/H-9509-2014; Buldt, Georg/K-5345-2013; Schlesinger, Ramona/W-2620-2018; Labahn, Jörg/G-9593-2013	Schlesinger, Ramona/0000-0002-7716-4439; Labahn, Jörg/0000-0002-0648-8145	Research Center Julich; QIAGEN GmbH	Research Center Julich(Helmholtz Association); QIAGEN GmbH	The work was supported by Research Center Julich and QIAGEN GmbH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benvenuti M, 2007, NAT PROTOC, V2, P1633, DOI 10.1038/nprot.2007.198; Brumshtein B, 2008, J APPL CRYSTALLOGR, V41, P969, DOI 10.1107/S0021889808024667; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Caffrey M, 2008, CRYST GROWTH DES, V8, P4244, DOI 10.1021/cg800693r; Chayen NE, 1997, J APPL CRYSTALLOGR, V30, P198, DOI 10.1107/S0021889896013532; Chen AH, 1998, CHEM PHYS LIPIDS, V95, P11, DOI 10.1016/S0009-3084(98)00060-7; Cherezov V, 2004, ACTA CRYSTALLOGR D, V60, P1795, DOI 10.1107/S0907444904019109; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Engstrom S, 1998, PROG COLL POL SCI S, V108, P93; Gordeliy VI, 2002, NATURE, V419, P484, DOI 10.1038/nature01109; Grabe M, 2003, BIOPHYS J, V84, P854, DOI 10.1016/S0006-3495(03)74904-2; Hato M, 2009, J PHYS CHEM B, V113, P10196, DOI 10.1021/jp902883q; HEYMANN JAW, 1993, MOL MICROBIOL, V7, P623, DOI 10.1111/j.1365-2958.1993.tb01153.x; Kolbe M, 2000, SCIENCE, V288, P1390, DOI 10.1126/science.288.5470.1390; Kors CA, 2009, ACTA CRYSTALLOGR D, V65, P1062, DOI 10.1107/S0907444909029163; Landau EM, 1996, P NATL ACAD SCI USA, V93, P14532, DOI 10.1073/pnas.93.25.14532; Liu W, 2010, BIOPHYS J, V98, P1539, DOI 10.1016/j.bpj.2009.12.4296; Luecke H, 2001, SCIENCE, V293, P1499, DOI 10.1126/science.1062977; Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027; McPherson A, 2006, J STRUCT BIOL, V156, P387, DOI 10.1016/j.jsb.2006.09.006; MICHEL H, 1982, EMBO J, V1, P1267, DOI 10.1002/j.1460-2075.1982.tb00023.x; Mironova OS, 2005, FEBS LETT, V579, P3147, DOI 10.1016/j.febslet.2005.05.010; Misquitta LV, 2004, STRUCTURE, V12, P2113, DOI 10.1016/j.str.2004.09.020; Misquitta Y, 2004, J STRUCT BIOL, V148, P169, DOI 10.1016/j.jsb.2004.06.008; Misquitta Y, 2003, BIOPHYS J, V85, P3084, DOI 10.1016/S0006-3495(03)74727-4; Moiseeva ES, 2009, J SURF INVESTIG, V3, P29, DOI 10.1134/S1027451009010054; Nollert P, 2001, FEBS LETT, V504, P179, DOI 10.1016/S0014-5793(01)02747-8; PebayPeyroula E, 1997, SCIENCE, V277, P1676, DOI 10.1126/science.277.5332.1676; Qiu H, 2000, BIOMATERIALS, V21, P223, DOI 10.1016/S0142-9612(99)00126-X; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Royant A, 2001, P NATL ACAD SCI USA, V98, P10131, DOI 10.1073/pnas.181203898; Wadsten P, 2006, J MOL BIOL, V364, P44, DOI 10.1016/j.jmb.2006.06.043; Wohri AB, 2008, STRUCTURE, V16, P1003, DOI 10.1016/j.str.2008.06.003	33	12	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e35458	10.1371/journal.pone.0035458	http://dx.doi.org/10.1371/journal.pone.0035458			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22536388	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336200043
J	Mazzaccara, C; Iafusco, D; Liguori, R; Ferrigno, M; Galderisi, A; Vitale, D; Simonelli, F; Landolfo, P; Prisco, F; Masullo, M; Sacchetti, L				Mazzaccara, Cristina; Iafusco, Dario; Liguori, Rosario; Ferrigno, Maddalena; Galderisi, Alfonso; Vitale, Domenico; Simonelli, Francesca; Landolfo, Paolo; Prisco, Francesco; Masullo, Mariorosario; Sacchetti, Lucia			Mitochondrial Diabetes in Children: Seek and You Will Find It	PLOS ONE			English	Article							MACULAR PATTERN DYSTROPHY; COMPLEX-I; CLINICAL CHARACTERISTICS; MOLECULAR-MECHANISMS; CELIAC-DISEASE; MUTATION; DEAFNESS; PREVALENCE; MELAS; HETEROPLASMY	Maternally Inherited Diabetes and Deafness (MIDD) is a rare form of diabetes due to defects in mitochondrial DNA (mtDNA). 3243 A. G is the mutation most frequently associated with this condition, but other mtDNA variants have been linked with a diabetic phenotype suggestive of MIDD. From 1989 to 2009, we clinically diagnosed mitochondrial diabetes in 11 diabetic children. Diagnosis was based on the presence of one or more of the following criteria: 1) maculopathy; 2) hearing impairment; 3) maternal heritability of diabetes/impaired fasting glucose and/or hearing impairment and/or maculopathy in three consecutive generations (or in two generations if 2 or 3 members of a family were affected). We sequenced the mtDNA in the 11 probands, in their mothers and in 80 controls. We identified 33 diabetes-suspected mutations, 1/33 was 3243A>G. Most patients (91%) and their mothers had mutations in complex I and/or IV of the respiratory chain. We measured the activity of these two enzymes and found that they were less active in mutated patients and their mothers than in the healthy control pool. The prevalence of hearing loss (36% vs 75-98%) and macular dystrophy (54% vs 86%) was lower in our mitochondrial diabetic adolescents than reported in adults. Moreover, we found a hitherto unknown association between mitochondrial diabetes and celiac disease. In conclusion, mitochondrial diabetes should be considered a complex syndrome with several phenotypic variants. Moreover, deafness is not an essential component of the disease in children. The whole mtDNA should be screened because the 3243A>G variant is not as frequent in children as in adults. In fact, 91% of our patients were mutated in the complex I and/or IV genes. The enzymatic assay may be a useful tool with which to confirm the pathogenic significance of detected variants.	[Mazzaccara, Cristina; Liguori, Rosario; Vitale, Domenico; Sacchetti, Lucia] CEINGE Adv Biotechnol SC aRL, Naples, Italy; [Mazzaccara, Cristina; Liguori, Rosario; Masullo, Mariorosario; Sacchetti, Lucia] Univ Naples Federico II, Dept Biochem & Med Biotechnol, Naples, Italy; [Iafusco, Dario; Galderisi, Alfonso; Prisco, Francesco] Univ Naples 2, Dept Pediat, Naples, Italy; [Ferrigno, Maddalena] SDN Fdn, Naples, Italy; [Simonelli, Francesca; Landolfo, Paolo] Univ Naples 2, Dept Ophthalmol, Naples, Italy; [Masullo, Mariorosario] Univ Naples Parthenope, Inst & Terr Syst, Dept Study, Naples, Italy	CEINGE Biotecnologie Avanzate; University of Naples Federico II; Universita della Campania Vanvitelli; IRCCS Istituto di Ricerca Diagnostica e Nucleare (SDN); Universita della Campania Vanvitelli; Parthenope University Naples	Mazzaccara, C (corresponding author), CEINGE Adv Biotechnol SC aRL, Naples, Italy.	sacchett@unina.it	Galderisi, Alfonso/G-3259-2018; Mazzaccara, Cristina/AAC-5361-2022; Simonelli, Francesca/AHE-7571-2022; Masullo, Mariorosario/H-4884-2016	Galderisi, Alfonso/0000-0001-8885-3056; Simonelli, Francesca/0000-0001-8520-6769; Ferrigno, Maddalena/0000-0003-4824-5886; Liguori, Rosario/0000-0002-2014-9502; Iafusco, Dario/0000-0002-9398-3856; Masullo, Mariorosario/0000-0003-4485-7383; Mazzaccara, Cristina/0000-0001-7774-2799	CEINGE Regione Campania (DGRC) [1901/2009]	CEINGE Regione Campania (DGRC)	This work was supported by CEINGE Regione Campania (DGRC 1901/2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcolado JC, 2002, DIABETIC MED, V19, P89, DOI 10.1046/j.1464-5491.2002.00675.x; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc13-S067, 10.2337/dc10-S062, 10.2337/dc12-s064, 10.2337/dc11-S062]; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Balestri P, 2000, J CHILD NEUROL, V15, P755, DOI 10.1177/088307380001501108; Bannwarth S, 2011, DIABETES CARE, V34, P2591, DOI 10.2337/dc11-1012; Boushel R, 2007, DIABETOLOGIA, V50, P790, DOI 10.1007/s00125-007-0594-3; Carelli V, 2003, TRENDS GENET, V19, P257, DOI 10.1016/S0168-9525(03)00072-6; Chen JF, 2007, GENE, V401, P4, DOI 10.1016/j.gene.2007.06.009; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Choo-Kang ATW, 2002, DIABETES, V51, P2317, DOI 10.2337/diabetes.51.7.2317; Crispim D, 2008, ARQ BRAS ENDOCRINOL, V52, P1228, DOI 10.1590/S0004-27302008000800005; de Wit LEA, 2007, J IMMUNOL METHODS, V326, P76, DOI 10.1016/j.jim.2007.07.009; Dube C, 2005, GASTROENTEROLOGY, V128, pS57, DOI 10.1053/j.gastro.2005.02.014; Elstner M, 2008, BIOCHEM BIOPH RES CO, V377, P379, DOI 10.1016/j.bbrc.2008.09.134; Fuss Ivan J, 2009, Curr Protoc Immunol, VChapter 7, DOI 10.1002/0471142735.im0701s85; Guillausseau PJ, 2004, DIABETES METAB, V30, P181, DOI 10.1016/S1262-3636(07)70105-2; Guillausseau PJ, 2001, ANN INTERN MED, V134, P721, DOI 10.7326/0003-4819-134-9_Part_1-200105010-00008; Gutierrez Cortes N, 2012, HUM MUTAT IN PRESS; Hanna MG, 1998, J NEUROL NEUROSUR PS, V65, P512, DOI 10.1136/jnnp.65.4.512; Horvath R, 2008, NEUROMUSCULAR DISORD, V18, P553, DOI 10.1016/j.nmd.2008.05.002; Hosszufalusi N, 2009, DIABETES-METAB RES, V25, P127, DOI 10.1002/dmrr.841; Howes T, 2008, J LARYNGOL OTOL, V122, P1249, DOI 10.1017/S0022215108001503; Kagnoff MF, 2007, J CLIN INVEST, V117, P41, DOI 10.1172/JCI30253; Kirby DM, 2007, METHOD CELL BIOL, V80, P93, DOI 10.1016/S0091-679X(06)80004-X; Laloi-Michelin M, 2009, J CLIN ENDOCR METAB, V94, P3025, DOI 10.1210/jc.2008-2680; Leo-Kottler B, 2002, GRAEF ARCH CLIN EXP, V240, P758, DOI 10.1007/s00417-002-0494-7; Maassen JA, 2006, ENDOCRIN METAB CLIN, V35, P385, DOI 10.1016/j.ecl.2006.02.014; Maassen JA, 2005, ANN MED, V37, P213, DOI 10.1080/07853890510007188; Maassen JA, 2004, DIABETES, V53, pS103, DOI 10.2337/diabetes.53.2007.S103; Maechler P, 2001, NATURE, V414, P807, DOI 10.1038/414807a; Malfatti E, 2007, BRAIN, V130, P1894, DOI 10.1093/brain/awm114; MARIOTTI C, 1994, J CLIN INVEST, V93, P1102, DOI 10.1172/JCI117061; MASSIN P, 1995, AM J OPHTHALMOL, V120, P247, DOI 10.1016/S0002-9394(14)72615-7; Massin P, 1999, OPHTHALMOLOGY, V106, P1821, DOI 10.1016/S0161-6420(99)90356-1; Murphy R, 2008, DIABETIC MED, V25, P383, DOI 10.1111/j.1464-5491.2008.02359.x; Murphy R, 2008, NAT CLIN PRACT ENDOC, V4, P200, DOI 10.1038/ncpendmet0778; Prisco F, 1996, DIABETES CARE, V19, P1454, DOI 10.2337/diacare.19.12.1454; Qian YP, 2005, BIOCHEM BIOPH RES CO, V332, P614, DOI 10.1016/j.bbrc.2005.05.003; Sawada S, 1997, AM J OTOL, V18, P332; Zhang Shi, 2009, Chinese Medical Sciences Journal, V24, P20	41	18	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e34956	10.1371/journal.pone.0034956	http://dx.doi.org/10.1371/journal.pone.0034956			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22536343	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336200017
J	Geng, JN; Chiu, CH; Tang, P; Chen, YP; Shieh, HR; Hu, SN; Chen, YYM				Geng, Jianing; Chiu, Cheng-Hsun; Tang, Petrus; Chen, Yaping; Shieh, Hui-Ru; Hu, Songnian; Chen, Yi-Ywan M.			Complete Genome and Transcriptomes of Streptococcus parasanguinis FW213: Phylogenic Relations and Potential Virulence Mechanisms	PLOS ONE			English	Article							SALIVA-COATED HYDROXYAPATITE; FIMBRIAE-ASSOCIATED ADHESIN; DAMAGED HEART-VALVES; BIOFILM FORMATION; BACTERIAL GENOMES; ESCHERICHIA-COLI; STAPHYLOCOCCUS-AUREUS; LACTOCOCCUS-LACTIS; COMPLETE SEQUENCE; OXIDATIVE STRESS	Streptococcus parasanguinis, a primary colonizer of the tooth surface, is also an opportunistic pathogen for subacute endocarditis. The complete genome of strain FW213 was determined using the traditional shotgun sequencing approach and further refined by the transcriptomes of cells in early exponential and early stationary growth phases in this study. The transcriptomes also discovered 10 transcripts encoding known hypothetical proteins, one pseudogene, five transcripts matched to the Rfam and additional 87 putative small RNAs within the intergenic regions defined by the GLIMMER analysis. The genome contains five acquired genomic islands (GIs) encoding proteins which potentially contribute to the overall pathogenic capacity and fitness of this microbe. The differential expression of the GIs and various open reading frames outside the GIs at the two growth phases suggested that FW213 possess a range of mechanisms to avoid host immune clearance, to colonize host tissues, to survive within oral biofilms and to overcome various environmental insults. Furthermore, the comparative genome analysis of five S. parasanguinis strains indicates that albeit S. parasanguinis strains are highly conserved, variations in the genome content exist. These variations may reflect differences in pathogenic potential between the strains.	[Geng, Jianing; Chen, Yaping; Hu, Songnian] Chinese Acad Sci, Beijing Inst Gen, Key Lab Genome Sci & Informat, Beijing, Peoples R China; [Chiu, Cheng-Hsun] Chang Gung Childrens Hosp, Mol Infect Dis Res Ctr, Div Pediat Infect Dis, Tao Yuan, Taiwan; [Chiu, Cheng-Hsun; Tang, Petrus; Shieh, Hui-Ru; Chen, Yi-Ywan M.] Chang Gung Univ, Grad Inst Basic Med Sci, Tao Yuan, Taiwan; [Tang, Petrus] Chang Gung Univ, Bioinformat Ctr, Tao Yuan, Taiwan; [Chen, Yaping] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Chen, Yi-Ywan M.] Chang Gung Univ, Dept Microbiol & Immunol, Tao Yuan, Taiwan	Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chang Gung University	Geng, JN (corresponding author), Chinese Acad Sci, Beijing Inst Gen, Key Lab Genome Sci & Informat, Beijing, Peoples R China.	mchen@mail.cgu.edu.tw	; Hu, Songnian/C-6509-2013	Tang, Petrus/0000-0002-2779-0116; Hu, Songnian/0000-0003-3966-3111	Chang Gung Memorial Hospital [CMRPG371602, CMPRD1A0451]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This study was supported by the Chang Gung Memorial Hospital grants CMRPG371602 and CMPRD1A0451. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanensen DM, 2007, J BACTERIOL, V189, P7856, DOI 10.1128/JB.00837-07; Ahn SJ, 2006, J BACTERIOL, V188, P6877, DOI 10.1128/JB.00536-06; Ajdic D, 2002, P NATL ACAD SCI USA, V99, P14434, DOI 10.1073/pnas.172501299; Ajdic D, 2007, J BACTERIOL, V189, P5049, DOI 10.1128/JB.00338-07; Alexeyenko A, 2006, BIOINFORMATICS, V22, pE9, DOI 10.1093/bioinformatics/btl213; AYOUBI P, 1991, J BACTERIOL, V173, P1617, DOI 10.1128/jb.173.5.1617-1622.1991; Bao QY, 2002, GENOME RES, V12, P689, DOI 10.1101/gr.219302; Bolotin A, 2004, NAT BIOTECHNOL, V22, P1554, DOI 10.1038/nbt1034; Burne RA, 2000, FEMS MICROBIOL LETT, V193, P1; BURNETTECURLEY D, 1995, INFECT IMMUN, V63, P4669, DOI 10.1128/IAI.63.12.4669-4674.1995; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; CASIANOCOLON A, 1988, APPL ENVIRON MICROB, V54, P1318; Chen YYM, 2008, APPL ENVIRON MICROB, V74, P1642, DOI 10.1128/AEM.01878-07; Chen YYM, 2011, APPL ENVIRON MICROB, V77, P3967, DOI 10.1128/AEM.02828-10; Chen YYM, 1996, INFECT IMMUN, V64, P585, DOI 10.1128/IAI.64.2.585-592.1996; Chen YYM, 1998, J BACTERIOL, V180, P5769, DOI 10.1128/JB.180.21.5769-5775.1998; COLE RM, 1976, J DENT RES, V55, pA142, DOI 10.1177/002203457605500106011; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Ding F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-158; FACHONKALWEIT S, 1985, INFECT IMMUN, V48, P617, DOI 10.1128/IAI.48.3.617-624.1985; FENNO JC, 1995, MOL MICROBIOL, V15, P849, DOI 10.1111/j.1365-2958.1995.tb02355.x; FIVESTAYLOR PM, 1985, INFECT IMMUN, V47, P752, DOI 10.1128/IAI.47.3.752-759.1985; Frangeul L, 1999, MICROBIOL-SGM, V145, P2625, DOI 10.1099/00221287-145-10-2625; Froeliger EH, 2001, INFECT IMMUN, V69, P2512, DOI 10.1128/IAI.69.4.2512-2519.2001; Gao F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-79; Geng JN, 2011, J BACTERIOL, V193, P5596, DOI 10.1128/JB.05670-11; GIAEVER HM, 1988, J BACTERIOL, V170, P2841, DOI 10.1128/jb.170.6.2841-2849.1988; GIBBONS RJ, 1975, ANNU REV MICROBIOL, V29, P19, DOI 10.1146/annurev.mi.29.100175.000315; Giefing-Kroll C, 2011, MICROBIOL-SGM, V157, P1897, DOI 10.1099/mic.0.045211-0; Griffiths-Jones S, 2005, NUCLEIC ACIDS RES, V33, pD121, DOI 10.1093/nar/gki081; Guell M, 2009, SCIENCE, V326, P1268, DOI 10.1126/science.1176951; Heilmann C, 1997, MOL MICROBIOL, V24, P1013, DOI 10.1046/j.1365-2958.1997.4101774.x; Hyink O, 2007, APPL ENVIRON MICROB, V73, P1107, DOI 10.1128/AEM.02265-06; InterPro Database, 2003, NUCL ACIDS RES, V31, P315; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; KAWAMURA Y, 1995, INT J SYST BACTERIOL, V45, P406, DOI 10.1099/00207713-45-2-406; Koide T, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.42; Kolenbrander PE, 2000, ANNU REV MICROBIOL, V54, P413, DOI 10.1146/annurev.micro.54.1.413; Kreth J, 2008, J BACTERIOL, V190, P4632, DOI 10.1128/JB.00276-08; KUIPERS OP, 1995, J BIOL CHEM, V270, P27299, DOI 10.1074/jbc.270.45.27299; Kurkivuori J, 2007, ORAL ONCOL, V43, P181, DOI 10.1016/j.oraloncology.2006.02.005; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lemos JAC, 2005, CURR ISSUES MOL BIOL, V7, P95; Lemos JA, 2008, MICROBIOL-SGM, V154, P3247, DOI 10.1099/mic.0.2008/023770-0; Liang XB, 2011, INFECT IMMUN, V79, P3239, DOI 10.1128/IAI.00029-11; Liu YL, 2008, APPL ENVIRON MICROB, V74, P5023, DOI 10.1128/AEM.00556-08; Livny J, 2005, NUCLEIC ACIDS RES, V33, P4096, DOI 10.1093/nar/gki715; Loo CY, 2003, J BACTERIOL, V185, P2887, DOI 10.1128/JB.185.9.2887-2900.2003; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Luo YF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-386; Lutwick LI, 1998, CRIT CARE CLIN, V14, P221, DOI 10.1016/S0749-0704(05)70393-6; Martinez B, 1999, MICROBIOL-SGM, V145, P3155, DOI 10.1099/00221287-145-11-3155; Mattos-Graner RO, 2006, J BACTERIOL, V188, P3813, DOI 10.1128/JB.01845-05; Mercier C, 2002, MOL MICROBIOL, V46, P235, DOI 10.1046/j.1365-2958.2002.03160.x; MILLS J, 1984, INFECT IMMUN, V43, P359, DOI 10.1128/IAI.43.1.359-367.1984; Morona JK, 1997, MOL MICROBIOL, V23, P751, DOI 10.1046/j.1365-2958.1997.2551624.x; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mulder N.J., 2008, CURR PROTOC BIOINFOR, V2, P2, DOI DOI 10.1002/0471250953.BI0207S21; Mulder NJ, 2003, NUCLEIC ACIDS RES, V31, P315, DOI 10.1093/nar/gkg046; Nakagawa I, 2003, GENOME RES, V13, P1042, DOI 10.1101/gr.1096703; Nakano S, 2003, P NATL ACAD SCI USA, V100, P13603, DOI 10.1073/pnas.2235180100; Oetjen J, 2002, INFECT IMMUN, V70, P5706, DOI 10.1128/IAI.70.10.5706-5714.2002; Passalacqua KD, 2009, J BACTERIOL, V191, P3203, DOI 10.1128/JB.00122-09; Perkins TT, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000569; RAMIREZRONDA CH, 1978, J CLIN INVEST, V62, P805, DOI 10.1172/JCI109192; RAMIREZRONDA CH, 1980, INFECT IMMUN, V29, P1; Roberts IS, 1996, ANNU REV MICROBIOL, V50, P285, DOI 10.1146/annurev.micro.50.1.285; Romualdi C, 2003, PHYSIOL GENOMICS, V12, P159, DOI 10.1152/physiolgenomics.00096.2002; Sakata N, 2005, CURR MICROBIOL, V50, P47, DOI 10.1007/s00284-004-4381-9; Selinger DW, 2000, NAT BIOTECHNOL, V18, P1262, DOI 10.1038/82367; Spatafora G, 2002, MICROBIOL-SGM, V148, P755, DOI 10.1099/00221287-148-3-755; Stapleton MR, 2007, J BACTERIOL, V189, P7316, DOI 10.1128/JB.00734-07; Stokes NR, 2003, P NATL ACAD SCI USA, V100, P15959, DOI 10.1073/pnas.2536607100; Suzek BE, 2001, BIOINFORMATICS, V17, P1123, DOI 10.1093/bioinformatics/17.12.1123; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Tettelin H, 1999, GENOMICS, V62, P500, DOI 10.1006/geno.1999.6048; Thompson Julie D, 2002, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0203s00; VANDERMEER JTM, 1991, EUR J CLIN MICROBIOL, V10, P728; Vickerman MM, 2007, J BACTERIOL, V189, P7799, DOI 10.1128/JB.01023-07; Viscount HB, 1997, INFECT IMMUN, V65, P994, DOI 10.1128/IAI.65.3.994-1002.1997; Vriesema AJM, 2000, INFECT IMMUN, V68, P1061, DOI 10.1128/IAI.68.3.1061-1068.2000; Wang BY, 2011, J DENT RES, V90, P501, DOI 10.1177/0022034510388808; Wang FY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004027; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wu H, 1999, MOL MICROBIOL, V34, P1070, DOI 10.1046/j.1365-2958.1999.01670.x; Wu H, 1998, MOL MICROBIOL, V28, P487, DOI 10.1046/j.1365-2958.1998.00805.x; Wu H, 2007, INFECT IMMUN, V75, P2181, DOI 10.1128/IAI.01544-06; Wu H, 2007, J BACTERIOL, V189, P1390, DOI 10.1128/JB.00836-06; Wurtzel O, 2010, GENOME RES, V20, P133, DOI 10.1101/gr.100396.109; Xu P, 2007, J BACTERIOL, V189, P3166, DOI 10.1128/JB.01808-06; Yoder-Himes DR, 2009, P NATL ACAD SCI USA, V106, P3976, DOI 10.1073/pnas.0813403106; Yoon SH, 2003, BIOTECHNOL BIOENG, V81, P753, DOI 10.1002/bit.10626	92	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e34769	10.1371/journal.pone.0034769	http://dx.doi.org/10.1371/journal.pone.0034769			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529932	gold, Green Published, Green Submitted			2022-12-27	WOS:000305350600025
J	Lyons, SM; Prasad, A				Lyons, Samanthe M.; Prasad, Ashok			Cross-Talk and Information Transfer in Mammalian and Bacterial Signaling	PLOS ONE			English	Article							TRANSDUCTION; EXPRESSION; NETWORKS; LIMITS; GENES	In mammalian and bacterial cells simple phosphorylation circuits play an important role in signaling. Bacteria have hundreds of two-component signaling systems that involve phosphotransfer between a receptor and a response regulator. In mammalian cells a similar pathway is the TGF-beta pathway, where extracellular TGF-beta ligands activate cell surface receptors that phosphorylate Smad proteins, which in turn activate many genes. In TGF-beta signaling the multiplicity of ligands begs the question as to whether cells can distinguish signals coming from different ligands, but transduced through a small set of Smads. Here we use information theory with stochastic simulations of networks to address this question. We find that when signals are transduced through only one Smad, the cell cannot distinguish between different levels of the external ligands. Increasing the number of Smads from one to two significantly improves information transmission as well as the ability to discriminate between ligands. Surprisingly, both total information transmitted and the capacity to discriminate between ligands are quite insensitive to high levels of cross-talk between the two Smads. Robustness against cross-talk requires that the average amplitude of the signals are large. We find that smaller systems, as exemplified by some two-component systems in bacteria, are significantly much less robust against cross-talk. For such system sizes phosphotransfer is also less robust against cross-talk than phosphorylation. This suggests that mammalian signal transduction can tolerate a high amount of cross-talk without degrading information content. This may have played a role in the evolution of new functionalities from small mutations in signaling pathways, allowed for the development of cross-regulation and led to increased overall robustness due to redundancy in signaling pathways. On the other hand the lack of cross-regulation observed in many bacterial two-component systems may partly be due to the loss of information content due to cross-talk.	[Lyons, Samanthe M.; Prasad, Ashok] Colorado State Univ, Sch Biomed Engn, Ft Collins, CO 80523 USA	Colorado State University	Lyons, SM (corresponding author), Colorado State Univ, Sch Biomed Engn, Ft Collins, CO 80523 USA.	ashokp@engr.colostate.edu	Prasad, Ashok/HDN-5956-2022		Colorado State University	Colorado State University	This work was funded by a startup grant from Colorado State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], SMAD SIGNAL TRANSDUC; Bais M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005393; Batchelor E, 2003, P NATL ACAD SCI USA, V100, P691, DOI 10.1073/pnas.0234782100; Bialek W, 2005, P NATL ACAD SCI USA, V102, P10040, DOI 10.1073/pnas.0504321102; Bomblies K, 2010, CURR BIOL, V20, pR320, DOI 10.1016/j.cub.2010.02.029; Cheong R, 2011, SCIENCE, V334, P354, DOI 10.1126/science.1204553; Cho TJ, 2002, J BONE MINER RES, V17, P513, DOI 10.1359/jbmr.2002.17.3.513; Clarke DC, 2006, IEE P SYST BIOL, V153, P412, DOI 10.1049/ip-syb:20050055; Cover T. M., 1991, ELEMENTS INFORM THEO; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Henke JM, 2004, J BACTERIOL, V186, P6902, DOI 10.1128/JB.186.20.6902-6914.2004; Hill CS, 2009, CELL RES, V19, P36, DOI 10.1038/cr.2008.325; Igoshin OA, 2008, MOL MICROBIOL, V68, P1196, DOI 10.1111/j.1365-2958.2008.06221.x; Jiang M, 2000, MOL MICROBIOL, V38, P535, DOI 10.1046/j.1365-2958.2000.02148.x; Kisseleva T, 2002, GENE, V285, P1, DOI 10.1016/S0378-1119(02)00398-0; Laub MT, 2007, ANNU REV GENET, V41, P121, DOI 10.1146/annurev.genet.41.042007.170548; Lavery K, 2008, J BIOL CHEM, V283, P20948, DOI 10.1074/jbc.M800850200; Lestas I, 2010, NATURE, V467, P174, DOI 10.1038/nature09333; Ma'ayan A, 2009, J BIOL CHEM, V284, P5451; Marom B, 2011, J BIOL CHEM; Mehta P, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.79; Prince VE, 2002, NAT REV GENET, V3, P827, DOI 10.1038/nrg928; Robinson VL, 2000, NAT STRUCT BIOL, V7, P626, DOI 10.1038/77915; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Tkacik G, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.011910; Tkacik G, 2008, P NATL ACAD SCI USA, V105, P12265, DOI 10.1073/pnas.0806077105; Ziv E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001077	28	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e34488	10.1371/journal.pone.0034488	http://dx.doi.org/10.1371/journal.pone.0034488			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529918	Green Submitted, Green Published, gold			2022-12-27	WOS:000305350600017
J	Vanschoenwinkel, B; Pinceel, T; Vanhove, MPM; Denis, C; Jocque, M; Timms, BV; Brendonck, L				Vanschoenwinkel, Bram; Pinceel, Tom; Vanhove, Maarten P. M.; Denis, Carla; Jocque, Merlijn; Timms, Brian V.; Brendonck, Luc			Toward a Global Phylogeny of the "Living Fossil'' Crustacean Order of the Notostraca	PLOS ONE			English	Article							BRANCHIOPODA NOTOSTRACA; TRIOPS BRANCHIOPODA; MOLECULAR TAXONOMY; MITOCHONDRIAL-DNA; GENETIC DIVERSITY; TADPOLE SHRIMP; EVOLUTIONARY; DIVERGENCE; LINEAGES; INVERTEBRATES	Tadpole shrimp (Crustacea, Notostraca) are iconic inhabitants of temporary aquatic habitats worldwide. Often cited as prime examples of evolutionary stasis, surviving representatives closely resemble fossils older than 200 mya, suggestive of an ancient origin. Despite significant interest in the group as 'living fossils' the taxonomy of surviving taxa is still under debate and both the phylogenetic relationships among different lineages and the timing of diversification remain unclear. We constructed a molecular phylogeny of the Notostraca using model based phylogenetic methods. Our analyses supported the monophyly of the two genera Triops and Lepidurus, although for Triops support was weak. Results also revealed high levels of cryptic diversity as well as a peculiar biogeographic link between Australia and North America presumably mediated by historic long distance dispersal. We concluded that, although some present day tadpole shrimp species closely resemble fossil specimens as old as 250 mya, no molecular support was found for an ancient (pre) Mesozoic radiation. Instead, living tadpole shrimp are most likely the result of a relatively recent radiation in the Cenozoic era and close resemblances between recent and fossil taxa are probably the result of the highly conserved general morphology in this group and of homoplasy.	[Vanschoenwinkel, Bram; Pinceel, Tom; Denis, Carla; Brendonck, Luc] Katholieke Univ Leuven, Lab Aquat Ecol & Evolutionary Biol, Louvain, Belgium; [Vanhove, Maarten P. M.] Katholieke Univ Leuven, Lab Anim Diversity & Systemat, Louvain, Belgium; [Jocque, Merlijn] Royal Belgian Inst Nat Sci, Brussels, Belgium; [Timms, Brian V.] Australian Museum, Sydney, NSW 2000, Australia	KU Leuven; KU Leuven; Royal Belgian Institute of Natural Sciences; Australian Museum	Vanschoenwinkel, B (corresponding author), Katholieke Univ Leuven, Lab Aquat Ecol & Evolutionary Biol, Louvain, Belgium.	vanschoenwinkel@bio.kuleuven.be	Vanschoenwinkel, Bram/I-9021-2019; Vanhove, Maarten/AAF-6446-2020	Vanschoenwinkel, Bram/0000-0002-8973-6297; Brendonck, Luc/0000-0001-5383-1420; Vanhove, Maarten/0000-0003-3100-7566	Research Foundation Flanders (FWO-Vlaanderen); fund for scientific research Flanders	Research Foundation Flanders (FWO-Vlaanderen)(FWO); fund for scientific research Flanders(FWO)	BV currently holds a postdoctoral fellowship with the Research Foundation Flanders (FWO-Vlaanderen). This research was funded by the fund for scientific research Flanders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Adamowicz SJ, 2009, MOL PHYLOGENET EVOL, V50, P423, DOI 10.1016/j.ympev.2008.11.026; Adamowicz SJ, 2005, GLOBAL ECOL BIOGEOGR, V14, P455, DOI 10.1111/j.1466-822x.2005.00164.x; AVISE JC, 1994, EVOLUTION, V48, P1986, DOI 10.1111/j.1558-5646.1994.tb02228.x; BOILEAU MG, 1992, J EVOLUTION BIOL, V5, P25, DOI 10.1046/j.1420-9101.1992.5010025.x; Brendonck L, 2003, HYDROBIOLOGIA, V491, P65, DOI 10.1023/A:1024454905119; Brendonck L, 1990, J CRUSTACEAN BIOL, V10, P676, DOI 10.2307/1548412; Brendonck L, 2008, HYDROBIOLOGIA, V595, P167, DOI 10.1007/s10750-007-9119-9; Caccone A, 2001, EVOLUTION, V55, P122; Calendini F., 2005, PAUPUP V1 0 3 1 FREE; Cao Y, 1998, J MOL EVOL, V47, P307, DOI 10.1007/PL00006389; Chernyschev BI, 1940, ACAD NAUK UKRIN SSR, V7, P5; Colbourne JK, 1996, PHILOS T ROY SOC B, V351, P349, DOI 10.1098/rstb.1996.0028; Cox AJ, 2001, MOL ECOL, V10, P371, DOI 10.1046/j.1365-294x.2001.01188.x; Darwin C.R., 1859, ORIGIN SPECIES MEANS; Duggen S, 2003, NATURE, V422, P602, DOI 10.1038/nature01553; Dumont H.J., 2002, GUIDES IDENTIFICATIO, V19, P1; Eldredge N, 2005, PALEOBIOLOGY, V31, P133, DOI 10.1666/0094-8373(2005)031[0133:TDOES]2.0.CO;2; FELSENSTEIN J, 1988, ANNU REV GENET, V22, P521, DOI 10.1146/annurev.ge.22.120188.002513; Figuerola J, 2005, AM NAT, V165, P274, DOI 10.1086/427092; Fisher D.C., 1990, P152; FRYER G, 1988, PHILOS T ROY SOC B, V321, P27, DOI 10.1098/rstb.1988.0091; FRYER G, 1995, HYDROBIOLOGIA, V307, P57, DOI 10.1007/BF00031997; Gand G, 1997, GEOBIOS-LYON, V30, P673, DOI 10.1016/S0016-6995(97)80157-X; Gill RE, 2005, CONDOR, V107, P1, DOI 10.1650/7613; Green AJ, 2005, DIVERS DISTRIB, V11, P149, DOI 10.1111/j.1366-9516.2005.00147.x; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Guthorl P., 1934, Abhandlungen der Preussischen Geologischen Landesanstalt N F, V164, P1; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hebert PDN, 2005, SYST BIOL, V54, P852, DOI 10.1080/10635150500354886; Hessen DO, 2004, HYDROBIOLOGIA, V519, P73, DOI 10.1023/B:HYDR.0000026486.16615.06; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Jeppesen E, 2001, HYDROBIOLOGIA, V442, P329, DOI 10.1023/A:1017508211819; Katayama H, 1980, TADPOLE SHRIMPS THEI; KELBER KP, 1998, HALLESCHES JB GEOWIS, V5, P85; Kelber KP, 1999, TRIAS GANZ ANDERE WE, P383; Kerfoot W.C., 1987, P367; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; King JL, 1998, MOL PHYLOGENET EVOL, V10, P23, DOI 10.1006/mpev.1997.0470; KISHINO H, 1989, J MOL EVOL, V29, P170, DOI 10.1007/BF02100115; Knowlton N, 1998, P ROY SOC B-BIOL SCI, V265, P2257, DOI 10.1098/rspb.1998.0568; Korn M, 2006, ZOOTAXA, P57; Korn M, 2006, ZOOL SCR, V35, P301, DOI 10.1111/j.1463-6409.2006.00230.x; Korn M, 2010, ORG DIVERS EVOL, V10, P409, DOI 10.1007/s13127-010-0026-y; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Linder F., 1952, Proceedings of the United States National Museum, V102, P1; LONGHURST ALAN R., 1955, BULL BRIT MUS [NAT HIST] ZOOL, V3, P1; LYNCH M, 1993, GENETICS, V135, P1197; Macdonald KS, 2011, J CRUSTACEAN BIOL, V31, P468, DOI 10.1651/10-3411.1; Mantovani B, 2008, HEREDITY, V100, P496, DOI 10.1038/hdy.2008.3; Mantovani B, 2004, ZOOL SCR, V33, P367, DOI 10.1111/j.0300-3256.2004.00155.x; Mantovani B, 2009, ITAL J ZOOL, V76, P358, DOI 10.1080/11250000802687461; Murugan G, 2002, HYDROBIOLOGIA, V486, P101, DOI 10.1023/A:1021334331277; Murugan G, 2009, AUST J ZOOL, V57, P77, DOI 10.1071/ZO08084; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rogers DC, 2001, J CRUSTACEAN BIOL, V21, P991, DOI 10.1651/0278-0372(2001)021[0991:ROTNLN]2.0.CO;2; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; RYDER OA, 1986, TRENDS ECOL EVOL, V1, P9, DOI 10.1016/0169-5347(86)90059-5; Sassaman C, 1997, HYDROBIOLOGIA, V359, P125, DOI 10.1023/A:1003168416080; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Schubart CD, 1998, NATURE, V393, P363, DOI 10.1038/30724; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; SunoUchi N, 1997, BIOL J LINN SOC, V61, P439, DOI 10.1006/bijl.1997.0138; Swofford DL, 2002, PAUP 4 0B10 PHYLOGEN; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tasch P, 1969, BRANCHIOPODA BOULDER, P129; Troger KA, 1984, ABRISS HIST GEOLOGIE; Vanschoenwinkel B, 2008, FRESHWATER BIOL, V53, P2264, DOI 10.1111/j.1365-2427.2008.02071.x; Vanschoenwinkel B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026730; Vendrasco MJ, 2004, NATURE, V429, P288, DOI 10.1038/nature02548; Voigt Sebastian, 2008, Abhandlungen und Berichte fuer Naturkunde, V31, P7; WALOSSEK D, 1993, LETHAIA, V26, P7, DOI 10.1111/j.1502-3931.1993.tb01504.x; Wares JP, 2001, MOL PHYLOGENET EVOL, V18, P104, DOI 10.1006/mpev.2000.0857; Williams W. D., 1968, Crustaceana, V14, P119, DOI 10.1163/156854068X00476; Xia XH, 2009, PHYLOGENETIC HANDBOOK: A PRACTICAL APPROACH TO PHYLOGENETIC ANALYSIS AND HYPOTHESIS TESTING, 2ND EDITION, P615; Yahya H, 2007, ATLAS CREATION; Zierold T, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-161; Zierold T, 2009, FRESHWATER BIOL, V54, P1392, DOI 10.1111/j.1365-2427.2009.02191.x; Zofkova M, 2009, HYDROBIOLOGIA, V635, P67, DOI 10.1007/s10750-009-9862-1	80	41	46	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e34998	10.1371/journal.pone.0034998	http://dx.doi.org/10.1371/journal.pone.0034998			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529967	Green Published, Green Submitted, gold			2022-12-27	WOS:000305350600050
J	Warnefors, M; Eyre-Walker, A				Warnefors, Maria; Eyre-Walker, Adam			A Selection Index for Gene Expression Evolution and Its Application to the Divergence between Humans and Chimpanzees	PLOS ONE			English	Article							PROBE LEVEL DATA; HUMAN GENOME; ADAPTIVE EVOLUTION; NATURAL-SELECTION; MOLECULAR EVOLUTION; NEGATIVE SELECTION; RAPID EVOLUTION; DROSOPHILA; TRANSCRIPTION; POPULATION	The importance of gene regulation in animal evolution is a matter of long-standing interest, but measuring the impact of selection on gene expression has proven a challenge. Here, we propose a selection index of gene expression as a straightforward method for assessing the mode and strength of selection operating on gene expression levels. The index is based on the widely used McDonald-Kreitman test and requires the estimation of four quantities: the within-species and between-species expression variances as well as the sequence heterozygosity and divergence of neutrally evolving sequences. We apply the method to data from human and chimpanzee lymphoblastoid cell lines and show that gene expression is in general under strong stabilizing selection. We also demonstrate how the same framework can be used to estimate the proportion of adaptive gene expression evolution.	[Warnefors, Maria; Eyre-Walker, Adam] Univ Sussex, Sch Life Sci, Brighton, E Sussex, England	University of Sussex	Warnefors, M (corresponding author), Univ Lausanne, Ctr Integrat Genom, Lausanne, Switzerland.	maria.warnefors@gmail.com; a.c.eyre-walker@sussex.ac.uk	Eyre-Walker, Adam/G-6216-2011	Eyre-Walker, Adam/0000-0001-5527-8729	University of Sussex	University of Sussex	This work was funded by the University of Sussex. The funder had no role in study design, data collection, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Andolfatto P, 2005, NATURE, V437, P1149, DOI 10.1038/nature04107; Babbitt CC, 2010, GENOME BIOL EVOL, V2, P67, DOI 10.1093/gbe/evq002; Becquet C, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030066; Bedford T, 2009, P NATL ACAD SCI USA, V106, P1133, DOI 10.1073/pnas.0812009106; Blekhman R, 2010, GENOME RES, V20, P180, DOI 10.1101/gr.099226.109; Blekhman R, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000271; Boyko AR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000083; Brawand D, 2011, NATURE, V478, P343, DOI 10.1038/nature10532; BRITTEN RJ, 1969, SCIENCE, V165, P349, DOI 10.1126/science.165.3891.349; Caliskan M, 2011, HUM MOL GENET, V20, P1643, DOI 10.1093/hmg/ddr041; Choy E, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000287; Denver DR, 2005, NAT GENET, V37, P544, DOI 10.1038/ng1554; Eyre-Walker A, 2002, MOL BIOL EVOL, V19, P2142, DOI 10.1093/oxfordjournals.molbev.a004039; Eyre-Walker A, 2006, TRENDS ECOL EVOL, V21, P569, DOI 10.1016/j.tree.2006.06.015; Eyre-Walker A, 2009, MOL BIOL EVOL, V26, P2097, DOI 10.1093/molbev/msp119; Fay JC, 2001, GENETICS, V158, P1227; Fischer A, 2006, CURR BIOL, V16, P1133, DOI 10.1016/j.cub.2006.04.033; Flicek P, 2010, NUCLEIC ACIDS RES, V38, pD557, DOI 10.1093/nar/gkp972; Fraser HB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002023; Gaffney DJ, 2006, PLOS GENET, V2, P1912, DOI 10.1371/journal.pgen.0020204; Gaffney DJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000157; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gilad Y, 2006, NATURE, V440, P242, DOI 10.1038/nature04559; Gojobori J, 2007, P NATL ACAD SCI USA, V104, P3907, DOI 10.1073/pnas.0605565104; Gordon KL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002432; Haygood R, 2007, NAT GENET, V39, P1140, DOI 10.1038/ng2104; Hey J, 2010, MOL BIOL EVOL, V27, P921, DOI 10.1093/molbev/msp298; Hodgins-Davis A, 2009, TRENDS ECOL EVOL, V24, P649, DOI 10.1016/j.tree.2009.06.011; Holloway AK, 2007, PLOS GENET, V3, P2007, DOI 10.1371/journal.pgen.0030187; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; JENKINS DL, 1995, P ROY SOC B-BIOL SCI, V261, P203, DOI 10.1098/rspb.1995.0137; Khaitovich P, 2005, GENETICS, V170, P929, DOI 10.1534/genetics.104.037135; Khaitovich P, 2004, PLOS BIOL, V2, P682, DOI 10.1371/journal.pbio.0020132; Khaitovich P, 2006, NAT REV GENET, V7, P693, DOI 10.1038/nrg1940; KIMURA M, 1969, GENETICS, V61, P893; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Kohn MH, 2004, MOL BIOL EVOL, V21, P374, DOI 10.1093/molbev/msh026; Kudaravalli S, 2009, MOL BIOL EVOL, V26, P649, DOI 10.1093/molbev/msn289; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lemos B, 2005, MOL BIOL EVOL, V22, P1345, DOI 10.1093/molbev/msi122; Lu J, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-108; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Nuzhdin SV, 2004, MOL BIOL EVOL, V21, P1308, DOI 10.1093/molbev/msh128; Pereira V, 2009, GENETICS, V183, P1597, DOI 10.1534/genetics.109.110247; Rhead B, 2010, NUCLEIC ACIDS RES, V38, pD613, DOI 10.1093/nar/gkp939; Rifkin SA, 2005, NATURE, V438, P220, DOI 10.1038/nature04114; Rifkin SA, 2003, NAT GENET, V33, P138, DOI 10.1038/ng1086; Rockman MV, 2005, PLOS BIOL, V3, P2208, DOI 10.1371/journal.pbio.0030387; Sahai H, 2003, ANAL VARIANCE RANDOM, VII; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; Shapiro JA, 2007, P NATL ACAD SCI USA, V104, P2271, DOI 10.1073/pnas.0610385104; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Sokal R.R., 2012, BIOMETRY; Somel M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001504; Svensson O, 2006, PLOS COMPUT BIOL, V2, P358, DOI 10.1371/journal.pcbi.0020046; Tachida H, 2000, GENE, V261, P3, DOI 10.1016/S0378-1119(00)00475-3; Torgerson DG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000592; Visel A, 2009, NATURE, V461, P199, DOI 10.1038/nature08451; Whitehead A, 2006, P NATL ACAD SCI USA, V103, P5425, DOI 10.1073/pnas.0507648103; Wilson MD, 2008, SCIENCE, V322, P434, DOI 10.1126/science.1160930; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063; Yanai I, 2004, OMICS, V8, P15, DOI 10.1089/153623104773547462; Yu N, 2003, GENETICS, V164, P1511	66	14	14	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e34935	10.1371/journal.pone.0034935	http://dx.doi.org/10.1371/journal.pone.0034935			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529958	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000305350600043
J	Soumare, POL; Freire, CCM; Faye, O; Diallo, M; de Oliveira, JVC; Zanotto, PMA; Sall, AA				Soumare, P. O. Ly; Freire, Caio C. M.; Faye, Ousmane; Diallo, Mawlouth; de Oliveira, Juliana Velasco C.; Zanotto, Paolo M. A.; Sall, Amadou Alpha			Phylogeography of Rift Valley Fever Virus in Africa Reveals Multiple Introductions in Senegal and Mauritania	PLOS ONE			English	Article							RECENT COMMON ANCESTRY; MOLECULAR EPIDEMIOLOGY; SEQUENCE ALIGNMENT; DIVERGENCE TIMES; ABSOLUTE RATES; SOUTH-AFRICA; NSS PROTEIN; OUTBREAK; EMERGENCE; EGYPT	Rift Valley Fever (RVF) virus (Family Bunyaviridae) is an arthropod-borne RNA virus that infects primarily domestic ruminants and occasionally humans. RVF epizootics are characterized by numerous abortions and mortality among young animals. In humans, the illness is usually characterized by a mild self-limited febrile illness, which could progress to more serious complications. RVF virus is widespread and endemic in many regions of Africa. In Western Africa, several outbreaks have been reported since 1987 when the first major one occurred at the frontier of Senegal and Mauritania. Aiming to evaluate the spreading and molecular epidemiology in these countries, RVFV isolates from 1944 to 2008 obtained from 18 localities in Senegal and Mauritania and 15 other countries were investigated. Our results suggest that a more intense viral activity possibly took place during the last century compared to the recent past and that at least 5 introductions of RVFV took place in Senegal and Mauritania from distant African regions. Moreover, Barkedji in Senegal was possibly a hub associated with the three distinct entries of RVFV in West Africa.	[Soumare, P. O. Ly; Faye, Ousmane; Diallo, Mawlouth; Sall, Amadou Alpha] Inst Pasteur, Dakar, Senegal; [Freire, Caio C. M.; de Oliveira, Juliana Velasco C.; Zanotto, Paolo M. A.] Univ Sao Paulo, Inst Biomed Sci, Dept Microbiol, Lab Mol Evolut & Bioinformat, Sao Paulo, Brazil	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar; Universidade de Sao Paulo	Soumare, POL (corresponding author), Inst Pasteur, Dakar, Senegal.	freire@ime.usp.br	faye, Ousmane/GMW-6500-2022; Freire, Caio/C-8248-2014; de A. Zanotto, Paolo M./B-9286-2019	Freire, Caio/0000-0002-7723-4230; de A. Zanotto, Paolo M./0000-0002-8167-0625	Institute Pasteur of Dakar in Senegal; FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil) [00/04205-6]; CAPES; CNPq-PQ	Institute Pasteur of Dakar in Senegal; FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq-PQ(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was funded by Institute Pasteur of Dakar in Senegal and FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil) project #00/04205-6 (VGDN program). CCMF has CAPES scholarship and PMAZ holds a CNPq-PQ scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, RIFT VALL FEV KEN SO; [Anonymous], 2006, THESIS U TEXAS AUSTI; Archer BN, 2011, SAMJ S AFR MED J, V101, P263, DOI 10.7196/SAMJ.4544; Ba Y, 2005, J MED ENTOMOL, V42, P739, DOI 10.1603/0022-2585(2005)042[0739:AOBOTR]2.0.CO;2; Billecocq A, 2004, J VIROL, V78, P9798, DOI 10.1128/JVI.78.18.9798-9806.2004; Bird BH, 2008, J VIROL, V82, P11152, DOI 10.1128/JVI.01519-08; Bird BH, 2007, J VIROL, V81, P2805, DOI 10.1128/JVI.02095-06; Bouloy MB, 1998, LANCET, V352, P1596, DOI 10.1016/S0140-6736(05)61043-4; Chevalier V, 2009, TRANSBOUND EMERG DIS, V56, P372, DOI 10.1111/j.1865-1682.2009.01083.x; COLLETT MS, 1985, VIROLOGY, V144, P228, DOI 10.1016/0042-6822(85)90320-4; Daubney R, 1932, LANCET, V1, P611; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Favier C, 2006, TROP MED INT HEALTH, V11, P1878, DOI 10.1111/j.1365-3156.2006.01746.x; Faye O, 2007, EMERG INFECT DIS, V13, P1016, DOI 10.3201/eid1307.061487; Findlay GM, 1931, LANCET, V2, P1350; GAD AM, 1986, J TROP MED HYG, V89, P233; GIORGI C, 1991, VIROLOGY, V180, P738, DOI 10.1016/0042-6822(91)90087-R; Grobbelaar AA, 2011, EMERG INFECT DIS, V17, P2270, DOI 10.3201/eid1712.111035; Johnson K, 1993, EMERGING VIRUSES; LaBeaud AD, 2011, AM J TROP MED HYG, V84, P641, DOI 10.4269/ajtmh.2011.10-0187; LAUGHLIN LW, 1979, T ROY SOC TROP MED H, V73, P630, DOI 10.1016/0035-9203(79)90006-3; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Marrama Laurence, 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P1487; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Martin V, 2008, REV SCI TECH OIE, V27, P413, DOI 10.20506/rst.27.2.1802; MEEGAN JM, 1979, T ROY SOC TROP MED H, V73, P618, DOI 10.1016/0035-9203(79)90004-X; Miller BR, 2002, EMERG INFECT DIS, V8, P1492, DOI 10.3201/eid0812.020194; Minin VN, 2008, MOL BIOL EVOL, V25, P1459, DOI 10.1093/molbev/msn090; Moutailler S, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001156; MULLER R, 1994, J GEN VIROL, V75, P1345, DOI 10.1099/0022-1317-75-6-1345; Pepin M, 2010, VET RES, V41, DOI 10.1051/vetres/2010033; Pfeffer M, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-35; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Rich KM, 2010, AM J TROP MED HYG, V83, P52, DOI 10.4269/ajtmh.2010.09-0291; Sall AA, 1999, J VIROL, V73, P8196, DOI 10.1128/JVI.73.10.8196-8200.1999; Sall AA, 1998, MEM I OSWALDO CRUZ, V93, P609, DOI 10.1590/S0074-02761998000500009; Sall AA, 1997, J GEN VIROL, V78, P2853, DOI 10.1099/0022-1317-78-11-2853; Sanderson MJ, 2002, MOL BIOL EVOL, V19, P101, DOI 10.1093/oxfordjournals.molbev.a003974; Sanderson MJ, 2003, BIOINFORMATICS, V19, P301, DOI 10.1093/bioinformatics/19.2.301; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Strimmer K, 1997, P NATL ACAD SCI USA, V94, P6815, DOI 10.1073/pnas.94.13.6815; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Traore-Lamizana M, 2001, J MED ENTOMOL, V38, P480, DOI 10.1603/0022-2585-38.4.480; Weaver SC, 2005, ARCH VIROL, P33; Wertheim JO, 2011, MOL BIOL EVOL, V28, P3355, DOI 10.1093/molbev/msr170; Wiens JJ, 2003, SYST BIOL, V52, P528, DOI 10.1080/10635150390218330; World Health Organization, 2010, RIFT VALL FEV S AFR; World Health Organization, 2008, RIFT VALL FEV SUD; World Health Organization, 2000, SAUD AR YEM 1 CAS RI; Zeller HG, 1997, AM J TROP MED HYG, V56, P265, DOI 10.4269/ajtmh.1997.56.265	51	21	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35216	10.1371/journal.pone.0035216	http://dx.doi.org/10.1371/journal.pone.0035216			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22539961	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341000025
J	Guerineau, M; Kriz, Z; Kozakova, L; Bednarova, K; Janos, P; Palecek, J				Guerineau, Marc; Kriz, Zdenek; Kozakova, Lucie; Bednarova, Katerina; Janos, Pavel; Palecek, Jan			Analysis of the Nse3/MAGE-Binding Domain of the Nse4/EID Family Proteins	PLOS ONE			English	Article							DNA-REPAIR; MOLECULAR-DYNAMICS; SMC PROTEIN; EID FAMILY; CELL-CYCLE; COMPLEX; DIFFERENTIATION; INHIBITOR; SMC5-SMC6; MEMBER	Background: The Nse1, Nse3 and Nse4 proteins form a tight sub-complex of the large SMC5-6 protein complex. hNSE3/MAGEG1, the mammalian ortholog of Nse3, is the founding member of the MAGE (melanoma-associated antigen) protein family and the Nse4 kleisin subunit is related to the EID (E1A-like inhibitor of differentiation) family of proteins. We have recently shown that human MAGE proteins can interact with NSE4/EID proteins through their characteristic conserved hydrophobic pocket. Methodology/Principal Findings: Using mutagenesis and protein-protein interaction analyses, we have identified a new Nse3/MAGE-binding domain (NMBD) of the Nse4/EID proteins. This short domain is located next to the Nse4 N-terminal kleisin motif and is conserved in all NSE4/EID proteins. The central amino acid residues of the human NSE4b/EID3 domain were essential for its binding to hNSE3/MAGEG1 in yeast two-hybrid assays suggesting they form the core of the binding domain. PEPSCAN ELISA measurements of the MAGEC2 binding affinity to EID2 mutant peptides showed that similar core residues contribute to the EID2-MAGEC2 interaction. In addition, the N-terminal extension of the EID2 binding domain took part in the EID2-MAGEC2 interaction. Finally, docking and molecular dynamic simulations enabled us to generate a structure model for EID2-MAGEC2. Combination of our experimental data and the structure modeling showed how the core helical region of the NSE4/EID domain binds into the conserved pocket characteristic of the MAGE protein family. Conclusions/Significance: We have identified a new Nse4/EID conserved domain and characterized its binding to Nse3/MAGE proteins. The conservation and binding of the interacting surfaces suggest tight co-evolution of both Nse4/EID and Nse3/MAGE protein families.	[Guerineau, Marc; Kriz, Zdenek; Kozakova, Lucie; Bednarova, Katerina; Janos, Pavel; Palecek, Jan] Masaryk Univ, Cent European Inst Technol, Brno, Czech Republic; [Kriz, Zdenek; Janos, Pavel] Masaryk Univ, Fac Sci, Natl Ctr Biomol Res, CS-61137 Brno, Czech Republic	Masaryk University Brno; Masaryk University Brno	Palecek, J (corresponding author), Masaryk Univ, Cent European Inst Technol, Brno, Czech Republic.	jpalecek@sci.muni.cz	Guerineau, Marc/AAR-1167-2021; Janoš, Pavel/A-1117-2015; Zabrady, Katerina/D-9232-2012; Palecek, Jan/D-6864-2012; Bozděchová, Lucie/D-9149-2012	Janoš, Pavel/0000-0002-3098-4333; Zabrady, Katerina/0000-0003-1946-0851; Palecek, Jan/0000-0002-6223-5169; Bozděchová, Lucie/0000-0002-7113-4343; Guerineau, Marc/0000-0002-0546-3106; Janos, Pavel/0000-0002-9068-2652	Grant Agency of the Czech Academy of Sciences [IAA501630902]; Grant Agency of the Czech Republic [204/08/H054]; Ministry of Education, Youth, and Sports of the Czech Republic [LM2010005]	Grant Agency of the Czech Academy of Sciences(Grant Agency of the Czech Republic); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Ministry of Education, Youth, and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic)	This work was supported by a grant to JP from the Grant Agency of the Czech Academy of Sciences (IAA501630902, http://www.gaav.cz/index2.html). Institutional support was provided by the Czech Ministry of Education, Youth and Sports (MSM0021622415, http://www.msmt.cz/index.php?lang = 2). MG was supported by the Grant Agency of the Czech Republic (204/08/H054, http://www.gacr.cz/international.htm). The access to the MetaCentrum computing facilities, provided under the programme LM2010005 funded by the Ministry of Education, Youth, and Sports of the Czech Republic, is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker PA, 2002, J NEUROSCI RES, V67, P705, DOI 10.1002/jnr.10160; Bavner A, 2005, NUCLEIC ACIDS RES, V33, P3561, DOI 10.1093/nar/gki667; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bush JR, 2008, DIFFERENTIATION, V76, P994, DOI 10.1111/j.1432-0436.2008.00281.x; Caballero OL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012773; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chomez P, 2001, CANCER RES, V61, P5544; De Piccoli G, 2009, CHROMOSOME RES, V17, P251, DOI 10.1007/s10577-008-9016-8; Doyle JM, 2010, MOL CELL, V39, P963, DOI 10.1016/j.molcel.2010.08.029; Duan XY, 2009, J BIOL CHEM, V284, P8507, DOI 10.1074/jbc.M809139200; Fousteri MI, 2000, EMBO J, V19, P1691, DOI 10.1093/emboj/19.7.1691; Haering CH, 2004, MOL CELL, V15, P951, DOI 10.1016/j.molcel.2004.08.030; Hudson JJR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017270; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ji AM, 2003, GENE, V318, P35, DOI 10.1016/j.gene.2003.06.001; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Katsura Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020365; Lehmann AR, 2005, DNA REPAIR, V4, P309, DOI 10.1016/j.dnarep.2004.07.009; LEHMANN AR, 1995, MOL CELL BIOL, V15, P7067; Miyake S, 2003, J BIOL CHEM, V278, P17060, DOI 10.1074/jbc.M212212200; Miyake S, 2000, MOL CELL BIOL, V20, P8889, DOI 10.1128/MCB.20.23.8889-8902.2000; Murray JM, 2008, NAT REV MOL CELL BIO, V9, P177, DOI 10.1038/nrm2309; Palecek J, 2006, J BIOL CHEM, V281, P36952, DOI 10.1074/jbc.M608004200; Pebernard S, 2006, MOL CELL BIOL, V26, P1617, DOI 10.1128/MCB.26.5.1617-1630.2006; Pospisilova S, 2000, J IMMUNOL METHODS, V237, P51, DOI 10.1016/S0022-1759(99)00246-X; Ritchie DW, 2008, BIOINFORMATICS, V24, P1865, DOI 10.1093/bioinformatics/btn334; Routzahn Karen M., 2002, Journal of Structural and Functional Genomics, V2, P83, DOI 10.1023/A:1020424023207; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Schleiffer A, 2003, MOL CELL, V11, P571, DOI 10.1016/S1097-2765(03)00108-4; Sergeant J, 2005, MOL CELL BIOL, V25, P172, DOI 10.1128/MCB.25.1.172-184.2005; Taylor EM, 2008, MOL CELL BIOL, V28, P1197, DOI 10.1128/MCB.00767-07; Taylor EM, 2001, MOL BIOL CELL, V12, P1583, DOI 10.1091/mbc.12.6.1583	33	25	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35813	10.1371/journal.pone.0035813	http://dx.doi.org/10.1371/journal.pone.0035813			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536443	Green Published, gold, Green Submitted			2022-12-27	WOS:000305339200115
J	Liu, YD; Su, Y; Sun, SG; Wang, T; Qiao, X; Run, XQ; Liang, ZH				Liu, Yudong; Su, Ying; Sun, Shenggang; Wang, Tao; Qiao, Xian; Run, Xiaoqin; Liang, Zhihou			Tau Phosphorylation and mu-Calpain Activation Mediate the Dexamethasone-Induced Inhibition on the Insulin-Stimulated Akt Phosphorylation	PLOS ONE			English	Article							TRANSGENIC MOUSE MODEL; GROWTH-FACTOR-I; ALZHEIMERS-DISEASE; DIABETES-MELLITUS; GLUCOSE-METABOLISM; SIGNALING PATHWAY; MEMORY DEFICITS; DOWN-REGULATION; AMYLOID-BETA; A-BETA	Evidence has suggested that insulin resistance (IR) or high levels of glucocorticoids (GCs) may be linked with the pathogenesis andor progression of Alzheimer's disease (AD). Although studies have shown that a high level of GCs results in IR, little is known about the molecular details that link GCs and IR in the context of AD. Abnormal phosphorylation of tau and activation of mu-calpain are two key events in the pathology of AD. Importantly, these two events are also related with GCs and IR. We therefore speculate that tau phosphorylation and mu-calpain activation may mediate the GCs-induced IR. Akt phosphorylation at Ser-473 (pAkt) is commonly used as a marker for assessing IR. We employed two cell lines, wild-type HEK293 cells and HEK293 cells stably expressing the longest human tau isoform (tau-441; HEK293tau441 cells). We examined whether DEX, a synthetic GCs, induces tau phosphorylation and mu-calpain activation. If so, we examined whether the DEX-induced tau phosphorylation and mu-calpain activation mediate the DEX-induced inhibition on the insulin-stimulated Akt phosphorylation. The results showed that DEX increased tau phosphorylation and induced tau-mediated mu-calpain activation. Furthermore, pre-treatment with LiCl prevented the effects of DEX on tau phosphorylation and mu-calpain activation. Finally, both LiCl pre-treatment and calpain inhibition prevented the DEX-induced inhibition on the insulin-stimulated Akt phosphorylation. In conclusion, our study suggests that the tau phosphorylation and mu-calpain activation mediate the DEX-induced inhibition on the insulin-stimulated Akt phosphorylation.	[Su, Ying; Sun, Shenggang; Wang, Tao; Qiao, Xian; Liang, Zhihou] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Neurol, Wuhan 430074, Hubei, Peoples R China; [Liu, Yudong] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Orthoped, Wuhan 430074, Hubei, Peoples R China; [Run, Xiaoqin] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Gen Surg, Wuhan 430074, Hubei, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Liang, ZH (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Neurol, Wuhan 430074, Hubei, Peoples R China.	zhihouliang@msn.com			National Nature Science Foundation of China [30901386]; Wuhan Science and Technology Bureau, China [200960323132]; Research Fund for the Doctoral Program of Higher Education of China [200804871026]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Wuhan Science and Technology Bureau, China; Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by grants from the National Nature Science Foundation of China (30901386), the Wuhan Science and Technology Bureau, China (200960323132), and the Research Fund for the Doctoral Program of Higher Education of China (200804871026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amadoro G, 2006, P NATL ACAD SCI USA, V103, P2892, DOI 10.1073/pnas.0511065103; Baier LJ, 2000, J CLIN INVEST, V106, pR69, DOI 10.1172/JCI10665; Baker LD, 2011, ARCH NEUROL-CHICAGO, V68, P51, DOI 10.1001/archneurol.2010.225; Beltran L, 2011, P NATL ACAD SCI USA, V108, P16217, DOI 10.1073/pnas.1107692108; Bosco D, 2011, J CELL MOL MED, V15, P1807, DOI 10.1111/j.1582-4934.2011.01318.x; Caccamo A, 2007, AM J PATHOL, V170, P1669, DOI 10.2353/ajpath.2007.061178; Cao DF, 2007, J BIOL CHEM, V282, P36275, DOI 10.1074/jbc.M703561200; Clodfelder-Miller BJ, 2006, DIABETES, V55, P3320, DOI 10.2337/db06-0485; Cohen P, 2004, NAT REV DRUG DISCOV, V3, P479, DOI 10.1038/nrd1415; Congdon EE, 2008, J ALZHEIMERS DIS, V14, P453; Cowan CM, 2010, ACTA NEUROPATHOL, V120, P593, DOI 10.1007/s00401-010-0716-8; Craft S, 2007, CURR ALZHEIMER RES, V4, P147, DOI 10.2174/156720507780362137; Craft S, 2012, ARCH NEUROL-CHICAGO, V69, P29, DOI 10.1001/archneurol.2011.233; de la Monte SM, 2005, J ALZHEIMERS DIS, V7, P45; Derbel S, 2006, J CYST FIBROS, V5, P47, DOI 10.1016/j.jcf.2005.09.011; Dimakopoulos Aristotelis C., 2005, Current Alzheimer Research, V2, P19, DOI 10.2174/1567205052772795; ELLIOTT EM, 1993, J NEUROCHEM, V61, P57, DOI 10.1111/j.1471-4159.1993.tb03537.x; Freude S, 2005, DIABETES, V54, P3343, DOI 10.2337/diabetes.54.12.3343; Frisardi V, 2010, J ALZHEIMERS DIS, V21, P57, DOI 10.3233/JAD-2010-100015; Gallagher EJ, 2011, MED CLIN N AM, V95, P855, DOI 10.1016/j.mcna.2011.06.001; Gong CX, 2010, DRUG AGING, V27, P351, DOI 10.2165/11536110-000000000-00000; Green KN, 2006, J NEUROSCI, V26, P9047, DOI 10.1523/JNEUROSCI.2797-06.2006; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Harmann A, 1998, NEUROBIOL AGING, V18, P285; Hiltunen M, 2011, J CELL MOL IN PRESS; Holsboer F, 2000, NEUROPSYCHOPHARMACOL, V23, P477, DOI 10.1016/S0893-133X(00)00159-7; Hong M, 1997, J BIOL CHEM, V272, P19547, DOI 10.1074/jbc.272.31.19547; Horikawa Y, 2003, J CLIN ENDOCR METAB, V88, P244, DOI 10.1210/jc.2002-020847; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Hsieh YY, 2008, INT J BIOL SCI, V4, P300; Jameson RR, 2006, NEUROPSYCHOPHARMACOL, V31, P1647, DOI 10.1038/sj.npp.1300967; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Kang ES, 2006, J HUM GENET, V51, P629, DOI 10.1007/s10038-006-0410-9; Ke YD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007917; Kim B, 2009, APOPTOSIS, V14, P665, DOI 10.1007/s10495-009-0331-0; Leroy K, 2010, J ALZHEIMERS DIS, V19, P705, DOI [10.3233/JAD-2010-1276, 10.3233/JAD-2009-1276]; Lesort M, 1999, J NEUROCHEM, V72, P576, DOI 10.1046/j.1471-4159.1999.0720576.x; Lesort M, 2000, NEUROSCIENCE, V99, P305, DOI 10.1016/S0306-4522(00)00200-1; Liang ZH, 2007, J NEUROCHEM, V103, P2462, DOI 10.1111/j.1471-4159.2007.04942.x; Liu F, 2005, J BIOL CHEM, V280, P1790, DOI 10.1074/jbc.M410775200; Liu Y, 2012, NEUROCHEM RES   0201, P1; Liu Y, 2011, J PATHOL, V225, P54, DOI 10.1002/path.2912; Lu FP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004144; Luo DZ, 2011, EUR J PHARMACOL, V664, P14, DOI 10.1016/j.ejphar.2011.04.045; Lupien SJ, 1998, NAT NEUROSCI, V1, P69, DOI 10.1038/271; Maccioni RB, 2010, ARCH MED RES, V41, P226, DOI 10.1016/j.arcmed.2010.03.007; Meier M, 2007, J ENDOCRINOL, V193, P45, DOI 10.1677/joe.1.07087; MukaetovaLadinska EB, 1996, DEMENTIA, V7, P95, DOI 10.1159/000106861; Nixon RA, 2003, AGEING RES REV, V2, P407, DOI 10.1016/S1568-1637(03)00029-1; Nolan CJ, 2011, LANCET, V378, P169, DOI 10.1016/S0140-6736(11)60614-4; Otani K, 2006, AM J PHYSIOL-ENDOC M, V291, pE544, DOI 10.1152/ajpendo.00510.2005; Park SA, 2011, J CLIN NEUROL, V7, P10, DOI 10.3988/jcn.2011.7.1.10; Paul DS, 2003, BIOCHEM J, V376, P625, DOI 10.1042/BJ20030681; Permutt MA, 2000, J CLIN INVEST, V106, P819, DOI 10.1172/JCI11228; Perrin BJ, 2002, INT J BIOCHEM CELL B, V34, P722, DOI 10.1016/S1357-2725(02)00009-2; Pfau A, 2007, MOL CELL ENDOCRINOL, V264, P35, DOI 10.1016/j.mce.2006.10.002; Planel E, 2007, J NEUROSCI, V27, P13635, DOI 10.1523/JNEUROSCI.3949-07.2007; Randriamboavonjy V, 2008, CIRCULATION, V117, P52, DOI 10.1161/CIRCULATIONAHA.107.719807; Reaven GM, 2011, MED CLIN N AM, V95, P875, DOI 10.1016/j.mcna.2011.06.002; Ren QG, 2007, FEBS LETT, V581, P1521, DOI 10.1016/j.febslet.2007.02.065; Riedere RP, 2011, NEUROTOX RES, V19, P253; Rissman RA, 2009, J ALZHEIMERS DIS, V18, P453, DOI 10.3233/JAD-2009-1153; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Schubert M, 2004, P NATL ACAD SCI USA, V101, P3100, DOI 10.1073/pnas.0308724101; Smith IJ, 2008, AM J PHYSIOL-ENDOC M, V295, pE762, DOI 10.1152/ajpendo.90226.2008; Smith IJ, 2007, EXP PHYSIOL, V92, P561, DOI 10.1113/expphysiol.2006.035790; Sreenan SK, 2001, DIABETES, V50, P2013, DOI 10.2337/diabetes.50.9.2013; Suzuki K, 2004, DIABETES, V53, pS12, DOI 10.2337/diabetes.53.2007.S12; SZENDREI GI, 1993, J NEUROSCI RES, V34, P243, DOI 10.1002/jnr.490340212; To AWM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016991; Town T, 2002, J NEUROSCI RES, V69, P362, DOI 10.1002/jnr.10299; Trinchese F, 2008, J CLIN INVEST, V118, P2796, DOI 10.1172/JCI34254; Tsoyi K, 2010, ATHEROSCLEROSIS, V213, P115, DOI 10.1016/j.atherosclerosis.2010.07.061; Turner MD, 2005, DIABETES-METAB RES, V21, P505, DOI 10.1002/dmrr.578; Vega IE, 2008, J NEUROCHEM, V106, P96, DOI 10.1111/j.1471-4159.2008.05339.x; Yaniv SP, 2008, EUR J PHARMACOL, V596, P14, DOI 10.1016/j.ejphar.2008.08.006; Yu G, 2011, J ALZHEIMERS DIS, V24, P525, DOI 10.3233/JAD-2011-101779; Zhang H, 2003, EXP CELL RES, V289, P352, DOI 10.1016/S0014-4827(03)00286-6	78	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35783	10.1371/journal.pone.0035783	http://dx.doi.org/10.1371/journal.pone.0035783			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536436	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339200110
J	Nickel, GC; Barnholtz-Sloan, J; Gould, MP; McMahon, S; Cohen, A; Adams, MD; Guda, K; Cohen, M; Sloan, AE; LaFramboise, T				Nickel, Gabrielle C.; Barnholtz-Sloan, Jill; Gould, Meetha P.; McMahon, Sarah; Cohen, Andrea; Adams, Mark D.; Guda, Kishore; Cohen, Mark; Sloan, Andrew E.; LaFramboise, Thomas			Characterizing Mutational Heterogeneity in a Glioblastoma Patient with Double Recurrence	PLOS ONE			English	Article							INTEGRATED GENOMIC ANALYSIS; ALLELE-SPECIFIC EXPRESSION; EVOLUTION; PATHWAYS; TGFBR1	Human cancers are driven by the acquisition of somatic mutations. Separating the driving mutations from those that are random consequences of general genomic instability remains a challenge. New sequencing technology makes it possible to detect mutations that are present in only a minority of cells in a heterogeneous tumor population. We sought to leverage the power of ultra-deep sequencing to study various levels of tumor heterogeneity in the serial recurrences of a single glioblastoma multiforme patient. Our goal was to gain insight into the temporal succession of DNA base-level lesions by querying intra-and inter-tumoral cell populations in the same patient over time. We performed targeted "next-generation" sequencing on seven samples from the same patient: two foci within the primary tumor, two foci within an initial recurrence, two foci within a second recurrence, and normal blood. Our study reveals multiple levels of mutational heterogeneity. We found variable frequencies of specific EGFR, PIK3CA, PTEN, and TP53 base substitutions within individual tumor regions and across distinct regions within the same tumor. In addition, specific mutations emerge and disappear along the temporal spectrum from tumor at the time of diagnosis to second recurrence, demonstrating evolution during tumor progression. Our results shed light on the spatial and temporal complexity of brain tumors. As sequencing costs continue to decline and deep sequencing technology eventually moves into the clinic, this approach may provide guidance for treatment choices as we embark on the path to personalized cancer medicine.	[Nickel, Gabrielle C.; Gould, Meetha P.; McMahon, Sarah; Cohen, Andrea; Adams, Mark D.; LaFramboise, Thomas] Case Western Reserve Univ, Sch Med, Dept Genet, Cleveland, OH 44106 USA; [Barnholtz-Sloan, Jill; Guda, Kishore] Case Western Reserve Univ, Sch Med, Dept Gen Med Sci Oncol, Cleveland, OH USA; [Barnholtz-Sloan, Jill; Guda, Kishore; Sloan, Andrew E.; LaFramboise, Thomas] Case Comprehens Canc Ctr, Cleveland, OH USA; [Cohen, Mark] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA; [Sloan, Andrew E.] Univ Hosp Case Med Ctr, Dept Neurol Surg, Neurol Inst, Cleveland, OH USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University Hospital	LaFramboise, T (corresponding author), Case Western Reserve Univ, Sch Med, Dept Genet, Cleveland, OH 44106 USA.	Thomas.LaFramboise@case.edu	Barnholtz-Sloan, Jill/A-4817-2011; Sloan, Andrew/AAE-9842-2020	Barnholtz-Sloan, Jill/0000-0001-6190-9304; 	National Institutes of Health, National Cancer Institute [R01CA131341, P30 CA043703]; National Science Foundation [IIS-0916102]; NATIONAL CANCER INSTITUTE [P30CA043703, R01CA131341] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250] Funding Source: NIH RePORTER; Div Of Information & Intelligent Systems [0916102] Funding Source: National Science Foundation	National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Div Of Information & Intelligent Systems(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	Supported by grants from the National Institutes of Health, National Cancer Institute (Grant Nos. R01CA131341 and P30 CA043703), and the National Science Foundation (IIS-0916102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Clarke J, 2010, ARCH NEUROL-CHICAGO, V67, P279, DOI 10.1001/archneurol.2010.5; Forbes SA, 2010, CURR PROTOC HUM GENE, P11; Franceschi E, 2009, EXPERT REV ANTICANC, V9, P613, DOI [10.1586/era.09.23, 10.1586/ERA.09.23]; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Guda K, 2009, CANCER RES, V69, P4959, DOI 10.1158/0008-5472.CAN-09-0225; Hou Lewis C, 2006, Neurosurg Focus, V20, pE5; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kaminker JS, 2007, CANCER RES, V67, P465, DOI 10.1158/0008-5472.CAN-06-1736; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li MK, 2010, AM J HUM GENET, V87, P237, DOI 10.1016/j.ajhg.2010.07.014; Liu WN, 2009, NAT MED, V15, P559, DOI 10.1038/nm.1944; Meyerson M, 2010, NAT REV GENET, V11, P685, DOI 10.1038/nrg2841; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Navin N, 2010, GENOME RES, V20, P68, DOI 10.1101/gr.099622.109; Ng PC, 2002, GENOME RES, V12, P436, DOI 10.1101/gr.212802; Ohgaki H, 2007, AM J PATHOL, V170, P1445, DOI 10.2353/ajpath.2007.070011; Ohgaki H, 2009, CANCER SCI, V100, P2235, DOI 10.1111/j.1349-7006.2009.01308.x; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Schuler GD, 1997, GENOME RES, V7, P541, DOI 10.1101/gr.7.5.541; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Thomas RK, 2006, NAT MED, V12, P852, DOI 10.1038/nm1437; Tomsic J, 2010, CARCINOGENESIS, V31, P1800, DOI 10.1093/carcin/bgq165; Tsiatis AC, 2010, J MOL DIAGN, V12, P425, DOI 10.2353/jmoldx.2010.090188; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515	28	50	50	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35262	10.1371/journal.pone.0035262	http://dx.doi.org/10.1371/journal.pone.0035262			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536362	Green Published, gold, Green Submitted			2022-12-27	WOS:000305339200047
J	Wan, LL; Han, J; Sang, M; Li, AF; Wu, H; Yin, SJ; Zhang, CW				Wan, LingLin; Han, Juan; Sang, Min; Li, AiFen; Wu, Hong; Yin, ShunJi; Zhang, ChengWu			De Novo Transcriptomic Analysis of an Oleaginous Microalga: Pathway Description and Gene Discovery for Production of Next-Generation Biofuels	PLOS ONE			English	Article							DIATOM CYCLOTELLA-CRYPTICA; CAROTENOID BIOSYNTHESIS; LYCOPENE CYCLASES; LIPID-METABOLISM; CARBON-DIOXIDE; OIL PRODUCTION; ALGAE; ACID; PROTEIN; GROWTH	Background: Eustigmatos cf. polyphem is a yellow-green unicellular soil microalga belonging to the eustimatophyte with high biomass and considerable production of triacylglycerols (TAGs) for biofuels, which is thus referred to as an oleaginous microalga. The paucity of microalgae genome sequences, however, limits development of gene-based biofuel feedstock optimization studies. Here we describe the sequencing and de novo transcriptome assembly for a non-model microalgae species, E. cf. polyphem, and identify pathways and genes of importance related to biofuel production. Results: We performed the de novo assembly of E. cf. polyphem transcriptome using Illumina paired-end sequencing technology. In a single run, we produced 29,199,432 sequencing reads corresponding to 2.33 Gb total nucleotides. These reads were assembled into 75,632 unigenes with a mean size of 503 bp and an N50 of 663 bp, ranging from 100 bp to >3,000 bp. Assembled unigenes were subjected to BLAST similarity searches and annotated with Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) orthology identifiers. These analyses identified the majority of carbohydrate, fatty acids, TAG and carotenoids biosynthesis and catabolism pathways in E. cf. polyphem. Conclusions: Our data provides the construction of metabolic pathways involved in the biosynthesis and catabolism of carbohydrate, fatty acids, TAG and carotenoids in E. cf. polyphem and provides a foundation for the molecular genetics and functional genomics required to direct metabolic engineering efforts that seek to enhance the quantity and character of microalgae-based biofuel feedstock.	[Wan, LingLin; Han, Juan; Sang, Min; Li, AiFen; Zhang, ChengWu] Jinan Univ, Inst Hydrobiol, Guangzhou, Guangdong, Peoples R China; [Wu, Hong; Yin, ShunJi] Xinao Sci & Technol Dev Co Ltd, State Key Lab Coal Based Low Carbon Energy, Langfang, Peoples R China	Chinese Academy of Sciences; Jinan University	Zhang, CW (corresponding author), Jinan Univ, Inst Hydrobiol, Guangzhou, Guangdong, Peoples R China.	tzhangcw@jnu.edu.cn	Zhang, Cheng/GRS-8698-2022		National High Technology Research and Development Program of China [2009AA06440]; National Basic Research Program of China [2011CB2009001]; National Natural Science Foundation of China [31170337]; Fundamental Research Funds for the Central Universities [21611309]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	The project was supported by the National High Technology Research and Development Program of China (2009AA06440), the National Basic Research Program of China (2011CB2009001), the National Natural Science Foundation of China (31170337) and the Fundamental Research Funds for the Central Universities (21611309). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTIA NJ, 1982, BRIT PHYCOL J, V17, P39, DOI 10.1080/00071618200650061; Armstrong GA, 1997, ANNU REV MICROBIOL, V51, P629, DOI 10.1146/annurev.micro.51.1.629; Bara MTF, 2003, FEMS MICROBIOL LETT, V219, P81, DOI 10.1016/S0378-1097(02)01191-6; BARTLEY GE, 1995, PLANT CELL, V7, P1027, DOI 10.1105/tpc.7.7.1027; BLOCH K, 1965, SCIENCE, V150, P19, DOI 10.1126/science.150.3692.19; Britton G, 1998, CAROTENOIDS BIOSYNTH, P13; BROWN MR, 1992, J EXP MAR BIOL ECOL, V161, P91, DOI 10.1016/0022-0981(92)90192-D; Cardozo KHM, 2007, COMP BIOCHEM PHYS C, V146, P60, DOI 10.1016/j.cbpc.2006.05.007; Chisti Y, 2007, BIOTECHNOL ADV, V25, P294, DOI 10.1016/j.biotechadv.2007.02.001; Coesel S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002896; Coleman RA, 2004, PROG LIPID RES, V43, P134, DOI 10.1016/S0163-7827(03)00051-1; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Courchesne NMD, 2009, J BIOTECHNOL, V141, P31, DOI 10.1016/j.jbiotec.2009.02.018; Dahlqvist A, 2000, P NATL ACAD SCI USA, V97, P6487, DOI 10.1073/pnas.120067297; Dinh LTT, 2009, ENVIRON PROG SUSTAIN, V28, P38, DOI 10.1002/ep.10335; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Eisenreich W, 2004, CELL MOL LIFE SCI, V61, P1401, DOI 10.1007/s00018-004-3381-z; Fernie AR, 2004, CURR OPIN PLANT BIOL, V7, P254, DOI 10.1016/j.pbi.2004.03.007; Flugge UI, 2011, J EXP BOT, V62, P2381, DOI 10.1093/jxb/erq361; Geigenberger P, 2005, J EXP BOT, V56, P1469, DOI 10.1093/jxb/eri178; GOODWIN TW, 1993, METHOD ENZYMOL, V214, P330; Granum E, 2002, HYDROBIOLOGIA, V477, P155, DOI 10.1023/A:1021077407766; Greenwell HC, 2010, J R SOC INTERFACE, V7, P703, DOI 10.1098/rsif.2009.0322; Guarnieri MT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025851; Guedes AC, 2011, MAR DRUGS, V9, P625, DOI 10.3390/md9040625; Guschina IA, 2006, PROG LIPID RES, V45, P160, DOI 10.1016/j.plipres.2006.01.001; Hannon M, 2010, BIOFUELS-UK, V1, P763, DOI 10.4155/BFS.10.44; Hardie DG, 2002, BIOCHEM SOC T, V30, P1064, DOI 10.1042/BST0301064; Hirsch RL, 2006, AICHE J, V52, P2, DOI 10.1002/aic.10747; Hites RA, 2004, SCIENCE, V303, P226, DOI 10.1126/science.1091447; Hu Q, 2008, PLANT J, V54, P621, DOI 10.1111/j.1365-313X.2008.03492.x; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; JAWORSKI JG, 1989, PLANT PHYSIOL, V90, P41, DOI 10.1104/pp.90.1.41; Johnson E A, 1996, Adv Biochem Eng Biotechnol, V53, P119; Khozin-Goldberg I, 2005, BBA-MOL CELL BIOL L, V1738, P63, DOI 10.1016/j.bbalip.2005.09.005; Khozin-Goldberg I, 2011, BIOCHIMIE, V93, P91, DOI 10.1016/j.biochi.2010.07.020; Kim JD, 2005, BIOTECHNOL BIOPROC E, V10, P418, DOI 10.1007/BF02989824; Kleczkowski LA, 2004, PLANT PHYSIOL, V134, P912, DOI 10.1104/pp.103.036053; Kroth PG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001426; Krubasik P, 2000, BIOCHEM SOC T, V28, P806, DOI 10.1042/BST0280806; Kurano N, 1998, STUD SURF SCI CATAL, V114, P55; Lee JH, 2009, NAT REV CARDIOL, V6, P753, DOI 10.1038/nrcardio.2009.188; Lee RE, 2008, PHYCOLOGY, P354; Lee SJ, 2011, BIOTECHNOL BIOPROC E, V16, P561, DOI 10.1007/s12257-010-0360-0; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li YQ, 2008, APPL MICROBIOL BIOT, V81, P629, DOI 10.1007/s00253-008-1681-1; Li YT, 2011, BIORESOURCE TECHNOL, V102, P123, DOI 10.1016/j.biortech.2010.06.036; Li ZR, 2012, PLANT PHYSIOL, V158, P313, DOI 10.1104/pp.111.181230; Licatalosi DD, 2010, NAT REV GENET, V11, P75, DOI 10.1038/nrg2673; Maresca JA, 2007, P NATL ACAD SCI USA, V104, P11784, DOI 10.1073/pnas.0702984104; Masamoto K, 2001, PLANT CELL PHYSIOL, V42, P1398, DOI 10.1093/pcp/pce167; Metzker Michael L, 2010, Nat Rev Genet, V11, P31, DOI 10.1038/nrg2626; Miziorko HM, 2011, ARCH BIOCHEM BIOPHYS, V505, P131, DOI 10.1016/j.abb.2010.09.028; Moellering ER, 2010, EUKARYOT CELL, V9, P97, DOI 10.1128/EC.00203-09; MORELL M, 1985, PLANT PHYSIOL, V78, P149, DOI 10.1104/pp.78.1.149; NELSON OE, 1978, PLANT PHYSIOL, V62, P383, DOI 10.1104/pp.62.3.383; OHLROGGE J, 1995, PLANT CELL, V7, P957, DOI 10.1105/tpc.7.7.957; OLSON JA, 1993, ANN NY ACAD SCI, V691, P156, DOI 10.1111/j.1749-6632.1993.tb26167.x; PARRY AD, 1991, PHYSIOL PLANTARUM, V82, P320, DOI 10.1111/j.1399-3054.1991.tb00100.x; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Plaxton WC, 1996, ANNU REV PLANT PHYS, V47, P185, DOI 10.1146/annurev.arplant.47.1.185; Radakovits R, 2010, EUKARYOT CELL, V9, P486, DOI 10.1128/EC.00364-09; RATLEDGE C., 1988, MICROBIAL LIPIDS, P3; Raven JA, 2003, ADV PHOTO RESPIRAT, V14, P205; REBEILLE F, 1988, PLANT PHYSIOL, V88, P973, DOI 10.1104/pp.88.4.973; Roach Peter J., 2002, Current Molecular Medicine (Hilversum), V2, P101, DOI 10.2174/1566524024605761; Rodolfi L, 2009, BIOTECHNOL BIOENG, V102, P100, DOI 10.1002/bit.22033; ROESSLER PG, 1987, J PHYCOL, V23, P494, DOI 10.1111/j.1529-8817.1987.tb02536.x; ROESSLER PG, 1988, ARCH BIOCHEM BIOPHYS, V267, P521, DOI 10.1016/0003-9861(88)90059-8; ROESSLER PG, 1994, ANN NY ACAD SCI, V721, P250, DOI 10.1111/j.1749-6632.1994.tb47398.x; Rosenberg JN, 2008, CURR OPIN BIOTECH, V19, P430, DOI 10.1016/j.copbio.2008.07.008; SANDMANN G, 1994, EUR J BIOCHEM, V223, P7, DOI 10.1111/j.1432-1033.1994.tb18961.x; Schwartz SH, 2003, PLANT PHYSIOL, V131, P1591, DOI 10.1104/pp.102.017921; Scott SA, 2010, CURR OPIN BIOTECH, V21, P277, DOI 10.1016/j.copbio.2010.03.005; Sheehan J, 1988, TP58024190 NAT REN E; Shiran D, 1996, LIPIDS, V31, P1277, DOI 10.1007/BF02587913; SIEFERMANNHARMS D, 1987, PHYSIOL PLANTARUM, V69, P561, DOI 10.1111/j.1399-3054.1987.tb09240.x; Sorek R, 2010, NAT REV GENET, V11, P9, DOI 10.1038/nrg2695; SRIHARAN S, 1991, APPL BIOCHEM BIOTECH, V28-9, P317, DOI 10.1007/BF02922611; Sukenik A, 2009, AQUAT MICROB ECOL, V56, P297, DOI 10.3354/ame01309; Takaichi S, 2007, CELL MOL LIFE SCI, V64, P2607, DOI 10.1007/s00018-007-7190-z; Takaichi S, 2011, MAR DRUGS, V9, P1101, DOI 10.3390/md9061101; TAYLOR HF, 1967, NATURE, V215, P1513, DOI 10.1038/2151513a0; VARUM KM, 1986, J EXP MAR BIOL ECOL, V102, P249, DOI 10.1016/0022-0981(86)90180-2; Velculescu VE, 2007, NAT BIOTECHNOL, V25, P878, DOI 10.1038/nbt0807-878; WHITTLE S J, 1975, British Phycological Journal, V10, P179; Yun YS, 1997, J CHEM TECHNOL BIOT, V69, P451, DOI 10.1002/(SICI)1097-4660(199708)69:4<451::AID-JCTB733>3.0.CO;2-M; Zaslavskaia LA, 2001, SCIENCE, V292, P2073, DOI 10.1126/science.160015; Zittelli GC, 1999, J BIOTECHNOL, V70, P299, DOI 10.1016/S0168-1656(99)00082-6	89	25	28	2	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35142	10.1371/journal.pone.0035142	http://dx.doi.org/10.1371/journal.pone.0035142			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536352	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339200038
J	Westesson, O; Lunter, G; Paten, B; Holmes, I				Westesson, Oscar; Lunter, Gerton; Paten, Benedict; Holmes, Ian			Accurate Reconstruction of Insertion-Deletion Histories by Statistical Phylogenetics	PLOS ONE			English	Article							SEQUENCE ALIGNMENT; MAXIMUM-LIKELIHOOD; EVOLUTIONARY TREES; SUBSTITUTION; PREDICTION; PLACEMENT; IMPACT; MODEL; RATES; TIME	The Multiple Sequence Alignment (MSA) is a computational abstraction that represents a partial summary either of indel history, or of structural similarity. Taking the former view (indel history), it is possible to use formal automata theory to generalize the phylogenetic likelihood framework for finite substitution models (Dayhoff's probability matrices and Felsenstein's pruning algorithm) to arbitrary-length sequences. In this paper, we report results of a simulation-based benchmark of several methods for reconstruction of indel history. The methods tested include a relatively new algorithm for statistical marginalization of MSAs that sums over a stochastically-sampled ensemble of the most probable evolutionary histories. For mammalian evolutionary parameters on several different trees, the single most likely history sampled by our algorithm appears less biased than histories reconstructed by other MSA methods. The algorithm can also be used for alignment-free inference, where the MSA is explicitly summed out of the analysis. As an illustration of our method, we discuss reconstruction of the evolutionary histories of human protein-coding genes.	[Westesson, Oscar; Holmes, Ian] Univ Calif Berkeley, Grad Program Bioengn, Univ Calif Berkeley & Univ Calif San Francisco Gr, Berkeley, CA 94720 USA; [Lunter, Gerton] Wellcome Trust Ctr Human Genet, Oxford, England; [Paten, Benedict] Univ Calif Santa Cruz, Baskin Sch Engn, Santa Cruz, CA 95064 USA	University of California System; University of California Berkeley; University of Oxford; Wellcome Centre for Human Genetics; University of California System; University of California Santa Cruz	Holmes, I (corresponding author), Univ Calif Berkeley, Grad Program Bioengn, Univ Calif Berkeley & Univ Calif San Francisco Gr, Berkeley, CA 94720 USA.	protpal@postbox.biowiki.org	Lunter, Gerton/H-4939-2016	Holmes, Ian/0000-0001-7639-5369; Lunter, Gerton/0000-0002-3798-2058	National Institutes of Health/National Human Genome Research Institute [R01-GM076705]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076705] Funding Source: NIH RePORTER	National Institutes of Health/National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Authors OW and IHH were supported by National Institutes of Health/National Human Genome Research Institute grant R01-GM076705. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, NATURE; Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088; Bradley RK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006478; Bradley RK, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000392; Cartwright RA, 2005, BIOINFORMATICS, V21, P31, DOI 10.1093/bioinformatics/bti1200; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; de la Chaux N, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-191; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Gomez-Valero L, 2008, MOL ECOL, V17, P4382, DOI 10.1111/j.1365-294X.2008.03912.x; Haussler, 2004, P 8 ANN INT C RES CO, P177, DOI DOI 10.1145/974614.974638; Heger A, 2008, NUCLEIC ACIDS RES, V36, pD267, DOI 10.1093/nar/gkm852; HIGGINS DG, 1992, COMPUT APPL BIOSCI, V8, P189; Holmes I, 2001, BIOINFORMATICS, V17, P803, DOI 10.1093/bioinformatics/17.9.803; Kamneva OK, 2010, GENOME BIOL EVOL, V2, P870, DOI 10.1093/gbe/evq071; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Knudsen B, 1999, BIOINFORMATICS, V15, P446, DOI 10.1093/bioinformatics/15.6.446; Kschischang FR, 2001, IEEE T INFORM THEORY, V47, P498, DOI 10.1109/18.910572; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee C, 2002, BIOINFORMATICS, V18, P452, DOI 10.1093/bioinformatics/18.3.452; Liu K, 2009, IEEE ACM T COMPUT BI, V6, P7, DOI 10.1109/TCBB.2008.63; Loytynoja A, 2005, P NATL ACAD SCI USA, V102, P10557, DOI 10.1073/pnas.0409137102; Loytynoja A, 2008, SCIENCE, V320, P1632, DOI 10.1126/science.1158395; Lunter G, 2007, BIOINFORMATICS, V23, pI289, DOI 10.1093/bioinformatics/btm185; Margulies EH, 2007, GENOME RES, V17, P760, DOI 10.1101/gr.6034307; Markova-Raina P, 2011, GENOME RES, V21, P863, DOI 10.1101/gr.115949.110; Matsen FA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-538; Miklos I, 2004, MOL BIOL EVOL, V21, P529, DOI 10.1093/molbev.msh043; Mills R, 2006, GENOME RES, V16; Mohri M, 2002, COMPUT SPEECH LANG, V16, P69, DOI 10.1006/csla.2001.0184; Moore E. F., 1956, AUTOMATA STUDIES, P129; Moses AM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-r98; Nelesen S, 2008, Pac Symp Biocomput, P25; Paten B, 2008, GENOME RES, V18, P1829, DOI 10.1101/gr.076521.108; Pedersen JS, 2006, PLOS COMPUT BIOL, V2, P251, DOI 10.1371/journal.pcbi.0020033; Pollard KS, 2006, NATURE, V443, P167, DOI 10.1038/nature05113; Qu XT, 2009, CURR PROTEIN PEPT SC, V10, P270, DOI 10.2174/138920309788452182; Rannala B, 1996, J MOL EVOL, V43, P304, DOI 10.1007/PL00006090; Saccone S, 2011, NUCL ACIDS RES; Siepel A, 2004, J COMPUT BIOL, V11, P413, DOI 10.1089/1066527041410472; Siepel A, 2004, MOL BIOL EVOL, V21, P468, DOI 10.1093/molbev/msh039; Sinha S, 2005, MBE, V22; Strope CL, 2009, MOL BIOL EVOL, V26, P2581, DOI 10.1093/molbev/msp174; Suchard MA, 2006, BIOINFORMATICS, V22, P2047, DOI 10.1093/bioinformatics/btl175; Thompson JD, 1999, NUCLEIC ACIDS RES, V27, P2682, DOI 10.1093/nar/27.13.2682; THORNE JL, 1991, J MOL EVOL, V33, P114, DOI 10.1007/BF02193625; Thorne JL, 1996, MOL BIOL EVOL, V13, P666, DOI 10.1093/oxfordjournals.molbev.a025627; Wang ZY, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-23; Westesson O, 2011, ALIGNMENT FREE GEN I; Wong KM, 2008, SCIENCE, V319, P473, DOI 10.1126/science.1151532; YANG ZB, 1994, J MOL EVOL, V39, P105; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang Z, 2011, MOL BIOL EVOL, V28, P291, DOI 10.1093/molbev/msq196; Zhu LC, 2009, MOL BIOL EVOL, V26, P2353, DOI 10.1093/molbev/msp144	55	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e34572	10.1371/journal.pone.0034572	http://dx.doi.org/10.1371/journal.pone.0034572			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536326	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339200015
J	Broderick, R; Ramadurai, S; Toth, K; Togashi, DM; Ryder, AG; Langowski, J; Nasheuer, HP				Broderick, Ronan; Ramadurai, Sivaramakrishnan; Toth, Katalin; Togashi, Denisio M.; Ryder, Alan G.; Langowski, Joerg; Nasheuer, Heinz Peter			Cell Cycle-Dependent Mobility of Cdc45 Determined in vivo by Fluorescence Correlation Spectroscopy	PLOS ONE			English	Article							EUKARYOTIC DNA-REPLICATION; PROTEIN-A; POLYMERASE-ALPHA; MCM2-7 HELICASE; S-PHASE; COMPLEX; INITIATION; DYNAMICS; CHROMATIN; GINS	Eukaryotic DNA replication is a dynamic process requiring the co-operation of specific replication proteins. We measured the mobility of eGFP-Cdc45 by Fluorescence Correlation Spectroscopy (FCS) in vivo in asynchronous cells and in cells synchronized at the G1/S transition and during S phase. Our data show that eGFP-Cdc45 mobility is faster in G1/S transition compared to S phase suggesting that Cdc45 is part of larger protein complex formed in S phase. Furthermore, the size of complexes containing Cdc45 was estimated in asynchronous, G1/S and S phase-synchronized cells using gel filtration chromatography; these findings complemented the in vivo FCS data. Analysis of the mobility of eGFP-Cdc45 and the size of complexes containing Cdc45 and eGFP-Cdc45 after UVC-mediated DNA damage revealed no significant changes in diffusion rates and complex sizes using FCS and gel filtration chromatography analyses. This suggests that after UV-damage, Cdc45 is still present in a large multi-protein complex and that its mobility within living cells is consistently similar following UVC-mediated DNA damage.	[Broderick, Ronan; Ramadurai, Sivaramakrishnan; Nasheuer, Heinz Peter] Syst Biol Ireland, Galway, Ireland; [Broderick, Ronan; Ramadurai, Sivaramakrishnan; Nasheuer, Heinz Peter] Natl Univ Ireland Galway, Sch Nat Sci, Ctr Chromosome Biol, Galway, Ireland; [Togashi, Denisio M.; Ryder, Alan G.] Natl Univ Ireland Galway, Sch Chem, Nanoscale Biophoton Lab, Galway, Ireland; [Toth, Katalin; Langowski, Joerg] German Canc Res Ctr, Heidelberg, Germany	Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway; Helmholtz Association; German Cancer Research Center (DKFZ)	Broderick, R (corresponding author), Syst Biol Ireland, Galway, Ireland.	h.nasheuer@nuigalway.ie	Toth, Katalin/ABA-2276-2021; Toth, Katalin/AAC-2064-2020; Ryder, Alan/C-1297-2009; Nasheuer, Heinz P./B-9025-2008; Langowski, Jörg/A-1843-2011; Ryder, Alan/AAW-1056-2020	Toth, Katalin/0000-0002-0081-4720; Ryder, Alan/0000-0002-3133-4340; Langowski, Jörg/0000-0001-8600-0666; Ryder, Alan/0000-0002-3133-4340; Nasheuer, Heinz Peter/0000-0002-9218-9079; broderick, ronan/0000-0001-6840-4755	Science Foundation Ireland through Systems Biology Ireland; Thomas Crawford Hayes Fund; Irish research council for science, engineering & technology (IRCSET)	Science Foundation Ireland through Systems Biology Ireland(Science Foundation Ireland); Thomas Crawford Hayes Fund; Irish research council for science, engineering & technology (IRCSET)(Irish Research Council for Science, Engineering and Technology)	This work was supported by the Science Foundation Ireland through Systems Biology Ireland, the Thomas Crawford Hayes Fund and Irish research council for science, engineering & technology (IRCSET). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baudendistel N, 2005, CHEMPHYSCHEM, V6, P984, DOI 10.1002/cphc.200400639; Bauerschmidt C, 2007, GENES CELLS, V12, P745, DOI 10.1111/j.1365-2443.2007.01090.x; Behlke-Steinert S, 2009, CELL CYCLE, V8, P2211, DOI 10.4161/cc.8.14.8979; Blow JJ, 2005, NAT REV MOL CELL BIO, V6, P476, DOI 10.1038/nrm1663; Braet C, 2007, EXP MOL PATHOL, V82, P156, DOI 10.1016/j.yexmp.2006.12.008; Brazda P, 2011, J CELL SCI, V124, P3631, DOI 10.1242/jcs.086082; Broderick R, 2009, BIOCHEM SOC T, V37, P926, DOI 10.1042/BST0370926; Chen Y, 2002, BIOPHYS J, V82, P133, DOI 10.1016/S0006-3495(02)75380-0; Costa A, 2011, NAT STRUCT MOL BIOL, V18, P471, DOI 10.1038/nsmb.2004; Dross N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005041; Fritsch CC, 2011, CHROMOSOME RES, V19, P63, DOI 10.1007/s10577-010-9168-1; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Gambus A, 2009, EMBO J, V28, P2992, DOI 10.1038/emboj.2009.226; Guigas G, 2008, BIOPHYS J, V95, pL25, DOI 10.1529/biophysj.108.136069; Haupts U, 1998, P NATL ACAD SCI USA, V95, P13573, DOI 10.1073/pnas.95.23.13573; Hemmerich P, 2011, CHROMOSOME RES, V19, P131, DOI 10.1007/s10577-010-9161-8; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Im JS, 2009, P NATL ACAD SCI USA, V106, P15628, DOI 10.1073/pnas.0908039106; Kaufmann WK, 2010, CARCINOGENESIS, V31, P751, DOI 10.1093/carcin/bgp230; Liu PJ, 2006, J BIOL CHEM, V281, P30631, DOI 10.1074/jbc.M602982200; Machida YJ, 2005, CELL, V123, P13, DOI 10.1016/j.cell.2005.09.019; Mahen R, 2011, P NATL ACAD SCI USA, V108, P9310, DOI 10.1073/pnas.1101112108; Masuda T, 2003, GENES CELLS, V8, P145, DOI 10.1046/j.1365-2443.2003.00621.x; Moyer SE, 2006, P NATL ACAD SCI USA, V103, P10236, DOI 10.1073/pnas.0602400103; Nasheuer HP, 2002, PROG NUCLEIC ACID RE, V72, P41, DOI 10.1016/S0079-6603(02)72067-9; Pestryakov PE, 2003, J BIOL CHEM, V278, P17515, DOI 10.1074/jbc.M301265200; Petrasek Z, 2010, METHOD ENZYMOL, V472, P317, DOI 10.1016/S0076-6879(10)72005-X; Pollok S, 2007, FEBS J, V274, P3669, DOI 10.1111/j.1742-4658.2007.05900.x; QIAN H, 1991, APPL OPTICS, V30, P1185, DOI 10.1364/AO.30.001185; Renz M, 2008, CHROMOSOME RES, V16, P427, DOI 10.1007/s10577-008-1234-6; Ritzi M, 1998, J BIOL CHEM, V273, P24543, DOI 10.1074/jbc.273.38.24543; Schwille P, 1999, BIOPHYS J, V77, P2251, DOI 10.1016/S0006-3495(99)77065-7; Slaughter BD, 2010, MOL BIOL CELL, V21, P4306, DOI 10.1091/mbc.E10-05-0451; Stephan H, 2009, NUCLEIC ACIDS RES, V37, P6028, DOI 10.1093/nar/gkp605; Takeda DY, 2005, ONCOGENE, V24, P2827, DOI 10.1038/sj.onc.1208616; Unsal-Kacmaz K, 2007, MOL CELL BIOL, V27, P3131, DOI 10.1128/MCB.02190-06; Wachsmuth M, 2000, J MOL BIOL, V298, P677, DOI 10.1006/jmbi.2000.3692; Wang ZF, 2006, BIOPHYS J, V91, P343, DOI 10.1529/biophysj.105.077891; Weidtkamp-Peters Stefanie, 2008, V464, P321; Widengren J, 1998, CELL MOL BIOL, V44, P857; Zhu WG, 2007, GENE DEV, V21, P2288, DOI 10.1101/gad.1585607	41	13	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e35537	10.1371/journal.pone.0035537	http://dx.doi.org/10.1371/journal.pone.0035537			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22536402	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336200052
J	Matsumura, G; Nitta, N; Matsuda, S; Sakamoto, Y; Isayama, N; Yamazaki, K; Ikada, Y				Matsumura, Goki; Nitta, Naotaka; Matsuda, Shojiro; Sakamoto, Yuki; Isayama, Noriko; Yamazaki, Kenji; Ikada, Yoshito			Long-Term Results of Cell-Free Biodegradable Scaffolds for In Situ Tissue-Engineering Vasculature: In a Canine Inferior Vena Cava Model	PLOS ONE			English	Article							INTRAVASCULAR ULTRASOUND ELASTOGRAPHY; EXTRACARDIAC FONTAN OPERATION; BONE-MARROW; CONDUIT; AUTOGRAFTS; GRAFTS; ARTERIES	We have developed a new biodegradable scaffold that does not require any cell seeding to create an in-situ tissue-engineering vasculature (iTEV). Animal experiments were conducted to test its characteristics and long-term efficacy. An 8-mm tubular biodegradable scaffold, consisting of polyglycolide knitted fibers and an L-lactide and epsilon-caprolactone copolymer sponge with outer glycolide and epsilon-caprolactone copolymer monofilament reinforcement, was implanted into the inferior vena cava (IVC) of 13 canines. All the animals remained alive without any major complications until euthanasia. The utility of the iTEV was evaluated from 1 to 24 months postoperatively. The elastic modulus of the iTEV determined by an intravascular ultrasound imaging system was about 90% of the native IVC after 1 month. Angiography of the iTEV after 2 years showed a well-formed vasculature without marked stenosis or thrombosis with a mean pressure gradient of 0.51 +/- 0.19 mmHg. The length of the iTEV at 2 years had increased by 0.48 +/- 0.15 cm compared with the length of the original scaffold (2-3 cm). Histological examinations revealed a well-formed vessel-like vasculature without calcification. Biochemical analyses showed no significant differences in the hydroxyproline, elastin, and calcium contents compared with the native IVC. We concluded that the findings shown above provide direct evidence that the new scaffold can be useful for cell-free tissue-engineering of vasculature. The long-term results revealed that the iTEV was of good quality and had adapted its shape to the needs of the living body. Therefore, this scaffold would be applicable for pediatric cardiovascular surgery involving biocompatible materials.	[Matsumura, Goki; Isayama, Noriko; Yamazaki, Kenji] Tokyo Womens Med Univ, Heart Inst Japan, Shinjuku Ku, Tokyo, Japan; [Nitta, Naotaka] Natl Inst Adv Ind Sci & Technol, Biomed Sensing & Imaging Grp, Human Technol Res Inst, Tsukuba, Ibaraki, Japan; [Matsuda, Shojiro; Sakamoto, Yuki] Gunze Ltd, Dept Res & Dev, Ayabe, Kyoto, Japan; [Ikada, Yoshito] Nara Med Univ, Dept Indoor Environm Med, Kashihara, Nara 634, Japan	Tokyo Women's Medical University; National Institute of Advanced Industrial Science & Technology (AIST); Nara Medical University	Matsumura, G (corresponding author), Tokyo Womens Med Univ, Heart Inst Japan, Shinjuku Ku, Tokyo, Japan.	smatumur@hij.twmu.ac.jp	MATSUMURA, GOKI/ABB-9716-2020; Nitta, Naotaka/M-4742-2018	MATSUMURA, GOKI/0000-0002-1134-3346; Nitta, Naotaka/0000-0002-6036-4805; Isayama, Noriko/0000-0002-4240-2134	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [20390373]	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in Aid for Scientific Research (B: number 20390373) from The Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexi-Meskishvili V, 2000, EUR J CARDIO-THORAC, V18, P690, DOI 10.1016/S1010-7940(00)00593-5; Amodeo A, 1997, J THORAC CARDIOV SUR, V114, P1020, DOI 10.1016/S0022-5223(97)70016-3; Bailey LL, 1997, J THORAC CARDIOV SUR, V114, P1030; de Korte CL, 1998, ULTRASOUND MED BIOL, V24, P401, DOI 10.1016/S0301-5629(97)00280-9; de Korte CL, 2000, CIRCULATION, V102, P617, DOI 10.1161/01.CIR.102.6.617; Hayabuchi Y, 2007, AM HEART J, V153, DOI 10.1016/j.ahj.2007.01.035; Hibino N, 2005, J THORAC CARDIOV SUR, V129, P1064, DOI 10.1016/j.jtcvs.2004.10.030; Hibino N, 2010, J THORAC CARDIOV SUR, V139, P431, DOI 10.1016/j.jtcvs.2009.09.057; Lee C, 2007, EUR J CARDIO-THORAC, V31, P1008, DOI 10.1016/j.ejcts.2007.03.013; Lemler MS, 2006, AM HEART J, V151, P928, DOI 10.1016/j.ahj.2005.06.015; Matsumura G, 2003, CIRCULATION, V108, P1729, DOI 10.1161/01.CIR.0000092165.32213.61; Matsumura G, 2003, BIOMATERIALS, V24, P2303, DOI 10.1016/S0142-9612(03)00043-7; Matsumura G, 2006, TISSUE ENG, V12, P3075, DOI 10.1089/ten.2006.12.3075; Mirensky TL, 2009, J PEDIATR SURG, V44, P1127, DOI 10.1016/j.jpedsurg.2009.02.035; Nitta N, 2008, IEEE ENG MED BIO, P5298, DOI 10.1109/IEMBS.2008.4650410; Ovroutskia S, 2004, EUR J CARDIO-THORAC, V26, P1073, DOI 10.1016/j.ejcts.2004.07.021; Roh JD, 2010, P NATL ACAD SCI USA, V107, P4669, DOI 10.1073/pnas.0911465107; Shin'oka T, 2005, J THORAC CARDIOV SUR, V129, P1330, DOI 10.1016/j.jtcvs.2004.12.047; Watanabe M, 2001, TISSUE ENG, V7, P429, DOI 10.1089/10763270152436481	19	39	40	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e35760	10.1371/journal.pone.0035760	http://dx.doi.org/10.1371/journal.pone.0035760			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22532873	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336200067
J	de Belchior, ACS; Angeli, JK; Faria, TD; Siman, FDM; Silveira, EA; Meira, EF; da Costa, CP; Vassallo, DV; Padilha, AS				de Belchior, Aucelia C. S.; Angeli, Jhuli K.; Faria, Thais de O.; Siman, Fabiana D. M.; Silveira, Edna A.; Meira, Eduardo F.; da Costa, Carlos P.; Vassallo, Dalton V.; Padilha, Alessandra S.			Post-Weaning Protein Malnutrition Increases Blood Pressure and Induces Endothelial Dysfunctions in Rats	PLOS ONE			English	Article							INTRAUTERINE GROWTH-RETARDATION; NITRIC-OXIDE SYNTHASE; OXIDATIVE STRESS; SUPEROXIDE GENERATION; VASCULAR REACTIVITY; MULTIDEFICIENT DIET; POSTNATAL-GROWTH; HEART-RATE; UNDERNUTRITION; EXPRESSION	Malnutrition during critical periods in early life may increase the subsequent risk of hypertension and metabolic diseases in adulthood, but the underlying mechanisms are still unclear. We aimed to evaluate the effects of post-weaning protein malnutrition on blood pressure and vascular reactivity in aortic rings (conductance artery) and isolated-perfused tail arteries (resistance artery) from control (fed with Labina (R)) and post-weaning protein malnutrition rats (offspring that received a diet with low protein content for three months). Systolic and diastolic blood pressure and heart rate increased in the post-weaning protein malnutrition rats. In the aortic rings, reactivity to phenylephrine (10(-10) -3.10(-4) M) was similar in both groups. Endothelium removal or L-NAME (10(-4) M) incubation increased the response to phenylephrine, but the L-NAME effect was greater in the aortic rings from the post-weaning protein malnutrition rats. The protein expression of the endothelial nitric oxide isoform increased in the aortic rings from the post-weaning protein malnutrition rats. Incubation with apocynin (0.3 mM) reduced the response to phenylephrine in both groups, but this effect was higher in the post-weaning protein malnutrition rats, suggesting an increase of superoxide anion release. In the tail artery of the post-weaning protein malnutrition rats, the vascular reactivity to phenylephrine (0.001-300 mu g) and the relaxation to acetylcholine (10(-10) -10(-3) M) were increased. Post-weaning protein malnutrition increases blood pressure and induces vascular dysfunction. Although the vascular reactivity in the aortic rings did not change, an increase in superoxide anion and nitric oxide was observed in the post-weaning protein malnutrition rats. However, in the resistance arteries, the increased vascular reactivity may be a potential mechanism underlying the increased blood pressure observed in this model.	[de Belchior, Aucelia C. S.; da Costa, Carlos P.] Univ Fed Pernambuco, Dept Fisiol & Farmacol, Recife, PE, Brazil; [de Belchior, Aucelia C. S.; Angeli, Jhuli K.; Faria, Thais de O.; Siman, Fabiana D. M.; Silveira, Edna A.; Meira, Eduardo F.; Vassallo, Dalton V.; Padilha, Alessandra S.] Univ Fed Espirito Santo, Programa Posgrad Ciencias Fisiol, Vitoria, ES, Brazil; [Vassallo, Dalton V.] EMESCAM, Escola Ensino Super Santa Casa Misericordia Vitor, Vitoria, ES, Brazil	Universidade Federal de Pernambuco; Universidade Federal do Espirito Santo; Escola Superior de Ciencias da Santa Casa de Misericordia de Vitoria	de Belchior, ACS (corresponding author), Univ Fed Pernambuco, Dept Fisiol & Farmacol, Recife, PE, Brazil.	ale_padilha@hotmail.com	Vassallo, Dalton/K-8289-2016	Vassallo, Dalton/0000-0002-4463-4174	Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Espirito Santo/fundacao de apoio a ciencia e tecnologia do espirito santo (FAPES/FUNCITEC); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE)(Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Espirito Santo/fundacao de apoio a ciencia e tecnologia do espirito santo (FAPES/FUNCITEC); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was funded by grants from Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao de Amparo a Pesquisa do Espirito Santo/fundacao de apoio a ciencia e tecnologia do espirito santo (FAPES/FUNCITEC) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Casanello P, 2002, CIRC RES, V91, P127, DOI 10.1161/01.RES.0000027813.55750.E7; Ceravolo GS, 2007, LIFE SCI, V80, P782, DOI 10.1016/j.lfs.2006.11.006; Chang HR, 2002, CLIN EXP PHARMACOL P, V29, P275, DOI 10.1046/j.1440-1681.2002.03643.x; Fazza EL, 1999, EXPER PHYSL, V84, P357; Fiorim J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017117; Franca AS, 1997, BRAZ J MED BIOL RES, V30, P891, DOI 10.1590/S0100-879X1997000700012; Franco MCP, 2007, LIFE SCI, V80, P709, DOI 10.1016/j.lfs.2006.10.028; Franco MD, 2002, J CARDIOVASC PHARM, V40, P501, DOI 10.1097/00005344-200210000-00002; Franco MDP, 2003, CARDIOVASC RES, V59, P767, DOI 10.1016/S0008-6363(03)00461-9; Franco MDP, 2002, CARDIOVASC RES, V56, P145, DOI 10.1016/S0008-6363(02)00508-4; Gardner DS, 1997, HYPERTENSION, V30, P1525, DOI 10.1161/01.HYP.30.6.1525; Goodfellow J, 1998, CARDIOVASC RES, V40, P600, DOI 10.1016/S0008-6363(98)00197-7; GRYGLEWSKI RJ, 1986, NATURE, V320, P454, DOI 10.1038/320454a0; Hernanz R, 2004, AM J PHYSIOL-HEART C, V287, pH225, DOI 10.1152/ajpheart.00548.2003; Hu XW, 2000, CARDIOVASC RES, V48, P233, DOI 10.1016/S0008-6363(00)00167-X; Lamireau D, 2002, STROKE, V33, P2992, DOI 10.1161/01.STR.0000039340.62995.F2; LangleyEvans SC, 1996, CLIN SCI, V91, P607, DOI 10.1042/cs0910607; Li JM, 2004, AM J PHYSIOL-REG I, V287, pR1014, DOI 10.1152/ajpregu.00124.2004; Massin MM, 2001, CARDIOLOGY, V95, P80, DOI 10.1159/000047350; Molendi-Coste O, 2009, NEUROENDOCRINOLOGY, V90, P54, DOI 10.1159/000209222; Monteiro FMF, 2001, BRAZ J MED BIOL RES, V34, P271, DOI 10.1590/S0100-879X2001000200017; NUTTER DO, 1979, CIRC RES, V45, P144, DOI 10.1161/01.RES.45.1.144; Oliveira EL, 2004, NUTR NEUROSCI, V7, P201, DOI 10.1080/10284150412331279827; Padilha AS, 2008, EUR J PHARMACOL, V600, P110, DOI 10.1016/j.ejphar.2008.10.023; Paixao ADO, 2005, NUTR METAB CARDIOVAS, V15, P302, DOI 10.1016/j.numecd.2005.01.005; Paixao ADO, 2003, NUTR RES, V23, P85, DOI 10.1016/S0271-5317(02)00494-3; Petry CJ, 2000, DIABETIC MED, V17, P848, DOI 10.1046/j.1464-5491.2000.00392.x; PISSAIA O, 1980, J NUTR, V110, P2035, DOI 10.1093/jn/110.10.2035; Rossoni LV, 2002, BRIT J PHARMACOL, V135, P771, DOI 10.1038/sj.bjp.0704501; Sawaya AL, 2005, MATERN CHILD NUTR, V1, P155, DOI 10.1111/j.1740-8709.2005.00033.x; Sesso R, 2004, NEPHRON CLIN PRACT, V97, pC61, DOI 10.1159/000078402; Sugizaki M, 2005, J BIOMED SCI, V12, P641, DOI 10.1007/s11373-005-7652-y; TEODOSIO NR, 1990, ARCH LATINOAM NUTR, V40, P533; Tropia FC, 2001, NUTR NEUROSCI, V4, P99, DOI 10.1080/1028415X.2001.11747354; VICTORA CG, 1986, B WORLD HEALTH ORGAN, V64, P299; Vieira LD, 2009, CLIN EXP PHARMACOL P, V36, P1157, DOI 10.1111/j.1440-1681.2009.05212.x; Woodall SM, 1996, PEDIATR RES, V40, P438, DOI 10.1203/00006450-199609000-00012	37	15	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e34876	10.1371/journal.pone.0034876	http://dx.doi.org/10.1371/journal.pone.0034876			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529948	gold, Green Published, Green Submitted			2022-12-27	WOS:000305350600035
J	Chotivanich, K; Udomsangpetch, R; Suwanarusk, R; Pukrittayakamee, S; Wilairatana, P; Beeson, JG; Day, NPJ; White, NJ				Chotivanich, Kesinee; Udomsangpetch, Rachanee; Suwanarusk, Rossarin; Pukrittayakamee, Sasithon; Wilairatana, Polrat; Beeson, James G.; Day, Nicholas P. J.; White, Nicholas J.			Plasmodium vivax Adherence to Placental Glycosaminoglycans	PLOS ONE			English	Article							FALCIPARUM-INFECTED ERYTHROCYTES; CHONDROITIN-SULFATE-A; HYALURONIC-ACID; MALARIA; ADHESION; PREGNANCY; RECEPTOR; AREA; CYTOADHERENCE; PATHOGENESIS	Background: Plasmodium vivax infections seldom kill directly but do cause indirect mortality by reducing birth weight and causing abortion. Cytoadherence and sequestration in the microvasculature are central to the pathogenesis of severe Plasmodium falciparum malaria, but the contribution of cytoadherence to pathology in other human malarias is less clear. Methodology: The adherence properties of P. vivax infected red blood cells (PvIRBC) were evaluated under static and flow conditions. Principal Findings: P. vivax isolates from 33 patients were studied. None adhered to immobilized CD36, ICAM-1, or thrombospondin, putative ligands for P. falciparum vascular cytoadherence, or umbilical vein endothelial cells, but all adhered to immobilized chondroitin sulphate A (CSA) and hyaluronic acid (HA), the receptors for adhesion of P. falciparum in the placenta. PvIRBC also adhered to fresh placental cells (N = 5). Pre-incubation with chondroitinase prevented PvIRBC adherence to CSA, and reduced binding to HA, whereas preincubation with hyaluronidase prevented adherence to HA, but did not reduce binding to CSA significantly. Pre-incubation of PvIRBC with soluble CSA and HA reduced binding to the immobilized receptors and prevented placental binding. PvIRBC adhesion was prevented by pre-incubation with trypsin, inhibited by heparin, and reduced by EGTA. Under laminar flow conditions the mean (SD) shear stress reducing maximum attachment by 50% was 0.06 (0.02) Pa but, having adhered, the PvIRBC could then resist detachment by stresses up to 5 Pa. At 37 degrees C adherence began approximately 16 hours after red cell invasion with maximal adherence at 30 hours. At 39 degrees C adherence began earlier and peaked at 24 hours. Significance: Adherence of P. vivax-infected erythrocytes to glycosaminoglycans may contribute to the pathogenesis of vivax malaria and lead to intrauterine growth retardation.	[Chotivanich, Kesinee; Pukrittayakamee, Sasithon; Wilairatana, Polrat; Day, Nicholas P. J.; White, Nicholas J.] Mahidol Univ, Fac Trop Med, Dept Clin Trop Med, Bangkok 10700, Thailand; [Udomsangpetch, Rachanee] Mahidol Univ, Fac Sci, Dept Pathobiol, Bangkok 10700, Thailand; [Suwanarusk, Rossarin] Agcy Sci Technol & Res, Lab Malaria Immunol, Singapore, Singapore; [Beeson, James G.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Infect & Immun Div, Parkville, Vic 3050, Australia; [Day, Nicholas P. J.; White, Nicholas J.] Churchill Hosp, Ctr Trop Med, Oxford OX3 7LJ, England	Mahidol University; Mahidol University; Agency for Science Technology & Research (A*STAR); Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of Oxford	Chotivanich, K (corresponding author), Mahidol Univ, Fac Trop Med, Dept Clin Trop Med, Bangkok 10700, Thailand.	nickw@tropmedres.ac	White, Nicholas J/I-4629-2012; White, Nick/AAC-6527-2019; Suwanarusk, Rossarin/E-2115-2013	White, Nick/0000-0002-1897-1978; Suwanarusk, Rossarin/0000-0002-7310-245X	Faculty of Tropical Medicine, Mahidol University; Wellcome Trust	Faculty of Tropical Medicine, Mahidol University; Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Faculty of Tropical Medicine, Mahidol University and The Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRYSIAK PM, 1986, AM J TROP MED HYG, V35, P251, DOI 10.4269/ajtmh.1986.35.251; Anstey NM, 2007, J INFECT DIS, V195, P589, DOI 10.1086/510756; Beeson JG, 2005, CURR TOP MICROBIOL, V297, P187; Beeson JG, 2004, J INFECT DIS, V189, P169, DOI 10.1086/380975; Beeson JG, 2002, INT J PARASITOL, V32, P1245, DOI 10.1016/S0020-7519(02)00097-8; Beeson JG, 2000, NAT MED, V6, P86, DOI 10.1038/71582; Buffet PA, 1999, P NATL ACAD SCI USA, V96, P12743, DOI 10.1073/pnas.96.22.12743; Carvalho BO, 2010, J INFECT DIS, V202, P638, DOI 10.1086/654815; Chai WG, 2002, J BIOL CHEM, V277, P22438, DOI 10.1074/jbc.M111401200; Chotivanich K, 2001, T ROY SOC TROP MED H, V95, P677, DOI 10.1016/S0035-9203(01)90113-0; Chotivanich KT, 1998, AM J TROP MED HYG, V59, P73, DOI 10.4269/ajtmh.1998.59.73; Fernando SD, 2003, AM J TROP MED HYG, V69, P582, DOI 10.4269/ajtmh.2003.69.582; Fried M, 1996, SCIENCE, V272, P1502, DOI 10.1126/science.272.5267.1502; Fried M, 1998, NATURE, V395, P851, DOI 10.1038/27570; Fried M, 2006, EXP PARASITOL, V113, P36, DOI 10.1016/j.exppara.2005.12.003; Gardner JP, 1996, P NATL ACAD SCI USA, V93, P3503, DOI 10.1073/pnas.93.8.3503; Luxemburger C, 2001, AM J EPIDEMIOL, V154, P459, DOI 10.1093/aje/154.5.459; McGready R, 2004, AM J TROP MED HYG, V70, P398, DOI 10.4269/ajtmh.2004.70.398; McGready R, 2011, LANCET INFECT D 1212; Mendis K, 2001, AM J TROP MED HYG, V64, P97, DOI 10.4269/ajtmh.2001.64.97; Nosten F, 1999, LANCET, V354, P546, DOI 10.1016/S0140-6736(98)09247-2; Poespoprodjo JR, 2008, CLIN INFECT DIS, V46, P1374, DOI 10.1086/586743; Price RN, 2007, AM J TROP MED HYG, V77, P79, DOI 10.4269/ajtmh.2007.77.79; Ribaut C, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-45; Rogerson SJ, 2007, LANCET INFECT DIS, V7, P105, DOI 10.1016/S1473-3099(07)70022-1; Singh K, 2008, NAT STRUCT MOL BIOL, V15, P932, DOI 10.1038/nsmb.1479; Snounou G, 1996, Methods Mol Biol, V50, P263; STAMPER HB, 1977, J IMMUNOL, V119, P772; Suwanarusk R, 2004, J INFECT DIS, V189, P190, DOI 10.1086/380468; Tjitra E, 2008, PLOS MED, V5, P890, DOI 10.1371/journal.pmed.0050128; UDOMSANGPETCH R, 1992, INFECT IMMUN, V60, P4483, DOI 10.1128/IAI.60.11.4483-4490.1992; Udomsangpetch R, 1995, T ROY SOC TROP MED H, V89, P635, DOI 10.1016/0035-9203(95)90422-0; Udomsangpetch R, 1997, J IMMUNOL, V158, P4358; Udomsangpetch R, 2002, P NATL ACAD SCI USA, V99, P11825, DOI 10.1073/pnas.172398999; Williams TN, 1997, QJM-INT J MED, V90, P751	35	64	64	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e34509	10.1371/journal.pone.0034509	http://dx.doi.org/10.1371/journal.pone.0034509			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22529919	Green Published, Green Submitted, gold			2022-12-27	WOS:000305347400013
J	Soo, KY; Atkin, JD; Farg, M; Walker, AK; Horne, MK; Nagley, P				Soo, Kai Y.; Atkin, Julie D.; Farg, Manal; Walker, Adam K.; Horne, Malcolm K.; Nagley, Phillip			Bim Links ER Stress and Apoptosis in Cells Expressing Mutant SOD1 Associated with Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; PROTEIN-DISULFIDE-ISOMERASE; MOTOR-NEURON DISEASE; FAMILY-MEMBER BIM; BCL-2 FAMILY; NEURODEGENERATIVE DISEASES; THERAPEUTIC IMPLICATIONS; MOTONEURON LOSS; SPINAL-CORDS; MOUSE MODEL	Endoplasmic reticulum (ER) stress is an important pathway to cell death in amyotrophic lateral sclerosis (ALS). We previously demonstrated that ER stress is linked to neurotoxicity associated with formation of inclusions of mutant Cu, Zn-superoxide dismutase 1 (SOD1). Cells bearing mutant inclusions undergo mitochondrial apoptotic signalling. Here, we demonstrate that the BH3-only protein, Bim, is a direct link between ER stress and mitochondrial apoptosis. In the murine neuroblastoma cell line, Neuro2a, bearing mutant SOD1 inclusions, indicators of both ER stress and apoptosis are expressed. Bim knockdown by siRNA significantly reduced nuclear apoptotic features in these inclusion-bearing cells (but did not affect the proportion of cells overall that bear inclusions). Further, both Bax recruitment to mitochondria and cytochrome c redistribution were also decreased under Bim-depletion conditions. However, upregulation of CHOP, a marker of ER stress, was not reduced by Bim knockdown. Significantly, knockdown of CHOP by siRNA reduced the extent of apoptosis in cells bearing mutant SOD1 inclusions. These sequential links between ER stress, CHOP upregulation, and Bim activation of mitochondrial apoptotic signalling indicate a clear pathway to cell death mediated by mutant SOD1.	[Soo, Kai Y.; Nagley, Phillip] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Soo, Kai Y.; Atkin, Julie D.; Farg, Manal; Walker, Adam K.] La Trobe Univ, Dept Biochem, La Trobe Inst Mol Sci, Bundoora, Vic 3083, Australia; [Atkin, Julie D.; Walker, Adam K.; Horne, Malcolm K.] Univ Melbourne, Florey Neurosci Inst, Parkville, Vic 3052, Australia; [Atkin, Julie D.; Walker, Adam K.; Horne, Malcolm K.] Univ Melbourne, Ctr Neurosci, Parkville, Vic 3052, Australia; [Horne, Malcolm K.] St Vincents Hosp, Dept Neurol, Fitzroy, Vic 3065, Australia	Monash University; La Trobe University; Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Melbourne; St Vincent's Hospital Melbourne	Soo, KY (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia.	phillip.nagley@monash.edu	Walker, Adam Keith/B-7418-2009; Horne, Malcolm/AAL-5214-2020	Walker, Adam Keith/0000-0001-7954-5801; Horne, Malcolm/0000-0001-9427-2100; Atkin, Julie/0000-0003-2427-499X	National Health and Medical Research Council of Australia (NHMRC) [236805, 454749]; Motor Neurone Disease Research Institute of Australia; NHMRC [400058]; Australian Postgraduate Award; Australian Rotary Health Research Fund; Bethlehem Griffiths Research Foundation	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Motor Neurone Disease Research Institute of Australia; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Australian Postgraduate Award(Australian Government); Australian Rotary Health Research Fund; Bethlehem Griffiths Research Foundation	Funding was obtained from grants from the National Health and Medical Research Council of Australia (NHMRC), www.nhmrc.gov.au, Program Grant on Brain Injury and Repair (236805) to M. Horne and P. Nagley, and Project Grant (454749) to J. Atkin; Bethlehem Griffiths Research Foundation, www.bethlehemgrf.com.au, to J. Atkin and M. Horne; and Motor Neurone Disease Research Institute of Australia, www.mndaust.asn.au/mndria, to J. Atkin. M. Horne was supported by an NHMRC Practitioner Fellowship (400058). J. Atkin was supported by a Fellowship from the Motor Neurone Disease Research Institute of Australia. A. Walker was supported by an Australian Postgraduate Award administered through the University of Melbourne, http://cms.services.unimelb.edu.au/scholarships/pgrad/local/available/apa, and a scholarship from the Australian Rotary Health Research Fund, www.australianrotaryhealth.org.au. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkin JD, 2008, NEUROBIOL DIS, V30, P400, DOI 10.1016/j.nbd.2008.02.009; Atkin JD, 2006, J BIOL CHEM, V281, P30152, DOI 10.1074/jbc.M603393200; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; Heath-Engel HM, 2008, ONCOGENE, V27, P6419, DOI 10.1038/onc.2008.309; Hetz C, 2007, CELL DEATH DIFFER, V14, P1386, DOI 10.1038/sj.cdd.4402166; Hetz CA, 2007, ANTIOXID REDOX SIGN, V9, P2345, DOI 10.1089/ars.2007.1793; Ilieva H, 2009, J CELL BIOL, V187, P761, DOI 10.1083/jcb.200908164; Johnston JA, 2000, P NATL ACAD SCI USA, V97, P12571, DOI 10.1073/pnas.220417997; Karch CM, 2009, P NATL ACAD SCI USA, V106, P7774, DOI 10.1073/pnas.0902505106; Kato S, 2000, ACTA NEUROPATHOL, V100, P490, DOI 10.1007/s004010000226; Kieran D, 2005, J CELL BIOL, V169, P561, DOI 10.1083/jcb.200501085; Kieran D, 2007, P NATL ACAD SCI USA, V104, P20606, DOI 10.1073/pnas.0707906105; Lei K, 2003, P NATL ACAD SCI USA, V100, P2432, DOI 10.1073/pnas.0438011100; Nagley P, 2010, BBA-MOL BASIS DIS, V1802, P167, DOI 10.1016/j.bbadis.2009.09.004; Nickson P, 2007, CARDIOVASC RES, V73, P48, DOI 10.1016/j.cardiores.2006.10.001; Oh YK, 2008, J NEUROCHEM, V104, P993, DOI 10.1111/j.1471-4159.2007.05053.x; Okuno S, 2004, J NEUROSCI, V24, P7879, DOI 10.1523/JNEUROSCI.1745-04.2004; Olzmann JA, 2008, CURR MED CHEM, V15, P47; Puthalakath H, 1999, MOL CELL, V3, P287, DOI 10.1016/S1097-2765(00)80456-6; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Reimertz C, 2003, J CELL BIOL, V162, P587, DOI 10.1083/jcb.200305149; Saxena S, 2009, NAT NEUROSCI, V12, P627, DOI 10.1038/nn.2297; Shaw BF, 2007, TRENDS BIOCHEM SCI, V32, P78, DOI 10.1016/j.tibs.2006.12.005; Shaw PJ, 2005, J NEUROL NEUROSUR PS, V76, P1046, DOI 10.1136/jnnp.2004.048652; Shi P, 2010, BBA-MOL BASIS DIS, V1802, P707, DOI 10.1016/j.bbadis.2010.05.008; Shibata N, 1996, DEV NEUROSCI-BASEL, V18, P492, DOI 10.1159/000111445; Soo KY, 2009, J NEUROCHEM, V108, P578, DOI 10.1111/j.1471-4159.2008.05799.x; Talbot K, 2002, POSTGRAD MED J, V78, P513, DOI 10.1136/pmj.78.923.513; Teuling E, 2008, HUM MOL GENET, V17, P2849, DOI 10.1093/hmg/ddn182; Turner BJ, 2005, J NEUROSCI, V25, P108, DOI 10.1523/JNEUROSCI.4253-04.2005; Walker AK, 2010, BRAIN, V133, P105, DOI 10.1093/brain/awp267; Wang J, 2002, NEUROBIOL DIS, V10, P128, DOI 10.1006/nbdi.2002.0498; Williams A, 2006, CURR TOP DEV BIOL, V76, P89, DOI 10.1016/S0070-2153(06)76003-3; Winklhofer KF, 2008, EMBO J, V27, P336, DOI 10.1038/sj.emboj.7601930; Woehlbier U, 2011, TRENDS BIOCHEM SCI, V36, P329, DOI 10.1016/j.tibs.2011.03.001; Zetterstrom P, 2007, P NATL ACAD SCI USA, V104, P14157, DOI 10.1073/pnas.0700477104	37	29	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e35413	10.1371/journal.pone.0035413	http://dx.doi.org/10.1371/journal.pone.0035413			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523592	gold, Green Published			2022-12-27	WOS:000305345000065
J	Sun, HX; Li, MF; Xu, GZ; Chen, H; Jiao, JD; Tian, B; Wang, LY; Hua, YJ				Sun, Hongxing; Li, Mingfeng; Xu, Guangzhi; Chen, Huan; Jiao, Jiandong; Tian, Bing; Wang, Liangyan; Hua, Yuejin			Regulation of MntH by a Dual Mn(II)- and Fe(II)-Dependent Transcriptional Repressor (DR2539) in Deinococcus radiodurans	PLOS ONE			English	Article							EXTREME RADIORESISTANCE; BACILLUS-SUBTILIS; ESCHERICHIA-COLI; RECA PROTEIN; MANGANESE; IDENTIFICATION; EXPRESSION; ACCUMULATION; TYPHIMURIUM; TRANSPORTER	The high intracellular Mn/Fe ratio observed within the bacteria Deinococcus radiodurans may contribute to its remarkable resistance to environmental stresses. We isolated DR2539, a novel regulator of intracellular Mn/Fe homeostasis in D. radiodurans. Electrophoretic gel mobility shift assays (EMSAs) revealed that DR2539 binds specifically to the promoter of the manganese acquisition transporter (MntH) gene, and that DR0865, the only Fur homologue in D. radiodurans, cannot bind to the promoter of mntH, but it can bind to the promoter of another manganese acquisition transporter, MntABC. beta-galactosidase expression analysis indicated that DR2539 acts as a manganese- and iron-dependent transcriptional repressor. Further sequence alignment analysis revealed that DR2539 has evolved some special characteristics. Site-directed mutagenesis suggested that His98 plays an important role in the activities of DR2539, and further protein-DNA binding activity assays showed that the activity of H98Y mutants decreased dramatically relative to wild type DR2539. Our study suggests that D. radiodurans has evolved a very efficient manganese regulation mechanism that involves its high intracellular Mn/Fe ratio and permits resistance to extreme conditions.	[Sun, Hongxing; Li, Mingfeng; Xu, Guangzhi; Jiao, Jiandong; Tian, Bing; Wang, Liangyan; Hua, Yuejin] Zhejiang Univ, Chinese Minist Agr, Key Lab Nucl Agr Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Sun, Hongxing; Li, Mingfeng; Xu, Guangzhi; Jiao, Jiandong; Tian, Bing; Wang, Liangyan; Hua, Yuejin] Zhejiang Univ, Inst Nucl Agr Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Chen, Huan] Wenzhou Med Coll, Sch Lab Med & Life Sci, Zhejiang Prov Key Lab Med Genet, Key Lab Lab Med,Minist Educ, Wenzhou, Zhejiang, Peoples R China; [Chen, Huan] Zhejiang Inst Microbiol, Hangzhou, Zhejiang, Peoples R China	Ministry of Agriculture & Rural Affairs; Zhejiang University; Zhejiang University; Wenzhou Medical University	Sun, HX (corresponding author), Zhejiang Univ, Chinese Minist Agr, Key Lab Nucl Agr Sci, Hangzhou 310003, Zhejiang, Peoples R China.	liangyanwang@zju.edu.cn; yjhua@zju.edu.cn	Sun, Hongxing/AAV-6028-2020; Chen, Huan/CAH-8180-2022		National Natural Science Foundation of China [30830006, 31170079, 31000045, 31100058, 31070080]; Ministry of Health of China [2009ZXJ09001-034]; major project for genetically modified organisms breeding [2009ZX08009-075B]; Ministry of Agriculture of China [201103007]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Health of China; major project for genetically modified organisms breeding; Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs)	This work was supported by grants from National Natural Science Foundation of China (30830006, 31170079, 31000045, 31100058, 31070080), a major scientific and technological project for significant new drug creation from the Ministry of Health of China (2009ZXJ09001-034), a major project for genetically modified organisms breeding (2009ZX08009-075B) and a grant of Special Fund for Agroscientific Research in the Public Interest from the Ministry of Agriculture of China (201103007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agranoff D, 1999, J EXP MED, V190, P717, DOI 10.1084/jem.190.5.717; Battista JR, 1999, TRENDS MICROBIOL, V7, P362, DOI 10.1016/S0966-842X(99)01566-8; Blasius M, 2006, MOL MICROBIOL, V60, P165, DOI 10.1111/j.1365-2958.2006.05077.x; Chen H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001602; Chen HA, 2010, BIOCHEM BIOPH RES CO, V396, P413, DOI 10.1016/j.bbrc.2010.04.106; Chen PR, 2008, CURR OPIN CHEM BIOL, V12, P214, DOI 10.1016/j.cbpa.2007.12.010; Daly MJ, 2007, PLOS BIOL, V5, P769, DOI 10.1371/journal.pbio.0050092; Daly MJ, 2012, DNA REPAIR, V11, P12, DOI 10.1016/j.dnarep.2011.10.024; Daly MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012570; Daly MJ, 2004, SCIENCE, V306, P1025, DOI 10.1126/science.1103185; de Almeida CB, 2002, MOL GENET GENOMICS, V268, P28, DOI 10.1007/s00438-002-0718-x; FISHER S, 1973, J BACTERIOL, V113, P1373, DOI 10.1128/JB.113.3.1373-1380.1973; Fuangthong M, 2002, P NATL ACAD SCI USA, V99, P6690, DOI 10.1073/pnas.102483199; Gao GJ, 2006, FEMS MICROBIOL LETT, V257, P195, DOI 10.1111/j.1574-6968.2006.00169.x; Guedon E, 2003, MOL MICROBIOL, V48, P495, DOI 10.1046/j.1365-2958.2003.03445.x; Horsburgh MJ, 2002, MOL MICROBIOL, V44, P1269, DOI 10.1046/j.1365-2958.2002.02944.x; Hua YJ, 2003, BIOCHEM BIOPH RES CO, V306, P354, DOI 10.1016/S0006-291X(03)00965-3; Huang LF, 2007, DNA REPAIR, V6, P167, DOI 10.1016/j.dnarep.2006.09.006; Kehres DG, 2000, MOL MICROBIOL, V36, P1085, DOI 10.1046/j.1365-2958.2000.01922.x; Kehres DG, 2002, J BACTERIOL, V184, P3151, DOI 10.1128/JB.184.12.3151-3158.2002; Kim JI, 2002, J BACTERIOL, V184, P1649, DOI 10.1128/JB.184.6.1649-1660.2002; LEIBOWITZ PJ, 1976, PHOTOCHEM PHOTOBIOL, V23, P45; Ma Z, 2009, CHEM REV, V109, P4644, DOI 10.1021/cr900077w; Makarova KS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000955; Makui H, 2000, MOL MICROBIOL, V35, P1065, DOI 10.1046/j.1365-2958.2000.01774.x; Patzer SI, 2001, J BACTERIOL, V183, P4806, DOI 10.1128/JB.183.16.4806-4813.2001; Qian YL, 2002, J BACTERIOL, V184, P4846, DOI 10.1128/JB.184.17.4846-4856.2002; Que Q, 2000, MOL MICROBIOL, V35, P1454, DOI 10.1046/j.1365-2958.2000.01811.x; Rainey FA, 1997, INT J SYST BACTERIOL, V47, P510, DOI 10.1099/00207713-47-2-510; Shu HY, 2010, AFR J BIOTECHNOL, V9, P2742; Sun HX, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-319; Wang LY, 2008, MOL MICROBIOL, V67, P1211, DOI 10.1111/j.1365-2958.2008.06113.x	32	17	18	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e35057	10.1371/journal.pone.0035057	http://dx.doi.org/10.1371/journal.pone.0035057			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523570	Green Published, Green Submitted, gold			2022-12-27	WOS:000305345000042
J	Wang, ZQ; Sturgis, EM; Guo, W; Song, XC; Zhang, FH; Xu, L; Wei, QY; Li, GJ				Wang, Zhongqiu; Sturgis, Erich M.; Guo, Wei; Song, Xicheng; Zhang, Fenghua; Xu, Li; Wei, Qingyi; Li, Guojun			Association of Combined p73 and p53 Genetic Variants with Tumor HPV16-Positive Oropharyngeal Cancer	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; HUMAN-PAPILLOMAVIRUS TYPE-16; NEVER-SMOKERS; NECK CANCERS; G4C14-TO-A4T14 POLYMORPHISM; TONSILLAR CANCER; ORAL-CANCER; E6 PROTEINS; RISK-FACTOR; CODON 72	p53 and p73 interact with human papillomavirus (HPV) E6 and E7 oncoproteins. The interplay between p53 and p73 and HPV16 may lead to deregulation of cell cycle and apoptosis, through which inflammation/immune responses control the HPV clearance and escape of immune surveillance, and subsequently contribute to tumor HPV16 status. In this case-case comparison study, HPV16 status in tumor specimens was analyzed and p53 codon 72 and p73 G4C14-to-A4T14 polymorphisms were genotyped using genomic DNA from blood of 309 oropharyngeal cancer patients. Odds ratios (ORs) and 95% confidence intervals (95% CIs) were calculated in univariate and multivariable logistic regression models to examine the association. The results from this study showed both p53 variant genotypes (Arg/Pro+Pro/Pro) and p73 variant genotypes (GC/AT+AT/AT) were significantly associated with HPV16-positive tumor in oropharyngeal cancer patients (OR, 1.9, 95% CI, 1.1-3.3 and OR, 2.1, 95% CI, 1.2-3.8, respectively), while the combined variant genotypes (p53 Pro carriers and p73 AT carriers) exhibited a significantly greater association with HPV16-positive tumor (OR, 3.2, 95% CI, 1.4-7.4), compared with combined wild-type genotypes (p53 Arg/Arg and p73 GC/GC), and the association was in a statistically significant dose-effect relationship (p = 0.001). Moreover, such association was more pronounced among several subgroups. These findings suggest that variant genotypes of p53 and p73 genes may be individually, or more likely jointly, associated with tumor HPV16-positive oropharyngeal cancer patients, particularly in never smokers. Identification of such susceptible biomarkers would greatly influence on individualized treatment for an improved prognosis.	[Wang, Zhongqiu; Sturgis, Erich M.; Guo, Wei; Song, Xicheng; Zhang, Fenghua; Xu, Li; Li, Guojun] Univ Texas MD Anderson Canc Ctr, Dept Head & Neck Surg, Houston, TX 77030 USA; [Wang, Zhongqiu] Tongji Univ, Sch Med, East Hosp, Dept Radiol, Shanghai 200092, Peoples R China; [Sturgis, Erich M.; Wei, Qingyi; Li, Guojun] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Guo, Wei] Capital Med Univ, Beijing Tongren Hosp, Dept Otolaryngol Head & Neck Surg, Beijing, Peoples R China; [Song, Xicheng] Qingdao Univ, Yuhuangding Hosp, Dept Otolaryngol Head & Neck Surg, Yantai, Peoples R China; [Zhang, Fenghua] Hebei Gen Hosp, Dept Gen Surg, Shijiazhuang, Peoples R China	University of Texas System; UTMD Anderson Cancer Center; Tongji University; University of Texas System; UTMD Anderson Cancer Center; Capital Medical University; Qingdao University	Wang, ZQ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Head & Neck Surg, Houston, TX 77030 USA.	gli@mdanderson.org	Xu, Li/B-9535-2012		National Institutes of Health (NIH) [ES011740-01]; NIH [CA135679, CA133099]; NATIONAL CANCER INSTITUTE [R03CA135679, K07CA133099] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES011740] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Supported by National Institutes of Health (NIH) R01 grant ES011740-01 (Q. W.), NIH R03 grant CA135679 (G. L.), and NIH K07 grant CA133099 (G. L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baez A, 2004, HEAD NECK-J SCI SPEC, V26, P778, DOI 10.1002/hed.20046; Chen X, 2008, CANCER, V113, P307; Chen XM, 2008, CARCINOGENESIS, V29, P2120, DOI 10.1093/carcin/bgn191; Dahlstrom KR, 2003, CLIN CANCER RES, V9, P2620; Das S, 2006, CANCER BIOL THER, V5, P210, DOI 10.4161/cbt.5.2.2402; Dobrossy L, 2005, CANCER METAST REV, V24, P9, DOI 10.1007/s10555-005-5044-4; Dumont P, 2003, NAT GENET, V33, P357, DOI 10.1038/ng1093; Fakhry C, 2006, J CLIN ONCOL, V24, P2606, DOI 10.1200/JCO.2006.06.1291; FAVRE A, 1986, Z MIKROSK ANAT FORSC, V100, P7; Fouret P, 1997, ARCH OTOLARYNGOL, V123, P513; Gillison ML, 2008, JNCI-J NATL CANCER I, V100, P407, DOI 10.1093/jnci/djn025; Gillison ML, 2000, JNCI-J NATL CANCER I, V92, P709, DOI 10.1093/jnci/92.9.709; Guan XX, 2010, CLIN CANCER RES, V16, P1416, DOI 10.1158/1078-0432.CCR-09-2877; Haber DA, 1998, LANCET, V351, P1; Hammarstedt L, 2006, INT J CANCER, V119, P2620, DOI 10.1002/ijc.22177; Haughey BH, 2011, HEAD NECK-J SCI SPEC, V33, P1683, DOI 10.1002/hed.21669; Helton ES, 2007, J CELL BIOCHEM, V100, P883, DOI 10.1002/jcb.21091; Herrero R, 2003, JNCI-J NATL CANCER I, V95, P1772, DOI [10.1093/jnci/djg/107, 10.1093/jnci/djg107]; Huang CC, 1998, MODERN PATHOL, V11, P971; Ji XM, 2008, CARCINOGENESIS, V29, P875, DOI 10.1093/carcin/bgn039; Ji XM, 2009, CANCER-AM CANCER SOC, V115, P1660, DOI 10.1002/cncr.24184; Jost CA, 1997, NATURE, V389, P191, DOI 10.1038/38298; Kaghad M, 1997, CELL, V90, P809, DOI 10.1016/S0092-8674(00)80540-1; Koch WM, 1999, LARYNGOSCOPE, V109, P1544, DOI 10.1097/00005537-199910000-00002; Koskinen WJ, 2003, INT J CANCER, V107, P401, DOI 10.1002/ijc.11381; Li FL, 2010, CANCER-AM CANCER SOC, V116, P2350, DOI 10.1002/cncr.25072; Li GJ, 2004, CARCINOGENESIS, V25, P1911, DOI 10.1093/carcin/bgh197; Li W, 2003, INT J CANCER, V106, P553, DOI 10.1002/ijc.11261; Lindel K, 2001, CANCER-AM CANCER SOC, V92, P805, DOI 10.1002/1097-0142(20010815)92:4<805::AID-CNCR1386>3.0.CO;2-9; Melino G, 2002, NAT REV CANCER, V2, P605, DOI 10.1038/nrc861; Melino G, 2003, TRENDS BIOCHEM SCI, V28, P663, DOI 10.1016/j.tibs.2003.10.004; Mellin H, 2000, INT J CANCER, V89, P300, DOI 10.1002/1097-0215(20000520)89:3<300::AID-IJC14>3.0.CO;2-G; Munger K, 2002, VIRUS RES, V89, P213, DOI 10.1016/S0168-1702(02)00190-9; Park JS, 2001, INT J CANCER, V91, P822, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1130>3.0.CO;2-0; Perrone F, 2007, CANCER, V109, P2461, DOI 10.1002/cncr.22702; Phillips AC, 2001, APOPTOSIS, V6, P173, DOI 10.1023/A:1011332625740; Pintos J, 1999, CANCER-AM CANCER SOC, V85, P1903, DOI 10.1002/(SICI)1097-0142(19990501)85:9<1903::AID-CNCR4>3.0.CO;2-6; Rich JT, 2011, LARYNGOSCOPE, V121, P2381, DOI 10.1002/lary.21406; Ritchie JM, 2003, INT J CANCER, V104, P336, DOI 10.1002/ijc.10960; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; Smith EM, 2004, INT J CANCER, V108, P766, DOI 10.1002/ijc.11633; Storey A, 1998, NATURE, V393, P229, DOI 10.1038/30400; Thomas M, 1999, MOL CELL BIOL, V19, P1092; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; VOKES EE, 1993, NEW ENGL J MED, V328, P184, DOI 10.1056/NEJM199301213280306; WERNESS BA, 1990, SCIENCE, V248, P76, DOI 10.1126/science.2157286	47	13	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e35522	10.1371/journal.pone.0035522	http://dx.doi.org/10.1371/journal.pone.0035522			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523600	Green Published, Green Submitted, gold			2022-12-27	WOS:000305345000074
J	Casteel, CL; Hansen, AK; Walling, LL; Paine, TD				Casteel, Clare L.; Hansen, Allison K.; Walling, Linda L.; Paine, Timothy D.			Manipulation of Plant Defense Responses by the Tomato Psyllid (Bactericerca cockerelli) and Its Associated Endosymbiont Candidatus Liberibacter Psyllaurous	PLOS ONE			English	Article							APHID BREVICORYNE-BRASSICAE; MEDIATED INTERACTIONS; INSECT VECTOR; ARABIDOPSIS; IMMUNITY; PHYTOPLASMA; MECHANISMS; RESISTANCE; SALICYLATE; PATHOGENS	Some plant pathogens form obligate relationships with their insect vector and are vertically transmitted via eggs analogous to insect endosymbionts. Whether insect endosymbionts manipulate plant defenses to benefit their insect host remains unclear. The tomato psyllid, Bactericerca cockerelli (Sulc), vectors the endosymbiont "Candidatus Liberibacter psyllaurous" (Lps) during feeding on tomato (Solanum lycopersicum L.). Lps titer in psyllids varied relative to the psyllid developmental stage with younger psyllids harboring smaller Lps populations compared to older psyllids. In the present study, feeding by different life stages of B. cockerelli infected with Lps, resulted in distinct tomato transcript profiles. Feeding by young psyllid nymphs, with lower Lps levels, induced tomato genes regulated by jasmonic acid (JA) and salicylic acid (SA) (Allene oxide synthase, Proteinase inhibitor 2, Phenylalanine ammonia-lyase 5, Pathogenesis-related protein 1) compared to feeding by older nymphs and adults, where higher Lps titers were found. In addition, inoculation of Lps without insect hosts suppressed accumulation of these defense transcripts. Collectively, these data suggest that the endosymbiont-like pathogen Lps manipulates plant signaling and defensive responses to benefit themselves and the success of their obligate insect vector on their host plant.	[Casteel, Clare L.] Cornell Univ, Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA; [Hansen, Allison K.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT USA; [Walling, Linda L.] Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA; [Paine, Timothy D.] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA; [Walling, Linda L.; Paine, Timothy D.] Univ Calif Riverside, Ctr Dis Vector Res, Riverside, CA 92521 USA	Cornell University; Boyce Thompson Institute for Plant Research; Yale University; University of California System; University of California Riverside; University of California System; University of California Riverside; University of California System; University of California Riverside	Casteel, CL (corresponding author), Cornell Univ, Boyce Thompson Inst Plant Res, Tower Rd, Ithaca, NY 14853 USA.	clc269@cornell.edu		Hansen, Allison/0000-0002-3066-5527	TIGR; NSF [IOS 0804008]	TIGR; NSF(National Science Foundation (NSF))	This research was funded partially by a grant from TIGR to TDP and CLC for cDNA microarrays and processing and an NSF grant (IOS 0804008) to LLW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramovitch RB, 2006, NAT REV MOL CELL BIO, V7, P601, DOI 10.1038/nrm1984; Bari R, 2009, PLANT MOL BIOL, V69, P473, DOI 10.1007/s11103-008-9435-0; Bhattarai KK, 2007, MOL PLANT MICROBE IN, V20, P276, DOI 10.1094/MPMI-20-3-0276; Bhattarai KK, 2010, PLANT J, V63, P229, DOI 10.1111/j.1365-313X.2010.04232.x; Boller T, 2009, SCIENCE, V324, P742, DOI 10.1126/science.1171647; Broekgaarden C, 2008, PLANT CELL ENVIRON, V31, P1592, DOI 10.1111/j.1365-3040.2008.01871.x; Carter RD, 1950, TOXICITY PARATRIOZA; Chang S, 1993, PLANT MOL BIOL REP, V11, P113, DOI DOI 10.1007/BF02670468; Chao WS, 1999, PLANT PHYSIOL, V120, P979, DOI 10.1104/pp.120.4.979; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Davis M. J., 1981, PROKARYOTES, P2172; Davis MJ, 1998, CURR MICROBIOL, V36, P80, DOI 10.1007/s002849900283; de Ilarduya OM, 2003, MOL PLANT MICROBE IN, V16, P699, DOI 10.1094/MPMI.2003.16.8.699; Delp G, 2009, MOL GENET GENOMICS, V281, P233, DOI 10.1007/s00438-008-0409-3; DOUGLAS AE, 1992, J INSECT PHYSIOL, V38, P565, DOI 10.1016/0022-1910(92)90107-O; Duan YP, 2009, MOL PLANT MICROBE IN, V22, P1011, DOI 10.1094/MPMI-22-8-1011; Felton GW, 2008, CURR OPIN PLANT BIOL, V11, P457, DOI 10.1016/j.pbi.2008.07.001; Frosch M, 1983, J APPL ENTOMOL, V95, P310; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Gao LL, 2007, MOL PLANT MICROBE IN, V20, P82, DOI 10.1094/MPMI-20-0082; Gatineau F, 2002, PHYTOPATHOLOGY, V92, P384, DOI 10.1094/PHYTO.2002.92.4.384; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Grant SR, 2006, ANNU REV MICROBIOL, V60, P425, DOI 10.1146/annurev.micro.60.080805.142251; Hansen AK, 2008, APPL ENVIRON MICROB, V74, P5862, DOI 10.1128/AEM.01268-08; HARTLEY JL, 1993, PCR METH APPL, V3, pS10; Howe GA, 2004, J PLANT GROWTH REGUL, V23, P223, DOI 10.1007/s00344-004-0030-6; Howe GA, 2008, ANNU REV PLANT BIOL, V59, P41, DOI 10.1146/annurev.arplant.59.032607.092825; Kempema LA, 2007, PLANT PHYSIOL, V143, P849, DOI 10.1104/pp.106.090662; KNOWLTON GEORGE F., 1934, JOUR ECON ENT, V27, P547, DOI 10.1093/jee/27.2.547; Koga R, 2003, P ROY SOC B-BIOL SCI, V270, P2543, DOI 10.1098/rspb.2003.2537; Kusnierczyk A, 2008, PLANT CELL ENVIRON, V31, P1097, DOI 10.1111/j.1365-3040.2008.01823.x; Leon-Reyes A, 2010, PLANTA, V232, P1423, DOI 10.1007/s00425-010-1265-z; Liefting LW, 2009, PLANT DIS, V93, P208, DOI 10.1094/PDIS-93-3-0208; LIN H, 2011, PLOS ONE, V6; List GM, 1939, COLORADO AGR EXPT ST; McSteen P, 2008, DEV CELL, V14, P467, DOI 10.1016/j.devcel.2008.03.013; Mur LAJ, 2006, PLANT PHYSIOL, V140, P249, DOI 10.1104/pp.105.072348; Nachappa P, 2012, PHYTOPATHOLOGY, V102, P41, DOI 10.1094/PHYTO-03-11-0084; Nachappa P, 2011, CURR MICROBIOL, V62, P1510, DOI 10.1007/s00284-011-9885-5; Oliver KM, 2010, ANNU REV ENTOMOL, V55, P247, DOI 10.1146/annurev-ento-112408-085305; Pieterse CMJ, 2007, TRENDS PLANT SCI, V12, P564, DOI 10.1016/j.tplants.2007.09.004; PLETSCH D. J., 1947, Bull. Mont. agric. Exp. Stn., V446; PURCELL AH, 1982, ANNU REV PHYTOPATHOL, V20, P397, DOI 10.1146/annurev.py.20.090182.002145; Puthoff DP, 2010, J CHEM ECOL, V36, P1271, DOI 10.1007/s10886-010-9868-1; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Rensink WA, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-124; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Semetey O, 2007, EUR J PLANT PATHOL, V117, P187, DOI 10.1007/s10658-006-9087-3; Stout MJ, 2006, ANNU REV ENTOMOL, V51, P663, DOI 10.1146/annurev.ento.51.110104.151117; TAKABAYASHI J, 1995, J CHEM ECOL, V21, P273, DOI 10.1007/BF02036717; Tang JY, 2006, J EXP BOT, V57, P527, DOI 10.1093/jxb/erj032; Thaler JS, 2010, ECOLOGY, V91, P1075, DOI 10.1890/08-2347.1; VANDENBERG MA, 1992, ISRAEL J ENTOMOL, V25, P51; Verhage A, 2010, PLANT PHYSIOL, V154, P536, DOI 10.1104/pp.110.161570; Walling LL, 2009, ADV BOT RES, V51, P551, DOI 10.1016/S0065-2296(09)51013-0; WALLIS R. L., 1955, Technical Bulletin. United States Department of Agriculture; Wettenhall JM, 2004, BIOINFORMATICS, V20, P3705, DOI 10.1093/bioinformatics/bth449; Zarate SI, 2007, PLANT PHYSIOL, V143, P866, DOI 10.1104/pp.106.090035; Zhang PJ, 2009, P NATL ACAD SCI USA, V106, P21202, DOI 10.1073/pnas.0907890106	60	80	86	1	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35191	10.1371/journal.pone.0035191	http://dx.doi.org/10.1371/journal.pone.0035191			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22539959	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341000023
J	Fimognari, C; Lenzi, M; Sestili, P; Turrini, E; Ferruzzi, L; Hrelia, P; Cantelli-Forti, G				Fimognari, Carmela; Lenzi, Monia; Sestili, Piero; Turrini, Eleonora; Ferruzzi, Lorenzo; Hrelia, Patrizia; Cantelli-Forti, Giorgio			Sulforaphane Potentiates RNA Damage Induced by Different Xenobiotics	PLOS ONE			English	Article							IN-VITRO; PHENETHYL ISOTHIOCYANATE; SUPEROXIDE GENERATION; CELLULAR ACCUMULATION; ALKYLATION DAMAGE; OXIDATIVE STRESS; CANCER; THIOREDOXIN; GLUTATHIONE; APOPTOSIS	Background: The isothiocyanate sulforaphane (SFN) possesses interesting anticancer activities. However, recent studies reported that SFN promotes the formation of reactive oxygen species (ROS) as well as DNA breakage. Methodology/Principal Findings: We investigated whether SFN is able to damage RNA, whose loss of integrity was demonstrated in different chronic diseases. Considering the ability of SFN to protect from genotoxicity, we also examined whether SFN is able to protect from RNA damage induced by different chemicals (doxorubicin, spermine, S-nitroso-N-acetylpenicillamine, H2O2). We observed that SFN was devoid of either RNA damaging and RNA protective activity in human leukemic cells. It was able to potentiate the RNA damage by doxorubicin and spermine. In the first case, the effect was attributable to its ability of modulating the bioreductive activation of doxorubicin. For spermine, the effects were mainly due to its modulation of ROS levels produced by spermine metabolism. As to the cytotoxic relevance of the RNA damage, we found that the treatment of cells with a mixture of spermine or doxorubicin plus SFN increased their proapoptotic potential. Thus it is conceivable that the presence of RNA damage might concur to the overall toxic response induced by a chemical agent in targeted cells. Conclusions/Significance: Since RNA is emerging as a potential target for anticancer drugs, its ability to enhance spermine- and doxorubicin-induced RNA damage and cytotoxicity could represent an additional mechanism for the potentiating effects of SFN associated with anticancer drugs.	[Fimognari, Carmela; Lenzi, Monia; Turrini, Eleonora; Ferruzzi, Lorenzo; Hrelia, Patrizia; Cantelli-Forti, Giorgio] Univ Bologna, Dept Pharmacol, Alma Mater Studiorum, Bologna, Italy; [Sestili, Piero] Univ Studi Urbino, Dipartimento Scienze Biomol, Urbino, Italy	University of Bologna; University of Urbino	Fimognari, C (corresponding author), Univ Bologna, Dept Pharmacol, Alma Mater Studiorum, Bologna, Italy.	carmela.fimognari@unibo.it	Turrini, Eleonora/I-3629-2019; Hrelia, Patrizia/AAC-2071-2020; Sestili, Piero/H-6082-2019; Fimognari, Carmela/J-7678-2019	Turrini, Eleonora/0000-0003-4743-1126; Sestili, Piero/0000-0001-9412-1660; Fimognari, Carmela/0000-0002-2461-8214; HRELIA, Patrizia/0000-0002-8415-3711	Ministero dell'Istruzione dell'Universita e della Ricerca [2007SSZMPK]; FIRB Piattaforme/Reti (Basic Research Investment Fund Platforms/Networks) [RBPR05NWWC_002]	Ministero dell'Istruzione dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); FIRB Piattaforme/Reti (Basic Research Investment Fund Platforms/Networks)	This work was supported by Ministero dell'Istruzione dell'Universita e della Ricerca (http://sitouniversitario.cineca.it; grant number: 2007SSZMPK) and FIRB Piattaforme/Reti 2006 (Basic Research Investment Fund Platforms/Networks 2006) (http://sitofirb.cineca.it; grant number: RBPR05NWWC_002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas PA, 2003, NATURE, V421, P859, DOI 10.1038/nature01363; Antosiewicz J, 2008, PLANTA MED, V74, P1570, DOI 10.1055/s-2008-1081307; Arnold U, 2006, BIOTECHNOL LETT, V28, P1615, DOI 10.1007/s10529-006-9145-0; Baltimore D, 2001, NATURE, V409, P814, DOI 10.1038/35057267; Barcelo S, 1996, CARCINOGENESIS, V17, P277, DOI 10.1093/carcin/17.2.277; Bellacosa A, 2003, CURR BIOL, V13, pR482, DOI 10.1016/S0960-9822(03)00408-1; Bregeon D, 2005, MUTAT RES-FUND MOL M, V577, P293, DOI 10.1016/j.mrfmmm.2005.04.002; Chen YR, 2002, J BIOL CHEM, V277, P39334, DOI 10.1074/jbc.M202070200; Cheung KL, 2010, AAPS J, V12, P87, DOI 10.1208/s12248-009-9162-8; Cho SD, 2005, NUTR CANCER, V52, P213, DOI 10.1207/s15327914nc5202_11; Clarke JD, 2008, CANCER LETT, V269, P291, DOI 10.1016/j.canlet.2008.04.018; Conaway CC, 2001, CHEM RES TOXICOL, V14, P1170, DOI 10.1021/tx010029w; Das KC, 2000, BIOCHEM BIOPH RES CO, V277, P443, DOI 10.1006/bbrc.2000.3689; Drablos F, 2004, DNA REPAIR, V3, P1389, DOI 10.1016/j.dnarep.2004.05.004; Drobnica J., 1977, CYANATES THEIR THIO, P1003; Fahey JW, 1997, P NATL ACAD SCI USA, V94, P10367, DOI 10.1073/pnas.94.19.10367; Fimognari C, 2005, ENVIRON MOL MUTAGEN, V46, P260, DOI 10.1002/em.20156; Fimognari C, 2005, MUTAT RES-GEN TOX EN, V582, P1, DOI 10.1016/j.mrgentox.2004.11.019; Fimognari C, 2008, MUTAT RES-FUND MOL M, V648, P15, DOI 10.1016/j.mrfmmm.2008.09.003; Fimognari C, 2007, MUTAT RES-REV MUTAT, V635, P90, DOI 10.1016/j.mrrev.2006.10.004; Fimognari C, 2009, MUTAT RES-FUND MOL M, V670, P59, DOI 10.1016/j.mrfmmm.2009.07.005; Gaona-Gaona L, 2011, TOXICOLOGY, V286, P20, DOI 10.1016/j.tox.2011.04.014; Hacker A, 2008, CANCER CHEMOTH PHARM, V63, P45, DOI 10.1007/s00280-008-0706-x; Hinman A, 2006, P NATL ACAD SCI USA, V103, P19564, DOI 10.1073/pnas.0609598103; HOUEN G, 1994, ACTA CHEM SCAND, V48, P52, DOI 10.3891/acta.chem.scand.48-0052; Hu Y, 2007, BIOL CHEM, V388, P1069, DOI 10.1515/BC.2007.135; Iordanov MS, 2000, CANCER RES, V60, P1983; Kallifatidis G, 2011, MOL THER, V19, P188, DOI 10.1038/mt.2010.216; Kawakami M, 2005, BIOSCI BIOTECH BIOCH, V69, P2439, DOI 10.1271/bbb.69.2439; Kim H, 2006, CANCER RES, V66, P1740, DOI 10.1158/0008-5472.CAN-05-1568; Kirsch-Volders M, 2003, MUTAT RES-GEN TOX EN, V540, P153, DOI 10.1016/j.mrgentox.2003.07.005; Martinet W, 2004, EUR J CLIN INVEST, V34, P323, DOI 10.1111/j.1365-2362.2004.01343.x; Martinet Wim, 2005, RNA Biol, V2, P4, DOI 10.4161/rna.2.1.1430; Miyoshi N, 2004, CARCINOGENESIS, V25, P567, DOI 10.1093/carcin/bgh051; Mustacich D, 2000, BIOCHEM J, V346, P1, DOI 10.1042/0264-6021:3460001; Nunomura A, 2007, CURR MED CHEM, V14, P2968, DOI 10.2174/092986707782794078; Nunomura A, 1999, J NEUROSCI, V19, P1959; Nunomura A, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/200682323; Nunomura A, 2006, J NEUROPATH EXP NEUR, V65, P631, DOI 10.1097/01.jnen.0000228136.58062.bf; Oliveira CJR, 2008, NITRIC OXIDE-BIOL CH, V18, P241, DOI 10.1016/j.niox.2008.02.001; Rausch V, 2010, CANCER RES, V70, P5004, DOI 10.1158/0008-5472.CAN-10-0066; Ravi D, 2004, CANCER CHEMOTH PHARM, V54, P449, DOI 10.1007/s00280-004-0833-y; RHEE Y, 1995, NUCLEIC ACIDS RES, V23, P3275, DOI 10.1093/nar/23.16.3275; Rodon J, 2010, ONCOLOGIST, V15, P37, DOI 10.1634/theoncologist.2009-0117; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Schulenhurg C, 2007, CANCER BIOL THER, V6, P1233; Sestili P, 2010, MUTAT RES-FUND MOL M, V689, P65, DOI 10.1016/j.mrfmmm.2010.05.003; Sharmin S, 2001, BIOCHEM BIOPH RES CO, V282, P228, DOI 10.1006/bbrc.2001.4569; Singh SV, 2005, J BIOL CHEM, V280, P19911, DOI 10.1074/jbc.M412443200; Sinha-Hikim I, 2010, AM J PHYSIOL-CELL PH, V299, pC638, DOI 10.1152/ajpcell.00434.2009; SMITH JA, 1993, J IMMUNOL METHODS, V162, P261, DOI 10.1016/0022-1759(93)90391-J; Tafech A, 2006, CURR MED CHEM, V13, P863, DOI 10.2174/092986706776361021; Wang LG, 2010, INT J ONCOL, V37, P533, DOI 10.3892/ijo_00000702; Witte I, 2007, TOXICOL SCI, V97, P21, DOI 10.1093/toxsci/kfl192; Yoshida K, 2008, TRENDS MOL MED, V14, P305, DOI 10.1016/j.molmed.2008.05.003; Zhang JS, 2003, CARCINOGENESIS, V24, P497, DOI 10.1093/carcin/24.3.497; Zhang YS, 2001, CARCINOGENESIS, V22, P425, DOI 10.1093/carcin/22.3.425; ZHANG YS, 1992, P NATL ACAD SCI USA, V89, P2399, DOI 10.1073/pnas.89.6.2399; Zhang YS, 2002, BIOCHEM J, V364, P301, DOI 10.1042/bj3640301; Zhang YS, 2000, CARCINOGENESIS, V21, P1175, DOI 10.1093/carcin/21.6.1175	60	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35267	10.1371/journal.pone.0035267	http://dx.doi.org/10.1371/journal.pone.0035267			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22539965	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341000029
J	Garcia, MP; Cavalheiro, JRT; Fernandes, MH				Garcia, Monica Pereira; Tinoco Cavalheiro, Jose Roberto; Fernandes, Maria Helena			Acute and Long-Term Effects of Hyperthermia in B16-F10 Melanoma Cells	PLOS ONE			English	Article							MAGNETITE CATIONIC LIPOSOMES; INTRACELLULAR HYPERTHERMIA; HEAT-TREATMENT; APOPTOSIS; INDUCTION; DIFFERENTIATION; IMMUNOTHERAPY; REGRESSION; RADIATION; PROTEINS	Objective: Hyperthermia uses exogenous heat induction as a cancer therapy. This work addresses the acute and long-term effects of hyperthermia in the highly metastatic melanoma cell line B16-F10. Materials and Methods: Melanoma cells were submitted to one heat treatment, 45 degrees C for 30 min, and thereafter were kept at 37 degrees C for an additional period of 14 days. Cultures maintained at 37 degrees C were used as control. Cultures were assessed for the heat shock reaction. Results: Immediately after the heat shock, cells began a process of fast degradation, and, in the first 24 h, cultures showed decreased viability, alterations in cell morphology and F-actin cytoskeleton organization, significant reduction in the number of adherent cells, most of them in a process of late apoptosis, and an altered gene expression profile. A follow-up of two weeks after heat exposure showed that viability and number of adherent cells remained very low, with a high percentage of early apoptotic cells. Still, heat-treated cultures maintained a low but relatively constant population of cells in S and G(2)/M phases for a long period after heat exposure, evidencing the presence of metabolically active cells. Conclusion: The melanoma cell line B16-F10 is susceptible to one hyperthermia treatment at 45 degrees C, with significant induced acute and long-term effects. However, a low but apparently stable percentage of metabolically active cells survived long after heat exposure.	[Garcia, Monica Pereira; Fernandes, Maria Helena] Univ Porto FMDUP, Lab Farmacol & Biocompatibilidade Celular, Fac Med Dent, Oporto, Portugal; [Tinoco Cavalheiro, Jose Roberto] Univ Porto, Inst Engn Biomed INEB, P-4100 Oporto, Portugal	Universidade do Porto; Universidade do Porto	Fernandes, MH (corresponding author), Univ Porto FMDUP, Lab Farmacol & Biocompatibilidade Celular, Fac Med Dent, Oporto, Portugal.	mhfernandes@fmd.up.pt	Garcia, Mónica Pereira/L-5488-2014; Fernandes, Maria Helena/K-6917-2014	Garcia, Mónica Pereira/0000-0002-8097-3114; Fernandes, Maria Helena/0000-0001-9391-9574	Project FCT [PTDC/SAU-BEB/69497/2006]; Faculty of Dental Medicine, University of Porto, Portugal	Project FCT(Portuguese Foundation for Science and Technology); Faculty of Dental Medicine, University of Porto, Portugal	This work was supported by Project FCT: PTDC/SAU-BEB/69497/2006 ("Hyperthermia treatment of experimental melanoma using a ferromagnetic cement") and Faculty of Dental Medicine, University of Porto, Portugal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aydin IT, 2012, PIGM CELL MELANOMA R, V25, P37, DOI 10.1111/j.1755-148X.2011.00910.x; Babsky A, 2005, INT J HYPERTHER, V21, P141, DOI 10.1080/02656730400023656; Brehmer M, 2000, BJU INT, V85, P535, DOI 10.1046/j.1464-410x.2000.00473.x; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Flanagan SW, 1998, FEBS LETT, V431, P285, DOI 10.1016/S0014-5793(98)00779-0; Fukao H, 2000, CLIN CHIM ACTA, V296, P17, DOI 10.1016/S0009-8981(00)00198-4; Goding CR, 2011, ONCOGENE, V30, P2304, DOI 10.1038/onc.2010.641; Grasso S, 2003, EXP BIOL MED, V228, P491, DOI 10.1177/15353702-0322805-12; Halliwell B, 1996, ANNU REV NUTR, V16, P33, DOI 10.1146/annurev.nu.16.070196.000341; Hildebrandt B, 2002, CRIT REV ONCOL HEMAT, V43, P33, DOI 10.1016/S1040-8428(01)00179-2; Ito A, 2003, J BIOSCI BIOENG, V96, P364, DOI 10.1263/jbb.96.364; Ito A, 2003, CANCER SCI, V94, P308, DOI 10.1111/j.1349-7006.2003.tb01438.x; Kanamori M, 2003, CANCER DETECT PREV, V27, P76, DOI 10.1016/S0361-090X(02)00178-2; Kawai N, 2005, PROSTATE, V64, P373, DOI 10.1002/pros.20253; LEGRAND C, 1992, J BIOTECHNOL, V25, P231, DOI 10.1016/0168-1656(92)90158-6; Manjili MH, 2002, INT J HYPERTHER, V18, P506, DOI 10.1080/02656730110116696; Matsuoka Fumiko, 2004, Biomagn Res Technol, V2, P3, DOI 10.1186/1477-044X-2-3; Medic S, 2007, PIGM CELL RES, V20, P80, DOI 10.1111/j.1600-0749.2006.00356.x; Milani V, 2005, INT IMMUNOL, V17, P257, DOI 10.1093/intimm/dxh203; Morgan DM, 1997, METHOD MOL BIOL, P179; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Motoyama Jun, 2008, Biomagn Res Technol, V6, P2, DOI 10.1186/1477-044X-6-2; Nakayama J, 1996, PIGM CELL RES, V9, P154, DOI 10.1111/j.1600-0749.1996.tb00104.x; Nijhuis EHA, 2008, INT J HYPERTHER, V24, P357, DOI 10.1080/02656730801944914; Nijhuis EHA, 2008, INT J RADIAT BIOL, V84, P99, DOI 10.1080/09553000701817084; Nijhuis EHA, 2006, INT J HYPERTHER, V22, P687, DOI 10.1080/02656730601045409; OliveiraFilho RS, 1997, BRAZ J MED BIOL RES, V30, P941, DOI 10.1590/S0100-879X1997000800005; Poon IKH, 2010, CELL DEATH DIFFER, V17, P381, DOI 10.1038/cdd.2009.195; Rong Y, 2000, INT J HYPERTHER, V16, P19, DOI 10.1080/026567300285394; Schmitt E, 2007, J LEUKOCYTE BIOL, V81, P15, DOI 10.1189/jlb.0306167; Sharif-Khatibi L, 2007, INT J HYPERTHER, V23, P645, DOI 10.1080/02656730701769833; Shinkai M, 1999, J MAGN MAGN MATER, V194, P176, DOI 10.1016/S0304-8853(98)00586-1; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Slominski A, 2009, EXP DERMATOL, V18, P760, DOI 10.1111/j.1600-0625.2009.00892.x; Suzuki M, 2003, MELANOMA RES, V13, P129, DOI 10.1097/00008390-200304000-00004; Thannickal VJ, 2000, AM J PHYSIOL-LUNG C, V279, pL1005; van der Zee J, 2002, ANN ONCOL, V13, P1173, DOI 10.1093/annonc/mdf280; Van Dyke T, 2007, NEW ENGL J MED, V356, P79, DOI 10.1056/NEJMcibr066301; Vertrees RA, 2007, CURR CLIN ONCOL, P71, DOI 10.1007/978-1-59745-195-6_6; Vorotnikova E, 2006, INT J RADIAT BIOL, V82, P549, DOI 10.1080/09553000600876678; Yanase M, 1998, JPN J CANCER RES, V89, P463, DOI 10.1111/j.1349-7006.1998.tb00586.x; Yanase M, 1998, JPN J CANCER RES, V89, P775, DOI 10.1111/j.1349-7006.1998.tb03283.x; Yonezawa M, 1996, INT J CANCER, V66, P347; Zhou M, 2007, INT J HYPERTHER, V23, P225, DOI 10.1080/02656730701295441; Zimmermann KC, 2001, J ALLERGY CLIN IMMUN, V108, pS99, DOI 10.1067/mai.2001.117819	45	17	17	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35489	10.1371/journal.pone.0035489	http://dx.doi.org/10.1371/journal.pone.0035489			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22532856	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339200070
J	Liu, Y; Hei, Y; Shu, QM; Dong, J; Gao, YP; Fu, HJ; Zheng, XF; Yang, G				Liu, Yu; Hei, Yan; Shu, Qingming; Dong, Jie; Gao, Yaping; Fu, Hanjiang; Zheng, Xiaofei; Yang, Guang			VCP/p97, Down-Regulated by microRNA-129-5p, Could Regulate the Progression of Hepatocellular Carcinoma	PLOS ONE			English	Article							VALOSIN-CONTAINING-PROTEIN; NF-KAPPA-B; ELEVATED EXPRESSION; INDUCED APOPTOSIS; CANCER; P97; PROGNOSIS; ATPASE; CELLS; LIVER	Valosin containing protein (VCP)/p97 plays various important roles in cells. Moreover, elevated expression of VCP in hepatocellular carcinoma (HCC) is correlated with increased incidence of recurrence. But the role of VCP in HCC progression in vitro and in vivo is unclear. And there are few reports about the regulation mechanism on the expression of VCP in HCC. In this study, it was identified that the level of VCP was frequently increased in human HCC tissues. In addition, down-regulation of VCP with siRNAs could dramatically suppress the genesis and progression of tumor in vivo. It was found that miR-129-5p directly inhibited the expression of VCP in several HCC cell lines. Meanwhile, the level of VCP in HCC tissues was negatively associated with the level of miR-129-5p. Our further investigation showed that the enhanced expression of miR-129-5p also suppressed tumor growth in vivo. Moreover, it was revealed that miR-129-5p could inhibit the degradation of I kappa B alpha and increase the apoptosis and reduce the migration of HCC cells by suppressing the expression of VCP. Our results revealed that the expression of VCP was directly regulated by miR-129-5p and this regulation played an important role in the progression of HCC.	[Liu, Yu; Dong, Jie; Gao, Yaping; Yang, Guang] Beijing Inst Basic Med Sci, Beijing, Peoples R China; [Hei, Yan; Shu, Qingming] Peoples Armed Police Corps Gen Hosp, Beijing, Peoples R China; [Fu, Hanjiang; Zheng, Xiaofei] Beijing Inst Radiat Med, Beijing, Peoples R China	Academy of Military Medical Sciences - China; Academy of Military Medical Sciences - China	Yang, G (corresponding author), Beijing Inst Basic Med Sci, Beijing, Peoples R China.	yanggg@hotmail.com		Fu, Hanjiang/0000-0002-4352-1178	Chinese National Key Program on Basic Research [2010CB529101, 2010CB912801]	Chinese National Key Program on Basic Research	This work was supported by grants from the Chinese National Key Program on Basic Research (2010CB529101, 2010CB912801). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2008, J CELL BIOCHEM, V105, P1461, DOI 10.1002/jcb.21966; Asai T, 2002, JPN J CANCER RES, V93, P296, DOI 10.1111/j.1349-7006.2002.tb02172.x; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Dai RM, 2001, NAT CELL BIOL, V3, P740, DOI 10.1038/35087056; Dai RM, 1998, J BIOL CHEM, V273, P3562, DOI 10.1074/jbc.273.6.3562; Du B, 1999, Pathol Oncol Res, V5, P214, DOI 10.1053/paor.1999.0217; Fornari F, 2008, ONCOGENE, V27, P5651, DOI 10.1038/onc.2008.178; Garzon R, 2006, TRENDS MOL MED, V12, P580, DOI 10.1016/j.molmed.2006.10.006; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hetzer M, 2001, NAT CELL BIOL, V3, P1086, DOI 10.1038/ncb1201-1086; Hou J, 2011, CANCER CELL, V19, P232, DOI 10.1016/j.ccr.2011.01.001; Huang YW, 2009, CANCER RES, V69, P9038, DOI 10.1158/0008-5472.CAN-09-1499; Ji JF, 2009, NEW ENGL J MED, V361, P1437, DOI 10.1056/NEJMoa0901282; Krajewska M, 1996, AM J PATHOL, V148, P1567; Lee TKW, 2011, HEPATOLOGY, V53, P160, DOI 10.1002/hep.24000; Li S, 2009, HEPATOLOGY, V49, P1194, DOI 10.1002/hep.22757; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Qiu Y, 2007, AM J PATHOL, V170, P152, DOI 10.2353/ajpath.2007.060722; RABOUILLE C, 1995, CELL, V82, P905, DOI 10.1016/0092-8674(95)90270-8; Schulze-Bergkamen H, 2004, SEMIN ONCOL, V31, P90, DOI 10.1053/j.seminoncol.2003.11.006; Stehlik C, 1998, J EXP MED, V188, P211, DOI 10.1084/jem.188.1.211; Su H, 2009, CANCER RES, V69, P1135, DOI 10.1158/0008-5472.CAN-08-2886; Tsujimoto Y, 2004, CLIN CANCER RES, V10, P3007, DOI 10.1158/1078-0432.CCR-03-0191; Wang Y, 2008, J BIOL CHEM, V283, P13205, DOI 10.1074/jbc.M707629200; Wong QWL, 2008, GASTROENTEROLOGY, V135, P257, DOI 10.1053/j.gastro.2008.04.003; Wu JJ, 2010, CELL CYCLE, V9, P1809, DOI 10.4161/cc.9.9.11535; Xiong YJ, 2010, HEPATOLOGY, V51, P836, DOI 10.1002/hep.23380; Yamamoto S, 2004, CLIN CANCER RES, V10, P5558, DOI 10.1158/1078-0432.CCR-0723-03; Yamamoto S, 2004, ANN ONCOL, V15, P1432, DOI 10.1093/annonc/mdh354; Yamamoto S, 2004, CLIN CANCER RES, V10, P651, DOI 10.1158/1078-0432.CCR-1576-03; Yamamoto S, 2003, J CLIN ONCOL, V21, P447, DOI 10.1200/JCO.2003.06.068; Yu MC, 2000, CAN J GASTROENTEROL, V14, P703, DOI 10.1155/2000/371801; Zeng CX, 2010, HEPATOLOGY, V52, P1702, DOI 10.1002/hep.23875	34	75	80	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35800	10.1371/journal.pone.0035800	http://dx.doi.org/10.1371/journal.pone.0035800			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536440	Green Published, gold, Green Submitted			2022-12-27	WOS:000305339200113
J	Maravelias, CD; Tserpes, G; Pantazi, M; Peristeraki, P				Maravelias, Christos D.; Tserpes, George; Pantazi, Maria; Peristeraki, Panagiota			Habitat Selection and Temporal Abundance Fluctuations of Demersal Cartilaginous Species in the Aegean Sea (Eastern Mediterranean)	PLOS ONE			English	Article							TRENDS; SHARKS; FISH	Predicting the occurrence of keystone top predators in a multispecies marine environment, such as the Mediterranean Sea, can be of considerable value to the long-term sustainable development of the fishing industry and to the protection of biodiversity. We analysed fisheries independent scientific bottom trawl survey data of two of the most abundant cartilaginous fish species (Scyliorhinus canicula, Raja clavata) in the Aegean Sea covering an 11-year sampling period. The current findings revealed a declining trend in R. clavata and S. canicula abundance from the late '90 s until 2004. Habitats with the higher probability of finding cartilaginous fish present were those located in intermediate waters (depth: 200-400 m). The present results also indicated a preferential species' clustering in specific geographic and bathymetric regions of the Aegean Sea. Depth appeared to be one of the key determining factors for the selection of habitats for all species examined. With cartilaginous fish species being among the more biologically sensitive fish species taken in European marine fisheries, our findings, which are based on a standardized scientific survey, can contribute to the rational exploitation and management of their stocks by providing important information on temporal abundance trends and habitat preferences.	[Maravelias, Christos D.; Pantazi, Maria] Hellen Ctr Marine Res, Anavyssos, Attica, Greece; [Tserpes, George; Peristeraki, Panagiota] Hellen Ctr Marine Res, Iraklion, Crete, Greece	Hellenic Centre for Marine Research; Hellenic Centre for Marine Research	Maravelias, CD (corresponding author), Hellen Ctr Marine Res, Anavyssos, Attica, Greece.	cmaravel@hcmr.gr	Tserpes, George/L-6201-2013; Maravelias, Christos/W-4151-2019	Tserpes, George/0000-0001-9052-4091; Maravelias, Christos/0000-0002-2440-3707				Aldebert Y, 1997, VIE MILIEU, V47, P275; [Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], 2000, BIOL MAR MEDITERR; Baino Romano, 2001, Rapport du Congress de la CIESM, V36, P234; Bertrand JA, 2002, SCI MAR, V66, P9, DOI 10.3989/scimar.2002.66s29; Damalas D, 2011, FISH RES, V108, P142, DOI 10.1016/j.fishres.2010.12.012; Damalas D, 2010, ESTUAR COAST SHELF S, V89, P107, DOI 10.1016/j.ecss.2010.06.002; Davis J.C., 1986, STAT DATA ANAL GEOLO; FAO, 1995, FAD FISHERIES TECHNI, V350, P52; Ferretti F., 2005, ICES 2005 ANN SCI C; Ferretti F, 2008, CONSERV BIOL, V22, P952, DOI 10.1111/j.1523-1739.2008.00938.x; Ferretti F, 2010, ECOL LETT, V13, P1055, DOI 10.1111/j.1461-0248.2010.01489.x; Fowler SL, 2005, SHARKS RAYS CHIMAERA; GoldenSoftware, 2002, SURF VERS 8; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Maravelias CD, 1997, MAR ECOL PROG SER, V159, P151, DOI 10.3354/meps159151; Relini G., 2000, Biologia Marina Mediterranea, V7, P347; Serena F, 2005, 1 INT S MAN BIOL DOG; Stevens JD, 2000, ICES J MAR SCI, V57, P476, DOI 10.1006/jmsc.2000.0724; Tserpes G, 2002, SCI MAR, V66, P243, DOI 10.3989/scimar.2002.66s2243; Walker P, 2005, SHARKS RAYS CHIMAERA, P86; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Wood SN, 2000, J ROY STAT SOC B, V62, P413, DOI 10.1111/1467-9868.00240; [No title captured]; [No title captured]	25	26	27	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35474	10.1371/journal.pone.0035474	http://dx.doi.org/10.1371/journal.pone.0035474			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536389	Green Published, gold, Green Submitted			2022-12-27	WOS:000305339200069
J	Vaz, MCM; Rocha-Santos, TAP; Rocha, RJM; Lopes, I; Pereira, R; Duarte, AC; Rubec, PJ; Calado, R				Vaz, Marcela C. M.; Rocha-Santos, Teresa A. P.; Rocha, Rui J. M.; Lopes, Isabel; Pereira, Ruth; Duarte, Armando C.; Rubec, Peter J.; Calado, Ricardo			Excreted Thiocyanate Detects Live Reef Fishes Illegally Collected Using Cyanide-A Non-Invasive and Non-Destructive Testing Approach	PLOS ONE			English	Article							RAINBOW-TROUT; EXTINCTION; CORALS	Cyanide fishing is a method employed to capture marine fish alive on coral reefs. They are shipped to markets for human consumption in Southeast Asia, as well as to supply the marine aquarium trade worldwide. Although several techniques can be used to detect cyanide in reef fish, there is still no testing method that can be used to survey the whole supply chain. Most methods for cyanide detection are time-consuming and require the sacrifice of the sampled fish. Thiocyanate anion (SCN-) is a metabolite produced by the main metabolic pathway for cyanide anion (CN-) detoxification. Our study employed an optical fiber (OF) methodology (analytical time <6 min) to detect SCN- in a non-invasive and non-destructive manner. Our OF methodology is able to detect trace levels (>3.16 mu g L-1) of SCN- in seawater. Given that marine fish exposed to cyanide excrete SCN- in the urine, elevated levels of SCN- present in the seawater holding live reef fish indicate that the surveyed specimens were likely exposed to cyanide. In our study, captive-bred clownfish (Amphiprion clarkii) pulse exposed for 60 s to either 12.5 or 25 mg L-1 of CN- excreted up to 6.96 +/- 0.03 and 9.84 +/- 0.03 mu g L-1 of SCN-, respectively, during the 28 days following exposure. No detectable levels of SCN- were recorded in the water holding control organisms not exposed to CN-, or in synthetic seawater lacking fish. While further research is necessary, our methodology allow a rapid detection of SCN- in the holding water and can be used as a screening tool to indicate if live reef fish were collected with cyanide.	[Vaz, Marcela C. M.; Rocha, Rui J. M.; Lopes, Isabel; Pereira, Ruth; Calado, Ricardo] Univ Aveiro, Dept Biol, P-3800 Aveiro, Portugal; [Vaz, Marcela C. M.; Rocha-Santos, Teresa A. P.; Rocha, Rui J. M.; Lopes, Isabel; Pereira, Ruth; Duarte, Armando C.; Calado, Ricardo] Univ Aveiro, CESAM, P-3800 Aveiro, Portugal; [Rocha-Santos, Teresa A. P.; Duarte, Armando C.] Univ Aveiro, Dept Quim, P-3800 Aveiro, Portugal; [Rocha-Santos, Teresa A. P.] Inst Piaget, ISEIT Viseu, Lordosa, Viseu, Portugal; [Rubec, Peter J.] Int Marinelife Alliance, St Petersburg, FL USA	Universidade de Aveiro; Universidade de Aveiro; Universidade de Aveiro	Calado, R (corresponding author), Univ Aveiro, Dept Biol, Campus Univ Santiago, P-3800 Aveiro, Portugal.	rjcalado@hotmail.com	Rocha, Rui/AAP-9828-2021; Pereira, Ruth/AAY-3535-2021; Rocha, Rui Miranda/F-5201-2011; Rocha-Santos, Teresa/A-2355-2009; Calado, Ricardo Jorge Guerra/C-7035-2008; Duarte, Armando/C-1424-2008; Lopes, Isabel/C-2858-2009	Rocha, Rui/0000-0002-4385-6074; Pereira, Ruth/0000-0001-6857-5968; Rocha, Rui Miranda/0000-0002-4385-6074; Rocha-Santos, Teresa/0000-0003-3660-4116; Calado, Ricardo Jorge Guerra/0000-0002-1670-9335; Duarte, Armando/0000-0002-4868-4099; Lopes, Isabel/0000-0002-9325-0329	Portuguese Science Foundation (FCT, Portugal) [SFRH/BD/46675/2008, SFRH/BPD/65410/2009]; Programa Ciencia (FCT, FSE and POPH); CESAM, University of Aveiro	Portuguese Science Foundation (FCT, Portugal)(Portuguese Foundation for Science and Technology); Programa Ciencia (FCT, FSE and POPH); CESAM, University of Aveiro	This work has been developed under the scope of the Portuguese Science Foundation (FCT, Portugal) research grants SFRH/BD/46675/2008 (to RJMR) and SFRH/BPD/65410/2009 (to TAPR-S), as well as Programa Ciencia 2007 (funded by FCT, FSE and POPH) (to IL, RP and RC). The research performed was partly financed by a starting grant of CESAM, University of Aveiro (to RC). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Baghshani H, 2010, COMP CLIN PATHOL, P1; Barber C.V., 1997, SULLIED SEAS STRATEG; BROWN DG, 1995, ECOTOX ENVIRON SAFE, V30, P302, DOI 10.1006/eesa.1995.1034; Bruckner A. W., 2008, P INT CYAN DET TEST; Burke L., 2011, REEFS RISK REVISITED; Cervino JM, 2003, MAR POLLUT BULL, V46, P573, DOI 10.1016/S0025-326X(03)00071-7; Cinner JE, 2009, CURR BIOL, V19, P206, DOI 10.1016/j.cub.2008.11.055; Cooper WJ, 2009, MOL PHYLOGENET EVOL, V52, P1, DOI 10.1016/j.ympev.2008.12.010; Derivera CE, 2007, MAR BIOL, V150, P1275, DOI 10.1007/s00227-006-0451-9; DIXON DG, 1981, ARCH ENVIRON CON TOX, V10, P117, DOI 10.1007/BF01057580; DonMcAllister E., 1999, SECRETARIAT PACIFIC, V5, P18; Evans DH, 2006, PHYSL FISHES; Fabinyi M, 2011, MAR POLICY, V35, P371, DOI 10.1016/j.marpol.2010.11.001; Hanawa M., 1998, Aquarium Sciences and Conservation, V2, P21, DOI 10.1007/BF00466403; Isom GE, 2010, COMPREHENSIVE TOXICOLOGY, VOL 4: BIOTRANSFORMATION, 2ND EDITION, P485; Jackson JBC, 2008, P NATL ACAD SCI USA, V105, P11458, DOI 10.1073/pnas.0802812105; Jones RJ, 1999, MAR ECOL PROG SER, V177, P83, DOI 10.3354/meps177083; Jones RJ, 1997, MAR FRESHWATER RES, V48, P517, DOI 10.1071/MF97048; Lanno RP, 1996, AQUAT TOXICOL, V36, P177, DOI 10.1016/S0166-445X(96)00815-6; Leduc G., 1984, AQUAT TOXICOL, V2, P153; Logue BA, 2010, CRIT REV ANAL CHEM, V40, P122, DOI 10.1080/10408340903535315; Ma JA, 2010, ANAL CHIM ACTA, V673, P117, DOI 10.1016/j.aca.2010.05.042; Mak KKW, 2005, BIOSENS BIOELECTRON, V20, P2581, DOI 10.1016/j.bios.2004.09.015; Mak KKW, 2005, MICROCHIM ACTA, V149, P131, DOI 10.1007/s00604-004-0286-3; Moorhead JA, 2010, REV FISH SCI, V18, P315, DOI 10.1080/10641262.2010.516035; Munday PL, 2004, GLOBAL CHANGE BIOL, V10, P1642, DOI 10.1111/j.1365-2486.2004.00839.x; Olivotto I, 2011, J WORLD AQUACULT SOC, V42, P135, DOI 10.1111/j.1749-7345.2011.00453.x; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Pet J., 1998, SPC LIVE REEF FISH I, V4, P17; RAYMOND P, 1986, CAN J FISH AQUAT SCI, V43, P2017, DOI 10.1139/f86-247; Reopanichkul P, 2009, MAR POLLUT BULL, V58, P1356, DOI 10.1016/j.marpolbul.2009.04.024; Riegl B, 2009, ANN NY ACAD SCI, V1162, P136, DOI 10.1111/j.1749-6632.2009.04493.x; Riepen, 1995, ENV EC SOCIAL IMPLIC; Rubec P. J., 2001, AQUARIUM SCI CONSERV, V3, P37, DOI DOI 10.1023/A:1011370106291; Rubec PJ, 2003, MARINE ORNAMENTAL SPECIES: COLLECTION, CULTURE & CONSERVATION, P327; Rubec PJ, 2008, P INT CYAN DET TEST, P43; Sadovy YJ, 2003, WHILE STOCKS LAST LI; Silva LIB, 2011, J ENVIRON MONITOR, V13, P1811, DOI 10.1039/c1em10043b; Varsamos S, 2005, COMP BIOCHEM PHYS A, V141, P401, DOI 10.1016/j.cbpb.2005.01.013; Wabnitz C, 2003, OCEAN AQUARIUM; Zar JH, 1999, BIOSTATISTICAL ANAL	41	15	15	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35355	10.1371/journal.pone.0035355	http://dx.doi.org/10.1371/journal.pone.0035355			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536375	gold, Green Published, Green Submitted			2022-12-27	WOS:000305339200060
J	Gaj, P; Maryan, N; Hennig, EE; Ledwon, JK; Paziewska, A; Majewska, A; Karczmarski, J; Nesteruk, M; Wolski, J; Antoniewicz, AA; Przytulski, K; Rutkowski, A; Teumer, A; Homuth, G; Starzynska, T; Regula, J; Ostrowski, J				Gaj, Pawel; Maryan, Natalia; Hennig, Ewa E.; Ledwon, Joanna K.; Paziewska, Agnieszka; Majewska, Aneta; Karczmarski, Jakub; Nesteruk, Monika; Wolski, Jan; Antoniewicz, Artur A.; Przytulski, Krzysztof; Rutkowski, Andrzej; Teumer, Alexander; Homuth, Georg; Starzynska, Teresa; Regula, Jaroslaw; Ostrowski, Jerzy			Pooled Sample-Based GWAS: A Cost-Effective Alternative for Identifying Colorectal and Prostate Cancer Risk Variants in the Polish Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; COMMON GENETIC-VARIANTS; SUSCEPTIBILITY LOCI; CHROMOSOME 8Q24; MULTIPLE LOCI; HIDDEN HERITABILITY; EARLY-ONSET; IDENTIFICATION; SNPS; MEN	Background: Prostate cancer (PCa) and colorectal cancer (CRC) are the most commonly diagnosed cancers and cancer-related causes of death in Poland. To date, numerous single nucleotide polymorphisms (SNPs) associated with susceptibility to both cancer types have been identified, but their effect on disease risk may differ among populations. Methods: To identify new SNPs associated with PCa and CRC in the Polish population, a genome-wide association study (GWAS) was performed using DNA sample pools on Affymetrix Genome-Wide Human SNP 6.0 arrays. A total of 135 PCa patients and 270 healthy men (PCa sub-study) and 525 patients with adenoma (AD), 630 patients with CRC and 690 controls (AD/CRC sub-study) were included in the analysis. Allele frequency distributions were compared with t-tests and chi(2)-tests. Only those significantly associated SNPs with a proxy SNP (p<0.001; distance of 100 kb; r(2)>0.7) were selected. GWAS marker selection was conducted using PLINK. The study was replicated using extended cohorts of patients and controls. The association with previously reported PCa and CRC susceptibility variants was also examined. Individual patients were genotyped using TaqMan SNP Genotyping Assays. Results: The GWAS selected six and 24 new candidate SNPs associated with PCa and CRC susceptibility, respectively. In the replication study, 17 of these associations were confirmed as significant in additive model of inheritance. Seven of them remained significant after correction for multiple hypothesis testing. Additionally, 17 previously reported risk variants have been identified, five of which remained significant after correction. Conclusion: Pooled-DNA GWAS enabled the identification of new susceptibility loci for CRC in the Polish population. Previously reported CRC and PCa predisposition variants were also identified, validating the global nature of their associations. Further independent replication studies are required to confirm significance of the newly uncovered candidate susceptibility loci.	[Gaj, Pawel; Maryan, Natalia; Hennig, Ewa E.; Ledwon, Joanna K.; Paziewska, Agnieszka; Majewska, Aneta; Nesteruk, Monika; Przytulski, Krzysztof; Regula, Jaroslaw; Ostrowski, Jerzy] Med Ctr Postgrad Educ, Dept Gastroenterol & Hepatol, Warsaw, Poland; [Hennig, Ewa E.; Karczmarski, Jakub; Przytulski, Krzysztof; Regula, Jaroslaw; Ostrowski, Jerzy] Maria Sklodowska Curie Mem Canc Ctr, Dept Oncol Genet, Warsaw, Poland; [Hennig, Ewa E.; Karczmarski, Jakub; Wolski, Jan; Przytulski, Krzysztof; Rutkowski, Andrzej; Regula, Jaroslaw; Ostrowski, Jerzy] Inst Oncol, Warsaw, Poland; [Wolski, Jan] Maria Sklodowska Curie Mem Canc Ctr, Dept Urol, Warsaw, Poland; [Antoniewicz, Artur A.] Med Ctr Postgrad Educ, Dept Urol, Warsaw, Poland; [Rutkowski, Andrzej] Maria Sklodowska Curie Mem Canc Ctr, Dept Colorectal Canc, Warsaw, Poland; [Teumer, Alexander; Homuth, Georg] Ernst Moritz Arndt Univ Greifswald, Interfac Inst Genet & Funct Genom, Greifswald, Germany; [Starzynska, Teresa] Pomeranian Med Univ, Dept Gastroenterol, Szczecin, Poland	Centre of Postgraduate Medical Education - Poland; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; Centre of Postgraduate Medical Education - Poland; Maria Sklodowska-Curie National Research Institute of Oncology; Ernst Moritz Arndt Universitat Greifswald; Pomeranian Medical University	Gaj, P (corresponding author), Med Ctr Postgrad Educ, Dept Gastroenterol & Hepatol, Warsaw, Poland.	jostrow@warman.com.pl	Teumer, Alexander/S-7438-2019; Ledwon, Joanna/GSD-2218-2022; Starzynska, Teresa/B-1549-2015; Ledwon, Joanna/AAH-9521-2021; Hennig, Ewa E/N-6459-2013	Teumer, Alexander/0000-0002-8309-094X; Starzynska, Teresa/0000-0001-5573-2397; Ledwon, Joanna/0000-0001-8047-4334; Hennig, Ewa E/0000-0002-6388-2237; Regula, Jaroslaw/0000-0001-7071-3151; Ostrowski, Jerzy/0000-0003-1363-3766; , Andrzej/0000-0002-9009-9475; Karczmarski, Jakub/0000-0002-7976-0365; Paziewska, Agnieszka/0000-0002-6644-1509	Polish Ministry of Science and Higher Education [PBZ-MNiSW-05/I/2007/01]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This work was supported by a PBZ-MNiSW-05/I/2007/01 grant from the Polish Ministry of Science and Higher Education (http://www.nauka.gov.pl/home/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affymetrix Inc., 2005, AFF GENECHIP GEN AN; Al Olama AA, 2009, NAT GENET, V41, P1058, DOI 10.1038/ng.452; Barratt BJ, 2002, ANN HUM GENET, V66, P393, DOI [10.1046/j.1469-1809.2002.00125.x, 10.1017/S0003480002001252]; Barrett JC, 2006, NAT GENET, V38, P659, DOI 10.1038/ng1801; Baye TM, 2009, PERS MED, V6, P623, DOI 10.2217/PME.09.54; Beebe-Dimmer JL, 2008, INT J CANCER, V122, P2876, DOI 10.1002/ijc.23471; Broderick P, 2007, NAT GENET, V39, P1315, DOI 10.1038/ng.2007.18; Cal S, 2002, GENE, V283, P49, DOI 10.1016/S0378-1119(01)00861-7; Chang BL, 2011, CANCER EPIDEM BIOMAR, V20, P23, DOI 10.1158/1055-9965.EPI-10-0698; Craig DW, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-138; Curtin K, 2009, CANCER EPIDEM BIOMAR, V18, P616, DOI 10.1158/1055-9965.EPI-08-0690; DUPONT WD, 1990, CONTROL CLIN TRIALS, V11, P116, DOI 10.1016/0197-2456(90)90005-M; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Edwards SM, 2003, AM J HUM GENET, V72, P1, DOI 10.1086/345310; Eeles RA, 2008, NAT GENET, V40, P316, DOI 10.1038/ng.90; Eeles RA, 2009, NAT GENET, V41, P1116, DOI 10.1038/ng.450; FitzGerald LM, 2009, CLIN CANCER RES, V15, P3231, DOI 10.1158/1078-0432.CCR-08-2190; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gao JF, 2007, SCAND J GASTROENTERO, V42, P345, DOI 10.1080/00365520600880856; Ghoussaini M, 2008, JNCI-J NATL CANCER I, V100, P962, DOI 10.1093/jnci/djn190; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gibson G, 2010, NAT GENET, V42, P558, DOI 10.1038/ng0710-558; Gudmundsson J, 2009, NAT GENET, V41, P1122, DOI 10.1038/ng.448; Guo FJ, 2010, PATHOL ONCOL RES, V16, P319, DOI 10.1007/s12253-009-9226-1; Haerian MS, 2011, J GASTROEN HEPATOL, V26, P1475, DOI 10.1111/j.1440-1746.2011.06831.x; Haiman CA, 2007, NAT GENET, V39, P954, DOI 10.1038/ng2098; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; Hakonarson H, 2011, ANN MED, V43, P451, DOI 10.3109/07853890.2011.573803; He J, 2011, CANCER EPIDEM BIOMAR, V20, P70, DOI 10.1158/1055-9965.EPI-10-0892; Houlston RS, 2010, NAT GENET, V42, P973, DOI 10.1038/ng.670; Houlston RS, 2008, NAT GENET, V40, P1426, DOI 10.1038/ng.262; Huang SP, 2009, CANCER EPIDEM BIOMAR, V18, P3068, DOI 10.1158/1055-9965.EPI-09-0665; Imamura M, 2011, ENDOCR J, V58, P723, DOI 10.1507/endocrj.EJ11-0113; Jaeger E, 2008, NAT GENET, V40, P26, DOI 10.1038/ng.2007.41; John U, 2001, SOZ PRAVENTIV MED, V46, P186, DOI 10.1007/BF01324255; Jostins L, 2011, HUM MOL GENET, V20, pR182, DOI 10.1093/hmg/ddr378; Kaklamani VG, 2008, JAMA-J AM MED ASSOC, V300, P1523, DOI 10.1001/jama.300.13.1523; Kiemeney LA, 2008, NAT GENET, V40, P1307, DOI 10.1038/ng.229; Kim ST, 2010, PROSTATE, V70, P1729, DOI 10.1002/pros.21208; Kraft P, 2009, STAT SCI, V24, P561, DOI 10.1214/09-STS290; Ku CS, 2010, J HUM GENET, V55, P195, DOI 10.1038/jhg.2010.19; Kupfer SS, 2010, GASTROENTEROLOGY, V139, P1677, DOI 10.1053/j.gastro.2010.07.038; Liao LH, 2007, CLIN CHIM ACTA, V380, P191, DOI 10.1016/j.cca.2007.02.033; Liu QR, 2005, P NATL ACAD SCI USA, V102, P11864, DOI 10.1073/pnas.0500329102; Macgregor S, 2007, EUR J HUM GENET, V15, P501, DOI 10.1038/sj.ejhg.5201768; Meaburn E, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj027; Montpetit A, 2006, PLOS GENET, V2, P282, DOI 10.1371/journal.pgen.0020027; Ostrowski J, 2009, EXPERT REV MOL DIAGN, V9, P623, DOI 10.1586/ERM.09.41; Osumi D, 2009, CANCER SCI, V100, P888, DOI 10.1111/j.1349-7006.2009.01125.x; Pal P, 2009, PROSTATE, V69, P1548, DOI 10.1002/pros.20999; Park JH, 2010, NAT GENET, V42, P570, DOI 10.1038/ng.610; Perez-Losada J, 2011, INTEGR BIOL-UK, V3, P316, DOI 10.1039/c0ib00094a; Peters U, 2012, HUM GENET, V131, P217, DOI 10.1007/s00439-011-1055-0; Pinho SS, 2011, CELL MOL LIFE SCI, V68, P1011, DOI 10.1007/s00018-010-0595-0; Prokunina-Olsson L, 2010, CANCER EPIDEM BIOMAR, V19, P1349, DOI 10.1158/1055-9965.EPI-09-1181; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Regula J, 2006, NEW ENGL J MED, V355, P1863, DOI 10.1056/NEJMoa054967; Regula J, 2010, BEST PRACT RES CL GA, V24, P407, DOI 10.1016/j.bpg.2010.06.007; Rivas MA, 2011, NAT GENET, V43, P1066, DOI 10.1038/ng.952; Salinas CA, 2009, PROSTATE, V69, P363, DOI 10.1002/pros.20887; Senchenko VN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015612; Slattery ML, 2012, INT J CANCER, V130, P653, DOI 10.1002/ijc.26047; Solovieff N, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-108; Takata R, 2010, NAT GENET, V42, P751, DOI 10.1038/ng.635; Tenesa A, 2008, NAT GENET, V40, P631, DOI 10.1038/ng.133; Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91; Thompson CL, 2009, CARCINOGENESIS, V30, P982, DOI 10.1093/carcin/bgp086; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; Tomlinson IPM, 2008, NAT GENET, V40, P623, DOI 10.1038/ng.111; Tomlinson IPM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002105; Tsilidis KK, 2009, CANCER CAUSE CONTROL, V20, P1739, DOI 10.1007/s10552-009-9427-7; Volzke H, 2011, INT J EPIDEMIOL, V40, P294, DOI 10.1093/ije/dyp394; von Holst S, 2010, BRIT J CANCER, V103, P575, DOI 10.1038/sj.bjc.6605774; Wang LL, 2011, GENOMICS, V98, P1, DOI 10.1016/j.ygeno.2011.04.006; Waters KM, 2009, CANCER EPIDEM BIOMAR, V18, P1285, DOI 10.1158/1055-9965.EPI-08-1142; Wiedl T, 2011, J PROTEOMICS, V74, P1884, DOI 10.1016/j.jprot.2011.04.030; Williams SM, 2011, ANN HUM GENET, V75, P348, DOI 10.1111/j.1469-1809.2011.00640.x; Wojciechowska U, 2010, CANC POLAND 2008, P1; Wokolorczyk D, 2009, JNCI-J NATL CANCER I, V101, DOI 10.1093/jnci/djn472; Wokolorczyk D, 2010, EUR J CANCER PREV, V19, P167, DOI 10.1097/CEJ.0b013e32832945c3; Wokolorczyk D, 2008, CANCER RES, V68, P9982, DOI 10.1158/0008-5472.CAN-08-1838; Yamada H, 2009, JNCI-J NATL CANCER I, V101, P1330, DOI 10.1093/jnci/djp287; Yeager M, 2008, HUM GENET, V124, P161, DOI 10.1007/s00439-008-0535-3; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Yeager M, 2009, NAT GENET, V41, P1055, DOI 10.1038/ng.444; YUAN M, 1987, J NATL CANCER I, V78, P479; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089; Zheng SL, 2008, NEW ENGL J MED, V358, P910, DOI 10.1056/NEJMoa075819; Zheng SL, 2010, PROSTATE, V70, P425, DOI 10.1002/pros.21076	90	30	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e35307	10.1371/journal.pone.0035307	http://dx.doi.org/10.1371/journal.pone.0035307			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22532847	gold, Green Published, Green Submitted			2022-12-27	WOS:000305336200033
J	Chang, YJ; Huang, YP; Li, ZL; Chen, CH				Chang, Yu-Jia; Huang, Yi-Ping; Li, Zih-Ling; Chen, Ching-Hsein			GRP78 Knockdown Enhances Apoptosis via the Down-Regulation of Oxidative Stress and Akt Pathway after Epirubicin Treatment in Colon Cancer DLD-1 Cells	PLOS ONE			English	Article							PI3K/AKT SIGNALING PATHWAY; UNFOLDED-PROTEIN RESPONSE; MAPK PATHWAY; SURVIVAL; INHIBITION; RESISTANCE; ACTIVATION; INDUCTION; TOXICITY; THERAPY	Introduction: The 78-kDa glucose-regulated protein (GRP78) is induced in the cancer microenvironment and can be considered as a novel predictor of responsiveness to chemotherapy in many cancers. In this study, we found that intracellular reactive oxygen species (ROS) and nuclear factor erythroid 2-related factor 2 (Nrf2) nuclear translocation were higher in GRP78 knockdown DLD-1 colon cancer cells compared with scrambled control cells. Methodology/Principal Findings: Treatment with epirubicin in GRP78 knockdown DLD-1 cells enhanced apoptosis and was associated with decreased production of intracellular ROS. In addition, apoptosis was increased by the antioxidants propyl gallate (PG) and dithiothreitol (DTT) in epirubicin-treated scrambled control cells. Epirubicin-treated GRP78 knockdown cells resulted in more inactivated Akt pathway members, such as phosphorylated Akt and GSK-3 beta, as well as downstream targets of beta-catenin expression. Knockdown of Nrf2 with small interfering RNA (siRNA) increased apoptosis in epirubicin-treated GRP78 knockdown cells, which suggested that Nrf2 may be a primary defense mechanism in GRP78 knockdown cells. We also demonstrated that epirubicin-treated GRP78 knockdown cells could decrease survival pathway signaling through the redox activation of protein phosphatase 2A (PP2A), which is a serine/threonine phosphatase that negatively regulates the Akt pathway. Conclusions: Our results indicate that epirubicin decreased the intracellular ROS in GRP78 knockdown cells, which decreased survival signaling through both the Akt pathway and the activation of PP2A. Together, these mechanisms contributed to the enhanced level of epirubicin-induced apoptosis that was observed in the GRP78 knockdown cells.	[Chang, Yu-Jia] Taipei Med Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan; [Chang, Yu-Jia] Taipei Med Univ, Coll Med, Dept Surg, Taipei, Taiwan; [Chang, Yu-Jia] Taipei Med Univ Hosp, Dept Surg, Taipei, Taiwan; [Chang, Yu-Jia] Taipei Med Univ Hosp, Canc Res Ctr, Taipei, Taiwan; [Huang, Yi-Ping; Li, Zih-Ling; Chen, Ching-Hsein] Natl Chiayi Univ, Coll Life Sci, Dept Microbiol Immunol & Biopharmaceut, Chiayi, Taiwan	Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University Hospital; National Chiayi University	Chang, YJ (corresponding author), Taipei Med Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan.	chench@mail.ncyu.edu.tw		Chang, Yu-Jia/0000-0003-3978-3244	National Science Council, Taiwan [NSC 99-2320-B-415-002-MY3]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by National Science Council, Taiwan (NSC 99-2320-B-415-002-MY3; National Science Council's Web site: http://web1.nsc.gov.tw/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afanas'ev I, 2011, AGING DIS, V2, P219; Akhdar H, 2009, EUR J CANCER, V45, P2219, DOI 10.1016/j.ejca.2009.05.017; Arafa ESA, 2009, CANCER RES, V69, P8910, DOI 10.1158/0008-5472.CAN-09-1543; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Chen L, 2008, FREE RADICAL BIO MED, V45, P1035, DOI 10.1016/j.freeradbiomed.2008.07.011; Chen L, 2009, INT J BIOCHEM CELL B, V41, P1284, DOI 10.1016/j.biocel.2008.10.029; Chiou JF, 2010, ANN SURG ONCOL, V17, P603, DOI 10.1245/s10434-009-0718-8; Clerkin JS, 2008, CANCER LETT, V266, P30, DOI 10.1016/j.canlet.2008.02.029; Conklin KA, 2000, NUTR CANCER, V37, P1, DOI 10.1207/S15327914NC3701_1; Cullinan SB, 2003, MOL CELL BIOL, V23, P7198, DOI 10.1128/MCB.23.20.7198-7209.2003; DeGracia DJ, 2002, J CEREBR BLOOD F MET, V22, P127, DOI 10.1097/00004647-200202000-00001; Ermakova SP, 2006, CANCER RES, V66, P9260, DOI 10.1158/0008-5472.CAN-06-1586; Falasca M, 2010, CURR PHARM DESIGN, V16, P1410, DOI 10.2174/138161210791033950; HOLDENER EE, 1985, INVEST NEW DRUG, V3, P63; HORTOBAGYI GN, 1989, AM J CLIN ONCOL-CANC, V12, P57, DOI 10.1097/00000421-198902000-00014; Kebieche M, 2009, EXP TOXICOL PATHOL, V61, P161, DOI 10.1016/j.etp.2008.06.002; Langer R, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-70; Li JZ, 2006, CURR MOL MED, V6, P45, DOI 10.2174/156652406775574523; Lin YD, 2011, LUNG CANCER, V71, P291, DOI 10.1016/j.lungcan.2010.06.004; Lister A, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-37; Lucke JF, 1996, ANN EMERG MED, V28, P408, DOI 10.1016/S0196-0644(96)70006-9; Mhaidat N., 2011, INT J BIOL BIOMED EN, V5, P41; Misra UK, 2006, J BIOL CHEM, V281, P13694, DOI 10.1074/jbc.M511694200; Naughton R, 2009, LEUKEMIA, V23, P1432, DOI 10.1038/leu.2009.49; Niture SK, 2010, TOXICOL APPL PHARM, V244, P37, DOI 10.1016/j.taap.2009.06.009; Ozkan A, 2004, POL J PHARMACOL, V56, P435; Rushworth Stuart A, 2011, Cancers (Basel), V3, P1605, DOI 10.3390/cancers3021605; Sowinski S, 2008, NAT CELL BIOL, V10, P211, DOI 10.1038/ncb1682; Toker A, 2006, CANCER RES, V66, P3963, DOI 10.1158/0008-5472.CAN-06-0743; Tousoulis Dimitris, 2011, Recent Pat Cardiovasc Drug Discov, V6, P103; Vara JAF, 2004, CANCER TREAT REV, V30, P193, DOI 10.1016/j.ctrv.2003.07.007; Wang SK, 2008, P NATL ACAD SCI USA, V105, P3690, DOI 10.1073/pnas.0712326105; Wendel HG, 2004, NATURE, V428, P332, DOI 10.1038/nature02369; Xing XM, 2011, ACTA HISTOCHEM, V113, P777, DOI 10.1016/j.acthis.2010.11.006; Zhang LH, 2011, BRAIN RES, V1371, P23, DOI 10.1016/j.brainres.2010.11.063	35	12	13	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35123	10.1371/journal.pone.0035123	http://dx.doi.org/10.1371/journal.pone.0035123			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529978	Green Submitted, gold, Green Published			2022-12-27	WOS:000305350600058
J	He, LJ; Serrano, C; Niphadkar, N; Shobnam, N; Hristova, K				He, Lijuan; Serrano, Christopher; Niphadkar, Nitish; Shobnam, Nadia; Hristova, Kalina			Effect of the G375C and G346E Achondroplasia Mutations on FGFR3 Activation	PLOS ONE			English	Article							RECEPTOR TYROSINE KINASES; GROWTH-FACTOR RECEPTOR-3; TRANSMEMBRANE DOMAIN; THANATOPHORIC DYSPLASIA; SKELETAL DYSPLASIAS; SIGNAL-TRANSDUCTION; MUENKE CRANIOSYNOSTOSIS; ACANTHOSIS NIGRICANS; CROUZON-SYNDROME; DOWN-REGULATION	Two mutations in FGFR3, G380R and G375C are known to cause achondroplasia, the most common form of human dwarfism. The G380R mutation accounts for 98% of the achondroplasia cases, and thus has been studied extensively. Here we study the effect of the G375C mutation on the phosphorylation and the cross-linking propensity of full-length FGFR3 in HEK 293 cells, and we compare the results to previously published results for the G380R mutant. We observe identical behavior of the two achondroplasia mutants in these experiments, a finding which supports a direct link between the severity of dwarfism phenotypes and the level and mechanism of FGFR3 over-activation. The mutations do not increase the cross-linking propensity of FGFR3, contrary to previous expectations that the achondroplasia mutations stabilize the FGFR3 dimers. Instead, the phosphorylation efficiency within un-liganded FGFR3 dimers is increased, and this increase is likely the underlying cause for pathogenesis in achondroplasia. We further investigate the G346E mutation, which has been reported to cause achondroplasia in one case. We find that this mutation does not increase FGFR3 phosphorylation and decreases FGFR3 cross-linking propensity, a finding which raises questions whether this mutation is indeed a genetic cause for human dwarfism.	[He, Lijuan; Serrano, Christopher; Niphadkar, Nitish; Shobnam, Nadia; Hristova, Kalina] Johns Hopkins Univ, Dept Mat Sci & Engn, Baltimore, MD 21218 USA	Johns Hopkins University	He, LJ (corresponding author), Johns Hopkins Univ, Dept Mat Sci & Engn, Baltimore, MD 21218 USA.	kh@jhu.edu	Hristova, Kalina/A-3326-2010		National Institutes of Health [GM68619]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068619] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health GM68619. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adar R, 2002, J BONE MINER RES, V17, P860, DOI 10.1359/jbmr.2002.17.5.860; Bellus GA, 2000, AM J HUM GENET, V67, P1411, DOI 10.1086/316892; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Bonaventure J, 2007, FEBS J, V274, P3078, DOI 10.1111/j.1742-4658.2007.05835.x; Browne BC, 2009, CURR CANCER DRUG TAR, V9, P419, DOI 10.2174/156800909788166484; Brunelleschi S, 2002, CURR PHARM DESIGN, V8, P1959, DOI 10.2174/1381612023393530; Casteran N, 2003, ONCOGENE, V22, P4710, DOI 10.1038/sj.onc.1206587; Chen FH, 2011, BIOCHEMISTRY-US, V50, P8576, DOI 10.1021/bi200986f; Chen FH, 2011, BBA-BIOMEMBRANES, V1808, P2045, DOI 10.1016/j.bbamem.2011.04.007; Cho JY, 2004, P NATL ACAD SCI USA, V101, P609, DOI 10.1073/pnas.2237184100; Choi SH, 2007, ONCOGENE, V26, P1567, DOI 10.1038/sj.onc.1209957; Cohen MM, 2006, AM J MED GENET A, V140A, P2646, DOI 10.1002/ajmg.a.31368; Cohen MM, 2002, AM J MED GENET, V112, P304, DOI 10.1002/ajmg.10780; Cohen MM, 1998, INT J ORAL MAX SURG, V27, P451, DOI 10.1016/S0901-5027(98)80036-2; Cohen MM, 1997, PEDIATR RADIOL, V27, P442, DOI 10.1007/s002470050165; FANTL WJ, 1993, ANNU REV BIOCHEM, V62, P453, DOI 10.1146/annurev.bi.62.070193.002321; Han X, 2006, BIOPHYS J, V91, P3736, DOI 10.1529/biophysj.106.092247; Harada D, 2009, J BONE MINER METAB, V27, P9, DOI 10.1007/s00774-008-0009-7; He LJ, 2011, J BIOL CHEM, V286, P13272, DOI 10.1074/jbc.M110.205583; He LJ, 2011, BBA-BIOMEMBRANES, V1808, P253, DOI 10.1016/j.bbamem.2010.08.007; He LJ, 2010, J BIOL CHEM, V285, P30103, DOI 10.1074/jbc.M109.094086; He LJ, 2008, J MOL BIOL, V384, P1130, DOI 10.1016/j.jmb.2008.10.036; Horton WA, 2007, LANCET, V370, P162, DOI 10.1016/S0140-6736(07)61090-3; Hubbard SR, 2007, CURR OPIN CELL BIOL, V19, P117, DOI 10.1016/j.ceb.2007.02.010; Ibrahimi OA, 2004, HUM MOL GENET, V13, P69, DOI 10.1093/hmg/ddh011; Li E, 2006, J MOL BIOL, V356, P600, DOI 10.1016/j.jmb.2005.11.077; Li E, 2006, BIOCHEMISTRY-US, V45, P6241, DOI 10.1021/bi060609y; MEYERS GA, 1995, NAT GENET, V11, P462, DOI 10.1038/ng1295-462; Mohammadi M, 1996, MOL CELL BIOL, V16, P977; Monsonego-Ornan E, 2000, MOL CELL BIOL, V20, P516, DOI 10.1128/MCB.20.2.516-522.2000; Monsonego-Ornan E, 2002, FEBS LETT, V528, P83, DOI 10.1016/S0014-5793(02)03255-6; Naski MC, 1996, NAT GENET, V13, P233, DOI 10.1038/ng0696-233; PARK WJ, 1995, AM J HUM GENET, V57, P748; Passos-Bueno MR, 1999, HUM MUTAT, V14, P115; Plotnikov AN, 1999, CELL, V98, P641, DOI 10.1016/S0092-8674(00)80051-3; PONSETI IV, 1970, J BONE JOINT SURG AM, VA 52, P701, DOI 10.2106/00004623-197052040-00004; PRINOS P, 1995, PEDIATR RES, V37, pA151; Robertson SC, 2000, TRENDS GENET, V16, P265, DOI 10.1016/S0168-9525(00)02021-7; Rump P, 2006, AM J MED GENET A, V140A, P284, DOI 10.1002/ajmg.a.31084; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; SHIANG R, 1994, CELL, V78, P335, DOI 10.1016/0092-8674(94)90302-6; Vajo Z, 2000, ENDOCR REV, V21, P23, DOI 10.1210/er.21.1.23; VANDERGEER P, 1994, ANNU REV CELL BIOL, V10, P251, DOI 10.1146/annurev.cellbio.10.1.251; Webster MK, 1996, EMBO J, V15, P520, DOI 10.1002/j.1460-2075.1996.tb00384.x; Webster MK, 1997, TRENDS GENET, V13, P178, DOI 10.1016/S0168-9525(97)01131-1; WEINER DB, 1989, NATURE, V339, P230, DOI 10.1038/339230a0; You M, 2007, BIOCHEMISTRY-US, V46, P11039, DOI 10.1021/bi700986n	47	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e34808	10.1371/journal.pone.0034808	http://dx.doi.org/10.1371/journal.pone.0034808			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529939	Green Published, Green Submitted, gold			2022-12-27	WOS:000305350600030
J	Kim, RS; Avivar-Valderas, A; Estrada, Y; Bragado, P; Sosa, MS; Aguirre-Ghiso, JA; Segall, JE				Kim, Ryung S.; Avivar-Valderas, Alvaro; Estrada, Yeriel; Bragado, Paloma; Sosa, Maria Soledad; Aguirre-Ghiso, Julio A.; Segall, Jeffrey E.			Dormancy Signatures and Metastasis in Estrogen Receptor Positive and Negative Breast Cancer	PLOS ONE			English	Article							CELL-LINES; EXPRESSION; THERAPY	Breast cancers can recur after removal of the primary tumor and treatment to eliminate remaining tumor cells. Recurrence may occur after long periods of time during which there are no clinical symptoms. Tumor cell dormancy may explain these prolonged periods of asymptomatic residual disease and treatment resistance. We generated a dormancy gene signature from published experimental models and applied it to both breast cancer cell line expression data as well as four published clinical studies of primary breast cancers. We found that estrogen receptor (ER) positive breast cell lines and primary tumors have significantly higher dormancy signature scores (P<0.0000001) than ER-cell lines and tumors. In addition, a stratified analysis combining all ER+ tumors in four studies indicated 2.1 times higher hazard of recurrence among patients whose tumors had low dormancy scores (LDS) compared to those whose tumors had high dormancy scores (HDS) (p<0.000005). The trend was shown in all four individual studies. Suppression of two dormancy genes, BHLHE41 and NR2F1, resulted in increased in vivo growth of ER positive MCF7 cells. The patient data analysis suggests that disseminated ER positive tumor cells carrying a dormancy signature are more likely to undergo prolonged dormancy before resuming metastatic growth. Furthermore, genes identified with this approach might provide insight into the mechanisms of dormancy onset and maintenance as well as dormancy models using human breast cancer cell lines.	[Kim, Ryung S.] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA; [Avivar-Valderas, Alvaro; Estrada, Yeriel; Bragado, Paloma; Sosa, Maria Soledad; Aguirre-Ghiso, Julio A.] Mt Sinai Sch Med, Tisch Canc Inst, Dept Med, Div Hematol & Oncol, New York, NY USA; [Avivar-Valderas, Alvaro; Estrada, Yeriel; Bragado, Paloma; Sosa, Maria Soledad; Aguirre-Ghiso, Julio A.] Mt Sinai Sch Med, Tisch Canc Inst, Dept Otolaryngol, New York, NY USA; [Segall, Jeffrey E.] Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10467 USA; [Segall, Jeffrey E.] Albert Einstein Coll Med, Gruss Lipper Biophoton Ctr, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Kim, RS (corresponding author), Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA.	julio.aguirre-ghiso@mssm.edu; jeffrey.segall@einstein.yu.edu	Bragado Domingo, Paloma/A-8679-2015	Bragado Domingo, Paloma/0000-0002-7642-1245; Aguirre-Ghiso, Julio/0000-0002-6694-6507	Samuel Waxman Cancer Research Foundation Tumor Dormancy Program; United States National Institutes of Health/National Cancer Institute [CA109182, CA163131, 5P30CA013330-37, 1UL1RR025750-0, CA77522, CA1000324]; NIEHS [ES017146]; NYSTEM; NATIONAL CANCER INSTITUTE [P30CA013330, U54CA163131, R01CA109182, R01CA077522] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025750] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES017146] Funding Source: NIH RePORTER	Samuel Waxman Cancer Research Foundation Tumor Dormancy Program; United States National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NYSTEM; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work is supported by grants from the Samuel Waxman Cancer Research Foundation Tumor Dormancy Program (J.A.A.-G), United States National Institutes of Health/National Cancer Institute (CA109182 and CA163131 to J.A.A.-G, 5P30CA013330-37 to R. K., 1UL1RR025750-0 to R. K., CA77522 and CA1000324 to J.E.S.), NIEHS (ES017146) and NYSTEM to J.A.A.-G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Adam AP, 2009, CANCER RES, V69, P5664, DOI 10.1158/0008-5472.CAN-08-3820; Adorno M, 2009, CELL, V137, P87, DOI 10.1016/j.cell.2009.01.039; Aguirre-Ghiso JA, 2007, NAT REV CANCER, V7, P834, DOI 10.1038/nrc2256; Almog N, 2009, CANCER RES, V69, P836, DOI 10.1158/0008-5472.CAN-08-2590; ANDERSEN PK, 1982, ANN STAT, V10, P1100, DOI 10.1214/aos/1176345976; Ben T, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2904; Hollander M., 1973, NONPARAMETRIC STAT M; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Klopp AH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012180; Li C., 2003, ANAL GENE EXPRESSION, P120; Loi S, 2007, J CLIN ONCOL, V25, P1239, DOI 10.1200/JCO.2006.07.1522; McGillicuddy FC, 2006, VASC PHARMACOL, V44, P469, DOI 10.1016/j.vph.2006.03.002; Muller V, 2005, CLIN CANCER RES, V11, P3678, DOI 10.1158/1078-0432.CCR-04-2469; Naumov GN, 2003, BREAST CANCER RES TR, V82, P199, DOI 10.1023/B:BREA.0000004377.12288.3c; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Pantel K, 2004, NAT REV CANCER, V4, P448, DOI 10.1038/nrc1370; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; Takekawa M, 2002, EMBO J, V21, P6473, DOI 10.1093/emboj/cdf643; Team RDC, 2009, R LANG ENV STAT COMP; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Vessella RL, 2007, CANC BIOL THER, P6; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1	23	122	123	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35569	10.1371/journal.pone.0035569	http://dx.doi.org/10.1371/journal.pone.0035569			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22530051	Green Submitted, Green Published, gold			2022-12-27	WOS:000305350600099
J	Menzies, BR; Renfree, MB; Heider, T; Mayer, F; Hildebrandt, TB; Pask, AJ				Menzies, Brandon R.; Renfree, Marilyn B.; Heider, Thomas; Mayer, Frieder; Hildebrandt, Thomas B.; Pask, Andrew J.			Limited Genetic Diversity Preceded Extinction of the Tasmanian Tiger	PLOS ONE			English	Article							POPULATION-STRUCTURE	The Tasmanian tiger or thylacine was the largest carnivorous marsupial when Europeans first reached Australia. Sadly, the last known thylacine died in captivity in 1936. A recent analysis of the genome of the closely related and extant Tasmanian devil demonstrated limited genetic diversity between individuals. While a similar lack of diversity has been reported for the thylacine, this analysis was based on just two individuals. Here we report the sequencing of an additional 12 museum-archived specimens collected between 102 and 159 years ago. We examined a portion of the mitochondrial DNA hypervariable control region and determined that all sequences were on average 99.5% identical at the nucleotide level. As a measure of accuracy we also sequenced mitochondrial DNA from a mother and two offspring. As expected, these samples were found to be 100% identical, validating our methods. We also used 454 sequencing to reconstruct 2.1 kilobases of the mitochondrial genome, which shared 99.91% identity with the two complete thylacine mitochondrial genomes published previously. Our thylacine genomic data also contained three highly divergent putative nuclear mitochondrial sequences, which grouped phylogenetically with the published thylacine mitochondrial homologs but contained 100-fold more polymorphisms than the conserved fragments. Together, our data suggest that the thylacine population in Tasmania had limited genetic diversity prior to its extinction, possibly as a result of their geographic isolation from mainland Australia approximately 10,000 years ago.	[Menzies, Brandon R.; Hildebrandt, Thomas B.] Leibniz Inst Zoo & Wildlife Res, Berlin, Germany; [Menzies, Brandon R.; Renfree, Marilyn B.] Univ Melbourne, Dept Zool, Royal Parade, Vic, Australia; [Heider, Thomas; Pask, Andrew J.] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT USA; [Mayer, Frieder] Berlin Museum Nat Kunde, Leibniz Inst Evolut & Biodivers Forsch, Berlin, Germany	Leibniz Institut fur Zoo und Wildtierforschung; University of Melbourne; University of Connecticut; Leibniz Institut fur Evolutions und Biodiversitatsforschung	Menzies, BR (corresponding author), Leibniz Inst Zoo & Wildlife Res, Berlin, Germany.	menzies@izw-berlin.de	Menzies, Brandon/K-8538-2012	Renfree, Marilyn/0000-0002-4589-0436; Pask, Andrew/0000-0002-1900-2263; Menzies, Brandon/0000-0002-1897-0115	Humboldt Research fellowship	Humboldt Research fellowship(Alexander von Humboldt Foundation)	This study was funded by a Humboldt Research fellowship awarded to BRM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bensasson D, 2001, TRENDS ECOL EVOL, V16, P314, DOI 10.1016/S0169-5347(01)02151-6; Dixon J.M., 1989, P549; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Guiler K. R., 1961, Australian Journal of Science, V23, P207; Hansen BD, 2009, MOL ECOL, V18, P3346, DOI 10.1111/j.1365-294X.2009.04269.x; Jones ME, 2004, MOL ECOL, V13, P2197, DOI 10.1111/j.1365-294X.2004.02239.x; Kolokotronis SO, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-67; Krajewski C, 1997, P ROY SOC B-BIOL SCI, V264, P911, DOI 10.1098/rspb.1997.0126; Leonard JA, 2005, MOL ECOL, V14, P9, DOI 10.1111/j.1365-294X.2004.02389.x; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Luo ZX, 2011, NATURE, V476, P442, DOI 10.1038/nature10291; Miller W, 2011, P NATL ACAD SCI USA, V108, P12348, DOI 10.1073/pnas.1102838108; Miller W, 2009, GENOME RES, V19, P213, DOI 10.1101/gr.082628.108; PAABO S, 1988, NUCLEIC ACIDS RES, V16, P9775, DOI 10.1093/nar/16.20.9775; Paddle R., 2000, LAST TASMANIAN TIGER; Pask AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002240; Savolainen P, 2004, P NATL ACAD SCI USA, V101, P12387, DOI 10.1073/pnas.0401814101; Siddle HV, 2007, P NATL ACAD SCI USA, V104, P16221, DOI 10.1073/pnas.0704580104; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vila C, 1997, SCIENCE, V276, P1687, DOI 10.1126/science.276.5319.1687	21	18	18	1	119	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35433	10.1371/journal.pone.0035433	http://dx.doi.org/10.1371/journal.pone.0035433			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22530022	gold, Green Published			2022-12-27	WOS:000305350600082
J	Patouraux, S; Bonnafous, S; Voican, CS; Anty, R; Saint-Paul, MC; Rosenthal-Allieri, MA; Agostini, H; Njike, M; Barri-Ova, N; Naveau, S; Le Marchand-Brustel, Y; Veillon, P; Cales, P; Perlemuter, G; Tran, A; Gual, P				Patouraux, Stephanie; Bonnafous, Stephanie; Voican, Cosmin S.; Anty, Rodolphe; Saint-Paul, Marie-Christine; Rosenthal-Allieri, Maria-Alessandra; Agostini, Helene; Njike, Micheline; Barri-Ova, Nadege; Naveau, Sylvie; Le Marchand-Brustel, Yannick; Veillon, Pascal; Cales, Paul; Perlemuter, Gabriel; Tran, Albert; Gual, Philippe			The Osteopontin Level in Liver, Adipose Tissue and Serum Is Correlated with Fibrosis in Patients with Alcoholic Liver Disease	PLOS ONE			English	Article							NONALCOHOLIC STEATOHEPATITIS; HEPATOCELLULAR-CARCINOMA; NEUTROPHIL INFILTRATION; INSULIN-RESISTANCE; GENE-EXPRESSION; STELLATE CELLS; RODENT MODEL; MICE; HEPATITIS; OBESITY	Background: Osteopontin (OPN) plays an important role in the progression of chronic liver diseases. We aimed to quantify the liver, adipose tissue and serum levels of OPN in heavy alcohol drinkers and to compare them with the histological severity of hepatic inflammation and fibrosis. Methodology/Principal Findings: OPN was evaluated in the serum of a retrospective and prospective group of 109 and 95 heavy alcohol drinkers, respectively, in the liver of 34 patients from the retrospective group, and in the liver and adipose tissue from an additional group of 38 heavy alcohol drinkers. Serum levels of OPN increased slightly with hepatic inflammation and progressively with the severity of hepatic fibrosis. Hepatic OPN expression correlated with hepatic inflammation, fibrosis, TGF beta expression, neutrophils accumulation and with the serum OPN level. Interestingly, adipose tissue OPN expression also correlated with hepatic fibrosis even after 7 days of alcohol abstinence. The elevated serum OPN level was an independent risk factor in estimating significant (F >= 2) fibrosis in a model combining alkaline phosphatase, albumin, hemoglobin, OPN and FibroMeter (R) levels. OPN had an area under the receiving operator curve that estimated significant fibrosis of 0.89 and 0.88 in the retrospective and prospective groups, respectively. OPN, Hyaluronate (AUROC: 0.88), total Cytokeratin 18 (AUROC: 0.83) and FibroMeter (R) (AUROC: 0.90) estimated significance to the same extent in the retrospective group. Finally, the serum OPN levels also correlated with hepatic fibrosis and estimated significant (F >= 2) fibrosis in 86 patients with chronic hepatitis C, which suggested that its elevated level could be a general response to chronic liver injury. Conclusion/Significance: OPN increased in the liver, adipose tissue and serum with liver fibrosis in alcoholic patients. Further, OPN is a new relevant biomarker for significant liver fibrosis. OPN could thus be an important actor in the pathogenesis of this chronic liver disease.	[Patouraux, Stephanie; Bonnafous, Stephanie; Anty, Rodolphe; Saint-Paul, Marie-Christine; Le Marchand-Brustel, Yannick; Tran, Albert; Gual, Philippe] INSERM, U1065, Equipe Complicat Hepat Obesite 8, Nice, France; [Patouraux, Stephanie; Anty, Rodolphe; Saint-Paul, Marie-Christine; Le Marchand-Brustel, Yannick; Tran, Albert; Gual, Philippe] Univ Nice Sophia Antipolis, Fac Med, Nice, France; [Patouraux, Stephanie; Saint-Paul, Marie-Christine] Ctr Hosp Univ Nice, Hop Archet, Dept Biol, Nice, France; [Bonnafous, Stephanie; Anty, Rodolphe; Le Marchand-Brustel, Yannick; Tran, Albert; Gual, Philippe] Ctr Hosp Univ Nice, Hop Archet, Dept Digest, Nice, France; [Voican, Cosmin S.; Agostini, Helene; Njike, Micheline; Barri-Ova, Nadege; Naveau, Sylvie; Perlemuter, Gabriel] INSERM, U996, IPSIT, Clamart, France; [Voican, Cosmin S.; Agostini, Helene; Njike, Micheline; Barri-Ova, Nadege; Naveau, Sylvie; Perlemuter, Gabriel] Univ Paris Sud, Fac Med Paris Sud, Le Kremlin Bicetre, France; [Agostini, Helene; Njike, Micheline; Barri-Ova, Nadege; Naveau, Sylvie; Perlemuter, Gabriel] AP HP, Hop Antoine Beclere, Serv Hepatogastroenterol, Clamart, France; [Saint-Paul, Marie-Christine] Ctr Hosp Univ Nice, Hop Archet, Dept Immunol, Nice, France; [Veillon, Pascal; Cales, Paul] Ctr Hosp Univ Angers, Serv Hepatol, Angers, France; [Voican, Cosmin S.] Univ Med & Farm Craiova, Craiova, Romania	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; CHU Nice; CHU Nice; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP; CHU Nice; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; University of Medicine & Pharmacy of Craiova	Patouraux, S (corresponding author), INSERM, U1065, Equipe Complicat Hepat Obesite 8, Nice, France.	gual@unice.fr	Gual, Philippe/M-8787-2017; CALES, Paul/AFN-9693-2022; Gual, Philippe/P-9833-2019	Gual, Philippe/0000-0001-7393-8356; CALES, Paul/0000-0003-4866-5274; Gual, Philippe/0000-0001-7393-8356; Albert, TRAN/0000-0003-0003-5361; Anty, Rodolphe/0000-0001-8194-9805; Anty, Rodolphe/0000-0002-8053-1957; patouraux, stephanie/0000-0001-6004-7685	Institut National de la Sante et de la Recherche Medicale (France); University of Nice; Programme Hospitalier de Recherche Clinique (Centre Hospitalier Universitaire de Nice); AFEF/Schering-Plough; AFEF/ROCHE; Fondation Recherche Medicale; Centre Hospitalier Universitaire de Nice	Institut National de la Sante et de la Recherche Medicale (France)(Institut National de la Sante et de la Recherche Medicale (Inserm)); University of Nice; Programme Hospitalier de Recherche Clinique (Centre Hospitalier Universitaire de Nice); AFEF/Schering-Plough(Merck & CompanySchering Plough Corporation); AFEF/ROCHE(Roche Holding); Fondation Recherche Medicale; Centre Hospitalier Universitaire de Nice	This work was supported by grants from the Institut National de la Sante et de la Recherche Medicale (France), the University of Nice, the Programme Hospitalier de Recherche Clinique (Centre Hospitalier Universitaire de Nice), and charities (AFEF/Schering-Plough and AFEF/ROCHE to PG and AT). SP was supported by the Fondation Recherche Medicale. PG is the recipient of an Interface Grant from Centre Hospitalier Universitaire de Nice. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apte UM, 2005, TOXICOL APPL PHARM, V207, P25, DOI 10.1016/j.taap.2004.12.018; Baneijee A, 2008, TOXICOL APPL PHARM, V233, P238, DOI 10.1016/j.taap.2008.08.008; Banerjee A, 2006, J PATHOL, V208, P473, DOI 10.1002/path.1917; Banerjee A, 2006, TOXICOL PATHOL, V34, P373, DOI 10.1080/01926230600806543; Bataller R, 2011, BEST PRACT RES CL GA, V25, P231, DOI 10.1016/j.bpg.2011.02.010; BEDOSSA P, 1994, HEPATOLOGY, V20, P15; Bertola A, 2009, DIABETES, V58, P125, DOI 10.2337/db08-0400; Bertola A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013577; Cales P, 2005, HEPATOLOGY, V42, P1373, DOI 10.1002/hep.20935; De Minicis S, 2007, GASTROENTEROLOGY, V132, P1937, DOI 10.1053/j.gastro.2007.02.033; Diao HY, 2004, IMMUNITY, V21, P539, DOI 10.1016/j.immuni.2004.08.012; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Gao B, 2011, GASTROENTEROLOGY, V141, P1572, DOI 10.1053/j.gastro.2011.09.002; Huang WB, 2010, CLIN CHIM ACTA, V411, P675, DOI 10.1016/j.cca.2010.01.029; Kawashima R, 1999, BIOCHEM BIOPH RES CO, V256, P527, DOI 10.1006/bbrc.1999.0372; Kiefer FW, 2011, DIABETOLOGIA, V54, P2132, DOI 10.1007/s00125-011-2170-0; Kiefer FW, 2010, DIABETES, V59, P935, DOI 10.2337/db09-0404; Koh A, 2007, IMMUNOLOGY, V122, P466, DOI 10.1111/j.1365-2567.2007.02682.x; Kon S, 2008, J EXP MED, V205, P25, DOI 10.1084/jem.20071324; Lavallard VJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017599; Lee SH, 2004, BIOCHEM PHARMACOL, V68, P2367, DOI 10.1016/j.bcp.2004.08.022; Lenga Y, 2008, CIRC RES, V102, P319, DOI 10.1161/CIRCRESAHA.107.160408; Lorena D, 2006, J HEPATOL, V44, P383, DOI 10.1016/j.jhep.2005.07.024; Lucey MR, 2009, NEW ENGL J MED, V360, P2758, DOI 10.1056/NEJMra0805786; Manning DS, 2008, GASTROENTEROLOGY, V134, P1670, DOI 10.1053/j.gastro.2008.03.001; Mimura S, 2004, J GASTROENTEROL, V39, P867, DOI 10.1007/s00535-004-1403-0; Naveau S, 1997, HEPATOLOGY, V25, P108, DOI 10.1002/hep.510250120; Naveau S, 2010, J HEPATOL, V52, P895, DOI 10.1016/j.jhep.2010.01.029; Naveau S, 2009, HEPATOLOGY, V49, P97, DOI 10.1002/hep.22576; Naveau S, 2009, ALCOHOL CLIN EXP RES, V33, P1104, DOI 10.1111/j.1530-0277.2009.00932.x; Nguyen-Khac E, 2008, ALIMENT PHARM THER, V28, P1188, DOI 10.1111/j.1365-2036.2008.03831.x; Nomiyama T, 2007, J CLIN INVEST, V117, P2877, DOI 10.1172/JCI31986; Orrego H, 1987, GASTROENTEROLOGY, V92, P208, DOI 10.1016/0016-5085(87)90861-4; Ramaiah SK, 2008, TOXICOL SCI, V103, P4, DOI 10.1093/toxsci/kfm246; Raynard B, 2002, HEPATOLOGY, V35, P635, DOI 10.1053/jhep.2002.31782; Rockey DC, 2009, HEPATOLOGY, V49, P1017, DOI 10.1002/hep.22742; Sahai A, 2004, AM J PHYSIOL-GASTR L, V287, pG264, DOI 10.1152/ajpgi.00002.2004; Sahai A, 2004, AM J PHYSIOL-GASTR L, V287, pG1035, DOI 10.1152/ajpgi.00199.2004; Seth' D, 2006, J HEPATOL, V45, P306, DOI 10.1016/j.jhep.2006.04.013; Sun BS, 2008, HEPATOLOGY, V48, P1834, DOI 10.1002/hep.22531; Syn WK, 2011, HEPATOLOGY, V53, P106, DOI 10.1002/hep.23998; Tran A, 2000, EUR J GASTROEN HEPAT, V12, P989, DOI 10.1097/00042737-200012090-00004; Tran A, 2000, GASTROEN CLIN BIOL, V24, P626; Zhao J, 2008, GASTROENTEROLOGY, V135, P956, DOI 10.1053/j.gastro.2008.05.025; Zhao L, 2008, INT J CLIN PRACT, V62, P1056, DOI 10.1111/j.1742-1241.2007.01368.x	45	62	67	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35612	10.1371/journal.pone.0035612	http://dx.doi.org/10.1371/journal.pone.0035612			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22530059	Green Published, gold			2022-12-27	WOS:000305350600105
J	van der Meij, L; Almela, M; Hidalgo, V; Villada, C; IJzerman, H; van Lange, PAM; Salvador, A				van der Meij, Leander; Almela, Mercedes; Hidalgo, Vanesa; Villada, Carolina; IJzerman, Hans; van Lange, Paul A. M.; Salvador, Alicia			Testosterone and Cortisol Release among Spanish Soccer Fans Watching the 2010 World Cup Final	PLOS ONE			English	Article							CHALLENGE HYPOTHESIS; HORMONAL RESPONSES; STRESS RESPONSES; HUMAN MALES; COMPETITION; STRATEGIES; MEN; GENDER; MOOD; AGE	This field study investigated the release of testosterone and cortisol of a vicarious winning experience in Spanish fans watching the finals between Spain and the Netherlands in the 2010 FIFA World Cup Soccer. Spanish fans (n = 50) watched the match with friends or family in a public place or at home and also participated in a control condition. Consistent with hypotheses, results revealed that testosterone and cortisol levels were higher when watching the match than on a control day. However, neither testosterone nor cortisol levels increased after the victory of the Spanish team. Moreover, the increase in testosterone secretion was not related to participants' sex, age or soccer fandom, but the increase in total cortisol secretion during the match was higher among men than among women and among fans that were younger. Also, increases in cortisol secretion were greater to the degree that people were a stronger fan of soccer. Level of fandom further appeared to account for the sex effect, but not for the age effect. Generally, the testosterone data from this study are in line with the challenge hypothesis, as testosterone levels of watchers increased to prepare their organism to defend or enhance their social status. The cortisol data from this study are in line with social self-preservation theory, as higher cortisol secretion among young and greater soccer fans suggests that especially they perceived that a negative outcome of the match would threaten their own social esteem.	[van der Meij, Leander; Almela, Mercedes; Hidalgo, Vanesa; Villada, Carolina; Salvador, Alicia] Univ Valencia, Lab Social Neurosci, Valencia, Spain; [van der Meij, Leander; IJzerman, Hans; van Lange, Paul A. M.] Vrije Univ Amsterdam, Dept Social & Org Psychol, Amsterdam, Netherlands	University of Valencia; Vrije Universiteit Amsterdam	van der Meij, L (corresponding author), Univ Valencia, Lab Social Neurosci, Valencia, Spain.	L.van.der.Meij@vu.nl	van der Meij, Leander/AAC-8945-2019; Almela, Mercedes/AAE-4481-2021; Salvador, Alicia/B-6045-2011	van der Meij, Leander/0000-0001-6394-3071; VILLADA, CAROLINA/0000-0003-1071-2362; IJzerman, Hans/0000-0002-0990-2276; Hidalgo, Vanesa/0000-0003-3920-1099; Almela, Mercedes/0000-0002-8930-0717; Van Lange, Paul/0000-0001-7774-6984; Salvador, Alicia/0000-0002-8686-8083	Santiago Grisolia; PROMETEO grants of the Generalitat Valenciana [2011-048]; Consolider Eje C Project [SEJ2006-1408];  [ACOMP2011-166]	Santiago Grisolia; PROMETEO grants of the Generalitat Valenciana; Consolider Eje C Project; 	This study was supported by the Santiago Grisolia, the ACOMP2011-166, and the PROMETEO 2011-048 grants of the Generalitat Valenciana, and was developed in the framework of the Consolider Eje C Project SEJ2006-1408. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler NE, 2000, HEALTH PSYCHOL, V19, P586, DOI 10.1037/0278-6133.19.6.586; Almela M, 2011, BIOL PSYCHOL, V87, P421, DOI 10.1016/j.biopsycho.2011.05.008; Archer J, 2006, NEUROSCI BIOBEHAV R, V30, P319, DOI 10.1016/j.neubiorev.2004.12.007; Barlovento comunicacion, 2011, ANAL TELEVISION 2010; Bernhardt PC, 1998, PHYSIOL BEHAV, V65, P59, DOI 10.1016/S0031-9384(98)00147-4; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Chatterton RT, 1997, J CLIN ENDOCR METAB, V82, P2503, DOI 10.1210/jc.82.8.2503; Dickerson SS, 2004, PSYCHOL BULL, V130, P355, DOI 10.1037/0033-2909.130.3.355; Diehl M, 1996, PSYCHOL AGING, V11, P127, DOI 10.1037/0882-7974.11.1.127; DIGGLE PJ, 1988, BIOMETRICS, V44, P959, DOI 10.2307/2531727; Edwards DA, 2006, HORM BEHAV, V50, P681, DOI 10.1016/j.yhbeh.2006.09.005; GLADUE BA, 1989, AGGRESSIVE BEHAV, V15, P409, DOI 10.1002/1098-2337(1989)15:6<409::AID-AB2480150602>3.0.CO;2-P; Gonzalez-Bono E, 1999, HORM BEHAV, V35, P55, DOI 10.1006/hbeh.1998.1496; Granger DA, 2009, PSYCHONEUROENDOCRINO, V34, P1437, DOI 10.1016/j.psyneuen.2009.06.017; Hasegawa M, 2008, BIOMED RES-TOKYO, V29, P43, DOI 10.2220/biomedres.29.43; KIRSCHBAUM C, 1993, NEUROPSYCHOBIOLOGY, V28, P76, DOI 10.1159/000119004; Kivlighan KT, 2005, PSYCHONEUROENDOCRINO, V30, P58, DOI 10.1016/j.psyneuen.2004.05.009; LUGER A, 1987, NEW ENGL J MED, V316, P1309, DOI 10.1056/NEJM198705213162105; MAZUR A, 1980, HORM BEHAV, V14, P236, DOI 10.1016/0018-506X(80)90032-X; Mazur A, 1998, BEHAV BRAIN SCI, V21, P353, DOI 10.1017/S0140525X98001228; Oliveira T, 2009, PSYCHONEUROENDOCRINO, V34, P1056, DOI 10.1016/j.psyneuen.2009.02.006; Otte C, 2005, PSYCHONEUROENDOCRINO, V30, P80, DOI 10.1016/j.psyneuen.2004.06.002; Peters ML, 1998, PSYCHONEUROENDOCRINO, V23, P1, DOI 10.1016/S0306-4530(97)00082-6; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Salvador A, 2005, NEUROSCI BIOBEHAV R, V29, P195, DOI 10.1016/j.neubiorev.2004.07.004; Salvador A, 2003, PSYCHONEUROENDOCRINO, V28, P364, DOI 10.1016/S0306-4530(02)00028-8; Salvador A, 2009, NEUROSCI BIOBEHAV R, V33, P160, DOI 10.1016/j.neubiorev.2008.09.005; Sandin B, 1999, PSICOTHEMA, V11, P37; SAPOLSKY RM, 1986, ENDOCR REV, V7, P284, DOI 10.1210/edrv-7-3-284; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; SEEMAN TE, 1995, J PSYCHOSOM RES, V39, P69, DOI 10.1016/0022-3999(94)00076-H; Serrano MA, 2000, PSICOTHEMA, V12, P440; Stichting KijkOnderzoek, 2011, SKO JAARV 2010; Suay F, 1999, PSYCHONEUROENDOCRINO, V24, P551, DOI 10.1016/S0306-4530(99)00011-6; Ursin H, 2004, PSYCHONEUROENDOCRINO, V29, P567, DOI 10.1016/S0306-4530(03)00091-X; van der Meij L, 2010, BIOL PSYCHOL, V84, P330, DOI 10.1016/j.biopsycho.2010.03.017; WINGFIELD JC, 1990, AM NAT, V136, P829, DOI 10.1086/285134	37	36	36	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e34814	10.1371/journal.pone.0034814	http://dx.doi.org/10.1371/journal.pone.0034814			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529940	gold, Green Published, Green Submitted			2022-12-27	WOS:000305350600031
J	Wong, PCM; Chandrasekaran, B; Zheng, J				Wong, Patrick C. M.; Chandrasekaran, Bharath; Zheng, Jing			The Derived Allele of ASPM Is Associated with Lexical Tone Perception	PLOS ONE			English	Article							ONGOING ADAPTIVE EVOLUTION; GENE-GENE INTERACTION; BRAIN-SIZE GENES; AUDITORY-CORTEX; HESCHLS GYRUS; PITCH; MICROCEPHALIN; LANGUAGE; SPEECH; MCPH1	The ASPM and MCPH1 genes have been implicated in the adaptive evolution of the human brain [Mekel-Bobrov N. et al., 2005. Ongoing adaptive evolution of ASPM, a brain size determinant in homo sapiens. Science 309; Evans P. D. et al., 2005. Microcephalin, a gene regulating brain size, continues to evolve adaptively in humans. Science 309]. Curiously, experimental attempts have failed to connect the implicated SNPs in these genes with higher-level brain functions. These results stand in contrast with a population-level study linking the population frequency of their alleles with the tendency to use lexical tones in a language [Dediu D., Ladd D. R., 2007. Linguistic tone is related to the population frequency of the adaptive haplogroups of two brain size genes, ASPM and microcephalin. Proc. Natl. Acad. Sci. U. S. A. 104]. In the present study, we found a significant correlation between the load of the derived alleles of ASPM and tone perception in a group of European Americans who did not speak a tone language. Moreover, preliminary results showed a significant correlation between ASPM load and hemodynamic responses to lexical tones in the auditory cortex, and such correlation remained after phonemic awareness, auditory working memory, and non-verbal IQ were controlled. As in previous studies, no significant correlation between ASPM and cognitive measures were found. MCPH1 did not correlate with any measures. These results suggest that the association between the recently derived allele of ASPM is likely to be specific and is tied to higher level brain functions in the temporal cortex related to human communication.	[Wong, Patrick C. M.; Chandrasekaran, Bharath] Northwestern Univ, Roxelyn & Richard Pepper Dept Commun Sci & Disord, Evanston, IL 60208 USA; [Wong, Patrick C. M.; Zheng, Jing] Northwestern Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Chicago, IL 60611 USA; [Wong, Patrick C. M.; Zheng, Jing] Northwestern Univ, Hugh Knowles Ctr Clin & Basic Sci Hearing & Disor, Chicago, IL USA	Northwestern University; Northwestern University; Northwestern University	Wong, PCM (corresponding author), Northwestern Univ, Roxelyn & Richard Pepper Dept Commun Sci & Disord, Evanston, IL 60208 USA.	pwong@northwestern.edu	Wong, Patrick/A-8102-2012; Zheng, Jing/F-5273-2017; Dediu, Dan/E-3279-2012	Zheng, Jing/0000-0003-2790-1143; Dediu, Dan/0000-0002-0704-6365; Chandrasekaran, Bharath/0000-0002-3673-9435; Wong, Patrick/0000-0002-6105-5027	National Science Foundation [BCS-1125144]; National Institutes of Health [R01DC008333, K02AG035382, R21DC009652, ARRA R21DC009652-S1, ARRA RC1DC010633]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025741] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K02AG035382] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC009652, R01DC008333, RC1DC010633, R01DC011813] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work is supported by grants from the National Science Foundation (BCS-1125144) and the National Institutes of Health (R01DC008333, K02AG035382, R21DC009652, & ARRA R21DC009652-S1) awarded to Dr. Wong (PI), and the National Institutes of Health (ARRA RC1DC010633) awarded to Dr. Zheng (PI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1932, STAT METHODS RES WOR; Bates TC, 2008, INTELLIGENCE, V36, P689, DOI 10.1016/j.intell.2008.04.001; Battle NC, 2007, AM J RESP CRIT CARE, V175, P881, DOI 10.1164/rccm.200607-992OC; Bendor D, 2005, NATURE, V436, P1161, DOI 10.1038/nature03867; Bishop DVM, 2001, PHILOS T R SOC B, V356, P369, DOI 10.1098/rstb.2000.0770; Bond J, 2002, NAT GENET, V32, P316, DOI 10.1038/ng995; Brown L., 1997, TEST NONVERBAL INTEL; Castles A, 2004, COGNITION, V91, P77, DOI 10.1016/S0010-0277(03)00164-1; Chandrasekaran B, 2011, J COGNITIVE NEUROSCI; Chandrasekaran B, 2010, J ACOUST SOC AM, V128, P456, DOI 10.1121/1.3445785; Chiao JY, 2010, P ROY SOC B-BIOL SCI, V277, P529, DOI 10.1098/rspb.2009.1650; CHURCH BA, 1994, J EXP PSYCHOL LEARN, V20, P521, DOI 10.1037/0278-7393.20.3.521; Comings DE, 2003, MOL PSYCHIATR, V8, P10, DOI 10.1038/sj.mp.4001095; Cox J, 2006, TRENDS MOL MED, V12, P358, DOI 10.1016/j.molmed.2006.06.006; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Dediu D, 2007, P NATL ACAD SCI USA, V104, P10944, DOI 10.1073/pnas.0610848104; Dobson-Stone C, 2007, NEUROIMAGE, V37, P394, DOI 10.1016/j.neuroimage.2007.05.011; Donald M, 1991, CHRONOLOGY ANATOMICA; Drayna D, 2001, SCIENCE, V291, P1969, DOI 10.1126/science.291.5510.1969; Dreher JC, 2009, P NATL ACAD SCI USA, V106, P617, DOI 10.1073/pnas.0805517106; Dryer Matthew S., 2013, WORLD ATLAS LANGUAGE; Evans PD, 2005, SCIENCE, V309, P1717, DOI 10.1126/science.1113722; Fish JL, 2006, P NATL ACAD SCI USA, V103, P10438, DOI 10.1073/pnas.0604066103; Gagnepain P, 2008, J NEUROSCI, V28, P5281, DOI 10.1523/JNEUROSCI.0565-08.2008; Grill-Spector K, 2006, TRENDS COGN SCI, V10, P14, DOI 10.1016/j.tics.2005.11.006; Grill-Spector K, 2001, ACTA PSYCHOL, V107, P293, DOI 10.1016/S0001-6918(01)00019-1; Jackson AP, 2002, AM J HUM GENET, V71, P136, DOI 10.1086/341283; Jackson AP, 1998, AM J HUM GENET, V63, P541, DOI 10.1086/301966; Jerison HJ., 1973, EVOLUTION BRAIN INTE; Jocham G, 2009, J NEUROSCI, V29, P3695, DOI 10.1523/JNEUROSCI.5195-08.2009; Kim HS, 2010, P NATL ACAD SCI USA, V107, P15717, DOI 10.1073/pnas.1010830107; Klein TA, 2007, SCIENCE, V318, P1642, DOI 10.1126/science.1145044; Lewin R, 1993, LANGUAGE MODERN HUMA; Liu XZ, 2003, HUM MOL GENET, V12, P1155, DOI 10.1093/hmg/ddg127; Luo H, 2006, P NATL ACAD SCI USA, V103, P19558, DOI 10.1073/pnas.0607065104; Mekel-Bobrov N, 2005, SCIENCE, V309, P1720, DOI 10.1126/science.1116815; Mekel-Bobrov N, 2007, HUM MOL GENET, V16, P600, DOI 10.1093/hmg/ddl487; Morell RJ, 2007, HUM GENET, V122, P103, DOI 10.1007/s00439-007-0384-5; Peretz I, 2007, AM J HUM GENET, V81, P582, DOI 10.1086/521337; Posthuma D, 2006, CURR DIR PSYCHOL SCI, V15, P151, DOI 10.1111/j.1467-8721.2006.00426.x; Rice M.L., 2007, HDB LANGUAGE DEV, P411; Rimol LM, 2009, P NATL ACAD SCI; Tang BL, 2006, BIOCHEM BIOPH RES CO, V345, P911, DOI 10.1016/j.bbrc.2006.05.040; Timpson N, 2007, SCIENCE, V317, DOI 10.1126/science.1141705; VARGHAKHADEM F, 1995, P NATL ACAD SCI USA, V92, P930, DOI 10.1073/pnas.92.3.930; Wang JK, 2008, HUM MOL GENET, V17, P1329, DOI 10.1093/hmg/ddn021; Warrier C, 2009, J NEUROSCI, V29, P61, DOI 10.1523/JNEUROSCI.3489-08.2009; Wiggs CL, 1998, CURR OPIN NEUROBIOL, V8, P227, DOI 10.1016/S0959-4388(98)80144-X; Wong PCM, 2008, CEREB CORTEX, V18, P828, DOI 10.1093/cercor/bhm115; Wong PCM, 2007, APPL PSYCHOLINGUIST, V28, P565, DOI 10.1017/S0142716407070312; Wong PCM, 2007, HUM BRAIN MAPP, V28, P995, DOI 10.1002/hbm.20330; Woodcock R, 2010, WOODCOCK JOHNSON PSY; Yacubian J, 2007, P NATL ACAD SCI USA, V104, P8125, DOI 10.1073/pnas.0702029104; Zatorre RJ, 2008, PHILOS T R SOC B, V363, P1087, DOI 10.1098/rstb.2007.2161; [No title captured]	55	17	17	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e34243	10.1371/journal.pone.0034243	http://dx.doi.org/10.1371/journal.pone.0034243			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22529908	gold, Green Published, Green Submitted			2022-12-27	WOS:000305347400008
J	Beq, S; Rozlan, S; Pelletier, S; Willems, B; Bruneau, J; Lelievre, JD; Levy, Y; Shoukry, NH; Cheynier, R				Beq, Stephanie; Rozlan, Sandra; Pelletier, Sandy; Willems, Bernard; Bruneau, Julie; Lelievre, Jean-Daniel; Levy, Yves; Shoukry, Naglaa H.; Cheynier, Remi			Altered Thymic Function during Interferon Therapy in HCV-Infected Patients	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; CD8 T-CELLS; IFN-ALPHA; COMBINATION TREATMENT; PEGYLATED INTERFERON; UP-REGULATION; INTERLEUKIN-7; EXPRESSION; RIBAVIRIN; CD4(+)	Interferon alpha (IFN alpha) therapy, despite good efficacy in curing HCV infection, leads to major side effects, in particular inducement of a strong peripheral T-cell lymphocytopenia. We here analyze the early consequences of IFN alpha therapy on both thymic function and peripheral T-cell homeostasis in patients in the acute or chronic phase of HCV-infection as well as in HIV/HCV co-infected patients. The evolution of T-cell subsets and T-cell homeostasis were estimated by flow cytometry while thymic function was measured through quantification of T-cell receptor excision circles (TREC) and estimation of intrathymic precursor T-cell proliferation during the first four months following the initiation of IFN alpha therapy. Beginning with the first month of therapy, a profound lymphocytopenia was observed for all T-cell subsets, including naive T-cells and recent thymic emigrants (RTE), associated with inhibition of intrathymic precursor T-cell proliferation. Interleukin (IL)-7 plasma concentration rapidly dropped while lymphocytopenia progressed. This was neither a consequence of higher consumption of the cytokine nor due to its neutralization by soluble CD127. Decrease in IL-7 plasma concentration under IFNa therapy correlated with the decline in HCV viral load, thymic activity and RTE concentration in blood. These data demonstrate that IFN alpha-based therapy rapidly impacts on thymopoiesis and, consequently, perturbs T-cell homeostasis. Such a side effect might be detrimental for the continuation of IFN alpha therapy and may lead to an increased level of infectious risk, in particular in HIV/HCV co-infected patients. Altogether, this study suggests the therapeutic potential of IL-7 in the maintenance of peripheral T-cell homeostasis in IFN alpha-treated patients.	[Beq, Stephanie; Rozlan, Sandra; Cheynier, Remi] Inst Pasteur, Dept Virol, Paris, France; [Pelletier, Sandy; Willems, Bernard; Bruneau, Julie; Shoukry, Naglaa H.] Hop St Luc, CRCHUM, Montreal, PQ H2X 1P1, Canada; [Pelletier, Sandy] Univ Montreal, Dept Microbiol & Immunol, Montreal, PQ H3C 3J7, Canada; [Willems, Bernard; Shoukry, Naglaa H.] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada; [Bruneau, Julie] Univ Montreal, Dept Med Familiale, Montreal, PQ, Canada; [Lelievre, Jean-Daniel; Levy, Yves] Univ Paris 12, INSERM, U955, Grp Henri Mondor Albert Chenevier,AP HP,Immunol C, Creteil, France; [Cheynier, Remi] Inst Cochin, INSERM, U1016, Dept Immunol Hematol, Paris, France; [Cheynier, Remi] Univ Paris 05, Fac Med Rene Descartes, UMR S 8104, Paris, France; [Cheynier, Remi] CNRS, UMR 8104, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite	Beq, S (corresponding author), Inst Pasteur, Dept Virol, Paris, France.	remi.cheynier@inserm.fr	, Lelievre/AAB-1398-2020; Cheynier, Remi/E-9921-2010	Cheynier, Remi/0000-0003-1146-660X; Lelievre, Jean-Daniel/0000-0002-8182-3628; Pelletier, Sandy/0000-0002-5869-424X	Institut Pasteur; ANRS (Agence Nationale de Recherches sur le SIDA et les hepatitis virales); SIDACTION; Canadian Institutes for Health Research (CIHR) [MOP-74524]; Fonds de la Recherche en Sante du Quebec (FRSQ) [FRSQ-12428]; FRSQ-AIDS and Infectious Disease Network (SIDA-MI)	Institut Pasteur(European Commission); ANRS (Agence Nationale de Recherches sur le SIDA et les hepatitis virales); SIDACTION; Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); FRSQ-AIDS and Infectious Disease Network (SIDA-MI)(Fonds de la Recherche en Sante du Quebec)	This work was supported by Institut Pasteur, the ANRS (Agence Nationale de Recherches sur le SIDA et les hepatitis virales), SIDACTION, the Canadian Institutes for Health Research (CIHR) (MOP-74524), Fonds de la Recherche en Sante du Quebec (FRSQ) (FRSQ-12428) and the FRSQ-AIDS and Infectious Disease Network (SIDA-MI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida ARM, 2001, J EXP MED, V194, P591, DOI 10.1084/jem.194.5.591; AMAN MJ, 1994, BLOOD, V84, P4142, DOI 10.1182/blood.V84.12.4142.bloodjournal84124142; Antonini MG, 2008, INFECTION, V36, P250, DOI 10.1007/s15010-007-7132-6; Arizcorreta A, 2006, CLIN EXP IMMUNOL, V146, P270, DOI 10.1111/j.1365-2249.2006.03220.x; Arstila TP, 1999, SCIENCE, V286, P958, DOI 10.1126/science.286.5441.958; Badr G, 2008, J VIROL, V82, P10017, DOI 10.1128/JVI.01083-08; Barata JT, 2001, BLOOD, V98, P1524, DOI 10.1182/blood.V98.5.1524; Beq S, 2006, J IMMUNOL, V176, P914, DOI 10.4049/jimmunol.176.2.914; Beq S, 2009, BLOOD; Bonder CS, 2002, CYTOKINE, V17, P187, DOI 10.1006/cyto.2001.0994; CARLOSTELLA C, 1987, BLOOD, V70, P1014; Chevaliez S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008209; Cox AL, 2009, GASTROENTEROLOGY, V136, P26, DOI 10.1053/j.gastro.2008.11.049; Dieterich DT, 2002, J INFECT DIS, V185, pS128, DOI 10.1086/340199; Dion Marie-Lise, 2007, Methods Mol Biol, V380, P197; Dion ML, 2007, BLOOD, V109, P2912, DOI 10.1182/blood-2006-09-047308; Dion ML, 2004, IMMUNITY, V21, P757, DOI 10.1016/j.immuni.2004.10.013; Dondi E, 2004, J IMMUNOL, V173, P3740, DOI 10.4049/jimmunol.173.6.3740; Douek DC, 1998, NATURE, V396, P690, DOI 10.1038/25374; Dulude G, 2008, J IMMUNOL, V181, P7818, DOI 10.4049/jimmunol.181.11.7818; Eguchi H, 2000, CLIN CANCER RES, V6, P2881; Fadilah S. A. W., 1999, Southeast Asian Journal of Tropical Medicine and Public Health, V30, P710; Feld JJ, 2005, NATURE, V436, P967, DOI 10.1038/nature04082; Golden-Mason L, 2006, HEPATOLOGY, V44, P1098, DOI 10.1002/hep.21365; Guimond M, 2009, NAT IMMUNOL, V10, P149, DOI 10.1038/ni.1695; He ZP, 2005, INT J INFECT DIS, V9, P323, DOI 10.1016/j.ijid.2004.07.014; Hofmann WP, 2011, NAT REV GASTRO HEPAT, V8, P257, DOI 10.1038/nrgastro.2011.49; Janot-Sardet C, 2009, J IMMUNOL METHODS; Kamphuis E, 2006, BLOOD, V108, P3253, DOI 10.1182/blood-2006-06-027599; Kaser A, 1999, CYTOKINE, V11, P736, DOI 10.1006/cyto.1998.0484; Kimmig S, 2002, J EXP MED, V195, P789, DOI 10.1084/jem.20011756; Kolumam GA, 2005, J EXP MED, V202, P637, DOI 10.1084/jem.20050821; Landau A, 2000, AIDS, V14, P839, DOI 10.1097/00002030-200005050-00010; Lin Q, 1998, J EXP MED, V187, P79, DOI 10.1084/jem.187.1.79; Manna SK, 2000, J IMMUNOL, V165, P4927, DOI 10.4049/jimmunol.165.9.4927; Mazzucchelli R, 2007, NAT REV IMMUNOL, V7, P144, DOI 10.1038/nri2023; McHutchison JG, 2004, GASTROENTEROL CLIN N, V33, pS51, DOI 10.1016/j.gtc.2003.12.001; Moirand R, 2007, CAN J GASTROENTEROL, V21, P355, DOI 10.1155/2007/576765; Napolitano LA, 2001, NAT MED, V7, P73, DOI 10.1038/83381; Neau D, 2003, HIV Med, V4, P120, DOI 10.1046/j.1468-1293.2003.00140.x; Offner F, 1998, LEUKEMIA LYMPHOMA, V30, P87, DOI 10.3109/10428199809050932; Okada H, 2000, ARCH VIROL, V145, P905, DOI 10.1007/s007050050683; Parker R, 2010, BLOOD, V116, P5589, DOI 10.1182/blood-2010-03-276261; PESCE A, 1993, LANCET, V341, P1597, DOI 10.1016/0140-6736(93)90736-Z; Puoti M, 2004, ANTIVIR THER, V9, P627; Sawa Y, 2009, IMMUNITY, V30, P447, DOI 10.1016/j.immuni.2009.01.007; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Segundo FDS, 2006, J VIROL, V80, P2369, DOI 10.1128/JVI.80.5.2369-2379.2006; Shire NJ, 2007, J VIRAL HEPATITIS, V14, P239, DOI 10.1111/j.1365-2893.2006.00824.x; SORIANO V, 1994, AIDS, V8, P1621, DOI 10.1097/00002030-199411000-00016; SORIANO V, 1995, J INFECTION, V31, P9, DOI 10.1016/S0163-4453(95)91178-2; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Tsukiyama T, 2001, J IMMUNOL, V166, P304, DOI 10.4049/jimmunol.166.1.304; VENTO S, 1993, LANCET, V341, P958, DOI 10.1016/0140-6736(93)91248-K	54	9	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e34326	10.1371/journal.pone.0034326	http://dx.doi.org/10.1371/journal.pone.0034326			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22529911	Green Published, Green Submitted, gold			2022-12-27	WOS:000305345000016
J	Garcia-Bocanegra, I; de Val, BP; Arenas-Montes, A; Paniagua, J; Boadella, M; Gortazar, C; Arenas, A				Garcia-Bocanegra, Ignacio; Perez de Val, Bernat; Arenas-Montes, Antonio; Paniagua, Jorge; Boadella, Mariana; Gortazar, Christian; Arenas, Antonio			Seroprevalence and Risk Factors Associated to Mycobacterium bovis in Wild Artiodactyl Species from Southern Spain, 2006-2010	PLOS ONE			English	Article							TUBERCULOSIS-LIKE LESIONS; BOAR SUS-SCROFA; RED DEER; SPOLIGOTYPE DIVERSITY; INFECTION; PREVALENCE; DIAGNOSIS; RESERVOIR; CAPRAE; TESTS	The control of bovine tuberculosis (bTB) is at a critical point in the last stage of eradication in livestock. Wildlife species recently have emerged infected with TB in Europe, particularly ungulates in the Iberian Peninsula. Epidemiological information regarding TB in wild ungulates including affected species, prevalence, associated risk factors and appropriate diagnostic methods need to be obtained in these countries. A cross-sectional study was carried out on wild artiodactyl species, including Eurasian wild boar (Sus scrofa) red deer (Cervus elaphus), roe deer (Capraelus capraelus), fallow deer (Dama dama), Spanish ibex (Capra pyrenaica hispanica) and mouflon (Ovis musimon), in Spain to assess the seroprevalence against Mycobacterium bovis or cross-reacting members of the Mycobcaterium tuberculosis complex (MTBC), and to provide information on associated risk factors. Previously, two in-house indirect enzyme linked immunosorbent assays (bPPD-ELISA and MPB83-ELISA) were developed using known TB status sera. Positive reference sera were selected from infected animals confirmed by culture. The M. bovis isolates belonged to spoligotypes SB0121, SB0120, SB0295, SB0265 and SB0134. Two hundred and two out of 1367 (7.5%; 95% CI: 6.1-8.9) animals presented antibodies against M. bovis by both bPPD-ELISA and MPB83-ELISA. Significantly higher TB seroprevalence was observed in wild boar compared to the other species analyzed. Interestingly, seropositivity against M. bovis was not found in any out of 460 Spanish ibex analyzed. The logistic regression model for wild boar indicated that the seropositivity to M. bovis was associated with age, location and year of sampling, while the only risk factor associated with M. bovis seroprevalence in red deer and fallow deer was the age. The seroprevalence observed indicates a widespread exposure to MTBC in several wild artiodactyl species in southern Spain, which may have important implications not only for conservation but also for animal and public health.	[Garcia-Bocanegra, Ignacio; Arenas-Montes, Antonio; Paniagua, Jorge; Arenas, Antonio] Univ Cordoba Agrifood Excellence Int Campus ceiA3, Fac Vet, Dept Sanidad Anim, Cordoba, Spain; UAB IRTA, Ctr Recerca Sanitat Anim CReSA, Barcelona, Spain; [Boadella, Mariana; Gortazar, Christian] Inst Invest Recursos Cineget IREC CSIC UCLM JCCM, Ciudad Real, Spain	IRTA; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigacion en Recursos Cinegeticos (IREC); Universidad de Castilla-La Mancha	Garcia-Bocanegra, I (corresponding author), Univ Cordoba Agrifood Excellence Int Campus ceiA3, Fac Vet, Dept Sanidad Anim, Cordoba, Spain.	nacho.garcia@uco.es	Gortazar, Christian/E-7918-2012; ARENAS, Antonio J/I-3997-2017; Bocanegra, Ignacio Garcia/G-1443-2016; DE VAL, BERNAT PÉREZ/G-6865-2012; Boadella, Mariana/I-8029-2012	Gortazar, Christian/0000-0003-0012-4006; ARENAS, Antonio J/0000-0001-5334-2440; Bocanegra, Ignacio Garcia/0000-0003-3388-2604; DE VAL, BERNAT PÉREZ/0000-0003-3127-9182; Boadella, Mariana/0000-0001-6402-9927	Ministry of Science and Innovation (MCINN) Plan [AGL 2011-30041]; National Institute for Agriculture and Food Research and Technology (INIA) [FAU2008-00019-C03-01]; EU [TBSTEP 212414]; Ministerio de Medio Ambiente y Medio Rural y Marino (SDGSPP); Grupo Santander - Fundacion Marcelino Botin	Ministry of Science and Innovation (MCINN) Plan; National Institute for Agriculture and Food Research and Technology (INIA)(Instituto de Investigacion Agropecuaria (INIA)); EU(European Commission); Ministerio de Medio Ambiente y Medio Rural y Marino (SDGSPP); Grupo Santander - Fundacion Marcelino Botin	This is a contribution to Ministry of Science and Innovation (MCINN) Plan Nacional research grant AGL 2011-30041, National Institute for Agriculture and Food Research and Technology (INIA) grant FAU2008-00019-C03-01 and European Regional Development Fund (FEDER), and to EU grant TBSTEP 212414. Studies on diseases shared between domestic animals and wildlife are also supported by Ministerio de Medio Ambiente y Medio Rural y Marino (SDGSPP), and Grupo Santander - Fundacion Marcelino Botin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo P, 2006, ACTA THERIOL, V51, P327, DOI 10.1007/BF03192685; Allepuz A, 2011, PREV VET MED, V100, P44, DOI 10.1016/j.prevetmed.2011.02.012; Aranaz A, 2004, J CLIN MICROBIOL, V42, P2602, DOI 10.1128/JCM.42.6.2602-2608.2004; Aurtenetxe O, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-43; Balseiro A, 2009, VET REC, V164, P468, DOI 10.1136/vr.164.15.468; Boadella M, 2012, PREV VET MED, V104, P160, DOI 10.1016/j.prevetmed.2011.10.005; Boadella M, 2011, ECOHEALTH, V8, P478, DOI 10.1007/s10393-011-0713-y; Boadella M, 2011, EUR J WILDLIFE RES, V57, P697, DOI 10.1007/s10344-011-0550-x; Boadella M, 2011, J VET DIAGN INVEST, V23, P77, DOI 10.1177/104063871102300111; Boniotti MB, 2009, J CLIN MICROBIOL, V47, P636, DOI 10.1128/JCM.01192-08; Carta T, 2012, VET J, V192, P544, DOI 10.1016/j.tvjl.2011.08.010; Castillo L, 2011, PREV VET MED, V98, P58, DOI 10.1016/j.prevetmed.2010.11.008; CORDES DO, 1981, NEW ZEAL VET J, V29, P60, DOI 10.1080/00480169.1981.34798; Cubero MJ, 2002, DISTRIBUCION GENETIC, P199; de Mendoza JH, 2006, PREV VET MED, V74, P239, DOI 10.1016/j.prevetmed.2005.10.005; Duarte EL, 2008, VET MICROBIOL, V130, P415, DOI 10.1016/j.vetmic.2008.02.012; Gortazar C, 2006, EUR J WILDLIFE RES, V52, P81, DOI 10.1007/s10344-005-0022-2; Gortazar C, 2011, VET MICROBIOL, V151, P170, DOI 10.1016/j.vetmic.2011.02.041; Gortazar C, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-27; Gortazar C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002776; Haddad N, 2001, J CLIN MICROBIOL, V39, P3623, DOI 10.1128/JCM.39.10.3623-3632.2001; HOSMER DW, 1989, APPL LOGISTIC REGRES; Jaroso R, 2010, VET MICROBIOL, V146, P285, DOI 10.1016/j.vetmic.2010.05.022; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; KRAEMER HC, 1982, ENCY STAT SCI, P352; Lyashchenko KP, 2008, VET MICROBIOL, V132, P283, DOI 10.1016/j.vetmic.2008.05.029; Mentaberre G, 2010, VET REC, V166, P700, DOI 10.1136/vr.c2552; Mendoza MM, 2012, VET J, V191, P267, DOI 10.1016/j.tvjl.2011.05.006; Naranjo V, 2008, VET MICROBIOL, V127, P1, DOI 10.1016/j.vetmic.2007.10.002; O'Brien DJ, 2006, VET MICROBIOL, V112, P313, DOI 10.1016/j.vetmic.2005.11.014; OREILLY LM, 1995, TUBERCLE LUNG DIS, V76, P1, DOI 10.1016/0962-8479(95)90591-X; Parra A, 2006, RES VET SCI, V80, P140, DOI 10.1016/j.rvsc.2005.05.010; de Val BP, 2011, CLIN VACCINE IMMUNOL, V18, P1872, DOI 10.1128/CVI.05323-11; Quintas H, 2010, VET REC, V166, P437, DOI 10.1136/vr.c1678; RITACCO V, 1990, J VET MED B, V37, P19, DOI 10.1111/j.1439-0450.1990.tb01021.x; Rodriguez E, 2009, INT J TUBERC LUNG D, V13, P1536; Rodriguez S, 2010, VET MICROBIOL, V141, P89, DOI 10.1016/j.vetmic.2009.08.007; Saenz De Buruaga M, 1991, RECONOCIMIENTO SEXO; Santos N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012663; Spanish Ministry of the Environment and Rural and Marine Affairs (MARM), 2011, REP SPAN SAN PROGR; Vicente J, 2006, VET RES, V37, P107, DOI 10.1051/vetres:2005044; Vicente J, 2007, VET RES, V38, P451, DOI 10.1051/vetres:2007002; Waters WR, 2006, CLIN VACCINE IMMUNOL, V13, P648, DOI 10.1128/CVI.00061-06; Wilson G, 2009, SCI REV TUBERC UNPUB; Wilton S, 1992, PCR Methods Appl, V1, P269; Zanella G, 2008, J WILDLIFE DIS, V44, P99, DOI 10.7589/0090-3558-44.1.99	46	32	33	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e34908	10.1371/journal.pone.0034908	http://dx.doi.org/10.1371/journal.pone.0034908			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523563	Green Published, gold, Green Submitted			2022-12-27	WOS:000305345000035
J	Uboldi, S; Calura, E; Beltrame, L; Nerini, IF; Marchini, S; Cavalieri, D; Erba, E; Chiorino, G; Ostano, P; D'Angelo, D; D'Incalci, M; Romualdi, C				Uboldi, Sarah; Calura, Enrica; Beltrame, Luca; Nerini, Ilaria Fuso; Marchini, Sergio; Cavalieri, Duccio; Erba, Eugenio; Chiorino, Giovanna; Ostano, Paola; D'Angelo, Daniela; D'Incalci, Maurizio; Romualdi, Chiara			A Systems Biology Approach to Characterize the Regulatory Networks Leading to Trabectedin Resistance in an In Vitro Model of Myxoid Liposarcoma	PLOS ONE			English	Article							PHASE-II; EXPRESSION; PLATINUM; ET-743; GENES; ECTEINASCIDIN-743; IDENTIFICATION; MECHANISM; AGENT; CELLS	Trabectedin, a new antitumor compound originally derived from a marine tunicate, is clinically effective in soft tissue sarcoma. The drug has shown a high selectivity for myxoid liposarcoma, characterized by the translocation t(12; 16)(q13; p11) leading to the expression of FUS-CHOP fusion gene. Trabectedin appears to act interfering with mechanisms of transcription regulation. In particular, the transactivating activity of FUS-CHOP was found to be impaired by trabectedin treatment. Even after prolonged response resistance occurs and thus it is important to elucidate the mechanisms of resistance to trabectedin. To this end we developed and characterized a myxoid liposarcoma cell line resistant to trabectedin (402-91/ET), obtained by exposing the parental 402-91 cell line to stepwise increases in drug concentration. The aim of this study was to compare mRNAs, miRNAs and proteins profiles of 402-91 and 402-91/ET cells through a systems biology approach. We identified 3,083 genes, 47 miRNAs and 336 proteins differentially expressed between 402-91 and 402-91/ET cell lines. Interestingly three miRNAs among those differentially expressed, miR-130a, miR-21 and miR-7, harbored CHOP binding sites in their promoter region. We used computational approaches to integrate the three regulatory layers and to generate a molecular map describing the altered circuits in sensitive and resistant cell lines. By combining transcriptomic and proteomic data, we reconstructed two different networks, i.e. apoptosis and cell cycle regulation, that could play a key role in modulating trabectedin resistance. This approach highlights the central role of genes such as CCDN1, RB1, E2F4, TNF, CDKN1C and ABL1 in both pre- and post-transcriptional regulatory network. The validation of these results in in vivo models might be clinically relevant to stratify myxoid liposarcoma patients with different sensitivity to trabectedin treatment.	[Uboldi, Sarah; Beltrame, Luca; Nerini, Ilaria Fuso; Marchini, Sergio; Erba, Eugenio; D'Incalci, Maurizio] Mario Negri Inst Pharmacol Res, Dept Oncol, Milan, Italy; [Calura, Enrica; Romualdi, Chiara] Univ Padua, Dept Biol, Padua, Italy; [Cavalieri, Duccio] Res & Innovat Ctr, Dept Computat Biol, San Michele All Adige, Trento, Italy; [Chiorino, Giovanna; Ostano, Paola] Fdn Edo & Elvo Tempia Valenta, Canc Genom Lab, Biella, Italy; [D'Angelo, Daniela] CNR, I-80125 Naples, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of Padua; Fondazione Edmund Mach; Consiglio Nazionale delle Ricerche (CNR)	Uboldi, S (corresponding author), Mario Negri Inst Pharmacol Res, Dept Oncol, Via Eritrea 62, Milan, Italy.	maurizio.dincalci@marionegri.it	Beltrame, Luca/AAB-1998-2020; Ostano, Paola/K-1979-2018; D'Incalci, Maurizio/AAA-9021-2020; D'Angelo, Daniela/GVT-9143-2022; Chiorino, Giovanna/K-5037-2016; Fuso Nerini, Ilaria/AAY-1505-2020; CAVALIERI, DUCCIO/T-3097-2017; Romualdi, Chiara/K-1132-2016; Marchini, sergio/J-3968-2018; Calura, Enrica/AAA-1847-2021	Beltrame, Luca/0000-0003-3631-6544; Ostano, Paola/0000-0002-4000-2954; D'Incalci, Maurizio/0000-0001-8784-1360; Chiorino, Giovanna/0000-0002-9502-6400; Fuso Nerini, Ilaria/0000-0002-1715-8299; CAVALIERI, DUCCIO/0000-0001-6426-5719; Romualdi, Chiara/0000-0003-4792-9047; Marchini, sergio/0000-0003-1783-7651; Calura, Enrica/0000-0001-8463-2432; Uboldi, Sarah/0000-0002-6430-0323	University of Padova [CPDR075919]; CINECA [HP10BDJ9X8]; ACTO foundation; Compagnia di San Paolo, Torino, Italy; Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	University of Padova; CINECA(CINECA, Italy); ACTO foundation; Compagnia di San Paolo, Torino, Italy(Compagnia di San Paolo); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	This work was supported by University of Padova (CPDR075919 to CR). Furthermore, the authors want to acknowledge the CINECA Award N. HP10BDJ9X8, 2010 for the availability of high performance computing resources and support. The authors acknowledge the generous contribution of the Italian Association for Cancer Research (AIRC). IFN is recipient of a fellowship from ACTO foundation. PO and GC are supported by Compagnia di San Paolo, Torino, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alao JP, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-24; Alexiou P, 2010, NUCLEIC ACIDS RES, V38, pD137, DOI 10.1093/nar/gkp888; AMAN P, 1992, GENE CHROMOSOME CANC, V5, P278, DOI 10.1002/gcc.2870050403; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Blower PE, 2007, MOL CANCER THER, V6, P1483, DOI 10.1158/1535-7163.MCT-07-0009; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Boni V, 2010, MOL CANCER THER, V9, P2265, DOI 10.1158/1535-7163.MCT-10-0061; Carter NJ, 2010, DRUGS, V70, P355, DOI 10.2165/11202860-000000000-00000; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Conyers Rachel, 2011, Sarcoma, V2011, P483154, DOI 10.1155/2011/483154; D'Incalci M, 2010, MOL CANCER THER, V9, P2157, DOI 10.1158/1535-7163.MCT-10-0263; Del Campo JM, 2009, ANN ONCOL, V20, P1794, DOI 10.1093/annonc/mdp198; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Duan ZF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006967; Forni C, 2009, MOL CANCER THER, V8, P449, DOI 10.1158/1535-7163.MCT-08-0848; Friard O, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-435; Giovannetti E, CRITICAL REV ONCOLOG; Grosso F, 2009, ANN ONCOL, V20, P1439, DOI 10.1093/annonc/mdp004; Grosso F, 2007, LANCET ONCOL, V8, P595, DOI 10.1016/S1470-2045(07)70175-4; Gu JY, 2011, MED ONCOL, V28, P211, DOI 10.1007/s12032-009-9413-7; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hebert C, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-5; Huber W., 2003, STAT APPL GENET MOL, V2, pARTICL, DOI [10.2202/1544-6115.1008, DOI 10.2202/1544-6115.1008]; Hurley LH, 2001, ADV EXP MED BIOL, V500, P289; Imoto I, 2001, CANCER RES, V61, P6629; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Krasner CN, 2007, BRIT J CANCER, V97, P1618, DOI 10.1038/sj.bjc.6604088; Li YM, 2010, HEMATOLOGY, V15, P215, DOI 10.1179/102453310X12647083620840; Marchini S, 2008, ANN ONCOL, V19, P501, DOI 10.1093/annonc/mdm519; Minuzzo M, 2005, MOL PHARMACOL, V68, P1496, DOI 10.1124/mol.105.013615; Minuzzo M, 2000, P NATL ACAD SCI USA, V97, P6780, DOI 10.1073/pnas.97.12.6780; Monk BJ, 2011, GYNECOL ONCOL, V120, P459, DOI 10.1016/j.ygyno.2010.11.012; Nikolsky Y, 2005, TOXICOL LETT, V158, P20, DOI 10.1016/j.toxlet.2005.02.004; Osella M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001101; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Sales G, 2010, NUCLEIC ACIDS RES, V38, pW352, DOI 10.1093/nar/gkq423; Sessa C, 2005, J CLIN ONCOL, V23, P1867, DOI 10.1200/JCO.2005.09.032; Shi L, 2010, BRAIN RES, V1352, P255, DOI 10.1016/j.brainres.2010.07.009; Sill M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-556; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Sorrentino A, 2008, GYNECOL ONCOL, V111, P478, DOI 10.1016/j.ygyno.2008.08.017; Sui SJH, 2005, NUCLEIC ACIDS RES, V33, P3154, DOI 10.1093/nar/gki624; Uboldi S, 2011, INT J CANC; Witkiewicz-Kucharczyk A, 2006, TOXICOL LETT, V162, P29, DOI 10.1016/j.toxlet.2005.10.018	47	11	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e35423	10.1371/journal.pone.0035423	http://dx.doi.org/10.1371/journal.pone.0035423			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523595	Green Published, Green Submitted, gold			2022-12-27	WOS:000305345000068
J	Yuan, JH; Cheng, FY; Zhou, SL				Yuan, Jun-Hui; Cheng, Fang-Yun; Zhou, Shi-Liang			Genetic Structure of the Tree Peony (Paeonia rockii) and the Qinling Mountains as a Geographic Barrier Driving the Fragmentation of a Large Population	PLOS ONE			English	Article							NUCLEAR MICROSATELLITES; HABITAT FRAGMENTATION; F-STATISTICS; PATTERNS; HISTORY; WESTERN; DIFFERENTIATION; PHYLOGEOGRAPHY; CONSERVATION; CONSEQUENCES	Background: Tree peonies are great ornamental plants associated with a rich ethnobotanical history in Chinese culture and have recently been used as an evolutionary model. The Qinling Mountains represent a significant geographic barrier in Asia, dividing mainland China into northern (temperate) and southern (semi-tropical) regions; however, their flora has not been well analyzed. In this study, the genetic differentiation and genetic structure of Paeonia rockii and the role of the Qinling Mountains as a barrier that has driven intraspecific fragmentation were evaluated using 14 microsatellite markers. Methodology/Principal Findings: Twenty wild populations were sampled from the distributional range of P. rockii. Significant population differentiation was suggested (F-ST value of 0.302). Moderate genetic diversity at the population level (H-S of 0.516) and high population diversity at the species level (H-T of 0.749) were detected. Significant excess homozygosity (F-IS of 0.076) and recent population bottlenecks were detected in three populations. Bayesian clusters, population genetic trees and principal coordinate analysis all classified the P. rockii populations into three genetic groups and one admixed Wenxian population. An isolation-by-distance model for P. rockii was suggested by Mantel tests (r = 0.6074, P<0.001) and supported by AMOVA (P<0.001), revealing a significant molecular variance among the groups (11.32%) and their populations (21.22%). These data support the five geographic boundaries surrounding the Qinling Mountains and adjacent areas that were detected with Monmonier's maximum-difference algorithm. Conclusions/Significance: Our data suggest that the current genetic structure of P. rockii has resulted from the fragmentation of a formerly continuously distributed large population following the restriction of gene flow between populations of this species by the Qinling Mountains. This study provides a fundamental genetic profile for the conservation and responsible exploitation of the extant germplasm of this species and for improving the genetic basis for breeding its cultivars.	[Yuan, Jun-Hui; Cheng, Fang-Yun] Beijing Forestry Univ, Landscape Architecture Coll, Beijing, Peoples R China; [Cheng, Fang-Yun] Natl Flower Engn Res Ctr, Key Lab Genet & Breeding Forestry Trees & Ornamen, Beijing, Peoples R China; [Yuan, Jun-Hui] Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China; [Yuan, Jun-Hui] Gansu Forestry Technol Coll, Tianshui, Gansu, Peoples R China	Beijing Forestry University; Chinese Academy of Sciences; Institute of Botany, CAS	Yuan, JH (corresponding author), Beijing Forestry Univ, Landscape Architecture Coll, Beijing, Peoples R China.	chengfy8@263.net; slzhou@ibcas.ac.cn		Yuan, Junhui/0000-0003-3312-8599	National Natural Science Foundation of China [31171984, 30930010]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by the National Natural Science Foundation of China (31171984, 30930010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizawa M, 2008, J BIOGEOGR, V35, P1295, DOI 10.1111/j.1365-2699.2008.01880.x; Angers B, 1998, MOL BIOL EVOL, V15, P143, DOI 10.1093/oxfordjournals.molbev.a025911; Bai WN, 2010, NEW PHYTOL, V188, P892, DOI 10.1111/j.1469-8137.2010.03407.x; Burg TM, 2005, MOL ECOL, V14, P3745, DOI 10.1111/j.1365-294X.2005.02710.x; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Cheng F. Y., 2007, INT J PLANT BREEDING, V1, P89, DOI [10.3923/ijpbg.2007.89.94, DOI 10.3923/IJPBG.2007.89.94, DOI 10.3923/ijpbg.2007.89.94]; Cheng FangYun, 1997, Acta Horticulturae Sinica, V24, P180; Cheng FY, CHINESE FLARE TREE P; Comes HP, 1998, TRENDS PLANT SCI, V3, P432, DOI 10.1016/S1360-1385(98)01327-2; Cornuet JM, 1996, GENETICS, V144, P2001; Dieringer D, 2003, MOL ECOL NOTES, V3, P167, DOI 10.1046/j.1471-8286.2003.00351.x; Dong YP, 2011, J ASIAN EARTH SCI, V41, P213, DOI 10.1016/j.jseaes.2011.03.002; Doyle J. J., 1987, PHYTOCHEM B, P11; ElMousadik A, 1996, THEOR APPL GENET, V92, P832, DOI 10.1007/BF00221895; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fu LG, 1992, CHINESE RED DATA BOO; Goudet J, 2002, FSTAT PROGRAM ESTIMA, DOI DOI 10.1093/OXFORDJOURNALS.JHERED.A111627; Hartl Daniel L., PRINCIPLES POPULATIO; Heuertz M, 2004, EVOLUTION, V58, P976; Hong D., 2010, PEONIES WORLD TAXONO; Hong DY, 2005, ACTA PHYTOTAXON SIN, V43, P169, DOI 10.1360/aps040065; HONG DY, 1998, ACTA PHYTOTAX SINICA, V36, P538; Honnay O, 2007, CONSERV BIOL, V21, P823, DOI 10.1111/j.1523-1739.2006.00646.x; Jing Xin-Ming, 1999, Acta Phytophysiologica Sinica, V25, P214; Keyghobadi N, 2007, CAN J ZOOL, V85, P1049, DOI 10.1139/Z07-095; Knowles LL, 2002, MOL ECOL, V11, P2623, DOI 10.1046/j.1365-294X.2002.01637.x; Lei FM, 2003, BIODIVERS CONSERV, V12, P239, DOI 10.1023/A:1021928801558; Li J.J., 2005, CHINESE TREE PEONY X; Liu JH, 2010, CHINESE J GEOPHYS-CH, V53, P2405, DOI 10.3969/j.issn.0001-5733.2010.10.014; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Manni F, 2004, HUM BIOL, V76, P173, DOI 10.1353/hub.2004.0034; MANTEL N, 1967, CANCER RES, V27, P209; MARUYAMA T, 1985, GENETICS, V111, P675; Meng Li, 2004, Scientia Silvae Sinicae, V40, P110; MONMONIER MS, 1973, GEOGR ANAL, V5, P245; Moore MJ, 2010, P NATL ACAD SCI USA, V107, P4623, DOI 10.1073/pnas.0907801107; NEI M, 1983, J MOL EVOL, V19, P153, DOI 10.1007/BF02300753; NEI M, 1975, EVOLUTION, V29, P1, DOI 10.2307/2407137; Nordborg M, 2001, HDB STAT GENETICS; Paetkau D, 1997, GENETICS, V147, P1943; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pei YL, 1995, ACTA PHYTO SIN, V33, P350; Pritchard JK, 2000, GENETICS, V155, P945; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Richard M, 2001, MOL PHYLOGENET EVOL, V20, P351, DOI 10.1006/mpev.2001.0981; Rousset F, 1997, GENETICS, V145, P1219; Sang T, 1997, AM J BOT, V84, P1120, DOI 10.2307/2446155; Schwarzbach AE, 2002, MOL ECOL, V11, P1703, DOI 10.1046/j.1365-294X.2002.01557.x; Shen L, 2005, HEREDITY, V94, P396, DOI 10.1038/sj.hdy.6800616; SLATKIN M, 1995, GENETICS, V139, P457; Sousa V, 2008, CONSERV GENET, V9, P791, DOI 10.1007/s10592-007-9399-7; Takahashi T, 2005, J PLANT RES, V118, P83, DOI 10.1007/s10265-005-0198-2; Tsuda Y, 2005, MOL ECOL, V14, P3929, DOI 10.1111/j.1365-294X.2005.02715.x; Wang HW, 2006, MOL ECOL, V15, P4109, DOI 10.1111/j.1365-294X.2006.03086.x; Wang JX, 2009, CONSERV GENET, V10, P1029, DOI 10.1007/s10592-008-9680-4; Wang Y, 2011, TRIBOL LETT, V41, P163, DOI 10.1007/s11249-010-9697-y; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Ying JS, 1994, ENDEMIC GENERA SEED; Ying T.-S., 1994, ACTA PHYTOTAXONOMICA, V32, P389; Young A, 1996, TRENDS ECOL EVOL, V11, P413, DOI 10.1016/0169-5347(96)10045-8; Yuan JH, 2011, CONSERV GENET, V12, P1539, DOI 10.1007/s10592-011-0251-8; Yuan JH, 2010, INT J PLANT SCI, V171, P409, DOI 10.1086/651228; Zhang JM, 2009, SCI CHINA SER C, V52, P568, DOI 10.1007/s11427-009-0069-5; Zhang YP, 2002, PURE APPL CHEM, V74, P575, DOI 10.1351/pac200274040575; Zou YuPing, 1999, Acta Phytotaxonomica Sinica, V37, P220	66	60	71	2	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e34955	10.1371/journal.pone.0034955	http://dx.doi.org/10.1371/journal.pone.0034955			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523566	Green Submitted, gold, Green Published			2022-12-27	WOS:000305345000038
J	Banerjee, J; Sharma, R; Agarwal, A; Maitra, D; Diamond, MP; Abu-Soud, HM				Banerjee, Jashoman; Sharma, Rakesh; Agarwal, Ashok; Maitra, Dhiman; Diamond, Michael P.; Abu-Soud, Husam M.			IL-6 and Mouse Oocyte Spindle	PLOS ONE			English	Article							OXIDATIVE STRESS; PERITONEAL-FLUID; CYTOKINE PRODUCTION; L-CARNITINE; TNF-ALPHA; IN-VITRO; ENDOMETRIOSIS; INTERLEUKIN-6; WOMEN; ASSOCIATION	Interleukin 6 (IL-6) is considered a major indicator of the acute-phase inflammatory response. Endometriosis and pelvic inflammation, diseases that manifest elevated levels of IL-6, are commonly associated with higher infertility. However, the mechanistic link between elevated levels of IL-6 and poor oocyte quality is still unclear. In this work, we explored the direct role of this cytokine as a possible mediator for impaired oocyte spindle and chromosomal structure, which is a critical hurdle in the management of infertility. Metaphase-II mouse oocytes were exposed to recombinant mouse IL-6 (50, 100 and 200 ng/mL) for 30 minutes and subjected to indirect immunofluorescent staining to identify alterations in the microtubule and chromosomal alignment compared to untreated controls. The deterioration in microtubule and chromosomal alignment were evaluated utilizing both fluorescence and confocal microscopy, and were quantitated with a previously reported scoring system. Our results showed that IL-6 caused a dose-dependent deterioration in microtubule and chromosomal alignment in the treated oocytes as compared to the untreated group. Indeed, IL-6 at a concentration as low as 50 ng/mL caused deterioration in the spindle structure in 60% of the oocytes, which increased significantly (P<0.0001) as IL-6 concentration was increased. In conclusion, elevated levels of IL-6 associated with endometriosis and pelvic inflammation may reduce the fertilizing capacity of human oocyte through a mechanism that involves impairment of the microtubule and chromosomal structure.	[Banerjee, Jashoman; Maitra, Dhiman; Diamond, Michael P.; Abu-Soud, Husam M.] Wayne State Univ, Dept Obstet & Gynecol, Detroit, MI 48202 USA; [Sharma, Rakesh; Agarwal, Ashok] Cleveland Clin, Ctr Reprod Med, Glickman Urol & Kidney Inst, Cleveland, OH 44106 USA; [Abu-Soud, Husam M.] Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI USA	Wayne State University; Cleveland Clinic Foundation; Wayne State University	Banerjee, J (corresponding author), Wayne State Univ, Dept Obstet & Gynecol, Detroit, MI 48202 USA.	habusoud@med.wayne.edu; jbanerje@med.wayne.edu	Agarwal, Ashok/B-1689-2013	Agarwal, Ashok/0000-0003-0585-1026; Diamond, Michael/0000-0001-6353-4489; , dhiman/0000-0002-8775-2963; Maitra, Dhiman/0000-0003-4604-3551				Agarwal SK, 2011, J MANAGE CARE PHARM, V17, pS14, DOI 10.18553/jmcp.2011.17.s9-b.S14; Banerjee J, 2012, J PINEAL RES; Bromfield JJ, 2011, ENDOCRINOLOGY; Chen CY, 1998, ARCH BIOCHEM BIOPHYS, V356, P127, DOI 10.1006/abbi.1998.0761; Choi WJ, 2007, FERTIL STERIL, V88, P1220, DOI 10.1016/j.fertnstert.2007.02.067; de Gonzalo-Calvo D, 2010, FREE RADICAL BIO MED, V49, P733, DOI 10.1016/j.freeradbiomed.2010.05.019; Demir B, 2009, AM J REPROD IMMUNOL, V62, P261, DOI 10.1111/j.1600-0897.2009.00734.x; Desmarquest P, 1998, RESP MED, V92, P951, DOI 10.1016/S0954-6111(98)90195-0; Eichenlaub-Ritter U, 2004, REPROD BIOMED ONLINE, V8, P45, DOI 10.1016/S1472-6483(10)60497-X; Falcone T, 2011, OBSTET GYNECOL, V118, P691, DOI 10.1097/AOG.0b013e31822adfd1; Gabay C, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1917; Gardiner CS, 1998, BIOL REPROD, V59, P431, DOI 10.1095/biolreprod59.2.431; Garrido N, 2000, HUM REPROD UPDATE, V6, P67, DOI 10.1093/humupd/6.1.67; Giwa MO, 2012, NEUROLOGY; Goud AP, 2008, FREE RADICAL BIO MED, V44, P1295, DOI 10.1016/j.freeradbiomed.2007.11.014; Goud AP, 2006, BIOCHEMISTRY-US, V45, P11366, DOI 10.1021/bi060910e; Haddad JJE, 2001, CYTOKINE, V13, P138, DOI 10.1006/cyto.2000.0789; Harada T, 1997, AM J OBSTET GYNECOL, V176, P593, DOI 10.1016/S0002-9378(97)70553-2; Helmy AA, 2012, NEURODEGENER DIS; Kang M, 2011, GENES NUTR, V6, P117, DOI 10.1007/s12263-010-0195-5; Kowaltowski AJ, 1999, FREE RADICAL BIO MED, V26, P463, DOI 10.1016/S0891-5849(98)00216-0; Kyama CM, 2006, FERTIL STERIL, V85, P1667, DOI 10.1016/j.fertnstert.2005.11.060; Lee WJ, 2010, J VASC SURG, V52, P1290, DOI 10.1016/j.jvs.2010.04.085; Liu ZL, 2009, ENDOCRINOLOGY, V150, P3360, DOI 10.1210/en.2008-1532; Mahnke JL, 2000, FERTIL STERIL, V73, P166, DOI 10.1016/S0015-0282(99)00466-5; Mansour G, 2010, FERTIL STERIL, V94, P1894, DOI 10.1016/j.fertnstert.2009.09.043; Mansour G, 2009, FERTIL STERIL, V91, P2079, DOI 10.1016/j.fertnstert.2008.02.097; MILLS JL, 1988, NEW ENGL J MED, V318, P671, DOI 10.1056/NEJM198803173181104; Nallella KP, 2004, UROLOGY, V64, P1010, DOI 10.1016/j.urology.2004.05.045; NASRESFAHANI MM, 1991, DEVELOPMENT, V113, P551; Negi G, 2011, J PINEAL RES, V50, P124, DOI 10.1111/j.1600-079X.2010.00821.x; Papaleo E, 2011, ACTA OBSTET GYN SCAN, V90, P878, DOI 10.1111/j.1600-0412.2011.01161.x; Papathanasiou A, 2008, FERTIL STERIL, V90, P391, DOI 10.1016/j.fertnstert.2007.07.1379; Pellicer A, 1998, FERTIL STERIL, V70, P425, DOI 10.1016/S0015-0282(98)00204-0; Punnonen J, 1996, AM J OBSTET GYNECOL, V174, P1522, DOI 10.1016/S0002-9378(96)70600-2; Richter HE, 1999, AM J OBSTET GYNECOL, V181, P940, DOI 10.1016/S0002-9378(99)70329-7; Rose-John S, 2006, J LEUKOCYTE BIOL, V80, P227, DOI 10.1189/jlb.1105674; Saito H, 2002, GYNECOL OBSTET INVES, V53, P46, DOI 10.1159/000049424; Tarin JJ, 2004, MOL REPROD DEV, V69, P402, DOI 10.1002/mrd.20180; Tseng JF, 1996, J CLIN ENDOCR METAB, V81, P1118, DOI 10.1210/jc.81.3.1118; VanVoorhis WC, 1996, J INFECT DIS, V174, P647, DOI 10.1093/infdis/174.3.647; Wang Wei-Hua, 2002, Cloning and Stem Cells, V4, P269, DOI 10.1089/15362300260339557; WINTER BK, 1995, BRIT J CANCER, V72, P1173, DOI 10.1038/bjc.1995.482; Yang HW, 1998, HUM REPROD, V13, P998, DOI 10.1093/humrep/13.4.998; Yi K, 2011, MOL VIS, V17, P2665	45	27	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35535	10.1371/journal.pone.0035535	http://dx.doi.org/10.1371/journal.pone.0035535			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536401	Green Submitted, Green Published, gold			2022-12-27	WOS:000305339200076
J	Chien, LC; Deshpande, AD; Jeffe, DB; Schootman, M				Chien, Lung-Chang; Deshpande, Anjali D.; Jeffe, Donna B.; Schootman, Mario			Influence of Primary Care Physician Availability and Socioeconomic Deprivation on Breast Cancer from 1988 to 2008: A Spatio-Temporal Analysis	PLOS ONE			English	Article							SCREENING MAMMOGRAPHY; FAMILY-HISTORY; MORTALITY; HEALTH; DISPARITIES; THERAPY; WOMEN; INEQUALITIES; COHORT; RATES	Background: Breast cancer is the most commonly diagnosed cancer and the second leading cause of cancer death among women in the United States. It is unclear how county-level primary care physician (PCP) availability and socioeconomic deprivation affect the spatial and temporal variation of breast cancer incidence and mortality. Methods: We used the 1988-2008 public-use county-based data from nine Surveillance, Epidemiology, and End Results (SEER) programs to analyze the temporal and spatial disparity of PCP availability and socioeconomic deprivation on early-stage incidence, advanced-stage incidence and breast cancer mortality. The spatio-temporal analysis was implemented by a novel structural additive modeling approach. Results: Greater PCP availability was significantly associated with higher early-stage incidence, advanced-stage incidence and mortality during the entire study period while socioeconomic deprivation was significantly negatively associated with early-stage incidence, advanced-stage incidence, and mortality up to 1992. However, the observed influence of PCP availability and socioeconomic deprivation varied by county. Conclusions: We showed important associations of PCP availability and socioeconomic deprivation with the three breast cancer indicators. However, the effect of these associations varied over time and across counties. The association of PCP availability and socioeconomic deprivation was stronger in selected counties.	[Chien, Lung-Chang; Deshpande, Anjali D.; Jeffe, Donna B.; Schootman, Mario] Washington Univ, Sch Med, Dept Internal Med, Div Hlth Behav Res, St Louis, MO 63110 USA	Washington University (WUSTL)	Chien, LC (corresponding author), Washington Univ, Sch Med, Dept Internal Med, Div Hlth Behav Res, St Louis, MO 63110 USA.	lchien@dom.wustl.edu	Schootman, Mario/AAF-3941-2019; Jeffe, Donna B./AAI-3732-2020	Schootman, Mario/0000-0003-1162-8824; Jeffe, Donna B./0000-0002-7642-3777	National Cancer Institute [CA109675, CA91842]; NATIONAL CANCER INSTITUTE [R01CA109675, P30CA091842] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported in part by grants from the National Cancer Institute (CA109675, CA91842). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Baade PD, 2011, J EPIDEMIOL COMMUN H, V65, P1037, DOI 10.1136/jech.2010.114777; BallardBarbash R, 1996, JNCI-J NATL CANCER I, V88, P716, DOI 10.1093/jnci/88.11.716; Belitz C, 2009, BAYESX SOFTWARE BAYE; BESAG J, 1991, ANN I STAT MATH, V43, P1, DOI 10.1007/BF00116466; Brezger A, 2006, COMPUT STAT DATA AN, V50, P967, DOI 10.1016/j.csda.2004.10.011; Brezger A, 2005, J STAT SOFTWARE, V14; Chang CH, 2011, JAMA-J AM MED ASSOC, V305, P2096, DOI 10.1001/jama.2011.665; Cui Y, 2007, J HEALTH CARE POOR U, V18, P102, DOI 10.1353/hpu.2007.0115; DeSantis C, 2008, CANCER CAUSE CONTROL, V19, P537, DOI 10.1007/s10552-008-9113-1; DeSantis C, 2011, CA-CANCER J CLIN, V61, P409, DOI 10.3322/caac.20134; Fahrmeir L, 2001, J ROY STAT SOC C-APP, V50, P201, DOI 10.1111/1467-9876.00229; Ferrante JM, 2000, J AM BOARD FAM PRACT, V13, P408, DOI DOI 10.3122/15572625-13-6-408; Glass AG, 2007, JNCI-J NATL CANCER I, V99, P1152, DOI 10.1093/jnci/djm059; Gonzalez P, 2011, WOMEN HEALTH ISS, V21, P165, DOI 10.1016/j.whi.2010.09.001; Goodwin JS, 1998, AM J PUBLIC HEALTH, V88, P458, DOI 10.2105/AJPH.88.3.458; Gorey KM, 2011, CAN J RURAL MED, V16, P47; Gramling R, 2009, EPIDEMIOLOGY, V20, P752, DOI 10.1097/EDE.0b013e3181a71279; Jemal A, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1672; Kazembe Lawrence N, 2007, Int J Equity Health, V6, P5, DOI 10.1186/1475-9276-6-5; Krieger N, 2002, AM J EPIDEMIOL, V156, P471, DOI 10.1093/aje/kwf068; Laden F, 1997, J NATL CANCER I, V89, P1373, DOI 10.1093/jnci/89.18.1373; Lang S, 2004, J COMPUT GRAPH STAT, V13, P183, DOI 10.1198/1061860043010; Lopez EDS, 2009, WOMEN HEALTH ISS, V19, P434, DOI 10.1016/j.whi.2009.07.008; Macinko J, 2007, INT J HEALTH SERV, V37, P111, DOI 10.2190/3431-G6T7-37M8-P224; Meissner HI, 2011, CANCER-AM CANCER SOC, V117, P3101, DOI 10.1002/cncr.25873; Merkin SS, 2002, AM J PUBLIC HEALTH, V92, P64, DOI 10.2105/AJPH.92.1.64; Messer LC, 2006, J URBAN HEALTH, V83, P1041, DOI 10.1007/s11524-006-9094-x; Price MA, 2010, BREAST CANCER RES TR, V124, P509, DOI 10.1007/s10549-010-0868-1; Roux AVD, 2001, ANN EPIDEMIOL, V11, P395, DOI 10.1016/S1047-2797(01)00221-6; Saenz R, 2009, TRENDS BREAST CANC M; Schootman M, 2010, BREAST CANCER RES TR, V122, P533, DOI 10.1007/s10549-009-0729-y; SHEEHAN TJ, 2004, INT J HEALTH GEOGR, V3, P17; Shi L, 2002, HEALTH SERV RES, V37, P529, DOI 10.1111/1475-6773.t01-1-00036; Shi LY, 2005, SOC SCI MED, V61, P65, DOI 10.1016/j.socscimed.2004.11.056; Shi LY, 2001, AM J PUBLIC HEALTH, V91, P1246, DOI 10.2105/AJPH.91.8.1246; Singh GK, 2003, AM J PUBLIC HEALTH, V93, P1137, DOI 10.2105/AJPH.93.7.1137; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Vieira VM, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-46; Vona-Davis L, 2009, J WOMENS HEALTH, V18, P883, DOI 10.1089/jwh.2008.1127; Yankaskas BC, 2010, AM J PUBLIC HEALTH, V100, P947, DOI 10.2105/AJPH.2008.150318	40	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35737	10.1371/journal.pone.0035737	http://dx.doi.org/10.1371/journal.pone.0035737			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UD	22536433	gold, Green Published, Green Submitted			2022-12-27	WOS:000305339200105
J	Li, JL; Li, HX; Gao, XJ; Zhang, JL; Li, S; Xu, SW; Tang, ZX				Li, Jin-Long; Li, Hui-Xin; Gao, Xue-Jiao; Zhang, Jiu-Li; Li, Shu; Xu, Shi-Wen; Tang, Zhao-Xin			Priority in Selenium Homeostasis Involves Regulation of SepSecS Transcription in the Chicken Brain	PLOS ONE			English	Article							SELENOPROTEIN-P; GENE-EXPRESSION; MOUSE-BRAIN; SELENOCYSTEINE; REGIONS; PROTEIN; BIOSYNTHESIS; DEFICIENCY; MACHINERY; MECHANISM	O-Phosphoseryl-tRNA: selenocysteinyl-tRNA synthase (SepSecS) is critical for the biosynthesis and transformation of selenocysteine (Sec) and plays an important role in the biological function of Se through the regulation of selenoprotein synthesis. Selenium (Se) and Selenoprotein play a pivotal role in brain function. However, how intake of the micronutrient Se affects gene expression and how genetic factors influence Se metabolism in the brain is unknown. To investigate the regulation of SepSecS transcription induced by Se in the chicken brain, we determined the Se content of brain tissue, SepSecS gene expression levels and mRNA stability in the chicken brain and primary cultured chicken embryos neurons receiving Se supplements. These results showed that Se content in the brain remains remarkably stable during Se supplementation. A significant increase in SepSecS mRNA levels was observed in all of the brain tissues of chickens fed diets containing 1-5 mg/kg sodium selenite. Most strikingly, significant changes in SepSecS mRNA levels were not observed in neurons treated with Se. However, Se altered the SepSecS mRNA half-life in cells. These data suggest that Se could regulate SepSecS mRNA stability in the avian brain and that SepSecS plays an important role in Se homeostasis regulation.	[Li, Jin-Long; Gao, Xue-Jiao; Zhang, Jiu-Li; Li, Shu; Xu, Shi-Wen] NE Agr Univ, Coll Vet Med, Harbin, Peoples R China; [Li, Jin-Long; Tang, Zhao-Xin] S China Agr Univ, Coll Vet Med, Guangzhou, Guangdong, Peoples R China; [Li, Hui-Xin] Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Div Avian Infect Dis, Harbin, Peoples R China	Northeast Agricultural University - China; South China Agricultural University; Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS	Xu, SW (corresponding author), NE Agr Univ, Coll Vet Med, Harbin, Peoples R China.	shiwenxu@neau.edu.cn; tangzx@scau.edu.cn	Li, Jin-Long/S-4288-2016	Li, Jin-Long/0000-0002-5133-9165	Program for New Century Excellent Talents in Heilongjiang Provincial University of China [1252-NCET-009]; National Natural Science Foundation of China [30901088, 30871902]; Science Foundation of the Education Department of Heilongjiang Province [12511031, 11551030]; China Postdoctoral Science Foundation [20110491021]	Program for New Century Excellent Talents in Heilongjiang Provincial University of China(Program for New Century Excellent Talents in University (NCET)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Foundation of the Education Department of Heilongjiang Province; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This study was supported by grants from the Program for New Century Excellent Talents in Heilongjiang Provincial University of China (1252-NCET-009), the National Natural Science Foundation of China (30901088 and 30871902), the Science Foundation of the Education Department of Heilongjiang Province (12511031 and 11551030), and China Postdoctoral Science Foundation (20110491021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aeby E, 2009, P NATL ACAD SCI USA, V106, P5088, DOI 10.1073/pnas.0901575106; Blanquicett C, 2010, FREE RADICAL BIO MED, V48, P1618, DOI 10.1016/j.freeradbiomed.2010.03.007; Brauer AU, 2004, REV NEUROSCIENCE, V15, P19; Burk RF, 2005, ANNU REV NUTR, V25, P215, DOI 10.1146/annurev.nutr.24.012003.132120; Chen J, 2003, J NEUROCHEM, V86, P1, DOI 10.1046/j.1471-4159.2003.01854.x; De Rubeis S, 2010, MOL CELL NEUROSCI, V43, P43, DOI 10.1016/j.mcn.2009.09.013; Driscoll DM, 2003, ANNU REV NUTR, V23, P17, DOI 10.1146/annurev.nutr.23.011702.073318; Ebeid TA, 2009, BRIT POULTRY SCI, V50, P641, DOI 10.1080/00071660903303415; FORCHHAMMER K, 1989, NATURE, V342, P453, DOI 10.1038/342453a0; Gu QP, 2002, BIOMETALS, V15, P411, DOI 10.1023/A:1020241032336; HASUNUMA R, 1982, ANAL BIOCHEM, V126, P242, DOI 10.1016/0003-2697(82)90510-3; Hatfield DL, 2006, PROG NUCLEIC ACID RE, V81, P97, DOI 10.1016/S0079-6603(06)81003-2; Hoppe B, 2008, CELL TISSUE RES, V332, P403, DOI 10.1007/s00441-008-0575-y; Kyriakopoulos A, 2000, J TRACE ELEM MED BIO, V14, P179, DOI 10.1016/S0946-672X(00)80008-5; Li JL, 2012, BIOMETALS, V25, P459, DOI 10.1007/s10534-012-9517-y; Li JL, 2011, BIOMETALS, V24, P291, DOI 10.1007/s10534-010-9395-0; Li JL, 2011, MOL BIOL REP, V38, P4015, DOI 10.1007/s11033-010-0520-5; Li JL, 2010, BIOMETALS, V23, P695, DOI 10.1007/s10534-010-9334-0; MANGOURA D, 1993, P NATL ACAD SCI USA, V90, P2915, DOI 10.1073/pnas.90.7.2915; Moriarty PM, 1998, MOL CELL BIOL, V18, P2932, DOI 10.1128/MCB.18.5.2932; Nakayama A, 2007, J NUTR, V137, P690, DOI 10.1093/jn/137.3.690; Peirson SN, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng073; Peng X, 2011, BIOL TRACE ELEM RES, V142, P167, DOI 10.1007/s12011-010-8756-4; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Renko K, 2008, BIOCHEM J, V409, P741, DOI 10.1042/BJ20071172; Richardson Des R, 2005, Biochem J, V386, pe5; Sachdev SW, 2001, BIOCHEM J, V357, P851; Savaskan NE, 2002, FASEB J, V16, P112, DOI 10.1096/fj.02-0067fje; Savaskan NE, 2007, BIOL CHEM, V388, P1007, DOI 10.1515/BC.2007.126; Schomburg L, 2004, CELL MOL LIFE SCI, V61, P1988, DOI 10.1007/s00018-004-4114-z; Schomburg L, 2009, BBA-GEN SUBJECTS, V1790, P1453, DOI 10.1016/j.bbagen.2009.03.015; Schweizer U, 2004, BRAIN RES REV, V45, P164, DOI 10.1016/j.brainresrev.2004.03.004; Schweizer U, 2004, J NUTR, V134, P707, DOI 10.1093/jn/134.4.707; Sheppard K, 2008, NUCLEIC ACIDS RES, V36, P1813, DOI 10.1093/nar/gkn015; St Germain DL, 2009, ENDOCRINOLOGY, V150, P1097, DOI 10.1210/en.2008-1588; Su D, 2009, IUBMB LIFE, V61, P35, DOI 10.1002/iub.136; Sun Y, 2001, J NUTR BIOCHEM, V12, P88, DOI 10.1016/S0955-2863(00)00130-3; Xu XM, 2007, PLOS BIOL, V5, P96, DOI 10.1371/journal.pbio.0050004; Zhang S, 2010, MECH AGEING DEV, V131, P253, DOI 10.1016/j.mad.2010.02.006; Zhang Y, 2008, J BIOL CHEM, V283, P2427, DOI 10.1074/jbc.M707951200; Zhou JC, 2009, J NUTR, V139, P1061, DOI 10.3945/jn.109.104901	41	24	24	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35761	10.1371/journal.pone.0035761	http://dx.doi.org/10.1371/journal.pone.0035761			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536434	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339200108
J	Fernandez-Martos, CM; Gonzalez, P; Rodriguez, FJ				Maria Fernandez-Martos, Carmen; Gonzalez, Pau; Javier Rodriguez, Francisco			Acute Leptin Treatment Enhances Functional Recovery after Spinal Cord Injury	PLOS ONE			English	Article							METHIONYL HUMAN LEPTIN; ACTIVE ANTIRETROVIRAL THERAPY; ALZHEIMERS-DISEASE; KAPPA-B; HYPOTHALAMIC NEURONS; TAU PHOSPHORYLATION; METABOLIC SYNDROME; NEUROPATHIC PAIN; GAIT ANALYSIS; OBESE GENE	Background: Spinal cord injury is a major cause of long-term disability and has no current clinically accepted treatment. Leptin, an adipocyte-derived hormone, is best known as a regulator of food intake and energy expenditure. Interestingly, several studies have demonstrated that leptin has significant effects on proliferation and cell survival in different neuropathologies. Here, we sought to evaluate the role of leptin after spinal cord injury. Findings: Based on its proposed neuroprotective role, we have evaluated the effects of a single, acute intraparenchymal injection of leptin in a clinically relevant animal model of spinal cord injury. As determined by quantitative Real Time-PCR, endogenous leptin and the long isoform of the leptin receptor genes show time-dependent variations in their expression in the healthy and injured adult spinal cord. Immunohistochemical analysis of post-injury tissue showed the long isoform of the leptin receptor expression in oligodendrocytes and, to a lesser extent, in astrocytes, microglia/macrophages and neurons. Moreover, leptin administered after spinal cord injury increased the expression of neuroprotective genes, reduced caspase-3 activity and decreased the expression of pro-inflammatory molecules. In addition, histological analysis performed at the completion of the study showed that leptin treatment reduced microglial reactivity and increased caudal myelin preservation, but it did not modulate astroglial reactivity. Consequently, leptin improved the recovery of sensory and locomotor functioning. Conclusions: Our data suggest that leptin has a prominent neuroprotective and anti-inflammatory role in spinal cord damage and highlights leptin as a promising therapeutic agent.	[Maria Fernandez-Martos, Carmen; Gonzalez, Pau; Javier Rodriguez, Francisco] HNP, Mol Neurol Lab, Toledo, Spain		Rodriguez, FJ (corresponding author), HNP, Mol Neurol Lab, Toledo, Spain.	fjrodriguez@sescam.jccm.es	Sanchez, Pau Gonzalez/J-2530-2019; Rodríguez Muñoz, Francisco Javier/GZM-5286-2022; Fernandez-Martos, Carmen/J-7770-2014	Sanchez, Pau Gonzalez/0000-0002-8871-8054; Rodríguez Muñoz, Francisco Javier/0000-0001-5902-7556; Fernandez-Martos, Carmen/0000-0002-6387-4456	Spanish Health Council [PI08/1475]; FEDER	Spanish Health Council; FEDER(European Commission)	This study has been supported by the project PI08/1475 from the "Fondo de Investigaciones Sanitarias" from the Spanish Health Council (cofunded by FEDER). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almad A, 2010, J COMP NEUROL, V518, P785, DOI 10.1002/cne.22242; Ankeny DP, 2009, NEUROSCIENCE, V158, P1112, DOI 10.1016/j.neuroscience.2008.07.001; Banks WA, 2008, CURR PHARM DESIGN, V14, P1606, DOI 10.2174/138161208784705496; Basso DM, 2004, J NEUROTRAUM, V21, P395, DOI 10.1089/089771504323004548; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Beattie MS, 2002, PROG BRAIN RES, V137, P37; Bjorbaek C, 2001, J BIOL CHEM, V276, P4747, DOI 10.1074/jbc.M007439200; Bouret SG, 2004, SCIENCE, V304, P108, DOI 10.1126/science.1095004; Brambilla R, 2005, J EXP MED, V202, P145, DOI 10.1084/jem.20041918; Brennan AM, 2009, EUR J ENDOCRINOL, V160, P173, DOI 10.1530/EJE-08-0597; Cafferty WBJ, 2004, J NEUROSCI, V24, P4432, DOI 10.1523/JNEUROSCI.2245-02.2004; Carro Eva M, 2009, Recent Pat CNS Drug Discov, V4, P200; Chan JL, 2008, CLIN PHARMACOKINET, V47, P753, DOI 10.2165/00003088-200847110-00006; Chan JL, 2007, J CLIN ENDOCR METAB, V92, P2307, DOI 10.1210/jc.2006-2864; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Davies JE, 2006, J NEUROTRAUM, V23, P397, DOI 10.1089/neu.2006.23.397; Davies JE, 2004, EUR J NEUROSCI, V19, P1226, DOI 10.1111/j.1460-9568.2004.03184.x; Dixon W, 1948, J AM STAT ASSOC, V48, P109; DomBourian MG, 2006, SPINE, V31, P2778, DOI 10.1097/01.brs.0000245865.97424.b4; Dominguez E, 2010, J NEUROSCI, V30, P5754, DOI 10.1523/JNEUROSCI.5007-09.2010; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Fujioka K, 1999, JAMA-J AM MED ASSOC, V282, P1517, DOI 10.1001/jama.282.16.1517; Garcia-Alias G, 2006, BRAIN RES, V1108, P195, DOI 10.1016/j.brainres.2006.06.029; Ghanizadeh A, 2011, BRAIN DEV-JPN, V33, P92, DOI 10.1016/j.braindev.2010.08.003; Greco SJ, 2008, BIOCHEM BIOPH RES CO, V376, P536, DOI 10.1016/j.bbrc.2008.09.026; Greco SJ, 2010, J ALZHEIMERS DIS, V19, P1155, DOI 10.3233/JAD-2010-1308; Greco SJ, 2009, NEUROSCI LETT, V455, P191, DOI 10.1016/j.neulet.2009.03.066; Greco SJ, 2009, BIOCHEM BIOPH RES CO, V380, P98, DOI 10.1016/j.bbrc.2009.01.041; Guo ZH, 2008, J BIOL CHEM, V283, P1754, DOI 10.1074/jbc.M703753200; Hamers FPT, 2006, J NEUROTRAUM, V23, P537, DOI 10.1089/neu.2006.23.537; Hamers FPT, 2001, J NEUROTRAUM, V18, P187, DOI 10.1089/08977150150502613; Harvey J, 2010, CLIN CHEM, V56, P696, DOI 10.1373/clinchem.2010.144006; Hwa JJ, 1996, HORM METAB RES, V28, P659, DOI 10.1055/s-2007-979873; Jiao JW, 2005, EMBO J, V24, P1068, DOI 10.1038/sj.emboj.7600589; Jones TB, 2005, CURR PHARM DESIGN, V11, P1223, DOI 10.2174/1381612053507468; Knafo S, 2008, BRIT J NEUROSURG, V22, P3, DOI 10.1080/02688690701593595; KUNKELBAGDEN E, 1993, EXP NEUROL, V119, P153, DOI 10.1006/exnr.1993.1017; Lankhorst AJ, 2001, J NEUROTRAUM, V18, P203, DOI 10.1089/08977150150502622; Lee GH, 1996, NATURE, V379, P632, DOI 10.1038/379632a0; Lee JH, 2006, J CLIN ENDOCR METAB, V91, P2605, DOI 10.1210/jc.2005-1545; Lim G, 2009, J CLIN INVEST, V119, P295, DOI 10.1172/JCI36785; Lindsey AE, 2000, NEUROREHAB NEURAL RE, V14, P287, DOI 10.1177/154596830001400405; Fernandez-Martos CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027000; McDonald JW, 2002, LANCET, V359, P417, DOI 10.1016/S0140-6736(02)07603-1; McLennan DN, 2003, PHARM RES-DORDR, V20, P1156, DOI 10.1023/A:1025036611949; Munzberg H, 2005, CELL MOL LIFE SCI, V62, P642, DOI 10.1007/s00018-004-4432-1; Niswender KD, 2001, NATURE, V413, P794, DOI 10.1038/35101657; Park SW, 2007, J PHARMACOL EXP THER, V320, P1002, DOI 10.1124/jpet.106.113472; Pinto S, 2004, SCIENCE, V304, P110, DOI 10.1126/science.1089459; Polak PE, 2005, J NEUROIMMUNOL, V168, P65, DOI 10.1016/j.jneuroim.2005.07.006; Popovich PG, 1999, EXP NEUROL, V158, P351, DOI 10.1006/exnr.1999.7118; Russo VC, 2004, ENDOCRINOLOGY, V145, P4103, DOI 10.1210/en.2003-1767; Shanley LJ, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-24-j0001.2001; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Spencer NFL, 1997, INT IMMUNOL, V9, P1581, DOI 10.1093/intimm/9.10.1581; STEPHENS TW, 1995, NATURE, V377, P530, DOI 10.1038/377530a0; Strauch ED, 2003, J AM COLL SURGEONS, V197, P974, DOI 10.1016/S1072-7515(03)00720-8; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; Tezapsidis N, 2009, J ALZHEIMERS DIS, V16, P731, DOI 10.3233/JAD-2009-1021; Tian YH, 2011, PAIN, V152, P1263, DOI 10.1016/j.pain.2011.01.054; Valerio A, 2006, J BIOL CHEM, V281, P12950, DOI 10.1074/jbc.M508691200; Weng Z, 2007, J BIOL CHEM, V282, P34479, DOI 10.1074/jbc.M705426200; Xu AW, 2005, J CLIN INVEST, V115, P951, DOI 10.1172/JCI200524301; Zhang EE, 2004, P NATL ACAD SCI USA, V101, P16064, DOI 10.1073/pnas.0405041101; Zhang F, 2007, STROKE, V38, P2329, DOI 10.1161/STROKEAHA.107.482786; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Zimmermann M, 2001, EUR J PHARMACOL, V429, P23, DOI 10.1016/S0014-2999(01)01303-6	67	48	50	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35594	10.1371/journal.pone.0035594	http://dx.doi.org/10.1371/journal.pone.0035594			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536415	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339200084
J	Petit-Paitel, A; Menard, B; Guyon, A; Beringue, V; Nahon, JL; Zsurger, N; Chabry, J				Petit-Paitel, Agnes; Menard, Baptiste; Guyon, Alice; Beringue, Vincent; Nahon, Jean-Louis; Zsuerger, Nicole; Chabry, Joelle			Prion Protein Is a Key Determinant of Alcohol Sensitivity through the Modulation of N-Methyl-D-Aspartate Receptor (NMDAR) Activity	PLOS ONE			English	Article							FYN-KINASE; ETHANOL SENSITIVITY; MICE LACKING; LIPID RAFTS; PRP; LOCALIZATION; MOLECULES; INFECTION; CAVEOLAE; BINDING	The prion protein (PrP) is absolutely required for the development of prion diseases; nevertheless, its physiological functions in the central nervous system remain elusive. Using a combination of behavioral, electrophysiological and biochemical approaches in transgenic mouse models, we provide strong evidence for a crucial role of PrP in alcohol sensitivity. Indeed, PrP knock out (PrP-/-) mice presented a greater sensitivity to the sedative effects of EtOH compared to wild-type (wt) control mice. Conversely, compared to wt mice, those over-expressing mouse, human or hamster PrP genes presented a relative insensitivity to ethanol-induced sedation. An acute tolerance (i.e. reversion) to ethanol inhibition of N-methyl-D-aspartate (NMDA) receptor-mediated excitatory post-synaptic potentials in hippocampal slices developed slower in PrP-/- mice than in wt mice. We show that PrP is required to induce acute tolerance to ethanol by activating a Src-protein tyrosine kinase-dependent intracellular signaling pathway. In an attempt to decipher the molecular mechanisms underlying PrP-dependent ethanol effect, we looked for changes in lipid raft features in hippocampus of ethanol-treated wt mice compared to PrP-/- mice. Ethanol induced rapid and transient changes of buoyancy of lipid raft-associated proteins in hippocampus of wt but not PrP-/- mice suggesting a possible mechanistic link for PrP-dependent signal transduction. Together, our results reveal a hitherto unknown physiological role of PrP on the regulation of NMDAR activity and highlight its crucial role in synaptic functions.	[Petit-Paitel, Agnes; Menard, Baptiste; Guyon, Alice; Nahon, Jean-Louis; Zsuerger, Nicole; Chabry, Joelle] CNRS, Inst Pharmacol Mol & Cellulaire, F-06560 Valbonne, France; [Beringue, Vincent] INRA, UR892, Jouy En Josas, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Chabry, J (corresponding author), CNRS, Inst Pharmacol Mol & Cellulaire, 660 Route Lucioles, F-06560 Valbonne, France.	chabry@ipmc.cnrs.fr	; NAHON, Jean-Louis/O-7977-2016; Guyon, Alice/P-5192-2016	Petit-Paitel, Agnes/0000-0003-1138-9966; NAHON, Jean-Louis/0000-0001-9572-7779; Guyon, Alice/0000-0003-3346-8411	Agence Nationale de Recherche [ANR-06-NEURO-007-01]; IREB (France)	Agence Nationale de Recherche(French National Research Agency (ANR)); IREB (France)	This work was supported by grants from the Agence Nationale de Recherche (ANR-06-NEURO-007-01) and by the IREB (France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi A, 2008, ANNU REV NEUROSCI, V31, P439, DOI 10.1146/annurev.neuro.31.060407.125620; Arevalo E, 2008, P NATL ACAD SCI USA, V105, P371, DOI 10.1073/pnas.0707815105; Beggs HE, 1997, J BIOL CHEM, V272, P8310, DOI 10.1074/jbc.272.13.8310; Beringue V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001419; Bjarnadottir M, 2007, J NEUROSCI, V27, P4519, DOI 10.1523/JNEUROSCI.4314-06.2007; Boehm SL, 2004, NEUROSCI LETT, V372, P6, DOI 10.1016/j.neulet.2004.08.028; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; COLLINGE J, 1994, NATURE, V370, P295, DOI 10.1038/370295a0; Criado JR, 2005, NEUROBIOL DIS, V19, P255, DOI 10.1016/j.nbd.2005.01.001; Cronier S, 2007, J VIROL, V81, P13794, DOI 10.1128/JVI.01502-07; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; Gourdain P, 2009, J IMMUNOL, V183, P6619, DOI 10.4049/jimmunol.0804385; GROVER CA, 1994, BRAIN RES, V642, P70, DOI 10.1016/0006-8993(94)90906-7; hare S, 2011, ALCOHOL CLIN EXP RES; HARRIS RA, 1995, P NATL ACAD SCI USA, V92, P3658, DOI 10.1073/pnas.92.9.3658; Herms J, 1999, J NEUROSCI, V19, P8866, DOI 10.1523/JNEUROSCI.19-20-08866.1999; Khosravani H, 2008, J CELL BIOL, V181, P551, DOI 10.1083/jcb.200711002; Lisanti Michael P., 1994, Trends in Cell Biology, V4, P231, DOI 10.1016/0962-8924(94)90114-7; Loeuillet C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013166; Marella M, 2004, J NEUROSCI, V24, P620, DOI 10.1523/JNEUROSCI.4303-03.2004; Miyakawa T, 1997, SCIENCE, V278, P698, DOI 10.1126/science.278.5338.698; Mouillet-Richard S, 2000, SCIENCE, V289, P1925, DOI 10.1126/science.289.5486.1925; Nourissat P, 2008, HEPATOLOGY, V47, P59, DOI 10.1002/hep.21958; Palachick B, 2008, ALCOHOL CLIN EXP RES, V32, P1479, DOI 10.1111/j.1530-0277.2008.00715.x; Peoples RW, 1996, ANNU REV PHARMACOL, V36, P185, DOI 10.1146/annurev.pa.36.040196.001153; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Ron D, 2004, NEUROSCIENTIST, V10, P325, DOI 10.1177/1073858404263516; Sales N, 1998, EUR J NEUROSCI, V10, P2464, DOI 10.1046/j.1460-9568.1998.00258.x; Santuccione A, 2005, J CELL BIOL, V169, P341, DOI 10.1083/jcb.200409127; Schmitt-Ulms G, 2001, J MOL BIOL, V314, P1209, DOI 10.1006/jmbi.2000.5183; Silveri MM, 2002, ALCOHOL CLIN EXP RES, V26, P449, DOI 10.1111/j.1530-0277.2002.tb02560.x; Szabo G, 2007, J IMMUNOL, V178, P1243, DOI 10.4049/jimmunol.178.3.1243; Tansey MG, 2000, NEURON, V25, P611, DOI 10.1016/S0896-6273(00)81064-8; Tobler I, 1996, NATURE, V380, P639, DOI 10.1038/380639a0; Tobler I, 1997, J NEUROSCI, V17, P1869; Vengeliene V, 2008, BRIT J PHARMACOL, V154, P299, DOI 10.1038/bjp.2008.30; Vey M, 1996, P NATL ACAD SCI USA, V93, P14945, DOI 10.1073/pnas.93.25.14945; Walz R, 1999, EPILEPSIA, V40, P1679, DOI 10.1111/j.1528-1157.1999.tb01583.x; WILSON WR, 1990, ALCOHOL, V7, P389, DOI 10.1016/0741-8329(90)90021-4; Yaka R, 2003, ALCOHOL CLIN EXP RES, V27, P1736, DOI 10.1097/01.ALC.0000095924.87729.D8; Yaka R, 2003, J NEUROSCI, V23, P3623	41	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e34691	10.1371/journal.pone.0034691	http://dx.doi.org/10.1371/journal.pone.0034691			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536327	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339200016
J	Twin, J; Jensen, JS; Bradshaw, CS; Garland, SM; Fairley, CK; Min, LY; Tabrizi, SN				Twin, Jimmy; Jensen, Jorgen S.; Bradshaw, Catriona S.; Garland, Suzanne M.; Fairley, Christopher K.; Min, Lim Yi; Tabrizi, Sepehr N.			Transmission and Selection of Macrolide Resistant Mycoplasma genitalium Infections Detected by Rapid High Resolution Melt Analysis	PLOS ONE			English	Article							REAL-TIME PCR; 23S RIBOSOMAL-RNA; NONGONOCOCCAL URETHRITIS; AZITHROMYCIN; PNEUMONIAE; MANAGEMENT; MUTATIONS; FAILURE; TRACT	Background: Mycoplasma genitalium (MG) causes urethritis, cervicitis and pelvic inflammatory disease. The MG treatment failure rate using 1 g azithromycin at an Australian Sexual Health clinic in 2007-9 was 31% (95%CI 23-40%). We developed a rapid high resolution melt analysis (HRMA) assay targeting resistance mutations in the MG 23S rRNA gene, and validated it against DNA sequencing by examining pre- and post-treatment archived samples from MG-infected patients. Methodology/Principal Findings: Available MG-positive pre-treatment (n = 82) and post-treatment samples from individuals with clinical treatment failure (n = 20) were screened for 23S rRNA gene mutations. Sixteen (20%) pre-treatment samples possessed resistance mutations (A2058G, A2059G, A2059C), which were significantly more common in patients with symptomatic azithromycin-treatment failure (12/26; 44%) than in those clinically cured (4/56; 7%), p<0.001. All 20 patients experiencing azithromycin-failure had detectable mutations in their post-treatment samples. In 9 of these cases, the same mutational types were present in both pre- and post-treatment samples indicating transmitted resistance, whilst in 11 of these cases (55%), mutations were absent in pre-treatment samples indicating likely selection of resistant isolates have occurred. HRMA was able to detect all mutational changes determined in this study by DNA sequencing. An additional HRMA assay incorporating an unlabelled probe was also developed to detect type 4 single-nucleotide polymorphisms found in other populations, with a slightly lower sensitivity of 90%. Conclusions/Significance: Treatment failure is associated with the detection of macrolide resistance mutations, which appear to be almost equally due to selection of resistant isolates following exposure to 1 g azithromycin and pre- existing transmitted resistance. The application of a rapid molecular assay to detect resistance at the time of initial detection of infection allows clinicians to shorten the time to initiate effective second line treatment. This has the potential to reduce transmission of resistant strains and to avoid sequelae associated with persistent untreated infection.	[Twin, Jimmy; Garland, Suzanne M.; Tabrizi, Sepehr N.] Royal Womens Hosp, Dept Microbiol & Infect Dis, Melbourne, Vic, Australia; [Twin, Jimmy; Garland, Suzanne M.; Tabrizi, Sepehr N.] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Jensen, Jorgen S.] Statens Serum Inst, DK-2300 Copenhagen, Denmark; [Bradshaw, Catriona S.; Fairley, Christopher K.; Min, Lim Yi] Alfred Hosp, Melbourne Sexual Hlth Ctr, Melbourne, Vic, Australia; [Bradshaw, Catriona S.] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Bradshaw, Catriona S.; Fairley, Christopher K.] Univ Melbourne, Melbourne Sch Populat Hlth, Melbourne, Vic, Australia; [Garland, Suzanne M.; Tabrizi, Sepehr N.] Univ Melbourne, Dept Obstet & Gynecol, Melbourne, Vic, Australia; [Garland, Suzanne M.] Royal Childrens Hosp, Dept Microbiol, Melbourne, Vic, Australia	Murdoch Children's Research Institute; Statens Serum Institut; Florey Institute of Neuroscience & Mental Health; Monash University; University of Melbourne; University of Melbourne; Royal Children's Hospital Melbourne	Twin, J (corresponding author), Royal Womens Hosp, Dept Microbiol & Infect Dis, Melbourne, Vic, Australia.	jimmy.twin@mcri.edu.au	Jensen, Jørgen/I-2917-2012; Jensen, Jørgen Skov/H-5159-2019	Jensen, Jørgen Skov/0000-0002-7464-7435; Christopher, Fairley/0000-0001-9081-1664; bradshaw, catriona/0000-0002-6643-5678				Bjornelius E, 2007, SEX TRANSM INFECT, V84, P72, DOI [10.1136/ti.2007.027375, 10.1136/sti.2007.027375]; Bradshaw CS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003618; Bradshaw CS, 2006, EMERG INFECT DIS, V12, P1149, DOI 10.3201/eid1207.051558; Bradshaw CS, 2010, 2010 AUSTR SEX HLTH; Cao B, 2010, CLIN INFECT DIS, V51, P189, DOI 10.1086/653535; Cohen CR, 2002, LANCET, V359, P765, DOI 10.1016/S0140-6736(02)07848-0; Deguchi T, 2002, J UROLOGY, V167, P1210, DOI 10.1016/S0022-5347(05)65268-8; FitzGerald M, 1996, INT J STD AIDS, V7, P298, DOI 10.1258/0956462961917861; FRASER CM, 1995, SCIENCE, V270, P397, DOI 10.1126/science.270.5235.397; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Hjorth SV, 2006, J CLIN MICROBIOL, V44, P2078, DOI 10.1128/JCM.00003-06; Horner PJ, 2010, SEX TRANSM INFECT; Ito S, 2011, SEX TRANSM INFECT, V87, P412, DOI 10.1136/sextrans-2011-050035; Jensen JS, 2008, CLIN INFECT DIS, V47, P1546, DOI 10.1086/593188; Jensen JS, 2004, J CLIN MICROBIOL, V42, P683, DOI 10.1128/JCM.42.2.683-692.2004; Jensen JS, 2004, J EUR ACAD DERMATOL, V18, P1, DOI 10.1111/j.1468-3083.2004.00923.x; Jernberg E, 2008, INT J STD AIDS, V19, P676, DOI 10.1258/ijsa.2008.008038; LUCIER TS, 1995, ANTIMICROB AGENTS CH, V39, P2770, DOI 10.1128/AAC.39.12.2770; Ma L, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-130; Mackinnon A, 2000, COMPUT BIOL MED, V30, P127, DOI 10.1016/S0010-4825(00)00006-8; Mena LA, 2009, CLIN INFECT DIS, V48, P1649, DOI 10.1086/599033; Morozumi M, 2010, J INFECT CHEMOTHER, V16, P78, DOI 10.1007/s10156-009-0021-4; Peuchant O, 2009, J ANTIMICROB CHEMOTH, V64, P52, DOI 10.1093/jac/dkp160; Rozen S, 2000, Methods Mol Biol, V132, P365; Sen Yew H, 2011, J CLIN MICROBIOL, V49, P1695, DOI 10.1128/JCM.02475-10; Shahmanesh M, 2009, INT J STD AIDS, V20, P458, DOI 10.1258/ijsa.2009.009143; Shimada Y, 2011, EMERG INFECT DIS, V17, P1148, DOI [10.3201/eid1706.101055, 10.3201/eid/1706.101055]; Svenstrup HF, 2005, J CLIN MICROBIOL, V43, P3121, DOI 10.1128/JCM.43.7.3121-3128.2005; Taylor-Robinson D, 2002, INT J STD AIDS, V13, P145, DOI 10.1258/0956462021924776; TULLY JG, 1981, LANCET, V1, P1288; Twin J, 2011, J CLIN MICROBIOL, V49, P1140, DOI 10.1128/JCM.02328-10; Uuskula A, 2002, INT J STD AIDS, V13, P79, DOI 10.1258/0956462021924695; Wolff BJ, 2008, ANTIMICROB AGENTS CH, V52, P3542, DOI 10.1128/AAC.00582-08	33	80	84	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35593	10.1371/journal.pone.0035593	http://dx.doi.org/10.1371/journal.pone.0035593			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22532861	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339200083
J	Vaas, LAI; Sikorski, J; Michael, V; Goker, M; Klenk, HP				Vaas, Lea A. I.; Sikorski, Johannes; Michael, Victoria; Goeker, Markus; Klenk, Hans-Peter			Visualization and Curve-Parameter Estimation Strategies for Efficient Exploration of Phenotype Microarray Kinetics	PLOS ONE			English	Article							METABOLIC RECONSTRUCTION; LONGITUDINAL DATA; SPLINE FUNCTIONS; GROWTH; BIOLOGY; MODELS; EVOLUTION; NETWORKS	Background: The Phenotype MicroArray (OmniLog (R) PM) system is able to simultaneously capture a large number of phenotypes by recording an organism's respiration over time on distinct substrates. This technique targets the object of natural selection itself, the phenotype, whereas previously addressed '-omics' techniques merely study components that finally contribute to it. The recording of respiration over time, however, adds a longitudinal dimension to the data. To optimally exploit this information, it must be extracted from the shapes of the recorded curves and displayed in analogy to conventional growth curves. Methodology: The free software environment R was explored for both visualizing and fitting of PM respiration curves. Approaches using either a model fit (and commonly applied growth models) or a smoothing spline were evaluated. Their reliability in inferring curve parameters and confidence intervals was compared to the native OmniLog (R) PM analysis software. We consider the post-processing of the estimated parameters, the optimal classification of curve shapes and the detection of significant differences between them, as well as practically relevant questions such as detecting the impact of cultivation times and the minimum required number of experimental repeats. Conclusions: We provide a comprehensive framework for data visualization and parameter estimation according to user choices. A flexible graphical representation strategy for displaying the results is proposed, including 95% confidence intervals for the estimated parameters. The spline approach is less prone to irregular curve shapes than fitting any of the considered models or using the native PM software for calculating both point estimates and confidence intervals. These can serve as a starting point for the automated post-processing of PM data, providing much more information than the strict dichotomization into positive and negative reactions. Our results form the basis for a freely available R package for the analysis of PM data.	[Vaas, Lea A. I.; Sikorski, Johannes; Michael, Victoria; Goeker, Markus; Klenk, Hans-Peter] DSMZ German Collect Microorganisms & Cell Culture, Braunschweig, Germany	Leibniz Institut fur Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ)	Goker, M (corresponding author), DSMZ German Collect Microorganisms & Cell Culture, Braunschweig, Germany.	markus.goeker@dsmz.de	Göker, Markus/AAX-6258-2021; Sikorski, Johannes/AAD-9775-2019; Sikorski, Johannes/AAX-1960-2020	Göker, Markus/0000-0002-5144-6200; Sikorski, Johannes/0000-0002-1890-5540	Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH; European Union [222886 MICROME]; German Research Foundation (DFG) [SFB/TRR 51]; DFG [SI1352/1-2]	Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH; European Union(European Commission); German Research Foundation (DFG)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG))	Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH funded this research through the employment of all authors, who contributed to all aspects of the study. This work was supported by the European Union grant 222886 MICROME and the German Research Foundation (DFG) SFB/TRR 51, which is gratefully acknowledged. Also, the DFG grant SI1352/1-2 to JS is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Asab MS, 2011, OMICS, V15, P105, DOI 10.1089/omi.2010.0023; Akaike H, 1983, INT STAT I, V44, P277, DOI DOI 10.1086/PHOS.50.4.187553; Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; [Anonymous], [No title captured]; [Anonymous], 2010, R LANG ENV STAT COMP; Baba Tomoya, 2008, V416, P183, DOI 10.1007/978-1-59745-321-9_12; Balding DJ, 2004, APPL LONGITUDINAL AN; Becker R.A., 1996, TOUR TRELLIS GRAPHIC; BiOLOG Inc, 2009, CONV FIL MAN SOFTW P; Birch CPD, 1999, ANN BOT-LONDON, V83, P713, DOI 10.1006/anbo.1999.0877; Bochner BR, 2009, FEMS MICROBIOL REV, V33, P191, DOI 10.1111/j.1574-6976.2008.00149.x; Bochner BR, 2001, GENOME RES, V11, P1246, DOI 10.1101/gr.186501; BOCHNER BR, 1977, APPL ENVIRON MICROB, V33, P434, DOI 10.1128/AEM.33.2.434-444.1977; Bretz F., 2010, MULTIPLE COMP USING; BRISBIN IL, 1987, AUK, V104, P552, DOI 10.2307/4087567; Buchanan AV, 2009, BIOESSAYS, V31, P198, DOI 10.1002/bies.200800133; Bujara M, 2010, CURR OPIN BIOTECH, V21, P586, DOI 10.1016/j.copbio.2010.07.007; Chang WLE, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-109; Chen C., 2008, HDB DATA VISUALIZATI; Christian BW, 2006, INT REV HYDROBIOL, V91, P257, DOI 10.1002/iroh.200510838; CRAVEN P, 1979, NUMER MATH, V31, P377, DOI 10.1007/BF01437407; Cumming G, 2007, J CELL BIOL, V177, P7, DOI 10.1083/jcb.200611141; Di Cagno R, 2010, INT J FOOD MICROBIOL, V143, P246, DOI 10.1016/j.ijfoodmicro.2010.08.018; Dudoit S, 2008, SPRINGER SER STAT, P1; Edwards RL, 2009, MOL MICROBIOL, V71, P1190, DOI [10.1111/j.1365-2958.2009.06593.x, 10.1111/j.1365-2958.2008.06593.x]; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Eilers PHC, 1996, STAT SCI, V11, P89, DOI 10.1214/ss/1038425655; Eugster MJA, 2009, J STAT SOFTW, V30, P1; FELLER W., 1940, ACTA BIOTHEORETICA, V5, P51, DOI 10.1007/BF01602862; Feng XY, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/460717; Fitzmaurice GM, 2008, CIRCULATION, V118, P2005, DOI 10.1161/CIRCULATIONAHA.107.714618; Fodor IK, 2005, JOINT STAT M MINN MN; GARDNER MJ, 1986, BMJ-BRIT MED J, V292, P746, DOI 10.1136/bmj.292.6522.746; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gottschalk PG, 2005, ANAL BIOCHEM, V343, P54, DOI 10.1016/j.ab.2005.04.035; HAACK SK, 1995, APPL ENVIRON MICROB, V61, P1458, DOI 10.1128/AEM.61.4.1458-1468.1995; Hackett CA, 1997, J MICROBIOL METH, V30, P63, DOI 10.1016/S0167-7012(97)00045-6; Hardle W., 1992, APPL NONPARAMETRIC R; Hofner B, 2011, ECOLOGY, V92, P1895, DOI 10.1890/10-2276.1; Homann OR, 2005, PLOS GENET, V1, P715, DOI 10.1371/journal.pgen.0010080; HUTT MT, 2001, DATENANALYSE BIOL; Jacobsen JS, 2007, 11 INT C INF VIS IV0; Johnson RA., 2007, APPL MULTIVARIATE ST; Kahm M, 2010, J STAT SOFTW, V33, P1; Kandpal RP, 2009, BIOTECHNIQUES, V46, P351, DOI 10.2144/000113137; Laird N M, 1992, Stat Methods Med Res, V1, P225, DOI 10.1177/096228029200100302; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Lay JO, 2006, TRAC-TREND ANAL CHEM, V25, P1046, DOI 10.1016/j.trac.2006.10.007; Le Cao KA, 2009, BIOINFORMATICS, V25, P2855, DOI 10.1093/bioinformatics/btp515; Legendre P., 2012, NUMERICAL ECOLOGY; Mayr E, 1997, P NATL ACAD SCI USA, V94, P2091, DOI 10.1073/pnas.94.6.2091; Medina I, 2010, NUCLEIC ACIDS RES, V38, pW210, DOI 10.1093/nar/gkq388; Mitchell DA, 2004, BIOCHEM ENG J, V17, P15, DOI 10.1016/S1369-703X(03)00120-7; Mithani A, 2011, MOL BIOL EVOL, V28, P483, DOI 10.1093/molbev/msq213; Neysens P, 2003, MICROBIOL-SGM, V149, P1073, DOI 10.1099/mic.0.25880-0; Nogales J, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-79; Oh YK, 2007, J BIOL CHEM, V282, P28791, DOI 10.1074/jbc.M703759200; Papin JA, 2004, TRENDS BIOCHEM SCI, V29, P641, DOI 10.1016/j.tibs.2004.10.001; Peugh JL, 2005, EDUC PSYCHOL MEAS, V65, P811, DOI 10.1177/0013164405278558; Puchalka J, 2008, PLOS COMPUT BIOL, V4, P1; Rabe-Hesketh S., 2008, MULTILEVEL LONGITUDI; Reed JL, 2006, P NATL ACAD SCI USA, V103, P17480, DOI 10.1073/pnas.0603364103; RICHARDS FJ, 1959, J EXP BOT, V10, P290, DOI 10.1093/jxb/10.2.290; Ritz C, 2005, J STAT SOFTW, V12, pi05; Ruppin E, 2010, CURR OPIN BIOTECH, V21, P502, DOI 10.1016/j.copbio.2010.07.002; Sabet S, 2009, EXTREMOPHILES, V13, P643, DOI 10.1007/s00792-009-0247-1; Sarkar D, 2008, USE R, P1; Schaarschmidt F, 2009, HORTSCIENCE, V44, P188, DOI 10.21273/HORTSCI.44.1.188; Schenker N, 2001, AM STAT, V55, P182, DOI 10.1198/000313001317097960; Serroyen J, 2009, AM STAT, V63, P378, DOI 10.1198/tast.2009.07256; Shipley B., 2000, CAUSE CORRELATIONS B; Sikorski J, 2007, ENVIRON MICROBIOL, V9, P716, DOI 10.1111/j.1462-2920.2006.01193.x; Singer JD, 1998, J EDUC BEHAV STAT, V23, P323; Spiegelman D, 2005, CAN J MICROBIOL, V51, P355, DOI 10.1139/W05-003; Sturino J, 2010, INT J BIOSTAT, V6, DOI 10.2202/1557-4679.1227; Ventura M, 2009, NAT REV MICROBIOL, V7, P61, DOI 10.1038/nrmicro2047; Verbyla AP, 1999, J ROY STAT SOC C-APP, V48, P269, DOI 10.1111/1467-9876.00154; Vilchez-Vargas R, 2010, ENVIRON MICROBIOL, V12, P3089, DOI 10.1111/j.1462-2920.2010.02340.x; Wang X, 2012, NATURE COMMUNICATION, V1, P147; Warringer J, 2003, YEAST, V20, P53, DOI 10.1002/yea.931; Wenk MR, 2010, CELL, V143, P888, DOI 10.1016/j.cell.2010.11.033; WOLD S, 1974, TECHNOMETRICS, V16, P1, DOI 10.2307/1267485; Xue XL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020075; Zhang WW, 2010, MICROBIOL-SGM, V156, P287, DOI 10.1099/mic.0.034793-0; Zhou L, 2003, J BACTERIOL, V185, P4956, DOI 10.1128/JB.185.16.4956-4972.2003; Zimmerman DL, 2001, TEST-SPAIN, V10, P1, DOI 10.1007/BF02595823; ZWIETERING MH, 1990, APPL ENVIRON MICROB, V56, P1875	87	138	138	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e34846	10.1371/journal.pone.0034846	http://dx.doi.org/10.1371/journal.pone.0034846			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536335	Green Published, gold			2022-12-27	WOS:000305339200023
J	Pedrosa-Gerasmio, IR; Babaran, RP; Santos, MD				Pedrosa-Gerasmio, Ivane R.; Babaran, Ricardo P.; Santos, Mudjekeewis D.			Discrimination of Juvenile Yellowfin (Thunnus albacares) and Bigeye (T-obesus) Tunas using Mitochondrial DNA Control Region and Liver Morphology	PLOS ONE			English	Article								Yellowfin tuna, Thunnus albacares (Bonnaterre, 1788) and bigeye tuna, Thunnus obesus (Lowe, 1839) are two of the most economically important tuna species in the world. However, identification of their juveniles, especially at sizes less than 40 cm, is very difficult, often leading to misidentification and miscalculation of their catch estimates. Here, we applied the mitochondrial DNA control region D-loop, a recently validated genetic marker used for identifying tuna species (Genus Thunnus), to discriminate juvenile tunas caught by purse seine and ringnet sets around fish aggregating devices (FADs) off the Southern Iloilo Peninsula in Central Philippines. We checked individual identifications using the Neighbor-Joining Method and compared results with morphometric analyses and the liver phenotype. We tested 48 specimens ranging from 13 to 31 cm fork length. Morpho-meristic analyses suggested that 12 specimens (25%) were bigeye tuna and 36 specimens (75%) were yellowfin tuna. In contrast, the genetic and liver analyses both showed that 5 specimens (10%) were bigeye tuna and 43 (90%) yellowfin tuna. This suggests that misidentification can occur even with highly stringent morpho-meristic characters and that the mtDNA control region and liver phenotype are excellent markers to discriminate juveniles of yellowfin and bigeye tunas.	[Pedrosa-Gerasmio, Ivane R.; Babaran, Ricardo P.] Univ Philippines Visayas, Coll Fisheries & Ocean Sci, Iloilo, Philippines; [Pedrosa-Gerasmio, Ivane R.; Santos, Mudjekeewis D.] Natl Fisheries Res & Dev Inst, Quezon City, Philippines	University of the Philippines System; University of the Philippines Visayas	Pedrosa-Gerasmio, IR (corresponding author), Natl Fisheries Res & Dev Inst, Quezon City, Philippines.	ivanepedrosa@yahoo.com.ph	Gerasmio, Ivane/ABC-5385-2021	BABARAN, RICARDO/0000-0003-4652-3619; Santos, Mudjekeewis/0000-0002-4770-1221; /0000-0003-0618-099X	Accelerated Science and Technology Human Resource Development (ASTHRD); Department of Science and Technology-Philippine Council for Aquatic and Marine Research and Development (DOST-PCAMRD); National Fisheries Research and Development Institute (NFRDI), Philippines	Accelerated Science and Technology Human Resource Development (ASTHRD); Department of Science and Technology-Philippine Council for Aquatic and Marine Research and Development (DOST-PCAMRD)(Department of Science & Technology (DOST), Philippines); National Fisheries Research and Development Institute (NFRDI), Philippines	This work was supported by the Accelerated Science and Technology Human Resource Development (ASTHRD) and Grants-in-Aid (GIA) Programs of the Department of Science and Technology-Philippine Council for Aquatic and Marine Research and Development (DOST-PCAMRD) and the National Fisheries Research and Development Institute (NFRDI), Philippines. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babaran R, 2006, WCPFCSC22006 U PHIL; Barut N, 2010, ANN REPORT COMMISS 1; Basit S. A., 2009, EMILIO AGUINALDO COL, V7, P1; Chow S, 2006, J FISH BIOL, V68, P24, DOI 10.1111/j.0022-1112.2006.00945.x; Chow Seinen, 1993, Bulletin of the National Research Institute of Far Seas Fisheries, V30, P207; Dickson J, 1997, MECH EFFECTS AGGREGA, P141; GREWE PM, 1998, SOEST PUBLICATION, V9805; Itano D, 2005, HDB IDENTIFICATION Y, P1; Langley A, 2007, WCPFCSC3SA SWG, P1; LANGLEY A, 2006, 7 SECR PAC COMM; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liu ZJ, 2004, AQUACULTURE, V238, P1, DOI 10.1016/j.aquaculture.2004.05.027; Martinez P, 2006, MOL PHYLOGENET EVOL, V39, P404, DOI 10.1016/j.ympev.2005.07.022; McCune B., 1999, MULTIVARIATE ANAL EC; Niwa Y, 2003, AQUACULTURE, V218, P387, DOI 10.1016/S0044-8486(03)00015-2; NOAA, 2009, NAT OC ATM ADM GUID; Pearson WR, 1997, GENOMICS, V46, P24, DOI 10.1006/geno.1997.4995; Santos Mudjekeewis D., 2010, Philippine Journal of Science, V139, P43; Smith L. I., 2002, TUTORIAL PRINCIPAL C; Takeyama H, 2001, J FISH BIOL, V58, P1646, DOI 10.1111/j.1095-8649.2001.tb02319.x; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Vinas J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007606; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716	24	25	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e35604	10.1371/journal.pone.0035604	http://dx.doi.org/10.1371/journal.pone.0035604			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22536417	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336200062
J	Bayer, T; Aranda, M; Sunagawa, S; Yum, LK; DeSalvo, MK; Lindquist, E; Coffroth, MA; Voolstra, CR; Medina, M				Bayer, Till; Aranda, Manuel; Sunagawa, Shinichi; Yum, Lauren K.; DeSalvo, Michael K.; Lindquist, Erika; Coffroth, Mary Alice; Voolstra, Christian R.; Medina, Monica			Symbiodinium Transcriptomes: Genome Insights into the Dinoflagellate Symbionts of Reef-Building Corals	PLOS ONE			English	Article							GENE-EXPRESSION; DNA-CONTENT; STRESS; EVOLUTION; PROTEINS; LINEAGE; SEARCH; MODEL; ZOOXANTHELLAE; THIOREDOXIN	Dinoflagellates are unicellular algae that are ubiquitously abundant in aquatic environments. Species of the genus Symbiodinium form symbiotic relationships with reef-building corals and other marine invertebrates. Despite their ecologic importance, little is known about the genetics of dinoflagellates in general and Symbiodinium in particular. Here, we used 454 sequencing to generate transcriptome data from two Symbiodinium species from different clades (clade A and clade B). With more than 56,000 assembled sequences per species, these data represent the largest transcriptomic resource for dinoflagellates to date. Our results corroborate previous observations that dinoflagellates possess the complete nucleosome machinery. We found a complete set of core histones as well as several H3 variants and H2A.Z in one species. Furthermore, transcriptome analysis points toward a low number of transcription factors in Symbiodinium spp. that also differ in the distribution of DNA-binding domains relative to other eukaryotes. In particular the cold shock domain was predominant among transcription factors. Additionally, we found a high number of antioxidative genes in comparison to non-symbiotic but evolutionary related organisms. These findings might be of relevance in the context of the role that Symbiodinium spp. play as coral symbionts. Our data represent the most comprehensive dinoflagellate EST data set to date. This study provides a comprehensive resource to further analyze the genetic makeup, metabolic capacities, and gene repertoire of Symbiodinium and dinoflagellates. Overall, our findings indicate that Symbiodinium possesses some unique characteristics, in particular the transcriptional regulation in Symbiodinium may differ from the currently known mechanisms of eukaryotic gene regulation.	[Bayer, Till; Aranda, Manuel; Yum, Lauren K.; Voolstra, Christian R.] KAUST, Red Sea Res Ctr, Thuwal, Saudi Arabia; [Sunagawa, Shinichi] European Mol Biol Lab, Heidelberg, Germany; [DeSalvo, Michael K.] Univ Calif San Francisco, UCSF Sch Med, Dept Anesthesia, San Francisco, CA 94143 USA; [Lindquist, Erika] Joint Genome Inst, Dept Energy, Walnut Creek, CA USA; [Coffroth, Mary Alice] SUNY Buffalo, Dept Geol, Grad Program Evolut Ecol & Behav, Buffalo, NY 14260 USA; [Medina, Monica] Univ Calif Merced, Sch Nat Sci, Merced, CA USA	King Abdullah University of Science & Technology; European Molecular Biology Laboratory (EMBL); University of California System; University of California San Francisco; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of California System; University of California Merced	Bayer, T (corresponding author), KAUST, Red Sea Res Ctr, Thuwal, Saudi Arabia.	christian.voolstra@kaust.edu.sa; mmedina@ucmerced.edu	Aranda Lastra, Manuel/D-9530-2011; Sunagawa, Shinichi/Q-5950-2019; Voolstra, Christian R/H-7158-2014; Bayer, Till/H-6826-2016	Aranda Lastra, Manuel/0000-0001-6673-016X; Sunagawa, Shinichi/0000-0003-3065-0314; Voolstra, Christian R/0000-0003-4555-3795; Bayer, Till/0000-0002-4704-2449	NSF (National Science Foundation) [IOS 0644438, IOS 0926906, OCE 0424994]; KAUST AEA (King Abdullah University of Science and Technology); King Abdullah University of Science and Technology; Office of Science of the U.S. Department of Energy [DE-AC02-05CH11231]; Directorate For Geosciences [0926822] Funding Source: National Science Foundation	NSF (National Science Foundation)(National Science Foundation (NSF)); KAUST AEA (King Abdullah University of Science and Technology); King Abdullah University of Science and Technology(King Abdullah University of Science & Technology); Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This study was supported through NSF (National Science Foundation) awards IOS 0644438 and IOS 0926906 (MM), OCE 0424994 (MAC), a KAUST AEA (King Abdullah University of Science and Technology) 3 Joint Collaborative Research award (CRV), and through a Collaborative Travel Fund to TB made by King Abdullah University of Science and Technology. The work conducted by the U.S. Department of Energy Joint Genome Institute is supported by the Office of Science of the U.S. Department of Energy under Contract No. DE-AC02-05CH11231. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad K, 2002, P NATL ACAD SCI USA, V99, P16477, DOI 10.1073/pnas.172403699; Andersson JO, 2005, CELL MOL LIFE SCI, V62, P1182, DOI 10.1007/s00018-005-4539-z; Aranda M, 2011, MOL ECOL, V20, P2955, DOI 10.1111/j.1365-294X.2011.05153.x; Aravind L, 2003, CELL, V115, P771, DOI 10.1016/S0092-8674(03)01023-7; Aravind L, 2000, P NATL ACAD SCI USA, V97, P11319, DOI 10.1073/pnas.200346997; Arnaiz O, 2007, NUCLEIC ACIDS RES, V35, pD439; Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD539; Balaji S, 2005, NUCLEIC ACIDS RES, V33, P3994, DOI 10.1093/nar/gki709; BLANK RJ, 1988, ARCH MICROBIOL, V149, P515, DOI 10.1007/BF00446754; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Bouligand Y, 2001, BIOCHIMIE, V83, P187, DOI 10.1016/S0300-9084(00)01211-6; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Chibani K, 2009, MOL PLANT, V2, P308, DOI 10.1093/mp/ssn076; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Desalvo MK, 2008, MOL ECOL, V17, P3952, DOI 10.1111/j.1365-294X.2008.03879.x; DeSalvo MK, 2010, MOL ECOL, V19, P1174, DOI 10.1111/j.1365-294X.2010.04534.x; Dietz KJ, 2011, PLANT PHYSIOL, V155, P1477, DOI 10.1104/pp.110.170043; Dodge J, 1966, CHROMOSOMES ALGAE; Dong HJ, 1996, J MOL BIOL, V260, P649, DOI 10.1006/jmbi.1996.0428; Dos Santos CV, 2006, TRENDS PLANT SCI, V11, P329, DOI 10.1016/j.tplants.2006.05.005; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Eckardt NA, 2007, PLANT CELL, V19, P1719, DOI 10.1105/tpc.107.054270; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Edge SE, 2005, MAR POLLUT BULL, V51, P507, DOI 10.1016/j.marpolbul.2005.07.007; Erdner DL, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-88; Eyre-Walker A, 2001, NAT REV GENET, V2, P549, DOI 10.1038/35080577; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Gonzalez-Romero R, 2008, J MOL EVOL, V66, P505, DOI 10.1007/s00239-008-9109-1; Graham LE, 2000, J PHYCOL, V36, P975; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hackett JD, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-80; Haider S, 2009, NUCLEIC ACIDS RES, V37, pW23; Hake SB, 2006, P NATL ACAD SCI USA, V103, P6428, DOI 10.1073/pnas.0600803103; Hershberg R, 2008, ANNU REV GENET, V42, P287, DOI 10.1146/annurev.genet.42.110807.091442; Hisabori T, 2007, PHOTOCHEM PHOTOBIOL, V83, P145, DOI 10.1562/2006-02-27-IR-816; Hou YB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006978; Hsiao YY, 2010, COMP FUNCT GENOM, DOI 10.1155/2010/138538; Iguchi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020140; Iyer LM, 2008, INT J PARASITOL, V38, P1, DOI 10.1016/j.ijpara.2007.07.018; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Keeling PJ, 2008, NAT REV GENET, V9, P605, DOI 10.1038/nrg2386; KELLENBERGER E, 1992, FEMS MICROBIOL LETT, V100, P361, DOI 10.1016/0378-1097(92)90233-E; Kim JM, 1997, SCIENCE, V278, P1954, DOI 10.1126/science.278.5345.1954; Kim S, 2011, MOL BIOL EVOL, V28, P1469, DOI 10.1093/molbev/msq332; Koumandou VL, 2004, TRENDS GENET, V20, P261, DOI 10.1016/j.tig.2004.03.008; Kovalchuk I., 2010, REACTIVE OXYGEN SPEC; LaJeunesse TC, 2005, J PHYCOL, V41, P880, DOI 10.1111/j.0022-3646.2005.04231.x; LaJeunesse TC, 2005, MOL BIOL EVOL, V22, P570, DOI 10.1093/molbev/msi042; LaJeunesse TC, 2001, J PHYCOL, V37, P866, DOI 10.1046/j.1529-8817.2001.01031.x; Leggat W, 2007, J PHYCOL, V43, P1010, DOI 10.1111/j.1529-8817.2007.00387.x; Lespinet O, 2002, GENOME RES, V12, P1048, DOI 10.1101/gr.174302; Lidie KB, 2005, MAR BIOTECHNOL, V7, P481, DOI 10.1007/s10126-004-4110-6; Lin S, 2008, DINOFLAGELLATE METAT, P166; Lin S., 2007, RNA DNA EDITING MOL, P280, DOI [10.1002/9780470262269.ch13, DOI 10.1002/9780470262269.CH13]; Lin SJ, 2011, RES MICROBIOL, V162, P551, DOI 10.1016/j.resmic.2011.04.006; Lin SJ, 2010, P NATL ACAD SCI USA, V107, P20033, DOI 10.1073/pnas.1007246107; Malik HS, 2003, NAT STRUCT BIOL, V10, P882, DOI 10.1038/nsb996; Mavrich TN, 2008, GENOME RES, V18, P1073, DOI 10.1101/gr.078261.108; Mavrich TN, 2008, NATURE, V453, P358, DOI 10.1038/nature06929; Merle PL, 2007, FREE RADICAL BIO MED, V42, P236, DOI 10.1016/j.freeradbiomed.2006.10.038; Mihailovich M, 2010, BIOESSAYS, V32, P109, DOI 10.1002/bies.200900122; Moore RB, 2003, INT J SYST EVOL MICR, V53, P1725, DOI 10.1099/ijs.0.02594-0; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Moshkin YM, 2009, MOL CELL, V35, P782, DOI 10.1016/j.molcel.2009.07.020; Moustafa A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009688; MUSCATINE L, 1984, PROC R SOC SER B-BIO, V222, P181, DOI 10.1098/rspb.1984.0058; MUSCATINE L, 1981, LIMNOL OCEANOGR, V26, P601, DOI 10.4319/lo.1981.26.4.0601; Nielsen R, 1998, GENETICS, V148, P929; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Nishiyama Y, 2011, PHYSIOL PLANTARUM, V142, P35, DOI 10.1111/j.1399-3054.2011.01457.x; Niwa T, 2007, J CHROMATOGR B, V855, P59, DOI 10.1016/j.jchromb.2006.12.029; Okamoto OK, 2003, J PHYCOL, V39, P519, DOI 10.1046/j.1529-8817.2003.02170.x; Painter HJ, 2011, MOL BIOCHEM PARASIT, V176, P1, DOI 10.1016/j.molbiopara.2010.11.014; Papp E, 2003, BIOFACTORS, V17, P249, DOI 10.1002/biof.5520170124; Peden JF, 1999, ANAL CODON USAGE; Plotkin JB, 2011, NAT REV GENET, V12, P32, DOI 10.1038/nrg2899; Pochon X, 2004, MAR BIOL, V146, P17, DOI 10.1007/s00227-004-1427-2; Pochon X, 2010, MOL PHYLOGENET EVOL, V56, P492, DOI 10.1016/j.ympev.2010.03.040; POLNEFULLER M, 1991, J PHYCOL, V27, P552, DOI 10.1111/j.0022-3646.1991.00552.x; Portune KJ, 2010, MAR GENOM, V3, P51, DOI 10.1016/j.margen.2010.03.002; Pusarla RH, 2005, FEBS J, V272, P5149, DOI 10.1111/j.1742-4658.2005.04930.x; RAE PMM, 1976, SCIENCE, V194, P1062, DOI 10.1126/science.988637; Ramirez-Parra E, 2007, TRENDS PLANT SCI, V12, P570, DOI 10.1016/j.tplants.2007.10.002; Reitzel AM, 2008, BIOL BULL-US, V214, P233, DOI 10.2307/25470666; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rizzo P, 1987, BIOL DINOFLAGELLATES; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; ROWAN R, 1991, SCIENCE, V251, P1348, DOI 10.1126/science.251.4999.1348; Ryu T, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-58; Sanchez-Puerta MV, 2007, PROTIST, V158, P105, DOI 10.1016/j.protis.2006.09.004; Schmidt A, 2009, J BASIC MICROB, V49, P109, DOI 10.1002/jobm.200800293; Schnitzler CE, 2010, MAR GENOM, V3, P107, DOI 10.1016/j.margen.2010.08.002; Sunagawa S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-258; Tamura K, 2011, MOL BIOL EVOLUTION; ten Lohuis MR, 1998, J PHYCOL, V34, P152; ten Lohuis MR, 1998, PLANT PHYSIOL, V117, P189, DOI 10.1104/pp.117.1.189; van Nimwegen E, 2003, TRENDS GENET, V19, P479, DOI 10.1016/S0168-9525(03)00203-8; Veldhuis MJW, 1997, J PHYCOL, V33, P527, DOI 10.1111/j.0022-3646.1997.00527.x; Voolstra CR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020392; Voolstra CR, 2009, COMP BIOCHEM PHYS D, V4, P67, DOI 10.1016/j.cbd.2008.11.001; Voolstra CR, 2009, MOL ECOL, V18, P1823, DOI 10.1111/j.1365-294X.2009.04167.x; Wallace, 1990, ECOSYSTEMS WORLD COR; Watanabe T, 2006, J APPL PHYCOL, V18, P219, DOI 10.1007/s10811-006-9106-y; Weis VM, 2008, J EXP BIOL, V211, P3059, DOI 10.1242/jeb.009597; Wilson D, 2007, NUCLEIC ACIDS RES, V36, pD88; WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9; Yuyama I, 2011, MAR BIOTECHNOL, V13, P32, DOI 10.1007/s10126-010-9265-3; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhang H, 2007, P NATL ACAD SCI USA, V104, P4618, DOI 10.1073/pnas.0700258104; Zhang ZD, 1999, NATURE, V400, P155, DOI 10.1038/22099; Zilberman D, 2008, NATURE, V456, P125, DOI 10.1038/nature07324	116	166	167	2	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35269	10.1371/journal.pone.0035269	http://dx.doi.org/10.1371/journal.pone.0035269			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529998	Green Submitted, gold, Green Published			2022-12-27	WOS:000305350600070
J	Goler-Baron, V; Assaraf, YG				Goler-Baron, Vicky; Assaraf, Yehuda G.			Overcoming Multidrug Resistance via Photodestruction of ABCG2-Rich Extracellular Vesicles Sequestering Photosensitive Chemotherapeutics	PLOS ONE			English	Article							BREAST-CANCER CELLS; ANTICANCER; PROTEIN; IMIDAZOACRIDINONES; MITOXANTRONE; INHIBITION; MECHANISMS; EXPRESSION; DRUGS; MCF-7	Multidrug resistance (MDR) remains a dominant impediment to curative cancer chemotherapy. Efflux transporters of the ATP-binding cassette (ABC) superfamily including ABCG2, ABCB1 and ABCC1 mediate MDR to multiple structurally and functionally distinct antitumor agents. Recently we identified a novel mechanism of MDR in which ABCG2-rich extracellular vesicles (EVs) form in between attached neighbor breast cancer cells and highly concentrate various chemotherapeutics in an ABCG2-dependent manner, thereby sequestering them away from their intracellular targets. Hence, development of novel strategies to overcome MDR modalities is a major goal of cancer research. Towards this end, we here developed a novel approach to selectively target and kill MDR cancer cells. We show that illumination of EVs that accumulated photosensitive cytotoxic drugs including imidazoacridinones (IAs) and topotecan resulted in intravesicular formation of reactive oxygen species (ROS) and severe damage to the EVs membrane that is shared by EVs-forming cells, thereby leading to tumor cell lysis and the overcoming of MDR. Furthermore, consistent with the weak base nature of IAs, MDR cells that are devoid of EVs but contained an increased number of lysosomes, highly accumulated IAs in lysosomes and upon photosensitization were efficiently killed via ROS-dependent lysosomal rupture. Combining targeted lysis of IAs-loaded EVs and lysosomes elicited a synergistic cytotoxic effect resulting in MDR reversal. In contrast, topotecan, a bona fide transport substrate of ABCG2, accumulated exclusively in EVs of MDR cells but was neither detected in lysosomes of normal breast epithelial cells nor in non-MDR breast cancer cells. This exclusive accumulation in EVs enhanced the selectivity of the cytotoxic effect exerted by photodynamic therapy to MDR cells without harming normal cells. Moreover, lysosomal alkalinization with bafilomycin A1 abrogated lysosomal accumulation of IAs, consequently preventing lysosomal photodestruction of normal breast epithelial cells. Thus, MDR modalities including ABCG2-dependent drug sequestration within EVs can be rationally converted to a pharmacologically lethal Trojan horse to selectively eradicate MDR cancer cells.	[Goler-Baron, Vicky; Assaraf, Yehuda G.] Technion Israel Inst Technol, Dept Biol, Fred Wyszkowski Canc Res Lab, IL-32000 Haifa, Israel	Technion Israel Institute of Technology	Goler-Baron, V (corresponding author), Technion Israel Inst Technol, Dept Biol, Fred Wyszkowski Canc Res Lab, IL-32000 Haifa, Israel.	assaraf@tx.technion.ac.il			Fred Wyszkowski Cancer Fund	Fred Wyszkowski Cancer Fund	This study was supported by the Fred Wyszkowski Cancer Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adar Y, 2012, CELL DEATH IN PRESS; Allen JD, 1999, CANCER RES, V59, P4237; Altan N, 1998, J EXP MED, V187, P1583, DOI 10.1084/jem.187.10.1583; Assaraf YG, 2007, CANCER METAST REV, V26, P153, DOI 10.1007/s10555-007-9049-z; BEIJNEN JH, 1988, ANAL PROFILES DRUG S, V17, P221; Borst P, 2002, ANNU REV BIOCHEM, V71, P537, DOI 10.1146/annurev.biochem.71.102301.093055; Bram EE, 2009, MOL PHARMACOL, V75, P1149, DOI 10.1124/mol.109.054791; Bugaj AM, 2011, PHOTOCH PHOTOBIO SCI, V10, P1097, DOI 10.1039/c0pp00147c; Burns JH, 1972, ANAL PROFILES DRUG S, V1, P463; Ciftci K, 2003, J PHARM PHARMACOL, V55, P1135, DOI 10.1211/002235703322277177; Diestra JE, 2002, J PATHOL, V198, P213, DOI 10.1002/path.1203; Dolmans DEJGJ, 2003, NAT REV CANCER, V3, P380, DOI 10.1038/nrc1071; Goler-Baron V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016007; Golubovskaya VM, 2008, MOL CARCINOGEN, V47, P222, DOI 10.1002/mc.20380; Gonzalez-Mariscal L, 2008, BBA-BIOMEMBRANES, V1778, P729, DOI 10.1016/j.bbamem.2007.08.018; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Haimeur A, 2004, CURR DRUG METAB, V5, P21, DOI 10.2174/1389200043489199; Hartsock A, 2008, BBA-BIOMEMBRANES, V1778, P660, DOI 10.1016/j.bbamem.2007.07.012; Ifergan I, 2005, CANCER RES, V65, P10952, DOI 10.1158/0008-5472.CAN-05-2021; Ifergan I, 2009, BIOCHEM BIOPH RES CO, V380, P5, DOI 10.1016/j.bbrc.2008.12.168; Kawabata S, 2003, CLIN CANCER RES, V9, P3052; Koster DA, 2007, NATURE, V448, P213, DOI 10.1038/nature05938; Larsen AK, 2000, PHARMACOL THERAPEUT, V85, P217, DOI 10.1016/S0163-7258(99)00073-X; Maliepaard M, 2001, CLIN CANCER RES, V7, P935; Niggli V, 2008, INT J BIOCHEM CELL B, V40, P344, DOI 10.1016/j.biocel.2007.02.012; O'Connor AE, 2009, PHOTOCHEM PHOTOBIOL, V85, P1053, DOI 10.1111/j.1751-1097.2009.00585.x; Pommier Y, 2010, CHEM BIOL, V17, P421, DOI 10.1016/j.chembiol.2010.04.012; Radu IA, 2008, ROMANIAN J BIOPHYSIC, V18, P265; Robey RW, 2007, CANCER METAST REV, V26, P39, DOI 10.1007/s10555-007-9042-6; Sarkadi B, 2004, FEBS LETT, V567, P116, DOI 10.1016/j.febslet.2004.03.123; Schindler M, 1996, BIOCHEMISTRY-US, V35, P2811, DOI 10.1021/bi952234e; Skladanowski A, 1996, MOL PHARMACOL, V49, P772; Spink BC, 2006, CELL BIOL INT, V30, P227, DOI 10.1016/j.cellbi.2005.11.006; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; TAYLOR CW, 1991, BRIT J CANCER, V63, P923, DOI 10.1038/bjc.1991.202	35	37	40	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35487	10.1371/journal.pone.0035487	http://dx.doi.org/10.1371/journal.pone.0035487			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22530032	Green Published, Green Submitted, gold			2022-12-27	WOS:000305350600088
J	Luo, ZH; Tang, SH; Li, CW; Fang, HX; Hu, HJ; Yang, J; Ding, JJ; Jiang, ZG				Luo, Zhenhua; Tang, Songhua; Li, Chunwang; Fang, Hongxia; Hu, Huijian; Yang, Ji; Ding, Jingjing; Jiang, Zhigang			Environmental Effects on Vertebrate Species Richness: Testing the Energy, Environmental Stability and Habitat Heterogeneity Hypotheses	PLOS ONE			English	Article							LARGE-SCALE PATTERNS; LATITUDINAL GRADIENTS; BETA DIVERSITY; CLIMATE; RANGE; CHINA; WATER; DETERMINANTS; BIODIVERSITY; BUTTERFLIES	Background: Explaining species richness patterns is a central issue in biogeography and macroecology. Several hypotheses have been proposed to explain the mechanisms driving biodiversity patterns, but the causes of species richness gradients remain unclear. In this study, we aimed to explain the impacts of energy, environmental stability, and habitat heterogeneity factors on variation of vertebrate species richness (VSR), based on the VSR pattern in China, so as to test the energy hypothesis, the environmental stability hypothesis, and the habitat heterogeneity hypothesis. Methodology/Principal Findings: A dataset was compiled containing the distributions of 2,665 vertebrate species and eleven ecogeographic predictive variables in China. We grouped these variables into categories of energy, environmental stability, and habitat heterogeneity and transformed the data into 1006100 km quadrat systems. To test the three hypotheses, AIC-based model selection was carried out between VSR and the variables in each group and correlation analyses were conducted. There was a decreasing VSR gradient from the southeast to the northwest of China. Our results showed that energy explained 67.6% of the VSR variation, with the annual mean temperature as the main factor, which was followed by annual precipitation and NDVI. Environmental stability factors explained 69.1% of the VSR variation and both temperature annual range and precipitation seasonality had important contributions. By contrast, habitat heterogeneity variables explained only 26.3% of the VSR variation. Significantly positive correlations were detected among VSR, annual mean temperature, annual precipitation, and NDVI, whereas the relationship of VSR and temperature annual range was strongly negative. In addition, other variables showed moderate or ambiguous relations to VSR. Conclusions/Significance: The energy hypothesis and the environmental stability hypothesis were supported, whereas little support was found for the habitat heterogeneity hypothesis.	[Luo, Zhenhua; Tang, Songhua; Li, Chunwang; Fang, Hongxia; Yang, Ji; Jiang, Zhigang] Chinese Acad Sci, Inst Zool, Key Lab Anim Ecol & Conservat Biol, Beijing, Peoples R China; [Luo, Zhenhua] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Hu, Huijian] Guangdong Acad Sci, S China Inst Endangered Anim, Guangzhou, Peoples R China; [Ding, Jingjing] Jiangsu Acad Forestry, Nanjing, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Guangdong Academy of Sciences	Luo, ZH (corresponding author), Chinese Acad Sci, Inst Zool, Key Lab Anim Ecol & Conservat Biol, Beijing, Peoples R China.	jiangzg@ioz.ac.cn	Jiang, Zhigang/E-4598-2014	Jiang, Zhigang/0000-0003-2154-8588	Ministry of Science and Technology of People's Republic of China [2008BAC39B04]; Chinese Academy of Sciences [KSCX2-EW-Z-4]	Ministry of Science and Technology of People's Republic of China(Ministry of Science and Technology, China); Chinese Academy of Sciences(Chinese Academy of Sciences)	This research was funded by the Science and Technology Supporting Project of Ministry of Science and Technology of People's Republic of China (2008BAC39B04) and the Key Program of Knowledge Innovation Program of Chinese Academy of Sciences (KSCX2-EW-Z-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JM, 1989, NATURE, V339, P699, DOI 10.1038/339699a0; Altamirano A, 2010, BIOL CONSERV, V143, P2080, DOI 10.1016/j.biocon.2010.05.016; Baillie J. E. M., 2004, 2004 IUCN RED LIST T; Brown J. H., 1998, BIOGEOGRAPHY; BROWN JH, 1981, AM ZOOL, V21, P877; Burnham KP, 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; Carrara R, 2010, ECOGRAPHY, V33, P942, DOI 10.1111/j.1600-0587.2009.05756.x; Carroll C, 2010, BIOL CONSERV, V143, P1432, DOI 10.1016/j.biocon.2010.03.018; CGIAR International Research Centers, 1999, CGIAR CONS SPAT INF; Chen C.D, 1998, CHINAS BIODIVERSITY; Clarke A, 2006, P ROY SOC B-BIOL SCI, V273, P2257, DOI 10.1098/rspb.2006.3545; CONNELL JH, 1964, AM NAT, V98, P399, DOI 10.1086/282335; COUSINS SH, 1989, NATURE, V340, P350, DOI 10.1038/340350b0; CURRIE DJ, 1991, AM NAT, V137, P27, DOI 10.1086/285144; Ding TS, 2006, J BIOGEOGR, V33, P683, DOI 10.1111/j.1365-2699.2006.01419.x; Diniz JAF, 2003, GLOBAL ECOL BIOGEOGR, V12, P53, DOI 10.1046/j.1466-822X.2003.00322.x; European Commission Joint Research Centre Institute for Environment and Sustainability, 2003, GLOB LAND COV 2000 D; Fei L, 1999, ATLAS AMPHIBIANS CHI; Francis AP, 2003, AM NAT, V161, P523, DOI 10.1086/368223; Gaston K.J., 2000, PATTERN PROCESS MACR, DOI [10.1002/9780470999592, DOI 10.1002/9780470999592]; Guegan JF, 1998, NATURE, V391, P382, DOI 10.1038/34899; Hawkins BA, 2003, ECOLOGY, V84, P3105, DOI 10.1890/03-8006; Hawkins BA, 2007, ECOLOGY, V88, P255, DOI 10.1890/0012-9658(2007)88[255:GMFPWP]2.0.CO;2; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hillebrand H, 2004, AM NAT, V163, P192, DOI 10.1086/381004; Hortal J, 2008, J BIOGEOGR, V35, P1202, DOI 10.1111/j.1365-2699.2007.01850.x; Hugo S, 2008, GLOBAL ECOL BIOGEOGR, V17, P611, DOI 10.1111/j.1466-8238.2008.00391.x; Huntley B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001439; Hurlbert AH, 2005, ECOL LETT, V8, P319, DOI 10.1111/j.1461-0248.2005.00726.x; Hurlbert AH, 2004, ECOL LETT, V7, P714, DOI 10.1111/j.1461-0248.2004.00630.x; Hurlbert AH, 2007, P NATL ACAD SCI USA, V104, P13384, DOI 10.1073/pnas.0704469104; Institute of Botany Chinese Academy of Sciences., 1996, CHIN VEG DAT; Institute of Geographic Sciences and Natural Resources Research Chinese Academy of Sciences, 2002, THEM DAT HUM EARTH S; JI DM, 2002, ATLAS REPTILES CHINA; Jiang Z, 2012, ASSESSMENT IN PRESS; Jiang Z, 2009, MODERN ECOLOGY FORUM, P75; Jiang Z, 2012, SURVEY REPO IN PRESS; Kerr JT, 1997, NATURE, V385, P252, DOI 10.1038/385252a0; KLOPFER PH, 1960, AM NAT, V94, P293, DOI 10.1086/282130; KLOPFER PH, 1959, AM NAT, V93, P337, DOI 10.1086/282092; Lin Xin, 2009, Shengwu Duoyangxing, V17, P652, DOI 10.3724/SP.J.1003.2009.09065; Luo ZH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027975; MAC ARTHUR ROBERT H., 1967; MACARTHUR R, 1961, ECOLOGY, V42, P594, DOI 10.2307/1932254; MacArthur R. H., 1966, BIOL POPULATIONS; MacKinnon J, 2000, FIELD GUIDE BIRDS CH; Mellin C, 2010, GLOBAL ECOL BIOGEOGR, V19, P212, DOI 10.1111/j.1466-8238.2009.00513.x; Murray K, 2009, ECOLOGY, V90, P348, DOI 10.1890/07-1929.1; OBRIEN EM, 1993, J BIOGEOGR, V20, P181, DOI 10.2307/2845670; Pan QH, 2007, FIELD GUIDE MAMMALS; PIANKA ER, 1966, AM NAT, V100, P33, DOI 10.1086/282398; Qian H, 2007, ECOL LETT, V10, P737, DOI 10.1111/j.1461-0248.2007.01066.x; Qian H, 2009, GLOBAL ECOL BIOGEOGR, V18, P111, DOI 10.1111/j.1466-8238.2008.00415.x; Rahbek C, 2001, P NATL ACAD SCI USA, V98, P4534, DOI 10.1073/pnas.071034898; Rodriguez MA, 2005, ACTA OECOL, V28, P65, DOI 10.1016/j.actao.2005.02.006; ROHDE K, 1992, OIKOS, V65, P514, DOI 10.2307/3545569; Rosa R, 2008, GLOBAL ECOL BIOGEOGR, V17, P600, DOI 10.1111/j.1466-8238.2008.00397.x; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Roy K, 1998, P NATL ACAD SCI USA, V95, P3699, DOI 10.1073/pnas.95.7.3699; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Sang A, 2010, BIOL CONSERV, V143, P1405, DOI 10.1016/j.biocon.2010.03.015; SCHALL JJ, 1978, SCIENCE, V201, P679, DOI 10.1126/science.201.4357.679; Sheng H, 2005, ATLAS MAMMALS CHINA; STEVENS GC, 1989, AM NAT, V133, P240, DOI 10.1086/284913; Storch D, 2006, ECOL LETT, V9, P1308, DOI 10.1111/j.1461-0248.2006.00984.x; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; TURNER JRG, 1988, NATURE, V335, P539, DOI 10.1038/335539a0; TURNER JRG, 1987, OIKOS, V48, P195, DOI 10.2307/3565855; Wang Zhiheng, 2009, Shengwu Duoyangxing, V17, P613, DOI 10.3724/SP.J.1003.2009.09161; White P, 2006, ECOGRAPHY, V29, P908, DOI 10.1111/j.2006.0906-7590.04685.x; Whittaker RJ, 2001, J BIOGEOGR, V28, P453, DOI 10.1046/j.1365-2699.2001.00563.x; Whittaker RJ, 2007, GLOBAL ECOL BIOGEOGR, V16, P76, DOI 10.1111/j.1466-8238.2006.00268.x; Willig MR, 2003, ANNU REV ECOL EVOL S, V34, P273, DOI 10.1146/annurev.ecolsys.34.012103.144032; Wright David H., 1993, P66; WRIGHT DH, 1983, OIKOS, V41, P496, DOI 10.2307/3544109; ZHANG RZ, 1985, ACTA ZOOL SINICA, V31, P187; Zhao SQ, 2006, CAN J ZOOL, V84, P1368, DOI 10.1139/Z06-132; Zhao SQ, 2006, GLOBAL ECOL BIOGEOGR, V15, P386, DOI 10.1111/j.1466-822x.2006.00236.x	78	30	35	7	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35514	10.1371/journal.pone.0035514	http://dx.doi.org/10.1371/journal.pone.0035514			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22530038	gold, Green Published, Green Submitted			2022-12-27	WOS:000305350600092
J	Reyal, F; Bollet, MA; Caly, M; Gentien, D; Carpentier, S; Peyro-Saint-Paul, H; Pierga, JY; Cottu, P; Dieras, V; Sigal-Zafrani, B; Vincent-Salomon, A; Sastre-Garau, X				Reyal, Fabien; Bollet, Marc A.; Caly, Martial; Gentien, David; Carpentier, Sabrina; Peyro-Saint-Paul, Helene; Pierga, Jean-Yves; Cottu, Paul; Dieras, Veronique; Sigal-Zafrani, Brigitte; Vincent-Salomon, Anne; Sastre-Garau, Xavier			Respective Prognostic Value of Genomic Grade and Histological Proliferation Markers in Early Stage (pN0) Breast Carcinoma	PLOS ONE			English	Article							INTERNATIONAL EXPERT CONSENSUS; IMMUNOHISTOCHEMICAL EVALUATION; MOLECULAR SUBTYPES; HORMONE-RECEPTORS; PARAFFIN SECTIONS; PRIMARY THERAPY; CANCER; RECOMMENDATIONS; METAANALYSIS; INDEX	Background: Genomic grade (GG) is a 97-gene signature which improves the accuracy and prognostic value of histological grade (HG) in invasive breast carcinoma. Since most of the genes included in the GG are involved in cell proliferation, we performed a retrospective study to compare the prognostic value of GG, Mitotic Index and Ki67 score. Methods: A series of 163 consecutive breast cancers was retained (pT1-2, pN0, pM0, 10-yr follow-up). GG was computed using MapQuant Dx(R). Results: GG was low (GG-1) in 48%, high (GG-3) in 31% and equivocal in 21% of cases. For HG-2 tumors, 50% were classified as GG-1, 18% as GG-3 whereas 31% remained equivocal. In a subgroup of 132 ER+/HER2- tumors GG was the most significant prognostic factor in multivariate Cox regression analysis adjusted for age and tumor size (HR = 5.23, p = 0.02). Conclusions: In a reference comprehensive cancer center setting, compared to histological grade, GG added significant information on cell proliferation in breast cancers. In patients with HG-2 carcinoma, applying the GG to guide the treatment scheme could lead to a reduction in adjuvant therapy prescription. However, based on the results observed and considering (i) the relatively close prognostic values of GG and Ki67, (ii) the reclassification of about 30% of HG-2 tumors as Equivocal GG and (iii) the economical and technical requirements of the MapQuant micro-array GG test, the availability in the near future of a PCR-based Genomic Grade test with improved performances may lead to an introduction in clinical routine of this test for histological grade 2, ER positive, HER2 negative breast carcinoma.	[Reyal, Fabien] Inst Curie, Dept Chirurg, Paris, France; [Bollet, Marc A.] Inst Curie, Dept Radiotherapie, Paris, France; [Caly, Martial; Sigal-Zafrani, Brigitte; Vincent-Salomon, Anne; Sastre-Garau, Xavier] Inst Curie, Dept Biol Tumeurs, Paris, France; [Gentien, David] Inst Curie, Dept Transfert, Paris, France; [Carpentier, Sabrina; Peyro-Saint-Paul, Helene] Ipsogen SA, Marseille, France; [Pierga, Jean-Yves; Cottu, Paul; Dieras, Veronique] Inst Curie, Dept Med Oncol, Paris, France; [Reyal, Fabien] Inst Curie, CNRS, UMR144, Equipe Oncol Mol, Paris, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite	Reyal, F (corresponding author), Inst Curie, Dept Chirurg, Paris, France.	Xavier.sastre@curie.net	Cottu, Paul/ABC-8595-2020; Gentien, David/O-9356-2019; Gentien, David/L-7757-2017	Gentien, David/0000-0001-8317-5188; Sastre-Garau, Xavier/0000-0001-5992-2083				[Anonymous], 2007, LANCET ONCOL, V8, P1079, DOI 10.1016/S1470-2045(07)70346-7; Balaton AJ, 1996, ANN PATHOL, V16, P144; Carlson RW, 2011, J NATL COMPR CANC NE, V9, P136, DOI 10.6004/jnccn.2011.0016; Carlson RW, 2009, J NATL COMPR CANC NE, V7, P122, DOI 10.6004/jnccn.2009.0012; Colozza M, 2005, ANN ONCOL, V16, P1723, DOI 10.1093/annonc/mdi352; Colozza M, 2010, LANCET ONCOL, V11, P414, DOI 10.1016/S1470-2045(10)70089-9; de Azambuja E, 2007, BRIT J CANCER, V96, P1504, DOI 10.1038/sj.bjc.6603756; Desmedt C, 2008, CLIN CANCER RES, V14, P5158, DOI 10.1158/1078-0432.CCR-07-4756; Desmedt C, 2006, CELL CYCLE, V5, P2198, DOI 10.4161/cc.5.19.3254; Desmedt C, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-40; Dowsett M, 2011, JNCI-J NATL CANCER I, V103, P1656, DOI 10.1093/jnci/djr393; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Goldhirsch A, 2007, ANN ONCOL, V18, P1133, DOI 10.1093/annonc/mdm271; Goldhirsch A, 2003, J CLIN ONCOL, V21, P3357, DOI 10.1200/JCO.2003.04.576; Group for Evaluation of Prognostic Factors using Immunohistochemistry in Breast Cancer (GEFPICS-FNCLCC), 1999, ANN PATHOL, V19, P336; Haibe-Kains B, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-394; Hornberger J, 2005, AM J MANAG CARE, V11, P313; Liedtke C, 2009, J CLIN ONCOL, V27, P3185, DOI 10.1200/JCO.2008.18.5934; Loi S, 2007, J CLIN ONCOL, V25, P1239, DOI 10.1200/JCO.2006.07.1522; Oratz R, 2007, J ONCOL PRACT, V3, P182, DOI 10.1200/JOP.0742001; Penault-Llorca F, 2010, ANN PATHOL, V30, P357, DOI 10.1016/j.annpat.2010.07.001; Rakha EA, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2607; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Stuart-Harris R, 2008, BREAST, V17, P323, DOI 10.1016/j.breast.2008.02.002; VANDIEST PJ, 1992, HUM PATHOL, V23, P603, DOI 10.1016/0046-8177(92)90313-R; VANDIEST PJ, 1992, PATHOL RES PRACT, V188, P405, DOI 10.1016/S0344-0338(11)80027-0; Viale G, 2008, J CLIN ONCOL, V26, P5569, DOI 10.1200/JCO.2008.17.0829; Wirapati P, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2124; Yerushalmi R, 2010, LANCET ONCOL, V11, P174, DOI 10.1016/S1470-2045(09)70262-1	29	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35184	10.1371/journal.pone.0035184	http://dx.doi.org/10.1371/journal.pone.0035184			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529987	Green Published, gold, Green Submitted			2022-12-27	WOS:000305350600064
J	Temiz, NA; Donohue, DE; Bacolla, A; Luke, BT; Collins, JR				Temiz, Nuri A.; Donohue, Duncan E.; Bacolla, Albino; Luke, Brian T.; Collins, Jack R.			The Role of Methylation in the Intrinsic Dynamics of B- and Z-DNA	PLOS ONE			English	Article							UNIQUE TETRANUCLEOTIDE SEQUENCES; MOLECULAR-DYNAMICS; NUCLEIC-ACIDS; Z TRANSITION; FORCE-FIELD; TO-Z; CONFORMATIONS; OLIGONUCLEOTIDES; SIMULATIONS; FLEXIBILITY	Methylation of cytosine at the 5-carbon position (5mC) is observed in both prokaryotes and eukaryotes. In humans, DNA methylation at CpG sites plays an important role in gene regulation and has been implicated in development, gene silencing, and cancer. In addition, the CpG dinucleotide is a known hot spot for pathologic mutations genome-wide. CpG tracts may adopt left-handed Z-DNA conformations, which have also been implicated in gene regulation and genomic instability. Methylation facilitates this B-Z transition but the underlying mechanism remains unclear. Herein, four structural models of the dinucleotide d(GC)(5) repeat sequence in B-, methylated B-, Z-, and methylated Z-DNA forms were constructed and an aggregate 100 nanoseconds of molecular dynamics simulations in explicit solvent under physiological conditions was performed for each model. Both unmethylated and methylated B-DNA were found to be more flexible than Z-DNA. However, methylation significantly destabilized the BII, relative to the BI, state through the Gp5mC steps. In addition, methylation decreased the free energy difference between B- and Z-DNA. Comparisons of alpha/gamma backbone torsional angles showed that torsional states changed marginally upon methylation for B-DNA, and Z-DNA. Methylation-induced conformational changes and lower energy differences may contribute to the transition to Z-DNA by methylated, over unmethylated, B-DNA and may be a contributing factor to biological function.	[Temiz, Nuri A.; Donohue, Duncan E.; Bacolla, Albino; Luke, Brian T.; Collins, Jack R.] SAIC Frederick Inc, Frederick Natl Lab Canc Res, Informat Syst Program, Adv Biomed Comp Ctr,Sil Res Ctr Excellence, Frederick, MD USA; [Bacolla, Albino] Univ Texas MD Anderson Canc Ctr, Dept Mol Carcinogenesis, Smithville, TX USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; University of Texas System; UTMD Anderson Cancer Center	Temiz, NA (corresponding author), SAIC Frederick Inc, Frederick Natl Lab Canc Res, Informat Syst Program, Adv Biomed Comp Ctr,Sil Res Ctr Excellence, Frederick, MD USA.	temizna@mail.nih.gov	Bacolla, Albino/N-3877-2013; Bacolla, Albino/AAP-1727-2020	Bacolla, Albino/0000-0003-0206-8423; Bacolla, Albino/0000-0003-0206-8423; Donohue, Duncan/0000-0002-3137-8773	Center for Biomedical Informatics and Information Technology (CBIIT)/Cancer Biomedical Informatics Grid (caBIG) ISRCE yellow task [09-260]; National Cancer Institute/National Institutes of Health [HHSN261200800001E]	Center for Biomedical Informatics and Information Technology (CBIIT)/Cancer Biomedical Informatics Grid (caBIG) ISRCE yellow task; National Cancer Institute/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Center for Biomedical Informatics and Information Technology (CBIIT)/Cancer Biomedical Informatics Grid (caBIG) ISRCE yellow task #09-260 to the Frederick National Laboratory for Cancer Research and National Cancer Institute/National Institutes of Health contract HHSN261200800001E (to AB). The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U. S. Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, AMBER 10; Bacolla A, 2009, MOL CARCINOGEN, V48, P273, DOI 10.1002/mc.20507; Bae S, 2011, J AM CHEM SOC, V133, P668, DOI 10.1021/ja107498y; BEHE M, 1981, P NATL ACAD SCI-BIOL, V78, P1619, DOI 10.1073/pnas.78.3.1619; Beveridge DL, 2004, BIOPHYS J, V87, P3799, DOI 10.1529/biophysj.104.045252; Bothe JR, 2011, J AM CHEM SOC, V133, P2016, DOI 10.1021/ja1073068; Brice AR, 2011, J COMPUT CHEM, V32, P1431, DOI 10.1002/jcc.21727; Cheatham TE, 2004, CURR OPIN STRUC BIOL, V14, P360, DOI 10.1016/j.sbi.2004.05.001; Cheatham TE, 1999, J BIOMOL STRUCT DYN, V16, P845, DOI 10.1080/07391102.1999.10508297; Cheatham TE, 2001, BIOPOLYMERS, V56, P232; Cooper David N, 2010, Hum Genomics, V4, P406; CRAWFORD JL, 1980, P NATL ACAD SCI-BIOL, V77, P4016, DOI 10.1073/pnas.77.7.4016; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dixit SB, 2005, BIOPHYS J, V89, P3721, DOI 10.1529/biophysj.105.067397; Djuranovic D, 2004, BIOPOLYMERS, V73, P356, DOI 10.1002/bip.10528; Djuranovic D, 2003, J BIOMOL STRUCT DYN, V20, P771, DOI 10.1080/07391102.2003.10506894; Feng SH, 2010, SCIENCE, V330, P622, DOI 10.1126/science.1190614; Ha SC, 2005, NATURE, V437, P1183, DOI 10.1038/nature04088; HARTMANN B, 1993, NUCLEIC ACIDS RES, V21, P561, DOI 10.1093/nar/21.3.561; Heddi B, 2006, J AM CHEM SOC, V128, P9170, DOI 10.1021/ja061686j; Heddi B, 2010, NUCLEIC ACIDS RES, V38, P1034, DOI 10.1093/nar/gkp962; Herbert A, 1999, GENETICA, V106, P37, DOI 10.1023/A:1003768526018; Hornik K, R FAQ; Illingworth RS, 2009, FEBS LETT, V583, P1713, DOI 10.1016/j.febslet.2009.04.012; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Killian BJ, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2746329; Kim D, 2009, NUCLEIC ACIDS RES, V37, P4353, DOI 10.1093/nar/gkp364; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Kulis M, 2010, ADV GENET, V70, P27, DOI [10.1016/S0065-2660(10)70002-X, 10.1016/B978-0-12-380866-0.60002-2]; Lavery R, 2009, NUCLEIC ACIDS RES, V37, P5917, DOI 10.1093/nar/gkp608; Lavery R, 2010, NUCLEIC ACIDS RES, V38, P299, DOI 10.1093/nar/gkp834; Lee J, 2010, J PHYS CHEM B, V114, P9872, DOI 10.1021/jp103419t; Lee M, 2010, P NATL ACAD SCI USA, V107, P4985, DOI 10.1073/pnas.0911528107; Maunakea AK, 2010, CIRC RES, V107, P327, DOI 10.1161/CIRCRESAHA.110.222463; Mirkin SM, 2008, FRONT BIOSCI-LANDMRK, V13, P1064, DOI 10.2741/2744; Orozco M, 2008, CURR OPIN STRUC BIOL, V18, P185, DOI 10.1016/j.sbi.2008.01.005; PECK LJ, 1983, P NATL ACAD SCI-BIOL, V80, P6206, DOI 10.1073/pnas.80.20.6206; Perez A, 2008, NUCLEIC ACIDS RES, V36, P2379, DOI 10.1093/nar/gkn082; Perez A, 2007, J AM CHEM SOC, V129, P14739, DOI 10.1021/ja0753546; Perez A, 2007, BIOPHYS J, V92, P3817, DOI 10.1529/biophysj.106.097782; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phan AT, 2006, CURR OPIN STRUC BIOL, V16, P288, DOI 10.1016/j.sbi.2006.05.011; Ponomarev SY, 2004, P NATL ACAD SCI USA, V101, P14771, DOI 10.1073/pnas.0406435101; Prabhu NV, 2008, J COMPUT CHEM, V29, P1113, DOI 10.1002/jcc.20874; Rauch C, 2005, J BIOMOL STRUCT DYN, V22, P695, DOI 10.1080/07391102.2005.10507036; Rauch C, 2005, J BIOMOL STRUCT DYN, V22, P595, DOI 10.1080/07391102.2005.10507029; Rauch C, 2003, J AM CHEM SOC, V125, P14990, DOI 10.1021/ja037218g; Rich A, 1996, J BIOL CHEM, V271, P11595, DOI 10.1074/jbc.271.20.11595; Rubin AF, 2009, P NATL ACAD SCI USA, V106, P21766, DOI 10.1073/pnas.0912499106; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sharma RP, 2010, NEUROPSYCHOPHARMACOL, V35, P2009, DOI 10.1038/npp.2010.85; Srinivasan J, 1998, J AM CHEM SOC, V120, P9401, DOI 10.1021/ja981844+; Srivastava HK, 2011, J CHEM INF MODEL, V51, P558, DOI 10.1021/ci100474n; Varnai P, 2004, NUCLEIC ACIDS RES, V32, P4269, DOI 10.1093/nar/gkh765; Varnai P, 2002, NUCLEIC ACIDS RES, V30, P5398, DOI 10.1093/nar/gkf680; Wells RD, 2007, TRENDS BIOCHEM SCI, V32, P271, DOI 10.1016/j.tibs.2007.04.003; Young MA, 1997, BIOPHYS J, V73, P2313, DOI 10.1016/S0006-3495(97)78263-8; Zheng GH, 2009, NUCLEIC ACIDS RES, V37, pW240, DOI 10.1093/nar/gkp358	58	56	58	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e35558	10.1371/journal.pone.0035558	http://dx.doi.org/10.1371/journal.pone.0035558			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22530050	Green Published, gold			2022-12-27	WOS:000305347400062
J	Huang, YY; Haug, MF; Gesemann, M; Neuhauss, SCF				Huang, Ying-Yu; Haug, Marion F.; Gesemann, Matthias; Neuhauss, Stephan C. F.			Novel Expression Patterns of Metabotropic Glutamate Receptor 6 in the Zebrafish Nervous System	PLOS ONE			English	Article							RETINAL BIPOLAR CELLS; PHYLOGENETIC ANALYSIS; 2-AMINO-4-PHOSPHONOBUTYRIC ACID; SYNAPTIC-TRANSMISSION; MAXIMUM-LIKELIHOOD; GENOME DUPLICATION; INPUT MECHANISMS; NIGHT BLINDNESS; LIGHT RESPONSE; GIANT DANIO	The metabotropic glutamate receptor 6 (mGluR6 or GRM6) belongs to the class III of the metabotropic glutamate receptor family. It is the only known mGluR that mediates direct synaptic transmission in the nervous system and is thought to mediate the ON-response in the ON-pathway of the vertebrate retina. Phylogenetic and gene structure analysis indicated that the zebrafish genome harbours two mglur6 paralogs, mglur6a and mglur6b. Besides expression in the inner nuclear layer and distinct regions in the brain, both mglur6 paralogs are expressed in ganglion cells of the retina, an expression pattern which can also be observed in the downstream effector molecules gnaoa and gnaob. This unexpected expression pattern is consistent with immunohistological labeling using a peptide antibody specific for the mGluR6b paralog. These expression patterns contradict the existing view that mGluR6 is solely located on ON-bipolar cells where it functions in signal transmission. Consistent with expression in ON-bipolar cells, we report a decreased b-wave amplitude in the electroretinogram after morpholino-based downregulation of mGluR6b, showing a function in the ON response. Our data suggest more widespread functions of mGluR6 mediated signaling in the central nervous system, possibly including sign reversing synapses in the inner retina.	Neurosci Ctr Zurich, Inst Mol Life Sci, Zurich, Switzerland; Univ Zurich, Ctr Integrat Human Physiol, Zurich, Switzerland	University of Zurich; Zurich Center Integrative Human Physiology (ZIHP)	Huang, YY (corresponding author), Univ Zurich Hosp, Dept Neurol, CH-8091 Zurich, Switzerland.	stephan.neuhauss@imls.uzh.ch	Neuhauss, Stephan/AAX-9915-2020	Neuhauss, Stephan/0000-0002-9615-480X; Huang, Melody Ying-Yu/0000-0003-4368-9648	EU framework7 project RETICIRC; EU framework7 project ZF-HEALTH; Swiss National Science Foundation [31003A_135598/1]	EU framework7 project RETICIRC; EU framework7 project ZF-HEALTH; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was partially funded by EU framework7 projects RETICIRC and ZF-HEALTH and the Swiss National Science Foundation (31003A_135598/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Bahadori R, 2006, EUR J NEUROSCI, V24, P1664, DOI 10.1111/j.1460-9568.2006.05053.x; Cao Y, 2011, J NEUROSCI, V31, P11521, DOI 10.1523/JNEUROSCI.1682-11.2011; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; DeVries SH, 2000, NEURON, V28, P847, DOI 10.1016/S0896-6273(00)00158-6; Dhingra A, 2000, J NEUROSCI, V20, P9053; Dryja TP, 2005, P NATL ACAD SCI USA, V102, P4884, DOI 10.1073/pnas.0501233102; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Fleisch VC, 2008, J NEUROSCI, V28, P8208, DOI 10.1523/JNEUROSCI.2367-08.2008; Gesemann M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-117; Ghosh PK, 1997, DEV BRAIN RES, V102, P1, DOI 10.1016/S0165-3806(97)00066-7; GRANT GB, 1995, J NEUROSCI, V15, P3852; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Klooster J, 2011, INVEST OPHTH VIS SCI, V52, P8356, DOI 10.1167/iovs.11-7575; Koike C, 2010, P NATL ACAD SCI USA, V107, P332, DOI 10.1073/pnas.0912730107; Makhankov YV, 2004, J NEUROSCI METH, V135, P205, DOI 10.1016/j.jneumeth.2003.12.015; MASSEY SC, 1983, VISION RES, V23, P1607, DOI 10.1016/0042-6989(83)90174-8; MASU M, 1995, CELL, V80, P757, DOI 10.1016/0092-8674(95)90354-2; Meyer A, 2005, BIOESSAYS, V27, P937, DOI 10.1002/bies.20293; Morgans CW, 2010, BIOESSAYS, V32, P609, DOI 10.1002/bies.200900198; Morgans CW, 2009, P NATL ACAD SCI USA, V106, P19174, DOI 10.1073/pnas.0908711106; MULLINS MC, 1994, CURR BIOL, V4, P189, DOI 10.1016/S0960-9822(00)00048-8; NAKAJIMA Y, 1993, J BIOL CHEM, V268, P11868; Nawy S, 1999, J NEUROSCI, V19, P2938; NAWY S, 1990, NATURE, V346, P269, DOI 10.1038/346269a0; NOMURA A, 1994, CELL, V77, P361, DOI 10.1016/0092-8674(94)90151-1; Saszik S, 2002, VISUAL NEUROSCI, V19, P521, DOI 10.1017/S0952523802194144; Schroeter EH, 2006, VISUAL NEUROSCI, V23, P833, DOI 10.1017/S0952523806230219; Shen Y, 2009, J NEUROSCI, V29, P6088, DOI 10.1523/JNEUROSCI.0132-09.2009; SHIELLS RA, 1981, NATURE, V294, P592, DOI 10.1038/294592a0; SLAUGHTER MM, 1981, SCIENCE, V211, P182, DOI 10.1126/science.6255566; Taylor JS, 2003, GENOME RES, V13, P382, DOI 10.1101/gr.640303; Tehrani A, 2000, INVEST OPHTH VIS SCI, V41, P314; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Vardi T, 2011, J HISTOCHEM CYTOCHEM, V59, P1076, DOI 10.1369/0022155411425386; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Wong KY, 2004, ZEBRAFISH, V1, P121, DOI 10.1089/zeb.2004.1.121; Wong KY, 2005, J NEUROPHYSIOL, V93, P84, DOI 10.1152/jn.00259.2004; Wong KY, 2005, J NEUROPHYSIOL, V93, P94, DOI 10.1152/jn.00270.2004; Zeitz C, 2005, INVEST OPHTH VIS SCI, V46, P4328, DOI 10.1167/iovs.05-0526	41	22	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e35256	10.1371/journal.pone.0035256	http://dx.doi.org/10.1371/journal.pone.0035256			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523578	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000305345000050
J	Li, B; Zhang, GS; Li, C; He, D; Li, XY; Zhang, CF; Tang, FQ; Deng, XY; Lu, JC; Tang, YH; Li, RJ; Chen, ZC; Duan, CJ				Li, Bin; Zhang, Guangsen; Li, Cui; He, Dan; Li, Xinying; Zhang, Chunfang; Tang, Faqing; Deng, Xiyun; Lu, Jingchen; Tang, Youhong; Li, Ruijuan; Chen, Zhuchu; Duan, Chaojun			Identification of JAK2 as a Mediator of FIP1L1-PDGFRA-Induced Eosinophil Growth and Function in CEL	PLOS ONE			English	Article							HYPEREOSINOPHILIC SYNDROME; FUSION GENE; LEUKEMIA; IMATINIB; APOPTOSIS; KINASE; EOL-1; IL-5; PROLIFERATION; INHIBITION	The Fip1-like1 (FIP1L1)-platelet-derived growth factor receptor alpha fusion gene (F/P) arising in the pluripotent hematopoietic stem cell (HSC), causes 14% to 60% of patients with hypereosinophilia syndrome (HES). These patients, classified as having F/P (+) chronic eosinophilic leukemia (CEL), present with clonal eosinophilia and display a more aggressive disease phenotype than patients with F/P (-) HES patients. The mechanisms underlying predominant eosinophil lineage targeting and the cytotoxicity of eosinophils in this leukemia remain unclear. Given that the Janus tyrosine kinase (JAK)/signal transducers and activators of transcription (Stat) signaling pathway is key to cytokine receptor-mediated eosinophil development and activated Stat3 and Stat5 regulate the expression of genes involved in F/P malignant transformation, we investigated whether and how JAK proteins were involved in the pathogenesis of F/P-induced CEL. F/P activation of JAK2, Stat3 and Stat5, were confirmed in all the 11 F/P (+) CEL patients examined. In vitro inhibition of JAK2 in EOL-1, primary F/P(+) CEL cells (PC) and T674I F/P Imatinib resistant cells(IR) by either JAK2-specific short interfering RNA (siRNA) or the tryphostin derivative AG490(AG490), significantly reduced cellular proliferation and induced cellular apoptosis. The F/P can enhance the IL-5-induced JAK2 activation, and further results indicated that JAK2 inhibition blocked IL-5-induced cellular migration and activation of the EOL-1 and PC cells in vitro. F/P-stimulation of the JAK2 suppressed cells led to a significantly reduction in Stat3 activation, but relatively normal induction of Stat5 activation. Interestingly, JAK2 inhibition also reduced PI3K, Akt and NF-kappa B activity in a dose-dependent manner, and suppressed expression levels of c-Myc and Survivin. These results strongly suggest that JAK2 is activated by F/P and is required for F/P stimulation of cellular proliferation and infiltration, possibly through induction of c-Myc and Survivin expression via activation of multiple signaling pathways, including NF-kappa B, Stat3, and PI3K/Akt.	[Li, Bin; Li, Cui; Li, Xinying; Zhang, Chunfang; Chen, Zhuchu; Duan, Chaojun] Cent S Univ, Xiangya Hosp, Chinese Minist Hlth, Key Lab Canc Prote, Changsha, Hunan, Peoples R China; [Li, Bin; Zhang, Guangsen; Li, Ruijuan] Cent S Univ, Xiang Ya Hosp 2, Inst Mol Hematol, Div Hematol, Changsha, Hunan, Peoples R China; [He, Dan; Duan, Chaojun] Cent S Univ, Xiangya Hosp, Med Res Ctr, Changsha, Hunan, Peoples R China; [Li, Bin; Lu, Jingchen; Tang, Youhong] Cent S Univ, Xiangya Hosp, Div Oncol, Changsha, Hunan, Peoples R China; [Tang, Faqing] Jinan Univ, Zhuhai Hosp, Clin Lab, Zhuhai, Peoples R China; [Deng, Xiyun] Univ Texas Hlth Sci Ctr Houston, Dept Surg, Houston, TX USA	Central South University; Central South University; Central South University; Central South University; Jinan University; University of Texas System; University of Texas Health Science Center Houston	Duan, CJ (corresponding author), Cent S Univ, Xiangya Hosp, Chinese Minist Hlth, Key Lab Canc Prote, Changsha, Hunan, Peoples R China.	duancjxy@126.com			National Natural Scientific Foundation of China [30670990, 30871189, 30973400, 81171841]; Province Natural Scientific Foundation of Hunan [07JJ5063, 2009JT3011]; Province Public Health Bureau [2007065]	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Province Natural Scientific Foundation of Hunan; Province Public Health Bureau	This work was supported by grants from the National Natural Scientific Foundation of China (Nos. 30670990, 30871189, 30973400, and 81171841) and the Province Natural Scientific Foundation of Hunan (No. 07JJ5063, 2009JT3011) and the Province Public Health Bureau (2007065). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar-Natan M, 2011, LEUKEMIA; Baumgartner C, 2008, EXP HEMATOL, V36, P1244, DOI 10.1016/j.exphem.2008.04.017; BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77; Buitenhuis N, 2007, CANCER RES, V67, P3759, DOI 10.1158/0008-5472.CAN-06-4183; Burbury K, 2011, LEUKEMIA LYMPHOMA, V52, P335, DOI 10.3109/10428194.2010.534210; Burgstaller S, 2007, LEUKEMIA, V21, P2428, DOI 10.1038/sj.leu.2404977; CHUSID MJ, 1975, MEDICINE, V54, P1, DOI 10.1097/00005792-197501000-00001; Cleyrat C, 2010, LEUKEMIA, V24, P1069, DOI 10.1038/leu.2010.23; Cools J, 2004, BLOOD, V103, P2802, DOI 10.1182/blood-2003-07-2479; Cools J, 2003, NEW ENGL J MED, V348, P1201, DOI 10.1056/NEJMoa025217; Fukushima K, 2009, J BIOL CHEM, V284, P7719, DOI 10.1074/jbc.M807489200; Galimberti S, 2007, CLIN EXP RHEUMATOL, V25, P17; Gotlib J, 2008, LEUKEMIA, V22, P1999, DOI 10.1038/leu.2008.287; Grivennikov SI, 2010, CYTOKINE GROWTH F R, V21, P11, DOI 10.1016/j.cytogfr.2009.11.005; Hebenstreit D, 2005, DRUG NEWS PERSPECT, V18, P243, DOI 10.1358/dnp.2005.18.4.908658; Hedvat M, 2009, CANCER CELL, V16, P487, DOI 10.1016/j.ccr.2009.10.015; Ip WK, 2003, CLIN EXP ALLERGY, V33, P241, DOI 10.1046/j.1365-2222.2003.01585.x; Irino T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022148; Ishihara K, 2008, BIOCHEM BIOPH RES CO, V366, P1007, DOI 10.1016/j.bbrc.2007.12.063; Jin YL, 2009, CANCER SCI, V100, P2210, DOI 10.1111/j.1349-7006.2009.01283.x; Kahn JE, 2011, J PROTEOME RES, V10, P1468, DOI 10.1021/pr100836p; Kampe M, 2011, INFLAMMATION; Kanie T, 2004, LEUKEMIA, V18, P548, DOI 10.1038/sj.leu.2403266; Klion AD, 2003, BLOOD, V101, P4660, DOI 10.1182/blood-2003-01-0006; Kudlacz E, 2008, EUR J PHARMACOL, V582, P154, DOI 10.1016/j.ejphar.2007.12.024; Lee JS, 2010, MOL BIOL REP, V37, P2149, DOI 10.1007/s11033-009-9687-z; Lee JS, 2009, CYTOKINE, V48, P186, DOI 10.1016/j.cyto.2009.07.008; Lee WH, 2009, J CELL BIOCHEM, V106, P929, DOI 10.1002/jcb.22069; Ma WL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012165; Monahan J, 1997, J IMMUNOL, V159, P4024; Pan J, 2007, LEUKEMIA, V21, P1395, DOI 10.1038/sj.leu.2404714; Pardanani A, 2006, LEUKEMIA RES, V30, P965, DOI 10.1016/j.leukres.2005.11.011; Pitini V, 2007, LEUKEMIA RES, V31, P725, DOI 10.1016/j.leukres.2006.07.011; Putters J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014676; Samanta AK, 2009, ONCOGENE, V28, P1669, DOI 10.1038/onc.2009.7; Samanta Ajoy K, 2010, Genes Cancer, V1, P346, DOI 10.1177/1947601910372232; Steelman LS, 2008, LEUKEMIA, V22, P686, DOI 10.1038/leu.2008.26; STRATH M, 1985, J IMMUNOL METHODS, V83, P209, DOI 10.1016/0022-1759(85)90242-X; Vardiman JW, 2009, BLOOD, V114, P937, DOI 10.1182/blood-2009-03-209262; Vassina EM, 2006, EUR J IMMUNOL, V36, P1975, DOI 10.1002/eji.200635943; Walz C, 2009, LEUKEMIA, V23, P271, DOI 10.1038/leu.2008.310; Yamada Y, 2006, BLOOD, V107, P4071, DOI 10.1182/blood-2005-08-3153; Yamada Y, 2010, INT ARCH ALLERGY IMM, V152, P101, DOI 10.1159/000312134; Zhu JF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023720; Zhu YM, 2011, J IMMUNOL, V186, P516, DOI 10.4049/jimmunol.1000955	45	17	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e34912	10.1371/journal.pone.0034912	http://dx.doi.org/10.1371/journal.pone.0034912			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523564	gold, Green Submitted, Green Published			2022-12-27	WOS:000305345000036
J	da Matta, JAM; Aras, R; de Macedo, CRB; da Cruz, CG; Netto, EM				Martins da Matta, Jose Alberto; Aras, Roque, Jr.; Bastos de Macedo, Cristiano Ricardo; da Cruz, Cristiano Goncalves; Netto, Eduardo Martins			Stroke Correlates in Chagasic and Non-Chagasic Cardiomyopathies	PLOS ONE			English	Article							RISK STRATIFICATION; ATRIAL-FIBRILLATION; DISEASE OUTBREAK; TRANSMISSION	Background: Aging and migration have brought changes to the epidemiology and stroke has been shown to be independently associated with Chagas disease. We studied stroke correlates in cardiomyopathy patients with focus on the chagasic etiology. Methodology/Principal Findings: We performed a cross-sectional review of medical records of 790 patients with a cardiomyopathy. Patients with chagasic (329) and non-chagasic (461) cardiomyopathies were compared. There were 108 stroke cases, significantly more frequent in the Chagas group (17.3% versus 11.1%; p<0.01). Chagasic etiology (odds ratio [OR], 1.79), pacemaker (OR, 2.49), atrial fibrillation (OR, 3.03) and coronary artery disease (OR, 1.92) were stroke predictors in a multivariable analysis of the entire cohort. In a second step, the population was split into those with or without a Chagas-related cardiomyopathy. Univariable post-stratification stroke predictors in the Chagas cohort were pacemaker (OR, 2.73), and coronary artery disease (CAD) (OR, 2.58); while atrial fibrillation (OR, 2.98), age over 55 (OR, 2.92), hypertension (OR, 2.62) and coronary artery disease (OR, 1.94) did so in the non-Chagas cohort. Chagasic stroke patients presented a very high frequency of individuals without any vascular risk factors (40.4%; OR, 4.8). In a post-stratification logistic regression model, stroke remained associated with pacemaker (OR, 2.72) and coronary artery disease (OR, 2.60) in 322 chagasic patients, and with age over 55 (OR, 2.38), atrial fibrillation (OR 3.25) and hypertension (OR 2.12; p = 0.052) in 444 non-chagasic patients. Conclusions/Significance: Chagas cardiomyopathy presented both a higher frequency of stroke and an independent association with it. There was a high frequency of strokes without any vascular risk factors in the Chagas as opposed to the non-Chagas cohort. Pacemaker rhythm and CAD were independently associated with stroke in the Chagas group while age over 55 years, hypertension and atrial fibrillation did so in the non-Chagas cardiomyopathies.	[Martins da Matta, Jose Alberto; Aras, Roque, Jr.; Bastos de Macedo, Cristiano Ricardo] Univ Fed Bahia, Hosp Univ Prof Edgard Santos, Salvador, BA, Brazil; [da Cruz, Cristiano Goncalves] Univ Fed Bahia, Hosp Ana Nery, Salvador, BA, Brazil; [Netto, Eduardo Martins] Univ Fed Bahia, Hosp Univ Prof Edgard Santos, Salvador, BA, Brazil	Universidade Federal da Bahia; Universidade Federal da Bahia; Universidade Federal da Bahia	da Matta, JAM (corresponding author), Univ Fed Bahia, Hosp Univ Prof Edgard Santos, Salvador, BA, Brazil.	jalb@ufba.br	Netto, Eduardo/D-1432-2013	Netto, Eduardo/0000-0003-1691-6761				[Anonymous], 2010, 1 WHO; Aras Roque, 2003, Arq. Bras. Cardiol., V81, P414, DOI 10.1590/S0066-782X2003001200008; Armaganijan L, 2010, STROKE, V41, P2453, DOI 10.1161/STROKEAHA.110.594051; Bastos CJC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000711; Biolo A, 2010, PROG CARDIOVASC DIS, V52, P300, DOI 10.1016/j.pcad.2009.11.008; Carod-Artal FJ, 2005, STROKE, V36, P965, DOI 10.1161/01.STR.0000163104.92943.50; Carod-Artal FJ, 2003, J NEUROL NEUROSUR PS, V74, P516, DOI 10.1136/jnnp.74.4.516; Costa MFFLE, 2001, INT J EPIDEMIOL, V30, P887, DOI 10.1093/ije/30.4.887; Coura JR, 2009, MEM I OSWALDO CRUZ, V104, P31, DOI 10.1590/S0074-02762009000900006; da Saude M., 2005, REV SOC BRAS MED TRO, P1; Valente SADS, 2009, T ROY SOC TROP MED H, V103, P291, DOI 10.1016/j.trstmh.2008.10.047; de Andrade JP, 2011, ARQ BRAS CARDIOL, V96, DOI 10.1590/S0066-782X2011000600002; Delgado S, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000970; Dias JP, 2008, REV SOC BRAS MED TRO, V41, P296, DOI 10.1590/S0037-86822008000300014; Gage BF, 2004, CIRCULATION, V110, P2287, DOI 10.1161/01.CIR.0000145172.55640.93; Goldstein LB, 2011, STROKE, V42, P517, DOI 10.1161/STR.0b013e3181fcb238; Hidron A, 2010, CLIN MICROBIOL REV, V23, P324, DOI 10.1128/CMR.00054-09; Hotez PJ, 2007, NEW ENGL J MED, V357, P1018, DOI 10.1056/NEJMra064142; Leon-Sarmiento FE, 2004, J NEUROL SCI, V217, P61, DOI 10.1016/j.jns.2003.08.015; Lima Costa MF, 2010, STROKE, V41, P2477; Lima-Costa MFF, 2002, INT J EPIDEMIOL, V31, P688, DOI 10.1093/ije/31.3.688; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Marin JA, 2007, CIRCULATION, V115, P1109, DOI 10.1161/CIRCULATIONAHA.106.624296; Nunes MCP, 2009, J NEUROL SCI, V278, P96, DOI 10.1016/j.jns.2008.12.015; OLIVEIRA JSM, 1983, AM J CARDIOL, V52, P147, DOI 10.1016/0002-9149(83)90085-1; OLIVEIRA JSM, 1981, BRIT HEART J, V46, P432, DOI 10.1136/hrt.46.4.432; Paixao LC, 2009, STROKE, V40, P3691, DOI 10.1161/STROKEAHA.109.560854; Pinto Dias J C, 1995, Arq Bras Cardiol, V65, P359; Prata A, 2001, Lancet Infect Dis, V1, P92, DOI 10.1016/S1473-3099(01)00065-2; Rassi A, 2000, CLIN CARDIOL, V23, P883, DOI 10.1002/clc.4960231205; Rassi A, 2006, NEW ENGL J MED, V355, P799, DOI 10.1056/NEJMoa053241; Richardson P, 1996, CIRCULATION, V93, P841, DOI 10.1161/01.CIR.93.5.841; de Sousa AS, 2008, ARQ BRAS CARDIOL, V91, P280; World Health Organization, 2005, WHO STEPS STROK MAN; World Health Organization, 2010, CHAG DIS GEN SWITZ F; World Health Organization, 2008, GLOB BURD DIS 2004 U	36	15	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e35116	10.1371/journal.pone.0035116	http://dx.doi.org/10.1371/journal.pone.0035116			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523572	gold, Green Submitted, Green Published			2022-12-27	WOS:000305345000044
J	Ng, N; Hakimi, M; Santosa, A; Byass, P; Wilopo, SA; Wall, S				Ng, Nawi; Hakimi, Mohammad; Santosa, Ailiana; Byass, Peter; Wilopo, Siswanto Agus; Wall, Stig			Is Self-Rated Health an Independent Index for Mortality among Older People in Indonesia?	PLOS ONE			English	Article							SUBSEQUENT MORTALITY; SOCIOECONOMIC-STATUS; PREDICTIVE POWER; ASSESSED HEALTH; ADULTS; INCOME; RISK; US	Background: Empirical studies on the association between self-rated health (SRH) and subsequent mortality are generally lacking in low-and middle-income countries. The evidence on whether socio-economic status and education modify this association is inconsistent. This study aims to fill these gaps using longitudinal data from a Health and Demographic Surveillance System (HDSS) site in Indonesia. Methods: In 2010, we assessed the mortality status of 11,753 men and women aged 50+ who lived in Purworejo HDSS and participated in the INDEPTH WHO SAGE baseline in 2007. Information on self-rated health, socio-demographic indicators, disability and chronic disease were collected through face-to-face interview at baseline. We used Cox-proportional hazards regression for mortality and included all variables measured at baseline, including interaction terms between SRH and both education and socio-economic status (SES). Results: During an average of 36 months follow-up, 11% of men and 9.5% of women died, resulting in death rates of 3.1 and 2.6 per 1,000 person-months, respectively. The age-adjusted Hazard Ratio (HR) for mortality was 17% higher in men than women (HR = 1.17; 95% CI = 1.04-1.31). After adjustment for covariates, the hazard ratios for mortality in men and women reporting bad health were 3.0 (95% CI = 2.0-4.4) and 4.9 (95% CI = 3.2-7.4), respectively. Education and SES did not modify this association for either sex. Conclusions: This study supports the predictive power of bad self-rated health for subsequent mortality in rural Indonesian men and women 50 years old and over. In these analyses, education and household socio-economic status do not modify the relationship between SRH and mortality. This means that older people who rate their own health poorly should be an important target group for health service interventions.	[Ng, Nawi; Santosa, Ailiana; Byass, Peter; Wall, Stig] Umea Univ, Dept Publ Hlth & Clin Med, Umea Ctr Global Hlth Res, Div Epidemiol & Global Hlth, Umea, Sweden; [Hakimi, Mohammad; Wilopo, Siswanto Agus] Gadjah Mada Univ, Fac Med, Ctr Reprod Hlth, Yogyakarta, Indonesia	Umea University; Gadjah Mada University	Ng, N (corresponding author), Umea Univ, Dept Publ Hlth & Clin Med, Umea Ctr Global Hlth Res, Div Epidemiol & Global Hlth, Umea, Sweden.	nawi.ng@epiph.umu.se	Santosa, Ailiana/AAY-9372-2020; Wilopo, Siswanto/AAC-9417-2022; Hakimi, Mohammad/GOV-6587-2022; Ng, Nawi/F-8373-2011; Wilopo, Siswanto/AAJ-2092-2020	Santosa, Ailiana/0000-0002-1848-2867; Ng, Nawi/0000-0003-0556-1483; Byass, Peter/0000-0001-5474-4361; Wilopo, Siswanto Agus/0000-0003-1284-7228	Umea Centre for Global Health Research; FAS, Swedish Council for Working Life and Social Research [2006-1512]; INDEPTH Network and its Adult Health and Aging Working Group; US National Institute on Aging's Division of Behavioral and Social Research through Interagency Agreements [OGHA 04034785, YA1323-08-CN-0020, Y1-AG-1005-01]; World Health Organization	Umea Centre for Global Health Research; FAS, Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); INDEPTH Network and its Adult Health and Aging Working Group; US National Institute on Aging's Division of Behavioral and Social Research through Interagency Agreements; World Health Organization(World Health Organization)	This research was supported by Umea Centre for Global Health Research with support from FAS, the Swedish Council for Working Life and Social Research (grant no. 2006-1512). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge with appreciation the support of the INDEPTH Network and its Adult Health and Aging Working Group, as well as the valuable guidance on manuscript development provided by the Harvard Centre for Population and Development, USA. The SAGE-INDEPTH collaboration is supported by the US National Institute on Aging's Division of Behavioral and Social Research through Interagency Agreements (OGHA 04034785; YA1323-08-CN-0020; Y1-AG-1005-01) with the World Health Organization. The authors would like to thank Hans Stenlund and Joacim Rocklov (Umea Centre for Global Health Research) for their statistical advice, and Martha Fay and Lisa Berkman (Harvard University) for their critical comments on the manuscript.	Bassuk SS, 2002, AM J EPIDEMIOL, V155, P520, DOI 10.1093/aje/155.6.520; Burstrom B, 2001, J EPIDEMIOL COMMUN H, V55, P836, DOI 10.1136/jech.55.11.836; Byass P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022897; DeSalvo KB, 2006, J GEN INTERN MED, V21, P267, DOI 10.1111/j.1525-1497.2005.00291.x; Dowd JB, 2007, INT J EPIDEMIOL, V36, P1214, DOI 10.1093/ije/dym214; Dowd JB, 2010, ANN EPIDEMIOL, V20, P743, DOI 10.1016/j.annepidem.2010.06.007; Frankenberg E, 2004, J HEALTH SOC BEHAV, V45, P441, DOI 10.1177/002214650404500406; Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316; Huisman M, 2007, INT J EPIDEMIOL, V36, P1207, DOI 10.1093/ije/dym095; Hull T. H., 2005, PEOPLE POPULATION PO; Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359; Jylha M, 2009, SOC SCI MED, V69, P307, DOI 10.1016/j.socscimed.2009.05.013; Kowal P, 2010, GLOB HLTH ACTION, V3, DOI [10.3402/gha.v3403i3400.5302., DOI 10.3402/GHA.V3403I3400.5302]; Mathers CD, 2005, B WORLD HEALTH ORGAN, V83, P171; McFadden E, 2009, SOC SCI MED, V68, P275, DOI 10.1016/j.socscimed.2008.10.012; Ng N, 2010, GLOB HLTH ACTION, V3, DOI [10.3402/gha.v3403i3400.2125., DOI 10.3402/GHA.V3403I3400.2125]; Pu C, 2011, J EPIDEMIOL, V21, P278, DOI 10.2188/jea.JE20100131; Sankoh O, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1001005; Singh-Manoux A, 2007, INT J EPIDEMIOL, V36, P1222, DOI 10.1093/ije/dym170; van Doorslaer E, 2003, SOC SCI MED, V57, P1621, DOI 10.1016/S0277-9536(02)00559-2; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; WILOPO S, 1997, KEY ISSUES RES DESIG	22	19	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e35308	10.1371/journal.pone.0035308	http://dx.doi.org/10.1371/journal.pone.0035308			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959VO	22523584	Green Published, gold, Green Submitted			2022-12-27	WOS:000305345000056
J	Munir, S; Larsen, SK; Iversen, TZ; Donia, M; Klausen, TW; Svane, IM; Straten, PT; Andersen, MH				Munir, Shamaila; Larsen, Stine Kiaer; Iversen, Trine Zeeberg; Donia, Marco; Klausen, Tobias Wirenfeldt; Svane, Inge Marie; Straten, Per Thor; Andersen, Mads Hald			Natural CD4(+) T-Cell Responses against Indoleamine 2,3-Dioxygenase	PLOS ONE			English	Article							DENDRITIC CELLS; TUMOR-IMMUNITY; TH17 CELLS; SUPPRESSION; INHIBITION; IDO; PHENOTYPE; MECHANISM; PATHWAY; TARGET	Background: The enzyme indoleamine 2,3-dioxygenase (IDO) contributes to immune tolerance in a variety of settings. In cancer IDO is expressed within the tumor itself as well as in antigen-presenting cells in tumor-draining lymph nodes, where it endorses the establishment of peripheral immune tolerance to tumor antigens. Recently, we described cytotoxic CD8(+) T-cell reactivity towards IDO-derived peptides. Methods and Findings: In the present study, we show that CD4(+) helper T cells additionally spontaneously recognize IDO. Hence, we scrutinized the vicinity of the previously described HLA-A*0201-restricted IDO-epitope for CD4(+) T-cell epitopes. We demonstrated the presence of naturally occurring IDO-specific CD4(+) T cells in cancer patients and to a lesser extent in healthy donors by cytokine release ELISPOT. IDO-reactive CD4(+) T cells released IFN-gamma, TNF-alpha, as well as IL-17. We confirm HLA class II-restriction by the addition of HLA class II specific blocking antibodies. In addition, we detected a trend between class I-and class II-restricted IDO responses and detected an association between IDO-specific CD4(+) T cells and CD8(+) CMV-responses. Finally, we could detect IL-10 releasing IDO-reactive CD4(+) T cells. Conclusion: IDO is spontaneously recognized by HLA class II-restricted, CD4(+) T cells in cancer patients and in healthy individuals. IDO-specific T cells may participate in immune-regulatory networks where the activation of pro-inflammatory IDO-specific CD4(+) responses may well overcome or delay the immune suppressive actions of the IDO-protein, which are otherwise a consequence of the early expression of IDO in maturing antigen presenting cells. In contrast, IDO-specific regulatory T cells may enhance IDO-mediated immune suppression.	[Munir, Shamaila; Larsen, Stine Kiaer; Iversen, Trine Zeeberg; Donia, Marco; Klausen, Tobias Wirenfeldt; Svane, Inge Marie; Straten, Per Thor; Andersen, Mads Hald] Copenhagen Univ Hosp, CCIT, Dept Hematol & Oncol, Herlev, Denmark; [Donia, Marco] Univ Catania, Dept Biomed Sci, Catania, Italy	University of Copenhagen; University of Catania	Munir, S (corresponding author), Copenhagen Univ Hosp, CCIT, Dept Hematol & Oncol, Herlev, Denmark.	mads.hald.andersen@regionh.dk		Donia, Marco/0000-0003-4966-9752; Andersen, Mads Hald/0000-0002-2914-9605; Munir Ahmad, Shamaila/0000-0001-5176-5212; thor Straten, Per/0000-0002-4731-4969; Svane, Inge Marie/0000-0002-9451-6037	Novo Nordisk Foundation; Danish Cancer Society; Danish Medical Research Council; Lundbeck Foundation; John and Birthe Meyer Foundation; Herlev University Hospital	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Cancer Society(Danish Cancer Society); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lundbeck Foundation(Lundbeckfonden); John and Birthe Meyer Foundation; Herlev University Hospital	This work was supported by grants from the Novo Nordisk Foundation, the Danish Cancer Society, Danish Medical Research Council, the Lundbeck Foundation, the John and Birthe Meyer Foundation, and Herlev University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen MH, 2001, CANCER RES, V61, P869; Ball HJ, 2007, GENE, V396, P203, DOI 10.1016/j.gene.2007.04.010; Banerjee T, 2008, ONCOGENE, V27, P2851, DOI 10.1038/sj.onc.1210939; Bauer TM, 2005, TRANSPL INT, V18, P95, DOI 10.1111/j.1432-2277.2004.00031.x; Chen W, 2008, J IMMUNOL, V181, P5396, DOI 10.4049/jimmunol.181.8.5396; Chen Z, 2008, IMMUNOL RES, V41, P87, DOI 10.1007/s12026-007-8014-9; Cherayil BJ, 2009, INFLAMM BOWEL DIS, V15, P1391, DOI 10.1002/ibd.20910; Divanovic S, 2012, J INFECT DIS, V205, P152, DOI 10.1093/infdis/jir621; Fallarino F, 2006, J IMMUNOL, V176, P6752, DOI 10.4049/jimmunol.176.11.6752; Furset G, 2008, IMMUNOLOGY, V123, P263, DOI 10.1111/j.1365-2567.2007.02695.x; Hou DY, 2007, CANCER RES, V67, P792, DOI 10.1158/0008-5472.CAN-06-2925; KEILHOLZ U, 1993, CANCER, V72, P607, DOI 10.1002/1097-0142(19930715)72:2<607::AID-CNCR2820720245>3.0.CO;2-R; Keilholz U, 2002, J IMMUNOTHER, V25, P97, DOI 10.1097/00002371-200203000-00001; Khan N, 2002, J IMMUNOL, V169, P1984, DOI 10.4049/jimmunol.169.4.1984; Kryczek I, 2009, BLOOD, V114, P1141, DOI 10.1182/blood-2009-03-208249; Kumar S, 2008, J MED CHEM, V51, P4968, DOI 10.1021/jm800512z; Kumar S, 2008, J MED CHEM, V51, P1706, DOI 10.1021/jm7014155; Martin-Orozco N, 2009, IMMUNITY, V31, P787, DOI 10.1016/j.immuni.2009.09.014; McCutcheon M, 1997, J IMMUNOL METHODS, V210, P149, DOI 10.1016/S0022-1759(97)00182-8; Mellor AL, 2008, NAT REV IMMUNOL, V8, P74, DOI 10.1038/nri2233; Metz R, 2010, MOL CANCER THER, V9, P1864, DOI 10.1158/1535-7163.MCT-10-0185; Muller AJ, 2005, NAT MED, V11, P312, DOI 10.1038/nm1196; Muller AJ, 2007, CURR CANCER DRUG TAR, V7, P31, DOI 10.2174/156800907780006896; Munn DH, 2007, J CLIN INVEST, V117, P1147, DOI 10.1172/JCI31178; Munn DH, 2004, J IMMUNOL, V172, P4100, DOI 10.4049/jimmunol.172.7.4100; O'Quinn DB, 2008, ADV IMMUNOL, V99, P115, DOI 10.1016/S0065-2776(08)00605-6; Platten M, 2005, SCIENCE, V310, P850, DOI 10.1126/science.1117634; Popov A, 2008, J MOL MED, V86, P145, DOI 10.1007/s00109-007-0262-6; Prendergast GC, 2009, CELL CYCLE, V8, P1818, DOI 10.4161/cc.8.12.8887; Rammensee HG, 1995, CURR BIOL, V5, P35, DOI DOI 10.1016/S0960-9822(95)00011-X; Scheler M, 2007, AM J PATHOL, V171, P1936, DOI 10.2353/ajpath.2007.070281; Sharma MD, 2007, J CLIN INVEST, V117, P2570, DOI 10.1172/JCI31911; Sorensen RB, 2011, BLOOD, V117, P2200, DOI 10.1182/blood-2010-06-288498; Sorensen RB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006910; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Uyttenhove C, 2003, NAT MED, V9, P1269, DOI 10.1038/nm934; Zhu LQ, 2006, J IMMUNOL, V177, P8226, DOI 10.4049/jimmunol.177.11.8226; Zou WP, 2010, NAT REV IMMUNOL, V10, P248, DOI 10.1038/nri2742	38	39	41	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e34568	10.1371/journal.pone.0034568	http://dx.doi.org/10.1371/journal.pone.0034568			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22539948	gold, Green Published, Green Submitted			2022-12-27	WOS:000305341000011
J	Oldham, P; Hall, S; Burton, G				Oldham, Paul; Hall, Stephen; Burton, Geoff			Synthetic Biology: Mapping the Scientific Landscape	PLOS ONE			English	Article							SYSTEMS BIOLOGY; REVERSE GENETICS; DESIGN; INTERDISCIPLINARY; PROPERTY; NETWORK; PROTEIN; VIRUS; TRANSCRIPTION; BISTABILITY	This article uses data from Thomson Reuters Web of Science to map and analyse the scientific landscape for synthetic biology. The article draws on recent advances in data visualisation and analytics with the aim of informing upcoming international policy debates on the governance of synthetic biology by the Subsidiary Body on Scientific, Technical and Technological Advice (SBSTTA) of the United Nations Convention on Biological Diversity. We use mapping techniques to identify how synthetic biology can best be understood and the range of institutions, researchers and funding agencies involved. Debates under the Convention are likely to focus on a possible moratorium on the field release of synthetic organisms, cells or genomes. Based on the empirical evidence we propose that guidance could be provided to funding agencies to respect the letter and spirit of the Convention on Biological Diversity in making research investments. Building on the recommendations of the United States Presidential Commission for the Study of Bioethical Issues we demonstrate that it is possible to promote independent and transparent monitoring of developments in synthetic biology using modern information tools. In particular, public and policy understanding and engagement with synthetic biology can be enhanced through the use of online interactive tools. As a step forward in this process we make existing data on the scientific literature on synthetic biology available in an online interactive workbook so that researchers, policy makers and civil society can explore the data and draw conclusions for themselves.	[Oldham, Paul; Hall, Stephen] Univ Lancaster, ESRC Ctr Econ & Social Aspects Genom Cesagen, Lancaster, England; [Oldham, Paul; Burton, Geoff] United Nations Univ, Inst Adv Studies UNU IAS, Yokohama, Kanagawa, Japan	Lancaster University; UK Research & Innovation (UKRI); Economic & Social Research Council (ESRC); United Nations University	Oldham, P (corresponding author), Univ Lancaster, ESRC Ctr Econ & Social Aspects Genom Cesagen, Lancaster, England.	poldham@mac.com		Oldham, Paul/0000-0002-1013-4390	Economic and Social Research Council (ESRC)	Economic and Social Research Council (ESRC)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	The support of the Economic and Social Research Council (ESRC) is gratefully acknowledged. This work is part of the Research Programme of the ESRC Genomics Network at Cesagen (ESRC Centre for Economic and Social Aspects of Genomics). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajikumar PK, 2008, MOL PHARMACEUT, V5, P167, DOI 10.1021/mp700151b; Alper H, 2009, NAT REV MICROBIOL, V7, P715, DOI 10.1038/nrmicro2186; Alterovitz G, 2010, BRIEF BIOINFORM, V11, P80, DOI 10.1093/bib/bbp054; Ashidi JS, 2010, J ETHNOPHARMACOL, V128, P501, DOI 10.1016/j.jep.2010.01.009; Aubel D, 2010, BIOESSAYS, V32, P332, DOI 10.1002/bies.200900149; Bambini S, 2009, DRUG DISCOV TODAY, V14, P252, DOI 10.1016/j.drudis.2008.12.007; Bar-Even A, 2010, P NATL ACAD SCI USA, V107, P8889, DOI 10.1073/pnas.0907176107; Barrett CL, 2006, CURR OPIN BIOTECH, V17, P488, DOI 10.1016/j.copbio.2006.08.001; Benner SA, 2005, NAT REV GENET, V6, P533, DOI 10.1038/nrg1637; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Bornmann L., 2008, ETHICS SCI ENV POLIT, V2014, DOI [10.3354/esep00084, DOI 10.3354/ESEP00084]; Bouloy M, 2009, ANTIVIR RES, V84, P101, DOI 10.1016/j.antiviral.2009.08.002; Bowen TA, 2008, NEW PHYTOL, V179, P583, DOI 10.1111/j.1469-8137.2008.02433.x; Calvert J, 2010, SOCIOL REV, V58, P95, DOI 10.1111/j.1467-954X.2010.01913.x; Calvert J, 2009, EMBO REP, V10, P201, DOI 10.1038/embor.2009.15; Cantone I, 2009, CELL, V137, P172, DOI 10.1016/j.cell.2009.01.055; Carr PA, 2009, NAT BIOTECHNOL, V27, P1151, DOI 10.1038/nbt.1590; Channon K, 2008, CURR OPIN STRUC BIOL, V18, P491, DOI 10.1016/j.sbi.2008.06.006; Chen BS, 2010, ENTROPY-SWITZ, V12, P1071, DOI 10.3390/e12051071; Collins JJ, 2010, NUCLEIC ACIDS RES, V38, P2513, DOI 10.1093/nar/gkq221; CONZELMANN KK, 1994, J VIROL, V68, P713, DOI 10.1128/JVI.68.2.713-719.1994; COURTIAL JP, 1994, SCIENTOMETRICS, V31, P251, DOI 10.1007/BF02016875; Danino T, 2010, NATURE, V463, P326, DOI 10.1038/nature08753; de Lorenzo V, 2008, CURR OPIN BIOTECH, V19, P579, DOI 10.1016/j.copbio.2008.10.004; de Lorenzo V, 2008, EMBO REP, V9, P822, DOI 10.1038/embor.2008.159; de Lorenzo V, 2010, BIOESSAYS, V32, P926, DOI 10.1002/bies.201000099; Doktycz MJ, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100165; Dunn WB, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/1/011001; Dunn WB, 2011, CHEM SOC REV, V40, P387, DOI 10.1039/b906712b; Dymond JS, 2009, GENETICS, V181, P13, DOI 10.1534/genetics.108.096784; Eaton D, 2002, BIOTECHNOLOGY D 0319, P19; Ellis T, 2009, NAT BIOTECHNOL, V27, P465, DOI 10.1038/nbt.1536; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Endler L, 2009, J ROYAL SOC INTERFAC, V6, P13; Endy D, 2005, NATURE, V438, P449, DOI 10.1038/nature04342; ETC Group, 2007, EXTR GEN ENG INTR SY, P28; Finke S, 2003, J GEN VIROL, V84, P1613, DOI 10.1099/vir.0.19128-0; Finley SD, 2009, BIOTECHNOL BIOENG, V103, P532, DOI 10.1002/bit.22285; Fischer CR, 2010, APPL MICROBIOL BIOT, V88, P265, DOI 10.1007/s00253-010-2749-2; Flick R, 2003, J VIROL, V77, P5997, DOI 10.1128/JVI.77.10.5997-6006.2003; Foley PL, 2010, BIOTECHNOL BIOENG, V105, P26, DOI 10.1002/bit.22575; Fung E, 2005, NATURE, V435, P118, DOI 10.1038/nature03508; Fussenegger M, 2010, NATURE, V463, P301, DOI 10.1038/463301a; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Garfinkel MS, 2007, BIOSECUR BIOTERROR, V5, P359, DOI 10.1089/bsp.2007.0923; Gibson DG, 2008, SCIENCE, V319, P1215, DOI 10.1126/science.1151721; Gitzinger M, 2009, PLANT BIOTECHNOL J, V7, P73, DOI 10.1111/j.1467-7652.2008.00376.x; Gitzinger M, 2009, P NATL ACAD SCI USA, V106, P10638, DOI 10.1073/pnas.0901501106; Greber D, 2007, J BIOTECHNOL, V130, P329, DOI 10.1016/j.jbiotec.2007.05.014; Guido NJ, 2006, NATURE, V439, P856, DOI 10.1038/nature04473; Henkel J, 2009, NAT BIOTECHNOL, V27, P1095, DOI 10.1038/nbt1209-1095; Herrgard MJ, 2008, NAT BIOTECHNOL, V26, P1155, DOI 10.1038/nbt1492; Hills MJ, 2007, TRENDS PLANT SCI, V12, P177, DOI 10.1016/j.tplants.2007.02.002; HOBOM B, 1980, MED KLIN, V75, P14; Huang HH, 2010, NUCLEIC ACIDS RES, V38, P2577, DOI 10.1093/nar/gkq164; HUFFORD KD, 1991, CYBERNET SYST, V22, P647, DOI 10.1080/01969729108902305; Isaacs FJ, 2006, NAT BIOTECHNOL, V24, P545, DOI 10.1038/nbt1208; Jarboe LR, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/761042; Jayaraman A, 2008, ANNU REV BIOMED ENG, V10, P145, DOI 10.1146/annurev.bioeng.10.061807.160536; Kamaruddin AH, 2009, CHIRALITY, V21, P449, DOI 10.1002/chir.20619; Kato A, 1997, EMBO J, V16, P578, DOI 10.1093/emboj/16.3.578; Katz E, 2010, CHEM SOC REV, V39, P1835, DOI 10.1039/b806038j; Keasling J, 2009, BIOSOCIETIES, V4, P275, DOI 10.1017/S1745855209990147; Kelle A, 2009, EMBO REP, V10, pS23, DOI 10.1038/embor.2009.119; Kool ET, 2000, CURR OPIN CHEM BIOL, V4, P602, DOI 10.1016/S1367-5931(00)00141-1; Kool ET, 2000, COLD SPRING HARB SYM, V65, P93, DOI 10.1101/sqb.2000.65.93; Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088; KRIMSKY S, 1982, ENVIRONMENT, V24, P2, DOI 10.1080/00139157.1982.9929782; Kumar S, 2007, TEX LAW REV, V85, P1745; Kuruma Y, 2009, BBA-BIOMEMBRANES, V1788, P567, DOI 10.1016/j.bbamem.2008.10.017; Lee SK, 2008, CURR OPIN BIOTECH, V19, P556, DOI 10.1016/j.copbio.2008.10.014; Leydesdorff L, 2009, J AM SOC INF SCI TEC, V60, P348, DOI 10.1002/asi.20967; Li JWH, 2009, SCIENCE, V325, P161, DOI 10.1126/science.1168243; Lindesmith LC, 2008, PLOS MED, V5, P269, DOI 10.1371/journal.pmed.0050031; LOPEZ N, 1995, J VIROL, V69, P3972, DOI 10.1128/JVI.69.7.3972-3979.1995; Luisi PL, 2007, CHEM BIODIVERS, V4, P603, DOI 10.1002/cbdv.200790053; Mackenzie A, 2010, BIOSOCIETIES, V5, P180, DOI 10.1057/biosoc.2010.4; Mashego MR, 2007, BIOTECHNOL LETT, V29, P1, DOI 10.1007/s10529-006-9218-0; Maurer SM, 2010, ISSUES SCI TECHNOL, V26, P9; May T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002372; Miller S, 2007, SCI ENG ETHICS, V13, P523, DOI 10.1007/s11948-007-9043-4; Mohimani H, 2011, J COMPUT BIOL, V18, P1371, DOI 10.1089/cmb.2011.0158; MULLER K, 1993, ARGUMENT, V35, P991; Na D, 2010, CURR OPIN MICROBIOL, V13, P363, DOI 10.1016/j.mib.2010.02.004; Nicolaou SA, 2010, METAB ENG, V12, P307, DOI 10.1016/j.ymben.2010.03.004; O'Malley MA, 2008, BIOESSAYS, V30, P57, DOI 10.1002/bies.20664; O'Malley MA, 2007, AM J BIOETHICS, V7, P67, DOI 10.1080/15265160701221285; Papapostolou D, 2009, MOL BIOSYST, V5, P723, DOI 10.1039/b902440a; Pennisi E, 2005, SCIENCE, V310, P769, DOI 10.1126/science.310.5749.769; Pfefferle S, 2009, EMERG INFECT DIS, V15, P1377, DOI 10.3201/eid1509.090224; Pirakitikulr N, 2010, PROTEIN SCI, V19, P2336, DOI 10.1002/pro.513; Porter AL, 2009, J NANOPART RES, V11, P1023, DOI 10.1007/s11051-009-9607-0; Presidential Commission for the Study of Bioethical Issues, 2010, NEW DIR ETH SYNTH BI; Purnick PEM, 2009, NAT REV MOL CELL BIO, V10, P410, DOI 10.1038/nrm2698; Rafols I, 2010, J AM SOC INF SCI TEC, V61, P1871, DOI 10.1002/asi.21368; Rai A, 2007, PLOS BIOL, V5, P389, DOI 10.1371/journal.pbio.0050058; Rawls RL, 2000, CHEM ENG NEWS, V78, P49; Richardson SM, 2010, NUCLEIC ACIDS RES, V38, P2603, DOI 10.1093/nar/gkq143; RIP A, 1984, SCIENTOMETRICS, V6, P381, DOI 10.1007/BF02025827; Roehr B, 2010, BRIT MED J, V341, P2; Rokem JS, 2007, NAT PROD REP, V24, P1262, DOI 10.1039/b617765b; Rude MA, 2009, CURR OPIN MICROBIOL, V12, P274, DOI 10.1016/j.mib.2009.04.004; Rutz B, 2010, BIOTECHNOL J, V5, P11, DOI 10.1002/biot.200900260; Schmidt M, 2010, BIOESSAYS, V32, P322, DOI 10.1002/bies.200900147; Silver PA, 2009, BIOSOCIETIES, V4, P283, DOI 10.1017/S1745855209990135; Simmons TL, 2008, P NATL ACAD SCI USA, V105, P4587, DOI 10.1073/pnas.0709851105; Simpson ML, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100104; Staab PR, 2010, BIOINFORMATICS, V26, P2782, DOI 10.1093/bioinformatics/btq518; Steen EJ, 2010, NATURE, V463, P559, DOI 10.1038/nature08721; Strack G, 2008, J AM CHEM SOC, V130, P4234, DOI 10.1021/ja7114713; Stricker J, 2008, NATURE, V456, P516, DOI 10.1038/nature07389; Tan C, 2009, NAT CHEM BIOL, V5, P842, DOI 10.1038/nchembio.218; Tanouchi Y, 2009, MOL BIOSYST, V5, P695, DOI 10.1039/b901584c; The International Civil Society Working Group on Synthetic Biology, 2011, CONVENTION BIO UNPUB; The Royal Academy of Engineering, 2009, SYNTH BIOL SCOP APPL; Veening JW, 2008, ANNU REV MICROBIOL, V62, P193, DOI 10.1146/annurev.micro.62.081307.163002; Venter M, 2007, TRENDS PLANT SCI, V12, P118, DOI 10.1016/j.tplants.2007.01.002; Wagner CS, 2011, J INFORMETR, V5, P14, DOI 10.1016/j.joi.2010.06.004; Walpita P, 2005, FEMS MICROBIOL LETT, V244, P9, DOI 10.1016/j.femsle.2005.01.046; Wang WG, 2010, CHEM-ASIAN J, V5, P1796, DOI 10.1002/asia.201000087; Weber W, 2006, J GENE MED, V8, P535, DOI 10.1002/jgm.903; Weber W, 2009, DRUG DISCOV TODAY, V14, P956, DOI 10.1016/j.drudis.2009.06.010; Weber W, 2009, METAB ENG, V11, P117, DOI 10.1016/j.ymben.2008.12.001; Weiss R, 2009, CURR OPIN BIOTECH, V20, P447, DOI 10.1016/j.copbio.2009.09.007; Westerhoff HV, 2009, FEBS LETT, V583, P3882, DOI 10.1016/j.febslet.2009.11.018; Wilkinson B, 2006, CURR OPIN CHEM BIOL, V10, P169, DOI 10.1016/j.cbpa.2006.02.006; ZELENY M, 1992, INT J GEN SYST, V21, P145, DOI 10.1080/03081079208945066	127	55	56	2	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e34368	10.1371/journal.pone.0034368	http://dx.doi.org/10.1371/journal.pone.0034368			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UP	22539946	Green Published, gold			2022-12-27	WOS:000305341000009
J	Perfito, N; Jeong, SY; Silverin, B; Calisi, RM; Bentley, GE; Hau, M				Perfito, Nicole; Jeong, Sun Young; Silverin, Bengt; Calisi, Rebecca M.; Bentley, George E.; Hau, Michaela			Anticipating Spring: Wild Populations of Great Tits (Parus major) Differ in Expression of Key Genes for Photoperiodic Time Measurement	PLOS ONE			English	Article							ZONOTRICHIA-LEUCOPHRYS-GAMBELII; WHITE-CROWNED SPARROW; TYPE-2 DEIODINASE GENE; JAPANESE-QUAIL; DEEP BRAIN; MEDIAN-EMINENCE; NERVE-TERMINALS; LH-SECRETION; LONG-DAY; HORMONE	Measuring day length is critical for timing annual changes in physiology and behavior in many species. Recently, rapid changes in several photoperiodically-controlled genes following exposure to a single long day have been described. Components of this 'first day release' model have so far only been tested in highly domesticated species: quail, sheep, goats and rodents. Because artificial selection accompanying domestication acts on genes related to photoperiodicity, we must also study this phenomenon in wild organisms for it to be accepted as universal. In a songbird, the great tit (Parus major), we tested whether a) these genes are involved in photoperiodic time measurement (PTM) in a wild species, and b) whether predictable species and population differences in expression patterns exist. Using quantitative RT-PCR, we compared gene expression after a single long day in male great tits from Sweden (57 degrees 42'N) with that from a German (47 degrees 43'N) population. Hypothalamic gene expression key for PTM changed only in the northern population, and occurred earlier after dawn during the single long day than demonstrated in quail; however, gonadotropins (secretion and synthesis) were stimulated in both populations, albeit with different timing. Our data are the first to show acute changes in gene expression in response to photostimulation in any wild species not selected for study of photoperiodism. The pronounced differences in gene expression in response to a single long day between two populations raise exciting new questions about potential environmental selection on photoperiodic cue sensitivity.	[Perfito, Nicole; Jeong, Sun Young; Calisi, Rebecca M.; Bentley, George E.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Perfito, Nicole; Hau, Michaela] Max Planck Inst Ornithol, Dept Migrat & Immunoecol, Radolfzell am Bodensee, Germany; [Silverin, Bengt] Gothenburg Univ, Dept Zool, S-40031 Gothenburg, Sweden; [Bentley, George E.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; Max Planck Society; University of Gothenburg; University of California System; University of California Berkeley	Perfito, N (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.	nperfito@berkeley.edu			Max Planck Society; National Science Foundation Integrative Organismal Systems (NSF IOS) [0920753]	Max Planck Society(Max Planck Society); National Science Foundation Integrative Organismal Systems (NSF IOS)	This study was funded by the Max Planck Society (MH) and National Science Foundation Integrative Organismal Systems (NSF IOS) 0920753 (GB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker JR, 1939, P ZOOL SOC LOND A-GE, V108, P557; BENOIT J, 1964, ANN NY ACAD SCI, V117, P204, DOI 10.1111/j.1749-6632.1964.tb48175.x; BERN HA, 1966, Z ZELLFORSCH MIK ANA, V69, P198, DOI 10.1007/BF00406275; Bronson Franklin H., 1994, P541; Davies WIL, 2011, BIOL LETT; Farner DS, 1967, NEUROENDOCRINOLOGY, P529; FARNER DS, 1979, HORMONES EVOLUTION, P829; FOLLETT BK, 1975, GEN COMP ENDOCR, V26, P126, DOI 10.1016/0016-6480(75)90223-3; FOLLETT BK, 1974, P NATL ACAD SCI USA, V71, P1666, DOI 10.1073/pnas.71.5.1666; FOLLETT BK, 1969, NATURE, V223, P968, DOI 10.1038/223968b0; FOSTER RG, 1994, NEUROSCI BIOBEHAV R, V18, P541, DOI 10.1016/0149-7634(94)90009-4; Gonzalez R, 2008, DATA ANAL EXPT DESIG; Halford S, 2009, CURR BIOL, V19, P1396, DOI 10.1016/j.cub.2009.06.066; Hanon EA, 2008, CURR BIOL, V18, P1147, DOI 10.1016/j.cub.2008.06.076; Hazlerigg D, 2008, CURR BIOL, V18, pR795, DOI 10.1016/j.cub.2008.07.040; Hazlerigg DG, 2006, TRENDS ENDOCRIN MET, V17, P83, DOI 10.1016/j.tem.2006.02.004; Helms C. W., 1960, BIRDBANDING, V31, P1, DOI [DOI 10.2307/4510793, 10.2307/4510793]; Kang SW, 2010, NEUROSCIENCE, V170, P200, DOI 10.1016/j.neuroscience.2010.06.082; LEWIS RA, 1975, CONDOR, V77, P111, DOI 10.2307/1365780; Meddle SL, 1997, J NEUROSCI, V17, P8909; MENAKER M, 1970, P NATL ACAD SCI USA, V67, P320, DOI 10.1073/pnas.67.1.320; Murton RK, 1977, AVIAN BREEDING CYCLE; Nakane Y, 2010, P NATL ACAD SCI USA, V107, P15264, DOI 10.1073/pnas.1006393107; Nakao N, 2008, NATURE, V452, P317, DOI 10.1038/nature06738; NICHOLLS TJ, 1983, J ENDOCRINOL, V97, P121, DOI 10.1677/joe.0.0970121; NICHOLLS TJ, 1974, J COMP PHYSIOL, V93, P301, DOI 10.1007/BF00606799; Ono H, 2008, P NATL ACAD SCI USA, V105, P18238, DOI 10.1073/pnas.0808952105; Paul MJ, 2008, PHILOS T R SOC B, V363, P341, DOI 10.1098/rstb.2007.2143; Revel FG, 2006, ENDOCRINOLOGY, V147, P4680, DOI 10.1210/en.2006-0606; Rubin CJ, 2010, NATURE, V464, P587, DOI 10.1038/nature08832; SILVER R, 1988, CELL TISSUE RES, V253, P189; SILVERIN B, 1994, ETHOL ECOL EVOL, V6, P131, DOI 10.1080/08927014.1994.9522990; SILVERIN B, 1993, GEN COMP ENDOCR, V90, P14, DOI 10.1006/gcen.1993.1055; STOKES TM, 1974, J COMP NEUROL, V156, P337, DOI 10.1002/cne.901560305; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; WADA M, 1979, GEN COMP ENDOCR, V39, P141, DOI 10.1016/0016-6480(79)90219-3; Wada Y, 1998, FEBS LETT, V424, P53, DOI 10.1016/S0014-5793(98)00138-0; Watanabe T, 2007, AM J PHYSIOL-REG I, V292, pR568, DOI 10.1152/ajpregu.00521.2006; Wingfield J.C., 1991, P181; Wingfield J. C., 1993, J ENDOCRINOL, P111; WINGFIELD JC, 1992, J EXP ZOOL, V261, P214, DOI 10.1002/jez.1402610212; Wingfield John C., 2000, P85; Yamamura T, 2006, CELL TISSUE RES, V324, P175, DOI 10.1007/s00441-005-0126-8; Yamamura T, 2004, ENDOCRINOLOGY, V145, P4264, DOI 10.1210/en.2004-0366; Yasuo S, 2006, ENDOCRINOLOGY, V147, P432, DOI 10.1210/en.2005-0507; YOKOYAMA K, 1978, CELL TISSUE RES, V189, P441; Yoshimura T, 2003, NATURE, V426, P178, DOI 10.1038/nature02117; Yoshimura T, 2009, PHOTOPERIODISM BIOL, P446; Yoshimura T, 2007, AM J PHYSL REG 1, V292, pR1315; Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047	50	43	43	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e34997	10.1371/journal.pone.0034997	http://dx.doi.org/10.1371/journal.pone.0034997			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22539953	Green Published, gold			2022-12-27	WOS:000305341000016
J	Cole, JW; Stine, OC; Liu, XY; Pratap, A; Cheng, YC; Tallon, LJ; Sadzewicz, LK; Dueker, N; Wozniak, MA; Stern, BJ; Meschia, JF; Mitchell, BD; Kittner, SJ; O'Connell, JR				Cole, John W.; Stine, O. Colin; Liu, Xinyue; Pratap, Abhishek; Cheng, Yuching; Tallon, Luke J.; Sadzewicz, Lisa K.; Dueker, Nicole; Wozniak, Marcella A.; Stern, Barney J.; Meschia, James F.; Mitchell, Braxton D.; Kittner, Steven J.; O'Connell, Jeffrey R.			Rare Variants in Ischemic Stroke: An Exome Pilot Study	PLOS ONE			English	Article							READ ALIGNMENT; ASSOCIATION; YOUNG; FRAMEWORK; DISEASE; GENES	The genetic architecture of ischemic stroke is complex and is likely to include rare or low frequency variants with high penetrance and large effect sizes. Such variants are likely to provide important insights into disease pathogenesis compared to common variants with small effect sizes. Because a significant portion of human functional variation may derive from the protein-coding portion of genes we undertook a pilot study to identify variation across the human exome (i.e., the coding exons across the entire human genome) in 10 ischemic stroke cases. Our efforts focused on evaluating the feasibility and identifying the difficulties in this type of research as it applies to ischemic stroke. The cases included 8 African-Americans and 2 Caucasians selected on the basis of similar stroke subtypes and by implementing a case selection algorithm that emphasized the genetic contribution of stroke risk. Following construction of paired-end sequencing libraries, all predicted human exons in each sample were captured and sequenced. Sequencing generated an average of 25.5 million read pairs (75 bp x 2) and 3.8 Gbp per sample. After passing quality filters, screening the exomes against dbSNP demonstrated an average of 2839 novel SNPs among African-Americans and 1105 among Caucasians. In an aggregate analysis, 48 genes were identified to have at least one rare variant across all stroke cases. One gene, CSN3, identified by screening our prior GWAS results in conjunction with our exome results, was found to contain an interesting coding polymorphism as well as containing excess rare variation as compared with the other genes evaluated. In conclusion, while rare coding variants may predispose to the risk of ischemic stroke, this fact has yet to be definitively proven. Our study demonstrates the complexities of such research and highlights that while exome data can be obtained, the optimal analytical methods have yet to be determined.	[Cole, John W.; Wozniak, Marcella A.; Stern, Barney J.; Kittner, Steven J.] Vet Adm Med Ctr, Baltimore, MD 21218 USA; [Cole, John W.; Stine, O. Colin; Liu, Xinyue; Pratap, Abhishek; Cheng, Yuching; Tallon, Luke J.; Sadzewicz, Lisa K.; Dueker, Nicole; Wozniak, Marcella A.; Stern, Barney J.; Mitchell, Braxton D.; Kittner, Steven J.; O'Connell, Jeffrey R.] Univ Maryland, Sch Med, Baltimore, MD 21201 USA; [Meschia, James F.] Mayo Clin, Jacksonville, FL 32224 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University System of Maryland; University of Maryland Baltimore; Mayo Clinic	Cole, JW (corresponding author), Vet Adm Med Ctr, Baltimore, MD 21218 USA.	jcole@som.umaryland.edu	Mitchell, Braxton/CAF-0876-2022; Meschia, James/GPP-1636-2022	Meschia, James/0000-0002-4475-8142; Pratap, Abhishek/0000-0002-5289-6932; Mitchell, Braxton/0000-0003-4920-4744	Department of Veterans Affairs, Baltimore, Office of Research and Development, Medical Research Service; Department of Veterans Affairs; Department of Veterans Affairs, Baltimore; Geriatrics Research, Education, and Clinical Center of Excellence; American Heart Association; National Institute of Neurological Disorders and Stroke (NINDS) [U01 NS069208-01, R01 NS39987]; NIH Office of Research on Women's Health (ORWH) [R01 NS45012]; National Human Genome Research Institute (NHGRI) [U01 HG004436]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004436] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072488] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS069208, R01NS039987, R01NS045012] Funding Source: NIH RePORTER	Department of Veterans Affairs, Baltimore, Office of Research and Development, Medical Research Service(US Department of Veterans Affairs); Department of Veterans Affairs(US Department of Veterans Affairs); Department of Veterans Affairs, Baltimore(US Department of Veterans Affairs); Geriatrics Research, Education, and Clinical Center of Excellence; American Heart Association(American Heart Association); National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH Office of Research on Women's Health (ORWH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Office of Research on Women's Health (ORWH)); National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by the Department of Veterans Affairs, Baltimore, Office of Research and Development, Medical Research Service; the Department of Veterans Affairs Stroke Research Enhancement Award Program; the Department of Veterans Affairs, Baltimore, Geriatrics Research, Education, and Clinical Center of Excellence; the American Heart Association Grant-in-Aid Program; the National Institute of Neurological Disorders and Stroke (NINDS) (Grants U01 NS069208-01 and R01 NS39987); the NIH Office of Research on Women's Health (ORWH) (Grant R01 NS45012); the National Human Genome Research Institute (NHGRI) (Grant U01 HG004436). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; [Anonymous], 2010, NATL VITAL STAT REPO; Bansal V, 2010, NAT REV GENET, V11, P773, DOI 10.1038/nrg2867; Botstein D, 2003, NAT GENET, V33, P228, DOI 10.1038/ng1090; Brass LM, 1998, STROKE, V29, P256; CDC, 2007, 2006 SUMM HLTH STAT; Cheng YC, 2011, G3-GENES GENOM GENET, V1, P505, DOI 10.1534/g3.111.001164; Cornelis MC, 2010, GENET EPIDEMIOL, V34, P364, DOI 10.1002/gepi.20492; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Foroud T, 2003, NEUROLOGY, V60, P796, DOI 10.1212/01.WNL.0000049470.00180.07; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Hassan A, 2000, BRAIN, V123, P1784, DOI 10.1093/brain/123.9.1784; Hong X, 2001, FEBS LETT, V499, P133, DOI 10.1016/S0014-5793(01)02535-2; Ikram MA, 2009, NEW ENGL J MED, V360, P1718, DOI 10.1056/NEJMoa0900094; Jacobs BS, 2002, STROKE, V33, P2789, DOI 10.1161/01.STR.0000038988.64376.3A; Ji WZ, 2008, NAT GENET, V40, P592, DOI 10.1038/ng.118; King JY, 2005, PHYSIOL GENOMICS, V23, P103, DOI 10.1152/physiolgenomics.00101.2005; Kittner SJ, 1998, NEUROLOGY, V50, P890, DOI 10.1212/WNL.50.4.890; Kleindorfer D, 2006, STROKE, V37, P2473, DOI 10.1161/01.STR.0000242766.65550.92; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lesage S, 2008, J MED GENET, V45, P43, DOI 10.1136/jmg.2007.051854; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; MacArthur D., 2008, GENETIC FUTURE; MacClellan LR, 2006, GENET EPIDEMIOL, V30, P602, DOI 10.1002/gepi.20171; Matarin M, 2009, STROKE, V40, P3436, DOI 10.1161/STROKEAHA.109.558015; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meschia James F, 2002, BMC Med Genet, V3, P1, DOI 10.1186/1471-2350-3-1; Ng PC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000160; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rampersaud E, 2007, DIABETES, V56, P3053, DOI 10.2337/db07-0457; Rosand J, 2010, NEW ENGL J MED, V362, P1547, DOI 10.1056/NEJMc0910050; Schulz UGR, 2004, STROKE, V35, P819, DOI 10.1161/01.STR.0000121646.23955.0f; Weeks JP, 2009, PLINK IRT SEPARATE C; Xin XY, 2009, THROMB RES, V124, P619, DOI 10.1016/j.thromres.2009.07.007; Yoneda-Kato N, 2008, MOL CELL BIOL, V28, P422, DOI 10.1128/MCB.02335-06	39	32	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35591	10.1371/journal.pone.0035591	http://dx.doi.org/10.1371/journal.pone.0035591			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536414	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339200082
J	Endeshaw, T; Graves, PM; Ayele, B; Mosher, AW; Gebre, T; Ayalew, F; Genet, A; Mesfin, A; Shargie, EB; Tadesse, Z; Teferi, T; Melak, B; Richards, FO; Emerson, PM				Endeshaw, Tekola; Graves, Patricia M.; Ayele, Berhan; Mosher, Aryc W.; Gebre, Teshome; Ayalew, Firew; Genet, Asrat; Mesfin, Alemayehu; Shargie, Estifanos Biru; Tadesse, Zerihun; Teferi, Tesfaye; Melak, Berhanu; Richards, Frank O.; Emerson, Paul M.			Performance of Local Light Microscopy and the ParaScreen Pan/Pf Rapid Diagnostic Test to Detect Malaria in Health Centers in Northwest Ethiopia	PLOS ONE			English	Article								Background: Diagnostic tests are recommended for suspected malaria cases before treatment, but comparative performance of microscopy and rapid diagnostic tests (RDTs) at rural health centers has rarely been studied compared to independent expert microscopy. Methods: Participants (N = 1997) with presumptive malaria were recruited from ten health centers with a range of transmission intensities in Amhara Regional State, Northwest Ethiopia during October to December 2007. Microscopy and ParaScreen Pan/Pf (R) RDT were done immediately by health center technicians. Blood slides were re-examined later at a central laboratory by independent expert microscopists. Results: Of 1,997 febrile patients, 475 (23.8%) were positive by expert microscopists, with 57.7% P. falciparum, 24.6% P. vivax and 17.7% mixed infections. Sensitivity of health center microscopists for any malaria species was >90% in five health centers (four of which had the highest prevalence), >70% in nine centers and 44% in one site with lowest prevalence. Specificity for health center microscopy was very good (>95%) in all centers. For ParaScreen RDT, sensitivity was >= 90% in three centers, >= 70% in six and <60% in four centers. Specificity was >= 90% in all centers except one where it was 85%. Conclusions: Health center microscopists performed well in nine of the ten health centers; while for ParaScreen RDT they performed well in only six centers. Overall the accuracy of local microscopy exceeded that of RDT for all outcomes. This study supports the introduction of RDTs only if accompanied by appropriate training, frequent supervision and quality control at all levels. Deficiencies in RDT use at some health centers must be rectified before universal replacement of good routine microscopy with RDTs. Maintenance and strengthening of good quality microscopy remains a priority at health center level.	[Graves, Patricia M.; Mosher, Aryc W.; Richards, Frank O.; Emerson, Paul M.] Emory Univ, Carter Ctr, Atlanta, GA 30322 USA; [Endeshaw, Tekola; Ayele, Berhan; Gebre, Teshome; Ayalew, Firew; Shargie, Estifanos Biru; Tadesse, Zerihun; Teferi, Tesfaye; Melak, Berhanu] Carter Ctr, Addis Ababa, Ethiopia; [Genet, Asrat; Mesfin, Alemayehu] Amhara Reg Hlth Bur, Bahir Dar, Ethiopia; [Shargie, Estifanos Biru] Global Fund Fight AIDS TB & Malaria, Strateg Informat Team, Geneva, Vernier, Switzerland	Emory University	Emerson, PM (corresponding author), Emory Univ, Carter Ctr, Atlanta, GA 30322 USA.	paul.emerson@emory.edu	Graves, Patricia M/J-8691-2014; AMNIE, ASRAT G/J-7522-2019; Gebre, Teshome/F-2973-2011	Graves, Patricia M/0000-0002-5215-3901; AMNIE, ASRAT G/0000-0002-9745-3377; Gebre, Teshome/0000-0002-9884-0344; Emerson, Paul/0000-0002-6478-8816	Carter Center Malaria Control Program	Carter Center Malaria Control Program	The study was funded by The Carter Center Malaria Control Program with health center staff time provided by the Amhara Regional Health Bureau. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashton RA, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-297; Durrheim DN, 1997, S AFR MED J, V87, P609; Endeshaw T, 2010, T ROY SOC TROP MED H, V104, P467, DOI 10.1016/j.trstmh.2010.03.003; Endeshaw T, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-118; Federal Ministry of Health, 2006, NAT 5 YEAR STRAT PLA; Federal Ministry of Health, 2011, MAL DIAGN TREATM GUI; Hailegiorgis B, 2010, TROP MED INT HEALTH, V15, P1449, DOI 10.1111/j.1365-3156.2010.02646.x; Hopkins H, 2008, J INFECT DIS, V197, P510, DOI 10.1086/526502; Long EG, 2009, AM J CLIN PATHOL, V131, P858, DOI 10.1309/AJCPVX71BXWOVWBY; WHO, 1991, BAS MAL MICR 1; WHO, 2010, GUID TREATM MAL, V2nd	11	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e33014	10.1371/journal.pone.0033014	http://dx.doi.org/10.1371/journal.pone.0033014			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536317	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000305339200005
J	Galban, S; Lemasson, B; Williams, TM; Li, F; Heist, KA; Johnson, TD; Leopold, JS; Chenevert, TL; Lawrence, TS; Rehemtulla, A; Mikkelsen, T; Holland, EC; Galban, CJ; Ross, BD				Galban, Stefanie; Lemasson, Benjamin; Williams, Terence M.; Li, Fei; Heist, Kevin A.; Johnson, Timothy D.; Leopold, Judith S.; Chenevert, Thomas L.; Lawrence, Theodore S.; Rehemtulla, Alnawaz; Mikkelsen, Tom; Holland, Eric C.; Galban, Craig J.; Ross, Brian D.			DW-MRI as a Biomarker to Compare Therapeutic Outcomes in Radiotherapy Regimens Incorporating Temozolomide or Gemcitabine in Glioblastoma	PLOS ONE			English	Article							FUNCTIONAL DIFFUSION MAP; HIGH-GRADE GLIOMAS; IMAGING BIOMARKER; MALIGNANT GLIOMA; MOUSE MODELS; ADJUVANT TEMOZOLOMIDE; PROMOTER METHYLATION; RESPONSE ASSESSMENT; PRECLINICAL TRIALS; BRAIN-TUMORS	The effectiveness of the radiosensitizer gemcitabine (GEM) was evaluated in a mouse glioma along with the imaging biomarker diffusion-weighted magnetic resonance imaging (DW-MRI) for early detection of treatment effects. A genetically engineered murine GBM model [Ink4a-Arf(-/-) Pten(loxP/loxP)/Ntv-a RCAS/PDGF(+)/Cre(+)] was treated with gemcitabine (GEM), temozolomide (TMZ) +/- ionizing radiation (IR). Therapeutic efficacy was quantified by contrast-enhanced MRI and DW-MRI for growth rate and tumor cellularity, respectively. Mice treated with GEM, TMZ and radiation showed a significant reduction in growth rates as early as three days post-treatment initiation. Both combination treatments (GEM/IR and TMZ/IR) resulted in improved survival over single therapies. Tumor diffusion values increased prior to detectable changes in tumor volume growth rates following administration of therapies. Concomitant GEM/IR and TMZ/IR was active and well tolerated in this GBM model and similarly prolonged median survival of tumor bearing mice. DW-MRI provided early changes to radiosensitization treatment warranting evaluation of this imaging biomarker in clinical trials.	[Lemasson, Benjamin; Li, Fei; Heist, Kevin A.; Lawrence, Theodore S.; Rehemtulla, Alnawaz; Galban, Craig J.; Ross, Brian D.] Univ Michigan, Dept Radiol, Ann Arbor, MI 48109 USA; [Galban, Stefanie; Williams, Terence M.; Leopold, Judith S.; Chenevert, Thomas L.; Rehemtulla, Alnawaz] Univ Michigan, Dept Radiat Oncol, Ann Arbor, MI 48109 USA; [Johnson, Timothy D.] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Mikkelsen, Tom] Henry Ford Hlth Syst, Hermelin Brain Tumor Ctr, Dept Neurosurg, Detroit, MI USA; [Holland, Eric C.] Mem Sloan Kettering Canc Ctr, Dept Canc Biol & Genet, New York, NY 10021 USA; [Holland, Eric C.] Mem Sloan Kettering Canc Ctr, Dept Neurosurg, New York, NY 10021 USA; [Holland, Eric C.] Mem Sloan Kettering Canc Ctr, Brain Tumor Ctr, New York, NY 10021 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Henry Ford Health System; Henry Ford Hospital; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Ross, BD (corresponding author), Univ Michigan, Dept Radiol, Ann Arbor, MI 48109 USA.	bdross@umich.edu	Williams, Terence M/I-9614-2014; Lemasson, Benjamin/AAC-4092-2019; Lemasson, Benjamin/L-1608-2014	Lemasson, Benjamin/0000-0003-0446-3531; Lemasson, Benjamin/0000-0003-0446-3531; Chenevert, Thomas/0000-0003-1476-4274	NIH [P01-CA085878, P50-CA093990]; NATIONAL CANCER INSTITUTE [P01CA085878, P50CA093990] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH funding only P01-CA085878 and P50-CA093990. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bleau AM, 2009, CELL STEM CELL, V4, P226, DOI 10.1016/j.stem.2009.01.007; Buijs M, 2007, J VASC INTERV RADIOL, V18, P957, DOI 10.1016/j.jvir.2007.04.025; Chenevert TL, 2009, NEUROIMAG CLIN N AM, V19, P559, DOI 10.1016/j.nic.2009.08.009; Chenevert TL, 1997, CLIN CANCER RES, V3, P1457; Chenevert TL, 2000, JNCI-J NATL CANCER I, V92, P2029, DOI 10.1093/jnci/92.24.2029; Colman H, 2010, NEURO-ONCOLOGY, V12, P49, DOI 10.1093/neuonc/nop007; Cui Y, 2008, RADIOLOGY, V248, P894, DOI 10.1148/radiol.2483071407; Dai C, 2001, GENE DEV, V15, P1913, DOI 10.1101/gad.903001; Dai CK, 2005, NEOPLASIA, V7, P397, DOI 10.1593/neo.04691; Day SE, 2011, MAGN RESON MED, V65, P557, DOI 10.1002/mrm.22698; Dudeck O, 2008, J MAGN RESON IMAGING, V27, P1109, DOI 10.1002/jmri.21358; Dzik-Jurasz A, 2002, LANCET, V360, P307, DOI 10.1016/S0140-6736(02)09520-X; Ellingson BM, 2010, J MAGN RESON IMAGING, V31, P538, DOI 10.1002/jmri.22068; Fabi A, 2008, J NEURO-ONCOL, V87, P79, DOI 10.1007/s11060-007-9489-x; Fisher GH, 1999, ONCOGENE, V18, P5253, DOI 10.1038/sj.onc.1203087; Galban CJ, 2010, CLIN CANCER RES, V16, P1542, DOI 10.1158/1078-0432.CCR-08-1812; Gertler SZ, 2000, ANN ONCOL, V11, P315, DOI 10.1023/A:1008336607135; Gupta T, 2002, LANCET ONCOL, V3, P557, DOI 10.1016/S1470-2045(02)00853-7; Hamstra DA, 2005, P NATL ACAD SCI USA, V102, P16759, DOI 10.1073/pnas.0508347102; Hamstra DA, 2008, J CLIN ONCOL, V26, P3387, DOI 10.1200/JCO.2007.15.2363; Hegi ME, 2004, CLIN CANCER RES, V10, P1871, DOI 10.1158/1078-0432.CCR-03-0384; Hu XY, 2005, MUTAT RES-FUND MOL M, V576, P54, DOI 10.1016/j.mrfmmm.2004.08.023; Jones TS, 2011, TOXICOL PATHOL, V39, P158, DOI 10.1177/0192623310387617; Koutcher JA, 2002, NEOPLASIA, V4, P480, DOI 10.1038/sj.neo.7900269; la Fougere C, 2011, NEURO-ONCOLOGY, V13, P806, DOI 10.1093/neuonc/nor054; LeBihan D, 1995, NMR BIOMED, V8, P375, DOI 10.1002/nbm.1940080711; MACDONALD DR, 1990, J CLIN ONCOL, V8, P1277, DOI 10.1200/JCO.1990.8.7.1277; McConville P, 2007, CLIN CANCER RES, V13, P2897, DOI 10.1158/1078-0432.CCR-06-3058; Metro G, 2010, CANCER CHEMOTH PHARM, V65, P391, DOI 10.1007/s00280-009-1155-x; Moffat BA, 2006, NEOPLASIA, V8, P259, DOI 10.1593/neo.05844; Momota H, 2009, BRAIN TUMOR PATHOL, V26, P43, DOI 10.1007/s10014-009-0253-0; Orsulic S, 2002, MAMM GENOME, V13, P543, DOI 10.1007/s00335-002-4003-4; Ostruszka LJ, 2000, CANCER RES, V60, P6080; Pauwels B, 2005, ONCOLOGIST, V10, P34, DOI 10.1634/theoncologist.10-1-34; Pitter KL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014545; Preusser M, 2011, CLIN NEUROPATHOL, V30, P217, DOI 10.5414/NP300422; Ross Brian D, 1994, Q Magn Reson Biol Med, V1, P89; Sigmond J, 2009, ANN ONCOL, V20, P182, DOI 10.1093/annonc/mdn543; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2006, ONCOLOGIST, V11, P165, DOI 10.1634/theoncologist.11-2-165; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Tchougounova E, 2007, ONCOGENE, V26, P6289, DOI 10.1038/sj.onc.1210455; Van Nifterik KA, 2007, INT J RADIAT ONCOL, V69, P1246, DOI 10.1016/j.ijrobp.2007.07.2366; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Waldman AD, 2009, NAT REV CLIN ONCOL, V6, P445, DOI 10.1038/nrclinonc.2009.92; Weller M, 2010, NAT REV NEUROL, V6, P39, DOI 10.1038/nrneurol.2009.197; Wen PY, 2010, J CLIN ONCOL, V28, P1963, DOI 10.1200/JCO.2009.26.3541	47	26	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35857	10.1371/journal.pone.0035857	http://dx.doi.org/10.1371/journal.pone.0035857			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536446	Green Submitted, Green Published, gold			2022-12-27	WOS:000305339200119
J	Okabe, Y; Takahashi, T; Mitsumasu, C; Kosai, K; Tanaka, E; Matsuishi, T				Okabe, Yasunori; Takahashi, Tomoyuki; Mitsumasu, Chiaki; Kosai, Ken-ichiro; Tanaka, Eiichiro; Matsuishi, Toyojiro			Alterations of Gene Expression and Glutamate Clearance in Astrocytes Derived from an MeCP2-Null Mouse Model of Rett Syndrome	PLOS ONE			English	Article							CPG-BINDING PROTEIN-2; EMBRYONIC STEM-CELL; DNA METHYLATION; DIFFERENTIATION; DYSFUNCTION; BRAIN; GLIA; TRANSPORTERS; DEFICIENCY; MICROGLIA	Rett syndrome (RTT) is a neurodevelopmetal disorder associated with mutations in the methyl-CpG-binding protein 2 (MeCP2) gene. MeCP2-deficient mice recapitulate the neurological degeneration observed in RTT patients. Recent studies indicated a role of not only neurons but also glial cells in neuronal dysfunction in RTT. We cultured astrocytes from MeCP2-null mouse brain and examined astroglial gene expression, growth rate, cytotoxic effects, and glutamate (Glu) clearance. Semi-quantitative RT-PCR analysis revealed that expression of astroglial marker genes, including GFAP and S100b, was significantly higher in MeCP2-null astrocytes than in control astrocytes. Loss of MeCP2 did not affect astroglial cell morphology, growth, or cytotoxic effects, but did alter Glu clearance in astrocytes. When high extracellular Glu was added to the astrocyte cultures and incubated, a time-dependent decrease of extracellular Glu concentration occurred due to Glu clearance by astrocytes. Although the shapes of the profiles of Glu concentration versus time for each strain of astrocytes were grossly similar, Glu concentration in the medium of MeCP2-null astrocytes were lower than those of control astrocytes at 12 and 18 h. In addition, MeCP2 deficiency impaired downregulation of excitatory amino acid transporter 1 and 2 (EAAT1/2) transcripts, but not induction of glutamine synthetase (GS) transcripts, upon high Glu exposure. In contrast, GS protein was significantly higher in MeCP2-null astrocytes than in control astrocytes. These findings suggest that MeCP2 affects astroglial genes expression in cultured astrocytes, and that abnormal Glu clearance in MeCP2-deficient astrocytes may influence the onset and progression of RTT.	[Okabe, Yasunori; Takahashi, Tomoyuki; Mitsumasu, Chiaki; Kosai, Ken-ichiro; Tanaka, Eiichiro; Matsuishi, Toyojiro] Kurume Univ, Div Gene Therapy & Regenerat Med, Cognit & Mol Res Inst Brain Dis, Kurume, Fukuoka 830, Japan; [Okabe, Yasunori; Tanaka, Eiichiro] Kurume Univ Med, Dept Physiol, Kurume, Fukuoka, Japan; [Takahashi, Tomoyuki; Mitsumasu, Chiaki; Kosai, Ken-ichiro; Matsuishi, Toyojiro] Kurume Univ Med, Dept Pediat, Kurume, Fukuoka, Japan; [Kosai, Ken-ichiro] Kagoshima Univ, Dept Gene Therapy & Regenerat Med, Adv Therapeut Course, Grad Sch Med & Dent Sci, Kagoshima 890, Japan	Kurume University; Kurume University; Kurume University; Kagoshima University	Takahashi, T (corresponding author), Kurume Univ, Div Gene Therapy & Regenerat Med, Cognit & Mol Res Inst Brain Dis, Kurume, Fukuoka 830, Japan.	takahashi_tomoyuki@kurume-u.ac.jp			Japan Society for the Promotion of Science	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by a Grant-in-Aid for Scientific Research (C) and a Grant-in-Aid for Young Scientists (B) from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Ballas N, 2009, NAT NEUROSCI, V12, P311, DOI 10.1038/nn.2275; Bienvenu T, 2006, NAT REV GENET, V7, P415, DOI 10.1038/nrg1878; Calfa G, 2011, EXP BIOL MED, V236, P3, DOI 10.1258/ebm.2010.010261; Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001; Chen CJ, 2000, J NEUROCHEM, V75, P1557, DOI 10.1046/j.1471-4159.2000.0751557.x; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Colantuoni C, 2001, NEUROBIOL DIS, V8, P847, DOI 10.1006/nbdi.2001.0428; Deguchi K, 2000, PEDIATR NEUROL, V22, P259, DOI 10.1016/S0887-8994(00)00120-X; Dunn HG, 2001, CAN J NEUROL SCI, V28, P16; Eid T, 2008, EPILEPSIA, V49, P42, DOI 10.1111/j.1528-1167.2008.01492.x; Erichsen MN, 2010, J MED CHEM, V53, P7180, DOI 10.1021/jm1009154; Eroglu C, 2010, NATURE, V468, P223, DOI 10.1038/nature09612; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; HAMBERGER A, 1992, NEUROPEDIATRICS, V23, P212, DOI 10.1055/s-2008-1071344; Horska A, 2009, ANN NEUROL, V65, P90, DOI 10.1002/ana.21562; JELLINGER K, 1988, ACTA NEUROPATHOL, V76, P142, DOI 10.1007/BF00688098; Kawai T, 2004, CIRC J, V68, P691, DOI 10.1253/circj.68.691; Kim SY, 2003, J NEUROCHEM, V87, P1485, DOI 10.1046/j.1471-4159.2003.02128.x; Lappalainen R, 1996, PEDIATR NEUROL, V15, P213, DOI 10.1016/S0887-8994(96)00218-4; Lehmann C, 2009, BRAIN RES, V1297, P1, DOI 10.1016/j.brainres.2009.08.070; Lioy DT, 2011, NATURE, V475, P497, DOI 10.1038/nature10214; Maezawa I, 2010, J NEUROSCI, V30, P5346, DOI 10.1523/JNEUROSCI.5966-09.2010; Maezawa I, 2009, J NEUROSCI, V29, P5051, DOI 10.1523/JNEUROSCI.0324-09.2009; Matsuishi T, 2011, BRAIN DEV-JPN, V33, P627, DOI 10.1016/j.braindev.2010.12.007; Naidu S, 2001, BRAIN DEV-JPN, V23, pS62, DOI 10.1016/S0387-7604(01)00381-3; Namihira M, 2004, FEBS LETT, V572, P184, DOI 10.1016/j.febslet.2004.07.029; Norenberg MD, 2007, METAB BRAIN DIS, V22, P219, DOI 10.1007/s11011-007-9062-5; Okabe Y, 2010, BRAIN RES, V1360, P17, DOI 10.1016/j.brainres.2010.08.090; Pan JW, 1999, J CHILD NEUROL, V14, P524, DOI 10.1177/088307389901400808; Ricciardi S, 2011, HUM MOL GENET, V20, P1182, DOI 10.1093/hmg/ddq563; Saywell W, 2006, BIOCHEM BIOPH RES CO, V340, P776, DOI 10.1016/j.bbrc.2005.12.080; Seifert G, 2006, NAT REV NEUROSCI, V7, P194, DOI 10.1038/nrn1870; Setoguchi H, 2006, J NEUROSCI RES, V84, P969, DOI 10.1002/jnr.21001; Sheldon AL, 2007, NEUROCHEM INT, V51, P333, DOI 10.1016/j.neuint.2007.03.012; Shigeri Y, 2004, BRAIN RES REV, V45, P250, DOI 10.1016/j.brainresrev.2004.04.004; Takahashi T, 2006, MOL THER, V14, P673, DOI 10.1016/j.ymthe.2006.05.010; Takeuchi H, 2005, J BIOL CHEM, V280, P10444, DOI 10.1074/jbc.M413863200; Tsujimura K, 2009, EXP NEUROL, V219, P104, DOI 10.1016/j.expneurol.2009.05.001; Ushikoshi H, 2005, LAB INVEST, V85, P862, DOI 10.1038/labinvest.3700282; Viola A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000157; Ward BC, 2009, J NEUROCHEM, V108, P361, DOI 10.1111/j.1471-4159.2008.05768.x; Yang YJ, 2010, GLIA, V58, P277, DOI 10.1002/glia.20922	43	63	65	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35354	10.1371/journal.pone.0035354	http://dx.doi.org/10.1371/journal.pone.0035354			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22532851	Green Published, gold, Green Submitted			2022-12-27	WOS:000305339200059
J	Worni, M; Pietrobon, R; Zammar, GR; Shah, J; Yoo, B; Maldonato, M; Takemoto, S; Vail, TP				Worni, Mathias; Pietrobon, Ricardo; Zammar, Guilherme Roberto; Shah, Jatin; Yoo, Bryan; Maldonato, Mauro; Takemoto, Steven; Vail, Thomas P.			System Dynamics to Model the Unintended Consequences of Denying Payment for Venous Thromboembolism after Total Knee Arthroplasty	PLOS ONE			English	Article							DEEP-VEIN THROMBOSIS; PAY-FOR-PERFORMANCE; QUALITY-OF-LIFE; PULMONARY-EMBOLISM; ETHNIC DISPARITIES; NEVER EVENTS; TOTAL HIP; ORTHOPEDIC-SURGERY; SURGICAL-PATIENTS; SETTING ENDORSE	Background: The Hospital Acquired Condition Strategy (HACS) denies payment for venous thromboembolism (VTE) after total knee arthroplasty (TKA). The intention is to reduce complications and associated costs, while improving the quality of care by mandating VTE prophylaxis. We applied a system dynamics model to estimate the impact of HACS on VTE rates, and potential unintended consequences such as increased rates of bleeding and infection and decreased access for patients who might benefit from TKA. Methods and Findings: The system dynamics model uses a series of patient stocks including the number needing TKA, deemed ineligible, receiving TKA, and harmed due to surgical complication. The flow of patients between stocks is determined by a series of causal elements such as rates of exclusion, surgery and complications. The number of patients harmed due to VTE, bleeding or exclusion were modeled by year by comparing patient stocks that results in scenarios with and without HACS. The percentage of TKA patients experiencing VTE decreased approximately 3-fold with HACS. This decrease in VTE was offset by an increased rate of bleeding and infection. Moreover, results from the model suggest HACS could exclude 1.5% or half a million patients who might benefit from knee replacement through 2020. Conclusion: System dynamics modeling indicates HACS will have the intended consequence of reducing VTE rates. However, an unintended consequence of the policy might be increased potential harm resulting from over administration of prophylaxis, as well as exclusion of a large population of patients who might benefit from TKA.	[Takemoto, Steven; Vail, Thomas P.] Philip R Lee Inst Hlth Policy Studies, San Francisco, CA USA; [Worni, Mathias; Pietrobon, Ricardo] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Zammar, Guilherme Roberto] Pontificia Univ Catolica Parana, Curitiba, Parana, Brazil; [Takemoto, Steven] Univ Calif San Francisco, Dept Orthopaed Surg, San Francisco, CA USA; [Worni, Mathias; Pietrobon, Ricardo; Zammar, Guilherme Roberto; Shah, Jatin; Maldonato, Mauro] Duke Univ, Dept Surg, Res Res Grp, Durham, NC 27706 USA; [Yoo, Bryan] Stanford Univ, Palo Alto, CA 94304 USA; [Maldonato, Mauro] Univ Basilicata, Dept Stor Linguist & Antropol Sci, I-85100 Potenza, Italy	Duke University; Pontificia Universidade Catolica do Parana; University of California System; University of California San Francisco; Duke University; Stanford University; University of Basilicata	Vail, TP (corresponding author), Philip R Lee Inst Hlth Policy Studies, San Francisco, CA USA.	vailt@orthosurg.ucsf.edu	Shah, Jatin/B-6039-2011; Worni, Mathias/L-1556-2019; MALDONATO, NELSON MAURO/AAG-3791-2021; Vail, Thomas/S-6892-2019	Shah, Jatin/0000-0002-2457-491X; MALDONATO, NELSON MAURO/0000-0002-6401-2305; Pietrobon, Ricardo/0000-0003-2996-2193; Worni, Mathias/0000-0001-9422-431X				Abrams DB, 2010, AM J PREV MED, V38, pS351, DOI 10.1016/j.amepre.2009.12.011; ANDERSON FA, 1991, ARCH INTERN MED, V151, P933, DOI 10.1001/archinte.151.5.933; [Anonymous], 2008, FED REG, V78; [Anonymous], 2008, SURG GEN CALL ACT PR; Ballal RD, 2008, CURR MED RES OPIN, V24, P753, DOI 10.1185/030079908X273048; Bozzette SA, 2003, NEW ENGL J MED, V348, P416, DOI 10.1056/NEJMsa025075; Brown J, 2009, CLIN INFECT DIS, V49, P743, DOI 10.1086/604719; Byrne GJ, 1996, BRIT MED J, V313, P917; Centers for Medicare and Medicaid Services. Washington DUS-DoHHS, 2010, HOSP ACQ COND PRES A; Chien AT, 2007, MED CARE RES REV, V64, p283S, DOI 10.1177/1077558707305426; Cohen AT, 2008, LANCET, V371, P387, DOI 10.1016/S0140-6736(08)60202-0; Cushman M, 2004, AM J MED, V117, P19, DOI 10.1016/j.amjmed.2004.01.018; Durieux P, 2000, JAMA-J AM MED ASSOC, V283, P2816, DOI 10.1001/jama.283.21.2816; Duska LR, 2010, GYNECOL ONCOL, V116, P374, DOI 10.1016/j.ygyno.2009.10.069; Fry DE, 2010, ARCH SURG-CHICAGO, V145, P148, DOI 10.1001/archsurg.2009.277; Galat DD, 2008, J BONE JOINT SURG AM, V90A, P2331, DOI 10.2106/JBJS.G.01370; Geerts WH, 2008, CHEST, V133, p381S, DOI 10.1378/chest.08-0656; Goldhaber SZ, 2004, AM J CARDIOL, V93, P259, DOI 10.1016/j.amjcard.2003.09.057; Hawker GA, 2004, ARTHRIT RHEUM-ARTHR, V51, P635, DOI 10.1002/art.20524; Heit JA, 2006, J THROMB THROMBOLYS, V21, P23, DOI 10.1007/s11239-006-5572-y; Heit JA, 2002, ARCH INTERN MED, V162, P1245, DOI 10.1001/archinte.162.11.1245; Homer JB, 2006, AM J PUBLIC HEALTH, V96, P452, DOI 10.2105/AJPH.2005.062059; Johanson NA, 2009, J AM ACAD ORTHOP SUR, V17, P183, DOI 10.5435/00124635-200903000-00007; Jordan JM, 2007, J RHEUMATOL, V34, P172; Kahn SR, 2007, THROMB RES, V119, P145, DOI 10.1016/j.thromres.2006.01.011; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kakkar AK, 2010, ANN SURG, V251, P330, DOI 10.1097/SLA.0b013e3181c0e58f; Kirsch M, 2009, AM J GASTROENTEROL, V104, P2671, DOI 10.1038/ajg.2009.196; Kohn LT, 2000, ERR IS HUMAN BUILDIN, Vxxi, P287; Losina E, 2009, ARCH INTERN MED, V169, P1113, DOI 10.1001/archinternmed.2009.136; McDonald R, 2009, J HEALTH POLIT POLIC, V34, P747, DOI 10.1215/03616878-2009-024; Millett C, 2008, ANN FAM MED, V6, P490, DOI 10.1370/afm.907; Millett C, 2007, PLOS MED, V4, P1087, DOI 10.1371/journal.pmed.0040191; Millett C, 2009, DIABETES CARE, V32, P404, DOI 10.2337/dc08-0912; NormanTaylor FH, 1996, J BONE JOINT SURG BR, V78B, P74, DOI 10.1302/0301-620X.78B1.0780074; Nutescu EA, 2008, ANN PHARMACOTHER, V42, P1216, DOI 10.1345/aph.1L135; Patel VP, 2007, J BONE JOINT SURG AM, V89A, P33, DOI 10.2106/JBJS.F.00163; Piazza G, 2009, CIRCULATION, V119, P2196, DOI 10.1161/CIRCULATIONAHA.108.841197; Pietrobon Ricardo, 2004, Health Qual Life Outcomes, V2, P59, DOI 10.1186/1477-7525-2-59; Porter M.E., 2006, REDEFINING HLTH CARE; Prandoni P., 2005, HEMATOLOGY AM SOC HE, P458; Pronovost PJ, 2008, JAMA-J AM MED ASSOC, V299, P2197, DOI 10.1001/jama.299.18.2197; Rasanen P, 2007, ACTA ORTHOP, V78, P108, DOI 10.1080/17453670610013501; Rogers SO, 2007, J AM COLL SURGEONS, V204, P1211, DOI 10.1016/j.jamcollsurg.2007.02.072; Rosenthal MB, 2007, JAMA-J AM MED ASSOC, V297, P740, DOI 10.1001/jama.297.7.740; Saleh K, 2002, J ORTHOP RES, V20, P506, DOI 10.1016/S0736-0266(01)00153-X; Shah J, 2009, ACAD MED, V84, P511, DOI 10.1097/ACM.0b013e31819a8c3c; Sorensen HT, 2007, LANCET, V370, P1773, DOI 10.1016/S0140-6736(07)61745-0; Sterman J.D., 2000, BUSINESS DYNAMICS, DOI DOI 10.4324/9781351152723-7; Sterman JD, 2006, AM J PUBLIC HEALTH, V96, P505, DOI 10.2105/AJPH.2005.066043; Streiff MB, 2009, JAMA-J AM MED ASSOC, V301, P1063, DOI 10.1001/jama.301.10.1063; Tooher R, 2005, ANN SURG, V241, P397, DOI 10.1097/01.sla.0000154120.96169.99; Turpie AGG, 2009, LANCET, V373, P1673, DOI 10.1016/S0140-6736(09)60734-0; Wachter RM, 2008, JT COMM J QUAL PATIE, V34, P116, DOI 10.1016/S1553-7250(08)34014-8; Werner RM, 2005, CIRCULATION, V111, P1257, DOI 10.1161/01.CIR.0000157729.59754.09; White RH, 2000, NEW ENGL J MED, V343, P1758, DOI 10.1056/NEJM200012143432403; Whitehouse JD, 2002, INFECT CONT HOSP EP, V23, P183, DOI 10.1086/502033	57	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e30578	10.1371/journal.pone.0030578	http://dx.doi.org/10.1371/journal.pone.0030578			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UD	22536313	Green Published, gold, Green Submitted			2022-12-27	WOS:000305339200003
J	Zhang, YL; Xi, QY; Ding, JH; Cai, WG; Meng, FM; Zhou, JY; Li, HY; Jiang, QY; Shu, G; Wang, SB; Zhu, XT; Gao, P; Wu, ZF				Zhang, Yongliang; Xi, Qianyun; Ding, Jinghua; Cai, Weiguang; Meng, Fanmin; Zhou, Junyun; Li, Hongyi; Jiang, Qingyan; Shu, Gang; Wang, Songbo; Zhu, Xiaotong; Gao, Ping; Wu, Zhenfang			Production of Transgenic Pigs Mediated by Pseudotyped Lentivirus and Sperm	PLOS ONE			English	Article							LINE STEM-CELLS; GENE-TRANSFER; IN-VIVO; FOREIGN DNA; REVERSE-TRANSCRIPTASE; FARM-ANIMALS; VECTORS; MICE; GENERATION; TRANSFORMATION	Sperm-mediated gene transfer can be a very efficient method to produce transgenic pigs, however, the results from different laboratories had not been widely repeated. Genomic integration of transgene by injection of pseudotyped lentivirus to the perivitelline space has been proved to be a reliable route to generate transgenic animals. To test whether transgene in the lentivirus can be delivered by sperm, we studied incubation of pseudotyped lentiviruses and sperm before insemination. After incubation with pig spermatozoa, 6263 lentiviral particles were detected per 100 sperm cells using quantitative real-time RT-PCR. The association of lentivirus with sperm was further confirmed by electron microscopy. The sperm incubated with lentiviral particles were artificially inseminated into pigs. Of the 59 piglets born from inseminated 5 sows, 6 piglets (10.17%) carried the transgene based on the PCR identification. Foreign gene and EGFP was successfully detected in ear tissue biopsies from two PCR-positive pigs, revealed via in situ hybridization and immunohistochemistry. Offspring of one PCR-positive boar with normal sows showed PCR-positive. Two PCR-positive founders and offsprings of PCR-positive boar were further identified by Southern-blot analysis, out of which the two founders and two offsprings were positive in Southern blotting, strongly indicating integration of foreign gene into genome. The results indicate that incubation of sperm with pseudotyped lentiviruses can incorporated with sperm-mediated gene transfer to produce transgenic pigs with improved efficiency.	[Zhang, Yongliang; Xi, Qianyun; Ding, Jinghua; Cai, Weiguang; Meng, Fanmin; Zhou, Junyun; Li, Hongyi; Jiang, Qingyan; Shu, Gang; Wang, Songbo; Zhu, Xiaotong; Gao, Ping; Wu, Zhenfang] S China Agr Univ, Guangdong Prov Key Lab Agroanim Genom & Mol Breed, Coll Anim Sci, Guangzhou, Guangdong, Peoples R China	South China Agricultural University	Xi, QY (corresponding author), S China Agr Univ, Guangdong Prov Key Lab Agroanim Genom & Mol Breed, Coll Anim Sci, Guangzhou, Guangdong, Peoples R China.	xqy0228@scau.edu.cn; wzf@scau.edu.cn		Wu, Zhenfang/0000-0002-5586-6771	National Key Project [2009ZX0890-024B, 2008ZX08006-004, 2008ZX08007-003]; National Natural Science Foundation of China [31072105]; Joint Funds of National Natural Science Foundation of China [u0731004]; Chinese Key Basic Plan [2009CB941600]	National Key Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Joint Funds of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Key Basic Plan	This work was supported by National Key Project 2009ZX0890-024B, 2008ZX08006-004 and 2008ZX08007-003, the National Natural Science Foundation of China (31072105), the Joint Funds of National Natural Science Foundation of China, u0731004, and the Chinese Key Basic Plan (No. 2009CB941600). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AREZZO F, 1989, CELL BIOL INT REP, V13, P391, DOI 10.1016/0309-1651(89)90166-5; BAGASRA O, 1994, AIDS, V8, P1669, DOI 10.1097/00002030-199412000-00005; BRINSTER RL, 1989, CELL, V59, P239, DOI 10.1016/0092-8674(89)90282-1; Celebi C, 2002, MOL REPROD DEV, V62, P477, DOI 10.1002/mrd.10143; De Palma M, 2005, BLOOD, V105, P2307, DOI 10.1182/blood-2004-03-0798; FURTH PA, 1991, NUCLEIC ACIDS RES, V19, P6205, DOI 10.1093/nar/19.22.6205; Hamra FK, 2002, P NATL ACAD SCI USA, V99, P14931, DOI 10.1073/pnas.222561399; Haruyama Naoto, 2009, Curr Protoc Cell Biol, VChapter 19, DOI 10.1002/0471143030.cb1910s42; Hofmann A, 2006, MOL THER, V13, P59, DOI 10.1016/j.ymthe.2005.07.685; Hofmann A, 2003, EMBO REP, V4, P1054, DOI 10.1038/sj.embor.7400007; KARPEN GH, 1994, CURR OPIN GENET DEV, V4, P281, DOI 10.1016/S0959-437X(05)80055-3; Kues WA, 2004, TRENDS BIOTECHNOL, V22, P286, DOI 10.1016/j.tibtech.2004.04.003; Kuznetsov AV, 2000, MOL REPROD DEV, V56, P292, DOI 10.1002/(SICI)1098-2795(200006)56:2+&lt;292::AID-MRD18&gt;3.0.CO;2-Z; LANDRY ML, 1995, J INFECT DIS, V172, P1641, DOI 10.1093/infdis/172.6.1641a; Lavitrano M, 2002, P NATL ACAD SCI USA, V99, P14230, DOI 10.1073/pnas.222550299; LAVITRANO M, 1989, CELL, V57, P717, DOI 10.1016/0092-8674(89)90787-3; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Maione B, 1998, MOL REPROD DEV, V50, P406, DOI 10.1002/(SICI)1098-2795(199808)50:4&lt;406::AID-MRD4&gt;3.0.CO;2-M; May C, 2000, NATURE, V406, P82, DOI 10.1038/35017565; Nagano M, 2002, FEBS LETT, V524, P111, DOI 10.1016/S0014-5793(02)03010-7; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; NUOVO GJ, 1994, AM J PATHOL, V144, P1142; Pfeifer A, 2002, P NATL ACAD SCI USA, V99, P2140, DOI 10.1073/pnas.251682798; Pittoggi C, 2006, MOL REPROD DEV, V73, P1239, DOI 10.1002/mrd.20550; Ritchie WA, 2007, TRANSGENIC RES, V16, P661, DOI 10.1007/s11248-007-9102-2; Robinson KO, 2000, INSECT MOL BIOL, V9, P625, DOI 10.1046/j.1365-2583.2000.00225.x; ROTTMANN OJ, 1992, J ANIM BREED GENET, V109, P64, DOI 10.1111/j.1439-0388.1992.tb00379.x; Rulicke T, 2000, EXP PHYSIOL, V85, P589, DOI 10.1017/S0958067000020923; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; Sciamanna I, 2003, BIOCHEM BIOPH RES CO, V312, P1039, DOI 10.1016/j.bbrc.2003.11.024; Scott BB, 2005, P NATL ACAD SCI USA, V102, P16443, DOI 10.1073/pnas.0508437102; Spadafora C, 1998, BIOESSAYS, V20, P955, DOI 10.1002/(SICI)1521-1878(199811)20:11&lt;955::AID-BIES11&gt;3.0.CO;2-8; Spadafora C, 2008, HUM REPROD, V23, P735, DOI 10.1093/humrep/dem425; van den Brandt J, 2004, GENESIS, V39, P94, DOI 10.1002/gene.20037; Wang HJ, 2001, ANIM BIOTECHNOL, V12, P101, DOI 10.1081/ABIO-100108336; Whitelaw CBA, 2004, FEBS LETT, V571, P233, DOI 10.1016/j.febslet.2004.06.076; Wu ZF, 2008, MOL REPROD DEV, V75, P26, DOI 10.1002/mrd.20778; Yonezawa T, 2002, J REPROD DEVELOP, V48, P281, DOI 10.1262/jrd.48.281; Yonezawa T, 2001, MOL REPROD DEV, V60, P196, DOI 10.1002/mrd.1077; Zhan Y, 2000, DNA CELL BIOL, V19, P639, DOI 10.1089/10445490050199045; Zoraqi G, 1997, DNA CELL BIOL, V16, P291, DOI 10.1089/dna.1997.16.291	41	9	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35335	10.1371/journal.pone.0035335	http://dx.doi.org/10.1371/journal.pone.0035335			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536374	gold, Green Published, Green Submitted			2022-12-27	WOS:000305339200057
J	Jain, S; Zweig, M; Peeters, E; Siewering, K; Hackett, KT; Dillard, JP; van der Does, C				Jain, Samta; Zweig, Maria; Peeters, Eveline; Siewering, Katja; Hackett, Kathleen T.; Dillard, Joseph P.; van der Does, Chris			Characterization of the Single Stranded DNA Binding Protein SsbB Encoded in the Gonoccocal Genetic Island	PLOS ONE			English	Article							AGROBACTERIUM VIRE2 PROTEIN; ESCHERICHIA-COLI SSB; SP STRAIN B13; NEISSERIA-GONORRHOEAE; NATURAL TRANSFORMATION; CLC ELEMENT; EXPRESSION; MYCOBACTERIUM; TUMEFACIENS; DELETION	Background: Most strains of Neisseria gonorrhoeae carry a Gonococcal Genetic Island which encodes a type IV secretion system involved in the secretion of ssDNA. We characterize the GGI-encoded ssDNA binding protein, SsbB. Close homologs of SsbB are located within a conserved genetic cluster found in genetic islands of different proteobacteria. This cluster encodes DNA-processing enzymes such as the ParA and ParB partitioning proteins, the TopB topoisomerase, and four conserved hypothetical proteins. The SsbB homologs found in these clusters form a family separated from other ssDNA binding proteins. Methodology/Principal Findings: In contrast to most other SSBs, SsbB did not complement the Escherichia coli ssb deletion mutant. Purified SsbB forms a stable tetramer. Electrophoretic mobility shift assays and fluorescence titration assays, as well as atomic force microscopy demonstrate that SsbB binds ssDNA specifically with high affinity. SsbB binds single-stranded DNA with minimal binding frames for one or two SsbB tetramers of 15 and 70 nucleotides. The binding mode was independent of increasing Mg2+ or NaCl concentrations. No role of SsbB in ssDNA secretion or DNA uptake could be identified, but SsbB strongly stimulated Topoisomerase I activity. Conclusions/Significance: We propose that these novel SsbBs play an unknown role in the maintenance of genetic islands.	[Jain, Samta; van der Does, Chris] Univ Groningen, Dept Microbiol, Groningen Biomol Sci & Biotechnol Inst, Groningen, Netherlands; [Peeters, Eveline] Vrije Univ Brussel, Microbiol Res Grp, Dept Sci & Bioengn Sci, Brussels, Belgium; [Hackett, Kathleen T.; Dillard, Joseph P.] Univ Wisconsin, Madison, WI USA; [Jain, Samta; Zweig, Maria; Siewering, Katja; van der Does, Chris] Max Planck Inst Terr Microbiol, Dept Ecophysiol, D-35043 Marburg, Germany	University of Groningen; Vrije Universiteit Brussel; University of Wisconsin System; University of Wisconsin Madison; Max Planck Society	Jain, S (corresponding author), Univ Groningen, Dept Microbiol, Groningen Biomol Sci & Biotechnol Inst, Groningen, Netherlands.	does@mpi-marburg.mpg.de			University of Groningen; Max-Planck-Gesellschaft; FWO-Vlaanderen (Research Foundation Flanders); National Institutes of Health [AI047958]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047958] Funding Source: NIH RePORTER	University of Groningen; Max-Planck-Gesellschaft(Max Planck Society); FWO-Vlaanderen (Research Foundation Flanders)(FWO); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by intramural funds of the University of Groningen and the Max-Planck-Gesellschaft to CvdD; by FWO-Vlaanderen (Research Foundation Flanders) to EP; and partially by the National Institutes of Health (AI047958) to JPD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Arish A, 2004, J BIOL CHEM, V279, P25359, DOI 10.1074/jbc.M401804200; Acharya N, 2002, J MOL BIOL, V318, P1251, DOI 10.1016/S0022-2836(02)00053-0; BUJALOWSKI W, 1989, J MOL BIOL, V207, P249, DOI 10.1016/0022-2836(89)90454-3; CHRYSOGELOS S, 1982, P NATL ACAD SCI-BIOL, V79, P5803, DOI 10.1073/pnas.79.19.5803; CITOVSKY V, 1989, P NATL ACAD SCI USA, V86, P1193, DOI 10.1073/pnas.86.4.1193; CITOVSKY V, 1992, SCIENCE, V256, P1802, DOI 10.1126/science.1615325; Despalins A, 2011, BIOINFORMATICS, V27, P2905, DOI 10.1093/bioinformatics/btr473; DEVRIES J, 1994, MICROBIOL-SGM, V140, P889, DOI 10.1099/00221287-140-4-889; Dillard JP, 2001, MOL MICROBIOL, V41, P263, DOI 10.1046/j.1365-2958.2001.02520.x; Dominguez NM, 2011, J BACTERIOL, V193, P377, DOI 10.1128/JB.00948-10; Fernandez-Lopez R, 2006, FEMS MICROBIOL REV, V30, P942, DOI 10.1111/j.1574-6976.2006.00042.x; Gaillard M, 2006, J BACTERIOL, V188, P1999, DOI 10.1128/JB.188.5.1999-2013.2006; Gelvin SB, 2010, CURR OPIN MICROBIOL, V13, P53, DOI 10.1016/j.mib.2009.11.003; GOLUB EI, 1985, J BACTERIOL, V162, P235, DOI 10.1128/JB.162.1.235-241.1985; Grange W, 2008, PLOS BIOL, V6, P343, DOI 10.1371/journal.pbio.0060044; Grove DE, 2005, J BIOL CHEM, V280, P11067, DOI 10.1074/jbc.M414057200; Hamilton HL, 2006, MOL MICROBIOL, V59, P376, DOI 10.1111/j.1365-2958.2005.04964.x; Hamilton HL, 2005, MOL MICROBIOL, V55, P1704, DOI 10.1111/j.1365-2958.2005.04521.x; Hamon L, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm147; Hobbs MD, 2007, J BIOL CHEM, V282, P11058, DOI 10.1074/jbc.M611007200; HOWLAND CJ, 1989, J BACTERIOL, V171, P2466, DOI 10.1128/jb.171.5.2466-2473.1989; Huang YH, 2011, PROTEIN J, V30, P102, DOI 10.1007/s10930-011-9309-1; Jan HC, 2011, PROTEIN J, V30, P20, DOI 10.1007/s10930-010-9297-6; KADO CI, 1981, J BACTERIOL, V145, P1365, DOI 10.1128/JB.145.3.1365-1373.1981; KELLOGG DS, 1963, J BACTERIOL, V85, P1274, DOI 10.1128/JB.85.6.1274-1279.1963; Kramer N, 2007, MOL MICROBIOL, V65, P454, DOI 10.1111/j.1365-2958.2007.05799.x; Krastanova SV, 2010, TRANSGENIC RES, V19, P949, DOI 10.1007/s11248-010-9373-x; Larbig KD, 2002, J BACTERIOL, V184, P6665, DOI 10.1128/JB.184.23.6665-6680.2002; Lindner C, 2004, J BACTERIOL, V186, P1097, DOI 10.1128/JB.186.4.1097-1105.2004; LOHMAN TM, 1994, ANNU REV BIOCHEM, V63, P527, DOI 10.1146/annurev.biochem.63.1.527; MORSE SA, 1974, P SOC EXP BIOL MED, V145, P1418; MULDERS WHAM, 1995, BRAIN RES, V689, P47, DOI 10.1016/0006-8993(95)00534-W; MURZIN AG, 1993, EMBO J, V12, P861, DOI 10.1002/j.1460-2075.1993.tb05726.x; Pelczar P, 2004, EMBO REP, V5, P632, DOI 10.1038/sj.embor.7400165; Pestryakov PE, 2008, BIOCHEMISTRY-MOSCOW+, V73, P1388, DOI 10.1134/S0006297908130026; PORTER RD, 1991, J BACTERIOL, V173, P2720, DOI 10.1128/jb.173.8.2720-2723.1991; Post DMB, 2005, J BIOL CHEM, V280, P38383, DOI 10.1074/jbc.M508063200; Purnapatre K, 1999, EUR J BIOCHEM, V264, P591, DOI 10.1046/j.1432-1327.1999.00684.x; Raghunathan S, 2000, NAT STRUCT BIOL, V7, P648, DOI 10.1038/77943; Roy R, 2007, J MOL BIOL, V369, P1244, DOI 10.1016/j.jmb.2007.03.079; Salgado-Pabon W, 2010, J BACTERIOL, V192, P1912, DOI 10.1128/JB.01357-09; Savvides SN, 2004, PROTEIN SCI, V13, P1942, DOI 10.1110/ps.04661904; SCHWARZ G, 1983, J MOL BIOL, V163, P467, DOI 10.1016/0022-2836(83)90069-4; SEN P, 1989, J BACTERIOL, V171, P2573, DOI 10.1128/jb.171.5.2573-2580.1989; Sikder D, 2001, J MOL BIOL, V306, P669, DOI 10.1006/jmbi.2000.4384; SPARLING PF, 1966, J BACTERIOL, V92, P1364, DOI 10.1128/JB.92.5.1364-1371.1966; Stohl EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017101; Sundberg C, 1996, J BACTERIOL, V178, P1207, DOI 10.1128/jb.178.4.1207-1212.1996; Szczepankowska AK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026942; UMEZU K, 1993, P NATL ACAD SCI USA, V90, P3875, DOI 10.1073/pnas.90.9.3875; van der Meer JR, 2001, ARCH MICROBIOL, V175, P79; Wade JJ, 2007, FEMS MICROBIOL LETT, V273, P35, DOI 10.1111/j.1574-6968.2007.00776.x	52	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e35285	10.1371/journal.pone.0035285	http://dx.doi.org/10.1371/journal.pone.0035285			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22536367	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336200032
J	Kang, SU; Shin, YS; Hwang, HS; Baek, SJ; Lee, SH; Kim, CH				Kang, Sung Un; Shin, Yoo Seob; Hwang, Hye Sook; Baek, Seung Joon; Lee, Seong-Ho; Kim, Chul-Ho			Tolfenamic Acid Induces Apoptosis and Growth Inhibition in Head and Neck Cancer: Involvement of NAG-1 Expression	PLOS ONE			English	Article							DRUG-ACTIVATED GENE; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; TGF-BETA SUPERFAMILY; COLORECTAL-CANCER; CYCLOOXYGENASE-2 INHIBITORS; COLON-CANCER; CELLS; MEMBER; PROTEIN; RISK	Nonsteroidal anti-inflammatory drug-activated gene-1 (NAG-1) is induced by nonsteroidal anti-inflammatory drugs and possesses proapoptotic and antitumorigenic activities. Although tolfenamic acid (TA) induces apoptosis in head and neck cancer cells, the relationship between NAG-1 and TA has not been determined. This study investigated the induction of apoptosis in head and neck cancer cells treated by TA and the role of NAG-1 expression in this induction. TA reduced head and neck cancer cell viability in a dose-dependent manner and induced apoptosis. The induced apoptosis was coincident with the expression of NAG-1. Overexpression of NAG-1 enhanced the apoptotic effect of TA, whereas suppression of NAG-1 expression by small interfering RNA attenuated TA-induced apoptosis. TA significantly inhibited tumor formation as assessed by xenograft models, and this result accompanied the induction of apoptotic cells and NAG-1 expression in tumor tissue samples. Taken together, these results demonstrate that TA induces apoptosis via NAG-1 expression in head and neck squamous cell carcinoma, providing an additional mechanistic explanation for the apoptotic activity of TA.	[Kang, Sung Un; Shin, Yoo Seob; Hwang, Hye Sook; Kim, Chul-Ho] Ajou Univ, Sch Med, Dept Otolaryngol, Suwon 441749, South Korea; [Kang, Sung Un; Shin, Yoo Seob; Hwang, Hye Sook; Kim, Chul-Ho] Ajou Univ, Sch Med, Ctr Cell Death Regulating Biodrug, Suwon 441749, South Korea; [Baek, Seung Joon] Univ Tennessee, Coll Vet Med, Dept Biomed & Diagnost Sci, Knoxville, TN USA; [Lee, Seong-Ho] Univ Maryland, Dept Nutr & Food Sci, Coll Agr & Nat Resources, College Pk, MD 20742 USA	Ajou University; Ajou University; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; University System of Maryland; University of Maryland College Park	Kang, SU (corresponding author), Ajou Univ, Sch Med, Dept Otolaryngol, Suwon 441749, South Korea.	ostium@ajou.ac.kr	kang, sung un/AAK-8050-2021		Korea Research Foundation [KRF-013-2009-1-E00015]; CCRB through Gyeonggi Provincial Government, Korea (GRRC) [Ajou-2011-A03]	Korea Research Foundation(National Research Foundation of Korea); CCRB through Gyeonggi Provincial Government, Korea (GRRC)	This study was supported by the Korea Research Foundation Grant (KRF-013-2009-1-E00015) and CCRB through the "GRRC" Project of Gyeonggi Provincial Government, Korea (GRRC Ajou-2011-A03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelrahim M, 2007, CANCER RES, V67, P3286, DOI 10.1158/0008-5472.CAN-06-3831; Abdelrahim M, 2006, J NATL CANCER I, V98, P855, DOI 10.1093/jnci/djj232; Baek SJ, 2006, PROG LIPID RES, V45, P1, DOI 10.1016/j.plipres.2005.10.001; Baek SJ, 2005, MOL PHARMACOL, V67, P356, DOI 10.1124/mol.104.005108; Baek SJ, 2004, CARCINOGENESIS, V25, P2425, DOI 10.1093/carcin/bgh255; Baek SJ, 2004, J BIOL CHEM, V279, P6883, DOI 10.1074/jbc.M305295200; Baek SJ, 2002, J PHARMACOL EXP THER, V301, P1126, DOI 10.1124/jpet.301.3.1126; Baek SJ, 2002, CARCINOGENESIS, V23, P425, DOI 10.1093/carcin/23.3.425; Baek SJ, 2001, MOL PHARMACOL, V59, P901, DOI 10.1124/mol.59.4.901; Bootcov MR, 1997, P NATL ACAD SCI USA, V94, P11514, DOI 10.1073/pnas.94.21.11514; Eling TE, 2006, J BIOCHEM MOL BIOL, V39, P649; Fairlie WD, 1999, J LEUKOCYTE BIOL, V65, P2, DOI 10.1002/jlb.65.1.2; Gately S, 2004, SEMIN ONCOL, V31, P2, DOI 10.1053/j.seminoncol.2004.03.040; GIOVANNUCCI E, 1995, NEW ENGL J MED, V333, P609, DOI 10.1056/NEJM199509073331001; Half Elizabeth E, 2006, Future Oncol, V2, P697; HANSEN PE, 1994, PHARMACOL TOXICOL, V75, P81, DOI 10.1111/j.1600-0773.1994.tb02005.x; He TC, 1999, CELL, V99, P335, DOI 10.1016/S0092-8674(00)81664-5; Kim JH, 2008, INT J CANCER, V122, P1765, DOI 10.1002/ijc.23302; Kim JS, 2005, MOL CANCER THER, V4, P487; Kim JH, 2010, J CLIN BIOCHEM NUTR, V47, P74, DOI 10.3164/jcbn.10-02; Kim KS, 2004, BIOCHEM BIOPH RES CO, V325, P1298, DOI 10.1016/j.bbrc.2004.10.176; Kim KS, 2002, GASTROENTEROLOGY, V122, P1388, DOI 10.1053/gast.2002.32972; Lawton LN, 1997, GENE, V203, P17, DOI 10.1016/S0378-1119(97)00485-X; Lee SH, 2008, MOL CANCER THER, V7, P3739, DOI 10.1158/1535-7163.MCT-08-0548; Lee SH, 2005, BIOCHEM BIOPH RES CO, V328, P63, DOI 10.1016/j.bbrc.2004.12.138; MARTINEZ ME, 1995, CANCER EPIDEM BIOMAR, V4, P703; Papineni S, 2009, CARCINOGENESIS, V30, P1193, DOI 10.1093/carcin/bgp092; Paralkar VM, 1998, J BIOL CHEM, V273, P13760, DOI 10.1074/jbc.273.22.13760; Peleg II, 1996, DIGEST DIS SCI, V41, P1319, DOI 10.1007/BF02088554; Reddy BS, 2000, CANCER RES, V60, P293; Shim M, 2005, J BIOL CHEM, V280, P18636, DOI 10.1074/jbc.M414613200; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; SPITZ MR, 1994, SEMIN ONCOL, V21, P281; Taketo MM, 1998, JNCI-J NATL CANCER I, V90, P1609, DOI 10.1093/jnci/90.21.1609; Taketo MM, 1998, J NATL CANCER I, V90, P1529, DOI 10.1093/jnci/90.20.1529; Tarnawski AS, 2003, J MOL MED, V81, P627, DOI 10.1007/s00109-003-0479-y; Williams CS, 1999, ONCOGENE, V18, P7908, DOI 10.1038/sj.onc.1203286; Wilson LC, 2003, INT J CANCER, V105, P747, DOI 10.1002/ijc.11173; Yamaguchi K, 2006, MOL CANCER THER, V5, P1352, DOI 10.1158/1535-7163.MCT-05-0528; Yuan ZP, 2006, CLIN CANCER RES, V12, P3193, DOI 10.1158/1078-0432.CCR-05-2365; Zhang L, 2000, SCIENCE, V290, P989, DOI 10.1126/science.290.5493.989	41	24	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e34988	10.1371/journal.pone.0034988	http://dx.doi.org/10.1371/journal.pone.0034988			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22536345	Green Published, gold			2022-12-27	WOS:000305336200018
J	Pauly, D; Worbs, S; Kirchner, S; Shatohina, O; Dorner, MB; Dorner, BG				Pauly, Diana; Worbs, Sylvia; Kirchner, Sebastian; Shatohina, Olena; Dorner, Martin B.; Dorner, Brigitte G.			Real-Time Cytotoxicity Assay for Rapid and Sensitive Detection of Ricin from Complex Matrices	PLOS ONE			English	Article							RIBOSOME-INACTIVATING PROTEINS; TANDEM MASS-SPECTROMETRY; BIOLOGICAL-ACTIVITY; FOOD MATRICES; LECTINS ABRIN; A-CHAIN; TOXICITY; ANTIBODY; TOXINS; AGGLUTININ	Background: In the context of a potential bioterrorist attack sensitive and fast detection of functionally active toxins such as ricin from complex matrices is necessary to be able to start timely countermeasures. One of the functional detection methods currently available for ricin is the endpoint cytotoxicity assay, which suffers from a number of technical deficits. Methodology/Findings: This work describes a novel online cytotoxicity assay for the detection of active ricin and Ricinus communis agglutinin, that is based on a real-time cell electronic sensing system and impedance measurement. Characteristic growth parameters of Vero cells were monitored online and used as standardized viability control. Upon incubation with toxin the cell status and the cytotoxic effect were visualized using a characteristic cell index-time profile. For ricin, tested in concentrations of 0.06 ng/mL or above, a concentration-dependent decrease of cell index correlating with cytotoxicity was recorded between 3.5 h and 60 h. For ricin, sensitive detection was determined after 24 h, with an IC50 of 0.4 ng/mL (for agglutinin, an IC50 of 30 ng/mL was observed). Using functionally blocking antibodies, the specificity for ricin and agglutinin was shown. For detection from complex matrices, ricin was spiked into several food matrices, and an IC50 ranging from 5.6 to 200 ng/mL was observed. Additionally, the assay proved to be useful in detecting active ricin in environmental sample materials, as shown for organic fertilizer containing R. communis material. Conclusions/Significance: The cell-electrode impedance measurement provides a sensitive online detection method for biologically active cytotoxins such as ricin. As the cell status is monitored online, the assay can be standardized more efficiently than previous approaches based on endpoint measurement. More importantly, the real-time cytotoxicity assay provides a fast and easy tool to detect active ricin in complex sample matrices.	[Pauly, Diana; Worbs, Sylvia; Kirchner, Sebastian; Shatohina, Olena; Dorner, Martin B.; Dorner, Brigitte G.] Robert Koch Inst, Ctr Biol Secur Microbial Toxins, Berlin, Germany	Robert Koch Institute	Pauly, D (corresponding author), Robert Koch Inst, Ctr Biol Secur Microbial Toxins, Berlin, Germany.	DornerB@rki.de	Dorner, Martin B/C-5703-2013; Kirchner, Sebastian/AAF-6646-2019	Dorner, Martin B/0000-0002-8176-797X; Kirchner, Sebastian/0000-0003-0415-5352; Dorner, Brigitte/0000-0002-5100-2546	Federal Ministry of Education and Research [13N9601]	Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This work was supported by grants from the Federal Ministry of Education and Research to BGD (BiGRUDI project, 13N9601; http://www.bmbf.de/en/index.php). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Albretsen JC, 2000, J AM ANIM HOSP ASSOC, V36, P229, DOI 10.5326/15473317-36-3-229; Atienza JM, 2005, J BIOMOL SCREEN, V10, P795, DOI 10.1177/1087057105279635; Audi J, 2005, JAMA-J AM MED ASSOC, V294, P2342, DOI 10.1001/jama.294.18.2342; Bagaria A, 2006, J BIOL CHEM, V281, P34465, DOI 10.1074/jbc.M601777200; BALINT GA, 1974, TOXICOLOGY, V2, P77, DOI 10.1016/0300-483X(74)90044-4; Becher F, 2007, ANAL CHEM, V79, P659, DOI 10.1021/ac061498b; Bevilacqua VLH, 2010, ANAL CHEM, V82, P798, DOI 10.1021/ac9025972; Beyer NH, 2009, CLIN TOXICOL, V47, P219, DOI 10.1080/15563650802716521; Bradberry Sally M., 2003, Toxicological Reviews, V22, P65, DOI 10.2165/00139709-200322010-00007; Brzezinski JL, 2007, J FOOD PROTECT, V70, P2377, DOI 10.4315/0362-028X-70.10.2377; COLOMBATTI M, 1987, J IMMUNOL, V138, P3339; Drociuk Dan, 2009, J S C Med Assoc, V105, P94; Endo Y, 1988, Nucleic Acids Symp Ser, P139; FODSTAD O, 1976, BRIT J CANCER, V34, P418, DOI 10.1038/bjc.1976.187; Garber EAE, 2008, J FOOD PROTECT, V71, P1875, DOI 10.4315/0362-028X-71.9.1875; Griffiths GD, 2007, INHAL TOXICOL, V19, P873, DOI 10.1080/08958370701432124; GRIFFITHS GD, 1994, TOXICOLOGY, V90, P11, DOI 10.1016/0300-483X(94)90201-1; Groseclose S. L., 2000, Morbidity and Mortality Weekly Report, V49, P1; Hale ML, 2001, PHARMACOL TOXICOL, V88, P255, DOI 10.1034/j.1600-0773.2001.d01-113.x; Halter M, 2009, ASSAY DRUG DEV TECHN, V7, DOI 10.1089/adt.2009.192; He XH, 2008, J FOOD PROTECT, V71, P2053, DOI 10.4315/0362-028X-71.10.2053; Hines HB, 2004, ANAL BIOCHEM, V330, P119, DOI 10.1016/j.ab.2004.03.046; Hong IH, 2011, EXP TOXICOL PATHOL, V63, P113, DOI 10.1016/j.etp.2009.10.004; Jang Hae-Young, 1993, Korean Biochemical Journal, V26, P98; Kalb SR, 2009, ANAL CHEM, V81, P2037, DOI 10.1021/ac802769s; Keener WK, 2006, ANAL BIOCHEM, V357, P200, DOI 10.1016/j.ab.2006.07.005; Kull S, 2010, ANAL CHEM, V82, P2916, DOI 10.1021/ac902909r; Langer M, 1996, ANAL BIOCHEM, V243, P150, DOI 10.1006/abio.1996.0493; LIN JY, 1986, TOXICON, V24, P757, DOI 10.1016/0041-0101(86)90100-5; LIN TTS, 1980, EUR J BIOCHEM, V105, P453; LORD JM, 1994, FASEB J, V8, P201, DOI 10.1096/fasebj.8.2.8119491; Lord Michael J., 2003, Toxicological Reviews, V22, P53, DOI 10.2165/00139709-200322010-00006; Lundholt BK, 2003, J BIOMOL SCREEN, V8, P566, DOI 10.1177/1087057103256465; McGrath SC, 2011, ANAL CHEM, V83, P2897, DOI 10.1021/ac102571f; McGuinness CR, 2006, INFECT IMMUN, V74, P3463, DOI 10.1128/IAI.00324-06; Oda T, 1997, BIOSCI BIOTECH BIOCH, V61, P291, DOI 10.1271/bbb.61.291; OLSNES S, 1974, NATURE, V249, P627, DOI 10.1038/249627a0; Pauly D, 2009, POULTRY SCI, V88, P281, DOI 10.3382/ps.2008-00323; Pauly D, 2009, ANALYST, V134, P2028, DOI 10.1039/b911525k; Pelat T, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-60; Pfuller U., 1988, LECTINS BIOL BIOCH C, V6, P299; Roday S, 2008, J BIOCHEM BIOPH METH, V70, P945, DOI 10.1016/j.jprot.2007.12.010; Roels S, 2010, J VET DIAGN INVEST, V22, P466, DOI 10.1177/104063871002200325; Schieltz DM, 2011, FORENSIC SCI INT, V209, P70, DOI 10.1016/j.forsciint.2010.12.013; Sweeney EC, 1997, PROTEINS, V28, P586, DOI 10.1002/(SICI)1097-0134(199708)28:4<586::AID-PROT12>3.0.CO;2-C; Thullier P, 2009, CLIN TOXICOL, V47, P643, DOI 10.1080/15563650903140415; Vang O., 1986, LECTINS BIOL BIOCH C, V6, P637; Vervecken W, 2000, INT J BIOCHEM CELL B, V32, P317, DOI 10.1016/S1357-2725(99)00135-1; Wahome PG, 2010, TOXICON, V56, P313, DOI 10.1016/j.toxicon.2010.03.016; Weingart OG, 2010, APPL ENVIRON MICROB, V76, P3293, DOI 10.1128/AEM.02937-09; Worbs S, 2011, TOXINS, V3, P1332, DOI 10.3390/toxins3101332; Zhan JB, 2003, TOXICOLOGY, V186, P119, DOI 10.1016/S0300-483X(02)00726-6	52	24	28	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e35360	10.1371/journal.pone.0035360	http://dx.doi.org/10.1371/journal.pone.0035360			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22532852	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000305336200035
J	Cacquevel, M; Aeschbach, L; Houacine, J; Fraering, PC				Cacquevel, Matthias; Aeschbach, Lorene; Houacine, Jemila; Fraering, Patrick C.			Alzheimer's Disease-Linked Mutations in Presenilin-1 Result in a Drastic Loss of Activity in Purified gamma-Secretase Complexes	PLOS ONE			English	Article							AMYLOID-PRECURSOR-PROTEIN; BETA-PROTEIN; TRANSGENIC MICE; MUTANT PRESENILIN-1; TRANSMEMBRANE ASPARTATES; INTRACELLULAR DOMAINS; MISSENSE MUTATIONS; SENILE PLAQUES; APP MUTATIONS; IN-VIVO	Background: Mutations linked to early onset, familial forms of Alzheimer's disease (FAD) are found most frequently in PSEN1, the gene encoding presenilin-1 (PS1). Together with nicastrin (NCT), anterior pharynx-defective protein 1 (APH1), and presenilin enhancer 2 (PEN2), the catalytic subunit PS1 constitutes the core of the c-secretase complex and contributes to the proteolysis of the amyloid precursor protein (APP) into amyloid-beta (A beta) peptides. Although there is a growing consensus that FAD-linked PS1 mutations affect Ab production by enhancing the A beta 1-42/A beta 1-40 ratio, it remains unclear whether and how they affect the generation of APP intracellular domain (AICD). Moreover, controversy exists as to how PS1 mutations exert their effects in different experimental systems, by either increasing A beta 1-42 production, decreasing A beta 1-40 production, or both. Because it could be explained by the heterogeneity in the composition of gamma-secretase, we purified to homogeneity complexes made of human NCT, APH1aL, PEN2, and the pathogenic PS1 mutants L166P, Delta E9, or P436Q. Methodology/Principal Findings: We took advantage of a mouse embryonic fibroblast cell line lacking PS1 and PS2 to generate different stable cell lines overexpressing human gamma-secretase complexes with different FAD-linked PS1 mutations. A multi-step affinity purification procedure was used to isolate semi-purified or highly purified gamma-secretase complexes. The functional characterization of these complexes revealed that all PS1 FAD-linked mutations caused a loss of gamma-secretase activity phenotype, in terms of A beta 1-40, A beta 1-42 and APP intracellular domain productions in vitro. Conclusion/Significance: Our data support the view that PS1 mutations lead to a strong gamma-secretase loss-of-function phenotype and an increased A beta 1-42/A beta 1-40 ratio, two mechanisms that are potentially involved in the pathogenesis of Alzheimer's disease.	[Cacquevel, Matthias; Aeschbach, Lorene; Houacine, Jemila; Fraering, Patrick C.] Ecole Polytech Fed Lausanne, Brain Mind Inst, Lab Mol & Cellular Biol Alzheimers Dis, Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Cacquevel, M (corresponding author), Ecole Polytech Fed Lausanne, Brain Mind Inst, Lab Mol & Cellular Biol Alzheimers Dis, Lausanne, Switzerland.	patrick.fraering@epfl.ch		Fraering, Patrick/0000-0002-5841-5327	Swiss National Foundation [31003A_134938/1]; National Centre for Competence in Research ("Neuronal Plasticity and Repair"); Strauss foundation	Swiss National Foundation(Swiss National Science Foundation (SNSF)); National Centre for Competence in Research ("Neuronal Plasticity and Repair"); Strauss foundation	This work was supported by the Swiss National Foundation (to and LA and PCF; grant 31003A_134938/1) and the National Centre for Competence in Research ("Neuronal Plasticity and Repair" (to JH and PCF)), and the Strauss foundation (to PCF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beel AJ, 2008, CELL MOL LIFE SCI, V65, P1311, DOI 10.1007/s00018-008-7462-2; Bentahir M, 2006, J NEUROCHEM, V96, P732, DOI 10.1111/j.1471-4159.2005.03578.x; Borchelt DR, 2002, NEUROBIOL AGING, V23, P171, DOI 10.1016/S0197-4580(01)00280-9; Bot N, 2010, J BIOL CHEM; BURDICK D, 1992, J BIOL CHEM, V267, P546; Cacquevel M, 2008, J NEUROCHEM, V104, P210, DOI 10.1111/j.1471-4159.2007.05041.x; Chen FS, 2006, NATURE, V440, P1208, DOI 10.1038/nature04667; Citron M, 1998, NEUROBIOL DIS, V5, P107, DOI 10.1006/nbdi.1998.0183; Citron M, 1997, NAT MED, V3, P67, DOI 10.1038/nm0197-67; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; Delacourte A, 2002, NEUROLOGY, V59, P398, DOI 10.1212/WNL.59.3.398; Dowjat WK, 2004, J ALZHEIMERS DIS, V6, P31; Duff K, 1996, NATURE, V383, P710, DOI 10.1038/383710a0; Dumanchin Cecile, 2006, Hum Mutat, V27, P1063, DOI 10.1002/humu.9458; Esler WP, 2000, NAT CELL BIOL, V2, P428, DOI 10.1038/35017062; Farmery MR, 2003, J BIOL CHEM, V278, P24277, DOI 10.1074/jbc.M211992200; Fraering PC, 2004, BIOCHEMISTRY-US, V43, P9774, DOI 10.1021/bi0494976; Fraering PC, 2004, BIOCHEMISTRY-US, V43, P323, DOI 10.1021/bi035748j; HAASS C, 1995, NAT MED, V1, P1291, DOI 10.1038/nm1295-1291; He G, 2010, NATURE, V467, P95, DOI 10.1038/nature09325; Heilig EA, 2010, J BIOL CHEM; Herreman A, 2003, J CELL SCI, V116, P1127, DOI 10.1242/jcs.00292; Herreman A, 1999, P NATL ACAD SCI USA, V96, P11872, DOI 10.1073/pnas.96.21.11872; Holcomb L, 1998, NAT MED, V4, P97, DOI 10.1038/nm0198-097; Houlden H, 2000, ANN NEUROL, V48, P806, DOI 10.1002/1531-8249(200011)48:5<806::AID-ANA18>3.0.CO;2-F; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; Jan A, 2008, J BIOL CHEM, V283, P28176, DOI 10.1074/jbc.M803159200; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; Kimberly WT, 2000, J BIOL CHEM, V275, P3173, DOI 10.1074/jbc.275.5.3173; Kumar-Singh S, 2006, HUM MUTAT, V27, P686, DOI 10.1002/humu.20336; Lazarov VK, 2006, P NATL ACAD SCI USA, V103, P6889, DOI 10.1073/pnas.0602321103; Lichtenthaler SF, 1999, FEBS LETT, V453, P288, DOI 10.1016/S0014-5793(99)00730-9; Liu Q, 2007, NEURON, V56, P66, DOI 10.1016/j.neuron.2007.08.008; Mehta ND, 1998, ANN NEUROL, V43, P256, DOI 10.1002/ana.410430217; Moehlmann T, 2002, P NATL ACAD SCI USA, V99, P8025, DOI 10.1073/pnas.112686799; Munter LM, 2010, J BIOL CHEM, V285, P21636, DOI 10.1074/jbc.M109.088005; Murayama O, 1999, NEUROSCI LETT, V265, P61, DOI 10.1016/S0304-3940(99)00187-1; Nelson O, 2007, J CLIN INVEST, V117, P1230, DOI 10.1172/JCI30447; Nyabi O, 2003, J BIOL CHEM, V278, P43430, DOI 10.1074/jbc.M306957200; Osenkowski P, 2009, J MOL BIOL, V385, P642, DOI 10.1016/j.jmb.2008.10.078; Pardossi-Piquard R, 2005, NEURON, V46, P541, DOI 10.1016/j.neuron.2005.04.008; Parks AL, 2007, TRENDS GENET, V23, P140, DOI 10.1016/j.tig.2007.01.008; Qi Y, 2003, BIOCHEMISTRY-US, V42, P1042, DOI 10.1021/bi0267590; Qi-Takahara Y, 2005, J NEUROSCI, V25, P436, DOI 10.1523/JNEUROSCI.1575-04.2005; Radde R, 2006, EMBO REP, V7, P940, DOI 10.1038/sj.embor.7400784; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; SALMON P, 2007, CURR PROTOC HUM GENE, pCH12, DOI DOI 10.1002/0471142905.HG0808S52; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Schor NF, 2011, ANN NEUROL, V69, P237, DOI 10.1002/ana.22365; Serneels L, 2009, SCIENCE, V324, P639, DOI 10.1126/science.1171176; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Siman R, 2000, J NEUROSCI, V20, P8717; Steiner H, 1999, J BIOL CHEM, V274, P7615, DOI 10.1074/jbc.274.12.7615; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Veeraraghavalu K, 2010, J NEUROSCI, V30, P6903, DOI 10.1523/JNEUROSCI.0527-10.2010; Wakabayashi T, 2008, PHYSIOLOGY, V23, P194, DOI 10.1152/physiol.00009.2008; Weihofen A, 2003, TRENDS CELL BIOL, V13, P71, DOI 10.1016/S0962-8924(02)00041-7; Wolfe MS, 2012, J NEUROCHEM, V120, P89, DOI 10.1111/j.1471-4159.2011.07501.x; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Xu XM, 2009, J ALZHEIMERS DIS, V16, P211, DOI 10.3233/JAD-2009-0957	61	55	56	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35133	10.1371/journal.pone.0035133	http://dx.doi.org/10.1371/journal.pone.0035133			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529981	Green Published, gold, Green Submitted			2022-12-27	WOS:000305350600060
J	Mani, RJ; Reichard, MV; Morton, RJ; Kocan, KM; Clinkenbeard, KD				Mani, Rinosh J.; Reichard, Mason V.; Morton, Rebecca J.; Kocan, Katherine M.; Clinkenbeard, Kenneth D.			Biology of Francisella tularensis Subspecies holarctica Live Vaccine Strain in the Tick Vector Dermacentor variabilis	PLOS ONE			English	Article							ANAPLASMA-MARGINALE RICKETTSIALES; POLYMERASE-CHAIN-REACTION; ACARI IXODIDAE; UNITED-STATES; TRANSMISSION; ANDERSONI; TULAREMIA; ENDOSYMBIONTS; SALIVA; HOST	Background: The gamma-proteobacterium Francisella tularensis is the etiologic agent of seasonal tick-transmitted tularemia epizootics in rodents and rabbits and of incidental infections in humans. The biology of F. tularensis in its tick vectors has not been fully described, particularly with respect to its quanta and duration of colonization, tissue dissemination, and transovarial transmission. A systematic study of the colonization of Dermacentor variabilis by the F. tularensis subsp. holarctica live vaccine strain (LVS) was undertaken to better understand whether D. variabilis may serve as an inter-epizootic reservoir for F. tularensis. Methodology/Principal Findings: Colony-reared larva, nymph, and adult D. variabilis were artificially fed LVS via glass capillary tubes fitted over the tick mouthparts, and the level of colonization determined by microbial culture. Larvae and nymphs were initially colonized with 8.8 +/- 0.8x10(1) and 1.1 +/- 0.03x10(3) CFU/tick, respectively. Post-molting, a significant increase in colonization of both molted nymphs and adults occurred, and LVS persisted in 42% of molted adult ticks at 126 days post-capillary tube feeding. In adult ticks, LVS initially colonized the gut, disseminated to hemolymph and salivary glands by 21 days, and persisted up to 165 days. LVS was detected in the salivary secretions of adult ticks after four days post intra-hemocoelic inoculation, and LVS recovered from salivary gland was infectious to mice with an infectious dose 50% of 3 CFU. LVS in gravid female ticks colonized via the intra-hemocoelic route disseminated to the ovaries and then to the oocytes, but the pathogen was not recovered from the subsequently-hatched larvae. Conclusions/Significance: This study demonstrates that D. variabilis can be efficiently colonized with F. tularensis using artificial methods. The persistence of F. tularensis in D. variabilis suggests that this tick species may be involved in the maintenance of enzootic foci of tularemia in the central United States.	[Mani, Rinosh J.; Reichard, Mason V.; Morton, Rebecca J.; Kocan, Katherine M.; Clinkenbeard, Kenneth D.] Oklahoma State Univ, Dept Vet Pathobiol, Ctr Vet Hlth Sci, Stillwater, OK 74078 USA	Oklahoma State University System; Oklahoma State University - Stillwater	Mani, RJ (corresponding author), Oklahoma State Univ, Dept Vet Pathobiol, Ctr Vet Hlth Sci, Stillwater, OK 74078 USA.	ken.clinkenbeard@okstate.edu			College of Veterinary Medicine, Oklahoma State University	College of Veterinary Medicine, Oklahoma State University	The study was funded by the College of Veterinary Medicine, Oklahoma State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assal N R, 1968, J Okla State Med Assoc, V61, P120; Baldridge GD, 2009, J MED ENTOMOL, V46, P625, DOI 10.1603/033.046.0330; BELL JF, 1945, J INFECT DIS, V76, P83, DOI 10.1093/infdis/76.2.83; Bowman AS, 1997, MED VET ENTOMOL, V11, P277, DOI 10.1111/j.1365-2915.1997.tb00407.x; Broadwater AH, 2002, J MED ENTOMOL, V39, P285, DOI 10.1603/0022-2585-39.2.285; Burg JG, 2001, MED VET ENTOMOL, V15, P413, DOI 10.1046/j.0269-283x.2001.00329.x; BURGDORFER W, 1988, ANN NY ACAD SCI, V539, P172, DOI 10.1111/j.1749-6632.1988.tb31851.x; Eisen L, 2007, J MED ENTOMOL, V44, P389, DOI 10.1603/0022-2585(2007)44[389:ACFRRO]2.0.CO;2; Eisen RJ, 2008, AM J TROP MED HYG, V78, P586, DOI 10.4269/ajtmh.2008.78.586; Eisen RJ, 2009, AM J TROP MED HYG, V80, P259, DOI 10.4269/ajtmh.2009.80.259; FRANCIS E., 1927, Public Health Reports, V42, P2763, DOI 10.2307/4578567; GAGE KL, 1992, MOL CELL PROBE, V6, P333, DOI 10.1016/0890-8508(92)90010-U; Goethert HK, 2010, TICKS TICK-BORNE DIS, V1, P66, DOI 10.1016/j.ttbdis.2010.01.001; Goodman J., 2005, TICK BORNE DIS HUMAN; HOPLA C E, 1960, South Med J, V53, P92, DOI 10.1097/00007611-196001000-00020; HOPLA CE, 1953, AM J HYG, V58, P101, DOI 10.1093/oxfordjournals.aje.a119585; Horka H, 2009, INT J MED MICROBIOL, V299, P373, DOI 10.1016/j.ijmm.2008.10.009; JAWORSKI DC, 1995, J INSECT PHYSIOL, V41, P369, DOI 10.1016/0022-1910(94)00107-R; JELLISON WL, 1950, PUBLIC HEALTH REP, V65, P1321, DOI 10.2307/4587498; JELLISON WL, 1974, TULAREMIA N AM; Kiszewski AE, 2001, ANNU REV ENTOMOL, V46, P167, DOI 10.1146/annurev.ento.46.1.167; Kocan KM, 2005, J MED ENTOMOL, V42, P864, DOI 10.1603/0022-2585(2005)042[0864:CTFSFS]2.0.CO;2; Kollars TM, 2000, EXP APPL ACAROL, V24, P631, DOI 10.1023/A:1026566301325; Kopacek P, 2010, ADV EXP MED BIOL, V708, P137; Krocova Z, 2003, J PARASITOL, V89, P14, DOI 10.1645/0022-3395(2003)089[0014:TSGEAP]2.0.CO;2; Lennette EH, 1964, DIAGNOSTIC PROCEDURE; Madden RD, 2004, EXP APPL ACAROL, V32, P129, DOI 10.1023/B:APPA.0000018316.80224.54; Maier TM, 2004, APPL ENVIRON MICROB, V70, P7511, DOI 10.1128/AEM.70.12.7511-7519.2004; Niebylski ML, 1997, APPL ENVIRON MICROB, V63, P3933, DOI 10.1128/AEM.63.10.3933-3940.1997; PHILIP C. B., 1934, Public Health Reports, V49, P386, DOI 10.2307/4581119; Reese SM, 2011, J MED ENTOMOL, V48, P884, DOI 10.1603/ME11005; Reese SM, 2010, AM J TROP MED HYG, V83, P645, DOI 10.4269/ajtmh.2010.10-0127; Reif KE, 2011, INFECT IMMUN, V79, P4941, DOI 10.1128/IAI.05676-11; Scofield R H, 1992, J Okla State Med Assoc, V85, P165; Scoles GA, 2004, J MED ENTOMOL, V41, P277, DOI 10.1603/0022-2585-41.3.277; Sjostedt A, 2007, ANN NY ACAD SCI, V1105, P1, DOI 10.1196/annals.1409.009; SONENSHINE DE, 1972, ANN ENTOMOL SOC AM, V65, P1164, DOI 10.1093/aesa/65.5.1164; Sonenshine DE., 1991, BIOL TICKS; Staples JE, 2006, EMERG INFECT DIS, V12, P1113; STICH RW, 1993, J MED ENTOMOL, V30, P789, DOI 10.1093/jmedent/30.4.789; Sun LV, 2000, J INVERTEBR PATHOL, V76, P301, DOI 10.1006/jipa.2000.4983; Versage JL, 2003, J CLIN MICROBIOL, V41, P5492, DOI 10.1128/JCM.41.12.5492-5499.2003; Zivkovic Z, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-7	43	12	12	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35441	10.1371/journal.pone.0035441	http://dx.doi.org/10.1371/journal.pone.0035441			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22530023	Green Published, gold, Green Submitted			2022-12-27	WOS:000305350600083
J	Neves, D; Estrozi, LF; Job, V; Gabel, F; Schoehn, G; Dessen, A				Neves, David; Estrozi, Leandro F.; Job, Viviana; Gabel, Frank; Schoehn, Guy; Dessen, Andrea			Conformational States of a Bacterial alpha(2)-Macroglobulin Resemble Those of Human Complement C3	PLOS ONE			English	Article							HUMAN ALPHA-2-MACROGLOBULIN; ALPHA-MACROGLOBULINS; CRYSTAL-STRUCTURE; COMPONENT C3; PROTEIN; SCATTERING; DOMAIN; MACROMOLECULES; ORGANIZATION; ACTIVATION	alpha(2) macroglobulins (alpha Ms-2) are broad-spectrum protease inhibitors that play essential roles in the innate immune system of eukaryotic species. These large, multi-domain proteins are characterized by a broad-spectrum bait region and an internal thioester, which, upon cleavage, becomes covalently associated to the target protease, allowing its entrapment by a large conformational modification. Notably, alpha Ms-2 are part of a larger protein superfamily that includes proteins of the complement system, such as C3, a multi-domain macromolecule which is also characterized by an internal thioester-carrying domain and whose activation represents the pivotal step in the complement cascade. Recently, alpha M-2/C3-like genes were identified in a large number of bacterial genomes, and the Escherichia coli alpha M-2 homolog (ECAM) was shown to be activated by proteases. In this work, we have structurally characterized ECAM by electron microscopy and small angle scattering (SAXS) techniques. ECAM is an elongated, flexible molecule with overall similarities to C3 in its inactive form; activation by methylamine, chymotrypsin, or elastase induces a conformational modification reminiscent of the one undergone by the transformation of C3 into its active form, C3b. In addition, the proposed C-terminus of ECAM displays high flexibility and different conformations, and could be the recognition site for partner macromolecules. This work sheds light on a potential bacterial defense mechanism that mimics structural rearrangements essential for activation of the complement cascade in eukaryotes, and represents a possible novel target for the development of antibacterials.	[Neves, David; Estrozi, Leandro F.; Job, Viviana; Gabel, Frank; Schoehn, Guy; Dessen, Andrea] Univ Grenoble 1, IBS, Grenoble, France; [Neves, David; Estrozi, Leandro F.; Job, Viviana; Gabel, Frank; Schoehn, Guy; Dessen, Andrea] CNRS, Grenoble, France; [Neves, David; Estrozi, Leandro F.; Job, Viviana; Gabel, Frank; Schoehn, Guy; Dessen, Andrea] CEA, Grenoble, France; [Schoehn, Guy] Unit Virus Host Cell Interact UMI 3265 UJF EMBL C, Grenoble, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CEA; European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Neves, D (corresponding author), Univ Grenoble 1, IBS, Grenoble, France.	andrea.dessen@ibs.fr	Estrozi, Leandro F/A-6578-2013	Estrozi, Leandro F/0000-0003-2548-2547; Gabel, Frank/0000-0003-3446-2601; Dessen, Andrea/0000-0001-6487-4020; Job, Viviana/0000-0001-8421-5292; Schoehn, Guy/0000-0002-1459-3201	Fondation pour la Recherche Medicale (FRM; French Medical Research Foundation) [DEQ20090515390]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq-Brasil); FRM	Fondation pour la Recherche Medicale (FRM; French Medical Research Foundation); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq-Brasil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FRM(Fondation pour la Recherche Medicale)	This work was funded by grant DEQ20090515390 from the Fondation pour la Recherche Medicale (FRM; French Medical Research Foundation - www.frm.org). DN was supported by a fellowship from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq-Brasil) and the FRM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcorlo M, 2011, P NATL ACAD SCI USA, V108, P13236, DOI 10.1073/pnas.1106746108; ARAKAWA H, 1989, J BIOL CHEM, V264, P2350; Armstrong PB, 2006, IMMUNOBIOLOGY, V211, P263, DOI 10.1016/j.imbio.2006.01.002; Baxter RHG, 2007, P NATL ACAD SCI USA, V104, P11615, DOI 10.1073/pnas.0704967104; BOISSET N, 1993, J MOL BIOL, V232, P522, DOI 10.1006/jmbi.1993.1408; Boisset N, 1996, J BIOL CHEM, V271, P25762, DOI 10.1074/jbc.271.42.25762; BRANEGARD B, 1982, EUR J BIOCHEM, V122, P663; Budd A, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-6-r38; CARLSSONBOSTEDT L, 1988, J BIOL CHEM, V263, P6738; Chen H, 2010, P NATL ACAD SCI USA, V107, P17621, DOI 10.1073/pnas.1003750107; DELAIN E, 1988, J BIOL CHEM, V263, P2981; DELAIN E, 1992, ELECTRON MICROSC REV, V5, P231, DOI 10.1016/0892-0354(92)90012-F; Doan N, 2008, J BIOL CHEM, V283, P28747, DOI 10.1074/jbc.M803127200; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Fredslund F, 2006, J MOL BIOL, V361, P115, DOI 10.1016/j.jmb.2006.06.009; Gros P, 2008, NAT REV IMMUNOL, V8, P48, DOI 10.1038/nri2231; Guinier A., 1955, SMALL ANGLE SCATTERI; Heymann JB, 2008, J STRUCT BIOL, V161, P232, DOI 10.1016/j.jsb.2007.08.002; Janssen BJC, 2006, NATURE, V444, P213, DOI 10.1038/nature05172; Janssen BJC, 2005, NATURE, V437, P505, DOI 10.1038/nature04005; Jenner L, 1998, STRUCTURE, V6, P595, DOI 10.1016/S0969-2126(98)00061-6; Kantyka T, 2010, BIOCHIMIE, V92, P1644, DOI 10.1016/j.biochi.2010.06.004; Kirkitadze MD, 2001, IMMUNOL REV, V180, P146, DOI 10.1034/j.1600-065X.2001.1800113.x; Kolodziej SJ, 2002, J BIOL CHEM, V277, P28031, DOI 10.1074/jbc.M202714200; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kotwal GJ, 2000, IMMUNOL TODAY, V21, P242, DOI 10.1016/S0167-5699(00)01606-6; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Marrero A, 2012, ANGEW CHEM INT ED EN; Mattei PJ, 2010, CURR OPIN STRUC BIOL, V20, P749, DOI 10.1016/j.sbi.2010.09.014; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Murthy KHM, 2001, CELL, V104, P301, DOI 10.1016/S0092-8674(01)00214-8; Nishida N, 2006, P NATL ACAD SCI USA, V103, P19737, DOI 10.1073/pnas.0609791104; OSTERBERG R, 1984, EUR J BIOCHEM, V143, P541, DOI 10.1111/j.1432-1033.1984.tb08403.x; Qazi U, 2000, J STRUCT BIOL, V131, P19, DOI 10.1006/jsbi.2000.4269; Rooijakkers SHM, 2007, MOL IMMUNOL, V44, P23, DOI 10.1016/j.molimm.2006.06.011; Sahu A, 2001, IMMUNOL REV, V180, P35, DOI 10.1034/j.1600-065X.2001.1800103.x; Schiffer G, 1999, J BIOL CHEM, V274, P32031, DOI 10.1074/jbc.274.45.32031; SOTTRUPJENSEN L, 1989, J BIOL CHEM, V264, P11539; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Trapani S, 2006, ACTA CRYSTALLOGR D, V62, P467, DOI 10.1107/S0907444906005361; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wiesmann C, 2006, NATURE, V444, P217, DOI 10.1038/nature05263	44	24	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e35384	10.1371/journal.pone.0035384	http://dx.doi.org/10.1371/journal.pone.0035384			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22530012	Green Published, gold, Green Submitted			2022-12-27	WOS:000305347400045
J	Pearson, C; Silva, A; Seddon, B				Pearson, Claire; Silva, Ana; Seddon, Benedict			Exogenous Amino Acids Are Essential for Interleukin-7 Induced CD8 T Cell Gowth	PLOS ONE			English	Article							RECEPTOR-DEFICIENT MICE; BCL-2 EXPRESSION; IL-7; DIFFERENTIATION; EXPANSION; CYTOKINE; SURVIVAL; NAIVE; LYMPHOPENIA; HOMEOSTASIS	IL-7 signalling is important in regulating both survival and cellular size (growth) of T cells. While glucose metabolism has previously been implicated in the mechanism of IL-7 induced survival and growth, the role of amino acids has not before been reported. Here, we show IL-7 dependent T cell survival does not require either exogenous glucose or amino acids. In contrast, maintenance of cell size and IL-7 induced growth were specifically dependent on amino acids. Furthermore, cellular amino acid uptake was implicated in the mechanism of IL-7 induced growth. Analysis of IL-7 regulated gene expression revealed that neutral and cationic amino acid transporters were specific transcriptional targets of IL-7 signalling. In contrast, none of the four glucose transporters expressed in T cells were modulated. Taken together, these data reveal for the first time the central importance of amino acid homeostasis for IL-7 regulated T cell growth.	[Pearson, Claire; Silva, Ana; Seddon, Benedict] MRC Natl Inst Med Res, Ridgeway, Div Immune Cell Biol, London, England	MRC National Institute for Medical Research	Pearson, C (corresponding author), Univ Oxford, John Radcliffe Hosp, Translat Gastroenterol Unit, Oxford OX3 9DU, England.	bseddon@nimr.mrc.ac.uk	Sánchez-Margalet, Victor/AAB-9986-2021	Sánchez-Margalet, Victor/0000-0001-8638-8680; Seddon, Benedict/0000-0003-4352-3373	Medical Research Council United Kingdom [U117573801]; Medical Research Council [MC_U117573801] Funding Source: researchfish; MRC [MC_U117573801] Funding Source: UKRI	Medical Research Council United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council United Kingdom under program code U117573801. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi K, 1997, CELL, V89, P1033, DOI 10.1016/S0092-8674(00)80291-3; Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; ARMANT M, 1995, IMMUNOLOGY, V85, P331; BLOMMAART EFC, 1995, J BIOL CHEM, V270, P2320, DOI 10.1074/jbc.270.5.2320; Graninger WB, 2000, CELL DEATH DIFFER, V7, P966, DOI 10.1038/sj.cdd.4400724; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Jacobs SR, 2010, J IMMUNOL, V184, P3461, DOI 10.4049/jimmunol.0902593; Liu XB, 2010, NAT MED, V16, P191, DOI 10.1038/nm.2077; Maraskovsky E, 1997, CELL, V89, P1011, DOI 10.1016/S0092-8674(00)80289-5; Matsumura I, 1999, EMBO J, V18, P1367, DOI 10.1093/emboj/18.5.1367; Pallard C, 1999, IMMUNITY, V10, P525, DOI 10.1016/S1074-7613(00)80052-7; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; Rathmell JC, 2001, J IMMUNOL, V167, P6869, DOI 10.4049/jimmunol.167.12.6869; Saini M, 2009, BLOOD, V113, P5793, DOI 10.1182/blood-2008-12-192252; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Seddon B, 2002, J IMMUNOL, V169, P3752, DOI 10.4049/jimmunol.169.7.3752; Sundrud MS, 2009, SCIENCE, V324, P1334, DOI 10.1126/science.1172638; Veldhoen M, 2009, J EXP MED, V206, P43, DOI 10.1084/jem.20081438; VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519; Wofford JA, 2008, BLOOD, V111, P2101, DOI 10.1182/blood-2007-06-096297	20	14	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e33998	10.1371/journal.pone.0033998	http://dx.doi.org/10.1371/journal.pone.0033998			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22529903	Green Submitted, Green Published, gold			2022-12-27	WOS:000305347400006
J	Rentoft, M; Coates, PJ; Laurell, G; Nylander, K				Rentoft, Matilda; Coates, Philip John; Laurell, Goran; Nylander, Karin			Transcriptional Profiling of Formalin Fixed Paraffin Embedded Tissue: Pitfalls and Recommendations for Identifying Biologically Relevant Changes	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMAS; GENE-EXPRESSION; NECK-CANCER; SAMPLES; RNA; DNA; PERFORMANCE; FAMILY; CHAIN; HEAD	Expression profiling techniques have been used to study the biology of many types of cancer but have been limited to some extent by the requirement for collection of fresh tissue. In contrast, formalin fixed paraffin embedded (FFPE) samples are widely available and represent a vast resource of potential material. The techniques used to handle the degraded and modified RNA from these samples are relatively new and all the pitfalls and limitations of this material for whole genome expression profiling are not yet clarified. Here, we analyzed 70 FFPE tongue carcinoma samples and 17 controls using the whole genome DASL array covering nearly 21000 genes. We identified that sample age is related to quality of extracted RNA and that sample quality influences apparent expression levels in a non-random manner related to gene probe sequence, leading to spurious results. However, by removing sub-standard samples and analysing only those 28 cancers and 15 controls that had similar quality we were able to generate a list of 934 genes significantly altered in tongue cancer compared to control samples of tongue. This list contained previously identified changes and was enriched for genes involved in many cancer-related processes such as tissue remodelling, inflammation, differentiation and apoptosis. Four novel genes of potential importance in tongue cancer development and maintenance, SH3BGL2, SLC2A6, SLC16A3 and CXCL10, were independently confirmed, validating our data. Hence, gene expression profiling can be performed usefully on archival material if appropriate quality assurance steps are taken to ensure sample consistency and we present some recommendations for the use of FFPE material based on our findings.	[Rentoft, Matilda; Nylander, Karin] Umea Univ, Dept Med Biosci Pathol, Umea, Sweden; [Coates, Philip John] Univ Dundee, Ninewells Hosp & Med Sch, Tayside Tissue Bank, Med Res Inst, Dundee DD1 9SY, Scotland; [Laurell, Goran] Norrlands Univ Hosp, Dept Clin Sci Otorhinolaryngol, Umea, Sweden	Umea University; University of Dundee; Umea University	Rentoft, M (corresponding author), Umea Univ, Dept Med Biosci Pathol, Umea, Sweden.	matilda.rentoft@medbio.umu.se	Rentoft, Matilda/AAL-2449-2021; Coates, Philip J/H-6854-2019	Coates, Philip J/0000-0003-1518-6306; Laurell, Goran/0000-0002-7760-246X	Cancer Research Foundation in Northern Sweden; Lion's Cancer Research Foundation; Umea University; Swedish Cancer Society; Vasterbotten County Council	Cancer Research Foundation in Northern Sweden; Lion's Cancer Research Foundation; Umea University; Swedish Cancer Society(Swedish Cancer Society); Vasterbotten County Council	This study was supported by grants from the Cancer Research Foundation in Northern Sweden, Lion's Cancer Research Foundation, Umea University, the Swedish Cancer Society and Vasterbotten County Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	April C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008162; Augustin R, 2010, IUBMB LIFE, V62, P315, DOI 10.1002/iub.315; Berghuis D, 2011, J PATHOL, V223, P347, DOI 10.1002/path.2819; Bibikova M, 2004, AM J PATHOL, V165, P1799, DOI 10.1016/S0002-9440(10)63435-9; Boldrup L, 2011, ORAL ONCOL, V47, P861, DOI 10.1016/j.oraloncology.2011.07.002; Chon HS, 2011, CANCER CONTROL, V18, P8, DOI 10.1177/107327481101800102; Clark-Langone KM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-279; Cronin M, 2004, AM J PATHOL, V164, P35, DOI 10.1016/S0002-9440(10)63093-3; Ganapathy V, 2009, PHARMACOL THERAPEUT, V121, P29, DOI 10.1016/j.pharmthera.2008.09.005; JOVANOVIC A, 1993, J ORAL PATHOL MED, V22, P459, DOI 10.1111/j.1600-0714.1993.tb00125.x; Kibriya MG, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-622; Kudla G, 2006, PLOS BIOL, V4, P933, DOI 10.1371/journal.pbio.0040180; Le Floch R, 2011, P NATL ACAD SCI USA, V108, P16663, DOI 10.1073/pnas.1106123108; Liu AH, 2009, INT J CLIN EXP PATHO, V2, P519; Loudig O, 2011, HUM PATHOL, V42, P1911, DOI 10.1016/j.humpath.2011.02.011; Majid SM, 2006, ONCOGENE, V25, P756, DOI 10.1038/sj.onc.1209107; Masuda N, 1999, NUCLEIC ACIDS RES, V27, P4436, DOI 10.1093/nar/27.22.4436; Mazzocco M, 2002, GENE, V291, P233, DOI 10.1016/S0378-1119(02)00602-9; Mellin H, 2000, INT J CANCER, V89, P300, DOI 10.1002/1097-0215(20000520)89:3<300::AID-IJC14>3.0.CO;2-G; Mittempergher L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017163; Nannini M, 2009, CANCER TREAT REV, V35, P201, DOI 10.1016/j.ctrv.2008.10.006; Pai SI, 2009, ANNU REV PATHOL-MECH, V4, P49, DOI 10.1146/annurev.pathol.4.110807.092158; Posner MR, 2005, ONCOLOGIST, V10, P11, DOI 10.1634/theoncologist.10-90003-11; Rautava J, 2007, ORAL ONCOL, V43, P911, DOI 10.1016/j.oraloncology.2006.11.012; Rentoft M, 2010, EXP THER MED, V1, P419, DOI 10.3892/etm_00000065; Rentoft M, 2010, ORAL ONCOL, V46, P893, DOI 10.1016/j.oraloncology.2010.05.007; Rentoft M, 2009, INT J ONCOL, V35, P1321, DOI 10.3892/ijo_00000450; Sadi A, 2011, BMC CANCER, V11, DOI [10.1186/1471-2407-11-253, 10.1186/1471-2407-11-25]; Saleh A, 2010, ORAL ONCOL, V46, P379, DOI 10.1016/j.oraloncology.2010.02.022; Sano D, 2007, CANCER METAST REV, V26, P645, DOI 10.1007/s10555-007-9082-y; Silverman S, 2001, J AM DENT ASSOC, V132, p7S, DOI 10.14219/jada.archive.2001.0382; Slodkowska EA, 2009, EXPERT REV MOL DIAGN, V9, P417, DOI 10.1586/ERM.09.32; Srinivasan M, 2002, AM J PATHOL, V161, P1961, DOI 10.1016/S0002-9440(10)64472-0; Vandercappellen J, 2008, CANCER LETT, V267, P226, DOI 10.1016/j.canlet.2008.04.050; Vitucci M, 2011, BRIT J CANCER, V104, P545, DOI 10.1038/sj.bjc.6606031; Ye H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-69; Ziober AF, 2006, CLIN CANCER RES, V12, P5960, DOI 10.1158/1078-0432.CCR-06-0535	37	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e35276	10.1371/journal.pone.0035276	http://dx.doi.org/10.1371/journal.pone.0035276			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22530001	gold, Green Published, Green Submitted			2022-12-27	WOS:000305347400040
J	Kampichler, C; van Turnhout, CAM; Devictor, V; van der Jeugd, HP				Kampichler, Christian; van Turnhout, Chris A. M.; Devictor, Vincent; van der Jeugd, Henk P.			Large-Scale Changes in Community Composition: Determining Land Use and Climate Change Signals	PLOS ONE			English	Article							AGRI-ENVIRONMENT SCHEMES; BIRD POPULATION; AGRICULTURAL LANDSCAPES; DECIDUOUS FOREST; HABITAT CHANGE; NETHERLANDS; BIODIVERSITY; DYNAMICS; CONSERVATION; RESPONSES	Human land use and climate change are regarded as the main driving forces of present-day and future species extinction. They may potentially lead to a profound reorganisation of the composition and structure of natural communities throughout the world. However, studies that explicitly investigate both forms of impact-land use and climate change-are uncommon. Here, we quantify community change of Dutch breeding bird communities over the past 25 years using time lag analysis. We evaluate the chronological sequence of the community temperature index (CTI) which reflects community response to temperature increase (increasing CTI indicates an increase in relative abundance of more southerly species), and the temporal trend of the community specialisation index (CSI) which reflects community response to land use change (declining CSI indicates an increase of generalist species). We show that the breeding bird fauna underwent distinct directional change accompanied by significant changes both in CTI and CSI which suggests a causal connection between climate and land use change and bird community change. The assemblages of particular breeding habitats neither changed at the same speed and nor were they equally affected by climate versus land use changes. In the rapidly changing farmland community, CTI and CSI both declined slightly. In contrast, CTI increased in the more slowly changing forest and heath communities, while CSI remained stable. Coastal assemblages experienced both an increase in CTI and a decline in CSI. Wetland birds experienced the fastest community change of all breeding habitat assemblages but neither CTI nor CSI showed a significant trend. Overall, our results suggest that the interaction between climate and land use changes differs between habitats, and that comparing trends in CSI and CTI may be useful in tracking the impact of each determinant.	[Kampichler, Christian; van der Jeugd, Henk P.] NIOO KNAW, Vogeltrekstn Dutch Ctr Avian Migrat & Demog, Wageningen, Netherlands; [Kampichler, Christian] Univ Juarez Autonoma Tabasco, Div Ciencias Biol, Villahermosa, Tabasco, Mexico; [van Turnhout, Chris A. M.] SOVON Dutch Ctr Field Ornithol, Nijmegen, Netherlands; [van Turnhout, Chris A. M.] Radboud Univ Nijmegen, Inst Water & Wetland Res, Dept Environm Sci, NL-6525 ED Nijmegen, Netherlands; [van Turnhout, Chris A. M.] Radboud Univ Nijmegen, Inst Water & Wetland Res, Dept Anim Ecol, NL-6525 ED Nijmegen, Netherlands; [Devictor, Vincent] Univ Montpellier 2, Inst Sci Evolut, UMR CNRS UM2 5554, Montpellier, France	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Universidad Juarez Autonoma de Tabasco; Radboud University Nijmegen; Radboud University Nijmegen; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Kampichler, C (corresponding author), NIOO KNAW, Vogeltrekstn Dutch Ctr Avian Migrat & Demog, Wageningen, Netherlands.	christian.kampichler@web.de	Vet, Louise E.M./B-1342-2009; van der Jeugd, Henk/S-3159-2019; van der Jeugd, Henk P/F-4891-2010; KNAW, NIOO-KNAW/A-4320-2012	Vet, Louise E.M./0000-0002-2287-1128; van der Jeugd, Henk/0000-0002-5332-9526; van der Jeugd, Henk P/0000-0002-5332-9526; KNAW, NIOO-KNAW/0000-0002-3835-159X	Fondation pour la Recherche sur la Biodiversite [FABIO 054974, PHYBIO AAP-SCEN-2010-1]	Fondation pour la Recherche sur la Biodiversite	VD received financial support from the Fondation pour la Recherche sur la Biodiversite, http://www.fondationbiodiversite.fr (projects FABIO 054974 and PHYBIO AAP-SCEN-2010-1). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, LAND TUINBOUWCIJFERS; Bennett AF, 2010, CONSERVATION BIOLOGY FOR ALL, P88; Bibby CJ, 2000, BIRD CENSUS TECHNIQU, DOI 10.1016/b978-0-12-095830-6.50007-9; Both C, 2010, P ROYAL SOC B, V1259-1266, P1259; Both C, 2009, J ANIM ECOL, V78, P73, DOI 10.1111/j.1365-2656.2008.01458.x; Brook BW, 2008, TRENDS ECOL EVOL, V23, P453, DOI 10.1016/j.tree.2008.03.011; Clavel J, 2011, FRONT ECOL ENVIRON, V9, P222, DOI 10.1890/080216; Clavero M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018581; Collins SL, 2001, AUK, V118, P583, DOI 10.1642/0004-8038(2001)118[0583:LTRATD]2.0.CO;2; Collins SL, 2000, OIKOS, V91, P285, DOI 10.1034/j.1600-0706.2000.910209.x; Cormont A, 2011, CLIM RES, V49, P59, DOI 10.3354/cr01007; Dawson TP, 2011, SCIENCE, V332, P53, DOI 10.1126/science.1200303; Devictor V, 2008, P ROY SOC B-BIOL SCI, V275, P2743, DOI 10.1098/rspb.2008.0878; Devictor V, 2008, OIKOS, V117, P507, DOI 10.1111/j.2008.0030-1299.16215.x; Devictor V, 2012, NAT CLIM CHANGE, V2, P121, DOI 10.1038/NCLIMATE1347; Devictor V, 2009, DIVERS DISTRIB, V15, P122, DOI 10.1111/j.1472-4642.2008.00510.x; Enemar Anders, 2004, Ornis Svecica, V14, P63; Filippi-Codaccioni O, 2010, BIOL CONSERV, V143, P1493, DOI 10.1016/j.biocon.2010.03.031; Fox AD, 2005, GLOBAL CHANGE BIOL, V11, P881, DOI 10.1111/j.1365-2486.2005.00941.x; Godet L, 2012, BIOL LETT IN PRESS; Gregory RD, 2005, PHILOS T R SOC B, V360, P269, DOI 10.1098/rstb.2004.1602; Hagemeijer W., 1997, EBCC ATLAS EUROPEAN; HALL GA, 1984, WILSON BULL, V96, P228; Holmes RT, 2001, AUK, V118, P589, DOI 10.1642/0004-8038(2001)118[0589:TYBPTI]2.0.CO;2; Hustings F, 2009, WATERVOGELS NEDERLAN; Julliard R, 2006, ECOL LETT, V9, P1237, DOI 10.1111/j.1461-0248.2006.00977.x; Kendeigh S. C., 1982, BIRD POPULATIONS E C; Kleijn D, 2004, CONSERV BIOL, V18, P775, DOI 10.1111/j.1523-1739.2004.00550.x; Kleijn D, 2001, NATURE, V413, P723, DOI 10.1038/35099540; Kleijn D, 2010, IBIS, V152, P475, DOI 10.1111/j.1474-919X.2010.01025.x; Klein Tank AMG, 2009, CLIMATE CHANGE NET S; Kooijman AM, 1998, J ECOL, V86, P511, DOI 10.1046/j.1365-2745.1998.00273.x; Laurance WF, 2010, CONSERVATION BIOLOGY FOR ALL, P73; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Leito A, 2006, ORNIS FENNICA, V83, P124; Lovejoy TE, 2010, CONSERVATION BIOLOGY FOR ALL, P153; Magurran AE, 2010, TRENDS ECOL EVOL, V25, P574, DOI 10.1016/j.tree.2010.06.016; Newton I, 2004, IBIS, V146, P579, DOI 10.1111/j.1474-919X.2004.00375.x; Ng M, 2010, BRIT J MATH STAT PSY, V63, P319, DOI 10.1348/000711009X456845; Nijssen M, 2010, 2011OBN144 MIN EL I; Pereira HM, 2010, SCIENCE, V330, P1496, DOI 10.1126/science.1196624; Perkins AJ, 2011, J APPL ECOL, V48, P514, DOI 10.1111/j.1365-2664.2011.01958.x; Roelofs JGM, 1996, ACTA BOT NEERL, V45, P517; Svensson Soren, 2010, Ornis Svecica, V20, P31; Svensson Soren, 2006, Ornis Svecica, V16, P183; Thibault KM, 2004, ECOLOGY, V85, P2649, DOI 10.1890/04-0321; Travis JMJ, 2003, P ROY SOC B-BIOL SCI, V270, P467, DOI 10.1098/rspb.2002.2246; Van Beusekom R, 2005, RODE LIJST NEDERLAND; Van Der Jeugd HP, 2009, GLOBAL CHANGE BIOL, V15, P1057, DOI 10.1111/j.1365-2486.2008.01804.x; van Eerden M. R., 1996, Gibier Faune Sauvage, V13, P681; van Oldenborgh GJ, 2009, CLIM PAST, V5, P1, DOI 10.5194/cp-5-1-2009; van Turnhout CAM, 2010, ARDEA, V98, P283, DOI 10.5253/078.098.0303; Van Turnhout CAM, 2007, BIOL CONSERV, V134, P505, DOI 10.1016/j.biocon.2006.09.011; Van Turnhout CAM, 2010, BIOL CONSERV, V143, P173, DOI 10.1016/j.biocon.2009.09.023; VANDIJK AJ, 2004, HANDLEIDING BROEDVOG; Warren MS, 2001, NATURE, V414, P65, DOI 10.1038/35102054; Wesolowski T, 2010, ACTA ORNITHOL, V45, P209, DOI 10.3161/000164510X551354	57	66	68	0	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e35272	10.1371/journal.pone.0035272	http://dx.doi.org/10.1371/journal.pone.0035272			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523579	Green Published, Green Submitted, gold			2022-12-27	WOS:000305345000051
J	Legrand, A; Bui-Quoc, E; Dore-Mazars, K; Lemoine, C; Gerard, CL; Bucci, MP				Legrand, Agathe; Bui-Quoc, Emmanuel; Dore-Mazars, Karine; Lemoine, Christelle; Gerard, Christophe-Loic; Bucci, Maria Pia			Effect of a Dual Task on Postural Control in Dyslexic Children	PLOS ONE			English	Article							SACCADIC EYE-MOVEMENTS; DEVELOPMENTAL DYSLEXIA; LEARNING-DIFFICULTIES; ATTENTIONAL DEMANDS; COGNITIVE LOAD; FOCUS; SWAY; POSTUROGRAPHY; INTERFERENCE; COORDINATION	Several studies have examined postural control in dyslexic children; however, their results were inconclusive. This study investigated the effect of a dual task on postural stability in dyslexic children. Eighteen dyslexic children (mean age 10.3 +/- 1.2 years) were compared with eighteen non-dyslexic children of similar age. Postural stability was recorded with a platform (TechnoConcept (R)) while the child, in separate sessions, made reflex horizontal and vertical saccades of 10 degrees of amplitude, and read a text silently. We measured the surface and the mean speed of the center of pressure (CoP). Reading performance was assessed by counting the number of words read during postural measures. Both groups of children were more stable while performing saccades than while reading a text. Furthermore, dyslexic children were significantly more unstable than non-dyslexic children, especially during the reading task. Finally, the number of words read by dyslexic children was significantly lower than that of non-dyslexic children and, in contrast to the non-dyslexic children. In line with the U-shaped non-linear interaction model, we suggest that the attention consumed by the reading task could be responsible for the loss of postural control in both groups of children. The postural instability observed in dyslexic children supports the hypothesis that such children have a lack of integration of multiple sensorimotor inputs.	[Legrand, Agathe; Dore-Mazars, Karine; Lemoine, Christelle; Bucci, Maria Pia] Univ Paris 05, Inst Psychol, IUPDP, Lab Psychol & Neuropsychol Cognit, Sorbonne Paris Cite, Boulogne Billan, France; [Bui-Quoc, Emmanuel] Hop Robert Debre, Serv Ophtalmol, F-75019 Paris, France; [Dore-Mazars, Karine] Inst Univ France, Paris, France; [Gerard, Christophe-Loic] Hop Robert Debre, Serv Psychopathol Enfant & Adolescent, F-75019 Paris, France	UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut Universitaire de France; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite	Legrand, A (corresponding author), Univ Paris 05, Inst Psychol, IUPDP, Lab Psychol & Neuropsychol Cognit, Sorbonne Paris Cite, Boulogne Billan, France.	agathe.legrand@etu.parisdescartes.fr						ABERNETHY B, 1988, J HUM MOVEMENT STUD, V14, P101; *AM PSYCH ASS, 1996, DSM 4 MAN DIAGN STAT; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Andersson G, 2003, OTOL NEUROTOL, V24, P289, DOI 10.1097/00129492-200303000-00026; Andersson G, 2002, BRAIN RES BULL, V58, P135, DOI 10.1016/S0361-9230(02)00770-0; Barela JA, 2011, RES DEV DISABIL, V32, P1814, DOI 10.1016/j.ridd.2011.03.011; Biscaldi M, 1998, NEUROPSYCHOLOGIA, V36, P1189, DOI 10.1016/S0028-3932(97)00170-X; Blanchard Yvette, 2005, Pediatr Phys Ther, V17, P189, DOI 10.1097/01.PEP.0000176578.57147.5d; Brandt T., 2003, VERTIGO ITS MULTISEN; Brookes RL, 2010, DYSLEXIA, V16, P358, DOI 10.1002/dys.420; Bruno E, 2009, J VOICE, V23, P71, DOI 10.1016/j.jvoice.2007.06.002; Bucci MP, 2008, GRAEF ARCH CLIN EXP, V246, P417, DOI 10.1007/s00417-007-0723-1; Bucci MP, 2009, J OPHTHALMOL, V2009, DOI 10.1155/2009/325214; Buderath P, 2009, GAIT POSTURE, V29, P249, DOI 10.1016/j.gaitpost.2008.08.016; Chevrie-Muller C, 1997, MEMOIRE ATTENTION L2; Dault MC, 2003, COGNITIVE BRAIN RES, V16, P434, DOI 10.1016/S0926-6410(03)00058-2; ELTERMAN RD, 1980, J LEARN DISABIL, V13, P11, DOI 10.1177/002221948001300104; Fawcett AJ, 1996, ANN DYSLEXIA, V46, P259, DOI 10.1007/BF02648179; FAWCETT AJ, 1995, J MOTOR BEHAV, V27, P235, DOI 10.1080/00222895.1995.9941713; Gagey P. M., 1993, CALCUL SURFACE STATO; GEURTS ACH, 1993, ARCH PHYS MED REHAB, V74, P1144; Glasauer S, 2005, NEUROLOGY, V65, P1291, DOI 10.1212/01.wnl.0000175132.01370.fc; Huang H J, 2001, Pediatr Phys Ther, V13, P133, DOI 10.1097/00001577-200110000-00005; Hutzler F, 2004, BRAIN LANG, V89, P235, DOI 10.1016/S0093-934X(03)00401-2; Huxhold O, 2006, BRAIN RES BULL, V69, P294, DOI 10.1016/j.brainresbull.2006.01.002; Ivanenko YP, 1999, J PHYSIOL-LONDON, V519, P301, DOI 10.1111/j.1469-7793.1999.0301o.x; Kirkby JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027105; Konczak J, 2005, BRAIN, V128, P1428, DOI 10.1093/brain/awh385; Lacour M, 2008, NEUROPHYSIOL CLIN, V38, P411, DOI 10.1016/j.neucli.2008.09.005; LAJOIE Y, 1993, EXP BRAIN RES, V97, P139; Laufer Y, 2008, GAIT POSTURE, V27, P347, DOI 10.1016/j.gaitpost.2007.04.013; Legrand A, 2011, NEUROSCI LETT, V501, P96, DOI 10.1016/j.neulet.2011.06.056; Leigh R. J., 2006, NEUROLOGY EYE MOVEME; Liberman I.Y., 1973, B ORTON SOC, V23, P65, DOI DOI 10.1007/BF02653842; LOVEGROVE WJ, 1980, SCIENCE, V210, P439, DOI 10.1126/science.7433985; MAKI BE, 1990, J AM GERIATR SOC, V38, P1, DOI 10.1111/j.1532-5415.1990.tb01588.x; McNevin NH, 2002, HUM MOVEMENT SCI, V21, P187, DOI 10.1016/S0167-9457(02)00095-7; Nicolson RI, 1999, LANCET, V353, P1662, DOI 10.1016/S0140-6736(98)09165-X; NICOLSON RI, 1990, COGNITION, V35, P159, DOI 10.1016/0010-0277(90)90013-A; Nicolson RI, 2007, TRENDS NEUROSCI, V30, P135, DOI 10.1016/j.tins.2007.02.003; Oblak B, 1985, EFFECTS VOLUNTARY EY; Olivier I, 2007, NEUROREPORT, V18, P817, DOI 10.1097/WNR.0b013e3280e129e1; Olivier I, 2010, GAIT POSTURE, V32, P494, DOI 10.1016/j.gaitpost.2010.07.008; OLSON RK, 1983, J EXP PSYCHOL HUMAN, V9, P816, DOI 10.1037/0096-1523.9.5.816; Pellecchia GL, 2003, GAIT POSTURE, V18, P29, DOI 10.1016/S0966-6362(02)00138-8; Poblano A, 2002, ARCH MED RES, V33, P485, DOI 10.1016/S0188-4409(02)00397-1; Quercia P, 2011, EXP BRAIN RES, V209, P599, DOI 10.1007/s00221-011-2593-3; Ramus F, 2003, CURR OPIN NEUROBIOL, V13, P212, DOI 10.1016/S0959-4388(03)00035-7; RIDDELL PM, 1990, PERCEPT MOTOR SKILL, V70, P707, DOI 10.2466/PMS.70.3.707-718; Riley MA, 2003, BRAIN RES BULL, V62, P191, DOI 10.1016/j.brainresbull.2003.09.012; RIZZOLATTI G, 1987, NEUROPSYCHOLOGIA, V25, P31, DOI 10.1016/0028-3932(87)90041-8; Rochelle KSH, 2006, J CHILD PSYCHOL PSYC, V47, P1159, DOI 10.1111/j.1469-7610.2006.01641.x; Rougier P, 2006, NEUROPHYSIOL CLIN, V36, P235, DOI 10.1016/j.neucli.2006.09.003; Rougier P, 2007, MOTOR CONTROL, V11, P213, DOI 10.1123/mcj.11.3.213; Schmid M, 2007, EXP BRAIN RES, V179, P375, DOI 10.1007/s00221-006-0795-x; Shumway-Cook A, 2000, J GERONTOL A-BIOL, V55, pM10; ShumwayCook A, 1997, J GERONTOL A-BIOL, V52, pM232, DOI 10.1093/gerona/52A.4.M232; Snowling M., 2000, DYSLEXIA; Stein J, 2001, Dyslexia, V7, P12, DOI 10.1002/dys.186; STEIN JF, 1987, EYE, V1, P433, DOI 10.1038/eye.1987.66; STEIN JF, 1988, BRIT J OPHTHALMOL, V72, P162, DOI 10.1136/bjo.72.3.162; Stoffregen TA, 2007, MOTOR CONTROL, V11, P86; Stoodley CJ, 2005, EXP BRAIN RES, V167, P370, DOI 10.1007/s00221-005-0042-x; STRAUBE A, 1989, CLIN VISION SCI, V4, P107; TALLAL P, 1980, BRAIN LANG, V9, P182, DOI 10.1016/0093-934X(80)90139-X; UCHIDA T, 1979, NEUROSCI LETT, V13, P253, DOI 10.1016/0304-3940(79)91503-9; Vieira S, 2009, NEUROSCI LETT, V462, P125, DOI 10.1016/j.neulet.2009.06.093; Vuillerme N, 2008, NEUROSCIENCE, V155, P291, DOI 10.1016/j.neuroscience.2008.05.018; Vuillerme N, 2000, NEUROSCI LETT, V291, P77, DOI 10.1016/S0304-3940(00)01374-4; WHITE KD, 1980, SCIENCE, V208, P621, DOI 10.1126/science.7367888; Wimmer H, 1999, J LEARN DISABIL, V32, P473, DOI 10.1177/002221949903200513; Wulf G, 2004, J MOTOR BEHAV, V36, P189, DOI 10.3200/JMBR.36.2.189-199	72	31	32	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e35301	10.1371/journal.pone.0035301	http://dx.doi.org/10.1371/journal.pone.0035301			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959VO	22523583	Green Published, Green Submitted, gold			2022-12-27	WOS:000305345000055
J	Zonari, A; Novikoff, S; Electo, NRP; Breyner, NM; Gomes, DA; Martins, A; Neves, NM; Reis, RL; Goes, AM				Zonari, Alessandra; Novikoff, Silviene; Electo, Naira R. P.; Breyner, Natalia M.; Gomes, Dawidson A.; Martins, Albino; Neves, Nuno M.; Reis, Rui L.; Goes, Alfredo M.			Endothelial Differentiation of Human Stem Cells Seeded onto Electrospun Polyhydroxybutyrate/Polyhydroxybutyrate-Co-Hydroxyvalerate Fiber Mesh	PLOS ONE			English	Article							HUMAN ADIPOSE-TISSUE; IN-VITRO; EXTRACELLULAR-MATRIX; NANOFIBER MESHES; BONE; SCAFFOLDS; VASCULARIZATION; CARTILAGE; BIOCOMPATIBILITY; GROWTH	Tissue engineering is based on the association of cultured cells with structural matrices and the incorporation of signaling molecules for inducing tissue regeneration. Despite its enormous potential, tissue engineering faces a major challenge concerning the maintenance of cell viability after the implantation of the constructs. The lack of a functional vasculature within the implant compromises the delivery of nutrients to and removal of metabolites from the cells, which can lead to implant failure. In this sense, our investigation aims to develop a new strategy for enhancing vascularization in tissue engineering constructs. This study's aim was to establish a culture of human adipose tissue-derived stem cells (hASCs) to evaluate the biocompatibility of electrospun fiber mesh made of polyhydroxybutyrate (PHB) and its copolymer poly-3-hydroxybutyrate-co-3-hydroxyvalerate (PHB-HV) and to promote the differentiation of hASCs into the endothelial lineage. Fiber mesh was produced by blending 30% PHB with 70% PHB-HV and its physical characterization was conducted using scanning electron microscopy analysis (SEM). Using electrospinning, fiber mesh was obtained with diameters ranging 300 nm to 1.3 mu m. To assess the biological performance, hASCs were extracted, cultured, characterized by flow cytometry, expanded and seeded onto electrospun PHB/PHB-HV fiber mesh. Various aspects of the cells were analyzed in vitro using SEM, MTT assay and Calcein-AM staining. The in vitro evaluation demonstrated good adhesion and a normal morphology of the hASCs. After 7, 14 and 21 days of seeding hASCs onto electrospun PHB/PHB-HV fiber mesh, the cells remained viable and proliferative. Moreover, when cultured with endothelial differentiation medium (i.e., medium containing VEGF and bFGF), the hASCs expressed endothelial markers such as VE-Cadherin and the vWF factor. Therefore, the electrospun PHB/PHB-HV fiber mesh appears to be a suitable material that can be used in combination with endothelial-differentiated cells to improve vascularization in engineered bone tissues.	[Zonari, Alessandra; Novikoff, Silviene; Electo, Naira R. P.; Breyner, Natalia M.; Gomes, Dawidson A.; Goes, Alfredo M.] Univ Fed Minas Gerais, Dept Biochem & Immunol, Belo Horizonte, MG, Brazil; [Martins, Albino; Neves, Nuno M.; Reis, Rui L.] Univ Minho, Res Grp Biomat Biodegradables & Biomimet 3Bs, Guimaraes, Portugal; [Martins, Albino; Neves, Nuno M.; Reis, Rui L.] Univ Minho, ICVS PT Govt Associate Lab 3Bs, Braga, Portugal	Universidade Federal de Minas Gerais; Universidade do Minho; Universidade do Minho	Zonari, A (corresponding author), Univ Fed Minas Gerais, Dept Biochem & Immunol, Belo Horizonte, MG, Brazil.	alessandrazonari@gmail.com	Zonari, Alessandra/C-2168-2013; Neves, Nuno M/B-4685-2008; Gomes, Dawidson Assis/O-1372-2013; Martins, Albino/C-8432-2012; Reis, Rui L./A-8938-2008	Zonari, Alessandra/0000-0002-0093-356X; Neves, Nuno M/0000-0003-3041-0687; Gomes, Dawidson Assis/0000-0001-7714-991X; Martins, Albino/0000-0003-3868-0251; Reis, Rui L./0000-0002-4295-6129; UMinho, 3B's Research Group/0000-0002-5195-3456; Breyner, Natalia/0000-0002-2109-9332; Novikoff, Silviene/0000-0002-6541-3477	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq/Brazil); Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG/Brazil); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq/Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG/Brazil)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq/Brazil), the Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG/Brazil) and the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre A, 2010, BIOCHEM BIOPH RES CO, V400, P284, DOI 10.1016/j.bbrc.2010.08.073; da Silva MLA, 2010, BIOMACROMOLECULES, V11, P3228, DOI 10.1021/bm100476r; Araujo JV, 2008, J BIOMAT SCI-POLYM E, V19, P1261, DOI 10.1163/156856208786052335; Arosarena Oneida, 2005, Curr Opin Otolaryngol Head Neck Surg, V13, P233, DOI 10.1097/01.moo.0000170526.51393.c5; Asran AS, 2010, BIOMACROMOLECULES, V11, P3413, DOI 10.1021/bm100912v; Breyner NM, 2010, CELLS TISSUES ORGANS, V191, P119, DOI 10.1159/000231472; Cao Y, 2005, BIOCHEM BIOPH RES CO, V332, P370, DOI 10.1016/j.bbrc.2005.04.135; Carvalho PP, 2011, CELLS TISSUES ORGANS, V194, P494, DOI 10.1159/000324892; Cassell OCS, 2002, BRIT J PLAST SURG, V55, P603, DOI 10.1054/bjps.2002.3950; CHALUPOWICZ DG, 1995, J CELL BIOL, V130, P207, DOI 10.1083/jcb.130.1.207; Chen GQ, 2005, BIOMATERIALS, V26, P6565, DOI 10.1016/j.biomaterials.2005.04.036; Cheng S, 2006, BIOMATERIALS, V27, P3758, DOI 10.1016/j.biomaterials.2006.02.046; Choi GG, 2005, BIOTECHNOL BIOPROC E, V10, P540, DOI 10.1007/BF02932291; Davis GE, 2005, CIRC RES, V97, P1093, DOI 10.1161/01.RES.0000191547.64391.e3; ENGELBERG I, 1991, BIOMATERIALS, V12, P292, DOI 10.1016/0142-9612(91)90037-B; Fischer LJ, 2009, J SURG RES, V152, P157, DOI 10.1016/j.jss.2008.06.029; Frohlich M, 2008, CURR STEM CELL RES T, V3, P254, DOI 10.2174/157488808786733962; Gloria A, 2010, J APPL BIOMATER BIOM, V8, P57; Gogotov IN, 2010, APPL BIOCHEM MICRO+, V46, P607, DOI 10.1134/S0003683810060086; Gory-Faure S, 1999, DEVELOPMENT, V126, P2093; Haimi S, 2009, TISSUE ENG PT A, V15, P1473, DOI 10.1089/ten.tea.2008.0241; Jain RK, 2005, NAT BIOTECHNOL, V23, P821, DOI 10.1038/nbt0705-821; Klenke FM, 2008, J BIOMED MATER RES A, V85A, P777, DOI 10.1002/jbm.a.31559; Kose GT, 2005, BIOMATERIALS, V26, P5187, DOI 10.1016/j.biomaterials.2005.01.037; Ku SH, 2010, BIOMATERIALS, V31, P9431, DOI 10.1016/j.biomaterials.2010.08.071; KUBOTA Y, 1988, J CELL BIOL, V107, P1589, DOI 10.1083/jcb.107.4.1589; LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529; Lee SY, 1996, BIOTECHNOL BIOENG, V49, P1; Lin SD, 2011, TISSUE ENG PT A, V17, P1489, DOI [10.1089/ten.tea.2010.0688, 10.1089/ten.TEA.2010.0688]; Liu HF, 2011, BIOMATERIALS, V32, P3784, DOI 10.1016/j.biomaterials.2011.02.002; Ma GP, 2010, J APPL POLYM SCI, V118, P3619, DOI 10.1002/app.32671; Martins A, 2007, NANOMEDICINE-UK, V2, P929, DOI 10.2217/17435889.2.6.929; Martins A, 2010, BIOMATERIALS, V31, P5875, DOI 10.1016/j.biomaterials.2010.04.010; McCullen SD, 2007, INT J NANOMED, V2, P253; Misra SK, 2006, BIOMACROMOLECULES, V7, P2249, DOI 10.1021/bm060317c; Mo XM, 2004, BIOMATERIALS, V25, P1883, DOI 10.1016/j.biomaterials.2003.08.042; Mountford JC, 2008, TRANSFUSION MED, V18, P1, DOI 10.1111/j.1365-3148.2007.00807.x; Muschler GF, 2003, J BIOMED BIOTECHNOL, P170, DOI 10.1155/s1110724303209165; Narmoneva DA, 2005, BIOMATERIALS, V26, P4837, DOI 10.1016/j.biomaterials.2005.01.005; Nomi M, 2002, MOL ASPECTS MED, V23, P463, DOI 10.1016/S0098-2997(02)00008-0; Oswald J, 2004, STEM CELLS, V22, P377, DOI 10.1634/stemcells.22-3-377; Rada T, 2009, TISSUE ENG PART B-RE, V15, P113, DOI 10.1089/ten.teb.2008.0423; Rathbone S, 2010, J BIOMED MATER RES A, V93A, P1391, DOI 10.1002/jbm.a.32641; Ravindran S, 2010, TISSUE ENG PT A, V16, P327, DOI [10.1089/ten.tea.2009.0110, 10.1089/ten.TEA.2009.0110]; Rouwkema J, 2008, TRENDS BIOTECHNOL, V26, P434, DOI 10.1016/j.tibtech.2008.04.009; Sadler JE, 2009, J THROMB HAEMOST, V7, P24, DOI 10.1111/j.1538-7836.2009.03375.x; Salerno S, 2011, BIOMATERIALS, V32, P8848, DOI 10.1016/j.biomaterials.2011.08.004; Santos MI, 2010, MACROMOL BIOSCI, V10, P12, DOI 10.1002/mabi.200900107; Seal BL, 2001, MAT SCI ENG R, V34, P147, DOI 10.1016/S0927-796X(01)00035-3; Sill TJ, 2008, BIOMATERIALS, V29, P1989, DOI 10.1016/j.biomaterials.2008.01.011; Smith IO, 2009, WIRES NANOMED NANOBI, V1, P226, DOI 10.1002/wnan.26; Sombatmankhong K, 2006, J POLYM SCI POL PHYS, V44, P2923, DOI 10.1002/polb.20915; Suwantong O, 2007, INT J BIOL MACROMOL, V40, P217, DOI 10.1016/j.ijbiomac.2006.07.006; Tokiwa Y, 2004, BIOTECHNOL LETT, V26, P1181, DOI 10.1023/B:BILE.0000036599.15302.e5; Toyokawa N, 2010, ARTHROSCOPY, V26, P375, DOI 10.1016/j.arthro.2009.08.006; Tsigkou O, 2010, P NATL ACAD SCI USA, V107, P3311, DOI 10.1073/pnas.0905445107; Unger RE, 2010, BIOMATERIALS, V31, P6959, DOI 10.1016/j.biomaterials.2010.05.057; Vailhe B, 1997, IN VITRO CELL DEV-AN, V33, P763; Wan C, 2008, P NATL ACAD SCI USA, V105, P686, DOI 10.1073/pnas.0708474105; Wang YY, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/5/054112; Wernike E, 2010, EUR CELLS MATER, V19, P30; Wu HJ, 2010, J MATER SCI-MATER M, V21, P3207, DOI 10.1007/s10856-010-4164-8; Wu Q, 2009, ARTIF CELL BLOOD SUB, V37, P1, DOI 10.1080/10731190802664429; Xiang P, 2011, INT J BIOL MACROMOL, V49, P281, DOI 10.1016/j.ijbiomac.2011.05.004; Xie JW, 2010, NANOSCALE, V2, P35, DOI 10.1039/b9nr00243j; Ye C, 2009, BIOMATERIALS, V30, P4401, DOI 10.1016/j.biomaterials.2009.05.001; Yu HY, 2009, BIOMATERIALS, V30, P508, DOI 10.1016/j.biomaterials.2008.09.047; Zhang ZY, 2010, BIOMATERIALS, V31, P608, DOI 10.1016/j.biomaterials.2009.09.078; Zhu YX, 2008, CELL BIOCHEM FUNCT, V26, P664, DOI 10.1002/cbf.1488; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	70	61	62	1	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e35422	10.1371/journal.pone.0035422	http://dx.doi.org/10.1371/journal.pone.0035422			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523594	Green Published, gold, Green Submitted			2022-12-27	WOS:000305345000067
J	Doss, CGP; Rajith, B				Doss, C. George Priya; Rajith, B.			Computational Refinement of Functional Single Nucleotide Polymorphisms Associated with ATM Gene	PLOS ONE			English	Article							NON-SYNONYMOUS SNPS; ATAXIA-TELANGIECTASIA; MISSENSE MUTATIONS; POINT MUTATIONS; PREDICTION; IDENTIFICATION; INACTIVATION; ACETYLATION; PHENOTYPES; VARIANTS	Background: Understanding and predicting molecular basis of disease is one of the major challenges in modern biology and medicine. SNPs associated with complex disorders can create, destroy, or modify protein coding sites. Single amino acid substitutions in the ATM gene are the most common forms of genetic variations that account for various forms of cancer. However, the extent to which SNPs interferes with the gene regulation and affects cancer susceptibility remains largely unknown. Principal findings: We analyzed the deleterious nsSNPs associated with ATM gene based on different computational methods. An integrative scoring system and sequence conservation of amino acid residues was adapted for a priori nsSNP analysis of variants associated with cancer. We further extended our approach on SNPs that could potentially influence protein Post Translational Modifications in ATM gene. Significance: In the lack of adequate prior reports on the possible deleterious effects of nsSNPs, we have systematically analyzed and characterized the functional variants in both coding and non coding region that can alter the expression and function of ATM gene. In silico characterization of nsSNPs affecting ATM gene function can aid in better understanding of genetic differences in disease susceptibility.	[Doss, C. George Priya; Rajith, B.] Vellore Inst Technol Univ, Sch Biosci & Technol, Ctr Nanobiotechnol, Med Biotechnol Div, Vellore, Tamil Nadu, India	Vellore Institute of Technology	Doss, CGP (corresponding author), Vellore Inst Technol Univ, Sch Biosci & Technol, Ctr Nanobiotechnol, Med Biotechnol Div, Vellore, Tamil Nadu, India.	georgepriyadoss@vit.ac.in	C, George/ABE-4676-2021; Alizadeh/AAK-1398-2021	C, George Priya Doss/0000-0002-5971-8290				Aly TA, 2006, DIABETES, V55, P1265, DOI 10.2337/db05-1276; [Anonymous], 2011, PLOS ONE, V6; Ansong C, 2011, BMC GENOMICS, V25, P12; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Bandele OJ, 2011, NUCLEIC ACIDS RES, V39, P178, DOI 10.1093/nar/gkq764; Basu A, 2009, P NATL ACAD SCI USA, V106, P13785, DOI 10.1073/pnas.0906801106; Becker-Catania SG, 2000, MOL GENET METAB, V70, P122, DOI 10.1006/mgme.2000.2998; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Botstein D, 2003, NAT GENET, V33, P228, DOI 10.1038/ng1090; Broeks A, 1998, HUM MUTAT, V12, P330, DOI 10.1002/(SICI)1098-1004(1998)12:5<330::AID-HUMU6>3.0.CO;2-H; Bullrich F, 1999, CANCER RES, V59, P24; Capriotti E, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S2-S6; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Castellvi-Bel S, 1999, HUM MUTAT, V14, P156, DOI 10.1002/(SICI)1098-1004(1999)14:2<156::AID-HUMU7>3.0.CO;2-E; Chen H, 2006, NUCLEIC ACIDS RES, V34, pW249, DOI 10.1093/nar/gkl233; Conde L, 2006, NUCLEIC ACIDS RES, V34, pW621, DOI 10.1093/nar/gkl071; Doniger SW, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000183; Doss CGP, 2008, FUNCT INTEGR GENOMIC, V8, P309, DOI 10.1007/s10142-008-0086-7; Doss CGP, 2010, INTERDISCIP SCI, V2, P320, DOI 10.1007/s12539-010-0003-3; Doss CGP, 2009, INTERDISCIP SCI, V1, P220, DOI 10.1007/s12539-009-0042-9; Flanagan SE, 2010, GENET TEST MOL BIOMA, V14, P533, DOI 10.1089/gtmb.2010.0036; Fukao T, 1998, HUM MUTAT, V12, P338, DOI 10.1002/(SICI)1098-1004(1998)12:5<338::AID-HUMU7>3.0.CO;2-9; Gilad S, 1996, HUM MOL GENET, V5, P433, DOI 10.1093/hmg/5.4.433; Grasbon-Frodl E, 2004, ACTA NEUROPATHOL, V108, P476, DOI 10.1007/s00401-004-0913-4; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Grillo G, 2010, NUCLEIC ACIDS RES, V38, pD75, DOI 10.1093/nar/gkp902; Ho AY, 2007, INT J RADIAT ONCOL, V69, P677, DOI 10.1016/j.ijrobp.2007.04.012; Izatt L, 1999, GENE CHROMOSOME CANC, V26, P286, DOI 10.1002/(SICI)1098-2264(199912)26:4<286::AID-GCC2>3.0.CO;2-X; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Karchin R, 2005, BIOINFORMATICS, V21, P2814, DOI 10.1093/bioinformatics/bti442; Khan S, 2010, HUM MUTAT, V31, P675, DOI 10.1002/humu.21242; Kozlov SV, 2011, J BIOL CHEM, V286, P9107, DOI 10.1074/jbc.M110.204065; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lee JE, 2005, MUTAT RES-FUND MOL M, V573, P195, DOI 10.1016/j.mrfmmm.2004.08.018; Li A, 2006, BIOCHEM BIOPH RES CO, V350, P818, DOI 10.1016/j.bbrc.2006.08.199; Li AR, 2000, AM J MED GENET, V92, P170, DOI 10.1002/(SICI)1096-8628(20000529)92:3<170::AID-AJMG3>3.0.CO;2-#; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Mitui M, 2003, HUM MUTAT, V22, P43, DOI 10.1002/humu.10232; Morandell S, 2006, PROTEOMICS, V6, P4047, DOI 10.1002/pmic.200600058; Nadeau JH, 2002, NATURE, V420, P517, DOI 10.1038/420517a; Ng PC, 2006, ANNU REV GENOM HUM G, V7, P61, DOI 10.1146/annurev.genom.7.080505.115630; Palmer JS, 2000, AM J HUM GENET, V66, P176, DOI 10.1086/302711; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Reinders J, 2007, BIOMOL ENG, V24, P169, DOI 10.1016/j.bioeng.2007.03.002; Ren J, 2009, PROTEOMICS, V9, P3409, DOI 10.1002/pmic.200800646; Sandoval N, 1999, HUM MOL GENET, V8, P69, DOI 10.1093/hmg/8.1.69; Sasaki T, 1998, HUM MUTAT, V12, P186, DOI 10.1002/(SICI)1098-1004(1998)12:3<186::AID-HUMU6>3.0.CO;2-F; Schaffner C, 2000, P NATL ACAD SCI USA, V97, P2773, DOI 10.1073/pnas.050400997; Schaffner C, 1999, BLOOD, V94, P748, DOI 10.1182/blood.V94.2.748.414k02_748_753; SCHNEIDER TD, 1986, J MOL BIOL, V188, P415, DOI 10.1016/0022-2836(86)90165-8; Sethumadhavan R, 2009, J BIOMED SCI, V24, P16; SONENBERG N, 1994, CURR OPIN GENET DEV, V4, P310, DOI 10.1016/S0959-437X(05)80059-0; Stankovic T, 1999, LANCET, V353, P26, DOI 10.1016/S0140-6736(98)10117-4; Stankovic T, 1998, AM J HUM GENET, V62, P334, DOI 10.1086/301706; Stilgenbauer S, 1997, NAT MED, V3, P1155, DOI 10.1038/nm1097-1155; Stoppa-Lyonnet D, 1998, BLOOD, V91, P3920, DOI 10.1182/blood.V91.10.3920.3920_3920_3926; Sun YL, 2007, MOL CELL BIOL, V27, P8502, DOI 10.1128/MCB.01382-07; Taylor KH, 2006, MAMM GENOME, V17, P892, DOI 10.1007/s00335-005-0148-2; Toyoshima M, 1998, AM J MED GENET, V75, P141, DOI 10.1002/(SICI)1096-8628(19980113)75:2<141::AID-AJMG4>3.0.CO;2-W; Vorechovsky I, 1997, NAT GENET, V17, P96, DOI 10.1038/ng0997-96; Vorechovsky I, 1996, CANCER RES, V56, P2726; Walsh C., 2006, POSTTRANSLATIONAL MO; Watters D, 1997, ONCOGENE, V14, P1911, DOI 10.1038/sj.onc.1201037; Wei XU, 2011, [Frontiers in Biology, 生物学前沿], V6, P213; Xue Y, 2011, PROTEIN ENG DES SEL, V24, P255, DOI 10.1093/protein/gzq094; Yuan HY, 2006, NUCLEIC ACIDS RES, V34, pW635, DOI 10.1093/nar/gkl236; Yuille MAR, 1998, ONCOGENE, V16, P789, DOI 10.1038/sj.onc.1201603; Zhou FF, 2006, NAT PROTOC, V1, P1318, DOI 10.1038/nprot.2006.209	69	30	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e34573	10.1371/journal.pone.0034573	http://dx.doi.org/10.1371/journal.pone.0034573			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22529920	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341600044
J	Terzano, C; Di Stefano, F; Conti, V; Di Nicola, M; Paone, G; Petroianni, A; Ricci, A				Terzano, Claudio; Di Stefano, Fabio; Conti, Vittoria; Di Nicola, Marta; Paone, Gregorino; Petroianni, Angelo; Ricci, Alberto			Mixed Acid-Base Disorders, Hydroelectrolyte Imbalance and Lactate Production in Hypercapnic Respiratory Failure: The Role of Noninvasive Ventilation	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; METABOLIC ALKALOSIS; SEVERE SEPSIS; PRIMARY-CARE; HYPOVENTILATION; ACETAZOLAMIDE; FUROSEMIDE; CLEARANCE; MORTALITY; PRESSURE	Background: Hypercapnic Chronic Obstructive Pulmonary Disease (COPD) exacerbation in patients with comorbidities and multidrug therapy is complicated by mixed acid-base, hydro-electrolyte and lactate disorders. Aim of this study was to determine the relationships of these disorders with the requirement for and duration of noninvasive ventilation (NIV) when treating hypercapnic respiratory failure. Methods: Sixty-seven consecutive patients who were hospitalized for hypercapnic COPD exacerbation had their clinical condition, respiratory function, blood chemistry, arterial blood gases, blood lactate and volemic state assessed. Heart and respiratory rates, pH, PaO2 and PaCO2 and blood lactate were checked at the 1st, 2nd, 6th and 24th hours after starting NIV. Results: Nine patients were transferred to the intensive care unit. NIV was performed in 11/17 (64.7%) mixed respiratory acidosis-metabolic alkalosis, 10/36 (27.8%) respiratory acidosis and 3/5 (60%) mixed respiratory-metabolic acidosis patients (p = 0.026), with durations of 45.1 +/- 9.8, 36.2 +/- 8.9 and 53.3 +/- 4.1 hours, respectively (p = 0.016). The duration of ventilation was associated with higher blood lactate (p<0.001), lower pH (p = 0.016), lower serum sodium (p = 0.014) and lower chloride (p = 0.038). Hyponatremia without hypervolemic hypochloremia occurred in 11 respiratory acidosis patients. Hypovolemic hyponatremia with hypochloremia and hypokalemia occurred in 10 mixed respiratory acidosis-metabolic alkalosis patients, and euvolemic hypochloremia occurred in the other 7 patients with this mixed acid-base disorder. Conclusions: Mixed acid-base and lactate disorders during hypercapnic COPD exacerbations predict the need for and longer duration of NIV. The combination of mixed acid-base disorders and hydro-electrolyte disturbances should be further investigated.	[Terzano, Claudio; Di Stefano, Fabio; Conti, Vittoria; Paone, Gregorino; Petroianni, Angelo; Ricci, Alberto] Sapienza Univ Rome, Fondazione Eleonora Lorillard Spencer Cenci, Rome, Italy; [Di Nicola, Marta] Univ G Annunzio Chieti Pescara, Lab Biostat, Dept Biomed Sci, Chieti, Italy	Sapienza University Rome; G d'Annunzio University of Chieti-Pescara	Terzano, C (corresponding author), Sapienza Univ Rome, Fondazione Eleonora Lorillard Spencer Cenci, Rome, Italy.	vittoria_conti@hotmail.com	Conti, Vittoria/J-9229-2016	Conti, Vittoria/0000-0002-1940-2603; Ricci, Alberto/0000-0002-1718-1587; DI NICOLA, MARTA/0000-0003-1748-1931; TERZANO, CLAUDIO/0000-0002-9851-7731				Adrogue HJ, 2000, NEW ENGL J MED, V342, P1493, DOI 10.1056/NEJM200005183422006; Adrogue HJ, 2000, NEW ENGL J MED, V342, P1581, DOI 10.1056/NEJM200005253422107; [Anonymous], GLOB STRAT DIAGN MAN; Baudouin S, 2002, THORAX, V57, P192; Baudouin SV, 1997, THORAX, V52, P401, DOI 10.1136/thx.52.5.401; BEAR R, 1977, CAN MED ASSOC J, V117, P900; Bernardin G, 1996, INTENS CARE MED, V22, P17; Brijker F, 2002, CHEST, V121, P377, DOI 10.1378/chest.121.2.377; Brijker F, 2001, RESP PHYSIOL, V124, P151, DOI 10.1016/S0034-5687(00)00196-1; Confalonieri M, 2005, EUR RESPIR J, V25, P348, DOI 10.1183/09031936.05.00085304; COOPER CB, 1994, CHEST, V105, P335, DOI 10.1378/chest.105.2.335; de Leeuw PW, 2003, EUR RESPIR J, V22, p33S, DOI 10.1183/09031936.03.00000603a; DICKINSON GE, 1981, ANESTH ANALG, V60, P608; Dubin A, 2007, CRIT CARE MED, V35, P1264, DOI 10.1097/01.CCM.0000259536.11943.90; Foucher P, 1998, CHEST, V113, P1580, DOI 10.1378/chest.113.6.1580; Garpestad E, 2007, CHEST, V132, P711, DOI 10.1378/chest.06-2643; GUTIERREZ G, 1993, AM REV RESPIR DIS, V148, P1204, DOI 10.1164/ajrccm/148.5.1204; JAVAHERI S, 1981, RESP PHYSIOL, V45, P141, DOI 10.1016/0034-5687(81)90056-6; JAVAHERI S, 1982, CHEST, V81, P296, DOI 10.1378/chest.81.3.296; JAVAHERI S, 1987, AM REV RESPIR DIS, V136, P1011, DOI 10.1164/ajrccm/136.4.1011; Kaplan LJ, 2004, CRIT CARE MED, V32, P1120, DOI 10.1097/01.CCM.0000125517.28517.74; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; KRAMER N, 1995, AM J RESP CRIT CARE, V151, P1799, DOI 10.1164/ajrccm.151.6.7767523; KREISBERG RA, 1972, NEW ENGL J MED, V287, P132, DOI 10.1056/NEJM197207202870307; MIZOCK BA, 1992, CRIT CARE MED, V20, P80, DOI 10.1097/00003246-199201000-00020; Nguyen HB, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-6; Nguyen HB, 2004, CRIT CARE MED, V32, P1637, DOI 10.1097/01.CCM.0000132904.35713.A7; Plant PK, 2000, LANCET, V355, P1931, DOI 10.1016/S0140-6736(00)02323-0; POKORSKI M, 1982, J APPL PHYSIOL, V53, P75, DOI 10.1152/jappl.1982.53.1.75; Price SR, 2001, AM J KIDNEY DIS, V37, pS112, DOI 10.1053/ajkd.2001.20764; Roberts CM, 2011, THORAX, V66, P43, DOI 10.1136/thx.2010.153114; Scott S, 2010, CRIT CARE RES PRACT, V2010, DOI 10.1155/2010/917053; Stewart PA, 1981, UNDERSTAND ACID BASE, P1; STINEBAUGH BJ, 1967, ARCH INTERN MED, V119, P182, DOI 10.1001/archinte.119.2.182; TEASDALE G, 1974, LANCET, V2, P81; Terzano C, 2010, LUNG, V188, P321, DOI 10.1007/s00408-009-9222-y; Ucgun I, 2008, RESPIRATION, V76, P270, DOI 10.1159/000131707; Valenza F, 2005, CRIT CARE, V9, P588, DOI 10.1186/cc3818; van de Ven MJT, 2002, CHEST, V121, P383, DOI 10.1378/chest.121.2.383; Wooten EW, 2004, CRIT CARE, V8, P448, DOI 10.1186/cc2910	40	38	39	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35245	10.1371/journal.pone.0035245	http://dx.doi.org/10.1371/journal.pone.0035245			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22539963	Green Submitted, gold, Green Published			2022-12-27	WOS:000305341000027
J	Tian, C; Yu, HP; Yang, B; Han, FC; Zheng, Y; Bartels, CF; Schelling, D; Arnold, JE; Scacheri, PC; Zheng, QY				Tian, Cong; Yu, Heping; Yang, Bin; Han, Fengchan; Zheng, Ye; Bartels, Cynthia F.; Schelling, Deborah; Arnold, James E.; Scacheri, Peter C.; Zheng, Qing Yin			Otitis Media in a New Mouse Model for CHARGE Syndrome with a Deletion in the Chd7 Gene	PLOS ONE			English	Article							MIDDLE-EAR EPITHELIUM; IMMUNE-DEFICIENCY; INBRED STRAINS; DOWN-SYNDROME; MICE; MUTATIONS; EXPRESSION; DEFECTS; PROLIFERATION; ASSOCIATION	Otitis media is a middle ear disease common in children under three years old. Otitis media can occur in normal individuals with no other symptoms or syndromes, but it is often seen in individuals clinically diagnosed with genetic diseases such as CHARGE syndrome, a complex genetic disease caused by mutation in the Chd7 gene and characterized by multiple birth defects. Although otitis media is common in human CHARGE syndrome patients, it has not been reported in mouse models of CHARGE syndrome. In this study, we report a mouse model with a spontaneous deletion mutation in the Chd7 gene and with chronic otitis media of early onset age accompanied by hearing loss. These mice also exhibit morphological alteration in the Eustachian tubes, dysregulation of epithelial proliferation, and decreased density of middle ear cilia. Gene expression profiling revealed up-regulation of Muc5ac, Muc5b and Tgf-beta 1 transcripts, the products of which are involved in mucin production and TGF pathway regulation. This is the first mouse model of CHARGE syndrome reported to show otitis media with effusion and it will be valuable for studying the etiology of otitis media and other symptoms in CHARGE syndrome.	[Tian, Cong; Yu, Heping; Han, Fengchan; Zheng, Ye; Arnold, James E.; Zheng, Qing Yin] Case Western Reserve Univ, Sch Med, Univ Hosp Cleveland, Dept Otolaryngol Head & Neck Surg, Cleveland, OH 44106 USA; [Tian, Cong; Bartels, Cynthia F.; Schelling, Deborah; Scacheri, Peter C.; Zheng, Qing Yin] Case Western Reserve Univ, Sch Med, Dept Genet & Genome Sci, Cleveland, OH USA; [Zheng, Qing Yin] Case Comprehens Canc Ctr, Cleveland, OH USA; [Tian, Cong; Yu, Heping; Yang, Bin; Han, Fengchan; Zheng, Qing Yin] Binzhou Med Univ, Transformat Otol & Neurosci Ctr, Yantai, Shandong Provin, Peoples R China	Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Case Western Reserve University; Case Western Reserve University; Binzhou Medical University	Tian, C (corresponding author), Case Western Reserve Univ, Sch Med, Univ Hosp Cleveland, Dept Otolaryngol Head & Neck Surg, Cleveland, OH 44106 USA.	qing.zheng@case.edu	Zheng, Qing/C-1731-2012; Tian, Cong/E-6300-2012; Tian, Cong/D-4921-2011	Tian, Cong/0000-0002-5645-6600	National Institute of Child Health and Development [R01HD056369]; National Human Genome Research Institute [R01HG004722]; National Institute on Deafness and Other Communication Disorders [R01DC009246, R01DC007392, R21DC005846]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD056369] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004722] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC005846, R01DC009246, R01DC007392] Funding Source: NIH RePORTER	National Institute of Child Health and Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the National Institute of Child Health and Development (R01HD056369 to PCS), the National Human Genome Research Institute (R01HG004722 to PCS) and the National Institute on Deafness and Other Communication Disorders (R01DC009246, R01DC007392, R21DC005846 and Taishan Scholar to QYZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aramaki M, 2007, BIRTH DEFECTS RES A, V79, P50, DOI 10.1002/bdra.20330; Bajpai R, 2010, NATURE, V463, P958, DOI 10.1038/nature08733; Bergman JEH, 2010, EUR J HUM GENET, V18, P171, DOI 10.1038/ejhg.2009.158; Borkowski G, 2000, LARYNGO RHINO OTOL, V79, P135; Bosman EA, 2005, HUM MOL GENET, V14, P3463, DOI 10.1093/hmg/ddi375; BUFFONE GJ, 1985, CLIN CHEM, V31, P164; Chopra C, 2009, ACTA PAEDIATR, V98, P408, DOI 10.1111/j.1651-2227.2008.01077.x; Depreux FFS, 2008, J CLIN INVEST, V118, P651, DOI 10.1172/JCI32899; Furukawa M, 2007, INFECT IMMUN, V75, P2562, DOI 10.1128/IAI.01656-06; Gennery AR, 2008, CLIN EXP IMMUNOL, V153, P75, DOI 10.1111/j.1365-2249.2008.03681.x; Han F, 2010, PHARMACOGENOMICS J; Han FC, 2009, INT J EXP PATHOL, V90, P480, DOI 10.1111/j.1365-2613.2009.00677.x; Han FC, 2009, INFECT IMMUN, V77, P3100, DOI 10.1128/IAI.00204-09; Hardisty RE, 2003, JARO-J ASSOC RES OTO, V4, P130, DOI 10.1007/s10162-002-3015-9; Hardisty-Hughes RE, 2006, HUM MOL GENET, V15, P3273, DOI 10.1093/hmg/ddl403; Hoorens PR, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-140; Hoover-Fong J, 2009, J PEDIATR-US, V154, P140, DOI 10.1016/j.jpeds.2008.07.049; Hurd EA, 2007, MAMM GENOME, V18, P94, DOI 10.1007/s00335-006-0107-6; Hurd EA, 2011, HEARING RES, V282, P184, DOI 10.1016/j.heares.2011.08.005; Kaur R, 2010, PEDIATR INFECT DIS J, V29, P741, DOI 10.1097/INF.0b013e3181d9e639; Kerschner JE, 2010, ARCH OTOLARYNGOL, V136, P819, DOI 10.1001/archoto.2010.123; Kerschner JE, 2010, INT J PEDIATR OTORHI, V74, P864, DOI 10.1016/j.ijporl.2010.04.014; Lalani SR, 2006, AM J HUM GENET, V78, P303, DOI 10.1086/500273; Layman WS, 2009, HUM MOL GENET, V18, P1909, DOI 10.1093/hmg/ddp112; MacArthur CJ, 2006, LARYNGOSCOPE, V116, P1071, DOI 10.1097/01.mlg.0000224527.41288.c4; Mao M, 2009, MAMM GENOME, V20, P462, DOI 10.1007/s00335-009-9210-9; PAGON RA, 1981, J PEDIATR-US, V99, P223, DOI 10.1016/S0022-3476(81)80454-4; Parkinson N, 2006, PLOS GENET, V2, P1556, DOI 10.1371/journal.pgen.0020149; Preciado D, 2010, PEDIATR RES, V68, P231, DOI 10.1203/00006450-201011001-00451; Qin Z, 2009, HEARING RES, V263, P93; Randall V, 2009, J CLIN INVEST, V119, P3301, DOI 10.1172/JCI37561; Richtsmeier JT, 2000, DEV DYNAM, V217, P137, DOI 10.1002/(SICI)1097-0177(200002)217:2<137::AID-DVDY1>3.0.CO;2-N; Roomans GM, 2006, UPSALA J MED SCI, V111, P155, DOI 10.3109/2000-1967-010; Rousseau K, 2007, AM J PHYSIOL-LUNG C, V292, pL1396, DOI 10.1152/ajplung.00444.2006; Schnetz MP, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001023; Schnetz MP, 2009, GENOME RES, V19, P590, DOI 10.1101/gr.086983.108; Seibert JW, 2006, OTOLARYNG CLIN N AM, V39, P1221, DOI 10.1016/j.otc.2006.08.011; SELBY PB, 1987, STAIN TECHNOL, V62, P143, DOI 10.3109/10520298709107984; Tateossian Hilda, 2009, Pathogenetics, V2, P5, DOI 10.1186/1755-8417-2-5; Theodoropoulos DS, 2003, PEDIATRICS, V111, P711, DOI 10.1542/peds.111.3.711-a; Trune DR, 2009, BRAIN RES, V1277, P90, DOI 10.1016/j.brainres.2009.02.047; Vernacchio L, 2004, INT J PEDIATR OTORHI, V68, P795, DOI 10.1016/j.ijporl.2004.01.012; Vissers LELM, 2004, NAT GENET, V36, P955, DOI 10.1038/ng1407; Zentner GE, 2010, HUM MOL GENET, V19, P3491, DOI 10.1093/hmg/ddq265; Zentner GE, 2010, AM J MED GENET A, V152A, P674, DOI 10.1002/ajmg.a.33323; Zhao SQ, 2009, CHINESE MED J-PEKING, V122, P2149, DOI 10.3760/cma.j.issn.0366-6999.2009.18.014; Zheng QY, 2007, HEARING RES, V231, P23, DOI 10.1016/j.heares.2007.05.011; Zheng QY, 2006, BRAIN RES, V1091, P9, DOI 10.1016/j.brainres.2006.01.046; Zheng QY, 1999, HEARING RES, V130, P94, DOI 10.1016/S0378-5955(99)00003-9	49	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e34944	10.1371/journal.pone.0034944	http://dx.doi.org/10.1371/journal.pone.0034944			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22539951	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341000014
J	Biasutti, M; Dufour, N; Ferroud, C; Dab, W; Temime, L				Biasutti, Maria; Dufour, Natacha; Ferroud, Clotilde; Dab, William; Temime, Laura			Cost-Effectiveness of Magnetic Resonance Imaging with a New Contrast Agent for the Early Diagnosis of Alzheimer's Disease	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; AMYLOID DEPOSITION; DECISION-ANALYSIS; MEMORY LOSS; MODERATE; DONEPEZIL; DEMENTIA; FRANCE; MODEL; APOE	Background: Used as contrast agents for brain magnetic resonance imaging (MRI), markers for beta-amyloid deposits might allow early diagnosis of Alzheimer's disease (AD). We evaluated the cost-effectiveness of such a diagnostic test, MRI+CLP (contrastophore-linker-pharmacophore), should it become clinically available. Methodology/Principal Findings: We compared the cost-effectiveness of MRI+CLP to that of standard diagnosis using currently available cognition tests and of standard MRI, and investigated the impact of a hypothetical treatment efficient in early AD. The primary analysis was based on the current French context for 70-year-old patients with Mild Cognitive Impairment (MCI). In alternative "screen and treat" scenarios, we analyzed the consequences of systematic screenings of over-60 individuals (either population-wide or restricted to the ApoE4 genotype population). We used a Markov model of AD progression; model parameters, as well as incurred costs and quality-of-life weights in France were taken from the literature. We performed univariate and probabilistic multivariate sensitivity analyses. The base-case preferred strategy was the standard MRI diagnosis strategy. In the primary analysis however, MRI+CLP could become the preferred strategy under a wide array of scenarios involving lower cost and/or higher sensitivity or specificity. By contrast, in the "screen and treat" analyses, the probability of MRI+CLP becoming the preferred strategy remained lower than 5%. Conclusions/Significance: It is thought that anti-beta-amyloid compounds might halt the development of dementia in early stage patients. This study suggests that, even should such treatments become available, systematically screening the over-60 population for AD would only become cost-effective with highly specific tests able to diagnose early stages of the disease. However, offering a new diagnostic test based on beta-amyloid markers to elderly patients with MCI might prove cost-effective.	[Biasutti, Maria; Dufour, Natacha; Dab, William; Temime, Laura] Conservatoire Natl Arts & Metiers, Lab Modelisat & Surveillance Risques Sanit, F-75003 Paris, France; [Biasutti, Maria; Dufour, Natacha] Ecole Ponts ParisTech, F-77700 Marne La Vallee, France; [Ferroud, Clotilde] Conservatoire Natl Arts & Metiers, Lab Transformat Chim & Pharmaceut, F-75003 Paris, France	heSam Universite; Conservatoire National Arts & Metiers (CNAM); Ecole des Ponts ParisTech; heSam Universite; Conservatoire National Arts & Metiers (CNAM)	Temime, L (corresponding author), Conservatoire Natl Arts & Metiers, Lab Modelisat & Surveillance Risques Sanit, F-75003 Paris, France.	laura.temime@cnam.fr	Temime, Laura/G-7010-2011	Temime, Laura/0000-0002-8850-5403	Cnam	Cnam	This research was financed by a grant from the Cnam, a public higher education establishment by which all authors were employed at the time. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], DICT VIDAL; Atri A, 2008, ALZ DIS ASSOC DIS, V22, P209, DOI 10.1097/WAD.0b013e31816653bc; Ballard C, 2011, LANCET, V377, P1019, DOI 10.1016/S0140-6736(10)61349-9; Blum-Boisgard C, 2007, MEDICAMENTS SPECIFIQ, P1; Bowen J, 1997, LANCET, V349, P763, DOI 10.1016/S0140-6736(96)08256-6; Caselli RJ, 2010, NEUROSCI LETT, V473, P168, DOI 10.1016/j.neulet.2010.02.016; Cohen JT, 2008, ALZHEIMERS DEMENT, V4, P212, DOI 10.1016/j.jalz.2008.02.003; Commenges D, 2004, STAT MED, V23, P199, DOI 10.1002/sim.1709; Drago V, 2011, J ALZHEIMERS DIS, V26, P159, DOI 10.3233/JAD-2011-0043; Edjerer TT, 2003, WHO GUIDE COST EFFEC; Elliott AF, 2010, J AM GERIATR SOC, V58, P30, DOI 10.1111/j.1532-5415.2009.02631.x; Fagnani F, 2004, DEMENT GERIATR COGN, V17, P5, DOI 10.1159/000074079; Faissol DM, 2009, MATH BIOSCI, V220, P143, DOI 10.1016/j.mbs.2009.05.005; Feldman H, 2004, NEUROLOGY, V63, P644, DOI 10.1212/01.WNL.0000134663.79663.6E; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Forlenza OV, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-89; Forsberg A, 2008, NEUROBIOL AGING, V29, P1456, DOI 10.1016/j.neurobiolaging.2007.03.029; France Benevolat, 2010, SIT BEN FRANC 2010; FRYBACK DG, 1993, MED DECIS MAKING, V13, P89, DOI 10.1177/0272989X9301300202; Furiak NM, 2010, BMC MED INFORM DECIS, V10, DOI 10.1186/1472-6947-10-24; Gagnon M, 2007, CAN J PSYCHIAT, V52, P519, DOI 10.1177/070674370705200810; Genin E, 2011, MOL PSYCHIATR, V16, P903, DOI 10.1038/mp.2011.52; Hampel Harald, 2009, Dialogues Clin Neurosci, V11, P141; Hansson O, 2006, LANCET NEUROL, V5, P228, DOI 10.1016/S1474-4422(06)70355-6; Harris GJ, 1998, AM J NEURORADIOL, V19, P1727; Helmer C, 2006, M S-MED SCI, V22, P288, DOI 10.1051/medsci/2006223288; Himes C L, 2000, J Cross Cult Gerontol, V15, P99, DOI 10.1023/A:1006797731500; INED, 2008, AG SEX SPEC MORT RAT; Katz MJ, 2011, ALZHEIMER DIS ASS DI; Kulasingam SL, 2003, VALUE HEALTH, V6, P542, DOI 10.1046/j.1524-4733.2003.65248.x; Lejeune C, 2005, J NUCL MED, V46, P2020; Marbot C, 2008, TRAVAILLER PARTICULI; Mauskopf J, 2011, AM J ALZHEIMERS DIS, V26, P298, DOI 10.1177/1533317511407481; McKhann GM, 2011, JAMA-J AM MED ASSOC, V305, P2458, DOI 10.1001/jama.2011.810; McMahon PM, 2000, RADIOLOGY, V217, P58, DOI 10.1148/radiology.217.1.r00se1358; McMahon PM, 2003, RADIOLOGY, V228, P515, DOI 10.1148/radiol.2282020915; McShane R, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003154.pub5; Mebane-Sims I, 2009, ALZHEIMERS DEMENT, V5, P234, DOI 10.1016/j.jalz.2009.03.001; Moatti JP, 2003, B CANCER, V90, P1010; Mormino EC, 2009, BRAIN, V132, P1310, DOI 10.1093/brain/awn320; Neumann PJ, 1999, NEUROLOGY, V52, P1138, DOI 10.1212/WNL.52.6.1138; Reese JP, 2011, J ALZHEIMERS DIS; Reimat A, 2002, INNOVATIONS, V15, P73; Reisberg B, 2003, NEW ENGL J MED, V348, P1333, DOI 10.1056/NEJMoa013128; Rigaud AS, 2003, J GERIATR PSYCH NEUR, V16, P140, DOI 10.1177/0891988703252558; Rogers SL, 1998, NEUROLOGY, V50, P136, DOI 10.1212/WNL.50.1.136; Sante Mdl, 2009, TAR CONV CONS MED SP; Sante Mdl, 2009, NOM ACT BIOL MED; Sante Mdl, 2009, CLASS COMM ACT MED; SCHACHTER F, 1994, NAT GENET, V6, P29, DOI 10.1038/ng0194-29; TreeAge Software I, 2009, TREEAGE PROH; Villemagne VL, 2008, NEUROPSYCHOLOGIA, V46, P1688, DOI 10.1016/j.neuropsychologia.2008.02.008; Weiner MW, 2010, ALZHEIMERS DEMENT, V6, P202, DOI 10.1016/j.jalz.2010.03.007; Winblad B, 2001, NEUROLOGY, V57, P489, DOI 10.1212/WNL.57.3.489; Wolk DA, 2009, ANN NEUROL, V65, P557, DOI 10.1002/ana.21598	55	20	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35559	10.1371/journal.pone.0035559	http://dx.doi.org/10.1371/journal.pone.0035559			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22532859	gold, Green Published, Green Submitted			2022-12-27	WOS:000305339200079
J	Ichikawa, S; Miyake, M; Fujii, R; Konishi, Y				Ichikawa, Shintaro; Miyake, Mika; Fujii, Rei; Konishi, Yutaka			MyD88 Associated ROS Generation Is Crucial for Lactobacillus Induced IL-12 Production in Macrophage	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; TOLL-LIKE RECEPTORS; IMMUNOGLOBULIN-E PRODUCTION; INNATE IMMUNITY; NADPH-OXIDASE; DENDRITIC CELLS; DOWN-REGULATION; CUTTING EDGE; MICE; KINASE	It is well known that some strains of lactic acid bacteria (LAB) can induce IL-12 which plays an important role in modulating immune responses. However, the mechanisms by which LAB induce IL-12 production remain unclear. Here, we examine the role of toll-like receptors (TLR's) and reactive oxygen species (ROS) in IL-12 production by LAB stimulated peritoneal macrophages. Our results indicate that a TLR is not necessary for IL-12 induction by LAB, whilst the universal adaptor protein, MyD88, is essential. Specific strains of LAB induced ROS that correlated with both the frequency of phagocytosis and IL-12 production. Reduction in IL-12 production by NADPH oxidase inhibitors or ROS scavengers demonstrates the crucial role of ROS in IL-12 induction. Interestingly, deficiency of TLR2, 4, 9 or MyD88 did not affect the phagocytosis of LAB strain KW3110, a potent IL-12 inducer, and ROS production was significantly reduced only in MyD88 deficient macrophages. These results suggest the existence of TLR-MyD88 independent LAB recognition and MyD88 related ROS induction mechanisms. We show here the importance of ROS for IL-12 induction and provide new insights into IL-12 induction by LAB.	[Ichikawa, Shintaro; Miyake, Mika; Fujii, Rei; Konishi, Yutaka] Kirin Holdings Co Ltd, Cent Labs Frontier Technol, Yokohama, Kanagawa, Japan	Kirin Holdings Co Ltd	Ichikawa, S (corresponding author), Kirin Holdings Co Ltd, Cent Labs Frontier Technol, Yokohama, Kanagawa, Japan.	Shintaro_Ichikawa@kirin.co.jp						Ahrne S, 1998, J APPL MICROBIOL, V85, P88; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Aramaki Y, 2002, BIOL PHARM BULL, V25, P351, DOI 10.1248/bpb.25.351; Bafica A, 2005, J EXP MED, V202, P1715, DOI 10.1084/jem.20051782; Christensen HR, 2002, J IMMUNOL, V168, P171, DOI 10.4049/jimmunol.168.1.171; DeLeo FR, 1999, J IMMUNOL, V163, P6732; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Edelson BT, 2002, J IMMUNOL, V169, P3869, DOI 10.4049/jimmunol.169.7.3869; EZEKOWITZ RAB, 1990, J EXP MED, V172, P1785, DOI 10.1084/jem.172.6.1785; Feng CG, 2003, J IMMUNOL, V171, P4758, DOI 10.4049/jimmunol.171.9.4758; Fujiwara D, 2004, INT ARCH ALLERGY IMM, V135, P205, DOI 10.1159/000081305; Guarner F, 1998, INT J FOOD MICROBIOL, V39, P237, DOI 10.1016/S0168-1605(97)00136-0; Hatao F, 2004, J LEUKOCYTE BIOL, V76, P904, DOI 10.1189/jlb.0504277; Hemmi H, 2003, J IMMUNOL, V170, P3059, DOI 10.4049/jimmunol.170.6.3059; Hou L, 2000, INFECT IMMUN, V68, P4681, DOI 10.1128/IAI.68.8.4681-4687.2000; Hsieh CC, 2006, FASEB J, V20, P259, DOI 10.1096/fj.05-4376com; Huang LY, 1999, INFECT IMMUN, V67, P6257; Ichikawa S, 2007, BIOSCI BIOTECH BIOCH, V71, P3026, DOI 10.1271/bbb.70414; Ichikawa S, 2009, BIOSCI BIOTECH BIOCH, V73, P1561, DOI 10.1271/bbb.90058; Kalliomaki MA, 2004, IMMUNOL ALLERGY CLIN, V24, P739, DOI 10.1016/j.iac.2004.06.006; Kato Y, 2000, INT J SYST EVOL MICR, V50, P1143, DOI 10.1099/00207713-50-3-1143; KIPS JC, 1995, INT ARCH ALLERGY IMM, V107, P115, DOI 10.1159/000236947; Laroux FS, 2005, J IMMUNOL, V175, P5596, DOI 10.4049/jimmunol.175.9.5596; Lekstrom-Himes JA, 2000, NEW ENGL J MED, V343, P1703, DOI 10.1056/NEJM200012073432307; Lu HT, 1999, EMBO J, V18, P1845, DOI 10.1093/emboj/18.7.1845; Matsuzaki T, 1998, J DAIRY SCI, V81, P48, DOI 10.3168/jds.S0022-0302(98)75549-3; Matsuzawa A, 2005, NAT IMMUNOL, V6, P587, DOI 10.1038/ni1200; Mazzeo D, 2002, CYTOKINE, V17, P285, DOI 10.1006/cyto.2002.1014; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; MONTALTO, 2002, ANN ITAL MED INT, V17, P157; Morita H, 2006, MICROBIOL IMMUNOL, V50, P701, DOI 10.1111/j.1348-0421.2006.tb03842.x; Murata Y, 2002, INT IMMUNOL, V14, P201, DOI 10.1093/intimm/14.2.201; Okusawa T, 2004, INFECT IMMUN, V72, P1657, DOI 10.1128/IAI.72.3.1657-1665.2004; Perdigon G, 2001, Curr Issues Intest Microbiol, V2, P27; Perera PY, 2001, J IMMUNOL, V166, P574, DOI 10.4049/jimmunol.166.1.574; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; ROSS GD, 1992, J LEUKOCYTE BIOL, V51, P109, DOI 10.1002/jlb.51.2.109; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Salminen S, 1998, BRIT J NUTR, V80, pS147, DOI 10.1079/BJN19980108; Scanga CA, 2002, J IMMUNOL, V168, P5997, DOI 10.4049/jimmunol.168.12.5997; Su SB, 2005, J IMMUNOL, V175, P6303, DOI 10.4049/jimmunol.175.10.6303; Sun J, 2005, WORLD J GASTROENTERO, V11, P6330, DOI 10.3748/wjg.v11.i40.6330; Takahashi N, 2006, FEMS IMMUNOL MED MIC, V46, P461, DOI 10.1111/j.1574-695X.2006.00064.x; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; TRINCHIERI G, 1994, BLOOD, V84, P4008, DOI 10.1182/blood.V84.12.4008.bloodjournal84124008; Underhill DM, 2002, ANNU REV IMMUNOL, V20, P825, DOI 10.1146/annurev.immunol.20.103001.114744; Utsugi M, 2002, J LEUKOCYTE BIOL, V71, P339; VanderVen BC, 2009, TRAFFIC, V10, P372, DOI [10.1111/j.1600-0854.2008.00877.x, 10.1111/j.1600-0854.2009.00877.x]; Vieira LQ, 2008, J CLIN GASTROENTEROL, V42, pS168, DOI 10.1097/MCG.0b013e31818063d4; Wakabayashi H, 2008, INT ARCH ALLERGY IMM, V145, P141, DOI 10.1159/000108139; West AP, 2011, NATURE, V472, P476, DOI 10.1038/nature09973; Xiao JZ, 2006, CLIN EXP ALLERGY, V36, P1425, DOI 10.1111/j.1365-2222.2006.02575.x; Yamin TT, 1997, J BIOL CHEM, V272, P21540, DOI 10.1074/jbc.272.34.21540	53	23	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35880	10.1371/journal.pone.0035880	http://dx.doi.org/10.1371/journal.pone.0035880			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536449	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339200122
J	Fita, A; Bowen, HC; Hayden, RM; Nuez, F; Pico, B; Hammond, JP				Fita, Ana; Bowen, Helen C.; Hayden, Rory M.; Nuez, Fernando; Pico, Belen; Hammond, John P.			Diversity in Expression of Phosphorus (P) Responsive Genes in Cucumis melo L.	PLOS ONE			English	Article							TRANSCRIPTOMIC ANALYSIS; PLASMA-MEMBRANE; PHOSPHATE STARVATION; ACID-PHOSPHATASES; METABOLIC-CHANGES; ROOT RESPONSES; WHITE LUPIN; ARABIDOPSIS; IDENTIFICATION; REVEALS	Background: Phosphorus (P) is a major limiting nutrient for plant growth in many soils. Studies in model species have identified genes involved in plant adaptations to low soil P availability. However, little information is available on the genetic bases of these adaptations in vegetable crops. In this respect, sequence data for melon now makes it possible to identify melon orthologues of candidate P responsive genes, and the expression of these genes can be used to explain the diversity in the root system adaptation to low P availability, recently observed in this species. Methodology and Findings: Transcriptional responses to P starvation were studied in nine diverse melon accessions by comparing the expression of eight candidate genes (Cm-PAP10.1, Cm-PAP10.2, Cm-RNS1, Cm-PPCK1, Cm-transferase, Cm-SQD1, Cm-DGD1 and Cm-SPX2) under P replete and P starved conditions. Differences among melon accessions were observed in response to P starvation, including differences in plant morphology, P uptake, P use efficiency (PUE) and gene expression. All studied genes were up regulated under P starvation conditions. Differences in the expression of genes involved in P mobilization and remobilization (Cm-PAP10.1, Cm-PAP10.2 and Cm-RNS1) under P starvation conditions explained part of the differences in P uptake and PUE among melon accessions. The levels of expression of the other studied genes were diverse among melon accessions, but contributed less to the phenotypical response of the accessions. Conclusions: This is the first time that these genes have been described in the context of P starvation responses in melon. There exists significant diversity in gene expression levels and P use efficiency among melon accessions as well as significant correlations between gene expression levels and phenotypical measurements.	[Fita, Ana; Nuez, Fernando; Pico, Belen] Univ Politecn Valencia, Ctr Conservac & Mejora Agrodiversidad Valenciana, E-46071 Valencia, Spain; [Bowen, Helen C.; Hayden, Rory M.; Hammond, John P.] Univ Warwick, Warwick HRI, Warwick, England	Universitat Politecnica de Valencia; University of Warwick	Fita, A (corresponding author), Univ Politecn Valencia, Ctr Conservac & Mejora Agrodiversidad Valenciana, E-46071 Valencia, Spain.	anfifer@btc.upv.es	PICO, BELEN/K-6517-2014; Hammond, John P/A-1876-2012; Fita, ANA/K-4250-2017	PICO, BELEN/0000-0001-7761-990X; Hammond, John P/0000-0002-6241-3551; FITA, ANA/0000-0002-8637-5852	programs of foreign mobility "Jose Castillejo" [JC2009-00147]; Universitat Politecnica de Valencia [PAID-00-10]; United Kingdom (UK) Department for the Environment, Food and Rural Affairs [WQ0119]	programs of foreign mobility "Jose Castillejo"; Universitat Politecnica de Valencia; United Kingdom (UK) Department for the Environment, Food and Rural Affairs	This work was supported by the programs of foreign mobility "Jose Castillejo" [JC2009-00147], Universitat Politecnica de Valencia Professor Mobility Program of the Universitat Politecnica de Valencia [PAID-00-10] and United Kingdom (UK) Department for the Environment, Food and Rural Affairs grant [WQ0119]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson MX, 2005, J BIOL CHEM, V280, P27578, DOI 10.1074/jbc.M503273200; Andersson MX, 2003, FEBS LETT, V537, P128, DOI 10.1016/S0014-5793(03)00109-1; BARIOLA PA, 1994, PLANT J, V6, P673, DOI 10.1046/j.1365-313X.1994.6050673.x; Calderon-Vazquez C, 2008, J EXP BOT, V59, P2479, DOI 10.1093/jxb/ern115; Chen ZH, 2007, BIOCHEM J, V405, P191, DOI 10.1042/BJ20070102; Cordell D, 2009, GLOBAL ENVIRON CHANG, V19, P292, DOI 10.1016/j.gloenvcha.2008.10.009; Ding GD, 2011, EUPHYTICA, V181, P305, DOI 10.1007/s10681-011-0428-8; Duan K, 2008, PLANT J, V54, P965, DOI 10.1111/j.1365-313X.2008.03460.x; DUFF SMG, 1994, PHYSIOL PLANTARUM, V90, P791, DOI 10.1111/j.1399-3054.1994.tb02539.x; Essigmann B, 1998, P NATL ACAD SCI USA, V95, P1950, DOI 10.1073/pnas.95.4.1950; Fang ZY, 2009, PLANT SCI, V176, P170, DOI 10.1016/j.plantsci.2008.09.007; Fita A, 2011, EUPHYTICA, P1; Fita A, 2008, J AM SOC HORTIC SCI, V133, P448, DOI 10.21273/JASHS.133.3.448; Fita A, 2006, J AM SOC HORTIC SCI, V131, P372, DOI 10.21273/JASHS.131.3.372; Gonzalez VM, 2010, BMC GENOMICS, V11; Gonzalez-Ibeas D, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-306; Graham MA, 2006, FUNCT PLANT BIOL, V33, P789, DOI 10.1071/FP06101; Hamburger D, 2002, PLANT CELL, V14, P889, DOI 10.1105/tpc.000745; Hammond JP, 2008, J EXP BOT, V59, P93, DOI 10.1093/jxb/erm221; Hammond JP, 2011, PLANT PHYSIOL, V156, P1230, DOI 10.1104/pp.111.175612; Hammond JP, 2011, PLANT PHYSIOL, V156, P1033, DOI 10.1104/pp.111.175380; Hammond JP, 2009, J EXP BOT, V60, P1953, DOI 10.1093/jxb/erp083; Hammond JP, 2004, ANN BOT-LONDON, V94, P323, DOI 10.1093/aob/mch156; Hammond JP, 2003, PLANT PHYSIOL, V132, P578, DOI 10.1104/pp.103.020941; Heffer P., 2006, PHOSPHORUS FERTILISA; Hernandez G, 2007, PLANT PHYSIOL, V144, P752, DOI 10.1104/pp.107.096958; Hernandez G, 2009, PLANT PHYSIOL, V151, P1221, DOI 10.1104/pp.109.143842; International Cucurbit Genomics Initiative (ICuGI), 2007, CUC GEN DAT; Li LH, 2010, CHINESE SCI BULL, V55, P251, DOI 10.1007/s11434-010-0012-y; Lynch JP, 2007, AUST J BOT, V55, P493, DOI 10.1071/BT06118; Lynch JP, 2011, PLANT PHYSIOL, V156, P1041, DOI 10.1104/pp.111.175414; Blanca JM, 2011, PLANT GENOME-US, V4, P118, DOI 10.3835/plantgenome2011.01.0003; Misson J, 2005, P NATL ACAD SCI USA, V102, P11934, DOI 10.1073/pnas.0505266102; Morcuende R, 2007, PLANT CELL ENVIRON, V30, P85, DOI 10.1111/j.1365-3040.2006.01608.x; Muller R, 2007, PLANT PHYSIOL, V143, P156, DOI 10.1104/pp.106.090167; Munger H.M., 1991, CUCURBIT GENETICS CO, V14, P43; Nagata T, 2003, J AGR FOOD CHEM, V51, P2992, DOI 10.1021/jf026179+; Pitrat Michel, 2008, V1, P283; Plaxton WC, 2011, PLANT PHYSIOL, V156, P1006, DOI 10.1104/pp.111.175281; Raven John A., 2008, V7, P271; Tiessen Holm, 2008, V7, P1; Tjellstrom H, 2008, CHEM PHYS LIPIDS, V154, pS30, DOI 10.1016/j.chemphyslip.2008.05.083; Uhde-Stone C, 2003, PLANT PHYSIOL, V131, P1064, DOI 10.1104/pp.102.016881; Uhde-Stone C, 2003, PLANT SOIL, V248, P99, DOI 10.1023/A:1022335519879; Vance CP, 2003, NEW PHYTOL, V157, P423, DOI 10.1046/j.1469-8137.2003.00695.x; Wang Y, 2004, PLANT PHYSIOL, V135, P400, DOI 10.1104/pp.103.037945; Wasaki J, 2003, PLANT CELL ENVIRON, V26, P1515, DOI 10.1046/j.1365-3040.2003.01074.x; Wasaki J, 2006, J EXP BOT, V57, P2049, DOI 10.1093/jxb/erj158; White PJ, 2009, J ENVIRON QUAL, V38, P13, DOI 10.2134/jeq2007.0658; Wu P, 2003, PLANT PHYSIOL, V132, P1260, DOI 10.1104/pp.103.021022; Zhang Q, 2011, PLANT BIOLOGY, V13, P7, DOI 10.1111/j.1438-8677.2010.00346.x; Zheng LQ, 2009, PLANT PHYSIOL, V151, P262, DOI 10.1104/pp.109.141051	52	11	11	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e35387	10.1371/journal.pone.0035387	http://dx.doi.org/10.1371/journal.pone.0035387			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22536378	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000305336200037
J	Grzywnowicz, M; Zaleska, J; Mertens, D; Tomczak, W; Wlasiuk, P; Kosior, K; Piechnik, A; Bojarska-Junak, A; Dmoszynska, A; Giannopoulos, K				Grzywnowicz, Maciej; Zaleska, Joanna; Mertens, Daniel; Tomczak, Waldemar; Wlasiuk, Paulina; Kosior, Kamila; Piechnik, Agnieszka; Bojarska-Junak, Agnieszka; Dmoszynska, Anna; Giannopoulos, Krzysztof			Programmed Death-1 and Its Ligand Are Novel Immunotolerant Molecules Expressed on Leukemic B Cells in Chronic Lymphocytic Leukemia	PLOS ONE			English	Article							HUMAN PD-1 GENE; CD4(+) T-CELLS; FOLLICULAR LYMPHOMA; HODGKIN-LYMPHOMA; TUMOR-CELLS; ACTIVATION; BLOCKADE; RECEPTOR; B7-H1; IMMUNITY	Programmed death-1 (PD-1) is an immunoreceptor predominantly expressed on exhausted T cells, which through an interaction with its ligand (PD-L1), controls peripheral tolerance by limiting effector functions of T lymphocytes. qRT-PCR for PD-1, PD-L1 and their splicing forms as well as flow cytometric assessment of surface expression was performed in a cohort of 58 chronic lymphocytic leukemia (CLL) patients. In functional studies, we assessed the influence of the proliferative response of leukemic B-cells induced by IL-4 and CD40L on PD-1 transcripts and expression on the protein level. The median level of PD-1, but not PD-L1, transcripts in CLL patients was higher in comparison to healthy volunteers (HVs, n = 43, p = 0.0057). We confirmed the presence of PD-1 and PD-L1 on the CLL cell surface, and found the expression of PD-1, but not PD-L1, to be higher among CLL patients in comparison to HVs (47.2% vs. 14.8%, p<0.0001). The Kaplan-Meier curves for the time to progression and overall survival in groups with high and low surface expression of PD-1 and PD-L1 revealed no prognostic value in CLL patients. After stimulation with IL-4 and CD40L, protein expression of PD-1 was significantly increased in samples that responded and up-regulated CD38. PD-1, which is aberrantly expressed both at mRNA and cell surface levels in CLL cells might represent a novel immunotolerant molecule involved in the pathomechanism of the disease, and could provide a novel target for future therapies.	[Grzywnowicz, Maciej; Zaleska, Joanna; Wlasiuk, Paulina; Piechnik, Agnieszka; Giannopoulos, Krzysztof] Med Univ Lublin, Dept Expt Hematooncol, Lublin, Poland; [Mertens, Daniel; Giannopoulos, Krzysztof] Univ Ulm, Dept Internal Med 3, D-7900 Ulm, Germany; [Mertens, Daniel] German Canc Res Ctr, Cooperat Unit Mech Leukemogenesis, D-6900 Heidelberg, Germany; [Tomczak, Waldemar; Kosior, Kamila; Dmoszynska, Anna; Giannopoulos, Krzysztof] Med Univ Lublin, Dept Hematooncol, Lublin, Poland; [Tomczak, Waldemar; Kosior, Kamila; Giannopoulos, Krzysztof] Med Univ Lublin, Bone Marrow Transplantat Unit, Lublin, Poland; [Bojarska-Junak, Agnieszka] Med Univ Lublin, Dept Clin Immunol, Lublin, Poland	Medical University of Lublin; Ulm University; Helmholtz Association; German Cancer Research Center (DKFZ); Medical University of Lublin; Medical University of Lublin; Medical University of Lublin	Grzywnowicz, M (corresponding author), Med Univ Lublin, Dept Expt Hematooncol, Lublin, Poland.	giannop@tlen.pl	Mertens, Daniel/F-4681-2011; Bojarska-Junak, Agnieszka/AAK-3714-2021	Mertens, Daniel/0000-0003-0227-7188; Bojarska-Junak, Agnieszka/0000-0003-2340-9442; Wlasiuk, Paulina/0000-0001-6738-5513; Karczmarczyk, Agnieszka/0000-0002-0178-4746; Zaleska, Joanna/0000-0002-4417-7831; Tomczak, Waldemar/0000-0002-3205-5781; Giannopoulos, Krzysztof/0000-0003-0135-4030	Polish Foundation for Science (FNP FOCUS) [01/08]	Polish Foundation for Science (FNP FOCUS)	This work was supported by grants from the Polish Foundation for Science (FNP FOCUS 01/08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agata Y, 1996, INT IMMUNOL, V8, P765, DOI 10.1093/intimm/8.5.765; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Berger R, 2008, CLIN CANCER RES, V14, P3044, DOI 10.1158/1078-0432.CCR-07-4079; Blank C, 2006, INT J CANCER, V119, P317, DOI 10.1002/ijc.21775; Brown JA, 2003, J IMMUNOL, V170, P1257, DOI 10.4049/jimmunol.170.3.1257; Caligaris-Cappio F, 2008, J CLIN ONCOL, V26, P4497, DOI 10.1200/JCO.2007.15.4393; Carreras J, 2009, J CLIN ONCOL, V27, P1470, DOI 10.1200/JCO.2008.18.0513; Chemnitz JM, 2004, J IMMUNOL, V173, P945, DOI 10.4049/jimmunol.173.2.945; Damle RN, 2007, BLOOD, V110, P3352, DOI 10.1182/blood-2007-04-083832; Damle RN, 2002, BLOOD, V99, P4087, DOI 10.1182/blood.V99.11.4087; Dohner H, 2000, NEW ENGL J MED, V343, P1910, DOI 10.1056/NEJM200012283432602; Dong HD, 2003, J MOL MED, V81, P281, DOI 10.1007/s00109-003-0430-2; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Dorfman DM, 2006, AM J SURG PATHOL, V30, P802, DOI 10.1097/01.pas.0000209855.28282.ce; Finger LR, 1997, GENE, V197, P177, DOI 10.1016/S0378-1119(97)00260-6; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Giannopoulos K, 2008, ONCOL REP, V20, P677, DOI 10.3892/or_00000059; Hamblin TJ, 1999, BLOOD, V94, P1848, DOI 10.1182/blood.V94.6.1848; He XH, 2005, ACTA PHARMACOL SIN, V26, P462, DOI 10.1111/j.1745-7254.2005.00086.x; Hirano F, 2005, CANCER RES, V65, P1089; Iwai Y, 2005, INT IMMUNOL, V17, P133, DOI 10.1093/intimm/dxh194; Iwai Y, 2002, P NATL ACAD SCI USA, V99, P12293, DOI 10.1073/pnas.192461099; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Kuppers R, 2005, NAT REV CANCER, V5, P251, DOI 10.1038/nrc1589; Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330; Murray F, 2008, BLOOD, V111, P1524, DOI 10.1182/blood-2007-07-099564; Nielsen C, 2005, CELL IMMUNOL, V235, P109, DOI 10.1016/j.cellimm.2005.07.007; Okazaki T, 2001, P NATL ACAD SCI USA, V98, P13866, DOI 10.1073/pnas.231486598; Richendollar BG, 2011, HUM PATHOL, V42, P552, DOI 10.1016/j.humpath.2010.08.015; Roncador G, 2007, HAEMATOLOGICA, V92, P1059, DOI 10.3324/haematol.10864; Sharpe AH, 2007, NAT IMMUNOL, V8, P239, DOI 10.1038/ni1443; Sheppard KA, 2004, FEBS LETT, V574, P37, DOI 10.1016/j.febslet.2004.07.083; Shimauchi T, 2007, INT J CANCER, V121, P2585, DOI 10.1002/ijc.23042; Stamatopoulos K, 2007, BLOOD, V109, P259, DOI 10.1182/blood-2006-03-012948; Wan B, 2006, J IMMUNOL, V177, P8844, DOI 10.4049/jimmunol.177.12.8844; Wiestner A, 2003, BLOOD, V101, P4944, DOI 10.1182/blood-2002-10-3306; Xerri L, 2008, HUM PATHOL, V39, P1050, DOI 10.1016/j.humpath.2007.11.012; Yamamoto R, 2008, BLOOD, V111, P3220, DOI 10.1182/blood-2007-05-085159; Yang ZZ, 2006, BLOOD, V107, P3639, DOI 10.1182/blood-2005-08-3376; Zhang L, 2009, BLOOD, V114, P1545, DOI 10.1182/blood-2009-03-206672	40	50	59	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e35178	10.1371/journal.pone.0035178	http://dx.doi.org/10.1371/journal.pone.0035178			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22532845	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336200027
J	Bello, G; Zanotto, PMD; Iamarino, A; Graf, T; Pinto, AR; Couto-Fernandez, JC; Morgado, MG				Bello, Gonzalo; Zanotto, Paolo M. de A.; Iamarino, Atila; Graef, Tiago; Pinto, Aguinaldo R.; Couto-Fernandez, Jose C.; Morgado, Mariza G.			Phylogeographic Analysis of HIV-1 Subtype C Dissemination in Southern Brazil	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; MOLECULAR EPIDEMIOLOGY; GENETIC DIVERSITY; DRUG-RESISTANCE; CLADE-C; PHYLOGENETICS; INDIVIDUALS; PREVALENCE; MUTATIONS; INFERENCE	The HIV-1 subtype C has spread efficiently in the southern states of Brazil (Rio Grande do Sul, Santa Catarina and Parana). Phylogeographic studies indicate that the subtype C epidemic in southern Brazil was initiated by the introduction of a single founder virus population at some time point between 1960 and 1980, but little is known about the spatial dynamics of viral spread. A total of 135 Brazilian HIV-1 subtype C pol sequences collected from 1992 to 2009 at the three southern state capitals (Porto Alegre, Florianopolis and Curitiba) were analyzed. Maximum-likelihood and Bayesian methods were used to explore the degree of phylogenetic mixing of subtype C sequences from different cities and to reconstruct the geographical pattern of viral spread in this country region. Phylogeographic analyses supported the monophyletic origin of the HIV-1 subtype C clade circulating in southern Brazil and placed the root of that clade in Curitiba (Parana state). This analysis further suggested that Florianopolis (Santa Catarina state) is an important staging post in the subtype C dissemination displaying high viral migration rates from and to the other cities, while viral flux between Curitiba and Porto Alegre (Rio Grande do Sul state) is very low. We found a positive correlation (r(2) = 0.64) between routine travel and viral migration rates among localities. Despite the intense viral movement, phylogenetic intermixing of subtype C sequences from different Brazilian cities is lower than expected by chance. Notably, a high proportion (67%) of subtype C sequences from Porto Alegre branched within a single local monophyletic sub-cluster. These results suggest that the HIV-1 subtype C epidemic in southern Brazil has been shaped by both frequent viral migration among states and in situ dissemination of local clades.	[Bello, Gonzalo; Couto-Fernandez, Jose C.; Morgado, Mariza G.] Fiocruz MS, Inst Oswaldo Cruz, Lab AIDS & Imunol Mol, BR-21045900 Rio De Janeiro, Brazil; [Bello, Gonzalo] Univ Fed Rio de Janeiro, IMPPG, Dept Virol, Rio De Janeiro, Brazil; [Zanotto, Paolo M. de A.; Iamarino, Atila] Univ Sao Paulo, Inst Ciencias Biomed, Dept Microbiol, LEMB, Sao Paulo, Brazil; [Graef, Tiago; Pinto, Aguinaldo R.] Univ Fed Santa Catarina, Dept Microbiol Immunol & Parasitol, Florianopolis, SC, Brazil	Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro; Universidade de Sao Paulo; Universidade Federal de Santa Catarina (UFSC)	Bello, G (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab AIDS & Imunol Mol, BR-21045900 Rio De Janeiro, Brazil.	gbellobr@gmail.com	de A. Zanotto, Paolo M./B-9286-2019; Bello, Gonzalo/E-6842-2013; Bentancor, Gonzalo Jose Bello/N-7377-2019; Pinto, Aguinaldo R/R-6625-2016; Gräf, Tiago/S-8535-2019	de A. Zanotto, Paolo M./0000-0002-8167-0625; Bentancor, Gonzalo Jose Bello/0000-0002-2724-2793; Pinto, Aguinaldo R/0000-0002-0991-8876; Gräf, Tiago/0000-0003-4921-7975; Iamarino, Atila/0000-0003-3904-0248; Couto-Fernandez, Jose Carlos/0000-0001-7091-9774	FAPERJ; CNPq	FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by FAPERJ and CNPq grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; [Anonymous], 2014, TRACER V1 6; Bello G, 2008, AIDS, V22, P1993, DOI 10.1097/QAD.0b013e328315e0aa; Bello G, 2009, AIDS RES HUM RETROV, V25, P1065, DOI 10.1089/aid.2009.0106; Brazilian Ministry of Health, 2011, AIDS EP B; Brazilian Ministry of Tourism, 2009, EX REP CHAR SIZ DOM; Brigido LFM, 2007, AIDS RES HUM RETROV, V23, P1579, DOI 10.1089/aid.2007.0102; Brindeiro RM, 2003, AIDS, V17, P1063, DOI 10.1097/00002030-200305020-00016; Veras NMC, 2011, J GEN VIROL, V92, P1698, DOI 10.1099/vir.0.028951-0; Couto-Fernandez JC, 2005, MEM I OSWALDO CRUZ, V100, P73, DOI 10.1590/S0074-02762005000100014; de Oliveira T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009311; Ferreira JLD, 2008, MEM I OSWALDO CRUZ, V103, P800, DOI 10.1590/S0074-02762008000800010; Drummond AJ, 2002, GENETICS, V161, P1307; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Fontella R, 2008, AIDS, V22, P2001, DOI 10.1097/QAD.0b013e3283108f69; da Silva MMG, 2010, BRAZ J INFECT DIS, V14, P495, DOI 10.1590/S1413-86702010000500012; Graf T, 2011, J CLIN VIROL, V51, P186, DOI 10.1016/j.jcv.2011.04.011; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Locateli D, 2007, J MED VIROL, V79, P1455, DOI 10.1002/jmv.20955; Machado LFA, 2009, AIDS RES HUM RETROV, V25, P961, DOI 10.1089/aid.2009.0027; Toledo PVM, 2010, BRAZ J INFECT DIS, V14, P230, DOI 10.1590/S1413-86702010000300006; Minin VN, 2008, MOL BIOL EVOL, V25, P1459, DOI 10.1093/molbev/msn090; Morgado MG, 1998, MEM I OSWALDO CRUZ, V93, P383, DOI 10.1590/S0074-02761998000300020; Pagel M, 2004, SYST BIOL, V53, P673, DOI 10.1080/10635150490522232; Parker J, 2008, INFECT GENET EVOL, V8, P239, DOI 10.1016/j.meegid.2007.08.001; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Raboni SM, 2010, MEM I OSWALDO CRUZ, V105, P1044, DOI 10.1590/S0074-02762010000800015; Rambaut A, 2009, FIGTREE V1 3 1 TREE; Rodrigues R, 2006, VIRUS RES, V116, P201, DOI 10.1016/j.virusres.2005.10.004; Rodrigues R, 2010, AIDS RES HUM RETROV, V26, P351, DOI 10.1089/aid.2009.0214; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Salustiano Cavalcanti AM, 2007, MEM I OSWALDO CRUZ, V102, P785, DOI 10.1590/S0074-02762007005000109; Santos AF, 2007, JAIDS-J ACQ IMM DEF, V45, P328; Simon D, 2010, REV SAUDE PUBLICA; SLATKIN M, 1989, GENETICS, V123, P603; Soares EAJM, 2003, JAIDS-J ACQ IMM DEF, V34, P520, DOI 10.1097/00126334-200312150-00012; Stefani MMA, 2007, J CLIN VIROL, V39, P205, DOI 10.1016/j.jcv.2007.04.012; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wang TH, 2001, J VIROL, V75, P11686, DOI 10.1128/JVI.75.23.11686-11699.2001	42	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35649	10.1371/journal.pone.0035649	http://dx.doi.org/10.1371/journal.pone.0035649			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22530062	Green Published, gold, Green Submitted			2022-12-27	WOS:000305350600108
J	Chen, MF; Huang, JJ; Yang, XJ; Liu, BQ; Zhang, WZ; Huang, L; Deng, F; Ma, J; Bai, YJ; Lu, R; Huang, B; Gao, QY; Zhuo, YH; Ge, J				Chen, Mengfei; Huang, Jingjing; Yang, Xuejiao; Liu, Bingqian; Zhang, Weizhong; Huang, Li; Deng, Fei; Ma, Jian; Bai, Yujing; Lu, Rong; Huang, Bing; Gao, Qianying; Zhuo, Yehong; Ge, Jian			Serum Starvation Induced Cell Cycle Synchronization Facilitates Human Somatic Cells Reprogramming	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; HUMAN FIBROBLASTS; EXPRESSION; GENERATION; INDUCTION; PROMOTE; DEPENDS; RANGE	Human induced pluripotent stem cells (iPSCs) provide a valuable model for regenerative medicine and human disease research. To date, however, the reprogramming efficiency of human adult cells is still low. Recent studies have revealed that cell cycle is a key parameter driving epigenetic reprogramming to pluripotency. As is well known, retroviruses such as the Moloney murine leukemia virus (MoMLV) require cell division to integrate into the host genome and replicate, whereas the target primary cells for reprogramming are a mixture of several cell types with different cell cycle rhythms. Whether cell cycle synchronization has potential effect on retrovirus induced reprogramming has not been detailed. In this study, utilizing transient serum starvation induced synchronization, we demonstrated that starvation generated a reversible cell cycle arrest and synchronously progressed through G2/M phase after release, substantially improving retroviral infection efficiency. Interestingly, synchronized human dermal fibroblasts (HDF) and adipose stem cells (ASC) exhibited more homogenous epithelial morphology than normal FBS control after infection, and the expression of epithelial markers such as E-cadherin and Epcam were strongly activated. Futhermore, synchronization treatment ultimately improved Nanog positive clones, achieved a 15-20 fold increase. These results suggested that cell cycle synchronization promotes the mesenchymal to epithelial transition (MET) and facilitates retrovirus mediated reprogramming. Our study, utilization of serum starvation rather than additional chemicals, provide a new insight into cell cycle regulation and induced reprogramming of human cells.	[Chen, Mengfei; Huang, Jingjing; Yang, Xuejiao; Liu, Bingqian; Zhang, Weizhong; Huang, Li; Deng, Fei; Ma, Jian; Bai, Yujing; Lu, Rong; Huang, Bing; Gao, Qianying; Zhuo, Yehong; Ge, Jian] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China; [Chen, Mengfei] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA USA	Sun Yat Sen University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Chen, MF (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China.	zhuoyh@mail.sysu.edu.cn; gejian@mail.sysu.edu.cn	Chen, Mengfei/T-7020-2018; Chen, Mengfei/N-2474-2019; Yang, Xuejiao/GPG-4151-2022	Chen, Mengfei/0000-0001-6922-1221; Yang, Xuejiao/0000-0002-5347-1071	National Basic Research Program of China (973 project) [2007CB512207]; National Natural Science Foundation of China [30973226/H1205, 30872832, 30901634]; China Postdoctoral Science Foundation [20090460814]; High-level Talents Project in Universities and Colleges of Guangdong Province	National Basic Research Program of China (973 project)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); High-level Talents Project in Universities and Colleges of Guangdong Province	Supported by the National Basic Research Program of China (973 project) no. 2007CB512207, National Natural Science Foundation of China nos. 30973226/H1205, 30872832, 30901634, China Postdoctoral Science Foundation funded project 20090460814, and High-level Talents Project in Universities and Colleges of Guangdong Province (2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Andreadis ST, 1997, J VIROL, V71, P7541, DOI 10.1128/JVI.71.10.7541-7548.1997; Attardi LD, 2004, ONCOGENE, V23, P973, DOI 10.1038/sj.onc.1207026; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Cai K, 1998, P NATL ACAD SCI USA, V95, P12254, DOI 10.1073/pnas.95.21.12254; Chen TT, 2010, STEM CELLS, V28, P1315, DOI 10.1002/stem.456; Chuck AS, 1996, HUM GENE THER, V7, P743, DOI 10.1089/hum.1996.7.6-743; Colman A, 2009, CELL STEM CELL, V5, P244, DOI 10.1016/j.stem.2009.08.010; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001; Feng B, 2009, CELL STEM CELL, V4, P301, DOI 10.1016/j.stem.2009.03.005; Gilroy DW, 2001, AM J PHYSIOL-CELL PH, V281, pC188, DOI 10.1152/ajpcell.2001.281.1.C188; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Hanna JH, 2010, CELL, V143, P508, DOI 10.1016/j.cell.2010.10.008; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Hu QR, 2010, STEM CELLS, V28, P1981, DOI 10.1002/stem.531; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Kondo T, 2005, P NATL ACAD SCI USA, V102, P4789, DOI 10.1073/pnas.0408239102; KULKARNI GV, 1994, J CELL SCI, V107, P1169; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Lin TX, 2009, NAT METHODS, V6, P805, DOI [10.1038/NMETH.1393, 10.1038/nmeth.1393]; Ling SY, 2011, J BIOL CHEM, V286, P14972, DOI 10.1074/jbc.M110.182527; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Marchetto MCN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007076; Marson A, 2008, CELL STEM CELL, V3, P132, DOI 10.1016/j.stem.2008.06.019; Meyer JS, 2011, STEM CELLS, V29, P1206, DOI 10.1002/stem.674; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Niibe K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017610; Olivera A, 1999, J CELL BIOL, V147, P545, DOI 10.1083/jcb.147.3.545; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; ROE TY, 1993, EMBO J, V12, P2099, DOI 10.1002/j.1460-2075.1993.tb05858.x; Ruiz S, 2011, CURR BIOL, V21, P45, DOI 10.1016/j.cub.2010.11.049; Ruiz S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015526; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Smith KP, 2009, J CELL PHYSIOL, V220, P21, DOI 10.1002/jcp.21681; Sun N, 2009, P NATL ACAD SCI USA, V106, P15720, DOI 10.1073/pnas.0908450106; Suzuki Y, 2007, NAT REV MICROBIOL, V5, P187, DOI 10.1038/nrmicro1579; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Wang Y, 2010, STEM CELL REV REP, V6, P282, DOI 10.1007/s12015-010-9137-2; Wernig M, 2008, NAT BIOTECHNOL, V26, P916, DOI 10.1038/nbt1483; Yang Z, 2008, NAT CELL BIOL, V10, P748, DOI 10.1038/ncb1738; Yoshimura K, 2006, J CELL PHYSIOL, V208, P64, DOI 10.1002/jcp.20636; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhao W, 2004, CELL RES, V14, P60, DOI 10.1038/sj.cr.7290203	44	62	62	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e28203	10.1371/journal.pone.0028203	http://dx.doi.org/10.1371/journal.pone.0028203			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529890	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000305350600001
J	Egea, PF; Muller-Steffner, H; Kuhn, I; Cakir-Kiefer, C; Oppenheimer, NJ; Stroud, RM; Kellenberger, E; Schuber, F				Egea, Pascal F.; Muller-Steffner, Helene; Kuhn, Isabelle; Cakir-Kiefer, Celine; Oppenheimer, Norman J.; Stroud, Robert M.; Kellenberger, Esther; Schuber, Francis			Insights into the Mechanism of Bovine CD38/NAD+Glycohydrolase from the X-Ray Structures of Its Michaelis Complex and Covalently-Trapped Intermediates	PLOS ONE			English	Article							ADP-RIBOSYL CYCLASE; ADENINE DINUCLEOTIDE GLYCOHYDROLASE; CALCIUM-MOBILIZING METABOLITES; HUMAN CD38; NAD+-GLYCOHYDROLASE; ACTIVE-SITE; CRYSTAL-STRUCTURE; TRANSITION-STATE; GLYCOSIDASE MECHANISMS; ENZYMATIC-HYDROLYSIS	Bovine CD38/NAD(+)glycohydrolase (bCD38) catalyses the hydrolysis of NAD(+) into nicotinamide and ADP-ribose and the formation of cyclic ADP-ribose (cADPR). We solved the crystal structures of the mono N-glycosylated forms of the ecto-domain of bCD38 or the catalytic residue mutant Glu218Gln in their apo state or bound to aFNAD or rFNAD, two 2'-fluorinated analogs of NAD(+). Both compounds behave as mechanism-based inhibitors, allowing the trapping of a reaction intermediate covalently linked to Glu218. Compared to the non-covalent (Michaelis) complex, the ligands adopt a more folded conformation in the covalent complexes. Altogether these crystallographic snapshots along the reaction pathway reveal the drastic conformational rearrangements undergone by the ligand during catalysis with the repositioning of its adenine ring from a solvent-exposed position stacked against Trp168 to a more buried position stacked against Trp181. This adenine flipping between conserved tryptophans is a prerequisite for the proper positioning of the N1 of the adenine ring to perform the nucleophilic attack on the C1' of the ribofuranoside ring ultimately yielding cADPR. In all structures, however, the adenine ring adopts the most thermodynamically favorable anti conformation, explaining why cyclization, which requires a syn conformation, remains a rare alternate event in the reactions catalyzed by bCD38 (cADPR represents only 1% of the reaction products). In the Michaelis complex, the substrate is bound in a constrained conformation; the enzyme uses this ground-state destabilization, in addition to a hydrophobic environment and desolvation of the nicotinamide-ribosyl bond, to destabilize the scissile bond leading to the formation of a ribooxocarbenium ion intermediate. The Glu218 side chain stabilizes this reaction intermediate and plays another important role during catalysis by polarizing the 2'-OH of the substrate NAD(+). Based on our structural analysis and data on active site mutants, we propose a detailed analysis of the catalytic mechanism.	[Egea, Pascal F.] Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90024 USA; [Muller-Steffner, Helene; Kuhn, Isabelle; Cakir-Kiefer, Celine; Schuber, Francis] Univ Strasbourg, CNRS, UMR 7199, Lab Concept & Applicat Mol Bioact,Fac Pharm, Illkirch Graffenstaden, France; [Cakir-Kiefer, Celine] Nancy Univ, UR AFPA, Vandoeuvre Les Nancy, France; [Oppenheimer, Norman J.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; [Stroud, Robert M.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Kellenberger, Esther] Univ Strasbourg, CNRS, UMR 7200, Lab Innovat Therapeut,Fac Pharm, Illkirch Graffenstaden, France	University of California System; University of California Los Angeles; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universite de Lorraine; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Egea, PF (corresponding author), Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90024 USA.	pegea@mednet.ucla.edu; schuber@unistra.fr	Egea, Pascal Francois/AAI-2759-2020; egea, pascal/V-7662-2019	egea, pascal/0000-0003-4432-8625; Kellenberger, Esther/0000-0002-9320-4840	CNRS; French Ministry of Research; Agence Nationale de la Recherche [ANR-05-BLAN-0076]; National Institute of Health [GM60641, GM094625]; UCLA David Geffen School of Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060641, U54GM094625] Funding Source: NIH RePORTER	CNRS(Centre National de la Recherche Scientifique (CNRS)); French Ministry of Research(Ministry of Research, FranceEuropean Commission); Agence Nationale de la Recherche(French National Research Agency (ANR)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCLA David Geffen School of Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the CNRS, the French Ministry of Research, and the Agence Nationale de la Recherche (Grant ANR-05-BLAN-0076 to FS and EK). PFE was supported by the National Institute of Health grants GM60641 (no longer active) and GM094625 and is currently supported by funds from the UCLA David Geffen School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya P, 2003, J ORG CHEM, V68, P1529, DOI 10.1021/jo026572e; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Augustin A, 2000, BIOCHEM J, V345, P43, DOI 10.1042/0264-6021:3450043; Bell CE, 1997, PROTEIN SCI, V6, P2084; Berthelier V, 1998, BIOCHEM J, V330, P1383, DOI 10.1042/bj3301383; Bissantz C, 2010, J MED CHEM, V53, P5061, DOI 10.1021/jm100112j; Bruice TC, 2006, CHEM REV, V106, P3119, DOI 10.1021/cr050283j; Buckley N, 1996, J ORG CHEM, V61, P7360, DOI 10.1021/jo960729j; BULL HG, 1978, J BIOL CHEM, V253, P5186; Cakir-Kiefer C, 2000, BIOCHEM J, V349, P203, DOI 10.1042/0264-6021:3490203; Dalvit C, 2011, CHEMMEDCHEM, V6, P104, DOI 10.1002/cmdc.201000412; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; De Flora A, 2004, ANN NY ACAD SCI, V1028, P176, DOI 10.1196/annals.1322.021; Degano M, 1998, BIOCHEMISTRY-US, V37, P6277, DOI 10.1021/bi973012e; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dudev T, 2010, J AM CHEM SOC, V132, P16533, DOI 10.1021/ja106600k; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fedorov A, 2001, BIOCHEMISTRY-US, V40, P853, DOI 10.1021/bi002499f; Goodrich SP, 2005, BIOCHEMISTRY-US, V44, P11082, DOI 10.1021/bi050704r; Graeff R, 2001, J BIOL CHEM, V276, P12169, DOI 10.1074/jbc.M011299200; Graeff R, 2009, J BIOL CHEM, V284, P27629, DOI 10.1074/jbc.M109.030965; GRAEFF RM, 1994, J BIOL CHEM, V269, P30260; HANDLON AL, 1994, J AM CHEM SOC, V116, P12087, DOI 10.1021/ja00105a073; Hawse WF, 2008, STRUCTURE, V16, P1368, DOI 10.1016/j.str.2008.05.015; Hohenstein EG, 2009, J PHYS CHEM A, V113, P878, DOI 10.1021/jp809062x; Holton J, 2004, P NATL ACAD SCI USA, V101, P1537, DOI 10.1073/pnas.0306241101; HONG L, 1992, J MED CHEM, V35, P3560, DOI 10.1021/jm00097a013; HOWARD M, 1993, SCIENCE, V262, P1056, DOI 10.1126/science.8235624; IUPAC-IUB Joint Commission on Biochemical Nomenclature (JCBN), 1983, EUR J BIOCHEM, V131, P9; JACKSON DG, 1990, J IMMUNOL, V144, P2811; Kahn K, 2001, J AM CHEM SOC, V123, P11960, DOI 10.1021/ja0113807; Kellenberger E, 2011, BIOORG MED CHEM LETT, V21, P3939, DOI 10.1016/j.bmcl.2011.05.022; Khalili-Araghi F, 2009, CURR OPIN STRUC BIOL, V19, P128, DOI 10.1016/j.sbi.2009.02.011; Kuhn I, 2006, BIOCHEMISTRY-US, V45, P11867, DOI 10.1021/bi060930g; Lacapere JJ, 2003, BBA-PROTEINS PROTEOM, V1652, P17, DOI 10.1016/j.bbapap.2003.07.002; LEE HC, 1991, CELL REGUL, V2, P203, DOI 10.1091/mbc.2.3.203; Lee HC, 1997, PHYSIOL REV, V77, P1133, DOI 10.1152/physrev.1997.77.4.1133; LEE HC, 1989, J BIOL CHEM, V264, P1608; Lee HC, 2001, ANNU REV PHARMACOL, V41, P317, DOI 10.1146/annurev.pharmtox.41.1.317; Lee HC, 2006, MOL MED, V12, P317, DOI 10.2119/2006-00086.Lee; Liu Q, 2005, STRUCTURE, V13, P1331, DOI 10.1016/j.str.2005.05.012; Liu Q, 2008, CHEM BIOL, V15, P1068, DOI 10.1016/j.chembiol.2008.08.007; Liu Q, 2007, J BIOL CHEM, V282, P5853, DOI 10.1074/jbc.M609093200; Liu Q, 2006, J BIOL CHEM, V281, P32861, DOI 10.1074/jbc.M606365200; Loverix S, 2005, J BIOL CHEM, V280, P14799, DOI 10.1074/jbc.M413231200; Ma JC, 1997, CHEM REV, V97, P1303, DOI 10.1021/cr9603744; Malavasi F, 2008, PHYSIOL REV, V88, P841, DOI 10.1152/physrev.00035.2007; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moreno-Garcia ME, 2004, EUR J BIOCHEM, V271, P1025, DOI 10.1111/j.1432-1033.2004.04006.x; Muller K, 2007, SCIENCE, V317, P1881, DOI 10.1126/science.1131943; MULLER CD, 1984, BIOCHEM J, V223, P715, DOI 10.1042/bj2230715; MULLER HM, 1983, BIOCHEM J, V212, P459, DOI 10.1042/bj2120459; Muller-Steffner H, 2010, PROTEIN EXPRES PURIF, V70, P151, DOI 10.1016/j.pep.2009.10.003; MULLERSTEFFNER H, 1994, BIOCHEM BIOPH RES CO, V204, P1279, DOI 10.1006/bbrc.1994.2601; MULLERSTEFFNER H, 1993, ARCH BIOCHEM BIOPHYS, V304, P154, DOI 10.1006/abbi.1993.1333; MullerSteffner HM, 1996, J BIOL CHEM, V271, P23967, DOI 10.1074/jbc.271.39.23967; MULLERSTEFFNER HM, 1992, J BIOL CHEM, V267, P9606; Munshi C, 2000, J BIOL CHEM, V275, P21566, DOI 10.1074/jbc.M909365199; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; O'Hagan D, 2008, CHEM SOC REV, V37, P308, DOI 10.1039/b711844a; OPPENHEIMER NJ, 1994, MOL CELL BIOCHEM, V138, P245, DOI 10.1007/BF00928468; Ortolan E, 2002, CELL BIOCHEM FUNCT, V20, P309, DOI 10.1002/cbf.978; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1997, ACTA CRYSTALLOGR D, V53, P448, DOI 10.1107/S0907444997005696; Philip V, 2011, BIOCHEMISTRY-US, V50, P2939, DOI 10.1021/bi200066k; Prasad GS, 1996, NAT STRUCT BIOL, V3, P957, DOI 10.1038/nsb1196-957; Price S.R., 1987, PYRIDINE NUCLEOTIDE, V2B, P513; Rempel BP, 2008, GLYCOBIOLOGY, V18, P570, DOI 10.1093/glycob/cwn041; Rye CS, 2000, CURR OPIN CHEM BIOL, V4, P573, DOI 10.1016/S1367-5931(00)00135-6; Saenger W., 1984, PRINCIPLES NUCL ACID; Sauve AA, 1998, BIOCHEMISTRY-US, V37, P13239, DOI 10.1021/bi981248s; Sauve AA, 2000, J AM CHEM SOC, V122, P7855, DOI 10.1021/ja001139c; SCHUBER F, 1978, EUR J BIOCHEM, V83, P205, DOI 10.1111/j.1432-1033.1978.tb12085.x; SCHUBER F, 1976, EUR J BIOCHEM, V69, P593, DOI 10.1111/j.1432-1033.1976.tb10945.x; Schuber F, 2004, CURR MOL MED, V4, P249, DOI 10.2174/1566524043360708; Singh NJ, 2009, J CHEM THEORY COMPUT, V5, P515, DOI 10.1021/ct800471b; Song EK, 2011, J BIOL CHEM, V286, P44480, DOI 10.1074/jbc.M111.307645; STOLARSKI R, 1980, EUR J BIOCHEM, V108, P111, DOI 10.1111/j.1432-1033.1980.tb04701.x; Sumoza-Toledo A, 2011, J PHYSIOL-LONDON, V589, P1515, DOI 10.1113/jphysiol.2010.201855; TARNUS C, 1987, BIOORG CHEM, V15, P31, DOI 10.1016/0045-2068(87)90004-6; TARNUS C, 1988, BIOORG CHEM, V16, P38, DOI 10.1016/0045-2068(88)90036-3; Tsuzuki S, 2007, J AM CHEM SOC, V129, P8656, DOI 10.1021/ja071372b; Yamamoto-Katayama S, 2002, J MOL BIOL, V316, P711, DOI 10.1006/jmbi.2001.5386; Zechel DL, 2000, ACCOUNTS CHEM RES, V33, P11, DOI 10.1021/ar970172+; Zhang HM, 2011, J MOL BIOL, V405, P1070, DOI 10.1016/j.jmb.2010.11.044; Zhang R, 2008, J ORG CHEM, V73, P3070, DOI 10.1021/jo702565q	86	19	19	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e34918	10.1371/journal.pone.0034918	http://dx.doi.org/10.1371/journal.pone.0034918			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529956	Green Submitted, Green Published, gold			2022-12-27	WOS:000305350600042
J	Gao, P; Song, YX; Wang, ZN; Xu, YY; Tong, LL; Zhu, JL; Tang, QC; Xu, HM				Gao, Peng; Song, Yong-xi; Wang, Zhen-ning; Xu, Ying-ying; Tong, Lin-lin; Zhu, Jin-liang; Tang, Qing-chao; Xu, Hui-mian			Integrated Ratio of Metastatic to Examined Lymph Nodes and Number of Metastatic Lymph Nodes into the AJCC Staging System for Colon Cancer	PLOS ONE			English	Article							III COLORECTAL-CANCER; PROGNOSTIC VALUE; SURVIVAL MODELS	Objective: At present, only the number of metastatic lymph nodes (LNs+) is used for the pN category of AJCC TNM system for colon cancer. Recently, the ratio of metastatic to examined lymph nodes (LNR) has been reported to represent powerful independent predictive capacity in colon cancer. We sought to propose a novel category (nLN) which intergrades LNR and LNs+ into the AJCC staging system for colon cancer. Design: 34476 patients from the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) dataset with stage III colon cancer were reviewed. Harrell's C statistic was used to evaluate the predictive capacity. The Cox proportional hazards model was used to construct a novel category. Results: The LNR category had more predictive capacity than the pN category in whole groups of patients (Harrell's C index: 0.6194 vs 0.6113, p = 0.003). Subgroup analysis showed that the LNR category was not better than pN category in predictive capacity if the number of lymph nodes examined was more than 13. We also found that there was significant survival heterogeneity among different pN categories at the same LNR category (P < 0.001). The Harrell's C index for our nLN category which intergrades LNR and LNs+ was 0.6228, which was significant higher than that of the pN category (Harrell's C index: 0.6113, P < 0.001) or LNR category (Harrell's C index: 0.6194, P = 0.005), respectively. Conclusion: To evaluate the prognosis of colon cancer, our nLN category which intergrades LNR with LNs+ is more accurate than the pN category or LNR category, respectively.	[Gao, Peng; Song, Yong-xi; Wang, Zhen-ning; Xu, Ying-ying; Tong, Lin-lin; Zhu, Jin-liang; Tang, Qing-chao; Xu, Hui-mian] China Med Univ, Dept Surg Oncol & Gen Surg, First Hosp, Shenyang, Peoples R China	China Medical University	Wang, ZN (corresponding author), China Med Univ, Dept Surg Oncol & Gen Surg, First Hosp, Shenyang, Peoples R China.	josieon826@yahoo.com.cn	Gao, Peng/B-8031-2013; wang, zhen ning/E-1878-2011; Xu, Yingying/E-3884-2018	wang, zhen ning/0000-0003-0557-3097; Xu, Yingying/0000-0003-4924-9379	National Science Foundation of China [30972879, 81172370]; Specialized Research Fund for the Doctoral Program of Higher Education [200801590006]; Natural Science Foundation of Liaoning Province [20092129]; Program of Scientific and Technological Department of Liaoning Province [2010225032]; Program of Education Department of Liaoning Province [L2011137]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Natural Science Foundation of Liaoning Province(Natural Science Foundation of Liaoning Province); Program of Scientific and Technological Department of Liaoning Province; Program of Education Department of Liaoning Province	This work was supported by National Science Foundation of China (no. 30972879 and no. 81172370), Specialized Research Fund for the Doctoral Program of Higher Education (no. 200801590006), Natural Science Foundation of Liaoning Province (no. 20092129), the Program of Scientific and Technological Department of Liaoning Province (no. 2010225032) and the Program of Education Department of Liaoning Province (L2011137). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benson AB, 2012, NCCN CLIN PRACTICE G; Berger AC, 2005, J CLIN ONCOL, V23, P8706, DOI 10.1200/JCO.2005.02.8852; Ceelen W, 2010, ANN SURG ONCOL, V17, P2847, DOI 10.1245/s10434-010-1158-1; Chen SL, 2006, ANN SURG, V244, P602, DOI 10.1097/01.sla.0000237655.11717.50; Chen SL, 2011, ANN SURG, V253, P82, DOI 10.1097/SLA.0b013e3181ffa780; Compton CC, 2000, ARCH PATHOL LAB MED, V124, P979; Derwinger K, 2008, EJSO-EUR J SURG ONC, V34, P771, DOI 10.1016/j.ejso.2007.11.002; Downing SR, 2010, J SURG RES, V163, P264, DOI 10.1016/j.jss.2010.03.017; Edge SB, 2010, AJCC CANC STAGING MA; Greene FL, 2007, LANCET ONCOL, V8, P572, DOI 10.1016/S1470-2045(07)70185-7; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hashiguchi Y, 2010, ANN SURG, V251, P872, DOI 10.1097/SLA.0b013e3181c0e5b1; Hong KD, 2011, J SURG ONCOL, V103, P406, DOI 10.1002/jso.21830; Huh JW, 2010, ANN SURG ONCOL, V17, P2640, DOI 10.1245/s10434-010-1015-2; Le Voyer TE, 2003, J CLIN ONCOL, V21, P2912, DOI 10.1200/JCO.2003.05.062; Moug SJ, 2009, BRIT J CANCER, V100, P1530, DOI 10.1038/sj.bjc.6605049; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Newson RB, 2010, STATA J, V10, P339, DOI 10.1177/1536867X1001000303; Noura S, 2010, WORLD J GASTRO SURG, V2, P70, DOI 10.4240/wjgs.v2.i3.70; Priolli DG, 2009, TECH COLOPROCTOL, V13, P113, DOI 10.1007/s10151-009-0467-5; Rosenberg R, 2010, ANN SURG, V251, P1070, DOI 10.1097/SLA.0b013e3181d7789d; Rosenberg R, 2008, ANN SURG, V248, P968, DOI 10.1097/SLA.0b013e318190eddc; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Song X, 2008, STAT SINICA, V18, P947; Swanson RS, 2003, ANN SURG ONCOL, V10, P65, DOI 10.1245/ASO.2003.03.058; Tong LL, 2011, ANN SURG ONCOL, V18, P2453, DOI 10.1245/s10434-011-1687-2; Vaccaro CA, 2009, DIS COLON RECTUM, V52, P1244, DOI 10.1007/DCR.0b013e3181a65f0b; Volinsky CT, 2000, BIOMETRICS, V56, P256, DOI 10.1111/j.0006-341X.2000.00256.x; Wong KP, 2011, COLORECTAL DIS, V13, P1116, DOI 10.1111/j.1463-1318.2010.02435.x	29	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35021	10.1371/journal.pone.0035021	http://dx.doi.org/10.1371/journal.pone.0035021			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529970	Green Published, gold, Green Submitted			2022-12-27	WOS:000305350600052
J	Kasuga, T; Kozanitas, M; Bui, M; Huberli, D; Rizzo, DM; Garbelotto, M				Kasuga, Takao; Kozanitas, Melina; Bui, Mai; Hueberli, Daniel; Rizzo, David M.; Garbelotto, Matteo			Phenotypic Diversification Is Associated with Host-Induced Transposon Derepression in the Sudden Oak Death Pathogen Phytophthora ramorum	PLOS ONE			English	Article							3 CLONAL LINEAGES; GENOME SEQUENCE; CALIFORNIA; EVOLUTION; TRANSMISSION; FOREST; VARIABILITY; POPULATIONS; CINNAMOMI; INFECTION	The oomycete pathogen Phytophthora ramorum is responsible for sudden oak death (SOD) in California coastal forests. P. ramorum is a generalist pathogen with over 100 known host species. Three or four closely related genotypes of P. ramorum (from a single lineage) were originally introduced in California forests and the pathogen reproduces clonally. Because of this the genetic diversity of P. ramorum is extremely low in Californian forests. However, P. ramorum shows diverse phenotypic variation in colony morphology, colony senescence, and virulence. In this study, we show that phenotypic variation among isolates is associated with the host species from which the microbe was originally cultured. Microarray global mRNA profiling detected derepression of transposable elements (TEs) and down-regulation of crinkler effector homologs (CRNs) in the majority of isolates originating from coast live oak (Quercus agrifolia), but this expression pattern was not observed in isolates from California bay laurel (Umbellularia californica). In some instances, oak and bay laurel isolates originating from the same geographic location had identical genotypes based on multilocus simples sequence repeat (SSR) marker analysis but had different phenotypes. Expression levels of the two marker genes analyzed by quantitative reverse transcription PCR were correlated with originating host species, but not with multilocus genotypes. Because oak is a nontransmissive dead-end host for P. ramorum, our observations are congruent with an epi-transposon hypothesis; that is, physiological stress is triggered on P. ramorum while colonizing oak stems and disrupts epigenetic silencing of TEs. This then results in TE reactivation and possibly genome diversification without significant epidemiological consequences. We propose the P. ramorum-oak host system in California forests as an ad hoc model for epi-transposon mediated diversification.	[Kasuga, Takao; Bui, Mai] USDA ARS, Crops Pathol & Genet Res Unit, Davis, CA USA; [Kozanitas, Melina; Hueberli, Daniel; Garbelotto, Matteo] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Rizzo, David M.] Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA	United States Department of Agriculture (USDA); University of California System; University of California Berkeley; University of California System; University of California Davis	Kasuga, T (corresponding author), USDA ARS, Crops Pathol & Genet Res Unit, Davis, CA USA.	matteog@berkeley.edu	Huberli, Daniel/C-7257-2013		National Science Foundation (NSF); National Institutes of Health (NIH) Ecology of Infectious Diseases [EF-0622770, 1115607]; Gordon and Betty Moore Foundation; Pacific Southwest Research Station, the United States Department of Agriculture (USDA) Forest Service; USDA Agricultural Research Service CRIS Project [5306-22000-014-00D]; Direct For Biological Sciences [1115607] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); National Institutes of Health (NIH) Ecology of Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Pacific Southwest Research Station, the United States Department of Agriculture (USDA) Forest Service; USDA Agricultural Research Service CRIS Project(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the National Science Foundation (NSF) and the National Institutes of Health (NIH) Ecology of Infectious Diseases # EF-0622770 (to DMR) and # 1115607 (to MG); The Gordon and Betty Moore Foundation (to DMR and to MG); the Pacific Southwest Research Station, the United States Department of Agriculture (USDA) Forest Service (to MG); and USDA Agricultural Research Service CRIS Project # 5306-22000-014-00D (to TK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-El Samen FM, 2003, PHYTOPATHOLOGY, V93, P293, DOI 10.1094/PHYTO.2003.93.3.293; Akinsanmi OA, 2007, ENVIRON MICROBIOL, V9, P512, DOI 10.1111/j.1462-2920.2006.01168.x; ANAGNOSTAKIS SL, 1987, MYCOLOGIA, V79, P23, DOI 10.2307/3807741; Bourhy H, 2008, J GEN VIROL, V89, P2673, DOI 10.1099/vir.0.2008/003913-0; Brasier C, 2006, PROGR RES PHYTOPHTHO, P166; BRASIER CM, 1995, MYCOL RES, V99, P205, DOI 10.1016/S0953-7562(09)80887-3; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Callahan ME, 1999, J VIROL, V73, P9619, DOI 10.1128/JVI.73.11.9619-9624.1999; Davidson JM, 2008, PHYTOPATHOLOGY, V98, P860, DOI 10.1094/PHYTO-98-8-0860; Davidson JM, 2011, PHYTOPATHOLOGY, V101, P492, DOI 10.1094/PHYTO-03-10-0064; Davidson JM, 2005, PHYTOPATHOLOGY, V95, P587, DOI 10.1094/PHYTO-95-0587; Dean RA, 2005, NATURE, V434, P980, DOI 10.1038/nature03449; Della Rocca G, 2011, PHYTOPATHOLOGY, V101, P1408, DOI 10.1094/PHYTO-05-11-0144; Denisov V, 2008, BIORAD B; Dobrowolski MP, 2003, PHYTOPATHOLOGY, V93, P695, DOI 10.1094/PHYTO.2003.93.6.695; Dodd RS, 2005, NEW PHYTOL, V165, P203, DOI 10.1111/j.1469-8137.2004.01200.x; Dudoit S, 2002, STAT SINICA, V12, P111; DUDZINSKI MJ, 1993, AUST J BOT, V41, P721, DOI 10.1071/BT9930721; Eldredge N., 1972, P82; Elliott M, 2011, FOREST PATHOL, V41, P7, DOI 10.1111/j.1439-0329.2009.00627.x; ENGLANDER L, 1980, PHYTOPATHOLOGY, V70, P650, DOI 10.1094/Phyto-70-650; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Gijzen M, 2009, OOMYCETE GENETICS GE; Gomez-Alpizar L, 2007, P NATL ACAD SCI USA, V104, P3306, DOI 10.1073/pnas.0611479104; Grunwald NJ, 2008, PLANT DIS, V92, P314, DOI 10.1094/PDIS-92-2-0314B; Grunwald NJ, 2005, ANNU REV PHYTOPATHOL, V43, P171, DOI 10.1146/annurev.phyto.43.040204.135906; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; Hayden K, 2006, PHYTOPATHOLOGY, V96, P846, DOI 10.1094/PHYTO-96-0846; Holmes EC, 2006, P NATL ACAD SCI USA, V103, P4803, DOI 10.1073/pnas.0601166103; Huberli D, 2001, MYCOL RES, V105, P1053, DOI 10.1016/S0953-7562(08)61967-X; Huberli D, 2012, FOREST PATHOL, V42, P8, DOI 10.1111/j.1439-0329.2011.00715.x; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ivors K, 2006, MOL ECOL, V15, P1493, DOI 10.1111/j.1365-294X.2006.02864.x; Ivors KL, 2004, MYCOL RES, V108, P378, DOI 10.1017/S0953756204009827; JONES J P, 1969, Plant Disease Reporter, V53, P907; JONES JP, 1969, PHYTOPATHOLOGY, V59, P504; Kasuga T, 2011, FUNGAL GENETICS REPO, V58, P4; Kerr MK, 2001, GENET RES, V77, P123; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Klosterman SJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002137; Kondrashov FA, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-2-research0008; Kozlakidis Z, 2010, VIRUS GENES, V40, P130, DOI 10.1007/s11262-009-0421-7; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma LJ, 2010, NATURE, V464, P367, DOI 10.1038/nature08850; Madlung A, 2004, ANN BOT-LONDON, V94, P481, DOI 10.1093/aob/mch172; Maloy OC, 1997, ANNU REV PHYTOPATHOL, V35, P87, DOI 10.1146/annurev.phyto.35.1.87; Mascheretti S, 2008, MOL ECOL, V17, P2755, DOI 10.1111/j.1365-294X.2008.03773.x; Mascheretti S, 2009, MOL ECOL, V18, P4577, DOI 10.1111/j.1365-294X.2009.04379.x; Nagle AM, 2011, FOREST PATHOL, V41, P464, DOI 10.1111/j.1439-0329.2010.00703.x; O'Fallon B, 2008, EVOLUTION, V62, P361, DOI 10.1111/j.1558-5646.2007.00289.x; Prospero S, 2007, MOL ECOL, V16, P2958, DOI 10.1111/j.1365-294X.2007.03343.x; Raffaele S, 2010, SCIENCE, V330, P1540, DOI 10.1126/science.1193070; Rebollo R, 2010, GENE, V454, P1, DOI 10.1016/j.gene.2010.01.003; Rizzo DM, 2005, ANNU REV PHYTOPATHOL, V43, P309, DOI 10.1146/annurev.phyto.42.040803.140418; RUTHERFORD FS, 1985, PHYTOPATHOLOGY, V75, P371, DOI 10.1094/Phyto-75-371; Seo J, 2002, COMPUTER, V35, P80; Shan WX, 2004, MOL PLANT MICROBE IN, V17, P394, DOI 10.1094/MPMI.2004.17.4.394; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; Spanu PD, 2010, SCIENCE, V330, P1543, DOI 10.1126/science.1194573; SWIECKI TJ, 2001, P 5 S OAK WOODL OAKS, P787; Tooley PW, 2009, PHYTOPATHOLOGY, V99, P1045, DOI 10.1094/PHYTO-99-9-1045; Torto TA, 2003, GENOME RES, V13, P1675, DOI 10.1101/gr.910003; TSAO PH, 1969, NATURE, V223, P636, DOI 10.1038/223636a0; Tyler BM, 2006, SCIENCE, V313, P1261, DOI 10.1126/science.1128796; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Weaver SC, 2004, NAT REV MICROBIOL, V2, P789, DOI 10.1038/nrmicro1006; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Zeh DW, 2009, BIOESSAYS, V31, P715, DOI 10.1002/bies.200900026; Zhang Z, 2010, FUNGAL GENET BIOL, V47, P199, DOI 10.1016/j.fgb.2009.12.001	69	46	47	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e34728	10.1371/journal.pone.0034728	http://dx.doi.org/10.1371/journal.pone.0034728			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529930	Green Submitted, gold, Green Published			2022-12-27	WOS:000305350600023
J	Schecklmann, M; Vielsmeier, V; Steffens, T; Landgrebe, M; Langguth, B; Kleinjung, T				Schecklmann, Martin; Vielsmeier, Veronika; Steffens, Thomas; Landgrebe, Michael; Langguth, Berthold; Kleinjung, Tobias			Relationship between Audiometric Slope and Tinnitus Pitch in Tinnitus Patients: Insights into the Mechanisms of Tinnitus Generation	PLOS ONE			English	Article							HEARING-LOSS; VALIDATION	Background: Different mechanisms have been proposed to be involved in tinnitus generation, among them reduced lateral inhibition and homeostatic plasticity. On a perceptual level these different mechanisms should be reflected by the relationship between the individual audiometric slope and the perceived tinnitus pitch. Whereas some studies found the tinnitus pitch corresponding to the maximum hearing loss, others stressed the relevance of the edge frequency. This study investigates the relationship between tinnitus pitch and audiometric slope in a large sample. Methodology: This retrospective observational study analyzed 286 patients. The matched tinnitus pitch was compared to the frequency of maximum hearing loss and the edge of the audiogram (steepest hearing loss) by t-tests and correlation coefficients. These analyses were performed for the whole group and for sub-groups (uni- vs. bilateral (117 vs. 338 ears), pure-tone vs. narrow-band (340 vs. 115 ears), and low and high audiometric slope (114 vs. 113 ears)). Findings: For the right ear, tinnitus pitch was in the same range and correlated significantly with the frequency of maximum hearing loss, but differed from and did not correlate with the edge frequency. For the left ear, similar results were found but the correlation between tinnitus pitch and maximum hearing loss did not reach significance. Sub-group analyses (bi- and unilateral, tinnitus character, slope steepness) revealed identical results except for the sub-group with high audiometric slope which revealed a higher frequency of maximum hearing loss as compared to the tinnitus pitch. Conclusion: The study-results confirm a relationship between tinnitus pitch and maximum hearing loss but not to the edge frequency, suggesting that tinnitus is rather a fill-in-phenomenon resulting from homeostatic mechanisms, than the result of deficient lateral inhibition. Sub-group analyses suggest that audiometric steepness and the side of affected ear affect this relationship. Future studies should control for these potential confounding factors.	[Schecklmann, Martin; Landgrebe, Michael; Langguth, Berthold] Univ Regensburg, Dept Psychiat & Psychotherapy, Regensburg, Germany; [Schecklmann, Martin; Vielsmeier, Veronika; Landgrebe, Michael; Langguth, Berthold; Kleinjung, Tobias] Univ Regensburg, Interdisciplinary Tinnitus Clin, Regensburg, Germany; [Vielsmeier, Veronika; Steffens, Thomas; Kleinjung, Tobias] Univ Regensburg, Dept Otorhinolaryngol, Regensburg, Germany; [Vielsmeier, Veronika; Steffens, Thomas; Kleinjung, Tobias] Univ Zurich, Dept Otorhinolaryngol, Zurich, Switzerland	University of Regensburg; University of Regensburg; University of Regensburg; University of Zurich	Schecklmann, M (corresponding author), Univ Regensburg, Dept Psychiat & Psychotherapy, Regensburg, Germany.	tobias.kleinjung@usz.ch	Kleinjung, Tobias/AAJ-3141-2020; Langguth, Berthold/AAP-2638-2021	Kleinjung, Tobias/0000-0003-3867-234X; 	Tinnitus Research Initiative (TRI)	Tinnitus Research Initiative (TRI)	The study was funded in part by the Tinnitus Research Initiative (TRI). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	De Ridder D, 2011, P NATL ACAD SCI USA, V108, P8075, DOI 10.1073/pnas.1018466108; GOEBEL G, 1994, HNO, V42, P166; Henry JA, 2006, ACTA OTO-LARYNGOL, V126, P34, DOI 10.1080/03655230600895291; Henry J A, 1999, J Am Acad Audiol, V10, P261; Hine DW, 2007, PSYCHOL ASSESSMENT, V19, P347, DOI 10.1037/1040-3590.19.3.347; Kaltenbach JA, 2011, HEARING RES, V276, P52, DOI 10.1016/j.heares.2010.12.003; Kleinjung T, 2007, PSYCHIAT PRAX, V34, pS140, DOI 10.1055/s-2006-940218; Konig O, 2006, HEARING RES, V221, P59, DOI 10.1016/j.heares.2006.07.007; Landgrebe M, 2010, BMC MED INFORM DECIS, V10, DOI 10.1186/1472-6947-10-42; Langguth B, 2007, PROG BRAIN RES, V166, P525, DOI 10.1016/S0079-6123(07)66050-6; Llinas RR, 1999, P NATL ACAD SCI USA, V96, P15222, DOI 10.1073/pnas.96.26.15222; Martines F, 2010, AURIS NASUS LARYNX, V37, P685, DOI 10.1016/j.anl.2010.03.008; Moffat G, 2009, HEARING RES, V254, P82, DOI 10.1016/j.heares.2009.04.016; Moller AR, 2003, OTOLARYNG CLIN N AM, V36, P249, DOI 10.1016/S0030-6665(02)00170-6; Moore BCJ, 2010, HEARING RES, V261, P51, DOI 10.1016/j.heares.2010.01.003; Moxon EC, 1970, SENSORINEURAL HEARIN; Norena A, 2002, AUDIOL NEURO-OTOL, V7, P358, DOI 10.1159/000066156; Norena AJ, 2011, NEUROSCI BIOBEHAV R, V35, P1089, DOI 10.1016/j.neubiorev.2010.11.003; Ochi K, 2003, LARYNGOSCOPE, V113, P427, DOI 10.1097/00005537-200303000-00007; Pan T, 2009, INT J AUDIOL, V48, P277, DOI 10.1080/14992020802581974; Roberts LE, 2006, ACTA OTO-LARYNGOL, V126, P27, DOI 10.1080/03655230600895358; Roberts LE, 2010, J NEUROSCI, V30, P14972, DOI 10.1523/JNEUROSCI.4028-10.2010; ROBERTSON D, 1989, J COMP NEUROL, V282, P456, DOI 10.1002/cne.902820311; Schaette R, 2010, HEARING RES, V269, P95, DOI 10.1016/j.heares.2010.06.022; Schaette R, 2009, J NEUROPHYSIOL, V101, P3042, DOI 10.1152/jn.91256.2008; Sereda M, 2011, INT J AUDIOL, V50, P303, DOI 10.3109/14992027.2010.551221; Tyler R S, 1983, Br J Audiol, V17, P101, DOI 10.3109/03005368309078916; Tyler R.S., 2000, TINNITUS HDB, P149	28	85	89	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e34878	10.1371/journal.pone.0034878	http://dx.doi.org/10.1371/journal.pone.0034878			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529949	Green Submitted, gold, Green Accepted, Green Published			2022-12-27	WOS:000305350600036
J	Simon, E; Petke, D; Boger, C; Behrens, HM; Warneke, V; Ebert, M; Rocken, C				Simon, Eva; Petke, Diana; Boeger, Christine; Behrens, Hans-Michael; Warneke, Viktoria; Ebert, Matthias; Roecken, Christoph			The Spatial Distribution of LGR5(+) Cells Correlates With Gastric Cancer Progression	PLOS ONE			English	Article							COUPLED RECEPTOR GPR49; STEM-CELLS; WNT/BETA-CATENIN; SOLID TUMORS; HUMAN COLON; EXPRESSION; MARKER; OVEREXPRESSION; MUSASHI-1; WNT	In this study we tested the prevalence, histoanatomical distribution and tumour biological significance of the Wnt target protein and cancer stem cell marker LGR5 in tumours of the human gastrointestinal tract. Differential expression of LGR5 was studied on transcriptional (real-time polymerase chain reaction) and translational level (immunohistochemistry) in malignant and corresponding non-malignant tissues of 127 patients comprising six different primary tumour sites, i.e. oesophagus, stomach, liver, pancreas, colon and rectum. The clinico-pathological significance of LGR5 expression was studied in 100 patients with gastric carcinoma (GC). Non-neoplastic tissue usually harboured only very few scattered LGR5(+) cells. The corresponding carcinomas of the oesophagus, stomach, liver, pancreas, colon and rectum showed significantly more LGR5(+) cells as well as significantly higher levels of LGR5-mRNA compared with the corresponding non-neoplastic tissue. Double staining experiments revealed a coexpression of LGR5 with the putative stem cell markers CD44, Musashi-1 and ADAM17. Next we tested the hypothesis that the sequential changes of gastric carcinogenesis, i.e. chronic atrophic gastritis, intestinal metaplasia and invasive carcinoma, are associated with a reallocation of the LGR5(+) cells. Interestingly, the spatial distribution of LGR5 changed: in non-neoplastic stomach mucosa, LGR5(+) cells were found predominantly in the mucous neck region; in intestinal metaplasia LGR5(+) cells were localized at the crypt base, and in GC LGR5(+) cells were present at the luminal surface, the tumour centre and the invasion front. The expression of LGR5 in the tumour centre and invasion front of GC correlated significantly with the local tumour growth (T-category) and the nodal spread (N-category). Furthermore, patients with LGR5(+) GCs had a shorter median survival (28.0 +/- 8.6 months) than patients with LGR5(+) GCs (54.5 +/- 6.3 months). Our results show that LGR5 is differentially expressed in gastrointestinal cancers and that the spatial histoanatomical distribution of LGR5(+) cells has to be considered when their tumour biological significance is sought.	[Simon, Eva; Petke, Diana; Boeger, Christine; Behrens, Hans-Michael; Warneke, Viktoria; Roecken, Christoph] Univ Kiel, Inst Pathol, D-2300 Kiel, Germany; [Ebert, Matthias] Heidelberg Univ, Fac Clin Med Mannheim, Dept Med 2, D-6800 Mannheim, Germany	University of Kiel; Ruprecht Karls University Heidelberg	Rocken, C (corresponding author), Univ Kiel, Inst Pathol, D-2300 Kiel, Germany.	christoph.roecken@uksh.de	Halske, Christine/K-1662-2017; Röcken, Christoph/A-9239-2010	Halske, Christine/0000-0001-7986-102X; Röcken, Christoph/0000-0002-6989-8002				Alkatout Ibrahim, 2008, P165, DOI 10.1007/978-1-4020-8274-0_10; Barker N, 2010, GASTROENTEROLOGY, V138, P1681, DOI 10.1053/j.gastro.2010.03.002; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Bjelakovic G, 2008, ALIMENT PHARM THER, V28, P689, DOI 10.1111/j.1365-2036.2008.03785.x; Boyle P., 2009, WORLD CANC REPORT 20; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; Cho RW, 2008, CURR OPIN GENET DEV, V18, P48, DOI 10.1016/j.gde.2008.01.017; CORREA P, 1992, CANCER RES, V52, P6735; Danciu M, 2005, Rev Med Chir Soc Med Nat Iasi, V109, P854; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; Draheim KM, 2011, METHODS MOL BIOL, V750, P261, DOI 10.1007/978-1-61779-145-1_18; Ebert MPA, 2006, ANN ONCOL, V17, pX253, DOI 10.1093/annonc/mdl269; Fan XS, 2010, INT J COLORECTAL DIS, V25, P583, DOI 10.1007/s00384-010-0903-z; Fanjul M, 2010, J HISTOCHEM CYTOCHEM, V58, P807, DOI 10.1369/jhc.2010.955807; Fenoglio-Preiser C, 2000, WHO CLASSIFICATION T, P39; Ferlay J, 2010, EUR J CANCER, V46, P765, DOI 10.1016/j.ejca.2009.12.014; Frank NY, 2010, J CLIN INVEST, V120, P41, DOI 10.1172/JCI41004; Glinka A, 2011, EMBO REP, V12, P1055, DOI 10.1038/embor.2011.175; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hemmings C, 2010, PATHOLOGY, V42, P105, DOI 10.3109/00313020903488773; Ingold B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010087; Leushacke M, 2012, ONCOGENE, V31, P3009, DOI 10.1038/onc.2011.479; Li F, 2007, CELL RES, V17, P3, DOI 10.1038/sj.cr.7310118; McClanahan T, 2006, CANCER BIOL THER, V5, P419, DOI 10.4161/cbt.5.4.2521; Nishimura S, 2003, DIGEST DIS SCI, V48, P1523, DOI 10.1023/A:1024763723240; Qiao XTT, 2011, J GASTROENTEROL, V46, P855, DOI 10.1007/s00535-011-0413-y; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Rezza A, 2010, J CELL SCI, V123, P3256, DOI 10.1242/jcs.065284; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Schmuck R, 2011, AM J PATHOL, V178, P1792, DOI 10.1016/j.ajpath.2010.12.043; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Sobin L.H., 2009, INT UNION CANC UICC, V7th; Sureban SM, 2008, GASTROENTEROLOGY, V134, P1448, DOI 10.1053/j.gastro.2008.02.057; Takahashi H, 2011, ANN SURG ONCOL, V18, P1166, DOI 10.1245/s10434-010-1373-9; Takaishi S, 2009, STEM CELLS, V27, P1006, DOI 10.1002/stem.30; Takeda K, 2011, ANTICANCER RES, V31, P263; Tanese K, 2008, AM J PATHOL, V173, P835, DOI 10.2353/ajpath.2008.071091; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408; Todaro M, 2010, GASTROENTEROLOGY, V138, P2151, DOI 10.1053/j.gastro.2009.12.063; Uchida H, 2010, CANCER SCI, V101, P1731, DOI 10.1111/j.1349-7006.2010.01571.x; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Walker F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022733; Wang T, 2011, BRIT J CANCER, V105, P658, DOI 10.1038/bjc.2011.287; Welte Y, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-6; Wenke AK, 2007, CELL ONCOL, V29, P373	46	83	92	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35486	10.1371/journal.pone.0035486	http://dx.doi.org/10.1371/journal.pone.0035486			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22530031	Green Published, gold, Green Submitted			2022-12-27	WOS:000305350600087
J	Alieva, M; Bago, JR; Aguilar, E; Soler-Botija, C; Vila, OF; Molet, J; Gambhir, SS; Rubio, N; Blanco, J				Alieva, Maria; Bago, Juli R.; Aguilar, Elisabet; Soler-Botija, Carolina; Vila, Olaia F.; Molet, Joan; Gambhir, Sanjiv S.; Rubio, Nuria; Blanco, Jeronimo			Glioblastoma Therapy with Cytotoxic Mesenchymal Stromal Cells Optimized by Bioluminescence Imaging of Tumor and Therapeutic Cell Response	PLOS ONE			English	Article							HUMAN ADIPOSE-TISSUE; CANCER GENE-THERAPY; STEM-CELLS; BONE-MARROW; SUICIDE GENE; VEHICLES; GLIOMAS; EXPRESSION; CARCINOMA; VECTORS	Genetically modified adipose tissue derived mesenchymal stromal cells (hAMSCs) with tumor homing capacity have been proposed for localized therapy of chemo- and radiotherapy resistant glioblastomas. We demonstrate an effective procedure to optimize glioblastoma therapy based on the use of genetically modified hAMSCs and in vivo non invasive monitoring of tumor and therapeutic cells. Glioblastoma U87 cells expressing Photinus pyralis luciferase (Pluc) were implanted in combination with hAMSCs expressing a trifunctional Renilla reniformis luciferase-red fluorescent protein-thymidine kinase reporter in the brains of SCID mice that were subsequently treated with ganciclovir (GCV). The resulting optimized therapy was effective and monitoring of tumor cells by bioluminescence imaging (BLI) showed that after 49 days GCV treatment reduced significantly the hAMSC treated tumors; by a factor of 10(4) relative to controls. Using a Pluc reporter regulated by an endothelial specific promoter and in vivo BLI to image hAMSC differentiation we gained insight on the therapeutic mechanism. Implanted hAMSCs homed to tumor vessels, where they differentiated to endothelial cells. We propose that the tumor killing efficiency of genetically modified hAMSCs results from their association with the tumor vascular system and should be useful vehicles to deliver localized therapy to glioblastoma surgical borders following tumor resection.	[Alieva, Maria; Bago, Juli R.; Aguilar, Elisabet; Vila, Olaia F.; Rubio, Nuria; Blanco, Jeronimo] CIBER BBN, Cardiovasc Res Ctr, CSIC ICCC, Barcelona, Spain; [Soler-Botija, Carolina] Hosp Univ Germans & Trias Pujol, Serv Cardiol, Badalona, Spain; [Molet, Joan] Hosp Santa Creu & Sant Pau, Neurosurg Unit, Barcelona, Spain; [Gambhir, Sanjiv S.] Stanford Univ, Dept Radiol, Bio X Program, Stanford, CA 94305 USA	CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Institut Catala de Ciencies Cardiovasculars (ICCC); Hospital Germans Trias i Pujol; Hospital of Santa Creu i Sant Pau; Stanford University	Alieva, M (corresponding author), CIBER BBN, Cardiovasc Res Ctr, CSIC ICCC, Barcelona, Spain.	jblancof@csic-iccc.org	BAGO, JULI R/M-3526-2018; Rubio, Nuria/H-3156-2015; Blanco, Jeronimo/H-2764-2015; Alieva, Maria/ACQ-0401-2022	BAGO, JULI R/0000-0002-2862-4048; Rubio, Nuria/0000-0003-2471-4684; Blanco, Jeronimo/0000-0003-3765-0640; Aguilar Bohorquez, Elisabet/0000-0002-3687-3861; Soler-Botija, Carolina/0000-0002-4584-9134; Vila, Olaia F/0000-0002-1238-2275; Alieva, Maria/0000-0002-1425-9908	EU [214402 Acronym Angioscaff]; Ministerio de Ciencia e Innovacio [SAF2009-07102]; Red Tematica de Investigacion Cooperativa TerCel (Instituto de Salud Carlos III); Ministerio de Ciencia e Innovacion [SAF2009-07315E Accion Explora]	EU(European Commission); Ministerio de Ciencia e Innovacio(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Red Tematica de Investigacion Cooperativa TerCel (Instituto de Salud Carlos III)(Instituto de Salud Carlos III); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	This work was supported by collaborative project no214402 Acronym Angioscaff (EU-FP7), SAF2009-07102 (Ministerio de Ciencia e Innovacio), Red Tematica de Investigacion Cooperativa TerCel (Instituto de Salud Carlos III), SAF2009-07315E Accion Explora (Ministerio de Ciencia e Innovacion). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboody KS, 2008, GENE THER, V15, P739, DOI 10.1038/gt.2008.41; Altaner C, 2008, CANCER LETT, V270, P191, DOI 10.1016/j.canlet.2008.04.023; Argyriou AA, 2009, MOL MED, V15, P115, DOI 10.2119/molmed.2008.00123; Benedetti S, 2000, NAT MED, V6, P447, DOI 10.1038/74710; Bexell D, 2010, MOL THER, V18, P1067, DOI 10.1038/mt.2010.58; Bexell D, 2009, MOL THER, V17, P183, DOI 10.1038/mt.2008.229; Buckner JC, 2007, MAYO CLIN PROC, V82, P1271, DOI 10.4065/82.10.1271; Carroll NM, 1997, J SURG RES, V69, P413, DOI 10.1006/jsre.1997.5089; CARUSO M, 1993, P NATL ACAD SCI USA, V90, P7024, DOI 10.1073/pnas.90.15.7024; Cihova M, 2011, INT J CANC; Dasari VR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011813; Djouad F, 2003, BLOOD, V102, P3837, DOI 10.1182/blood-2003-04-1193; Ehtesham M, 2002, CANCER RES, V62, P5657; Hall B, 2007, INT J HEMATOL, V86, P8, DOI 10.1532/IJH97.06230; Hamada H, 2005, CANCER SCI, V96, P149, DOI 10.1111/j.1349-7006.2005.00032.x; Huang Q, 2007, J NEURO-ONCOL, V82, P239, DOI 10.1007/s11060-006-9279-x; Kucerova L, 2007, CANCER RES, V67, P6304, DOI 10.1158/0008-5472.CAN-06-4024; Marconi P, 2000, MOL THER, V1, P71, DOI 10.1006/mthe.1999.0008; Menon LG, 2009, STEM CELLS, V27, P2320, DOI 10.1002/stem.136; MOOLTEN FL, 1986, CANCER RES, V46, P5276; Nakamizo A, 2005, CANCER RES, V65, P3307, DOI 10.1158/0008-5472.CAN-04-1874; Nakanishi C, 2011, CIRC J, V75, P2260, DOI 10.1253/circj.CJ-11-0246; Oertel S, 2006, STRAHLENTHER ONKOL, V182, P400, DOI 10.1007/s00066-006-1445-8; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Ray P, 2004, CANCER RES, V64, P1323, DOI 10.1158/0008-5472.CAN-03-1816; Reiser J, 2005, EXPERT OPIN BIOL TH, V5, P1571, DOI 10.1517/14712598.5.12.1571; Sangro B, 2010, CANCER GENE THER, V17, P837, DOI 10.1038/cgt.2010.40; Sanz L, 2008, MICROVASC RES, V75, P308, DOI 10.1016/j.mvr.2007.11.007; Schneider A, 2010, DTSCH ARZTEBL INT, V107, P776, DOI [10.3238/arztebl.2010.0799, 10.3238/arztebl.2010.0776]; Schneider HJ, 2010, DTSCH ARZTEBL INT, V107, P826, DOI 10.3238/arztebl.2010.0826a; van der Bogt KEA, 2009, TRANSPLANTATION, V87, P642, DOI 10.1097/TP.0b013e31819609d9; Vilalta M, 2009, GENE THER, V16, P547, DOI 10.1038/gt.2008.176; Vilalta M, 2008, STEM CELLS DEV, V17, P993, DOI 10.1089/scd.2007.0201; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	35	37	37	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e35148	10.1371/journal.pone.0035148	http://dx.doi.org/10.1371/journal.pone.0035148			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22529983	gold, Green Published, Green Submitted			2022-12-27	WOS:000305347400033
J	Kacsoh, BZ; Schlenke, TA				Kacsoh, Balint Z.; Schlenke, Todd A.			High Hemocyte Load Is Associated with Increased Resistance against Parasitoids in Drosophila suzukii, a Relative of D. melanogaster	PLOS ONE			English	Article							CELLULAR IMMUNE-RESPONSE; SPOTTED WING DROSOPHILA; TABIDA NEES BRACONIDAE; LEPTOPILINA-BOULARDI; EVOLUTIONARY ECOLOGY; HOST DISCRIMINATION; ASOBARA-TABIDA; HYMENOPTERA; LARVAE; ENCAPSULATION	Among the most common parasites of Drosophila in nature are parasitoid wasps, which lay their eggs in fly larvae and pupae. D. melanogaster larvae can mount a cellular immune response against wasp eggs, but female wasps inject venom along with their eggs to block this immune response. Genetic variation in flies for immune resistance against wasps and genetic variation in wasps for virulence against flies largely determines the outcome of any fly-wasp interaction. Interestingly, up to 90% of the variation in fly resistance against wasp parasitism has been linked to a very simple mechanism: flies with increased constitutive blood cell (hemocyte) production are more resistant. However, this relationship has not been tested for Drosophila hosts outside of the melanogaster subgroup, nor has it been tested across a diversity of parasitoid wasp species and strains. We compared hemocyte levels in two fly species from different subgroups, D. melanogaster and D. suzukii, and found that D. suzukii constitutively produces up to five times more hemocytes than D. melanogaster. Using a panel of 24 parasitoid wasp strains representing fifteen species, four families, and multiple virulence strategies, we found that D. suzukii was significantly more resistant to wasp parasitism than D. melanogaster. Thus, our data suggest that the relationship between hemocyte production and wasp resistance is general. However, at least one sympatric wasp species was a highly successful infector of D. suzukii, suggesting specialists can overcome the general resistance afforded to hosts by excessive hemocyte production. Given that D. suzukii is an emerging agricultural pest, identification of the few parasitoid wasps that successfully infect D. suzukii may have value for biocontrol.	[Kacsoh, Balint Z.; Schlenke, Todd A.] Emory Univ, Dept Biol, Atlanta, GA 30322 USA	Emory University	Kacsoh, BZ (corresponding author), Emory Univ, Dept Biol, Atlanta, GA 30322 USA.	tschlen@emory.edu	Kacsoh, Balint/AAF-2165-2019	Kacsoh, Balint/0000-0001-9171-0611; Schlenke, Todd/0000-0003-3091-3057	National Institutes of Health (NIH) [AI081879]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081879] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by National Institutes of Health (NIH) grant AI081879 to TAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allemand R, 2002, ANN SOC ENTOMOL FR, V38, P319, DOI 10.1080/00379271.2002.10697346; Askew R.R., 1986, P225; BAKKER K, 1967, ENTOMOL EXP APPL, V10, P295, DOI 10.1007/BF00430053; BAKKER K, 1972, OECOLOGIA, V10, P29, DOI 10.1007/BF00822760; Beers EH, 2011, PEST MANAG SCI, V67, P1386, DOI 10.1002/ps.2279; Bolda MP, 2010, GIANNINI FDN AGR EC, V13, P5; BREHELIN M, 1982, CELL TISSUE RES, V221, P607; Bruck DJ, 2011, PEST MANAG SCI, V67, P1375, DOI 10.1002/ps.2242; Calabria G, 2012, J APPL ENTOMOL, V136, P139, DOI 10.1111/j.1439-0418.2010.01583.x; Carton Y, 2001, IMMUNOGENETICS, V52, P157; CARTON Y, 1981, BIOL J LINN SOC, V16, P227, DOI 10.1111/j.1095-8312.1981.tb01849.x; Carton Y., 1986, P347; Carton Y, 2008, INSECT SCI, V15, P67, DOI 10.1111/j.1744-7917.2008.00188.x; Chiu HL, 2001, ADV EXP MED BIOL, V484, P161; Clausen C.P., 1978, INTRO PARASITES PRED; DeBach P, 1974, BIOL CONTROL NATURAL; Dent D., 1995, INTEGRATED PEST MANA; Dowton M, 2001, BIOL J LINN SOC, V74, P87, DOI 10.1006/bijl.2001.0577; DRIESSEN G, 1990, NETH J ZOOL, V40, P409, DOI 10.1163/156854290X00019; Dubuffet A, 2009, ADV PARASIT, V70, P147, DOI 10.1016/S0065-308X(09)70006-5; Dupas S, 1999, EVOL ECOL, V13, P211, DOI 10.1023/A:1006691431658; Eslin P, 1996, CAN J ZOOL, V74, P2193, DOI 10.1139/z96-248; Eslin P, 1998, J INSECT PHYSIOL, V44, P807, DOI 10.1016/S0022-1910(98)00013-4; Eslin P, 2006, DEV COMP IMMUNOL, V30, P977, DOI 10.1016/j.dci.2006.02.007; Eslin P, 2009, ADV PARASIT, V70, P189, DOI 10.1016/S0065-308X(09)70007-7; Fellowes MDE, 2000, HEREDITY, V84, P1, DOI 10.1046/j.1365-2540.2000.00685.x; Fleury F, 2004, GENETICA, V120, P181, DOI 10.1023/B:GENE.0000017640.78087.9e; Fleury F, 2009, ADV PARASIT, V70, P3, DOI 10.1016/S0065-308X(09)70001-6; Godfray H. C. J., 1994, PARASITOIDS BEHAV EV, DOI 10.1515/9780691207025; Goodhue RE, 2011, PEST MANAG SCI, V67, P1396, DOI 10.1002/ps.2259; Greathead D.J., 1986, P289; Hauser M, 2011, PEST MANAG SCI, V67, P1352, DOI 10.1002/ps.2265; Havard S, 2009, CAN J ZOOL, V87, P635, DOI 10.1139/Z09-046; HERTLEIN MB, 1986, ENVIRON ENTOMOL, V15, P859, DOI 10.1093/ee/15.4.859; Honti V, 2010, MOL IMMUNOL, V47, P1997, DOI 10.1016/j.molimm.2010.04.017; Huffaker C.B, 1971, BIOL CONTROL; Ideo S, 2008, ENTOMOL SCI, V11, P1, DOI 10.1111/j.1479-8298.2007.00244.x; JANSSEN A, 1988, NETH J ZOOL, V38, P61, DOI 10.1163/156854288X00049; Kraaijeveld AR, 2001, P ROY SOC B-BIOL SCI, V268, P259, DOI 10.1098/rspb.2000.1354; Kraaijeveld AR, 2001, EVOLUTION, V55, P1815, DOI 10.1111/j.0014-3820.2001.tb00830.x; La Salle J., 1993, HYMENOPTERA BIODIVER; Labrosse C, 2005, J INSECT PHYSIOL, V51, P161, DOI 10.1016/j.jinsphys.2004.10.004; Lanot R, 2001, DEV BIOL, V230, P243, DOI 10.1006/dbio.2000.0123; Lee JC, 2011, PEST MANAG SCI, V67, P1349, DOI 10.1002/ps.2271; LERNER AB, 1950, PHYSIOL REV, V30, P91, DOI 10.1152/physrev.1950.30.1.91; Markus R, 2005, IMMUNOL LETT, V101, P108, DOI 10.1016/j.imlet.2005.03.021; Mitsui H, 2007, J NAT HIST, V41, P1731, DOI 10.1080/00222930701504797; Moreau SJM, 2005, DEV COMP IMMUNOL, V29, P205, DOI 10.1016/j.dci.2004.07.002; Moreau SJM, 2003, DEV COMP IMMUNOL, V27, P273, DOI 10.1016/S0145-305X(02)00101-5; Poirie M, 2000, P ROY SOC B-BIOL SCI, V267, P1417, DOI 10.1098/rspb.2000.1158; RIZKI MOHAMMED TAHIR MIRZA, 1957, J MORPH, V100, P437, DOI 10.1002/jmor.1051000303; RIZKI MTM, 1959, J BIOPHYS BIOCHEM CY, V5, P235, DOI 10.1083/jcb.5.2.235; RIZKI RM, 1990, P NATL ACAD SCI USA, V87, P8388, DOI 10.1073/pnas.87.21.8388; RIZKI TM, 1992, DEV COMP IMMUNOL, V16, P103, DOI 10.1016/0145-305X(92)90011-Z; ROUAULT J, 1979, CR ACAD SCI D NAT, V289, P643; Russo J, 2001, J INSECT PHYSIOL, V47, P167, DOI 10.1016/S0022-1910(00)00102-5; Schilthuizen M, 1998, SYST ENTOMOL, V23, P253, DOI 10.1046/j.1365-3113.1998.00049.x; Schlenke TA, 2007, PLOS PATHOG, V3, P1486, DOI 10.1371/journal.ppat.0030158; Schmid-Hempel P, 2005, ANNU REV ENTOMOL, V50, P529, DOI 10.1146/annurev.ento.50.071803.130420; Seyahooei MA, 2011, BIOL J LINN SOC, V103, P45, DOI 10.1111/j.1095-8312.2011.01637.x; Sheldon BC, 1996, TRENDS ECOL EVOL, V11, P317, DOI 10.1016/0169-5347(96)10039-2; Siva-Jothy MT, 2005, ADV INSECT PHYSIOL, V32, P1, DOI 10.1016/S0065-2806(05)32001-7; Sorrentino RP, 2004, GENETICS, V166, P1343, DOI 10.1534/genetics.166.3.1343; van Lenteren J.C., 1981, P153; van Lenteren JC, 1976, NETHERLANDS J ZOOLOG, V26, P1; VANALPHEN JJM, 1982, NETH J ZOOL, V32, P232, DOI 10.1163/002829682X00157; VANALPHEN JJM, 1982, NETH J ZOOL, V32, P194, DOI 10.1163/002829682X00139; VET LEM, 1984, ANIM BEHAV, V32, P871, DOI 10.1016/S0003-3472(84)80164-5; WAJNBERG E, 1985, ENTOMOPHAGA, V30, P187, DOI 10.1007/BF02372252; Walsh DB, 2011, J INTEGR PEST MANAG, V2, DOI 10.1603/IPM10010; Williams MJ, 2005, GENES CELLS, V10, P813, DOI 10.1111/j.1365-2443.2005.00883.x	71	148	150	1	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e34721	10.1371/journal.pone.0034721	http://dx.doi.org/10.1371/journal.pone.0034721			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22529929	Green Submitted, gold, Green Published			2022-12-27	WOS:000305347400017
J	Morin, L; Aveyard, R; Lidbetter, JR; Wilson, PG				Morin, Louise; Aveyard, Ruth; Lidbetter, Jonathan R.; Wilson, Peter G.			Investigating the Host-Range of the Rust Fungus Puccinia psidii sensu lato across Tribes of the Family Myrtaceae Present in Australia	PLOS ONE			English	Article							MELALEUCA-QUINQUENERVIA; EUCALYPTUS RUST; GUAVA RUST; DISEASE; THREAT; AGENT	The exotic rust fungus Puccinia psidii sensu lato was first detected in Australia in April 2010. This study aimed to determine the host-range potential of this accession of the rust by testing its pathogenicity on plants of 122 taxa, representative of the 15 tribes of the subfamily Myrtoideae in the family Myrtaceae. Each taxon was tested in two separate trials (unless indicated otherwise) that comprised up to five replicates per taxon and six replicates of a positive control (Syzygium jambos). No visible symptoms were observed on the following four taxa in either trial: Eucalyptus grandis x camaldulensis, E. moluccana, Lophostemon confertus and Sannantha angusta. Only small chlorotic or necrotic flecks without any uredinia (rust fruiting bodies) were observed on inoculated leaves of seven other taxa (Acca sellowiana, Corymbia calophylla 'Rosea', Lophostemon suaveolens, Psidium cattleyanum, P. guajava 'Hawaiian' and 'Indian', Syzygium unipunctatum). Fully-developed uredinia were observed on all replicates across both trials of 28 taxa from 8 tribes belonging to the following 17 genera: Agonis, Austromyrtus, Beaufortia, Callistemon, Calothamnus, Chamelaucium, Darwinia, Eucalyptus, Gossia, Kunzea, Leptospermum, Melaleuca, Metrosideros, Syzygium, Thryptomene, Tristania, Verticordia. In contrast, the remaining 83 taxa inoculated, including the majority of Corymbia and Eucalyptus species, developed a broad range of symptoms, often across the full spectrum, from fully-developed uredinia to no visible symptoms. These results were encouraging as they indicate that some levels of genetic resistance to the rust possibly exist in these taxa. Overall, our results indicated no apparent association between the presence or absence of disease symptoms and the phylogenetic relatedness of taxa. It is most likely that the majority of the thousands of Myrtaceae species found in Australia have the potential to become infected to some degree by the rust, although this wide host range may not be fully realized in the field.	[Morin, Louise; Aveyard, Ruth] CSIRO, Ecosyst Sci, Canberra, ACT, Australia; [Lidbetter, Jonathan R.] Cent Coast Primary Ind Ctr, New S Wales Dept Primary Ind, Gosford, NSW, Australia; [Wilson, Peter G.] Royal Bot Gardens & Domain Trust, Sydney, NSW, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); NSW Department of Primary Industries	Morin, L (corresponding author), CSIRO, Ecosyst Sci, Canberra, ACT, Australia.	louise.morin@csiro.au	Morin, Louise/B-4822-2009	Morin, Louise/0000-0002-9515-2255	National Management Group on Myrtle Rust (under the auspices of the Australian Government); Commonwealth Scientific and Industrial Research Organisation (CSIRO); New South Wales Department of Primary Industries; Royal Botanic Gardens and Domain Trust	National Management Group on Myrtle Rust (under the auspices of the Australian Government); Commonwealth Scientific and Industrial Research Organisation (CSIRO)(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); New South Wales Department of Primary Industries; Royal Botanic Gardens and Domain Trust	Financial support was provided by the National Management Group on Myrtle Rust (under the auspices of the Australian Government) as part of the nationally-funded interim response plan for myrtle rust, with co-investments from the Commonwealth Scientific and Industrial Research Organisation (CSIRO), New South Wales Department of Primary Industries, and the Royal Botanic Gardens and Domain Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfenas AC, 2005, AUSTRALAS PLANT PATH, V34, P285, DOI 10.1071/AP05023; Alfenas AC, 2003, AUSTRALAS PLANT PATH, V32, P325, DOI 10.1071/AP03021; Anderson R, 2006, WORLDWIDE PUCCINIA P; Aparecido Christiane C., 2003, Summa Phytopathologica, V29, P239; Australian Plant Census, 2011, IBIS DAT; Brown JKM, 2002, SCIENCE, V297, P537, DOI 10.1126/science.1072678; Carnegie AJ, 2010, AUSTRALAS PLANT PATH, V39, P463, DOI 10.1071/AP10102; Carnegie AJ, 2012, AUSTRALAS PLANT PATH, V41, P13, DOI 10.1007/s13313-011-0082-6; Carnegie AJ, 2011, AUSTRALAS PLANT PATH, V40, P346, DOI 10.1007/s13313-011-0066-6; Coelho Lisias, 2001, Summa Phytopathologica, V27, P295; Coutinho TA, 1998, PLANT DIS, V82, P819, DOI 10.1094/PDIS.1998.82.7.819; ESHED N, 1981, PHYTOPATHOLOGY, V71, P156, DOI 10.1094/Phyto-71-156; Evans K. J., 2011, Plant Pathology, V60, P532, DOI 10.1111/j.1365-3059.2010.02396.x; Ferreira F. A., 1983, Revista Arvore, V7, P91; Glen M, 2007, AUSTRALAS PLANT PATH, V36, P1, DOI 10.1071/AP06088; Govaerts R, 2011, WORLD CHECKLIST MYRT; Grgurinovic C. A., 2006, Bulletin OEPP, V36, P486; Junghans DT, 2003, THEOR APPL GENET, V108, P175, DOI 10.1007/s00122-003-1415-9; Kawanishi T, 2009, J GEN PLANT PATHOL, V75, P428, DOI 10.1007/s10327-009-0202-0; Kolmer JA., 2009, ENCY LIFE SCI ELS, P1, DOI [DOI 10.1002/9780470015902.A0021264, 10.1002/9780470015902.a0021264]; Leonard KJ, 2005, MOL PLANT PATHOL, V6, P99, DOI 10.1111/j.1364-3703.2005.00273.x; LOOPE L, 2010, 20101002 US GEOL SUR; MacLachlan JD, 1938, PHYTOPATHOLOGY, V28, P157; MARLATT RB, 1979, PLANT DIS REP, V63, P510; Mellano V, 2006, HLTH GARD HLTH HOME, V1, P3; Morin L, 2011, C20109785 CSIRO EC S; Myerscough Peter J., 1998, Cunninghamia, V5, P787; NSW Department of Primary Industries, 2011, MYRTL RUST HOST LIST; Perez CA, 2011, MYCOL PROG, V10, P273, DOI 10.1007/s11557-010-0698-x; Queensland Department of Primary Industries and Fisheries, 2011, LIST KNOWN PLANTS AF; Rayachhetry MB, 2001, BIOL CONTROL, V22, P38, DOI 10.1006/bcon.2001.0949; Rayachhetry MB, 1997, PLANT DIS, V81, P831, DOI 10.1094/PDIS.1997.81.7.831A; Rayamajhi MB, 2010, BIOL CONTROL, V53, P1, DOI 10.1016/j.biocontrol.2009.07.017; Ribeiro IJA, 2004, ACTA HORTIC, P75, DOI 10.17660/ActaHortic.2004.632.9; RUIZ R A R, 1989, Fitopatologia Brasileira, V14, P70; RYTTER JL, 1984, PLANT DIS, V68, P818, DOI 10.1094/PD-69-818; Simpson JA, 2006, AUSTRALAS PLANT PATH, V35, P549, DOI 10.1071/AP06057; SKINNER DZ, 1995, PLANT DIS, V79, P456, DOI 10.1094/PD-79-0456; Stokstad E, 2007, SCIENCE, V315, P1786, DOI 10.1126/science.315.5820.1786; Tessmann D. J., 2002, Fitopatologia Brasileira, V27, P538, DOI 10.1590/S0100-41582002000500017; Tommerup I. C., 2003, New Zealand Journal of Forestry Science, V33, P420; Uchida J, 2006, PLANT DIS, V90, P524, DOI 10.1094/PD-90-0524C; Uchida JY, 2009, PLANT DIS, V93, P429, DOI 10.1094/PDIS-93-4-0429B; Wilson PG, 2005, PLANT SYST EVOL, V251, P3, DOI 10.1007/s00606-004-0162-y; Zauza EAV, 2010, AUSTRALAS PLANT PATH, V39, P406, DOI 10.1071/AP10077; [Zhuang Jianyun 庄剑云], 2011, [菌物学报, Mygosystema], V30, P853	46	83	87	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e35434	10.1371/journal.pone.0035434	http://dx.doi.org/10.1371/journal.pone.0035434			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523596	Green Submitted, Green Published, gold			2022-12-27	WOS:000305345000069
J	Bury, L; Malara, A; Gresele, P; Balduini, A				Bury, Loredana; Malara, Alessandro; Gresele, Paolo; Balduini, Alessandra			Outside-In Signalling Generated by a Constitutively Activated Integrin alpha(IIb)beta(3) Impairs Proplatelet Formation in Human Megakaryocytes	PLOS ONE			English	Article							RECEPTOR; ECTODOMAIN; PLATELETS	Background: The interaction of megakaryocytes with matrix proteins of the osteoblastic and vascular niche is essential for megakaryocyte maturation and proplatelet formation. Fibrinogen is present in the vascular niche and the fibrinogen receptor alpha(IIb)beta(3) is abundantly expressed on megakaryocytes, however the role of the interaction between fibrinogen and alpha(IIb)beta(3) in proplatelet formation in humans is not yet fully understood. We have recently reported a novel congenital macrothrombocytopenia associated with a heterozygous mutation of the beta(3) subunit of alpha(IIb)beta(3). The origin of thrombocytopenia in this condition remains unclear and this may represent an interesting natural model to get further insight into the role of the megakaryocyte fibrinogen receptor in megakaryopoiesis. Methodology/Principal Findings: Patients' peripheral blood CD45+ cells in culture were differentiated into primary megakaryocytes and their maturation, spreading on different extracellular matrix proteins, and proplatelet formation were analyzed. Megakaryocyte maturation was normal but proplatelet formation was severely impaired, with tips decreased in number and larger in size than those of controls. Moreover, megakaryocyte spreading on fibrinogen was abnormal, with 50% of spread cells showing disordered actin distribution and more evident focal adhesion points than stress fibres. Integrin alpha(IIb)beta(3) expression was reduced but the receptor was constitutively activated and a sustained, and substrate-independent, activation of proteins of the outside-in signalling was observed. In addition, platelet maturation from preplatelets was impaired. Conclusions/Significance: Our data show that constitutive activation of alpha(IIb)beta(3)-mediated outside-in signalling in human megakaryocytes negatively influences proplatelet formation, leading to macrothombocytopenia.	[Bury, Loredana; Malara, Alessandro; Gresele, Paolo] Univ Perugia, Dept Internal Med, Div Internal & Cardiovasc Med, I-06100 Perugia, Italy; [Bury, Loredana; Malara, Alessandro; Balduini, Alessandra] Univ Pavia, IRCCS San Matteo Fdn, Dept Biochem, Biotechnol Labs, I-27100 Pavia, Italy	University of Perugia; IRCCS Fondazione San Matteo; University of Pavia	Bury, L (corresponding author), Univ Perugia, Dept Internal Med, Div Internal & Cardiovasc Med, I-06100 Perugia, Italy.	grespa@unipg.it	Bury, Loredana/O-2581-2017; BALDUINI, ALESSANDRA/AAC-3363-2022; Balduini, Alessandra/K-6802-2016; Gresele, Paolo/F-6775-2013; gresele, paolo/AAG-8019-2019; malara, alessandro/K-4027-2016; Bury, Loredana/K-1186-2019	Bury, Loredana/0000-0003-0333-0948; BALDUINI, ALESSANDRA/0000-0003-3145-1245; Balduini, Alessandra/0000-0003-3145-1245; Gresele, Paolo/0000-0001-5365-8445; malara, alessandro/0000-0002-3396-3693; Bury, Loredana/0000-0003-0333-0948	Telethon grant [GGP10155]; Cariplo Foundation [2006.0596/10.8485]	Telethon grant(Fondazione Telethon); Cariplo Foundation(Fondazione Cariplo)	This work was supported by a Telethon grant (GGP10155) to PG and by a Cariplo Foundation grant (2006.0596/10.8485) to AB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avecilla ST, 2004, NAT MED, V10, P64, DOI 10.1038/nm973; Balduini A, 2008, J THROMB HAEMOST, V6, P1900, DOI 10.1111/j.1538-7836.2008.03132.x; Balduini A, 2006, J THROMB HAEMOST, V4, P848, DOI 10.1111/j.1538-7836.2006.01802.x; Balduini A, 2009, J THROMB HAEMOST, V7, P478, DOI 10.1111/j.1538-7836.2008.03255.x; Bender M, 2010, BLOOD, V116, P1767, DOI 10.1182/blood-2010-03-274340; Chen Z, 2007, BLOOD, V110, P171, DOI 10.1182/blood-2007-02-071589; Coller BS, 2008, BLOOD, V112, P3011, DOI 10.1182/blood-2008-06-077891; Ghevaert C, 2008, BLOOD, V111, P3407, DOI 10.1182/blood-2007-09-112615; Giannini S, 2008, CYTOM PART B-CLIN CY, V74B, P194, DOI 10.1002/cyto.b.20396; Gresele P, 2009, HAEMATOL-HEMATOL J, V94, P663, DOI 10.3324/haematol.2008.002246; Italiano JE, 1999, J CELL BIOL, V147, P1299, DOI 10.1083/jcb.147.6.1299; Junt T, 2007, SCIENCE, V317, P1767, DOI 10.1126/science.1146304; Kasirer-Friede A, 2004, BLOOD, V103, P3403, DOI 10.1182/blood-2003-10-3664; KIEFFER N, 1991, J CELL BIOL, V113, P451, DOI 10.1083/jcb.113.2.451; Kunishima S, 2011, BLOOD, V117, P5479, DOI 10.1182/blood-2010-12-323691; Larson MK, 2006, BLOOD, V108, P1509, DOI 10.1182/blood-2005-11-011957; Mekrache M, 2009, BRIT J HAEMATOL, V119, P1024; Nurden AT, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-10; Nurden P, 2010, BLOOD, V115, P2649, DOI 10.1182/blood-2009-07-231886; Obergfell A, 2002, J CELL BIOL, V157, P265, DOI 10.1083/jcb.200112113; Parsons JT, 2000, ONCOGENE, V19, P5606, DOI 10.1038/sj.onc.1203877; Pecci A, 2009, THROMB HAEMOSTASIS, V102, P90, DOI 10.1160/TH09-01-0068; Thon JN, 2010, J CELL BIOL, V191, P861, DOI 10.1083/jcb.201006102; WILLIAMS N, 1982, BRIT J HAEMATOL, V52, P173, DOI 10.1111/j.1365-2141.1982.tb03878.x; Xiong JP, 2009, J CELL BIOL, V186, P589, DOI 10.1083/jcb.200905085; Zhu JH, 2008, MOL CELL, V32, P849, DOI 10.1016/j.molcel.2008.11.018	26	46	47	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e34449	10.1371/journal.pone.0034449	http://dx.doi.org/10.1371/journal.pone.0034449			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22539947	gold, Green Published, Green Submitted			2022-12-27	WOS:000305341000010
J	Fan, BA; Dachrut, S; Coral, H; Yuen, ST; Chu, KM; Law, S; Zhang, LH; Ji, JF; Leung, SY; Chen, X				Fan, Biao; Dachrut, Somkid; Coral, Ho; Yuen, Siu Tsan; Chu, Kent Man; Law, Simon; Zhang, Lianhai; Ji, Jiafu; Leung, Suet Yi; Chen, Xin			Integration of DNA Copy Number Alterations and Transcriptional Expression Analysis in Human Gastric Cancer	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; GENE-EXPRESSION; BREAST-CANCER; HEPATOCELLULAR-CARCINOMA; PANCREATIC-CANCER; PROTEIN EXPRESSION; PROSTATE-CANCER; CELL-LINES; AMPLIFICATION; MYC	Background: Genomic instability with frequent DNA copy number alterations is one of the key hallmarks of carcinogenesis. The chromosomal regions with frequent DNA copy number gain and loss in human gastric cancer are still poorly defined. It remains unknown how the DNA copy number variations contributes to the changes of gene expression profiles, especially on the global level. Principal Findings: We analyzed DNA copy number alterations in 64 human gastric cancer samples and 8 gastric cancer cell lines using bacterial artificial chromosome (BAC) arrays based comparative genomic hybridization (aCGH). Statistical analysis was applied to correlate previously published gene expression data obtained from cDNA microarrays with corresponding DNA copy number variation data to identify candidate oncogenes and tumor suppressor genes. We found that gastric cancer samples showed recurrent DNA copy number variations, including gains at 5p, 8q, 20p, 20q, and losses at 4q, 9p, 18q, 21q. The most frequent regions of amplification were 20q12 (7/72), 20q12-20q13.1 (12/72), 20q13.1-20q13.2 (11/72) and 20q13.2-20q13.3 (6/72). The most frequent deleted region was 9p21 (8/72). Correlating gene expression array data with aCGH identified 321 candidate oncogenes, which were overexpressed and showed frequent DNA copy number gains; and 12 candidate tumor suppressor genes which were down-regulated and showed frequent DNA copy number losses in human gastric cancers. Three networks of significantly expressed genes in gastric cancer samples were identified by ingenuity pathway analysis. Conclusions: This study provides insight into DNA copy number variations and their contribution to altered gene expression profiles during human gastric cancer development. It provides novel candidate driver oncogenes or tumor suppressor genes for human gastric cancer, useful pathway maps for the future understanding of the molecular pathogenesis of this malignancy, and the construction of new therapeutic targets.	[Fan, Biao; Dachrut, Somkid; Coral, Ho; Chen, Xin] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Fan, Biao; Zhang, Lianhai; Ji, Jiafu] Peking Univ, Sch Oncol, Key Lab Carcinogenesis & Translat Res, Beijing Canc Hosp & Inst,Dept Surg,Minist Educ, Beijing 100871, Peoples R China; [Dachrut, Somkid] Khon Kaen Univ, Fac Med, Liver Fluke & Cholangiocarcinoma Res Ctr, Khon Kaen, Thailand; [Yuen, Siu Tsan; Leung, Suet Yi] Univ Hong Kong, Queen Mary Hosp, Dept Pathol, Pokfulam, Hong Kong, Peoples R China; [Chu, Kent Man; Law, Simon] Univ Hong Kong, Queen Mary Hosp, Dept Surg, Pokfulam, Hong Kong, Peoples R China	University of California System; University of California San Francisco; Peking University; Khon Kaen University; University of Hong Kong; University of Hong Kong	Fan, BA (corresponding author), Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA.	jiafuj@gmail.com; suetyi@hku.hk; xin.chen@ucsf.edu	Yuen, Siu/K-6311-2014; Leung, Suet Yi/C-4340-2009; Law, Simon/C-4324-2009; Leung, Suet Yi/T-9620-2019	Law, Simon/0000-0002-6518-5806; JI, JIAFU/0000-0001-6878-5543; Leung, Suet Yi/0000-0001-8614-4619	University of California Cancer Research Coordinate Committee; China Scholarship Council [2010601079]	University of California Cancer Research Coordinate Committee; China Scholarship Council(China Scholarship Council)	This work is supported by the funding provided by University of California Cancer Research Coordinate Committee to XC. BF is supported by China Scholarship Council Contract No.2010601079. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikary S, 2005, NAT REV MOL CELL BIO, V6, P635, DOI 10.1038/nrm1703; Albertson DG, 2003, NAT GENET, V34, P369, DOI 10.1038/ng1215; Allen TD, 2011, CANCER RES, V71, P6010, DOI 10.1158/0008-5472.CAN-11-0595; An CH, 2011, APMIS, V119, P317, DOI 10.1111/j.1600-0463.2011.02734.x; Andre F, 2009, CLIN CANCER RES, V15, P441, DOI 10.1158/1078-0432.CCR-08-1791; Atienza JM, 2005, MOL CANCER THER, V4, P361; Benjamini Y, 1995, J ROY STAT SOC, V57, P289; Chen X, 2003, MOL BIOL CELL, V14, P3208, DOI 10.1091/mbc.E02-12-0833; Chu D, 2011, ANN ONCOL; Gorringe KL, 2005, GENE CHROMOSOME CANC, V42, P247, DOI 10.1002/gcc.20136; HAUPT Y, 1991, CELL, V65, P753, DOI 10.1016/0092-8674(91)90383-A; Heidenblad M, 2005, ONCOGENE, V24, P1794, DOI 10.1038/sj.onc.1208383; Hippo Y, 2002, CANCER RES, V62, P233; Hodgson JG, 2003, BREAST CANCER RES TR, V78, P337, DOI 10.1023/A:1023085825042; Jain AN, 2002, GENOME RES, V12, P325, DOI 10.1101/gr.210902; Japanese Gastric Cancer A, 1998, GASTRIC CANC, V1, P10; Ji JF, 2002, ONCOGENE, V21, P6549, DOI 10.1038/sj.onc.1205829; Jin SH, 2008, INT J CANCER, V122, P1040, DOI 10.1002/ijc.23181; Junnila S, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-73; Kallioniemi A, 2008, CURR OPIN BIOTECH, V19, P36, DOI 10.1016/j.copbio.2007.11.004; Kaptain S, 2001, DIAGN MOL PATHOL, V10, P139, DOI 10.1097/00019606-200109000-00001; Kosinski C, 2007, P NATL ACAD SCI USA, V104, P15418, DOI 10.1073/pnas.0707210104; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; Lee K, 2008, J INVEST DERMATOL, V128, P9, DOI 10.1038/sj.jid.5700949; Lee SA, 2008, HEPATOLOGY, V47, P1200, DOI 10.1002/hep.22169; Mahlamaki EH, 2002, GENE CHROMOSOME CANC, V35, P353, DOI 10.1002/gcc.10122; Miyoshi M, 2007, BIOCHEM J, V404, P373, DOI 10.1042/BJ20061597; Mlkvy P, 2010, DIGEST DIS, V28, P615, DOI 10.1159/000320063; Myllykangas S, 2008, INT J CANCER, V123, P817, DOI 10.1002/ijc.23574; Nakamura R, 2005, CANCER SCI, V96, P42, DOI 10.1111/j.1349-7006.2005.00007.x; Nesbit CE, 1999, ONCOGENE, V18, P3004, DOI 10.1038/sj.onc.1202746; Noguchi T, 2001, AM J CLIN PATHOL, V115, P828; Nupponen NN, 2000, GENE CHROMOSOME CANC, V28, P203; Potla L, 2002, CANCER LETT, V175, P187, DOI 10.1016/S0304-3835(01)00613-9; Sakakura C, 2000, INT J CANCER, V89, P217; Schmidt VA, 2008, MOL CELL BIOL, V28, P1489, DOI 10.1128/MCB.01090-07; Schuell B, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-123; Snijders AM, 2003, ONCOGENE, V22, P4370, DOI 10.1038/sj.onc.1206482; Song WJ, 2010, CANCER SCI, V101, P1754, DOI 10.1111/j.1349-7006.2010.01577.x; Thollet A, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-291; Tsukamoto Y, 2008, J PATHOL, V216, P471, DOI 10.1002/path.2424; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van Dekken H, 2006, CANCER GENET CYTOGEN, V166, P157, DOI 10.1016/j.cancergencyto.2005.11.002; Wang HZ, 2009, CELL RES, V19, P1150, DOI 10.1038/cr.2009.99; Wang Q, 2009, J CELL BIOCHEM, V106, P16, DOI 10.1002/jcb.21969; Weiss MM, 2003, ONCOGENE, V22, P1872, DOI 10.1038/sj.onc.1206350; White CD, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-125; Yeh TS, 2009, CANCER RES, V69, P5039, DOI 10.1158/0008-5472.CAN-08-4021; YUEN ST, 1994, AM J SURG PATHOL, V18, P1158, DOI 10.1097/00000478-199411000-00010; Zhang XW, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-40	50	49	50	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e29824	10.1371/journal.pone.0029824	http://dx.doi.org/10.1371/journal.pone.0029824			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22539939	gold, Green Published, Green Submitted			2022-12-27	WOS:000305341000002
J	Alonso-Gonzalez, L; Couldrey, C; Meinhardt, MW; Cole, SA; Wells, DN; Laible, G				Alonso-Gonzalez, Lucia; Couldrey, Christine; Meinhardt, Marcus W.; Cole, Sally A.; Wells, David N.; Laible, Goetz			Primary Transgenic Bovine Cells and Their Rejuvenated Cloned Equivalents Show Transgene-Specific Epigenetic Differences	PLOS ONE			English	Article							DNA METHYLATION PATTERNS; NUCLEAR TRANSFER; MASS-SPECTROMETRY; STRESS RESPONSES; PRION PROTEIN; GENE; CATTLE; MICE; EXPRESSION; LIVESTOCK	Cell-mediated transgenesis, based on somatic cell nuclear transfer (SCNT), provides the opportunity to shape the genetic make-up of cattle. Bovine primary fetal fibroblasts, commonly used cells for SCNT, have a limited lifespan, and complex genetic modifications that require sequential transfections can be challenging time and cost-wise. To overcome these limitations, SCNT is frequently used to rejuvenate the cell lines and restore exhausted growth potential. We have designed a construct to be used in a 2-step cassette exchange experiment. Our transgene contains a puromycin resistance marker gene and an enhanced green fluorescence protein (EGFP) expression cassette, both driven by a strong mammalian promoter, and flanked by loxP sites and sequences from the bovine beta-casein locus. Several transgenic cell lines were generated by random insertion into primary bovine cell lines. Two of these original cell lines were rederived by SCNT and new primary cells, with the same genetic makeup as the original donors, were established. While the original cell lines were puromycin-resistant and had a characteristic EGFP expression profile, all rejuvenated cell lines were sensitive to puromycin, and displayed varied EGFP expression, indicative of various degrees of silencing. When the methylation states of individual CpG sites within the transgene were analyzed, a striking increase in transgene-specific methylation was observed in all rederived cell lines. The results indicate that original transgenic donor cells and their rejuvenated derivatives may not be equivalent and differ in the functionality of their transgene sequences.	[Alonso-Gonzalez, Lucia; Couldrey, Christine; Meinhardt, Marcus W.; Cole, Sally A.; Wells, David N.; Laible, Goetz] AgRes Ruakura Res Ctr, Hamilton, New Zealand	AgResearch - New Zealand	Laible, G (corresponding author), Univ Otago, Dept Paediat, Christchurch, New Zealand.	goetz.laible@agresearch.co.nz		Wells, David/0000-0002-8729-4958; Cole, Sally/0000-0002-6997-9056; Laible, Goetz/0000-0003-1048-2819	Ministry of Science and Innovation [C10X0303, C10X0305, C10X0805]	Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by grants from the New Zealand Foundation for Research, Science and Technology (now the Ministry of Science and Innovation) C10X0303, C10X0305 and C10X0805. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brophy B, 2003, NAT BIOTECHNOL, V21, P157, DOI 10.1038/nbt783; Chevalier-Mariette C, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r53; Clark AJ, 2000, TRANSGENIC RES, V9, P263, DOI 10.1023/A:1008974616402; Clark AJ, 1997, NUCLEIC ACIDS RES, V25, P1009, DOI 10.1093/nar/25.5.1009; Clark AJ, 2003, NAT CELL BIOL, V5, P535, DOI 10.1038/ncb992; Coolen MW, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm662; Couldrey C, 2011, CELL REPROGRAM, V13, P171, DOI 10.1089/cell.2010.0065; Couldrey C, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-27; Dean W, 2001, P NATL ACAD SCI USA, V98, P13734, DOI 10.1073/pnas.241522698; Denning C, 2001, Cloning Stem Cells, V3, P221, DOI 10.1089/15362300152725945; Denning C, 2001, NAT BIOTECHNOL, V19, P559, DOI 10.1038/89313; Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102; Garrick D, 1998, NAT GENET, V18, P56, DOI 10.1038/ng0198-56; Graham Catriona, 2009, Biotechnology Journal, V4, P108, DOI 10.1002/biot.200800200; Humphreys D, 2002, P NATL ACAD SCI USA, V99, P12889, DOI 10.1073/pnas.192433399; Kuroiwa Y, 2004, NAT GENET, V36, P775, DOI 10.1038/ng1373; Laible Goetz, 2009, Biotechnology Journal, V4, P1278, DOI 10.1002/biot.200900006; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Oback B, 2003, CLONING STEM CELLS, V5, P3, DOI 10.1089/153623003321512111; Oberlander TF, 2008, EPIGENETICS-US, V3, P97, DOI 10.4161/epi.3.2.6034; Rassoulzadegan M, 2002, EMBO J, V21, P440, DOI 10.1093/emboj/21.3.440; Rosser JM, 2010, GENE, V456, P15, DOI 10.1016/j.gene.2010.02.005; Szyf M, 2005, FRONT NEUROENDOCRIN, V26, P139, DOI 10.1016/j.yfrne.2005.10.002; Vassena R, 2007, DEV BIOL, V304, P75, DOI 10.1016/j.ydbio.2006.12.015; Weaver ICG, 2005, J NEUROSCI, V25, P11045, DOI 10.1523/JNEUROSCI.3652-05.2005; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276	26	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35619	10.1371/journal.pone.0035619	http://dx.doi.org/10.1371/journal.pone.0035619			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22532863	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339200086
J	Gong, P; Li, CS; Hua, R; Zhao, H; Tang, ZR; Mei, X; Zhang, MY; Cui, J				Gong, Ping; Li, Chun-Sheng; Hua, Rong; Zhao, Hong; Tang, Zi-Ren; Mei, Xue; Zhang, Ming-Yue; Cui, Juan			Mild Hypothermia Attenuates Mitochondrial Oxidative Stress by Protecting Respiratory Enzymes and Upregulating MnSOD in a Pig Model of Cardiac Arrest	PLOS ONE			English	Article							MULTIPLE ORGAN FAILURE; CARDIOPULMONARY-RESUSCITATION; THERAPEUTIC HYPOTHERMIA; MODERATE HYPOTHERMIA; CEREBRAL-ISCHEMIA; GENE-EXPRESSION; PORCINE MODEL; SEX STEROIDS; BRAIN-INJURY; STROKE	Mild hypothermia is the only effective treatment confirmed clinically to improve neurological outcomes for comatose patients with cardiac arrest. However, the underlying mechanism is not fully elucidated. In this study, our aim was to determine the effect of mild hypothermia on mitochondrial oxidative stress in the cerebral cortex. We intravascularly induced mild hypothermia (33 degrees C), maintained this temperature for 12 h, and actively rewarmed in the inbred Chinese Wuzhishan minipigs successfully resuscitated after 8 min of untreated ventricular fibrillation. Cerebral samples were collected at 24 and 72 h following return of spontaneous circulation (ROSC). We found that mitochondrial malondialdehyde and protein carbonyl levels were significantly increased in the cerebral cortex in normothermic pigs even at 24 h after ROSC, whereas mild hypothermia attenuated this increase. Moreover, mild hypothermia attenuated the decrease in Complex I and Complex III (i.e., major sites of reactive oxygen species production) activities of the mitochondrial respiratory chain and increased antioxidant enzyme manganese superoxide dismutase (MnSOD) activity. This increase in MnSOD activity was consistent with the upregulation of nuclear factor erythroid 2-related factor 2 (Nrf2) mRNA and protein expressions, and with the increase of Nrf2 nuclear translocation in normothermic pigs at 24 and 72 h following ROSC, whereas mild hypothermia enhanced these tendencies. Thus, our findings indicate that mild hypothermia attenuates mitochondrial oxidative stress in the cerebral cortex, which may be associated with reduced impairment of mitochondrial respiratory chain enzymes, and enhancement of MnSOD activity and expression via Nrf2 activation.	[Gong, Ping; Li, Chun-Sheng; Hua, Rong; Zhao, Hong; Tang, Zi-Ren; Mei, Xue; Zhang, Ming-Yue; Cui, Juan] Capital Med Univ, Dept Emergency, Beijing Chaoyang Hosp, Beijing, Peoples R China	Capital Medical University	Li, CS (corresponding author), Capital Med Univ, Dept Emergency, Beijing Chaoyang Hosp, Beijing, Peoples R China.	lcscyyy@163.com	Gong, Ping/AAV-1936-2021	Gong, Ping/0000-0001-9910-7948	National Natural Science Foundation of China [30972863]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (No. 30972863, http://159.226.244.22/portal/proj_search.asp). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALMEIDA A, 1995, J NEUROCHEM, V65, P1698; Arnold S, 2009, J NEUROCHEM, V110, P1, DOI 10.1111/j.1471-4159.2009.06133.x; Bakthavatchalu V, 2012, ONCOGENE, V31, P2129, DOI 10.1038/onc.2011.407; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; BELZER FO, 1988, TRANSPLANTATION, V45, P673, DOI 10.1097/00007890-198804000-00001; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Busl KM, 2010, NEUROREHABILITATION, V26, P5, DOI 10.3233/NRE-2010-0531; Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8; Camara AKS, 2004, AM J PHYSIOL-HEART C, V286, pH1289, DOI 10.1152/ajpheart.00811.2003; Carswell HVO, 2000, AM J PHYSIOL-HEART C, V278, pH290, DOI 10.1152/ajpheart.2000.278.1.H290; Chan PH, 2005, ANN NY ACAD SCI, V1042, P203, DOI 10.1196/annals.1338.022; Cherubini A, 2005, FREE RADICAL BIO MED, V39, P841, DOI 10.1016/j.freeradbiomed.2005.06.025; Enna B, 2000, RESUSCITATION, V47, P41, DOI 10.1016/S0300-9572(00)00200-8; Fredriksson K, 2005, ACTA ANAESTH SCAND, V49, P1101, DOI 10.1111/j.1399-6576.2005.00718.x; Fredriksson K, 2006, AM J PHYSIOL-ENDOC M, V291, pE1044, DOI 10.1152/ajpendo.00218.2006; Fredriksson K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003686; Han Y, 2011, AM J EMERG MED, V29, P731, DOI 10.1016/j.ajem.2010.02.005; HANSFORD RG, 1982, MECH AGEING DEV, V19, P191, DOI 10.1016/0047-6374(82)90010-0; Helfaer MA, 1998, STROKE, V29, P824, DOI 10.1161/01.STR.29.4.824; Herlitz J, 2001, RESUSCITATION, V49, P15, DOI 10.1016/S0300-9572(00)00342-7; Herson PS, 2009, SEMIN REPROD MED, V27, P229, DOI 10.1055/s-0029-1216276; Holzer M, 2002, NEW ENGL J MED, V346, P549; Hoye AT, 2008, ACCOUNTS CHEM RES, V41, P87, DOI 10.1021/ar700135m; Huang Q, 2010, J AGR FOOD CHEM, V58, P5194, DOI 10.1021/jf904536v; Jaiswal AK, 2004, FREE RADICAL BIO MED, V36, P1199, DOI 10.1016/j.freeradbiomed.2004.02.074; Ji XF, 2011, RESUSCITATION   1122; Ji XF, 2011, SHOCK, V35, P530, DOI 10.1097/SHK.0b013e31820e2058; Ji XF, 2010, RESUSCITATION, V81, P1031, DOI 10.1016/j.resuscitation.2010.04.023; Kipp M, 2012, J NEUROENDOCRINOL, V24, P62, DOI 10.1111/j.1365-2826.2011.02163.x; Kudin AP, 2004, J BIOL CHEM, V279, P4127, DOI 10.1074/jbc.M310341200; Lebesgue D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008642; LEI BP, 1994, STROKE, V25, P147, DOI 10.1161/01.STR.25.1.147; MarinGarcia J, 1997, BIOCHEM CELL BIOL, V75, P137, DOI 10.1139/bcb-75-2-137; Marion D, 2009, J NEUROTRAUM, V26, P455, DOI 10.1089/neu.2008.0582; Meybohm P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007588; Neumar RW, 2008, CIRCULATION, V118, P2452, DOI 10.1161/CIRCULATIONAHA.108.190652; Polderman KH, 2008, LANCET, V371, P1955, DOI 10.1016/S0140-6736(08)60837-5; Rea TD, 2003, CIRCULATION, V107, P2780, DOI 10.1161/01.CIR.0000070950.17208.2A; Su ZY, 2011, AM J EMERG MED, V29, P913, DOI 10.1016/j.ajem.2010.04.001; Szabo C, 2003, TOXICOL LETT, V140, P105, DOI 10.1016/S0378-4274(02)00507-6; Wang S, 2010, CRIT CARE MED, V38, P2024, DOI 10.1097/CCM.0b013e3181eed90a; Wu JY, 2009, AM J EMERG MED, V27, P823, DOI 10.1016/j.ajem.2008.07.001; Xu LJ, 2002, J CEREBR BLOOD F MET, V22, P21, DOI 10.1097/00004647-200201000-00003; Zhao H, 2005, J CEREBR BLOOD F MET, V25, P1119, DOI 10.1038/sj.jcbfm.9600111; Zhao H, 2012, RESUSCITATION   0112; Zhao H, 2007, J CEREBR BLOOD F MET, V27, P1879, DOI 10.1038/sj.jcbfm.9600540	46	57	68	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35313	10.1371/journal.pone.0035313	http://dx.doi.org/10.1371/journal.pone.0035313			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22532848	gold, Green Published, Green Submitted			2022-12-27	WOS:000305339200054
J	Naidoo, N; Ferber, M; Galante, RJ; McShane, B; Hu, JH; Zimmerman, J; Maislin, G; Cater, J; Wyner, A; Worley, P; Pack, AI				Naidoo, Nirinjini; Ferber, Megan; Galante, Raymond J.; McShane, Blake; Hu, Jia Hua; Zimmerman, John; Maislin, Greg; Cater, Jacqui; Wyner, Abraham; Worley, Paul; Pack, Allan I.			Role of Homer Proteins in the Maintenance of Sleep-Wake States	PLOS ONE			English	Article							GENE-EXPRESSION; DROSOPHILA-MELANOGASTER; MESSENGER-RNA; MICE; WAKEFULNESS; NEURONS; BRAIN; RATS; TIME; HOMEOSTASIS	Sleep is an evolutionarily conserved process that is linked to diurnal cycles and normal daytime wakefulness. Healthy sleep and wakefulness are integral to a healthy lifestyle; this occurs when an organism is able to maintain long bouts of both sleep and wake. Homer proteins, which function as adaptors for group 1 metabotropic glutamate receptors, have been implicated in genetic studies of sleep in both Drosophila and mouse. Drosophila express a single Homer gene product that is upregulated during sleep. By contrast, vertebrates express Homer as both constitutive and immediate early gene (H1a) forms, and H1a is up-regulated during wakefulness. Genetic deletion of Homer in Drosophila results in fragmented sleep and in failure to sustain long bouts of sleep, even under increased sleep drive. However, deletion of Homer1a in mouse results in failure to sustain long bouts of wakefulness. Further evidence for the role of Homer1a in the maintenance of wake comes from the CREB alpha delta mutant mouse, which displays a reduced wake phenotype similar to the Homer1a knockout and fails to up-regulate Homer1a upon sleep loss. Homer1a is a gene whose expression is induced by CREB. Sustained behaviors of the sleep/wake cycle are created by molecular pathways that are distinct from those for arousal or short bouts, and implicate an evolutionarily-conserved role for Homer in sustaining these behaviors.	[Naidoo, Nirinjini; Ferber, Megan; Galante, Raymond J.; Zimmerman, John; Maislin, Greg; Cater, Jacqui; Pack, Allan I.] Univ Penn, Ctr Sleep & Circadian Neurobiol, Philadelphia, PA 19104 USA; [Naidoo, Nirinjini; Maislin, Greg; Pack, Allan I.] Univ Penn, Div Sleep Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [McShane, Blake] Northwestern Univ, Kellogg Sch Management, Chicago, IL 60611 USA; [Hu, Jia Hua; Worley, Paul] Johns Hopkins Univ, Dept Neurosci, Baltimore, MD USA; [Wyner, Abraham] Univ Penn, Wharton Sch, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Northwestern University; Johns Hopkins University; University of Pennsylvania	Naidoo, N (corresponding author), Univ Penn, Ctr Sleep & Circadian Neurobiol, Philadelphia, PA 19104 USA.	naidoo@mail.med.upenn.edu	Maislin, Greg/S-5322-2019	Pack, Allan/0000-0002-2879-0484	National Institutes of Health [AG17628, AG032500]; NATIONAL INSTITUTE ON AGING [R21AG032500, P01AG017628] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by National Institutes of Health grants AG17628 and AG032500. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Adamantidis AR, 2007, NATURE, V450, P420, DOI 10.1038/nature06310; Anaclet C, 2009, J NEUROSCI, V29, P14423, DOI 10.1523/JNEUROSCI.2604-09.2009; Andretic R, 2005, METHOD ENZYMOL, V393, P759, DOI 10.1016/S0076-6879(05)93040-1; ASTONJONES G, 1981, J NEUROSCI, V1, P876; Behn CGD, 2008, J NEUROPHYSIOL, V99, P3090, DOI 10.1152/jn.01243.2007; Behn CGD, 2007, J NEUROPHYSIOL, V97, P3828, DOI 10.1152/jn.01184.2006; Berke JD, 1998, J NEUROSCI, V18, P5301, DOI 10.1523/JNEUROSCI.18-14-05301.1998; Blanco-Centurion C, 2007, J NEUROSCI, V27, P14041, DOI 10.1523/JNEUROSCI.3217-07.2007; Blumberg MS, 2007, EUR J NEUROSCI, V25, P512, DOI 10.1111/j.1460-9568.2006.05292.x; Blumberg MS, 2005, P NATL ACAD SCI USA, V102, P14860, DOI 10.1073/pnas.0506340102; Bottai D, 2002, J NEUROSCI, V22, P167, DOI 10.1523/JNEUROSCI.22-01-00167.2002; Brakeman PR, 1997, NATURE, V386, P284, DOI 10.1038/386284a0; Cirelli C, 2004, NEURON, V41, P35, DOI 10.1016/S0896-6273(03)00814-6; Diagana TT, 2002, J NEUROSCI, V22, P428, DOI 10.1523/JNEUROSCI.22-02-00428.2002; Franken P, 2001, J NEUROSCI, V21, P2610, DOI 10.1523/JNEUROSCI.21-08-02610.2001; Franken P, 1999, SLEEP, V22, P155; Fuller P, 2011, J COMP NEUROL, V519, P933, DOI 10.1002/cne.22559; Graves LA, 2003, J NEUROPHYSIOL, V90, P1152, DOI 10.1152/jn.00882.2002; Hu JH, 2010, NEURON, V68, P1128, DOI 10.1016/j.neuron.2010.11.008; Huber R, 2004, SLEEP, V27, P628, DOI 10.1093/sleep/27.4.628; Huber R, 2007, SLEEP, V30, P129, DOI 10.1093/sleep/30.2.129; Hunsley MS, 2003, SLEEP, V26, P521; Joho RH, 2006, EUR J NEUROSCI, V23, P1567, DOI 10.1111/j.1460-9568.2006.04672.x; Ko EM, 2003, BRAIN RES, V992, P220, DOI 10.1016/j.brainres.2003.08.044; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lo CC, 2004, P NATL ACAD SCI USA, V101, P17545, DOI 10.1073/pnas.0408242101; Lo CC, 2002, EUROPHYS LETT, V57, P625, DOI 10.1209/epl/i2002-00508-7; Lu J, 2006, J NEUROSCI, V26, P193, DOI 10.1523/JNEUROSCI.2244-05.2006; Mackiewicz M, 2008, PHYSIOL GENOMICS, V33, P91, DOI 10.1152/physiolgenomics.00189.2007; Mackiewicz M., 2007, PHYSL GENOMICS; Maret S, 2007, P NATL ACAD SCI USA, V104, P20090, DOI 10.1073/pnas.0710131104; McShane BB, 2010, J NEUROSCI METH, V193, P321, DOI 10.1016/j.jneumeth.2010.08.024; Naidoo N, 2007, SLEEP, V30, P557, DOI 10.1093/sleep/30.5.557; Nelson SE, 2004, NEUROSCI LETT, V367, P105, DOI 10.1016/j.neulet.2004.05.089; Nielsen HS, 2002, MOL BRAIN RES, V105, P79, DOI 10.1016/S0169-328X(02)00395-9; Nitz DA, 2002, CURR BIOL, V12, P1934, DOI 10.1016/S0960-9822(02)01300-3; Pack AI, 2007, PHYSIOL GENOMICS, V28, P232, DOI 10.1152/physiolgenomics.00139.2006; Parmentier R, 2002, J NEUROSCI, V22, P7695; Peyron C, 1998, J NEUROSCI, V18, P9996; Saper CB, 2010, NEURON, V68, P1023, DOI 10.1016/j.neuron.2010.11.032; Sato M, 2001, J NEUROSCI, V21, P3797, DOI 10.1523/JNEUROSCI.21-11-03797.2001; SCHWARTZ WJ, 1990, J NEUROSCI, V10, P3685; Simasko SM, 2009, BEHAV BRAIN RES, V196, P228, DOI 10.1016/j.bbr.2008.09.003; Stickgold R, 2001, SCIENCE, V294, P1052, DOI 10.1126/science.1063530; Walters CL, 2001, J NEUROSCI, V21, P9438, DOI 10.1523/JNEUROSCI.21-23-09438.2001; Zhang GC, 2007, MOL PHARMACOL, V71, P1148, DOI 10.1124/mol.106.028399; Zimmerman JE, 2008, SLEEP, V31, P1587, DOI 10.1093/sleep/31.11.1587; Zimmerman JE, 2006, PHYSIOL GENOMICS, V27, P337, DOI 10.1152/physiolgenomics.00030.2006	48	44	44	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35174	10.1371/journal.pone.0035174	http://dx.doi.org/10.1371/journal.pone.0035174			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22532843	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339200042
J	Tewarie, P; Balk, L; Costello, F; Green, A; Martin, R; Schippling, S; Petzold, A				Tewarie, Prejaas; Balk, Lisanne; Costello, Fiona; Green, Ari; Martin, Roland; Schippling, Sven; Petzold, Axel			The OSCAR-IB Consensus Criteria for Retinal OCT Quality Assessment	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; FIBER LAYER THICKNESS; MULTIPLE-SCLEROSIS	Background: Retinal optical coherence tomography (OCT) is an imaging biomarker for neurodegeneration in multiple sclerosis (MS). In order to become validated as an outcome measure in multicenter studies, reliable quality control (QC) criteria with high inter-rater agreement are required. Methods/Principal Findings: A prospective multicentre study on developing consensus QC criteria for retinal OCT in MS: (1) a literature review on OCT QC criteria; (2) application of these QC criteria to a training set of 101 retinal OCT scans from patients with MS; (3) kappa statistics for inter-rater agreement; (4) identification reasons for inter-rater disagreement; (5) development of new consensus QC criteria; (6) testing of the new QC criteria on the training set and (7) prospective validation on a new set of 159 OCT scans from patients with MS. The inter-rater agreement for acceptable scans among OCT readers (n = 3) was moderate (kappa 0.45) based on the non-validated QC criteria which were entirely based on the ophthalmological literature. A new set of QC criteria was developed based on recognition of: (O) obvious problems, (S) poor signal strength, (C) centration of scan, (A) algorithm failure, (R) retinal pathology other than MS related, (I) illumination and (B) beam placement. Adhering to these OSCAR-IB QC criteria increased the inter-rater agreement to kappa from moderate to substantial (0.61 training set and 0.61 prospective validation). Conclusions: This study presents the first validated consensus QC criteria for retinal OCT reading in MS. The high inter-rater agreement suggests the OSCAR-IB QC criteria to be considered in the context of multicentre studies and trials in MS.	[Tewarie, Prejaas; Balk, Lisanne] Vrije Univ Amsterdam, Med Ctr, MS Ctr Amsterdam, Amsterdam, Netherlands; [Costello, Fiona] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada; [Costello, Fiona] Univ Calgary, Dept Surg, Calgary, AB, Canada; [Green, Ari] Univ Calif San Francisco, Dept Neurol, Multiple Sclerosis Ctr, San Francisco, CA USA; [Martin, Roland; Schippling, Sven] Univ Med Ctr Hamburg Eppendorf, Inst Neuroimmunol & Clin Multiple Sclerosis Res I, Hamburg, Germany; [Petzold, Axel] UCL Inst Neurol, London, England	Vrije Universiteit Amsterdam; University of Calgary; University of Calgary; University of California System; University of California San Francisco; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of London; University College London	Tewarie, P (corresponding author), Vrije Univ Amsterdam, Med Ctr, MS Ctr Amsterdam, Amsterdam, Netherlands.	a.petzold@vumc.nl	Petzold, Axel/C-1090-2009	Petzold, Axel/0000-0002-0344-9749; Martin, Roland/0000-0002-0982-1329	Dutch MS Research Foundation [09 - 358 d MS]; Gemeinnuetzige Hertie-Stiftung	Dutch MS Research Foundation; Gemeinnuetzige Hertie-Stiftung	The MS Center VUMC is funded by a program grant of the Dutch MS Research Foundation (grant 09 - 358 d MS). The Institute for Neuroimmunology and Clinical Multiple Sclerosis is supported by an unrestricted grant of the Gemeinnuetzige Hertie-Stiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balk L, 2011, RETINA IN PRESS; Barkhof F, 2009, NAT REV NEUROL, V5, P256, DOI 10.1038/nrneurol.2009.41; Cheung CYL, 2008, OPHTHALMOLOGY, V115, P1347, DOI 10.1016/j.ophtha.2007.11.027; Costello F, 2011, MULT SCLER INT, V2011, DOI 10.1155/2011/148394; Domalpally A, 2009, RETINA-J RET VIT DIS, V29, P775, DOI 10.1097/IAE.0b013e3181a0848b; Fleiss JL, 2003, STAT METHODS RATES P, P618; Frohman E, 2006, LANCET NEUROL, V5, P853, DOI 10.1016/S1474-4422(06)70573-7; Green AJ, 2010, BRAIN, V133, P1591, DOI 10.1093/brain/awq080; Huang JJ, 2011, OPHTHAL SURG LAS IM, V42, P216, DOI 10.3928/15428877-20110324-01; Jindahra P, 2010, CURR OPIN NEUROL, V23, P16, DOI 10.1097/WCO.0b013e328334e99b; Kanamori A, 2003, AM J OPHTHALMOL, V135, P513, DOI 10.1016/S0002-9394(02)02003-2; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Otani T, 2011, RETINA-J RET VIT DIS, V31, P497, DOI 10.1097/IAE.0b013e3181ed8dae; Petzold A, 2010, LANCET NEUROL, V9, P921, DOI 10.1016/S1474-4422(10)70168-X; Talman LS, 2010, ANN NEUROL, V67, P749, DOI 10.1002/ana.22005; Vizzeri G, 2009, AM J OPHTHALMOL, V148, P249, DOI 10.1016/j.ajo.2009.03.002	16	325	325	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e34823	10.1371/journal.pone.0034823	http://dx.doi.org/10.1371/journal.pone.0034823			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22536333	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000305336200009
J	Baos, R; Jovani, R; Serrano, D; Tella, JL; Hiraldo, F				Baos, Raquel; Jovani, Roger; Serrano, David; Tella, Jose L.; Hiraldo, Fernando			Developmental Exposure to a Toxic Spill Compromises Long-Term Reproductive Performance in a Wild, Long-Lived Bird: The White Stork (Ciconia ciconia)	PLOS ONE			English	Article							KITES MILVUS-MIGRANS; VALDEZ OIL-SPILL; OXIDATIVE STRESS; HEAVY-METAL; ENVIRONMENTAL-CONDITIONS; ADRENOCORTICAL-RESPONSE; SOUTHWESTERN SPAIN; GENOTOXIC DAMAGE; LIFE; NEUROENDOCRINE	Background/Objective: Exposure to environmental contaminants may result in reduced reproductive success and long-lasting population declines in vertebrates. Emerging data from laboratory studies on model species suggest that certain life-stages, such as development, should be of special concern. However, detailed investigations of long-term consequences of developmental exposure to environmental chemicals on breeding performance are currently lacking in wild populations of long-lived vertebrates. Here, we studied how the developmental exposure to a mine spill (Aznalcollar, SW Spain, April 1998) may affect fitness under natural conditions in a long-lived bird, the White Stork (Ciconia ciconia). Methodology: The reproductive performance of individually-banded storks that were or not developmentally exposed to the spill (i.e. hatched before or after the spill) was compared when these individuals were simultaneously breeding during the seven years after the spill occurred (1999-2005). Principal Findings: Female storks developmentally exposed to the spill experienced a premature breeding senescence compared with their non-developmentally exposed counterparts, doing so after departing from an unusually higher productivity in their early reproductive life (non-developmentally exposed females: 0.5 +/- 0.33SE fledglings/year at 3-yr old vs. 1.38 +/- 0.31SE at 6-7 yr old; developmentally exposed females: 1.5 +/- 0.30SE fledglings/year at 3-yr old vs. 0.86 +/- 0.25SE at 67 yr old). Conclusions/Significance: Following life-history theory, we propose that costly sub-lethal effects reported in stork nestlings after low-level exposure to the spill-derived contaminants might play an important role in shaping this pattern of reproduction, with a clear potential impact on population dynamics. Overall, our study provides evidence that environmental disasters can have long-term, multigenerational consequences on wildlife, particularly when affecting developing individuals, and warns about the risk of widespread low-level contamination in realistic scenarios.	[Baos, Raquel; Serrano, David; Tella, Jose L.; Hiraldo, Fernando] Estac Biol Donana CSIC, Dept Conservat Biol, Seville, Spain; [Jovani, Roger] Estac Biol Donana CSIC, Dept Evolutionary Ecol, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD)	Baos, R (corresponding author), Estac Biol Donana CSIC, Dept Conservat Biol, Seville, Spain.	raquel@ebd.csic.es	Baos, Raquel/L-9206-2015; Serrano, David/B-5352-2013; Jovani, Roger/C-7080-2013; Tella, José L/I-3707-2015; Hiraldo, Fernando/AAA-8314-2019	Baos, Raquel/0000-0003-1283-6270; Serrano, David/0000-0001-6205-386X; Jovani, Roger/0000-0002-8693-9742; Tella, José L/0000-0002-3038-7424; 	Junta de Andalucia; Ministry of Science and Technology [B0S2002-00857]; EGMASA; CSIC in an i3P grant; Ministry of Education and Culture in an FPU Pre-doctoral Fellowship; Ramon y Cajal from the Ministry of Science and Innovation [RYC-2009-03967]	Junta de Andalucia(Junta de Andalucia); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); EGMASA; CSIC in an i3P grant; Ministry of Education and Culture in an FPU Pre-doctoral Fellowship; Ramon y Cajal from the Ministry of Science and Innovation	Partial funding for this work was provided by the Junta de Andalucia and the Ministry of Science and Technology (B0S2002-00857). RB was supported by EGMASA and CSIC in an i3P grant, and by the Ministry of Education and Culture in an FPU Pre-doctoral Fellowship. During writing, RJ has been supported by a Ramon y Cajal research contract (RYC-2009-03967) from the Ministry of Science and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alzaga R, 1999, SCI TOTAL ENVIRON, V242, P167, DOI 10.1016/S0048-9697(99)00382-4; Baos R, 2006, ENVIRON HEALTH PERSP, V114, P1497, DOI 10.1289/ehp.9099; Baos R, 2006, ENVIRON TOXICOL CHEM, V25, P2794, DOI 10.1897/05-570R.1; Baos R, 2006, ENVIRON TOXICOL CHEM, V25, P1153, DOI 10.1897/05-395R.1; Bateson P, 2004, NATURE, V430, P419, DOI 10.1038/nature02725; Bernanke J, 2009, REV ENVIRON CONTAM T, V198, P1, DOI 10.1007/978-0-387-09647-6_1; Bize P, 2008, ECOLOGY, V89, P2584, DOI 10.1890/07-1135.1; Blas J, 2007, P NATL ACAD SCI USA, V104, P8880, DOI 10.1073/pnas.0700232104; Blas J, 2006, GEN COMP ENDOCR, V148, P172, DOI 10.1016/j.ygcen.2006.02.011; Bonilla-Valverde D, 2004, TOXICOLOGY, V197, P123, DOI 10.1016/j.tox.2003.12.010; Chernetsov N, 2006, AUK, V123, P1103, DOI 10.1642/0004-8038(2006)123[1103:SNDOWS]2.0.CO;2; CLUTTONBROCK TH, 1984, AM NAT, V123, P212, DOI 10.1086/284198; Colborn T., 1992, CHEM INDUCED ALTERAT; Consejeria de Medio Ambiente Junta de Andalucia, 2003, CIENC REST RIO GUAD; Damstra T., 2002, GLOBAL ASSESSMENT ST; Di Giulio RT, 1999, REPROD DEV EFFECTS C; Dickerson SM, 2007, REV ENDOCR METAB DIS, V8, P143, DOI 10.1007/s11154-007-9048-y; Eeva T, 2005, OECOLOGIA, V145, P629, DOI 10.1007/s00442-005-0145-x; Ellegren H, 1996, P ROY SOC B-BIOL SCI, V263, P1635, DOI 10.1098/rspb.1996.0239; Elliott John E., 2001, Reviews in Toxicology (Amsterdam), V4, P1; Esler D, 2010, ENVIRON TOXICOL CHEM, V29, P1138, DOI 10.1002/etc.129; FORSLUND P, 1995, TRENDS ECOL EVOL, V10, P374, DOI 10.1016/S0169-5347(00)89141-7; Gil F, 2006, SCI TOTAL ENVIRON, V372, P49, DOI 10.1016/j.scitotenv.2006.08.004; Gore AC, 2008, FRONT NEUROENDOCRIN, V29, P358, DOI 10.1016/j.yfrne.2008.02.002; Grimalt JO, 1999, SCI TOT ENV, V242; Gump BB, 2008, ENVIRON HEALTH PERSP, V116, P249, DOI 10.1289/ehp.10391; Guterman L, 2009, SCIENCE, V323, P1558, DOI 10.1126/science.323.5921.1558; Hanssen SA, 2006, ECOLOGY, V87, P2440, DOI 10.1890/0012-9658(2006)87[2440:COAICA]2.0.CO;2; Harshman LG, 2007, TRENDS ECOL EVOL, V22, P80, DOI 10.1016/j.tree.2006.10.008; Hegyi G, 2011, BEHAV ECOL SOCIOBIOL, V65, P1647, DOI 10.1007/s00265-011-1175-5; Henriksen EO, 2001, J ENVIRON MONITOR, V3, P493, DOI 10.1039/b102683f; Hotchkiss AK, 2008, TOXICOL SCI, V105, P235, DOI 10.1093/toxsci/kfn030; Iwaniuk AN, 2006, BEHAV BRAIN RES, V173, P1, DOI 10.1016/j.bbr.2006.05.026; Jovani R, 2004, ARDEOLA, V51, P357; Jovani R, 2004, ECOGRAPHY, V27, P611, DOI 10.1111/j.0906-7590.2004.03925.x; Jovani R, 2007, P ROY SOC B-BIOL SCI, V274, P2465, DOI 10.1098/rspb.2007.0527; Kim SY, 2010, EVOLUTION, V64, P852, DOI 10.1111/j.1558-5646.2009.00862.x; Lindstrom J, 1999, TRENDS ECOL EVOL, V14, P343, DOI 10.1016/S0169-5347(99)01639-0; Littell R. C., 2006, SAS SYSTEMS MIXED MO, V2nd; Marchamalo J., 1996, Butlleti del Grup Catala d'Anellament, V13, P37; Metcalfe NB, 2001, TRENDS ECOL EVOL, V16, P254, DOI 10.1016/S0169-5347(01)02124-3; Moller AP, 2008, J COMP PHYSIOL B, V178, P735, DOI 10.1007/s00360-008-0262-z; Monaghan P, 2008, FUNCT ECOL, V22, P371, DOI 10.1111/j.1365-2435.2008.01418.x; Monaghan P, 2009, ECOL LETT, V12, P75, DOI 10.1111/j.1461-0248.2008.01258.x; Munoz-Arnanz J, 2008, ORGANOH COMP, V70, P1562; Munoz-Arnanz J, 2011, ENVIRON INT, V37, P1164, DOI 10.1016/j.envint.2011.03.025; Munoz-Arnanz J, 2011, ENVIRON INT, V37, P572, DOI 10.1016/j.envint.2010.11.013; Murtaugh PA, 2009, ECOL LETT, V12, P1061, DOI 10.1111/j.1461-0248.2009.01361.x; Newton I., 1998, POPULATION LIMITATIO; Norris D.O, 2006, ENDOCRINE DISRUPTION; Nowicki S, 1998, AM ZOOL, V38, P179; Nussey DH, 2007, CURR BIOL, V17, pR1000, DOI 10.1016/j.cub.2007.10.005; Ottinger MA, 2008, BRAIN RES REV, V57, P376, DOI 10.1016/j.brainresrev.2007.08.011; Paine RT, 1996, ANNU REV ECOL SYST, V27, P197, DOI 10.1146/annurev.ecolsys.27.1.197; Pastor N, 2004, MUTAGENESIS, V19, P61, DOI 10.1093/mutage/geg035; Pastor N, 2001, MUTAGENESIS, V16, P219, DOI 10.1093/mutage/16.3.219; Peterson CH, 2003, SCIENCE, V302, P2082, DOI 10.1126/science.1084282; PIATT JF, 1990, AUK, V107, P387, DOI 10.2307/4087623; Quinn MJ, 2008, HORM BEHAV, V53, P249, DOI 10.1016/j.yhbeh.2007.10.004; Reed TE, 2008, AM NAT, V171, pE89, DOI 10.1086/524957; Romero-Ruiz A, 2003, ENVIRON TOXICOL CHEM, V22, P92, DOI 10.1002/etc.5620220112; Rowe CL, 2008, BIOSCIENCE, V58, P623, DOI 10.1641/B580709; Sabbioni G, 2002, BIOMARKERS, V7, P347, DOI 10.1080/13547500210147253; Segner H, 2007, NATO SCI PEACE SECUR, P39, DOI 10.1007/978-1-4020-6335-0_4; Sih A, 2004, TRENDS ECOL EVOL, V19, P274, DOI 10.1016/j.tree.2004.02.010; Smits JEG, 2005, TOXICOL PATHOL, V33, P441, DOI 10.1080/01926230590953097; Smits JE, 2007, ENVIRON POLLUT, V145, P538, DOI 10.1016/j.envpol.2006.04.032; Spencer KA, 2010, BEHAV ECOL, V21, P999, DOI 10.1093/beheco/arq090; Stearns S.C., 1992, pi; Symonds MRE, 2011, BEHAV ECOL SOCIOBIOL, V65, P13, DOI 10.1007/s00265-010-1037-6; Tablado Z, 2010, CONSERV BIOL, V24, P1230, DOI 10.1111/j.1523-1739.2010.01483.x; Velando A, 2005, J ORNITHOL, V146, P116, DOI 10.1007/s10336-004-0068-z; Velando A, 2006, P ROY SOC B-BIOL SCI, V273, P1443, DOI 10.1098/rspb.2006.3480; White LD, 2007, TOXICOL APPL PHARM, V225, P1, DOI 10.1016/j.taap.2007.08.001; Wiens JA, 2004, ECOL APPL, V14, P1806, DOI 10.1890/02-5340; WIENS JA, 1995, ECOL APPL, V5, P1069, DOI 10.2307/2269355; Wikelski M, 2002, NATURE, V417, P607, DOI 10.1038/417607a; Wingfield JC, 2009, GEN COMP ENDOCR, V163, P92, DOI 10.1016/j.ygcen.2009.04.030; Zuberogoitia I, 2006, MAR POLLUT BULL, V52, P1176, DOI 10.1016/j.marpolbul.2006.02.016	79	20	20	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e34716	10.1371/journal.pone.0034716	http://dx.doi.org/10.1371/journal.pone.0034716			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529928	gold, Green Published, Green Submitted			2022-12-27	WOS:000305350600022
J	Pan, LP; Zhang, W; Zhang, L; Wu, XP; Zhu, XL; Yan, BY; Li, JY; Xu, AQ; Liu, Y; Li, H				Pan, Li-Ping; Zhang, Wei; Zhang, Li; Wu, Xiao-Pan; Zhu, Xi-Lin; Yan, Bing-Yu; Li, Jing-Yun; Xu, Ai-Qiang; Liu, Ying; Li, Hui			CD3Z Genetic Polymorphism in Immune Response to Hepatitis B Vaccination in Two Independent Chinese Populations	PLOS ONE			English	Article							T-CELL-RECEPTOR; DECREASED EXPRESSION; ANTIBODY-RESPONSE; VIRUS; CD28; IMMUNOGENETICS; COSTIMULATION; ASSOCIATIONS; MODULATION; ACTIVATION	Vaccination against hepatitis B virus is an effective and routine practice that can prevent infection. However, vaccine-induced immunity to hepatitis B varies among individuals. CD4(+) T helper cells, which play an important role in both cellular and humoral immunity, are involved in the immune response elicited by vaccination. Polymorphisms in the genes involved in stimulating the activation and proliferation of CD4(+) T helper cells may influence the immune response to hepatitis B vaccination. In the first stage of the present study, a total of 111 single nucleotide polymorphisms (SNPs) in 17 genes were analyzed, using the iPLEX MassARRAY system, among 214 high responders and 107 low responders to hepatitis B vaccination. Three SNPs (rs12133337 and rs10918706 in CD3Z, rs10912564 in OX40L) were associated significantly with the immune response to hepatitis B vaccination (P = 0.008, 0.041, and 0.019, respectively). The three SNPs were analyzed further with the TaqMan-MGB or TaqMan-BHQ probe-based real-time polymerase chain reaction in another independent population, which included 1090 high responders and 636 low responders. The minor allele 'C' of rs12133337 continued to show an association with a lower response to hepatitis B vaccination (P = 0.033, odds radio = 1.28, 95% confidence interval = 1.01-1.61). Furthermore, in the stratified analysis for both the first and second populations, the association of the minor allele 'C' of rs12133337 with a lower response to hepatitis B vaccination was more prominent after individuals who were overweight or obese (body mass index >= 25 kg/m(2)) were excluded (1st stage: P = 0.003, 2nd stage: P = 0.002, P-combined = 9.47e-5). These findings suggest that the rs12133337 polymorphism in the CD3Z gene might affect the immune response to hepatitis B vaccination, and that a lower BMI might increase the contribution of the polymorphism to immunity to hepatitis B vaccination.	[Pan, Li-Ping; Wu, Xiao-Pan; Zhu, Xi-Lin; Li, Jing-Yun; Liu, Ying] Chinese Acad Med Sci, Sch Basic Med, Peking Union Med Coll, Natl Lab Med Mol Biol,Inst Basic Med Sci, Beijing 100730, Peoples R China; [Zhang, Wei] Beijing Ctr Dis Control & Prevent, Beijing, Peoples R China; [Zhang, Li; Yan, Bing-Yu; Xu, Ai-Qiang] Shandong Ctr Dis Control & Prevent, Jinan, Peoples R China; [Li, Hui] Chinese Acad Med Sci, Sch Basic Med, Peking Union Med Coll, Dept Epidemiol,Inst Basic Med Sci, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS	Pan, LP (corresponding author), Chinese Acad Med Sci, Sch Basic Med, Peking Union Med Coll, Natl Lab Med Mol Biol,Inst Basic Med Sci, Beijing 100730, Peoples R China.	aqxuepi@163.com; liuyingpumc@yahoo.com; lihui99360@vip.sohu.com			Major Project of National Science and Technology [2008zx10002-001, 2009ZX10002-028]; National Basic Research Program of China (973 Program) [2007CB512806]; National High Technology Research and Development Program of China (863 Program) [2006AA02A4100]; Science Fund for Creative Research Groups [30721063]	Major Project of National Science and Technology; National Basic Research Program of China (973 Program)(National Basic Research Program of China); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Science Fund for Creative Research Groups(Science Fund for Creative Research Groups)	This work was supported by grants from the Major Project of National Science and Technology (No. 2008zx10002-001 and No. 2009ZX10002-028), the National Basic Research Program of China (973 Program) (No. 2007CB512806), the National High Technology Research and Development Program of China (863 Program) (No. 2006AA02A4100), and the Science Fund for Creative Research Groups (No. 30721063). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alegre ML, 2001, NAT REV IMMUNOL, V1, P220, DOI 10.1038/35105024; Aviles DH, 2009, PEDIATR NEPHROL, V24, P769, DOI 10.1007/s00467-008-1061-1; Banatvala J, 2000, LANCET, V355, P561, DOI 10.1016/S0140-6736(99)07239-6; Boland GJ, 2003, ADV EXP MED BIOL, V531, P185; Bretscher PA, 1999, P NATL ACAD SCI USA, V96, P185, DOI 10.1073/pnas.96.1.185; Caballero B, 2007, EPIDEMIOL REV, V29, P1, DOI 10.1093/epirev/mxm012; Cantrell DA, 2002, IMMUNOLOGY, V105, P369, DOI 10.1046/j.1365-2567.2002.01391.x; Chen J, 2011, VACCINE, V29, P706, DOI 10.1016/j.vaccine.2010.11.023; CLEVERS H, 1988, ANNU REV IMMUNOL, V6, P629, DOI 10.1146/annurev.iy.06.040188.003213; Croft M, 2009, IMMUNOL REV, V229, P173, DOI 10.1111/j.1600-065X.2009.00766.x; D'Oro U, 2002, J IMMUNOL, V169, P6269, DOI 10.4049/jimmunol.169.11.6269; Davila S, 2010, GENES IMMUN, V11, P232, DOI 10.1038/gene.2010.1; De Jager PL, 2009, P NATL ACAD SCI USA, V106, P5264, DOI 10.1073/pnas.0813310106; Geertsma MF, 1999, J INFECT DIS, V180, P649, DOI 10.1086/314941; Godkin A, 2005, HEPATOLOGY, V41, P1383, DOI 10.1002/hep.20716; Goncalves L, 2004, VIROLOGY, V326, P20, DOI 10.1016/j.virol.2004.04.042; Harris NL, 1999, IMMUNOL CELL BIOL, V77, P304, DOI 10.1046/j.1440-1711.1999.00835.x; Hennig BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001898; Hohler T, 2005, HEPATOLOGY, V42, P72, DOI 10.1002/hep.20740; Hohler T, 2002, LANCET, V360, P991, DOI 10.1016/S0140-6736(02)11083-X; HOLLINGER FB, 1989, AM J MED, V87, pS36; Huang IC, 2006, INT J OBESITY, V30, P1250, DOI 10.1038/sj.ijo.0803250; IRVING BA, 1991, CELL, V64, P891, DOI 10.1016/0092-8674(91)90314-O; JANEWAY CA, 1989, IMMUNOL REV, V109, P77, DOI 10.1111/j.1600-065X.1989.tb00020.x; JANEWAY CA, 1992, ANNU REV IMMUNOL, V10, P645, DOI 10.1146/annurev.immunol.10.1.645; Kimman TG, 2007, COMMUNITY GENET, V10, P201, DOI 10.1159/000106559; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; Lu FM, 2009, CHINESE MED J-PEKING, V122, P2925, DOI 10.3760/cma.j.issn.0366-6999.2009.24.001; Lundholm M, 2010, J IMMUNOL, V184, P5537, DOI 10.4049/jimmunol.0904012; Maddrey WC, 2000, J MED VIROL, V61, P362, DOI 10.1002/1096-9071(200007)61:3&lt;362::AID-JMV14&gt;3.0.CO;2-I; Maki A, 2004, J GASTROEN HEPATOL, V19, P1348, DOI 10.1111/j.1440-1746.2004.03455.x; McDermott AB, 1997, TISSUE ANTIGENS, V50, P8, DOI 10.1111/j.1399-0039.1997.tb02827.x; Milich DR, 2003, AUTOIMMUN REV, V2, P248, DOI 10.1016/S1568-9972(03)00031-4; Newport MJ, 2004, GENES IMMUN, V5, P122, DOI 10.1038/sj.gene.6364051; Pan LP, 2012, J MED VIROL, V84, P26, DOI 10.1002/jmv.22251; Png E, 2011, HUM MOL GENET; Poland GA, 2007, CLIN PHARMACOL THER, V82, P653, DOI 10.1038/sj.clpt.6100415; Poland GA, 1998, AM J PREV MED, V15, P73; Portoles P, 2009, CURR PHARM DESIGN, V15, P3290, DOI 10.2174/138161209789105199; Radstake TRDJ, 2010, NAT GENET, V42, P426, DOI 10.1038/ng.565; Rahman F, 2000, HEPATOLOGY, V31, P521, DOI 10.1002/hep.510310237; Rogers PR, 2000, J IMMUNOL, V164, P2955, DOI 10.4049/jimmunol.164.6.2955; Ryckman KK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012273; Sharpe AH, 2002, NAT REV IMMUNOL, V2, P116, DOI 10.1038/nri727; TREADWELL TL, 1993, AM J MED, V95, P584, DOI 10.1016/0002-9343(93)90353-Q; Wang CB, 2004, HEPATOLOGY, V39, P978, DOI 10.1002/hep.20142; Watts TH, 2005, ANNU REV IMMUNOL, V23, P23, DOI 10.1146/annurev.immunol.23.021704.115839; WEBER DJ, 1985, JAMA-J AM MED ASSOC, V254, P3187, DOI 10.1001/jama.254.22.3187; WEISSMAN JY, 1988, JAMA-J AM MED ASSOC, V260, P1734, DOI 10.1001/jama.260.12.1734; WOOD RC, 1993, JAMA-J AM MED ASSOC, V270, P2935, DOI 10.1001/jama.270.24.2935; Yucesoy B, 2002, VACCINE, V20, P3193, DOI 10.1016/S0264-410X(02)00267-0; Yucesoy B, 2009, VACCINE, V27, P6991, DOI 10.1016/j.vaccine.2009.09.076; Yudushkin IA, 2010, P NATL ACAD SCI USA, V107, P22128, DOI 10.1073/pnas.1016388108; Zhernakova A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002004; Zuckerman JN, 2000, J INFECTION, V41, P130, DOI 10.1053/jinf.2000.0720; Zuckerman JN, 2006, J MED VIROL, V78, P169, DOI 10.1002/jmv.20524	56	12	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35303	10.1371/journal.pone.0035303	http://dx.doi.org/10.1371/journal.pone.0035303			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22536368	Green Published, gold, Green Submitted			2022-12-27	WOS:000305350600073
J	Saragosti, J; Silberzan, P; Buguin, A				Saragosti, Jonathan; Silberzan, Pascal; Buguin, Axel			Modeling E. coli Tumbles by Rotational Diffusion. Implications for Chemotaxis	PLOS ONE			English	Article							BACTERIAL MOTILITY; MOVEMENT	The bacterium Escherichia coli in suspension in a liquid medium swims by a succession of runs and tumbles, effectively describing a random walk. The tumbles randomize incompletely, i.e. with a directional persistence, the orientation taken by the bacterium. Here, we model these tumbles by an active rotational diffusion process characterized by a diffusion coefficient and a diffusion time. In homogeneous media, this description accounts well for the experimental reorientations. In shallow gradients of nutrients, tumbles are still described by a unique rotational diffusion coefficient. Together with an increase in the run length, these tumbles significantly contribute to the net chemotactic drift via a modulation of their duration as a function of the direction of the preceding run. Finally, we discuss the limits of this model in propagating concentration waves characterized by steep gradients. In that case, the effective rotational diffusion coefficient itself varies with the direction of the preceding run. We propose that this effect is related to the number of flagella involved in the reorientation process.	[Saragosti, Jonathan; Silberzan, Pascal; Buguin, Axel] UPMC, CNRS, Inst Curie, Ctr Rech,Lab Phys Chim Curie,UMR 168, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie	Saragosti, J (corresponding author), UPMC, CNRS, Inst Curie, Ctr Rech,Lab Phys Chim Curie,UMR 168, Paris, France.	axel.buguin@curie.fr	Silberzan, Pascal/L-5934-2016	Silberzan, Pascal/0000-0002-8554-882X; Buguin, Axel/0000-0002-1246-4422	C'Nano Ile-de-France; Institut Curie incitative program "nosocomial infections"	C'Nano Ile-de-France(Region Ile-de-France); Institut Curie incitative program "nosocomial infections"	This work was supported by the C'Nano Ile-de-France and the Institut Curie incitative program "nosocomial infections"? The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER J, 1966, SCIENCE, V153, P708, DOI 10.1126/science.153.3737.708; Alon U, 1998, EMBO J, V17, P4238, DOI 10.1093/emboj/17.15.4238; Berg, 2018, RANDOM WALKS BIOL; BERG HC, 1972, NATURE, V239, P500, DOI 10.1038/239500a0; Berg HC, E COLI MOTION; BLOCK SM, 1983, J BACTERIOL, V154, P312, DOI 10.1128/JB.154.1.312-323.1983; Brenner MP, 1998, BIOPHYS J, V74, P1677, DOI 10.1016/S0006-3495(98)77880-4; Cluzel P, 2000, SCIENCE, V287, P1652, DOI 10.1126/science.287.5458.1652; Da Re S, 2007, APPL ENVIRON MICROB, V73, P3391, DOI 10.1128/AEM.02625-06; Lambert G, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.168102; LAUFFENBURGER DA, 1991, MICROB ECOL, V22, P175, DOI 10.1007/BF02540222; LOVELY PS, 1975, J THEOR BIOL, V50, P477, DOI 10.1016/0022-5193(75)90094-6; Min TL, 2009, NAT METHODS, V6, P831, DOI [10.1038/NMETH.1380, 10.1038/nmeth.1380]; PARKINSON JS, 1982, J BACTERIOL, V151, P106, DOI 10.1128/JB.151.1.106-113.1982; Perrin F, 1934, J PHYS-PARIS, V5, P497, DOI 10.1051/jphysrad:01934005010049700; Perrin F, 1936, J PHYS-PARIS, V7, P1, DOI 10.1051/jphysrad:01936007010100; Perrin F., 1928, ANN SCI ENS, V45, P1; PURCELL EM, 1977, AM J PHYS, V45, P3, DOI 10.1119/1.10903; Salman H, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.118101; Saragosti J, 2011, P NATL ACAD SCI USA, V108, P16235, DOI 10.1073/pnas.1101996108; Sourjik V, 2002, P NATL ACAD SCI USA, V99, P123, DOI 10.1073/pnas.011589998; Staropoli JF, 2000, BIOPHYS J, V78, P513, DOI 10.1016/S0006-3495(00)76613-6; Vladimirov N, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000717; Webre DJ, 2003, CURR BIOL, V13, pR47, DOI 10.1016/S0960-9822(02)01424-0; Wu XL, 2000, PHYS REV LETT, V84, P3017, DOI 10.1103/PhysRevLett.84.3017	25	68	68	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35412	10.1371/journal.pone.0035412	http://dx.doi.org/10.1371/journal.pone.0035412			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22530021	Green Published, gold, Green Submitted			2022-12-27	WOS:000305350600081
J	Tunstall, NE; Herr, A; de Bruyne, M; Warr, CG				Tunstall, Narelle E.; Herr, Anabel; de Bruyne, Marien; Warr, Coral G.			A Screen for Genes Expressed in the Olfactory Organs of Drosophila melanogaster Identifies Genes Involved in Olfactory Behaviour	PLOS ONE			English	Article							ODORANT RECEPTORS; DISRUPTION PROJECT; DOMAIN PROTEINS	Background: For insects the sense of smell and associated olfactory-driven behaviours are essential for survival. Insects detect odorants with families of olfactory receptor proteins that are very different to those of mammals, and there are likely to be other unique genes and genetic pathways involved in the function and development of the insect olfactory system. Methodology/Principal Findings: We have performed a genetic screen of a set of 505 Drosophila melanogaster gene trap insertion lines to identify novel genes expressed in the adult olfactory organs. We identified 16 lines with expression in the olfactory organs, many of which exhibited expression of the trapped genes in olfactory receptor neurons. Phenotypic analysis showed that six of the lines have decreased olfactory responses in a behavioural assay, and for one of these we showed that precise excision of the P element reverts the phenotype to wild type, confirming a role for the trapped gene in olfaction. To confirm the identity of the genes trapped in the lines we performed molecular analysis of some of the insertion sites. While for many lines the reported insertion sites were correct, we also demonstrated that for a number of lines the reported location of the element was incorrect, and in three lines there were in fact two pGT element insertions. Conclusions/Significance: We identified 16 new genes expressed in the Drosophila olfactory organs, the majority in neurons, and for several of the gene trap lines demonstrated a defect in olfactory-driven behaviour. Further characterisation of these genes and their roles in olfactory system function and development will increase our understanding of how the insect olfactory system has evolved to perform the same essential function to that of mammals, but using very different molecular genetic mechanisms.	[Tunstall, Narelle E.; Herr, Anabel; de Bruyne, Marien; Warr, Coral G.] Monash Univ, Sch Biol Sci, Clayton, Vic, Australia	Monash University	Tunstall, NE (corresponding author), Monash Univ, Sch Biol Sci, Clayton, Vic, Australia.	coral.warr@monash.edu		Warr, Coral/0000-0002-5289-3950	Australian Research Council	Australian Research Council(Australian Research Council)	This study was funded by a Discovery Project grant from the Australian Research Council to CGW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bainton RJ, 2000, CURR BIOL, V10, P187, DOI 10.1016/S0960-9822(00)00336-5; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; BELLEN HJ, 1992, GENE DEV, V6, P2125, DOI 10.1101/gad.6.11.2125; BELLEN HJ, 1992, GENETICS, V131, P365; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Cho KS, 2001, P NATL ACAD SCI USA, V98, P6144, DOI 10.1073/pnas.101596998; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; de Bruyne M, 1999, J NEUROSCI, V19, P4520; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; Diao FQ, 2009, MOL CELL NEUROSCI, V42, P33, DOI 10.1016/j.mcn.2009.05.003; Edwards Alexis C, 2009, BMC Biol, V7, P29, DOI 10.1186/1741-7007-7-29; Greil F, 2003, GENE DEV, V17, P2825, DOI 10.1101/gad.281503; Harbison ST, 2004, GENETICS, V166, P1807, DOI 10.1534/genetics.166.4.1807; Harbison ST, 2008, GENETICS, V178, P2341, DOI 10.1534/genetics.107.081232; Kitajiri S, 2010, CELL, V141, P786, DOI 10.1016/j.cell.2010.03.049; Leal SM, 2002, J NEUROBIOL, V50, P245, DOI 10.1002/neu.10030; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Li W, 1996, LEARN MEMORY, V2, P320, DOI 10.1101/lm.2.6.320; Lukacsovich T, 2001, GENETICS, V157, P727; Nagel KI, 2011, NAT NEUROSCI, V14, P208, DOI 10.1038/nn.2725; Norga KK, 2003, CURR BIOL, V13, P1388, DOI 10.1016/S0960-9822(03)00546-3; Phillips A M, 1994, Methods Mol Biol, V33, P193; Robertson HM, 2003, P NATL ACAD SCI USA, V100, P14537, DOI 10.1073/pnas.2335847100; SALKOFF L, 1992, TRENDS NEUROSCI, V15, P161, DOI 10.1016/0166-2236(92)90165-5; Sambandan D, 2006, GENETICS, V174, P1349, DOI 10.1534/genetics.106.060574; Sargsyan V, 2011, FRONT CELL NEUROSCI, V5, DOI 10.3389/fncel.2011.00005; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Shin OH, 2005, J BIOL CHEM, V280, P1641, DOI 10.1074/jbc.M407305200; SKOULAKIS EMC, 1993, NEURON, V11, P197, DOI 10.1016/0896-6273(93)90178-T; Smart R, 2008, INSECT BIOCHEM MOLEC, V38, P770, DOI 10.1016/j.ibmb.2008.05.002; Spradling AC, 1999, GENETICS, V153, P135; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; WOODARD C, 1989, GENETICS, V123, P315; Yamamoto A, 2008, P NATL ACAD SCI USA, V105, P12393, DOI 10.1073/pnas.0804889105; Yang P, 2000, GENETICS, V155, P1161	37	17	17	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35641	10.1371/journal.pone.0035641	http://dx.doi.org/10.1371/journal.pone.0035641			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22530061	gold, Green Published, Green Accepted			2022-12-27	WOS:000305350600107
J	Vaidya, NK; Wang, FB; Zou, XF; Wahl, LM				Vaidya, Naveen K.; Wang, Feng-bin; Zou, Xingfu; Wahl, Lindi M.			Transmission Dynamics of the Recently-Identified BYD Virus Causing Duck Egg-Drop Syndrome	PLOS ONE			English	Article							MATHEMATICAL-MODEL; MALARIA; INFECTION; DISEASE	Baiyangdian (BYD) virus is a recently-identified mosquito-borne flavivirus that causes severe disease in ducks, with extremely rapid transmission, up to 15% mortality within 10 days and 90% reduction in egg production on duck farms within 5 days of infection. Because of the zoonotic nature of flaviviruses, the characterization of BYD virus and its epidemiology are important public health concerns. Here, we develop a mathematical model for the transmission dynamics of this novel virus. We validate the model against BYD outbreak data collected from duck farms in Southeast China, as well as experimental data obtained from an animal facility. Based on our model, the basic reproductive number of BYD virus is high (R-0 = 21) indicating that this virus is highly transmissible, consistent with the dramatic epidemiology observed in BYDV-affected duck farms. Our results indicate that younger ducks are more vulnerable to BYD disease and that ducks infected with BYD virus reduce egg production (to about 33% on average) for about 3 days post-infection; after 3 days infected ducks are no longer able to produce eggs. Using our model, we predict that control measures which reduce contact between mosquitoes and ducks such as mosquito nets are more effective than insecticides.	[Vaidya, Naveen K.; Wang, Feng-bin; Zou, Xingfu; Wahl, Lindi M.] Univ Western Ontario, Dept Appl Math, London, ON N6A 5B9, Canada	Western University (University of Western Ontario)	Vaidya, NK (corresponding author), Univ Western Ontario, Dept Appl Math, London, ON N6A 5B9, Canada.	lwahl@uwo.ca			Natural Sciences and Engineering Research Council (NSERC) of Canada; NSERC Canada Research Chairs Program; NCE-MITACS of Canada	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC Canada Research Chairs Program; NCE-MITACS of Canada	This work was supported by the Natural Sciences and Engineering Research Council (NSERC) of Canada, the NSERC Canada Research Chairs Program, and NCE-MITACS of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron JL, 1982, POPULATION DYNAMICS; Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279; ANDERSON R M, 1991; Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; Chitnis N, 2006, SIAM J APPL MATH, V67, P24, DOI 10.1137/050638941; Diekmann O, 2010, J R SOC INTERFACE, V7, P873, DOI 10.1098/rsif.2009.0386; Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X; Heffernan JM, 2005, J R SOC INTERFACE, V2, P281, DOI 10.1098/rsif.2005.0042; Hvistendahl M, 2011, SCIENCENOW      0329; KOELLA JC, 1991, ACTA TROP, V49, P1, DOI 10.1016/0001-706X(91)90026-G; Lopez O., 2011, GREEN TRENDS INSECT; Macey R, 2001, BERKELEY MADONNA VER; Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144; NEDELMAN J, 1985, MATH BIOSCI, V73, P159, DOI 10.1016/0025-5564(85)90010-0; Ngwa GA, 2000, MATH COMPUT MODEL, V32, P747, DOI 10.1016/S0895-7177(00)00169-2; Rohani P, 2009, P NATL ACAD SCI USA, V106, P10365, DOI 10.1073/pnas.0809026106; Sogoba N, 2007, AM J TROP MED HYG, V77, P82, DOI 10.4269/ajtmh.2007.77.82; Su JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018106; van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6; Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008; WHO - WORLD HEALTH ORGANIZATION, 2011, MAL; Yan PX, 2011, VIROLOGY, V417, P1, DOI 10.1016/j.virol.2011.06.003	22	8	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35161	10.1371/journal.pone.0035161	http://dx.doi.org/10.1371/journal.pone.0035161			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529985	Green Published, gold, Green Submitted			2022-12-27	WOS:000305350600063
J	Correia, M; Michel, V; Matos, AA; Carvalho, P; Oliveira, MJ; Ferreira, RM; Dillies, MA; Huerre, M; Seruca, R; Figueiredo, C; Machado, JC; Touati, E				Correia, Marta; Michel, Valerie; Matos, Antonio A.; Carvalho, Patricia; Oliveira, Maria J.; Ferreira, Rui M.; Dillies, Marie-Agnes; Huerre, Michel; Seruca, Raquel; Figueiredo, Ceu; Machado, Jose C.; Touati, Eliette			Docosahexaenoic Acid Inhibits Helicobacter pylori Growth In Vitro and Mice Gastric Mucosa Colonization	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; MONOGLYCERIDES; INFECTION	H. pylori drug-resistant strains and non-compliance to therapy are the major causes of H. pylori eradication failure. For some bacterial species it has been demonstrated that fatty acids have a growth inhibitory effect. Our main aim was to assess the ability of docosahexaenoic acid (DHA) to inhibit H. pylori growth both in vitro and in a mouse model. The effectiveness of standard therapy (ST) in combination with DHA on H. pylori eradication and recurrence prevention success was also investigated. The effects of DHA on H. pylori growth were analyzed in an in vitro dose-response study and n in vivo model. We analized the ability of H. pylori to colonize mice gastric mucosa following DHA, ST or a combination of both treatments. Our data demonstrate that DHA decreases H. pylori growth in vitro in a dose-dependent manner. Furthermore, DHA inhibits H. pylori gastric colonization in vivo as well as decreases mouse gastric mucosa inflammation. Addition of DHA to ST was also associated with lower H. pylori infection recurrence in the mouse model. In conclusion, DHA is an inhibitor of H. pylori growth and its ability to colonize mouse stomach. DHA treatment is also associated with a lower recurrence of H. pylori infection in combination with ST. These observations pave the way to consider DHA as an adjunct agent in H. pylori eradication treatment.	[Correia, Marta; Oliveira, Maria J.; Ferreira, Rui M.; Seruca, Raquel; Figueiredo, Ceu; Machado, Jose C.] Univ Porto, Inst Mol Pathol & Immunol, P-4100 Oporto, Portugal; [Correia, Marta; Ferreira, Rui M.; Seruca, Raquel; Figueiredo, Ceu; Machado, Jose C.] Univ Porto, Fac Med, P-4100 Oporto, Portugal; [Correia, Marta; Michel, Valerie; Touati, Eliette] Inst Pasteur, Unite Pathogenese Helicobacter, Paris, France; [Matos, Antonio A.; Carvalho, Patricia] Hosp Curry Cabral, Serv Microscopia Elect, Lisbon, Portugal; [Dillies, Marie-Agnes] Genopole Inst Pasteur, Paris, France; [Huerre, Michel] Inst Pasteur, Unite Rech & Expertise Histotechnol & Pathol, Paris, France; [Matos, Antonio A.; Carvalho, Patricia] Univ Aveiro, Ctr Environm & Marine Studies CESAM, P-3800 Aveiro, Portugal	Universidade do Porto; Universidade do Porto; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Universidade de Aveiro	Correia, M (corresponding author), Univ Porto, Inst Mol Pathol & Immunol, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	josem@ipatimup.pt; etouati@pasteur.fr	seruca, raquel/F-8187-2011; Ferreira, Rui M./J-6915-2013; Figueiredo, Ceu/B-8776-2008; carvalho, patricia A/C-1150-2009; Carvalho, Patricia A/D-8078-2015; Carvalho, Patrícia Sousa Vindeirinho Albuquerque/HCI-2410-2022; Matos, Antonio P. A./A-4539-2013; Machado, Jose Carlos/C-5907-2009; Oliveira, Maria Jose/K-3275-2013	Ferreira, Rui M./0000-0003-0961-2356; Figueiredo, Ceu/0000-0001-5247-840X; carvalho, patricia A/0000-0002-5447-0409; Carvalho, Patricia A/0000-0002-5447-0409; Matos, Antonio P. A./0000-0001-9386-0349; Machado, Jose Carlos/0000-0003-4741-8415; Oliveira, Maria Jose/0000-0002-0724-0272; Seruca, Raquel/0000-0002-8851-4166; Correia, Maria Marta/0000-0001-5040-735X; Touati, Eliette/0000-0002-3450-1773	Fundacao para a Ciencia e a Tecnologia (FCT), Portugal [BD/36689/2007]; Accoes integradas Luso-Francesas (CRUP-PAULIF) Portugal [AF-8/09]; Accoes integradas Luso-Francesas (CRUP-PAULIF) France [AF-8/09]	Fundacao para a Ciencia e a Tecnologia (FCT), Portugal(Portuguese Foundation for Science and Technology); Accoes integradas Luso-Francesas (CRUP-PAULIF) Portugal; Accoes integradas Luso-Francesas (CRUP-PAULIF) France	The Fundacao para a Ciencia e a Tecnologia (FCT), Portugal, provided funds for this study and to Dr. Correia by a PhD fellowship BD/36689/2007. The Accoes integradas Luso-Francesas (CRUP-PAULIF) Portugal and France also provided financial support (AF-8/09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergsson G, 2002, INT J ANTIMICROB AG, V20, P258, DOI 10.1016/S0924-8579(02)00205-4; BORGSTROM B, 1957, J CLIN INVEST, V36, P1521, DOI 10.1172/JCI103549; Chaput C, 2006, PLOS PATHOG, V2, P844, DOI 10.1371/journal.ppat.0020097; Dammann HG, 2000, HELICOBACTER, V5, P41, DOI 10.1046/j.1523-5378.2000.00006.x; DAS UN, 1985, CAN MED ASSOC J, V132, P1350; DAS UN, 1989, PROSTAGLANDINS, V38, P689, DOI 10.1016/0090-6980(89)90050-6; Duggan AE, 1997, BRIT J NUTR, V78, P515, DOI 10.1079/BJN19970171; Eaton KA, 2007, COMPARATIVE MED, V57, P57; Ferrero RL, 1998, INFECT IMMUN, V66, P1349, DOI 10.1128/IAI.66.4.1349-1355.1998; Furuyashiki T, 2011, NAT REV ENDOCRINOL, V7, P163, DOI 10.1038/nrendo.2010.194; Gerhard M, 2002, HELICOBACTER, V7, P17, DOI 10.1046/j.1523-5378.7.s1.3.x; Glupczynski F, 2000, EUR J CLIN MICROBIOL, V11, P820; Graham DY, 2002, ARCH INTERN MED, V162, P169, DOI 10.1001/archinte.162.2.169; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Israel DA, 2001, J CLIN INVEST, V107, P611, DOI 10.1172/JCI11450; Kelley DS, 2007, AM J CLIN NUTR, V86, P324, DOI 10.1093/ajcn/86.2.324; KNAPP HR, 1986, J INFECT DIS, V154, P84, DOI 10.1093/infdis/154.1.84; Kuriki K, 2007, CANCER EPIDEM BIOMAR, V16, P2406, DOI 10.1158/1055-9965.EPI-07-0655; Lee A, 1997, GASTROENTEROLOGY, V112, P1386, DOI 10.1016/S0016-5085(97)70155-0; Malfertheiner P, 2007, GUT, V56, P772, DOI 10.1136/gut.2006.101634; Megraud F, 2003, SURVEILLANCE NATL MA, P327; Parsons HK, 2001, ALIMENT PHARM THERAP, V15, P1473, DOI 10.1046/j.1365-2036.2001.01068.x; Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703; Petschow BW, 1996, ANTIMICROB AGENTS CH, V40, P302, DOI 10.1128/AAC.40.2.302; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Roomi M. W., 2010, Experimental Oncology, V32, P84; SANDS JA, 1977, ANTIMICROB AGENTS CH, V12, P523, DOI 10.1128/AAC.12.4.523; Sorberg M, 1996, EUR J CLIN MICROBIOL, V15, P216, DOI 10.1007/BF01591357; Sun CQ, 2003, FEMS IMMUNOL MED MIC, V36, P9, DOI 10.1016/S0928-8244(03)00008-7; TARNAWSKI A, 1987, CLIN INVEST MED, V10, P132; THOMPSON L, 1994, GUT, V35, P1557, DOI 10.1136/gut.35.11.1557; Vakil N, 2006, AM J GASTROENTEROL, V101, P497, DOI 10.1111/j.1572-0241.2006.00454.x; van Zanten SJOV, 2003, ANTIMICROB AGENTS CH, V47, P2249, DOI 10.1128/AAC.47.7.2249-2255.2003	33	62	66	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e35072	10.1371/journal.pone.0035072	http://dx.doi.org/10.1371/journal.pone.0035072			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22529974	Green Published, gold, Green Submitted			2022-12-27	WOS:000305347400030
J	Hu, ZY; Hua, W; Huang, SM; Yang, HL; Zhan, GM; Wang, XF; Liu, GH; Wang, HZ				Hu, Zhiyong; Hua, Wei; Huang, Shunmou; Yang, Hongli; Zhan, Gaomiao; Wang, Xinfa; Liu, Guihua; Wang, Hanzhong			Discovery of Pod Shatter-Resistant Associated SNPs by Deep Sequencing of a Representative Library Followed by Bulk Segregant Analysis in Rapeseed	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; BRASSICA-NAPUS; REDUCED REPRESENTATION; OILSEED RAPE; ORYZA-RUFIPOGON; GENETIC-MARKERS; GENOME; CULTIVARS; REGIONS; SATIVA	Background: Single nucleotide polymorphisms (SNPs) are an important class of genetic marker for target gene mapping. As of yet, there is no rapid and effective method to identify SNPs linked with agronomic traits in rapeseed and other crop species. Methodology/Principal Findings: We demonstrate a novel method for identifying SNP markers in rapeseed by deep sequencing a representative library and performing bulk segregant analysis. With this method, SNPs associated with rapeseed pod shatter-resistance were discovered. Firstly, a reduced representation of the rapeseed genome was used. Genomic fragments ranging from 450-550 bp were prepared from the susceptible bulk (ten F2 plants with the silique shattering resistance index, SSRI <0.10) and the resistance bulk (ten F2 plants with SSRI >0.90), and also Solexa sequencing-produced 90 bp reads. Approximately 50 million of these sequence reads were assembled into contigs to a depth of 20-fold coverage. Secondly, 60,396 'simple SNPs' were identified, and the statistical significance was evaluated using Fisher's exact test. There were 70 associated SNPs whose -log(10)p value over 16 were selected to be further analyzed. The distribution of these SNPs appeared a tight cluster, which consisted of 14 associated SNPs within a 396 kb region on chromosome A09. Our evidence indicates that this region contains a major quantitative trait locus (QTL). Finally, two associated SNPs from this region were mapped on a major QTL region. Conclusions/Significance: 70 associated SNPs were discovered and a major QTL for rapeseed pod shatter-resistance was found on chromosome A09 using our novel method. The associated SNP markers were used for mapping of the QTL, and may be useful for improving pod shatter-resistance in rapeseed through marker-assisted selection and map-based cloning. This approach will accelerate the discovery of major QTLs and the cloning of functional genes for important agronomic traits in rapeseed and other crop species.	[Hu, Zhiyong; Hua, Wei; Huang, Shunmou; Yang, Hongli; Zhan, Gaomiao; Wang, Xinfa; Liu, Guihua; Wang, Hanzhong] Chinese Acad Agr Sci, Oil Crops Res Inst, Minist Agr, Key Lab Biol & Genet Improvement Oil Crops, Wuhan, Hubei, Peoples R China	Chinese Academy of Agricultural Sciences; Oil Crops Research Institute, CAAS; Ministry of Agriculture & Rural Affairs	Hu, ZY (corresponding author), Chinese Acad Agr Sci, Oil Crops Res Inst, Minist Agr, Key Lab Biol & Genet Improvement Oil Crops, Wuhan, Hubei, Peoples R China.	wanghz@oilcrops.cn			National Key Basic Research Program of China [2011CB109300]; Ministry of Agriculture Genetically Modified Organisms Breeding Major Projects of China [2009ZX08009-018B]; Wuhan Chenguang Project [201271031411]	National Key Basic Research Program of China(National Basic Research Program of China); Ministry of Agriculture Genetically Modified Organisms Breeding Major Projects of China; Wuhan Chenguang Project	This work was supported by the National Key Basic Research Program of China (2011CB109300), the Ministry of Agriculture Genetically Modified Organisms Breeding Major Projects of China (2009ZX08009-018B), and Wuhan Chenguang Project (201271031411). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2000, NATURE, V407, P513, DOI 10.1038/35035083; Amar S, 2008, THEOR APPL GENET, V116, P1051, DOI 10.1007/s00122-008-0734-2; Barbazuk WB, 2007, PLANT J, V51, P910, DOI 10.1111/j.1365-313X.2007.03193.x; Batley J, 2003, PLANT PHYSIOL, V132, P84, DOI 10.1104/pp.102.019422; Bhattramakki D, 2002, PLANT MOL BIOL, V48, P539, DOI 10.1023/A:1014841612043; Bi IV, 2006, CROP SCI, V46, P12, DOI 10.2135/cropsci2004.0706; Feltus FA, 2004, GENOME RES, V14, P1812, DOI 10.1101/gr.2479404; Feng H, 2012, MOL BREEDING, V29, P235, DOI 10.1007/s11032-010-9542-x; Hajduch M, 2006, PLANT PHYSIOL, V141, P32, DOI 10.1104/pp.105.075390; Hasan M, 2008, THEOR APPL GENET, V116, P1035, DOI 10.1007/s00122-008-0733-3; Huang Z, 2012, MOL BREEDING, V29, P181, DOI 10.1007/s11032-010-9536-8; Hyten DL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-38; KADKOL GP, 1984, EUPHYTICA, V33, P63, DOI 10.1007/BF00022751; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li WQ, 2010, PLANT CELL REP, V29, P617, DOI 10.1007/s00299-010-0848-2; Liu NJ, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-S1-S26; Martins-Lopes P, 2001, PLANT MOL BIOL REP, V19, P159, DOI 10.1007/BF02772158; MICHELMORE RW, 1991, P NATL ACAD SCI USA, V88, P9828, DOI 10.1073/pnas.88.21.9828; Mittelbach M, 2001, J AM OIL CHEM SOC, V78, P573, DOI 10.1007/s11746-001-0306-z; Monna L, 2006, DNA RES, V13, P43, DOI 10.1093/dnares/dsi030; Morgan CL, 1998, FIELD CROP RES, V58, P153, DOI 10.1016/S0378-4290(98)00099-9; Nasu S, 2002, DNA RES, V9, P163, DOI 10.1093/dnares/9.5.163; Need AC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000373; Novaes E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-312; Price JS, 1996, J AGR ENG RES, V65, P183, DOI 10.1006/jaer.1996.0091; Salunkhe AS, 2011, MOL BIOTECHNOL, V49, P90, DOI 10.1007/s12033-011-9382-x; Sanchez CC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-559; Sun YP, 2010, MOL BREEDING, V26, P493, DOI 10.1007/s11032-010-9390-8; Trick M, 2009, PLANT BIOTECHNOL J, V7, P334, DOI 10.1111/j.1467-7652.2008.00396.x; Van Ooijen JW, 2001, JOINMAP3 0 SOFTWAREF; Van Tassell CP, 2008, NAT METHODS, V5, P247, DOI 10.1038/NMETH.1185; Venuprasad R, 2009, THEOR APPL GENET, V120, P177, DOI 10.1007/s00122-009-1168-1; Wang R, 2007, PLANT BREEDING, V126, P588, DOI 10.1111/j.1439-0523.2007.01382.x; Wang S., 2011, WINDOWS QTL CARTOGRA; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Wen YanCheng, 2008, Acta Agronomica Sinica, V34, P163, DOI 10.3724/SP.J.1006.2008.00163; Wenger JW, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000942; Westermeier P, 2009, THEOR APPL GENET, V119, P1301, DOI 10.1007/s00122-009-1135-x; Wiedmann RT, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-81; Xu AX, 2010, MOL BREEDING, V25, P57, DOI 10.1007/s11032-009-9308-5; ZHANG HB, 1995, PLANT J, V7, P175, DOI 10.1046/j.1365-313X.1995.07010175.x	41	16	20	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e34253	10.1371/journal.pone.0034253	http://dx.doi.org/10.1371/journal.pone.0034253			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22529909	gold, Green Submitted, Green Published			2022-12-27	WOS:000305347400009
J	Lanca, EFC; Magalhaes, BML; Vitor-Silva, S; Siqueira, AM; Benzecry, SG; Alexandre, MAA; O'Brien, C; Bassat, Q; Lacerda, MVG				Caetano Lanca, Ellen Fatima; Lopes Magalhaes, Belisa Maria; Vitor-Silva, Sheila; Siqueira, Andre Machado; Benzecry, Silvana Gomes; Araujo Alexandre, Marcia Almeida; O'Brien, Connor; Bassat, Quique; Guimaraes Lacerda, Marcus Vinicius			Risk Factors and Characterization of Plasmodium Vivax-Associated Admissions to Pediatric Intensive Care Units in the Brazilian Amazon	PLOS ONE			English	Article							MALARIA; CHILDREN; PAPUA; FALCIPARUM; MORTALITY; MANAUS	Background: Plasmodium vivax is responsible for a significant proportion of malaria cases worldwide and is increasingly reported as a cause of severe disease. The objective of this study was to characterize severe vivax disease among children hospitalized in intensive care units (ICUs) in the Western Brazilian Amazon, and to identify risk factors associated with disease severity. Methods and Findings: In this retrospective study, clinical records of 34 children, 0-14 years of age hospitalized in the 11 public pediatric and neonatal ICUs of the Manaus area, were reviewed. P. falciparum monoinfection or P. falciparum/P. vivax mixed infection was diagnosed by microscopy in 10 cases, while P. vivax monoinfection was confirmed in the remaining 24 cases. Two of the 24 patients with P. vivax monoinfection died. Respiratory distress, shock and severe anemia were the most frequent complications associated with P. vivax infection. Ninety-one children hospitalized with P. vivax monoinfections but not requiring ICU were consecutively recruited in a tertiary care hospital for infectious diseases to serve as a reference population (comparators). Male sex (p = 0.039), age less than five years (p = 0.028), parasitemia greater than 500/mm(3) (p = 0.018), and the presence of any acute (p = 0.023) or chronic (p = 0.017) co-morbidity were independently associated with ICU admission. At least one of the WHO severity criteria for malaria (formerly validated for P. falciparum) was present in 23/24 (95.8%) of the patients admitted to the ICU and in 17/91 (18.7%) of controls, making these criteria a good predictor of ICU admission (p = 0.001). The only investigated criterion not associated with ICU admission was hyperbilirubinemia (p = 0.513)]. Conclusions: Our study points to the importance of P. vivax-associated severe disease in children, causing 72.5% of the malaria admissions to pediatric ICUs. WHO severity criteria demonstrated good sensitivity in predicting severe P. vivax infection in this small case series.	[Caetano Lanca, Ellen Fatima; Lopes Magalhaes, Belisa Maria; Vitor-Silva, Sheila; Siqueira, Andre Machado; Benzecry, Silvana Gomes; Araujo Alexandre, Marcia Almeida; Guimaraes Lacerda, Marcus Vinicius] Univ Estado Amazonas, Manaus, Amazonas, Brazil; [Siqueira, Andre Machado; Araujo Alexandre, Marcia Almeida; Guimaraes Lacerda, Marcus Vinicius] Fundacao Med Trop Dr Heitor Vieira Dourado, Manaus, Amazonas, Brazil; [Araujo Alexandre, Marcia Almeida; Guimaraes Lacerda, Marcus Vinicius] Univ Nilton Lins, Manaus, Amazonas, Brazil; [Lopes Magalhaes, Belisa Maria; Vitor-Silva, Sheila; Siqueira, Andre Machado; Guimaraes Lacerda, Marcus Vinicius] Natl Inst Sci & Technol Innovat Neglected Dis, Rio De Janeiro, Brazil; [Caetano Lanca, Ellen Fatima] Univ Fed Amazonas, Manaus, Amazonas, Brazil; [O'Brien, Connor] Columbia Univ, Med Ctr, New York, NY USA; [Bassat, Quique] Univ Barcelona, Ctr Recerca Salut Int Barcelona CRESIB, Hosp Clin, Barcelona, Spain	Universidade do Estado do Amazonas; Centro Universitario Nilton Lins; Universidade Federal de Amazonas; Columbia University; ISGlobal; CRESIB; University of Barcelona	Lanca, EFC (corresponding author), Univ Estado Amazonas, Manaus, Amazonas, Brazil.	marcuslacerda.br@gmail.com	Siqueira, Andre M/G-1340-2010; O'Brien, Connor/ABA-3538-2021; Idn, Inct/J-8385-2013; Bassat, Quique/P-2341-2016	Siqueira, Andre M/0000-0003-2208-0294; O'Brien, Connor/0000-0002-2325-8317; Bassat, Quique/0000-0003-0875-7596	PRONEX Malaria Network; Brazilian Ministry of Science and Technology (MCT); National Council for Scientific and Technological Development (CNPq); Brazilian Ministry of Health (DECIT/SCTIE/MS); Research Support Foundation from Amazonas (FAPEAM); Fundacio Cellex; National Institute of Science and Technology for Innovation in Neglected Diseases (INCT-IDN)	PRONEX Malaria Network; Brazilian Ministry of Science and Technology (MCT); National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian Ministry of Health (DECIT/SCTIE/MS); Research Support Foundation from Amazonas (FAPEAM); Fundacio Cellex(Foundation CELLEX); National Institute of Science and Technology for Innovation in Neglected Diseases (INCT-IDN)	This work was supported by: PRONEX Malaria Network, funded by the Brazilian Ministry of Science and Technology (MCT), National Council for Scientific and Technological Development (CNPq), Brazilian Ministry of Health (DECIT/SCTIE/MS) and the Research Support Foundation from Amazonas (FAPEAM); Fundacio Cellex; and the National Institute of Science and Technology for Innovation in Neglected Diseases (INCT-IDN). Dr. Lacerda is a level 2 productivity fellow from CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alecrim M das G, 1999, Rev Soc Bras Med Trop, V32, P67, DOI 10.1590/S0037-86821999000100013; Alexandre MA, 2010, EMERG INFECT DIS, V16, P1611, DOI 10.3201/eid1610.100685; Alonso PL, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000406; Andrade BB, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-13; [Anonymous], 1986, Trans R Soc Trop Med Hyg, V80 Suppl, P3; [Anonymous], 2008, WORLD MAL REP 2008; Anstey NM, 2007, J INFECT DIS, V195, P589, DOI 10.1086/510756; Anstey NM, 2007, PLOS MED, V4, P1291, DOI 10.1371/journal.pmed.0040267; Barcus MJ, 2007, AM J TROP MED HYG, V77, P984, DOI 10.4269/ajtmh.2007.77.984; Bassat Q, 2011, NAT MED, V17, P48, DOI 10.1038/nm0111-48; Bassat Q, 2009, TROP MED INT HEALTH, V14, P1011, DOI 10.1111/j.1365-3156.2009.02326.x; Beg MA, 2002, AM J TROP MED HYG, V67, P230, DOI 10.4269/ajtmh.2002.67.230; Burgoine KL, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-376; Caicedo O, 2009, AM J TROP MED HYG, V80, P146, DOI 10.4269/ajtmh.2009.80.146; Carvalho BO, 2010, J INFECT DIS, V202, P638, DOI 10.1086/654815; Caulfield LE, 2004, AM J TROP MED HYG, V71, P55, DOI 10.4269/ajtmh.2004.71.55; Costa MRF, 2008, REV SOC BRAS MED TRO, V41, P381, DOI 10.1590/S0037-86822008000400011; Saraiva MDG, 2009, REV SOC BRAS MED TRO, V42, P515, DOI 10.1590/S0037-86822009000500008; de Lacerda MVG, 2008, REV SOC BRAS MED TRO, V41, P522, DOI 10.1590/S0037-86822008000500021; de Lacerda MVG, 2009, REV SOC BRAS MED TRO, V42, P79, DOI 10.1590/S0037-86822009000100017; Khoo K. L., 1998, Annals Academy of Medicine Singapore, V27, P353; Kochar DK, 2010, AM J TROP MED HYG, V83, P981, DOI 10.4269/ajtmh.2010.09-0633; Kochar DK, 2005, EMERG INFECT DIS, V11, P132, DOI 10.3201/eid1101.040519; Koh K. H., 2004, SMJ Singapore Medical Journal, V45, P28; Lacerda MVG, 2004, ACTA TROP, V90, P187, DOI 10.1016/j.actatropica.2003.12.001; LACERDA MVG, 2007, REV SOC BRAS MED TRO, V40, P96; Lampah DA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001032; Lomar André V., 2005, Braz J Infect Dis, V9, P425, DOI 10.1590/S1413-86702005000500011; Maitland K, 1996, T ROY SOC TROP MED H, V90, P614, DOI 10.1016/S0035-9203(96)90406-X; Mueller I, 2005, AM J TROP MED HYG, V72, P554, DOI 10.4269/ajtmh.2005.72.554; Mueller I, 2009, LANCET INFECT DIS, V9, P555, DOI 10.1016/S1473-3099(09)70177-X; Oliveira-Ferreira J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-115; Orjuela-Sanchez P, 2009, AM J TROP MED HYG, V81, P961, DOI 10.4269/ajtmh.2009.09-0337; Poespoprodjo JR, 2009, CLIN INFECT DIS; Price RN, 2009, CURR OPIN INFECT DIS, V22, P430, DOI 10.1097/QCO.0b013e32832f14c1; Ramos WM, 2010, BRAZ J INFECT DIS, V14, P410, DOI 10.1590/S1413-86702010000400017; SANTANA FS, 2007, EMERG INFECT DIS, V13, P1125; Santana MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005259; Santos-Ciminera PD, 2007, EMERG INFECT DIS, V13, P1597, DOI 10.3201/eid1310.070052; Shann F, 1997, INTENS CARE MED, V23, P201, DOI 10.1007/s001340050317; Siqueira AM, 2010, AM J TROP MED HYG, V83, P271, DOI 10.4269/ajtmh.2010.10-0027; Tjitra E, 2008, PLOS MED, V5, P890, DOI 10.1371/journal.pmed.0050128; Valecha N, 2009, AM J TROP MED HYG, V81, P758, DOI 10.4269/ajtmh.2009.09-0348; WHO, 2010, GUID TREATM MAL, V2nd; Wildig J, 2006, J INFECT DIS, V194, P146, DOI 10.1086/505082; World Health Organization, 2006, MICR DIAGN MAL	46	51	51	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e35406	10.1371/journal.pone.0035406	http://dx.doi.org/10.1371/journal.pone.0035406			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523591	Green Published, Green Submitted, gold			2022-12-27	WOS:000305345000064
J	Powder, KE; Ku, YC; Brugmann, SA; Veile, RA; Renaud, NA; Helms, JA; Lovett, M				Powder, Kara E.; Ku, Yuan-Chieh; Brugmann, Samantha A.; Veile, Rose A.; Renaud, Nicole A.; Helms, Jill A.; Lovett, Michael			A Cross-Species Analysis of MicroRNAs in the Developing Avian Face	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; NEURAL CREST CELLS; OSTEOBLAST DIFFERENTIATION; DARWINS FINCHES; VERTEBRATE EVOLUTION; EXPRESSION ANALYSIS; METAZOAN MICRORNAS; BEAK MORPHOLOGY; FEEDBACK LOOP; STEM-CELLS	Higher vertebrates use similar genetic tools to derive very different facial features. This diversity is believed to occur through temporal, spatial and species-specific changes in gene expression within cranial neural crest (NC) cells. These contribute to the facial skeleton and contain species-specific information that drives morphological variation. A few signaling molecules and transcription factors are known to play important roles in these processes, but little is known regarding the role of micro-RNAs (miRNAs). We have identified and compared all miRNAs expressed in cranial NC cells from three avian species (chicken, duck, and quail) before and after species-specific facial distinctions occur. We identified 170 differentially expressed miRNAs. These include thirty-five novel chicken orthologs of previously described miRNAs, and six avian-specific miRNAs. Five of these avian-specific miRNAs are conserved over 120 million years of avian evolution, from ratites to galliforms, and their predicted target mRNAs include many components of Wnt signaling. Previous work indicates that mRNA gene expression in NC cells is relatively static during stages when the beak acquires species-specific morphologies. However, miRNA expression is remarkably dynamic within this timeframe, suggesting that the timing of specific developmental transitions is altered in birds with different beak shapes. We evaluated one miRNA: mRNA target pair and found that the cell cycle regulator p27(KIP1) is a likely target of miR-222 in frontonasal NC cells, and that the timing of this interaction correlates with the onset of phenotypic variation. Our comparative genomic approach is the first comprehensive analysis of miRNAs in the developing facial primordial, and in species-specific facial development.	[Powder, Kara E.; Ku, Yuan-Chieh; Veile, Rose A.; Renaud, Nicole A.; Lovett, Michael] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Brugmann, Samantha A.] Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Div Plast Surg, Cincinnati, OH USA; [Helms, Jill A.] Stanford Univ, Dept Plast & Reconstruct Surg, Stanford, CA 94305 USA	Washington University (WUSTL); Cincinnati Children's Hospital Medical Center; Stanford University	Powder, KE (corresponding author), Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA.	lovett@genetics.wustl.edu		Lovett, Michael/0000-0002-6510-5829; Helms, Jill/0000-0002-0463-396X; Powder, Kara/0000-0001-7415-4262	National Institutes of Health [NRSA F32DE017499-01, RO1-DE012462-06A1, R01NS039818-09S1]; Louisiana State University Museum of Natural Sciences (LSUMNS); The University of Alaska Museum (UAM); University of Cincinnati; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE012462, F32DE017499] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039818] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Louisiana State University Museum of Natural Sciences (LSUMNS); The University of Alaska Museum (UAM); University of Cincinnati; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health [NRSA F32DE017499-01 to SAB, RO1-DE012462-06A1 JAH, and R01NS039818-09S1 ML]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Tissues and DNAs from various bird species used to assess avian-specific miRNAs were provided by a grant from the Louisiana State University Museum of Natural Sciences (LSUMNS, Dr. R.T Brumfield), The University of Alaska Museum (UAM, Dr. K. Winker) and Dr. K. Petren (University of Cincinnati). We thank the Washington University School of Medicine GTAC for Next-Gen Sequencing services. We are grateful to Drs. Anne Bowcock and Cailin Joyce for critical comments on this manuscript.	Abzhanov A, 2004, SCIENCE, V305, P1462, DOI 10.1126/science.1098095; Abzhanov A, 2006, NATURE, V442, P563, DOI 10.1038/nature04843; Adkins RM, 2001, MOL BIOL EVOL, V18, P777, DOI 10.1093/oxfordjournals.molbev.a003860; Albertson RC, 2005, P NATL ACAD SCI USA, V102, P16287, DOI 10.1073/pnas.0506649102; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Berezikov E, 2006, NAT GENET, V38, P1375, DOI 10.1038/ng1914; Brabletz S, 2010, EMBO REP, V11, P670, DOI 10.1038/embor.2010.117; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Brameier Markus, 2010, BMC Res Notes, V3, P64, DOI 10.1186/1756-0500-3-64; Braun J, 2010, ONCOGENE, V29, P4237, DOI 10.1038/onc.2010.169; Brugmann SA, 2006, AM J MED GENET A, V140A, P2521, DOI 10.1002/ajmg.a.31361; Brugmann SA, 2010, HUM MOL GENET, V19, P920, DOI 10.1093/hmg/ddp559; Burnside J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-185; CARROLL SB, 2005, ENDLESS FORMS MOST B; Chen K, 2006, NAT GENET, V38, P1452, DOI 10.1038/ng1910; Christodoulou F, 2010, NATURE, V463, P1084, DOI 10.1038/nature08744; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Dobreva G, 2006, CELL, V125, P971, DOI 10.1016/j.cell.2006.05.012; Eames BF, 2004, DEV DYNAM, V231, P4, DOI 10.1002/dvdy.20134; Eberhart JK, 2008, NAT GENET, V40, P290, DOI 10.1038/ng.82; Fehniger TA, 2010, GENOME RES, V20, P1590, DOI 10.1101/gr.107995.110; FitzPatrick DR, 2003, HUM MOL GENET, V12, P2491, DOI 10.1093/hmg/ddg248; Galardi S, 2007, J BIOL CHEM, V282, P23716, DOI 10.1074/jbc.M701805200; Gessert S, 2010, DEV BIOL, V341, P222, DOI 10.1016/j.ydbio.2010.02.031; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Glazov EA, 2008, GENOME RES, V18, P957, DOI 10.1101/gr.074740.107; Grant P. R., 1986, ECOLOGY EVOLUTION DA; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Grimson A, 2008, NATURE, V455, P1193, DOI 10.1038/nature07415; Hackenberg M, 2009, NUCLEIC ACIDS RES, V37, pW68, DOI 10.1093/nar/gkp347; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hassan MQ, 2010, P NATL ACAD SCI USA, V107, P19879, DOI 10.1073/pnas.1007698107; Hawkins RD, 2006, GENOMICS, V87, P801, DOI 10.1016/j.ygeno.2005.12.014; Heimberg AM, 2008, P NATL ACAD SCI USA, V105, P2946, DOI 10.1073/pnas.0712259105; Hertel J, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-25; Hiard S, 2010, NUCLEIC ACIDS RES, V38, pD640, DOI 10.1093/nar/gkp926; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Huang TW, 2010, J MOL CELL BIOL, V2, P152, DOI 10.1093/jmcb/mjq008; Huang YW, 2009, CANCER RES, V69, P9038, DOI 10.1158/0008-5472.CAN-09-1499; JACOB F, 1977, SCIENCE, V196, P1161, DOI 10.1126/science.860134; Joglekar MV, 2009, ISLETS, V1, P137, DOI 10.4161/isl.1.2.9578; Kennell JA, 2008, P NATL ACAD SCI USA, V105, P15417, DOI 10.1073/pnas.0807763105; Kersigo J, 2011, GENESIS, V49, P326, DOI 10.1002/dvg.20714; Kocher TD, 2004, NAT REV GENET, V5, P288, DOI 10.1038/nrg1316; Kontges G, 1996, DEVELOPMENT, V122, P3229; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Lambeth LS, 2009, J GEN VIROL, V90, P1164, DOI 10.1099/vir.0.007831-0; Larroux C, 2008, MOL BIOL EVOL, V25, P980, DOI 10.1093/molbev/msn047; Li JJ, 2010, MOL BIOL EVOL, V27, P671, DOI 10.1093/molbev/msp284; Lin SL, 2008, RNA, V14, P2115, DOI 10.1261/rna.1162708; Lin SL, 2011, NUCLEIC ACIDS RES, V39, P1054, DOI 10.1093/nar/gkq850; Lin SL, 2010, NUCL ACIDS RES; Liu B, 2010, SEMIN CELL DEV BIOL, V21, P309, DOI 10.1016/j.semcdb.2009.09.002; Liu W, 2005, DEVELOPMENT, V132, P1453, DOI 10.1242/dev.01676; Loh YHE, 2011, GENOME BIOL EVOL, V3, P55, DOI 10.1093/gbe/evq085; LUMSDEN A, 1991, DEVELOPMENT, V113, P1281; Mallarino R, 2011, P NATL ACAD SCI USA, V108, P4057, DOI 10.1073/pnas.1011480108; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mukhopadhyay P, 2010, BIRTH DEFECTS RES A, V88, P511, DOI 10.1002/bdra.20684; Nichols SA, 2006, P NATL ACAD SCI USA, V103, P12451, DOI 10.1073/pnas.0604065103; Nie XG, 2011, MECH DEVELOP, V128, P200, DOI 10.1016/j.mod.2010.12.002; NODEN DM, 1978, DEV BIOL, V67, P296, DOI 10.1016/0012-1606(78)90201-4; Noonan JP, 2006, SCIENCE, V314, P1113, DOI 10.1126/science.1131412; Okamura K, 2008, NAT STRUCT MOL BIOL, V15, P354, DOI 10.1038/nsmb.1409; Peterson KJ, 2009, BIOESSAYS, V31, P736, DOI 10.1002/bies.200900033; Prochnik SE, 2007, DEV GENES EVOL, V217, P73, DOI 10.1007/s00427-006-0116-1; Romualdi C, 2001, HUM MOL GENET, V10, P2133, DOI 10.1093/hmg/10.19.2133; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Santagati F, 2003, NAT REV NEUROSCI, V4, P806, DOI 10.1038/nrn1221; Sauka-Spengler T, 2008, NAT REV MOL CELL BIO, V9, P557, DOI 10.1038/nrm2428; Schneider RA, 2003, SCIENCE, V299, P565, DOI 10.1126/science.1077827; Sempere LF, 2006, J EXP ZOOL PART B, V306B, P575, DOI 10.1002/jez.b.21118; Sheehy NT, 2010, DEVELOPMENT, V137, P4307, DOI 10.1242/dev.052647; Shen RZ, 2010, BIOCHEM BIOPH RES CO, V394, P1047, DOI 10.1016/j.bbrc.2010.03.121; Sibley C.G., 1990, PHYLOGENY CLASSIFICA; Silber J, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-14; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Sun DZ, 2000, DEV BIOL, V228, P337, DOI 10.1006/dbio.2000.9946; Suzuki S, 2009, AM J HUM GENET, V84, P406, DOI 10.1016/j.ajhg.2009.02.002; Tapadia MD, 2005, J ANAT, V207, P461, DOI 10.1111/j.1469-7580.2005.00484.x; Terai Y, 2002, MOL BIOL EVOL, V19, P1628, DOI 10.1093/oxfordjournals.molbev.a004225; Thatcher EJ, 2008, P NATL ACAD SCI USA, V105, P18384, DOI 10.1073/pnas.0803713105; van Tuinen M, 2001, MOL BIOL EVOL, V18, P206, DOI 10.1093/oxfordjournals.molbev.a003794; Wang T, 2010, BIOCHEM BIOPH RES CO, V402, P186, DOI 10.1016/j.bbrc.2010.08.031; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Wheeler BM, 2009, EVOL DEV, V11, P50, DOI 10.1111/j.1525-142X.2008.00302.x; Wu P, 2004, SCIENCE, V305, P1465, DOI 10.1126/science.1098109; Wu P, 2006, DEV DYNAM, V235, P1400, DOI 10.1002/dvdy.20825; Yang JS, 2010, WIDESPREAD REGULATOR; Yuan ZD, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-346; Zehir A, 2010, DEV BIOL, V340, P459, DOI 10.1016/j.ydbio.2010.01.039	93	23	24	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e35111	10.1371/journal.pone.0035111	http://dx.doi.org/10.1371/journal.pone.0035111			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523571	Green Published, Green Submitted, gold			2022-12-27	WOS:000305345000043
J	Toffanello, ED; Perissinotto, E; Sergi, G; Zambon, S; Musacchio, E; Maggi, S; Coin, A; Sartori, L; Corti, MC; Baggio, G; Crepaldi, G; Manzato, E				Toffanello, Elena D.; Perissinotto, Egle; Sergi, Giuseppe; Zambon, Sabina; Musacchio, Estella; Maggi, Stefania; Coin, Alessandra; Sartori, Leonardo; Corti, Maria-Chiara; Baggio, Giovannella; Crepaldi, Gaetano; Manzato, Enzo			Vitamin D and Physical Performance in Elderly Subjects: The Pro.V.A Study	PLOS ONE			English	Article							SERUM 25-HYDROXYVITAMIN D; MUSCLE STRENGTH; POSTMENOPAUSAL WOMEN; HYPOVITAMINOSIS-D; 6-MINUTE WALK; ASSOCIATION; DISABILITY; PREVALENCE; FRACTURES; CAPACITY	Background: The role of Vitamin D in musculoskeletal functionality among elderly people is still controversial. We investigated the association between serum 25-hydroxyvitamin D (25OHD) levels and physical performance in older adults. Methods: 2694 community-dwelling elderly women and men from the Progetto Veneto Anziani (Pro.V.A.) were included. Physical performances were assessed by: tandem test, 5 timed chair stands (TCS), gait speed, 6-minute walking (6 mW) distance, handgrip strength, and quadriceps strength. For each test, separate general linear models and loess plots were obtained in both genders, in relation to serum 25OHD concentrations, controlling for several potential confounders. Results: Linear associations with 25OHD levels were observed for TCS, gait speed, 6 mW test and handgrip strength, but not for tandem test and quadriceps strength. After adjusting for potential confounders, linear associations with 25OHD levels were still evident for the 6 mW distance in both genders (p=.0002 in women; <.0001 in men), for TCS in women (p=.004) and for gait speed (p=.0006) and handgrip strength (p=.03) in men. In loess analyses, performance in TCS in women, in gait speed and handgrip strength in men and in 6 mW in both genders, improved with increasing levels of 25OHD, with most of the improvements occurring for 25OHD levels from 20 to 100 nmol/L. Conclusion: lower 25OHD levels are associated with a worse coordination and weaker strength (TCS) in women, a slower walking time and a lower upper limb strength in men, and a weaker aerobic capacity (6 mW) in both genders. For optimal physical performances, 25OHD concentrations of 100 nmol/L appear to be more advantageous in elderly men and women, and Vitamin D supplementation should be encouraged to maintain their 25OHD levels as high as this threshold.	[Toffanello, Elena D.; Sergi, Giuseppe; Coin, Alessandra; Manzato, Enzo] Univ Padua, Dept Med & Surg Sci, Div Geriatr, Padua, Italy; [Perissinotto, Egle] Univ Padua, Dept Environm Med & Publ Hlth, Padua, Italy; [Zambon, Sabina; Maggi, Stefania; Crepaldi, Gaetano; Manzato, Enzo] CNR, Aging Branch, Inst Neurosci, Padua, Italy; [Corti, Maria-Chiara] Azienda Unita Locale Socio Sanit, Padua, Italy; [Baggio, Giovannella] Azienda Osped Padova, Div Internal Med, Padua, Italy	University of Padua; University of Padua; Consiglio Nazionale delle Ricerche (CNR); University of Padua; Azienda Ospedaliera - Universita di Padova	Toffanello, ED (corresponding author), Univ Padua, Dept Med & Surg Sci, Div Geriatr, Padua, Italy.	elenadebora.toffanello@sanita.padova.it	SERGI, GIUSEPPE/J-9396-2018; Coin, Alessandra/J-9256-2018	SERGI, GIUSEPPE/0000-0001-9757-856X; Coin, Alessandra/0000-0003-1687-4493; Musacchio, Estella/0000-0001-9811-9103	Fondazione Cassa di Risparmio di Padova e Rovigo; University of Padova; Azienda Unita Locale Socio Sanitaria [15]; Veneto region [18]; National Institute on Aging, National Institutes of Health; Veneto Region Research Project [104/02]	Fondazione Cassa di Risparmio di Padova e Rovigo(Fondazione Cariparo); University of Padova; Azienda Unita Locale Socio Sanitaria; Veneto region(Regione Veneto); National Institute on Aging, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veneto Region Research Project	This study was funded by Fondazione Cassa di Risparmio di Padova e Rovigo, University of Padova, Azienda Unita Locale Socio Sanitaria 15 and 18 of the Veneto region; by the Intramural Research Program of the National Institute on Aging, National Institutes of Health; and by Veneto Region Research Project 104/02 (GC). The funding institutes had no role in the design, methods, subject recruitment, data collection, analysis, or preparation of the manuscript or in the decision to submit the manuscript for publication.	Annweiler C, 2009, J NUTR HEALTH AGING, V13, P893, DOI 10.1007/s12603-009-0248-x; Annweiler C, 2009, J NUTR HEALTH AGING, V13, P90, DOI 10.1007/s12603-009-0013-1; Annweiler C, 2009, J AM GERIATR SOC, V57, P368, DOI 10.1111/j.1532-5415.2009.02118.x; Bandinelli S, 1999, AGING-CLIN EXP RES, V11, P287, DOI 10.1007/BF03339802; Bettica P, 1999, OSTEOPOROSIS INT, V9, P226, DOI 10.1007/s001980050141; Bischoff HA, 1999, ARCH PHYS MED REHAB, V80, P54, DOI 10.1016/S0003-9993(99)90307-6; Bischoff HA, 2001, HISTOCHEM J, V33, P19, DOI 10.1023/A:1017535728844; Bischoff-Ferrari HA, 2004, AM J CLIN NUTR, V80, P752; Bischoff-Ferrari HA, 2004, JAMA-J AM MED ASSOC, V291, P1999, DOI 10.1001/jama.291.16.1999; Boxer RS, 2008, J AM GERIATR SOC, V56, P454, DOI 10.1111/j.1532-5415.2007.01601.x; Boxer RS, 2010, AM HEART J, V160, P893, DOI 10.1016/j.ahj.2010.08.004; Ceglia L, 2008, MOL ASPECTS MED, V29, P407, DOI 10.1016/j.mam.2008.07.002; Corti MC, 2002, J AM GERIATR SOC, V50, P1535, DOI 10.1046/j.1532-5415.2002.50409.x; Dam TTL, 2009, OSTEOPOROSIS INT, V20, P751, DOI 10.1007/s00198-008-0749-1; Dhesi JK, 2002, J BONE MINER RES, V17, P891, DOI 10.1359/jbmr.2002.17.5.891; Faulkner KA, 2006, OSTEOPOROSIS INT, V17, P1318, DOI 10.1007/s00198-006-0071-8; FOLSTEIN MF, 1983, ARCH GEN PSYCHIAT, V40, P812; Fried LP, 2000, J GERONTOL A-BIOL, V55, pM43; Gerdhem P, 2005, OSTEOPOROSIS INT, V16, P1425, DOI 10.1007/s00198-005-1860-1; Grundberg E, 2004, EUR J ENDOCRINOL, V150, P323, DOI 10.1530/eje.0.1500323; GUYATT GH, 1985, CAN MED ASSOC J, V132, P919; Holick MF, 2004, AM J CLIN NUTR, V80, p1678S, DOI 10.1093/ajcn/80.6.1678S; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Houston DK, 2007, J GERONTOL A-BIOL, V62, P440, DOI 10.1093/gerona/62.4.440; Isaia G, 2003, OSTEOPOROSIS INT, V14, P577, DOI 10.1007/s00198-003-1390-7; Kalueff AV, 2007, CURR OPIN CLIN NUTR, V10, P12, DOI 10.1097/MCO.0b013e328010ca18; Lips P, 1999, OSTEOPOROSIS INT, V9, P394, DOI 10.1007/s001980050162; Parmelee PA, 1989, PSYCHOL ASSESSMENT J, V1, P331, DOI DOI 10.1037/1040-3590.1.4.331; Pfeifer M, 2001, EXP CLIN ENDOCR DIAB, V109, P87, DOI 10.1055/s-2001-14831; Ross AC, 2011, J CLIN ENDOCR METAB, V96, P53, DOI 10.1210/jc.2010-2704; SIMPSON RU, 1985, J BIOL CHEM, V260, P8882; Stewart JW, 2009, MENOPAUSE, V16, P1093, DOI 10.1097/gme.0b013e3181a8f7ed; Swanenburg J, 2007, CLIN REHABIL, V21, P523, DOI 10.1177/0269215507075206; Verreault R, 2002, J AM GERIATR SOC, V50, P912, DOI 10.1046/j.1532-5415.2002.50219.x; Wicherts IS, 2007, J CLIN ENDOCR METAB, V92, P2058, DOI 10.1210/jc.2006-1525; Zamboni M, 2002, J GERONTOL A-BIOL, V57, pM7, DOI 10.1093/gerona/57.1.M7	36	74	77	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e34950	10.1371/journal.pone.0034950	http://dx.doi.org/10.1371/journal.pone.0034950			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22539952	gold, Green Published, Green Submitted			2022-12-27	WOS:000305341000015
J	Bokulich, NA; Bamforth, CW; Mills, DA				Bokulich, Nicholas A.; Bamforth, Charles W.; Mills, David A.			Brewhouse-Resident Microbiota Are Responsible for Multi-Stage Fermentation of American Coolship Ale	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; FRAGMENT-LENGTH-POLYMORPHISMS; WORT ENTEROBACTERIA; LAMBIC FERMENTATION; COMMUNITIES; GUEUZE; GENES; POPULATIONS; DIVERSITY; PRIMERS	American coolship ale (ACA) is a type of spontaneously fermented beer that employs production methods similar to traditional Belgian lambic. In spite of its growing popularity in the American craft-brewing sector, the fermentation microbiology of ACA has not been previously described, and thus the interface between production methodology and microbial community structure is unexplored. Using terminal restriction fragment length polymorphism (TRFLP), barcoded amplicon sequencing (BAS), quantitative PCR (qPCR) and culture-dependent analysis, ACA fermentations were shown to follow a consistent fermentation progression, initially dominated by Enterobacteriaceae and a range of oxidative yeasts in the first month, then ceding to Saccharomyces spp. and Lactobacillales for the following year. After one year of fermentation, Brettanomyces bruxellensis was the dominant yeast population (occasionally accompanied by minor populations of Candida spp., Pichia spp., and other yeasts) and Lactobacillales remained dominant, though various aerobic bacteria became more prevalent. This work demonstrates that ACA exhibits a conserved core microbial succession in absence of inoculation, supporting the role of a resident brewhouse microbiota. These findings establish this core microbial profile of spontaneous beer fermentations as a target for production control points and quality standards for these beers.	[Bokulich, Nicholas A.; Mills, David A.] Univ Calif Davis, Robert Mondavi Inst Wine & Food Sci, Dept Viticulture & Enol, Davis, CA 95616 USA; [Bokulich, Nicholas A.; Bamforth, Charles W.; Mills, David A.] Univ Calif Davis, Robert Mondavi Inst Wine & Food Sci, Dept Food Sci & Technol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Bokulich, NA (corresponding author), Univ Calif Davis, Robert Mondavi Inst Wine & Food Sci, Dept Viticulture & Enol, Davis, CA 95616 USA.	damills@ucdavis.edu	Mills, David Andrew/G-2282-2011; Mills, David/GXF-1821-2022	Mills, David Andrew/0000-0003-1913-9865; Bokulich, Nicholas/0000-0002-1784-8935	Roger C. Briess ASBC scholarship; Cargill Malt ASBC scholarship; Michael J. Lewis endowment; David E. Gallo educational enhancement fund; Adolf L. & Richie C. Heck research fellowship	Roger C. Briess ASBC scholarship; Cargill Malt ASBC scholarship; Michael J. Lewis endowment; David E. Gallo educational enhancement fund; Adolf L. & Richie C. Heck research fellowship	NB was supported in part by the Roger C. Briess ASBC scholarship and Cargill Malt ASBC scholarship, the Michael J. Lewis endowment, David E. Gallo educational enhancement fund, Adolf L. & Richie C. Heck research fellowship, and Wine Spectator scholarship during the completion of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdo Z, 2006, ENVIRON MICROBIOL, V8, P929, DOI 10.1111/j.1462-2920.2005.00959.x; Blanco P, 2011, J IND MICROBIOL BIOT, V38, P235, DOI 10.1007/s10295-010-0818-2; Bokulich NA, 2012, AM J ENOL VITICULT, V63, P185, DOI 10.5344/ajev.2011.11077; Bokulich NA, 2012, FOOD MICROBIOL, V31, P126, DOI 10.1016/j.fm.2012.02.007; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Ciani M, 2004, ANTON LEEUW INT J G, V85, P159, DOI 10.1023/B:ANTO.0000020284.05802.d7; Cole JR, 2007, NUCLEIC ACIDS RES, V35, pD169, DOI 10.1093/nar/gkl889; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fleet GH, 2003, INT J FOOD MICROBIOL, V86, P11, DOI 10.1016/S0168-1605(03)00245-9; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Hamady M, 2009, GENOME RES, V19, P1141, DOI 10.1101/gr.085464.108; Hierro N, 2006, APPL ENVIRON MICROB, V72, P7148, DOI 10.1128/AEM.00388-06; Lafarge V, 2004, APPL ENVIRON MICROB, V70, P5644, DOI 10.1128/AEM.70.9.5644-5650.2004; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; MARTENS H, 1992, J I BREWING, V98, P421, DOI 10.1002/j.2050-0416.1992.tb01126.x; MARTENS H, 1991, J I BREWING, V97, P435, DOI 10.1002/j.2050-0416.1991.tb01082.x; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; PRIEST FG, 1974, J I BREWING, V80, P342, DOI 10.1002/j.2050-0416.1974.tb03629.x; Santamaria P, 2008, EUR FOOD RES TECHNOL, V227, P1563, DOI 10.1007/s00217-008-0855-5; Shyu C, 2007, MICROB ECOL, V53, P562, DOI 10.1007/s00248-006-9106-0; SPAEPEN M, 1978, J I BREWING, V84, P278, DOI 10.1002/j.2050-0416.1978.tb03888.x; VANOEVELEN D, 1977, J I BREWING, V83, P356, DOI 10.1002/j.2050-0416.1977.tb03825.x; VANOEVELEN D, 1976, J I BREWING, V82, P322; Verachtert H, 1990, YEAST BIOTECHNOLOGY; Wang Q, 2007, APPL ENV MICROBIOL, V73; White TJ., 1990, PCR PROTOCOLS GUIDE, P315	30	120	122	3	121	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35507	10.1371/journal.pone.0035507	http://dx.doi.org/10.1371/journal.pone.0035507			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22530036	Green Published, gold			2022-12-27	WOS:000305350600091
J	Chan, RCK; Shi, YF; Lai, MK; Wang, YN; Wang, Y; Kring, AM				Chan, Raymond C. K.; Shi, Yan-fang; Lai, Man-kin; Wang, Yu-na; Wang, Ya; Kring, Ann M.			The Temporal Experience of Pleasure Scale (TEPS): Exploration and Confirmation of Factor Structure in a Healthy Chinese Sample	PLOS ONE			English	Article							BOLLEN-STINE BOOTSTRAP; OF-FIT MEASURES; REWARD; SCHIZOPHRENIA; ANTICIPATION; VALIDATION; ANHEDONIA; DOPAMINE	Background: The Temporal Experience of Pleasure Scale (TEPS) is a measure specifically designed to capture the anticipatory and consummatory facets of pleasure. However, few studies have examined the structure of the measure in non-Western samples. The current study aimed to evaluate the factor structure and psychometric properties of the TEPS in a Chinese sample. Methods: We administered the Chinese version of the TEPS to 2275 healthy Chinese college students. They were randomly split into two sub-samples. The first sub-sample was used for exploratory factor analysis (EFA) to examine the structure of the TEPS in a Chinese sample. The second sub-sample was used as a validation sample for the identified structure from the EFA and confirmatory factor analysis (CFA) was adopted. Results: Results of the EFA suggested a four-factor model (consummatory contextual, consummatory abstract, anticipatory contextual, and anticipatory abstract factors) instead of the original two-factor model (consummatory and anticipatory factors) ascertained from Western samples in the United States. The CFA results confirmed these results in the second sub-sample. Internal consistency and test-retest stability of the TEPS factors were good. Conclusions: The TEPS has four factors among Chinese participants. Possible reasons for cultural difference and potential applications of the TEPS for cross-cultural comparison are discussed.	[Chan, Raymond C. K.; Shi, Yan-fang; Wang, Yu-na; Wang, Ya] Chinese Acad Sci, Inst Psychol, Neuropsychol & Appl Cognit Neurosci Lab, Key Lab Mental Hlth, Beijing, Peoples R China; [Shi, Yan-fang; Wang, Yu-na] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Lai, Man-kin] Hong Kong Polytech Univ, Network Hlth & Welf Studies, Hong Kong, Hong Kong, Peoples R China; [Kring, Ann M.] Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA	Chinese Academy of Sciences; Institute of Psychology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Hong Kong Polytechnic University; University of California System; University of California Berkeley	Chan, RCK (corresponding author), Chinese Acad Sci, Inst Psychol, Neuropsychol & Appl Cognit Neurosci Lab, Key Lab Mental Hlth, Beijing, Peoples R China.	rckchan@psych.ac.cn	Chan, Raymond CK/B-6717-2009; Lai, Man Kin/A-6692-2012; Lai, Man Kin/F-8754-2015	Chan, Raymond CK/0000-0002-3414-450X; Lai, Man Kin/0000-0001-7292-1480; Lai, Man Kin/0000-0001-7292-1480; Wang, Ya/0000-0001-5764-6740	National Key Technologies RD Programme [2012BAI36B01]; National Science Fund China [81088001, 91132701]; Chinese Academy of Sciences [KSCX2-EW-J-8]; Key Laboratory of Mental Health, Institute of Psychology	National Key Technologies RD Programme(National Key Technology R&D Program); National Science Fund China; Chinese Academy of Sciences(Chinese Academy of Sciences); Key Laboratory of Mental Health, Institute of Psychology	This study was supported partially by a grant from the National Key Technologies R&D Programme (2012BAI36B01), the National Science Fund China (81088001, 91132701), the Knowledge Innovation Project of the Chinese Academy of Sciences (KSCX2-EW-J-8), and a grant from the Key Laboratory of Mental Health, Institute of Psychology. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014; BENTLER PM, 2003, EQS 6 1 WINDOWS USER; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Berridge KC, 2008, PSYCHOPHARMACOLOGY, V199, P457, DOI 10.1007/s00213-008-1099-6; BOLLEN KA, 1992, SOCIOL METHOD RES, V21, P205, DOI 10.1177/0049124192021002004; Chan RCK, 2010, PSYCHIAT RES, V175, P181, DOI 10.1016/j.psychres.2009.01.020; Chapman L. J., 1978, REVISED PHYS A UNPUB; Conway MA, 2005, J MEM LANG, V53, P594, DOI 10.1016/j.jml.2005.08.005; Dillon DG, 2007, PSYCHOPHYSIOLOGY, V44, P1; Dreher JC, 2009, P NATL ACAD SCI USA, V106, P617, DOI 10.1073/pnas.0805517106; Eckblad M.L., 1982, REVISED SOCIAL UNPUB; Eid M, 2001, J PERS SOC PSYCHOL, V81, P869, DOI 10.1037//0022-3514.81.5.869; Enders CK, 2005, STRUCT EQU MODELING, V12, P620, DOI 10.1207/s15328007sem1204_6; Enders CK, 2002, MULTIVAR BEHAV RES, V37, P359, DOI 10.1207/S15327906MBR3703_3; Gard DE, 2006, J RES PERS, V40, P1086, DOI 10.1016/j.jrp.2005.11.001; Gard DE, 2007, SCHIZOPHR RES, V93, P253, DOI 10.1016/j.schres.2007.03.008; Germans MK, 2000, PERS INDIV DIFFER, V28, P659, DOI 10.1016/S0191-8869(99)00129-4; Horan WP, 2008, SCHIZOPHRENIA BULL, V34, P856, DOI 10.1093/schbul/sbn083; JORESKOG K. G., 2004, LISREL 8 7 USERS REF; Kelley ME, 1999, AM J PSYCHIAT, V156, P406; Keshavan MS, 2011, SCHIZOPHR RES, V126, P1, DOI 10.1016/j.schres.2010.10.006; Klein DN., 1984, ANHEDONIA AFFECT DEF, P1; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Knutson B, 2008, PHILOS T R SOC B, V363, P3771, DOI 10.1098/rstb.2008.0155; Liu WH, 2011, PROG NEURO-PSYCHOPH, V35, P1045, DOI 10.1016/j.pnpbp.2011.02.018; MacLeod AK, 2005, COGNITION EMOTION, V19, P357, DOI 10.1080/02699930441000247; Nevitt J, 2001, STRUCT EQU MODELING, V8, P353, DOI 10.1207/S15328007SEM0803_2; Pregadio Fabrizio, 2008, ENCY TAOISM; RINDSKOPF D, 1988, MULTIVAR BEHAV RES, V23, P51, DOI 10.1207/s15327906mbr2301_3; Satorra A., 1994, LATENT VARIABLES ANA, P399, DOI DOI 10.2307/2291370; Tsai JL, 2006, EMOTION, V6, P484, DOI 10.1037/1528-3542.6.3.484; Tsai JL, 2006, J PERS SOC PSYCHOL, V90, P288, DOI 10.1037/0022-3514.90.2.288; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; West S. G., 1995, STRUCTURAL EQUATION, P56	34	100	111	6	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35352	10.1371/journal.pone.0035352	http://dx.doi.org/10.1371/journal.pone.0035352			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959XD	22530007	Green Published, gold			2022-12-27	WOS:000305350600076
J	Fiore-Donno, AM; Kamono, A; Meyer, M; Schnittler, M; Fukui, M; Cavalier-Smith, T				Fiore-Donno, Anna Maria; Kamono, Akiko; Meyer, Marianne; Schnittler, Martin; Fukui, Manabu; Cavalier-Smith, Thomas			18S rDNA Phylogeny of Lamproderma and Allied Genera (Stemonitales, Myxomycetes, Amoebozoa)	PLOS ONE			English	Article							REPRODUCTIVE-SYSTEMS; RIBOSOMAL-RNA; SLIME-MOLDS; HYPERAMOEBA; INFERENCE; ECOLOGY	The phylogenetic position of the slime-mould genus Lamproderma (Myxomycetes, Amoebozoa) challenges traditional taxonomy: although it displays the typical characters of the order Stemonitales, it appears to be sister to Physarales. This study provides a small subunit (18S or SSU) ribosomal RNA gene-based phylogeny of Lamproderma and its allies, with new sequences from 49 specimens in 12 genera. We found that the order Stemonitales and Lamproderma were both ancestral to Physarales and that Lamproderma constitutes several clades intermingled with species of Diacheopsis, Colloderma and Elaeomyxa. We suggest that these genera may have evolved from Lamproderma by multiple losses of fruiting body stalks and that many taxonomic revisions are needed. We found such high genetic diversity within three Lamproderma species that they probably consist of clusters of sibling species. We discuss the contrasts between genetic and morphological divergence and implications for the morphospecies concept, highlighting the phylogenetically most reliable morphological characters and pointing to others that have been overestimated. In addition, we showed that the first part (similar to 600 bases) of the SSU rDNA gene is a valuable tool for phylogeny in Myxomycetes, since it displayed sufficient variability to distinguish closely related taxa and never failed to cluster together specimens considered of the same species.	[Fiore-Donno, Anna Maria; Schnittler, Martin] Ernst Moritz Arndt Univ Greifswald, Inst Bot & Landscape Ecol, Greifswald, Germany; [Kamono, Akiko; Fukui, Manabu] Hokkaido Univ, Inst Low Temp Sci, Sapporo, Hokkaido 060, Japan; [Meyer, Marianne] Le Bayet, Rognaix, France; [Cavalier-Smith, Thomas] Univ Oxford, Dept Zool, Oxford OX1 3PS, England	Ernst Moritz Arndt Universitat Greifswald; Hokkaido University; University of Oxford	Fiore-Donno, AM (corresponding author), Ernst Moritz Arndt Univ Greifswald, Inst Bot & Landscape Ecol, Greifswald, Germany.	afiore-donno6@infomaniak.ch	Schnittler, Martin/A-8916-2013; Fukui, Manabu/E-1323-2012	Fiore-Donno, Anna Maria/0000-0001-6265-1907	Royal Society	Royal Society(Royal Society of London)	This work was supported by a Royal Society International Joint Project between the Zoology Department of the University of Oxford (UK) and the Institute of Low Temperature Science, Hokkaido University (JP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXOPOULOS CJ, 1971, MYCOLOGIA, V63, P925, DOI 10.2307/3758063; Alexopoulos CJ, 1973, FUNGI ADV TREATISE, P39; Andersen RA, 2000, ILLUSTRATED GUIDE PR; Cavalier-Smith T, 2004, EUR J PROTISTOL, V40, P21, DOI 10.1016/j.ejop.2003.10.001; Clark J, 1997, MYCOLOGIA, V89, P241, DOI 10.2307/3761077; CLARK J, 1990, MYCOLOGIA, V82, P274, DOI 10.2307/3759860; Clark J, 2010, MYCOSPHERE, V1, P337; COLLINS O R, 1981, Journal of the Elisha Mitchell Scientific Society, V97, P101; DENNISON ML, 1945, MYCOLOGIA, V37, P197, DOI 10.2307/3754918; DENNISON ML, 1945, MYCOLOGIA, V37, P80, DOI 10.2307/3754852; Dykova I, 2007, FOLIA PARASIT, V54, P1; ElHage N, 2000, MYCOLOGIA, V92, P54, DOI 10.2307/3761450; Fiore-Donno AM, 2008, MOL PHYLOGENET EVOL, V46, P878, DOI 10.1016/j.ympev.2007.12.011; Fiore-Donno AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022872; Fiore-Donno AM, 2010, J EUKARYOT MICROBIOL, V57, P189, DOI 10.1111/j.1550-7408.2009.00466.x; Fiore-Donno AM, 2010, PROTIST, V161, P55, DOI 10.1016/j.protis.2009.05.002; Fiore-Donno AM, 2009, MYCOLOGIA, V101, P773, DOI 10.3852/08-075; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Haskins EF, 1978, PUB WISSENSCH FILM S, V11, P1; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; ING B, 1983, J BIOGEOGR, V10, P299, DOI 10.2307/2844739; Ing B, 1999, MYXOMYCETES BRITAIN; JOHANSEN T, 1988, CURR GENET, V14, P265, DOI 10.1007/BF00376747; KALYANASUNDARAM I, 1989, MYCOL RES, V93, P233, DOI 10.1016/S0953-7562(89)80124-8; Kalyanasundaram I, 1973, TAXONOMY FUNGI, P9; Karpov SA, 1997, EUR J PROTISTOL, V33, P349, DOI 10.1016/S0932-4739(97)80046-6; KOWALSKI DT, 1970, MYCOLOGIA, V62, P621, DOI 10.2307/3757653; Lado C., 2001, CUADERNOS TRABAJO FL, V16, P1; Lado C, 1997, MYXOMYCETES; LANAVE C, 1984, J MOL EVOL, V20, P86, DOI 10.1007/BF02101990; Lundblad EW, 2004, MOL BIOL EVOL, V21, P1283, DOI 10.1093/molbev/msh126; Meylan C, 1931, B SOC VAUD SCI NAT, V57, P359; MEYLAN CH, 1930, BULL SOC VAUDOISE SCI NAT, V57, P147; Moreno G, 2002, FUNGI NON DELINEATI, P1; Neubert H, 2000, MYXOMYCETEN DEUTCHLA; Olive LS, 1975, MYCETOZOANS; Poulain M, 2011, MYXOMYCETES FEDERATI; RODRIGUEZ F, 1990, J THEOR BIOL, V142, P485, DOI 10.1016/S0022-5193(05)80104-3; Ronikier A, 2009, MYCOLOGIA, V101, P1, DOI 10.3852/08-090; Schnittler M., 2000, Stapfia, V73, P55; Schnittler M, 2010, NOVA HEDWIGIA, V90, P277, DOI 10.1127/0029-5035/2010/0090-0277; Shadwick LL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006754; Smirnov AV, 2011, PROTIST, V162, P545, DOI 10.1016/j.protis.2011.04.004; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Stephenson SL, 2000, J BIOGEOGR, V27, P741, DOI 10.1046/j.1365-2699.2000.00442.x; Urich T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002527; Walochnik J, 2004, J EUKARYOT MICROBIOL, V51, P433, DOI 10.1111/j.1550-7408.2004.tb00391.x; Wuyts J, 2000, NUCLEIC ACIDS RES, V28, P4698, DOI 10.1093/nar/28.23.4698; Wuyts J, 2002, NUCLEIC ACIDS RES, V30, P183, DOI 10.1093/nar/30.1.183; Zaman V, 1999, EUR J PROTISTOL, V35, P197, DOI 10.1016/S0932-4739(99)80038-8	51	68	81	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35359	10.1371/journal.pone.0035359	http://dx.doi.org/10.1371/journal.pone.0035359			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22530009	Green Submitted, gold, Green Published			2022-12-27	WOS:000305350600078
J	Lee, LC; Chen, CM; Wang, HC; Hsieh, HH; Chiu, IS; Su, MT; Hsieh-Li, HM; Wu, CH; Lee, GC; Lee-Chen, GJ; Lin, JY				Lee, Li-Ching; Chen, Chiung-Mei; Wang, Hao-Chun; Hsieh, Hsiao-Han; Chiu, I-Sheng; Su, Ming-Tsan; Hsieh-Li, Hsiu-Mei; Wu, Chung-Hsin; Lee, Guan-Chiun; Lee-Chen, Guey-Jen; Lin, Jung-Yaw			Role of the CCAAT-Binding Protein NFY in SCA17 Pathogenesis	PLOS ONE			English	Article							Y TRANSCRIPTION FACTOR; NUCLEAR-FACTOR-Y; ENDOPLASMIC-RETICULUM; EXPANDED POLYGLUTAMINE; CBF/NF-Y; EXPRESSION; GENE; TBP; ASSOCIATION; ACTIVATION	Spinocerebellar ataxia 17 (SCA17) is caused by expansion of the polyglutamine (polyQ) tract in human TATA-box binding protein (TBP) that is ubiquitously expressed in both central nervous system and peripheral tissues. The spectrum of SCA17 clinical presentation is broad. The precise pathogenic mechanism in SCA17 remains unclear. Previously proteomics study using a cellular model of SCA17 has revealed reduced expression of heat shock 70 kDa protein 5 (HSPA5) and heat shock 70 kDa protein 8 (HSPA8), suggesting that impaired protein folding may contribute to the cell dysfunction of SCA17 (Lee et al., 2009). In lymphoblastoid cells, HSPA5 and HSPA8 expression levels in cells with mutant TBP were also significantly lower than that of the control cells (Chen et al., 2010). As nuclear transcription factor Y (NFY) has been reported to regulate HSPA5 transcription, we focused on if NFY activity and HSPA5 expression in SCA17 cells are altered. Here, we show that TBP interacts with NFY subunit A (NFYA) in HEK-293 cells and NFYA incorporated into mutant TBP aggregates. In both HEK-293 and SH-SY5Y cells expressing TBP/Q(61 similar to 79), the level of soluble NFYA was significantly reduced. In vitro binding assay revealed that the interaction between TBP and NFYA is direct. HSPA5 luciferase reporter assay and endogenous HSPA5 expression analysis in NFYA cDNA and siRNA transfection cells further clarified the important role of NFYA in regulating HSPA5 transcription. In SCA17 cells, HSPA5 promoter activity was activated as a compensatory response before aggregate formation. NFYA dysfunction was indicated in SCA17 cells as HSPA5 promoter activity reduced along with TBP aggregate formation. Because essential roles of HSPA5 in protection from neuronal apoptosis have been shown in a mouse model, NFYA could be a target of mutant TBP in SCA17.	[Lee, Li-Ching; Wang, Hao-Chun; Hsieh, Hsiao-Han; Chiu, I-Sheng; Su, Ming-Tsan; Hsieh-Li, Hsiu-Mei; Wu, Chung-Hsin; Lee, Guan-Chiun; Lee-Chen, Guey-Jen; Lin, Jung-Yaw] Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan; [Chen, Chiung-Mei] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Dept Neurol, Taipei, Taiwan; [Lin, Jung-Yaw] Natl Taiwan Univ, Coll Med, Inst Biochem & Mol Biol, Taipei 10764, Taiwan	National Taiwan Normal University; Chang Gung Memorial Hospital; Chang Gung University; National Taiwan University	Lee, LC (corresponding author), Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan.	t43019@ntnu.edu.tw; jylin@ha.mc.ntu.edu.tw	Chen, Chiung-Mei/AAL-6260-2020; Wu, Chung-Hsin/B-7176-2015; Lin, Jung-Yaw/AGW-9336-2022	Wu, Chung-Hsin/0000-0002-4470-2448; Lin, Jung-Yaw/0000-0002-6341-1160	National Science Council, Executive Yuan [NSC97-2311-B-003-008-MY3, NSC97-2311-B-182A-001-MY3, NSC98-2321-B-003-004, NSC100-2325-B-003-001]; National Taiwan Normal University Taipei [96TOP001, NTNU100-D-02]; Chang Gung Memorial Hospital, Taipei, Taiwan [CMRGP38138]	National Science Council, Executive Yuan(Ministry of Science and Technology, Taiwan); National Taiwan Normal University Taipei; Chang Gung Memorial Hospital, Taipei, Taiwan(Chang Gung Memorial Hospital)	This work was supported by grants NSC97-2311-B-003-008-MY3, NSC97-2311-B-182A-001-MY3, NSC98-2321-B-003-004 and NSC100-2325-B-003-001 from National Science Council, Executive Yuan, 96TOP001 and NTNU100-D-02 from National Taiwan Normal University Taipei, and CMRGP38138 from Chang Gung Memorial Hospital, Taipei, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anttonen AK, 2005, NAT GENET, V37, P1309, DOI 10.1038/ng1677; Chen CM, 2010, CLIN CHIM ACTA, V411, P375, DOI 10.1016/j.cca.2009.12.002; Chen CM, 2009, AM J MED GENET B, V150B, P124, DOI 10.1002/ajmg.b.30785; Chow MKM, 2006, METHOD ENZYMOL, V413, P1, DOI 10.1016/S0076-6879(06)13001-3; Fan WH, 2002, J BIOL CHEM, V277, P8061, DOI 10.1074/jbc.M110225200; Friedman MJ, 2008, J BIOL CHEM, V283, P8283, DOI 10.1074/jbc.M709674200; Friedman MJ, 2007, NAT NEUROSCI, V10, P1519, DOI 10.1038/nn2011; GOSTOUT B, 1993, AM J HUM GENET, V52, P1182; Hayashi K, 2010, J BIOMOL NMR, V48, P147, DOI 10.1007/s10858-010-9445-5; Huang SS, 2011, BRAIN, V134, P1943, DOI 10.1093/brain/awr146; Jacobs SBR, 2003, MOL ENDOCRINOL, V17, P1470, DOI 10.1210/me.2002-0286; Kim S, 2008, PROTEIN EXPRES PURIF, V62, P116, DOI 10.1016/j.pep.2008.06.015; Koide R, 1999, HUM MOL GENET, V8, P2047, DOI 10.1093/hmg/8.11.2047; Lai MT, 2003, CELL SIGNAL, V15, P585, DOI 10.1016/S0898-6568(03)00004-4; Lasek K, 2006, BRAIN, V129, P2341, DOI 10.1093/brain/awl148; Lee LC, 2009, CLIN CHIM ACTA, V400, P56, DOI 10.1016/j.cca.2008.10.013; LI XY, 1992, J BIOL CHEM, V267, P8984; Luo R, 2008, J CELL BIOCHEM, V104, P1708, DOI 10.1002/jcb.21736; Maity SN, 1998, TRENDS BIOCHEM SCI, V23, P174, DOI 10.1016/S0968-0004(98)01201-8; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; Maltecca F, 2003, NEUROLOGY, V61, P1441, DOI 10.1212/01.WNL.0000094123.09098.A0; Mantovani R, 1999, GENE, V239, P15, DOI 10.1016/S0378-1119(99)00368-6; Marcus N, 1997, DNA CELL BIOL, V16, P1123, DOI 10.1089/dna.1997.16.1123; Nakamura K, 2001, HUM MOL GENET, V10, P1441, DOI 10.1093/hmg/10.14.1441; Onken B, 2006, P NATL ACAD SCI USA, V103, P9045, DOI 10.1073/pnas.0603318103; Reid SJ, 2003, NEUROBIOL DIS, V13, P37, DOI 10.1016/S0969-9961(03)00014-7; Reinert LS, 2006, CANCER RES, V66, P8994, DOI 10.1158/0008-5472.CAN-06-1999; Roder K, 1999, GENE, V234, P61, DOI 10.1016/S0378-1119(99)00180-8; Silveira I, 2002, ARCH NEUROL-CHICAGO, V59, P623, DOI 10.1001/archneur.59.4.623; Wang M, 2010, CELL DEATH DIFFER, V17, P488, DOI 10.1038/cdd.2009.144; Wyttenbach A, 2002, HUM MOL GENET, V11, P1137, DOI 10.1093/hmg/11.9.1137; Yamanaka T, 2008, EMBO J, V27, P827, DOI 10.1038/emboj.2008.23; Yoshida H, 2001, MOL CELL BIOL, V21, P1239, DOI 10.1128/MCB.21.4.1239-1248.2001; Zhu J, 2003, BLOOD, V102, P2420, DOI 10.1182/blood-2003-01-0251; Zhu QS, 2004, J BIOL CHEM, V279, P29902, DOI 10.1074/jbc.M400438200	35	24	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e35302	10.1371/journal.pone.0035302	http://dx.doi.org/10.1371/journal.pone.0035302			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22530004	gold, Green Published, Green Submitted			2022-12-27	WOS:000305347400043
J	Nikovics, K; Dazza, MC; Ekwalanga, M; Mammano, F; Clavel, F; Saragosti, S				Nikovics, Kristina; Dazza, Marie-Christine; Ekwalanga, Michel; Mammano, Fabrizio; Clavel, Francois; Saragosti, Sentob			Counteraction of Tetherin Antiviral Activity by Two Closely Related SIVs Differing by the Presence of a Vpu Gene	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ANCIENT ADAPTIVE EVOLUTION; PARTICLE RELEASE; TYPE-1 VPU; ENVELOPE GLYCOPROTEIN; HIV-1 RELEASE; CELL-SURFACE; PROTEIN; RESTRICTION; NEF	In different primate lentiviruses, three proteins (Vpu, Env and Nef) have been shown to have anti-tetherin activities. SIVden is a primate lentivirus harbored by a Cercopithecus denti (C. denti) whose genome code for a Vpu gene. We have compared the activity of HIV-1 Vpu and of SIVden Vpu on tetherin proteins from humans, from C. denti and from Cercopithecus neglectus (C. neglectus), a monkey species that is naturally infected by SIVdeb, a virus closely related to SIVden but which does not encode a Vpu protein. Here, we demonstrate that SIVden Vpu, is active against C. denti tetherin, but not against human tetherin. Interestingly, C. neglectus tetherin was more sensitive to SIVden Vpu than to HIV-1 Vpu. We also identify residues in the tetherin transmembrane domains that are responsible for the species-specific Vpu effect. Simultaneous mutation (P40L and T45I) of human tetherin conferred sensitivity to SIVden Vpu, while abolishing its sensitivity to HIV-1 Vpu. We next analyzed the anti-tetherin activity of the Nef proteins from HIV-1, SIVden and SIVdeb. All three Nef proteins were unable to rescue virus release in the presence of human or C. denti tetherin. Conversely, SIVdeb Nef enhanced virus release in the presence of C. neglectus tetherin, suggesting that SIVdeb relies on Nef in its natural host. Finally, while HIV-1 Vpu not only removed human tetherin from the cell surface but also directed it for degradation, SIVden Vpu only induced the redistribution of both C. denti and C. neglectus tetherins, resulting in a predominantly perinuclear localization.	[Nikovics, Kristina; Dazza, Marie-Christine; Mammano, Fabrizio; Clavel, Francois; Saragosti, Sentob] INSERM U941, Paris, France; [Nikovics, Kristina; Dazza, Marie-Christine; Mammano, Fabrizio; Clavel, Francois; Saragosti, Sentob] Univ Paris Diderot, IUH, Paris, France; [Ekwalanga, Michel] Univ Lubumbashi, Lab Clin Univ, Lubumbashi, DEM REP CONGO	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Nikovics, K (corresponding author), INSERM U941, Paris, France.	sentob.saragosti@inserm.fr	Mammano, Fabrizio/H-9423-2019	Mammano, Fabrizio/0000-0002-9193-7696	Agence National de Recherche sur le SIDA (ANRS)	Agence National de Recherche sur le SIDA (ANRS)(ANRSFrench National Research Agency (ANR))	This work was supported by Agence National de Recherche sur le SIDA (ANRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arhel NJ, 2009, CURR TOP MICROBIOL, V339, P147, DOI 10.1007/978-3-642-02175-6_8; Bailes E, 2003, SCIENCE, V300, P1713, DOI 10.1126/science.1080657; Bibollet-Ruche F, 2004, J VIROL, V78, P7748, DOI 10.1128/JVI.78.14.7748-7762.2004; Bour S, 1996, J VIROL, V70, P8285, DOI 10.1128/JVI.70.12.8285-8300.1996; Bour S, 1996, J VIROL, V70, P820, DOI 10.1128/JVI.70.2.820-829.1996; Courgnaud V, 2003, J VIROL, V77, P12523, DOI 10.1128/JVI.77.23.12523-12534.2003; Courgnaud V, 2002, J VIROL, V76, P8298, DOI 10.1128/JVI.76.16.8298-8309.2002; Dazza MC, 2005, J VIROL, V79, P8560, DOI 10.1128/JVI.79.13.8560-8571.2005; Dube M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000856; Evans DT, 2010, TRENDS MICROBIOL, V18, P388, DOI 10.1016/j.tim.2010.06.010; Fitzpatrick K, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000701; Goffinet C, 2010, J VIROL, V84, P4089, DOI 10.1128/JVI.01549-09; Gupta RK, 2009, P NATL ACAD SCI USA, V106, P20889, DOI 10.1073/pnas.0907075106; Gupta RK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000443; Hammonds J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000749; Iwabu Y, 2009, J BIOL CHEM, V284, P35060, DOI 10.1074/jbc.M109.058305; Jia B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000429; Jouvenet N, 2009, J VIROL, V83, P1837, DOI 10.1128/JVI.02211-08; Kaletsky RL, 2009, P NATL ACAD SCI USA, V106, P2886, DOI 10.1073/pnas.0811014106; KLIMKAIT T, 1990, J VIROL, V64, P621, DOI 10.1128/JVI.64.2.621-629.1990; Kobayashi T, 2011, J VIROL, V85, P932, DOI 10.1128/JVI.01668-10; Lim ES, 2010, J VIROL, V84, P7124, DOI 10.1128/JVI.00468-10; Lim ES, 2009, J VIROL, V83, P11673, DOI 10.1128/JVI.00569-09; Liu J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011904; Matsuoka S, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-21; McNatt MW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000300; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Perez-Caballero D, 2009, CELL, V139, P499, DOI 10.1016/j.cell.2009.08.039; Piguet V, 1999, IMMUNOL REV, V168, P51, DOI 10.1111/j.1600-065X.1999.tb01282.x; Ritter GD, 1996, J VIROL, V70, P2669, DOI 10.1128/JVI.70.4.2669-2673.1996; Ruiz A, 2010, VIROLOGY, V406, P312, DOI 10.1016/j.virol.2010.07.021; Sauter D, 2011, HUM MUTAT; Sauter D, 2010, CELL, V141, P392, DOI 10.1016/j.cell.2010.04.022; Sauter D, 2009, CELL HOST MICROBE, V6, P409, DOI 10.1016/j.chom.2009.10.004; Sawyer SL, 2005, P NATL ACAD SCI USA, V102, P2832, DOI 10.1073/pnas.0409853102; Sawyer SL, 2004, PLOS BIOL, V2, P1278, DOI 10.1371/journal.pbio.0020275; Schmokel J, 2011, J VIROL, V85, P742, DOI 10.1128/JVI.02087-10; Schubert U, 1996, J VIROL, V70, P809, DOI 10.1128/JVI.70.2.809-819.1996; Shingai M, 2011, J VIROL, V85, P9708, DOI 10.1128/JVI.00626-11; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; Yang SJ, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-13; Zhang FW, 2009, CELL HOST MICROBE, V6, P54, DOI 10.1016/j.chom.2009.05.008	42	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e35411	10.1371/journal.pone.0035411	http://dx.doi.org/10.1371/journal.pone.0035411			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22530020	Green Published, gold, Green Submitted			2022-12-27	WOS:000305347400051
J	Reeves, CV; Wang, X; Charles-Horvath, PC; Vink, JY; Borisenko, VY; Young, JAT; Kitajewski, JK				Reeves, Claire V.; Wang, Xing; Charles-Horvath, Pelisa C.; Vink, Joy Y.; Borisenko, Valeriya Y.; Young, John A. T.; Kitajewski, Jan K.			Anthrax Toxin Receptor 2 Functions in ECM Homeostasis of the Murine Reproductive Tract and Promotes MMP Activity	PLOS ONE			English	Article							CAPILLARY MORPHOGENESIS PROTEIN-2; JUVENILE HYALINE FIBROMATOSIS; METALLOPROTEINASE MT1-MMP; MATRIX; CELLS; EXPRESSION; ACTIVATION; SURFACE; TISSUE; PROGELATINASE	Anthrax Toxin Receptor proteins function as receptors for anthrax toxin, however physiological activity remains unclear. To evaluate the biological role of Antxr2, we generated Antxr2-/- mice. Antxr2-/- mice were viable, however Antxr2 is required for parturition in young females and for preserving fertility in older female mice. Histological analysis of the uterus and cervix revealed aberrant deposition of extracellular matrix proteins such as type I collagen, type VI collagen and fibronectin. A marked disruption of both the circular and longitudinal myometrial cell layers was evident in Antxr2-/- mice. These changes progressed as the mice aged, resulting in a thickened, collagen dense, acellular stroma and the disappearance of normal uterine architecture. To investigate the molecular mechanism underlying the uterine fibrosis we performed immunoblotting for MMP2 using uterine lysates and zymography using conditioned medium from Antxr2-/- mouse embryonic fibroblasts and found reduced levels of activated MMP2 in both. This prompted us to investigate MT1-MMP status, as MMP2 processing is regulated by MT1-MMP. We found MT1-MMP activity, as measured by MMP2 processing and activation, was enhanced by expression of either ANTXR1 or ANTXR2. We identified an ANTXR2/MT1-MMP complex and demonstrated that MT1-MMP activity is dependent on ANTXR2 expression levels in cells. Thus, we have discovered that ANTXR1 and ANTXR2 function as positive regulators of MT1-MMP activity.	[Reeves, Claire V.; Wang, Xing; Vink, Joy Y.; Borisenko, Valeriya Y.; Kitajewski, Jan K.] Columbia Univ, Med Ctr, Dept Obstet & Gynecol, New York, NY 10027 USA; [Charles-Horvath, Pelisa C.] Columbia Univ, Dept Pharmacol, Med Ctr, New York, NY USA; [Young, John A. T.] Salk Inst Biol Studies, Nomis Ctr Immunobiol & Microbial Pathogenesis, La Jolla, CA 92037 USA; [Kitajewski, Jan K.] Columbia Univ, Dept Pathol, Med Ctr, New York, NY USA; [Kitajewski, Jan K.] Columbia Univ, Herbert Irving Comprehens Canc Ctr, Med Ctr, New York, NY USA	Columbia University; Columbia University; Salk Institute; Columbia University; Columbia University	Reeves, CV (corresponding author), Columbia Univ, Med Ctr, Dept Obstet & Gynecol, New York, NY 10027 USA.	jkk9@columbia.edu	Wang, Xing/G-2917-2015	Young, John/0000-0003-1824-2561	NIH [RO1 AI064654]; DOD Breast Cancer Program [X81WH-06-1-0355];  [5T32 CA 009503-24]; NATIONAL CANCER INSTITUTE [T32CA009503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064654] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD Breast Cancer Program(United States Department of Defense); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH RO1 AI064654. CR was supported by a fellowship from the DOD Breast Cancer Program X81WH-06-1-0355. PCH was supported by training grant 5T32 CA 009503-24. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson SJ, 1995, J BIOL CHEM, V270, P30479, DOI 10.1074/jbc.270.51.30479; Bell SE, 2001, J CELL SCI, V114, P2755; Burroughs KD, 2000, BIOL REPROD, V63, P1322, DOI 10.1095/biolreprod63.5.1322; Cullen M, 2009, CANCER RES, V69, P6021, DOI 10.1158/0008-5472.CAN-09-1086; Dowling O, 2003, AM J HUM GENET, V73, P957, DOI 10.1086/378781; Fata JE, 2000, CELL MOL LIFE SCI, V57, P77, DOI 10.1007/s000180050500; Hanks S, 2003, AM J HUM GENET, V73, P791, DOI 10.1086/378418; Hernandez-Barrantes S, 2000, J BIOL CHEM, V275, P12080, DOI 10.1074/jbc.275.16.12080; Holmbeck K, 1999, CELL, V99, P81, DOI 10.1016/S0092-8674(00)80064-1; Holmbeck K, 2004, J CELL PHYSIOL, V200, P11, DOI 10.1002/jcp.20065; Hotchkiss KA, 2005, EXP CELL RES, V305, P133, DOI 10.1016/j.yexcr.2004.12.025; HUNT JS, 1985, J LEUKOCYTE BIOL, V38, P255, DOI 10.1002/jlb.38.2.255; Lehti K, 2005, GENE DEV, V19, P979, DOI 10.1101/gad.1294605; LEPPERT PC, 1995, CLIN OBSTET GYNECOL, V38, P267, DOI 10.1097/00003081-199506000-00009; Liu SL, 2009, P NATL ACAD SCI USA, V106, P12424, DOI 10.1073/pnas.0905409106; Morikawa A, 2008, HUM REPROD, V23, P944, DOI 10.1093/humrep/den025; Nanda A, 2004, CANCER RES, V64, P817, DOI 10.1158/0008-5472.CAN-03-2408; NATHANIELSZ PW, 1978, ANNU REV PHYSIOL, V40, P411, DOI 10.1146/annurev.ph.40.030178.002211; OBRIEN WF, 1995, CLIN OBSTET GYNECOL, V38, P221, DOI 10.1097/00003081-199506000-00004; Ohuchi E, 1997, J BIOL CHEM, V272, P2446, DOI 10.1074/jbc.272.4.2446; Overall CM, 2002, BIOL CHEM, V383, P1059, DOI 10.1515/BC.2002.114; Pei DQ, 1996, J BIOL CHEM, V271, P9135, DOI 10.1074/jbc.271.15.9135; Reeves CV, 2010, ONCOGENE, V29, P789, DOI 10.1038/onc.2009.383; Rmali KA, 2005, BIOCHEM BIOPH RES CO, V334, P231, DOI 10.1016/j.bbrc.2005.06.085; ROSSI MJ, 1992, ENDOCRINOLOGY, V130, P1716, DOI 10.1210/en.130.3.1716; Rozanov DV, 2005, INT J BIOCHEM CELL B, V37, P142, DOI 10.1016/j.biocel.2004.06.005; RudolphOwen LA, 1997, ENDOCRINOLOGY, V138, P4902, DOI 10.1210/en.138.11.4902; SATO H, 1994, NATURE, V370, P61, DOI 10.1038/370061a0; Scobie HM, 2006, PLOS PATHOG, V2, P949, DOI 10.1371/journal.ppat.0020111; Scobie HM, 2005, J INFECT DIS, V192, P1047, DOI 10.1086/432731; Scobie HM, 2003, P NATL ACAD SCI USA, V100, P5170, DOI 10.1073/pnas.0431098100; Shynlova O, 2006, BIOL REPROD, V74, P839, DOI 10.1095/biolreprod.105.048124; STRONGIN AY, 1995, J BIOL CHEM, V270, P5331, DOI 10.1074/jbc.270.10.5331; Stucki U, 2001, AM J MED GENET, V100, P122, DOI 10.1002/1096-8628(20010422)100:2<122::AID-AJMG1236>3.0.CO;2-0; Tanaka K, 2009, J DERMATOL SCI, V55, P197, DOI 10.1016/j.jdermsci.2009.06.005; Wang X, 1999, FEBS LETT, V462, P261, DOI 10.1016/S0014-5793(99)01534-3; Wang X, 2009, J ANDROL, V30, P259, DOI 10.2164/jandrol.108.006494; Whittaker CA, 2002, MOL BIOL CELL, V13, P3369, DOI 10.1091/mbc.E02-05-0259; Wood GA, 2007, REPRODUCTION, V133, P1035, DOI 10.1530/REP-06-0302; Young JAT, 2007, ANNU REV BIOCHEM, V76, P243, DOI 10.1146/annurev.biochem.75.103004.142728; Zhou ZJ, 2000, P NATL ACAD SCI USA, V97, P4052, DOI 10.1073/pnas.060037197	41	34	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e34862	10.1371/journal.pone.0034862	http://dx.doi.org/10.1371/journal.pone.0034862			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22529944	Green Submitted, Green Published, gold			2022-12-27	WOS:000305347400022
J	Rodriguez, D; Gonzalez-Aseguinolaza, G; Rodriguez, JR; Vijayan, A; Gherardi, M; Rueda, P; Casal, JI; Esteban, M				Rodriguez, Dolores; Gonzalez-Aseguinolaza, Gloria; Rodriguez, Juan R.; Vijayan, Aneesh; Gherardi, Magdalena; Rueda, Paloma; Casal, J. Ignacio; Esteban, Mariano			Vaccine Efficacy against Malaria by the Combination of Porcine Parvovirus-Like Particles and Vaccinia Virus Vectors Expressing CS of Plasmodium	PLOS ONE			English	Article							CD8(+) T-CELLS; PROTECTIVE IMMUNITY; IMMUNIZATION SCHEDULES; AFRICAN CHILDREN; ANTIGEN CARRIER; DENDRITIC CELLS; INFLUENZA-VIRUS; TRIAL; MVA; INDUCTION	With the aim to develop an efficient and cost-effective approach to control malaria, we have generated porcine parvovirus-like particles (PPV-VLPs) carrying the CD8(+) T cell epitope (SYVPSAEQI) of the circumsporozoite (CS) protein from Plasmodium yoelii fused to the PPV VP2 capsid protein (PPV-PYCS), and tested in prime/boost protocols with poxvirus vectors for efficacy in a rodent malaria model. As a proof-of concept, we have characterized the anti-CS CD8(+) T cell response elicited by these hybrid PPV-VLPs in BALB/c mice after immunizations with the protein PPV-PYCS administered alone or in combination with recombinant vaccinia virus (VACV) vectors from the Western Reserve (WR) and modified virus Ankara (MVA) strains expressing the entire P. yoelii CS protein. The results of different immunization protocols showed that the combination of PPV-PYCS prime/poxvirus boost was highly immunogenic, inducing specific CD8+ T cell responses to CS resulting in 95% reduction in liver stage parasites two days following sporozoite challenge. In contrast, neither the administration of PPV-PYCS alone nor the immunization with the vectors given in the order poxvirus/VLPs was as effective. The immune profile induced by VLPs/MVA boost was associated with polyfunctional and effector memory CD8+ T cell responses. These findings highlight the use of recombinant parvovirus PPV-PYCS particles as priming agents and poxvirus vectors, like MVA, as booster to enhance specific CD8+ T cell responses to Plasmodium antigens and to control infection. These observations are relevant in the design of T cell-inducing vaccines against malaria.	[Rodriguez, Dolores; Rodriguez, Juan R.; Vijayan, Aneesh; Esteban, Mariano] CSIC, CNB, Dept Mol & Cellular Biol, Madrid, Spain; [Gonzalez-Aseguinolaza, Gloria] CIMA, Pamplona, Spain; [Rueda, Paloma; Casal, J. Ignacio] INGENASA, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Rodriguez, D (corresponding author), CSIC, CNB, Dept Mol & Cellular Biol, Madrid, Spain.	mesteban@cnb.csic.es	Casal, Ignacio/M-2312-2014; Esteban, Mariano/ABG-5375-2020; Gonzalez-Aseguinolaza, Gloria/H-9928-2015; Vijayan, Aneesh/AAH-5640-2019; VIJAYAN, ANEESH/K-1961-2014; Rodriguez, Dolores/ABF-9855-2020	Casal, Ignacio/0000-0003-1085-2840; Esteban, Mariano/0000-0003-0846-2827; Gonzalez-Aseguinolaza, Gloria/0000-0002-1600-4562; Vijayan, Aneesh/0000-0002-2828-5285; VIJAYAN, ANEESH/0000-0002-2828-5285; Rodriguez Fernandez-Alba, Juan Ramon/0000-0002-0819-8280; Rodriguez, Dolores/0000-0001-6365-4501	Marcelino Botin Foundation; La Caixa Foundation;  [SAF-2008-02036]	Marcelino Botin Foundation; La Caixa Foundation(La Caixa Foundation); 	This work was supported by SAF-2008-02036 and the Marcelino Botin Foundation (to Dr. Esteban) La Caixa Foundation International PhD Program Fellowship (to Dr. Vijayan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnandji ST, 2011, NEW ENGL J MED, V365, P1863, DOI 10.1056/NEJMoa1102287; Alonso PL, 2004, LANCET, V364, P1411, DOI 10.1016/S0140-6736(04)17223-1; Antonis AFG, 2006, VACCINE, V24, P5481, DOI 10.1016/j.vaccine.2006.03.089; Aponte JJ, 2007, LANCET, V370, P1543, DOI 10.1016/S0140-6736(07)61542-6; Barbosa A, 2009, INFECT IMMUN, V77, P4502, DOI 10.1128/IAI.00442-09; Delaloye J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000480; Gomez CE, 2011, J VIROL, V85, P11468, DOI 10.1128/JVI.05165-11; ESTEBAN M, 1984, VIROLOGY, V133, P220, DOI 10.1016/0042-6822(84)90443-4; Garcia-Arriaza J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012395; Gherardi MM, 2003, J VIROL, V77, P7048, DOI 10.1128/JVI.77.12.7048-7057.2003; Gomez CE, 2008, CURR GENE THER, V8, P97, DOI 10.2174/156652308784049363; Gonzalez-Aseguinolaza G, 2003, J VIROL, V77, P11859, DOI 10.1128/JVI.77.21.11859-11866.2003; Good MF, 2010, IMMUNITY, V33, P555, DOI 10.1016/j.immuni.2010.10.005; Guerra S, 2007, J VIROL, V81, P8707, DOI 10.1128/JVI.00444-07; Hill AVS, 2010, HUM VACCINES, V6, P78, DOI 10.4161/hv.6.1.10116; Hurtado A, 1996, J VIROL, V70, P5422, DOI 10.1128/JVI.70.8.5422-5429.1996; Kester KE, 2008, VACCINE, V26, P2191, DOI 10.1016/j.vaccine.2008.02.048; LI SQ, 1993, P NATL ACAD SCI USA, V90, P5214, DOI 10.1073/pnas.90.11.5214; Lo-Man R, 1998, EUR J IMMUNOL, V28, P1401, DOI 10.1002/(SICI)1521-4141(199804)28:04<1401::AID-IMMU1401>3.0.CO;2-M; MARTINEZ C, 1992, VACCINE, V10, P684, DOI 10.1016/0264-410X(92)90090-7; MIYAHIRA Y, 1995, J IMMUNOL METHODS, V181, P45, DOI 10.1016/0022-1759(94)00327-S; Moron G, 2002, J EXP MED, V195, P1233, DOI 10.1084/jem.20011930; Olotu A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025786; Olotu A, 2011, LANCET INFECT DIS, V11, P102, DOI 10.1016/S1473-3099(10)70262-0; Overstreet MG, 2008, IMMUNOL REV, V225, P272, DOI 10.1111/j.1600-065X.2008.00671.x; Porter DW, 2011, VACCINE; Reyes-Sandoval A, 2011, J IMMUNOL, V187, P1347, DOI 10.4049/jimmunol.1100302; Reyes-Sandoval A, 2010, INFECT IMMUN, V78, P145, DOI 10.1128/IAI.00740-09; RODRIGUES M, 1994, J IMMUNOL, V153, P4636; Rueda P, 2004, J GEN VIROL, V85, P563, DOI 10.1099/vir.0.19525-0; Sedlik C, 1997, P NATL ACAD SCI USA, V94, P7503, DOI 10.1073/pnas.94.14.7503; Sedlik C, 2000, J VIROL, V74, P5769, DOI 10.1128/JVI.74.13.5769-5775.2000; WHO, 2010, WORLD MALARIA REPORT 2010, P1	33	12	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e34445	10.1371/journal.pone.0034445	http://dx.doi.org/10.1371/journal.pone.0034445			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22529915	gold, Green Published			2022-12-27	WOS:000305347400012
J	Tenenbaum, A; Medvedofsky, D; Fisman, EZ; Bubyr, L; Matetzky, S; Tanne, D; Klempfner, R; Shemesh, J; Goldenberg, I				Tenenbaum, Alexander; Medvedofsky, Diego; Fisman, Enrique Z.; Bubyr, Liudmila; Matetzky, Shlomi; Tanne, David; Klempfner, Robert; Shemesh, Joseph; Goldenberg, Ilan			Cardiovascular Events in Patients Received Combined Fibrate/Statin Treatment versus Statin Monotherapy: Acute Coronary Syndrome Israeli Surveys Data	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; ACUTE MYOCARDIAL-INFARCTION; HEART-DISEASE; SECONDARY PREVENTION; GEMFIBROZIL; BEZAFIBRATE; CHOLESTEROL; DYSLIPIDEMIA; MANAGEMENT; MORBIDITY	Background: The effect of combination of fibrate with statin on major adverse cardiovascular events (MACE) following acute coronary syndrome (ACS) hospitalization is unclear. The main aim of this study was to investigate the 30-day rate of MACE in patients who participated in the nationwide ACS Israeli Surveys (ACSIS) and were treated on discharge with a fibrate (mainly bezafibrate) and statin combination vs. statin alone. Methods: The study population comprised 8,982 patients from the ACSIS 2000, 2002, 2004, 2006, 2008 and 2010 enrollment waves who were alive on discharge and received statin. Of these, 8,545 (95%) received statin alone and 437 (5%) received fibrate/statin combination. MACE was defined as a composite measure of death, recurrent MI, recurrent ischemia, stent thrombosis, ischemic stroke and urgent revascularization. Results: Patients from the combination group were younger (58.1 +/- 11.9 vs. 62.9 +/- 12.6 years). However, they had significantly more co-morbidities (hypertension, diabetes), current smokers and unfavorable cardio-metabolic profiles (with respect to glucose, total cholesterol, triglyceride and HDL-cholesterol). Development of MACE was recorded in 513 (6.0%) patients from the statin monotherapy group vs. 13 (3.2%) from the combination group, p = 0.01. 30-day re-hospitalization rate was significantly lower in the combination group: 68 (15.6%) vs. 1691 (19.8%) of patients, respectively; p = 0.03. Multivariable analysis identified the fibrate/statin combination as an independent predictor of reduced risk of MACE with odds ratio of 0.54, 95% confidence interval 0.32-0.94. Conclusion: A significantly lower risk of 30-day MACE rate was observed in patients receiving combined fibrate/statin treatment following ACS compared with statin monotherapy. However, caution should be exercised in interpreting these findings taking into consideration baseline differences between our observational study groups.	[Tenenbaum, Alexander; Klempfner, Robert; Shemesh, Joseph; Goldenberg, Ilan] Chaim Sheba Med Ctr, Cardiac Rehabil Inst, IL-52621 Tel Hashomer, Israel; [Tenenbaum, Alexander; Medvedofsky, Diego; Bubyr, Liudmila; Matetzky, Shlomi; Tanne, David; Klempfner, Robert; Shemesh, Joseph; Goldenberg, Ilan] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Tenenbaum, Alexander; Medvedofsky, Diego; Matetzky, Shlomi; Klempfner, Robert; Goldenberg, Ilan] Chaim Sheba Med Ctr, Leviev Heart Inst, IL-52621 Tel Hashomer, Israel; [Tenenbaum, Alexander; Bubyr, Liudmila; Matetzky, Shlomi; Tanne, David; Klempfner, Robert; Goldenberg, Ilan] Chaim Sheba Med Ctr, Israeli Soc Prevent Heart Attacks, IL-52621 Tel Hashomer, Israel; [Tenenbaum, Alexander; Fisman, Enrique Z.] Cardiovasc Diabetol Res Fdn, Holon, Israel; [Goldenberg, Ilan] Univ Rochester, Med Ctr, Heart Res Follow Up Program, Rochester, NY 14642 USA	Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Chaim Sheba Medical Center; Chaim Sheba Medical Center; University of Rochester	Tenenbaum, A (corresponding author), Chaim Sheba Med Ctr, Cardiac Rehabil Inst, IL-52621 Tel Hashomer, Israel.	altenen@yahoo.com	Tanne, David/F-2560-2010; Klempfner, Robert/M-4989-2016	Tanne, David/0000-0002-6699-2220; Medvedofsky, Diego/0000-0003-3944-9297; Fisman, Enrique/0000-0001-7055-4488; Klempfner, Robert/0000-0002-7754-6736				Aronow HD, 2001, LANCET, V357, P1063, DOI 10.1016/S0140-6736(00)04257-4; Behar S, 2003, ISR MED ASSOC J, V5, P249; Briel M, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b92; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Fonarow GC, 2005, AM J CARDIOL, V96, P611, DOI 10.1016/j.amjcard.2005.04.029; FRICK MH, 1987, NEW ENGL J MED, V317, P1237, DOI 10.1056/NEJM198711123172001; Ginsberg HN, 2010, NEW ENGL J MED, V362, P1563, DOI 10.1056/NEJMoa1001282; Goldenberg I, 2009, ARCH INTERN MED, V169, P508, DOI 10.1001/archinternmed.2008.584; Jun M, 2010, LANCET, V375, P1875, DOI 10.1016/S0140-6736(10)60656-3; Madrid-Miller A, 2010, CIR CIR, V78, P229; MANNINEN V, 1988, JAMA-J AM MED ASSOC, V260, P641, DOI 10.1001/jama.260.5.641; MANNINEN V, 1992, CIRCULATION, V85, P37, DOI 10.1161/01.CIR.85.1.37; Natarajan P, 2010, J AM COLL CARDIOL, V55, P1283, DOI 10.1016/j.jacc.2010.01.008; Nusca A, 2010, CURR OPIN CARDIOL, V25, P373, DOI 10.1097/HCO.0b013e32833987ca; OLIVER M F, 1978, British Heart Journal, V40, P1069, DOI 10.1136/hrt.40.10.1069; Robins SJ, 2001, JAMA-J AM MED ASSOC, V285, P1585, DOI 10.1001/jama.285.12.1585; Rosenblit PD, 2012, CURR CARDIOL REP, V14, DOI 10.1007/s11886-011-0237-7; Rubins HB, 1999, NEW ENGL J MED, V341, P410, DOI 10.1056/NEJM199908053410604; Sacks FM, 2010, NEW ENGL J MED, V363, P692, DOI 10.1056/NEJMc1006407; Schlesinger Z, 2000, CIRCULATION, V102, P21, DOI 10.1161/01.CIR.102.1.21; Schwartz GG, 2001, JAMA-J AM MED ASSOC, V285, P1711, DOI 10.1001/jama.285.13.1711; Tang XL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025320; Tenenbaum A, 2005, ARCH INTERN MED, V165, P1154, DOI 10.1001/archinte.165.10.1154; Tenenbaum A, 2008, ADV CARDIOL, V45, P127, DOI 10.1159/000115192; Tenenbaum A, 2011, JAMA-J AM MED ASSOC, V306, P157, DOI 10.1001/jama.2011.945; Tenenbaum A, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-24	26	26	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e35298	10.1371/journal.pone.0035298	http://dx.doi.org/10.1371/journal.pone.0035298			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523582	gold, Green Submitted, Green Published			2022-12-27	WOS:000305345000054
J	Lech, GP; Reigh, RC				Lech, Gregory P.; Reigh, Robert C.			Plant Products Affect Growth and Digestive Efficiency of Cultured Florida Pompano (Trachinotus carolinus) Fed Compounded Diets	PLOS ONE			English	Article							APPARENT DIGESTIBILITY COEFFICIENTS; JUVENILE JAPANESE FLOUNDER; AMINO-ACID AVAILABILITY; SOY PROTEIN-CONCENTRATE; RED-SEA BREAM; FEED INGREDIENTS; FISH-MEAL; SOYBEAN-MEAL; CANOLA-MEAL; PARTIAL REPLACEMENT	Costs of compounded diets containing fish meal as a primary protein source can be expected to rise as fish meal prices increase in response to static supply and growing demand. Alternatives to fish meal are needed to reduce production costs in many aquaculture enterprises. Some plant proteins are potential replacements for fish meal because of their amino acid composition, lower cost and wide availability. In this study, we measured utilization of soybean meal (SBM) and soy protein concentrate (SPC) by Florida pompano fed compounded diets, to determine the efficacy of these products as fish meal replacements. We also calculated apparent digestibility coefficients (ADCs) for canola meal (CM), corn gluten meal (CGM), and distillers dried grains with solubles (DDGS), following typical methods for digestibility trials. Juvenile Florida pompano were fed fish-meal-free diets containing graded levels of SBM and SPC, and weight gain was compared to a control diet that contained SBM, SPC, and fish meal. Fish fed diets that contained 25-30 percent SBM in combination with 43-39 percent SPC had weight gain equivalent to fish fed the control diet with fish meal, while weight gain of fish fed other soy combinations was significantly less than that of the control group. Apparent crude protein digestibility of CGM was significantly higher than that of DDGS but not significantly different from CM. Apparent energy digestibility of DDGS was significantly lower than CGM but significantly higher than CM. Findings suggested that composition of the reference diet used in a digestibility trial affects the values of calculated ADCs, in addition to the chemical and physical attributes of the test ingredient.	[Lech, Gregory P.; Reigh, Robert C.] Louisiana State Univ, Ctr Agr, Aquaculture Res Stn, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Reigh, RC (corresponding author), Louisiana State Univ, Ctr Agr, Aquaculture Res Stn, Baton Rouge, LA 70803 USA.	rreigh@agcenter.lsu.edu			National Oceanic and Atmospheric Administration [NA08OAR4170840]; Louisiana Agricultural Experiment Station [LAB94014]	National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); Louisiana Agricultural Experiment Station	This research was funded in part by Grant Number NA08OAR4170840 from the National Oceanic and Atmospheric Administration (www.noaa.gov) Marine Aquaculture Research program to RCR, with additional support from the Louisiana Agricultural Experiment Station under Project LAB94014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan GL, 2000, AQUACULTURE, V186, P293, DOI 10.1016/S0044-8486(99)00380-4; ANDERSON JS, 1992, AQUACULTURE, V108, P111, DOI 10.1016/0044-8486(92)90322-C; AUSTRENG E, 1978, AQUACULTURE, V13, P265, DOI 10.1016/0044-8486(78)90008-X; Biswas AK, 2007, AQUACULTURE, V267, P284, DOI 10.1016/j.aquaculture.2007.01.014; Bonaldo A, 2006, AQUACULTURE, V261, P580, DOI 10.1016/j.aquaculture.2006.08.013; Burel C, 2000, AQUACULTURE, V188, P285, DOI 10.1016/S0044-8486(00)00337-9; Burel C., 2008, ALTERNATIVE PROTEIN, P343; Burr GS, 2012, AQUACULTURE, V334, P110, DOI 10.1016/j.aquaculture.2011.12.044; Chatzifotis S, 2008, AQUACULTURE, V275, P201, DOI 10.1016/j.aquaculture.2007.12.013; Cheng Z. J., 2004, Journal of Applied Aquaculture, V15, P101, DOI 10.1300/J028v15n03_08; Cheng ZJJ, 2003, AQUACULT NUTR, V9, P77, DOI 10.1046/j.1365-2095.2003.00226.x; Cho C Y, 1990, World Rev Nutr Diet, V61, P132; CHO CY, 1982, COMP BIOCHEM PHYS B, V73, P25, DOI 10.1016/0305-0491(82)90198-5; Deng JM, 2006, AQUACULTURE, V258, P503, DOI 10.1016/j.aquaculture.2006.04.004; Denstadli V, 2006, AQUACULTURE, V256, P365, DOI 10.1016/j.aquaculture.2006.02.021; Erdogan F, 2010, J ANIM VET ADV, V9, P831, DOI 10.3923/javaa.2010.831.836; FAO, 2011, 5001 FAO UN; Forster I, 1999, AQUACULT NUTR, V5, P143, DOI 10.1046/j.1365-2095.1999.00082.x; Francis G, 2001, AQUACULTURE, V199, P197, DOI 10.1016/S0044-8486(01)00526-9; Gatlin DM, 2007, AQUAC RES, V38, P551, DOI 10.1111/j.1365-2109.2007.01704.x; Glencross B, 2004, AQUAC RES, V35, P15, DOI 10.1111/j.1365-2109.2004.00974.x; Glencross BD, 2007, AQUACULT NUTR, V13, P17, DOI 10.1111/j.1365-2095.2007.00450.x; Gonzalez-Felix ML, 2010, AQUACULTURE, V310, P240, DOI 10.1016/j.aquaculture.2010.10.016; Gothreaux C.T., 2008, THESIS LOUISIANA STA; Gothreaux CT, 2010, N AM J AQUACULT, V72, P309, DOI 10.1577/A09-079.1; HAJEN WE, 1993, AQUACULTURE, V112, P333, DOI 10.1016/0044-8486(93)90394-E; Halver JE, 2002, FISH NUTR, P780; Hansen AC, 2007, AQUACULTURE, V272, P599, DOI 10.1016/j.aquaculture.2007.08.034; Horwitz W., 2002, GAITHERSBERGOFFICIAL; Kader MA, 2010, AQUACULTURE, V308, P136, DOI 10.1016/j.aquaculture.2010.07.037; Khan MA, 2003, AQUACULT NUTR, V9, P391, DOI 10.1046/j.1365-2095.2003.00268.x; Kissil GW, 2000, AQUAC RES, V31, P595, DOI 10.1046/j.1365-2109.2000.00477.x; Krogdahl A, 2010, AQUAC RES, V41, P333, DOI 10.1111/j.1365-2109.2009.02426.x; Landero JL, 2011, ANIM FEED SCI TECH, V170, P136, DOI 10.1016/j.anifeedsci.2011.08.003; Lazo JP, 1998, AQUACULTURE, V169, P225, DOI 10.1016/S0044-8486(98)00384-6; Lee SM, 2002, AQUACULTURE, V207, P79, DOI 10.1016/S0044-8486(01)00751-7; Matsunari H, 2008, AQUACULTURE, V274, P142, DOI 10.1016/j.aquaculture.2007.11.002; McGoogan BB, 1996, AQUACULTURE, V141, P233, DOI 10.1016/0044-8486(95)01217-6; Muirhead S, 2011, FEEDSTUFFS WEEK 1212; National Research Council, 2011, NUTR REQ FISH SHRIMP; National Research Council, 1993, NUTR REQ FISH; Park GS, 2002, FISHERIES SCI, V68, P824, DOI 10.1046/j.1444-2906.2002.00498.x; Pereira TG, 2003, AQUAC RES, V34, P1111, DOI 10.1046/j.1365-2109.2003.00909.x; Peres H, 2008, ALTERNATIVE PROTEIN, P281; Riche M, 2010, AQUACULT NUTR, V16, P223, DOI 10.1111/j.1365-2095.2009.00654.x; Riche M, 2009, J WORLD AQUACULT SOC, V40, P45, DOI 10.1111/j.1749-7345.2008.00234.x; Sajjadi M, 2004, AQUACULTURE, V240, P417, DOI 10.1016/j.aquaculture.2004.07.003; Salze G, 2010, AQUACULTURE, V298, P294, DOI 10.1016/j.aquaculture.2009.11.003; SMITH RR, 1980, PROG FISH CULT, V42, P195, DOI 10.1577/1548-8659(1980)42[195:EOLOAD]2.0.CO;2; Sugiura SH, 1998, AQUACULTURE, V159, P177, DOI 10.1016/S0044-8486(97)00177-4; Sullivan JA, 1995, AQUACULTURE, V138, P313, DOI 10.1016/0044-8486(95)01071-8; Takagi S, 2008, AQUACULTURE, V280, P198, DOI 10.1016/j.aquaculture.2008.05.012; Takagi S, 2010, FISHERIES SCI, V76, P119, DOI 10.1007/s12562-009-0185-y; Tibbetts SM, 2006, AQUACULTURE, V261, P1314, DOI 10.1016/j.aquaculture.2006.08.052; Tibbetts SM, 2004, AQUAC RES, V35, P643, DOI 10.1111/j.1365-2109.2004.01060.x; Walker AB, 2010, N AM J AQUACULT, V72, P343, DOI 10.1577/A09-085.1; Webster C.D., 2008, ALTERNATIVE PROTEIN, P475; Weirich CR, 2006, N AM J AQUACULT, V68, P330, DOI 10.1577/A05-082.1; Williams T.N., 2008, THESIS U MAINE ORONO; Zhao H, 2010, AQUACULT NUTR, V16, P648, DOI 10.1111/j.1365-2095.2009.00708.x; Zhou P, 2010, N AM J AQUACULT, V72, P298, DOI 10.1577/A10-002.1; Zhou QC, 2004, AQUACULTURE, V241, P441, DOI 10.1016/j.aquaculture.2004.08.044	62	45	50	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e34981	10.1371/journal.pone.0034981	http://dx.doi.org/10.1371/journal.pone.0034981			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536344	Green Submitted, Green Published, gold			2022-12-27	WOS:000305339200030
J	Nogi, Y; Nagashima, M; Terasaki, M; Nohtomi, K; Watanabe, T; Hirano, T				Nogi, Yukinori; Nagashima, Masaharu; Terasaki, Michishige; Nohtomi, Kyoko; Watanabe, Takuya; Hirano, Tsutomu			Glucose-Dependent Insulinotropic Polypeptide Prevents the Progression of Macrophage-Driven Atherosclerosis in Diabetic Apolipoprotein E-Null Mice	PLOS ONE			English	Article							FOAM CELL-FORMATION; GASTRIC-INHIBITORY POLYPEPTIDE; GIP RECEPTOR EXPRESSION; E-DEFICIENT MICE; E-KNOCKOUT MICE; DOWN-REGULATION; LESION; INCRETINS; INFUSION	Aim: We recently reported that glucose-dependent insulinotropic polypeptide (GIP) prevents the development of atherosclerosis in apolipoprotein E-null (Apoe(-/-)) mice. GIP receptors (GIPRs) are found to be severely down-regulated in diabetic animals. We examined whether GIP can exert anti-atherogenic effects in diabetes. Methods: Nondiabetic Apoe(-/-) mice, streptozotocin-induced diabetic Apoe(-/-) mice, and db/db mice were administered GIP (25 nmol/kg/day) or saline (vehicle) through osmotic mini-pumps for 4 weeks. The animals were assessed for aortic atherosclerosis and for oxidized low-density lipoprotein-induced foam cell formation in exudate peritoneal macrophages. Results: Diabetic Apoe(-/-) mice of 21 weeks of age exhibited more advanced atherosclerosis than nondiabetic Apoe(-/-) mice of the same age. GIP infusion in diabetic Apoe(-/-) mice increased plasma total GIP levels by 4-fold without improving plasma insulin, glucose, or lipid profiles. GIP infusion significantly suppressed macrophage-driven atherosclerotic lesions, but this effect was abolished by co-infusions with [Pro 3] GIP, a GIPR antagonist. Foam cell formation was stimulated by 3-fold in diabetic Apoe(-/-) mice compared with their nondiabetic counterparts, but this effect was halved by GIP infusion. GIP infusion also attenuated the foam cell formation in db/db mice. In vitro treatment with GIP (1 nM) reduced foam cell formation by 15% in macrophages from diabetic Apoe(-/-) mice, and this attenuating effect was weaker than that attained by the same treatment of macrophages from nondiabetic counterparts (35%). While GIPR expression was reduced by only about a half in macrophages from diabetic mice, it was reduced much more dramatically in pancreatic islets from the same animals. Incubation with high glucose (500 mg/dl) for 9-10 days markedly reduced GIPR expression in pancreatic islet cells, but not in macrophages. Conclusions: Long-term infusion of GIP conferred significant anti-atherogenic effects in diabetic mice even though the GIPR expression in macrophages was mildly down-regulated in the diabetic state.	[Nogi, Yukinori; Nagashima, Masaharu; Terasaki, Michishige; Nohtomi, Kyoko; Hirano, Tsutomu] Showa Univ, Sch Med, Dept Med, Div Diabet Metab & Endocrinol, Tokyo 142, Japan; [Watanabe, Takuya] Univ Pharm & Life Sci, Lab Cardiovasc Med, Tokyo, Japan	Showa University	Hirano, T (corresponding author), Showa Univ, Sch Med, Dept Med, Div Diabet Metab & Endocrinol, Tokyo 142, Japan.	hirano@med.showa-u.ac.jp	Terasaki, Michishige/I-1659-2016	Terasaki, Michishige/0000-0002-7405-7419	Grants-in-Aid for Scientific Research [22590831] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Arakawa M, 2010, DIABETES, V59, P1030, DOI 10.2337/db09-1694; Ban K, 2009, J AM SOC HYPERTENS, V3, P245, DOI 10.1016/j.jash.2009.04.001; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; ELAHI D, 1994, REGUL PEPTIDES, V51, P63, DOI 10.1016/0167-0115(94)90136-8; Goto H, 2011, BIOCHEM BIOPH RES CO, V405, P79, DOI 10.1016/j.bbrc.2010.12.131; Gupta D, 2010, DIABETES, V59, P1445, DOI 10.2337/db09-1655; Hayek T, 2005, ATHEROSCLEROSIS, V183, P25, DOI 10.1016/j.atherosclerosis.2005.02.018; Kim W, 2008, PHARMACOL REV, V60, P470, DOI 10.1124/pr.108.000604; Lee S, 2010, ENDOCR J, V57, P119, DOI 10.1507/endocrj.K09E-269; Lynn FC, 2002, FASEB J, V16, P91, DOI 10.1096/fj.02-0243fje; Lynn FC, 2001, DIABETES, V50, P1004, DOI 10.2337/diabetes.50.5.1004; Matsubara J, 2012, J AM COLL CARDIOL, V59, P265, DOI 10.1016/j.jacc.2011.07.053; Matsui T, 2011, PHARMACOL RES, V63, P383, DOI 10.1016/j.phrs.2011.02.003; Mauerer R, 2009, EXP MOL MED, V41, P126, DOI 10.3858/emm.2009.41.2.015; Nagashima M, 2011, DIABETOLOGIA, V54, P2649, DOI 10.1007/s00125-011-2241-2; Nagashima M, 2010, ATHEROSCLEROSIS, V212, P70, DOI 10.1016/j.atherosclerosis.2010.04.027; NAUCK MA, 1993, J CLIN INVEST, V91, P301, DOI 10.1172/JCI116186; Shah Z, 2011, CIRCULATION, V124, P2339, DOI 10.1161/CIRCULATIONAHA.111.041418; Shiraishi Y, 2008, J HYPERTENS, V26, P1955, DOI 10.1097/HJH.0b013e32830b61d8; Takeda Y, 2012, DIABETOLOGIA, V55, P404, DOI 10.1007/s00125-011-2365-4; Terasaki M, 2012, METABOLISM IN PRESS; Xu G, 2007, DIABETES, V56, P1551, DOI 10.2337/db06-1033; Xu G, 2009, CIRC RES, V105, P500, DOI 10.1161/CIRCRESAHA.109.193870; Zhou HY, 2005, BIOCHEM BIOPH RES CO, V335, P937, DOI 10.1016/j.bbrc.2005.07.164; Zhou J, 2007, AM J PHYSIOL-ENDOC M, V293, pE538, DOI 10.1152/ajpendo.00070.2007	25	51	54	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35683	10.1371/journal.pone.0035683	http://dx.doi.org/10.1371/journal.pone.0035683			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536426	Green Submitted, Green Published, gold			2022-12-27	WOS:000305339200098
J	Chen, YQ; Cao, LY; Zhong, MH; Zhang, Y; Han, C; Li, QL; Yang, JY; Zhou, DH; Shi, W; He, BX; Liu, F; Yu, J; Sun, Y; Cao, Y; Li, YM; Li, WX; Guo, DY; Cao, ZJ; Yan, HM				Chen, Yaoqing; Cao, Luyang; Zhong, Maohua; Zhang, Yan; Han, Chen; Li, Qiaoli; Yang, Jingyi; Zhou, Dihan; Shi, Wei; He, Benxia; Liu, Fang; Yu, Jie; Sun, Ying; Cao, Yuan; Li, Yaoming; Li, Wenxin; Guo, Deying; Cao, Zhijian; Yan, Huimin			Anti-HIV-1 Activity of a New Scorpion Venom Peptide Derivative Kn2-7	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ANTIMICROBIAL PEPTIDES; HIV-1 INFECTION; ANTIVIRAL ACTIVITY; CATIONIC PEPTIDES; NEUTRALIZING ANTIBODIES; VIRUCIDAL ACTIVITY; DOUBLE-BLIND; MICROBICIDES; VACCINE	For over 30 years, HIV/AIDS has wreaked havoc in the world. In the absence of an effective vaccine for HIV, development of new anti-HIV agents is urgently needed. We previously identified the antiviral activities of the scorpion-venom-peptide-derived mucroporin-M1 for three RNA viruses (measles viruses, SARS-CoV, and H5N1). In this investigation, a panel of scorpion venom peptides and their derivatives were designed and chosen for assessment of their anti-HIV activities. A new scorpion venom peptide derivative Kn2-7 was identified as the most potent anti-HIV-1 peptide by screening assays with an EC50 value of 2.76 mu g/ml (1.65 mu M) and showed low cytotoxicity to host cells with a selective index (SI) of 13.93. Kn2-7 could inhibit all members of a standard reference panel of HIV-1 subtype B pseudotyped virus (PV) with CCR5-tropic and CXCR4-tropic NL4-3 PV strain. Furthermore, it also inhibited a CXCR4-tropic replication-competent strain of HIV-1 subtype B virus. Binding assay of Kn2-7 to HIV-1 PV by Octet Red system suggested the anti-HIV-1 activity was correlated with a direct interaction between Kn2-7 and HIV-1 envelope. These results demonstrated that peptide Kn2-7 could inhibit HIV-1 by direct interaction with viral particle and may become a promising candidate compound for further development of microbicide against HIV-1.	[Chen, Yaoqing; Cao, Luyang; Li, Wenxin; Guo, Deying; Cao, Zhijian; Yan, Huimin] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China; [Zhong, Maohua; Zhang, Yan; Han, Chen; Li, Qiaoli; Yang, Jingyi; Zhou, Dihan; Shi, Wei; He, Benxia; Liu, Fang; Yu, Jie; Sun, Ying; Cao, Yuan; Li, Yaoming; Yan, Huimin] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Peoples R China	Wuhan University; Chinese Academy of Sciences; Wuhan Institute of Virology, CAS	Chen, YQ (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China.	zjcao@whu.edu.cn; hmyan@wh.iov.cn	chen, yaoqing/S-2623-2016	chen, yaoqing/0000-0002-1278-3327; Yan, Huimin/0000-0002-7243-8429	National Natural Science Foundation of China (NSFC) [30670097]; National Basic Research Program of China (973 Program) [2005CB522903, 2010CB530100, 2012CB518904]; Ministry of Science and Technology of the People's Republic of China [2008ZX10001-010, 2012ZX10001-008]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China)	This work was financially supported by the National Natural Science Foundation of China (NSFC) (No. 30670097 to HY), the National Basic Research Program of China (973 Program) (Nos. 2005CB522903, 2010CB530100, and 2012CB518904), and the National S&T Major Project on Major Infectious Diseases (Nos. 2008ZX10001-010, 2012ZX10001-008) from the Ministry of Science and Technology of the People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdiche Y, 2008, ANAL BIOCHEM, V377, P209, DOI 10.1016/j.ab.2008.03.035; ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Arien KK, 2011, REV MED VIROL, V21, P110, DOI 10.1002/rmv.684; Boman HG, 2000, IMMUNOL REV, V173, P5, DOI 10.1034/j.1600-065X.2000.917301.x; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Cao ZJ, 2006, TOXICON, V47, P348, DOI 10.1016/j.toxicon.2005.11.013; Carriel-Gomes MC, 2007, MEM I OSWALDO CRUZ, V102, P469, DOI 10.1590/S0074-02762007005000028; Choudhry V, 2007, VIROLOGY, V363, P79, DOI 10.1016/j.virol.2007.01.015; Cole AL, 2006, J IMMUNOL, V176, P6900, DOI 10.4049/jimmunol.176.11.6900; Conde R, 2000, FEBS LETT, V471, P165, DOI 10.1016/S0014-5793(00)01384-3; CORY AH, 1991, CANCER COMMUN, V3, P207, DOI 10.3727/095535491820873191; Dai C, 2008, ANTIMICROB AGENTS CH, V52, P3967, DOI 10.1128/AAC.00542-08; Dai L, 2001, BIOCHEM BIOPH RES CO, V286, P820, DOI 10.1006/bbrc.2001.5472; DALGLEISH AG, 1984, NATURE, V312, P763, DOI 10.1038/312763a0; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Do T, 2008, PROTEIN EXPRES PURIF, V60, P147, DOI 10.1016/j.pep.2008.04.009; Doranz BJ, 1996, CELL, V85, P1149, DOI 10.1016/S0092-8674(00)81314-8; EHRENSTEIN G, 1977, Q REV BIOPHYS, V10, P1, DOI 10.1017/S0033583500000123; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Fjell CD, 2007, BIOINFORMATICS, V23, P1148, DOI 10.1093/bioinformatics/btm068; HAMILTON MA, 1977, NEW ZEAL MED J, V86, P327; Hancock REW, 1998, TRENDS BIOTECHNOL, V16, P82, DOI 10.1016/S0167-7799(97)01156-6; Jenssen H, 2006, CLIN MICROBIOL REV, V19, P491, DOI 10.1128/CMR.00056-05; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Li QL, 2011, PEPTIDES, V32, P1518, DOI 10.1016/j.peptides.2011.05.015; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Ma YB, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-290; MARTIN E, 1995, J LEUKOCYTE BIOL, V58, P128, DOI 10.1002/jlb.58.2.128; Matanic VCA, 2004, INT J ANTIMICROB AG, V23, P382, DOI 10.1016/j.ijantimicag.2003.07.022; McCormack S, 2010, LANCET, V376, P1329, DOI 10.1016/S0140-6736(10)61086-0; Moerman L, 2002, EUR J BIOCHEM, V269, P4799, DOI 10.1046/j.1432-1033.2002.03177.x; Mohan KVK, 2010, ANTIVIR RES, V86, P306, DOI 10.1016/j.antiviral.2010.03.012; Montefiori DC., 2005, CURR PROTOC IMMUNOL, VChapter 12:12.11.11-12.11.15, DOI [10.1002/0471142735.im1211s64, DOI 10.1002/0471142735.IM1211S64]; Neurath AR, 2002, BMC INFECT DIS, V2, DOI 10.1186/1471-2334-2-27; Oren Z, 1998, BIOPOLYMERS, V47, P451; PearcePratt R, 1996, BIOL REPROD, V54, P173, DOI 10.1095/biolreprod54.1.173; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Possani LD, 2000, BIOCHIMIE, V82, P861, DOI 10.1016/S0300-9084(00)01167-6; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; ROST B, 1993, J MOL BIOL, V232, P584, DOI 10.1006/jmbi.1993.1413; SAKAI K, 1991, J VIROL, V65, P5765, DOI 10.1128/JVI.65.11.5765-5773.1991; Sun LL, 2005, J VIROL, V79, P14318, DOI 10.1128/JVI.79.22.14318-14329.2005; Tao J, 2007, ANTIVIR RES, V75, P227, DOI 10.1016/j.antiviral.2007.03.008; Tao W, 2008, AIDS RES HUM RETROV, V24, P925, DOI 10.1089/aid.2008.0043; Telwatte S, 2011, ANTIVIR RES, V90, P195, DOI 10.1016/j.antiviral.2011.03.186; Titti F, 2007, EXPERT OPIN EMERG DR, V12, P23, DOI 10.1517/14728214.12.1.23; Torre VS, 2000, J VIROL, V74, P4868, DOI 10.1128/JVI.74.10.4868-4876.2000; Torres-Larios A, 2000, EUR J BIOCHEM, V267, P5023, DOI 10.1046/j.1432-1327.2000.01556.x; UNAIDS, 2010, UNAIDS REP GLOB AIDS; Vzorov AN, 2007, ANTIVIR RES, V73, P60, DOI 10.1016/j.antiviral.2006.07.008; Wang Z, 2004, NUCLEIC ACIDS RES, V32, pD590, DOI 10.1093/nar/gkh025; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Yan R, 2011, PEPTIDES, V32, P11, DOI 10.1016/j.peptides.2010.10.008; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zeng XC, 2004, PEPTIDES, V25, P143, DOI 10.1016/j.peptides.2003.12.003; Zhang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024296; Zhao ZH, 2009, ANTIMICROB AGENTS CH, V53, P3472, DOI 10.1128/AAC.01436-08	60	49	53	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e34947	10.1371/journal.pone.0034947	http://dx.doi.org/10.1371/journal.pone.0034947			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22536342	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336200015
J	Manabe, YC; Wang, YP; Elbireer, A; Auerbach, B; Castelnuovo, B				Manabe, Yukari C.; Wang, Yaping; Elbireer, Ali; Auerbach, Brandon; Castelnuovo, Barbara			Evaluation of Portable Point-of-Care CD4 Counter with High Sensitivity for Detecting Patients Eligible for Antiretroviral Therapy	PLOS ONE			English	Article							SOUTH-AFRICA; FOLLOW-UP; HIV-1-INFECTED PATIENTS; PERFORMANCE EVALUATION; COLLABORATIVE ANALYSIS; PIMA CD4; COHORT; HIV; INITIATION; ANALYZER	Background: Accurate, inexpensive point-of-care CD4+ T cell testing technologies are needed that can deliver CD4+ T cell results at lower level health centers or community outreach voluntary counseling and testing. We sought to evaluate a point-of-care CD4+ T cell counter, the Pima CD4 Test System, a portable, battery-operated bench-top instrument that is designed to use finger stick blood samples suitable for field use in conjunction with rapid HIV testing. Methods: Duplicate measurements were performed on both capillary and venous samples using Pima CD4 analyzers, compared to the BD FACSCalibur (reference method). The mean bias was estimated by paired Student's t-test. Bland Altman plots were used to assess agreement. Results: 206 participants were enrolled with a median CD4 count of 396 (range; 18-1500). The finger stick PIMA had a mean bias of -66.3 cells/mu L (95% CI -83-4-49.2, P<0.001) compared to the FACSCalibur; the bias was smaller at lower CD4 counts (0-250 cells/mL) with a mean bias of -10.8 (95% CI -27.3-+5.6, P = 0.198), and much greater at higher CD4 cell counts (>500 cells/mu L) with a mean bias of -120.6 (95% CI -162.8, -78.4, P<0.001). The sensitivity (95% CI) of the Pima CD4 analyzer was 96.3% (79.1-99.8%) for a <250 cells/ul cut-off with a negative predictive value of 99.2% (95.1-99.9%). Conclusions: The Pima CD4 finger stick test is an easy-to-use, portable, relatively fast device to test CD4+ T cell counts in the field. Issues of negatively-biased CD4 cell counts especially at higher absolute numbers will limit its utility for longitudinal immunologic response to ART. The high sensitivity and negative predictive value of the test makes it an attractive option for field use to identify patients eligible for ART, thus potentially reducing delays in linkage to care and ART initiation.	[Manabe, Yukari C.; Auerbach, Brandon; Castelnuovo, Barbara] Makerere Coll Hlth Sci, Infect Dis Inst, Kampala, Uganda; [Manabe, Yukari C.; Wang, Yaping] Johns Hopkins Univ, Sch Med, Dept Med, Div Infect Dis, Baltimore, MD 21205 USA; [Manabe, Yukari C.; Elbireer, Ali] Johns Hopkins Univ, Sch Med, Dept Pathol, Makerere Univ,Clin Core Lab, Baltimore, MD 21205 USA; [Elbireer, Ali] Johns Hopkins Univ, Sch Med, Dept Med, Div Pathol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Manabe, YC (corresponding author), Makerere Coll Hlth Sci, Infect Dis Inst, Kampala, Uganda.	ymanabe@jhmi.edu		Elbireer, Ali/0000-0002-2513-3497	Alere Technologies	Alere Technologies	Alere Technologies (http://www.aleretechnologies.co.uk) funded the study and assisted with study design. The funders had no role in the data collection and analysis, decision to publish or preparation of the manuscript.; Alere Technologies funded the study. There are no patents, products in development, or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Amuron B, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-290; Bassett IV, 2009, JAIDS-J ACQ IMM DEF, V51, P135, DOI 10.1097/QAI.0b013e3181a44ef2; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Cohen GM, 2007, AIDS, V21, pS81, DOI 10.1097/01.aids.0000279710.47298.5c; Diaw PA, 2011, JAIDS-J ACQ IMM DEF, V58, pE103, DOI 10.1097/QAI.0b013e318235b378; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Elbireer AM, 2011, LAB MED IN PRESS; Fairall LR, 2008, ARCH INTERN MED, V168, P86, DOI 10.1001/archinternmed.2007.10; Glencross DK, 2012, J INT AIDS SOC, V15, DOI 10.1186/1758-2652-15-3; Jaffar Shabbar, 2008, AIDS Res Ther, V5, P4, DOI 10.1186/1742-6405-5-4; Jani IV, 2011, LANCET, V378, P1572, DOI 10.1016/S0140-6736(11)61052-0; Jani IV, 2011, AIDS, V25, P807, DOI 10.1097/QAD.0b013e328344f424; Kagaayi J, 2007, AIDS, V21, P1208, DOI 10.1097/QAD.0b013e32810c8dce; Karcher H, 2007, TROP MED INT HEALTH, V12, P687, DOI 10.1111/j.1365-3156.2007.01830.x; Kitahata MM, 2009, NEW ENGL J MED, V360, P1815, DOI 10.1056/NEJMoa0807252; Lawn SD, 2011, J ACQUIR IMMUNE DEFI; Losina E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009538; Micek MA, 2009, JAIDS-J ACQ IMM DEF, V52, P397, DOI 10.1097/QAI.0b013e3181ab73e2; Mtapuri-Zinyowera S, 2010, JAIDS-J ACQ IMM DEF, V55, P1, DOI 10.1097/QAI.0b013e3181e93071; Sterne JAC, 2005, LANCET, V366, P378, DOI 10.1016/S0140-6736(05)67022-5; Sterne JAC, 2009, LANCET, V373, P1352, DOI 10.1016/S0140-6736(09)60612-7; Sukapirom K, 2011, JAIDS-J ACQ IMM DEF, V58, P141, DOI 10.1097/QAI.0b013e31822866a2; WHO, 2010, ANT THER HIV INF AD	23	52	54	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e34319	10.1371/journal.pone.0034319	http://dx.doi.org/10.1371/journal.pone.0034319			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22536323	Green Published, gold			2022-12-27	WOS:000305336200006
J	Talan, MI; Ahmet, I; Lakatta, EG				Talan, Mark I.; Ahmet, Ismayil; Lakatta, Edward G.			Did Clinical Trials in Which Erythropoietin Failed to Reduce Acute Myocardial Infarct Size Miss a Narrow Therapeutic Window?	PLOS ONE			English	Article							RECOMBINANT-HUMAN-ERYTHROPOIETIN; CONTROLLED PILOT TRIAL; CARDIOPROTECTION; REPERFUSION; RATIONALE; REVEAL; DESIGN	Background: To test a hypothesis that in negative clinical trials of erythropoietin in patients with acute myocardial infarction (MI) the erythropoietin (rhEPO) could be administered outside narrow therapeutic window. Despite overwhelming evidence of cardioprotective properties of rhEPO in animal studies, the outcomes of recently concluded phase II clinical trials have failed to demonstrate the efficacy of rhEPO in patients with acute MI. However, the time between symptoms onset and rhEPO administration in negative clinical trials was much longer that in successful animal experiments. Methodology/Principal Findings: MI was induced in rats either by a permanent ligation of a descending coronary artery or by a 2-hr occlusion followed by a reperfusion. rhEPO, 3000 IU/kg, was administered intraperitoneally at the time of reperfusion, 4 hrs after beginning of reperfusion, or 6 hrs after permanent occlusion. MI size was measured histologically 24 hrs after coronary occlusion. The area of myocardium at risk was similar among groups. The MI size in untreated rats averaged similar to 42% of area at risk, or similar to 24% of left ventricle, and was reduced by more than 50% (p<0.001) in rats treated with rhEPO at the time of reperfusion. The MI size was not affected by treatment administered 4 hrs after reperfusion or 6 hrs after permanent coronary occlusion. Therefore, our study in a rat experimental model of MI demonstrates that rhEPO administered within 2 hrs of a coronary occlusion effectively reduces MI size, but when rhEPO was administered following a delay similar to that encountered in clinical trials, it had no effect on MI size. Conclusions/Significance: The clinical trials that failed to demonstrate rhEPO efficacy in patients with MI may have missed a narrow therapeutic window defined in animal experiments.	[Talan, Mark I.; Ahmet, Ismayil; Lakatta, Edward G.] NIA, Cardiovasc Sci Lab, Intramural Res Program, Natl Inst Hlth, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Talan, MI (corresponding author), NIA, Cardiovasc Sci Lab, Intramural Res Program, Natl Inst Hlth, Baltimore, MD 21224 USA.	talanm@grc.nia.nih.gov	Lakatta, Edward G/AAL-1447-2020; Stefanadis, Christodoulos/ABH-2232-2020	Lakatta, Edward/0000-0002-4772-0035; Stefanadis, Christodoulos/0000-0001-5974-6454	NATIONAL INSTITUTE ON AGING [ZIAAG000866] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Ahmet I, 2005, CIRCULATION, V112, P3115, DOI 10.1161/CIRCULATIONAHA.105.563817; Ahmet I, 2011, J MOL CELL CARDIOL, V51, P263, DOI 10.1016/j.yjmcc.2011.04.015; Belonje AM, 2008, AM HEART J, V155, P817, DOI 10.1016/j.ahj.2007.12.036; Bhatt DL, 2011, JAMA-J AM MED ASSOC, V305, P1908, DOI 10.1001/jama.2011.600; Binbrek AS, 2007, CORONARY ARTERY DIS, V18, P583, DOI 10.1097/MCA.0b013e3282ef4ed6; Binbrek AS, 2009, AM J CARDIOL, V104, P1035, DOI 10.1016/j.amjcard.2009.05.050; Bogoyevitch MA, 2004, CARDIOVASC RES, V63, P208, DOI 10.1016/j.cardiores.2004.03.017; Ferrario M, 2011, INT J CARDIOL, V147, P124, DOI 10.1016/j.ijcard.2009.10.028; Gibson CM, 2008, AM HEART J, V156, P1035, DOI 10.1016/j.ahj.2008.07.029; Hirata A, 2006, J AM COLL CARDIOL, V48, P176, DOI 10.1016/j.jacc.2006.04.008; Koul Deepak, 2007, Recent Pat Cardiovasc Drug Discov, V2, P5, DOI 10.2174/157489007779606112; Latini R, 2008, HEART FAIL REV, V13, P415, DOI 10.1007/s10741-008-9084-z; Liem A, 2009, INT J CARDIOL, V131, P285, DOI 10.1016/j.ijcard.2007.07.076; Lipsic E, 2006, J AM COLL CARDIOL, V48, P2161, DOI 10.1016/j.jacc.2006.08.031; Lipsic E, 2006, CARDIOVASC DRUG THER, V20, P135, DOI 10.1007/s10557-006-7680-5; Melloni C, 2010, AM HEART J, V160, P795, DOI 10.1016/j.ahj.2010.09.007; Moon C, 2005, CARDIOVASC DRUG THER, V19, P243, DOI 10.1007/s10557-005-3189-6; Najjar SS, 2011, JAMA-J AM MED ASSOC, V305, P1863, DOI 10.1001/jama.2011.592; Ott I, 2010, CIRC-CARDIOVASC INTE, V3, P408, DOI 10.1161/CIRCINTERVENTIONS.109.904425; Ozawa T, 2010, CIRC J, V74, P1415, DOI 10.1253/circj.CJ-10-0109; Riksen NP, 2008, TRENDS PHARMACOL SCI, V29, P258, DOI 10.1016/j.tips.2008.02.002; Taniguchi N, 2010, CIRC J, V74, P2365, DOI 10.1253/circj.CJ-10-0267; Vogiatzi G, 2010, EXPERT OPIN BIOL TH, V10, P251, DOI 10.1517/14712590903547819; Voors AA, 2010, EUR HEART J, V31, P2593, DOI 10.1093/eurheartj/ehq304; Yoshimura N, 2010, CIRC J, V74, P2741, DOI 10.1253/circj.CJ-10-0912	25	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e34819	10.1371/journal.pone.0034819	http://dx.doi.org/10.1371/journal.pone.0034819			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529941	Green Published, Green Submitted, gold			2022-12-27	WOS:000305350600032
J	Willis, PM; Rosenthal, GG; Ryan, MJ				Willis, Pamela M.; Rosenthal, Gil G.; Ryan, Michael J.			An Indirect Cue of Predation Risk Counteracts Female Preference for Conspecifics in a Naturally Hybridizing Fish Xiphophorus birchmanni	PLOS ONE			English	Article							MATE CHOICE; SEXUAL SELECTION; BODY-SIZE; GREEN SWORDTAIL; SPECIATION; NIGRENSIS; COMMUNICATION; CRICKETS; BEHAVIOR; ZONES	Mate choice is context dependent, but the importance of current context to interspecific mating and hybridization is largely unexplored. An important influence on mate choice is predation risk. We investigated how variation in an indirect cue of predation risk, distance to shelter, influences mate choice in the swordtail Xiphophorus birchmanni, a species which sometimes hybridizes with X. malinche in the wild. We conducted mate choice experiments to determine whether females attend to the distance to shelter and whether this cue of predation risk can counteract female preference for conspecifics. Females were sensitive to shelter distance independent of male presence. When conspecific and heterospecific X. malinche males were in equally risky habitats (i.e., equally distant from shelter), females associated primarily with conspecifics, suggesting an innate preference for conspecifics. However, when heterospecific males were in less risky habitat (i.e., closer to shelter) than conspecific males, females no longer exhibited a preference, suggesting that females calibrate their mate choices in response to predation risk. Our findings illustrate the potential for hybridization to arise, not necessarily through reproductive "mistakes'', but as one of many potential outcomes of a context dependent mate choice strategy.	[Willis, Pamela M.; Ryan, Michael J.] Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA; [Rosenthal, Gil G.] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA; [Rosenthal, Gil G.] Ctr Invest Cient Huastecas Aguazarca, Calnali, Hidalgo, Mexico	University of Texas System; University of Texas Austin; Texas A&M University System; Texas A&M University College Station	Willis, PM (corresponding author), Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA.	pamwillis@utexas.edu	Rosenthal, Gil/E-6924-2015	Rosenthal, Gil/0000-0003-0342-9024	Society for Integrative and Comparative Biology; Southwestern Association of Naturalists; American Livebearer Association; PADI Foundation grants; Zoology Scholarship Endowment for Excellence Fellowship from the University of Texas	Society for Integrative and Comparative Biology; Southwestern Association of Naturalists; American Livebearer Association; PADI Foundation grants; Zoology Scholarship Endowment for Excellence Fellowship from the University of Texas	This work was funded by grants to PMW from the Society for Integrative and Comparative Biology, the Southwestern Association of Naturalists, the American Livebearer Association, and the PADI Foundation grants. PMW was supported by a Zoology Scholarship Endowment for Excellence Fellowship from the University of Texas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1963, ANIMAL SPECIES EVOLU; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Basolo AL, 2004, BIOL J LINN SOC, V83, P87, DOI 10.1111/j.1095-8312.2004.00369.x; Basolo AL, 1995, P R SOC B, V259, P2223; BERGLUND A, 1995, BEHAVIOUR, V132, P213, DOI 10.1163/156853995X00702; BREDEN F, 1987, NATURE, V329, P831, DOI 10.1038/329831a0; Brooksmythe I, 2008, ANIM BEHAV, V76, P1775; Burke JM, 2001, ANNU REV GENET, V35, P31, DOI 10.1146/annurev.genet.35.102401.085719; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Coleman SW, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000118; Cotton S, 2006, CURR BIOL, V16, pR755, DOI 10.1016/j.cub.2006.08.022; Culumber ZW, 2011, MOL ECOL, V20, P342, DOI 10.1111/j.1365-294X.2010.04949.x; Cummings ME, 2003, P ROY SOC B-BIOL SCI, V270, P897, DOI 10.1098/rspb.2003.2334; Cummings M, 2006, ANIM BEHAV, V72, P217, DOI 10.1016/j.anbehav.2006.01.009; DILL LM, 1984, BEHAV ECOL SOCIOBIOL, V16, P65, DOI 10.1007/BF00293105; Fisher HS, 2007, BIOL LETTERS, V3, P5, DOI 10.1098/rsbl.2006.0556; Fisher HS, 2006, P ROY SOC B-BIOL SCI, V273, P1187, DOI 10.1098/rspb.2005.3406; Fisher HS, 2010, ETHOLOGY, V116, P32, DOI 10.1111/j.1439-0310.2009.01710.x; FORSGREN E, 1992, AM NAT, V140, P1041, DOI 10.1086/285455; Gerlai R, 2007, ETHOLOGY, V113, P673, DOI 10.1111/j.1439-0310.2007.01372.x; GOMULKIEWICZ R, 1991, AM NAT, V138, P1396, DOI 10.1086/285293; GORDON M, 1953, COPEIA, P148; Gow JL, 2006, MOL ECOL, V15, P739, DOI 10.1111/j.1365-294X.2006.02825.x; Gray DA, 1999, J INSECT BEHAV, V12, P691, DOI 10.1023/A:1020983821436; Hebets EA, 2008, ANIM BEHAV, V76, P355, DOI 10.1016/j.anbehav.2007.12.021; HEDRICK AV, 1993, ANIM BEHAV, V46, P193, DOI 10.1006/anbe.1993.1176; HEWITT GM, 1988, TRENDS ECOL EVOL, V3, P158, DOI 10.1016/0169-5347(88)90033-X; HUGHES JJ, 1993, ANIM BEHAV, V46, P1243, DOI 10.1006/anbe.1993.1320; Jennions MD, 1997, BIOL REV, V72, P283, DOI 10.1017/S0006323196005014; Johnson JB, 2003, BEHAV ECOL, V14, P619, DOI 10.1093/beheco/arg046; Kallman KD, 2006, ZEBRAFISH, V3, P271, DOI 10.1089/zeb.2006.3.271; Kodric-Brown A, 2001, AM NAT, V157, P316, DOI 10.1086/319191; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Lynch KS, 2005, ANIM BEHAV, V69, P689, DOI 10.1016/j.anbehav.2004.05.016; Mallet J, 2007, NATURE, V446, P279, DOI 10.1038/nature05706; MORRIS MR, 1995, BEHAV ECOL SOCIOBIOL, V37, P303, DOI 10.1007/BF00174134; Naisbit RE, 2001, P ROY SOC B-BIOL SCI, V268, P1849, DOI 10.1098/rspb.2001.1753; Nuechterlein GL, 1998, BEHAV ECOL, V9, P313, DOI 10.1093/beheco/9.3.313; Orrock JL, 2004, BEHAV ECOL, V15, P433, DOI 10.1093/beheco/arh031; Pfennig KS, 2007, SCIENCE, V318, P965, DOI 10.1126/science.1146035; POCKLINGTON R, 1995, ANIM BEHAV, V49, P1122, DOI 10.1006/anbe.1995.0141; RAUCHENBERGER M, 1990, AM MUS NOVIT, P1; Rosenthal GG, 2001, AM NAT, V158, P146, DOI 10.1086/321309; Rosenthal GG, 2003, COPEIA, P299, DOI 10.1643/0045-8511(2003)003[0299:DOSSCI]2.0.CO;2; RYAN MJ, 1990, BEHAV ECOL SOCIOBIOL, V26, P231; Seehausen O, 1997, SCIENCE, V277, P1808, DOI 10.1126/science.277.5333.1808; Seehausen O, 2004, TRENDS ECOL EVOL, V19, P198, DOI 10.1016/j.tree.2004.01.003; Seehausen O, 2008, MOL ECOL, V17, P30, DOI 10.1111/j.1365-294X.2007.03529.x; SHELLY TE, 1992, BEHAV ECOL SOCIOBIOL, V30, P277, DOI 10.1007/BF00166713; Tatarenkov A, 2010, MOL ECOL, V19, P257, DOI 10.1111/j.1365-294X.2009.04464.x; Taylor EB, 2006, MOL ECOL, V15, P343, DOI 10.1111/j.1365-294X.2005.02794.x; Thibert-Plante X, 2011, J EVOLUTION BIOL, V24, P2186, DOI 10.1111/j.1420-9101.2011.02348.x; Velema G., 2010, THESIS U BRIT COLUMB; Walling CA, 2010, BEHAV ECOL SOCIOBIOL, V64, P541, DOI 10.1007/s00265-009-0869-4; Wiley C, 2007, J EVOLUTION BIOL, V20, P854, DOI 10.1111/j.1420-9101.2007.01316.x; Willis PM, 2011, BEHAV ECOL; WILSON D S, 1982, Evolutionary Theory, V6, P15; Wirtz P, 1999, ANIM BEHAV, V58, P1, DOI 10.1006/anbe.1999.1144; Wong BBM, 2006, AM NAT, V167, P136, DOI 10.1086/498278	59	25	25	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e34802	10.1371/journal.pone.0034802	http://dx.doi.org/10.1371/journal.pone.0034802			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529936	Green Published, gold			2022-12-27	WOS:000305350600028
J	Albrecht, E; Komolka, K; Kuzinski, J; Maak, S				Albrecht, Elke; Komolka, Katrin; Kuzinski, Judith; Maak, Steffen			Agouti Revisited: Transcript Quantification of the ASIP Gene in Bovine Tissues Related to Protein Expression and Localization	PLOS ONE			English	Article							BLACK-AND-TAN; COPY NUMBER VARIATION; SIGNALING PROTEIN; COAT COLOR; MOLECULAR CHARACTERIZATION; ECTOPIC EXPRESSION; ADIPOSE-TISSUES; HUMAN HOMOLOG; MUTATIONS; RECEPTOR	Beside its role in melanogenesis, the agouti signaling protein (ASIP) has been related to obesity. The potentially crucial role in adipocyte development makes it a tempting candidate for economic relevant, fat related traits in farm animals. The objective of our study was to characterize the mRNA expression of different ASIP transcripts and of putative targets in different bovine tissues, as well as to study consequences on protein abundance and localization. ASIP mRNA abundance was determined by RT-qPCR in adipose and further tissues of cattle representing different breeds and crosses. ASIP mRNA was up-regulated more than 9-fold in intramuscular fat of Japanese Black cattle compared to Holstein (p < 0.001). Further analyses revealed that a transposon-derived transcript was solely responsible for the increased ASIP mRNA abundance. This transcript was observed in single individuals of different breeds indicating a wide spread occurrence of this insertion at the ASIP locus in cattle. The protein was detected in different adipose tissues, skin, lung and liver, but not in skeletal muscle by Western blot with a bovine-specific ASIP antibody. However, the protein abundance was not related to the observed ASIP mRNA over-expression. Immuno-histochemical analyses revealed a putative nuclear localization of ASIP additionally to the expected cytosolic signal in different cell types. The expression of melanocortin receptors (MCR) 1 to 5 as potential targets for ASIP was analyzed by RT-PCR in subcutaneous fat. Only MC1R and MC4R were detected indicating a similar receptor expression like in human adipose tissue. Our results provide evidence for a widespread expression of ASIP in bovine tissues at mRNA and, for the first time, at protein level. ASIP protein is detectable in adipocytes as well as in further cells of adipose tissue. We generated a basis for a more detailed investigation of ASIP function in peripheral tissues of various mammalian species.	[Albrecht, Elke; Komolka, Katrin; Kuzinski, Judith; Maak, Steffen] Leibniz Inst Farm Anim Biol FBN, Res Unit Muscle Biol & Growth, Dummerstorf, Germany	Forschungsinstitut fur Nutztierbiologie (FBN)	Albrecht, E (corresponding author), Leibniz Inst Farm Anim Biol FBN, Res Unit Muscle Biol & Growth, Dummerstorf, Germany.	maak@fbn-dummerstorf.de	Albrecht, Elke/ABB-6155-2021	Albrecht, Elke/0000-0001-5974-1514				Adelson DL, 2009, P NATL ACAD SCI USA, V106, P12855, DOI 10.1073/pnas.0901282106; Albrecht E, 2011, MEAT SCI, V89, P13, DOI 10.1016/j.meatsci.2011.03.012; Amweg AN, 2011, THERIOGENOLOGY, V75, P628, DOI 10.1016/j.theriogenology.2010.10.003; Anno S, 2008, INT J BIOL SCI, V4, P81; Badaoui B, 2011, BIOCHEM GENET, V49, P523, DOI 10.1007/s10528-011-9427-7; Bae JS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-232; BULTMAN SJ, 1991, P NATL ACAD SCI USA, V88, P8062, DOI 10.1073/pnas.88.18.8062; BULTMAN SJ, 1994, GENE DEV, V8, P481, DOI 10.1101/gad.8.4.481; BULTMAN SJ, 1992, CELL, V71, P1195, DOI 10.1016/S0092-8674(05)80067-4; Chagnon YC, 1997, MOL MED, V3, P663, DOI 10.1007/BF03401705; Claycombe KJ, 2000, PHYSIOL GENOMICS, V2, P101, DOI 10.1152/physiolgenomics.2000.2.3.101; Cone RD, 1996, RECENT PROG HORM RES, V51, P287; Doghman M, 2004, ENDOCRINOLOGY, V145, P541, DOI 10.1210/en.2003-0605; Dreger DL, 2011, J HERED, V102, pS11, DOI 10.1093/jhered/esr042; Drogemuller C, 2006, MAMM GENOME, V17, P58, DOI 10.1007/s00335-005-0104-1; DUHL DMJ, 1994, NAT GENET, V8, P59, DOI 10.1038/ng0994-59; Fadista J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-284; Fontanesi L, 2009, CYTOGENET GENOME RES, V126, P333, DOI 10.1159/000268089; Fontanesi L, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-59; Fontanesi L, 2010, GENOMICS, V95, P166, DOI 10.1016/j.ygeno.2009.11.003; Girardot M, 2005, PIGM CELL RES, V18, P34, DOI 10.1111/j.1600-0749.2004.00195.x; Girardot M, 2006, PIGM CELL RES, V19, P346, DOI 10.1111/j.1600-0749.2006.00312.x; Gotoh T, 2009, MEAT SCI; Graphodatskaya D, 2006, ANIM SCI J, V77, P33, DOI 10.1111/j.1740-0929.2006.00317.x; Gratten J, 2010, HEREDITY, V104, P206, DOI 10.1038/hdy.2009.105; Hiller B, 2011, LIPIDS, V46, P557, DOI 10.1007/s11745-011-3571-z; Hiragaki T, 2008, GENETICS, V178, P771, DOI 10.1534/genetics.107.077040; Hoch M, 2007, OBESITY, V15, P40, DOI 10.1038/oby.2007.525; Jackson PJ, 2006, CHEM BIOL, V13, P1297, DOI 10.1016/j.chembiol.2006.10.006; Kanetsky PA, 2002, AM J HUM GENET, V70, P770, DOI 10.1086/339076; Kijas JW, 2011, GENE, V482, P73, DOI 10.1016/j.gene.2011.04.011; KLEBIG ML, 1995, P NATL ACAD SCI USA, V92, P4728, DOI 10.1073/pnas.92.11.4728; KLUNGLAND H, 1995, MAMM GENOME, V6, P636, DOI 10.1007/BF00352371; KWON HY, 1994, P NATL ACAD SCI USA, V91, P9760, DOI 10.1073/pnas.91.21.9760; Leeb T, 2000, ANIM GENET, V31, P335, DOI 10.1046/j.1365-2052.2000.00656.x; Liakos P, 1998, ENDOCR RES, V24, P427, DOI 10.3109/07435809809032628; Liakos P, 2000, MOL CELL ENDOCRINOL, V159, P99, DOI 10.1016/S0303-7207(99)00196-3; Liu GE, 2010, GENOME RES, V20, P693, DOI 10.1101/gr.105403.110; LU DS, 1994, NATURE, V371, P799, DOI 10.1038/371799a0; Matsunaga N, 2000, BIOCHEM BIOPH RES CO, V270, P176, DOI 10.1006/bbrc.2000.2409; Michaud EJ, 1997, J ENDOCRINOL, V155, P207, DOI 10.1677/joe.0.1550207; MICHAUD EJ, 1993, GENE DEV, V7, P1203, DOI 10.1101/gad.7.7a.1203; Miltenberger RJ, 2002, GENETICS, V160, P659; Mynatt RL, 2001, AM J PHYSIOL-CELL PH, V280, pC954, DOI 10.1152/ajpcell.2001.280.4.C954; Norris BJ, 2008, GENOME RES, V18, P1282, DOI 10.1101/gr.072090.107; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Rieder S, 2001, MAMM GENOME, V12, P450, DOI 10.1007/s003350020017; Royo LJ, 2005, J ANIM BREED GENET, V122, P357, DOI 10.1111/j.1439-0388.2005.00541.x; Shi KR, 2006, ANIM GENET, V37, P300, DOI 10.1111/j.1365-2052.2006.01446.x; SIRACUSA LD, 1994, TRENDS GENET, V10, P423, DOI 10.1016/0168-9525(94)90112-0; Smith SR, 2003, DIABETES, V52, P2914, DOI 10.2337/diabetes.52.12.2914; Sumida Takeshi, 2004, Animal Science Journal, V75, P49, DOI 10.1111/j.1740-0929.2004.00154.x; VRIELING H, 1994, P NATL ACAD SCI USA, V91, P5667, DOI 10.1073/pnas.91.12.5667; WILSON BD, 1995, HUM MOL GENET, V4, P223, DOI 10.1093/hmg/4.2.223; Xue BZ, 1998, FASEB J, V12, P1391, DOI 10.1096/fasebj.12.13.1391; Yabuuchi M, 2010, J POULT SCI, V47, P176, DOI 10.2141/jpsa.009110; Yang YK, 1997, MOL ENDOCRINOL, V11, P274, DOI 10.1210/me.11.3.274; YEN TT, 1994, FASEB J, V8, P479, DOI 10.1096/fasebj.8.8.8181666; Zhang CL, 2011, RES VET SCI, V90, P241, DOI 10.1016/j.rvsc.2010.06.007; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42	60	28	29	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e35282	10.1371/journal.pone.0035282	http://dx.doi.org/10.1371/journal.pone.0035282			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22530003	Green Submitted, Green Published, gold			2022-12-27	WOS:000305347400042
J	Kloog, I; Coull, BA; Zanobetti, A; Koutrakis, P; Schwartz, JD				Kloog, Itai; Coull, Brent A.; Zanobetti, Antonella; Koutrakis, Petros; Schwartz, Joel D.			Acute and Chronic Effects of Particles on Hospital Admissions in New-England	PLOS ONE			English	Article							PARTICULATE AIR-POLLUTION; CONGESTIVE-HEART-FAILURE; LONG-TERM EXPOSURE; CASE-CROSSOVER ANALYSIS; FINE PARTICULATE; CARDIOVASCULAR-DISEASE; MEDICARE BENEFICIARIES; MYOCARDIAL-INFARCTION; RESPIRATORY-DISEASES; EMERGENCY ADMISSIONS	Background: Many studies have reported significant associations between exposure to PM2.5 and hospital admissions, but all have focused on the effects of short-term exposure. In addition all these studies have relied on a limited number of PM2.5 monitors in their study regions, which introduces exposure error, and excludes rural and suburban populations from locations in which monitors are not available, reducing generalizability and potentially creating selection bias. Methods: Using our novel prediction models for exposure combining land use regression with physical measurements (satellite aerosol optical depth) we investigated both the long and short term effects of PM2.5 exposures on hospital admissions across New-England for all residents aged 65 and older. We performed separate Poisson regression analysis for each admission type: all respiratory, cardiovascular disease (CVD), stroke and diabetes. Daily admission counts in each zip code were regressed against long and short-term PM2.5 exposure, temperature, socio-economic data and a spline of time to control for seasonal trends in baseline risk. Results: We observed associations between both short-term and long-term exposure to PM2.5 and hospitalization for all of the outcomes examined. In example, for respiratory diseases, for every 10-mu g/m(3) increase in short-term PM2.5 exposure there is a 0.70 percent increase in admissions (CI = 0.35 to 0.52) while concurrently for every 10-mu g/m(3) increase in long-term PM2.5 exposure there is a 4.22 percent increase in admissions (CI = 1.06 to 4.75). Conclusions: As with mortality studies, chronic exposure to particles is associated with substantially larger increases in hospital admissions than acute exposure and both can be detected simultaneously using our exposure models.	[Kloog, Itai; Zanobetti, Antonella; Koutrakis, Petros; Schwartz, Joel D.] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Exposure Epidemiol & Risk Program, Boston, MA 02115 USA; [Coull, Brent A.] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Kloog, I (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Exposure Epidemiol & Risk Program, 665 Huntington Ave, Boston, MA 02115 USA.	ekloog@hsph.harvard.edu			Harvard Environmental Protection Agency (EPA) Center [R-832416, RD 83479801]; NIH [ES00002, ES012044]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012044, P30ES000002] Funding Source: NIH RePORTER	Harvard Environmental Protection Agency (EPA) Center(United States Environmental Protection Agency); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The research was supported by the Harvard Environmental Protection Agency (EPA) Center, Grants R-832416 and RD 83479801, NIH grants ES00002 and ES012044. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adar SD, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000372; Andersen ZJ, 2011, THORAX; Andersen ZJ, 2012, DIABETES CARE, V35, P92, DOI 10.2337/dc11-1155; [Anonymous], 2000, US CENS POP HOUS; Baja ES, 2010, ENVIRON HEALTH PERSP, V118, P840, DOI 10.1289/ehp.0901396; Bartoli CR, 2009, ENVIRON HEALTH PERSP, V117, P333, DOI 10.1289/ehp.11380; Bauer M, 2010, J AM COLL CARDIOL, V56, P1803, DOI 10.1016/j.jacc.2010.04.065; Brauner EV, 2008, AM J RESP CRIT CARE, V177, P419, DOI 10.1164/rccm.200704-632OC; Brook RD, 2004, CIRCULATION, V109, P2655, DOI 10.1161/01.CIR.0000128587.30041.C8; Brunekreef B, 2002, LANCET, V360, P1233, DOI 10.1016/S0140-6736(02)11274-8; Soares SRC, 2009, ATHEROSCLEROSIS, V207, P368, DOI 10.1016/j.atherosclerosis.2009.04.041; D'Ippoliti D, 2003, EPIDEMIOLOGY, V14, P528, DOI 10.1097/01.ede.0000082046.22919.72; Dominici F, 2006, JAMA-J AM MED ASSOC, V295, P1127, DOI 10.1001/jama.295.10.1127; Engel-Cox JA, 2004, ATMOS ENVIRON, V38, P2495, DOI 10.1016/j.atmosenv.2004.01.039; Fusco D, 2001, EUR RESPIR J, V17, P1143, DOI 10.1183/09031936.01.00005501; Gryparis A, 2009, BIOSTATISTICS, V10, P258, DOI 10.1093/biostatistics/kxn033; Gupta P, 2006, ATMOS ENVIRON, V40, P5880, DOI 10.1016/j.atmosenv.2006.03.016; Halonen JI, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-42; Hansen CS, 2007, TOXICOL APPL PHARM, V219, P24, DOI 10.1016/j.taap.2006.10.032; Hruba F, 2001, J EXPO ANAL ENV EPID, V11, P33, DOI 10.1038/sj.jea.7500141; Ilabaca M, 1999, J AIR WASTE MANAGE, V49, P154, DOI 10.1080/10473289.1999.10463879; Kloog I, 2011, ATMOSPHERIC ENV; Koelemeijer RBA, 2006, ATMOS ENVIRON, V40, P5304, DOI 10.1016/j.atmosenv.2006.04.044; Kramer U, 2010, ENVIRON HEALTH PERSP, V118, P1273, DOI 10.1289/ehp.0901689; Krewski D, 2009, RES REP HLTH EFF I, V2009, P115; Krewski Daniel, 2009, Res Rep Health Eff Inst, P5; Kunzli N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009096; Laden F, 2000, ENVIRON HEALTH PERSP, V108, P941, DOI 10.2307/3435052; LAIRD N, 1981, J AM STAT ASSOC, V76, P231, DOI 10.2307/2287816; Liu Y., 2004, J GEOPHYS RES D, V109, P3269; Madrigano J, 2010, OCCUP ENVIRON MED, V67, P312, DOI 10.1136/oem.2009.046193; Mann JK, 2002, ENVIRON HEALTH PERSP, V110, P1247, DOI 10.1289/ehp.021101247; Medina-Ramon M, 2006, AM J EPIDEMIOL, V163, P579, DOI 10.1093/aje/kwj078; Miller KA, 2007, NEW ENGL J MED, V356, P447, DOI 10.1056/NEJMoa054409; NCDC, 2010, NAT CLIM DAT CTR DAT; O'Neill MS, 2005, CIRCULATION, V111, P2913, DOI 10.1161/CIRCULATIONAHA.104.517110; Ostro B, 2010, ENVIRON HEALTH PERSP, V118, P363, DOI 10.1289/ehp.0901181; Oudin A, 2011, CEREBROVASC DIS, V31, P284, DOI 10.1159/000322600; Paciorek CJ, 2009, ANN APPL STAT, V3, P370, DOI 10.1214/08-AOAS204; Pope CA, 2006, J AIR WASTE MANAGE, V56, P709, DOI 10.1080/10473289.2006.10464485; POPE CA, 1995, INHAL TOXICOL, V7, P1, DOI 10.3109/08958379509014267; Puett RC, 2009, ENVIRON HEALTH PERSP, V117, P1697, DOI 10.1289/ehp.0900572; Schwartz J, 1996, J AIR WASTE MANAGE, V46, P927, DOI 10.1080/10473289.1996.10467528; Schwartz J, 1996, EPIDEMIOLOGY, V7, P20, DOI 10.1097/00001648-199601000-00005; SCHWARTZ J, 1995, AM J EPIDEMIOL, V142, P23, DOI 10.1093/oxfordjournals.aje.a117541; SCHWARTZ J, 1994, AM J EPIDEMIOL, V139, P589, DOI 10.1093/oxfordjournals.aje.a117048; Schwartz J, 1997, EPIDEMIOLOGY, V8, P371, DOI 10.1097/00001648-199707000-00004; Spix C, 1998, ARCH ENVIRON HEALTH, V53, P54, DOI 10.1080/00039899809605689; Sun QH, 2005, JAMA-J AM MED ASSOC, V294, P3003, DOI 10.1001/jama.294.23.3003; Sun QH, 2008, INHAL TOXICOL, V20, P127, DOI [10.1080/08958370701821482, 10.1080/08958370701821482 ]; Symons JM, 2006, AM J EPIDEMIOL, V164, P421, DOI 10.1093/aje/kwj206; USCB, 2000, US CENS BUR 2000; Wellenius GA, 2005, STROKE, V36, P2549, DOI 10.1161/01.STR.0000189687.78760.47; Wellenius GA, 2005, AM J EPIDEMIOL, V161, P1030, DOI 10.1093/aje/kwi135; Wellenius GA, 2003, ENVIRON HEALTH PERSP, V111, P402, DOI 10.1289/ehp.5775; Zanobetti A, 2001, AM J RESP CRIT CARE, V164, P831, DOI 10.1164/ajrccm.164.5.2012039; Zanobetti A, 2005, ENVIRON HEALTH PERSP, V113, P978, DOI 10.1289/ehp.7550; Zanobetti A, 2000, ENVIRON HEALTH PERSP, V108, P1071, DOI 10.2307/3434961; Zanobetti A, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-58; Zeger SL, 2000, ENVIRON HEALTH PERSP, V108, P419, DOI 10.2307/3454382	60	118	120	4	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e34664	10.1371/journal.pone.0034664	http://dx.doi.org/10.1371/journal.pone.0034664			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22529923	Green Published, gold, Green Submitted			2022-12-27	WOS:000305347400015
J	Nguyen, MTA; Chen, A; Lu, WJ; Fan, WQ; Li, PP; Oh, DY; Patsouris, D				Nguyen, M. T. Audrey; Chen, Ai; Lu, Wendell J.; Fan, WuQiang; Li, Ping-Ping; Oh, Da Young; Patsouris, David			Regulation of Chemokine and Chemokine Receptor Expression by PPAR gamma in Adipocytes and Macrophages	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; ENDOPLASMIC-RETICULUM STRESS; INDUCED INSULIN-RESISTANCE; TOLL-LIKE RECEPTORS; FREE FATTY-ACIDS; FACTOR-KAPPA-B; ADIPOSE-TISSUE; INDUCED INFLAMMATION; METABOLIC DISEASE; 3T3-L1 ADIPOCYTES	Background: PPAR gamma plays a key role in adipocyte biology, and Rosiglitazone (Rosi), a thiazolidinedione (TZD)/PPAR gamma agonist, is a potent insulin-sensitizing agent. Recent evidences demonstrate that adipose tissue inflammation links obesity with insulin resistance and that the insulin-sensitizing effects of TZDs result, in part, from their anti-inflammatory properties. However the underlying mechanisms are unclear. Methodology and Principal Findings: In this study, we establish a link between free fatty acids (FFAs) and PPAR gamma in the context of obesity-associated inflammation. We show that treatment of adipocytes with FFAs, in particular Arachidonic Acid (ARA), downregulates PPAR gamma protein and mRNA levels. Furthermore, we demonstrate that the downregulation of PPAR gamma by ARA requires the activation the of Endoplamsic Reticulum (ER) stress by the TLR4 pathway. Knockdown of adipocyte PPAR gamma resulted in upregulation of MCP1 gene expression and secretion, leading to enhanced macrophage chemotaxis. Rosi inhibited these effects. In a high fat feeding mouse model, we show that Rosi treatment decreases recruitment of proinflammatory macrophages to epididymal fat. This correlates with decreased chemokine and decreased chemokine receptor expression in adipocytes and macrophages, respectively. Conclusions and Significance: In summary, we describe a novel link between FAs, the TLR4/ER stress pathway and PPAR gamma, and adipocyte-driven recruitment of macrophages. We thus both describe an additional potential mechanism for the anti-inflammatory and insulin-sensitizing actions of TZDs and an additional detrimental property associated with the activation of the TLR4 pathway by FA.	[Nguyen, M. T. Audrey; Chen, Ai; Lu, Wendell J.; Fan, WuQiang; Li, Ping-Ping; Oh, Da Young; Patsouris, David] Univ Calif San Diego, Dept Med 0673, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Nguyen, MTA (corresponding author), Genentech Inc, San Francisco, CA 94080 USA.	david.patsouris@inserm.fr	Li, Pingping/F-1109-2019	Li, Pingping/0000-0003-0679-270X	National Institution of Health [DK033651, DK074868, T32 DK 007494, DK063491]; Eunice Kennedy Shriver National Institute of Child Health and Human Development/National Institutes of Health (NICHD/NIH) [U54 HD 012303-25]; l'agence nationale pour la recherche (ANR) [ANR-09-RPDOC-018-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD012303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK074868, R01DK033651, P30DK063491, R37DK033651, T32DK007494] Funding Source: NIH RePORTER	National Institution of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eunice Kennedy Shriver National Institute of Child Health and Human Development/National Institutes of Health (NICHD/NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); l'agence nationale pour la recherche (ANR)(French National Research Agency (ANR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Institution of Health: DK033651, DK074868, T32 DK 007494, and DK063491. This work was also supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development/National Institutes of Health (NICHD/NIH) through cooperative agreement of U54 HD 012303-25 as part of the specialized Cooperative Centers Program in Reproduction and Infertility Research. DP is supported by l'agence nationale pour la recherche (ANR; ANR-09-RPDOC-018-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9; Camp HS, 1999, FEBS LETT, V447, P186, DOI 10.1016/S0014-5793(99)00268-9; Choi JH, 2010, NATURE, V466, P451, DOI 10.1038/nature09291; Chung S, 2006, ENDOCRINOLOGY, V147, P5340, DOI 10.1210/en.2006-0536; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; Fan WQ, 2009, J BIOL CHEM, V284, P12188, DOI 10.1074/jbc.M808915200; Gregoire FM, 2009, MOL ENDOCRINOL, V23, P975, DOI 10.1210/me.2008-0473; Han CY, 2010, DIABETES, V59, P386, DOI 10.2337/db09-0925; He WM, 2003, P NATL ACAD SCI USA, V100, P15712, DOI 10.1073/pnas.2536828100; Hevener AL, 2000, DIABETES, V49, P2154, DOI 10.2337/diabetes.49.12.2154; Hevener AL, 2003, NAT MED, V9, P1491, DOI 10.1038/nm956; Hevener AL, 2007, J CLIN INVEST, V117, P1658, DOI 10.1172/JCI31561; Hirabara SM, 2007, J CELL PHYSIOL, V210, P7, DOI 10.1002/jcp.20811; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Imai T, 2004, P NATL ACAD SCI USA, V101, P4543, DOI 10.1073/pnas.0400356101; Inouye KE, 2007, DIABETES, V56, P2242, DOI 10.2337/db07-0425; Jiao P, 2009, DIABETES, V58, P104, DOI 10.2337/db07-1344; Jiao P, 2011, OBESITY, V19, P483, DOI 10.1038/oby.2010.200; Kersten S, 2000, NATURE, V405, P421, DOI 10.1038/35013000; KLIEWER SA, 1995, CELL, V83, P813, DOI 10.1016/0092-8674(95)90194-9; Lee JY, 2003, J LIPID RES, V44, P479, DOI 10.1194/jlr.M200361-JLR200; Liao W, 2007, AM J PHYSIOL-ENDOC M, V293, pE219, DOI 10.1152/ajpendo.00695.2006; Liu N, 2010, LIFE SCI, V87, P367, DOI 10.1016/j.lfs.2010.07.012; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lumeng CN, 2008, DIABETES, V57, P3239, DOI 10.2337/db08-0872; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Martinon F, 2010, NAT IMMUNOL, V11, P411, DOI 10.1038/ni.1857; McClelland S, 2010, ATHEROSCLEROSIS, V211, P96, DOI 10.1016/j.atherosclerosis.2010.02.003; Nguyen MTA, 2007, J BIOL CHEM, V282, P35279, DOI 10.1074/jbc.M706762200; Nguyen MTA, 2005, J BIOL CHEM, V280, P35361, DOI 10.1074/jbc.M504611200; Odegaard JI, 2011, ANNU REV PATHOL-MECH, V6, P275, DOI 10.1146/annurev-pathol-011110-130138; Ogawa S, 2005, CELL, V122, P707, DOI 10.1016/j.cell.2005.06.029; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Park SH, 2010, J BIOL CHEM, V285, P35330, DOI 10.1074/jbc.M110.136259; Pascual Gabriel, 2007, Novartis Found Symp, V286, P183; Patsouris D, 2008, CELL METAB, V8, P301, DOI 10.1016/j.cmet.2008.08.015; Patsouris David, 2004, Curr Opin Investig Drugs, V5, P1045; Patsouris D, 2009, J BIOL CHEM, V284, P31223, DOI 10.1074/jbc.M109.041665; RON D, 1992, GENE DEV, V6, P439, DOI 10.1101/gad.6.3.439; Ruan H, 2003, J BIOL CHEM, V278, P28181, DOI 10.1074/jbc.M303141200; Schenk S, 2008, J CLIN INVEST, V118, P2992, DOI 10.1172/JCI34260; Sears DD, 2007, BIOCHEM BIOPH RES CO, V364, P515, DOI 10.1016/j.bbrc.2007.10.057; Sears DD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007250; Semple RK, 2006, J CLIN INVEST, V116, P581, DOI 10.1172/JCI28003; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Solinas G, 2007, CELL METAB, V6, P386, DOI 10.1016/j.cmet.2007.09.011; Straus DS, 2000, P NATL ACAD SCI USA, V97, P4844, DOI 10.1073/pnas.97.9.4844; Suganami T, 2005, ARTERIOSCL THROM VAS, V25, P2062, DOI 10.1161/01.ATV.0000183883.72263.13; Suganami T, 2007, ARTERIOSCL THROM VAS, V27, P84, DOI 10.1161/01.ATV.0000251608.09329.9a; Sun K, 2011, J CLIN INVEST, V121, P2094, DOI 10.1172/JCI45887; TONTONOZ P, 1995, MOL CELL BIOL, V15, P351, DOI 10.1128/MCB.15.1.351; WU ZD, 1995, GENE DEV, V9, P2350, DOI 10.1101/gad.9.19.2350; ZHU YJ, 1995, P NATL ACAD SCI USA, V92, P7921, DOI 10.1073/pnas.92.17.7921	53	37	39	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e34976	10.1371/journal.pone.0034976	http://dx.doi.org/10.1371/journal.pone.0034976			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22529965	gold, Green Published			2022-12-27	WOS:000305347400027
J	Zhao, YX; Guo, SC; Sun, JF; Huang, ZH; Zhu, TY; Zhang, HY; Gu, J; He, YH; Wang, W; Ma, KL; Wang, JN; Yu, J				Zhao, Yangxing; Guo, Shicheng; Sun, Jinfeng; Huang, Zhaohui; Zhu, Tongyu; Zhang, Hongyu; Gu, Jun; He, Yinghua; Wang, Wei; Ma, Kelong; Wang, Jina; Yu, Jian			Methylcap-Seq Reveals Novel DNA Methylation Markers for the Diagnosis and Recurrence Prediction of Bladder Cancer in a Chinese Population	PLOS ONE			English	Article							URINE SEDIMENTS; GENES; HYPERMETHYLATION; EPIGENETICS; BIOMARKERS; PATTERNS	Purpose: There is a need to supplement or supplant the conventional diagnostic tools, namely, cystoscopy and B-type ultrasound, for bladder cancer (BC). We aimed to identify novel DNA methylation markers for BC through genome-wide profiling of BC cell lines and subsequent methylation-specific PCR (MSP) screening of clinical urine samples. Experimental Design: The methyl-DNA binding domain (MBD) capture technique, methylCap/seq, was performed to screen for specific hypermethylated CpG islands in two BC cell lines (5637 and T24). The top one hundred hypermethylated targets were sequentially screened by MSP in urine samples to gradually narrow the target number and optimize the composition of the diagnostic panel. The diagnostic performance of the obtained panel was evaluated in different clinical scenarios. Results: A total of 1,627 hypermethylated promoter targets in the BC cell lines was identified by Illumina sequencing. The top 104 hypermethylated targets were reduced to eight genes (VAX1, KCNV1, ECEL1, TMEM26, TAL1, PROX1, SLC6A20, and LMX1A) after the urine DNA screening in a small sample size of 8 normal control and 18 BC subjects. Validation in an independent sample of 212 BC patients enabled the optimization of five methylation targets, including VAX1, KCNV1, TAL1, PPOX1, and CFTR, which was obtained in our previous study, for BC diagnosis with a sensitivity and specificity of 88.68% and 87.25%, respectively. In addition, the methylation of VAX1 and LMX1A was found to be associated with BC recurrence. Conclusions: We identified a promising diagnostic marker panel for early non-invasive detection and subsequent BC surveillance.	[Zhao, Yangxing; Sun, Jinfeng; Zhang, Hongyu; Gu, Jun; He, Yinghua; Wang, Wei; Ma, Kelong; Yu, Jian] Shanghai Jiao Tong Univ, State Key Lab Oncogenes & Related Genes, Shanghai Canc Inst, Renji Hosp,Sch Med, Shanghai 200030, Peoples R China; [Guo, Shicheng] Fudan Univ, Minist Educ, Key Lab Contemporary Anthropol, Shanghai 200433, Peoples R China; [Guo, Shicheng] Fudan Univ, State Key Lab Genet Engn, Sch Life Sci, Shanghai 200433, Peoples R China; [Guo, Shicheng] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Huang, Zhaohui] Suzhou Univ, Oncol Inst Wuxi, Affiliated Hosp 4, Wuxi, Peoples R China; [Zhu, Tongyu; Wang, Jina] Fudan Univ, Dept Urol, Shanghai Key Lab Organ Transplantat, Zhongshan Hosp, Shanghai 200433, Peoples R China	Shanghai Jiao Tong University; Fudan University; Fudan University; Fudan University; Fudan University	Zhao, YX (corresponding author), Shanghai Jiao Tong Univ, State Key Lab Oncogenes & Related Genes, Shanghai Canc Inst, Renji Hosp,Sch Med, Shanghai 200030, Peoples R China.	gyujian@163.com	SUN, JIN/GPX-9641-2022; Huang, Zhaohui/S-9410-2019; Guo, Shicheng/A-1204-2016	Huang, Zhaohui/0000-0002-0117-9976; Guo, Shicheng/0000-0002-7047-9972	National Science foundation [30872963]; State Key Laboratory of Oncogenes and Related Genes foundation [91-11-01]; Science and Technology Commission of Shanghai [114119a4100]; Shanghai Science foundation [09ZR1429900]; Shanghai Cancer institute, master & doctoral foundation [SB09-07]	National Science foundation(National Science Foundation (NSF)); State Key Laboratory of Oncogenes and Related Genes foundation; Science and Technology Commission of Shanghai(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Science foundation; Shanghai Cancer institute, master & doctoral foundation	This work was supported by the National Science foundation grants (30872963); the State Key Laboratory of Oncogenes and Related Genes foundation (91-11-01); Medical guide project from Science and Technology Commission of Shanghai (114119a4100); Shanghai Science foundation grants (09ZR1429900); and Shanghai Cancer institute, master & doctoral foundation (SB09-07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleman A, 2008, BRIT J CANCER, V98, P466, DOI 10.1038/sj.bjc.6604143; Battagli C, 2003, CANCER RES, V63, P8695; Baylin SB, 2006, NAT REV CANCER, V6, P107, DOI 10.1038/nrc1799; Baylin Stephen B, 2005, Nat Clin Pract Oncol, V2 Suppl 1, pS4, DOI 10.1038/ncponc0354; Benoit A, 2004, BIOCHEM J, V380, P881, DOI 10.1042/BJ20040215; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bharti K, 2011, DEVELOPMENT, V138, P873, DOI 10.1242/dev.056465; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; Botteman MF, 2003, PHARMACOECONOMICS, V21, P1315, DOI 10.1007/BF03262330; Brinkman AB, 2010, METHODS, V52, P232, DOI 10.1016/j.ymeth.2010.06.012; Cardoso BA, 2011, LEUKEMIA, V25, P1578, DOI 10.1038/leu.2011.140; Chan MWY, 2002, CLIN CANCER RES, V8, P464; Chen RZ, 1998, NATURE, V395, P89, DOI 10.1038/25779; Chung W, 2011, CANCER EPIDEM BIOMAR, V20, P1483, DOI 10.1158/1055-9965.EPI-11-0067; Costa VL, 2010, CLIN CANCER RES, V16, P5842, DOI 10.1158/1078-0432.CCR-10-1312; Dong WJ, 2011, CANCER SCI, V102, P361, DOI 10.1111/j.1349-7006.2010.01804.x; Dumache R, 2011, MED-SURG J, V115, P163; Ebihara M, 2004, GENE, V325, P89, DOI 10.1016/j.gene.2003.09.044; Eden A, 2003, SCIENCE, V300, P455, DOI 10.1126/science.1083557; Enokida H, 2008, INT J CLIN ONCOL, V13, P298, DOI 10.1007/s10147-008-0811-1; Feinberg AP, 2007, NATURE, V447, P433, DOI 10.1038/nature05919; Friedrich MG, 2004, CLIN CANCER RES, V10, P7457, DOI 10.1158/1078-0432.CCR-04-0930; Herr Harry W., 1997, P273; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kaufman DS, 2009, LANCET, V374, P239, DOI 10.1016/S0140-6736(09)60491-8; Kitamura Hiroshi, 2006, Int J Clin Oncol, V11, P28, DOI 10.1007/s10147-006-0552-y; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li N, 2010, METHODS, V52, P203, DOI 10.1016/j.ymeth.2010.04.009; [刘恩莉 Liu Enchi], 2004, [肿瘤, Tumor], V24, P11; Ma YH, 2005, J CELL SCI, V118, P1607, DOI 10.1242/jcs.02291; Mitra AP, 2009, ANNU REV PATHOL-MECH, V4, P251, DOI 10.1146/annurev.pathol.4.110807.092230; Negraes PD, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-238; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Reinert T, 2011, CLIN CANC RES; Rodriguez-Paredes M, 2011, NAT MED, V17, P330, DOI 10.1038/nm.2305; Tada Y, 2000, CLIN CANCER RES, V6, P4618; Town L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025228; Tsou JA, 2007, LUNG CANCER, V58, P220, DOI 10.1016/j.lungcan.2007.06.015; Urakami S, 2006, CLIN CANCER RES, V12, P2109, DOI 10.1158/1078-0432.CCR-05-2468; Versmold B, 2007, INT J CANCER, V121, P547, DOI 10.1002/ijc.22705; Wilhelm-Benartzi CS, 2010, CARCINOGENESIS, V31, P1972, DOI 10.1093/carcin/bgq178; Wolff EM, 2010, CANCER RES, V70, P8169, DOI 10.1158/0008-5472.CAN-10-1335; Yagi K, 2010, CLIN CANCER RES, V16, P21, DOI 10.1158/1078-0432.CCR-09-2006; Yu J, 2003, CELL RES, V13, P319, DOI 10.1038/sj.cr.7290177; Yu J, 2007, CLIN CANCER RES, V13, P7296, DOI 10.1158/1078-0432.CCR-07-0861; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	46	47	47	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e35175	10.1371/journal.pone.0035175	http://dx.doi.org/10.1371/journal.pone.0035175			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22529986	gold, Green Published, Green Submitted			2022-12-27	WOS:000305347400034
J	Han, MA; Choi, KS; Lee, HY; Jun, JK; Jung, KW; Kang, S; Park, EC				Han, Mi Ah; Choi, Kui Son; Lee, Hoo-Yeon; Jun, Jae Kwan; Jung, Kyu Won; Kang, Sokbom; Park, Eun-Cheol			Performance of Papanicolaou Testing and Detection of Cervical Carcinoma In Situ in Participants of Organized Cervical Cancer Screening in South Korea	PLOS ONE			English	Article							SOCIOECONOMIC-STATUS; UNITED-STATES; MORTALITY; TRENDS; SURVIVAL; WOMEN; RISK; DISPARITIES; BREAST; EFFICIENCY	Background: The present study measured the performance of the Papanicolaou (Pap) test and detection of cervical carcinoma in situ (CIS) and cancer in participants of organized cervical cancer screening in South Korea, and examined differences in the proportion of CIS according to socio-demographic factors. Methods: Data were obtained from the National Cancer Screening Program and National Health Insurance Cancer Screening Program databases. We analyzed data from 4,072,997 screenings of women aged 30 years or older who underwent cervical cancer screening by Pap test between January 1, 2005 and December 31, 2006. We calculated the performances of the Pap test and compared that according to socio-demographic factors. Results: The positivity rate for all screenings was 6.6%. The cancer detection rate (CDR) and interval cancer rate (ICR) were 0.32 per 1,000 screenings, and 0.13 per 1,000 negative screenings, respectively. About 63.4% of screen-detected CIS+ cases (CIS or invasive cervical cancer) were CIS. The CDR and ICR, and percentage of CIS among all CIS+ were significantly different by age group and health insurance status. The odds ratios of CDR and ICR were higher for Medical Aid Program (MAP) recipients compared with National Health Insurance (NHI) beneficiaries. The likelihood of a detected CIS+ case to be CIS was significantly lower among MAP recipients than among NHI beneficiaries. Conclusions: The difference in performance of cervical cancer screening among different socio-demographic groups may indicate an important influence of socio-demographic factors on preventive behavior. The findings of the study support the critical need for increasing efforts to raise awareness and provide more screening in at-risk populations, specifically low-income groups.	[Han, Mi Ah] Chosun Univ, Dept Prevent Med, Coll Med, Kwangju, South Korea; [Choi, Kui Son; Jun, Jae Kwan; Jung, Kyu Won] Natl Canc Ctr, Natl Canc Control Res Inst, Goyang, South Korea; [Lee, Hoo-Yeon] Dankook Univ, Dept Social Med, Coll Med, Cheonan, South Korea; [Kang, Sokbom] Natl Canc Ctr, Res Inst & Hosp, Branch Uterine Canc, Goyang, South Korea; [Park, Eun-Cheol] Yonsei Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Park, Eun-Cheol] Yonsei Univ, Coll Med, Inst Hlth Serv Res, Seoul, South Korea	Chosun University; National Cancer Center - Korea (NCC); Dankook University; National Cancer Center - Korea (NCC); Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Han, MA (corresponding author), Chosun Univ, Dept Prevent Med, Coll Med, Kwangju, South Korea.	kschoi@ncc.re.kr	Park, Eun-Cheol/O-5644-2019	Park, Eun-Cheol/0000-0002-2306-5398; Kang, Sokbom/0000-0002-8428-9555	National Cancer Center of Korea [1010200]; National R&D Program for Cancer Control, Ministry of Health and Welfare, Republic of Korea [0820420]	National Cancer Center of Korea; National R&D Program for Cancer Control, Ministry of Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported by a Grant-in-Aid for Cancer Research and Control from the National Cancer Center of Korea (grant number: 1010200) and a grant from the National R&D Program for Cancer Control, Ministry of Health and Welfare, Republic of Korea (0820420). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aklimunnessa K, 2006, JPN J CLIN ONCOL, V36, P511, DOI 10.1093/jjco/hyl060; [Anonymous], MAN INT STAT CLASS D; Bergstrom R, 1999, BRIT J CANCER, V81, P159, DOI 10.1038/sj.bjc.6690666; Day N, 1995, J Med Screen, V2, P180; DAY NE, 1989, BRIT J CANCER, V59, P954, DOI 10.1038/bjc.1989.203; DEVESA SS, 1987, J NATL CANCER I, V79, P701; Ferlay J, 2010, IARC CANCERBASE, V10; Fritz A, 2000, INT CLASSIFICATION D; Goldie SJ, 2005, NEW ENGL J MED, V353, P2158, DOI 10.1056/NEJMsa044278; GUSTAFSSON L, 1995, BRIT J CANCER, V72, P498, DOI 10.1038/bjc.1995.362; Gustafsson L, 1995, INT J CANCER, V63, P804, DOI 10.1002/ijc.2910630610; Halapy E, 2005, BREAST CANCER RES TR, V90, P299, DOI 10.1007/s10549-004-5168-1; HENSCHKE UK, 1973, CANCER-AM CANCER SOC, V31, P763, DOI 10.1002/1097-0142(197304)31:4<763::AID-CNCR2820310401>3.0.CO;2-S; Hiatt RA, 2001, PREV MED, V33, P190, DOI 10.1006/pmed.2001.0871; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2004, IARC WORK GROUP EV C; Insinga RP, 2004, AM J OBSTET GYNECOL, V191, P105, DOI 10.1016/j.ajog.2004.01.043; JANERICH DT, 1995, AM J PUBLIC HEALTH, V85, P791, DOI 10.2105/AJPH.85.6.791; Jun JK, 2009, INT J CANCER, V124, P188, DOI 10.1002/ijc.23841; Jung KW, 2010, J KOREAN MED SCI, V25, P1113, DOI 10.3346/jkms.2010.25.8.1113; KERNER JF, 1993, ANNU REV PUBL HEALTH, V14, P355; Khan MJ, 2005, CANCER-AM CANCER SOC, V104, P61, DOI 10.1002/cncr.21129; Kim CW, 2008, PUBLIC HEALTH, V122, P229, DOI 10.1016/j.puhe.2007.07.003; Kim Y, 2011, ASIAN PAC J CANCER P, V12, P725; KOSARY CL, 1994, SEMIN SURG ONCOL, V10, P31, DOI 10.1002/ssu.2980100107; Kwak MS, 2009, PREV MED, V49, P48, DOI 10.1016/j.ypmed.2009.05.007; Laaksonen M, 2005, EUR J PUBLIC HEALTH, V15, P262, DOI 10.1093/eurpub/cki115; Lee HY, 2010, CANCER EPIDEM BIOMAR, V19, P1919, DOI 10.1158/1055-9965.EPI-09-1308; Levi F, 1996, BRIT J CANCER, V74, P1321, DOI 10.1038/bjc.1996.538; Mackillop WJ, 1997, J CLIN ONCOL, V15, P1680, DOI 10.1200/JCO.1997.15.4.1680; Marcus AC, 1998, PREV MED, V27, P13, DOI 10.1006/pmed.1997.0251; Miller MG, 2003, OBSTET GYNECOL, V101, P29, DOI 10.1016/S0029-7844(02)02454-7; Ministry of Health & Welfare = National Cancer Center, 2008, QUAL GUID CERV CANC; MITCHELL H, 1990, BRIT MED J, V300, P1622, DOI 10.1136/bmj.300.6740.1622; National Cancer Center, 2010, ANN REP NAT CANC SCR; Parikh S, 2003, INT J CANCER, V105, P687, DOI 10.1002/ijc.11141; Park Mi Jin, 2010, J Prev Med Public Health, V43, P330, DOI 10.3961/jpmph.2010.43.4.330; POLETTO L, 1990, CANCER LETT, V49, P201, DOI 10.1016/0304-3835(90)90159-U; Sambamoorthi U, 2003, PREV MED, V37, P475, DOI 10.1016/S0091-7435(03)00172-5; Sasieni P, 2009, BRIT MED J, V339, pb2968, DOI DOI 10.1136/BMJ.B2968; Schindeler S, 2008, J MED SCREEN, V15, P36, DOI 10.1258/jms.2008.007036; Segnan N, 1997, SOCIOECONOMIC STATUS; Shanta V, 2000, J Indian Med Assoc, V98, P49; SHELTON D, 1992, Ethnicity and Disease, V2, P47; Shin HR, 2008, INT J CANCER, V122, P393, DOI 10.1002/ijc.23015; SOBUE T, 1988, JPN J CANCER RES, V79, P1269, DOI 10.1111/j.1349-7006.1988.tb01555.x; Sung HY, 2000, CANCER, V88, P2283, DOI 10.1002/(SICI)1097-0142(20000515)88:10<2283::AID-CNCR12>3.3.CO;2-4; Tabora N, 2009, CANCER CAUSE CONTROL, V20, P1663, DOI 10.1007/s10552-009-9414-z; THOMS WW, 1995, CANCER, V76, P2518, DOI 10.1002/1097-0142(19951215)76:12<2518::AID-CNCR2820761217>3.0.CO;2-#; Vinh-Hung V, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-164; Ward E, 2004, CA-CANCER J CLIN, V54, P78, DOI 10.3322/canjclin.54.2.78; Won YJ, 2009, CANCER RES TREAT, V41, P122, DOI 10.4143/crt.2009.41.3.122; Yoo KY, 2008, JPN J CLIN ONCOL, V38, P327, DOI 10.1093/jjco/hyn026	52	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e35469	10.1371/journal.pone.0035469	http://dx.doi.org/10.1371/journal.pone.0035469			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959VO	22530028	Green Published, gold, Green Submitted			2022-12-27	WOS:000305345000072
J	Geisinger, MT; Astaiza, R; Butler, T; Popoff, SN; Planey, SL; Arnott, JA				Geisinger, Max T.; Astaiza, Randy; Butler, Tiffany; Popoff, Steven N.; Planey, Sonia Lobo; Arnott, John A.			Ets-1 Is Essential for Connective Tissue Growth Factor (CTGF/CCN2) Induction by TGF-beta 1 in Osteoblasts	PLOS ONE			English	Article							CHONDROCYTE-SPECIFIC GENE; FETAL-RAT CALVARIAE; FACTOR-BETA; TGF-BETA; TRANSCRIPTION FACTORS; CTGF EXPRESSION; TRANSFORMING GROWTH-FACTOR-BETA-1; SKELETAL DEVELOPMENT; BONE-FORMATION; BINDING-SITES	Background: Ets-1 controls osteoblast differentiation and bone development; however, its downstream mechanism of action in osteoblasts remains largely undetermined. CCN2 acts as an anabolic growth factor to regulate osteoblast differentiation and function. CCN2 is induced by TGF-beta 1 and acts as a mediator of TGF-beta 1 induced matrix production in osteoblasts; however, the molecular mechanisms that control CCN2 induction are poorly understood. In this study, we investigated the role of Ets-1 for CCN2 induction by TGF-beta 1 in primary osteoblasts. Results: We demonstrated that Ets-1 is expressed and induced by TGF-beta 1 treatment in osteoblasts, and that Ets-1 overexpression induces CCN2 protein expression and promoter activity at a level similar to TGF-beta 1 treatment alone. Additionally, we found that simultaneous Ets-1 over-expression and TGF-beta 1 treatment synergize to enhance CCN2 induction, and that CCN2 induction by TGF-beta 1 treatment was impaired using Ets-1 siRNA, demonstrating the requirement of Ets-1 for CCN2 induction by TGF-beta 1. Site-directed mutagenesis of eight putative Ets-1 motifs (EBE) in the CCN2 promoter demonstrated that specific EBE sites are required for CCN2 induction, and that mutation of EBE sites in closer proximity to TRE or SBE (two sites previously shown to regulate CCN2 induction by TGF-beta 1) had a greater effect on CCN2 induction, suggesting potential synergetic interaction among these sites for CCN2 induction. In addition, mutation of EBE sites prevented protein complex binding, and this protein complex formation was also inhibited by addition of Ets-1 antibody or Smad 3 antibody, demonstrating that protein binding to EBE motifs as a result of TGF-beta 1 treatment require synergy between Ets-1 and Smad 3. Conclusions: This study demonstrates that Ets-1 is an essential downstream signaling component for CCN2 induction by TGF-beta 1 in osteoblasts, and that specific EBE sites in the CCN2 promoter are required for CCN2 promoter transactivation in osteoblasts.	[Geisinger, Max T.; Astaiza, Randy; Butler, Tiffany; Planey, Sonia Lobo; Arnott, John A.] Commonwealth Med Coll, Dept Basic Sci, Scranton, PA USA; [Popoff, Steven N.] Temple Univ, Sch Med, Dept Anat & Cell Biol, Philadelphia, PA 19122 USA	Geisinger Commonwealth School of Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Geisinger, MT (corresponding author), Commonwealth Med Coll, Dept Basic Sci, Scranton, PA USA.	jarnott@tcmedc.org	Lobo, Sonia/H-6889-2018	Lobo, Sonia/0000-0002-7406-6956	National Institute of Arthritis and Musculoskeletal and Skin Disease of the National Institutes of Health [1R03AR057193-01]; Commonwealth Medical College; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR057193] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Disease of the National Institutes of Health; Commonwealth Medical College; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was supported by the National Institute of Arthritis and Musculoskeletal and Skin Disease of the National Institutes of Health, grant number 1R03AR057193-01 (to JA) and by The Commonwealth Medical College (to JA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollah S, 1997, J BIOL CHEM, V272, P27678, DOI 10.1074/jbc.272.44.27678; Arnott JA, 2008, BONE, V42, P871, DOI 10.1016/j.bone.2008.01.006; Arnott JA, 2007, J CELL PHYSIOL, V210, P843, DOI 10.1002/jcp.20917; Ascione L, 1992, G Ital Cardiol, V22, P829; Blom IE, 2002, MATRIX BIOL, V21, P473, DOI 10.1016/S0945-053X(02)00055-0; Bonewald L.F., 2002, PRINCIPLES BONE BIOL, Vsecond, P903; BONEWALD LF, 1994, J CELL BIOCHEM, V55, P350, DOI 10.1002/jcb.240550312; Brigstock DR, 2003, J ENDOCRINOL, V178, P169, DOI 10.1677/joe.0.1780169; CENTRELLA M, 1987, J BONE MINER RES, V2, P29; Chang F, 2003, LEUKEMIA, V17, P1263, DOI 10.1038/sj.leu.2402945; Chen YJ, 2002, KIDNEY INT, V62, P1149, DOI 10.1111/j.1523-1755.2002.kid567.x; Czuwara-Ladykowska J, 2002, J BIOL CHEM, V277, P20399, DOI 10.1074/jbc.M200206200; DALTON S, 1992, CELL, V68, P597, DOI 10.1016/0092-8674(92)90194-H; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Foulds CE, 2004, MOL CELL BIOL, V24, P10954, DOI 10.1128/MCB.24.24.10954-10964.2004; Graves BJ, 1998, ADV CANCER RES, V75, P1, DOI 10.1016/S0065-230X(08)60738-1; HOCK JM, 1990, ENDOCRINOLOGY, V126, P421, DOI 10.1210/endo-126-1-421; Hodge DR, 1996, ONCOGENE, V12, P11; Huang Hai-Chang, 2005, Zhonghua Yi Xue Za Zhi, V85, P328; Ivkovic S, 2003, DEVELOPMENT, V130, P2779, DOI 10.1242/dev.00505; Kadota H, 2004, J BONE MINER METAB, V22, P293, DOI 10.1007/s00774-004-0486-2; Katabami K, 2005, CLIN EXP METASTAS, V22, P539, DOI 10.1007/s10585-005-5260-x; Kretzschmar M, 1999, GENE DEV, V13, P804, DOI 10.1101/gad.13.7.804; Leask A, 2003, J BIOL CHEM, V278, P13008, DOI 10.1074/jbc.M210366200; Leask A, 2003, BIOCHEM CELL BIOL, V81, P355, DOI 10.1139/O03-069; Leivonen SK, 2005, J INVEST DERMATOL, V124, P1162, DOI 10.1111/j.0022-202X.2005.23750.x; Massague J, 2000, GENE DEV, V14, P627; McCarthy SA, 1997, MOL CELL BIOL, V17, P2401, DOI 10.1128/MCB.17.5.2401; Mori Y, 2004, ARTHRITIS RHEUM-US, V50, P4008, DOI 10.1002/art.20658; Nakanishi T, 2000, ENDOCRINOLOGY, V141, P264, DOI 10.1210/endo.141.1.7267; Nakanishi T, 1997, BIOCHEM BIOPH RES CO, V234, P206, DOI 10.1006/bbrc.1997.6528; Nakata E, 2002, BONE, V31, P441, DOI 10.1016/S8756-3282(02)00846-3; Nakerakanti SS, 2006, J BIOL CHEM, V281, P25259, DOI 10.1074/jbc.M600466200; Nishida T, 2002, J CELL PHYSIOL, V192, P55, DOI 10.1002/jcp.10113; Nishida T, 2000, J CELL PHYSIOL, V184, P197, DOI 10.1002/1097-4652(200008)184:2<197::AID-JCP7>3.0.CO;2-R; PARISI MS, 2005, BONE; Pei HP, 2003, ONCOGENE, V22, P2699, DOI 10.1038/sj.onc.1206374; Qi MC, 2008, INT J ORAL MAX SURG, V37, P453, DOI 10.1016/j.ijom.2007.12.008; Raouf A, 2000, ONCOGENE, V19, P6455, DOI 10.1038/sj.onc.1204037; Razmpour R, 2011, TEMPLE U J ORTHOPAED, V6, P47; Safadi FF, 2003, J CELL PHYSIOL, V196, P51, DOI 10.1002/jcp.10319; Sato M, 1998, ONCOGENE, V17, P1517, DOI 10.1038/sj.onc.1202064; SETH A, 1993, ONCOGENE, V8, P1783; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Takigawa M, 2003, J CELL PHYSIOL, V194, P256, DOI 10.1002/jcp.10206; Tanaka H, 2004, J AM SOC NEPHROL, V15, P3083, DOI 10.1097/01.ASN.0000145459.54236.D3; Utsugi M, 2003, AM J RESP CELL MOL, V28, P754, DOI 10.1165/rcmb.4892; Van Beek JP, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1890; Venanzoni MC, 1996, ONCOGENE, V12, P1199; Watson DK, 1997, ONCOGENE, V14, P213, DOI 10.1038/sj.onc.1200839; WRANA JL, 1988, J CELL BIOL, V106, P915, DOI 10.1083/jcb.106.3.915; Xie SP, 2005, AM J PHYSIOL-LUNG C, V288, pL68, DOI 10.1152/ajplung.00156.2004; Xu J, 2000, J CELL BIOCHEM, V77, P103, DOI 10.1002/(SICI)1097-4644(20000401)77:1<103::AID-JCB11>3.0.CO;2-G; Yamashiro T, 2001, J DENT RES, V80, P461, DOI 10.1177/00220345010800021201; Zhang X, 2010, J CELL PHYSIOL, V224, P691, DOI 10.1002/jcp.22173	56	19	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35258	10.1371/journal.pone.0035258	http://dx.doi.org/10.1371/journal.pone.0035258			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22539964	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341000028
J	Fite, BZ; Liu, Y; Kruse, DE; Caskey, CF; Walton, JH; Lai, CY; Mahakian, LM; Larrat, B; Dumont, E; Ferrara, KW				Fite, Brett Z.; Liu, Yu; Kruse, Dustin E.; Caskey, Charles F.; Walton, Jeffrey H.; Lai, Chun-Yen; Mahakian, Lisa M.; Larrat, Benoit; Dumont, Erik; Ferrara, Katherine W.			Magnetic Resonance Thermometry at 7T for Real-Time Monitoring and Correction of Ultrasound Induced Mild Hyperthermia	PLOS ONE			English	Article							RECOMMENDED REFERENCE MATERIALS; TEMPORAL TEMPERATURE CONTROL; IN-VIVO; THERMAL-CONDUCTIVITY; MR THERMOMETRY; NMR; REALIZATION; OXYGENATION; GUIDANCE; WATER	While Magnetic Resonance Thermometry (MRT) has been extensively utilized for non-invasive temperature measurement, there is limited data on the use of high field (>= 7T) scanners for this purpose. MR-guided Focused Ultrasound (MRgFUS) is a promising non-invasive method for localized hyperthermia and drug delivery. MRT based on the temperature sensitivity of the proton resonance frequency (PRF) has been implemented in both a tissue phantom and in vivo in a mouse Met-1 tumor model, using partial parallel imaging (PPI) to speed acquisition. An MRgFUS system capable of delivering a controlled 3D acoustic dose during real time MRT with proportional, integral, and derivative (PID) feedback control was developed and validated. Real-time MRT was validated in a tofu phantom with fluoroptic temperature measurements, and acoustic heating simulations were in good agreement with MR temperature maps. In an in vivo Met-1 mouse tumor, the real-time PID feedback control is capable of maintaining the desired temperature with high accuracy. We found that real time MR control of hyperthermia is feasible at high field, and k-space based PPI techniques may be implemented for increasing temporal resolution while maintaining temperature accuracy on the order of 1 degrees C.	[Fite, Brett Z.; Liu, Yu; Kruse, Dustin E.; Caskey, Charles F.; Lai, Chun-Yen; Mahakian, Lisa M.; Ferrara, Katherine W.] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA; [Fite, Brett Z.] Univ Calif Davis, Biophys Grad Grp, Davis, CA 95616 USA; [Walton, Jeffrey H.] Univ Calif Davis, NMR Facil, Davis, CA 95616 USA; [Walton, Jeffrey H.] Univ Calif Davis, Biomed Engn Grad Grp, Davis, CA 95616 USA; [Larrat, Benoit] ESPCI Paristech, Inst Langevin, CNRS UMR7589, INSERM, Paris, France; [Dumont, Erik] Image Guided Therapy, Pessac, France	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI); Universite Paris Cite	Ferrara, KW (corresponding author), Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA.	kwferrara@ucdavis.edu	, Jeff/AAI-3575-2020; Larrat, Benoit/AAC-4920-2019; Larrat, Benoit/C-3123-2014	, Jeff/0000-0002-2359-955X; Larrat, Benoit/0000-0003-1577-6293; Larrat, Benoit/0000-0003-1577-6293; Ferrara, Katherine/0000-0002-4976-9107	National Institutes of Health [R01CA103828, HL086350-01A1]; National Institute of Biomedical Imaging and Bioengineering (NIBIB) [5T32EB009434]; NATIONAL CANCER INSTITUTE [P30CA093373, R01CA134659, R01CA103828] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL086350] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB003827] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Biomedical Imaging and Bioengineering (NIBIB)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the National Institutes of Health grants R01CA103828, HL086350-01A1 [http://www.nih.gov], and the National Institute of Biomedical Imaging and Bioengineering (NIBIB) Training Program Engineering Approach to Molecular Imaging grant 5T32EB009434 [http://www.nibib.nih.gov]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Bankson JA, 2005, MAGNET RESON MED, V53, P658, DOI 10.1002/mrm.20378; BILANIUK N, 1993, J ACOUST SOC AM, V93, P1609, DOI 10.1121/1.406819; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Chen J, 2006, J MAGN RESON IMAGING, V23, P430, DOI 10.1002/jmri.20516; Cheng HLM, 2002, J MAGN RESON IMAGING, V16, P598, DOI 10.1002/jmri.10199; Chung AH, 1996, MAGNET RESON MED, V36, P745, DOI 10.1002/mrm.1910360513; Dietrich O, 2007, J MAGN RESON IMAGING, V26, P375, DOI 10.1002/jmri.20969; Enholm JK, 2010, IEEE T BIO-MED ENG, V57, P103, DOI 10.1109/TBME.2009.2034636; Ergun AS, 2011, ULTRASONICS, V51, P786, DOI 10.1016/j.ultras.2011.03.006; Galiana G, 2008, SCIENCE, V322, P421, DOI 10.1126/science.1163242; Graham SJ, 1999, MAGNET RESON MED, V42, P1061, DOI 10.1002/(SICI)1522-2594(199912)42:6<1061::AID-MRM10>3.0.CO;2-T; Guo JY, 2006, MAGN RESON IMAGING, V24, P903, DOI 10.1016/j.mri.2006.03.001; HENLE KJ, 1978, CANCER RES, V38, P1843; HERINGTON EFG, 1976, PURE APPL CHEM, V48, P243; ISHIHARA Y, 1995, MAGNET RESON MED, V34, P814, DOI 10.1002/mrm.1910340606; Jones EL, 2004, CLIN CANCER RES, V10, P4287, DOI 10.1158/1078-0432.CCR-04-0133; Kickhefel A, 2010, PHYS MEDICA, V26, P192, DOI 10.1016/j.ejmp.2009.11.006; Kim YT, 2009, ULTRASOUND MED BIOL, V35, P472, DOI 10.1016/j.ultrasmedbio.2008.09.005; Kohler MO, 2009, MED PHYS, V36, P3521, DOI 10.1118/1.3152112; Kong G, 2001, CANCER RES, V61, P3027; Larrat B, 2010, PHYS MED BIOL, V55, P365, DOI 10.1088/0031-9155/55/2/003; LEBIHAN D, 1989, RADIOLOGY, V171, P853, DOI 10.1148/radiology.171.3.2717764; Lohr F, 2000, INT J RADIAT ONCOL, V48, P1513, DOI 10.1016/S0360-3016(00)00788-4; MARKHAM JJ, 1951, REV MOD PHYS, V23, P353, DOI 10.1103/RevModPhys.23.353; Maruvada S, 2007, J ACOUST SOC AM, V121, P1434, DOI 10.1121/1.2431332; Mougenot C, 2004, MAGNET RESON MED, V52, P1005, DOI 10.1002/mrm.20280; Mougenot C, 2009, MAGN RESON MED, V61, P603, DOI 10.1002/mrm.21887; MULLER M, 1985, ACUSTICA, V58, P215; Needham D, 2000, CANCER RES, V60, P1197; ONEIL HT, 1949, J ACOUST SOC AM, V21, P516, DOI 10.1121/1.1906542; PARKER DL, 1984, IEEE T BIO-MED ENG, V31, P161, DOI 10.1109/TBME.1984.325382; PARKER DL, 1983, MED PHYS, V10, P321, DOI 10.1118/1.595307; PENNES HH, 1948, J APPL PHYSIOL, V1, P93, DOI 10.1152/jappl.1948.1.2.93; Peters RD, 1998, MAGNET RESON MED, V40, P454, DOI 10.1002/mrm.1910400316; Quesson B, 2000, J MAGN RESON IMAGING, V12, P525, DOI 10.1002/1522-2586(200010)12:4<525::AID-JMRI3>3.0.CO;2-V; Rieke V, 2008, J MAGN RESON IMAGING, V27, P376, DOI 10.1002/jmri.21265; Song CW, 2005, INT J HYPERTHER, V21, P761, DOI 10.1080/02656730500204487; Sun Y, 2000, NMR BIOMED, V13, P460, DOI 10.1002/nbm.676; Todd N, 2011, MAGN RESON MED, V65, P515, DOI 10.1002/mrm.22636; VANVAALS JJ, 1993, JMRI-J MAGN RESON IM, V3, P671, DOI 10.1002/jmri.1880030419; Weidensteiner C, 2004, J MAGN RESON IMAGING, V19, P438, DOI 10.1002/jmri.20019; Wu JR, 2001, ULTRASOUND MED BIOL, V27, P1297, DOI 10.1016/S0301-5629(01)00424-0; YATVIN MB, 1978, SCIENCE, V202, P1290, DOI 10.1126/science.364652; YOUNG IR, 1994, MAGNET RESON MED, V31, P342, DOI 10.1002/mrm.1910310317; Zabransky M, 2010, J PHYS CHEM REF DATA, V39, DOI 10.1063/1.3182831; Zeng XZ, 2008, J ACOUST SOC AM, V123, P68, DOI 10.1121/1.2812579; ZIEBLAND H, 1981, PURE APPL CHEM, V53, P1863, DOI 10.1351/pac198153101863; Zotev V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024522	48	39	40	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35509	10.1371/journal.pone.0035509	http://dx.doi.org/10.1371/journal.pone.0035509			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536396	Green Submitted, Green Published, gold			2022-12-27	WOS:000305339200072
J	Graham, JC; Zarbl, H				Graham, Jessica C.; Zarbl, Helmut			Use of Cell-SELEX to Generate DNA Aptamers as Molecular Probes of HPV-Associated Cervical Cancer Cells	PLOS ONE			English	Article							IN-VITRO SELECTION; NONTUMORIGENIC REVERTANTS; EXPONENTIAL ENRICHMENT; SYSTEMATIC EVOLUTION; LIGANDS; ANGIOGENESIS; PEGAPTANIB; TOXIN	Background: Disease-specific biomarkers are an important tool for the timely and effective management of pathological conditions, including determination of susceptibility, diagnosis, and monitoring efficacy of preventive or therapeutic strategies. Aptamers, comprising single-stranded or double-stranded DNA or RNA, can serve as biomarkers of disease or biological states. Aptamers can bind to specific epitopes on macromolecules by virtue of their three dimensional structures and, much like antibodies, aptamers can be used to target specific epitopes on the basis of their molecular shape. The Systematic Evolution of Ligands by EXponential enrichment (SELEX) is the approach used to select high affinity aptamers for specific macromolecular targets from among the >10(13) oligomers comprising typical random oligomer libraries. In the present study, we used live cell-based SELEX to identify DNA aptamers which recognize cell surface differences between HPV-transformed cervical carcinoma cancer cells and isogenic, nontumorigenic, revertant cell lines. Methodology/Principal Findings: Whole-cell SELEX methodology was adapted for use with adherent cell lines (which we termed Adherent Cell-SELEX (AC-SELEX)). Using this approach, we identified high affinity aptamers (nanomolar range K-d) to epitopes specific to the cell surface of two nontumorigenic, nontumorigenic revertants derived from the human cervical cancer HeLa cell line, and demonstrated the loss of these epitopes in another human papillomavirus transformed cervical cancer cell line (SiHa). We also performed preliminary investigation of the aptamer epitopes and their binding characteristics. Conclusions/Significance: Using AC-SELEX we have generated several aptamers that have high affinity and specificity to the nontumorigenic, revertant of HPV-transformed cervical cancer cells. These aptamers can be used to identify new biomarkers that are related to carcinogenesis. Panels of aptamers, such as these may be useful in predicting the tumorigenic potential and properties of cancer biopsies and aid in the effective management of pathological conditions (diagnosis, predicted outcome, and treatment options).	[Graham, Jessica C.; Zarbl, Helmut] Univ Med & Dent New Jersey, Sch Med, Dept Environm & Occupat Med, Piscataway, NJ 08854 USA; [Zarbl, Helmut] Canc Inst New Jersey, Div Publ Hlth Sci, Program Carcinogenesis & Chemoprevent, New Brunswick, NJ USA; [Zarbl, Helmut] Univ Med & Dent New Jersey, NIEHS Ctr Environm Exposures & Dis, Environm & Occupat Hlth Sci Inst, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Rutgers State University New Brunswick; Rutgers State University Medical Center	Zarbl, H (corresponding author), Univ Med & Dent New Jersey, Sch Med, Dept Environm & Occupat Med, Piscataway, NJ 08854 USA.	zarbl@eohsi.rutgers.edu		Graham, Jessica/0000-0002-3601-1743	Public Health Services Grant [NIEHS P30ES005022]; New Jersey Commission on Cancer Research [09-1962-CCR-EO]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005022] Funding Source: NIH RePORTER	Public Health Services Grant(United States Department of Health & Human ServicesUnited States Public Health Service); New Jersey Commission on Cancer Research; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Supported by Public Health Services Grant #NIEHS P30ES005022 (HZ), a fellowship to JCG from the New Jersey Commission on Cancer Research, Award #: 09-1962-CCR-EO, and institutional support from the Robert Wood Johnson Medical School, UMDNJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athanassiou M, 1999, CELL GROWTH DIFFER, V10, P729; Boylan MO, 1996, CELL GROWTH DIFFER, V7, P725; Centers for Disease Control and Prevention: Division of Cancer Prevention and Control, 2010, HUM PAP HPV ASS CANC; Cerchia L, 2005, PLOS BIOL, V3, P697, DOI 10.1371/journal.pbio.0030123; Cerchia L, 2002, FEBS LETT, V528, P12, DOI 10.1016/S0014-5793(02)03275-1; Cerchia L, 2010, TRENDS BIOTECHNOL, V28, P517, DOI 10.1016/j.tibtech.2010.07.005; Chaturvedi AK, 2011, J CLIN ONCOL, V29, P4294, DOI 10.1200/JCO.2011.36.4596; Cunningham ET, 2005, OPHTHALMOLOGY, V112, P1747, DOI 10.1016/j.ophtha.2005.06.007; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Hermann T, 2000, SCIENCE, V287, P820, DOI 10.1126/science.287.5454.820; HIRT B, 1967, J MOL BIOL, V26, P365, DOI 10.1016/0022-2836(67)90307-5; Jayasena SD, 1999, CLIN CHEM, V45, P1628; Kyrgiou M, 2008, OBSTET GYNAECOL REPR, V19, P26; Laurenson S, ANAL BIOCH, V410, P161; Lee JH, 2005, P NATL ACAD SCI USA, V102, P18902, DOI 10.1073/pnas.0509069102; Liu X, 2006, J BIOL CHEM, V281, P578, DOI 10.1074/jbc.M508455200; Morris KN, 1998, P NATL ACAD SCI USA, V95, P2902, DOI 10.1073/pnas.95.6.2902; Musheev MU, 2006, ANAL CHIM ACTA, V564, P91, DOI 10.1016/j.aca.2005.09.069; Ng EWM, 2005, CAN J OPHTHALMOL, V40, P352, DOI 10.1016/S0008-4182(05)80078-X; Nimjee SM, 2006, MOL THER, V14, P408, DOI 10.1016/j.ymthe.2006.04.006; Nutiu R, 2005, ANGEW CHEM INT EDIT, V44, P1061, DOI 10.1002/anie.200461848; Orava EW, 2010, BBA-BIOMEMBRANES, V1798, P2190, DOI 10.1016/j.bbamem.2010.02.004; Osborne SE, 1997, CHEM REV, V97, P349, DOI 10.1021/cr960009c; Phillips JA, 2008, ANAL CHIM ACTA, V621, P101, DOI 10.1016/j.aca.2008.05.031; Shangguan DH, 2007, CLIN CHEM, V53, P1153, DOI 10.1373/clinchem.2006.083246; Shangguan D, 2006, P NATL ACAD SCI USA, V103, P11838, DOI 10.1073/pnas.0602615103; Siddiqui MAA, 2005, DRUGS, V65, P1571, DOI 10.2165/00003495-200565110-00010; SUMMERHAYES IC, 1982, P NATL ACAD SCI-BIOL, V79, P5292, DOI 10.1073/pnas.79.17.5292; Tang JJ, 2007, BIOSENS BIOELECTRON, V22, P2456, DOI 10.1016/j.bios.2006.09.015; Tang JJ, 2006, ELECTROPHORESIS, V27, P1303, DOI 10.1002/elps.200500489; Toscano-Garibay JD, 2011, ARCH MED RES, V42, P88, DOI 10.1016/j.arcmed.2011.02.005; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Watanabe M, 2011, CANC LETT; Wilson DS, 1999, ANNU REV BIOCHEM, V68, P611, DOI 10.1146/annurev.biochem.68.1.611; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	37	64	74	1	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e36103	10.1371/journal.pone.0036103	http://dx.doi.org/10.1371/journal.pone.0036103			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536456	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339200128
J	Lauinger, IL; Bible, JM; Halligan, EP; Aarons, EJ; MacMahon, E; Tong, CYW				Lauinger, Ina L.; Bible, Jon M.; Halligan, Eugene P.; Aarons, Emma J.; MacMahon, Eithne; Tong, Cheuk Y. W.			Lineages, Sub-Lineages and Variants of Enterovirus 68 in Recent Outbreaks	PLOS ONE			English	Article							HUMAN RHINOVIRUS-87; INFECTIONS; CHILDREN; RECOMBINATION; EMERGENCE; ILLNESS; STRAINS	Enterovirus 68 (EV68) was first isolated in 1962. Very few cases of EV68 infection were described over the ensuing 40 years. However, in the past few years, an increase in severe respiratory tract infections associated with EV68 has been reported. We identified two clusters of EV68 infection in South London, UK, one each in the autumn/winters of 2009 and 2010. Sequence comparison showed significant homology of the UK strains with those from other countries including the Netherlands, Japan and the Philippines, which reported EV68 outbreaks between 2008 and 2010. Phylogenetic analysis of all available VP1 sequences indicated the presence of two modern EV68 lineages. The 2010 UK strains belonged to lineage 2. Lineage 1 could be further divided into two sub-lineages: some Japanese and Dutch strains collected between 2004 and 2010 form a distinct sub-lineages (sub-lineage 1.1), whereas other strains from the UK, Japan, Netherlands and Philippines collected between 2008 and 2010 represent sub-lineage 1.2. The UK 2009 strains together with several Dutch and Japanese strains from 2009/2010 represents one variant (1.2.1), whereas those from the Philippines a second variant (1.2.2). Based on specific deletions and substitutions, we suggest rules for the assignment of lineages and sub-lineages. Molecular epidemiological analysis indicates rapid recent evolution of EV68 and this may explain the recent findings of a global resurgence of EV68. Continuous global monitoring of the clinical and molecular epidemiology of EV68 is recommended.	[Lauinger, Ina L.; Tong, Cheuk Y. W.] Kings Coll London, Sch Med, Dept Infect Dis, London WC2R 2LS, England; [Bible, Jon M.; Halligan, Eugene P.] GSTS Pathol, Infect Sci, London, England; [Aarons, Emma J.; MacMahon, Eithne; Tong, Cheuk Y. W.] Guys & St Thomas NHS Fdn Trust, Dept Infect Dis, London, England	University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust	Tong, CYW (corresponding author), Kings Coll London, Sch Med, Dept Infect Dis, London WC2R 2LS, England.	William.Tong@kcl.ac.uk	Tong, Cheuk Yan William/C-1312-2012	Tong, Cheuk Yan William/0000-0001-8401-6832	British Medical Association (BMA) H C Roscoe grant	British Medical Association (BMA) H C Roscoe grant	This study was funded by the British Medical Association (BMA) H C Roscoe grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blomqvist S, 2002, J CLIN MICROBIOL, V40, P4218, DOI 10.1128/JCM.40.11.4218-4223.2002; Hasegawa S, 2011, ALLERGY, V66, P1618, DOI 10.1111/j.1398-9995.2011.02725.x; Imamura T, 2011, EMERG INFECT DIS, V17, P1430, DOI 10.3201/eid1708.101328; Ishiko H, 2002, INTERVIROLOGY, V45, P136, DOI 10.1159/000065866; Kaida A, 2011, EMERG INFECT DIS, V17, P1494, DOI 10.3201/eid1708.110028; Khetsuriani Nino, 2006, Morbidity and Mortality Weekly Report, V55, P18; Kiang D, 2008, J CLIN MICROBIOL, V46, P3736, DOI 10.1128/JCM.00674-08; Kiang D, 2007, J CLIN VIROL, V38, P227, DOI 10.1016/j.jcv.2006.12.016; Kreuter JD, 2011, ARCH PATHOL LAB MED, V135, P793, DOI 10.1043/2010-0174-CR.1; Leitch ECM, 2012, J VIROL, V86, P2676, DOI 10.1128/JVI.06065-11; Leitch ECM, 2009, J VIROL, V83, P2109, DOI 10.1128/JVI.02109-08; McIntyre CL, 2010, J VIROL, V84, P10297, DOI 10.1128/JVI.00962-10; Meijer A, 2012, VIROLOGY, V423, P49, DOI 10.1016/j.virol.2011.11.021; Oberste MS, 2004, J GEN VIROL, V85, P2577, DOI 10.1099/vir.0.79925-0; Petitjean-Lecherbonnier J, 2011, PATHOL BIOL, V59, P113, DOI 10.1016/j.patbio.2010.07.010; Rahamat-Langendoen J, 2011, J CLIN VIROL, V52, P103, DOI 10.1016/j.jcv.2011.06.019; Savolainen C, 2002, J GEN VIROL, V83, P333, DOI 10.1099/0022-1317-83-2-333; SCHIEBLE JH, 1967, AM J EPIDEMIOL, V85, P297, DOI 10.1093/oxfordjournals.aje.a120693; Smura T, 2010, J MED VIROL, V82, P1940, DOI 10.1002/jmv.21894; Tee KK, 2010, J VIROL, V84, P3339, DOI 10.1128/JVI.01019-09; Tokarz R, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-288	21	47	50	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e36005	10.1371/journal.pone.0036005	http://dx.doi.org/10.1371/journal.pone.0036005			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536453	gold, Green Published, Green Submitted			2022-12-27	WOS:000305339200124
J	Moreira, R; Balseiro, P; Planas, JV; Fuste, B; Beltran, S; Novoa, B; Figueras, A				Moreira, Rebeca; Balseiro, Pablo; Planas, Josep V.; Fuste, Berta; Beltran, Sergi; Novoa, Beatriz; Figueras, Antonio			Transcriptomics of In Vitro Immune-Stimulated Hemocytes from the Manila Clam Ruditapes philippinarum Using High-Throughput Sequencing	PLOS ONE			English	Article							PROTEINASE-INHIBITOR GENE; MESSENGER-RNA EXPRESSION; OYSTER CRASSOSTREA-GIGAS; DUPLEX-SPECIFIC NUCLEASE; SCALLOP CHLAMYS-FARRERI; HEAT-SHOCK PROTEINS; TNF-ALPHA FACTOR; MOLECULAR-CLONING; ZHIKONG SCALLOP; PACIFIC OYSTER	Background: The Manila clam (Ruditapes philippinarum) is a worldwide cultured bivalve species with important commercial value. Diseases affecting this species can result in large economic losses. Because knowledge of the molecular mechanisms of the immune response in bivalves, especially clams, is scarce and fragmentary, we sequenced RNA from immune-stimulated R. philippinarum hemocytes by 454- pyrosequencing to identify genes involved in their immune defense against infectious diseases. Methodology and Principal Findings: High-throughput deep sequencing of R. philippinarum using 454 pyrosequencing technology yielded 974,976 high-quality reads with an average read length of 250 bp. The reads were assembled into 51,265 contigs and the 44.7% of the translated nucleotide sequences into protein were annotated successfully. The 35 most frequently found contigs included a large number of immune-related genes, and a more detailed analysis showed the presence of putative members of several immune pathways and processes like the apoptosis, the toll like signaling pathway and the complement cascade. We have found sequences from molecules never described in bivalves before, especially in the complement pathway where almost all the components are present. Conclusions: This study represents the first transcriptome analysis using 454- pyrosequencing conducted on R. philippinarum focused on its immune system. Our results will provide a rich source of data to discover and identify new genes, which will serve as a basis for microarray construction and the study of gene expression as well as for the identification of genetic markers. The discovery of new immune sequences was very productive and resulted in a large variety of contigs that may play a role in the defense mechanisms of Ruditapes philippinarum.	[Moreira, Rebeca; Balseiro, Pablo; Novoa, Beatriz; Figueras, Antonio] CSIC, Inst Invest Marinas, Vigo, Spain; [Planas, Josep V.] Univ Barcelona, Fac Biol, Dept Fisiol & Immunol, Barcelona, Spain; [Planas, Josep V.] Univ Barcelona, Inst Biomed, Barcelona, Spain; [Fuste, Berta; Beltran, Sergi] Univ Barcelona, Ctr Cient & Tecnol, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Marinas (IIM); University of Barcelona; University of Barcelona; University of Barcelona	Moreira, R (corresponding author), CSIC, Inst Invest Marinas, Vigo, Spain.	antoniofigueras@iim.csic.es	Novoa, Beatriz/K-3785-2014; Figueras, Antonio/AAB-8921-2019; Figueras, Antonio/B-5133-2015; Balseiro, Pablo/I-7406-2013; Beltran, Sergi/I-3408-2015	Figueras, Antonio/0000-0002-0617-0030; Figueras, Antonio/0000-0002-0617-0030; Beltran, Sergi/0000-0002-2810-3445; Planas, Josep/0000-0002-6525-9617; Balseiro, Pablo/0000-0002-9365-6775; Novoa, Beatriz/0000-0003-4888-8419; Moreira, Rebeca/0000-0001-7797-7221	Spanish Ministerio de Ciencia e Innovacion (MICINN) [AGL2008-05111]; EU [245119]; Spanish MICINN through a Formacion de Personal Investigador [BES-2009029765]	Spanish Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); EU(European Commission); Spanish MICINN through a Formacion de Personal Investigador	This work has been funded by the Spanish Ministerio de Ciencia e Innovacion (MICINN) (AGL2008-05111) and by the EU Project REPROSEED (245119). R. M. wishes to acknowledge additional funding from the Spanish MICINN through a Formacion de Personal Investigador Spanish research grant (BES-2009029765). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adl SM, 2005, J EUKARYOT MICROBIOL, V52, P399, DOI 10.1111/j.1550-7408.2005.00053.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bai XD, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016336, 10.1371/journal.pone.0016368]; Balseiro P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023140; Batista FM, 2007, J VIROL METHODS, V139, P1, DOI 10.1016/j.jviromet.2006.09.005; Beaz-Hidalgo R, 2010, ENV MICROBIOL REP, V2, P34, DOI 10.1111/j.1758-2229.2010.00135.x; Bettencourt R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-559; Bower SM, 2003, SYNOPSIS INFECT DIS; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Bulgakov AA, 2004, FISH SHELLFISH IMMUN, V16, P487, DOI 10.1016/j.fsi.2003.08.006; Canesi L, 2002, MICROSC RES TECHNIQ, V57, P469, DOI 10.1002/jemt.10100; Charlet M, 1996, J BIOL CHEM, V271, P21808, DOI 10.1074/jbc.271.36.21808; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Clark MS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-362; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Costa MM, 2009, DEV COMP IMMUNOL, V33, P162, DOI 10.1016/j.dci.2008.08.005; Craft JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008875; CROOK NE, 1993, J VIROL, V67, P2168, DOI 10.1128/JVI.67.4.2168-2174.1993; DAVIS HC, 1954, SCIENCE, V120, P36, DOI 10.1126/science.120.3105.36; De Maio A, 1999, SHOCK, V11, P1, DOI 10.1097/00024382-199901000-00001; Do Carmo S, 2008, J NEUROSCI, V28, P10330, DOI 10.1523/JNEUROSCI.2644-08.2008; Do Carmo S, 2007, BBA-MOL CELL RES, V1773, P954, DOI 10.1016/j.bbamcr.2007.03.007; Dunkelberger JR, 2010, CELL RES, V20, P34, DOI 10.1038/cr.2009.139; Fleischer A, 2002, EUR J IMMUNOL, V32, P3498, DOI 10.1002/1521-4141(200212)32:12<3498::AID-IMMU3498>3.0.CO;2-C; Fleury E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-341; FUJII N, 1992, J BIOL CHEM, V267, P22452; Gerdol M, 2011, DEV COMP IMMUNOL, V35, P635, DOI 10.1016/j.dci.2011.01.018; Gestal C, 2007, GENE, V406, P134, DOI 10.1016/j.gene.2007.07.030; Gestal C, 2010, DEV COMP IMMUNOL, V34, P926, DOI 10.1016/j.dci.2010.02.012; Gestal C, 2008, REV FISH SCI, V16, P133, DOI 10.1080/10641260802325518; Ghiselli F, 2011, MOL BIOL EV IN PRESS; Gourdine JP, 2007, FISH SHELLFISH IMMUN, V22, P498, DOI 10.1016/j.fsi.2006.06.013; Gueguen Y, 2003, GENE, V303, P139, DOI 10.1016/S0378-1119(02)01149-6; Henderson NC, 2009, IMMUNOL REV, V230, P160, DOI 10.1111/j.1600-065X.2009.00794.x; Huan P, 2011, MAR BIOTECH IN PRESS; Hubert F, 1996, EUR J BIOCHEM, V240, P302, DOI 10.1111/j.1432-1033.1996.0302h.x; Itoh N, 2008, COMP BIOCHEM PHYS B, V150, P409, DOI 10.1016/j.cbpb.2008.04.011; Jenny MJ, 2002, MAR BIOTECHNOL, V4, P81, DOI 10.1007/s10126-001-0072-8; Kadomatsu T, 2011, FEBS J, V278, P559, DOI 10.1111/j.1742-4658.2010.07979.x; Kang YS, 2006, DEV COMP IMMUNOL, V30, P1119, DOI 10.1016/j.dci.2006.03.005; Kim JY, 2008, DEV COMP IMMUNOL, V32, P1131, DOI 10.1016/j.dci.2008.03.002; Kim JY, 2008, FISH SHELLFISH IMMUN, V25, P598, DOI 10.1016/j.fsi.2008.07.015; Kim YM, 2008, NATURE, V452, P234, DOI 10.1038/nature06726; Kim YM, 2006, J BIOL CHEM, V281, P26854, DOI 10.1074/jbc.M601251200; Kishore U, 2004, TRENDS IMMUNOL, V25, P551, DOI 10.1016/j.it.2004.08.006; La Peyre JF, 2010, DEV COMP IMMUNOL, V34, P84, DOI 10.1016/j.dci.2009.08.007; Lakhal F, 2008, APPL ENVIRON MICROB, V74, P5750, DOI 10.1128/AEM.01043-08; Li CH, 2011, FISH SHELLFISH IMMUN, V30, P447, DOI 10.1016/j.fsi.2010.10.023; Li CH, 2010, CELL STRESS CHAPERON, V15, P897, DOI 10.1007/s12192-010-0198-6; Li L, 2009, FISH SHELLFISH IMMUN, V27, P625, DOI 10.1016/j.fsi.2009.07.009; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Milan M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-234; Montagnani C, 2001, FEBS LETT, V500, P64, DOI 10.1016/S0014-5793(01)02559-5; Moreira R, 2012, DEV COMP IMMUNOL, V36, P140, DOI 10.1016/j.dci.2011.06.012; Ni DJ, 2007, DEV COMP IMMUNOL, V31, P548, DOI 10.1016/j.dci.2006.09.001; OLAFSEN JA, 1995, ADV EXP MED BIOL, V371, P343; Ordas MC, 2000, FISH SHELLFISH IMMUN, V10, P611, DOI 10.1006/fsim.2000.0276; Ordas MC, 2000, FISH SHELLFISH IMMUN, V10, P597, DOI 10.1006/fsim.2000.0274; Paillard C, 2004, AQUAT LIVING RESOUR, V17, P477, DOI 10.1051/alr:2004054; Pallavicini A, 2008, DEV COMP IMMUNOL, V32, P213, DOI 10.1016/j.dci.2007.05.008; Parcellier A, 2003, BIOCHEM BIOPH RES CO, V304, P505, DOI 10.1016/S0006-291X(03)00623-5; Park EM, 2008, FISH SHELLFISH IMMUN, V24, P11, DOI 10.1016/j.fsi.2007.07.003; Phan IQH, 2003, NUCLEIC ACIDS RES, V31, P3822, DOI 10.1093/nar/gkg516; Prado-Alvarez M, 2009, FISH SHELLFISH IMMUN, V26, P305, DOI 10.1016/j.fsi.2008.11.015; Prado-Alvarez M, 2009, FISH SHELLFISH IMMUN, V26, P72, DOI 10.1016/j.fsi.2008.03.002; Qiu LM, 2007, FISH SHELLFISH IMMUN, V22, P451, DOI 10.1016/j.fsi.2006.05.003; Qiu LM, 2009, FISH SHELLFISH IMMUN, V26, P359, DOI 10.1016/j.fsi.2008.10.010; Rassart E, 2000, BBA-PROTEIN STRUCT M, V1482, P185, DOI 10.1016/S0167-4838(00)00162-X; Roach JC, 2005, P NATL ACAD SCI USA, V102, P9577, DOI 10.1073/pnas.0502272102; Ruddell RG, 2009, HEPATOLOGY, V49, P887, DOI 10.1002/hep.22716; Shagin DA, 2002, GENOME RES, V12, P1935, DOI 10.1101/gr.547002; Su JG, 2004, AQUACULTURE, V239, P69, DOI 10.1016/j.aquaculture.2004.03.012; Su JG, 2007, FISH SHELLFISH IMMUN, V23, P646, DOI 10.1016/j.fsi.2007.01.023; Tafalla C, 2003, DEV COMP IMMUNOL, V27, P197, DOI 10.1016/S0145-305X(02)00098-8; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tanguy A, 2008, GENE, V408, P27, DOI 10.1016/j.gene.2007.10.021; Vasta GR, 2004, CURR OPIN STRUC BIOL, V14, P617, DOI 10.1016/j.sbi.2004.09.008; Venier P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-69; Venier P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-72; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Villalba A, 2004, AQUAT LIVING RESOUR, V17, P411, DOI 10.1051/alr:2004050; Wang AM, 2011, MAR BIOTECHNOL, V13, P275, DOI 10.1007/s10126-010-9296-9; Wang B, 2008, FISH SHELLFISH IMMUN, V24, P629, DOI 10.1016/j.fsi.2008.01.017; Xue QG, 2006, COMP BIOCHEM PHYS B, V145, P16, DOI 10.1016/j.cbpb.2006.05.010; Xue QG, 2009, FISH SHELLFISH IMMUN, V27, P250, DOI 10.1016/j.fsi.2009.05.006; Yu YD, 2007, FISH SHELLFISH IMMUN, V23, P419, DOI 10.1016/j.fsi.2006.12.004; Zhang DC, 2009, FISH SHELLFISH IMMUN, V27, P391, DOI 10.1016/j.fsi.2009.04.006; Zhang DK, 2004, SCIENCE, V303, P1522, DOI 10.1126/science.1094351; Zhang H, 2008, FISH SHELLFISH IMMUN, V25, P281, DOI 10.1016/j.fsi.2008.06.003; Zhao JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013480; Zhao JM, 2010, COMP BIOCHEM PHYS B, V156, P56, DOI 10.1016/j.cbpb.2010.02.001; Zhu L, 2006, FISH SHELLFISH IMMUN, V20, P320, DOI 10.1016/j.fsi.2005.05.009; Zhulidov PA, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh031	94	98	102	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e35009	10.1371/journal.pone.0035009	http://dx.doi.org/10.1371/journal.pone.0035009			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22536348	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336200021
J	Regier, JC; Brown, JW; Mitter, C; Baixeras, J; Cho, S; Cummings, MP; Zwick, A				Regier, Jerome C.; Brown, John W.; Mitter, Charles; Baixeras, Joaquin; Cho, Soowon; Cummings, Michael P.; Zwick, Andreas			A Molecular Phylogeny for the Leaf-Roller Moths (Lepidoptera: Tortricidae) and Its Implications for Classification and Life History Evolution	PLOS ONE			English	Article							BIOLOGICAL-CONTROL; FEMALE FRENULUM; NEW-CALEDONIA; NUCLEAR GENE; MISSING DATA; COCHYLIDAE; PATTERNS; SUPPORT	Background: Tortricidae, one of the largest families of microlepidopterans, comprise about 10,000 described species worldwide, including important pests, biological control agents and experimental models. Understanding of tortricid phylogeny, the basis for a predictive classification, is currently provisional. We present the first detailed molecular estimate of relationships across the tribes and subfamilies of Tortricidae, assess its concordance with previous morphological evidence, and re-examine postulated evolutionary trends in host plant use and biogeography. Methodology/Principal Findings: We sequenced up to five nuclear genes (6,633 bp) in each of 52 tortricids spanning all three subfamilies and 19 of the 22 tribes, plus up to 14 additional genes, for a total of 14,826 bp, in 29 of those taxa plus all 14 outgroup taxa. Maximum likelihood analyses yield trees that, within Tortricidae, differ little among data sets and character treatments and are nearly always strongly supported at all levels of divergence. Support for several nodes was greatly increased by the additional 14 genes sequenced in just 29 of 52 tortricids, with no evidence of phylogenetic artifacts from deliberately incomplete gene sampling. There is strong support for the monophyly of Tortricinae and of Olethreutinae, and for grouping of these to the exclusion of Chlidanotinae. Relationships among tribes are robustly resolved in Tortricinae and mostly so in Olethreutinae. Feeding habit (internal versus external) is strongly conserved on the phylogeny. Within Tortricinae, a clade characterized by eggs being deposited in large clusters, in contrast to singly or in small batches, has markedly elevated incidence of polyphagous species. The five earliest-branching tortricid lineages are all species-poor tribes with mainly southern/tropical distributions, consistent with a hypothesized Gondwanan origin for the family. Conclusions/Significance: We present the first robustly supported phylogeny for Tortricidae, and a revised classification in which all of the sampled tribes are now monophyletic.	[Regier, Jerome C.; Mitter, Charles] Univ Maryland, Dept Entomol, College Pk, MD 20742 USA; [Regier, Jerome C.] Inst Biosci & Biotechnol Res, College Pk, MD USA; [Brown, John W.] ARS, Systemat Entomol Lab, USDA, Beltsville, MD USA; [Baixeras, Joaquin] Univ Valencia, Cavanilles Inst Biodivers & Evolutionary Biol, Valencia, Spain; [Cho, Soowon] Chungbuk Natl Univ, Dept Plant Med, Cheongju, South Korea; [Cummings, Michael P.] Univ Maryland, Lab Mol Evolut, Ctr Bioinformat & Computat Biol, College Pk, MD 20742 USA; [Zwick, Andreas] State Museum Nat Hist, Dept Entomol, Stuttgart, Germany	University System of Maryland; University of Maryland College Park; Smithsonian Institution; United States Department of Agriculture (USDA); University of Valencia; Chungbuk National University; University System of Maryland; University of Maryland College Park	Regier, JC (corresponding author), Univ Maryland, Dept Entomol, College Pk, MD 20742 USA.	cmitter@umd.edu	Almela, Joaquin Baixeras/L-1734-2014; Zwick, Andreas/A-5735-2015; Cho, Soowon/AAF-7890-2019	Almela, Joaquin Baixeras/0000-0002-6092-0496; Zwick, Andreas/0000-0002-7532-1752; 	U.S. National Science Foundation [0531626, 0531769]; Spanish Government (Ministerio de Ciencia e Innovacion) [CGL2008-00605]; Division Of Environmental Biology [1042845] Funding Source: National Science Foundation	U.S. National Science Foundation(National Science Foundation (NSF)); Spanish Government (Ministerio de Ciencia e Innovacion)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Financial support was provided by the U.S. National Science Foundation's Assembling the Tree of Life program, award numbers 0531626 and 0531769, and grant CGL2008-00605 of the Spanish Government (Ministerio de Ciencia e Innovacion) to Dr. Brown. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarvik Leif, 2004, Norwegian Journal of Entomology, V51, P71; Aarvik L, 2009, ZOOTAXA, P18, DOI 10.11646/zootaxa.2026.1.2; Alipanah H, 2011, ZOOTAXA, P33; Baixeras J, 2010, TARTS ONLINE WORLD C; Bazinet A. L, 2009, DISTRIBUTED GRID COM; Brower AVZ, 1998, INSECT MOL BIOL, V7, P73, DOI 10.1046/j.1365-2583.1998.71052.x; BROWN J.W., 1991, U CALIFORNIA PUBLICA, V111, P1; Brown JW, 2007, PAN-PAC ENTOMOL, V83, P352, DOI 10.3956/2007-22.1; Brown John W., 2005, World Catalogue of Insects, V5, P1; BROWN JW, 1989, ENTOMOL SCAND, V20, P439; BROWN JW, 1990, J NEW YORK ENTOMOL S, V98, P369; Brown JW, 2004, P ENTOMOL SOC WASH, V106, P288; BROWN JW, 1990, ENTOMOL NEWS, V101, P109; Brown JW, 1998, PAN-PAC ENTOMOL, V74, P1; Brown JW, 2003, J LEPID SOC, V56, P113; Brown JW, 2010, FOOD PLANT DATABASE; Brown JW, 2000, U CALIF PUBL ENTOMOL, V120; CHAPMAN PJ, 1971, TORTRICID FAUNA APPL; Cho S, 2011, SYST BIOL, V60, P782, DOI 10.1093/sysbio/syr079; COMMON I. F. B., 1965, AUSTRALIAN J ZOOL, V13, P613, DOI 10.1071/ZO9650613; COMMON I. F. B., 1963, AUSTRALIAN JOUR ZOOL, V11, P81, DOI 10.1071/ZO9630081; Cummings M. P, 2005, EDUCAUSE REV, V40, P116; DANG P T, 1990, Journal of the Lepidopterists' Society, V44, P77; Danilevsky AS, 1968, INSECTA LEPIDOPTERA, V5, P1; Dhileepan K, 2004, ENTOMOL EXP APPL, V113, P63, DOI 10.1111/j.0013-8703.2004.00209.x; Dhileepan K, 2003, B ENTOMOL RES, V93, P393, DOI 10.1079/BER2003255; DIAKONOFF A, 1981, P K NED AKAD C BIOL, V84, P155; DIAKONOFF A., 1950, BULL BRIT MUS [NAT HIST] ENT, V1, P173; Diakonoff A., 1977, Zoologische Verh. Leiden, VNo. 158, P1; DIAKONOFF A, 1957, ACTA PHYSIOL PHARM N, V6, P410; Diakonoff A, 1973, ZOOLOGY MONOGRAPHS R, V1; Diakonoff A, 1977, ENTOMOL BER, V37, P36; Falkovitsh ML, 1962, ENTOMOL OBOZR, V41, P546; Fang QQ, 1997, SYST BIOL, V46, P269, DOI 10.2307/2413623; Farrell BD, 2001, EVOLUTION, V55, P2011, DOI 10.1111/j.0014-3820.2001.tb01318.x; Haston E, 2009, BOT J LINN SOC, V161, P128, DOI 10.1111/j.1095-8339.2009.00996.x; HEINRICH C., 1923, Bulletin. United States National Museum; HEPPNER JB, 1978, PAN-PAC ENTOMOL, V54, P48; HORAK M, 1984, ENTOMOL SCAND, V15, P423; Horak M., 1991, TORTRICID PESTS THEI, P23; Horak M, 1998, HDB ZOOLOGY 35, VIV, P199; HORAK M., 2006, MONOGRAPHS AUSTR LEP, V10, DOI DOI 10.1071/9780643094086; Horak Marianne, 1996, Monographs on Australian Lepidoptera, V4, P123; Janzen DH, 2010, DYNAMIC DATABASE INV; Jinbo Utsugi, 2000, Tokyo Metropolitan University Bulletin of Natural History, V4, P33; Kawahara AY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005719; Kawahara AY, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-182; Komai F, 2006, MONOGRAPHS AUSTR LEP, V10, P396; Komai Furumi, 1999, Entomologica Scandinavica Supplement, V55, P1; Kuznetsov V. I., 1994, Entomologicheskoe Obozrenie, V73, P700; KUZNETSOV V I, 1970, ENTOMOL REV (ENGL TRANSL ENTOMOL OBOZR), V49, P260; Kuznetsov V. I, 1977, Trudy zool Inst Leningr, V70, P65; Kuznetzov V.I., 1973, Trudy vses ent Obshch, V56, P18; Kuznetzov V.I., 1984, 36 HOL MEM LECT 1 AP, P51; Lemmon AR, 2009, SYST BIOL, V58, P130, DOI 10.1093/sysbio/syp017; Meyrick E., 1895, HDB BRIT LEPIDOPTERA; Monsalve S, 2011, P ENTOMOL SOC WASH, V113, P335, DOI 10.4289/0013-8797.113.3.335; Moulton JK, 2004, MOL PHYLOGENET EVOL, V31, P363, DOI 10.1016/S1055-7903(03)00284-7; MULLER H, 1988, CAN ENTOMOL, V120, P109, DOI 10.4039/Ent120109-2; Mutanen M, 2010, P ROY SOC B-BIOL SCI, V277, P2839, DOI 10.1098/rspb.2010.0392; Nyman T, 2006, EVOLUTION, V60, P1622, DOI 10.1111/j.0014-3820.2006.tb00507.x; Obraztsov N., 1949, Entomologische Zeitschrift Stuttgart, V59, P45; Obraztsov NS, 1964, TIJDSCHR ENTOMOL, V107, P1; Phillips MJ, 2004, MOL BIOL EVOL, V21, P1455, DOI 10.1093/molbev/msh137; Pogue M, 1986, THESIS U MINNESOTA; POINAR GO, 1993, ENTOMOL SCAND, V24, P25; Powell GW, 2000, CAN ENTOMOL, V132, P223, DOI 10.4039/Ent132223-2; Powell J. A., 1983, CHECK LIST LEPIDOPTE, P31; POWELL JA, 1985, AUST J ZOOL, V33, P179, DOI 10.1071/ZO9850179; POWELL JA, 1976, PAN-PAC ENTOMOL, V52, P91; POWELL JA, 1986, PAN-PAC ENTOMOL, V62, P372; Powell JA, 1964, U CALIFORNIA PUBLICA, V32; Powell JA, 2011, TORTRICIDAE TORTRICI; Powell Jerry A., 1999, Handbuch der Zoologie (Berlin), V4, P403; RAZOWSKI J, 1976, Acta Zoologica Cracoviensia, V21, P73; RAZOWSKI J, 1988, Acta Zoologica Cracoviensia, V31, P387; RAZOWSKI J, 1987, Acta Zoologica Cracoviensia, V30, P141; Razowski J, 1970, MICROLEPIDOPTERA PAL, V3; Razowski Jozef, 1993, Acta Zoologica Cracoviensia, V35, P665; Razowski J, 2010, FOLIA BIOL-KRAKOW, V58, P189, DOI 10.3409/fb58_3-4.189-194; Regier JC, 1998, MOL BIOL EVOL, V15, P1172, DOI 10.1093/oxfordjournals.molbev.a026024; Regier JC, 2008, SYST ENTOMOL, V33, P219, DOI 10.1111/j.1365-3113.2007.00416.x; Regier JC, 2008, SYST ENTOMOL, V33, P175, DOI 10.1111/j.1365-3113.2007.00409.x; Regier JC, 2010, NATURE, V463, P1079, DOI 10.1038/nature08742; Regier JC, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-280; Regier JC, 2008, SYST BIOL, V57, P920, DOI 10.1080/10635150802570791; Robinson G.S., 2010, HOSTS A DATABASE WOR; Roe AD, 2009, GENETICS MOL BIOL LE, P1, DOI [10.1201/9781420060201-c1, DOI 10.1201/9781420060201-C1]; Safonkin AF, 2007, ZOOL ZH, V86, P1464; Smith L, 2003, BIOL CONTROL, V26, P270, DOI 10.1016/S1049-9644(02)00169-X; Staden R, 1999, STADEN PACKAGE; TUCK KR, 1981, SYST ENTOMOL, V6, P337, DOI 10.1111/j.1365-3113.1981.tb00442.x; van der Geest LPS., 1991, TORTRICID PESTS THEI; von Kennel J, 1908, ZOOLOGICA, V21, P1; Wiens JJ, 2003, SYST BIOL, V52, P528, DOI 10.1080/10635150390218330; Wiens JJ, 1998, SYST BIOL, V47, P625, DOI 10.1080/106351598260635; Wiens JJ, 2011, SYST BIOL, V60, P719, DOI 10.1093/sysbio/syr025; Winkler IS, 2008, SPECIALIZATION, SPECIATION, AND RADIATION: THE EVOLUTIONARY BIOLOGY OF HERBIVOROUS INSECTS, P240; Yang A, 2009, P ENTOMOL SOC WASH, V111, P743, DOI 10.4289/0013-8797-111.3.743; Zhang B.C., 1994, INDEX EC IMPORTANT L; Zhang ZQ, 2011, ZOOTAXA, P7, DOI 10.11646/zootaxa.3148.1.3; Zwick A, 2011, SYST ENTOMOL, V36, P31, DOI 10.1111/j.1365-3113.2010.00543.x; Zwickl D. J, 2006, GENETIC ALGORITHM AP	103	67	76	3	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e35574	10.1371/journal.pone.0035574	http://dx.doi.org/10.1371/journal.pone.0035574			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22536410	Green Submitted, Green Published, gold			2022-12-27	WOS:000305336200057
J	Zhang, M; Xu, GZ; Liu, W; Ni, YQ; Zhou, WT				Zhang, Meng; Xu, Gezhi; Liu, Wei; Ni, Yingqin; Zhou, Wenting			Role of Fractalkine/CX3CR1 Interaction in Light-Induced Photoreceptor Degeneration through Regulating Retinal Microglial Activation and Migration	PLOS ONE			English	Article							CHEMOKINE RECEPTORS; CX3CR1/CX3CL1 AXIS; CEREBRAL-ISCHEMIA; NERVOUS-SYSTEM; BRAIN-INJURY; RAT-BRAIN; CX3CR1; EXPRESSION; INFLAMMATION; CX(3)CR1	Background: Excessive exposure to light enhances the progression and severity of some human retinal degenerative diseases. While retinal microglia are likely to be important in neuron damage associated with these diseases, the relationship between photoreceptor damage and microglial activation remains poorly understood. Some recent studies have indicated that the chemokine fractalkine is involved in the pathogenesis of many neurodegenerative diseases. The present study was performed to investigate the cross-talk between injured photoreceptors and activated retinal microglia, focusing on the role of fractalkine and its receptor CX3CR1 in light-induced photoreceptor degeneration. Methodology/Principal Findings: Both in vivo and in vitro experiments were involved in the research. In vivo, Sprague-Dawley rats were exposed to blue light for 24 hours. In vitro, the co-culture of primary retinal microglia and a photoreceptor cell line (661W cell) was exposed to blue light for five hours. Some cultures were pretreated by the addition of anti-CX3CR1 neutralizing antibody or recombinant fractalkine. Expression of fractalkine/CX3CR1 and inflammatory cytokines was detected by immunofluorescence, real-time PCR, Western immunoblot analysis, and ELISA assay. TUNEL method was used to detect cell apoptosis. In addition, chemotaxis assay was performed to evaluate the impact of soluble fractalkine on microglial migration. Our results showed that the expression of fractalkine that was significantly upregulated after exposure to light, located mainly at the photoreceptors. The extent of photoreceptor degeneration and microglial migration paralleled the increased level of fractalkine/CX3CR1. Compared with the control, the expression of inflammatory cytokines was significantly downregulated in the anti-CX3CR1 neutralizing antibody-treated group, and the number of photoreceptors was also well preserved. The addition of recombinant full-length fractalkine or soluble fractalkine resulted in fewer TUNEL-positive photoreceptors and an increased number of migratory microglia respectively. Conclusions/Significance: These findings demonstrate that fractalkine/CX3CR1 interaction may play an important role in the photoreceptor-microglia cross-talk in light-induced photoreceptor degeneration.	[Zhang, Meng; Xu, Gezhi; Liu, Wei; Ni, Yingqin; Zhou, Wenting] Fudan Univ, Dept Ophthalmol, Eye & ENT Hosp, Shanghai 200433, Peoples R China; [Xu, Gezhi] Fudan Univ, Inst Brain Sci, Shanghai 200433, Peoples R China; [Xu, Gezhi] Fudan Univ, State Key Lab Med Neurobiol, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University	Zhang, M (corresponding author), Fudan Univ, Dept Ophthalmol, Eye & ENT Hosp, Shanghai 200433, Peoples R China.	10111260008@fudan.edu.cn			National Basic Research grants of China [30872825, 81170857]; Program Of Shanghai Subject Chief Scientist [09XD1400900]; Shanghai Rising-Star Program [10QA1401200]; National Natural Science Foundation for Young Scholar of China [30901641]	National Basic Research grants of China; Program Of Shanghai Subject Chief Scientist; Shanghai Rising-Star Program; National Natural Science Foundation for Young Scholar of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars)	This work has been supported by National Basic Research grants of China (30872825, 81170857), Program Of Shanghai Subject Chief Scientist (A type, 09XD1400900), Shanghai Rising-Star Program (10QA1401200) and National Natural Science Foundation for Young Scholar of China (30901641). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apostolakis S, 2010, J THROMB THROMBOLYS, V29, P443, DOI 10.1007/s11239-009-0424-1; Battista D, 2006, EUR J NEUROSCI, V23, P83, DOI 10.1111/j.1460-9568.2005.04539.x; Bazan JF, 1997, NATURE, V385, P640, DOI 10.1038/385640a0; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Cardona AE, 2006, NAT NEUROSCI, V9, P917, DOI 10.1038/nn1715; Ceyhan GO, 2009, LAB INVEST, V89, P347, DOI 10.1038/labinvest.2008.170; Chapman GA, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-15-j0004.2000; Clark AK, 2007, P NATL ACAD SCI USA, V104, P10655, DOI 10.1073/pnas.0610811104; Combadiere C, 2007, J CLIN INVEST, V117, P2920, DOI 10.1172/JCI31692; CRUICKSHANKS KJ, 1993, ARCH OPHTHALMOL-CHIC, V111, P514, DOI 10.1001/archopht.1993.01090040106042; Dagkalis A, 2009, IMMUNOLOGY, V128, P25, DOI 10.1111/j.1365-2567.2009.03046.x; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Denes A, 2008, J CEREBR BLOOD F MET, V28, P1707, DOI 10.1038/jcbfm.2008.64; Fuhrmann M, 2010, NAT NEUROSCI, V13, P411, DOI 10.1038/nn.2511; Garton KJ, 2001, J BIOL CHEM, V276, P37993; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Harrison JK, 1998, P NATL ACAD SCI USA, V95, P10896, DOI 10.1073/pnas.95.18.10896; Huang DR, 2000, IMMUNOL REV, V177, P52, DOI 10.1034/j.1600-065X.2000.17709.x; Hughes PM, 2002, GLIA, V37, P314, DOI 10.1002/glia.10037; Hundhausen C, 2003, BLOOD, V102, P1186, DOI 10.1182/blood-2002-12-3775; Kempermann G, 2003, SCIENCE, V302, P1689, DOI 10.1126/science.1092864; Klosowska K, 2009, CLIN EXP IMMUNOL, V156, P312, DOI 10.1111/j.1365-2249.2009.03903.x; Kremlev SG, 2005, J NEUROIMMUNOL, V162, P71, DOI 10.1016/j.jneuroim.2005.01.010; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Langmann T, 2007, J LEUKOCYTE BIOL, V81, P1345, DOI 10.1189/jlb.0207114; Lauro C, 2008, J IMMUNOL, V180, P7590, DOI 10.4049/jimmunol.180.11.7590; Lauro C, 2006, J IMMUNOL, V177, P7599, DOI 10.4049/jimmunol.177.11.7599; Lesnik P, 2003, J CLIN INVEST, V111, P333, DOI 10.1172/JCI200315555; Li L, 2008, KIDNEY INT, V74, P1526, DOI 10.1038/ki.2008.500; Liang KJ, 2009, INVEST OPHTH VIS SCI, V50, P4444, DOI 10.1167/iovs.08-3357; Limatola C, 2005, J NEUROIMMUNOL, V166, P19, DOI 10.1016/j.jneuroim.2005.03.023; Liu C, 2008, J NEUROIMMUNOL, V198, P98, DOI 10.1016/j.jneuroim.2008.04.016; Liu ZQ, 2010, J NEUROSCI, V30, P17091, DOI 10.1523/JNEUROSCI.4403-10.2010; Lu PR, 2009, CORNEA, V28, P562, DOI 10.1097/ICO.0b013e3181930bcd; Marchesi F, 2010, J NEUROIMMUNOL, V224, P39, DOI 10.1016/j.jneuroim.2010.05.007; Meucci O, 2000, P NATL ACAD SCI USA, V97, P8075, DOI 10.1073/pnas.090017497; Milligan ED, 2004, EUR J NEUROSCI, V20, P2294, DOI 10.1111/j.1460-9568.2004.03709.x; Minghetti L, 2005, CURR OPIN NEUROL, V18, P315, DOI 10.1097/01.wco.0000169752.54191.97; Mizuno T, 2003, BRAIN RES, V979, P65, DOI 10.1016/S0006-8993(03)02867-1; Murphy PM, 2000, PHARMACOL REV, V52, P145; Ng TF, 2001, INVEST OPHTH VIS SCI, V42, P3301; Ni YQ, 2008, INVEST OPHTH VIS SCI, V49, P2589, DOI 10.1167/iovs.07-1173; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Nishiyori A, 1998, FEBS LETT, V429, P167, DOI 10.1016/S0014-5793(98)00583-3; Ransohoff RM, 2009, IMMUNITY, V31, P711, DOI 10.1016/j.immuni.2009.09.010; Raoul W, 2008, J NEUROIMMUNOL, V198, P56, DOI 10.1016/j.jneuroim.2008.04.014; Re DB, 2006, NAT NEUROSCI, V9, P859; Ross RJ, 2008, EXP EYE RES, V86, P675, DOI 10.1016/j.exer.2008.01.014; Sciume G, 2010, NEURO-ONCOLOGY, V12, P701, DOI 10.1093/neuonc/nop076; Soriano SG, 2002, J NEUROIMMUNOL, V125, P59, DOI 10.1016/S0165-5728(02)00033-4; Streit WJ, 2004, J NEUROSCI RES, V77, P1, DOI 10.1002/jnr.20093; Sunnemark D, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-17; Tan E, 2004, INVEST OPHTH VIS SCI, V45, P764, DOI 10.1167/iovs.03-1114; Tarozzo G, 2002, EUR J NEUROSCI, V15, P1663, DOI 10.1046/j.1460-9568.2002.02007.x; Tuo JS, 2007, INVEST OPHTH VIS SCI, V48, P3827, DOI 10.1167/iovs.07-0051; Verge GM, 2004, EUR J NEUROSCI, V20, P1150, DOI 10.1111/j.1460-9568.2004.03593.x; Walton NM, 2006, GLIA, V54, P815, DOI 10.1002/glia.20419; Xu HP, 2009, PROG RETIN EYE RES, V28, P348, DOI 10.1016/j.preteyeres.2009.06.001; Yang LP, 2007, MOL VIS, V13, P231; Zhang C, 2005, MOL VIS, V11, P887; Zujovic V, 2000, GLIA, V29, P305, DOI 10.1002/(SICI)1098-1136(20000215)29:4<305::AID-GLIA2>3.0.CO;2-V	62	61	65	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e35446	10.1371/journal.pone.0035446	http://dx.doi.org/10.1371/journal.pone.0035446			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22536384	gold, Green Submitted, Green Published			2022-12-27	WOS:000305336200041
J	Finer, M; Jenkins, CN				Finer, Matt; Jenkins, Clinton N.			Proliferation of Hydroelectric Dams in the Andean Amazon and Implications for Andes-Amazon Connectivity	PLOS ONE			English	Article							GREENHOUSE-GAS EMISSIONS; HYDROLOGIC CONNECTIVITY; FLOW REGULATION; RIVER; FRAGMENTATION; CONSERVATION; PERSPECTIVE; SEDIMENT; THREATS; WORLDS	Due to rising energy demands and abundant untapped potential, hydropower projects are rapidly increasing in the Neotropics. This is especially true in the wet and rugged Andean Amazon, where regional governments are prioritizing new hydroelectric dams as the centerpiece of long-term energy plans. However, the current planning for hydropower lacks adequate regional and basin-scale assessment of potential ecological impacts. This lack of strategic planning is particularly problematic given the intimate link between the Andes and Amazonian flood plain, together one of the most species rich zones on Earth. We examined the potential ecological impacts, in terms of river connectivity and forest loss, of the planned proliferation of hydroelectric dams across all Andean tributaries of the Amazon River. Considering data on the full portfolios of existing and planned dams, along with data on roads and transmission line systems, we developed a new conceptual framework to estimate the relative impacts of all planned dams. There are plans for 151 new dams greater than 2 MW over the next 20 years, more than a 300% increase. These dams would include five of the six major Andean tributaries of the Amazon. Our ecological impact analysis classified 47% of the potential new dams as high impact and just 19% as low impact. Sixty percent of the dams would cause the first major break in connectivity between protected Andean headwaters and the lowland Amazon. More than 80% would drive deforestation due to new roads, transmission lines, or inundation. We conclude with a discussion of three major policy implications of these findings. 1) There is a critical need for further strategic regional and basin scale evaluation of dams. 2) There is an urgent need for a strategic plan to maintain Andes-Amazon connectivity. 3) Reconsideration of hydropower as a low-impact energy source in the Neotropics.	[Finer, Matt] Save Amer Forests, Washington, DC USA; [Finer, Matt] Ctr Int Environm Law, Washington, DC USA; [Jenkins, Clinton N.] N Carolina State Univ, Dept Biol, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University	Finer, M (corresponding author), Save Amer Forests, Washington, DC USA.	matt.finer@gmail.com	Jenkins, Clinton/D-6134-2011	Jenkins, Clinton/0000-0003-2198-0637	National Geographic Society Committee for Research and Exploration; Blue Moon Fund; Gordon and Betty Moore Foundation; Threshold Foundation; Conservation, Food and Health Foundation; NASA [ROSES-NNX09AK22G]	National Geographic Society Committee for Research and Exploration(National Geographic Society); Blue Moon Fund; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Threshold Foundation; Conservation, Food and Health Foundation; NASA(National Aeronautics & Space Administration (NASA))	This research was supported by the National Geographic Society Committee for Research and Exploration, Blue Moon Fund, Gordon and Betty Moore Foundation, Threshold Foundation, and Conservation, Food and Health Foundation. Jenkins was supported by a NASA Biodiversity Grant (ROSES-NNX09AK22G). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalto R, 2002, IAHS-AISH P, P339; Anderson EP, 2008, AQUAT CONSERV, V18, P408, DOI 10.1002/aqc.882; Anderson EP, 2006, AQUAT CONSERV, V16, P679, DOI 10.1002/aqc.806; Anderson EP, 2011, CONSERV BIOL, V25, P30, DOI 10.1111/j.1523-1739.2010.01568.x; Anderson EP, 2010, ENV FLOWS CONCEPT AD; [Anonymous], 2011, HYDR SUST ASS PROT; [Anonymous], 2011, NATURE, V474, P420; Asamblea Nacional, 2008, CONST REPBL EC; BARROW C, 1988, J BIOGEOGR, V15, P67, DOI 10.2307/2845047; Barthem R., 1997, CATFISH CONNECTION E; Bass MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008767; Consejo Nacional de Electricidad, 2009, INV REC EN EC CON FI; Consejo Nacional de Electricidad, 2009, PLAN MAESTR EL 2009; Dunne T, 1998, GEOL SOC AM BULL, V110, P450, DOI 10.1130/0016-7606(1998)110<0450:EOSBTF>2.3.CO;2; DYNESIUS M, 1994, SCIENCE, V266, P753, DOI 10.1126/science.266.5186.753; Electro Oriente, 2011, POT HIDR REG LOR; Empresa Nacional de Electricidad, 2009, MEM AN 2008; Empresa Nacional de Electricidad, 2010, PLAN ESTR 2007 2014; Esselman PC, 2010, ECOL SOC, V15; Fearnside PM, 2004, CLIMATIC CHANGE, V66, P1, DOI 10.1023/B:CLIM.0000043174.02841.23; Fearnside PM, 2002, WATER AIR SOIL POLL, V133, P69, DOI 10.1023/A:1012971715668; Finer M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002932; Freeman MC, 2007, J AM WATER RESOUR AS, V43, P5, DOI 10.1111/j.1752-1688.2007.00002.x; Fundacion Alisos, 2011, RET DES SOST TRANSF; Goulding M, 2010, CUENCA RIO INAMBARI; Graf WL, 1999, WATER RESOUR RES, V35, P1305, DOI 10.1029/1999WR900016; Greathouse EA, 2006, ECOL APPL, V16, P339, DOI 10.1890/05-0243; Hoorn C, 2010, SCIENCE, V330, P927, DOI 10.1126/science.1194585; International Labour Organisation, 1989, CONV NO 169 IND TRIB; International Rivers, 2010, DAMS AM; International Rivers, 2008, RIP OFFS FAIL KYOT P; Jansson R, 2000, ECOLOGY, V81, P899, DOI 10.1890/0012-9658(2000)081[0899:FORFIR]2.0.CO;2; Josse C, 2007, DIGITAL ECOLOGICAL S; Laraque A, 2009, HYDROL PROCESS, V23, P3509, DOI 10.1002/hyp.7463; Laurance WF, 2009, TRENDS ECOL EVOL, V24, P659, DOI 10.1016/j.tree.2009.06.009; Lehner B., 2008, EOS T AM GEOPHYS UN, P93, DOI [DOI 10.1029/2008EO100001, 10.1029/2008EO100001]; Mcclain ME, 2008, BIOSCIENCE, V58, P325, DOI 10.1641/B580408; McLarney MO, THREAT BIODIVERSITY; MEADE RH, 1985, SCIENCE, V228, P488, DOI 10.1126/science.228.4698.488; Ministerio de Energia y Minas, 2009, PER SECT EL 2009 DOC; Ministerio de Energia y Minas, 2007, EL RES EJ FICH EST C; Ministerio de Energia y Minas, 1976, EV POT HIDR NAC 1973; Ministerio de Energia y Minas, 2008, PORT PROYECT GEN TRA; Ministerio de Energia y Minas, 2009, AN EST EL 2008; Ministerio de Energia y Minas, 2009, PLAN REF EL 2008 201; Ministerio de Hidrocarburos y Energia, 2010, PLAN ESTR I 2010 201; Ministerio de Hidrocarburos y Energia, 2009, PLAN DES EN AN ESX 2; Ministerio de Hidrocarburos y Energia, 2010, PROYECC SECT 2010 20; Ministerio de Hidrocarburos y Energia, 2009, BAL EN NAC 2000 2007; Ministerio de Minas y Energia, 2007, PORT PROYECT GEN EN; Ministerio de Minas y Energia, 2009, B EST MIN EN 2003 20; Ministerio de Minas y Energia, 2009, PLAN EXP REF GEN TRA; NatureServe, 2009, SIST EC AND NORT CTR; Nilsson C, 2005, SCIENCE, V308, P405, DOI 10.1126/science.1107887; Nogueira C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011390; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Orme CDL, 2005, NATURE, V436, P1016, DOI 10.1038/nature03850; Pringle C, 2003, HYDROL PROCESS, V17, P2685, DOI 10.1002/hyp.5145; Pringle CM, 2000, BIOSCIENCE, V50, P807, DOI 10.1641/0006-3568(2000)050[0807:REOHAO]2.0.CO;2; Red Amazonica de Informacion Socioambiental Georreferenciada, 2009, MAP AM 2009 AR PROT; Republica del Peru, 2011, LEY DER CONS PREV PU; Revenga C, 2005, PHILOS T ROY SOC B, V360, P397, DOI 10.1098/rstb.2004.1595; Revenga C., 2000, PILOT ANAL GLOBAL EC; St Louis VL, 2000, BIOSCIENCE, V50, P766, DOI 10.1641/0006-3568(2000)050[0766:RSASOG]2.0.CO;2; Stanford JA, 2001, REGUL RIVER, V17, P303, DOI 10.1002/rrr.659; Tollefson J, 2011, NATURE, V474, P430, DOI 10.1038/474430a; United Nations, 2011, UN DECL RIGHTS IND P; Vorosmarty CJ, 2010, NATURE, V467, P555, DOI 10.1038/nature09440; Wipfli MS, 2007, J AM WATER RESOUR AS, V43, P72, DOI 10.1111/j.1752-1688.2007.00007.x; World Commission on Dams, 2000, DAMS DEV NEW FRAMEWO	70	287	296	4	137	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35126	10.1371/journal.pone.0035126	http://dx.doi.org/10.1371/journal.pone.0035126			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529979	Green Published, Green Submitted, gold			2022-12-27	WOS:000305350600059
J	Lichter, S; Rafferty, B; Flohr, Z; Martini, A				Lichter, Seth; Rafferty, Benjamin; Flohr, Zachary; Martini, Ashlie			Protein High-Force Pulling Simulations Yield Low-Force Results	PLOS ONE			English	Article							STEERED MOLECULAR-DYNAMICS; FRACTURE-MECHANICS; ESCHERICHIA-COLI; SINGLE PROTEIN; RNASE-H; UBIQUITIN; TITIN; DOMAINS; INTERMEDIATE; BARNASE	All-atom explicit-solvent molecular dynamics simulations are used to pull with extremely large constant force (750-3000 pN) on three small proteins. The introduction of a nondimensional timescale permits direct comparison of unfolding across all forces. A crossover force of approximately 1100 pN divides unfolding dynamics into two regimes. At higher forces, residues sequentially unfold from the pulling end while maintaining the remainder of the protein force-free. Measurements of hydrodynamic viscous stresses are made easy by the high speeds of unfolding. Using an exact low-Reynolds-number scaling, these measurements can be extrapolated to provide, for the first time, an estimate of the hydrodynamic force on low-force unfolding. Below 1100 pN, but surprisingly still at extremely large applied force, intermediate states and cooperative unfoldings as seen at much lower forces are observed. The force-insensitive persistence of these structures indicates that decomposition into unfolded fragments requires a large fluctuation. This finding suggests how proteins are constructed to resist transient high force. The progression of alpha helix and beta sheet unfolding is also found to be insensitive to force. The force-insensitivity of key aspects of unfolding opens the possibility that numerical simulations can be accelerated by high applied force while still maintaining critical features of unfolding.	[Lichter, Seth] Northwestern Univ, Dept Mech Engn, Evanston, IL 60208 USA; [Rafferty, Benjamin; Flohr, Zachary] Purdue Univ, Coll Engn, W Lafayette, IN 47907 USA; [Martini, Ashlie] Univ Calif Merced, Sch Engn, Merced, CA USA	Northwestern University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of California System; University of California Merced	Lichter, S (corresponding author), Northwestern Univ, Dept Mech Engn, Evanston, IL 60208 USA.	s-lichter@northwestern.edu	Martini, Ashlie/F-9320-2012; Lichter, Seth H/B-7598-2009	Martini, Ashlie/0000-0003-2017-6081; 	Network for Computational Nanotechnology under National Science Foundation Cooperative Agreement [EEC-0634750]	Network for Computational Nanotechnology under National Science Foundation Cooperative Agreement	AM, BR and ZF were supported by the Network for Computational Nanotechnology under National Science Foundation Cooperative Agreement EEC-0634750. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackbarow T, 2007, P NATL ACAD SCI USA, V104, P16410, DOI 10.1073/pnas.0705759104; Baker D, 2000, NATURE, V405, P39, DOI 10.1038/35011000; Balsera M, 1997, BIOPHYS J, V73, P1281, DOI 10.1016/S0006-3495(97)78161-X; Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451; Best RB, 2008, J PHYS CHEM B, V112, P5968, DOI 10.1021/jp075955j; Best RB, 2008, J AM CHEM SOC, V130, P3706, DOI 10.1021/ja0762691; Branden C., 1998, INTRO PROTEIN STRUCT, V2nd; Buehler MJ, 2007, MATER TODAY, V10, P46, DOI 10.1016/S1369-7021(07)70208-0; BYCROFT M, 1991, BIOCHEMISTRY-US, V30, P8697, DOI 10.1021/bi00099a030; Cecconi C, 2005, SCIENCE, V309, P2057, DOI 10.1126/science.1116702; Chamberlain AK, 1996, NAT STRUCT BIOL, V3, P782, DOI 10.1038/nsb0996-782; Cieplak M, 2002, PROTEINS, V49, P104, DOI 10.1002/prot.10188; Cieplak M, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2192768; Connell KB, 2009, J MOL BIOL, V391, P450, DOI 10.1016/j.jmb.2009.05.085; Creighton T. E., 1993, PROTEINS STRUCTURES; Das A, 2009, PROTEINS, V75, P1024, DOI 10.1002/prot.22314; Djikaev YS, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.011909; Elston T, 1998, NATURE, V391, P510, DOI 10.1038/35185; Evans E, 1997, BIOPHYS J, V72, P1541, DOI 10.1016/S0006-3495(97)78802-7; Evans E., 2002, PHYS BIOMOLECULES CE, P145, DOI DOI 10.1007/3-540-45701-1_4; Fernandez JM, 2004, SCIENCE, V303, P1674, DOI 10.1126/science.1092497; Forman JR, 2007, CURR OPIN STRUC BIOL, V17, P58, DOI 10.1016/j.sbi.2007.01.006; Fujiwara M, 2000, BIOL PHARM BULL, V23, P1147; Gao M, 2002, J MUSCLE RES CELL M, V23, P513, DOI 10.1023/A:1023466608163; Gao M, 2002, BIOPHYS J, V83, P3435, DOI 10.1016/S0006-3495(02)75343-5; Gao M, 2002, J MOL BIOL, V323, P939, DOI 10.1016/S0022-2836(02)01001-X; Imparato A, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.158104; Irback A, 2005, P NATL ACAD SCI USA, V102, P13427, DOI 10.1073/pnas.0501581102; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; Jorgensen WL, 1983, J CHEM PHYS, V79; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kaminski GA, 2001, J PHYS CHEM B, V105, P6474, DOI 10.1021/jp003919d; Kirmizialtin S, 2006, PHYS STATUS SOLIDI B, V243, P2038, DOI 10.1002/pssb.200666812; Kleiner A, 2007, BIOPHYS J, V92, P2054, DOI 10.1529/biophysj.106.081257; Lee EH, 2009, STRUCTURE, V17, P1295, DOI 10.1016/j.str.2009.09.001; Li AJ, 1998, J MOL BIOL, V275, P677, DOI 10.1006/jmbi.1997.1484; Li MS, 2007, BIOPHYS J, V92, P547, DOI 10.1529/biophysj.106.087684; Li PC, 2004, J PHYS CHEM B, V108, P745, DOI 10.1021/jp0363895; Li PC, 2003, J CHEM PHYS, V119, P9260, DOI 10.1063/1.1615233; Lu H, 1998, BIOPHYS J, V75, P662, DOI 10.1016/S0006-3495(98)77556-3; Luccioli S, 2010, PHYS REV E, V81; Matouschek A, 2003, CURR OPIN STRUC BIOL, V13, P98, DOI 10.1016/S0959-440X(03)00010-1; MATOUSCHEK A, 1989, NATURE, V340, P122, DOI 10.1038/340122a0; Matysiak S, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.118103; Mitsui K, 2000, BIOCHEM BIOPH RES CO, V272, P55, DOI 10.1006/bbrc.2000.2742; Nova A, 2010, NANO LETT, V10, P2626, DOI 10.1021/nl101341w; Oberhauser AF, 1998, NATURE, V393, P181, DOI 10.1038/30270; Paramore S, 2006, BIOPHYS J, V90, P92, DOI 10.1529/biophysj.105.066969; Pedersen JA, 2010, J BIOMECH, V43, P900, DOI 10.1016/j.jbiomech.2009.11.007; Raschke TM, 1999, NAT STRUCT BIOL, V6, P825; Raschke TM, 1997, NAT STRUCT BIOL, V4, P298, DOI 10.1038/nsb0497-298; Rohs R, 1999, BIOPHYS J, V76, P2760, DOI 10.1016/S0006-3495(99)77429-1; Schlierf M, 2004, P NATL ACAD SCI USA, V101, P7299, DOI 10.1073/pnas.0400033101; Schmitt TJ, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3270167; Shank EA, 2010, NATURE, V465, P637, DOI 10.1038/nature09021; Shaqfeh ESG, 2005, J NON-NEWTON FLUID, V130, P1, DOI 10.1016/j.jnnfm.2005.05.011; Shieh AC, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/1/015012; SIMON SM, 1992, P NATL ACAD SCI USA, V89, P3770, DOI 10.1073/pnas.89.9.3770; Spudich GM, 2004, J MOL BIOL, V335, P609, DOI 10.1016/j.jmb.2003.10.052; Szymczak P, 2006, J PHYS-CONDENS MAT, V18, pL21, DOI 10.1088/0953-8984/18/1/L04; TIRADO MM, 1980, J CHEM PHYS, V73, P1986, DOI 10.1063/1.440288; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; VIJAYKUMAR S, 1987, J MOL BIOL, V194, P531, DOI 10.1016/0022-2836(87)90679-6; Wilcox AJ, 2005, P NATL ACAD SCI USA, V102, P15435, DOI 10.1073/pnas.0507324102; Wong KB, 2000, J MOL BIOL, V296, P1257, DOI 10.1006/jmbi.2000.3523	67	2	2	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e34781	10.1371/journal.pone.0034781	http://dx.doi.org/10.1371/journal.pone.0034781			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529933	gold, Green Published, Green Submitted			2022-12-27	WOS:000305350600026
J	Miehe, S; Crause, P; Schmidt, T; Lohn, M; Kleemann, HW; Licher, T; Dittrich, W; Rutten, H; Strubing, C				Miehe, Susanne; Crause, Peter; Schmidt, Thorsten; Loehn, Matthias; Kleemann, Heinz-Werner; Licher, Thomas; Dittrich, Werner; Ruetten, Hartmut; Struebing, Carsten			Inhibition of Diacylglycerol-Sensitive TRPC Channels by Synthetic and Natural Steroids	PLOS ONE			English	Article							VASCULAR SMOOTH-MUSCLE; CALCIUM-ENTRY; RAT AORTA; PROGESTERONE; MICE; CELLS; PREGNANCY; ACTIVATION; EXPRESSION; MECHANISMS	TRPC channels are a family of nonselective cation channels that regulate ion homeostasis and intracellular Ca2+ signaling in numerous cell types. Important physiological functions such as vasoregulation, neuronal growth, and pheromone recognition have been assigned to this class of ion channels. Despite their physiological relevance, few selective pharmacological tools are available to study TRPC channel function. We, therefore, screened a selection of pharmacologically active compounds for TRPC modulating activity. We found that the synthetic gestagen norgestimate inhibited diacylglycerol-sensitive TRPC3 and TRPC6 with IC(50)s of 3-5 mu M, while half-maximal inhibition of TRPC5 required significantly higher compound concentrations (>10 mu M). Norgestimate blocked TRPC-mediated vasopressin-induced cation currents in A7r5 smooth muscle cells and caused vasorelaxation of isolated rat aorta, indicating that norgestimate could be an interesting tool for the investigation of TRP channel function in native cells and tissues. The steroid hormone progesterone, which is structurally related to norgestimate, also inhibited TRPC channel activity with IC(50)s ranging from 6 to 18 mu M but showed little subtype selectivity. Thus, TRPC channel inhibition by high gestational levels of progesterone may contribute to the physiological decrease of uterine contractility and immunosuppression during pregnancy.	[Miehe, Susanne; Crause, Peter; Schmidt, Thorsten; Loehn, Matthias; Kleemann, Heinz-Werner; Licher, Thomas; Dittrich, Werner; Ruetten, Hartmut; Struebing, Carsten] Sanofi Aventis Deutschland GmbH, Res & Dev, Frankfurt, Germany	Sanofi-Aventis	Miehe, S (corresponding author), Sanofi Aventis Deutschland GmbH, Res & Dev, Frankfurt, Germany.	carsten.struebing@sanofi.com			Sanofi-Aventis	Sanofi-Aventis(Sanofi-Aventis)	This work was funded by Sanofi-Aventis. The funder employed the authors, who designed the study, collected the data, analyzed the data, and prepared the manuscript. Sanofi-Aventis approved the decision to publish the manuscript.	Barbagallo M, 2001, HYPERTENSION, V37, P142, DOI 10.1161/01.HYP.37.1.142; Becker EBE, 2009, P NATL ACAD SCI USA, V106, P6706, DOI 10.1073/pnas.0810599106; Beech DJ, 2005, CLIN EXP PHARMACOL P, V32, P597, DOI 10.1111/j.1440-1681.2005.04251.x; Boulay G, 1997, J BIOL CHEM, V272, P29672, DOI 10.1074/jbc.272.47.29672; Chang K, 2008, REPROD SCI, V15, P336, DOI 10.1177/1933719108317975; Crews JK, 1999, ARTERIOSCL THROM VAS, V19, P1034, DOI 10.1161/01.ATV.19.4.1034; Dalrymple A, 2002, MOL HUM REPROD, V8, P946, DOI 10.1093/molehr/8.10.946; Dietrich A, 2005, MOL CELL BIOL, V25, P6980, DOI 10.1128/MCB.25.16.6980-6989.2005; Dietrich A, 2010, THROMB HAEMOSTASIS, V103, P262, DOI 10.1160/TH09-08-0517; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Facemire CS, 2004, AM J PHYSIOL-RENAL, V286, pF546, DOI 10.1152/ajprenal.00338.2003; Freichel M, 2001, NAT CELL BIOL, V3, P121, DOI 10.1038/35055019; GANGRADE NK, 1992, BIOPHARM DRUG DISPOS, V13, P703, DOI 10.1002/bdd.2510130908; Glusa E, 1997, MATURITAS, V28, P181, DOI 10.1016/S0378-5122(97)00057-1; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hartmann J, 2008, NEURON, V59, P392, DOI 10.1016/j.neuron.2008.06.009; He LP, 2005, J BIOL CHEM, V280, P10997, DOI 10.1074/jbc.M411797200; JOHANSSON ED, 1969, ACTA ENDOCRINOL-COP, V61, P607, DOI 10.1530/acta.0.0610607; Jung S, 2002, AM J PHYSIOL-CELL PH, V282, pC347, DOI 10.1152/ajpcell.00283.2001; Kawabata A, 1999, J PHARMACOL EXP THER, V288, P358; Kiyonaka S, 2009, P NATL ACAD SCI USA, V106, P5400, DOI 10.1073/pnas.0808793106; Kraft R, 2007, BIOCHEM BIOPH RES CO, V361, P230, DOI 10.1016/j.bbrc.2007.07.019; Ku CY, 2006, J SOC GYNECOL INVEST, V13, P217, DOI 10.1016/j.jsgi.2005.12.007; Leypold BG, 2002, P NATL ACAD SCI USA, V99, P6376, DOI 10.1073/pnas.082127599; Majeed Y, 2011, BRIT J PHARMACOL, V162, P1509, DOI 10.1111/j.1476-5381.2010.01136.x; Maruyama Y, 2006, CIRC RES, V98, P1520, DOI 10.1161/01.RES.0000226495.34949.28; Mukerji MS, 2000, J PHARM PHARMACOL, V52, P843, DOI 10.1211/0022357001774525; Pena F, 2008, MINI-REV MED CHEM, V8, P812, DOI 10.2174/138955708784912166; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Riccio A, 2009, CELL, V137, P761, DOI 10.1016/j.cell.2009.03.039; RUNNEBAUM B, 1975, ACTA ENDOCRINOL-COP, V80, P569, DOI 10.1530/acta.0.0800569; Schwarz E. C., 2007, V179, P445; Seth M, 2009, CIRC RES, V105, P1023, DOI 10.1161/CIRCRESAHA.109.206581; Soboloff J, 2005, J BIOL CHEM, V280, P39786, DOI 10.1074/jbc.M506064200; STITES DP, 1983, IMMUNOL REV, V75, P117, DOI 10.1111/j.1600-065X.1983.tb01093.x; Stowers L, 2002, SCIENCE, V295, P1493, DOI 10.1126/science.1069259; Trebak M., 2007, V179, P593; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Yang M, 2002, BIOL REPROD, V67, P988, DOI 10.1095/biolreprod.102.004119; Zanou N, 2010, AM J PHYSIOL-CELL PH, V298, pC149, DOI 10.1152/ajpcell.00241.2009; Zhang ML, 2002, J PHARM PHARMACOL, V54, P1667, DOI 10.1211/002235702405; Zitt C, 2004, J BIOL CHEM, V279, P12427, DOI 10.1074/jbc.M309297200	42	35	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e35393	10.1371/journal.pone.0035393	http://dx.doi.org/10.1371/journal.pone.0035393			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22530015	Green Published, gold, Green Submitted			2022-12-27	WOS:000305347400047
J	Chen, B; Zhong, L; Roush, SF; Pentassuglia, L; Peng, XY; Samaras, S; Davidson, JM; Sawyer, DB; Lim, CC				Chen, Billy; Zhong, Lin; Roush, Sarah F.; Pentassuglia, Laura; Peng, Xuyang; Samaras, Susan; Davidson, Jeffrey M.; Sawyer, Douglas B.; Lim, Chee Chew			Disruption of a GATA4/Ankrd1 Signaling Axis in Cardiomyocytes Leads to Sarcomere Disarray: Implications for Anthracycline Cardiomyopathy	PLOS ONE			English	Article							ANKYRIN-REPEAT PROTEIN; HUMAN DILATED CARDIOMYOPATHY; INDUCED CARDIOTOXICITY; CARDIAC MYOCYTES; SKELETAL-MUSCLE; NUCLEAR-PROTEIN; GENE-EXPRESSION; Z-DISC; CARP; TITIN	Doxorubicin (Adriamycin) is an effective anti-cancer drug, but its clinical usage is limited by a dose-dependent cardiotoxicity characterized by widespread sarcomere disarray and loss of myofilaments. Cardiac ankyrin repeat protein (CARP, ANKRD1) is a transcriptional regulatory protein that is extremely susceptible to doxorubicin; however, the mechanism(s) of doxorubicin-induced CARP depletion and its specific role in cardiomyocytes have not been completely defined. We report that doxorubicin treatment in cardiomyocytes resulted in inhibition of CARP transcription, depletion of CARP protein levels, inhibition of myofilament gene transcription, and marked sarcomere disarray. Knockdown of CARP with small interfering RNA (siRNA) similarly inhibited myofilament gene transcription and disrupted cardiomyocyte sarcomere structure. Adenoviral overexpression of CARP, however, was unable to rescue the doxorubicin-induced sarcomere disarray phenotype. Doxorubicin also induced depletion of the cardiac transcription factor GATA4 in cardiomyocytes. CARP expression is regulated in part by GATA4, prompting us to examine the relationship between GATA4 and CARP in cardiomyocytes. We show in co-transfection experiments that GATA4 operates upstream of CARP by activating the proximal CARP promoter. GATA4-siRNA knockdown in cardiomyocytes inhibited CARP expression and myofilament gene transcription, and induced extensive sarcomere disarray. Adenoviral overexpression of GATA4 (AdV-GATA4) in cardiomyocytes prior to doxorubicin exposure maintained GATA4 levels, modestly restored CARP levels, and attenuated sarcomere disarray. Interestingly, siRNA-mediated depletion of CARP completely abolished the Adv-GATA4 rescue of the doxorubicin-induced sarcomere phenotype. These data demonstrate co-dependent roles for GATA4 and CARP in regulating sarcomere gene expression and maintaining sarcomeric organization in cardiomyocytes in culture. The data further suggests that concurrent depletion of GATA4 and CARP in cardiomyocytes by doxorubicin contributes in large part to myofibrillar disarray and the overall pathophysiology of anthracycline cardiomyopathy.	[Zhong, Lin; Roush, Sarah F.; Pentassuglia, Laura; Peng, Xuyang; Sawyer, Douglas B.; Lim, Chee Chew] Vanderbilt Univ, Sch Med, Div Cardiovasc Med, Nashville, TN 37212 USA; [Chen, Billy] Boston Univ, Sch Med, Dept Med, Program Mol Med, Boston, MA 02118 USA; [Samaras, Susan; Davidson, Jeffrey M.] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37212 USA; [Davidson, Jeffrey M.] Vet Affairs Tennessee Valley Healthcare Syst, Res Serv, Nashville, TN USA	Vanderbilt University; Boston University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Lim, CC (corresponding author), Vanderbilt Univ, Sch Med, Div Cardiovasc Med, Nashville, TN 37212 USA.	chee.lim@vanderbilt.edu	Davidson, Jeff/AAI-7288-2021		American Heart Association Established Investigator Award; NIH [RO1HL068144, RO1DK065656, K01AG024056, RO1HL095813]; VA; Genentech, Inc.; Roche, Inc.; Acorda Therapeutics, Inc.; Roch, Inc.; Acorda Therapuetics, Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095813, R01HL068144] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK065656] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K01AG024056] Funding Source: NIH RePORTER	American Heart Association Established Investigator Award(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA(US Department of Veterans Affairs); Genentech, Inc.(Roche HoldingGenentech); Roche, Inc.(Roche Holding); Acorda Therapeutics, Inc.; Roch, Inc.; Acorda Therapuetics, Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by the American Heart Association Established Investigator Award and NIH grant RO1HL068144 to DBS, NIH grant RO1DK065656 and VA support to JMD, and NIH grants K01AG024056 and RO1HL095813 to CCL. DBS has received grant support from Genentech, Inc., Roche, Inc., and Acorda Therapeutics, Inc. DBS has been a consultant for Oncothyreon, Millennium Pharmaceuticals, and Regeneron. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: DBS has received grant support from Genentech, Inc., Roch, Inc., and Acorda Therapuetics, Inc. DBS has been a consultant for Oncothyreon, Millenium Pharmaceuticals, and Regeneron. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Aihara Y, 2000, J MOL CELL CARDIOL, V32, P1401, DOI 10.1006/jmcc.2000.1173; Aihara Y, 2000, HYPERTENSION, V36, P48, DOI 10.1161/01.HYP.36.1.48; Aries A, 2004, P NATL ACAD SCI USA, V101, P6975, DOI 10.1073/pnas.0401833101; Arimura T, 2009, J AM COLL CARDIOL, V54, P334, DOI 10.1016/j.jacc.2008.12.082; Bang ML, 2001, J CELL BIOL, V153, P413, DOI 10.1083/jcb.153.2.413; Barash IA, 2007, AM J PHYSIOL-CELL PH, V293, pC218, DOI 10.1152/ajpcell.00055.2007; Belgrano A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025519; Charron F, 2001, GENE DEV, V15, P2702, DOI 10.1101/gad.915701; Chen B, 2007, CARDIOVASC TOXICOL, V7, P114, DOI 10.1007/s12012-007-0005-5; CHU W, 1995, J BIOL CHEM, V270, P10236, DOI 10.1074/jbc.270.17.10236; Coumans JVF, 1997, J MOL CELL CARDIOL, V29, P895, DOI 10.1006/jmcc.1996.0317; Duboscq-Bidot L, 2009, EUR HEART J, V30, P2128, DOI 10.1093/eurheartj/ehp225; Durocher D, 1997, EMBO J, V16, P5687, DOI 10.1093/emboj/16.18.5687; Granzier HL, 2004, CIRC RES, V94, P284, DOI 10.1161/01.RES.0000117769.88862.F8; Ikeda K, 2003, J BIOL CHEM, V278, P3514, DOI 10.1074/jbc.M204563200; Jeyaseelan R, 1997, J BIOL CHEM, V272, P22800, DOI 10.1074/jbc.272.36.22800; Kemp TJ, 2000, GENOMICS, V66, P229, DOI 10.1006/geno.2000.6213; Kim Y, 2003, MOL PHARMACOL, V63, P368, DOI 10.1124/mol.63.2.368; Knoll R, 2002, CELL, V111, P943, DOI 10.1016/s0092-8674(02)01226-6; Kobayashi S, 2010, J BIOL CHEM, V285, P793, DOI 10.1074/jbc.M109.070037; Kojic S, 2010, ARCH BIOCHEM BIOPHYS, V502, P60, DOI 10.1016/j.abb.2010.06.029; Kuo HC, 1999, DEVELOPMENT, V126, P4223; Lange S, 2005, SCIENCE, V308, P1599, DOI 10.1126/science.1110463; Lim CC, 2004, J BIOL CHEM, V279, P8290, DOI 10.1074/jbc.M308033200; Linke WA, 2008, CARDIOVASC RES, V77, P637, DOI 10.1016/j.cardiores.2007.03.029; Maeda T, 2002, GENE, V297, P1, DOI 10.1016/S0378-1119(02)00924-1; Mikhailov AT, 2008, INT J DEV BIOL, V52, P811, DOI 10.1387/ijdb.082655am; Miller MK, 2003, J MOL BIOL, V333, P951, DOI 10.1016/j.jmb.2003.09.012; Oka T, 2006, CIRC RES, V98, P837, DOI 10.1161/01.RES.0000215985.18538.c4; Pikkarainen S, 2003, J BIOL CHEM, V278, P23807, DOI 10.1074/jbc.M302719200; Sawyer DB, 2002, CIRCULATION, V105, P1551, DOI 10.1161/01.CIR.0000013839.41224.1C; Sawyer DB, 2010, PROG CARDIOVASC DIS, V53, P105, DOI 10.1016/j.pcad.2010.06.007; Sheikh F, 2008, J CLIN INVEST, V118, P3870, DOI 10.1172/JCI34472; Shi Y, 2005, AM J PATHOL, V166, P303, DOI 10.1016/S0002-9440(10)62254-7; Singal P, 2000, MOL CELL BIOCHEM, V207, P77, DOI 10.1023/A:1007094214460; SINGAL PK, 1987, J MOL CELL CARDIOL, V19, P817, DOI 10.1016/S0022-2828(87)80392-9; Torrado Mario, 2005, J Mol Cell Cardiol, V38, P353, DOI 10.1016/j.yjmcc.2004.11.034; Warren CM, 2003, ELECTROPHORESIS, V24, P1695, DOI 10.1002/elps.200305392; Witt CC, 2008, EMBO J, V27, P350, DOI 10.1038/sj.emboj.7601952; Witt SH, 2005, J MUSCLE RES CELL M, V26, P401, DOI 10.1007/s10974-005-9022-9; Zou YM, 1997, DEVELOPMENT, V124, P793	41	29	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35743	10.1371/journal.pone.0035743	http://dx.doi.org/10.1371/journal.pone.0035743			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22532871	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339200106
J	Kim, BK; Kim, SU; Kim, HS; Park, JY; Ahn, SH; Chon, CY; Cho, IR; Joh, DH; Park, YN; Han, KH; Kim, DY				Kim, Beom Kyung; Kim, Seung Up; Kim, Hyon Suk; Park, Jun Yong; Ahn, Sang Hoon; Chon, Chae Yoon; Cho, In Rae; Joh, Dong-Hoo; Park, Young Nyun; Han, Kwang-Hyub; Kim, Do Young			Prospective Validation of FibroTest in Comparison with Liver Stiffness for Predicting Liver Fibrosis in Asian Subjects with Chronic Hepatitis B	PLOS ONE			English	Article							OPERATING CHARACTERISTIC CURVES; TRANSIENT ELASTOGRAPHY; BIOCHEMICAL MARKERS; NONINVASIVE ASSESSMENT; BIOPSY; CIRRHOSIS; DIAGNOSIS; VARIABILITY; LAMIVUDINE; ACTITEST	Background and Aims: Diagnostic values of FibroTest (FT) for hepatic fibrosis have rarely been assessed in Asian chronic hepatitis B (CHB) patients. We aimed to validate its diagnostic performances in comparison with liver stiffness (LS). Methods: From 2008 to 2010, 194 CHB patients who underwent liver biopsies along with FT and transient elastography were prospectively enrolled. Fibrosis stage was assessed according to the Batts and Ludwig system. Results: To predict significant fibrosis (F >= 2), advanced fibrosis (F >= 3), and cirrhosis (F=4), areas under receiver operating characteristic curves (AUROCs) of FT were 0.903, 0.907, and 0.866, comparable to those of LS (0.873, 0.897, and 0.910, respectively). Optimized cutoffs of FT to maximize sum of sensitivity and specificity were 0.32, 0.52, and 0.68 for F >= 2, F >= 3, and F=4, while those of LS were 8.8, 10.2, and 14.1 kPa, respectively. According to FT and LS cutoffs, 123 (63.4%) and 124 (63.9%) patients were correctly classified consistent with histological fibrosis (F1, F2, F3, and F4), respectively. Overall concordance between each fibrosis stage estimated by FT and LS was observed in 111 patients, where 88 were correctly classified with histological results. A combination formula adding LS to FT (LS+FT) showed similar AUROC levels (0.885, 0.905, and 0.915), while another multiplying LS by FT (LSxFT) showed the best AUROCs (0.941, 0.931, and 0.929 for F >= 2, F >= 3, and F4, respectively). Conclusions: FT provides good fibrosis prediction, with comparable outcomes to LS in Asian CHB patients. FT substantially reduces need for liver biopsy, especially when used in combination with LS.	[Kim, Beom Kyung; Kim, Seung Up; Park, Jun Yong; Ahn, Sang Hoon; Chon, Chae Yoon; Cho, In Rae; Joh, Dong-Hoo; Han, Kwang-Hyub; Kim, Do Young] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Kim, Beom Kyung; Kim, Seung Up; Park, Jun Yong; Ahn, Sang Hoon; Chon, Chae Yoon; Han, Kwang-Hyub; Kim, Do Young] Yonsei Univ, Coll Med, Yonsei Inst Gastroenterol, Seoul, South Korea; [Kim, Hyon Suk] Yonsei Univ, Coll Med, Dept Lab Med, Seoul, South Korea; [Park, Young Nyun] Yonsei Univ, Coll Med, Dept Pathol, Seoul, South Korea; [Kim, Beom Kyung; Kim, Seung Up; Park, Jun Yong; Ahn, Sang Hoon; Chon, Chae Yoon; Han, Kwang-Hyub; Kim, Do Young] Yonsei Univ, Coll Med, Liver Cirrhosis Clin Res Ctr, Seoul, South Korea; [Ahn, Sang Hoon; Han, Kwang-Hyub; Kim, Do Young] Yonsei Univ, Coll Med, Brain Korea Project Med Sci 21, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Kim, DY (corresponding author), Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea.	dyk1025@yuhs.ac	Park, Jun Yong/H-7127-2019; Kim, Hyon-Suk/R-4113-2017	Kim, Hyon-Suk/0000-0001-5662-7740; Han, Kwang-Hyub/0000-0003-3960-6539; Park, Jun Yong/0000-0001-6324-2224; Park, Young Nyun/0000-0003-0357-7967; Kim, Beom Kyung/0000-0002-5363-2496; Ahn, Sang Hoon/0000-0002-3629-4624; Kim, Seung Up/0000-0002-9658-8050	Korea Healthcare technology R & D project, Ministry of Health and Welfare, Republic of Korea [A102065]	Korea Healthcare technology R & D project, Ministry of Health and Welfare, Republic of Korea	This study was supported by a grant of the Korea Healthcare technology R & D project, Ministry of Health and Welfare, Republic of Korea (A102065). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afdhal NH, 2003, HEPATOLOGY, V37, P972, DOI 10.1053/jhep.2003.50223; BATTS KP, 1995, AM J SURG PATHOL, V19, P1409, DOI 10.1097/00000478-199512000-00007; Bedossa P, 2003, HEPATOLOGY, V38, P1449, DOI 10.1016/j.hep.2003.09.022; Castera L, 2005, GASTROENTEROLOGY, V128, P343, DOI 10.1053/j.gastro.2004.11.018; Castera L, 2008, J HEPATOL, V48, P835, DOI 10.1016/j.jhep.2008.02.008; Chang PE, 2008, ALIMENT PHARM THER, V28, P51, DOI 10.1111/j.1365-2036.2008.03711.x; de Franchis R, 2008, J HEPATOL, V49, P520, DOI 10.1016/j.jhep.2008.07.009; Degertekin B, 2009, HEPATOLOGY, V49, pS129, DOI 10.1002/hep.22931; Fluss R, 2005, BIOMETRICAL J, V47, P458, DOI 10.1002/bimj.200410135; Fontaine H, 2007, GASTROEN CLIN BIOL, V31, P504, DOI 10.1016/S0399-8320(07)89420-6; Forns X, 2002, HEPATOLOGY, V36, P986, DOI 10.1053/jhep.2002.36128; Friedrich-Rust M, 2008, GASTROENTEROLOGY, V134, P960, DOI 10.1053/j.gastro.2008.01.034; Fung J, 2011, AM J GASTROENTEROL, V106, P492, DOI 10.1038/ajg.2010.463; Halfon P, 2008, GASTROEN CLIN BIOL, V32, P22, DOI 10.1016/S0399-8320(08)73991-5; Han KH, 2008, INTERVIROLOGY, V51, P11, DOI 10.1159/000122594; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; Imbert-Bismut F, 2001, LANCET, V357, P1069, DOI 10.1016/S0140-6736(00)04258-6; Jung KS, 2011, HEPATOLOGY, V53, P885, DOI 10.1002/hep.24121; Kim BK, 2010, LIVER INT, V30, P1073, DOI 10.1111/j.1478-3231.2010.02269.x; Kim BK, 2010, LIVER INT, V30, P546, DOI 10.1111/j.1478-3231.2009.02192.x; Kim DY, 2009, DIGEST DIS SCI, V54, P1758, DOI 10.1007/s10620-008-0541-2; Kim SU, 2010, ALIMENT PHARM THER, V32, P498, DOI 10.1111/j.1365-2036.2010.04353.x; Kim SU, 2010, WORLD J GASTROENTERO, V16, P5173, DOI 10.3748/wjg.v16.i41.5173; Kim SU, 2009, J CLIN GASTROENTEROL, V43, P267, DOI 10.1097/MCG.0b013e31816f212e; Lackner C, 2005, HEPATOLOGY, V41, P1376, DOI 10.1002/hep.20717; Liaw YF, 2004, NEW ENGL J MED, V351, P1521, DOI 10.1056/NEJMoa033364; Lok ASF, 2007, HEPATOLOGY, V45, P507, DOI 10.1002/hep.21513; Myers RP, 2003, J HEPATOL, V39, P222, DOI 10.1016/S0168-8278(03)00171-5; Poynard T, 2007, ALIMENT PHARM THER, V25, P733, DOI 10.1111/j.1365-2036.2007.03252.x; Poynard T, 2005, AM J GASTROENTEROL, V100, P1970, DOI 10.1111/j.1572-0241.2005.41957.x; Poynard T, 2004, CLIN CHEM, V50, P1344, DOI 10.1373/clinchem.2004.032227; Poynard T, 2007, BMC GASTROENTEROL, V7, DOI 10.1186/1471-230X-7-40; Raftopoulos SC, 2011, HEPATOL INT; Sebastiani G, 2007, WORLD J GASTROENTERO, V13, P525, DOI 10.3748/wjg.v13.i4.525; Shaheen AAM, 2007, AM J GASTROENTEROL, V102, P2589, DOI 10.1111/j.1572-0241.2007.01466.x; Sheth SG, 1998, AM J GASTROENTEROL, V93, P44, DOI 10.1111/j.1572-0241.1998.044_c.x; Spinzi G, 2001, NEW ENGL J MED, V344, P2030; Stibbe KJM, 2011, SCAND J GASTROENTERO, V46, P962, DOI 10.3109/00365521.2011.574725; Wai CT, 2006, LIVER INT, V26, P666, DOI 10.1111/j.1478-3231.2006.01287.x; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; Ziol M, 2005, HEPATOLOGY, V41, P48, DOI 10.1002/hep.20506	41	42	44	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35825	10.1371/journal.pone.0035825	http://dx.doi.org/10.1371/journal.pone.0035825			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536445	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339200117
J	Mirabella, G; Iaconelli, S; Spadacenta, S; Federico, P; Gallese, V				Mirabella, Giovanni; Iaconelli, Sara; Spadacenta, Silvia; Federico, Paolo; Gallese, Vittorio			Processing of Hand-Related Verbs Specifically Affects the Planning and Execution of Arm Reaching Movements	PLOS ONE			English	Article							FIXED-EFFECT FALLACY; MOTOR SYSTEM; ACTION WORDS; LANGUAGE COMPREHENSION; SENTENCE COMPREHENSION; PREMOTOR CORTEX; HUMAN BRAIN; TIME-COURSE; ASYMMETRIES; REPRESENTATIONS	Even though a growing body of research has shown that the processing of action language affects the planning and execution of motor acts, several aspects of this interaction are still hotly debated. The directionality (i.e. does understanding action-related language induce a facilitation or an interference with the corresponding action?), the time course, and the nature of the interaction (i.e. under what conditions does the phenomenon occur?) are largely unclear. To further explore this topic we exploited a go/no-go paradigm in which healthy participants were required to perform arm reaching movements toward a target when verbs expressing either hand or foot actions were shown, and to refrain from moving when abstract verbs were presented. We found that reaction times (RT) and percentages of errors increased when the verb involved the same effector used to give the response. This interference occurred very early, when the interval between verb presentation and the delivery of the go signal was 50 ms, and could be elicited until this delay was about 600 ms. In addition, RTs were faster when subjects used the right arm than when they used the left arm, suggesting that action-verb understanding is left-lateralized. Furthermore, when the color of the printed verb and not its meaning was the cue for movement execution the differences between RTs and error percentages between verb categories disappeared, unequivocally indicating that the phenomenon occurs only when the semantic content of a verb has to be retrieved. These results are compatible with the theory of embodied language, which hypothesizes that comprehending verbal descriptions of actions relies on an internal simulation of the sensory-motor experience of the action, and provide a new and detailed view of the interplay between action language and motor acts.	[Mirabella, Giovanni; Iaconelli, Sara] Ist Neurol Mediterraneo Neuromed, Dept Neurosci, Pozzilli, IS, Italy; [Mirabella, Giovanni; Federico, Paolo] Univ Aquila, Dept Expt Med, I-67100 Laquila, Italy; [Spadacenta, Silvia] Univ Roma La Sapienza, Dept Physiol & Pharmacol, Rome, Italy; [Gallese, Vittorio] Univ Parma, Dept Neurosci, Physiol Sect, I-43100 Parma, Italy; [Gallese, Vittorio] Brain Ctr Social & Motor Cognit, IIT, Parma, Italy	IRCCS Neuromed; University of L'Aquila; Sapienza University Rome; University of Parma; Istituto Italiano di Tecnologia - IIT	Mirabella, G (corresponding author), Ist Neurol Mediterraneo Neuromed, Dept Neurosci, Pozzilli, IS, Italy.	giovanni.mirabella@uniroma1.it; vittorio.gallese@unipr.it	Mirabella, Giovanni/AAB-2818-2019; Federico, Paolo/K-8865-2016; Gallese, Vittorio/ABD-5097-2021	Mirabella, Giovanni/0000-0002-4405-2609; Federico, Paolo/0000-0001-5218-2545; Gallese, Vittorio/0000-0003-4815-3607	Italian Ministry of Work, Health and Social Policies; Italian Ministry of University and Research [2008_RBFNLH_005]; EU	Italian Ministry of Work, Health and Social Policies(Ministry of Health, Italy); Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); EU(European Commission)	This research was supported by the Italian Ministry of Work, Health and Social Policies (Bando Giovani Ricercatori 2007 to GM), by the Italian Ministry of University and Research (PRIN n. 2008_RBFNLH_005 to GM), and by the EU grants TESIS and ROSSI to V. G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravena P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011751; Aziz-Zadeh L, 2006, CURR BIOL, V16, P1818, DOI 10.1016/j.cub.2006.07.060; Bak TH, 2001, BRAIN, V124, P103, DOI 10.1093/brain/124.1.103; Barthelemy S, 2002, EXP BRAIN RES, V147, P305, DOI 10.1007/s00221-002-1247-x; Barthelemy S, 2001, NEUROSCI LETT, V315, P41, DOI 10.1016/S0304-3940(01)02313-8; Bertinetto P. M., 2005, CORPUS LESSICO FREQU; Borreggine KL, 2006, COGNITIVE SCI, V30, P1097, DOI 10.1207/s15516709cog0000_91; Boulenger V, 2008, J PHYSIOL-PARIS, V102, P130, DOI 10.1016/j.jphysparis.2008.03.015; Boulenger V, 2008, NEUROPSYCHOLOGIA, V46, P743, DOI 10.1016/j.neuropsychologia.2007.10.007; Boulenger V, 2006, J COGNITIVE NEUROSCI, V18, P1607, DOI 10.1162/jocn.2006.18.10.1607; Boulenger V, 2009, CEREB CORTEX, V19, P1905, DOI 10.1093/cercor/bhn217; Boulinguez P, 2001, CORTEX, V37, P101, DOI 10.1016/S0010-9452(08)70561-6; Bub DN, 2010, COGNITION, V116, P394, DOI 10.1016/j.cognition.2010.06.001; Buccino G, 2005, COGNITIVE BRAIN RES, V24, P355, DOI 10.1016/j.cogbrainres.2005.02.020; Cisek P, 2003, J NEUROPHYSIOL, V89, P922, DOI 10.1152/jn.00607.2002; CLARK HH, 1973, J VERB LEARN VERB BE, V12, P335, DOI 10.1016/S0022-5371(73)80014-3; Dehaene S, 2001, NAT NEUROSCI, V4, P752, DOI 10.1038/89551; Desai RH, 2010, CEREB CORTEX, V20, P468, DOI 10.1093/cercor/bhp115; Donchin O, 2002, J NEUROPHYSIOL, V88, P3498, DOI 10.1152/jn.00335.2001; Fischer MH, 2008, Q J EXP PSYCHOL, V61, P825, DOI 10.1080/17470210701623605; GALABURDA AM, 1978, SCIENCE, V199, P852, DOI 10.1126/science.341314; Gallese V, 2005, COGN NEUROPSYCHOL, V22, P455, DOI 10.1080/02643290442000310; Gallese V, 2008, SOC NEUROSCI-UK, V3, P317, DOI 10.1080/17470910701563608; Glenberg AM, 2002, PSYCHON B REV, V9, P558, DOI 10.3758/BF03196313; Hauk O, 2008, J PHYSIOL-PARIS, V102, P50, DOI 10.1016/j.jphysparis.2008.03.013; Hauk O, 2006, NEUROIMAGE, V30, P1383, DOI 10.1016/j.neuroimage.2005.11.048; Hauk O, 2004, NEURON, V41, P301, DOI 10.1016/S0896-6273(03)00838-9; Hauk O, 2004, HUM BRAIN MAPP, V21, P191, DOI 10.1002/hbm.10157; Kaschak MP, 2008, Q J EXP PSYCHOL, V61, P883, DOI 10.1080/17470210701623852; Kawashima R, 1998, EUR J NEUROSCI, V10, P2254, DOI 10.1046/j.1460-9568.1998.00237.x; Kobayashi M, 2003, NEUROIMAGE, V20, P2259, DOI 10.1016/S1053-8119(03)00220-9; Mahon BZ, 2005, COGN NEUROPSYCHOL, V22, P480, DOI 10.1080/02643290442000446; Naccache L, 2005, P NATL ACAD SCI USA, V102, P7713, DOI 10.1073/pnas.0500542102; Neininger B, 2003, NEUROPSYCHOLOGIA, V41, P53, DOI 10.1016/S0028-3932(02)00126-4; OJEMANN GA, 1991, J NEUROSCI, V11, P2281; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pulvermuller F, 2005, NAT REV NEUROSCI, V6, P576, DOI 10.1038/nrn1706; Pulvermuller F, 2005, EUR J NEUROSCI, V21, P793, DOI 10.1111/j.1460-9568.2005.03900.x; Pulvermuller F., 2002, NEUROSCIENCE LANGUAG; Raaijmakers JGW, 2003, CAN J EXP PSYCHOL, V57, P141, DOI 10.1037/h0087421; Sato M, 2008, BRAIN LANG, V105, P83, DOI 10.1016/j.bandl.2007.10.001; Scorolli C, 2007, BRAIN RES, V1130, P119, DOI 10.1016/j.brainres.2006.10.033; Tettamanti M, 2005, J COGNITIVE NEUROSCI, V17, P273, DOI 10.1162/0898929053124965; Willems RM, 2010, PSYCHOL SCI, V21, P67, DOI 10.1177/0956797609354072; Zwaan RA, 2002, PSYCHOL SCI, V13, P168, DOI 10.1111/1467-9280.00430; Zwaan RA, 2006, J EXP PSYCHOL GEN, V135, P1, DOI 10.1037/0096-3445.135.1.1	46	41	41	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35403	10.1371/journal.pone.0035403	http://dx.doi.org/10.1371/journal.pone.0035403			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UD	22536380	Green Published, gold, Green Submitted			2022-12-27	WOS:000305339200062
J	Moore, JM; Rabaia, NA; Smith, LE; Fagerlie, S; Gurley, K; Loukinov, D; Disteche, CM; Collins, SJ; Kemp, CJ; Lobanenkov, VV; Filippova, GN				Moore, James M.; Rabaia, Natalia A.; Smith, Leslie E.; Fagerlie, Sara; Gurley, Kay; Loukinov, Dmitry; Disteche, Christine M.; Collins, Steven J.; Kemp, Christopher J.; Lobanenkov, Victor V.; Filippova, Galina N.			Loss of Maternal CTCF Is Associated with Peri-Implantation Lethality of Ctcf Null Embryos	PLOS ONE			English	Article							ENHANCER-BLOCKING ACTIVITY; PROTEIN CTCF; ZYGOTIC TRANSITION; GENE-EXPRESSION; X-INACTIVATION; BINDING-SITES; METHYLATION; OOCYTE; TRANSCRIPTION; PROMOTER	CTCF is a highly conserved, multifunctional zinc finger protein involved in critical aspects of gene regulation including transcription regulation, chromatin insulation, genomic imprinting, X-chromosome inactivation, and higher order chromatin organization. Such multifunctional properties of CTCF suggest an essential role in development. Indeed, a previous report on maternal depletion of CTCF suggested that CTCF is essential for pre-implantation development. To distinguish between the effects of maternal and zygotic expression of CTCF, we studied pre-implantation development in mice harboring a complete loss of function Ctcf knockout allele. Although we demonstrated that homozygous deletion of Ctcf is early embryonically lethal, in contrast to previous observations, we showed that the Ctcf nullizygous embryos developed up to the blastocyst stage (E3.5) followed by peri-implantation lethality (E4.5-E5.5). Moreover, one-cell stage Ctcf nullizygous embryos cultured ex vivo developed to the 16-32 cell stage with no obvious abnormalities. Using a single embryo assay that allowed both genotype and mRNA expression analyses of the same embryo, we demonstrated that pre-implantation development of the Ctcf nullizygous embryos was associated with the retention of the maternal wild type Ctcf mRNA. Loss of this stable maternal transcript was temporally associated with loss of CTCF protein expression, apoptosis of the developing embryo, and failure to further develop an inner cell mass and trophoectoderm ex vivo. This indicates that CTCF expression is critical to early embryogenesis and loss of its expression rapidly leads to apoptosis at a very early developmental stage. This is the first study documenting the presence of the stable maternal Ctcf transcript in the blastocyst stage embryos. Furthermore, in the presence of maternal CTCF, zygotic CTCF expression does not seem to be required for pre-implantation development.	[Moore, James M.; Rabaia, Natalia A.; Smith, Leslie E.; Fagerlie, Sara; Gurley, Kay; Collins, Steven J.; Kemp, Christopher J.; Filippova, Galina N.] Fred Hutchinson Canc Res Ctr, Human Biol Div, Seattle, WA 98104 USA; [Loukinov, Dmitry; Lobanenkov, Victor V.] NIAID, Mol Pathol Sect, Immunopathol Lab, NIH, Rockville, MD USA; [Disteche, Christine M.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Washington; University of Washington Seattle	Filippova, GN (corresponding author), Fred Hutchinson Canc Res Ctr, Human Biol Div, 1124 Columbia St, Seattle, WA 98104 USA.	gfilippo@fhcrc.org	Lobanenkov, Victor/ABD-5710-2021; Lobanenkov, Victor V./AGQ-8903-2022	Lobanenkov, Victor/0000-0001-6665-3635	National Institutes of Health [CA68360];  [GM 46883]; NATIONAL CANCER INSTITUTE [P30CA015704, R01CA068360] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001021, ZIAAI000860] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046883] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grant CA68360 (G.N.F. and V. V. L.) and in part by grant GM 46883 (C. M. D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreu-Vieyra CV, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000453; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Bultman SJ, 2006, GENE DEV, V20, P1744, DOI 10.1101/gad.1435106; Burcin M, 1997, MOL CELL BIOL, V17, P1281, DOI 10.1128/MCB.17.3.1281; Cai CL, 2010, MOL BIOL CELL, V21, P3137, DOI 10.1091/mbc.E10-03-0255; Chao W, 2002, SCIENCE, V295, P345, DOI 10.1126/science.1065982; Colegrove-Otero LJ, 2005, CRIT REV BIOCHEM MOL, V40, P21, DOI 10.1080/10409230590918612; Cuddapah S, 2009, GENOME RES, V19, P24, DOI 10.1101/gr.082800.108; Docquier F, 2005, CANCER RES, V65, P5112, DOI 10.1158/0008-5472.CAN-03-3498; Dodge JE, 2004, MOL CELL BIOL, V24, P2478, DOI 10.1128/MCB.24.6.2478-2486.2004; EDELHOFF S, 1994, ONCOGENE, V9, P665; Fedoriw AM, 2004, SCIENCE, V303, P238, DOI 10.1126/science.1090934; Filippova GN, 2008, CURR TOP DEV BIOL, V80, P337, DOI 10.1016/S0070-2153(07)80009-3; Filippova GN, 2005, DEV CELL, V8, P31, DOI 10.1016/j.devcel.2004.10.018; Filippova GN, 1996, MOL CELL BIOL, V16, P2802; Filippova GN, 1998, GENE CHROMOSOME CANC, V22, P26, DOI 10.1002/(SICI)1098-2264(199805)22:1<26::AID-GCC4>3.0.CO;2-9; GEBAUER F, 1994, EMBO J, V13, P5712, DOI 10.1002/j.1460-2075.1994.tb06909.x; Ghirlando R., 2012, BIOCH BIOPHYS ACTA; Hamatani T, 2004, DEV CELL, V6, P117, DOI 10.1016/S1534-5807(03)00373-3; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Heath H, 2008, EMBO J, V27, P2839, DOI 10.1038/emboj.2008.214; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; KLENOVA EM, 1993, MOL CELL BIOL, V13, P7612, DOI 10.1128/MCB.13.12.7612; Ling JQ, 2006, SCIENCE, V312, P269, DOI 10.1126/science.1123191; LOBANENKOV VV, 1990, ONCOGENE, V5, P1743; Lykke-Andersen K, 2008, MOL BIOL CELL, V19, P4383, DOI 10.1091/mbc.E08-02-0219; Ma J, 2006, DEVELOPMENT, V133, P2053, DOI 10.1242/dev.02371; Ma PP, 2008, DEV BIOL, V319, P110, DOI 10.1016/j.ydbio.2008.04.011; Mager J, 2006, MAMM GENOME, V17, P941, DOI 10.1007/s00335-006-0034-6; Mukhopadhyay R, 2004, GENOME RES, V14, P1594, DOI 10.1101/gr.2408304; Nagy A., 2003, MANIPULATING MOUSE E; Oh B, 2000, DEVELOPMENT, V127, P3795; Ohlsson R, 2001, TRENDS GENET, V17, P520, DOI 10.1016/S0168-9525(01)02366-6; Payer B, 2003, CURR BIOL, V13, P2110, DOI 10.1016/j.cub.2003.11.026; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Rasko JEJ, 2001, CANCER RES, V61, P6002; Renaud S, 2005, NUCLEIC ACIDS RES, V33, P6850, DOI 10.1093/nar/gki989; Rhee HS, 2011, CELL, V147, P1408, DOI 10.1016/j.cell.2011.11.013; ROWE LB, 1994, MAMM GENOME, V5, P253, DOI 10.1007/BF00389540; Schier AF, 2007, SCIENCE, V316, P406, DOI 10.1126/science.1140693; Schoenherr CJ, 2003, NAT GENET, V33, P66, DOI 10.1038/ng1057; Schultz RM, 2002, HUM REPROD UPDATE, V8, P323, DOI 10.1093/humupd/8.4.323; Stitzel ML, 2007, SCIENCE, V316, P407, DOI 10.1126/science.1138236; Tadros W, 2009, DEVELOPMENT, V136, P3033, DOI 10.1242/dev.033183; Tallquist MD, 2000, GENESIS, V26, P113, DOI 10.1002/(SICI)1526-968X(200002)26:2<113::AID-GENE3>3.0.CO;2-2; Vastenhouw NL, 2010, NATURE, V464, P922, DOI 10.1038/nature08866; Vostrov AA, 1997, J BIOL CHEM, V272, P33353, DOI 10.1074/jbc.272.52.33353; Wallace JA, 2007, CURR OPIN GENET DEV, V17, P400, DOI 10.1016/j.gde.2007.08.005; Wan LB, 2008, DEVELOPMENT, V135, P2729, DOI 10.1242/dev.024539; Wu XM, 2003, BIOL REPROD, V69, P861, DOI 10.1095/biolreprod.103.016022; Xu N, 2007, NAT GENET, V39, P1390, DOI 10.1038/ng.2007.5; Yang YX, 1999, J NEUROCHEM, V73, P2286, DOI 10.1046/j.1471-4159.1999.0732286.x; Zeng FY, 2005, DEV BIOL, V283, P40, DOI 10.1016/j.ydbio.2005.03.038; Zhang H, 2011, J CELL BIOL, V193, P475, DOI 10.1083/jcb.201101021	56	107	110	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e34915	10.1371/journal.pone.0034915	http://dx.doi.org/10.1371/journal.pone.0034915			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22532833	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339200027
J	Prado, P; Tomas, F; Pinna, S; Farina, S; Roca, G; Ceccherelli, G; Romero, J; Alcoverro, T				Prado, Patricia; Tomas, Fiona; Pinna, Stefania; Farina, Simone; Roca, Guillem; Ceccherelli, Giulia; Romero, Javier; Alcoverro, Teresa			Habitat and Scale Shape the Demographic Fate of the Keystone Sea Urchin Paracentrotus lividus in Mediterranean Macrophyte Communities	PLOS ONE			English	Article							SUPPLY-SIDE ECOLOGY; LONG-DISTANCE DISPERSAL; STRONGYLOCENTROTUS-DROEBACHIENSIS; BENTHIC INVERTEBRATES; SEDIMENT RETENTION; LARVAL DISPERSAL; TROPHIC LINKAGES; SEAGRASS MEADOW; ABUNDANCE; RECRUITMENT	Demographic processes exert different degrees of control as individuals grow, and in species that span several habitats and spatial scales, this can influence our ability to predict their population at a particular life-history stage given the previous life stage. In particular, when keystone species are involved, this relative coupling between demographic stages can have significant implications for the functioning of ecosystems. We examined benthic and pelagic abundances of the sea urchin Paracentrotus lividus in order to: 1) understand the main life-history bottlenecks by observing the degree of coupling between demographic stages; and 2) explore the processes driving these linkages. P. lividus is the dominant invertebrate herbivore in the Mediterranean Sea, and has been repeatedly observed to overgraze shallow beds of the seagrass Posidonia oceanica and rocky macroalgal communities. We used a hierarchical sampling design at different spatial scales (100 s, 10 s and <1 km) and habitats (seagrass and rocky macroalgae) to describe the spatial patterns in the abundance of different demographic stages (larvae, settlers, recruits and adults). Our results indicate that large-scale factors (potentially currents, nutrients, temperature, etc.) determine larval availability and settlement in the pelagic stages of urchin life history. In rocky macroalgal habitats, benthic processes (like predation) acting at large or medium scales drive adult abundances. In contrast, adult numbers in seagrass meadows are most likely influenced by factors like local migration (from adjoining rocky habitats) functioning at much smaller scales. The complexity of spatial and habitat-dependent processes shaping urchin populations demands a multiplicity of approaches when addressing habitat conservation actions, yet such actions are currently mostly aimed at managing predation processes and fish numbers. We argue that a more holistic ecosystem management also needs to incorporate the landscape and habitat-quality level processes (eutrophication, fragmentation, etc.) that together regulate the populations of this keystone herbivore.	[Prado, Patricia] IRTA, Tarragona, Spain; [Prado, Patricia] E Carolina Univ, Dept Biol, Greenville, NC USA; [Tomas, Fiona] Inst Mediterraneo Estudios Avanzados IMEDEA, Islas Baleares, Spain; [Pinna, Stefania; Ceccherelli, Giulia] Univ Sassari, Dept Sci Nat & Environm Resources, I-07100 Sassari, Italy; [Farina, Simone; Roca, Guillem; Alcoverro, Teresa] CSIC, CEAB, Girona, Spain; [Romero, Javier] Univ Barcelona, Dept Ecol, Fac Biol, E-08028 Barcelona, Spain	IRTA; University of North Carolina; East Carolina University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); University of Sassari; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB); University of Barcelona	Prado, P (corresponding author), IRTA, Tarragona, Spain.	patricia.prado@irta.cat	Alcoverro, Teresa/J-9258-2012; Farina, Simone/ABF-4876-2021; Villegas, Patricia Prado/J-7483-2012; Prado, Patricia/N-9903-2019; Farina, Simone/AAB-9308-2021; Romero, Javier/A-8905-2013; Tomas, Fiona/G-3713-2010	Alcoverro, Teresa/0000-0002-3910-9594; Villegas, Patricia Prado/0000-0002-4986-2010; Prado, Patricia/0000-0002-4986-2010; Farina, Simone/0000-0003-0169-8044; Romero, Javier/0000-0002-2772-8486; Ceccherelli, Giulia/0000-0002-9832-9677; Roca, Guillem/0000-0002-8225-6047; Tomas, Fiona/0000-0001-8682-2504	Plan Nacional de I+D+i - Ministerio de Ciencia e Innovacion (Spain) [CTM2010-22273-C02]; Juan de la Cierva program	Plan Nacional de I+D+i - Ministerio de Ciencia e Innovacion (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Juan de la Cierva program	This work was supported by the project CTM2010-22273-C02 awarded by the Plan Nacional de I+D+i - Ministerio de Ciencia e Innovacion (Spain) and F.T. was funded by the Juan de la Cierva program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAILEY KM, 1989, ADV MAR BIOL, V25, P1; BALLESTEROS E, 1993, MONOGRAFIES SOC HIST, V2, P663; Ballesteros E, 1992, ARXIU SECCIO CIENCIE, V101, P616; Barnes DKA, 2001, J MAR BIOL ASSOC UK, V81, P359, DOI 10.1017/S0025315401003927; Baums IB, 2006, LIMNOL OCEANOGR, V51, P1969, DOI 10.4319/lo.2006.51.5.1969; Bittner M, SEA SURFACE TEMPERAT; Boudouresque C.F., 1987, C INT PAR LIV OURS C, P159; BOUDOURESQUE CF, 2001, EDIBLE SEA URCHINS B, V32, P177; Calderon I, 2009, MOL ECOL, V18, P962; Hernandez JC, 2010, MAR ECOL PROG SER, V413, P69, DOI 10.3354/meps08684; Ceccherelli G, 2009, J SHELLFISH RES, V28, P397, DOI 10.2983/035.028.0224; Cowen Robert K., 2003, Gulf and Caribbean Research, V14, P129; Cowen RK, 2009, ANNU REV MAR SCI, V1, P443, DOI 10.1146/annurev.marine.010908.163757; DANCE C, 1987, MAR ECOL-P S Z N I, V8, P131, DOI 10.1111/j.1439-0485.1987.tb00179.x; DENNY M, 1992, BIOL BULL, V183, P220, DOI 10.2307/1542209; EMLET RB, 1983, BIOL BULL, V164, P433, DOI 10.2307/1541253; Estrada M, 1996, SCI MAR, V60, P55; Fagan WE, 1999, AM NAT, V153, P165, DOI 10.1086/303162; Farina S, 2009, MAR ECOL PROG SER, V377, P131, DOI 10.3354/meps07692; FENAUX L, 1994, LIMNOL OCEANOGR, V39, P84, DOI 10.4319/lo.1994.39.1.0084; Fernandez C, 2001, J MAR BIOL ASSOC UK, V81, P361, DOI 10.1017/S0025315401003939; FORMAN RTT, 1981, BIOSCIENCE, V31, P733, DOI 10.2307/1308780; Francour P, 1997, MAR ECOL-P S Z N I, V18, P157, DOI 10.1111/j.1439-0485.1997.tb00434.x; Friedlander AM, 1991, J EXPT MARINE BIOL E, V224, P1; Gacia E, 2001, ESTUAR COAST SHELF S, V52, P505, DOI 10.1006/ecss.2000.0753; Gacia E, 1999, AQUAT BOT, V65, P255, DOI 10.1016/S0304-3770(99)00044-3; GAINES S, 1985, P NATL ACAD SCI USA, V82, P3707, DOI 10.1073/pnas.82.11.3707; Garcia-Charton JA, 2001, MAR BIOL, V138, P917, DOI 10.1007/s002270000524; GROSBERG RK, 1992, TRENDS ECOL EVOL, V7, P130, DOI 10.1016/0169-5347(92)90148-5; Guidetti P, 2004, HELGOLAND MAR RES, V58, P110, DOI 10.1007/s10152-004-0176-4; Harrold C., 1987, Echinoderm Studies, V2, P137; Hereu B, 2005, MAR BIOL, V146, P293, DOI 10.1007/s00227-004-1439-y; Hereu B, 2004, MAR BIOL, V144, P1011, DOI 10.1007/s00227-003-1266-6; Hereu B, 2008, ECOLOGY, V89, P3423, DOI 10.1890/07-0613.1; Hughes TP, 2000, ECOLOGY, V81, P2241, DOI 10.1890/0012-9658(2000)081[2241:SSEWBW]2.0.CO;2; Hughes TP, 1999, NATURE, V397, P59, DOI 10.1038/16237; Iuri V, 2007, HYDROBIOLOGIA, V580, P77, DOI 10.1007/s10750-006-0464-x; KEOUGH MJ, 1984, ECOLOGY, V65, P423, DOI 10.2307/1941405; Kramer DL, 1999, ENVIRON BIOL FISH, V55, P65, DOI 10.1023/A:1007481206399; LEWIN R, 1986, SCIENCE, V234, P25, DOI 10.1126/science.234.4772.25; LODGE DM, 1987, CAN J FISH AQUAT SCI, V44, P591, DOI 10.1139/f87-072; Lopez S, 1998, MAR ECOL PROG SER, V172, P239, DOI 10.3354/meps172239; Marcus NH, 1998, LIMNOL OCEANOGR, V43, P763, DOI 10.4319/lo.1998.43.5.0763; Mariani S, 2000, MAR BIOL, V137, P783, DOI 10.1007/s002270000400; Maron JL, 2001, OECOLOGIA, V126, P595, DOI 10.1007/s004420000558; MCCLANAHAN TR, 1990, OECOLOGIA, V83, P362, DOI 10.1007/BF00317561; Micheli F, 1999, CONSERV BIOL, V13, P869, DOI 10.1046/j.1523-1739.1999.98233.x; Pace ML, 1999, TRENDS ECOL EVOL, V14, P483, DOI 10.1016/S0169-5347(99)01723-1; PEARCE CM, 1990, BIOL BULL-US, V179, P304, DOI 10.2307/1542322; PEARCE CM, 1991, J EXP MAR BIOL ECOL, V147, P147, DOI 10.1016/0022-0981(91)90179-Z; Peterson BJ, 2002, OIKOS, V97, P361, DOI 10.1034/j.1600-0706.2002.970306.x; Pinna S, 2012, MAR ECOL PROG SER, V445, P173, DOI 10.3354/meps09457; Planes S, 2011, MAR ECOL PROG SER, V431, P205, DOI 10.3354/meps09089; Prado P, 2008, MAR ECOL PROG SER, V371, P11, DOI 10.3354/meps07662; Prado P, 2007, MAR ECOL PROG SER, V340, P63, DOI 10.3354/meps340063; Prado P, 2009, ESTUAR COAST SHELF S, V85, P472, DOI 10.1016/j.ecss.2009.09.012; RAIMONDI PT, 1990, ECOL MONOGR, V60, P283, DOI 10.2307/1943059; RICHMOND RH, 1987, MAR BIOL, V93, P527, DOI 10.1007/BF00392790; Ries L, 2004, ECOLOGY, V85, P2917, DOI 10.1890/03-8021; Rilov G, 2006, ECOLOGY, V87, P731, DOI 10.1890/04-1853; Rilov G, 2006, MAR ECOL PROG SER, V327, P83, DOI 10.3354/meps327083; Rilov G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023958; Robinson A.R., 2001, OCEAN CURRENTS MEDIT, DOI [10.1006/rwos.2001.0376, DOI 10.1006/RWOS.2001.0376]; Ruiz JM, 2009, BOT MAR, V52, P449, DOI 10.1515/BOT.2009.053; Sala E, 1998, OIKOS, V82, P425, DOI 10.2307/3546364; Sala E, 1996, MAR ECOL PROG SER, V140, P71, DOI 10.3354/meps140071; SCHELTEMA RS, 1988, BIOL BULL, V174, P145, DOI 10.2307/1541781; SCHELTEMA RS, 1986, B MAR SCI, V39, P241; Shanks AL, 2003, ECOL APPL, V13, pS159; Tomas F, 2006, MAR ECOL PROG SER, V306, P125, DOI 10.3354/meps306125; Tomas F, 2005, MAR ECOL PROG SER, V287, P115, DOI 10.3354/meps287115; Tomas F, 2004, MAR ECOL PROG SER, V282, P173, DOI 10.3354/meps282173; Underwood T., 1997, EXPT ECOLOGY THEIR L; Zacherl D, 2003, J BIOGEOGR, V30, P913, DOI 10.1046/j.1365-2699.2003.00899.x	74	32	32	3	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35170	10.1371/journal.pone.0035170	http://dx.doi.org/10.1371/journal.pone.0035170			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536355	Green Published, gold			2022-12-27	WOS:000305339200040
J	Qiao, H; May, JM				Qiao, Huan; May, James M.			Interaction of the Transcription Start Site Core Region and Transcription Factor YY1 Determine Ascorbate Transporter SVCT2 Exon 1a Promoter Activity	PLOS ONE			English	Article							VITAMIN-C TRANSPORTER; RNA-POLYMERASE-II; BINDING-PROTEIN; DNA-BINDING; ACTIVATES TRANSCRIPTION; INITIATOR; GENE; EXPRESSION; P300; ACETYLATION	Transcription of the ascorbate transporter, SVCT2, is driven by two distinct promoters in exon 1 of the transporter sequence. The exon 1a promoter lacks a classical transcription start site and little is known about regulation of promoter activity in the transcription start site core (TSSC) region. Here we present evidence that the TSSC binds the multifunctional initiator-binding protein YY1. Electrophoresis shift assays using YY1 antibody showed that YY1 is present as one of two major complexes that specifically bind to the TSSC. The other complex contains the transcription factor NF-Y. Mutations in the TSSC that decreased YY1 binding also impaired the exon 1a promoter activity despite the presence of an upstream activating NF-Y/USF complex, suggesting that YY1 is involved in the regulation of the exon 1a transcription. Furthermore, YY1 interaction with NF-Y and/or USF synergistically enhanced the exon 1a promoter activity in transient transfections and co-activator p300 enhanced their synergistic activation. We propose that the TSSC plays a vital role in the exon 1a transcription and that this function is partially carried out by the transcription factor YY1. Moreover, co-activator p300 might be able to synergistically enhance the TSSC function via a "bridge" mechanism with upstream sequences.	[Qiao, Huan; May, James M.] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA	Vanderbilt University	Qiao, H (corresponding author), Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA.	huan.qiao@vanderbilt.edu			National Institutes of Health [NS 057674]; core facilities of the Vanderbilt Diabetes Research and Training Center [DK 020593]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020593, P60DK020593] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057674] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); core facilities of the Vanderbilt Diabetes Research and Training Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a grant from the National Institutes of Health (NS 057674) and by the core facilities of the Vanderbilt Diabetes Research and Training Center (DK 020593). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austen M, 1998, ONCOGENE, V17, P511, DOI 10.1038/sj.onc.1201968; Barlev NA, 2001, MOL CELL, V8, P1243, DOI 10.1016/S1097-2765(01)00414-2; BASU A, 1993, J BIOL CHEM, V268, P4188; Biondi C, 2007, MOL HUM REPROD, V13, P77, DOI 10.1093/molehr/gal092; De Smet C, 2004, MOL CELL BIOL, V24, P4781, DOI 10.1128/MCB.24.11.4781-4790.2004; De Smet C, 1999, MOL CELL BIOL, V19, P7327; DESMET C, 1995, IMMUNOGENETICS, V42, P282, DOI 10.1007/BF00176446; Erkeland SJ, 2003, BLOOD, V101, P1111, DOI 10.1182/blood-2002-04-1207; Frontini M, 2002, J BIOL CHEM, V277, P5841, DOI 10.1074/jbc.M103651200; Fujita I, 2001, BRIT J NUTR, V86, P145, DOI 10.1079/BJN2001406; Gess B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017139; Gilthorpe J, 2002, DEVELOPMENT, V129, P3887; Goueli BS, 2003, ONCOGENE, V22, P8042, DOI 10.1038/sj.onc.1206847; GUTMAN A, 1994, MOL CELL BIOL, V14, P8143, DOI 10.1128/MCB.14.12.8143; HARIHARAN N, 1991, P NATL ACAD SCI USA, V88, P9799, DOI 10.1073/pnas.88.21.9799; Harrison FE, 2010, FREE RADICAL BIO MED, V49, P821, DOI 10.1016/j.freeradbiomed.2010.06.008; HYDEDERUYSCHER RP, 1995, NUCLEIC ACIDS RES, V23, P4457, DOI 10.1093/nar/23.21.4457; Iacobazzi V, 2009, BIOCHEM BIOPH RES CO, V385, P220, DOI 10.1016/j.bbrc.2009.05.030; JAVAHERY R, 1994, MOL CELL BIOL, V14, P116, DOI 10.1128/MCB.14.1.116; Kim J, 2003, HUM MOL GENET, V12, P233, DOI 10.1093/hmg/ddg028; Kraus RJ, 1996, NUCLEIC ACIDS RES, V24, P1531, DOI 10.1093/nar/24.8.1531; Li Q, 1998, EMBO J, V17, P6300, DOI 10.1093/emboj/17.21.6300; Lin IG, 2000, MOL CELL BIOL, V20, P2343, DOI 10.1128/MCB.20.7.2343-2349.2000; Mantovani R, 1999, GENE, V239, P15, DOI 10.1016/S0378-1119(99)00368-6; MANTOVANI R, 1994, J BIOL CHEM, V269, P20340; Matsumura N, 2009, MOL CANCER RES, V7, P210, DOI 10.1158/1541-7786.MCR-08-0255; Munshi N, 2001, SCIENCE, V293, P1133, DOI 10.1126/science.293.5532.1133; Mutskov VJ, 2002, GENE DEV, V16, P1540, DOI 10.1101/gad.988502; Okada Y, 2004, BLOOD, V104, P2027, DOI 10.1182/blood-2003-09-3107; Puri PL, 1997, EMBO J, V16, P369, DOI 10.1093/emboj/16.2.369; Qiao H, 2008, BRAIN RES, V1208, P79, DOI 10.1016/j.brainres.2008.02.102; Qiao H, 2011, BIOCHEM J, V440, P73, DOI 10.1042/BJ20110392; Qiao H, 2011, FREE RADICAL BIO MED, V50, P1196, DOI 10.1016/j.freeradbiomed.2011.02.006; Qiao H, 2009, FREE RADICAL BIO MED, V46, P1221, DOI 10.1016/j.freeradbiomed.2009.02.004; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; RONCHI A, 1995, NUCLEIC ACIDS RES, V23, P4565, DOI 10.1093/nar/23.22.4565; ROY AL, 1991, NATURE, V354, P245, DOI 10.1038/354245a0; Rubin SA, 2005, BBA-GENE STRUCT EXPR, V1732, P76, DOI 10.1016/j.bbaexp.2005.11.002; Salsi V, 2003, J BIOL CHEM, V278, P6642, DOI 10.1074/jbc.M210065200; Sankar N, 2008, ONCOGENE, V27, P5717, DOI 10.1038/onc.2008.181; Savini I, 2007, BIOCHEM BIOPH RES CO, V361, P385, DOI 10.1016/j.bbrc.2007.07.007; SETO E, 1991, NATURE, V354, P241, DOI 10.1038/354241a0; Sotiriou S, 2002, NAT MED, V8, P514, DOI 10.1038/nm0502-514; Tamaru H, 2001, NATURE, V414, P277, DOI 10.1038/35104508; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; Tsukaguchi H, 1999, NATURE, V399, P70, DOI 10.1038/19986; USHEVA A, 1994, CELL, V76, P1115, DOI 10.1016/0092-8674(94)90387-5; Weis L, 1997, MOL CELL BIOL, V17, P2973, DOI 10.1128/MCB.17.6.2973; Wu XM, 2003, ARCH BIOCHEM BIOPHYS, V420, P114, DOI 10.1016/j.abb.2003.09.013; Wu XM, 2003, BBA-MOL CELL RES, V1641, P65, DOI 10.1016/S0167-4889(03)00065-X; YANT SR, 1995, NUCLEIC ACIDS RES, V23, P4353, DOI 10.1093/nar/23.21.4353	51	8	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35746	10.1371/journal.pone.0035746	http://dx.doi.org/10.1371/journal.pone.0035746			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22532872	Green Published, gold, Green Submitted			2022-12-27	WOS:000305339200107
J	Spiro, AS; Wong, A; Boucher, AA; Arnold, JC				Spiro, Adena S.; Wong, Alexander; Boucher, Aurelie A.; Arnold, Jonathon C.			Enhanced Brain Disposition and Effects of Delta(9)-Tetrahydrocannabinol in P-Glycoprotein and Breast Cancer Resistance Protein Knockout Mice	PLOS ONE			English	Article							HETEROZYGOUS NEUREGULIN-1 MICE; MULTIDRUG-RESISTANCE; CANNABIS USE; EXPRESSION; GENE; DRUGS; DELTA-9-TETRAHYDROCANNABINOL; SCHIZOPHRENIA; TRANSPORTERS; IMPACT	The ABC transporters P-glycoprotein (P-gp, Abcb1) and breast cancer resistance protein (Bcrp, Abcg2) regulate the CNS disposition of many drugs. The main psychoactive constituent of cannabis Delta(9)-tetrahydrocannabinol (THC) has affinity for P-gp and Bcrp, however it is unknown whether these transporters modulate the brain accumulation of THC and its functional effects on the CNS. Here we aim to show that mice devoid of Abcb1 and Abcg2 retain higher brain THC levels and are more sensitive to cannabinoid-induced hypothermia than wild-type (WT) mice. Abcb1a/b (-/-), Abcg2 (-/-) and wild-type (WT) mice were injected with THC before brain and blood were collected and THC concentrations determined. Another cohort of mice was examined for THC-induced hypothermia by measuring rectal body temperature. Brain THC concentrations were higher in both Abcb1a/b (-/-) and Abcg2 (-/-) mice than WT mice. ABC transporter knockout mice exhibited delayed elimination of THC from the brain with the effect being more prominent in Abcg2 (-/-) mice. ABC transporter knockout mice were more sensitive to THC-induced hypothermia compared to WT mice. These results show P-gp and Bcrp prolong the brain disposition and hypothermic effects of THC and offer a novel mechanism for both genetic vulnerability to the psychoactive effects of cannabis and drug interactions between CNS therapies and cannabis.	[Spiro, Adena S.; Wong, Alexander; Arnold, Jonathon C.] Univ Sydney, Discipline Pharmacol, Sydney, NSW 2006, Australia; [Boucher, Aurelie A.; Arnold, Jonathon C.] Brain & Mind Res Inst, Sydney, NSW, Australia; [Arnold, Jonathon C.] Schizophrenia Res Inst, Sydney, NSW, Australia	University of Sydney; University of Sydney	Arnold, JC (corresponding author), Univ Sydney, Discipline Pharmacol, Sydney, NSW 2006, Australia.	jonathon.arnold@sydney.edu.au	Arnold, Jonathon C/ACF-5231-2022; Wong, Alexander/GZM-2929-2022	Wong, Alexander/0000-0002-5295-2797; Arnold, Jonathon/0000-0002-0159-9997	University of Sydney Bridging Grant; Brain & Behavior Research Foundation	University of Sydney Bridging Grant; Brain & Behavior Research Foundation(NARSAD)	This work was supported by a University of Sydney Bridging Grant and the Brain & Behavior Research Foundation (formerly National Alliance for Research on Schizophrenia and Depression: Young Investigator Award). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baltes S, 2007, NEUROPHARMACOLOGY, V52, P333, DOI 10.1016/j.neuropharm.2006.07.038; Benyamina A, 2009, PROG NEURO-PSYCHOPH, V33, P1270, DOI 10.1016/j.pnpbp.2009.07.016; Bonhomme-Faivre L, 2008, ADDICT BIOL, V13, P295, DOI 10.1111/j.1369-1600.2008.00096.x; BORNHEIM LM, 1995, DRUG METAB DISPOS, V23, P825; Boucher AA, 2007, NEUROSCIENCE, V149, P861, DOI 10.1016/j.neuroscience.2007.08.020; Boucher AA, 2007, PSYCHOPHARMACOLOGY, V192, P325, DOI 10.1007/s00213-007-0721-3; Boucher AA, 2011, INT J NEUROPSYCHOPH, V14, P631, DOI 10.1017/S146114571000091X; BOWERS MB, 1990, SCHIZOPHRENIA BULL, V16, P81, DOI 10.1093/schbul/16.1.81; Breedveld P, 2006, TRENDS PHARMACOL SCI, V27, P17, DOI 10.1016/j.tips.2005.11.009; Caspi A, 2005, BIOL PSYCHIAT, V57, P1117, DOI 10.1016/j.biopsych.2005.01.026; CORDONCARDO C, 1990, J HISTOCHEM CYTOCHEM, V38, P1277, DOI 10.1177/38.9.1974900; de Vries NA, 2007, CLIN CANCER RES, V13, P6440, DOI 10.1158/1078-0432.CCR-07-1335; Doran A, 2005, DRUG METAB DISPOS, V33, P165, DOI 10.1124/dmd.104.001230; FITTON AG, 1982, BRIT J PHARMACOL, V75, P409, DOI 10.1111/j.1476-5381.1982.tb08802.x; Gunasekaran N, 2009, BRIT J PHARMACOL, V158, P1330, DOI 10.1111/j.1476-5381.2009.00399.x; Hall MD, 2009, TRENDS PHARMACOL SCI, V30, P546, DOI 10.1016/j.tips.2009.07.003; Hall W, 2004, DRUG ALCOHOL REV, V23, P433, DOI 10.1080/09595230412331324554; Hemauer SJ, BIOCH PHARM, V80, P1080; Henquet C, 2008, SCHIZOPHRENIA BULL, V34, P1111, DOI 10.1093/schbul/sbn108; Hoffmeyer S, 2000, P NATL ACAD SCI USA, V97, P3473, DOI 10.1073/pnas.050585397; Holland ML, 2007, BRIT J PHARMACOL, V152, P815, DOI 10.1038/sj.bjp.0707467; Holland ML, 2008, EUR J PHARMACOL, V591, P128, DOI 10.1016/j.ejphar.2008.06.079; Holland ML, 2006, BIOCHEM PHARMACOL, V71, P1146, DOI 10.1016/j.bcp.2005.12.033; Jonker JW, 2002, P NATL ACAD SCI USA, V99, P15649, DOI 10.1073/pnas.202607599; Kamiie J, 2008, PHARM RES-DORDR, V25, P1469, DOI 10.1007/s11095-008-9532-4; Klein C, 2011, PSYCHOPHARMACOLOGY B; Lagas JS, 2009, CLIN CANCER RES, V15, P2344, DOI 10.1158/1078-0432.CCR-08-2253; Langmann T, 2003, CLIN CHEM, V49, P230, DOI 10.1373/49.2.230; Lazarowski A, 2007, EPILEPSIA, V48, P140, DOI 10.1111/j.1528-1167.2007.01302.x; Long LE, 2010, INT J NEUROPSYCHOPH, V13, P861, DOI 10.1017/S1461145709990605; Malone DT, 2009, PHARMACOL BIOCHEM BE, V93, P91, DOI 10.1016/j.pbb.2009.04.010; Morgan CJA, 2008, BRIT J PSYCHIAT, V192, P306, DOI 10.1192/bjp.bp.107.046649; Morgan CJA, 2010, BRIT J PSYCHIAT, V197, P285, DOI 10.1192/bjp.bp.110.077503; MURPHY LL, 1990, NEUROENDOCRINOLOGY, V52, P316, DOI 10.1159/000125604; Nieri P, 2006, BRIT J PHARMACOL, V148, P682, DOI 10.1038/sj.bjp.0706778; O'Brien FE, BR J PHARM; O'Tuathaigh CM, NEUROPSYCHOPHARMACOL, V35, P2262; Potschka H, 2010, EPILEPSIA, V51, P1333, DOI 10.1111/j.1528-1167.2010.02585.x; Quinn HR, 2008, NEUROPSYCHOPHARMACOL, V33, P1113, DOI 10.1038/sj.npp.1301475; Schinkel AH, 2003, ADV DRUG DELIVER REV, V55, P3, DOI 10.1016/S0169-409X(02)00169-2; Schinkel AH, 1997, SEMIN CANCER BIOL, V8, P161, DOI 10.1006/scbi.1997.0068; Schinkel AH, 1997, P NATL ACAD SCI USA, V94, P4028, DOI 10.1073/pnas.94.8.4028; Tournier N, 2011, CURR PHARM DES; TURNER WM, 1990, SCHIZOPHRENIA BULL, V16, P87, DOI 10.1093/schbul/16.1.87; Urquhart BL, 2009, EUR J CLIN PHARMACOL, V65, P1063, DOI 10.1007/s00228-009-0714-8; Varvel SA, 2006, PSYCHOPHARMACOLOGY, V186, P226, DOI 10.1007/s00213-006-0356-9; Wang JS, 2004, INT J NEUROPSYCHOPH, V7, P415, DOI 10.1017/S1461145704004390; Wang JS, 2004, NEUROPSYCHOPHARMACOL, V29, P551, DOI 10.1038/sj.npp.1300372; Wang JS, 2008, BASIC CLIN PHARMACOL, V103, P336, DOI 10.1111/j.1742-7843.2008.00298.x; Warren MS, 2009, PHARMACOL RES, V59, P404, DOI 10.1016/j.phrs.2009.02.007; Wenger T, 2002, PROSTAG LEUKOTR ESS, V66, P301, DOI 10.1054/plef.2001.0353; Yanase K, 2006, CANCER LETT, V234, P73, DOI 10.1016/j.canlet.2005.04.039; Yang Johnny J, 2010, Drug Metab Lett, V4, P201; Zhu HJ, 2006, J PHARMACOL EXP THER, V317, P850, DOI 10.1124/jpet.105.098541; Zimmermann C, 2005, DRUG METAB DISPOS, V33, P219, DOI 10.1124/dmd.104.001354	55	39	40	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35937	10.1371/journal.pone.0035937	http://dx.doi.org/10.1371/journal.pone.0035937			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536451	gold, Green Published, Green Submitted			2022-12-27	WOS:000305339200123
J	Steinmeyer, JD; Yanik, MF				Steinmeyer, Joseph D.; Yanik, Mehmet Fatih			High-Throughput Single-Cell Manipulation in Brain Tissue	PLOS ONE			English	Article							ORGANOTYPIC SLICE CULTURES; NEURONS IN-VIVO; GENE-EXPRESSION; DENDRITIC SPINES; RNA INTERFERENCE; TRANSGENIC MICE; EXCHANGE FACTOR; ELECTROPORATION; KALIRIN-7; TRANSFECTION	The complexity of neurons and neuronal circuits in brain tissue requires the genetic manipulation, labeling, and tracking of single cells. However, current methods for manipulating cells in brain tissue are limited to either bulk techniques, lacking single-cell accuracy, or manual methods that provide single-cell accuracy but at significantly lower throughputs and repeatability. Here, we demonstrate high-throughput, efficient, reliable, and combinatorial delivery of multiple genetic vectors and reagents into targeted cells within the same tissue sample with single-cell accuracy. Our system automatically loads nanoliter-scale volumes of reagents into a micropipette from multiwell plates, targets and transfects single cells in brain tissues using a robust electroporation technique, and finally preps the micropipette by automated cleaning for repeating the transfection cycle. We demonstrate multi-colored labeling of adjacent cells, both in organotypic and acute slices, and transfection of plasmids encoding different protein isoforms into neurons within the same brain tissue for analysis of their effects on linear dendritic spine density. Our platform could also be used to rapidly deliver, both ex vivo and in vivo, a variety of genetic vectors, including optogenetic and cell-type specific agents, as well as fast-acting reagents such as labeling dyes, calcium sensors, and voltage sensors to manipulate and track neuronal circuit activity at single-cell resolution.	[Steinmeyer, Joseph D.; Yanik, Mehmet Fatih] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; [Yanik, Mehmet Fatih] MIT, Dept Biol Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Steinmeyer, JD (corresponding author), MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA.	yanik@mit.edu		Yanik, Mehmet/0000-0002-8963-2893	National Institutes of Health (NIH) [R01 NS066352]; Packard Award in Science and Engineering; National Defense Science and Engineering (NDSEG) Fellowship; National Science Foundation (NSF); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS066352] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Packard Award in Science and Engineering; National Defense Science and Engineering (NDSEG) Fellowship; National Science Foundation (NSF)(National Science Foundation (NSF)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work is supported by the National Institutes of Health (NIH) Eureka Award (R01NS066352) and a Packard Award in Science and Engineering. J.D.S. was supported by the National Defense Science and Engineering (NDSEG) Fellowship and the National Science Foundation (NSF) Graduate Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	del Rio JA, 2010, NAT PROTOC, V5, P217, DOI 10.1038/nprot.2009.202; Bohland JW, 2010, METHODS, V50, P105, DOI 10.1016/j.ymeth.2009.09.001; Boudes M, 2008, J NEUROSCI METH, V170, P204, DOI 10.1016/j.jneumeth.2008.01.018; Brown KT, 1986, ADV MICROPIPETTE TEC; Cho S, 2007, CURR NEUROPHARMACOL, V5, P19, DOI 10.2174/157015907780077105; De Simoni A, 2003, J PHYSIOL-LONDON, V550, P135, DOI 10.1113/jphysiol.2003.039099; De Simoni A, 2006, NAT PROTOC, V1, P1439, DOI 10.1038/nprot.2006.228; Dittgen T, 2004, P NATL ACAD SCI USA, V101, P18206, DOI 10.1073/pnas.0407976101; Duff K, 2002, J MOL NEUROSCI, V19, P317, DOI 10.1385/JMN:19:3:317; Dundr M, 2007, J CELL BIOL, V179, P1095, DOI 10.1083/jcb.200710058; Elias L, 2007, J VISUALIZED EXPT JO; Flusberg BA, 2008, NAT METHODS, V5, P935, DOI 10.1038/nmeth.1256; Ghosh KK, 2011, NAT METHODS, V8, P871, DOI [10.1038/NMETH.1694, 10.1038/nmeth.1694]; Gogolla N, 2006, NAT PROTOC, V1, P1223, DOI 10.1038/nprot.2006.169; Gogolla N, 2006, NAT PROTOC, V1, P1165, DOI 10.1038/nprot.2006.168; Haas K, 2001, NEURON, V29, P583, DOI 10.1016/S0896-6273(01)00235-5; Haas K, 2002, DIFFERENTIATION, V70, P148, DOI 10.1046/j.1432-0436.2002.700404.x; Hall AA, 2009, NEUROSCIENCE, V164, P470, DOI 10.1016/j.neuroscience.2009.08.051; Helmstaedter M, 2011, NAT NEUROSCI, V14, P1081, DOI 10.1038/nn.2868; Hovis KR, 2010, J NEUROSCI METH, V191, P1, DOI 10.1016/j.jneumeth.2010.05.017; Jessberger S, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100122; Johnson RC, 2000, J BIOL CHEM, V275, P19324, DOI 10.1074/jbc.M000676200; Judkewitz B, 2009, NAT PROTOC, V4, P862, DOI 10.1038/nprot.2009.56; Kasri NN, 2008, CHARACTERIZATION OLI; Kitamura K, 2008, NAT METHODS, V5, P61, DOI 10.1038/NMETH1150; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Lovell P, 2006, J NEUROSCI METH, V151, P114, DOI 10.1016/j.jneumeth.2005.06.030; Ma XM, 2008, J NEUROSCI, V28, P711, DOI 10.1523/JNEUROSCI.5283-07.2008; Ma XM, 2003, J NEUROSCI, V23, P10593; Marshel JH, 2010, NEURON, V67, P562, DOI 10.1016/j.neuron.2010.08.001; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; Murphy RC, 2001, MOL THER, V3, P113, DOI 10.1006/mthe.2000.0235; Nelson Sacha B., 2002, Neuron, V36, P19, DOI 10.1016/S0896-6273(02)00944-3; Nitsche JM, 2004, BIOPHYS J, V86, P2058, DOI 10.1016/S0006-3495(04)74267-8; Nolkrantz K, 2001, ANAL CHEM, V73, P4469, DOI 10.1021/ac010403x; Noraberg J, 2004, ATLA-ALTERN LAB ANIM, V32, P329, DOI 10.1177/026119290403200403; O'Brien JA, 2006, NAT PROTOC, V1, P977, DOI 10.1038/nprot.2006.145; Penzes P, 2001, NEURON, V29, P229, DOI 10.1016/S0896-6273(01)00193-3; Penzes P, 2000, J BIOL CHEM, V275, P6395, DOI 10.1074/jbc.275.9.6395; Penzes P, 2003, NEURON, V37, P263, DOI 10.1016/S0896-6273(02)01168-6; Penzes P, 2008, TRENDS NEUROSCI, V31, P419, DOI 10.1016/j.tins.2008.06.001; Pi HJ, 2010, P NATL ACAD SCI USA, V107, P14437, DOI 10.1073/pnas.1009268107; Prazeres DMF, 2008, BIOTECHNOL BIOENG, V99, P1040, DOI 10.1002/bit.21626; Qing Q, 2010, P NATL ACAD SCI USA, V107, P1882, DOI 10.1073/pnas.0914737107; Rancz EA, 2011, NAT NEUROSCI, V14, P527, DOI 10.1038/nn.2765; Rathenberg J, 2003, J NEUROSCI METH, V126, P91, DOI 10.1016/S0165-0270(03)00069-4; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Schiller MR, 2008, EXP CELL RES, V314, P2674, DOI 10.1016/j.yexcr.2008.05.011; Smith Donna L., 2004, V277, P161; Smith SJ, 2007, CURR OPIN NEUROBIOL, V17, P601, DOI 10.1016/j.conb.2007.11.004; Sommer JE, 2009, J NEUROSCI, V29, P5367, DOI 10.1523/JNEUROSCI.0235-09.2009; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Tanaka M, 2009, J NEUROSCI METH, V178, P80, DOI 10.1016/j.jneumeth.2008.11.025; Teschemacher AG, 2005, EXP PHYSIOL, V90, P61, DOI 10.1113/expphysiol.2004.028191; Uesaka N, 2005, J NEUROSCI, V25, P1, DOI 10.1523/JNEUROSCI.3855-04.2005; Uesaka N, 2008, DEV GROWTH DIFFER, V50, P475, DOI [10.1111/j.1440-169x.2008.01024.x, 10.1111/j.1440-169X.2008.01024.x]; Vaira V, 2010, P NATL ACAD SCI USA, V107, P8352, DOI 10.1073/pnas.0907676107; Wei W, 2010, NAT NEUROSCI, V13, P190, DOI 10.1038/nn.2476; Xie Z, 2007, NEURON, V56, P640, DOI 10.1016/j.neuron.2007.10.005; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004; Zhang F, 2006, NAT METHODS, V3, P785, DOI 10.1038/nmeth936	61	16	16	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35603	10.1371/journal.pone.0035603	http://dx.doi.org/10.1371/journal.pone.0035603			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536416	Green Published, Green Accepted, gold			2022-12-27	WOS:000305339200085
J	Orton, RJ; Bessell, PR; Birch, CPD; O'Hare, A; Kao, RR				Orton, Richard J.; Bessell, Paul R.; Birch, Colin P. D.; O'Hare, Anthony; Kao, Rowland R.			Risk of Foot-and-Mouth Disease Spread Due to Sole Occupancy Authorities and Linked Cattle Holdings	PLOS ONE			English	Article							GREAT-BRITAIN; UK FOOT; EPIDEMIC; TRANSMISSION; MOVEMENTS; DYNAMICS; NETWORK; IMPACT	Livestock movements in Great Britain are well recorded, have been extensively analysed with respect to their role in disease spread, and have been used in real time to advise governments on the control of infectious diseases. Typically, livestock holdings are treated as distinct entities that must observe movement standstills upon receipt of livestock, and must report livestock movements. However, there are currently two dispensations that can exempt holdings from either observing standstills or reporting movements, namely the Sole Occupancy Authority (SOA) and Cattle Tracing System (CTS) Links, respectively. In this report we have used a combination of data analyses and computational modelling to investigate the usage and potential impact of such linked holdings on the size of a Foot-and-Mouth Disease (FMD) epidemic. Our analyses show that although SOAs are abundant, their dynamics appear relatively stagnant. The number of CTS Links is also abundant, and increasing rapidly. Although most linked holdings are only involved in a single CTS Link, some holdings are involved in numerous links that can be amalgamated to form "CTS Chains" which can be both large and geographically dispersed. Our model predicts that under a worst case scenario of "one infected - all infected", SOAs do pose a risk of increasing the size (in terms of number of infected holdings) of a FMD epidemic, but this increase is mainly due to intra-SOA infection spread events. Furthermore, although SOAs do increase the geographic spread of an epidemic, this increase is predominantly local. Whereas, CTS Chains pose a risk of increasing both the size and the geographical spread of the disease substantially, under a worse case scenario. Our results highlight the need for further investigations into whether CTS Chains are transmission chains, and also investigations into intra-SOA movements and livestock distributions due to the lack of current data.	[Orton, Richard J.; Bessell, Paul R.; O'Hare, Anthony; Kao, Rowland R.] Univ Glasgow, Boyd Orr Ctr Populat & Ecosyst Hlth, Inst Biodivers Anim Hlth & Comparat Med, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland; [Birch, Colin P. D.] Vet Labs Agcy, Addlestone, Surrey, England	University of Glasgow; Veterinary Laboratories Agency	Orton, RJ (corresponding author), Univ Glasgow, Boyd Orr Ctr Populat & Ecosyst Hlth, Inst Biodivers Anim Hlth & Comparat Med, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland.	Richard.Orton@glasgow.ac.uk	O'Hare, Anthony/K-8241-2013; Birch, Colin P. D./C-7572-2011	O'Hare, Anthony/0000-0003-2561-9582; Birch, Colin P. D./0000-0002-4608-9093; Kao, Rowland/0000-0003-0919-6401	Department for Environment Food and Rural Affairs (DEFRA); Wellcome Trust	Department for Environment Food and Rural Affairs (DEFRA)(Department for Environment, Food & Rural Affairs (DEFRA)); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was funded by Department for Environment Food and Rural Affairs (DEFRA; http://www.defra.gov.uk). RRK and AO are funded under a Wellcome Trust Senior Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandersen S, 2003, J COMP PATHOL, V129, P268, DOI 10.1016/S0021-9975(03)00045-8; Anderson I., 2002, FOOT MOUTH DIS 2001; Anon, 2003, IDENTIFYING TRACKING; Anon, 2009, GUIDANCE KEEPERS ENG; Davies G, 2002, COMP IMMUNOL MICROB, V25, P331, DOI 10.1016/S0147-9571(02)00030-9; DEFRA, 2006, REV LIV MOV CONTR; Ferguson NM, 2001, SCIENCE, V292, P1155, DOI 10.1126/science.1061020; Gibbens JC, 2001, VET REC, V149, P729, DOI 10.1136/vr.149.24.729; Green DM, 2006, P ROY SOC B-BIOL SCI, V273, P2729, DOI 10.1098/rspb.2006.3648; Green DM, 2008, P R SOC B, V275, P1001, DOI 10.1098/rspb.2007.1601; Haydon DT, 2004, NAT REV MICROBIOL, V2, P675, DOI 10.1038/nrmicro960; Kao RR, 2007, J R SOC INTERFACE, V4, P907, DOI 10.1098/rsif.2007.1129; Kao RR, 2003, P ROY SOC B-BIOL SCI, V270, P2557, DOI 10.1098/rspb.2003.2546; Keeling MJ, 2001, SCIENCE, V294, P813, DOI 10.1126/science.1065973; Kiss IZ, 2006, J R SOC INTERFACE, V3, P669, DOI 10.1098/rsif.2006.0129	15	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e35089	10.1371/journal.pone.0035089	http://dx.doi.org/10.1371/journal.pone.0035089			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22532841	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000305336200023
J	Taylor, S; Kumar, L; Reid, N; Kriticos, DJ				Taylor, Subhashni; Kumar, Lalit; Reid, Nick; Kriticos, Darren J.			Climate Change and the Potential Distribution of an Invasive Shrub, Lantana camara L.	PLOS ONE			English	Article							GEOGRAPHICAL-DISTRIBUTION; PLANT; WEED; VERBENACEAE; MODELS; SHIFTS; RANGE; NICHE	The threat posed by invasive species, in particular weeds, to biodiversity may be exacerbated by climate change. Lantana camara L. (lantana) is a woody shrub that is highly invasive in many countries of the world. It has a profound economic and environmental impact worldwide, including Australia. Knowledge of the likely potential distribution of this invasive species under current and future climate will be useful in planning better strategies to manage the invasion. A process-oriented niche model of L. camara was developed using CLIMEX to estimate its potential distribution under current and future climate scenarios. The model was calibrated using data from several knowledge domains, including phenological observations and geographic distribution records. The potential distribution of lantana under historical climate exceeded the current distribution in some areas of the world, notably Africa and Asia. Under future scenarios, the climatically suitable areas for L. camara globally were projected to contract. However, some areas were identified in North Africa, Europe and Australia that may become climatically suitable under future climates. In South Africa and China, its potential distribution could expand further inland. These results can inform strategic planning by biosecurity agencies, identifying areas to target for eradication or containment. Distribution maps of risk of potential invasion can be useful tools in public awareness campaigns, especially in countries that have been identified as becoming climatically suitable for L. camara under the future climate scenarios.	[Taylor, Subhashni; Kumar, Lalit; Reid, Nick] Univ New England, Sch Environm & Rural Sci, Armidale, NSW, Australia; [Kriticos, Darren J.] CSIRO Ecosyst Sci, Canberra, ACT, Australia; [Kriticos, Darren J.] Charles Sturt Univ, EH Graham Ctr, Wagga Wagga, NSW, Australia	University of New England; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Charles Sturt University	Taylor, S (corresponding author), Univ New England, Sch Environm & Rural Sci, Armidale, NSW, Australia.	btaylo36@une.edu.au	Kumar, Lalit/A-6397-2011; Reid, Nick Charles H./A-6393-2011; Taylor, Subhashni/Q-6338-2018; Kriticos, Darren J/A-4170-2008	Kumar, Lalit/0000-0002-9205-756X; Reid, Nick Charles H./0000-0002-4377-9734; Taylor, Subhashni/0000-0002-1624-0901; Kriticos, Darren J/0000-0003-2599-8105	National Climate Change Adaptation Research Facility (NCCARF)	National Climate Change Adaptation Research Facility (NCCARF)	The National Climate Change Adaptation Research Facility (NCCARF) kindly provided a grant that allowed the main author to purchase the CLIMEX software as well as attend a training workshop for CLIMEX. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	ACHHIREDDY NR, 1984, WEED SCI, V32, P757, DOI 10.1017/S0043174500059944; Andrewartha H.G., 1984, ECOLOGICAL WEB MORE; ANDREWARTHA HG, 1954, DISTRIBUTION ABUNDAN; [Anonymous], 1991, WORLDS WORST WEEDS D; Araujo MB, 2006, J BIOGEOGR, V33, P1677, DOI 10.1111/j.1365-2699.2006.01584.x; Begon M, 1986, ECOLOGY INDIVIDUALS; Bhuju DR, 2006, NEPAL J SCI TECHNOLO, V7, P35; Binggeli P, 1996, J VEG SCI, V7, P121, DOI 10.2307/3236424; Biswas K., 1934, INDIAN FOR, V60, P861; Chejara VK, 2010, WEED RES, V50, P174, DOI 10.1111/j.1365-3180.2010.00765.x; Chen S., 1994, FLORA CHINA; CILLIERS C J, 1983, Journal of the Entomological Society of Southern Africa, V46, P131; CILLIERS CJ, 1991, AGR ECOSYST ENVIRON, V37, P57, DOI 10.1016/0167-8809(91)90139-O; Colwell RK, 2008, SCIENCE, V322, P258, DOI 10.1126/science.1162547; Crossman ND, 2011, ECOL INDIC, V11, P183, DOI 10.1016/j.ecolind.2008.10.011; Crossman ND, 2008, DIVERS DISTRIB, V14, P213, DOI 10.1111/j.1472-4642.2007.00436.x; Danin A., 2000, Willdenowia, V30, P305, DOI 10.3372/wi.30.30209; Darin GMS, 2011, J ENVIRON MANAGE, V92, P131, DOI 10.1016/j.jenvman.2010.08.013; Davis AJ, 1998, NATURE, V391, P783, DOI 10.1038/35842; Day M.D., 2003, BIOCONTROL NEWS INFO, V24, P63; DERM, 2010, MAPP LANT US LANDS R; Dobhal P. K., 2011, Journal of Ecology and the Natural Environment, V3, P11; Dukes JS, 1999, TRENDS ECOL EVOL, V14, P135, DOI 10.1016/S0169-5347(98)01554-7; FENSHAM RJ, 1994, AUST J ECOL, V19, P297, DOI 10.1111/j.1442-9993.1994.tb00493.x; Follak S, 2010, WEED RES, V50, P544, DOI 10.1111/j.1365-3180.2010.00802.x; Garibaldi A, 2008, PLANT DIS, V92, P1369, DOI 10.1094/PDIS-92-9-1369B; GBIF, 2010, GBIF DAT PORT; Gentle CB, 1997, AUST J ECOL, V22, P298, DOI 10.1111/j.1442-9993.1997.tb00675.x; Gooden B, 2009, BIOL CONSERV, V142, P2631, DOI 10.1016/j.biocon.2009.06.012; Gordon H. B., 2002, 60 CSIRO ATM RES; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; GUJRAL GS, 1983, J SCI IND RES INDIA, V42, P281; Hearne Scientific Software, 2007, CLIMEX SOFTW VERS 3; Henderson S, 2006, PROG PHYS GEOG, V30, P25, DOI 10.1191/0309133306pp468ra; Hennessy K., 2007, GLOBAL CLIMATE CHANG; HUMPHRIES SE, 1992, WEED ASSESSMENT WET; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Intergovernmental Panel on Climate Change, 2022, CLIMATE CHANGE 2022; IPCC, 2000, SPEC REP EM SCEN SPE; Jafri S.H., 1974, FLORA PAKISTAN; Keane RM, 2002, TRENDS ECOL EVOL, V17, P164, DOI 10.1016/S0169-5347(02)02499-0; Kohli RK, 2006, BIOL INVASIONS, V8, P1501, DOI 10.1007/s10530-005-5842-1; Kriticos D., 2009, CLIMATE CHANGE INVAS; Kriticos D. J., 2006, 15th Australian Weeds Conference, Papers and Proceedings, Adelaide, South Australia, 24-28 September 2006: Managing weeds in a changing climate, P27; Kriticos D. J., 2001, Weed risk assessment, P61; Kriticos DJ, 2010, ECOGRAPHY, V33, P115, DOI 10.1111/j.1600-0587.2009.06042.x; Kriticos DJ, 2005, WEED RES, V45, P246, DOI 10.1111/j.1365-3180.2005.00458.x; Kriticos DJ, 2003, J APPL ECOL, V40, P111, DOI 10.1046/j.1365-2664.2003.00777.x; Kriticos DJ, 2008, 16 AUSTR WEEDS C, P506; Kriticos DJ, 2011, CLIMOND GLOBAL HIGH; LAMB D, 1991, TROPICAL RAINFOREST, P177; Mabberley DJ, 1997, PLANT BOOK; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Moldenke HN, 1944, BOT GAZ, V106, P158, DOI 10.1086/335282; Munir Ahmad Abid, 1996, Journal of the Adelaide Botanic Gardens, V17, P1; Murali KS, 2001, CURR SCI INDIA, V80, P675; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Poutsma J, 2008, BIOCONTROL, V53, P103, DOI 10.1007/s10526-007-9140-y; Press JR., 2000, ANNOTATED CHECKLIST; Rahmstorf S, 2007, SCIENCE, V316, P709, DOI 10.1126/science.1136843; SANDERS RW, 1987, AM J BOT, V74, P914, DOI 10.2307/2443872; SAPIA, 2006, MON EM SPREAD INV AL; Sharma GP, 2006, APPL ECOL ENV RES, V5, P109; Sharma GR, 2005, WEED BIOL MANAG, V5, P157, DOI 10.1111/j.1445-6664.2005.00178.x; SHELFORD VE, 1963, ECOLOGY N AM; Smith LS, 1982, NATURALISED LANTANA; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; Stirton C. H., 1977, Proceedings of the Second National Weeds Conference of South Africa., P321; Stock D., 2009, LANTANA BEST PRACTIC; Sutherst RW, 2009, BIOL INVASIONS, V11, P1231, DOI 10.1007/s10530-008-9335-x; Sutherst R W, 2007, CLIMEX VERSION 3 USE; Sutherst R. W., 2007, TERRESTRIAL ECOSYSTE, P211, DOI DOI 10.1007/978-3-540-32730-1_17; Sutherst RW, 2003, J BIOGEOGR, V30, P805, DOI 10.1046/j.1365-2699.2003.00861.x; SUTHERST RW, 1985, AGR ECOSYST ENVIRON, V13, P281, DOI 10.1016/0167-8809(85)90016-7; Thakur M. L., 1992, Indian Forester, V118, P466; THAMAN R R, 1974, Micronesica, V10, P17; Thomas SE, 2000, P 10 INT S BIOL CONT; van der Ploeg RR, 1999, SOIL SCI SOC AM J, V63, P1055, DOI 10.2136/sssaj1999.6351055x; Vitousek PM, 1996, AM SCI, V84, P468; Walther GR, 2009, TRENDS ECOL EVOL, V24, P686, DOI 10.1016/j.tree.2009.06.008; Waterhouse D. F., 1987, Biological control: Pacific prospects.; Watt MS, 2009, WEED RES, V49, P381, DOI 10.1111/j.1365-3180.2009.00704.x; Webber BL, 2011, DIVERS DISTRIB, V17, P978, DOI 10.1111/j.1472-4642.2011.00811.x; Wharton TN, 2004, DIVERS DISTRIB, V10, P253, DOI 10.1111/j.1366-9516.2004.00090.x; WINDER JA, 1982, B ENTOMOL RES, V72, P599, DOI 10.1017/S0007485300008634; Winder JA, FACTORS AFFECTING GR; Woodward F.I., 1987, CLIMATE PLANT DISTRI	87	75	79	0	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e35565	10.1371/journal.pone.0035565	http://dx.doi.org/10.1371/journal.pone.0035565			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22536408	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000305336200055
J	Chen, CL; Wang, P; Su, Q; Wang, SL; Wang, FJ				Chen, Chuanli; Wang, Pei; Su, Qin; Wang, Shiliang; Wang, Fengjun			Myosin Light Chain Kinase Mediates Intestinal Barrier Disruption following Burn Injury	PLOS ONE			English	Article							EPITHELIAL BARRIER; TNF-ALPHA; BACTERIAL TRANSLOCATION; INTERFERON-GAMMA; GUT; TIGHT; APOPTOSIS; PERMEABILITY; EXPRESSION; DYSFUNCTION	Background: Severe burn injury results in the loss of intestinal barrier function, however, the underlying mechanism remains unclear. Myosin light chain (MLC) phosphorylation mediated by MLC kinase (MLCK) is critical to the pathophysiological regulation of intestinal barrier function. We hypothesized that the MLCK-dependent MLC phosphorylation mediates the regulation of intestinal barrier function following burn injury, and that MLCK inhibition attenuates the burn-induced intestinal barrier disfunction. Methodology/Principal Findings: Male balb/c mice were assigned randomly to either sham burn (control) or 30% total body surface area (TBSA) full thickness burn without or with intraperitoneal injection of ML-9 (2 mg/kg), an MLCK inhibitor. In vivo intestinal permeability to fluorescein isothiocyanate (FITC)-dextran was measured. Intestinal mucosa injury was assessed histologically. Tight junction proteins ZO-1, occludin and claudin-1 was analyzed by immunofluorescent assay. Expression of MLCK and phosphorylated MLC in ileal mucosa was assessed by Western blot. Intestinal permeability was increased significantly after burn injury, which was accompanied by mucosa injury, tight junction protein alterations, and increase of both MLCK and MLC phosphorylation. Treatment with ML-9 attenuated the burn-caused increase of intestinal permeability, mucosa injury, tight junction protein alterations, and decreased MLC phosphorylation, but not MLCK expression. Conclusions/Significance: The MLCK-dependent MLC phosphorylation mediates intestinal epithelial barrier dysfunction after severe burn injury. It is suggested that MLCK-dependent MLC phosphorylation may be a critical target for the therapeutic treatment of intestinal epithelial barrier disruption after severe burn injury.	[Chen, Chuanli; Wang, Pei; Su, Qin; Wang, Shiliang; Wang, Fengjun] Third Mil Med Univ, Southwest Hosp, Inst Burn Res, State Key Lab Trauma Burns & Combined Injury, Chongqing, Peoples R China; [Su, Qin] Third Mil Med Univ, Sch Nursing, Dept Mil Nursing, Chongqing, Peoples R China	Army Medical University; Army Medical University	Chen, CL (corresponding author), Third Mil Med Univ, Southwest Hosp, Inst Burn Res, State Key Lab Trauma Burns & Combined Injury, Chongqing, Peoples R China.	wangfj@tmmu.edu.cn	Wang, Fengjun/A-4114-2009		National Natural Science Foundation of China [30571923]; Chongqing Natural Science Foundation [CSTC-2005BB5045]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry [2006-331]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chongqing Natural Science Foundation(Natural Science Foundation of Chongqing); Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars)	This work was supported by the National Natural Science Foundation of China (30571923), the Chongqing Natural Science Foundation (CSTC-2005BB5045), and the Project Sponsored by the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry (2006-331). The relevant grant number is 3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Sadi R, 2008, J IMMUNOL, V180, P5653, DOI 10.4049/jimmunol.180.8.5653; Beaurepaire C, 2009, J INTERF CYTOK RES, V29, P133, DOI 10.1089/jir.2008.0057; Blikslager AT, 2007, PHYSIOL REV, V87, P545, DOI 10.1152/physrev.00012.2006; Bojarski C, 2000, ANN NY ACAD SCI, V915, P270; Bruewer M, 2003, J IMMUNOL, V171, P6164, DOI 10.4049/jimmunol.171.11.6164; Chin AC, 2003, P NATL ACAD SCI USA, V100, P11104, DOI 10.1073/pnas.1831452100; Clayburgh DR, 2004, LAB INVEST, V84, P282, DOI 10.1038/labinvest.3700050; Costantini TW, 2010, MOL IMAGING, V9, P30, DOI 10.2310/7290.2010.00001; Costantini TW, 2009, J SURG RES, V156, P64, DOI 10.1016/j.jss.2009.03.066; Costantini TW, 2009, SHOCK, V31, P416, DOI 10.1097/SHK.0b013e3181863080; Costantini TW, 2009, J TRAUMA, V66, P17, DOI 10.1097/TA.0b013e318191bb1f; Deitch EA, 2002, SURGERY, V131, P241, DOI 10.1067/msy.2002.116408; Feighery LM, 2008, PHARM RES-DORDR, V25, P1377, DOI 10.1007/s11095-007-9527-6; Finnerty CC, 2007, SHOCK, V27, P4, DOI 10.1097/01.shk.0000235138.20775.36; Finnerty CC, 2009, CYTOKINE, V45, P20, DOI 10.1016/j.cyto.2008.10.005; Fujiyoshi N, 2006, SURGERY, V140, P810, DOI 10.1016/j.surg.2006.03.003; Gitter AH, 2000, FASEB J, V14, P1749, DOI 10.1096/fj.99-0898com; Iiboshi Y, 1996, JPEN-PARENTER ENTER, V20, P406, DOI 10.1177/0148607196020006406; Jones BA, 1997, AM J PHYSIOL-GASTR L, V273, pG1174, DOI 10.1152/ajpgi.1997.273.6.G1174; Kannan KB, 2011, AM J PHYSIOL-GASTR L, V300, pG853, DOI 10.1152/ajpgi.00459.2010; Leaphart CL, 2007, SURGERY, V141, P563, DOI 10.1016/j.surg.2007.01.021; Liu HM, 2011, CYTOKINE, V56, P56, DOI 10.1016/j.cyto.2011.07.355; [刘依凌 LIU Yiling], 2008, [第三军医大学学报, Acta Academiae Medicinae Militaris Tertiae], V30, P817; Ma TY, 2005, AM J PHYSIOL-GASTR L, V288, pG422, DOI 10.1152/ajpgi.00412.2004; Magnotti LJ, 2005, J BURN CARE REHABIL, V26, P383, DOI 10.1097/01.bcr.0000176878.79267.e8; Orman MA, 2011, CYTOKINE, V55, P362, DOI 10.1016/j.cyto.2011.05.010; OTAMIRI T, 1987, ACTA CHIR SCAND, V153, P51; Peterson CY, 2010, SURG INFECT, V11, P137, DOI 10.1089/sur.2009.053; Prasad S, 2005, LAB INVEST, V85, P1139, DOI 10.1038/labinvest.3700316; Qi HB, 2011, CELL PHYSIOL BIOCHEM, V27, P251, DOI 10.1159/000327951; Ramzy PI, 2000, J AM COLL SURGEONS, V190, P281, DOI 10.1016/S1072-7515(99)00269-0; Rosenberger P, 2007, FASEB J, V21, P2613, DOI 10.1096/fj.06-8004com; Schulzke JD, 2006, ANN NY ACAD SCI, V1072, P288, DOI 10.1196/annals.1326.027; Schwarz BT, 2007, GASTROENTEROLOGY, V132, P2383, DOI 10.1053/j.gastro.2007.02.052; Shao LJ, 2005, BURNS, V31, P838, DOI 10.1016/j.burns.2005.05.005; Shen L, 2006, J CELL SCI, V119, P2095, DOI 10.1242/jcs.02915; Shen L, 2011, ANNU REV PHYSIOL, V73, P283, DOI 10.1146/annurev-physiol-012110-142150; Spies M, 2002, AM J PHYSIOL-GASTR L, V283, pG703, DOI 10.1152/ajpgi.00149.2001; Suzuki T, 2011, J BIOL CHEM, V286, P31263, DOI 10.1074/jbc.M111.238147; Turner JR, 2006, AM J PATHOL, V169, P1901, DOI 10.2353/ajpath.2006.060681; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Wang FJ, 2006, GASTROENTEROLOGY, V131, P1153, DOI 10.1053/j.gastro.2006.08.022; Wang FJ, 2005, AM J PATHOL, V166, P409, DOI 10.1016/S0002-9440(10)62264-X; Wang Pei, 2009, Zhonghua Shao Shang Za Zhi, V25, P57; Weber CR, 2010, J BIOL CHEM, V285, P12037, DOI 10.1074/jbc.M109.064808; WILMORE DW, 1988, SURGERY, V104, P917; Wolf SE, 1999, J AM COLL SURGEONS, V188, P10, DOI 10.1016/S1072-7515(98)00260-9; Yeh WL, 2007, MOL PHARMACOL, V72, P440, DOI 10.1124/mol.107.036418; Yuan ZQ, 2008, BURNS, V34, P247, DOI 10.1016/j.burns.2007.03.016; Zhao Yun, 2004, Zhonghua Shao Shang Za Zhi, V20, P214; [赵云 Zhao Yun], 2004, [第三军医大学学报, Acta Academiae Medicinae Militaris Tertiae], V26, P1631	51	62	72	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e34946	10.1371/journal.pone.0034946	http://dx.doi.org/10.1371/journal.pone.0034946			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529961	Green Published, Green Submitted, gold			2022-12-27	WOS:000305350600046
J	Ma, XL; Chang, WJ; Zhang, CP; Zhou, X; Yu, FY				Ma, Xiaoling; Chang, Wenjiao; Zhang, Cuiping; Zhou, Xin; Yu, Fangyou			Staphylococcal Panton-Valentine Leukocidin Induces Pro-Inflammatory Cytokine Production and Nuclear Factor-Kappa B Activation in Neutrophils	PLOS ONE			English	Article							VIRULENCE DETERMINANTS; MEDICAL PROGRESS; AUREUS; LUNG; ASSOCIATION; APOPTOSIS; GENE	Panton-Valentine leukocidin (PVL) is a cytotoxin secreted by Staphylococcus aureus and associated with severe necrotizing infections. PVL targets polymorphonuclear leukocytes, especially neutrophils, which are the first line of defense against infections. Although PVL can induce neutrophil death by necrosis or apoptosis, the specific inflammatory responses of neutrophils to this toxin are unclear. In this study, both in vivo and in vitro studies demonstrated that recombinant PVL has an important cytotoxic role in human neutrophils, leading to apoptosis at low concentrations and necrosis at high concentrations. Recombinant PVL also increased the levels of pro-inflammatory cytokine secretion from neutrophils. The up-regulation of pro-inflammatory cytokines was due to nuclear factor-kappa B (NF-kappa B) activation induced by PVL. Moreover, blocking NF-kB inhibited the production of inflammatory cytokines. To test the role of neutrophil immune responses during the pathogenesis of PVL-induced acute lung injury, we used immunocompetent or neutropenic rabbits to develop a model of necrotizing pneumonia. Immunocompetent rabbits challenged with PVL demonstrated increased inflammation containing neutrophilic infiltrates. In addition, there were elevated levels of inflammatory cytokines (IL-6, IL-8, TNF-alpha and IL-10) and NF-kappa B in the lung homogenate. In contrast, the lung tissues from neutropenic rabbits contained mild or moderate inflammation, and the levels of inflammatory cytokines and NF-kappa B increased only slightly. Data from the current study support growing evidence that neutrophils play an important role in the pathogenesis of PVL-induced tissue injury and inflammation. PVL can stimulate neutrophils to release pro-inflammatory mediators, thereby causing an acute inflammatory response. The ability of PVL to induce inflammatory cytokine release may be associated with the activation of NF-kappa B or its pore-forming properties.	[Ma, Xiaoling; Chang, Wenjiao; Zhang, Cuiping; Zhou, Xin] Anhui Med Univ, Anhui Prov Hosp, Dept Lab Med, Hefei, Peoples R China; [Yu, Fangyou] First Affiliated Hosp, Wenzhou Med Coll, Dept Lab Med, Wenzhou, Peoples R China	Anhui Medical University; Wenzhou Medical University	Ma, XL (corresponding author), Anhui Med Univ, Anhui Prov Hosp, Dept Lab Med, Hefei, Peoples R China.	xiaolingma@126.com	MA, XIAO/HHN-5611-2022		Anhui Provincial Natural Science Foundation [11040606M205]	Anhui Provincial Natural Science Foundation(Natural Science Foundation of Anhui Province)	This work ws supported by the Anhui Provincial Natural Science Foundation-11040606M205(http://220.178.98.52/zrkxjj/2011jjxmb.xls). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barr Beth, 2006, Tex Med, V102, P56; Boehning D, 2003, NAT CELL BIOL, V5, P1051, DOI 10.1038/ncb1063; Boehning D, 2005, P NATL ACAD SCI USA, V102, P1466, DOI 10.1073/pnas.0409650102; Boyle-Vavra S, 2007, LAB INVEST, V87, P3, DOI 10.1038/labinvest.3700501; Brown EL, 2008, CLIN VACCINE IMMUNOL; Diep BA, 2008, TRENDS MICROBIOL, V16, P361, DOI 10.1016/j.tim.2008.05.002; Diep BA, 2010, P NATL ACAD SCI USA, V107, P5587, DOI 10.1073/pnas.0912403107; Dubrous P, 2007, ANN BIOL CLIN-PARIS, V65, P277, DOI 10.1684/abc.2007.0049; Fridkin SK, 2005, NEW ENGL J MED, P352; Genestier AL, 2005, J CLIN INVEST, V115, P3117, DOI 10.1172/JCI22684; Gilbert M, 2006, CAN MED ASSOC J, V175, P149, DOI 10.1503/cmaj.051565; Gillet Y, 2002, LANCET, V359, P753, DOI 10.1016/S0140-6736(02)07877-7; Goodman RB, 2003, CYTOKINE GROWTH F R, V14, P523, DOI 10.1016/S1359-6101(03)00059-5; Jayasinghe L, 2005, PROTEIN SCI, V14, P2550, DOI 10.1110/ps.051648505; Kazakova SV, 2005, NEW ENGL J MED, P352; KONIG B, 1995, J INFECT DIS, V171, P607, DOI 10.1093/infdis/171.3.607; Labandeira-Rey M, 2007, SCIENCE, V315, P1130, DOI 10.1126/science.1137165; Liu C, 2008, CLIN INFECT DIS, V46, P1637, DOI 10.1086/587893; Loffler B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000715; Lopez-Aguilar C, 2007, J CLIN MICROBIOL, V45, P274, DOI 10.1128/JCM.02032-06; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Miles G, 2002, PROTEIN SCI, V11, P894, DOI 10.1110/ps.4360102; Montgomery CP, 2009, INFECT IMMUN, V77, P2159, DOI 10.1128/IAI.00021-09; Otto M, 2010, ANNU REV MICROBIOL, P64; Purcell K, 2005, ARCH PEDIAT ADOL MED, V159, P980, DOI 10.1001/archpedi.159.10.980; Tseng CW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006387; Wang R, 2007, NAT MED, V13, P1510, DOI 10.1038/nm1656; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Wu BQ, 2010, CAN J MICROBIOL, V56, P229, DOI [10.1139/W10-002, 10.1139/w10-002]; Zivkovic A, 2011, J IMMUNOL, V186, P1608, DOI 10.4049/jimmunol.1001665	30	41	45	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e34970	10.1371/journal.pone.0034970	http://dx.doi.org/10.1371/journal.pone.0034970			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529963	gold, Green Published, Green Submitted			2022-12-27	WOS:000305350600048
J	Zhang, JW; Zhou, F; Niu, F; Lu, M; Wu, XL; Sun, JG; Wang, GJ				Zhang, Jingwei; Zhou, Fang; Niu, Fang; Lu, Meng; Wu, Xiaolan; Sun, Jianguo; Wang, Guangji			Stereoselective Regulations of P-Glycoprotein by Ginsenoside Rh2 Epimers and the Potential Mechanisms From the View of Pharmacokinetics	PLOS ONE			English	Article							INTESTINAL BACTERIA; CACO-2 CELLS; IN-VITRO; 20(S)-GINSENOSIDE; ENANTIOMERS; STEREOSPECIFICITY; TRANSPORTERS; METABOLISM; VERAPAMIL; RECEPTOR	Chirality is an interesting topic and it is meaningful to explore the interactions between chiral small molecules and stereoselective biomacromolecules, with pre-clinical and clinical significances. We have previously demonstrated that 20(S)- ginsenoside Rh2 is an effective P-glycoprotein (P-gp) inhibitor in vitro and in vivo. Considering the stereochemistry of ginsenoside Rh2, in our present study, the regulatory effects of 20(R)-Rh2 on P-gp were assayed in vivo, and the differential regulations of P-gp by ginsenoside Rh2 epimers in vivo were compared and studied. Results showed that 20(S)-Rh2 enhanced the oral absorption of digoxin in rats in a dose-dependent manner; 20(R)-Rh2 at low dosage increased the oral absorption of digoxin, but this effect diminished with elevated dosage of 20(R)-Rh2. Further studies indicated stereoselective pharmacokinetic profiles and intestinal biotransformations of Rh2 epimers. In vitro studies showed that Rh2 epimers and their corresponding deglycosylation metabolites protopanaxadiol (Ppd) epimers all exhibited stereoselective regulations of P-gp. In conclusion, in view of the in vitro and in vivo dispositions of Rh2 and the regulations of P-gp by Rh2 and Ppd, it is suggested that the P-gp regulatory effect of Rh2 in vivo actually is a double actions of both Rh2 and Ppd, and the net effect is determined by the relative balance between Rh2 and Ppd with the same configuration. Our study provides new evidence of the chiral characteristics of P-gp, and is helpful to elucidate the stereoselective P-gp regulation mechanisms of ginsenoside Rh2 epimers in vivo from a pharmacokinetic view.	[Zhang, Jingwei; Zhou, Fang; Niu, Fang; Lu, Meng; Wu, Xiaolan; Sun, Jianguo; Wang, Guangji] China Pharmaceut Univ, Key Lab Drug Metab & Pharmacokinet, Nanjing 210009, Jiangsu, Peoples R China	China Pharmaceutical University	Zhang, JW (corresponding author), China Pharmaceut Univ, Key Lab Drug Metab & Pharmacokinet, Nanjing 210009, Jiangsu, Peoples R China.	zhoufangcpu@hotmail.com; guangjiwang@hotmail.com	niu, fang/A-8912-2019	niu, fang/0000-0002-5035-7409	China National Nature Science Foundation [30973583, 30801411]; China 'Creation of New Drugs' Key Technology Projects [2009ZX09304-001, 2009ZX09502-004]; Jiangsu Province Nature Science Foundation [BE2010723, BK2010437]	China National Nature Science Foundation(National Natural Science Foundation of China (NSFC)); China 'Creation of New Drugs' Key Technology Projects; Jiangsu Province Nature Science Foundation	This work was supported by China National Nature Science Foundation No. 30973583 (GW) and No. 30801411 (FZ); China 'Creation of New Drugs' Key Technology Projects No. 2009ZX09304-001 (HH) and 2009ZX09502-004 (GW); Jiangsu Province Nature Science Foundation No. BE2010723 (GW) and No. BK2010437 (FZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Bae EA, 2002, BIOL PHARM BULL, V25, P58, DOI 10.1248/bpb.25.58; Berginc K, 2011, J MED FOOD, V14, P135, DOI 10.1089/jmf.2010.0041; Berginc K, 2010, DRUG METAB PHARMACOK, V25, P307, DOI 10.2133/dmpk.25.307; Bhatia P, 2008, XENOBIOTICA, V38, P656, DOI [10.1080/00498250802109207, 10.1080/00498250802109207 ]; Bhatti MM, 1997, BIOPHARM DRUG DISPOS, V18, P387, DOI 10.1002/(SICI)1099-081X(199707)18:5<387::AID-BDD26>3.0.CO;2-X; BLASCHKE G, 1979, ARZNEIMITTEL-FORSCH, V29-2, P1640; Dey S, 1999, BIOCHEMISTRY-US, V38, P6630, DOI 10.1021/bi983038l; Gu Y, 2010, XENOBIOTICA, V40, P602, DOI 10.3109/00498254.2010.500744; Gu Y, 2009, FOOD CHEM TOXICOL, V47, P2257, DOI 10.1016/j.fct.2009.06.013; Hasegawa H, 2004, J PHARMACOL SCI, V95, P153, DOI 10.1254/jphs.FMJ04001X4; Jeong SM, 2004, MOL CELLS, V18, P383; Kang DI, 2005, BIOCHEM BIOPH RES CO, V333, P1194, DOI 10.1016/j.bbrc.2005.06.026; Liu J, 2010, FITOTERAPIA, V81, P902, DOI 10.1016/j.fitote.2010.05.020; Liu J, 2009, BIOORG MED CHEM LETT, V19, P3320, DOI 10.1016/j.bmcl.2009.04.054; Lv H, 2008, INT J PHARM, V351, P31, DOI 10.1016/j.ijpharm.2007.09.026; Nunez MC, 2009, CURR MED CHEM, V16, P2064, DOI 10.2174/092986709788682173; Oswald S, 2011, HANDB EXP PHARMACOL, V201, P403, DOI 10.1007/978-3-642-14541-4_11; Qi LW, 2011, PHYTOCHEMISTRY, V72, P689, DOI 10.1016/j.phytochem.2011.02.012; Qi LW, 2010, BIOCHEM PHARMACOL, V80, P947, DOI 10.1016/j.bcp.2010.06.023; Qian Tianxiu, 2010, Chin Med, V5, P19, DOI 10.1186/1749-8546-5-19; Robinson MA, 1996, BIOPHARM DRUG DISPOS, V17, P577, DOI 10.1002/(SICI)1099-081X(199610)17:7<577::AID-BDD984>3.3.CO;2-G; Rulcova A, 2010, J THROMB HAEMOST, V8, P2708, DOI 10.1111/j.1538-7836.2010.04036.x; Smith SW, 2009, TOXICOL SCI, V110, P4, DOI 10.1093/toxsci/kfp097; Sun H, 2008, EXPERT OPIN DRUG MET, V4, P395, DOI 10.1517/17425255.4.4.395 ; Tawab MA, 2003, DRUG METAB DISPOS, V31, P1065, DOI 10.1124/dmd.31.8.1065; WAINER IW, 1992, AM J HOSP PHARM, V49, pS4, DOI 10.1093/ajhp/49.9_Suppl_1.S4; Weiss M, 2012, J CLIN PHARMACOL, V52, P381, DOI 10.1177/0091270010396711; Xie HT, 2005, BIOL PHARM BULL, V28, P383, DOI 10.1248/bpb.28.383; Zhang JW, 2010, DRUG METAB DISPOS, V38, P2179, DOI 10.1124/dmd.110.034793	30	24	29	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35768	10.1371/journal.pone.0035768	http://dx.doi.org/10.1371/journal.pone.0035768			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22530069	Green Submitted, Green Published, gold			2022-12-27	WOS:000305350600114
J	Audet, JN; Gowing, G; Paradis, R; Soucy, G; Julien, JP				Audet, Jean-Nicolas; Gowing, Genevieve; Paradis, Renee; Soucy, Genevieve; Julien, Jean-Pierre			Ablation of Proliferating Cells in the CNS Exacerbates Motor Neuron Disease Caused by Mutant Superoxide Dismutase	PLOS ONE			English	Article							GROWTH-FACTOR-I; MOUSE MODEL; EXTEND SURVIVAL; ANIMAL-MODEL; SPINAL-CORD; MICROGLIA; IGF-1; PROGRESSION; ASTROCYTES; SOD1	Proliferation of glia and immune cells is a common pathological feature of many neurodegenerative diseases including amyotrophic lateral sclerosis (ALS). Here, to investigate the role of proliferating cells in motor neuron disease, SOD1(G93A) transgenic mice were treated intracerebroventicularly (ICV) with the anti-mitotic drug cytosine arabinoside (Ara-C). ICV delivery of Ara-C accelerated disease progression in SOD1(G93A) mouse model of ALS. Ara-C treatment caused substantial decreases in the number of microglia, NG2+ progenitors, Olig2+ cells and CD3+ T cells in the lumbar spinal cord of symptomatic SOD1(G93A) transgenic mice. Exacerbation of disease was also associated with significant alterations in the expression inflammatory molecules IL-1 beta, IL-6, TGF-beta and the growth factor IGF-1.	[Audet, Jean-Nicolas; Gowing, Genevieve; Paradis, Renee; Soucy, Genevieve; Julien, Jean-Pierre] Univ Laval, CHUQ, Res Ctr, Dept Psychiat & Neurosci, Quebec City, PQ, Canada	Laval University	Audet, JN (corresponding author), Univ Laval, CHUQ, Res Ctr, Dept Psychiat & Neurosci, Quebec City, PQ, Canada.	jean-pierre.julien@crchul.ulaval.ca	Audet, Jean-Nicolas/P-2535-2014	Audet, Jean-Nicolas/0000-0002-0511-183X	Canadian Institutes in Health Research (CIHR)	Canadian Institutes in Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes in Health Research (CIHR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002740; Beers DR, 2008, P NATL ACAD SCI USA, V105, P15558, DOI 10.1073/pnas.0807419105; Beers DR, 2006, P NATL ACAD SCI USA, V103, P16021, DOI 10.1073/pnas.0607423103; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Chiu IM, 2008, P NATL ACAD SCI USA, V105, P17913, DOI 10.1073/pnas.0804610105; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; Day WA, 2005, NEUROBIOL DIS, V19, P323, DOI 10.1016/j.nbd.2005.01.010; Di Giorgio FP, 2007, NAT NEUROSCI, V10, P608, DOI 10.1038/nn1885; Dobrowolny G, 2005, J CELL BIOL, V168, P193, DOI 10.1083/jcb.200407021; Dodge JC, 2010, MOL THER, V18, P2075, DOI 10.1038/mt.2010.206; Franz CK, 2009, NEUROBIOL DIS, V33, P473, DOI 10.1016/j.nbd.2008.12.003; Gowing G, 2008, J NEUROSCI, V28, P10234, DOI 10.1523/JNEUROSCI.3494-08.2008; Gowing G, 2009, EXP NEUROL, V220, P267, DOI 10.1016/j.expneurol.2009.08.021; Henkel JS, 2009, J NEUROIMMUNE PHARM, V4, P389, DOI 10.1007/s11481-009-9171-5; Ilieva H, 2009, J CELL BIOL, V187, P761, DOI 10.1083/jcb.200908164; Kaspar BK, 2003, SCIENCE, V301, P839, DOI 10.1126/science.1086137; Katsuno M, 2011, Curr Mol Med, V11, P48, DOI 10.2174/156652411794474356; Lasiene J, 2011, NEUROL RES INT, V2011, DOI 10.1155/2011/718987; Lepore AC, 2008, NAT NEUROSCI, V11, P1294, DOI 10.1038/nn.2210; Lepore AC, 2007, BRAIN RES, V1185, P256, DOI 10.1016/j.brainres.2007.09.034; Liu Y, 2009, J BIOL CHEM, V284, P3691, DOI 10.1074/jbc.M804446200; Marchetto MCN, 2008, CELL STEM CELL, V3, P649, DOI 10.1016/j.stem.2008.10.001; Masahira N, 2006, DEV BIOL, V293, P358, DOI 10.1016/j.ydbio.2006.02.029; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; Nagano I, 2005, J NEUROL SCI, V235, P61, DOI 10.1016/j.jns.2005.04.011; Narai H, 2005, J NEUROSCI RES, V82, P452, DOI 10.1002/jnr.20668; Nguyen MD, 2004, J NEUROSCI, V24, P1340, DOI 10.1523/JNEUROSCI.4786-03.2004; Nishiyama A, 2009, NAT REV NEUROSCI, V10, P9, DOI 10.1038/nrn2495; Ono K, 2009, MOL CELLS, V27, P397, DOI 10.1007/s10059-009-0067-2; Riddoch-Contreras J, 2009, EXP NEUROL, V215, P281, DOI 10.1016/j.expneurol.2008.10.014; Rothstein JD, 2009, ANN NEUROL, V65, pS3, DOI 10.1002/ana.21543; Tada S, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-19; Turner BJ, 2008, PROG NEUROBIOL, V85, P94, DOI 10.1016/j.pneurobio.2008.01.001; Weydt P, 2004, GLIA, V48, P179, DOI 10.1002/glia.20062; Xiao Q, 2007, J NEUROCHEM, V102, P2008, DOI 10.1111/j.1471-4159.2007.04677.x; Yamanaka K, 2008, P NATL ACAD SCI USA, V105, P7594, DOI 10.1073/pnas.0802556105; Yamanaka K, 2008, NAT NEUROSCI, V11, P251, DOI 10.1038/nn2047; Zhao WH, 2010, GLIA, V58, P231, DOI 10.1002/glia.20919	38	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e34932	10.1371/journal.pone.0034932	http://dx.doi.org/10.1371/journal.pone.0034932			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523565	Green Published, gold, Green Submitted			2022-12-27	WOS:000305345000037
J	Nishijima, N; Marusawa, H; Ueda, Y; Takahashi, K; Nasu, A; Osaki, Y; Kou, T; Yazumi, S; Fujiwara, T; Tsuchiya, S; Shimizu, K; Uemoto, S; Chiba, T				Nishijima, Norihiro; Marusawa, Hiroyuki; Ueda, Yoshihide; Takahashi, Ken; Nasu, Akihiro; Osaki, Yukio; Kou, Tadayuki; Yazumi, Shujiro; Fujiwara, Takeshi; Tsuchiya, Soken; Shimizu, Kazuharu; Uemoto, Shinji; Chiba, Tsutomu			Dynamics of Hepatitis B Virus Quasispecies in Association with Nucleos(t)ide Analogue Treatment Determined by Ultra-Deep Sequencing	PLOS ONE			English	Article							PRECORE REGION; E-ANTIGEN; FULMINANT; VARIANTS; ANTIBODY; THERAPY; DNA; NUCLEOSIDE; INFECTION; MUTATION	Background and Aims: Although the advent of ultra-deep sequencing technology allows for the analysis of heretofore-undetectable minor viral mutants, a limited amount of information is currently available regarding the clinical implications of hepatitis B virus (HBV) genomic heterogeneity. Methods: To characterize the HBV genetic heterogeneity in association with anti-viral therapy, we performed ultra-deep sequencing of full-genome HBV in the liver and serum of 19 patients with chronic viral infection, including 14 therapy-naive and 5 nucleos(t)ide analogue(NA)-treated cases. Results: Most genomic changes observed in viral variants were single base substitutions and were widely distributed throughout the HBV genome. Four of eight (50%) chronic therapy-naive HBeAg-negative patients showed a relatively low prevalence of the G1896A pre-core (pre-C) mutant in the liver tissues, suggesting that other mutations were involved in their HBeAg seroconversion. Interestingly, liver tissues in 4 of 5 (80%) of the chronic NA-treated anti-HBe-positive cases had extremely low levels of the G1896A pre-C mutant (0.0%, 0.0%, 0.1%, and 1.1%), suggesting the high sensitivity of the G1896A pre-C mutant to NA. Moreover, various abundances of clones resistant to NA were common in both the liver and serum of treatment-naive patients, and the proportion of M204VI mutants resistant to lamivudine and entecavir expanded in response to entecavir treatment in the serum of 35.7% (5/14) of patients, suggesting the putative risk of developing drug resistance to NA. Conclusion: Our findings illustrate the strong advantage of deep sequencing on viral genome as a tool for dissecting the pathophysiology of HBV infection.	[Nishijima, Norihiro; Marusawa, Hiroyuki; Ueda, Yoshihide; Takahashi, Ken; Nasu, Akihiro; Chiba, Tsutomu] Kyoto Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Kyoto, Japan; [Osaki, Yukio] Osaka Red Cross Hosp, Dept Gastroenterol & Hepatol, Osaka, Japan; [Kou, Tadayuki; Yazumi, Shujiro] Kitano Hosp, Tazuke Kofukai Med Res Inst, Dept Gastroenterol & Hepatol, Osaka, Japan; [Fujiwara, Takeshi; Tsuchiya, Soken; Shimizu, Kazuharu] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Nanobio Drug Discovery, Kyoto, Japan; [Uemoto, Shinji] Kyoto Univ, Grad Sch Med, Dept Surg, Kyoto, Japan	Kyoto University; Osaka Red Cross Hospital; Kitano Hospital; Kyoto University; Kyoto University	Nishijima, N (corresponding author), Kyoto Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Kyoto, Japan.	maru@kuhp.kyoto-u.ac.jp	Ueda, Yoshihide/S-7620-2016; Nishijima, Norihiro/GMX-2899-2022	Ueda, Yoshihide/0000-0003-3196-3494; Marusawa, Hiroyuki/0000-0002-4286-2712	JSPS [21229009, 23390196]; Health and Labor Science Research [H22-08]; Research on Hepatitis from the Ministry of Health, Labor and Welfare, Japan	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Health and Labor Science Research; Research on Hepatitis from the Ministry of Health, Labor and Welfare, Japan	This work was supported by JSPS Grant-in-aid for Scientific Research 21229009, 23390196, and Health and Labor Science Research Grants (H22-08) and Research on Hepatitis from the Ministry of Health, Labor and Welfare, Japan. (http://mhlw-grants.niph.go.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAHANE Y, 1990, GASTROENTEROLOGY, V99, P1113, DOI 10.1016/0016-5085(90)90632-B; CARMAN WF, 1991, HEPATOLOGY, V14, P219, DOI 10.1002/hep.1840140203; Chang KM, 2010, CLIN LIVER DIS, V14, P409, DOI 10.1016/j.cld.2010.05.012; Chowdhury A, 2005, J GASTROEN HEPATOL, V20, P1712, DOI 10.1111/j.1440-1746.2005.04070.x; Dienstag JL, 2008, NEW ENGL J MED, V359, P1486, DOI 10.1056/NEJMra0801644; Dienstag JL, 2009, HEPATOLOGY, V49, pS112, DOI 10.1002/hep.22920; Domingo E, 2007, VIRUS RES, V127, P131, DOI 10.1016/j.virusres.2007.02.001; Fishman SL, 2009, INFECT GENET EVOL, V9, P1158, DOI 10.1016/j.meegid.2009.07.011; Ghany MG, 2009, HEPATOLOGY, V49, pS174, DOI 10.1002/hep.22900; Han Y, 2009, J GASTROEN HEPATOL, V24, P1417, DOI 10.1111/j.1440-1746.2009.05864.x; Hedskog C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011345; Hollinger FB, 2007, J VIRAL HEPATITIS, V14, P11, DOI 10.1111/j.1365-2893.2007.00910.x; Ikeda K, 2007, ANN INTERN MED, V146, P649, DOI 10.7326/0003-4819-146-9-200705010-00008; Kramvis A, 1999, J VIRAL HEPATITIS, V6, P415, DOI 10.1046/j.1365-2893.1999.00189.x; Kwon H, 2011, NAT REV GASTROENTERO; Lataillade M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010952; Lisotti Andrea, 2008, Int J Med Sci, V5, P309; Lok AS, 2007, HEPATOLOGY, V46, P254, DOI 10.1002/hep.21698; Lok ASF, 2007, HEPATOLOGY, V45, P507, DOI 10.1002/hep.21513; Louvel S, 2008, HIV MED, V9, P133, DOI 10.1111/j.1468-1293.2007.00529.x; Margeridon-Thermet S, 2009, J INFECT DIS, V199, P1275, DOI 10.1086/597808; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Marusawa H, 2003, EMBO J, V22, P2729, DOI 10.1093/emboj/cdg263; Matsumoto Y, 2007, NAT MED, V13, P470, DOI 10.1038/nm1566; Murray JM, 2006, HEPATOLOGY, V44, P1117, DOI 10.1002/hep.21364; Nasu A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024907; Ngui SL, 1997, J VIRAL HEPATITIS, V4, P309, DOI 10.1046/j.1365-2893.1997.00066.x; Ntziora F, 2009, J CLIN MICROBIOL, V47, P2544, DOI 10.1128/JCM.00045-09; OKAMOTO H, 1990, J VIROL, V64, P1298, DOI 10.1128/JVI.64.3.1298-1303.1990; OMATA M, 1991, NEW ENGL J MED, V324, P1699, DOI 10.1056/NEJM199106133242404; Orito E, 2001, HEPATOLOGY, V33, P218, DOI 10.1053/jhep.2001.20532; Rozera G, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-15; Ruike Y, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-137; Simen BB, 2009, J INFECT DIS, V199, P693, DOI 10.1086/596736; Solmone M, 2009, J VIROL, V83, P1718, DOI 10.1128/JVI.02011-08; Yu JW, 2011, LIVER INT, V31, P499, DOI 10.1111/j.1478-3231.2011.02450.x; Zoulim F, 2009, GASTROENTEROLOGY, V137, P1593, DOI 10.1053/j.gastro.2009.08.063	37	68	70	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e35052	10.1371/journal.pone.0035052	http://dx.doi.org/10.1371/journal.pone.0035052			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523569	Green Submitted, gold, Green Published			2022-12-27	WOS:000305345000041
J	Wu, CL; Chou, YH; Chang, YJ; Teng, NY; Hsu, HL; Chen, LY				Wu, Chia-Ling; Chou, Yu-Han; Chang, Yu-Jung; Teng, Nan-Yuan; Hsu, Hsin-Ling; Chen, Linyi			Interplay between Cell Migration and Neurite Outgrowth Determines SH2B1 beta-Enhanced Neurite Regeneration of Differentiated PC12 Cells	PLOS ONE			English	Article							PROTEIN-KINASE-C; NERVE GROWTH-FACTOR; HUMAN NEURODEGENERATIVE DISORDERS; NEURONAL MIGRATION; AXONAL-TRANSPORT; MAP KINASE; PHOSPHATIDYLINOSITOL-3 KINASE; NEUROTROPHIC FACTORS; SENSORY NEURONS; BRAIN-INJURY	The regulation of neurite outgrowth is crucial in developing strategies to promote neurite regeneration after nerve injury and in degenerative diseases. In this study, we demonstrate that overexpression of an adaptor/scaffolding protein SH2B1 beta promotes neurite re-growth of differentiated PC12 cells, an established neuronal model, using wound healing (scraping) assays. Cell migration and the subsequent remodeling are crucial determinants during neurite regeneration. We provide evidence suggesting that overexpressing SH2B1 beta enhances protein kinase C (PKC)-dependent cell migration and phosphatidylinositol 3-kinase (PI3K)-AKT-, mitogen activated protein kinase (MAPK)/extracellular signal-regulated protein kinase (ERK) kinase (MEK)-ERK-dependent neurite re-growth. Our results further reveal a cross-talk between pathways involving PKC and ERK1/2 in regulating neurite re-growth and cell migration. We conclude that temporal regulation of cell migration and neurite outgrowth by SH2B1 beta contributes to the enhanced regeneration of differentiated PC12 cells.	[Wu, Chia-Ling; Chou, Yu-Han; Chang, Yu-Jung; Chen, Linyi] Natl Tsing Hua Univ, Inst Mol Med, Hsinchu, Taiwan; [Chen, Linyi] Natl Tsing Hua Univ, Dept Med Sci, Hsinchu, Taiwan; [Teng, Nan-Yuan] Natl Tsing Hua Univ, Dept Life Sci, Hsinchu, Taiwan; [Hsu, Hsin-Ling] Natl Hlth Res Inst, Div Mol & Genom Med, Miaoli Cty, Taiwan	National Tsing Hua University; National Tsing Hua University; National Tsing Hua University; National Health Research Institutes - Taiwan	Wu, CL (corresponding author), Natl Tsing Hua Univ, Inst Mol Med, Hsinchu, Taiwan.	lchen@life.nthu.edu.tw	Chen, Linyi/AAV-2632-2020; Hsu, Hsin-Ling/E-3672-2010	Chen, Linyi/0000-0001-7258-8817; Chang, Yu-Jung/0000-0002-4781-0946	National Health Research Institutes of Taiwan [NHRI-EX100-9719NC]; National Science Council of Taiwan [NSC97-2311-B-007-007-MY3]; National Tsing Hua University [100N7726E1, 100N2772E1]	National Health Research Institutes of Taiwan(National Health Research Institutes - Taiwan); National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); National Tsing Hua University	This study was supported by grants from the National Health Research Institutes of Taiwan (NHRI-EX100-9719NC), the National Science Council of Taiwan (NSC97-2311-B-007-007-MY3) and the National Tsing Hua University (100N7726E1 and 100N2772E1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe N, 2008, CURR OPIN NEUROBIOL, V18, P276, DOI 10.1016/j.conb.2008.06.005; AltunGultekin ZF, 1996, J NEUROSCI RES, V44, P308, DOI 10.1002/(SICI)1097-4547(19960515)44:4<308::AID-JNR2>3.0.CO;2-G; Arevalo JC, 2006, CELL MOL LIFE SCI, V63, P1523, DOI 10.1007/s00018-006-6010-1; Battaini F, 2001, PHARMACOL RES, V44, P353, DOI 10.1006/phrs.2001.0893; Becchetti A, 2010, ADV EXP MED BIOL, V674, P107; Bloch J, 2001, EXP NEUROL, V172, P425, DOI 10.1006/exnr.2001.7778; Bonsall J, 1999, BRAIN RES, V839, P120, DOI 10.1016/S0006-8993(99)01725-4; BURGESS GM, 1984, NATURE, V309, P63, DOI 10.1038/309063a0; CAMPENOT RB, 1994, J NEUROCHEM, V63, P868; Cary LA, 1996, J CELL SCI, V109, P1787; Cavalli V, 2005, J CELL BIOL, V168, P775, DOI 10.1083/jcb.200410136; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; Cui Q, 2006, MOL NEUROBIOL, V33, P155, DOI 10.1385/MN:33:2:155; Grills BL, 1997, J ORTHOPAED RES, V15, P235, DOI 10.1002/jor.1100150212; Hanz S, 2003, NEURON, V40, P1095, DOI 10.1016/S0896-6273(03)00770-0; Hatten ME, 1999, ANNU REV NEUROSCI, V22, P511, DOI 10.1146/annurev.neuro.22.1.511; Heacock AM, 1997, NEUROCHEM RES, V22, P1179, DOI 10.1023/A:1021916509858; Herrington J, 2000, J BIOL CHEM, V275, P13126, DOI 10.1074/jbc.275.17.13126; Hoffman PN, 2010, EXP NEUROL, V223, P11, DOI 10.1016/j.expneurol.2009.09.006; Huang YZ, 2010, J BIOL CHEM, V285, P8207, DOI 10.1074/jbc.M109.091041; Ikeda T, 2008, CELL TISSUE RES, V331, P263, DOI 10.1007/s00441-007-0546-8; Jones NP, 2005, J CELL SCI, V118, P2695, DOI 10.1242/jcs.02374; Kimpinski K, 2001, J NEUROSCI RES, V63, P486, DOI 10.1002/jnr.1043; Kojima T, 2010, STEM CELLS, V28, P545, DOI 10.1002/stem.306; Kolkova K, 2000, J NEUROSCI, V20, P2238; Kong M, 2002, J BIOL CHEM, V277, P15962, DOI 10.1074/jbc.M102777200; KRUG E, 1987, J BIOL CHEM, V262, P11852; Kumada T, 2004, P NATL ACAD SCI USA, V101, P8479, DOI 10.1073/pnas.0401000101; Larsson C, 2006, CELL SIGNAL, V18, P276, DOI 10.1016/j.cellsig.2005.07.010; Le Merrer J, 2000, PHARMACOL RES, V41, P503; LEE V, 1977, P NATL ACAD SCI USA, V74, P5021, DOI 10.1073/pnas.74.11.5021; Lin WF, 2009, CELL SIGNAL, V21, P1060, DOI 10.1016/j.cellsig.2009.02.009; Lindvall O, 2004, NAT MED, V10, pS42, DOI 10.1038/nm1064; Lindvall O, 2010, J CLIN INVEST, V120, P29, DOI 10.1172/JCI40543; Lindwall C, 2005, MOL CELL NEUROSCI, V29, P269, DOI 10.1016/j.mcn.2005.03.002; Lu W, 2010, NEW J PHYS, V12, P1, DOI 10.1088/1367-2630/12/8/085002; Markus A, 2002, CURR OPIN NEUROBIOL, V12, P523, DOI 10.1016/S0959-4388(02)00372-0; Markus A, 2002, NEURON, V35, P65, DOI 10.1016/S0896-6273(02)00752-3; Metzger F, 2000, EUR J NEUROSCI, V12, P1993, DOI 10.1046/j.1460-9568.2000.00086.x; Mikule K, 2003, J BIOL CHEM, V278, P21168, DOI 10.1074/jbc.M211828200; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Namikawa K, 2000, J NEUROSCI, V20, P2875; Nelms K, 1999, MAMM GENOME, V10, P1160, DOI 10.1007/s003359901183; Nomura N, 2007, INT J MOL MED, V20, P511; PANG L, 1995, J BIOL CHEM, V270, P13585, DOI 10.1074/jbc.270.23.13585; Park DH, 2009, STEM CELLS DEV, V18, P693, DOI 10.1089/scd.2009.0008; Perlson E, 2005, NEURON, V45, P715, DOI 10.1016/j.neuron.2005.01.023; Qian XZ, 1998, NEURON, V21, P1017, DOI 10.1016/S0896-6273(00)80620-0; Read DE, 2009, CELL MOL LIFE SCI, V66, P2975, DOI 10.1007/s00018-009-0057-8; Reynolds AJ, 2001, NEUROSCIENCE, V105, P761, DOI 10.1016/S0306-4522(01)00235-4; Riedel H, 2000, ONCOGENE, V19, P39, DOI 10.1038/sj.onc.1203253; RODRIGUES PD, 1990, P NATL ACAD SCI USA, V87, P9693, DOI 10.1073/pnas.87.24.9693; Romero MI, 2001, J NEUROSCI, V21, P8408, DOI 10.1523/JNEUROSCI.21-21-08408.2001; Ross ME, 2001, ANNU REV NEUROSCI, V24, P1041, DOI 10.1146/annurev.neuro.24.1.1041; Rosse C, 2010, NAT REV MOL CELL BIO, V11, P103, DOI 10.1038/nrm2847; Rui LY, 1999, J BIOL CHEM, V274, P10590, DOI 10.1074/jbc.274.15.10590; Shioda N, 2009, INT REV NEUROBIOL, V85, P375, DOI 10.1016/S0074-7742(09)85026-5; Snider WD, 2002, NEURON, V35, P13, DOI 10.1016/S0896-6273(02)00762-6; Song W, 2010, CELL METAB, V11, P427, DOI 10.1016/j.cmet.2010.04.002; Suh PG, 2008, BMB REP, V41, P415, DOI 10.5483/BMBRep.2008.41.6.415; TANAKA C, 1994, ANNU REV NEUROSCI, V17, P551, DOI 10.1146/annurev.ne.17.030194.003003; THEODORE L, 1995, J NEUROSCI, V15, P7158; TODDERUD G, 1990, SCIENCE, V249, P296, DOI 10.1126/science.2374928; Toni N, 1997, SYNAPSE, V27, P199, DOI 10.1002/(SICI)1098-2396(199711)27:3<199::AID-SYN6>3.3.CO;2-I; VALIUS M, 1993, CELL, V73, P321, DOI 10.1016/0092-8674(93)90232-F; Waetzig V, 2005, MOL CELL NEUROSCI, V30, P67, DOI 10.1016/j.mcn.2005.06.001; Wang XH, 2004, J BIOL CHEM, V279, P133, DOI 10.1074/jbc.M310040200; YAO RJ, 1995, SCIENCE, V267, P2003, DOI 10.1126/science.7701324; Zhang Y, 2006, J CELL SCI, V119, P1666, DOI 10.1242/jcs.02845; Zheng JQ, 2007, ANNU REV CELL DEV BI, V23, P375, DOI 10.1146/annurev.cellbio.23.090506.123221	70	18	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e34999	10.1371/journal.pone.0034999	http://dx.doi.org/10.1371/journal.pone.0034999			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22539954	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341000017
J	de Zeeuw, P; Schnack, HG; van Belle, J; Weusten, J; van Dijk, S; Langen, M; Brouwer, RM; van Engeland, H; Durston, S				de Zeeuw, Patrick; Schnack, Hugo G.; van Belle, Janna; Weusten, Juliette; van Dijk, Sarai; Langen, Marieke; Brouwer, Rachel M.; van Engeland, Herman; Durston, Sarah			Differential Brain Development with Low and High IQ in Attention-Deficit/Hyperactivity Disorder	PLOS ONE			English	Article							DEFICIT HYPERACTIVITY DISORDER; NORMAL PEDIATRIC POPULATION; WHITE-MATTER ARCHITECTURE; AUTOMATED 3-D EXTRACTION; CORTICAL GRAY-MATTER; DIFFUSION-TENSOR MRI; HUMAN INTELLIGENCE; CEREBRAL-CORTEX; INTELLECTUAL-PERFORMANCE; GENETIC INFLUENCES	Attention-Deficit/Hyperactivity Disorder (ADHD) and intelligence (IQ) are both heritable phenotypes. Overlapping genetic effects have been suggested to influence both, with neuroimaging work suggesting similar overlap in terms of morphometric properties of the brain. Together, this evidence suggests that the brain changes characteristic of ADHD may vary as a function of IQ. This study investigated this hypothesis in a sample of 108 children with ADHD and 106 typically developing controls, who participated in a cross-sectional anatomical MRI study. A subgroup of 64 children also participated in a diffusion tensor imaging scan. Brain volumes, local cortical thickness and average cerebral white matter microstructure were analyzed in relation to diagnostic group and IQ. Dimensional analyses investigated possible group differences in the relationship between anatomical measures and IQ. Second, the groups were split into above and below median IQ subgroups to investigate possible differences in the trajectories of cortical development. Dimensionally, cerebral gray matter volume and cerebral white matter microstructure were positively associated with IQ for controls, but not for ADHD. In the analyses of the below and above median IQ subgroups, we found no differences from controls in cerebral gray matter volume in ADHD with below-median IQ, but a delay of cortical development in a number of regions, including prefrontal areas. Conversely, in ADHD with above-median IQ, there were significant reductions from controls in cerebral gray matter volume, but no local differences in the trajectories of cortical development. In conclusion, the basic relationship between IQ and neuroanatomy appears to be altered in ADHD. Our results suggest that there may be multiple brain phenotypes associated with ADHD, where ADHD combined with above median IQ is characterized by small, more global reductions in brain volume that are stable over development, whereas ADHD with below median IQ is associated more with a delay of cortical development.	[de Zeeuw, Patrick; van Belle, Janna; Weusten, Juliette; van Dijk, Sarai; Langen, Marieke; van Engeland, Herman; Durston, Sarah] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Child & Adolescent Psychiat, Neuroimaging Lab, Utrecht, Netherlands; [Schnack, Hugo G.; Brouwer, Rachel M.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Psychiat, Struct Neuroimaging Grp, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	de Zeeuw, P (corresponding author), Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Child & Adolescent Psychiat, Neuroimaging Lab, Utrecht, Netherlands.	p.dezeeuw@umcutrecht.nl	Hassan, Randa/AAW-3624-2021		Netherlands Organization for Scientific Research (Nederlandse Organisatie voor Wetenschappelijk Onderzoek, NWO) [Vidi-91.776.384]; Unilever Foods	Netherlands Organization for Scientific Research (Nederlandse Organisatie voor Wetenschappelijk Onderzoek, NWO)(Netherlands Organization for Scientific Research (NWO)); Unilever Foods(Unilever)	This work was supported by a grant from the Netherlands Organization for Scientific Research (Nederlandse Organisatie voor Wetenschappelijk Onderzoek, NWO, www.nwo.nl) in the Innovational Research Incentives Scheme (also known as the "Veni, Vidi, Vici"-programme) to SD (grant number: Vidi-91.776.384, further information can be found on http://www.nwo.nl/nwohome.nsf/pages/NWOA_4YJDQ3_Eng). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; SD has received a research grant from Unilever Foods that is unrelated to this manuscript. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. The other authors have declared that no competing interests exist.	Almeida LG, 2010, J PSYCHIATR RES, V44, P1214, DOI 10.1016/j.jpsychires.2010.04.026; Andersson JLR, 2002, NEUROIMAGE, V16, P177, DOI 10.1006/nimg.2001.1039; [Anonymous], 2006, J NEUROSCI, V26, P4930, DOI [10.1523/JNEUROSCI.5480-05, DOI 10.1523/JNEUROSCI.5480-05, DOI 10.1523/JNEUROSCI.1312-06.2006]; Antshel KM, 2008, J AM ACAD CHILD PSY, V47, P817, DOI 10.1097/CHI.0b013e318172eecf; Antshel KM, 2008, DEV DISABIL RES REV, V14, P293, DOI 10.1002/ddrr.34; Banaschewski T, 2010, EUR CHILD ADOLES PSY, V19, P237, DOI 10.1007/s00787-010-0090-z; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; Batty MJ, 2010, J AM ACAD CHILD PSY, V49, P229, DOI 10.1016/j.jaac.2009.11.008; Betjemann RS, 2010, BEHAV GENET, V40, P135, DOI 10.1007/s10519-009-9328-2; Brans RGH, 2010, J NEUROSCI, V30, P5519, DOI 10.1523/JNEUROSCI.5841-09.2010; Bridgett DJ, 2006, PSYCHOL ASSESSMENT, V18, P1, DOI 10.1037/1040-3590.18.1.1; Brouwer RM, 2010, NEUROIMAGE, V49, P467, DOI 10.1016/j.neuroimage.2009.07.041; BUITELAAR JK, 1995, J AM ACAD CHILD PSY, V34, P1025, DOI 10.1097/00004583-199508000-00012; Chang LC, 2005, MAGN RESON MED, V53, P1088, DOI 10.1002/mrm.20426; Charil A, 2010, BRAIN RES REV, V65, P56, DOI 10.1016/j.brainresrev.2010.06.002; Charman T, 2011, PSYCHOL MED, V41, P619, DOI 10.1017/S0033291710000991; Chiang MC, 2009, J NEUROSCI, V29, P2212, DOI 10.1523/JNEUROSCI.4184-08.2009; Choi YY, 2008, J NEUROSCI, V28, P10323, DOI 10.1523/JNEUROSCI.3259-08.2008; Chung MK, 2003, NEUROIMAGE, V18, P198, DOI 10.1016/S1053-8119(02)00017-4; CLEVELAND WS, 1988, J AM STAT ASSOC, V83, P596, DOI 10.2307/2289282; de Zeeuw P, 2012, HUM BRAIN MAPP, V33, P1941, DOI 10.1002/hbm.21335; Deary IJ, 2010, NAT REV NEUROSCI, V11, P201, DOI 10.1038/nrn2793; Deary IJ, 2009, HUM GENET, V126, P215, DOI 10.1007/s00439-009-0655-4; Deary IJ, 2006, NEUROLOGY, V66, P505, DOI 10.1212/01.wnl.0000199954.81900.e2; Dennis M, 2009, J INT NEUROPSYCH SOC, V15, P331, DOI 10.1017/S1355617709090481; Deutsch CK, 2008, DEV DISABIL RES REV, V14, P285, DOI 10.1002/ddrr.42; Durston S, 2009, NEUROSCI BIOBEHAV R, V33, P674, DOI 10.1016/j.neubiorev.2008.08.009; Durston S, 2009, J AM ACAD CHILD PSY, V48, P206, DOI 10.1097/CHI.0b013e3181930673; Dwyer JB, 2009, PHARMACOL THERAPEUT, V122, P125, DOI 10.1016/j.pharmthera.2009.02.003; Faraone SV, 2005, BIOL PSYCHIAT, V57, P1313, DOI 10.1016/j.biopsych.2004.11.024; Frangou S, 2004, NEUROIMAGE, V23, P800, DOI 10.1016/j.neuroimage.2004.05.027; Frazier TW, 2004, NEUROPSYCHOLOGY, V18, P543, DOI 10.1037/0894-4105.18.3.543; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Gray JR, 2004, NAT REV NEUROSCI, V5, P471, DOI 10.1038/nrn1405; Hart AR, 2008, DEV MED CHILD NEUROL, V50, P655, DOI 10.1111/j.1469-8749.2008.03050.x; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Hechtman L, 1999, PEDIATR CLIN N AM, V46, P1039, DOI 10.1016/S0031-3955(05)70171-1; Joshi AA, 2011, NEUROREPORT, V22, P101, DOI 10.1097/WNR.0b013e3283424c84; Jung RE, 2007, BEHAV BRAIN SCI, V30, P135, DOI 10.1017/S0140525X07001185; Kabani N, 2001, NEUROIMAGE, V13, P375, DOI 10.1006/nimg.2000.0652; Karama S, 2009, INTELLIGENCE, V37, P145, DOI 10.1016/j.intell.2008.09.006; Karama S, 2011, NEUROIMAGE, V55, P1443, DOI 10.1016/j.neuroimage.2011.01.016; Katusic MZ, 2011, J DEV BEHAV PEDIATR, V32, P103, DOI 10.1097/DBP.0b013e318206d700; Kim JS, 2005, NEUROIMAGE, V27, P210, DOI 10.1016/j.neuroimage.2005.03.036; Kuntsi J, 2004, AM J MED GENET B, V124B, P41, DOI 10.1002/ajmg.b.20076; Lange N, 2010, DEV NEUROPSYCHOL, V35, P296, DOI 10.1080/87565641003696833; Langen M, 2009, BIOL PSYCHIAT, V66, P327, DOI 10.1016/j.biopsych.2009.03.017; Langer N, 2012, HUM BRAIN MAPP, V33, P1393, DOI 10.1002/hbm.21297; Li J, 2009, AM J MED GENET B, V150B, P375, DOI 10.1002/ajmg.b.30825; Li XB, 2007, BRAIN DEV-JPN, V29, P649, DOI 10.1016/j.braindev.2007.04.008; Lyttelton O, 2007, NEUROIMAGE, V34, P1535, DOI 10.1016/j.neuroimage.2006.10.041; MacDonald D, 2000, NEUROIMAGE, V12, P340, DOI 10.1006/nimg.1999.0534; Maes F, 1997, IEEE T MED IMAGING, V16, P187, DOI 10.1109/42.563664; Makris N, 2007, CEREB CORTEX, V17, P1364, DOI 10.1093/cercor/bhl047; Makris N, 2009, DEV NEUROSCI-BASEL, V31, P36, DOI 10.1159/000207492; Mazzone L, 2011, CNS DRUGS, V25, P503, DOI 10.2165/11590450-000000000-00000; McDaniel MA, 2005, INTELLIGENCE, V33, P337, DOI 10.1016/j.intell.2004.11.005; Nakao T, 2011, AM J PSYCHIAT, V168, P1154, DOI 10.1176/appi.ajp.2011.11020281; Narr KL, 2007, CEREB CORTEX, V17, P2163, DOI 10.1093/cercor/bhl125; Narr KL, 2009, J AM ACAD CHILD PSY, V48, P1014, DOI 10.1097/CHI.0b013e3181b395c0; Neubauer AC, 2009, NEUROSCI BIOBEHAV R, V33, P1004, DOI 10.1016/j.neubiorev.2009.04.001; Nigg JT, 2005, DEV PSYCHOPATHOL, V17, P785, DOI 10.1017/S0954579405050376; O'Donnell S, 2005, NEUROIMAGE, V24, P948, DOI 10.1016/j.neuroimage.2004.10.014; Owens EB, 2003, J CONSULT CLIN PSYCH, V71, P540, DOI 10.1037/0022-006X.71.3.540; Polderman TJC, 2006, ACTA NEUROL BELG, V106, P191; Posthuma D, 2002, NAT NEUROSCI, V5, P83, DOI 10.1038/nn0202-83; Rees S, 2008, INT J DEV NEUROSCI, V26, P3, DOI 10.1016/j.ijdevneu.2007.08.020; Rommelse NNJ, 2008, PSYCHOL MED, V38, P1595, DOI 10.1017/S0033291708002869; Schmithorst VJ, 2005, HUM BRAIN MAPP, V26, P139, DOI 10.1002/hbm.20149; Schnack HG, 2001, NEUROIMAGE, V14, P95, DOI 10.1006/nimg.2001.0800; Schnack HG, 2001, NEUROIMAGE, V13, P230, DOI 10.1006/nimg.2000.0669; Shaffer D, 2000, J AM ACAD CHILD PSY, V39, P28, DOI 10.1097/00004583-200001000-00014; Shaw P, 2007, P NATL ACAD SCI USA, V104, P19649, DOI 10.1073/pnas.0707741104; Shaw P, 2006, ARCH GEN PSYCHIAT, V63, P540, DOI 10.1001/archpsyc.63.5.540; Shaw P, 2006, NATURE, V440, P676, DOI 10.1038/nature04513; Shaw P, 2008, J NEUROSCI, V28, P3586, DOI 10.1523/JNEUROSCI.5309-07.2008; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Sowell ER, 2004, J NEUROSCI, V24, P8223, DOI 10.1523/JNEUROSCI.1798-04.2004; Sowell ER, 2003, LANCET, V362, P1699, DOI 10.1016/S0140-6736(03)14842-8; Sowell ER, 2001, J NEUROSCI, V21, P8819, DOI 10.1523/JNEUROSCI.21-22-08819.2001; Stanfield AC, 2008, EUR PSYCHIAT, V23, P289, DOI 10.1016/j.eurpsy.2007.05.006; Swanson JM, 2007, J AM ACAD CHILD PSY, V46, P1003, DOI 10.1097/CHI.0b013e3180686d63; Talairach J., 1988, COPLANAR STEREOTAXIC; Tamnes CK, 2010, HUM BRAIN MAPP, V31, P1609, DOI 10.1002/hbm.20962; Thompson PM, 2001, NAT NEUROSCI, V4, P1253, DOI 10.1038/nn758; Valera EM, 2007, BIOL PSYCHIAT, V61, P1361, DOI 10.1016/j.biopsych.2006.06.011; van den Heuvel MP, 2009, J NEUROSCI, V29, P7619, DOI 10.1523/JNEUROSCI.1443-09.2009; van der Oord S, 2008, EUR CHILD ADOLES PSY, V17, P73, DOI 10.1007/s00787-007-0638-8; van Leeuwen M, 2009, INTELLIGENCE, V37, P181, DOI 10.1016/j.intell.2008.10.005; Verhulst F.C., 1996, HANDLEIDING CBCL4 18; Verhulst F.C., 1997, HANDLEIDING TEACHERS; Wallace GL, 2010, BEHAV GENET, V40, P125, DOI 10.1007/s10519-009-9329-1; Wechsler D, 2005, WECHSLER INTELLIGENC; Wilke M, 2003, NEUROIMAGE, V20, P202, DOI 10.1016/S1053-8119(03)00199-X; Wilson VB, 2011, J CHILD PSYCHOL PSYC, V52, P256, DOI 10.1111/j.1469-7610.2010.02347.x; Wolosin SM, 2009, HUM BRAIN MAPP, V30, P175, DOI 10.1002/hbm.20496; Wood AC, 2011, PSYCHOL MED, V41, P861, DOI 10.1017/S003329171000108X; Wood AC, 2010, PSYCHOL MED, V40, P1027, DOI 10.1017/S003329170999119X; Yu CS, 2008, NEUROIMAGE, V40, P1533, DOI 10.1016/j.neuroimage.2008.01.063	99	40	40	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35770	10.1371/journal.pone.0035770	http://dx.doi.org/10.1371/journal.pone.0035770			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UD	22536435	Green Submitted, Green Published, gold			2022-12-27	WOS:000305339200109
J	Faro-Trindade, I; Willment, JA; Kerrigan, AM; Redelinghuys, P; Hadebe, S; Reid, DM; Srinivasan, N; Wainwright, H; Lang, DM; Steele, C; Brown, GD				Faro-Trindade, Ines; Willment, Janet A.; Kerrigan, Ann M.; Redelinghuys, Pierre; Hadebe, Sabelo; Reid, Delyth M.; Srinivasan, Naren; Wainwright, Helen; Lang, Dirk M.; Steele, Chad; Brown, Gordon D.			Characterisation of Innate Fungal Recognition in the Lung	PLOS ONE			English	Article							ASPERGILLUS-FUMIGATUS CONIDIA; SURFACTANT-PROTEIN-D; BETA-GLUCAN RECEPTOR; TOLL-LIKE RECEPTORS; PULMONARY HOST-DEFENSE; ALVEOLAR MACROPHAGES; STAPHYLOCOCCUS-AUREUS; ANTIFUNGAL IMMUNITY; DECTIN-1; PHAGOCYTOSIS	The innate recognition of fungi by leukocytes is mediated by pattern recognition receptors (PRR), such as Dectin-1, and is thought to occur at the cell surface triggering intracellular signalling cascades which lead to the induction of protective host responses. In the lung, this recognition is aided by surfactant which also serves to maintain the balance between inflammation and pulmonary function, although the underlying mechanisms are unknown. Here we have explored pulmonary innate recognition of a variety of fungal particles, including zymosan, Candida albicans and Aspergillus fumigatus, and demonstrate that opsonisation with surfactant components can limit inflammation by reducing host-cell fungal interactions. However, we found that this opsonisation does not contribute directly to innate fungal recognition and that this process is mediated through non-opsonic PRRs, including Dectin-1. Moreover, we found that pulmonary inflammatory responses to resting Aspergillus conidia were initiated by these PRRs in acidified phagolysosomes, following the uptake of fungal particles by leukocytes. Our data therefore provides crucial new insights into the mechanisms by which surfactant can maintain pulmonary function in the face of microbial challenge, and defines the phagolysosome as a novel intracellular compartment involved in the innate sensing of extracellular pathogens in the lung.	[Faro-Trindade, Ines; Srinivasan, Naren; Brown, Gordon D.] Univ Cape Town, Div Immunol, Inst Infect Dis & Mol Med, Observatory, South Africa; [Willment, Janet A.; Kerrigan, Ann M.; Redelinghuys, Pierre; Hadebe, Sabelo; Reid, Delyth M.; Brown, Gordon D.] Univ Aberdeen, Aberdeen Fungal Grp, Sect Immunol & Infect, Div Appl Med,Inst Med Sci, Aberdeen, Scotland; [Wainwright, Helen] Univ Cape Town, Div Anat Pathol, Observatory, South Africa; [Lang, Dirk M.] Univ Cape Town, Dept Human Biol, Observatory, South Africa; [Steele, Chad] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA	University of Cape Town; University of Aberdeen; University of Cape Town; University of Cape Town; University of Alabama System; University of Alabama Birmingham	Brown, GD (corresponding author), Univ Cape Town, Div Immunol, Inst Infect Dis & Mol Med, Observatory, South Africa.	gordon.brown@abdn.ac.uk	Lang, Dirk/I-2554-2015	Lang, Dirk/0000-0003-3901-2079; brown, gordon/0000-0002-0287-5383; Willment, Janet/0000-0002-7040-0857; Hadebe, Sabelo/0000-0002-6049-8395	Wellcome Trust; National Institutes of Health [HL080317, AI068917]; American Lung Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068917] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lung Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank the Wellcome Trust and National Institutes of Health for funding. This work was also supported by grants from the American Lung Association and National Institutes of Health grants HL080317 and AI068917 (to CS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimanianda V, 2009, NATURE, V460, P1117, DOI 10.1038/nature08264; Allen MJ, 1999, INFECT IMMUN, V67, P4563, DOI 10.1128/IAI.67.9.4563-4569.1999; Allen MJ, 2001, INFECT IMMUN, V69, P2037, DOI 10.1128/IAI.69.4.2037-2044.2001; Asmus MJ, 2001, J ALLERGY CLIN IMMUN, V107, P68, DOI 10.1067/mai.2001.111591; Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; Brown GD, 2002, J EXP MED, V196, P407, DOI 10.1084/jem.20020470; Brown GD, 2003, J EXP MED, V197, P1119, DOI 10.1084/jem.20021890; Brown GD, 2006, NAT REV IMMUNOL, V6, P33, DOI 10.1038/nri1745; Brown GD, 2011, ANNU REV IMMUNOL, V29, P1, DOI 10.1146/annurev-immunol-030409-101229; Chroneos ZC, 2010, CELL PHYSIOL BIOCHEM, V25, P13, DOI 10.1159/000272047; Crouch E, 2001, ANNU REV PHYSIOL, V63, P521, DOI 10.1146/annurev.physiol.63.1.521; Dagenais TRT, 2009, CLIN MICROBIOL REV, V22, P447, DOI 10.1128/CMR.00055-08; Dennehy KM, 2008, EUR J IMMUNOL, V38, P500, DOI 10.1002/eji.200737741; Drummond RA, 2011, CURR OPIN MICROBIOL; Evans Scott E, 2010, Proc Am Thorac Soc, V7, P197, DOI 10.1513/pats.200907-075AL; Ewald SE, 2008, NATURE, V456, P658, DOI 10.1038/nature07405; Fernandez-Mora E, 2005, TRAFFIC, V6, P635, DOI 10.1111/j.1600-0854.2005.00304.x; Flannagan RS, 2009, NAT REV MICROBIOL, V7, P355, DOI 10.1038/nrmicro2128; Gardai SJ, 2003, CELL, V115, P13, DOI 10.1016/S0092-8674(03)00758-X; Goodridge HS, 2009, J IMMUNOL, V182, P1146, DOI 10.4049/jimmunol.182.2.1146; Graham LM, 2006, J IMMUNOL METHODS, V314, P164, DOI 10.1016/j.jim.2006.05.013; GRINGHUIS SI, 2009, NAT IMMUNOL; Gross O, 2006, NATURE, V442, P651, DOI 10.1038/nature04926; Haagsman HP, 2008, NEONATOLOGY, V93, P288, DOI 10.1159/000121454; Heinsbroek SEM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000218; Hernanz-Falcon P, 2009, EUR J IMMUNOL, V39, P507, DOI 10.1002/eji.200838687; Hohl TM, 2005, PLOS PATHOG, V1, P232, DOI 10.1371/journal.ppat.0010030; Ibrahim-Granet O, 2003, INFECT IMMUN, V71, P891, DOI 10.1128/IAI.71.2.891-903.2003; Ip WKE, 2010, J IMMUNOL, V184, P7071, DOI 10.4049/jimmunol.1000110; Kasperkovitz PV, 2010, J IMMUNOL, V185, P7614, DOI 10.4049/jimmunol.1002760; Kelly MM, 2008, AM J RESP CELL MOL, V38, P227, DOI 10.1165/rcmb.2007-0045OC; Kishore U, 2007, IMMUNOLOGY FUNGAL IN, P151; Lekkala M, 2006, INFECT IMMUN, V74, P4549, DOI 10.1128/IAI.00243-06; Luther K, 2007, CELL MICROBIOL, V9, P368, DOI 10.1111/j.1462-5822.2006.00796.x; Madan T, 1997, INFECT IMMUN, V65, P3171, DOI 10.1128/IAI.65.8.3171-3179.1997; Madan T, 2010, MOL IMMUNOL, V47, P1923, DOI 10.1016/j.molimm.2010.02.027; Maxeiner JH, 2007, NAT PROTOC, V2, P105, DOI 10.1038/nprot.2007.8; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Pastva Amy M, 2007, Proc Am Thorac Soc, V4, P252, DOI 10.1513/pats.200701-018AW; Philippe B, 2003, INFECT IMMUN, V71, P3034, DOI 10.1128/IAI.71.6.3034-3042.2003; Ramirez-Ortiz ZG, 2008, INFECT IMMUN, V76, P2123, DOI 10.1128/IAI.00047-08; Robinson MJ, 2009, J EXP MED, V206, P2037, DOI 10.1084/jem.20082818; Shepherd VL, 2002, AM J RESP CELL MOL, V26, P257, DOI 10.1165/ajrcmb.26.3.f227; Shimada T, 2010, CELL HOST MICROBE, V7, P38, DOI 10.1016/j.chom.2009.12.008; Singh M, 2009, MOL IMMUNOL, V46, P2363, DOI 10.1016/j.molimm.2009.03.019; Steele C, 2005, PLOS PATHOG, V1, P323, DOI 10.1371/journal.ppat.0010042; Stokes RW, 1998, J IMMUNOL, V160, P5514; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Taylor PR, 2003, EUR J IMMUNOL, V33, P2090, DOI 10.1002/eji.200324003; Thywissen A, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00096; Tsoni SV, 2009, INFECT IMMUN, V77, P3679, DOI 10.1128/IAI.00233-09; Underhill DM, 2003, J ENDOTOXIN RES, V9, P176, DOI 10.1179/096805103125001586; van Rozendaal BAWM, 2000, J INFECT DIS, V182, P917, DOI 10.1086/315799; Werner JL, 2009, J IMMUNOL, V182, P4938, DOI 10.4049/jimmunol.0804250; Wright JR, 2005, NAT REV IMMUNOL, V5, P58, DOI 10.1038/nri1528; Yamasaki S, 2009, P NATL ACAD SCI USA, V106, P1897, DOI 10.1073/pnas.0805177106	56	47	48	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35675	10.1371/journal.pone.0035675	http://dx.doi.org/10.1371/journal.pone.0035675			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536422	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339200094
J	Ryland, GL; Bearfoot, JL; Doyle, MA; Boyle, SE; Choong, DYH; Rowley, SM; Tothill, RW; Gorringe, KL; Campbell, IG				Ryland, Georgina L.; Bearfoot, Jennifer L.; Doyle, Maria A.; Boyle, Samantha E.; Choong, David Y. H.; Rowley, Simone M.; Tothill, Richard W.; Gorringe, Kylie L.; Campbell, Ian G.		Australian Ovarian Canc Study Grp	MicroRNA Genes and Their Target 3 '-Untranslated Regions Are Infrequently Somatically Mutated in Ovarian Cancers	PLOS ONE			English	Article							SEQUENCE VARIATIONS; MESSENGER-RNAS; EXPRESSION; PROGRESSION; BIOGENESIS; SIGNATURES; GENOMICS; SURVIVAL; 5'-UTR; MARKER	MicroRNAs are key regulators of gene expression and have been shown to have altered expression in a variety of cancer types, including epithelial ovarian cancer. MiRNA function is most often achieved through binding to the 3'-untranslated region of the target protein coding gene. Mutation screening using massively-parallel sequencing of 712 miRNA genes in 86 ovarian cancer cases identified only 5 mutated miRNA genes, each in a different case. One mutation was located in the mature miRNA, and three mutations were predicted to alter the secondary structure of the miRNA transcript. Screening of the 3'-untranslated region of 18 candidate cancer genes identified one mutation in each of AKT2, EGFR, ERRB2 and CTNNB1. The functional effect of these mutations is unclear, as expression data available for AKT2 and EGFR showed no increase in gene transcript. Mutations in miRNA genes and 3'-untranslated regions are thus uncommon in ovarian cancer.	[Ryland, Georgina L.; Bearfoot, Jennifer L.; Boyle, Samantha E.; Choong, David Y. H.; Rowley, Simone M.; Gorringe, Kylie L.; Campbell, Ian G.] Peter MacCallum Canc Ctr, Victorian Breast Canc Res Consortium Canc Genet L, Melbourne, Vic, Australia; [Ryland, Georgina L.] Monash Univ, Monash Inst Med Res, Ctr Canc Res, Clayton, Vic, Australia; [Bearfoot, Jennifer L.; Gorringe, Kylie L.; Campbell, Ian G.] Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia; [Doyle, Maria A.] Peter MacCallum Canc Ctr, Bioinformat Core Facil, Melbourne, Vic, Australia; [Tothill, Richard W.] Peter MacCallum Canc Ctr, Mol Genom Core Facil, Melbourne, Vic, Australia	Peter Maccallum Cancer Center; Monash University; University of Melbourne; Peter Maccallum Cancer Center; Peter Maccallum Cancer Center	Campbell, IG (corresponding author), Peter MacCallum Canc Ctr, Victorian Breast Canc Res Consortium Canc Genet L, Melbourne, Vic, Australia.	ian.campbell@petermac.org	Bowtell, David/H-1007-2016; campbell, Ian G/F-6006-2011; Ryland, Georgina L/AAD-9273-2022; Gorringe, Kylie L/H-3264-2019	Bowtell, David/0000-0001-9089-7525; Ryland, Georgina L/0000-0002-4990-0961; Gorringe, Kylie L/0000-0001-5681-2022; Chenevix-Trench, Georgia/0000-0002-1878-2587; Campbell, Ian/0000-0002-7773-4155; Doyle, Maria/0000-0003-4847-8436; Rowley, Simone/0000-0002-5897-7979; Tothill, Richard William/0000-0003-4522-1184	Victorian Breast Cancer Research Consortium, Australia; Australian National Health and Medical Research Council (NHMRC); Australian Postgraduate Award; U.S. Army Medical Research and Materiel Command [DAMD17-01-1-0729]; Cancer Council Tasmania; Cancer Foundation of Western Australia; NHMRC	Victorian Breast Cancer Research Consortium, Australia; Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Postgraduate Award(Australian Government); U.S. Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Cancer Council Tasmania(Cancer Council Tasmania); Cancer Foundation of Western Australia(Cancer Council Western Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the Victorian Breast Cancer Research Consortium, Australia, and the Australian National Health and Medical Research Council (NHMRC). GLR is supported by an Australian Postgraduate Award. The Australian Ovarian Cancer Study Group was supported by the U.S. Army Medical Research and Materiel Command under DAMD17-01-1-0729, The Cancer Council Tasmania, The Cancer Foundation of Western Australia and the NHMRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers CA, 2010, GENOME RES; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bearfoot JL, 2008, CLIN CANCER RES, V14, P7246, DOI 10.1158/1078-0432.CCR-08-1348; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Birrer MJ, 2007, J CLIN ONCOL, V25, P2281, DOI 10.1200/JCO.2006.09.0795; Bryan EJ, 1996, CANCER RES, V56, P719; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Cheng KW, 2004, NAT MED, V10, P1251, DOI 10.1038/nm1125; Chin LJ, 2008, CANCER RES, V68, P8535, DOI 10.1158/0008-5472.CAN-08-2129; Dahiya N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002436; Diederichs S, 2006, CANCER RES, V66, P6097, DOI 10.1158/0008-5472.CAN-06-0537; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Guttilla IK, 2009, J BIOL CHEM, V284, P23204, DOI 10.1074/jbc.M109.031427; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lee I, 2009, GENOME RES, V19, P1175, DOI 10.1101/gr.089367.108; Lytle JR, 2007, P NATL ACAD SCI USA, V104, P9667, DOI 10.1073/pnas.0703820104; Maragkakis M, 2009, NUCLEIC ACIDS RES, V37, pW273, DOI 10.1093/nar/gkp292; Maragkakis M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-295; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Melo SA, 2011, CELL CYCLE, V10, P922, DOI 10.4161/cc.10.6.15119; Merritt WM, 2008, NEW ENGL J MED, V359, P2641, DOI 10.1056/NEJMoa0803785; Nam EJ, 2008, CLIN CANCER RES, V14, P2690, DOI 10.1158/1078-0432.CCR-07-1731; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Ramakrishna M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009983; Ramsingh G, 2010, BLOOD, V116, P5316, DOI 10.1182/blood-2010-05-285395; Ratner E, 2010, CANCER RES, V70, P6509, DOI 10.1158/0008-5472.CAN-10-0689; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Ryan BM, 2010, NAT REV CANCER, V10, P389, DOI 10.1038/nrc2867; Said N, 2007, AM J PATHOL, V170, P1054, DOI 10.2353/ajpath.2007.060903; Sheach LA, 2009, BRIT J CANCER, V101, P498, DOI 10.1038/sj.bjc.6605153; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Tothill RW, 2008, CLIN CANCER RES, V14, P5198, DOI 10.1158/1078-0432.CCR-08-0196; van Kouwenhove M, 2011, NAT REV CANC; Wu MQ, 2008, CARCINOGENESIS, V29, P1710, DOI 10.1093/carcin/bgn073; Wyman SK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005311; Wynendaele J, 2010, CANCER RES, V70, P9641, DOI 10.1158/0008-5472.CAN-10-0527; Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488; Yang J, 2008, MUTAT RES-FUND MOL M, V638, P205, DOI 10.1016/j.mrfmmm.2007.08.007; Yiu GK, 2001, AM J PATHOL, V159, P609, DOI 10.1016/S0002-9440(10)61732-4; Zhang L, 2008, P NATL ACAD SCI USA, V105, P7004, DOI 10.1073/pnas.0801615105; Zhang L, 2006, P NATL ACAD SCI USA, V103, P9136, DOI 10.1073/pnas.0508889103	50	21	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35805	10.1371/journal.pone.0035805	http://dx.doi.org/10.1371/journal.pone.0035805			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536442	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339200114
J	Sheng, MHC; Wergedal, JE; Mohan, S; Amoui, M; Baylink, DJ; Lau, KHW				Sheng, Matilda H-C; Wergedal, Jon E.; Mohan, Subburaman; Amoui, Mehran; Baylink, David J.; Lau, K-H William			Targeted Overexpression of Osteoactivin in Cells of Osteoclastic Lineage Promotes Osteoclastic Resorption and Bone Loss in Mice	PLOS ONE			English	Article							OSTEOBLAST DIFFERENTIATION; TRANSMEMBRANE PROTEIN; IFN-GAMMA; IN-VIVO; DC-HIL; EXPRESSION; TRANSCRIPTION; REGULATOR; MELANOMA; CLONING	This study sought to test whether targeted overexpression of osteoactivin (OA) in cells of osteoclastic lineage, using the tartrate-resistant acid phosphase (TRAP) exon 1B/C promoter to drive OA expression, would increase bone resorption and bone loss in vivo. OA transgenic osteoclasts showed similar to 2- fold increases in OA mRNA and proteins compared wild- type (WT) osteoclasts. However, the OA expression in transgenic osteoblasts was not different. At 4, 8, and 15.3 week-old, transgenic mice showed significant bone loss determined by pQCT and confirmed by mu-CT. In vitro, transgenic osteoclasts were twice as large, had twice as much TRAP activity, resorbed twice as much bone matrix, and expressed twice as much osteoclastic genes (MMP9, calciton receptor, and ADAM12), as WT osteoclasts. The siRNA-mediated suppression of OA expression in RAW264.7-derived osteoclasts reduced cell size and osteoclastic gene expression. Bone histomorphometry revealed that transgenic mice had more osteoclasts and osteoclast surface. Plasma c-telopeptide (a resorption biomarker) measurements confirmed an increase in bone resorption in transgenic mice in vivo. In contrast, histomorphometric bone formation parameters and plasma levels of bone formation biomarkers (osteocalcin and pro-collagen type I N-terminal peptide) were not different between transgenic mice and WT littermates, indicating the lack of bone formation effects. In conclusion, this study provides compelling in vivo evidence that osteoclast-derived OA is a novel stimulator of osteoclast activity and bone resorption.	[Sheng, Matilda H-C; Baylink, David J.; Lau, K-H William] Loma Linda Univ, Sch Med, Dept Med, Regenerat Med Div, Loma Linda, CA 92354 USA; [Sheng, Matilda H-C; Wergedal, Jon E.; Mohan, Subburaman; Amoui, Mehran; Lau, K-H William] Jerry L Pettis Mem Vet Affair Med Ctr, Musculoskeletal Dis Ctr, Loma Linda, CA USA	Loma Linda University	Sheng, MHC (corresponding author), Loma Linda Univ, Sch Med, Dept Med, Regenerat Med Div, Loma Linda, CA 92354 USA.	MSheng@llu.edu		Lau, Kin-Hing/0000-0003-1109-5052	National Insititutes of Health [AR55135]; Department of Medicine, School of Medicine of the Loma Linda University; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR055135] Funding Source: NIH RePORTER	National Insititutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Medicine, School of Medicine of the Loma Linda University; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported in part by a National Insititutes of Health RO3 grant (AR55135), from a special appropriation to the Jerry L. Pettis Memorial Veterans Affairs Medical Center - Musculoskeletal Disease Center, and departmental funds of Department of Medicine, School of Medicine of the Loma Linda University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Abdelmagid SM, 2008, EXP CELL RES, V314, P2334, DOI 10.1016/j.yexcr.2008.02.006; Abdelmagid SM, 2007, J CELL PHYSIOL, V210, P26, DOI 10.1002/jcp.20841; Abe H, 2007, BIOCHEM BIOPH RES CO, V356, P610, DOI 10.1016/j.bbrc.2007.03.035; Anderson MG, 2002, NAT GENET, V30, P81, DOI 10.1038/ng794; AOKI Y, 1986, Hokkaido Journal of Medical Science, V61, P399; Bachner Dietmar, 2002, Brain Res Gene Expr Patterns, V1, P159; Bandari PS, 2003, REGUL PEPTIDES, V111, P169, DOI 10.1016/S0167-0115(02)00288-4; Boggon TJ, 2004, ONCOGENE, V23, P7918, DOI 10.1038/sj.onc.1208081; Chung JS, 2007, BLOOD, V109, P4320, DOI 10.1182/blood-2006-11-053769; Furochi Harumi, 2007, J Med Invest, V54, P248, DOI 10.2152/jmi.54.248; Furochi H, 2007, FEBS LETT, V581, P5743, DOI 10.1016/j.febslet.2007.11.036; Gao YH, 2007, J CLIN INVEST, V117, P122, DOI 10.1172/JCI30074; Haralanova-Ilieva B, 2005, J HEPATOL, V42, P565, DOI 10.1016/j.jhep.2004.12.021; Horne WC, 2005, IMMUNOL REV, V208, P106, DOI 10.1111/j.0105-2896.2005.00335.x; Huovila APJ, 2005, TRENDS BIOCHEM SCI, V30, P413, DOI 10.1016/j.tibs.2005.05.006; KANATANI M, 1995, J BONE MINER RES, V10, P1681, DOI 10.1002/jbmr.5650101110; Karlsson C, 2010, OSTEOARTHR CARTILAGE, V18, P581, DOI 10.1016/j.joca.2009.12.002; Kuan CT, 2006, CLIN CANCER RES, V12, P1970, DOI 10.1158/1078-0432.CCR-05-2797; Ogawa T, 2005, AM J PHYSIOL-CELL PH, V289, pC697, DOI 10.1152/ajpcell.00565.2004; Onaga M, 2003, J HEPATOL, V39, P779, DOI 10.1016/S0168-8278(03)00361-1; Owen TA, 2003, CRIT REV EUKAR GENE, V13, P205; Pahl MV, 2010, CLIN J AM SOC NEPHRO, V5, P56, DOI 10.2215/CJN.03390509; Pan WH, 2005, J BIOL CHEM, V280, P4888, DOI 10.1074/jbc.M409052200; Ripoll VM, 2008, GENE, V413, P32, DOI 10.1016/j.gene.2008.01.014; Ripoll VM, 2007, J IMMUNOL, V178, P6557, DOI 10.4049/jimmunol.178.10.6557; Rose AAN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012093; Safadi FF, 2002, J CELL BIOCHEM, V84, P12, DOI 10.1002/jcb.1259; Schwarzbich MA, 2012, CANCER IMMUNOL IMMUN, V61, P193, DOI 10.1007/s00262-011-1096-1; Selim AA, 2003, CRIT REV EUKAR GENE, V13, P265; Sheng MHC, 2008, FEBS LETT, V582, P1451, DOI 10.1016/j.febslet.2008.03.030; Sheng MHC, 2009, J BIOL CHEM, V284, P11531, DOI 10.1074/jbc.M808324200; Sheng MHC, 2004, BONE, V35, P711, DOI 10.1016/j.bone.2004.05.013; Shikano S, 2001, J BIOL CHEM, V276, P8125, DOI 10.1074/jbc.M008539200; Shinohara Masahiro, 2007, Curr Osteoporos Rep, V5, P67; Singh M, 2012, J CELL PHYSIOL, V227, P390, DOI 10.1002/jcp.22791; Tse KF, 2006, CLIN CANCER RES, V12, P1373, DOI 10.1158/1078-0432.CCR-05-2018; Walsh NC, 2003, GENE, V307, P111, DOI 10.1016/S0378-1119(03)00449-9; Williams MD, 2010, MELANOMA RES, V20, P184, DOI 10.1097/CMR.0b013e3283364a08; Zou W, 2010, ANN NY ACAD SCI, V1192, P27, DOI 10.1111/j.1749-6632.2009.05245.x	39	22	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35280	10.1371/journal.pone.0035280	http://dx.doi.org/10.1371/journal.pone.0035280			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536365	Green Submitted, Green Published, gold			2022-12-27	WOS:000305339200048
J	Xue, J; Lv, DD; Jiao, S; Zhao, WT; Li, XB; Sun, H; Yan, B; Fan, L; Hu, RG; Fang, J				Xue, Jing; Lv, Dan-dan; Jiao, Shi; Zhao, Wenting; Li, Xuebing; Sun, Heng; Yan, Bing; Fan, Li; Hu, Rong-gui; Fang, Jing			pVHL Mediates K63-Linked Ubiquitination of nCLU	PLOS ONE			English	Article							LINDAU TUMOR-SUPPRESSOR; PROLINE HYDROXYLATION; PROTEIN-KINASE; HIF-ALPHA; CLUSTERIN; UBIQUITYLATION; COMPONENT; COMPLEX; FATE	pVHL, product of von Hippel-Lindau (VHL) tumor suppressor gene, functions as the substrate recognition component of an E3-ubiquitin ligase that targets proteins for ubiquitination and proteasomal degradation. Hypoxia-inducible factor alpha (HIF alpha) is the well-known substrate of pVHL. Besides HIF alpha, pVHL also binds to many other proteins and has multiple functions. In this manuscript, we report that the nuclear clusterin (nCLU) is a target of pVHL. We found that pVHL had a direct interaction with nCLU. nCLU bound to pVHL at pVHL's beta domain, the site for recognition of substrate, indicating that nCLU might be a substrate of pVHL. Interestingly, pVHL bound to nCLU but did not lead to nCLU destruction. Further studies indicated that pVHL mediated K63-linked ubiquitination of nCLU and promoted nCLU nuclear translocation. In summary, our results disclose a novel function of pVHL that mediates K63-linked ubiquitination and identify nCLU as a new target of pVHL.	[Xue, Jing; Lv, Dan-dan; Jiao, Shi; Zhao, Wenting; Li, Xuebing; Sun, Heng; Yan, Bing; Fan, Li; Fang, Jing] Chinese Acad Sci, SIBS, Inst Nutr Sci, Key Lab Nutr & Metab, Shanghai, Peoples R China; [Hu, Rong-gui] Chinese Acad Sci, SIBS, Inst Biochem & Cell Biol, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Fang, J (corresponding author), Chinese Acad Sci, SIBS, Inst Nutr Sci, Key Lab Nutr & Metab, Shanghai, Peoples R China.	jfang@sibs.ac.cn	Yan, Binghua/ACD-0393-2022	Yan, Binghua/0000-0003-3255-6559	National Natural Science Foundation of China [30970586]; Chinese Academy of Sciences [KSCX2-EW-R-08]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	The work was supported by National Natural Science Foundation of China (30970586)(http://www.nsfc.gov.cn); Chinese Academy of Sciences (KSCX2-EW-R-08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bettuzzi S, 2009, ADV CANCER RES, V104, P59, DOI 10.1016/S0065-230X(09)04005-6; Bhoj VG, 2009, NATURE, V458, P430, DOI 10.1038/nature07959; Chitalia VC, 2008, NAT CELL BIOL, V10, P1208, DOI 10.1038/ncb1781; Czyzyk-Krzeska MF, 2004, TRENDS MOL MED, V10, P146, DOI 10.1016/j.molmed.2004.02.004; DESILVA HV, 1990, BIOCHEMISTRY-US, V29, P5380, DOI 10.1021/bi00474a025; Frew IJ, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.124pe30; Geetha T, 2005, EMBO J, V24, P3859, DOI 10.1038/sj.emboj.7600845; Grosfeld A, 2007, J BIOL CHEM, V282, P13264, DOI 10.1074/jbc.M611648200; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Iwai K, 1999, P NATL ACAD SCI USA, V96, P12436, DOI 10.1073/pnas.96.22.12436; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kaelin WG, 2008, NAT REV CANCER, V8, P865, DOI 10.1038/nrc2502; Kaelin WG, 2007, ANNU REV PATHOL-MECH, V2, P145, DOI 10.1146/annurev.pathol.2.010506.092049; Kamura T, 1999, SCIENCE, V284, P657, DOI 10.1126/science.284.5414.657; Kim WY, 2004, J CLIN ONCOL, V22, P4991, DOI 10.1200/JCO.2004.05.061; Klock G, 2009, ADV CANCER RES, V104, P115, DOI 10.1016/S0065-230X(09)04007-X; Kuznetsova AV, 2003, P NATL ACAD SCI USA, V100, P2706, DOI 10.1073/pnas.0436037100; Leskov KS, 2003, J BIOL CHEM, V278, P11590, DOI 10.1074/jbc.M209233200; Lisztwan J, 1999, GENE DEV, V13, P1822, DOI 10.1101/gad.13.14.1822; Nakamura E, 2006, AM J PATHOL, V168, P574, DOI 10.2353/ajpath.2006.050867; Nath D, 2009, NATURE, V458, P421, DOI 10.1038/458421a; Ohh M, 1998, MOL CELL, V1, P959, DOI 10.1016/S1097-2765(00)80096-9; Okuda H, 2001, J BIOL CHEM, V276, P43611, DOI 10.1074/jbc.M107880200; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Pucci S, 2004, ONCOGENE, V23, P2298, DOI 10.1038/sj.onc.1207404; Rizzi F, 2009, J CELL PHYSIOL, V219, P314, DOI 10.1002/jcp.21671; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Shannan B, 2006, CELL DEATH DIFFER, V13, P12, DOI 10.1038/sj.cdd.4401779; van Wijk SJL, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.55; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Xue J, 2010, GASTROENTEROLOGY, V138, P606, DOI 10.1053/j.gastro.2009.09.049; Yang H, 2007, MOL CELL, V28, P15, DOI 10.1016/j.molcel.2007.09.010; Yang WL, 2010, ONCOGENE, V29, P4493, DOI 10.1038/onc.2010.190	33	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35848	10.1371/journal.pone.0035848	http://dx.doi.org/10.1371/journal.pone.0035848			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22532874	Green Published, gold, Green Submitted			2022-12-27	WOS:000305339200118
J	Yang, HC; Chang, LC; Liang, YJ; Lin, CH; Wang, PL				Yang, Hsin-Chou; Chang, Lun-Ching; Liang, Yu-Jen; Lin, Chien-Hsing; Wang, Pei-Li			A Genome-Wide Homozygosity Association Study Identifies Runs of Homozygosity Associated with Rheumatoid Arthritis in the Human Major Histocompatibility Complex	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; RECENT POSITIVE SELECTION; EXTENDED TRACTS; RISK LOCUS; SUSCEPTIBILITY; GENE; HETEROZYGOSITY; DISEASE; PTPN22; COMMON	Rheumatoid arthritis (RA) is a chronic inflammatory disorder with a polygenic mode of inheritance. This study examined the hypothesis that runs of homozygosity (ROHs) play a recessive-acting role in the underlying RA genetic mechanism and identified RA-associated ROHs. Ours is the first genome-wide homozygosity association study for RA and characterized the ROH patterns associated with RA in the genomes of 2,000 RA patients and 3,000 normal controls of the Wellcome Trust Case Control Consortium. Genome scans consistently pinpointed two regions within the human major histocompatibility complex region containing RA-associated ROHs. The first region is from 32,451,664 bp to 32,846,093 bp (-log10(p)>22.6591). RA-susceptibility genes, such as HLA-DRB1, are contained in this region. The second region ranges from 32,933,485 bp to 33,585,118 bp (-log10(p)>8.3644) and contains other HLA-DPA1 and HLA-DPB1 genes. These two regions are physically close but are located in different blocks of linkage disequilibrium, and similar to 40% of the RA patients' genomes carry these ROHs in the two regions. By analyzing homozygote intensities, an ROH that is anchored by the single nucleotide polymorphism rs2027852 and flanked by HLA-DRB6 and HLA-DRB1 was found associated with increased risk for RA. The presence of this risky ROH provides a 62% accuracy to predict RA disease status. An independent genomic dataset from 868 RA patients and 1,194 control subjects of the North American Rheumatoid Arthritis Consortium successfully validated the results obtained using the Wellcome Trust Case Control Consortium data. In conclusion, this genome-wide homozygosity association study provides an alternative to allelic association mapping for the identification of recessive variants responsible for RA. The identified RA-associated ROHs uncover recessive components and missing heritability associated with RA and other autoimmune diseases.	[Yang, Hsin-Chou; Chang, Lun-Ching; Liang, Yu-Jen; Wang, Pei-Li] Acad Sinica, Inst Stat Sci, Taipei 11529, Taiwan; [Liang, Yu-Jen] Natl Taiwan Univ, Grad Inst Biomed Elect & Bioinformat, Taipei 10764, Taiwan; [Lin, Chien-Hsing] Natl Hlth Res Inst, Div Mol & Genom Med, Miaoli Cty, Taiwan	Academia Sinica - Taiwan; National Taiwan University; National Health Research Institutes - Taiwan	Yang, HC (corresponding author), Acad Sinica, Inst Stat Sci, Taipei 11529, Taiwan.	hsinchou@stat.sinica.edu.tw	Yang, Hsin-Chou/AAP-2547-2021	Yang, Hsin-Chou/0000-0001-6853-7881	National Science Council of Taiwan [NSC 97-2314-B-001-006-MY3, NSC 100-2314B-001-005-MY3]; National Research Program for Genomic Medicine [NSC 97-3112-B-001-027, NSC 98-3112-B-001-013, NSC 99-3112-B-001-009, NSC 99-3112-B-001029]; Academia Sinica [AS-100-CDA-M03]; Wellcome Trust [079113]; National Institutes of Health [N01-AR-2-2263, R01-AR-44422]; National Arthritis Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044422, N01AR022263] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031575] Funding Source: NIH RePORTER	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); National Research Program for Genomic Medicine(Ministry of Science and Technology, Taiwan); Academia Sinica(Academia Sinica - Taiwan); Wellcome Trust(Wellcome Trust); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Arthritis Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by a National Science Council of Taiwan grant (NSC 97-2314-B-001-006-MY3, NSC 100-2314B-001-005-MY3), by grants from the National Research Program for Genomic Medicine (NSC 97-3112-B-001-027, NSC 98-3112-B-001-013, NSC 99-3112-B-001-009, and NSC 99-3112-B-001029), and the Career Development Award of Academia Sinica (AS-100-CDA-M03). This study made use of data generated by the Wellcome Trust Case Control Consortium. A full list of the investigators who contributed to the generation of the data is available at www.wtccc.org.uk. The Wellcome Trust (Award 079113) provided funding for that project. This study also made use of data provided by Genetic Analysis Workshop 16 (R01 GM031575) and gathered with the support of grants from the National Institutes of Health (N01-AR-2-2263 and R01-AR-44422) and the National Arthritis Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamanos Y, 2005, AUTOIMMUN REV, V4, P130, DOI 10.1016/j.autrev.2004.09.002; ALBANI S, 1995, NAT MED, V1, P448, DOI 10.1038/nm0595-448; Barton A, 2008, NAT GENET, V40, P1156, DOI 10.1038/ng.218; Baschal EE, 2009, CLIN IMMUNOL, V132, P203, DOI 10.1016/j.clim.2009.03.530; BEGOVICH AB, 1989, P NATL ACAD SCI USA, V86, P9489, DOI 10.1073/pnas.86.23.9489; Begovich AB, 2004, AM J HUM GENET, V75, P330, DOI 10.1086/422827; Bersaglieri T, 2004, AM J HUM GENET, V74, P1111, DOI 10.1086/421051; Broman KW, 1999, AM J HUM GENET, V65, P1493, DOI 10.1086/302661; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Campbell H, 2007, HUM MOL GENET, V16, P233, DOI 10.1093/hmg/ddl473; Campbell H, 2009, GENOME MED, V1, DOI 10.1186/gm91; Carlton VEH, 2005, AM J HUM GENET, V77, P567, DOI 10.1086/468189; CARTHY D, 1995, REV RHUM, V62, P163; CAVENEE WK, 1983, NATURE, V305, P779, DOI 10.1038/305779a0; Christodoulou K, 1997, HUM MOL GENET, V6, P635, DOI 10.1093/hmg/6.4.635; Constantin A, 2002, J RHEUMATOL, V29, P15; Curtis D, 2008, ANN HUM GENET, V72, P261, DOI 10.1111/j.1469-1809.2007.00411.x; Datta SK, 2000, NAT MED, V6, P259, DOI 10.1038/73101; Fernando MMA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000024; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Gibson J, 2006, HUM MOL GENET, V15, P789, DOI 10.1093/hmg/ddi493; Goldberg EK, 2000, AM J HUM GENET, V67, P417, DOI 10.1086/302999; Gregersen PK, 2010, BULL HOSP JT DIS, V68, P179; Gregersen PK, 2009, NAT GENET, V41, P820, DOI 10.1038/ng.395; GREGERSEN PK, 1987, ARTHRITIS RHEUM, V30, P1205, DOI 10.1002/art.1780301102; Gunduz E, 2009, CANCER INVEST, V27, P661, DOI 10.1080/07357900802563010; HASTIE T, 1994, J AM STAT ASSOC, V89, P1255, DOI 10.2307/2290989; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Huggins R, 2008, J HUM GENET, V53, P983, DOI 10.1007/s10038-008-0340-9; Huie ML, 2002, AM J HUM GENET, V70, P1054, DOI 10.1086/339691; Jawaheer D, 2002, AM J HUM GENET, V71, P585, DOI 10.1086/342407; Jawaheer D, 2001, AM J HUM GENET, V68, P927, DOI 10.1086/319518; John S, 2004, AM J HUM GENET, V75, P54, DOI 10.1086/422195; Klareskog L, 2006, ARTHRITIS RHEUM-US, V54, P38, DOI 10.1002/art.21575; KOUFOS A, 1985, NATURE, V316, P330, DOI 10.1038/316330a0; Kretz-Rommel A, 2000, NAT MED, V6, P298; Ku CS, 2011, HUM GENET, V129, P1, DOI 10.1007/s00439-010-0920-6; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; Kurreeman FAS, 2007, PLOS MED, V4, P1515, DOI 10.1371/journal.pmed.0040278; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; Lencz T, 2007, P NATL ACAD SCI USA, V104, P19942, DOI 10.1073/pnas.0710021104; Li LH, 2006, HUM MUTAT, V27, P1115, DOI 10.1002/humu.20399; Limaye N, 2008, GENES IMMUN, V9, P61, DOI 10.1038/sj.gene.6364446; Loader C., 1999, LOCAL REGRESSION LIK; LYNN AH, 1995, AM J HUM GENET, V57, P150; Mahdi H, 2009, NAT GENET, V41, P1319, DOI 10.1038/ng.480; Marigorta UM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-55; McQuillan R, 2008, AM J HUM GENET, V83, P359, DOI 10.1016/j.ajhg.2008.08.007; Nalls MA, 2009, NEUROGENETICS, V10, P183, DOI 10.1007/s10048-009-0182-4; Nalls MA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000415; Newton JL, 2004, GENES IMMUN, V5, P151, DOI 10.1038/sj.gene.6364045; Nothnagel M, 2010, HUM MOL GENET, V19, P2927, DOI 10.1093/hmg/ddq198; OLLIER W, 1992, RHEUM DIS CLIN N AM, V18, P741; Parvari R, 1998, AM J HUM GENET, V63, P163, DOI 10.1086/301915; Peiffer DA, 2006, GENOME RES, V16, P1136, DOI 10.1101/gr.5402306; Pfeifer D, 2007, BLOOD, V109, P1202, DOI 10.1182/blood-2006-07-034256; Plenge RM, 2005, AM J HUM GENET, V77, P1044, DOI 10.1086/498651; Plenge RM, 2007, NEW ENGL J MED, V357, P1199, DOI 10.1056/NEJMoa073491; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raychaudhuri S, 2008, NAT GENET, V40, P1216, DOI 10.1038/ng.233; Remmers EF, 2007, NEW ENGL J MED, V357, P977, DOI 10.1056/NEJMoa073003; Ridgway WM, 1999, SCIENCE, V284, P749, DOI 10.1126/science.284.5415.749; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Seldin MF, 1999, ARTHRITIS RHEUM, V42, P1071, DOI 10.1002/1529-0131(199906)42:6<1071::AID-ANR1>3.0.CO;2-8; SHEFFIELD VC, 1994, HUM MOL GENET, V3, P1331, DOI 10.1093/hmg/3.8.1331; Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Thomson W, 2007, NAT GENET, V39, P1431, DOI 10.1038/ng.2007.32; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Wang S, 2009, GENET EPIDEMIOL, V33, P172, DOI 10.1002/gepi.20344; WEYAND CM, 1992, ANN INTERN MED, V117, P801, DOI 10.7326/0003-4819-117-10-801; Weyand CM, 2000, ARTHRITIS RES, V2, P212, DOI 10.1186/ar90; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; Winick JD, 1999, AM J HUM GENET, V64, P1679, DOI 10.1086/302423; WORDSWORTH BP, 1989, P NATL ACAD SCI USA, V86, P10049, DOI 10.1073/pnas.86.24.10049; WORDSWORTH P, 1991, ANN RHEUM DIS, V50, P343, DOI 10.1136/ard.50.6.343; Wu CC, 2009, HUM GENET, V126, P303, DOI 10.1007/s00439-009-0672-3; Yamamoto G, 2007, AM J HUM GENET, V81, P114, DOI 10.1086/518809; Yang HC, 2011, GENET EPIDEMIOL, V35, P247, DOI 10.1002/gepi.20573; Yang HC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-415; Yang HC, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-196; Yang TL, 2010, J CLIN ENDOCR METAB, V95, P3777, DOI 10.1210/jc.2009-1715; YEN JH, 1995, J RHEUMATOL, V22, P2034; YOKOTA J, 1987, P NATL ACAD SCI USA, V84, P9252, DOI 10.1073/pnas.84.24.9252; Zhang L, 2011, HUM MUTAT, V32, P345, DOI 10.1002/humu.21432	87	24	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e34840	10.1371/journal.pone.0034840	http://dx.doi.org/10.1371/journal.pone.0034840			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536334	Green Published, gold, Green Submitted			2022-12-27	WOS:000305339200022
J	Buckens, CF; Verkooijen, HM; Gondrie, MJ; Jairam, P; Mali, WP; van der Graaf, Y				Buckens, Constantinus F.; Verkooijen, Helena M.; Gondrie, Martijn J.; Jairam, Pushpa; Mali, Willem P.; van der Graaf, Yolanda			Unrequested Findings on Cardiac Computed Tomography: Looking Beyond the Heart	PLOS ONE			English	Article							INCIDENTAL EXTRACARDIAC FINDINGS; NONCARDIAC FINDINGS; CLINICAL-SIGNIFICANCE; CORONARY-ANGIOGRAPHY; CT ANGIOGRAPHY; PREVALENCE; RISK; SURGERY; SCANS; SCORE	Objectives: To determine the prevalence of clinically relevant unrequested extra-cardiac imaging findings on cardiac Computed Tomography (CT) and explanatory factors thereof. Methods: A systematic review of studies drawn from online electronic databases followed by meta-analysis with meta-regression was performed. The prevalence of clinically relevant unrequested findings and potentially explanatory variables were extracted (proportion of smokers, mean age of patients, use of full FOV, proportion of men, years since publication). Results: Nineteen radiological studies comprising 12922 patients met the inclusion criteria. The pooled prevalence of clinically relevant unrequested findings was 13% (95% confidence interval 9-18, range: 3-39%). The large differences in prevalence observed were not explained by the predefined (potentially explanatory) variables. Conclusions: Clinically relevant extra-cardiac findings are common in patients undergoing routine cardiac CT, and their prevalence differs substantially between studies. These differences may be due to unreported factors such as different definitions of clinical relevance and differences between populations. We present suggestions for basic reporting which may improve the interpretability and comparability of future research.	[Buckens, Constantinus F.; Verkooijen, Helena M.; Gondrie, Martijn J.; Jairam, Pushpa; Mali, Willem P.] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands; [Buckens, Constantinus F.; Gondrie, Martijn J.; Jairam, Pushpa; van der Graaf, Yolanda] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Buckens, CF (corresponding author), Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands.	c.f.m.buckens@umcutrecht.nl	Mali, Willem PThM/I-1123-2014	Mali, Willem PThM/0000-0003-4391-0904; Buckens, Constantinus F/0000-0002-3190-258X	Netherlands Organization for Scientific Research-Medical Sciences (NWO-MW) [40-00812-9807-005]	Netherlands Organization for Scientific Research-Medical Sciences (NWO-MW)(Netherlands Organization for Scientific Research (NWO))	This study was funded by a program grant from the Netherlands Organization for Scientific Research-Medical Sciences (NWO-MW) grant 40-00812-9807-005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aglan I, 2010, EUR J RADIOL, V74, P166, DOI 10.1016/j.ejrad.2009.01.038; Brenner DJ, 2010, JAMA-J AM MED ASSOC, V304, P208, DOI 10.1001/jama.2010.973; Budoff Matthew J, 2007, J Cardiovasc Comput Tomogr, V1, P97, DOI 10.1016/j.jcct.2007.04.002; Burt JR, 2008, ARCH INTERN MED, V168, P756, DOI 10.1001/archinte.168.7.756; Chia PL, 2009, INT J CARDIOVAS IMAG, V25, P537, DOI 10.1007/s10554-009-9455-0; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dewey M, 2007, EUR RADIOL, V17, P2038, DOI 10.1007/s00330-006-0570-1; Elias-Smale SE, 2010, J AM COLL CARDIOL, V56, P1407, DOI 10.1016/j.jacc.2010.06.029; Garvey CJ, 2002, BMJ-BRIT MED J, V324, P1077, DOI 10.1136/bmj.324.7345.1077; Greenberg-Wolff I, 2008, ISR MED ASSOC J, V10, P806; Greenland P, 2007, J AM COLL CARDIOL, V49, P378, DOI 10.1016/j.jacc.2006.10.001; Haller S, 2006, AM J ROENTGENOL, V187, P105, DOI 10.2214/AJR.04.1988; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hillman BJ, 2010, NEW ENGL J MED, V363, P4, DOI 10.1056/NEJMp1003173; Horton KM, 2002, CIRCULATION, V106, P532, DOI 10.1161/01.CIR.0000027136.56615.DE; Hunold P, 2001, EUR HEART J, V22, P1748, DOI 10.1053/euhj.2000.2586; Hussain A, 2010, ANN ROY COLL SURG, V92, P124, DOI 10.1308/003588410X12518836439083; Johnson KM, 2010, AM J ROENTGENOL, V194, P1235, DOI 10.2214/AJR.09.2487; Kawano Y, 2007, AM J CARDIOL, V99, P1608, DOI 10.1016/j.amjcard.2007.01.038; Kim JW, 2009, INT J CARDIOVAS IMAG, V25, P75, DOI 10.1007/s10554-008-9417-y; Kirsch J, 2007, J THORAC IMAG, V22, P330, DOI 10.1097/RTI.0b013e31813434a9; Koonce J, 2009, EUR RADIOL, V19, P570, DOI 10.1007/s00330-008-1195-3; Law YM, 2008, J MED IMAG RADIAT ON, V52, P49, DOI 10.1111/j.1440-1673.2007.01911.x; Lazoura O, 2010, KOREAN J RADIOL, V11, P60, DOI 10.3348/kjr.2010.11.1.60; Lehman SJ, 2009, AM J MED, V122, P543, DOI 10.1016/j.amjmed.2008.10.039; MacHaalany J, 2009, J AM COLL CARDIOL, V54, P1533, DOI 10.1016/j.jacc.2009.06.026; MacMahon H, 2005, RADIOLOGY, V237, P395, DOI 10.1148/radiol.2372041887; Mettler FA, 2009, RADIOLOGY, V253, P520, DOI 10.1148/radiol.2532082010; Mueller J, 2007, AM J ROENTGENOL, V189, P414, DOI 10.2214/AJR.06.0736; Onuma Y, 2006, J AM COLL CARDIOL, V48, P402, DOI 10.1016/j.jacc.2006.04.071; Orme NM, 2010, ARCH INTERN MED, V170, P1525, DOI 10.1001/archinternmed.2010.317; Quentin M, 2011, RADIOLOGE, V51, P59, DOI 10.1007/s00117-010-2071-0; R Core Team, 2016, R FDN STAT COMP; Schragin JG, 2004, J THORAC IMAG, V19, P82, DOI 10.1097/00005382-200404000-00004; Scrutinio D, 2008, EUR J CARDIOV PREV R, V15, P379, DOI 10.1097/HJR.0b013e3282fd5c6f; Smith-Bindman R, 2010, NEW ENGL J MED, V363, P1, DOI 10.1056/NEJMp1002530; Sosnouski D, 2007, J THORAC IMAG, V22, P77, DOI 10.1097/RTI.0b013e3180317a5b; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Vandenbroucke JP, 2007, EPIDEMIOLOGY, V18, P805, DOI 10.1097/EDE.0b013e3181577511; Venkatesh V, 2010, CAN ASSOC RADIOL J, V61, P286, DOI 10.1016/j.carj.2009.11.001; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI 10.2471/BLT.07.045120	42	18	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e32184	10.1371/journal.pone.0032184	http://dx.doi.org/10.1371/journal.pone.0032184			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22536315	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336200002
J	Yu, Y; Zhang, L; Li, XJ; Run, XQ; Liang, ZH; Li, Y; Liu, Y; Lee, MH; Grundke-Iqbal, I; Iqbal, K; Vocadlo, DJ; Liu, F; Gong, CX				Yu, Yang; Zhang, Lan; Li, Xiaojing; Run, Xiaoqin; Liang, Zhihou; Li, Yi; Liu, Ying; Lee, Moon H.; Grundke-Iqbal, Inge; Iqbal, Khalid; Vocadlo, David J.; Liu, Fei; Gong, Cheng-Xin			Differential Effects of an O-GlcNAcase Inhibitor on Tau Phosphorylation	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; SUBCELLULAR-DISTRIBUTION; PROTEIN PHOSPHATASES; INSULIN-RESISTANCE; HYPERPHOSPHORYLATION; EXPRESSION; GLYCOSYLATION; GLCNACYLATION; PP2A; PHOSPHOPROTEIN	Abnormal hyperphosphorylation of microtubule-associated protein tau plays a crucial role in neurodegeneration in Alzheimer's disease (AD). The aggregation of hyperphosphorylated tau into neurofibrillary tangles is also a hallmark brain lesion of AD. Tau phosphorylation is regulated by tau kinases, tau phosphatases, and O-GlcNAcylation, a posttranslational modification of proteins on the serine or threonine residues with beta-N-acetylglucosamine (GlcNAc). O-GlcNAcylation is dynamically regulated by O-GlcNAc transferase, the enzyme catalyzing the transfer of GlcNAc to proteins, and N-acetylglucosaminidase (OGA), the enzyme catalyzing the removal of GlcNAc from proteins. Thiamet-G is a recently synthesized potent OGA inhibitor, and initial studies suggest it can influence O-GlcNAc levels in the brain, allowing OGA inhibition to be a potential route to altering disease progression in AD. In this study, we injected thiamet-G into the lateral ventricle of mice to increase O-GlcNAcylation of proteins and investigated the resulting effects on site-specific tau phosphorylation. We found that acute thiamet-G treatment led to a decrease in tau phosphorylation at Thr181, Thr212, Ser214, Ser262/Ser356, Ser404 and Ser409, and an increase in tau phosphorylation at Ser199, Ser202, Ser396 and Ser422 in the mouse brain. Investigation of the major tau kinases showed that acute delivery of a high dose of thiamet-G into the brain also led to a marked activation of glycogen synthase kinase-3 beta (GSK-3 beta), possibly as a consequence of down-regulation of its upstream regulating kinase, AKT. However, the elevation of tau phosphorylation at the sites above was not observed and GSK-3 beta was not activated in cultured adult hippocampal progenitor cells or in PC12 cells after thiamet-G treatment. These results suggest that acute high-dose thiamet-G injection can not only directly antagonize tau phosphorylation, but also stimulate GSK-3 beta activity, with the downstream consequence being site-specific, bi-directional regulation of tau phosphorylation in the mammalian brain.	[Yu, Yang; Zhang, Lan; Li, Xiaojing; Run, Xiaoqin; Liang, Zhihou; Li, Yi; Liu, Ying; Grundke-Iqbal, Inge; Iqbal, Khalid; Liu, Fei; Gong, Cheng-Xin] New York State Inst Basic Res Dev Disabil, Dept Neurochem, Staten Isl, NY 10314 USA; [Lee, Moon H.] New York State Inst Basic Res Dev Disabil, Dept Dev Neurobiol, Staten Isl, NY 10314 USA; [Vocadlo, David J.] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada	Institute for Basic Research in Developmental Disabilities; Institute for Basic Research in Developmental Disabilities; Simon Fraser University	Yu, Y (corresponding author), Shanghai Jiao Tong Univ, Sch Pharm, Shanghai 200030, Peoples R China.	chengxin.gong@csi.cuny.edu	Vocadlo, David J/E-5508-2014	Vocadlo, David J/0000-0001-6897-5558	New York State Office for People with Developmental Disabilities; National Institutes of Health [R21 AG031969, R01 AG027429, R03 TW008123, R01 AG031969, R01 AG019158]; Alzheimer's Association [IIRG-10-170405]; FOGARTY INTERNATIONAL CENTER [R03TW008123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG019158, R21AG031969, R01AG027429] Funding Source: NIH RePORTER	New York State Office for People with Developmental Disabilities; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by the New York State Office for People with Developmental Disabilities as well as grants from the National Institutes of Health (R21 AG031969, R01 AG027429, R03 TW008123, R01 AG031969 and R01 AG019158) and the Alzheimer's Association (IIRG-10-170405). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso AD, 2004, J BIOL CHEM, V279, P34873, DOI 10.1074/jbc.M405131200; Arias EB, 2004, DIABETES, V53, P921, DOI 10.2337/diabetes.53.4.921; BENSADOUN A, 1976, ANAL BIOCHEM, V70, P241, DOI 10.1016/S0003-2697(76)80064-4; Buee L, 2000, BRAIN RES REV, V33, P95, DOI 10.1016/S0165-0173(00)00019-9; Butkinaree C, 2010, BBA-GEN SUBJECTS, V1800, P96, DOI 10.1016/j.bbagen.2009.07.018; Camins A, 2006, DRUG NEWS PERSPECT, V19, P453, DOI 10.1358/dnp.2006.19.8.1043961; Chen HH, 2007, NEUROBIOL AGING, V28, P1148, DOI 10.1016/j.neurobiolaging.2006.05.036; Dauphinee SM, 2005, J CELL BIOCHEM, V96, P579, DOI 10.1002/jcb.20508; Deng YQ, 2009, AM J PATHOL, V175, P2089, DOI 10.2353/ajpath.2009.090157; GOEDERT M, 1995, J NEUROCHEM, V65, P2804; Gong CX, 2008, CURR MED CHEM, V15, P2321, DOI 10.2174/092986708785909111; Gong CX, 2010, DRUG AGING, V27, P351, DOI 10.2165/11536110-000000000-00000; GONG CX, 1994, NEUROSCIENCE, V61, P765, DOI 10.1016/0306-4522(94)90400-6; GONG CX, 1993, J NEUROCHEM, V61, P921, DOI 10.1111/j.1471-4159.1993.tb03603.x; Hernandez F, 2009, BRAIN RES BULL, V80, P248, DOI 10.1016/j.brainresbull.2009.05.017; Iqbal K, 1998, NEUROBIOL AGING, V19, pS124; Iqbal K, 2009, ACTA NEUROPATHOL, V118, P53, DOI 10.1007/s00401-009-0486-3; Ksiezak-Reding H, 2003, BBA-MOL BASIS DIS, V1639, P159, DOI 10.1016/j.bbadis.2003.09.001; Lefebvre T, 2003, BBA-GEN SUBJECTS, V1619, P167, DOI 10.1016/S0304-4165(02)00477-4; Li X, 2006, EUR J NEUROSCI, V23, P2078, DOI 10.1111/j.1460-9568.2006.04735.x; Liu F, 2005, EUR J NEUROSCI, V22, P1942, DOI 10.1111/j.1460-9568.2005.04391.x; Liu F, 2004, P NATL ACAD SCI USA, V101, P10804, DOI 10.1073/pnas.0400348101; Liu F, 2007, EUR J NEUROSCI, V26, P3429, DOI 10.1111/j.1460-9568.2007.05955.x; Liu F, 2009, BRAIN, V132, P1820, DOI 10.1093/brain/awp099; Loring JF, 2001, DNA CELL BIOL, V20, P683, DOI 10.1089/10445490152717541; Lovestone S, 1997, NEUROSCIENCE, V78, P309; Luo B, 2008, ARTERIOSCL THROM VAS, V28, P651, DOI 10.1161/ATVBAHA.107.159533; Macauley MS, 2010, CHEM BIOL, V17, P937, DOI 10.1016/j.chembiol.2010.07.006; Macauley MS, 2008, J BIOL CHEM, V283, P34687, DOI 10.1074/jbc.M804525200; Paez Juan, 2003, Cancer Treat Res, V115, P145; Pei JJ, 1997, J NEUROPATH EXP NEUR, V56, P70, DOI 10.1097/00005072-199701000-00007; Pei JJ, 1998, J NEURAL TRANSM, V105, P69, DOI 10.1007/s007020050039; Planel E, 2001, J BIOL CHEM, V276, P34298, DOI 10.1074/jbc.M102780200; Planel E, 2007, J NEUROSCI, V27, P3090, DOI 10.1523/JNEUROSCI.4854-06.2007; Qian W, 2010, J ALZHEIMERS DIS, V19, P1221, DOI [10.3233/JAD-2009-1317, 10.3233/JAD-2010-1317]; Robertson LA, 2004, J ALZHEIMERS DIS, V6, P489; Run XQ, 2009, J ALZHEIMERS DIS, V16, P619, DOI 10.3233/JAD-2009-1003; Sontag E, 1996, NEURON, V17, P1201, DOI 10.1016/S0896-6273(00)80250-0; Sontag E, 2004, J NEUROPATH EXP NEUR, V63, P287, DOI 10.1093/jnen/63.4.287; Tanemura K, 2002, J NEUROSCI, V22, P133, DOI 10.1523/JNEUROSCI.22-01-00133.2002; Tatebayashi Y, 1999, J NEUROSCI, V19, P5245; Vogelsberg-Ragaglia V, 2001, EXP NEUROL, V168, P402, DOI 10.1006/exnr.2001.7630; Whelan SA, 2010, J BIOL CHEM, V285, P5204, DOI 10.1074/jbc.M109.077818; Yang XY, 2008, NATURE, V451, P964, DOI 10.1038/nature06668; Yuzwa SA, 2008, NAT CHEM BIOL, V4, P483, DOI 10.1038/nchembio.96	45	67	70	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e35277	10.1371/journal.pone.0035277	http://dx.doi.org/10.1371/journal.pone.0035277			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22536363	gold, Green Published, Green Submitted			2022-12-27	WOS:000305336200030
J	Bloemberg, D; Quadrilatero, J				Bloemberg, Darin; Quadrilatero, Joe			Rapid Determination of Myosin Heavy Chain Expression in Rat, Mouse, and Human Skeletal Muscle Using Multicolor Immunofluorescence Analysis	PLOS ONE			English	Article							FIBER-TYPE COMPOSITION; RESISTANCE EXERCISE; ACTOMYOSIN ATPASE; MITOCHONDRIAL BIOGENESIS; ADENOSINE TRIPHOSPHATASE; CONTRACTILE PROPERTIES; DEHYDROGENASE ACTIVITY; MONOCLONAL-ANTIBODIES; METABOLIC PROPERTIES; DIAPHRAGM MUSCLE	Skeletal muscle is a heterogeneous tissue comprised of fibers with different morphological, functional, and metabolic properties. Different muscles contain varying proportions of fiber types; therefore, accurate identification is important. A number of histochemical methods are used to determine muscle fiber type; however, these techniques have several disadvantages. Immunofluorescence analysis is a sensitive method that allows for simultaneous evaluation of multiple MHC isoforms on a large number of fibers on a single cross-section, and offers a more precise means of identifying fiber types. In this investigation we characterized pure and hybrid fiber type distribution in 10 rat and 10 mouse skeletal muscles, as well as human vastus lateralis (VL) using multicolor immunofluorescence analysis. In addition, we determined fiber type-specific cross-sectional area (CSA), succinate dehydrogenase (SDH) activity, and a-glycerophosphate dehydrogenase (GPD) activity. Using this procedure we were able to easily identify pure and hybrid fiber populations in rat, mouse, and human muscle. Hybrid fibers were identified in all species and made up a significant portion of the total population in some rat and mouse muscles. For example, rat mixed gastrocnemius (MG) contained 12.2% hybrid fibers whereas mouse white tibialis anterior (WTA) contained 12.1% hybrid fibers. Collectively, we outline a simple and time-efficient method for determining MHC expression in skeletal muscle of multiple species. In addition, we provide a useful resource of the pure and hybrid fiber type distribution, fiber CSA, and relative fiber type-specific SDH and GPD activity in a number of rat and mouse muscles.	[Bloemberg, Darin; Quadrilatero, Joe] Univ Waterloo, Dept Kinesiol, Waterloo, ON N2L 3G1, Canada	University of Waterloo	Bloemberg, D (corresponding author), Univ Waterloo, Dept Kinesiol, Waterloo, ON N2L 3G1, Canada.	jquadril@uwaterloo.ca			Natural Sciences and Engineering Research Council of Canada (NSERC)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimoto T, 2004, AM J PHYSIOL-CELL PH, V287, pC1311, DOI 10.1152/ajpcell.00248.2004; Allen DL, 2001, AM J PHYSIOL-CELL PH, V280, pC637, DOI 10.1152/ajpcell.2001.280.3.C637; Andersen JL, 1999, J APPL PHYSIOL, V86, P455, DOI 10.1152/jappl.1999.86.2.455; Arany Z, 2007, CELL METAB, V5, P35, DOI 10.1016/j.cmet.2006.12.003; ARMSTRONG RB, 1984, AM J ANAT, V171, P259, DOI 10.1002/aja.1001710303; Bamman MM, 1998, J APPL PHYSIOL, V84, P157, DOI 10.1152/jappl.1998.84.1.157; BARNARD RJ, 1971, AM J PHYSIOL, V220, P410, DOI 10.1152/ajplegacy.1971.220.2.410; BLANCO CE, 1988, HISTOCHEM J, V20, P230, DOI 10.1007/BF01747468; BROOKE MH, 1970, J HISTOCHEM CYTOCHEM, V18, P670, DOI 10.1177/18.9.670; Delp MD, 1996, J APPL PHYSIOL, V80, P261, DOI 10.1152/jappl.1996.80.1.261; Dunn SE, 1997, AM J PHYSIOL-CELL PH, V273, pC371, DOI 10.1152/ajpcell.1997.273.2.C371; Dunn SE, 1999, PFLUG ARCH EUR J PHY, V437, P432, DOI 10.1007/s004240050798; FUCHTBAUER EM, 1991, J HISTOCHEM CYTOCHEM, V39, P355, DOI 10.1177/39.3.1825216; Garcia-Roves PM, 2008, J BIOL CHEM, V283, P35724, DOI 10.1074/jbc.M805078200; Geng TY, 2010, AM J PHYSIOL-CELL PH, V298, pC572, DOI 10.1152/ajpcell.00481.2009; GOLLNICK PD, 1984, HISTOCHEMISTRY, V81, P379, DOI 10.1007/BF00514333; GORZA L, 1990, J HISTOCHEM CYTOCHEM, V38, P257, DOI 10.1177/38.2.2137154; Graziotti GH, 2001, J HISTOCHEM CYTOCHEM, V49, P1033, DOI 10.1177/002215540104900811; Green H, 1999, AM J PHYSIOL-REG I, V276, pR591, DOI 10.1152/ajpregu.1999.276.2.R591; GREEN HJ, 1991, J APPL PHYSIOL, V70, P2032, DOI 10.1152/jappl.1991.70.5.2032; Gregory CM, 2003, CAN J APPL PHYSIOL, V28, P491, DOI 10.1139/h03-036; Gregory CM, 2001, MUSCLE NERVE, V24, P387, DOI 10.1002/1097-4598(200103)24:3<387::AID-MUS1010>3.0.CO;2-M; GUTH L, 1970, EXP NEUROL, V28, P365, DOI 10.1016/0014-4886(70)90244-X; HALKJAERKRISTENSEN J, 1979, HISTOCHEM J, V11, P127, DOI 10.1007/BF01002990; Hallauer PL, 2002, AM J PHYSIOL-CELL PH, V282, pC113, DOI 10.1152/ajpcell.00294.2001; Harridge SDR, 1996, PFLUG ARCH EUR J PHY, V432, P913, DOI 10.1007/s004240050215; Harrison BC, 2003, J APPL PHYSIOL, V95, P2462, DOI 10.1152/japplphysiol.00603.2003; Landisch RM, 2008, MUSCLE NERVE, V38, P1290, DOI 10.1002/mus.21141; Louhglin M, 1993, MUSCLE BIOPSY LAB IN; Lucas CA, 2000, BIOCHEM BIOPH RES CO, V272, P303, DOI 10.1006/bbrc.2000.2768; McClung JM, 2007, J PHYSIOL-LONDON, V585, P203, DOI 10.1113/jphysiol.2007.141119; Miller TA, 2001, AM J PHYSIOL-REG I, V281, pR1710, DOI 10.1152/ajpregu.2001.281.5.R1710; Norenberg KM, 2004, J APPL PHYSIOL, V97, P2322, DOI 10.1152/japplphysiol.00955.2003; PADYKULA HA, 1955, J HISTOCHEM CYTOCHEM, V3, P170, DOI 10.1177/3.3.170; PETER JB, 1972, BIOCHEMISTRY-US, V11, P2627, DOI 10.1021/bi00764a013; Pette D, 1990, Rev Physiol Biochem Pharmacol, V116, P1; Quadrilatero J, 2010, AM J PHYSIOL-ENDOC M, V298, pE534, DOI 10.1152/ajpendo.00678.2009; Rivero JLL, 1998, J MUSCLE RES CELL M, V19, P733, DOI 10.1023/A:1005482816442; Rivero JLL, 1999, HISTOCHEM CELL BIOL, V111, P277, DOI 10.1007/s004180050358; Ryall JG, 2004, J PHYSIOL-LONDON, V555, P175, DOI 10.1113/jphysiol.2003.056770; SCHIAFFINO S, 1989, J MUSCLE RES CELL M, V10, P197, DOI 10.1007/BF01739810; Schiaffino S, 2010, ACTA PHYSIOL, V199, P451, DOI 10.1111/j.1748-1716.2010.02130.x; SCHIAFFINO S, 1994, J APPL PHYSIOL, V77, P493, DOI 10.1152/jappl.1994.77.2.493; Schuenke MD, 2008, GROWTH HORM IGF RES, V18, P479, DOI 10.1016/j.ghir.2008.04.003; Seth A, 2007, CELL METAB, V6, P236, DOI 10.1016/j.cmet.2007.08.004; Shortreed KE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007293; SIECK GC, 1995, J APPL PHYSIOL, V79, P1629, DOI 10.1152/jappl.1995.79.5.1629; Smerdu V, 2008, EUR J HISTOCHEM, V52, P179; SMERDU V, 1994, AM J PHYSIOL-CELL PH, V267, pC1723, DOI 10.1152/ajpcell.1994.267.6.C1723; Spangenburg EE, 2003, ACTA PHYSIOL SCAND, V178, P413, DOI 10.1046/j.1365-201X.2003.01158.x; STARON RS, 1993, HISTOCHEMISTRY, V100, P149, DOI 10.1007/BF00572901; Staron RS, 1999, HISTOCHEM CELL BIOL, V111, P117, DOI 10.1007/s004180050341; Totsuka Y, 2003, J APPL PHYSIOL, V95, P720, DOI 10.1152/japplphysiol.00946.2002; Trollet C, 2010, HUM MOL GENET, V19, P2191, DOI 10.1093/hmg/ddq098; Zierath JR, 2004, PLOS BIOL, V2, P1523, DOI 10.1371/journal.pbio.0020348	55	368	374	6	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35273	10.1371/journal.pone.0035273	http://dx.doi.org/10.1371/journal.pone.0035273			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22530000	Green Published, Green Submitted, gold			2022-12-27	WOS:000305350600072
J	Rosenberger, T; Brulle, JK; Sander, P				Rosenberger, Tobias; Bruelle, Juliane K.; Sander, Peter			A beta-Lactamase Based Reporter System for ESX Dependent Protein Translocation in Mycobacteria	PLOS ONE			English	Article							OUTER-MEMBRANE; VII SECRETION; CELL-WALL; TUBERCULOSIS; ESAT-6; INFECTION; VIRULENCE; SMEGMATIS; DELETION	Protein secretion is essential for all bacteria in order to interact with their environment. Mycobacterium tuberculosis depends on protein secretion to subvert host immune response mechanisms. Both the general secretion system (Sec) and the twin-arginine translocation system (Tat) are functional in mycobacteria. Furthermore, a novel type of protein translocation system named ESX has been identified. In the genome of M. tuberculosis five paralogous ESX regions (ESX-1 to ESX-5) have been found. Several components of the ESX translocation apparatus have been identified over the last ten years. The ESX regions are composed of a basic set of genes for the translocation machinery and the main substrate - a heterodimer. The best studied of these heterodimers is EsxA (ESAT-6)/EsxB (CFP-10), which has been shown to be exported by ESX-1. EsxA/B is heavily involved in virulence of M. tuberculosis. EsxG/H is exported by ESX-3 and seems to be involved in an essential iron-uptake mechanism in M. tuberculosis. These findings make ESX-3 components high profile drug targets. Until now, reporter systems for determination of ESX protein translocation have not been developed. In order to create such a reporter system, a truncated beta-lactamase ('bla TEM-1) was fused to the N-terminus of EsxB, EsxG and EsxU, respectively. These constructs have then been tested in a beta-lactamase (BlaS) deletion strain of Mycobacterium smegmatis. M. smegmatis Delta blaS is highly susceptible to ampicillin. An ampicillin resistant phenotype was conferred by translocation of Bla TEM-1-Esx fusion proteins into the periplasm. BlaTEM-1-Esx fusion proteins were not found in the culture filtrate suggesting that plasma membrane translocation and outer membrane translocation are two distinct steps in ESX secretion. Thus we have developed a powerful tool to dissect the molecular mechanisms of ESX dependent protein translocation and to screen for novel components of the ESX systems on a large scale.	[Rosenberger, Tobias; Bruelle, Juliane K.; Sander, Peter] Univ Zurich, Inst Med Microbiol, Zurich, Switzerland; [Sander, Peter] Natl Zentrum Mykobakterien, Zurich, Switzerland	University of Zurich	Rosenberger, T (corresponding author), Univ Zurich, Inst Med Microbiol, Zurich, Switzerland.	psander@imm.uzh.ch			University of Zurich; Swiss National Foundation [31003A_135705]; European Union (EU FP-7 NewTBVac) [241745]	University of Zurich; Swiss National Foundation(Swiss National Science Foundation (SNSF)); European Union (EU FP-7 NewTBVac)	This work was supported in part by the University of Zurich, the Swiss National Foundation (31003A_135705) and the European Union (EU FP-7 NewTBVac, project No. 241745). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah AM, 2009, MOL MICROBIOL, V73, P329, DOI 10.1111/j.1365-2958.2009.06783.x; Abdallah AM, 2007, NAT REV MICROBIOL, V5, P883, DOI 10.1038/nrmicro1773; Abdallah AM, 2006, MOL MICROBIOL, V62, P667, DOI 10.1111/j.1365-2958.2006.05409.x; Abdallah AM, 2011, J IMMUNOL, V187, P4744, DOI 10.4049/jimmunol.1101457; Arbing MA, 2010, PROTEIN SCI, V19, P1692, DOI 10.1002/pro.451; Braunstein M, 2003, MOL MICROBIOL, V48, P453, DOI 10.1046/j.1365-2958.2003.03438.x; Brodin P, 2002, INFECT IMMUN, V70, P5568, DOI 10.1128/IAI.70.10.5568-5578.2002; Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299; Champion PAD, 2006, SCIENCE, V313, P1632, DOI 10.1126/science.1131167; Clark-Curtiss JE, 2003, ANNU REV MICROBIOL, V57, P517, DOI 10.1146/annurev.micro.57.030502.090903; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Coros A, 2008, MOL MICROBIOL, V69, P794, DOI 10.1111/j.1365-2958.2008.06299.x; Das C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027980; DATTA N, 1965, NATURE, V208, P239, DOI 10.1038/208239a0; de Jonge MI, 2007, J BACTERIOL, V189, P6028, DOI 10.1128/JB.00469-07; Desvaux M, 2009, TRENDS MICROBIOL, V17, P139, DOI 10.1016/j.tim.2009.01.004; Feltcher ME, 2010, FUTURE MICROBIOL, V5, P1581, DOI [10.2217/fmb.10.112, 10.2217/FMB.10.112]; Flores AR, 2005, J BACTERIOL, V187, P1892, DOI 10.1128/JB.187.6.1892-1900.2005; Flores AR, 2005, MICROBIOL-SGM, V151, P521, DOI 10.1099/mic.0.27629-0; Ganguly N, 2008, TUBERCULOSIS, V88, P510, DOI 10.1016/j.tube.2008.05.002; Gaora PO, 1997, MED PRIN PRACT, V6, P91; Gey van Pittius NC, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-95; Hoffmann C, 2008, P NATL ACAD SCI USA, V105, P3963, DOI 10.1073/pnas.0709530105; Ilghari D, 2011, J BIOL CHEM, V286, P29993, DOI 10.1074/jbc.M111.248732; Lewis KN, 2003, J INFECT DIS, V187, P117, DOI 10.1086/345862; Maciag A, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-48; Malen H, 2007, PROTEOMICS, V7, P1702, DOI 10.1002/pmic.200600853; McCann JR, 2007, MICROBIOL-SGM, V153, P3350, DOI 10.1099/mic.0.2007/008516-0; McDonough JA, 2008, J BACTERIOL, V190, P6428, DOI 10.1128/JB.00749-08; McLaughlin B, 2007, PLOS PATHOG, V3, P1051, DOI 10.1371/journal.ppat.0030105; NIKAIDO H, 1993, MOL MICROBIOL, V8, P1025, DOI 10.1111/j.1365-2958.1993.tb01647.x; Pallen MJ, 2002, TRENDS MICROBIOL, V10, P209, DOI 10.1016/S0966-842X(02)02345-4; Rohde K, 2007, IMMUNOL REV, V219, P37, DOI 10.1111/j.1600-065X.2007.00547.x; SANDER P, 1995, MOL MICROBIOL, V16, P991, DOI 10.1111/j.1365-2958.1995.tb02324.x; Sani M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000794; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Serafini A, 2009, J BACTERIOL, V191, P6340, DOI 10.1128/JB.00756-09; Siegrist MS, 2009, P NATL ACAD SCI USA, V106, P18792, DOI 10.1073/pnas.0900589106; SORENSEN AL, 1995, INFECT IMMUN, V63, P1710; Stanley SA, 2003, P NATL ACAD SCI USA, V100, P13001, DOI 10.1073/pnas.2235593100; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Sutcliffe IC, 2010, ANTON LEEUW INT J G, V99, P127; Sweeney KA, 2011, NAT MED; Torrelles JB, 2010, TUBERCULOSIS, V90, P84, DOI 10.1016/j.tube.2010.02.003; VANPITTIUS NCG, 2001, GENOME BIOL, V2, DOI DOI 10.1186/GB-2001-2-10-RESEARCH0044; Wanner RM, 2009, J BACTERIOL, V191, P6312, DOI 10.1128/JB.00613-09; Wiker HG, 2000, MICROBIOL-SGM, V146, P1525, DOI 10.1099/00221287-146-7-1525; Xu J, 2007, MOL MICROBIOL, V66, P787, DOI 10.1111/j.1365-2958.2007.05959.x; Zuber B, 2008, J BACTERIOL, V190, P5672, DOI 10.1128/JB.01919-07	50	3	3	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35453	10.1371/journal.pone.0035453	http://dx.doi.org/10.1371/journal.pone.0035453			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22530024	Green Submitted, Green Published, gold			2022-12-27	WOS:000305350600084
J	Wu, CK; Huang, YT; Lee, JK; Chiang, LT; Chiang, FT; Huang, SW; Lin, JL; Tseng, CD; Chen, YH; Tsai, CT				Wu, Cho-Kai; Huang, Yin-Tsen; Lee, Jen-Kuang; Chiang, Liang-Ting; Chiang, Fu-Tien; Huang, Shu-Wei; Lin, Jiunn-Lee; Tseng, Chuen-Den; Chen, Yau-Hung; Tsai, Chia-Ti			Cardiac Myosin Binding Protein C and MAP-Kinase Activating Death Domain-Containing Gene Polymorphisms and Diastolic Heart Failure	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; HYPERTROPHIC CARDIOMYOPATHY; PHOSPHORYLATION; MYOCARDIUM; MUTATIONS; MYOCYTES; VARIANT	Objective: Myosin binding protein C (MYBPC3) plays a role in ventricular relaxation. The aim of the study was to investigate the association between cardiac myosin binding protein C (MYBPC3) gene polymorphisms and diastolic heart failure (DHF) in a human case-control study. Methods: A total of 352 participants of 1752 consecutive patients from the National Taiwan University Hospital and its affiliated hospital were enrolled. 176 patients diagnosed with DHF confirmed by echocardiography were recruited. Controls were matched 1-to-1 by age, sex, hypertension, diabetes, renal function and medication use. We genotyped 12 single nucleotide polymorphisms (SNPs) according to HapMap Han Chinese Beijing databank across a 40 kb genetic region containing the MYBPC3 gene and the neighboring DNA sequences to capture 100% of haplotype variance in all SNPs with minor allele frequencies >= 5%. We also analyzed associations of these tagging SNPs and haplotypes with DHF and linkage disequilibrium (LD) structure of the MYBPC3 gene. Results: In a single locus analysis, SNP rs2290149 was associated with DHF (allele-specific p = 0.004; permuted p = 0.031). The SNP with a minor allele frequency of 9.4%, had an odds ratio 2.14 (95% CI 1.25-3.66; p = 0.004) for the additive model and 2.06 for the autosomal dominant model (GG+GA : AA, 95% CI 1.17-3.63; p = 0.013), corresponding to a population attributable risk fraction of 12.02%. The haplotypes in a LD block of rs2290149 (C-C-G-C) was also significantly associated with DHF (odds ratio 2.10 (1.53-2.89); permuted p = 0.029). Conclusions: We identified a SNP (rs2290149) among the tagging SNP set that was significantly associated with early DHF in a Chinese population.	[Wu, Cho-Kai; Chiang, Liang-Ting; Lin, Jiunn-Lee; Tseng, Chuen-Den; Tsai, Chia-Ti] Natl Taiwan Univ, Div Cardiol, Dept Internal Med, Coll Med & Hosp, Taipei 10764, Taiwan; [Wu, Cho-Kai; Chiang, Fu-Tien] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei 10764, Taiwan; [Huang, Yin-Tsen; Chiang, Fu-Tien] Far Eastern Mem Hosp, Dept Family Med, New Taipei City, Taiwan; [Huang, Yin-Tsen; Chiang, Fu-Tien] Far Eastern Mem Hosp, Hlth Management Ctr, New Taipei City, Taiwan; [Lee, Jen-Kuang] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei, Taiwan; [Lee, Jen-Kuang] Far Eastern Mem Hosp, Dept Clin Pathol, New Taipei City, Taiwan; [Lee, Jen-Kuang] Natl Taiwan Univ, Grad Inst Biomed Elect & Bioinformat, Taipei 10764, Taiwan; [Huang, Shu-Wei] Natl Yang Ming Univ, Coll Med, Grad Inst Biomed Engn, Taipei 112, Taiwan; [Chen, Yau-Hung] Tamkang Univ, Dept Chem, Tamsui 25137, Taiwan	National Taiwan University; National Taiwan University; Far Eastern Memorial Hospital; Far Eastern Memorial Hospital; National Taiwan University; National Taiwan University Hospital; Far Eastern Memorial Hospital; National Taiwan University; National Yang Ming Chiao Tung University; Tamkang University	Wu, CK (corresponding author), Natl Taiwan Univ, Div Cardiol, Dept Internal Med, Coll Med & Hosp, Taipei 10764, Taiwan.	yauhung@mail.tku.edu.tw; fang31@ms39.hinet.net		WU, CHO-KAI/0000-0002-3867-150X; CHIANG, FU-TIEN/0000-0003-4936-8968; TSAI, CHIA-TI/0000-0002-4853-8665	Institute of Biomedical Medical Sciences CRC Research Program of Institute of Biomedical Science, Academia Sinica [IBMS-CRC99-P02]; National Science Council of Tiawan R.O.C. [NSC 99-2314-B-002-131-MY3]	Institute of Biomedical Medical Sciences CRC Research Program of Institute of Biomedical Science, Academia Sinica; National Science Council of Tiawan R.O.C.	This work was supported in part by the Institute of Biomedical Medical Sciences CRC Research Program of Institute of Biomedical Science, Academia Sinica (IBMS-CRC99-P02) and by a grant (NSC 99-2314-B-002-131-MY3) from the National Science Council of Tiawan R.O.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angeja BG, 2003, CIRCULATION, V107, P659, DOI 10.1161/01.CIR.0000053948.10914.49; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Borbely A, 2009, CIRC RES, V104, P780, DOI 10.1161/CIRCRESAHA.108.193326; Chatterjee K, 2007, J CARD FAIL, V13, P569, DOI 10.1016/j.cardfail.2007.04.006; Cowie MR, 1997, EUR HEART J, V18, P208; Defer N, 2007, J BIOL CHEM, V282, P35564, DOI 10.1074/jbc.M704003200; Dhandapany PS, 2009, NAT GENET, V41, P187, DOI 10.1038/ng.309; El-Armouche A, 2007, J MOL CELL CARDIOL, V43, P223, DOI 10.1016/j.yjmcc.2007.05.003; Flashman E, 2004, CIRC RES, V94, P1279, DOI 10.1161/01.RES.0000127175.21818.C2; Girolami F, 2010, J AM COLL CARDIOL, V55, P1444, DOI 10.1016/j.jacc.2009.11.062; GULICK T, 1989, P NATL ACAD SCI USA, V86, P6753, DOI 10.1073/pnas.86.17.6753; Harris SP, 2002, CIRC RES, V90, P594, DOI 10.1161/01.RES.0000012222.70819.64; Jurinke Christian, 2002, Adv Biochem Eng Biotechnol, V77, P57; Katz AM, 2006, CIRCULATION, V113, P1922, DOI 10.1161/CIRCULATIONAHA.106.620765; Kubo T, 2005, J AM COLL CARDIOL, V46, P1737, DOI 10.1016/j.jacc.2005.05.087; Kurada BRVVSN, 2009, J BIOL CHEM, V284, P13533, DOI 10.1074/jbc.M808554200; Leszek P, 2008, J CARD FAIL, V14, P873, DOI 10.1016/j.cardfail.2008.07.232; McClellan G, 2001, BIOPHYS J, V81, P1083, DOI 10.1016/S0006-3495(01)75765-7; Niimura H, 1998, NEW ENGL J MED, V338, P1248, DOI 10.1056/NEJM199804303381802; Pohlmann L, 2007, CIRC RES, V101, P928, DOI 10.1161/CIRCRESAHA.107.158774; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Sadayappan S, 2006, P NATL ACAD SCI USA, V103, P16918, DOI 10.1073/pnas.0607069103; Spinale FG, 2000, CIRCULATION, V102, P1944, DOI 10.1161/01.CIR.102.16.1944; Stelzer JE, 2006, BIOPHYS J, V90, P4119, DOI 10.1529/biophysj.105.078147; Wu CK, 2010, PHARMACOGENOMICS J, V10, P46, DOI 10.1038/tpj.2009.39; Wu CK, 2009, ATHEROSCLEROSIS, V205, P497, DOI 10.1016/j.atherosclerosis.2008.12.033; Wu CK, 2009, J HYPERTENS, V27, P502, DOI 10.1097/HJH.0b013e32831fda3a; Yip GWK, 2008, HEART, V94, P573, DOI 10.1136/hrt.2007.117978; YOKOYAMA T, 1993, J CLIN INVEST, V92, P2303, DOI 10.1172/JCI116834	29	12	12	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e35242	10.1371/journal.pone.0035242	http://dx.doi.org/10.1371/journal.pone.0035242			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22529996	Green Submitted, Green Published, gold			2022-12-27	WOS:000305347400038
J	He, HL; Guo, J; Chen, XL; Xie, BB; Zhang, XY; Yu, Y; Chen, B; Zhou, BC; Zhang, YZ				He, Hai-Lun; Guo, Jun; Chen, Xiu-Lan; Xie, Bin-Bin; Zhang, Xi-Ying; Yu, Yong; Chen, Bo; Zhou, Bai-Cheng; Zhang, Yu-Zhong			Structural and Functional Characterization of Mature Forms of Metalloprotease E495 from Arctic Sea-Ice Bacterium Pseudoalteromonas sp SM495	PLOS ONE			English	Article							KIDNEY-DISEASE DOMAIN; MARINE BACTERIUM; BINDING DOMAIN; SP SM9913; DEEP-SEA; PROTEASE; PURIFICATION; SEQUENCE; CLONING; GENE	E495 is the most abundant protease secreted by the Arctic sea-ice bacterium Pseudoalteromonas sp. SM495. As a thermolysin family metalloprotease, E495 was found to have multiple active forms in the culture of strain SM495. E495-M (containing only the catalytic domain) and E495-M-C1 (containing the catalytic domain and one PPC domain) were two stable mature forms, and E495-M-C1-C2 (containing the catalytic domain and two PPC domains) might be an intermediate. Compared to E495-M, E495-M-C1 had similar affinity and catalytic efficiency to oligopeptides, but higher affinity and catalytic efficiency to proteins. The PPC domains from E495 were expressed as GST-fused proteins. Both of the recombinant PPC domains were shown to have binding ability to proteins C-phycocyanin and casein, and domain PPC1 had higher affinity to C-phycocyanin than domain PPC2. These results indicated that the domain PPC1 in E495-M-C1 could be helpful in binding protein substrate, and therefore, improving the catalytic efficiency. Site-directed mutagenesis on the PPC domains showed that the conserved polar and aromatic residues, D26, D28, Y30, Y/W65, in the PPC domains played key roles in protein binding. Our study may shed light on the mechanism of organic nitrogen degradation in the Arctic sea ice.	[He, Hai-Lun; Guo, Jun; Chen, Xiu-Lan; Xie, Bin-Bin; Zhang, Xi-Ying; Zhou, Bai-Cheng; Zhang, Yu-Zhong] Shandong Univ, Marine Biotechnol Res Ctr, State Key Lab Microbial Technol, Jinan 250100, Peoples R China; [Yu, Yong; Chen, Bo] Polar Res Inst China, SOA Key Lab Polar Sci, Shanghai, Peoples R China	Shandong University; Polar Research Institute of China	He, HL (corresponding author), Shandong Univ, Marine Biotechnol Res Ctr, State Key Lab Microbial Technol, Jinan 250100, Peoples R China.	zhangyz@sdu.edu.cn			National Natural Science Foundation of China [31025001, 31070061, 40876072, 31000034]; Hi-Tech Research and Development program of China [2006AA09Z414]; Natural Science Foundation of Shandong Province, P. R. China [JQ200910, ZR2009DZ002]; Foundation for Young Scientists in Shandong Province [2007BS07007]; Independent Innovation Foundation of Shandong University [2009TS079]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hi-Tech Research and Development program of China(National High Technology Research and Development Program of China); Natural Science Foundation of Shandong Province, P. R. China(Natural Science Foundation of Shandong Province); Foundation for Young Scientists in Shandong Province; Independent Innovation Foundation of Shandong University	The work was supported by National Natural Science Foundation of China (31025001, 31070061, 40876072, 31000034), Hi-Tech Research and Development program of China (2006AA09Z414), Natural Science Foundation of Shandong Province, P. R. China (JQ200910, ZR2009DZ002), Foundation for Young Scientists in Shandong Province (2007BS07007), Independent Innovation Foundation of Shandong University (2009TS079). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becquevort S, 2009, POLAR BIOL, V32, P879, DOI 10.1007/s00300-009-0589-2; Bowman JP, 1997, APPL ENVIRON MICROB, V63, P3068, DOI 10.1128/AEM.63.8.3068-3078.1997; Chakrabarti SK, 2000, CURR MICROBIOL, V40, P239, DOI 10.1007/s002849910048; Chang AK, 2007, J BACTERIOL, V189, P6832, DOI 10.1128/JB.00396-07; Chen XL, 2007, MICROBIOL-SGM, V153, P2116, DOI 10.1099/mic.0.2007/006056-0; Cushing PR, 2008, BIOCHEMISTRY-US, V47, P10084, DOI 10.1021/bi8003928; FEDER J, 1970, BIOCHEMISTRY-US, V9, P2784, DOI 10.1021/bi00816a005; Ferrandon S, 2003, BBA-GEN SUBJECTS, V1621, P31, DOI 10.1016/S0304-4165(03)00029-1; Gary R, 1997, J BIOL CHEM, V272, P24522, DOI 10.1074/jbc.272.39.24522; He HL, 2004, FOOD CHEM, V84, P307, DOI 10.1016/S0308-8146(03)00242-5; Hu ZJ, 2000, PROTEINS, V39, P331, DOI 10.1002/(SICI)1097-0134(20000601)39:4<331::AID-PROT60>3.0.CO;2-A; Inouye K, 2007, BIOTECHNOL ANN REV, V13, P43, DOI 10.1016/S1387-2656(07)13003-9; Jin F, 1996, INFECT IMMUN, V64, P230, DOI 10.1128/IAI.64.1.230-237.1996; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee SO, 2002, BIOSCI BIOTECH BIOCH, V66, P1366, DOI 10.1271/bbb.66.1366; Liu LN, 2005, J BIOTECHNOL, V116, P91, DOI 10.1016/j.jbiotec.2004.09.017; Marchler-Bauer A, 2005, NUCLEIC ACIDS RES, V33, pD192, DOI 10.1093/nar/gki069; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; Miyoshi S, 1997, J BACTERIOL, V179, P7606, DOI 10.1128/jb.179.23.7606-7609.1997; NARUKAWA H, 1993, FEMS MICROBIOL LETT, V108, P43; NIES M, 1980, PLANTA, V150, P330, DOI 10.1007/BF00384663; Nirasawa S, 2004, HDB PROTEOLYTIC ENZY, P374; Orikoshi H, 2005, J APPL MICROBIOL, V99, P551, DOI 10.1111/j.1365-2672.2005.02630.x; Pace CN, 2009, NAT STRUCT MOL BIOL, V16, P681, DOI 10.1038/nsmb0709-681; PHILLIPS PK, 1984, J CLIN PATHOL, V37, P329, DOI 10.1136/jcp.37.3.329; Rao MB, 1998, MICROBIOL MOL BIOL R, V62, P597, DOI 10.1128/MMBR.62.3.597-635.1998; Rawlings ND, 2002, NUCLEIC ACIDS RES, V30, P343, DOI 10.1093/nar/30.1.343; Rawlings ND, 2008, NUCLEIC ACIDS RES, V36, pD320, DOI 10.1093/nar/gkm954; Su HN, 2010, J APPL PHYCOL, V22, P65, DOI 10.1007/s10811-009-9427-8; Takahashi T, 2005, J BIOCHEM, V138, P701, DOI 10.1093/jb/mvi173; Takashima S, 2007, FEBS LETT, V581, P5891, DOI 10.1016/j.febslet.2007.11.068; THOMAS DN, 2003, SEA ICE AN INTRO ITS; Tsujibo H, 1996, BIOSCI BIOTECH BIOCH, V60, P1284, DOI 10.1271/bbb.60.1284; Verkhivker GM, 2002, PROTEINS, V48, P539, DOI 10.1002/prot.10164; Weigt M, 2009, P NATL ACAD SCI USA, V106, P67, DOI 10.1073/pnas.0805923106; Worthington Biochemical Corporation, 1972, WORTH ENZ MAN; Wu JW, 2011, APPL MICROBIOL BIOT, V92, P253, DOI 10.1007/s00253-011-3532-8; Xie BB, 2009, J BIOL CHEM, V284, P9257, DOI 10.1074/jbc.M808421200; Yan BQ, 2009, EXTREMOPHILES, V13, P725, DOI 10.1007/s00792-009-0263-1; Yeats C, 2003, BMC MICROBIOL, V3, DOI 10.1186/1471-2180-3-3; Zhao GY, 2008, J BIOL CHEM, V283, P36100, DOI 10.1074/jbc.M804438200	41	15	16	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e35442	10.1371/journal.pone.0035442	http://dx.doi.org/10.1371/journal.pone.0035442			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523598	Green Submitted, gold, Green Published			2022-12-27	WOS:000305345000071
J	Agostino, M; Yuriev, E; Ramsland, PA				Agostino, Mark; Yuriev, Elizabeth; Ramsland, Paul A.			Antibody Recognition of Cancer-Related Gangliosides and Their Mimics Investigated Using in silico Site Mapping	PLOS ONE			English	Article							GUILLAIN-BARRE-SYNDROME; GD2 GANGLIOSIDE; MONOCLONAL-ANTIBODY; PEPTIDES MIMICKING; ANTIGANGLIOSIDE ANTIBODIES; XENOREACTIVE ANTIBODIES; CARBOHYDRATE ANTIGENS; CANONICAL STRUCTURES; MOLECULAR MIMICRY; LIGAND DOCKING	Modified gangliosides may be overexpressed in certain types of cancer, thus, they are considered a valuable target in cancer immunotherapy. Structural knowledge of their interaction with antibodies is currently limited, due to the large size and high flexibility of these ligands. In this study, we apply our previously developed site mapping technique to investigate the recognition of cancer-related gangliosides by anti-ganglioside antibodies. The results reveal a potential ganglioside-binding motif in the four antibodies studied, suggesting the possibility of structural convergence in the anti-ganglioside immune response. The structural basis of the recognition of ganglioside-mimetic peptides is also investigated using site mapping and compared to ganglioside recognition. The peptides are shown to act as structural mimics of gangliosides by interacting with many of the same binding site residues as the cognate carbohydrate epitopes. These studies provide important clues as to the structural basis of immunological mimicry of carbohydrates.	[Agostino, Mark; Yuriev, Elizabeth] Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic, Australia; [Ramsland, Paul A.] Burnet Inst, Ctr Immunol, Melbourne, Vic, Australia; [Ramsland, Paul A.] Univ Melbourne, Dept Surg Austin Hlth, Heidelberg, Vic, Australia; [Ramsland, Paul A.] Monash Univ, Dept Immunol, Melbourne, Vic 3004, Australia	Monash University; Burnet Institute; Austin Research Institute; University of Melbourne; Monash University	Yuriev, E (corresponding author), Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic, Australia.	Elizabeth.Yuriev@monash.edu; pramsland@burnet.edu.au	Yuriev, Elizabeth/A-7132-2016; Agostino, Mark/H-5481-2019	Yuriev, Elizabeth/0000-0002-3909-0379; Agostino, Mark/0000-0002-1799-0392; Ramsland, Paul/0000-0002-2107-2738	Faculty of Pharmacy and Pharmaceutical Sciences, Monash University; Monash University Postgraduate Publication Award; Sir Zelman Cowen Fellowship Fund, Burnet Institute	Faculty of Pharmacy and Pharmaceutical Sciences, Monash University(Monash University); Monash University Postgraduate Publication Award(Monash University); Sir Zelman Cowen Fellowship Fund, Burnet Institute	This research was supported by a small grant from the Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, to EY. MA is a recipient of the Monash University Postgraduate Publication Award. PAR is the Sir Zelman Cowen Senior Research Fellow (Sir Zelman Cowen Fellowship Fund, Burnet Institute). The authors gratefully acknowledge the contribution to this work of the Victorian Operational Infrastructure Support Program received by the Burnet Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostino M., 2012, ANTICARBOHYDRATE ANT, P203; Agostino M, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00023; Agostino M, 2011, EXPERT OPIN BIOL TH, V11, P211, DOI 10.1517/14712598.2011.542140; Agostino M, 2011, BIOPOLYMERS, V96, P193, DOI 10.1002/bip.21427; Agostino M, 2010, GLYCOBIOLOGY, V20, P724, DOI 10.1093/glycob/cwq022; Agostino M, 2009, MOL IMMUNOL, V47, P233, DOI 10.1016/j.molimm.2009.09.031; Agostino M, 2009, J CHEM INF MODEL, V49, P2749, DOI 10.1021/ci900388a; AlLazikani B, 1997, J MOL BIOL, V273, P927, DOI 10.1006/jmbi.1997.1354; [Anonymous], 2010, PRIM VERS 2 2; [Anonymous], 2010, GLID VERS 5 6; Astronomo RD, 2010, NAT REV DRUG DISCOV, V9, P308, DOI 10.1038/nrd3012; Blackler RJ, 2011, BIOCHEMISTRY-US, V50, P3357, DOI 10.1021/bi101886v; Brooks CL, 2010, BIOCHEMISTRY-US, V49, P570, DOI 10.1021/bi9011308; Cazet A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2577; CHOTHIA C, 1987, J MOL BIOL, V196, P901, DOI 10.1016/0022-2836(87)90412-8; Chou HH, 1998, P NATL ACAD SCI USA, V95, P11751, DOI 10.1073/pnas.95.20.11751; de Chaves EP, 2010, FEBS LETT, V584, P1748, DOI 10.1016/j.febslet.2009.12.010; Diaz Y, 2009, CANCER IMMUNOL IMMUN, V58, P1117, DOI 10.1007/s00262-008-0634-y; Fernandez Luis E, 2003, Expert Rev Vaccines, V2, P817, DOI 10.1586/14760584.2.6.817; Fernandez LE, 2010, CLIN DEV IMMUNOL, DOI 10.1155/2010/814397; Foster-Waldl E, 2005, MOL IMMUNOL, V42, P319, DOI 10.1016/j.molimm.2004.07.011; Fredman P, 2003, BIODRUGS, V17, P155, DOI 10.2165/00063030-200317030-00002; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Gorelik B, 2008, PROTEINS, V71, P1373, DOI 10.1002/prot.21847; Hakomori S, 2001, ADV EXP MED BIOL, V491, P369; HERRON JN, 1991, PROTEINS, V11, P159, DOI 10.1002/prot.340110302; Horwacik I, 2007, INT J MOL MED, V19, P829; Horwacik I, 2011, INT J MOL MED, V28, P47, DOI 10.3892/ijmm.2011.655; Inoue S, 2010, GLYCOBIOLOGY, V20, P752, DOI 10.1093/glycob/cwq030; James LC, 2003, SCIENCE, V299, P1362, DOI 10.1126/science.1079731; Kaminski MJ, 1999, J BIOL CHEM, V274, P5597, DOI 10.1074/jbc.274.9.5597; Koga M, 1999, J NEUROIMMUNOL, V96, P245, DOI 10.1016/S0165-5728(99)00040-5; Krengel U, 2004, J BIOL CHEM, V279, P5597, DOI 10.1074/jbc.M311693200; Krishnan L, 2008, BIOPHYS J, V94, P1367, DOI 10.1529/biophysj.107.108654; Kusunoki S, 2011, J NEUROCHEM, V116, P828, DOI 10.1111/j.1471-4159.2010.07029.x; Lang PT, 2009, RNA, V15, P1219, DOI 10.1261/rna.1563609; Lefranc MP, 2003, DEV COMP IMMUNOL, V27, P55, DOI 10.1016/S0145-305X(02)00039-3; Milland J, 2007, IMMUNOL CELL BIOL, V85, P623, DOI 10.1038/sj.icb.7100111; MOND JJ, 1995, ANNU REV IMMUNOL, V13, P655, DOI 10.1146/annurev.iy.13.040195.003255; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Navid F, 2010, CURR CANCER DRUG TAR, V10, P200, DOI 10.2174/156800910791054167; Neisser A, 2000, J NEUROIMMUNOL, V102, P85, DOI 10.1016/S0165-5728(99)00159-9; Nguyen HP, 2003, NAT STRUCT BIOL, V10, P1019, DOI 10.1038/nsb1014; Pichla SL, 1997, J STRUCT BIOL, V119, P6, DOI 10.1006/jsbi.1997.3857; Popa I, 2006, FEBS LETT, V580, P1398, DOI 10.1016/j.febslet.2006.01.063; Ramsland PA, 2004, J MOL BIOL, V340, P809, DOI 10.1016/j.jmb.2004.05.037; Rodriguez M, 2003, HYBRIDOMA HYBRIDOM, V22, P307, DOI 10.1089/153685903322538836; Schnaar RL, 2010, FEBS LETT, V584, P1741, DOI 10.1016/j.febslet.2009.10.011; Schrodinger LLC, 2010, PYMOL MOL GRAPH SYST; Schrodinger LLC, 2010, MAESTR VERS 9 2; Snapper CM, 1996, J IMMUNOL, V157, P2229; Talavera A, 2009, MOL IMMUNOL, V46, P3466, DOI 10.1016/j.molimm.2009.07.032; Tangvoranuntakul P, 2003, P NATL ACAD SCI USA, V100, P12045, DOI 10.1073/pnas.2131556100; Thielges MC, 2008, BIOCHEMISTRY-US, V47, P7237, DOI 10.1021/bi800374q; Usuki S, 2010, J NEUROCHEM, V113, P351, DOI 10.1111/j.1471-4159.2010.06627.x; Vazquez AM, 1998, HYBRIDOMA, V17, P527, DOI 10.1089/hyb.1998.17.527; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Willers J, 1999, PEPTIDES, V20, P1021, DOI 10.1016/S0196-9781(99)00095-9; WILSON IA, 1994, CURR OPIN STRUC BIOL, V4, P857, DOI 10.1016/0959-440X(94)90267-4; Wolchok JD, 2001, LANCET ONCOL, V2, P205, DOI 10.1016/S1470-2045(00)00290-4; Wondimu A, 2008, CANCER IMMUNOL IMMUN, V57, P1079, DOI 10.1007/s00262-007-0439-4; Yuriev E, 2008, MOL SIMULAT, V34, P461, DOI 10.1080/08927020701665995; Yuriev E, 2002, SCAND J IMMUNOL, V55, P242, DOI 10.1046/j.0300-9475.2002.01032.x; Yuriev E, 2001, J MOL RECOGNIT, V14, P172, DOI 10.1002/jmr.533; Yuriev E, 2011, J MOL RECOGNIT, V24, P149, DOI 10.1002/jmr.1077	66	14	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35457	10.1371/journal.pone.0035457	http://dx.doi.org/10.1371/journal.pone.0035457			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536387	Green Published, gold			2022-12-27	WOS:000305339200067
J	Caceres, ID; Valmas, N; Hilliard, MA; Lu, H				Caceres, Ivan de Carlos; Valmas, Nicholas; Hilliard, Massimo A.; Lu, Hang			Laterally Orienting C. elegans Using Geometry at Microscale for High-Throughput Visual Screens in Neurodegeneration and Neuronal Development Studies	PLOS ONE			English	Article							GENETIC SCREENS; SIGNALS	C. elegans is an excellent model system for studying neuroscience using genetics because of its relatively simple nervous system, sequenced genome, and the availability of a large number of transgenic and mutant strains. Recently, microfluidic devices have been used for high-throughput genetic screens, replacing traditional methods of manually handling C. elegans. However, the orientation of nematodes within microfluidic devices is random and often not conducive to inspection, hindering visual analysis and overall throughput. In addition, while previous studies have utilized methods to bias head and tail orientation, none of the existing techniques allow for orientation along the dorso-ventral body axis. Here, we present the design of a simple and robust method for passively orienting worms into lateral body positions in microfluidic devices to facilitate inspection of morphological features with specific dorso-ventral alignments. Using this technique, we can position animals into lateral orientations with up to 84% efficiency, compared to 21% using existing methods. We isolated six mutants with neuronal development or neurodegenerative defects, showing that our technology can be used for on-chip analysis and high-throughput visual screens.	[Caceres, Ivan de Carlos; Lu, Hang] Georgia Inst Technol, Interdisciplinary Bioengn Grad Program, Atlanta, GA 30332 USA; [Valmas, Nicholas; Hilliard, Massimo A.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Lu, Hang] Georgia Inst Technol, Sch Chem & Biomol Engn, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; University of Queensland; University System of Georgia; Georgia Institute of Technology	Lu, H (corresponding author), Georgia Inst Technol, Interdisciplinary Bioengn Grad Program, Atlanta, GA 30332 USA.	hang.lu@gatech.edu		Hilliard, Massimo A/0000-0001-7458-5812; Valmas, Nicholas/0000-0002-6925-9673	Goizueta Foundation; U.S. National Science Foundation [IGERT DGE-0333411, CAREER CBET 0954578]; U.S. National Institutes of Health [F31GM093351, R21EB012803, R01GM088333, R01AG035317, R01NS060129]; National Health and Medical Research Council of Australia [569500, 631605, 631634]; Directorate For Engineering [0954578] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB012803] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088333, F31GM093351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060129] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG035317] Funding Source: NIH RePORTER	Goizueta Foundation; U.S. National Science Foundation(National Science Foundation (NSF)); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work is supported by the Goizueta Foundation (fellowship to IC), the U.S. National Science Foundation (IGERT DGE-0333411 for IC, CAREER CBET 0954578 to HL), U.S. National Institutes of Health (F31GM093351 to IC; R21EB012803, R01GM088333, and R01AG035317 to HL; R01NS060129 to MAH), and the National Health and Medical Research Council of Australia (Project Grants # 569500, 631605, 631634 to MAH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler CE, 2006, NAT NEUROSCI, V9, P511, DOI 10.1038/nn1666; Altun Z.F., 2008, WORMATLAS; Antebi Adam, 1997, Cold Spring Harbor Monograph Series, V33, P583; Arimura N, 2007, NAT REV NEUROSCI, V8, P194, DOI 10.1038/nrn2056; Ben-Yakar A, 2009, CURR OPIN NEUROBIOL, V19, P561, DOI 10.1016/j.conb.2009.10.010; BRENNER S, 1974, GENETICS, V77, P71; Chokshi TV, 2010, LAB CHIP, V10, P2758, DOI 10.1039/c004658b; Chung KH, 2008, NAT METHODS, V5, P637, DOI 10.1038/nmeth.1227; Crane MM, 2010, LAB CHIP, V10, P1509, DOI 10.1039/b927258e; Crane MM, 2009, LAB CHIP, V9, P38, DOI 10.1039/b813730g; Hao JC, 2001, NEURON, V32, P25, DOI 10.1016/S0896-6273(01)00448-2; Hilliard MA, 2006, DEV CELL, V10, P379, DOI 10.1016/j.devcel.2006.01.013; Hobert O, 2005, SPECIFICATION NERVOU; Huang X, 2002, NEURON, V34, P563, DOI 10.1016/S0896-6273(02)00672-4; Jorgensen EM, 2002, NAT REV GENET, V3, P356, DOI 10.1038/nrg794; Kaletta T, 2006, NAT REV DRUG DISCOV, V5, P387, DOI 10.1038/nrd2031; Krajniak J, 2010, LAB CHIP, V10, P1862, DOI 10.1039/c001986k; Samara C, 2010, P NATL ACAD SCI USA, V107, P18342, DOI 10.1073/pnas.1005372107; Shaham S, 2006, S METHODS CELL BIOL; Shaham S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001117; Stirman JN, 2010, J NEUROSCI METH, V191, P90, DOI 10.1016/j.jneumeth.2010.05.019; Unger MA, 2000, SCIENCE, V288, P113, DOI 10.1126/science.288.5463.113; Zeng F, 2008, LAB CHIP, V8, P653, DOI 10.1039/b804808h	23	41	41	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35037	10.1371/journal.pone.0035037	http://dx.doi.org/10.1371/journal.pone.0035037			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536350	Green Submitted, Green Published, gold			2022-12-27	WOS:000305339200033
J	Gunnarsson, G; Latorre-Margalef, N; Hobson, KA; Van Wilgenburg, SL; Elmberg, J; Olsen, B; Fouchier, RAM; Waldenstrom, J				Gunnarsson, Gunnar; Latorre-Margalef, Neus; Hobson, Keith A.; Van Wilgenburg, Steven L.; Elmberg, Johan; Olsen, Bjorn; Fouchier, Ron A. M.; Waldenstrom, Jonas			Disease Dynamics and Bird Migration-Linking Mallards Anas platyrhynchos and Subtype Diversity of the Influenza A Virus in Time and Space	PLOS ONE			English	Article							AVIAN INFLUENZA; STABLE-HYDROGEN; AQUATIC BIRDS; LESSER SCAUP; INFECTION; DUCKS; SURVEILLANCE; POPULATIONS; WATERFOWL; ISOTOPES	The mallard Anas platyrhynchos is a reservoir species for influenza A virus in the northern hemisphere, with particularly high prevalence rates prior to as well as during its prolonged autumn migration. It has been proposed that the virus is brought from the breeding grounds and transmitted to conspecifics during subsequent staging during migration, and so a better understanding of the natal origin of staging ducks is vital to deciphering the dynamics of viral movement pathways. Ottenby is an important stopover site in southeast Sweden almost halfway downstream in the major Northwest European flyway, and is used by millions of waterfowl each year. Here, mallards were captured and sampled for influenza A virus infection, and positive samples were subtyped in order to study possible links to the natal area, which were determined by a novel approach combining banding recovery data and isotopic measurements (delta H-2) of feathers grown on breeding grounds. Geographic assignments showed that the core natal areas of studied mallards were in Estonia, southern and central Finland, and northwestern Russia. This study demonstrates a clear temporal succession of latitudes of natal origin during the course of autumn migration. We also demonstrate a corresponding and concomitant shift in virus subtypes. Acknowledging that these two different patterns were based in part upon different data, a likely interpretation worth further testing is that the early arriving birds with more proximate origins have different influenza A subtypes than the more distantly originating late autumn birds. If true, this knowledge would allow novel insight into the origins and transmission of the influenza A virus among migratory hosts previously unavailable through conventional approaches.	[Gunnarsson, Gunnar; Elmberg, Johan] Kristianstad Univ, Div Nat Sci, Kristianstad, Sweden; [Latorre-Margalef, Neus; Waldenstrom, Jonas] Linnaeus Univ, Sch Nat Sci, Sect Zoonot Ecol & Epidemiol, Kalmar, Sweden; [Hobson, Keith A.; Van Wilgenburg, Steven L.] Environm Canada, Wildlife & Landscape Sci, Saskatoon, SK, Canada; [Olsen, Bjorn] Univ Uppsala Hosp, Dept Med Sci, Infect Dis Sect, Uppsala, Sweden; [Fouchier, Ron A. M.] Erasmus MC, Dept Virol, Rotterdam, Netherlands	Kristianstad University; Linnaeus University; Environment & Climate Change Canada; Uppsala University; Uppsala University Hospital; Erasmus University Rotterdam; Erasmus MC	Gunnarsson, G (corresponding author), Kristianstad Univ, Div Nat Sci, Kristianstad, Sweden.	gunnar.gunnarsson@hkr.se	Hobson, Keith/Q-9306-2019; Elmberg, Johan/H-1868-2014; Gunnarsson, Gunnar/G-8458-2014; Waldenström, Jonas/E-4460-2013; Fouchier, Ron A/A-1911-2014	Gunnarsson, Gunnar/0000-0003-2345-3953; Waldenström, Jonas/0000-0002-1152-4235; Fouchier, Ron A/0000-0001-8095-2869; Olsen, Bjorn/0000-0002-4646-691X; Van Wilgenburg, Steven/0000-0002-6742-4567	Swedish Research Council Formas [2009-1220]; Swedish Environmental Protection Agency [09-210]; National Institute of Allergy and Infectious Diseases/National Institutes of Health, United States [HHSN266200700010C]	Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas); Swedish Environmental Protection Agency; National Institute of Allergy and Infectious Diseases/National Institutes of Health, United States(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was funded by the Swedish Research Council Formas (grant 2009-1220 to BO), the Swedish Environmental Protection Agency (grant 09-210 to JE), and the National Institute of Allergy and Infectious Diseases/National Institutes of Health, United States (contract HHSN266200700010C to RAMF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alerstam T, 1990, BIRD MIGRATION; Altizer S, 2011, SCIENCE, V331, P296, DOI 10.1126/science.1194694; Bakken V., 2003, NORWEGIAN BIRD RINGI; Bowen GJ, 2005, OECOLOGIA, V143, P337, DOI 10.1007/s00442-004-1813-y; Brochet AL, 2009, ECOHEALTH, V6, P449, DOI 10.1007/s10393-010-0275-4; Brown JD, 2007, AVIAN DIS, V51, P285, DOI 10.1637/7636-042806R.1; Brown JD, 2009, VET MICROBIOL, V136, P20, DOI 10.1016/j.vetmic.2008.10.027; Capua I, 2002, ACTA TROP, V83, P7, DOI 10.1016/S0001-706X(02)00057-8; Capua I, 2007, INFLUENZA OTHER RESP, V1, P11, DOI 10.1111/j.1750-2659.2006.00004.x; Chamberlain CP, 1997, OECOLOGIA, V109, P132, DOI 10.1007/s004420050067; Chen H, 2005, NATURE, V436, P191, DOI 10.1038/nature03974; Clark RG, 2006, CAN J ZOOL, V84, P1395, DOI 10.1139/Z06-135; Clark RG, 2009, CAN J ZOOL, V87, P553, DOI 10.1139/Z09-059; Costa TP, 2010, AVIAN DIS, V54, P581, DOI 10.1637/8692-031309-ResNote.1; Cramp S, 1977, BIRDS W PALEARCTIC C; Daoust PY, 2011, J WILDLIFE DIS, V47, P401, DOI 10.7589/0090-3558-47.2.401; Fereidouni SR, 2010, AVIAN DIS, V54, P79, DOI 10.1637/9005-073109-Reg.1; Fereidouni SR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006706; Fisher N., 1995, STAT ANAL CIRCULAR D; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Globig A, 2009, EMERG INFECT DIS, V15, P1633, DOI 10.3201/eid1510.090439; Guillemain M, 2005, IBIS, V147, P688, DOI 10.1111/j.1474-919X.2005.00446.x; Hirschfeld Axel, 2005, Berichte zum Vogelschutz, V42, P47; Hobson KA, 2008, TERR ECOL SER, V2, P1; Hobson KA, 1997, OECOLOGIA, V109, P142, DOI 10.1007/s004420050068; Hobson KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007915; Hoye BJ, 2012, P ROY SOC B-BIOL SCI, V279, P529, DOI 10.1098/rspb.2011.0958; Hoye BJ, 2011, OIKOS, V120, P748, DOI 10.1111/j.1600-0706.2010.18961.x; Jahangir A, 2008, AVIAN DIS, V52, P49, DOI 10.1637/8035-062507-Reg; Jourdain E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008935; Keawcharoen J, 2008, EMERG INFECT DIS, V14, P600, DOI 10.3201/eid1404.071016; Kilpatrick AM, 2006, P NATL ACAD SCI USA, V103, P19368, DOI 10.1073/pnas.0609227103; Kleijn D, 2010, P ROY SOC B-BIOL SCI, V277, P2041, DOI 10.1098/rspb.2010.0026; Krauss S, 2004, VECTOR-BORNE ZOONOT, V4, P177, DOI 10.1089/vbz.2004.4.177; Latorre-Margalef N, 2009, P ROY SOC B-BIOL SCI, V276, P1029, DOI 10.1098/rspb.2008.1501; Lebarbenchon C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026566; Lebarbenchon C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007289; Marra PP, 2004, BIOSCIENCE, V54, P393, DOI 10.1641/0006-3568(2004)054[0393:WNVAW]2.0.CO;2; Munster VJ, 2007, PLOS PATHOG, V3, P630, DOI 10.1371/journal.ppat.0030061; Newton I., 2010, BIRD MIGRATION; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Pettersson J, 2001, SVENSK RINGMARKNINGS; Prochazka P, 2011, J AVIAN BIOL, V42, P103, DOI 10.1111/j.1600-048X.2010.05161.x; Prosser DJ, 2009, IBIS, V151, P568, DOI 10.1111/j.1474-919X.2009.00932.x; Reperant LA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000854; Scott D.A., 1996, ATLAS ANATIDAE POPUL; SLATKIN M, 1985, ANNU REV ECOL SYST, V16, P393, DOI 10.1146/annurev.ecolsys.16.1.393; Sorensen T., 1948, K DAN VIDENSK SELSK, V5, P1; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; Stallknecht DE, 2010, AVIAN DIS, V54, P461, DOI 10.1637/8760-033109-Reg.1; Sturm-Ramirez KM, 2005, J VIROL, V79, P11269, DOI 10.1128/JVI.79.17.11269-11279.2005; SUSS J, 1994, ARCH VIROL, V135, P101, DOI 10.1007/BF01309768; van Gils JA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000184; Van Noordwijk, 2001, EURING EXCHANGE CODE; Van Wilgenburg SL, 2011, ECOL APPL, V21, P1340, DOI 10.1890/09-2047.1; Wallensten A, 2007, EMERG INFECT DIS, V13, P404, DOI 10.3201/eid1303.061130; Wassenaar LI, 2006, RAPID COMMUN MASS SP, V20, P2505, DOI 10.1002/rcm.2626; Webster MS, 2002, TRENDS ECOL EVOL, V17, P76, DOI 10.1016/S0169-5347(01)02380-1; Wunder MB, 2010, ISOSCAPES: UNDERSTANDING MOVEMENT, PATTERN, AND PROCESS ON EARTH THROUGH ISOTOPE MAPPING, P251, DOI 10.1007/978-90-481-3354-3_12; Yohannes E, 2008, OECOLOGIA, V158, P299, DOI 10.1007/s00442-008-1138-3	60	46	46	0	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35679	10.1371/journal.pone.0035679	http://dx.doi.org/10.1371/journal.pone.0035679			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536424	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339200096
J	Wang, W; Xiao, F; Zeng, XH; Yao, J; Ming, YC; Ding, JP				Wang, Wei; Xiao, Feng; Zeng, Xuhui; Yao, Jing; Ming Yuchi; Ding, Jiuping			Optimal Estimation of Ion-Channel Kinetics from Macroscopic Currents	PLOS ONE			English	Article							GENETIC-ALGORITHM	Markov modeling provides an effective approach for modeling ion channel kinetics. There are several search algorithms for global fitting of macroscopic or single-channel currents across different experimental conditions. Here we present a particle swarm optimization(PSO)-based approach which, when used in combination with golden section search (GSS), can fit macroscopic voltage responses with a high degree of accuracy (errors within 1%) and reasonable amount of calculation time (less than 10 hours for 20 free parameters) on a desktop computer. We also describe a method for initial value estimation of the model parameters, which appears to favor identification of global optimum and can further reduce the computational cost. The PSO-GSS algorithm is applicable for kinetic models of arbitrary topology and size and compatible with common stimulation protocols, which provides a convenient approach for establishing kinetic models at the macroscopic level.	[Wang, Wei; Yao, Jing; Ding, Jiuping] Huazhong Univ Sci & Technol, Minist Educ, Key Lab Mol Biophys, Sch Life Sci & Technol, Wuhan 430074, Hubei, Peoples R China; [Xiao, Feng; Ming Yuchi] Huazhong Univ Sci & Technol, Minist Educ, Key Lab Image Proc & Intelligent Control, Sch Life Sci & Technol, Wuhan 430074, Hubei, Peoples R China; [Zeng, Xuhui] Nanchang Univ, Inst Life Sci, Nanchang, Jiangxi, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Nanchang University	Ming, YC (corresponding author), Huazhong Univ Sci & Technol, Minist Educ, Key Lab Mol Biophys, Sch Life Sci & Technol, Wuhan 430074, Hubei, Peoples R China.	m.yuchi@mail.hust.edu.cn; jpding@mail.hust.edu.cn	Yuchi, Ming/AHB-9595-2022	Yuchi, Ming/0000-0003-1506-0631	National Basic Research Program of China [2010CB529804, 2011CB933103]; National Science Foundation of China [30971179, 31170814, 31028006, 31070767, 31171116, 61001141]; Research Fund for the Doctoral Program of Higher Education of China [20090142120091]; Fundamental Research Funds for the Central Universities', HUST [2010ZD028, 2010MS038, 2010QN050, 2011TS086]	National Basic Research Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Fundamental Research Funds for the Central Universities', HUST(Fundamental Research Funds for the Central Universities)	This work was supported by grants from the National Basic Research Program of China (2010CB529804, 2011CB933103), the National Science Foundation of China (30971179, 31170814, 31028006, 31070767, 31171116, 61001141), the Research Fund for the Doctoral Program of Higher Education of China (20090142120091) and the Fundamental Research Funds for the Central Universities', HUST (2010ZD028, 2010MS038, 2010QN050, 2011TS086). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	COELLO CAC, 2000, INT J SMART ENG SYST, V2, P299; Colquhoun D, 2004, BIOPHYS J, V86, P3510, DOI 10.1529/biophysj.103.038679; Cox DH, 1997, J GEN PHYSIOL, V110, P257, DOI 10.1085/jgp.110.3.257; Gurkiewicz M, 2007, PLOS COMPUT BIOL, V3, P1633, DOI 10.1371/journal.pcbi.0030169; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Horrigan FT, 1999, J GEN PHYSIOL, V114, P277, DOI 10.1085/jgp.114.2.277; Kennedy J., 1995, 1995 IEEE International Conference on Neural Networks Proceedings (Cat. No.95CH35828), P1942, DOI 10.1109/ICNN.1995.488968; Kewley RH, 2002, IEEE T SYST MAN CY C, V32, P161, DOI 10.1109/TSMCC.2002.801352; KIEFER J, 1953, P AM MATH SOC, V4, P502, DOI 10.2307/2032161; Lo CC, 2000, IEEE T SYST MAN CY B, V30, P461, DOI 10.1109/3477.846234; Lovbjerg M., 2001, P GEN EV COMP C GECC; Milescu LS, 2005, BIOPHYS J, V88, P2494, DOI 10.1529/biophysj.104.053256; Miller J. F., 2000, GENET PROGRAM EVOLVA, V1, P8, DOI DOI 10.1023/A:1010016313373; Qin F, 2000, BIOPHYS J, V79, P1915, DOI 10.1016/S0006-3495(00)76441-1; Qin F, 1996, BIOPHYS J, V70, P264, DOI 10.1016/S0006-3495(96)79568-1; Sakmann B, 1995, SINGLE CHANNEL RECOR, P589; Shi YH, 1998, IEEE C EVOL COMPUTAT, P69, DOI 10.1109/ICEC.1998.699146; Sun L, 2009, BIOPHYS J, V97, P1832, DOI 10.1016/j.bpj.2009.06.042; Wang L, 1997, J PARALLEL DISTR COM, V47, P8, DOI 10.1006/jpdc.1997.1392; Xia XM, 2000, J NEUROSCI, V20, P4890; Xunxue Cui, 2004, Fifth World Congress on Intelligent Control and Automation (IEEE Cat. No.04EX788), P2117; Zhao XC, 2010, APPL SOFT COMPUT, V10, P119, DOI 10.1016/j.asoc.2009.06.010; Zhou XX, 1999, IEE P-GENER TRANSM D, V146, P301, DOI 10.1049/ip-gtd:19990047	23	9	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35208	10.1371/journal.pone.0035208	http://dx.doi.org/10.1371/journal.pone.0035208			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536358	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339200044
J	Drummond, SPA; Anderson, DE; Straus, LD; Vogel, EK; Perez, VB				Drummond, Sean P. A.; Anderson, Dane E.; Straus, Laura D.; Vogel, Edward K.; Perez, Veronica B.			The Effects of Two Types of Sleep Deprivation on Visual Working Memory Capacity and Filtering Efficiency	PLOS ONE			English	Article							SHORT-TERM-MEMORY; INDIVIDUAL-DIFFERENCES; PREFRONTAL CORTEX; NEURAL BASIS; PERFORMANCE; TASK; ATTENTION; COST; DISTRACTION; VARIABILITY	Sleep deprivation has adverse consequences for a variety of cognitive functions. The exact effects of sleep deprivation, though, are dependent upon the cognitive process examined. Within working memory, for example, some component processes are more vulnerable to sleep deprivation than others. Additionally, the differential impacts on cognition of different types of sleep deprivation have not been well studied. The aim of this study was to examine the effects of one night of total sleep deprivation and 4 nights of partial sleep deprivation (4 hours in bed/night) on two components of visual working memory: capacity and filtering efficiency. Forty-four healthy young adults were randomly assigned to one of the two sleep deprivation conditions. All participants were studied: 1) in a well-rested condition (following 6 nights of 9 hours in bed/night); and 2) following sleep deprivation, in a counter-balanced order. Visual working memory testing consisted of two related tasks. The first measured visual working memory capacity and the second measured the ability to ignore distractor stimuli in a visual scene (filtering efficiency). Results showed neither type of sleep deprivation reduced visual working memory capacity. Partial sleep deprivation also generally did not change filtering efficiency. Total sleep deprivation, on the other hand, did impair performance in the filtering task. These results suggest components of visual working memory are differentially vulnerable to the effects of sleep deprivation, and different types of sleep deprivation impact visual working memory to different degrees. Such findings have implications for operational settings where individuals may need to perform with inadequate sleep and whose jobs involve receiving an array of visual information and discriminating the relevant from the irrelevant prior to making decisions or taking actions (e. g., baggage screeners, air traffic controllers, military personnel, health care providers).	[Drummond, Sean P. A.] VA San Diego Healthcare Syst, Psychol Serv, San Diego, CA USA; [Drummond, Sean P. A.; Anderson, Dane E.; Straus, Laura D.] VA San Diego Healthcare Syst, Res Serv, San Diego, CA USA; [Drummond, Sean P. A.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA; [Drummond, Sean P. A.; Straus, Laura D.] SDSU UCSD, Joint Doctoral Program Clin Psychol, San Diego, CA USA; [Vogel, Edward K.] Univ Oregon, Dept Psychol, Eugene, OR 97403 USA; [Perez, Veronica B.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego; University of Oregon; University of California System; University of California San Francisco	Drummond, SPA (corresponding author), VA San Diego Healthcare Syst, Psychol Serv, San Diego, CA USA.	drummond@ucsd.edu	Vogel, Edward K/AAW-9466-2021	Drummond, Sean/0000-0002-9815-626X	National Science Foundation [0729021]; VA San Diego Healthcare System Center for Excellence in Stress and Mental Health; Direct For Social, Behav & Economic Scie [0729021] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); VA San Diego Healthcare System Center for Excellence in Stress and Mental Health(US Department of Veterans Affairs); Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	This work was supported by a grant from the National Science Foundation (www.nsf.gov; award #0729021 to SPAD). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Lesley Wetherell for support with IT issues related to collection and processing of data, and Ryan Wong for assistance coordinating the project. We would also like to thank the VA San Diego Healthcare System Center for Excellence in Stress and Mental Health for support.	Anderson BA, 2011, P NATL ACAD SCI USA, V108, P10367, DOI 10.1073/pnas.1104047108; Anticevic A, 2011, BIOL PSYCHIAT; Awh E, 2007, PSYCHOL SCI, V18, P622, DOI 10.1111/j.1467-9280.2007.01949.x; Broadway JM, 2010, BEHAV RES METHODS, V42, P563, DOI 10.3758/BRM.42.2.563; Burgess GC, 2011, J EXPT PSYCHOL GEN; Chee MWL, 2007, P NATL ACAD SCI USA, V104, P9487, DOI 10.1073/pnas.0610712104; Chee MWL, 2004, J NEUROSCI, V24, P4560, DOI 10.1523/JNEUROSCI.0007-04.2004; Chen Z, 2000, PERCEPT PSYCHOPHYS, V62, P482, DOI 10.3758/BF03212100; Chuah YML, 2006, J NEUROSCI, V26, P7156, DOI 10.1523/JNEUROSCI.0906-06.2006; Clapp WC, 2010, CEREB CORTEX, V20, P859, DOI 10.1093/cercor/bhp150; Cohen J.E., 1988, STAT POWER ANAL BEHA; Conway ARA, 2003, TRENDS COGN SCI, V7, P547, DOI 10.1016/j.tics.2003.10.005; Cowan N, 2005, COGNITIVE PSYCHOL, V51, P42, DOI 10.1016/j.cogpsych.2004.12.001; Cowan N, 2001, BEHAV BRAIN SCI, V24, P87, DOI 10.1017/S0140525X01003922; Dinges DF, 1997, SLEEP, V20, P267; DINGES DF, 1985, BEHAV RES METH INSTR, V17, P652, DOI 10.3758/BF03200977; Dolcos F, 2007, BRAIN RES, V1152, P171, DOI 10.1016/j.brainres.2007.03.059; Doran SM, 2001, ARCH ITAL BIOL, V139, P253; Drummond SPA, 2004, SLEEP, V27, P445; Drummond SPA, 1999, NEUROREPORT, V10, P3745, DOI 10.1097/00001756-199912160-00004; Drummond SPA, 2001, NEUROPSYCHOPHARMACOL, V25, pS68, DOI 10.1016/S0893-133X(01)00325-6; Drummond SPA, 2001, J SLEEP RES, V10, P85, DOI 10.1046/j.1365-2869.2001.00245.x; Drummond SPA, 2005, SLEEP, V28, P1059; Frey DJ, 2004, J SLEEP RES, V13, P305, DOI 10.1111/j.1365-2869.2004.00429.x; Fukuda K, 2011, PSYCHOL SCI, V22, P361, DOI 10.1177/0956797611398493; Fukuda K, 2010, PSYCHON B REV, V17, P673, DOI 10.3758/17.5.673; Fukuda K, 2009, J NEUROSCI, V29, P8726, DOI 10.1523/JNEUROSCI.2145-09.2009; KAHNEMAN D, 1983, J EXP PSYCHOL HUMAN, V9, P510, DOI 10.1037/0096-1523.9.4.510; Kurtz Matthew M, 2006, Expert Rev Neurother, V6, P47, DOI 10.1586/14737175.6.1.47; Mcnab F, 2008, NAT NEUROSCI, V11, P103, DOI 10.1038/nn2024; PASHLER H, 1988, PERCEPT PSYCHOPHYS, V44, P369, DOI 10.3758/BF03210419; Raidy DJ, 2005, PERCEPT MOTOR SKILL, V101, P451, DOI 10.2466/pms.101.2.451-467; Smith K, 2002, MANAGE SCI, V48, P711, DOI 10.1287/mnsc.48.6.711.194; Todd JJ, 2004, NATURE, V428, P751, DOI 10.1038/nature02466; Toepper M, 2010, NEUROSCIENCE, V165, P1244, DOI 10.1016/j.neuroscience.2009.11.019; Turner TH, 2007, NEUROPSYCHOLOGY, V21, P787, DOI 10.1037/0894-4105.21.6.787; Van Dongen HPA, 2003, SLEEP, V26, P117, DOI 10.1093/sleep/26.2.117; Vandewalle G, 2009, J NEUROSCI, V29, P7948, DOI 10.1523/JNEUROSCI.0229-09.2009; Vogel EK, 2005, NATURE, V438, P500, DOI 10.1038/nature04171; Vogel EK, 2004, NATURE, V428, P748, DOI 10.1038/nature02447; Vogel EK, 2001, J EXP PSYCHOL HUMAN, V27, P92, DOI 10.1037/0096-1523.27.1.92; Yoon JH, 2006, NEUROIMAGE, V29, P1117, DOI 10.1016/j.neuroimage.2005.08.024	42	62	63	1	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35653	10.1371/journal.pone.0035653	http://dx.doi.org/10.1371/journal.pone.0035653			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959XD	22530064	Green Published, gold			2022-12-27	WOS:000305350600110
J	Liu, L; Feng, TY; Suo, T; Lee, K; Li, H				Liu, Lei; Feng, Tingyong; Suo, Tao; Lee, Kang; Li, Hong			Adapting to the Destitute Situations: Poverty Cues Lead to Short-Term Choice	PLOS ONE			English	Article							SOCIAL-CLASS; INEQUALITY; IMPATIENCE; DECISION; REWARDS; MONEY; DELAY	Background: Why do some people live for the present, whereas others save for the future? The evolutionary framework of life history theory predicts that preference for delay of gratification should be influenced by social economic status (SES). However, here we propose that the decision to choose alternatives in immediate and delayed gratification in poverty environments may have a psychological dimension. Specifically, the perception of environmental poverty cues may induce people alike to favor choices with short-term, likely smaller benefit than choices with long-term, greater benefit. Methodology/Principal Findings: The present study was conducted to explore how poverty and affluence cues affected individuals' intertemporal choices. In our first two experiments, individuals exposed explicitly (Experiment 1) and implicitly (Experiment 2) to poverty pictures (the poverty cue) were induced to prefer immediate gratification compared with those exposed to affluence pictures (the affluence cue). Furthermore, by the manipulation of temporary perceptions of poverty and affluence status using a lucky draw game; individuals in the poverty state were more impulsive in a manner, which made them pursue immediate gratification in intertemporal choices (Experiment 3). Thus, poverty cues can lead to short-term choices. Conclusions/Significance: Decision makers chose more frequently the sooner-smaller reward over the later-larger reward as they were exposed to the poverty cue. This indicates that it is that just the feeling of poverty influences intertemporal choice - the actual reality of poverty (restricted resources, etc.) is not necessary to get the effect. Furthermore, our findings emphasize that it is a change of the poverty-affluence status, not a trait change, can influence individual preference in intertemporal choice.	[Liu, Lei; Feng, Tingyong; Suo, Tao; Li, Hong] Southwest Univ, Sch Psychol, Chongqing, Peoples R China; [Feng, Tingyong; Li, Hong] Minist Educ, Key Lab Cognit & Personal, Chongqing, Peoples R China; [Lee, Kang] Univ Toronto, Inst Child Study, Toronto, ON, Canada; [Li, Hong] Liaoning Normal Univ, Sch Educ, Dalian, Peoples R China	Southwest University - China; University of Toronto; Liaoning Normal University	Liu, L (corresponding author), Southwest Univ, Sch Psychol, Chongqing, Peoples R China.	fengty0@163.com		Feng, Tingyong/0000-0001-9278-6474	National Natural Science Foundation of China [30800292]; National Key Discipline of Basic Psychology in Southwest University of China [NSKD08007]; Fundamental Research Funds for the Central Universities [SWU1109009]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Discipline of Basic Psychology in Southwest University of China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study was supported by the National Natural Science Foundation of China (30800292), the National Key Discipline of Basic Psychology in Southwest University of China (NSKD08007) and the Fundamental Research Funds for the Central Universities (SWU1109009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger J, 2008, P NATL ACAD SCI USA, V105, P8846, DOI 10.1073/pnas.0711988105; Cacioppo JT, 1999, ANNU REV PSYCHOL, V50, P191, DOI 10.1146/annurev.psych.50.1.191; Christie AM, 2010, J APPL PSYCHOL, V95, P920, DOI 10.1037/a0019856; De Martino B, 2006, SCIENCE, V313, P684, DOI 10.1126/science.1128356; Delplanque S, 2005, BIOL PSYCHOL, V68, P107, DOI 10.1016/j.biopsycho.2004.04.006; Fehr E, 2002, NATURE, V415, P269, DOI 10.1038/415269a; Frederick S, 2002, J ECON LIT, V40, P351, DOI 10.1257/002205102320161311; Green L, 2004, PSYCHOL BULL, V130, P769, DOI 10.1037/0033-2909.130.5.769; Griskevicius V, 2011, J PERS SOC PSYCHOL, V100, P1015, DOI 10.1037/a0022403; Hackman DA, 2009, TRENDS COGN SCI, V13, P65, DOI 10.1016/j.tics.2008.11.003; Haisley E, 2008, J BEHAV DECIS MAKING, V21, P283, DOI 10.1002/bdm.588; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kraus MW, 2010, PSYCHOL SCI, V21, P1716, DOI 10.1177/0956797610387613; Kraus MW, 2009, J PERS SOC PSYCHOL, V97, P992, DOI 10.1037/a0016357; Lipina S. J., 2005, INTERAM J PSYCHOL, V39, P49; Luhmann CC, 2008, J NEUROSCI, V28, P14459, DOI 10.1523/JNEUROSCI.5058-08.2008; MAZUR JE, 1989, J EXP ANAL BEHAV, V51, P87, DOI 10.1901/jeab.1989.51-87; McClure SM, 2004, SCIENCE, V306, P503, DOI 10.1126/science.1100907; Oakes JM, 2003, SOC SCI MED, V56, P796; Piff PK, 2010, J PERS SOC PSYCHOL, V99, P771, DOI 10.1037/a0020092; Singh-Manoux A, 2005, ANN EPIDEMIOL, V15, P572, DOI 10.1016/j.annepidem.2004.10.007; Snibbe AC, 2005, J PERS SOC PSYCHOL, V88, P703, DOI 10.1037/0022-3514.88.4.703; Sprengelmeyer R, 2006, NEUROPSYCHOLOGIA, V44, P2899, DOI 10.1016/j.neuropsychologia.2006.06.020; Stevens JR, 2010, ENCY ANIMAL BEHAV; Tricomi E, 2010, NATURE, V463, P1089, DOI 10.1038/nature08785; Vohs KD, 2006, SCIENCE, V314, P1154, DOI 10.1126/science.1132491; Wilkinson Richard G, 2000, MIND GAP HIERARCHIES; Wood M, 1998, J ECON PSYCHOL, V19, P295, DOI 10.1016/S0167-4870(98)00009-9; Yuan JJ, 2009, HUM BRAIN MAPP, V30, P3676, DOI 10.1002/hbm.20796; Zhong CB, 2010, PSYCHOL SCI, V21, P619, DOI 10.1177/0956797610366090; Zhou XY, 2009, PSYCHOL SCI, V20, P700, DOI 10.1111/j.1467-9280.2009.02353.x	31	29	36	5	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e33950	10.1371/journal.pone.0033950	http://dx.doi.org/10.1371/journal.pone.0033950			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959XD	22529902	Green Published, gold, Green Submitted			2022-12-27	WOS:000305350600009
J	Novakova, L; Bojanowski, V; Havlicek, J; Croy, I				Novakova, Lenka; Bojanowski, Viola; Havlicek, Jan; Croy, Ilona			Differential Patterns of Food Appreciation during Consumption of a Simple Food in Congenitally Anosmic Individuals: An Explorative Study	PLOS ONE			English	Article							SENSORY-SPECIFIC SATIETY; OLFACTORY DYSFUNCTION; HUMAN BRAIN; SATIATION; IMPACT; TASTE; PLEASANTNESS; DISORDERS; QUALITY; HUMANS	Food is evaluated for various attributes. One of the key food evaluation domains is hedonicity. As food is consumed, its hedonic valence decreases (due to prolonged sensory stimulation) and hedonic habituation results. The aim of the present study was to investigate changes in food pleasantness ratings during consumption of a simple food by individuals without olfactory experience with food as compared to normosmics. 15 congenital anosmics and 15 normosmic controls were each presented with ten 10 g banana slices. Each was visually inspected, then smelled and chewed for ten seconds and subsequently rated for hedonicity on a 21-point scale. There was a significant difference in pleasantness ratings between congenital anosmics and controls (F(1, 26) = 6.71, p =.02) with the anosmics exhibiting higher ratings than the controls, a significant main repeated-measures effect on the ratings (F(1.85, 48) = 12.15, p<.001), which showed a decreasing trend over the course of consumption, as well as a significant portion* group interaction (F(1.85, 48) = 3.54, p = .04), with the anosmic participants experiencing a less pronounced decline. The results of the present explorative study suggest that over the course of consumption of a simple food, congenitally anosmic individuals experience differential patterns of appreciation of food as compared to normosmics. In this particular case, the decrease of hedonic valence was less pronounced in congenital anosmics.	[Novakova, Lenka; Havlicek, Jan] Charles Univ Prague, Fac Humanities, Dept Anthropol, Prague, Czech Republic; [Bojanowski, Viola; Croy, Ilona] Univ Dresden, Sch Med, Dept Otorhinolaryngol, Interdisciplinary Ctr Smell & Taste Res, Dresden, Germany	Charles University Prague; Technische Universitat Dresden	Novakova, L (corresponding author), Charles Univ Prague, Fac Humanities, Dept Anthropol, Prague, Czech Republic.	lenka.novakova@fhs.cuni.cz	Havlíček, Jan/F-8985-2011; Martinec Nováková, Lenka/F-6474-2015	Havlíček, Jan/0000-0003-2374-7337; Martinec Nováková, Lenka/0000-0002-5695-2903; Croy, Ilona/0000-0002-0361-5559	Grant Agency of the Charles University [GAUK 6010]; Czech Science Foundation [GACR P407/10/1303]; Czech Ministry of Education [MSM 0021620843]	Grant Agency of the Charles University; Czech Science Foundation(Grant Agency of the Czech Republic); Czech Ministry of Education(Ministry of Education, Youth & Sports - Czech Republic)	The study was supported by the Grant Agency of the Charles University (GAUK 6010), Czech Science Foundation (GACR P407/10/1303) and the Czech Ministry of Education (MSM 0021620843). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aschenbrenner K, 2008, J PSYCHIATR RES, V43, P129, DOI 10.1016/j.jpsychires.2008.03.003; Blundell J, 2010, OBES REV, V11, P251, DOI 10.1111/j.1467-789X.2010.00714.x; DAVIDSON TM, 1987, WESTERN J MED, V146, P434; de Araujo IET, 2003, EUR J NEUROSCI, V18, P2059, DOI 10.1046/j.1460-9568.2003.02915.x; FERRIS AM, 1989, ANN NY ACAD SCI, V561, P113, DOI 10.1111/j.1749-6632.1989.tb20975.x; Gottfried JA, 2003, NEURON, V39, P375, DOI 10.1016/S0896-6273(03)00392-1; Graaf C. de, 2005, Food, diet and obesity, P137, DOI 10.1533/9781845690840.1.137; Havermans RC, 2010, CHEM SENSES, V35, P735, DOI 10.1093/chemse/bjq074; HENION KE, 1971, J EXP PSYCHOL, V90, P275, DOI 10.1037/h0031549; HETHERINGTON M, 1989, APPETITE, V12, P57, DOI 10.1016/0195-6663(89)90068-8; Kringelbach ML, 2004, NEUROSCIENCE, V126, P807, DOI 10.1016/j.neuroscience.2004.04.035; Lawless H. T., 1998, SENSORY EVALUATION F; MATTES RD, 1990, AM J CLIN NUTR, V51, P233, DOI 10.1093/ajcn/51.2.233; Mela DJ, 2006, APPETITE, V47, P10, DOI 10.1016/j.appet.2006.02.006; Miwa T, 2001, ARCH OTOLARYNGOL, V127, P497, DOI 10.1001/archotol.127.5.497; Morrot G, 2001, BRAIN LANG, V79, P309, DOI 10.1006/brln.2001.2493; Nordin S, 2000, INT J PSYCHOL, V35, P108; ROLLS BJ, 1981, PHYSIOL BEHAV, V27, P137, DOI 10.1016/0031-9384(81)90310-3; Rolls ET, 1997, PHYSIOL BEHAV, V61, P461, DOI 10.1016/S0031-9384(96)00464-7; Ruijschop RMAJ, 2010, CHEM SENSES, V35, P91, DOI 10.1093/chemse/bjp086; Steiner JE, 2001, NEUROSCI BIOBEHAV R, V25, P53, DOI 10.1016/S0149-7634(00)00051-8; Stevenson RJ, 2010, CHEM SENSES, V35, P3, DOI 10.1093/chemse/bjp083; Temmel AFP, 2002, ARCH OTOLARYNGOL, V128, P635, DOI 10.1001/archotol.128.6.635; Van Toller S, 1999, CHEM SENSES, V24, P705, DOI 10.1093/chemse/24.6.705; Vickers Z, 2001, FOOD QUAL PREFER, V12, P521, DOI 10.1016/S0950-3293(01)00047-7; Weijzen PLG, 2009, BRIT J NUTR, V102, P1091, DOI 10.1017/S000711450932574X; Yeomans MR, 2010, CHEMOSENS PERCEPT, V3, P34, DOI 10.1007/s12078-009-9052-6; Yeomans MR, 1996, APPETITE, V27, P119, DOI 10.1006/appe.1996.0040; Zandstra EH, 1999, FOOD QUAL PREFER, V10, P411, DOI 10.1016/S0950-3293(98)00050-0; Zijlstra N, 2009, AM J CLIN NUTR, V90, P269, DOI 10.3945/ajcn.2009.27694	30	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e33921	10.1371/journal.pone.0033921	http://dx.doi.org/10.1371/journal.pone.0033921			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529901	gold, Green Submitted, Green Published			2022-12-27	WOS:000305350600008
J	Rigo, A; Gottardi, M; Damiani, E; Bonifacio, M; Ferrarini, I; Mauri, P; Vinante, F				Rigo, Antonella; Gottardi, Michele; Damiani, Ernesto; Bonifacio, Massimiliano; Ferrarini, Isacco; Mauri, Pierluigi; Vinante, Fabrizio			CXCL12 and [N33A]CXCL12 in 5637 and HeLa Cells: Regulating HER1 Phosphorylation via Calmodulin/Calcineurin	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; 7-TRANSMEMBRANE RECEPTORS; DIPHTHERIA-TOXIN; CANCER GROWTH; CXCR4; ACTIVATION; EXPRESSION; EGF; DIFFERENTIATION; DOWNSTREAM	In the human neoplastic cell lines 5637 and HeLa, recombinant CXCL12 elicited, as expected, downstream signals via both G-protein-dependent and beta-arrestin-dependent pathways responsible for inducing a rapid and a late wave, respectively, of ERK1/2 phosphorylation. In contrast, the structural variant [N33A]CXCL12 triggered no beta-arrestin-dependent phosphorylation of ERK1/2, and signaled via G protein-dependent pathways alone. Both CXCL12 and [N33A]CXCL12, however, generated signals that transinhibited HER1 phosphorylation via intracellular pathways. 1) Prestimulation of CXCR4/HER1-positive 5637 or HeLa cells with CXCL12 modified the HB-EGF-dependent activation of HER1 by delaying the peak phosphorylation of tyrosine 1068 or 1173. 2) Prestimulation with the synthetic variant [N33A]CXCL12, while preserving CXCR4-related chemotaxis and CXCR4 internalization, abolished HER1 phosphorylation. 3) In cells knockdown of beta-arrestin 2, CXCL12 induced a full inhibition of HER1 like [N33A]CXCL12 in non-silenced cells. 4) HER1 phosphorylation was restored as usual by inhibiting PCK, calmodulin or calcineurin, whereas the inhibition of CaMKII had no discernable effect. We conclude that both recombinant CXCL12 and its structural variant [N33A]CXCL12 may transinhibit HER1 via G-proteins/calmodulin/calcineurin, but [N33A]CXCL12 does not activate beta-arrestin-dependent ERK1/2 phosphorylation and retains a stronger inhibitory effect. Therefore, we demonstrated that CXCL12 may influence the magnitude and the persistence of signaling downstream of HER1 in turn involved in the proliferative potential of numerous epithelial cancer. In addition, we recognized that [N33A]CXCL12 activates preferentially G-protein-dependent pathways and is an inhibitor of HER1.	[Rigo, Antonella; Gottardi, Michele; Bonifacio, Massimiliano; Ferrarini, Isacco; Vinante, Fabrizio] Univ Verona, Sect Hematol, Dept Med, I-37100 Verona, Italy; [Damiani, Ernesto] Univ Padua, Dept Expt Biomed Sci, Padua, Italy; [Mauri, Pierluigi] CNR, Inst Biomed Technol, Prote & Metabol Unit, I-20133 Milan, Italy	University of Verona; University of Padua; Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR)	Rigo, A (corresponding author), Univ Verona, Sect Hematol, Dept Med, I-37100 Verona, Italy.	fabrizio.vinante@univr.it	Mauri, Pietro Luigi/AAC-3095-2019; damiani, ernesto/J-6060-2012; damiani, ernesto/AAI-5709-2020; Bonifacio, Massimiliano/AAL-4520-2020	Mauri, Pietro Luigi/0000-0003-4364-0393; damiani, ernesto/0000-0002-9557-6496; damiani, ernesto/0000-0002-9557-6496; Bonifacio, Massimiliano/0000-0003-0716-1686; Gottardi, Michele/0000-0003-0704-6979; Vinante, Fabrizio/0000-0002-3855-6747	Italian Association for Cancer Research (AIRC, Milan, Italy)/Cariverona Foundation (Verona, Italy); Venetian Institute of Oncology (IOV, Padua, Italy)	Italian Association for Cancer Research (AIRC, Milan, Italy)/Cariverona Foundation (Verona, Italy)(Fondazione AIRC per la ricerca sul cancro); Venetian Institute of Oncology (IOV, Padua, Italy)	This work was supported by grants from the Italian Association for Cancer Research (AIRC, Milan, Italy)/Cariverona Foundation (Verona, Italy) and from the Venetian Institute of Oncology (IOV, Padua, Italy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreev J, 2001, J BIOL CHEM, V276, P20130, DOI 10.1074/jbc.M102307200; Baribaud F, 2001, J VIROL, V75, P8957, DOI 10.1128/JVI.75.19.8957-8967.2001; Cabioglu N, 2005, CANCER RES, V65, P6493, DOI 10.1158/0008-5472.CAN-04-1303; D'Ambrosio D, 2002, J IMMUNOL, V169, P2303, DOI 10.4049/jimmunol.169.5.2303; Daub H, 1996, NATURE, V379, P557, DOI 10.1038/379557a0; Dealwis C, 1998, P NATL ACAD SCI USA, V95, P6941, DOI 10.1073/pnas.95.12.6941; Duda DG, 2011, CLIN CANCER RES, V17, P2074, DOI 10.1158/1078-0432.CCR-10-2636; Guo L, 2003, J AM SOC MASS SPECTR, V14, P1022, DOI 10.1016/S1044-0305(03)00206-X; HIGASHIYAMA S, 1991, SCIENCE, V251, P936, DOI 10.1126/science.1840698; Kim S, 2009, NATURE, V457, P36; Koizumi K, 2007, CANCER SCI, V98, P1652, DOI 10.1111/j.1349-7006.2007.00606.x; Krampera M, 2005, BLOOD, V106, P59, DOI 10.1182/blood-2004-09-3645; Kryczek I, 2007, AM J PHYSIOL-CELL PH, V292, pC987, DOI 10.1152/ajpcell.00406.2006; Lefkowitz RJ, 2007, ACTA PHYSIOL, V190, P9, DOI 10.1111/j.1365-201X.2007.01693.x; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Li HB, 2004, BIOCHEM J, V381, P257, DOI 10.1042/BJ20040515; Li YM, 2004, CANCER CELL, V6, P459, DOI 10.1016/j.ccr.2004.09.027; Mahtouk K, 2005, ONCOGENE, V24, P3512, DOI 10.1038/sj.onc.1208536; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Mantovani A, 2010, CANCER CELL, V17, P111, DOI 10.1016/j.ccr.2010.01.019; Mauri P, 2003, BIOL CHEM, V384, P575, DOI 10.1515/BC.2003.065; McCormick PJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008102; Moll NM, 2010, EXPERT REV HEMATOL, V3, P315, DOI 10.1586/EHM.10.16; Montresor A, 2009, CANCER RES, V69, P9281, DOI 10.1158/0008-5472.CAN-09-2009; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Reiter E, 2012, ANNU REV PHARMACOL, V52, P179, DOI 10.1146/annurev.pharmtox.010909.105800; Rigo A, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-273; Saito T, 2004, ENDOCRINOLOGY, V145, P4232, DOI 10.1210/en.2004-0401; Sanchez-Martin L, 2011, BLOOD, V117, P88, DOI 10.1182/blood-2009-12-258186; Sengupta P, 2007, J BIOL CHEM, V282, P8474, DOI 10.1074/jbc.M607211200; Shenoy SK, 2011, TRENDS PHARMACOL SCI, V32, P521, DOI 10.1016/j.tips.2011.05.002; Shepard HM, 2008, J CLIN INVEST, V118, P3574, DOI 10.1172/JCI36049; Shukla AK, 2008, P NATL ACAD SCI USA, V105, P9988, DOI 10.1073/pnas.0804246105; Shukla AK, 2011, TRENDS BIOCHEM SCI, V36, P457, DOI 10.1016/j.tibs.2011.06.003; Singh RK, 2011, CANCER RES, V71, P3268, DOI 10.1158/0008-5472.CAN-10-2769; Solinas G, 2009, J LEUKOCYTE BIOL, V86, P1065, DOI 10.1189/jlb.0609385; Sun Y, 2002, J BIOL CHEM, V277, P49212, DOI 10.1074/jbc.M207294200; Tan Y, 2006, EXP HEMATOL, V34, P1553, DOI 10.1016/j.exphem.2006.07.001; Thalappilly S, 2010, ONCOGENE, V29, P2528, DOI 10.1038/onc.2010.1; Thelen M, 2008, J NEUROIMMUNOL, V198, P9, DOI 10.1016/j.jneuroim.2008.04.020; Tilley DG, 2009, J BIOL CHEM, V284, P20375, DOI 10.1074/jbc.M109.005793; Ueda H, 1997, J BIOL CHEM, V272, P24966, DOI 10.1074/jbc.272.40.24966; Vinante F, 1999, BLOOD, V93, P1715, DOI 10.1182/blood.V93.5.1715.405k26_1715_1723; Vinante F, 2002, BLOOD, V99, P52, DOI 10.1182/blood.V99.1.52; Vinante F, 1999, BLOOD, V94, P3169, DOI 10.1182/blood.V94.9.3169.421k30_3169_3177; Whalen EJ, 2011, TRENDS MOL MED, V17, P126, DOI 10.1016/j.molmed.2010.11.004; Xiao KH, 2010, P NATL ACAD SCI USA, V107, P15299, DOI 10.1073/pnas.1008461107; Zandstra PW, 2000, BLOOD, V96, P1215, DOI 10.1182/blood.V96.4.1215.h8001215_1215_1222	48	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e34432	10.1371/journal.pone.0034432	http://dx.doi.org/10.1371/journal.pone.0034432			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529914	gold, Green Published, Green Submitted			2022-12-27	WOS:000305350600014
J	Ritchie, ML; Romanuk, TN				Ritchie, Marina L.; Romanuk, Tamara N.			A Meta-Analysis of Probiotic Efficacy for Gastrointestinal Diseases	PLOS ONE			English	Article							IRRITABLE-BOWEL-SYNDROME; ANTIBIOTIC-ASSOCIATED DIARRHEA; CLOSTRIDIUM-DIFFICILE DISEASE; LACTOBACILLUS-PLANTARUM 299V; PLACEBO-CONTROLLED TRIALS; DOUBLE-BLIND; HELICOBACTER-PYLORI; SACCHAROMYCES-BOULARDII; BIFIDOBACTERIUM-LONGUM; ORAL BACTERIOTHERAPY	Background: Meta-analyses on the effects of probiotics on specific gastrointestinal diseases have generally shown positive effects on disease prevention and treatment; however, the relative efficacy of probiotic use for treatment and prevention across different gastrointestinal diseases, with differing etiology and mechanisms of action, has not been addressed. Methods/Principal Findings: We included randomized controlled trials in humans that used a specified probiotic in the treatment or prevention of Pouchitis, Infectious diarrhea, Irritable Bowel Syndrome, Helicobacter pylori, Clostridium difficile Disease, Antibiotic Associated Diarrhea, Traveler's Diarrhea, or Necrotizing Enterocolitis. Random effects models were used to evaluate efficacy as pooled relative risks across the eight diseases as well as across probiotic species, single vs. multiple species, patient ages, dosages, and length of treatment. Probiotics had a positive significant effect across all eight gastrointestinal diseases with a relative risk of 0.58 (95% (CI) 0.51-0.65). Six of the eight diseases: Pouchitis, Infectious diarrhea, Irritable Bowel Syndrome, Helicobacter pylori, Clostridium difficile Disease, and Antibiotic Associated Diarrhea, showed positive significant effects. Traveler's Diarrhea and Necrotizing Enterocolitis did not show significant effects of probiotcs. Of the 11 species and species mixtures, all showed positive significant effects except for Lactobacillus acidophilus, Lactobacillus plantarum, and Bifidobacterium infantis. Across all diseases and probiotic species, positive significant effects of probiotics were observed for all age groups, single vs. multiple species, and treatment lengths. Conclusions/Significance: Probiotics are generally beneficial in treatment and prevention of gastrointestinal diseases. Efficacy was not observed for Traveler's Diarrhea or Necrotizing Enterocolitis or for the probiotic species L. acidophilus, L. plantarum, and B. infantis. When choosing to use probiotics in the treatment or prevention of gastrointestinal disease, the type of disease and probiotic species (strain) are the most important factors to take into consideration.	[Ritchie, Marina L.; Romanuk, Tamara N.] Dalhousie Univ, Dept Biol, Halifax, NS, Canada	Dalhousie University	Ritchie, ML (corresponding author), Dalhousie Univ, Dept Biol, Halifax, NS, Canada.	marina.ritchie@gmail.com	Romanuk, t N/C-6493-2008		National Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant	National Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was supported by a National Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant to Tamara Romanuk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], BAX L MIX 2 0 PROF S; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bengmark S, 1998, GUT, V42, P2, DOI 10.1136/gut.42.1.2; BENNO Y, 1992, MICROBIOL IMMUNOL, V36, P683, DOI 10.1111/j.1348-0421.1992.tb02071.x; Bezkorovainy A, 2001, AM J CLIN NUTR, V73, p399S, DOI 10.1093/ajcn/73.2.399s; Blumberg D, 2002, GASTROENTEROL CLIN N, V31, P219, DOI 10.1016/S0889-8553(01)00013-9; Bodilis J., 1983, MED ACTUELLE, V10, P232; BOULLOCHE J, 1994, ANN PEDIATR-PARIS, V41, P457; Canducci F, 2000, ALIMENT PHARM THER, V14, P1625, DOI 10.1046/j.1365-2036.2000.00885.x; Carol M, 1998, GUT, V42, P643, DOI 10.1136/gut.42.5.643; Cats A, 2003, ALIMENT PHARM THER, V17, P429, DOI 10.1046/j.1365-2036.2003.01452.x; Cindoruk M, 2007, HELICOBACTER, V12, P309, DOI 10.1111/j.1523-5378.2007.00516.x; Cremonini F, 2002, ALIMENT PHARM THER, V16, P1461, DOI 10.1046/j.1365-2036.2002.01318.x; D'Souza AL, 2002, BRIT MED J, V324, P1361, DOI 10.1136/bmj.324.7350.1361; Dendukuri N, 2005, CAN MED ASSOC J, V173, P167, DOI 10.1503/cmaj.050350; Deshpande G, 2007, LANCET, V369, P1614, DOI 10.1016/S0140-6736(07)60748-X; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; EGGER M, 1995, BRIT MED J, V311, P753, DOI 10.1136/bmj.311.7007.753c; Elahi B, 2008, DIGEST DIS SCI, V53, P1278, DOI 10.1007/s10620-007-0006-z; Elmer GW, 2001, AM J HEALTH-SYST PH, V58, P1101, DOI 10.1093/ajhp/58.12.1101; Fric P, 2002, Z GASTROENTEROL, V40, P197, DOI 10.1055/s-2002-22328; Gade J, 1989, Scand J Prim Health Care, V7, P23, DOI 10.3109/02813438909103666; Gionchetti P, 2000, GASTROENTEROLOGY, V119, P305, DOI 10.1053/gast.2000.9370; Gionchetti P, 2003, BEST PRACT RES CL GA, V17, P821, DOI 10.1016/S1521-6918(03)00071-4; Goodgame Richard, 2003, Curr Infect Dis Rep, V5, P66, DOI 10.1007/s11908-003-0067-x; Gorbach SL, 1996, NUTRITION, V31, P2; Halpern GM, 1996, AM J GASTROENTEROL, V91, P1579; Hart AL, 2003, J CLIN GASTROENTEROL, V36, P111, DOI 10.1097/00004836-200302000-00005; Hawrelak JA, 2005, DIGESTION, V72, P51, DOI 10.1159/000087637; Hilton, 1997, J Travel Med, V4, P41, DOI 10.1111/j.1708-8305.1997.tb00772.x; Hoveyda N, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-15; ISOLAURI E, 1994, DIGEST DIS SCI, V39, P2595, DOI 10.1007/BF02087695; Isolauri E, 2001, AM J CLIN NUTR, V73, p1142S; ISOLAURI E, 1993, PEDIATR RES, V33, P548, DOI 10.1203/00006450-199306000-00002; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Johnston BC, 2006, CAN MED ASSOC J, V175, P377, DOI 10.1503/cmaj.051603; Katelaris PH, 1995, NEW ENGL J MED, V333, P1046; Keighley MRB, 1996, ALIMENT PHARM THER, V10, P449, DOI 10.1046/j.1365-2036.1996.32174000.x; KMIOT WA, 1993, BRIT J SURG, V80, P1445, DOI 10.1002/bjs.1800801132; Lin HC, 2004, JAMA-J AM MED ASSOC, V292, P852, DOI 10.1001/jama.292.7.852; LING WH, 1994, J NUTR, V124, P18, DOI 10.1093/jn/124.1.18; Marteau PR, 2001, AM J CLIN NUTR, V73, p430S, DOI 10.1093/ajcn/73.2.430s; McFarland LV, 1998, DIGEST DIS, V16, P292, DOI 10.1159/000016879; McFarland LV, 2006, AM J GASTROENTEROL, V101, P812, DOI 10.1111/j.1572-0241.2006.00465.x; MCFARLAND LV, 1994, JAMA-J AM MED ASSOC, V271, P1913, DOI 10.1001/jama.271.24.1913; McFarland LV, 2008, WORLD J GASTROENTERO, V14, P2650, DOI 10.3748/wjg.14.2650; McFarland Lynne V., 2000, Microbial Ecology in Health and Disease, V12, P193, DOI 10.1080/08910600050216183; Mimura T, 2004, GUT, V53, P108, DOI 10.1136/gut.53.1.108; Nicholls RJ, 1998, WORLD J SURG, V22, P347, DOI 10.1007/s002689900395; Niedzielin K, 2001, EUR J GASTROEN HEPAT, V13, P1143, DOI 10.1097/00042737-200110000-00004; Nobaek S, 2000, AM J GASTROENTEROL, V95, P1231; Olson JW, 2002, SCIENCE, V298, P1788, DOI 10.1126/science.1077123; ORRHAGE K, 1994, MICROB ECOL HEALTH D, V7, P17, DOI 10.3109/08910609409141570; Perin NM, 1997, J PEDIATR GASTR NUTR, V24, P419, DOI 10.1097/00005176-199704000-00011; Pessi T, 1999, APPL ENVIRON MICROB, V65, P4725; POZOOLANO JDD, 1978, GASTROENTEROLOGY, V74, P829; Qamar A, 2001, INFECT IMMUN, V69, P2762, DOI 10.1128/IAI.69.4.2762-2765.2001; Rath HC, 2003, EUR J GASTROEN HEPAT, V15, P615, DOI 10.1097/00042737-200306000-00006; Ruszczynski M, 2008, ALIMENT PHARM THER, V28, P154, DOI 10.1111/j.1365-2036.2008.03714.x; Saarela M, 2002, INT J FOOD MICROBIOL, V78, P99, DOI 10.1016/S0168-1605(02)00235-0; SAAVEDRA JM, 1994, LANCET, V344, P1046, DOI 10.1016/S0140-6736(94)91708-6; Sakaguchi T, 2002, CELL MICROBIOL, V4, P367, DOI 10.1046/j.1462-5822.2002.00197.x; Salminen S, 1998, BRIT J NUTR, V80, pS147, DOI 10.1079/BJN19980108; SANDBORN WJ, 1994, GASTROENTEROLOGY, V107, P1856, DOI 10.1016/0016-5085(94)90832-X; SANDERSON IR, 1993, GASTROENTEROLOGY, V104, P622, DOI 10.1016/0016-5085(93)90436-G; Santosa S, 2006, NUTR REV, V64, P265, DOI [10.1111/j.1753-4887.2006.tb00209.x, 10.1301/nr.2006.jun.265-274]; SARTOR RB, 1995, GASTROENTEROL CLIN N, V24, P475; Sazawal S, 2006, LANCET INFECT DIS, V6, P374, DOI 10.1016/S1473-3099(06)70495-9; Sen S, 2002, DIGEST DIS SCI, V47, P2615, DOI 10.1023/A:1020597001460; SIMON GL, 1986, DIGEST DIS SCI, V31, pS147; Simren M, 2006, GASTROENTEROLOGY, V130, pA600; Sistrom CL, 2004, RADIOLOGY, V230, P12, DOI 10.1148/radiol.2301031028; Soutar A, 1997, THORAX, V52, P166, DOI 10.1136/thx.52.2.166; Sutas Y, 1996, J ALLERGY CLIN IMMUN, V98, P216, DOI 10.1016/S0091-6749(96)70245-2; Tannock GW, 1997, TRENDS BIOTECHNOL, V15, P270, DOI 10.1016/S0167-7799(97)01056-1; Tong JL, 2007, ALIMENT PHARM THER, V25, P155, DOI 10.1111/j.1365-2036.2006.03179.x; Van Niel CW, 2005, PEDIATRICS, V115, P174, DOI 10.1542/peds.2004-2356; Vanderhoof JA, 2000, J PEDIATR GASTR NUTR, V30, pS34, DOI 10.1097/00005176-200000002-00006; VANEMBDEN JGHR, 1994, GUT, V35, P658, DOI 10.1136/gut.35.5.658; Weizman Z, 2005, PEDIATRICS, V115, P5, DOI 10.1542/peds.2004-1815; Wenus C, 2008, EUR J CLIN NUTR, V62, P299, DOI 10.1038/sj.ejcn.1602718; Whorwell PJ, 2006, AM J GASTROENTEROL, V101, P1581, DOI 10.1111/j.1572-0241.2006.00734.x; Wilson M., 2008, BACTERIOLOGY HUMANS; WITSELL DL, 1995, J OTOLARYNGOL, V24, P230; Wullt M, 2003, SCAND J INFECT DIS, V35, P365, DOI 10.1080/00365540310010985	85	282	293	9	100	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e34938	10.1371/journal.pone.0034938	http://dx.doi.org/10.1371/journal.pone.0034938			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529959	Green Published, gold			2022-12-27	WOS:000305350600044
J	Waite, DW; Deines, P; Taylor, MW				Waite, David W.; Deines, Peter; Taylor, Michael W.			Gut Microbiome of the Critically Endangered New Zealand Parrot, the Kakapo (Strigops habroptilus)	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; GRADIENT GEL-ELECTROPHORESIS; PHYLOGENETIC ANALYSIS; GASTROINTESTINAL-TRACT; BACTERIAL COMMUNITIES; INTESTINAL-TRACT; SEQUENCE DATA; METHANOGENS; DIVERSITY; ARCHAEA	The kakapo, a parrot endemic to New Zealand, is currently the focus of intense research and conservation efforts with the aim of boosting its population above the current 'critically endangered' status. While virtually nothing is known about the microbiology of the kakapo, given the acknowledged importance of gut-associated microbes in vertebrate nutrition and pathogen defense, it should be of great conservation value to analyze the microbes associated with kakapo. Here we describe the first study of the bacterial communities that reside within the gastrointestinal tract (GIT) of both juvenile and adult kakapo. Samples from along the GIT, taken from the choana (approximate to throat), crop and faeces, were subjected to 16 S rRNA gene library analysis. Phylogenetic analysis of >1000 16 S rRNA gene clones, derived from six birds, revealed low phylum-level diversity, consisting almost exclusively of Firmicutes (including lactic acid bacteria) and Gammaproteobacteria. The relative proportions of Firmicutes and Gammaproteobacteria were highly consistent among individual juveniles, irrespective of sampling location, but differed markedly among adult birds. Diversity at a finer phylogenetic resolution (i.e. operational taxonomic units (OTUs) of 99% sequence identity) was also low in all samples, with only one or two OTUs dominating each sample. These data represent the first analysis of the bacterial communities associated with the kakapo GIT, providing a baseline for further microbiological study, and facilitating conservation efforts for this unique bird.	[Waite, David W.; Deines, Peter; Taylor, Michael W.] Univ Auckland, Sch Biol Sci, Ctr Microbial Innovat, Auckland 1, New Zealand; [Deines, Peter] Massey Univ, Inst Nat Sci, Auckland, New Zealand	University of Auckland; Massey University	Waite, DW (corresponding author), Univ Auckland, Sch Biol Sci, Ctr Microbial Innovat, Auckland 1, New Zealand.	mw.taylor@auckland.ac.nz	Deines, Peter/B-7022-2012	Deines, Peter/0000-0003-0926-489X; Waite, David/0000-0002-0184-2942; Taylor, Michael/0000-0002-0463-7813	Department of Conservation; University of Auckland [9841 3626187]; Alexander von Humboldt Foundation	Department of Conservation; University of Auckland; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	This work was supported by funding from the Department of Conservation as well as a University of Auckland Faculty Research Development Fund (grant 9841 3626187) to MWT, Feodor Lynen Research Fellowship from the Alexander von Humboldt Foundation to PD, and a University of Auckland Doctoral Scholarship to DW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashelford KE, 2006, APPL ENVIRON MICROB, V72, P5734, DOI 10.1128/AEM.00556-06; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Bjorkholm B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006958; Blanco G, 2006, J APPL ECOL, V43, P990, DOI 10.1111/j.1365-2664.2006.01200.x; Bolam DN, 2011, GUT MICROBES, V2, P86, DOI 10.4161/gmic.2.2.15232; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Brangenberg N, 2003, J AVIAN MED SURG, V17, P203, DOI 10.1647/2003-023; Brisbin Jennifer T., 2008, Animal Health Research Reviews, V9, P101, DOI 10.1017/S146625230800145X; Burtt EH, 2011, BIOL LETTERS, V7, P214, DOI 10.1098/rsbl.2010.0716; Chassard C, 2007, FEMS MICROBIOL ECOL, V61, P121, DOI 10.1111/j.1574-6941.2007.00314.x; Christensen H, 2003, J APPL MICROBIOL, V95, P354, DOI 10.1046/j.1365-2672.2003.01986.x; CLENCH MH, 1995, WILSON BULL, V107, P93; Costa R, 2004, BRAZ J MICROBIOL, V35, P230, DOI 10.1590/S1517-83822004000200011; DELONG EF, 1992, P NATL ACAD SCI USA, V89, P5685, DOI 10.1073/pnas.89.12.5685; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Dongowski G, 2000, APPL ENVIRON MICROB, V66, P1321, DOI 10.1128/AEM.66.4.1321-1327.2000; Drummond A, 2010, GENEIOUS 5 5; DUBOS R, 1964, AM J MED SCI, V248, P267, DOI 10.1097/00000441-196409000-00003; Eason Daryl K., 2006, Notornis, V53, P116; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Elliott GP, 2001, BIOL CONSERV, V99, P121, DOI 10.1016/S0006-3207(00)00191-9; Eribe ERK, 2008, ANAEROBE, V14, P131, DOI 10.1016/j.anaerobe.2008.04.004; FINEGOLD SM, 1974, AM J CLIN NUTR, V27, P1456, DOI 10.1093/ajcn/27.12.1456; Gartrell BD, 2005, AVIAN PATHOL, V34, P383, DOI 10.1080/03079450500268583; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Godoy-Vitorino F, 2008, APPL ENVIRON MICROB, V74, P5905, DOI 10.1128/AEM.00574-08; Godoy-Vitorino F, 2012, ISME J, V6, P531, DOI 10.1038/ismej.2011.131; Godoy-Vitorino F, 2010, ISME J, V4, P611, DOI 10.1038/ismej.2009.147; GRAJAL A, 1989, SCIENCE, V245, P1236, DOI 10.1126/science.245.4923.1236; Gregersen RH, 2010, J APPL MICROBIOL, V108, P1235, DOI 10.1111/j.1365-2672.2009.04518.x; Hehemann JH, 2010, NATURE, V464, P908, DOI 10.1038/nature08937; Hiura T, 2010, ANIM FEED SCI TECH, V155, P1, DOI 10.1016/j.anifeedsci.2009.09.015; HOOIJKAAS H, 1984, EUR J IMMUNOL, V14, P1127, DOI 10.1002/eji.1830141212; Hopkins MJ, 2001, GUT, V48, P198, DOI 10.1136/gut.48.2.198; Horrocks M, 2008, REV PALAEOBOT PALYNO, V149, P229, DOI 10.1016/j.revpalbo.2007.12.009; Houston D, 2007, BIOL CONSERV, V138, P248, DOI 10.1016/j.biocon.2007.04.023; HUDSON JA, 1964, P SOC EXP BIOL MED, V116, P628; Ichinohe T, 2011, P NATL ACAD SCI USA, V108, P5354, DOI 10.1073/pnas.1019378108; Irbis C, 2004, J GEN APPL MICROBIOL, V50, P203, DOI 10.2323/jgam.50.203; Ishii K, 2001, APPL ENVIRON MICROB, V67, P3753, DOI 10.1128/AEM.67.8.3753-3755.2001; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Janiga M, 2007, J ORNITHOL, V148, P135, DOI 10.1007/s10336-006-0104-2; Khachatryan ZA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003064; Kim YS, 2007, J NUTR, V137, p2576S, DOI 10.1093/jn/137.11.2576S; Klomp JE, 2008, J AVIAN BIOL, V39, P530, DOI 10.1111/j.0908-8857.2008.04333.x; Laure R, 2005, ENVIRON MICROBIOL, V7, P530; Ley RE, 2008, NAT REV MICROBIOL, V6, P776, DOI 10.1038/nrmicro1978; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; LLOYD BD, 1994, BIOL CONSERV, V69, P75, DOI 10.1016/0006-3207(94)90330-1; Lu JR, 2008, J MICROBIOL, V46, P469, DOI 10.1007/s12275-008-0117-z; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Martens EC, 2009, J BIOL CHEM, V284, P24673, DOI 10.1074/jbc.R109.022848; Martinez I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015046; Matsui H, 2010, ANAEROBE, V16, P83, DOI 10.1016/j.anaerobe.2009.07.005; Meinl W, 2009, DRUG METAB DISPOS, V37, P1179, DOI 10.1124/dmd.108.025916; MERTON DV, 1984, IBIS, V126, P277, DOI 10.1111/j.1474-919X.1984.tb00250.x; Moreno J, 2003, AUK, V120, P784, DOI 10.1642/0004-8038(2003)120[0784:BEOCBO]2.0.CO;2; Morton E.S., 1978, P123; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; O'Hara AM, 2006, EMBO REP, V7, P688, DOI 10.1038/sj.embor.7400731; Ohkuma M, 2008, TRENDS MICROBIOL, V16, P345, DOI 10.1016/j.tim.2008.04.004; OLIVER WRB, 1955, NZ BIRDS; Pacheco MA, 2004, CONDOR, V106, P139, DOI 10.1650/7406; Petersen A, 2010, LETT APPL MICROBIOL, V51, P61, DOI 10.1111/j.1472-765X.2010.02861.x; Polz MF, 1998, APPL ENVIRON MICROB, V64, P3724; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Rajilic-Stojanovic M, 2009, ENVIRON MICROBIOL, V11, P1736, DOI 10.1111/j.1462-2920.2009.01900.x; Russell JB, 2001, SCIENCE, V292, P1119, DOI 10.1126/science.1058830; Sabathe F, 2002, FEMS MICROBIOL LETT, V217, P15, DOI 10.1016/S0378-1097(02)00991-6; Sadeghi H., 2008, J BIOL SCI, V8, P826, DOI DOI 10.3923/JBS.2008.826.830; SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shanks OC, 2011, APPL ENVIRON MICROB, V77, P2992, DOI 10.1128/AEM.02988-10; Shawkey MD, 2007, AM NAT, V169, pS112, DOI 10.1086/510100; Shin EC, 2004, ANAEROBE, V10, P313, DOI 10.1016/j.anaerobe.2004.08.002; Shoham Y, 1999, TRENDS MICROBIOL, V7, P275, DOI 10.1016/S0966-842X(99)01533-4; Spring S, 1998, ARCH MICROBIOL, V169, P136, DOI 10.1007/s002030050553; Stappenbeck TS, 2002, P NATL ACAD SCI USA, V99, P15451, DOI 10.1073/pnas.202604299; Tajima K, 2001, FEMS MICROBIOL LETT, V200, P67, DOI 10.1111/j.1574-6968.2001.tb10694.x; Thomas F, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00093; Tokura M, 1999, CURR MICROBIOL, V39, P123, DOI 10.1007/s002849900432; Torok VA, 2008, APPL ENVIRON MICROB, V74, P783, DOI 10.1128/AEM.01384-07; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Vaahtovuo J, 2001, ANTON LEEUW INT J G, V80, P35, DOI 10.1023/A:1012058107731; Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791; van der Wielen PWJJ, 2002, MICROBIAL ECOL, V44, P286, DOI 10.1007/s00248-002-2015-y; VAREL VH, 1992, APPL ENVIRON MICROB, V58, P1645, DOI 10.1128/AEM.58.5.1645-1649.1992; von Wintzingerode F, 1997, FEMS MICROBIOL REV, V21, P213; Warnick TA, 2002, INT J SYST EVOL MICR, V52, P1155, DOI [10.1099/ijs.0.02125-0, 10.1099/00207713-52-4-1155]; Webster NS, 2004, ENVIRON MICROBIOL, V6, P288, DOI 10.1111/j.1462-2920.2004.00570.x; Xenoulis PG, 2010, VET MICROBIOL, V146, P320, DOI 10.1016/j.vetmic.2010.05.024; Yegani M, 2008, POULTRY SCI, V87, P2052, DOI 10.3382/ps.2008-00091; Yi P, 2011, VET MICROBI IN PRESS; Yu ZT, 2008, APPL ENVIRON MICROB, V74, P889, DOI 10.1128/AEM.00684-07; Zoetendal EG, 2008, GUT, V57, P1605, DOI 10.1136/gut.2007.133603	95	57	59	4	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35803	10.1371/journal.pone.0035803	http://dx.doi.org/10.1371/journal.pone.0035803			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22530070	gold, Green Submitted, Green Published			2022-12-27	WOS:000305350600115
J	Birznieks, I; Boonstra, TW; Macefield, VG				Birznieks, Ingvars; Boonstra, Tjeerd W.; Macefield, Vaughan G.			Modulation of Human Muscle Spindle Discharge by Arterial Pulsations - Functional Effects and Consequences	PLOS ONE			English	Article							SYMPATHETIC-NERVE; LEG MUSCLES; CAT; AFFERENTS; RESPONSES; STRETCH; NOISE; PAIN; LOCALIZATION; STIMULATION	Arterial pulsations are known to modulate muscle spindle firing; however, the physiological significance of such synchronised modulation has not been investigated. Unitary recordings were made from 75 human muscle spindle afferents innervating the pretibial muscles. The modulation of muscle spindle discharge by arterial pulsations was evaluated by R-wave triggered averaging and power spectral analysis. We describe various effects arterial pulsations may have on muscle spindle afferent discharge. Afferents could be "driven" by arterial pulsations, e. g., showing no other spontaneous activity than spikes generated with cardiac rhythmicity. Among afferents showing ongoing discharge that was not primarily related to cardiac rhythmicity we illustrate several mechanisms by which individual spikes may become phase-locked. However, in the majority of afferents the discharge rate was modulated by the pulse wave without spikes being phase locked. Then we assessed whether these influences changed in two physiological conditions in which a sustained increase in muscle sympathetic nerve activity was observed without activation of fusimotor neurones: a maximal inspiratory breath-hold, which causes a fall in systolic pressure, and acute muscle pain, which causes an increase in systolic pressure. The majority of primary muscle spindle afferents displayed pulse-wave modulation, but neither apnoea nor pain had any significant effect on the strength of this modulation, suggesting that the physiological noise injected by the arterial pulsations is robust and relatively insensitive to fluctuations in blood pressure. Within the afferent population there was a similar number of muscle spindles that were inhibited and that were excited by the arterial pulse wave, indicating that after signal integration at the population level, arterial pulsations of opposite polarity would cancel each other out. We speculate that with close-to-threshold stimuli the arterial pulsations may serve as an endogenous noise source that may synchronise the sporadic discharge within the afferent population and thus facilitate the detection of weak stimuli.	[Birznieks, Ingvars] Univ Western Sydney, Sch Sci & Hlth, Sydney, NSW, Australia; [Birznieks, Ingvars; Macefield, Vaughan G.] Neurosci Res Australia, Sydney, NSW, Australia; [Boonstra, Tjeerd W.] Black Dog Inst, Sydney, NSW, Australia; [Macefield, Vaughan G.] Univ Western Sydney, Sch Med, Sydney, NSW, Australia; [Birznieks, Ingvars] Univ New S Wales, Sch Med Sci, Sydney, NSW, Australia; [Boonstra, Tjeerd W.] Univ New S Wales, Sch Psychiat, Sydney, NSW, Australia	Western Sydney University; Neuroscience Research Australia; Black Dog Institute; Western Sydney University; University of New South Wales Sydney; University of New South Wales Sydney	Birznieks, I (corresponding author), Univ Western Sydney, Sch Sci & Hlth, Sydney, NSW, Australia.	i.birznieks@uws.edu.au	Boonstra, Tjeerd/C-5433-2011; B, Ingvars/Q-8634-2019; Birznieks, Ingvars/D-4181-2012	Boonstra, Tjeerd/0000-0002-6969-7243; B, Ingvars/0000-0003-4916-1254; Birznieks, Ingvars/0000-0003-4916-1254; Macefield, Vaughan/0000-0003-3325-6566	Australian Research Council (ARC); National Health and Medical Research Council (NHMRC) of Australia [TS0669860]; NHMRC [APP1029782]	Australian Research Council (ARC)(Australian Research Council); National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This research was supported by a grant from the Australian Research Council (ARC; http://www.arc.gov.au/) and National Health and Medical Research Council (NHMRC; http://www.nhmrc.gov.au) of Australia TS0669860 and NHMRC Project Grant APP1029782. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong B, 2008, SPORTS MED, V38, P101, DOI 10.2165/00007256-200838020-00002; BARKER D, 1981, PROC R SOC SER B-BIO, V212, P317, DOI 10.1098/rspb.1981.0042; Birznieks I, 2008, J PHYSIOL-LONDON, V586, P2713, DOI 10.1113/jphysiol.2008.151746; Bombardi C, 2006, TISSUE CELL, V38, P121, DOI 10.1016/j.tice.2005.12.003; Boonstra TW, 2007, NEUROIMAGE, V36, P370, DOI 10.1016/j.neuroimage.2007.03.012; Boonstra TW, 2009, EUR J NEUROSCI, V29, P613, DOI 10.1111/j.1460-9568.2008.06584.x; Breakspear M, 2003, PHYSICA D, V182, P1, DOI 10.1016/S0167-2789(03)00136-2; BROWN AG, 1967, J PHYSIOL-LONDON, V193, P707, DOI 10.1113/jphysiol.1967.sp008390; BURKE D, 1979, J PHYSIOL-LONDON, V291, P277, DOI 10.1113/jphysiol.1979.sp012812; BURKE D, 1987, J NEUROPHYSIOL, V58, P417, DOI 10.1152/jn.1987.58.2.417; Cordo P, 1996, NATURE, V383, P769, DOI 10.1038/383769a0; EDIN BB, 1990, J NEUROPHYSIOL, V63, P1307, DOI 10.1152/jn.1990.63.6.1307; EDIN BB, 1990, J NEUROPHYSIOL, V63, P1314, DOI 10.1152/jn.1990.63.6.1314; Efron B., 1986, STAT SCI, V1, P54, DOI DOI 10.1214/SS/1177013815; ELLAWAY PH, 1977, J PHYSIOL-LONDON, V273, pP92; EMONETDENAND F, 1985, J PHYSIOL-LONDON, V360, P201, DOI 10.1113/jphysiol.1985.sp015612; EMONETDENAND F, 1985, J PHYSIOL-LONDON, V360, P187, DOI 10.1113/jphysiol.1985.sp015611; HAMM TM, 1985, J PHYSIOL-LONDON, V365, P77, DOI 10.1113/jphysiol.1985.sp015760; Hellstrom F, 2005, EXP BRAIN RES, V165, P328, DOI 10.1007/s00221-005-2309-7; HUNT CC, 1982, ARCH ITAL BIOL, V120, P371; JACKSON DA, 1993, ECOLOGY, V74, P2204, DOI 10.2307/1939574; Jarvis MR, 2001, NEURAL COMPUT, V13, P717, DOI 10.1162/089976601300014312; JOHANSSON H, 1991, MED HYPOTHESES, V35, P196, DOI 10.1016/0306-9877(91)90233-O; KIRKWOOD PA, 1982, J PHYSIOL-LONDON, V322, P287, DOI 10.1113/jphysiol.1982.sp014038; MACEFIELD G, 1990, J PHYSIOL-LONDON, V429, P113, DOI 10.1113/jphysiol.1990.sp018247; Macefield VG, 2003, EXP PHYSIOL, V88, P617, DOI 10.1113/eph8802548; Macefield VG, 2003, J PHYSIOL-LONDON, V551, P1005, DOI 10.1113/jphysiol.2003.040196; MACEFIELD VG, 1995, J AUTONOM NERV SYST, V53, P137, DOI 10.1016/0165-1838(94)00173-H; Matre D, 2002, EUR J PAIN, V6, P245, DOI 10.1053/eujp.2002.0332; Matre D, 2003, ACTA PHYSIOL SCAND, V178, P261, DOI 10.1046/j.1365-201X.2003.01122.x; MATTHEWS PB, 1969, J PHYSIOL-LONDON, V202, P59, DOI 10.1113/jphysiol.1969.sp008795; MATTHEWS PBC, 1981, J PHYSIOL-LONDON, V320, P1; McDonnell MD, 2011, NAT REV NEUROSCI, V12, P415, DOI 10.1038/nrn3061; McIntosh AR, 2004, NEUROIMAGE, V23, P764, DOI 10.1016/j.neuroimage.2004.05.018; MCKEON B, 1981, J NEUROPHYSIOL, V46, P788, DOI 10.1152/jn.1981.46.4.788; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; NORDH E, 1983, BRAIN RES, V271, P89, DOI 10.1016/0006-8993(83)91367-7; Noteboom JT, 2001, J APPL PHYSIOL, V91, P2093, DOI 10.1152/jappl.2001.91.5.2093; Powers RK, 2000, J NEUROPHYSIOL, V83, P483, DOI 10.1152/jn.2000.83.1.483; PROSKE U, 1985, EXP BRAIN RES, V59, P166; Rivlin-Etzion M, 2006, J NEUROPHYSIOL, V95, P3245, DOI 10.1152/jn.00055.2005; Siegel S, 1988, NONPARAMETRIC STAT B, V2; Taylor A, 1976, Prog Brain Res, V44, P171; Thunberg J, 2002, EXP BRAIN RES, V142, P319, DOI 10.1007/s00221-001-0941-4; WELCH PD, 1967, IEEE T ACOUST SPEECH, VAU15, P70, DOI 10.1109/TAU.1967.1161901	47	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e35091	10.1371/journal.pone.0035091	http://dx.doi.org/10.1371/journal.pone.0035091			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22529975	Green Submitted, Green Published, gold			2022-12-27	WOS:000305347400031
J	Du, GW; Lewis, MM; Shaffer, ML; Chen, HL; Yang, QX; Mailman, RB; Huang, XM				Du, Guangwei; Lewis, Mechelle M.; Shaffer, Michele L.; Chen, Honglei; Yang, Qing X.; Mailman, Richard B.; Huang, Xuemei			Serum Cholesterol and Nigrostriatal R2*Values in Parkinson's Disease	PLOS ONE			English	Article							SUBSTANTIA-NIGRA; BRAIN IRON; ALZHEIMERS-DISEASE; ALPHA-SYNUCLEIN; BASAL GANGLIA; RISK-FACTORS; IN-VITRO; NEURODEGENERATION; TRANSFERRIN; FERRITIN	Background: The occurrence of Parkinson's disease (PD) is known to be associated both with increased nigrostriatal iron content and with low serum cholesterol and PD, but there has been no study to determine a potential relationship between these two factors. Methods: High-resolution MRI (T1-, T2, and multiple echo T2*-weighted imaging) and fasting lipid levels were obtained from 40 patients with PD and 29 healthy controls. Iron content was estimated from mean R2* values (R2* = 1/T2*) calculated for each nigrostriatal structure including substantia nigra, caudate, putamen, and globus pallidus. This was correlated with serum cholesterol levels after controlling for age, gender, and statin use. Results: In patients with PD, higher serum cholesterol levels were associated with lower iron content in the substantia nigra (R = -0.43, p = 0.011 for total-cholesterol, R = -0.31, p = 0.080 for low-density lipoprotein) and globus pallidus (R = -0.38, p = 0.028 for total-cholesterol, R = -0.27, p = 0.127 for low-density lipoprotein), but only a trend toward significant association of higher total-cholesterol with lower iron content in the striatum (R = -0.34, p = 0.052 for caudate; R = -0.32, p = 0.061 for putamen). After adjusting for clinical measures, the cholesterol-iron relationships held or became even stronger in the substantia nigra and globus pallidus, but weaker in the caudate and putamen. There was no significant association between serum cholesterol levels and nigrostriatal iron content for controls. Conclusions: The data show that higher serum total-cholesterol concentration is associated with lower iron content in substantia nigra and globus pallidus in Parkinson's disease patients. Further studies should investigate whether this is mechanistic or epiphenomenological relationship.	[Du, Guangwei; Lewis, Mechelle M.; Mailman, Richard B.; Huang, Xuemei] Penn State Univ, Milton S Hershey Med Ctr, Dept Neurol, Hershey, PA 17033 USA; [Lewis, Mechelle M.; Mailman, Richard B.; Huang, Xuemei] Penn State Univ, Milton S Hershey Med Ctr, Dept Pharmacol, Hershey, PA 17033 USA; [Yang, Qing X.; Huang, Xuemei] Penn State Univ, Milton S Hershey Med Ctr, Dept Radiol, Hershey, PA 17033 USA; [Yang, Qing X.; Huang, Xuemei] Penn State Univ, Milton S Hershey Med Ctr, Dept Neurosurg, Hershey, PA 17033 USA; [Huang, Xuemei] Penn State Univ, Milton S Hershey Med Ctr, Dept Kinesiol, Hershey, PA 17033 USA; [Shaffer, Michele L.] Penn State Univ, Milton S Hershey Med Ctr, Dept Publ Hlth Sci, Hershey, PA 17033 USA; [Chen, Honglei] NIEHS, Epidemiol Branch, Res Triangle Pk, NC 27709 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Du, GW (corresponding author), Penn State Univ, Milton S Hershey Med Ctr, Dept Neurol, Hershey, PA 17033 USA.	Xuemei@psu.edu	Yang, Heroine/GRY-2630-2022	Chen, Honglei/0000-0003-3446-7779; Mailman, Richard/0000-0003-1353-2738	National Institute of Neurological Disorders and Stroke [NS060722]; General Clinical Research Center from National Institutes of Health (NIH) [M01RR10732]; GCRC [C06RR016499]; Pennsylvania Department of Health Tobacco CURE Funds; National Institute of Health; National Institute of Environmental Health Sciences; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR000125, UL1TR000127] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR016499, M01RR010732] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES101986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060722] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); General Clinical Research Center from National Institutes of Health (NIH); GCRC(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Pennsylvania Department of Health Tobacco CURE Funds; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institute of Neurological Disorders and Stroke (NS060722 to XH), General Clinical Research Center grant from National Institutes of Health (NIH) (M01RR10732) and GCRC Construction Grant (C06RR016499) awarded to the Pennsylvania State University College of Medicine, the Pennsylvania Department of Health Tobacco CURE Funds, and the intramural research program of the National Institute of Health and the National Institute of Environmental Health Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altamura S, 2009, J ALZHEIMERS DIS, V16, P879, DOI 10.3233/JAD-2009-1010; Bar-On P, 2008, J NEUROCHEM, V105, P1656, DOI 10.1111/j.1471-4159.2008.05254.x; BAUDREXEL S, 2010, NEUROIMAGE; Beard J, 2003, J NUTR, V133, p1468S, DOI 10.1093/jn/133.5.1468S; BEARD JL, 1993, NUTR REV, V51, P157, DOI 10.1111/j.1753-4887.1993.tb03096.x; Benarroch EE, 2009, NEUROLOGY, V72, P1436, DOI 10.1212/WNL.0b013e3181a26b30; CALNE DB, 1992, ANN NEUROL, V32, pS125, DOI 10.1002/ana.410320721; Curtis ARJ, 2001, NAT GENET, V28, P350, DOI 10.1038/ng571; Damier P, 1999, BRAIN, V122, P1421, DOI 10.1093/brain/122.8.1421; Damier P, 1999, BRAIN, V122, P1437, DOI 10.1093/brain/122.8.1437; de Lau LML, 2006, AM J EPIDEMIOL, V164, P998, DOI 10.1093/aje/kwj283; Denk C, 2010, J MAGN RESON IMAGING, V31, P185, DOI 10.1002/jmri.21995; DEXTER DT, 1989, J NEUROCHEM, V52, P1830, DOI 10.1111/j.1471-4159.1989.tb07264.x; DEXTER DT, 1991, BRAIN, V114, P1953, DOI 10.1093/brain/114.4.1953; Dorman DC, 2006, TOXICOL SCI, V92, P219, DOI 10.1093/toxsci/kfj209; FEARNLEY JM, 1991, BRAIN, V114, P2283, DOI 10.1093/brain/114.5.2283; Gitlin JD, 1998, PEDIATR RES, V44, P271, DOI 10.1203/00006450-199809000-00001; GORELL JM, 1995, NEUROLOGY, V45, P1138, DOI 10.1212/WNL.45.6.1138; Gouttard S., 2007, MED IM COMP COMP ASS, P37; Graham JM, 2000, BRAIN, V123, P2423, DOI 10.1093/brain/123.12.2423; Gregory A, 2005, FOLIA NEUROPATHOL, V43, P286, DOI 10.1016/B978-0-444-63233-3.00019-1; Griffiths PD, 1999, BRAIN, V122, P667, DOI 10.1093/brain/122.4.667; Griffiths PD, 1996, NEUROSCI LETT, V211, P53, DOI 10.1016/0304-3940(96)12719-1; Haacke EM, 2005, MAGN RESON IMAGING, V23, P1, DOI 10.1016/j.mri.2004.10.001; HALLGREN B, 1958, J NEUROCHEM, V3, P41, DOI 10.1111/j.1471-4159.1958.tb12607.x; Herzog J, 2003, MOVEMENT DISORD, V18, P1332, DOI 10.1002/mds.10518; Hu G, 2008, NEUROLOGY, V70, P1972, DOI 10.1212/01.wnl.0000312511.62699.a8; Huang X, 2011, PLOS ONE IN PRESS; Huang XM, 2008, MOVEMENT DISORD, V23, P1013, DOI 10.1002/mds.22013; Huang XM, 2007, MOVEMENT DISORD, V22, P377, DOI 10.1002/mds.21290; Ikeda K, 2011, NEURODEGENER DIS; Jenner P, 2003, ANN NEUROL, V53, pS26, DOI 10.1002/ana.10483; Joshi S, 2004, NEUROIMAGE, V23, pS151, DOI 10.1016/j.neuroimage.2004.07.068; Klos KJ, 2006, EUR J NEUROL, V13, P1139, DOI 10.1111/j.1468-1331.2006.01407.x; Kwon DH, 2012, ANN NEUROL, V71, P267, DOI 10.1002/ana.22592; Langkammer C, 2010, RADIOLOGY, V257, P455, DOI 10.1148/radiol.10100495; LaVaute T, 2001, NAT GENET, V27, P209, DOI 10.1038/84859; Lewis MM, 2011, MOV DISORD; LOEFFLER DA, 1995, J NEUROCHEM, V65, P710; Lotfipour AK, 2012, J MAGN RESON IMAGING, V35, P48, DOI 10.1002/jmri.22752; Manova ES, 2009, AM J NEURORADIOL, V30, P569, DOI 10.3174/ajnr.A1401; Martin WRW, 2008, NEUROLOGY, V70, P1411, DOI 10.1212/01.wnl.0000286384.31050.b5; Massey LA, 2010, NEUROIMAG CLIN N AM, V20, P7, DOI 10.1016/j.nic.2009.10.001; Miyake Y, 2010, J NEUROL SCI, V293, P82, DOI 10.1016/j.jns.2010.03.002; Oikawa H, 2002, AM J NEURORADIOL, V23, P1747; Peran P, 2010, BRAIN; Powers KM, 2009, PARKINSONISM RELAT D, V15, P47, DOI 10.1016/j.parkreldis.2008.03.002; Scigliano G, 2006, STROKE, V37, P1184, DOI 10.1161/01.STR.0000217384.03237.9c; Simon KC, 2007, NEUROLOGY, V69, P1688, DOI 10.1212/01.wnl.0000271883.45010.8a; SOFIC E, 1988, J NEURAL TRANSM, V74, P199, DOI 10.1007/BF01244786; Stepien K, 2005, PHARMACOL REP, V57, P561; Tofaris GK, 2007, ARCH NEUROL-CHICAGO, V64, P280, DOI 10.1001/archneur.64.2.280; VAILLANCOURT DE, 2010, NEUROBIOL AGING; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015; Zecca L, 2004, NAT REV NEUROSCI, V5, P863, DOI 10.1038/nrn1537; Zecca L, 2008, J NEUROCHEM, V106, P1866, DOI 10.1111/j.1471-4159.2008.05541.x; Zhou B, 2001, NAT GENET, V28, P345, DOI 10.1038/ng572	57	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e35397	10.1371/journal.pone.0035397	http://dx.doi.org/10.1371/journal.pone.0035397			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22530017	Green Published, Green Submitted, gold			2022-12-27	WOS:000305347400049
J	Fritzsche, C; Stachs, O; Holtfreter, MC; Nohr-Luczak, C; Guthoff, RF; Reisinger, EC				Fritzsche, Carlos; Stachs, Oliver; Holtfreter, Martha Charlotte; Nohr-Luczak, Constanze; Guthoff, Rudolf Friedrich; Reisinger, Emil Christian			Confocal Laser Scanning Microscopy, a New In Vivo Diagnostic Tool for Schistosomiasis	PLOS ONE			English	Article								Background: The gold standard for the diagnosis of schistosomiasis is the detection of the parasite's characteristic eggs in urine, stool, or rectal and bladder biopsy specimens. Direct detection of eggs is difficult and not always possible in patients with low egg-shedding rates. Confocal laser scanning microscopy (CLSM) permits non-invasive cell imaging in vivo and is an established way of obtaining high-resolution images and 3-dimensional reconstructions. Recently, CLSM was shown to be a suitable method to visualize Schistosoma mansoni eggs within the mucosa of dissected mouse gut. In this case, we evaluated the suitability of CLSM to detect eggs of Schistosoma haematobium in a patient with urinary schistosomiasis and low egg-shedding rates. Methodology/Principal Findings: The confocal laser scanning microscope used in this study was based on a scanning laser system for imaging the retina of a living eye, the Heidelberg Retina Tomograph II, in combination with a lens system (image modality). Standard light cystoscopy was performed using a rigid cystoscope under general anaesthesia. The CLSM endoscope was then passed through the working channel of the rigid cystoscope. The mucosal tissue of the bladder was scanned using CLSM. Schistoma haematobium eggs appeared as bright structures, with the characteristic egg shape and typical terminal spine. Conclusion/Significance: We were able to detect schistosomal eggs in the urothelium of a patient with urinary schistosomiasis. Thus, CLSM may be a suitable tool for the diagnosis of schistosomiasis in humans, especially in cases where standard diagnostic tools are not suitable.	[Fritzsche, Carlos; Holtfreter, Martha Charlotte; Reisinger, Emil Christian] Univ Rostock, Dept Internal Med, Div Trop Med & Infect Dis, D-2500 Rostock, Germany; [Stachs, Oliver; Guthoff, Rudolf Friedrich] Univ Rostock, Dept Ophthalmol, Rostock, Germany; [Nohr-Luczak, Constanze] Univ Rostock, Dept Urol, Rostock, Germany	University of Rostock; University of Rostock; University of Rostock	Fritzsche, C (corresponding author), Univ Rostock, Dept Internal Med, Div Trop Med & Infect Dis, D-2500 Rostock, Germany.	carlos.fritzsche@med.uni-rostock.de						Bar-Joseph H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023492; Dailey ME, 1995, HDB BIOL CONFOCAL MI, P381; Doenhoff MJ, 2004, TRENDS PARASITOL, V20, P35, DOI 10.1016/j.pt.2003.10.019; EDUNGBOLA L D, 1988, African Journal of Medicine and Medical Sciences, V17, P187; Farahati B, 2010, J ORAL PATHOL MED, V39, P318, DOI 10.1111/j.1600-0714.2009.00841.x; Gerger A, 2009, BRIT J DERMATOL, V160, P475, DOI 10.1111/j.1365-2133.2008.08995.x; GIBODA M, 1994, FOLIA PARASIT, V41, P55; Goetz M, 2010, AM J PHYSIOL-GASTR L, V298, pG797, DOI 10.1152/ajpgi.00027.2010; Guthoff RF, 2009, CLIN EXP OPHTHALMOL, V37, P100, DOI 10.1111/j.1442-9071.2009.02016.x; Holtfreter MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018799; Jung JC, 2003, OPT LETT, V28, P902, DOI 10.1364/OL.28.000902; Loebermann M, 2009, TROP MED INT HEALTH, V14, P1418, DOI 10.1111/j.1365-3156.2009.02387.x; Nohr-Westphal C, 2009, UROLOGE, V48, P1025, DOI 10.1007/s00120-009-2078-1; Sonn GA, 2009, J UROLOGY, V182, P1299, DOI 10.1016/j.juro.2009.06.039; Zhang WH, 2000, WORLD J GASTROENTERO, V6, P344	15	12	12	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e34869	10.1371/journal.pone.0034869	http://dx.doi.org/10.1371/journal.pone.0034869			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22529947	Green Submitted, Green Published, gold			2022-12-27	WOS:000305347400023
J	Leray, M; Beraud, M; Anker, A; Chancerelle, Y; Mills, SC				Leray, Matthieu; Beraud, Maxime; Anker, Arthur; Chancerelle, Yannick; Mills, Suzanne C.			Acanthaster planci Outbreak: Decline in Coral Health, Coral Size Structure Modification and Consequences for Obligate Decapod Assemblages	PLOS ONE			English	Article							SPATIAL-DISTRIBUTION; COMMUNITY STRUCTURE; TERRESTRIAL RUNOFF; SPECIES RICHNESS; CLIMATE-CHANGE; REEF FISHES; RECRUITMENT; TRAPEZIA; DIVERSITY; CRUSTACEA	Although benthic motile invertebrate communities encompass the vast majority of coral reef diversity, their response to habitat modification has been poorly studied. A variety of benthic species, particularly decapods, provide benefits to their coral host enabling them to cope with environmental stressors, and as a result benefit the overall diversity of coral-associated species. However, little is known about how invertebrate assemblages associated with corals will be affected by global perturbations, (either directly or indirectly via their coral host) or their consequences for ecosystem resilience. Analysis of a ten year dataset reveals that the greatest perturbation at Moorea over this time was an outbreak of the corallivorous sea star Acanthaster planci from 2006 to 2009 impacting habitat health, availability and size structure of Pocillopora spp. populations and highlights a positive relationship between coral head size and survival. We then present the results of a mensurative study in 2009 conducted at the end of the perturbation (A. planci outbreak) describing how coral-decapod communities change with percent coral mortality for a selected coral species, Pocillopora eydouxi. The loss of coral tissue as a consequence of A. planci consumption led to an increase in rarefied total species diversity, but caused drastic modifications in community composition driven by a shift from coral obligate to non-obligate decapod species. Our study highlights that larger corals left with live tissue in 2009, formed a restricted habitat where coral obligate decapods, including mutualists, could subsist. We conclude that the size structure of Pocillopora populations at the time of an A. planci outbreak may greatly condition the magnitude of coral mortality as well as the persistence of local populations of obligate decapods.	[Leray, Matthieu; Beraud, Maxime; Mills, Suzanne C.] Univ Perpignan, CBETM, USR CRIOBE CNRS EPHE 3278, Lab Excellence CORAIL, F-66025 Perpignan, France; [Anker, Arthur] Univ Fed Ceara, Lab Ciencias Mar Labomar, Fortaleza, Ceara, Brazil; [Chancerelle, Yannick] CRIOBE, USR CRIOBE CNRS EPHE 3278, Lab Excellence CORAIL, Moorea, France	Universite Perpignan Via Domitia; Universidade Federal do Ceara	Leray, M (corresponding author), Univ Perpignan, CBETM, USR CRIOBE CNRS EPHE 3278, Lab Excellence CORAIL, F-66025 Perpignan, France.	leray.upmc@gmail.com	Anker, Arthur/AAL-5555-2021; Mills, Suzanne/K-5538-2012	Mills, Suzanne/0000-0001-8948-3384	Partner University Fund of the French American Cultural Exchange; ANR [ANR-12-JCJC-Live]; Polynesia Mana; CRISP (Coral Reef InitiativeS for the Pacific); Total Foundation; Gordon and Betty Moore Foundation	Partner University Fund of the French American Cultural Exchange; ANR(French National Research Agency (ANR)); Polynesia Mana; CRISP (Coral Reef InitiativeS for the Pacific); Total Foundation(Total SA); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation)	This research was supported by grants from the Partner University Fund of the French American Cultural Exchange, ANR (ANR-12-JCJC-Live and Let Die), Polynesia Mana, CRISP (Coral Reef InitiativeS for the Pacific) and Total Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r We thank volunteers from CRIOBE station in Moorea and Planete Urgence for field assistance, C. W. Osenberg, A. C. Stier, S. Lemer, M. Gil, S. C. McKeon, R. Galzin and two anonymous reviewers for helpful comments, G. Paulay and J. Poupin for assistance with identification of some decapod specimens, and the Moorea BIOCODE project (funded through Gordon and Betty Moore Foundation) for logistical support. This study was part of M. Leray PhD research program at Universite Pierre et Marie Curie (Paris VI) and Ecole Pratique des Hautes Etudes (EPHE) under the supervision of S.C. Mills.	ABELE LG, 1976, AM ZOOL, V16, P194; Adjeroud M, 2009, CORAL REEFS, V28, P775, DOI 10.1007/s00338-009-0515-7; Almany GR, 2007, SCIENCE, V316, P742, DOI 10.1126/science.1140597; Anderson MJ, 2006, ECOL LETT, V9, P683, DOI 10.1111/j.1461-0248.2006.00926.x; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Bak RPM, 1999, AM ZOOL, V39, P56; Balmford A, 2002, SCIENCE, V297, P950, DOI 10.1126/science.1073947; Beldade R, 2012, P ROYAL S B IN PRESS; BIRKELAND C, 1982, MAR BIOL, V69, P175, DOI 10.1007/BF00396897; Bouchet P, 2002, BIOL J LINN SOC, V75, P421, DOI 10.1046/j.1095-8312.2002.00052.x; BRANHAM JM, 1971, SCIENCE, V172, P1155, DOI 10.1126/science.172.3988.1155; BRODIE JE, 1992, AUST J MAR FRESH RES, V43, P539; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Caley MJ, 2001, ECOLOGY, V82, P3435, DOI 10.2307/2680163; Caley MJ, 1996, ANNU REV ECOL SYST, V27, P477, DOI 10.1146/annurev.ecolsys.27.1.477; CASTRO P, 1976, Micronesica, V12, P99; CASTRO P, 1978, MAR BIOL, V46, P237, DOI 10.1007/BF00390685; CHACE FA, 1993, SMITHSONIAN CONTRIBU, V543; CHESHER RH, 1969, SCIENCE, V165, P280, DOI 10.1126/science.165.3890.280; COLES SL, 1980, MAR ECOL PROG SER, V2, P281, DOI 10.3354/meps002281; COLWELL R. K, 2009, ESTIMATES STAT ESTIM; Colwell RK, 2004, ECOLOGY, V85, P2717, DOI 10.1890/03-0557; Enquist BJ, 2011, GLOBAL CHANGE BIOL, V17, P1408, DOI 10.1111/j.1365-2486.2010.02326.x; Fabricius KE, 2010, CORAL REEFS, V29, P593, DOI 10.1007/s00338-010-0628-z; Feary DA, 2007, OECOLOGIA, V153, P727, DOI 10.1007/s00442-007-0773-4; GLYNN P W, 1974, Environmental Conservation, V1, P295; GLYNN PW, 1980, OECOLOGIA, V47, P287, DOI 10.1007/BF00398518; GLYNN PW, 1985, BIOL BULL, V168, P276, DOI 10.2307/1541240; GLYNN PW, 1987, SYMBIOSIS, V4, P301; GLYNN PW, 1976, ECOL MONOGR, V46, P431, DOI 10.2307/1942565; GOTELLI NJ, 1985, MAR ECOL PROG SER, V21, P89, DOI 10.3354/meps021089; GOTELLI NJ, 1983, MAR ECOL PROG SER, V13, P131, DOI 10.3354/meps013131; HECK KL, 1975, ECOLOGY, V56, P1459, DOI 10.2307/1934716; Hedley J., 2003, VIDANA 1 0 VIDEO ANA; Henle K, 2004, BIODIVERS CONSERV, V13, P207, DOI 10.1023/B:BIOC.0000004319.91643.9e; Holbrook SJ, 2008, MAR ECOL PROG SER, V371, P263, DOI 10.3354/meps07690; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Jones GP, 2004, P NATL ACAD SCI USA, V101, P8251, DOI 10.1073/pnas.0401277101; Kaandorp JA, 1999, MAR BIOL, V134, P295, DOI 10.1007/s002270050547; Kane C, 2009, ENVIRON BIOL FISH, V84, P1, DOI 10.1007/s10641-008-9377-z; Kayal M, 2011, CORAL REEFS, V30, P827, DOI 10.1007/s00338-011-0763-1; KNUDSEN JW, 1967, PAC SCI, V21, P51; LASSIG BR, 1977, MAR BIOL, V42, P85, DOI 10.1007/BF00392016; LUCAS J S, 1973, Micronesica, V9, P197; McKeon CS, 2010, THESIS U FLORIDA GAI; McManus JW, 2004, PROG OCEANOGR, V60, P263, DOI 10.1016/j.pocean.2004.02.014; Mills SC, 2004, ANIM CONSERV, V7, P257, DOI 10.1017/S1367943004001416; Mills SC, 2012, CORAL REEFS IN PRESS; MORAN PJ, 1986, OCEANOGR MAR BIOL, V24, P379; Odinetz MO, 1983, THESIS U PIERRE MARI; Oksanen J, 2022, COMMUNITY ECOLOGY PA; Pearson R. G., 1969, Fish Notes Qd, V3, P27; PEARSON RG, 1981, MAR ECOL PROG SER, V4, P105, DOI 10.3354/meps004105; Penin L, 2007, B MAR SCI, V80, P379; Pratchett M, 2000, CORAL REEFS, V19, P36, DOI 10.1007/s003380050223; Pratchett MS, 2009, MAR ENVIRON RES, V67, P230, DOI 10.1016/j.marenvres.2009.03.001; Pratchett MS, 2001, MAR ECOL PROG SER, V214, P111, DOI 10.3354/meps214111; PRESTON NP, 1994, MAR ECOL PROG SER, V104, P27, DOI 10.3354/meps104027; Przeslawski R, 2008, GLOBAL CHANGE BIOL, V14, P2773, DOI 10.1111/j.1365-2486.2008.01693.x; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Riegl Bernhard, 2007, V192, P315, DOI 10.1007/978-0-387-33537-7_10; Sheppard CRC, 2003, NATURE, V425, P294, DOI 10.1038/nature01987; Shima JS, 2008, ECOLOGY, V89, P86, DOI 10.1890/07-0021.1; Stella JS, 2011, CORAL REEFS, V30, P719, DOI 10.1007/s00338-011-0748-0; Stella JS, 2011, OCEANOGR MAR BIOL, V49, P43; Stewart HL, 2006, CORAL REEFS, V25, P609, DOI 10.1007/s00338-006-0132-7; Stier AC, 2010, CORAL REEFS, V29, P1019, DOI 10.1007/s00338-010-0663-9; Stier AC, 2012, PLOS ONE IN PRESS; Swihart RK, 2003, DIVERS DISTRIB, V9, P1, DOI 10.1046/j.1472-4642.2003.00158.x; Syms C, 2000, ECOLOGY, V81, P2714, DOI 10.1890/0012-9658(2000)081[2714:DHSATD]2.0.CO;2; Tsuchiya M, 1999, GALAXEA, V1, P65; Uthicke S, 2009, ECOL MONOGR, V79, P3, DOI 10.1890/07-2136.1; Wilkinson C., 2004, STATUS CORAL REEFS W, V1; Wilson SK, 2006, GLOBAL CHANGE BIOL, V12, P2220, DOI 10.1111/j.1365-2486.2006.01252.x; YAMAGUCHI M, 1986, CORAL REEFS, V5, P23, DOI 10.1007/BF00302168	77	35	36	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e35456	10.1371/journal.pone.0035456	http://dx.doi.org/10.1371/journal.pone.0035456			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22530026	gold, Green Published			2022-12-27	WOS:000305347400053
J	Lu, Z; Lu, YH				Lu, Zhe; Lu, Yahai			Methanocella conradii sp nov., a Thermophilic, Obligate Hydrogenotrophic Methanogen, Isolated from Chinese Rice Field Soil	PLOS ONE			English	Article							CLUSTER-I METHANOGENS; ARCHAEAL COMMUNITY; GENOME; TAXONOMY; PROPOSAL; SUBUNIT; ACETATE; ROOTS	Background: Methanocellales contributes significantly to anthropogenic methane emissions that cause global warming, but few pure cultures for Methanocellales are available to permit subsequent laboratory studies (physiology, biochemistry, etc.). Methodology/Principal Findings: By combining anaerobic culture and molecular techniques, a novel thermophilic methanogen, strain HZ254(T) was isolated from a Chinese rice field soil located in Hangzhou, China. The phylogenetic analyses of both the 16S rRNA gene and mcrA gene (encoding the alpha subunit of methyl-coenzyme M reductase) confirmed its affiliation with Methanocellales, and Methanocella paludicola SANAE(T) was the most closely related species. Cells were non-motile rods, albeit with a flagellum, 1.4-2.8 mu m long and by 0.2-0.3 mu m in width. They grew at 37-60 degrees C (optimally at 55 degrees C) and salinity of 0-5 g NaCl l(-1) (optimally at 0-1 g NaCl l(-1)). The pH range for growth was 6.4-7.2 (optimum 6.8). Under the optimum growth condition, the doubling time was 6.5-7.8 h, which is the shortest ever observed in Methanocellales. Strain HZ254(T) utilized H-2/CO2 but not formate for growth and methane production. The DNA G+C content of this organism was 52.7 mol%. The sequence identities of 16S rRNA gene and mcrA gene between strain HZ254(T) and SANAE(T) were 95.0 and 87.5% respectively, and the genome based Average Nucleotide Identity value between them was 74.8%. These two strains differed in phenotypic features with regard to substrate utilization, possession of a flagellum, doubling time (under optimal conditions), NaCl and temperature ranges. Taking account of the phenotypic and phylogenetic characteristics, we propose strain HZ254(T) as a representative of a novel species, Methanocella conradii sp. nov. The type strain is HZ254(T) (= CGMCC 1.5162(T) = JCM 17849(T) = DSM 24694(T)). Conclusions/Significance: Strain HZ254(T) could potentially serve as an excellent laboratory model for studying Methanocellales due to its fast growth and consistent cultivability.	[Lu, Zhe; Lu, Yahai] China Agr Univ, Coll Resources & Environm Sci, Beijing 100094, Peoples R China	China Agricultural University	Lu, Z (corresponding author), China Agr Univ, Coll Resources & Environm Sci, Beijing 100094, Peoples R China.	yhlu@cau.edu.cn	Lu, Yahai/A-5030-2013; Lyu, Zhe/H-8273-2019	Lu, Yahai/0000-0002-1702-9868; Lyu, Zhe/0000-0003-0184-6609	Natural Science Foundation of China [40625003, 40830534]; Chinese Ministry of Education	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Education(Ministry of Education, China)	The study was supported by the Natural Science Foundation of China (grant no: 40625003; 40830534; www.nsfc.gov.cn) and the Chang Jiang Scholars Program of Chinese Ministry of Education (www.cksp.edu.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angel R, 2012, ISME J, V6, P847, DOI 10.1038/ismej.2011.141; Angel R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020453; BOONE DR, 1988, INT J SYST BACTERIOL, V38, P212, DOI 10.1099/00207713-38-2-212; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Conrad R, 2006, CURR OPIN BIOTECH, V17, P262, DOI 10.1016/j.copbio.2006.04.002; DELONG EF, 1992, P NATL ACAD SCI USA, V89, P5685, DOI 10.1073/pnas.89.12.5685; Erkel C, 2005, FEMS MICROBIOL ECOL, V53, P187, DOI 10.1016/j.femsec.2004.12.004; Erkel C, 2006, SCIENCE, V313, P370, DOI 10.1126/science.1127062; Fey A, 2001, ENVIRON MICROBIOL, V3, P295, DOI 10.1046/j.1462-2920.2001.00195.x; Fukada H, 1998, PROTEINS, V33, P159, DOI 10.1002/(SICI)1097-0134(19981101)33:2<159::AID-PROT2>3.0.CO;2-E; Garrity GM, 2001, BERGEYS MANUAL SYSTE, V1, P211; Goris J, 2007, INT J SYST EVOL MICR, V57, P81, DOI 10.1099/ijs.0.64483-0; Grosskopf R, 1998, APPL ENVIRON MICROB, V64, P4983; Hungate RE., 1969, METHODS MICROBIOLO B, Vvol 3, P117, DOI 10.1016/S0580-9517(08)70503-8; KOGA Y, 1993, MICROBIOL REV, V57, P164, DOI 10.1128/MMBR.57.1.164-182.1993; Konstantinidis KT, 2007, CURR OPIN MICROBIOL, V10, P504, DOI 10.1016/j.mib.2007.08.006; Konstantinidis KT, 2005, J BACTERIOL, V187, P6258, DOI 10.1128/JB.187.18.6258-6264.2005; Liu FH, 2010, ENVIRON MICROBIOL, V12, P2341, DOI 10.1111/j.1462-2920.2010.02289.x; Lu YH, 2005, SCIENCE, V309, P1088, DOI 10.1126/science.1113435; Lu YH, 2005, ENVIRON MICROBIOL, V7, P326, DOI 10.1111/j.1462-2920.2005.00697.x; Lu Z, 2012, J BACTERIOL, V194, P2398, DOI 10.1128/JB.00207-12; Lueders T, 2001, ENVIRON MICROBIOL, V3, P194, DOI 10.1046/j.1462-2920.2001.00179.x; Peng JJ, 2008, APPL ENVIRON MICROB, V74, P2894, DOI 10.1128/AEM.00070-08; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; Rui JP, 2011, FEMS MICROBIOL ECOL, V77, P264, DOI 10.1111/j.1574-6941.2011.01104.x; Sakai S, 2008, INT J SYST EVOL MICR, V58, P929, DOI 10.1099/ijs.0.65571-0; Sakai S, 2007, APPL ENVIRON MICROB, V73, P4326, DOI 10.1128/AEM.03008-06; Sakai S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022898; Sakai S, 2010, INT J SYST EVOL MICR, V60, P2918, DOI 10.1099/ijs.0.020883-0; Sizova MV, 2003, FEMS MICROBIOL ECOL, V45, P301, DOI 10.1016/S0168-6496(03)00165-X; SPRINGER E, 1995, INT J SYST BACTERIOL, V45, P554, DOI 10.1099/00207713-45-3-554; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Widdel F., 1992, PROKARYOTES, DOI 10.1007/978-1-4757-2191-1_2; Wu LQ, 2009, MICROB ECOL, V58, P819, DOI 10.1007/s00248-009-9554-4; Yuan QA, 2009, ENV MICROBIOL REP, V1, P362, DOI 10.1111/j.1758-2229.2009.00065.x; Yuan YL, 2009, ENV MICROBIOL REP, V1, P347, DOI 10.1111/j.1758-2229.2009.00036.x; ZWIETERING MH, 1990, APPL ENVIRON MICROB, V56, P1875	38	39	49	0	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e35279	10.1371/journal.pone.0035279	http://dx.doi.org/10.1371/journal.pone.0035279			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22530002	Green Published, gold, Green Submitted			2022-12-27	WOS:000305347400041
J	Wood, DO; Hines, A; Tucker, AM; Woodard, A; Driskell, LO; Burkhardt, NY; Kurtti, TJ; Baldridge, GD; Munderloh, UG				Wood, David O.; Hines, Andria; Tucker, Aimee M.; Woodard, Andrew; Driskell, Lonnie O.; Burkhardt, Nicole Y.; Kurtti, Timothy J.; Baldridge, Gerald D.; Munderloh, Ulrike G.			Establishment of a Replicating Plasmid in Rickettsia prowazekii	PLOS ONE			English	Article							HOST CELL-INTERACTIONS; ESCHERICHIA-COLI; TRANSPOSON MUTAGENESIS; VERO CELLS; GENE; TRANSFORMATION; MONACENSIS; RESISTANCE; PROTEINS; VIRULENT	Rickettsia prowazekii, the causative agent of epidemic typhus, grows only within the cytosol of eukaryotic host cells. This obligate intracellular lifestyle has restricted the genetic analysis of this pathogen and critical tools, such as replicating plasmid vectors, have not been developed for this species. Although replicating plasmids have not been reported in R. prowazekii, the existence of well-characterized plasmids in several less pathogenic rickettsial species provides an opportunity to expand the genetic systems available for the study of this human pathogen. Competent R. prowazekii were transformed with pRAM18dRGA, a 10.3 kb vector derived from pRAM18 of R. amblyommii. A plasmid-containing population of R. prowazekii was obtained following growth under antibiotic selection, and the rickettsial plasmid was maintained extrachromosomally throughout multiple passages. The transformant population exhibited a generation time comparable to that of the wild type strain with a copy number of approximately 1 plasmid per rickettsia. These results demonstrate for the first time that a plasmid can be maintained in R. prowazekii, providing an important genetic tool for the study of this obligate intracellular pathogen.	[Wood, David O.; Hines, Andria; Tucker, Aimee M.; Woodard, Andrew; Driskell, Lonnie O.] Univ S Alabama, Coll Med, Dept Microbiol & Immunol, Mol Biol Lab, Mobile, AL 36688 USA; [Burkhardt, Nicole Y.; Kurtti, Timothy J.; Baldridge, Gerald D.; Munderloh, Ulrike G.] Univ Minnesota, Dept Entomol, St Paul, MN USA	University of South Alabama; University of Minnesota System; University of Minnesota Twin Cities	Wood, DO (corresponding author), Univ S Alabama, Coll Med, Dept Microbiol & Immunol, Mol Biol Lab, Mobile, AL 36688 USA.	dowood@jaguar1.usouthal.edu			Public Health Service [AI020384, AI049424]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI049424, R56AI020384, R01AI020384, R37AI020384, R01AI049424, R01AI081690] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Public Health Service grants AI020384 to DOW and AI049424 to UGM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldridge GD, 2005, APPL ENVIRON MICROB, V71, P2095, DOI 10.1128/AEM.71.4.2095-2105.2005; Baldridge GD, 2008, APPL ENVIRON MICROB, V74, P645, DOI 10.1128/AEM.02262-07; Baldridge GD, 2007, APPL ENVIRON MICROB, V73, P4984, DOI 10.1128/AEM.00988-07; Baldridge GD, 2010, APPL ENVIRON MICROB, V76, P1718, DOI 10.1128/AEM.02988-09; Bechah Y, 2010, GENOME RES, V20, P655, DOI 10.1101/gr.103564.109; Burkhardt NY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029511; Clark TR, 2011, INFECT IMMUN, V79, P1631, DOI 10.1128/IAI.00048-11; Driskell LO, 2009, INFECT IMMUN, V77, P3244, DOI 10.1128/IAI.00395-09; Felsheim RF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008361; GIMENEZ DF, 1964, STAIN TECHNOL, V39, P135, DOI 10.3109/10520296409061219; Heinzen RA, 1999, INFECT IMMUN, V67, P4201, DOI 10.1128/IAI.67.8.4201-4207.1999; HEINZEN RA, 1993, INFECT IMMUN, V61, P1926, DOI 10.1128/IAI.61.5.1926-1935.1993; Liu ZM, 2007, APPL ENVIRON MICROB, V73, P6644, DOI 10.1128/AEM.01727-07; Ogata H, 2005, PLOS BIOL, V3, P1391, DOI 10.1371/journal.pbio.0030248; Qin AP, 2004, APPL ENVIRON MICROB, V70, P2816, DOI 10.1128/AEM.70.5.2816-2822.2004; Rachek LI, 1998, J BACTERIOL, V180, P2118, DOI 10.1128/JB.180.8.2118-2124.1998; Rachek LI, 2000, J BACTERIOL, V182, P3289, DOI 10.1128/JB.182.11.3289-3291.2000; Seitz H, 2000, MOL MICROBIOL, V37, P1270, DOI 10.1046/j.1365-2958.2000.02096.x; SILVERMAN DJ, 1980, INFECT IMMUN, V29, P778; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; Sutton MD, 1998, J BIOL CHEM, V273, P34255, DOI 10.1074/jbc.273.51.34255; Van Kirk LS, 2000, INFECT IMMUN, V68, P4706, DOI 10.1128/IAI.68.8.4706-4713.2000; WEISS E, 1982, ANNU REV MICROBIOL, V36, P345, DOI 10.1146/annurev.mi.36.100182.002021; WEISS E, 1973, BACTERIOL REV, V37, P259, DOI 10.1128/MMBR.37.3.259-283.1973; WINKLER HH, 1976, J BIOL CHEM, V251, P389; WISSEMAN CL, 1975, INFECT IMMUN, V11, P1391, DOI 10.1128/IAI.11.6.1391-1401.1975; WOOD HE, 1990, GENE, V96, P83, DOI 10.1016/0378-1119(90)90344-Q	27	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e34715	10.1371/journal.pone.0034715	http://dx.doi.org/10.1371/journal.pone.0034715			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22529927	Green Submitted, Green Published, gold			2022-12-27	WOS:000305347400016
J	Hofmann, AD; Beyer, M; Krause-Buchholz, U; Wobus, M; Bornhauser, M; Rodel, G				Hofmann, Andreas D.; Beyer, Mandy; Krause-Buchholz, Udo; Wobus, Manja; Bornhaeuser, Martin; Roedel, Gerhard			OXPHOS Supercomplexes as a Hallmark of the Mitochondrial Phenotype of Adipogenic Differentiated Human MSCs	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; OXIDATIVE-PHOSPHORYLATION; ANTIOXIDANT ENZYMES; BIOGENESIS; ORGANIZATION; OXIDASE; COMPLEX; NICHE; YEAST	Mitochondria are essential organelles with multiple functions, especially in energy metabolism. Recently, an increasing number of data has highlighted the role of mitochondria for cellular differentiation processes. Metabolic differences between stem cells and mature derivatives require an adaptation of mitochondrial function during differentiation. In this study we investigated alterations of the mitochondrial phenotype of human mesenchymal stem cells undergoing adipogenic differentiation. Maturation of adipocytes is accompanied by mitochondrial biogenesis and an increase of oxidative metabolism. Adaptation of the mt phenotype during differentiation is reflected by changes in the distribution of the mitochondrial network as well as marked alterations of gene expression and organization of the oxidative phosphorylation system (OXPHOS). Distinct differences in the supramolecular organization forms of cytochrome c oxidase (COX) were detected using 2D blue native (BN)-PAGE analysis. Most remarkably we observed a significant increase in the abundance of OXPHOS supercomplexes in mitochondria, emphasizing the change of the mitochondrial phenotype during adipogenic differentiation.	[Hofmann, Andreas D.; Beyer, Mandy; Krause-Buchholz, Udo; Roedel, Gerhard] Tech Univ Dresden, Inst Genet, D-01062 Dresden, Germany; [Wobus, Manja; Bornhaeuser, Martin] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Med Clin & Polyclin 1, D-01062 Dresden, Germany	Technische Universitat Dresden; Technische Universitat Dresden; Carl Gustav Carus University Hospital	Hofmann, AD (corresponding author), Tech Univ Dresden, Inst Genet, D-01062 Dresden, Germany.	andreas.hofmann@mailbox.tu-dresden.de	Roedel, Gerhard/AAH-3762-2022; Roedel, Gerhard/AFQ-8997-2022; Krause, Udo/N-8167-2014	Krause, Udo/0000-0001-9493-4522	Dresden International Graduate School for Biomedicine and Bioengineering (DIGS-BB); Center for Regenerative Therapies Dresden (CRTD)	Dresden International Graduate School for Biomedicine and Bioengineering (DIGS-BB); Center for Regenerative Therapies Dresden (CRTD)	The work was supported by the Dresden International Graduate School for Biomedicine and Bioengineering (DIGS-BB) and by a seed grant of the Center for Regenerative Therapies Dresden (CRTD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acin-Perez R, 2008, MOL CELL, V32, P529, DOI 10.1016/j.molcel.2008.10.021; Chen CT, 2008, STEM CELLS, V26, P960, DOI 10.1634/stemcells.2007-0509; Cho YM, 2006, BIOCHEM BIOPH RES CO, V348, P1472, DOI 10.1016/j.bbrc.2006.08.020; Chung Susan, 2007, Nat Clin Pract Cardiovasc Med, V4 Suppl 1, pS60, DOI 10.1038/ncpcardio0766; Cross M, 2008, CELLS TISSUES ORGANS, V188, P150, DOI 10.1159/000114206; Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Gey U, 2008, J BIOL CHEM, V283, P9759, DOI 10.1074/jbc.M708779200; Godecke A, J TISSUE ENG REGEN M, V5, P648; Inoue SI, 2010, FEBS LETT, V584, P3402, DOI 10.1016/j.febslet.2010.06.036; Ivanovic Z, 2009, J CELL PHYSIOL, V219, P271, DOI 10.1002/jcp.21690; Johnson DT, 2007, AM J PHYSIOL-CELL PH, V292, pC698, DOI 10.1152/ajpcell.00109.2006; Krings A, 2012, BONE, V50, P546, DOI 10.1016/j.bone.2011.06.016; Lonergan T, 2007, MITOCHONDRION, V7, P289, DOI 10.1016/j.mito.2007.05.002; Lonergan T, 2006, J CELL PHYSIOL, V208, P149, DOI 10.1002/jcp.20641; Moyes CD, 1997, AM J PHYSIOL-CELL PH, V272, pC1345, DOI 10.1152/ajpcell.1997.272.4.C1345; Nesti C, 2007, BIOSCIENCE REP, V27, P165, DOI 10.1007/s10540-007-9044-1; Nogueira V, 2001, J BIOL CHEM, V276, P46104, DOI 10.1074/jbc.M107425200; Oswald C, 2009, J MOL BIOL, V389, P470, DOI 10.1016/j.jmb.2009.04.034; Piccoli C, 2005, J BIOL CHEM, V280, P26467, DOI 10.1074/jbc.M500047200; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Rehman J, 2010, J MOL MED, V88, P981, DOI 10.1007/s00109-010-0678-2; Rosca MG, 2008, CARDIOVASC RES, V80, P30, DOI 10.1093/cvr/cvn184; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; Schagger H, 2001, J BIOL CHEM, V276, P37861; St John JC, 2005, CLONING STEM CELLS, V7, P141, DOI 10.1089/clo.2005.7.141; Suda T, 2005, TRENDS IMMUNOL, V26, P426, DOI 10.1016/j.it.2005.06.006; Van Raam BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002013; Wilson-Fritch L, 2003, MOL CELL BIOL, V23, P1085, DOI 10.1128/MCB.23.3.1085-1094.2003	29	60	61	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e35160	10.1371/journal.pone.0035160	http://dx.doi.org/10.1371/journal.pone.0035160			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523573	gold, Green Submitted, Green Published			2022-12-27	WOS:000305345000045
J	Crepin, A; Barbey, C; Beury-Cirou, A; Helias, V; Taupin, L; Reverchon, S; Nasser, W; Faure, D; Dufour, A; Orange, N; Feuilloley, M; Heurlier, K; Burini, JF; Latour, X				Crepin, Alexandre; Barbey, Corinne; Beury-Cirou, Amelie; Helias, Valerie; Taupin, Laure; Reverchon, Sylvie; Nasser, William; Faure, Denis; Dufour, Alain; Orange, Nicole; Feuilloley, Marc; Heurlier, Karin; Burini, Jean-Francois; Latour, Xavier			Quorum Sensing Signaling Molecules Produced by Reference and Emerging Soft-Rot Bacteria (Dickeya and Pectobacterium spp.)	PLOS ONE			English	Article							ACYL-HOMOSERINE LACTONE; CAROTOVORA SUBSP ATROSEPTICA; N-ACYLHOMOSERINE LACTONES; III SECRETION SYSTEM; ERWINIA-CAROTOVORA; PSEUDOMONAS-AERUGINOSA; ENTERIC PHYTOPATHOGEN; SP-NOV.; VIRULENCE; POTATO	Background: Several small diffusible molecules are involved in bacterial quorum sensing and virulence. The production of autoinducers-1 and -2, quinolone, indole and gamma-amino butyrate signaling molecules was investigated in a set of soft-rot bacteria belonging to six Dickeya or Pectobacterium species including recent or emerging potato isolates. Methodology/Principal Findings: Using bacterial biosensors, immunoassay, and chromatographic analysis, we showed that soft-rot bacteria have the common ability to produce transiently during their exponential phase of growth the N-3-oxohexanoyl- or the N-3-oxo-octanoyl-L-homoserine lactones and a molecule of the autoinducer-2 family. Dickeya spp. produced in addition the indole-3-acetic acid in tryptophan-rich conditions. All these signaling molecules have been identified for the first time in the novel Dickeya solani species. In contrast, quinolone and gamma-amino butyrate signals were not identified and the corresponding synthases are not present in the available genomes of soft-rot bacteria. To determine if the variations of signal production according to growth phase could result from expression modifications of the corresponding synthase gene, the respective mRNA levels were estimated by reverse transcriptase-PCR. While the N-acyl-homoserine lactone production is systematically correlated to the synthase expression, that of the autoinducer-2 follows the expression of an enzyme upstream in the activated methyl cycle and providing its precursor, rather than the expression of its own synthase. Conclusions/Significance: Despite sharing the S-adenosylmethionine precursor, no strong link was detected between the production kinetics or metabolic pathways of autoinducers-1 and -2. In contrast, the signaling pathway of autoinducer-2 seems to be switched off by the indole-3-acetic acid pathway under tryptophan control. It therefore appears that the two genera of soft-rot bacteria have similarities but also differences in the mechanisms of communication via the diffusible molecules. Our results designate autoinducer-1 lactones as the main targets for a global biocontrol of soft-rot bacteria communications, including those of emerging isolates.	[Crepin, Alexandre; Barbey, Corinne; Orange, Nicole; Feuilloley, Marc; Burini, Jean-Francois; Latour, Xavier] Univ Rouen, Normandie Univ, LMSM, EA 4312,IUT Evreux, Evreux, France; [Crepin, Alexandre; Beury-Cirou, Amelie] SIPRE Comite No Stn Rech & Creat Varietale, Bretteville Grand Caux, France; [Beury-Cirou, Amelie; Faure, Denis] CNRS, ISV, UPR 2355, Gif Sur Yvette, France; [Helias, Valerie] FN3PT, Paris, France; [Helias, Valerie] INRA, IGEPP, UMR 1349, F-35042 Rennes, France; [Taupin, Laure; Dufour, Alain] Univ Bretagne S, EA 3884, LBCM, Lorient, France; [Reverchon, Sylvie; Nasser, William] Univ Lyon 1, CNRS, Bayer CropSci,INSA, Microbiol Adaptat & Pathogenie MAP UMR 5240, F-69622 Villeurbanne, France; [Heurlier, Karin] Univ Nottingham, Dept Food Sci, Loughborough, England	Universite de Rouen Normandie; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; INRAE; Bayer AG; Bayer CropScience; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; University of Nottingham	Crepin, A (corresponding author), Univ Rouen, Normandie Univ, LMSM, EA 4312,IUT Evreux, Evreux, France.	xavier.latour@univ-rouen.fr	Sylvie, Reverchon/P-7932-2016; NASSER, William/C-9611-2019	Sylvie, Reverchon/0000-0002-0478-3474; NASSER, William/0000-0001-9848-3597; FEUILLOLEY, Marc G.J./0000-0001-6467-4336; Crepin, Alexandre/0000-0003-0957-4708; Dufour, Alain/0000-0003-0112-6046	European Union; Conventions Industrielles de Formation par la Recherche (CIFRE); Conseil Regional de Haute-Normandie & Ministere delegue a l'Enseignement Superieur et a la Recherche through the Grand Reseau de recherche Regional Vegetal, Agronomie, Sols et Innovations; National Association of Technical Research through the Compte d'Affectation Speciale pour le Developpement Agricole et Rural;  [CAS-DAR AAP 7124]	European Union(European Commission); Conventions Industrielles de Formation par la Recherche (CIFRE); Conseil Regional de Haute-Normandie & Ministere delegue a l'Enseignement Superieur et a la Recherche through the Grand Reseau de recherche Regional Vegetal, Agronomie, Sols et Innovations(Region Normandie); National Association of Technical Research through the Compte d'Affectation Speciale pour le Developpement Agricole et Rural; 	This work was supported by: European Union grants: Fonds Europeens de DEveloppement Regional (FEDER); National grants: the National Association of Technical Research through the Compte d'Affectation Speciale pour le Developpement Agricole et Rural, (CAS-DAR AAP 7124 and the Conventions Industrielles de Formation par la Recherche (CIFRE) carried by the Association Nationale de la Recherche et de la Technologie (ANRT); Regional grants: Conseil Regional de Haute-Normandie & Ministere delegue a l'Enseignement Superieur et a la Recherche through the Grand Reseau de recherche Regional Vegetal, Agronomie, Sols et Innovations (GRR VASI, ex-GRR VATA). All for financial supports of researches. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAINTON NJ, 1992, BIOCHEM J, V288, P997, DOI 10.1042/bj2880997; Barnard AML, 2007, ANAL BIOANAL CHEM, V387, P415, DOI 10.1007/s00216-006-0701-1; BASSLER BL, 1993, MOL MICROBIOL, V9, P773, DOI 10.1111/j.1365-2958.1993.tb01737.x; Bassler BL, 1997, J BACTERIOL, V179, P4043, DOI 10.1128/jb.179.12.4043-4045.1997; Bell KS, 2004, P NATL ACAD SCI USA, V101, P11105, DOI 10.1073/pnas.0402424101; Bolton MD, 2009, MOL PLANT MICROBE IN, V22, P487, DOI 10.1094/MPMI-22-5-0487; Brader G, 2005, J BIOL CHEM, V280, P10403, DOI 10.1074/jbc.M408603200; Broek AV, 1999, J BACTERIOL, V181, P1338, DOI 10.1128/JB.181.4.1338-1342.1999; Burr T, 2006, MOL MICROBIOL, V59, P113, DOI 10.1111/j.1365-2958.2005.04939.x; Cha C, 1998, MOL PLANT MICROBE IN, V11, P1119, DOI 10.1094/MPMI.1998.11.11.1119; Charkowski AO, 2009, CURR OPIN BIOTECH, V20, P178, DOI 10.1016/j.copbio.2009.01.005; Charkowski AO, 2006, PLANT-ASSOCIATED BACTERIA, P423; Chatterjee A, 2005, J BACTERIOL, V187, P8026, DOI 10.1128/JB.187.23.8026-8038.2005; Chen X, 2002, NATURE, V415, P545, DOI 10.1038/415545a; Chevrot R, 2006, P NATL ACAD SCI USA, V103, P7460, DOI 10.1073/pnas.0600313103; Cirou A, 2011, RES MICROBIOL, V162, P945, DOI 10.1016/j.resmic.2011.01.010; Cirou A, 2009, PLANT PATH 21ST, V1, P121, DOI 10.1007/978-1-4020-8804-9_10; Coulthurst SJ, 2006, MOL PLANT PATHOL, V7, P31, DOI 10.1111/J.1364-3703.2005.00314.X; Crepin A, 2012, PLANT SOIL, V358, P25, DOI 10.1007/s11104-011-1030-5; Cui Y, 2006, J BACTERIOL, V188, P4715, DOI 10.1128/JB.00351-06; Czajkowski R, 2011, PLANT PATHOL, V60, P999, DOI 10.1111/j.1365-3059.2011.02470.x; Czajkowski R, 2009, EUR J PLANT PATHOL, V125, P263, DOI 10.1007/s10658-009-9480-9; Deziel E, 2004, P NATL ACAD SCI USA, V101, P1339, DOI 10.1073/pnas.0307694100; Diallo S, 2011, FEMS MICROBIOL ECOL, V75, P351, DOI 10.1111/j.1574-6941.2010.01023.x; Diallo S, 2009, EUR J PLANT PATHOL, V125, P349, DOI 10.1007/s10658-009-9477-4; Faure D, 2007, EUR J PLANT PATHOL, V119, P353, DOI 10.1007/s10658-007-9149-1; Fernandez-Pinar R, 2011, RES MICROBIOL, V162, P773, DOI 10.1016/j.resmic.2011.06.013; Fessehaie A, 2002, CAN J MICROBIOL, V48, P387, DOI 10.1139/W02-026; Fuqua C, 1999, CELL-CELL SIGNALING IN BACTERIA, P211; FUQUA WC, 1994, J BACTERIOL, V176, P269, DOI 10.1128/JB.176.2.269-275.1994; Gardan L, 2003, INT J SYST EVOL MICR, V53, P381, DOI 10.1099/ijs.0.02423-0; Glasner JD, 2008, MOL PLANT MICROBE IN, V21, P1549, DOI 10.1094/MPMI-21-12-1549; Glasner JD, 2011, J BACTERIOL, V193, P2076, DOI 10.1128/JB.01513-10; GLICKMANN E, 1995, APPL ENVIRON MICROB, V61, P793, DOI 10.1128/AEM.61.2.793-796.1995; Ham JH, 2004, MOL PLANT MICROBE IN, V17, P184, DOI 10.1094/MPMI.2004.17.2.184; HANCOCK REW, 1979, J BACTERIOL, V140, P902, DOI 10.1128/JB.140.3.902-910.1979; Hardie KR, 2008, NAT REV MICROBIOL, V6, P635, DOI 10.1038/nrmicro1916; Hasegawa H, 2005, APPL ENVIRON MICROB, V71, P4655, DOI 10.1128/AEM.71.8.4655-4663.2005; Heeb S, 2011, FEMS MICROBIOL REV, V35, P247, DOI 10.1111/j.1574-6976.2010.00247.x; Helias V, 2012, PLANT PATHOL, V61, P339, DOI 10.1111/j.1365-3059.2011.02508.x; Hussain MBBM, 2008, J BACTERIOL, V190, P1045, DOI 10.1128/JB.01472-07; Jaeger CH, 1999, APPL ENVIRON MICROB, V65, P2685; Jafra S, 2006, J PHYTOPATHOL, V154, P729, DOI 10.1111/j.1439-0434.2006.01185.x; Kamilova F, 2006, MOL PLANT MICROBE IN, V19, P250, DOI 10.1094/MPMI-19-0250; Keller L, 2006, NAT REV MICROBIOL, V4, P249, DOI 10.1038/nrmicro1383; Kim HS, 2009, APPL ENVIRON MICROB, V75, P4539, DOI 10.1128/AEM.01336-08; Kim K, 2010, IMMUNOLOGY, V129, P578, DOI 10.1111/j.1365-2567.2009.03160.x; KOTOUJANSKY A, 1982, J BACTERIOL, V150, P122, DOI 10.1128/JB.150.1.122-131.1982; Laasik E, 2006, FEMS MICROBIOL LETT, V258, P227, DOI 10.1111/j.1574-6968.2006.00222.x; Latour X, 2008, CAH AGRIC, V17, P355, DOI 10.1684/agr.2008.0210; Latour X, 2007, APPL ENVIRON MICROB, V73, P4078, DOI 10.1128/AEM.02681-06; Lee JH, 2010, FEMS MICROBIOL REV, V34, P426, DOI 10.1111/j.1574-6976.2009.00204.x; Liu H, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000093; Ma B, 2007, PHYTOPATHOLOGY, V97, P1150, DOI 10.1094/PHYTO-97-9-1150; Miller ST, 2004, MOL CELL, V15, P677, DOI 10.1016/j.molcel.2004.07.020; Morin D, 2003, J CHROMATOGR A, V1002, P79, DOI 10.1016/S0021-9673(03)00730-1; Nasser W, 1998, MOL MICROBIOL, V29, P1391, DOI 10.1046/j.1365-2958.1998.01022.x; Ortori CA, 2011, ANAL BIOANAL CHEM, V399, P839, DOI 10.1007/s00216-010-4341-0; Parveen N, 2011, MOL MICROBIOL, V79, P7, DOI 10.1111/j.1365-2958.2010.07455.x; Patten CL, 1996, CAN J MICROBIOL, V42, P207, DOI 10.1139/m96-032; Perombelon MCM, 2002, PLANT PATHOL, V51, P1, DOI 10.1046/j.0032-0862.2001.Short title.doc.x; PIRHONEN M, 1993, EMBO J, V12, P2467, DOI 10.1002/j.1460-2075.1993.tb05901.x; Pitman AR, 2010, EUR J PLANT PATHOL, V126, P423, DOI 10.1007/s10658-009-9551-y; Reading NC, 2006, FEMS MICROBIOL LETT, V254, P1, DOI 10.1111/j.1574-6968.2005.00001.x; Ryan RP, 2008, MICROBIOL-SGM, V154, P1845, DOI 10.1099/mic.0.2008/017871-0; Sambroock J., 1989, MOL CLONING LAB MANU; Samson R, 2005, INT J SYST EVOL MICR, V55, P1415, DOI 10.1099/ijs.0.02791-0; Shaw PD, 1997, P NATL ACAD SCI USA, V94, P6036, DOI 10.1073/pnas.94.12.6036; Shelp BJ, 2006, PLANT PHYSIOL, V142, P1350, DOI 10.1104/pp.106.088955; Shen DK, 2008, MICROBIOL-SGM, V154, P2195, DOI 10.1099/mic.0.2007/013680-0; Sjobolm S, 2006, MOL MICROBIOL, V60, P1474, DOI 10.1111/j.1365-2958.2006.05210.x; Slawiak M, 2009, EUR J PLANT PATHOL, V125, P245, DOI 10.1007/s10658-009-9479-2; Smadja B, 2004, MOL PLANT MICROBE IN, V17, P1269, DOI 10.1094/MPMI.2004.17.11.1269; Smadja B, 2004, CAN J MICROBIOL, V50, P19, DOI 10.1139/W03-099; Spaepen S, 2007, FEMS MICROBIOL REV, V31, P425, DOI 10.1111/j.1574-6976.2007.00072.x; Surette MG, 1998, P NATL ACAD SCI USA, V95, P7046, DOI 10.1073/pnas.95.12.7046; Takle GW, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-50; Toth IK, 2011, PLANT PATHOL, V60, P385, DOI 10.1111/j.1365-3059.2011.02427.x; Toth IK, 2006, ANNU REV PHYTOPATHOL, V44, P305, DOI 10.1146/annurev.phyto.44.070505.143444; Tsror L, 2009, EUR J PLANT PATHOL, V123, P311, DOI 10.1007/s10658-008-9368-0; Ueno H, 2000, J MOL CATAL B-ENZYM, V10, P67, DOI 10.1016/S1381-1177(00)00114-4; Vendeville A, 2005, NAT REV MICROBIOL, V3, P383, DOI 10.1038/nrmicro1146; Wang C, 2006, MOL MICROBIOL, V62, P45, DOI 10.1111/j.1365-2958.2006.05351.x; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; Welch M, 2005, BIOORG MED CHEM LETT, V15, P4235, DOI 10.1016/j.bmcl.2005.06.066; Winson MK, 1998, FEMS MICROBIOL LETT, V163, P185, DOI 10.1111/j.1574-6968.1998.tb13044.x; Yang SH, 2007, APPL ENVIRON MICROB, V73, P1079, DOI 10.1128/AEM.01770-06; Yuan ZC, 2008, CELL MICROBIOL, V10, P2339, DOI 10.1111/j.1462-5822.2008.01215.x; ZINK RT, 1984, J BACTERIOL, V157, P809, DOI 10.1128/JB.157.3.809-814.1984	89	38	40	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35176	10.1371/journal.pone.0035176	http://dx.doi.org/10.1371/journal.pone.0035176			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22539957	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341000021
J	Mukhopadhyay, A; Maulik, U; Bandyopadhyay, S				Mukhopadhyay, Anirban; Maulik, Ujjwal; Bandyopadhyay, Sanghamitra			A Novel Biclustering Approach to Association Rule Mining for Predicting HIV-1-Human Protein Interactions	PLOS ONE			English	Article							SMALL-MOLECULE INHIBITORS; HIV-1 GP120; ALGORITHMS; ACTIVATION; MECHANISM; TYPE-1	Identification of potential viral-host protein interactions is a vital and useful approach towards development of new drugs targeting those interactions. In recent days, computational tools are being utilized for predicting viral-host interactions. Recently a database containing records of experimentally validated interactions between a set of HIV-1 proteins and a set of human proteins has been published. The problem of predicting new interactions based on this database is usually posed as a classification problem. However, posing the problem as a classification one suffers from the lack of biologically validated negative interactions. Therefore it will be beneficial to use the existing database for predicting new viral-host interactions without the need of negative samples. Motivated by this, in this article, the HIV-1-human protein interaction database has been analyzed using association rule mining. The main objective is to identify a set of association rules both among the HIV-1 proteins and among the human proteins, and use these rules for predicting new interactions. In this regard, a novel association rule mining technique based on biclustering has been proposed for discovering frequent closed itemsets followed by the association rules from the adjacency matrix of the HIV-1-human interaction network. Novel HIV-1-human interactions have been predicted based on the discovered association rules and tested for biological significance. For validation of the predicted new interactions, gene ontology-based and pathway-based studies have been performed. These studies show that the human proteins which are predicted to interact with a particular viral protein share many common biological activities. Moreover, literature survey has been used for validation purpose to identify some predicted interactions that are already validated experimentally but not present in the database. Comparison with other prediction methods is also discussed.	[Mukhopadhyay, Anirban] Univ Kalyani, Dept Comp Sci & Engn, Kalyani 741235, W Bengal, India; [Maulik, Ujjwal] Jadavpur Univ, Dept Comp Sci & Engn, Kolkata, W Bengal, India; [Bandyopadhyay, Sanghamitra] Indian Stat Inst, Machine Intelligence Unit, Kolkata, W Bengal, India	Kalyani University; Jadavpur University; Indian Statistical Institute; Indian Statistical Institute Kolkata	Mukhopadhyay, A (corresponding author), Univ Kalyani, Dept Comp Sci & Engn, Kalyani 741235, W Bengal, India.	anirban@klyuniv.ac.in	Maulik, Ujjwal/AAO-8754-2020; Bandyopadhyay, Sanghamitra/AAP-4578-2020; Bandyopadhyay, Sanghamitra/A-6597-2010; Mukhopadhyay, Anirban/H-3220-2012; Mukhopadhyay, Anirban/ABB-5739-2021; Bandyopadhyay, Sanghamitra/AAO-7010-2020	Bandyopadhyay, Sanghamitra/0000-0001-6370-2083; Mukhopadhyay, Anirban/0000-0001-8128-3521; Maulik, Ujjwal/0000-0003-1167-0774	Humboldt Foundation; Humboldt fellowship for experienced researchers	Humboldt Foundation(Alexander von Humboldt Foundation); Humboldt fellowship for experienced researchers	UM acknowledges the partial support received from Humboldt Foundation during his visit to German Cancer Research Center (DKFZ), Heidelberg, Germany with the Humboldt fellowship for experienced researchers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal R., 1993, SIGMOD Record, V22, P207, DOI 10.1145/170036.170072; Agrawal R., 1994, VLDB, P487, DOI DOI 10.1007/BF02948845; Arkin MR, 2004, NAT REV DRUG DISCOV, V3, P301, DOI 10.1038/nrd1343; Bandyopadhyay S., 2005, ADV METHODS KNOWLEDG; Ben-Hur A, 2005, BIOINFORMATICS, V21, pI38, DOI 10.1093/bioinformatics/bti1016; Cheung R, 2008, J IMMUNOL, V180, P6675, DOI 10.4049/jimmunol.180.10.6675; DeFranco A., 2007, IMMUNITY IMMUNE RESP; Doolittle JM, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-82; Dyer MD, 2011, INFECT GENET EVOL, V11, P917, DOI 10.1016/j.meegid.2011.02.022; Fu W, 2009, NUCLEIC ACIDS RES, V37, pD417, DOI 10.1093/nar/gkn708; Gibellini D, 2010, BIOCHEM BIOPH RES CO, V401, P429, DOI 10.1016/j.bbrc.2010.09.071; Goethals B, 2002, THESIS U LIMBURG BEL; Gupta P, 2011, J MOL BIOL, V410, P681, DOI 10.1016/j.jmb.2011.03.022; Hipp J., 2000, SIGKDD EXPLOR NEWSL, P1, DOI DOI 10.1145/360402.360421; Huang J, 1997, P NATL ACAD SCI USA, V94, P13396, DOI 10.1073/pnas.94.25.13396; Jansen R, 2003, SCIENCE, V302, P449, DOI 10.1126/science.1087361; Jiang J, 2010, CARDIOVASC RES, V87, P366, DOI 10.1093/cvr/cvq013; Lin N, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-154; MacPherson JI, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000863; Madeira SC, 2004, IEEE ACM T COMPUT BI, V1, P24, DOI 10.1109/TCBB.2004.2; Maulik U., 2011, MULTIOBJECTIVE GENET; Maulik U, 2011, MOL BIOSYST, V7, P1842, DOI 10.1039/c1mb05026e; Maulik U, 2009, IEEE T INF TECHNOL B, V13, P969, DOI 10.1109/TITB.2009.2017527; Maulik U, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-27; Mukhopadhyay A., 2010, 2010 International Conference on Systems in Medicine and Biology (ICSMB), P344, DOI 10.1109/ICSMB.2010.5735401; Mukhopadhyay A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013803; Mukhopadhyay A, 2010, CURR BIOINFORM, V5, P204, DOI 10.2174/157489310792006701; Panchenko A., 2008, PROTEIN PROTEIN INTE, V9; Pasquier N, 1999, LECT NOTES COMPUT SC, V1540, P398; Prelic A, 2006, BIOINFORMATICS, V22, P1122, DOI 10.1093/bioinformatics/btl060; Ptak RG, 2008, AIDS RES HUM RETROV, V24, P1497, DOI 10.1089/aid.2008.0113; Qi Y, 2007, BMC BIOINFORMATICS, V8; Qi Y, 2010, BIOINFORMATICS, V26; Saha RN, 2007, FREE RADICAL BIO MED, V42, P1866, DOI 10.1016/j.freeradbiomed.2007.03.022; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Tastan O, 2009, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2009, P516; Vashistha H, 2009, RENAL FAILURE, V31, P303, DOI 10.1080/08860220902780101; Wang XQ, 2009, MOL IMMUNOL, V46, P3462, DOI 10.1016/j.molimm.2009.08.001; Yamanishi Y, 2004, BIOINFORMATICS, V20, P363, DOI 10.1093/bioinformatics/bth910; Zaki MJ, 2005, IEEE T KNOWL DATA EN, V17, P462, DOI 10.1109/TKDE.2005.60; Zhang LV, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-38; Zhou C, 2011, J BIOL CHEM, V286, P44869, DOI 10.1074/jbc.M111.267393	42	37	38	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e32289	10.1371/journal.pone.0032289	http://dx.doi.org/10.1371/journal.pone.0032289			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22539940	Green Published, gold			2022-12-27	WOS:000305341000003
J	Barosi, G; Rosti, V; Bonetti, E; Campanelli, R; Carolei, A; Catarsi, P; Isgro, AM; Lupo, L; Massa, M; Poletto, V; Viarengo, G; Villani, L; Magrini, U				Barosi, Giovanni; Rosti, Vittorio; Bonetti, Elisa; Campanelli, Rita; Carolei, Adriana; Catarsi, Paolo; Isgro, Antonina M.; Lupo, Letizia; Massa, Margherita; Poletto, Valentina; Viarengo, Gianluca; Villani, Laura; Magrini, Umberto			Evidence that Prefibrotic Myelofibrosis Is Aligned along a Clinical and Biological Continuum Featuring Primary Myelofibrosis	PLOS ONE			English	Article							INTERNATIONAL WORKING GROUP; BONE-MARROW BIOPSY; ESSENTIAL THROMBOCYTHEMIA; MYELOID METAPLASIA; MYELOPROLIFERATIVE DISORDERS; IDIOPATHIC MYELOFIBROSIS; DIAGNOSTIC-CRITERIA; PROGNOSTIC-FACTORS; POLYCYTHEMIA-VERA; VEIN-THROMBOSIS	Purpose: In the WHO diagnostic classification, prefibrotic myelofibrosis (pre-MF) is included in the category of primary myelofibrosis (PMF). However, strong evidence for this position is lacking. Patients and Methods: We investigated whether pre-MF may be aligned along a clinical and biological continuum in 683 consecutive patients who received a WHO diagnosis of PMF. Results: As compared with PMF-fibrotic type, pre-MF (132 cases) showed female dominance, younger age, higher hemoglobin, higher platelet count, lower white blood cell count, smaller spleen index and higher incidence of splanchnic vein thrombosis. Female to male ratio and hemoglobin steadily decreased, while age increased from pre-MF to PMF- fibrotic type with early and to advanced bone marrow (BM) fibrosis. Likely, circulating CD34+ cells, LDH levels, and frequency of chromosomal abnormalities increased, while CXCR4 expression on CD34+ cells and serum cholesterol decreased along the continuum of BM fibrosis. Median survival of the entire cohort of PMF cases was 21 years. Ninety-eight, eighty-one and fifty-six percent of patients with pre-MF, PMF- fibrotic type with early and with advanced BM fibrosis, respectively, were alive at 10 years from diagnosis. Conclusion: Pre-MF is a presentation mode of PMF with a very indolent phenotype. The major consequences of this contention is a new clinical vision of PMF, and the need to improve prognosis prediction of the disease.	[Barosi, Giovanni; Rosti, Vittorio; Bonetti, Elisa; Campanelli, Rita; Carolei, Adriana; Catarsi, Paolo; Isgro, Antonina M.; Lupo, Letizia; Poletto, Valentina; Villani, Laura; Magrini, Umberto] IRCCS Policlin S Matteo Fdn, Lab Clin Epidemiol, Pavia, Italy; [Barosi, Giovanni; Rosti, Vittorio; Bonetti, Elisa; Campanelli, Rita; Carolei, Adriana; Catarsi, Paolo; Isgro, Antonina M.; Lupo, Letizia; Poletto, Valentina; Villani, Laura; Magrini, Umberto] IRCCS Policlin S Matteo Fdn, Ctr Study Myelofibrosis, Pavia, Italy; [Massa, Margherita] IRCCS Policlin S Matteo Fdn, Biotechnol Res Area, Pavia, Italy; [Viarengo, Gianluca] IRCCS Policlin S Matteo Fdn, Unit Clin Immunol Immunohematol & Transfus Serv, Pavia, Italy	IRCCS Fondazione San Matteo; IRCCS Fondazione San Matteo; IRCCS Fondazione San Matteo; IRCCS Fondazione San Matteo	Barosi, G (corresponding author), IRCCS Policlin S Matteo Fdn, Lab Clin Epidemiol, Pavia, Italy.	barosig@smatteo.pv.it	Carolei, Adriana/AAQ-7656-2021; Massa, Margherita/K-4682-2016; Rosti, Vittorio/K-1743-2018; Bonetti, Elisa/D-4478-2016; Barosi, Giovanni/AAI-1714-2019; Villani, Laura/K-1794-2018; Campanelli, Rita/K-4686-2016; Catarsi, Paolo/J-4463-2016	Carolei, Adriana/0000-0002-5254-8532; Massa, Margherita/0000-0001-8037-0439; Rosti, Vittorio/0000-0003-4195-2289; Bonetti, Elisa/0000-0002-8406-5252; Villani, Laura/0000-0003-4199-5633; Campanelli, Rita/0000-0003-4923-2761; Catarsi, Paolo/0000-0002-1862-8168	Associazione Italiana per la Ricerca sul Cancro (AIRC, Milano)	Associazione Italiana per la Ricerca sul Cancro (AIRC, Milano)(Fondazione AIRC per la ricerca sul cancro)	This work has been supported by a grant from Associazione Italiana per la Ricerca sul Cancro (AIRC, Milano) "Special Program Molecular Clinical Oncology 5 x 1000" to AGIMM (AIRC-Gruppo Italiano Malattie Mieloproliferative). A detailed description of the AGIMM project is available at http://www.progettoagimm.it. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allegra A, 2009, ACTA HAEMATOL-BASEL, V121, P218, DOI 10.1159/000221962; Balduini A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021015; Barbui T, 2011, J CLIN ONCOL, V29, P3179, DOI 10.1200/JCO.2010.34.5298; Barosi G, 1999, BRIT J HAEMATOL, V104, P730, DOI 10.1046/j.1365-2141.1999.01262.x; BAROSI G, 1988, BRIT J HAEMATOL, V70, P397, DOI 10.1111/j.1365-2141.1988.tb02507.x; BAROSI G, 1991, CANCER, V68, P2310, DOI 10.1002/1097-0142(19911115)68:10<2310::AID-CNCR2820681034>3.0.CO;2-2; BAROSI G, 1981, BRIT J HAEMATOL, V48, P263; Barosi G, 2001, BLOOD, V98, P3249, DOI 10.1182/blood.V98.12.3249; Barosi G, 2007, BLOOD, V110, P4030, DOI 10.1182/blood-2007-07-099184; Brousseau M, 2010, HISTOPATHOLOGY, V56, P758, DOI 10.1111/j.1365-2559.2010.03545.x; Buhr T, 2011, HAEMATOLOGICA   1104; Cervantes F, 1997, BRIT J HAEMATOL, V97, P635, DOI 10.1046/j.1365-2141.1997.782714.x; Cervantes F, 2009, BLOOD, V113, P2895, DOI 10.1182/blood-2008-07-170449; DAMESHEK W, 1951, BLOOD, V6, P372, DOI 10.1182/blood.V6.4.372.372; De Stefano V, 2007, J THROMB HAEMOST, V5, P708, DOI 10.1111/j.1538-7836.2007.02424.x; Dupriez B, 1996, BLOOD, V88, P1013; Finazzi G, 2011, LEUKEMIA; Gilbert H S, 1984, Prog Clin Biol Res, V154, P3; Guglielmelli P, 2011, BLOOD           0914; Hussein K, 2009, EXP HEMATOL, V37, P1186, DOI 10.1016/j.exphem.2009.07.005; Koopmans SM, 2011, AM J CLIN PATHOL, V136, P618, DOI 10.1309/AJCP2UG9SGGWAHUA; Kreft A, 2003, ANN HEMATOL, V82, P605, DOI 10.1007/s00277-003-0719-9; Kvasnicka HM, 1997, CANCER, V80, P708, DOI 10.1002/(SICI)1097-0142(19970815)80:4<708::AID-CNCR9>3.0.CO;2-I; Landolfi R, 2011, INTERN EMERG ME 0610; LASZLO J, 1975, SEMIN HEMATOL, V12, P409; Orr DW, 2010, ALIMENT PHARM THER, V31, P1330, DOI 10.1111/j.1365-2036.2010.04299.x; PAGLIUCA A, 1990, Q J MED, V76, P981; Pardanani A, 2011, LEUKEMIA; Passamonti F, 2010, BLOOD, V115, P1703, DOI 10.1182/blood-2009-09-245837; Primignani M, 2006, HEPATOLOGY, V44, P1528, DOI 10.1002/hep.21435; Reilly JT, 1997, BRIT J HAEMATOL, V98, P96, DOI 10.1046/j.1365-2141.1997.1722990.x; Risum M, 2011, APMIS, V119, P498, DOI 10.1111/j.1600-0463.2011.02754.x; Rosti V, 2007, BLOOD CELL MOL DIS, V38, P280, DOI 10.1016/j.bcmd.2007.01.003; Rosti V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015277; RUPOLI S, 1994, ANN HEMATOL, V68, P205, DOI 10.1007/BF01834368; Stein BL, 2010, HAEMATOL-HEMATOL J, V95, P1090, DOI 10.3324/haematol.2009.014407; Tefferi A, 2007, BLOOD, V110, P1092, DOI 10.1182/blood-2007-04-083501; Tefferi A, 2010, AM J HEMATOL, V85, P14, DOI 10.1002/ajh.21574; Thiele J, 1999, LEUKEMIA, V13, P1741, DOI 10.1038/sj.leu.2401553; Thiele J, 1999, LEUKEMIA LYMPHOMA, V33, P207, DOI 10.3109/10428199909058421; Thiele J, 1996, LEUKEMIA LYMPHOMA, V22, P303, DOI 10.3109/10428199609051762; THIELE J, 2001, WHO CLASSIFICATION T, P35; Thiele J, 2005, HAEMATOLOGICA, V90, P1128; Thiele J, 2011, BLOOD, V117, P5710, DOI 10.1182/blood-2010-07-293761; VISANI G, 1990, BRIT J HAEMATOL, V75, P4, DOI 10.1111/j.1365-2141.1990.tb02609.x; Wilkins BS, 2008, BLOOD, V111, P60, DOI 10.1182/blood-2007-05-091850	46	71	72	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35631	10.1371/journal.pone.0035631	http://dx.doi.org/10.1371/journal.pone.0035631			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536419	Green Submitted, gold, Green Published			2022-12-27	WOS:000305339200088
J	Hu, YY; Yuan, H; Jiang, GB; Chen, N; Wen, L; Leng, WD; Zeng, XT; Niu, YM				Hu, Yuan Yuan; Yuan, Hua; Jiang, Guang Bing; Chen, Ning; Wen, Li; Leng, Wei Dong; Zeng, Xian Tao; Niu, Yu Ming			Associations between XPD Asp312Asn Polymorphism and Risk of Head and Neck Cancer: A Meta-Analysis Based on 7,122 Subjects	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; SINGLE-NUCLEOTIDE POLYMORPHISMS; EXCISION-REPAIR GENES; DNA-REPAIR; SMOKING; PREVALENCE; ADDUCTS; TRIALS; SAMPLE; DAMAGE	Background: To investigate the association between XPD Asp312Asn polymorphism and head and neck cancer risk through this meta-analysis. Methods: We performed a meta-analysis of 9 published case-control studies including 2,670 patients with head and neck cancer and 4,452 controls. An odds ratio (OR) with a 95% confidence interval (CI) was applied to assess the association between XPD Asp312Asn polymorphism and head and neck cancer risk. Results: Overall, no significant association between XPD Asp312Asn polymorphism and head and neck cancer risk was found in this meta-analysis (Asn/Asn vs. Asp/Asp: OR = 0.95, 95% CI = 0.80-1.13, P = 0.550, P-heterogeneity = 0.126; Asp/Asn vs. Asp/Asp: OR = 1.11, 95% CI = 0.99-1.24, P = 0.065, P-heterogeneity = 0.663; Asn/Asn+Asp/Asn vs. Asp/Asp: OR = 1.07, 95% CI = 0.97-1.19, P = 0.189, P-heterogeneity = 0.627; Asn/Asn vs. Asp/Asp+Asp/Asn: OR = 0.87, 95% CI = 0.68-1.10, P = 0.243, P-heterogeneity = 0.089). In the subgroup analysis by HWE, ethnicity, and study design, there was still no significant association detected in all genetic models. Conclusions: This meta-analysis demonstrates that XPD Asp312Asn polymorphism may not be a risk factor for developing head and neck cancer.	[Hu, Yuan Yuan; Leng, Wei Dong; Zeng, Xian Tao; Niu, Yu Ming] Hubei Univ Med, Taihe Hosp, Dept Stomatol, Shiyan, Peoples R China; [Yuan, Hua; Chen, Ning; Niu, Yu Ming] Nanjing Med Univ, Inst Dent Res, Nanjing, Jiangsu, Peoples R China; [Jiang, Guang Bing] Hubei Univ Med, Taihe Hosp, Dept Radiol, Shiyan, Peoples R China; [Wen, Li] Hubei Univ Med, Taihe Hosp, Dept Dermatol, Shiyan, Peoples R China	Hubei University of Medicine; Nanjing Medical University; Hubei University of Medicine; Hubei University of Medicine	Niu, YM (corresponding author), Hubei Univ Med, Taihe Hosp, Dept Stomatol, Shiyan, Peoples R China.	niuyuming@yeah.net		Zeng, Xian-Tao/0000-0003-1262-725X; Chen, Ning/0000-0003-4785-5076	Medical Development Foundation of Health Department of Jiangsu Province [H200811]; Natural Science Foundation of Jiangsu Higher Education Institutions [08KJB320008]	Medical Development Foundation of Health Department of Jiangsu Province; Natural Science Foundation of Jiangsu Higher Education Institutions	This work was partly supported by grants from the Medical Development Foundation of Health Department of Jiangsu Province (H200811) and Natural Science Foundation of Jiangsu Higher Education Institutions (08KJB320008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi R, 2009, INT J CANCER, V125, P1431, DOI 10.1002/ijc.24442; An J, 2007, CANCER EPIDEM BIOMAR, V16, P1633, DOI 10.1158/1055-9965.EPI-07-0252; Argiris A, 2008, LANCET, V371, P1695, DOI 10.1016/S0140-6736(08)60728-X; BLOT WJ, 1988, CANCER RES, V48, P3282; Coin F, 1998, NAT GENET, V20, P184, DOI 10.1038/2491; de Boer J, 2000, CARCINOGENESIS, V21, P453, DOI 10.1093/carcin/21.3.453; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Flores-Obando RE, 2010, BIOMARKERS, V15, P379, DOI 10.3109/13547501003797664; Goode EL, 2002, CANCER EPIDEM BIOMAR, V11, P1513; Gugatschka M, 2011, EXP MOL PATHOL, V91, P331, DOI 10.1016/j.yexmp.2011.03.004; Harbord RM, 2006, STAT MED, V25, P3443, DOI 10.1002/sim.2380; Harth V, 2008, J TOXICOL ENV HEAL A, V71, P887, DOI 10.1080/15287390801988160; Hou SM, 2002, CARCINOGENESIS, V23, P599, DOI 10.1093/carcin/23.4.599; Jelonek K, 2010, J APPL GENET, V51, P343, DOI 10.1007/BF03208865; Ji YB, 2010, CLIN EXP OTORHINOLAR, V3, P42, DOI 10.3342/ceo.2010.3.1.42; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Little J, 2002, AM J EPIDEMIOL, V156, P300, DOI 10.1093/oxfordjournals.aje.a000179; Majumder M, 2007, INT J CANCER, V120, P2148, DOI 10.1002/ijc.22547; Matullo G, 2006, CARCINOGENESIS, V27, P997, DOI 10.1093/carcin/bgi280; Matullo G, 2001, CARCINOGENESIS, V22, P1437, DOI 10.1093/carcin/22.9.1437; Pabalan N, 2010, BREAST CANCER RES TR, V124, P531, DOI 10.1007/s10549-010-0863-6; Pastorelli R, 2002, INT J CANCER, V100, P9, DOI 10.1002/ijc.10463; Sturgis EM, 2002, ARCH OTOLARYNGOL, V128, P1084, DOI 10.1001/archotol.128.9.1084; Wang F, 2008, CANCER EPIDEM BIOMAR, V17, P507, DOI 10.1158/1055-9965.EPI-07-2507; Winkler GS, 2000, J BIOL CHEM, V275, P4258, DOI 10.1074/jbc.275.6.4258; Wolfe KJ, 2007, PHARMACOGENET GENOM, V17, P897, DOI 10.1097/FPC.0b013e3280115e63; Zhang J, 2011, MED ONCOL, V28, P655, DOI 10.1007/s12032-010-9501-8	29	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35220	10.1371/journal.pone.0035220	http://dx.doi.org/10.1371/journal.pone.0035220			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536360	Green Submitted, Green Published, gold			2022-12-27	WOS:000305339200046
J	Martel, G; Crawford, A; Barkun, JS; Boushey, RP; Ramsay, CR; Fergusson, DA				Martel, Guillaume; Crawford, Alyson; Barkun, Jeffrey S.; Boushey, Robin P.; Ramsay, Craig R.; Fergusson, Dean A.			Expert Opinion on Laparoscopic Surgery for Colorectal Cancer Parallels Evidence from a Cumulative Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Article							TOTAL MESORECTAL EXCISION; VS. OPEN COLECTOMY; MRC CLASICC TRIAL; QUALITY-OF-LIFE; RECTAL-CANCER; CLINICAL-TRIAL; COLON-CANCER; RESECTION; CARCINOMA; COMPLICATIONS	Background: This study sought to synthesize survival outcomes from trials of laparoscopic and open colorectal cancer surgery, and to determine whether expert acceptance of this technology in the literature has parallel cumulative survival evidence. Study Design: A systematic review of randomized trials was conducted. The primary outcome was survival, and meta-analysis of time-to-event data was conducted. Expert opinion in the literature (published reviews, guidelines, and textbook chapters) on the acceptability of laparoscopic colorectal cancer was graded using a 7-point scale. Pooled survival data were correlated in time with accumulating expert opinion scores. Results: A total of 5,800 citations were screened. Of these, 39 publications pertaining to 23 individual trials were retained. As well, 414 reviews were included (28 guidelines, 30 textbook chapters, 20 systematic reviews, 336 narrative reviews). In total, 5,782 patients were randomized to laparoscopic (n = 3,031) and open (n = 2,751) colorectal surgery. Survival data were presented in 16 publications. Laparoscopic surgery was not inferior to open surgery in terms of overall survival (HR = 0.94, 95% CI 0.80, 1.09). Expert opinion in the literature pertaining to the oncologic acceptability of laparoscopic surgery for colon cancer correlated most closely with the publication of large RCTs in 2002-2004. Although increasingly accepted since 2006, laparoscopic surgery for rectal cancer remained controversial. Conclusions: Laparoscopic surgery for colon cancer is non-inferior to open surgery in terms of overall survival, and has been so since 2004. The majority expert opinion in the literature has considered these two techniques to be equivalent since 2002-2004. Laparoscopic surgery for rectal cancer has been increasingly accepted since 2006, but remains controversial. Knowledge translation efforts in this field appear to have paralleled the accumulation of clinical trial evidence.	[Martel, Guillaume; Crawford, Alyson; Boushey, Robin P.; Fergusson, Dean A.] Univ Ottawa, Ottawa Hosp, Dept Surg, Dept Epidemiol & Community Med, Ottawa, ON, Canada; [Martel, Guillaume; Crawford, Alyson; Boushey, Robin P.; Fergusson, Dean A.] Univ Ottawa, Ottawa Hosp, Res Inst, Ottawa, ON, Canada; [Barkun, Jeffrey S.] McGill Univ, Dept Surg, Montreal, PQ H3A 2T5, Canada; [Barkun, Jeffrey S.] McGill Univ, Div Clin Epidemiol, Montreal, PQ, Canada; [Ramsay, Craig R.] Univ Aberdeen, Hlth Serv Res Unit, Aberdeen, Foresterhill, Scotland	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; McGill University; McGill University; University of Aberdeen	Martel, G (corresponding author), Univ Ottawa, Ottawa Hosp, Dept Surg, Dept Epidemiol & Community Med, Ottawa, ON, Canada.	guill_martel@hotmail.com	Ramsay, Craig/AAD-8249-2021	Ramsay, Craig/0000-0003-4043-7349; Fergusson, Dean/0000-0002-3389-2485	Canadian Society of Colon and Rectal Surgeons; Canadian Institutes of Health Research; Chief Scientist Office [HSRU1] Funding Source: researchfish	Canadian Society of Colon and Rectal Surgeons; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Chief Scientist Office	This work is supported by an Operating Grant from the Canadian Society of Colon and Rectal Surgeons (http://www.cscrs.ca/en/index.asp). GM was supported by a Fellowship Award in the Area of Knowledge Translation from the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/36678.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American College of Surgeons Oncology Group, 2011, LAP ASS RES OP RES T; Araujo Sergio Eduardo Alonso, 2003, Rev. Hosp. Clin., V58, P133, DOI 10.1590/S0041-87812003000300002; Barkun JS, 2009, LANCET, V374, P1089, DOI 10.1016/S0140-6736(09)61083-7; Bonjer HJ, 2009, DAN MED BULL, V56, P89; Bonjer HJ, 2009, LANCET ONCOL, V10, P44, DOI 10.1016/S1470-2045(08)70310-3; Bonjer HJ, 2005, LANCET ONCOL, V6, P477, DOI 10.1016/S1470-2045(05)70221-7; Braga M, 2005, DIS COLON RECTUM, V48, P2217, DOI 10.1007/s10350-005-0185-7; Braga M, 2007, DIS COLON RECTUM, V50, P464, DOI 10.1007/s10350-006-0798-5; Chung CC, 2007, ANN SURG, V246, P728, DOI 10.1097/SLA.0b013e318123fbdf; Curet MJ, 2000, SURG ENDOSC-ULTRAS, V14, P1062, DOI 10.1007/s004640000092; Delgado S, 2000, SURG ENDOSC, V14, P22, DOI 10.1007/s004649900004; Fleshman J, 2007, ANN SURG, V246, P655, DOI 10.1097/SLA.0b013e318155a762; Fowler D L, 1991, Surg Laparosc Endosc, V1, P183; Gonzalez IA, 2006, INT J COLORECTAL DIS, V21, P590, DOI 10.1007/s00384-005-0057-6; Guillou PJ, 2005, LANCET, V365, P1718, DOI 10.1016/S0140-6736(05)66545-2; Hasegawa H, 2003, SURG ENDOSC, V17, P636, DOI 10.1007/s00464-002-8516-4; Hewett PJ, 2008, ANN SURG, V248, P728, DOI 10.1097/SLA.0b013e31818b7595; Jackson TD, 2007, J AM COLL SURGEONS, V204, P439, DOI 10.1016/j.jamcollsurg.2006.12.008; Janson M, 2007, SURG ENDOSC, V21, P747, DOI 10.1007/s00464-007-9217-9; Jayne DG, 2007, J CLIN ONCOL, V25, P3061, DOI 10.1200/JCO.2006.09.7758; Jayne DG, 2005, BRIT J SURG, V92, P1124, DOI 10.1002/bjs.4989; Kaiser AM, 2004, J LAPAROENDOSC ADV A, V14, P329, DOI 10.1089/lap.2004.14.329; King PM, 2008, INT J COLORECTAL DIS, V23, P795, DOI 10.1007/s00384-008-0478-0; King PM, 2006, BRIT J SURG, V93, P300, DOI 10.1002/bjs.5216; Kuhry E, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003432.pub2; LACY AM, 1995, SURG ENDOSC-ULTRAS, V9, P1101; Lacy AM, 1998, SURG ENDOSC-ULTRAS, V12, P1039, DOI 10.1007/s004649900776; Lacy AM, 2002, LANCET, V359, P2224, DOI 10.1016/S0140-6736(02)09290-5; Lacy AM, 2008, ANN SURG, V248, P1, DOI 10.1097/SLA.0b013e31816a9d65; Leung KL, 2004, LANCET, V363, P1187, DOI 10.1016/S0140-6736(04)15947-3; Liang JT, 2007, ANN SURG ONCOL, V14, P109, DOI 10.1245/s10434-006-9135-4; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Martel G, 2006, SURG CLIN N AM, V86, P867, DOI 10.1016/j.suc.2006.05.006; Martel G, 2012, SYST REV-LONDON, V1, DOI 10.1186/2046-4053-1-14; Milsom JW, 2005, SURG CLIN N AM, V85, P25, DOI 10.1016/j.suc.2004.10.002; Milsom JW, 1998, J AM COLL SURGEONS, V187, P46, DOI 10.1016/S1072-7515(98)00132-X; Murray A, 2006, HEALTH TECHNOL ASSES, V10, P1; Nelson H, 2004, NEW ENGL J MED, V350, P2050; Ng SSM, 2008, ANN SURG ONCOL, V15, P2418, DOI 10.1245/s10434-008-9895-0; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Pechlivanides G, 2007, DIGEST DIS, V25, P94, DOI 10.1159/000099176; Quah HM, 2002, BRIT J SURG, V89, P1551, DOI 10.1046/j.1365-2168.2002.02275.x; Ramacciato Giovanni, 2008, Chir Ital, V60, P1; Ramsay C R, 2001, Health Technol Assess, V5, P1; Schwenk W, 1998, SURG ENDOSC, V12, P1131, DOI 10.1007/s004649900799; Schwenk W, 1998, LANGENBECK ARCH SURG, V383, P49, DOI 10.1007/s004230050091; Schwenk W, 1999, ARCH SURG-CHICAGO, V134, P6, DOI 10.1001/archsurg.134.1.6; Schwenk W, 1998, ZBL CHIR, V123, P483; Senagore AJ, 2005, SURG CLIN N AM, V85, P19, DOI 10.1016/j.suc.2004.09.007; Stage JG, 1997, BRIT J SURG, V84, P391, DOI 10.1046/j.1365-2168.1997.02516.x; Sydes M, CALCULATION SPREADSH; [The Colon cancer Laparoscopic Open Resection Study Group], 2005, SURG LAPARO ENDO PER, V6, P477; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Weeks JC, 2000, JAMA-J AM MED ASSOC, V287, P321; Williamson PR, 2002, STAT MED, V21, P3337, DOI 10.1002/sim.1303; Winslow ER, 2002, SURG ENDOSC, V16, P1420, DOI 10.1007/s00464-002-8837-3; Zhou ZG, 2004, SURG ENDOSC, V18, P1211, DOI 10.1007/s00464-003-9170-1	57	39	46	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35292	10.1371/journal.pone.0035292	http://dx.doi.org/10.1371/journal.pone.0035292			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22532846	Green Published, gold, Green Submitted			2022-12-27	WOS:000305339200050
J	Martinez-Garcia, M; Brazel, DM; Swan, BK; Arnosti, C; Chain, PSG; Reitenga, KG; Xie, G; Poulton, NJ; Gomez, ML; Masland, DED; Thompson, B; Bellows, WK; Ziervogel, K; Lo, CC; Ahmed, S; Gleasner, CD; Detter, CJ; Stepanauskas, R				Martinez-Garcia, Manuel; Brazel, David M.; Swan, Brandon K.; Arnosti, Carol; Chain, Patrick S. G.; Reitenga, Krista G.; Xie, Gary; Poulton, Nicole J.; Gomez, Monica Lluesma; Masland, Dashiell E. D.; Thompson, Brian; Bellows, Wendy K.; Ziervogel, Kai; Lo, Chien-Chi; Ahmed, Sanaa; Gleasner, Cheryl D.; Detter, Chris J.; Stepanauskas, Ramunas			Capturing Single Cell Genomes of Active Polysaccharide Degraders: An Unexpected Contribution of Verrucomicrobia	PLOS ONE			English	Article							RIBOSOMAL-RNA; HYDROLYSIS RATES; MARINE-BACTERIA; GEN. NOV.; SEQUENCE; IDENTIFICATION; AMPLIFICATION; DEGRADATION; ASSEMBLAGES; METABOLISM	Microbial hydrolysis of polysaccharides is critical to ecosystem functioning and is of great interest in diverse biotechnological applications, such as biofuel production and bioremediation. Here we demonstrate the use of a new, efficient approach to recover genomes of active polysaccharide degraders from natural, complex microbial assemblages, using a combination of fluorescently labeled substrates, fluorescence-activated cell sorting, and single cell genomics. We employed this approach to analyze freshwater and coastal bacterioplankton for degraders of laminarin and xylan, two of the most abundant storage and structural polysaccharides in nature. Our results suggest that a few phylotypes of Verrucomicrobia make a considerable contribution to polysaccharide degradation, although they constituted only a minor fraction of the total microbial community. Genomic sequencing of five cells, representing the most predominant, polysaccharide-active Verrucomicrobia phylotype, revealed significant enrichment in genes encoding a wide spectrum of glycoside hydrolases, sulfatases, peptidases, carbohydrate lyases and esterases, confirming that these organisms were well equipped for the hydrolysis of diverse polysaccharides. Remarkably, this enrichment was on average higher than in the sequenced representatives of Bacteroidetes, which are frequently regarded as highly efficient biopolymer degraders. These findings shed light on the ecological roles of uncultured Verrucomicrobia and suggest specific taxa as promising bioprospecting targets. The employed method offers a powerful tool to rapidly identify and recover discrete genomes of active players in polysaccharide degradation, without the need for cultivation.	[Martinez-Garcia, Manuel; Brazel, David M.; Swan, Brandon K.; Poulton, Nicole J.; Gomez, Monica Lluesma; Masland, Dashiell E. D.; Thompson, Brian; Bellows, Wendy K.; Stepanauskas, Ramunas] Bigelow Lab Ocean Sci, W Boothbay Harbor, ME USA; [Brazel, David M.] Colby Coll, Waterville, ME 04901 USA; [Arnosti, Carol; Ziervogel, Kai] Univ N Carolina, Dept Marine Sci, Chapel Hill, NC USA; [Chain, Patrick S. G.; Reitenga, Krista G.; Xie, Gary; Lo, Chien-Chi; Ahmed, Sanaa; Gleasner, Cheryl D.; Detter, Chris J.] Los Alamos Natl Lab, Genome Sci Grp, Los Alamos, NM USA; [Chain, Patrick S. G.; Reitenga, Krista G.; Xie, Gary; Lo, Chien-Chi; Ahmed, Sanaa; Gleasner, Cheryl D.; Detter, Chris J.] Joint Genome Inst, Microbial & Metagenome Program, Walnut Creek, CA USA	Bigelow Laboratory for Ocean Sciences; Colby College; University of North Carolina; University of North Carolina Chapel Hill; United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI	Stepanauskas, R (corresponding author), Univ Alicante, Dept Physiol Genet & Microbiol, E-03080 Alicante, Spain.	rstepanauskas@bigelow.org	Chain, Patrick/O-4140-2019; chain, patrick/B-9777-2013; Martínez-García, Manuel/AAT-1935-2021; Swan, Brandon K/O-9824-2018	Chain, Patrick/0000-0003-3949-3634; Martínez-García, Manuel/0000-0001-5056-1525; Swan, Brandon K/0000-0003-0465-1444; xie, gary/0000-0002-9176-924X; Stepanauskas, Ramunas/0000-0003-4458-3108; Brazel, David/0000-0001-5361-2498; Lo, Chien-Chi/0000-0003-3470-1078; Poulton, Nicole/0000-0003-3020-4509	NSF [DEB-841933, OCE-821374, OCE-0848703]; Maine Technology Institute; U.S. Department of Energy Joint Genome Institute through the Office of Science of the U.S. Department of Energy [DE-AC02-05CH11231]; U.S. Defense Threat Reduction Agency [B104153I, B084531I]; Division Of Ocean Sciences [0848703] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Maine Technology Institute; U.S. Department of Energy Joint Genome Institute through the Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE)); U.S. Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This research was supported by the NSF grants DEB-841933 and OCE-821374 to RS, OCE-0848703 to CA and by a Maine Technology Institute research infrastructure grant to the Bigelow Laboratory. The Los Alamos National Laboratory researchers were supported in part by the U.S. Department of Energy Joint Genome Institute through the Office of Science of the U.S. Department of Energy under Contract Number DE-AC02-05CH11231 and grants from the U.S. Defense Threat Reduction Agency under contract numbers B104153I and B084531I. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderkamp AC, 2007, FEMS MICROBIOL ECOL, V59, P108, DOI 10.1111/j.1574-6941.2006.00219.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arnds J, 2010, SYST APPL MICROBIOL, V33, P139, DOI 10.1016/j.syapm.2009.12.005; ARNOSTI C, 1995, GEOCHIM COSMOCHIM AC, V59, P4247, DOI 10.1016/0016-7037(95)00247-W; Arnosti C, 1996, ORG GEOCHEM, V25, P105, DOI 10.1016/S0146-6380(96)00112-X; Arnosti C, 2003, J CHROMATOGR B, V793, P181, DOI 10.1016/S1570-0232(03)00375-1; Arnosti C, 2011, ANNU REV MAR SCI, V3, P401, DOI 10.1146/annurev-marine-120709-142731; Bayer EA, 2004, ANNU REV MICROBIOL, V58, P521, DOI 10.1146/annurev.micro.57.030502.091022; Besemer J, 2005, NUCLEIC ACIDS RES, V33, pW451, DOI 10.1093/nar/gki487; Biddanda B, 1997, LIMNOL OCEANOGR, V42, P506, DOI 10.4319/lo.1997.42.3.0506; Blanch HW, 2008, ACS CHEM BIOL, V3, P17, DOI 10.1021/cb700267s; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Bruckner CG, 2008, APPL ENVIRON MICROB, V74, P7740, DOI 10.1128/AEM.01399-08; Brulc JM, 2009, P NATL ACAD SCI USA, V106, P1948, DOI 10.1073/pnas.0806191105; Buckley DH, 2001, FEMS MICROBIOL ECOL, V35, P105, DOI 10.1111/j.1574-6941.2001.tb00793.x; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Casamayor EO, 2000, APPL ENVIRON MICROB, V66, P499, DOI 10.1128/AEM.66.2.499-508.2000; Chin KJ, 1999, APPL ENVIRON MICROB, V65, P5042; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; Derrien M, 2004, INT J SYST EVOL MICR, V54, P1469, DOI 10.1099/ijs.0.02873-0; Fleming EJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017769; Freitas S, 2012, ISME J; Fuhrman J.A., 2008, MICROBIAL ECOLOGY OC; Gasol JM, 2007, AQUAT MICROB ECOL, V46, P71, DOI 10.3354/ame046071; Glockner FO, 2003, P NATL ACAD SCI USA, V100, P8298, DOI 10.1073/pnas.1431443100; Goris J, 2007, INT J SYST EVOL MICR, V57, P81, DOI 10.1099/ijs.0.64483-0; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Hess M, 2011, SCIENCE, V331, P463, DOI 10.1126/science.1200387; Heywood JL, 2011, ISME J, V5, P674, DOI 10.1038/ismej.2010.155; Hoefel D, 2003, J MICROBIOL METH, V52, P379, DOI 10.1016/S0167-7012(02)00207-5; KENNEDY JF, 1988, CARBOHYDRATE CHEM, P220; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lane D.J., 1991, NUCL ACID TECHNIQUES, DOI [10.1099/ijs.0.060731-0, DOI 10.1099/ijs.0.060731-0]; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Markowitz VM, 2010, NUCLEIC ACIDS RES, V38, pD382, DOI 10.1093/nar/gkp887; Martinez-Garcia M, 2012, ISME J, V6, P703, DOI 10.1038/ismej.2011.126; Martinez-Garcia M, 2012, ISME J, V6, P113, DOI 10.1038/ismej.2011.84; Park BH, 2010, GLYCOBIOLOGY, V20, P1574, DOI 10.1093/glycob/cwq106; Petroni G, 2000, P NATL ACAD SCI USA, V97, P1813, DOI 10.1073/pnas.030438197; Pope PB, 2010, P NATL ACAD SCI USA, V107, P14793, DOI 10.1073/pnas.1005297107; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Raghunathan A, 2005, APPL ENVIRON MICROB, V71, P3342, DOI 10.1128/AEM.71.6.3342-3347.2005; Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759; Rawlings ND, 2008, NUCLEIC ACIDS RES, V36, pD320, DOI 10.1093/nar/gkm954; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; Rubin EM, 2008, NATURE, V454, P841, DOI 10.1038/nature07190; Scheuermayer M, 2006, INT J SYST EVOL MICR, V56, P2119, DOI 10.1099/ijs.0.64360-0; Sieracki M., 2005, ALGAL CULTURING TECH, P101, DOI DOI 10.1016/B978-012088426-1/50008-1; Sieracki ME, 1999, APPL ENVIRON MICROB, V65, P2409; Sigrist CJA, 2010, NUCLEIC ACIDS RES, V38, pD161, DOI 10.1093/nar/gkp885; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stepanauskas R, 2007, P NATL ACAD SCI USA, V104, P9052, DOI 10.1073/pnas.0700496104; Swan BK, 2011, SCIENCE, V333, P1296, DOI 10.1126/science.1203690; Teeling H, 2004, ENVIRON MICROBIOL, V6, P938, DOI 10.1111/j.1462-2920.2004.00624.x; Ullrich S, 1996, APPL ENVIRON MICROB, V62, P4587, DOI 10.1128/AEM.62.12.4587-4593.1996; Weiner RM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000087; WEISS MS, 1991, SCIENCE, V254, P1627, DOI 10.1126/science.1721242; Woyke T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026161; Woyke T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005299; Yoon HS, 2011, SCIENCE, V332, P714, DOI 10.1126/science.1203163; Zeng XH, 2011, RENEW SUST ENERG REV, V15, P3252, DOI 10.1016/j.rser.2011.04.014; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang K, 2006, NAT BIOTECHNOL, V24, P680, DOI 10.1038/nbt1214; Zwart G, 2002, AQUAT MICROB ECOL, V28, P141, DOI 10.3354/ame028141	67	162	164	2	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35314	10.1371/journal.pone.0035314	http://dx.doi.org/10.1371/journal.pone.0035314			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536372	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339200055
J	Thelen, M; Damme, M; Schweizer, M; Hagel, C; Wong, AMS; Cooper, JD; Braulke, T; Galliciotti, G				Thelen, Melanie; Damme, Markus; Schweizer, Michaela; Hagel, Christian; Wong, Andrew M. S.; Cooper, Jonathan D.; Braulke, Thomas; Galliciotti, Giovanna			Disruption of the Autophagy-Lysosome Pathway Is Involved in Neuropathology of the nclf Mouse Model of Neuronal Ceroid Lipofuscinosis	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; STORAGE DISEASE; TRANSMEMBRANE PROTEIN; CELL-DEATH; DEGRADATION; ACTIVATION; MUTATIONS; CLN6; ER; NEURODEGENERATION	Variant late-infantile neuronal ceroid lipofuscinosis, a fatal lysosomal storage disorder accompanied by regional atrophy and pronounced neuron loss in the brain, is caused by mutations in the CLN6 gene. CLN6 is a non-glycosylated endoplasmic reticulum (ER)-resident membrane protein of unknown function. To investigate mechanisms contributing to neurodegeneration in CLN6 disease we examined the nclf mouse, a naturally occurring model of the human CLN6 disease. Prominent autofluorescent and electron-dense lysosomal storage material was found in cerebellar Purkinje cells, thalamus, hippocampus, olfactory bulb and in cortical layer II to V. Another prominent early feature of nclf pathogenesis was the localized astrocytosis that was evident in many brain regions and the more widespread microgliosis. Expression analysis of mutant Cln6 found in nclf mice demonstrated synthesis of a truncated protein with a reduced half-life. Whereas the rapid degradation of the mutant Cln6 protein can be inhibited by proteasomal inhibitors, there was no evidence for ER stress or activation of the unfolded protein response in various brain areas during postnatal development. Age-dependent increases in LC3-II, ubiquitinated proteins, and neuronal p62-positive aggregates were observed, indicating a disruption of the autophagy-lysosome degradation pathway of proteins in brains of nclf mice, most likely due to defective fusion between autophagosomes and lysosomes. These data suggest that proteasomal degradation of mutant Cln6 is sufficient to prevent the accumulation of misfolded Cln6 protein, whereas lysosomal dysfunction impairs constitutive autophagy promoting neurodegeneration.	[Thelen, Melanie; Braulke, Thomas; Galliciotti, Giovanna] Univ Med Ctr Hamburg Eppendorf, Dept Biochem, Childrens Hosp, Hamburg, Germany; [Damme, Markus] Univ Bielefeld, Dept Biochem 1, D-33615 Bielefeld, Germany; [Schweizer, Michaela] Univ Med Ctr Hamburg Eppendorf, Ctr Mol Neurobiol, Hamburg, Germany; [Hagel, Christian] Univ Med Ctr Hamburg Eppendorf, Inst Neuropathol, Hamburg, Germany; [Wong, Andrew M. S.; Cooper, Jonathan D.] Kings Coll London, Dept Neurosci, MRC Ctr Neurodegenerat Res, Inst Psychiat, London WC2R 2LS, England; [Wong, Andrew M. S.; Cooper, Jonathan D.] Kings Coll London, Ctr Cellular Basis Behav, MRC Ctr Neurodegenerat Res, Inst Psychiat, London WC2R 2LS, England	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Bielefeld; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of London; King's College London; University of London; King's College London	Galliciotti, G (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Biochem, Childrens Hosp, Hamburg, Germany.	g.galliciotti@uke.uni-hamburg.de	Cooper, Jonathan/C-8117-2009; Braulke, Thomas/AAV-9121-2020; Cooper, Jonathan/V-9962-2019	Cooper, Jonathan/0000-0003-1339-4750; Braulke, Thomas/0000-0002-2336-8532; Cooper, Jonathan/0000-0003-1339-4750; Thelen, Melanie/0000-0003-0707-5921; Galliciotti, Giovanna/0000-0002-2697-2364	Swiss National Science Foundation [PA00A3-117483]; Deutsche Forschungsgemeinschaft [FG885]; Wellcome Trust [GR079491MA]; Batten Disease Support and Research Association; Batten Disease Family Association; Natalie Fund; parent organisation Nachstenliebe e.V. [cgh 0328]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Wellcome Trust(Wellcome TrustEuropean Commission); Batten Disease Support and Research Association; Batten Disease Family Association; Natalie Fund; parent organisation Nachstenliebe e.V.	This work was financed by the Swiss National Science Foundation (http://www.snf.ch) PA00A3-117483; the Deutsche Forschungsgemeinschaft (http://www.dfg.de) FG885; the Wellcome Trust (http://www.wellcome.ac.uk/) GR079491MA; the Batten Disease Support and Research Association (http://www.bdsra.org/); the Batten Disease Family Association (http://www.bdfa-uk.org.uk/); the Natalie Fund (http://nataliefund.org/); and parent organisation Nachstenliebe e.V. (cgh 0328). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arsov T, 2011, AM J HUM GENET, V88, P566, DOI 10.1016/j.ajhg.2011.04.004; Bible E, 2004, NEUROBIOL DIS, V16, P346, DOI 10.1016/j.nbd.2004.02.010; Bronson RT, 1998, AM J MED GENET, V77, P289, DOI 10.1002/(SICI)1096-8628(19980526)77:4<289::AID-AJMG8>3.0.CO;2-I; Cao Y, 2006, J BIOL CHEM, V281, P20483, DOI 10.1074/jbc.M602180200; Cooper JD, 2006, BBA-MOL BASIS DIS, V1762, P873, DOI 10.1016/j.bbadis.2006.08.002; Cooper JD, 2010, BIOCHEM SOC T, V38, P1448, DOI 10.1042/BST0381448; Damme M, 2011, J NEUROPATH EXP NEUR, V70, P83, DOI 10.1097/NEN.0b013e31820428fa; Farfel-Becker T, 2009, HUM MOL GENET, V18, P1482, DOI 10.1093/hmg/ddp061; Gao HL, 2002, AM J HUM GENET, V70, P324, DOI 10.1086/338190; Goebel HH, 2004, BRAIN PATHOL, V14, P61, DOI 10.1111/j.1750-3639.2004.tb00499.x; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Heine C, 2004, J BIOL CHEM, V279, P22347, DOI 10.1074/jbc.M400643200; Heine C, 2007, MOL MEMBR BIOL, V24, P74, DOI 10.1080/09687860600967317; Jabs S, 2008, J NEUROCHEM, V106, P1415, DOI 10.1111/j.1471-4159.2008.05497.x; Jalanko A, 2009, BBA-MOL CELL RES, V1793, P697, DOI 10.1016/j.bbamcr.2008.11.004; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kamimoto T, 2006, J BIOL CHEM, V281, P4467, DOI 10.1074/jbc.M509409200; Kay GW, 2006, BRAIN PATHOL, V16, P110, DOI 10.1111/j.1750-3639.2006.00002.x; Kielar C, 2007, NEUROBIOL DIS, V25, P150, DOI 10.1016/j.nbd.2006.09.001; Kiselyov K, 2007, AUTOPHAGY, V3, P259, DOI 10.4161/auto.3906; Koike M, 2005, AM J PATHOL, V167, P1713, DOI 10.1016/S0002-9440(10)61253-9; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kurze AK, 2010, HUM MUTAT, V31, pE1163, DOI 10.1002/humu.21184; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Lindholm D, 2006, CELL DEATH DIFFER, V13, P385, DOI 10.1038/sj.cdd.4401778; Mitchison HM, 2004, BRAIN PATHOL, V14, P86, DOI 10.1111/j.1750-3639.2004.tb00502.x; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mole SE, 2005, NEUROGENETICS, V6, P107, DOI 10.1007/s10048-005-0218-3; Mole SE, 2004, EXP CELL RES, V298, P399, DOI 10.1016/j.yexcr.2004.04.042; Nakatsukasa K, 2008, CELL, V132, P101, DOI 10.1016/j.cell.2007.11.023; Nedelsky NB, 2008, BBA-MOL BASIS DIS, V1782, P691, DOI 10.1016/j.bbadis.2008.10.002; Ni M, 2007, FEBS LETT, V581, P3641, DOI 10.1016/j.febslet.2007.04.045; Noskova L, 2011, AM J HUM GENET, V89, P241, DOI 10.1016/j.ajhg.2011.07.003; Oswald MJ, 2008, NEUROBIOL DIS, V32, P50, DOI 10.1016/j.nbd.2008.06.004; Oswald MJ, 2005, NEUROBIOL DIS, V20, P49, DOI 10.1016/j.nbd.2005.01.025; PALMER DN, 1986, J BIOL CHEM, V261, P1773; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pontikis CC, 2005, NEUROBIOL DIS, V20, P823, DOI 10.1016/j.nbd.2005.05.018; Pontikis CC, 2004, BRAIN RES, V1023, P231, DOI 10.1016/j.brainres.2004.07.030; Pressey SNR, 2010, J NEUROPATH EXP NEUR, V69, P1228, DOI 10.1097/NEN.0b013e3181ffe742; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Settembre C, 2008, HUM MOL GENET, V17, P119, DOI 10.1093/hmg/ddm289; Thelen M, 2012, J NEUROSCI RES, V90, P568, DOI 10.1002/jnr.22773; WAHEED A, 1988, EMBO J, V7, P2351, DOI 10.1002/j.1460-2075.1988.tb03079.x; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Wei H, 2008, HUM MOL GENET, V17, P469, DOI 10.1093/hmg/ddm324; Wheeler RB, 2002, AM J HUM GENET, V70, P537, DOI 10.1086/338708; Yla-Anttila P, 2009, METHOD ENZYMOL, V452, P143, DOI 10.1016/S0076-6879(08)03610-0; Zhang ZJ, 2006, HUM MOL GENET, V15, P337, DOI 10.1093/hmg/ddi451	50	63	63	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35493	10.1371/journal.pone.0035493	http://dx.doi.org/10.1371/journal.pone.0035493			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536393	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339200071
J	Agnvall, B; Jongren, M; Strandberg, E; Jensen, P				Agnvall, Beatrix; Jongren, Markus; Strandberg, Erling; Jensen, Per			Heritability and Genetic Correlations of Fear-Related Behaviour in Red Junglefowl-Possible Implications for Early Domestication	PLOS ONE			English	Article							WHITE LEGHORN LAYERS; GALLUS-GALLUS; RESOURCE-ALLOCATION; SELECTION; DEPRIVATION; FEARFULNESS; EXPRESSION; EVOLUTION; RESPONSES; CHICKENS	Domesticated species differ from their wild ancestors in a number of traits, generally referred to as the domesticated phenotype. Reduced fear of humans is assumed to have been an early prerequisite for the successful domestication of virtually all species. We hypothesized that fear of humans is linked to other domestication related traits. For three generations, we selected Red Junglefowl (ancestors of domestic chickens) solely on the reaction in a standardized Fear of Human-test. In this, the birds were exposed for a gradually approaching human, and their behaviour was continuously scored. This generated three groups of animals, high (H), low (L) and intermediate (I) fearful birds. The birds in each generation were additionally tested in a battery of behaviour tests, measuring aspects of fearfulness, exploration, and sociality. The results demonstrate that the variation in fear response of Red Junglefowl towards humans has a significant genetic component and is genetically correlated to behavioural responses in other contexts, of which some are associated with fearfulness and others with exploration. Hence, selection of Red Junglefowl on low fear for humans can be expected to lead to a correlated change of other behavioural traits over generations. It is therefore likely that domestication may have caused an initial suite of behavioural modifications, even without selection on anything besides tameness.	[Agnvall, Beatrix; Jongren, Markus; Jensen, Per] Linkoping Univ, IFM Biol, Div Zool, Avian Behav Genom & Physiol Grp, Linkoping, Sweden; [Strandberg, Erling] Swedish Univ Agr Sci, Dept Anim Breeding & Genet, S-75007 Uppsala, Sweden	Linkoping University; Swedish University of Agricultural Sciences	Agnvall, B (corresponding author), Linkoping Univ, IFM Biol, Div Zool, Avian Behav Genom & Physiol Grp, Linkoping, Sweden.	perje@ifm.liu.se	Strandberg, Erling/G-9579-2011	Strandberg, Erling/0000-0001-5154-8146	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (Formas); Swedish Research Council (VR)	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (Formas)(Swedish Research Council Formas); Swedish Research Council (VR)(Swedish Research Council)	This study was financed by the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (Formas), and by the Swedish Research Council (VR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Nasser A, 2007, WORLD POULTRY SCI J, V63, P285, DOI 10.1017/S004393390700147X; Albert FW, 2008, HORM BEHAV, V53, P413, DOI 10.1016/j.yhbeh.2007.11.010; Appelby MC, 2004, POULTRY BEHAV WELFAR; BELYAEV DK, 1985, APPL ANIM BEHAV SCI, V13, P359, DOI 10.1016/0168-1591(85)90015-2; BELYAEV DK, 1979, J HERED, V70, P301, DOI 10.1093/oxfordjournals.jhered.a109263; Bracha HS, 2004, CNS SPECTRUMS, V9, P679, DOI 10.1017/S1092852900001954; Campler M, 2009, BEHAV PROCESS, V81, P39, DOI 10.1016/j.beproc.2008.12.018; CASTLE WE, 1947, P NATL ACAD SCI USA, V33, P109, DOI 10.1073/pnas.33.5.109; Clutton-Brock J, 1999, NATURAL HIST DOMESTI; Collias NE, 1996, ANIM BEHAV, V51, P1337, DOI 10.1006/anbe.1996.0137; COLLIAS NE, 1967, CONDOR, V69, P360, DOI 10.2307/1366199; Devlin RH, 2001, NATURE, V409, P781, DOI 10.1038/35057314; Edelaar P, 2012, BEHAV ECOLOGY; Eklund B, 2011, BEHAV PROCESS, V86, P250, DOI 10.1016/j.beproc.2010.12.010; Erhard HW, 1999, APPL ANIM BEHAV SCI, V64, P31, DOI 10.1016/S0168-1591(99)00028-3; Eriksson J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000010; Forkman B, 2007, PHYSIOL BEHAV, V92, P340, DOI 10.1016/j.physbeh.2007.03.016; Hakansson J, 2008, APPL ANIM BEHAV SCI, V114, P409, DOI 10.1016/j.applanim.2008.04.003; HAMMER RP, 1992, PHARMACOL BIOCHEM BE, V42, P25, DOI 10.1016/0091-3057(92)90440-Q; Jackson S, 1996, EVOLUTION, V50, P1638, DOI [10.2307/2410900, 10.1111/j.1558-5646.1996.tb03936.x]; Jones RB, 2002, APPL ANIM BEHAV SCI, V75, P337, DOI 10.1016/S0168-1591(01)00198-8; Jongren M, 2010, GENES BRAIN BEHAV, V9, P751, DOI 10.1111/j.1601-183X.2010.00612.x; Keeling LJ, SOCIAL BEHAV FARM AN; Kunzl C, 1999, HORM BEHAV, V35, P28, DOI 10.1006/hbeh.1998.1493; Lindqvist CES, 2002, BEHAVIOUR, V139, P1195, DOI 10.1163/15685390260437335; Liu YP, 2006, MOL PHYLOGENET EVOL, V38, P12, DOI 10.1016/j.ympev.2005.09.014; Malmkvist J, 2002, ANIM BEHAV, V64, P487, DOI 10.1006/anbe.2002.3058; Mormede P, 2002, PSYCHONEUROENDOCRINO, V27, P563, DOI 10.1016/S0306-4530(01)00093-2; Park CC, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-43; Ponder CA, 2008, BEHAV GENET, V38, P277, DOI 10.1007/s10519-008-9203-6; PRICE EO, 1984, Q REV BIOL, V59, P1, DOI 10.1086/413673; Price EO, 1999, APPL ANIM BEHAV SCI, V65, P245, DOI 10.1016/S0168-1591(99)00087-8; Savolainen P, 2002, SCIENCE, V298, P1610, DOI 10.1126/science.1073906; Schutz K, 2002, BEHAV GENET, V32, P423, DOI 10.1023/A:1020880211144; Schutz KE, 2001, APPL ANIM BEHAV SCI, V74, P1, DOI 10.1016/S0168-1591(01)00156-3; Schutz KE, 2001, ETHOLOGY, V107, P753, DOI 10.1046/j.1439-0310.2001.00703.x; Serpell J, 1985, DOMESTIC DOG ITS EVO; Talbot CJ, 2003, MAMM GENOME, V14, P223, DOI 10.1007/s00335-002-3059-5; Tartar JL, 2009, BEHAV BRAIN RES, V197, P450, DOI 10.1016/j.bbr.2008.08.035; Trut LN, 2004, RUSS J GENET+, V40, P644, DOI 10.1023/B:RUGE.0000033312.92773.c1; Vaisanen J, 2005, BRIT POULTRY SCI, V46, P156, DOI 10.1080/00071660500062638; WEST B, 1988, J ARCHAEOL SCI, V15, P515, DOI 10.1016/0305-4403(88)90080-5; Wright D, 2010, MOL ECOL, V19, P5140, DOI 10.1111/j.1365-294X.2010.04882.x	43	57	59	1	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e35162	10.1371/journal.pone.0035162	http://dx.doi.org/10.1371/journal.pone.0035162			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22536354	Green Published, gold, Green Accepted			2022-12-27	WOS:000305336200026
J	Fukunishi, Y; Browman, HI; Durif, CMF; Bjelland, RM; Skiftesvik, AB				Fukunishi, Yuichi; Browman, Howard I.; Durif, Caroline M. F.; Bjelland, Reidun M.; Skiftesvik, Anne Berit			Effect of Sub-Lethal Exposure to Ultraviolet Radiation on the Escape Performance of Atlantic Cod Larvae (Gadus morhua)	PLOS ONE			English	Article							CARP CYPRINUS-CARPIO; B RADIATION; DNA-DAMAGE; NORTHERN ANCHOVY; CALANUS-FINMARCHICUS; ENGRAULIS-MORDAX; 280-400 NM; SOLAR; EGGS; REPAIR	The amount of ultraviolet (UV) radiation reaching the earth's surface has increased due to depletion of the ozone layer. Several studies have reported that UV radiation reduces survival of fish larvae. However, indirect and sub-lethal impacts of UV radiation on fish behavior have been given little consideration. We observed the escape performance of larval cod (24 dph, SL: 7.6 +/- 0.2 mm; 29 dph, SL: 8.2 +/- 0.3 mm) that had been exposed to sub-lethal levels of UV radiation vs. unexposed controls. Two predators were used (in separate experiments): two-spotted goby (Gobiusculus flavescens; a suction predator) and lion's mane jellyfish (Cyanea capillata; a "passive'' ambush predator). Ten cod larvae were observed in the presence of a predator for 20 minutes using a digital video camera. Trials were replicated 4 times for goby and 5 times for jellyfish. Escape rate (total number of escapes/total number of attacks x 100), escape distance and the number of larvae remaining at the end of the experiment were measured. In the experiment with gobies, in the UV-treated larvae, both escape rate and escape distance (36%, 38 +/- 7.5 mm respectively) were significantly lower than those of control larvae (75%, 69 +/- 4.7 mm respectively). There was a significant difference in survival as well (UV: 35%, Control: 63%). No apparent escape response was observed, and survival rate was not significantly different, between treatments (UV: 66%, Control: 74%) in the experiment with jellyfish. We conclude that the effect and impact of exposure to sub-lethal levels of UV radiation on the escape performance of cod larvae depends on the type of predator. Our results also suggest that prediction of UV impacts on fish larvae based only on direct effects are underestimations.	[Fukunishi, Yuichi; Browman, Howard I.; Durif, Caroline M. F.; Bjelland, Reidun M.; Skiftesvik, Anne Berit] Inst Marine Res, Austevoll Res Stn, Storebo, Norway	Institute of Marine Research - Norway	Fukunishi, Y (corresponding author), Inst Marine Res, Austevoll Res Stn, Storebo, Norway.	yuichi.fukunishi@imr.no	Browman, Howard/B-4441-2009; Skiftesvik, Anne Berit/M-1266-2013; Browman, Howard/CAA-2802-2022; Durif, Caroline/A-6406-2011	Browman, Howard/0000-0002-6282-7316; Skiftesvik, Anne Berit/0000-0002-7754-5661; Browman, Howard/0000-0002-6282-7316; 	Japan Society for the Promotion of Science; Norwegian Institute of Marine Research [11529]; Research Council of Norway [178731/S40, 201981/F11]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Norwegian Institute of Marine Research; Research Council of Norway(Research Council of Norway)	YF was supported by the FY 2010 Researcher Exchange Program between the Japan Society for the Promotion of Science and the Research Council of Norway; Project number: 201981/F11. This research was supported by the Norwegian Institute of Marine Research (Fine-scale interactions in the plankton -Project 11529 - to HIB) and the Research Council of Norway project "Cascading effects of climate change and UV envirotoxins on the nutritional quality of the food base in marine ecosystems (Project # 178731/S40 to HIB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas E, 2001, OCEANOLOGIA, V43, P139; Alemanni ME, 2003, PHOTOCH PHOTOBIO SCI, V2, P867, DOI 10.1039/b301564e; ANDERSON JT, 1995, CAN J FISH AQUAT SCI, V52, P1978, DOI 10.1139/f95-789; Armstrong TN, 2002, AQUAT TOXICOL, V58, P1, DOI 10.1016/S0166-445X(01)00212-0; BAMSTEDT U, 1994, ICES J MAR SCI, V51, P369, DOI 10.1006/jmsc.1994.1039; Barz K, 2007, MAR BIOL, V151, P1021, DOI 10.1007/s00227-006-0545-4; Beland F, 1999, CAN J FISH AQUAT SCI, V56, P1058, DOI 10.1139/cjfas-56-6-1058; Blazer VS, 1997, J AQUAT ANIM HEALTH, V9, P132, DOI 10.1577/1548-8667(1997)009&lt;0132:EOUBRO&gt;2.3.CO;2; Browman HI, 2002, ECOL STU AN, V153, P261; Browman HI, 2003, PHOTOCHEM PHOTOBIOL, V77, P397, DOI 10.1562/0031-8655(2003)077<0397:UNDDIT>2.0.CO;2; Browman HI, 2000, MAR ECOL PROG SER, V199, P293, DOI 10.3354/meps199293; Dong Q, 2007, J PHOTOCH PHOTOBIO B, V88, P137, DOI 10.1016/j.jphotobiol.2007.07.002; Fields DM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026333; Gronkjaer P, 1997, MAR ECOL PROG SER, V154, P91, DOI 10.3354/meps154091; Hader DP, 2011, PHOTOCH PHOTOBIO SCI, V10, P242, DOI 10.1039/c0pp90036b; Helmholz H, 2010, HYDROBIOLOGIA, V645, P223, DOI 10.1007/s10750-010-0216-9; Holtby LB, 2008, CAN J FISH AQUAT SCI, V65, P701, DOI 10.1139/F08-013; Houde ED, 1987, AM FISH SOC S, V2, P17; HUNTER JR, 1979, PHOTOCHEM PHOTOBIOL, V29, P325, DOI 10.1111/j.1751-1097.1979.tb07055.x; HUNTER JR, 1981, PHOTOCHEM PHOTOBIOL, V34, P477, DOI 10.1111/j.1751-1097.1981.tb09028.x; Jokinen IE, 2008, PHOTOCHEM PHOTOBIOL, V84, P1265, DOI 10.1111/j.1751-1097.2008.00358.x; Kelly DJ, 2002, CAN J FISH AQUAT SCI, V59, P474, DOI 10.1139/F02-023; KERR JB, 1993, SCIENCE, V262, P1032, DOI 10.1126/science.262.5136.1032; Koster FW, 2000, ICES J MAR SCI, V57, P310, DOI 10.1006/jmsc.1999.0528; Kouwenberg JHM, 1999, MAR BIOL, V134, P269, DOI 10.1007/s002270050545; Krzyscin JW, 2011, ACTA GEOPHYS, V59, P155, DOI 10.2478/s11600-010-0036-3; Kuhn PS, 2000, LIMNOL OCEANOGR, V45, P1797, DOI 10.4319/lo.2000.45.8.1797; Lassen S, 2010, HYDROBIOLOGIA, V645, P213, DOI 10.1007/s10750-010-0215-x; LEGGETT WC, 1994, NETH J SEA RES, V32, P119, DOI 10.1016/0077-7579(94)90036-1; Lesser MP, 2001, J EXP BIOL, V204, P157; Lough RG, 1996, DEEP-SEA RES PT II, V43, P1875, DOI 10.1016/S0967-0645(96)00053-7; Madronich S, 1998, J PHOTOCH PHOTOBIO B, V46, P5, DOI 10.1016/S1011-1344(98)00182-1; Malloy KD, 1997, P NATL ACAD SCI USA, V94, P1258, DOI 10.1073/pnas.94.4.1258; Manney GL, 2011, NATURE, V478, P469, DOI 10.1038/nature10556; Markkula E, 2009, PHOTOCHEM PHOTOBIOL, V85, P347, DOI 10.1111/j.1751-1097.2008.00446.x; Markkula SE, 2006, FISH SHELLFISH IMMUN, V21, P70, DOI 10.1016/j.fsi.2005.10.007; Markkula SE, 2005, PHOTOCHEM PHOTOBIOL, V81, P595, DOI 10.1562/2004-07-13-RA-231.1; McFadzen I, 2000, MAR ENVIRON RES, V50, P273, DOI 10.1016/S0141-1136(00)00085-4; McKenzie RL, 2007, PHOTOCH PHOTOBIO SCI, V6, P218, DOI 10.1039/b700017k; McKenzie RL, 2011, PHOTOCH PHOTOBIO SCI, V10, P182, DOI 10.1039/c0pp90034f; Miller P.J., 1986, P1019; Paz J., 1992, Journal of Northwest Atlantic Fishery Science, V14, P129; Ravishankara A. R., 2009, Science (Washington), V326, P123, DOI 10.1126/science.1176985; Romansic JM, 2009, HYDROBIOLOGIA, V624, P219, DOI 10.1007/s10750-009-9703-2; Steeger HU, 1999, J SEA RES, V42, P27, DOI 10.1016/S1385-1101(99)00009-X; Svensson PA, 2000, J FISH BIOL, V56, P1477, DOI 10.1111/j.1095-8649.2000.tb02158.x; Tedetti M, 2006, PHOTOCHEM PHOTOBIOL, V82, P389, DOI 10.1562/2005-11-09-IR-733; Tedetti M, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029823; Tucker Andrew J., 2011, Freshwater Reviews, V4, P115, DOI 10.1608/FRJ-4.2.474; van der Meeren T, 2007, AQUACULTURE, V265, P206, DOI [10.1016/j.aquaculture.2007.01.042, 10.1016/j.aquaculture.2007.06.038]; Vehniainen ER, 2007, BOREAL ENVIRON RES, V12, P673; Vetter RD, 1999, PHOTOCHEM PHOTOBIOL, V69, P27, DOI 10.1562/0031-8655(1999)069<0027:DCODDA>2.3.CO;2; WALDSTEI.EA, 1974, P NATL ACAD SCI USA, V71, P2651, DOI 10.1073/pnas.71.7.2651; WHEELER A, 1969, P613	54	20	20	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e35554	10.1371/journal.pone.0035554	http://dx.doi.org/10.1371/journal.pone.0035554			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22536406	Green Published, gold			2022-12-27	WOS:000305336200054
J	Byrne, R; Rath, E; Hladik, A; Niederreiter, B; Bonelli, M; Frantal, S; Smolen, JS; Scheinecker, C				Byrne, Ruth; Rath, Eva; Hladik, Anastasiya; Niederreiter, Birgit; Bonelli, Michael; Frantal, Sophie; Smolen, Josef S.; Scheinecker, Clemens			A Dynamic Real Time In Vivo and Static Ex Vivo Analysis of Granulomonocytic Cell Migration in the Collagen-Induced Arthritis Model	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; INFLAMMATORY ARTHRITIS; IMAGING REVEALS; IMMUNE-SYSTEM; MURINE MODEL; LYMPH-NODES; BONE-MARROW; NEUTROPHILS; MICE; GLUCOCORTICOIDS	Neutrophilic granulocytes and monocytes (granulomonocytic cells; GMC) drive the inflammatory process at the earliest stages of rheumatoid arthritis (RA). The migratory behavior and functional properties of GMC within the synovial tissue are, however, only incompletely characterized. Here we have analyzed GMC in the murine collagen-induced arthritis (CIA) model of RA using multi-photon real time in vivo microscopy together with ex vivo analysis of GMC in tissue sections. GMC were abundant as soon as clinical arthritis was apparent. GMC were motile and migrated randomly through the synovial tissue. In addition, we observed the frequent formation of cell clusters consisting of both neutrophilic granulocytes and monocytes that actively contributed to the inflammatory process of arthritis. Treatment of animals with a single dose of prednisolone reduced the mean velocity of cell migration and diminished the overall immigration of GMC. In summary, our study shows that the combined application of real time in vivo microscopy together with elaborate static post-mortem analysis of GMC enables the description of dynamic migratory characteristics of GMC together with their precise location in a complex anatomical environment. Moreover, this approach is sensitive enough to detect subtle therapeutic effects within a very short period of time.	[Byrne, Ruth; Rath, Eva; Hladik, Anastasiya; Niederreiter, Birgit; Bonelli, Michael; Smolen, Josef S.; Scheinecker, Clemens] Med Univ Vienna, Div Rheumatol, Vienna, Austria; [Frantal, Sophie] Med Univ Vienna, Ctr Med Stat Informat & Intelligent Syst, Vienna, Austria	Medical University of Vienna; Medical University of Vienna	Byrne, R (corresponding author), Med Univ Vienna, Div Rheumatol, Vienna, Austria.	clemens.scheinecker@meduniwien.ac.at		Bonelli, Michael/0000-0002-6122-7482	European Community [HEALTH-F2-2008-223404]	European Community(European Commission)	The research leading to these results has received funding from the European Community's Seventh Framework Programme FP7 under grant agreement no. HEALTH-F2-2008-223404 (Masterswitch). This study is a publication of the Joint and Bone Center - Center for musculoskeletal research of the Medical University of Vienna. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajenoff M, 2007, EUR J IMMUNOL, V37, pS18, DOI 10.1002/eji.200737663; BAXTER JD, 1972, AM J MED, V53, P573, DOI 10.1016/0002-9343(72)90154-4; Brand DD, 2003, SPRINGER SEMIN IMMUN, V25, P3, DOI 10.1007/s00281-003-0127-1; Campbell IK, 2000, EUR J IMMUNOL, V30, P1568, DOI 10.1002/1521-4141(200006)30:6<1568::AID-IMMU1568>3.0.CO;2-R; Chtanova T, 2008, IMMUNITY, V29, P487, DOI 10.1016/j.immuni.2008.07.012; Cox G, 1997, J LEUKOCYTE BIOL, V61, P224, DOI 10.1002/jlb.61.2.224; Cox Guy, 2006, V319, P15; Eyles JL, 2008, BLOOD, V112, P5193, DOI 10.1182/blood-2008-02-139535; Faust N, 2000, BLOOD, V96, P719; Feldmann M, 1996, CELL, V85, P307, DOI 10.1016/S0092-8674(00)81109-5; Goldring SR, 2000, CURR OPIN RHEUMATOL, V12, P195, DOI 10.1097/00002281-200005000-00006; Gompels LL, 2010, RHEUMATOLOGY, V49, P1436, DOI 10.1093/rheumatology/keq012; Graham DB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004652; HADLER NM, 1979, J IMMUNOL, V123, P572; Hayer S, 2007, ARTHRITIS RHEUM-US, V56, P79, DOI 10.1002/art.22313; Khapli SM, 2003, J IMMUNOL, V171, P142, DOI 10.4049/jimmunol.171.1.142; Kreisel D, 2010, P NATL ACAD SCI USA, V107, P18073, DOI 10.1073/pnas.1008737107; Lean JM, 2000, BONE, V27, P29, DOI 10.1016/S8756-3282(00)00306-9; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Liu L, 2005, INFLAMM RES, V54, P37, DOI 10.1007/s00011-004-1320-y; MODDERMAN WE, 1991, BONE, V12, P81, DOI 10.1016/8756-3282(91)90004-3; MOHR W, 1981, ANN RHEUM DIS, V40, P171, DOI 10.1136/ard.40.2.171; Pesu M, 2008, IMMUNOL REV, V223, P132, DOI 10.1111/j.1600-065X.2008.00644.x; Peters NC, 2008, SCIENCE, V321, P970, DOI 10.1126/science.1159194; Pettit AR, 2001, AM J PATHOL, V159, P1689, DOI 10.1016/S0002-9440(10)63016-7; Redlich K, 2002, J CLIN INVEST, V110, P1419, DOI 10.1172/JCI200215582; Scheinecker C, 2005, ARTHRITIS RES THER, V7, P246, DOI 10.1186/ar1843; SCHLEIMER RP, 1993, EUR J CLIN PHARMACOL, V45, pS43, DOI 10.1007/BF01844203; SCHLEIMER RP, 1993, EUR J CLIN PHARMACOL, V45, pS3, DOI 10.1007/BF01844196; Schramm R, 2004, INFLAMM RES, V53, P644, DOI 10.1007/s00011-004-1307-8; Stoll S, 2002, SCIENCE, V296, P1873, DOI 10.1126/science.1071065; Sumen C, 2004, IMMUNITY, V21, P315, DOI 10.1016/S1074-7613(04)00237-7; Suzuki M, 1997, EXP ANIM TOKYO, V46, P259, DOI 10.1538/expanim.46.259; VANDEWIJNGAERT FP, 1987, BONE MINER, V3, P111; WILLIAMS RO, 1992, P NATL ACAD SCI USA, V89, P9784, DOI 10.1073/pnas.89.20.9784; Wipke BT, 2001, J IMMUNOL, V167, P1601, DOI 10.4049/jimmunol.167.3.1601; Wright HL, 2010, RHEUMATOLOGY, V49, P1618, DOI 10.1093/rheumatology/keq045; Zinselmeyer BH, 2008, INFLAMM RES, V57, P93, DOI 10.1007/s00011-007-7195-y; Zwerina J, 2007, P NATL ACAD SCI USA, V104, P11742, DOI 10.1073/pnas.0610812104	40	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35194	10.1371/journal.pone.0035194	http://dx.doi.org/10.1371/journal.pone.0035194			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529989	gold, Green Published, Green Submitted			2022-12-27	WOS:000305350600065
J	Horio, M; Kohno, M; Fujita, Y; Ishima, T; Inoue, R; Mori, H; Hashimoto, K				Horio, Mao; Kohno, Mami; Fujita, Yuko; Ishima, Tamaki; Inoue, Ran; Mori, Hisashi; Hashimoto, Kenji			Role of Serine Racemase in Behavioral Sensitization in Mice after Repeated Administration of Methamphetamine	PLOS ONE			English	Article							SIGNAL-REGULATED KINASE; CONDITIONED PLACE PREFERENCE; KNOCK-OUT MICE; AMPHETAMINE TREATMENT; MOUSE-BRAIN; DOPAMINE; GLUTAMATE; NMDA; NEUROTOXICITY; MK-801	Background: The N-methyl-D-aspartate (NMDA) receptors play a role in behavioral abnormalities observed after administration of the psychostimulant, methamphetamine (METH). Serine racemase (SRR) is an enzyme which synthesizes D-serine, an endogenous co-agonist of NMDA receptors. Using Srr knock-out (KO) mice, we investigated the role of SRR on METH-induced behavioral abnormalities in mice. Methodology/Principal Findings: Evaluations of behavior in acute hyperlocomotion, behavioral sensitization, and conditioned place preference (CPP) were performed. The role of SRR on the release of dopamine (DA) in the nucleus accumbens after administration of METH was examined using in vivo microdialysis technique. Additionally, phosphorylation levels of ERK1/2 proteins in the striatum, frontal cortex and hippocampus were examined using Western blot analysis. Acute hyperlocomotion after a single administration of METH (3 mg/kg) was comparable between wild-type (WT) and Srr-KO mice. However, repeated administration of METH (3 mg/kg/day, once daily for 5 days) resulted in behavioral sensitization in WT, but not Srr-KO mice. Pretreatment with D-serine (900 mg/kg, 30 min prior to each METH treatment) did not affect the development of behavioral sensitization after repeated METH administration. In the CPP paradigm, METH-induced rewarding effects were demonstrable in both WT and Srr-KO mice. In vivo microdialysis study showed that METH (1 mg/kg)induced DA release in the nucleus accumbens of Srr-KO mice previously treated with METH was significantly lower than that of the WT mice previously treated with METH. Interestingly, a single administration of METH (3 mg/kg) significantly increased the phosphorylation status of ERK1/2 in the striatum of WT, but not Srr-KO mice. Conclusions/Significance: These findings suggest first, that SRR plays a role in the development of behavioral sensitization in mice after repeated administration of METH, and second that phosphorylation of ERK1/2 by METH may contribute to the development of this sensitization as seen in WT but not Srr-KO mice.	[Horio, Mao; Kohno, Mami; Fujita, Yuko; Ishima, Tamaki; Hashimoto, Kenji] Chiba Univ, Ctr Forens Mental Hlth, Div Clin Neurosci, Chiba, Japan; [Inoue, Ran; Mori, Hisashi] Toyama Univ, Grad Sch Med, Dept Mol Neurosci, Toyama 930, Japan	Chiba University; University of Toyama	Horio, M (corresponding author), Chiba Univ, Ctr Forens Mental Hlth, Div Clin Neurosci, Chiba, Japan.	hashimoto@faculty.chiba-u.jp	Hashimoto, Kenji/I-5800-2015	Hashimoto, Kenji/0000-0002-8892-0439	Japan Society for the Promotion of Science, Japan; Intramural Research Grant for Neurological and Psychiatric Disorders of National Center of Neurology and Psychiatry (NCNP), Japan; Ishidsu Shun Memorial Scholarship, Japan	Japan Society for the Promotion of Science, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Intramural Research Grant for Neurological and Psychiatric Disorders of National Center of Neurology and Psychiatry (NCNP), Japan; Ishidsu Shun Memorial Scholarship, Japan	This study was supported by grants from Grants-in-Aid for Scientific Research of Japan Society for the Promotion of Science, Japan (to K. H.) and Intramural Research Grant for Neurological and Psychiatric Disorders of National Center of Neurology and Psychiatry (NCNP), Japan (to K. H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Mao Horio was supported by Ishidsu Shun Memorial Scholarship, Japan. We would like to thank Professor Masaomi Iyo (Department of Psychiatry, Chiba University Graduate School of Medicine) for his support.	Basu AC, 2009, MOL PSYCHIATR, V14, P719, DOI 10.1038/mp.2008.130; Berke JD, 2000, NEURON, V25, P515, DOI 10.1016/S0896-6273(00)81056-9; Bertran-Gonzalez J, 2008, J NEUROSCI, V28, P5671, DOI 10.1523/JNEUROSCI.1039-08.2008; Cadet JL, 2003, FASEB J, V17, P1775, DOI 10.1096/fj.03-0073rev; Chao J, 2004, ANNU REV MED, V55, P113, DOI 10.1146/annurev.med.55.091902.103730; Chen H, 2012, PSYCHOPHARM IN PRESS; Chen Hongxian, 2010, Curr Drug Abuse Rev, V3, P222; Chen JC, 2001, LIFE SCI, V68, P973, DOI 10.1016/S0024-3205(00)00995-4; EARLE ML, 1991, J NEURAL TRANSM-GEN, V86, P217, DOI 10.1007/BF01250707; Featherstone RE, 2007, PROG NEURO-PSYCHOPH, V31, P1556, DOI 10.1016/j.pnpbp.2007.08.025; Franklin K. B. J., 2008, PAXINOS FRANKLINS MO; Fujita Y, 2012, PHARMACOL BIOCHEM BE, V101, P303, DOI 10.1016/j.pbb.2012.01.005; Gerfen CR, 2008, J NEUROSCI, V28, P7113, DOI 10.1523/JNEUROSCI.3952-07.2008; Girault JA, 2007, CURR OPIN PHARMACOL, V7, P77, DOI 10.1016/j.coph.2006.08.012; Gonzales R, 2010, ANNU REV PUBL HEALTH, V31, P385, DOI 10.1146/annurev.publhealth.012809.103600; Hagiwara H, 2009, BRAIN RES, V1301, P189, DOI 10.1016/j.brainres.2009.09.010; Hashimoto K, 2007, NEW RES METHAMPHETAM, P1; HOFFMAN DC, 1994, PHARMACOL BIOCHEM BE, V47, P907, DOI 10.1016/0091-3057(94)90295-X; Horio M, 2011, NEUROCHEM INT, V59, P853, DOI 10.1016/j.neuint.2011.08.017; Inoue R, 2008, J NEUROSCI, V28, P14486, DOI 10.1523/JNEUROSCI.5034-08.2008; Karila L, 2010, BRIT J CLIN PHARMACO, V69, P578, DOI 10.1111/j.1365-2125.2010.03639.x; KARLER R, 1991, BRAIN RES, V552, P295, DOI 10.1016/0006-8993(91)90095-D; Kim HS, 1997, BRAIN RES BULL, V44, P221, DOI 10.1016/S0361-9230(97)00093-2; KURIBARA H, 1992, PSYCHOPHARMACOLOGY, V108, P271, DOI 10.1007/BF02245111; Martineau M, 2006, TRENDS NEUROSCI, V29, P481, DOI 10.1016/j.tins.2006.06.008; Miya K, 2008, J COMP NEUROL, V510, P641, DOI 10.1002/cne.21822; Miyamoto Y, 2004, EUR J NEUROSCI, V19, P151, DOI 10.1111/j.1460-9568.2004.03086.x; Mizoguchi H, 2004, MOL PHARMACOL, V65, P1293, DOI 10.1124/mol.65.5.1293; ODELL SJ, 1991, BRAIN RES, V564, P256, DOI 10.1016/0006-8993(91)91461-9; OHMORI T, 1994, PHARMACOL BIOCHEM BE, V48, P587, DOI 10.1016/0091-3057(94)90318-2; Pierce RC, 1997, BRAIN RES REV, V25, P192, DOI 10.1016/S0165-0173(97)00021-0; Rajadhyaksha A, 2004, J NEUROSCI, V24, P7464, DOI 10.1523/JNEUROSCI.0612-04.2004; Robinson TE, 1986, BRAIN RES REV, V396, P157; SATO M, 1983, BIOL PSYCHIAT, V18, P429; Schell MJ, 2004, PHILOS T R SOC B, V359, P943, DOI 10.1098/rstb.2003.1399; Segal DS, 1997, J PHARMACOL EXP THER, V282, P561; Shi XD, 2007, J NEUROCHEM, V103, P706, DOI 10.1111/j.1471-4159.2007.04760.x; Tata DA, 2007, ADDICTION, V102, P49, DOI 10.1111/j.1360-0443.2007.01770.x; Tzschentke TM, 1998, PROG NEUROBIOL, V56, P613, DOI 10.1016/S0301-0082(98)00060-4; Ujike H, 2004, ANN NY ACAD SCI, V1025, P279, DOI 10.1196/annals.1316.035; Valjent E, 2005, P NATL ACAD SCI USA, V102, P491, DOI 10.1073/pnas.0408305102; Valjent E, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-20; Vanderschuren LJMJ, 2000, PSYCHOPHARMACOLOGY, V151, P99, DOI 10.1007/s002130000493; WOLF ME, 1991, BRAIN RES, V562, P164, DOI 10.1016/0006-8993(91)91202-C; Wolosker H, 1999, P NATL ACAD SCI USA, V96, P13409, DOI 10.1073/pnas.96.23.13409; Wolosker H, 1999, P NATL ACAD SCI USA, V96, P721, DOI 10.1073/pnas.96.2.721; Wolosker H, 2007, MOL NEUROBIOL, V36, P152, DOI 10.1007/s12035-007-0038-6; Zhai HF, 2008, CELL MOL NEUROBIOL, V28, P157, DOI 10.1007/s10571-007-9240-3; Zhang L, 2006, PROG NEURO-PSYCHOPH, V30, P1381, DOI 10.1016/j.pnpbp.2006.05.015	49	18	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35494	10.1371/journal.pone.0035494	http://dx.doi.org/10.1371/journal.pone.0035494			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22530033	Green Submitted, Green Published, gold			2022-12-27	WOS:000305350600089
J	Mallmann, AB; Fuchs, SC; Gus, M; Fuchs, FD; Moreira, LB				Mallmann, Adroaldo Baseggio; Fuchs, Sandra Costa; Gus, Miguel; Fuchs, Flavio Danni; Moreira, Leila Beltrami			Population-Attributable Risks for Ischemic Stroke in a Community in South Brazil: A Case-Control Study	PLOS ONE			English	Article							CAROTID BRUITS; MORTALITY; ASSOCIATION; CARDIOLOGY; LIFE; CHOLESTEROL; PREVENTION; ADULTS	Background: Risk factors for ischemic stroke are mostly known, but it is still unclear in most countries, what are their combined population-attributable risk percent (PAR%). In a case-control study the individual odds ratios (ORs) and the individual and combined PAR%, including risk factors not addressed in previous studies were estimated. Methods: Cases and controls were selected from patients attending to an emergency department. Cases were patients aged with 45 years or more with the first episode of ischemic stroke, characterized by a focal neurological deficit or change in the mental status occurring during the previous 24 hours. Controls, matched to cases by age and gender, were selected from patients without neurological complaints. Results: 133 cases and 272 controls were studied. Odds ratios for ischemic stroke were: atrial fibrillation (27.3; CI 95% 7.5-99.9), left ventricular hypertrophy (20.3; CI 95% 8.8-46.4), history of hypertension (11.2; CI 95% 5.4-23.3), physical inactivity (6.6; CI 95% 3.3-13.1), low levels of HDL-cholesterol (5.0; CI 95% 2.8-8.9), heavy smoking (2.8; CI 95% 1.5-5.0), carotid bruit (2.5; CI 95% 1.3-4.6), diabetes (2.4; CI 95% 1.4-4.0) and alcohol abuse (2.1; CI 95% 1.1-4.0), The combination of these risk factors accounted for 98.9% (95% CI; 96.4%-99.7%) of the PAR% for all stroke. Conclusions: Nine risk factors, easily identified, explain almost 100% of the population attributable risk for ischemic stroke.	[Mallmann, Adroaldo Baseggio] Univ Passo Fundo, Sch Med, Passo Fundo, Brazil; [Fuchs, Sandra Costa; Moreira, Leila Beltrami] Univ Fed Rio Grande do Sul, Postgrad Program Cardiol, Porto Alegre, RS, Brazil; [Gus, Miguel; Fuchs, Flavio Danni] Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Div Cardiol, Porto Alegre, RS, Brazil	Universidade de Passo Fundo; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul	Mallmann, AB (corresponding author), Univ Passo Fundo, Sch Med, Passo Fundo, Brazil.	mgus@terra.com.br	MOREIRA, LEILA LEILA B/AAC-2240-2019; Moreira, Leila/G-1251-2013; Fuchs, Sandra C/T-2670-2019; Fuchs, Flávio D/L-5078-2016; Iats, Inct/K-2300-2013	MOREIRA, LEILA LEILA B/0000-0002-4730-7988; Moreira, Leila/0000-0002-4730-7988; fuchs, flavio/0000-0002-1191-0523				Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; BONITA R, 1988, STROKE, V19, P1497, DOI 10.1161/01.STR.19.12.1497; Chiuve SE, 2008, CIRCULATION, V118, P947, DOI 10.1161/CIRCULATIONAHA.108.781062; Curioni C, 2009, REV PANAM SALUD PUBL, V25, P9, DOI 10.1590/S1020-49892009000100002; de Oliveira GMM, 2006, REV PANAM SALUD PUBL, V19, P85, DOI 10.1590/S1020-49892006000200003; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Goldstein LB, 2011, STROKE, V42, P517, DOI 10.1161/STR.0b013e3181fcb238; Greenland P, 2010, CIRCULATION, V122, pE584, DOI 10.1161/CIR.0b013e3182051b4c; Gus M, 2004, AM J HYPERTENS, V17, P50, DOI 10.1016/j.amjhyper.2003.08.010; Hancock EW, 2009, J AM COLL CARDIOL, V53, P992, DOI 10.1016/j.jacc.2008.12.015; Johansson EP, 2008, BMC NEUROL, V8, DOI 10.1186/1471-2377-8-23; Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4; Lotufo Paulo Andrade, 2005, Sao Paulo Med. J., V123, P3; Martins T, 2006, REV NEUROLOGIA, V42, P655, DOI 10.33588/rn.4211.2005301; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Pickett CA, 2010, STROKE, V41, P2295, DOI 10.1161/STROKEAHA.110.585554; Rothwell PM, 2004, LANCET, V363, P1925, DOI 10.1016/S0140-6736(04)16405-2; Sacco RL, 1998, STROKE, V29, P380, DOI 10.1161/01.STR.29.2.380; Song JW, 2010, PLAST RECONSTR SURG, V126, P2234, DOI 10.1097/PRS.0b013e3181f44abc; Souza Maria de Fátima Marinho de, 2006, Arq. Bras. Cardiol., V87, P735, DOI 10.1590/S0066-782X2006001900009; Sposito AC, 2007, ARQ BRAS CARDIOL, V88, P2, DOI 10.1590/S0066-782X2007000700002; Steffens AA, 2006, J HYPERTENS, V24, P1489, DOI 10.1097/01.hjh.0000239282.27938.0f; Strong K, 2007, LANCET NEUROL, V6, P182, DOI 10.1016/S1474-4422(07)70031-5; Thrift AG, 2010, LANCET, V376, P1538, DOI 10.1016/S0140-6736(10)62025-9; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Zhang YR, 2011, ARCH INTERN MED, V171, P1811, DOI 10.1001/archinternmed.2011.443	26	16	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35680	10.1371/journal.pone.0035680	http://dx.doi.org/10.1371/journal.pone.0035680			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22530066	Green Published, gold, Green Submitted			2022-12-27	WOS:000305350600112
J	Porter, KM; Epstein, DL; Liton, PB				Porter, Kristine M.; Epstein, David L.; Liton, Paloma B.			Up-Regulated Expression of Extracellular Matrix Remodeling Genes in Phagocytically Challenged Trabecular Meshwork Cells	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; DISTINCT SIGNALING PATHWAYS; OXIDATIVE STRESS; ELECTRON-MICROSCOPY; OUTFLOW PATHWAY; MEDFLY HEMOCYTES; ANTERIOR CHAMBER; AQUEOUS OUTFLOW; ORGAN-CULTURE; PHAGOCYTOSIS	Background: Cells in the trabecular meshwork (TM), the tissue responsible for draining aqueous humor out of the eye, are known to be highly phagocytic. Phagocytic function in TM cells is thought to play an important role in the normal functioning of the outflow pathway. Dysfunction of phagocytosis could lead to abnormalities of outflow resistance and increased intraocular pressure (IOP). However, the molecular mechanisms triggered by phagocytosis in TM cells are completely unknown. Methodology/Principal Findings: Gene expression profile analysis of human TM cells phagocytically challenged to E. coli or pigment under physiological and oxidative stress environment were performed using Affymetrix U133 plus 2.0 array and analyzed with Genespring GX. Despite the differential biological response elicited by E. coli and pigment particles, a number of genes, including MMP1, MMP3, TNFSF11, DIO2, KYNU, and KCCN2 showed differential expression with both phagocytic ligands in all conditions. Data was confirmed by qPCR in both human and porcine TM cells. Metacore pathway analysis and the usage of recombinant adenovirus encoding the dominant negative mutant of IkB identified NF-kappa B as a transcription factor mediating the up-regulation of at least MMP1 and MMP3 in TM cells with phagocytosis. In-gel zymography demonstrated increased collagenolytic and caseinolytic activities in the culture media of TM cells challenge to E. coli. In addition, collagenolytic I activity was further confirmed using the self-quenched fluorescent substrate DQ-Collagen I. Conclusions/Significance: Here we report for the first time the differential gene expression profile of TM cells phagocytically challenged with either E. coli or pigment. Our data indicate a potential role of phagocytosis in outflow pathway tissue homeostasis through the up-regulation and/or proteolytic activation of extracellular matrix remodeling genes.	[Porter, Kristine M.; Epstein, David L.; Liton, Paloma B.] Duke Univ, Dept Ophthalmol, Durham, NC 27706 USA	Duke University	Porter, KM (corresponding author), Duke Univ, Dept Ophthalmol, Durham, NC 27706 USA.	paloma.liton@duke.edu	Liton, Paloma/K-4229-2019	Liton, Paloma/0000-0002-1440-3762	National Institutes of Health [R21EY019137, ARRA R21EY019137-S, R01EY020491, P30EY005722]; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [P30EY005722, R21EY019137, R01EY020491] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	National Institutes of Health Grants R21EY019137, ARRA R21EY019137-S, R01EY020491, P30EY005722, Research to Prevent Blindness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVARADO J, 1984, OPHTHALMOLOGY, V91, P564; Baud'huin M, 2007, CELL MOL LIFE SCI, V64, P2334, DOI 10.1007/s00018-007-7104-0; BILL A, 1975, INVEST OPHTH VISUAL, V14, P1; Bradley JMB, 1998, INVEST OPHTH VIS SCI, V39, P2649; BULLER C, 1990, INVEST OPHTH VIS SCI, V31, P2156; Dismuke WM, 2009, J OCUL PHARMACOL TH, V25, P309, DOI 10.1089/jop.2008.0133; EPSTEIN DL, 1986, INVEST OPHTH VIS SCI, V27, P387; Gogly B, 1998, ANAL BIOCHEM, V255, P211, DOI 10.1006/abio.1997.2318; GRANT GA, 1987, J BIOL CHEM, V262, P5886; GRIERSON I, 1973, BRIT J OPHTHALMOL, V57, P400, DOI 10.1136/bjo.57.6.400; GRIERSON I, 1978, BRIT J OPHTHALMOL, V62, P694, DOI 10.1136/bjo.62.10.694; Hoffmann E, 2010, EUR J CELL BIOL, V89, P693, DOI 10.1016/j.ejcb.2010.04.006; IWAMOTO T, 1971, AM J OPHTHALMOL, V72, P420, DOI 10.1016/0002-9394(71)91315-8; JOHNSON DH, 1989, CURR EYE RES, V8, P1121, DOI 10.3109/02713688909000037; Keller KE, 2009, EXP EYE RES, V88, P676, DOI 10.1016/j.exer.2008.11.023; Kumar DM, 2007, J GLAUCOMA, V16, P334; Lamirand A, 2011, J ENDOCRINOL, V208, P183, DOI 10.1677/JOE-10-0218; Lamprou I, 2005, BBA-MOL CELL RES, V1744, P1, DOI 10.1016/j.bbamcr.2004.09.031; Lamprou I, 2007, IMMUNOLOGY, V121, P314, DOI 10.1111/j.1365-2567.2007.02576.x; Leske MC, 2008, OPHTHALMOLOGY, V115, P85, DOI 10.1016/j.ophtha.2007.03.017; Liton PB, 2008, INVEST OPHTH VIS SCI, V49, P3961, DOI 10.1167/iovs.08-1915; Liton P, 2006, MOL VIS, V12, P774; Liton PB, 2009, AUTOPHAGY, V5, P122, DOI 10.4161/auto.5.1.7304; Liton PB, 2005, EXP GERONTOL, V40, P745, DOI 10.1016/j.exger.2005.06.005; Lutjen-Drecoll E, 1999, PROG RETIN EYE RES, V18, P91, DOI 10.1016/S1350-9462(98)00011-1; Popov Y, 2010, AM J PHYSIOL-GASTR L, V298, pG323, DOI 10.1152/ajpgi.00394.2009; Quigley HA, 2011, LANCET, V377, P1367, DOI 10.1016/S0140-6736(10)61423-7; Rohen J W, 1968, Albrecht Von Graefes Arch Klin Exp Ophthalmol, V175, P143, DOI 10.1007/BF02385060; Ronkko S, 2007, GRAEF ARCH CLIN EXP, V245, P697, DOI 10.1007/s00417-006-0440-1; Sacca SC, 2007, EXP EYE RES, V84, P389, DOI 10.1016/j.exer.2006.10.008; SAMUELSON DA, 1984, AM J VET RES, V45, P2359; SHABO AL, 1972, AM J OPHTHALMOL, V73, P25, DOI 10.1016/0002-9394(72)90300-5; SHIRATO S, 1989, INVEST OPHTH VIS SCI, V30, P2499; Snoek-van Beurden PAM, 2005, BIOTECHNIQUES, V38, P73, DOI 10.2144/05381RV01; Spiga MG, 2010, INVEST OPHTH VIS SCI, V51, P3029, DOI 10.1167/iovs.09-4918; Tamm ER, 2009, EXP EYE RES, V88, P648, DOI 10.1016/j.exer.2009.02.007; TRIPATHI RC, 1982, EXP EYE RES, V35, P611, DOI 10.1016/S0014-4835(82)80074-2; VANBUSKIRK EM, 1978, AM J OPHTHALMOL, V85, P160; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Vu TH, 2000, GENE DEV, V14, P2123, DOI 10.1101/gad.815400; Walker DG, 2006, J LEUKOCYTE BIOL, V79, P596, DOI 10.1189/jlb.0705377; Wang N, 2001, NAT MED, V7, P304, DOI 10.1038/85446; WILHELM SM, 1984, COLLAGEN REL RES, V4, P129; YAMASHITA T, 1965, AM J OPHTHALMOL, V60, P427, DOI 10.1016/0002-9394(65)90706-3; Yang P, 2004, INVEST OPHTH VIS SCI, V45, P2438, DOI 10.1167/iovs.03-0805; Zanon-Moreno V, 2008, J GLAUCOMA, V17, P263, DOI 10.1097/IJG.0b013e31815c3a7f; Zeold A, 2006, ENDOCRINOLOGY, V147, P4419, DOI 10.1210/en.2005-1608; ZHOU LL, 1995, INVEST OPHTH VIS SCI, V36, P787	48	26	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e34792	10.1371/journal.pone.0034792	http://dx.doi.org/10.1371/journal.pone.0034792			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529935	Green Published, gold, Green Submitted			2022-12-27	WOS:000305350600027
J	Block, GJ; Petek, LM; Narayanan, D; Amell, AM; Moore, JM; Rabaia, NA; Tyler, A; van der Maarel, SM; Tawil, R; Filippova, GN; Miller, DG				Block, Gregory J.; Petek, Lisa M.; Narayanan, Divya; Amell, Amanda M.; Moore, James M.; Rabaia, Natalia A.; Tyler, Ashlee; van der Maarel, Silvere M.; Tawil, Rabi; Filippova, Galina N.; Miller, Daniel G.			Asymmetric Bidirectional Transcription from the FSHD-Causing D4Z4 Array Modulates DUX4 Production	PLOS ONE			English	Article							CANDIDATE GENE; BINDING-SITES; PROMOTERS; LOCUS; HYPOMETHYLATION; SEQUENCE; REPEATS; ENCODES; CTCF; YY1	Facioscapulohumeral Disease (FSHD) is a dominantly inherited progressive myopathy associated with aberrant production of the transcription factor, Double Homeobox Protein 4 (DUX4). The expression of DUX4 depends on an open chromatin conformation of the D4Z4 macrosatellite array and a specific haplotype on chromosome 4. Even when these requirements are met, DUX4 transcripts and protein are only detectable in a subset of cells indicating that additional constraints govern DUX4 production. Since the direction of transcription, along with the production of non-coding antisense transcripts is an important regulatory feature of other macrosatellite repeats, we developed constructs that contain the non-coding region of a single D4Z4 unit flanked by genes that report transcriptional activity in the sense and antisense directions. We found that D4Z4 contains two promoters that initiate sense and antisense transcription within the array, and that antisense transcription predominates. Transcriptional start sites for the antisense transcripts, as well as D4Z4 regions that regulate the balance of sense and antisense transcripts were identified. We show that the choice of transcriptional direction is reversible but not mutually exclusive, since sense and antisense reporter activity was often present in the same cell and simultaneously upregulated during myotube formation. Similarly, levels of endogenous sense and antisense D4Z4 transcripts were upregulated in FSHD myotubes. These studies offer insight into the autonomous distribution of muscle weakness that is characteristic of FSHD.	[Block, Gregory J.; Petek, Lisa M.; Narayanan, Divya; Amell, Amanda M.; Miller, Daniel G.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Moore, James M.; Rabaia, Natalia A.; Tyler, Ashlee; Filippova, Galina N.] Fred Hutchinson Canc Res Ctr, Human Biol Div, Seattle, WA 98104 USA; [Tawil, Rabi] Univ Rochester, Med Ctr, Rochester, NY 14642 USA; [van der Maarel, Silvere M.] Leiden Univ, Med Ctr, Leiden, Netherlands	University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Rochester; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Miller, DG (corresponding author), Univ Washington, Dept Pediat, Seattle, WA 98195 USA.	dgmiller@uw.edu	van der Maarel, Silvere/X-3631-2018	van der Maarel, Silvere/0000-0001-8103-711X; Miller, Daniel/0000-0002-5700-3048	NIH NINDS [P01NS069539-02/03]; Pacific Northwest Friends of FSH Research; Shaw Family Foundation; Muscular Dystrophy Association; Fields Center for FSHD and Neuromuscular Research; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS069539] Funding Source: NIH RePORTER	NIH NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Pacific Northwest Friends of FSH Research; Shaw Family Foundation; Muscular Dystrophy Association(Muscular Dystrophy Association); Fields Center for FSHD and Neuromuscular Research; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH NINDS P01NS069539-02/03 (DGM(02), GNF(03)), the Pacific Northwest Friends of FSH Research (GJB, DGM), the Shaw Family Foundation (GNF), the Muscular Dystrophy Association (GNF), and the Fields Center for FSHD and Neuromuscular Research (RT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austen M, 1997, J BIOL CHEM, V272, P1709, DOI 10.1074/jbc.272.3.1709; Bosnakovski D, 2008, EMBO J, V27, P2766, DOI 10.1038/emboj.2008.201; Bosnakovski D, 2008, EXP NEUROL, V214, P87, DOI 10.1016/j.expneurol.2008.07.022; Chadwick BP, 2008, GENOME RES, V18, P1259, DOI 10.1101/gr.075713.107; Cho DH, 2005, MOL CELL, V20, P483, DOI 10.1016/j.molcel.2005.09.002; de Greef JC, 2007, NEUROLOGY, V69, P1018, DOI 10.1212/01.wnl.0000271391.44352.fe; de Greef JC, 2008, MUTAT RES-FUND MOL M, V647, P94, DOI 10.1016/j.mrfmmm.2008.07.011; Dixit M, 2007, P NATL ACAD SCI USA, V104, P18157, DOI 10.1073/pnas.0708659104; Dmitriev P, J BIOL CHEM; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Filippova GN, 2001, NAT GENET, V28, P335, DOI 10.1038/ng570; Frisullo G, 2011, J CLIN IMMUNOL, V31, P155, DOI 10.1007/s10875-010-9474-6; Gabellini D, 2002, CELL, V110, P339, DOI 10.1016/S0092-8674(02)00826-7; Gabriels J, 1999, GENE, V236, P25, DOI 10.1016/S0378-1119(99)00267-X; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Kan HE, 2010, NMR BIOMED, V23, P563, DOI 10.1002/nbm.1494; Kowaljow V, 2007, NEUROMUSCULAR DISORD, V17, P611, DOI 10.1016/j.nmd.2007.04.002; Lemmers RJLF, 2007, AM J HUM GENET, V81, P884, DOI 10.1086/521986; Lemmers RJLF, 2010, SCIENCE, V329, P1650, DOI 10.1126/science.1189044; Moseley SC, 2004, NUCLEIC ACIDS RES, V40, P1596; Ottaviani A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000394; Petek LM, 2010, MOL THER, V18, P1624, DOI 10.1038/mt.2010.102; Petrov A, 2008, GENOME RES, V18, P39, DOI 10.1101/gr.6620908; Reuter M, 2011, NATURE, V480, P264, DOI 10.1038/nature10672; Snider L, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001181; Snider L, 2009, HUM MOL GENET, V18, P2414, DOI 10.1093/hmg/ddp180; Tawil R, 2008, NEUROTHERAPEUTICS, V5, P601, DOI 10.1016/j.nurt.2008.07.005; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; van Overveld PGM, 2003, NAT GENET, V35, P315, DOI 10.1038/ng1262; VANDEUTEKOM JCT, 1993, HUM MOL GENET, V2, P2037; Wallace LM, 2011, ANN NEUROL, V69, P540, DOI 10.1002/ana.22275; Wan Y, 2010, CELL CYCLE, V9, P3391, DOI 10.4161/cc.9.17.13122; Wuebbles RD, 2010, INT J CLIN EXP PATHO, V3, P386; Xu ZY, 2009, NATURE, V457, P1033, DOI 10.1038/nature07728; Yang MQ, 2007, LECT N BIOINFORMAT, V4463, P361; YANT SR, 1995, NUCLEIC ACIDS RES, V23, P4353, DOI 10.1093/nar/23.21.4353; Yu WQ, 2008, NATURE, V451, P202, DOI 10.1038/nature06468; Zeng WH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000559	39	18	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35532	10.1371/journal.pone.0035532	http://dx.doi.org/10.1371/journal.pone.0035532			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536400	gold, Green Submitted, Green Published			2022-12-27	WOS:000305339200075
J	Gulledge, AT; Carnevale, NT; Stuart, GJ				Gulledge, Allan T.; Carnevale, Nicholas T.; Stuart, Greg J.			Electrical Advantages of Dendritic Spines	PLOS ONE			English	Article							LONG-TERM POTENTIATION; CA1 PYRAMIDAL NEURONS; AMPA RECEPTOR EXPRESSION; SYNAPTIC INTEGRATION; CALCIUM-CHANNELS; STRUCTURAL PLASTICITY; BASAL DENDRITES; SODIUM-CHANNELS; RAT HIPPOCAMPUS; NERVOUS-SYSTEM	Many neurons receive excitatory glutamatergic input almost exclusively onto dendritic spines. In the absence of spines, the amplitudes and kinetics of excitatory postsynaptic potentials (EPSPs) at the site of synaptic input are highly variable and depend on dendritic location. We hypothesized that dendritic spines standardize the local geometry at the site of synaptic input, thereby reducing location-dependent variability of local EPSP properties. We tested this hypothesis using computational models of simplified and morphologically realistic spiny neurons that allow direct comparison of EPSPs generated on spine heads with EPSPs generated on dendritic shafts at the same dendritic locations. In all morphologies tested, spines greatly reduced location-dependent variability of local EPSP amplitude and kinetics, while having minimal impact on EPSPs measured at the soma. Spine-dependent standardization of local EPSP properties persisted across a range of physiologically relevant spine neck resistances, and in models with variable neck resistances. By reducing the variability of local EPSPs, spines standardized synaptic activation of NMDA receptors and voltage-gated calcium channels. Furthermore, spines enhanced activation of NMDA receptors and facilitated the generation of NMDA spikes and axonal action potentials in response to synaptic input. Finally, we show that dynamic regulation of spine neck geometry can preserve local EPSP properties following plasticity-driven changes in synaptic strength, but is inefficient in modifying the amplitude of EPSPs in other cellular compartments. These observations suggest that one function of dendritic spines is to standardize local EPSP properties throughout the dendritic tree, thereby allowing neurons to use similar voltage-sensitive postsynaptic mechanisms at all dendritic locations.	[Gulledge, Allan T.] Geisel Sch Med Dartmouth, Dept Physiol & Neurobiol, Hanover, NH USA; [Carnevale, Nicholas T.] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT USA; [Stuart, Greg J.] Australian Natl Univ, John Curtin Sch Med Res, Eccles Inst Neurosci, Canberra, ACT 2601, Australia	Dartmouth College; Yale University; Australian National University; John Curtin School of Medical Research	Gulledge, AT (corresponding author), Geisel Sch Med Dartmouth, Dept Physiol & Neurobiol, Hanover, NH USA.	allan.gulledge@dartmouth.edu	Gulledge, Allan T/C-2733-2008	Gulledge, Allan T/0000-0002-5721-374X; stuart, greg/0000-0001-9395-2219	National Institutes of Health [R01 MH83806]; National Health and Medical Research Council of Australia; NIH [NS11613, DC00086]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH083806] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS011613] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009977] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institutes of Health grant R01 MH83806 (ATG), the National Health and Medical Research Council of Australia (GJS), and NIH grants NS11613 and DC00086 (NTC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araya R, 2007, P NATL ACAD SCI USA, V104, P12347, DOI 10.1073/pnas.0705282104; Araya R, 2006, P NATL ACAD SCI USA, V103, P17961, DOI 10.1073/pnas.0608755103; Arellano JI, 2007, FRONT NEUROSCI-SWITZ, V1, P131, DOI 10.3389/neuro.01.1.1.010.2007; Bekkers JM, 2000, J PHYSIOL-LONDON, V525, P611, DOI 10.1111/j.1469-7793.2000.t01-2-00611.x; Berger T, 2001, J NEUROPHYSIOL, V85, P855, DOI 10.1152/jn.2001.85.2.855; Bloodgood BL, 2005, SCIENCE, V310, P866, DOI 10.1126/science.1114816; Bloodgood BL, 2007, NEURON, V53, P249, DOI 10.1016/j.neuron.2006.12.017; Bloodgood BL, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000190; Branco T, 2011, NEURON, V69, P885, DOI 10.1016/j.neuron.2011.02.006; Cajal S, 1899, REGIAS CONSEJOS INVE; Carnevale NT, 2006, NEURON BOOK; CHANG HT, 1952, COLD SPRING HARB SYM, V17, P189, DOI 10.1101/SQB.1952.017.01.019; Chklovskii DB, 2004, NEURON, V43, P609, DOI 10.1016/j.neuron.2004.08.012; Diamond J, 1970, EXCITATORY SYNAPTIC, P213; Dunaevsky A, 1999, P NATL ACAD SCI USA, V96, P13438, DOI 10.1073/pnas.96.23.13438; Faber ESL, 2005, NAT NEUROSCI, V8, P635, DOI 10.1038/nn1450; FIFKOVA E, 1981, EXP NEUROL, V74, P621, DOI 10.1016/0014-4886(81)90197-7; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; Grunditz A, 2008, J NEUROSCI, V28, P13457, DOI 10.1523/JNEUROSCI.2702-08.2008; Gulledge AT, 2005, J NEUROBIOL, V64, P75, DOI 10.1002/neu.20144; HARRIS KM, 1989, J NEUROSCI, V9, P2982; HARRIS KM, 1992, J NEUROSCI, V12, P2685; Hines ML, 2001, NEUROSCIENTIST, V7, P123, DOI 10.1177/107385840100700207; Holbro N, 2010, P NATL ACAD SCI USA, V107, P15975, DOI 10.1073/pnas.1004562107; Isope P, 2005, J PHYSIOL-LONDON, V562, P257, DOI 10.1113/jphysiol.2004.074211; Jaffe DB, 1999, J NEUROPHYSIOL, V82, P3268, DOI 10.1152/jn.1999.82.6.3268; JASLOVE SW, 1992, NEUROSCIENCE, V47, P495, DOI 10.1016/0306-4522(92)90161-T; Kasai H, 2003, TRENDS NEUROSCI, V26, P360, DOI 10.1016/S0166-2236(03)00162-0; Katz Y, 2009, NEURON, V63, P171, DOI 10.1016/j.neuron.2009.06.023; KAWATO M, 1984, BIOPHYS J, V46, P155, DOI 10.1016/S0006-3495(84)84008-4; KAWATO M, 1983, J THEOR BIOL, V103, P507, DOI 10.1016/0022-5193(83)90280-1; KOCH C, 1993, J NEUROSCI, V13, P413; Kole MHP, 2008, NAT NEUROSCI, V11, P178, DOI 10.1038/nn2040; Kole MHP, 2006, J NEUROSCI, V26, P1677, DOI 10.1523/JNEUROSCI.3664-05.2006; Kopec CD, 2006, J NEUROSCI, V26, P2000, DOI 10.1523/JNEUROSCI.3918-05.2006; Korkotian E, 2007, CELL CALCIUM, V42, P41, DOI 10.1016/j.ceca.2006.11.006; Korkotian E, 2006, CELL CALCIUM, V40, P441, DOI 10.1016/j.ceca.2006.08.008; Korngreen A, 2000, J PHYSIOL-LONDON, V525, P621, DOI 10.1111/j.1469-7793.2000.00621.x; Lamprecht R, 2004, NAT REV NEUROSCI, V5, P45, DOI 10.1038/nrn1301; Lang C, 2004, P NATL ACAD SCI USA, V101, P16665, DOI 10.1073/pnas.0407581101; Larkum ME, 2009, SCIENCE, V325, P756, DOI 10.1126/science.1171958; Lee SJR, 2009, NATURE, V458, P299, DOI 10.1038/nature07842; Leitch B, 2009, NEUROSCIENCE, V164, P641, DOI 10.1016/j.neuroscience.2009.08.006; LESTER RAJ, 1990, NATURE, V346, P565, DOI 10.1038/346565a0; Lorincz A, 2010, SCIENCE, V328, P906, DOI 10.1126/science.1187958; Magee JC, 1998, J NEUROSCI, V18, P7613; Mainen ZF, 1996, NATURE, V382, P363, DOI 10.1038/382363a0; Martone ME, 2002, J STRUCT BIOL, V138, P145, DOI 10.1016/S1047-8477(02)00006-0; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; MULLER W, 1991, NATURE, V354, P73, DOI 10.1038/354073a0; Nevian T, 2007, NAT NEUROSCI, V10, P206, DOI 10.1038/nn1826; Ngo-Anh TJ, 2005, NAT NEUROSCI, V8, P642, DOI 10.1038/nn1449; Nicholson DA, 2006, NEURON, V50, P431, DOI 10.1016/j.neuron.2006.03.022; Oertner TG, 2009, FRONT COMPUT NEUROSC, V3, DOI 10.3389/neuro.10.007.2009; Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311; Otmakhov N, 2004, J NEUROSCI, V24, P9324, DOI 10.1523/JNEUROSCI.2350-04.2004; Palmer LM, 2009, J NEUROSCI, V29, P6897, DOI 10.1523/JNEUROSCI.5847-08.2009; Peterka DS, 2011, NEURON, V69, P9, DOI 10.1016/j.neuron.2010.12.010; PETERS A, 1970, AM J ANAT, V127, P321, DOI 10.1002/aja.1001270402; Rall W., 1974, CELLULAR MECH SUBSER, P13; RINZEL J, 1974, BIOPHYS J, V14, P759, DOI 10.1016/S0006-3495(74)85948-5; Roth A, 2001, J PHYSIOL-LONDON, V535, P445, DOI 10.1111/j.1469-7793.2001.00445.x; Sabatini BL, 2000, NATURE, V408, P589, DOI 10.1038/35046076; Sabatini BL, 2002, NEURON, V33, P439, DOI 10.1016/S0896-6273(02)00573-1; Schiller J, 2000, NATURE, V404, P285, DOI 10.1038/35005094; Schmidt-Hieber C, 2007, J NEUROSCI, V27, P8430, DOI 10.1523/JNEUROSCI.1787-07.2007; Segev I, 2000, SCIENCE, V290, P744, DOI 10.1126/science.290.5492.744; SEGEV I, 1995, J COMPUT NEUROSCI, V2, P117, DOI 10.1007/BF00961883; Spruston N, 2008, NAT REV NEUROSCI, V9, P206, DOI 10.1038/nrn2286; Stuart G, 1998, J NEUROSCI, V18, P3501; STUART GJ, 1994, NATURE, V367, P69, DOI 10.1038/367069a0; Svoboda K, 1996, SCIENCE, V272, P716, DOI 10.1126/science.272.5262.716; Tanaka JI, 2008, SCIENCE, V319, P1683, DOI 10.1126/science.1152864; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; WILSON CJ, 1984, J NEUROSCI, V4, P281; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0	77	54	54	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e36007	10.1371/journal.pone.0036007	http://dx.doi.org/10.1371/journal.pone.0036007			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22532875	Green Submitted, Green Published, gold			2022-12-27	WOS:000305339200125
J	Trinquart, L; Abbe, A; Ravaud, P				Trinquart, Ludovic; Abbe, Adeline; Ravaud, Philippe			Impact of Reporting Bias in Network Meta-Analysis of Antidepressant Placebo-Controlled Trials	PLOS ONE			English	Article							INDUSTRY SPONSORSHIP; PUBLICATION BIASES; HEALTH-CARE; INTERVENTIONS; DATABASE; REGISTRY	Background: Indirect comparisons of competing treatments by network meta-analysis (NMA) are increasingly in use. Reporting bias has received little attention in this context. We aimed to assess the impact of such bias in NMAs. Methods: We used data from 74 FDA-registered placebo-controlled trials of 12 antidepressants and their 51 matching publications. For each dataset, NMA was used to estimate the effect sizes for 66 possible pair-wise comparisons of these drugs, the probabilities of being the best drug and ranking the drugs. To assess the impact of reporting bias, we compared the NMA results for the 51 published trials and those for the 74 FDA-registered trials. To assess how reporting bias affecting only one drug may affect the ranking of all drugs, we performed 12 different NMAs for hypothetical analysis. For each of these NMAs, we used published data for one drug and FDA data for the 11 other drugs. Findings: Pair-wise effect sizes for drugs derived from the NMA of published data and those from the NMA of FDA data differed in absolute value by at least 100% in 30 of 66 pair-wise comparisons (45%). Depending on the dataset used, the top 3 agents differed, in composition and order. When reporting bias hypothetically affected only one drug, the affected drug ranked first in 5 of the 12 NMAs but second (n = 2), fourth (n = 1) or eighth (n = 2) in the NMA of the complete FDA network. Conclusions: In this particular network, reporting bias biased NMA-based estimates of treatments efficacy and modified ranking. The reporting bias effect in NMAs may differ from that in classical meta-analyses in that reporting bias affecting only one drug may affect the ranking of all drugs.	[Trinquart, Ludovic; Abbe, Adeline; Ravaud, Philippe] French Cochrane Ctr, Paris, France; [Trinquart, Ludovic; Abbe, Adeline; Ravaud, Philippe] Univ Paris Descartes Sorbonne Paris Cite, Paris, France; [Trinquart, Ludovic; Abbe, Adeline; Ravaud, Philippe] INSERM, U738, Paris, France; [Trinquart, Ludovic; Abbe, Adeline; Ravaud, Philippe] Hop Hotel Dieu, AP HP, Ctr Epidemiol Clin, F-75181 Paris, France; [Ravaud, Philippe] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA	UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; Columbia University	Ravaud, P (corresponding author), French Cochrane Ctr, Paris, France.	philippe.ravaud@htd.aphp.fr	Trinquart, Ludovic/H-4961-2019; ravaud, philippe/C-1694-2009	Trinquart, Ludovic/0000-0002-3028-4900; Ravaud, Philippe/0000-0001-8264-9206; ABBE, Adeline/0000-0001-6170-9572	French Ministry of Health Programme Hospitalier de Recherche Clinique National [PHRC 2011 MIN01-66]; European Union [285453]	French Ministry of Health Programme Hospitalier de Recherche Clinique National; European Union(European Commission)	Grant support was from the French Ministry of Health Programme Hospitalier de Recherche Clinique National (PHRC 2011 MIN01-66) and European Union Seventh Framework Programme (FP7 - HEALTH.2011.4.1-2) under grant agreement no 285453 (www.open-project.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bero L, 2007, PLOS MED, V4, P1001, DOI 10.1371/journal.pmed.0040184; Chalmers I, 2006, LANCET, V367, P449, DOI 10.1016/S0140-6736(06)68153-1; Cipriani A, 2009, LANCET, V373, P746, DOI 10.1016/S0140-6736(09)60046-5; Cohen J.E., 1988, STAT POWER ANAL BEHA; DeAngelis CD, 2010, JAMA-J AM MED ASSOC, V303, P1196, DOI 10.1001/jama.2010.337; Dickersin K, 2010, SCIENCE, V329, P516, DOI 10.1126/science.1189330; Donegan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011054; Estellat C, 2012, ARCH INTERN MED, V172, P237, DOI 10.1001/archinternmed.2011.1209; Eyding D, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4737; Gartlehner G, 2008, ANN INTERN MED, V149, P734, DOI 10.7326/0003-4819-149-10-200811180-00008; Glenny AM, 2005, HEALTH TECHNOL ASSES, V9, P1; Godlee F, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5641; Hart B, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7202; Higgins JPT, 1996, STAT MED, V15, P2733, DOI 10.1002/(SICI)1097-0258(19961230)15:24<2733::AID-SIM562>3.0.CO;2-0; Hochman M, 2010, JAMA-J AM MED ASSOC, V303, P951, DOI 10.1001/jama.2010.240; Hopewell S, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000006.pub3; Institute of Medicine, 2009, IN NAT PRIOR COMP EF, P227, DOI [10.17226/12648, DOI 10.17226/12648]; Ioannidis JPA, 2007, CAN MED ASSOC J, V176, P1091, DOI 10.1503/cmaj.060410; Ioannidis JPA, 2011, ARCH GEN PSYCHIAT, V68, P773, DOI 10.1001/archgenpsychiatry.2011.28; Kent DM, 2008, NEW ENGL J MED, V359, P1287, DOI 10.1056/NEJMe0806806; Lathyris DN, 2010, EUR J CLIN INVEST, V40, P172, DOI 10.1111/j.1365-2362.2009.02240.x; Lee K, 2008, PLOS MED, V5, P1348, DOI 10.1371/journal.pmed.0050191; Lexchin J, 2003, BMJ-BRIT MED J, V326, P1167, DOI 10.1136/bmj.326.7400.1167; Lu G, 2004, STAT MED, V23, P3105, DOI 10.1002/sim.1875; Lumley T, 2002, STAT MED, V21, P2313, DOI 10.1002/sim.1201; Miller JD, 2010, JAMA-J AM MED ASSOC, V303, P773, DOI 10.1001/jama.2010.207; Montori V, 2008, USERS GUIDE MED LIT, P543; Moreno SG, 2011, J CLIN EPIDEMIOL, V64, P1230, DOI 10.1016/j.jclinepi.2011.01.009; Moreno SG, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2981; O'Connor AB, 2009, JAMA-J AM MED ASSOC, V302, P191, DOI 10.1001/jama.2009.973; O'Regan C, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-86; Rising K, 2008, PLOS MED, V5, P1561, DOI 10.1371/journal.pmed.0050217; Salanti G, 2008, STAT METHODS MED RES, V17, P279, DOI 10.1177/0962280207080643; Salanti G, 2008, ANN INTERN MED, V148, P544, DOI 10.7326/0003-4819-148-7-200804010-00011; Salanti G, 2011, J CLIN EPIDEMIOL, V64, P163, DOI 10.1016/j.jclinepi.2010.03.016; Salanti G, 2009, J CLIN EPIDEMIOL, V62, P857, DOI 10.1016/j.jclinepi.2008.10.001; Song F, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14080; Song FJ, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1147; Stafford RS, 2009, NEW ENGL J MED, V361, P1230, DOI 10.1056/NEJMp0906490; Sterne JAC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4002; Turner E, 2005, PLOS MED, V2, P1343, DOI 10.1371/journal.pmed.0020422; Turner EH, 2004, PLOS MED, V1, P180, DOI 10.1371/journal.pmed.0010060; Turner Erick H, 2008, N Engl J Med, V358, P252, DOI 10.1056/NEJMsa065779; Vedula SS, 2009, NEW ENGL J MED, V361, P1963, DOI 10.1056/NEJMsa0906126; Vlopp KG, 2009, NEW ENGL J MED, V361, P331, DOI 10.1056/NEJMp0903496; Welton NJ, 2009, AM J EPIDEMIOL, V169, P1158, DOI 10.1093/aje/kwp014; Zarin DA, 2008, SCIENCE, V319, P1340, DOI 10.1126/science.1153632	47	39	40	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35219	10.1371/journal.pone.0035219	http://dx.doi.org/10.1371/journal.pone.0035219			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536359	Green Published, gold, Green Submitted			2022-12-27	WOS:000305339200045
J	Wu, ST; Li, RW; Li, WZ; Beshah, E; Dawson, HD; Urban, JF				Wu, Sitao; Li, Robert W.; Li, Weizhong; Beshah, Ethiopia; Dawson, Harry D.; Urban, Joseph F., Jr.			Worm Burden-Dependent Disruption of the Porcine Colon Microbiota by Trichuris suis Infection	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; ALTERNATIVELY ACTIVATED MACROPHAGES; CAMPYLOBACTER-JEJUNI; SWINE; EXPRESSION; INDUCTION; ULTRAFAST; SEQUENCES; NEMATODES; ALIGNMENT	Helminth infection in pigs serves as an excellent model for the study of the interaction between human malnutrition and parasitic infection and could have important implications in human health. We had observed that pigs infected with Trichuris suis for 21 days showed significant changes in the proximal colon microbiota. In this study, interactions between worm burden and severity of disruptions to the microbial composition and metabolic potentials in the porcine proximal colon microbiota were investigated using metagenomic tools. Pigs were infected by a single dose of T. suis eggs for 53 days. Among infected pigs, two cohorts were differentiated that either had adult worms or were worm-free. Infection resulted in a significant change in the abundance of approximately 13% of genera detected in the proximal colon microbiota regardless of worm status, suggesting a relatively persistent change over time in the microbiota due to the initial infection. A significant reduction in the abundance of Fibrobacter and Ruminococcus indicated a change in the fibrolytic capacity of the colon microbiota in T. suis infected pigs. In addition, similar to 10% of identified KEGG pathways were affected by infection, including ABC transporters, peptidoglycan biosynthesis, and lipopolysaccharide biosynthesis as well as alpha-linolenic acid metabolism. Trichuris suis infection modulated host immunity to Campylobacter because there was a 3-fold increase in the relative abundance in the colon microbiota of infected pigs with worms compared to naive controls, but a 3-fold reduction in worm-free infected pigs compared to controls. The level of pathology observed in infected pigs with worms compared to worm-free infected pigs may relate to the local host response because expression of several Th2-related genes were enhanced in infected pigs with worms versus those worm-free. Our findings provided insight into the dynamics of the proximal colon microbiota in pigs in response to T. suis infection.	[Li, Robert W.] ARS, USDA, Bovine Funct Genom Lab, Beltsville, MD USA; [Wu, Sitao; Li, Weizhong] Univ Calif San Diego, Ctr Res Biol Syst, San Diego, CA 92103 USA; [Beshah, Ethiopia; Dawson, Harry D.; Urban, Joseph F., Jr.] ARS, USDA, Diet Genom & Immunol Lab, Beltsville, MD USA	United States Department of Agriculture (USDA); University of California System; University of California San Diego; United States Department of Agriculture (USDA)	Li, RW (corresponding author), ARS, USDA, Bovine Funct Genom Lab, Beltsville, MD USA.	robert.li@ars.usda.gov	Dawson, Harry/H-8242-2013; Dawson, Harry/ABG-2734-2021; Li, Weizhong/A-9735-2008	Dawson, Harry/0000-0002-7648-9952; Li, Weizhong/0000-0003-1804-9403; Urban, Joseph/0000-0002-1590-8869	National Human Genome Research Institute (NHGRI) [R01HG005978]; National Center for Research Resources (NCRR) [R01RR025030]; CAMERA project; Gordon and Betty Moore Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR025030] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005978] Funding Source: NIH RePORTER	National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); CAMERA project; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	SW and WL were supported by Award R01HG005978 from the National Human Genome Research Institute (NHGRI), Award R01RR025030 from National Center for Research Resources (NCRR) and CAMERA project funded by Gordon and Betty Moore Foundation. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NHGRI, NCRR or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony RM, 2006, NAT MED, V12, P955, DOI 10.1038/nm1451; Artis D, 2004, P NATL ACAD SCI USA, V101, P13596, DOI 10.1073/pnas.0404034101; Bager P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022346; Boes J, 2000, PARASITOLOGY, V121, pS97, DOI 10.1017/S003118200000648X; Cliffe LJ, 2005, SCIENCE, V308, P1463, DOI 10.1126/science.1108661; Cox MP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-485; Dawson HD, 2012, MINIPIG IN BIOMEDICAL RESEARCH, P323; Dawson HD, 2005, INFECT IMMUN, V73, P1116, DOI 10.1128/IAI.73.2.1116-1128.2005; Famularo G, 2003, CURR PHARM DESIGN, V9, P1973, DOI 10.2174/1381612033454207; Festi D, 2011, DIGEST DIS, V29, P518, DOI 10.1159/000332975; Glass EM, 2010, COLD SPRING HARB PRO; Hasnain SZ, 2011, J EXP MED, V208, P893, DOI 10.1084/jem.20102057; HIGUCHI R, 1993, BIO-TECHNOL, V11, P1026, DOI 10.1038/nbt0993-1026; Khodoun M, 2009, J ALLERGY CLIN IMMUN, V123, P342, DOI 10.1016/j.jaci.2008.11.004; Kringel H, 2006, INT J PARASITOL, V36, P915, DOI 10.1016/j.ijpara.2006.04.008; Kringel H, 2006, VET PARASITOL, V139, P132, DOI 10.1016/j.vetpar.2006.03.002; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li RW, 2012, ENVIRON MICROBIOL, V14, P129, DOI 10.1111/j.1462-2920.2011.02543.x; Li RW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024417; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li RW, 2012, INFECT IMMUNITY; Liu B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S2-S4; Mansfield LS, 2004, COMPARATIVE MED, V54, P514; Mansfield LS, 2003, AM J TROP MED HYG, V68, P70; Mansfield LS, 1996, VET IMMUNOL IMMUNOP, V50, P1, DOI 10.1016/0165-2427(95)05482-0; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Morimoto M, 2006, J IMMUNOL, V176, P491, DOI 10.4049/jimmunol.176.1.491; Nair MG, 2008, J IMMUNOL, V181, P4709, DOI 10.4049/jimmunol.181.7.4709; Neeb ZP, 2010, COMPARATIVE MED, V60, P300; Parthasarathy G, 2009, MICROB PATHOGENESIS, V47, P38, DOI 10.1016/j.micpath.2009.04.011; Rho MN, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq747; Roepstorff A, 2011, VET PARASITOL, V180, P72, DOI 10.1016/j.vetpar.2011.05.029; Seksik P, 2003, GUT, V52, P237, DOI 10.1136/gut.52.2.237; Shanahan F, 2001, GASTROENTEROLOGY, V120, P622, DOI 10.1053/gast.2001.22122; Shin JL, 2004, CAN J GASTROENTEROL, V18, P175, DOI 10.1155/2004/298064; Stephenson LS, 2000, PARASITOLOGY, V121, pS73, DOI 10.1017/S0031182000006867; Suen G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018814; Summers RW, 2005, GASTROENTEROLOGY, V128, P825, DOI 10.1053/j.gastro.2005.01.005; Summers RW, 2003, AM J GASTROENTEROL, V98, P2034, DOI [10.1016/S0002-9270(03)00623-3, 10.1111/j.1572-0241.2003.07660.x]; Van Kruiningen HJ, 2005, INFLAMM BOWEL DIS, V11, P515, DOI 10.1097/01.MIB.0000160369.47671.a2; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Wilson MS, 2011, GASTROENTEROLOGY, V140, P254, DOI 10.1053/j.gastro.2010.09.047; Xu J, 2007, PLOS BIOL, V5, P1574, DOI 10.1371/journal.pbio.0050156; Young VB, 2011, CURRENT OPINION GAST; Zaiss DM, 2006, SCIENCE, V314, P1746, DOI 10.1126/science.1133715; Zhao AP, 2008, GASTROENTEROLOGY, V135, P217, DOI 10.1053/j.gastro.2008.03.077; Zheng J, 2008, INFECT IMMUN, V76, P4498, DOI 10.1128/IAI.01317-07	47	86	88	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35470	10.1371/journal.pone.0035470	http://dx.doi.org/10.1371/journal.pone.0035470			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22532855	Green Published, gold, Green Submitted			2022-12-27	WOS:000305339200068
J	Mizutani, R; Wakamatsu, A; Tanaka, N; Yoshida, H; Tochigi, N; Suzuki, Y; Oonishi, T; Tani, H; Tano, K; Ijiri, K; Isogai, T; Akimitsu, N				Mizutani, Rena; Wakamatsu, Ai; Tanaka, Noriyuki; Yoshida, Hiroshi; Tochigi, Naobumi; Suzuki, Yoshio; Oonishi, Tadahiro; Tani, Hidenori; Tano, Keiko; Ijiri, Kenichi; Isogai, Takao; Akimitsu, Nobuyoshi			Identification and Characterization of Novel Genotoxic Stress-Inducible Nuclear Long Noncoding RNAs in Mammalian Cells	PLOS ONE			English	Article							DOSAGE COMPENSATION; MESSENGER-RNAS; HUMAN GENOME; GENE; TRANSCRIPTION; EXPRESSION; CHROMATIN; PATHWAYS; DECAY	Whole transcriptome analyses have revealed a large number of novel transcripts including long and short noncoding RNAs (ncRNAs). Currently, there is great interest in characterizing the functions of the different classes of ncRNAs and their relevance to cellular processes. In particular, nuclear long ncRNAs may be involved in controlling various aspects of biological regulation, such as stress responses. By a combination of bioinformatic and experimental approaches, we identified 25 novel nuclear long ncRNAs from 6,088,565 full-length human cDNA sequences. Some nuclear long ncRNAs were conserved among vertebrates, whereas others were found only among primates. Expression profiling of the nuclear long ncRNAs in human tissues revealed that most were expressed ubiquitously. A subset of the identified nuclear long ncRNAs was induced by the genotoxic agents mitomycin C or doxorubicin, in HeLa Tet-off cells. There were no commonly altered nuclear long ncRNAs between mitomycin C- and doxorubicin-treated cells. These results suggest that distinct sets of nuclear long ncRNAs play roles in cellular defense mechanisms against specific genotoxic agents, and that particular long ncRNAs have the potential to be surrogate indicators of a specific cell stress.	[Mizutani, Rena; Tani, Hidenori; Tano, Keiko; Ijiri, Kenichi; Akimitsu, Nobuyoshi] Univ Tokyo, Radioisotope Ctr, Tokyo, Japan; [Wakamatsu, Ai; Isogai, Takao] Univ Tokyo, Grad Sch Pharmaceut Sci, Tokyo, Japan; [Tanaka, Noriyuki; Yoshida, Hiroshi; Tochigi, Naobumi; Suzuki, Yoshio] Asahi Gen Hosp, Chiba, Japan; [Oonishi, Tadahiro] Med Consultat Off Inc, Yokohama, Kanagawa, Japan	University of Tokyo; University of Tokyo	Mizutani, R (corresponding author), Univ Tokyo, Radioisotope Ctr, Tokyo, Japan.	akimitsu@ric.u-tokyo.ac.jp	Tani, Hidenori/F-2042-2010; Tani, Hidenori/A-7175-2017	Tani, Hidenori/0000-0001-6390-4136; Tani, Hidenori/0000-0001-6390-4136	Takeda Science Foundation; Naito Foundation; Japan Society for the Promotion of Science	Takeda Science Foundation(Takeda Science Foundation (TSF)); Naito Foundation(Naito Memorial Foundation); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was financially supported by the Takeda Science Foundation, the Naito Foundation, and Grants-in-Aid for Scientific Research and a Research Fellowship from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker KE, 2004, CURR OPIN CELL BIOL, V16, P293, DOI 10.1016/j.ceb.2004.03.003; BALABAN N, 1995, FEMS MICROBIOL LETT, V133, P155, DOI 10.1016/0378-1097(95)00356-A; Bernard D, 2010, EMBO J, V29, P3082, DOI 10.1038/emboj.2010.199; Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Brosnan CA, 2009, CURR OPIN CELL BIOL, V21, P416, DOI 10.1016/j.ceb.2009.04.001; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Chen LL, 2009, MOL CELL, V35, P467, DOI 10.1016/j.molcel.2009.06.027; Cheng J, 2005, SCIENCE, V308, P1149, DOI 10.1126/science.1108625; Clemson CM, 2009, MOL CELL, V33, P717, DOI 10.1016/j.molcel.2009.01.026; Ebisuya M, 2008, NAT CELL BIOL, V10, P1106, DOI 10.1038/ncb1771; Emberley E, 2003, BIOCHEM BIOPH RES CO, V301, P509, DOI 10.1016/S0006-291X(02)03070-X; Erwin JA, 2008, CURR OPIN CELL BIOL, V20, P349, DOI 10.1016/j.ceb.2008.04.007; Faghihi MA, 2008, NAT MED, V14, P723, DOI 10.1038/nm1784; Fejes-Toth K, 2009, NATURE, V457, P1028, DOI 10.1038/nature07759; Frith MC, 2006, PLOS GENET, V2, P515, DOI 10.1371/journal.pgen.0020052; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Hanyu-Nakamura K, 2008, NATURE, V451, P730, DOI 10.1038/nature06498; He F, 2003, MOL CELL, V12, P1439, DOI 10.1016/S1097-2765(03)00446-5; Heard E, 2006, GENE DEV, V20, P1848, DOI 10.1101/gad.1422906; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Jolly C, 2004, J CELL BIOL, V164, P25, DOI 10.1083/jcb.200306104; Jolly C, 2006, NUCLEIC ACIDS RES, V34, P5508, DOI 10.1093/nar/gkl711; Kikuchi K, 2009, NUCLEIC ACIDS RES, V37, P4987, DOI 10.1093/nar/gkp426; Kondo T, 2007, NAT CELL BIOL, V9, P660, DOI 10.1038/ncb1595; Kotake Y, 2011, ONCOGENE, V30, P1956, DOI 10.1038/onc.2010.568; Kultz D, 2005, ANNU REV PHYSIOL, V67, P225, DOI 10.1146/annurev.physiol.67.040403.103635; Leung AKL, 2010, MOL CELL, V40, P205, DOI 10.1016/j.molcel.2010.09.027; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Mattick JS, 2011, SCIENCE, V331, P874, DOI 10.1126/science.1203703; Mattick JS, 2004, NAT REV GENET, V5, P316, DOI 10.1038/nrg1321; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Pandey RR, 2008, MOL CELL, V32, P232, DOI 10.1016/j.molcel.2008.08.022; Payer B, 2008, ANNU REV GENET, V42, P733, DOI 10.1146/annurev.genet.42.110807.091711; Preker P, 2008, SCIENCE, V322, P1851, DOI 10.1126/science.1164096; Quiles JL, 2002, TOXICOLOGY, V180, P79, DOI 10.1016/S0300-483X(02)00383-9; Quinones A, 2001, MUTAT RES-GEN TOX EN, V494, P73, DOI 10.1016/S1383-5718(01)00179-6; Rajski SR, 1998, CHEM REV, V98, P2723, DOI 10.1021/cr9800199; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Rizzi N, 2004, MOL BIOL CELL, V15, P543, DOI 10.1091/mbc.E03-07-0487; Sasaki YTF, 2007, BIOCHEM BIOPH RES CO, V357, P991, DOI 10.1016/j.bbrc.2007.04.034; Sasaki YTF, 2009, P NATL ACAD SCI USA, V106, P2525, DOI 10.1073/pnas.0807899106; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Sonkoly E, 2005, J BIOL CHEM, V280, P24159, DOI 10.1074/jbc.M501704200; Sunwoo H, 2009, GENOME RES, V19, P347, DOI 10.1101/gr.087775.108; Tano K, 2010, FEBS LETT, V584, P4575, DOI 10.1016/j.febslet.2010.10.008; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; vandeSande K, 1996, SCIENCE, V273, P370, DOI 10.1126/science.273.5273.370; Wadler CS, 2007, P NATL ACAD SCI USA, V104, P20454, DOI 10.1073/pnas.0708102104; Wakamatsu A, 2009, DNA RES, V16, P371, DOI 10.1093/dnares/dsp022; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030; Yap KL, 2010, MOL CELL, V38, P662, DOI 10.1016/j.molcel.2010.03.021; Yu WQ, 2008, NATURE, V451, P202, DOI 10.1038/nature06468	54	44	45	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e34949	10.1371/journal.pone.0034949	http://dx.doi.org/10.1371/journal.pone.0034949			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22532836	Green Submitted, Green Published, gold			2022-12-27	WOS:000305336200016
J	Thomas, PS; Sridurongrit, S; Ruiz-Lozano, P; Kaartinen, V				Thomas, Penny S.; Sridurongrit, Somyoth; Ruiz-Lozano, Pilar; Kaartinen, Vesa			Deficient Signaling via Alk2 (Acvr1) Leads to Bicuspid Aortic Valve Development	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; NEURAL CREST CELLS; OUTFLOW TRACT; SEMILUNAR VALVES; EMBRYONIC HEARTS; CHICK-EMBRYOS; MICE; DISEASE; EXPRESSION; DEFECTS	Bicuspid aortic valve (BAV) is the most common congenital cardiac anomaly in humans. Despite recent advances, the molecular basis of BAV development is poorly understood. Previously it has been shown that mutations in the Notch1 gene lead to BAV and valve calcification both in human and mice, and mice deficient in Gata5 or its downstream target Nos3 have been shown to display BAVs. Here we show that tissue-specific deletion of the gene encoding Activin Receptor Type I (Alk2 or Acvr1) in the cushion mesenchyme results in formation of aortic valve defects including BAV. These defects are largely due to a failure of normal development of the embryonic aortic valve leaflet precursor cushions in the outflow tract resulting in either a fused right- and non-coronary leaflet, or the presence of only a very small, rudimentary non-coronary leaflet. The surviving adult mutant mice display aortic stenosis with high frequency and occasional aortic valve insufficiency. The thickened aortic valve leaflets in such animals do not show changes in Bmp signaling activity, while Map kinase pathways are activated. Although dysfunction correlated with some pro-osteogenic differences in gene expression, neither calcification nor inflammation were detected in aortic valves of Alk2 mutants with stenosis. We conclude that signaling via Alk2 is required for appropriate aortic valve development in utero, and that defects in this process lead to indirect secondary complications later in life.	[Thomas, Penny S.; Sridurongrit, Somyoth; Kaartinen, Vesa] Univ Michigan, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA; [Ruiz-Lozano, Pilar] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA	University of Michigan System; University of Michigan; Stanford University	Thomas, PS (corresponding author), Univ Michigan, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA.	vesa@umich.edu	Kaartinen, Vesa/AAU-5396-2021	Kaartinen, Vesa/0000-0002-9432-510X	National Institutes of Health [HL074862]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074862] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was financially supported by the National Institutes of Health RO1 grant number HL074862 (http://www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGELINI A, 1989, J THORAC CARDIOV SUR, V98, P362; Bajolle F, 2008, DEV BIOL, V313, P25, DOI 10.1016/j.ydbio.2007.09.023; Biben C, 2000, CIRC RES, V87, P888, DOI 10.1161/01.RES.87.10.888; Braverman AC, 2005, CURR PROB CARDIOLOGY, V30, P470, DOI 10.1016/j.cpcardiol.2005.06.002; Cai CL, 2008, NATURE, V454, P104, DOI 10.1038/nature06969; COLVEE E, 1983, ANAT EMBRYOL, V168, P59, DOI 10.1007/BF00305399; Desgrosellier JS, 2005, DEV BIOL, V280, P201, DOI 10.1016/j.ydbio.2004.12.037; Dudas M, 2004, MECH DEVELOP, V121, P173, DOI 10.1016/j.mod.2003.12.003; Dupuis LE, 2011, DEV BIOL, V357, P152, DOI 10.1016/j.ydbio.2011.06.041; Egorova AD, 2011, CIRC RES, V108, P1093, DOI 10.1161/CIRCRESAHA.110.231860; Fernandes SM, 2004, J AM COLL CARDIOL, V44, P1648, DOI 10.1016/j.jacc.2004.05.063; Fernandes SM, 2007, J AM COLL CARDIOL, V49, P2211, DOI 10.1016/j.jacc.2007.01.090; Fernandez B, 2009, J AM COLL CARDIOL, V54, P2312, DOI 10.1016/j.jacc.2009.07.044; Gan LM, 2000, CARDIOVASC RES, V48, P168, DOI 10.1016/S0008-6363(00)00174-7; Garg V, 2005, NATURE, V437, P270, DOI 10.1038/nature03940; Gu XX, 2009, AM J PHYSIOL-HEART C, V296, pH1748, DOI 10.1152/ajpheart.00099.2009; Harlow E., 1988, ANTIBODIES LAB MANUA; Hinton RB, 2011, ANNU REV PHYSIOL, V73, P29, DOI 10.1146/annurev-physiol-012110-142145; Hogan B, 1994, MANIPULATING MOUSE E; HURLE JM, 1980, ANAT EMBRYOL, V160, P83, DOI 10.1007/BF00315651; HURLE JM, 1990, ANAT EMBRYOL, V181, P149; Jiang XB, 2000, DEVELOPMENT, V127, P1607; Joziasse IC, 2011, EUR J HUM GENET, V19, P389, DOI 10.1038/ejhg.2010.224; Kaartinen V, 2004, DEVELOPMENT, V131, P3481, DOI 10.1242/dev.01214; KRUG EL, 1985, DEV BIOL, V112, P414, DOI 10.1016/0012-1606(85)90414-2; Laforest B, 2011, J CLIN INVEST, V121, P2876, DOI 10.1172/JCI44555; Lee TC, 2000, CIRCULATION, V101, P2345, DOI 10.1161/01.CIR.101.20.2345; Ma LJ, 2005, DEVELOPMENT, V132, P5601, DOI 10.1242/dev.02156; MANNER J, 1993, ANAT EMBRYOL, V188, P269; MARKWALD RR, 1981, SCAN ELECTRON MICROS, P261; Merki E, 2005, P NATL ACAD SCI USA, V102, P18455, DOI 10.1073/pnas.0504343102; Merryman WD, 2010, J BIOMECH, V43, P87, DOI 10.1016/j.jbiomech.2009.09.013; MITSIADIS TA, 1995, J CELL BIOL, V130, P407, DOI 10.1083/jcb.130.2.407; Moorman AFM, 2001, J HISTOCHEM CYTOCHEM, V49, P1, DOI 10.1177/002215540104900101; Nadaud S, 1996, CIRC RES, V79, P857, DOI 10.1161/01.RES.79.4.857; Nagy E, 2011, CIRCULATION, V123, P1316, DOI 10.1161/CIRCULATIONAHA.110.966846; Nus M, 2011, ARTERIOSCL THROM VAS, V31, P1580, DOI 10.1161/ATVBAHA.111.227561; Peacock JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026769; Person AD, 2005, INT REV CYTOL, V243, P287, DOI 10.1016/S0074-7696(05)43005-3; Rivera-Feliciano J, 2006, DEV BIOL, V295, P580, DOI 10.1016/j.ydbio.2006.03.043; Sacks MS, 2007, PHILOS T R SOC B, V362, P1369, DOI 10.1098/rstb.2007.2122; Schaefer BM, 2007, AM J CARDIOL, V99, P686, DOI 10.1016/j.amjcard.2006.09.118; Sievers HH, 2007, J THORAC CARDIOV SUR, V133, P1226, DOI 10.1016/j.jtcvs.2007.01.039; Siu SC, 2010, J AM COLL CARDIOL, V55, P2789, DOI 10.1016/j.jacc.2009.12.068; Smith KA, 2009, CIRCULATION, V119, P3062, DOI 10.1161/CIRCULATIONAHA.108.843714; Song LY, 2007, DEV BIOL, V301, P276, DOI 10.1016/j.ydbio.2006.08.004; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Stennard FA, 2005, DEVELOPMENT, V132, P2451, DOI 10.1242/dev.01799; Stewart BF, 1997, J AM COLL CARDIOL, V29, P630, DOI 10.1016/S0735-1097(96)00563-3; Sugi Y, 2004, DEV BIOL, V269, P505, DOI 10.1016/j.ydbio.2004.01.045; Tamamura Y, 2005, J BIOL CHEM, V280, P19185, DOI 10.1074/jbc.M414275200; Tomanek Robert J., 2005, Angiogenesis, V8, P273, DOI 10.1007/s10456-005-9014-9; VOLLEBERGH FEMG, 1977, BRIT HEART J, V39, P1006; Wang JK, 2005, DEV BIOL, V286, P299, DOI 10.1016/j.ydbio.2005.07.035; Ya J, 1998, CIRC RES, V82, P464, DOI 10.1161/01.RES.82.4.464; Ya J, 1997, J MOL MED, V75, P551, DOI 10.1007/s001090050140; Yener Nuran, 2002, Ann Thorac Cardiovasc Surg, V8, P264	57	53	54	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e35539	10.1371/journal.pone.0035539	http://dx.doi.org/10.1371/journal.pone.0035539			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22536403	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336200053
J	Wu, Y; Zhang, C; Dong, YZ; Wang, SX; Song, P; Viollet, B; Zou, MH				Wu, Yong; Zhang, Cheng; Dong, Yunzhou; Wang, Shuangxi; Song, Ping; Viollet, Benoit; Zou, Ming-Hui			Activation of the AMP-Activated Protein Kinase by Eicosapentaenoic Acid (EPA, 20:5 n-3) Improves Endothelial Function In Vivo	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; UNCOUPLING PROTEIN-2; FATTY-ACIDS; MALONYL-COA; FISH-OIL; INSULIN-RESISTANCE; ENERGY-CHARGE; CELLS; EXPRESSION; METFORMIN	The aim of the present study was to test the hypothesis that the cardiovascular-protective effects of eicosapentaenoic acid (EPA) may be due, in part, to its ability to stimulate the AMP-activated protein kinase (AMPK)-induced endothelial nitric oxide synthase (eNOS) activation. The role of AMPK in EPA-induced eNOS phosphorylation was investigated in bovine aortic endothelial cells (BAEC), in mice deficient of either AMPK alpha 1 or AMPK alpha 2, in eNOS knockout (KO) mice, or in Apo-E/AMPK alpha 1 dual KO mice. EPA-treatment of BAEC increased both AMPK-Thr172 phosphorylation and AMPK activity, which was accompanied by increased eNOS phosphorylation, NO release, and upregulation of mitochondrial uncoupling protein-2 (UCP-2). Pharmacologic or genetic inhibition of AMPK abolished EPA-enhanced NO release and eNOS phosphorylation in HUVEC. This effect of EPA was absent in the aortas isolated from either eNOS KO mice or AMPK alpha 1 KO mice fed a high-fat, high-cholesterol (HFHC) diet. EPA via upregulation of UCP-2 activates AMPK alpha 1 resulting in increased eNOS phosphorylation and consequent improvement of endothelial function in vivo.	[Wu, Yong; Zhang, Cheng; Dong, Yunzhou; Wang, Shuangxi; Song, Ping; Zou, Ming-Hui] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Div Endocrinol & Diabet, Oklahoma City, OK 73190 USA; [Viollet, Benoit] Univ Paris 05, CNRS, INSERM, Dept Genet Dev & Pathol Mol,Inst Cochil,U567, F-75270 Paris, France	University of Oklahoma System; University of Oklahoma Health Sciences Center; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Wu, Y (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Med, Div Endocrinol & Diabet, Oklahoma City, OK 73190 USA.	ming-hui-zou@ouhsc.edu	Viollet, Benoit/N-2397-2019; Viollet, Benoit/O-6927-2017; Song, Ping/N-8456-2018	Viollet, Benoit/0000-0002-0121-0224; Viollet, Benoit/0000-0002-0121-0224; Song, Ping/0000-0002-6143-4270	National Institutes of Health [HL079584, HL080499, HL07439, HL089920, HL096032, HL105157, HL110448]; National Established Investigator of the American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079584, R01HL096032, R01HL089920, R01HL105157, R43HL110448, R01HL080499, R01HL110488, T32HL007439] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Established Investigator of the American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants (HL079584, HL080499, HL07439, HL089920, HL096032, HL105157, and HL110448). MZ is a recipient of the National Established Investigator of the American Heart Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander JW, 1998, NUTRITION, V14, P627, DOI 10.1016/S0899-9007(98)00004-5; Armstrong MB, 2001, AM J PHYSIOL-ENDOC M, V281, pE1197, DOI 10.1152/ajpendo.2001.281.6.E1197; Aubert J, 1997, BIOCHEM BIOPH RES CO, V238, P606, DOI 10.1006/bbrc.1997.7348; Camirand A, 1998, ENDOCRINOLOGY, V139, P428, DOI 10.1210/en.139.1.428; Chen H, 2003, J BIOL CHEM, V278, P45021, DOI 10.1074/jbc.M307878200; Chen LY, 2000, J CARDIOVASC PHARM, V35, P502, DOI 10.1097/00005344-200003000-00022; Choi HC, 2008, J BIOL CHEM, V283, P20186, DOI 10.1074/jbc.M803020200; Connor SL, 1997, AM J CLIN NUTR, V66, P1020; Davignon J, 2004, CIRCULATION, V109, P27, DOI 10.1161/01.CIR.0000131515.03336.f8; Davis BJ, 2006, DIABETES, V55, P496, DOI 10.2337/diabetes.55.02.06.db05-1064; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Dulloo AG, 2001, BRIT J NUTR, V86, P123, DOI 10.1079/BJN2001412; Hardie DG, 2001, BIOESSAYS, V23, P1112, DOI 10.1002/bies.10009; Hardie DG, 1999, BIOCHEM J, V338, P717, DOI 10.1042/0264-6021:3380717; HARRIS WS, 1989, J LIPID RES, V30, P785; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hennig B, 1996, J AM COLL NUTR, V15, P345; Hu HB, 2004, AM J PHYSIOL-LUNG C, V286, pL1066, DOI 10.1152/ajplung.00378.2003; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; Johansen O, 1999, ARTERIOSCL THROM VAS, V19, P1681, DOI 10.1161/01.ATV.19.7.1681; Kemp BE, 2003, BIOCHEM SOC T, V31, P162; Krauss RM, 2000, CIRCULATION, V102, P2284; Kris-Etherton PM, 2002, CIRCULATION, V106, P2747, DOI 10.1161/01.CIR.0000038493.65177.94; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Marfella R, 1996, DIABETES CARE, V19, P934, DOI 10.2337/diacare.19.9.934; Marx N, 1999, ARTERIOSCL THROM VAS, V19, P546, DOI 10.1161/01.ATV.19.3.546; Mattiasson G, 2006, ANTIOXID REDOX SIGN, V8, P1, DOI 10.1089/ars.2006.8.1; McBride A, 2009, CELL METAB, V9, P23, DOI 10.1016/j.cmet.2008.11.008; MCVEIGH GE, 1994, ARTERIOSCLER THROMB, V14, P1425, DOI 10.1161/01.ATV.14.9.1425; Medvedev AV, 2001, J BIOL CHEM, V276, P10817, DOI 10.1074/jbc.M010587200; Nishimura M, 2000, CLIN EXP PHARMACOL P, V27, P618, DOI 10.1046/j.1440-1681.2000.03311.x; Ogita H, 2003, J CARDIOVASC PHARM, V41, P964, DOI 10.1097/00005344-200306000-00020; Ouchi N, 2004, J BIOL CHEM, V279, P1304, DOI 10.1074/jbc.M310389200; Park H, 2002, J BIOL CHEM, V277, P32571, DOI 10.1074/jbc.M201692200; Patane G, 2002, DIABETES, V51, P2749, DOI 10.2337/diabetes.51.9.2749; Reilly JM, 2000, BIOCHEM BIOPH RES CO, V277, P541, DOI 10.1006/bbrc.2000.3705; Rotstein NP, 1996, J NEUROCHEM, V66, P1851; Ruderman NB, 1999, AM J PHYSIOL-ENDOC M, V276, pE1, DOI 10.1152/ajpendo.1999.276.1.E1; Ruderman NB, 2003, BIOCHEM SOC T, V31, P202, DOI 10.1042/bst0310202; Saraswathi V, 2004, J LIPID RES, V45, P794, DOI 10.1194/jlr.M300497-JLR200; Schulz E, 2005, CIRCULATION, V111, P3473, DOI 10.1161/CIRCULATIONAHA.105.546812; Stahmann N, 2006, MOL CELL BIOL, V26, P5933, DOI 10.1128/MCB.00383-06; TURNER RC, 1995, DIABETES RES CLIN PR, V28, pS151, DOI 10.1016/0168-8227(95)01105-M; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Wu GY, 2002, ANNU REV NUTR, V22, P61, DOI 10.1146/annurev.nutr.22.110901.145329; Zhang YJ, 2006, ARTERIOSCL THROM VAS, V26, P1281, DOI 10.1161/01.ATV.0000221230.08596.98; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505; Zou MH, 2004, J BIOL CHEM, V279, P43940, DOI 10.1074/jbc.M404421200; Zou MH, 2003, J BIOL CHEM, V278, P34003, DOI 10.1074/jbc.M300215200; Zou MH, 2002, J BIOL CHEM, V277, P32552, DOI 10.1074/jbc.M204512200	51	42	45	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e35508	10.1371/journal.pone.0035508	http://dx.doi.org/10.1371/journal.pone.0035508			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22532857	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336200049
J	Ackers, ML; Greenberg, AE; Lin, CY; Bartholow, BN; Goodman, AH; Longhi, M; Gurwith, M				Ackers, Marta-Louise; Greenberg, Alan E.; Lin, Carol Y.; Bartholow, Bradford N.; Goodman, Adrian Hirsch; Longhi, Michael; Gurwith, Marc			High and Persistent HIV Seroincidence in Men Who Have Sex with Men across 47 US Cities	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS VACCINE; SEXUALLY-TRANSMITTED-DISEASES; RISK BEHAVIOR; YOUNG MEN; SUBSTANCE USE; DRUG-USE; HOMOSEXUAL-MEN; SAN-FRANCISCO; UNITED-STATES; ANAL SEX	Objective: To provide HIV seroincidence data among men who have sex with men (MSM) in the United States and to identify predictive factors for seroconversion. Methods: From 1998-2002, 4684 high-risk MSM, age 18-60 years, participated in a randomized, placebo-controlled HIV vaccine efficacy trial at 56 U. S. clinical trial sites. Demographics, behavioral data, and HIV status were assessed at baseline and 6 month intervals. Since no overall vaccine efficacy was detected, data were combined from both trial arms to calculate HIV incidence based on person-years (py) of follow-up. Predictors of seroconversion, adjusted hazards ratio (aHR), were evaluated using a Cox proportional hazard model with time-varying covariates. Results: Overall, HIV incidence was 2.7/100 py and was relatively uniform across study sites and study years. HIV incidence was highest among young men and men reporting unprotected sex, recreational drug use, and a history of a sexually transmitted infection. Independent predictors of HIV seroconversion included: age 18-30 years (aHR = 2.4; 95% CI 1.4,4.0), having >10 partners (aHR = 2.4; 95% CI 1.7,3.3), having a known HIV-positive male sex partner (aHR = 1.6; 95% CI 1.2, 2.0), unprotected anal intercourse with HIV positive/unknown male partners (aHR = 1.7; 95% CI 1.3, 2.3), and amphetamine (aHR = 1.6; 95% CI 1.1, 2.1) and popper (aHR = 1.7; 95% CI 1.3, 2.2) use. Conclusions: HIV seroincidence was high among MSM despite repeated HIV counseling and reported declines in sexual risk behaviors. Continuing development of new HIV prevention strategies and intensification of existing efforts will be necessary to reduce the rate of new HIV infections, especially among young men.	[Ackers, Marta-Louise; Greenberg, Alan E.; Lin, Carol Y.; Bartholow, Bradford N.] Ctr Dis Control & Prevent, Natl Ctr HIV STD & TB Prevent, Div HIV AIDS Prevent, Epidemiol Branch, Atlanta, GA USA; [Lin, Carol Y.] Ctr Dis Control & Prevent, Natl Ctr HIV STD & TB Prevent, Div HIV AIDS Prevent, Quantitat Sci & Data Management Branch, Atlanta, GA USA; [Goodman, Adrian Hirsch; Longhi, Michael; Gurwith, Marc] VaxGen Inc, Brisbane, CA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Ackers, ML (corresponding author), Ctr Dis Control & Prevent, Div Global HIV AIDS, Atlanta, GA 30333 USA.	mda6@cdc.gov			VaxGen, Inc.; US Centers for Disease Control and Prevention	VaxGen, Inc.; US Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was supported by VaxGen, Inc., and US Centers for Disease Control and Prevention. No funding bodies had any role in the study design, data collection, analysis, decision to publish or preparation of the manuscript.	Sifakis F., 2005, Morbidity and Mortality Weekly Report, V54, P597; [Anonymous], 2001, MMWR Recomm Rep, V50, P1, DOI 10.1103/PhysRevE.106.055304; Bartholow BN, 2005, JAIDS-J ACQ IMM DEF, V39, P90, DOI 10.1097/01.qai.0000143600.41363.78; Benotsch EG, 2002, ARCH SEX BEHAV, V31, P177, DOI 10.1023/A:1014739203657; Buchacz K, 2008, JAIDS-J ACQ IMM DEF, V47, P234, DOI 10.1097/QAI.0b013e31815e4011; Buchbinder SP, 1996, J INFECT DIS, V174, P954, DOI 10.1093/infdis/174.5.954; BURCHAM JL, 1989, MED J AUSTRALIA, V150, P634, DOI 10.5694/j.1326-5377.1989.tb136727.x; Catania JA, 2001, AM J PUBLIC HEALTH, V91, P907, DOI 10.2105/AJPH.91.6.907; CDC, 2001, HIV SURV REP, V21; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P853; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P1117; Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P117; Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P440; Chen SY, 2002, AM J PUBLIC HEALTH, V92, P1387, DOI 10.2105/AJPH.92.9.1387-a; Clatts MC, 2005, J URBAN HEALTH, V82, pI9, DOI 10.1093/jurban/jti019; Cohen J, 2003, SCIENCE, V300, P28; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Colfax G, 2005, J URBAN HEALTH, V82, pI62, DOI 10.1093/jurban/jti025; Colfax GN, 2001, J ACQ IMMUN DEF SYND, V28, P373, DOI 10.1097/00126334-200112010-00011; Crepaz N, 2000, AIDS EDUC PREV, V12, P405; Ekstrand ML, 1999, AIDS, V13, P1525, DOI 10.1097/00002030-199908200-00013; Fernandez MI, 2005, J URBAN HEALTH, V82, pI79, DOI 10.1093/jurban/jti027; Fernyak SE, 2002, JAIDS-J ACQ IMM DEF, V31, P63, DOI 10.1097/00126334-200209010-00009; Flores SA, 2009, AIDS EDUC PREV, V21, P91, DOI 10.1521/aeap.2009.21.2.91; Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404; Garofalo R, 2007, AM J PUBLIC HEALTH, V97, P1113, DOI 10.2105/AJPH.2005.075630; Golden MR, 2004, JAIDS-J ACQ IMM DEF, V36, P734, DOI 10.1097/00126334-200406010-00011; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; Harro CD, 2004, JAIDS-J ACQ IMM DEF, V37, P1385, DOI 10.1097/01.qai.0000122983.87519.b5; Hirshfield S, 2004, AIDS CARE, V16, P1036, DOI 10.1080/09540120412331292525; Holmberg SD, 1996, AM J PUBLIC HEALTH, V86, P642, DOI 10.2105/AJPH.86.5.642; Kim AA, 2001, J ACQ IMMUN DEF SYND, V28, P89; Koblin B, 2004, LANCET, V364, P41, DOI 10.1016/S0140-6736(04)16588-4; Koblin BA, 2000, AIDS, V14, P1793, DOI 10.1097/00002030-200008180-00015; Koblin BA, 2006, AIDS, V20, P731, DOI 10.1097/01.aids.0000216374.61442.55; Mansergh G, 2006, SEX TRANSM INFECT, V82, P131, DOI 10.1136/sti.2005.017129; Mansergh G, 1998, AIDS, V12, P1119, DOI 10.1097/00002030-199810000-00003; McFarlane M, 2000, JAMA-J AM MED ASSOC, V284, P443, DOI 10.1001/jama.284.4.443; McNall M, 1999, ARCH PEDIAT ADOL MED, V153, P1130, DOI 10.1001/archpedi.153.11.1130; Metsch LR, 2008, CLIN INFECT DIS, V47, P577, DOI 10.1086/590153; MORRIS M, 1995, AIDS EDUC PREV, V7, P24; Oster Alexandra M., 2011, Morbidity and Mortality Weekly Report, V60, P694; PageShafer K, 1997, AM J EPIDEMIOL, V146, P531, DOI 10.1093/oxfordjournals.aje.a009311; Prejean J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017502; Rietmeijer CA, 2003, SEX TRANSM DIS, V30, P15, DOI 10.1097/00007435-200301000-00004; Rusch M, 2004, SEX TRANSM DIS, V31, P492, DOI 10.1097/01.olq.0000135991.21755.18; Seage GR, 2001, AM J EPIDEMIOL, V153, P619, DOI 10.1093/aje/153.7.619; Smith A., 2010, Morbidity and Mortality Weekly Report, V59, P1201; Stone E, 1999, J ACQ IMMUN DEF SYND, V20, P495, DOI 10.1097/00042560-199904150-00013; Sullivan PS, 2009, ANN EPIDEMIOL, V19, P423, DOI 10.1016/j.annepidem.2009.03.004; Valleroy LA, 2000, JAMA-J AM MED ASSOC, V284, P198, DOI 10.1001/jama.284.2.198; Weber AE, 2003, AIDS, V17, P774, DOI 10.1097/00002030-200303280-00024; Weinstock H, 1998, J ACQ IMMUN DEF SYND, V19, P506, DOI 10.1097/00042560-199812150-00010; Woody GE, 1999, DRUG ALCOHOL DEPEN, V53, P197, DOI 10.1016/S0376-8716(98)00134-3; Workowski Kimberly A, 2010, MMWR Recomm Rep, V59, P1	56	43	48	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e34972	10.1371/journal.pone.0034972	http://dx.doi.org/10.1371/journal.pone.0034972			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529964	Green Published, gold			2022-12-27	WOS:000305350600049
J	Bribian, A; Fontana, X; Llorens, F; Gavin, R; Reina, M; Garcia-Verdugo, JM; Torres, JM; de Castro, F; del Rio, JA				Bribian, Ana; Fontana, Xavier; Llorens, Franc; Gavin, Rosalina; Reina, Manuel; Manuel Garcia-Verdugo, Jose; Maria Torres, Juan; de Castro, Fernando; Antonio del Rio, Jose			Role of the Cellular Prion Protein in Oligodendrocyte Precursor Cell Proliferation and Differentiation in the Developing and Adult Mouse CNS	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; PROGENITOR CELLS; GLIA GENERATE; PSA-NCAM; EXPRESSION; MIGRATION; MICE; PRPC; LINEAGE; PROTEOGLYCAN	There are numerous studies describing the signaling mechanisms that mediate oligodendrocyte precursor cell (OPC) proliferation and differentiation, although the contribution of the cellular prion protein (PrPc) to this process remains unclear. PrPc is a glycosyl-phosphatidylinositol (GPI)-anchored glycoprotein involved in diverse cellular processes during the development and maturation of the mammalian central nervous system (CNS). Here we describe how PrPc influences oligodendrocyte proliferation in the developing and adult CNS. OPCs that lack PrPc proliferate more vigorously at the expense of a delay in differentiation, which correlates with changes in the expression of oligodendrocyte lineage markers. In addition, numerous NG2-positive cells were observed in cortical regions of adult PrPc knockout mice, although no significant changes in myelination can be seen, probably due to the death of surplus cells.	[Bribian, Ana; Llorens, Franc; Antonio del Rio, Jose] Catalonian Inst Bioengn IBEC, Barcelona, Spain; [Bribian, Ana; Fontana, Xavier; Llorens, Franc; Gavin, Rosalina; Reina, Manuel; Antonio del Rio, Jose] Univ Barcelona, Dept Cell Biol, Barcelona, Spain; [Bribian, Ana; Llorens, Franc; Gavin, Rosalina; Antonio del Rio, Jose] Ctr Invest Biomed Red Sobre Enfermedades Neurodeg, Barcelona, Spain; [Manuel Garcia-Verdugo, Jose] Univ Valencia, Inst Cabanillas Biodiversidad & Biol Evolutiva, Lab Neurobiol Comparada, Valencia, Spain; [Maria Torres, Juan] Ctr Invest Sanidad Anim CISA INIA, Madrid, Spain; [de Castro, Fernando] Hosp Nacl Paraplejicos, Unidad Neurol Expt, GNDe Grp Neurobiol Desarrollo, Toledo, Spain; [de Castro, Fernando] Inst Cajal CSIC, Madrid, Spain	Barcelona Institute of Science & Technology; Institut de Bioenginyeria de Catalunya; University of Barcelona; CIBERNED; University of Valencia; Hospital Nacional de Paraplejicos; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC)	Bribian, A (corresponding author), Catalonian Inst Bioengn IBEC, Parc Cientific Barcelona, Barcelona, Spain.	jadelrio@ibec.pcb.ub.es	del rio, jose antonio/L-9232-2014; Bribian, Ana/M-2978-2014; García-Verdugo, José Manuel/L-8421-2017; Torres, Juan Maria/L-8768-2013; Gavín, Rosalina/D-4341-2014; Del Rio Fernandez, Jose A/AAD-1121-2020; de Castro, Fernando/Q-8624-2018; Reina, Manuel/D-4655-2014	del rio, jose antonio/0000-0002-5214-4909; García-Verdugo, José Manuel/0000-0001-9872-6499; Torres, Juan Maria/0000-0003-0443-9232; Gavín, Rosalina/0000-0003-1982-2162; de Castro, Fernando/0000-0002-7018-8032; Reina, Manuel/0000-0002-0701-200X; , Franc/0000-0002-9756-7497	Instituto de Salud Carlos III, MICINN [BFU2009-10848, SAF2009-07845]; FP7-PRIORITY; Generalitat of Catalunya [SGR2009-366]; FISCAM [PAI08-0242-3822]	Instituto de Salud Carlos III, MICINN(Instituto de Salud Carlos IIIMinistry of Science and Innovation, Spain (MICINN)Spanish Government); FP7-PRIORITY; Generalitat of Catalunya(Generalitat de Catalunya); FISCAM	This work was supported by grants from the Instituto de Salud Carlos III, MICINN (BFU2009-10848 to JADR and SAF2009-07845 to FdC), FP7-PRIORITY, Generalitat of Catalunya (SGR2009-366) to JAD and FISCAM (PAI08-0242-3822) to FDC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre A, 2007, NEURON GLIA BIOL, V3, P209, DOI 10.1017/S1740925X08000082; Bailly Y, 2004, J COMP NEUROL, V473, P244, DOI 10.1002/cne.20117; Bainbridge J, 2005, IMMUNOL LETT, V96, P147, DOI 10.1016/j.imlet.2004.08.006; Barmada S, 2004, NEUROBIOL DIS, V16, P527, DOI 10.1016/j.nbd.2004.05.005; BARRES BA, 1993, CURR BIOL, V3, P489, DOI 10.1016/0960-9822(93)90039-Q; Belachew S, 2002, J NEUROSCI, V22, P8553; Bonfanti L, 2006, PROG NEUROBIOL, V80, P129, DOI 10.1016/j.pneurobio.2006.08.003; Bremer J, 2010, NAT NEUROSCI, V13, P310, DOI 10.1038/nn.2483; Bribian A, 2006, MOL CELL NEUROSCI, V33, P2, DOI 10.1016/j.mcn.2006.05.009; Brown DR, 1998, NEUROREPORT, V9, P1425, DOI 10.1097/00001756-199805110-00032; Brown DR, 2002, J NEUROSCI RES, V67, P211, DOI 10.1002/jnr.10118; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Calver AR, 1998, NEURON, V20, P869, DOI 10.1016/S0896-6273(00)80469-9; Chong SYC, 2010, J CELL BIOL, V188, P305, DOI 10.1083/jcb.200905111; de Castro F, 2005, BRAIN RES REV, V49, P227, DOI 10.1016/j.brainresrev.2004.12.034; DELRIO JA, 1989, DEV BRAIN RES, V49, P311, DOI 10.1016/0165-3806(89)90033-3; Diers-Fenger M, 2001, GLIA, V34, P213, DOI 10.1002/glia.1055; Dimou L, 2008, J NEUROSCI, V28, P10434, DOI 10.1523/JNEUROSCI.2831-08.2008; Etxeberria A, 2010, NAT NEUROSCI, V13, P287, DOI 10.1038/nn.2500; Fontana X, 2006, CEREB CORTEX, V16, P301, DOI 10.1093/cercor/bhi120; Ford MJ, 2002, NEUROSCIENCE, V113, P177, DOI 10.1016/S0306-4522(02)00155-0; Ford MJ, 2002, NEUROSCIENCE, V111, P533, DOI 10.1016/S0306-4522(01)00603-0; FOURNIER JG, 1995, CR ACAD SCI III-VIE, V318, P339; Fujisawa M, 2004, J REPROD DEVELOP, V50, P565, DOI 10.1262/jrd.50.565; GALLO V, 1995, J NEUROSCI, V15, P394; Hermann A, 2010, CELL TISSUE RES, V340, P45, DOI 10.1007/s00441-010-0940-5; Hu W, 2010, BRAIN, V133, P375, DOI 10.1093/brain/awp298; Kang SH, 2010, NEURON, V68, P668, DOI 10.1016/j.neuron.2010.09.009; Karapetyan YE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005730; Karram K, 2005, J ANAT, V207, P735, DOI 10.1111/j.1469-7580.2005.00461.x; Kim BH, 2005, NEUROREPORT, V16, P425, DOI 10.1097/00001756-200504040-00002; Lee YJ, 2010, J NEUROCHEM, V114, P362, DOI 10.1111/j.1471-4159.2010.06601.x; Levine JM, 1996, PERSPECT DEV NEUROBI, V3, P245; Levine JM, 2001, TRENDS NEUROSCI, V24, P39, DOI 10.1016/S0166-2236(00)01691-X; Li RL, 2001, CELL IMMUNOL, V207, P49, DOI 10.1006/cimm.2000.1751; Liang J, 2007, FASEB J, V21, P2247, DOI 10.1096/fj.06-7799com; Liebmann C, 2011, MOL CELL ENDOCRINOL, V331, P222, DOI 10.1016/j.mce.2010.04.008; Ligon KL, 2006, P NATL ACAD SCI USA, V103, P7853, DOI 10.1073/pnas.0511001103; Lin G, 2009, GLIA, V57, P592, DOI 10.1002/glia.20788; Liu T, 2001, BRAIN RES, V896, P118, DOI 10.1016/S0006-8993(01)02050-9; Loubet D, 2011, FASEB J IN PRESS; Lytle JM, 2009, GLIA, V57, P270, DOI 10.1002/glia.20755; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; Merchan P, 2007, MOL CELL NEUROSCI, V36, P355, DOI 10.1016/j.mcn.2007.07.012; Mingorance A, 2005, MOL CELL NEUROSCI, V29, P471, DOI 10.1016/j.mcn.2005.03.016; Molina-Holgado E, 2002, J NEUROSCI, V22, P9742, DOI 10.1523/jneurosci.22-22-09742.2002; Monnet C, 2004, FEBS LETT, V576, P114, DOI 10.1016/j.febslet.2004.08.076; Morel E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003000; MOSER M, 1995, NEURON, V14, P509, DOI 10.1016/0896-6273(95)90307-0; Nguyen L, 2003, CURR MED CHEM, V10, P2185, DOI 10.2174/0929867033456774; Nishiyama A, 1999, J NEUROPATH EXP NEUR, V58, P1113, DOI 10.1097/00005072-199911000-00001; Nishiyama A, 2009, NAT REV NEUROSCI, V10, P9, DOI 10.1038/nrn2495; Parchi P, 2000, MICROSC RES TECHNIQ, V50, P16, DOI 10.1002/1097-0029(20000701)50:1<16::AID-JEMT4>3.0.CO;2-Y; Pasquini LA, 2003, J NEUROSCI, V23, P4635; Prestori F, 2008, J NEUROSCI, V28, P7091, DOI 10.1523/JNEUROSCI.0409-08.2008; Radovanovic I, 2005, J NEUROSCI, V25, P4879, DOI 10.1523/JNEUROSCI.0328-05.2005; Raff M, 2006, BIOCHEM SOC T, V34, P663, DOI 10.1042/BST0340663; Raff M, 2007, COLD SPRING HARB SYM, V72, P431, DOI 10.1101/sqb.2007.72.007; Raff M, 2001, NOVART FDN SYMP, V237, P100, DOI 10.1002/0470846666.ch9; Raff M., 2001, NOVART FDN SYMP, V237, P158; Rivers LE, 2008, NAT NEUROSCI, V11, P1392, DOI 10.1038/nn.2220; Santos TG, 2011, STEM CELLS, V29, P1126, DOI 10.1002/stem.664; Seki Tatsunori, 2003, Anatomical Science International, V78, P69, DOI 10.1046/j.0022-7722.2003.00043.x; Simons M, 2006, J CELL SCI, V119, P4381, DOI 10.1242/jcs.03242; Sohn J, 2006, J NEUROSCI, V26, P9722, DOI 10.1523/JNEUROSCI.1716-06.2006; SORIANO E, 1991, J HISTOCHEM CYTOCHEM, V39, P255, DOI 10.1177/39.3.1671576; Spassky N, 2002, J NEUROSCI, V22, P5992; Steele AD, 2006, P NATL ACAD SCI USA, V103, P3416, DOI 10.1073/pnas.0511290103; Tichopad A, 2003, MOL CELL PROBE, V17, P5, DOI 10.1016/S0890-8508(02)00114-7; Tripathi RB, 2010, J NEUROSCI, V30, P16383, DOI 10.1523/JNEUROSCI.3411-10.2010; Trotter J, 2010, BRAIN RES REV, V63, P72, DOI 10.1016/j.brainresrev.2009.12.006; Tsutsui S, 2008, AM J PATHOL, V173, P1029, DOI 10.2353/ajpath.2008.071062; von Bohlen und Halbach O, 2011, CELL TISSUE RES, V345, P1, DOI 10.1007/s00441-011-1196-4; WESTAWAY D, 1994, CELL, V76, P117, DOI 10.1016/0092-8674(94)90177-5; Wong BS, 2001, J NEUROCHEM, V76, P565, DOI 10.1046/j.1471-4159.2001.00028.x; Zhang CC, 2006, P NATL ACAD SCI USA, V103, P2184, DOI 10.1073/pnas.0510577103; Zhu XQ, 2008, DEVELOPMENT, V135, P145, DOI 10.1242/dev.004895	77	40	40	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e33872	10.1371/journal.pone.0033872	http://dx.doi.org/10.1371/journal.pone.0033872			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529900	Green Published, Green Submitted, gold			2022-12-27	WOS:000305350600007
J	Chen, JQ; Korostyshevsky, D; Lee, S; Perlstein, EO				Chen, Jingqiu; Korostyshevsky, Daniel; Lee, Sean; Perlstein, Ethan O.			Accumulation of an Antidepressant in Vesiculogenic Membranes of Yeast Cells Triggers Autophagy	PLOS ONE			English	Article							CHLORPROMAZINE; DRUGS; DESIPRAMINE; ANESTHETICS; EXPRESSION; SERTRALINE; TRANSPORT; PATHWAYS; GENES; STATE	Many antidepressants are cationic amphipaths, which spontaneously accumulate in natural or reconstituted membranes in the absence of their specific protein targets. However, the clinical relevance of cellular membrane accumulation by antidepressants in the human brain is unknown and hotly debated. Here we take a novel, evolutionarily informed approach to studying the effects of the selective-serotonin reuptake inhibitor sertraline/Zoloft (R) on cell physiology in the model eukaryote Saccharomyces cerevisiae (budding yeast), which lacks a serotonin transporter entirely. We biochemically and pharmacologically characterized cellular uptake and subcellular distribution of radiolabeled sertraline, and in parallel performed a quantitative ultrastructural analysis of organellar membrane homeostasis in untreated vs. sertraline-treated cells. These experiments have revealed that sertraline enters yeast cells and then reshapes vesiculogenic membranes by a complex process. Internalization of the neutral species proceeds by simple diffusion, is accelerated by proton motive forces generated by the vacuolar H+-ATPase, but is counteracted by energy-dependent xenobiotic efflux pumps. At equilibrium, a small fraction (10-15%) of reprotonated sertraline is soluble while the bulk (90-85%) partitions into organellar membranes by adsorption to interfacial anionic sites or by intercalation into the hydrophobic phase of the bilayer. Asymmetric accumulation of sertraline in vesiculogenic membranes leads to local membrane curvature stresses that trigger an adaptive autophagic response. In mutants with altered clathrin function, this adaptive response is associated with increased lipid droplet formation. Our data not only support the notion of a serotonin transporter-independent component of antidepressant function, but also enable a conceptual framework for characterizing the physiological states associated with chronic but not acute antidepressant administration in a model eukaryote.	[Chen, Jingqiu; Korostyshevsky, Daniel; Lee, Sean; Perlstein, Ethan O.] Princeton Univ, Lewis Sigler Inst Integrat Gen, Princeton, NJ 08544 USA	Princeton University	Chen, JQ (corresponding author), Princeton Univ, Lewis Sigler Inst Integrat Gen, Princeton, NJ 08544 USA.	eperlste@princeton.edu		Perlstein, Ethan/0000-0002-4734-4391	Lewis-Sigler Institute	Lewis-Sigler Institute	The Lewis-Sigler Institute provided all financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANTA LM, 1988, J CELL BIOL, V107, P1369, DOI 10.1083/jcb.107.4.1369; BOIRON P, 1987, ANTIMICROB AGENTS CH, V31, P244, DOI 10.1128/AAC.31.2.244; BOULANGER Y, 1980, CAN J BIOCHEM CELL B, V58, P986, DOI 10.1139/o80-134; Brett CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017619; Calabrese F, 2010, MOL PHARMACOL, V77, P846, DOI 10.1124/mol.109.063081; Chen CY, 1998, GENETICS, V150, P577; Chen JY, 1997, BBA-BIOMEMBRANES, V1323, P299, DOI 10.1016/S0005-2736(96)00197-6; Daniel WA, 2003, PROG NEURO-PSYCHOPH, V27, P65, DOI 10.1016/S0278-5846(02)00317-2; de Duve C, 1978, Ann N Y Acad Sci, V308, P226; De Filippi L, 2007, CURR GENET, V52, P171, DOI 10.1007/s00294-007-0151-0; Duman RS, 1997, ARCH GEN PSYCHIAT, V54, P597; Fornai F, 2002, ANN NY ACAD SCI, V965, P381; Gaspar ML, 2008, J BIOL CHEM, V283, P25735, DOI 10.1074/jbc.M802685200; GOLDSTEIN DB, 1984, ANNU REV PHARMACOL, V24, P43, DOI 10.1146/annurev.pa.24.040184.000355; Graham TR, 2011, TRENDS CELL BIOL, V21, P113, DOI 10.1016/j.tcb.2010.10.002; HONEGGER UE, 1983, J PHARMACOL EXP THER, V225, P436; Jerabek H, 2010, J AM CHEM SOC, V132, P7990, DOI 10.1021/ja910843d; KAISER CA, 1990, CELL, V61, P723, DOI 10.1016/0092-8674(90)90483-U; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; KEAN LS, 1993, J CELL BIOL, V123, P1403, DOI 10.1083/jcb.123.6.1403; KOE BK, 1983, J PHARMACOL EXP THER, V226, P686; Li NX, 2010, SCIENCE, V329, P959, DOI 10.1126/science.1190287; LIEBER MR, 1984, J BIOL CHEM, V259, P9225; NOVICK P, 1979, P NATL ACAD SCI USA, V76, P1858, DOI 10.1073/pnas.76.4.1858; Peropadre A, 2011, CHEM RES TOXICOL, V24, P185, DOI 10.1021/tx100262c; Pickholz M, 2007, BIOPHYS CHEM, V125, P425, DOI 10.1016/j.bpc.2006.10.010; Rainey MM, 2010, GENETICS, V185, P1221, DOI 10.1534/genetics.110.117846; Santos JS, 2004, MAGN RESON CHEM, V42, P105, DOI 10.1002/mrc.1327; SEEMAN P, 1972, PHARMACOL REV, V24, P583; SHEETZ MP, 1974, P NATL ACAD SCI USA, V71, P4457, DOI 10.1073/pnas.71.11.4457; SHIH CK, 1988, MOL CELL BIOL, V8, P3094, DOI 10.1128/MCB.8.8.3094; STOFFEL P, 1987, BIOCHEM PHARMACOL, V36, P655, DOI 10.1016/0006-2952(87)90716-7; STURTON RG, 1977, BIOCHEM J, V162, P25, DOI 10.1042/bj1620025; Thompson BJ, 2011, P NATL ACAD SCI USA, V108, P3785, DOI 10.1073/pnas.1011920108; Vaden DL, 2001, J BIOL CHEM, V276, P15466, DOI 10.1074/jbc.M004179200; WANG LH, 1993, J CELL BIOL, V123, P1107, DOI 10.1083/jcb.123.5.1107; Young TJ, 2003, J ANTIMICROB CHEMOTH, V51, P1045, DOI 10.1093/jac/dkg184; Zhang JZ, 2007, BIOPHYS J, V92, P3988, DOI 10.1529/biophysj.106.102434; Zhang LQ, 2010, J PHARMACOL EXP THER, V332, P977, DOI 10.1124/jpet.109.162644; Zschocke J, 2011, NEUROPSYCHOPHARMACOL, V36, P1754, DOI 10.1038/npp.2011.57	40	15	15	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e34024	10.1371/journal.pone.0034024	http://dx.doi.org/10.1371/journal.pone.0034024			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529904	Green Submitted, Green Published, gold			2022-12-27	WOS:000305350600010
J	Hammarstrom, A; Annandale, E				Hammarstrom, Anne; Annandale, Ellen			A Conceptual Muddle: An Empirical Analysis of the Use of 'Sex' and 'Gender' in 'Gender-Specific Medicine' Journals	PLOS ONE			English	Article							WOMENS HEALTH; DEPRESSION	Background: At the same time as there is increasing awareness in medicine of the risks of exaggerating differences between men and women, there is a growing professional movement of 'gender-specific medicine' which is directed towards analysing 'sex' and 'gender' differences. The aim of this article is to empirically explore how the concepts of 'sex' and 'gender' are used in the new field of 'gender-specific medicine', as reflected in two medical journals which are foundational to this relatively new field. Method and Principal Findings: The data consist of all articles from the first issue of each journal in 2004 and an issue published three years later (n = 43). In addition, all editorials over this period were included (n = 61). Quantitative and qualitative content analyses were undertaken by the authors. Less than half of the 104 papers used the concepts of 'sex' and 'gender'. Less than 1 in 10 papers attempted any definition of the concepts. Overall, the given definitions were simple, unspecific and created dualisms between men and women. Almost all papers which used the two concepts did so interchangeably, with any possible interplay between 'sex' and gender' referred to only in six of the papers. Conclusion: The use of the concepts of 'sex' and gender' in 'gender-specific medicine' is conceptually muddled. The simple, dualistic and individualised use of these concepts increases the risk of essentialism and reductivist thinking. It therefore highlights the need to clarify the use of the terms 'sex' and 'gender' in medical research and to develop more effective ways of conceptualising the interplay between 'sex' and 'gender' in relation to different diseases.	[Hammarstrom, Anne; Annandale, Ellen] Umea Univ, Umea Ctr Gender Studies Med, Dept Publ Hlth & Clin Med, Umea, Sweden; [Annandale, Ellen] Univ Leicester, Dept Sociol, Leicester, Leics, England	Umea University; University of Leicester	Hammarstrom, A (corresponding author), Umea Univ, Umea Ctr Gender Studies Med, Dept Publ Hlth & Clin Med, Umea, Sweden.	anne.hammarstrom@fammed.umu.se		Hammarstrom, Anne/0000-0002-4095-7961	Swedish Research Council; University of Leicester, UK	Swedish Research Council(Swedish Research CouncilEuropean Commission); University of Leicester, UK	The Swedish Research Council finances the Centre of Gender Excellence at Umea University in Sweden and this funding made it possible for AH to perform the study. EA is funded by the University of Leicester, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annandale E, 2011, HEALTH-LONDON, V15, P571, DOI 10.1177/1363459310364157; [Anonymous], 2007, INCLUSION POLITICS D; Bird PP, 2008, GENDER HLTH EFFECTS; Birke L., 1999, FEMINISM BIOL BODY; Chatkin Jose M, 2004, Gend Med, V1, P41, DOI 10.1016/S1550-8579(04)80009-3; Connell R.W., 2002, GENDER; Connell R. W., 1995, MASCULINITIES; Doyal L, 2001, BRIT MED J, V323, P1061, DOI 10.1136/bmj.323.7320.1061; Eckman A., 1998, VISIBLE WOMAN IMAGIN, P130; Eriksson K, 1997, SCAND J CARING SCI, V11, P195, DOI 10.1111/j.1471-6712.1997.tb00455.x; Fausto-Sterling A, 2005, SIGNS, V30, P1491, DOI 10.1086/424932; Fausto-Sterling Anne, 1992, MYTHS GENDER BIOL TH; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Graziottin A., 2004, JMHG, V1, P71, DOI DOI 10.1016/J.JMHG.2004.03.011; Grumbach MM., 2004, J MENS HLTH GENDER, V1, P12, DOI [10.1016/j.jmhg.2004.03.013, DOI 10.1016/J.JMHG.2004.03.013]; Haig D, 2000, NAT GENET, V25, P373, DOI 10.1038/78033; Hammarstrom A, 2003, WOMEN HEALTH, V37, P121, DOI 10.1300/J013v37n04_09; Hammarstrom A, 2007, GENDER MED, V4, pS123, DOI 10.1016/S1550-8579(07)80053-2; Hanson B, 2000, RES SOC H, V18, P53; Kazanjian A, 2008, WOMEN HEALTH ISS, V18, P343, DOI 10.1016/j.whi.2008.06.002; Kendler KS, 2006, AM J PSYCHIAT, V163, P115, DOI 10.1176/appi.ajp.163.1.115; Krieger N, 2003, INT J EPIDEMIOL, V32, P652, DOI 10.1093/ije/dyg156; Krieger N, 1995, CURR ISSUES PUB HLTH, V1, P251; Kuehner C, 2003, ACTA PSYCHIAT SCAND, V108, P163, DOI 10.1034/j.1600-0447.2003.00204.x; Lagro-Janssen T, 2007, EUR J WOMENS STUD, V14, P9, DOI 10.1177/1350506807072314; Legato M, 2004, GENDER MED, V1, P1; Legato Marianne J, 2004, Gend Med, V1, P61, DOI 10.1016/S1550-8579(04)80011-1; Legato Marianne J, 2005, Gend Med, V2, P59, DOI 10.1016/S1550-8579(05)80010-5; Legato MJ, 2003, MED CLIN N AM, V87, P917, DOI 10.1016/S0025-7125(03)00063-4; Meryn S, 2008, J MENS HEALTH, V5, P2, DOI 10.1016/j.jomh.2008.02.004; Oakley Ann, 1972, SEX GENDER SOC; Patsopoulos NA, 2007, JAMA-J AM MED ASSOC, V298, P880, DOI 10.1001/jama.298.8.880; Patton M. Q., 2001, QUALITATIVE EVALUATI, V3rd; Payne S., 2006, HLTH MEN WOMEN; Payne Sarah, 2004, Gend Med, V1, P18, DOI 10.1016/S1550-8579(04)80007-X; Piccinelli M, 2000, BRIT J PSYCHIAT, V177, P486, DOI 10.1192/bjp.177.6.486; Pinn Vivian W, 2004, Gend Med, V1, P5, DOI 10.1016/S1550-8579(04)80004-4; Pinn VW, 2003, JAMA-J AM MED ASSOC, V289, P397, DOI 10.1001/jama.289.4.397; Rieder A, 2006, J MENS HLTH GENDER, V3, P7; Sharman Z, 2012, SOC SCI MED, V74, P1812, DOI 10.1016/j.socscimed.2011.08.039; Simmons R, 2011, P NUTR SOC, V70, P73, DOI 10.1017/S0029665110003988; Skeggs B., 1997, FORMATIONS CLASS GEN; Stewart D, 2004, J MENS HLTH GENDER, V1, P20; WGEKN, 2007, UN UNF IN IN GEND IN; White A, 2004, J MENS HLTH GENDER, V1, P60, DOI DOI 10.1016/J.JMHG.2004.03.001; Wizeman TM, EXPLORING BIOL CONTR	46	34	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e34193	10.1371/journal.pone.0034193	http://dx.doi.org/10.1371/journal.pone.0034193			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959XD	22529907	Green Submitted, Green Published, gold			2022-12-27	WOS:000305350600012
J	Thompson, CK; Meitzen, J; Replogle, K; Drnevich, J; Lent, KL; Wissman, AM; Farin, FM; Bammler, TK; Beyer, RP; Clayton, DF; Perkel, DJ; Brenowitz, EA				Thompson, Christopher K.; Meitzen, John; Replogle, Kirstin; Drnevich, Jenny; Lent, Karin L.; Wissman, Anne Marie; Farin, Federico M.; Bammler, Theo K.; Beyer, Richard P.; Clayton, David F.; Perkel, David J.; Brenowitz, Eliot A.			Seasonal Changes in Patterns of Gene Expression in Avian Song Control Brain Regions	PLOS ONE			English	Article							MYOCYTE ENHANCER FACTOR-2; FEMALE CANARY BRAIN; ZEBRA FINCH BRAIN; GROWTH-FACTOR-I; FACTOR 2D MEF2D; CONTROL-SYSTEM; NEURONAL APOPTOSIS; BREEDING CONDITIONS; CELL-PROLIFERATION; PROJECTION NEURONS	Photoperiod and hormonal cues drive dramatic seasonal changes in structure and function of the avian song control system. Little is known, however, about the patterns of gene expression associated with seasonal changes. Here we address this issue by altering the hormonal and photoperiodic conditions in seasonally-breeding Gambel's white-crowned sparrows and extracting RNA from the telencephalic song control nuclei HVC and RA across multiple time points that capture different stages of growth and regression. We chose HVC and RA because while both nuclei change in volume across seasons, the cellular mechanisms underlying these changes differ. We thus hypothesized that different genes would be expressed between HVC and RA. We tested this by using the extracted RNA to perform a cDNA microarray hybridization developed by the SoNG initiative. We then validated these results using qRT-PCR. We found that 363 genes varied by more than 1.5 fold (> log(2) 0.585) in expression in HVC and/or RA. Supporting our hypothesis, only 59 of these 363 genes were found to vary in both nuclei, while 132 gene expression changes were HVC specific and 172 were RA specific. We then assigned many of these genes to functional categories relevant to the different mechanisms underlying seasonal change in HVC and RA, including neurogenesis, apoptosis, cell growth, dendrite arborization and axonal growth, angiogenesis, endocrinology, growth factors, and electrophysiology. This revealed categorical differences in the kinds of genes regulated in HVC and RA. These results show that different molecular programs underlie seasonal changes in HVC and RA, and that gene expression is time specific across different reproductive conditions. Our results provide insights into the complex molecular pathways that underlie adult neural plasticity.	[Thompson, Christopher K.] Freie Univ, Inst Biol, Berlin, Germany; [Meitzen, John] Univ Minnesota, Dept Neurosci, Minneapolis, MN USA; [Replogle, Kirstin; Clayton, David F.] Univ Illinois, Dept Cell & Dev Biol, Champaign, IL USA; [Drnevich, Jenny] Univ Illinois, Roy J Carver Biotechnol Ctr, Urbana, IL USA; [Lent, Karin L.; Brenowitz, Eliot A.] Univ Washington, Dept Psychol, Seattle, WA 98195 USA; [Wissman, Anne Marie] Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA; [Farin, Federico M.; Bammler, Theo K.; Beyer, Richard P.] Univ Washington, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA; [Perkel, David J.] Univ Washington, Dept Otolaryngol, Seattle, WA 98195 USA; [Perkel, David J.; Brenowitz, Eliot A.] Univ Washington, Dept Biol, Seattle, WA 98195 USA	Free University of Berlin; University of Minnesota System; University of Minnesota Twin Cities; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Washington; University of Washington Seattle; Northwestern University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Thompson, CK (corresponding author), Freie Univ, Inst Biol, Berlin, Germany.	ckt@zedat.fu-berlin.de	Clayton, David/B-2190-2008	Clayton, David/0000-0002-6395-3488	United States National Institutes of Health [MH53032, MH066128, NS045264, P30ES07033, P30HD02274, T32 DA07234]; Alexander von Humboldt Foundation; BBSRC [BBS/E/D/20310000] Funding Source: UKRI; MRC [MR/K001744/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/D/20310000] Funding Source: researchfish; Medical Research Council [MR/K001744/1] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD002274] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007033] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R56MH066128, R01MH053032, R01MH066128] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045264, R01NS075331] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007234] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by United States National Institutes of Health grants MH53032 to EAB, MH066128 to DJP, NS045264 to DFC, P30ES07033 and P30HD02274 to FMF, T32 DA07234 to JM, and a fellowship from the Alexander von Humboldt Foundation to CKT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVAREZBUYLLA A, 1988, P NATL ACAD SCI USA, V85, P8722, DOI 10.1073/pnas.85.22.8722; ANSCOMBE FJ, 1973, AM STAT, V27, P17, DOI 10.2307/2682899; Bottjer SW, 1997, BRAIN BEHAV EVOLUT, V50, P284, DOI 10.1159/000113342; Brenowitz EA, 2008, NEUROSCIENCE BIRDSON; Butts BD, 2005, MOL CELL NEUROSCI, V30, P279, DOI 10.1016/j.mcn.2005.07.011; Butts BD, 2003, HORM METAB RES, V35, P763; Camby I, 2006, GLYCOBIOLOGY, V16, p137R, DOI 10.1093/glycob/cwl025; CANADY RA, 1988, J NEUROSCI, V8, P3770; Catchpole C. K., 1995; Chen XQ, 2005, P NATL ACAD SCI USA, V102, P7730, DOI 10.1073/pnas.0408350102; Dittrich F, 1999, P NATL ACAD SCI USA, V96, P8241, DOI 10.1073/pnas.96.14.8241; GOLDMAN SA, 1983, P NATL ACAD SCI-BIOL, V80, P2390, DOI 10.1073/pnas.80.8.2390; Harris JA, 2008, J NEUROSCI, V28, P10990, DOI 10.1523/JNEUROSCI.2697-08.2008; Hartog TE, 2009, J NEUROSCI, V29, P15511, DOI 10.1523/JNEUROSCI.2564-09.2009; HIDALGO A, 1995, J NEUROBIOL, V27, P470, DOI 10.1002/neu.480270404; HILL KM, 1991, BEHAV NEURAL BIOL, V56, P240, DOI 10.1016/0163-1047(91)90379-5; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Huesmann GR, 2006, NEURON, V52, P1061, DOI 10.1016/j.neuron.2006.10.033; Jarvis ED, 1997, P NATL ACAD SCI USA, V94, P4097, DOI 10.1073/pnas.94.8.4097; Jiang JW, 1998, J NEUROBIOL, V36, P1, DOI 10.1002/(SICI)1097-4695(199807)36:1<1::AID-NEU1>3.0.CO;2-6; Jiang L, 2008, INT J CANCER, V123, P1779, DOI 10.1002/ijc.23734; Katz A, 2008, EUR J NEUROSCI, V28, P99, DOI 10.1111/j.1460-9568.2008.06303.x; Key MD, 2006, METHOD ENZYMOL, V407, P513, DOI 10.1016/S0076-6879(05)07041-2; Kim DH, 2008, J NEUROSCI, V28, P208, DOI 10.1523/JNEUROSCI.3674-07.2008; Kimpo RR, 1997, NEURON, V18, P315, DOI 10.1016/S0896-6273(00)80271-8; KIRN J, 1994, P NATL ACAD SCI USA, V91, P7844, DOI 10.1073/pnas.91.17.7844; Li J, 2006, BEHAV BRAIN RES, V172, P202, DOI 10.1016/j.bbr.2006.04.022; Li MT, 2001, J NEUROSCI, V21, P6544, DOI 10.1523/JNEUROSCI.21-17-06544.2001; Li XC, 2000, P NATL ACAD SCI USA, V97, P8584, DOI 10.1073/pnas.140222497; Linseman DA, 2003, J BIOL CHEM, V278, P41472, DOI 10.1074/jbc.M307245200; Linseman DA, 2003, J NEUROCHEM, V85, P1488, DOI 10.1046/j.1471-4159.2003.09799.x; Lombardino AJ, 2006, J NEUROSCI METH, V157, P195, DOI 10.1016/j.jneumeth.2006.04.026; Louissaint A, 2002, NEURON, V34, P945, DOI 10.1016/S0896-6273(02)00722-5; Lovell PV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003440; Meitzen J, 2008, HORM BEHAV; Meitzen J, 2008, GEN COMP ENDOCRINOL; Meitzen J, 2007, J NEUROSCI, V27, P12045, DOI 10.1523/JNEUROSCI.3289-07.2007; Meitzen J, 2007, J COMP PHYSIOL A, V193, P677, DOI 10.1007/s00359-007-0222-1; Meitzen J, 2009, J NEUROSCI, V29, P6558, DOI 10.1523/JNEUROSCI.5571-08.2009; Meitzen J, 2009, HORM BEHAV, V55, P217, DOI 10.1016/j.yhbeh.2008.10.006; Mello CV, 2002, J COMP PHYSIOL A, V188, P943, DOI 10.1007/s00359-002-0347-1; Mukai M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008182; Newman AEM, 2010, J COMP NEUROL, V518, P3662, DOI 10.1002/cne.22395; NOTTEBOHM F, 1981, SCIENCE, V214, P1368, DOI 10.1126/science.7313697; Nottebohm F, 1987, HDB PHYSL 1, V5, P85; Okamoto S, 2002, P NATL ACAD SCI USA, V99, P3974, DOI 10.1073/pnas.022036399; Park KHJ, 2005, J NEUROBIOL, V64, P181, DOI 10.1002/neu.20145; Park SW, 2007, J NEUROSURG, V107, P593, DOI 10.3171/JNS-07/09/0593; Pearen MA, 2010, MOL ENDOCRINOL, V24, P1891, DOI 10.1210/me.2010-0015; Rasika S, 1999, NEURON, V22, P53, DOI 10.1016/S0896-6273(00)80678-9; Reiner A, 2004, J COMP NEUROL, V473, P377, DOI 10.1002/cne.20118; Replogle K, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-131; Rothermundt M, 2003, MICROSC RES TECHNIQ, V60, P614, DOI 10.1002/jemt.10303; Schlinger BA, 2006, J EXP ZOOL PART A, V305A, P743, DOI 10.1002/jez.a.303; Scotto-Lomassese S, 2007, EUR J NEUROSCI, V25, P1663, DOI 10.1111/j.1460-9568.2007.05418.x; Seasholtz AF, 2002, J ENDOCRINOL, V175, P89, DOI 10.1677/joe.0.1750089; Singh TD, 2003, J NEUROBIOL, V54, P593, DOI 10.1002/neu.10178; SMITH GT, 1995, J NEUROBIOL, V28, P114; Smith PD, 2006, J NEUROSCI, V26, P440, DOI 10.1523/JNEUROSCI.2875-05.2006; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Song B, 2003, NEUROSCI LETT, V349, P183, DOI 10.1016/S0304-3940(03)00830-9; Sperry TS, 2005, BEHAV BRAIN RES, V157, P119, DOI 10.1016/j.bbr.2004.06.015; Sperry TS, 2003, J NEUROENDOCRINOL, V15, P150, DOI 10.1046/j.1365-2826.2003.00968.x; Spinazzi R, 2006, INT J MOL MED, V18, P1107; Storey John D, 2003, Methods Mol Biol, V224, P149; Tang XL, 2005, J NEUROSCI, V25, P4823, DOI 10.1523/JNEUROSCI.1331-05.2005; Thompson CK, 2008, J NEUROSCI, V28, P7130, DOI 10.1523/JNEUROSCI.0663-08.2008; Thompson CK, 2007, P NATL ACAD SCI USA, V104, P15520, DOI 10.1073/pnas.0707239104; Thompson CK, 2009, J NEUROSCI, V29, P4586, DOI 10.1523/JNEUROSCI.5423-08.2009; Tramontin AD, 1999, J NEUROBIOL, V40, P316, DOI 10.1002/(SICI)1097-4695(19990905)40:3<316::AID-NEU4>3.0.CO;2-S; Tramontin AD, 2000, J NEUROSCI, V20, P854, DOI 10.1523/JNEUROSCI.20-02-00854.2000; Tramontin AD, 2003, J NEUROBIOL, V57, P130, DOI 10.1002/neu.10263; Tramontin AD, 1998, J COMP NEUROL, V396, P186, DOI 10.1002/(SICI)1096-9861(19980629)396:2<186::AID-CNE4>3.0.CO;2-X; Velho TAF, 2005, EUR J NEUROSCI, V22, P1667, DOI 10.1111/j.1460-9568.2005.04369.x; Vinci MC, 2007, AM J PHYSIOL-HEART C, V293, pH2140, DOI 10.1152/ajpheart.00390.2007; Wade J, 2004, ANN NY ACAD SCI, V1016, P540, DOI 10.1196/annals.1298.015; Wang XM, 2009, J BIOL CHEM, V284, P32619, DOI 10.1074/jbc.M109.067785; Warren WC, 2010, NATURE, V464, P757, DOI 10.1038/nature08819; WINGFIELD JC, 1978, BIOL REPROD, V19, P1046, DOI 10.1095/biolreprod19.5.1046; Wissman AM, 2009, J NEUROSCI, V29, P6461, DOI 10.1523/JNEUROSCI.0638-09.2009; Wood WE, 2011, J NEUROSCI, V31, P13808, DOI 10.1523/JNEUROSCI.2281-11.2011; Wu X, 2009, BIOINFORMATICS, V25, P832, DOI 10.1093/bioinformatics/btp059; Xie F, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-28; Zeigler HP, 2008, NEUROSCIENCE BIRDSON	84	30	31	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35119	10.1371/journal.pone.0035119	http://dx.doi.org/10.1371/journal.pone.0035119			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529977	Green Published, Green Submitted, gold			2022-12-27	WOS:000305350600057
J	Sorensen, G; Gupta, PC; Nagler, E; Viswanath, K				Sorensen, Glorian; Gupta, Prakash C.; Nagler, Eve; Viswanath, Kasisomayajula			Promoting Life Skills and Preventing Tobacco Use among Low-Income Mumbai Youth: Effects of Salaam Bombay Foundation Intervention	PLOS ONE			English	Article							SMOKING PREVENTION; DISSEMINATION RESEARCH; CIGARETTE-SMOKING; YOUNG-PEOPLE; PROGRAM; INDIA; TRANSLATION; DIFFUSION; BURDEN; POLICY	Background: In response to India's growing tobacco epidemic, strategies are needed to decrease tobacco use among Indian youth, particularly among those who are economically disadvantaged. The objective of this study was to assess the effectiveness of a school-based life-skills tobacco control program for youth of low socio-economic status in Mumbai and the surrounding state of Maharashtra. We hypothesized that compared to youth in control schools, youth exposed to the program would have greater knowledge of effects of tobacco use; be more likely to take action to prevent others from using tobacco; demonstrate more positive life skills and attitudes; and be less likely to report tobacco use. Methods/Findings: Using a quasi-experimental design, we assessed program effectiveness by comparing 8th and 9th grade students in intervention schools to 8th grade students in comparable schools that did not receive the program. Across all schools, 1851 students completed a survey that assessed core program components in early 2010. The program consisted of activities focused on building awareness about the hazards of tobacco, developing life skills, and advocacy development. The primary outcome measure was self-reported tobacco use in the last 30 days. Findings indicate that 4.1% of 8th grade intervention students (OR = 0.51) and 3.6% of 9th grade intervention students (OR = 0.33) reported using tobacco at least once in the last 30 days, compared to 8.7% of students in the control schools. Intervention group students were also significantly more knowledgeable about tobacco and related legislation, reported more efforts to prevent tobacco use among others, and reported stronger life skills and self-efficacy than students in control schools. Limitations to the study include schools not being randomly assigned to condition and tobacco use being measured by self-report. Conclusions: This program represents an effective model of school-based tobacco use prevention that low-income schools in India and other low-and middle-income countries can replicate.	[Sorensen, Glorian; Nagler, Eve; Viswanath, Kasisomayajula] Dana Farber Canc Inst, Ctr Community Based Res, Boston, MA 02115 USA; [Sorensen, Glorian; Gupta, Prakash C.; Nagler, Eve; Viswanath, Kasisomayajula] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Gupta, Prakash C.] Healis, Sekhsaria Inst Publ Hlth, Navi Mumbai, India	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health	Sorensen, G (corresponding author), Dana Farber Canc Inst, Ctr Community Based Res, Boston, MA 02115 USA.	Glorian_Sorensen@dfci.harvard.edu			National Cancer Institute [K05 CA108663]; NATIONAL CANCER INSTITUTE [K05CA108663] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Dr. Sorensen's effort was supported in part by her established investigator award from the National Cancer Institute (K05 CA108663). No additional external funding received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonnie RJ, ENDING TOBACCO PROBL; Botvin G. J., 2004, J PRIM PREV, V25, P211, DOI DOI 10.1023/B:J0PP.0000042391.58573.5B; Botvin Gilbert J, 2002, Int J Emerg Ment Health, V4, P41; Botvin GJ, 2000, ADDICT BEHAV, V25, P887, DOI 10.1016/S0306-4603(00)00119-2; Bowen DJ, 2009, CANCER CAUSE CONTROL, V20, P473, DOI 10.1007/s10552-009-9308-0; Centers for Disease Control website, COR QUEST GLOB YOUTH; Cuijpers P, 2002, ADDICT BEHAV, V27, P1009, DOI 10.1016/S0306-4603(02)00295-2; Eckhardt L, 1997, AM J HEALTH PROMOT, V11, P418, DOI 10.4278/0890-1171-11.6.418; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Faggiano F, 2008, PREV MED, V47, P537, DOI 10.1016/j.ypmed.2008.06.018; Flay BR, 2000, ADDICT BEHAV, V25, P861, DOI 10.1016/S0306-4603(00)00130-1; Flay BR, 2007, ENDING TOBACCO PROBL, P449; Flay Brian R, 2009, Tob Induc Dis, V5, P6, DOI 10.1186/1617-9625-5-6; Flynn B, 1995, J HLTH ED, V26, pS45; Gajalakshmi V, 2010, TOB USE INSIGHTS, V3, P23; Glasgow RE, 2006, ANN BEHAV MED, V31, P105, DOI 10.1207/s15324796abm3102_1; Glasgow RE, 2007, ANNU REV PUBL HEALTH, V28, P413, DOI 10.1146/annurev.publhealth.28.021406.144145; Green LW, 2009, AM J PREV MED, V37, pS187, DOI 10.1016/j.amepre.2009.08.017; Green LW, 2009, ANNU REV PUBL HEALTH, V30, P151, DOI 10.1146/annurev.publhealth.031308.100049; Green LW, 2006, EVAL HEALTH PROF, V29, P126, DOI 10.1177/0163278705284445; Greenhalgh T, 2004, MILBANK Q, V82, P581, DOI 10.1111/j.0887-378X.2004.00325.x; Health Related Information Dissemination Amongst Youth-Student Health Action Network website, STUD ASS FORM; Jarvis MJ., 2006, SOCIAL DETERMINANTS, P224; Jha P, 2008, NEW ENGL J MED, V358, P1137, DOI 10.1056/NEJMsa0707719; Kerner J, 2005, HEALTH PSYCHOL, V24, P443, DOI 10.1037/0278-6133.24.5.443; Kessler R, 2011, AM J PREV MED, V40, P637, DOI 10.1016/j.amepre.2011.02.023; Kotwal A, 2005, Indian J Med Sci, V59, P243; Mathur C, 2008, NICOTINE TOB RES, V10, P109, DOI 10.1080/14622200701767779; O'Loughlin J, 2009, AM J EPIDEMIOL, V170, P585, DOI 10.1093/aje/kwp179; Patel Dilip R., 1999, Indian Journal of Pediatrics, V66, P817, DOI 10.1007/BF02723844; Perry CL, 2009, AM J PUBLIC HEALTH, V99, P899, DOI 10.2105/AJPH.2008.145433; PERRY CL, 1992, AM J PUBLIC HEALTH, V82, P1210, DOI 10.2105/AJPH.82.9.1210; Reddy KS, 2004, REPORT TOBACCO CONTR; Resnicow K, 2008, ANN BEHAV MED, V36, P231, DOI 10.1007/s12160-008-9072-5; Sharma DC, 2009, LANCET ONCOL, V10, P844, DOI 10.1016/S1470-2045(09)70248-7; Sinha DN, 2008, J SCHOOL HEALTH, V78, P368, DOI 10.1111/j.1746-1561.2008.00316.x; Stigler MH, 2011, HEALTH EDUC BEHAV, V38, P231, DOI 10.1177/1090198110372330; Warren Charles W., 2008, Morbidity and Mortality Weekly Report, V57, P1; Warren CW, 2006, LANCET, V367, P749, DOI 10.1016/S0140-6736(06)68192-0; Wen XZ, 2010, INT J EPIDEMIOL, V39, P860, DOI 10.1093/ije/dyq001; World Health Organization, 2009, WHO REP GLOB TOB EP	41	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e34982	10.1371/journal.pone.0034982	http://dx.doi.org/10.1371/journal.pone.0034982			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959VO	22523567	Green Submitted, gold, Green Published			2022-12-27	WOS:000305345000039
J	Zhang, CY; Zhang, JL; Weissing, FJ; Perc, M; Xie, GM; Wang, L				Zhang, Chunyan; Zhang, Jianlei; Weissing, Franz J.; Perc, Matjaz; Xie, Guangming; Wang, Long			Different Reactions to Adverse Neighborhoods in Games of Cooperation	PLOS ONE			English	Article							EVOLUTIONARY PRISONERS-DILEMMA; NETWORKS; INDIVIDUALS; COEVOLUTION; EMERGENCE; DYNAMICS	In social dilemmas, cooperation among randomly interacting individuals is often difficult to achieve. The situation changes if interactions take place in a network where the network structure jointly evolves with the behavioral strategies of the interacting individuals. In particular, cooperation can be stabilized if individuals tend to cut interaction links when facing adverse neighborhoods. Here we consider two different types of reaction to adverse neighborhoods, and all possible mixtures between these reactions. When faced with a gloomy outlook, players can either choose to cut and rewire some of their links to other individuals, or they can migrate to another location and establish new links in the new local neighborhood. We find that in general local rewiring is more favorable for the evolution of cooperation than emigration from adverse neighborhoods. Rewiring helps to maintain the diversity in the degree distribution of players and favors the spontaneous emergence of cooperative clusters. Both properties are known to favor the evolution of cooperation on networks. Interestingly, a mixture of migration and rewiring is even more favorable for the evolution of cooperation than rewiring on its own. While most models only consider a single type of reaction to adverse neighborhoods, the coexistence of several such reactions may actually be an optimal setting for the evolution of cooperation.	[Zhang, Chunyan; Zhang, Jianlei; Xie, Guangming; Wang, Long] Peking Univ, Coll Engn, State Key Lab Turbulence & Complex Syst, Beijing 100871, Peoples R China; [Zhang, Chunyan; Zhang, Jianlei; Weissing, Franz J.] Univ Groningen, Theoret Biol Grp, Groningen, Netherlands; [Perc, Matjaz] Univ Maribor, Fac Nat Sci & Math, Dept Phys, SLO-2000 Maribor, Slovenia	Peking University; University of Groningen; University of Maribor	Zhang, CY (corresponding author), Peking Univ, Coll Engn, State Key Lab Turbulence & Complex Syst, Beijing 100871, Peoples R China.	f.j.weissing@rug.nl; matjaz.perc@uni-mb.si; xiegming@pku.edu.cn	Wang, Long/A-7798-2010; Perc, Matjaz/A-5148-2009; Gao, Y./GWZ-3665-2022	Wang, Long/0000-0001-5600-8157; Perc, Matjaz/0000-0002-3087-541X; Zhang, Jianlei/0000-0002-9932-9265; Weissing, Franz J./0000-0003-3281-663X	National Nature Science Foundation of China [60736022, 10972002, 60774089, 10972003, 10926195]; Erasmus Mundus Action (EMA2 Lotus Grant); Slovenian Research Agency [J1-4055]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Erasmus Mundus Action (EMA2 Lotus Grant); Slovenian Research Agency(Slovenian Research Agency - Slovenia)	This work was supported by the National Nature Science Foundation of China (grant nos. 60736022, 10972002, 60774089, 10972003, and 10926195). In addition, CZ and JZ acknowledge support from the Erasmus Mundus Action (EMA2 Lotus Grant), and MP acknowledges support from the Slovenian Research Agency (grant no. J1-4055). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Assenza S, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.017101; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Brauchli K, 1999, J THEOR BIOL, V200, P405, DOI 10.1006/jtbi.1999.1000; Droz M, 2009, EUR PHYS J B, V71, P579, DOI 10.1140/epjb/e2009-00160-1; DURRETT R, 1994, THEOR POPUL BIOL, V46, P363, DOI 10.1006/tpbi.1994.1032; Eguiluz VM, 2005, AM J SOCIOL, V110, P977, DOI 10.1086/428716; Floria LM, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.026106; Gomez-Gardenes J, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.108103; Gracia-Lazaro C, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.067101; Graser O, 2009, EPL-EUROPHYS LETT, V87, DOI 10.1209/0295-5075/87/38003; GRIM P, 1995, J THEOR BIOL, V173, P353, DOI 10.1006/jtbi.1995.0068; Hanaki N, 2007, MANAGE SCI, V53, P1036, DOI 10.1287/mnsc.1060.0625; Hauert C., 2003, Complexity, V8, P31, DOI 10.1002/cplx.10092; Hauert C, 2004, NATURE, V428, P643, DOI 10.1038/nature02360; Helbing D, 2008, ADV COMPLEX SYST, V11, P641, DOI 10.1142/S0219525908001866; Helbing D, 2009, P NATL ACAD SCI USA, V106, P3680, DOI 10.1073/pnas.0811503106; Hofbauer J, 1998, EVOLUTIONARY GAMES P; Kun A, 2009, BIOSYSTEMS, V96, P65, DOI 10.1016/j.biosystems.2008.11.009; LINDGREN K, 1994, PHYSICA D, V75, P292, DOI 10.1016/0167-2789(94)90289-5; Majeski S. J., 1999, Complexity, V5, P16, DOI 10.1002/(SICI)1099-0526(199909/10)5:1<16::AID-CPLX3>3.0.CO;2-M; Maynard Smith J., 1982, pi; McNamara JM, 2010, SOCIAL BEHAV GENES E, P109; Meloni S, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.067101; Nowak M., 2011, SUPERCOOPERATORS ALT; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Nowak MA, 1993, INT J BIFURCAT CHAOS, V3, P35, DOI 10.1142/S0218127493000040; Ohtsuki H, 2006, J THEOR BIOL, V243, P86, DOI 10.1016/j.jtbi.2006.06.004; Pacheco JM, 2008, J THEOR BIOL, V250, P723, DOI 10.1016/j.jtbi.2007.10.040; Pacheco JM, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.258103; Pacheco JM, 2006, J THEOR BIOL, V243, P437, DOI 10.1016/j.jtbi.2006.06.027; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; Poncela J, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/6/184; Poncela J, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.057101; Roca CP, 2011, P NATL ACAD SCI USA, V108, P11370, DOI 10.1073/pnas.1101044108; Roca CP, 2009, PHYS LIFE REV, V6, P208, DOI 10.1016/j.plrev.2009.08.001; Rong ZH, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.027101; Santos FC, 2006, J EVOLUTION BIOL, V19, P726, DOI 10.1111/j.1420-9101.2005.01063.x; Santos FC, 2006, PLOS COMPUT BIOL, V2, P1284, DOI 10.1371/journal.pcbi.0020140; Szabo G, 1998, PHYS REV E, V58, P69, DOI 10.1103/PhysRevE.58.69; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Szolnoki A, 2009, EUR PHYS J B, V67, P337, DOI 10.1140/epjb/e2008-00470-8; Szolnoki A, 2008, EPL-EUROPHYS LETT, V84, DOI 10.1209/0295-5075/84/50007; Szolnoki A, 2008, PHYSICA A, V387, P2075, DOI 10.1016/j.physa.2007.11.021; Szolnoki A, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/9/093033; Szolnoki A, 2009, EPL-EUROPHYS LETT, V86, DOI 10.1209/0295-5075/86/30007; Szolnoki A, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/4/043036; Tanimoto J, 2009, PHYSICA A, V388, P953, DOI 10.1016/j.physa.2008.11.023; Vainstein MH, 2007, J THEOR BIOL, V244, P722, DOI 10.1016/j.jtbi.2006.09.012; Vainstein MH, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.051905; Van Segbroeck S, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.058105; Wang WX, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.056113; Zimmermann MG, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.065102	55	13	13	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35183	10.1371/journal.pone.0035183	http://dx.doi.org/10.1371/journal.pone.0035183			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22539958	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341000022
J	Corbo, RM; Gambina, G; Scacchi, R				Corbo, Rosa Maria; Gambina, Giuseppe; Scacchi, Renato			How Contemporary Human Reproductive Behaviors Influence the Role of Fertility-Related Genes: The Example of the P53 Gene	PLOS ONE			English	Article							ACE I/D POLYMORPHISM; OVARIAN STIMULATION; ASSOCIATION; DISORDERS; MUTATIONS; SELECTION; GENOTYPE; PATHWAY; BIOLOGY	Studies on human fertility genes have identified numerous risk/protective alleles involved in the occurrence of reproductive system diseases causing infertility or subfertility. Investigations we carried out in populations at natural fertility seem to suggest that the clinical relevance that some fertility genes are now acquiring depends on their interaction with contemporary reproductive behaviors (birth control, delayed childbearing, and spacing birth order, among others). In recent years, a new physiological role in human fertility regulation has emerged for the tumor-suppressor p53 gene (P53), and the P53 Arg72Pro polymorphism has been associated with recurrent implantation failure in humans. To lend support to our previous observations, we examined the impact of Arg72Pro polymorphism on fertility in two samples of Italian women not selected for impaired fertility but collected from populations with different (premodern and modern) reproductive behaviors. Among the women at near-natural fertility (n = 98), the P53 genotypes were not associated with different reproductive efficiency, whereas among those with modern reproductive behaviors (n = 68), the P53 genotypes were associated with different mean numbers of children [Pro/Pro = 0.75, Pro/Arg = 1.7<Arg/Arg = 2, (p = 0.056)] and a significant negative relationship between the number of children and P53 Pro allele frequencies (p = 0.028) was observed. These results are consistent with those of clinical studies reporting an association between the P53 Pro allele and recurrent implantation failure. By combining these findings with previous ones, we suggest here that some common variants of fertility genes may have become "detrimental" following exposure to modern reproductive patterns and might therefore be associated with reduced reproductive success. Set within an evolutionary framework, this change could lead to the selection of a set of gene variants fitter to current reproductive behaviors as the shift to later child-bearing age in developed countries.	[Corbo, Rosa Maria] Univ Roma La Sapienza, Dept Biol & Biotechnol Charles Darwin, Rome, Italy; [Gambina, Giuseppe] Hosp Verona, Alzheimers Dis & Other Dementias Ctr, Div Neurol, Verona, Italy; [Corbo, Rosa Maria; Scacchi, Renato] CNR Inst Mol Biol & Pathol, Rome, Italy	Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR)	Corbo, RM (corresponding author), Univ Roma La Sapienza, Dept Biol & Biotechnol Charles Darwin, Rome, Italy.	rosamaria.corbo@uniroma1.it			La Sapienza University, Progetti AST	La Sapienza University, Progetti AST	This work was supported by La Sapienza University, Progetti AST 2009 (to RMC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmae S, 2011, HUM REPROD UPDATE, V17, P813, DOI 10.1093/humupd/dmr034; Altmae S, 2007, MOL HUM REPROD, V13, P521, DOI 10.1093/molehr/gam035; Armitage P., 2001, STAT METHODS MED RES; Buchholz T, 2003, HUM REPROD, V18, P2473, DOI 10.1093/humrep/deg474; Cohen J.E., 1988, STAT POWER ANAL BEHA; Corbo RM, 2007, MOL HUM REPROD, V13, P537, DOI 10.1093/molehr/gam041; Corbo RM, 2011, ANN HUM BIOL, V38, P102, DOI 10.3109/03014460.2010.481265; Corbo RM, 2011, J GERONTOL A-BIOL, V66, P51, DOI 10.1093/gerona/glq160; Di Rienzo A, 2005, TRENDS GENET, V21, P596, DOI 10.1016/j.tig.2005.08.007; Dossenbach-Glaninger A, 2008, BRIT J HAEMATOL, V141, P269, DOI 10.1111/j.1365-2141.2008.07058.x; Fatini C, 2000, BLOOD COAGUL FIBRIN, V11, P657, DOI 10.1097/00001721-200010000-00010; Fisher, 1958, GENETICAL THEORY NAT; Frejka T, 2006, DEMOGR RES, V15, P147, DOI 10.4054/DemRes.2006.15.6; Giannoudis A, 1999, INT J CANCER, V83, P66, DOI 10.1002/(SICI)1097-0215(19990924)83:1<66::AID-IJC13>3.0.CO;2-K; Hu WW, 2008, CELL CYCLE, V7, P848, DOI 10.4161/cc.7.7.5658; Hu WW, 2007, NATURE, V450, P721, DOI 10.1038/nature05993; Hu WW, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001073; Istituto Centrale di Statistica, 1974, NOTE RELAZIONI, V50, P96; Istituto Nazionale di Statistica, 1997, ANALISI COORTI INFOR, V35, P59; Jeong BS, 2010, FASEB J, V24, P1347, DOI 10.1096/fj.09-146001; Kang HJ, 2009, P NATL ACAD SCI USA, V106, P9761, DOI 10.1073/pnas.0904280106; Kay C, 2006, REPROD BIOMED ONLINE, V13, P492, DOI 10.1016/S1472-6483(10)60635-9; Kohler HP, 2006, INT J ANDROL, V29, P46, DOI 10.1111/j.1365-2605.2005.00606.x; Kosova G, 2010, P NATL ACAD SCI USA, V107, P1772, DOI 10.1073/pnas.0906196106; Layman LC, 2002, J MED GENET, V39, P153, DOI 10.1136/jmg.39.3.153; Levine AJ, 2006, CELL DEATH DIFFER, V13, P1027, DOI 10.1038/sj.cdd.4401910; Levine AJ, 2011, NAT REV MOL CELL BIO, V12, P259, DOI 10.1038/nrm3086; Lussiana C, 2008, OBSTET GYNECOL SURV, V63, P785, DOI 10.1097/OGX.0b013e31818957eb; Matzuk MM, 2008, NAT MED, V14, P1197, DOI 10.1038/nm.f.1895; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Neel JV, 1999, NUTR REV, V57, pS2, DOI 10.1111/j.1753-4887.1999.tb01782.x; NEEL JV, 1962, AM J HUM GENET, V14, P353; O'Brien KLO, 2010, FERTIL STERIL, V93, P1, DOI 10.1016/j.fertnstert.2009.10.045; Rodgers JL, 2001, CURR DIR PSYCHOL SCI, V10, P184, DOI 10.1111/1467-8721.00145; Simoni M, 2008, HUM REPROD UPDATE, V14, P459, DOI 10.1093/humupd/dmn024; Sucheston L, 2011, HUM MOL GENET, V20, P1502, DOI 10.1093/hmg/ddr028; Sundarrajan C, 1999, MOL HUM REPROD, V5, P797, DOI 10.1093/molehr/5.9.797; Tempfer CB, 2009, HUM REPROD UPDATE, V15, P97, DOI 10.1093/humupd/dmn040; Tenti P, 2000, CANCER EPIDEM BIOMAR, V9, P435; ULIZZI L, 1979, ANN HUM GENET, V43, P137, DOI 10.1111/j.1469-1809.1979.tb02006.x; Velde ERT, 2002, HUM REPROD UPDATE, V8, P141, DOI 10.1093/humupd/8.2.141; Yoon SH, 2010, HUM REPROD, V25, P283, DOI 10.1093/humrep/dep375	42	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35431	10.1371/journal.pone.0035431	http://dx.doi.org/10.1371/journal.pone.0035431			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22532853	Green Published, gold, Green Submitted			2022-12-27	WOS:000305339200064
J	Hoch, AI; Binder, BY; Genetos, DC; Leach, JK				Hoch, Allison I.; Binder, Bernard Y.; Genetos, Damian C.; Leach, J. Kent			Differentiation-Dependent Secretion of Proangiogenic Factors by Mesenchymal Stem Cells	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; BONE REGENERATION; HUMAN MARROW; IN-VITRO; OSTEOGENIC DIFFERENTIATION; PROGENITOR CELLS; STROMAL CELLS; ANGIOGENESIS; EXPRESSION; DEXAMETHASONE	Mesenchymal stem cells (MSCs) are a promising cell population for cell-based bone repair due to their proliferative potential, ability to differentiate into bone-forming osteoblasts, and their secretion of potent trophic factors that stimulate angiogenesis and neovascularization. To promote bone healing, autogenous or allogeneic MSCs are transplanted into bone defects after differentiation to varying degrees down the osteogenic lineage. However, the contribution of the stage of osteogenic differentiation upon angiogenic factor secretion is unclear. We hypothesized that the proangiogenic potential of MSCs was dependent upon their stage of osteogenic differentiation. After 7 days of culture, we observed the greatest osteogenic differentiation of MSCs when cells were cultured with dexamethasone (OM+). Conversely, VEGF protein secretion and upregulation of angiogenic genes were greatest in MSCs cultured in growth media (GM). Using conditioned media from MSCs in each culture condition, GM-conditioned media maximized proliferation and enhanced chemotactic migration and tubule formation of endothelial colony forming cells (ECFCs). The addition of a neutralizing VEGF(165/121) antibody to conditioned media attenuated ECFC proliferation and chemotactic migration. ECFCs seeded on microcarrier beads and co-cultured with MSCs previously cultured in GM in a fibrin gel exhibited superior sprouting compared to MSCs previously cultured in OM+. These results confirm that MSCs induced farther down the osteogenic lineage possess reduced proangiogenic potential, thereby providing important findings for consideration when using MSCs for bone repair.	[Hoch, Allison I.; Binder, Bernard Y.; Leach, J. Kent] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA; [Genetos, Damian C.] Univ Calif Davis, Sch Vet Med, Dept Anat Physiol & Cell Biol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Leach, JK (corresponding author), Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA.	jkleach@ucdavis.edu	Genetos, Damian C/A-6480-2012; Genetos, Damian/AAF-5953-2021	Genetos, Damian/0000-0002-8599-2867; Hoch, Allison/0000-0002-2418-8736	National Institutes of Health (NIH) [R03-DE021704, R21-AG036963, EB003827]; AO Foundation [C10-39L]; Center of Excellence in Translational Human Stem Cell Research (NIH) [P50-HL085036]; California Institute for Regenerative Medicine University of California Davis [CIRM T1-00006, CIRM TG2-01163];  [R03-AR057547]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL085036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR057547] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB003827] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R03DE021704] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG036963] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AO Foundation; Center of Excellence in Translational Human Stem Cell Research (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute for Regenerative Medicine University of California Davis; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institutes of Health (NIH) Grants R03-DE021704 and R21-AG036963 and the AO Foundation (C10-39L) to JKL. DCG was supported by R03-AR057547. The authors acknowledge the University of California Davis Center of Excellence in Translational Human Stem Cell Research for providing GFP-transduced ECFCs. These studies were supported by a pilot grant from the Center of Excellence in Translational Human Stem Cell Research (NIH grant P50-HL085036), the NIH T32 Molecular Imaging Training Grant (NIH grant EB003827), and the California Institute for Regenerative Medicine University of California Davis Stem Cell Training Program (CIRM T1-00006, CIRM TG2-01163). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre A, 2010, BIOCHEM BIOPH RES CO, V400, P284, DOI 10.1016/j.bbrc.2010.08.073; Aozuka Y, 2004, CANCER LETT, V216, P35, DOI 10.1016/j.canlet.2004.06.050; BERESFORD JN, 1992, J CELL SCI, V102, P341; Bischoff DS, 2008, J CELL BIOCHEM, V103, P812, DOI 10.1002/jcb.21450; Buschmann J, 2011, TISSUE ENG PT A, V17, P291, DOI 10.1089/ten.TEA.2010.0278; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Chen LW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001886; CHENG SL, 1994, ENDOCRINOLOGY, V134, P277, DOI 10.1210/en.134.1.277; Coelho MJ, 2000, BIOMATERIALS, V21, P1095, DOI 10.1016/S0142-9612(99)00192-1; Decaris ML, 2009, ANGIOGENESIS, V12, P303, DOI 10.1007/s10456-009-9152-6; Deckers MML, 2000, ENDOCRINOLOGY, V141, P1667, DOI 10.1210/en.141.5.1667; DELANY AM, 1994, J CELL BIOCHEM, V56, P295, DOI 10.1002/jcb.240560304; Dragoo JL, 2003, J BONE JOINT SURG BR, V85B, P740, DOI 10.1302/0301-620X.85B5.13587; Elbjeirami WM, 2006, TISSUE ENG, V12, P381, DOI 10.1089/ten.2006.12.381; Fierro FA, 2011, STEM CELLS BIOL REG; Furumatsu T, 2003, J BIOCHEM, V133, P633, DOI 10.1093/jb/mvg081; Gerber HP, 1999, NAT MED, V5, P623, DOI 10.1038/9467; Ghajar CM, 2008, BIOPHYS J, V94, P1930, DOI 10.1529/biophysj.107.120774; Grellier M, 2009, J CELL BIOCHEM, V106, P390, DOI 10.1002/jcb.22018; Gruber R, 2005, TISSUE ENG, V11, P896, DOI 10.1089/ten.2005.11.896; Grunert M, 2007, J MOL HISTOL, V38, P393, DOI 10.1007/s10735-007-9119-0; Hariawala MD, 1996, J SURG RES, V63, P77, DOI 10.1006/jsre.1996.0226; HAYNESWORTH SE, 1992, BONE, V13, P81, DOI 10.1016/8756-3282(92)90364-3; Haynesworth SE, 1996, J CELL PHYSIOL, V166, P585, DOI 10.1002/(SICI)1097-4652(199603)166:3<585::AID-JCP13>3.0.CO;2-6; He JW, 2010, TISSUE ENG PT A, V16, P127, DOI [10.1089/ten.tea.2009.0255, 10.1089/ten.TEA.2009.0255]; He JW, 2010, J CELL BIOCHEM, V110, P87, DOI 10.1002/jcb.22514; Hocking AM, 2010, EXP CELL RES, V316, P2213, DOI 10.1016/j.yexcr.2010.05.009; Huang YC, 2005, J BONE MINER RES, V20, P848, DOI 10.1359/JBMR.041226; Hung SC, 2007, STEM CELLS, V25, P2363, DOI 10.1634/stemcells.2006-0686; Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I; Kanczler JM, 2008, EUR CELLS MATER, V15, P100, DOI 10.22203/eCM.v015a08; Le Blanc K, 2004, LANCET, V363, P1439, DOI 10.1016/S0140-6736(04)16104-7; Leach JK, 2006, BIOMATERIALS, V27, P3249, DOI 10.1016/j.biomaterials.2006.01.033; Majumdar MK, 2000, J HEMATOTH STEM CELL, V9, P841, DOI 10.1089/152581600750062264; Mayer H, 2005, J CELL BIOCHEM, V95, P827, DOI 10.1002/jcb.20462; Nakatsu MN, 2007, J VIS EXP; Patel ZS, 2008, BONE, V43, P931, DOI 10.1016/j.bone.2008.06.019; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Saadeh PB, 2000, ENDOCRINOLOGY, V141, P2075, DOI 10.1210/en.141.6.2075; Schmid J, 1997, CLIN ORAL IMPLAN RES, V8, P244, DOI 10.1034/j.1600-0501.1997.080311.x; Schubert T, 2011, BIOMATERIALS, V32, P8880, DOI 10.1016/j.biomaterials.2011.08.009; Staton C.A., 2006, ANGIOGENESIS ASSAYS; Vater C, 2011, ACTA BIOMATER, V7, P463, DOI 10.1016/j.actbio.2010.07.037; Yoder MC, 2007, BLOOD, V109, P1801, DOI 10.1182/blood-2006-08-043471	45	97	100	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35579	10.1371/journal.pone.0035579	http://dx.doi.org/10.1371/journal.pone.0035579			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536411	Green Submitted, gold, Green Published			2022-12-27	WOS:000305339200081
J	Kalpakidou, AK; Allin, MP; Walshe, M; Giampietro, V; Nam, KW; McGuire, P; Rifkin, L; Murray, RM; Nosarti, C				Kalpakidou, Anastasia K.; Allin, Matthew P.; Walshe, Muriel; Giampietro, Vincent; Nam, Kie-woo; McGuire, Philip; Rifkin, Larry; Murray, Robin M.; Nosarti, Chiara			Neonatal Brain Injury and Neuroanatomy of Memory Processing following Very Preterm Birth in Adulthood: An fMRI Study	PLOS ONE			English	Article							DEFICIT HYPERACTIVITY DISORDER; SCHOOL-AGED CHILDREN; INTRAVENTRICULAR HEMORRHAGE; PREFRONTAL CORTEX; EPISODIC MEMORY; WORKING-MEMORY; ULTRASOUND APPEARANCE; NEURODEVELOPMENTAL IMPAIRMENT; FUNCTIONAL NEUROANATOMY; RESPONSE-INHIBITION	Altered functional neuroanatomy of high-order cognitive processing has been described in very preterm individuals (born before 33 weeks of gestation; VPT) compared to controls in childhood and adolescence. However, VPT birth may be accompanied by different types of adverse neonatal events and associated brain injury, the severity of which may have differential effects on brain development and subsequent neurodevelopmental outcome. We conducted a functional magnetic resonance imaging (fMRI) study to investigate how differing degrees of neonatal brain injury, detected by neonatal ultrasounds, affect the functional neuroanatomy of memory processing in VPT young adults. We used a verbal paired associates learning task, consisting of four encoding, four cued-recall and four baseline condition blocks. To further investigate whether differences in neural activation between the groups were modulated by structural brain changes, structural MRI data were also collected. We studied 12 VPT young adults with a history of periventricular haemorrhage with associated ventricular dilatation, 17 VPT individuals with a history of uncomplicated periventricular haemorrhage, 12 individuals with normal ultrasonographic findings, and 17 controls. Results of a linear trend analysis demonstrated that during completion of the paired associates learning task right frontal and right parietal brain activation decreased as the severity of neonatal brain injury increased. There were no statistically significant between-group differences in on-line task performance and participants' intelligence quotient (IQ) at assessment. This pattern of differential activation across the groups was observed particularly in the right middle frontal gyrus during encoding and in the right posterior cingulate gyrus during recall. Structural MRI data analysis revealed that grey matter volume in the right superior temporal gyrus, right cerebellum, left middle temporal gyrus, right globus pallidus and right medial frontal gyrus decreased with increasing severity of neonatal brain injury. However, the significant between-group functional neuroanatomical differences were not directly attributable to the detected structural regional differences.	[Kalpakidou, Anastasia K.; Allin, Matthew P.; Walshe, Muriel; Nam, Kie-woo; McGuire, Philip; Rifkin, Larry; Murray, Robin M.; Nosarti, Chiara] Kings Coll London, Inst Psychiat, Dept Psychosis Studies, Kings Hlth Partners, London WC2R 2LS, England; [Giampietro, Vincent] Kings Coll London, Inst Psychiat, Dept Neuroimaging, Kings Hlth Partners, London WC2R 2LS, England	University of London; King's College London; University of London; King's College London	Nosarti, C (corresponding author), Kings Coll London, Inst Psychiat, Dept Psychosis Studies, Kings Hlth Partners, London WC2R 2LS, England.	chiara.nosarti@kcl.ac.uk	Nosarti, Chiara/G-5638-2010; Murray, Robin M/F-8658-2012; Walshe, Muriel/E-5214-2010; Giampietro, Vincent P/D-1279-2011; Walshe, Margaret/M-9102-2016	Nosarti, Chiara/0000-0001-6305-9710; Murray, Robin M/0000-0003-0829-0519; Walshe, Muriel/0000-0001-6829-1105; Giampietro, Vincent P/0000-0002-9381-8201; Walshe, Margaret/0000-0003-3924-8073; McGuire, Philip/0000-0003-4381-0532; Rifkin, Larry/0000-0003-2590-9010	Cerebra Foundation for The Brain Injured Infant	Cerebra Foundation for The Brain Injured Infant	The study was funded by the Cerebra Foundation for The Brain Injured Infant (CN and RMM). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allin M, 2008, J NEUROL NEUROSUR PS, V79, P381, DOI 10.1136/jnnp.2006.110858; Allin M, 2004, DEV MED CHILD NEUROL, V46, P46, DOI 10.1017/S0012162204000088; Anderson PJ, 2004, PEDIATRICS, V114, P50, DOI 10.1542/peds.114.1.50; [Anonymous], 1983, CANADIAN PSYCHOL; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Bhattacharyya S, 2009, ARCH GEN PSYCHIAT, V66, P442, DOI 10.1001/archgenpsychiatry.2009.17; Blumenfeld RS, 2007, NEUROSCIENTIST, V13, P280, DOI 10.1177/1073858407299290; Blumenfeld RS, 2006, J NEUROSCI, V26, P916, DOI 10.1523/JNEUROSCI.2353-05.2006; BOWER GH, 1970, J VERB LEARN VERB BE, V9, P529, DOI 10.1016/S0022-5371(70)80096-2; Brammer MJ, 1997, MAGN RESON IMAGING, V15, P763, DOI 10.1016/S0730-725X(97)00135-5; Buckner RL, 1998, P NATL ACAD SCI USA, V95, P891, DOI 10.1073/pnas.95.3.891; Bullmore ET, 1999, IEEE T MED IMAGING, V18, P32, DOI 10.1109/42.750253; Bullmore ET, 2001, HUM BRAIN MAPP, V12, P61, DOI 10.1002/1097-0193(200102)12:2<61::AID-HBM1004>3.0.CO;2-W; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Cansino S, 2002, CEREB CORTEX, V12, P1048, DOI 10.1093/cercor/12.10.1048; Castellanos FX, 2002, JAMA-J AM MED ASSOC, V288, P1740, DOI 10.1001/jama.288.14.1740; Castellanos FX, 1996, ARCH GEN PSYCHIAT, V53, P607; COSTELLO AMD, 1988, DEV MED CHILD NEUROL, V30, P711; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Curtis WJ, 2006, DEV NEUROPSYCHOL, V29, P341, DOI 10.1207/s15326942dn2902_4; Dickstein SG, 2006, J CHILD PSYCHOL PSYC, V47, P1051, DOI 10.1111/j.1469-7610.2006.01671.x; Downie ALS, 2005, CHILD NEUROPSYCHOL, V11, P479, DOI 10.1080/09297040591001085; Elvevag B, 2000, NEUROPSYCHOLOGIA, V38, P1565, DOI 10.1016/S0028-3932(00)00074-9; Fletcher JM, 1997, DEV MED CHILD NEUROL, V39, P596; Fletcher PC, 1998, BRAIN, V121, P1239, DOI 10.1093/brain/121.7.1239; Fletcher PC, 1998, BRAIN, V121, P1249, DOI 10.1093/brain/121.7.1249; FLETCHER PC, 1995, BRAIN, V118, P401, DOI 10.1093/brain/118.2.401; FRISK V, 1994, DEV NEUROPSYCHOL, V10, P313, DOI 10.1080/87565649409540586; Friston KJ, 1999, NEUROIMAGE, V10, P1, DOI 10.1006/nimg.1999.0439; Gimenez M, 2005, NEUROIMAGE, V25, P561, DOI 10.1016/j.neuroimage.2004.10.046; Gimenez M, 2004, NEUROIMAGE, V23, P869, DOI 10.1016/j.neuroimage.2004.07.029; GRESSENS P, 1992, BIOL NEONATE, V61, P4; HMSO (1991) Her Majesty's Stationary Office (HMSO), 1991, STANDARD OCCUPATIONA; Inder TE, 2006, J PEDIATR-US, V149, P152, DOI 10.1016/j.jpeds.2006.05.046; Isaacs EB, 2000, PEDIATR RES, V47, P713, DOI 10.1203/00006450-200006000-00006; Isaacs EB, 2003, P NATL ACAD SCI USA, V100, P13060, DOI 10.1073/pnas.1233825100; Kesler SR, 2004, PEDIATR NEUROL, V31, P318, DOI 10.1016/j.pediatrneurol.2004.06.008; Kuban K, 1999, J PEDIATR-US, V134, P539, DOI 10.1016/S0022-3476(99)70237-4; Kucera H, 1967, COMPUTATIONAL ANALUS; Lacadie CM, 2008, NEUROIMAGE, V42, P717, DOI 10.1016/j.neuroimage.2008.04.240; Langenecker SA, 2007, BRAIN RES, V1135, P58, DOI 10.1016/j.brainres.2006.11.068; Lawrence EJ, 2010, J PEDIAT; Lawrence EJ, 2009, HUM BRAIN MAPP, V30, P1038, DOI 10.1002/hbm.20564; Levitan IB, 1997, NEURON, P23; Lubsen J, 2011, SEMIN PERINATOL, V35, P34, DOI 10.1053/j.semperi.2010.10.006; Luciana M, 1999, DEV MED CHILD NEUROL, V41, P521, DOI 10.1017/S0012162299001140; Luu TM, 2009, PEDIATRICS, V123, P1037, DOI 10.1542/peds.2008-1162; Maddock RF, 2001, NEUROSCIENCE, V104, P667, DOI 10.1016/S0306-4522(01)00108-7; Meltzer JA, 2005, NEUROIMAGE, V24, P384, DOI 10.1016/j.neuroimage.2004.09.001; Morris R, 1999, EUR J NEUROSCI, V11, P2506, DOI 10.1046/j.1460-9568.1999.00672.x; Narberhaus A, 2009, NEUROIMAGE; Nosarti C, 2006, DEV MED CHILD NEUROL, V48, P265, DOI 10.1017/S0012162206000582; Nosarti C, 2011, DEV NEUROPSYCHOL, V36, P118, DOI 10.1080/87565641.2011.540546; Nosarti C, 2002, BRAIN, V125, P1616, DOI 10.1093/brain/awf157; Nosarti C, 2009, NEUROIMAGE; Nosarti C, 2008, BRAIN; PANETH N, 1994, BRAIN DAMAGE PRETERM; PETRIDES M, 1995, P NATL ACAD SCI USA, V92, P5803, DOI 10.1073/pnas.92.13.5803; Rose SA, 1996, CHILD DEV, V67, P2005, DOI 10.1111/j.1467-8624.1996.tb01840.x; ROSS G, 1992, DEV PSYCHOL, V28, P1067, DOI 10.1037/0012-1649.28.6.1067; ROTH SC, 1993, DEV MED CHILD NEUROL, V35, P755; Rushe TM, 1999, SCHIZOPHR RES, V35, P85, DOI 10.1016/S0920-9964(98)00117-0; Simmons A, 1999, MAGNET RESON MED, V41, P1274, DOI 10.1002/(SICI)1522-2594(199906)41:6<1274::AID-MRM27>3.0.CO;2-1; STEWART AL, 1989, DEV MED CHILD NEUROL, V31, P756; Stewart AL, 1999, LANCET, V353, P1653, DOI 10.1016/S0140-6736(98)07130-X; STEWART AL, 1983, ARCH DIS CHILD, V58, P598, DOI 10.1136/adc.58.8.598; Summerfield C, 2006, PLOS BIOL, V4, P855, DOI 10.1371/journal.pbio.0040128; SUZUKI WA, 1994, J COMP NEUROL, V350, P497, DOI 10.1002/cne.903500402; Talairach I., 1988, COPLANAR STEREOTACTI; VALENSTEIN E, 1987, BRAIN, V110, P1631, DOI 10.1093/brain/110.6.1631; Valera EM, 2010, AM J PSYCHIAT, V167, P86, DOI 10.1176/appi.ajp.2009.09020249; Vasileiadis GT, 2004, PEDIATRICS, V114, pE367, DOI 10.1542/peds.2004-0500; Vollmer B, 2006, DEV MED CHILD NEUROL, V48, P348, DOI 10.1017/S0012162206000764; Wechsler D, 1987, WMS R WECHSLER MEMOR; Wechsler D., 2011, WASI 2 WECHSLER ABBR; WILSON M, 1988, BEHAV RES METH INSTR, V20, P6, DOI 10.3758/BF03202594; Woodward LJ, 2005, BRAIN, V128, P2578, DOI 10.1093/brain/awh618	77	24	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e34858	10.1371/journal.pone.0034858	http://dx.doi.org/10.1371/journal.pone.0034858			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22532832	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339200025
J	Patron, JP; Fendler, A; Bild, M; Jung, U; Muller, H; Arntzen, MO; Piso, C; Stephan, C; Thiede, B; Mollenkopf, HJ; Jung, K; Kaufmann, SHE; Schreiber, J				Patron, Juan P.; Fendler, Annika; Bild, Matthias; Jung, Ulrike; Mueller, Henrik; Arntzen, Magnus O.; Piso, Chloe; Stephan, Carsten; Thiede, Bernd; Mollenkopf, Hans-Joachim; Jung, Klaus; Kaufmann, Stefan H. E.; Schreiber, Joerg			MiR-133b Targets Antiapoptotic Genes and Enhances Death Receptor-Induced Apoptosis	PLOS ONE			English	Article							GLUTATHIONE-S-TRANSFERASE; NF-KAPPA-B; TUMOR-SUPPRESSIVE MICRORNAS; SQUAMOUS-CELL CARCINOMA; INHIBITORY MOLECULE; COLORECTAL-CANCER; PROTEIN-SYNTHESIS; EXPRESSION; IDENTIFICATION; FAS	Despite the importance of microRNAs (miRs) for regulation of the delicate balance between cell proliferation and death, evidence for their specific involvement during death receptor (DR)-mediated apoptosis is scarce. Transfection with miR-133b rendered resistant HeLa cells sensitive to tumor necrosis factor-alpha (TNF alpha)-induced cell death. Similarly, miR-133b caused exacerbated proapoptotic responses to TNF-related apoptosis-inducing ligand (TRAIL) or an activating antibody to Fas/CD95. Comprehensive analysis, encompassing global RNA or protein expression profiling performed by microarray experiments and pulsed stable isotope labeling with amino acids in cell culture (pSILAC), led to the discovery of the antiapoptotic protein Fas apoptosis inhibitory molecule (FAIM) as immediate miR-133b target. Moreover, miR-133b impaired the expression of the detoxifying protein glutathione-S-transferase pi (GSTP1). Expression of miR-133b in tumor specimens of prostate cancer patients was significantly downregulated in 75% of the cases, when compared with matched healthy tissue. Furthermore, introduction of synthetic miR-133b into an ex-vivo model of prostate cancer resulted in impaired proliferation and cellular metabolic activity. PC3 cells were also sensitized to apoptotic stimuli after transfection with miR-133b similar to HeLa cells. These data reveal the ability of a single miR to influence major apoptosis pathways, suggesting an essential role for this molecule during cellular transformation, tumorigenesis and tissue homeostasis.	[Patron, Juan P.; Bild, Matthias; Jung, Ulrike; Mueller, Henrik; Piso, Chloe; Kaufmann, Stefan H. E.; Schreiber, Joerg] Max Planck Inst Infect Biol, Dept Immunol, Berlin, Germany; [Fendler, Annika; Stephan, Carsten] Charite, Dept Urol, D-13353 Berlin, Germany; [Fendler, Annika; Jung, Klaus] Berlin Inst Urol Res, Berlin, Germany; [Fendler, Annika] Free Univ Berlin, Dept Biol Chem & Pharm, Berlin, Germany; [Arntzen, Magnus O.; Thiede, Bernd] Univ Oslo, Biotechnol Ctr Oslo, Oslo, Norway; [Arntzen, Magnus O.] Univ Oslo, Rikshosp, Prote Core Facil, N-0027 Oslo, Norway; [Arntzen, Magnus O.] Norwegian Univ Life Sci, Prote Core Facil, As, Norway; [Mollenkopf, Hans-Joachim] Max Planck Inst Infect Biol, Core Facil Microarray, Berlin, Germany	Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; University of Oslo; University of Oslo; National Hospital Norway; Norwegian University of Life Sciences; Max Planck Society	Kaufmann, SHE (corresponding author), Max Planck Inst Infect Biol, Dept Immunol, Berlin, Germany.	kaufmann@mpiib-berlin.mpg.de	Jung, Klaus/Z-2122-2018; Arntzen, Magnus Ø/N-6983-2016; Mollenkopf, Hans-Joachim/AAH-2500-2019; Kaufmann, Stefan HE/I-5454-2014	Jung, Klaus/0000-0001-9797-5362; Arntzen, Magnus Ø/0000-0002-1803-727X; Mollenkopf, Hans-Joachim/0000-0003-1167-4783; Kaufmann, Stefan HE/0000-0001-9866-8268; Stephan, Carsten/0000-0002-3270-258X; Fendler, Annika/0000-0002-7267-0981				Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Bandres E, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-29; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Crawford M, 2009, BIOCHEM BIOPH RES CO, V388, P483, DOI 10.1016/j.bbrc.2009.07.143; Dutta J, 2006, ONCOGENE, V25, P6800, DOI 10.1038/sj.onc.1209938; Fischer U, 2003, CELL DEATH DIFFER, V10, P76, DOI 10.1038/sj.cdd.4401160; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Garofalo M, 2010, CELL DEATH DIFFER, V17, P200, DOI 10.1038/cdd.2009.105; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Haas JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020171; Hansen T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000873; Hu G, 2010, CANCER BIOL THER, V10, P190, DOI 10.4161/cbt.10.2.12186; Hudson RS, 2011, NUCL ACIDS RES; Huo J, 2009, CELL DEATH DIFFER, V16, P1062, DOI 10.1038/cdd.2009.26; Hutvagner G, 2004, PLOS BIOL, V2, P465, DOI 10.1371/journal.pbio.0020098; Ichimi T, 2009, INT J CANCER, V125, P345, DOI 10.1002/ijc.24390; Kano M, 2010, INT J CANCER, V127, P2804, DOI 10.1002/ijc.25284; KAUFMANN SH, 1993, CANCER RES, V53, P3976; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kim J, 2007, SCIENCE, V317, P1220, DOI 10.1126/science.1140481; Kojima S, 2012, BRIT J CANCER, V106, P405, DOI 10.1038/bjc.2011.462; Kozaki KI, 2008, CANCER RES, V68, P2094, DOI 10.1158/0008-5472.CAN-07-5194; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; McCarthy JJ, 2008, BBA-GENE REGUL MECH, V1779, P682, DOI 10.1016/j.bbagrm.2008.03.001; Meister G, 2004, RNA, V10, P544, DOI 10.1261/rna.5235104; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Mutallip M, 2011, INT J MOL MED, V27, P345, DOI 10.3892/ijmm.2010.589; Navon R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008003; Nohata N, 2012, ONCOTARGET, V3, P9; Patel VA, 2006, J BIOL CHEM, V281, P4663, DOI 10.1074/jbc.M508342200; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Qin W, 2011, ONCOGENE; Rodriguez-Berriguete G, 2012, PROSTATE, V72, P40, DOI 10.1002/pros.21404; Schaefer A, 2010, INT J CANCER, V126, P1166, DOI 10.1002/ijc.24827; Schneider TJ, 1999, J EXP MED, V189, P949, DOI 10.1084/jem.189.6.949; Segura MF, 2007, J NEUROSCI, V27, P11228, DOI 10.1523/JNEUROSCI.3462-07.2007; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Sole C, 2004, J CELL BIOL, V167, P479, DOI 10.1083/jcb.200403093; Song GS, 2009, J BIOL CHEM, V284, P31921, DOI 10.1074/jbc.M109.046862; Townsend DM, 2003, ONCOGENE, V22, P7369, DOI 10.1038/sj.onc.1206940; Tran N, 2007, BIOCHEM BIOPH RES CO, V358, P12, DOI 10.1016/j.bbrc.2007.03.201; Ungefroren H, 1998, CANCER RES, V58, P1741; Walden TB, 2009, J CELL PHYSIOL, V218, P444, DOI 10.1002/jcp.21621; Wang XH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002557; Witten D, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-58; Wong TS, 2008, CLIN CANCER RES, V14, P2588, DOI 10.1158/1078-0432.CCR-07-0666; Wu Y, 2006, ONCOGENE, V25, P5787, DOI 10.1038/sj.onc.1209576; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Yoshino H, 2011, BRIT J CANCER, V104, P808, DOI 10.1038/bjc.2011.23	54	76	84	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35345	10.1371/journal.pone.0035345	http://dx.doi.org/10.1371/journal.pone.0035345			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22532850	Green Submitted, Green Published, gold			2022-12-27	WOS:000305339200058
J	Rodrigues-Ferreira, S; Abdelkarim, M; Dillenburg-Pilla, P; Luissint, AC; di-Tommaso, A; Deshayes, F; Pontes, CLS; Molina, A; Cagnard, N; Letourneur, F; Morel, M; Reis, RI; Casarini, DE; Terris, B; Couraud, PO; Costa-Neto, CM; Di Benedetto, M; Nahmias, C				Rodrigues-Ferreira, Sylvie; Abdelkarim, Mohamed; Dillenburg-Pilla, Patricia; Luissint, Anny-Claude; di-Tommaso, Anne; Deshayes, Frederique; Pontes, Carmen Lucia S.; Molina, Angie; Cagnard, Nicolas; Letourneur, Franck; Morel, Marina; Reis, Rosana I.; Casarini, Dulce E.; Terris, Benoit; Couraud, Pierre-Olivier; Costa-Neto, Claudio M.; Di Benedetto, Melanie; Nahmias, Clara			Angiotensin II Facilitates Breast Cancer Cell Migration and Metastasis	PLOS ONE			English	Article							HUMAN GASTRIC-CANCER; TYPE-1 RECEPTOR; TUMOR ANGIOGENESIS; GROWTH; MICROENVIRONMENT; SYSTEM; RISK; DISSEMINATION; METAANALYSIS; PROGRESSION	Breast cancer metastasis is a leading cause of death by malignancy in women worldwide. Efforts are being made to further characterize the rate-limiting steps of cancer metastasis, i.e. extravasation of circulating tumor cells and colonization of secondary organs. In this study, we investigated whether angiotensin II, a major vasoactive peptide both produced locally and released in the bloodstream, may trigger activating signals that contribute to cancer cell extravasation and metastasis. We used an experimental in vivo model of cancer metastasis in which bioluminescent breast tumor cells (D3H2LN) were injected intra-cardiacally into nude mice in order to recapitulate the late and essential steps of metastatic dissemination. Real-time intravital imaging studies revealed that angiotensin II accelerates the formation of metastatic foci at secondary sites. Pre-treatment of cancer cells with the peptide increases the number of mice with metastases, as well as the number and size of metastases per mouse. In vitro, angiotensin II contributes to each sequential step of cancer metastasis by promoting cancer cell adhesion to endothelial cells, trans-endothelial migration and tumor cell migration across extracellular matrix. At the molecular level, a total of 102 genes differentially expressed following angiotensin II pretreatment were identified by comparative DNA microarray. Angiotensin II regulates two groups of connected genes related to its precursor angiotensinogen. Among those, up-regulated MMP2/MMP9 and ICAM1 stand at the crossroad of a network of genes involved in cell adhesion, migration and invasion. Our data suggest that targeting angiotensin II production or action may represent a valuable therapeutic option to prevent metastatic progression of invasive breast tumors.	[Rodrigues-Ferreira, Sylvie; Dillenburg-Pilla, Patricia; Luissint, Anny-Claude; di-Tommaso, Anne; Deshayes, Frederique; Molina, Angie; Cagnard, Nicolas; Letourneur, Franck; Morel, Marina; Terris, Benoit; Couraud, Pierre-Olivier; Nahmias, Clara] INSERM, Inst Cochin, Paris, France; [Rodrigues-Ferreira, Sylvie; Dillenburg-Pilla, Patricia; Luissint, Anny-Claude; di-Tommaso, Anne; Deshayes, Frederique; Molina, Angie; Cagnard, Nicolas; Letourneur, Franck; Morel, Marina; Terris, Benoit; Couraud, Pierre-Olivier; Nahmias, Clara] Univ Paris 05, Paris, France; [Abdelkarim, Mohamed; Di Benedetto, Melanie] Univ Paris 13, Bobigny, France; [Abdelkarim, Mohamed; Di Benedetto, Melanie] CNRS, UMRS 940, IGM, Paris, France; [Dillenburg-Pilla, Patricia; Reis, Rosana I.; Costa-Neto, Claudio M.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Biochem & Immunol, Ribeirao Preto, Brazil; [Pontes, Carmen Lucia S.] Univ Fed Sao Carlos, Dept Physiol Sci, BR-13560 Sao Carlos, SP, Brazil; [Casarini, Dulce E.] Univ Fed Sao Paulo, Dept Med, Div Nephrol, Sao Paulo, Brazil	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Universite Paris 13; Centre National de la Recherche Scientifique (CNRS); Universidade de Sao Paulo; Universidade Federal de Sao Carlos; Universidade Federal de Sao Paulo (UNIFESP)	Nahmias, C (corresponding author), INSERM, Inst Cochin, Paris, France.	clara.nahmias@inserm.fr	Luissint, Anny/GNM-8096-2022; Terris, Benoit/P-1497-2017; abdelkarim, mohamed/AAK-5563-2020; Di Benedetto, Melanie MD/C-1512-2018; Casarini, Dulce E/D-4091-2012; dos Reis, Rosana Maria/E-3346-2012; Cagnard, Nicolas/K-2754-2014; Costa-Neto, Claudio/K-7291-2015	abdelkarim, mohamed/0000-0002-0984-6083; Di Benedetto, Melanie MD/0000-0003-1119-3752; dos Reis, Rosana Maria/0000-0001-9631-4167; Cagnard, Nicolas/0000-0002-9051-1896; Reis, Rosana/0000-0002-0465-8331; Nahmias, Clara/0000-0001-6863-370X; Costa-Neto, Claudio/0000-0002-7256-6412; Casarini, Dulce/0000-0003-1912-4292; Morel, Marina/0000-0001-6610-3772	University Paris Descartes; Inserm; Centre National de la Recherche Scientifique; Ligue Contre le Cancer-Comite Ile de France; Association pour la Recherche contre le Cancer (ARC); Fondation RAJA; association Prolific	University Paris Descartes; Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Ligue Contre le Cancer-Comite Ile de France(Ligue nationale contre le cancer); Association pour la Recherche contre le Cancer (ARC)(Fondation ARC pour la Recherche sur le CancerFrench National Research Agency (ANR)); Fondation RAJA; association Prolific	This work was supported by the University Paris Descartes, the Inserm, the Centre National de la Recherche Scientifique, the Ligue Contre le Cancer-Comite Ile de France, the Association pour la Recherche contre le Cancer (ARC), the Fondation RAJA, and the association Prolific. S.R-F was supported by a fellowship from ARC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelkarim M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023334; Alvarez A, 2004, BLOOD, V104, P402, DOI 10.1182/blood-2003-08-2974; Bidard FC, 2008, CANCER METAST REV, V27, P5, DOI 10.1007/s10555-007-9103-x; Bissell MJ, 2011, NAT MED, V17, P320, DOI 10.1038/nm.2328; Bockhorn M, 2007, LANCET ONCOL, V8, P444, DOI 10.1016/S1470-2045(07)70140-7; Carl-McGrath S, 2007, CANCER BIOL THER, V6, P1218; Chae YK, 2011, CANCER INVEST, V29, P585, DOI 10.3109/07357907.2011.616252; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Chen Q, 2011, CANCER CELL, V20, P538, DOI 10.1016/j.ccr.2011.08.025; Deshayes F, 2005, TRENDS ENDOCRIN MET, V16, P293, DOI 10.1016/j.tem.2005.07.009; Eccles SA, 2007, LANCET, V369, P1742, DOI 10.1016/S0140-6736(07)60781-8; Egami K, 2003, J CLIN INVEST, V112, P67, DOI 10.1172/JCI200316645; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Fujita M, 2002, BIOCHEM BIOPH RES CO, V294, P441, DOI 10.1016/S0006-291X(02)00496-5; George AJ, 2010, NAT REV CANCER, V10, P745, DOI 10.1038/nrc2945; Huang W, 2008, DIGEST DIS SCI, V53, P163, DOI 10.1007/s10620-007-9838-9; Hunyady L, 2006, MOL ENDOCRINOL, V20, P953, DOI 10.1210/me.2004-0536; Imai N, 2007, LAB INVEST, V87, P189, DOI 10.1038/labinvest.3700504; Jenkins DE, 2005, BREAST CANCER RES, V7, pR444, DOI 10.1186/bcr1026; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kinoshita J, 2009, INT J ONCOL, V34, P1573, DOI 10.3892/ijo_00000287; Miyajima A, 2002, CANCER RES, V62, P4176; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Naumov GN, 2002, CANCER RES, V62, P2162; Nectoux J, 2011, J MOL MED, V89, P193, DOI 10.1007/s00109-010-0699-x; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Rhodes DR, 2009, P NATL ACAD SCI USA, V106, P10284, DOI 10.1073/pnas.0900351106; Rodrigues-Ferreira S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007239; Schroder C, 2011, J CANCER RES CLIN, V137, P1193, DOI 10.1007/s00432-011-0984-2; Shibue T, 2011, SEMIN CANCER BIOL, V21, P99, DOI 10.1016/j.semcancer.2010.12.003; Sipahi I, 2010, LANCET ONCOL, V11, P627, DOI 10.1016/S1470-2045(10)70106-6; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Tahmasebi M, 2006, BRIT J CANCER, V95, P67, DOI 10.1038/sj.bjc.6603213; Teo KK, 2011, J HYPERTENS, V29, P623, DOI 10.1097/HJH.0b013e328344a7de; Weksler BB, 2005, FASEB J, V19, P1872, DOI 10.1096/fj.04-3458fje; Witz IP, 2008, ADV CANCER RES, V100, P203, DOI 10.1016/S0065-230X(08)00007-9; Yoon C, 2011, CAN MED ASSOC J, V183, pE1073, DOI 10.1503/cmaj.101497	38	76	81	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35667	10.1371/journal.pone.0035667	http://dx.doi.org/10.1371/journal.pone.0035667			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536420	Green Published, gold, Green Submitted			2022-12-27	WOS:000305339200092
J	Tseng, CT; Sbrana, E; Iwata-Yoshikawa, N; Newman, PC; Garron, T; Atmar, RL; Peters, CJ; Couch, RB				Tseng, Chien-Te; Sbrana, Elena; Iwata-Yoshikawa, Naoko; Newman, Patrick C.; Garron, Tania; Atmar, Robert L.; Peters, Clarence J.; Couch, Robert B.			Immunization with SARS Coronavirus Vaccines Leads to Pulmonary Immunopathology on Challenge with the SARS Virus	PLOS ONE			English	Article							ACUTE-RESPIRATORY-SYNDROME; IMMUNE-RESPONSES; NEUTRALIZING ANTIBODY; S-GLYCOPROTEIN; PROTECT MICE; COV; INFECTION; PARTICLES; EFFICACY; IMMUNOGENICITY	Background: Severe acute respiratory syndrome (SARS) emerged in China in 2002 and spread to other countries before brought under control. Because of a concern for reemergence or a deliberate release of the SARS coronavirus, vaccine development was initiated. Evaluations of an inactivated whole virus vaccine in ferrets and nonhuman primates and a virus-like-particle vaccine in mice induced protection against infection but challenged animals exhibited an immunopathologictype lung disease. Design: Four candidate vaccines for humans with or without alum adjuvant were evaluated in a mouse model of SARS, a VLP vaccine, the vaccine given to ferrets and NHP, another whole virus vaccine and an rDNA-produced S protein. Balb/c or C57BL/6 mice were vaccinated IM on day 0 and 28 and sacrificed for serum antibody measurements or challenged with live virus on day 56. On day 58, challenged mice were sacrificed and lungs obtained for virus and histopathology. Results: All vaccines induced serum neutralizing antibody with increasing dosages and/or alum significantly increasing responses. Significant reductions of SARS-CoV two days after challenge was seen for all vaccines and prior live SARS-CoV. All mice exhibited histopathologic changes in lungs two days after challenge including all animals vaccinated (Balb/C and C57BL/6) or given live virus, influenza vaccine, or PBS suggesting infection occurred in all. Histopathology seen in animals given one of the SARS-CoV vaccines was uniformly a Th2-type immunopathology with prominent eosinophil infiltration, confirmed with special eosinophil stains. The pathologic changes seen in all control groups lacked the eosinophil prominence. Conclusions: These SARS-CoV vaccines all induced antibody and protection against infection with SARS-CoV. However, challenge of mice given any of the vaccines led to occurrence of Th2-type immunopathology suggesting hypersensitivity to SARS-CoV components was induced. Caution in proceeding to application of a SARS-CoV vaccine in humans is indicated.	[Atmar, Robert L.; Couch, Robert B.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Tseng, Chien-Te; Iwata-Yoshikawa, Naoko; Peters, Clarence J.] Univ Texas Med Branch, Ctr Biodef & Emerging Dis, Galveston, TX USA; [Tseng, Chien-Te; Sbrana, Elena; Iwata-Yoshikawa, Naoko; Newman, Patrick C.; Garron, Tania; Peters, Clarence J.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX USA; [Atmar, Robert L.; Couch, Robert B.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA	Baylor College of Medicine; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Baylor College of Medicine	Couch, RB (corresponding author), Baylor Coll Med, Dept Med, Houston, TX 77030 USA.	rcouch@bcm.edu	Atmar, Robert/AFQ-5392-2022	Atmar, Robert/0000-0001-9989-6772	Public Health Service from the National Institute of Allergy and Infectious Diseases [NO1 AI 30039]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI030039] Funding Source: NIH RePORTER	Public Health Service from the National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research performed by the authors and summarized in this report was supported by Public Health Service Contract NO1 AI 30039 from the National Institute of Allergy and Infectious Diseases. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, UPD INT US CAS DEF S; Bolles M, 2011, J VIROL, V85, P12201, DOI 10.1128/JVI.06048-11; Castilow EM, 2007, IMMUNOL RES, V39, P225, DOI 10.1007/s12026-007-0071-6; Collins PL, 2008, J VIROL, V82, P2040, DOI 10.1128/JVI.01625-07; Deming D, 2006, PLOS MED, V3, P2359, DOI 10.1371/journal.pmed.0030525; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; Du LY, 2010, VIRAL IMMUNOL, V23, P211, DOI 10.1089/vim.2009.0090; Enjuanes L, 2008, VIRUS RES, V133, P45, DOI 10.1016/j.virusres.2007.01.021; Fowler RA, 2003, JAMA-J AM MED ASSOC, V290, P367, DOI 10.1001/jama.290.3.367; Garcon N, 2007, EXPERT REV VACCINES, V6, P723, DOI 10.1586/14760584.6.5.723; Gorham JD, 1996, P NATL ACAD SCI USA, V93, P12467, DOI 10.1073/pnas.93.22.12467; Haagmans BL, 2005, 10 INT NID S COL SPR; HSIEH CS, 1995, J EXP MED, V181, P713, DOI 10.1084/jem.181.2.713; Jordan MB, 2004, SCIENCE, V304, P1808, DOI 10.1126/science.1089926; KAPIKIAN AZ, 1969, AM J EPIDEMIOL, V89, P405, DOI 10.1093/oxfordjournals.aje.a120954; KIM HW, 1969, AM J EPIDEMIOL, V89, P422, DOI 10.1093/oxfordjournals.aje.a120955; Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781; Kusters IC, 2009, VACCINES FOR BIODEFENSE AND EMERGING AND NEGLECTED DISEASES, P147, DOI 10.1016/B978-0-12-369408-9.00011-1; Lamirande EW, 2008, J VIROL, V82, P7721, DOI 10.1128/JVI.00304-08; Launois P, 1997, IMMUNITY, V6, P541, DOI 10.1016/S1074-7613(00)80342-8; Lee N, 2003, NEW ENGL J MED, V348, P1986, DOI 10.1056/NEJMoa030685; Li WD, 2005, SCIENCE, V310, P676, DOI 10.1126/science.1118391; Lin JT, 2007, ANTIVIR THER, V12, P1107; Liu YV, 2011, VACCINE, V29, P6606, DOI 10.1016/j.vaccine.2011.06.111; Lokugamage KG, 2008, VACCINE, V26, P797, DOI 10.1016/j.vaccine.2007.11.092; Lu BJ, 2010, IMMUNOLOGY, V130, P254, DOI 10.1111/j.1365-2567.2010.03231.x; Martin JE, 2008, VACCINE, V26, P6338, DOI 10.1016/j.vaccine.2008.09.026; Peiris JSM, 2003, NEW ENGL J MED, V349, P2431, DOI 10.1056/NEJMra032498; Perlman S, 2005, NAT REV IMMUNOL, V5, P917, DOI 10.1038/nri1732; Polack FP, 2002, J EXP MED, V196, P859, DOI 10.1084/jem.20020781; Poutanen SM, 2003, NEW ENGL J MED, V348, P1995, DOI 10.1056/NEJMoa030634; Power UF, 2001, J VIROL, V75, P12421, DOI 10.1128/JVI.75.24.12421-12430.2001; Protheroe C, 2009, CLIN GASTROENTEROL H, V7, P749, DOI 10.1016/j.cgh.2009.03.022; Roberts A, 2010, VIRAL IMMUNOL, V23, P509, DOI 10.1089/vim.2010.0028; See RH, 2008, J GEN VIROL, V89, P2136, DOI 10.1099/vir.0.2008/001891-0; See RH, 2006, J GEN VIROL, V87, P641, DOI 10.1099/vir.0.81579-0; Spruth M, 2006, VACCINE, V24, P652, DOI 10.1016/j.vaccine.2005.08.055; Subbarao K, 2004, J VIROL, V78, P3572, DOI 10.1128/JVI.78.7.3572-3577.2004; Tsang KW, 2003, NEW ENGL J MED, V348, P1977, DOI 10.1056/NEJMoa030666; Tseng CTK, 2007, J VIROL, V81, P1162, DOI 10.1128/JVI.01702-06; Waris ME, 1996, J VIROL, V70, P2852, DOI 10.1128/JVI.70.5.2852-2860.1996; WEISS RC, 1981, COMP IMMUNOL MICROB, V4, P175, DOI 10.1016/0147-9571(81)90003-5; Wentworth DE, 2004, EMERG INFECT DIS, V10, P1293, DOI 10.3201/eid1007.031119; World Health Organization, 2003, CAS DEF SURV SEV AC; Yasui F, 2008, J IMMUNOL, V181, P6337, DOI 10.4049/jimmunol.181.9.6337; Yoshikawa N, 2009, J VIROL, V83, P5451, DOI 10.1128/JVI.02272-08; Zhou ZM, 2006, VACCINE, V24, P3624, DOI 10.1016/j.vaccine.2006.01.059	47	331	350	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35421	10.1371/journal.pone.0035421	http://dx.doi.org/10.1371/journal.pone.0035421			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536382	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339200063
J	Vilotti, S; Codrich, M; Dal Ferro, M; Pinto, M; Ferrer, I; Collavin, L; Gustincich, S; Zucchelli, S				Vilotti, Sandra; Codrich, Marta; Dal Ferro, Marco; Pinto, Milena; Ferrer, Isidro; Collavin, Licio; Gustincich, Stefano; Zucchelli, Silvia			Parkinson's Disease DJ-1 L166P Alters rRNA Biogenesis by Exclusion of TTRAP from the Nucleolus and Sequestration into Cytoplasmic Aggregates via TRAF6	PLOS ONE			English	Article							MITOCHONDRIAL-FUNCTION; DOPAMINERGIC-NEURONS; OXIDATIVE DAMAGE; ALPHA-SYNUCLEIN; LEWY BODIES; DYSFUNCTION; PROTEASOME; UBIQUITIN; PROTEIN; STRESS	Mutations in PARK7/DJ-1 gene are associated to autosomal recessive early onset forms of Parkinson's disease (PD). Although large gene deletions have been linked to a loss-of-function phenotype, the pathogenic mechanism of missense mutations is less clear. The L166P mutation causes misfolding of DJ-1 protein and its degradation. L166P protein may also accumulate into insoluble cytoplasmic aggregates with a mechanism facilitated by the E3 ligase TNF receptor associated factor 6 (TRAF6). Upon proteasome impairment L166P activates the JNK/p38 MAPK apoptotic pathway by its interaction with TRAF and TNF Receptor Associated Protein (TTRAP). When proteasome activity is blocked in the presence of wild-type DJ-1, TTRAP forms aggregates that are localized to the cytoplasm or associated to nucleolar cavities, where it is required for a correct rRNA biogenesis. In this study we show that in post-mortem brains of sporadic PD patients TTRAP is associated to the nucleolus and to Lewy Bodies, cytoplasmic aggregates considered the hallmark of the disease. In SH-SY5Y neuroblastoma cells, misfolded mutant DJ-1 L166P alters rRNA biogenesis inhibiting TTRAP localization to the nucleolus and enhancing its recruitment into cytoplasmic aggregates with a mechanism that depends in part on TRAF6 activity. This work suggests that TTRAP plays a role in the molecular mechanisms of both sporadic and familial PD. Furthermore, it unveils the existence of an interplay between cytoplasmic and nucleolar aggregates that impacts rRNA biogenesis and involves TRAF6.	[Vilotti, Sandra; Codrich, Marta; Pinto, Milena; Gustincich, Stefano; Zucchelli, Silvia] SISSA, Neurobiol Sect, I-34014 Trieste, Italy; [Dal Ferro, Marco; Collavin, Licio] Lab Nazl Consorzio Interuniv Biotecnol, Trieste, Italy; [Dal Ferro, Marco; Collavin, Licio] Univ Trieste, Dept Life Sci DSV, Trieste, Italy; [Ferrer, Isidro; Gustincich, Stefano; Zucchelli, Silvia] Univ Barcellona, Univ Hosp Bellvitge, Inst Neuropathol, Inst Invest Biomed Bellvitge, Llbregat, Spain; [Ferrer, Isidro; Gustincich, Stefano; Zucchelli, Silvia] Italian Inst Technol, SISSA Unit, Trieste, Italy	International School for Advanced Studies (SISSA); University of Trieste; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; International School for Advanced Studies (SISSA); Istituto Italiano di Tecnologia - IIT	Gustincich, S (corresponding author), SISSA, Neurobiol Sect, I-34014 Trieste, Italy.	gustinci@sissa.it; silvia.zucchelli@sissa.it	Pinto, Milena/K-6095-2017; Collavin, Licio/A-5312-2010; Codrich, Marta/AAC-7724-2022	Pinto, Milena/0000-0001-9202-1527; Collavin, Licio/0000-0001-6815-5381; Zucchelli, Silvia/0000-0003-4556-2990; Gustincich, Stefano/0000-0002-2749-2514	Telethon [GGP06268]; Giovanni Armenise-Harvard Foundation; Italian Institute of Technology	Telethon(Fondazione Telethon); Giovanni Armenise-Harvard Foundation; Italian Institute of Technology(Istituto Italiano di Tecnologia - IIT)	The following fundings have supported this work: Telethon Grant GGP06268; The Giovanni Armenise-Harvard Foundation; and the Italian Institute of Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres-Mateos E, 2007, P NATL ACAD SCI USA, V104, P14807, DOI 10.1073/pnas.0703219104; Betarbet R, 2005, EXP NEUROL, V191, pS17, DOI 10.1016/j.expneurol.2004.08.021; Blaise R, 2001, LEUKEMIA LYMPHOMA, V42, P1173, DOI 10.3109/10428190109097742; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Carnemolla A, 2009, J BIOL CHEM, V284, P18167, DOI 10.1074/jbc.M109.018325; Cattaneo E, 2001, TRENDS NEUROSCI, V24, P182, DOI 10.1016/S0166-2236(00)01721-5; Caudle WM, 2009, NEUROSCI LETT, V459, P11, DOI 10.1016/j.neulet.2009.04.060; Dez C, 2006, EMBO J, V25, P1534, DOI 10.1038/sj.emboj.7601035; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Ding QX, 2005, J NEUROSCI, V25, P9171, DOI 10.1523/JNEUROSCI.3040-05.2005; Foti R, 2010, J BIOL CHEM, V285, P18565, DOI 10.1074/jbc.M109.088294; Hao LY, 2010, P NATL ACAD SCI USA, V107, P9747, DOI 10.1073/pnas.0911175107; Henras AK, 2008, CELL MOL LIFE SCI, V65, P2334, DOI 10.1007/s00018-008-8027-0; Herrera FE, 2007, J BIOL CHEM, V282, P24905, DOI 10.1074/jbc.M701013200; Kim RH, 2005, P NATL ACAD SCI USA, V102, P5215, DOI 10.1073/pnas.0501282102; Kruger T, 2010, J CELL SCI, V123, P1203, DOI 10.1242/jcs.062398; LaRiviere FJ, 2006, MOL CELL, V24, P619, DOI 10.1016/j.molcel.2006.10.008; Latonen L, 2011, ONCOGENE; Ledesma FC, 2009, NATURE, V461, P674, DOI 10.1038/nature08444; Lesage S, 2009, HUM MOL GENET, V18, pR48, DOI 10.1093/hmg/ddp012; Macedo MG, 2003, HUM MOL GENET, V12, P2807, DOI 10.1093/hmg/ddg304; McNaught KS, 2003, EXP NEUROL, V179, P38, DOI 10.1006/exnr.2002.8050; Murayama A, 2008, CELL, V133, P627, DOI 10.1016/j.cell.2008.03.030; Narla A, 2010, BLOOD, V115, P3196, DOI 10.1182/blood-2009-10-178129; Navarro A, 2009, FREE RADICAL BIO MED, V46, P1574, DOI 10.1016/j.freeradbiomed.2009.03.007; Olzmann JA, 2007, J CELL BIOL, V178, P1025, DOI 10.1083/jcb.200611128; Parlato R, 2008, J NEUROSCI, V28, P12759, DOI 10.1523/JNEUROSCI.2439-08.2008; Pei HP, 2003, ONCOGENE, V22, P2699, DOI 10.1038/sj.onc.1206374; Petrucelli L, 2002, NEURON, V36, P1007, DOI 10.1016/S0896-6273(02)01125-X; Pype S, 2000, J BIOL CHEM, V275, P18586, DOI 10.1074/jbc.M000531200; Rideout HJ, 2005, J NEUROCHEM, V93, P1304, DOI 10.1111/j.1471-4159.2005.03124.x; Rieker C, 2011, J NEUROSCI, V31, P453, DOI 10.1523/JNEUROSCI.0590-10.2011; Sau D, 2007, HUM MOL GENET, V16, P1604, DOI 10.1093/hmg/ddm110; Schmid M, 2008, TRENDS BIOCHEM SCI, V33, P501, DOI 10.1016/j.tibs.2008.07.003; Schmitz KM, 2010, GENE DEV, V24, P2264, DOI 10.1101/gad.590910; Schultheiss U, 2001, EMBO J, V20, P5678, DOI 10.1093/emboj/20.20.5678; Stavreva DA, 2006, MOL CELL BIOL, V26, P5131, DOI 10.1128/MCB.02227-05; Thomas KJ, 2011, HUM MOL GENET, V20, P40, DOI 10.1093/hmg/ddq430; Vasseur S, 2009, P NATL ACAD SCI USA, V106, P1111, DOI 10.1073/pnas.0812745106; Vilotti S, 2011, CELL DEATH DIFFER; Wang C, 2005, HUM MOL GENET, V14, P3885, DOI 10.1093/hmg/ddi413; Zucchelli S, 2009, CELL DEATH DIFFER, V16, P428, DOI 10.1038/cdd.2008.169; Zucchelli S, 2011, J BIOL CHEM; Zucchelli S, 2010, HUM MOL GENET, V19, P3759, DOI 10.1093/hmg/ddq290	44	42	45	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35051	10.1371/journal.pone.0035051	http://dx.doi.org/10.1371/journal.pone.0035051			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22532838	Green Published, gold, Green Submitted			2022-12-27	WOS:000305339200034
J	Chen, J; Lippincott-Schwartz, J; Liu, J				Chen, Jing; Lippincott-Schwartz, Jennifer; Liu, Jian			Intracellular Spatial Localization Regulated by the Microtubule Network	PLOS ONE			English	Article							DROSOPHILA NEUROBLASTS; CELL-DIVISION; CYTOPLASMIC DYNEIN; CORTICAL POLARITY; SPINDLE POLES; MESSENGER-RNA; LIVING CELLS; PROTEIN; DORSAL; EMBRYOS	The commonly recognized mechanisms for spatial regulation inside the cell are membrane-bounded compartmentalization and biochemical association with subcellular organelles. We use computational modeling to investigate another spatial regulation mechanism mediated by the microtubule network in the cell. Our results demonstrate that the mitotic spindle can impose strong sequestration and concentration effects on molecules with binding affinity for microtubules, especially dynein-directed cargoes. The model can recapitulate the essence of three experimental observations on distinct microtubule network morphologies: the sequestration of germ plasm components by the mitotic spindles in the Drosophila syncytial embryo, the asymmetric cell division initiated by the time delay in centrosome maturation in the Drosophila neuroblast, and the diffusional block between neighboring energids in the Drosophila syncytial embryo. Our model thus suggests that the cell cycle-dependent changes in the microtubule network are critical for achieving different spatial regulation effects. The microtubule network provides a spatially extensive docking platform for molecules and gives rise to a "structured cytoplasm", in contrast to a free and fluid environment.	[Chen, Jing; Liu, Jian] NHLBI, NIH, Bethesda, MD 20892 USA; [Lippincott-Schwartz, Jennifer] NICHHD, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Chen, J (corresponding author), NHLBI, NIH, Bldg 10, Bethesda, MD 20892 USA.	Jian.Liu@nih.gov	Chen, Jing/D-4845-2016	Chen, Jing/0000-0001-6321-0505; Liu, Jian/0000-0003-2935-0349	National Heart, Lung and Blood Institute at National Institutes of Health (NIH); National Institute of Child Health and Human Development at NIH; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001609] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006086] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute at National Institutes of Health (NIH); National Institute of Child Health and Human Development at NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Dr. Chen and Dr. Liu were supported by the Intramural Research Program of National Heart, Lung and Blood Institute at National Institutes of Health (NIH); Dr. Lippincott-Schwartz was supported by the Intramural Research Program of National Institute of Child Health and Human Development at NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B, 2008, MOL BIOL CELL; Becalska AN, 2009, DEVELOPMENT, V136, P2493, DOI 10.1242/dev.032391; Boucrot E, 2007, P NATL ACAD SCI USA, V104, P7939, DOI 10.1073/pnas.0702511104; DeLotto R, 2007, DEVELOPMENT, V134, P4233, DOI 10.1242/dev.010934; Dunster K, 2002, EUR J CELL BIOL, V81, P117, DOI 10.1078/0171-9335-00232; FERRANDON D, 1994, CELL, V79, P1221, DOI 10.1016/0092-8674(94)90013-2; FOE VE, 1983, J CELL SCI, V61, P31; Frescas D, 2006, J CELL BIOL, V173, P219, DOI 10.1083/jcb.200601156; GILLESPIE SKH, 1994, MOL CELL BIOL, V14, P3559, DOI 10.1128/MCB.14.6.3559; Howell BJ, 2000, J CELL BIOL, V150, P1233, DOI 10.1083/jcb.150.6.1233; Howell BJ, 2001, J CELL BIOL, V155, P1159, DOI 10.1083/jcb.200105093; Januschke J, 2010, J CELL BIOL, V188, P693, DOI 10.1083/jcb.200905024; KARR TL, 1986, J CELL BIOL, V102, P1494, DOI 10.1083/jcb.102.4.1494; King SJ, 2000, NAT CELL BIOL, V2, P20, DOI 10.1038/71338; Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007; Kozlowski C, 2007, CELL, V129, P499, DOI 10.1016/j.cell.2007.03.027; Lerit DA, 2011, CURR BIOL, V21, P439, DOI 10.1016/j.cub.2011.01.073; Lippincott-Schwartz J, 2001, NAT REV MOL CELL BIO, V2, P444, DOI 10.1038/35073068; Mavrakis M, 2009, DEV CELL, V16, P93, DOI 10.1016/j.devcel.2008.11.003; Miller JR, 1999, J CELL BIOL, V146, P427, DOI 10.1083/jcb.146.2.427; Montagnac G, 2008, CURR OPIN CELL BIOL, V20, P454, DOI 10.1016/j.ceb.2008.03.011; Nipper RW, 2007, P NATL ACAD SCI USA, V104, P14306, DOI 10.1073/pnas.0701812104; Odell GM, 2008, J CELL BIOL, V183, P471, DOI 10.1083/jcb.200807129; PRENDERGAST FG, 1978, BIOCHEMISTRY-US, V17, P3448, DOI 10.1021/bi00610a004; Ross JL, 2006, NAT CELL BIOL, V8, P562, DOI 10.1038/ncb1421; Rowning BA, 1997, P NATL ACAD SCI USA, V94, P1224, DOI 10.1073/pnas.94.4.1224; Rusan NM, 2007, J CELL BIOL, V177, P13, DOI 10.1083/jcb.200612140; Siegrist SE, 2005, CELL, V123, P1323, DOI 10.1016/j.cell.2005.09.043; St Johnston D, 2005, NAT REV MOL CELL BIO, V6, P363, DOI 10.1038/nrm1643; Wang ZH, 1999, CELL STRUCT FUNCT, V24, P373, DOI 10.1247/csf.24.373; Yang G, 2008, J CELL BIOL, V182, P631, DOI 10.1083/jcb.200801105; Zheng YX, 2010, NAT REV MOL CELL BIO, V11, P529, DOI 10.1038/nrm2919	32	10	10	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e34919	10.1371/journal.pone.0034919	http://dx.doi.org/10.1371/journal.pone.0034919			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22532834	Green Submitted, gold, Green Published			2022-12-27	WOS:000305336200013
J	Dusingize, JC; Hoover, DR; Shi, QH; Mutimura, E; Kiefer, E; Cohen, M; Anastos, K				Dusingize, Jean-Claude; Hoover, Donald R.; Shi, Qiuhu; Mutimura, Eugene; Kiefer, Elizabeth; Cohen, Mardge; Anastos, Kathryn			Association of Serum Albumin with Markers of Nutritional Status among HIV-Infected and Uninfected Rwandan Women	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS-INFECTION; BIOELECTRICAL-IMPEDANCE ANALYSIS; PROTEIN-ENERGY MALNUTRITION; BODY CELL MASS; FAT-FREE MASS; PULMONARY TUBERCULOSIS; DISEASE PROGRESSION; OLDER PERSONS; MORTALITY; SEVERITY	Introduction: The objectives of this study are to address if and how albumin can be used as an indication of malnutrition in HIV infected and uninfected Africans. Methods: In 2005, 710 HIV-infected and 226 HIV-uninfected women enrolled in a cohort study. Clinical/demographic parameters, CD4 count, albumin, liver transaminases; anthropometric measurements and Bioelectrical Impedance Analysis (BIA) were performed. Malnutrition outcomes were defined as body mass index (BMI), Fat-free mass index (FFMI) and Fat mass index (FMI). Separate linear predictive models including albumin were fit to these outcomes in HIV negative and HIV positive women by CD4 strata (CD4>350,200-350 and,200 cells/mu l). Results: In unadjusted models for each outcome in HIV-negative and HIV positive women with CD4>350 cells/mu l, serum albumin was not significantly associated with BMI, FFMI or FMI. Albumin was significantly associated with all three outcomes (p<0.05) in HIV+ women with CD4 200-350 cells/mu l, and highly significant in HIV+ women with CD4<200 cells/mu l (P<0.001). In multivariable linear regression, albumin remained associated with FFMI in women with CD4 count<200 cells/mu l (p<0.01) but not in HIV+ women with CD4>200. Discussion: While serum albumin is widely used to indicate nutritional status it did not consistently predict malnutrition outcomes in HIV- women or HIV+ women with higher CD4. This result suggests that albumin may measure end stage disease as well as malnutrition and should not be used as a proxy for nutritional status without further study of its association with validated measures.	[Dusingize, Jean-Claude; Kiefer, Elizabeth; Anastos, Kathryn] Albert Einstein Coll Med, Bronx, NY 10467 USA; [Hoover, Donald R.] Rutgers State Univ, Dept Stat & Biostat, Piscataway, NJ USA; [Hoover, Donald R.] Rutgers State Univ, Inst Hlth Hlth Care Policy & Aging Res, Piscataway, NJ USA; [Shi, Qiuhu] New York Med Coll, Valhalla, NY 10595 USA; [Mutimura, Eugene] Womens Equity Access Care & Treatment WE ACTx, Kigali, Rwanda; [Mutimura, Eugene] Kigali Hlth Inst, Kigali, Rwanda; [Cohen, Mardge] Rush Univ, Chicago, IL 60612 USA; [Cohen, Mardge] Stroger Cook Cty Hosp, Chicago, IL USA	Yeshiva University; Albert Einstein College of Medicine; Rutgers State University New Brunswick; Rutgers State University New Brunswick; New York Medical College; Rush University; John H Stroger Junior Hospital Cook County	Dusingize, JC (corresponding author), Albert Einstein Coll Med, Bronx, NY 10467 USA.	dusingize@gmail.com		Dusingize, Jean Claude/0000-0001-5721-100X	National Institute of Allergy and Infectious Diseases [UO1-AI-35004]; Fogarty International Center, United States National Institutes of Health [D43-TW001403]; Center for AIDS Research of the Albert Einstein College of Medicine; Montefiore Medical Center; National Institutes of Health (NIH) [AI-51519]; National Institute of Diabetes and Digestive and Kidney Disease [DK54615]; Chicago WIHS [U01-AI-34993]; CTSA Grant [UL1 RR025750]; FOGARTY INTERNATIONAL CENTER [D43TW001403] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [D43CA153793] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025750] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI035004, P30AI051519, U01AI034993, U01AI096299] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054615] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Fogarty International Center, United States National Institutes of Health; Center for AIDS Research of the Albert Einstein College of Medicine; Montefiore Medical Center; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Chicago WIHS; CTSA Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by supplements from the National Institute of Allergy and Infectious Diseases to the Bronx/Manhattan Women's Interagency HIV Study (WIHS), which is funded by the National Institute of Allergy and Infectious Diseases (UO1-AI-35004). This work was also supported by the AIDS International Training and Research Program (Fogarty International Center, United States National Institutes of Health D43-TW001403) and the Center for AIDS Research of the Albert Einstein College of Medicine and Montefiore Medical Center funded by the National Institutes of Health (NIH AI-51519) and by the National Institute of Diabetes and Digestive and Kidney Disease (DK54615), and the Chicago WIHS (U01-AI-34993). This study was also supported in part by the CTSA Grant UL1 RR025750, a component of the National Institutes of Health (NIH), and NIH roadmap for Medical Research. Its contents are solely the responsibility of the authors and do not necessarily represent the official view of the NCRR or NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, Stud Fam Plann, V39, P147; Beck FK, 2002, AM FAM PHYSICIAN, V65, P1575; Brown Todd T, 2009, AIDS Res Ther, V6, P8, DOI 10.1186/1742-6405-6-8; Bukusuba J, 2007, BRIT J NUTR, V98, P211, DOI 10.1017/S0007114507691806; CEDERHOLM T, 1995, AM J MED, V98, P67, DOI 10.1016/S0002-9343(99)80082-5; Covinsky KE, 2002, J AM GERIATR SOC, V50, P631, DOI 10.1046/j.1532-5415.2002.50156.x; DOWEIKO JP, 1991, JPEN-PARENTER ENTER, V15, P476, DOI 10.1177/0148607191015004476; Eveleth PB, 1996, AM J HUM BIOL, V8, P786, DOI 10.1002/(SICI)1520-6300(1996)8:6<786::AID-AJHB11>3.0.CO;2-I; Feldman JG, 2000, AIDS, V14, P863, DOI 10.1097/00002030-200005050-00013; Goldwasser P, 1997, J CLIN EPIDEMIOL, V50, P693, DOI 10.1016/S0895-4356(97)00015-2; Graham SM, 2007, AIDS RES HUM RETROV, V23, P1197, DOI 10.1089/aid.2007.0065; Hattori K, 1997, AM J HUM BIOL, V9, P573, DOI 10.1002/(SICI)1520-6300(1997)9:5<573::AID-AJHB5>3.0.CO;2-V; Kotler D, 2004, JAIDS-J ACQ IMM DEF, V37, pS280, DOI 10.1097/01.qai.0000144383.55091.c1; Kotler Donald P., 1996, American Journal of Clinical Nutrition, V64, p489S, DOI 10.1093/ajcn/64.3.489S; Kresge KJ, 2006, IAVI REP, V10, P16; Kyle UG, 2004, CLIN NUTR, V23, P1430, DOI 10.1016/j.clnu.2004.09.012; Kyle UG, 2003, CURR OPIN CLIN NUTR, V6, P387, DOI 10.1097/01.mco.0000078988.18774.3d; Kyle UG, 2002, CURR OPIN CLIN NUTR, V5, P427, DOI 10.1097/00075197-200207000-00012; Larmarange J, 2009, MED SCI PARIS, P87; MACALLAN DC, 1995, NEW ENGL J MED, V333, P83, DOI 10.1056/NEJM199507133330202; Mupere E, 2010, ANN EPIDEMIOL, V20, P210, DOI 10.1016/j.annepidem.2009.11.001; Omran ML, 2000, NUTRITION, V16, P50, DOI 10.1016/S0899-9007(99)00224-5; Papathakis PC, 2006, JAIDS-J ACQ IMM DEF, V43, P467, DOI 10.1097/01.qai.0000243094.42276.92; PHILLIPS A, 1989, LANCET, V2, P1434; Powanda MC, 2003, J NUTR, V133, p322S, DOI 10.1093/jn/133.1.322S; REUBEN DB, 1995, J AM GERIATR SOC, V43, P415, DOI 10.1111/j.1532-5415.1995.tb05818.x; Roubenoff Ronenn, 1996, American Journal of Clinical Nutrition, V64, p459S, DOI 10.1093/ajcn/64.3.459S; Sabin CA, 2002, LANCET, V360, P1546, DOI 10.1016/S0140-6736(02)11519-4; Semba RD, 1999, BRIT J NUTR, V81, P181, DOI 10.1017/S0007114599000379; Shah S, 2001, J NUTR, V131, P2843, DOI 10.1093/jn/131.11.2843; Tang AM, 2002, JAIDS-J ACQ IMM DEF, V31, P230, DOI 10.1097/00126334-200210010-00014; Van Lettow M, 2004, INT J TUBERC LUNG D, V8, P211; VANITALLIE TB, 1990, AM J CLIN NUTR, V52, P953, DOI 10.1093/ajcn/52.6.953	33	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e35079	10.1371/journal.pone.0035079	http://dx.doi.org/10.1371/journal.pone.0035079			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22532840	gold, Green Published, Green Submitted			2022-12-27	WOS:000305336200022
J	Wang, W; Lycett, SJ; von Cramon-Taubadel, N; Jin, JJH; Bae, CJ				Wang, Wei; Lycett, Stephen J.; von Cramon-Taubadel, Noreen; Jin, Jennie J. H.; Bae, Christopher J.			Comparison of Handaxes from Bose Basin (China) and the Western Acheulean Indicates Convergence of Form, Not Cognitive Differences	PLOS ONE			English	Article							MORPHOMETRIC-ANALYSIS; HOMININ DISPERSALS; FOSSIL RECORD; STONE TOOLS; QUESTIONS; EAST; ASIA	Alleged differences between Palaeolithic assemblages from eastern Asia and the west have been the focus of controversial discussion for over half a century, most famously in terms of the so-called 'Movius Line'. Recent discussion has centered on issues of comparability between handaxes from eastern Asian and 'Acheulean' examples from western portions of the Old World. Here, we present a multivariate morphometric analysis in order to more fully document how Mid-Pleistocene (i.e.,803 Kyr) handaxes from Bose Basin, China compare to examples from the west, as well as with additional (Mode 1) cores from across the Old World. Results show that handaxes from both the western Old World and Bose are significantly different from the Mode 1 cores, suggesting a gross comparability with regard to functionally-related form. Results also demonstrate overlap between the ranges of shape variation in Acheulean handaxes and those from Bose, demonstrating that neither raw material nor cognitive factors were an absolute impediment to Bose hominins in making comparable handaxe forms to their hominin kin west of the Movius Line. However, the shapes of western handaxes are different from the Bose examples to a statistically significant degree. Moreover, the handaxe assemblages from the western Old World are all more similar to each other than any individual assemblage is to the Bose handaxes. Variation in handaxe form is also comparatively high for the Bose material, consistent with suggestions that they represent an emergent, convergent instance of handaxe technology authored by Pleistocene hominins with cognitive capacities directly comparable to those of 'Acheulean' hominins.	[Wang, Wei] Guangxi Museum Nationalities, Nanning, Peoples R China; [Lycett, Stephen J.; von Cramon-Taubadel, Noreen] Univ Kent, Dept Anthropol, Sch Anthropol & Conservat, Canterbury, Kent, England; [Jin, Jennie J. H.] Cent Identificat Lab JPAC CIL, Joint POW MIA Accounting Command, Hickam AFB, HI USA; [Jin, Jennie J. H.; Bae, Christopher J.] Univ Hawaii Manoa, Dept Anthropol, Honolulu, HI 96822 USA	University of Kent; United States Department of Defense; United States Air Force; University of Hawaii System; University of Hawaii Manoa	Wang, W (corresponding author), Guangxi Museum Nationalities, Nanning, Peoples R China.	S.J.Lycett@kent.ac.uk		Wang, Wei/0000-0002-5118-7093	National Natural Science Foundation of China [40772011]; Natural Science Foundation of Guangxi [0991236]; Wenner-Gren Foundation (ICRG) [82]; National Geographic Society [8372-07]; British Academy [SG-52210]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangxi(National Natural Science Foundation of Guangxi Province); Wenner-Gren Foundation (ICRG); National Geographic Society(National Geographic Society); British Academy	This study has been supported financially by the National Natural Science Foundation of China grant 40772011, Natural Science Foundation of Guangxi grant 0991236, the Wenner-Gren Foundation (ICRG #82), the National Geographic Society (#8372-07), and the British Academy (SG-52210). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrose SH, 2001, SCIENCE, V291, P1748, DOI 10.1126/science.1059487; Bae CJ, 2010, YEARB PHYS ANTHROPOL, V53, P75; Bae K. D., 1994, PALEOLITHIC CULTURE, P193; Bar-Yosef O, QUAT INT IN PRESS; Bello SM, 2009, J ARCHAEOL SCI, V36, P1869, DOI 10.1016/j.jas.2009.04.014; Chapman R.E., 1990, P MICHIGAN MORPHOMET, P251; Clark G., 1969, WORLD PREHISTORY NEW, DOI DOI 10.1016/j.jhevol.2018.01.003; Clark J.D., 2001, KALAMBO FALLS PREHIS, pCambridg; Clark J. D., 1994, INTEGRATIVE PATHS PA, P451; Coon CS, 1965, LIVING RACES MAN; Corvinus G, 2004, QUATERN INT, V117, P141, DOI 10.1016/S1040-6182(03)00124-1; Dennell RW, 2009, PALAEOLITHIC SETTLEM; Dominguez-Rodrigo M, 2001, J HUM EVOL, V40, P289, DOI 10.1006/jhev.2000.0466; Dryden IL, 1998, STAT SHAPE ANAL, DOI DOI 10.5555/1046920.1088707; Faisal A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013718; Goodman ME, 1944, AM ANTIQUITY, V9, P415, DOI 10.2307/275093; GOWER JC, 1975, PSYCHOMETRIKA, V40, P33, DOI 10.1007/BF02291478; Gowlett J.A.J., 2006, AXE AGE ACHEULIAN TO, P203; Gowlett JAJ, 2011, CASTING NET WIDE PAP, P93; Hou YM, 2000, SCIENCE, V287, P1622, DOI 10.1126/science.287.5458.1622; Huang S, 2012, QUAT INT IN PRESS; Huang W. W., 1989, HUMAN EVOLUTION, V4, P87, DOI DOI 10.1016/J.QUAINT.2011.10.013; Isaac GL, 1977, OLORGESAILIE ARCHAEO; JONES PR, 1980, WORLD ARCHAEOL, V12, P153, DOI 10.1080/00438243.1980.9979789; JONES PR, 1981, PHILOS T ROY SOC B, V292, P189, DOI 10.1098/rstb.1981.0027; Keates S. G., 2002, B INDOPACIFIC PREHIS, V22, P17; Keeley L.H., 1980, EXPT DETERMINATION S; Krause J, 2010, NATURE, V464, P894, DOI 10.1038/nature08976; Leakey M.D., 1971, OLDUVAI GORGE EXCAVA, V3; Leng J., 2000, J E ASIAN ARCHAEOLOG, V2, P9; Lepre CJ, 2011, NATURE, V477, P82, DOI 10.1038/nature10372; Lycett SJ, 2006, J ARCHAEOL SCI, V33, P847, DOI 10.1016/j.jas.2005.10.014; Lycett SJ, 2008, WORLD ARCHAEOL, V40, P295, DOI 10.1080/00438240802260970; Lycett SJ, 2008, J ARCHAEOL SCI, V35, P553, DOI 10.1016/j.jas.2007.05.003; Lycett SJ, 2010, WORLD ARCHAEOL, V42, P521, DOI 10.1080/00438243.2010.517667; Lycett SJ, 2010, J ARCHAEOL SCI, V37, P1110, DOI 10.1016/j.jas.2009.12.011; Lycett SJ, 2010, QUATERN INT, V211, P55, DOI 10.1016/j.quaint.2008.12.001; Lycett SJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007404; Lyman RL, 2008, J ARCHAEOL SCI, V35, P2805, DOI 10.1016/j.jas.2008.05.008; Mahalanobis P.C., 1936, P NATL I SCI INDIA, V2, P49, DOI DOI 10.1145/1390156.1390302; Movius H.L., 1948, T AM PHILOS SOC, V38, P329; Movius HL, 1944, PEABODY MUSEUM PAPER; MOVIUS HL, 1969, STUDIES PHYS ANTHR, V1, P17; Noble W., 1996, HUMAN EVOLUTION LANG; Norton CJ, 2006, J HUM EVOL, V51, P527, DOI 10.1016/j.jhevol.2006.07.004; NORTON CJ, 2009, J HUM EVOL, V57, P331; Norton CJ, 2010, VERTEBRATE PALEOBIOL; O'Higgins P, 2000, J ANAT, V197, P103, DOI 10.1046/j.1469-7580.2000.19710103.x; O'Higgins P, 1998, J ANAT, V193, P251, DOI 10.1046/j.1469-7580.1998.19320251.x; PETRAGLIA MD, 2009, J HUM EVOL, V57, P326; Roberts MB., 1999, BOXGROVE MIDDLE PLEI; ROE D, 1976, PROBLEMS EC SOCIAL A, P61; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schick K. D, 1994, INTEGRATIVE PATHS PA, P569; Schick K. D., 1993, MAKING SILENT STONES; Simanjuntak T, 2010, QUATERN INT, V223, P418, DOI 10.1016/j.quaint.2009.07.022; Simao J, 2002, BEHAV BRAIN SCI, V25, P419, DOI 10.1017/S0140525X02380075; Wang S, 2005, PERSPECTIVES HOMINID; Wang W, 2008, CHINESE SCI BULL, V53, P878, DOI 10.1007/s11434-008-0134-7; Wynn T, 2002, BEHAV BRAIN SCI, V25, P389, DOI 10.1017/S0140525X02000079; Xu GL, 2012, QUAT INT IN PRESS; YI S, 1983, CURR ANTHROPOL, V24, P181, DOI 10.1086/202964; Yravedra J, 2010, J ARCHAEOL SCI, V37, P2469, DOI 10.1016/j.jas.2010.05.007	63	57	62	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e35804	10.1371/journal.pone.0035804	http://dx.doi.org/10.1371/journal.pone.0035804			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TL	22536441	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336200069
J	Pitchers, KK; Schmid, S; Di Sebastiano, AR; Wang, X; Laviolette, SR; Lehman, MN; Coolen, LM				Pitchers, Kyle K.; Schmid, Susanne; Di Sebastiano, Andrea R.; Wang, Xu; Laviolette, Steven R.; Lehman, Michael N.; Coolen, Lique M.			Natural Reward Experience Alters AMPA and NMDA Receptor Distribution and Function in the Nucleus Accumbens	PLOS ONE			English	Article							MEDIAL PREFRONTAL CORTEX; RATS RATTUS-NORVEGICUS; BEHAVIORAL SENSITIZATION; SEXUAL-BEHAVIOR; DELTA-FOSB; SURFACE EXPRESSION; SILENT SYNAPSES; PREOPTIC AREA; INSTRUMENTAL BEHAVIOR; STRUCTURAL PLASTICITY	Natural reward and drugs of abuse converge upon the mesolimbic system which mediates motivation and reward behaviors. Drugs induce neural adaptations in this system, including transcriptional, morphological, and synaptic changes, which contribute to the development and expression of drug-related memories and addiction. Previously, it has been reported that sexual experience in male rats, a natural reward behavior, induces similar neuroplasticity in the mesolimbic system and affects natural reward and drug-related behavior. The current study determined whether sexual experience causes long-lasting changes in mating, or ionotropic glutamate receptor trafficking or function in the nucleus accumbens (NAc), following 3 different reward abstinence periods: 1 day, 1 week, or 1 month after final mating session. Male Sprague Dawley rats mated during 5 consecutive days (sexual experience) or remained sexually naive to serve as controls. Sexually experienced males displayed facilitation of initiation and performance of mating at each time point. Next, intracellular and membrane surface expression of N-methyl-D-aspartate (NMDA: NR1 subunit) and alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate (AMPA: GluA1, GluA2 subunits) receptors in the NAc was determined using a bis(sulfosuccinimidyl) suberate (BS3) protein cross-linking assay followed by Western Blot analysis. NR1 expression was increased at 1 day abstinence both at surface and intracellular, but decreased at surface at 1 week of abstinence. GluA2 was increased intracellularly at 1 week and increased at the surface after 1 month of abstinence. Finally, whole-cell patch clamp electrophysiological recordings determined reduced AMPA/NMDA ratio of synaptic currents in NAc shell neurons following stimulation of cortical afferents in sexually experienced males after all reward abstinence periods. Together, these data show that sexual experience causes long-term alterations in glutamate receptor expression and function in the NAc. Although not identical, this sex experience-induced neuroplasticity has similarities to that caused by psychostimulants, suggesting common mechanisms for reinforcement of natural and drug reward.	[Pitchers, Kyle K.; Schmid, Susanne; Di Sebastiano, Andrea R.; Wang, Xu; Laviolette, Steven R.; Lehman, Michael N.; Coolen, Lique M.] Univ Western Ontario, Schulich Sch Med & Dent, Dept Anat, London, ON, Canada; [Pitchers, Kyle K.; Schmid, Susanne; Di Sebastiano, Andrea R.; Wang, Xu; Laviolette, Steven R.; Lehman, Michael N.; Coolen, Lique M.] Univ Western Ontario, Schulich Sch Med & Dent, Dept Cell Biol, London, ON, Canada; [Pitchers, Kyle K.; Di Sebastiano, Andrea R.; Lehman, Michael N.; Coolen, Lique M.] Univ Michigan, Dept Mol, Ann Arbor, MI 48109 USA; [Pitchers, Kyle K.; Di Sebastiano, Andrea R.; Lehman, Michael N.; Coolen, Lique M.] Univ Michigan, Dept Integrat Physiol, Ann Arbor, MI 48109 USA; [Coolen, Lique M.] Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA	Western University (University of Western Ontario); Western University (University of Western Ontario); University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Pitchers, KK (corresponding author), Univ Western Ontario, Schulich Sch Med & Dent, Dept Anat, London, ON, Canada.	coolenlm@umich.edu	Lehman, Michael/ABC-9076-2020; Schmid, Susanne/J-3201-2012	Schmid, Susanne/0000-0001-5366-8061; Coolen, Lique/0000-0003-2920-1116; Lehman, Michael/0000-0002-9076-5108	Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	Canadian Institutes of Health Research to LMC and ARD, and Natural Sciences and Engineering Research Council to LMC and KKP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGMO A, 1993, BEHAV NEUROSCI, V107, P812, DOI 10.1037/0735-7044.107.5.812; AGMO A, 1990, BEHAV NEUROSCI, V104, P177, DOI 10.1037/0735-7044.104.1.177; Agmo A, 1997, BRAIN RES PROTOC, V1, P203, DOI 10.1016/S1385-299X(96)00036-0; Avena NM, 2008, PHYSIOL BEHAV, V94, P309, DOI 10.1016/j.physbeh.2008.01.008; Avena Nicole M, 2009, Eat Disord, V17, P89, DOI 10.1080/10640260802371604; Avena NM, 2009, J NUTR, V139, P623, DOI 10.3945/jn.108.097584; Bachtell RK, 2008, J NEUROSCI, V28, P12808, DOI 10.1523/JNEUROSCI.2060-08.2008; Balfour ME, 2004, NEUROPSYCHOPHARMACOL, V29, P718, DOI 10.1038/sj.npp.1300350; Belujon P, 2011, ANN NY ACAD SCI, V1216, P114, DOI 10.1111/j.1749-6632.2010.05896.x; Bisaga A, 2007, HUM PSYCHOPHARM CLIN, V22, P41, DOI 10.1002/hup.816; Boudreau AC, 2005, J NEUROSCI, V25, P9144, DOI 10.1523/JNEUROSCI.2252-05.2005; Boudreau AC, 2007, J NEUROSCI, V27, P10621, DOI 10.1523/JNEUROSCI.2163-07.2007; Boudreau AC, 2009, J NEUROCHEM, V110, P363, DOI 10.1111/j.1471-4159.2009.06140.x; Bradley KC, 2005, GENES BRAIN BEHAV, V4, P31, DOI 10.1111/j.1601-183X.2004.00093.x; Bradley KC, 2001, J NEUROSCI, V21, P2123, DOI 10.1523/JNEUROSCI.21-06-02123.2001; Brown TE, 2011, J NEUROSCI, V31, P8163, DOI 10.1523/JNEUROSCI.0016-11.2011; Chen BT, 2008, NEURON, V59, P288, DOI 10.1016/j.neuron.2008.05.024; Conrad KL, 2008, NATURE, V454, P118, DOI 10.1038/nature06995; Cornish JL, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-15-j0006.2000; Davis JF, 2010, BIOL PSYCHIAT, V67, P1199, DOI 10.1016/j.biopsych.2009.12.029; Dietz DM, 2009, PHARMACOPSYCHIATRY, V42, pS69, DOI 10.1055/s-0029-1202847; Dominguez JM, 2007, BEHAV NEUROSCI, V121, P1023, DOI 10.1037/0735-7044.121.5.1023; EVERITT BJ, 1987, J COMP PSYCHOL, V101, P407, DOI 10.1037/0735-7036.101.4.407; EVERITT BJ, 1989, NEUROSCIENCE, V30, P63, DOI 10.1016/0306-4522(89)90353-9; EVERITT BJ, 1987, J COMP PSYCHOL, V101, P395, DOI 10.1037/0735-7036.101.4.395; Famous KR, 2008, J NEUROSCI, V28, P11061, DOI 10.1523/JNEUROSCI.1221-08.2008; Feil J, 2010, NEUROSCI BIOBEHAV R, V35, P248, DOI 10.1016/j.neubiorev.2010.03.001; Ferrario CR, 2010, NEUROPSYCHOPHARMACOL, V35, P818, DOI 10.1038/npp.2009.190; FLEMING AS, 1991, BEHAV NEURAL BIOL, V56, P319, DOI 10.1016/0163-1047(91)90499-G; Frohmader KS, 2011, J NEUROSCI, V31, P16473, DOI 10.1523/JNEUROSCI.4013-11.2011; Frohmader KS, 2010, HORM BEHAV, V58, P149, DOI 10.1016/j.yhbeh.2009.11.009; Gao C, 2008, J NEUROCHEM, V106, P2489, DOI 10.1111/j.1471-4159.2008.05597.x; Ghasemzadeh MB, 2009, NEUROSCIENCE, V159, P414, DOI 10.1016/j.neuroscience.2008.10.027; Goldstein RZ, 2011, NAT REV NEUROSCI, V12, P652, DOI 10.1038/nrn3119; Grimm JW, 2001, NATURE, V412, P141, DOI 10.1038/35084134; Groc L, 2006, TRENDS NEUROSCI, V29, P132, DOI 10.1016/j.tins.2006.01.005; Hu XT, 2005, NEUROPSYCHOPHARMACOL, V30, P916, DOI 10.1038/sj.npp.1300654; Hu XT, 2004, J NEUROPHYSIOL, V92, P1597, DOI 10.1152/jn.00217.2004; Huang YHH, 2009, NEURON, V63, P40, DOI 10.1016/j.neuron.2009.06.007; Ishikawa A, 2008, NEUROSCIENCE, V155, P573, DOI 10.1016/j.neuroscience.2008.06.037; Ishikawa M, 2009, J NEUROSCI, V29, P5820, DOI 10.1523/JNEUROSCI.5703-08.2009; KAGAN J, 1955, J COMP PHYSIOL PSYCH, V48, P59, DOI 10.1037/h0043461; Kalivas PW, 2009, NAT REV NEUROSCI, V10, P561, DOI 10.1038/nrn2515; KARLER R, 1989, LIFE SCI, V45, P599, DOI 10.1016/0024-3205(89)90045-3; Kourrich S, 2007, J NEUROSCI, V27, P7921, DOI 10.1523/JNEUROSCI.1859-07.2007; Kourrich S, 2009, J NEUROSCI, V29, P12275, DOI 10.1523/JNEUROSCI.3028-09.2009; Li YH, 2006, J PSYCHOPHARMACOL, V20, P40, DOI [10.1177/02698881105057250, 10.1177/0269881105057250]; Liao DH, 1999, NAT NEUROSCI, V2, P37, DOI 10.1038/4540; Lopez HH, 2002, PHARMACOL BIOCHEM BE, V72, P65, DOI 10.1016/S0091-3057(01)00732-8; Mameli M, 2009, NAT NEUROSCI, V12, P1036, DOI 10.1038/nn.2367; Marie H, 2005, NEURON, V45, P741, DOI 10.1016/j.neuron.2005.01.039; McClung CA, 2003, NAT NEUROSCI, V6, P1208, DOI 10.1038/nn1143; McCutcheon JE, 2011, J NEUROSCI, V31, P5737, DOI 10.1523/JNEUROSCI.0350-11.2011; MCGEORGE AJ, 1989, NEUROSCIENCE, V29, P503, DOI 10.1016/0306-4522(89)90128-0; Morgane PJ, 2005, PROG NEUROBIOL, V75, P143, DOI 10.1016/j.pneurobio.2005.01.001; Moussawi K, 2009, NAT NEUROSCI, V12, P182, DOI 10.1038/nn.2250; Mu P, 2010, J NEUROSCI, V30, P3689, DOI 10.1523/JNEUROSCI.4063-09.2010; Nelson CL, 2009, J NEUROCHEM, V109, P35, DOI 10.1111/j.1471-4159.2009.05911.x; Numan M, 2007, DEV PSYCHOBIOL, V49, P12, DOI 10.1002/dev.20198; Pickard L, 2000, J NEUROSCI, V20, P7922; Pierce RC, 1996, J NEUROSCI, V16, P1550; Pitchers KK, 2010, GENES BRAIN BEHAV, V9, P831, DOI 10.1111/j.1601-183X.2010.00621.x; Pitchers KK, 2010, BIOL PSYCHIAT, V67, P872, DOI 10.1016/j.biopsych.2009.09.036; Powell WS, 2003, BEHAV NEUROSCI, V117, P69, DOI 10.1037/0735-7044.117.1.69; Robinson TE, 2004, NEUROPHARMACOLOGY, V47, P33, DOI 10.1016/j.neuropharm.2004.06.025; Schumann J, 2009, J NEUROSCI, V29, P6955, DOI 10.1523/JNEUROSCI.1329-09.2009; SHEFFIELD FD, 1951, J COMP PHYSIOL PSYCH, V44, P3, DOI 10.1037/h0060074; Stuber GD, 2011, NATURE, V475, P377, DOI 10.1038/nature10194; Suto N, 2004, NEUROPSYCHOPHARMACOL, V29, P2149, DOI 10.1038/sj.npp.1300533; Tenk CM, 2009, HORM BEHAV, V55, P93, DOI 10.1016/j.yhbeh.2008.08.012; Thomas MJ, 2008, BRIT J PHARMACOL, V154, P327, DOI 10.1038/bjp.2008.77; Thomas MJ, 2001, NAT NEUROSCI, V4, P1217, DOI 10.1038/nn757; Vanderschuren LJMJ, 2000, PSYCHOPHARMACOLOGY, V151, P99, DOI 10.1007/s002130000493; vanFurth WR, 1995, BRAIN RES REV, V21, P162, DOI 10.1016/0165-0173(96)82985-7; Vialou V, 2010, NAT NEUROSCI, V13, P745, DOI 10.1038/nn.2551; Vucetic Z, 2010, WIRES SYST BIOL MED, V2, P577, DOI 10.1002/wsbm.77; Wallace DL, 2008, J NEUROSCI, V28, P10272, DOI 10.1523/JNEUROSCI.1531-08.2008; Wolf ME, 2010, NEUROSCI BIOBEHAV R, V35, P185, DOI 10.1016/j.neubiorev.2010.01.013; Wolf ME, 2010, TRENDS NEUROSCI, V33, P391, DOI 10.1016/j.tins.2010.06.003; Wolf ME, 1998, PROG NEUROBIOL, V54, P679, DOI 10.1016/S0301-0082(97)00090-7; YOSHIDA M, 1992, NEUROSCI LETT, V139, P73, DOI 10.1016/0304-3940(92)90861-Z; Young LJ, 2004, NAT NEUROSCI, V7, P1048, DOI 10.1038/nn1327; Young LJ, 2001, HORM BEHAV, V40, P133, DOI 10.1006/hbeh.2001.1691; Zhang XF, 2002, J PHARMACOL EXP THER, V301, P1119, DOI 10.1124/jpet.301.3.1119; Zhang XF, 1998, J NEUROSCI, V18, P488	85	39	39	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e34700	10.1371/journal.pone.0034700	http://dx.doi.org/10.1371/journal.pone.0034700			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529926	gold, Green Published, Green Submitted			2022-12-27	WOS:000305350600021
J	Zhang, XM; Azhar, G; Wei, JY				Zhang, Xiaomin; Azhar, Gohar; Wei, Jeanne Y.			The Expression of microRNA and microRNA Clusters in the Aging Heart	PLOS ONE			English	Article							SERUM RESPONSE FACTOR; CARDIAC-HYPERTROPHY; ARGONAUTE PROTEINS; GENE-EXPRESSION; BIOGENESIS PATHWAYS; CELL-PROLIFERATION; MESSENGER-RNAS; CANCER-CELLS; RAT-HEART; SENESCENCE	Background: The microRNAs have been implicated in the process of cardiac development, cardiac hypertrophy, and heart failure. However, the impact of adult aging on cardiac expression of miRNA clusters, as well as both miRNA guide (miR) and passenger (miR*) strands has not been well established. Methods/Results: We explored the expression profile of both miR and miR* in the hearts of young adult versus old mice. We found that 65 miRNAs were differentially expressed in the old versus young adult hearts; approximately half of them were clustered miRNAs that were distributed in 11 miRNA clusters. Each miRNA cluster contained from 2 to as many as 71 miRNA genes. The majority of the clusters displayed similar expression, with most cluster members within a cluster being either increased or decreased together, suggesting that most clusters are likely to be regulated by a common signaling mechanism and that the combined expression of multiple miRNA genes in a cluster could pose an impact on a broad range of targets during aging. We also found age-related changes in the expression of miR*s. The expression of both miR and miR* correlated with that of pri-miRNA transcript over the time course from development and maturation through adult aging. Age-related changes in the expression of Ago1 and Ago2 proteins in the heart were also observed. Transfection assay revealed that both Ago1 and Ago2 synergistically induced miR-21 and miR-21* when the mir-21 plasmid was co-transfected with either. Conclusion: The data revealed age-related changes in the expression of pri-miRNA transcript, Argonaut proteins and both miR and miR* strands. The major changes occurred later in life, from middle to old age. It is likely that the expression of miR and miR* is regulated by both pri-miRNA transcription as well as Ago1 and Ago2 proteins during adult aging.	[Zhang, Xiaomin; Azhar, Gohar; Wei, Jeanne Y.] Univ Arkansas Med Sci & Geriatr Res, Cent Arkansas Vet Healthcare Syst, Educ & Clin Ctr, Donald W Reynolds Dept Geriatr, Little Rock, AR USA	Geriatric Research Education & Clinical Center; University of Arkansas System; University of Arkansas Medical Sciences; US Department of Veterans Affairs; Veterans Health Administration (VHA); Central Arkansas Veterans Healthcare System	Zhang, XM (corresponding author), Univ Arkansas Med Sci & Geriatr Res, Cent Arkansas Vet Healthcare Syst, Educ & Clin Ctr, Donald W Reynolds Dept Geriatr, Little Rock, AR USA.	weijeanne@uams.edu	Zhang, Xiaomin/GVT-8927-2022		National Institutes of Health from the Department of Health and Human Services [AG-018388, AG-026091, AG-028718]; Geriatric Research, Education, and Clinical Center (GRECC); Central Arkansas Veterans Healthcare System; NATIONAL INSTITUTE ON AGING [R01AG018388, P30AG028718, R01AG026091] Funding Source: NIH RePORTER	National Institutes of Health from the Department of Health and Human Services; Geriatric Research, Education, and Clinical Center (GRECC); Central Arkansas Veterans Healthcare System(US Department of Veterans Affairs); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported in part by National Institutes of Health grants AG-018388, AG-026091, and AG-028718 from the Department of Health and Human Services, The Geriatric Research, Education, and Clinical Center (GRECC), and the Central Arkansas Veterans Healthcare System. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Arvey A, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.24; BALL KL, 1994, J MOL CELL CARDIOL, V26, P519, DOI 10.1006/jmcc.1994.1062; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bennett LB, 2009, GENE CHROMOSOME CANC, V48, P828, DOI 10.1002/gcc.20687; BESSE S, 1993, AM J PHYSIOL, V265, pH183, DOI 10.1152/ajpheart.1993.265.1.H183; Brett JO, 2011, AGING-US, V3, P108, DOI 10.18632/aging.100285; Busk PK, 2010, BIOCHEM BIOPH RES CO, V396, P989, DOI 10.1016/j.bbrc.2010.05.039; CARRIER L, 1992, CIRC RES, V70, P999, DOI 10.1161/01.RES.70.5.999; Cenik ES, 2011, CURR BIOL, V21, pR446, DOI 10.1016/j.cub.2011.05.020; Chatterjee S, 2011, DEV CELL, V20, P388, DOI 10.1016/j.devcel.2011.02.008; Cheloufi S, 2010, NATURE, V465, P584, DOI 10.1038/nature09092; Chen LH, 2010, AGEING RES REV, V9, pS59, DOI 10.1016/j.arr.2010.08.002; CHEVALIER B, 1992, BASIC RES CARDIOL, V87, P187; Chinchilla A, 2011, CARDIOVASC RES, V89, P98, DOI 10.1093/cvr/cvq264; Corcoran DL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005279; Cullen BR, 2004, MOL CELL, V16, P861, DOI 10.1016/j.molcel.2004.12.002; Czech B, 2011, NAT REV GENET, V12, P19, DOI 10.1038/nrg2916; Czech B, 2009, MOL CELL, V36, P445, DOI 10.1016/j.molcel.2009.09.028; Drummond MJ, 2011, PHYSIOL GENOMICS, V43, P595, DOI 10.1152/physiolgenomics.00148.2010; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Ghildiyal M, 2010, RNA, V16, P43, DOI 10.1261/rna.1972910; Grillari J, 2010, BIOGERONTOLOGY, V11, P501, DOI 10.1007/s10522-010-9272-9; Grillari J, 2010, EXP GERONTOL, V45, P302, DOI 10.1016/j.exger.2010.01.007; Hackl M, 2010, AGING CELL, V9, P291, DOI 10.1111/j.1474-9726.2010.00549.x; Han M, 2011, CURR OPIN CARDIOL, V26, P181, DOI 10.1097/HCO.0b013e328345983d; Havens MA, 2012, NUCLEIC ACIDS RES, V40, P4626, DOI 10.1093/nar/gks026; Hertel J, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-25; Khan AA, 2009, NAT BIOTECHNOL, V27, P549, DOI 10.1038/nbt.1543; KIMBALL KA, 1991, EUR J PHARM-MOLEC PH, V208, P231, DOI 10.1016/0922-4106(91)90100-V; Kuzmin A, 2008, GENE EXPR PATTERNS, V8, P107, DOI 10.1016/j.modgep.2007.09.005; Lanceta J, 2010, EXP GERONTOL, V45, P269, DOI 10.1016/j.exger.2009.12.009; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li GR, 2009, MECH AGEING DEV, V130, P731, DOI 10.1016/j.mad.2009.09.002; Lin ZQ, 2009, P NATL ACAD SCI USA, V106, P12103, DOI 10.1073/pnas.0811371106; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martineza I, 2011, P NATL ACAD SCI USA, V108, P522, DOI 10.1073/pnas.1017346108; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Morrisey EE, 2010, J CLIN INVEST, V120, P3817, DOI 10.1172/JCI44596; Nishi H, 2011, MOL CELL BIOL, V31, P744, DOI 10.1128/MCB.00581-10; Ohdaira H, 2012, CELL PROLIFERAT, V45, P32, DOI 10.1111/j.1365-2184.2011.00798.x; Okamura K, 2008, NAT STRUCT MOL BIOL, V15, P354, DOI 10.1038/nsmb.1409; Okamura K, 2009, MOL CELL, V36, P431, DOI 10.1016/j.molcel.2009.09.027; Pugh KG, 2001, DRUG AGING, V18, P263, DOI 10.2165/00002512-200118040-00004; Saini HK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-564; Saito Takaya, 2012, Silence, V3, P3, DOI 10.1186/1758-907X-3-3; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Sayed D, 2007, CIRC RES, V100, P416, DOI 10.1161/01.RES.0000257913.42552.23; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seitz H, 2008, CURR BIOL, V18, P147, DOI 10.1016/j.cub.2007.12.049; Shomron N, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/594678; Siomi H, 2010, MOL CELL, V38, P323, DOI 10.1016/j.molcel.2010.03.013; Thum T, 2007, CIRCULATION, V116, P258, DOI 10.1161/CIRCULATIONAHA.107.687947; Turchinovich A, 2011, NUCLEIC ACIDS RES, V39, P7223, DOI 10.1093/nar/gkr254; van Almen GC, 2011, AGING CELL, V10, P769, DOI 10.1111/j.1474-9726.2011.00714.x; Vasa-Nicotera M, 2011, ATHEROSCLEROSIS, V217, P326, DOI 10.1016/j.atherosclerosis.2011.03.034; VIJG J, 1995, J AM GERIATR SOC, V43, P426, DOI 10.1111/j.1532-5415.1995.tb05819.x; Wang BB, 2009, NAT STRUCT MOL BIOL, V16, P1259, DOI 10.1038/nsmb.1712; Wei JY, 2000, AGING WELL COMPLETE; Winter J, 2011, RNA BIOL, V8, P1149, DOI 10.4161/rna.8.6.17665; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Woods K, 2007, J BIOL CHEM, V282, P2130, DOI 10.1074/jbc.C600252200; Yang JS, 2011, MOL CELL, V43, P892, DOI 10.1016/j.molcel.2011.07.024; YOUNES A, 1995, AM J PHYSIOL-HEART C, V269, pH1003, DOI 10.1152/ajpheart.1995.269.3.H1003; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444; Zhang XM, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-15; Zhang XM, 2004, J BIOL CHEM, V279, P55626, DOI 10.1074/jbc.M405945200; Zhang XM, 2003, AM J PHYSIOL-REG I, V285, pR552, DOI 10.1152/ajpregu.00631.2002	68	62	68	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e34688	10.1371/journal.pone.0034688	http://dx.doi.org/10.1371/journal.pone.0034688			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529925	gold, Green Published, Green Submitted			2022-12-27	WOS:000305350600020
J	Ayele, K; Tesfa, B; Abebe, L; Tilahun, T; Girma, E				Ayele, Ketema; Tesfa, Bisrat; Abebe, Lakew; Tilahun, Tizta; Girma, Eshetu			Self Care Behavior among Patients with Diabetes in Harari, Eastern Ethiopia: The Health Belief Model Perspective	PLOS ONE			English	Article								Background: Diabetes mellitus is a chronic disease that requires lifelong medical treatments and a life style adjustment. To prevent serious morbidity and mortality, it requires dedication to demanding self-care behaviors in multiple domains. The objective of this study was to identify predictors of self care behaviors among patients with diabetes. Methods: From a total of 425 follow up diabetic patients, a quantitative cross sectional study was conducted among 222 of them from three different hospitals in Harar town, from March to April, 2011. The sample was taken using simple random sampling method. Data was collected using pretested questionnaire. Descriptive statistics multiple logistic regression analysis were also used to assess the predicators of self care behaviors among patients with diabetes. Result: Majority of the study respondents 134 (60.4%) were female and the mean age was 49.7 (SD +/- 14.7) years. More than half 147(66.2%) of them were medically diagnosed with type-2 diabetes. 208(93.7%) had general knowledge about diabetes and specific knowledge about diabetes self care 207(93.2%). Large proportion of them had moderate perceived susceptibility 174(78.4%) and severity 112(50.5%). More than half of the respondents 149(67.1%) had less perceived barrier while only 30 (13.5%) of them had high self efficacy to self care practices related to diabetes mellitus. Only 87(39.2%) followed the recommended self care practices on diabetes. Conclusions: Patients with less frequent information were less likely to take diabetes self care. Patients who were more educated, middle income, had high perceived severity of diabetes and less perceived barrier to self care were more likely to take diabetes self care. To increase the self care behavior, diabetes messages should focus on severity of diabetes and how to overcome barriers for self care by segmenting the audiences based on income and educational status with increasing the frequency and reach of message on diabetes.	[Ayele, Ketema] Harar Hlth Sci Coll, Harai, Ethiopia; [Tesfa, Bisrat; Abebe, Lakew; Girma, Eshetu] Jimma Univ, Dept Hlth Educ & Behav Sci, Jimma, Ethiopia; [Tilahun, Tizta] Jimma Univ, Dept Populat & Family Hlth, Jimma, Ethiopia	Jimma University; Jimma University	Ayele, K (corresponding author), Harar Hlth Sci Coll, Harai, Ethiopia.	grm_sht@yahoo.com	Tilahun, Tizta/K-7468-2017	Tilahun, Tizta/0000-0002-3842-9844	Jimma University	Jimma University	This study was funded by Jimma University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abduelkarem A, CHANGES SOME HLTH IN; Aburuz SM, 2002, INT J PHARM PRACTICE, V10S, P96; Adibe O, 2009, INT J DRUG DEV RES, V1, P85; Bahru Y, 2009, ASSESSMENT DIABETES; Ben Abdelaziz Ahmed, 2006, Tunis Med, V84, P415; Brooke L, 2008, ENV FACTORS DIABETES; Deshmukh S, 2000, INT J DIAB DEV COUNT, V20; Diabetes Monitor, 2005, DIAB MON INF ED SUPP; Elizabeth R, DIABETES SELF CARE A; Julia L, 2010, AUST PRESCR, V33, P138; Katie W, 2005, DIABETES CARE, V28, P1346; Khattab M, 2010, J DIABETES COMPLICAT, V24, P84, DOI 10.1016/j.jdiacomp.2008.12.008; King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414; Lefebvre C., 1998, HLTH ED Q, V15, P299; LESTER FT, 1991, DIABETIC MED, V8, P272, DOI 10.1111/j.1464-5491.1991.tb01585.x; Levetan C, 2003, DIABETES CARE, V26, P1, DOI 10.2337/diacare.26.1.1; Morowati A, 2009, DANESHVAR MED, V16, P81; Okolie VU, 2009, INT J MED MED SCI, V1, P353; Peyrot M, 2005, DIABETIC MED, V22, P1379, DOI 10.1111/j.1464-5491.2005.01644.x; Rachel G, 2006, BRIT J HEALTH PSYCH, V11, P155; Rosenstock M, 1988, HLTH ED Q, V15, P175; Sigurthardottir AK, 2005, J CLIN NURS, V14, P301, DOI 10.1111/j.1365-2702.2004.01043.x; Tan M, 2009, SELF CARE PRACTICES; Venkat N, 2003, DIABETES PANDEMIC PO; *WHO, 2003, DIAB EST PROJ; World Health Organization, 2005, RES HLTH ACT CRIS DI; Yeweyenhareg Feleke, 2005, Ethiopian Journal of Health Development, V19, P203	27	99	103	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e35515	10.1371/journal.pone.0035515	http://dx.doi.org/10.1371/journal.pone.0035515			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22530039	Green Published, gold, Green Submitted			2022-12-27	WOS:000305347400057
J	Greibe, E; Fedosov, S; Nexo, E				Greibe, Eva; Fedosov, Sergey; Nexo, Ebba			The Cobalamin-Binding Protein in Zebrafish Is an Intermediate between the Three Cobalamin-Binding Proteins in Human	PLOS ONE			English	Article							HUMAN TRANSCOBALAMIN-II; HUMAN INTRINSIC-FACTOR; GENOMIC STRUCTURE; HAPTOCORRIN; PURIFICATION; RABBIT; SERUM; CDNA	In humans, three soluble extracellular cobalamin-binding proteins; transcobalamin (TC), intrinsic factor (IF), and haptocorrin (HC), are involved in the uptake and transport of cobalamin. In this study, we investigate a cobalamin-binding protein from zebrafish (Danio rerio) and summarize current knowledge concerning the phylogenetic evolution of kindred proteins. We identified a cobalamin binding capacity in zebrafish protein extracts (8.2 pmol/fish) and ambient water (13.5 pmol/fish) associated with a single protein. The protein showed resistance toward degradation by trypsin and chymotrypsin (like human IF, but unlike human HC and TC). The cobalamin analogue, cobinamide, bound weaker to the zebrafish cobalamin binder than to human HC, but stronger than to human TC and IF. Affinity for another analogue, adenosyl-pseudo-cobalamin was low compared with human HC and TC, but high compared with human IF. The absorbance spectrum of the purified protein in complex with hydroxo-cobalamin resembled those of human HC and IF, but not TC. We searched available databases to further explore the phylogenies of the three cobalamin-binding proteins in higher vertebrates. Apparently, TC-like proteins are the oldest evolutionary derivatives followed by IF and HC (the latter being present only in reptiles and most but not all mammals). Our findings suggest that the only cobalamin-binding protein in zebrafish is an intermediate between the three human cobalamin binders. These findings support the hypothesis about a common ancestral gene for all cobalamin-binding proteins in higher vertebrates.	[Greibe, Eva; Nexo, Ebba] Aarhus Univ Hosp, Dept Clin Biochem, DK-8000 Aarhus, Denmark; [Fedosov, Sergey] Aarhus Univ, Dept Mol Biol, Dept Mol Biol & Genet, DK-8000 Aarhus, Denmark	Aarhus University; Aarhus University	Greibe, E (corresponding author), Aarhus Univ Hosp, Dept Clin Biochem, DK-8000 Aarhus, Denmark.	evagreibe@gmail.com	Greibe, Eva/E-3375-2018; Fedosov, Sergey N./J-2340-2019	Greibe, Eva/0000-0002-0417-1195; Fedosov, Sergey N./0000-0002-7016-2959; Nexo, Ebba/0000-0001-9406-9081	Danish Medical Research Council; Lundbeck Foundation	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lundbeck Foundation(Lundbeckfonden)	The study was funded by the Danish Medical Research Council and the Lundbeck Foundation. Funding was given to cover lab expensis in general (not just this project) and no grant number is relevant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Fedosov SN, 2007, BIOCHEMISTRY-US, V46, P6446, DOI 10.1021/bi062063l; Fedosov SN, 2002, J BIOL CHEM, V277, P9989, DOI 10.1074/jbc.M111399200; Fieber W, 2002, HELV CHIM ACTA, V85, P927, DOI 10.1002/1522-2675(200203)85:3<927::AID-HLCA927>3.0.CO;2-A; GOTTLIEB C, 1965, BLOOD-J HEMATOL, V25, P875, DOI 10.1182/blood.V25.6.875.875; HANSEN M, 1992, SCAND J CLIN LAB INV, V52, P647, DOI 10.3109/00365519209115508; HEWITT JE, 1990, EUR J BIOCHEM, V189, P125, DOI 10.1111/j.1432-1033.1990.tb15468.x; HEWITT JE, 1991, GENOMICS, V10, P432, DOI 10.1016/0888-7543(91)90329-D; Hygum K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020638; JOHNSTON J, 1992, GENOMICS, V12, P459, DOI 10.1016/0888-7543(92)90435-U; Kalra S, 2004, ARCH BIOCHEM BIOPHYS, V431, P189, DOI 10.1016/j.abb.2004.08.011; Kim S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008403; LI N, 1993, BIOCHIM BIOPHYS ACTA, V1172, P21, DOI 10.1016/0167-4781(93)90264-E; LI N, 1995, BIOCHEM BIOPH RES CO, V208, P756, DOI 10.1006/bbrc.1995.1402; Morkbak AL, 2007, CLIN CHEM LAB MED, V45, P1751, DOI 10.1515/CCLM.2007.343; NEXO BA, 1982, BIOCHIM BIOPHYS ACTA, V708, P178, DOI 10.1016/0167-4838(82)90218-7; NEXO E, 1988, SCAND J CLIN LAB INV, V48, P269, DOI 10.3109/00365518809167494; NEXO E, 1975, BIOCHIM BIOPHYS ACTA, V379, P189, DOI 10.1016/0005-2795(75)90021-5; NEXO E, 1981, BIOCHIM BIOPHYS ACTA, V667, P370, DOI 10.1016/0005-2795(81)90204-X; POLAK DM, 1979, J DAIRY SCI, V62, P697, DOI 10.3168/jds.S0022-0302(79)83312-3; Quardros EV, 2010, BRIT J HAEMATOL, V148, P195; Spence R, 2008, BIOL REV, V83, P13, DOI 10.1111/j.1469-185X.2007.00030.x; STUPPERICH E, 1991, EUR J BIOCHEM, V199, P299, DOI 10.1111/j.1432-1033.1991.tb16124.x; UCSC website, HUM GEN BROWS GAT; Wuerges J, 2007, BIOCHEM J, V403, P431, DOI 10.1042/BJ20061394	24	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35660	10.1371/journal.pone.0035660	http://dx.doi.org/10.1371/journal.pone.0035660			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22532867	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339200091
J	Liu, W; Fang, LR; Li, M; Li, S; Guo, SH; Luo, R; Feng, ZX; Li, B; Zhou, ZM; Shao, GQ; Chen, HC; Xiao, SB				Liu, Wei; Fang, Liurong; Li, Mao; Li, Sha; Guo, Shaohua; Luo, Rui; Feng, Zhixin; Li, Bin; Zhou, Zhemin; Shao, Guoqing; Chen, Huanchun; Xiao, Shaobo			Comparative Genomics of Mycoplasma: Analysis of Conserved Essential Genes and Diversity of the Pan-Genome	PLOS ONE			English	Article							DETECTING POSITIVE SELECTION; SEQUENCE-ANALYSIS; PHYLOGENY; PATHOGEN; EVOLUTION; CORE; TREE; RECONSTRUCTION; HYOPNEUMONIAE; MOLLICUTES	Mycoplasma, the smallest self-replicating organism with a minimal metabolism and little genomic redundancy, is expected to be a close approximation to the minimal set of genes needed to sustain bacterial life. This study employs comparative evolutionary analysis of twenty Mycoplasma genomes to gain an improved understanding of essential genes. By analyzing the core genome of mycoplasmas, we finally revealed the conserved essential genes set for mycoplasma survival. Further analysis showed that the core genome set has many characteristics in common with experimentally identified essential genes. Several key genes, which are related to DNA replication and repair and can be disrupted in transposon mutagenesis studies, may be critical for bacteria survival especially over long period natural selection. Phylogenomic reconstructions based on 3,355 homologous groups allowed robust estimation of phylogenetic relatedness among mycoplasma strains. To obtain deeper insight into the relative roles of molecular evolution in pathogen adaptation to their hosts, we also analyzed the positive selection pressures on particular sites and lineages. There appears to be an approximate correlation between the divergence of species and the level of positive selection detected in corresponding lineages.	[Liu, Wei; Fang, Liurong; Li, Mao; Li, Sha; Guo, Shaohua; Luo, Rui; Chen, Huanchun; Xiao, Shaobo] Huazhong Agr Univ, Coll Vet Med, State Key Lab Agr Microbiol, Div Anim Infect Dis, Wuhan, Peoples R China; [Feng, Zhixin; Li, Bin; Shao, Guoqing] Jiangsu Acad Agr Sci, Inst Vet Med, Nanjing, Jiangsu, Peoples R China; [Zhou, Zhemin] Natl Univ Ireland Univ Coll Cork, Environm Res Inst, Cork, Ireland	Huazhong Agricultural University; Jiangsu Academy of Agricultural Sciences; University College Cork	Xiao, SB (corresponding author), Huazhong Agr Univ, Coll Vet Med, State Key Lab Agr Microbiol, Div Anim Infect Dis, Wuhan, Peoples R China.	vet@mail.hzau.edu.cn	Zhou, Zhemin/AAX-5539-2020	Zhou, Zhemin/0000-0001-9783-0366; Xiao, Shaobo/0000-0003-0023-9188	National Natural Sciences Foundation of China [31170160, 31001080, 31001066]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Sciences Foundation of China (31170160, 31001080 and 31001066). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anisimova M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-154; Bapteste E, 2004, TRENDS MICROBIOL, V12, P406, DOI 10.1016/j.tim.2004.07.002; Calderon-Copete SP, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S6-S7; Chambaud I, 2001, NUCLEIC ACIDS RES, V29, P2145, DOI 10.1093/nar/29.10.2145; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Dandekar T, 2000, NUCLEIC ACIDS RES, V28, P3278, DOI 10.1093/nar/28.17.3278; Daubin V, 2002, GENOME RES, V12, P1080, DOI 10.1101/gr.187002; DEBEY MC, 1994, INFECT IMMUN, V62, P5312, DOI 10.1128/IAI.62.12.5312-5318.1994; Ding KY, 2005, MOL BIOL EVOL, V22, P148, DOI 10.1093/molbev/msh266; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Fang G, 2005, MOL BIOL EVOL, V22, P2147, DOI 10.1093/molbev/msi211; Fitzpatrick DA, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-99; FRASER CM, 1995, SCIENCE, V270, P397, DOI 10.1126/science.270.5235.397; Gadagkar SR, 2005, J EXP ZOOL PART B, V304B, P64, DOI 10.1002/jez.b.21026; Gil R, 2004, MICROBIOL MOL BIOL R, V68, P518, DOI 10.1128/MMBR.68.3.518-537.2004; Glass JI, 2006, P NATL ACAD SCI USA, V103, P425, DOI 10.1073/pnas.0510013103; Glass JI, 2000, NATURE, V407, P757, DOI 10.1038/35037619; Guilbaud O, 2007, BIOMETRICAL J, V49, P917, DOI 10.1002/bimj.200610361; Himmelreich R, 1996, NUCLEIC ACIDS RES, V24, P4420, DOI 10.1093/nar/24.22.4420; Huang S, 2001, WORLD J GASTROENTERO, V7, P266; Hutchison CA, 1999, SCIENCE, V286, P2165, DOI 10.1126/science.286.5447.2165; Iguchi A, 2009, J BACTERIOL, V191, P347, DOI 10.1128/JB.01238-08; Jaffe JD, 2004, GENOME RES, V14, P1447, DOI 10.1101/gr.2674004; Jin Q, 2002, NUCLEIC ACIDS RES, V30, P4432, DOI 10.1093/nar/gkf566; Kosiol C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000144; KOTANI H, 1990, IN VITRO CELL DEV B, V26, P91; Kunin V, 2005, NUCLEIC ACIDS RES, V33, P616, DOI 10.1093/nar/gki181; Lefebure T, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r71; Liu W, 2010, J BACTERIOL, V192, P5844, DOI 10.1128/JB.00946-10; McGlynn P, 2001, P NATL ACAD SCI USA, V98, P8227, DOI 10.1073/pnas.111008698; Minion FC, 2004, J BACTERIOL, V186, P7123, DOI 10.1128/JB.186.21.7123-7133.2004; MOROWITZ HJ, 1962, SCI AM, V206, P117, DOI 10.1038/scientificamerican0362-117; O'Brien KP, 2005, NUCLEIC ACIDS RES, V33, pD476, DOI 10.1093/nar/gki107; Ouzounis C, 1996, FEBS LETT, V390, P119, DOI 10.1016/0014-5793(96)00631-X; Papazisi L, 2003, MICROBIOL-SGM, V149, P2307, DOI 10.1099/mic.0.26427-0; Papp B, 2004, NATURE, V429, P661, DOI 10.1038/nature02636; Parkhill J, 2003, NAT GENET, V35, P32, DOI 10.1038/ng1227; Petersen L, 2007, GENOME RES, V17, P1336, DOI 10.1101/gr.6254707; Razin S, 1998, MICROBIOL MOL BIOL R, V62, P1094, DOI 10.1128/MMBR.62.4.1094-1156.1998; Rokas A, 2003, NATURE, V425, P798, DOI 10.1038/nature02053; Sasaki Y, 2002, NUCLEIC ACIDS RES, V30, P5293, DOI 10.1093/nar/gkf667; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Shapiro BJ, 2008, PLOS GENET, V4, DOI [10.1371/journal.pgen.0040023.eor, 10.1371/journal.pgen.0040023]; Sirand-Pugnet P, 2007, RES MICROBIOL, V158, P754, DOI 10.1016/j.resmic.2007.09.007; Snel B, 1999, NAT GENET, V21, P108, DOI 10.1038/5052; Szczepanek SM, 2010, INFECT IMMUN, V78, P1760, DOI 10.1128/IAI.01172-09; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vasconcelos ATR, 2005, J BACTERIOL, V187, P7548, DOI 10.1128/JB.187.21.7548.2005; Voelker LL, 1999, GENE, V233, P101, DOI 10.1016/S0378-1119(99)00150-X; Waites KB, 2005, CLIN MICROBIOL REV, V18, P757, DOI 10.1128/CMR.18.4.757-789.2005; Westberg J, 2004, GENOME RES, V14, P221, DOI 10.1101/gr.1673304; Wolf M, 2004, INT J SYST EVOL MICR, V54, P871, DOI 10.1099/ijs.0.02868-0; Yang ZH, 2002, MOL BIOL EVOL, V19, P908, DOI 10.1093/oxfordjournals.molbev.a004148; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957; Zhaxybayeva O, 2002, BMC GENOMICS, V3, DOI 10.1186/1471-2164-3-4	56	43	48	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35698	10.1371/journal.pone.0035698	http://dx.doi.org/10.1371/journal.pone.0035698			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536428	Green Published, gold, Green Submitted			2022-12-27	WOS:000305339200100
J	Pacheco, MA; Reid, MJC; Schillaci, MA; Lowenberger, CA; Galdikas, BMF; Jones-Engel, L; Escalante, AA				Pacheco, M. Andreina; Reid, Michael J. C.; Schillaci, Michael A.; Lowenberger, Carl A.; Galdikas, Birute M. F.; Jones-Engel, Lisa; Escalante, Ananias A.			The Origin of Malarial Parasites in Orangutans	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; RIBOSOMAL-RNA; CYTOCHROME-B; GENE; EVOLUTION; VIVAX; MADAGASCAR; PHYLOGENY; MIOCENE; ANTIGEN	Background: Recent findings of Plasmodium in African apes have changed our perspectives on the evolution of malarial parasites in hominids. However, phylogenetic analyses of primate malarias are still missing information from Southeast Asian apes. In this study, we report molecular data for a malaria parasite lineage found in orangutans. Methodology/Principal Findings: We screened twenty-four blood samples from Pongo pygmaeus (Kalimantan, Indonesia) for Plasmodium parasites by PCR. For all the malaria positive orangutan samples, parasite mitochondrial genomes (mtDNA) and two antigens: merozoite surface protein 1 42 kDa (MSP-1(42)) and circumsporozoite protein gene (CSP) were amplified, cloned, and sequenced. Fifteen orangutans tested positive and yielded 5 distinct mitochondrial haplotypes not previously found. The haplotypes detected exhibited low genetic divergence among them, indicating that they belong to one species. We report phylogenetic analyses using mitochondrial genomes, MSP-1(42) and CSP. We found that the orangutan malaria parasite lineage was part of a monophyletic group that includes all the known non-human primate malaria parasites found in Southeast Asia; specifically, it shares a recent common ancestor with P. inui (a macaque parasite) and P. hylobati (a gibbon parasite) suggesting that this lineage originated as a result of a host switch. The genetic diversity of MSP-1(42) in orangutans seems to be under negative selection. This result is similar to previous findings in non-human primate malarias closely related to P. vivax. As has been previously observed in the other Plasmodium species found in non-human primates, the CSP shows high polymorphism in the number of repeats. However, it has clearly distinctive motifs from those previously found in other malarial parasites. Conclusion: The evidence available from Asian apes indicates that these parasites originated independently from those found in Africa, likely as the result of host switches from other non-human primates.	[Pacheco, M. Andreina; Escalante, Ananias A.] Arizona State Univ, Ctr Evolutionary Med & Informat, Biodesign Inst, Tempe, AZ 85287 USA; [Reid, Michael J. C.] Univ Toronto, Dept Anthropol, Toronto, ON M5S 1A1, Canada; [Schillaci, Michael A.] Univ Toronto Scarborough, Dept Social Sci, Toronto, ON, Canada; [Lowenberger, Carl A.] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada; [Galdikas, Birute M. F.] Simon Fraser Univ, Dept Archaeol, Burnaby, BC V5A 1S6, Canada; [Jones-Engel, Lisa] Univ Washington, Natl Primate Res Ctr, Seattle, WA 98195 USA; [Escalante, Ananias A.] Arizona State Univ, Sch Life Sci, Tempe, AZ USA	Arizona State University; Arizona State University-Tempe; University of Toronto; University of Toronto; University Toronto Scarborough; Simon Fraser University; Simon Fraser University; University of Washington; University of Washington Seattle; Arizona State University; Arizona State University-Tempe	Escalante, AA (corresponding author), Arizona State Univ, Ctr Evolutionary Med & Informat, Biodesign Inst, Tempe, AZ 85287 USA.	Ananias.Escalante@asu.edu	Reid, Michael/AAM-1640-2020	Jones-Engel, Lisa/0000-0001-6912-494X; Pacheco, Maria Andreina/0000-0002-5682-7299; Escalante, Ananias/0000-0002-1532-3430	U.S. National Institutes of Health [GM084320]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084320, R01GM080586] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by a grant from the U.S. National Institutes of Health, GM084320 to AAE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Ali JR, 2010, NATURE, V463, P653, DOI 10.1038/nature08706; Arora N, 2010, P NATL ACAD SCI USA, V107, P21376, DOI 10.1073/pnas.1010169107; Begun DR, 2010, ANNU REV ANTHROPOL, V39, P67, DOI 10.1146/annurev.anthro.012809.105047; Benton MJ, 2007, MOL BIOL EVOL, V24, P26, DOI 10.1093/molbev/msl150; Bird MI, 2005, QUATERNARY SCI REV, V24, P2228, DOI 10.1016/j.quascirev.2005.04.004; Chaimanee Y, 2004, NATURE, V427, P439, DOI 10.1038/nature02245; Coatney R.G., 1971, PRIMATE MALARIA; COLLINS WE, 1970, EXP PARASITOL, V27, P507, DOI 10.1016/0014-4894(70)90054-8; Cornejo OE, 2006, TRENDS PARASITOL, V22, P558, DOI 10.1016/j.pt.2006.09.007; CORREDOR V, 1993, MOL BIOL EVOL, V10, P924; Delson E., 1980, P10; Dhorda M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019801; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; ESCALANTE AA, 1995, MOL BIOL EVOL, V12, P616; Escalante AA, 1998, P NATL ACAD SCI USA, V95, P8124, DOI 10.1073/pnas.95.14.8124; Escalante AA, 2005, P NATL ACAD SCI USA, V102, P1980, DOI 10.1073/pnas.0409652102; ESCALANTE AA, 1994, P NATL ACAD SCI USA, V91, P11373, DOI 10.1073/pnas.91.24.11373; GALINSKI MR, 1987, CELL, V48, P311, DOI 10.1016/0092-8674(87)90434-X; Garnham PCC., 1966, MALARIA PARASITES OT; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hayakawa T, 2008, MOL BIOL EVOL, V25, P2233, DOI 10.1093/molbev/msn171; HOLDER AA, 1982, J EXP MED, V156, P1528, DOI 10.1084/jem.156.5.1528; Huang CC, 2010, J PARASITOL, V96, P8, DOI 10.1645/GE-2165.1; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Imwong M, 2009, J CLIN MICROBIOL, V47, P4173, DOI 10.1128/JCM.00811-09; Krief S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000765; Lee KS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002015; Liu WM, 2010, NATURE, V467, P420, DOI 10.1038/nature09442; Locke DP, 2011, NATURE, V469, P529, DOI 10.1038/nature09687; Lohman DJ, 2011, ANNU REV ECOL EVOL S, V42, P205, DOI 10.1146/annurev-ecolsys-102710-145001; Mailund T, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001319; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Mendes C, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001192; Mu JB, 2005, MOL BIOL EVOL, V22, P1686, DOI 10.1093/molbev/msi160; Ollomo B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000446; Pacheco MA, 2007, INFECT GENET EVOL, V7, P180, DOI 10.1016/j.meegid.2006.08.002; Pacheco MA, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-299; Perkins SL, 2002, J PARASITOL, V88, P972, DOI 10.1645/0022-3395(2002)088[0972:AMPOMP]2.0.CO;2; PETERS W, 1976, PHILOS T R SOC B, V275, P439, DOI 10.1098/rstb.1976.0089; Poux C, 2005, SYST BIOL, V54, P719, DOI 10.1080/10635150500234534; Prugnolle F, 2010, P NATL ACAD SCI USA, V107, P1458, DOI 10.1073/pnas.0914440107; Reid MJC, 2006, EMERG INFECT DIS, V12, P1902; Rich SM, 2009, P NATL ACAD SCI USA, V106, P14902, DOI 10.1073/pnas.0907740106; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Singh B, 2004, LANCET, V363, P1017, DOI 10.1016/S0140-6736(04)15836-4; Singh B, 2009, EMERG INFECT DIS, V15, P1657, DOI 10.3201/eid1510.090364; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thinh VN, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-74	48	36	36	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e34990	10.1371/journal.pone.0034990	http://dx.doi.org/10.1371/journal.pone.0034990			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536346	gold, Green Published, Green Submitted			2022-12-27	WOS:000305339200031
J	Schmidt, N; Brandsch, C; Kuhne, H; Thiele, A; Hirche, F; Stangl, GI				Schmidt, Nadine; Brandsch, Corinna; Kuehne, Hagen; Thiele, Alexandra; Hirche, Frank; Stangl, Gabriele I.			Vitamin D Receptor Deficiency and Low Vitamin D Diet Stimulate Aortic Calcification and Osteogenic Key Factor Expression in Mice	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELL; VASCULAR CALCIFICATION; CARDIOVASCULAR-DISEASE; RISK; ATHEROSCLEROSIS; 25-HYDROXYVITAMIN-D; ASSOCIATION; PREVALENCE; MECHANISMS; CALCITRIOL	Low levels of 25-hydroxy vitamin D (25(OH)D) are associated with cardiovascular diseases. Herein, we tested the hypothesis that vitamin D deficiency could be a causal factor in atherosclerotic vascular changes and vascular calcification. Aortic root sections of vitamin D receptor knockout (VDR-/-) mice that were stained for vascular calcification and immunostained for osteoblastic differentiation factors showed more calcified areas and a higher expression of the osteogenic key factors Msx2, Bmp2, and Runx2 than the wild-type mice (P<0.01). Data from LDL receptor knockout (LDLR-/-) mice that were fed western diet with either low (50 IU/kg), recommended (1,000 IU/kg), or high (10,000 IU/kg) amounts of vitamin D-3 over 16 weeks revealed increasing plasma concentrations of 25(OH)D (P<0.001) with increasing intake of vitamin D, whereas levels of calcium and phosphorus in plasma and femur were not influenced by the dietary treatment. Mice treated with the low vitamin D diet had more calcified lesions and a higher expression of Msx2, Bmp2, and Runx2 in aortic roots than mice fed recommended or high amounts of vitamin D (P<0.001). Taken together, these findings indicate vitamin D deficiency as a risk factor for aortic valve and aortic vessel calcification and a stimulator of osteogenic key factor expression in these vascular areas.	[Schmidt, Nadine; Brandsch, Corinna; Kuehne, Hagen; Thiele, Alexandra; Hirche, Frank; Stangl, Gabriele I.] Univ Halle Wittenberg, Inst Agr & Nutr Sci, Halle, Saale, Germany	Martin Luther University Halle Wittenberg	Stangl, GI (corresponding author), Univ Halle Wittenberg, Inst Agr & Nutr Sci, Halle, Saale, Germany.	gabriele.stangl@landw.uni-halle.de		Schutkowski, Alexandra/0000-0002-9387-7869	Federal Ministry of Education and Research of Germany [0315668A]	Federal Ministry of Education and Research of Germany(Federal Ministry of Education & Research (BMBF))	This work was supported by grant 0315668A from the Federal Ministry of Education and Research of Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedin M, 2004, ARTERIOSCL THROM VAS, V24, P1161, DOI 10.1161/01.ATV.0000133194.94939.42; AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Allison MA, 2004, ARTERIOSCL THROM VAS, V24, P331, DOI 10.1161/01.ATV.0000110786.02097.0c; Artaza JN, 2009, CLIN J AM SOC NEPHRO, V4, P1515, DOI 10.2215/CJN.02260409; BASSLER R, 1993, CHEM UNTERSUCHUNG FU, V2; BRAUNWALD, 1997, J MOD, V337, P1360; Breslow JL, 1997, NAT MED, V3, P600, DOI 10.1038/nm0697-600; Cannata-Andia JB, 2006, J AM SOC NEPHROL, V17, pS267, DOI 10.1681/ASN.2006080925; Dobnig H, 2008, ARCH INTERN MED, V168, P1340, DOI 10.1001/archinte.168.12.1340; Fleet JC, 2008, J NUTR, V138, P1114, DOI 10.1093/jn/138.6.1114; Giovannucci E, 2008, ARCH INTERN MED, V168, P1174, DOI 10.1001/archinte.168.11.1174; Higashi T, 2008, ANAL BIOANAL CHEM, V391, P229, DOI 10.1007/s00216-007-1780-3; HOLICK MF, 1980, SCIENCE, V210, P203, DOI 10.1126/science.6251551; Johnson RC, 2006, CIRC RES, V99, P1044, DOI 10.1161/01.RES.0000249379.55535.21; KELLY RP, 1992, CIRC RES, V71, P490, DOI 10.1161/01.RES.71.3.490; Kilkkinen A, 2009, AM J EPIDEMIOL, V170, P1032, DOI 10.1093/aje/kwp227; Lips P, 2006, J INTERN MED, V260, P245, DOI 10.1111/j.1365-2796.2006.01685.x; Mathew S, 2008, J AM SOC NEPHROL, V19, P1509, DOI 10.1681/ASN.2007080902; Mizobuchi M, 2009, J AM SOC NEPHROL, V20, P1453, DOI 10.1681/ASN.2008070692; Mori K, 1999, ARTERIOSCL THROM VAS, V19, P2112, DOI 10.1161/01.ATV.19.9.2112; Nagpal S, 2005, ENDOCR REV, V26, P662, DOI 10.1210/er.2004-0002; *NRC, 1995, NUTR REQ LAB AN, P80, DOI DOI 10.1038/NATURE08778; Rahman A, 2007, J STEROID BIOCHEM, V103, P416, DOI 10.1016/j.jsbmb.2006.12.081; Vinas BR, 2011, ANN NUTR METAB, V59, P84, DOI 10.1159/000332762; ROSS R, 1973, SCIENCE, V180, P1332, DOI 10.1126/science.180.4093.1332; Shoben AB, 2008, J AM SOC NEPHROL, V19, P1613, DOI 10.1681/ASN.2007111164; Speer MY, 2010, J CELL BIOCHEM, V110, P935, DOI 10.1002/jcb.22607; Steitz SA, 2001, CIRC RES, V89, P1147, DOI 10.1161/hh2401.101070; Takeda M, 2010, ARTERIOSCL THROM VAS, V30, P2495, DOI 10.1161/ATVBAHA.110.215459; Towler DA, 2006, ANN NY ACAD SCI, V1068, P327, DOI 10.1196/annals.1346.036; Wang TJ, 2008, CIRCULATION, V117, P503, DOI 10.1161/CIRCULATIONAHA.107.706127; Watson KE, 1997, CIRCULATION, V96, P1755, DOI 10.1161/01.CIR.96.6.1755; Wolf M, 2008, J AM SOC NEPHROL, V19, P1379, DOI 10.1681/ASN.2007091002; Zebboudj AF, 2003, J CELL BIOCHEM, V90, P756, DOI 10.1002/jcb.10669	34	66	69	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35316	10.1371/journal.pone.0035316	http://dx.doi.org/10.1371/journal.pone.0035316			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536373	Green Submitted, Green Published, gold			2022-12-27	WOS:000305339200056
J	Yang, P; Zhu, JY; Gong, ZJ; Xu, DL; Chen, XM; Liu, WW; Lin, XD; Li, YF				Yang, Pu; Zhu, Jia-Ying; Gong, Zhong-Jun; Xu, Dong-Li; Chen, Xiao-Ming; Liu, Wei-Wei; Lin, Xin-Da; Li, Yan-Fei			Transcriptome Analysis of the Chinese White Wax Scale Ericerus pela with Focus on Genes Involved in Wax Biosynthesis	PLOS ONE			English	Article							FATTY-ACYL REDUCTASE; PHEROMONE-GLAND; COENZYME; ACYLTRANSFERASE; IDENTIFICATION; SYNTHASE; CLONING; ESTER; PURIFICATION; ENCODES	Background: The Chinese white wax scale, Ericerus pela Chavannes is economically significant for its role in wax production. This insect has been bred in China for over a thousand years. The wax secreted by the male scale insect during the second-instar larval stage has been widespread used in wax candle production, wax printing, engraving, Chinese medicine, and more recently in the chemical, pharmaceutical, food, and cosmetics industries. However, little is known about the mechanisms responsible for white wax biosynthesis. The characterization of its larval transcriptome may promote better understanding of wax biosynthesis. Methodology/Principal Findings: In this study, characterization of the transcriptome of E. pela during peak wax secretion was performed using Illumina sequencing technology. Illumina sequencing produced 41,839 unigenes. These unigenes were annotated by blastx alignment against the NCBI Non-Redundant (NR), Swiss-Prot, KEGG, and COG databases. A total of 104 unigenes related to white wax biosynthesis were identified, and 15 of them were selected for quantitative real-time PCR analysis. We evaluated the variations in gene expression across different development stages, including egg, first/second instar larvae, male pupae, and male and female adults. Then we identified five genes involved in white wax biosynthesis. These genes were expressed most strongly during the second-instar larval stage of male E. pela. Conclusion/Significance: The transcriptome analysis of E. pela during peak wax secretion provided an overview of gene expression information at the transcriptional level and a resource for gene mining. Five genes related to white wax biosynthesis were identified.	[Yang, Pu; Xu, Dong-Li; Chen, Xiao-Ming; Liu, Wei-Wei; Li, Yan-Fei] Chinese Acad Forestry, Res Inst Resources Insects, Key Lab Cultivating & Utilizat Resources Insects, Kunming, Peoples R China; [Zhu, Jia-Ying] SW Forestry Univ, Coll Forestry, Key Lab Forest Disaster Warning & Control Yunnan, Kunming, Peoples R China; [Gong, Zhong-Jun] Henan Acad Agr Sci, Inst Plant Protect, Key Lab Crop Pest Control Henan Prov, Zhengzhou, Peoples R China; [Lin, Xin-Da] China Jiliang Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China	Chinese Academy of Forestry; Research Institute of Resources Insects, CAF; Henan Academy of Agricultural Sciences; China Jiliang University	Chen, XM (corresponding author), Chinese Acad Forestry, Res Inst Resources Insects, Key Lab Cultivating & Utilizat Resources Insects, Kunming, Peoples R China.	cafchxm@tom.com	Gong, Zhongjun/AAZ-4442-2020; Yang, Pu/L-1442-2019		National Natural Science Foundation of China [31000983]; Applied Basic Research Foundation of Yunnan Province [2010ZC235]; National Nonprofit Institute Research Grant of RIRI-CAF [riricaf200904M-3, riricaf2011006M]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Applied Basic Research Foundation of Yunnan Province; National Nonprofit Institute Research Grant of RIRI-CAF	Funding provided by National Natural Science Foundation of China (Youth Program) (Grant No. 31000983)(Website:http://www.nsfc.gov.cn/Portal0/default152.htm); Applied Basic Research Foundation of Yunnan Province (Grant No. 2010ZC235); National Nonprofit Institute Research Grant of RIRI-CAF (Grant No. riricaf200904M-3, riricaf2011006M). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antony B, 2009, INSECT BIOCHEM MOLEC, V39, P90, DOI 10.1016/j.ibmb.2008.10.008; Biester EM, 2012, BMC BIOCHEM, V13, DOI 10.1186/1471-2091-13-4; Chen X. M., 2009, INTRO RESOURCE ENTOM, P29; Cheng JB, 2004, J BIOL CHEM, V279, P37789, DOI 10.1074/jbc.M406225200; Cheng JB, 2004, J BIOL CHEM, V279, P37798, DOI 10.1074/jbc.M406226200; Costaglioli P, 2005, BBA-MOL CELL BIOL L, V1734, P247, DOI 10.1016/j.bbalip.2005.04.002; Doan TTP, 2009, J PLANT PHYSIOL, V166, P787, DOI 10.1016/j.jplph.2008.10.003; Hellenbrand J, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-64; Holtzapple E, 2007, J BACTERIOL, V189, P3804, DOI 10.1128/JB.01932-06; Kalscheuer R, 2003, J BIOL CHEM, V278, P8075, DOI 10.1074/jbc.M210533200; King A, 2007, PLANTA, V226, P381, DOI 10.1007/s00425-007-0489-z; Kunst L, 2003, PROG LIPID RES, V42, P51, DOI 10.1016/S0163-7827(02)00045-0; Lardizabal KD, 2000, PLANT PHYSIOL, V122, P645, DOI 10.1104/pp.122.3.645; Lassance JM, 2010, NATURE, V466, P486, DOI 10.1038/nature09058; Leonard AE, 2004, PROG LIPID RES, V43, P36, DOI 10.1016/S0163-7827(03)00040-7; Li F, 2008, PLANT PHYSIOL, V148, P97, DOI 10.1104/pp.108.123471; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Lienard MA, 2010, P NATL ACAD SCI USA, V107, P10955, DOI 10.1073/pnas.1000823107; Lung Tsuen-ni, 2004, AGR HIST CHINA, P18; Metz JG, 2000, PLANT PHYSIOL, V122, P635, DOI 10.1104/pp.122.3.635; Moto K, 2003, P NATL ACAD SCI USA, V100, P9156, DOI 10.1073/pnas.1531993100; Rowland O, 2006, PLANT PHYSIOL, V142, P866, DOI 10.1104/pp.106.086785; Sakuradani E, 2009, APPL MICROBIOL BIOT, V84, P709, DOI 10.1007/s00253-009-1999-3; Shi J, 2011, PLANT CELL, V23, P2225, DOI 10.1105/tpc.111.087528; Suarez E, 2011, ANAL CHIM ACTA, V706, P157, DOI 10.1016/j.aca.2011.08.033; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang Q. Y., 2010, DPS DATA PROCESSING, P82; Teerawanichpan P, 2010, INSECT BIOCHEM MOLEC, V40, P641, DOI 10.1016/j.ibmb.2010.06.004; Teerawanichpan P, 2010, LIPIDS, V45, P263, DOI 10.1007/s11745-010-3395-2; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vogel H, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-29; Yang P, 2011, AFR J MICROBIOL RES, V5, P1246; Yang P, 2011, AFR J MICROBIOL RES, V5, P1108	33	32	45	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35719	10.1371/journal.pone.0035719	http://dx.doi.org/10.1371/journal.pone.0035719			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536429	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339200101
J	Hammond, JA; Hauton, C; Bennett, KA; Hall, AJ				Hammond, John A.; Hauton, Chris; Bennett, Kimberley A.; Hall, Ailsa J.			Phocid Seal Leptin: Tertiary Structure and Hydrophobic Receptor Binding Site Preservation during Distinct Leptin Gene Evolution	PLOS ONE			English	Article							BODY-MASS; LUNG; HYPOTHESIS; LACTATION; MOTHERS; MODEL; DIVES	The cytokine hormone leptin is a key signalling molecule in many pathways that control physiological functions. Although leptin demonstrates structural conservation in mammals, there is evidence of positive selection in primates, lagomorphs and chiropterans. We previously reported that the leptin genes of the grey and harbour seals (phocids) have significantly diverged from other mammals. Therefore we further investigated the diversification of leptin in phocids, other marine mammals and terrestrial taxa by sequencing the leptin genes of representative species. Phylogenetic reconstruction revealed that leptin diversification was pronounced within the phocid seals with a high dN/dS ratio of 2.8, indicating positive selection. We found significant evidence of positive selection along the branch leading to the phocids, within the phocid clade, but not over the dataset as a whole. Structural predictions indicate that the individual residues under selection are away from the leptin receptor (LEPR) binding site. Predictions of the surface electrostatic potential indicate that phocid seal leptin is notably different to other mammalian leptins, including the otariids. Cloning the grey seal leptin binding domain of LEPR confirmed that this was structurally conserved. These data, viewed in toto, support a hypothesis that phocid leptin divergence is unlikely to have arisen by random mutation. Based upon these phylogenetic and structural assessments, and considering the comparative physiology and varying life histories among species, we postulate that the unique phocid diving behaviour has produced this selection pressure. The Phocidae includes some of the deepest diving species, yet have the least modified lung structure to cope with pressure and volume changes experienced at depth. Therefore, greater surfactant production is required to facilitate rapid lung re-inflation upon surfacing, while maintaining patent airways. We suggest that this additional surfactant requirement is met by the leptin pulmonary surfactant production pathway which normally appears only to function in the mammalian foetus.	[Hammond, John A.] Inst Anim Hlth, Newbury, Berks, England; [Hauton, Chris] Univ Southampton, Natl Oceanog Ctr Southampton, Southampton, Hants, England; [Bennett, Kimberley A.] Univ Plymouth, Marine Biol & Ecol Res Ctr, Sch Marine Sci & Engn, Plymouth PL4 8AA, Devon, England; [Hall, Ailsa J.] Univ St Andrews, Sea Mammal Res Unit, Scottish Oceans Inst, St Andrews, Fife, Scotland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; NERC National Oceanography Centre; University of Southampton; University of Plymouth; University of St Andrews	Hammond, JA (corresponding author), Inst Anim Hlth, Newbury, Berks, England.	ajh7@st-andrews.ac.uk	Hall, Ailsa/E-1596-2011; Bennett, Kimberley/O-9142-2016	Bennett, Kimberley/0000-0003-2168-6112; Hammond, John/0000-0002-2213-3248; Hauton, Chris/0000-0002-2313-4226; Hall, Ailsa/0000-0002-7562-1771	UK Natural Environment Research Council; BBSRC from the Institute for Animal Health [BBS/E/I/00001410]; BBSRC [BBS/E/I/00001410] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/I/00001410] Funding Source: researchfish; Natural Environment Research Council [smru10001] Funding Source: researchfish	UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); BBSRC from the Institute for Animal Health(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by the UK Natural Environment Research Council and a BBSRC Fellowship awarded to JAH from the Institute for Animal Health, BBSRC grant number BBS/E/I/00001410. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahima RS, 2000, TRENDS ENDOCRIN MET, V11, P327, DOI 10.1016/S1043-2760(00)00301-5; Alende N, 2011, PROTEINS, V79, P1635, DOI 10.1002/prot.22990; Arnason U, 2002, CYTOGENET GENOME RES, V96, P20, DOI 10.1159/000063023; Arnason U, 2006, MOL PHYLOGENET EVOL, V41, P345, DOI 10.1016/j.ympev.2006.05.022; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BOWEN WD, 1992, PHYSIOL ZOOL, V65, P844, DOI 10.1086/physzool.65.4.30158543; Cao Y, 2000, GENE, V259, P149, DOI 10.1016/S0378-1119(00)00427-3; DENISON DM, 1973, RESP PHYSIOL, V17, P1, DOI 10.1016/0034-5687(73)90105-9; Denver RJ, 2011, NEUROENDOCRINOLOGY, V94, P21, DOI 10.1159/000328435; Fong TM, 1998, MOL PHARMACOL, V53, P234, DOI 10.1124/mol.53.2.234; Fruhbeck G, 1998, CLIN PHYSIOL, V18, P399, DOI 10.1046/j.1365-2281.1998.00129.x; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hamann A, 1996, EXP CLIN ENDOCR DIAB, V104, P293, DOI 10.1055/s-0029-1211457; HAMMILL MO, 1991, CAN J FISH AQUAT SCI, V48, P2471, DOI 10.1139/f91-288; Hammond JA, 2005, AM J PHYSIOL-REG I, V289, pR545, DOI 10.1152/ajpregu.00203.2004; Harvey J, 2003, NEUROPHARMACOLOGY, V44, P845, DOI 10.1016/S0028-3908(03)00076-5; HINDELL MA, 1992, CAN J ZOOL, V70, P370, DOI 10.1139/z92-055; Iserentant H, 2005, J CELL SCI, V118, P2519, DOI 10.1242/jcs.02386; Kirwin SM, 2006, PEDIATR RES, V60, P200, DOI 10.1203/01.pdr.0000227478.29271.52; Kooyman GL, 2006, MAR MAMMAL SCI, V22, P507, DOI 10.1111/j.1748-7692.2006.00069.x; KOOYMAN GL, 1973, AM ZOOL, V13, P457; KOVACS KM, 1991, J ZOOL, V223, P213, DOI 10.1111/j.1469-7998.1991.tb04761.x; Krol E, 2007, J ENDOCRINOL, V192, P271, DOI 10.1677/JOE-06-0074; Li XS, 2007, PHYSIOL BIOCHEM ZOOL, V80, P326, DOI 10.1086/513189; Pabst D.A., 1999, MARINE MAMMALS, P15; Peelman F, 2004, J BIOL CHEM, V279, P41038, DOI 10.1074/jbc.M404962200; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Sato K, 2002, POLAR BIOL, V25, P696, DOI 10.1007/s00300-002-0406-7; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Teodorescu O, 2004, PROTEINS, V54, P41, DOI 10.1002/prot.10474; Torday JS, 2002, AM J PHYSIOL-LUNG C, V282, pL405, DOI 10.1152/ajplung.2002.282.3.L405; Torday JS, 2002, AM J PHYSIOL-LUNG C, V283, pL130, DOI 10.1152/ajplung.00380.2001; Tsuchiya T, 1999, EUR J PHARMACOL, V365, P273, DOI 10.1016/S0014-2999(98)00884-X; Wheatley KE, 2008, OECOLOGIA, V155, P11, DOI 10.1007/s00442-007-0888-7; Yang J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001472; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yu L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026579; Yuan LH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027189; Zhang FM, 1997, NATURE, V387, P206, DOI 10.1038/387206a0	40	8	8	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e35395	10.1371/journal.pone.0035395	http://dx.doi.org/10.1371/journal.pone.0035395			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22536379	Green Published, gold, Green Accepted			2022-12-27	WOS:000305336200038
J	Liang, SN; Lan, BL				Liang, Shiuan-Ni; Lan, Boon Leong			Comparison of Newtonian and Special-Relativistic Trajectories with the General-Relativistic Trajectory for a Low-Speed Weak-Gravity System	PLOS ONE			English	Article								We show, contrary to expectation, that the trajectory predicted by general-relativistic mechanics for a low-speed weak-gravity system is not always well-approximated by the trajectories predicted by special-relativistic and Newtonian mechanics for the same parameters and initial conditions. If the system is dissipative, the breakdown of agreement occurs for chaotic trajectories only. If the system is non-dissipative, the breakdown of agreement occurs for chaotic trajectories and non-chaotic trajectories. The agreement breaks down slowly for non-chaotic trajectories but rapidly for chaotic trajectories. When the predictions are different, general-relativistic mechanics must therefore be used, instead of special-relativistic mechanics (Newtonian mechanics), to correctly study the dynamics of a weak-gravity system (a low-speed weak-gravity system).	[Liang, Shiuan-Ni; Lan, Boon Leong] Monash Univ, Sch Sci, Bandar Sunway, Selangor, Malaysia	Monash University; Monash University Sunway	Liang, SN (corresponding author), Monash Univ, Sch Sci, Bandar Sunway, Selangor, Malaysia.	lan.boon.leong@monash.edu		Liang, Shiuan-Ni/0000-0001-9953-339X	Fundamental Research Grant Scheme [FRGS/2/2010/ST/MUSM/02/1]	Fundamental Research Grant Scheme	This work was funded by a Fundamental Research Grant Scheme FRGS/2/2010/ST/MUSM/02/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Choquet-Bruhat Y., 2009, GEN RELATIVITY EINST; Davies P., 1992, NEW PHYS, P1; de Pater I, 2010, PLANETARY SCI, P302; Einstein A., 1961, RELATIVITY SPECIAL G, P115; French A. P., 1968, SPECIAL RELATIVITY; Hartle J.B., 2003, GRAVITY INTRO EINSTE; Lan BL, 2009, TOPICS ON CHAOTIC SYSTEMS, P199, DOI 10.1142/9789814271349_0023; Lan BL, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.036201; Lan BL, 2010, COMMUN NONLINEAR SCI, V15, P2497, DOI 10.1016/j.cnsns.2009.10.008; Lan BL, 2009, CHAOS SOLITON FRACT, V42, P534, DOI 10.1016/j.chaos.2009.01.021; Lan BL, 2006, CHAOS, V16, DOI 10.1063/1.2218379; LAPIDUS IR, 1972, AM J PHYS, V40, P1509, DOI 10.1119/1.1986879; Liang SN, 2011, RESULTS PHYS, V1, P36, DOI 10.1016/j.rinp.2011.10.001; LICHTENBERG AJ, 1983, REGULAR STOCHASTIC M; Lissauer JJ, 1999, REV MOD PHYS, V71, P835, DOI 10.1103/RevModPhys.71.835; Sprott JC, 2003, CHAOS TIME SERIES AN; TUFILLARO NB, 1986, J PHYS-PARIS, V47, P1477, DOI 10.1051/jphys:019860047090147700; TUFILLARO NB, 1992, EXPT APPROACH NONLIN; Wald R., 1984, GEN RELATIVITY	19	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e34720	10.1371/journal.pone.0034720	http://dx.doi.org/10.1371/journal.pone.0034720			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22536328	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336200008
J	Fabrick, JA; Tabashnik, BE				Fabrick, Jeffrey A.; Tabashnik, Bruce E.			Similar Genetic Basis of Resistance to Bt Toxin Cry1Ac in Boll-Selected and Diet-Selected Strains of Pink Bollworm	PLOS ONE			English	Article							BACILLUS-THURINGIENSIS TOXINS; PECTINOPHORA-GOSSYPIELLA; INSECT RESISTANCE; TRANSGENIC COTTON; FITNESS COSTS; HELICOVERPA-ARMIGERA; HELIOTHIS-VIRESCENS; CROSS-RESISTANCE; DIAMONDBACK MOTH; CROPS	Genetically engineered cotton and corn plants producing insecticidal Bacillus thuringiensis (Bt) toxins kill some key insect pests. Yet, evolution of resistance by pests threatens long-term insect control by these transgenic Bt crops. We compared the genetic basis of resistance to Bt toxin Cry1Ac in two independently derived, laboratory-selected strains of a major cotton pest, the pink bollworm (Pectinophora gossypiella [Saunders]). The Arizona pooled resistant strain (AZP-R) was started with pink bollworm from 10 field populations and selected with Cry1Ac in diet. The Bt4R resistant strain was started with a long-term susceptible laboratory strain and selected first with Bt cotton bolls and later with Cry1Ac in diet. Previous work showed that AZP-R had three recessive mutations (r1, r2, and r3) in the pink bollworm cadherin gene (PgCad1) linked with resistance to Cry1Ac and Bt cotton producing Cry1Ac. Here we report that inheritance of resistance to a diagnostic concentration of Cry1Ac was recessive in Bt4R. In interstrain complementation tests for allelism, F-1 progeny from crosses between AZP-R and Bt4R were resistant to Cry1Ac, indicating a shared resistance locus in the two strains. Molecular analysis of the Bt4R cadherin gene identified a novel 15-bp deletion (r4) predicted to cause the loss of five amino acids upstream of the Cry1Ac-binding region of the cadherin protein. Four recessive mutations in PgCad1 are now implicated in resistance in five different strains, showing that mutations in cadherin are the primary mechanism of resistance to Cry1Ac in laboratory-selected strains of pink bollworm from Arizona.	[Fabrick, Jeffrey A.] USDA ARS, US Arid Land Agr Res Ctr, Maricopa, AZ USA; [Tabashnik, Bruce E.] Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA	United States Department of Agriculture (USDA); University of Arizona	Fabrick, JA (corresponding author), USDA ARS, US Arid Land Agr Res Ctr, Maricopa, AZ USA.	jeff.fabrick@ars.usda.gov		Fabrick, Jeffrey/0000-0002-3893-9545	USDA-Agriculture and Food Research Initiative [2008-35302-0390]	USDA-Agriculture and Food Research Initiative(United States Department of Agriculture (USDA))	This work was supported by USDA-Agriculture and Food Research Initiative Grant 2008-35302-0390. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagla P, 2010, SCIENCE, V327, P1439, DOI 10.1126/science.327.5972.1439; Bartlett A. C., 1995, 1995 Proceedings Beltwide Cotton Conferences, San Antonio, TX, USA, January 4-7, 1995: Volume 2., P766; Bartlett A. C., 1985, HDB INSECT REARING, V2, P415; Baxter SW, 2011, GENETICS, V189, P675, DOI 10.1534/genetics.111.130971; Bravo A, 2011, INSECT BIOCHEM MOLEC, V41, P423, DOI 10.1016/j.ibmb.2011.02.006; Carriere Y, 2005, J ECON ENTOMOL, V98, P947, DOI 10.1603/0022-0493-98.3.947; Carriere Y, 2003, P NATL ACAD SCI USA, V100, P1519, DOI 10.1073/pnas.0436708100; Carriere Y, 2001, J ECON ENTOMOL, V94, P1571, DOI 10.1603/0022-0493-94.6.1571; Carriere Y, 2006, J ECON ENTOMOL, V99, P1925, DOI 10.1603/0022-0493-99.6.1925; Dhurua S, 2011, PEST MANAG SCI, V67, P898, DOI 10.1002/ps.2127; Fabrick JA, 2007, INSECT BIOCHEM MOLEC, V37, P97, DOI 10.1016/j.ibmb.2006.10.010; Fabrick JA, 2011, INSECT MOL BIOL, V20, P651, DOI 10.1111/j.1365-2583.2011.01095.x; Fabrick JA, 2009, J INSECT SCI, V9, DOI 10.1673/031.009.2401; Ferre J, 2002, ANNU REV ENTOMOL, V47, P501, DOI 10.1146/annurev.ento.47.091201.145234; Gahan LJ, 2001, SCIENCE, V293, P857, DOI 10.1126/science.1060949; Gassmann AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022629; Gonzalez-Cabrera J, 2003, INSECT BIOCHEM MOLEC, V33, P929, DOI 10.1016/S0965-1748(03)00099-7; Henneberry TJ, 2006, SOUTHWEST ENTOMOL, V31, P169; Henneberry T. J., 1998, Integrated Pest Management Reviews, V3, P31, DOI 10.1023/A:1009673622862; Herrero S, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-96; Hutchison WD, 2010, SCIENCE, V330, P222, DOI 10.1126/science.1190242; Jurat-Fuentes JL, 2004, BIOCHEMISTRY-US, V43, P14299, DOI 10.1021/bi048500i; Kruger M, 2009, CROP PROT, V28, P684, DOI 10.1016/j.cropro.2009.04.001; Liu YB, 2001, J ECON ENTOMOL, V94, P1237, DOI 10.1603/0022-0493-94.5.1237; Liu YB, 1999, NATURE, V400, P519, DOI 10.1038/22919; Liu YB, 2001, J ECON ENTOMOL, V94, P248, DOI 10.1603/0022-0493-94.1.248; Liu YB, 1997, APPL ENVIRON MICROB, V63, P2218, DOI 10.1128/AEM.63.6.2218-2223.1997; Mendelsohn M, 2003, NAT BIOTECHNOL, V21, P1003, DOI 10.1038/nbt0903-1003; Morin S, 2004, INSECT BIOCHEM MOLEC, V34, P1225, DOI 10.1016/j.ibmb.2004.08.003; Morin S, 2003, P NATL ACAD SCI USA, V100, P5004, DOI 10.1073/pnas.0831036100; National Research Council, 2010, IMP GEN ENG CROPS FA; Sanahuja G, 2011, PLANT BIOTECHNOL J, V9, P283, DOI 10.1111/j.1467-7652.2011.00595.x; Storer NP, 2010, J ECON ENTOMOL, V103, P1031, DOI 10.1603/EC10040; Tabashnik BE, 2000, P NATL ACAD SCI USA, V97, P12980, DOI 10.1073/pnas.97.24.12980; Tabashnik BE, 2003, J ECON ENTOMOL, V96, P1031, DOI 10.1603/0022-0493-96.4.1031; Tabashnik BE, 2000, APPL ENVIRON MICROB, V66, P4582, DOI 10.1128/AEM.66.10.4582-4584.2000; TABASHNIK BE, 1994, ANNU REV ENTOMOL, V39, P47, DOI 10.1146/annurev.en.39.010194.000403; Tabashnik BE, 2005, J ECON ENTOMOL, V98, P635, DOI 10.1603/0022-0493-98.3.635; Tabashnik BE, 2004, J ECON ENTOMOL, V97, P721, DOI 10.1603/0022-0493(2004)097[0721:SGBORT]2.0.CO;2; Tabashnik BE, 1997, P NATL ACAD SCI USA, V94, P12780, DOI 10.1073/pnas.94.24.12780; Tabashnik BE, 2002, APPL ENVIRON MICROB, V68, P3790, DOI 10.1128/AEM.68.8.3790-3794.2002; Tabashnik BE, 2002, J ECON ENTOMOL, V95, P1018, DOI 10.1603/0022-0493-95.5.1018; Tabashnik BE, 2005, P NATL ACAD SCI USA, V102, P15389, DOI 10.1073/pnas.0507857102; Tabashnik BE, 2008, NAT BIOTECHNOL, V26, P199, DOI 10.1038/nbt1382; Tabashnik BE, 2006, J ECON ENTOMOL, V99, P1525, DOI 10.1603/0022-0493-99.5.1525; Tabashnik BE, 2010, NAT BIOTECHNOL, V28, P1304, DOI 10.1038/nbt.1704; Tabashnik BE, 2009, J ECON ENTOMOL, V102, P2011, DOI 10.1603/029.102.0601; Tabashnik BE, 2009, P NATL ACAD SCI USA, V106, P11889, DOI 10.1073/pnas.0901351106; Wan P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029975; Williams JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021863; Wu KM, 2008, SCIENCE, V321, P1676, DOI 10.1126/science.1160550; Xu XJ, 2005, APPL ENVIRON MICROB, V71, P948, DOI 10.1128/AEM.71.2.948-954.2005; Zhang XB, 2006, P NATL ACAD SCI USA, V103, P9897, DOI 10.1073/pnas.0604017103; Zhao J, 2010, INSECT BIOCHEM MOLEC, V40, P113, DOI 10.1016/j.ibmb.2010.01.001	54	43	45	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35658	10.1371/journal.pone.0035658	http://dx.doi.org/10.1371/journal.pone.0035658			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22530065	Green Submitted, gold, Green Published			2022-12-27	WOS:000305350600111
J	Lee, NS; Rohan, JG; Zitting, M; Kamath, S; Weitz, A; Sipos, A; Salvaterra, PM; Hasegawa, K; Pera, M; Chow, RH				Lee, Nan Sook; Rohan, Joyce G.; Zitting, Madison; Kamath, Sonia; Weitz, Andrew; Sipos, Arnold; Salvaterra, Paul M.; Hasegawa, Kouichi; Pera, Martin; Chow, Robert H.			A Novel Dual-Color Reporter for Identifying Insulin-Producing Beta- Cells and Classifying Heterogeneity of Insulinoma Cell Lines	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; GENE-EXPRESSION; TRANSGENIC MICE; ENDOCRINE PANCREAS; ADULT HUMAN; IN-VIVO; MOUSE; SECRETION; PROMOTER; GLUCOSE	Many research studies use immortalized cell lines as surrogates for primary beta-cells. We describe the production and use of a novel "indirect" dual-fluorescent reporter system that leads to mutually exclusive expression of EGFP in insulin-producing (INS+) beta-cells or mCherry in non-beta-cells. Our system uses the human insulin promoter to initiate a Cre-mediated shift in reporter color within a single transgene construct and is useful for FACS selection of cells from single cultures for further analysis. Application of our reporter to presumably clonal HIT-T15 insulinoma cells, as well as other presumably clonal lines, indicates that these cultures are in fact heterogeneous with respect to INS+ phenotype. Our strategy could be easily applied to other cell-or tissue-specific promoters. We anticipate its utility for FACS purification of INS+ and glucose-responsive beta-like-cells from primary human islet cell isolates or in vitro differentiated pluripotent stem cells.	[Lee, Nan Sook; Rohan, Joyce G.; Kamath, Sonia; Chow, Robert H.] Univ So Calif, Dept Physiol & Biophys, Los Angeles, CA 90089 USA; [Lee, Nan Sook; Rohan, Joyce G.; Kamath, Sonia; Chow, Robert H.] Univ So Calif, Zilkha Neurogenet Inst, Los Angeles, CA USA; [Zitting, Madison; Weitz, Andrew] Univ So Calif, Dept Biomed Engn, Los Angeles, CA 90089 USA; [Sipos, Arnold] Univ So Calif, Sch Med, Los Angeles, CA USA; [Salvaterra, Paul M.] Beckman Res Inst City Hope, Div Neurosci, Duarte, CA USA; [Hasegawa, Kouichi; Pera, Martin] Univ So Calif, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California; City of Hope; Beckman Research Institute of City of Hope; University of Southern California	Lee, NS (corresponding author), Univ So Calif, Dept Physiol & Biophys, Los Angeles, CA 90089 USA.	nanlee@usc.edu	Chow, Robert/B-8155-2013; PERA, MARTIN/A-9812-2012; Hasegawa, Kouichi/Y-9349-2019	PERA, MARTIN/0000-0001-6239-0428; Hasegawa, Kouichi/0000-0001-5947-5471; Rohan, Joyce/0000-0001-5102-6639	Wright Foundation (USC)	Wright Foundation (USC)	This work was supported by the Wright Foundation (USC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerman I, 2011, DEV CELL, V20, P411, DOI 10.1016/j.devcel.2011.04.002; Alexopoulou AN, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-2; ALWINE JC, 1985, MOL CELL BIOL, V5, P1034, DOI 10.1128/MCB.5.5.1034; Bonini P, 2001, JOP, V2, P105; Chung SM, 2002, STEM CELLS, V20, P139, DOI 10.1634/stemcells.20-2-139; Collombat P, 2005, DEVELOPMENT, V132, P2969, DOI 10.1242/dev.01870; Collombat P, 2003, GENE DEV, V17, P2591, DOI 10.1101/gad.269003; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; deVargas LM, 1997, J BIOL CHEM, V272, P26573, DOI 10.1074/jbc.272.42.26573; Dhawan S, 2011, DEV CELL, V20, P419, DOI 10.1016/j.devcel.2011.03.012; EFRAT S, 1988, P NATL ACAD SCI USA, V85, P9037, DOI 10.1073/pnas.85.23.9037; Emerich DF, 2002, EXPERT OPIN BIOL TH, V2, P793, DOI 10.1517/14712598.2.8.793; FROMONTRACINE M, 1990, MOL ENDOCRINOL, V4, P669, DOI 10.1210/mend-4-5-669; GILLIGAN A, 1989, DIABETES, V38, P1056, DOI 10.2337/diabetes.38.8.1056; Gopel S, 2004, J PHYSIOL-LONDON, V556, P711, DOI 10.1113/jphysiol.2003.059675; GROMADA J, 1995, DIABETES, V44, P767, DOI 10.2337/diabetes.44.7.767; Han GC, 2007, J AGR FOOD CHEM, V55, P10641, DOI 10.1021/jf0722598; Hasegawa K, 2002, FEBS LETT, V520, P47, DOI 10.1016/S0014-5793(02)02761-8; Hay CW, 2006, DIABETES, V55, P3201, DOI 10.2337/db06-0788; Heikal AA, 2010, BIOMARK MED, V4, P241, DOI 10.2217/BMM.10.1; Hill JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012958; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Irminger JC, 1996, BIOCHEM J, V320, P11, DOI 10.1042/bj3200011; Itier JM, 1996, DIFFERENTIATION, V60, P309, DOI 10.1046/j.1432-0436.1996.6050309.x; Kawamura Y, 2006, MOL ENDOCRINOL, V20, P844, DOI 10.1210/me.2005-0138; Kiselyuk A, 2010, J BIOMOL SCREEN, V15, P663, DOI 10.1177/1087057110372257; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; LAIMINS L, 1986, P NATL ACAD SCI USA, V83, P3151, DOI 10.1073/pnas.83.10.3151; Le Lay J, 2004, J BIOL CHEM, V279, P22228, DOI 10.1074/jbc.M312673200; Lee NS, 2008, BIOCHEM BIOPH RES CO, V377, P434, DOI 10.1016/j.bbrc.2008.09.159; Lester Linda B, 2004, Reprod Biol Endocrinol, V2, P42, DOI 10.1186/1477-7827-2-42; Lorenz P, 2004, BIOTECHNOL LETT, V26, P1589, DOI 10.1023/B:BILE.0000045658.33723.d6; Meyer K, 1998, DIABETES, V47, P1974, DOI 10.2337/diabetes.47.12.1974; Mezzanotte L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019277; Moede T, 2001, DIABETES, V50, pS15, DOI 10.2337/diabetes.50.2007.S15; RADVANYI F, 1993, MOL CELL BIOL, V13, P4223, DOI 10.1128/MCB.13.7.4223; Rorsman P, 2011, PROG BIOPHYS MOL BIO; Rovira M, 2007, CLONING STEM CELLS, V9, P327, DOI 10.1089/clo.2006.0064; Russ HA, 2008, DIABETES, V57, P1575, DOI 10.2337/db07-1283; SANTERRE RF, 1981, P NATL ACAD SCI-BIOL, V78, P4339, DOI 10.1073/pnas.78.7.4339; SJOHOLM A, 1993, J CLIN INVEST, V92, P1910, DOI 10.1172/JCI116784; Skelin M, 2010, ALTEX-ALTERN ANIM EX, V27, P105; Smith-Arica JR, 2003, CLONING STEM CELLS, V5, P51, DOI 10.1089/153623003321512166; SWOPE SL, 1984, P NATL ACAD SCI-BIOL, V81, P1822, DOI 10.1073/pnas.81.6.1822; Szabat M, 2010, DIABETOLOGIA, V53, P1680, DOI 10.1007/s00125-010-1758-0; Szabat M, 2011, ISLETS, V3, P175, DOI 10.4161/isl.3.4.15881; Szabat M, 2009, ENDOCRINOLOGY, V150, P1627, DOI 10.1210/en.2008-1224; Ulrich AB, 2002, PANCREAS, V24, P111, DOI 10.1097/00006676-200203000-00001; Wang SZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004200; Ward CM, 2002, STEM CELLS, V20, P472, DOI 10.1634/stemcells.20-5-472; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	51	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35521	10.1371/journal.pone.0035521	http://dx.doi.org/10.1371/journal.pone.0035521			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22530041	Green Published, gold			2022-12-27	WOS:000305350600094
J	Marum, L; Miguel, A; Ricardo, CP; Miguel, C				Marum, Liliana; Miguel, Andreia; Ricardo, Candido P.; Miguel, Celia			Reference Gene Selection for Quantitative Real-time PCR Normalization in Quercus suber	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; SUPERIOR REFERENCE GENES; TISSUE-SPECIFIC GENES; RT-PCR; HOUSEKEEPING GENES; TRANSCRIPT NORMALIZATION; RELATIVE QUANTIFICATION; EXPRESSION; IDENTIFICATION; VALIDATION	The use of reverse transcription quantitative PCR technology to assess gene expression levels requires an accurate normalization of data in order to avoid misinterpretation of experimental results and erroneous analyses. Despite being the focus of several transcriptomics projects, oaks, and particularly cork oak (Quercus suber), have not been investigated regarding the identification of reference genes suitable for the normalization of real-time quantitative PCR data. In this study, ten candidate reference genes (Act, CACs, EF-1 alpha, GAPDH, His3, PsaH, Sand, PP2A, ss-Tub and Ubq) were evaluated to determine the most stable internal reference for quantitative PCR normalization in cork oak. The transcript abundance of these genes was analysed in several tissues of cork oak, including leaves, reproduction cork, and periderm from branches at different developmental stages (1-, 2-, and 3-year old) or collected in different dates (active growth period versus dormancy). The three statistical methods (geNorm, NormFinder, and CV method) used in the evaluation of the most suitable combination of reference genes identified Act and CACs as the most stable candidates when all the samples were analysed together, while ss-Tub and PsaH showed the lowest expression stability. However, when different tissues, developmental stages, and collection dates were analysed separately, the reference genes exhibited some variation in their expression levels. In this study, and for the first time, we have identified and validated reference genes in cork oak that can be used for quantification of target gene expression in different tissues and experimental conditions and will be useful as a starting point for gene expression studies in other oaks.	[Marum, Liliana; Miguel, Andreia; Ricardo, Candido P.; Miguel, Celia] ITQB UNL, IBET, Oeiras, Portugal		Marum, L (corresponding author), ITQB UNL, IBET, Oeiras, Portugal.	marum@itqb.unl.pt; cmiguel@itqb.unl.pt	Miguel, Celia/D-2153-2012; Ricardo, Candido/B-7891-2008	Miguel, Celia/0000-0002-1427-952X; Ricardo, Candido/0000-0003-4905-1274; Marum, Liliana/0000-0002-6938-479X	Fundacao Ciencia e Tecnologia (FCT) [PEst-OE/EQB/LA0004/2011, PTDC/AGR-GPL/098369/2008, BPD/SFRH/47679/2008, BD/SFRH/44474/2008]	Fundacao Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and Technology)	This research was supported by Fundacao Ciencia e Tecnologia (FCT;http://www.fct.pt), through projects PEst-OE/EQB/LA0004/2011 and PTDC/AGR-GPL/098369/2008, and grants BPD/SFRH/47679/2008 (to LM) and BD/SFRH/44474/2008 (to AM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Artico S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-49; Beisson F, 2007, PLANT CELL, V19, P351, DOI 10.1105/tpc.106.048033; Brunner Amy M., 2004, BMC Plant Biology, V4, P14, DOI 10.1186/1471-2229-4-14; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Demidenko NV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019434; Die JV, 2010, PLANTA, V232, P145, DOI 10.1007/s00425-010-1158-1; Exposito-Rodriguez M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-131; Farre D, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r140; Gutierrez L, 2008, PLANT BIOTECHNOL J, V6, P609, DOI 10.1111/j.1467-7652.2008.00346.x; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hong SM, 2010, PLANT CELL PHYSIOL, V51, P1694, DOI 10.1093/pcp/pcq128; Huis R, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-71; Jarosova J, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-146; Kakar K, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-18; Kamphuis W, 2001, INVEST OPHTH VIS SCI, V42, P3209; Kouadjo KE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-127; Kuijk EW, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-58; Lawson MJ, 2008, GENE, V407, P54, DOI 10.1016/j.gene.2007.09.017; Li QF, 2010, PLANT MOL BIOL REP, V28, P49, DOI 10.1007/s11105-009-0124-1; Lin YL, 2010, PLANT SCI, V178, P359, DOI 10.1016/j.plantsci.2010.02.005; Maroufi A, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-15; Marum L, 2011, BMC P; Migocka M, 2011, MOL BREEDING, DOI [10.1007/s11032-11010-19487-11030, DOI 10.1007/S11032-11010-19487-11030]; Miguel A, 2011, BMC P; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Paiva JA, 2011, BMC P; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Phillips MA, 2009, PLANT MOL BIOL REP, V27, P407, DOI 10.1007/s11105-008-0072-1; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Ramos M, 2011, BMC P; Reid KE, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-27; Remans T, 2008, PLANTA, V227, P1343, DOI 10.1007/s00425-008-0706-4; Rozen S, PRIMER3 WWW GEN USER, P365; Schmidt GW, 2010, MOL GENET GENOMICS, V283, P233, DOI 10.1007/s00438-010-0511-1; Silva SP, 2005, INT MATER REV, V50, P345, DOI 10.1179/174328005X41168; Silveira ED, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-84; Soler M, 2008, TREE PHYSIOL, V28, P743, DOI 10.1093/treephys/28.5.743; Soler M, 2007, PLANT PHYSIOL, V144, P419, DOI 10.1104/pp.106.094227; Stothard P, 2000, BIOTECHNIQUES, V28, P1102, DOI 10.2144/00286ir01; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vashisth T, 2011, PLANT CELL REP, DOI [10.1007/s00299-00011-01121-z, DOI 10.1007/S00299-00011-01121-Z]; Warrington JA, 2000, PHYSIOL GENOMICS, V2, P143, DOI 10.1152/physiolgenomics.2000.2.3.143; Xu M, 2011, ANAL BIOCHEM, V408, P337, DOI 10.1016/j.ab.2010.08.044; Yang YF, 2010, MOL BIOL REP, V37, P507, DOI 10.1007/s11033-009-9703-3; Zhang LQ, 2004, MOL BIOL EVOL, V21, P236, DOI 10.1093/molbev/msh010; Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047	49	84	86	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35113	10.1371/journal.pone.0035113	http://dx.doi.org/10.1371/journal.pone.0035113			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529976	gold, Green Submitted, Green Published			2022-12-27	WOS:000305350600056
J	Nepusz, T; Petroczi, A; Naughton, DP				Nepusz, Tamas; Petroczi, Andrea; Naughton, Declan P.			Interactive Network Analytical Tool for Instantaneous Bespoke Interrogation of Food Safety Notifications	PLOS ONE			English	Article							PATTERNS; CONTAMINATION; LEAD	Background: The globalization of food supply necessitates continued advances in regulatory control measures to ensure that citizens enjoy safe and adequate nutrition. The aim of this study was to extend previous reports on network analysis relating to food notifications by including an optional filter by type of notification and in cases of contamination, by type of contaminant in the notified foodstuff. Methodology/Principal Findings: A filter function has been applied to enable processing of selected notifications by contaminant or type of notification to i) capture complexity, ii) analyze trends, and iii) identify patterns of reporting activities between countries. The program rapidly assesses nations' roles as transgressor and/or detector for each category of contaminant and for the key class of border rejection. In the open access demonstration version, the majority of notifications in the Rapid Alert System for Food and Feed were categorized by contaminant type as mycotoxin (50.4%), heavy metals (10.9%) or bacteria (20.3%). Examples are given demonstrating how network analytical approaches complement, and in some cases supersede, descriptive statistics such as frequency counts, which may give limited or potentially misleading information. One key feature is that network analysis takes the relationship between transgressor and detector countries, along with number of reports and impact simultaneously into consideration. Furhermore, the indices that compliment the network maps and reflect each country's transgressor and detector activities allow comparisons to be made between (transgressing vs. detecting) as well as within (e. g. transgressing) activities. Conclusions/significance: This further development of the network analysis approach to food safety contributes to a better understanding of the complexity of the effort ensuring food is safe for consumption in the European Union. The unique patterns of the interplay between detectors and transgressors, instantly revealed by our approach, could supplement the intelligence gathered by regulatory authorities and inform risk based sampling protocols.	[Nepusz, Tamas; Petroczi, Andrea; Naughton, Declan P.] Kingston Univ, Sch Life Sci, London, England	Kingston University	Nepusz, T (corresponding author), Kingston Univ, Sch Life Sci, London, England.	D.Naughton@kingston.ac.uk	Petroczi, Andrea/ABG-9863-2021	Petroczi, Andrea/0000-0002-8365-6173				[Anonymous], [No title captured]; Brin S, 1998, COMPUT NETWORKS ISDN, V30, P107, DOI 10.1016/S0169-7552(98)00110-X; Commission Regulation 2006/401/EC, 2006, OFF J EUR UNION, V70, P12; European Commission, 2006, OFF J EUR COMMUNITIE, P5; Kleinberg J.M., 1998, P 9 ANN ACM SIAM S D, P668; Kleter GA, 2009, FOOD CHEM TOXICOL, V47, P932, DOI 10.1016/j.fct.2007.12.022; Nepusz T, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-308; Nepusz T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006680; Nepusz T, 2009, ENVIRON INT, V35, P1030, DOI 10.1016/j.envint.2009.05.003; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Petroczi A, 2011, WORLD MYCOTOXIN J, V4, P329, DOI 10.3920/WMJ2010.1271; Petroczi A, 2010, FOOD CHEM TOXICOL, V48, P1957, DOI 10.1016/j.fct.2010.04.043; Petroczi A, 2009, FOOD CHEM TOXICOL, V47, P298, DOI 10.1016/j.fct.2008.11.007; Pons P, 2005, LECT NOTES COMPUT SC, V3733, P284; Rortais A, 2010, FOOD RES INT, V43, P1553, DOI 10.1016/j.foodres.2010.04.009; SEIDMAN SB, 1983, SOC NETWORKS, V5, P269, DOI 10.1016/0378-8733(83)90028-X	16	2	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35652	10.1371/journal.pone.0035652	http://dx.doi.org/10.1371/journal.pone.0035652			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22530063	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000305350600109
J	Vabret, N; Bailly-Bechet, M; Najburg, V; Muller-Trutwin, M; Verrier, B; Tangy, F				Vabret, Nicolas; Bailly-Bechet, Marc; Najburg, Valerie; Mueller-Trutwin, Michaela; Verrier, Bernard; Tangy, Frederic			The Biased Nucleotide Composition of HIV-1 Triggers Type I Interferon Response and Correlates with Subtype D Increased Pathogenicity	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELLS; DISEASE PROGRESSION; IMMUNE ACTIVATION; INNATE IMMUNITY; POOL IMBALANCE; SIV INFECTION; VIRAL SUBTYPE; VIRUS; RECOGNITION; GENOME	The genome of human immunodeficiency virus (HIV) has an average nucleotide composition strongly biased as compared to the human genome. The consequence of such nucleotide composition on HIV pathogenicity has not been investigated yet. To address this question, we analyzed the role of nucleotide bias of HIV-derived nucleic acids in stimulating type-I interferon response in vitro. We found that the biased nucleotide composition of HIV is detected in human cells as compared to humanized sequences, and triggers a strong innate immune response, suggesting the existence of cellular immune mechanisms able to discriminate RNA sequences according to their nucleotide composition or to detect specific secondary structures or linear motifs within biased RNA sequences. We then extended our analysis to the entire genome scale by testing more than 1300 HIV-1 complete genomes to look for an association between nucleotide composition of HIV-1 group M subtypes and their pathogenicity. We found that subtype D, which has an increased pathogenicity compared to the other subtypes, has the most divergent nucleotide composition relative to the human genome. These data support the hypothesis that the biased nucleotide composition of HIV-1 may be related to its pathogenicity.	[Vabret, Nicolas; Najburg, Valerie; Tangy, Frederic] Inst Pasteur, CNRS, URA 3015, Unite Genom Virale & Vaccinat, Paris, France; [Bailly-Bechet, Marc] Univ Lyon 1, CNRS, UMR 5558, Lab Biometrie & Biol Evolut, F-69622 Villeurbanne, France; [Mueller-Trutwin, Michaela] Inst Pasteur, Unite Regulat Infect Retrovirales, Paris, France; [Verrier, Bernard] Univ Lyon 1, CNRS, FRE 3310, Inst Biol & Chim Prot, F-69365 Lyon, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Vabret, N (corresponding author), Inst Pasteur, CNRS, URA 3015, Unite Genom Virale & Vaccinat, Paris, France.	ftangy@pasteur.fr	Bailly-Bechet, Marc/B-6292-2012; verrier, bernard/J-4094-2017	Muller-Trutwin, Michaela/0000-0002-3854-2396; verrier, bernard/0000-0002-8478-7095	Centre National de la Recherche Scientifique [PEPS-60593a]; Agence Nationale de la Recherche contre le SIDA [ANRS-2010-311]; European Commission (Europrise) [LSHP CT-2006-037611]	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche contre le SIDA(French National Research Agency (ANR)); European Commission (Europrise)(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the Centre National de la Recherche Scientifique (PEPS-60593a), the Agence Nationale de la Recherche contre le SIDA (ANRS-2010-311), and the European Commission (Europrise, LSHP CT-2006-037611). Dr. Vabret is a fellow from Ecole Normale Superieure (ENS), Lyon. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer S, 2009, ADV EXP MED BIOL, V653, P15; Beignon AS, 2005, J CLIN INVEST, V115, P3265, DOI 10.1172/JCI26032; BERKHOUT B, 1994, NUCLEIC ACIDS RES, V22, P1705, DOI 10.1093/nar/22.9.1705; Berkhout B, 2002, AIDS RES HUM RETROV, V18, P133, DOI 10.1089/08892220252779674; Bishop KN, 2004, SCIENCE, V305, P645, DOI 10.1126/science.1100658; Bousheri S, 2009, JAIDS-J ACQ IMM DEF, V52, P548, DOI 10.1097/QAI.0b013e3181c1d456; Brenchley JM, 2010, IMMUNITY, V32, P737, DOI 10.1016/j.immuni.2010.06.004; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Deforche K, 2007, J COMPUT BIOL, V14, P1105, DOI 10.1089/cmb.2007.0073; Diebold S, 2010, IMMUNOL LETT, V128, P17, DOI 10.1016/j.imlet.2009.09.010; Doitsh G, 2010, CELL, V143, P789, DOI 10.1016/j.cell.2010.11.001; Easterbrook PJ, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-4; Grossman Z, 2002, NAT MED, V8, P319, DOI 10.1038/nm0402-319; Harris LD, 2010, J VIROL, V84, P7886, DOI 10.1128/JVI.02612-09; Jacquelin B, 2009, J CLIN INVEST, V119, P3544, DOI 10.1172/JCI40093; Kaleebu P, 2002, J INFECT DIS, V185, P1244, DOI 10.1086/340130; Kiwanuka N, 2010, JAIDS-J ACQ IMM DEF, V54, P180, DOI 10.1097/QAI.0b013e3181c98fc0; Lepelley A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001284; Malathi K, 2007, NATURE, V448, P816, DOI 10.1038/nature06042; Mandl JN, 2008, NAT MED, V14, P1077, DOI 10.1038/nm.1871; Manel N, 2010, NATURE, V467, P214, DOI 10.1038/nature09337; Meier A, 2007, J VIROL, V81, P8180, DOI 10.1128/JVI.00421-07; Mulder LCF, 2008, P NATL ACAD SCI USA, V105, P5501, DOI 10.1073/pnas.0710190105; Nascimbeni M, 2009, BLOOD, V113, P6112, DOI 10.1182/blood-2008-07-170803; Pandrea I, 2008, TRENDS IMMUNOL, V29, P419, DOI 10.1016/j.it.2008.05.004; Rehwinkel J, 2010, J CLIN IMMUNOL, V30, P491, DOI 10.1007/s10875-010-9384-7; Saito T, 2008, NATURE, V454, P523, DOI 10.1038/nature07106; Sauter D, 2009, CELL HOST MICROBE, V6, P409, DOI 10.1016/j.chom.2009.10.004; Silvestri G, 2005, J VIROL, V79, P4043, DOI 10.1128/JVI.79.7.4043-4054.2005; Smith HC, 2011, TRENDS BIOCH SCI; Sodora DL, 2008, AIDS, V22, P439, DOI 10.1097/QAD.0b013e3282f2dbe7; Sodora DL, 2009, NAT MED, V15, P861, DOI 10.1038/nm.2013; Solis M, 2010, J VIROL; VANHEMERT FJ, 1995, J MOL EVOL, V41, P132, DOI 10.1007/BF00170664; VARTANIAN JP, 1994, P NATL ACAD SCI USA, V91, P3092, DOI 10.1073/pnas.91.8.3092; Wood N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000414; Yoneyama M, 2010, REV MED VIROL, V20, P4, DOI 10.1002/rmv.633	37	28	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e33502	10.1371/journal.pone.0033502	http://dx.doi.org/10.1371/journal.pone.0033502			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529893	Green Published, gold, Green Submitted			2022-12-27	WOS:000305350600004
J	Zhang, JB; Shan, LY; Koussih, L; Redhu, NS; Halayko, AJ; Chakir, J; Gounni, AS				Zhang, Jingbo; Shan, Lianyu; Koussih, Latifa; Redhu, Naresh Singh; Halayko, Andrew J.; Chakir, Jamila; Gounni, Abdelilah S.			Pentraxin 3 (PTX3) Expression in Allergic Asthmatic Airways: Role in Airway Smooth Muscle Migration and Chemokine Production	PLOS ONE			English	Article							RECOGNITION RECEPTOR PTX3; FC-EPSILON-RI; BRONCHOALVEOLAR LAVAGE FLUID; ACUTE MYOCARDIAL-INFARCTION; GAMMA-INDUCIBLE PROTEIN-10; FIBROBLAST-GROWTH-FACTOR; C-REACTIVE PROTEIN; ENDOTHELIAL-CELLS; INNATE IMMUNITY; TNF-ALPHA	Background: Pentraxin 3 (PTX3) is a soluble pattern recognition receptor with non-redundant functions in inflammation and innate immunity. PTX3 is produced by immune and structural cells. However, very little is known about the expression of PTX3 and its role in allergic asthma. Objectives and Methods: We sought to determine the PTX3 expression in asthmatic airways and its function in human airway smooth muscle cells (HASMC). In vivo PTX3 expression in bronchial biopsies of mild, moderate and severe asthmatics was analyzed by immunohistochemistry. PTX3 mRNA and protein were measured by real-time RT-PCR and ELISA, respectively. Proliferation and migration were examined using H-3-thymidine incorporation, cell count and Boyden chamber assays. Results: PTX3 immunoreactivity was increased in bronchial tissues of allergic asthmatics compared to healthy controls, and mainly localized in the smooth muscle bundle. PTX3 protein was expressed constitutively by HASMC and was significantly up-regulated by TNF, and IL-1 beta but not by Th2 (IL-4, IL-9, IL-13), Th1 (IFN-gamma), or Th-17 (IL-17) cytokines. In vitro, HASMC released significantly higher levels of PTX3 at the baseline and upon TNF stimulation compared to airway epithelial cells (EC). Moreover, PTX3 induced CCL11/eotaxin-1 release whilst inhibited the fibroblast growth factor-2 (FGF-2)-driven HASMC chemotactic activity. Conclusions: Our data provide the first evidence that PTX3 expression is increased in asthmatic airways. HASMC can both produce and respond to PTX3. PTX3 is a potent inhibitor of HASMC migration induced by FGF-2 and can upregulate CCL11/eotaxin-1 release. These results raise the possibility that PTX3 may play a dual role in allergic asthma.	[Zhang, Jingbo; Shan, Lianyu; Koussih, Latifa; Redhu, Naresh Singh; Halayko, Andrew J.; Gounni, Abdelilah S.] Univ Manitoba, Fac Med, Dept Immunol, Winnipeg, MB R3E 0W3, Canada; [Halayko, Andrew J.] Univ Manitoba, Fac Med, Dept Physiol, Winnipeg, MB, Canada; [Chakir, Jamila] Univ Laval, Inst Univ Cardiol & Pneumol Quebec, Ste Foy, PQ G1K 7P4, Canada; [Zhang, Jingbo] Third Mil Med Univ, Xinqiao Hosp, Chongqing, Peoples R China	University of Manitoba; University of Manitoba; Laval University; Army Medical University	Zhang, JB (corresponding author), Univ Manitoba, Fac Med, Dept Immunol, Winnipeg, MB R3E 0W3, Canada.	gounni@cc.umanitoba.ca	Gounni, Abdelilah Soussi/AAH-3456-2020	Soussi Gounni, Abdelilah/0000-0002-7282-0388; Gounni, Abdelilah/0000-0003-1265-6560; Halayko, Andrew/0000-0002-7865-4552	Canadian Institutes of Health Research (CIHR) grant; Manitoba Research Chair; Manitoba Health Research Council-Manitoba Institute of Child Health (MHRC-MICH); Canadian Thoracic Society-Canada Lung Association (CTS-CLA) graduate studentship	Canadian Institutes of Health Research (CIHR) grant(Canadian Institutes of Health Research (CIHR)); Manitoba Research Chair; Manitoba Health Research Council-Manitoba Institute of Child Health (MHRC-MICH); Canadian Thoracic Society-Canada Lung Association (CTS-CLA) graduate studentship	This work was supported by the Canadian Institutes of Health Research (CIHR) grant and Manitoba Research Chair to ASG. JZ is supported by a postdoctoral fellowship from the Manitoba Health Research Council-Manitoba Institute of Child Health (MHRC-MICH). NSR is supported by the Canadian Thoracic Society-Canada Lung Association (CTS-CLA) graduate studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amrani Y, 2007, AM J RESP CELL MOL, V36, P387, DOI 10.1165/ajrcmb.36.3.387; [Anonymous], 1987, AM REV RESPIR DIS, V136, P225; Azzurri A, 2005, MICROBES INFECT, V7, P1, DOI 10.1016/j.micinf.2004.09.004; Berry MA, 2006, NEW ENGL J MED, V354, P697, DOI 10.1056/NEJMoa050580; Bosse Y, 2008, TRENDS MOL MED, V14, P3, DOI 10.1016/j.molmed.2007.11.003; Bozza S, 2006, BLOOD, V108, P3387, DOI 10.1182/blood-2006-03-009266; BREVIARIO F, 1992, J BIOL CHEM, V267, P22190; Camozzi M, 2005, ARTERIOSCL THROM VAS, V25, P1837, DOI 10.1161/01.ATV.0000177807.54959.7d; Camozzi M, 2006, J BIOL CHEM, V281, P22605, DOI 10.1074/jbc.M601023200; Chakir J, 2001, J ALLERGY CLIN IMMUN, V107, P36, DOI 10.1067/mai.2001.111929; Chambers LS, 2003, AM J PHYSIOL-LUNG C, V285, pL619, DOI 10.1152/ajplung.00416.2002; Chambers LS, 2001, AM J PHYSIOL-LUNG C, V281, pL1369, DOI 10.1152/ajplung.2001.281.6.L1369; Cheng SS, 2002, EXP MOL PATHOL, V73, P1, DOI 10.1006/exmp.2002.2439; Cheng SS, 2002, J IMMUNOL, V168, P2887, DOI 10.4049/jimmunol.168.6.2887; Deban L, 2010, NAT IMMUNOL, V11, P328, DOI 10.1038/ni.1854; Dekkers Bart G J, 2009, Proc Am Thorac Soc, V6, P683, DOI 10.1513/pats.200907-056DP; Dias AAM, 2001, J LEUKOCYTE BIOL, V69, P928; Doni A, 2003, EUR J IMMUNOL, V33, P2886, DOI 10.1002/eji.200324390; Doni A, 2008, J BIOL CHEM, V283, P29983, DOI 10.1074/jbc.M805631200; Fazzini F, 2001, ARTHRITIS RHEUM, V44, P2841, DOI 10.1002/1529-0131(200112)44:12<2841::AID-ART472>3.0.CO;2-6; Fregonese L, 2005, J ALLERGY CLIN IMMUN, V115, P1148, DOI 10.1016/j.jaci.2005.01.068; Fukakusa M, 2005, J ALLERGY CLIN IMMUN, V115, P280, DOI 10.1016/j.jaci.2004.10.036; Fulkerson PC, 2006, AM J PATHOL, V169, P2117, DOI 10.2353/ajpath.2006.060617; Garlanda C, 2002, NATURE, V420, P182, DOI 10.1038/nature01195; Gaziano R, 2004, ANTIMICROB AGENTS CH, V48, P4414, DOI 10.1128/AAC.48.11.4414-4421.2004; Goncharova EA, 2006, NAT PROTOC, V1, P2933, DOI 10.1038/nprot.2006.434; Goncharova EA, 2006, NAT PROTOC, V1, P2905, DOI 10.1038/nprot.2006.433; Gounni AS, 2006, AM J PHYSIOL-LUNG C, V291, pL312, DOI 10.1152/ajplung.00005.2006; Gounni AS, 2005, J IMMUNOL, V175, P2613, DOI 10.4049/jimmunol.175.4.2613; Hakonarson H, 1998, P NATL ACAD SCI USA, V95, P5257, DOI 10.1073/pnas.95.9.5257; Halayko AJ, 2003, RESP PHYSIOL NEUROBI, V137, P209, DOI 10.1016/S1569-9048(03)00148-4; Han B, 2005, J IMMUNOL, V175, P8303, DOI 10.4049/jimmunol.175.12.8303; Humbles AA, 1997, J EXP MED, V186, P601, DOI 10.1084/jem.186.4.601; Jaillon S, 2007, J EXP MED, V204, P793, DOI 10.1084/jem.20061301; Klouche M, 2004, ATHEROSCLEROSIS, V175, P221, DOI 10.1016/j.atherosclerosis.2004.03.020; Koppelman GH, 2002, J ALLERGY CLIN IMMUN, V109, P498, DOI 10.1067/mai.2002.122235; Latini R, 2004, CIRCULATION, V110, P2349, DOI 10.1161/01.CIR.0000145167.30987.2E; Luchetti MM, 2000, CLIN EXP IMMUNOL, V119, P196, DOI 10.1046/j.1365-2249.2000.01110.x; Maina V, 2009, J LEUKOCYTE BIOL, V86, P123, DOI 10.1189/jlb.0608345; Manfredi AA, 2008, CURR OPIN IMMUNOL, V20, P538, DOI 10.1016/j.coi.2008.05.004; Mantovani A, 2008, J CLIN IMMUNOL, V28, P1, DOI 10.1007/s10875-007-9126-7; Mauri T, INTENSIVE CARE MED, V36, P621; Mauri T, 2008, CRIT CARE MED, V36, P2302, DOI 10.1097/CCM.0b013e3181809aaf; Naureckas ET, 1999, AM J RESP CRIT CARE, V160, P2062, DOI 10.1164/ajrccm.160.6.9903131; Norata GD, 2008, ARTERIOSCL THROM VAS, V28, P925, DOI 10.1161/ATVBAHA.107.160606; Ortega-Hernandez OD, 2008, LONG PENTRAXIN 3 ITS; Panettieri RA, 2003, RESP PHYSIOL NEUROBI, V137, P277, DOI 10.1016/S1569-9048(03)00153-8; Pauwels NS, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-134; Pizzichini M. M., 2009, AM J RESP CRIT  0401, V179, pA2532; Redhu NS, 2011, AM J PHYSIOL-LUNG C, V300, pL479, DOI 10.1152/ajplung.00301.2009; Redhu NS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006153; Redington AE, 2001, J ALLERGY CLIN IMMUN, V107, P384, DOI 10.1067/mai.2001.112268; Renauld JC, 2001, J CLIN PATHOL, V54, P577, DOI 10.1136/jcp.54.8.577; Roth M, 2010, SWISS MED WKLY; Roth M, 2010, ANN ALLERG ASTHMA IM, V104, P152, DOI 10.1016/j.anai.2009.11.022; Salio M, 2008, CIRCULATION, V117, P1055, DOI 10.1161/CIRCULATIONAHA.107.749234; Salustri A, 2004, DEVELOPMENT, V131, P1577, DOI 10.1242/dev.01056; Scarchilli L, 2007, J BIOL CHEM, V282, P30161, DOI 10.1074/jbc.M703738200; Semiali A, 2008, AM J RESP CELL MOL, V38, P202, DOI 10.1165/rcmb.2007-0031OC; Shan LY, 2010, J IMMUNOL, V184, P7134, DOI 10.4049/jimmunol.0902515; Shelton RC, 2004, NEUROPSYCHOPHARMACOL, V29, P126, DOI 10.1038/sj.npp.1300307; Tliba O, 2009, ANNU REV PHYSIOL, V71, P509, DOI 10.1146/annurev.physiol.010908.163227; Tong M, 2007, CLIN J AM SOC NEPHRO, V2, P889, DOI 10.2215/CJN.00870207; Van Pottelberge GR, 2011, EUR RESP J; Varani S, 2002, MOL ENDOCRINOL, V16, P1154, DOI 10.1210/me.16.6.1154	65	24	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e34965	10.1371/journal.pone.0034965	http://dx.doi.org/10.1371/journal.pone.0034965			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529962	Green Published, Green Submitted, gold			2022-12-27	WOS:000305350600047
J	Kim, SJ; Oh, HJ; Yoo, DE; Shin, DH; Lee, MJ; Kim, HR; Park, JT; Han, SH; Yoo, TH; Choi, KH; Kang, SW				Kim, Seung Jun; Oh, Hyung Jung; Yoo, Dong Eun; Shin, Dong Ho; Lee, Mi Jung; Kim, Hyoung Rae; Park, Jung Tak; Han, Seung Hyeok; Yoo, Tae-Hyun; Choi, Kyu Hun; Kang, Shin-Wook			Electrocardiographic Left Ventricular Hypertrophy and Outcome in Hemodialysis Patients	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; HYPERTENSIVE PATIENTS; MORTALITY RISK; RENAL-DISEASE; MASS INDEX; FOLLOW-UP; DIALYSIS; HEART; ASSOCIATION; REGRESSION	Background and Aims: Electrocardiography (ECG) is the most widely used initial screening test for the assessment of left ventricular hypertrophy (LVH), an independent predictor of cardiovascular mortality in patients with end-stage renal disease (ESRD). However, traditional ECG criteria based only on voltage to detect LVH have limited clinical utility for the detection of LVH because of their poor sensitivity. Methods: This prospective observational study was undertaken to compare the prognostic significance of commonly used ECG criteria for LVH, namely Sokolow-Lyon voltage (SV) or voltage-duration product (SP) and Cornell voltage (CV) or voltage-duration product (CP) criteria, and to investigate the association between echocardiographic LV mass index (LVMI) and ECG-LVH criteria in ESRD patients, who consecutively started maintenance hemodialysis (HD) between January 2006 and December 2008. Results: A total of 317 patients, who underwent both ECG and echocardiography, were included. Compared to SV and CV criteria, SP and CP criteria, respectively, correlated more closely with LVMI. In addition, CP criteria provided the highest positive predictive value for echocardiographic LVH. The 5-year cardiovascular survival rates were significantly lower in patients with ECG-LVH by each criterion. In multivariate analyses, echocardiographic LVH [adjusted hazard ratio (HR): 11.71; 95% confidence interval (CI): 1.57-87.18; P = 0.016] and ECG-LVH by SP (HR: 3.43; 95% CI: 1.32-8.92; P = 0.011) and CP (HR: 3.07; 95% CI: 1.16-8.11; P = 0.024) criteria, but not SV and CV criteria, were significantly associated with cardiovascular mortality. Conclusions: The product of QRS voltage and duration is helpful in identifying the presence of LVH and predicting cardiovascular mortality in incident HD patients.	[Kim, Seung Jun; Oh, Hyung Jung; Yoo, Dong Eun; Shin, Dong Ho; Lee, Mi Jung; Kim, Hyoung Rae; Park, Jung Tak; Han, Seung Hyeok; Yoo, Tae-Hyun; Choi, Kyu Hun; Kang, Shin-Wook] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Kang, Shin-Wook] Yonsei Univ, Severance Biomed Sci Inst, Seoul 120749, South Korea	Yonsei University; Yonsei University Health System; Yonsei University	Kim, SJ (corresponding author), Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea.	kswkidney@yuhs.ac	Kim, Seung Jun/N-5248-2019; Han, Seung Hyeok/W-8825-2019; Han, Seung Hyeok/K-4559-2018	Kim, Seung Jun/0000-0002-6913-6358; Han, Seung Hyeok/0000-0001-7923-5635; Han, Seung Hyeok/0000-0001-7923-5635; Kang, Shin-Wook/0000-0002-5677-4756; Park, Jung Tak/0000-0002-2325-8982; Yoo, Tae-Hyun/0000-0002-9183-4507; Choi, Kyu Hun/0000-0003-0095-9011; Lee, Mi Jung/0000-0001-8888-029X	Yonsei University; National Research Foundation of Korea (NRF); Korea government (MEST) [2011-0030711]; Ministry of Health and Welfare, Republic of Korea [A102065]	Yonsei University; National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Ministry of Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported by the Brain Korea 21 Project for Medical Science, Yonsei University, by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (No. 2011-0030711), and by a grant of the Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (A102065). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2011, CLIN J AM SOC NEPHRO, V6, P528, DOI 10.2215/CJN.07770910; Barrios V, 2006, J RENIN-ANGIO-ALDO S, V7, P236, DOI 10.3317/jraas.2006.044; Bolton K, 2005, AM J KIDNEY DIS, V45, pS7, DOI 10.1053/j.ajkd.2005.01.016; Calderon A, 2010, CLIN EXP HYPERTENS, V32, P145, DOI 10.3109/10641960903254455; CASALE PN, 1985, J AM COLL CARDIOL, V6, P572, DOI 10.1016/S0735-1097(85)80115-7; Cheung AK, 2004, KIDNEY INT, V65, P2380, DOI 10.1111/j.1523-1755.2004.00657.x; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; Foley RN, 1998, AM J KIDNEY DIS, V32, pS112, DOI 10.1053/ajkd.1998.v32.pm9820470; FOLEY RN, 1995, KIDNEY INT, V47, P186, DOI 10.1038/ki.1995.22; Fujii H, 2007, INTERNAL MED, V46, P1507, DOI 10.2169/internalmedicine.46.0269; Glassock RJ, 2009, CLIN J AM SOC NEPHRO, V4, pS79, DOI 10.2215/CJN.04860709; Goodkin DA, 2003, J AM SOC NEPHROL, V14, P3270, DOI 10.1097/01.ASN.0000100127.54107.57; GOTCH FA, 1985, KIDNEY INT, V28, P526, DOI 10.1038/ki.1985.160; Gross ML, 2008, SEMIN DIALYSIS, V21, P308, DOI 10.1111/j.1525-139X.2008.00454.x; HARNETT JD, 1993, NEPHRON, V65, P212, DOI 10.1159/000187476; Krane V, 2009, CLIN J AM SOC NEPHRO, V4, P394, DOI 10.2215/CJN.02020408; Levin A, 2005, AM J KIDNEY DIS, V46, P799, DOI 10.1053/j.ajkd.2005.08.007; Levin A, 1999, AM J KIDNEY DIS, V34, P125, DOI 10.1016/S0272-6386(99)70118-6; LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203; LEVY D, 1990, CIRCULATION, V81, P815, DOI 10.1161/01.CIR.81.3.815; Liao YL, 1997, J AM COLL CARDIOL, V29, P641, DOI 10.1016/S0735-1097(96)00552-9; London GM, 2001, J AM SOC NEPHROL, V12, P2759, DOI 10.1681/ASN.V12122759; MacRae JM, 2006, SEMIN DIALYSIS, V19, P349, DOI 10.1111/j.1525-139X.2006.00185.x; Martin LC, 2004, AM J HYPERTENS, V17, P1163, DOI 10.1016/j.amjhyper.2004.07.017; Mathew J, 2001, CIRCULATION, V104, P1615, DOI 10.1161/hc3901.096700; Middleton RJ, 2001, J AM SOC NEPHROL, V12, P1079, DOI 10.1681/ASN.V1251079; MOLLOY TJ, 1992, J AM COLL CARDIOL, V20, P1180, DOI 10.1016/0735-1097(92)90376-X; Naito Y, 2009, AM J PHYSIOL-HEART C, V296, pH585, DOI 10.1152/ajpheart.00463.2008; Okin PM, 2004, JAMA-J AM MED ASSOC, V292, P2343, DOI 10.1001/jama.292.19.2343; OKIN PM, 1995, J AM COLL CARDIOL, V25, P417, DOI 10.1016/0735-1097(94)00371-V; Okin PM, 2001, AM J HYPERTENS, V14, P775, DOI 10.1016/S0895-7061(01)01291-2; Okin PM, 2000, HYPERTENSION, V35, P13, DOI 10.1161/01.HYP.35.1.13; Rautaharju PM, 2009, J AM COLL CARDIOL, V53, P982, DOI 10.1016/j.jacc.2008.12.014; Shlipak MG, 2005, JAMA-J AM MED ASSOC, V293, P1737, DOI 10.1001/jama.293.14.1737; SILBERBERG JS, 1989, KIDNEY INT, V36, P286, DOI 10.1038/ki.1989.192; Stewart GA, 1999, KIDNEY INT, V56, P2248, DOI 10.1046/j.1523-1755.1999.00786.x; Truong QA, 2010, J HYPERTENS, V28, P1959, DOI 10.1097/HJH.0b013e32833b49cb; WILLEMS JL, 1972, CIRCULATION, V45, P1057, DOI 10.1161/01.CIR.45.5.1057; Zoccali C, 2004, KIDNEY INT, V65, P1492, DOI 10.1111/j.1523-1755.2004.00530.x	39	22	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e35534	10.1371/journal.pone.0035534	http://dx.doi.org/10.1371/journal.pone.0035534			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22530043	Green Published, Green Submitted, gold			2022-12-27	WOS:000305347400058
J	Vanheel, A; Daniels, R; Plaisance, S; Baeten, K; Hendriks, JJA; Leprince, P; Dumont, D; Robben, J; Brone, B; Stinissen, P; Noben, JP; Hellings, N				Vanheel, Annelies; Daniels, Ruth; Plaisance, Stephane; Baeten, Kurt; Hendriks, Jerome J. A.; Leprince, Pierre; Dumont, Debora; Robben, Johan; Brone, Bert; Stinissen, Piet; Noben, Jean-Paul; Hellings, Niels			Identification of Protein Networks Involved in the Disease Course of Experimental Autoimmune Encephalomyelitis, an Animal Model of Multiple Sclerosis	PLOS ONE			English	Article							CEREBROSPINAL-FLUID PROTEOME; DIFFERENCE GEL-ELECTROPHORESIS; BRAIN-DAMAGE; SJL MICE; MOUSE; EXPRESSION; PATHOLOGY; INFLAMMATION; CHANNELS; MARKERS	A more detailed insight into disease mechanisms of multiple sclerosis (MS) is crucial for the development of new and more effective therapies. MS is a chronic inflammatory autoimmune disease of the central nervous system. The aim of this study is to identify novel disease associated proteins involved in the development of inflammatory brain lesions, to help unravel underlying disease processes. Brainstem proteins were obtained from rats with MBP induced acute experimental autoimmune encephalomyelitis (EAE), a well characterized disease model of MS. Samples were collected at different time points: just before onset of symptoms, at the top of the disease and following recovery. To analyze changes in the brainstem proteome during the disease course, a quantitative proteomics study was performed using two-dimensional difference in-gel electrophoresis (2D-DIGE) followed by mass spectrometry. We identified 75 unique proteins in 92 spots with a significant abundance difference between the experimental groups. To find disease-related networks, these regulated proteins were mapped to existing biological networks by Ingenuity Pathway Analysis (IPA). The analysis revealed that 70% of these proteins have been described to take part in neurological disease. Furthermore, some focus networks were created by IPA. These networks suggest an integrated regulation of the identified proteins with the addition of some putative regulators. Post-synaptic density protein 95 (DLG4), a key player in neuronal signalling and calcium-activated potassium channel alpha 1 (KCNMA1), involved in neurotransmitter release, are 2 putative regulators connecting 64% of the identified proteins. Functional blocking of the KCNMA1 in macrophages was able to alter myelin phagocytosis, a disease mechanism highly involved in EAE and MS pathology. Quantitative analysis of differentially expressed brainstem proteins in an animal model of MS is a first step to identify disease-associated proteins and networks that warrant further research to study their actual contribution to disease pathology.	[Vanheel, Annelies; Daniels, Ruth; Baeten, Kurt; Hendriks, Jerome J. A.; Dumont, Debora; Brone, Bert; Stinissen, Piet; Noben, Jean-Paul; Hellings, Niels] Hasselt Univ, Biomed Res Inst, Hasselt, Belgium; [Vanheel, Annelies; Daniels, Ruth; Baeten, Kurt; Hendriks, Jerome J. A.; Dumont, Debora; Brone, Bert; Stinissen, Piet; Noben, Jean-Paul; Hellings, Niels] Transnat Univ Limburg, Sch Life Sci, Hasselt, Belgium; [Leprince, Pierre] Univ Liege, GIGA Neurosci, Liege, Belgium; [Plaisance, Stephane] VIB, Bioinformat Training & Serv Facil BITS, Ghent, Belgium; [Robben, Johan] Katholieke Univ Leuven, B-3001 Heverlee, Belgium	Hasselt University; Hasselt University; University of Liege; Flanders Institute for Biotechnology (VIB); KU Leuven	Vanheel, A (corresponding author), Hasselt Univ, Biomed Res Inst, Hasselt, Belgium.	Niels.hellings@uhasselt.be	Noben, Jean-Paul/E-8066-2011; Plaisance, Stephane/ABI-6307-2020; Hendriks, Jerome J/C-7698-2013; HELLINGS, Niels/AAS-5033-2020; Plaisance, Stephane/B-3488-2009	Noben, Jean-Paul/0000-0003-3368-5686; Plaisance, Stephane/0000-0002-1651-241X; Hendriks, Jerome J/0000-0002-7717-8582; Plaisance, Stephane/0000-0002-1651-241X; Hellings, Niels/0000-0003-2308-406X; Stinissen, Piet/0000-0002-4830-4084; Leprince, pierre/0000-0002-7233-6553; Brone, Bert/0000-0002-4851-9480	Alma-In-Silico [EMR INT4.-1.3.-2008-03/003]; LSM tUL impuls phase II; Hasselt University; Research Foundation - Flanders (FWO)	Alma-In-Silico; LSM tUL impuls phase II; Hasselt University; Research Foundation - Flanders (FWO)(FWO)	This work was supported by Alma-In-Silico NR. EMR INT4.-1.3.-2008-03/003, LSM tUL impuls phase II and Hasselt University. JJAH was supported by The Research Foundation - Flanders (FWO). PL is a FRS-FNRS Research Associate. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alt C, 2005, BRAIN PATHOL, V15, P1; Baeten K, 2008, J NEUROIMMUNOL, V195, P1, DOI 10.1016/j.jneuroim.2007.11.008; BANATI RB, 1995, GLIA, V14, P209, DOI 10.1002/glia.440140306; Barnett MH, 2004, ANN NEUROL, V55, P458, DOI 10.1002/ana.20016; Bhat R, 2010, P NATL ACAD SCI USA, V107, P2580, DOI 10.1073/pnas.0915139107; Bhat R, 2009, NEURON, V64, P123, DOI 10.1016/j.neuron.2009.09.015; Bogie JFJ, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-85; Cross AH, 2001, J NEUROIMMUNOL, V112, P1, DOI 10.1016/S0165-5728(00)00409-4; Dasgupta B, 2005, CANCER RES, V65, P9843, DOI 10.1158/0008-5472.CAN-05-1842; Dumont D, 2004, PROTEOMICS, V4, P2117, DOI 10.1002/pmic.200300715; Duzhak T, 2003, CELL MOL BIOL, V49, P723; Ebers GC, 2008, LANCET NEUROL, V7, P268, DOI 10.1016/S1474-4422(08)70042-5; Fountoulakis M, 2005, J CHROMATOGR B, V819, P115, DOI 10.1016/j.jchromb.2005.01.037; Han MH, 2008, NATURE, V451, P1076, DOI 10.1038/nature06559; Imlach WL, 2008, J PHARMACOL EXP THER, V327, P657, DOI 10.1124/jpet.108.143933; Lafon-Cazal M, 2003, J BIOL CHEM, V278, P24438, DOI 10.1074/jbc.M211980200; Lassmann H, 2007, BRAIN PATHOL, V17, P210, DOI 10.1111/j.1750-3639.2007.00064.x; Lau A, 2010, PFLUG ARCH EUR J PHY, V460, P525, DOI 10.1007/s00424-010-0809-1; Lehmensiek V, 2007, MULT SCLER, V13, P840, DOI 10.1177/1352458507076406; Linker RA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007624; Liu SL, 2009, J CELL MOL MED, V13, P1586, DOI 10.1111/j.1582-4934.2009.00850.x; Liu T, 2007, J PROTEOME RES, V6, P2565, DOI 10.1021/pr070012k; Luhder F, 2009, J NEUROIMMUNOL, V217, P1, DOI 10.1016/j.jneuroim.2009.08.008; Marouga R, 2005, ANAL BIOANAL CHEM, V382, P669, DOI 10.1007/s00216-005-3126-3; Mikkat S, 2010, PROTEOMICS, V10, P1050, DOI 10.1002/pmic.200800932; Pitt D, 2000, NAT MED, V6, P67, DOI 10.1038/71555; Qin ZY, 2009, CELL MOL NEUROBIOL, V29, P203, DOI 10.1007/s10571-008-9312-z; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Siman R, 2004, NEUROBIOL DIS, V16, P311, DOI 10.1016/j.nbd.2004.03.016; Sironi L, 2004, J NEUROSCI RES, V78, P115, DOI 10.1002/jnr.20219; Sizova D, 2007, NEUROBIOL AGING, V28, P357, DOI 10.1016/j.neurobiolaging.2006.01.011; STORNETTA RL, 1988, SCIENCE, V242, P1444, DOI 10.1126/science.3201232; Svejgaard A, 2008, IMMUNOGENETICS, V60, P275, DOI 10.1007/s00251-008-0295-1; Szewczyk A, 2009, IUBMB LIFE, V61, P134, DOI 10.1002/iub.155; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Tuller T, 2011, HUM MOL GENET; Tumani H, 2009, NEUROSCI LETT, V452, P214, DOI 10.1016/j.neulet.2009.01.057; Tumani H, 2010, EXPERT REV PROTEOMIC, V7, P29, DOI 10.1586/EPR.09.99; van Horssen J, 2010, FREE RADICAL BIO MED, V49, P1283, DOI 10.1016/j.freeradbiomed.2010.07.013; Viswanathan S, 2006, NAT PROTOC, V1, P1351, DOI 10.1038/nprot.2006.234; Zellner M, 2008, ELECTROPHORESIS, V29, P3621, DOI 10.1002/elps.200700935; Zhu B, 2003, AM J PATHOL, V162, P1639, DOI 10.1016/S0002-9440(10)64298-8; Zipp F, 2009, J NEUROL SCI, V287, pS24, DOI 10.1016/S0022-510X(09)71297-3	43	29	31	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e35544	10.1371/journal.pone.0035544	http://dx.doi.org/10.1371/journal.pone.0035544			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22530047	Green Published, gold			2022-12-27	WOS:000305347400060
J	Boratko, A; Gergely, P; Csortos, C				Boratko, Anita; Gergely, Pal; Csortos, Csilla			Cell Cycle Dependent Association of EBP50 with Protein Phosphatase 2A in Endothelial Cells	PLOS ONE			English	Article							EXCHANGER REGULATORY FACTOR; MITOTIC EXIT; EZRIN; BINDING; PHOSPHORYLATION; RECEPTOR; RADIXIN; PHOSPHOPROTEIN; MIGRATION; OLIGOMERIZATION	Ezrin-radixin-moesin (ERM)-binding phosphoprotein 50 (EBP50) is a phosphorylatable PDZ domain-containing adaptor protein that is abundantly expressed in epithelium but was not yet studied in the endothelium. We report unusual nuclear localization of EBP50 in bovine pulmonary artery endothelial cells (BPAEC). Immunofluorescent staining and cellular fractionation demonstrated that EBP50 is present in the nuclear and perinuclear region in interphase cells. In the prophase of mitosis EBP50 redistributes to the cytoplasmic region in a phosphorylation dependent manner and during mitosis EBP50 co-localizes with protein phosphatase 2A (PP2A). Furthermore, in vitro wound healing of BPAEC expressing phospho-mimic mutant of EBP50 was accelerated indicating that EBP50 is involved in the regulation of the cell division. Cell cycle dependent specific interactions were detected between EBP50 and the subunits of PP2A (A, C, and B alpha) with immunoprecipitation and pull-down experiments. The interaction of EBP50 with the Ba containing form of PP2A suggests that this holoenzyme of PP2A can be responsible for the dephosphorylation of EBP50 in cytokinesis. Moreover, the results underline the significance of EBP50 in cell division via reversible phosphorylation of the protein with cyclin dependent kinase and PP2A in normal cells.	[Boratko, Anita; Gergely, Pal; Csortos, Csilla] Univ Debrecen, Dept Med Chem, H-4012 Debrecen, Hungary; [Boratko, Anita; Gergely, Pal; Csortos, Csilla] Hlth Sci Ctr, Debrecen, Hungary; [Gergely, Pal] Univ Debrecen, Hungarian Acad Sci, Cell Biol & Signaling Res Grp, H-4012 Debrecen, Hungary	University of Debrecen; Hungarian Academy of Sciences; University of Debrecen	Boratko, A (corresponding author), Univ Debrecen, Dept Med Chem, H-4012 Debrecen, Hungary.	csortos@med.unideb.hu	Gergely, Pál/A-5547-2008		Hungarian Science Research Fund [CNK80709]; New Hungary Development Plan [TAMOP 4.2.1./B-09/1/KONV-2010-0007]; European Social Fund	Hungarian Science Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); New Hungary Development Plan; European Social Fund(European Social Fund (ESF))	This work was supported by CNK80709 (GP) from the Hungarian Science Research Fund (www.otka.hu) and the TAMOP 4.2.1./B-09/1/KONV-2010-0007 project implemented through the New Hungary Development Plan, co-financed by the European Social Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baeyens N, 2011, J CELL BIOCHEM, V112, P2574, DOI 10.1002/jcb.23183; Baeyens N, 2010, AM J PHYSIOL-CELL PH, V299, pC1530, DOI 10.1152/ajpcell.00175.2010; Batchelor CL, 2004, EXP CELL RES, V296, P208, DOI 10.1016/j.yexcr.2004.02.010; Bhattacharya S, 2010, J BIOL CHEM, V285, P9981, DOI 10.1074/jbc.M109.074005; Csortos C, 2007, AM J PHYSIOL-LUNG C, V293, pL843, DOI 10.1152/ajplung.00120.2007; Dai JL, 2004, ONCOGENE, V23, P8681, DOI 10.1038/sj.onc.1207962; Donowitz M, 2005, J PHYSIOL-LONDON, V567, P3, DOI 10.1113/jphysiol.2005.090399; Fievet B, 2007, BBA-MOL CELL RES, V1773, P653, DOI 10.1016/j.bbamcr.2006.06.013; Fouassier L, 2000, J BIOL CHEM, V275, P25039, DOI 10.1074/jbc.C000092200; Fouassier L, 2005, EXP CELL RES, V306, P264, DOI 10.1016/j.yexcr.2005.02.011; Fouassier L, 2009, AM J PATHOL, V174, P869, DOI 10.2353/ajpath.2009.080079; Garbett D, 2010, J CELL BIOL, V191, P397, DOI 10.1083/jcb.201004115; Hall RA, 1999, J BIOL CHEM, V274, P24328, DOI 10.1074/jbc.274.34.24328; Hall RA, 1998, P NATL ACAD SCI USA, V95, P8496, DOI 10.1073/pnas.95.15.8496; He JQ, 2001, J BIOL CHEM, V276, P41559, DOI 10.1074/jbc.M106859200; Hsu CC, 2010, AM J PHYSIOL-CELL PH, V299, pC528, DOI 10.1152/ajpcell.00504.2009; Ingraffea J, 2002, EUR J CELL BIOL, V81, P61, DOI 10.1078/0171-9335-00218; Keese CR, 2004, P NATL ACAD SCI USA, V101, P1554, DOI 10.1073/pnas.0307588100; Kutay U, 2008, CURR OPIN CELL BIOL, V20, P669, DOI 10.1016/j.ceb.2008.09.010; LaLonde DP, 2010, MOL BIOL CELL, V21, P1519, DOI 10.1091/mbc.E10-01-0008; Lau AG, 2001, BIOCHEMISTRY-US, V40, P8572, DOI 10.1021/bi0103516; Mochida S, 2009, EMBO J, V28, P2777, DOI 10.1038/emboj.2009.238; Muranen T, 2005, ONCOGENE, V24, P1150, DOI 10.1038/sj.onc.1208283; Nigg EA, 1997, NATURE, V386, P779, DOI 10.1038/386779a0; Pan Y, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1616; Raghuram V, 2003, P NATL ACAD SCI USA, V100, P9620, DOI 10.1073/pnas.1633250100; Reczek D, 1997, J CELL BIOL, V139, P169, DOI 10.1083/jcb.139.1.169; Schmieder S, 2004, J AM SOC NEPHROL, V15, P2289, DOI 10.1097/01.ASN.0000135968.49899.E8; Schmitz MHA, 2010, NAT CELL BIOL, V12, P886, DOI 10.1038/ncb2092; Sharma GD, 2003, J BIOL CHEM, V278, P21989, DOI 10.1074/jbc.M302650200; Shibata T, 2003, HEPATOLOGY, V38, P178, DOI 10.1053/jhep.2003.50270; Vereb G, 2000, P NATL ACAD SCI USA, V97, P6013, DOI 10.1073/pnas.97.11.6013; Voltz JW, 2007, J BIOL CHEM, V282, P33879, DOI 10.1074/jbc.M703481200; Wade JB, 2001, AM J PHYSIOL-CELL PH, V280, pC192, DOI 10.1152/ajpcell.2001.280.1.C192; Wang SS, 1998, FEBS LETT, V427, P103, DOI 10.1016/S0014-5793(98)00402-5; Weinman EJ, 2006, ANNU REV PHYSIOL, V68, P491, DOI 10.1146/annurev.physiol.68.040104.131050; WEINMAN EJ, 1995, J CLIN INVEST, V95, P2143, DOI 10.1172/JCI117903; Weinman EJ, 1998, J CLIN INVEST, V101, P2199, DOI 10.1172/JCI204; Wu JQ, 2009, NAT CELL BIOL, V11, P644, DOI 10.1038/ncb1871	39	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e35595	10.1371/journal.pone.0035595	http://dx.doi.org/10.1371/journal.pone.0035595			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523604	Green Published, gold			2022-12-27	WOS:000305345000078
J	Johnen, G; Gawrych, K; Bontrup, H; Pesch, B; Taeger, D; Banek, S; Kluckert, M; Wellhausser, H; Eberle, F; Nasterlack, M; Leng, G; Stenzl, A; Bruning, T				Johnen, Georg; Gawrych, Katarzyna; Bontrup, Heike; Pesch, Beate; Taeger, Dirk; Banek, Severine; Kluckert, Matthias; Wellhaeusser, Harald; Eberle, Friedhelm; Nasterlack, Michael; Leng, Gabriele; Stenzl, Arnulf; Bruening, Thomas		UroScreen Study Grp	Performance of Survivin mRNA as a Biomarker for Bladder Cancer in the Prospective Study UroScreen	PLOS ONE			English	Article							INTERNATIONAL CONSENSUS PANEL; TUMOR-MARKERS; PROGNOSTIC-SIGNIFICANCE; URINE DETECTION; AURORA B; EXPRESSION; CARCINOMA; DIAGNOSIS; REVEALS; RECURRENCE	Background: Urinary biomarkers have the potential to improve the early detection of bladder cancer. Most of the various known markers, however, have only been evaluated in studies with cross-sectional design. For proper validation a longitudinal design would be preferable. We used the prospective study UroScreen to evaluate survivin, a potential biomarker that has multiple functions in carcinogenesis. Methods/Results: Survivin was analyzed in 5,716 urine samples from 1,540 chemical workers previously exposed to aromatic amines. The workers participated in a surveillance program with yearly examinations between 2003 and 2010. RNA was extracted from urinary cells and survivin was determined by Real-Time PCR. During the study, 19 bladder tumors were detected. Multivariate generalized estimation equation (GEE) models showed that beta-actin, representing RNA yield and quality, had the strongest influence on survivin positivity. Inflammation, hematuria and smoking did not confound the results. Survivin had a sensitivity of 21.1% for all and 36.4% for high-grade tumors. Specificity was 97.5%, the positive predictive value (PPV) 9.5%, and the negative predictive value (NPV) 99.0%. Conclusions: In this prospective and so far largest study on survivin, the marker showed a good NPV and specificity but a low PPV and sensitivity. This was partly due to the low number of cases, which limits the validity of the results. Compliance, urine quality, problems with the assay, and mRNA stability influenced the performance of survivin. However, most issues could be addressed with a more reliable assay in the future. One important finding is that survivin was not influenced by confounders like inflammation and exhibited a relatively low number of false-positives. Therefore, despite the low sensitivity, survivin may still be considered as a component of a multimarker panel.	[Johnen, Georg; Gawrych, Katarzyna; Bontrup, Heike; Pesch, Beate; Taeger, Dirk; Kluckert, Matthias; Bruening, Thomas] Inst Ruhr Univ Bochum IPA, Inst Prevent & Occupat Med German Social Accid In, Bochum, Germany; [Banek, Severine; Stenzl, Arnulf] Univ Tubingen, Inst Urol, Tubingen, Germany; [Kluckert, Matthias; Wellhaeusser, Harald] German Social Accid Insurances Inst Raw Mat & Che, Heidelberg, Germany; [Eberle, Friedhelm; Nasterlack, Michael] BASF SE, Ludwigshafen, Germany; [Leng, Gabriele] Currenta GmbH & Co OHG, Safety Hlth Protect, Leverkusen, Germany	Ruhr University Bochum; Eberhard Karls University of Tubingen; BASF; Lanxess	Johnen, G (corresponding author), Inst Ruhr Univ Bochum IPA, Inst Prevent & Occupat Med German Social Accid In, Bochum, Germany.	johnen@ipa-dguv.de	Brüning, Thomas/G-8120-2015; Johnen, Georg/AFG-8027-2022	Brüning, Thomas/0000-0001-9560-5464; Johnen, Georg/0000-0002-3773-5946; Burek, Katarzyna/0000-0003-4251-4942; Taeger, Dirk/0000-0002-5340-5584	German Social Accident Insurance (DGUV; Sankt Augustin, Germany) [FB093]; Matritech/Alere	German Social Accident Insurance (DGUV; Sankt Augustin, Germany); Matritech/Alere	Fujirebio Diagnostics, Inc. (FDI; Malvern, PA; http://www.fdi.com) has provided survivin reagents at no costs. Part of the study was supported by a grant (FB093 to AS) of the German Social Accident Insurance (DGUV; Sankt Augustin, Germany; http://www.dguv.de), by Abbott Laboratories (Abbott Park, IL; http://www.abbottmolecular.com) who supplied UroVysion kits, and Matritech/Alere GmbH (Koln, Germany; http://www.alere.com) who supplied NMP22 ELISA kits. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: The author GL is an employee of Currenta GmbH & Co. OHG. FE and MN are employees of BASF SE. AS received free assay kits from Abbott Laboratories and Matritech/Alere GmbH. AS also received travel grants from Matritech/Alere. GJ received free assay reagents from Fujirebio Diagnostics, Inc. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. The authors declare no other competing interests.	Adida C, 2000, BLOOD, V96, P1921; Altieri DC, 2008, NAT REV CANCER, V8, P61, DOI 10.1038/nrc2293; Altieri DC, 2001, TRENDS MOL MED, V7, P542, DOI 10.1016/S1471-4914(01)02243-2; Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Caldas H, 2007, BLOOD, V109, P1479, DOI 10.1182/blood-2006-02-003749; Chantalat L, 2000, MOL CELL, V6, P183, DOI 10.1016/S1097-2765(00)00019-8; Freedman ND, 2011, JAMA-J AM MED ASSOC, V306, P737, DOI 10.1001/jama.2011.1142; Habuchi T, 2005, UROLOGY, V66, P64, DOI 10.1016/j.urology.2005.08.065; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Horstmann M, 2010, WORLD J UROL, V28, P399, DOI 10.1007/s00345-010-0538-2; Huber S, 2012, BJU INT IN PRESS; Jeyaprakash AA, 2007, CELL, V131, P271, DOI 10.1016/j.cell.2007.07.045; Kelly AE, 2010, SCIENCE, V330, P235, DOI 10.1126/science.1189505; Kenney DM, 2007, TUMOR BIOL, V28, P57, DOI 10.1159/000099033; Kren L, 2004, APPL IMMUNOHISTO M M, V12, P44; Lokeshwar VB, 2005, UROLOGY, V66, P35, DOI 10.1016/j.urology.2005.08.064; Lotan Y, 2006, CANCER-AM CANCER SOC, V107, P982, DOI 10.1002/cncr.22084; Lotan Y, 2010, UROL ONCOL-SEMIN ORI, V28, P441, DOI 10.1016/j.urolonc.2009.11.004; Lotan Y, 2009, CANCER-AM CANCER SOC, V115, P4096, DOI 10.1002/cncr.24463; Mehrotra S, 2010, CANCER CELL, V17, P53, DOI 10.1016/j.ccr.2009.11.021; Moussa O, 2006, J UROLOGY, V175, P2312, DOI 10.1016/S0022-5347(06)00254-0; Nasterlack M, 2011, AKTUEL UROL, V42, P128, DOI 10.1055/s-0031-1271424; Nasterlack M, 2001, S MED, V12, P17; Pesch B, 2011, BJU INT, V108, P546, DOI 10.1111/j.1464-410X.2010.09971.x; Ransohoff DF, 2010, J CLIN ONCOL, V28, P698, DOI 10.1200/JCO.2009.25.6065; Rathert P, 1991, URINZYTOLOGIE PRAXIS; Robert-Koch-Institut und die Gesellschaft der epidemiologischen Krebsregister in Deutschland e. V, 2010, KREBS DEUTSCHL 2005, V7; Sanchez-Carbayo M, 2001, CANCER-AM CANCER SOC, V92, P2820, DOI 10.1002/1097-0142(20011201)92:11<2820::AID-CNCR10092>3.0.CO;2-I; Sarela AI, 2000, GUT, V46, P645, DOI 10.1136/gut.46.5.645; Schmitz-Drager BJ, 2012, ICUD BLADDER TUMORS, V21, P1; Shariat SF, 2004, J UROLOGY, V171, P626, DOI 10.1097/01.ju.0000107826.78479.90; Shariat SF, 2009, CLIN CANCER RES, V15, P7012, DOI 10.1158/1078-0432.CCR-08-2554; Smith SD, 2001, JAMA-J AM MED ASSOC, V285, P324, DOI 10.1001/jama.285.3.324; Sun CH, 2005, BIOCHEMISTRY-US, V44, P11, DOI 10.1021/bi0485171; Swana HS, 1999, NEW ENGL J MED, V341, P452, DOI 10.1056/NEJM199908053410614; Takai N, 2002, CANCER LETT, V184, P105, DOI 10.1016/S0304-3835(02)00190-8; Tran J, 2002, P NATL ACAD SCI USA, V99, P4349, DOI 10.1073/pnas.072586399; Verdecia MA, 2000, NAT STRUCT BIOL, V7, P602; Wang FW, 2010, SCIENCE, V330, P231, DOI 10.1126/science.1189435; Wang HD, 2004, J CANCER RES CLIN, V130, P487, DOI 10.1007/s00432-004-0561-z; Weber DG, 2010, BIOMARK INSIGHTS, V5, P95; Weikert S, 2005, INT J CANCER, V116, P100, DOI 10.1002/ijc.21000; Yamagishi Y, 2010, SCIENCE, V330, P239, DOI 10.1126/science.1194498	43	21	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e35363	10.1371/journal.pone.0035363	http://dx.doi.org/10.1371/journal.pone.0035363			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22530010	Green Published, gold, Green Submitted			2022-12-27	WOS:000305345000059
J	Galati, A; Magdinier, F; Colasanti, V; Bauwens, S; Pinte, S; Ricordy, R; Giraud-Panis, MJ; Pusch, MC; Savino, M; Cacchione, S; Gilson, E				Galati, Alessandra; Magdinier, Frederique; Colasanti, Valentina; Bauwens, Serge; Pinte, Sebastien; Ricordy, Ruggero; Giraud-Panis, Marie-Josephe; Pusch, Miriam Caroline; Savino, Maria; Cacchione, Stefano; Gilson, Eric			TRF2 Controls Telomeric Nucleosome Organization in a Cell Cycle Phase-Dependent Manner	PLOS ONE			English	Article							CHROMATIN-STRUCTURE; CHROMOSOME ENDS; BINDING-SITES; DNA-DAMAGE; SEQUENCES; COMPLEX; INTEGRITY; INTERACTS; PROTEINS; H3.3	Mammalian telomeres stabilize chromosome ends as a result of their assembly into a peculiar form of chromatin comprising a complex of non-histone proteins named shelterin. TRF2, one of the shelterin components, binds to the duplex part of telomeric DNA and is essential to fold the telomeric chromatin into a protective cap. Although most of the human telomeric DNA is organized into tightly spaced nucleosomes, their role in telomere protection and how they interplay with telomere-specific factors in telomere organization is still unclear. In this study we investigated whether TRF2 can regulate nucleosome assembly at telomeres. By means of chromatin immunoprecipitation (ChIP) and Micrococcal Nuclease (MNase) mapping assay, we found that the density of telomeric nucleosomes in human cells was inversely proportional to the dosage of TRF2 at telomeres. This effect was not observed in the G1 phase of the cell cycle but appeared coincident of late or post-replicative events. Moreover, we showed that TRF2 overexpression altered nucleosome spacing at telomeres increasing internucleosomal distance. By means of an in vitro nucleosome assembly system containing purified histones and remodeling factors, we reproduced the short nucleosome spacing found in telomeric chromatin. Importantly, when in vitro assembly was performed in the presence of purified TRF2, nucleosome spacing on a telomeric DNA template increased, in agreement with in vivo MNase mapping. Our results demonstrate that TRF2 negatively regulates the number of nucleosomes at human telomeres by a cell cycle-dependent mechanism that alters internucleosomal distance. These findings raise the intriguing possibility that telomere protection is mediated, at least in part, by the TRF2-dependent regulation of nucleosome organization.	[Galati, Alessandra; Colasanti, Valentina; Savino, Maria; Cacchione, Stefano] Univ Roma La Sapienza, Dipartimento Biol & Biotecnol, Rome, Italy; [Galati, Alessandra; Magdinier, Frederique; Bauwens, Serge; Pinte, Sebastien; Giraud-Panis, Marie-Josephe; Gilson, Eric] Univ Lyon, CNRS, Ecole Normale Super Lyon, Lab Biol Mol Cellule,UMR5239, Lyon, France; [Ricordy, Ruggero; Savino, Maria] CNR, Ist Biol & Patol Mol, Rome, Italy; [Giraud-Panis, Marie-Josephe; Gilson, Eric] Univ Nice, CNRS, INSERM, U1081,IRCAN,UMR 7284,Fac Med 28, F-06034 Nice, France; [Pusch, Miriam Caroline] Univ Munich, Adolf Butenandt Inst, Munich, Germany; [Gilson, Eric] CHU Nice, Archet Hosp 2, Dept Med Genet, Nice, France; [Savino, Maria; Cacchione, Stefano] Ist Pasteur Fdn Cenci Bolognetti, Rome, Italy	Sapienza University Rome; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); Universite Jean Monnet; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Nice; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; University of Munich; CHU Nice; Fondazione Cenci Bolognetti	Cacchione, S (corresponding author), Univ Roma La Sapienza, Dipartimento Biol & Biotecnol, Rome, Italy.	stefano.cacchione@uniroma1.it; Eric.Gilson@unice.fr	Magdinier, Frederique/I-4735-2016	Magdinier, Frederique/0000-0002-0159-9559; Giraud-Panis, Marie-Josephe/0000-0001-7941-2873; Cacchione, Stefano/0000-0002-7278-3695	Ligue Nationale contre le Cancer ("equipe labellisee"); Institut National du Cancer (INCa); ANR; European Community [RISC-RAD FI6R-CT-2003- 508842, TELOMARKER Health-F2-2007-200950]; Istituto Pasteur-Fondazione Cenci Bolognetti; Ministero dell'Istruzione dell'Universita e della Ricerca; Agenzia Spaziale Italiana (ASI) [CUP F11J11000010001]; EMBO	Ligue Nationale contre le Cancer ("equipe labellisee")(Ligue nationale contre le cancer); Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); ANR(French National Research Agency (ANR)); European Community(European Commission); Istituto Pasteur-Fondazione Cenci Bolognetti(Istituto Pasteur Italia Fondazione Cenci Bolognetti); Ministero dell'Istruzione dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); Agenzia Spaziale Italiana (ASI)(Agenzia Spaziale Italiana (ASI)); EMBO(European Molecular Biology Organization (EMBO))	The work in EG's lab is supported by grants from the Ligue Nationale contre le Cancer ("equipe labellisee"), the Institut National du Cancer (INCa, program TELOFUN), the ANR program TELOREP and the European Community (RISC-RAD FI6R-CT-2003- 508842, TELOMARKER Health-F2-2007-200950). The work in SC's lab was supported by grants from Istituto Pasteur-Fondazione Cenci Bolognetti (http://www.istitutopasteur.it/), by Ministero dell'Istruzione dell'Universita e della Ricerca (PRIN 2009), and by Agenzia Spaziale Italiana (ASI, CUP F11J11000010001). AG has been supported by a short-term EMBO fellowship and by a post-doctoral fellowship from Istituto Pasteur-Fondazione Cenci Bolognetti. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiard S, 2007, NAT STRUCT MOL BIOL, V14, P147, DOI 10.1038/nsmb1192; Azzalin CM, 2007, SCIENCE, V318, P798, DOI 10.1126/science.1147182; Baker AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019124; Baker AM, 2009, NUCLEIC ACIDS RES, V37, P5019, DOI 10.1093/nar/gkp515; Baur JA, 2001, SCIENCE, V292, P2075, DOI 10.1126/science.1062329; Benetti R, 2008, CELL CYCLE, V7, P3461, DOI 10.4161/cc.7.21.7013; Blank TA, 1997, METHODS, V12, P28, DOI 10.1006/meth.1997.0444; Blasco MA, 2007, NAT REV GENET, V8, P299, DOI 10.1038/nrg2047; Brunori M, 2006, ONCOGENE, V25, P990, DOI 10.1038/sj.onc.1209135; Cacchione S, 1997, FEBS LETT, V400, P37, DOI 10.1016/S0014-5793(96)01318-X; CONRAD MN, 1990, CELL, V63, P739, DOI 10.1016/0092-8674(90)90140-A; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; FAJKUS J, 1995, MOL GEN GENET, V247, P633, DOI 10.1007/BF00290355; Galati A, 2006, J MOL BIOL, V360, P377, DOI 10.1016/j.jmb.2006.04.071; Gilson E, 2007, NAT REV MOL CELL BIO, V8, P825, DOI 10.1038/nrm2259; Goldberg AD, 2010, CELL, V140, P678, DOI 10.1016/j.cell.2010.01.003; Groth A, 2007, CELL, V128, P721, DOI 10.1016/j.cell.2007.01.030; Karlseder J, 1999, SCIENCE, V283, P1321, DOI 10.1126/science.283.5406.1321; Koerber RT, 2009, MOL CELL, V35, P889, DOI 10.1016/j.molcel.2009.09.011; Koering CE, 2002, EMBO REP, V3, P1055, DOI 10.1093/embo-reports/kvf215; LEJNINE S, 1995, P NATL ACAD SCI USA, V92, P2393, DOI 10.1073/pnas.92.6.2393; Liu D, 2004, J BIOL CHEM, V279, P51338, DOI 10.1074/jbc.M409293200; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; MAKAROV VL, 1993, CELL, V73, P775, DOI 10.1016/0092-8674(93)90256-P; Mattern KA, 2004, MOL CELL BIOL, V24, P5587, DOI 10.1128/MCB.24.12.5587-5594.2004; McEachern MJ, 2000, ANNU REV GENET, V34, P331, DOI 10.1146/annurev.genet.34.1.331; Mechelli R, 2004, FEBS LETT, V566, P131, DOI 10.1016/j.febslet.2004.04.032; Munoz P, 2005, NAT GENET, V37, P1063, DOI 10.1038/ng1633; Nikitina T, 2004, J CELL BIOL, V166, P161, DOI 10.1083/jcb.200403118; O'Sullivan RJ, 2010, NAT STRUCT MOL BIOL, V17, P1218, DOI 10.1038/nsmb.1897; Ottaviani A, 2008, BIOCHIMIE, V90, P93, DOI 10.1016/j.biochi.2007.07.022; Pisano S, 2008, CELL MOL LIFE SCI, V65, P3553, DOI 10.1007/s00018-008-8307-8; Pisano S, 2007, J MOL BIOL, V369, P1153, DOI 10.1016/j.jmb.2007.04.027; Pisano S, 2006, BIOPHYS CHEM, V124, P81, DOI 10.1016/j.bpc.2006.05.012; Pisano S, 2010, NUCLEIC ACIDS RES, V38, P2247, DOI 10.1093/nar/gkp1228; Poulet A, 2011, NUCL ACIDS IN PRESS; Rossetti L, 1998, BIOCHEMISTRY-US, V37, P6727, DOI 10.1021/bi9726180; Rossetti L, 2001, J MOL BIOL, V306, P903, DOI 10.1006/jmbi.2001.4458; Simonet T, 2011, CELL RES, V21, P1028, DOI 10.1038/cr.2011.40; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; TOMMERUP H, 1994, MOL CELL BIOL, V14, P5777, DOI 10.1128/MCB.14.9.5777; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; Wong LH, 2010, GENOME RES, V20, P351, DOI 10.1101/gr.101477.109; WRIGHT JH, 1992, GENE DEV, V6, P197, DOI 10.1101/gad.6.2.197; Wu P, 2008, MOL CELL BIOL, V28, P5724, DOI 10.1128/MCB.01764-07; Xin HW, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-232; Yang D, 2011, CELL RES, V21, P1013, DOI 10.1038/cr.2011.39; Ye J, 2010, CELL, V142, P230, DOI 10.1016/j.cell.2010.05.032; Yu LN, 1999, MOL CELL BIOL, V19, P5279	50	32	34	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e34386	10.1371/journal.pone.0034386	http://dx.doi.org/10.1371/journal.pone.0034386			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536324	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339200012
J	Kim, A; Feng, P; Ohkuri, T; Sauers, D; Cohn, ZJ; Chai, JH; Nelson, T; Bachmanov, AA; Huang, LQ; Wang, H				Kim, Agnes; Feng, Pu; Ohkuri, Tadahiro; Sauers, Daniel; Cohn, Zachary J.; Chai, Jinghua; Nelson, Theodore; Bachmanov, Alexander A.; Huang, Liquan; Wang, Hong			Defects in the Peripheral Taste Structure and Function in the MRL/lpr Mouse Model of Autoimmune Disease	PLOS ONE			English	Article							RAT CIRCUMVALLATE PAPILLAE; BUD CELLS; SJOGRENS-SYNDROME; RECEPTOR-CELLS; SIGNALING PATHWAYS; GENE-EXPRESSION; MAMMALIAN TASTE; SOFT PALATE; MICE; INFLAMMATION	While our understanding of the molecular and cellular aspects of taste reception and signaling continues to improve, the aberrations in these processes that lead to taste dysfunction remain largely unexplored. Abnormalities in taste can develop in a variety of diseases, including infections and autoimmune disorders. In this study, we used a mouse model of autoimmune disease to investigate the underlying mechanisms of taste disorders. MRL/MpJ-Fas(lpr)/J (MRL/lpr) mice develop a systemic autoimmunity with phenotypic similarities to human systemic lupus erythematosus and Sjogren's syndrome. Our results show that the taste tissues of MRL/lpr mice exhibit characteristics of inflammation, including infiltration of T lymphocytes and elevated levels of some inflammatory cytokines. Histological studies reveal that the taste buds of MRL/lpr mice are smaller than those of wild-type congenic control (MRL/+/+) mice. 5-Bromo-2'-deoxyuridine (BrdU) pulse-chase experiments show that fewer BrdU-labeled cells enter the taste buds of MRL/lpr mice, suggesting an inhibition of taste cell renewal. Real-time RT-PCR analyses show that mRNA levels of several type II taste cell markers are lower in MRL/lpr mice. Immunohistochemical analyses confirm a significant reduction in the number of gustducin-positive taste receptor cells in the taste buds of MRL/lpr mice. Furthermore, MRL/lpr mice exhibit reduced gustatory nerve responses to the bitter compound quinine and the sweet compound saccharin and reduced behavioral responses to bitter, sweet, and umami taste substances compared with controls. In contrast, their responses to salty and sour compounds are comparable to those of control mice in both nerve recording and behavioral experiments. Together, our results suggest that type II taste receptor cells, which are essential for bitter, sweet, and umami taste reception and signaling, are selectively affected in MRL/lpr mice, a model for autoimmune disease with chronic inflammation.	[Kim, Agnes; Feng, Pu; Ohkuri, Tadahiro; Sauers, Daniel; Cohn, Zachary J.; Chai, Jinghua; Nelson, Theodore; Bachmanov, Alexander A.; Huang, Liquan; Wang, Hong] Monell Chem Senses Ctr, Philadelphia, PA 19104 USA	Monell Chemical Senses Center	Kim, A (corresponding author), Drexel Univ, Coll Med, Philadelphia, PA 19104 USA.	hwang@monell.org	Bachmanov, Alexander A./AAH-8857-2020	Bachmanov, Alexander A./0000-0002-2861-3322; Huang, Liquan/0000-0003-3400-0685; Wang, Hong/0000-0003-4130-8741	National Institutes of Health/National Institute on Deafness and Other Communication Disorders [DC010012, DC007487, DC00882, P30 DC011735, T32DC000014]; National Science Foundation [DBJ-0216310]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007487, P30DC011735, R01DC010012, T32DC000014, R01DC000882] Funding Source: NIH RePORTER	National Institutes of Health/National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This study was supported by grants from the National Institutes of Health/National Institute on Deafness and Other Communication Disorders (DC010012 to H.W., DC007487 to L.H., DC00882 to A.A.B., P30 DC011735, and T32DC000014) and from the National Science Foundation (DBJ-0216310). The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerlund K, 1999, CLIN EXP IMMUNOL, V115, P32; ANDREWS BS, 1978, J EXP MED, V148, P1198, DOI 10.1084/jem.148.5.1198; [Anonymous], 1995, NEUROL DIS; Ballok DA, 2004, HIPPOCAMPUS, V14, P649, DOI 10.1002/hipo.10205; BEIDLER LM, 1965, J CELL BIOL, V27, P263, DOI 10.1083/jcb.27.2.263; Boughter JD, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-36; Boughter JD, 2002, CHEM SENSES, V27, P133, DOI 10.1093/chemse/27.2.133; Brand JG, 2000, LANCET, V356, P1371, DOI 10.1016/S0140-6736(00)02836-1; Breslin PAS, 2006, ADV OTO-RHINO-LARYNG, V63, P152, DOI 10.1159/000093760; Bromley S. M., 2003, Handbook of olfaction and gustation, P935; CAMPBELL SM, 1983, AM J OTOLARYNG, V4, P187, DOI 10.1016/S0196-0709(83)80042-8; Cavallin MA, 2005, J NEUROSCI RES, V80, P75, DOI 10.1002/jnr.20438; Chandrashekar J, 2006, NATURE, V444, P288, DOI 10.1038/nature05401; Chandrashekar J, 2010, NATURE, V464, P297, DOI 10.1038/nature08783; Chaudhari N, 2010, J CELL BIOL, V190, P285, DOI 10.1083/jcb.201003144; Clapp TR, 2004, J COMP NEUROL, V468, P311, DOI 10.1002/cne.10963; Cohn ZJ, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-72; FARBMAN AI, 1980, CELL TISSUE KINET, V13, P349, DOI 10.1111/j.1365-2184.1980.tb00474.x; Feng P, 2010, CHEM SENSES, V35, P501, DOI 10.1093/chemse/bjq040; Feng P, 2009, BRAIN BEHAV IMMUN, V23, P760, DOI 10.1016/j.bbi.2009.02.016; Finger TE, 2005, CHEM SENSES, V30, pI54, DOI 10.1093/chemse/bjh110; Finger TE, 2005, SCIENCE, V310, P1495, DOI 10.1126/science.1118435; FOSTER RF, 1987, DEV BIOL, V122, P11, DOI 10.1016/0012-1606(87)90327-7; Fox RI, 2005, LANCET, V366, P321, DOI 10.1016/S0140-6736(05)66990-5; FURUKAWA F, 1984, ARCH DERMATOL RES, V276, P186, DOI 10.1007/BF00414018; Glendinning JI, 2002, CHEM SENSES, V27, P461, DOI 10.1093/chemse/27.5.461; Goldstein BJ, 2004, OTOLARYNG CLIN N AM, V37, P1281, DOI 10.1016/j.otc.2004.06.004; Gomez FE, 2004, EUR J CLIN NUTR, V58, P629, DOI 10.1038/sj.ejcn.1601858; Harrison TA, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-34; Heald A E, 1997, N C Med J, V58, P100; HENKIN RI, 1972, ANN INTERN MED, V76, P375, DOI 10.7326/0003-4819-76-3-375; Hevezi P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006395; Huang AL, 2006, NATURE, V442, P934, DOI [10.1038/nature05084, 10.1038/nature050084]; Huang LQ, 2003, J COMP NEUROL, V455, P1, DOI 10.1002/cne.10396; Huang YA, 2008, J PHYSIOL-LONDON, V586, P2903, DOI 10.1113/jphysiol.2008.151233; Hutton JL, 2007, J PAIN SYMPTOM MANAG, V33, P156, DOI 10.1016/j.jpainsymman.2006.07.017; Iguchi N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023165; Inoue M, 2004, CHEM SENSES, V29, P789, DOI 10.1093/chemse/bjh083; JABS DA, 1994, ADV EXP MED BIOL, V350, P623; Jonsson R, 2007, ANN NY ACAD SCI, V1108, P433, DOI 10.1196/annals.1422.046; Kataoka S, 2008, CHEM SENSES, V33, P243, DOI 10.1093/chemse/bjm083; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Manita S, 2006, CHEM SENSES, V31, P785, DOI 10.1093/chemse/bjl020; Mann NM, 2002, CLEV CLIN J MED, V69, P329, DOI 10.3949/ccjm.69.4.329; Matsumoto I, 2011, NAT NEUROSCI, V14, P685, DOI 10.1038/nn.2820; Medler KF, 2003, J NEUROSCI, V23, P2608; Miura H, 2005, CHEM SENSES, V30, P367, DOI 10.1093/chemse/bji031; Miura H, 2010, ARCH ITAL BIOL, V148, P107; Murata Y, 2009, PHYSIOL BEHAV, V98, P481, DOI 10.1016/j.physbeh.2009.07.016; Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320; Nelson TM, 2003, CHEM SENSES, V28, P695, DOI 10.1093/chemse/bjg062; Ohkuri T, 2012, RESIDUAL CHEMORESPON; Ohkuri T, 2006, CHEM SENSES, V31, P565, DOI 10.1093/chemse/bjj061; Ohkuri T, 2009, AM J PHYSIOL-REG I, V296, pR960, DOI 10.1152/ajpregu.91018.2008; Ohtubo Y, 2011, BRAIN RES, V1367, P13, DOI 10.1016/j.brainres.2010.10.060; Okubo T, 2009, STEM CELLS, V27, P442, DOI 10.1634/stemcells.2008-0611; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Peng SL, 1998, CLIN EXP IMMUNOL, V111, P107; Perez CA, 2002, NAT NEUROSCI, V5, P1169, DOI 10.1038/nn952; Phillips LM, 1996, AM J PHYSIOL-REG I, V271, pR857, DOI 10.1152/ajpregu.1996.271.4.R857; Pribitkin E, 2003, ANN OTO RHINOL LARYN, V112, P971, DOI 10.1177/000348940311201110; Pumplin DW, 2000, J COMP NEUROL, V427, P171, DOI 10.1002/1096-9861(20001113)427:2<171::AID-CNE1>3.0.CO;2-W; Reed DR, 2004, J NEUROSCI, V24, P938, DOI 10.1523/JNEUROSCI.1374-03.2004; Reiter ER, 2006, ADV OTO-RHINO-LARYNG, V63, P265, DOI 10.1159/000093765; Sakic B, 1996, BRAIN RES BULL, V41, P305, DOI 10.1016/S0361-9230(96)00190-6; Sakic B, 1997, BRAIN RES BULL, V44, P155, DOI 10.1016/S0361-9230(97)00107-X; SCHIFFMAN SS, 1983, NEW ENGL J MED, V308, P1275; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Steen PW, 2010, NEUROSCIENCE, V167, P894, DOI 10.1016/j.neuroscience.2010.02.056; Suzuki Y, 2002, CELL TISSUE RES, V307, P423, DOI 10.1007/s00441-001-0504-9; Tesch GH, 1999, J EXP MED, V190, P1813, DOI 10.1084/jem.190.12.1813; Thirumangalathu S, 2009, DEVELOPMENT, V136, P1519, DOI 10.1242/dev.029090; Vandenbeuch A, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-1; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Wang H, 2007, J NEUROSCI, V27, P10703, DOI 10.1523/JNEUROSCI.3102-07.2007; Wang H, 2009, ANN NY ACAD SCI, V1170, P596, DOI 10.1111/j.1749-6632.2009.04480.x; Wang H, 2009, J COMP NEUROL, V512, P384, DOI 10.1002/cne.21899; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0; WEIFFENBACH JM, 1995, PHYSIOL BEHAV, V57, P89, DOI 10.1016/0031-9384(94)00211-M; Wong GT, 1996, NATURE, V381, P796, DOI 10.1038/381796a0; WU JG, 1993, J EXP MED, V178, P461, DOI 10.1084/jem.178.2.461; Yang RB, 2000, J COMP NEUROL, V424, P205, DOI 10.1002/1096-9861(20000821)424:2<205::AID-CNE2>3.0.CO;2-F; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0; Zipp F, 2006, TRENDS NEUROSCI, V29, P518, DOI 10.1016/j.tins.2006.07.006	85	23	27	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e35588	10.1371/journal.pone.0035588	http://dx.doi.org/10.1371/journal.pone.0035588			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22536412	Green Submitted, Green Published, gold			2022-12-27	WOS:000305336200059
J	Kucyi, A; Moayedi, M; Weissman-Fogel, I; Hodaie, M; Davis, KD				Kucyi, Aaron; Moayedi, Massieh; Weissman-Fogel, Irit; Hodaie, Mojgan; Davis, Karen D.			Hemispheric Asymmetry in White Matter Connectivity of the Temporoparietal Junction with the Insula and Prefrontal Cortex	PLOS ONE			English	Article							TRACTOGRAPHY-BASED PARCELLATION; STATE FUNCTIONAL CONNECTIVITY; MULTIPLE SENSORY MODALITIES; HUMAN BRAIN; STRUCTURAL CONNECTIVITY; IMAGING TRACTOGRAPHY; SPATIAL AWARENESS; CORTICAL NETWORK; DIFFUSION TRACTOGRAPHY; VISUOSPATIAL ATTENTION	The temporoparietal junction (TPJ) is a key node in the brain's ventral attention network (VAN) that is involved in spatial awareness and detection of salient sensory stimuli, including pain. The anatomical basis of this network's right-lateralized organization is poorly understood. Here we used diffusion-weighted MRI and probabilistic tractography to compare the strength of white matter connections emanating from the right versus left TPJ to target regions in both hemispheres. Symmetry of structural connectivity was evaluated for connections between TPJ and target regions that are key cortical nodes in the right VAN (insula and inferior frontal gyrus) as well as target regions that are involved in salience and/or pain (putamen, cingulate cortex, thalamus). We found a rightward asymmetry in connectivity strength between the TPJ and insula in healthy human subjects who were scanned with two different sets of diffusion-weighted MRI acquisition parameters. This rightward asymmetry in TPJ-insula connectivity was stronger in females than in males. There was also a leftward asymmetry in connectivity strength between the TPJ and inferior frontal gyrus, consistent with previously described lateralization of language pathways. The rightward lateralization of the pathway between the TPJ and insula supports previous findings on the roles of these regions in stimulus-driven attention, sensory awareness, interoception and pain. The findings also have implications for our understanding of acute and chronic pains and stroke-induced spatial hemineglect.	[Kucyi, Aaron; Moayedi, Massieh; Weissman-Fogel, Irit; Davis, Karen D.] Univ Hlth Network, Toronto Western Res Inst, Div Brain Imaging & Behav Syst Neurosci, Toronto, ON, Canada; [Kucyi, Aaron; Moayedi, Massieh; Hodaie, Mojgan; Davis, Karen D.] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A1, Canada; [Hodaie, Mojgan; Davis, Karen D.] Toronto Western Hosp, Div Neurosurg, Toronto, ON M5T 2S8, Canada; [Hodaie, Mojgan; Davis, Karen D.] Univ Toronto, Dept Surg, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Kucyi, A (corresponding author), Univ Hlth Network, Toronto Western Res Inst, Div Brain Imaging & Behav Syst Neurosci, Toronto, ON, Canada.	kdavis@uhnres.utoronto.ca	Moayedi, Massieh/D-7430-2013	Moayedi, Massieh/0000-0002-7324-2540	Canadian Institutes of Health Research; Physicians' Services Incorporated	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Physicians' Services Incorporated	This study was funded by grants from the Canadian Institutes of Health Research and Physicians' Services Incorporated. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anwander A, 2007, CEREB CORTEX, V17, P816, DOI 10.1093/cercor/bhk034; Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Blankstein U, 2010, GASTROENTEROLOGY, V138, P1783, DOI 10.1053/j.gastro.2009.12.043; Catani M, 2007, P NATL ACAD SCI USA, V104, P17163, DOI 10.1073/pnas.0702116104; Cauda F, 2011, NEUROIMAGE, V55, P8, DOI 10.1016/j.neuroimage.2010.11.049; Chica AB, 2011, J NEUROSCI, V31, P8143, DOI 10.1523/JNEUROSCI.5463-10.2010; Committeri G, 2007, BRAIN, V130, P431, DOI 10.1093/brain/awl265; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Davis KD, 2008, NEUROLOGY, V70, P153, DOI 10.1212/01.wnl.0000295509.30630.10; Decety J, 2007, NEUROSCIENTIST, V13, P580, DOI 10.1177/1073858407304654; Doricchi F, 2008, CORTEX, V44, P983, DOI 10.1016/j.cortex.2008.03.006; Downar J, 2003, NEUROIMAGE, V20, P1540, DOI 10.1016/S1053-8119(03)00407-5; Downar J, 2002, J NEUROPHYSIOL, V87, P615, DOI 10.1152/jn.00636.2001; Downar J, 2001, NEUROIMAGE, V14, P1256, DOI 10.1006/nimg.2001.0946; Downar J, 2001, NEUROIMAGE, V13, pS310; Downar J, 2000, NAT NEUROSCI, V3, P277, DOI 10.1038/72991; Downar J, 2000, SOC NEUROSCIENCE, V26, P1587; Eickhoff SB, 2010, J NEUROSCI, V30, P6409, DOI 10.1523/JNEUROSCI.5664-09.2010; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; Friederici AD, 2009, TRENDS COGN SCI, V13, P175, DOI 10.1016/j.tics.2009.01.001; Friedrich FJ, 1998, NEUROPSYCHOLOGY, V12, P193, DOI 10.1037/0894-4105.12.2.193; Friston KJ, 2011, BRAIN CONNECT, V1, P13, DOI 10.1089/brain.2011.0008; Geha PY, 2008, NEURON, V60, P570, DOI 10.1016/j.neuron.2008.08.022; Hagmann P, 2010, J NEUROSCI METH, V194, P34, DOI 10.1016/j.jneumeth.2010.01.014; Halligan PW, 2003, TRENDS COGN SCI, V7, P125, DOI 10.1016/S1364-6613(03)00032-9; He BJ, 2007, NEURON, V53, P905, DOI 10.1016/j.neuron.2007.02.013; Heiervang E, 2006, NEUROIMAGE, V33, P867, DOI 10.1016/j.neuroimage.2006.07.037; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Iturria-Medina Y, 2011, CEREB CORTEX, V21, P56, DOI 10.1093/cercor/bhq058; Jbabdi S, 2011, TRACTOGRAPHY WE GO H; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Johansen-Berg H, 2009, ANNU REV NEUROSCI, V32, P75, DOI 10.1146/annurev.neuro.051508.135735; Kaplan E, 2010, NEUROIMAGE, V52, P436, DOI 10.1016/j.neuroimage.2010.04.247; Langner R, 2011, HUM BRAIN MAPP; Loui P, 2011, NEUROIMAGE, V55, P500, DOI 10.1016/j.neuroimage.2010.12.022; Malinen S, 2010, P NATL ACAD SCI USA, V107, P6493, DOI 10.1073/pnas.1001504107; Mars RB, 2011, CONNECTIVITY BASED S; Mars RB, 2011, J NEUROSCI, V31, P4087, DOI 10.1523/JNEUROSCI.5102-10.2011; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; Medford N, 2010, BRAIN STRUCT FUNCT, V214, P535, DOI 10.1007/s00429-010-0265-x; MESULAM MM, 1982, J COMP NEUROL, V212, P38, DOI 10.1002/cne.902120104; Moayedi M, 2011, NEUROIMAGE, V55, P277, DOI 10.1016/j.neuroimage.2010.12.013; Mukherjee P, 2008, AM J NEURORADIOL, V29, P843, DOI 10.3174/ajnr.A1052; Naidich TP, 2004, AM J NEURORADIOL, V25, P222; PANDYA DN, 1969, BRAIN RES, V13, P13, DOI 10.1016/0006-8993(69)90141-3; Parker GJM, 2005, PHILOS T R SOC B, V360, P893, DOI 10.1098/rstb.2005.1639; Petrides M, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000170; Powell HW, 2006, NEUROIMAGE; Salomons TV, 2007, J COGNITIVE NEUROSCI, V19, P993, DOI 10.1162/jocn.2007.19.6.993; Saur D, 2008, P NATL ACAD SCI USA, V105, P18035, DOI 10.1073/pnas.0805234105; Schmahmann JD, 2006, FIBER PATHWAYS BRAIN, DOI DOI 10.1093/ACPROF:OSO/9780195104233.003.0014; Schmahmann JD, 2007, BRAIN, V130, P630, DOI 10.1093/brain/awl359; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Starr CJ, 2011, BRAIN, V134, P1987, DOI 10.1093/brain/awr117; Symonds LL, 2006, J NEUROPHYSIOL, V95, P3823, DOI 10.1152/jn.01162.2005; Taylor KS, 2009, HUM BRAIN MAPP, V30, P2731, DOI 10.1002/hbm.20705; Tensaouti F, 2011, J MAGN RESON IMAGING, V34, P165, DOI 10.1002/jmri.22584; Thiebaut de Schotten M, 2005, SCIENCE, V309, P2226, DOI 10.1126/science.1116251; Thiebaut de Schotten M, 2011, NAT NEUROSCI, V14, P1245, DOI 10.1038/nn.2905; Thiebaut de Schotten M, 2011, NEUROIMAGE, V54, P49, DOI 10.1016/j.neuroimage.2010.07.055; Tomassini V, 2007, J NEUROSCI, V27, P10259, DOI 10.1523/JNEUROSCI.2144-07.2007; Ture U, 1999, J NEUROSURG, V90, P720, DOI 10.3171/jns.1999.90.4.0720; Umarova RM, 2010, CEREB CORTEX, V20, P121, DOI 10.1093/cercor/bhp086; Urbanski M, 2008, J NEUROL NEUROSUR PS, V79, P598, DOI 10.1136/jnnp.2007.126276; Urbanski M, 2011, EXP BRAIN RES, V208, P491, DOI 10.1007/s00221-010-2496-8; Vallar G, 1998, TRENDS COGN SCI, V2, P87, DOI 10.1016/S1364-6613(98)01145-0; Vogt BA, 2005, NAT REV NEUROSCI, V6, P533, DOI 10.1038/nrn1704; VOGT BA, 1987, J COMP NEUROL, V262, P271, DOI 10.1002/cne.902620208; Wager TD, 2007, P NATL ACAD SCI USA, V104, P11056, DOI 10.1073/pnas.0702413104; Weissman-Fogel I, 2011, PAIN, V152, P384, DOI 10.1016/j.pain.2010.10.046	77	62	62	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e35589	10.1371/journal.pone.0035589	http://dx.doi.org/10.1371/journal.pone.0035589			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22536413	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336200060
J	Luo, S; Mach, J; Abramson, B; Ramirez, R; Schurr, R; Barone, P; Copenhaver, G; Folkerts, O				Luo, Song; Mach, Jennifer; Abramson, Bradley; Ramirez, Rolando; Schurr, Robert; Barone, Pierluigi; Copenhaver, Gregory; Folkerts, Otto			The Cotton Centromere Contains a Ty3-gypsy-like LTR Retroelement	PLOS ONE			English	Article							REPETITIVE DNA ELEMENT; SEQUENCE-ANALYSIS; TRANSPOSABLE ELEMENTS; TANDEM REPEATS; RETROTRANSPOSONS; ORGANIZATION; EVOLUTION; PROTEIN; REGION; WHEAT	The centromere is a repeat-rich structure essential for chromosome segregation; with the long-term aim of understanding centromere structure and function, we set out to identify cotton centromere sequences. To isolate centromere-associated sequences from cotton, (Gossypium hirsutum) we surveyed tandem and dispersed repetitive DNA in the genus. Centromere-associated elements in other plants include tandem repeats and, in some cases, centromere-specific retroelements. Examination of cotton genomic survey sequences for tandem repeats yielded sequences that did not localize to the centromere. However, among the repetitive sequences we also identified a gypsy-like LTR retrotransposon (Centromere Retroelement Gossypium, CRG) that localizes to the centromere region of all chromosomes in domestic upland cotton, Gossypium hirsutum, the major commercially grown cotton. The location of the functional centromere was confirmed by immunostaining with antiserum to the centromere-specific histone CENH3, which co-localizes with CRG hybridization on metaphase mitotic chromosomes. G. hirsutum is an allotetraploid composed of A and D genomes and CRG is also present in the centromere regions of other AD cotton species. Furthermore, FISH and genomic dot blot hybridization revealed that CRG is found in D-genome diploid cotton species, but not in A-genome diploid species, indicating that this retroelement may have invaded the A-genome centromeres during allopolyploid formation and amplified during evolutionary history. CRG is also found in other diploid Gossypium species, including B and E2 genome species, but not in the C, E1, F, and G genome species tested. Isolation of this centromere-specific retrotransposon from Gossypium provides a probe for further understanding of centromere structure, and a tool for future engineering of centromere mini-chromosomes in this important crop species.	[Luo, Song; Mach, Jennifer; Abramson, Bradley; Ramirez, Rolando; Schurr, Robert] Chromatin Inc, Chicago, IL USA; [Copenhaver, Gregory] Univ N Carolina, Dept Biol, Chapel Hill, NC USA; [Copenhaver, Gregory] Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC USA; [Barone, Pierluigi; Folkerts, Otto] Chromatin Inc, Champaign, IL USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Luo, S (corresponding author), Chromatin Inc, Chicago, IL USA.	ofolkerts@chromatininc.com	Copenhaver, Gregory/AAH-2031-2022; Barone, Pierluigi/A-9730-2008; Copenhaver, Gregory P/A-7549-2014; Copenhaver, Gregory/AFL-9831-2022	Copenhaver, Gregory/0000-0002-7962-3862; Barone, Pierluigi/0000-0002-2579-0913; Copenhaver, Gregory P/0000-0002-7962-3862; Copenhaver, Gregory/0000-0002-7962-3862; Mach, Jennifer/0000-0002-1141-6306				Ananiev EV, 1998, P NATL ACAD SCI USA, V95, P13073, DOI 10.1073/pnas.95.22.13073; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Birchler JA, 2011, CURR OPIN PLANT BIOL, V14, P217, DOI 10.1016/j.pbi.2011.02.004; Birchler JA, 2009, ANNU REV GENET, V43, P287, DOI 10.1146/annurev-genet-102108-134834; Cheng ZJ, 2003, GENETICS, V164, P665; Cheng ZK, 2002, PLANT CELL, V14, P1691, DOI 10.1105/tpc.003079; Copenhaver GP, 1999, SCIENCE, V286, P2468, DOI 10.1126/science.286.5449.2468; Csaikl UM, 1998, PLANT MOL BIOL REP, V16, P69, DOI 10.1023/A:1007428009556; Dooner HK, 2007, CURR OPIN GENET DEV, V17, P486, DOI 10.1016/j.gde.2007.08.010; Ewing B, 2000, NAT GENET, V25, P232, DOI 10.1038/76115; Gindullis F, 2001, GENOME RES, V11, P253, DOI 10.1101/gr.162301; Hanson RE, 1998, AM J BOT, V85, P1364, DOI 10.2307/2446394; HARRISON GE, 1995, THEOR APPL GENET, V90, P157, DOI 10.1007/BF00222197; Havecker ER, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-6-225; Hawkins JS, 2006, GENOME RES, V16, P1252, DOI 10.1101/gr.5282906; Houben A, 2007, CHROMOSOMA, V116, P275, DOI 10.1007/s00412-007-0102-z; Hu GJ, 2010, GENOME, V53, P599, DOI [10.1139/g10-038, 10.1139/G10-038]; Jiang JM, 1996, P NATL ACAD SCI USA, V93, P14210, DOI 10.1073/pnas.93.24.14210; Jiang JM, 2003, TRENDS PLANT SCI, V8, P570, DOI 10.1016/j.tplants.2003.10.011; Kato A, 2006, BIOTECH HISTOCHEM, V81, P71, DOI 10.1080/10520290600643677; Khan H, 2007, J MOL EVOL, V64, P223, DOI 10.1007/s00239-006-0088-9; Kishii M, 2001, CHROMOSOME RES, V9, P417, DOI 10.1023/A:1016739719421; Kulikova O, 2004, CHROMOSOMA, V113, P276, DOI 10.1007/s00412-004-0315-3; Lim KB, 2007, PLANT J, V49, P173, DOI 10.1111/j.1365-313X.2006.02952.x; Liu B, 2000, GENOME, V43, P874, DOI 10.1139/gen-43-5-874; Liu Z, 2008, CHROMOSOMA, V117, P445, DOI 10.1007/s00412-008-0161-9; Ma JX, 2007, TRENDS GENET, V23, P134, DOI 10.1016/j.tig.2007.01.004; MALUSZYNSKA J, 1991, PLANT J, V1, P159, DOI 10.1111/j.1365-313X.1991.00159.x; Miller JT, 1998, GENETICS, V150, P1615; Miller JT, 1998, THEOR APPL GENET, V96, P832, DOI 10.1007/s001220050809; Mroczek RJ, 2003, GENETICS, V165, P809; Nagaki K, 1998, CHROMOSOME RES, V6, P295, DOI 10.1023/A:1009270824142; Neumann P, 2007, GENETICS, V176, P749, DOI 10.1534/genetics.107.071902; PALMER DK, 1991, P NATL ACAD SCI USA, V88, P3734, DOI 10.1073/pnas.88.9.3734; Parisod C, 2010, NEW PHYTOL, V186, P37, DOI 10.1111/j.1469-8137.2009.03096.x; Petit M, 2010, NEW PHYTOL, V186, P135, DOI 10.1111/j.1469-8137.2009.03140.x; Presting GG, 1998, PLANT J, V16, P721, DOI 10.1046/j.1365-313x.1998.00341.x; Round EK, 1997, GENOME RES, V7, P1045, DOI 10.1101/gr.7.11.1045; SanMiguel P, 1998, NAT GENET, V20, P43, DOI 10.1038/1695; Schatz MC, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r34; Shi JH, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000327; STOLER S, 1995, GENE DEV, V9, P573, DOI 10.1101/gad.9.5.573; Sun XP, 2003, GENOME RES, V13, P182, DOI 10.1101/gr.681703; Sun XP, 1997, CELL, V91, P1007, DOI 10.1016/S0092-8674(00)80491-2; Talbert PB, 2002, PLANT CELL, V14, P1053, DOI 10.1105/tpc.010425; Tek AL, 2010, CHROMOSOME RES, V18, P337, DOI 10.1007/s10577-010-9119-x; Topp CN, 2004, P NATL ACAD SCI USA, V101, P15986, DOI 10.1073/pnas.0407154101; Vahedian M, 1995, PLANT MOL BIOL, V29, P857, DOI 10.1007/BF00041174; Weber B, 2009, CHROMOSOME RES, V17, P379, DOI 10.1007/s10577-009-9029-y; Wendel JF, 2003, ADV AGRON, V78, P139, DOI 10.1016/S0065-2113(02)78004-8; Wolfgruber TK, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000743; Yang TJ, 2005, CHROMOSOMA, V114, P103, DOI 10.1007/s00412-005-0342-8; Zhao XP, 1998, GENOME RES, V8, P479, DOI 10.1101/gr.8.5.479; Zhong CX, 2002, PLANT CELL, V14, P2825, DOI 10.1105/tpc.006106	54	26	28	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e35261	10.1371/journal.pone.0035261	http://dx.doi.org/10.1371/journal.pone.0035261			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22536361	gold, Green Published, Green Submitted			2022-12-27	WOS:000305336200029
J	Spellberg, B; Lewis, RJ; Sue, D; Chavoshan, B; Vintch, J; Munekata, M; Kim, C; Lanks, C; Witt, MD; Stringer, W; Harrington, D				Spellberg, Brad; Lewis, Roger J.; Sue, Darryl; Chavoshan, Bahman; Vintch, Janine; Munekata, Mark; Kim, Caroline; Lanks, Charles; Witt, Mallory D.; Stringer, William; Harrington, Darrell			A Controlled Investigation of Optimal Internal Medicine Ward Team Structure at a Teaching Hospital	PLOS ONE			English	Article							PNEUMONIA CARE; SERVICE; COMMUNITY; OUTCOMES; QUALITY; FACULTY; IMPLEMENTATION; EXPERIENCE; PHYSICIANS; EFFICIENCY	Background: The optimal structure of an internal medicine ward team at a teaching hospital is unknown. We hypothesized that increasing the ratio of attendings to housestaff would result in an enhanced perceived educational experience for residents. Methods: Harbor-UCLA Medical Center (HUMC) is a tertiary care, public hospital in Los Angeles County. Standard ward teams at HUMC, with a housestaff: attending ratio of 5:1, were split by adding one attending and then dividing the teams into two experimental teams containing ratios of 3:1 and 2:1. Web-based Likert satisfaction surveys were completed by housestaff and attending physicians on the experimental and control teams at the end of their rotations, and objective healthcare outcomes (e.g., length of stay, hospital readmission, mortality) were compared. Results: Nine hundred and ninety patients were admitted to the standard control teams and 184 were admitted to the experimental teams (81 to the one-intern team and 103 to the two-intern team). Patients admitted to the experimental and control teams had similar age and disease severity. Residents and attending physicians consistently indicated that the quality of the educational experience, time spent teaching, time devoted to patient care, and quality of life were superior on the experimental teams. Objective healthcare outcomes did not differ between experimental and control teams. Conclusions: Altering internal medicine ward team structure to reduce the ratio of housestaff to attending physicians improved the perceived educational experience without altering objective healthcare outcomes.	[Spellberg, Brad; Chavoshan, Bahman; Vintch, Janine; Munekata, Mark; Harrington, Darrell] Harbor Univ Calif Los Angeles UCLA Med Ctr, Los Angeles Biomed Res Inst, Div Gen Internal Med, Torrance, CA USA; [Spellberg, Brad; Lewis, Roger J.; Sue, Darryl; Chavoshan, Bahman; Vintch, Janine; Munekata, Mark; Witt, Mallory D.; Stringer, William; Harrington, Darrell] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Lewis, Roger J.] Harbor Univ Calif Los Angeles UCLA Med Ctr, Los Angeles Biomed Res Inst, Dept Emergency Med, Torrance, CA USA; [Sue, Darryl; Kim, Caroline; Stringer, William] Harbor Univ Calif Los Angeles UCLA Med Ctr, Los Angeles Biomed Res Inst, Div Pulm & Crit Care Med, Torrance, CA USA; [Lanks, Charles] Harbor Univ Calif Los Angeles UCLA Med Ctr, Los Angeles Biomed Res Inst, Dept Med, Torrance, CA USA; [Witt, Mallory D.] Harbor Univ Calif Los Angeles UCLA Med Ctr, Los Angeles Biomed Res Inst, Div HIV Med, Torrance, CA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute	Spellberg, B (corresponding author), Harbor Univ Calif Los Angeles UCLA Med Ctr, Los Angeles Biomed Res Inst, Div Gen Internal Med, Torrance, CA USA.	bspellberg@labiomed.org	Chavoshan, Bahman/ABD-2957-2021; Sue, Darryl/ABD-1685-2021; Stringer, William/AAC-2147-2019	Chavoshan, Bahman/0000-0002-8860-3951; 				Auerbach AD, 2002, ANN INTERN MED, V137, P859, DOI 10.7326/0003-4819-137-11-200212030-00006; Craig DE, 1999, ANN INTERN MED, V130, P355, DOI 10.7326/0003-4819-130-4-199902161-00005; Diamond HS, 1998, ANN INTERN MED, V129, P197, DOI 10.7326/0003-4819-129-3-199808010-00006; Hackner D, 2001, CHEST, V119, P580, DOI 10.1378/chest.119.2.580; Halasyamani LK, 2005, AM J MED, V118, P536, DOI 10.1016/j.amjmed.2005.01.027; Kaboli PJ, 2004, AM J MANAG CARE, V10, P561; Kearns PJ, 2001, ARCH INTERN MED, V161, P235, DOI 10.1001/archinte.161.2.235; Lindenauer PK, 2007, NEW ENGL J MED, V357, P2589, DOI 10.1056/NEJMsa067735; Lopez L, 2009, ARCH INTERN MED, V169, P1389, DOI 10.1001/archinternmed.2009.222; McMahon GT, 2010, NEW ENGL J MED, V362, P1304, DOI 10.1056/NEJMsa0908136; Meltzer D, 2002, ANN INTERN MED, V137, P866, DOI 10.7326/0003-4819-137-11-200212030-00007; Palmer HC, 2001, AM J MED, V111, P627, DOI 10.1016/S0002-9343(01)00976-7; Peterson MC, 2009, MAYO CLIN PROC, V84, P248, DOI 10.1016/S0025-6196(11)61142-7; Phy MP, 2005, ARCH INTERN MED, V165, P796, DOI 10.1001/archinte.165.7.796; Rifkin WD, 2002, MAYO CLIN PROC, V77, P1053, DOI 10.4065/77.10.1053; Scheurer DB, 2005, SOUTH MED J, V98, P607, DOI 10.1097/01.SMJ.0000157532.78673.2F; Stein MD, 1998, J GEN INTERN MED, V13, P774, DOI 10.1046/j.1525-1497.1998.00231.x; ULMER C, 2008, COMMITTEE OPTIMIZING; Wachter RM, 1998, JAMA-J AM MED ASSOC, V279, P1560, DOI 10.1001/jama.279.19.1560	19	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e35576	10.1371/journal.pone.0035576	http://dx.doi.org/10.1371/journal.pone.0035576			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22532860	gold, Green Published, Green Submitted			2022-12-27	WOS:000305336200058
J	Chatterjee, S; Seifried, L; Feigin, ME; Gibbons, DL; Scuoppo, C; Lin, W; Rizvi, ZH; Lind, E; Dissanayake, D; Kurie, J; Ohashi, P; Muthuswamy, SK				Chatterjee, Samit; Seifried, Laurie; Feigin, Michael E.; Gibbons, Don L.; Scuoppo, Claudio; Lin, Wei; Rizvi, Zain H.; Lind, Evan; Dissanayake, Dilan; Kurie, Jonathan; Ohashi, Pam; Muthuswamy, Senthil K.			Dysregulation of Cell Polarity Proteins Synergize with Oncogenes or the Microenvironment to Induce Invasive Behavior in Epithelial Cells	PLOS ONE			English	Article							BREAST-CANCER; MESENCHYMAL TRANSITION; MOUSE MODEL; EXPRESSION; METASTASIS; RECEPTORS; ERBB2; PROLIFERATION; TUMORIGENESIS; INFLAMMATION	Changes in expression and localization of proteins that regulate cell and tissue polarity are frequently observed in carcinoma. However, the mechanisms by which changes in cell polarity proteins regulate carcinoma progression are not well understood. Here, we report that loss of polarity protein expression in epithelial cells primes them for cooperation with oncogenes or changes in tissue microenvironment to promote invasive behavior. Activation of ErbB2 in cells lacking the polarity regulators Scribble, Dlg1 or AF-6, induced invasive properties. This cooperation required the ability of ErbB2 to regulate the Par6/aPKC polarity complex. Inhibition of the ErbB2-Par6 pathway was sufficient to block ErbB2-induced invasion suggesting that two polarity hits may be needed for ErbB2 to promote invasion. Interestingly, in the absence of ErbB2 activation, either a combined loss of two polarity proteins, or exposure of cells lacking one polarity protein to cytokines IL-6 or TNFa induced invasive behavior in epithelial cells. We observed the invasive behavior only when cells were plated on a stiff matrix (Matrigel/Collagen-1) and not when plated on a soft matrix (Matrigel alone). Cells lacking two polarity proteins upregulated expression of EGFR and activated Akt. Inhibition of Akt activity blocked the invasive behavior identifying a mechanism by which loss of polarity promotes invasion of epithelial cells. Thus, we demonstrate that loss of polarity proteins confers phenotypic plasticity to epithelial cells such that they display normal behavior under normal culture conditions but display aggressive behavior in response to activation of oncogenes or exposure to cytokines.	[Chatterjee, Samit; Seifried, Laurie; Lind, Evan; Dissanayake, Dilan; Ohashi, Pam; Muthuswamy, Senthil K.] Univ Toronto, Campbell Family Inst Breast Canc Res, Ontario Canc Inst, Toronto, ON, Canada; [Chatterjee, Samit; Feigin, Michael E.; Scuoppo, Claudio; Muthuswamy, Senthil K.] Watson Sch Biol Sci, Cold Spring Harbor Lab, Cold Spring Harbor, NY USA; [Gibbons, Don L.; Lin, Wei; Rizvi, Zain H.; Kurie, Jonathan] Univ Texas MD Anderson Canc Ctr, Dept Thoracic Head & Neck Med Oncol, Houston, TX 77030 USA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Cold Spring Harbor Laboratory; University of Texas System; UTMD Anderson Cancer Center	Chatterjee, S (corresponding author), Univ Toronto, Campbell Family Inst Breast Canc Res, Ontario Canc Inst, Toronto, ON, Canada.	s.muthuswamy@utoronto.ca	Muthuswamy, Senthil K/AGY-2834-2022	Muthuswamy, Senthil K/0000-0001-6564-9634; Feigin, Michael/0000-0002-8189-5568; Dissanayake, Dilan/0000-0003-4270-7015; Lind, Evan/0000-0001-7026-2012; Ohashi, Pamela S./0000-0003-2915-9317	Terri Brodeur Breast Cancer Foundation; Era of Hope Scholar award from DOD Breast Cancer Research Program [CA098830, BC075024]; Rita Allen Foundation, Lee K Margaret Lau Chair for breast cancer research; Campbell Family Institute For Breast cancer research [NCI K08CA151651]; Howard Hughes Medical Institute Research Training Fellowship Award; Ontario Ministry of Health and Long Term Care; NATIONAL CANCER INSTITUTE [R01CA098830, K08CA151651, R56CA098830] Funding Source: NIH RePORTER	Terri Brodeur Breast Cancer Foundation; Era of Hope Scholar award from DOD Breast Cancer Research Program; Rita Allen Foundation, Lee K Margaret Lau Chair for breast cancer research; Campbell Family Institute For Breast cancer research; Howard Hughes Medical Institute Research Training Fellowship Award; Ontario Ministry of Health and Long Term Care(Ministry of Health and Long-Term Care, Ontario); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Terri Brodeur Breast Cancer Foundation fellowship to SC and by CA098830, BC075024, Era of Hope Scholar award from DOD Breast Cancer Research Program; Rita Allen Foundation, Lee K Margaret Lau Chair for breast cancer research; Campbell Family Institute For Breast cancer research to SKM; NCI K08CA151651 to DLG and Howard Hughes Medical Institute Research Training Fellowship Award to ZHR. This was also funded in part by the Ontario Ministry of Health and Long Term Care. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrechek ER, 2000, P NATL ACAD SCI USA, V97, P3444, DOI 10.1073/pnas.050408497; Aranda V, 2006, NAT CELL BIOL, V8, P1235, DOI 10.1038/ncb1485; Benoy Ina, 2002, Clin Breast Cancer, V2, P311, DOI 10.3816/CBC.2002.n.008; Damonte P, 2007, LAB INVEST, V87, P1218, DOI 10.1038/labinvest.3700683; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Dow LE, 2008, ONCOGENE, V27, P5988, DOI 10.1038/onc.2008.219; Ebnet K, 2000, J BIOL CHEM, V275, P27979; Etienne-Manneville S, 2008, ONCOGENE, V27, P6970, DOI 10.1038/onc.2008.347; Gibbons DL, 2009, GENE DEV, V23, P2140, DOI 10.1101/gad.1820209; Gibbons DL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005401; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Hennessy BT, 2007, CLIN CANCER RES, V13, P7421, DOI 10.1158/1078-0432.CCR-07-0760; Hennessy BT, 2009, CANCER RES, V69, P4116, DOI 10.1158/0008-5472.CAN-08-3441; Huang L, 2010, CURR OPIN GENET DEV, V20, P41, DOI 10.1016/j.gde.2009.12.001; Humbert PO, 2006, TRENDS CELL BIOL, V16, P622, DOI 10.1016/j.tcb.2006.10.005; Joshi A, 2010, FRONT BIOSCI-LANDMRK, V15, P180, DOI 10.2741/3614; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Karreth FA, 2009, CURR OPIN GENET DEV, V19, P4, DOI 10.1016/j.gde.2008.12.006; Kondapaka SB, 2003, MOL CANCER THER, V2, P1093; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Lee MH, 2008, J CELL SCI, V121, P1141, DOI 10.1242/jcs.016634; Leek RD, 1998, BRIT J CANCER, V77, P2246, DOI 10.1038/bjc.1998.373; Lu J, 2009, CANCER CELL, V16, P195, DOI 10.1016/j.ccr.2009.08.010; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Macara IG, 2008, CELL, V135, P801, DOI 10.1016/j.cell.2008.11.006; Mandai K, 1997, J CELL BIOL, V139, P517, DOI 10.1083/jcb.139.2.517; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; MILES DW, 1994, INT J CANCER, V56, P777, DOI 10.1002/ijc.2910560603; Miyata M, 2009, J CELL SCI, V122, P4319, DOI 10.1242/jcs.048439; Muthuswamy SK, 2001, NAT CELL BIOL, V3, P785, DOI 10.1038/ncb0901-785; Nelson WJ, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000513; Nofech-Mozes S, 2005, ADV ANAT PATHOL, V12, P256, DOI 10.1097/01.pap.0000184177.65919.5e; Ozdamar B, 2005, SCIENCE, V307, P1603, DOI 10.1126/science.1105718; Pagliarini RA, 2003, SCIENCE, V302, P1227, DOI 10.1126/science.1088474; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Pollard JW, 2008, J LEUKOCYTE BIOL, V84, P623, DOI 10.1189/jlb.1107762; Reischauer S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000720; Salgado R, 2003, INT J CANCER, V103, P642, DOI 10.1002/ijc.10833; Sarrio D, 2008, CANCER RES, V68, P989, DOI 10.1158/0008-5472.CAN-07-2017; SCHOENENBERGER CA, 1991, J CELL BIOL, V112, P873, DOI 10.1083/jcb.112.5.873; Spaderna S, 2008, CANCER RES, V68, P537, DOI 10.1158/0008-5472.CAN-07-5682; Suzuki A, 2006, J CELL SCI, V119, P979, DOI 10.1242/jcs.02898; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Wang SC, 2001, SEMIN ONCOL, V28, P115, DOI 10.1016/S0093-7754(01)90289-1; Xiang B, 2006, METHOD ENZYMOL, V406, P692, DOI 10.1016/S0076-6879(06)06054-X	45	27	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e34343	10.1371/journal.pone.0034343	http://dx.doi.org/10.1371/journal.pone.0034343			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529912	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000305350600013
J	Fiaz, AW; Leon-Kloosterziel, KM; Gort, G; Schulte-Merker, S; van Leeuwen, JL; Kranenbarg, S				Fiaz, Ansa W.; Leon-Kloosterziel, Karen M.; Gort, Gerrit; Schulte-Merker, Stefan; van Leeuwen, Johan L.; Kranenbarg, Sander			Swim-Training Changes the Spatio-Temporal Dynamics of Skeletogenesis in Zebrafish Larvae (Danio rerio)	PLOS ONE			English	Article							DEVELOPMENTAL CONSTRAINTS; SKELETAL-MUSCLE; AXIAL SKELETON; TELEOST FISH; GROWTH-PLATE; OSTARIOPHYSI; PERFORMANCE; MORPHOLOGY; EVOLUTION; CARTILAGE	Fish larvae experience many environmental challenges during development such as variation in water velocity, food availability and predation. The rapid development of structures involved in feeding, respiration and swimming increases the chance of survival. It has been hypothesized that mechanical loading induced by muscle forces plays a role in prioritizing the development of these structures. Mechanical loading by muscle forces has been shown to affect larval and embryonic bone development in vertebrates, but these investigations were limited to the appendicular skeleton. To explore the role of mechanical load during chondrogenesis and osteogenesis of the cranial, axial and appendicular skeleton, we subjected zebrafish larvae to swim-training, which increases physical exercise levels and presumably also mechanical loads, from 5 until 14 days post fertilization. Here we show that an increased swimming activity accelerated growth, chondrogenesis and osteogenesis during larval development in zebrafish. Interestingly, swim-training accelerated both perichondral and intramembranous ossification. Furthermore, swim-training prioritized the formation of cartilage and bone structures in the head and tail region as well as the formation of elements in the anal and dorsal fins. This suggests that an increased swimming activity prioritized the development of structures which play an important role in swimming and thereby increasing the chance of survival in an environment where water velocity increases. Our study is the first to show that already during early zebrafish larval development, skeletal tissue in the cranial, axial and appendicular skeleton is competent to respond to swim-training due to increased water velocities. It demonstrates that changes in water flow conditions can result into significant spatio-temporal changes in skeletogenesis.	[Fiaz, Ansa W.; Leon-Kloosterziel, Karen M.; Gort, Gerrit; Schulte-Merker, Stefan; van Leeuwen, Johan L.; Kranenbarg, Sander] Univ Wageningen & Res Ctr, Dept Anim Sci, Expt Zool Grp, Wageningen, Netherlands; [Schulte-Merker, Stefan] KNAW & UMC Utrecht, Hubrecht Inst, Utrecht, Netherlands	Wageningen University & Research; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW)	Fiaz, AW (corresponding author), Univ Wageningen & Res Ctr, Dept Anim Sci, Expt Zool Grp, Wageningen, Netherlands.	ansa.fiaz@wur.nl	van Leeuwen, Johan/N-3437-2019; van Leeuwen, Johan L/B-7897-2011	van Leeuwen, Johan/0000-0002-4433-880X; 	Netherlands Organization for Scientific Research	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This work was supported by the Netherlands Organization for Scientific Research (www.nwo.nl,017.005.014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagatto B, 2001, J EXP BIOL, V204, P4335; BALLINTIJN CM, 1969, J EXP BIOL, V50, P569; Bensimon-Brito A, 2010, J APPL ICHTHYOL, V26, P235, DOI 10.1111/j.1439-0426.2010.01412.x; Bird NC, 2003, DEV DYNAM, V228, P337, DOI 10.1002/dvdy.10387; BRETT JR, 1964, J FISH RES BOARD CAN, V21, P1183, DOI 10.1139/f64-103; Cahu C, 2003, AQUACULTURE, V227, P245, DOI 10.1016/S0044-8486(03)00507-6; Carter DR, 2003, PHILOS T ROY SOC B, V358, P1461, DOI 10.1098/rstb.2003.1346; Cloutier R, 2010, INT J ZOOL, V2010, P1; Cubbage CC, 1996, J MORPHOL, V229, P121, DOI 10.1002/(SICI)1097-4687(199608)229:2<121::AID-JMOR1>3.0.CO;2-4; Danos N, 2010, J APPL ICHTHYOL, V26, P156, DOI 10.1111/j.1439-0426.2010.01396.x; DAVISON W, 1989, COMP BIOCHEM PHYS A, V94, P1, DOI 10.1016/0300-9629(89)90775-5; FUIMAN LA, 1983, J FISH BIOL, V23, P117, DOI 10.1111/j.1095-8649.1983.tb02886.x; Germiller JA, 1997, J ORTHOP RES, V15, P362, DOI 10.1002/jor.1100150308; Gibb AC, 2006, PHYSIOL BIOCHEM ZOOL, V79, P7, DOI 10.1086/498192; Glucksman A, 1941, J ANAT, V76, P231; Gomez C, 2007, J ANAT, V210, P259, DOI 10.1111/j.1469-7580.2007.00698.x; Grande T, 2004, ZOOL J LINN SOC-LOND, V140, P241, DOI 10.1111/j.1096-3642.2003.00097.x; Hammond CL, 2007, J EXP BIOL, V210, P2667, DOI 10.1242/jeb.005751; Hernandez LP, 2002, INTEGR COMP BIOL, V42, P222, DOI 10.1093/icb/42.2.222; Heywood JL, 2005, J MUSCLE RES CELL M, V26, P49, DOI 10.1007/s10974-005-9007-8; Kardong KV, 2002, VERTEBRATES COMP ANA; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; KLEINNULEND J, 1986, ARTHRITIS RHEUM-US, V29, P1002, DOI 10.1002/art.1780290809; Lamb KJ, 2003, INT J EXP PATHOL, V84, P191, DOI 10.1046/j.1365-2613.2003.00353.x; Mikic B, 2004, ANN BIOMED ENG, V32, P18, DOI 10.1023/B:ABME.0000007787.39262.a7; Muller UK, 2004, J EXP BIOL, V207, P853, DOI 10.1242/jeb.00821; Nowlan NC, 2007, ANN NY ACAD SCI, V1101, P389, DOI 10.1196/annals.1389.003; Nusslein-Volhard C., 2002, ZEBRAFISH PRACTICAL; Osse J. W. M., 1999, Journal of Fish Biology, V55, P156, DOI 10.1006/jfbi.1999.1071; Palstra AP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014483; Parichy DM, 2009, DEV DYNAM, V238, P2975, DOI 10.1002/dvdy.22113; Plaut I, 2001, COMP BIOCHEM PHYS A, V131, P41, DOI 10.1016/S1095-6433(01)00462-7; Richardson MK, 2003, J EXP ZOOL PART B, V296B, P8, DOI 10.1002/jez.b.00013; RODRIGUEZ JI, 1988, J BONE JOINT SURG AM, V70A, P1052, DOI 10.2106/00004623-198870070-00014; Rombough P, 2002, J EXP BIOL, V205, P1787; Saint-Amant L, 1998, J NEUROBIOL, V37, P622, DOI 10.1002/(SICI)1097-4695(199812)37:4<622::AID-NEU10>3.0.CO;2-S; Sfakianakis DG, 2011, ENVIRON BIOL FISH, V92, P197, DOI 10.1007/s10641-011-9833-z; SMITH JM, 1985, Q REV BIOL, V60, P265, DOI 10.1086/414425; Spoorendonk KM, 2008, DEVELOPMENT, V135, P3765, DOI 10.1242/dev.024034; van der Meulen T, 2005, THESIS WAGENINGEN U; Videler JJ, 1993, FISH SWIMMING, P1, DOI [10.1007/978-94-011-1580-3, DOI 10.1007/978-94-011-1580-3]; vonHerbing IH, 1996, J MORPHOL, V227, P15; WEBB PW, 1977, J EXP BIOL, V68, P123; WEISEL GF, 1967, J MORPHOL, V121, P1, DOI 10.1002/jmor.1051210102; Witten PE, 2009, BIOL REV, V84, P315, DOI 10.1111/j.1469-185X.2009.00077.x	45	44	45	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e34072	10.1371/journal.pone.0034072	http://dx.doi.org/10.1371/journal.pone.0034072			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529905	Green Published, Green Submitted, gold			2022-12-27	WOS:000305350600011
J	Klose, C; Surma, MA; Gerl, MJ; Meyenhofer, F; Shevchenko, A; Simons, K				Klose, Christian; Surma, Michal A.; Gerl, Mathias J.; Meyenhofer, Felix; Shevchenko, Andrej; Simons, Kai			Flexibility of a Eukaryotic Lipidome - Insights from Yeast Lipidomics	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; PLASMA-MEMBRANE ATPASE; SACCHAROMYCES-CEREVISIAE; SUBCELLULAR MEMBRANES; MOLECULAR-BIOLOGY; CELL-SURFACE; CHAIN-LENGTH; FATTY-ACIDS; SPHINGOLIPIDS; GENE	Mass spectrometry-based shotgun lipidomics has enabled the quantitative and comprehensive assessment of cellular lipid compositions. The yeast Saccharomyces cerevisiae has proven to be a particularly valuable experimental system for studying lipid-related cellular processes. Here, by applying our shotgun lipidomics platform, we investigated the influence of a variety of commonly used growth conditions on the yeast lipidome, including glycerophospholipids, triglycerides, ergosterol as well as complex sphingolipids. This extensive dataset allowed for a quantitative description of the intrinsic flexibility of a eukaryotic lipidome, thereby providing new insights into the adjustments of lipid biosynthetic pathways. In addition, we established a baseline for future lipidomic experiments in yeast. Finally, flexibility of lipidomic features is proposed as a new parameter for the description of the physiological state of an organism.	[Klose, Christian; Surma, Michal A.; Gerl, Mathias J.; Meyenhofer, Felix; Shevchenko, Andrej; Simons, Kai] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany	Max Planck Society	Klose, C (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany.	simons@mpi-cbg.de	Surma, Michal/B-1955-2016	Surma, Michal/0000-0001-7833-2214; Klose, Christian/0000-0003-2853-4533; Simons, Kai/0000-0002-9231-9996; Meyenhofer, Felix/0000-0001-8870-8369; Gerl, Mathias/0000-0002-8074-7221	DFG [SI459/2-1, TRR83 TP02]; ESF "LIPIDPROD" [SI459/3-1]; BMBF "ForMaT" [03FO1212]; Klaus Tschira Foundation	DFG(German Research Foundation (DFG)); ESF "LIPIDPROD"; BMBF "ForMaT"(Federal Ministry of Education & Research (BMBF)); Klaus Tschira Foundation	This work was supported by DFG "Schwerpunktprogramm1175" grant no: SI459/2-1, DFG "Transregio 83" grant no: TRR83 TP02, ESF "LIPIDPROD" grant no: SI459/3-1, BMBF "ForMaT" grant no: 03FO1212 and the Klaus Tschira Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MS, 1996, J BIOL CHEM, V271, P26596, DOI 10.1074/jbc.271.43.26596; Barz WP, 1999, MOL BIOL CELL, V10, P1043, DOI 10.1091/mbc.10.4.1043; Beattie ME, 2005, BIOPHYS J, V89, P1760, DOI 10.1529/biophysj.104.049635; Berthold MR, 2008, STUD CLASS DATA ANAL, P319, DOI 10.1145/1656274.1656280; BOGGS JM, 1987, BIOCHIM BIOPHYS ACTA, V906, P353, DOI 10.1016/0304-4157(87)90017-7; Boumann HA, 2005, BIOCHEM SOC T, V33, P1146, DOI 10.1042/BST0331146; Boumann HA, 2004, FEBS LETT, V569, P173, DOI 10.1016/j.febslet.2004.05.043; Boumann HA, 2003, BIOCHEMISTRY-US, V42, P3054, DOI 10.1021/bi026801r; Breslow DK, 2010, NATURE, V463, P1048, DOI 10.1038/nature08787; Carman GM, 2007, J BIOL CHEM, V282, P37293, DOI 10.1074/jbc.R700038200; Carman GM, 2011, ANNU REV BIOCHEM, V80, P859, DOI 10.1146/annurev-biochem-060409-092229; Carvalho M, 2010, DEVELOPMENT, V137, P3675, DOI 10.1242/dev.044560; CEVC G, 1991, BIOCHEMISTRY-US, V30, P7186, DOI 10.1021/bi00243a021; CRONAN JE, 1978, ANNU REV BIOCHEM, V47, P163, DOI 10.1146/annurev.bi.47.070178.001115; Daum G, 1998, YEAST, V14, P1471, DOI 10.1002/(SICI)1097-0061(199812)14:16<1471::AID-YEA353>3.0.CO;2-Y; Dennis EA, 2010, J BIOL CHEM, V285, P39976, DOI 10.1074/jbc.M110.182915; Ejsing CS, 2009, P NATL ACAD SCI USA, V106, P2136, DOI 10.1073/pnas.0811700106; Funk M, 2002, METHOD ENZYMOL, V350, P248, DOI 10.1016/S0076-6879(02)50967-8; Gaigg B, 2005, J BIOL CHEM, V280, P22515, DOI 10.1074/jbc.M413472200; Gaigg B, 2006, J BIOL CHEM, V281, P34135, DOI 10.1074/jbc.M603791200; Gallet PF, 1997, BIOCHEM J, V324, P627, DOI 10.1042/bj3240627; Gaspar ML, 2006, J BIOL CHEM, V281, P22773, DOI 10.1074/jbc.M603548200; Gerl MJ, 2012, J CELL BIOL, V196, P213, DOI 10.1083/jcb.201108175; Goffrini P, 2002, J BACTERIOL, V184, P427, DOI 10.1128/JB.184.2.427-432.2002; Graessler J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006261; Guan XL, 2009, MOL BIOL CELL, V20, P2083, DOI 10.1091/mbc.E08-11-1126; Herzog R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029851; Herzog R, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r8; HUNTER K, 1972, BIOCHIM BIOPHYS ACTA, V260, P639, DOI 10.1016/0005-2760(72)90013-6; Janssen MJFW, 2000, YEAST, V16, P641, DOI 10.1002/(SICI)1097-0061(200005)16:7<641::AID-YEA578>3.0.CO;2-U; Jiang JC, 1998, GENOME RES, V8, P1259, DOI 10.1101/gr.8.12.1259; JOLLOW D, 1968, J CELL BIOL, V37, P221, DOI 10.1083/jcb.37.2.221; Kaiser HJ, 2009, P NATL ACAD SCI USA, V106, P16645, DOI 10.1073/pnas.0908987106; Klose C, 2010, J BIOL CHEM, V285, P30224, DOI 10.1074/jbc.M110.123554; Kohlwein SD, 2010, J BIOL CHEM, V285, P15663, DOI 10.1074/jbc.R110.118356; KOVAC L, 1967, BIOCHIM BIOPHYS ACTA, V144, P94, DOI 10.1016/0005-2760(67)90080-X; Kurat CF, 2006, J BIOL CHEM, V281, P491, DOI 10.1074/jbc.M508414200; Kurat CF, 2009, MOL CELL, V33, P53, DOI 10.1016/j.molcel.2008.12.019; Lee AG, 2004, BBA-BIOMEMBRANES, V1666, P62, DOI 10.1016/j.bbamem.2004.05.012; LESTER RL, 1993, J BIOL CHEM, V268, P845; Martin CE, 2007, BBA-MOL CELL BIOL L, V1771, P271, DOI 10.1016/j.bbalip.2006.06.010; Mouritsen OG, 2005, FRONT COLLECT, P1, DOI 10.1007/b138577; Nagiec MM, 1997, J BIOL CHEM, V272, P9809, DOI 10.1074/jbc.272.15.9809; NAGIEC MM, 1993, J BIOL CHEM, V268, P22156; Oh CS, 1997, J BIOL CHEM, V272, P17376, DOI 10.1074/jbc.272.28.17376; OKUYAMA H, 1979, J BIOL CHEM, V254, P2281; Proszynski TJ, 2004, MOL BIOL CELL, V15, P1533, DOI 10.1091/mbc.E03-07-0511; PROUDLOC.JW, 1969, BIOCHEM BIOPH RES CO, V37, P847, DOI 10.1016/0006-291X(69)90969-3; Qian OY, 1999, GENETICS, V152, P89; RATTRAY JBM, 1975, BACTERIOL REV, V39, P197, DOI 10.1128/MMBR.39.3.197-231.1975; Sampaio JL, 2011, P NATL ACAD SCI USA, V108, P1903, DOI 10.1073/pnas.1019267108; Sandhoff R, 1999, J LIPID RES, V40, P126; Santangelo GM, 2006, MICROBIOL MOL BIOL R, V70, P253, DOI 10.1128/MMBR.70.1.253-282.2006; Schneiter R, 1999, J CELL BIOL, V146, P741, DOI 10.1083/jcb.146.4.741; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Stottrup BL, 2006, BIOPHYS J, V90, P3176, DOI 10.1529/biophysj.105.072959; Surma MA, 2011, TRAFFIC, V12, P1139, DOI 10.1111/j.1600-0854.2011.01221.x; Tuller G, 1999, YEAST, V15, P1555, DOI 10.1002/(SICI)1097-0061(199910)15:14<1555::AID-YEA479>3.0.CO;2-Z; Wenk MR, 2010, CELL, V143, P888, DOI 10.1016/j.cell.2010.11.033	59	175	180	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35063	10.1371/journal.pone.0035063	http://dx.doi.org/10.1371/journal.pone.0035063			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529973	Green Published, Green Submitted, gold			2022-12-27	WOS:000305350600055
J	Wefers, B; Hitz, C; Holter, SM; Trumbach, D; Hansen, J; Weber, P; Putz, B; Deussing, JM; de Angelis, MH; Roenneberg, T; Zheng, F; Alzheimer, C; Silva, A; Wurst, W; Kuhn, R				Wefers, Benedikt; Hitz, Christiane; Hoelter, Sabine M.; Truembach, Dietrich; Hansen, Jens; Weber, Peter; Puetz, Benno; Deussing, Jan M.; de Angelis, Martin Hrabe; Roenneberg, Till; Zheng, Fang; Alzheimer, Christian; Silva, Alcino; Wurst, Wolfgang; Kuehn, Ralf			MAPK Signaling Determines Anxiety in the Juvenile Mouse Brain but Depression-Like Behavior in Adults	PLOS ONE			English	Article							HIPPOCAMPAL CA1 AREA; B-RAF; SYNAPTIC PLASTICITY; POSTNATAL ONTOGENY; PATHWAY; GENE; SYSTEM; STRESS; EXPRESSION; NEURONS	MAP kinase signaling has been implicated in brain development, long-term memory, and the response to antidepressants. Inducible Braf knockout mice, which exhibit protein depletion in principle forebrain neurons, enabled us to unravel a new role of neuronal MAPK signaling for emotional behavior. Braf mice that were induced during adulthood showed normal anxiety but increased depression-like behavior, in accordance with pharmacological findings. In contrast, the inducible or constitutive inactivation of Braf in the juvenile brain leads to normal depression-like behavior but decreased anxiety in adults. In juvenile, constitutive mutants we found no alteration of GABAergic neurotransmission but reduced neuronal arborization in the dentate gyrus. Analysis of gene expression in the hippocampus revealed nine downregulated MAPK target genes that represent candidates to cause the mutant phenotype. Our results reveal the differential function of MAPK signaling in juvenile and adult life phases and emphasize the early postnatal period as critical for the determination of anxiety in adults. Moreover, these results validate inducible gene inactivation as a new valuable approach, allowing it to discriminate between gene function in the adult and the developing postnatal brain.	[Wefers, Benedikt; Hitz, Christiane; Hoelter, Sabine M.; Truembach, Dietrich; Hansen, Jens; Wurst, Wolfgang; Kuehn, Ralf] Helmholtz Zentrum Munchen, Inst Dev Genet, German Res Ctr Environm Hlth, Neuherberg, Germany; [de Angelis, Martin Hrabe] Helmholtz Zentrum Munchen GmbH, Inst Expt Genet, German Res Ctr Environm Hlth, Neuherberg, Germany; [Roenneberg, Till] Univ Munich, Inst Med Psychol, D-80804 Munich, Germany; [Zheng, Fang; Alzheimer, Christian] Univ Erlangen Nurnberg, Inst Physiol & Pathophysiol, D-91054 Erlangen, Germany; [Silva, Alcino] Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA USA; [Wurst, Wolfgang; Kuehn, Ralf] Tech Univ Munchen Weihenstephan, Lehrstuhl Entwicklungsgenet, Neuherberg, Germany; [Wurst, Wolfgang] Deutsch Zentrum Neurodegenerat Erkrankungen eV DZ, Munich, Germany; [Weber, Peter; Puetz, Benno; Deussing, Jan M.; Wurst, Wolfgang] Max Planck Inst Psychiat, D-80804 Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Erlangen Nuremberg; University of California System; University of California Los Angeles; Technical University of Munich; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Max Planck Society	Wefers, B (corresponding author), Helmholtz Zentrum Munchen, Inst Dev Genet, German Res Ctr Environm Hlth, Neuherberg, Germany.	ralf.kuehn@helmholtz-muenchen.de	Hölter, Sabine M./N-5868-2014; Hansen, Jens/E-8791-2015; Pütz, Benno/P-2630-2016; Hansen, Jens/ABF-4463-2020; Deussing, Jan M/ABB-5993-2021; Silva, Alcino/ABD-7684-2021; de Angelis, Martin Hrabe/F-5531-2012; Kühn, Ralf/U-1278-2017	Hölter, Sabine M./0000-0003-4878-5241; Hansen, Jens/0000-0001-7520-1577; Pütz, Benno/0000-0002-2208-209X; Hansen, Jens/0000-0001-7520-1577; Silva, Alcino/0000-0002-1587-4558; de Angelis, Martin Hrabe/0000-0002-7898-2353; Kühn, Ralf/0000-0003-1694-9803; Deussing, Jan/0000-0002-9329-5252; Wurst, Wolfgang/0000-0003-4422-7410; Roenneberg, Till/0000-0003-2939-0332	Klinische Kooperationsgruppe (KKG) of the Max-Planck-Institute of Psychiatry; Federal Ministry of Education and Research (BMBF) in the framework of the National Genome Research Network (NGFN) [01GS08151]; BMBF [01GS0858]; Deutsche Forschungsgemeinschaft (DFG) [AL 294/9-1]; Helmholtz Alliance "Mental Health in an Ageing Society" [HA215]; Helmholtz Zentrum Munchen; EUMODIC [LSHG-2006-037188]	Klinische Kooperationsgruppe (KKG) of the Max-Planck-Institute of Psychiatry; Federal Ministry of Education and Research (BMBF) in the framework of the National Genome Research Network (NGFN)(Federal Ministry of Education & Research (BMBF)); BMBF(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Helmholtz Alliance "Mental Health in an Ageing Society"; Helmholtz Zentrum Munchen(Helmholtz Association); EUMODIC	This work was possible with support of the Klinische Kooperationsgruppe (KKG) of the Max-Planck-Institute of Psychiatry and the Helmholtz Zentrum Munchen, and by the Federal Ministry of Education and Research (BMBF) in the framework of the National Genome Research Network (NGFN, http://www.ngfn.de/) #01GS08151, EUMODIC grant (http://www.eumodic.org/) #LSHG-2006-037188, and the DIGTOP grant by BMBF #01GS0858 (Disease Genes to Protein Pathways, http://www.digtop.de/), the Deutsche Forschungsgemeinschaft (Dr. Alzheimer) DFG AL 294/9-1 as well as the Helmholtz Alliance "Mental Health in an Ageing Society" (http://www.neuro-ageing.de/) HA215. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki Y, 2008, HUM MUTAT, V29, P992, DOI 10.1002/humu.20748; Arur S, 2009, P NATL ACAD SCI USA, V106, P4776, DOI 10.1073/pnas.0812285106; Barkus C, 2010, EUR J PHARMACOL, V626, P49, DOI 10.1016/j.ejphar.2009.10.014; Bell-Horner CL, 2006, J NEUROBIOL, V66, P1467, DOI 10.1002/neu.20327; Bentires-Alj M, 2006, NAT MED, V12, P283, DOI 10.1038/nm0306-283; Bergami M, 2008, P NATL ACAD SCI USA, V105, P15570, DOI 10.1073/pnas.0803702105; Bergami Matteo, 2009, Commun Integr Biol, V2, P14; Chen AP, 2006, J NEUROSCI RES, V83, P28, DOI 10.1002/jnr.20703; Chen ZY, 2006, SCIENCE, V314, P140, DOI 10.1126/science.1129663; Cohen CD, 2006, P NATL ACAD SCI USA, V103, P5682, DOI 10.1073/pnas.0511257103; Coogan AN, 2004, J NEUROCHEM, V90, P769, DOI 10.1111/j.1471-4159.2004.02554.x; Cook EH, 2008, NATURE, V455, P919, DOI 10.1038/nature07458; Corson LB, 2003, DEVELOPMENT, V130, P4527, DOI 10.1242/dev.00669; Coyle JT, 2003, NEURON, V38, P157, DOI 10.1016/S0896-6273(03)00195-8; Crusio WE, 2009, GENES BRAIN BEHAV, V8, P1, DOI 10.1111/j.1601-183X.2008.00438.x; Duman CH, 2007, BIOL PSYCHIAT, V61, P661, DOI 10.1016/j.biopsych.2006.05.047; Duric V, 2010, NAT MED; Ebner K, 2002, EUR J NEUROSCI, V15, P384, DOI 10.1046/j.0953-816x.2001.01869.x; Einat H, 2003, J NEUROSCI, V23, P7311; Erdmann G, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-63; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Gailus-Durner V, 2005, NAT METHODS, V2, P403, DOI 10.1038/nmeth0605-403; Galabova-Kovacs G, 2008, J CELL BIOL, V180, P947, DOI 10.1083/jcb.200709069; Gerlai R, 1996, TRENDS NEUROSCI, V19, P177, DOI 10.1016/S0166-2236(96)20020-7; Gross C, 2004, NAT REV NEUROSCI, V5, P545, DOI 10.1038/nrn1429; Gross C, 2002, NATURE, V416, P396, DOI 10.1038/416396a; Hao YL, 2004, J NEUROSCI, V24, P6590, DOI 10.1523/JNEUROSCI.5747-03.2004; Holmes A, 2001, NEUROSCI BIOBEHAV R, V25, P261, DOI 10.1016/S0149-7634(01)00012-4; Ko Shanelle W., 2005, Shengli Xuebao, V57, P421; Kopnisky KL, 2003, NEUROSCIENCE, V116, P425, DOI 10.1016/S0306-4522(02)00573-0; Ma XM, 2008, J NEUROSCI, V28, P711, DOI 10.1523/JNEUROSCI.5283-07.2008; Minichiello L, 1999, NEURON, V24, P401, DOI 10.1016/S0896-6273(00)80853-3; Mozhui K, 2010, J NEUROSCI, V30, P5357, DOI 10.1523/JNEUROSCI.5017-09.2010; Muller MB, 2003, NAT NEUROSCI, V6, P1100, DOI 10.1038/nn1123; Nakatani N, 2006, HUM MOL GENET, V15, P1949, DOI 10.1093/hmg/ddl118; Obrietan K, 1998, NAT NEUROSCI, V1, P693, DOI 10.1038/3695; Oler JA, 2010, NATURE, V466, P864, DOI 10.1038/nature09282; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; Pinheiro J., 2011, NLME LINEAR NONLINEA; POKORNY J, 1981, BRAIN RES BULL, V7, P113, DOI 10.1016/0361-9230(81)90075-7; POKORNY J, 1981, BRAIN RES BULL, V7, P121, DOI 10.1016/0361-9230(81)90076-9; Porsolt R D, 2001, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0810as14; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Refojo D, 2005, P NATL ACAD SCI USA, V102, P6183, DOI 10.1073/pnas.0502070102; Revest JM, 2005, NAT NEUROSCI, V8, P664, DOI 10.1038/nn1441; Roenneberg T, 2000, METHOD ENZYMOL, V305, P104; Scobie KN, 2009, J NEUROSCI, V29, P9875, DOI 10.1523/JNEUROSCI.2260-09.2009; STORM SM, 1990, ONCOGENE, V5, P345; Sweatt JD, 2001, J NEUROCHEM, V76, P1, DOI 10.1046/j.1471-4159.2001.00054.x; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Vaillant AR, 2002, NEURON, V34, P985, DOI 10.1016/S0896-6273(02)00717-1; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Wojnowski L, 1997, NAT GENET, V16, P293, DOI 10.1038/ng0797-293; Wolfer DP, 2002, TRENDS NEUROSCI, V25, P336, DOI 10.1016/S0166-2236(02)02192-6; Wulff K, 2010, NAT REV NEUROSCI, V11, P589, DOI 10.1038/nrn2868; Yacubova E, 2002, NATURE, V415, P77, DOI 10.1038/415077a; Yasuda S, 2009, MOL PSYCHIATR, V14, P51, DOI 10.1038/sj.mp.4002099; Zambrowicz BP, 2003, NAT REV DRUG DISCOV, V2, P38, DOI 10.1038/nrd987; Zhong J, 2007, NAT NEUROSCI, V10, P598, DOI 10.1038/nn1898; Zou H, 2011, GENES BRAIN BEHAV, V10, P615, DOI 10.1111/j.1601-183X.2011.00702.x	61	31	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35035	10.1371/journal.pone.0035035	http://dx.doi.org/10.1371/journal.pone.0035035			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529971	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000305350600053
J	Chan, RCK; Wang, Y; Yan, C; Zhao, Q; McGrath, J; Hsi, XL; Stone, WS				Chan, Raymond C. K.; Wang, Yi; Yan, Chao; Zhao, Qing; McGrath, John; Hsi, Xiaolu; Stone, William S.			A Study of Trait Anhedonia in Non-Clinical Chinese Samples: Evidence from the Chapman Scales for Physical and Social Anhedonia	PLOS ONE			English	Article							SCHIZOTYPAL PERSONALITY FEATURES; INDIVIDUAL-DIFFERENCES; SCHIZOPHRENIA; PLEASURE; REWARD; SCHIZOTAXIA; DISORDERS; BEHAVIOR	Background: Recent studies suggest that anhedonia, an inability to experience pleasure, can be measured as an enduring trait in non-clinical samples. In order to examine trait anhedonia in a non-clinical sample, we examined the properties of a range of widely used questionnaires capturing anhedonia. Methods: 887 young adults were recruited from colleges. All of them were administered a set of checklists, including Chapman Scale for Social Anhedonia (CRSAS) and the Chapman Scale for Physical Anhedonia Scale (CPAS), The Temporal Experience of Pleasure Scale(TEPS), and The Schizotypal Personality Questionnaire (SPQ). Results: Males showed significantly higher level of physical (F = 5.09, p<0.001) and social (F = 4.38, p<0.005) anhedonia than females. As expected, individuals with schizotypal personality features also demonstrated significantly higher scores of physical (t = 3.81, p<0.001) and social (t = 7.33, p<0.001) trait anhedonia than individuals without SPD features, but no difference on self-report anticipatory and consummatory pleasure experience. Conclusions: Concerning the comparison on each item of physical and social anhedonia, the results indicated that individuals with SPD feature exhibited higher than individuals without SPD features on more items of social anhedonia than physical anhedonia scale. These preliminary findings suggested that trait anhedonia can be identified a non-clinical sample. Exploring the demographic and clinical correlates of trait anhedonia in the general population may provide clues to the pathogenesis of psychotic disorder.	[Chan, Raymond C. K.; Wang, Yi; Yan, Chao; Zhao, Qing] Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Neuropsychol & Appl Cognit Neurosci Lab, Beijing 100101, Peoples R China; [Wang, Yi; Yan, Chao; Zhao, Qing] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [McGrath, John] Pk Ctr Mental Hlth, Queensland Ctr Mental Hlth Res, Wacol, Australia; [McGrath, John] Univ Queensland, Queensland Brain Inst, St Lucia, Qld, Australia; [McGrath, John] Univ Queensland, Dept Psychiat, St Lucia, Qld, Australia; [Hsi, Xiaolu] MIT, MIT Med, Cambridge, MA USA; [Hsi, Xiaolu; Stone, William S.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Psychiat, Boston, MA 02215 USA	Chinese Academy of Sciences; Institute of Psychology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Queensland Centre for Mental Health Research; University of Queensland; University of Queensland; Massachusetts Institute of Technology (MIT); Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Chan, RCK (corresponding author), Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Neuropsychol & Appl Cognit Neurosci Lab, Beijing 100101, Peoples R China.	rckchan@psych.ac.cn	Chan, Raymond CK/B-6717-2009; Zhao, Qing/E-3000-2010; wang, yi/AAI-8689-2020; McGrath, John Joseph/G-5493-2010	Chan, Raymond CK/0000-0002-3414-450X; wang, yi/0000-0001-6880-5831; McGrath, John Joseph/0000-0002-4792-6068	National Key Technologies RD Program [2012BAI36B01]; National Science Fund China Grant [81088001, 91132701]; Knowledge Innovation Project of the Chinese Academy of Sciences [KSCX2-EW-J-8]; Key Laboratory of Mental Health, Institute of Psychology	National Key Technologies RD Program(National Key Technology R&D Program); National Science Fund China Grant; Knowledge Innovation Project of the Chinese Academy of Sciences(Knowledge Innovation Program of the Chinese Academy of Sciences); Key Laboratory of Mental Health, Institute of Psychology	This study was supported partially by a grant from the National Key Technologies R&D Program (2012BAI36B01), the National Science Fund China Grant (81088001, 91132701), the Knowledge Innovation Project of the Chinese Academy of Sciences (KSCX2-EW-J-8), and the Key Laboratory of Mental Health, Institute of Psychology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auriacombe M, 1997, PSYCHOPHARMACOLOGY, V134, P337, DOI 10.1007/s002130050459; Berenbaum H, 2006, J ABNORM PSYCHOL, V115, P359, DOI 10.1037/0021-843X.115.2.359; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Berridge KC, 2003, TRENDS NEUROSCI, V26, P507, DOI 10.1016/S0166-2236(03)00233-9; Berridge KC, 2008, PSYCHOPHARMACOLOGY, V199, P457, DOI 10.1007/s00213-008-1099-6; Blanchard JJ, 2011, SCHIZOPHRENIA BULL, V37, P291, DOI 10.1093/schbul/sbq104; Blanchard JJ, 2000, J ABNORM PSYCHOL, V109, P87, DOI 10.1037/0021-843X.109.1.87; Camisa KM, 2005, PSYCHIAT RES, V133, P23, DOI 10.1016/j.psychres.2004.09.002; Chan RCK, 2011, PSYCHIAT RES, V185, P340, DOI 10.1016/j.psychres.2010.06.009; Chan RCK, 2011, PSYCHIAT RES, V185, P254, DOI 10.1016/j.psychres.2009.10.008; Chan RCK, 2010, AUST NZ J PSYCHIAT, V44, P800, DOI 10.3109/00048674.2010.482920; Chan RCK, 2010, PSYCHIAT RES, V178, P208, DOI 10.1016/j.psychres.2010.03.017; Chan RCK, 2010, PSYCHIAT RES, V175, P181, DOI 10.1016/j.psychres.2009.01.020; CHAN RCK, 3 FACTOR STRUC UNPUB; Chapman L. J., 1978, REVISED PHYS A UNPUB; Eckblad M.L., 1982, REVISED SOCIAL UNPUB; Faraone SV, 2001, SCHIZOPHRENIA BULL, V27, P1; FENTON WS, 1991, ARCH GEN PSYCHIAT, V48, P978; Gard DE, 2006, J RES PERS, V40, P1086, DOI 10.1016/j.jrp.2005.11.001; Gard DE, 2007, SCHIZOPHR RES, V93, P253, DOI 10.1016/j.schres.2007.03.008; HAFNER H, 1992, EUR ARCH PSY CLIN N, V242, P109, DOI 10.1007/BF02191557; Harvey PO, 2007, MOL PSYCHIATR, V12, P767, DOI 10.1038/sj.mp.4002021; Harvey PO, 2010, J PSYCHIATR RES, V44, P707, DOI 10.1016/j.jpsychires.2009.12.008; HOLLENBECK JR, 1987, J APPL PSYCHOL, V72, P212, DOI 10.1037/0021-9010.72.2.212; Horan WP, 2007, PSYCHIAT RES, V149, P147, DOI 10.1016/j.psychres.2006.06.002; HORAN WP, 2008, SCHIZOPHR B; Kerns JG, 2006, J ABNORM PSYCHOL, V115, P418, DOI 10.1037/0021-843X.115.3.418; Kirkpatrick B, 2011, SCHIZOPHRENIA BULL, V37, P300, DOI 10.1093/schbul/sbq059; Kwapil T. R., 1998, NORMS WISCONSIN PSYC; Kwapil TR, 1998, J ABNORM PSYCHOL, V107, P558, DOI 10.1037/0021-843X.107.4.558; Marder SR, 2011, SCHIZOPHRENIA BULL, V37, P250, DOI 10.1093/schbul/sbq161; Martin EA, 2011, PSYCHIAT RES, V187, P94, DOI 10.1016/j.psychres.2010.12.028; Meehl PE, 1973, READINGS ABNORMAL PS, V17, P83; Meehl PE., 1990, J PERS DISORD, V4, P1, DOI [10.1521/pedi.1990.4.1.1, DOI 10.1521/PEDI.1990.4.1.1]; RAINE A, 1991, SCHIZOPHRENIA BULL, V17, P555, DOI 10.1093/schbul/17.4.555; Tsuang MT, 2002, SCHIZOPHR RES, V54, P169, DOI 10.1016/S0920-9964(01)00364-4; van Os J, 2009, PSYCHOL MED, V39, P179, DOI 10.1017/S0033291708003814; Xiao ZW, 2011, AIDS CARE, V23, P105, DOI 10.1080/09540121.2010.532537; Yan Chao, 2011, East Asian Arch Psychiatry, V21, P115; Zhang K, 1999, AIDS CARE, V11, P581, DOI 10.1080/09540129947730; Zong JG, 2010, SCHIZOPHR RES, V122, P185, DOI 10.1016/j.schres.2010.04.013	41	80	86	4	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e34275	10.1371/journal.pone.0034275	http://dx.doi.org/10.1371/journal.pone.0034275			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959WC	22529910	Green Published, gold, Green Submitted			2022-12-27	WOS:000305347400010
J	Lepelletier, D; Ravaud, P; Baron, G; Lucet, JC				Lepelletier, Didier; Ravaud, Philippe; Baron, Gabriel; Lucet, Jean-Christophe			Agreement among Health Care Professionals in Diagnosing Case Vignette-Based Surgical Site Infections	PLOS ONE			English	Article							QUALITY-OF-CARE; SURVEILLANCE METHODS; RATES; PERFORMANCE; INPATIENTS; PNEUMONIA; HELICS	Objective: To assess agreement in diagnosing surgical site infection (SSI) among healthcare professionals involved in SSI surveillance. Methods: Case-vignette study done in 2009 in 140 healthcare professionals from seven specialties (20 in each specialty, Anesthesiologists, Surgeons, Public health specialists, Infection control physicians, Infection control nurses, Infectious diseases specialists, Microbiologists) in 29 University and 36 non-University hospitals in France. We developed 40 case-vignettes based on cardiac and gastrointestinal surgery patients with suspected SSI. Each participant scored six randomly assigned case-vignettes before and after reading the SSI definition on an online secure relational database. The intraclass correlation coefficient (ICC) was used to assess agreement regarding SSI diagnosis on a seven-point Likert scale and the kappa coefficient to assess agreement for superficial or deep SSI on a three-point scale. Results: Based on a consensus, SSI was present in 21 of 40 vignettes (52.5%). Intraspecialty agreement for SSI diagnosis ranged across specialties from 0.15 (95% confidence interval, 0.00-0.59) (anesthesiologists and infection control nurses) to 0.73 (0.32-0.90) (infectious diseases specialists). Reading the SSI definition improved agreement in the specialties with poor initial agreement. Intraspecialty agreement for superficial or deep SSI ranged from 0.10 (-0.19-0.38) to 0.54 (0.25-0.83) (surgeons) and increased after reading the SSI definition only among the infection control nurses from 0.10 (-0.19-0.38) to 0.41 (-0.09-0.72). Interspecialty agreement for SSI diagnosis was 0.36 (0.22-0.54) and increased to 0.47 (0.31-0.64) after reading the SSI definition. Conclusion: Among healthcare professionals evaluating case-vignettes for possible surgical site infection, there was large disagreement in diagnosis that varied both between and within specialties.	[Lepelletier, Didier; Lucet, Jean-Christophe] Hop Bichat Claude Bernard, Assistance Publ Hop Paris, Infect Control Unit, F-75877 Paris 18, France; [Lepelletier, Didier; Ravaud, Philippe; Baron, Gabriel; Lucet, Jean-Christophe] Univ Paris Diderot, Paris, France; [Ravaud, Philippe; Baron, Gabriel] Hop Hotel Dieu, Assistance Publ Hop Paris, Ctr Epidemiol Clin, Paris, France; [Ravaud, Philippe; Baron, Gabriel] INSERM, U738, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Lepelletier, D (corresponding author), Hop Bichat Claude Bernard, Assistance Publ Hop Paris, Infect Control Unit, F-75877 Paris 18, France.	jean-christophe.lucet@bch.aphp.fr	ravaud, philippe/C-1694-2009	Ravaud, Philippe/0000-0001-8264-9206	French Ministry of Health [PREQHOS 0901]	French Ministry of Health	This study was supported by the French Ministry of Health (national grant PREQHOS 0901). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astagneau P, 2010, CURR OPIN INFECT DIS, V23, P306, DOI 10.1097/QCO.0b013e32833ae7e3; Beaujean D, 2002, EUR J CLIN MICROBIOL, V21, P444, DOI 10.1007/s10096-002-0745-x; Bonett DG, 2002, STAT MED, V21, P1331, DOI 10.1002/sim.1108; Chalfine A, 2006, INFECT CONT HOSP EP, V27, P794, DOI 10.1086/506393; Culver DH, 1991, AM J MED S3B, V91, P152, DOI DOI 10.1016/0002-9343(91)90361-Z; Edmond MB, 2007, J HOSP INFECT, V65, P182, DOI 10.1016/S0195-6701(07)60040-1; Edwards JR, 2009, AM J INFECT CONTROL, V37, P783, DOI 10.1016/j.ajic.2009.10.001; Fleiss J.L., 2013, STAT METHODS RATES P; Fung CH, 2008, ANN INTERN MED, V148, P111, DOI 10.7326/0003-4819-148-2-200801150-00006; GLENISTER HM, 1993, J HOSP INFECT, V23, P229, DOI 10.1016/0195-6701(93)90028-X; Haustein T, 2011, LANCET INFECT DIS, V11, P471, DOI 10.1016/S1473-3099(10)70315-7; Hejblum G, 2008, CHEST, V133, P1107, DOI 10.1378/chest.06-3014; HORAN TC, 1992, INFECT CONT HOSP EP, V13, P606; Hospital in Europe Link for Infection Control through Surveillance, 2004, SURV SURG SIT INF; Klompas M, 2008, CLIN INFECT DIS, V46, P1443, DOI 10.1086/587103; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lin MY, 2010, JAMA-J AM MED ASSOC, V304, P2035, DOI 10.1001/jama.2010.1637; Mangram AJ, 1999, INFECT CONT HOSP EP, V20, P250, DOI 10.1086/501620; McKibben L, 2005, INFECT CONT HOSP EP, V26, P580, DOI 10.1086/502585; Niedner MF, 2010, AM J INFECT CONTROL, V38, P585, DOI 10.1016/j.ajic.2010.04.211; Nunnaly JC, PSYCHOMETRIC THEORY; Perla RJ, 2009, AM J INFECT CONTROL, V37, P615, DOI 10.1016/j.ajic.2009.03.003; Pittet D, 2004, ANN INTERN MED, V141, P1, DOI 10.7326/0003-4819-141-1-200407060-00008; Rosenthal R, 2010, J HOSP INFECT, V75, P178, DOI 10.1016/j.jhin.2009.10.028; Seror R, 2010, ANN RHEUM DIS, V69, P1103, DOI 10.1136/ard.2009.110619; Suetens C, 2007, J HOSP INFECT, V65, P171, DOI 10.1016/S0195-6701(07)60038-3; TAYLOR G, 1990, AM J INFECT CONTROL, V18, P295, DOI 10.1016/0196-6553(90)90228-K; Wachter RM, 2008, ANN INTERN MED, V149, P29, DOI 10.7326/0003-4819-149-1-200807010-00007; Wilson AP, 2004, BRIT MED J, V14, P14; Wilson J, 2007, J HOSP INFECT, V65, P165, DOI 10.1016/S0195-6701(07)60037-1; Wong ES., 2004, HOSP EPIDEMIOLOGY IN, P287; Yokoe DS, 2004, EMERG INFECT DIS, V10, P1924, DOI 10.3201/eid1011.040572	32	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e35131	10.1371/journal.pone.0035131	http://dx.doi.org/10.1371/journal.pone.0035131			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22529980	Green Published, gold, Green Submitted			2022-12-27	WOS:000305347400032
J	Nadal, P; Pinto, A; Svobodova, M; Canela, N; O'Sullivan, CK				Nadal, Pedro; Pinto, Alessandro; Svobodova, Marketa; Canela, Nuria; O'Sullivan, Ciara K.			DNA Aptamers against the Lup an 1 Food Allergen	PLOS ONE			English	Article							IN-VITRO SELECTION; SINGLE-STRANDED-DNA; RNA APTAMER; HIGH ENANTIOSELECTIVITY; L-ARGININE; BIND; RECOGNITION; BIOSENSOR; PROTEINS; MOLECULES	Using in vitro selection, high affinity DNA aptamers to the food allergen Lup an 1, beta-conglutin, were selected from a pool of DNA, 93 bases in length, containing a randomised sequence of 49 bases. beta-conglutin was purified from lupin flour and chemically crosslinked to carboxylated magnetic beads. Peptide mass fingerprinting was used to confirm the presence of the beta-conglutin. Single stranded DNA was generated from the randomised pool using T7 Gene 6 Exonuclease and was subsequently incubated with the magnetic beads and the captured DNA was released and amplified prior to a further round of Systematic Evolution of Ligands by Exponential Enrichment (SELEX). Evolution was monitored using enzyme linked oligonucleotide assay and surface plasmon resonance. Once a plateau in evolution was reached, the isolated DNA sequences were cloned and sequenced. The consensus motif was identified via alignment of the sequences and the affinities of these sequences for immobilised beta-conglutin were determined using surface plasmon resonance. The selected aptamer was demonstrated to be highly specific, showing no cross-reactivity with other flour ingredients or with other conglutin fractions of lupin. The secondary structures of the selected aptamers were predicted using m-fold. Finally, the functionality of the selected aptamers was demonstrated using a competitive assay for the quantitative detection of beta-conglutin. Future work will focus on structure elucidation and truncation of the selected sequences to generate a smaller aptamer for application to the analysis of the Lup an 1 allergen in foodstuffs.	[Nadal, Pedro; Pinto, Alessandro; Svobodova, Marketa; O'Sullivan, Ciara K.] Univ Rovira & Virgili, Dept Engn Quim, Tarragona, Spain; [Canela, Nuria] Univ Rovira & Virgili, Serv Recursos Cient & Tecn, Tarragona, Spain; [O'Sullivan, Ciara K.] Inst Catalana Recerca & Estudis Avancats, Barcelona, Spain	Universitat Rovira i Virgili; Universitat Rovira i Virgili; ICREA	Nadal, P (corresponding author), Univ Rovira & Virgili, Dept Engn Quim, Tarragona, Spain.	ciara.osullivan@urv.cat	O'Sullivan, Ciara K/G-2428-2019; Sullivan, Ciara O'/U-9481-2019; pinto, alessandro/A-2762-2011; Svobodova, Marketa/L-6258-2014; Sullivan, Ciara K O'/J-8655-2014; Canela, Núria/I-5401-2015	O'Sullivan, Ciara K/0000-0003-2603-2230; pinto, alessandro/0000-0003-3369-4910; Svobodova, Marketa/0000-0001-7612-6724; Sullivan, Ciara K O'/0000-0002-0965-4655; Canela, Núria/0000-0003-0261-2396; Nadal Polo, Pedro/0000-0002-9460-0386	ICREA Funding Source: Custom	ICREA(ICREA)		[Anonymous], 2006, OFFICIAL J EUROPEA L, P110; Berens C, 2001, BIOORGAN MED CHEM, V9, P2549, DOI 10.1016/S0968-0896(01)00063-3; BOCK LC, 1992, NATURE, V355, P564, DOI 10.1038/355564a0; Cao XX, 2009, NUCLEIC ACIDS RES, V37, P4621, DOI 10.1093/nar/gkp489; Chen JH, 2012, FOOD CONTROL, V25, P555, DOI 10.1016/j.foodcont.2011.11.039; Conrad RC, 1996, METHOD ENZYMOL, V267, P336; Cowan JA, 2000, NUCLEIC ACIDS RES, V28, P2935, DOI 10.1093/nar/28.15.2935; Cox JC, 2001, BIOORGAN MED CHEM, V9, P2525, DOI 10.1016/S0968-0896(01)00028-1; Darwin Charles, 1958, ORIGIN SPECIES MEANS; Dooper MMBW, 2007, INT ARCH ALLERGY IMM, V143, P49, DOI 10.1159/000098224; Duranti M, 2008, TRENDS FOOD SCI TECH, V19, P624, DOI 10.1016/j.tifs.2008.07.002; Ecker C, 2012, FOOD CHEM, V130, P759, DOI 10.1016/j.foodchem.2011.07.100; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; FAMULOK M, 1994, J AM CHEM SOC, V116, P1698, DOI 10.1021/ja00084a010; Geiger A, 1996, NUCLEIC ACIDS RES, V24, P1029, DOI 10.1093/nar/24.6.1029; Goggin DE, 2008, J AGR FOOD CHEM, V56, P6370, DOI 10.1021/jf800840u; Grate D, 1999, P NATL ACAD SCI USA, V96, P6131, DOI 10.1073/pnas.96.11.6131; HARUNA I, 1965, P NATL ACAD SCI USA, V54, P1189, DOI 10.1073/pnas.54.4.1189; HARUNA I, 1965, SCIENCE, V150, P884, DOI 10.1126/science.150.3698.884; HARUNA I, 1965, P NATL ACAD SCI USA, V54, P579, DOI 10.1073/pnas.54.2.579; Holden L, 2007, J AGR FOOD CHEM, V55, P2536, DOI 10.1021/jf063320w; Huang HP, 2009, ELECTROCHEM COMMUN, V11, P816, DOI 10.1016/j.elecom.2009.01.009; HUIZENGA DE, 1995, BIOCHEMISTRY-US, V34, P656, DOI 10.1021/bi00002a033; Jappe U, 2010, MOL NUTR FOOD RES, V54, P113, DOI 10.1002/mnfr.200900365; Keefe AD, 2010, NAT REV DRUG DISCOV, V9, P537, DOI 10.1038/nrd3141; Kikin O, 2006, NUCLEIC ACIDS RES, V34, pW676, DOI 10.1093/nar/gkl253; Kwon M, 2001, MOL CELLS, V11, P303; Lee YJ, 2012, BIOCHEM BIOPH RES CO, V417, P414, DOI 10.1016/j.bbrc.2011.11.130; McKeague M, 2010, INT J MOL SCI, V11, P4864, DOI 10.3390/ijms11124864; Mehta J, 2011, J BIOTECHNOL, V155, P361, DOI 10.1016/j.jbiotec.2011.06.043; MILLS DR, 1967, P NATL ACAD SCI USA, V58, P217, DOI 10.1073/pnas.58.1.217; Nadal P, 2011, J AGR FOOD CHEM, V59, P2752, DOI 10.1021/jf104062d; NIKIFOROV TT, 1994, NUCLEIC ACIDS RES, V22, P4167, DOI 10.1093/nar/22.20.4167; Ohk SH, 2010, J APPL MICROBIOL, V109, P808, DOI 10.1111/j.1365-2672.2010.04709.x; Potty ASR, 2011, INT J BIOL MACROMOL, V48, P392, DOI 10.1016/j.ijbiomac.2010.12.007; ROBERTSON DL, 1990, NATURE, V344, P467, DOI 10.1038/344467a0; SASSANFAR M, 1993, NATURE, V364, P550, DOI 10.1038/364550a0; SCHNEIDER DJ, 1995, BIOCHEMISTRY-US, V34, P9599, DOI 10.1021/bi00029a037; Shoji A, 2007, J AM CHEM SOC, V129, P1456, DOI 10.1021/ja067098n; Singh G, 2012, ECOTOXICOLO IN PRESS; Song KM, 2011, ANAL BIOCHEM, V415, P175, DOI 10.1016/j.ab.2011.04.007; Su W, 2012, BIOSENS BIOELECTRON, V32, P32, DOI 10.1016/j.bios.2011.11.009; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Zhou J, 2010, ANAL BIOANAL CHEM, V398, P2471, DOI 10.1007/s00216-010-3987-y; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	45	108	113	1	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e35253	10.1371/journal.pone.0035253	http://dx.doi.org/10.1371/journal.pone.0035253			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22529997	gold, Green Submitted, Green Published			2022-12-27	WOS:000305347400039
J	Verma, D; Sarndahl, E; Andersson, H; Eriksson, P; Fredrikson, M; Jonsson, JI; Lerm, M; Soderkvist, P				Verma, Deepti; Sarndahl, Eva; Andersson, Henrik; Eriksson, Per; Fredrikson, Mats; Jonsson, Jan-Ingvar; Lerm, Maria; Soderkvist, Peter			The Q705K Polymorphism in NLRP3 Is a Gain-of-Function Alteration Leading to Excessive Interleukin-1 beta and IL-18 Production	PLOS ONE			English	Article							NF-KAPPA-B; FAMILIAL MEDITERRANEAN FEVER; CIAS1 MUTATIONS; CUTTING EDGE; RHEUMATOID-ARTHRITIS; PERIODIC SYNDROME; INFLAMMASOME ACTIVATION; PROCESSING INFLAMMASOME; IL-1-BETA SECRETION; NALP3 INFLAMMASOME	Background: The Q705K polymorphism in NLRP3 has been implicated in several chronic inflammatory diseases. In this study we determine the functional role of this commonly occurring polymorphism using an in-vitro system. Principal Findings: NLRP3-WT and NLRP3-Q705K were retrovirally transduced into the human monocytic cell line THP-1, followed by the assessment of IL-1 beta and IL-18 levels in the cell culture supernatant. THP-1 cells expressing the above NLRP3 variants were sorted based upon Green Fluorescent Protein (GFP) expression. Cytokine response to alum (one of the most widely used adjuvants in vaccines) in the cells stably expressing NLRP3-WT and NLRP3-Q705K were determined. IL-1 beta and IL-18 levels were found to be elevated in THP-1 cells transduced with NLRP3-Q705K compared to the NLRP3-WT. Upon exposure to alum, THP-1 cells stably expressing NLRP3-Q705K displayed an increased release of IL-1 beta, IL-18 and TNF-alpha, in a caspase-1 and IL-1 receptor-dependent manner. Conclusions: Collectively, these findings show that the Q705K polymorphism in NLRP3 is a gain-of-function alteration leading to an overactive NLRP3 inflammasome. The option of IL-1 beta blockade may be considered in patients with chronic inflammatory disorders that are unresponsive to conventional treatments.	[Verma, Deepti; Soderkvist, Peter] Linkoping Univ, Fac Hlth Sci, Dept Clin & Expt Med, Div Cell Biol, Linkoping, Sweden; [Sarndahl, Eva] Univ Orebro, Dept Clin Med, Sch Hlth & Med Sci, Orebro, Sweden; [Andersson, Henrik; Jonsson, Jan-Ingvar; Lerm, Maria] Linkoping Univ, Fac Hlth Sci, Div Microbiol & Mol Med, Dept Clin & Expt Med, Linkoping, Sweden; [Eriksson, Per] Linkoping Univ, Fac Hlth Sci, Div Rheumatol, Dept Clin & Expt Med, Linkoping, Sweden; [Fredrikson, Mats] Linkoping Univ, Fac Hlth Sci, Div Occupat & Environm Med, Dept Clin & Expt Med, Linkoping, Sweden	Linkoping University; Orebro University; Linkoping University; Linkoping University; Linkoping University	Verma, D (corresponding author), Linkoping Univ, Fac Hlth Sci, Dept Clin & Expt Med, Div Cell Biol, Linkoping, Sweden.	deepti.verma@liu.se	Lerm, Maria/AAA-1780-2020; Verma, Deepti/AAI-9039-2020; Lerm, Maria/AAM-8705-2020	Lerm, Maria/0000-0002-5092-9892; Andersson, Henrik/0000-0002-6020-5177	Medical Research Council of Southeast Sweden [FORSS-8984]; County Council of Ostergotland; King Gustaf V Memorial Foundation; Swedish Research Council [529-2003-5994, 2005-7046, 2007-2673, 2009-3821, K2010-64X-21463-01-3, K2010-57X-21435-01-3, K2010-55X-20451-04-03]	Medical Research Council of Southeast Sweden(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); County Council of Ostergotland; King Gustaf V Memorial Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission)	Funding for this study was provided by grants from the Medical Research Council of Southeast Sweden (FORSS-8984), the County Council of Ostergotland, King Gustaf V Memorial Foundation and the Swedish Research Council (ML, #529-2003-5994, #2005-7046, #2007-2673, #2009-3821, JIJ K2010-64X-21463-01-3, ES K2010-57X-21435-01-3, PS, K2010-55X-20451-04-03). The founders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Aksentijevich I, 2002, ARTHRITIS RHEUM-US, V46, P3340, DOI 10.1002/art.10688; Aksentijevich I, 2007, ARTHRITIS RHEUM-US, V56, P1273, DOI 10.1002/art.22491; Allen IC, 2009, IMMUNITY, V30, P556, DOI 10.1016/j.immuni.2009.02.005; ALTOMONTE L, 1992, CLIN RHEUMATOL, V11, P202, DOI 10.1007/BF02207957; Barker BR, 2011, CURR OPIN IMMUNOL, V23, P591, DOI 10.1016/j.coi.2011.07.005; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Blomgran JR BP, 2012, PLOS ONE IN PRESS; Bodar EJ, 2009, BRIT J HAEMATOL, V144, P279, DOI 10.1111/j.1365-2141.2008.07036.x; Born TL, 1998, J BIOL CHEM, V273, P29445, DOI 10.1074/jbc.273.45.29445; Burns K, 2003, J EXP MED, V197, P263, DOI 10.1084/jem.20021790; Dinarello CA, 2000, NEW ENGL J MED, V343, P732, DOI 10.1056/NEJM200009073431011; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; DINARELLO CA, 1987, J IMMUNOL, V139, P1902; Dowds TA, 2004, J BIOL CHEM, V279, P21924, DOI 10.1074/jbc.M401178200; Duncan JA, 2007, P NATL ACAD SCI USA, V104, P8041, DOI 10.1073/pnas.0611496104; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Eliasson P, 2010, EXP HEMATOL, V38, P301, DOI 10.1016/j.exphem.2010.01.005; Fontalba A, 2007, J IMMUNOL, V179, P4867, DOI 10.4049/jimmunol.179.7.4867; Franchi L, 2008, EUR J IMMUNOL, V38, P2085, DOI 10.1002/eji.200838549; Franchi L, 2009, J IMMUNOL, V183, P792, DOI 10.4049/jimmunol.0900173; Gattorno M, 2007, ARTHRITIS RHEUM, V56, P3138, DOI 10.1002/art.22842; Gershoni-Baruch R, 2002, EUR J HUM GENET, V10, P145, DOI 10.1038/sj.ejhg.5200776; Greten FR, 2007, CELL, V130, P918, DOI 10.1016/j.cell.2007.07.009; Hasegawa M, 2005, J BIOL CHEM, V280, P15122, DOI 10.1074/jbc.M412284200; ISSAID, 2003, INF; Kastbom A, 2008, RHEUMATOLOGY, V47, P415, DOI 10.1093/rheumatology/kem372; Kastner Daniel L, 2005, Hematology Am Soc Hematol Educ Program, P74; Li HF, 2008, J IMMUNOL, V181, P17, DOI 10.4049/jimmunol.181.1.17; Li HF, 2007, J IMMUNOL, V178, P5271, DOI 10.4049/jimmunol.178.8.5271; Li XX, 2005, J MOL MED, V83, P258, DOI 10.1007/s00109-004-0622-4; Lindblad EB, 2004, IMMUNOL CELL BIOL, V82, P497, DOI 10.1111/j.0818-9641.2004.01286.x; Martinon F, 2004, CURR BIOL, V14, P1929, DOI 10.1016/j.cub.2004.10.027; Masumoto J, 2003, BIOCHEM BIOPH RES CO, V303, P69, DOI 10.1016/S0006-291X(03)00309-7; Ozen S, 2009, ANN RHEUM DIS, V68, P246, DOI 10.1136/ard.2008.092031; Pontillo A, 2010, AUTOIMMUNITY, V43, P583, DOI 10.3109/08916930903540432; Pontillo A, 2011, AM J GASTROENTEROL, V106, P539, DOI 10.1038/ajg.2010.474; Roberts RL, 2010, GENES IMMUN, V11, P351, DOI 10.1038/gene.2010.11; Rosengren S, 2007, J ALLERGY CLIN IMMUN, V119, P991, DOI 10.1016/j.jaci.2006.12.649; Schoultz I, 2009, AM J GASTROENTEROL, V104, P1180, DOI 10.1038/ajg.2009.29; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Singh-Grewal D, 2007, ANN RHEUM DIS, V66, P1541, DOI 10.1136/ard.2007.075655; Stojanov Silvia, 2005, Expert Reviews in Molecular Medicine, V7, P1, DOI 10.1017/S1462399405009749; Taxman DJ, 2006, J IMMUNOL, V177, P4252, DOI 10.4049/jimmunol.177.7.4252; Ting TV, 2007, PEDIATR NEUROL, V36, P338, DOI 10.1016/j.pediatrneurol.2006.12.008; Touitou I, 2006, ANN RHEUM DIS, V65, P1530, DOI 10.1136/ard.2006.054312; Touitou I, 2007, ARTHRITIS RHEUM, V56, P1706, DOI 10.1002/art.22507; van den Berg WB, 2000, ANN RHEUM DIS, V59, P81, DOI 10.1136/ard.59.suppl_1.i81; Verma D, 2008, ARTHRITIS RHEUM, V58, P888, DOI 10.1002/art.23286; Verma D, 2010, ARTHRITIS RHEUM-US, V62, P2138, DOI 10.1002/art.27489; Willingham SB, 2007, CELL HOST MICROBE, V2, P147, DOI 10.1016/j.chom.2007.07.009	51	104	105	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e34977	10.1371/journal.pone.0034977	http://dx.doi.org/10.1371/journal.pone.0034977			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22529966	Green Published, gold, Green Submitted			2022-12-27	WOS:000305347400028
J	Driscoll, I; Martin, B; An, Y; Maudsley, S; Ferrucci, L; Mattson, MP; Resnick, SM				Driscoll, Ira; Martin, Bronwen; An, Yang; Maudsley, Stuart; Ferrucci, Luigi; Mattson, Mark P.; Resnick, Susan M.			Plasma BDNF Is Associated with Age-Related White Matter Atrophy but Not with Cognitive Function in Older, Non-Demented Adults	PLOS ONE			English	Article							FACTOR VAL66MET POLYMORPHISM; NEUROTROPHIC FACTOR; ENERGY RESTRICTION; HIPPOCAMPAL; VOLUME; HEALTHY; WEIGHT; IMPACT; IMPAIRMENT; DEPRESSION	Brain derived neurotrophic factor (BDNF) seems to be involved in regulation of synaptic plasticity and neurogenesis. BDNF plasma and serum levels have been associated with depression, Alzheimer's disease, and other psychiatric and neurodegenerative disorders. In a community sample, drawn from the Baltimore Longitudinal Study of Aging (BLSA), we examined whether BDNF plasma concentration was associated with rates of age-related change in cognitive performance (n = 429) and regional brain volume (n = 59). Plasma BDNF levels, which were significantly higher in females (p<0.05), were not associated with either concurrent cognitive performance or rates of age-related change in performance across cognitive domains (p's>0.05). Sex differences in the relationship between BDNF and the trajectories of regional brain volume changes were observed for the whole brain and frontal white matter volumes (p<0.05), whereby lower plasma BDNF was associated with steeper volume decline in females but not males. Together, our findings contribute to furthering the understanding of the relationships between plasma BDNF, structural brain integrity and cognition. Potential mechanisms mediating these relationships merit further investigation.	[Driscoll, Ira; An, Yang; Resnick, Susan M.] NIA, Lab Behav Neurosci, Baltimore, MD 21224 USA; [Driscoll, Ira] Univ Wisconsin Milwaukee, Dept Psychol, Milwaukee, WI USA; [Martin, Bronwen] NIA, Clin Invest Lab, Baltimore, MD 21224 USA; [Maudsley, Stuart; Mattson, Mark P.] NIA, Neurosci Lab, Baltimore, MD 21224 USA; [Ferrucci, Luigi] NIA, Clin Res Branch, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Wisconsin System; University of Wisconsin Milwaukee; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Driscoll, I (corresponding author), NIA, Lab Behav Neurosci, Baltimore, MD 21224 USA.	driscoli@uwm.edu	Maudsley, Stuart/AAV-9929-2021; Maudsley, Stuart/Q-4782-2019	Maudsley, Stuart/0000-0002-1868-184X; Martin, Bronwen/0000-0002-9185-6925	Intramural Research Program of the National Institute on Aging; NATIONAL INSTITUTE ON AGING [ZIAAG000916, ZIAAG000015, ZIAAG000319, ZIAAG000318, ZIAAG000915, ZIAAG000191, ZIAAG000331, ZIAAG000917, ZIAAG000312, ZIAAG000325] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the Intramural Research Program of the National Institute on Aging. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENTON AL, 1968, NEUROPSYCHOLOGIA, V6, P53, DOI 10.1016/0028-3932(68)90038-9; Brunoni AR, 2008, INT J NEUROPSYCHOPH, V11, P1169, DOI 10.1017/S1461145708009309; Bueller JA, 2006, BIOL PSYCHIAT, V59, P812, DOI 10.1016/j.biopsych.2005.09.022; Carlson O, 2007, METABOLISM, V56, P1729, DOI 10.1016/j.metabol.2007.07.018; Cirulli F, 2011, PSYCHONEUROENDOCRINO, V36, P372, DOI 10.1016/j.psyneuen.2010.10.019; Davatzikos C, 2001, NEUROIMAGE, V14, P1361, DOI 10.1006/nimg.2001.0937; DEFRIES JC, 1974, SCIENCE, V183, P338, DOI 10.1126/science.183.4122.338; Delis DC., 2000, CALIFORNIA VERBAL LE; Driscoll I, 2006, ANN NEUROL, V60, P688, DOI 10.1002/ana.21031; Erickson KI, 2010, J NEUROSCI, V30, P5368, DOI 10.1523/JNEUROSCI.6251-09.2010; Golden E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010099; Goldszal AF, 1998, J COMPUT ASSIST TOMO, V22, P827, DOI 10.1097/00004728-199809000-00030; GROBER E, 1987, DEV NEUROPSYCHOL, V3, P13, DOI 10.1080/87565648709540361; Grundman M, 2002, J MOL NEUROSCI, V19, P23, DOI 10.1007/s12031-002-0006-6; Gunstad J, 2008, J GERIATR PSYCH NEUR, V21, P166, DOI 10.1177/0891988708316860; Harrell FE, 2001, REGRESSION MODELING; HARTLEY HO, 1967, BIOMETRIKA, V54, P93, DOI 10.1093/biomet/54.1-2.93; Harvie MN, 2011, INT J OBESITY, V35, P714, DOI 10.1038/ijo.2010.171; Husson I, 2005, CEREB CORTEX, V15, P250, DOI 10.1093/cercor/bhh127; Johnson JB, 2007, FREE RADICAL BIO MED, V42, P665, DOI 10.1016/j.freeradbiomed.2006.12.005; Kapczinski F, 2011, J PSYCHIATR RES, V45, P156, DOI 10.1016/j.jpsychires.2010.05.015; Komulainen P, 2008, NEUROBIOL LEARN MEM, V90, P596, DOI 10.1016/j.nlm.2008.07.014; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Lee HY, 2008, NEUROPSYCHOBIOLOGY, V57, P194, DOI 10.1159/000149817; Li G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005424; Lommatzsch M, 2005, NEUROBIOL AGING, V26, P115, DOI 10.1016/j.neurobiolaging.2004.03.002; Martin B, 2007, ENDOCRINOLOGY, V148, P4318, DOI 10.1210/en.2007-0161; Mattson MP, 2004, TRENDS NEUROSCI, V27, P589, DOI 10.1016/j.tins.2004.08.001; Mattson MP, 2004, AGEING RES REV, V3, P445, DOI 10.1016/j.arr.2004.08.001; Meltser I, 2008, J CLIN INVEST, V118, P1563, DOI 10.1172/JCI32796; Mercader JM, 2007, GENES BRAIN BEHAV, V6, P706, DOI 10.1111/j.1601-183X.2007.00301.x; Newcombe F., 1969, MISSILE WOUNDS BRAIN; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Pezawas L, 2004, J NEUROSCI, V24, P10099, DOI 10.1523/JNEUROSCI.2680-04.2004; Piccinni A, 2008, CHRONOBIOL INT, V25, P819, DOI 10.1080/07420520802387773; Reitan RM, 1992, TRAIL MAKING TEST MA; Resnick SM, 2000, CEREB CORTEX, V10, P464, DOI 10.1093/cercor/10.5.464; Rybakowski JK, 2006, MOL PSYCHIATR, V11, P122, DOI 10.1038/sj.mp.4001765; Sasahara K, 2007, J NEUROSCI, V27, P7408, DOI 10.1523/JNEUROSCI.0710-07.2007; Savitz J, 2006, GENES BRAIN BEHAV, V5, P311, DOI 10.1111/j.1601-183X.2005.00163.x; Savitz JB, 2009, NEUROSCIENCE, V164, P300, DOI 10.1016/j.neuroscience.2009.03.082; Shen DG, 2002, IEEE T MED IMAGING, V21, P1421, DOI 10.1109/TMI.2002.803111; SHOCK NW, 1984, 842450 NIH; Szeszko PR, 2005, MOL PSYCHIATR, V10, P631, DOI 10.1038/sj.mp.4001656; Terracciano A, 2010, GENES BRAIN BEHAV, V9, P512, DOI 10.1111/j.1601-183X.2010.00579.x; Trajkovska V, 2007, BRAIN RES BULL, V73, P143, DOI 10.1016/j.brainresbull.2007.03.009; van Haren NE, 2008, CURR OPIN PSYCHIATR, V21, P161, DOI 10.1097/YCO.0b013e3282f4f25b; Wechsler D, 2008, WAIS 3 WECHSLER ADUL, VFourth; Weinstock-Guttman B, 2007, J NEUROIMMUNOL, V188, P167, DOI 10.1016/j.jneuroim.2007.06.003; Wilson JR, 1978, SEXUAL BEHAV, P317; Young E A, 1998, J Gend Specif Med, V1, P21; ZONDERMAN AB, 1995, ARCH CLIN NEUROPSYCH, V10, P111, DOI 10.1016/0887-6177(94)00040-9	52	77	77	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e35217	10.1371/journal.pone.0035217	http://dx.doi.org/10.1371/journal.pone.0035217			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523577	gold, Green Submitted, Green Published			2022-12-27	WOS:000305345000049
J	Summanen, M; Granqvist, N; Tuominen, RK; Yliperttula, M; Verrips, CT; Boonstra, J; Blanchetot, C; Ekokoski, E				Summanen, Milla; Granqvist, Niko; Tuominen, Raimo K.; Yliperttula, Marjo; Verrips, C. Theo; Boonstra, Johannes; Blanchetot, Christophe; Ekokoski, Elina			Kinetics of PKC epsilon Activating and Inhibiting Llama Single Chain Antibodies and Their Effect on PKC epsilon Translocation in HeLa Cells	PLOS ONE			English	Article							PROTEIN-KINASE-C; AMYLOID PRECURSOR PROTEIN; PHOSPHORYLATION; TARGET; CHIP	Dysregulation of PKC epsilon is involved in several serious diseases such as cancer, type II diabetes and Alzheimer's disease. Therefore, specific activators and inhibitors of PKC epsilon hold promise as future therapeutics, in addition to being useful in research into PKC epsilon regulated pathways. We have previously described llama single chain antibodies (VHHs) that specifically activate (A10, C1 and D1) or inhibit (E6 and G8) human recombinant PKC epsilon. Here we report a thorough kinetic analysis of these VHHs. The inhibiting VHHs act as non-competitive inhibitors of PKC epsilon activity, whereas the activating VHHs have several different modes of action, either increasing V-max and/or decreasing K-m values. We also show that the binding of the VHHs to PKC epsilon is conformation-dependent, rendering the determination of affinities difficult. Apparent affinities are in the micromolar range based on surface plasmon resonance studies. Furthermore, the VHHs have no effect on the activity of rat PKC epsilon nor can they bind the rat form of the protein in immunoprecipitation studies despite the 98% identity between the human and rat PKC epsilon proteins. Finally, we show for the first time that the VHHs can influence PKC epsilon function also in cells, since an activating VHH increases the rate of PKC epsilon translocation in response to PMA in HeLa cells, whereas an inhibiting VHH slows down the translocation. These results give insight into the mechanisms of PKC epsilon activity modulation and highlight the importance of protein conformation on VHH binding.	[Summanen, Milla; Verrips, C. Theo; Boonstra, Johannes; Blanchetot, Christophe] Univ Utrecht, Dept Biol, Utrecht, Netherlands; [Summanen, Milla; Tuominen, Raimo K.; Ekokoski, Elina] Univ Helsinki, Div Pharmacol & Toxicol, Fac Pharm, Helsinki, Finland; [Granqvist, Niko; Yliperttula, Marjo] Univ Helsinki, Fac Pharm, Div Biopharmaceut & Pharmacokinet, Helsinki, Finland	Utrecht University; University of Helsinki; University of Helsinki	Boonstra, J (corresponding author), Univ Utrecht, Dept Biol, Utrecht, Netherlands.	j.boonstra@uu.nl		Summanen, Milla/0000-0003-3843-2741; Blanchetot, christophe/0000-0001-9152-9978	Finnish Pharmaceutical Society; Finnish Diabetes Research Foundation	Finnish Pharmaceutical Society; Finnish Diabetes Research Foundation	This work was supported by grants from the Finnish Pharmaceutical Society and the Finnish Diabetes Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akita Y, 2002, J BIOCHEM, V132, P847, DOI 10.1093/oxfordjournals.jbchem.a003296; Basu A, 2007, CELL SIGNAL, V19, P1633, DOI 10.1016/j.cellsig.2007.04.008; Bhattacharya S, 2007, J BIOSCIENCES, V32, P405, DOI 10.1007/s12038-007-0038-8; Brandman R, 2007, J BIOL CHEM, V282, P4113, DOI 10.1074/jbc.M608521200; Cha T, 2005, PROTEOMICS, V5, P416, DOI 10.1002/pmic.200400948; Cisse M, 2011, MOL CELL NEUROSCI, V47, P223, DOI 10.1016/j.mcn.2011.04.008; de Barry J, 2010, EXP GERONTOL, V45, P64, DOI 10.1016/j.exger.2009.10.015; De Genst E, 2006, P NATL ACAD SCI USA, V103, P4586, DOI 10.1073/pnas.0505379103; Dey D, 2007, BIOCHEM BIOPH RES CO, V357, P474, DOI 10.1016/j.bbrc.2007.03.183; Dorn GW, 1999, P NATL ACAD SCI USA, V96, P12798, DOI 10.1073/pnas.96.22.12798; Durgan J, 2008, BIOCHEM J, V411, P319, DOI [10.1042/BJ20071348, 10.1042/bj20071348]; Gorin MA, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-9; Harmsen MM, 2007, APPL MICROBIOL BIOT, V77, P13, DOI 10.1007/s00253-007-1142-2; Hongpaisan J, 2011, J NEUROSCI, V31, P630, DOI 10.1523/JNEUROSCI.5209-10.2011; Johnson JA, 1996, J BIOL CHEM, V271, P24962, DOI 10.1074/jbc.271.40.24962; Kang JH, 2007, J CHROMATOGR A, V1161, P9, DOI 10.1016/j.chroma.2007.05.023; Liron T, 2007, NEUROSCIENCE, V146, P152, DOI 10.1016/j.neuroscience.2007.01.024; Liu WS, 1998, CELL SIGNAL, V10, P529, DOI 10.1016/S0898-6568(98)00012-6; Mackay HJ, 2007, NAT REV CANCER, V7, P554, DOI 10.1038/nrc2168; Muyldermans S, 2001, J Biotechnol, V74, P277; Nelson TJ, 2009, J BIOL CHEM, V284, P34514, DOI 10.1074/jbc.M109.016683; Newton AC, 1997, CURR OPIN CELL BIOL, V9, P161, DOI 10.1016/S0955-0674(97)80058-0; Newton AC, 2003, BIOCHEM J, V370, P361, DOI 10.1042/BJ20021626; Newton AC, 2010, AM J PHYSIOL-ENDOC M, V298, pE395, DOI 10.1152/ajpendo.00477.2009; Nieba L, 1997, ANAL BIOCHEM, V252, P217, DOI 10.1006/abio.1997.2326; Paalanen MMI, 2011, EUR J PHARM SCI, V42, P332, DOI 10.1016/j.ejps.2010.12.012; Sampson SR, 2006, MOL GENET METAB, V89, P32, DOI 10.1016/j.ymgme.2006.04.017; Sandler C, 2005, INFLAMM RES, V54, P304, DOI 10.1007/s00011-005-1358-5; Saurin AT, 2009, CELL CYCLE, V8, P549, DOI 10.4161/cc.8.4.7653; Schasfoort RBM, 2008, HANDBOOK OF SURFACE PLASMON RESONANCE, P1, DOI 10.1039/9781847558220; Schmitz-Peiffer C, 2007, CELL METAB, V6, P320, DOI 10.1016/j.cmet.2007.08.012; Shou M, 2001, CURR DRUG METAB, V2, P17, DOI 10.2174/1389200013338784; Tammela P, 2004, DRUG DEVELOP RES, V63, P76, DOI 10.1002/ddr.10399; Toton E, 2011, PHARMACOL REP, V63, P19, DOI 10.1016/S1734-1140(11)70395-4; Van Bockstaele F, 2009, CURR OPIN INVEST DR, V10, P1212; Verheesen P, 2006, HUM MOL GENET, V15, P105, DOI 10.1093/hmg/ddi432; Verheesen P, 2006, BBA-PROTEINS PROTEOM, V1764, P1307, DOI 10.1016/j.bbapap.2006.05.011; Wilson DS, 2002, CURR OPIN CHEM BIOL, V6, P81, DOI 10.1016/S1367-5931(01)00281-2	38	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35630	10.1371/journal.pone.0035630	http://dx.doi.org/10.1371/journal.pone.0035630			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536418	Green Submitted, Green Published, gold			2022-12-27	WOS:000305339200087
J	Testerink, N; Ajat, M; Houweling, M; Brouwers, JF; Pully, VV; van Manen, HJ; Otto, C; Helms, JB; Vaandrager, AB				Testerink, Nicole; Ajat, Mokrish; Houweling, Martin; Brouwers, Jos F.; Pully, Vishnu V.; van Manen, Henk-Jan; Otto, Cees; Helms, J. Bernd; Vaandrager, Arie B.			Replacement of Retinyl Esters by Polyunsaturated Triacylglycerol Species in Lipid Droplets of Hepatic Stellate Cells during Activation	PLOS ONE			English	Article							RAT-LIVER; RAMAN-SPECTROSCOPY; KUPFFER CELLS; BIOLOGY; PROLIFERATION; DEGRADATION; EXPRESSION; EXPANSION; PROTEIN; FAT	Activation of hepatic stellate cells has been recognized as one of the first steps in liver injury and repair. During activation, hepatic stellate cells transform into myofibroblasts with concomitant loss of their lipid droplets (LDs) and production of excessive extracellular matrix. Here we aimed to obtain more insight in the dynamics and mechanism of LD loss. We have investigated the LD degradation processes in rat hepatic stellate cells in vitro with a combined approach of confocal Raman microspectroscopy and mass spectrometric analysis of lipids (lipidomics). Upon activation of the hepatic stellate cells, LDs reduce in size, but increase in number during the first 7 days, but the total volume of neutral lipids did not decrease. The LDs also migrate to cellular extensions in the first 7 days, before they disappear. In individual hepatic stellate cells. all LDs have a similar Raman spectrum, suggesting a similar lipid profile. However, Raman studies also showed that the retinyl esters are degraded more rapidly than the triacylglycerols upon activation. Lipidomic analyses confirmed that after 7 days in culture hepatic stellate cells have lost most of their retinyl esters, but not their triacylglycerols and cholesterol esters. Furthermore, we specifically observed a large increase in triacylglycerol-species containing polyunsaturated fatty acids, partly caused by an enhanced incorporation of exogenous arachidonic acid. These results reveal that lipid droplet degradation in activated hepatic stellate cells is a highly dynamic and regulated process. The rapid replacement of retinyl esters by polyunsaturated fatty acids in LDs suggests a role for both lipids or their derivatives like eicosanoids during hepatic stellate cell activation.	[Testerink, Nicole; Ajat, Mokrish; Houweling, Martin; Brouwers, Jos F.; Helms, J. Bernd; Vaandrager, Arie B.] Univ Utrecht, Dept Biochem & Cell Biol, Fac Vet Sci, Utrecht, Netherlands; [Pully, Vishnu V.; van Manen, Henk-Jan; Otto, Cees] Univ Twente, MIRA Inst Biomed Technol & Tech Med, Dept Sci & Technol, NL-7500 AE Enschede, Netherlands	Utrecht University; University of Twente	Vaandrager, AB (corresponding author), Univ Utrecht, Dept Biochem & Cell Biol, Fac Vet Sci, Utrecht, Netherlands.	A.B.Vaandrager@uu.nl	Otto, Cees/H-8421-2019; Ajat, Mokrish/AAD-4086-2021; Brouwers, Jos F/AAH-1444-2019	Brouwers, Jos F/0000-0003-2924-3279; Ajat, Mokrish/0000-0002-2905-4630; Vaandrager, Arie/0000-0001-9394-9239	European Union [202272]	European Union(European Commission)	This work was supported by the seventh framework program of the European Union-funded "LipidomicNet" project (proposal number 202272). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blaner WS, 2009, BBA-MOL CELL BIOL L, V1791, P467, DOI 10.1016/j.bbalip.2008.11.001; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bozza PT, 2009, BBA-MOL CELL BIOL L, V1791, P540, DOI 10.1016/j.bbalip.2009.01.005; Cao Y, 1998, GENOMICS, V49, P327, DOI 10.1006/geno.1998.5268; CLEMENT B, 1984, CELL MOL BIOL, V30, P489; Cubero FJ, 2008, HEPATOLOGY, V48, P2027, DOI 10.1002/hep.22592; Darios F, 2006, NATURE, V440, P813, DOI 10.1038/nature04598; Dudas J, 2003, CELL TISSUE RES, V313, P301, DOI 10.1007/s00441-003-0768-3; Failloux N, 2003, APPL SPECTROSC, V57, P1117, DOI 10.1366/00037020360695973; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; FRIEDMAN SL, 1993, AM J PHYSIOL, V264, pG947, DOI 10.1152/ajpgi.1993.264.5.G947; Gressner AM, 1998, CELL TISSUE RES, V292, P447, DOI 10.1007/s004410051073; Hanlon EB, 2000, PHYS MED BIOL, V45, pR1, DOI 10.1088/0031-9155/45/2/201; Harizi H, 2008, TRENDS MOL MED, V14, P461, DOI 10.1016/j.molmed.2008.08.005; HENDRIKS HFJ, 1988, EUR J BIOCHEM, V171, P237, DOI 10.1111/j.1432-1033.1988.tb13782.x; HENDRIKS HFJ, 1985, EXP CELL RES, V160, P138, DOI 10.1016/0014-4827(85)90243-5; Hernandez-Gea V, 2012, GASTROENTEROLOGY; Kluwe J, 2011, GUT, V60, P1260, DOI 10.1136/gut.2010.209551; Krahmer N, 2011, CELL METAB, V14, P504, DOI 10.1016/j.cmet.2011.07.013; Long AP, 2012, TRAFFIC; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; Mathew J, 1996, HEPATO-GASTROENTEROL, V43, P72; Mello T, 2008, BIOCHEM BIOPH RES CO, V374, P460, DOI 10.1016/j.bbrc.2008.07.024; MORIWAKI H, 1988, J LIPID RES, V29, P1523; PUPPELS GJ, 1990, NATURE, V347, P301, DOI 10.1038/347301a0; Rapoport SI, 2001, J MOL NEUROSCI, V16, P243, DOI 10.1385/JMN:16:2-3:243; Retra K, 2008, RAPID COMMUN MASS SP, V22, P1853, DOI 10.1002/rcm.3562; Riccalton-Banks L, 2003, MOL CELL BIOCHEM, V248, P97, DOI 10.1023/A:1024184826728; Safadi Rifaat, 2002, MedGenMed, V4, P27; Schreiber R, 2009, J LIPID RES, V50, P2514, DOI 10.1194/jlr.M000950; SMEDSROD B, 1994, GUT, V35, P1509, DOI 10.1136/gut.35.11.1509; Smirnova E, 2006, EMBO REP, V7, P106, DOI 10.1038/sj.embor.7400559; Uzunbajakava N, 2003, BIOPHYS J, V84, P3968, DOI 10.1016/S0006-3495(03)75124-8; van Manen HJ, 2005, P NATL ACAD SCI USA, V102, P10159, DOI 10.1073/pnas.0502746102; Vinas O, 2003, HEPATOLOGY, V38, P919, DOI 10.1053/jhep.2003.50392; Welte MA, 2009, BIOCHEM SOC T, V37, P991, DOI 10.1042/BST0370991; Xia YH, 2010, J CANCER RES CLIN, V136, P309, DOI 10.1007/s00432-009-0666-5; YAMADA M, 1987, HEPATOLOGY, V7, P1224, DOI 10.1002/hep.1840070609; Yamaguchi K, 2008, HEPATOLOGY, V47, P625, DOI 10.1002/hep.21988; YOST RW, 1988, J BIOL CHEM, V263, P18693	40	62	64	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e34945	10.1371/journal.pone.0034945	http://dx.doi.org/10.1371/journal.pone.0034945			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536341	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339200028
J	Wouters, E; Booysen, FL; Ponnet, K; Van Loon, FB				Wouters, Edwin; Booysen, Frederik le Roux; Ponnet, Koen; Van Loon, Francis Baron			Wording Effects and the Factor Structure of the Hospital Anxiety & Depression Scale in HIV/AIDS Patients on Antiretroviral Treatment in South Africa	PLOS ONE			English	Article							ROSENBERG SELF-ESTEEM; HIV-INFECTED INDIVIDUALS; QUALITY-OF-LIFE; MODEL; DISORDERS; HEALTH; OUTPATIENT; PREVALENCE; VALIDATION; PREDICTORS	Background: Given the immense burden of HIV/AIDS on health systems in sub-Saharan Africa and the intricate link between HIV/AIDS and mental health problems, health care providers need a valid and reliable instrument to assess mental health rapidly. The Hospital Anxiety and Depression Scale (HADS) may constitute such an instrument. The aims of this study were to: (1) examine the factor structure of the HADS in a population of South African HIV/AIDS patients on antiretroviral treatment (ART); and (2) identify and control the disturbing influence of systematic wording effects in vulnerable respondent groups. Methodology/Principal Findings: The translated scale was administered to 716 HIV/AIDS patients enrolled in the public sector ART program in South Africa. A combined confirmatory factor analysis and correlated-traits-correlated-methods framework was used to determine the preferred factor structure of the HADS, while controlling for the disturbing influence of systematic wording effects. When assessing the structure without a negative wording factor, all three factor structures displayed an acceptable fit to the data. The three-factor solution best fitted the data. Addition of a method factor significantly improved the fit of all three factor solutions. Using x 2 difference testing, Razavi's one-factor solution displayed a superior fit compared to the other two factor solutions. Conclusions: The study outcomes support the use of the HADS as a valid and reliable means to screen for mental health problems in HIV/AIDS patients enrolled in a public-sector ART program in a resource-limited context. The results demonstrate the importance of evaluating and correcting for wording effects when examining the factor structure of the screening instrument in vulnerable patient groups. In light of the inter-relationships between HIV/AIDS and mental health problems and the scarcity of adequate screening tools, additional studies on this topic are required.	[Wouters, Edwin; Ponnet, Koen; Van Loon, Francis Baron] Univ Antwerp, Dept Sociol, B-2020 Antwerp, Belgium; [Wouters, Edwin; Ponnet, Koen; Van Loon, Francis Baron] Univ Antwerp, Res Ctr Longitudinal & Life Course Studies, B-2020 Antwerp, Belgium; [Wouters, Edwin; Booysen, Frederik le Roux] Univ Orange Free State, Ctr Hlth Syst Res & Dev, Bloemfontein, South Africa; [Booysen, Frederik le Roux] Univ Orange Free State, Dept Econ, Bloemfontein, South Africa; [Ponnet, Koen] Univ Antwerp, MIOS, B-2020 Antwerp, Belgium	University of Antwerp; University of Antwerp; University of the Free State; University of the Free State; University of Antwerp	Wouters, E (corresponding author), Univ Antwerp, Dept Sociol, B-2020 Antwerp, Belgium.	edwin.wouters@ua.ac.be	le R Booysen, Frederik/K-9152-2015; Wouters, Edwin/AAE-1649-2021; Ponnet, Koen/K-9389-2017; Booysen, Frederik/ABB-2868-2021	le R Booysen, Frederik/0000-0001-7449-3221; Wouters, Edwin/0000-0003-2268-3829; Ponnet, Koen/0000-0002-6911-7632; 	Research Committee of the World Bank; Bank Netherlands Program Partnership; WB-DfiD 'Evaluation of the Community Response to HIV and AIDS'; Health Economics and Aids Research Division (HEARD) at the University of Kwazulu-Natal; University of the Free State (UFS); National Research Foundation (NRF) of South Africa	Research Committee of the World Bank; Bank Netherlands Program Partnership; WB-DfiD 'Evaluation of the Community Response to HIV and AIDS'; Health Economics and Aids Research Division (HEARD) at the University of Kwazulu-Natal; University of the Free State (UFS); National Research Foundation (NRF) of South Africa(National Research Foundation - South Africa)	The study was funded by the Research Committee of the World Bank, The Bank Netherlands Program Partnership, the WB-DfiD 'Evaluation of the Community Response to HIV and AIDS,' the Health Economics and Aids Research Division (HEARD) at the University of Kwazulu-Natal, the University of the Free State (UFS), and the National Research Foundation (NRF) of South Africa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The findings, interpretations, and conclusions in the article are those of the authors and do not reflect the views of funding agencies.	Alessandri G, 2010, STRUCT EQU MODELING, V17, P642, DOI 10.1080/10705511.2010.510064; [Anonymous], GLOB BURD DIS 2004 U; Au A, 2004, AIDS BEHAV, V8, P119, DOI 10.1023/B:AIBE.0000030243.50415.c0; Barnette JJ, 2000, EDUC PSYCHOL MEAS, V60, P361, DOI 10.1177/00131640021970592; Barth Jurgen, 2005, Health Qual Life Outcomes, V3, P15, DOI 10.1186/1477-7525-3-15; Berard RMF, 1998, PSYCHO-ONCOL, V7, P112, DOI 10.1002/(SICI)1099-1611(199803/04)7:2<112::AID-PON300>3.0.CO;2-W; Billiet JB, 2000, STRUCT EQU MODELING, V7, P608, DOI 10.1207/S15328007SEM0704_5; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Boarts JM, 2009, J EVID-INFORM SOC WO, V6, P4, DOI 10.1080/15433710802633247; Brown T.A., 2006, CONFIRMATORY FACTOR, Vxiii; Caci H, 2003, PSYCHIAT RES, V118, P89, DOI 10.1016/S0165-1781(03)00044-1; Campos LN, 2010, AIDS BEHAV, V14, P289, DOI 10.1007/s10461-008-9435-8; Chandra PS, 2003, J PSYCHOSOM RES, V54, P199, DOI 10.1016/S0022-3999(02)00567-6; Chen Y.-H., 2010, INT J ED PSYCHOL ASS, V6, P21; CLARK LA, 1991, J ABNORM PSYCHOL, V100, P316, DOI 10.1037/0021-843X.100.3.316; Corwyn RF, 2000, J RES PERS, V34, P357, DOI 10.1006/jrpe.2000.2291; Desmond DM, 2005, INT J GERIATR PSYCH, V20, P344, DOI 10.1002/gps.1289; DiStefano C, 2006, STRUCT EQU MODELING, V13, P440, DOI 10.1207/s15328007sem1303_6; DiStefano C, 2009, STRUCT EQU MODELING, V16, P134, DOI 10.1080/10705510802565403; DiStefano C, 2009, PERS INDIV DIFFER, V46, P309, DOI 10.1016/j.paid.2008.10.020; Dunbar M, 2000, BRIT J CLIN PSYCHOL, V39, P79, DOI 10.1348/014466500163121; Eid M, 2000, PSYCHOMETRIKA, V65, P241, DOI 10.1007/BF02294377; Eidecker J, 2010, J ANXIETY DISORD, V24, P596, DOI 10.1016/j.janxdis.2010.03.020; Farinpour R, 2003, J CLIN EXP NEUROPSYC, V25, P654, DOI 10.1076/jcen.25.5.654.14577; Floyd FJ, 1995, PSYCHOL ASSESSMENT, V7, P286, DOI 10.1037/1040-3590.7.3.286; Greenberger E, 2003, PERS INDIV DIFFER, V35, P1241, DOI 10.1016/S0191-8869(02)00331-8; Gupta R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014252; Hand GA, 2006, AIDS CARE, V18, P1011, DOI 10.1080/09540120600568376; Holzemer WL, 1999, AIDS PATIENT CARE ST, V13, P185, DOI 10.1089/apc.1999.13.185; Horan PM, 2003, STRUCT EQU MODELING, V10, P435, DOI 10.1207/S15328007SEM1003_6; Hunt-Shanks T, 2010, BRIT J HEALTH PSYCH, V15, P97, DOI 10.1348/135910709X432745; Ickovics JR, 2001, JAMA-J AM MED ASSOC, V285, P1466, DOI 10.1001/jama.285.11.1466; Johnston M, 2000, J PSYCHOSOM RES, V48, P579, DOI 10.1016/S0022-3999(00)00102-1; Lambert S, 2005, SEX TRANSM INFECT, V81, P333, DOI 10.1136/sti.2004.013516; Lisspers J, 1997, ACTA PSYCHIAT SCAND, V96, P281, DOI 10.1111/j.1600-0447.1997.tb10164.x; Marsh H.W., 1995, STRUCTURAL EQUATION, P177; Marsh HW, 1996, J PERS SOC PSYCHOL, V70, P810, DOI 10.1037/0022-3514.70.4.810; Martin CR, 2008, J EVAL CLIN PRACT, V14, P281, DOI 10.1111/j.1365-2753.2007.00850.x; Martin CR, 2005, CURR PSYCHIATRY REV, V1, P69, DOI 10.2174/1573400052953510; Martin CR, 2004, BRIT J CLIN PSYCHOL, V43, P51, DOI 10.1348/014466504772812968; Matsudaira T, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-42; Meade CS, 2005, CLIN PSYCHOL REV, V25, P433, DOI 10.1016/j.cpr.2005.02.001; Montazeri Ali, 2003, Health Qual Life Outcomes, V1, P14, DOI 10.1186/1477-7525-1-14; MUTHEN B, 1984, PSYCHOMETRIKA, V49, P115, DOI 10.1007/BF02294210; Muthen B., 2010, MPLUS USERS GUIDE; Myer L, 2008, AIDS PATIENT CARE ST, V22, P147, DOI 10.1089/apc.2007.0102; Quilty LC, 2006, STRUCT EQU MODELING, V13, P99, DOI 10.1207/s15328007sem1301_5; Rauch WA, 2007, PERS INDIV DIFFER, V42, P1597, DOI 10.1016/j.paid.2006.10.035; Raykov T, 2009, MEAS EVAL COUNS DEV, V42, P223, DOI 10.1177/0748175609344096; RAZAVI D, 1990, BRIT J PSYCHIAT, V156, P79, DOI 10.1192/bjp.156.1.79; Reda AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016049; Schmitt DP, 2005, J PERS SOC PSYCHOL, V89, P623, DOI 10.1037/0022-3514.89.4.623; Schonberger M, 2010, PSYCHIAT RES, V179, P342, DOI 10.1016/j.psychres.2009.07.003; Smit J, 2006, PUBLIC HEALTH, V120, P534, DOI 10.1016/j.puhe.2006.01.009; SNAITH RP, 1986, BRIT MED J, V292, P344, DOI 10.1136/bmj.292.6516.344; Tomas JM, 1999, STRUCT EQU MODELING, V6, P84, DOI 10.1080/10705519909540120; UNAIDS, 2010, GLOB REP UNAIDS REP; Van der Bijl H, S AFRICAN J PSYCHIAT, V13, P46; Weems G. H., 2003, ASSESS EVAL HIGH EDU, V28, P587, DOI DOI 10.1080/0260293032000130234; Ye SQ, 2009, PERS INDIV DIFFER, V46, P197, DOI 10.1016/j.paid.2008.09.027; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	61	29	30	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e34881	10.1371/journal.pone.0034881	http://dx.doi.org/10.1371/journal.pone.0034881			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UD	22536338	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339200026
J	Zhang, Y; Xu, ST; Wang, HL; Zhu, Z; Ji, YX; Liu, CY; Zhang, XJ; Sun, LW; Zhou, JH; Lu, PS; Hu, Y; Feng, DX; Zhang, ZY; Wang, CY; Fang, XQ; Zheng, HY; Liu, L; Sun, XD; Tang, W; Wang, Y; Liu, Y; Gao, H; Tian, H; Ma, JT; Gu, SY; Wang, S; Feng, Y; Bo, F; Liu, JF; Si, Y; Zhou, SJ; Ma, YY; Wu, SW; Zhou, SD; Li, FC; Ding, ZR; Yang, ZH; Rota, PA; Featherstone, D; Jee, Y; Bellini, WJ; Xu, WB				Zhang, Yan; Xu, Songtao; Wang, Huiling; Zhu, Zhen; Ji, Yixin; Liu, Chunyu; Zhang, Xiaojie; Sun, Liwei; Zhou, Jianhui; Lu, Peishan; Hu, Ying; Feng, Daxing; Zhang, Zhenying; Wang, Changyin; Fang, Xueqiang; Zheng, Huanying; Liu, Leng; Sun, Xiaodong; Tang, Wei; Wang, Yan; Liu, Yan; Gao, Hui; Tian, Hong; Ma, Jiangtao; Gu, Suyi; Wang, Shuang; Feng, Yan; Bo, Fang; Liu, Jianfeng; Si, Yuan; Zhou, Shujie; Ma, Yuyan; Wu, Shengwei; Zhou, Shunde; Li, Fangcai; Ding, Zhengrong; Yang, Zhaohui; Rota, Paul A.; Featherstone, David; Jee, Youngmee; Bellini, William J.; Xu, Wenbo			Single Endemic Genotype of Measles Virus Continuously Circulating in China for at Least 16 Years	PLOS ONE			English	Article							REPUBLIC-OF-CHINA; GENETIC-CHARACTERIZATION; MOLECULAR EPIDEMIOLOGY; UNITED-STATES; ELIMINATION	The incidence of measles in China from 1991 to 2008 was reviewed, and the nucleotide sequences from 1507 measles viruses (MeV) isolated during 1993 to 2008 were phylogenetically analyzed. The results showed that measles epidemics peaked approximately every 3 to 5 years with the range of measles cases detected between 56,850 and 140,048 per year. The Chinese MeV strains represented three genotypes; 1501 H1, 1 H2 and 5 A. Genotype H1 was the predominant genotype throughout China continuously circulating for at least 16 years. Genotype H1 sequences could be divided into two distinct clusters, H1a and H1b. A 4.2% average nucleotide divergence was found between the H1a and H1b clusters, and the nucleotide sequence and predicted amino acid homologies of H1a viruses were 92.3%-100% and 84.7%-100%, H1b were 97.1%-100% and 95.3%-100%, respectively. Viruses from both clusters were distributed throughout China with no apparent geographic restriction and multiple co-circulating lineages were present in many provinces. Cluster H1a and H1b viruses were co-circulating during 1993 to 2005, while no H1b viruses were detected after 2005 and the transmission of that cluster has presumably been interrupted. Analysis of the nucleotide and predicted amino acid changes in the N proteins of H1a and H1b viruses showed no evidence of selective pressure. This study investigated the genotype and cluster distribution of MeV in China over a 16-year period to establish a genetic baseline before MeV elimination in Western Pacific Region (WPR). Continuous and extensive MeV surveillance and the ability to quickly identify imported cases of measles will become more critical as measles elimination goals are achieved in China in the near future. This is the first report that a single endemic genotype of measles virus has been found to be continuously circulating in one country for at least 16 years.	[Zhang, Yan; Xu, Songtao; Wang, Huiling; Zhu, Zhen; Ji, Yixin; Xu, Wenbo] China Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, WHO WPRO Reg Reference Measles Lab, Beijing, Peoples R China; [Liu, Chunyu] Chinese Acad Med Sci, Inst Pathogen Biol, Beijing 100730, Peoples R China; [Liu, Chunyu] Peking Union Med Coll, Beijing 100021, Peoples R China; [Zhang, Xiaojie; Sun, Liwei] Changchun Childrens Hosp, Changchun, Jilin, Peoples R China; [Zhou, Jianhui; Wang, Shuang] Jilin Prov Ctr Dis Control & Prevent, Changchun, Jilin, Peoples R China; [Lu, Peishan; Hu, Ying] Jiangsu Prov Ctr Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China; [Feng, Daxing; Zhang, Zhenying] Henan Prov Ctr Dis Control & Prevent, Zhengzhou, Henan, Peoples R China; [Wang, Changyin; Fang, Xueqiang] Shandong Prov Ctr Dis Control & Prevent, Jinan, Shandong, Peoples R China; [Zheng, Huanying; Liu, Leng] Guangdong Prov Ctr Dis Control & Prevent, Guangzhou, Guangdong, Peoples R China; [Sun, Xiaodong; Tang, Wei] Shanghai Prov Ctr Dis Control & Prevent, Shanghai, Peoples R China; [Wang, Yan] Liaoning Prov Ctr Dis Control & Prevent, Shenyang, Liaoning, Peoples R China; [Liu, Yan] Hebei Prov Ctr Dis Control & Prevent, Baoding, Hebei, Peoples R China; [Gao, Hui] Shanxi Prov Ctr Dis Control & Prevent, Taiyuan, Shanxi, Peoples R China; [Tian, Hong] Tianjin Prov Ctr Dis Control & Prevent, Tianjin, Peoples R China; [Ma, Jiangtao] Ningxia Prov Ctr Dis Control & Prevent, Ningxia, Peoples R China; [Gu, Suyi] Innermongolia Prov Ctr Dis Control & Prevent, Hohhot, Innermongolia, Peoples R China; [Feng, Yan] Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China; [Bo, Fang] Heilongjiang Prov Ctr Dis Control & Prevent, Haerbin, Heilongjiang, Peoples R China; [Liu, Jianfeng] Gansu Prov Ctr Dis Control & Prevent, Lanzhou, Gansu, Peoples R China; [Si, Yuan] Shannxi Prov Ctr Dis Control & Prevent, Xian, Shannxi, Peoples R China; [Zhou, Shujie] Anhui Prov Ctr Dis Control & Prevent, Hefei, Anhui, Peoples R China; [Ma, Yuyan] Guangxi Prov Ctr Dis Control & Prevent, Nanning, Guangxi, Peoples R China; [Wu, Shengwei] Guizhou Prov Ctr Dis Control & Prevent, Guiyang, Guizhou, Peoples R China; [Zhou, Shunde] Jiangxi Prov Ctr Dis Control & Prevent, Nanchang, Jiangxi, Peoples R China; [Li, Fangcai] Hunan Prov Ctr Dis Control & Prevent, Changsha, Hunan, Peoples R China; [Ding, Zhengrong] Yunnan Prov Ctr Dis Control & Prevent, Kunming, Yunnan, Peoples R China; [Yang, Zhaohui] Hubei Prov Ctr Dis Control & Prevent, Wuhan, Hubei, Peoples R China; [Rota, Paul A.; Bellini, William J.] Ctr Dis Control & Prevent, Div Viral Dis, Atlanta, GA USA; [Featherstone, David] WHO, CH-1211 Geneva, Switzerland; [Jee, Youngmee] WHO, Western Pacific Reg Off, Expanded Programme Immunizat, Manila, Philippines	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Jiangsu Provincial Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; Guangdong Provincial Center for Disease Control & Prevention; Shanghai Center for Disease Control & Prevention; Tianjin Center for Disease Control & Prevention; Zhejiang Provincial Center for Disease Control & Prevention; Centers for Disease Control & Prevention - USA; World Health Organization; WHO Western Pacific Regional Office; World Health Organization	Xu, WB (corresponding author), China Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, WHO WPRO Reg Reference Measles Lab, Beijing, Peoples R China.	wenbo_xu1@yahoo.com.cn	Jee, Youngmee/AGW-0164-2022	Jee, Youngmee/0000-0001-5369-6628	WHO; WHO headquarters, WPRO, US CDC	WHO(World Health Organization); WHO headquarters, WPRO, US CDC	This study was supported by the grants of WHO fund for WPRO Measles Regional Reference Laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank all the provincial and prefecture measles laboratory staffs and epidemiologists in mainland China for providing clinical specimens, isolates and epidemiologic data; We thank WHO headquarters, WPRO, US CDC for the technical and financial support. We also acknowledge anonymous reviewers for comments that improved the manuscript.	[Anonymous], 2009, Wkly Epidemiol Rec, V84, P509; [Anonymous], WKLY EPIDEMIOL REC; Bellini WJ, 1998, EMERG INFECT DIS, V4, P29, DOI 10.3201/eid0401.980105; Cui AL, 2009, INFECT GENET EVOL, V9, P71, DOI 10.1016/j.meegid.2008.10.004; Ji YX, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-105; Ji Yixin, 2009, Virol J, V6, P135, DOI 10.1186/1743-422X-6-135; KOBUNE F, 1990, J VIROL, V64, P700, DOI 10.1128/JVI.64.2.700-705.1990; Liffick SL, 2001, VIRUS RES, V77, P81, DOI 10.1016/S0168-1702(01)00268-4; Ma C, 2011, J INFECT DIS, V204, pS447, DOI 10.1093/infdis/jir103; Ono N, 2001, J VIROL, V75, P4399, DOI 10.1128/JVI.75.9.4399-4401.2001; Rota JS, 1998, J INFECT DIS, V177, P204, DOI 10.1086/513825; Rota PA, 2003, J INFECT DIS, V187, pS270, DOI 10.1086/368042; Rota PA, 2002, EMERG INFECT DIS, V8, P902, DOI 10.3201/eid0809.020206; Wang Hui-ling, 2010, Chinese Journal of Virology, V26, P103; WHO, 2005, Wkly Epidemiol Rec, V80, P347; WHO, 2005, 56 SESS WHO REG COMM; WHO, 2003, WKLY EPIDEMIOL REC, V78, P229; *WHO, 2001, WKLY EPIDEMIOL REC, V76, P241; World Health Organization, 2005, Wkly Epidemiol Rec, V80, P384; World Health Organization, 2001, WKLY EPIDEMIOL REC, V76, P249; Xu WB, 1998, VIRUS RES, V54, P147, DOI 10.1016/S0168-1702(98)00020-3; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7; Zhang Y, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-14; Zhang Y, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-120; Zhang Yan, 2009, Zhongguo Yi Miao He Mian Yi, V15, P304; Zhang Y, 2010, EMERG INFECT DIS, V16, P943, DOI 10.3201/eid1606.100089; Zhang Y, 2010, J CLIN MICROBIOL, V48, P619, DOI 10.1128/JCM.02338-09; Zhang Y, 2009, J CLIN VIROL, V44, P262, DOI 10.1016/j.jcv.2009.02.002; Zhu Z, 2010, J CLIN MICROBIOL, V48, P1775, DOI 10.1128/JCM.02055-09	29	20	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e34401	10.1371/journal.pone.0034401	http://dx.doi.org/10.1371/journal.pone.0034401			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22532829	Green Published, gold, Green Submitted			2022-12-27	WOS:000305339200013
J	Li, YY				Li, Yan-yan			Tumor Necrosis Factor-Alpha G308 alpha Gene Polymorphism and Essential Hypertension: A Meta-Analysis Involving 2244 Participants	PLOS ONE			English	Article							BLOOD-PRESSURE; ASSOCIATION; ADOLESCENTS; PROMOTER; DISEASE; ADULTS; BIAS	Background: The tumor necrosis factor-alpha (TNF alpha) G308A gene polymorphism has been implicated in susceptibility to essential hypertension (EH), but study results are still controversial. Objective and Methods: The present meta-analysis is performed to investigate the relationship between the TNF alpha G308A gene polymorphism and EH. Electronic databases were searched and seven separate studies on the association of the TNF alpha G308A gene polymorphism with EH were analyzed. The meta-analysis involved 1092 EH patients and 1152 controls. The pooled odds ratios (ORs) and their corresponding 95% confidence interval (CI) were calculated by a fixed or random effect model. Results: A significant relationship between the TNF alpha G308A gene polymorphism and EH was found in an allelic genetic model (OR: 1.45, 95% CI: 1.17 to 1.80, P = 0.0008), a recessive genetic model (OR: 3.181, 95% CI: 1.204 to 8.408, P = 0.02), and a homozygote model (OR: 3.454, 95% CI: 1.286 to 9.278, P = 0.014). No significant association between them was detected in both a dominant genetic model (OR: 1.55, 95% CI: 0.99 to 2.42, P = 0.06) or a heterozygote genetic model (OR: 1.45, 95% CI: 0.90 to 2.33, P = 0.13). Conclusion: The TNF alpha G308A gene polymorphism is associated with EH susceptibility.	Nanjing Med Univ, Affiliated Hosp 1, Dept Geriatr, Nanjing, Peoples R China	Nanjing Medical University	Li, YY (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Geriatr, Nanjing, Peoples R China.	lyynjmu123@126.com			National Natural Science Foundation of China (NSFC) [81100073]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was funded by the National Natural Science Foundation of China (NSFC 81100073 to YL) and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer MS, 2011, J AM SOC HYPERTENS, V5, P395, DOI 10.1016/j.jash.2011.03.004; Bogdanski P, 2003, POL MERKURIUSZ LEK, V15, P349; Bogdanski Pawel, 2003, Pol Merkur Lekarski, V15, P347; COCHRAN WG, 1968, BIOMETRICS, V24, P295, DOI 10.2307/2528036; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Guo LW, 2009, J XINXIANG MED COLL, V26, P352; Ito H, 2001, CLIN EXP PHARMACOL P, V28, P188, DOI 10.1046/j.1440-1681.2001.03429.x; Kahaleh MB, 1997, CLIN EXP RHEUMATOL, V15, P163; Krikovszky D, 2002, CLIN GENET, V62, P474, DOI 10.1034/j.1399-0004.2002.620609.x; Li CQ, 2010, MOL CARDIOLOGY CHINA, V10, P29; Li H, 2003, CLIN BASIC RES ESSEN; Liu ZW, 2009, ANAT RES, V31, P259; MANTEL N, 1959, J NATL CANCER I, V22, P719; Martens FMAC, 2006, EUR HEART J, V27, P1605, DOI 10.1093/eurheartj/ehl079; Mathieu P, 2009, HYPERTENSION, V53, P577, DOI 10.1161/HYPERTENSIONAHA.108.110320; Mazor R, 2010, HYPERTENSION, V55, P353, DOI 10.1161/HYPERTENSIONAHA.109.144154; Newhouse SJ, 2005, HUM MOL GENET, V14, P1805, DOI 10.1093/hmg/ddi187; [彭翠英 PENG Cuiying], 2011, [中国临床药理学与治疗学, Chinese Journal of Clinical Pharmacology and Therapeutics], V16, P57; Sheu WHH, 2001, METABOLISM, V50, P1447, DOI 10.1053/meta.2001.27192; Sookoian S, 2005, AM J HYPERTENS, V18, P1271, DOI 10.1016/j.amjhyper.2005.04.014; Wilson AG, 1997, P NATL ACAD SCI USA, V94, P3195, DOI 10.1073/pnas.94.7.3195; Won JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027891; [吴旭斌 Wu Xubin], 2004, [高血压杂志, Chinese Journal of Hypertension], V12, P415; Yee LJ, 2000, GENES IMMUN, V1, P386, DOI 10.1038/sj.gene.6363696; Yoo CS, 2007, AM J CHINESE MED, V35, P621, DOI 10.1142/S0192415X07005119	26	17	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e35408	10.1371/journal.pone.0035408	http://dx.doi.org/10.1371/journal.pone.0035408			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22536381	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336200039
J	Mohamed, W; Sethi, S; Tchatalbachev, S; Darji, A; Chakraborty, T				Mohamed, Walid; Sethi, Shneh; Tchatalbachev, Svetlin; Darji, Ayub; Chakraborty, Trinad			Protective Immunity to Listeria Monocytogenes Infection Mediated by Recombinant Listeria innocua Harboring the VGC Locus	PLOS ONE			English	Article							T-CELL RESPONSES; BACTERIAL-INFECTION; ACQUIRED-IMMUNITY; GRANULOMA-FORMATION; GENE-EXPRESSION; MICE; RESISTANCE; INDUCTION; MEMORY; LYMPHOCYTES	In this study we propose a novel bacterial vaccine strategy where non-pathogenic bacteria are complemented with traits desirable for the induction of protective immunity. To illustrate the proof of principle of this novel vaccination strategy, we use the model organism of intracellular immunity Listeria. We introduced a, low copy number BAC-plasmid harbouring the virulence gene cluster (vgc) of L. monocytogenes (Lm) into the non-pathogenic L. innocua (L.inn) strain and examined for its ability to induce protective cellular immunity. The resulting strain (L.inn::vgc) was attenuated for virulence in vivo and showed a strongly reduced host detrimental inflammatory response compared to Lm. Like Lm, L.inn::vgc induced the production of Type I Interferon's and protection was mediated by Listeria-specific CD8(+) T cells. Rational vaccine design whereby avirulent strains are equipped with the capabilities to induce protection but lack detrimental inflammatory effects offer great promise towards future studies using non-pathogenic bacteria as vectors for vaccination.	[Mohamed, Walid; Sethi, Shneh; Tchatalbachev, Svetlin; Darji, Ayub; Chakraborty, Trinad] Univ Giessen, German Ctr Infect Res DZIF, Inst Med Microbiol, Giessen, Germany; [Darji, Ayub] Univ Autonoma Barcelona, Ctr Recerca Sanitat Anim, E-08193 Barcelona, Spain	German Center for Infection Research; Justus Liebig University Giessen; Autonomous University of Barcelona; IRTA	Mohamed, W (corresponding author), Univ Giessen, German Ctr Infect Res DZIF, Inst Med Microbiol, Giessen, Germany.	trinad.chakraborty@mikrobio.med.uni-giessen.de	Sethi, Shneh/F-1796-2013; Tawfik, Walid/F-5109-2013	Tawfik, Walid/0000-0002-1675-4187	Federal Ministry of Education and Research (BMBF)	Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	The work was funded by the Federal Ministry of Education and Research (BMBF) through the ERA-NET Pathogenomics SPATELIS project. This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahjat KS, 2006, INFECT IMMUN, V74, P6387, DOI 10.1128/IAI.01088-06; BARRY RA, 1992, INFECT IMMUN, V60, P1625, DOI 10.1128/IAI.60.4.1625-1632.1992; Bouwer HGA, 2006, P NATL ACAD SCI USA, V103, P5102, DOI 10.1073/pnas.0509381103; Brockstedt DG, 2005, NAT MED, V11, P853, DOI 10.1038/nm1276; Busch DH, 1999, IMMUNOL LETT, V65, P93, DOI 10.1016/S0165-2478(98)00130-8; Casswall TH, 2005, EXPERT REV VACCINES, V4, P725, DOI 10.1586/14760584.4.5.725; Darji A, 2003, VACCINE, V21, pS102, DOI 10.1016/S0264-410X(03)00208-1; Du LY, 2008, DRUG TODAY, V44, P63, DOI 10.1358/dot.2008.44.1.1131830; EHLERS S, 1992, J IMMUNOL, V149, P3016; FARBER JM, 1988, CAN MED ASSOC J, V138, P413; Francis KP, 1997, J IND MICROBIOL BIOT, V19, P286, DOI 10.1038/sj.jim.2900463; Glaser P, 2001, SCIENCE, V294, P849; GOOSSENS PL, 1995, INT IMMUNOL, V7, P797, DOI 10.1093/intimm/7.5.797; GOOSSENS PL, 1992, INT IMMUNOL, V4, P591, DOI 10.1093/intimm/4.5.591; Hain T, 2008, APPL ENVIRON MICROB, V74, P1892, DOI 10.1128/AEM.00415-07; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; KAUFMANN SHE, 1984, INFECT IMMUN, V45, P234, DOI 10.1128/IAI.45.1.234-241.1984; LADEL CH, 1994, J IMMUNOL, V153, P3116; LANE FC, 1972, J EXP MED, V135, P1104, DOI 10.1084/jem.135.5.1104; Lecuit M, 2007, MICROBES INFECT, V9, P1216, DOI 10.1016/j.micinf.2007.05.009; Luthy KE, 2006, J AM ACAD NURSE PRAC, V18, P494, DOI 10.1111/j.1745-7599.2006.00163.x; Manjunath N, 2001, J CLIN INVEST, V108, P871, DOI 10.1172/JCI13296; McCaffrey RL, 2004, P NATL ACAD SCI USA, V101, P11386, DOI 10.1073/pnas.0403215101; Mercado R, 2000, J IMMUNOL, V165, P6833, DOI 10.4049/jimmunol.165.12.6833; MICHEL E, 1990, MOL MICROBIOL, V4, P2167, DOI 10.1111/j.1365-2958.1990.tb00578.x; MIELKE MEA, 1989, J EXP MED, V170, P589, DOI 10.1084/jem.170.2.589; MIELKE MEA, 1988, IMMUNOL LETT, V19, P211, DOI 10.1016/0165-2478(88)90144-7; MIELKE MEA, 1992, INFECT IMMUN, V60, P1875, DOI 10.1128/IAI.60.5.1875-1882.1992; MIYAHIRA Y, 1995, J IMMUNOL METHODS, V181, P45, DOI 10.1016/0022-1759(94)00327-S; NORTH RJ, 1981, J IMMUNOL, V127, P342; NORTH RJ, 1973, CELL IMMUNOL, V7, P166, DOI 10.1016/0008-8749(73)90193-7; PAMER EG, 1991, NATURE, V353, P852, DOI 10.1038/353852a0; Peters C, 2003, FEMS IMMUNOL MED MIC, V35, P243, DOI 10.1016/S0928-8244(02)00469-8; PORTNOY DA, 1992, INFECT IMMUN, V60, P1263, DOI 10.1128/IAI.60.4.1263-1267.1992; ROBERTS AD, 1993, INFECT IMMUN, V61, P1113, DOI 10.1128/IAI.61.3.1113-1116.1993; SAFLEY SA, 1991, J IMMUNOL, V146, P3604; Shata MT, 2000, MOL MED TODAY, V6, P66, DOI 10.1016/S1357-4310(99)01633-0; SHEN H, 1995, P NATL ACAD SCI USA, V92, P3987, DOI 10.1073/pnas.92.9.3987; Tanabe Y, 1999, INFECT IMMUN, V67, P568, DOI 10.1128/IAI.67.2.568-575.1999; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; WIPKE BT, 1993, EUR J IMMUNOL, V23, P2005, DOI 10.1002/eji.1830230842; Zwaferink H, 2008, J IMMUNOL, V180, P4116, DOI 10.4049/jimmunol.180.6.4116	42	7	8	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e35503	10.1371/journal.pone.0035503	http://dx.doi.org/10.1371/journal.pone.0035503			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22536395	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336200048
J	Taniuchi, K; Yokotani, K; Saibara, T				Taniuchi, Keisuke; Yokotani, Kunihiko; Saibara, Toshiji			BART Inhibits Pancreatic Cancer Cell Invasion by PKC alpha Inactivation through Binding to ANX7	PLOS ONE			English	Article							PROTEIN-KINASE-C; TUMOR-SUPPRESSOR GENE; POSTTRANSCRIPTIONAL REGULATION; MIGRATION; PROLIFERATION; ACTIVATION; CLONING; MOUSE; G3BP	A novel function for the binder of Arl two (BART) molecule in pancreatic cancer cells is reported. BART inhibits invasiveness of pancreatic cancer cells through binding to a Ca2+-dependent, phosphorylated, guanosine triphosphatase (GTPase) membrane fusion protein, annexin7 (ANX7). A tumor suppressor function for ANX7 was previously reported based on its prognostic role in human cancers and the cancer-prone mouse phenotype ANX7(+/-). Further investigation demonstrated that the BART-ANX7 complex is transported toward cell protrusions in migrating cells when BART supports the binding of ANX7 to the protein kinase C (PKC) isoform PKC alpha. Recent evidence has suggested that phosphorylation of ANX7 by PKC significantly potentiates ANX7-induced fusion of phospholipid vesicles; however, the current data suggest that the BART-ANX7 complex reduces PKC alpha activity. Knocking down endogenous BART and ANX7 increases activity of PKC alpha, and specific inhibitors of PKC alpha significantly abrogate invasiveness induced by BART and ANX7 knockdown. These results imply that BART contributes to regulating PKC alpha activity through binding to ANX7, thereby affecting the invasiveness of pancreatic cancer cells. Thus, it is possible that BART and ANX7 can distinctly regulate the downstream signaling of PKC alpha that is potentially relevant to cell invasion by acting as anti-invasive molecules.	[Taniuchi, Keisuke; Yokotani, Kunihiko] Kochi Univ, Sch Med, Dept Pharmacol, Nanko Ku, Kochi 780, Japan; [Saibara, Toshiji] Kochi Univ, Dept Gastroenterol & Hepatol, Sch Med, Nanko Ku, Kochi 780, Japan	Kochi University; Kochi University	Taniuchi, K (corresponding author), Kochi Univ, Sch Med, Dept Pharmacol, Nanko Ku, Kochi 780, Japan.	ktaniuchi@kochi-u.ac.jp			Ministry of Health, Labour, and Welfare of Japan	Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by a Grant-in-Aid from the Ministry of Health, Labour, and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrendt SA, 2002, ONCOLOGY-NY, V16, P725; Baumgart M, 2005, CELL ONCOL, V27, P3; CLARK J, 1993, P NATL ACAD SCI USA, V90, P8952, DOI 10.1073/pnas.90.19.8952; Edwards AS, 1997, J BIOL CHEM, V272, P18382, DOI 10.1074/jbc.272.29.18382; Haughian JM, 2009, J CELL PHYSIOL, V220, P112, DOI 10.1002/jcp.21741; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Hung CH, 2001, J BIOL CHEM, V276, P12813, DOI 10.1074/jbc.M008482200; Huttenlocher A, 1998, J CELL BIOL, V141, P515, DOI 10.1083/jcb.141.2.515; IWAMURA T, 1987, JPN J CANCER RES, V78, P54; Jiang XH, 2004, CANCER RES, V64, P5787, DOI 10.1158/0008-5472.CAN-03-1172; Mauro LV, 2010, PANCREAS, V39, pE31, DOI 10.1097/MPA.0b013e3181bce796; Mellor H, 1998, BIOCHEM J, V332, P281, DOI 10.1042/bj3320281; Musashi M, 2000, INT J HEMATOL, V72, P12; NISHIZUKA Y, 1995, FASEB J, V9, P484, DOI 10.1096/fasebj.9.7.7737456; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; Nomura N, 2007, MOL VIS, V13, P2320; Park MJ, 2000, NEUROSCI LETT, V290, P201, DOI 10.1016/S0304-3940(00)01358-6; Ron D, 1999, FASEB J, V13, P1658, DOI 10.1096/fasebj.13.13.1658; Schonwasser DC, 1998, MOL CELL BIOL, V18, P790, DOI 10.1128/MCB.18.2.790; Sharer JD, 1999, J BIOL CHEM, V274, P27553, DOI 10.1074/jbc.274.39.27553; Srivastava M, 2003, P NATL ACAD SCI USA, V100, P14287, DOI 10.1073/pnas.2235927100; Srivastava M, 2001, P NATL ACAD SCI USA, V98, P4575, DOI 10.1073/pnas.071055798; Srivastava M, 1999, P NATL ACAD SCI USA, V96, P13783, DOI 10.1073/pnas.96.24.13783; Taniuchi K, 2011, INT J ONCOL, V39, P1243, DOI 10.3892/ijo.2011.1156; Taniuchi K, 2011, MOL CANCER RES, V9, P856, DOI 10.1158/1541-7786.MCR-10-0574; Taniuchi K, 2011, CANCER RES, V71, P895, DOI 10.1158/0008-5472.CAN-10-2743; Waterman-Storer CM, 2000, MOL BIOL CELL, V11, P2471, DOI 10.1091/mbc.11.7.2471; Wu TT, 2008, J CELL BIOCHEM, V103, P9, DOI 10.1002/jcb.21378; Zhou CJ, 2006, MOL BIOL CELL, V17, P2476, DOI 10.1091/mbc.E05-10-0929	29	14	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e35674	10.1371/journal.pone.0035674	http://dx.doi.org/10.1371/journal.pone.0035674			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22532868	gold, Green Published, Green Submitted			2022-12-27	WOS:000305336200064
J	Eisen, RJ; Borchert, JN; Mpanga, JT; Atiku, LA; MacMillan, K; Boegler, KA; Montenieri, JA; Monaghan, A; Gage, KL				Eisen, Rebecca J.; Borchert, Jeff N.; Mpanga, Joseph T.; Atiku, Linda A.; MacMillan, Katherine; Boegler, Karen A.; Montenieri, John A.; Monaghan, Andrew; Gage, Kenneth L.			Flea Diversity as an Element for Persistence of Plague Bacteria in an East African Plague Focus	PLOS ONE			English	Article							WESTERN USAMBARA MOUNTAINS; EARLY-PHASE TRANSMISSION; SOUTHWESTERN UNITED-STATES; YERSINIA-PESTIS; ENDEMIC REGION; NILE REGION; NEW-MEXICO; CLIMATE; RISK; RODENTS	Plague is a flea-borne rodent-associated zoonotic disease that is caused by Yersinia pestis and characterized by long quiescent periods punctuated by rapidly spreading epidemics and epizootics. How plague bacteria persist during inter-epizootic periods is poorly understood, yet is important for predicting when and where epizootics are likely to occur and for designing interventions aimed at local elimination of the pathogen. Existing hypotheses of how Y. pestis is maintained within plague foci typically center on host abundance or diversity, but little attention has been paid to the importance of flea diversity in enzootic maintenance. Our study compares host and flea abundance and diversity along an elevation gradient that spans from low elevation sites outside of a plague focus in the West Nile region of Uganda (similar to 725-1160 m) to higher elevation sites within the focus (similar to 1380-1630 m). Based on a year of sampling, we showed that host abundance and diversity, as well as total flea abundance on hosts was similar between sites inside compared with outside the plague focus. By contrast, flea diversity was significantly higher inside the focus than outside. Our study highlights the importance of considering flea diversity in models of Y. pestis persistence.	[Eisen, Rebecca J.; Borchert, Jeff N.; MacMillan, Katherine; Boegler, Karen A.; Montenieri, John A.; Gage, Kenneth L.] Ctr Dis Control & Prevent, Div Vector Borne Dis, Ft Collins, CO USA; [Mpanga, Joseph T.; Atiku, Linda A.] Uganda Virus Res Inst, Entebbe, Uganda; [Monaghan, Andrew] Natl Ctr Atmospher Res, Boulder, CO 80307 USA	Centers for Disease Control & Prevention - USA; Uganda Virus Research Institute; National Center Atmospheric Research (NCAR) - USA	Eisen, RJ (corresponding author), Ctr Dis Control & Prevent, Div Vector Borne Dis, Ft Collins, CO USA.	dyn2@cdc.gov	Borchert, Jeff/GSD-7753-2022	Monaghan, Andrew/0000-0002-8170-2359	Centers for Disease Control and Prevention's Climate and Health Program; US Agency for International Development Emerging Pandemic Threats Program	Centers for Disease Control and Prevention's Climate and Health Program; US Agency for International Development Emerging Pandemic Threats Program(United States Agency for International Development (USAID))	This study was funded by the Centers for Disease Control and Prevention's Climate and Health Program and the US Agency for International Development Emerging Pandemic Threats Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amatre G, 2009, AM J TROP MED HYG, V81, P718, DOI 10.4269/ajtmh.2009.09-0104; Anisimov AP, 2004, CLIN MICROBIOL REV, V17, P434, DOI 10.1128/CMR.17.2.434-464.2004; Bacot A W, 1914, J Hyg (Lond), V13, P423; Brown HE, 2010, AM J TROP MED HYG, V82, P95, DOI 10.4269/ajtmh.2010.09-0247; BURROUGHS AL, 1953, PARASITOLOGY, V43, P35, DOI 10.1017/S0031182000018321; CAMPBELL GL, 1995, ANN INTERN MED, V122, P151, DOI 10.7326/0003-4819-122-2-199501150-00014; DAVIS DHS, 1968, T ROY SOC TROP MED H, V62, P838, DOI 10.1016/0035-9203(68)90013-8; Davis S, 2004, SCIENCE, V304, P736, DOI 10.1126/science.1095854; Eisen RJ, 2008, AM J TROP MED HYG, V78, P949, DOI 10.4269/ajtmh.2008.78.949; Eisen RJ, 2007, J MED ENTOMOL, V44, P678, DOI 10.1603/0022-2585(2007)44[678:ETOYPB]2.0.CO;2; Eisen RJ, 2007, AM J TROP MED HYG, V77, P121, DOI 10.4269/ajtmh.2007.77.121; Eisen RJ, 2007, J MED ENTOMOL, V44, P530, DOI 10.1603/0022-2585(2007)44[530:HPITSU]2.0.CO;2; Eisen RJ, 2010, AM J TROP MED HYG, V82, P904, DOI 10.4269/ajtmh.2010.09-0737; Eisen RJ, 2009, VET RES, V40, DOI 10.1051/vetres:2008039; Enscore RE, 2002, AM J TROP MED HYG, V66, P186, DOI 10.4269/ajtmh.2002.66.186; Gage KL, 2008, AM J PREV MED, V35, P436, DOI 10.1016/j.amepre.2008.08.030; Gage KL, 2005, ANNU REV ENTOMOL, V50, P505, DOI 10.1146/annurev.ento.50.071803.130337; Gratz N., 1999, PLAGUE MANUAL EPIDEM, V6, P63; Haselbarth E, 1966, ARTHROPOD PARASITES, P117; Hopkins G. H. E., 1947, Uganda Journal, V11, P133; Hopkins G. H. E., 1966, ILLUSTRATED CATALOGU; Hopkins G.H.E., 1949, REPORT RATS FLEAS PL; ISAACSON M, 1981, J INFECT DIS, V144, P80, DOI 10.1093/infdis/144.1.80; Kausrud KL, 2007, P ROY SOC B-BIOL SCI, V274, P1963, DOI 10.1098/rspb.2007.0568; Kilonzo B.S., 1976, East Afr J med Res, V3, P117; KILONZO BS, 1992, ACTA TROP, V50, P323, DOI 10.1016/0001-706X(92)90067-8; Kilonzo BS, 1977, SIMPLE LIGHT TRAP FI; KRASNOV B. R., 2008, FUNCTIONAL EVOLUTION; Krasnov BR, 2001, J MED ENTOMOL, V38, P629, DOI 10.1603/0022-2585-38.5.629; Laudisoit Anne, 2009, Current Zoology, V55, P200; Link VB, 1955, HIST PLAGUE US; Liu Y., 2000, ATLAS PLAGUE ITS ENV; MacMillan K, 2012, AM J TROP MED HYG, V86, P514, DOI 10.4269/ajtmh.2012.11-0569; Monaghan AJ, 2012, J APPL METE IN PRESS; Msangi A.S., 1975, University Sci J Dar-es-Salaam, V1, P8; Nakazawa Y, 2007, VECTOR-BORNE ZOONOT, V7, P529, DOI 10.1089/vbz.2007.0125; Neerinckx S, 2010, AM J TROP MED HYG, V82, P492, DOI 10.4269/ajtmh.2010.09-0426; Neerinckx S, 2010, VECTOR-BORNE ZOONOT, V10, P101; Neerinckx SB, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-54; NJUNWA KJ, 1989, MED VET ENTOMOL, V3, P17, DOI 10.1111/j.1365-2915.1989.tb00469.x; Perry RD, 1997, CLIN MICROBIOL REV, V10, P35, DOI 10.1128/CMR.10.1.35; POLLITZER B., 1954, Plague; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Skamarock WC, 2008, J COMPUT PHYS, V227, P3465, DOI 10.1016/j.jcp.2007.01.037; Smit F.G.A.M., 1973, P325; Stenseth NC, 2006, P NATL ACAD SCI USA, V103, P13110, DOI 10.1073/pnas.0602447103; Tikhomirov E., 1999, PLAGUE MANUAL EPIDEM, P11; TURNER R. W., 1974, Bull. Hlth. Stud. Indonesia, V2, P15; VELIMIROVIC B, 1969, Z TROPENMED PARASIT, V20, P373; Vetter SM, 2010, MICROBIOL-SGM, V156, P2216, DOI 10.1099/mic.0.037952-0; Winters AM, 2009, AM J TROP MED HYG, V80, P1014, DOI 10.4269/ajtmh.2009.80.1014	51	31	35	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35598	10.1371/journal.pone.0035598	http://dx.doi.org/10.1371/journal.pone.0035598			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22530057	Green Submitted, Green Published, gold			2022-12-27	WOS:000305350600103
J	Li, QR; Wang, CY; Tang, C; Li, N; Li, JS				Li, Qiurong; Wang, Chenyang; Tang, Chun; Li, Ning; Li, Jieshou			Molecular-Phylogenetic Characterization of the Microbiota in Ulcerated and Non-Ulcerated Regions in the Patients with Crohn's Disease	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; INVASIVE ESCHERICHIA-COLI; FECAL MICROBIOTA; ILEAL MUCOSA; MICROFLORA; FLORA; SUSCEPTIBILITY; PREVALENCE; BACTERIA; EPIDEMIOLOGY	Background: The dysbiosis of intestinal microbiota has been established in Crohn's disease (CD), but the molecular characterization of this dysbiosis in Chinese subjects with CD remains unclear. This study aims to investigate the predominant bacterial composition of the faecal and mucosal-associated microbiota in Chinese CD patients using culture-independent techniques. Methods/Principal Findings: Eighteen patients with CD and 9 healthy controls were included in this study. The faeces and the intestinal mucosal tissues from the ulcerated and nonulcerated sites were subjected to bacterial community fingerprinting using denaturing gradient gel electrophoresis (DGGE). The predominant bacterial composition in the faeces and mucosa was determined with DNA sequencing and BLAST. We showed that the bacterial diversity in the faeces of CD patients was reduced compared with that in healthy controls (p<0.01). The faecal bacterial dysbiosis of the patients was characterized by an elevated abundance of gamma-Proteobacteria (especially Escherichia coli and Shigella flexneri) and a reduced proportion of Bacteroidetes and Firmicutes. Five bacterial species defined the microbiota imbalance of the ulcerated mucosa in CD, including an increase in Escherichia coli, a decrease in Faecalibacterium prausnitzii, Lactobacillus coleohominis, Bacteroides sp and Streptococcus gallolyticus in the bacterial community as compared with the nonulcerated (p<0.01). Conclusions/Significance: This is the first description of intestinal microbiota dysbiosis in Chinese CD patients. These results allow a better understanding of the faecal and mucosal microbiota in CD, showing a predominance of some opportunistic pathogenic bacteria and a decrease in beneficial bacterial species. The findings may provide novel insights into the pathogenesis of CD in Chinese population.	[Li, Qiurong; Wang, Chenyang; Tang, Chun; Li, Ning; Li, Jieshou] Jinling Hosp, Res Inst Gen Surg, Nanjing, Jiangsu, Peoples R China; [Li, Qiurong; Wang, Chenyang; Li, Ning; Li, Jieshou] Nanjing Univ, Sch Med, Dept Surg, Nanjing, Jiangsu, Peoples R China	Nanjing University	Li, QR (corresponding author), Jinling Hosp, Res Inst Gen Surg, Nanjing, Jiangsu, Peoples R China.	liqiurong@yahoo.com	Li, jie/GXG-4583-2022		National Natural Science Foundation in China [81070375]; Key Project of National Natural Science Foundation in China [30830098]; National High-tech R&D Program (863 Program) of China [2012AA021007]; National Basic Research Program (973 Program) in China [2009CB522405]; Scientific Research Fund in Jiangsu Province [BK2009317]; Deutscher Akademischer Austauschdienst Researcher Fellowship (Bioscience Special Program, Germany)	National Natural Science Foundation in China(National Natural Science Foundation of China (NSFC)); Key Project of National Natural Science Foundation in China(National Natural Science Foundation of China (NSFC)); National High-tech R&D Program (863 Program) of China(National High Technology Research and Development Program of China); National Basic Research Program (973 Program) in China(National Basic Research Program of China); Scientific Research Fund in Jiangsu Province; Deutscher Akademischer Austauschdienst Researcher Fellowship (Bioscience Special Program, Germany)(Deutscher Akademischer Austausch Dienst (DAAD))	This work was supported by the National Natural Science Foundation in China (81070375), Key Project of National Natural Science Foundation in China (30830098), National High-tech R&D Program (863 Program) of China (2012AA021007), National Basic Research Program (973 Program) in China (No. 2009CB522405) and Scientific Research Fund in Jiangsu Province (BK2009317). The funders of the study had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Deutscher Akademischer Austauschdienst Researcher Fellowship (Bioscience Special Program, Germany) for Dr. Qiurong Li.	Andoh A, 2009, ALIMENT PHARM THER, V29, P75, DOI 10.1111/j.1365-2036.2008.03860.x; BENNO Y, 1989, APPL ENVIRON MICROB, V55, P1100, DOI 10.1128/AEM.55.5.1100-1105.1989; Bercik P, 2011, GASTROENTEROLOGY, V141, P599, DOI 10.1053/j.gastro.2011.04.052; BEST WR, 1976, GASTROENTEROLOGY, V70, P439; Bibiloni R, 2006, J MED MICROBIOL, V55, P1141, DOI 10.1099/jmm.0.46498-0; Cho JH, 1998, P NATL ACAD SCI USA, V95, P7502, DOI 10.1073/pnas.95.13.7502; D'Haens GR, 1998, GASTROENTEROLOGY, V114, P262, DOI 10.1016/S0016-5085(98)70476-7; Darfeuille-Michaud A, 1998, GASTROENTEROLOGY, V115, P1405, DOI 10.1016/S0016-5085(98)70019-8; Darfeuille-Michaud A, 2004, GASTROENTEROLOGY, V127, P412, DOI 10.1053/j.gastro.2004.04.061; Darfeuille-Michaud A, 2002, INT J MED MICROBIOL, V292, P185, DOI 10.1078/1438-4221-00201; Dicksved J, 2007, APPL ENVIRON MICROB, V73, P2284, DOI 10.1128/AEM.02223-06; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; El-Tawil AM, 2004, INT J COLORECTAL DIS, V19, P498, DOI 10.1007/s00384-004-0605-5; Elson CO, 2002, NEW ENGL J MED, V346, P614, DOI 10.1056/NEJM200202213460812; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; GIAFFER MH, 1991, J MED MICROBIOL, V35, P238, DOI 10.1099/00222615-35-4-238; Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; Hugot JP, 2003, LANCET, V362, P2012, DOI 10.1016/S0140-6736(03)15024-6; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Kleessen B, 2002, SCAND J GASTROENTERO, V37, P1034, DOI 10.1080/003655202320378220; Lay C, 2005, APPL ENVIRON MICROB, V71, P4153, DOI 10.1128/AEM.71.7.4153-4155.2005; LENNARDJONES JE, 1989, SCAND J GASTROENTERO, V24, P2, DOI 10.3109/00365528909091339; Leong RWL, 2004, INFLAMM BOWEL DIS, V10, P646, DOI 10.1097/00054725-200409000-00022; Li QR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020460; Loftus EV, 2004, GASTROENTEROLOGY, V126, P1504, DOI 10.1053/j.gastro.2004.01.063; Mai V, 2004, J NUTR, V134, P473, DOI 10.1093/jn/134.2.473; Mai V, 2009, NUTR J, V8, DOI 10.1186/1475-2891-8-49; Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817; Marteau P, 2004, ALIMENT PHARM THER, V20, P18, DOI 10.1111/j.1365-2036.2004.02062.x; Martin HM, 2004, GASTROENTEROLOGY, V127, P80, DOI 10.1053/j.gastro.2004.03.054; Martinez-Medina M, 2006, INFLAMM BOWEL DIS, V12, P1136, DOI 10.1097/01.mib.0000235828.09305.0c; Ng SC, 2012, INFLAMM BOWEL DIS, V18, P1164, DOI 10.1002/ibd.21845; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Ott SJ, 2004, GUT, V53, P685, DOI 10.1136/gut.2003.025403; RUSELERVANEMBDEN JGH, 1983, A VAN LEEUW J MICROB, V49, P125, DOI 10.1007/BF00393670; RUTGEERTS P, 1991, LANCET, V338, P771, DOI 10.1016/0140-6736(91)90663-A; Sartor RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/j.gastro.2007.11.059; Sartor RB, 1997, INFLAMM BOWEL DIS, V3, P230, DOI 10.1002/ibd.3780030309; Sasaki M, 2007, LAB INVEST, V87, P1042, DOI 10.1038/labinvest.3700661; Seksik P, 2006, ALIMENT PHARM THER, V24, P11, DOI 10.1111/j.1365-2036.2006.03053.x; Seksik P, 2003, GUT, V52, P237, DOI 10.1136/gut.52.2.237; Shanon CE, 1963, MATH THEORY COMMUNIC; Sokol H, 2006, INFLAMM BOWEL DIS, V12, P106, DOI 10.1097/01.MIB.0000200323.38139.c6; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Swidsinski A, 2002, GASTROENTEROLOGY, V122, P44, DOI 10.1053/gast.2002.30294; Vanhoutte T, 2006, APPL ENVIRON MICROB, V72, P5990, DOI 10.1128/AEM.00233-06; Zheng JJ, 2010, J DIGEST DIS, V11, P161, DOI 10.1111/j.1751-2980.2010.00431.x; Zoetendal EG, 2002, APPL ENVIRON MICROB, V68, P3401, DOI 10.1128/AEM.68.7.3401-3407.2002	50	40	44	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e34939	10.1371/journal.pone.0034939	http://dx.doi.org/10.1371/journal.pone.0034939			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529960	Green Published, Green Submitted, gold			2022-12-27	WOS:000305350600045
J	Bao, H; Duong, F				Bao, Huan; Duong, Franck			Discovery of an Auto-Regulation Mechanism for the Maltose ABC Transporter MalFGK(2)	PLOS ONE			English	Article							BINDING CASSETTE TRANSPORTER; ESCHERICHIA-COLI; LIGAND-BINDING; MATHEMATICAL TREATMENT; CYTOPLASMIC MEMBRANE; CRYSTAL-STRUCTURE; ACTIVE-TRANSPORT; TRANSITION-STATE; ATP HYDROLYSIS; DOMINANT ROLE	The maltose transporter MalFGK(2), together with the substrate-binding protein MalE, is one of the best-characterized ABC transporters. In the conventional model, MalE captures maltose in the periplasm and delivers the sugar to the transporter. Here, using nanodiscs and proteoliposomes, we instead find that MalE is bound with high-affinity to MalFGK2 to facilitate the acquisition of the sugar. When the maltose concentration exceeds the transport capacity, MalE captures maltose and dissociates from the transporter. This mechanism explains why the transport rate is high when MalE has low affinity for maltose, and low when MalE has high affinity for maltose. Transporter-bound MalE facilitates the acquisition of the sugar at low concentrations, but also captures and dissociates from the transporter past a threshold maltose concentration. In vivo, this maltose-forced dissociation limits the rate of transport. Given the conservation of the substrate-binding proteins, this mode of allosteric regulation may be universal to ABC importers.	[Bao, Huan; Duong, Franck] Univ British Columbia, Fac Med, Dept Biochem & Mol Biol, Fac Med,Life Sci Inst, Vancouver, BC, Canada	University of British Columbia	Bao, H (corresponding author), Univ British Columbia, Fac Med, Dept Biochem & Mol Biol, Fac Med,Life Sci Inst, Vancouver, BC, Canada.	FDuong@mail.ubc.ca	Bao, Huan/K-8531-2012	Bao, Huan/0000-0002-8135-6492; Bao, Huan/0000-0002-4301-4627; Duong Van Hoa, Franck/0000-0001-7328-6124	Natural Sciences and Engineering Research Council of Canada (NSERC) [312067-10]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by grant 312067-10 from the Natural Sciences and Engineering Research Council of Canada to FD (NSERC, www.nserc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ames GFL, 1996, J BIOL CHEM, V271, P14264, DOI 10.1074/jbc.271.24.14264; Austermuhle MI, 2004, J BIOL CHEM, V279, P28243, DOI 10.1074/jbc.M403508200; Bayburt TH, 2010, FEBS LETT, V584, P1721, DOI 10.1016/j.febslet.2009.10.024; BOHL E, 1995, J THEOR BIOL, V172, P83, DOI 10.1006/jtbi.1995.0006; Bordignon E, 2010, MOL MICROBIOL, V77, P1354, DOI 10.1111/j.1365-2958.2010.07319.x; BRASS JM, 1986, J BACTERIOL, V165, P787, DOI 10.1128/jb.165.3.787-795.1986; Chen J, 2001, P NATL ACAD SCI USA, V98, P1525, DOI 10.1073/pnas.041542498; Dalal K, 2010, METHODS MOL BIOL, V619, P145, DOI 10.1007/978-1-60327-412-8_9; Dalal K, 2009, J BIOL CHEM, V284, P7897, DOI 10.1074/jbc.M808305200; Daus ML, 2009, J BACTERIOL, V191, P754, DOI 10.1128/JB.01439-08; Davdison AL, 1990, J BIOL CHEM, V265, P4254; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; Davidson AL, 2007, TRENDS MICROBIOL, V15, P448, DOI 10.1016/j.tim.2007.09.005; DEAN DA, 1989, P NATL ACAD SCI USA, V86, P9134, DOI 10.1073/pnas.86.23.9134; Denisov IG, 2004, J AM CHEM SOC, V126, P3477, DOI 10.1021/ja0393574; DIETZEL I, 1978, ARCH MICROBIOL, V118, P207, DOI 10.1007/BF00415731; DOUVILLE K, 1995, J BIOL CHEM, V270, P20106, DOI 10.1074/jbc.270.34.20106; Duan XQ, 2002, BIOCHEMISTRY-US, V41, P706, DOI 10.1021/bi015784n; Frank GA, 2008, BIOCONJUGATE CHEM, V19, P1339, DOI 10.1021/bc800118j; George AM, 2011, STRUCTURE, V19, P1540, DOI 10.1016/j.str.2011.10.007; Gould AD, 2009, BIOCHEMISTRY-US, V48, P8051, DOI 10.1021/bi9007066; Grote M, 2009, J BIOL CHEM, V284, P17521, DOI 10.1074/jbc.M109.006270; Hall JA, 1997, J BIOL CHEM, V272, P17605, DOI 10.1074/jbc.272.28.17605; Holland IB, 2011, ESSAYS BIOCHEM, V50, P1, DOI [10.1042/BSE0500001, 10.1042/bse0500001]; Hollenstein K, 2007, CURR OPIN STRUC BIOL, V17, P412, DOI 10.1016/j.sbi.2007.07.003; Khare D, 2009, MOL CELL, V33, P528, DOI 10.1016/j.molcel.2009.01.035; Landmesser H, 2002, BBA-BIOMEMBRANES, V1565, P64, DOI 10.1016/S0005-2736(02)00506-0; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Ledvina PS, 1998, PROTEIN SCI, V7, P2550, DOI 10.1002/pro.5560071208; Lewinson O, 2010, NAT STRUCT MOL BIOL, V17, P332, DOI 10.1038/nsmb.1770; MANSON MD, 1985, J BIOL CHEM, V260, P9727; Marme N, 2003, BIOCONJUGATE CHEM, V14, P1133, DOI 10.1021/bc0341324; Marvin JS, 2001, NAT STRUCT BIOL, V8, P795, DOI 10.1038/nsb0901-795; MERINO G, 1995, J THEOR BIOL, V177, P171, DOI 10.1006/jtbi.1995.0236; Merino G, 1997, J BACTERIOL, V179, P7687, DOI 10.1128/jb.179.24.7687-7694.1997; MILLER DM, 1983, J BIOL CHEM, V258, P3665; Millet O, 2003, P NATL ACAD SCI USA, V100, P12700, DOI 10.1073/pnas.2134311100; Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264; Oldham ML, 2011, SCIENCE, V332, P1202, DOI 10.1126/science.1200767; Oldham ML, 2008, CURR OPIN STRUC BIOL, V18, P726, DOI 10.1016/j.sbi.2008.09.007; Oliveira ASF, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002128; Orelle C, 2008, P NATL ACAD SCI USA, V105, P12837, DOI 10.1073/pnas.0803799105; Reich-Slotky R, 2000, J BACTERIOL, V182, P993, DOI 10.1128/JB.182.4.993-1000.2000; Rizk SS, 2011, NAT STRUCT MOL BIOL, V18, P437, DOI 10.1038/nsmb.2002; Seeger MA, 2009, BBA-PROTEINS PROTEOM, V1794, P725, DOI 10.1016/j.bbapap.2008.12.004; SHARFF AJ, 1992, BIOCHEMISTRY-US, V31, P10657, DOI 10.1021/bi00159a003; SHUMAN HA, 1982, J BIOL CHEM, V257, P5455; SILHAVY TJ, 1975, P NATL ACAD SCI USA, V72, P2120, DOI 10.1073/pnas.72.6.2120; Telmer PG, 2003, J BIOL CHEM, V278, P34555, DOI 10.1074/jbc.M301004200; Tirado-Lee L, 2011, STRUCTURE, V19, P1701, DOI 10.1016/j.str.2011.10.004; TREPTOW NA, 1985, J BACTERIOL, V163, P654, DOI 10.1128/JB.163.2.654-660.1985; WANDERSMAN C, 1979, J BACTERIOL, V140, P1	52	33	33	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e34836	10.1371/journal.pone.0034836	http://dx.doi.org/10.1371/journal.pone.0034836			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22529943	Green Submitted, gold, Green Published			2022-12-27	WOS:000305347400021
J	Hamfjord, J; Stangeland, AM; Hughes, T; Skrede, ML; Tveit, KM; Ikdahl, T; Kure, EH				Hamfjord, Julian; Stangeland, Astrid M.; Hughes, Timothy; Skrede, Martina L.; Tveit, Kjell M.; Ikdahl, Tone; Kure, Elin H.			Differential Expression of miRNAs in Colorectal Cancer: Comparison of Paired Tumor Tissue and Adjacent Normal Mucosa Using High-Throughput Sequencing	PLOS ONE			English	Article							DIGITAL GENE-EXPRESSION; CLINICOPATHOLOGICAL FEATURES; TARGETING TAGLN2; MICRORNAS; PROFILES; GROWTH; MICROARRAYS; THERAPY; PATHWAY; AND-145	We present the results of a global study of dysregulated miRNAs in paired samples of normal mucosa and tumor from eight patients with colorectal cancer. Although there is existing data of miRNA contribution to colorectal tumorigenesis, these studies are typically small to medium scale studies of cell lines or non-paired tumor samples. The present study is to our knowledge unique in two respects. Firstly, the normal and adjacent tumor tissue samples are paired, thus taking into account the baseline differences between individuals when testing for differential expression. Secondly, we use high-throughput sequencing, thus enabling a comprehensive survey of all miRNAs expressed in the tissues. We use Illumina sequencing technology to perform sequencing and two different tools to statistically test for differences in read counts per gene between samples: edgeR when using the pair information and DESeq when ignoring this information, i.e., treating tumor and normal samples as independent groups. We identify 37 miRNAs that are significantly dysregulated in both statistical approaches, 19 down-regulated and 18 up-regulated. Some of these miRNAs are previously published as potential regulators in colorectal adenocarcinomas such as miR-1, miR-96 and miR-145. Our comprehensive survey of differentially expressed miRNAs thus confirms some existing findings. We have also discovered 16 dysregulated miRNAs, which to our knowledge have not previously been associated with colorectal carcinogenesis: the following significantly down-regulated miR-490-3p, -628-3p/-5p, -1297, -3151, -3163, -3622a-5p, 3656 and the up-regulated miR-105, -549, -1269, -1827, -3144-3p, -3177, -3180-3p, -4326. Although the study is preliminary with only eight patients included, we believe the results add to the present knowledge on miRNA dysregulation in colorectal carcinogenesis. As such the results would serve as a robust training set for validation of potential biomarkers in a larger cohort study. Finally, we also present data supporting the hypothesis that there are differences in miRNA expression between adenocarcinomas and neuroendocrine tumors of the colon.	[Hamfjord, Julian; Stangeland, Astrid M.; Skrede, Martina L.; Kure, Elin H.] Oslo Univ Hosp, Inst Canc Res, Dept Genet, Oslo, Norway; [Hughes, Timothy] Oslo Univ Hosp, Dept Med Genet, Oslo, Norway; [Hamfjord, Julian; Skrede, Martina L.; Tveit, Kjell M.; Ikdahl, Tone; Kure, Elin H.] Oslo Univ Hosp, Dept Oncol, Oslo, Norway; [Stangeland, Astrid M.; Kure, Elin H.] Oslo Univ Hosp, Dept Pathol, Oslo, Norway; [Hamfjord, Julian; Tveit, Kjell M.] Univ Oslo, Fac Med, Oslo, Norway; [Kure, Elin H.] Telemark Univ Coll, Fac Arts & Sci, Dept Environm & Hlth Studies, Bo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo; University College of Southeast Norway	Hamfjord, J (corresponding author), Oslo Univ Hosp, Inst Canc Res, Dept Genet, Oslo, Norway.	elin.kure@rr-research.no		Hughes, Thomas/0000-0001-5880-9951	"Ivar, Ragna og Morten Holes legat til fremme av kreftforskningen i Norge" (Ivar, Ragna and Morten Holes' Foundation to serve cancer research in Norway); Research Council of Norway; Southeastern Regional Health Authorities	"Ivar, Ragna og Morten Holes legat til fremme av kreftforskningen i Norge" (Ivar, Ragna and Morten Holes' Foundation to serve cancer research in Norway); Research Council of Norway(Research Council of Norway); Southeastern Regional Health Authorities	External funding received from "Ivar, Ragna og Morten Holes legat til fremme av kreftforskningen i Norge" (Ivar, Ragna and Morten Holes' Foundation to serve cancer research in Norway). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The sequencing service was provided by the Norwegian High-Throughput Sequencing Centre, a national technology platform supported by the "Functional Genomics" and "Infrastructure" programs of the Research Council of Norway and the Southeastern Regional Health Authorities.	Akao Y, 2010, CANCER GENE THER, V17, P398, DOI 10.1038/cgt.2009.88; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Asghar U, 2010, CLIN COLORECTAL CANC, V9, P274, DOI 10.3816/CCC.2010.n.040; Bandres E, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-29; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boyerinas B, 2010, ENDOCR-RELAT CANCER, V17, pF19, DOI 10.1677/ERC-09-0184; Caldarella A, 2011, PATHOL ONCOL RES; Cho WCS, 2010, INT J BIOCHEM CELL B, V42, P1273, DOI 10.1016/j.biocel.2009.12.014; Cho WCS, 2010, BBA-REV CANCER, V1805, P209, DOI 10.1016/j.bbcan.2009.11.003; Chou YT, 2010, CANCER RES, V70, P8822, DOI 10.1158/0008-5472.CAN-10-0638; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Di Pietro M, 2005, GASTROENTEROLOGY, V129, P1047, DOI 10.1053/j.gastro.2005.06.028; Farazi TA, 2011, J PATHOL, V223, P102, DOI 10.1002/path.2806; Feng M, 2011, ONCOGENE, V30, P2242, DOI 10.1038/onc.2010.602; Ferlay J, 2008, IARC CANCERBASE; Galamb O, 2010, BRIT J CANCER, V102, P765, DOI 10.1038/sj.bjc.6605515; Gaur A, 2007, CANCER RES, V67, P2456, DOI 10.1158/0008-5472.CAN-06-2698; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Guo JM, 2009, J GASTROEN HEPATOL, V24, P652, DOI 10.1111/j.1440-1746.2008.05666.x; Hackenberg M, 2009, NUCLEIC ACIDS RES, V37, pW68, DOI 10.1093/nar/gkp347; Hao J, 2011, FEBS LETT, V585, P207, DOI 10.1016/j.febslet.2010.11.039; Hiroki E, 2010, CANCER SCI, V101, P241, DOI 10.1111/j.1349-7006.2009.01385.x; Hua Z, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000116; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; La Rocca G, 2009, J CELL PHYSIOL, V220, P485, DOI 10.1002/jcp.21796; Lee DY, 2007, P NATL ACAD SCI USA, V104, P20350, DOI 10.1073/pnas.0706901104; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Linsen SEV, 2009, NAT METHODS, V6, P474, DOI 10.1038/nmeth0709-474; Liu L, 2010, BIOCHEM BIOPH RES CO, V400, P236, DOI 10.1016/j.bbrc.2010.08.046; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Luo HC, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-82; Malone JH, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-34; Matsuzaki S, 2009, ANN SURG ONCOL, V16, P2042, DOI 10.1245/s10434-009-0469-6; MELO SA, 2010, FEBS LETT; Michael MZ, 2003, MOL CANCER RES, V1, P882; Motoyama K, 2009, INT J ONCOL, V34, P1069, DOI 10.3892/ijo_00000233; Nagel R, 2008, CANCER RES, V68, P5795, DOI 10.1158/0008-5472.CAN-08-0951; Navon R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008003; Nguyen HTT, 2010, J BIOL CHEM, V285, P1479, DOI 10.1074/jbc.M109.057141; Nohata N, 2011, ONCOTARGET, V2, P29; Pradervand S, 2010, BIOTECHNIQUES, V48, P219, DOI 10.2144/000113367; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roukos DH, 2010, EXPERT REV MOL DIAGN, V10, P33, DOI 10.1586/ERM.09.69; Sabates-Beliver J, 2007, MOL CANCER RES, V5, P1263, DOI 10.1158/1541-7786.MCR-07-0267; Sarver AL, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-401; Saydam O, 2011, CANCER RES, V71, P852, DOI 10.1158/0008-5472.CAN-10-1219; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Shi B, 2007, J BIOL CHEM, V282, P32582, DOI 10.1074/jbc.M702806200; Slaby O, 2007, ONCOLOGY-BASEL, V72, P397, DOI 10.1159/000113489; Slaby O, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-102; Stark MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009685; Tazawa H, 2011, EXPERT OPIN BIOL TH, V11, P145, DOI 10.1517/14712598.2011.542749; Veronese A, 2010, CANCER RES, V70, P3140, DOI 10.1158/0008-5472.CAN-09-4456; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang CJ, 2009, DIS MARKERS, V26, P27, DOI [10.3233/DMA-2009-0601, 10.1155/2009/921907]; Wang X., 2011, MED ONCOL; Wang YX, 2010, J DIGEST DIS, V11, P50, DOI 10.1111/j.1751-2980.2009.00413.x; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Yan HL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020628; Yoon A, 2011, NUCLEIC ACIDS RES, V39, P8078, DOI 10.1093/nar/gkr492; Yoshino H, 2011, BRIT J CANCER, V104, P808, DOI 10.1038/bjc.2011.23	63	126	129	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e34150	10.1371/journal.pone.0034150	http://dx.doi.org/10.1371/journal.pone.0034150			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22529906	gold, Green Published, Green Submitted			2022-12-27	WOS:000305347400007
J	Lichtenfels, R; Rappl, G; Hombach, AA; Recktenwald, CV; Dressler, SP; Abken, H; Seliger, B				Lichtenfels, Rudolf; Rappl, Gunter; Hombach, Andreas A.; Recktenwald, Christian V.; Dressler, Sven P.; Abken, Hinrich; Seliger, Barbara			A Proteomic View at T Cell Costimulation	PLOS ONE			English	Article							GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; CD28 COSTIMULATION; B7/CD28 COSTIMULATION; MASS-SPECTROMETRY; PROTEIN; ACTIVATION; IDENTIFICATION; MICROTUBULES; EXPRESSION; BLOCKADE	The "two-signal paradigm" in T cell activation predicts that the cooperation of "signal 1," provided by the T cell receptor (TCR) through engagement of major histocompatility complex (MHC)-presented peptide, with "signal 2" provided by costimulatory molecules, the prototype of which is CD28, is required to induce T cell effector functions. While the individual signalling pathways are well understood, little is known about global changes in the proteome pattern during TCR/CD28-mediated activation. Therefore, comparative 2-DE-based proteome analyses of CD3(+) CD69(-) resting T cells versus cells incubated with (i) the agonistic anti-CD3 antibody OKT3 mimicking signal 1 in absence or presence of IL-2 and/or with (ii) the agonistic antibody 15E8 triggering CD28-mediated signaling were performed. Differentially regulated spots were defined leading to the identification of proteins involved in the regulation of the metabolism, shaping and maintenance of the cytoskeleton and signal transduction. Representative members of the differentially expressed protein families, such as calmodulin (CALM), glyceraldehyde-3-phosphate dehydrogenase (GAPDH), L-lactate dehydrogenase (LDH), Rho GDP-dissociation inhibitor 2 (GDIR2), and platelet basic protein (CXCL7), were independently verified by flow cytometry. Data provide a detailed map of individual protein alterations at the global proteome level in response to TCR/CD28-mediated T cell activation.	[Lichtenfels, Rudolf; Recktenwald, Christian V.; Dressler, Sven P.; Seliger, Barbara] Univ Halle Wittenberg, Inst Med Immunol, Halle, Germany; [Rappl, Gunter; Hombach, Andreas A.; Abken, Hinrich] Univ Cologne, Clin Internal Med 1, CMMC, D-50931 Cologne, Germany; [Rappl, Gunter; Hombach, Andreas A.; Abken, Hinrich] Univ Cologne, Clin Internal Med 1, Tumor Genet Sect, D-50931 Cologne, Germany	Martin Luther University Halle Wittenberg; University of Cologne; University of Cologne	Lichtenfels, R (corresponding author), Univ Halle Wittenberg, Inst Med Immunol, Halle, Germany.	Barbara.Seliger@medizin.uni-halle.de		Seliger, Barbara/0000-0002-5544-4958; Recktenwald, Christian Viktor/0000-0003-1710-1863; Hombach, Andreas/0000-0001-9328-8442	Dr. Mildred Scheel Foundation [107967]; intramural Wilhelm-Roux-Program [18/05]	Dr. Mildred Scheel Foundation(Deutsche Krebshilfe); intramural Wilhelm-Roux-Program	The work presented in this report was in part supported by the Dr. Mildred Scheel Foundation, grant 107967 (B.S.) and the intramural Wilhelm-Roux-Program, grant 18/05 (B.S.). The funders had no role in the study design, the data collection and analysis, decision to publish and preparation of the manuscript.	Bhatia S, 2010, J IMMUNOL, V184, P1821, DOI 10.4049/jimmunol.0902869; Bini L, 2003, BIOCHEM J, V369, P301, DOI 10.1042/BJ20020503; Boesteanu AC, 2009, SEMIN IMMUNOL, V21, P69, DOI 10.1016/j.smim.2009.02.005; Boise LH, 2010, J IMMUNOL, V185, P3788; Borowski AB, 2007, J IMMUNOL, V179, P6494, DOI 10.4049/jimmunol.179.10.6494; Bour-Jordan H, 2009, IMMUNOL REV, V229, P41, DOI 10.1111/j.1600-065X.2009.00775.x; Brockmeyer C, 2011, J BIOL CHEM, V286, P7535, DOI 10.1074/jbc.M110.201236; Carujo S, 2006, ONCOGENE, V25, P4033, DOI 10.1038/sj.onc.1209433; Chmielewski M, 2011, GENE THER, V18, P62, DOI 10.1038/gt.2010.127; Croci S, 2010, PROTEOMICS, V10, P3835, DOI 10.1002/pmic.200900643; de Wet B, 2011, J BIOL CHEM, V286, P4072, DOI 10.1074/jbc.M110.165415; DURRIEU C, 1987, ARCH BIOCHEM BIOPHYS, V252, P32, DOI 10.1016/0003-9861(87)90005-1; Duttagupta PA, 2009, CRIT REV IMMUNOL, V29, P469, DOI 10.1615/CritRevImmunol.v29.i6.20; Fathman CG, 2007, NAT REV IMMUNOL, V7, P599, DOI 10.1038/nri2131; Ford ML, 2009, IMMUNOL REV, V229, P294, DOI 10.1111/j.1600-065X.2009.00776.x; Fuse S, 2008, J IMMUNOL, V180, P1148, DOI 10.4049/jimmunol.180.2.1148; Fuse S, 2011, CELL IMMUNOL, V266, P130, DOI 10.1016/j.cellimm.2010.09.008; Garcon F, 2008, BLOOD, V111, P1464, DOI 10.1182/blood-2007-08-108050; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Heller M, 2000, ELECTROPHORESIS, V21, P2180, DOI 10.1002/1522-2683(20000601)21:11<2180::AID-ELPS2180>3.0.CO;2-#; Hombach AA, 2007, J IMMUNOL, V179, P7924, DOI 10.4049/jimmunol.179.11.7924; Iida N, 1996, FASEB J, V10, P1336, DOI 10.1096/fasebj.10.11.8836048; Iwai LK, 2010, J PROTEOME RES, V9, P3135, DOI 10.1021/pr100035b; JENKINS MK, 1990, J IMMUNOL, V144, P16; Jindra PT, 2010, J IMMUNOL, V185, P990, DOI 10.4049/jimmunol.1000793; Kobayashi M, 2007, ELECTROPHORESIS, V28, P2035, DOI 10.1002/elps.200600675; Kronfeld K, 2005, MOL CELL PROTEOMICS, V4, P1876, DOI 10.1074/mcp.M500194-MCP200; KUMAGAI H, 1983, J BIOCHEM-TOKYO, V93, P1259, DOI 10.1093/oxfordjournals.jbchem.a134260; LAFFERTY KJ, 1983, ANNU REV IMMUNOL, V1, P143, DOI 10.1146/annurev.iy.01.040183.001043; Lange S, 2010, J PROTEOME RES, V9, P4113, DOI 10.1021/pr1003054; Lichtenfels R, 2009, MOL CELL PROTEOMICS, V8, P2827, DOI 10.1074/mcp.M900168-MCP200; Lin SL, 2010, J PROTEOME RES, V9, P283, DOI 10.1021/pr9006156; Linsley PS, 2009, IMMUNOL REV, V229, P307, DOI 10.1111/j.1600-065X.2009.00780.x; Mayya V, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000007; Michalek RD, 2007, J IMMUNOL, V179, P6456, DOI 10.4049/jimmunol.179.10.6456; Nguyen V, 2009, MOL CELL PROTEOMICS, V8, P2418, DOI 10.1074/mcp.M800307-MCP200; Nguyen VH, 2008, BLOOD, V111, P945, DOI 10.1182/blood-2007-07-103895; Nyman TA, 2001, ELECTROPHORESIS, V22, P4375, DOI 10.1002/1522-2683(200112)22:20<4375::AID-ELPS4375>3.0.CO;2-P; Park J, 2009, BBA-PROTEINS PROTEOM, V1794, P254, DOI 10.1016/j.bbapap.2008.10.003; Paterson AM, 2009, CELL, V137, P974, DOI 10.1016/j.cell.2009.05.015; Patterson RL, 2005, P NATL ACAD SCI USA, V102, P1357, DOI 10.1073/pnas.0409657102; Poirier N, 2011, TRANSPL INT, V24, P2, DOI 10.1111/j.1432-2277.2010.01176.x; Reiss N, 1996, BIOCHEM MOL BIOL INT, V40, P1191; Rosenblatt J, 2010, J IMMUNOTHER, V33, P155, DOI 10.1097/CJI.0b013e3181bed253; SCHWARTZ RH, 1989, COLD SPRING HARB SYM, V54, P605; Seliger B, 2005, PROTEOMICS, V5, P2631, DOI 10.1002/pmic.200401264; Sharpe AH, 2009, IMMUNOL REV, V229, P5, DOI 10.1111/j.1600-065X.2009.00784.x; Shen K, 2008, P NATL ACAD SCI USA, V105, P7791, DOI 10.1073/pnas.0710295105; Sheng WY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006322; Thiel M, 2010, IMMUNOLOGY, V129, P28, DOI 10.1111/j.1365-2567.2009.03155.x; Tisdale EJ, 2009, J BIOL CHEM, V284, P5876, DOI 10.1074/jbc.M807756200; Tristan C, 2011, CELL SIGNAL, V23, P317, DOI 10.1016/j.cellsig.2010.08.003; Verbinnen B, 2008, J IMMUNOL, V181, P1034, DOI 10.4049/jimmunol.181.2.1034; Vinh A, 2010, CIRCULATION, V122, P2529, DOI 10.1161/CIRCULATIONAHA.109.930446; von Hundelshausen P, 2007, THROMB HAEMOSTASIS, V97, P704, DOI 10.1160/TH07-01-0066; Waibler Z, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001708; Yang J, 2009, AM J TRANSPLANT, V9, P2837, DOI 10.1111/j.1600-6143.2009.02839.x; Yokosuka T, 2009, IMMUNOL REV, V229, P27, DOI 10.1111/j.1600-065X.2009.00779.x	58	15	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e32994	10.1371/journal.pone.0032994	http://dx.doi.org/10.1371/journal.pone.0032994			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22539942	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341000005
J	Firn, J; Prober, SM; Buckley, YM				Firn, Jennifer; Prober, Suzanne M.; Buckley, Yvonne M.			Plastic Traits of an Exotic Grass Contribute to Its Abundance but Are Not Always Favourable	PLOS ONE			English	Article							PHENOTYPIC PLASTICITY; INVASIVE PLANTS; RESOURCE-USE; LEAF-AREA; FRAMEWORK; ECOSYSTEMS; COMMUNITIES; DISTURBANCE; PASSENGERS; DIVERSITY	In herbaceous ecosystems worldwide, biodiversity has been negatively impacted by changed grazing regimes and nutrient enrichment. Altered disturbance regimes are thought to favour invasive species that have a high phenotypic plasticity, although most studies measure plasticity under controlled conditions in the greenhouse and then assume plasticity is an advantage in the field. Here, we compare trait plasticity between three co-occurring, C-4 perennial grass species, an invader Eragrostis curvula, and natives Eragrostis sororia and Aristida personata to grazing and fertilizer in a three-year field trial. We measured abundances and several leaf traits known to correlate with strategies used by plants to fix carbon and acquire resources, i.e. specific leaf area (SLA), leaf dry matter content (LDMC), leaf nutrient concentrations (N, C:N, P), assimilation rates (Amax) and photosynthetic nitrogen use efficiency (PNUE). In the control treatment (grazed only), trait values for SLA, leaf C:N ratios, Amax and PNUE differed significantly between the three grass species. When trait values were compared across treatments, E. curvula showed higher trait plasticity than the native grasses, and this correlated with an increase in abundance across all but the grazed/fertilized treatment. The native grasses showed little trait plasticity in response to the treatments. Aristida personata decreased significantly in the treatments where E. curvula increased, and E. sororia abundance increased possibly due to increased rainfall and not in response to treatments or invader abundance. Overall, we found that plasticity did not favour an increase in abundance of E. curvula under the grazed/fertilized treatment likely because leaf nutrient contents increased and subsequently its' palatability to consumers. E. curvula also displayed a higher resource use efficiency than the native grasses. These findings suggest resource conditions and disturbance regimes can be manipulated to disadvantage the success of even plastic exotic species.	[Firn, Jennifer] Queensland Univ Technol, Sch Earth Environm & Biol Sci, Brisbane, Qld 4001, Australia; [Prober, Suzanne M.] CSIRO, Ecosyst Sci, Wembley, WA, Australia; [Buckley, Yvonne M.] Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia; [Buckley, Yvonne M.] Ecosyst Sci CSIRO, Dutton Pk, Qld, Australia	Queensland University of Technology (QUT); Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Queensland; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Firn, J (corresponding author), Queensland Univ Technol, Sch Earth Environm & Biol Sci, Brisbane, Qld 4001, Australia.	jennifer.firn@qut.edu.au	Prober, Suzanne/G-6465-2010; Buckley, Yvonne/B-1281-2008	Prober, Suzanne/0000-0002-6518-239X; Buckley, Yvonne/0000-0001-7599-3201; Firn, Jennifer/0000-0001-6026-8912	Australian Research Council [DP0771387]; CSIRO Ecosystem Sciences	Australian Research Council(Australian Research Council); CSIRO Ecosystem Sciences	Thank you to CSIRO Ecosystem Sciences and Australian Research Council (YB, DP0771387) for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert CH, 2011, PERSPECT PLANT ECOL, V13, P217, DOI 10.1016/j.ppees.2011.04.003; Albert CH, 2010, J ECOL, V98, P604, DOI 10.1111/j.1365-2745.2010.01651.x; Anderson E, 2003, PLANTS CENTRAL QUEEN; [Anonymous], 1986, ECOLOGY BIOL INVASIO; Baker HG, 1964, GENETICS COLONIZING, P147; Baruch Z, 1999, OECOLOGIA, V121, P183, DOI 10.1007/s004420050920; Biggs A, 1999, CENTRAL DARLING LAND; Burns JH, 2006, BIOL INVASIONS, V8, P797, DOI 10.1007/s10530-005-3838-5; Chesson P, 2004, OECOLOGIA, V141, P236, DOI 10.1007/s00442-004-1551-1; Cornelissen JHC, 2003, AUST J BOT, V51, P335, DOI 10.1071/BT02124; Daehler CC, 2003, ANNU REV ECOL EVOL S, V34, P183, DOI 10.1146/annurev.ecolsys.34.011802.132403; Davidson AM, 2011, ECOL LETT, V14, P419, DOI 10.1111/j.1461-0248.2011.01596.x; Davis MA, 2000, J ECOL, V88, P528, DOI 10.1046/j.1365-2745.2000.00473.x; DeWitt TJ, 1998, TRENDS ECOL EVOL, V13, P77, DOI 10.1016/S0169-5347(97)01274-3; Diaz S, 2004, J VEG SCI, V15, P295, DOI 10.1111/j.1654-1103.2004.tb02266.x; Durand LZ, 2001, AM FERN J, V91, P25, DOI 10.1640/0002-8444(2001)091[0025:GLCASP]2.0.CO;2; Elton C. S., 1958, ECOLOGY INVASIONS AN; EVERSON CS, 1987, VEGETATIO, V73, P47, DOI 10.1007/BF00031850; Firn J, 2008, J APPL ECOL, V45, P1143, DOI 10.1111/j.1365-2664.2008.01510.x; Firn J, 2010, J APPL ECOL, V47, P96, DOI 10.1111/j.1365-2664.2009.01741.x; Firn J, 2009, TROP GRASSLANDS, V43, P86; Funk JL, 2008, J ECOL, V96, P1162, DOI 10.1111/j.1365-2745.2008.01435.x; Funk JL, 2007, NATURE, V446, P1079, DOI 10.1038/nature05719; Garnier E, 2001, FUNCT ECOL, V15, P688, DOI 10.1046/j.0269-8463.2001.00563.x; Godoy O, 2011, FUNCTIONAL ECOLOGY, V25, P1428; Grime JP, 1998, J ECOL, V86, P902, DOI 10.1046/j.1365-2745.1998.00306.x; Grotkopp E, 2002, AM NAT, V159, P396, DOI 10.1086/338995; Gulias J, 2003, ANN BOT-LONDON, V92, P215, DOI 10.1093/aob/mcg123; HENRY DR, 1995, PASTURE PLANTS SO IN; HilleRisLambers J, 2010, J ECOL, V98, P1147, DOI 10.1111/j.1365-2745.2010.01706.x; Hobbs RJ, 2006, GLOBAL ECOL BIOGEOGR, V15, P1, DOI 10.1111/j.1466-822x.2006.00212.x; HOBBS RJ, 1988, AUST J ECOL, V13, P171, DOI 10.1111/j.1442-9993.1988.tb00966.x; Hulme PE, 2008, FUNCT ECOL, V22, P3, DOI 10.1111/j.1365-2435.2007.01369.x; Ives AR, 2006, ECOL APPL, V16, P20, DOI 10.1890/04-0702; LEIGH J. H., 1968, Plant Introduction Review, C.S.I.R.O., V5, P21; Leishman MR, 2007, NEW PHYTOL, V176, P635, DOI 10.1111/j.1469-8137.2007.02189.x; Leishman MR, 2010, J ECOL, V98, P28, DOI 10.1111/j.1365-2745.2009.01608.x; MacDougall AS, 2005, ECOLOGY, V86, P42, DOI 10.1890/04-0669; McIntyre S, 2005, AUST J BOT, V53, P757, DOI 10.1071/BT05088; McIntyre S., 2006, AGR ECOSYST ENVIRON, V2007, P11; Melbourne BA, 2007, ECOL LETT, V10, P77, DOI 10.1111/j.1461-0248.2006.00987.x; Mitchell M, 2002, NATIVE GRASSES IDENT; Moles AT, 2008, J ECOL, V96, P13, DOI 10.1111/j.1365-2745.2007.01332.x; Muth NZ, 2007, J ECOL, V95, P1001, DOI 10.1111/j.1365-2745.2007.01268.x; Pickett STA, 2009, APPL VEG SCI, V12, P9, DOI 10.1111/j.1654-109X.2009.01019.x; Pinheiro J, 2001, MIXED EFFECTS MODELS; Pysek P., 2007, BIOL INVASIONS; Rasband W., 2006, IMAGEJ; Raymont GE, 1992, AUSTR HDB SOIL WATER; Rejmanek M, 1996, ECOLOGY, V77, P1655, DOI 10.2307/2265768; Reuter DJ, 1986, PLANT ANAL INTERPRET; Richards CL, 2006, ECOL LETT, V9, P981, DOI 10.1111/j.1461-0248.2006.00950.x; Rout ME, 2009, SCIENCE, V324, P734, DOI 10.1126/science.1173651; Sax DF, 2000, GLOBAL ECOL BIOGEOGR, V9, P363, DOI 10.1046/j.1365-2699.2000.00217.x; Seabloom EW, 2003, P NATL ACAD SCI USA, V100, P13384, DOI 10.1073/pnas.1835728100; Sharp D, 2002, AUSGRASS GRASSES AUS; Suding KN, 2008, GLOBAL CHANGE BIOL, V14, P1125, DOI 10.1111/j.1365-2486.2008.01557.x; Suding KN, 2001, ECOLOGY, V82, P2133, DOI 10.2307/2680221; Thompson K, 2011, TRENDS ECOL EVOL, V26, P155, DOI 10.1016/j.tree.2011.01.007; Voight PW, 1968, AGRON J, V62, P673; Westoby M, 2006, TRENDS ECOL EVOL, V21, P261, DOI 10.1016/j.tree.2006.02.004; Wright IJ, 2005, NEW PHYTOL, V166, P485, DOI 10.1111/j.1469-8137.2005.01349.x; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Zavaleta ES, 2001, TRENDS ECOL EVOL, V16, P454, DOI 10.1016/S0169-5347(01)02194-2; Zou J, 2007, FUNCT ECOL, V21, P721, DOI 10.1111/j.1365-2435.2007.01298.x	65	20	20	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35870	10.1371/journal.pone.0035870	http://dx.doi.org/10.1371/journal.pone.0035870			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536448	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339200121
J	Pelletier, L; Kato, A; Chiaradia, A; Ropert-Coudert, Y				Pelletier, Laure; Kato, Akiko; Chiaradia, Andre; Ropert-Coudert, Yan			Can Thermoclines Be a Cue to Prey Distribution for Marine Top Predators? A Case Study with Little Penguins	PLOS ONE			English	Article							THICK-BILLED MURRES; EUDYPTULA-MINOR; CLIMATE; TEMPERATURE; ECOSYSTEMS; BEHAVIOR; ISLAND; CYCLE	The use of top predators as bio-platforms is a modern approach to understanding how physical changes in the environment may influence their foraging success. This study examined if the presence of thermoclines could be a reliable signal of resource availability for a marine top predator, the little penguin (Eudyptula minor). We studied weekly foraging activity of 43 breeding individual penguins equipped with accelerometers. These loggers also recorded water temperature, which we used to detect changes in thermal characteristics of their foraging zone over 5 weeks during the penguin's guard phase. Data showed the thermocline was detected in the first 3 weeks of the study, which coincided with higher foraging efficiency. When a thermocline was not detected in the last two weeks, foraging efficiency decreased as well. We suggest that thermoclines can represent temporary markers of enhanced food availability for this top-predator to which they must optimally adjust their breeding cycle.	[Pelletier, Laure; Kato, Akiko; Ropert-Coudert, Yan] Univ Strasbourg, IPHC, Strasbourg, France; [Pelletier, Laure; Kato, Akiko; Ropert-Coudert, Yan] CNRS, UMR7178, Strasbourg, France; [Chiaradia, Andre] Phillip Isl Nat Pk, Cowes, Vic, Australia	UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Pelletier, L (corresponding author), Univ Strasbourg, IPHC, Strasbourg, France.	laure.pelletier@iphc.cnrs.fr	Kato, Akiko/W-2447-2019; Chiaradia, Andre/AFK-6634-2022; Chiaradia, Andre/AAG-4928-2022	Chiaradia, Andre/0000-0002-6178-4211; Chiaradia, Andre/0000-0002-6178-4211; Kato, Akiko/0000-0002-8947-3634	Japan Society for Promotion of Science; Region Alsace; Centre National de la Recherche Scientifique (CNRS); BHP-Billiton	Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Region Alsace(Region Grand-Est); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); BHP-Billiton	This study was funded by grants from the Japan Society for Promotion of Science, the Region Alsace, the Centre National de la Recherche Scientifique (CNRS) and the BHP-Billiton. Note that Phillip Island Nature Park is a not-for profit organization dedicated to the protection and conservation of little penguins. The Park is controlled by a Board of Management appointed by the Minister for Environment of Victoria, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainley DG, 2004, ECOL MONOGR, V74, P159, DOI 10.1890/02-4073; Ashmole N.P., 1971, AVIAN BIOL, P224; Bates D, IME4 LINEAR MIXED EF; Bost CA, 2009, J MARINE SYST, V78, P363, DOI 10.1016/j.jmarsys.2008.11.022; Chiaradia A, 2007, MAR BIOL, V151, P1535, DOI 10.1007/s00227-006-0593-9; Chiaradia A, 2006, ARDEA, V94, P257; Chiaradia A, 2012, AUSTRAL ECOL, V37, P610, DOI 10.1111/j.1442-9993.2011.02323.x; Collins M, 1999, WILDLIFE RES, V26, P705, DOI 10.1071/WR98003; Cullen JM, 2009, MAR ECOL PROG SER, V378, P269, DOI 10.3354/meps07881; Daunt F, 2003, MAR ECOL PROG SER, V255, P283, DOI 10.3354/meps255283; Durant JM, 2007, CLIM RES, V33, P271, DOI 10.3354/cr033271; Elliott KH, 2009, AUK, V126, P613, DOI 10.1525/auk.2009.08245; Francis RC, 1998, FISH OCEANOGR, V7, P1, DOI 10.1046/j.1365-2419.1998.00052.x; FRANKS PJS, 1992, MAR ECOL PROG SER, V82, P1, DOI 10.3354/meps082001; GALES R, 1990, ECOLOGY, V71, P2297, DOI 10.2307/1938641; GASPAR P, 1988, J PHYS OCEANOGR, V18, P161, DOI 10.1175/1520-0485(1988)018<0161:MTSCOT>2.0.CO;2; Gaston Anthony J., 2007, Marine Ornithology, V35, P119; Georges JY, 2003, CR GEOSCI, V335, P551, DOI 10.1016/S1631-0713(03)00101-9; Hansen JE, 2001, FISH OCEANOGR, V10, P193, DOI 10.1046/j.1365-2419.2001.00166.x; Kato A, 2006, MAR ECOL PROG SER, V308, P293, DOI 10.3354/meps308293; Kitagawa T, 2000, MAR ECOL PROG SER, V206, P251, DOI 10.3354/meps206251; Kitagawa T, 2001, MAR ECOL PROG SER, V220, P253, DOI 10.3354/meps220253; Kokubun N, 2010, AQUAT BIOL, V8, P289, DOI 10.3354/ab00243; Matsumoto Kei, 2008, Ornithological Science, V7, P37, DOI 10.2326/1347-0558(2008)7[37:EFAORA]2.0.CO;2; Minster JF, 1997, MACHINE OCEAN, P87; Nisbet ICT, 2009, J AVIAN BIOL, V40, P296, DOI 10.1111/j.1600-048X.2008.04563.x; R Core Team, 2020, R LANG ENV STAT COMP; Ropert-Coudert Y, 2006, MAR BIOL, V149, P139, DOI 10.1007/s00227-005-0188-x; Ropert-Coudert Y, 2007, DEEP-SEA RES PT II, V54, P415, DOI 10.1016/j.dsr2.2006.11.018; Ropert-Coudert Y, 2009, P ROY SOC B-BIOL SCI, V276, P4105, DOI 10.1098/rspb.2009.1399; Ropert-Coudert Yan, 2006, Marine Ornithology, V34, P71; Russell RW, 1999, MAR ECOL PROG SER, V182, P77, DOI 10.3354/meps182077; Saether BE, 2000, SCIENCE, V288, P1975; SCHREIBER E.A., 2001, BIOL MARINE BIRDS, V1st; Shultz MT, 2009, MAR ECOL PROG SER, V393, P247, DOI 10.3354/meps08136; Solomon S., 2007, PHYS SCI BASIS WORKI; Takahashi A, 2008, DEEP-SEA RES PT II, V55, P1837, DOI 10.1016/j.dsr2.2008.04.005; Thomas DW, 2001, SCIENCE, V291, P2598, DOI 10.1126/science.1057487; Visser ME, 2005, P ROY SOC B-BIOL SCI, V272, P2561, DOI 10.1098/rspb.2005.3356; Wilson RP, 1997, WILDLIFE SOC B, V25, P101; Zimmer I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016098	41	36	36	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e31768	10.1371/journal.pone.0031768	http://dx.doi.org/10.1371/journal.pone.0031768			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536314	Green Published, gold, Green Submitted			2022-12-27	WOS:000305339200004
J	Ross, F; Hernandez, P; Porcal, W; Lopez, GV; Cerecetto, H; Gonzalez, M; Basika, T; Carmona, C; Flo, M; Maggioli, G; Bonilla, M; Gladyshev, VN; Boiani, M; Salinas, G				Ross, Fabiana; Hernandez, Paola; Porcal, Williams; Lopez, Gloria V.; Cerecetto, Hugo; Gonzalez, Mercedes; Basika, Tatiana; Carmona, Carlos; Flo, Martin; Maggioli, Gabriela; Bonilla, Mariana; Gladyshev, Vadim N.; Boiani, Mariana; Salinas, Gustavo			Identification of Thioredoxin Glutathione Reductase Inhibitors That Kill Cestode and Trematode Parasites	PLOS ONE			English	Article							CRASSICEPS METACESTODE CYSTICERCI; ESCHERICHIA-COLI; SCHISTOSOMA-MANSONI; ECHINOCOCCOSIS; PLATYHELMINTHS; SELENOCYSTEINE; DISEASES; SELENIUM; SYSTEMS; ASSAY	Parasitic flatworms are responsible for serious infectious diseases that affect humans as well as livestock animals in vast regions of the world. Yet, the drug armamentarium available for treatment of these infections is limited: praziquantel is the single drug currently available for 200 million people infected with Schistosoma spp. and there is justified concern about emergence of drug resistance. Thioredoxin glutathione reductase (TGR) is an essential core enzyme for redox homeostasis in flatworm parasites. In this work, we searched for flatworm TGR inhibitors testing compounds belonging to various families known to inhibit thioredoxin reductase or TGR and also additional electrophilic compounds. Several furoxans and one thiadiazole potently inhibited TGRs from both classes of parasitic flatworms: cestoda (tapeworms) and trematoda (flukes), while several benzofuroxans and a quinoxaline moderately inhibited TGRs. Remarkably, five active compounds from diverse families possessed a phenylsulfonyl group, strongly suggesting that this moiety is a new pharmacophore. The most active inhibitors were further characterized and displayed slow and nearly irreversible binding to TGR. These compounds efficiently killed Echinococcus granulosus larval worms and Fasciola hepatica newly excysted juveniles in vitro at a 20 mu M concentration. Our results support the concept that the redox metabolism of flatworm parasites is precarious and particularly susceptible to destabilization, show that furoxans can be used to target both flukes and tapeworms, and identified phenylsulfonyl as a new drug-hit moiety for both classes of flatworm parasites.	[Ross, Fabiana; Flo, Martin; Bonilla, Mariana; Salinas, Gustavo] Univ Republica, Catedra Inmunol, Fac Quim, Montevideo, Uruguay; [Basika, Tatiana; Carmona, Carlos; Maggioli, Gabriela] Univ Republica, Fac Ciencias, Unidad Biol Parasitaria, Montevideo, Uruguay; [Hernandez, Paola; Porcal, Williams; Lopez, Gloria V.; Cerecetto, Hugo; Gonzalez, Mercedes; Boiani, Mariana] Univ Republica, Grp Quim Med, Lab Quim Organ, Fac Quim, Montevideo, Uruguay; [Gladyshev, Vadim N.] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [Gladyshev, Vadim N.] Harvard Univ, Sch Med, Boston, MA USA	Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Salinas, G (corresponding author), Univ Republica, Catedra Inmunol, Fac Quim, Montevideo, Uruguay.	gsalin@fq.edu.uy	Gladyshev, Vadim N/A-9894-2013; Lopez, Gloria Virginia/ABA-3286-2021; Gladyshev, Vadim N/J-6187-2013	Lopez, Gloria Virginia/0000-0001-7515-3915; Bonilla, Mariana/0000-0002-9206-345X; Hernandez, Paola/0000-0002-3515-1082; Gonzalez, Mercedes/0000-0002-0808-0610; Gladyshev, Vadim/0000-0002-0372-7016; Salinas, Gustavo/0000-0003-3350-3002	Fogarty International Research Collaboration Award/National Institutes of Health - FIRCA/NIH [RO3TW008588]; Universidad de la Republica [CSIC 625]; NIH [GM065204]; FOGARTY INTERNATIONAL CENTER [R03TW008588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM065204, R01GM065204] Funding Source: NIH RePORTER	Fogarty International Research Collaboration Award/National Institutes of Health - FIRCA/NIH; Universidad de la Republica; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants RO3TW008588 (Fogarty International Research Collaboration Award/National Institutes of Health - FIRCA/NIH) and CSIC 625 (Universidad de la Republica) to GS, and grant GM065204 (NIH) to VNG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alger HM, 2002, MOL BIOCHEM PARASIT, V121, P129, DOI 10.1016/S0166-6851(02)00031-2; Andricopulo AD, 2006, BIOORG MED CHEM LETT, V16, P2283, DOI 10.1016/j.bmcl.2006.01.027; Arner ESJ, 1999, J MOL BIOL, V292, P1003, DOI 10.1006/jmbi.1999.3085; Arner ESJ, 1999, METHOD ENZYMOL, V300, P226; Bar-Noy S, 2001, FREE RADICAL BIO MED, V30, P51, DOI 10.1016/S0891-5849(00)00448-2; BAZ A, 1995, IMMUNOLOGY, V84, P350; Bonilla M, 2008, J BIOL CHEM, V283, P17898, DOI 10.1074/jbc.M710609200; Brennan GP, 2007, EXP MOL PATHOL, V82, P104, DOI 10.1016/j.yexmp.2007.01.009; CARLBERG I, 1985, METHOD ENZYMOL, V113, P484; CARMONA C, 1993, MOL BIOCHEM PARASIT, V62, P9, DOI 10.1016/0166-6851(93)90172-T; Cioli D, 2008, TRENDS PARASITOL, V24, P379, DOI 10.1016/j.pt.2008.05.006; GHOSE AK, 1987, J CHEM INF COMP SCI, V27, P21, DOI 10.1021/ci00053a005; Guevara-Flores A, 2011, PARASITOL INT, V60, P156, DOI 10.1016/j.parint.2011.01.005; Hotez PJ, 2008, J CLIN INVEST, V118, P1311, DOI 10.1172/JCI34261; Huang HH, 2011, BIOCHEMISTRY; Jolliffe I., 2005, SPRINGERLINK PRINCIP, DOI 10.1007/b98835; Keiser J, 2005, EMERG INFECT DIS, V11, P1507, DOI 10.3201/eid1110.050614; Kern P, 2010, CURR OPIN INFECT DIS, V23, P505, DOI 10.1097/QCO.0b013e32833d7516; Maggioli G, 2011, EXP PARASITOL, V129, P323, DOI 10.1016/j.exppara.2011.09.013; Mansour TE., 2002, CHEMOTHERAPEUTIC TAR, DOI 10.1017/CBO9780511546440; Martinez-Gonzalez JJ, 2010, PARASITOL RES, V107, P227, DOI 10.1007/s00436-010-1867-1; Muller S, 1997, ARCH MICROBIOL, V168, P421, DOI 10.1007/s002030050517; Nwaka S, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000440; Otero L, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-237; Rai G, 2009, TETRAHEDRON LETT, V50, P1710, DOI 10.1016/j.tetlet.2009.01.120; Rai G, 2009, J MED CHEM, V52, P6474, DOI 10.1021/jm901021k; Rendon JL, 2004, MOL BIOCHEM PARASIT, V133, P61, DOI 10.1016/j.molbiopara.2003.09.003; Rengby O, 2004, APPL ENVIRON MICROB, V70, P5159, DOI 10.1128/AEM.70.9.5159-5167.2004; Salinas G, 2004, TRENDS PARASITOL, V20, P340, DOI 10.1016/j.pt.2004.05.002; Sayed AA, 2008, NAT MED, V14, P407, DOI 10.1038/nm1737; Simeonov A, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000127; Storer JW, 1994, STRUCTURE REACTIVITY; TADA H, 1986, J IMMUNOL METHODS, V93, P157, DOI 10.1016/0022-1759(86)90183-3; Torgerson PR, 2003, RES VET SCI, V74, P191, DOI 10.1016/S0034-5288(03)00006-7	34	31	32	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35033	10.1371/journal.pone.0035033	http://dx.doi.org/10.1371/journal.pone.0035033			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536349	Green Published, gold, Green Submitted			2022-12-27	WOS:000305339200032
J	Sun, MX; Liang, AP; Watson, GS; Watson, JA; Zheng, YM; Ju, J; Jiang, L				Sun, Mingxia; Liang, Aiping; Watson, Gregory S.; Watson, Jolanta A.; Zheng, Yongmei; Ju, Jie; Jiang, Lei			Influence of Cuticle Nanostructuring on the Wetting Behaviour/States on Cicada Wings	PLOS ONE			English	Article							HIGH ADHESIVE FORCE; WATER; SURFACES; LOTUS; LEGS; FABRICATION; DESIGN; FILMS	The nanoscale protrusions of different morphologies on wing surfaces of four cicada species were examined under an environmental scanning electron microscope (ESEM). The water contact angles (CAs) of the wing surfaces were measured along with droplet adhesion values using a high-sensitivity microelectromechanical balance system. The water CA and adhesive force measurements obtained were found to relate to the nanostructuring differences of the four species. The adhesive forces in combination with the Cassie-Baxter and Wenzel approximations were used to predict wetting states of the insect wing cuticles. The more disordered and inhomogeneous surface of the species Leptopsalta bifuscata demonstrated a Wenzel type wetting state or an intermediate state of spreading and imbibition with a CA of 81.3 degrees and high adhesive force of 149.5 mu N. Three other species (Cryptotympana atrata, Meimuna opalifer and Aola bindusara) exhibited nanostructuring of the form of conically shaped protrusions, which were spherically capped. These surfaces presented a range of high adhesional values; however, the CAs were highly hydrophobic (C. atrata and A. bindusara) and in some cases close to superhydrophobic (M. opalifer). The wetting states of A. bindusara, C. atrata and M. opalifer (based on adhesion and CAs) are most likely represented by the transitional region between the Cassie-Baxter and Wenzel approximations to varying degrees.	[Sun, Mingxia; Liang, Aiping] Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing, Peoples R China; [Watson, Gregory S.; Watson, Jolanta A.] James Cook Univ, Sch Pharm & Mol Sci, Townsville, Qld 4811, Australia; [Zheng, Yongmei] Beihang Univ, Minist Educ, Sch Chem & Environm, Key Lab Bioinspired Smart Interfacial Sci & Techn, Beijing, Peoples R China; [Ju, Jie; Jiang, Lei] Chinese Acad Sci, Inst Chem, Ctr Mol Sci, Beijing 100080, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; James Cook University; Beihang University; Chinese Academy of Sciences; Institute of Chemistry, CAS	Liang, AP (corresponding author), Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing, Peoples R China.	liangap@ioz.ac.cn; zhengym@buaa.edu.cn	Watson, Gregory S/D-2195-2009; , 许永傲/AAC-2581-2019; Ju, Jie/M-6709-2017; Sun (孙), Mingxia (明霞)/ABA-7705-2021; Jiang, Lei/B-1066-2011; Watson, Jolanta A/A-9332-2008	Ju, Jie/0000-0001-8931-3270; Watson, Jolanta A/0000-0002-5027-9025; Sun, Mingxia/0000-0002-1184-516X; Watson, Gregory/0000-0001-9843-9211	Chinese Academy of Sciences [KSCX2-EW-G-4]; National Basic Research Program of China (973 Program) [2011CB302102]; National Natural Science Foundation of China [30970400, 31172128]; Key Laboratory of the Zoological Systematics and Evolution of the Chinese Academy of Sciences [O529YX5105]	Chinese Academy of Sciences(Chinese Academy of Sciences); National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Laboratory of the Zoological Systematics and Evolution of the Chinese Academy of Sciences	This work was supported by the following sources: Main Direction Program of Knowledge Innovation of Chinese Academy of Sciences (grant no KSCX2-EW-G-4), the National Basic Research Program of China (973 Program) (grant no 2011CB302102), the National Natural Science Foundation of China (grant nos 30970400, 31172128), and the Key Laboratory of the Zoological Systematics and Evolution of the Chinese Academy of Sciences (grant no O529YX5105). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barthlott W, 1997, PLANTA, V202, P1, DOI 10.1007/s004250050096; Bhushan B., 2002, INTRO TRIBOLOGY, P169; Bhushan B, 2010, LANGMUIR, V26, P8207, DOI 10.1021/la904585j; Bico J, 2002, COLLOID SURFACE A, V206, P41, DOI 10.1016/S0927-7757(02)00061-4; Cassie ABD, 1944, T FARADAY SOC, V40, P0546, DOI 10.1039/tf9444000546; Chang FM, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3204006; Cheng ZJ, 2010, LANGMUIR, V26, P8233, DOI 10.1021/la904510n; Cho WK, 2008, ADV FUNCT MATER, V18, P1089, DOI 10.1002/adfm.200701454; Cong Q, 2004, J BIONIC ENG, V1, P249; Feng L, 2008, LANGMUIR, V24, P4114, DOI 10.1021/la703821h; Feng XQ, 2007, LANGMUIR, V23, P4892, DOI 10.1021/la063039b; Gao XF, 2004, NATURE, V432, P36, DOI 10.1038/432036a; Gorb SN, 2000, ARTHROPOD STRUCT DEV, V29, P129, DOI 10.1016/S1467-8039(00)00020-7; Green DW, 2012, ADV HEALTHC MATER, V1, P140, DOI 10.1002/adhm.201100039; HOLDGATE MW, 1955, J EXP BIOL, V32, P591; Hong SH, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/38/385303; Hu HM, 2011, BIOFOULING, V27, P1125, DOI 10.1080/08927014.2011.637187; Hu HMS, 2011, J EXP BIOL, V214, P915, DOI 10.1242/jeb.051128; Jin MH, 2005, ADV MATER, V17, P1977, DOI 10.1002/adma.200401726; JOANNY JF, 1984, J CHEM PHYS, V81, P552, DOI 10.1063/1.447337; Koch K, 2009, SOFT MATTER, V5, P1386, DOI 10.1039/b818940d; Kostovski G, 2009, BIOSENS BIOELECTRON, V24, P1531, DOI 10.1016/j.bios.2008.10.016; Kostovski G, 2011, ADV MATER, V23, P531, DOI 10.1002/adma.201002796; Neithhuis C, 1997, ANN BOT, V79, P667; Parker AR, 2001, NATURE, V414, P33, DOI 10.1038/35102108; Quere D, 2008, PHILOS T R SOC A, V366, P1539, DOI 10.1098/rsta.2007.2171; Song F, 2004, J EXP BIOL, V207, P3035, DOI 10.1242/jeb.01122; Stoddart PR, 2006, NANOTECHNOLOGY, V17, P680, DOI 10.1088/0957-4484/17/3/011; Sun MX, 2011, BIOINSPIR BIOMIM, V6, DOI 10.1088/1748-3182/6/2/026003; Sun MX, 2009, J EXP BIOL, V212, P3148, DOI 10.1242/jeb.033373; Vincent JFV, 2004, ARTHROPOD STRUCT DEV, V33, P187, DOI 10.1016/j.asd.2004.05.006; Wagner P., 1996, ACTA ZOOLOGICA, V77, P213, DOI DOI 10.1111/J.1463-6395.1996.TB01265.X; Wang S, 2007, ADV MATER, V19, P3423, DOI 10.1002/adma.200700934; Watson GS, 2008, BIOPHYS J, V94, P3352, DOI 10.1529/biophysj.107.109348; Watson GS, 2010, ACS NANO, V4, P129, DOI 10.1021/nn900869b; Watson GS, 2010, J STRUCT BIOL, V171, P44, DOI 10.1016/j.jsb.2010.03.008; Watson J. A., 2006, P SOC PHOTO-OPT INS, V6037, P375; Watson JA, 2011, BIOPHYS J, V100, P1149, DOI 10.1016/j.bpj.2010.12.3736; Wenzel RN, 1936, IND ENG CHEM, V28, P988, DOI 10.1021/ie50320a024; Xie GY, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/9/095605; Zhang GM, 2006, SMALL, V2, P1440, DOI 10.1002/smll.200600255; Zhang JH, 2008, SOFT MATTER, V4, P2232, DOI 10.1039/b807857b; Zhao WJ, 2010, J PHYS CHEM C, V114, P11509, DOI 10.1021/jp102052e; Zheng YM, 2007, SOFT MATTER, V3, P178, DOI 10.1039/b612667g	44	51	51	1	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35056	10.1371/journal.pone.0035056	http://dx.doi.org/10.1371/journal.pone.0035056			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536351	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000305339200036
J	Tang, JW; Nicolle, A; Pantelic, J; Koh, GC; De Wang, L; Amin, M; Klettner, CA; Cheong, DKW; Sekhar, C; Tham, KW				Tang, Julian W.; Nicolle, Andre; Pantelic, Jovan; Koh, Gerald C.; De Wang, Liang; Amin, Muhammad; Klettner, Christian A.; Cheong, David K. W.; Sekhar, Chandra; Tham, Kwok Wai			Airflow Dynamics of Coughing in Healthy Human Volunteers by Shadowgraph Imaging: An Aid to Aerosol Infection Control	PLOS ONE			English	Article							INFLUENZA-VIRUS	Cough airflow dynamics have been previously studied using a variety of experimental methods. In this study, real-time, non-invasive shadowgraph imaging was applied to obtain additional analyses of cough airflows produced by healthy volunteers. Twenty healthy volunteers (10 women, mean age 32.2 +/- 12.9 years; 10 men, mean age 25.3 +/- 2.5 years) were asked to cough freely, then into their sleeves (as per current US CDC recommendations) in this study to analyze cough airflow dynamics. For the 10 females (cases 1-10), their maximum detectable cough propagation distances ranged from 0.16-0.55 m, with maximum derived velocities of 2.2-5.0 m/s, and their maximum detectable 2-D projected areas ranged from 0.010-0.11 m(2), with maximum derived expansion rates of 0.15-0.55 m(2)/s. For the 10 males (cases 11-20), their maximum detectable cough propagation distances ranged from 0.31-0.64 m, with maximum derived velocities of 3.2-14 m/s, and their maximum detectable 2-D projected areas ranged from 0.04-0.14 m(2), with maximum derived expansion rates of 0.25-1.4 m(2)/s. These peak velocities were measured when the visibility of the exhaled airflows was optimal and compare favorably with those reported previously using other methods, and may be seen as a validation of these previous approaches in a more natural setting. However, the propagation distances can only represent a lower limit due to the inability of the shadowgraph method to visualize these cough airflows once their temperature cools to that of the ambient air, which is an important limitation of this methodology. The qualitative high-speed video footage of these volunteers coughing into their sleeves demonstrates that although this method rarely completely blocks the cough airflow, it decelerates, splits and redirects the airflow, eventually reducing its propagation. The effectiveness of this intervention depends on optimum positioning of the arm over the nose and mouth during coughing, though unsightly stains on sleeves may make it unacceptable to some.	[Tang, Julian W.; Nicolle, Andre; De Wang, Liang; Amin, Muhammad; Klettner, Christian A.] Natl Univ Hosp, Dept Lab Med, Queenstown, Singapore; [Pantelic, Jovan; Cheong, David K. W.; Sekhar, Chandra; Tham, Kwok Wai] Natl Univ Singapore, Sch Design & Environm, Dept Bldg, Queenstown, Singapore; [Koh, Gerald C.] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Queenstown, Singapore	National University of Singapore; National University of Singapore	Tang, JW (corresponding author), Natl Univ Hosp, Dept Lab Med, Queenstown, Singapore.	jwtang49@hotmail.com	THAM, Kwok Wai/B-6541-2009; Sekhar, Chandra/F-3253-2017	THAM, Kwok Wai/0000-0002-2957-1152; Koh, Choon Huat Gerald/0000-0002-6453-6897; Tang, Julian/0000-0002-4963-1028; Pantelic, Jovan/0000-0001-7541-8274; Cheong, David/0000-0001-7680-4281; Sekhar, Chandra/0000-0002-0814-8662	National Medical Research Council (NMRC) of Singapore [NMRC/1208/2009]	National Medical Research Council (NMRC) of Singapore(National Medical Research Council, Singapore)	Funding for this study (including the support to Dr. Nicolle) is provided by the National Medical Research Council (NMRC) of Singapore, Grant No. NMRC/1208/2009 to Dr. Tang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blachere FM, 2009, CLIN INFECT DIS, V48, P438, DOI 10.1086/596478; Chao CYH, 2009, J AEROSOL SCI, V40, P122, DOI 10.1016/j.jaerosci.2008.10.003; Clark RP, 2009, J R SOC INTERFACE, V6, pS767, DOI 10.1098/rsif.2009.0236.focus; Eames I, 2009, J R SOC INTERFACE, V6, pS697, DOI 10.1098/rsif.2009.0407.focus; Fabian P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002691; Gupta JK, 2009, INDOOR AIR, V19, P517, DOI 10.1111/j.1600-0668.2009.00619.x; Lindsley WG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015100; Lindsley WG, 2010, CLIN INFECT DIS, V50, P693, DOI 10.1086/650457; McCool FD, 2006, CHEST, V129, p48S, DOI 10.1378/chest.129.1_suppl.48S; Stelzer-Braid S, 2009, J MED VIROL, V81, P1674, DOI 10.1002/jmv.21556; Tang JW, 2008, NEW ENGL J MED, V359, pE19, DOI 10.1056/NEJMicm072576; Tang JW, 2006, J HOSP INFECT, V64, P100, DOI 10.1016/j.jhin.2006.05.022; Tang JW, 2011, J HOSP INFECT, V77, P213, DOI 10.1016/j.jhin.2010.09.037; Tang JLW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021392; Tang JW, 2009, J R SOC INTERFACE, V6, pS727, DOI 10.1098/rsif.2009.0295.focus; Tang JWT, 2009, NEW ENGL J MED, V361, pE62, DOI 10.1056/NEJMicm0904279; VanSciver M, 2011, AEROSOL SCI TECH, V45, P415, DOI 10.1080/02786826.2010.542785; Xie XJ, 2009, J R SOC INTERFACE, V6, pS703, DOI 10.1098/rsif.2009.0388.focus; Yang W, 2011, J R SOC INTERFACE, V8, P1176, DOI 10.1098/rsif.2010.0686; Zhu SW, 2006, BUILD ENVIRON, V41, P1691, DOI 10.1016/j.buildenv.2005.06.024	20	46	47	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e34818	10.1371/journal.pone.0034818	http://dx.doi.org/10.1371/journal.pone.0034818			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536332	Green Submitted, Green Published, gold			2022-12-27	WOS:000305339200021
J	Cordero, MD; Cano-Garcia, FJ; Alcocer-Gomez, E; De Miguel, M; Sanchez-Alcazar, JA				Cordero, Mario D.; Javier Cano-Garcia, Francisco; Alcocer-Gomez, Elisabet; De Miguel, Manuel; Antonio Sanchez-Alcazar, Jose			Oxidative Stress Correlates with Headache Symptoms in Fibromyalgia: Coenzyme Q(10) Effect on Clinical Improvement	PLOS ONE			English	Article							TRIGGERS MITOCHONDRIA DEGRADATION; LIPID-PEROXIDATION; CHRONIC-FATIGUE; RISK-FACTOR; DEFICIENCY; MIGRAINE; SUPPLEMENTATION; INFLAMMATION; DYSFUNCTION; BRAIN	Background: Fibromyalgia (FM) is a chronic pain syndrome with unknown etiology and a wide spectrum of symptoms such as allodynia, debilitating fatigue, joint stiffness and migraine. Recent studies have shown some evidences demonstrating that oxidative stress is associated to clinical symptoms in FM of fibromyalgia. We examined oxidative stress and bioenergetic status in blood mononuclear cells (BMCs) and its association to headache symptoms in FM patients. The effects of oral coenzyme Q(10) (CoQ(10)) supplementation on biochemical markers and clinical improvement were also evaluated. Methods: We studied 20 FM patients and 15 healthy controls. Clinical parameters were evaluated using the Fibromyalgia Impact Questionnaire (FIQ), visual analogues scales (VAS), and the Headache Impact Test (HIT-6). Oxidative stress was determined by measuring CoQ(10), catalase and lipid peroxidation (LPO) levels in BMCs. Bioenergetic status was assessed by measuring ATP levels in BMCs. Results: We found decreased CoQ(10), catalase and ATP levels in BMCs from FM patients as compared to normal control (P<0.05 and P<0.001, respectively) We also found increased level of LPO in BMCs from FM patients as compared to normal control (P<0.001). Significant negative correlations between CoQ(10) or catalase levels in BMCs and headache parameters were observed (r = -0.59, P<0.05; r = -0.68, P<0.05, respectively). Furthermore, LPO levels showed a significant positive correlation with HIT-6 (r = 0.33, P<0.05). Oral CoQ(10) supplementation restored biochemical parameters and induced a significant improvement in clinical and headache symptoms (P<0.001). Discussion: The results of this study suggest a role for mitochondrial dysfunction and oxidative stress in the headache symptoms associated with FM. CoQ10 supplementation should be examined in a larger placebo controlled trial as a possible treatment in FM.	[Cordero, Mario D.; Antonio Sanchez-Alcazar, Jose] Univ Pablo de Olavide CSIC Junta de Andalucia, Ctr Andaluz Biol Desarrollo CABD, Seville, Spain; [Cordero, Mario D.; Antonio Sanchez-Alcazar, Jose] ISCIII, Ctr Invest Biomed Red Enfermedades Raras CIBERER, Seville, Spain; [Cordero, Mario D.; De Miguel, Manuel] Univ Seville, Fac Med, Dept Citol & Histol Normal & Patol, Seville, Spain; [Javier Cano-Garcia, Francisco; Alcocer-Gomez, Elisabet] Univ Seville, Fac Psicol, Dept Personalidad Evaluac & Tratamiento Psicol, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; CSIC - Andalusian Center for Developmental Biology (CABD); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III; University of Sevilla; University of Sevilla	Cordero, MD (corresponding author), Univ Pablo de Olavide CSIC Junta de Andalucia, Ctr Andaluz Biol Desarrollo CABD, Seville, Spain.	mdcormor@upo.es	Sanchéz-Alcázar, José A. A/L-4925-2014; Magaña, Felipe/B-6966-2013; Cordero, Mario D./L-8006-2014; Cano-García, Francisco Javier/A-5005-2008; De-Miguel, Manuel/B-3713-2017	Sanchéz-Alcázar, José A. A/0000-0001-9705-1469; Cordero, Mario D./0000-0003-0151-3644; Cano-García, Francisco Javier/0000-0002-7581-2455; De-Miguel, Manuel/0000-0002-6751-1695; Alcocer-Gomez, Elisabet/0000-0001-9799-431X	IV Plan Propio de Investigacion (University of Seville) [2010/00000453, FIS PI10/00543, FIS EC08/00076]; Ministerio de Sanidad, Spain and Fondo Europeo de Desarrollo Regional (FEDER-Union Europea) [SAS 111242]; Servicio Andaluz de Salud-Junta de Andalucia [CTS-5725]; Federacion Andaluza de Fibromialgia y Fatiga Cronica (ALBA Andalucia)	IV Plan Propio de Investigacion (University of Seville); Ministerio de Sanidad, Spain and Fondo Europeo de Desarrollo Regional (FEDER-Union Europea); Servicio Andaluz de Salud-Junta de Andalucia; Federacion Andaluza de Fibromialgia y Fatiga Cronica (ALBA Andalucia)	This work has been supported by IV Plan Propio de Investigacion (University of Seville, ref. 2010/00000453), FIS PI10/00543 grant, FIS EC08/00076 grant, Ministerio de Sanidad, Spain and Fondo Europeo de Desarrollo Regional (FEDER-Union Europea), SAS 111242 grant, Servicio Andaluz de Salud-Junta de Andalucia, Proyecto de Investigacion de Excelencia de la Junta de Andalucia CTS-5725 and Federacion Andaluza de Fibromialgia y Fatiga Cronica (ALBA Andalucia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JK, 2004, NAT MED, V10, pS18, DOI 10.1038/nrn1434; BATTINO M, 1990, INT J TISSUE REACT, V12, P137; BEERS RF, 1952, J BIOL CHEM, V195, P133; Belaunzaran OM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018268; Bisaglia M, 2002, NEUROCHEM INT, V41, P43, DOI 10.1016/S0197-0186(01)00136-X; Centonze V, 2004, NEUROL SCI, V25, pS291, DOI 10.1007/s10072-004-0314-4; Ciancarelli I, 2003, CEPHALALGIA, V23, P39, DOI 10.1046/j.1468-2982.2003.00447.x; Cordero MD, 2009, CLIN BIOCHEM, V42, P732, DOI 10.1016/j.clinbiochem.2008.12.010; Cotan D, 2011, FASEB J, V25, P2669, DOI 10.1096/fj.10-165340; Dupic L, 2011, CRIT CARE, V15, DOI 10.1186/cc10429; Gupta R, 2009, ANN INDIAN ACAD NEUR, V12, P167, DOI 10.4103/0972-2327.56316; Gur A, 2008, CURR PAIN HEADACHE R, V12, P175, DOI 10.1007/s11916-008-0031-4; Hershey AD, 2007, HEADACHE, V47, P73, DOI 10.1111/j.1526-4610.2007.00652.x; Keller JN, 1998, REV NEUROSCIENCE, V9, P105; Kunitomo M, 2008, J PHARMACOL SCI, V107, P128, DOI 10.1254/jphs.FP0072365; Lawrence RC, 2008, ARTHRITIS RHEUM, V58, P26, DOI 10.1002/art.23176; LENAZ G, 1990, FREE RADICAL RES COM, V8, P317, DOI 10.3109/10715769009053365; Littarru GP, 2010, NUTRITION, V26, P250, DOI 10.1016/j.nut.2009.08.008; Lodi R, 1997, J NEUROL NEUROSUR PS, V62, P574, DOI 10.1136/jnnp.62.6.574; Lucas HJ, 2006, INT J IMMUNOPATH PH, V19, P5; Maes M, 2009, NEUROENDOCRINOL LETT, V30, P462; Maes M, 2009, NEUROENDOCRINOL LETT, V30, P470; Maharaj H, 2006, METAB BRAIN DIS, V21, P189, DOI 10.1007/s11011-006-9012-7; Marcus DA, 2005, CLIN RHEUMATOL, V24, P595, DOI 10.1007/s10067-005-1121-x; MOSKOWITZ MA, 1993, NEUROLOGY, V43, P16; Peres MFP, 2001, NEUROLOGY, V57, P1326, DOI 10.1212/WNL.57.7.1326; RAUCHOVA H, 1992, J BIOENERG BIOMEMBR, V24, P235, DOI 10.1007/BF00762682; Rodriguez-Hernandez A, 2009, AUTOPHAGY, V5, P19, DOI 10.4161/auto.5.1.7174; Salemi S, 2003, J RHEUMATOL, V30, P146; SAMORI B, 1992, J MEMBRANE BIOL, V128, P193; Sarzi-Puttini P, 2008, SEMIN ARTHRITIS RHEU, V37, P353, DOI 10.1016/j.semarthrit.2007.08.008; Sarzi-Puttini P, 2011, BEST PRACT RES CL RH, V25, P311, DOI 10.1016/j.berh.2011.03.001; Sparaco M, 2006, CEPHALALGIA, V26, P361, DOI 10.1111/j.1468-2982.2005.01059.x; Staud Roland, 2002, Curr Rheumatol Rep, V4, P299, DOI 10.1007/s11926-002-0038-5; Tomasetti M, 2001, FASEB J, V15, P1425, DOI 10.1096/fj.00-0694fje; Tuncel D, 2008, BIOL TRACE ELEM RES, V126, P92, DOI 10.1007/s12011-008-8193-9; Turunen M, 2004, BBA-BIOMEMBRANES, V1660, P171, DOI 10.1016/j.bbamem.2003.11.012; Uzar E, 2011, EUR REV MED PHARMACO, V15, P1111; Vanmolkot FH, 2007, CEPHALALGIA, V27, P843, DOI 10.1111/j.1468-2982.2007.01324.x; Wang ZQ, 2004, J PHARMACOL EXP THER, V309, P869, DOI 10.1124/jpet.103.064154; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; Wolfe F, 1997, ARTHRITIS RHEUM, V40, P1571, DOI 10.1002/art.1780400905	42	65	65	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e35677	10.1371/journal.pone.0035677	http://dx.doi.org/10.1371/journal.pone.0035677			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22532869	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336200065
J	Gomez, CE; Perdiguero, B; Jimenez, V; Filali-Mouhim, A; Ghneim, K; Haddad, EK; Quakkerlaar, ED; Delaloye, J; Harari, A; Roger, T; Dunhen, T; Sekaly, RP; Melief, CJM; Calandra, T; Sallusto, F; Lanzavecchia, A; Wagner, R; Pantaleo, G; Esteban, M				Elena Gomez, Carmen; Perdiguero, Beatriz; Jimenez, Victoria; Filali-Mouhim, Abdelali; Ghneim, Khader; Haddad, Elias K.; Quakkerlaar, Esther D.; Delaloye, Julie; Harari, Alexandre; Roger, Thierry; Dunhen, Thomas; Sekaly, Rafick P.; Melief, Cornelis J. M.; Calandra, Thierry; Sallusto, Federica; Lanzavecchia, Antonio; Wagner, Ralf; Pantaleo, Giuseppe; Esteban, Mariano			Systems Analysis of MVA-C Induced Immune Response Reveals Its Significance as a Vaccine Candidate against HIV/AIDS of Clade C	PLOS ONE			English	Article							T-CELL RESPONSES; POXVIRUS VECTORS MVA; VIRUS ANKARA; DENDRITIC CELLS; HIV-1 INFECTION; PHASE-1 SAFETY; DNA PRIME; IMMUNOGENICITY; NYVAC; ANTIGENS	Based on the partial efficacy of the HIV/AIDS Thai trial (RV144) with a canarypox vector prime and protein boost, attenuated poxvirus recombinants expressing HIV-1 antigens are increasingly sought as vaccine candidates against HIV/AIDS. Here we describe using systems analysis the biological and immunological characteristics of the attenuated vaccinia virus Ankara strain expressing the HIV-1 antigens Env/Gag-Pol-Nef of HIV-1 of clade C (referred as MVA-C). MVA-C infection of human monocyte derived dendritic cells (moDCs) induced the expression of HIV-1 antigens at high levels from 2 to 8 hpi and triggered moDCs maturation as revealed by enhanced expression of HLA-DR, CD86, CD40, HLA-A2, and CD80 molecules. Infection ex vivo of purified mDC and pDC with MVA-C induced the expression of immunoregulatory pathways associated with antiviral responses, antigen presentation, T cell and B cell responses. Similarly, human whole blood or primary macrophages infected with MVA-C express high levels of proinflammatory cytokines and chemokines involved with T cell activation. The vector MVA-C has the ability to cross-present antigens to HIV-specific CD8 T cells in vitro and to increase CD8 T cell proliferation in a dose-dependent manner. The immunogenic profiling in mice after DNA-C prime/MVA-C boost combination revealed activation of HIV-1-specific CD4 and CD8 T cell memory responses that are polyfunctional and with effector memory phenotype. Env-specific IgG binding antibodies were also produced in animals receiving DNA-C prime/MVA-C boost. Our systems analysis of profiling immune response to MVA-C infection highlights the potential benefit of MVA-C as vaccine candidate against HIV/AIDS for clade C, the prevalent subtype virus in the most affected areas of the world.	[Elena Gomez, Carmen; Perdiguero, Beatriz; Jimenez, Victoria; Esteban, Mariano] CSIC, Ctr Nacl Biotecnol, Dept Mol & Cellular Biol, Madrid, Spain; [Filali-Mouhim, Abdelali; Ghneim, Khader; Haddad, Elias K.; Sekaly, Rafick P.] Vaccine & Gene Therapy Inst Florida, Port St Lucie, FL USA; [Quakkerlaar, Esther D.; Melief, Cornelis J. M.] Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, Leiden, Netherlands; [Delaloye, Julie; Roger, Thierry; Calandra, Thierry] CHU Vaudois, Dept Med, Infect Dis Serv, CH-1011 Lausanne, Switzerland; [Delaloye, Julie; Roger, Thierry; Calandra, Thierry] Univ Lausanne, Lausanne, Switzerland; [Harari, Alexandre; Pantaleo, Giuseppe] CHU Vaudois, Div Immunol & Allergy, CH-1011 Lausanne, Switzerland; [Dunhen, Thomas; Sallusto, Federica; Lanzavecchia, Antonio] Biomed Res Inst, Bellinzona, Switzerland; [Wagner, Ralf] Univ Regensburg, Regensburg, Germany	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Vaccine & Gene Therapy Institute of Florida; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Universita della Svizzera Italiana; University of Regensburg	Gomez, CE (corresponding author), CSIC, Ctr Nacl Biotecnol, Dept Mol & Cellular Biol, Madrid, Spain.	mesteban@cnb.csic.es	Gomez, Carmen Elena/K-1940-2014; Perdiguero, Beatriz/K-6587-2017; Roger, Thierry/G-2007-2012; Esteban, Mariano/ABG-5375-2020; Calandra, Thierry/D-9017-2015; Pantaleo, Giuseppe/K-6163-2016	Gomez, Carmen Elena/0000-0002-5414-7935; Perdiguero, Beatriz/0000-0001-6276-7766; Roger, Thierry/0000-0002-9358-0109; Esteban, Mariano/0000-0003-0846-2827; Calandra, Thierry/0000-0003-3051-1285; Harari, Alexandre/0000-0002-1055-2090	Bill & Melinda Gates Foundation; SAF [2008-02036]; Swiss National Science Foundation [313600-115680]	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); SAF; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was conducted as part of the Poxvirus T Cell Vaccine Discovery Consortium (PTVDC) under the Collaboration for AIDS Vaccine Discovery with support from the Bill & Melinda Gates Foundation and by Spanish grant SAF 2008-02036. JD was supported by a grant from the Swiss National Science Foundation (number 313600-115680). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benjamini Y, 1995, J ROY STAT SOC, V57, P289; Clark RH, 2006, J GEN VIROL, V87, P29, DOI 10.1099/vir.0.81417-0; Climent N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019644; Currier JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013983; Delaloye J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000480; Gomez CE, 2007, VACCINE, V25, P1969, DOI 10.1016/j.vaccine.2006.11.051; Gomez CE, 2011, J VIROL, V85, P11468, DOI 10.1128/JVI.05165-11; Flynn BJ, 2011, P NATL ACAD SCI USA, V108, P7131, DOI 10.1073/pnas.1103869108; Garcia F, 2011, VACCINE, V29, P8309, DOI 10.1016/j.vaccine.2011.08.098; Garcia-Arriaza J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024244; Garcia-Arriaza J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012395; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Goepfert PA, 2011, J INFECT DIS, V203, P610, DOI 10.1093/infdis/jiq105; Gomez CE, 2011, CURR GENE THER, V11, P189; Gomez CE, 2009, VACCINE, V27, P3165, DOI 10.1016/j.vaccine.2009.03.049; Gomez CE, 2007, VACCINE, V25, P2863, DOI 10.1016/j.vaccine.2006.09.090; Guerra S, 2007, J VIROL, V81, P8707, DOI 10.1128/JVI.00444-07; Guerra S, 2010, J VIROL, V84, P8141, DOI 10.1128/JVI.00749-10; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Hansen SG, 2009, NAT MED, V15, P293, DOI 10.1038/nm.1935; Harari A, 2008, J EXP MED, V205, P63, DOI 10.1084/jem.20071331; Harari A, 2007, P NATL ACAD SCI USA, V104, P16233, DOI 10.1073/pnas.0707570104; Keefer MC, 2011, VACCINE, V29, P1948, DOI 10.1016/j.vaccine.2010.12.104; Kibler KV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025674; Kresge KJ, 2011, IAVI REP, V15, P4; Najera JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011406; McCormack S, 2008, VACCINE, V26, P3162, DOI 10.1016/j.vaccine.2008.02.072; McElrath MJ, 2010, IMMUNITY, V33, P542, DOI 10.1016/j.immuni.2010.09.011; Mooij P, 2008, J VIROL, V82, P2975, DOI 10.1128/JVI.02216-07; Pantaleo G, 2010, CURR OPIN HIV AIDS, V5, P391, DOI 10.1097/COH.0b013e32833d1e87; Pascutti MF, 2011, J VIROL, V85, P5532, DOI 10.1128/JVI.02267-10; Quakkelaar ED, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016819; Ramanathan VD, 2009, AIDS RES HUM RETROV, V25, P1107, DOI 10.1089/aid.2009.0096; Ramirez JC, 2000, J VIROL, V74, P923, DOI 10.1128/JVI.74.2.923-933.2000; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Sandstrom E, 2008, J INFECT DIS, V198, P1482, DOI 10.1086/592507; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Staib C, 2005, J GEN VIROL, V86, P1997, DOI 10.1099/vir.0.80646-0; Vasan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008816; Zhu YP, 2011, P NATL ACAD SCI USA, V108, P15834, DOI 10.1073/pnas.1101676108	40	21	22	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e35485	10.1371/journal.pone.0035485	http://dx.doi.org/10.1371/journal.pone.0035485			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22536391	Green Published, gold			2022-12-27	WOS:000305336200045
J	Guntas, G; Kanwar, M; Ostermeier, M				Guntas, Gurkan; Kanwar, Manu; Ostermeier, Marc			Circular Permutation in the Omega-Loop of TEM-1 beta-Lactamase Results in Improved Activity and Altered Substrate Specificity	PLOS ONE			English	Article							LIPASE-B; CANDIDA-ANTARCTICA; PROTEIN SWITCHES; MUTAGENESIS; INSERTION; EVOLUTION	Generating diverse protein libraries that contain improved variants at a sufficiently high frequency is critical for improving the properties of proteins using directed evolution. Many studies have illustrated how random mutagenesis, cassette mutagenesis, DNA shuffling and similar approaches are effective diversity generating methods for directed evolution. Very few studies have explored random circular permutation, the intramolecular relocation of the N- and C-termini of a protein, as a diversity-generating step for directed evolution. We subjected a library of random circular permutations of TEM-1 beta-lactamase to selections on increasing concentrations of a variety of beta-lactam antibiotics including cefotaxime. We identified two circularly permuted variants that conferred elevated resistance to cefotaxime but decreased resistance to other antibiotics. These variants were circularly permuted in the Omega-loop proximal to the active site. Remarkably, one variant was circularly permuted such that the key catalytic residue Glu166 was located at the N- terminus of the mature protein.	[Guntas, Gurkan; Kanwar, Manu; Ostermeier, Marc] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD USA	Johns Hopkins University	Guntas, G (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27515 USA.	oster@jhu.edu	Ostermeier, Marc/A-2697-2010	Ostermeier, Marc/0000-0003-0900-3665	National Institute of General Medicine at the National Institutes of Health [R01 GM066972]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066972] Funding Source: NIH RePORTER	National Institute of General Medicine at the National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by funding from the National Institute of General Medicine at the National Institutes of Health (R01 GM066972). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird GS, 1999, P NATL ACAD SCI USA, V96, P11241, DOI 10.1073/pnas.96.20.11241; Bosley AD, 2005, BIOMOL ENG, V22, P57, DOI 10.1016/j.bioeng.2004.11.002; Cheltsov AV, 2001, J BIOL CHEM, V276, P19141, DOI 10.1074/jbc.M100329200; Fisher JF, 2009, CURR PROTEIN PEPT SC, V10, P401, DOI 10.2174/138920309789351967; Graf R, 1996, P NATL ACAD SCI USA, V93, P11591, DOI 10.1073/pnas.93.21.11591; Guntas G, 2005, P NATL ACAD SCI USA, V102, P11224, DOI 10.1073/pnas.0502673102; Guntas G, 2004, CHEM BIOL, V11, P1483, DOI 10.1016/j.chembiol.2004.08.020; Hayes F, 1997, J BIOL CHEM, V272, P28833, DOI 10.1074/jbc.272.46.28833; Iwakura M, 2000, NAT STRUCT BIOL, V7, P580, DOI 10.1038/76811; MEISTER GE, 2009, PROTEIN ENG HDB; Minasov G, 2002, J AM CHEM SOC, V124, P5333, DOI 10.1021/ja0259640; Ostermeier M, 1999, NAT BIOTECHNOL, V17, P1205, DOI 10.1038/70754; Ostermeier M, 2005, PROTEIN ENG DES SEL, V18, P359, DOI 10.1093/protein/gzi048; Ostermeier M, 1999, P NATL ACAD SCI USA, V96, P3562, DOI 10.1073/pnas.96.7.3562; Osuna J, 2002, PROTEIN ENG, V15, P463, DOI 10.1093/protein/15.6.463; Petrosino JF, 1996, J BACTERIOL, V178, P1821, DOI 10.1128/jb.178.7.1821-1828.1996; Qian Z, 2005, J AM CHEM SOC, V127, P13466, DOI 10.1021/ja053932h; Qian Z, 2007, CHEMBIOCHEM, V8, P1989, DOI 10.1002/cbic.200700373; Qian Z, 2009, J MOL BIOL, V393, P191, DOI 10.1016/j.jmb.2009.08.008; Reitinger S, 2010, BIOCHEMISTRY-US, V49, P2464, DOI 10.1021/bi100036f; Salverda MLM, 2010, FEMS MICROBIOL REV, V34, P1015, DOI 10.1111/j.1574-6976.2010.00222.x; Topell S, 1999, FEBS LETT, V457, P283, DOI 10.1016/S0014-5793(99)01044-3; Yu Y, 2010, BIOTECHNOL BIOENG, V105, P44, DOI 10.1002/bit.22471	23	23	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e35998	10.1371/journal.pone.0035998	http://dx.doi.org/10.1371/journal.pone.0035998			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22536452	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336200071
J	Ma, TF; Zhao, XL; Cai, L; Zhang, N; Ren, SQ; Ji, F; Tian, T; Lu, W				Ma, Teng-Fei; Zhao, Xiao-Lei; Cai, Lei; Zhang, Nan; Ren, Si-Qiang; Ji, Fang; Tian, Tian; Lu, Wei			Regulation of Spike Timing-Dependent Plasticity of Olfactory Inputs in Mitral Cells in the Rat Olfactory Bulb	PLOS ONE			English	Article							NEOCORTICAL PYRAMIDAL NEURONS; ACTION-POTENTIAL PROPAGATION; GRANULE CELLS; LATERAL INHIBITION; SYNAPTIC PLASTICITY; ODOR DISCRIMINATION; TERM PLASTICITY; NMDA RECEPTORS; CALCIUM INFLUX; IN-VIVO	The recent history of activity input onto granule cells (GCs) in the main olfactory bulb can affect the strength of lateral inhibition, which functions to generate contrast enhancement. However, at the plasticity level, it is unknown whether and how the prior modification of lateral inhibition modulates the subsequent induction of long-lasting changes of the excitatory olfactory nerve (ON) inputs to mitral cells (MCs). Here we found that the repetitive stimulation of two distinct excitatory inputs to the GCs induced a persistent modification of lateral inhibition in MCs in opposing directions. This bidirectional modification of inhibitory inputs differentially regulated the subsequent synaptic plasticity of the excitatory ON inputs to the MCs, which was induced by the repetitive pairing of excitatory postsynaptic potentials (EPSPs) with postsynaptic bursts. The regulation of spike timing-dependent plasticity (STDP) was achieved by the regulation of the interspike-interval (ISI) of the postsynaptic bursts. This novel form of inhibition-dependent regulation of plasticity may contribute to the encoding or processing of olfactory information in the olfactory bulb.	[Ma, Teng-Fei; Zhao, Xiao-Lei; Cai, Lei; Zhang, Nan; Ren, Si-Qiang; Ji, Fang; Tian, Tian; Lu, Wei] Nanjing Med Univ, Dept Neurobiol, Nanjing, Jiangsu, Peoples R China; [Ma, Teng-Fei; Zhao, Xiao-Lei; Cai, Lei; Zhang, Nan; Ren, Si-Qiang; Ji, Fang; Tian, Tian; Lu, Wei] Nanjing Med Univ, Key Lab Neurodegenerat Dis Jiangsu Prov, Nanjing, Jiangsu, Peoples R China; [Lu, Wei] Nanjing Med Univ, Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Lu, Wei] Nanjing Med Univ, Key Lab Human Funct Genom Jiangsu Prov, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Lu, W (corresponding author), Nanjing Med Univ, Dept Neurobiol, Nanjing, Jiangsu, Peoples R China.	lu@njmu.edu.cn	Ma, Tengfei/B-6383-2017	Ma, Tengfei/0000-0002-8916-7370	National Natural Science Foundation of China (NSFC) [31025011, 30770704]; Major State Basic Research Program of China [2010CB912002]; State Key Laboratory of Bioelectronics, Southeast University; National Natural Science Foundation of China (NSFC) [31025011, 30770704]; Major State Basic Research Program of China [2010CB912002]; State Key Laboratory of Bioelectronics, Southeast University	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Major State Basic Research Program of China(National Basic Research Program of China); State Key Laboratory of Bioelectronics, Southeast University; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Major State Basic Research Program of China(National Basic Research Program of China); State Key Laboratory of Bioelectronics, Southeast University	This work was supported by grants to W.L. from the National Natural Science Foundation of China (NSFC. no. 31025011 and no. 30770704), the Major State Basic Research Program of China (2010CB912002) and the Open Research fund of State Key Laboratory of Bioelectronics, Southeast University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham NM, 2010, NEURON, V65, P399, DOI 10.1016/j.neuron.2010.01.009; Arevian AC, 2008, NAT NEUROSCI, V11, P80, DOI 10.1038/nn2030; Balu R, 2007, J NEUROSCI, V27, P5621, DOI 10.1523/JNEUROSCI.4630-06.2007; Birtoli B, 2004, J NEUROSCI, V24, P4935, DOI 10.1523/JNEUROSCI.0795-04.2004; Brennan PA, 1997, PROG NEUROBIOL, V51, P457, DOI 10.1016/S0301-0082(96)00069-X; Cang JH, 2003, J NEUROSCI, V23, P4108; Carlson GC, 2000, J NEUROSCI, V20, P2011; Cassenaer S, 2007, NATURE, V448, P709, DOI 10.1038/nature05973; Chen WR, 1997, BRAIN RES, V745, P189, DOI 10.1016/S0006-8993(96)01150-X; Chen WR, 2000, NEURON, V25, P625, DOI 10.1016/S0896-6273(00)81065-X; Debarbieux F, 2003, J NEUROSCI, V23, P5553; Dietz SB, 2005, J PHYSIOL-LONDON, V569, P475, DOI 10.1113/jphysiol.2005.095844; Egger V, 2003, J NEUROSCI, V23, P7551; Egger V, 2006, SEMIN CELL DEV BIOL, V17, P424, DOI 10.1016/j.semcdb.2006.04.006; Ennis M, 1998, ANN NY ACAD SCI, V855, P457, DOI 10.1111/j.1749-6632.1998.tb10606.x; Friedrich RW, 2004, J NEUROPHYSIOL, V91, P2658, DOI 10.1152/jn.01143.2003; Gao Y, 2009, NAT NEUROSCI, V12, P731, DOI 10.1038/nn.2319; Gire DH, 2008, J NEUROPHYSIOL, V99, P2021, DOI 10.1152/jn.01324.2007; Hayar A, 2007, J NEUROPHYSIOL, V98, P1052, DOI 10.1152/jn.01214.2006; Kapoor V, 2006, J NEUROSCI, V26, P11709, DOI 10.1523/JNEUROSCI.3371-06.2006; Kononenko NI, 2004, J NEUROPHYSIOL, V91, P267, DOI 10.1152/jn.00314.2003; Krahe R, 2004, NAT REV NEUROSCI, V5, P13, DOI 10.1038/nrn1296; Lagier S, 2004, J NEUROSCI, V24, P4382, DOI 10.1523/JNEUROSCI.5570-03.2004; Li CY, 2007, J PHYSIOL-LONDON, V581, P221, DOI 10.1113/jphysiol.2006.123810; Lledo PM, 2005, PHYSIOL REV, V85, P281, DOI 10.1152/physrev.00008.2004; Lobb CJ, 2010, J NEUROPHYSIOL, V104, P403, DOI 10.1152/jn.00204.2010; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Margrie TW, 2001, P NATL ACAD SCI USA, V98, P319, DOI 10.1073/pnas.011523098; Mutoh H, 2005, J NEUROSCI, V25, P4252, DOI 10.1523/JNEUROSCI.4721-04.2005; Najac M, 2011, J NEUROSCI, V31, P8722, DOI 10.1523/JNEUROSCI.0527-11.2011; Nevian T, 2006, J NEUROSCI, V26, P11001, DOI 10.1523/JNEUROSCI.1749-06.2006; Pressler RT, 2006, NEURON, V49, P889, DOI 10.1016/j.neuron.2006.02.019; Schaefer AT, 2006, PLOS BIOL, V4, P1010, DOI 10.1371/journal.pbio.0040163; Schoppa NE, 2006, NEURON, V49, P271, DOI 10.1016/j.neuron.2005.11.038; Schoppa NE, 2003, TRENDS NEUROSCI, V26, P501, DOI 10.1016/S0166-2236(03)00228-5; Schoppa NE, 2001, NEURON, V31, P639, DOI 10.1016/S0896-6273(01)00389-0; Schoppa NE, 1998, J NEUROSCI, V18, P6790; Schoppa NE, 1999, NAT NEUROSCI, V2, P1106, DOI 10.1038/16033; Shao Z, 2009, J NEUROPHYSIOL, V101, P1988, DOI 10.1152/jn.91116.2008; Shepherd GM, 2004, OLFACTORY BULB SYNAP; SOFTKY WR, 1993, J NEUROSCI, V13, P334; SPRUSTON N, 1995, SCIENCE, V268, P297, DOI 10.1126/science.7716524; Stopfer M, 1997, NATURE, V390, P70, DOI 10.1038/36335; Strowbridge BW, 2010, NEURON, V65, P295, DOI 10.1016/j.neuron.2010.01.029; Urban NN, 2002, PHYSIOL BEHAV, V77, P607, DOI 10.1016/S0031-9384(02)00895-8; Wachowiak M, 2006, SEMIN CELL DEV BIOL, V17, P411, DOI 10.1016/j.semcdb.2006.04.007; Williams SR, 2000, J NEUROSCI, V20, P8238, DOI 10.1523/JNEUROSCI.20-22-08238.2000; Xiong WH, 2002, NEURON, V34, P115, DOI 10.1016/S0896-6273(02)00628-1; YOKOI M, 1995, P NATL ACAD SCI USA, V92, P3371, DOI 10.1073/pnas.92.8.3371; Yuan Q, 2009, LEARN MEMORY, V16, P676, DOI 10.1101/lm.1569309	51	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e35001	10.1371/journal.pone.0035001	http://dx.doi.org/10.1371/journal.pone.0035001			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22536347	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336200019
J	Balbach, ST; Esteves, TC; Houghton, FD; Siatkowski, M; Pfeiffer, MJ; Tsurumi, C; Kanzler, B; Fuellen, G; Boiani, M				Balbach, Sebastian Thomas; Esteves, Telma Cristina; Houghton, Franchesca Dawn; Siatkowski, Marcin; Pfeiffer, Martin Johannes; Tsurumi, Chizuko; Kanzler, Benoit; Fuellen, Georg; Boiani, Michele			Nuclear Reprogramming: Kinetics of Cell Cycle and Metabolic Progression as Determinants of Success	PLOS ONE			English	Article							CLONED MOUSE EMBRYOS; ZYGOTIC GENOME ACTIVATION; NITRIC-OXIDE; STEM-CELLS; PREIMPLANTATION EMBRYO; FERTILIZED BLASTOCYSTS; IN-VIVO; EXPRESSION; CULTURE; PROLIFERATION	Establishment of totipotency after somatic cell nuclear transfer (NT) requires not only reprogramming of gene expression, but also conversion of the cell cycle from quiescence to the precisely timed sequence of embryonic cleavage. Inadequate adaptation of the somatic nucleus to the embryonic cell cycle regime may lay the foundation for NT embryo failure and their reported lower cell counts. We combined bright field and fluorescence imaging of histone H-2b-GFP expressing mouse embryos, to record cell divisions up to the blastocyst stage. This allowed us to quantitatively analyze cleavage kinetics of cloned embryos and revealed an extended and inconstant duration of the second and third cell cycles compared to fertilized controls generated by intracytoplasmic sperm injection (ICSI). Compared to fertilized embryos, slow and fast cleaving NT embryos presented similar rates of errors in M phase, but were considerably less tolerant to mitotic errors and underwent cleavage arrest. Although NT embryos vary substantially in their speed of cell cycle progression, transcriptome analysis did not detect systematic differences between fast and slow NT embryos. Profiling of amino acid turnover during pre-implantation development revealed that NT embryos consume lower amounts of amino acids, in particular arginine, than fertilized embryos until morula stage. An increased arginine supplementation enhanced development to blastocyst and increased embryo cell numbers. We conclude that a cell cycle delay, which is independent of pluripotency marker reactivation, and metabolic restraints reduce cell counts of NT embryos and impede their development.	[Balbach, Sebastian Thomas; Esteves, Telma Cristina; Pfeiffer, Martin Johannes; Boiani, Michele] Max Planck Inst Mol Biomed, Munster, Germany; [Houghton, Franchesca Dawn] Univ Southampton, Southampton Gen Hosp, Fac Med, Southampton, Hants, England; [Siatkowski, Marcin] DZNE, German Ctr Neurodegenerat Disorders, Rostock, Germany; [Siatkowski, Marcin; Fuellen, Georg] Univ Rostock, Inst Biostat & Informat Med & Ageing Res, Rostock, Germany; [Tsurumi, Chizuko] Univ Hosp Freiburg, Dept Radiat Oncol, Freiburg, Germany; [Kanzler, Benoit] Max Planck Inst Immunobiol & Epigenet, Freiburg, Germany	Max Planck Society; University of Southampton; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Rostock; University of Freiburg; Max Planck Society	Balbach, ST (corresponding author), Max Planck Inst Mol Biomed, Munster, Germany.	mboiani@mpi-muenster.mpg.de	Balbach, Sebastian Thomas/A-1107-2009; Boiani, Michele/M-3519-2015; Pfeiffer, Martin Johannes/A-9332-2011	Balbach, Sebastian Thomas/0000-0003-0212-5758; Boiani, Michele/0000-0003-2765-2781; Pfeiffer, Martin Johannes/0000-0001-9264-9218; Houghton, Franchesca/0000-0002-5167-1694; Esteves, Telma Cristina/0000-0002-8642-4722	Deutsche Forschungsgemeinschaft (DFG) [SPP 1356]; UK Medical Research Council [G0701153]; MRC [G0701153] Funding Source: UKRI; Medical Research Council [G0701153] Funding Source: researchfish	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This project was supported in part by the Deutsche Forschungsgemeinschaft (DFG, www.dfg.de), SPP 1356. Dr. Houghton acknowledges support from the UK Medical Research Council (G0701153; www.mrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balbach ST, 2010, DEV BIOL, V343, P71, DOI 10.1016/j.ydbio.2010.04.012; Balbach ST, 2007, DEV BIOL, V308, P309, DOI 10.1016/j.ydbio.2007.05.034; Becker KA, 2006, J CELL PHYSIOL, V209, P883, DOI 10.1002/jcp.20776; Blake JA, 2011, NUCLEIC ACIDS RES, V39, pD842, DOI 10.1093/nar/gkq1008; Boiani M, 2005, STEM CELLS, V23, P1089, DOI 10.1634/stemcells.2004-0352; Boiani M, 2004, CYTOGENET GENOME RES, V105, P270, DOI 10.1159/000078198; Boiani M, 2003, EMBO J, V22, P5304, DOI 10.1093/emboj/cdg507; Boiani M, 2002, GENE DEV, V16, P1209, DOI 10.1101/gad.966002; Booth PJ, 2005, REPRODUCTION, V130, P655, DOI 10.1530/rep.1.00727; BOWMAN P, 1970, J EMBRYOL EXP MORPH, V24, P203; Brambrink T, 2006, P NATL ACAD SCI USA, V103, P933, DOI 10.1073/pnas.0510485103; Brison DR, 2004, HUM REPROD, V19, P2319, DOI 10.1093/humrep/deh409; Bultman SJ, 2006, GENE DEV, V20, P1744, DOI 10.1101/gad.1435106; Castedo M, 2004, ONCOGENE, V23, P2825, DOI 10.1038/sj.onc.1207528; Cavaleri FM, 2008, MECH DEVELOP, V125, P153, DOI 10.1016/j.mod.2007.09.007; Chirino-Galindo G, 2009, BIRTH DEFECTS RES B, V86, P58, DOI 10.1002/bdrb.20182; Chu L, 2008, EUR J PHARMACOL, V591, P59, DOI 10.1016/j.ejphar.2008.06.066; Colussi C, 2009, FASEB J, V23, P2131, DOI 10.1096/fj.08-115618; Day ML, 2001, REPROD FERT DEVELOP, V13, P69, DOI 10.1071/RD00048; Ding JJ, 2009, PROTEOMICS, V9, P2711, DOI 10.1002/pmic.200800824; Du P, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-16; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Esteves TC, 2011, AGING CELL, V10, P80, DOI 10.1111/j.1474-9726.2010.00644.x; Falco G, 2007, DEV BIOL, V307, P539, DOI 10.1016/j.ydbio.2007.05.003; Foster David A, 2010, Genes Cancer, V1, P1124, DOI 10.1177/1947601910392989; Gao SR, 2003, BIOL REPROD, V69, P48, DOI 10.1095/biolreprod.102.014522; Gates AH, 2008, CIBA FDN S PREIMPL S, P270; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Goval JJ, 2000, EUR J MORPHOL, V38, P88, DOI 10.1076/0924-3860(200004)38:2;1-F;FT088; Hamatani T, 2004, DEV CELL, V6, P117, DOI 10.1016/S1534-5807(03)00373-3; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; HARLOW GM, 1982, AUST J BIOL SCI, V35, P187, DOI 10.1071/BI9820187; Houghton FD, 2006, DIFFERENTIATION, V74, P11, DOI 10.1111/j.1432-0436.2006.00052.x; Houghton FD, 2002, HUM REPROD, V17, P999, DOI 10.1093/humrep/17.4.999; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; KALOUSEK DK, 1983, SCIENCE, V221, P665, DOI 10.1126/science.6867735; Kawasumi M, 2007, J REPROD DEVELOP, V53, P615, DOI 10.1262/jrd.19007; Kim JY, 2011, BIOL REPROD, V84, P70, DOI 10.1095/biolreprod.110.085753; Kubiak JZ, 2001, NOVART FDN SYMP, V237, P79, DOI 10.1002/0470846666.ch7; Lane M, 1998, HUM REPROD, V13, P991, DOI 10.1093/humrep/13.4.991; LEMAIRE P, 1995, CELL, V81, P85, DOI 10.1016/0092-8674(95)90373-9; Li CB, 2011, ZYGOTE, V19, P271, DOI 10.1017/S0967199410000377; Lightfoot DA, 2006, DEV BIOL, V289, P384, DOI 10.1016/j.ydbio.2005.11.001; Loi P, 2008, BIOESSAYS, V30, P66, DOI 10.1002/bies.20684; LUK GD, 1980, SCIENCE, V210, P195, DOI 10.1126/science.6774420; Maccarrone M, 2001, FEBS LETT, V507, P30, DOI 10.1016/S0014-5793(01)02949-0; Manser RC, 2004, BIOL REPROD, V71, P528, DOI 10.1095/biolreprod.103.025742; Marzluff WF, 2002, GENOMICS, V80, P487, DOI 10.1006/geno.2002.6850; Munne S, 2005, FERTIL STERIL, V84, P1328, DOI 10.1016/j.fertnstert.2005.06.025; Pfeiffer MJ, 2011, J PROTEOME RES, V10, P2140, DOI 10.1021/pr100706k; Pfeiffer MJ, 2010, INT J DEV BIOL, V54, P1649, DOI 10.1387/ijdb.103197mp; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; ROWLEY R, 1992, NATURE, V356, P353, DOI 10.1038/356353a0; Schultz RM, 2002, HUM REPROD UPDATE, V8, P323, DOI 10.1093/humupd/8.4.323; Sean D, 2007, BIOINFORMATICS, V23, P1846, DOI 10.1093/bioinformatics/btm254; Singhal N, 2010, CELL, V141, P943, DOI 10.1016/j.cell.2010.04.037; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Stokes PJ, 2007, HUM REPROD, V22, P829, DOI 10.1093/humrep/del447; STREFFER C, 1980, CELL TISSUE KINET, V13, P135, DOI 10.1111/j.1365-2184.1980.tb00456.x; Sturmey RG, 2008, REPROD BIOMED ONLINE, V17, P486, DOI 10.1016/S1472-6483(10)60234-9; Szabo PE, 2002, MECH DEVELOP, V115, P157, DOI 10.1016/S0925-4773(02)00087-4; Tay JI, 1997, HUM REPROD, V12, P2451, DOI 10.1093/humrep/12.11.2451; Varshavsky A., 2011, PROTEIN SCI; Vassena R, 2007, MOL REPROD DEV, V74, P1548, DOI 10.1002/mrd.20723; Wakayama S, 2006, STEM CELLS, V24, P2023, DOI 10.1634/stemcells.2005-0537; WANG JP, 1992, J REPROD FERTIL, V94, P431, DOI 10.1530/jrf.0.0940431; Wang JL, 2011, CHEM BIOL, V18, P121, DOI 10.1016/j.chembiol.2010.10.016; Wang QT, 2004, DEV CELL, V6, P133, DOI 10.1016/S1534-5807(03)00404-0; Wang QX, 1997, MOL REPROD DEV, V47, P265, DOI 10.1002/(SICI)1098-2795(199707)47:3&lt;265::AID-MRD5&gt;3.0.CO;2-J; Wong CC, 2010, NAT BIOTECHNOL, V28, P1115, DOI 10.1038/nbt.1686; Wossidlo M, 2010, EMBO J, V29, P1877, DOI 10.1038/emboj.2010.80; Yamagata K, 2009, J REPROD DEVELOP, V55, P343, DOI 10.1262/jrd.20166; Yu Y, 2007, REPRODUCTION, V133, P947, DOI 10.1530/REP-06-0358; Zeng FY, 2004, DEV BIOL, V272, P483, DOI 10.1016/j.ydbio.2004.05.018; Zuccotti M, 2002, MOL REPROD DEV, V61, P14, DOI 10.1002/mrd.1126	76	17	17	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35322	10.1371/journal.pone.0035322	http://dx.doi.org/10.1371/journal.pone.0035322			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22530006	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000305350600075
J	Fei, JW; de Villiers, EM				Fei, Jian-Wei; de Villiers, Ethel-Michele			Differential Regulation of Cutaneous Oncoprotein HPVE6 by wtp53, Mutant p53R248W and Delta Np63 alpha is HPV Type Dependent	PLOS ONE			English	Article							SQUAMOUS-CELL-CARCINOMA; HUMAN-PAPILLOMAVIRUS; INDUCED APOPTOSIS; E6 PROTEINS; E7 ONCOPROTEIN; SKIN-CANCER; CYCLIN D1; B PATHWAY; WILD-TYPE; P53	UV exposure and p53 mutations are major factors in non-melanoma skin cancer, whereas a role for HPV infections has not been defined. Previous data demonstrated the wtp53-mediated degradation of cutaneous HPV20E6 by caspase-3. Delta Np63 alpha and hot-spot mutant p53R248W conveyed a protective effect on HPV20E6 under these conditions. We demonstrate a differential regulation by wtp53 of the E6 genes of cutaneous types HPV4, HPV5, HPV7, HPV27, HPV38, HPV48, HPV60 and HPV77. Caspase- or proteasome-mediated down-regulation was HPV type dependent. Mutant p53R248W up-regulated expression of all these E6 proteins as did Delta Np63 alpha except for HPV38E6 which was down-regulated by the latter. None of these cellular proteins affected HPV41E6 expression. Ectopic expression of both mutp53R248W and Delta Np63 alpha in the normal NIKS keratinocyte cell line harbouring endogenous p53 and p63however led to a down-regulation of HPV20E6. We demonstrate that HPV20E6 expression in these cells is modulated by additional, yet unidentified, cellular protein(s), which are not necessarily involved in apoptosis or autophagy. We further demonstrate proliferation of HPV20E6-expressing keratinocytes. Levels of proteins involved in cell cycle control, cyclin-D1, cdk6 and p16(INK4a), phosphorylated pRB, as well as c-Jun and p-c-Jun, were all increased in these cells. HPV20E6 did not compete for the interaction between p16(INK4a) with cyclin-D1 or cdk6. Phosphorylation of pRB in the HPV20E6 expressing cells seems to be sufficient to override the cytokenetic block induced by the p16(INK4a)/pRB pathway. The present study demonstrates the diverse influence of p53 family members on individual cutaneous HPVE6 proteins. HPV20E6 expression also resulted in varying protein levels of factors involved in proliferation and differentiation.	[Fei, Jian-Wei; de Villiers, Ethel-Michele] Deutsch Krebsforschungszentrum, Div Characterizat Tumorviruses, D-6900 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ)	Fei, JW (corresponding author), Deutsch Krebsforschungszentrum, Div Characterizat Tumorviruses, D-6900 Heidelberg, Germany.	e.devilliers@dkfz.de						Alam S, 2010, J VIROL, V84, P4630, DOI 10.1128/JVI.02431-09; Antonsson A, 2000, J VIROL, V74, P11636, DOI 10.1128/JVI.74.24.11636-11641.2000; Arron ST, 2011, J INVEST DERMATOL, V131, P1745, DOI 10.1038/jid.2011.91; Asgari MM, 2008, J INVEST DERMATOL, V128, P1409, DOI 10.1038/sj.jid.5701227; Astori G, 1998, J INVEST DERMATOL, V110, P752, DOI 10.1046/j.1523-1747.1998.00191.x; Aylon Y, 2011, CURR OPIN GENET DEV, V21, P86, DOI 10.1016/j.gde.2010.10.002; Bedard KM, 2008, J VIROL, V82, P3894, DOI 10.1128/JVI.01818-07; Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002; BRASH DE, 1991, P NATL ACAD SCI USA, V88, P10124, DOI 10.1073/pnas.88.22.10124; Cain K, 2003, DRUG METAB REV, V35, P337, DOI 10.1081/DMR-120026497; Chen ACH, 2008, J GEN VIROL, V89, P2891, DOI 10.1099/vir.0.2008/003665-0; de Koning MNC, 2009, J GEN VIROL, V90, P1611, DOI 10.1099/vir.0.010017-0; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; de Villiers EM, 1999, SEMIN CANCER BIOL, V9, P413, DOI 10.1006/scbi.1999.0145; Dell'Orso S, 2011, OMICS, V15, P305, DOI 10.1089/omi.2010.0084; Eisenberg-Lerner A, 2009, CELL DEATH DIFFER, V16, P966, DOI 10.1038/cdd.2009.33; Ekstrom J, 2011, INT J CANCER, V129, P2643, DOI 10.1002/ijc.26204; Fei JW, 2006, ONCOGENE, V25, P3914, DOI 10.1038/sj.onc.1209420; Fei JW, 2008, INT J CANCER, V123, P108, DOI 10.1002/ijc.23506; Fei JW, 2005, CELL CYCLE, V4, P689, DOI 10.4161/cc.4.5.1653; Flores ER, 2007, CELL CYCLE, V6, P300, DOI 10.4161/cc.6.3.3793; Forslund O, 2007, J INFECT DIS, V196, P876, DOI 10.1086/521031; Gabet AS, 2008, FASEB J, V22, P622, DOI 10.1096/fj.07-8389com; Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; Ghittoni R, 2010, VIRUS GENES, V40, P1, DOI 10.1007/s11262-009-0412-8; Goldstein I, 2011, CANCER GENE THER, V18, P2, DOI 10.1038/cgt.2010.63; Graziano V, 2011, BBA-REV CANCER, V1816, P57, DOI 10.1016/j.bbcan.2011.04.002; Hibi K, 2000, P NATL ACAD SCI USA, V97, P5462, DOI 10.1073/pnas.97.10.5462; Howie HL, 2009, VIROLOGY, V384, P324, DOI 10.1016/j.virol.2008.11.017; Inoue S, 2009, CELL DEATH DIFFER, V16, P1053, DOI 10.1038/cdd.2009.29; Jackson S, 2000, GENE DEV, V14, P3065, DOI 10.1101/gad.182100; Kawamura K, 2006, CANCER SCI, V97, P252, DOI 10.1111/j.1349-7006.2006.00168.x; King KE, 2008, CANCER RES, V68, P5122, DOI 10.1158/0008-5472.CAN-07-6123; KIYONO T, 1992, VIROLOGY, V186, P628, DOI 10.1016/0042-6822(92)90029-O; Lambert PF, 2005, METH MOLEC MED, V119, P141; Larsson LG, 2011, SEMIN CANCER BIOL, V21, P367, DOI 10.1016/j.semcancer.2011.10.005; Leverrier S, 2007, APOPTOSIS, V12, P549, DOI 10.1007/s10495-006-0004-1; Mantovani F, 2001, ONCOGENE, V20, P7874, DOI 10.1038/sj.onc.1204869; Massimi P, 2008, VIROLOGY, V371, P374, DOI 10.1016/j.virol.2007.10.015; Melino G, 2011, CELL DEATH DIFFER, V18, P1487, DOI 10.1038/cdd.2011.81; Michel A, 2006, J VIROL, V80, P11153, DOI 10.1128/JVI.00954-06; Nobre RJ, 2009, J VIROL, V83, P2907, DOI 10.1128/JVI.02490-08; Olivier M, 2002, HUM MUTAT, V19, P607, DOI 10.1002/humu.10081; Ortega S, 2002, BBA-REV CANCER, V1602, P73, DOI 10.1016/S0304-419X(02)00037-9; Petitjean A, 2008, CARCINOGENESIS, V29, P273, DOI 10.1093/carcin/bgm258; Pim D, 2005, ONCOGENE, V24, P7830, DOI 10.1038/sj.onc.1208935; Pim D, 2002, ONCOGENE, V21, P8140, DOI 10.1038/sj.onc.1206026; Plasmeijer EI, 2010, INT J CANCER, V126, P2614, DOI 10.1002/ijc.24991; Sablina AA, 2008, CANCER METAST REV, V27, P137, DOI 10.1007/s10555-008-9116-0; Struijk L, 2008, J GEN VIROL, V89, P2303, DOI 10.1099/vir.0.83317-0; Su XH, 2009, EMBO J, V28, P1904, DOI 10.1038/emboj.2009.151; Sun Y, 2004, CLIN CANCER RES, V10, P5087, DOI 10.1158/1078-0432.CCR-03-0622; Takahashi A, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-10; Tashiro E, 2007, CANCER SCI, V98, P629, DOI 10.1111/j.1349-7006.2007.00449.x; Underbrink MP, 2008, J VIROL, V82, P10408, DOI 10.1128/JVI.00902-08; Van Dross R, 2005, JNCI-J NATL CANCER I, V97, P656, DOI 10.1093/jnci/dji113; Vasiljevic N, 2008, VIRUS RES, V137, P213, DOI 10.1016/j.virusres.2008.07.013; Wang X, 2011, AM J PATHOL, V178, P345, DOI 10.1016/j.ajpath.2010.11.032; Westermarck J, 2008, TRENDS MOL MED, V14, P152, DOI 10.1016/j.molmed.2008.02.001; Woods M, 2010, INT J ONCOL, V37, P1471, DOI 10.3892/ijo_00000799; Xu J, 2011, NAT CHEM BIOL, V7, P285, DOI 10.1038/nchembio.546; Yan JL, 2007, P NATL ACAD SCI USA, V104, P1841, DOI 10.1073/pnas.0605562104; ZIEGLER A, 1993, P NATL ACAD SCI USA, V90, P4216, DOI 10.1073/pnas.90.9.4216; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	64	4	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35540	10.1371/journal.pone.0035540	http://dx.doi.org/10.1371/journal.pone.0035540			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22530045	gold, Green Submitted, Green Published			2022-12-27	WOS:000305350600097
J	Harbison, NW; Bhattacharya, S; Eliezer, D				Harbison, Nicholas W.; Bhattacharya, Shibani; Eliezer, David			Assigning Backbone NMR Resonances for Full Length Tau Isoforms: Efficient Compromise between Manual Assignments and Reduced Dimensionality	PLOS ONE			English	Article							MICROTUBULE-ASSOCIATED PROTEIN; PAIRED HELICAL FILAMENT; SPECTRAL INFORMATION; ALZHEIMERS-DISEASE; NERVOUS-SYSTEM; REPEAT DOMAIN; GFT-NMR; BINDING; PHOSPHORYLATION; SPECTROSCOPY	Tau protein is the longest disordered protein for which nearly complete backbone NMR resonance assignments have been reported. Full-length tau protein was initially assigned using a laborious combination of bootstrapping assignments from shorter tau fragments and conventional triple resonance NMR experiments. Subsequently it was reported that assignments of comparable quality could be obtained in a fully automated fashion from data obtained using reduced dimensionality NMR (RDNMR) experiments employing a large number of indirect dimensions. Although the latter strategy offers many advantages, it presents some difficulties if manual intervention, confirmation, or correction of the assignments is desirable, as may often be the case for long disordered and degenerate polypeptide sequences. Here we demonstrate that nearly complete backbone resonance assignments for full-length tau isoforms can be obtained without resorting either to bootstrapping from smaller fragments or to very high dimensionality experiments and automation. Instead, a set of RDNMR triple resonance experiments of modest dimensionality lend themselves readily to efficient and unambiguous manual assignments. An analysis of the backbone chemical shifts obtained in this fashion indicates several regions in full length tau with a notable propensity for helical or strand-like structure that are in good agreement with previous observations.	[Harbison, Nicholas W.; Eliezer, David] Weill Cornell Med Coll, Dept Biochem, Tri Inst Program Chem Biol, New York, NY USA; [Bhattacharya, Shibani] New York Struct Biol Ctr, New York, NY USA	Cornell University	Harbison, NW (corresponding author), Weill Cornell Med Coll, Dept Biochem, Tri Inst Program Chem Biol, New York, NY USA.	dae2005@med.cornell.edu			NIH/NIA [AG025440, AG019391]; NSF (National Science Foundation) [DMR-0454672]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM066354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG025440, R01AG019391, R37AG019391] Funding Source: NIH RePORTER	NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NSF (National Science Foundation)(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIH/NIA grants AG025440 and AG019391 (Dr. Eliezer) and GM066354 (NYSBC - New York Structural Biology Center,) (www.nih.gov) and NSF (National Science Foundation) agreement DMR-0454672 (NYSBC) (www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atreya HS, 2005, J AM CHEM SOC, V127, P4554, DOI 10.1021/ja042562e; Atreya HS, 2004, P NATL ACAD SCI USA, V101, P9642, DOI 10.1073/pnas.0403529101; Barre P, 2006, J MOL BIOL, V362, P312, DOI 10.1016/j.jmb.2006.07.018; Bibow S, 2011, ANGEW CHEM INT EDIT, V50, P11520, DOI 10.1002/anie.201105493; Bibow S, 2011, J AM CHEM SOC, V133, P15842, DOI 10.1021/ja205836j; BINDER LI, 1985, J CELL BIOL, V101, P1371, DOI 10.1083/jcb.101.4.1371; BRANDT R, 1995, J CELL BIOL, V131, P1327, DOI 10.1083/jcb.131.5.1327; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P1; CLEVELAND DW, 1977, J MOL BIOL, V116, P207, DOI 10.1016/0022-2836(77)90213-3; CLEVELAND DW, 1977, J MOL BIOL, V116, P227, DOI 10.1016/0022-2836(77)90214-5; COUCHIE D, 1992, P NATL ACAD SCI USA, V89, P4378, DOI 10.1073/pnas.89.10.4378; Drewes G, 1997, CELL, V89, P297, DOI 10.1016/S0092-8674(00)80208-1; Dyson HJ, 1998, NAT STRUCT BIOL, V5, P499, DOI 10.1038/739; Eliezer D, 2005, BIOCHEMISTRY-US, V44, P1026, DOI 10.1021/bi048953n; Eliezer D, 2009, CURR OPIN STRUC BIOL, V19, P23, DOI 10.1016/j.sbi.2008.12.004; Fauquant C, 2011, J BIOL CHEM, V286, P33358, DOI 10.1074/jbc.M111.223545; Freuh D, 2006, PHI7AJ AM CHEM SOC, V128, P5757; Garcia ML, 2001, CURR OPIN CELL BIOL, V13, P41, DOI 10.1016/S0955-0674(00)00172-1; Goedert M, 2000, ANN NY ACAD SCI, V920, P74; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; GUSTKE N, 1994, BIOCHEMISTRY-US, V33, P9511, DOI 10.1021/bi00198a017; Ingram EM, 2002, TRENDS MOL MED, V8, P555, DOI 10.1016/S1471-4914(02)02440-1; Jeganathan S, 2006, BIOCHEMISTRY-US, V45, P2283, DOI 10.1021/bi0521543; Jenkins SM, 1998, NEUROREPORT, V9, P67, DOI 10.1097/00001756-199801050-00014; Kim S, 2003, J AM CHEM SOC, V125, P1385, DOI 10.1021/ja028197d; KSIEZAKREDING H, 1991, NEURON, V6, P717, DOI 10.1016/0896-6273(91)90169-Z; Landrieu I, 2006, J AM CHEM SOC, V128, P3575, DOI 10.1021/ja054656+; Landrieu I, 2010, BIOCHEM SOC T, V38, P1006, DOI 10.1042/BST0381006; Leroy A, 2010, J BIOL CHEM, V285, P33435, DOI 10.1074/jbc.M110.149419; Lippens G, 2006, PROTEIN PEPTIDE LETT, V13, P235, DOI 10.2174/092986606775338461; LOPRESTI P, 1995, P NATL ACAD SCI USA, V92, P10369, DOI 10.1073/pnas.92.22.10369; Mukrasch MD, 2007, J BIOL CHEM, V282, P12230, DOI 10.1074/jbc.M607159200; Mukrasch MD, 2009, PLOS BIOL, V7, P399, DOI 10.1371/journal.pbio.1000034; Narayanan RL, 2010, J AM CHEM SOC, V132, P11906, DOI 10.1021/ja105657f; Peterson DW, 2008, BIOCHEMISTRY-US, V47, P7393, DOI 10.1021/bi702466a; Sibille N, 2012, PROTEINS, V80, P454, DOI 10.1002/prot.23210; Sillen A, 2007, BIOCHEMISTRY-US, V46, P3055, DOI 10.1021/bi061920i; Smet C, 2004, CHEMBIOCHEM, V5, P1639, DOI 10.1002/cbic.200400145; Szyperski T, 2006, MAGN RESON CHEM, V44, pS51, DOI 10.1002/mrc.1817; von Bergen M, 2000, P NATL ACAD SCI USA, V97, P5129, DOI 10.1073/pnas.97.10.5129; Wagner U, 1996, J CELL SCI, V109, P1537; Wei ML, 1998, J NEUROCHEM, V70, P1346; WEISEMANN R, 1993, J BIOMOL NMR, V3, P113; WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4884, DOI 10.1073/pnas.85.13.4884; Wishart DS, 2001, METHOD ENZYMOL, V338, P3; WUTHRICK K, 1986, NMR PROTEINS NUCL AC; Xia YL, 2004, J BIOMOL NMR, V29, P467, DOI 10.1023/B:JNMR.0000034352.75619.3f	47	30	30	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e34679	10.1371/journal.pone.0034679	http://dx.doi.org/10.1371/journal.pone.0034679			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529924	Green Published, Green Submitted, gold			2022-12-27	WOS:000305350600019
J	Martinez-Vaquero, LA; Cuesta, JA; Sanchez, A				Martinez-Vaquero, Luis A.; Cuesta, Jose A.; Sanchez, Angel			Generosity Pays in the Presence of Direct Reciprocity: A Comprehensive Study of 2x2 Repeated Games	PLOS ONE			English	Article							TIT-FOR-TAT; WIN-STAY; EVOLUTION; COOPERATION; AUTOMATA; RULES	By applying a technique previously developed to study ecosystem assembly [Capitan et al., Phys. Rev. Lett. 103, 168101 (2009)] we study the evolutionary stable strategies of iterated 2x2 games. We focus on memory-one strategies, whose probability to play a given action depends on the actions of both players in the previous time step. We find the asymptotically stable populations resulting from all possible invasions of any known stable population. The results of this invasion process are interpreted as transitions between different populations that occur with a certain probability. Thus the whole process can be described as a Markov chain whose states are the different stable populations. With this approach we are able to study the whole space of symmetric 2x2 games, characterizing the most probable results of evolution for the different classes of games. Our analysis includes quasi-stationary mixed equilibria that are relevant as very long-lived metastable states and is compared to the predictions of a fixation probability analysis. We confirm earlier results on the success of the Pavlov strategy in a wide range of parameters for the iterated Prisoner's Dilemma, but find that as the temptation to defect grows there are many other possible successful strategies. Other regions of the diagram reflect the equilibria structure of the underlying one-shot game, albeit often some non-expected strategies arise as well. We thus provide a thorough analysis of iterated 2x2 games from which we are able to extract some general conclusions. Our most relevant finding is that a great deal of the payoff parameter range can still be understood by focusing on win-stay, lose-shift strategies, and that very ambitious ones, aspiring to obtaining always a high payoff, are never evolutionary stable.	[Martinez-Vaquero, Luis A.; Cuesta, Jose A.; Sanchez, Angel] Univ Carlos III Madrid, Dept Matemat, GISC, Madrid, Spain; [Cuesta, Jose A.; Sanchez, Angel] Univ Zaragoza, Inst Biocomput & Fis Sistemas Complejos BIFI, Zaragoza, Spain	Universidad Carlos III de Madrid; University of Zaragoza	Martinez-Vaquero, LA (corresponding author), Univ Carlos III Madrid, Dept Matemat, GISC, Madrid, Spain.	cuesta@math.uc3m.es	Cuesta, Jose A/Z-4696-2019; Martinez-Vaquero, Luis A./AAD-3883-2021; Sánchez, Angel/A-9229-2008; Cuesta, Jose A/A-7157-2008	Martinez-Vaquero, Luis A./0000-0001-8194-8757; Sánchez, Angel/0000-0003-1874-2881; Cuesta, Jose A/0000-0001-9890-9367	Ministerio de Ciencia e Innovacion, Spain; European Research Area Complexity-Net; Comunidad de Madrid, Spain; Alianza 4 Universidades	Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Research Area Complexity-Net; Comunidad de Madrid, Spain(Comunidad de Madrid); Alianza 4 Universidades	This work was supported in part by Ministerio de Ciencia e Innovacion, Spain (http://www.micinn.es) through grants MOSAICO and PRODIEVO, by European Research Area Complexity-Net (http://www.complexitynet.eu) though grant RESINEE, and by Comunidad de Madrid, Spain (http://www.madrid.org) through grant MODELICO. Luis A. Martinez-Vaquero was supported by a postdoctoral fellowship from Alianza 4 Universidades (http://www.alliance4universities.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; BINMORE KG, 1992, J ECON THEORY, V57, P278, DOI 10.1016/0022-0531(92)90037-I; Capitan JA, 2011, J THEOR BIOL, V269, P330, DOI 10.1016/j.jtbi.2010.09.032; Capitan JA, 2011, J THEOR BIOL, V269, P344, DOI 10.1016/j.jtbi.2010.10.031; Capitan JA, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.168101; Darwin C., 1871, P423; Dugatkin L.A., 1997, COOPERATION ANIMALS; FUDENBERG D, 1990, AM ECON REV, V80, P274; Fudenberg D, 2012, AM EC REV IN PRESS; Fudenberg D, 2006, J ECON THEORY, V131, P251, DOI 10.1016/j.jet.2005.04.006; Gracia A, 2009, P NATL ACAD SCI USA, V106, P6573, DOI 10.1073/pnas.0900965106; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Hammerstein P, 2003, DAHL WS ENV, P83; Hammerstein P, GENETIC CULTURAL EVO; Hofbauer J, 1998, EVOLUTIONARY GAMES P; Hublin JJ, 2009, P NATL ACAD SCI USA, V106, P6429, DOI 10.1073/pnas.0902614106; Imhof LA, 2005, P NATL ACAD SCI USA, V102, P10797, DOI 10.1073/pnas.0502589102; Imhof LA, 2007, J THEOR BIOL, V247, P574, DOI 10.1016/j.jtbi.2007.03.027; Kappeler PM, COOPERATION PRIMATES; Karlin S., 1975, 1 COURSE STOCHASTIC, V2; Kollock P, 1998, ANNU REV SOCIOL, V24, P183, DOI 10.1146/annurev.soc.24.1.183; KRAINES D, 1989, THEOR DECIS, V26, P47, DOI 10.1007/BF00134056; Lordkipanidze D, 2005, NATURE, V434, P717, DOI 10.1038/434717b; NOWAK M, 1993, NATURE, V364, P56, DOI 10.1038/364056a0; NOWAK M, 1989, J THEOR BIOL, V137, P21, DOI 10.1016/S0022-5193(89)80146-8; NOWAK M, 1993, P NATL ACAD SCI USA, V90, P5091, DOI 10.1073/pnas.90.11.5091; NOWAK MA, 1992, NATURE, V355, P250, DOI 10.1038/355250a0; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; NOWAK MA, 1995, J MATH BIOL, V33, P703; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Posch M, 1999, P ROY SOC B-BIOL SCI, V266, P1427, DOI 10.1098/rspb.1999.0797; Rand DG, 2009, J THEOR BIOL, V256, P45, DOI 10.1016/j.jtbi.2008.09.015; Rapoport Anatol, 1966, GEN SYST, P203, DOI DOI 10.1007/BF00132457; Roca CP, 2009, PHYS LIFE REV, V6, P208, DOI 10.1016/j.plrev.2009.08.001; RUBINSTEIN A, 1986, J ECON THEORY, V39, P83, DOI 10.1016/0022-0531(86)90021-9; SELTEN R, 1984, BEHAV BRAIN SCI, V7, P115, DOI 10.1017/S0140525X00026479; Seneta E, 2006, SPRINGER SER STAT, P1, DOI 10.1007/0-387-32792-4; Sigmund K, 2010, PRINC SER THEOR COMP, P1; Sugden R, 1986, EC RIGHTS COOPERATIO; Szathmary E, 1995, MAJOR TRANSITIONS EV; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755	42	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35135	10.1371/journal.pone.0035135	http://dx.doi.org/10.1371/journal.pone.0035135			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959XD	22529982	Green Published, gold, Green Submitted			2022-12-27	WOS:000305350600061
J	Ramirez, AG; Weiss, NS; Holden, AEC; Suarez, L; Cooper, SP; Munoz, E; Naylor, SL				Ramirez, Amelie G.; Weiss, Nancy S.; Holden, Alan E. C.; Suarez, Lucina; Cooper, Sharon P.; Munoz, Edgar; Naylor, Susan L.			Incidence and Risk Factors for Hepatocellular Carcinoma in Texas Latinos: Implications for Prevention Research	PLOS ONE			English	Article							PRIMARY LIVER-CANCER; C VIRUS-INFECTION; UNITED-STATES; PREVALENCE; INCREASES; OBESITY; NATION; IMPACT	Background: Hepatocellular carcinoma (HCC) is increasing in the U. S. despite a decline in cancer overall. Latinos have higher rates of HCC than the general population according to the Surveillance, Epidemiology, and End Results (SEER) Program. Not included in SEER, Texas Latinos make up one-fifth of the U. S. Latino population. To determine whether HCC incidence differs among U. S. and Texas Latinos, this descriptive study compares HCC incidence from 1995 through 2006 among three Latino populations: U. S. SEER, Texas overall and a South Texas subset. To identify lines of prevention research, we compare prevalence of known HCC risk factors among these Latino groups. Methods: Data were collected from the U. S. SEER Program, Texas Cancer Registry and Texas Department of State Health Services (TDSHS). Annual age-specific and age-adjusted HCC incidence rates, annual percent changes (APCs) and 95% confidence intervals were calculated as well as prevalence of obesity, diabetes, heavy alcohol use and cigarette smoking. Results: Of the three Latino groups compared, South Texas Latinos had the highest age-adjusted HCC incidence rates and SEER Latinos had the lowest (10.6/100,000 (10.1-11.1) and 7.5/100,000 (7.2-7.7), respectively). HCC incidence significantly increased over time (APCs>0) among Latinos in all three geographic groups. Between 1995 and 2006, there was an increase in obesity among all three populations, and obesity was highest among South Texas Latinos. Diabetes increased among U. S. Latinos, and Latino women in South Texas had significantly higher diabetes prevalence than U. S. Latino women. Cigarette smoking and heavy alcohol use were similar among groups. Conclusions: The incidence of HCC among Latinos in South Texas is higher than elsewhere in the United States. Higher rates of HCC among Texas and South Texas Latinos may be associated with greater prevalence of obesity and diabetes, risk factors for HCC that are amenable to intervention.	[Ramirez, Amelie G.; Weiss, Nancy S.; Holden, Alan E. C.; Munoz, Edgar] Univ Texas Hlth Sci Ctr San Antonio, Inst Hlth Promot Res, San Antonio, TX 78229 USA; [Ramirez, Amelie G.; Holden, Alan E. C.] Univ Texas Hlth Sci Ctr San Antonio, Canc Therapy & Res Ctr, San Antonio, TX 78229 USA; [Naylor, Susan L.] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Suarez, Lucina] Texas Dept State Hlth Serv, Environm Epidemiol & Dis Registries, Austin, TX USA; [Cooper, Sharon P.] Univ Texas Hlth Sci Ctr Houston, Sch Publ Health, San Antonio, TX USA	University of Texas System; University of Texas Health San Antonio; Cancer Therapy & Research Center; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Texas Department of State Health Services; University of Texas System; University of Texas Health Science Center Houston	Ramirez, AG (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Inst Hlth Promot Res, San Antonio, TX 78229 USA.	ramirezag@uthscsa.edu	Munoz, Edgar/L-1857-2019	Munoz, Edgar/0000-0002-1555-8408	Cancer Center Support Group of the Cancer Therapy and Research Center at the University of Texas Health Science at Center San Antonio, an NCI-designated Cancer Center [P30CA054174]; Redes En Accion: The National Latino Cancer Research Network [U01 CA114657-05]; NATIONAL CANCER INSTITUTE [P30CA054174, U01CA114657] Funding Source: NIH RePORTER	Cancer Center Support Group of the Cancer Therapy and Research Center at the University of Texas Health Science at Center San Antonio, an NCI-designated Cancer Center; Redes En Accion: The National Latino Cancer Research Network; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors gratefully acknowledge the Cancer Center Support Group of the Cancer Therapy and Research Center at the University of Texas Health Science at Center San Antonio, an NCI-designated Cancer Center (grant # P30CA054174) and Redes En Accion: The National Latino Cancer Research Network (U01 CA114657-05) for support of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter MJ, 1999, NEW ENGL J MED, V341, P556, DOI 10.1056/NEJM199908193410802; [Anonymous], 2010, GLOBOCAN 2008 CANC I; Barazani Y, 2007, WORLD J SURG, V31, P1243, DOI 10.1007/s00268-007-9041-3; Barnard ND, 2009, NUTRITION, V25, P58, DOI 10.1016/j.nut.2008.07.012; Bennett P H, 1976, Recent Prog Horm Res, V32, P333; Bouvier L, SHAPING TEXAS EFFECT; Caldwell SH, 2004, GASTROENTEROLOGY, V127, pS97, DOI 10.1053/j.gastro.2004.09.021; Davila JA, 2005, GUT, V54, P533, DOI 10.1136/gut.2004.052167; Edwards BK, 2010, CANCER-AM CANCER SOC, V116, P544, DOI 10.1002/cncr.24760; El-Serag H, 2010, J FAM PRACTICE, V59, pS37; GOTTLIEB K, 1979, AM J PHYS ANTHROPOL, V50, P444; Gwynn ER, 2005, HDB HISPANIC CULTURE, P339; Hassan MM, 2002, J CLIN GASTROENTEROL, V35, P266, DOI 10.1097/00004836-200209000-00013; Howe HL, 2006, CANCER-AM CANCER SOC, V107, P1711, DOI 10.1002/cncr.22193; Institute for Health Promotion Research UTHSCSA, 2007, S TEX HLTH STAT REV; McGlynn KA, 2011, CLIN LIVER DIS, V15, P223, DOI 10.1016/j.cld.2011.03.006; Modiano M, 1995, J NATL CANC I MONOGR; Morgan TR, 2004, GASTROENTEROLOGY, V127, pS87, DOI 10.1053/j.gastro.2004.09.020; NAACCR: North American Association of Central Cancer Registries, 2008, GUID ENH LAT LAT ID; Ogden CL, 2010, CHANGES TERMINOLOGY; Polesel J, 2009, ANN ONCOL, V20, P353, DOI 10.1093/annonc/mdn565; Ramirez AG, 2004, PREV MED, V39, P263, DOI 10.1016/j.ypmed.2004.03.034; REED TE, 1974, SCIENCE, V185, P283, DOI 10.1126/science.185.4147.283; *SEER, 2008, SURV EP END RES SEER; SEER: SEER: Surveillance Epidemiology and End Results (SEER) Program SEER* Stat Database: Incidence-SEER 13 Regs Limited-Use Nov 2008 Sub, 1992, SEER SURV EP END RES; SUAREZ L, 1987, AM J PUBLIC HEALTH, V77, P631, DOI 10.2105/AJPH.77.5.631; Sun G, 2007, FOOD ADDIT CONTAM A, V24, P181, DOI 10.1080/02652030601013471; TDSHS: Texas Department of State Health Services IDCU, 2009, TEX CANC REG PUBL US; U.S. Census Bureau, 2010, AM FACTFINDER; *USDA, 2006, MEAS RUR RUR URB CON; Welzel TM, 2011, HEPATOLOGY, V54, P463, DOI 10.1002/hep.24397; Yalamanchili Kanthi, 2005, Proc (Bayl Univ Med Cent), V18, P3	32	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35573	10.1371/journal.pone.0035573	http://dx.doi.org/10.1371/journal.pone.0035573			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22530052	gold, Green Submitted, Green Published			2022-12-27	WOS:000305350600100
J	Wegner, W; Burckhardt, BC; Burckhardt, G; Henjakovic, M				Wegner, Waja; Burckhardt, Birgitta Christina; Burckhardt, Gerhard; Henjakovic, Maja			Male-Dominant Activation of Rat Renal Organic Anion Transporter 1 (Oat1) and 3 (Oat3) Expression by Transcription Factor BCL6	PLOS ONE			English	Article							ADVERSE DRUG-REACTIONS; RNA-POLYMERASE-III; GENE-EXPRESSION; GENDER-DIFFERENCES; ANDROGEN RECEPTOR; SEX-DIFFERENCES; CATION TRANSPORTERS; AMINOHIPPURIC ACID; MOLECULAR-CLONING; KIDNEY	Background: Organic anion transporters 1 (Oat1) and 3 (Oat3) mediate the transport of organic anions, including frequently prescribed drugs, across cell membranes in kidney proximal tubule cells. In rats, these transporters are known to be male-dominant and testosterone-dependently expressed. The molecular mechanisms that are involved in the sex-dependent expression are unknown. Our aim was to identify genes that show a sex-dependent expression and could be involved in male-dominant regulation of Oat1 and Oat3. Methodology/Principal Findings: Promoter activities of Oat1 and Oat3 were analyzed using luciferase assays. Expression profiling was done using a SurePrint G3 rat GE 8x60K microarray. RNA was isolated from renal cortical slices of four adult rats per sex. To filter the achieved microarray data for genes expressed in proximal tubule cells, transcription database alignment was carried out. We demonstrate that predicted androgen response elements in the promoters of Oat1 and Oat3 are not functional when the promoters were expressed in OK cells. Using microarray analyses we analyzed 17,406 different genes. Out of these genes, 56 exhibit a sex-dependent expression in rat proximal tubule cells. As genes potentially involved in the regulation of Oat1 and Oat3 expression, we identified, amongst others, the male-dominant hydroxysteroid (17-beta) dehydrogenase 1 (Hsd17b1), B-cell CLL/lymphoma 6 (BCL6), and polymerase (RNA) III (DNA directed) polypeptide G (Polr3g). Moreover, our results revealed that the transcription factor BCL6 activates promoter constructs of Oat1 and Oat3. Conclusion: The results indicate that the male-dominant expression of both transporters, Oat1 and Oat3, is possibly not directly regulated by the classical androgen receptor mediated transcriptional pathway but appears to be regulated by the transcription factor BCL6.	[Wegner, Waja; Burckhardt, Birgitta Christina; Burckhardt, Gerhard; Henjakovic, Maja] Univ Med Ctr Gottingen, Dept Syst Physiol & Pathophysiol, Gottingen, Germany	University of Gottingen	Wegner, W (corresponding author), Univ Med Ctr Gottingen, Dept Syst Physiol & Pathophysiol, Gottingen, Germany.	maja.henjakovic@med.uni-goettingen.de			Deutsche Forschungsgemeinschaft (DFG; German Research Foundation)	Deutsche Forschungsgemeinschaft (DFG; German Research Foundation)(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft (DFG; German Research Foundation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albagli O, 1999, ONCOGENE, V18, P5063, DOI 10.1038/sj.onc.1202892; Anderson GD, 2005, J WOMENS HEALTH, V14, P19, DOI 10.1089/jwh.2005.14.19; Asaka J, 2006, PHARM RES-DORDR, V23, P697, DOI 10.1007/s11095-006-9665-2; Burckhardt G, 2011, HANDB EXP PHARMACOL, V201, P29, DOI 10.1007/978-3-642-14541-4_2; Cerrutti JA, 2002, MOL CELL BIOCHEM, V233, P175, DOI 10.1023/A:1015563021602; Cha SH, 2001, MOL PHARMACOL, V59, P1277, DOI 10.1124/mol.59.5.1277; Cleutjens KBJM, 1996, J BIOL CHEM, V271, P6379, DOI 10.1074/jbc.271.11.6379; Dent AL, 2002, CRIT REV ONCOL HEMAT, V41, P1, DOI 10.1016/S1040-8428(01)00164-0; Franconi F, 2007, PHARMACOL RES, V55, P81, DOI 10.1016/j.phrs.2006.11.001; Gabr MM, 2011, J PHYSL PATHOPHYSIOL, V2, P6; Gandhi M, 2004, ANNU REV PHARMACOL, V44, P499, DOI [10.1146/annurev.pharmtox.44.101802.121453, 10.2165/00003088-200948030-00001]; Garcia JF, 2006, J HISTOCHEM CYTOCHEM, V54, P31, DOI 10.1369/jhc.5A6646.2005; Giacomini KM, 2010, NAT REV DRUG DISCOV, V9, P215, DOI 10.1038/nrd3028; Hasegawa M, 2002, J PHARMACOL EXP THER, V300, P746, DOI 10.1124/jpet.300.3.746; Hosoyamada M, 1999, AM J PHYSIOL-RENAL, V276, pF122, DOI 10.1152/ajprenal.1999.276.1.F122; HUANG KC, 1955, AM J PHYSIOL, V183, P387, DOI 10.1152/ajplegacy.1955.183.3.387; Kaulfuss S, 2008, MOL ENDOCRINOL, V22, P1606, DOI 10.1210/me.2006-0546; Kenneth NS, 2008, NUCLEIC ACIDS RES, V36, P3757, DOI 10.1093/nar/gkn272; Keppler D, 2011, HANDB EXP PHARMACOL, V201, P299, DOI 10.1007/978-3-642-14541-4_8; Khamdang S, 2002, J PHARMACOL EXP THER, V303, P534, DOI 10.1124/jpet.102.037580; Kikuchi R, 2006, MOL PHARMACOL, V70, P887, DOI 10.1124/mol.106.025494; KLEINMAN LI, 1966, ENDOCRINOLOGY, V78, P403, DOI 10.1210/endo-78-2-403; Koepsell H, 2007, PHARM RES-DORDR, V24, P1227, DOI 10.1007/s11095-007-9254-z; Kojima R, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V134848; Kusuhara H, 1999, J BIOL CHEM, V274, P13675, DOI 10.1074/jbc.274.19.13675; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ljubojevic M, 2004, AM J PHYSIOL-RENAL, V287, pF124, DOI 10.1152/ajprenal.00029.2004; Luu-The V, 2001, J STEROID BIOCHEM, V76, P143, DOI 10.1016/S0960-0760(00)00155-2; Marchais-Oberwinkler S, 2011, J STEROID BIOCHEM, V125, P66, DOI 10.1016/j.jsbmb.2010.12.013; MARTEL C, 1992, J STEROID BIOCHEM, V41, P597, DOI 10.1016/0960-0760(92)90390-5; Martin RM, 1998, BRIT J CLIN PHARMACO, V46, P505, DOI 10.1046/j.1365-2125.1998.00817.x; Meyer RD, 2009, MOL ENDOCRINOL, V23, P1914, DOI 10.1210/me.2009-0242; Morey JS, 2006, BIOL PROCED ONLINE, V8, P175, DOI 10.1251/bpo126; Morris ME, 2003, PHARMACOL REV, V55, P229, DOI 10.1124/pr.55.2.1; Ogasawara K, 2007, AM J PHYSIOL-RENAL, V292, pF1819, DOI 10.1152/ajprenal.00017.2007; Opitz L, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-36; PALVIMO JJ, 1993, MOL ENDOCRINOL, V7, P1399, DOI 10.1210/me.7.11.1399; Perez-Rosado A, 2008, J PATHOL, V214, P498, DOI 10.1002/path.2279; Puranen T, 1997, ENDOCRINOLOGY, V138, P3532, DOI 10.1210/en.138.8.3532; RENNIE PS, 1993, MOL ENDOCRINOL, V7, P23, DOI 10.1210/me.7.1.23; Reyes JL, 1998, ENDOCRINOLOGY, V139, P1581, DOI 10.1210/en.139.4.1581; Saji T, 2008, J PHARMACOL EXP THER, V324, P784, DOI 10.1124/jpet.107.128249; Schneider R, 2007, AM J PHYSIOL-RENAL, V292, pF1599, DOI 10.1152/ajprenal.00473.2006; Sekine T, 1997, J BIOL CHEM, V272, P18526, DOI 10.1074/jbc.272.30.18526; Sugiyama D, 2001, J PHARMACOL EXP THER, V298, P316; Sweet DH, 1997, J BIOL CHEM, V272, P30088, DOI 10.1074/jbc.272.48.30088; Tojo A, 1999, J AM SOC NEPHROL, V10, P464; VanWert AL, 2008, PHARM RES-DORDR, V25, P453, DOI 10.1007/s11095-007-9407-0; VanWert AL, 2008, MOL PHARMACOL, V74, P122, DOI 10.1124/mol.107.042853; VanWert AL, 2010, BIOPHARM DRUG DISPOS, V31, P1, DOI 10.1002/bdd.693; Wagner SD, 2011, BRIT J HAEMATOL, V152, P3, DOI 10.1111/j.1365-2141.2010.08420.x; White RJ, 2011, NAT REV GENET, V12, P459, DOI 10.1038/nrg3001; Zopf Y, 2009, PHARMACOLOGY, V84, P333, DOI 10.1159/000248311	53	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35556	10.1371/journal.pone.0035556	http://dx.doi.org/10.1371/journal.pone.0035556			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22530049	Green Submitted, Green Published, gold			2022-12-27	WOS:000305350600098
J	Vazquez, SG; Martinez, AA; Flores-Alonso, JC				Garcia Vazquez, Susana; Aragon Martinez, Andres; Carlos Flores-Alonso, Juan			Confocal Microscopy and Image Analysis Indicates a Region-Specific Relation between Active Caspases and Cytoplasm in Ejaculated and Epididymal Sperm	PLOS ONE			English	Article							SWIM-UP PROCEDURE; HUMAN SPERMATOZOA; APOPTOSIS; ACTIVATION; MARKERS; CELLS; PARAMETERS; INHIBITOR; VIABILITY; MEMBRANE	Previously, it was suggested a relation between the presence of apoptosis markers with cytoplasm in mammalian sperm. In this work, flow cytometry, confocal microscopy and image analysis were used to analyze the relationship between active caspase-3 and -7 and intracellular esterases expression in ejaculated or epididymal ram sperm. Sperm obtained from ejaculates from the caput, corpus, or cauda of the epididymis were treated with an inhibitor of active caspase-3 and -7 and a marker of cytoplasmic esterases. Additionally, ejaculated sperm were incubated for one, two, or three hours before evaluation for active caspases. Sperm subpopulations positive for active caspases and/or intracellular esterases were detected by flow cytometry and confocal microscopy; however, image analysis of confocal images showed that the correlation between active caspases and cytoplasmic esterases in sperm is region-specific. Lower values of Spearman correlation coefficients were found when whole sperm or head sperm was analyzed; however, a high correlation was observed for midpiece sperm. Incubation of sperm for two or three hours promoted the autoactivation of caspases. It has been suggested that the presence of apoptotic markers in sperm are related with a process of abortive apoptosis and with errors during spermiogenesis. Our results permit us suggest that the origin of the relationship between active caspases and cytoplasmic esterases is due to differentiation errors occurring during spermiogenesis because the percentages of sperm with active caspases are not different in the caput, corpus, or cauda of the epididymis. In this study we demonstrate that existing sperm subpopulations can express active caspases and intracellular esterases and that the correlation between these molecules is high in midpiece sperm.	[Garcia Vazquez, Susana; Aragon Martinez, Andres] Univ Autonoma Estado Mexico, Fac Med Vet & Zootecnia, Reprod Biol Lab, El Cerrillo, Toluca, Mexico; [Aragon Martinez, Andres] Univ Autonoma Metropolitana Iztapalapa, Dept Reprod Biol, Mexico City 09340, DF, Mexico; [Carlos Flores-Alonso, Juan] Hosp Gen Zona 5, Inst Mexicano Seguro Social, Ctr Invest Biomed Oriente, Reprod Biol Lab, Puebla, Mexico	Universidad Autonoma Metropolitana - Mexico; Instituto Mexicano del Seguro Social	Vazquez, SG (corresponding author), Univ Autonoma Estado Mexico, Fac Med Vet & Zootecnia, Reprod Biol Lab, El Cerrillo, Toluca, Mexico.	armandres@gmail.com	Martínez, Andrés Aragón/AAH-6750-2020; Flores-Alonso, Juan/ABB-9987-2020	Martínez, Andrés Aragón/0000-0003-2352-2197; Flores Alonso, Juan Carlos/0000-0002-0366-1256	Programa Integral de Fortalecimiento Institucional [FE009/2009]; Universida Autonoma del Estado de Mexico [2887/2010]	Programa Integral de Fortalecimiento Institucional; Universida Autonoma del Estado de Mexico	This work was supported by Programa Integral de Fortalecimiento Institucional managed by Secretaria de Educacion Publica (grant number FE009/2009) and Universida Autonoma del Estado de Mexico (grant number 2887/2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham MC, 2004, TRENDS CELL BIOL, V14, P184, DOI 10.1016/j.tcb.2004.03.002; Bauer G, 2007, INT J RADIAT BIOL, V83, P873, DOI 10.1080/09553000701727523; Blanco-Rodriguez J, 1999, BIOL REPROD, V61, P1541, DOI 10.1095/biolreprod61.6.1541; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; Cisternas P, 2006, MOL REPROD DEV, V73, P1318, DOI 10.1002/mrd.20561; Cooper TG, 2011, ASIAN J ANDROL, V13, P130, DOI 10.1038/aja.2010.97; French AP, 2008, NAT PROTOC, V3, P619, DOI 10.1038/nprot.2008.31; Grunewald S, 2005, FERTIL STERIL, V83, P1106, DOI 10.1016/j.fertnstert.2004.12.011; Hendricks KEM, 2009, THERIOGENOLOGY, V71, P1138, DOI 10.1016/j.theriogenology.2008.12.006; Hikim APS, 2003, J STEROID BIOCHEM, V85, P175, DOI 10.1016/S0960-0760(03)00193-6; Kerr JB, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P827; Kotwicka M, 2008, REPROD BIOMED ONLINE, V16, P657, DOI 10.1016/S1472-6483(10)60479-8; Kuzelova K, 2007, CYTOM PART A, V71A, P605, DOI 10.1002/cyto.a.20415; Marchetti C, 2004, HUM REPROD, V19, P1127, DOI 10.1093/humrep/deh222; Marti E, 2008, ANIM REPROD SCI, V106, P113, DOI 10.1016/j.anireprosci.2007.04.009; Mattioli M, 2009, REPRODUCTION, V138, P679, DOI 10.1530/REP-08-0316; Morales ECL, 2012, J ANIM VET ADV, V11, P431; Moran JM, 2008, THERIOGENOLOGY, V70, P91, DOI 10.1016/j.theriogenology.2008.02.010; Paasch U, 2003, J ANDROL, V24, P246; Pichardo AI, 2010, J ANDROL, V31, P169, DOI 10.2164/jandrol.108.007021; Pozarowski P, 2003, CYTOM PART A, V55A, P50, DOI 10.1002/cyto.a.10074; Rasband W.S., 2005, IMAGEJ COMPUTER PROG; Ricci G, 2009, FERTIL STERIL, V91, P632, DOI 10.1016/j.fertnstert.2007.11.068; Sakkas D, 1999, EXP CELL RES, V251, P350, DOI 10.1006/excr.1999.4586; Sakkas D, 2002, BIOL REPROD, V66, P1061, DOI 10.1095/biolreprod66.4.1061; Team RDC, 2009, R LANG ENV STAT COMP; Tripathi R, 2009, J REPROD IMMUNOL, V83, P31, DOI 10.1016/j.jri.2009.05.009; Uggeri J, 2004, HISTOCHEM CELL BIOL, V122, P499, DOI 10.1007/s00418-004-0712-y; Well M, 1998, J CELL SCI, V111, P2707; Weng SL, 2002, MOL HUM REPROD, V8, P984, DOI 10.1093/molehr/8.11.984	30	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e35477	10.1371/journal.pone.0035477	http://dx.doi.org/10.1371/journal.pone.0035477			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22530029	gold, Green Published, Green Submitted			2022-12-27	WOS:000305347400054
J	Pogue, J; Devereaux, PJ; Thabane, L; Yusuf, S				Pogue, Janice; Devereaux, P. J.; Thabane, Lehana; Yusuf, Salim			Designing and Analyzing Clinical Trials with Composite Outcomes: Consideration of Possible Treatment Differences between the Individual Outcomes	PLOS ONE			English	Article							END-POINT SELECTION; FAILURE TIME DATA; SUBGROUP ANALYSIS; ADJUSTMENT; ISSUES	When the individual outcomes within a composite outcome appear to have different treatment effects, either in magnitude or direction, researchers may question the validity or appropriateness of using this composite outcome as a basis for measuring overall treatment effect in a randomized controlled trial. The question remains as to how to distinguish random variation in estimated treatment effects from important heterogeneity within a composite outcome. This paper suggests there may be some utility in directly testing the assumption of homogeneity of treatment effect across the individual outcomes within a composite outcome. We describe a treatment heterogeneity test for composite outcomes based on a class of models used for the analysis of correlated data arising from the measurement of multiple outcomes for the same individuals. Such a test may be useful in planning a trial with a primary composite outcome and at trial end with final analysis and presentation. We demonstrate how to determine the statistical power to detect composite outcome treatment heterogeneity using the POISE Trial data. Then we describe how this test may be incorporated into a presentation of trial results with composite outcomes. We conclude that it may be informative for trialists to assess the consistency of treatment effects across the individual outcomes within a composite outcome using a formalized methodology and the suggested test represents one option.	[Pogue, Janice; Devereaux, P. J.; Thabane, Lehana; Yusuf, Salim] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Pogue, Janice; Devereaux, P. J.; Yusuf, Salim] McMaster Univ, Fac Hlth Sci, Hamilton, ON, Canada	McMaster University; McMaster University	Pogue, J (corresponding author), McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada.	janice.pogue@phri.ca	Devereaux, PJ/AAY-1757-2021; Devereaux, PJ/AAF-2862-2019	Yusuf, Salim/0000-0003-4776-5601; Devereaux, PJ/0000-0003-2935-637X	Canadian Institutes of Health Research; Commonwealth Government of Australia's National Medical Research Council; Instituto de Salud Carlos III (Ministerio de Sanidad y Consumo), Spain; British Heart Foundation; AstraZeneca	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Commonwealth Government of Australia's National Medical Research Council; Instituto de Salud Carlos III (Ministerio de Sanidad y Consumo), Spain(Instituto de Salud Carlos III); British Heart Foundation(British Heart Foundation); AstraZeneca(AstraZeneca)	Canadian Institutes of Health Research; Commonwealth Government of Australia's National Medical Research Council; Instituto de Salud Carlos III (Ministerio de Sanidad y Consumo), Spain; British Heart Foundation; AstraZeneca. All funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assmann SF, 2000, LANCET, V355, P1064, DOI 10.1016/S0140-6736(00)02039-0; Burton A, 2006, STAT MED, V25, P4279, DOI 10.1002/sim.2673; Chi GYH, 2005, FUND CLIN PHARMACOL, V19, P609, DOI 10.1111/j.1472-8206.2005.00370.x; COX DR, 1972, J R STAT SOC B, V34, P187; DeMets DL, 2002, CIRCULATION, V106, P746, DOI 10.1161/01.CIR.0000023219.51483.66; Devereaux PJ, 2008, LANCET, V371, P1839, DOI 10.1016/S0140-6736(08)60601-7; DONALD A, 1987, STAT MED, V6, P491, DOI 10.1002/sim.4780060408; Duchateau L, 2008, STAT BIOL HEALTH, P1; Ferreira-Gonzalez I, 2007, BRIT MED J; Freemantle N, 2003, JAMA-J AM MED ASSOC, V289, P2554, DOI 10.1001/jama.289.19.2554; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Huque M F, 1997, J Biopharm Stat, V7, P545, DOI 10.1080/10543409708835206; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; LIN JS, 1992, J AM STAT ASSOC, V87, P1091, DOI 10.2307/2290646; McCullagh P, 1989, GEN LINEAR MODELS; Montgomery D. C., 2021, INTRO LINEAR REGRESS, P12; Montori Victor M, 2005, ACP J Club, V143, pA8; Montori VM, 2005, BMJ-BRIT MED J, V330, P594, DOI 10.1136/bmj.330.7491.594; Moye L. A., 2003, MULTIPLE ANAL CLIN T; Neaton JD, 2005, J CARD FAIL, V11, P567, DOI 10.1016/j.cardfail.2005.08.350; Petitti DB, 2001, STAT MED, V20, P3625, DOI 10.1002/sim.1091; Pocock SJ, 2002, STAT MED, V21, P2917, DOI 10.1002/sim.1296; Pogue J, 2012, THESIS MCMASTER U; Pogue J, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-49; R Core Team, 2018, R LANG ENV STAT COMP; RAO JNK, 1992, BIOMETRICS, V48, P577, DOI 10.2307/2532311; Sankoh AJ, 2003, STAT MED, V22, P3133, DOI 10.1002/sim.1557; Tilley BC, 1996, STROKE, V27, P2136, DOI 10.1161/01.STR.27.11.2136; WEI LJ, 1989, J AM STAT ASSOC, V84, P1065, DOI 10.2307/2290084; Wei LJ, 1997, STAT MED, V16, P833, DOI 10.1002/(SICI)1097-0258(19970430)16:8<833::AID-SIM538>3.0.CO;2-2; YUSUF S, 1991, JAMA-J AM MED ASSOC, V266, P93, DOI 10.1001/jama.266.1.93; ZEGER SL, 1992, STAT MED, V11, P1825, DOI 10.1002/sim.4780111406	32	32	33	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e34785	10.1371/journal.pone.0034785	http://dx.doi.org/10.1371/journal.pone.0034785			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22529934	Green Submitted, Green Published, gold			2022-12-27	WOS:000305347400018
J	Pomponi, D; Bernardi, ML; Liso, M; Palazzo, P; Tuppo, L; Rafaiani, C; Santoro, M; Labrada, A; Ciardiello, MA; Mari, A; Scala, E				Pomponi, Debora; Bernardi, Maria Livia; Liso, Marina; Palazzo, Paola; Tuppo, Lisa; Rafaiani, Chiara; Santoro, Mario; Labrada, Alexis; Ciardiello, Maria Antonietta; Mari, Adriano; Scala, Enrico			Allergen Micro-Bead Array for IgE Detection: A Feasibility Study Using Allergenic Molecules Tested on a Flexible Multiplex Flow Cytometric Immunoassay	PLOS ONE			English	Article							MICROARRAYED RECOMBINANT ALLERGENS; IMMUNOGLOBULIN-E REACTIVITY; PURIFIED ALLERGENS; DETECTION SYSTEM; ANTIBODIES; PROTEIN; DIAGNOSIS; KIWELLIN	Background: Allergies represent the most prevalent non infective diseases worldwide. Approaching IgE-mediated sensitizations improved much by adopting allergenic molecules instead of extracts, and by using the micro-technology for multiplex testing. Objective and Methods: To provide a proof-of-concept that a flow cytometric bead array is a feasible mean for the detection of specific IgE reactivity to allergenic molecules in a multiplex-like way. A flow cytometry Allergenic Molecule-based micro-bead Array system (ABA) was set by coupling allergenic molecules with commercially available micro-beads. Allergen specific polyclonal and monoclonal antibodies, as well as samples from 167 allergic patients, characterized by means of the ISAC microarray system, were used as means to show the feasibility of the ABA. Three hundred and thirty-six sera were tested for 1 or more of the 16 selected allergens, for a total number of 1,519 tests on each of the two systems. Results: Successful coupling was initially verified by detecting the binding of rabbit polyclonal IgG, mouse monoclonal, and pooled human IgE toward three allergens, namely nDer s 1, nPen m 1, and nPru p 3. The ABA assay showed to detect IgE to nAct d 1, nAct d 11, rAln g 1, nAmb a 1, nArt v 3, rBet v 1, rCor a 1, nCup a 1, nDer p 1, nDer s 1, rHev b 5, nOle e 1, rPar j 2, nPen m 1, rPhl p 1, and nPru p 3. Results obtained by ABA IgE testing were highly correlated to ISAC testing (r = 0.87, p<0.0001). No unspecific binding was recorded because of high total IgE values. Conclusion: The ABA assay represents a useful and flexible method for multiplex IgE detection using allergenic molecules. As also shown by our initial experiments with monoclonals and polyclonals, ABA is suitable for detecting other human and non-human immunoglobulins.	[Pomponi, Debora; Bernardi, Maria Livia; Liso, Marina; Palazzo, Paola; Tuppo, Lisa; Rafaiani, Chiara; Santoro, Mario; Mari, Adriano; Scala, Enrico] IDI IRCCS, Ctr Mol Allergol, Rome, Italy; [Tuppo, Lisa; Ciardiello, Maria Antonietta] CNR, Inst Prot Biochem, I-80125 Naples, Italy; [Labrada, Alexis] Ctr Nacl Biopreparados, Allergens Dept, Havana, Cuba	IRCCS Istituto Dermopatico dell'Immacolata (IDI); Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR)	Pomponi, D (corresponding author), IDI IRCCS, Ctr Mol Allergol, Rome, Italy.	adriano.mari@idi.it	Santoro, Mario/GVU-5164-2022; Liso, Marina/AAB-3723-2019; Scala, Enrico/H-6997-2012; Labrada, Alexis/AAD-9750-2019	Santoro, Mario/0000-0001-6626-9430; Scala, Enrico/0000-0002-9391-9168; Labrada, Alexis/0000-0003-0956-7946; LISO, MARINA/0000-0002-8766-1869; CIARDIELLO, MARIA ANTONIETTA/0000-0002-7203-0554	Italian Ministry of Health, Programma Ricerca Corrente	Italian Ministry of Health, Programma Ricerca Corrente	This study has been funded by the Italian Ministry of Health, Programma Ricerca Corrente 2008-2010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernardi ML, 2010, CLIN EXP ALLERGY, V40, P1819, DOI 10.1111/j.1365-2222.2010.03603.x; Bomert M, 2011, CLIN CHEM LAB MED, V49, P1691, DOI 10.1515/CCLM.2011.631; Ciardiello MA, 2010, ALLERGY, V65, P597, DOI 10.1111/j.1398-9995.2009.02277.x; Cox L, 2008, ANN ALLERG ASTHMA IM, V101, P580, DOI 10.2500/aap.2008.29.3162; D'Avino R, 2011, ALLERGY, V66, P870, DOI 10.1111/j.1398-9995.2011.02555.x; Duffort OA, 2002, J AGR FOOD CHEM, V50, P7738, DOI 10.1021/jf0258398; Egger M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019062; Erwin EA, 2005, J ALLERGY CLIN IMMUN, V115, P1029, DOI 10.1016/j.jaci.2004.12.1131; Ferbas J, 2007, CLIN VACCINE IMMUNOL, V14, P1165, DOI 10.1128/CVI.00157-07; Fulton RJ, 1997, CLIN CHEM, V43, P1749; Harwanegg C, 2003, CLIN EXP ALLERGY, V33, P7, DOI 10.1046/j.1365-2222.2003.01550.x; Herbert OC, 2009, WORLD ALLERGY ORGAN, V2, P130, DOI 10.1097/WOX.0b013e3181accf27; Hiller R, 2002, FASEB J, V16, P414, DOI 10.1096/fj.01-0711fje; Kettman JR, 1998, CYTOMETRY, V33, P234, DOI 10.1002/(SICI)1097-0320(19981001)33:2<234::AID-CYTO19>3.3.CO;2-5; King EM, 2007, J ALLERGY CLIN IMMUN, V120, P1126, DOI 10.1016/j.jaci.2007.06.043; KING TP, 1964, BIOCHEMISTRY-US, V3, P458, DOI 10.1021/bi00891a026; Mari A, 2010, CURR ALLERGY ASTHM R, V10, P357, DOI 10.1007/s11882-010-0132-0; Mari A, 2009, CURR ALLERGY ASTHM R, V9, P376, DOI 10.1007/s11882-009-0055-9; Matsson PNJ, 2009, ILA20A229 CLSI, V29, P1; Morgan E, 2004, CLIN IMMUNOL, V110, P252, DOI 10.1016/j.clim.2003.11.017; Portnoy JA, 2006, CURR ALLERGY ASTHM R, V6, P455, DOI 10.1007/s11882-006-0021-8; Radauer C, 2011, MOL IMMUNOL, V48, P600, DOI 10.1016/j.molimm.2010.10.019; Ring J, 1999, INT ARCH ALLERGY IMM, V118, P403, DOI 10.1159/000024148; Scala E, 2010, CLIN EXP ALLERGY, V40, P911, DOI 10.1111/j.1365-2222.2010.03470.x; Scala E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024912; Sewer M, 2000, INT ARCH ALLERGY IMM, V123, P242, DOI 10.1159/000024450; Shreffler WG, 2011, J ALLERGY CLIN IMMUN, V127, P843, DOI 10.1016/j.jaci.2011.02.011; Tuppo L, 2008, J AGR FOOD CHEM, V56, P3812, DOI 10.1021/jf703620m; Varro Rudolf, 2007, Methods Mol Biol, V378, P125, DOI 10.1007/978-1-59745-323-3_9	29	36	38	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e35697	10.1371/journal.pone.0035697	http://dx.doi.org/10.1371/journal.pone.0035697			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22530068	Green Submitted, Green Published, gold			2022-12-27	WOS:000305347400065
J	Arama, J; Boulay, AC; Bosc, C; Delphin, C; Loew, D; Rostaing, P; Amigou, E; Ezan, P; Wingertsmann, L; Guillaud, L; Andrieux, A; Giaume, C; Cohen-Salmon, M				Arama, Jessica; Boulay, Anne-Cecile; Bosc, Christophe; Delphin, Christian; Loew, Damarys; Rostaing, Philippe; Amigou, Edwige; Ezan, Pascal; Wingertsmann, Laure; Guillaud, Laurent; Andrieux, Annie; Giaume, Christian; Cohen-Salmon, Martine			Bmcc1s, a Novel Brain-Isoform of Bmcc1, Affects Cell Morphology by Regulating MAP6/STOP Functions	PLOS ONE			English	Article							STOP PROTEINS; CDC42GAP HOMOLOGY/SEC14P-LIKE; INTERMEDIATE-FILAMENTS; BCH DOMAIN; BNIP-2; MICROTUBULES; EXPRESSION; PHOSPHORYLATION; LOCALIZATION; PURIFICATION	The BCH (BNIP2 and Cdc42GAP Homology) domain-containing protein Bmcc1/Prune2 is highly enriched in the brain and is involved in the regulation of cytoskeleton dynamics and cell survival. However, the molecular mechanisms accounting for these functions are poorly defined. Here, we have identified Bmcc1s, a novel isoform of Bmcc1 predominantly expressed in the mouse brain. In primary cultures of astrocytes and neurons, Bmcc1s localized on intermediate filaments and microtubules and interacted directly with MAP6/STOP, a microtubule-binding protein responsible for microtubule cold stability. Bmcc1s overexpression inhibited MAP6-induced microtubule cold stability by displacing MAP6 away from microtubules. It also resulted in the formation of membrane protrusions for which MAP6 was a necessary cofactor of Bmcc1s. This study identifies Bmcc1s as a new MAP6 interacting protein able to modulate MAP6-induced microtubule cold stability. Moreover, it illustrates a novel mechanism by which Bmcc1 regulates cell morphology.	[Arama, Jessica; Boulay, Anne-Cecile; Amigou, Edwige; Ezan, Pascal; Giaume, Christian; Cohen-Salmon, Martine] Coll France, INSERM, U1050, CIRB,CNRS,Unite Mixte Rech 7241, F-75231 Paris, France; [Arama, Jessica; Boulay, Anne-Cecile; Amigou, Edwige; Ezan, Pascal; Giaume, Christian; Cohen-Salmon, Martine] Univ Paris 06, Paris, France; [Arama, Jessica; Boulay, Anne-Cecile; Amigou, Edwige; Ezan, Pascal; Giaume, Christian; Cohen-Salmon, Martine] MEMOLIFE Lab Excellence, Paris, France; [Arama, Jessica; Boulay, Anne-Cecile; Amigou, Edwige; Ezan, Pascal; Giaume, Christian; Cohen-Salmon, Martine] Paris Sci Lettre Res Univ, Paris, France; [Bosc, Christophe; Delphin, Christian; Andrieux, Annie] Univ Grenoble 1, Fac Med, INSERM, U836,Inst Neurosci,Equipe Physiopathol Cytosquele, La Tronche, France; [Loew, Damarys] Inst Curie, Lab Prote Mass Spectrometry, Paris, France; [Rostaing, Philippe; Wingertsmann, Laure] Ecole Normale Super, Inst Biol, INSERM, U1024, F-75231 Paris, France; [Guillaud, Laurent] Okinawa Inst Sci & Technol, Cell & Mol Synapt Funct Unit, Okinawa, Japan	UDICE-French Research Universities; PSL Research University Paris; College de France; Ecole Normale Superieure (ENS); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Okinawa Institute of Science & Technology Graduate University	Arama, J (corresponding author), Univ London, Sch Pharm, Dept Pharmacol, London WC1N 1AX, England.	martine.cohen-salmon@college-de-france.fr	Guillaud, Laurent/Q-4214-2016; Bosc, Christophe/Q-8877-2019; Bosc, Christophe/P-3401-2017; ANDRIEUX, ANNIE/B-2134-2017; Boulay, Anne-Cecile/I-1257-2017; Christian, Delphin/P-9284-2017	Guillaud, Laurent/0000-0002-9688-0991; Bosc, Christophe/0000-0002-3195-6692; Bosc, Christophe/0000-0002-3195-6692; ANDRIEUX, ANNIE/0000-0002-4022-6405; Boulay, Anne-Cecile/0000-0001-5620-6209; Damarys, Loew/0000-0002-9111-8842; Christian, Delphin/0000-0003-3240-8695; Cohen-Salmon, Martine/0000-0002-5312-8476	Agence Nationale pour la Recherche ANR-programme blanc Neurosciences; Canceropole Ile-de-France; "'l'Institut National du Cancer"	Agence Nationale pour la Recherche ANR-programme blanc Neurosciences(French National Research Agency (ANR)); Canceropole Ile-de-France(Region Ile-de-France); "'l'Institut National du Cancer"(Institut National du Cancer (INCA) France)	This work was supported by Agence Nationale pour la Recherche ANR-programme blanc Neurosciences. The Laboratory of Proteomic Mass Spectrometry is supported by "Canceropole Ile-de-France" and "'l'Institut National du Cancer". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrieux A, 2002, GENE DEV, V16, P2350, DOI 10.1101/gad.223302; Aoyama T, 2009, J CELL SCI, V122, P4177, DOI 10.1242/jcs.048579; Baratier J, 2006, J BIOL CHEM, V281, P19561, DOI 10.1074/jbc.M509602200; Bosc C, 2003, BIOCHEMISTRY-US, V42, P12125, DOI 10.1021/bi0352163; Bosc C, 1996, P NATL ACAD SCI USA, V93, P2125, DOI 10.1073/pnas.93.5.2125; Buschdorf JP, 2006, J CELL SCI, V119, P3337, DOI 10.1242/jcs.03061; Buschdorf JP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002686; Clarke RA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004995; del Castillo FJ, 2010, HUM MOL GENET, V19, P262, DOI 10.1093/hmg/ddp490; Fevrier B, 2004, P NATL ACAD SCI USA, V101, P9683, DOI 10.1073/pnas.0308413101; Froger N, 2009, J NEUROCHEM, V111, P1383, DOI 10.1111/j.1471-4159.2009.06407.x; Galiano MR, 2004, J NEUROSCI RES, V78, P329, DOI 10.1002/jnr.20260; Gory-Faure S, 2006, J BIOL CHEM, V281, P28387, DOI 10.1074/jbc.M603380200; Guillaud L, 1998, J CELL BIOL, V142, P167, DOI 10.1083/jcb.142.1.167; GURLAND G, 1995, J CELL BIOL, V131, P1275, DOI 10.1083/jcb.131.5.1275; Hornung JP, 1999, J COMP NEUROL, V414, P348; Iwama E, 2011, J MOL NEUROSCI; Kang JS, 2008, J CELL BIOL, V182, P497, DOI 10.1083/jcb.200801119; Kreitzer G, 1999, MOL BIOL CELL, V10, P1105, DOI 10.1091/mbc.10.4.1105; Letournel F, 2003, J NEUROPATH EXP NEUR, V62, P1211, DOI 10.1093/jnen/62.12.1211; Li SM, 2011, NEUROSCI LETT, V503, P208, DOI 10.1016/j.neulet.2011.08.037; Low BC, 1999, J BIOL CHEM, V274, P33123, DOI 10.1074/jbc.274.46.33123; Low BC, 2000, J BIOL CHEM, V275, P14415, DOI 10.1074/jbc.275.19.14415; Lua BL, 2005, J CELL SCI, V118, P2707, DOI 10.1242/jcs.02383; Machida T, 2006, ONCOGENE, V25, P1931, DOI 10.1038/sj.onc.1209225; MARGOLIS RL, 1986, P NATL ACAD SCI USA, V83, P639, DOI 10.1073/pnas.83.3.639; MASSON D, 1993, J CELL BIOL, V123, P357, DOI 10.1083/jcb.123.2.357; Nectoux J, 2010, J CELL MOL MED, V14, P1962, DOI 10.1111/j.1582-4934.2010.01107.x; PIROLLET F, 1989, BIOCHEMISTRY-US, V28, P835, DOI 10.1021/bi00428a064; Poullet P, 2007, PROTEOMICS, V7, P2553, DOI 10.1002/pmic.200600784; Rouach N, 2003, J PHYSIOL-LONDON, V553, P729, DOI 10.1113/jphysiol.2003.053439; Shang X, 2003, J BIOL CHEM, V278, P45903, DOI 10.1074/jbc.M304514200; Soh UJK, 2008, J CELL SCI, V121, P1739, DOI 10.1242/jcs.021774; Zhou Yi Ting, 2005, Experimental Cell Research, V303, P263, DOI 10.1016/j.yexcr.2004.08.044; Zhou YT, 2002, J BIOL CHEM, V277, P7483, DOI 10.1074/jbc.M109459200; Zhou YT, 2010, MOL BIOL CELL	36	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e35488	10.1371/journal.pone.0035488	http://dx.doi.org/10.1371/journal.pone.0035488			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523599	Green Submitted, Green Published, gold			2022-12-27	WOS:000305345000073
J	Brassart-Pasco, S; Senechal, K; Thevenard, J; Ramont, L; Devy, J; Di Stefano, L; Dupont-Deshorgue, A; Brezillon, S; Feru, J; Jazeron, JF; Diebold, MD; Ricard-Blum, S; Maquart, FX; Monboisse, JC				Brassart-Pasco, Sylvie; Senechal, Karine; Thevenard, Jessica; Ramont, Laurent; Devy, Jerome; Di Stefano, Ludivine; Dupont-Deshorgue, Aurelie; Brezillon, Stephane; Feru, Jezabel; Jazeron, Jean-Francois; Diebold, Marie-Daniele; Ricard-Blum, Sylvie; Maquart, Francois-Xavier; Monboisse, Jean Claude			Tetrastatin, the NC1 Domain of the alpha 4(IV) Collagen Chain: A Novel Potent Anti-Tumor Matrikine	PLOS ONE			English	Article							IV COLLAGEN; ALPHA(V)BETA(3) INTEGRIN; NONCOLLAGENOUS DOMAIN; EXTRACELLULAR-MATRIX; ALPHA-3(IV) CHAIN; CELL-SURFACE; TUMOR-CELLS; ANGIOGENESIS; TUMSTATIN; METALLOPROTEINASE	Background: NC1 domains from alpha 1, alpha 2, alpha 3 and alpha 6(IV) collagen chains were shown to exert anti-tumor or anti-angiogenic activities, whereas the NC1 domain of the alpha 4(IV) chain did not show such activities so far. Methodology/Principal Findings: We demonstrate in the present paper that the NC1 alpha 4(IV) domain exerts a potent antitumor activity both in vitro and in an experimental human melanoma model in vivo. The overexpression of NC1 alpha 4(IV) in human UACC-903 melanoma cells strongly inhibited their in vitro proliferative (-38%) and invasive (-52%) properties. MT1-MMP activation was largely decreased and its cellular distribution was modified, resulting in a loss of expression at the migration front associated with a loss of migratory phenotype. In an in vivo xenograft model in athymic nude mice, the subcutaneous injection of NC1 alpha 4(IV)-overexpressing melanoma cells induced significantly smaller tumors (-80% tumor volume) than the Mock cells, due to a strong inhibition of tumor growth. Exogenously added recombinant human NC1 alpha 4(IV) reproduced the inhibitory effects of NC1 alpha 4(IV) overexpression in UACC-903 cells but not in dermal fibroblasts. An anti-alpha v beta 3 integrin blocking antibody inhibited cell adhesion on recombinant human NC1 alpha 4(IV) substratum. The involvement of alpha v beta 3 integrin in mediating NC1 alpha 4(IV) effect was confirmed by surface plasmon resonance (SPR) binding assays showing that recombinant human NC1 alpha 4(IV) binds to alpha v beta 3 integrin (K-D = 148 +/- 9.54 nM). Conclusion/Significance: Collectively, our results demonstrate that the NC1 alpha 4(IV) domain, named tetrastatin, is a new endogenous anti-tumor matrikine.	[Brassart-Pasco, Sylvie; Senechal, Karine; Thevenard, Jessica; Ramont, Laurent; Devy, Jerome; Di Stefano, Ludivine; Dupont-Deshorgue, Aurelie; Brezillon, Stephane; Feru, Jezabel; Maquart, Francois-Xavier; Monboisse, Jean Claude] Univ Reims, CNRS, UMR 6237, Reims, France; [Ramont, Laurent; Maquart, Francois-Xavier; Monboisse, Jean Claude] CHU Reims, Cent Biochim Lab, Reims, France; [Jazeron, Jean-Francois; Diebold, Marie-Daniele] CHU Reims, Lab Anat & Cytol Pathol, Reims, France; [Ricard-Blum, Sylvie] Univ Lyon 1, IBCP, CNRS, UMR 5086, F-69365 Lyon, France	Centre National de la Recherche Scientifique (CNRS); Universite de Reims Champagne-Ardenne; CHU de Reims; Universite de Reims Champagne-Ardenne; CHU de Reims; Universite de Reims Champagne-Ardenne; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Brassart-Pasco, S (corresponding author), Univ Reims, CNRS, UMR 6237, Reims, France.	sylvie.brassart-pasco@univ-reims.fr		Brassart-Pasco, Sylvie/0000-0002-1340-7868; BREZILLON, stephane/0000-0001-7954-8340	Centre National de la Recherche Scientifique [UMR 6237]; University of Reims Champagne-Ardenne; Ligue Nationale Contre le Cancer (Comites de l'Aisne et de la Haute-Marne); Region Champagne-Ardenne; FEDER (Contrat de Plan Etat-Region); ANR [07-NANO-050SEEC]	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); University of Reims Champagne-Ardenne; Ligue Nationale Contre le Cancer (Comites de l'Aisne et de la Haute-Marne); Region Champagne-Ardenne(Region Grand-Est); FEDER (Contrat de Plan Etat-Region); ANR(French National Research Agency (ANR))	This work was supported by grants from the Centre National de la Recherche Scientifique (UMR 6237), the University of Reims Champagne-Ardenne, the Ligue Nationale Contre le Cancer (Comites de l'Aisne et de la Haute-Marne), the Region Champagne-Ardenne, the FEDER (Contrat de Plan Etat-Region 2007-2013) and the ANR (07-NANO-050SEEC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbolina MV, 2008, SEMIN CELL DEV BIOL, V19, P24, DOI 10.1016/j.semcdb.2007.06.008; Brooks PC, 1996, CELL, V85, P683, DOI 10.1016/S0092-8674(00)81235-0; CHELBERG MK, 1989, CANCER RES, V49, P4796; Colorado PC, 2000, CANCER RES, V60, P2520; Faye C, 2009, J BIOL CHEM, V284, P22029, DOI 10.1074/jbc.M109.002840; Floquet N, 2004, J BIOL CHEM, V279, P2091, DOI 10.1074/jbc.M307736200; Hamano Y, 2003, CANCER CELL, V3, P589, DOI 10.1016/S1535-6108(03)00133-8; Hofmann UB, 2005, BIOCHIMIE, V87, P307, DOI 10.1016/j.biochi.2005.01.013; Hudson BG, 2003, NEW ENGL J MED, V348, P2543, DOI 10.1056/NEJMra022296; Itoh Y, 2006, J CELL PHYSIOL, V206, P1, DOI 10.1002/jcp.20431; Kalluri R, 2003, NAT REV CANCER, V3, P422, DOI 10.1038/nrc1094; Kamphaus GD, 2000, J BIOL CHEM, V275, P1209, DOI 10.1074/jbc.275.2.1209; Karagiannis ED, 2007, BIOCHEM BIOPH RES CO, V354, P434, DOI 10.1016/j.bbrc.2006.12.231; Labrecque L, 2004, J BIOL CHEM, V279, P52132, DOI 10.1074/jbc.M409617200; Maeshima Y, 2000, J BIOL CHEM, V275, P23745, DOI 10.1074/jbc.C000186200; Maeshima Y, 2000, J BIOL CHEM, V275, P21340, DOI 10.1074/jbc.M001956200; Maeshima Y, 2002, SCIENCE, V295, P140, DOI 10.1126/science.1065298; Maeshima Y, 2001, J BIOL CHEM, V276, P31959, DOI 10.1074/jbc.M103024200; Maeshima Y, 2001, J BIOL CHEM, V276, P15240, DOI 10.1074/jbc.M007764200; Magnon C, 2005, CANCER RES, V65, P4353, DOI 10.1158/0008-5472.CAN-04-3536; Maquoi E, 2000, EXP CELL RES, V261, P348, DOI 10.1006/excr.2000.5063; MEISSAUER A, 1992, EXP CELL RES, V199, P179, DOI 10.1016/0014-4827(92)90423-6; MONTGOMERY AMP, 1993, CANCER RES, V53, P693; Mundel TM, 2008, INT J CANCER, V122, P1738, DOI 10.1002/ijc.23269; Mundel TM, 2007, MICROVASC RES, V74, P85, DOI 10.1016/j.mvr.2007.05.005; Pasco S, 2000, CANCER RES, V60, P467; Pasco S, 2000, J BIOL CHEM, V275, P32999, DOI 10.1074/jbc.M005235200; Pasco S, 2004, EXP CELL RES, V301, P251, DOI 10.1016/j.yexcr.2004.07.036; Pasco S, 2004, CRIT REV ONCOL HEMAT, V49, P221, DOI 10.1016/j.critrevonc.2003.09.006; Pedchenko V, 2004, J BIOL CHEM, V279, P2772, DOI 10.1074/jbc.M311901200; Petitclerc E, 2000, J BIOL CHEM, V275, P8051, DOI 10.1074/jbc.275.11.8051; Seiki M, 2003, CANCER LETT, V194, P1, DOI 10.1016/S0304-3835(02)00699-7; Seiki M, 2002, CURR OPIN CELL BIOL, V14, P624, DOI 10.1016/S0955-0674(02)00363-0; Shahan TA, 1999, CANCER RES, V59, P4584; Sudhakar A, 2005, J CLIN INVEST, V115, P2801, DOI 10.1172/JCI24813; Thevenard J, 2006, CHEM BIOL, V13, P1307, DOI 10.1016/j.chembiol.2006.10.007; Thevenard J, 2010, INT J CANCER, V126, P1055, DOI 10.1002/ijc.24688; TRENT JM, 1990, SCIENCE, V247, P568, DOI 10.1126/science.2300817; Wald M, 2001, CANCER CHEMOTH PHARM, V47, pS16, DOI 10.1007/s002800170004; Yamaguchi H, 2009, CANCER RES, V69, P8594, DOI 10.1158/0008-5472.CAN-09-2305; ZHOU J, 1994, J BIOL CHEM, V269, P13193	41	40	44	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e29587	10.1371/journal.pone.0029587	http://dx.doi.org/10.1371/journal.pone.0029587			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22539938	Green Submitted, Green Published, gold			2022-12-27	WOS:000305341000001
J	Najbauer, J; Huszthy, PC; Barish, ME; Garcia, E; Metz, MZ; Myers, SM; Gutova, M; Frank, RT; Miletic, H; Kendall, SE; Glackin, CA; Bjerkvig, R; Aboody, KS				Najbauer, Joseph; Huszthy, Peter C.; Barish, Michael E.; Garcia, Elizabeth; Metz, Marianne Z.; Myers, Sarah M.; Gutova, Margarita; Frank, Richard T.; Miletic, Hrvoje; Kendall, Stephen E.; Glackin, Carlotta A.; Bjerkvig, Rolf; Aboody, Karen S.			Cellular Host Responses to Gliomas	PLOS ONE			English	Article							NEURAL STEM-CELLS; CHEMOKINE RECEPTORS; ADJUVANT TEMOZOLOMIDE; NESTIN EXPRESSION; MALIGNANT GLIOMAS; BRAIN-TUMORS; GLIOBLASTOMA; ANGIOGENESIS; MIGRATION; GROWTH	Background: Glioblastoma multiforme (GBM) is the most aggressive type of malignant primary brain tumors in adults. Molecular and genetic analysis has advanced our understanding of glioma biology, however mapping the cellular composition of the tumor microenvironment is crucial for understanding the pathology of this dreaded brain cancer. In this study we identified major cell populations attracted by glioma using orthotopic rodent models of human glioma xenografts. Marker-specific, anatomical and morphological analyses revealed a robust influx of host cells into the main tumor bed and tumor satellites. Methodology/Principal Findings: Human glioma cell lines and glioma spheroid orthotopic implants were used in rodents. In both models, the xenografts recruited large numbers of host nestin-expressing cells, which formed a 'network' with glioma. The host nestin-expressing cells appeared to originate in the subventricular zone ipsilateral to the tumor, and were clearly distinguishable from pericytes that expressed smooth muscle actin. These distinct cell populations established close physical contact in a 'pair-wise' manner and migrated together to the deeper layers of tumor satellites and gave rise to tumor vasculature. The GBM biopsy xenografts displayed two different phenotypes: (a) low-generation tumors (first in vivo passage in rats) were highly invasive and non-angiogenic, and host nestin-positive cells that infiltrated into these tumors displayed astrocytic or elongated bipolar morphology; (b) high-generation xenografts (fifth passage) had pronounced cellularity, were angiogenic with 'glomerulus-like' microvascular proliferations that contained host nestin-positive cells. Stromal cell-derived factor-1 and its receptor CXCR4 were highly expressed in and around glioma xenografts, suggesting their role in glioma progression and invasion. Conclusions/Significance: Our data demonstrate a robust migration of nestin-expressing host cells to glioma, which together with pericytes give rise to tumor vasculature. Mapping the cellular composition of glioma microenvironment and deciphering the complex 'crosstalk' between tumor and host may ultimately aid the development of novel anti-glioma therapies.	[Najbauer, Joseph; Barish, Michael E.; Garcia, Elizabeth; Metz, Marianne Z.; Myers, Sarah M.; Gutova, Margarita; Frank, Richard T.; Kendall, Stephen E.; Glackin, Carlotta A.; Aboody, Karen S.] City Hope Natl Med Ctr, Dept Neurosci, Duarte, CA 91010 USA; [Najbauer, Joseph; Barish, Michael E.; Garcia, Elizabeth; Metz, Marianne Z.; Myers, Sarah M.; Gutova, Margarita; Frank, Richard T.; Kendall, Stephen E.; Glackin, Carlotta A.; Aboody, Karen S.] City Hope Natl Med Ctr, Beckman Res Inst, Duarte, CA 91010 USA; [Aboody, Karen S.] City Hope Natl Med Ctr, Div Neurosurg, Duarte, CA 91010 USA; [Huszthy, Peter C.; Miletic, Hrvoje; Bjerkvig, Rolf] Univ Bergen, Dept Biomed, NorLux Neurooncol, Bergen, Norway; [Bjerkvig, Rolf] NorLux Neurooncol, Ctr Rech Publ Sante, Luxembourg, Luxembourg	City of Hope; City of Hope; Beckman Research Institute of City of Hope; City of Hope; University of Bergen; Luxembourg Institute of Health	Najbauer, J (corresponding author), City Hope Natl Med Ctr, Dept Neurosci, 1500 E Duarte Rd, Duarte, CA 91010 USA.	jnajbauer@coh.org; Peter.Huszthy@biomed.uib.no	Huszthy, Peter Csaba/H-1414-2016	Huszthy, Peter Csaba/0000-0003-0184-8989	Rosalinde and Arthur Gilbert Foundation; STOP CANCER; California Institute for Regenerative Medicine (CIRM) [DR1-01421]	Rosalinde and Arthur Gilbert Foundation; STOP CANCER; California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine)	The authors acknowledge the generous financial support by the Rosalinde and Arthur Gilbert Foundation, STOP CANCER, and the California Institute for Regenerative Medicine (CIRM, DR1-01421). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboody KS, 2008, GENE THER, V15, P739, DOI 10.1038/gt.2008.41; Aboody K, 2011, NEURON, V70, P597, DOI 10.1016/j.neuron.2011.05.007; Aboody KS, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000023; Aboody KS, 2000, P NATL ACAD SCI USA, V97, P12846, DOI 10.1073/pnas.97.23.12846; Aghi M, 2006, CANCER RES, V66, P9054, DOI 10.1158/0008-5472.CAN-05-3759; Amoh Y, 2005, CANCER RES, V65, P5352, DOI 10.1158/0008-5472.CAN-05-0821; Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7; Bababeygy SR, 2008, STEM CELLS DEV, V17, P11, DOI 10.1089/scd.2007.0117; Bello L, 2002, CLIN CANCER RES, V8, P3539; Benedetti S, 2000, NAT MED, V6, P447, DOI 10.1038/74710; BJERKVIG R, 1990, J NEUROSURG, V72, P463, DOI 10.3171/jns.1990.72.3.0463; Bjerkvig R, 2005, NAT REV CANCER, V5, P899, DOI 10.1038/nrc1740; Brat DJ, 2004, CANCER RES, V64, P920, DOI 10.1158/0008-5472.CAN-03-2073; Cabioglu N, 2009, ANN ONCOL, V20, P1013, DOI 10.1093/annonc/mdn740; Candolfi M, 2007, J NEURO-ONCOL, V85, P133, DOI 10.1007/s11060-007-9400-9; Charles NA, 2011, GLIA, V59, P1169, DOI 10.1002/glia.21136; Christensen K, 2010, NEUROSURGERY, V66, P933, DOI 10.1227/01.NEU.0000368393.45935.46; Curtis MA, 2007, NAT REV NEUROSCI, V8, P712, DOI 10.1038/nrn2216; Du R, 2008, CANCER CELL, V13, P206, DOI 10.1016/j.ccr.2008.01.034; Dziembowska M, 2005, GLIA, V50, P258, DOI 10.1002/glia.20170; Engebraaten O, 1999, J NEUROSURG, V90, P125, DOI 10.3171/jns.1999.90.1.0125; Gilbertson RJ, 2007, NAT REV CANCER, V7, P733, DOI 10.1038/nrc2246; Gilyarov A V, 2008, Neurosci Behav Physiol, V38, P165, DOI 10.1007/s11055-008-0025-z; Glass R, 2005, J NEUROSCI, V25, P2637, DOI 10.1523/JNEUROSCI.5118-04.2005; Goings GE, 2004, BRAIN RES, V996, P213, DOI 10.1016/j.brainres.2003.10.034; Grunewald M, 2006, CELL, V124, P175, DOI 10.1016/j.cell.2005.10.036; Hamer PCDW, 2008, ONCOGENE, V27, P2091, DOI 10.1038/sj.onc.1210850; Huszthy PC, 2005, HUM GENE THER, V16, P381, DOI 10.1089/hum.2005.16.381; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; Imitola J, 2004, P NATL ACAD SCI USA, V101, P18117, DOI 10.1073/pnas.0408258102; Kalluri R, 2003, NAT REV CANCER, V3, P422, DOI 10.1038/nrc1094; Kioi M, 2010, J CLIN INVEST, V120, P694, DOI 10.1172/JCI40283; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Kucia M, 2005, STEM CELLS, V23, P879, DOI 10.1634/stemcells.2004-0342; Lee S, 2005, J CELL BIOL, V169, P681, DOI 10.1083/jcb.200409115; Lin D, 2007, NEUROIMAGE, V37, pS18, DOI 10.1016/j.neuroimage.2007.03.076; Lindvall O, 2010, J CLIN INVEST, V120, P29, DOI 10.1172/JCI40543; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; Magnon C, 2011, METHODS MOL BIOL, V750, P3, DOI 10.1007/978-1-61779-145-1_1; Morikawa S, 2002, AM J PATHOL, V160, P985, DOI 10.1016/S0002-9440(10)64920-6; Najbauer J, 2007, PROGR GENE THERAPY A, P335; Niclou SP, 2008, FASEB J, V22, P3120, DOI 10.1096/fj.08-109611; Polajeva J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025222; Pollard JW, 2009, NAT REV IMMUNOL, V9, P259, DOI 10.1038/nri2528; Rempel SA, 2000, CLIN CANCER RES, V6, P102; Ricci-Vitiani L, 2010, NATURE, V468, P824, DOI 10.1038/nature09557; Robin AM, 2006, J CEREBR BLOOD F MET, V26, P125, DOI 10.1038/sj.jcbfm.9600172; Rong Y, 2006, J NEUROPATH EXP NEUR, V65, P529, DOI 10.1097/00005072-200606000-00001; Rubin JB, 2003, P NATL ACAD SCI USA, V100, P13513, DOI 10.1073/pnas.2235846100; Sakariassen PO, 2006, P NATL ACAD SCI USA, V103, P16466, DOI 10.1073/pnas.0607668103; Santarelli JG, 2006, NEUROSURGERY, V59, P374, DOI 10.1227/01.NEU.0000222658.66878.CC; Schulte A, 2011, GLIA, V59, P590, DOI 10.1002/glia.21127; Sica G, 2011, INT J ONCOL, V38, P41, DOI 10.3892/ijo_00000822; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sontheimer H, 2003, TRENDS NEUROSCI, V26, P543, DOI 10.1016/j.tins.2003.08.007; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Tran PB, 2004, J NEUROSCI RES, V76, P20, DOI 10.1002/jnr.20001; Tran PB, 2003, NAT REV NEUROSCI, V4, P444, DOI 10.1038/nrn1116; Tran PB, 2007, J COMP NEUROL, V500, P1007, DOI 10.1002/cne.21229; Ubiali F, 2007, INT IMMUNOL, V19, P1063, DOI 10.1093/intimm/dxm079; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; VanMeter TE, 2001, J NEURO-ONCOL, V53, P213, DOI 10.1023/A:1012280925031; Walzlein JH, 2008, STEM CELLS, V26, P2945, DOI 10.1634/stemcells.2008-0307; Wang J, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-465; Wang R, 2010, NATURE, V468, P829, DOI 10.1038/nature09624; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Wesseling P, 1997, J NEURO-ONCOL, V32, P253, DOI 10.1023/A:1005746320099; Westphal M, 2011, NAT REV NEUROSCI, V12, P495, DOI 10.1038/nrn3060; Wiese C, 2004, CELL MOL LIFE SCI, V61, P2510, DOI 10.1007/s00018-004-4144-6; Zagzag D, 2006, LAB INVEST, V86, P1221, DOI 10.1038/labinvest.3700482; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhao DH, 2008, MOL CANCER RES, V6, P1819, DOI 10.1158/1541-7786.MCR-08-0146	74	28	28	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35150	10.1371/journal.pone.0035150	http://dx.doi.org/10.1371/journal.pone.0035150			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22539956	Green Submitted, Green Published, gold			2022-12-27	WOS:000305341000020
J	Sepuri, NBV; Gorla, M; King, MP				Sepuri, Naresh Babu V.; Gorla, Madhavi; King, Michael P.			Mitochondrial Lysyl-tRNA Synthetase Independent Import of tRNA Lysine into Yeast Mitochondria	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; PROTEIN IMPORT; MECHANISM; TRANSLOCATION; REQUIREMENTS; TRANSLATION; EXPRESSION; TRNA(LYS); MEMBRANE; CONTAINS	Aminoacyl tRNA synthetases play a central role in protein synthesis by charging tRNAs with amino acids. Yeast mitochondrial lysyl tRNA synthetase (Msk1), in addition to the aminoacylation of mitochondrial tRNA, also functions as a chaperone to facilitate the import of cytosolic lysyl tRNA. In this report, we show that human mitochondrial Kars (lysyl tRNA synthetase) can complement the growth defect associated with the loss of yeast Msk1 and can additionally facilitate the in vitro import of tRNA into mitochondria. Surprisingly, the import of lysyl tRNA can occur independent of Msk1 in vivo. This suggests that an alternative mechanism is present for the import of lysyl tRNA in yeast.	[Sepuri, Naresh Babu V.; Gorla, Madhavi] Univ Hyderabad, Sch Life Sci, Dept Biochem, Hyderabad 500134, Andhra Pradesh, India; [Sepuri, Naresh Babu V.; King, Michael P.] Thomas Jefferson Univ, Dept Biochem & Mol Pharmacol, Philadelphia, PA 19107 USA	University of Hyderabad; Jefferson University	Sepuri, NBV (corresponding author), Univ Hyderabad, Sch Life Sci, Dept Biochem, Hyderabad 500134, Andhra Pradesh, India.	nareshuohyd@gmail.com; Michael.King@jefferson.edu	Sepuri, Naresh/AAF-2704-2020		Department of Biotechnology, India; Department of Science and Technology; National Institutes of Health (NIH); American Heart Association; CSIR (Council of Scientific and Industrial Research)	Department of Biotechnology, India(Department of Biotechnology (DBT) India); Department of Science and Technology(Department of Science & Technology (India)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); CSIR (Council of Scientific and Industrial Research)(Council of Scientific & Industrial Research (CSIR) - India)	The Department of Biotechnology, India provided funding for school facility in terms of DBT-Center for Research Excellence in Biotechnology, and Department of Science and Technology has provided funding to the Department of Biochemistry. DBT, India has provided funding for studying the tRNA import to Naresh Babu V. Sepuri. Also, the National Institutes of Health (NIH) provided funding to Michael P. King. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Debkumar Pain for providing antibodies for Tim23, put2, CCPO. We thank members of NBVS's and MK's labs for giving valuable suggestions throughout the study. NBVS acknowledges post-doctoral fellowship from American Heart Association (2001-2003). GM is supported by a JRF fellowship from CSIR (Council of Scientific and Industrial Research).	Anandatheerthavarada HK, 2009, J BIOL CHEM, V284, P17352, DOI 10.1074/jbc.M109.007492; Brandina I, 2007, FEBS LETT, V581, P4248, DOI 10.1016/j.febslet.2007.08.013; Diaz-Lazcoz Y, 1998, MOL BIOL EVOL, V15, P1548, DOI 10.1093/oxfordjournals.molbev.a025882; Dietmeier K, 1997, NATURE, V388, P195, DOI 10.1038/40663; Dietrich A, 1996, BIOCHIMIE, V78, P518, DOI 10.1016/0300-9084(96)84758-4; Entelis N, 2006, GENE DEV, V20, P1609, DOI 10.1101/gad.385706; Entelis NS, 1998, P NATL ACAD SCI USA, V95, P2838, DOI 10.1073/pnas.95.6.2838; Entelis NS, 2001, J BIOL CHEM, V276, P45642, DOI 10.1074/jbc.M103906200; HONLINGER A, 1995, BIOL CHEM H-S, V376, P515; Kamenski P, 2007, MOL CELL, V26, P625, DOI 10.1016/j.molcel.2007.04.019; Kazakova HA, 1999, FEBS LETT, V442, P193, DOI 10.1016/S0014-5793(98)01653-6; Kolesnikova OA, 2000, SCIENCE, V289, P1931, DOI 10.1126/science.289.5486.1931; MARTIN RP, 1979, BIOCHEMISTRY-US, V18, P4600, DOI 10.1021/bi00588a021; Mireau H, 2000, J BIOL CHEM, V275, P13291, DOI 10.1074/jbc.275.18.13291; Mukherjee S, 1999, J BIOL CHEM, V274, P31249, DOI 10.1074/jbc.274.44.31249; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; Park H, 2003, BIOCHEMISTRY-US, V42, P958, DOI 10.1021/bi026882r; Puranam RS, 2001, MOL CELL BIOL, V21, P548, DOI 10.1128/MCB.21.2.548-561.2001; Rinehart J, 2005, GENE DEV, V19, P583, DOI 10.1101/gad.1269305; Rose M, 1990, LAB COURSE MANUAL ME; Rubio MAT, 2008, P NATL ACAD SCI USA, V105, P9186, DOI 10.1073/pnas.0804283105; Rusconi CP, 1996, EMBO J, V15, P3286, DOI 10.1002/j.1460-2075.1996.tb00693.x; RYAN KR, 1995, CELL, V83, P517, DOI 10.1016/0092-8674(95)90089-6; Schneider A, 2011, ANNU REV BIOCHEM, V80, P1033, DOI 10.1146/annurev-biochem-060109-092838; Sepuri NBV, 1998, J BIOL CHEM, V273, P20941, DOI 10.1074/jbc.273.33.20941; Sepuri NBV, 1998, J BIOL CHEM, V273, P1420, DOI 10.1074/jbc.273.3.1420; TARASSOV I, 1995, EMBO J, V14, P3461, DOI 10.1002/j.1460-2075.1995.tb07352.x; TARASSOV I, 1995, J MOL BIOL, V245, P315, DOI 10.1006/jmbi.1994.0026; Tolkunova E, 2000, J BIOL CHEM, V275, P35063, DOI 10.1074/jbc.M006265200; Woese CR, 2000, MICROBIOL MOL BIOL R, V64, P202, DOI 10.1128/MMBR.64.1.202-236.2000; Yermovsky-Kammerer AE, 1999, MOL CELL BIOL, V19, P6253	31	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35321	10.1371/journal.pone.0035321	http://dx.doi.org/10.1371/journal.pone.0035321			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22539966	Green Submitted, Green Published, gold			2022-12-27	WOS:000305341000031
J	Amado, GM; Moura, RL; Bastos, AC; Salgado, LT; Sumida, PY; Guth, AZ; Francini, RB; Pereira, GH; Abrantes, DP; Brasileiro, PS; Bahia, RG; Leal, RN; Kaufman, L; Kleypas, JA; Farina, M; Thompson, FL				Amado-Filho, Gilberto M.; Moura, Rodrigo L.; Bastos, Alex C.; Salgado, Leonardo T.; Sumida, Paulo Y.; Guth, Arthur Z.; Francini-Filho, Ronaldo B.; Pereira-Filho, Guilherme H.; Abrantes, Douglas P.; Brasileiro, Poliana S.; Bahia, Ricardo G.; Leal, Rachel N.; Kaufman, Les; Kleypas, Joanie A.; Farina, Marcos; Thompson, Fabiano L.			Rhodolith Beds Are Major CaCO3 Bio-Factories in the Tropical South West Atlantic	PLOS ONE			English	Article							ESPIRITO-SANTO STATE; CARBONATE PRODUCTION; OCEAN ACIDIFICATION; CORALLINE ALGAE; RHODOPHYTA; COMMUNITY; MAERL; DIVERSITY; REEFS; COAST	Rhodoliths are nodules of non-geniculate coralline algae that occur in shallow waters (<150 m depth) subjected to episodic disturbance. Rhodolith beds stand with kelp beds, seagrass meadows, and coralline algal reefs as one of the world's four largest macrophyte-dominated benthic communities. Geographic distribution of rhodolith beds is discontinuous, with large concentrations off Japan, Australia and the Gulf of California, as well as in the Mediterranean, North Atlantic, eastern Caribbean and Brazil. Although there are major gaps in terms of seabed habitat mapping, the largest rhodolith beds are purported to occur off Brazil, where these communities are recorded across a wide latitudinal range (2 degrees N - 27 degrees S). To quantify their extent, we carried out an inter-reefal seabed habitat survey on the Abrolhos Shelf (16 degrees 50' - 19 degrees 45'S) off eastern Brazil, and confirmed the most expansive and contiguous rhodolith bed in the world, covering about 20,900 km(2). Distribution, extent, composition and structure of this bed were assessed with side scan sonar, remotely operated vehicles, and SCUBA. The mean rate of CaCO3 production was estimated from in situ growth assays at 1.07 kg m(-2) yr(-1), with a total production rate of 0.025 Gt yr(-1), comparable to those of the world's largest biogenic CaCO3 deposits. These gigantic rhodolith beds, of areal extent equivalent to the Great Barrier Reef, Australia, are a critical, yet poorly understood component of the tropical South Atlantic Ocean. Based on the relatively high vulnerability of coralline algae to ocean acidification, these beds are likely to experience a profound restructuring in the coming decades.	[Moura, Rodrigo L.; Thompson, Fabiano L.] Univ Fed Rio de Janeiro, Inst Biol, Rio De Janeiro, RJ, Brazil; [Amado-Filho, Gilberto M.; Salgado, Leonardo T.; Abrantes, Douglas P.; Brasileiro, Poliana S.; Bahia, Ricardo G.; Leal, Rachel N.] Inst Pesquisas Jardim Bot Rio de Janeiro, Rio De Janeiro, RJ, Brazil; [Bastos, Alex C.] Univ Fed Espirito Santo, Dept Ecol & Recursos Nat, Vitoria, ES, Brazil; [Sumida, Paulo Y.; Guth, Arthur Z.] Univ Sao Paulo, Inst Oceanog, Sao Paulo, Brazil; [Francini-Filho, Ronaldo B.] Univ Fed Paraiba, Ctr Ciencias Aplicadas & Educ, Rio Tinto, PB, Brazil; [Pereira-Filho, Guilherme H.] Univ Fed Rural Rio de Janeiro, Dept Bot, Seropedica, RJ, Brazil; [Kaufman, Les] Boston Univ, Marine Program, Boston, MA 02215 USA; [Kleypas, Joanie A.] Natl Ctr Atmospher Res, Boulder, CO 80307 USA; [Farina, Marcos] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Rio De Janeiro, RJ, Brazil	Universidade Federal do Rio de Janeiro; Jardim Botanico do Rio de Janeiro; Universidade Federal do Espirito Santo; Universidade de Sao Paulo; Universidade Federal da Paraiba; Universidade Federal Rural do Rio de Janeiro (UFRRJ); Boston University; National Center Atmospheric Research (NCAR) - USA; Universidade Federal do Rio de Janeiro	Moura, RL (corresponding author), Univ Fed Rio de Janeiro, Inst Biol, Rio De Janeiro, RJ, Brazil.	moura@biologia.ufrj.br	de Moura, Rodrigo Leao/AAL-5781-2020; Farina, Marcos/I-3744-2014; Francini-Filho, Ronaldo/I-5708-2012; Güth, Arthur Z/F-2559-2011; Salgado, Leonardo T/F-1123-2013; Sumida, Paulo Y G/F-2561-2011; Bahia, Ricardo/J-8724-2015; FILHO, GILBERTO M AMADO/I-1324-2012; Pereira-Filho, Guilherme-Henrique/I-2946-2013; Bastos, Alex/H-3674-2014	de Moura, Rodrigo Leao/0000-0002-5597-6196; Francini-Filho, Ronaldo/0000-0002-7678-6797; Güth, Arthur Z/0000-0001-8388-4187; Sumida, Paulo Y G/0000-0001-7549-4541; Pereira-Filho, Guilherme-Henrique/0000-0001-6078-2241; Bastos, Alex/0000-0002-1272-1134; Thompson, Fabiano/0000-0002-7562-1683	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - Brazil; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brazil; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro - Brazil; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - Brazil; Conservation International, USA; Gordon and Betty Moore Foundation, USA	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro - Brazil(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conservation International, USA; Gordon and Betty Moore Foundation, USA(Gordon and Betty Moore Foundation)	Funders are the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - Brazil, the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brazil, the Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro - Brazil, the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - Brazil, Conservation International, USA, and The Gordon and Betty Moore Foundation, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amado GM, 2007, CIENC MAR, V33, P399, DOI 10.7773/cm.v33i4.1148; Amado GM, 2010, CIENC MAR, V36, P371, DOI 10.7773/cm.v36i4.1782; Andersson AJ, 2005, AM J SCI, V305, P875, DOI 10.2475/ajs.305.9.875; [Anonymous], ANN 28 BRAZ C GEOL; Anthony KRN, 2008, P NATL ACAD SCI USA, V105, P17442, DOI 10.1073/pnas.0804478105; Bahia RG, 2010, BRAZ J OCEANOGR, V58, P323, DOI 10.1590/S1679-87592010000400007; Blake C, 2003, PHYCOLOGIA, V42, P606, DOI 10.2216/i0031-8884-42-6-606.1; BOHM L, 1978, J PHYCOL, V14, P486, DOI 10.1111/j.1529-8817.1978.tb02474.x; Bosence D, 2003, AQUAT CONSERV, V13, pS21, DOI 10.1002/aqc.565; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Foster MS, 2007, CIENC MAR, V33, P367, DOI 10.7773/cm.v33i4.1174; Foster MS, 2001, J PHYCOL, V37, P659, DOI 10.1046/j.1529-8817.2001.00195.x; Frantz BR, 2005, J PHYCOL, V41, P770, DOI 10.1111/j.1529-8817.2005.00107.x; FREIWALD A, 1994, SEDIMENTOLOGY, V41, P963, DOI 10.1111/j.1365-3091.1994.tb01435.x; Guimaraes SMPB, 2008, BOT MAR, V51, P378, DOI 10.1515/BOT.2008.048; Harvey AS, 2006, AUST SYST BOT, V19, P387, DOI 10.1071/SB05029; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; KEMPF M, 1970, MAR BIOL, V5, P213, DOI 10.1007/BF00346909; KINSEY DW, 1991, GLOBAL PLANET CHANGE, V89, P363, DOI 10.1016/0921-8181(91)90117-F; Kleypas JA, 1997, PALEOCEANOGRAPHY, V12, P533, DOI 10.1029/97PA01134; Kohler KE, 2006, COMPUT GEOSCI-UK, V32, P1259, DOI 10.1016/j.cageo.2005.11.009; Leao Z, 1997, P 8 INT COR REEF S, V2, P1767; Leao Z.M.A.N., 1996, ANAIS ACAD BRAS CIEN, V68, P339; Martin S, 2007, MAR ECOL PROG SER, V335, P19, DOI 10.3354/meps335019; Martin S, 2009, GLOBAL CHANGE BIOL, V15, P2089, DOI 10.1111/j.1365-2486.2009.01874.x; MELO U, 1975, CONTRIB SEDIMENTOL, V4, P78; Milliman JD, 1996, GEOL RUNDSCH, V85, P496, DOI 10.1007/s005310050090; MILLIMAN JD, 1993, GLOBAL BIOGEOCHEM CY, V7, P927, DOI 10.1029/93GB02524; Nelson WA, 2009, MAR FRESHWATER RES, V60, P787, DOI 10.1071/MF08335; PAYRI CE, 1995, B SOC GEOL FR, V166, P77; Pena V, 2008, AQUAT CONSERV, V18, P339, DOI 10.1002/aqc.847; POTIN P, 1990, HYDROBIOLOGIA, V204, P263, DOI 10.1007/BF00040243; Riul P, 2009, AQUAT BOT, V90, P315, DOI 10.1016/j.aquabot.2008.12.002; RODRIGUEZ-RAMIREZ A, 2008, STATUS CORAL REEFS W, P281; Spalding MD, 1997, CORAL REEFS, V16, P225, DOI 10.1007/s003380050078; STEARN CW, 1977, B MAR SCI, V27, P479; Vecsei A, 2000, FACIES, V43, P205, DOI 10.1007/BF02536991; Vecsei A, 2004, PALAEOGEOGR PALAEOCL, V214, P3, DOI 10.1016/j.palaeo.2004.06.009; Vecsei A, 2004, GLOBAL PLANET CHANGE, V43, P1, DOI 10.1016/j.gloplacha.2003.12.002; VERHEIJ E, 1993, PHYCOLOGIA, V32, P184, DOI 10.2216/i0031-8884-32-3-184.1; Veron JEN, 2009, MAR POLLUT BULL, V58, P1428, DOI 10.1016/j.marpolbul.2009.09.009; Villas-Boas AB, 2009, PHYCOLOGIA, V48, P237, DOI 10.2216/08-35.1; Wilson S, 2004, BIOL CONSERV, V120, P279, DOI 10.1016/j.biocon.2004.03.001	43	195	197	2	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35171	10.1371/journal.pone.0035171	http://dx.doi.org/10.1371/journal.pone.0035171			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536356	gold, Green Published, Green Submitted			2022-12-27	WOS:000305339200041
J	Chi, F; Bo, T; Wu, CH; Jong, A; Huang, SH				Chi, Feng; Bo, Tao; Wu, Chun-Hua; Jong, Ambrose; Huang, Sheng-He			Vimentin and PSF Act in Concert to Regulate IbeA plus E-coli K1 Induced Activation and Nuclear Translocation of NF-kappa B in Human Brain Endothelial Cells	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; SIGNALING PATHWAY; BINDING PROTEIN; BREAST-CANCER; IN-VITRO; INVASION; VIRULENCE; EXPRESSION; SYSTEM; IDENTIFICATION	Background: IbeA-induced NF-kappa B signaling through its primary receptor vimentin as well as its co-receptor PSF is required for meningitic E. coli K1 penetration and leukocyte transmigration across the blood-brain barrier (BBB), which are the hallmarks of bacterial meningitis. However, it is unknown how vimentin and PSF cooperatively contribute to IbeA-induced cytoplasmic activation and nuclear translocation of NF-kappa B, which are required for bacteria-mediated pathogenicities. Methodology/Principal Findings: IbeA-induced E. coli K1 invasion, polymorphonuclear leukocyte (PMN) transmigration and IKK/NF-kappa B activation are blocked by Caffeic acid phenethyl ester (CAPE), an inhibitor of NF-kappa B. IKK alpha/beta phosphorylation is blocked by ERK inhibitors. Co-immunoprecipitation analysis shows that vimentin forms a complex with I kappa B, NF-kappa B and tubulins in the resting cells. A dissociation of this complex and a simultaneous association of PSF with NF-kappa B could be induced by IbeA in a time-dependent manner. The head domain of vimentin is required for the complex formation. Two cytoskeletal components, vimentin filaments and microtubules, contribute to the regulation of NF-kappa B. SiRNA-mediated knockdown studies demonstrate that IKK alpha/beta phosphorylation is completely abolished in HBMECs lacking vimentin and PSF. Phosphorylation of ERK and nuclear translocation of NF-kappa B are entirely dependent on PSF. These findings suggest that vimentin and PSF cooperatively contribute to IbeA-induced cytoplasmic activation and nuclear translocation of NF-kappa B activation. PSF is essential for translocation of NF-kappa B and ERK to the nucleus. Conclusion/Significance: These findings reveal previously unappreciated facets of the IbeA-binding proteins. Cooperative contributions of vimentin and PSF to IbeA-induced cytoplasmic activation and nuclear translocation of NF-kappa B may represent a new paradigm in pathogen-induced signal transduction and lead to the development of novel strategies for the prevention and treatment of bacterial meningitis.	[Chi, Feng; Bo, Tao; Wu, Chun-Hua; Jong, Ambrose; Huang, Sheng-He] Univ So Calif, Dept Pediat, Childrens Hosp Los Angeles, Saban Res Inst, Los Angeles, CA 90089 USA; [Bo, Tao] Cent S Univ, Xiangya Hosp 2, Dept Pediat, Div Neonatol, Changsha, Hunan, Peoples R China	Children's Hospital Los Angeles; University of Southern California; Central South University	Huang, SH (corresponding author), Univ So Calif, Dept Pediat, Childrens Hosp Los Angeles, Saban Res Inst, Los Angeles, CA 90089 USA.	shhuang@hsc.usc.edu	Chi, Feng/H-5895-2012		Public Health Service [R56-AI40635, R01-NS047599]; Saban Research Institute Research Career Development Fellowship (RCDF); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI040635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047599] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Saban Research Institute Research Career Development Fellowship (RCDF); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This project was financially supported by Public Health Service grants R56-AI40635 (Dr. Huang) and R01-NS047599 (Dr. Jong), and a Saban Research Institute Research Career Development Fellowship (RCDF) (Dr. Chi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Latif MMM, 2005, BRIT J PHARMACOL, V146, P1139, DOI 10.1038/sj.bjp.0706421; Bargagna-Mohan P, 2007, CHEM BIOL, V14, P623, DOI 10.1016/j.chembiol.2007.04.010; BENNETT V, 1981, P NATL ACAD SCI-BIOL, V78, P7550, DOI 10.1073/pnas.78.12.7550; Bingen E, 1998, J INFECT DIS, V177, P642, DOI 10.1086/514217; Chang L, 2004, NAT REV MOL CELL BIO, V5, P601, DOI 10.1038/nrm1438; Che XJ, 2011, BRAIN PATHOL, V21, P389, DOI 10.1111/j.1750-3639.2010.00463.x; Chen M, 2003, CLIN EXP DERMATOL, V28, P193, DOI 10.1046/j.1365-2230.2003.01191.x; Chen YH, 2002, CELL MICROBIOL, V4, P503, DOI 10.1046/j.1462-5822.2002.00209.x; Chi F, 2005, APPL ENVIRON MICROB, V71, P7271, DOI 10.1128/AEM.71.11.7271-7278.2005; Chi F, 2011, FUTURE MICROBIOL, V6, P953, DOI 10.2217/FMB.11.65; Chi F, 2010, BIOCHEM J, V427, P79, DOI 10.1042/BJ20091097; Chi F, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/520283; Cortes MAM, 2008, INFECT IMMUN, V76, P4129, DOI 10.1128/IAI.00334-08; David E, 2010, BLOOD, V116, P5285, DOI 10.1182/blood-2010-03-272393; Dawson S, 1997, MOL BIOL REP, V24, P39, DOI 10.1023/A:1006800522814; Denner L, 2010, ENDOCRINOLOGY, V151, P2819, DOI 10.1210/en.2009-1439; Dev A, 2011, CURR TOP MICROBIOL, V349, P115, DOI 10.1007/82_2010_102; Dong XS, 2005, J BIOL CHEM, V280, P13329, DOI 10.1074/jbc.M409187200; Dziva F, 2008, AVIAN PATHOL, V37, P355, DOI 10.1080/03079450802216652; GEORGATOS SD, 1985, J CELL BIOL, V100, P1955, DOI 10.1083/jcb.100.6.1955; GEORGATOS SD, 1985, J CELL BIOL, V100, P1962, DOI 10.1083/jcb.100.6.1962; Ghoda L, 1997, J BIOL CHEM, V272, P21281, DOI 10.1074/jbc.272.34.21281; Griffiths NJ, 2007, CELL MICROBIOL, V9, P2968, DOI 10.1111/j.1462-5822.2007.01038.x; He L, OJAPPS IN PRESS; Higuero AM, 2010, J BIOL CHEM, V285, P1343, DOI 10.1074/jbc.M109.024703; Huang SH, 2000, MICROBES INFECT, V2, P1237, DOI 10.1016/S1286-4579(00)01277-6; HUANG SH, 1995, INFECT IMMUN, V63, P4470, DOI 10.1128/IAI.63.11.4470-4475.1995; Huang SH, 2001, J INFECT DIS, V183, P1071, DOI 10.1086/319290; Huang Sheng-he, 2001, Functional and Integrative Genomics, V1, P312, DOI 10.1007/s101420100039; Huber MA, 2004, J CLIN INVEST, V114, P569, DOI 10.1172/JCI200421358; Ichiyama T, 2002, NEUROL RES, V24, P709, DOI 10.1179/016164102101200627; Jackman RW, 2009, EXP CELL RES, V315, P3242, DOI 10.1016/j.yexcr.2009.08.020; Johnson TJ, 2012, FOODBORNE PATHOG DIS, V9, P37, DOI 10.1089/fpd.2011.0961; Johnson TJ, 2012, INFECT IMMUN    0206, V6; Khan M, 2007, J NEUROCHEM, V102, P365, DOI 10.1111/j.1471-4159.2007.04526.x; Koedel U, 2000, J INFECT DIS, V182, P1437, DOI 10.1086/315877; Kokkinos MI, 2007, CELLS TISSUES ORGANS, V185, P191, DOI 10.1159/000101320; Koudelka KJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000417; Lukong KE, 2009, CELL SIGNAL, V21, P1415, DOI 10.1016/j.cellsig.2009.04.008; Luna GM, 2010, APPL ENVIRON MICROB, V76, P5659, DOI 10.1128/AEM.03138-09; Mackenzie GG, 2006, J NEUROCHEM, V99, P402, DOI 10.1111/j.1471-4159.2006.04005.x; Mankan AK, 2009, J CELL MOL MED, V13, P631, DOI 10.1111/j.1582-4934.2009.00632.x; Mikenberg I, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000589; Mikenberg I, 2006, EUR J CELL BIOL, V85, P529, DOI 10.1016/j.ejcb.2006.02.007; Mor-Vaknin N, 2003, NAT CELL BIOL, V5, P59, DOI 10.1038/ncb898; Mora A, 2010, APPL ENVIRON MICROB, V76, P6991, DOI 10.1128/AEM.01112-10; Moreland JG, 2006, AM J PHYSIOL-LUNG C, V290, pL833, DOI 10.1152/ajplung.00333.2005; Moreland JG, 2004, J IMMUNOL, V172, P426, DOI 10.4049/jimmunol.172.1.426; MouraNeto V, 1996, GENE, V168, P261, DOI 10.1016/0378-1119(95)00789-X; Negrini B, 2000, PEDIATRICS, V105, P316, DOI 10.1542/peds.105.2.316; Nemeth ZH, 2004, J CELL PHYSIOL, V200, P71, DOI 10.1002/jcp.10477; Nieminen M, 2006, NAT CELL BIOL, V8, P156, DOI 10.1038/ncb1355; Panta GR, 2004, MOL CELL BIOL, V24, P1823, DOI 10.1128/MCB.24.5.1823-1835.2004; Perlson E, 2006, J MOL BIOL, V364, P938, DOI 10.1016/j.jmb.2006.09.056; Phua DCY, 2009, MOL BIOL CELL, V20, P2841, DOI 10.1091/mbc.E08-02-0199; Rosenberger U, 2002, J CELL BIOCHEM, V86, P394, DOI 10.1002/jcb.10233; Saegusa M, 2007, J PATHOL, V213, P35, DOI 10.1002/path.2198; Shav-Tal Y, 2002, FEBS LETT, V531, P109, DOI 10.1016/S0014-5793(02)03447-6; Shin SR, 2006, CANCER RES, V66, P2570, DOI 10.1158/0008-5472.CAN-05-3056; Soto SM, 2008, J CLIN MICROBIOL, V46, P1123, DOI 10.1128/JCM.01682-07; Stins MF, 1999, INFECT IMMUN, V67, P5522, DOI 10.1128/IAI.67.10.5522-5525.1999; van der Flier M, 2003, CLIN MICROBIOL REV, V16, P415, DOI 10.1128/CMR.16.3.415-429.2003; Wang SH, 2011, INFECT IMMUN, V79, P279, DOI 10.1128/IAI.00821-10; Watt S, 2003, J CLIN MICROBIOL, V41, P1929, DOI 10.1128/JCM.41.5.1929-1935.2003; Xu B, 2004, MOL CELL BIOL, V24, P9198, DOI 10.1128/MCB.24.20.9198-9206.2004; Yang HJ, 2007, MOL PHARMACOL, V71, P426, DOI 10.1124/mol.106.030015; Zhang Q, 2009, CLIN CANCER RES, V15, P3557, DOI 10.1158/1078-0432.CCR-08-1656; Zhao J, 2012, J NEUROTRAUMA   0130, V30; Zolotukhin AS, 2003, MOL CELL BIOL, V23, P6618, DOI 10.1128/MCB.23.18.6618-6630.2003; Zou YM, 2007, MED MICROBIOL IMMUN, V196, P135, DOI 10.1007/s00430-006-0034-x; Zou YM, 2006, BIOCHEM BIOPH RES CO, V351, P625, DOI 10.1016/j.bbrc.2006.10.091	71	24	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35862	10.1371/journal.pone.0035862	http://dx.doi.org/10.1371/journal.pone.0035862			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536447	Green Submitted, Green Published, gold			2022-12-27	WOS:000305339200120
J	He, WM; Li, JJ; Peng, PH				He, Wei-Ming; Li, Jing-Ji; Peng, Pei-Hao			A Congeneric Comparison Shows That Experimental Warming Enhances the Growth of Invasive Eupatorium adenophorum	PLOS ONE			English	Article							NITROGEN ALLOCATION; PHOTOSYNTHESIS	Rising air temperatures may change the risks of invasive plants; however, little is known about how different warming timings affect the growth and stress-tolerance of invasive plants. We conducted an experiment with an invasive plant Eupatorium adenophorum and a native congener Eupatorium chinense, and contrasted their mortality, plant height, total biomass, and biomass allocation in ambient, day-, night-, and daily-warming treatments. The mortality of plants was significantly higher in E. chinense than E. adenophorum in four temperature regimes. Eupatorium adenophorum grew larger than E. chinense in the ambient climate, and this difference was amplified with warming. On the basis of the net effects of warming, daily-warming exhibited the strongest influence on E. adenophorum, followed by day-warming and night-warming. There was a positive correlation between total biomass and root weight ratio in E. adenophorum, but not in E. chinense. These findings suggest that climate warming may enhance E. adenophorum invasions through increasing its growth and stress-tolerance, and that day-, night- and daily-warming may play different roles in this facilitation.	[He, Wei-Ming] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China; [Li, Jing-Ji; Peng, Pei-Hao] Chengdu Univ Technol, Dept Landscape Architecture, Chengdu, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Chengdu University of Technology	He, WM (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China.	weiminghe@ibcas.ac.cn		jingji, li/0000-0002-0611-1364	National Natural Science Foundation of China [31170507]; State Key Laboratory of Vegetation and Environmental Change [2011zyts02]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Vegetation and Environmental Change	Two grants from the National Natural Science Foundation of China (31170507) and State Key Laboratory of Vegetation and Environmental Change (2011zyts02) to WMH funded this research. The website is www.nsfc.gov.cn for the National Natural Science Foundation of Chia, and the website is www.ibcas.ac.cn for the State Key Laboratory of Vegetation and Environmental Change. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Begon M., 2009, ECOLOGY INDIVIDUALS; Bradley BA, 2010, TRENDS ECOL EVOL, V25, P310, DOI 10.1016/j.tree.2009.12.003; Bradley BA, 2010, BIOL INVASIONS, V12, P1855, DOI 10.1007/s10530-009-9597-y; Callaway RM, 2006, TRENDS ECOL EVOL, V21, P369, DOI 10.1016/j.tree.2006.04.008; Caplan JS, 2010, PLANT ECOL, V210, P169, DOI 10.1007/s11258-010-9747-4; Cervera JC, 2009, PLANT ECOL, V205, P285, DOI 10.1007/s11258-009-9617-0; Cronk QCB, 1995, PLANT INVADERS THREA; Dukes JS, 1999, TRENDS ECOL EVOL, V14, P135, DOI 10.1016/S0169-5347(98)01554-7; Feng YL, 2008, PHYSIOL PLANTARUM, V133, P318, DOI 10.1111/j.1399-3054.2008.01072.x; Feng YL, 2009, P NATL ACAD SCI USA, V106, P1853, DOI 10.1073/pnas.0808434106; Funk JL, 2007, NATURE, V446, P1079, DOI 10.1038/nature05719; He WM, 2011, ECOGRAPHY, V34, P1059, DOI 10.1111/j.1600-0587.2011.06835.x; IPCC, 2007, CLIM CHANG 2007 PHYS; Li JJ, 2012, PLANT BIOLOGY, V14, P265, DOI 10.1111/j.1438-8677.2011.00500.x; Mack RN, 1996, BIOL CONSERV, V78, P107, DOI 10.1016/0006-3207(96)00021-3; McCormick AJ, 2006, NEW PHYTOL, V171, P759, DOI 10.1111/j.1469-8137.2006.01785.x; Milberg P, 1999, PLANT ECOL, V145, P125, DOI 10.1023/A:1009817804815; Morrison JA, 2007, J ECOL, V95, P1036, DOI 10.1111/j.1365-2745.2007.01270.x; Paul MJ, 2001, J EXP BOT, V52, P1383, DOI 10.1093/jexbot/52.360.1383; Prieto P, 2009, GLOBAL ECOL BIOGEOGR, V18, P473, DOI 10.1111/j.1466-8238.2009.00460.x; Richardson DM, 2011, 50 YEARS INVASIVE EC; Turnbull MH, 2002, PLANT CELL ENVIRON, V25, P1729, DOI 10.1046/j.1365-3040.2002.00947.x; van Kleunen M, 2010, ECOL LETT, V13, P235, DOI 10.1111/j.1461-0248.2009.01418.x; Verlinden M, 2010, BIOL INVASIONS, V12, P2777, DOI 10.1007/s10530-009-9683-1; Walther GR, 2009, TRENDS ECOL EVOL, V24, P686, DOI 10.1016/j.tree.2009.06.008; Wan SQ, 2009, ECOLOGY, V90, P2700, DOI 10.1890/08-2026.1; Wang R, 2006, DIVERS DISTRIB, V12, P397, DOI 10.1111/j.1366-9516.2006.00250.x; Williams AL, 2007, NEW PHYTOL, V176, P365, DOI 10.1111/j.1469-8137.2007.02170.x; Woodward F.I., 1987, CLIMATE PLANT DISTRI; Working Group for National Report of Climate Change in China, 2007, NAT REP CLIM CHANG C	30	18	21	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35681	10.1371/journal.pone.0035681	http://dx.doi.org/10.1371/journal.pone.0035681			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536425	Green Published, gold, Green Submitted			2022-12-27	WOS:000305339200097
J	Jain, S; Chen, ST; Chang, KC; Lin, YJ; Hu, CT; Boldbaatar, B; Hamilton, JP; Lin, SY; Chang, TT; Chen, SH; Song, W; Meltzer, SJ; Block, TM; Su, YH				Jain, Surbhi; Chen, Sitong; Chang, Kung-Chao; Lin, Yih-Jyh; Hu, Chi-Tan; Boldbaatar, Batbold; Hamilton, James P.; Lin, Selena Y.; Chang, Ting-Tsung; Chen, Shun-Hua; Song, Wei; Meltzer, Stephen J.; Block, Timothy M.; Su, Ying-Hsiu			Impact of the Location of CpG Methylation within the GSTP1 Gene on Its Specificity as a DNA Marker for Hepatocellular Carcinoma	PLOS ONE			English	Article							ABERRANT PROMOTER METHYLATION; TUMOR-SUPPRESSOR GENES; ISLAND HYPERMETHYLATION; MULTIPLE GENES; GLUTATHIONE TRANSFERASES; QUANTITATIVE-ANALYSIS; CANCER; LIVER; HEPATITIS; HEPATOCARCINOGENESIS	Hypermethylation of the glutathione S-transferase pi 1 (GSTP1) gene promoter region has been reported to be a potential biomarker to distinguish hepatocellular carcinoma (HCC) from other liver diseases. However, reports regarding how specific a marker it is have ranged from 100% to 0%. We hypothesized that, to a large extent, the variation of specificity depends on the location of the CpG sites analyzed. To test this hypothesis, we compared the methylation status of the GSTP1 promoter region of the DNA isolated from HCC, cirrhosis, hepatitis, and normal liver tissues by bisulfite-PCR sequencing. We found that the 5' region of the position -48 nt from the transcription start site of the GSTP1 gene is selectively methylated in HCC, whereas the 3' region is methylated in all liver tissues examined, including normal liver and the HCC tissue. Interestingly, when DNA derived from fetal liver and 11 nonhepatic normal tissue was also examined by bisulfite-PCR sequencing, we found that methylation of the 3' region of the promoter appeared to be liver-specific. A methylation-specific PCR assay targeting the 5' region of the promoter was developed and used to quantify the methylated GSTP1 gene in various diseased liver tissues including HCC. When we used an assay targeting the 3' region, we found that the methylation of the 5'-end of the GSTP1 promoter was significantly more specific than that of the 3'-end (97.1% vs. 60%, p < 0.0001 by Fisher's exact test) for distinguishing HCC (n = 120) from hepatitis (n = 35) and cirrhosis (n = 35). Encouragingly, 33.8% of the AFP-negative HCC contained the methylated GSTP1 gene. This study clearly demonstrates the importance of the location of CpG site methylation for HCC specificity and how liver-specific DNA methylation should be considered when an epigenetic DNA marker is studied for detection of HCC.	[Jain, Surbhi; Chen, Sitong; Boldbaatar, Batbold; Lin, Selena Y.; Block, Timothy M.; Su, Ying-Hsiu] Drexel Univ, Coll Med, Dept Microbiol & Immunol, Philadelphia, PA 19104 USA; [Chang, Kung-Chao] Natl Cheng Kung Univ, Coll Med, Dept Pathol, Tainan 70101, Taiwan; [Lin, Yih-Jyh] Natl Cheng Kung Univ Hosp, Dept Surg, Tainan 70428, Taiwan; [Hu, Chi-Tan] Buddhist Tzu Chi Gen Hosp, Dept Med, Hualien, Taiwan; [Hu, Chi-Tan] Tzu Chi Univ, Hualien, Taiwan; [Hamilton, James P.; Meltzer, Stephen J.] Johns Hopkins Univ, Sch Med, Dept Med, Div Gastroenterol & Hepatol, Baltimore, MD 21205 USA; [Chang, Ting-Tsung] Natl Cheng Kung Univ, Coll Med, Dept Med, Tainan 70101, Taiwan; [Chen, Shun-Hua] Natl Cheng Kung Univ, Coll Med, Dept Microbiol, Tainan 70101, Taiwan; [Song, Wei] JBS Sci Inc, Doylestown, PA USA; [Meltzer, Stephen J.] Sidney Kimmel Comprehens Canc Ctr, Dept Oncol, Baltimore, MD USA	Drexel University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University Hospital; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Tzu Chi University; Johns Hopkins University; National Cheng Kung University; National Cheng Kung University; Johns Hopkins University; Johns Hopkins Medicine	Su, YH (corresponding author), Drexel Univ, Coll Med, Dept Microbiol & Immunol, Philadelphia, PA 19104 USA.	Ying-hsiu.Su@drexelmed.edu	CHEN, SI/GZL-4800-2022		National Institute of Health [R01 CA125642, CA146799, CA133012, CA085069, DK087454, K08]; Johns Hopkins University School of Medicine; Prevent Cancer Foundation Postdoctoral Fellowship Award; Early Detection Research Network grant of The National Cancer Institute; Hepatitis B Foundation of America; Commonwealth of Pennsylvania; NATIONAL CANCER INSTITUTE [R01CA133012, R01CA146799, R01CA125642, U01CA085069] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087454] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johns Hopkins University School of Medicine(Johns Hopkins University); Prevent Cancer Foundation Postdoctoral Fellowship Award; Early Detection Research Network grant of The National Cancer Institute; Hepatitis B Foundation of America; Commonwealth of Pennsylvania; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institute of Health R01 CA125642 (YHS), CA146799(SJM), CA133012 (SJM), CA085069 (SJM), DK087454 (SJM), and K08 (JPH). a Clinician-Scientist Award from Johns Hopkins University School of Medicine (JPH); Prevent Cancer Foundation Postdoctoral Fellowship Award (SJ); The Early Detection Research Network grant of The National Cancer Institute (TMB); The Hepatitis B Foundation of America (TMB); and an appropriation from The Commonwealth of Pennsylvania (TMB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	American Cancer Society, 2010, CANC FACTS FIG 2010; Bakker J, 2002, J BIOL CHEM, V277, P22573, DOI 10.1074/jbc.M203009200; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Chai H, 2009, ANN CLIN LAB SCI, V39, P331; Chan KCA, 2008, CLIN CHEM, V54, P1528, DOI 10.1373/clinchem.2008.104653; Chang H, 2008, EXP MOL PATHOL, V85, P96, DOI 10.1016/j.yexmp.2008.07.001; COLES B, 1990, CRIT REV BIOCHEM MOL, V25, P47, DOI 10.3109/10409239009090605; Esteller M, 2001, CANCER RES, V61, P3225; Feng QH, 2010, EXP MOL PATHOL, V88, P287, DOI 10.1016/j.yexmp.2010.01.002; Formeister EJ, 2010, MUTAT RES-FUND MOL M, V692, P26, DOI 10.1016/j.mrfmmm.2010.07.013; Giovannucci E, 2005, JNCI-J NATL CANCER I, V97, P1317, DOI 10.1093/jnci/dji305; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harder J, 2008, INT J CANCER, V122, P2800, DOI 10.1002/ijc.23433; Hayes JD, 1995, CRIT REV BIOCHEM MOL, V30, P445, DOI 10.3109/10409239509083491; Hernandez-Vargas H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009749; Hoshida Yujin, 2009, Expert Rev Gastroenterol Hepatol, V3, P101, DOI 10.1586/egh.09.5; Hua D, 2011, EXP MOL PATHOL, V91, P455, DOI 10.1016/j.yexmp.2011.05.001; Huang ZH, 2011, EXP MOL PATHOL, V91, P702, DOI 10.1016/j.yexmp.2011.08.004; Jain S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026799; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Katoh H, 2006, AM J PATHOL, V168, P1375, DOI 10.2353/ajpath.2006.050989; Lambert MP, 2011, J HEPATOL, V54, P705, DOI 10.1016/j.jhep.2010.07.027; Lee S, 2003, AM J PATHOL, V163, P1371, DOI 10.1016/S0002-9440(10)63495-5; Lehmann U, 2005, CLIN CANCER RES, V11, P3654, DOI 10.1158/1078-0432.CCR-04-2462; Millar DS, 2000, J BIOL CHEM, V275, P24893, DOI 10.1074/jbc.M906538199; Millar DS, 1999, ONCOGENE, V18, P1313, DOI 10.1038/sj.onc.1202415; Moribe T, 2009, INT J CANCER, V125, P388, DOI 10.1002/ijc.24394; Nishida N, 2008, HEPATOLOGY, V47, P908, DOI 10.1002/hep.22110; Nomoto S, 2007, BRIT J CANCER, V97, P1260, DOI 10.1038/sj.bjc.6604016; Park IY, 2007, GASTROENTEROLOGY, V132, P1476, DOI 10.1053/j.gastro.2007.01.034; RUSHMORE TH, 1993, J BIOL CHEM, V268, P11475; Sherman M, 2008, NEW ENGL J MED, V359, P2045, DOI 10.1056/NEJMe0807581; Su PF, 2007, INT J CANCER, V121, P1257, DOI 10.1002/ijc.22849; Tchou JC, 2000, INT J ONCOL, V16, P663; TSUCHIDA S, 1992, CRIT REV BIOCHEM MOL, V27, P337, DOI 10.3109/10409239209082566; van Vlodrop IJH, 2011, CLIN CANCER RES, V17, P4225, DOI 10.1158/1078-0432.CCR-10-3394; van Vlodrop IJH, 2010, AM J PATHOL, V176, P575, DOI 10.2353/ajpath.2010.090442; Wang JH, 2006, CLIN BIOCHEM, V39, P344, DOI 10.1016/j.clinbiochem.2006.01.008; Whittaker S, 2010, ONCOGENE, V29, P4989, DOI 10.1038/onc.2010.236; Yang B, 2003, AM J PATHOL, V163, P1101, DOI 10.1016/S0002-9440(10)63469-4; Yang JD, 2011, SEMIN CANCER BIOL, V21, P35, DOI 10.1016/j.semcancer.2010.10.007; Zhong S, 2002, CLIN CANCER RES, V8, P1087	42	33	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35789	10.1371/journal.pone.0035789	http://dx.doi.org/10.1371/journal.pone.0035789			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536438	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339200112
J	Lim, M; Choi, SK; Cho, YE; Yeon, SI; Kim, EC; Ahn, DS; Lee, YH				Lim, Mihwa; Choi, Soo-Kyoung; Cho, Young-Eun; Yeon, Soo-In; Kim, Eok-Cheon; Ahn, Duck-Sun; Lee, Young-Ho			The Role of Sphingosine Kinase 1/Sphingosine-1-Phosphate Pathway in the Myogenic Tone of Posterior Cerebral Arteries	PLOS ONE			English	Article							BASILAR ARTERIES; IN-VIVO; SPHINGOSINE-1-PHOSPHATE; VASOSPASM; PRESSURE; MEDIATOR; PLASMA; DEPOLARIZATION; 1-PHOSPHATE; ACTIVATION	Aims: The goal of the current study was to determine whether the sphingosine kinase 1 (SK1)/sphingosine-1-phosphate (S1P) pathway is involved in myogenic vasoconstriction under normal physiological conditions. In the present study, we assessed whether endogenous S1P generated by pressure participates in myogenic vasoconstriction and which signaling pathways are involved in SK1/S1P-induced myogenic response under normal physiological conditions. Methods and Results: We measured pressure-induced myogenic response, Ca2+ concentration, and 20 kDa myosin light chain phosphorylation (MLC20) in rabbit posterior cerebral arteries (PCAs). SK1 was expressed and activated by elevated transmural pressure in rabbit PCAs. Translocation of SK1 by pressure elevation was blocked in the absence of external Ca2+ and in the presence of mechanosensitive ion channel and voltage-sensitive Ca2+ channel blockers. Pressure-induced myogenic tone was inhibited in rabbit PCAs treated with sphingosine kinase inhibitor (SKI), but was augmented by treatment with NaF, which is an inhibitor of sphingosine-1-phosphate phosphohydrolase. Exogenous S1P further augmented pressure-induced myogenic responses. Pressure induced an increase in Ca2+ concentration leading to the development of myogenic tone, which was inhibited by SKI. Exogenous S1P further increased the pressure-induced increased Ca2+ concentration and myogenic tone, but SKI had no effect. Pressure- and exogenous S1P-induced myogenic tone was inhibited by pre-treatment with the Rho kinase inhibitor and NADPH oxidase inhibitors. Pressure- and exogenous S1P-induced myogenic tone were inhibited by pre-treatment with S1P receptor blockers, W146 (S1P1), JTE013 (S1P2), and CAY10444 (S1P3). MLC20 phosphorylation was increased when the transmural pressure was raised from 40 to 80 mmHg and exogenous S1P further increased MLC20 phosphorylation. The pressure-induced increase of MLC20 phosphorylation was inhibited by pre-treatment of arteries with SKI. Conclusions: Our results suggest that the SK1/S1P pathway may play an important role in pressure-induced myogenic responses in rabbit PCAs under normal physiological conditions.	[Lim, Mihwa; Choi, Soo-Kyoung; Cho, Young-Eun; Yeon, Soo-In; Kim, Eok-Cheon; Ahn, Duck-Sun; Lee, Young-Ho] Yonsei Univ, Coll Med, Dept Physiol, BK Project Med Sci 21, Seoul, South Korea	Yonsei University; Yonsei University Health System	Lee, YH (corresponding author), Yonsei Univ, Coll Med, Dept Physiol, BK Project Med Sci 21, Seoul, South Korea.	yhlee@yuhs.ac		Ahn, Duck Sun/0000-0001-9351-6951; Lee, Young-Ho/0000-0002-5749-1045; Choi, Soo-Kyoung/0000-0002-7115-6358	Yonsei University College of Medicine [6-2010-0056]	Yonsei University College of Medicine(General Electric)	This study was supported by a faculty research grant from Yonsei University College of Medicine in 2010 (No. 6-2010-0056). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemany R, 2001, FEBS LETT, V509, P239, DOI 10.1016/S0014-5793(01)03168-4; Alewijnse AE, 2004, BRIT J PHARMACOL, V143, P666, DOI 10.1038/sj.bjp.0705934; Bayliss WM, 1902, J PHYSIOL-LONDON, V28, P220; Bolz SS, 2003, CIRCULATION, V108, P342, DOI 10.1161/01.CIR.0000080324.12530.0D; Cho YE, 2011, CARDIOVASC RES, V91, P162, DOI 10.1093/cvr/cvr043; Choi SK, 2009, CARDIOVASC RES, V82, P324, DOI 10.1093/cvr/cvp054; COOK DA, 1984, PHARMACOLOGY, V29, P1, DOI 10.1159/000137986; DAVIS MJ, 1992, AM J PHYSIOL, V262, pC1083, DOI 10.1152/ajpcell.1992.262.4.C1083; Dietrich HH, 2000, NEUROSURGERY, V46, P517, DOI 10.1097/00006123-200003000-00001; Dora KA, 2005, AM J PHYSIOL-HEART C, V289, pH1323, DOI 10.1152/ajpheart.00513.2005; Drummond HA, 2004, HYPERTENSION, V44, P643, DOI 10.1161/01.HYP.0000144465.56360.ad; Duong CQ, 2004, BBA-MOL CELL BIOL L, V1682, P112; FOLKOW B, 1962, ARCH INT PHARMACOD T, V139, P455; Grand T, 2008, BRIT J PHARMACOL, V153, P1697, DOI 10.1038/bjp.2008.38; HARDER DR, 1984, CIRC RES, V55, P197, DOI 10.1161/01.RES.55.2.197; Hill MA, 2006, CLIN HEMORHEOL MICRO, V34, P67; Hla T, 1999, BIOCHEM PHARMACOL, V58, P201; Keller M, 2006, FASEB J, V20, P702, DOI 10.1096/fj.05-4075fje; Liliom K, 2001, BIOCHEM J, V355, P189, DOI 10.1042/0264-6021:3550189; MEININGER GA, 1990, AM J PHYSIOL, V258, pH1032, DOI 10.1152/ajpheart.1990.258.4.H1032; MERRITT JE, 1990, BIOCHEM J, V271, P515, DOI 10.1042/bj2710515; Michel MC, 2007, ACTA PAEDIATR, V96, P44, DOI 10.1111/j.1651-2227.2007.00207.x; Mulders ACM, 2006, ARTERIOSCL THROM VAS, V26, P2043, DOI 10.1161/01.ATV.0000237569.95046.b9; Nowicki PT, 2001, CIRC RES, V89, P114, DOI 10.1161/hh1401.094367; Okajima F, 2002, BBA-MOL CELL BIOL L, V1582, P132, DOI 10.1016/S1388-1981(02)00147-6; Peter BF, 2008, CIRC RES, V103, P315, DOI 10.1161/CIRCRESAHA.108.173575; Peters SLM, 2007, CURR OPIN PHARMACOL, V7, P186, DOI 10.1016/j.coph.2006.09.008; Pitson SM, 2005, J EXP MED, V201, P49, DOI 10.1084/jem.20040559; Salomone S, 2010, PHARMACOL RES, V62, P465, DOI 10.1016/j.phrs.2010.09.002; Scherer EQ, 2006, CARDIOVASC RES, V70, P79, DOI 10.1016/j.cardiores.2006.01.011; Tosaka M, 2001, STROKE, V32, P2913, DOI 10.1161/hs1201.099525; WEIR B, 1995, BRIT J NEUROSURG, V9, P375, DOI 10.1080/02688699550041386; Yeon DS, 2002, CARDIOVASC RES, V53, P431, DOI 10.1016/S0008-6363(01)00496-5	33	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35177	10.1371/journal.pone.0035177	http://dx.doi.org/10.1371/journal.pone.0035177			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22532844	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339200043
J	Lovly, CM; Dahlman, KB; Fohn, LE; Su, ZL; Dias-Santagata, D; Hicks, DJ; Hucks, D; Berry, E; Terry, C; Duke, M; Su, YJ; Sobolik-Delmaire, T; Richmond, A; Kelley, MC; Vnencak-Jones, CL; Iafrate, AJ; Sosman, J; Pao, W				Lovly, Christine M.; Dahlman, Kimberly Brown; Fohn, Laurel E.; Su, Zengliu; Dias-Santagata, Dora; Hicks, Donna J.; Hucks, Donald; Berry, Elizabeth; Terry, Charles; Duke, MarKeesa; Su, Yingjun; Sobolik-Delmaire, Tammy; Richmond, Ann; Kelley, Mark C.; Vnencak-Jones, Cindy L.; Iafrate, A. John; Sosman, Jeffrey; Pao, William			Routine Multiplex Mutational Profiling of Melanomas Enables Enrollment in Genotype-Driven Therapeutic Trials	PLOS ONE			English	Article							METASTATIC MALIGNANT-MELANOMA; PHASE-III TRIAL; BRAF MUTATIONS; BETA-CATENIN; TUMOR PROGRESSION; UVEAL MELANOMA; COPY NUMBER; N-RAS; KIT; GENE	Purpose: Knowledge of tumor mutation status is becoming increasingly important for the treatment of cancer, as mutation-specific inhibitors are being developed for clinical use that target only sub-populations of patients with particular tumor genotypes. Melanoma provides a recent example of this paradigm. We report here development, validation, and implementation of an assay designed to simultaneously detect 43 common somatic point mutations in 6 genes (BRAF, NRAS, KIT, GNAQ, GNA11, and CTNNB1) potentially relevant to existing and emerging targeted therapies specifically in melanoma. Methods: The test utilizes the SNaPshot method (multiplex PCR, multiplex primer extension, and capillary electrophoresis) and can be performed rapidly with high sensitivity (requiring 5-10% mutant allele frequency) and minimal amounts of DNA (10-20 nanograms). The assay was validated using cell lines, fresh-frozen tissue, and formalin-fixed paraffin embedded tissue. Clinical characteristics and the impact on clinical trial enrollment were then assessed for the first 150 melanoma patients whose tumors were genotyped in the Vanderbilt molecular diagnostics lab. Results: Directing this test to a single disease, 90 of 150 (60%) melanomas from sites throughout the body harbored a mutation tested, including 57, 23, 6, 3, and 2 mutations in BRAF, NRAS, GNAQ, KIT, and CTNNB1, respectively. Among BRAF V600 mutations, 79%, 12%, 5%, and 4% were V600E, V600K, V600R, and V600M, respectively. 23 of 54 (43%) patients with mutation harboring metastatic disease were subsequently enrolled in genotype-driven trials. Conclusion: We present development of a simple mutational profiling screen for clinically relevant mutations in melanoma. Adoption of this genetically-informed approach to the treatment of melanoma has already had an impact on clinical trial enrollment and prioritization of therapy for patients with the disease.	[Lovly, Christine M.; Fohn, Laurel E.; Su, Zengliu; Berry, Elizabeth; Terry, Charles; Duke, MarKeesa; Sosman, Jeffrey; Pao, William] Vanderbilt Univ, Sch Med, Div Hematol Oncol, Dept Med,Vanderbilt Ingram Canc Ctr, Nashville, TN 37212 USA; [Dahlman, Kimberly Brown; Su, Yingjun; Sobolik-Delmaire, Tammy] Vanderbilt Univ, Sch Med, Dept Canc Biol, Vanderbilt Ingram Canc Ctr, Nashville, TN 37212 USA; [Dias-Santagata, Dora; Iafrate, A. John] Massachusetts Gen Hosp, Dept Pathol, Translat Res Lab, Boston, MA 02114 USA; [Dias-Santagata, Dora; Iafrate, A. John] Harvard Univ, Sch Med, Boston, MA USA; [Hicks, Donna J.; Hucks, Donald] Vanderbilt Univ, Vanderbilt Ingram Canc Ctr, Med Ctr, Nashville, TN 37212 USA; [Richmond, Ann] Vanderbilt Univ, Sch Med, Dept Canc Biol, Dept Vet Affairs,Vanderbilt Ingram Canc Ctr, Nashville, TN 37212 USA; [Kelley, Mark C.] Vanderbilt Univ, Sch Med, Div Surg Oncol, Vanderbilt Ingram Canc Ctr, Nashville, TN 37212 USA; [Vnencak-Jones, Cindy L.] Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN 37212 USA; [Vnencak-Jones, Cindy L.] Vanderbilt Univ, Med Ctr, Dept Microbiol, Nashville, TN 37212 USA; [Vnencak-Jones, Cindy L.] Vanderbilt Univ, Med Ctr, Dept Immunol & Pediat, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Pao, W (corresponding author), Vanderbilt Univ, Sch Med, Div Hematol Oncol, Dept Med,Vanderbilt Ingram Canc Ctr, Nashville, TN 37212 USA.	william.pao@vanderbilt.edu	Richmond, Ann/A-3048-2014	RICHMOND, ANN/0000-0002-9580-900X; Berry, Elizabeth/0000-0002-7574-6718; Lovly, Christine/0000-0002-3641-6361	VICC Cancer Center [CA68485]; TJ Martell Foundation; Kleberg Foundation; National Institutes of Health / National Cancer Institute [5K24 CA97588-06]; American Cancer Society; Department of Veterans Affairs; Valvano Foundation; Vanderbilt Institute for Clinical and Translational Research (VICTR) CTSA [UL1 RR024975-01]; AstraZeneca; NATIONAL CANCER INSTITUTE [K24CA097588, P30CA068485, R01CA116021, U54CA163072] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024975, TL1RR024978, KL2RR024977] Funding Source: NIH RePORTER	VICC Cancer Center; TJ Martell Foundation; Kleberg Foundation; National Institutes of Health / National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); Department of Veterans Affairs(US Department of Veterans Affairs); Valvano Foundation; Vanderbilt Institute for Clinical and Translational Research (VICTR) CTSA; AstraZeneca(AstraZeneca); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by a VICC Cancer Center Core Grant (CA68485), the TJ Martell Foundation, the Kleberg Foundation, the National Institutes of Health / National Cancer Institute 5K24 CA97588-06 (JS), the American Cancer Society (Mary Hendrickson-Johnson Melanoma Professorship to JS), the Department of Veterans Affairs (Senior Research Career Scientist Award to AR), the Valvano Foundation (to JS and AR), the Vanderbilt Institute for Clinical and Translational Research (VICTR) CTSA grant (UL1 RR024975-01), and an anonymous donor. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Please note: WP has done consulting for Bristol-Myers Squibb and has received research funding from AstraZeneca. However, this is NOT related to the current study.	Andre F, 2011, J CLIN ONCOL, V29, P1236, DOI 10.1200/JCO.2010.31.6877; Antonescu CR, 2007, INT J CANCER, V121, P257, DOI 10.1002/ijc.22681; Atkins MB, 2008, J CLIN ONCOL, V26, P5748, DOI 10.1200/JCO.2008.17.5448; Bauer J, 2009, BRIT J CANCER, V101, P813, DOI 10.1038/sj.bjc.6605226; Beadling C, 2008, CLIN CANCER RES, V14, P6821, DOI 10.1158/1078-0432.CCR-08-0575; CARVAJAL RD, 2009, J CLIN ONCOL, V27; Carvajal RD, 2011, JAMA-J AM MED ASSOC, V305, P2327, DOI 10.1001/jama.2011.746; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Chapman PB, 1999, J CLIN ONCOL, V17, P2745, DOI 10.1200/JCO.1999.17.9.2745; Chattopadhyay C, 2011, INT J CANC; Curtin JA, 2005, NEW ENGL J MED, V353, P2135, DOI 10.1056/NEJMoa050092; Curtin JA, 2006, J CLIN ONCOL, V24, P4340, DOI 10.1200/JCO.2006.06.2984; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Delmas V, 2007, GENE DEV, V21, P2923, DOI 10.1101/gad.450107; Demunter A, 2002, MODERN PATHOL, V15, P454, DOI 10.1038/modpathol.3880546; Dias-Santagata D, 2010, EMBO MOL MED, V2, P146, DOI 10.1002/emmm.201000070; Dunn EF, 2011, ONCOGENE, V30, P561, DOI 10.1038/onc.2010.430; Falkson CI, 1998, J CLIN ONCOL, V16, P1743, DOI 10.1200/JCO.1998.16.5.1743; Fisher D E, 2010, Pigment Cell Melanoma Res, V23, P14, DOI 10.1111/j.1755-148X.2009.00655.x; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Guo J, 2011, J CLIN ONCOL; Handolias D, 2010, BRIT J CANCER, V102, P1219, DOI 10.1038/sj.bjc.6605635; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Hodi FS, 2008, J CLIN ONCOL, V26, P2046, DOI 10.1200/JCO.2007.14.0707; Infante JR, 2010, J CLIN ONCOL, V28, DOI 10.1200/jco.2010.28.15_suppl.2503; Jaiswal BS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005717; Jiang XF, 2008, CLIN CANCER RES, V14, P7726, DOI 10.1158/1078-0432.CCR-08-1144; Kefford R. F., 2010, J CLIN ONCOL, V28; King AJ, 2006, CANCER RES, V66, P11100, DOI 10.1158/0008-5472.CAN-06-2554; Levy C, 2010, MOL CELL, V40, P841, DOI 10.1016/j.molcel.2010.11.020; Long GV, 2011, J CLIN ONCOL, V29, P1239, DOI 10.1200/JCO.2010.32.4327; Lutzky J, 2008, PIGM CELL MELANOMA R, V21, P492, DOI 10.1111/j.1755-148X.2008.00475.x; Maldonado JL, 2003, J NATL CANCER I, V95, P1878, DOI 10.1093/jnci/djg123; McGuinness C, 2008, FRONT BIOSCI-LANDMRK, V13, P2435, DOI 10.2741/2856; Middleton MR, 2000, J CLIN ONCOL, V18, P158, DOI 10.1200/JCO.2000.18.1.158; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Omholt K, 2001, INT J CANCER, V92, P839, DOI 10.1002/ijc.1270; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Reifenberger J, 2002, INT J CANCER, V100, P549, DOI 10.1002/ijc.10512; Rubinstein JC, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-67; Sequist LV, 2011, ANN ONCOL, V22, P2616, DOI 10.1093/annonc/mdr489; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; SOSMAN J, 2010, PIGMENT CELL MELANOM, V23; Sosman J, 2012, NEW ENGLAND IN PRESS; Spittle C, 2007, J MOL DIAGN, V9, P464, DOI 10.2353/jmoldx.2007.060191; Su ZL, 2011, J MOL DIAGN, V13, P74, DOI 10.1016/j.jmoldx.2010.11.010; Terheyden P, 2010, J INVEST DERMATOL, V130, P314, DOI 10.1038/jid.2009.197; Tsai J, 2008, P NATL ACAD SCI USA, V105, P3041, DOI 10.1073/pnas.0711741105; Tsao H, 2004, J INVEST DERMATOL, V122, P337, DOI 10.1046/j.0022-202X.2004.22243.x; Van Raamsdonk CD, 2010, NEW ENGL J MED, V363, P2191, DOI 10.1056/NEJMoa1000584; Van Raamsdonk CD, 2009, NATURE, V457, P599, DOI 10.1038/nature07586; Woodman SE, 2009, MOL CANCER THER, V8, P2079, DOI 10.1158/1535-7163.MCT-09-0459; Xing F, 2011, ONCOGENE; Yang H, 2010, CANCER RES, V70, P5518, DOI 10.1158/0008-5472.CAN-10-0646; Zuidervaart W, 2003, BRIT J CANCER, V89, P1914, DOI 10.1038/sj.bjc.6601374	56	151	157	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35309	10.1371/journal.pone.0035309	http://dx.doi.org/10.1371/journal.pone.0035309			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536370	Green Published, gold, Green Submitted			2022-12-27	WOS:000305339200052
J	Stauber, EJ; Kuczka, P; van Ohlen, M; Vogt, B; Janowitz, T; Piotrowski, M; Beuerle, T; Wittstock, U				Stauber, Einar J.; Kuczka, Petrissa; van Ohlen, Maike; Vogt, Birgit; Janowitz, Tim; Piotrowski, Markus; Beuerle, Till; Wittstock, Ute			Turning the 'Mustard Oil Bomb' into a 'Cyanide Bomb': Aromatic Glucosinolate Metabolism in a Specialist Insect Herbivore	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; CYANOGENIC GLYCOSIDES; NITRILE FORMATION; GENETIC-BASIS; PIERIS-RAPAE; EVOLUTION; DEFENSE; PLANTS; L.; ISOTHIOCYANATES	Plants have evolved a variety of mechanisms for dealing with insect herbivory among which chemical defense through secondary metabolites plays a prominent role. Physiological, behavioural and sensorical adaptations to these chemicals provide herbivores with selective advantages allowing them to diversify within the newly occupied ecological niche. In turn, this may influence the evolution of plant metabolism giving rise to e. g. new chemical defenses. The association of Pierid butterflies and plants of the Brassicales has been cited as an illustrative example of this adaptive process known as 'coevolutionary armsrace'. All plants of the Brassicales are defended by the glucosinolate-myrosinase system to which larvae of cabbage white butterflies and related species are biochemically adapted through a gut nitrile-specifier protein. Here, we provide evidence by metabolite profiling and enzyme assays that metabolism of benzylglucosinolate in Pieris rapae results in release of equimolar amounts of cyanide, a potent inhibitor of cellular respiration. We further demonstrate that P. rapae larvae develop on transgenic Arabidopsis plants with ectopic production of the cyanogenic glucoside dhurrin without ill effects. Metabolite analyses and fumigation experiments indicate that cyanide is detoxified by beta-cyanoalanine synthase and rhodanese in the larvae. Based on these results as well as on the facts that benzylglucosinolate was one of the predominant glucosinolates in ancient Brassicales and that ancient Brassicales lack nitrilases involved in alternative pathways, we propose that the ability of Pierid species to safely handle cyanide contributed to the primary host shift from Fabales to Brassicales that occured about 75 million years ago and was followed by Pierid species diversification.	[Stauber, Einar J.; Kuczka, Petrissa; van Ohlen, Maike; Vogt, Birgit; Beuerle, Till; Wittstock, Ute] Tech Univ Carolo Wilhelmina Braunschweig, Inst Pharmaceut Biol, D-38106 Braunschweig, Germany; [Janowitz, Tim; Piotrowski, Markus] Ruhr Univ Bochum, Dept Plant Physiol, Bochum, Germany	Braunschweig University of Technology; Ruhr University Bochum	Wittstock, U (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Inst Pharmaceut Biol, D-38106 Braunschweig, Germany.	u.wittstock@tu-bs.de	Piotrowski, Markus/F-5419-2010	Piotrowski, Markus/0000-0002-6347-3337; Wittstock, Ute/0000-0002-0914-8453; Beuerle, Till/0000-0001-5037-6653	German Research Foundation [WI 2668/4-1]	German Research Foundation(German Research Foundation (DFG))	Funding provided by the German Research Foundation (http://www.dfg.de/en/index.jsp) grant number: WI 2668/4-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agerbirk N, 2008, PHYTOCHEMISTRY, V69, P2937, DOI 10.1016/j.phytochem.2008.08.014; Agerbirk N, 2007, INSECT BIOCHEM MOLEC, V37, P1119, DOI 10.1016/j.ibmb.2007.06.009; Agerbirk N, 2010, INSECT BIOCHEM MOLEC, V40, P126, DOI 10.1016/j.ibmb.2010.01.003; Bak Soren, 2006, Phytochemistry Reviews, V5, P309, DOI 10.1007/s11101-006-9033-1; Ballhorn DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005450; Becerra JX, 1997, SCIENCE, V276, P253, DOI 10.1126/science.276.5310.253; BEESLEY SG, 1985, J CHEM ECOL, V11, P45, DOI 10.1007/BF00987603; Biesgen C, 1999, PLANTA, V208, P155, DOI 10.1007/s004250050545; Bottcher C, 2009, PLANT CELL, V21, P1830, DOI 10.1105/tpc.109.066670; Braby MF, 2006, J EVOLUTION BIOL, V19, P1677, DOI 10.1111/j.1420-9101.2006.01109.x; Braby MF, 2006, ZOOL J LINN SOC-LOND, V147, P238; Burow M, 2009, PLANT PHYSIOL, V149, P561, DOI 10.1104/pp.108.130732; Burow M, 2006, J CHEM ECOL, V32, P2333, DOI 10.1007/s10886-006-9149-1; Cipollone R, 2007, IUBMB LIFE, V59, P51, DOI 10.1080/15216540701206859; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; CONN EE, 1980, ANNU REV PLANT PHYS, V31, P433, DOI 10.1146/annurev.pp.31.060180.002245; EHRLICH PR, 1964, EVOLUTION, V18, P586, DOI 10.2307/2406212; Engelen-Eigles G, 2006, J AGR FOOD CHEM, V54, P328, DOI 10.1021/jf051857o; Fahey JW, 2001, PHYTOCHEMISTRY, V56, P5, DOI 10.1016/S0031-9422(00)00316-2; Gleadow RM, 2002, J CHEM ECOL, V28, P1301, DOI 10.1023/A:1016298100201; Halkier BA, 2006, ANNU REV PLANT BIOL, V57, P303, DOI 10.1146/annurev.arplant.57.032905.105228; Hall JC, 2002, AM J BOT, V89, P1826, DOI 10.3732/ajb.89.11.1826; Hansen CH, 2001, J BIOL CHEM, V276, P24790, DOI 10.1074/jbc.M102637200; Hartmann T, 2007, PHYTOCHEMISTRY, V68, P2831, DOI 10.1016/j.phytochem.2007.09.017; Hatzfeld Y, 2000, PLANT PHYSIOL, V123, P1163, DOI 10.1104/pp.123.3.1163; Hopkins RJ, 2009, ANNU REV ENTOMOL, V54, P57, DOI 10.1146/annurev.ento.54.110807.090623; Janowitz T, 2009, PHYTOCHEMISTRY, V70, P1680, DOI 10.1016/j.phytochem.2009.07.028; Jensen NB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1271; Kessler A, 2007, CURR OPIN PLANT BIOL, V10, P409, DOI 10.1016/j.pbi.2007.06.001; Kleinwachter M, 2008, J AGR FOOD CHEM, V56, P11165, DOI 10.1021/jf802053n; Kliebenstein DJ, 2001, PLANT PHYSIOL, V126, P811, DOI 10.1104/pp.126.2.811; MATILE P, 1980, BIOCHEM PHYSIOL PFL, V175, P722, DOI 10.1016/S0015-3796(80)80059-X; Mesaik MA, 2004, BIOORGAN MED CHEM, V12, P2049, DOI 10.1016/j.bmc.2004.02.034; MEYERS DM, 1991, BIOCHIM BIOPHYS ACTA, V1075, P195, DOI 10.1016/0304-4165(91)90252-C; Mithen R, 2010, PHYTOCHEMISTRY, V71, P2074, DOI 10.1016/j.phytochem.2010.09.017; Piotrowski M, 2001, J BIOL CHEM, V276, P2616, DOI 10.1074/jbc.M007890200; Sonderby IE, 2010, TRENDS PLANT SCI, V15, P283, DOI 10.1016/j.tplants.2010.02.005; Takos AM, 2011, PLANT J, V68, P273, DOI 10.1111/j.1365-313X.2011.04685.x; Tattersall DB, 2001, SCIENCE, V293, P1826, DOI 10.1126/science.1062249; THIES W, 1988, FETT WISS TECHNOL, V90, P311, DOI 10.1002/lipi.19880900806; Traka M, 2009, PHYTOCHEM REV, V8, P269, DOI 10.1007/s11101-008-9103-7; Vergara F, 2007, CHEMBIOCHEM, V8, P1757, DOI 10.1002/cbic.200790053; Vergara F, 2006, CHEMBIOCHEM, V7, P1982, DOI 10.1002/cbic.200600280; Vorwerk S, 2001, PLANTA, V212, P508, DOI 10.1007/s004250000420; Wheat CW, 2007, P NATL ACAD SCI USA, V104, P20427, DOI 10.1073/pnas.0706229104; Wikstrom N, 2001, P ROY SOC B-BIOL SCI, V268, P2211, DOI 10.1098/rspb.2001.1782; WILKINSON CF, 1972, DRUG METAB REV, V1, P153, DOI 10.3109/03602537208993912; Wittstock U, 2004, P NATL ACAD SCI USA, V101, P4859, DOI 10.1073/pnas.0308007101; Wittstock U, 2000, J BIOL CHEM, V275, P14659, DOI 10.1074/jbc.275.19.14659; Wittstock U, 2002, CURR OPIN PLANT BIOL, V5, P300, DOI 10.1016/S1369-5266(02)00264-9; Wittstock U, 2003, RECENT ADV PHYTOCHEM, V37, P101; Zagrobelny M, 2004, PHYTOCHEMISTRY, V65, P293, DOI 10.1016/j.phytochem.2003.10.016; Zagrobelny M, 2011, PHYTOCHEMISTRY, V72, P1585, DOI 10.1016/j.phytochem.2011.02.023	53	51	52	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35545	10.1371/journal.pone.0035545	http://dx.doi.org/10.1371/journal.pone.0035545			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536404	gold, Green Published, Green Submitted			2022-12-27	WOS:000305339200077
J	Ingham, CJ; Schneeberger, PM				Ingham, Colin J.; Schneeberger, Peter M.			Microcolony Imaging of Aspergillus fumigatus Treated with Echinocandins Reveals Both Fungistatic and Fungicidal Activities	PLOS ONE			English	Article							CASPOFUNGIN; MICAFUNGIN	Background: The echinocandins are lipopeptides that can be employed as antifungal drugs that inhibit the synthesis of 1,3-beta-glucans within the fungal cell wall. Anidulafungin and caspofungin are echinocandins used in the treatment of Candida infections and have activity against other fungi including Aspergillus fumigatus. The echinocandins are generally considered fungistatic against Aspergillus species. Methods: Culture of A. fumigatus from conidia to microcolonies on a support of porous aluminium oxide (PAO), combined with fluorescence microscopy and scanning electron microscopy, was used to investigate the effects of anidulafungin and caspofungin. The PAO was an effective matrix for conidial germination and microcolony growth. Additionally, PAO supports could be moved between agar plates containing different concentrations of echinocandins to change dosage and to investigate the recovery of fungal microcolonies from these drugs. Culture on PAO combined with microscopy and image analysis permits quantitative studies on microcolony growth with the flexibility of adding or removing antifungal agents, dyes, fixatives or osmotic stresses during growth with minimal disturbance of fungal microcolonies. Significance: Anidulafungin and caspofungin reduced but did not halt growth at the microcony level; additionally both drugs killed individual cells, particularly at concentrations around the MIC. Intact but not lysed cells showed rapid recovery when the drugs were removed. The classification of these drugs as either fungistatic or fungicidal is simplistic. Microcolony analysis on PAO appears to be a valuable tool to investigate the action of antifungal agents.	[Ingham, Colin J.; Schneeberger, Peter M.] Jeroen Bosch Hosp, Dept Med Microbiol & Infect Control, Shertogenbosch, Netherlands; [Ingham, Colin J.] Wageningen Univ, Microbiol Lab, Wageningen, Netherlands; [Ingham, Colin J.] MicroDish BV, Wageningen, Netherlands	Jeroen Bosch Ziekenhuis; Wageningen University & Research	Ingham, CJ (corresponding author), Jeroen Bosch Hosp, Dept Med Microbiol & Infect Control, Shertogenbosch, Netherlands.	colinutrecht@gmail.com			JBZ Hospital	JBZ Hospital	This work was funded by the JBZ Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antachopoulos C, 2008, ANTIMICROB AGENTS CH, V52, P321, DOI 10.1128/AAC.00699-07; Bowman JC, 2002, ANTIMICROB AGENTS CH, V46, P3001, DOI 10.1128/AAC.46.9.3001-3012.2002; Chiou CC, 2001, ANTIMICROB AGENTS CH, V45, P3310, DOI 10.1128/AAC.45.12.3310-3321.2001; den Besten HM, 2008, APPL ENVIRON MICROB, V73, P4797; Denning DW, 2002, J ANTIMICROB CHEMOTH, V49, P889, DOI 10.1093/jac/dkf045; Douglas CM, 1997, ANTIMICROB AGENTS CH, V41, P2471, DOI 10.1128/AAC.41.11.2471; Hiemenz JW, 2010, EUR J CLIN MICROBIOL, V29, P1387, DOI 10.1007/s10096-010-1013-0; Hill TW, 2006, MYCOLOGIA, V98, P399, DOI 10.3852/mycologia.98.3.399; Ingham CJ, 2005, APPL ENVIRON MICROB, V71, P8978, DOI 10.1128/AEM.71.12.8978-8981.2005; Ingham CJ, 2012, ROLE NEW TECHNOLOGIE, P86; Ingham CJ, 2007, P NATL ACAD SCI USA, V104, P18217, DOI 10.1073/pnas.0701693104; Ingham CJ, 2006, J MED MICROBIOL, V55, P1511, DOI 10.1099/jmm.0.46585-0; Ingham CJ, 2012, BIOTECHNOL ADV, V30, P1089, DOI 10.1016/j.biotechadv.2011.08.005; Jones BV, 2004, INFECT IMMUN, V72, P3941, DOI 10.1128/IAI.72.7.3941-3950.2004; Perlin DS, 2011, FUTURE MICROBIOL, V6, P441, DOI [10.2217/fmb.11.19, 10.2217/FMB.11.19]; Steinbach WJ, 2004, ANTIMICROB AGENTS CH, V48, P1664, DOI 10.1128/AAC.48.5.1664-1669.2004; Templeton SP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018777; Walker LA, 2010, FUNGAL GENET BIOL, V47, P117, DOI 10.1016/j.fgb.2009.09.003; Watabe E, 2003, ANTIMICROB AGENTS CH, V47, P1995, DOI 10.1128/AAC.47.6.1995-1998.2003	19	24	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e35478	10.1371/journal.pone.0035478	http://dx.doi.org/10.1371/journal.pone.0035478			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22536390	gold, Green Submitted, Green Published			2022-12-27	WOS:000305336200044
J	Khatabi, B; Molitor, A; Lindermayr, C; Pfiffi, S; Durner, J; von Wettstein, D; Kogel, KH; Schafer, P				Khatabi, Behnam; Molitor, Alexandra; Lindermayr, Christian; Pfiffi, Stefanie; Durner, Joerg; von Wettstein, Diter; Kogel, Karl-Heinz; Schaefer, Patrick			Ethylene Supports Colonization of Plant Roots by the Mutualistic Fungus Piriformospora indica	PLOS ONE			English	Article							1-AMINOCYCLOPROPANE-1-CARBOXYLIC ACID; TRANSCRIPTION FACTORS; ARABIDOPSIS-THALIANA; EXPRESSION PATTERNS; BACTERIAL FLAGELLIN; SYSTEMIC RESISTANCE; DISEASE RESISTANCE; NEGATIVE REGULATOR; SIGNALING PATHWAY; INNATE IMMUNITY	The mutualistic basidiomycete Piriformospora indica colonizes roots of mono- and dicotyledonous plants, and thereby improves plant health and yield. Given the capability of P. indica to colonize a broad range of hosts, it must be anticipated that the fungus has evolved efficient strategies to overcome plant immunity and to establish a proper environment for nutrient acquisition and reproduction. Global gene expression studies in barley identified various ethylene synthesis and signaling components that were differentially regulated in P. indica-colonized roots. Based on these findings we examined the impact of ethylene in the symbiotic association. The data presented here suggest that P. indica induces ethylene synthesis in barley and Arabidopsis roots during colonization. Moreover, impaired ethylene signaling resulted in reduced root colonization, Arabidopsis mutants exhibiting constitutive ethylene signaling, -synthesis or ethylene-related defense were hyper-susceptible to P. indica. Our data suggest that ethylene signaling is required for symbiotic root colonization by P. indica.	[Khatabi, Behnam; Molitor, Alexandra; Pfiffi, Stefanie; von Wettstein, Diter; Kogel, Karl-Heinz; Schaefer, Patrick] Univ Giessen, Inst Phytopathol & Appl Zool, Res Ctr Biosyst Land Use & Nutr, Giessen, Germany; [Lindermayr, Christian; Durner, Joerg] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Biochem Plant Pathol, Oberschleissheim, Germany; [von Wettstein, Diter] Washington State Univ, Dept Crop & Soil Sci, Pullman, WA 99164 USA; [von Wettstein, Diter] Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA	Justus Liebig University Giessen; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Washington State University; Washington State University	Khatabi, B (corresponding author), Univ Giessen, Inst Phytopathol & Appl Zool, Res Ctr Biosyst Land Use & Nutr, Giessen, Germany.	Patrick.schaefer@agrar.uni-giessen.de	Kogel, KH/K-1626-2019; Schäfer, Patrick/I-2681-2013; ALSUDAYS, IBTISAM/H-9378-2012; Lindermayr, Christian/M-7338-2014; Kogel, Karl-Heinz/N-4016-2014	Kogel, KH/0000-0003-1226-003X; Schäfer, Patrick/0000-0002-0366-6858; Lindermayr, Christian/0000-0002-9343-4996; Kogel, Karl-Heinz/0000-0003-1226-003X	Deutsche Forschungsgemeinschaft (DFG) [FOR666]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was funded by the Deutsche Forschungsgemeinschaft (DFG)-FOR666 grant to PS and KHK and a Mercator professorship from the DFG to DvW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adie B, 2007, J PLANT GROWTH REGUL, V26, P160, DOI 10.1007/s00344-007-0012-6; Berrocal-Lobo M, 2004, MOL PLANT MICROBE IN, V17, P763, DOI 10.1094/MPMI.2004.17.7.763; Berrocal-Lobo M, 2002, PLANT J, V29, P23, DOI 10.1046/j.1365-313x.2002.01191.x; Bleecker AB, 2000, ANNU REV CELL DEV BI, V16, P1, DOI 10.1146/annurev.cellbio.16.1.1; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Boutrot F, 2010, P NATL ACAD SCI USA, V107, P14502, DOI 10.1073/pnas.1003347107; BRADFORD KJ, 1980, PLANT PHYSIOL, V65, P322, DOI 10.1104/pp.65.2.322; Brady SM, 2007, SCIENCE, V318, P801, DOI 10.1126/science.1146265; Broekaert WF, 2006, ANNU REV PHYTOPATHOL, V44, P393, DOI 10.1146/annurev.phyto.44.070505.143440; Camehl I, 2010, NEW PHYTOL, V185, P1062, DOI 10.1111/j.1469-8137.2009.03149.x; Cartwright DA, 2009, BIOINFORMATICS, V25, P2581, DOI 10.1093/bioinformatics/btp437; Chae HS, 2005, TRENDS PLANT SCI, V10, P291, DOI 10.1016/j.tplants.2005.04.006; Chae HS, 2003, PLANT CELL, V15, P545, DOI 10.1105/tpc.006882; Deshmukh S, 2006, P NATL ACAD SCI USA, V103, P18450, DOI 10.1073/pnas.0605697103; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; FINLAYSON SA, 1991, PLANT PHYSIOL, V96, P1360, DOI 10.1104/pp.96.4.1360; Gomez-Gomez L, 1999, PLANT J, V18, P277, DOI 10.1046/j.1365-313X.1999.00451.x; Guinel FC, 2002, CAN J BOT, V80, P695, DOI [10.1139/b02-066, 10.1139/B02-066]; Guo HW, 2004, CURR OPIN PLANT BIOL, V7, P40, DOI 10.1016/j.pbi.2003.11.011; Jacobs S, 2011, PLANT PHYSIOL, V156, P726, DOI 10.1104/pp.111.176446; Kendrick MD, 2008, CURR OPIN PLANT BIOL, V11, P479, DOI 10.1016/j.pbi.2008.06.011; KIEBER JJ, 1993, CELL, V72, P427, DOI 10.1016/0092-8674(93)90119-B; LANGEBARTELS C, 1991, PLANT PHYSIOL, V95, P882, DOI 10.1104/pp.95.3.882; Leon-Reyes A, 2010, MOL PLANT MICROBE IN, V23, P187, DOI 10.1094/MPMI-23-2-0187; Liu YD, 2004, PLANT CELL, V16, P3386, DOI 10.1105/tpc.104.026609; LIZADA MCC, 1979, ANAL BIOCHEM, V100, P140, DOI 10.1016/0003-2697(79)90123-4; Mersmann S, 2010, PLANT PHYSIOL, V154, P391, DOI 10.1104/pp.110.154567; Penmetsa RV, 2008, PLANT J, V55, P580, DOI 10.1111/j.1365-313X.2008.03531.x; Penmetsa RV, 1997, SCIENCE, V275, P527, DOI 10.1126/science.275.5299.527; Peskan-Berghofer T, 2004, PHYSIOL PLANTARUM, V122, P465, DOI 10.1111/j.1399-3054.2004.00424.x; Pieterse CMJ, 1998, PLANT CELL, V10, P1571, DOI 10.1105/tpc.10.9.1571; Pieterse CMJ, 2009, NAT CHEM BIOL, V5, P308, DOI 10.1038/nchembio.164; Qiang XY, 2012, PLANT CELL, V24, P794, DOI 10.1105/tpc.111.093260; Riedel T, 2008, PLANT CELL ENVIRON, V31, P1203, DOI 10.1111/j.1365-3040.2008.01827.x; Ruzicka K, 2007, PLANT CELL, V19, P2197, DOI 10.1105/tpc.107.052126; Schafer P, 2009, PLANT J, V59, P461, DOI 10.1111/j.1365-313X.2009.03887.x; Schafer P, 2009, PLANT RELATIONSHIPS, V5, P99; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sirrenberg A, 2007, PHYSIOL PLANTARUM, V131, P581, DOI 10.1111/j.1399-3054.2007.00983.x; Sisler EC, 2003, PLANT BIOLOGY, V5, P473, DOI 10.1055/s-2003-44782; Stein E, 2008, PLANT CELL PHYSIOL, V49, P1747, DOI 10.1093/pcp/pcn147; Stepanova AN, 2007, PLANT CELL, V19, P2169, DOI 10.1105/tpc.107.052068; SUNDARESAN V, 1995, GENE DEV, V9, P1797, DOI 10.1101/gad.9.14.1797; Tamaoki M, 2003, PLANTA, V216, P552, DOI 10.1007/s00425-002-0894-2; Tsuchisaka A, 2004, PLANT PHYSIOL, V136, P2982, DOI 10.1104/pp.104.049999; Tsuda K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000772; TUDELA D, 1992, PLANT PHYSIOL, V100, P131, DOI 10.1104/pp.100.1.131; Van der Ent S, 2009, PHYTOCHEMISTRY, V70, P1581, DOI 10.1016/j.phytochem.2009.06.009; van Loon LC, 2006, TRENDS PLANT SCI, V11, P184, DOI 10.1016/j.tplants.2006.02.005; Varma A, 1999, APPL ENVIRON MICROB, V65, P2741; Verma S, 1998, MYCOLOGIA, V90, P896, DOI 10.2307/3761331; Waller F, 2005, P NATL ACAD SCI USA, V102, P13386, DOI 10.1073/pnas.0504423102; Wang KLC, 2004, NATURE, V428, P945, DOI 10.1038/nature02516; Wang KLC, 2002, PLANT CELL, V14, pS131, DOI 10.1105/tpc.001768; Yoo SD, 2008, NATURE, V451, P789, DOI 10.1038/nature06543; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367; Zuccaro A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002290	57	58	63	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e35502	10.1371/journal.pone.0035502	http://dx.doi.org/10.1371/journal.pone.0035502			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22536394	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336200047
J	Pathak, S; Awuh, JA; Leversen, NA; Flo, TH; Asjo, B				Pathak, Sharad; Awuh, Jane A.; Leversen, Nils Anders; Flo, Trude H.; Asjo, Birgitta			Counting Mycobacteria in Infected Human Cells and Mouse Tissue: A Comparison between qPCR and CFU	PLOS ONE			English	Article							REAL-TIME PCR; TUBERCULOSIS; DNA; AVIUM; MACROPHAGES; GROWTH	Due to the slow growth rate and pathogenicity of mycobacteria, enumeration by traditional reference methods like colony counting is notoriously time-consuming, inconvenient and biohazardous. Thus, novel methods that rapidly and reliably quantify mycobacteria are warranted in experimental models to facilitate basic research, development of vaccines and anti-mycobacterial drugs. In this study we have developed quantitative polymerase chain reaction (qPCR) assays for simultaneous quantification of mycobacterial and host DNA in infected human macrophage cultures and in mouse tissues. The qPCR method cannot discriminate live from dead bacteria and found a 10- to 100-fold excess of mycobacterial genomes, relative to colony formation. However, good linear correlations were observed between viable colony counts and qPCR results from infected macrophage cultures (Pearson correlation coefficient [r] for M. tuberculosis = 0.82; M. a. avium = 0.95; M. a. paratuberculosis = 0.91). Regression models that predict colony counts from qPCR data in infected macrophages were validated empirically and showed a high degree of agreement with observed counts. Similar correlation results were also obtained in liver and spleen homogenates of M. a. avium infected mice, although the correlations were distinct for the early phase (<day 9 post-infection) and later phase (>= day 20 post-infection) liver r = 0.94 and r = 0.91; spleen r = 0.91 and r = 0.87, respectively. Interestingly, in the mouse model the number of live bacteria as determined by colony counts constituted a much higher proportion of the total genomic qPCR count in the early phase (geometric mean ratio of 0.37 and 0.34 in spleen and liver, respectively), as compared to later phase of infection (geometric mean ratio of 0.01 in both spleen and liver). Overall, qPCR methods offer advantages in biosafety, time-saving, assay range and reproducibility compared to colony counting. Additionally, the duplex format allows enumeration of bacteria per host cell, an advantage in experiments where variable cell death can give misleading colony counts.	[Pathak, Sharad; Leversen, Nils Anders; Asjo, Birgitta] Univ Bergen, Gade Inst, Microbiol & Immunol Sect, Bergen, Norway; [Pathak, Sharad; Asjo, Birgitta] Haukeland Hosp, Dept Microbiol & Immunol, N-5021 Bergen, Norway; [Awuh, Jane A.; Flo, Trude H.] Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, N-7034 Trondheim, Norway	University of Bergen; University of Bergen; Haukeland University Hospital; Norwegian University of Science & Technology (NTNU)	Pathak, S (corresponding author), Univ Bergen, Gade Inst, Microbiol & Immunol Sect, Bergen, Norway.	sharad.pathak@gades.uib.no	Flo, Trude Helen/E-1311-2013	Flo, Trude Helen/0000-0002-2569-0381; Awuh, Jane Atesoh/0000-0001-9737-927X	University of Bergen; Regional Health Authorities of Western Norway [911239]; Research Council of Norway [180578/V50]	University of Bergen; Regional Health Authorities of Western Norway; Research Council of Norway(Research Council of Norway)	This study was supported by the University of Bergen and the Regional Health Authorities of Western Norway project number 911239 (to SP), and the Research Council of Norway (180578/V50 to THF/JAA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldous WK, 2005, J CLIN MICROBIOL, V43, P2471, DOI 10.1128/JCM.43.5.2471-2473.2005; Amaro A, 2008, LETT APPL MICROBIOL, V47, P8, DOI 10.1111/j.1472-765X.2008.02372.x; Baba K, 2008, DIAGN MOL PATHOL, V17, P112, DOI 10.1097/PDM.0b013e31814ceac3; Belisle JT, 1998, METH MOL B, V101, P31, DOI 10.1385/0-89603-471-2:31; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; COLSTON MJ, 1999, MYCOBACTERIA MOL BIO, P198; Cook KL, 2007, J MICROBIOL METH, V69, P154, DOI 10.1016/j.mimet.2006.12.017; Cooper AM, 2009, ANNU REV IMMUNOL, V27, P393, DOI 10.1146/annurev.immunol.021908.132703; deWit D, 1995, TUBERCLE LUNG DIS, V76, P555, DOI 10.1016/0962-8479(95)90534-0; Eishi Y, 2002, J CLIN MICROBIOL, V40, P198, DOI 10.1128/JCM.40.1.198-204.2002; Halaas O, 2010, J INFECT DIS, V201, P783, DOI 10.1086/650493; Lewin A, 2003, J VET MED B, V50, P505, DOI 10.1046/j.1439-0450.2003.00715.x; Lukey P T, 2001, Methods Mol Med, V54, P271, DOI 10.1385/1-59259-147-7:271; Munoz-Elias EJ, 2005, INFECT IMMUN, V73, P546, DOI 10.1128/IAI.73.1.546-551.2005; Niesters HGM, 2001, METHODS, V25, P419, DOI 10.1006/meth.2001.1264; North RJ, 2004, ANNU REV IMMUNOL, V22, P599, DOI 10.1146/annurev.immunol.22.012703.104635; Pathak S, 2010, INFECT IMMUN, V78, P4022, DOI 10.1128/IAI.00106-10; Rutledge RG, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng093; Tell LA, 2003, AVIAN DIS, V47, P1486, DOI 10.1637/7070; van Helden P D, 2001, Methods Mol Med, V54, P19, DOI 10.1385/1-59259-147-7:019; Yuan Y, 1998, P NATL ACAD SCI USA, V95, P9578, DOI 10.1073/pnas.95.16.9578	21	27	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e34931	10.1371/journal.pone.0034931	http://dx.doi.org/10.1371/journal.pone.0034931			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22532835	Green Submitted, Green Published, gold			2022-12-27	WOS:000305336200014
J	Kobie, JJ; Alcena, DC; Zheng, B; Bryk, P; Mattiacio, JL; Brewer, M; LaBranche, C; Young, FM; Dewhurst, S; Montefiori, DC; Rosenberg, AF; Feng, CY; Jin, X; Keefer, MC; Sanz, I				Kobie, James J.; Alcena, Danielle C.; Zheng, Bo; Bryk, Peter; Mattiacio, Jonelle L.; Brewer, Matthew; LaBranche, Celia; Young, Faith M.; Dewhurst, Stephen; Montefiori, David C.; Rosenberg, Alexander F.; Feng, Changyong; Jin, Xia; Keefer, Michael C.; Sanz, Ignacio			9G4 Autoreactivity Is Increased in HIV-Infected Patients and Correlates with HIV Broadly Neutralizing Serum Activity	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; SYSTEMIC-LUPUS-ERYTHEMATOSUS; CONNECTIVE-TISSUE DISEASE; V(H)4-21 GENE SEGMENT; RED-BLOOD-CELLS; MEMORY B-CELLS; PERIPHERAL-BLOOD; ANTIPHOSPHOLIPID ANTIBODIES; ANTICARDIOLIPIN ANTIBODIES; I-ANTIGEN	The induction of a broadly neutralizing antibody (BNAb) response against HIV-1 would be a desirable feature of a protective vaccine. Vaccine strategies thus far have failed to elicit broadly neutralizing antibody responses; however a minority of HIV-infected patients do develop circulating BNAbs, from which several potent broadly neutralizing monoclonal antibodies (mAbs) have been isolated. The findings that several BNmAbs exhibit autoreactivity and that autoreactive serum antibodies are observed in some HIV patients have advanced the possibility that enforcement of self-tolerance may contribute to the rarity of BNAbs. To examine the possible breakdown of tolerance in HIV patients, we utilized the 9G4 anti-idiotype antibody system, enabling resolution of both autoreactive VH4-34 gene-expressing B cells and serum antibodies. Compared with healthy controls, HIV patients had significantly elevated 9G4+ serum IgG antibody concentrations and frequencies of 9G4+ B cells, a finding characteristic of systemic lupus erythematosus (SLE) patients, both of which positively correlated with HIV viral load. Compared to the global 9G4-IgD- memory B cell population, the 9G4+IgD- memory fraction in HIV patients was dominated by isotype switched IgG+ B cells, but had a more prominent bias toward "IgM only" memory. HIV envelope reactivity was observed both in the 9G4+ serum antibody and 9G4+ B cell population. 9G4+ IgG serum antibody levels positively correlated (r = 0.403, p = 0.0019) with the serum HIV BNAbs. Interestingly, other serum autoantibodies commonly found in SLE (anti-dsDNA, ANA, anti-CL) did not correlate with serum HIV BNAbs. 9G4-associated autoreactivity is preferentially expanded in chronic HIV infection as compared to other SLE autoreactivities. Therefore, the 9G4 system provides an effective tool to examine autoreactivity in HIV patients. Our results suggest that the development of HIV BNAbs is not merely a consequence of a general breakdown in tolerance, but rather a more intricate expansion of selective autoreactive B cells and antibodies.	[Kobie, James J.; Zheng, Bo; Bryk, Peter; Rosenberg, Alexander F.; Sanz, Ignacio] Univ Rochester, Med Ctr, Div Allergy Immunol & Rheumatol, Rochester, NY 14642 USA; [Alcena, Danielle C.; Mattiacio, Jonelle L.; Brewer, Matthew; Dewhurst, Stephen] Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA; [LaBranche, Celia; Montefiori, David C.] Duke Univ, Med Ctr, Dept Surg, Lab AIDS Vaccine Res & Dev, Durham, NC 27710 USA; [Young, Faith M.] Univ Rochester, Med Ctr, JP Wilmot Canc Ctr, Rochester, NY 14642 USA; [Feng, Changyong] Univ Rochester, Med Ctr, Dept Biostat & Computat Biol, Rochester, NY 14642 USA; [Jin, Xia; Keefer, Michael C.] Univ Rochester, Med Ctr, Div Infect Dis, Rochester, NY 14642 USA	University of Rochester; University of Rochester; Duke University; University of Rochester; University of Rochester; University of Rochester	Kobie, JJ (corresponding author), Univ Rochester, Med Ctr, Div Allergy Immunol & Rheumatol, Rochester, NY 14642 USA.	james_kobie@urmc.rochester.edu	Alcéna-Stiner, Danielle C./ABG-9478-2020; Alcena-Stiner, Danielle/GVS-5132-2022	Dewhurst, Stephen/0000-0001-7729-7920; Alcena-Stiner, Danielle C./0000-0002-7466-9423	National Institutes of Health (NIH) [R01AI084808, R21AI078459, R37AI049660]; University of Rochester Developmental Center for AIDS Research [P30 AI078498]; University of Washington Center for AIDS Research [5P30AI027757]; Bill and Melinda Gates Foundation [38619]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI078459, P30AI027757, R01AI084808, R37AI049660, UM1AI068614, P30AI078498, T32AI049815] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Rochester Developmental Center for AIDS Research; University of Washington Center for AIDS Research; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work supported by National Institutes of Health (NIH) grants R01AI084808, R21AI078459, and R37AI049660 to IS, the University of Rochester Developmental Center for AIDS Research grant P30 AI078498 (NIH/NIAID), the University of Washington Center for AIDS Research grant 5P30AI027757 (NIH/NIAID), and the Collaboration for AIDS Vaccine Discovery grant 38619 from the Bill and Melinda Gates Foundation to DM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhat Neelima M, 2004, Hum Antibodies, V13, P63; BHAT NM, 1993, J IMMUNOL, V151, P5011; Bhat NM, 2002, J RHEUMATOL, V29, P2114; BORRETZEN M, 1995, SCAND J IMMUNOL, V42, P90, DOI 10.1111/j.1365-3083.1995.tb03630.x; Cappione A, 2005, J CLIN INVEST, V115, P3205, DOI 10.1172/JCI24179; Cappione AJ, 2004, J IMMUNOL, V172, P4298, DOI 10.4049/jimmunol.172.7.4298; Catera R, 2008, MOL MED, V14, P665, DOI 10.2119/2008-00102.Catera; Dennison SM, 2011, J VIROL, V85, P1340, DOI 10.1128/JVI.01680-10; Doria-Rose NA, 2010, J VIROL, V84, P1631, DOI 10.1128/JVI.01482-09; Doria-Rose NA, 2009, J VIROL, V83, P188, DOI 10.1128/JVI.01583-08; Douvas A, 1996, AIDS RES HUM RETROV, V12, P1509, DOI 10.1089/aid.1996.12.1509; Forster J, 1996, INFECTION, V24, P407, DOI 10.1007/BF01713039; Gray ES, 2009, J VIROL, V83, P8925, DOI 10.1128/JVI.00758-09; Haas A, 2011, J VIROL; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Jenks SA, 2010, ARTHRITIS RHEUM S10, V62, P486; KLEIN U, 1993, EUR J IMMUNOL, V23, P3272, DOI 10.1002/eji.1830231232; KLEIN U, 1994, J EXP MED, V180, P1383, DOI 10.1084/jem.180.4.1383; Martinez V, 2009, CLIN INFECT DIS, V48, P123, DOI 10.1086/595013; Mascola JR, 2005, J VIROL, V79, P10103, DOI 10.1128/JVI.79.16.10103-10107.2005; Mattiacio J, 2011, VACCINE, V29, P2637, DOI 10.1016/j.vaccine.2011.01.038; Mikell I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001251; Milner ECB, 2005, SPRINGER SEMIN IMMUN, V26, P433, DOI 10.1007/s00281-004-0188-9; Mockridge CI, 2004, AUTOIMMUNITY, V37, P9, DOI 10.1080/08916930310001624656; Moir S, 2008, J EXP MED, V205, P1797, DOI 10.1084/jem.20072683; Moir S, 2009, NAT REV IMMUNOL, V9, P235, DOI 10.1038/nri2524; Morrow M, 2008, AIDS RES HUM RETROV, V24, P621, DOI 10.1089/aid.2007.0186; PASCUAL V, 1991, J IMMUNOL, V146, P4385; Petrovas C, 1999, J AUTOIMMUN, V13, P347, DOI 10.1006/jaut.1999.0324; Piantadosi A, 2009, J VIROL, V83, P10269, DOI 10.1128/JVI.01149-09; POTTER KN, 1993, J EXP MED, V178, P1419, DOI 10.1084/jem.178.4.1419; Potter KN, 2002, J IMMUNOL, V169, P3777, DOI 10.4049/jimmunol.169.7.3777; Pugh-Bernard AE, 2001, J CLIN INVEST, V108, P1061, DOI 10.1172/JCI12462; SANZ I, 1989, EMBO J, V8, P3741, DOI 10.1002/j.1460-2075.1989.tb08550.x; Sather DN, 2009, J VIROL, V83, P757, DOI 10.1128/JVI.02036-08; Scheid JF, 2011, SCIENCE; Scherer EM, 2007, AIDS, V21, P2131, DOI 10.1097/QAD.0b013e3282a4a632; Scherl M, 2006, LUPUS, V15, P865, DOI 10.1177/0961203306071405; Simek MD, 2009, J VIROL, V83, P7337, DOI 10.1128/JVI.00110-09; Singh H, 2011, AIDS, V25, P1247, DOI 10.1097/QAD.0b013e32834785cf; STEVENSON FK, 1988, NOUV REV FR HEMATOL, V30, P299; STEVENSON FK, 1993, J AUTOIMMUN, V6, P809, DOI 10.1006/jaut.1993.1066; Tomaras GD, 2009, CURR OPIN HIV AIDS, V4, P373, DOI 10.1097/COH.0b013e32832f00c0; Uthman IW, 2002, SEMIN ARTHRITIS RHEU, V31, P256, DOI 10.1053/sarh.2002.28303; van Gils MJ, 2009, AIDS, V23, P2405, DOI 10.1097/QAD.0b013e32833243e7; VANES JH, 1991, J EXP MED, V173, P461, DOI 10.1084/jem.173.2.461; Verkoczy L, 2011, CURR OPIN IMMUNOL, V23, P383, DOI 10.1016/j.coi.2011.04.003; Weller S, 2004, BLOOD, V104, P3647, DOI 10.1182/blood-2004-01-0346; Zachou K, 2006, CLIN IMMUNOL, V119, P203, DOI 10.1016/j.clim.2006.01.002; Zheng NY, 2004, J CLIN INVEST, V113, P1188, DOI 10.1172/JCI200420255; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	51	34	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35356	10.1371/journal.pone.0035356	http://dx.doi.org/10.1371/journal.pone.0035356			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22530008	Green Published, Green Submitted, gold			2022-12-27	WOS:000305350600077
J	AuCoin, DP; Reed, DE; Marlenee, NL; Bowen, RA; Thorkildson, P; Judy, BM; Torres, AG; Kozel, TR				AuCoin, David P.; Reed, Dana E.; Marlenee, Nicole L.; Bowen, Richard A.; Thorkildson, Peter; Judy, Barbara M.; Torres, Alfredo G.; Kozel, Thomas R.			Polysaccharide Specific Monoclonal Antibodies Provide Passive Protection against Intranasal Challenge with Burkholderia pseudomallei	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; CAPSULAR POLYSACCHARIDE; PSEUDOMONAS-PSEUDOMALLEI; CRYPTOCOCCUS-NEOFORMANS; IN-VITRO; LIPOPOLYSACCHARIDE; MELIOIDOSIS; SUSCEPTIBILITY; IMMUNOTHERAPY; RESISTANCE	Burkholderia pseudomallei is a Gram-negative bacillus that is the causative agent of melioidosis. The bacterium is inherently resistant to many antibiotics and mortality rates remain high in endemic areas. The lipopolysaccharide (LPS) and capsular polysaccharide (CPS) are two surface-associated antigens that contribute to pathogenesis. We previously developed two monoclonal antibodies (mAbs) specific to the CPS and LPS; the CPS mAb was shown to identify antigen in serum and urine from melioidosis patients. The goal of this study was to determine if passive immunization with CPS and LPS mAbs alone and in combination would protect mice from a lethal challenge with B. pseudomallei. Intranasal (i.n.) challenge experiments were performed with B. pseudomallei strains 1026b and K96423. Both mAbs provided significant protection when administered alone. A combination of mAbs was protective when low doses were administered. In addition, combination therapy provided a significant reduction in spleen colony forming units (cfu) compared to results when either the CPS or LPS mAbs were administered alone.	[AuCoin, David P.; Reed, Dana E.; Thorkildson, Peter; Kozel, Thomas R.] Univ Nevada, Sch Med, Dept Microbiol & Immunol, Reno, NV 89557 USA; [Marlenee, Nicole L.; Bowen, Richard A.] Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA; [Torres, Alfredo G.] Univ Texas Med Branch, Dept Pathol, Galveston, TX USA; [Judy, Barbara M.; Torres, Alfredo G.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX USA	Nevada System of Higher Education (NSHE); University of Nevada Reno; Colorado State University; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	AuCoin, DP (corresponding author), Univ Nevada, Sch Med, Dept Microbiol & Immunol, Reno, NV 89557 USA.	daucoin@medicine.nevada.edu	Pacific-Southwest, RCE/B-6155-2009	Torres, Alfredo/0000-0001-6450-0643	National Institute of Allergy and Infectious Diseases [U54AI065359];  [NO1-AI-30065]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059348, U54AI065359] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was supported by award number U54AI065359 from the National Institute of Allergy and Infectious Diseases to D.P.A., and by NO1-AI-30065 to A.G.T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anuntagool N, 1998, CLIN DIAGN LAB IMMUN, V5, P225, DOI 10.1128/CDLI.5.2.225-229.1998; Anuntagool N, 2002, MICROBIOL IMMUNOL, V46, P143, DOI 10.1111/j.1348-0421.2002.tb02679.x; Anuntagool N, 2000, Southeast Asian J Trop Med Public Health, V31 Suppl 1, P146; Arjcharoen S, 2007, INFECT IMMUN, V75, P4298, DOI 10.1128/IAI.00285-07; Bottex C, 2005, IMMUNOPHARM IMMUNOT, V27, P565, DOI 10.1080/08923970500493995; Brett PJ, 1996, INFECT IMMUN, V64, P2824, DOI 10.1128/IAI.64.7.2824-2828.1996; Bryan LE, 1995, CAN J INFECT DIS, V5, P170; CHAOWAGUL W, 1993, J INFECT DIS, V168, P1181, DOI 10.1093/infdis/168.5.1181; Charuchaimontri C, 1999, CLIN INFECT DIS, V29, P813, DOI 10.1086/520441; Cheng AC, 2004, EUR J CLIN MICROBIOL, V23, P205, DOI 10.1007/s10096-003-1088-y; Cheng AC, 2004, CLIN INFECT DIS, V38, P32, DOI 10.1086/380456; Cheng Allen C, 2003, Commun Dis Intell Q Rep, V27, P272; CHOU TC, 1994, JNCI-J NATL CANCER I, V86, P1517, DOI 10.1093/jnci/86.20.1517; CHOU TC, 1983, TRENDS PHARMACOL SCI, V4, P450, DOI 10.1016/0165-6147(83)90490-X; Currie BJ, 2000, T ROY SOC TROP MED H, V94, P301, DOI 10.1016/S0035-9203(00)90333-X; DANCE DAB, 1989, J ANTIMICROB CHEMOTH, V24, P295, DOI 10.1093/jac/24.3.295; DeShazer D, 1998, MOL MICROBIOL, V30, P1081, DOI 10.1046/j.1365-2958.1998.01139.x; Estes DM, 2010, EXPERT REV ANTI-INFE, V8, P325, DOI [10.1586/eri.10.4, 10.1586/ERI.10.4]; Ho M, 1997, INFECT IMMUN, V65, P3648, DOI 10.1128/IAI.65.9.3648-3653.1997; Jenney AWJ, 2001, INT J ANTIMICROB AG, V17, P109, DOI 10.1016/S0924-8579(00)00334-4; Jones SM, 2002, J MED MICROBIOL, V51, P1055, DOI 10.1099/0022-1317-51-12-1055; KNIREL YA, 1992, CARBOHYD RES, V233, P185, DOI 10.1016/S0008-6215(00)90930-3; Kozel TR, 2007, INFECT IMMUN, V75, P152, DOI 10.1128/IAI.01133-06; Kozel TR, 2004, P NATL ACAD SCI USA, V101, P5042, DOI 10.1073/pnas.0401351101; Limmathurotsakul D, 2010, AM J TROP MED HYG, V82, P1113, DOI 10.4269/ajtmh.2010.10-0038; Nelson M, 2004, J MED MICROBIOL, V53, P1177, DOI 10.1099/jmm.0.45766-0; Nuti DE, 2011, MBIO, V2, DOI 10.1128/mBio.00136-11; Panomket P, 2009, ANN TROP MED PARASIT, V103, P635, DOI 10.1179/000349809X12502035776117; PERRY MB, 1995, INFECT IMMUN, V63, P3348, DOI 10.1128/IAI.63.9.3348-3352.1995; Powell K, 2003, FEMS MICROBIOL LETT, V224, P315, DOI 10.1016/S0378-1097(03)00473-7; Propst KL, 2010, ANTIMICROB AGENTS CH, V54, P1785, DOI 10.1128/AAC.01513-09; Reckseidler SL, 2001, INFECT IMMUN, V69, P34, DOI 10.1128/IAI.69.1.34-44.2001; Reckseidler-Zenteno SL, 2009, MINI-REV MED CHEM, V9, P265, DOI 10.2174/138955709787316047; Reckseidler-Zenteno SL, 2005, INFECT IMMUN, V73, P1106, DOI 10.1128/IAI.73.2.1106-1115.2005; Sarkar-Tyson M, 2010, CLIN THER, V32, P1437, DOI 10.1016/j.clinthera.2010.07.020; Taborda CP, 2003, J IMMUNOL, V170, P3621, DOI 10.4049/jimmunol.170.7.3621; Taborda CP, 2001, J IMMUNOL, V166, P2100, DOI 10.4049/jimmunol.166.3.2100; White NJ, 2003, LANCET, V361, P1715, DOI 10.1016/S0140-6736(03)13374-0; Whitlock GC, 2009, J MED MICROBIOL, V58, P554, DOI 10.1099/jmm.0.007724-0; Woods DE, 1999, MICROBES INFECT, V1, P157, DOI 10.1016/S1286-4579(99)80007-0; Zaragoza O, 2007, INFECT IMMUN, V75, P2729, DOI 10.1128/IAI.00094-07; Zhang SM, 2011, CLIN VACCINE IMMUNOL, V18, P825, DOI 10.1128/CVI.00533-10; Zou NX, 2008, HYBRIDOMA, V27, P231, DOI 10.1089/hyb.2008.0012	43	33	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e35386	10.1371/journal.pone.0035386	http://dx.doi.org/10.1371/journal.pone.0035386			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22530013	gold, Green Published, Green Submitted			2022-12-27	WOS:000305347400046
J	Chou, AH; Liu, CC; Chang, CP; Guo, MS; Hsieh, SY; Yang, WH; Chao, HJ; Wu, CL; Huang, JL; Lee, MS; Hu, AYC; Lin, SC; Huang, YY; Hu, MH; Chow, YH; Chiang, JR; Chang, JY; Chong, PL				Chou, Ai-Hsiang; Liu, Chia-Chyi; Chang, Cheng-Peng; Guo, Meng-Shin; Hsieh, Shih-Yang; Yang, Wen-Hsueh; Chao, Hsin-Ju; Wu, Chien-Long; Huang, Ju-Lan; Lee, Min-Shi; Hu, Alan Yung-Chi; Lin, Sue-Chen; Huang, Yu-Yun; Hu, Mei-Hua; Chow, Yen-Hung; Chiang, Jen-Ron; Chang, Jui-Yuan; Chong, Pele			Pilot Scale Production of Highly Efficacious and Stable Enterovirus 71 Vaccine Candidates	PLOS ONE			English	Article							INACTIVATED VACCINE; CELL-CULTURE; INFECTION; MICE; IDENTIFICATION; IMMUNIZATION; EVOLUTION; RECEPTOR; TAIWAN; LETHAL	Background: Enterovirus 71 (EV71) has caused several epidemics of hand, foot and mouth diseases (HFMD) in Asia and now is being recognized as an important neurotropic virus. Effective medications and prophylactic vaccine against EV71 infection are urgently needed. Based on the success of inactivated poliovirus vaccine, a prototype chemically inactivated EV71 vaccine candidate has been developed and currently in human phase 1 clinical trial. Principal Finding: In this report, we present the development of a serum-free cell-based EV71 vaccine. The optimization at each step of the manufacturing process was investigated, characterized and quantified. In the up-stream process development, different commercially available cell culture media either containing serum or serum-free was screened for cell growth and virus yield using the roller-bottle technology. VP-SFM serum-free medium was selected based on the Vero cell growth profile and EV71 virus production. After the up-stream processes (virus harvest, diafiltration and concentration), a combination of gel-filtration liquid chromatography and/or sucrose-gradient ultracentrifugation down-stream purification processes were investigated at a pilot scale of 40 liters each. Although the combination of chromatography and sucrose-gradient ultracentrifugation produced extremely pure EV71 infectious virus particles, the overall yield of vaccine was 7-10% as determined by a VP2-based quantitative ELISA. Using chromatography as the downstream purification, the virus yield was 30-43%. To retain the integrity of virus neutralization epitopes and the stability of the vaccine product, the best virus inactivation was found to be 0.025% formalin-treatment at 37 degrees C for 3 to 6 days. Furthermore, the formalin-inactivated virion vaccine candidate was found to be stable for >18 months at 4 degrees C and a microgram of viral proteins formulated with alum adjuvant could induce strong virus-neutralizing antibody responses in mice, rats, rabbits, and non-human primates. Conclusion: These results provide valuable information supporting the current cell-based serum-free EV71 vaccine candidate going into human Phase I clinical trials.	[Chou, Ai-Hsiang; Liu, Chia-Chyi; Chang, Cheng-Peng; Guo, Meng-Shin; Hsieh, Shih-Yang; Yang, Wen-Hsueh; Chao, Hsin-Ju; Wu, Chien-Long; Huang, Ju-Lan; Lee, Min-Shi; Hu, Alan Yung-Chi; Lin, Sue-Chen; Huang, Yu-Yun; Hu, Mei-Hua; Chow, Yen-Hung; Chang, Jui-Yuan; Chong, Pele] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Vaccine R&D Ctr, Zhunan, Taiwan; [Chiang, Jen-Ron] Taiwan Ctr Dis Control, Vaccine Ctr, Taipei, Taiwan; [Chong, Pele] China Med Univ, Grad Inst Immunol, Taichung, Taiwan	National Health Research Institutes - Taiwan; China Medical University Taiwan	Chou, AH (corresponding author), Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Vaccine R&D Ctr, Zhunan, Taiwan.	pelechong@nhri.org.tw	Hu, Alan Yung-Chih/G-3708-2011; Liu, Chia-Chyi/A-8215-2012; Chong, Pele/E-3855-2010; Lee, Min-Shi/E-3992-2010; Chow, Yen-Hung/E-3863-2010	Liu, Chia-Chyi/0000-0002-6257-0389; 	National Science Council(NSC) of Taiwan [98A1-VCSP01-014]	National Science Council(NSC) of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by a grant (No. 98A1-VCSP01-014) from the National Science Council(NSC) of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bek EJ, 2011, VACCINE, V29, P4829, DOI 10.1016/j.vaccine.2011.04.070; Bible JM, 2008, J CLIN MICROBIOL, V46, P3192, DOI 10.1128/JCM.00628-08; Brown BA, 1995, VIRUS RES, V39, P195, DOI 10.1016/0168-1702(95)00087-9; Chan YF, 2010, INFECT GENET EVOL, V10, P404, DOI 10.1016/j.meegid.2009.05.010; Chang HW, 2011, J VIROL METHODS, V173, P189, DOI 10.1016/j.jviromet.2011.02.003; Chang JY, 2012, VACCINE, V30, P703, DOI 10.1016/j.vaccine.2011.11.087; Chung YC, 2008, VACCINE, V26, P1855, DOI 10.1016/j.vaccine.2008.01.058; Dong CH, 2011, VACCINE, V29, P6269, DOI 10.1016/j.vaccine.2011.06.044; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Huang ML, 2011, J FORMOS MED ASSOC, V110, P425, DOI 10.1016/S0929-6646(11)60063-6; Huang SW, 2009, J CLIN MICROBIOL, V47, P3653, DOI 10.1128/JCM.00630-09; Lee MS, 2010, EXPERT REV VACCINES, V9, P149, DOI [10.1586/erv.09.152, 10.1586/ERV.09.152]; Liu CC, 2007, VACCINE, V25, P19, DOI 10.1016/j.vaccine.2006.06.083; Liu CC, 2011, J VIROL METHODS, V176, P60, DOI 10.1016/j.jviromet.2011.06.001; Liu CC, 2011, VACCINE, V29, P4362, DOI 10.1016/j.vaccine.2011.04.010; Liu CC, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0020005, 10.1371/journal.pone.0021464]; McMinn PC, 2002, FEMS MICROBIOL REV, V26, P91, DOI 10.1111/j.1574-6976.2002.tb00601.x; Nishimura Y, 2009, NAT MED, V15, P794, DOI 10.1038/nm.1961; PANEZUTTI H, 1993, INFECT IMMUN, V61, P1867, DOI 10.1128/IAI.61.5.1867-1872.1993; REED L. J., 1938, AMER JOUR HYG, V27, P493; SCHMIDT NJ, 1974, J INFECT DIS, V129, P304, DOI 10.1093/infdis/129.3.304; Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8; Tung Wong Siew, 2007, Genet Vaccines Ther, V5, P6, DOI 10.1186/1479-0556-5-6; Wu CN, 2001, VACCINE, V20, P895, DOI 10.1016/S0264-410X(01)00385-1; Wu SC, 2004, VACCINE, V22, P3858, DOI 10.1016/j.vaccine.2004.05.037; Xu J, 2010, VACCINE, V28, P3516, DOI 10.1016/j.vaccine.2010.03.003; Yamayoshi S, 2009, NAT MED, V15, P798, DOI 10.1038/nm.1992	27	47	55	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e34834	10.1371/journal.pone.0034834	http://dx.doi.org/10.1371/journal.pone.0034834			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22529942	Green Submitted, Green Published, gold			2022-12-27	WOS:000305347400020
J	Goyret, J; Kelber, A				Goyret, Joaquin; Kelber, Almut			Chromatic Signals Control Proboscis Movements during Hovering Flight in the Hummingbird Hawkmoth Macroglossum stellatarum	PLOS ONE			English	Article							ANIMAL COLOR-VISION; INNATE PREFERENCES; BOMBUS-TERRESTRIS; SENSORY CONTROL; MANDUCA-SEXTA; MOTH; DISCRIMINATION; PERCEPTION; HONEYBEES; PATTERNS	Most visual systems are more sensitive to luminance than to colour signals. Animals resolve finer spatial detail and temporal changes through achromatic signals than through chromatic ones. Probably, this explains that detection of small, distant, or moving objects is typically mediated through achromatic signals. Macroglossum stellatarum are fast flying nectarivorous hawkmoths that inspect flowers with their long proboscis while hovering. They can visually control this behaviour using floral markings known as nectar guides. Here, we investigate whether this is mediated by chromatic or achromatic cues. We evaluated proboscis placement, foraging efficiency, and inspection learning of naive moths foraging on flower models with coloured markings that offered either chromatic, achromatic or both contrasts. Hummingbird hawkmoths could use either achromatic or chromatic signals to inspect models while hovering. We identified three, apparently independent, components controlling proboscis placement: After initial contact, 1) moths directed their probing towards the yellow colour irrespectively of luminance signals, suggesting a dominant role of chromatic signals; and 2) moths tended to probe mainly on the brighter areas of models that offered only achromatic signals. 3) During the establishment of the first contact, naive moths showed a tendency to direct their proboscis towards the small floral marks independent of their colour or luminance. Moths learned to find nectar faster, but their foraging efficiency depended on the flower model they foraged on. Our results imply that M. stellatarum can perceive small patterns through colour vision. We discuss how the different informational contents of chromatic and luminance signals can be significant for the control of flower inspection, and visually guided behaviours in general.	[Goyret, Joaquin; Kelber, Almut] Lund Univ, Dept Biol, Lund Vis Grp, Lund, Skane, Sweden	Lund University	Goyret, J (corresponding author), Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA.	jg549@cornell.edu	; Kelber, Almut/H-6216-2014	Goyret, Joaquin/0000-0002-6509-4824; Kelber, Almut/0000-0003-3937-2808	Swedish Research Council; Wenner Foundation; Gren Foundation; Royal Physiographic Society in Lund	Swedish Research Council(Swedish Research CouncilEuropean Commission); Wenner Foundation; Gren Foundation; Royal Physiographic Society in Lund	The work was supported by the following funding agencies: Swedish Research Council, The Wenner-Gren Foundations, and Royal Physiographic Society in Lund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blackiston D, 2011, J EXP BIOL, V214, P509, DOI 10.1242/jeb.048728; Briscoe AD, 2001, ANNU REV ENTOMOL, V46, P471, DOI 10.1146/annurev.ento.46.1.471; Endler JA, 1996, AM NAT, V148, P421, DOI 10.1086/285934; FARINA WM, 1994, J COMP PHYSIOL A, V174, P239; FARINA WM, 1995, J COMP PHYSIOL A, V176, P551, DOI 10.1007/BF00196420; Frisch K. von, 1914, Zool Jahrb Allg Jena, V35; Giger AD, 1996, J COMP PHYSIOL A, V178, P763; GOULSON D, 1993, ECOL ENTOMOL, V18, P315, DOI 10.1111/j.1365-2311.1993.tb01107.x; Goyret J, 2006, J EXP BIOL, V209, P1585, DOI 10.1242/jeb.02169; Goyret J, 2011, BEHAV ECOL, V22, P976, DOI 10.1093/beheco/arr078; Goyret J, 2010, J EXP BIOL, V213, P3676, DOI 10.1242/jeb.045831; HELVERSEN OV, 1972, J COMP PHYSIOL, V80, P439, DOI 10.1007/BF00696438; Hori S, 2006, J COMP PHYSIOL A, V192, P691, DOI 10.1007/s00359-005-0091-4; Johnsen S, 2006, J EXP BIOL, V209, P789, DOI 10.1242/jeb.02053; Kaiser W., 1975, P359; Kelber A, 1999, J COMP PHYSIOL A, V184, P535, DOI 10.1007/s003590050353; Kelber A, 2003, BIOL REV, V78, P81, DOI 10.1017/S1464793102005985; Kelber A, 2005, P ROY SOC B-BIOL SCI, V272, P2143, DOI 10.1098/rspb.2005.3207; Kelber A, 2003, INTEGR COMP BIOL, V43, P571, DOI 10.1093/icb/43.4.571; Kelber A, 2002, P ROY SOC B-BIOL SCI, V269, P2573, DOI 10.1098/rspb.2002.2201; Kelber A, 1996, J EXP BIOL, V199, P1127; Kelber A, 1997, J EXP BIOL, V200, P827; Kelber A, 1999, J EXP BIOL, V202, P2619; Kelber A, 2010, P ROY SOC B-BIOL SCI, V277, P1617, DOI 10.1098/rspb.2009.2118; Kern R, 1998, J COMP PHYSIOL A, V182, P225, DOI 10.1007/s003590050173; Koshitaka H, 2011, J COMP PHYSIOL A, V197, P1105, DOI 10.1007/s00359-011-0671-4; LEHRER M, 1995, NATURWISSENSCHAFTEN, V82, P145, DOI 10.1007/BF01177278; LEHRER M, 1990, PROC R SOC SER B-BIO, V238, P321, DOI 10.1098/rspb.1990.0002; LEHRER M, 1985, J COMP PHYSIOL A, V157, P405, DOI 10.1007/BF00615140; Lehrer M, 1993, SENSORY SYSTEMS ARTH, P966; Lind O, 2011, J VISION, V11, DOI 10.1167/11.7.2; Lindstedt C, 2011, BEHAV ECOL, V22, P580, DOI 10.1093/beheco/arr017; LIVINGSTONE MS, 1987, J NEUROSCI, V7, P3416; Lorenz Konrad, 1981, FDN ETHOLOGY; Lunau K, 2006, NATURWISSENSCHAFTEN, V93, P325, DOI 10.1007/s00114-006-0105-2; LUNAU K, 1995, J COMP PHYSIOL A, V177, P1; LUNAU K, 1994, J COMP PHYSIOL A, V174, P575, DOI 10.1007/BF00217378; Lunau K, 2009, J COMP PHYSIOL A, V195, P1121, DOI 10.1007/s00359-009-0484-x; MAZOKHIN-PORSHNIAKOV G A, 1962, Biofizika, V7, P211; Osorio D, 1999, EVOL ECOL, V13, P673, DOI 10.1023/A:1011059715610; Pelkwijk J. J.ter, 1937, Zeitschrift fuer Tierpsychologie Berlin, V1, P193; Pfaff M, 1991, ZOOL JB PHYSL, P315; Reisenman CE, 2006, J COMP PHYSIOL A, V192, P39, DOI 10.1007/s00359-005-0045-x; Schaerer S, 1996, VISION RES, V36, P4025, DOI 10.1016/S0042-6989(96)00149-6; Schwemer J, 1973, J COMP PHYSIOL A, V86, P99; Skorupski P, 2010, J NEUROSCI, V30, P3896, DOI 10.1523/JNEUROSCI.5700-09.2010; Sprayberry JDH, 2007, J EXP BIOL, V210, P37, DOI 10.1242/jeb.02616; Weiss MR, 2003, ANIM BEHAV, V65, P425, DOI 10.1006/anbe.2003.2084	49	17	17	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e34629	10.1371/journal.pone.0034629	http://dx.doi.org/10.1371/journal.pone.0034629			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22529922	Green Published, gold, Green Submitted			2022-12-27	WOS:000305347400014
J	Dawes, FE; Bulach, DM; Kuzevski, A; Bettelheim, KA; Venturini, C; Djordjevic, SP; Walker, MJ				Dawes, Fay E.; Bulach, Dieter M.; Kuzevski, Alexander; Bettelheim, Karl A.; Venturini, Carola; Djordjevic, Steven P.; Walker, Mark J.			Molecular Characterization of a 21.4 Kilobase Antibiotic Resistance Plasmid from an alpha-Hemolytic Escherichia coli O108:H- Human Clinical Isolate	PLOS ONE			English	Article							NUCLEOTIDE-SEQUENCE; GENES; INSERTION; BACTERIA; DNA; IDENTIFICATION; SALMONELLA; INTEGRONS; INCX1; PCR	This study characterizes the 21.4 kilobase plasmid pECTm80 isolated from Escherichia coli strain 80, an alpha hemolytic human clinical diarrhoeal isolate (serotype O108:H-). DNA sequence analysis of pECTm80 revealed it belonged to incompatibility group X1, and contained plasmid partition and toxin-antitoxin systems, an R6K-like triple origin (ori) replication system, genes required for replication regulation, insertion sequences IS1R, ISEc37 and a truncated transposase gene (Tn3-like Delta tnpA) of the Tn3 family, and carried a class 2 integron. The class 2 integron of pECTm80 contains an intact cassette array dfrA1-sat2, encoding resistance to trimethoprim and streptothricin, and an aadA1 gene cassette truncated by the insertion of IS1R. The complex plasmid replication system includes alpha, beta and gamma origins of replication. Pairwise BLASTn comparison of pECTm80 with plasmid pE001 reveals a conserved plasmid backbone suggestive of a common ancestral lineage. Plasmid pECTm80 is of potential clinical importance, as it carries multiple genes to ensure its stable maintenance through successive bacterial cell divisions and multiple antibiotic resistance genes.	[Dawes, Fay E.; Walker, Mark J.] Univ Wollongong, Sch Biol Sci, Wollongong, NSW 2522, Australia; [Bulach, Dieter M.] Monash Univ, Dept Microbiol, Clayton, Vic 3168, Australia; [Bulach, Dieter M.] Monash Univ, Victorian Bioinformat Consortium, Clayton, Vic, Australia; [Kuzevski, Alexander; Bettelheim, Karl A.] Univ Melbourne, Dept Microbiol & Immunol, Microbiol Diagnost Unit, Parkville, Vic 3052, Australia; [Venturini, Carola; Walker, Mark J.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia; [Venturini, Carola; Walker, Mark J.] Univ Queensland, Australian Infect Dis Res Ctr, Brisbane, Qld, Australia; [Djordjevic, Steven P.] Elizabeth Macarthur Agr Inst, Microbiol & Immunol Sect, Menangle, NSW, Australia; [Djordjevic, Steven P.] Univ Technol Sydney, Ithree Inst, Sydney, NSW 2007, Australia	University of Wollongong; Monash University; Monash University; University of Melbourne; University of Queensland; University of Queensland; University of Technology Sydney	Walker, MJ (corresponding author), Univ Wollongong, Sch Biol Sci, Wollongong, NSW 2522, Australia.	mark.walker@uq.edu.au	Djordjevic, Steven/A-2024-2013; Venturini, Carola/G-6642-2018; djordjevic, steven/GNP-4000-2022; Bulach, Dieter M/D-5793-2011; Walker, Mark J./F-6940-2011	Djordjevic, Steven/0000-0001-9301-5372; Venturini, Carola/0000-0003-2370-8661; djordjevic, steven/0000-0001-9301-5372; Bulach, Dieter M/0000-0001-9823-6078; Walker, Mark/0000-0001-7423-2769	University of Wollongong, Industry and Investment New South Wales; Australian Research Council [LP0348851]; Australian Postgraduate Award	University of Wollongong, Industry and Investment New South Wales; Australian Research Council(Australian Research Council); Australian Postgraduate Award(Australian Government)	This research was supported by grants from the University of Wollongong, Industry and Investment New South Wales and the Australian Research Council (grant no. LP0348851). FED was supported by an Australian Postgraduate Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELES AL, 1985, J MOL BIOL, V185, P261, DOI 10.1016/0022-2836(85)90402-4; ACHESON DWK, 1990, J INFECT DIS, V161, P134, DOI 10.1093/infdis/161.1.134; Besemer J, 2001, NUCLEIC ACIDS RES, V29, P2607, DOI 10.1093/nar/29.12.2607; Bettelheim KA, 2003, J MED MICROBIOL, V52, P155, DOI 10.1099/jmm.0.04903-0; BETTELHEIM KA, 1995, J APPL BACTERIOL, V79, P178, DOI 10.1111/j.1365-2672.1995.tb00932.x; Bielak E, 2011, J ANTIMICROB CHEMOTH, V66, P2465, DOI 10.1093/jac/dkr331; Chen J, 1998, LETT APPL MICROBIOL, V27, P369, DOI 10.1046/j.1472-765X.1998.00445.x; Chu CS, 2006, MICROBES INFECT, V8, P1931, DOI 10.1016/j.micinf.2005.12.026; Dawes FE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012754; Dillon B, 2005, J MICROBIOL METH, V62, P221, DOI 10.1016/j.mimet.2005.02.007; FINAN TM, 1986, J BACTERIOL, V167, P66, DOI 10.1128/jb.167.1.66-72.1986; Flashner Y, 1996, MOL MICROBIOL, V19, P985, DOI 10.1046/j.1365-2958.1996.428960.x; Hansson K, 2002, J BACTERIOL, V184, P1712, DOI 10.1128/JB.184.6.1712-1721.2002; Hayes F, 1998, J BACTERIOL, V180, P6415; Holcik M, 1997, MICROBIOL-SGM, V143, P3403, DOI 10.1099/00221287-143-11-3403; JENSEN RB, 1995, MOL MICROBIOL, V17, P205, DOI 10.1111/j.1365-2958.1995.mmi_17020205.x; JONES CS, 1993, J GEN MICROBIOL, V139, P735, DOI 10.1099/00221287-139-4-735; KONOWALCHUK J, 1977, INFECT IMMUN, V18, P775, DOI 10.1128/IAI.18.3.775-779.1977; Literak I, 2010, APPL ENVIRON MICROB, V76, P8126, DOI 10.1128/AEM.01446-10; Mahillon J, 1998, MICROBIOL MOL BIOL R, V62, P725, DOI 10.1128/MMBR.62.3.725-774.1998; Mazel D, 2000, ANTIMICROB AGENTS CH, V44, P1568, DOI 10.1128/AAC.44.6.1568-1574.2000; Norman A, 2008, PLASMID, V60, P59, DOI 10.1016/j.plasmid.2008.03.003; Normark BH, 2002, J INTERN MED, V252, P91, DOI 10.1046/j.1365-2796.2002.01026.x; Nunez B, 1997, MOL MICROBIOL, V24, P1157, DOI 10.1046/j.1365-2958.1997.4111778.x; OHTSUBO H, 1978, P NATL ACAD SCI USA, V75, P615, DOI 10.1073/pnas.75.2.615; ORSKOV F, 1978, J INFECT DIS, V137, P630, DOI 10.1093/infdis/137.5.630; Ratnakar PVAL, 1996, P NATL ACAD SCI USA, V93, P5522, DOI 10.1073/pnas.93.11.5522; Rozen S, 2000, Methods Mol Biol, V132, P365; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Salyers AA, 1997, ANTIMICROB AGENTS CH, V41, P2321, DOI 10.1128/AAC.41.11.2321; Sambrook J., 2001, MOL CLONING LAB MANU; Sullivan MJ, 2011, BIOINFORMATICS, V27, P1009, DOI 10.1093/bioinformatics/btr039; SUNDSTROM L, 1991, J BACTERIOL, V173, P3025; TALMADGE K, 1980, GENE, V12, P235, DOI 10.1016/0378-1119(80)90105-5; THRELFALL EJ, 1986, J ANTIMICROB CHEMOTH, V18, P175, DOI 10.1093/jac/18.Supplement_C.175; Toukdarian A, 2004, PLASMID BIOL; Toussaint A, 2002, PLASMID, V47, P26, DOI 10.1006/plas.2001.1552; Venturini C, 2010, FASEB J, V24, P1160, DOI 10.1096/fj.09-144972; Wild J, 2004, ANN MICROBIOL, V54, P471; YOUNG HK, 1994, J ANTIMICROB CHEMOTH, V34, P715, DOI 10.1093/jac/34.5.715	40	0	0	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e34718	10.1371/journal.pone.0034718	http://dx.doi.org/10.1371/journal.pone.0034718			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22532831	Green Published, gold			2022-12-27	WOS:000305339200017
J	Hess, K; Ajjan, R; Phoenix, F; Dobo, J; Gal, P; Schroeder, V				Hess, Katharina; Ajjan, Ramzi; Phoenix, Fladia; Dobo, Jozsef; Gal, Peter; Schroeder, Verena			Effects of MASP-1 of the Complement System on Activation of Coagulation Factors and Plasma Clot Formation	PLOS ONE			English	Article							FACTOR-XIII; SERINE PROTEASE-1; FIBRIN CLOT; GENERATION; PATHWAY; POLYMORPHISM; INFARCTION; PHENOTYPE; PEPTIDES; MUTANTS	Background: Numerous interactions between the coagulation and complement systems have been shown. Recently, links between coagulation and mannan-binding lectin-associated serine protease-1 (MASP-1) of the complement lectin pathway have been proposed. Our aim was to investigate MASP-1 activation of factor XIII (FXIII), fibrinogen, prothrombin, and thrombin-activatable fibrinolysis inhibitor (TAFI) in plasma-based systems, and to analyse effects of MASP-1 on plasma clot formation, structure and lysis. Methodology/Principal Findings: We used a FXIII incorporation assay and specific assays to measure the activation products prothrombin fragment F1+2, fibrinopeptide A (FPA), and activated TAFI (TAFIa). Clot formation and lysis were assessed by turbidimetric assay. Clot structure was studied by scanning electron microscopy. MASP-1 activated FXIII and, contrary to thrombin, induced FXIII activity faster in the Val34 than the Leu34 variant. MASP-1-dependent generation of F1+2, FPA and TAFIa showed a dose-dependent response in normal citrated plasma (NCP), albeit MASP-1 was much less efficient than FXa or thrombin. MASP-1 activation of prothrombin and TAFI cleavage were confirmed in purified systems. No FPA generation was observed in prothrombin-depleted plasma. MASP-1 induced clot formation in NCP, affected clot structure, and prolonged clot lysis. Conclusions/Significance: We show that MASP-1 interacts with plasma clot formation on different levels and influences fibrin structure. Although MASP-1-induced fibrin formation is thrombin-dependent, MASP-1 directly activates prothrombin, FXIII and TAFI. We suggest that MASP-1, in concerted action with other complement and coagulation proteins, may play a role in fibrin clot formation.	[Hess, Katharina; Ajjan, Ramzi; Phoenix, Fladia; Schroeder, Verena] Univ Leeds, Div Cardiovasc & Diabet Res, LIGHT Labs, Multidisciplinary Cardiovasc Res Ctr, Leeds, W Yorkshire, England; [Hess, Katharina] Univ Hosp Aachen, Dept Internal Med, Aachen, Germany; [Dobo, Jozsef; Gal, Peter] Hungarian Acad Sci, Inst Enzymol, Biol Res Ctr, Budapest, Hungary; [Schroeder, Verena] Univ Bern, Bern, Switzerland; [Schroeder, Verena] Univ Hosp Bern, Univ Clin Hematol & Cent Hematol Lab, Hemostasis Res Lab, CH-3010 Bern, Switzerland	University of Leeds; RWTH Aachen University; RWTH Aachen University Hospital; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; Hungarian Research Centre for Natural Sciences; University of Bern; University of Bern; University Hospital of Bern	Schroeder, V (corresponding author), Univ Leeds, Div Cardiovasc & Diabet Res, LIGHT Labs, Multidisciplinary Cardiovasc Res Ctr, Leeds, W Yorkshire, England.	verena.schroeder@insel.ch	Gal, Peter/B-5886-2011; Dobo, Jozsef/C-7331-2014	Schroeder, Verena/0000-0001-6508-3271; Dobo, Jozsef/0000-0001-9187-8502	Rosetrees Trust (UK); Betty and Charles Stilwell Fund (UK); OPO Foundation (Switzerland); Deutsche Forschungsgemeinschaft; Swiss National Science Foundation/Swiss Foundation for Medical-Biological; Novartis Foundation	Rosetrees Trust (UK)(Rosetrees Trust); Betty and Charles Stilwell Fund (UK); OPO Foundation (Switzerland); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Swiss National Science Foundation/Swiss Foundation for Medical-Biological; Novartis Foundation(Novartis)	This work was supported by grants awarded to VS by the Rosetrees Trust (UK), The Betty and Charles Stilwell Fund (UK), and OPO Foundation (Switzerland). At the University of Leeds, KH was supported by a grant from the Deutsche Forschungsgemeinschaft and VS was supported by fellowships from the Swiss National Science Foundation/Swiss Foundation for Medical-Biological Grants and the Novartis Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajjan R, 2008, BLOOD, V111, P643, DOI 10.1182/blood-2007-05-091231; Amara U, 2010, J IMMUNOL, V185, P5628, DOI 10.4049/jimmunol.0903678; Ambrus G, 2003, J IMMUNOL, V170, P1374, DOI 10.4049/jimmunol.170.3.1374; Ariens RAS, 2002, BLOOD, V100, P743, DOI 10.1182/blood.V100.3.743; Bajzar L, 1996, J BIOL CHEM, V271, P16603, DOI 10.1074/jbc.271.28.16603; Banda NK, 2010, J IMMUNOL, V185, P5598, DOI 10.4049/jimmunol.1001564; Bereczky Z, 2007, THROMB RES, V120, P567, DOI 10.1016/j.thromres.2006.12.013; BLOMBACK B, 1978, NATURE, V275, P501, DOI 10.1038/275501a0; Carter AM, 2007, ARTERIOSCL THROM VAS, V27, P2783, DOI 10.1161/ATVBAHA.107.153221; Collet JP, 2006, ARTERIOSCL THROM VAS, V26, P2567, DOI 10.1161/01.ATV.0000241589.52950.4c; Collet JP, 2000, ARTERIOSCL THROM VAS, V20, P1354, DOI 10.1161/01.ATV.20.5.1354; Dobo J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020036; Dobo J, 2009, J IMMUNOL, V183, P1207, DOI 10.4049/jimmunol.0901141; Fatah K, 1996, THROMB HAEMOSTASIS, V76, P535; Gal P, 2007, IMMUNOBIOLOGY, V212, P267, DOI 10.1016/j.imbio.2006.11.002; Gulla KC, 2010, IMMUNOLOGY, V129, P482, DOI 10.1111/j.1365-2567.2009.03200.x; Hajela K, 2002, IMMUNOBIOLOGY, V205, P467, DOI 10.1078/0171-2985-00147; Hess K, 2012, DIABETOLOGI IN PRESS; Howes JM, 2012, DIAB VASC D IN PRESS; Jadhav MA, 2011, BBA-PROTEINS PROTEOM, V1814, P1955, DOI 10.1016/j.bbapap.2011.07.012; Kocsis A, 2010, J IMMUNOL, V185, P4169, DOI 10.4049/jimmunol.1001819; Kohler HP, 1998, THROMB HAEMOSTASIS, V80, P704; Krarup A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000623; Krarup A, 2008, BBA-PROTEINS PROTEOM, V1784, P1294, DOI 10.1016/j.bbapap.2008.03.020; La Bonte LR, 2012, J IMMUNOL, V188, P885, DOI 10.4049/jimmunol.1102916; Lim BCB, 2003, LANCET, V361, P1424, DOI 10.1016/S0140-6736(03)13135-2; Markiewski MM, 2007, TRENDS IMMUNOL, V28, P184, DOI 10.1016/j.it.2007.02.006; Megyeri M, 2009, J IMMUNOL, V183, P3409, DOI 10.4049/jimmunol.0900879; Mikkola H, 1997, BLOOD, V89, P1279, DOI 10.1182/blood.V89.4.1279; Moller-Kristensen M, 2007, INT IMMUNOL, V19, P141, DOI 10.1093/intimm/dxl131; Muszbek L, 2010, SEMIN THROMB HEMOST, V36, P18, DOI 10.1055/s-0030-1248721; Opal SM, 2000, CRIT CARE MED, V28, pS77, DOI 10.1097/00003246-200009001-00017; Presanis JS, 2004, MOL IMMUNOL, V40, P921, DOI 10.1016/j.molimm.2003.10.013; Ryan EA, 1999, BIOPHYS J, V77, P2813, DOI 10.1016/S0006-3495(99)77113-4; Schroeder V, 2010, J THROMB HAEMOST, V8, P2080, DOI 10.1111/j.1538-7836.2010.03966.x; Schwaeble WJ, 2011, P NATL ACAD SCI USA, V108, P7523, DOI 10.1073/pnas.1101748108; Speidl WS, 2011, J THROMB HAEMOST, V9, P428, DOI 10.1111/j.1538-7836.2010.04172.x; Takahashi K, 2011, IMMUNOBIOLOGY, V216, P96, DOI 10.1016/j.imbio.2010.02.005; Takahashi M, 2008, J IMMUNOL, V180, P6132, DOI 10.4049/jimmunol.180.9.6132; Takahashi M, 2010, J EXP MED, V207, P29, DOI 10.1084/jem.20090633; Terai I, 1997, CLIN EXP IMMUNOL, V110, P317; Thiel S, 2011, MOL IMMUNOL, V48, P1710, DOI 10.1016/j.molimm.2011.06.361; Trumbo TA, 2002, BIOCHEMISTRY-US, V41, P2859, DOI 10.1021/bi0157823; Weisel JW, 2004, BIOPHYS CHEM, V112, P267, DOI 10.1016/j.bpc.2004.07.029; Wolberg AS, 2007, BLOOD REV, V21, P131, DOI 10.1016/j.blre.2006.11.001	45	81	81	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35690	10.1371/journal.pone.0035690	http://dx.doi.org/10.1371/journal.pone.0035690			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536427	Green Submitted, Green Published, gold			2022-12-27	WOS:000305339200099
J	Li, LPH; Shiao, AS; Chen, KC; Lee, PL; Niddam, DM; Chang, SY; Hsieh, JC				Li, Lieber Po-Hung; Shiao, An-Suey; Chen, Kuang-Chao; Lee, Po-Lei; Niddam, David M.; Chang, Shyue-Yih; Hsieh, Jen-Chuen			Neuromagnetic Index of Hemispheric Asymmetry Prognosticating the Outcome of Sudden Hearing Loss	PLOS ONE			English	Article							AUDITORY CORTICAL RESPONSES; HEALTHY-SIDE DOMINANCE; UNILATERAL DEAFNESS; BRAIN-STEM; PLASTICITY; SYSTEM; CORTEX; INHIBITION; EXPERIENCE; RECOVERY	The longitudinal relationship between central plastic changes and clinical presentations of peripheral hearing impairment remains unknown. Previously, we reported a unique plastic pattern of "healthy-side dominance" in acute unilateral idiopathic sudden sensorineural hearing loss (ISSNHL). This study aimed to explore whether such hemispheric asymmetry bears any prognostic relevance to ISSNHL along the disease course. Using magnetoencephalography (MEG), interhemispheric differences in peak dipole amplitude and latency of N100m to monaural tones were evaluated in 21 controls and 21 ISSNHL patients at two stages: initial and fixed stage (1 month later). Dynamics/Prognostication of hemispheric asymmetry were assessed by the interplay between hearing level/hearing gain and ipsilateral/contralateral ratio (I/C) of N100m latency and amplitude. Healthy-side dominance of N100m amplitude was observed in ISSNHL initially. The pattern changed with disease process. There is a strong correlation between the hearing level at the fixed stage and initial I/C-amplitude on affected-ear stimulation in ISSNHL. The optimal cut-off value with the best prognostication effect for the hearing improvement at the fixed stage was an initial I/C-latency on affected-ear stimulation of 1.34 (between subgroups of complete and partial recovery) and an initial I/C-latency on healthy-ear stimulation of 0.76 (between subgroups of partial and no recovery), respectively. This study suggested that a dynamic process of central auditory plasticity can be induced by peripheral lesions. The hemispheric asymmetry at the initial stage bears an excellent prognostic potential for the treatment outcomes and hearing level at the fixed stage in ISSNHL. Our study demonstrated that such brain signature of central auditory plasticity in terms of both N100m latency and amplitude at defined time can serve as a prognostication predictor for ISSNHL. Further studies are needed to explore the long-term temporal scenario of auditory hemispheric asymmetry and to get better psychoacoustic correlates of pathological hemispheric asymmetry in ISSNHL.	[Li, Lieber Po-Hung; Niddam, David M.; Hsieh, Jen-Chuen] Taipei Vet Gen Hosp, Dept Med Res & Educ, Integrated Brain Res Lab, Taipei, Taiwan; [Li, Lieber Po-Hung; Chen, Kuang-Chao; Chang, Shyue-Yih] Cheng Hsin Gen Hosp, Dept Otolaryngol, Taipei, Taiwan; [Shiao, An-Suey] Taipei Vet Gen Hosp, Dept Otolaryngol, Taipei, Taiwan; [Li, Lieber Po-Hung; Shiao, An-Suey; Chen, Kuang-Chao; Chang, Shyue-Yih] Natl Yang Ming Univ, Fac Med, Taipei 112, Taiwan; [Niddam, David M.; Hsieh, Jen-Chuen] Natl Yang Ming Univ, Brain Res Ctr, Taipei 112, Taiwan; [Hsieh, Jen-Chuen] Natl Yang Ming Univ, Inst Brain Sci, Taipei 112, Taiwan; [Lee, Po-Lei] Natl Cent Univ, Dept Elect Engn, Tao Yuan, Taiwan	Taipei Veterans General Hospital; Cheng Hsin General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Central University	Hsieh, JC (corresponding author), Taipei Vet Gen Hosp, Dept Med Res & Educ, Integrated Brain Res Lab, Taipei, Taiwan.	jcbrain.hsieh@gmail.com	Niddam, David/AAB-1910-2022; Li, Lieber/AAG-7397-2022; Li, Lieber/AFL-7454-2022	Niddam, David/0000-0002-4488-9310; 	National Health Research Institute [NHRI-EX95-9332SI]; National Science Council (NSC) [97-2314-B-075-025]; National Yang-Ming University [100F117CY14]; Taipei Veterans General Hospital [V98C1-150, V99C1-184, V100C-189]; Cheng Hsin General Hospital of Taiwan [9943]	National Health Research Institute(National Health Research Institutes - Taiwan); National Science Council (NSC)(Ministry of Science and Technology, Taiwan); National Yang-Ming University; Taipei Veterans General Hospital(Taipei Veterans General Hospital); Cheng Hsin General Hospital of Taiwan	This work was supported by the National Health Research Institute (NHRI-EX95-9332SI), National Science Council (NSC 97-2314-B-075-025), National Yang-Ming University (100F117CY14), Taipei Veterans General Hospital (V98C1-150, V99C1-184, V100C-189), and Cheng Hsin General Hospital (9943) of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BYL FM, 1984, LARYNGOSCOPE, V94, P647; Dijkhuizen RM, 2003, J NEUROSCI, V23, P510, DOI 10.1523/JNEUROSCI.23-02-00510.2003; Durham D, 2000, HEARING RES, V147, P145, DOI 10.1016/S0378-5955(00)00128-3; Fetterman BL, 1996, AM J OTOL, V17, P529; Fujiki N, 1998, NEUROREPORT, V9, P3129, DOI 10.1097/00001756-199810050-00002; GSTOETTNER W, 1992, EUR ARCH OTO-RHINO-L, V249, P253, DOI 10.1007/BF00714487; Harada T, 1996, BRIT J AUDIOL, V30, P363, DOI 10.3109/03005369609078423; HARI R, 1988, EXP BRAIN RES, V71, P87; Hirano Koji, 1999, Auris Nasus Larynx, V26, P111, DOI 10.1016/S0385-8146(98)00072-8; Hoth S, 2005, EUR ARCH OTO-RHINO-L, V262, P217, DOI 10.1007/s00405-004-0797-x; Hsieh JC, 2002, ANN NEUROL, V51, P381, DOI 10.1002/ana.10149; Illing RB, 2006, HEARING RES, V216, P189, DOI 10.1016/j.heares.2005.12.014; JACOBSON GP, 1994, J CLIN NEUROPHYSIOL, V11, P343, DOI 10.1097/00004691-199405000-00005; Kanno A, 2000, NEUROSCI LETT, V293, P187, DOI 10.1016/S0304-3940(00)01525-1; Li LPH, 2006, EUR J NEUROSCI, V24, P937, DOI 10.1111/j.1460-9568.2006.04961.x; Li LPH, 2003, ANN NEUROL, V53, P810, DOI 10.1002/ana.10599; Mamak Aydin, 2005, Ear Nose Throat J, V84, P641; Morita T, 2007, NEUROSCI RES, V58, P6, DOI 10.1016/j.neures.2007.01.010; Mossop JE, 2000, HEARING RES, V147, P183, DOI 10.1016/S0378-5955(00)00054-X; MURAI K, 1994, ACTA OTO-LARYNGOL, P17; Narozny W, 2006, ANN OTO RHINOL LARYN, V115, P553, DOI 10.1177/000348940611500710; Ochi K, 2003, LARYNGOSCOPE, V113, P427, DOI 10.1097/00005537-200303000-00007; PEKKONEN E, 1995, NEUROREPORT, V6, P1803, DOI 10.1097/00001756-199509000-00023; Ponton CW, 2001, HEARING RES, V154, P32, DOI 10.1016/S0378-5955(01)00214-3; Sato K, 2000, HEARING RES, V147, P137, DOI 10.1016/S0378-5955(00)00127-1; Scheffler K, 1998, CEREB CORTEX, V8, P156, DOI 10.1093/cercor/8.2.156; Suzuki M, 2002, NEUROREPORT, V13, P1829, DOI 10.1097/00001756-200210070-00029; VASAMA JP, 1994, HEARING RES, V78, P91, DOI 10.1016/0378-5955(94)90047-7; WILSON WR, 1980, ARCH OTOLARYNGOL, V106, P772; Woldorff MG, 1999, HUM BRAIN MAPP, V7, P49, DOI 10.1002/(SICI)1097-0193(1999)7:1<49::AID-HBM5>3.3.CO;2-A	30	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35055	10.1371/journal.pone.0035055	http://dx.doi.org/10.1371/journal.pone.0035055			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22532839	Green Published, gold			2022-12-27	WOS:000305339200035
J	Martin, LJ; Gupta, J; Jyothula, SSSK; Kovacic, MB; Myers, JMB; Patterson, TL; Ericksen, MB; He, H; Gibson, AM; Baye, TM; Amirisetty, S; Tsoras, AM; Sha, YB; Eissa, NT; Hershey, GKK				Martin, Lisa J.; Gupta, Jayanta; Jyothula, Soma S. S. K.; Kovacic, Melinda Butsch; Myers, Jocelyn M. Biagini; Patterson, Tia L.; Ericksen, Mark B.; He, Hua; Gibson, Aaron M.; Baye, Tesfaye M.; Amirisetty, Sushil; Tsoras, Anna M.; Sha, Youbao; Eissa, N. Tony; Hershey, Gurjit K. Khurana			Functional Variant in the Autophagy-Related 5 Gene Promotor is Associated with Childhood Asthma	PLOS ONE			English	Article							ALLERGIC DISEASES; NASAL; RISK; IMMUNOLOGY; EXPRESSION; LOCI; SNP	Rationale and Objective: Autophagy is a cellular process directed at eliminating or recycling cellular proteins. Recently, the autophagy pathway has been implicated in immune dysfunction, the pathogenesis of inflammatory disorders, and response to viral infection. Associations between two genes in the autophagy pathway, ATG5 and ATG7, with childhood asthma were investigated. Methods: Using genetic and experimental approaches, we examined the association of 13 HapMap-derived tagging SNPs in ATG5 and ATG7 with childhood asthma in 312 asthmatic and 246 non-allergic control children. We confirmed our findings by using independent cohorts and imputation analysis. Finally, we evaluated the functional relevance of a disease associated SNP. Measurements and Main Results: We demonstrated that ATG5 single nucleotide polymorphisms rs12201458 and rs510432 were associated with asthma (p = 0.00085 and 0.0025, respectively). In three independent cohorts, additional variants in ATG5 in the same LD block were associated with asthma (p<0.05). We found that rs510432 was functionally relevant and conferred significantly increased promotor activity. Furthermore, Atg5 expression was increased in nasal epithelium of acute asthmatics compared to stable asthmatics and non-asthmatic controls. Conclusion: Genetic variants in ATG5, including a functional promotor variant, are associated with childhood asthma. These results provide novel evidence for a role for ATG5 in childhood asthma.	[Martin, Lisa J.; Gupta, Jayanta; Kovacic, Melinda Butsch; Myers, Jocelyn M. Biagini; Patterson, Tia L.; Ericksen, Mark B.; He, Hua; Gibson, Aaron M.; Baye, Tesfaye M.; Amirisetty, Sushil; Tsoras, Anna M.; Hershey, Gurjit K. Khurana] Univ Cincinnati, Dept Pediat, Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45221 USA; [Jyothula, Soma S. S. K.; Sha, Youbao; Eissa, N. Tony] Baylor Coll Med, Dept Med, Houston, TX 77030 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Baylor College of Medicine	Hershey, GKK (corresponding author), Univ Cincinnati, Dept Pediat, Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45221 USA.	Gurjit.Khurana.Hershey@cchmc.org	Martin, Lisa/E-2425-2016; Jyothula, Soma S.S.K/AAJ-2911-2020	Martin, Lisa/0000-0001-8702-9946; Jyothula, Soma S.S.K/0000-0002-8837-7878; Biagini, Jocelyn/0000-0002-4378-6133	National Institutes of Health [U19 AI070235, U19 AI07041209]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI070235] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by National Institutes of Health grants U19 AI070235 (GKKH and LJM) and U19 AI07041209 (NTE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1987, AM REV RESPIR DIS, V136, P225; Baye TM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016522; Binia A, 2011, J HUM GENET, V56, P97, DOI 10.1038/jhg.2010.134; Bloom B, 2010, HYATTSVILLE VITAL HL, P1; Braunstahl GJ, 2001, J ALLERGY CLIN IMMUN, V107, P469, DOI 10.1067/mai.2001.113046; Braunstahl GJ, 2001, AM J RESP CRIT CARE, V164, P858, DOI 10.1164/ajrccm.164.5.2006082; Butsch Kovacic M, 2011, PLOS ONE IN PRESS; Chen ZH, 2010, P NATL ACAD SCI US; Chen ZH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003316; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Eder W, 2006, NEW ENGL J MED, V355, P2226, DOI 10.1056/NEJMra054308; Gaga M, 2000, CLIN EXP ALLERGY, V30, P663; Guajardo JR, 2005, J ALLERGY CLIN IMMUN, V115, P243, DOI 10.1016/j.jaci.2004.10.032; Guevin C, 2010, VIROLOGY, V405, P1, DOI 10.1016/j.virol.2010.05.032; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hussey S, 2009, SEMIN IMMUNOL, V21, P233, DOI 10.1016/j.smim.2009.05.004; Inoue D, 2011, BIOCHEM BIOPH RES CO, V405, P13, DOI 10.1016/j.bbrc.2010.12.092; Jounai N, 2007, P NATL ACAD SCI USA, V104, P14050, DOI 10.1073/pnas.0704014104; Kay AB, 2001, NEW ENGL J MED, V344, P30, DOI 10.1056/NEJM200101043440106; Kay AB, 2001, NEW ENGL J MED, V344, P109, DOI 10.1056/NEJM200101113440206; Lee HK, 2010, IMMUNITY, V32, P227, DOI 10.1016/j.immuni.2009.12.006; Lee N, 2009, J INFECT DIS, V200, P492, DOI 10.1086/600383; Litonjua AA, 1998, AM J RESP CRIT CARE, V158, P176, DOI 10.1164/ajrccm.158.1.9710014; Miller BC, 2008, AUTOPHAGY, V4, P309, DOI 10.4161/auto.5474; Naclerio RM, 1998, J ALLERGY CLIN IMMUN, V101, pS345, DOI 10.1016/S0091-6749(98)70217-9; Nothnagel M, 2009, HUM GENET, V125, P163, DOI 10.1007/s00439-008-0606-5; Orvedahl A, 2010, CELL HOST MICROBE, V7, P115, DOI 10.1016/j.chom.2010.01.007; Poon A, 2011, CURR OPIN ALLERGY CL, V11, P407, DOI 10.1097/ACI.0b013e32834a9540; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Ryter SW, 2011, AUTOPHAGY, V7, P436, DOI 10.4161/auto.7.4.14501; TOGIAS A, 1988, J ALLERGY CLIN IMMUN, V81, P782, DOI 10.1016/0091-6749(88)90932-3; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Willis-Owen SAG, 2009, J ALLERGY CLIN IMMUN, V123, P14, DOI 10.1016/j.jaci.2008.09.016; Woo D, 2002, STROKE, V33, P1190, DOI 10.1161/01.STR.0000014774.88027.22; Yousefi S, 2006, NAT CELL BIOL, V8, P1124, DOI 10.1038/ncb1482; Yuan HY, 2006, NUCLEIC ACIDS RES, V34, pW635, DOI 10.1093/nar/gkl236; Zhang J, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-4	38	125	130	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e33454	10.1371/journal.pone.0033454	http://dx.doi.org/10.1371/journal.pone.0033454			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536318	gold, Green Published, Green Submitted			2022-12-27	WOS:000305339200006
J	Merrins, MJ; Bertram, R; Sherman, A; Satin, LS				Merrins, Matthew J.; Bertram, Richard; Sherman, Arthur; Satin, Leslie S.			Phosphofructo-2-kinase/Fructose-2,6-bisphosphatase Modulates Oscillations of Pancreatic Islet Metabolism	PLOS ONE			English	Article							LIVER 6-PHOSPHOFRUCTO-2-KINASE FRUCTOSE-2,6-BISPHOSPHATASE; SITE-DIRECTED MUTAGENESIS; PULSATILE INSULIN-SECRETION; FRUCTOSE 2,6-BISPHOSPHATE; GLUCOSE-METABOLISM; CRYSTAL-STRUCTURE; GLYCOLYTIC OSCILLATIONS; BETA-CELLS; MUSCLE PHOSPHOFRUCTOKINASE; LIVING CELLS	Pulses of insulin from pancreatic beta-cells help maintain blood glucose in a narrow range, although the source of these pulses is unclear. It has been proposed that a positive feedback circuit exists within the glycolytic pathway, the autocatalytic activation of phosphofructokinase-1 (PFK1), which endows pancreatic beta-cells with the ability to generate oscillations in metabolism. Flux through PFK1 is controlled by the bifunctional enzyme PFK2/FBPase2 (6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase) in two ways: via (1) production/degradation of fructose-2,6-bisphosphate (Fru2,6-BP), a potent allosteric activator of PFK1, as well as (2) direct activation of glucokinase due to a protein-protein interaction. In this study, we used a combination of live-cell imaging and mathematical modeling to examine the effects of inducibly-expressed PFK2/FBPase2 mutants on glucose-induced Ca2+ pulsatility in mouse islets. Irrespective of the ability to bind glucokinase, mutants of PFK2/FBPase2 that increased the kinase: phosphatase ratio reduced the period and amplitude of Ca2+ oscillations. Mutants which reduced the kinase: phosphatase ratio had the opposite effect. These results indicate that the main effect of the bifunctional enzyme on islet pulsatility is due to Fru2,6-BP alteration of the threshold for autocatalytic activation of PFK1 by Fru1,6-BP. Using computational models based on PFK1-generated islet oscillations, we then illustrated how moderate elevation of Fru-2,6-BP can increase the frequency of glycolytic oscillations while reducing their amplitude, with sufficiently high activation resulting in termination of slow oscillations. The concordance we observed between PFK2/FBPase2-induced modulation of islet oscillations and the models of PFK1-driven oscillations furthermore suggests that metabolic oscillations, like those found in yeast and skeletal muscle, are shaped early in glycolysis.	[Merrins, Matthew J.; Satin, Leslie S.] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Merrins, Matthew J.; Satin, Leslie S.] Univ Michigan, Brehm Diabet Ctr, Ann Arbor, MI 48109 USA; [Bertram, Richard] Florida State Univ, Dept Math, Tallahassee, FL 32306 USA; [Bertram, Richard] Florida State Univ, Program Neurosci, Tallahassee, FL 32306 USA; [Bertram, Richard] Florida State Univ, Program Mol Biophys, Tallahassee, FL 32306 USA; [Sherman, Arthur] NIDDKD, Lab Biol Modeling, NIH, Bethesda, MD 20892 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; State University System of Florida; Florida State University; State University System of Florida; Florida State University; State University System of Florida; Florida State University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Merrins, MJ (corresponding author), Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA.	mmerrins@umich.edu	Bertram, Richard/ABI-5859-2020	Sherman, Arthur/0000-0002-8372-5941; Merrins, Matthew J./0000-0003-1599-9227	National Institutes of Health [F32DK085960, R01DK46409]; National Science Foundation [NSF-DMS0917664]; NIH/NIDDK; Michigan Diabetes Research and Training Center (MDRTC) Morphology and Image Analysis Core [DK20572]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572, ZIADK013027, R01DK046409, P60DK020572, F32DK085960] Funding Source: NIH RePORTER; Division Of Mathematical Sciences [0917664] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Michigan Diabetes Research and Training Center (MDRTC) Morphology and Image Analysis Core; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Division Of Mathematical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by the National Institutes of Health (F32DK085960 to MJM, R01DK46409 to LS), the National Science Foundation (NSF-DMS0917664 to RB), and the NIH/NIDDK Intramural Research Program (AS). Additional support was provided by the Michigan Diabetes Research and Training Center (MDRTC) Morphology and Image Analysis Core (DK20572). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arden C, 2008, BIOCHEM J, V411, P41, DOI 10.1042/BJ20070962; Baltrusch S, 2001, J BIOL CHEM, V276, P43915, DOI 10.1074/jbc.M105470200; Baltrusch S, 2006, ENDOCRINOLOGY, V147, P5768, DOI 10.1210/en.2006-0694; Banaszynski LA, 2006, CELL, V126, P995, DOI 10.1016/j.cell.2006.07.025; Beemiller P, 2006, PLOS BIOL, V4, P987, DOI 10.1371/journal.pbio.0040162; Bertram R, 2004, BIOPHYS J, V87, P3074, DOI 10.1529/biophysj.104.049262; Bertram R, 2007, AM J PHYSIOL-ENDOC M, V293, pE890, DOI 10.1152/ajpendo.00359.2007; Bertram R, 2007, BIOPHYS J, V92, P1544, DOI 10.1529/biophysj.106.097154; Boada J, 2000, FEBS LETT, V480, P261, DOI 10.1016/S0014-5793(00)01950-5; BRATUSCHMARRAIN PR, 1986, DIABETES, V35, P922, DOI 10.2337/diabetes.35.8.922; BURCH PT, 1985, DIABETES, V34, P1014, DOI 10.2337/diabetes.34.10.1014; ELMAGHRABI MR, 1987, J BIOL CHEM, V262, P11714; FOE LG, 1983, BIOCHEMISTRY-US, V22, P4601, DOI 10.1021/bi00288a039; Garcia-Herrero CM, 2007, DIABETOLOGIA, V50, P325, DOI 10.1007/s00125-006-0542-7; GILON P, 1993, J BIOL CHEM, V268, P22265; Gopel S, 1999, J PHYSIOL-LONDON, V521, P717, DOI 10.1111/j.1469-7793.1999.00717.x; Hasemann CA, 1996, STRUCTURE, V4, P1017, DOI 10.1016/S0969-2126(96)00109-8; Hoppe A, 2002, BIOPHYS J, V83, P3652, DOI 10.1016/S0006-3495(02)75365-4; HUE L, 1987, BIOCHEM J, V245, P313, DOI 10.1042/bj2450313; Jung SK, 2000, J BIOL CHEM, V275, P6642, DOI 10.1074/jbc.275.9.6642; KEIZER J, 1989, BIOPHYS J, V56, P229, DOI 10.1016/S0006-3495(89)82669-4; KURLAND IJ, 1992, J BIOL CHEM, V267, P4416; LANG DA, 1979, NEW ENGL J MED, V301, P1023, DOI 10.1056/NEJM197911083011903; Langer S, 2010, MOL ENDOCRINOL, V24, P1988, DOI 10.1210/me.2010-0115; Lee YH, 1997, NAT STRUCT BIOL, V4, P615, DOI 10.1038/nsb0897-615; Lee YH, 1996, BIOCHEMISTRY-US, V35, P6010, DOI 10.1021/bi9600613; Luciani DS, 2006, J PHYSIOL-LONDON, V572, P379, DOI 10.1113/jphysiol.2005.101766; MacDonald MJ, 2003, J BIOL CHEM, V278, P51894, DOI 10.1074/jbc.M309038200; MALAISSE WJ, 1982, DIABETES, V31, P90, DOI 10.2337/diabetes.31.1.90; Massa L, 2004, DIABETES, V53, P1020, DOI 10.2337/diabetes.53.4.1020; Matschinsky FM, 1996, DIABETES, V45, P223, DOI 10.2337/diabetes.45.2.223; Meier JJ, 2005, DIABETES, V54, P1649, DOI 10.2337/diabetes.54.6.1649; Menge BA, 2011, DIABETES, V60, P2160, DOI 10.2337/db11-0251; Merrins MJ, 2010, BIOPHYS J, V99, P76, DOI 10.1016/j.bpj.2010.04.012; Nilsson T, 1996, BIOCHEM J, V314, P91, DOI 10.1042/bj3140091; Nunemaker CS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008428; Nunemaker CS, 2005, DIABETES, V54, P3517, DOI 10.2337/diabetes.54.12.3517; ORAHILLY S, 1988, NEW ENGL J MED, V318, P1225, DOI 10.1056/NEJM198805123181902; Perez JX, 2000, AM J PHYSIOL-CELL PH, V279, pC1359, DOI 10.1152/ajpcell.2000.279.5.C1359; Richard P, 2003, FEMS MICROBIOL REV, V27, P547, DOI 10.1016/S0168-6445(03)00065-2; Sakurai T, 1996, BIOCHEM BIOPH RES CO, V218, P159, DOI 10.1006/bbrc.1996.0028; SENER A, 1984, BIOCHEM J, V221, P759, DOI 10.1042/bj2210759; Smith WE, 2007, MOL ENDOCRINOL, V21, P1478, DOI 10.1210/me.2006-0356; SMOLEN P, 1995, J THEOR BIOL, V174, P137, DOI 10.1006/jtbi.1995.0087; TAULER A, 1988, P NATL ACAD SCI USA, V85, P6642, DOI 10.1073/pnas.85.18.6642; TAULER A, 1990, J BIOL CHEM, V265, P15617; TORNHEIM K, 1979, J THEOR BIOL, V79, P491, DOI 10.1016/0022-5193(79)90240-6; TORNHEIM K, 1988, J BIOL CHEM, V263, P2619; Tornheim K, 1997, DIABETES, V46, P1375, DOI 10.2337/diabetes.46.9.1375; Vertommen D, 1996, J BIOL CHEM, V271, P17875, DOI 10.1074/jbc.271.30.17875; Westermark PO, 2003, BIOPHYS J, V85, P126, DOI 10.1016/S0006-3495(03)74460-9; Wu CD, 2002, AM J PHYSIOL-ENDOC M, V282, pE38, DOI 10.1152/ajpendo.2002.282.1.E38; Wu CD, 2006, AM J PHYSIOL-ENDOC M, V291, pE536, DOI 10.1152/ajpendo.00126.2006; YANEY GC, 1995, DIABETES, V44, P1285, DOI 10.2337/diabetes.44.11.1285; Yuen MH, 1999, J BIOL CHEM, V274, P2176, DOI 10.1074/jbc.274.4.2176	55	20	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e34036	10.1371/journal.pone.0034036	http://dx.doi.org/10.1371/journal.pone.0034036			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22532827	gold, Green Published, Green Submitted			2022-12-27	WOS:000305339200009
J	Machida, RJ; Kweskin, M; Knowlton, N				Machida, Ryuji J.; Kweskin, Matthew; Knowlton, Nancy			PCR Primers for Metazoan Mitochondrial 12S Ribosomal DNA Sequences	PLOS ONE			English	Article							RNA GENE; DIVERSITY	Background: Assessment of the biodiversity of communities of small organisms is most readily done using PCR-based analysis of environmental samples consisting of mixtures of individuals. Known as metagenetics, this approach has transformed understanding of microbial communities and is beginning to be applied to metazoans as well. Unlike microbial studies, where analysis of the 16S ribosomal DNA sequence is standard, the best gene for metazoan metagenetics is less clear. In this study we designed a set of PCR primers for the mitochondrial 12S ribosomal DNA sequence based on 64 complete mitochondrial genomes and then tested their efficacy. Methodology/Principal Findings: A total of the 64 complete mitochondrial genome sequences representing all metazoan classes available in GenBank were downloaded using the NCBI Taxonomy Browser. Alignment of sequences was performed for the excised mitochondrial 12S ribosomal DNA sequences, and conserved regions were identified for all 64 mitochondrial genomes. These regions were used to design a primer pair that flanks a more variable region in the gene. Then all of the complete metazoan mitochondrial genomes available in NCBI's Organelle Genome Resources database were used to determine the percentage of taxa that would likely be amplified using these primers. Results suggest that these primers will amplify target sequences for many metazoans. Conclusions/Significance: Newly designed 12S ribosomal DNA primers have considerable potential for metazoan metagenetic analysis because of their ability to amplify sequences from many metazoans.	[Machida, Ryuji J.; Kweskin, Matthew; Knowlton, Nancy] Smithsonian Inst, Natl Museum Nat Hist, Washington, DC 20560 USA	Smithsonian Institution; Smithsonian National Museum of Natural History	Machida, RJ (corresponding author), Acad Sinica, Biodivers Res Ctr, Taipei 115, Taiwan.	ryujimachida@gate.sinica.edu.tw		Kweskin, Matthew/0000-0002-1885-0930	Alfred P. Sloan Foundation; Sant Chair of Marine Science	Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Sant Chair of Marine Science	Financial support was provided by the Alfred P. Sloan Foundation and the Sant Chair of Marine Science discretionary funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral-Zettler LA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006372; Bottger-Schnack R, 2011, HYDROBIOLOGIA, V666, P111, DOI 10.1007/s10750-010-0094-1; Bru D, 2008, APPL ENVIRON MICROB, V74, P1660, DOI 10.1128/AEM.02403-07; Committee on Metagenomics National Research Council, 2007, CHALL FUNCT APPL NEW, P170; Costello MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012110; Creer S, 2010, MOL ECOL, V19, P4, DOI 10.1111/j.1365-294X.2009.04473.x; Fonseca VG, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1095; Gibson JF, 2010, MOL PHYLOGENET EVOL, V56, P91, DOI 10.1016/j.ympev.2010.03.026; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; HILLIS DM, 1991, Q REV BIOL, V66, P411, DOI 10.1086/417338; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li J, 2010, PARASITOL RES, V107, P561, DOI 10.1007/s00436-010-1895-x; Machida RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010278; Maddison D. R., 2000, MACCLADE 4 ANAL PHYL; Makowsky R, 2010, MOL PHYLOGENET EVOL, V57, P485, DOI 10.1016/j.ympev.2010.05.009; McIntyre A., 2010, LIFE WORLDS OCEANS D; Mueller RL, 2006, SYST BIOL, V55, P289, DOI 10.1080/10635150500541672; Pawlowski DR, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017585, 10.1371/journal.pone.0018169]; Schindel DE, 2005, NATURE, V435, P17, DOI 10.1038/435017b; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Snelgrove PVR, 2010, DISCOVERIES CENSUS M, P286; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; van der Kuyl AC, 2002, MOL PHYLOGENET EVOL, V22, P174, DOI 10.1006/mpev.2001.1052	24	19	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e35887	10.1371/journal.pone.0035887	http://dx.doi.org/10.1371/journal.pone.0035887			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22536450	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336200070
J	Benavides, VC; Mallela, MK; Booth, CJ; Wendler, CC; Rivkees, SA				Benavides, Valeria C.; Mallela, Murali K.; Booth, Carmen J.; Wendler, Christopher C.; Rivkees, Scott A.			Propylthiouracil Is Teratogenic in Murine Embryos	PLOS ONE			English	Article							PRENATAL METHIMAZOLE EXPOSURE; ANTITHYROID DRUGS; GRAVES-DISEASE; MATERNAL HYPERTHYROIDISM; PREGNANCY; MANAGEMENT; HYPOTHYROIDISM; CARBIMAZOLE; DEFECTS; THERAPY	Background: Hyperthyroidism during pregnancy is treated with the antithyroid drugs (ATD) propylthiouracil (PTU) and methimazole (MMI). PTU currently is recommended as the drug of choice during early pregnancy. Yet, despite widespread ATD use in pregnancy, formal studies of ATD teratogenic effects have not been performed. Methods: We examined the teratogenic effects of PTU and MMI during embryogenesis in mice. To span different periods of embryogenesis, dams were treated with compounds or vehicle daily from embryonic day (E) 7.5 to 9.5 or from E3.5 to E7.5. Embryos were examined for gross malformations at E10.5 or E18.5 followed by histological and micro-CT analysis. Influences of PTU on gene expression levels were examined by RNA microarray analysis. Results: When dams were treated from E7.5 to E9.5 with PTU, neural tube and cardiac abnormalities were observed at E10.5. Cranial neural tube defects were significantly more common among the PTU-exposed embryos than those exposed to MMI or vehicle. Blood in the pericardial sac, which is a feature indicative of abnormal cardiac function and/or abnormal vasculature, was observed more frequently in PTU-treated than MMI-treated or vehicle-treated embryos. Following PTU treatment, a total of 134 differentially expressed genes were identified. Disrupted genetic pathways were those associated with cytoskeleton remodeling and keratin filaments. At E 18.5, no gross malformations were evident in either ATD group, but the number of viable PTU embryos per dam at E18.5 was significantly lower from those at E10.5, indicating loss of malformed embryos. These data show that PTU exposure during embryogenesis is associated with delayed neural tube closure and cardiac abnormalities. In contrast, we did not observe structural or cardiac defects associated with MMI exposure except at the higher dose. We find that PTU exposure during embryogenesis is associated with fetal loss. These observations suggest that PTU has teratogenic potential.	[Benavides, Valeria C.; Mallela, Murali K.; Wendler, Christopher C.; Rivkees, Scott A.] Yale Univ, Sch Med, Yale Pediat Thyroid Ctr, Sect Dev Endocrinol & Biol,Dept Pediat, New Haven, CT 06520 USA; [Booth, Carmen J.] Yale Univ, Sch Med, Comparat Med Sect, New Haven, CT 06510 USA; [Mallela, Murali K.; Wendler, Christopher C.; Rivkees, Scott A.] Univ Florida, Dept Pediat, Gainesville, FL USA	Yale University; Yale University; State University System of Florida; University of Florida	Benavides, VC (corresponding author), Yale Univ, Sch Med, Yale Pediat Thyroid Ctr, Sect Dev Endocrinol & Biol,Dept Pediat, New Haven, CT 06520 USA.	srivkees@ufl.edu			National Institutes of Health [RO1HD065200]; Endocrine Fellows Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD065200] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000064] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Endocrine Fellows Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by National Institutes of Health grant RO1HD065200 to SAR and an award from the Endocrine Fellows Foundation to VB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abalovich M, 2007, J CLIN ENDOCR METAB, V92, pS1, DOI 10.1210/jc.2007-0141; [Anonymous], 2000, GUID DEV TOX STUD; [Anonymous], NATL VITAL STAT REPO; Aramaki M, 2005, AM J MED GENET A, V139A, P156, DOI 10.1002/ajmg.a.30917; Bahn Rebecca S, 2009, Thyroid, V19, P673, DOI 10.1089/thy.2009.0169; Barbero P, 2004, AM J MED GENET A, V129A, P83, DOI 10.1002/ajmg.a.20668; Barbero P, 2008, AM J MED GENET A, V146A, P2390, DOI 10.1002/ajmg.a.32497; Blidda S, 2011, THYROID, V21, P75, DOI 10.1089/thy.2010.0286; Bliddal S, 2011, NAT REV ENDOCRINOL, V7, P396, DOI 10.1038/nrendo.2011.34; Briggs GG, 2005, PROPYLTHIOURACIL DRU, P1365; Calikoglu AS, 1996, NEUROSCI LETT, V213, P132; Chan GW, 2007, NAT CLIN PRACT ENDOC, V3, P470, DOI 10.1038/ncpendmet0508; Chattaway JM, 2007, ANN PHARMACOTHER, V41, P1018, DOI 10.1345/aph.1H535; Clark SM, 2006, THER DRUG MONIT, V28, P477, DOI 10.1097/00007691-200608000-00001; Clementi M, 2010, J CLIN ENDOCR METAB, V95, pE337, DOI 10.1210/jc.2010-0652; Cooper DS, 2005, NEW ENGL J MED, V352, P905, DOI 10.1056/NEJMra042972; Cooper DS, 2003, LANCET, V362, P459, DOI 10.1016/S0140-6736(03)14073-1; Cunningham AR, 2009, INT J PEDIATR ENDOCR, DOI 10.1155/2009/936154; De Felice Mario, 2007, V10, P1, DOI 10.1159/000106814; Di Gianantonio E, 2001, TERATOLOGY, V64, P262, DOI 10.1002/tera.1072; Diav-Citrin O, 2002, TERATOLOGY, V65, P38, DOI 10.1002/tera.1095.abs; Feldt-Rasmussen U, 2011, J THROID RES, V2011, DOI 10.4061/2011/598712; Gittenberger-De Groot AC, 2005, PEDIATR RES, V57, P169, DOI 10.1203/01.PDR.0000148710.69159.61; GOLDEY ES, 1995, TOXICOL APPL PHARM, V135, P67, DOI 10.1006/taap.1995.1209; GREENMAN GW, 1962, NEW ENGL J MED, V267, P426, DOI 10.1056/NEJM196208302670902; Griffin CT, 2001, SCIENCE, V293, P1666, DOI 10.1126/science.1061259; HERBST AL, 1965, NEW ENGL J MED, V273, P627, DOI 10.1056/NEJM196509162731203; Kaufman M.H., 1992, ATLAS MOUSE DEV; Koren G, 2006, THER DRUG MONIT, V28, P12, DOI 10.1097/01.ftd.0000192135.54477.d9; KREMENTZ ET, 1957, SURGERY, V41, P619; Laurberg P, 2009, EUR J ENDOCRINOL, V160, P1, DOI 10.1530/EJE-08-0663; Luna LG, 1968, MANUAL HISTOLOGIC ST, V3; Luton D, 2005, J CLIN ENDOCR METAB, V90, P6093, DOI 10.1210/jc.2004-2555; MANDEL SJ, 1994, THYROID, V4, P129, DOI 10.1089/thy.1994.4.129; Mandel SR, 2001, J CLIN ENDOCR METAB, V86, P2354, DOI 10.1210/jc.86.6.2354; MOMOTANI N, 1984, CLIN ENDOCRINOL, V20, P695, DOI 10.1111/j.1365-2265.1984.tb00119.x; de Escobar GM, 2008, SEMIN PERINATOL, V32, P380, DOI 10.1053/j.semperi.2008.09.002; Mortimer RH, 1997, J CLIN ENDOCR METAB, V82, P3099, DOI 10.1210/jc.82.9.3099; MUJTABA Q, 1975, OBSTET GYNECOL, V46, P282; Nucera C, 2010, J CELL MOL MED, V14, P2417, DOI 10.1111/j.1582-4934.2009.00947.x; Ohta K, 2007, CLIN NEPHROL, V68, P315; Olson EN, 2004, NAT MED, V10, P467, DOI 10.1038/nm0504-467; Patil-Sisodia K, 2010, ENDOCR PRACT, V16, P118, DOI 10.4158/EP09233.RA; Pearce SHS, 2004, CLIN ENDOCRINOL, V61, P589, DOI 10.1111/j.1365-2265.2004.02135.x; Rivkees SA, 2010, HORM RES PAEDIAT, V74, P305, DOI 10.1159/000320028; Rivkees SA, 2009, INT J PEDIATR ENDOCR, DOI 10.1155/2009/132041; SCHARDEIN JL, 1985, ENVIRON HEALTH PERSP, V61, P55, DOI 10.2307/3430062; STANISSTREET M, 1990, TERATOLOGY, V41, P721, DOI 10.1002/tera.1420410609; VANDIJKE CP, 1987, ANN INTERN MED, V106, P60, DOI 10.7326/0003-4819-106-1-60; Weetman AP, 2003, HORM RES, V59, P114, DOI 10.1159/000067837; WING DA, 1994, AM J OBSTET GYNECOL, V170, P90; ZOLCINSKI A, 1964, Ginekol Pol, V35, P593	52	17	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35213	10.1371/journal.pone.0035213	http://dx.doi.org/10.1371/journal.pone.0035213			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529993	gold, Green Published, Green Submitted			2022-12-27	WOS:000305350600068
J	Li, HY; Zheng, XM; Che, MX; Hu, HY				Li, Hai-Yin; Zheng, Xue-Ming; Che, Mei-Xia; Hu, Hong-Yu			A Redox-Sensitive Luciferase Assay for Determining the Localization and Topology of Endoplasmic Reticulum Proteins	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; GAUSSIA LUCIFERASE; SECRETORY PATHWAY; QUALITY-CONTROL; DEGRADATION; STRESS; DOMAIN	Correct localization and transmembrane topology are crucial for the proteins residing and functioning in the endoplasmic reticulum (ER). We have developed a rapid and convenient assay, based on the redox-sensitive luciferase from Gaussia princeps (Gluc) and green fluorescence protein (GFP), to determine the localization or topology of ER proteins. Using the tandem Gluc-GFP reporter fused to different positions of a target protein, we successfully characterized the topologies of two ER transmembrane proteins Herp and HRD1 that are involved in the ER quality control system. This assay method may also be applicable to the proteins in secretory pathway, plasma membrane, and other compartments of cells.	[Li, Hai-Yin; Zheng, Xue-Ming; Che, Mei-Xia; Hu, Hong-Yu] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Li, HY (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai, Peoples R China.	hyhu@sibs.ac.cn	Che, Meixia/Q-2119-2019	Che, Meixia/0000-0002-4515-1414	National Basic Research Program of China [2012CB911003]; National Natural Science Foundation of China [30870485]; Sino-Swiss Joint Research Projects [GJHZ0909]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sino-Swiss Joint Research Projects	This work was supported by grants from the National Basic Research Program of China (2012CB911003), the National Natural Science Foundation of China (30870485), and the Sino-Swiss Joint Research Projects (GJHZ0909). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badr CE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000571; Becker T, 2009, SCIENCE, V326, P1369, DOI 10.1126/science.1178535; Bernasconi R, 2010, J CELL BIOL, V188, P223, DOI 10.1083/jcb.200910042; Brach T, 2009, PLANT J, V57, P534, DOI 10.1111/j.1365-313X.2008.03704.x; Buchberger A, 2010, MOL CELL, V40, P238, DOI 10.1016/j.molcel.2010.10.001; Dayel MJ, 1999, BIOPHYS J, V76, P2843, DOI 10.1016/S0006-3495(99)77438-2; Deak PM, 2001, J BIOL CHEM, V276, P10663, DOI 10.1074/jbc.M008608200; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Inouye S, 2008, BIOCHEM BIOPH RES CO, V365, P96, DOI 10.1016/j.bbrc.2007.10.152; Kokame K, 2000, J BIOL CHEM, V275, P32846, DOI 10.1074/jbc.M002063200; Laudon H, 2005, J BIOL CHEM, V280, P35352, DOI 10.1074/jbc.M507217200; Lohman JR, 2008, BIOCHEMISTRY-US, V47, P8678, DOI 10.1021/bi800498g; Lorenz H, 2006, NAT METHODS, V3, P205, DOI 10.1038/nmeth857; OU WJ, 1995, J BIOL CHEM, V270, P18051, DOI 10.1074/jbc.270.30.18051; Pan CJ, 1998, J BIOL CHEM, V273, P6144, DOI 10.1074/jbc.273.11.6144; Rathnayaka T, 2010, BBA-PROTEINS PROTEOM, V1804, P1902, DOI 10.1016/j.bbapap.2010.04.014; Remy I, 2006, NAT METHODS, V3, P977, DOI 10.1038/nmeth979; Snapp EL, 2009, TRENDS CELL BIOL, V19, P649, DOI 10.1016/j.tcb.2009.08.002; Tannous BA, 2005, MOL THER, V11, P435, DOI 10.1016/j.ymthe.2004.10.016; van Lith M, 2011, J CELL SCI, V124, P2349, DOI 10.1242/jcs.085530; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wright LP, 2009, MOL CELL BIOL, V29, P1826, DOI 10.1128/MCB.01719-08	22	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35628	10.1371/journal.pone.0035628	http://dx.doi.org/10.1371/journal.pone.0035628			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22530060	Green Published, gold, Green Submitted			2022-12-27	WOS:000305350600106
J	Li, J; Gong, CY; Feng, XD; Zhou, XK; Xu, XP; Xie, L; Wang, RN; Zhang, DF; Wang, H; Deng, P; Zhou, M; Ji, N; Zhou, Y; Wang, Y; Wang, ZY; Liao, G; Geng, N; Chu, LY; Qian, ZY; Wang, Z; Chen, QM				Li, Jing; Gong, Changyang; Feng, Xiaodong; Zhou, Xikun; Xu, Xiaoping; Xie, Liang; Wang, Ruinan; Zhang, Dunfang; Wang, Hui; Deng, Peng; Zhou, Min; Ji, Ning; Zhou, Yu; Wang, Yun; Wang, Zhiyong; Liao, Ga; Geng, Ning; Chu, Liangyin; Qian, Zhiyong; Wang, Zhi; Chen, Qianming			Biodegradable Thermosensitive Hydrogel for SAHA and DDP Delivery: Therapeutic Effects on Oral Squamous Cell Carcinoma Xenografts	PLOS ONE			English	Article							SUBEROYLANILIDE HYDROXAMIC ACID; HISTONE DEACETYLASE INHIBITOR; PCL-PEG HYDROGEL; PHASE-II TRIAL; IN-VITRO; CISPLATIN; SYSTEM; ANGIOGENESIS; MECHANISMS; EXPRESSION	Background: OSCC is one of the most common malignancies and numerous clinical agents currently applied in combinative chemotherapy. Here we reported a novel therapeutic strategy, SAHA and DDP-loaded PECE (SAHA-DDP/PECE), can improve the therapeutic effects of intratumorally chemotherapy on OSCC cell xenografts. Objective/Purpose: The objective of this study was to evaluate the therapeutic efficacy of the SAHA-DDP/PECE in situ controlled drug delivery system on OSCC cell xenografts. Methods: A biodegradable and thermosensitive hydrogel was successfully developed to load SAHA and DDP. Tumor-beared mice were intratumorally administered with SAHA-DDP/PECE at 50 mg/kg (SAHA) +2 mg/kg (DDP) in 100 ul PECE hydrogel every two weeks, SAHA-DDP at 50 mg/kg(SAHA) +2 mg/kg(DDP) in NS, 2 mg/kg DDP solution, 50 mg/kg SAHA solution, equal volume of PECE hydrogel, or equal volume of NS on the same schedule, respectively. The antineoplastic actions of SAHA and DDP alone and in combination were evaluated using the determination of tumor volume, immunohistochemistry, western blot, and TUNEL analysis. Results: The hydrogel system was a free-flowing sol at 10 degrees C, become gel at body temperature, and could sustain more than 14 days in situ. SAHA-DDP/PECE was subsequently injected into tumor OSCC tumor-beared mice. The results demonstrated that such a strategy as this allows the carrier system to show a sustained release of SAHA and DDP in vivo, and could improved therapeutic effects compared with a simple additive therapeutic effect of SAHA and DDP on mouse model. Conclusions: Our research indicated that the novel SAHA-DDP/PECE system based on biodegradable PECE copolymer enhanced the therapeutic effects and could diminished the side effects of SAHA/DDP. The present work might be of great importance to the further exploration of the potential application of SAHA/DDP-hydrogel controlled drug release system in the treatment of OSCC.	[Li, Jing; Feng, Xiaodong; Xu, Xiaoping; Xie, Liang; Wang, Ruinan; Zhang, Dunfang; Wang, Hui; Deng, Peng; Zhou, Min; Ji, Ning; Zhou, Yu; Wang, Yun; Wang, Zhiyong; Liao, Ga; Geng, Ning; Chu, Liangyin; Wang, Zhi; Chen, Qianming] Sichuan Univ, W China Coll Stomatol, State Key Lab Oral Dis, Chengdu 610064, Peoples R China; [Gong, Changyang; Zhou, Xikun; Qian, Zhiyong] Sichuan Univ, W China Med Sch, W China Hosp, State Key Lab Biotherapy, Chengdu 610064, Peoples R China; [Gong, Changyang; Zhou, Xikun; Qian, Zhiyong] Sichuan Univ, W China Med Sch, W China Hosp, Ctr Canc, Chengdu 610064, Peoples R China	Sichuan University; Sichuan University; Sichuan University	Li, J (corresponding author), Sichuan Univ, W China Coll Stomatol, State Key Lab Oral Dis, Chengdu 610064, Peoples R China.	anderson-qian@163.com; wangzhi0506@vip.163.com; qmchen@scu.edu.cn	Zhou, Xikun/T-8272-2019	Zhang, Dunfang/0000-0001-7545-9930	National Science Foundation for Distinguished Young Scholars of China [30725041]; State Key Program of National Natural Science of China [30930100]; National Natural Science Foundation of China [30901676, 81072218, 30801294]; Science Funds for Talented Professionals of Sichuan Province in China [09ZQ026-037]; Fok Ying-Tong Education Foundation, China [122030]	National Science Foundation for Distinguished Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); State Key Program of National Natural Science of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Funds for Talented Professionals of Sichuan Province in China; Fok Ying-Tong Education Foundation, China(Fok Ying Tung Education Foundation)	This work was supported by grants from the National Science Foundation for Distinguished Young Scholars of China (No. 30725041), State Key Program of National Natural Science of China (No. 30930100), the National Natural Science Foundation of China (No. 30901676, 81072218, 30801294), the Science Funds for Talented Professionals of Sichuan Province in China (No. 09ZQ026-037), the Fok Ying-Tong Education Foundation, China (No. 122030). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagan J, 2010, ORAL ONCOL, V46, P414, DOI 10.1016/j.oraloncology.2010.03.009; Blumenschein GR, 2008, INVEST NEW DRUG, V26, P81, DOI 10.1007/s10637-007-9075-2; Brandwein-Gensler A, 2005, AM J SURG PATHOL, V29, P167; Crump M, 2007, EJC SUPPL, V5, P346, DOI 10.1016/S1359-6349(07)71294-6; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Debaere D, 2011, B-ENT, V7, P1; Dong GE, 2010, AM J PHYSIOL-RENAL, V298, pF293, DOI 10.1152/ajprenal.00410.2009; El-Awady EE, 2011, EUR J PHARMACOL, V650, P335, DOI 10.1016/j.ejphar.2010.09.085; Fang F, 2009, ACS NANO, V3, P4080, DOI 10.1021/nn900785b; Gong CY, 2009, J PHARM SCI-US, V98, P3707, DOI 10.1002/jps.21694; Gong CY, 2009, J BIOMED MATER RES B, V91B, P26, DOI 10.1002/jbm.b.31370; Gong CY, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-8; Gong CY, 2009, GROWTH FACTORS, V27, P377, DOI 10.3109/08977190903159938; Gong CY, 2007, SMART MATER STRUCT, V16, P927, DOI 10.1088/0964-1726/16/3/043; Gong CY, 2011, J NANOPART RES, V13, P721, DOI 10.1007/s11051-010-0071-7; Gong CY, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/21/215103; Gong CY, 2009, J PHYS CHEM B, V113, P10183, DOI 10.1021/jp902697d; Gong CY, 2009, INT J PHARMACEUT, V365, P89, DOI 10.1016/j.ijpharm.2008.08.027; Gou ML, 2010, J BIOMED MATER RES A, V93A, P219, DOI 10.1002/jbm.a.32546; Gregorc V, 2011, CLIN CANCER RES, V17, P1964, DOI 10.1158/1078-0432.CCR-10-1376; Iamaroon A, 2003, J ORAL PATHOL MED, V32, P195, DOI 10.1034/j.1600-0714.2003.00128.x; Jin KL, 2010, J GYNECOL ONCOL, V21, P262, DOI 10.3802/jgo.2010.21.4.262; Kelly WK, 2005, J CLIN ONCOL, V23, P3923, DOI 10.1200/JCO.2005.14.167; Kelly WK, 2003, CLIN CANCER RES, V9, P3578; Koberle B, 2010, BBA-REV CANCER, V1806, P172, DOI 10.1016/j.bbcan.2010.07.004; Maisch B, 2010, EUR HEART J, V31, P337; Marks PA, 2007, ONCOGENE, V26, P1351, DOI 10.1038/sj.onc.1210204; McCaul JA, 2008, ORAL ONCOL, V44, P261, DOI 10.1016/j.oraloncology.2007.02.010; Plummer R, 2011, BRIT J CANCER, V104, P593, DOI 10.1038/bjc.2011.6; Prestwich RJ, 2011, CLIN ONCOL-UK, V23, pS23, DOI 10.1016/j.clon.2011.01.376; Richon VM, 2000, P NATL ACAD SCI USA, V97, P10014, DOI 10.1073/pnas.180316197; Rikiishi H, 2007, INT J ONCOL, V30, P1181; Sato T, 2006, INT J ONCOL, V28, P1233; Shen J, 2007, BIOCHEM PHARMACOL, V73, P1901, DOI 10.1016/j.bcp.2007.03.009; Shieh YS, 2004, J ORAL PATHOL MED, V33, P601, DOI 10.1111/j.1600-0714.2004.00252.x; Shivamallappa SM, 2011, INT J ORAL SCI, V3, P216, DOI 10.4248/IJOS11077; Suzuki M, 2009, CANCER CHEMOTH PHARM, V64, P1115, DOI 10.1007/s00280-009-0969-x; Wang YS, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-402; Xu LP, 2011, MOL CANCER THER, V10, P550, DOI 10.1158/1535-7163.MCT-10-0571; Yin D, 2007, CLIN CANCER RES, V13, P1045, DOI 10.1158/1078-0432.CCR-06-1261	40	63	65	4	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e33860	10.1371/journal.pone.0033860	http://dx.doi.org/10.1371/journal.pone.0033860			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529899	Green Published, gold, Green Submitted			2022-12-27	WOS:000305350600006
J	Zou, Q; Hu, YX; Xue, J; Fan, XX; Jin, Y; Shi, XH; Meng, D; Wang, XZ; Feng, CC; Xie, XP; Zhang, YZ; Kang, YM; Liang, XX; Wu, B; Wang, M; Wang, B				Zou, Qiang; Hu, Yanxin; Xue, Jia; Fan, Xiaoxu; Jin, Yi; Shi, Xianghua; Meng, Di; Wang, Xianzheng; Feng, Congcong; Xie, Xiaoping; Zhang, Yizhi; Kang, Youmin; Liang, Xiaoxuan; Wu, Bing; Wang, Ming; Wang, Bin			Use of Praziquantel as an Adjuvant Enhances Protection and Tc-17 Responses to Killed H5N1 Virus Vaccine in Mice	PLOS ONE			English	Article							CYTOTOXIC T-LYMPHOCYTE; INFLUENZA-A VIRUSES; IMMUNE-RESPONSES; HUMAN CD8(+); TC17 CELLS; INFECTION; INDUCTION; CHALLENGE; COMBINATION; RECOGNITION	Background: H5N1 is a highly pathogenic influenza A virus, which can cause severe illness or even death in humans. Although the widely used killed vaccines are able to provide some protection against infection via neutralizing antibodies, cytotoxic T-lymphocyte responses that are thought to eradicate viral infections are lacking. Methodology/Principal Findings: Aiming to promote cytotoxic responses against H5N1 infection, we extended our previous finding that praziquantel (PZQ) can act as an adjuvant to induce IL-17-producing CD8(+) T cells (Tc17). We found that a single immunization of 57BL/6 mice with killed viral vaccine plus PZQ induced antigen-specific Tc17 cells, some of which also secreted IFN-gamma. The induced Tc17 had cytolytic activities. Induction of these cells was impaired in CD8 knockout (KO) or IFN-gamma KO mice, and was even lower in IL-17 KO mice. Importantly, the inoculation of killed vaccine with PZQ significantly reduced virus loads in the lung tissues and prolonged survival. Protection against H5N1 virus infection was obtained by adoptively transferring PZQ-primed wild type CD8(+) T cells and this was more effective than transfer of activated IFN-gamma KO or IL-17 KO CD8(+) T cells. Conclusions/Significance: Our results demonstrated that adding PZQ to killed H5N1 vaccine could promote broad Tc17-mediated cytotoxic T lymphocyte activity, resulting in improved control of highly pathogenic avian influenza virus infection.	[Zou, Qiang; Wang, Xianzheng; Wang, Bin] Fudan Univ, Shanghai Med Coll, Key Lab Med Mol Virol MOH & MOE, Shanghai 200433, Peoples R China; [Zou, Qiang; Shi, Xianghua; Feng, Congcong; Xie, Xiaoping; Zhang, Yizhi; Kang, Youmin; Liang, Xiaoxuan; Wu, Bing; Wang, Bin] China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China; [Hu, Yanxin; Xue, Jia; Fan, Xiaoxu; Jin, Yi; Meng, Di; Wang, Ming] China Agr Univ, Coll Vet Med, Beijing 100094, Peoples R China	Fudan University; China Agricultural University; China Agricultural University	Zou, Q (corresponding author), Fudan Univ, Shanghai Med Coll, Key Lab Med Mol Virol MOH & MOE, Shanghai 200433, Peoples R China.	bwang3@fudan.edu.cn; bwang3@fudan.edu.cn	Xie, Xiaoping/K-5710-2018	Xie, Xiaoping/0000-0001-6616-1059; Kang, Youmin/0000-0003-2597-6117; Xue, Jia/0000-0001-8683-621X	National High-Tech 863 Project of China; Scientific Technology Development Foundation of Shanghai [09DZ1908602]	National High-Tech 863 Project of China; Scientific Technology Development Foundation of Shanghai	This work was partly supported by the National High-Tech 863 Project of China (Development of Novel Adjuvants for Influenza Vaccines) and Scientific Technology Development Foundation of Shanghai (09DZ1908602). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENDER BS, 1992, J EXP MED, V175, P1143, DOI 10.1084/jem.175.4.1143; Boon ACM, 2002, J VIROL, V76, P582, DOI 10.1128/JVI.76.2.582-590.2002; Cho Y, 2003, J VIROL, V77, P4679, DOI 10.1128/JVI.77.8.4679-4684.2003; Cioli D, 2003, PARASITOL RES, V90, pS3, DOI 10.1007/s00436-002-0751-z; Ciric B, 2009, J IMMUNOL, V182, P5296, DOI 10.4049/jimmunol.0900036; CROFT M, 1994, J EXP MED, V180, P1715, DOI 10.1084/jem.180.5.1715; Curtis MM, 2009, J IMMUNOL, V183, P381, DOI 10.4049/jimmunol.0900939; Doherty PC, 2006, NAT IMMUNOL, V7, P449, DOI 10.1038/ni1343; EICHELBERGER M, 1991, J EXP MED, V174, P875, DOI 10.1084/jem.174.4.875; El Sahly H, 2010, EXPERT REV VACCINES, V9, P1135, DOI [10.1586/ERV.10.111, 10.1586/erv.10.111]; Epstein SL, 2006, J INFECT DIS, V193, P49, DOI 10.1086/498980; ERARD F, 1993, SCIENCE, V260, P1802, DOI 10.1126/science.8511588; Exley C, 2004, LANCET INFECT DIS, V4, P324, DOI 10.1016/S1473-3099(04)01039-4; Hamada H, 2009, J IMMUNOL, V182, P3469, DOI 10.4049/jimmunol.0801814; Hien TT, 2004, NEW ENGL J MED, V350, P1179, DOI 10.1056/NEJMoa040419; Hinrichs CS, 2009, BLOOD, V114, P596, DOI 10.1182/blood-2009-02-203935; Huang MH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012279; Huber M, 2009, EUR J IMMUNOL, V39, P1716, DOI 10.1002/eji.200939412; Intlekofer AM, 2008, SCIENCE, V321, P408, DOI 10.1126/science.1159806; Jameson J, 1999, J IMMUNOL, V162, P7578; Jameson J, 1998, J VIROL, V72, P8682, DOI 10.1128/JVI.72.11.8682-8689.1998; Jin Y, 2011, J GENE MED, V13, P243, DOI 10.1002/jgm.1558; Kienzle N, 2002, J IMMUNOL, V168, P1672, DOI 10.4049/jimmunol.168.4.1672; Kistner O, 2007, VACCINE, V25, P6028, DOI 10.1016/j.vaccine.2007.05.013; Kondo T, 2009, J IMMUNOL, V182, P1794, DOI 10.4049/jimmunol.0801347; Kreijtz JHCM, 2008, J VIROL, V82, P5161, DOI 10.1128/JVI.02694-07; Kreijtz JHCM, 2007, VACCINE, V25, P612, DOI 10.1016/j.vaccine.2006.08.036; Lau YF, 2010, J VIROL, V84, P8639, DOI 10.1128/JVI.00596-10; Lee HK, 2007, SCIENCE, V315, P1398, DOI 10.1126/science.1136880; Lee LYH, 2008, J CLIN INVEST, V118, P3478, DOI 10.1172/JCI32460; Liu SJ, 2007, J LEUKOCYTE BIOL, V82, P354, DOI 10.1189/jlb.0207111; MCMICHAEL AJ, 1983, NEW ENGL J MED, V309, P13, DOI 10.1056/NEJM198307073090103; Nicholson KG, 2001, LANCET, V357, P1937, DOI 10.1016/S0140-6736(00)05066-2; Ninomiya A, 2007, VACCINE, V25, P3554, DOI 10.1016/j.vaccine.2007.01.083; Ortega C, 2009, J LEUKOCYTE BIOL, V86, P435, DOI [10.1189/jlb.0109046, 10.1189/JLB.0109046]; Palese P, 2002, J CLIN INVEST, V110, P9, DOI 10.1172/JCI200215999; Park KD, 2006, BLOOD, V108, P1770, DOI 10.1182/blood-2005-10-006536; REISS CS, 1980, J IMMUNOL, V125, P2182; Russell CJ, 2005, CELL, V123, P368, DOI 10.1016/j.cell.2005.10.019; Sawai T, 2008, IMMUNOLOGY, V124, P155, DOI 10.1111/j.1365-2567.2007.02745.x; Schmitz JE, 2003, J VIROL, V77, P2165, DOI 10.1128/JVI.77.3.2165-2173.2003; Schubert C, 2009, NAT MED, V15, P984, DOI [10.1038/nm0909-986, 10.1038/nm0909-985, 10.1038/nm0909-984]; Sha Z, 2000, J VIROL, V74, P4999, DOI 10.1128/JVI.74.11.4999-5005.2000; Uiprasertkul M, 2005, EMERG INFECT DIS, V11, P1036, DOI 10.3201/eid1107.041313; Wack A, 2008, VACCINE, V26, P552, DOI 10.1016/j.vaccine.2007.11.054; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352; Yamada S, 2006, NATURE, V444, P378, DOI 10.1038/nature05264; Yeh N, 2010, J IMMUNOL, V185, P2089, DOI 10.4049/jimmunol.1000818; Zou Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025525; Zou Q, 2010, VACCINE, V28, P2032, DOI 10.1016/j.vaccine.2009.10.101	50	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e34865	10.1371/journal.pone.0034865	http://dx.doi.org/10.1371/journal.pone.0034865			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529945	Green Published, Green Submitted, gold			2022-12-27	WOS:000305350600033
J	Donovan, J; Copeland, PR				Donovan, Jesse; Copeland, Paul R.			Selenocysteine Insertion Sequence Binding Protein 2L Is Implicated as a Novel Post-Transcriptional Regulator of Selenoprotein Expression	PLOS ONE			English	Article							EUKARYOTIC SECIS ELEMENTS; RNA-BINDING; MAMMALIAN SELENOPROTEIN; INCORPORATION MACHINERY; BINDING-PROTEIN-2; DOMAIN; SBP2; IDENTIFICATION; TRANSLATION; EFFICIENCY	The amino acid selenocysteine (Sec) is encoded by UGA codons. Recoding of UGA from stop to Sec requires a Sec insertion sequence (SECIS) element in the 3' UTR of selenoprotein mRNAs. SECIS binding protein 2 (SBP2) binds the SECIS element and is essential for Sec incorporation into the nascent peptide. SBP2-like (SBP2L) is a paralogue of SBP2 in vertebrates and is the only SECIS binding protein in some invertebrates where it likely directs Sec incorporation. However, vertebrate SBP2L does not promote Sec incorporation in in vitro assays. Here we present a comparative analysis of SBP2 and SBP2L SECIS binding properties and demonstrate that its inability to promote Sec incorporation is not due to lower SECIS affinity but likely due to lack of a SECIS dependent domain association that is found in SBP2. Interestingly, however, we find that an invertebrate version of SBP2L is fully competent for Sec incorporation in vitro. Additionally, we present the first evidence that SBP2L interacts with selenoprotein mRNAs in mammalian cells, thereby implying a role in selenoprotein expression.	[Donovan, Jesse; Copeland, Paul R.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Microbiol Mol Genet & Immunol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Donovan, J (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	paul.copeland@umdnj.edu		Copeland, Paul/0000-0003-3343-0587	National Institutes of Health [GM077073]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077073] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by National Institutes of Health grant GM077073. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allmang C, 2002, RNA, V8, P1308, DOI 10.1017/S1355838202020034; Allmang C., 2006, SELENIUM ITS MOL BIO, V5, P51; BERRY MJ, 1993, EMBO J, V12, P3315, DOI 10.1002/j.1460-2075.1993.tb06001.x; Bubenik JL, 2007, J BIOL CHEM, V282, P34653, DOI 10.1074/jbc.M707059200; Budiman ME, 2009, MOL CELL, V35, P479, DOI 10.1016/j.molcel.2009.06.026; Caban K, 2006, CELL MOL LIFE SCI, V63, P73, DOI 10.1007/s00018-005-5402-y; Chapple CE, 2009, BIOINFORMATICS, V25, P674, DOI 10.1093/bioinformatics/btp020; Clery A, 2007, NUCLEIC ACIDS RES, V35, P1868, DOI 10.1093/nar/gkm066; Copeland PR, 2000, EMBO J, V19, P306, DOI 10.1093/emboj/19.2.306; Copeland PR, 1999, J BIOL CHEM, V274, P25447, DOI 10.1074/jbc.274.36.25447; Copeland PR, 2001, MOL CELL BIOL, V21, P1491, DOI 10.1128/MCB.21.5.1491-1498.2001; Donovan J, 2010, J MOL BIOL, V400, P659, DOI 10.1016/j.jmb.2010.05.026; Donovan J, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-229; Donovan J, 2008, J BIOL CHEM, V283, P35129, DOI 10.1074/jbc.M806008200; Fagegaltier D, 2000, NUCLEIC ACIDS RES, V28, P2679, DOI 10.1093/nar/28.14.2679; Fletcher JE, 2001, RNA, V7, P1442; Gagnon KT, 2010, RNA, V16, P79, DOI 10.1261/rna.1692310; Hornbeck PV, 2004, PROTEOMICS, V4, P1551, DOI 10.1002/pmic.200300772; Jiang L, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-289; Kinzy SA, 2005, NUCLEIC ACIDS RES, V33, P5172, DOI 10.1093/nar/gki826; Korotkov KV, 2002, MOL CELL BIOL, V22, P1402, DOI 10.1128/MCB.22.5.1402-1411.2002; Latreche L, 2009, NUCLEIC ACIDS RES, V37, P5868, DOI 10.1093/nar/gkp635; Lescure A, 2002, GENE, V291, P279, DOI 10.1016/S0378-1119(02)00629-7; Lobanov AV, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r62; Mehta A, 2004, J BIOL CHEM, V279, P37852, DOI 10.1074/jbc.M404639200; Shepherdley CA, 2004, ENDOCRINOLOGY, V145, P1255, DOI 10.1210/en.2003-1248; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Takeuchi A, 2009, NUCLEIC ACIDS RES, V37, P2126, DOI 10.1093/nar/gkp078; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130	29	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e35581	10.1371/journal.pone.0035581	http://dx.doi.org/10.1371/journal.pone.0035581			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22530054	Green Submitted, gold, Green Published			2022-12-27	WOS:000305347400064
J	Klitgaard, K; Friis, C; Jensen, TK; Angen, O; Boye, M				Klitgaard, Kirstine; Friis, Carsten; Jensen, Tim K.; Angen, Oystein; Boye, Mette			Transcriptional Portrait of Actinobacillus pleuropneumoniae during Acute Disease - Potential Strategies for Survival and Persistence in the Host	PLOS ONE			English	Article							ARGININE TRANSLOCATION PATHWAY; SIALIC-ACID METABOLISM; IN-VITRO GROWTH; ESCHERICHIA-COLI; HAEMOPHILUS-INFLUENZAE; PSEUDOMONAS-AERUGINOSA; VIRULENCE FACTORS; IRON HOMEOSTASIS; UREASE ACTIVITY; TRANSCRIBED SEQUENCES	Background: Gene expression profiles of bacteria in their natural hosts can provide novel insight into the host-pathogen interactions and molecular determinants of bacterial infections. In the present study, the transcriptional profile of the porcine lung pathogen Actinobacillus pleuropneumoniae was monitored during the acute phase of infection in its natural host. Methodology/Principal Findings: Bacterial expression profiles of A. pleuropneumoniae isolated from lung lesions of 25 infected pigs were compared in samples taken 6, 12, 24 and 48 hours post experimental challenge. Within 6 hours, focal, fibrino hemorrhagic lesions could be observed in the pig lungs, indicating that A. pleuropneumoniae had managed to establish itself successfully in the host. We identified 237 differentially regulated genes likely to encode functions required by the bacteria for colonization and survival in the host. This group was dominated by genes involved in various aspects of energy metabolism, especially anaerobic respiration and carbohydrate metabolism. Remodeling of the bacterial envelope and modifications of posttranslational processing of proteins also appeared to be of importance during early infection. The results suggested that A. pleuropneumoniae is using various strategies to increase its fitness, such as applying Na+ pumps as an alternative way of gaining energy. Furthermore, the transcriptional data provided potential clues as to how A. pleuropneumoniae is able to circumvent host immune factors and survive within the hostile environment of host macrophages. This persistence within macrophages may be related to urease activity, mobilization of various stress responses and active evasion of the host defenses by cell surface sialylation. Conclusions/Significance: The data presented here highlight the importance of metabolic adjustments to host conditions as virulence factors of infecting microorganisms and help to provide insight into the mechanisms behind the efficient colonization and persistence of A. pleuropneumoniae during acute disease.	[Klitgaard, Kirstine; Jensen, Tim K.; Angen, Oystein; Boye, Mette] Tech Univ Denmark, Natl Vet Inst, Frederiksberg C, Denmark; [Friis, Carsten] Tech Univ Denmark, Natl Food Inst, DK-2800 Lyngby, Denmark	Technical University of Denmark; Technical University of Denmark	Klitgaard, K (corresponding author), Tech Univ Denmark, Natl Vet Inst, Frederiksberg C, Denmark.	kksc@vet.dtu.dk		Klitgaard, Kirstine/0000-0002-8379-9430; Jensen, Tim Kare/0000-0002-8048-4695	Danish Research Council for Technology and Production Sciences [274-07-0127]	Danish Research Council for Technology and Production Sciences	This work was supported by the Danish Research Council for Technology and Production Sciences (274-07-0127), http://www.fi.dk/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Auger E, 2009, INFECT IMMUN, V77, P1426, DOI 10.1128/IAI.00297-08; Baker J, 2010, APPL ENVIRON MICROB, V76, P150, DOI 10.1128/AEM.02268-09; Baltes N, 2005, INFECT IMMUN, V73, P4614, DOI 10.1128/IAI.73.8.4614-4619.2005; Baltes N, 2004, INFECT IMMUN, V72, P6711, DOI 10.1128/IAI.72.11.6711-6716.2004; Baltes N, 2003, INFECT IMMUN, V71, P6784, DOI 10.1128/IAI.71.12.6784-6792.2003; Baltes N, 2001, INFECT IMMUN, V69, P472, DOI 10.1128/IAI.69.1.472-478.2001; Baltes N, 2007, VET MICROBIOL, V123, P110, DOI 10.1016/j.vetmic.2007.03.026; Beenken KE, 2012, INFECT IMMU IN PRESS; Bizzini A, 2010, J BACTERIOL, V192, P779, DOI 10.1128/JB.00959-09; Boekema BKHL, 2004, INFECT IMMUN, V72, P691, DOI 10.1128/IAI.72.2.691-700.2004; Bogdan CT, 2000, IMMUNOL REV, V173, P17, DOI 10.1034/j.1600-065X.2000.917307.x; Booth IR, 2003, BIOCHEM SOC T, V31, P1406; Bosse JT, 2002, MICROBES INFECT, V4, P225, DOI 10.1016/S1286-4579(01)01534-9; Bosse JT, 2001, J BACTERIOL, V183, P1242, DOI 10.1128/JB.183.4.1242-1247.2001; Bosse JT, 2000, CAN J VET RES, V64, P145; Bouchet V, 2003, P NATL ACAD SCI USA, V100, P8898, DOI 10.1073/pnas.1432026100; Boyce JD, 2004, EMERG INFECT DIS, V10, P1357, DOI 10.3201/eid1008.031036; Boysen A, 2010, J BIOL CHEM, V285, P10690, DOI 10.1074/jbc.M109.089755; Buettner FFR, 2009, PROTEOMICS, V9, P2383, DOI 10.1002/pmic.200800439; Camejo A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000449; Carter MQ, 2011, APPL ENVIRON MICROB, V77, P3685, DOI 10.1128/AEM.02315-10; Challacombe Jean F., 2008, P53; Chiers K, 2010, VET RES, V41, DOI 10.1051/vetres/2010037; Chin N, 1996, FEMS MICROBIOL LETT, V143, P1, DOI 10.1111/j.1574-6968.1996.tb08452.x; Cross BCS, 2009, NAT REV MOL CELL BIO, V10, P255, DOI 10.1038/nrm2657; CRUIJSEN TLM, 1992, INFECT IMMUN, V60, P4867, DOI 10.1128/IAI.60.11.4867-4871.1992; De Buck E, 2008, TRENDS MICROBIOL, V16, P442, DOI 10.1016/j.tim.2008.06.004; Deslandes V, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-98; Dreyfus A, 2004, VET MICROBIOL, V99, P227, DOI 10.1016/j.vetmic.2004.01.004; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ferguson GP, 1998, ARCH MICROBIOL, V170, P209, DOI 10.1007/s002030050635; FREY J, 1995, TRENDS MICROBIOL, V3, P257, DOI 10.1016/S0966-842X(00)88939-8; Fuller TE, 1999, MICROB PATHOGENESIS, V27, P311, DOI 10.1006/mpat.1999.0309; Fuller TE, 2000, MICROB PATHOGENESIS, V29, P39, DOI 10.1006/mpat.2000.0364; Gawronski JD, 2009, P NATL ACAD SCI USA, V106, P16422, DOI 10.1073/pnas.0906627106; Genevaux P, 2007, MOL MICROBIOL, V66, P840, DOI 10.1111/j.1365-2958.2007.05961.x; Graham MR, 2005, AM J PATHOL, V166, P455, DOI 10.1016/S0002-9440(10)62268-7; Hartlova A, 2011, PROTEOMICS, V11, P3212, DOI 10.1002/pmic.201000767; Hase CC, 2001, MICROBIOL MOL BIOL R, V65, P353, DOI 10.1128/MMBR.65.3.353-370.2001; Heyes DJ, 2009, J BIOL CHEM, V284, P35514, DOI 10.1074/jbc.M109.056630; HOLTJE JV, 1991, J GEN MICROBIOL, V137, P441, DOI 10.1099/00221287-137-3-441; Hong M, 2011, VET MICROBIOL, V148, P89, DOI 10.1016/j.vetmic.2010.07.023; Hood DW, 1999, MOL MICROBIOL, V33, P679, DOI 10.1046/j.1365-2958.1999.01509.x; Horst SA, 2010, J BACTERIOL, V192, P2929, DOI 10.1128/JB.01652-09; Huang KX, 1999, APPL ENVIRON MICROB, V65, P3244; Hung MN, 2006, J BACTERIOL, V188, P5606, DOI 10.1128/JB.00306-06; Inzana Thomas J., 2008, P177; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jack RL, 2001, J BACTERIOL, V183, P1801, DOI 10.1128/JB.183.5.1801-1804.2001; Jacobsen I, 2005, INFECT IMMUN, V73, P3740, DOI 10.1128/IAI.73.6.3740-3744.2005; Jacobsen I, 2005, INFECT IMMUN, V73, P226, DOI 10.1128/IAI.73.1.226-234.2005; Kachlany Scott C., 2008, P113; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Kemmer G, 2001, J BACTERIOL, V183, P3974, DOI 10.1128/JB.183.13.3974-3981.2001; Klitgaard K, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-698; Labrie J, 2010, VET RES, V41, DOI 10.1051/vetres/2009051; LaRocque RC, 2005, INFECT IMMUN, V73, P4488, DOI 10.1128/IAI.73.8.4488-4493.2005; Lee VT, 2001, GENE DEV, V15, P1725, DOI 10.1101/gad.896801; Li YJ, 2009, CHEM REV, V109, P4617, DOI 10.1021/cr900010n; Lone AG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006139; Masse E, 2005, TRENDS BIOCHEM SCI, V30, P462, DOI 10.1016/j.tibs.2005.06.005; Masse E, 2002, P NATL ACAD SCI USA, V99, P4620, DOI 10.1073/pnas.032066599; Maughan Heather, 2008, P79; McHugh JP, 2003, J BIOL CHEM, V278, P29478, DOI 10.1074/jbc.M303381200; Mikael LG, 2003, INFECT IMMUN, V71, P2911, DOI 10.1128/IAI.71.5.2911-2915.2003; Mills DC, 2012, INFECT IMMU IN PRESS; Morton DJ, 2007, MICROBES INFECT, V9, P932, DOI 10.1016/j.micinf.2007.03.013; Mullen LM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003991; Nielsen KK, 2005, APPL ENVIRON MICROB, V71, P2949, DOI 10.1128/AEM.71.6.2949-2954.2005; NIVEN DF, 1990, INT J SYST BACTERIOL, V40, P1, DOI 10.1099/00207713-40-1-1; Novotny LA, 2011, MUCOSAL IMMUNOL, V4, P456, DOI 10.1038/mi.2011.6; Ochsner UA, 2002, P NATL ACAD SCI USA, V99, P8312, DOI 10.1073/pnas.082238299; Ogunnariwo JA, 2001, J BACTERIOL, V183, P890, DOI 10.1128/JB.183.3.890-896.2001; Palchevskiy V, 2006, J BACTERIOL, V188, P3902, DOI 10.1128/JB.01974-05; Palmer T, 2005, TRENDS MICROBIOL, V13, P175, DOI 10.1016/j.tim.2005.02.002; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; POHL S, 1983, INT J SYST BACTERIOL, V33, P510, DOI 10.1099/00207713-33-3-510; Price CE, 2010, BBA-MOL CELL RES, V1803, P748, DOI 10.1016/j.bbamcr.2010.01.019; Reidl J, 1996, J EXP MED, V183, P621, DOI 10.1084/jem.183.2.621; Renesto P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003681; Rioux S, 2000, MICROB PATHOGENESIS, V28, P279, DOI 10.1006/mpat.1999.0347; Rose RW, 2002, MOL MICROBIOL, V45, P943, DOI 10.1046/j.1365-2958.2002.03090.x; Rozen S, 2000, Methods Mol Biol, V132, P365; Schaller A, 1999, MICROBIOL-SGM, V145, P2105, DOI 10.1099/13500872-145-8-2105; Severi E, 2007, MICROBIOL-SGM, V153, P2817, DOI 10.1099/mic.0.2007/009480-0; Sheehan BJ, 2003, INFECT IMMUN, V71, P3960, DOI 10.1128/IAI.71.7.3960-3970.2003; Sheikh A, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001419; Son MS, 2007, INFECT IMMUN, V75, P5313, DOI 10.1128/IAI.01807-06; Srikumar R, 2004, MICROBIOL-SGM, V150, P1723, DOI 10.1099/mic.0.27046-0; Steenbergen SM, 2005, INFECT IMMUN, V73, P1284, DOI 10.1128/IAI.73.3.1284-1294.2005; STOJILJKOVIC I, 1994, MOL MICROBIOL, V13, P719, DOI 10.1111/j.1365-2958.1994.tb00465.x; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Turner S, 2003, BIOCHEM J, V373, P865, DOI 10.1042/BJ20030088; Vasil ML, 2007, BIOMETALS, V20, P587, DOI 10.1007/s10534-006-9067-2; Vasil ML, 1999, MOL MICROBIOL, V34, P399, DOI 10.1046/j.1365-2958.1999.01586.x; Vimr ER, 2004, MICROBIOL MOL BIOL R, V68, P132, DOI 10.1128/MMBR.68.1.132-153.2004; WEISER JN, 1994, INFECT IMMUN, V62, P2582, DOI 10.1128/IAI.62.6.2582-2589.1994; Yin X, 2012, MICROBIOLOG IN PRESS; Zakharian E, 2007, BIOPHYS J, V92, P588, DOI 10.1529/biophysj.106.095273; Zhang W, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-32	102	27	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e35549	10.1371/journal.pone.0035549	http://dx.doi.org/10.1371/journal.pone.0035549			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22530048	Green Published, Green Submitted, gold			2022-12-27	WOS:000305347400061
J	Nouri, MN; Ahmed, A; Bril, V; Orszag, A; Ng, E; Nwe, P; Perkins, BA				Nouri, Maryam Nabavi; Ahmed, Ausma; Bril, Vera; Orszag, Andrej; Ng, Eduardo; Nwe, Patti; Perkins, Bruce A.			Diabetic Neuropathy and Axon Reflex-Mediated Neurogenic Vasodilatation in Type 1 Diabetes	PLOS ONE			English	Article							DISTAL SYMMETRIC POLYNEUROPATHY; C-FIBER FUNCTION; PERIPHERAL NEUROPATHY; PITTSBURGH EPIDEMIOLOGY; ELECTRODIAGNOSTIC-MEDICINE; AMERICAN-ASSOCIATION; PHYSICAL-MEDICINE; SCREENING-TESTS; COMPLICATIONS; PREVALENCE	Objective: Axon reflex-mediated neurogenic vasodilatation in response to cutaneous heating may reflect early, pre-clinical small fibre dysfunction. We aimed to evaluate the distribution of the vascular flare area measured by laser doppler imaging ("LDIFLARE area") in type 1 diabetes and in healthy volunteers. Research and Methods: Concurrent with clinical and electrophysiological examination to classify diabetic sensorimotor polyneuropathy (DSP), LDIFLARE area (cm(2)) was determined in 89 type 1 diabetes subjects matched to 64 healthy volunteers. We examined the association and diagnostic performance of LDI with clinical and subclinical measures of DSP and its severity. Results: Compared to the 64 healthy volunteers, the 56 diabetes controls without DSP had significantly lower LDIFLARE area (p = 0.006). The 33 diabetes cases with DSP had substantially lower LDIFLARE area as compared to controls without DSP (p = 0.002). There was considerable overlap in LDIFLARE area between all groups such that the ROC curve had an AUC of 0.72 and optimal sensitivity of 70% for the detection of clinical DSP. Use of a subclinical definition for DSP, according to subclinical sural nerve impairment, was associated with improved AUC of 0.75 and sensitivity of 79%. In multivariate analysis higher HbA1c and body mass index had independent associations with smaller LDIFLARE area. Conclusions: Axon reflex-mediated neurogenic vasodilatation in response to cutaneous heating is a biomarker of early nerve dysfunction in DSP. Its independent association with glycemic exposure in diabetes subjects and both glycemic exposure and BMI in healthy volunteers highlights the existence of small-fibre dysfunction in the natural history of DSP.	[Nouri, Maryam Nabavi; Bril, Vera; Ng, Eduardo; Nwe, Patti] Univ Toronto, Dept Med, Div Neurol, Toronto, ON, Canada; [Ahmed, Ausma; Orszag, Andrej; Perkins, Bruce A.] Univ Toronto, Dept Med, Div Endocrinol & Metab, Toronto, ON, Canada	University of Toronto; University of Toronto	Nouri, MN (corresponding author), Univ Toronto, Dept Med, Div Neurol, Toronto, ON, Canada.	bruce.perkins@uhn.on.ca	BRIL, vera/ABA-6509-2020; Perkins, Bruce A/L-3726-2017	Orszag, Andrej/0000-0002-0027-1607; Nabavi Nouri, Maryam/0000-0001-6317-4890	Juvenile Diabetes Research Foundation [17-2008-715]; Banting and Best Diabetes Centre	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Banting and Best Diabetes Centre	Funded by the Juvenile Diabetes Research Foundation (operating grant No.17-2008-715). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; BAP was a Canadian Diabetes Association Scholar. AA was supported by a Charles Hollenberg Studentship from the Banting and Best Diabetes Centre.	Baba M, 2002, INTERNAL MED, V41, P1079, DOI 10.2169/internalmedicine.41.1079; Bornmyr S, 1999, DIABETES CARE, V22, P593, DOI 10.2337/diacare.22.4.593; Boulton AJM, 2005, DIABETES CARE, V28, P956, DOI 10.2337/diacare.28.4.956; Bril V, 2002, DIABETES CARE, V25, P2048, DOI 10.2337/diacare.25.11.2048; Caselli A, 2006, J NEUROL NEUROSUR PS, V77, P927, DOI 10.1136/jnnp.2005.069609; Dworkin RH, 2010, J PAIN, V11, P360, DOI 10.1016/j.jpain.2009.08.005; England JD, 2009, NEUROLOGY, V72, P177, DOI 10.1212/01.wnl.0000336345.70511.0f; England JD, 2005, NEUROLOGY, V64, P199, DOI 10.1212/01.WNL.0000149522.32823.EA; Green AQ, 2010, DIABETES CARE, V33, P174, DOI 10.2337/dc09-0101; Green AQ, 2009, MUSCLE NERVE, V40, P985, DOI 10.1002/mus.21333; Hossain P, 2005, LANCET, V366, P1340, DOI 10.1016/S0140-6736(05)67546-0; KAHN R, 1992, DIABETES CARE, V15, P1092; Krishnan STM, 2007, DIABETES CARE, V30, P3058, DOI 10.2337/dc07-1421; Krishnan STM, 2009, DIABETES CARE, V32, P451, DOI 10.2337/dc08-1453; Krishnan STM, 2004, DIABETES CARE, V27, P2930, DOI 10.2337/diacare.27.12.2930; Lin Q, 1999, J NEUROPHYSIOL, V82, P2602, DOI 10.1152/jn.1999.82.5.2602; MASER RE, 1989, DIABETES, V38, P1456, DOI 10.2337/diabetes.38.11.1456; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Oh SJ, 2002, CLIN ELECTROMYOGRAPH, P86; Olaleye D, 2001, DIABETES RES CLIN PR, V54, P115, DOI 10.1016/S0168-8227(01)00278-9; ORCHARD TJ, 1990, DIABETES, V39, P1116, DOI 10.2337/diabetes.39.9.1116; Pambianco G, 2011, DIABETES RES CLIN PR, V92, P280, DOI 10.1016/j.diabres.2011.02.005; Perkins BA, 2003, CLIN NEUROPHYSIOL, V114, P1167, DOI 10.1016/S1388-2457(03)00025-7; Perkins BA, 2001, DIABETES CARE, V24, P250, DOI 10.2337/diacare.24.2.250; Perkins BA, 2010, DIABETES CARE, V33, P1549, DOI 10.2337/dc09-1835; Quadrado MJ, 2006, CORNEA, V25, P761, DOI 10.1097/01.ico.0000224635.49439.d1; Quattrini C, 2007, DIABETES, V56, P2148, DOI 10.2337/db07-0285; Schmelz M, 2000, NEUROREPORT, V11, P645, DOI 10.1097/00001756-200002280-00041; Smith AG, 2008, NEUROLOGIST, V14, P23, DOI 10.1097/NRL.0b013e31815a3956; Sumner CJ, 2003, NEUROLOGY, V60, P108, DOI 10.1212/WNL.60.1.108; Tavakoli M, 2011, JOVE-J VIS EXP, DOI 10.3791/2194; Tesfaye S, 1996, DIABETOLOGIA, V39, P1377, DOI 10.1007/s001250050586; Vinik AI, 2005, MUSCLE NERVE, V32, P619, DOI 10.1002/mus.20423; Yarnitsky D, 1997, MUSCLE NERVE, V20, P198; Zinman LH, 2004, DIABETES CARE, V27, P1674, DOI 10.2337/diacare.27.7.1674	35	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e34807	10.1371/journal.pone.0034807	http://dx.doi.org/10.1371/journal.pone.0034807			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22529938	Green Published, Green Submitted, gold			2022-12-27	WOS:000305347400019
J	Kapoor, P; Singh, H; Gautam, A; Chaudhary, K; Kumar, R; Raghava, GPS				Kapoor, Pallavi; Singh, Harinder; Gautam, Ankur; Chaudhary, Kumardeep; Kumar, Rahul; Raghava, Gajendra P. S.			TumorHoPe: A Database of Tumor Homing Peptides	PLOS ONE			English	Article							DELIVERY; NANOPARTICLES; PREDICTION; THERAPY	Background: Cancer is responsible for millions of immature deaths every year and is an economical burden on developing countries. One of the major challenges in the present era is to design drugs that can specifically target tumor cells not normal cells. In this context, tumor homing peptides have drawn much attention. These peptides are playing a vital role in delivering drugs in tumor tissues with high specificity. In order to provide service to scientific community, we have developed a database of tumor homing peptides called TumorHoPe. Description: TumorHoPe is a manually curated database of experimentally validated tumor homing peptides that specifically recognize tumor cells and tumor associated microenvironment, i.e., angiogenesis. These peptides were collected and compiled from published papers, patents and databases. Current release of TumorHoPe contains 744 peptides. Each entry provides comprehensive information of a peptide that includes its sequence, target tumor, target cell, techniques of identification, peptide receptor, etc. In addition, we have derived various types of information from these peptide sequences that include secondary/tertiary structure, amino acid composition, and physicochemical properties of peptides. Peptides in this database have been found to target different types of tumors that include breast, lung, prostate, melanoma, colon, etc. These peptides have some common motifs including RGD (Arg-Gly-Asp) and NGR (Asn-Gly-Arg) motifs, which specifically recognize tumor angiogenic markers. TumorHoPe has been integrated with many web-based tools like simple/complex search, database browsing and peptide mapping. These tools allow a user to search tumor homing peptides based on their amino acid composition, charge, polarity, hydrophobicity, etc. Conclusion: TumorHoPe is a unique database of its kind, which provides comprehensive information about experimentally validated tumor homing peptides and their target cells. This database will be very useful in designing peptide-based drugs and drug-delivery system. It is freely available at http://crdd.osdd.net/raghava/tumorhope/.	[Kapoor, Pallavi; Singh, Harinder; Gautam, Ankur; Chaudhary, Kumardeep; Kumar, Rahul; Raghava, Gajendra P. S.] Inst Microbial Technol, CSIR, Bioinformat Ctr, Sect 39A, Chandigarh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Kapoor, P (corresponding author), Inst Microbial Technol, CSIR, Bioinformat Ctr, Sect 39A, Chandigarh, India.	raghava@imtech.res.in	Chaudhary, Kumardeep/Q-9740-2018; Kumar, Rahul/ABB-3530-2020; Raghava, Gajendra P.S./AAA-2413-2022; Singh, Harinder/V-7699-2019; Raghava, Gajendra/B-1717-2009; kumar, rahul/GZG-2171-2022	Chaudhary, Kumardeep/0000-0002-4117-6403; Raghava, Gajendra P.S./0000-0002-8902-2876; Singh, Harinder/0000-0003-4897-9759; Kumar, Rahul/0000-0002-6927-5390	Council of Scientific and Industrial Research (CSIR); Open Source Drug Discovery (OSDD); Department of Biotechnology, Government of India	Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); Open Source Drug Discovery (OSDD); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	The authors are thankful to Council of Scientific and Industrial Research (CSIR), Open Source Drug Discovery (OSDD) and Department of Biotechnology, Government of India for providing research fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Blanco E, 2011, CANCER SCI, V102, P1247, DOI 10.1111/j.1349-7006.2011.01941.x; Brahmachary M, 2004, NUCLEIC ACIDS RES, V32, pD586, DOI 10.1093/nar/gkh032; Corti A, 2011, MED RES REV; Corti A, 2008, BLOOD, V112, P2628, DOI 10.1182/blood-2008-04-150862; EISENBERG D, 1984, ANNU REV BIOCHEM, V53, P595, DOI 10.1146/annurev.bi.53.070184.003115; Ellerby HM, 1999, NAT MED, V5, P1032, DOI 10.1038/12469; Engel JB, 2007, MOL PHARM, V4, P652, DOI 10.1021/mp0700514; HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jiang YQ, 2006, MOL MED, V12, P81, DOI 10.2119/2006-00011.Jiang; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Karmali PP, 2009, NANOMED-NANOTECHNOL, V5, P73, DOI 10.1016/j.nano.2008.07.007; Kaur H, 2007, PROTEIN PEPTIDE LETT, V14, P626; Khandare JJ, 2006, CRIT REV THER DRUG, V23, P401; Laakkonen P, 2010, INTEGR BIOL-UK, V2, P326, DOI 10.1039/c0ib00013b; Lata Sneh, 2009, BMC Res Notes, V2, P61, DOI 10.1186/1756-0500-2-61; Pearson W R, 2000, Methods Mol Biol, V132, P185; Rashid M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-307; Reubi JC, 2003, ENDOCR REV, V24, P389, DOI 10.1210/er.2002-0007; Rosca EV, 2011, CURR PHARM BIOTECHNO, V12, P1101; Ru BB, 2010, MOLECULES, V15, P8279, DOI 10.3390/molecules15118279; Ruoslahti E, 2010, J CELL BIOL, V188, P759, DOI 10.1083/jcb.200910104; Ruoslahti ESR, 1997, US005622699A, Patent No. US005622699A; Saha S, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-79; Tang Y, 2010, PHARM RES-DORDR, V27, P2242, DOI 10.1007/s11095-010-0231-6; Temming K, 2006, BIOCONJUGATE CHEM, V17, P1385, DOI 10.1021/bc060087z; Thomas S, 2010, NUCLEIC ACIDS RES, V38, pD774, DOI 10.1093/nar/gkp1021	28	86	89	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e35187	10.1371/journal.pone.0035187	http://dx.doi.org/10.1371/journal.pone.0035187			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523575	Green Published, gold, Green Submitted			2022-12-27	WOS:000305345000047
J	Wither, RG; Colic, S; Wu, CP; Bardakjian, BL; Zhang, L; Eubanks, JH				Wither, Robert G.; Colic, Sinisa; Wu, Chiping; Bardakjian, Berj L.; Zhang, Liang; Eubanks, James H.			Daily Rhythmic Behaviors and Thermoregulatory Patterns Are Disrupted in Adult Female MeCP2-Deficient Mice	PLOS ONE			English	Article							CPG-BINDING PROTEIN-2; RETT-SYNDROME; MOUSE MODEL; CIRCADIAN-CLOCK; HEART-RATE; MECP2; SLEEP; ABNORMALITIES; DEFICIENCY; MUTATIONS	Mutations in the X-linked gene encoding Methyl-CpG-binding protein 2 (MECP2) have been associated with neurodevelopmental and neuropsychiatric disorders including Rett Syndrome, X-linked mental retardation syndrome, severe neonatal encephalopathy, and Angelman syndrome. Although alterations in the performance of MeCP2-deficient mice in specific behavioral tasks have been documented, it remains unclear whether or not MeCP2 dysfunction affects patterns of periodic behavioral and electroencephalographic (EEG) activity. The aim of the current study was therefore to determine whether a deficiency in MeCP2 is sufficient to alter the normal daily rhythmic patterns of core body temperature, gross motor activity and cortical delta power. To address this, we monitored individual wild-type and MeCP2-deficient mice in their home cage environment via telemetric recording over 24 hour cycles. Our results show that the normal daily rhythmic behavioral patterning of cortical delta wave activity, core body temperature and mobility are disrupted in one-year old female MeCP2-deficient mice. Moreover, female MeCP2-deficient mice display diminished overall motor activity, lower average core body temperature, and significantly greater body temperature fluctuation than wild-type mice in their home-cage environment. Finally, we show that the epileptiform discharge activity in female MeCP2-deficient mice is more predominant during times of behavioral activity compared to inactivity. Collectively, these results indicate that MeCP2 deficiency is sufficient to disrupt the normal patterning of daily biological rhythmic activities.	[Wither, Robert G.; Eubanks, James H.] Univ Hlth Network, Toronto Western Res Inst, Div Genet & Dev, Toronto, ON, Canada; [Wu, Chiping; Zhang, Liang] Univ Hlth Network, Toronto Western Res Inst, Div Fundamental Neurobiol, Toronto, ON, Canada; [Wu, Chiping; Bardakjian, Berj L.; Zhang, Liang; Eubanks, James H.] Univ Toronto, Epilepsy Res Program, Toronto, ON, Canada; [Wither, Robert G.; Eubanks, James H.] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Zhang, Liang] Univ Toronto, Dept Med Neurol, Toronto, ON, Canada; [Eubanks, James H.] Univ Toronto, Dept Surg Neurosurg, Toronto, ON, Canada; [Colic, Sinisa; Bardakjian, Berj L.] Univ Toronto, Dept Elect & Comp Engn, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto	Wither, RG (corresponding author), Univ Hlth Network, Toronto Western Res Inst, Div Genet & Dev, Toronto, ON, Canada.	jeubanks@uhnres.utoronto.ca		Eubanks, James/0000-0001-8595-2024	Canadian Institutes of Health Research [MOP-106481, MOP-20158]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Funding provided by an operating grant awarded by the Canadian Institutes of Health Research to JHE (MOP-106481), and by a Canadian Institutes of Health Research to BLJ (MOP-20158). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adegbola AA, 2009, HUM GENET, V124, P615, DOI 10.1007/s00439-008-0585-6; Alvarez-Saavedra M, 2011, HUM MOL GENET, V20, P731, DOI 10.1093/hmg/ddq519; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Boggio Elena M, 2010, Front Synaptic Neurosci, V2, P28, DOI 10.3389/fnsyn.2010.00028; Buzsaki G., 2006, RHYTHMS BRAIN; Calfa G, 2011, J NEUROPHYSIOL, V105, P1768, DOI 10.1152/jn.00800.2010; Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Cheng HYM, 2007, NEURON, V54, P813, DOI 10.1016/j.neuron.2007.05.017; Chiu AWL, 2006, J NEURAL ENG, V3, P9, DOI 10.1088/1741-2560/3/1/002; D'Cruz JA, 2010, NEUROBIOL DIS, V38, P8, DOI 10.1016/j.nbd.2009.12.018; De Filippis B, 2010, GENES BRAIN BEHAV, V9, P213, DOI 10.1111/j.1601-183X.2009.00551.x; El-Hayek YH, 2011, CEREB CORTEX, V21, P2863, DOI 10.1093/cercor/bhr080; Ellaway C, 2001, BRAIN DEV-JPN, V23, pS101, DOI 10.1016/S0387-7604(01)00356-4; Franken P, 2009, EUR J NEUROSCI, V29, P1820, DOI 10.1111/j.1460-9568.2009.06723.x; Franken P, 2001, J NEUROSCI, V21, P2610, DOI 10.1523/JNEUROSCI.21-08-02610.2001; Franken P, 1998, AM J PHYSIOL-REG I, V275, pR1127, DOI 10.1152/ajpregu.1998.275.4.R1127; Gonzales ML, 2010, CURR PSYCHIAT REP, V12, P127, DOI 10.1007/s11920-010-0097-7; GROSSMANN A, 1984, SIAM J MATH ANAL, V15, P723, DOI 10.1137/0515056; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; Hammer S, 2002, MENT RETARD DEV D R, V8, P94, DOI 10.1002/mrdd.10023; Jentarra GM, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-19; Jugloff DGM, 2008, HUM MOL GENET, V17, P1386, DOI 10.1093/hmg/ddn026; Lusardi TA, 2010, J CEREBR BLOOD F MET, V30, P744, DOI 10.1038/jcbfm.2009.253; Moretti P, 2005, HUM MOL GENET, V14, P205, DOI 10.1093/hmg/ddi016; Nagarajan RP, 2008, AUTISM RES, V1, P169, DOI 10.1002/aur.24; Nomura Y, 2005, BRAIN DEV-JPN, V27, pS35, DOI 10.1016/j.braindev.2005.03.017; Pelka GJ, 2006, BRAIN, V129, P887, DOI 10.1093/brain/awl022; PIAZZA CC, 1990, BRAIN DEV-JPN, V12, P488, DOI 10.1016/S0387-7604(12)80213-0; Rothman SM, 2005, EPILEPSY BEHAV, V7, P214, DOI 10.1016/j.yebeh.2005.05.021; Shahbazian MD, 2002, NEURON, V35, P243, DOI 10.1016/S0896-6273(02)00768-7; Sheward WJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009783; Suffczynski P, 2006, IEEE T BIO-MED ENG, V53, P524, DOI 10.1109/TBME.2005.869800; Ward CS, 2011, J NEUROSCI, V31, P10359, DOI 10.1523/JNEUROSCI.0057-11.2011; Yang JN, 2009, AM J PHYSIOL-HEART C, V296, pH1141, DOI 10.1152/ajpheart.00754.2008	36	36	36	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e35396	10.1371/journal.pone.0035396	http://dx.doi.org/10.1371/journal.pone.0035396			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523589	Green Published, gold, Green Submitted			2022-12-27	WOS:000305345000062
J	Sollmann, R; Gardner, B; Belant, JL				Sollmann, Rahel; Gardner, Beth; Belant, Jerrold L.			How Does Spatial Study Design Influence Density Estimates from Spatial Capture-Recapture Models?	PLOS ONE			English	Article							POPULATION-SIZE; HIERARCHICAL MODEL; BROWN BEARS; BLACK; SEX	When estimating population density from data collected on non-invasive detector arrays, recently developed spatial capture-recapture (SCR) models present an advance over non-spatial models by accounting for individual movement. While these models should be more robust to changes in trapping designs, they have not been well tested. Here we investigate how the spatial arrangement and size of the trapping array influence parameter estimates for SCR models. We analysed black bear data collected with 123 hair snares with an SCR model accounting for differences in detection and movement between sexes and across the trapping occasions. To see how the size of the trap array and trap dispersion influence parameter estimates, we repeated analysis for data from subsets of traps: 50% chosen at random, 50% in the centre of the array and 20% in the South of the array. Additionally, we simulated and analysed data under a suite of trap designs and home range sizes. In the black bear study, we found that results were similar across trap arrays, except when only 20% of the array was used. Black bear density was approximately 10 individuals per 100 km(2). Our simulation study showed that SCR models performed well as long as the extent of the trap array was similar to or larger than the extent of individual movement during the study period, and movement was at least half the distance between traps. SCR models performed well across a range of spatial trap setups and animal movements. Contrary to non-spatial capture-recapture models, they do not require the trapping grid to cover an area several times the average home range of the studied species. This renders SCR models more appropriate for the study of wide-ranging mammals and more flexible to design studies targeting multiple species.	[Sollmann, Rahel; Gardner, Beth] N Carolina State Univ, Dept Environm Resources, Fisheries & Wildlife Program, Raleigh, NC 27695 USA; [Belant, Jerrold L.] Mississippi State Univ, Forest & Wildlife Res Ctr, Carnivore Ecol Lab, Mississippi State, MS 39762 USA	University of North Carolina; North Carolina State University; Mississippi State University	Sollmann, R (corresponding author), N Carolina State Univ, Dept Environm Resources, Fisheries & Wildlife Program, Raleigh, NC 27695 USA.	rsollma@ncsu.edu	Belant, Jerrold/HDM-7749-2022		US National Park Service	US National Park Service	Field work was funded by the US National Park Service. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1982, ESTIMATION ANIMAL AB; Belant JL, 2005, URSUS, V16, P85, DOI 10.2192/1537-6176(2005)016[0085:ABBPSA]2.0.CO;2; Benson JF, 2006, ANIM BEHAV, V71, P685, DOI 10.1016/j.anbehav.2005.08.005; BONDRUPNIELSEN S, 1983, CAN J ZOOL, V61, P2361, DOI 10.1139/z83-313; Boulanger J, 2001, CAN J ZOOL, V79, P642, DOI 10.1139/cjz-79-4-642; Carter NH, 2010, URSUS, V21, P57, DOI 10.2192/09GR011.1; CASELLA G, 1992, AM STAT, V46, P167, DOI 10.2307/2685208; Dahle B, 2003, J ZOOL, V260, P329, DOI 10.1017/S0952836903003753; Dillon A, 2007, ORYX, V41, P469, DOI 10.1017/S0030605307000518; Efford M, 2004, OIKOS, V106, P598, DOI 10.1111/j.0030-1299.2004.13043.x; ENNIS S, 1994, ANIM GENET, V25, P425, DOI 10.1111/j.1365-2052.1994.tb00533.x; Gardner B, 2010, J WILDLIFE MANAGE, V74, P318, DOI 10.2193/2009-101; Gelman A., 2004, BAYESIAN DATA ANAL; Gelman A., 2007, DATA ANAL USING REGR, DOI 10.1017/CBO9780511790942; GILKS WR, 1994, J R STAT SOC D-STAT, V43, P169, DOI DOI 10.2307/2348941; JETT DA, 1987, J MAMMAL, V68, P888, DOI 10.2307/1381576; Karanth KU, 1998, ECOLOGY, V79, P2852; Koehler GM, 2003, J MAMMAL, V84, P81, DOI 10.1644/1545-1542(2003)084<0081:BBHRSI>2.0.CO;2; Maffei L, 2008, BIOTROPICA, V40, P71, DOI 10.1111/j.1744-7429.2007.00341.x; Marques TA, 2011, ECOLOGY, V92, P526, DOI 10.1890/10-1440.1; Mowat G, 2000, J WILDLIFE MANAGE, V64, P183, DOI 10.2307/3802989; Mulders R, 2007, WILDLIFE BIOL, V13, P38, DOI 10.2981/0909-6396(2007)13[38:EOPSFW]2.0.CO;2; Oli Madan K., 2002, Journal for Nature Conservation (Jena), V10, P87, DOI 10.1078/1617-1381-00010; OTIS DL, 1978, WILDLIFE MONOGR, P1; Paetkau D, 1998, MOL ECOL, V7, P1283, DOI 10.1046/j.1365-294x.1998.00440.x; Parmenter RR, 2003, ECOL MONOGR, V73, P1, DOI 10.1890/0012-9615(2003)073[0001:SMDEAF]2.0.CO;2; Poelker RJ, 1973, BLACK BEAR WASHINGTO; POLLOCK KH, 1990, WILDLIFE MONOGR, P1; R Core Team, 2016, R FDN STAT COMP; Reppucci J, 2011, J MAMMAL, V92, P140, DOI 10.1644/10-MAMM-A-053.1; Royle J. A., 2008, HIERARCHICAL MODELIN; Royle JA, 2008, ECOLOGY, V89, P2281, DOI 10.1890/07-0601.1; Royle JA, 2007, J COMPUT GRAPH STAT, V16, P67, DOI 10.1198/106186007X181425; Royle JA, 2009, J APPL ECOL, V46, P118, DOI 10.1111/j.1365-2664.2008.01578.x; Samson C, 2001, CAN J ZOOL, V79, P633, DOI 10.1139/cjz-79-4-633; STICKEL LF, 1954, J MAMMAL, V35, P1, DOI 10.2307/1376067; Sturtz S, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i03; Williams B. K., 2002, ANAL MANAGEMENT ANIM; WILSON KR, 1985, J MAMMAL, V66, P13, DOI 10.2307/1380951; Woods JG, 1999, WILDLIFE SOC B, V27, P616	40	137	140	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e34575	10.1371/journal.pone.0034575	http://dx.doi.org/10.1371/journal.pone.0034575			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22539949	Green Submitted, gold, Green Published			2022-12-27	WOS:000305341000012
J	Guan, HB; Singh, NP; Singh, UP; Nagarkatti, PS; Nagarkatti, M				Guan, Hongbing; Singh, Narendra P.; Singh, Udai P.; Nagarkatti, Prakash S.; Nagarkatti, Mitzi			Resveratrol Prevents Endothelial Cells Injury in High-Dose Interleukin-2 Therapy against Melanoma	PLOS ONE			English	Article							VASCULAR LEAK SYNDROME; IMMATURE MYELOID CELLS; SUPPRESSOR-CELLS; T-CELLS; RECOMBINANT INTERLEUKIN-2; CYTOSOLIC FOXO1; NK CELLS; IMMUNOTHERAPY; INDUCTION; CARCINOMA	Immunotherapy with high-dose interleukin-2 (HDIL-2) is an effective treatment for patients with metastatic melanoma and renal cell carcinoma. However, it is accompanied by severe toxicity involving endothelial cell injury and induction of vascular leak syndrome (VLS). In this study, we found that resveratrol, a plant polyphenol with anti-inflammatory and anti-cancer properties, was able to prevent the endothelial cell injury and inhibit the development of VLS while improving the efficacy of HDIL-2 therapy in the killing of metastasized melanoma. Specifically, C57BL/6 mice were injected with B16F10 cells followed by resveratrol by gavage the next day and continued treatment with resveratrol once a day. On day 9, mice received HDIL-2. On day 12, mice were evaluated for VLS and tumor metastasis. We found that resveratrol significantly inhibited the development of VLS in lung and liver by protecting endothelial cell integrity and preventing endothelial cells from undergoing apoptosis. The metastasis and growth of the tumor in lung were significantly inhibited by HDIL-2 and HDIL-2 + resveratrol treatment. Notably, HDIL-2 + resveratrol co-treatment was more effective in inhibiting tumor metastasis and growth than HDIL-2 treatment alone. We also analyzed the immune status of Gr-1(+)CD11b(+) myeloid-derived suppressor cells (MDSC) and FoxP3(+)CD4(+) regulatory T cells (Treg). We found that resveratrol induced expansion and suppressive function of MDSC which inhibited the development of VLS after adoptive transfer. However, resveratrol suppressed the HDIL-2-induced expansion of Treg cells. We also found that resveratrol enhanced the susceptibility of melanoma to the cytotoxicity of IL-2-activated killer cells, and induced the expression of the tumor suppressor gene FoxO1. Our results suggested the potential use of resveratrol in HDIL-2 treatment against melanoma. We also demonstrated, for the first time, that MDSC is the dominant suppressor cell than regulatory T cell in the development of VLS.	[Guan, Hongbing; Singh, Narendra P.; Singh, Udai P.; Nagarkatti, Prakash S.; Nagarkatti, Mitzi] Univ S Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC 29208 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Nagarkatti, M (corresponding author), Univ S Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC 29208 USA.	Mitzi.Nagarkatti@uscmed.sc.edu		Nagarkatti, Prakash/0000-0003-2663-0759; Singh, Udai/0000-0002-7048-4325	National Institute of Health [R01 AI053703, R01 AI058300, R01 HL058641, P01 AT003961]; National Center for Complementary & Integrative Health [P01AT003961] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058641] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058300, R01AI053703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES019313] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in part by National Institute of Health Grants R01 AI053703, R01 AI058300, R01 HL058641, and P01 AT003961. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assier E, 2004, J IMMUNOL, V172, P7661, DOI 10.4049/jimmunol.172.12.7661; Baluna R, 1997, IMMUNOPHARMACOLOGY, V37, P117, DOI 10.1016/S0162-3109(97)00041-6; Baluna R, 1999, P NATL ACAD SCI USA, V96, P3957, DOI 10.1073/pnas.96.7.3957; COTRAN RS, 1988, J IMMUNOL, V140, P1883; DAMLE NK, 1989, J IMMUNOL, V142, P2660; Donskov F, 2004, CANCER IMMUNOL IMMUN, V53, P729, DOI 10.1007/s00262-004-0525-9; Dutcher J, 2002, ONCOLOGY-NY, V16, P4; Elies J, 2011, MOL NUTR FOOD RES, V55, P1237, DOI 10.1002/mnfr.201100240; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Gatouillat G, 2010, J CELL BIOCHEM, V110, P893, DOI 10.1002/jcb.22601; Greten TF, 2011, INT IMMUNOPHARMACOL, V11, P802, DOI 10.1016/j.intimp.2011.01.003; Guan H, 2007, J IMMUNOL, V179, P3715, DOI 10.4049/jimmunol.179.6.3715; Gupta SC, 2011, ANN NY ACAD SCI, V1215, P150, DOI 10.1111/j.1749-6632.2010.05852.x; Hoechst B, 2009, HEPATOLOGY, V50, P799, DOI 10.1002/hep.23054; Kusmartsev S, 2005, J IMMUNOL, V174, P4880, DOI 10.4049/jimmunol.174.8.4880; Kusmartsev S, 2004, J IMMUNOL, V172, P989, DOI 10.4049/jimmunol.172.2.989; Lentsch AB, 1999, CANCER IMMUNOL IMMUN, V47, P243, DOI 10.1007/s002620050527; Li HQ, 2009, J IMMUNOL, V182, P240, DOI 10.4049/jimmunol.182.1.240; McDermott DF, 2009, CANCER-AM CANCER SOC, V115, P2298, DOI 10.1002/cncr.24236; McKallip RJ, 2003, J BIOL CHEM, V278, P43818, DOI 10.1074/jbc.M304467200; Medema RH, 2010, NAT CELL BIOL, V12, P642, DOI 10.1038/ncb0710-642; Melencio L, 2006, INT IMMUNOL, V18, P1461, DOI 10.1093/intimm/dxl079; Movahedi K, 2008, BLOOD, V111, P4233, DOI 10.1182/blood-2007-07-099226; Mustafa A, 2002, J IMMUNOTHER, V25, P476, DOI 10.1097/00002371-200211000-00004; Nagaraj S, 2007, NAT MED, V13, P828, DOI 10.1038/nm1609; Namasivayam N, 2011, ANN NY ACAD SCI, V1215, P60, DOI 10.1111/j.1749-6632.2010.05873.x; Narita Y, 2009, BIOMED RES-TOKYO, V30, P7, DOI 10.2220/biomedres.30.7; Osmond GW, 2012, J SURG RES, V172, P109, DOI 10.1016/j.jss.2010.07.033; Rafi AQ, 1998, J IMMUNOL, V161, P3077; Rodriguez PC, 2009, CANCER RES, V69, P1553, DOI 10.1158/0008-5472.CAN-08-1921; ROSENBERG SA, 1985, J EXP MED, V161, P1169, DOI 10.1084/jem.161.5.1169; ROSENSTEIN M, 1986, J IMMUNOL, V137, P1735; Schwartz RN, 2002, ONCOLOGY-NY, V16, P11; Singh NP, 2007, MOL PHARMACOL, V72, P1508, DOI 10.1124/mol.107.038984; Singh NP, 2011, MOL NUTR FOOD RES, V55, P1207, DOI 10.1002/mnfr.201000576; Singh UP, 2012, BRAIN BEHAV IMMUN, V26, P72, DOI 10.1016/j.bbi.2011.07.236; Wang H, 2011, HEART FAIL REV; Watanabe S, 2008, J IMMUNOL, V181, P3291, DOI 10.4049/jimmunol.181.5.3291; Yang Y, 2008, INT IMMUNOPHARMACOL, V8, P542, DOI 10.1016/j.intimp.2007.12.006; Zhao Y, 2010, NAT CELL BIOL, V12, P665, DOI 10.1038/ncb2069	40	39	41	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35650	10.1371/journal.pone.0035650	http://dx.doi.org/10.1371/journal.pone.0035650			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22532866	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339200090
J	Liu, YC; Lin, IH; Chung, WJ; Hu, WS; Ng, WV; Lu, CY; Huang, TY; Shu, HW; Hsiao, KJ; Tsai, SF; Chang, CH; Lin, CH				Liu, Yi-Chang; Lin, I-Hsuan; Chung, Wei-Jen; Hu, Wensi S.; Ng, Wailap Victor; Lu, Chi-Yu; Huang, Tsung-Yen; Shu, Hung-Wei; Hsiao, Kwang-Jen; Tsai, Shih-Feng; Chang, Chuan-Hsiung; Lin, Chao-Hsiung			Proteomics Characterization of Cytoplasmic and Lipid-Associated Membrane Proteins of Human Pathogen Mycoplasma fermentans M64	PLOS ONE			English	Article							FREQUENCY PHASE VARIATION; TOLL-LIKE RECEPTORS; NF-KAPPA-B; SURFACE LIPOPROTEIN; 2-DIMENSIONAL ELECTROPHORESIS; PHYLOGENETIC ANALYSIS; COMPLETE GENOME; PNEUMONIAE; CELL; IDENTIFICATION	Mycoplasma fermentans is a potent human pathogen which has been implicated in several diseases. Notably, its lipid-associated membrane proteins (LAMPs) play a role in immunomodulation and development of infection-associated inflammatory diseases. However, the systematic protein identification of pathogenic M. fermentans has not been reported. From our recent sequencing results of M. fermentans M64 isolated from human respiratory tract, its genome is around 1.1 Mb and encodes 1050 predicted protein-coding genes. In the present study, soluble proteome of M. fermentans was resolved and analyzed using two-dimensional gel electrophoresis. In addition, Triton X-114 extraction was carried out to enrich amphiphilic proteins including putative lipoproteins and membrane proteins. Subsequent mass spectrometric analyses of these proteins had identified a total of 181 M. fermentans ORFs. Further bioinformatics analysis of these ORFs encoding proteins with known or so far unknown orthologues among bacteria revealed that a total of 131 proteins are homologous to known proteins, 11 proteins are conserved hypothetical proteins, and the remaining 39 proteins are likely M. fermentans-specific proteins. Moreover, Triton X-114-enriched fraction was shown to activate NF-kB activity of raw264.7 macrophage and a total of 21 lipoproteins with predicted signal peptide were identified therefrom. Together, our work provides the first proteome reference map of M. fermentans as well as several putative virulence-associated proteins as diagnostic markers or vaccine candidates for further functional study of this human pathogen.	[Lin, I-Hsuan; Chung, Wei-Jen; Ng, Wailap Victor; Tsai, Shih-Feng; Chang, Chuan-Hsiung; Lin, Chao-Hsiung] Natl Yang Ming Univ, Inst Biomed Informat, Taipei 112, Taiwan; [Liu, Yi-Chang; Lin, Chao-Hsiung] Natl Yang Ming Univ, Inst Biopharmaceut Res, Taipei 112, Taiwan; [Lin, I-Hsuan] Acad Sinica, Bioinformat Program, Taiwan Int Grad Program, Taipei 115, Taiwan; [Hu, Wensi S.; Ng, Wailap Victor; Shu, Hung-Wei] Natl Yang Ming Univ, Inst Biotechnol Med, Taipei 112, Taiwan; [Ng, Wailap Victor; Lu, Chi-Yu; Lin, Chao-Hsiung] Natl Yang Ming Univ, Prote Res Ctr, Taipei 112, Taiwan; [Huang, Tsung-Yen; Tsai, Shih-Feng; Lin, Chao-Hsiung] Natl Yang Ming Univ, Dept Life Sci, Taipei 112, Taiwan; [Huang, Tsung-Yen; Tsai, Shih-Feng; Lin, Chao-Hsiung] Natl Yang Ming Univ, Inst Genome Sci, Taipei 112, Taiwan; [Hsiao, Kwang-Jen; Lin, Chao-Hsiung] Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan; [Tsai, Shih-Feng] Natl Hlth Res Inst, Div Mol & Genom Med, Zhunan, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Health Research Institutes - Taiwan	Chang, CH (corresponding author), Natl Yang Ming Univ, Inst Biomed Informat, Taipei 112, Taiwan.	cchang@ym.edu.tw; chlin2@ym.edu.tw	Tsai, Shih-Feng/E-3997-2010; Lin, I-Hsuan/N-6501-2013	LIN, CHAO-HSIUNG/0000-0001-6344-271X; Lin, I-Hsuan/0000-0002-6207-1299	National Science Council, Taiwan [NSC 98-2311-B-010-MY3, NSC 99-3112-B-010-018]; "Aim for the Top University Plan" from the Ministry of Education, Taiwan	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); "Aim for the Top University Plan" from the Ministry of Education, Taiwan	This work was supported by grant NSC 98-2311-B-010-MY3 (to CHL) and NSC 99-3112-B-010-018 (to CHC) from the National Science Council, Taiwan, as well as a funding of "Aim for the Top University Plan" from the Ministry of Education, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ansai T, 2003, ORAL MICROBIOL IMMUN, V18, P398, DOI 10.1046/j.0902-0055.2003.00080.x; Ashton PD, 2001, TRENDS PARASITOL, V17, P198, DOI 10.1016/S1471-4922(00)01947-4; Bizarro CV, 2007, GENET MOL BIOL, V30, P190, DOI 10.1590/S1415-47572007000200005; BLANCHARD A, 1994, ANNU REV MICROBIOL, V48, P687, DOI 10.1146/annurev.mi.48.100194.003351; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; BORDIER C, 1981, J BIOL CHEM, V256, P1604; Cacciotto C, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-225; Calcutt MJ, 1999, INFECT IMMUN, V67, P760, DOI 10.1128/IAI.67.2.760-771.1999; Calcutt MJ, 2002, J BACTERIOL, V184, P6929, DOI 10.1128/JB.184.24.6929-6941.2002; Carvalho FM, 2005, GENE, V360, P111, DOI 10.1016/j.gene.2005.06.012; Catrein I, 2011, PROTEOMICS, V11, P3614, DOI 10.1002/pmic.201100076; Chang AH, 2010, CLIN MICROBIOL REV, V23, P837, DOI 10.1128/CMR.00012-10; DUDLER R, 1988, EMBO J, V7, P3963, DOI 10.1002/j.1460-2075.1988.tb03283.x; FENG SH, 1994, INFECT IMMUN, V62, P3916, DOI 10.1128/IAI.62.9.3916-3921.1994; Ferrer-Navarro M, 2006, J PROTEOME RES, V5, P688, DOI 10.1021/pr050340p; Fisunov GY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021964; Fu SL, 2006, BIOCHEM BIOPH RES CO, V339, P137, DOI 10.1016/j.bbrc.2005.11.005; Fuchs TM, 1996, J BACTERIOL, V178, P4445, DOI 10.1128/jb.178.15.4445-4452.1996; Garnier M, 2001, CR ACAD SCI III-VIE, V324, P923, DOI 10.1016/S0764-4469(01)01372-5; Gharahdaghi F, 1999, ELECTROPHORESIS, V20, P601, DOI 10.1002/(SICI)1522-2683(19990301)20:3<601::AID-ELPS601>3.0.CO;2-6; Gorg A, 2000, ELECTROPHORESIS, V21, P1037, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1037::AID-ELPS1037>3.0.CO;2-V; Gorg A, 2004, PROTEOMICS, V4, P3665, DOI 10.1002/pmic.200401031; Havlis J, 2003, ANAL CHEM, V75, P1300, DOI 10.1021/ac026136s; He X, 2006, MICROB PATHOGENESIS, V41, P199, DOI 10.1016/j.micpath.2006.07.001; Herrmann R, 1998, CURR OPIN MICROBIOL, V1, P572, DOI 10.1016/S1369-5274(98)80091-X; Hopfe M, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-46; Hopfe M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-55; Hu WS, 1998, CURR MICROBIOL, V37, P1, DOI 10.1007/s002849900327; Hutchison CA, 1999, SCIENCE, V286, P2165, DOI 10.1126/science.286.5447.2165; Jaffe JD, 2004, GENOME RES, V14, P1447, DOI 10.1101/gr.2674004; Jaffe JD, 2004, PROTEOMICS, V4, P59, DOI 10.1002/pmic.200300511; Johnson SJ, 2008, J MOL BIOL, V377, P1460, DOI 10.1016/j.jmb.2008.01.096; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; Jungblut PR, 2001, MICROBES INFECT, V3, P831, DOI 10.1016/S1286-4579(01)01441-1; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kitzerow A, 2001, MOL MICROBIOL, V41, P279, DOI 10.1046/j.1365-2958.2001.02524.x; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kuhner S, 2009, SCIENCE, V326, P1235, DOI 10.1126/science.1176343; Leigh SA, 2002, INFECT IMMUN, V70, P4925, DOI 10.1128/IAI.70.9.4925-4935.2002; Lenz LL, 1996, IMMUNITY, V5, P63, DOI 10.1016/S1074-7613(00)80310-6; LO SC, 1989, AM J TROP MED HYG, V41, P586, DOI 10.4269/ajtmh.1989.41.586; Lu T, 2009, CHARACTERIZATION STR; Magnan CN, 2010, BIOINFORMATICS, V26, P2936, DOI 10.1093/bioinformatics/btq551; Matsuda K, 2009, MYCOPLASMA FERMENTAN; McGowin CL, 2009, INFECT IMMUN, V77, P1175, DOI 10.1128/IAI.00845-08; Menegatti ACO, 2010, VET MICROBIOL, V145, P134, DOI 10.1016/j.vetmic.2010.03.006; MITCHELL A, 1977, J BACTERIOL, V130, P1047, DOI 10.1128/JB.130.3.1047-1054.1977; Nouvel LX, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-86; OLSON LD, 1993, FEMS MICROBIOL LETT, V108, P47; Pinto PM, 2009, PROTEOME SCI, V7, DOI 10.1186/1477-5956-7-45; Pinto PM, 2007, VET MICROBIOL, V121, P83, DOI 10.1016/j.vetmic.2006.11.018; Pollack J. Dennis, 2002, OMICS A Journal of Integrative Biology, V6, P247, DOI 10.1089/15362310260256909; Rawadi G, 2000, MICROBES INFECT, V2, P955, DOI 10.1016/S1286-4579(00)00395-6; RAZIN S, 1978, MICROBIOL REV, V42, P414, DOI 10.1128/MMBR.42.2.414-470.1978; Razin S, 1998, MICROBIOL MOL BIOL R, V62, P1094, DOI 10.1128/MMBR.62.4.1094-1156.1998; Regula JT, 2000, ELECTROPHORESIS, V21, P3765, DOI 10.1002/1522-2683(200011)21:17<3765::AID-ELPS3765>3.0.CO;2-6; Regula JT, 2001, MICROBIOL-UK, V147, P1045, DOI 10.1099/00221287-147-4-1045; Romero F, 2004, CURR MICROBIOL, V48, P237, DOI 10.1007/s00284-003-4134-1; Seya T, 2002, INT J BIOCHEM CELL B, V34, P901, DOI 10.1016/S1357-2725(01)00164-9; Sharma A, 1998, INFECT IMMUN, V66, P5703, DOI 10.1128/IAI.66.12.5703-5710.1998; Shimizu T, 2004, IMMUNOLOGY, V113, P121, DOI 10.1111/j.1365-2567.2004.01937.x; Shimizu T, 2008, INFECT IMMUN, V76, P3672, DOI 10.1128/IAI.00257-08; Shu H-W, 2011, J BACTERIOLJB, P05228; Sippel KH, 2009, J BACTERIOL, V191, P2585, DOI 10.1128/JB.01680-08; Sirand-Pugnet P, 2007, PLOS GENET, V3, P744, DOI 10.1371/journal.pgen.0030075; Strittmatter A, MYCOPLASMA FERMENTAN; Sweredoski MJ, 2009, PROTEIN ENG DES SEL, V22, P113, DOI 10.1093/protein/gzn075; Tamura K, 2011, MOL BIOL EVOL; Theiss P, 1997, J BACTERIOL, V179, P4013, DOI 10.1128/jb.179.12.4013-4022.1997; Theiss P, 1996, INFECT IMMUN, V64, P1800, DOI 10.1128/IAI.64.5.1800-1809.1996; Tola S, 2001, FEMS MICROBIOL LETT, V202, P45, DOI 10.1111/j.1574-6968.2001.tb10778.x; Ueberle B, 2002, PROTEOMICS, V2, P754, DOI 10.1002/1615-9861(200206)2:6<754::AID-PROT754>3.0.CO;2-2; Vasconcelos ATR, 2005, J BACTERIOL, V187, P5568, DOI 10.1128/JB.187.16.5568-5577.2005; von Mering C, 2007, NUCLEIC ACIDS RES, V35, pD358, DOI 10.1093/nar/gkl825; Wang LY, 2001, MOL MICROBIOL, V42, P1065, DOI 10.1046/j.1365-2958.2001.02700.x; Wasinger VC, 2000, EUR J BIOCHEM, V267, P1571, DOI 10.1046/j.1432-1327.2000.01183.x; WEISBURG WG, 1989, J BACTERIOL, V171, P6455, DOI 10.1128/jb.171.12.6455-6467.1989; WOESE CR, 1980, P NATL ACAD SCI-BIOL, V77, P494, DOI 10.1073/pnas.77.1.494; Wright SH, 2011, ADV NPS PAS, V2, P32; Wright Sonja Huebner, 2011, Adv NPs PAs, V2, P29; Yus E, 2009, SCIENCE, V326, P1263, DOI 10.1126/science.1177263	83	16	22	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35304	10.1371/journal.pone.0035304	http://dx.doi.org/10.1371/journal.pone.0035304			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536369	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339200051
J	Masuda, K; Koizumi, A; Nakajima, K; Tanaka, T; Abe, K; Misaka, T; Ishiguro, M				Masuda, Katsuyoshi; Koizumi, Ayako; Nakajima, Ken-ichiro; Tanaka, Takaharu; Abe, Keiko; Misaka, Takumi; Ishiguro, Masaji			Characterization of the Modes of Binding between Human Sweet Taste Receptor and Low-Molecular-Weight Sweet Compounds	PLOS ONE			English	Article							METABOTROPIC GLUTAMATE-RECEPTOR; PROTEIN-COUPLED RECEPTORS; AMINO-TERMINAL DOMAIN; LIGAND-BINDING; UMAMI TASTE; EXTRACELLULAR DOMAIN; T1R2-T1R3 RECEPTOR; MAMMALIAN SWEET; MECHANISM; T1R3	One of the most distinctive features of human sweet taste perception is its broad tuning to chemically diverse compounds ranging from low-molecular-weight sweeteners to sweet-tasting proteins. Many reports suggest that the human sweet taste receptor (hT1R2-hT1R3), a heteromeric complex composed of T1R2 and T1R3 subunits belonging to the class C G protein-coupled receptor family, has multiple binding sites for these sweeteners. However, it remains unclear how the same receptor recognizes such diverse structures. Here we aim to characterize the modes of binding between hT1R2-hT1R3 and low-molecular-weight sweet compounds by functional analysis of a series of site-directed mutants and by molecular modeling-based docking simulation at the binding pocket formed on the large extracellular amino-terminal domain (ATD) of hT1R2. We successfully determined the amino acid residues responsible for binding to sweeteners in the cleft of hT1R2 ATD. Our results suggest that individual ligands have sets of specific residues for binding in correspondence with the chemical structures and other residues responsible for interacting with multiple ligands.	[Koizumi, Ayako; Nakajima, Ken-ichiro; Abe, Keiko; Misaka, Takumi] Univ Tokyo, Dept Appl Biol Chem, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo, Japan; [Masuda, Katsuyoshi; Tanaka, Takaharu; Ishiguro, Masaji] Suntory Inst Bioorgan Res, Osaka, Japan; [Abe, Keiko] Kanagawa Acad Sci & Technol, Food Safety & Reliabil Project, Kawasaki, Kanagawa, Japan; [Ishiguro, Masaji] Niigata Univ Pharm & Appl Life Sci, Akiha Ku, Niigata, Japan	University of Tokyo; Suntory Holdings Ltd; Kanagawa Academy Science & Technology; Niigata University	Misaka, T (corresponding author), Univ Tokyo, Dept Appl Biol Chem, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo, Japan.	amisaka@mail.ecc.u-tokyo.ac.jp; ishiguro@nupals.ac.jp		Nakajima, Ken-ichiro/0000-0003-1932-418X; Misaka, Takumi/0000-0002-9547-5767	Research and Development Program for New Bio-industry Initiatives of the Bio-oriented Technology Research Advancement Institution; Japan Society for the Promotion of Science Research Fellowship for Young Scientists; Ministry of Education, Culture, Sports, Science and Technology of Japan [21880015, 20688015, 21658046, 20380183]	Research and Development Program for New Bio-industry Initiatives of the Bio-oriented Technology Research Advancement Institution; Japan Society for the Promotion of Science Research Fellowship for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was performed with a grant from the Research and Development Program for New Bio-industry Initiatives of the Bio-oriented Technology Research Advancement Institution. This work was also supported by the Japan Society for the Promotion of Science Research Fellowship for Young Scientists (to AK) and by Grants-in-aid for Scientific Research 21880015 (to KN), 20688015 and 21658046 (to TM) and 20380183 (to KA) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assadi-Porter FM, 2010, J MOL BIOL, V398, P584, DOI 10.1016/j.jmb.2010.03.017; Brauner-Osborne H, 1999, J BIOL CHEM, V274, P18382, DOI 10.1074/jbc.274.26.18382; Chandrashekar J, 2006, NATURE, V444, P288, DOI 10.1038/nature05401; Cui M, 2006, CURR PHARM DESIGN, V12, P4591, DOI 10.2174/138161206779010350; Galindo-Cuspinera V, 2006, NATURE, V441, P354, DOI 10.1038/nature04765; Galvez T, 2000, J BIOL CHEM, V275, P41166, DOI 10.1074/jbc.M007848200; Galvez T, 1999, J BIOL CHEM, V274, P13362, DOI 10.1074/jbc.274.19.13362; Hammerland LG, 1999, MOL PHARMACOL, V55, P642; Imada T, 2010, BIOCHEM BIOPH RES CO, V397, P220, DOI 10.1016/j.bbrc.2010.05.088; Jiang PH, 2005, J BIOL CHEM, V280, P34296, DOI 10.1074/jbc.M505255200; Jiang PH, 2004, J BIOL CHEM, V279, P45068, DOI 10.1074/jbc.M406779200; Koizumi A, 2007, BIOCHEM BIOPH RES CO, V358, P585, DOI 10.1016/j.bbrc.2007.04.171; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; Li XD, 2002, P NATL ACAD SCI USA, V99, P4692, DOI 10.1073/pnas.072090199; Liu B, 2011, J NEUROSCI, V31, P11070, DOI 10.1523/JNEUROSCI.0791-11.2011; Morini G, 2005, J MED CHEM, V48, P5520, DOI 10.1021/jm0503345; Muto T, 2007, P NATL ACAD SCI USA, V104, P3759, DOI 10.1073/pnas.0611577104; Nakajima K, 2006, NEUROREPORT, V17, P1241, DOI 10.1097/01.wnr.0000230513.01339.3b; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; Pin JP, 2003, PHARMACOL THERAPEUT, V98, P325, DOI 10.1016/S0163-7258(03)00038-X; Temussi PA, 2002, FEBS LETT, V526, P1, DOI 10.1016/S0014-5793(02)03155-1; Tsuchiya D, 2002, P NATL ACAD SCI USA, V99, P2660, DOI 10.1073/pnas.052708599; Ueda T, 2003, J NEUROSCI, V23, P7376; Walters DE, 2006, J AGR FOOD CHEM, V54, P10129, DOI 10.1021/jf062359y; Walters DE, 2002, PURE APPL CHEM, V74, P1117, DOI 10.1351/pac200274071117; Wellendorph P, 2009, BRIT J PHARMACOL, V156, P869, DOI 10.1111/j.1476-5381.2008.00078.x; Winnig M, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-66; Xu H, 2004, P NATL ACAD SCI USA, V101, P14258, DOI 10.1073/pnas.0404384101; Zhang F, 2010, P NATL ACAD SCI USA, V107, P4752, DOI 10.1073/pnas.0911660107; Zhang F, 2008, P NATL ACAD SCI USA, V105, P20930, DOI 10.1073/pnas.0810174106; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4	31	96	96	5	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35380	10.1371/journal.pone.0035380	http://dx.doi.org/10.1371/journal.pone.0035380			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536376	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339200061
J	Mutanga, JN; Raymond, J; Towle, MS; Mutembo, S; Fubisha, RC; Lule, F; Muhe, L				Mutanga, Jane N.; Raymond, Juliette; Towle, Megan S.; Mutembo, Simon; Fubisha, Robert Captain; Lule, Frank; Muhe, Lulu			Institutionalizing Provider-Initiated HIV Testing and Counselling for Children: An Observational Case Study from Zambia	PLOS ONE			English	Article							CARE; CHALLENGES; SETTINGS; AFRICA	Background: Provider-initiated testing and counselling (PITC) is a priority strategy for increasing access for HIV-exposed children to prevention measures, and infected children to treatment and care interventions. This article examines efforts to scale-up paediatric PITC at a second-level hospital located in Zambia's Southern Province, and serving a catchment area of 1.2 million people. Methods and Principal Findings: Our retrospective case study examined best practices and enabling factors for rapid institutionalization of PITC in Livingstone General Hospital. Methods included clinical observations, key informant interviews with programme management, and a desk review of hospital management information systems (HMIS) uptake data following the introduction of PITC. After PITC roll-out, the hospital experienced considerably higher testing uptake. In a 36-month period following PITC institutionalization, of total inpatient children eligible for PITC (n = 5074), 98.5% of children were counselled, and 98.2% were tested. Of children tested (n = 4983), 15.5% were determined HIV-infected; 77.6% of these results were determined by DNA polymerase chain reaction (PCR) testing in children under the age of 18 months. Of children identified as HIV-infected in the hospital's inpatient and outpatient departments (n = 1342), 99.3% were enrolled in HIV care, including initiation on co-trimoxazole prophylaxis. A number of good operational practices and enabling factors in the Livingstone General Hospital experience can inform rapid PITC institutionalization for inpatient and outpatient children. These include the placement of full-time nurse counsellors at key areas of paediatric intake, who interface with patients immediately and conduct testing and counselling. They are reinforced through task-shifting to peer counsellors in the wards. Nurse counsellor capacity to draw specimen for DNA PCR for children under 18 months has significantly enhanced early infant diagnosis. The hospital's bolstered antiretroviral supply chain, package of on-site HIV services, and follow-up care for children and families improved the continuum of service uptake. Conclusions and Significance: The clinical impact and operational experience emphasizes that institutional PITC is a feasible strategy for increasing access to paediatric HIV care, particularly in generalized epidemic settings.	[Mutanga, Jane N.] Livingstone Gen Hosp, Livingstone, Zambia; [Mutembo, Simon] So Prov Med Off, Livingstone, Zambia; [Fubisha, Robert Captain] Livingstone Paediat Ctr Excellence, Dept Paediat & Child Hlth, Livingstone, Zambia; [Lule, Frank] WHO, Reg Off Afr, Brazzaville, Rep Congo; [Muhe, Lulu] World Hlth Org Headquarters, Geneva, Switzerland	World Health Organization; World Health Organization	Muhe, L (corresponding author), Livingstone Gen Hosp, Livingstone, Zambia.	muhel@who.int	Mutanga, Jane N./AAO-1771-2020	Mutanga, Jane Namangolwa/0000-0002-1951-3565; mutembo, simon/0000-0002-5389-5966; Muhe, Lulu M/0000-0002-2776-9923	World Health Organization (WHO) Headquarters, Maternal, Child and Adolescent Health Department	World Health Organization (WHO) Headquarters, Maternal, Child and Adolescent Health Department	World Health Organization (WHO) Headquarters, Maternal, Child and Adolescent Health Department, provided financial support for the documentation of best practices at Livingstone General Hospital by an external consultant. LM is a staff member at the WHO Headquarters Maternal, Child and Adolescent Health Department. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, EP FACT SHEET HIV AI; Bolu OO, 2007, AM J OBSTET GYNECOL, V197, pS83, DOI 10.1016/j.ajog.2007.03.006; Eley B, 2007, ANN TROP PAEDIATR, V27, P1, DOI 10.1179/146532807X170448; Jones SA, 2005, B WORLD HEALTH ORGAN, V83, P559; Kankasa C, 2009, JAIDS-J ACQ IMM DEF, V51, P202, DOI 10.1097/QAI.0b013e31819c173f; Livingstone General Hospital, HLTH INF MAN SYST; McCollum ED, 2011, PEDIATR INFECT DIS J, V30, pE75, DOI 10.1097/INF.0b013e3182103f8a; McCollum ED, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009626; Meyers T, 2007, J INFECT DIS, V196, pS474, DOI 10.1086/521116; Ministry of Health Republic of Zambia, 2007, ZAMB DEM HLTH SURV; Ministry of Health Republic of Zambia, 2006, ZAMB NAT GUID HIV CO; Ministry of Health Republic of Zambia, 2007, PS MEM PROV IN TEST; Mwale JC, 2008, USING QUALITY IMPROV; Newell ML, 2004, LANCET, V364, P1236, DOI 10.1016/S0140-6736(04)17140-7; Orne-Gliemann J, 2008, AIDS, V22, P797, DOI 10.1097/QAD.0b013e3282f4f45a; Republic of Zambia Ministry of Health, 2008, ASS IMPL STAT PROV I; Sabin M, 2010, JAMA-J AM MED ASSOC, V304, P342, DOI 10.1001/jama.2010.995; Sherman GG, 2004, SAMJ S AFR MED J, V94, P289; Tene G, 2006, OPTIMIZING ENTRY CAR; Topp SM, 2011, B WORLD HEALTH ORGAN, V89, P328, DOI 10.2471/BLT.10.084442; UNAIDS, 2009, ZAMB COUNTR PROF; UNICEF, 2008, CHILDR AIDS 3 STOCKT; van Dijk JH, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-169; Wanyenze RK, 2010, TROP MED INT HEALTH, V15, P113, DOI 10.1111/j.1365-3156.2009.02417.x; Weigel R, 2009, BMC PEDIAT, V9, P80; WHO, 2010, UNAIDS REP GLOB AIDS; WHO UNICEF, 2008, SCAL HIV REL PREV DI; World Health Organization, 2007, GUID PROV IN HIV TES; World Health Organization, 2010, UN ACC SCAL PRIOR HI	29	39	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e29656	10.1371/journal.pone.0029656	http://dx.doi.org/10.1371/journal.pone.0029656			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536311	gold, Green Published			2022-12-27	WOS:000305339200001
J	Ucher, AJ; Linehan, EK; Teebor, GW; Schrader, CE; Stavnezer, J				Ucher, Anna J.; Linehan, Erin K.; Teebor, George W.; Schrader, Carol E.; Stavnezer, Janet			The DNA Glycosylases Ogg1 and Nth1 Do Not Contribute to Ig Class Switching in Activated Mouse Splenic B Cells	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; SOMATIC HYPERMUTATION; TARGETED DELETION; RECOMBINATION; AID; DEFICIENCY; GENES; TRANSLOCATIONS; LYMPHOCYTES; REVEALS	During activation of B cells to undergo class switching, B cell metabolism is increased, and levels of reactive oxygen species (ROS) are increased. ROS can oxidize DNA bases resulting in substrates for the DNA glycosylases Ogg1 and Nth1. Ogg1 and Nth1 excise oxidized bases, and nick the resulting abasic sites, forming single-strand DNA breaks (SSBs) as intermediates during the repair process. In this study, we asked whether splenic B cells from mice deficient in these two enzymes would show altered class switching and decreased DNA breaks in comparison with wild-type mice. As the c-myc gene frequently recombines with the IgH S region in B cells induced to undergo class switching, we also analyzed the effect of deletion of these two glycosylases on DSBs in the c-myc gene. We did not detect a reduction in S region or c-myc DSBs or in class switching in splenic B cells from Ogg1- or Nth1-deficient mice or from mice deficient in both enzymes.	[Ucher, Anna J.; Linehan, Erin K.; Schrader, Carol E.; Stavnezer, Janet] Univ Massachusetts, Sch Med, Dept Microbiol & Physiol Syst, Worcester, MA 01605 USA; [Teebor, George W.] NYU, Med Ctr, Kaplan Comprehens Canc Ctr, Dept Pathol, New York, NY 10016 USA	University of Massachusetts System; University of Massachusetts Worcester; New York University	Stavnezer, J (corresponding author), Univ Massachusetts, Sch Med, Dept Microbiol & Physiol Syst, Worcester, MA 01605 USA.	janet.stavnezer@umassmed.edu		Schrader, Carol/0000-0001-8920-6803; Teebor, George/0000-0002-7397-2500	National Institutes of Health (NIH) [AI-RO1-023283, AI-R21-088578]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI088578, R01AI023283] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (NIH) AI-RO1-023283 and AI-R21-088578. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Catalan N, 2003, J IMMUNOL, V171, P2504, DOI 10.4049/jimmunol.171.5.2504; Chan MK, 2009, DNA REPAIR, V8, P786, DOI 10.1016/j.dnarep.2009.03.001; FEDYK ER, 1994, INT J IMMUNOPHARMACO, V16, P533, DOI 10.1016/0192-0561(94)90105-8; Guikema JEJ, 2007, J EXP MED, V204, P3017, DOI 10.1084/jem.20071289; Guikema JEJ, 2010, J IMMUNOL, V184, P6177, DOI 10.4049/jimmunol.0904085; Imai K, 2003, NAT IMMUNOL, V4, P1023, DOI 10.1038/ni974; Ito K, 2007, J IMMUNOL, V178, P103, DOI 10.4049/jimmunol.178.1.103; Klungland A, 1999, P NATL ACAD SCI USA, V96, P13300, DOI 10.1073/pnas.96.23.13300; Liu M, 2008, NATURE, V451, P841, DOI 10.1038/nature06547; Longerich S, 2007, DNA REPAIR AMST; Ocampo MTA, 2002, MOL CELL BIOL, V22, P6111, DOI 10.1128/MCB.22.17.6111-6121.2002; Peron S, 2008, J EXP MED, V205, P2465, DOI 10.1084/jem.20080789; Robbiani DF, 2009, MOL CELL, V36, P631, DOI 10.1016/j.molcel.2009.11.007; Robbiani DF, 2008, CELL, V135, P1028, DOI 10.1016/j.cell.2008.09.062; Schrader CE, 2007, J IMMUNOL, V179, P6064, DOI 10.4049/jimmunol.179.9.6064; Schrader CE, 2005, J EXP MED, V202, P561, DOI 10.1084/jem.20050872; Staszewski O, 2011, MOL CELL, V41, P232, DOI 10.1016/j.molcel.2011.01.007; Stavnezer J, 2008, ANNU REV IMMUNOL, V26, P261, DOI 10.1146/annurev.immunol.26.021607.090248; Tokuyama H, 1999, CELL IMMUNOL, V192, P41, DOI 10.1006/cimm.1998.1438; Winter DB, 2003, J IMMUNOL, V170, P5558, DOI 10.4049/jimmunol.170.11.5558; Yamane A, 2011, NAT IMMUNOL, V12, P62, DOI 10.1038/ni.1964	21	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e36061	10.1371/journal.pone.0036061	http://dx.doi.org/10.1371/journal.pone.0036061			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536455	Green Published, gold, Green Submitted			2022-12-27	WOS:000305339200127
J	Verde, I; Bassil, N; Scalabrin, S; Gilmore, B; Lawley, CT; Gasic, K; Micheletti, D; Rosyara, UR; Cattonaro, F; Vendramin, E; Main, D; Aramini, V; Blas, AL; Mockler, TC; Bryant, DW; Wilhelm, L; Troggio, M; Sosinski, B; Aranzana, MJ; Arus, P; Iezzoni, A; Morgante, M; Peace, C				Verde, Ignazio; Bassil, Nahla; Scalabrin, Simone; Gilmore, Barbara; Lawley, Cynthia T.; Gasic, Ksenija; Micheletti, Diego; Rosyara, Umesh R.; Cattonaro, Federica; Vendramin, Elisa; Main, Dorrie; Aramini, Valeria; Blas, Andrea L.; Mockler, Todd C.; Bryant, Douglas W.; Wilhelm, Larry; Troggio, Michela; Sosinski, Bryon; Jose Aranzana, Maria; Arus, Pere; Iezzoni, Amy; Morgante, Michele; Peace, Cameron			Development and Evaluation of a 9K SNP Array for Peach by Internationally Coordinated SNP Detection and Validation in Breeding Germplasm	PLOS ONE			English	Article							PRUNUS-PERSICA CULTIVARS; LINKAGE DISEQUILIBRIUM; GENOTYPING ASSAY; QTLS; QUALITY; GENES; SET	Although a large number of single nucleotide polymorphism (SNP) markers covering the entire genome are needed to enable molecular breeding efforts such as genome wide association studies, fine mapping, genomic selection and marker-assisted selection in peach [Prunus persica (L.) Batsch] and related Prunus species, only a limited number of genetic markers, including simple sequence repeats (SSRs), have been available to date. To address this need, an international consortium (The International Peach SNP Consortium; IPSC) has pursued a coordinated effort to perform genome-scale SNP discovery in peach using next generation sequencing platforms to develop and characterize a high-throughput Illumina Infinium (R) SNP genotyping array platform. We performed whole genome re-sequencing of 56 peach breeding accessions using the Illumina and Roche/454 sequencing technologies. Polymorphism detection algorithms identified a total of 1,022,354 SNPs. Validation with the Illumina GoldenGate (R) assay was performed on a subset of the predicted SNPs, verifying similar to 75% of genic (exonic and intronic) SNPs, whereas only about a third of intergenic SNPs were verified. Conservative filtering was applied to arrive at a set of 8,144 SNPs that were included on the IPSC peach SNP array v1, distributed over all eight peach chromosomes with an average spacing of 26.7 kb between SNPs. Use of this platform to screen a total of 709 accessions of peach in two separate evaluation panels identified a total of 6,869 (84.3%) polymorphic SNPs. The almost 7,000 SNPs verified as polymorphic through extensive empirical evaluation represent an excellent source of markers for future studies in genetic relatedness, genetic mapping, and dissecting the genetic architecture of complex agricultural traits. The IPSC peach SNP array v1 is commercially available and we expect that it will be used worldwide for genetic studies in peach and related stone fruit and nut species.	[Verde, Ignazio; Vendramin, Elisa; Aramini, Valeria] Fruit Tree Res Ctr, Rome, Italy; [Bassil, Nahla; Gilmore, Barbara] ARS, USDA, Corvallis, OR USA; [Scalabrin, Simone; Cattonaro, Federica; Morgante, Michele] Ist Genom Applicata, Udine, Italy; [Lawley, Cynthia T.] Illumina Inc, Hayward, CA USA; [Gasic, Ksenija] Clemson Univ, Sch Agr Forest & Environm Sci, Clemson, SC USA; [Micheletti, Diego; Blas, Andrea L.; Jose Aranzana, Maria; Arus, Pere] Ctr Recerca Agrigen CSIC IRTA UAB UB, IRTA, Barcelona, Spain; [Rosyara, Umesh R.; Iezzoni, Amy] Michigan State Univ, Dept Hort, E Lansing, MI 48824 USA; [Main, Dorrie; Peace, Cameron] Washington State Univ, Dept Hort & Landscape Architecture, Pullman, WA 99164 USA; [Mockler, Todd C.; Bryant, Douglas W.] Donald Danforth Plant Sci Ctr, St Louis, MO USA; [Mockler, Todd C.] Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA; [Mockler, Todd C.] Oregon State Univ, Ctr Genome Res & Biocomp, Corvallis, OR 97331 USA; [Bryant, Douglas W.] Intuit Genom Inc, St Louis, MO USA; [Wilhelm, Larry] Oregon Hlth & Sci Univ, Portland, OR USA; [Troggio, Michela] Fdn Edmund Mach, Ist Agr San Michele Adige Res & Innovat Ct, San Michele All Adige, Italy; [Sosinski, Bryon] N Carolina State Univ, Dept Hort Sci, Raleigh, NC 27695 USA; [Morgante, Michele] Univ Udine, Dipartimento Sci Agr & Ambientali, I-33100 Udine, Italy	United States Department of Agriculture (USDA); Illumina; Clemson University; Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); Centre de Recerca en Agrigenomica (CRAG); IRTA; Michigan State University; Washington State University; Donald Danforth Plant Science Center; Oregon State University; Oregon State University; Oregon Health & Science University; Fondazione Edmund Mach; University of North Carolina; North Carolina State University; University of Udine	Verde, I (corresponding author), Fruit Tree Res Ctr, Rome, Italy.	ignazio.verde@entecra.it; cpeace@wsu.edu	Vendramin, Elisa/AAI-8762-2020; Gasic, Ksenija/H-8254-2017; Mockler, Todd C/L-2609-2013; Arús, Pere/F-6443-2015; Aranzana, Maria Jose/H-7799-2015; Gasic, Ksenija/AAN-6234-2021; Verde, Ignazio/K-6348-2019	Gasic, Ksenija/0000-0003-4391-5262; Mockler, Todd C/0000-0002-0462-5775; Arús, Pere/0000-0003-0939-8038; Aranzana, Maria Jose/0000-0002-0240-8021; Gasic, Ksenija/0000-0003-4391-5262; Verde, Ignazio/0000-0002-9139-955X; Vendramin, Elisa/0000-0002-7324-7237; Lawley, Cynthia/0000-0001-7001-4705; Micheletti, Diego/0000-0001-9175-9853; MORGANTE, Michele/0000-0003-2591-2156	United States Department of Agriculture's National Institute of Food and Agriculture [2009-51181-05808]; Ministero delle Politiche Agricole Alimentari e Forestali -Italy (MiPAAF) [DM14999/7303/08]; European Union [FP7-265582]; Spanish Ministry of Science and Innovation [AGL2009-07305, CSD2007-00036]	United States Department of Agriculture's National Institute of Food and Agriculture; Ministero delle Politiche Agricole Alimentari e Forestali -Italy (MiPAAF); European Union(European Commission); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was funded by: United States Department of Agriculture's National Institute of Food and Agriculture - Specialty Crop Research Initiative project (http://www.csrees.usda.gov/fo/specialtycropresearchinitiative.cfm), "RosBREED: Enabling marker-assisted breeding in Rosaceae" (Grant # 2009-51181-05808); Ministero delle Politiche Agricole Alimentari e Forestali -Italy (MiPAAF, http://www.politicheagricole.it) through the project "DRUPOMICS: Sequenziamento del genoma del pesco ed utilizzo della sequenza in programmi di miglioramento della qualita del frutto del pesco e della resistenza alle malattie" (Grant # DM14999/7303/08). European Union-funded project "FruitBreedomics: Integrated approach for increasing breeding efficiency in fruit tree crops" (Grant # FP7-265582; http://fruitbreedomics.com/; http://ec.europa.eu/research/fp7/index_en.cfm). AGL2009-07305 project and Consolider-Ingenio 2010 Program project (grant # CSD2007-00036) both funded by the Spanish Ministry of Science and Innovation (http://www.micinn.es/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnaud A, 2006, THEOR APPL GENET, V112, P708, DOI 10.1007/s00122-005-0174-1; Cabrera A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-562; Cantin CM, 2010, POSTHARVEST BIOL TEC, V58, P79, DOI 10.1016/j.postharvbio.2010.06.002; Chagne D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031745; Decroocq V, 2005, MOL GENET GENOMICS, V272, P680, DOI 10.1007/s00438-004-1099-0; Dirlewanger E, 1999, THEOR APPL GENET, V98, P18, DOI 10.1007/s001220051035; Dirlewanger E, 2004, P NATL ACAD SCI USA, V101, P9891, DOI 10.1073/pnas.0307937101; Etienne C, 2002, THEOR APPL GENET, V105, P145, DOI 10.1007/s00122-001-0841-9; Fan S, 2010, NEW PHYTOL, V185, P917, DOI 10.1111/j.1469-8137.2009.03119.x; Groenen MAM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-274; Gunderson Kevin L., 2009, V529, P197, DOI 10.1007/978-1-59745-538-1_13; Gunderson KL, 2005, NAT GENET, V37, P549, DOI 10.1038/ng1547; Howad W, 2005, GENETICS, V171, P1305, DOI 10.1534/genetics.105.043661; Aranzana MJ, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-69; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Lijavetzky D, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-424; Marchese A, 2005, J HORTIC SCI BIOTECH, V80, P121, DOI 10.1080/14620316.2005.11511902; Matukumalli LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005350; Ogundiwin EA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-587; Quilot B, 2004, THEOR APPL GENET, V109, P884, DOI 10.1007/s00122-004-1703-z; Ramos AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006524; Remington DL, 2001, P NATL ACAD SCI USA, V98, P11479, DOI 10.1073/pnas.201394398; SCORZA R, 1985, J AM SOC HORTIC SCI, V110, P547; Vendramin E, 2007, MOL ECOL NOTES, V7, P307, DOI 10.1111/j.1471-8286.2006.01590.x; Verde I, 2002, ACTA HORTIC, P291, DOI 10.17660/ActaHortic.2002.592.41; Yoon JH, 2006, J AM SOC HORTIC SCI, V131, P513, DOI 10.21273/JASHS.131.4.513	26	188	196	0	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35668	10.1371/journal.pone.0035668	http://dx.doi.org/10.1371/journal.pone.0035668			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536421	Green Published, gold, Green Submitted			2022-12-27	WOS:000305339200093
J	Alguacil, MD; Torrecillas, E; Hernandez, G; Roldan, A				del Mar Alguacil, Maria; Torrecillas, Emma; Hernandez, Guillermina; Roldan, Antonio			Changes in the Diversity of Soil Arbuscular Mycorrhizal Fungi after Cultivation for Biofuel Production in a Guantanamo (Cuba) Tropical System	PLOS ONE			English	Article							MOLECULAR DIVERSITY; PLANT; COMMUNITIES; GRASSLAND; CARBON; ROOTS; BIODIVERSITY; INOCULATION; RHIZOSPHERE; ECOSYSTEM	The arbuscular mycorrhizal fungi (AMF) are a key, integral component of the stability, sustainability and functioning of ecosystems. In this study, we characterised the AMF biodiversity in a native vegetation soil and in a soil cultivated with Jatropha curcas or Ricinus communis, in a tropical system in Guantanamo (Cuba), in order to verify if a change of land use to biofuel plant production had any effect on the AMF communities. We also asses whether some soil properties related with the soil fertility (total N, Organic C, microbial biomass C, aggregate stability percentage, pH and electrical conductivity) were changed with the cultivation of both crop species. The AM fungal small sub-unit (SSU) rRNA genes were subjected to PCR, cloning, sequencing and phylogenetic analyses. Twenty AM fungal sequence types were identified: 19 belong to the Glomeraceae and one to the Paraglomeraceae. Two AMF sequence types related to cultured AMF species (Glo G3 for Glomus sinuosum and Glo G6 for Glomus intraradices-G. fasciculatum-G. irregulare) did not occur in the soil cultivated with J. curcas and R. communis. The soil properties (total N, Organic C and microbial biomass C) were higher in the soil cultivated with the two plant species. The diversity of the AMF community decreased in the soil of both crops, with respect to the native vegetation soil, and varied significantly depending on the crop species planted. Thus, R. communis soil showed higher AMF diversity than J. curcas soil. In conclusion, R. communis could be more suitable for the long-term conservation and sustainable management of these tropical ecosytems.	[del Mar Alguacil, Maria; Torrecillas, Emma; Roldan, Antonio] CSIC Ctr Edafol & Biol Aplicada Segura, Dept Soil & Water Conservat, Murcia, Spain; [Hernandez, Guillermina] Inst Ecol & Sistemat CITMA, Grp Ecol Suelo, Havana, Cuba	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Edafologia y Biologia Aplicada del Segura (CEBAS)	Alguacil, MD (corresponding author), CSIC Ctr Edafol & Biol Aplicada Segura, Dept Soil & Water Conservat, Campus Espinardo, Murcia, Spain.	mmalguacil@cebas.csic.es	del Mar Alguacil, Maria/M-3859-2014; Roldan, Antonio/F-6241-2013	del Mar Alguacil, Maria/0000-0001-8495-8707; Roldan, Antonio/0000-0002-2610-7784	Ministerio de Educacion y Ciencia, Spain	Ministerio de Educacion y Ciencia, Spain(Spanish Government)	MM Alguacil was supported by the Ramon and Cajal programme (Ministerio de Educacion y Ciencia, Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; MM Alguacil was supported by the Ramon and Cajal programme (Ministerio de Educacion y Ciencia, Spain).	Alguacil MM, 2011, SOIL BIOL BIOCHEM, V43, P167, DOI 10.1016/j.soilbio.2010.09.029; Alguacil MM, 2009, ENVIRON MICROBIOL, V11, P2649, DOI 10.1111/j.1462-2920.2009.01990.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Auge RM, 2001, PLANT SOIL, V230, P87, DOI 10.1023/A:1004891210871; Blaszkowski J, 2010, BOTANY, V88, P132, DOI 10.1139/B09-104; Cano Asseleih L. M., 1989, Journal of Food Biochemistry, V13, P1, DOI 10.1111/j.1745-4514.1989.tb00381.x; Caravaca F, 2002, APPL SOIL ECOL, V20, P107, DOI 10.1016/S0929-1393(02)00015-X; Cesaro P, 2008, APPL ENVIRON MICROB, V74, P5776, DOI 10.1128/AEM.00719-08; Charoenpakdee S, 2010, MYCOSPHERE, V1, P167; Colwell R.K., 2016, ESTIMATES STAT ESTIM; DELUCA TH, 1993, SOIL SCI SOC AM J, V57, P1296, DOI 10.2136/sssaj1993.03615995005700050022x; FAO, 1998, WORLD REF BAS SOIL R; Florez JP, 2004, THESIS U F DEPAULA S; Garcia C, 1997, COMMUN SOIL SCI PLAN, V28, P123, DOI 10.1080/00103629709369777; GIOVANNETTI M, 1980, NEW PHYTOL, V84, P489, DOI 10.1111/j.1469-8137.1980.tb04556.x; Gonzalez JM, 2005, BIOINFORMATICS, V21, P333, DOI 10.1093/bioinformatics/bti008; Hempel S, 2007, ENVIRON MICROBIOL, V9, P1930, DOI 10.1111/j.1462-2920.2007.01309.x; Hijri I, 2006, MOL ECOL, V15, P2277, DOI 10.1111/j.1365-294X.2006.02921.x; Husband R, 2002, MOL ECOL, V11, P2669, DOI 10.1046/j.1365-294X.2002.01647.x; Jumpponen A, 2005, BIOL FERT SOILS, V41, P217, DOI 10.1007/s00374-005-0845-8; Kovacs GM, 2002, PHYTON-ANN REI BOT A, V42, P211; Kumar A, 2010, J PLANT GROWTH REGUL, V29, P297, DOI 10.1007/s00344-009-9136-1; Lapola DM, 2009, BIOMASS BIOENERG, V33, P1087, DOI 10.1016/j.biombioe.2009.04.005; LAX A, 1994, ARID SOIL RES REHAB, V8, P9; Lee J, 2008, FEMS MICROBIOL ECOL, V65, P339, DOI 10.1111/j.1574-6941.2008.00531.x; Lekberg Y, 2007, J ECOL, V95, P95, DOI 10.1111/j.1365-2745.2006.01193.x; Li LF, 2010, FEMS MICROBIOL ECOL, V71, P418, DOI 10.1111/j.1574-6941.2009.00815.x; Nicholas KB., 1997, GENEDOC TOOL EDITING; Opik M, 2003, NEW PHYTOL, V160, P581, DOI 10.1046/j.1469-8137.2003.00917.x; Opik M, 2008, NEW PHYTOL, V179, P867, DOI 10.1111/j.1469-8137.2008.02515.x; Opik M, 2006, J ECOL, V94, P778, DOI 10.1111/j.1365-2745.2006.01136.x; PHILLIPS JM, 1970, T BRIT MYCOL SOC, V55, P158, DOI 10.1016/S0007-1536(70)80110-3; Picone C, 2003, ADV AGROECOL, P95; Pozo MJ, 2007, CURR OPIN PLANT BIOL, V10, P393, DOI 10.1016/j.pbi.2007.05.004; Prueksakorn K, 2 JOINT INT C SUST E; Recalde ER, 2009, CULTIVOS ENERGETICOS; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schreiner RP, 2009, MYCOLOGIA, V101, P599, DOI 10.3852/08-169; Sikes BA, 2009, J ECOL, V97, P1274, DOI 10.1111/j.1365-2745.2009.01557.x; Singh AK, 2011, NATL ACAD SCI LETT, V34, P27; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Swofford D. L, 2002, PAUP PHYLOGENETIC AN; Sykorova Z, 2007, APPL ENVIRON MICROB, V73, P5426, DOI 10.1128/AEM.00987-07; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; ter Braak C.F.J., 2004, CANOCO REFERENCE MAN; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Vandenkoornhuyse P, 2002, MOL ECOL, V11, P1555, DOI 10.1046/j.1365-294X.2002.01538.x; Vandenkoornhuyse P, 2003, MOL ECOL, V12, P3085, DOI 10.1046/j.1365-294X.2003.01967.x; Wardle DA, 1999, SOIL BIOL BIOCHEM, V31, P1707, DOI 10.1016/S0038-0717(99)00090-5; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Wilson GWT, 2009, ECOL LETT, V12, P452, DOI 10.1111/j.1461-0248.2009.01303.x; Wirsel SGR, 2004, FEMS MICROBIOL ECOL, V48, P129, DOI 10.1016/j.femsec.2004.01.006; YEOMANS JC, 1988, COMMUN SOIL SCI PLAN, V19, P1467, DOI 10.1080/00103628809368027	56	29	33	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e34887	10.1371/journal.pone.0034887	http://dx.doi.org/10.1371/journal.pone.0034887			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22536339	Green Submitted, Green Published, gold			2022-12-27	WOS:000305336200011
J	Hamshou, M; Van Damme, EJM; Vandenborre, G; Ghesquiere, B; Trooskens, G; Gevaert, K; Smagghe, G				Hamshou, Mohamad; Van Damme, Els J. M.; Vandenborre, Gianni; Ghesquiere, Bart; Trooskens, Geert; Gevaert, Kris; Smagghe, Guy			GalNAc/Gal-Binding Rhizoctonia solani Agglutinin Has Antiproliferative Activity in Drosophila melanogaster S2 Cells via MAPK and JAK/STAT Signaling	PLOS ONE			English	Article							TRANSDUCTION PATHWAY; TYROSINE KINASE; FUNGAL LECTIN; PROTEIN; LINES; ACTIVATION	Rhizoctonia solani agglutinin, further referred to as RSA, is a lectin isolated from the plant pathogenic fungus Rhizoctonia solani. Previously, we reported a high entomotoxic activity of RSA towards the cotton leafworm Spodoptera littoralis. To better understand the mechanism of action of RSA, Drosophila melanogaster Schneider S2 cells were treated with different concentrations of the lectin and FITC-labeled RSA binding was examined using confocal fluorescence microscopy. RSA has antiproliferative activity with a median effect concentration (EC50) of 0.35 mu M. In addition, the lectin was typically bound to the cell surface but not internalized. In contrast, the N-acetylglucosamine-binding lectin WGA and the galactose-binding lectin PNA, which were both also inhibitory for S2 cell proliferation, were internalized whereas the mannose-binding lectin GNA did not show any activity on these cells, although it was internalized. Extracted DNA and nuclei from S2 cells treated with RSA were not different from untreated cells, confirming inhibition of proliferation without apoptosis. Pre-incubation of RSA with N-acetylgalactosamine clearly inhibited the antiproliferative activity by RSA in S2 cells, demonstrating the importance of carbohydrate binding. Similarly, the use of MEK and JAK inhibitors reduced the activity of RSA. Finally, RSA affinity chromatography of membrane proteins from S2 cells allowed the identification of several cell surface receptors involved in both signaling transduction pathways.	[Hamshou, Mohamad; Vandenborre, Gianni; Smagghe, Guy] Univ Ghent, Fac Biosci Engn, Dept Crop Protect, Lab Agrozool, B-9000 Ghent, Belgium; [Hamshou, Mohamad; Van Damme, Els J. M.; Vandenborre, Gianni] Univ Ghent, Fac Biosci Engn, Dept Mol Biotechnol, Lab Biochem & Glycobiol, B-9000 Ghent, Belgium; [Ghesquiere, Bart; Gevaert, Kris] VIB, Dept Med Prot Res, Ghent, Belgium; [Ghesquiere, Bart; Gevaert, Kris] Univ Ghent, Dept Biochem, B-9000 Ghent, Belgium; [Trooskens, Geert] Univ Ghent, Fac Biosci Engn, Dept Math Modelling Stat & Bioinformat, B-9000 Ghent, Belgium	Ghent University; Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University	Hamshou, M (corresponding author), Univ Ghent, Fac Biosci Engn, Dept Crop Protect, Lab Agrozool, B-9000 Ghent, Belgium.	guy.smagghe@ugent.be	Gevaert, Kris/D-6489-2017; Ghesquiere, Bart/HGU-8736-2022; Gevaert, Kris/H-3637-2013; Gevaert, Kris/AAE-4212-2019; Van Damme, Els/U-3904-2019; Smagghe, Guy/AAE-8914-2019; Van Damme, Els J/B-4410-2015	Gevaert, Kris/0000-0002-4237-0283; Ghesquiere, Bart/0000-0003-1547-1705; Gevaert, Kris/0000-0002-4237-0283; Gevaert, Kris/0000-0002-4237-0283; Van Damme, Els/0000-0001-9848-766X; Smagghe, Guy/0000-0001-8334-3313; 	Research Council of Ghent University (BOF-UGent) [BOF10/GOA/003]; Hercules Foundation; Fund for Scientific Research-Flanders (FWO-Vlaanderen) [3G016306]; FWO-Vlaanderen [3G016306, G.0156.05, G.0077.06, G.0042.07]; Concerted Research Actions [BOF07/GOA/012, BOF343 UGent]; Interuniversity Attraction Poles [IUAP06]	Research Council of Ghent University (BOF-UGent)(Ghent University); Hercules Foundation; Fund for Scientific Research-Flanders (FWO-Vlaanderen)(FWO); FWO-Vlaanderen(FWO); Concerted Research Actions; Interuniversity Attraction Poles(Belgian Federal Science Policy Office)	This research was supported by the Research Council of Ghent University (BOF-UGent; project BOF10/GOA/003), the Hercules Foundation, and the Fund for Scientific Research-Flanders (FWO-Vlaanderen; 3G016306) to GS and EVD. The UGent/VIB lab acknowledges support by research grants from the FWO-Vlaanderen (3G016306, G.0156.05, G.0077.06, G.0042.07), the Concerted Research Actions (BOF07/GOA/012) from BOF343 UGent, and the Interuniversity Attraction Poles (IUAP06). BG is a postdoctoral research fellow of the FWO-Vlaanderen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Arbouzova NI, 2006, DEVELOPMENT, V133, P2605, DOI 10.1242/dev.02411; BIGGS WH, 1994, EMBO J, V13, P1628, DOI 10.1002/j.1460-2075.1994.tb06426.x; BRUNNER D, 1994, CELL, V76, P875, DOI 10.1016/0092-8674(94)90362-X; Candy L, 2001, BIOCHEM BIOPH RES CO, V282, P655, DOI 10.1006/bbrc.2001.4626; DAVIS RJ, 1993, J BIOL CHEM, V268, P14553; Francis F, 2003, EUR J CELL BIOL, V82, P515, DOI 10.1078/0171-9335-00338; Goldsmith ZG, 2007, ONCOGENE, V26, P3122, DOI 10.1038/sj.onc.1210407; Guillot J, 1997, BIOCHEM SYST ECOL, V25, P203, DOI 10.1016/S0305-1978(96)00110-X; Hamshou M, 2010, FUNGAL BIOL-UK, V114, P34, DOI 10.1016/j.mycres.2009.10.002; Hamshou M, 2007, Commun Agric Appl Biol Sci, V72, P639; Hamshou M, 2010, INSECT BIOCHEM MOLEC, V40, P883, DOI 10.1016/j.ibmb.2010.08.008; Howard MC, 1993, FUNDAMENTAL IMMUNOLO, V3, P763; IHLE JN, 1995, NATURE, V377, P591, DOI 10.1038/377591a0; KELLENS JTC, 1990, J GEN MICROBIOL, V136, P2489, DOI 10.1099/00221287-136-12-2489; Konska Grazyna, 2006, International Journal of Medicinal Mushrooms, V8, P19, DOI 10.1615/IntJMedMushr.v8.i1.20; Kuramoto T, 2005, J BIOCHEM, V137, P41, DOI 10.1093/jb/mvi005; Leonard WJ, 2000, J ALLERGY CLIN IMMUN, V105, P877, DOI 10.1067/mai.2000.106899; McKay MM, 2007, ONCOGENE, V26, P3113, DOI 10.1038/sj.onc.1210394; Ojaniemi M, 1997, J BIOL CHEM, V272, P25993, DOI 10.1074/jbc.272.41.25993; Patterson M, 2002, NAT REV GENET, V3, P162, DOI 10.1038/nrg763; Pujari R, 2010, BBA-GEN SUBJECTS, V1800, P1268, DOI 10.1016/j.bbagen.2010.09.003; Ragab A, 2011, EMBO J, V30, P1123, DOI 10.1038/emboj.2011.4; Rawal S, 2005, MOL CELL BIOCHEM, V268, P93, DOI 10.1007/s11010-005-3698-4; Rawlings JS, 2004, J CELL SCI, V117, P1281, DOI 10.1242/jcs.00963; SCHNEIDER I, 1972, J EMBRYOL EXP MORPH, V27, P353; Shahidi-Noghabi S, 2011, ARCH INSECT BIOCHEM, V76, P211, DOI 10.1002/arch.20405; Shahidi-Noghabi S, 2010, J INSECT PHYSIOL, V56, P1101, DOI 10.1016/j.jinsphys.2010.03.012; SIMON MA, 1991, CELL, V67, P701, DOI 10.1016/0092-8674(91)90065-7; Soin T, 2008, J INSECT PHYSIOL, V54, P429, DOI 10.1016/j.jinsphys.2007.11.001; Trigueros V, 2003, BBA-GEN SUBJECTS, V1621, P292, DOI 10.1016/S0304-4165(03)00098-9; TSUDA L, 1993, CELL, V72, P407, DOI 10.1016/0092-8674(93)90117-9; Van Damme EJM, 1998, HDB PLANT LECTINS PR; Vandenborre G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016682; Vandenborre G, 2010, J PROTEOME RES, V9, P3235, DOI 10.1021/pr1001753; VRANKEN AM, 1987, FEBS LETT, V216, P67, DOI 10.1016/0014-5793(87)80758-5; Wang M, 2002, J ECON ENTOMOL, V95, P603, DOI 10.1603/0022-0493-95.3.603; WASSARMAN DA, 1997, ADV DEV BIO, V5, P1; Xu SC, 1997, MOL ENDOCRINOL, V11, P1618, DOI 10.1210/me.11.11.1618	39	16	17	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e33680	10.1371/journal.pone.0033680	http://dx.doi.org/10.1371/journal.pone.0033680			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529896	Green Published, gold, Green Submitted			2022-12-27	WOS:000305350600005
J	Ohi, K; Hashimoto, R; Nakazawa, T; Okada, T; Yasuda, Y; Yamamori, H; Fukumoto, M; Umeda-Yano, S; Iwase, M; Kazui, H; Yamamoto, T; Kano, M; Takeda, M				Ohi, Kazutaka; Hashimoto, Ryota; Nakazawa, Takanobu; Okada, Takeya; Yasuda, Yuka; Yamamori, Hidenaga; Fukumoto, Motoyuki; Umeda-Yano, Satomi; Iwase, Masao; Kazui, Hiroaki; Yamamoto, Tadashi; Kano, Masanobu; Takeda, Masatoshi			The p250GAP Gene Is Associated with Risk for Schizophrenia and Schizotypal Personality Traits	PLOS ONE			English	Article							GTPASE-ACTIVATING-PROTEIN; IONOTROPIC GLUTAMATE RECEPTORS; HIGH-ACTIVITY ALLELE; COGNITIVE ENDOPHENOTYPES; POPULATION-LEVEL; RHO-FAMILY; EXPRESSION; DISORDERS; SUBUNIT; COMT	Background: Hypofunction of the glutamate N-Methyl-d-aspartate (NMDA) receptor has been implicated in the pathophysiology of schizophrenia. p250GAP is a brain-enriched NMDA receptor-interacting RhoGAP. p250GAP is involved in spine morphology, and spine morphology has been shown to be altered in the post-mortem brains of patients with schizophrenia. Schizotypal personality disorder has a strong familial relationship with schizophrenia. Several susceptibility genes for schizophrenia have been related to schizotypal traits. Methods: We first investigated the association of eight linkage disequilibrium-tagging single-nucleotide polymorphisms (SNPs) that cover the p250GAP gene with schizophrenia in a Japanese sample of 431 schizophrenia patients and 572 controls. We then investigated the impact of the risk genetic variant in the p250GAP gene on schizotypal personality traits in 180 healthy subjects using the Schizotypal Personality Questionnaire. Results: We found a significant difference in genotype frequency between the patients and the controls in rs2298599 (chi(2) = 17.6, p = 0.00015). The minor A/A genotype frequency of rs2298599 was higher in the patients (18%) than in the controls (9%) (chi(2) = 15.5, p = 0.000083). Moreover, we found that subjects with the rs2298599 risk A/A genotype, compared with G allele carriers, had higher scores of schizotypal traits (F-1,F-178 = 4.08, p = 0.045), particularly the interpersonal factor (F1,178 = 5.85, p = 0.017). Discussion: These results suggest that a genetic variation in the p250GAP gene might increase susceptibility not only for schizophrenia but also for schizotypal personality traits. We concluded that the p250GAP gene might be a new candidate gene for susceptibility to schizophrenia.	[Ohi, Kazutaka; Hashimoto, Ryota; Okada, Takeya; Yasuda, Yuka; Yamamori, Hidenaga; Fukumoto, Motoyuki; Iwase, Masao; Kazui, Hiroaki; Takeda, Masatoshi] Osaka Univ, Grad Sch Med, Dept Psychiat, Osaka, Japan; [Ohi, Kazutaka; Hashimoto, Ryota; Okada, Takeya; Yasuda, Yuka; Yamamori, Hidenaga; Fukumoto, Motoyuki] Japan Sci & Technol Agcy JST, CREST, Saitama, Japan; [Ohi, Kazutaka] Natl Hosp Org, Yamato Mental Med Ctr, Nara, Japan; [Hashimoto, Ryota; Takeda, Masatoshi] Kanazawa Univ, Osaka Univ, United Grad Sch Child Dev, Mol Res Ctr Childrens Mental Dev, Osaka, Japan; [Hashimoto, Ryota; Takeda, Masatoshi] Hamamatsu Univ Sch Med, Osaka, Japan; [Nakazawa, Takanobu; Yamamoto, Tadashi] Univ Tokyo, Inst Med Sci, Div Oncol, Tokyo, Japan; [Nakazawa, Takanobu; Kano, Masanobu] Univ Tokyo, Grad Sch Med, Dept Neurophysiol, Tokyo, Japan; [Yamamori, Hidenaga; Umeda-Yano, Satomi] Osaka Univ, Grad Sch Med, Dept Mol Neuropsychiat, Osaka, Japan	Osaka University; Japan Science & Technology Agency (JST); Kanazawa University; Osaka University; Hamamatsu University School of Medicine; University of Tokyo; University of Tokyo; Osaka University	Ohi, K (corresponding author), Osaka Univ, Grad Sch Med, Dept Psychiat, Osaka, Japan.	hashimor@psy.med.osaka-u.ac.jp	Hashimoto, Ryota/AAE-3200-2019; Hashimoto, Ryota/P-8572-2014; Nakazawa, Takanobu/E-1012-2014; Ohi, Kazutaka/J-7851-2019	Hashimoto, Ryota/0000-0002-5941-4238; Hashimoto, Ryota/0000-0002-5941-4238; Nakazawa, Takanobu/0000-0002-5049-9140; Ohi, Kazutaka/0000-0001-9577-9640; NAKAZAWA, Takanobu/0000-0003-4863-1277; Kano, Masanobu/0000-0002-0725-3292	Japanese Ministry of Health, Labor and Welfare [H22-seishin-ippan-001]; Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI [22390225, 23659565, 221S0003]; CREST of JST; Japan Foundation for Neuroscience and Mental Health; Ministry of Education, Culture, Sports, Science, and Technology, Japan; Grants-in-Aid for Scientific Research [23791331, 22390225] Funding Source: KAKEN	Japanese Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); CREST of JST(Core Research for Evolutional Science and Technology (CREST)); Japan Foundation for Neuroscience and Mental Health(Japan Foundation for Neuroscience and Mental Health); Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by research grants from the Japanese Ministry of Health, Labor and Welfare (H22-seishin-ippan-001); the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI [22390225-Grant-in-Aid for Scientific Research (B), 23659565-Grant-in-Aid for Challenging Exploratory Research and 221S0003-Grant-in-Aid for Scientific Research on Innovative Areas (Comprehensive Brain Science Network)]; the CREST of JST; and the Japan Foundation for Neuroscience and Mental Health. Additionally, this work was supported by the Strategic Research Program for Brain Sciences (Development of Biomarker Candidates for Social Behavior) of the Ministry of Education, Culture, Sports, Science, and Technology, Japan. No additional external funding was received for this study. The funders had no role in the study design, data collection and analyses, decision to publish, or preparation of the manuscript.	Arnsten AFT, 2011, INT J DEV NEUROSCI, V29, P215, DOI 10.1016/j.ijdevneu.2011.02.006; Avramopoulos D, 2002, MOL PSYCHIATR, V7, P706, DOI 10.1038/sj.mp.4001070; Beneyto M, 2008, NEUROPSYCHOPHARMACOL, V33, P2175, DOI 10.1038/sj.npp.1301604; Bennett MR, 2011, PROG NEUROBIOL, V95, P275, DOI 10.1016/j.pneurobio.2011.08.003; Cardno AG, 2000, AM J MED GENET, V97, P12, DOI 10.1002/(SICI)1096-8628(200021)97:1<12::AID-AJMG3>3.3.CO;2-L; Cichon S, 2009, AM J PSYCHIAT, V166, P540, DOI 10.1176/appi.ajp.2008.08091354; du Bois TM, 2007, BRAIN RES REV, V53, P260, DOI 10.1016/j.brainresrev.2006.09.001; Ericson M, 2011, BEHAV GENET, V41, P499, DOI 10.1007/s10519-010-9401-x; Gao XM, 2000, AM J PSYCHIAT, V157, P1141, DOI 10.1176/appi.ajp.157.7.1141; Harrison PJ, 2005, MOL PSYCHIATR, V10, P40, DOI 10.1038/sj.mp.4001558; Hashimoto R, 2007, MOL PSYCHIATR, V12, P1026, DOI 10.1038/sj.mp.4001982; Hashimoto R, 2006, HUM MOL GENET, V15, P3024, DOI 10.1093/hmg/ddl244; Heimer L, 2000, BRAIN RES REV, V31, P205, DOI 10.1016/S0165-0173(99)00039-9; Herin GA, 2004, EUR J PHARMACOL, V500, P101, DOI 10.1016/j.ejphar.2004.07.015; Iijima Y, 2010, KOUDOURYOUHOUKENKYU, V36, P29, DOI DOI 10.24468/jjbt.36.1_29; Kendler KS, 2007, PSYCHOL MED, V37, P655, DOI 10.1017/S0033291706009755; KENDLER KS, 1993, ARCH GEN PSYCHIAT, V50, P781; Kircher T, 2009, PSYCHOL MED, V39, P1657, DOI 10.1017/S0033291709005388; KORNHUBER J, 1989, J NEURAL TRANSM, V77, P231, DOI 10.1007/BF01248936; Kristiansen LV, 2010, SYNAPSE, V64, P495, DOI 10.1002/syn.20754; Lin CCH, 2007, BEHAV GENET, V37, P334, DOI 10.1007/s10519-006-9104-5; Lin HF, 2005, PSYCHOL MED, V35, P1589, DOI 10.1017/S0033291705005957; Ma XH, 2007, PSYCHIAT RES, V153, P7, DOI 10.1016/j.psychres.2007.02.003; Moon SY, 2003, J BIOL CHEM, V278, P4151, DOI 10.1074/jbc.M207789200; Mueller HT, 2004, MOL BRAIN RES, V121, P60, DOI 10.1016/j.molbrainres.2003.11.004; Nakamura T, 2002, MOL CELL BIOL, V22, P8721, DOI 10.1128/MCB.22.24.8721-8734.2002; Nakazawa T, 2003, MOL BIOL CELL, V14, P2921, DOI 10.1091/mbc.e02-09-0623; Nakazawa T, 2008, J NEUROCHEM, V105, P1384, DOI 10.1111/j.1471-4159.2008.05335.x; Ohi K, 2010, SCHIZOPHR RES, V116, P126, DOI 10.1016/j.schres.2009.12.002; Ohi K, 2009, SCHIZOPHR RES, V109, P80, DOI 10.1016/j.schres.2009.01.019; Okabe T, 2003, J BIOL CHEM, V278, P9920, DOI 10.1074/jbc.M208872200; Olney JW, 1999, J PSYCHIAT RES, V33, P523, DOI 10.1016/S0022-3956(99)00029-1; PorteraCailliau C, 1996, J NEUROCHEM, V66, P692, DOI 10.1046/j.1471-4159.1996.66020692.x; Pulay Attila J, 2009, Prim Care Companion J Clin Psychiatry, V11, P53; RAINE A, 1994, SCHIZOPHRENIA BULL, V20, P191, DOI 10.1093/schbul/20.1.191; RAINE A, 1991, SCHIZOPHRENIA BULL, V17, P555, DOI 10.1093/schbul/17.4.555; Schurhoff F, 2007, AM J MED GENET B, V144B, P64, DOI 10.1002/ajmg.b.30395; Sheldrick AJ, 2008, EUR PSYCHIAT, V23, P385, DOI 10.1016/j.eurpsy.2008.05.002; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Solano JJR, 2000, SCHIZOPHR RES, V44, P137, DOI 10.1016/S0920-9964(99)00203-0; Someya T, 1994, P 32 SCI M U HLTH CA, P286; Stefanis NC, 2007, BIOL PSYCHIAT, V62, P784, DOI 10.1016/j.biopsych.2006.11.015; Stefanis NC, 2008, BEHAV BRAIN FUNCT, V4, DOI 10.1186/1744-9081-4-46; Tada T, 2006, CURR OPIN NEUROBIOL, V16, P95, DOI 10.1016/j.conb.2005.12.001; Torgersen S, 2000, COMPR PSYCHIAT, V41, P416, DOI 10.1053/comp.2000.16560; Tsuang M, 2000, BIOL PSYCHIAT, V47, P210, DOI 10.1016/S0006-3223(99)00289-9; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102; WATANABE M, 1992, NEUROREPORT, V3, P1138, DOI 10.1097/00001756-199212000-00027; Wenzel A, 1997, J NEUROCHEM, V68, P469; Yasuda Y, 2011, NEUROSCI LETT, V495, P216, DOI 10.1016/j.neulet.2011.03.069; Yoshihara Y, 2009, CURR OPIN NEUROBIOL, V19, P146, DOI 10.1016/j.conb.2009.05.013; Zavitsanou K, 2002, NEUROPSYCHOPHARMACOL, V27, P826, DOI 10.1016/S0893-133X(02)00347-0	52	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35696	10.1371/journal.pone.0035696	http://dx.doi.org/10.1371/journal.pone.0035696			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22530067	Green Published, Green Submitted, gold			2022-12-27	WOS:000305350600113
J	Pabst, S; Hammerstingl, C; Hundt, F; Gerhardt, T; Grohe, C; Nickenig, G; Woitas, R; Skowasch, D				Pabst, Stefan; Hammerstingl, Christoph; Hundt, Felix; Gerhardt, Thomas; Grohe, Christian; Nickenig, Georg; Woitas, Rainer; Skowasch, Dirk			Pulmonary Hypertension in Patients with Chronic Kidney Disease on Dialysis and without Dialysis: Results of the PEPPER-Study	PLOS ONE			English	Article							HEMODIALYSIS-PATIENTS; NITRIC-OXIDE; ENDOTHELIN-1; PREVALENCE	Pulmonary hypertension (PH) is common in patients with dialysis-dependent chronic kidney disease and is an independent predictor of mortality. However, specific hemodynamics of the pulmonary circulation, changes induced by hemodialysis and characterization into pre- or postcapillary PH have not been evaluated in patients with chronic kidney disease. We assessed consecutive patients with end-stage chronic kidney disease in WHO FC >= II with dyspnea unexplained by other causes on hemodialysis (group 1, n = 31) or without dialysis (group 2, n = 31) using right heart catheterization (RHC). In group 1, RHC was performed before and after dialysis. In end-stage chronic kidney disease, prevalence of precapillary PH was 13% (4/31), and postcapillary PH was discovered in 65% (20/31). All four cases of precapillary PH were unmasked after dialysis. In group 2, two cases of precapillary PH were detected (6%), and postcapillary PH was diagnosed in 22 cases (71%). This is the first study examining a large cohort of patients with chronic kidney disease invasively by RHC for the prevalence of PH. The prevalence of precapillary PH was 13% in patients with end-stage kidney disease. That suggests careful screening for precapillary PH in this selected patient population. RHC should be performed after hemodialysis.	[Pabst, Stefan; Hammerstingl, Christoph; Nickenig, Georg; Skowasch, Dirk] Univ Bonn, Dept Internal Med Cardiol Pneumol 2, Bonn, Germany; [Hundt, Felix; Woitas, Rainer] Univ Bonn, Dept Internal Med Nephrol 1, Bonn, Germany; [Gerhardt, Thomas] Praxis Nieren & Hochdruckkrankheiten Bonn, Bonn, Germany; [Grohe, Christian] Lungenklin Berlin Buch, Berlin, Germany	University of Bonn; University of Bonn	Pabst, S (corresponding author), Univ Bonn, Dept Internal Med Cardiol Pneumol 2, Bonn, Germany.	Dirk.Skowasch@ukb.uni-bonn.de	Hammerstingl, Christoph/GQQ-3316-2022		Actelion Pharmaceuticals; GlaxoSmithKline	Actelion Pharmaceuticals; GlaxoSmithKline(GlaxoSmithKline)	The study was sponsored by Actelion Pharmaceuticals. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: SP, CH, and DS received remuneration for lecturing and grants for travel expenses from Actelion Pharmaceuticals and GlaxoSmithKline. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Abdelwhab S, 2008, AM J NEPHROL, V28, P990, DOI 10.1159/000146076; ARESE M, 1995, NEPHROL DIAL TRANSPL, V10, P1386; AznarSalatti J, 1995, NEPHROL DIAL TRANSPL, V10, P2199, DOI 10.1093/ndt/10.12.2199; Bozbas SS, 2009, TRANSPL P, V41, P2753, DOI 10.1016/j.transproceed.2009.07.049; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; El-Shafey EM, 2008, CLIN EXP NEPHROL, V12, P370, DOI 10.1007/s10157-008-0065-2; Galie N, 2009, EUR RESPIR J, V34, P1219, DOI 10.1183/09031936.00139009; Havlucu Y, 2007, RESPIRATION, V74, P503, DOI 10.1159/000102953; Humbert M, 2006, AM J RESP CRIT CARE, V173, P1023, DOI 10.1164/rccm.200510-1668OC; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Liefeldt L, 2004, AM J KIDNEY DIS, V43, P923, DOI 10.1053/j.ajkd.2003.12.054; Nakhoul F, 2005, NEPHROL DIAL TRANSPL, V20, P1686, DOI 10.1093/ndt/gfh840; Odetti P, 2006, HORM METAB RES, V38, P817, DOI 10.1055/s-2006-956501; Ramasubbu K, 2010, INT J GEN MED, V3, P279, DOI 10.2147/IJGM.S12946; Simonneau G, 2009, J AM COLL CARDIOL, V54, pS43, DOI [10.1016/j.jacc.2009.04.012, 10.1016/j.jacc.2013.10.029]; Stefanidis I, 2004, J CARDIOVASC PHARM, V44, pS43, DOI 10.1097/01.fjc.0000166215.50415.36; Thambyrajah J, 2000, HEART, V83, P205, DOI 10.1136/heart.83.2.205; Tomic M, 2008, RENAL FAILURE, V30, P836, DOI 10.1080/08860220802356218; Unal A, 2010, HEMODIAL INT, V14, P398, DOI 10.1111/j.1542-4758.2010.00478.x; Yigla M, 2003, CHEST, V123, P1577, DOI 10.1378/chest.123.5.1577; Yigla M, 2009, KIDNEY INT, V75, P969, DOI 10.1038/ki.2009.10	22	96	107	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35310	10.1371/journal.pone.0035310	http://dx.doi.org/10.1371/journal.pone.0035310			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22530005	gold, Green Published, Green Submitted			2022-12-27	WOS:000305350600074
J	Peng, CB; Jin, XG; Wong, KC; Shi, MX; Lio, P				Peng, Chengbin; Jin, Xiaogang; Wong, Ka-Chun; Shi, Meixia; Lio, Pietro			Collective Human Mobility Pattern from Taxi Trips in Urban Area	PLOS ONE			English	Article							NONNEGATIVE MATRIX FACTORIZATION; TRAVEL BEHAVIOR; LAND-USE; STATISTICAL PHYSICS; METROPOLITAN-AREA; TRAFFIC FLOW; NETWORKS; SIMULATION; EPIDEMIC; DYNAMICS	We analyze the passengers' traffic pattern for 1.58 million taxi trips of Shanghai, China. By employing the non-negative matrix factorization and optimization methods, we find that, people travel on workdays mainly for three purposes: commuting between home and workplace, traveling from workplace to workplace, and others such as leisure activities. Therefore, traffic flow in one area or between any pair of locations can be approximated by a linear combination of three basis flows, corresponding to the three purposes respectively. We name the coefficients in the linear combination as traffic powers, each of which indicates the strength of each basis flow. The traffic powers on different days are typically different even for the same location, due to the uncertainty of the human motion. Therefore, we provide a probability distribution function for the relative deviation of the traffic power. This distribution function is in terms of a series of functions for normalized binomial distributions. It can be well explained by statistical theories and is verified by empirical data. These findings are applicable in predicting the road traffic, tracing the traffic pattern and diagnosing the traffic related abnormal events. These results can also be used to infer land uses of urban area quite parsimoniously.	[Peng, Chengbin; Wong, Ka-Chun] King Abdullah Univ Sci & Technol, Math & Comp Sci & Engn Div, Jeddah, Saudi Arabia; [Peng, Chengbin; Jin, Xiaogang] Zhejiang Univ, Coll Comp Sci, Inst Artificial Intelligence, Hangzhou 310003, Zhejiang, Peoples R China; [Shi, Meixia] Zhejiang Univ, Coll Environm & Resource Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Lio, Pietro] Univ Cambridge, Comp Lab, Cambridge CB2 3QG, England	King Abdullah University of Science & Technology; Zhejiang University; Zhejiang University; University of Cambridge	Peng, CB (corresponding author), King Abdullah Univ Sci & Technol, Math & Comp Sci & Engn Div, Jeddah, Saudi Arabia.	Pietro.Lio@cl.cam.ac.uk	P. Lió, Pietro Lio/AAV-3358-2021; Wong, Ka-Chun/L-7160-2019	P. Lió, Pietro Lio/0000-0002-0540-5053; Wong, Ka-Chun/0000-0001-6062-733X; Shi, Meixia/0000-0002-4357-6873	King Abdullah University of Science and Technology; National Science Foundation of China [61070069]; RECOGNITION: Relevance and Cognition for Self-Awareness in a Content-Centric Internet [257756]; European Commission	King Abdullah University of Science and Technology(King Abdullah University of Science & Technology); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); RECOGNITION: Relevance and Cognition for Self-Awareness in a Content-Centric Internet; European Commission(European CommissionEuropean Commission Joint Research Centre)	CP was supported by Graduate Fellowship from King Abdullah University of Science and Technology. CP and XJ were supported by the National Science Foundation of China under Grant No. 61070069. PL was supported by the following project: RECOGNITION: Relevance and Cognition for Self-Awareness in a Content-Centric Internet (257756), which is funded by the European Commission within the 7th Framework Programme (FP7). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RM, 2004, PHILOS T R SOC B, V359, P1091, DOI 10.1098/rstb.2004.1490; Andrade EL, 2006, INT C PATT RECOG, P175; Ben-Akiva M., 1998, TRANSPORTATION MODEL, P4; Boarnet M, 2001, TRANSPORT RES A-POL, V35, P823, DOI 10.1016/S0965-8564(00)00019-7; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; Candia J, 2008, J PHYS A-MATH THEOR, V41, DOI 10.1088/1751-8113/41/22/224015; Castellano C, 2009, REV MOD PHYS, V81, P591, DOI 10.1103/RevModPhys.81.591; Chowdhury D, 2000, PHYS REP, V329, P199, DOI 10.1016/S0370-1573(99)00117-9; Dieleman FM, 2002, URBAN STUD, V39, P507, DOI 10.1080/00420980220112801; Easley D, 2010, NETWORKS CROWDS MARK; Esser J, 1997, INT J MOD PHYS C, V8, P1025, DOI 10.1142/S0129183197000904; Eubank S, 2004, NATURE, V429, P180, DOI 10.1038/nature02541; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Han XP, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.036117; Handy S, 1996, TRANSPORT RES D-TR E, V1, P151, DOI 10.1016/S1361-9209(96)00010-7; Handy S, 2005, INT REGIONAL SCI REV, V28, P146, DOI 10.1177/0160017604273626; HELBING D, 1995, PHYS REV E, V51, P3164, DOI 10.1103/PhysRevE.51.3164; Hollick M, 2004, COMPUT COMMUN, V27, P751, DOI 10.1016/j.comcom.2003.10.015; Horner MW., 2001, J TRANSP GEOGR, V9, P255, DOI DOI 10.1016/S0966-6923(01)00019-9; Hua H, 2009, P NATL ACAD SCI USA, V106, P1318, DOI 10.1073/pnas.0811973106; Hufnagel L, 2004, P NATL ACAD SCI USA, V101, P15124, DOI 10.1073/pnas.0308344101; Jiang B, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.021136; Kaltenbrunner A., 2008, ARXIV08104187; Kerner BS, 2009, INTRODUCTION TO MODERN TRAFFIC FLOW THEORY AND CONTROL, P1, DOI 10.1007/978-3-642-02605-8; Kitamura R, 2000, TRANSPORTATION, V27, P25, DOI 10.1023/A:1005259324588; Kleinberg J, 2007, NATURE, V449, P287, DOI 10.1038/449287a; Kuppam AR, 2001, TRANSPORTATION, V28, P33, DOI 10.1023/A:1005253813277; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; Leutzbach W., 1987, INTRO THEORY TRAFFIC; Liang X, 2012, PHYSICA A, V391, P2135, DOI 10.1016/j.physa.2011.11.035; Lin CJ, 2007, NEURAL COMPUT, V19, P2756, DOI 10.1162/neco.2007.19.10.2756; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; Mehran R, 2009, PROC CVPR IEEE, P935, DOI 10.1109/CVPRW.2009.5206641; Nagel K, 1996, PHYS REV E, V53, P4655, DOI 10.1103/PhysRevE.53.4655; Onnela JP, 2007, P NATL ACAD SCI USA, V104, P7332, DOI 10.1073/pnas.0610245104; Perc M, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/1/003; Rhee I., 2008, IEEE INFOCOM, DOI DOI 10.1109/INFOCOM.2008.145; Riley S, 2007, SCIENCE, V316, P1298, DOI 10.1126/science.1134695; Shanghai Jiao Tong University China, 2007, SUVNET TRAC DAT; Shanghai Municipal Bureau of Planning and Land Resources China, 2009, SHANGH URB PLANN LAN; Shanghai Population and Family Planning Commission China, 2001, 5 POP CENS EV POP CO; Shlesinger M, 1995, LEVY FLIGHTS RELATED, V450; Simon P, 1998, CONDMAT9801022 ARXIV; Waddell P, 2002, J AM PLANN ASSOC, V68, P297, DOI 10.1080/01944360208976274; Wegener M., 2004, HDB TRANSPORT GEOGRA, P127, DOI [DOI 10.1108/9781615832538-009, 10.1108/9781615832538-009]; Zhang LQ, 2004, LANDSCAPE URBAN PLAN, V69, P1, DOI 10.1016/j.landurbplan.2003.08.006; Zhenmei Liao, 2010, Proceedings of the 2010 IEEE/ACM Int'l Conference on Green Computing and Communications (GreenCom) and Int'l Conference on Cyber, Physical and Social Computing (CPSCom), P600, DOI 10.1109/GreenCom-CPSCom.2010.51	48	103	114	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e34487	10.1371/journal.pone.0034487	http://dx.doi.org/10.1371/journal.pone.0034487			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529917	Green Submitted, Green Published, gold			2022-12-27	WOS:000305350600016
J	Szczesniak, R				Szczesniak, Radoslaw			Pairing Mechanism for the High-T-C Superconductivity: Symmetries and Thermodynamic Properties	PLOS ONE			English	Article							ELECTRON-PHONON INTERACTION; VAN-HOVE SINGULARITY; 2-DIMENSIONAL HUBBARD-MODEL; TRANSITION-TEMPERATURE; ENERGY-GAP; TUNNELING SPECTROSCOPY; SPECTRAL-FUNCTION; VORTEX CORES; PSEUDOGAP; ISOTOPE	The pairing mechanism for the high-T-C superconductors based on the electron-phonon (EPH) and electron-electron-phonon (EEPH) interactions has been presented. On the fold mean-field level, it has been proven, that the obtained s-wave model supplements the predictions based on the BCS van Hove scenario. In particular: (i) For strong EEPH coupling and T<TC the energy gap (Delta(tot)) is very weak temperature dependent; up to the critical temperature Delta(tot) extends into the anomalous normal state to the Nernst temperature. (ii) The model explains well the experimental dependence of the ratio R-1 equivalent to 2 Delta((0))(tot)/k(B)T(C) on doping for the reported superconductors in the terms of the few fundamental parameters. In the presented paper, the properties of the d-wave superconducting state in the two-dimensional system have been also studied. The obtained results, like for s-wave, have shown the energy gap amplitude crossover from the BCS to non-BCS behavior, as the value of the EEPH potential increases. However, for T>T-C the energy gap amplitude extends into the anomalous normal state to the pseudogap temperature. Finally, it has been presented that the anisotropic model explains the dependence of the ratio R-1 on doping for the considered superconductors.	Czestochowa Tech Univ, Inst Phys, Czestochowa, Poland	Technical University Czestochowa	Szczesniak, R (corresponding author), Czestochowa Tech Univ, Inst Phys, Czestochowa, Poland.	szczesni@wip.pcz.pl		Szczesniak, Radoslaw/0000-0002-2996-7077	Czestochowa University of Technology [BS/PB-203-301/2011]	Czestochowa University of Technology	This work is supported by Czestochowa University of Technology, BS/PB-203-301/2011. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen PB, 1982, SOLID STATE PHYS ADV; Almasan C., 1991, CHEM HIGH TEMPERATUR; Andersen OK, 1995, J PHYS CHEM SOLIDS, V56, P1573, DOI 10.1016/0022-3697(95)00269-3; ANDERSON PW, 1987, SCIENCE, V235, P1196, DOI 10.1126/science.235.4793.1196; Balci H, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.174510; BARDEEN J, 1957, PHYS REV, V108, P1175, DOI 10.1103/PhysRev.108.1175; BARDEEN J, 1957, PHYS REV, V106, P162, DOI 10.1103/PhysRev.106.162; BEDNORZ JG, 1988, REV MOD PHYS, V60, P585, DOI 10.1103/RevModPhys.60.585; BEDNORZ JG, 1986, Z PHYS B CON MAT, V64, P189, DOI 10.1007/BF01303701; Bennemann K.H., 2003, PHYS SUPERCONDUCTORS; Biswas A, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.207004; Bohnen KP, 2003, EUROPHYS LETT, V64, P104, DOI 10.1209/epl/i2003-00143-x; Born V, 2002, PHYSICA C, V382, P224, DOI 10.1016/S0921-4534(02)01140-1; Campuzano JC, 1999, PHYS REV LETT, V83, P3709, DOI 10.1103/PhysRevLett.83.3709; CARBOTTE JP, 1990, REV MOD PHYS, V62, P1027, DOI 10.1103/RevModPhys.62.1027; CHAO KA, 1977, J PHYS C SOLID STATE, V10, pL271, DOI 10.1088/0022-3719/10/10/002; Cuk T, 2005, PHYS STATUS SOLIDI B, V242, P11, DOI 10.1002/pssb.200404959; Czerwonko J, 1998, ACTA PHYS POL B, V29, P3885; Czerwonko J, 2000, J PHYS ELEMENT PART, V31, P145; Dagan Y, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.147004; DAGOTTO E, 1994, REV MOD PHYS, V66, P763, DOI 10.1103/RevModPhys.66.763; Damascelli A, 2003, REV MOD PHYS, V75, P473, DOI 10.1103/RevModPhys.75.473; EDWARDS HL, 1995, PHYS REV LETT, V75, P1387, DOI 10.1103/PhysRevLett.75.1387; EDWARDS HL, 1992, PHYS REV LETT, V69, P2967, DOI 10.1103/PhysRevLett.69.2967; ELIASHBERG GM, 1960, SOV PHYS JETP-USSR, V11, P696; EMERY VJ, 1987, PHYS REV LETT, V58, P2794, DOI 10.1103/PhysRevLett.58.2794; Fong HF, 1997, PHYS REV LETT, V78, P713, DOI 10.1103/PhysRevLett.78.713; Fournier P, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.094507; Franck J. P., 1994, PHYS PROPERTIES HIGH; FROHLICH H, 1950, PHYS REV, V79, P845, DOI 10.1103/PhysRev.79.845; FROHLICH H, 1954, PROC R SOC LON SER-A, V223, P296, DOI 10.1098/rspa.1954.0116; Gasser W., 1999, GREENSCHE FUNKTIONEN; GOICOCHEA AG, 1994, PHYS REV B, V49, P6864, DOI 10.1103/PhysRevB.49.6864; Gonnelli RS, 1997, PHYSICA C, V275, P162, DOI 10.1016/S0921-4534(96)00700-9; Gupta AK, 1998, PHYS REV B, V58, pR8901, DOI 10.1103/PhysRevB.58.R8901; Gweon GH, 2004, NATURE, V430, P187, DOI 10.1038/nature02731; Hackl A, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.235124; Hague JP, 2006, AIP CONF PROC, V846, P255; Heid R, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.024507; Hewitt KC, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.054516; HIRSCH JE, 1994, PHYSICA B, V199, P366, DOI 10.1016/0921-4526(94)91840-6; Hirsch JE, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.064507; Hirsch JE, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.206402; Hofer J, 2000, PHYS REV LETT, V84, P4192, DOI 10.1103/PhysRevLett.84.4192; Hoffman JE, 2002, SCIENCE, V295, P466, DOI 10.1126/science.1066974; HOFFMANN A, 1995, J LOW TEMP PHYS, V99, P201, DOI 10.1007/BF00752288; Homes CC, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.214515; Howald C, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.100504; HUBBARD J, 1963, PROC R SOC LON SER-A, V276, P238, DOI 10.1098/rspa.1963.0204; HYBERTSEN MS, 1990, PHYS REV B, V41, P11068, DOI 10.1103/PhysRevB.41.11068; IMADA M, 1991, J PHYS SOC JPN, V60, P2740, DOI 10.1143/JPSJ.60.2740; IMADA M, 1989, J PHYS SOC JPN, V58, P3752, DOI 10.1143/JPSJ.58.3752; Johannsen N, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.020512; Kaminski A, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.212509; Kanigel A, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.157001; Kato T, 2003, PHYSICA C, V392, P221, DOI 10.1016/S0921-4534(03)01076-1; Khlopkin MN, 1999, PHYS SOLID STATE+, V41, P1050, DOI 10.1134/1.1130935; Kim C, 1998, PHYS REV LETT, V80, P4245, DOI 10.1103/PhysRevLett.80.4245; KIM JH, 1993, PHYS REV LETT, V71, P4218, DOI 10.1103/PhysRevLett.71.4218; Krasnov VM, 2000, PHYS REV LETT, V84, P5860, DOI 10.1103/PhysRevLett.84.5860; Kulic ML, 2006, J SUPERCOND NOV MAGN, V19, P213, DOI 10.1007/s10948-006-0159-6; Kulic ML, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.132511; Kulic ML, 2004, AIP CONF PROC, V715, P75, DOI 10.1063/1.1800734; Kulic ML, 2000, PHYS REP, V338, P1, DOI 10.1016/S0370-1573(00)00008-9; LANG IG, 1963, SOV PHYS JETP-USSR, V16, P1301; Lee PA, 2006, REV MOD PHYS, V78, P17, DOI 10.1103/RevModPhys.78.17; Li PC, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.184509; Li PC, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.174512; Liang RX, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.180505; Lin J, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.214506; LITTLEWOOD PB, 1989, PHYS REV LETT, V63, P2602, DOI 10.1103/PhysRevLett.63.2602; Mamedov TA, 1999, PHYS LETT A, V257, P201, DOI 10.1016/S0375-9601(99)00318-7; Markiewicz RS, 1997, J PHYS CHEM SOLIDS, V58, P1179, DOI 10.1016/S0022-3697(97)00025-5; Marsiglio F, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.224507; Matsuda A, 2003, PHYSICA C, V388, P207, DOI 10.1016/S0921-4534(02)02378-X; Matsuda A, 1999, PHYS REV B, V60, P1377, DOI 10.1103/PhysRevB.60.1377; McElroy K, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.197005; MILLIS AJ, 1990, PHYS REV B, V42, P167, DOI 10.1103/PhysRevB.42.167; MONTHOUX P, 1992, PHYS REV LETT, V69, P961, DOI 10.1103/PhysRevLett.69.961; Morr DK, 1998, PHYS REV LETT, V81, P1086, DOI 10.1103/PhysRevLett.81.1086; Murakami H, 2001, APPL SURF SCI, V175, P306, DOI 10.1016/S0169-4332(01)00047-2; MURAKAMI H, 1995, J PHYS SOC JPN, V64, P1287, DOI 10.1143/JPSJ.64.1287; Nakano T, 1998, J PHYS SOC JPN, V67, P2622, DOI 10.1143/JPSJ.67.2622; Nakayama K, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.140503; NEWNS DM, 1995, PHYS REV B, V52, P13611, DOI 10.1103/PhysRevB.52.13611; Nunner TS, 1999, PHYS REV B, V59, P8859, DOI 10.1103/PhysRevB.59.8859; Oda M, 1997, PHYSICA C, V281, P135, DOI 10.1016/S0921-4534(97)00505-4; Oda M, 2000, PHYSICA C, V341, P847, DOI 10.1016/S0921-4534(00)00710-3; Oki T, 2001, PHYSICA C, V353, P213, DOI 10.1016/S0921-4534(00)01751-2; Ong NP, 2004, ANN PHYS-BERLIN, V13, P9, DOI 10.1002/andp.200310034; Plate M, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.077001; Ponomarev YG, 2000, C SERIES I PHYS, V2, P167; PRESLAND MR, 1991, PHYSICA C, V176, P95, DOI 10.1016/0921-4534(91)90700-9; Pryadko LP, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.067002; RADTKE RJ, 1993, PHYS REV B, V48, P15957, DOI 10.1103/PhysRevB.48.15957; Renner C, 1998, PHYS REV LETT, V80, P149, DOI 10.1103/PhysRevLett.80.149; Renner C, 1998, PHYS REV LETT, V80, P3606, DOI 10.1103/PhysRevLett.80.3606; Rullier-Albenque F, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.067002; Sarkar S, 1996, PHYS REV B, V54, P14974, DOI 10.1103/PhysRevB.54.14974; SARKAR S, 1995, PHYS REV B, V52, P12545, DOI 10.1103/PhysRevB.52.12545; SARKAR S, 1995, PHYS REV B, V51, P12854, DOI 10.1103/PhysRevB.51.12854; SCALAPINO DJ, 1992, PHYS REV LETT, V68, P2830, DOI 10.1103/PhysRevLett.68.2830; Schneider T, 2005, PHYS STATUS SOLIDI B, V242, P58, DOI 10.1002/pssb.200404955; Sutherland M, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.174520; Szczesniak R, 2008, SOLID STATE COMMUN, V145, P137, DOI 10.1016/j.ssc.2007.10.010; Szczesniak R, 2007, PHYS STATUS SOLIDI B, V244, P2538, DOI 10.1002/pssb.200674629; Szczesniak R, 2006, SOLID STATE COMMUN, V138, P347, DOI 10.1016/j.ssc.2006.03.012; Szczesniak R, 2006, ACTA PHYS POL A, V109, P179, DOI 10.12693/APhysPolA.109.179; Szczesniak R, 2003, ACTA PHYS SLOVACA, V53, P477; Szczesniak R, 2012, J SUPERCOND NOV MAGN, V25, P399, DOI 10.1007/s10948-011-1326-y; Szczesniak R, 2012, PHYSICA C, V472, P15, DOI 10.1016/j.physc.2011.09.017; Szczesniak R, 2011, PHYSICA B, V406, P3493, DOI 10.1016/j.physb.2011.06.033; Szczesniak R, 2011, PHYSICA B, V406, P2235, DOI 10.1016/j.physb.2011.03.038; Szczesniak R, 2010, PHYSICA B, V405, P4897, DOI 10.1016/j.physb.2010.09.036; Szczesniak R, 2002, ACTA PHYS POL A, V102, P401, DOI 10.12693/APhysPolA.102.401; Szczesniak R, 2009, SOLID STATE COMMUN, V149, P2053, DOI 10.1016/j.ssc.2009.08.019; Szczesniak R, 2009, PHYS LETT A, V373, P473, DOI 10.1016/j.physleta.2008.11.040; Szczesniak R, 2001, SOLID STATE COMMUN, V117, P369, DOI 10.1016/S0038-1098(00)00477-4; Tanaka K, 2006, SCIENCE, V314, P1910, DOI 10.1126/science.1133411; Tohayama T., 2003, PHYS REV B, V67; Tohyama T, 2000, SUPERCOND SCI TECH, V13, pR17, DOI 10.1088/0953-2048/13/4/201; Tsuei CC, 1997, NATURE, V387, P481, DOI 10.1038/387481a0; Tsuei CC, 1996, SCIENCE, V271, P329, DOI 10.1126/science.271.5247.329; VANHOVE L, 1953, PHYS REV, V89, P1189, DOI 10.1103/PhysRev.89.1189; VEDENEEV SI, 1995, PHYS REV B, V51, P16380, DOI 10.1103/PhysRevB.51.16380; Wang Y, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.064512; Wang YY, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.247002; Wen HH, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.134507; WON H, 1994, PHYS REV B, V49, P1397, DOI 10.1103/PhysRevB.49.1397; XU JH, 1987, PHYS LETT A, V120, P489, DOI 10.1016/0375-9601(87)90118-6; Xu ZA, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.144527; Yeh NC, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.087003; Yoshida T, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/12/125209; Zimmers A, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.132502; Zimmers A, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.064515	137	44	44	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e31873	10.1371/journal.pone.0031873	http://dx.doi.org/10.1371/journal.pone.0031873			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529891	gold, Green Published, Green Submitted			2022-12-27	WOS:000305350600002
J	Wang, LB; Yin, F; Xu, X; Hu, XX; Zhao, DB				Wang, Libing; Yin, Fan; Xu, Xia; Hu, Xiaoxia; Zhao, Dongbao			X-Ray Repair Cross-Complementing Group 1 (XRCC1) Genetic Polymorphisms and Risk of Childhood Acute Lymphoblastic Leukemia: A Meta-Analysis	PLOS ONE			English	Article							XENOBIOTIC-METABOLIZING ENZYMES; BASE EXCISION-REPAIR; CANCER RISK; GASTRIC-CANCER; BREAST-CANCER; DNA-DAMAGE; ASSOCIATION; SUSCEPTIBILITY; XPD	Background: Recently, there have been a number of studies on the association between XRCC1 polymorphisms and childhood acute lymphoblastic leukemia (ALL) risk. However, the results of previous reports are inconsistent. Thus, we performed a meta-analysis to clarify the effects of XRCC1 variants on childhood ALL risk. Methods: A meta-analysis was performed to examine the association between XRCC1 polymorphisms (Arg399Gln, Arg194Trp, and Arg280His) and childhood ALL risk. We critically reviewed 7 studies with a total of 880 cases and 1311 controls for Arg399Gln polymorphism, 3 studies with a total of 345 cases and 554 controls for Arg280His polymorphism, and 6 studies with a total of 783 cases and 1180 controls for Arg194Trp polymorphism, respectively. Odds ratio (OR) and its 95% confidence interval (CI) were used. Results: Significant association between XRCC1 Arg399Gln polymorphism and childhood ALL risk was observed in total population analyses (ORadditive model = 1.501, 95% CI 1.112-2.026, P-OR = 0.008; ORdominant model = 1.316, 95% CI = 1.104-1.569, P-OR = 0.002) and Asian subgroup analyses (ORadditive model = 2.338, 95% CI = 1.254-4.359, P-OR = 0.008; ORdominant model = 2.108, 95% CI = 1.498-2.967, P-OR = 0.000). No association was detected in Caucasians, Metizo and mixed populations. Ethnicity was considered as a significant source of heterogeneity in the meta-regression model. For the other two XRCC1 polymorphisms, no association with childhood ALL risk was found. Conclusions: The meta-analysis results suggested that XRCC1 Arg399Gln polymorphism might be associated with elevated childhood ALL risk among Asian population.	[Wang, Libing; Hu, Xiaoxia] Second Mil Med Univ, Changhai Hosp, Dept Hematol, Shanghai, Peoples R China; [Yin, Fan; Xu, Xia; Zhao, Dongbao] Second Mil Med Univ, Changhai Hosp, Dept Rheumatol & Immunol, Shanghai, Peoples R China	Naval Medical University; Naval Medical University	Wang, LB (corresponding author), Second Mil Med Univ, Changhai Hosp, Dept Hematol, Shanghai, Peoples R China.	zhaodongbao@yahoo.com.cn			Young Scholar Grant from National Natural Science Foundation of China [30800488]; Excellent Young Scholarship from Shanghai Health Bureau [XYQ2011007]	Young Scholar Grant from National Natural Science Foundation of China; Excellent Young Scholarship from Shanghai Health Bureau	This work was financially supported by Young Scholar Grant from National Natural Science Foundation of China (Grant Number: 30800488) and Excellent Young Scholarship from Shanghai Health Bureau(XYQ2011007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batar B, 2009, LEUKEMIA RES, V33, P759, DOI 10.1016/j.leukres.2008.11.005; Canalle R, 2011, LEUKEMIA LYMPHOMA, V52, P1118, DOI 10.3109/10428194.2011.559672; Cardwell CR, 2008, BRIT J CANCER, V99, P1529, DOI 10.1038/sj.bjc.6604696; Chou WC, 2008, EMBO J, V27, P3140, DOI 10.1038/emboj.2008.229; COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; Coppede F, 2009, AMYOTROPH LATERAL SC, V25, P1; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Geng J, 2009, UROLOGY, V74, P648, DOI 10.1016/j.urology.2009.02.046; Harth V, 2008, J TOXICOL ENV HEAL A, V71, P887, DOI 10.1080/15287390801988160; Joseph T, 2005, CANCER LETT, V217, P17, DOI 10.1016/j.canlet.2004.06.055; Kiyohara C, 2006, LUNG CANCER, V54, P267, DOI 10.1016/j.lungcan.2006.08.009; Krajinovic M, 2002, CLIN CANCER RES, V8, P802; Lan L, 2004, P NATL ACAD SCI USA, V101, P13738, DOI 10.1073/pnas.0406048101; Lao T, 2008, MUTAGENESIS, V23, P523, DOI 10.1093/mutage/gen046; Lee SG, 2002, CANCER LETT, V187, P53, DOI 10.1016/S0304-3835(02)00381-6; MANTEL N, 1959, J NATL CANCER I, V22, P719; Mehta PA, 2006, LEUKEMIA, V20, P1539, DOI 10.1038/sj.leu.2404299; Meza-Espinoza J P, 2009, Genet Mol Res, V8, P1451, DOI 10.4238/vol8-4gmr687; Pakakasama S, 2007, PEDIATR BLOOD CANCER, V48, P16, DOI 10.1002/pbc.20742; Roberts MR, 2011, CARCINOGENESIS, V32, P1223, DOI 10.1093/carcin/bgr096; Saadat M, 2009, BREAST CANCER RES TR, V115, P137, DOI 10.1007/s10549-008-0051-0; Schafer ES, 2011, NAT REV CLIN ONCOL, V8, P417, DOI 10.1038/nrclinonc.2011.77; Shiraishi K, 2010, J CLIN ONCOL, V28, P4945, DOI 10.1200/JCO.2010.30.5334; Silveira VD, 2009, LEUKEMIA RES, V33, P898, DOI 10.1016/j.leukres.2008.12.006; Stanczyk M, 2011, MOL BIOL REP, V38, P445, DOI 10.1007/s11033-010-0127-x; Tobias A., 1999, STATA TECHNICAL B, V8, P15; Tumer TB, 2012, ARCH TOXICOL, V86, P431, DOI 10.1007/s00204-011-0760-8; Tumer TB, 2010, LEUKEMIA RES, V34, P1275, DOI 10.1016/j.leukres.2010.02.035; Vijayakrishnan J, 2010, HAEMATOL-HEMATOL J, V95, P1405, DOI 10.3324/haematol.2010.022095; Vural P, 2009, EUR J OBSTET GYN R B, V146, P160, DOI 10.1016/j.ejogrb.2009.06.007; Wang CY, 2008, UROLOGY, V72, P869, DOI 10.1016/j.urology.2007.12.059; Xing DY, 2002, INT J CANCER, V100, P600, DOI 10.1002/ijc.10528; Xue HP, 2011, AM J EPIDEMIOL, V173, P363, DOI 10.1093/aje/kwq378	34	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e34897	10.1371/journal.pone.0034897	http://dx.doi.org/10.1371/journal.pone.0034897			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529951	Green Published, Green Submitted, gold			2022-12-27	WOS:000305350600038
J	Barrett, MA; Zheng, SB; Roshankar, G; Alsop, RJ; Belanger, RKR; Huynh, C; Kucerka, N; Rheinstadter, MC				Barrett, Matthew A.; Zheng, Songbo; Roshankar, Golnaz; Alsop, Richard J.; Belanger, Randy K. R.; Huynh, Chris; Kucerka, Norbert; Rheinstaedter, Maikel C.			Interaction of Aspirin (Acetylsalicylic Acid) with Lipid Membranes	PLOS ONE			English	Article							SUBGEL PHASE; DMPC; BILAYERS; CHOLESTEROL; HYDRATION; DPPC	We studied the interaction of Aspirin (acetylsalicylic acid) with lipid membranes using x-ray diffraction for bilayers containing up to 50 mol% of aspirin. From 2D x-ray intensity maps that cover large areas of reciprocal space we determined the position of the ASA molecules in the phospholipid bilayers and the molecular arrangement of the molecules in the plane of the membranes. We present direct experimental evidence that ASA molecules participate in saturated lipid bilayers of DMPC (1,2-dimyristoyl-sn-glycero-3-phosphocholine) and preferably reside in the head group region of the membrane. Up to 50 mol% ASA molecules can be dissolved in this type of bilayer before the lateral membrane organization is disturbed and the membranes are found to form an ordered, 2D crystal-like structure. Furthermore, ASA and cholesterol were found to co-exist in saturated lipid bilayers, with the ASA molecules residing in the head group region and the cholesterol molecules participating in the hydrophobic membrane core.	[Barrett, Matthew A.; Zheng, Songbo; Roshankar, Golnaz; Alsop, Richard J.; Belanger, Randy K. R.; Huynh, Chris; Rheinstaedter, Maikel C.] McMaster Univ, Dept Phys & Astron, Hamilton, ON L8S 4M1, Canada; [Kucerka, Norbert; Rheinstaedter, Maikel C.] Natl Res Council Canada, Canadian Neutron Beam Ctr, Chalk River, ON, Canada	McMaster University; Atomic Energy of Canada Limited; National Research Council Canada	Barrett, MA (corresponding author), McMaster Univ, Dept Phys & Astron, Hamilton, ON L8S 4M1, Canada.	rheinstadter@mcmaster.ca	Rheinstadter, Maikel C/D-5322-2009; Kucerka, Norbert/Q-7476-2016	Rheinstadter, Maikel C/0000-0002-0558-7475; Kucerka, Norbert/0000-0002-1075-6640	Natural Sciences and Engineering Research Council of Canada (NSERC); National Research Council Canada (NRC); Canada Foundation for Innovation (CFI); Ontario Ministry of Economic Development and Innovation	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Research Council Canada (NRC); Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation); Ontario Ministry of Economic Development and Innovation	This research was funded by the Natural Sciences and Engineering Research Council of Canada (NSERC), the National Research Council Canada (NRC), the Canada Foundation for Innovation (CFI), and the Ontario Ministry of Economic Development and Innovation. Silicon substrates were partially provided by ComDev. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi T, 2000, CHEM PHYS LIPIDS, V107, P93, DOI 10.1016/S0009-3084(00)00154-7; CASAL HL, 1987, CHEM PHYS LIPIDS, V43, P47, DOI 10.1016/0009-3084(87)90016-8; de Meyer FJM, 2010, J PHYS CHEM B, V114, P10451, DOI 10.1021/jp103903s; Fragneto G, 2007, CR PHYS, V8, P865, DOI 10.1016/j.crhy.2007.09.003; KATSARAS J, 1995, BIOCHEMISTRY-US, V34, P4684, DOI 10.1021/bi00014a023; KING GI, 1971, PHYS LETT A, VA 35, P259, DOI 10.1016/0375-9601(71)90371-9; Kucerka N, 2010, BIOCHEMISTRY-US, V49, P7485, DOI 10.1021/bi100891z; Kucerka N, 2009, J AM CHEM SOC, V131, P16358, DOI 10.1021/ja907659u; Meyer HW, 2000, CHEM PHYS LIPIDS, V105, P149, DOI 10.1016/S0009-3084(00)00124-9; NAGLE JF, 1989, BIOPHYS J, V55, P309, DOI 10.1016/S0006-3495(89)82806-1; Nagle JF, 1996, BIOPHYS J, V70, P1419, DOI 10.1016/S0006-3495(96)79701-1; Nomura K, 2011, J PHYS CHEM B, V115, P14991, DOI 10.1021/jp208958a; Pabst G, 2010, CHEM PHYS LIPIDS, V163, P460, DOI 10.1016/j.chemphyslip.2010.03.010; RAGHUNATHAN VA, 1995, PHYS REV LETT, V74, P4456, DOI 10.1103/PhysRevLett.74.4456; Seddon AM, 2009, CHEM SOC REV, V38, P2509, DOI 10.1039/b813853m; Tristram-Nagle S, 2002, BIOPHYS J, V83, P3324, DOI 10.1016/S0006-3495(02)75333-2; VANDENBERG ET, 1991, J COLLOID INTERF SCI, V147, P103, DOI 10.1016/0021-9797(91)90139-Y	17	57	57	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e34357	10.1371/journal.pone.0034357	http://dx.doi.org/10.1371/journal.pone.0034357			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22529913	Green Published, Green Submitted, gold			2022-12-27	WOS:000305347400011
J	Ceci, M; Welshhans, K; Ciotti, MT; Brandi, R; Parisi, C; Paoletti, F; Pistillo, L; Bassell, GJ; Cattaneo, A				Ceci, Marcello; Welshhans, Kristy; Ciotti, Maria Teresa; Brandi, Rossella; Parisi, Chiara; Paoletti, Francesca; Pistillo, Luana; Bassell, Gary J.; Cattaneo, Antonino			RACK1 Is a Ribosome Scaffold Protein for beta-actin mRNA/ZBP1 Complex	PLOS ONE			English	Article							ACTIVATED C-KINASE; MESSENGER-RNA; STRESS GRANULES; SRC; LOCALIZATION; TRANSLATION; RECEPTOR; SUBUNIT; GROWTH; PHOSPHORYLATION	In neurons, specific mRNAs are transported in a translationally repressed manner along dendrites or axons by transport ribonucleic-protein complexes called RNA granules. ZBP1 is one RNA binding protein present in transport RNPs, where it transports and represses the translation of cotransported mRNAs, including beta-actin mRNA. The release of beta-actin mRNA from ZBP1 and its subsequent translation depends on the phosphorylation of ZBP1 by Src kinase, but little is known about how this process is regulated. Here we demonstrate that the ribosomal-associated protein RACK1, another substrate of Src, binds the beta-actin mRNA/ZBP1 complex on ribosomes and contributes to the release of beta-actin mRNA from ZBP1 and to its translation. We identify the Src binding and phosphorylation site Y246 on RACK1 as the critical site for the binding to the beta-actin mRNA/ZBP1 complex. Based on these results we propose RACK1 as a ribosomal scaffold protein for specific mRNA-RBP complexes to tightly regulate the translation of specific mRNAs.	[Ceci, Marcello; Brandi, Rossella; Parisi, Chiara; Paoletti, Francesca; Pistillo, Luana; Cattaneo, Antonino] EBRI, Rome, Italy; [Welshhans, Kristy] Kent State Univ, Dept Biol Sci, Kent, OH 44242 USA; [Ciotti, Maria Teresa] CNR, Inst Neurobiol & Mol Med, Rome, Italy; [Bassell, Gary J.] Emory Univ, Sch Med, Dept Cell Biol, Atlanta, GA USA; [Cattaneo, Antonino] Scuola Normale Super Pisa, Pisa, Italy	University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; Consiglio Nazionale delle Ricerche (CNR); Emory University; Scuola Normale Superiore di Pisa	Ceci, M (corresponding author), EBRI, Rome, Italy.	a.cattaneo@ebri.it	parisi, Chiara/K-6330-2016; Cattaneo, Antonino/AAA-7252-2019; Welshhans, Kristy/ABD-9300-2020; Cattaneo, Antonino/K-4471-2016	parisi, Chiara/0000-0003-1350-3929; Cattaneo, Antonino/0000-0002-6975-8923; Welshhans, Kristy/0000-0001-6624-4719; Ceci, Marcello/0000-0002-5066-1590	IIT, Technology Italian Institute; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS064727] Funding Source: NIH RePORTER	IIT, Technology Italian Institute; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work is supported by grant from IIT, Technology Italian Institute (WWW.iit.itproject to A. Cattaneo) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Angenstein F, 2002, J NEUROSCI, V22, P8827; Arimoto K, 2008, NAT CELL BIOL, V10, P1324, DOI 10.1038/ncb1791; Ashique AM, 2006, BRAIN RES, V1069, P31, DOI 10.1016/j.brainres.2005.11.018; Atlas R, 2007, J NEUROSCI RES, V85, P173, DOI 10.1002/jnr.21099; Bramham CR, 2007, NAT REV NEUROSCI, V8, P776, DOI 10.1038/nrn2150; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Capsoni S, 2002, P NATL ACAD SCI USA, V99, P12432, DOI 10.1073/pnas.192442999; Ceci M, 2003, NATURE, V426, P579, DOI 10.1038/nature02160; Chang BY, 1998, MOL CELL BIOL, V18, P3245, DOI 10.1128/MCB.18.6.3245; Coyle SM, 2009, MOL CELL BIOL, V29, P1626, DOI 10.1128/MCB.01718-08; Daftuar L, 2010, CELL CYCLE, V9, P4259, DOI 10.4161/cc.9.21.13527; Doan AT, 2007, EXP CELL RES, V313, P2667, DOI 10.1016/j.yexcr.2007.05.013; Eom T, 2003, J NEUROSCI, V23, P10433; Farina KL, 2003, J CELL BIOL, V160, P77, DOI 10.1083/jcb.200206003; FREDERICKSON RM, 1991, MOL CELL BIOL, V11, P2896, DOI 10.1128/MCB.11.5.2896; Huang YZ, 2010, J BIOL CHEM, V285, P8207, DOI 10.1074/jbc.M109.091041; Huttelmaier S, 2005, NATURE, V438, P512, DOI 10.1038/nature04115; Jannot G, 2011, EMBO REP, V12, P581, DOI 10.1038/embor.2011.66; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Karni R, 2005, MOL CELL BIOL, V25, P5031, DOI 10.1128/MCB.25.12.5031-5039.2005; Kedersha N, 2002, MOL BIOL CELL, V13, P195, DOI 10.1091/mbc.01-05-0221; Krichevsky AM, 2001, NEURON, V32, P683, DOI 10.1016/S0896-6273(01)00508-6; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Bergami P, 2007, CANCER CELL, V11, P447, DOI 10.1016/j.ccr.2007.03.009; Luo M, 2002, BIOCHEM J, V365, P817, DOI 10.1042/BJ20020263; Mamidipudi V, 2004, MOL CELL BIOL, V24, P6788, DOI 10.1128/MCB.24.15.6788-6798.2004; Nho RS, 2011, J BIOL CHEM; Otsuka M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024359; Perycz M, 2011, J NEUROSCI, V31, P5271, DOI 10.1523/JNEUROSCI.2387-10.2011; Rabl J, 2011, SCIENCE, V331, P730, DOI 10.1126/science.1198308; RON D, 1994, P NATL ACAD SCI USA, V91, P839, DOI 10.1073/pnas.91.3.839; Sasaki Y, 2010, J NEUROSCI, V30, P9349, DOI 10.1523/JNEUROSCI.0499-10.2010; Sengupta J, 2004, NAT STRUCT MOL BIOL, V11, P957, DOI 10.1038/nsmb822; Shi GX, 2008, MOL CELL BIOL, V28, P4940, DOI 10.1128/MCB.02193-07; Sutton MA, 2006, CELL, V127, P49, DOI 10.1016/j.cell.2006.09.014; Tongiorgi E, 1997, J NEUROSCI, V17, P9492; Vojtechova M, 2008, NEOPLASIA, V10, P99, DOI 10.1593/neo.07905; Zeitelhofer M, 2008, J NEUROSCI, V28, P7555, DOI 10.1523/JNEUROSCI.0104-08.2008; Zhang HL, 2001, NEURON, V31, P261, DOI 10.1016/S0896-6273(01)00357-9	40	39	39	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e35034	10.1371/journal.pone.0035034	http://dx.doi.org/10.1371/journal.pone.0035034			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523568	gold, Green Submitted, Green Published			2022-12-27	WOS:000305345000040
J	Horstmann, H; Korber, C; Satzler, K; Aydin, D; Kuner, T				Horstmann, Heinz; Koerber, Christoph; Saetzler, Kurt; Aydin, Daniel; Kuner, Thomas			Serial Section Scanning Electron icroscopy ((SEM)-E-3) on Silicon Wafers for Ultra-Structural Volume Imaging of Cells and Tissues	PLOS ONE			English	Article							SYNAPTIC VESICLE ENDOCYTOSIS; 3-DIMENSIONAL RECONSTRUCTION; NERVOUS-SYSTEM; MICROSCOPY; TRANSMISSION; CALYX; TOMOGRAPHY; PLASTICITY; BRAIN; ARCHITECTURE	High resolution, three-dimensional (3D) representations of cellular ultrastructure are essential for structure function studies in all areas of cell biology. While limited subcellular volumes have been routinely examined using serial section transmission electron microscopy (ssTEM), complete ultrastructural reconstructions of large volumes, entire cells or even tissue are difficult to achieve using ssTEM. Here, we introduce a novel approach combining serial sectioning of tissue with scanning electron microscopy (SEM) using a conductive silicon wafer as a support. Ribbons containing hundreds of 35 nm thick sections can be generated and imaged on the wafer at a lateral pixel resolution of 3.7 nm by recording the backscattered electrons with the in-lens detector of the SEM. The resulting electron micrographs are qualitatively comparable to those obtained by conventional TEM. (SEM)-E-3 images of the same region of interest in consecutive sections can be used for 3D reconstructions of large structures. We demonstrate the potential of this approach by reconstructing a 31.7 mu m(3) volume of a calyx of Held presynaptic terminal. The approach introduced here, Serial Section SEM ((SEM)-E-3), for the first time provides the possibility to obtain 3D ultrastructure of large volumes with high resolution and to selectively and repetitively home in on structures of interest. (SEM)-E-3 accelerates process duration, is amenable to full automation and can be implemented with standard instrumentation.	[Horstmann, Heinz; Koerber, Christoph; Kuner, Thomas] Univ Heidelberg, Inst Anat & Cell Biol, Heidelberg, Germany; [Saetzler, Kurt] Univ Ulster, Biomed Sci Res Inst, Coleraine BT52 1SA, Londonderry, North Ireland; [Aydin, Daniel] Univ Heidelberg, Dept Biophys Chem, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ulster University; Ruprecht Karls University Heidelberg	Horstmann, H (corresponding author), Univ Heidelberg, Inst Anat & Cell Biol, Heidelberg, Germany.	kuner@uni-heidelberg.de		Korber, Christoph/0000-0003-1418-9724	Royal Society UK [JP080844]; CellNetworks Cluster of Excellence [EXC81]	Royal Society UK(Royal Society of London); CellNetworks Cluster of Excellence	This work has been supported by the Royal Society UK (International Joint Project Grant no. JP080844 to Dr. Satzler and Dr. Kuner) and the CellNetworks Cluster of Excellence (EXC81, Dr. Kuner). http://royalsociety.orghttp://www.cellnetworks.uni-hd.de. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beesley J. E., 1991, PRACTICAL METHODS EL, P239; Blumer MJF, 2002, J NEUROSCI METH, V120, P11, DOI 10.1016/S0165-0270(02)00166-8; Bock DD, 2011, NATURE, V471, P177, DOI 10.1038/nature09802; Bodor AL, 2008, J NEUROSCI, V28, P3090, DOI 10.1523/JNEUROSCI.5266-07.2008; Briggman KL, 2011, NATURE, V471, P183, DOI 10.1038/nature09818; Cardona A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000502; Chklovskii DB, 2010, CURR OPIN NEUROBIOL, V20, P667, DOI 10.1016/j.conb.2010.08.002; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; Ferguson SM, 2007, SCIENCE, V316, P570, DOI 10.1126/science.1140621; Fernandez-Busnadiego R, 2010, J CELL BIOL, V188, P145, DOI 10.1083/jcb.200908082; Fiala JC, 1998, J NEUROSCI, V18, P8900; Fiala JC, 2005, J MICROSC-OXFORD, V218, P52, DOI 10.1111/j.1365-2818.2005.01466.x; Harris KM, 1999, CURR OPIN NEUROBIOL, V9, P343, DOI 10.1016/S0959-4388(99)80050-6; Harris KM, 2006, J NEUROSCI, V26, P12101, DOI 10.1523/JNEUROSCI.3994-06.2006; Hayworth K., 2006, MICROSCOPY MICROA S2, V12, P86, DOI [10.1017/s1431927606066268, DOI 10.1017/S1431927606066268]; HIROKAWA N, 1980, J NEUROCYTOL, V9, P243, DOI 10.1007/BF01205160; Hoffpauir BK, 2007, NAT PROTOC, V2, P9, DOI 10.1038/nprot.2007.9; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Kasthuri N, 2007, MICROSC MICROANAL, V13, P26, DOI 10.1017/S1431927607078002; Knott G, 2008, J NEUROSCI, V28, P2959, DOI 10.1523/JNEUROSCI.3189-07.2008; LANDIS DMD, 1988, NEURON, V1, P201, DOI 10.1016/0896-6273(88)90140-7; Li JL, 2011, NEURON, V69, P273, DOI 10.1016/j.neuron.2010.12.022; Lichtman JW, 2011, SCIENCE, V334, P618, DOI 10.1126/science.1209168; London M, 2005, ANNU REV NEUROSCI, V28, P503, DOI 10.1146/annurev.neuro.28.061604.135703; Malecki M, 1987, PROTOPLASMA, V39, P160; Micheva KD, 2007, NEURON, V55, P25, DOI 10.1016/j.neuron.2007.06.014; Micheva KD, 2010, NEURON, V68, P639, DOI 10.1016/j.neuron.2010.09.024; Mishchenko Y, 2010, NEURON, V67, P1009, DOI 10.1016/j.neuron.2010.08.014; Raimondi A, 2011, NEURON, V70, P1100, DOI 10.1016/j.neuron.2011.04.031; Rollenhagen A, 2007, J NEUROSCI, V27, P10434, DOI 10.1523/JNEUROSCI.1946-07.2007; Satzler K, 2002, J NEUROSCI, V22, P10567; Schneggenburger R, 2006, CELL TISSUE RES, V326, P311, DOI 10.1007/s00441-006-0272-7; Soto G E, 1994, Neuroimage, V1, P230, DOI 10.1006/nimg.1994.1008; Tapia JC, 2012, NAT PROTOC, V7, P193, DOI 10.1038/nprot.2011.439; Taschenberger H, 2002, NEURON, V36, P1127, DOI 10.1016/S0896-6273(02)01137-6; von Gersdorff H, 2002, NAT REV NEUROSCI, V3, P53, DOI 10.1038/nrn705; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056	37	70	73	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e35172	10.1371/journal.pone.0035172	http://dx.doi.org/10.1371/journal.pone.0035172			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523574	Green Published, Green Submitted, gold			2022-12-27	WOS:000305345000046
J	Nemeth, J; Winkler, HM; Zwick, RH; Muller, C; Rumetshofer, R; Boeck, L; Burghuber, OC; Winkler, S				Nemeth, Johannes; Winkler, Heide-Maria; Zwick, Ralph H.; Mueller, Catharina; Rumetshofer, Rudolf; Boeck, Lucas; Burghuber, Otto C.; Winkler, Stefan			Peripheral T Cell Cytokine Responses for Diagnosis of Active Tuberculosis	PLOS ONE			English	Article							GAMMA RELEASE ASSAYS; PULMONARY TUBERCULOSIS; IMMUNE-RESPONSES; CENTRAL-AFRICA; INFECTION; CD4(+); METAANALYSIS; LYMPHOCYTES; DISEASE; SITE	Background: A test for diagnosis of active Tuberculosis (TB) from peripheral blood could tremendously improve clinical management of patients. Methods: Of 178 prospectively enrolled patients with possible TB, 60 patients were diagnosed with pulmonary and 27 patients with extrapulmonary TB. The frequencies of Mycobacterium tuberculosis (MTB) specific CD4(+) T cells and CD8(+) T cells producing cytokines were assessed using overnight stimulation with purified protein derivate (PPD) or early secretory antigenic target (ESAT)-6, respectively. Results: Among patients with active TB, an increased type 1 cytokine profile consisting of mainly CD4(+) T cell derived interferon (IFN)-gamma was detectable. Despite contributing to the cytokine profile as a whole, the independent diagnostic performance of one cytokine producing T cells as well as polyfunctional T cells was poor. IFN-gamma/Interleukin(IL)-2 cytokine ratios discriminated best between active TB and other diseases. Conclusion: T cells producing one cytokine and polyfunctional T cells have a limited role in diagnosis of active TB. The significant shift from a "memory type" to an "effector type" cytokine profile may be useful for further development of a rapid immune-diagnostic tool for active TB.	[Nemeth, Johannes; Winkler, Heide-Maria; Mueller, Catharina; Winkler, Stefan] Med Univ Vienna, Dept Internal Med 1, Div Infect Dis & Trop Med, Vienna, Austria; [Nemeth, Johannes] Univ Zurich Hosp, Div Infect Dis & Hosp Epidemiol, CH-8091 Zurich, Switzerland; [Zwick, Ralph H.; Rumetshofer, Rudolf; Burghuber, Otto C.] Otto Wagner Hosp, Dept Resp & Crit Care Med, Vienna, Austria; [Boeck, Lucas] Univ Basel Hosp, Clin Pulm Med & Resp Cell Res, CH-4031 Basel, Switzerland	Medical University of Vienna; University of Zurich; University Zurich Hospital; University of Basel	Nemeth, J (corresponding author), Med Univ Vienna, Dept Internal Med 1, Div Infect Dis & Trop Med, Vienna, Austria.	stefan.winkler@meduniwien.ac.at	Nemeth, Johannes/M-2591-2017	Nemeth, Johannes/0000-0003-0683-456X; burghuber, otto/0000-0002-8419-621X				Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Caccamo N, 2010, EUR J IMMUNOL, V40, P2211, DOI 10.1002/eji.201040455; Ciuffreda D, 2008, EUR J IMMUNOL, V38, P2665, DOI 10.1002/eji.200838336; Commandeur S, 2011, EUR J IMMUNOL, V41, P2925, DOI 10.1002/eji.201141602; Cooper AM, 2009, ANNU REV IMMUNOL, V27, P393, DOI 10.1146/annurev.immunol.021908.132703; Day CL, 2011, J IMMUNOL, V187, P2222, DOI 10.4049/jimmunol.1101122; Diel R, 2011, EUR RESPIR J, V37, P88, DOI 10.1183/09031936.00115110; Diel R, 2011, EUR RESP J SWITZERLA, P88; Duvall MG, 2008, EUR J IMMUNOL, V38, P350, DOI 10.1002/eji.200737768; Fuhrmann S, 2008, CYTOM PART A, V73A, P1100, DOI 10.1002/cyto.a.20614; Gaucher D, 2008, J EXP MED, V205, P3119, DOI 10.1084/jem.20082292; Grotzke JE, 2005, MICROBES INFECT, V7, P776, DOI 10.1016/j.micinf.2005.03.001; Harari A, 2005, J IMMUNOL, V174, P1037, DOI 10.4049/jimmunol.174.2.1037; Harari A, 2011, NAT MED, V17, P372, DOI 10.1038/nm.2299; Hernandez-Garduno E, 2004, THORAX, V59, P286, DOI 10.1136/thx.2003.011759; Jafari C, 2011, J INTERN MED, V270, P254, DOI 10.1111/j.1365-2796.2011.02378.x; Kannanganat S, 2007, J VIROL, V81, P12071, DOI 10.1128/JVI.01261-07; Krummel B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011670; Lawn SD, 2011, LANCET, V378, P57, DOI 10.1016/S0140-6736(10)62173-3; Millington KA, 2007, J IMMUNOL, V178, P5217, DOI 10.4049/jimmunol.178.8.5217; Nemeth J, 2009, J INTERN MED, V265, P163, DOI 10.1111/j.1365-2796.2008.02012.x; Nemeth J, 2011, CLIN IMMUNOL, V138, P50, DOI 10.1016/j.clim.2010.09.005; Nemeth J, 2010, EUR CYTOKINE NETW, V21, P34, DOI 10.1684/ecn.2009.0182; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sester M, 2011, EUR RESPIR J, V37, P100, DOI 10.1183/09031936.00114810; Sester U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017813; Sharma PK, 2009, AM J RESP CRIT CARE, V179, P1061, DOI 10.1164/rccm.200804-529OC; Streitz M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000735; Sutherland JS, 2009, EUR J IMMUNOL, V39, P723, DOI 10.1002/eji.200838693; Winkler S, 2005, MICROBES INFECT, V7, P1161, DOI 10.1016/j.micinf.2005.03.020; Young JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011237	31	20	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e35290	10.1371/journal.pone.0035290	http://dx.doi.org/10.1371/journal.pone.0035290			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523581	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000305345000053
J	Reber, A; Chapuisat, M				Reber, Anabelle; Chapuisat, Michel			No Evidence for Immune Priming in Ants Exposed to a Fungal Pathogen	PLOS ONE			English	Article							RED FLOUR BEETLE; DISEASE RESISTANCE; GROUP FACILITATION; MEALWORM BEETLE; SOCIAL IMMUNITY; INSECT; PROPHYLAXIS; DEFENSE; RESIN; INFECTION	There is accumulating evidence that invertebrates can acquire long-term protection against pathogens through immune priming. However, the range of pathogens eliciting immune priming and the specificity of the response remain unclear. Here, we tested if the exposure to a natural fungal pathogen elicited immune priming in ants. We found no evidence for immune priming in Formica selysi workers exposed to Beauveria bassiana. The initial exposure of ants to the fungus did not alter their resistance in a subsequent challenge with the same fungus. There was no sign of priming when using homologous and heterologous combinations of fungal strains for exposure and subsequent challenges at two time intervals. Hence, within the range of conditions tested, the immune response of this social insect to the fungal pathogen appears to lack memory and strain-specificity. These results show that immune priming is not ubiquitous across pathogens, hosts and conditions, possibly because of immune evasion by the pathogen or efficient social defences by the host.	[Reber, Anabelle; Chapuisat, Michel] Univ Lausanne, Dept Ecol & Evolut, Lausanne, Switzerland	University of Lausanne	Reber, A (corresponding author), Univ Lausanne, Dept Ecol & Evolut, Lausanne, Switzerland.	Michel.Chapuisat@unil.ch	Chapuisat, Michel/T-8686-2017	Chapuisat, Michel/0000-0001-7207-199X	Swiss National Science Foundation [31003A_125306]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was supported by grant 31003A_125306 from the Swiss National Science Foundation to MC (http://www.snf.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-Ami F, 2010, AM NAT, V175, P106, DOI 10.1086/648672; Boughton RK, 2011, FUNCT ECOL, V25, P81, DOI 10.1111/j.1365-2435.2010.01817.x; Castella G, 2008, ECOL ENTOMOL, V33, P408, DOI 10.1111/j.1365-2311.2007.00983.x; Chai LYA, 2009, MED MYCOL, V47, P227, DOI 10.1080/13693780802209082; Chapuisat M, 2004, EVOLUTION, V58, P1064, DOI 10.1111/j.0014-3820.2004.tb00440.x; Chapuisat M, 2007, P ROY SOC B-BIOL SCI, V274, P2013, DOI 10.1098/rspb.2007.0531; Cotter SC, 2010, BEHAV ECOL, V21, P663, DOI 10.1093/beheco/arq070; Cremer S, 2007, CURR BIOL, V17, pR693, DOI 10.1016/j.cub.2007.06.008; Gonzalez-Tokman DM, 2010, PHYSIOL ENTOMOL, V35, P364, DOI 10.1111/j.1365-3032.2010.00752.x; HAJEK AE, 1994, ANNU REV ENTOMOL, V39, P293, DOI 10.1146/annurev.en.39.010194.001453; Hamilton C, 2011, BIOL LETTERS, V7, P89, DOI 10.1098/rsbl.2010.0466; Hamilton W.D., 1987, P81; Hauton C, 2007, BIOESSAYS, V29, P1138, DOI 10.1002/bies.20650; Heinze J, 2010, CURR BIOL, V20, P249, DOI 10.1016/j.cub.2009.12.031; Korner P, 2004, J INVERTEBR PATHOL, V87, P59, DOI 10.1016/j.jip.2004.07.004; Kurtti TJ, 2008, MICROBIOL-SGM, V154, P1700, DOI 10.1099/mic.0.2008/016667-0; Kurtz J, 2005, TRENDS IMMUNOL, V26, P186, DOI 10.1016/j.it.2005.02.001; Kurtz J, 2003, NATURE, V425, P37, DOI 10.1038/425037a; Lacey L.A, 1997, MANUAL TECHNIQUES IN; Little TJ, 2005, NAT IMMUNOL, V6, P651, DOI 10.1038/ni1219; Little TJ, 2003, CURR BIOL, V13, P489, DOI 10.1016/S0960-9822(03)00163-5; Meunier J, 2009, J EVOLUTION BIOL, V22, P1906, DOI 10.1111/j.1420-9101.2009.01805.x; Moino Jr. Alcides, 2002, Sci. agric. (Piracicaba, Braz.), V59, P267, DOI 10.1590/S0103-90162002000200010; Moret Y, 2001, NATURE, V414, P506, DOI 10.1038/35107138; Moret Y, 2006, P R SOC B, V273, P1399, DOI 10.1098/rspb.2006.3465; Moret Y, 2003, P ROY SOC B-BIOL SCI, V270, P2475, DOI 10.1098/rspb.2003.2511; Mowlds P, 2008, MICROBES INFECT, V10, P628, DOI 10.1016/j.micinf.2008.02.011; Pham LN, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030026; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Reber A, 2012, INSECT SOC, V59, P231, DOI 10.1007/s00040-011-0209-3; Reber A, 2011, J EVOLUTION BIOL, V24, P954, DOI 10.1111/j.1420-9101.2011.02230.x; Reber A, 2008, ECOL LETT, V11, P682, DOI 10.1111/j.1461-0248.2008.01177.x; Rodrigues J, 2010, SCIENCE, V330, P448; Rosengaus RB, 1999, NATURWISSENSCHAFTEN, V86, P588, DOI 10.1007/s001140050679; Rosset H, 2007, EVOL ECOL, V21, P577, DOI 10.1007/s10682-006-9139-3; Roth O, 2009, P ROY SOC B-BIOL SCI, V276, P145, DOI 10.1098/rspb.2008.1157; Roth O, 2010, J ANIM ECOL, V79, P403, DOI 10.1111/j.1365-2656.2009.01617.x; Sadd BM, 2007, CURR BIOL, V17, pR1046, DOI 10.1016/j.cub.2007.11.007; Sadd BM, 2006, CURR BIOL, V16, P1206, DOI 10.1016/j.cub.2006.04.047; Sadd BM, 2009, EVOL APPL, V2, P113, DOI 10.1111/j.1752-4571.2008.00057.x; Sadd BM, 2005, BIOL LETTERS, V1, P386, DOI 10.1098/rsbl.2005.0369; Schmid-Hempel P, 2003, P ROY SOC B-BIOL SCI, V270, P357, DOI 10.1098/rspb.2002.2265; Schmid-Hempel P, 2005, ANNU REV ENTOMOL, V50, P529, DOI 10.1146/annurev.ento.50.071803.130420; Schmid-Hempel P., 1998, Parasites in social insects.; Schmid-Hempel P, 2009, PHILOS T R SOC B, V364, P85, DOI 10.1098/rstb.2008.0157; Schmid-Hempel P, 2008, TRENDS ECOL EVOL, V23, P318, DOI 10.1016/j.tree.2008.02.011; Simone M, 2009, EVOLUTION, V63, P3016, DOI 10.1111/j.1558-5646.2009.00772.x; Thomas AM, 2010, ECOL ENTOMOL, V35, P200, DOI 10.1111/j.1365-2311.2009.01169.x; Tidbury HJ, 2011, P ROY SOC B-BIOL SCI, V278, P871, DOI 10.1098/rspb.2010.1517; Traniello JFA, 2002, P NATL ACAD SCI USA, V99, P6838, DOI 10.1073/pnas.102176599; Ugelvig LV, 2007, CURR BIOL, V17, P1967, DOI 10.1016/j.cub.2007.10.029; Wilson-Rich N, 2009, ANNU REV ENTOMOL, V54, P405, DOI 10.1146/annurev.ento.53.103106.093301	53	63	64	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e35372	10.1371/journal.pone.0035372	http://dx.doi.org/10.1371/journal.pone.0035372			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523588	Green Submitted, Green Published, gold			2022-12-27	WOS:000305345000061
J	Sundram, V; Chauhan, SC; Ebeling, M; Jaggi, M				Sundram, Vasudha; Chauhan, Subhash C.; Ebeling, Mara; Jaggi, Meena			Curcumin Attenuates beta-catenin Signaling in Prostate Cancer Cells through Activation of Protein Kinase D1	PLOS ONE			English	Article							E-CADHERIN; ANDROGEN RECEPTOR; SUBCELLULAR-LOCALIZATION; C-MU; PHOSPHORYLATION; EXPRESSION; MOTILITY; PROLIFERATION; APOPTOSIS; GROWTH	Prostate cancer is the most commonly diagnosed cancer affecting 1 in 6 males in the US. Understanding the molecular basis of prostate cancer progression can serve as a tool for early diagnosis and development of novel treatment strategies for this disease. Protein Kinase D1 (PKD1) is a multifunctional kinase that is highly expressed in normal prostate. The decreased expression of PKD1 has been associated with the progression of prostate cancer. Therefore, synthetic or natural products that regulate this signaling pathway can serve as novel therapeutic modalities for prostate cancer prevention and treatment. Curcumin, the active ingredient of turmeric, has shown anti-cancer properties via modulation of a number of different molecular pathways. Herein, we have demonstrated that curcumin activates PKD1, resulting in changes in beta-catenin signaling by inhibiting nuclear beta-catenin transcription activity and enhancing the levels of membrane beta-catenin in prostate cancer cells. Modulation of these cellular events by curcumin correlated with decreased cell proliferation, colony formation and cell motility and enhanced cell-cell aggregation in prostate cancer cells. In addition, we have also revealed that inhibition of cell motility by curcumin is mediated by decreasing the levels of active cofilin, a downstream target of PKD1. The potent anti-cancer effects of curcumin in vitro were also reflected in a prostate cancer xenograft mouse model. The in vivo inhibition of tumor growth also correlated with enhanced membrane localization of beta-catenin. Overall, our findings herein have revealed a novel molecular mechanism of curcumin action via the activation of PKD1 in prostate cancer cells.	[Sundram, Vasudha; Chauhan, Subhash C.; Ebeling, Mara; Jaggi, Meena] Sanford Res USD, Canc Biol Res Ctr, Sioux Falls, SD USA; [Chauhan, Subhash C.; Jaggi, Meena] Univ S Dakota, Sanford Sch Med, Dept OB GYN, Sioux Falls, SD USA; [Chauhan, Subhash C.; Jaggi, Meena] Univ S Dakota, Sanford Sch Med, Basic Biomed Sci Div, Sioux Falls, SD USA	Sanford Health; University of South Dakota; University of South Dakota	Sundram, V (corresponding author), Sanford Res USD, Canc Biol Res Ctr, Sioux Falls, SD USA.	meena.jaggi@sanfordhealth.org			NIH [P20 RR024219]; department of defense (DOD) [DOD PC073643, DOD PC073887]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); department of defense (DOD)(United States Department of Defense)	This project was supported by COBRE Grant (P20 RR024219) from NIH (http://www.ncrr.nih.gov/) and by grants from the department of defense (DOD) (http://cdmrp.army.mil/) to MJ (DOD PC073643) and to SCC (DOD PC073887). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2003, ANTICANCER RES, V23, P363; Anand P, 2008, BIOCHEM PHARMACOL, V76, P1590, DOI 10.1016/j.bcp.2008.08.008; Biswas MHU, 2010, CANCER RES, V70, P2095, DOI 10.1158/0008-5472.CAN-09-4155; Chauhan SC, 2009, CANCER RES, V69, P765, DOI 10.1158/0008-5472.CAN-08-0587; Chesire DR, 2002, ONCOGENE, V21, P2679, DOI 10.1038/sj.onc.1205352; Choi HY, 2010, PROSTATE CANCER P D, V13, P343, DOI 10.1038/pcan.2010.26; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Dorai T, 2001, PROSTATE, V47, P293, DOI 10.1002/pros.1074; Dorai T, 2000, MOL UROL, V4, P1; Dorai T, 2000, PROSTATE CANCER P D, V3, P84, DOI 10.1038/sj.pcan.4500399; Du C, 2010, CANCER RES, V70, P7810, DOI 10.1158/0008-5472.CAN-09-4481; Du C, 2009, CANCER RES, V69, P1117, DOI 10.1158/0008-5472.CAN-07-6270; Eiseler T, 2010, J BIOL CHEM, V285, P18672, DOI 10.1074/jbc.M109.093880; Eiseler T, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2232; Eiseler T, 2009, NAT CELL BIOL, V11, P545, DOI 10.1038/ncb1861; Goel A, 2008, MOL NUTR FOOD RES, V52, P1010, DOI 10.1002/mnfr.200700354; Guha S, 2010, BIOCHEM PHARMACOL, V80, P1946, DOI 10.1016/j.bcp.2010.07.002; Hassan S, 2009, ONCOGENE, V28, P4386, DOI 10.1038/onc.2009.291; Jaggi M, 2005, UROL ONCOL-SEMIN ORI, V23, P402, DOI 10.1016/j.urolonc.2005.03.024; Jaggi M, 2005, CANCER RES, V65, P483; Jaggi M, 2003, BIOCHEM BIOPH RES CO, V307, P254, DOI 10.1016/S0006-291X(03)01161-6; Jaggi M, 2008, MOL CANCER THER, V7, P2703, DOI 10.1158/1535-7163.MCT-08-0119; Jaggi M, 2007, FRONT BIOSCI-LANDMRK, V12, P3757, DOI 10.2741/2349; Jaiswal AS, 2002, ONCOGENE, V21, P8414, DOI 10.1038/sj.onc.1205947; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; JOHNSON KR, 1993, EXP CELL RES, V207, P252, DOI 10.1006/excr.1993.1191; Kisfalvi K, 2010, J CELL PHYSIOL, V223, P309, DOI 10.1002/jcp.22036; LaValle CR, 2010, BBA-REV CANCER, V1806, P183, DOI 10.1016/j.bbcan.2010.05.003; Lin YC, 2011, J BIOL CHEM, V286, P27039, DOI 10.1074/jbc.M111.244418; Lopez-Lazaro M, 2008, MOL NUTR FOOD RES, V52, pS103, DOI 10.1002/mnfr.200700238; Maher DM, 2011, MOL CARCINOGEN, V50, P47, DOI 10.1002/mc.20695; Mak P, 2008, BIOCHEM BIOPH RES CO, V373, P618, DOI 10.1016/j.bbrc.2008.06.097; Mukhopadhyay A, 2001, ONCOGENE, V20, P7597, DOI 10.1038/sj.onc.1204997; Nakamura K, 2002, INT J ONCOL, V21, P825; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Park CH, 2005, FEBS LETT, V579, P2965, DOI 10.1016/j.febslet.2005.04.013; Peterburs P, 2009, CANCER RES, V69, P5634, DOI 10.1158/0008-5472.CAN-09-0718; Rozengurt E, 2005, J BIOL CHEM, V280, P13205, DOI 10.1074/jbc.R500002200; Rykx A, 2003, FEBS LETT, V546, P81, DOI 10.1016/S0014-5793(03)00487-3; Sharma RA, 2004, CLIN CANCER RES, V10, P6847, DOI 10.1158/1078-0432.CCR-04-0744; Spratley SJ, 2011, J BIOL CHEM; Storz P, 2009, CELL CYCLE, V8, P1975; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Sundram V, 2011, MOL CANCER RES, V9, P985, DOI 10.1158/1541-7786.MCR-10-0365; Syed V, 2008, J CELL BIOCHEM, V104, P82, DOI 10.1002/jcb.21603; Teiten MH, 2011, INT J ONCOL, V38, P603, DOI 10.3892/ijo.2011.905; VALVERDE AM, 1994, P NATL ACAD SCI USA, V91, P8572, DOI 10.1073/pnas.91.18.8572; Van Lint J, 2002, TRENDS CELL BIOL, V12, P193, DOI 10.1016/S0962-8924(02)02262-6; Wheelock MJ, 2003, ANNU REV CELL DEV BI, V19, P207, DOI 10.1146/annurev.cellbio.19.011102.111135; Yallapu MM, 2010, J OVARIAN RES, V3, DOI 10.1186/1757-2215-3-11	50	70	74	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e35368	10.1371/journal.pone.0035368	http://dx.doi.org/10.1371/journal.pone.0035368			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523587	Green Submitted, Green Published, gold			2022-12-27	WOS:000305345000060
J	Regev-Yochay, G; Abullaish, I; Malley, R; Shainberg, B; Varon, M; Roytman, Y; Ziv, A; Goral, A; Elhamdany, A; Rahav, G; Raz, M				Regev-Yochay, Gili; Abullaish, Izzeldin; Malley, Richard; Shainberg, Bracha; Varon, Miriam; Roytman, Yulia; Ziv, Arnona; Goral, Aviva; Elhamdany, Abedallah; Rahav, Galia; Raz, Meir		Palestinian-Israeli Collaborative	Streptococcus pneumoniae Carriage in the Gaza Strip	PLOS ONE			English	Article							PNEUMOCOCCAL CONJUGATE VACCINE; NASOPHARYNGEAL CARRIAGE; CHILDREN; DISEASE; SEROTYPE; IMPACT; SURVEILLANCE; RESISTANCE; REDUCTION; PROGRAM	Background: Pneumococcal infections cause major morbidity and mortality in developing countries. We report the epidemiology of S. pneumoniae carriage in a developing region, the Gaza strip, and evaluate the theoretical coverage of carriage strains by pneumococcal conjugate vaccines (PCVs). Methodology: In 2009 we conducted a cross-sectional survey of S. pneumoniae carriage in healthy children and their parents, living throughout the Gaza strip. Data were collected and nasopharyngeal swabs were obtained. Antibiotic susceptibilities were determined by Vitek-2 and serotypes by the Quellung reaction. Principal Findings: S. pneumoniae carriage was detected in 189/379 (50%) of children and 30/376 (8%) of parents. Carriage prevalence was highest in children <6 months of age (63%). Significant predictors for child carriage were number of household members and DCC attendance. The proportion of pediatric and adults isolates with serotypes included in PCV7 were 32% and 20% respectively, and 46% and 33% in PCV13 respectively. The most prominent non-vaccine serotypes (NVT) were 35B, 15B/C and 23B. Penicillin-nonsusceptible strains were carried by70% of carriers, penicillin-resistant strains (PRSP) by 13% and Multi-drug-resistant (MDR) by 30%. Of all PRSP isolates 54% belonged to serotypes included in PCV7 and 71% in the PCV13. Similarly, 59% and 73% of MDR-SP isolates, would theoretically be covered by PCV7 and PCV13, respectively. Conclusions: This study demonstrates that, PCV13-included strains were carried by 46% and 33% of pediatric and adult subjects respectively. In the absence of definitive data regarding the virulence of the NVT strains, it is difficult to predict the effect of PCVs on IPD in this region.	[Regev-Yochay, Gili; Roytman, Yulia; Goral, Aviva; Rahav, Galia] Chaim Sheba Med Ctr, Infect Dis Unit, IL-52621 Tel Hashomer, Israel; [Regev-Yochay, Gili; Roytman, Yulia; Goral, Aviva; Rahav, Galia] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel; [Regev-Yochay, Gili; Abullaish, Izzeldin; Ziv, Arnona; Goral, Aviva] Gertner Inst Epidemiol Res, Ramat Gan, Israel; [Malley, Richard] Childrens Hosp Boston, Div Infect Dis, Boston, MA USA; [Malley, Richard] Harvard Univ, Sch Med, Boston, MA USA; [Shainberg, Bracha] Macabbi Healthcare Serv, Cent Lab, Rehovot, Israel; [Varon, Miriam; Raz, Meir] Macabbi Healthcare Serv, Modiin, Israel; [Abullaish, Izzeldin] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, BC, Canada; [Elhamdany, Abedallah] Keystone Consulting Agcy, Gaza City, Gaza Strip, Israel	Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of Toronto	Regev-Yochay, G (corresponding author), Chaim Sheba Med Ctr, Infect Dis Unit, IL-52621 Tel Hashomer, Israel.	gregev@hsph.harvard.edu	Goral, Aviva/K-8254-2016	Goral, Aviva/0000-0002-0784-0569; Regev-Yochay, Gili/0000-0001-7163-4607	Gertner Institute; Maccabi Healthcare Services Research Institute [RC-24010]; NIH [R01 AI066013]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066013] Funding Source: NIH RePORTER	Gertner Institute; Maccabi Healthcare Services Research Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by Gertner Institute grant 2009, Maccabi Healthcare Services Research Institute grant RC-24010 and NIH grant R01 AI066013. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript. No additional external funding was received for this study.	Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Brueggemann AB, 2004, J INFECT DIS, V190, P1203, DOI 10.1086/423820; Cutts FT, 2005, LANCET, V365, P1139, DOI 10.1016/S0140-6736(05)71876-6; Dagan R, 2008, LANCET INFECT DIS, V8, P785, DOI 10.1016/S1473-3099(08)70281-0; Dagan R, 2010, J INFECT DIS, V201, P1570, DOI 10.1086/652006; ElAstal Z, 1997, PEDIATR INFECT DIS J, V16, P905, DOI 10.1097/00006454-199709000-00016; Falade AG, 2009, CLIN INFECT DIS, V48, pS190, DOI 10.1086/596500; Flasche S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001017; Granat SM, 2007, PEDIATR INFECT DIS J, V26, P319, DOI 10.1097/01.inf.0000257425.24492.11; Hanage WP, 2005, INFECT IMMUN, V73, P431, DOI 10.1128/IAI.73.1.431-435.2005; Hill PC, 2006, CLIN INFECT DIS, V43, P673, DOI 10.1086/506941; Hsu KK, 2010, PEDIATR INFECT DIS J, V29, P289, DOI 10.1097/INF.0b013e3181c15471; Huang SS, 2005, PEDIATRICS, V116, pE408, DOI 10.1542/peds.2004-2338; Huang SS, 2009, PEDIATRICS, V124, pE1, DOI 10.1542/peds.2008-3099; Jacoby P, 2011, PEDIATR INFECT DIS J, V30, P480, DOI 10.1097/INF.0b013e318217dc6e; Kaplan SL, 2004, PEDIATRICS, V113, P443, DOI 10.1542/peds.113.3.443; Kim SY, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-260; Kisakye A, 2009, CLIN INFECT DIS, V48, pS153, DOI 10.1086/596495; Klugman KP, 2003, NEW ENGL J MED, V349, P1341, DOI 10.1056/NEJMoa035060; Labout JAM, 2008, J PEDIATR-US, V153, P771, DOI 10.1016/j.jpeds.2008.05.061; Lagos R, 2008, J INFECT DIS, V198, P1809, DOI 10.1086/593334; Levine OS, 2006, LANCET, V367, P1880, DOI 10.1016/S0140-6736(06)68703-5; Millar EV, 2009, PEDIATR INFECT DIS J, V28, P711, DOI 10.1097/INF.0b013e3181a06303; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Pilishvili T, 2010, J INFECT DIS, V201, P32, DOI 10.1086/648593; Regev-Yochay G, 2003, SCAND J INFECT DIS, V35, P219, DOI 10.1080/00365540310000319; Regev-Yochay G, 2004, CLIN INFECT DIS, V38, P632, DOI 10.1086/381547; Simoes AS, 2011, J CLIN MICROBIOL, V49, P2810, DOI 10.1128/JCM.00517-11; Spijkerman J, 2011, EMERG INFECT DIS, V17, P584, DOI 10.3201/eid1704.101115; Stamboulidis K, 2011, PEDIATR INFECT DIS J, V30, P551, DOI 10.1097/INF.0b013e31821038d9; Talbot TR, 2004, CLIN INFECT DIS, V39, P641, DOI 10.1086/422653; Tyrrell GJ, 2009, VACCINE, V27, P3553, DOI 10.1016/j.vaccine.2009.03.063; Vestrheim DF, 2010, CLIN VACCINE IMMUNOL, V17, P325, DOI 10.1128/CVI.00435-09; Weinberger DM, 2011, LANCET, V378, P1962, DOI 10.1016/S0140-6736(10)62225-8; Weinberger DM, 2010, CLIN INFECT DIS, V51, P692, DOI 10.1086/655828; Yildirim I, 2010, VACCINE, V29, P283, DOI 10.1016/j.vaccine.2010.10.032	36	13	14	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35061	10.1371/journal.pone.0035061	http://dx.doi.org/10.1371/journal.pone.0035061			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22539955	gold, Green Submitted, Green Published			2022-12-27	WOS:000305341000019
J	Callan, DE; Gamez, M; Cassel, DB; Terzibas, C; Callan, A; Kawato, M; Sato, M				Callan, Daniel E.; Gamez, Mario; Cassel, Daniel B.; Terzibas, Cengiz; Callan, Akiko; Kawato, Mitsuo; Sato, Masa-aki			Dynamic Visuomotor Transformation Involved with Remote Flying of a Plane Utilizes the 'Mirror Neuron' System	PLOS ONE			English	Article							CORTICAL ACTIVITY; INTERNAL-MODELS; MENTAL ROTATION; VIRTUAL-REALITY; BRAIN ACTIVITY; VISUAL-CORTEX; IMITATION; MOTION; MECHANISMS; FMRI	Brain regions involved with processing dynamic visuomotor representational transformation are investigated using fMRI. The perceptual-motor task involved flying (or observing) a plane through a simulated Red Bull Air Race course in first person and third person chase perspective. The third person perspective is akin to remote operation of a vehicle. The ability for humans to remotely operate vehicles likely has its roots in neural processes related to imitation in which visuomotor transformation is necessary to interpret the action goals in an egocentric manner suitable for execution. In this experiment for 3rd person perspective the visuomotor transformation is dynamically changing in accordance to the orientation of the plane. It was predicted that 3rd person remote flying, over 1st, would utilize brain regions composing the 'Mirror Neuron' system that is thought to be intimately involved with imitation for both execution and observation tasks. Consistent with this prediction differential brain activity was present for 3rd person over 1st person perspectives for both execution and observation tasks in left ventral premotor cortex, right dorsal premotor cortex, and inferior parietal lobule bilaterally (Mirror Neuron System) (Behaviorally: 1st>3rd). These regions additionally showed greater activity for flying (execution) over watching (observation) conditions. Even though visual and motor aspects of the tasks were controlled for, differential activity was also found in brain regions involved with tool use, motion perception, and body perspective including left cerebellum, temporo-occipital regions, lateral occipital cortex, medial temporal region, and extrastriate body area. This experiment successfully demonstrates that a complex perceptual motor real-world task can be utilized to investigate visuomotor processing. This approach (Aviation Cerebral Experimental Sciences ACES) focusing on direct application to lab and field is in contrast to standard methodology in which tasks and conditions are reduced to their simplest forms that are remote from daily life experience.	[Callan, Daniel E.; Gamez, Mario; Cassel, Daniel B.; Terzibas, Cengiz; Sato, Masa-aki] ATR Neural Informat Anal Labs, Kyoto, Japan; [Callan, Akiko] NICT Multimodal Commun Grp, Kyoto, Japan; [Kawato, Mitsuo] ATR Computat Neurosci Labs, Kyoto, Japan	National Institute of Information & Communications Technology (NICT) - Japan	Callan, DE (corresponding author), ATR Neural Informat Anal Labs, Kyoto, Japan.	dcallan@atr.jp		Callan, Daniel/0000-0002-8851-6065	National Institute of Information and Communications Technology; KAKENHI [21500321]; Ministry of Internal Affairs and Communications	National Institute of Information and Communications Technology; KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Internal Affairs and Communications	This research was supported in part by the National Institute of Information and Communications Technology, by KAKENHI Grant-in-Aid for Scientific Research(C) (21500321), and by a contract with the Ministry of Internal Affairs and Communications entitled, 'Novel and innovative R&D making use of brain structures.' The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartels A, 2008, CEREB CORTEX, V18, P705, DOI 10.1093/cercor/bhm107; Busan P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004621; Caplovitz GP, 2010, NEUROPSYCHOLOGIA, V48, P2699, DOI 10.1016/j.neuropsychologia.2010.05.017; Caspers S, 2010, NEUROIMAGE, V50, P1148, DOI 10.1016/j.neuroimage.2009.12.112; Cate AD, 2011, BRAIN RES, V1388, P109, DOI 10.1016/j.brainres.2011.02.022; Chaminade T, 2005, NEUROPSYCHOLOGIA, V43, P115, DOI 10.1016/j.neuropsychologia.2004.04.026; Chaminade T, 2002, NEUROREPORT, V13, P1975, DOI 10.1097/00001756-200210280-00029; Chan AWY, 2004, NEUROREPORT, V15, P2407, DOI 10.1097/00001756-200410250-00021; Chen AH, 2011, J NEUROSCI, V31, P11617, DOI 10.1523/JNEUROSCI.1266-11.2011; Creem-Regehr SH, 2007, NEUROIMAGE, V35, P916, DOI 10.1016/j.neuroimage.2006.11.057; Decety J, 2003, NEUROPSYCHOLOGIA, V41, P127, DOI 10.1016/S0028-3932(02)00143-4; Decety J, 2002, NEUROIMAGE, V15, P265, DOI 10.1006/nimg.2001.0938; Doeller CF, 2010, NATURE, V463, P657, DOI 10.1038/nature08704; Ekstrom AD, 2003, NATURE, V425, P184, DOI 10.1038/nature01964; Ellis S. R., 2002, Proceedings of the Human Factors and Ergonomics Society 46th Annual Meeting, P1551; Franklin DW, 2011, NEURON, V72, P425, DOI 10.1016/j.neuron.2011.10.006; GIBSON J J, 1955, Am J Psychol, V68, P372, DOI 10.2307/1418521; Grafton ST, 2001, J COGNITIVE NEUROSCI, V13, P217, DOI 10.1162/089892901564270; Graydon FX, 2005, COGNITIVE BRAIN RES, V22, P373, DOI 10.1016/j.cogbrainres.2004.09.007; Grefkes C, 2004, NEUROIMAGE, V23, P1494, DOI 10.1016/j.neuroimage.2004.08.031; Howe PD, 2009, J VISION, V9, DOI 10.1167/9.4.10; Huddleston WE, 2008, CEREB CORTEX, V18, P1272, DOI 10.1093/cercor/bhm158; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Imamizu H, 2000, NATURE, V403, P192, DOI 10.1038/35003194; Imamizu H, 2003, P NATL ACAD SCI USA, V100, P5461, DOI 10.1073/pnas.0835746100; Imamizu H, 2012, CEREBELLUM IN PRESS; Imamizu H, 2007, CORTEX, V43, P338, DOI 10.1016/S0010-9452(08)70459-3; Jackson PL, 2006, NEUROIMAGE, V31, P429, DOI 10.1016/j.neuroimage.2005.11.026; Kovacs G, 2008, CEREB CORTEX, V18, P1779, DOI 10.1093/cercor/bhm203; Lamm C, 2007, NEUROIMAGE, V36, P1374, DOI 10.1016/j.neuroimage.2007.04.012; Langner R, 2011, CEREB CORTEX, V21, P2850, DOI 10.1093/cercor/bhr083; Larsson J, 2006, J NEUROSCI, V26, P13128, DOI 10.1523/JNEUROSCI.1657-06.2006; Lissek S, 2007, NEUROIMAGE, V37, P912, DOI 10.1016/j.neuroimage.2007.05.037; Liu S, 2009, J NEUROSCI, V29, P8936, DOI 10.1523/JNEUROSCI.1607-09.2009; Loose R, 1999, CLIN NEUROPHYSIOL, V110, P192, DOI 10.1016/S0168-5597(98)00058-6; Mellet E, 2010, HUM BRAIN MAPP, V31, P1065, DOI 10.1002/hbm.20917; Meltzoff AN, 2003, PHILOS T R SOC B, V358, P491, DOI 10.1098/rstb.2002.1261; Mikhelashvili-Browner N, 2003, AM J NEURORADIOL, V24, P488; Molenberghs P, 2009, NEUROSCI BIOBEHAV R, V33, P975, DOI 10.1016/j.neubiorev.2009.03.010; Pine DS, 2002, NEUROIMAGE, V15, P396, DOI 10.1006/nimg.2001.0988; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; Saxe R, 2006, CEREB CORTEX, V16, P178, DOI 10.1093/cercor/bhi095; Stark A, 2008, CEREB CORTEX, V18, P2358, DOI 10.1093/cercor/bhm260; Stein BE., 1993, MERGING SENSES; Stiers P, 2006, NEUROIMAGE, V29, P74, DOI 10.1016/j.neuroimage.2005.07.033; Stoodley C, NEUROIMAGE IN PRESS; Takahashi K, 2007, J NEUROSCI, V27, P9742, DOI 10.1523/JNEUROSCI.0817-07.2007; Tanaka S, 2002, NEUROREPORT, V13, P1599, DOI 10.1097/00001756-200209160-00005; Van Overwalle F, 2009, NEUROIMAGE, V48, P564, DOI 10.1016/j.neuroimage.2009.06.009; Vogeley K, 2004, J COGNITIVE NEUROSCI, V16, P817, DOI 10.1162/089892904970799; Wise SP, 1998, EXP BRAIN RES, V121, P285, DOI 10.1007/s002210050462; Wolbers T, 2008, NAT NEUROSCI, V11, P1223, DOI 10.1038/nn.2189; Yamagishi N, 2008, BRAIN RES, V1197, P115, DOI 10.1016/j.brainres.2007.12.063; Zacks J, 1999, NEUROPSYCHOLOGIA, V37, P1029, DOI 10.1016/S0028-3932(99)00012-3; Zacks JM, 2008, J COGNITIVE NEUROSCI, V20, P1, DOI 10.1162/jocn.2008.20013; Zacks JM, 2002, NEUROIMAGE, V16, P857, DOI 10.1006/nimg.2002.1129	56	14	14	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e33873	10.1371/journal.pone.0033873	http://dx.doi.org/10.1371/journal.pone.0033873			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536320	Green Submitted, Green Published, gold			2022-12-27	WOS:000305339200007
J	Esposito, R; D'Aniello, S; Squarzoni, P; Pezzotti, MR; Ristoratore, F; Spagnuolo, A				Esposito, Rosaria; D'Aniello, Salvatore; Squarzoni, Paola; Pezzotti, Maria Rosa; Ristoratore, Filomena; Spagnuolo, Antonietta			New Insights into the Evolution of Metazoan Tyrosinase Gene Family	PLOS ONE			English	Article							ASCIDIAN EMBRYOS; PIGMENT-CELLS; CIONA-INTESTINALIS; AMPHIOXUS GENOME; SIMPLE CHORDATE; EXPRESSION; PROTEINS; MELANIN; MECHANISM; TYRP1	Tyrosinases, widely distributed among animals, plants and fungi, are involved in the biosynthesis of melanin, a pigment that has been exploited, in the course of evolution, to serve different functions. We conducted a deep evolutionary analysis of tyrosinase family amongst metazoa, thanks to the availability of new sequenced genomes, assessing that tyrosinases (tyr) represent a distinctive feature of all the organisms included in our study and, interestingly, they show an independent expansion in most of the analyzed phyla. Tyrosinase-related proteins (tyrp), which derive from tyr but show distinct key residues in the catalytic domain, constitute an invention of chordate lineage. In addition we here reported a detailed study of the expression territories of the ascidian Ciona intestinalis tyr and tyrps. Furthermore, we put efforts in the identification of the regulatory sequences responsible for their expression in pigment cell lineage. Collectively, the results reported here enlarge our knowledge about the tyrosinase gene family as valuable resource for understanding the genetic components involved in pigment cells evolution and development.	[Esposito, Rosaria; D'Aniello, Salvatore; Squarzoni, Paola; Pezzotti, Maria Rosa; Ristoratore, Filomena; Spagnuolo, Antonietta] Stn Zool Anton Dohrn, Cellular & Dev Biol Dept, Naples, Italy	Stazione Zoologica Anton Dohrn di Napoli	Spagnuolo, A (corresponding author), Ecole Normale Super, Inst Biol, IBENS, INSERM,U1024,Avenir Team, 24 Rue Lhomond, F-75231 Paris, France.	nietta.spagnuolo@szn.it	Esposito, Rosaria/M-8422-2016	Spagnuolo, Antonietta/0000-0001-6660-071X				AROCA P, 1990, BIOCHIM BIOPHYS ACTA, V1035, P266, DOI 10.1016/0304-4165(90)90088-E; Beh J, 2007, DEVELOPMENT, V134, P3297, DOI 10.1242/dev.010140; Bertrand V, 2003, CELL, V115, P615, DOI 10.1016/S0092-8674(03)00928-0; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Camacho-Hubner A, 2002, GENE, V285, P59, DOI 10.1016/S0378-1119(02)00411-0; Caracciolo A, 1997, DEV GROWTH DIFFER, V39, P437; Catchen JM, 2009, GENOME RES, V19, P1497, DOI 10.1101/gr.090480.108; Corbo JC, 1997, DEVELOPMENT, V124, P589; Davidson B, 2005, DEVELOPMENT, V132, P4811, DOI 10.1242/dev.02051; Davidson B, 2006, GENE DEV, V20, P2728, DOI 10.1101/gad.1467706; Dehal P, 2002, SCIENCE, V298, P2157, DOI 10.1126/science.1080049; Di Gregorio A, 2002, DIFFERENTIATION, V70, P132; EAKIN RM, 1973, 3 EYE; Garcia-Borron JC, 2002, PIGM CELL RES, V15, P162, DOI 10.1034/j.1600-0749.2002.02012.x; Gillespie JP, 1997, ANNU REV ENTOMOL, V42, P611, DOI 10.1146/annurev.ento.42.1.611; Goding CR, 2007, INT J BIOCHEM CELL B, V39, P275, DOI 10.1016/j.biocel.2006.10.003; Hearing VJ, 2000, PIGM CELL RES, V13, P23, DOI 10.1034/j.1600-0749.13.s8.7.x; Higgins DG, 1996, METHOD ENZYMOL, V266, P383; Huang GH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000206; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; JACKSON IJ, 1994, PIGM CELL RES, V7, P241, DOI 10.1111/j.1600-0749.1994.tb00056.x; JIMENEZ M, 1991, J BIOL CHEM, V266, P1147; JIMENEZCERVANTES C, 1993, EUR J BIOCHEM, V217, P549, DOI 10.1111/j.1432-1033.1993.tb18276.x; JIMENEZCERVANTES C, 1994, J BIOL CHEM, V269, P17993; Johnson DS, 2004, GENOME RES, V14, P2448, DOI 10.1101/gr.2964504; KOBAYASHI T, 1994, EMBO J, V13, P5818, DOI 10.1002/j.1460-2075.1994.tb06925.x; Kobayashi T, 1998, J BIOL CHEM, V273, P31801, DOI 10.1074/jbc.273.48.31801; Lacalli TC, 2004, BRAIN BEHAV EVOLUT, V64, P148, DOI 10.1159/000079744; Le Douarin N.M., 1982, NEURAL CREST; LUO D, 1994, EXP CELL RES, V213, P231, DOI 10.1006/excr.1994.1195; Manga P, 2000, PIGM CELL RES, V13, P364, DOI 10.1034/j.1600-0749.2000.130510.x; Martinez-Morales JR, 2004, BIOESSAYS, V26, P766, DOI 10.1002/bies.20064; Murisier F, 2006, HISTOL HISTOPATHOL, V21, P567, DOI 10.14670/HH-21.567; NISHIDA H, 1987, DEV BIOL, V121, P526, DOI 10.1016/0012-1606(87)90188-6; Olivares C, 2009, PIGM CELL MELANOMA R, V22, P750, DOI 10.1111/j.1755-148X.2009.00636.x; PORCHETHENNERE E, 1992, CELL TISSUE RES, V269, P167, DOI 10.1007/BF00384737; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Ristoratore F, 1999, DEVELOPMENT, V126, P5149; Sarangarajan R, 2001, PIGM CELL RES, V14, P437, DOI 10.1034/j.1600-0749.2001.140603.x; Sato S, 1997, DEV DYNAM, V208, P363; Sato S, 2001, PIGM CELL RES, V14, P428, DOI 10.1034/j.1600-0749.2001.140602.x; Sato S, 1999, DEV DYNAM, V215, P225, DOI 10.1002/(SICI)1097-0177(199907)215:3<225::AID-AJA5>3.0.CO;2-S; Satoh N, 2001, DIFFERENTIATION, V68, P1, DOI 10.1046/j.1432-0436.2001.068001001.x; SILVERS WK (ED), 1979, COAT COLORS MICE MOD; Squarzoni P, 2011, DEVELOPMENT, V138, P1421, DOI 10.1242/dev.057323; STEEL KP, 1992, DEVELOPMENT, V115, P1111; STURM RA, 1995, GENOMICS, V29, P24, DOI 10.1006/geno.1995.1211; Sugumaran H, 2002, PIGM CELL RES, V15, P2, DOI 10.1034/j.1600-0749.2002.00056.x; Sugumaran M, 1998, ADV INSECT PHYSIOL, V27, P229, DOI 10.1016/S0065-2806(08)60014-4; Takeuchi K, 2005, ZOOL SCI, V22, P723, DOI 10.2108/zsj.22.723; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Toyoda R, 2004, GENE, V332, P61, DOI 10.1016/j.gene.2004.01.030; Toyoda R, 2000, GENE, V259, P159, DOI 10.1016/S0378-1119(00)00433-9; Tsuda M, 2003, J EXP BIOL, V206, P1409, DOI 10.1242/jeb.00235; TSUKAMOTO K, 1992, EMBO J, V11, P519, DOI 10.1002/j.1460-2075.1992.tb05082.x; Vinson JP, 2005, GENOME RES, V15, P1127, DOI 10.1101/gr.3722605; Wang TT, 2009, FISH SHELLFISH IMMUN, V27, P757, DOI 10.1016/j.fsi.2009.09.002; WHITTAKER JR, 1973, DEV BIOL, V30, P441, DOI 10.1016/0012-1606(73)90101-2; WINDER A, 1994, CELL MOL BIOL RES, V40, P613; Xiang ZX, 2006, CURR PROTEIN PEPT SC, V7, P217, DOI 10.2174/138920306777452312; Yajima I, 2003, MECH DEVELOP, V120, P1489, DOI 10.1016/j.mod.2003.08.009; Yu JK, 2008, GENOME RES, V18, P1127, DOI 10.1101/gr.076208.108; Zhang SC, 2009, PROG NAT SCI-MATER, V19, P923, DOI 10.1016/j.pnsc.2008.07.025	66	27	34	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35731	10.1371/journal.pone.0035731	http://dx.doi.org/10.1371/journal.pone.0035731			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536431	Green Published, gold, Green Submitted			2022-12-27	WOS:000305339200103
J	Gittenberger, E; Hamann, TD; Asami, T				Gittenberger, Edmund; Hamann, Thomas D.; Asami, Takahiro			Chiral Speciation in Terrestrial Pulmonate Snails	PLOS ONE			English	Article							WHOLE-BODY ENANTIOMORPHY; SINGLE-GENE SPECIATION; MATERNAL INHERITANCE; EVOLUTION; COILING; ASYMMETRY; GASTROPOD; DIRECTIONS; DIMORPHISM; HANDEDNESS	On the basis of data in the literature, the percentages of dextral versus sinistral species of snails have been calculated for western Europe, Turkey, North America (north of Mexico), and Japan. When the family of Clausiliidae is represented, about a quarter of all snail species may be sinistral, whereas less than one per cent of the species may be sinistral where that family does not occur. The number of single-gene speciation events on the basis of chirality, resulting in the origin of mirror image species, is not closely linked to the percentage of sinistral versus dextral species in a particular region. Turkey is nevertheless exceptional by both a high percentage of sinistral species and a high number of speciation events resulting in mirror image species. Shell morphology and genetic background may influence the ease of chirality-linked speciation, whereas sinistrality may additionally be selected against by internal selection. For the Clausiliidae, the fossil record and the recent fauna suggest that successful reversals in coiling direction occurred with a frequency of once every three to four million years.	[Gittenberger, Edmund; Hamann, Thomas D.] Netherlands Ctr Biodivers, Leiden, Netherlands; [Asami, Takahiro] Shinshu Univ, Dept Biol, Matsumoto, Nagano 390, Japan	Naturalis Biodiversity Center; Shinshu University	Gittenberger, E (corresponding author), Netherlands Ctr Biodivers, Leiden, Netherlands.	Edi.Gittenberger@ncbnaturalis.nnm.nl			Grants-in-Aid for Scientific Research [20405007] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Asami T, 1998, AM NAT, V152, P225, DOI 10.1086/286163; Asami T., 1993, FORMA, V8, P263; Asami T, 2008, J HERED, V99, P552, DOI 10.1093/jhered/esn032; Bromham L, 2001, TRENDS ECOL EVOL, V16, P125, DOI 10.1016/S0169-5347(00)02076-0; CAIN AJ, 1977, PHILOS T ROY SOC B, V277, P377, DOI 10.1098/rstb.1977.0026; Davison A, 2009, HEREDITY, V103, P268, DOI 10.1038/hdy.2009.49; De Weerd DRU, 2006, BIOL J LINN SOC, V88, P155; Deniu C, 2004, INVERTEBRATA, V37; Dietl GP, 2006, BIOL LETTERS, V2, P439, DOI 10.1098/rsbl.2006.0465; FREEMAN G, 1982, ROUX ARCH DEV BIOL, V191, P69, DOI 10.1007/BF00848443; GITTENBERGER E, 1995, NATURE, V373, P19, DOI 10.1038/373019b0; GITTENBERGER E, 1988, EVOLUTION, V42, P826, DOI 10.1111/j.1558-5646.1988.tb02502.x; GOULD SJ, 1985, EVOLUTION, V39, P1364, DOI 10.1111/j.1558-5646.1985.tb05701.x; Harada Y, 2004, DEV GENES EVOL, V214, P159, DOI 10.1007/s00427-004-0392-6; Hierck BP, 2005, J MOLLUS STUD, V71, P192, DOI 10.1093/mollus/eyi023; Hoso M, 2007, BIOL LETTERS, V3, P169, DOI 10.1098/rsbl.2006.0600; Hoso M, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1133; Inoda T, 2003, AM NAT, V162, P811, DOI 10.1086/378903; Johnson Michael S., 1993, Oxford Surveys in Evolutionary Biology, V9, P167; KERNEY MP, 1983, LANDSCHNECKEN NORD U; Meisenheimer J., 1912, LEIPZIG, V4, P1, DOI [10.1017/CBO9781107415324.004., DOI 10.1017/CBO9781107415324.004]; Minato H., 1988, SYSTEMATIC BIBLIOGRA; Minato H, 1994, VENUS S, P21; Nakadera Y, 2010, J EVOLUTION BIOL, V23, P2377, DOI 10.1111/j.1420-9101.2010.02099.x; Nordsieck H., 2007, WORLDWIDE DOOR SNAIL; Nunes GKM, 2007, REV BRAS ZOOL, V24, P258, DOI 10.1590/S0101-81752007000100036; Okumura T, 2008, DEV DYNAM, V237, P3497, DOI 10.1002/dvdy.21788; Oliverio M, 2010, AM J MED GENET A, V152A, P2419, DOI 10.1002/ajmg.a.33655; ORR HA, 1991, EVOLUTION, V45, P764, DOI 10.1111/j.1558-5646.1991.tb04345.x; Pilsbry H., 1939, ACAD NAT SCI PHILA M, V3, P1; Pilsbry H. A, 1940, ACAD NATURAL SCI MON ACAD NATURAL SCI MON, V1, P575; Pilsbry H.A., 1948, ACAD NATURAL SCI PHI, V3, P521; Pilsbry HA, 1946, ACAD NATURAL SCI PHI, V3, P1; Preece R. C., 2008, Basteria, V72, P267; ROBERTSON R, 1993, RES EXPLOR, V9, P104; Schilthuizen M, 2007, J EVOLUTION BIOL, V20, P1941, DOI 10.1111/j.1420-9101.2007.01370.x; Schilthuizen M, 2005, NATURWISSENSCHAFTEN, V92, P504, DOI 10.1007/s00114-05-0045-2; Schilthuizen M, 2005, HEREDITY, V95, P216, DOI 10.1038/sj.hdy.6800715; Schuatt H., 2005, TURKISH LAND SNAILS; Stone J, 2002, P ROY SOC B-BIOL SCI, V269, P861, DOI 10.1098/rspb.2001.1934; Sutcharit C, 2007, J EVOLUTION BIOL, V20, P661, DOI 10.1111/j.1420-9101.2006.01246.x; Sutcharit C, 2006, J MOLLUS STUD, V72, P1, DOI 10.1093/mollus/eyi044; Ueshima R, 2003, NATURE, V425, P679, DOI 10.1038/425679a; Utsuno H, 2011, EVOLUTION, V65, P2399, DOI 10.1111/j.1558-5646.2011.01293.x; Utsuno H, 2010, MOLLUSCAN RES, V30, P37; Utsuno H, 2010, J HERED, V101, P11, DOI 10.1093/jhered/esp058; VanBatenburg FHD, 1996, HEREDITY, V76, P278, DOI 10.1038/hdy.1996.41; Vermeij Geerat J., 1993, pi; VERMEIJ GJ, 1975, NATURE, V254, P419, DOI 10.1038/254419a0; Wade CM, 2007, J MOLLUS STUD, V73, P411, DOI 10.1093/mollus/eym030; Wandelt J, 2004, CURR BIOL, V14, pR654, DOI 10.1016/j.cub.2004.08.010; Wood WB, 1998, SEMIN CELL DEV BIOL, V9, P53, DOI 10.1006/scdb.1997.0189; Wood WB, 2005, PLOS BIOL, V3, P1348, DOI 10.1371/journal.pbio.0030292; Zilch A., 1960, HDB PALAOZOOLOGIE, P401	54	31	34	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e34005	10.1371/journal.pone.0034005	http://dx.doi.org/10.1371/journal.pone.0034005			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22532825	gold, Green Submitted, Green Published			2022-12-27	WOS:000305339200008
J	Gong, YB; Zheng, JL; Jin, B; Zhuo, DX; Huang, ZQ; Qi, H; Zhang, W; Duan, W; Fu, JT; Wang, CJ; Mao, ZB				Gong, Yan-Bing; Zheng, Jian-Ling; Jin, Bo; Zhuo, De-Xiang; Huang, Zhu-Qing; Qi, He; Zhang, Wei; Duan, Wei; Fu, Ji-Ting; Wang, Chui-Jie; Mao, Ze-Bin			Particular Candida albicans Strains in the Digestive Tract of Dyspeptic Patients, Identified by Multilocus Sequence Typing	PLOS ONE			English	Article							UPPER GASTROINTESTINAL-TRACT; MOLECULAR PHYLOGENETICS; AUTOIMMUNE PANCREATITIS; HELICOBACTER-PYLORI; EPITHELIAL-CELLS; COLONIZATION; POPULATION; INFECTIONS; PREVALENCE; DIVERSITY	Background: Candida albicans is a human commensal that is also responsible for chronic gastritis and peptic ulcerous disease. Little is known about the genetic profiles of the C. albicans strains in the digestive tract of dyspeptic patients. The aim of this study was to evaluate the prevalence, diversity, and genetic profiles among C. albicans isolates recovered from natural colonization of the digestive tract in the dyspeptic patients. Methods and Findings: Oral swab samples (n = 111) and gastric mucosa samples (n = 102) were obtained from a group of patients who presented dyspeptic symptoms or ulcer complaints. Oral swab samples (n = 162) were also obtained from healthy volunteers. C. albicans isolates were characterized and analyzed by multilocus sequence typing. The prevalence of Candida spp. in the oral samples was not significantly different between the dyspeptic group and the healthy group (36.0%, 40/111 vs. 29.6%, 48/162; P > 0.05). However, there were significant differences between the groups in the distribution of species isolated and the genotypes of the C. albicans isolates. C. albicans was isolated from 97.8% of the Candida-positive subjects in the dyspeptic group, but from only 56.3% in the healthy group (P < 0.001). DST1593 was the dominant C. albicans genotype from the digestive tract of the dyspeptic group (60%, 27/45), but not the healthy group (14.8%, 4/27) (P < 0.001). Conclusions: Our data suggest a possible link between particular C. albicans strain genotypes and the host microenvironment. Positivity for particular C. albicans genotypes could signify susceptibility to dyspepsia.	[Gong, Yan-Bing; Jin, Bo; Zhuo, De-Xiang; Mao, Ze-Bin] Peking Univ, Lab Ze Bin Mao, Dept Biochem & Mol Biol, Sch Basic Med Sci,Hlth Sci Ctr, Beijing 100871, Peoples R China; [Zheng, Jian-Ling; Huang, Zhu-Qing; Qi, He; Zhang, Wei; Duan, Wei] Med Sci Inst Liaoning, Dept Microbiol, Shenyang, Peoples R China; [Fu, Ji-Ting; Wang, Chui-Jie] Liaoning Univ Tradit Chinese Med, Div Gastroenterol, Hosp 1, Shenyang, Peoples R China	Peking University; Liaoning University of Traditional Chinese Medicine	Gong, YB (corresponding author), Peking Univ, Lab Ze Bin Mao, Dept Biochem & Mol Biol, Sch Basic Med Sci,Hlth Sci Ctr, Beijing 100871, Peoples R China.	gongyanbing@bjmu.edu.cn; shenyangzheng@hotmail.com; zbmao@bjmu.edu.cn		GONG, Yan-Bing/0000-0001-8896-3765				Asherson RA, 2008, NAT CLIN PRACT RHEUM, V4, P439, DOI 10.1038/ncprheum0839; Borman AM, 2009, J CLIN MICROBIOL, V47, P2307, DOI 10.1128/JCM.00240-09; Bougnoux ME, 2008, INTENS CARE MED, V34, P292, DOI 10.1007/s00134-007-0865-y; Bougnoux ME, 2004, INFECT GENET EVOL, V4, P243, DOI 10.1016/j.meegid.2004.06.002; Bougnoux ME, 2006, J CLIN MICROBIOL, V44, P1810, DOI 10.1128/JCM.44.5.1810-1820.2006; Bougnoux ME, 2003, J CLIN MICROBIOL, V41, P5265, DOI 10.1128/JCM.41.11.5265-5266.2003; Bougnoux ME, 2002, J CLIN MICROBIOL, V40, P1290, DOI 10.1128/JCM.40.4.1290-1297.2002; Chang MC, 2009, PANCREAS, V38, P442, DOI 10.1097/MPA.0b013e31819b5f3c; Chavez-Galarza J, 2010, INFECT GENET EVOL, V10, P697, DOI 10.1016/j.meegid.2010.03.007; Chen KW, 2006, J CLIN MICROBIOL, V44, P2172, DOI 10.1128/JCM.00320-06; Chen YC, 2010, DIAGN MICR INFEC DIS, V68, P284, DOI 10.1016/j.diagmicrobio.2010.07.004; Cliff PR, 2008, J HOSP INFECT, V69, P24, DOI 10.1016/j.jhin.2008.02.006; d'Enfert C, 2009, CURR OPIN MICROBIOL, V12, P358, DOI 10.1016/j.mib.2009.05.008; Da Matta DA, 2010, J CLIN MICROBIOL, V48, P3062, DOI 10.1128/JCM.00262-10; Dalle F, 2010, CELL MICROBIOL, V12, P248, DOI 10.1111/j.1462-5822.2009.01394.x; Davis DA, 2009, CURR OPIN MICROBIOL, V12, P365, DOI 10.1016/j.mib.2009.05.006; Ge SH, 2012, FUNGAL GENET BIOL, V49, P86, DOI 10.1016/j.fgb.2011.10.006; Grubb SEW, 2008, INFECT IMMUN, V76, P4370, DOI 10.1128/IAI.00332-08; Hirasaki S, 1999, J GASTROENTEROL, V34, P688, DOI 10.1007/s005350050320; Jacobsen MD, 2008, FEMS YEAST RES, V8, P1334, DOI 10.1111/j.1567-1364.2008.00438.x; Jacobsen MD, 2008, RES MICROBIOL, V159, P436, DOI 10.1016/j.resmic.2008.05.003; KALOGEROPOULOS NK, 1988, J CLIN PATHOL, V41, P1093, DOI 10.1136/jcp.41.10.1093; Karczewska E, 2009, J PHYSIOL PHARMACOL, V60, P33; Karkowska-Kuleta J, 2009, ACTA BIOCHIM POL, V56, P211; Laverdiere M, 2006, J ANTIMICROB CHEMOTH, V57, P705, DOI 10.1093/jac/dkl022; MacCallum DM, 2009, EUKARYOT CELL, V8, P373, DOI 10.1128/EC.00387-08; Mansueto P, 2012, CLIN EXP MED, V12, P201, DOI 10.1007/s10238-011-0158-1; McManus BA, 2011, J CLIN MICROBIOL, V49, P1879, DOI 10.1128/JCM.00026-11; MIRHENDI H, 2006, JPN J MED MYCOL, V47, P225; Moreno-Ruiz E, 2009, CELL MICROBIOL, V11, P1179, DOI 10.1111/j.1462-5822.2009.01319.x; Odds FC, 2006, J CLIN MICROBIOL, V44, P3647, DOI 10.1128/JCM.00934-06; Odds FC, 2008, EUKARYOT CELL, V7, P1075, DOI 10.1128/EC.00062-08; Odds FC, 2007, J MED MICROBIOL, V56, P1066, DOI 10.1099/jmm.0.47239-0; Odds FC, 2007, EUKARYOT CELL, V6, P1041, DOI 10.1128/EC.00041-07; Odds FC, 2010, FUTURE MICROBIOL, V5, P67, DOI 10.2217/FMB.09.113; Odds FC, 2009, FEMS YEAST RES, V9, P1091, DOI 10.1111/j.1567-1364.2009.00577.x; Parnanen P, 2010, J ORAL PATHOL MED, V39, P275, DOI 10.1111/j.1600-0714.2009.00866.x; Ramaswamy K, 2007, Indian J Med Microbiol, V25, P57; Robles JC, 2004, J CLIN MICROBIOL, V42, P2480, DOI 10.1128/JCM.42.6.2480-2488.2004; Rollenhagen C, 2009, CELL MICROBIOL, V11, P946, DOI 10.1111/j.1462-5822.2009.01303.x; Sampaio P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010155; Selmecki A, 2010, EUKARYOT CELL, V9, P991, DOI 10.1128/EC.00060-10; Shin JH, 2011, J CLIN MICROBIOL, V49, P2572, DOI 10.1128/JCM.02153-10; Shinji A, 2004, GASTROINTEST ENDOSC, V59, P506, DOI 10.1016/S0016-5107(03)02874-8; Takakura S, 2008, INT J MED MICROBIOL, V298, P663, DOI 10.1016/j.ijmm.2007.11.002; Tavanti A, 2005, J CLIN MICROBIOL, V43, P5601, DOI 10.1128/JCM.43.11.5601-5613.2005; Tavanti A, 2004, FUNGAL GENET BIOL, V41, P553, DOI 10.1016/j.fgb.2003.12.008; Tavanti A, 2003, J CLIN MICROBIOL, V41, P3765, DOI 10.1128/JCM.41.8.3765-3776.2003; Wrobel L, 2008, EUKARYOT CELL, V7, P1475, DOI 10.1128/EC.00162-08; Zhu WD, 2010, CELL MICROBIOL, V12, P273, DOI 10.1111/j.1462-5822.2009.01412.x; Zwolinska-Wcislo M, 2006, J PHYSIOL PHARMACOL, V57, P35; Zwolinska-Wcislo M, 2001, MED SCI MONITOR, V7, P266	53	26	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35311	10.1371/journal.pone.0035311	http://dx.doi.org/10.1371/journal.pone.0035311			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536371	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339200053
J	Kohler, J; Erlenkamp, G; Eberlin, A; Rumpf, T; Slynko, I; Metzger, E; Schule, R; Sippl, W; Jung, M				Koehler, Jens; Erlenkamp, German; Eberlin, Adrien; Rumpf, Tobias; Slynko, Inna; Metzger, Eric; Schuele, Roland; Sippl, Wolfgang; Jung, Manfred			Lestaurtinib Inhibits Histone Phosphorylation and Androgen-Dependent Gene Expression in Prostate Cancer Cells	PLOS ONE			English	Article							MOLECULAR-DYNAMICS; KINASE INHIBITOR; DOCKING; CHROMATIN; RECEPTOR; EPIGENETICS; ALIGNMENT; ACCURACY; PROTEINS; CEP701	Background: Epigenetics is defined as heritable changes in gene expression that are not based on changes in the DNA sequence. Posttranslational modification of histone proteins is a major mechanism of epigenetic regulation. The kinase PRK1 (protein kinase C related kinase 1, also known as PKN1) phosphorylates histone H3 at threonine 11 and is involved in the regulation of androgen receptor signalling. Thus, it has been identified as a novel drug target but little is known about PRK1 inhibitors and consequences of its inhibition. Methodology/Principal Finding: Using a focused library screening approach, we identified the clinical candidate lestaurtinib (also known as CEP-701) as a new inhibitor of PRK1. Based on a generated 3D model of the PRK1 kinase using the homolog PKC-theta (protein kinase c theta) protein as a template, the key interaction of lestaurtinib with PRK1 was analyzed by means of molecular docking studies. Furthermore, the effects on histone H3 threonine phosphorylation and androgen-dependent gene expression was evaluated in prostate cancer cells. Conclusions/Significance: Lestaurtinib inhibits PRK1 very potently in vitro and in vivo. Applied to cell culture it inhibits histone H3 threonine phosphorylation and androgen-dependent gene expression, a feature that has not been known yet. Thus our findings have implication both for understanding of the clinical activity of lestaurtinib as well as for future PRK1 inhibitors.	[Koehler, Jens; Rumpf, Tobias; Jung, Manfred] Univ Freiburg, Inst Pharmaceut Sci, D-79106 Freiburg, Germany; [Erlenkamp, German; Slynko, Inna; Sippl, Wolfgang] Univ Halle Wittenberg, Dept Pharmaceut Chem, Halle, Germany; [Eberlin, Adrien; Metzger, Eric; Schuele, Roland] Univ Freiburg, Med Ctr, Womens Hosp, Dept Urol, Freiburg, Germany; [Eberlin, Adrien; Metzger, Eric; Schuele, Roland] Univ Freiburg, Med Ctr, Clin Res Ctr, Freiburg, Germany	University of Freiburg; Martin Luther University Halle Wittenberg; University of Freiburg; University of Freiburg	Jung, M (corresponding author), Univ Munster, Inst Pharmaceut & Med Chem, Munster, Germany.	manfred.jung@pharmazie.uni-freiburg.de	Sippl, Wolfgang/P-5944-2014; Jung, Manfred/Q-8029-2016	Sippl, Wolfgang/0000-0002-5985-9261; Jung, Manfred/0000-0002-6361-7716				Allis CD, 2007, CELL, V131, P633, DOI 10.1016/j.cell.2007.10.039; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2008, AMBER 10; Berger SL, 2009, GENE DEV, V23, P781, DOI 10.1101/gad.1787609; Case D, 2006, AMBER 9; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Charifson PS, 1999, J MED CHEM, V42, P5100, DOI 10.1021/jm990352k; DARDEN TA, 1993, J CHEM PHYS, V103, P8577; Englebienne P, 2009, J CHEM INF MODEL, V49, P1568, DOI 10.1021/ci8004308; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Frigo DE, 2009, MOL ENDOCRINOL, V23, P1385, DOI 10.1210/me.2009-0010; Gingrich DE, 2002, BIOORG MED CHEM LETT, V12, P2829, DOI 10.1016/S0960-894X(02)00638-8; Handel AE, 2009, TRENDS MOL MED; Hexner EO, 2008, BLOOD, V111, P5663, DOI 10.1182/blood-2007-04-083402; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Hurd PJ, 2009, J BIOL CHEM, V284, P16575, DOI 10.1074/jbc.M109.005421; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Knapper S, 2006, BLOOD, V108, P3262, DOI 10.1182/blood-2006-04-015560; Kufareva I, 2008, J MED CHEM, V51, P7921, DOI 10.1021/jm8010299; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Ma AH, 2006, CANCER RES, V66, P8439, DOI 10.1158/0008-5472.CAN-06-1636; Markaki Y, 2009, J CELL SCI, V122, P2809, DOI 10.1242/jcs.043810; Meier R, 2010, J CHEM INF MODEL, V50, P879, DOI 10.1021/ci900467x; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Metzger E, 2008, NAT CELL BIOL, V10, P53, DOI 10.1038/ncb1668; Metzger E, 2010, NATURE, V464, P792, DOI 10.1038/nature08839; Ngan S, 2009, ONCOGENE, V28, P2051, DOI 10.1038/onc.2009.68; Pandini G, 2005, CANCER RES, V65, P1849, DOI 10.1158/0008-5472.CAN-04-1837; Papait R, 2009, IDRUGS, V12, P264; PASTOR RW, 1988, MOL PHYS, V65, P1409, DOI 10.1080/00268978800101881; Patnaik D, 2008, J BIOMOL SCREEN, V13, P1025, DOI 10.1177/1087057108326081; Fidalgo JAP, 2009, CLIN TRANSL ONCOL, V11, P787, DOI 10.1007/s12094-009-0447-2; Prescott JL, 1998, PROSTATE, V35, P71, DOI 10.1002/(SICI)1097-0045(19980401)35:1<71::AID-PROS10>3.0.CO;2-H; Rae JM, 2006, PROSTATE, V66, P886, DOI 10.1002/pros.20403; Revill P, 2007, DRUG FUTURE, V32, P215, DOI 10.1358/dof.2007.032.03.1084137; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Shabbir M, 2010, EXPERT OPIN INV DRUG, V19, P427, DOI 10.1517/13543781003598862; Shen YQ, 2001, ACTA CRYSTALLOGR D, V57, P1196, DOI 10.1107/S0907444901007703; Sobel RE, 2005, J UROLOGY, V173, P342, DOI 10.1097/01.ju.0000141580.30910.57; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Xu ZB, 2004, J BIOL CHEM, V279, P50401, DOI 10.1074/jbc.M409216200	42	29	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e34973	10.1371/journal.pone.0034973	http://dx.doi.org/10.1371/journal.pone.0034973			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22532837	Green Submitted, Green Published, gold			2022-12-27	WOS:000305339200029
J	Larson, B; Schnippel, K; Ndibongo, B; Long, L; Fox, MP; Rosen, S				Larson, Bruce; Schnippel, Kathryn; Ndibongo, Buyiswa; Long, Lawrence; Fox, Matthew P.; Rosen, Sydney			How to Estimate the Cost of Point-of-Care CD4 Testing in Program Settings: An Example Using the Alere Pima (TM) Analyzer in South Africa	PLOS ONE			English	Article							T-CELL ENUMERATION; HIV; PERFORMANCE; LINKAGE; BLOOD	Integrating POC CD4 testing technologies into HIV counseling and testing (HCT) programs may improve post-HIV testing linkage to care and treatment. As evaluations of these technologies in program settings continue, estimates of the costs of POC CD4 tests to the service provider will be needed and estimates have begun to be reported. Without a consistent and transparent methodology, estimates of the cost per CD4 test using POC technologies are likely to be difficult to compare and may lead to erroneous conclusions about costs and cost-effectiveness. This paper provides a step-by-step approach for estimating the cost per CD4 test from a provider's perspective. As an example, the approach is applied to one specific POC technology, the Pima (TM) Analyzer. The costing approach is illustrated with data from a mobile HCT program in Gauteng Province of South Africa. For this program, the cost per test in 2010 was estimated at $23.76 (material costs = $8.70; labor cost per test = $7.33; and equipment, insurance, and daily quality control = $7.72). Labor and equipment costs can vary widely depending on how the program operates and the number of CD4 tests completed over time. Additional costs not included in the above analysis, for on-going training, supervision, and quality control, are likely to increase further the cost per test. The main contribution of this paper is to outline a methodology for estimating the costs of incorporating POC CD4 testing technologies into an HCT program. The details of the program setting matter significantly for the cost estimate, so that such details should be clearly documented to improve the consistency, transparency, and comparability of cost estimates.	[Larson, Bruce; Fox, Matthew P.; Rosen, Sydney] Boston Univ, Ctr Global Hlth & Dev, Boston, MA 02215 USA; [Schnippel, Kathryn; Ndibongo, Buyiswa; Long, Lawrence; Fox, Matthew P.; Rosen, Sydney] Univ Witwatersrand, Dept Med, Hlth Econ & Epidemiol Res Off, Fac Hlth Sci, ZA-2001 Johannesburg, South Africa; [Fox, Matthew P.] Boston Univ, Dept Epidemiol, Sch Publ Hlth, Boston, MA USA; [Larson, Bruce] Boston Univ, Dept Int Hlth, Sch Publ Hlth, Boston, MA USA	Boston University; University of Witwatersrand; Boston University; Boston University	Larson, B (corresponding author), Boston Univ, Ctr Global Hlth & Dev, Boston, MA 02215 USA.	blarson@bu.edu	Fox, Matthew/K-2004-2019	Fox, Matthew/0000-0001-9887-0634; Rosen, Sydney/0000-0002-6560-2964; Schnippel, Kathryn/0000-0003-0757-4325; Long, Lawrence/0000-0003-4986-4988; Larson, Bruce/0000-0002-9322-2387	South Africa Mission of the United States Agency for International Development [GHSA-00-00020-00]; National Institute of Allergy and Infectious Diseases [K01AI083097]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K01AI083097] Funding Source: NIH RePORTER	South Africa Mission of the United States Agency for International Development; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for this study was provided by the South Africa Mission of the United States Agency for International Development under the terms of Cooperative Agreement GHSA-00-00020-00, Country Research Activity (G/PHN/HN/CS). MF was supported by Award Number K01AI083097 from the National Institute of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boardman A, 2006, COST BENEFIT ANAL CO; Diaw PA, 2011, 6 IAS C HIV PATH TRE; Diaw PA, 2011, JAIDS-J ACQ IMM DEF, V58, pE103, DOI 10.1097/QAI.0b013e318235b378; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Faal M, 2011, JAIDS-J ACQ IMM DEF, V58, pE54, DOI 10.1097/QAI.0b013e3182303921; Glencross D, 2011, 6 IAS C HIV PATH TRE; Glencross DK, 2008, CYTOM PART B-CLIN CY, V74B, pS69, DOI 10.1002/cyto.b.20397; Glencross DK, 2012, J INT AIDS SOC, V15, DOI 10.1186/1758-2652-15-3; Govindasamy D, 2011, JAIDS-J ACQ IMM DEF, V58, P344, DOI 10.1097/QAI.0b013e31822e0c4c; Jani IV, 2010, CLIN INFECT DIS, V51, P609, DOI 10.1086/655763; Jani IV, 2011, LANCET; Larson BA, 2011, RAPID POINT OF CARE; Larson BA, 2010, B WORLD HEALTH ORGAN, V88, P675, DOI 10.2471/BLT.09.068981; Losina E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009538; McCoy SI, 2009, AIDS CARE, V21, P1313, DOI 10.1080/09540120902803174; Mtapuri-Zinyowera S, 2010, JAIDS-J ACQ IMM DEF, V55, P1, DOI 10.1097/QAI.0b013e3181e93071; Nsigaye R, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-31; Pai NP, 2012, DISCOV MED, V13, P35; Rosen S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001056; Sitoe N, COST COMPARISON POIN; Sukapirom K, 2011, JAIDS J ACQ IN PRESS	21	45	45	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35444	10.1371/journal.pone.0035444	http://dx.doi.org/10.1371/journal.pone.0035444			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22532854	Green Published, gold, Green Submitted			2022-12-27	WOS:000305339200065
J	Meiklejohn, J; Connor, J; Kypri, K				Meiklejohn, Jessica; Connor, Jennie; Kypri, Kypros			The Effect of Low Survey Response Rates on Estimates of Alcohol Consumption in a General Population Survey	PLOS ONE			English	Article							NONRESPONSE BIAS; BINGE DRINKING	Background: Response rates for surveys of alcohol use are declining for all modes of administration (postal, telephone, face-to-face). Low response rates may result in estimates that are biased by selective non-response. We examined non-response bias in the NZ GENACIS survey, a postal survey of a random electoral roll sample, with a response rate of 49.5% (n = 1924). Our aim was to estimate the magnitude of non-response bias in estimating the prevalence of current drinking and heavy episodic (binge) drinking. Methods: We used the "continuum of resistance" model to guide the investigation. In this model the likelihood of response by sample members is related to the amount of effort required from the researchers to elicit a response. First, the demographic characteristics of respondents and non-respondents were compared. Second, respondents who returned their questionnaire before the first reminder (early), before the second reminder (intermediate) or after the second reminder (late) were compared by demographic characteristics, 12-month prevalence of drinking and prevalence of binge drinking. Results: Demographic characteristics and prevalence of binge drinking were significantly different between late respondents and early/intermediate respondents, with the demographics of early and intermediate respondents being similar to people who refused to participate while late respondents were similar to all other non-respondents. Assuming non-respondents who did not actively refuse to participate had the same drinking patterns as late respondents, the prevalence of binge drinking amongst current drinkers was underestimated. Adjusting the prevalence of binge drinkers amongst current drinkers using population weights showed that this method of adjustment still resulted in an underestimate of the prevalence. Conclusions: The findings suggest non-respondents who did not actively refuse to participate are likely to have similar or more extreme drinking behaviours than late respondents, and that surveys of health compromising behaviours such as alcohol use are likely to underestimate the prevalence of these behaviours.	[Meiklejohn, Jessica; Kypri, Kypros] Univ Otago, Injury Prevent Res Unit, Dept Prevent & Social Med, Dunedin, New Zealand; [Kypri, Kypros] Univ Newcastle, Sch Med & Publ Hlth, Ctr Clin Epidemiol & Biostat, Newcastle, NSW 2300, Australia	University of Otago; University of Newcastle	Meiklejohn, J (corresponding author), Univ Otago, Injury Prevent Res Unit, Dept Prevent & Social Med, Dunedin, New Zealand.	jessica.meiklejohn@otago.ac.nz	Kypri, Kypros/D-2809-2009	Kypri, Kypros/0000-0002-9657-9904; Connor, Jennie/0000-0002-3209-8693	Otago University; Alcohol Advisory Council of New Zealand	Otago University; Alcohol Advisory Council of New Zealand	The survey was funded by an Otago University Research Grant. Jessica Meiklejohn was supported by a scholarship from the Alcohol Advisory Council of New Zealand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caetano R, 2001, ADDICTION, V96, P1541, DOI 10.1046/j.1360-0443.2001.961115411.x; Dillman D. A., 2000, MAIL INTERNET SURVEY, V2; Hardie JA, 2003, SCAND J PUBLIC HEALT, V31, P411, DOI 10.1177/140349480303100603; Kypri K, 2004, ALCOHOL CLIN EXP RES, V28, P630, DOI 10.1097/01.ALC.0000121654.99277.26; Kypri K, 2011, PREVENTIVE IN PRESS; LIN IF, 1995, PUBLIC OPIN QUART, V59, P236, DOI 10.1086/269471; Verlato G, 2010, RESP MED, V104, P172, DOI 10.1016/j.rmed.2009.09.022; Wechsler H, 1998, J STUD ALCOHOL, V59, P122, DOI 10.15288/jsa.1998.59.122; WECHSLER H, 1995, AM J PUBLIC HEALTH, V85, P921, DOI 10.2105/AJPH.85.7.921; Wild TC, 2001, J STUD ALCOHOL, V62, P257, DOI 10.15288/jsa.2001.62.257	10	61	61	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35527	10.1371/journal.pone.0035527	http://dx.doi.org/10.1371/journal.pone.0035527			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UD	22532858	Green Published, gold, Green Submitted			2022-12-27	WOS:000305339200073
J	Saint-Lary, O; Boisnault, P; Naiditch, M; Szidon, P; Duhot, D; Bourgueil, Y; Pelletier-Fleury, N				Saint-Lary, Olivier; Boisnault, Philippe; Naiditch, Michel; Szidon, Philippe; Duhot, Didier; Bourgueil, Yann; Pelletier-Fleury, Nathalie			Performance Scores in General Practice: A Comparison between the Clinical versus Medication-Based Approach to Identify Target Populations	PLOS ONE			English	Article							PAY-FOR-PERFORMANCE; PRIMARY-CARE; UNITED-KINGDOM; OUTCOMES FRAMEWORK; QUALITY; FRANCE; HYPERTENSION; INDICATORS; PREVALENCE	Context: From one country to another, the pay-for-performance mechanisms differ on one significant point: the identification of target populations, that is, populations which serve as a basis for calculating the indicators. The aim of this study was to compare clinical versus medication-based identification of populations of patients with diabetes and hypertension over the age of 50 (for men) or 60 (for women), and any consequences this may have on the calculation of P4P indicators. Methods: A comparative, retrospective, observational study was carried out with clinical and prescription data from a panel of general practitioners (GPs), the Observatory of General Medicine (OMG) for the year 2007. Two indicators regarding the prescription for statins and aspirin in these populations were calculated. Results: We analyzed data from 21.690 patients collected by 61 GPs via electronic medical files. Following the clinical-based approach, 2.278 patients were diabetic, 8,271 had hypertension and 1.539 had both against respectively 1.730, 8.511 and 1.304 following the medication-based approach (% agreement = 96%, kappa = 0.69). The main reasons for these differences were: forgetting to code the morbidities in the clinical approach, not taking into account the population of patients who were given life style and diet rules only or taking into account patients for whom morbidities other than hypertension could justify the use of antihypertensive drugs in the medication-based approach. The mean (confidence interval) per doctor was 33.7% (31.5-35.9) for statin indicator and 38.4% (35.4-41.4) for aspirin indicator when the target populations were identified on the basis of clinical criteria whereas they were 37.9% (36.3-39.4) and 43.8% (41.4-46.3) on the basis of treatment criteria. Conclusion: The two approaches yield very "similar" scores but these scores cover different realities and offer food for thought on the possible usage of these indicators in the framework of P4P programmes.	[Saint-Lary, Olivier; Boisnault, Philippe; Naiditch, Michel; Szidon, Philippe; Duhot, Didier; Bourgueil, Yann; Pelletier-Fleury, Nathalie] Prospere, Paris, France; [Saint-Lary, Olivier; Boisnault, Philippe] Univ Versailles St Quentin Yvelines, Dept Med Gen PIFO, Guyancourt, France; [Saint-Lary, Olivier; Boisnault, Philippe; Szidon, Philippe; Duhot, Didier] SFMG, Issy Les Moulineaux, France; [Naiditch, Michel; Bourgueil, Yann] IRDES, Paris, France; [Pelletier-Fleury, Nathalie] INSERM, U988, CERMES3, UMR 8211, Villejuif, France	UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Saint-Lary, O (corresponding author), Prospere, Paris, France.	olivier.saint-lary@uvsq.fr	Bourgueil, Yann/GWZ-3505-2022; Pelletier-Fleury, Nathalie/R-4220-2018	Pelletier-Fleury, Nathalie/0000-0002-4821-4863; Saint-Lary, Olivier/0000-0003-3731-3476				[Anonymous], 2010, REV PRESCRIRE, V30, P854; Attali C, 2007, RES DIABETE, V31, P4; Botsis T, 2010, BMC MED INFORM DECIS, V10, DOI 10.1186/1472-6947-10-11; Bringer J, 2009, DIABETES METAB, V35, P25, DOI 10.1016/j.diabet.2008.06.004; Calvert M, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1870; Campbell SA, 2008, ANN FAM MED, V6, P228, DOI 10.1370/afm.844; Chaix-Couturier C, 2000, INT J QUAL HEALTH C, V12, P133, DOI 10.1093/intqhc/12.2.133; Chamontin B, 2001, ARCH MAL COEUR VAISS, V94, P869; Dassow PL, 2007, J AM BOARD FAM MED, V20, P1, DOI 10.3122/jabfm.2007.01.060082; Detournay B, 2000, DIABETES METAB, V26, P363; Doran T, 2006, NEW ENGL J MED, V355, P375, DOI 10.1056/NEJMsa055505; Egan BM, 2010, JAMA-J AM MED ASSOC, V303, P2043, DOI 10.1001/jama.2010.650; Endsley Scott, 2004, Fam Pract Manag, V11, P45; Ferru P., 2004, DOC RECH MED GEN, V62, P3; Gross Revital, 2008, J Health Organ Manag, V22, P23, DOI 10.1108/14777260810862380; Guthrie B, 2006, BRIT J GEN PRACT, V56, P836; HAS, 2007, GUID AFF LONG DUR DI; Hippisley-Cox J, 2004, LANCET, V364, P423, DOI 10.1016/S0140-6736(04)16765-2; Lester HE, 2011, BMJ QUAL SAF, V20, P1057, DOI 10.1136/bmjqs.2010.048371; Morgan MAJ, 2011, MED J AUSTRALIA, V194, P213; Rosenthal MB, 2007, JAMA-J AM MED ASSOC, V297, P740, DOI 10.1001/jama.297.7.740; Rosman S, 2008, EUR J PUBLIC HEALTH, V18, P312, DOI 10.1093/eurpub/ckm118; Rosman S, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-28; Societe Francaise de Medecine Generale, 2006, OBS MED GEN; Thiru K, 2003, BMJ-BRIT MED J, V326, P1070, DOI 10.1136/bmj.326.7398.1070	25	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35721	10.1371/journal.pone.0035721	http://dx.doi.org/10.1371/journal.pone.0035721			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536430	Green Published, gold, Green Submitted			2022-12-27	WOS:000305339200102
J	Yamashita, H; Chen, SL; Komagata, S; Hishida, R; Iwasato, T; Itohara, S; Yagi, T; Endo, N; Shibata, M; Shibuki, K				Yamashita, Haruyoshi; Chen, Shanlin; Komagata, Seiji; Hishida, Ryuichi; Iwasato, Takuji; Itohara, Shigeyoshi; Yagi, Takeshi; Endo, Naoto; Shibata, Minoru; Shibuki, Katsuei			Restoration of Contralateral Representation in the Mouse Somatosensory Cortex after Crossing Nerve Transfer	PLOS ONE			English	Article							PROTOCADHERIN-ALPHA FAMILY; VISUAL-CORTEX; FLAVOPROTEIN AUTOFLUORESCENCE; HAND REPRESENTATION; CORPUS-CALLOSUM; AUDITORY-CORTEX; SENSORY NEURONS; INJURED ARM; PLASTICITY; MICE	Avulsion of spinal nerve roots in the brachial plexus (BP) can be repaired by crossing nerve transfer via a nerve graft to connect injured nerve ends to the BP contralateral to the lesioned side. Sensory recovery in these patients suggests that the contralateral primary somatosensory cortex (S1) is activated by afferent inputs that bypassed to the contralateral BP. To confirm this hypothesis, the present study visualized cortical activity after crossing nerve transfer in mice through the use of transcranial flavoprotein fluorescence imaging. In naive mice, vibratory stimuli applied to the forepaw elicited localized fluorescence responses in the S1 contralateral to the stimulated side, with almost no activity in the ipsilateral S1. Four weeks after crossing nerve transfer, forepaw stimulation in the injured and repaired side resulted in cortical responses only in the S1 ipsilateral to the stimulated side. At eight weeks after crossing nerve transfer, forepaw stimulation resulted in S1 cortical responses of both hemispheres. These cortical responses were abolished by cutting the nerve graft used for repair. Exposure of the ipsilateral S1 to blue laser light suppressed cortical responses in the ipsilateral S1, as well as in the contralateral S1, suggesting that ipsilateral responses propagated to the contralateral S1 via cortico-cortical pathways. Direct high-frequency stimulation of the ipsilateral S1 in combination with forepaw stimulation acutely induced S1 bilateral cortical representation of the forepaw area in naive mice. Cortical responses in the contralateral S1 after crossing nerve transfer were reduced in cortex-restricted heterotypic GluN1 (NMDAR1) knockout mice. Functional bilateral cortical representation was not clearly observed in genetically manipulated mice with impaired cortico-cortical pathways between S1 of both hemispheres. Taken together, these findings strongly suggest that activity-dependent potentiation of cortico-cortical pathways has a critical role for sensory recovery in patients after crossing nerve transfer.	[Yamashita, Haruyoshi; Chen, Shanlin; Komagata, Seiji; Hishida, Ryuichi; Shibuki, Katsuei] Niigata Univ, Brain Res Inst, Dept Neurophysiol, Niigata, Japan; [Yamashita, Haruyoshi; Chen, Shanlin; Shibata, Minoru] Niigata Univ, Fac Med, Dept Plast Surg, Niigata, Japan; [Yamashita, Haruyoshi; Endo, Naoto] Niigata Univ, Fac Med, Dept Orthoped Surg, Niigata, Japan; [Chen, Shanlin] Beijing Jishuitan Hosp, Beijing, Peoples R China; [Iwasato, Takuji] Natl Inst Genet, Div Neurogenet, Mishima, Shizuoka 411, Japan; [Itohara, Shigeyoshi] RIKEN Brain Sci Inst, Lab Behav Genet, Wako, Saitama, Japan; [Yagi, Takeshi] Osaka Univ, KOKORO Biol Grp, Labs Integrated Biol, Grad Sch Frontier Biosci, Osaka, Japan	Niigata University; Niigata University; Niigata University; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; RIKEN; Osaka University	Shibuki, K (corresponding author), Niigata Univ, Brain Res Inst, Dept Neurophysiol, Niigata, Japan.	shibuki@bri.niigata-u.ac.jp	Itohara, Shigeyoshi/I-8769-2012	Itohara, Shigeyoshi/0000-0002-2410-9989	Japanese Government;  [22115011];  [22240044]; Grants-in-Aid for Scientific Research [23500383, 19100006] Funding Source: KAKEN	Japanese Government; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research (Nos. 22115011 and 22240044) and Core Research for Evolutional Science and Technology program from the Japanese Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addas BMJ, 2009, NEUROSURG CLIN N AM, V20, P27, DOI 10.1016/j.nec.2008.07.018; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; CHANCE B, 1962, SCIENCE, V137, P499, DOI 10.1126/science.137.3529.499; Citri A, 2008, NEUROPSYCHOPHARMACOL, V33, P18, DOI 10.1038/sj.npp.1301559; Donnerer J, 2003, PHARMACOLOGY, V67, P169, DOI 10.1159/000068405; Fabri M, 2006, EUR J NEUROSCI, V23, P3139, DOI 10.1111/j.1460-9568.2006.04823.x; Fabri M, 2005, COGNITIVE BRAIN RES, V24, P73, DOI 10.1016/j.cogbrainres.2004.12.003; Ferezou I, 2006, NEURON, V50, P617, DOI 10.1016/j.neuron.2006.03.043; GU YD, 1994, J HAND SURG-BRIT EUR, V19B, P69, DOI 10.1016/0266-7681(94)90053-1; GU YD, 1992, J HAND SURG-BRIT EUR, V17B, P518, DOI 10.1016/S0266-7681(05)80235-9; Hasegawa S, 2008, MOL CELL NEUROSCI, V38, P66, DOI 10.1016/j.mcn.2008.01.016; Hishida R, 2011, J NEUROSCI METH, V201, P315, DOI 10.1016/j.jneumeth.2011.08.007; Iwamura Y, 2002, BEHAV BRAIN RES, V135, P185, DOI 10.1016/S0166-4328(02)00164-X; IWAMURA Y, 1994, NATURE, V369, P554, DOI 10.1038/369554a0; Iwasato T, 2000, NATURE, V406, P726, DOI 10.1038/35021059; Jain N, 2008, J NEUROSCI, V28, P11042, DOI 10.1523/JNEUROSCI.2334-08.2008; Kamatani D, 2007, NEUROIMAGE, V35, P47, DOI 10.1016/j.neuroimage.2006.08.049; Katori S, 2009, J NEUROSCI, V29, P9137, DOI 10.1523/JNEUROSCI.5478-08.2009; Kitaura H, 2010, BRAIN RES, V1319, P54, DOI 10.1016/j.brainres.2010.01.020; Kohmura N, 1998, NEURON, V20, P1137, DOI 10.1016/S0896-6273(00)80495-X; Komagata S, 2011, J NEUROSCI, V31, P4896, DOI 10.1523/JNEUROSCI.6753-10.2011; Kubota Y, 2008, NEUROSCI RES, V60, P422, DOI 10.1016/j.neures.2007.12.013; Lou L, 2006, NEUROSCIENCE, V138, P1225, DOI 10.1016/j.neuroscience.2005.11.062; Lundborg G, 2007, ACTA PHYSIOL, V189, P207, DOI 10.1111/j.1748-1716.2006.01653.x; MERZENICH MM, 1983, NEUROSCIENCE, V8, P33, DOI 10.1016/0306-4522(83)90024-6; Murakami H, 2004, EUR J NEUROSCI, V19, P1352, DOI 10.1111/j.1460-9568.2004.03237.x; Romo R, 2001, ANNU REV NEUROSCI, V24, P107, DOI 10.1146/annurev.neuro.24.1.107; Schreiner D, 2010, P NATL ACAD SCI USA, V107, P14893, DOI 10.1073/pnas.1004526107; Schuett S, 2002, J NEUROSCI, V22, P6549; Shibuki K, 2003, J PHYSIOL-LONDON, V549, P919, DOI 10.1113/jphysiol.2003.040709; SHIMOJO S, 1981, PERCEPTION, V10, P391, DOI 10.1068/p100391; Sugita Y, 1996, NATURE, V380, P523, DOI 10.1038/380523a0; Takahashi K, 2006, EUR J NEUROSCI, V23, P1365, DOI 10.1111/j.1460-9568.2006.04662.x; Tanaka Y, 2007, VISION RES, V47, P1350, DOI 10.1016/j.visres.2006.10.028; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Tohmi M, 2006, J NEUROSCI, V26, P11775, DOI 10.1523/JNEUROSCI.1643-06.2006; VITERBO F, 1994, BRIT J PLAST SURG, V47, P75, DOI 10.1016/0007-1226(94)90162-7; Wang M, 2010, NEUROSURGERY, V67, P136, DOI 10.1227/01.NEU.0000370603.45342.6B; WANG XQ, 1995, NATURE, V378, P71, DOI 10.1038/378071a0; Watanabe K, 2007, BRAIN RES, V1166, P20, DOI 10.1016/j.brainres.2007.06.049; Wiest MC, 2010, J NEUROPHYSIOL, V104, P300, DOI 10.1152/jn.00194.2010; Zuo CT, 2010, J NEUROSURG, V113, P133, DOI 10.3171/2010.1.JNS09448	42	16	17	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35676	10.1371/journal.pone.0035676	http://dx.doi.org/10.1371/journal.pone.0035676			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536423	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339200095
J	Zhu, YL; Jiang, QL; Lou, XJ; Ji, XW; Wen, ZZ; Wu, J; Tao, HY; Jiang, TT; He, W; Wang, CH; Du, Q; Zheng, S; Mao, JS; Huang, J				Zhu, Yongliang; Jiang, Qiaoli; Lou, Xiaojun; Ji, Xiaowei; Wen, Zhenzhen; Wu, Jia; Tao, Haiying; Jiang, Tingting; He, Wei; Wang, Caihua; Du, Qin; Zheng, Shu; Mao, Jianshan; Huang, Jian			MicroRNAs Up-Regulated by CagA of Helicobacter pylori Induce Intestinal Metaplasia of Gastric Epithelial Cells	PLOS ONE			English	Article							VIRULENCE FACTOR CAGA; MESENCHYMAL TRANSDIFFERENTIATION; CARCINOMA-CELLS; CANCER; PROTEIN; FOXA1; TRANSCRIPTION; PHOSPHORYLATION; DIFFERENTIATION; CARCINOGENESIS	CagA of Helicobacter pylori is a bacterium-derived oncogenic protein closely associated with the development of gastric cancers. MicroRNAs (miRNAs) are a class of widespread non-coding RNAs, many of which are involved in cell growth, cell differentiation and tumorigenesis. The relationship between CagA protein and miRNAs is unclear. Using mammalian miRNA profile microarrays, we found that miRNA-584 and miRNA-1290 expression was up-regulated in CagA-transformed cells, miRNA-1290 was up-regulated in an Erk1/2-dependent manner, and miRNA-584 was activated by NF-kappa B. miRNA-584 sustained Erk1/2 activities through inhibition of PPP2a activities, and miRNA-1290 activated NF-kappa B by knockdown of NKRF. Foxa1 was revealed to be an important target of miRNA-584 and miRNA-1290. Knockdown of Foxa1 promoted the epithelial-mesenchymal transition significantly. Overexpression of miRNA-584 and miRNA-1290 induced intestinal metaplasia of gastric epithelial cells in knock-in mice. These results indicate that miRNA-584 and miRNA-1290 interfere with cell differentiation and remodel the tissues. Thus, the miRNA pathway is a new pathogenic mechanism of CagA.	[Zhu, Yongliang; Jiang, Qiaoli; Lou, Xiaojun; Ji, Xiaowei; Wen, Zhenzhen; Wu, Jia; Tao, Haiying; Jiang, Tingting; He, Wei; Wang, Caihua; Du, Qin; Mao, Jianshan] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Gastroenterol, Hangzhou 310003, Zhejiang, Peoples R China; [Zheng, Shu; Huang, Jian] Zhejiang Univ, Sch Med, Inst Canc, Hangzhou 310003, Zhejiang, Peoples R China; [Zheng, Shu; Huang, Jian] Zhejiang Univ, Sch Med, Educ Minist, Key Lab Canc Prevent & Intervent, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University	Zhu, YL (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Gastroenterol, Hangzhou 310003, Zhejiang, Peoples R China.	zhuyongliangch@yahoo.com.cn			National Science Foundation Committee of China [30670113, 81071768, 31090361]; Natural Science Foundation of Zhejiang province [R2090074, Y2090322]; Foundation of Scientific technology bureau of Zhejiang province [2009C33081, 2011C23091]	National Science Foundation Committee of China; Natural Science Foundation of Zhejiang province(Natural Science Foundation of Zhejiang Province); Foundation of Scientific technology bureau of Zhejiang province	This work was supported by grants from National Science Foundation Committee of China (30670113, 81071768, 31090361) (http://isisn.nsfc.gov.cn/egrantweb/), Natural Science Foundation of Zhejiang province (R2090074, Y2090322) (http://www.zjnsf.gov.cn/), and Foundation of Scientific technology bureau of Zhejiang province (2009C33081, 2011C23091) (http://www.zjkjt.gov.cn/html/node02/zxsb.jsp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida R, 2005, J PATHOL, V207, P396, DOI 10.1002/path.1861; Amieva MR, 2003, SCIENCE, V300, P1430, DOI 10.1126/science.1081919; Belian E, 2010, ANTICANCER RES, V30, P629; Bhowmick NA, 2001, MOL BIOL CELL, V12, P27, DOI 10.1091/mbc.12.1.27; Calin GA, 2008, P NATL ACAD SCI USA, V105, P5166, DOI 10.1073/pnas.0800121105; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Ellenrieder V, 2001, CANCER RES, V61, P4222; Gao N, 2005, DEVELOPMENT, V132, P3431, DOI 10.1242/dev.01917; Hatakeyama M, 2005, CANCER SCI, V96, P835, DOI 10.1111/j.1349-7006.2005.00130.x; Hatakeyama M, 2004, NAT REV CANCER, V4, P688, DOI 10.1038/nrc1433; Hatakeyama M, 2008, ONCOGENE, V27, P7047, DOI 10.1038/onc.2008.353; Higashi H, 2002, SCIENCE, V295, P683, DOI 10.1126/science.1067147; Hirata Y, 2002, GASTROENTEROLOGY, V123, P1962, DOI 10.1053/gast.2002.37044; Hornstein E, 2005, NATURE, V438, P671, DOI 10.1038/nature04138; Iliopoulos D, 2010, MOL CELL, V39, P493, DOI 10.1016/j.molcel.2010.07.023; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Lee IO, 2010, J BIOL CHEM, V285, P16042, DOI 10.1074/jbc.M110.111054; Li ZY, 2009, J CLIN INVEST, V119, P1537, DOI 10.1172/JCI38201; Liu Z, 2010, MICROBES INFECT, V12, P854, DOI 10.1016/j.micinf.2010.06.002; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; Matsushima K, 2011, INT J CANCER, V128, P361, DOI 10.1002/ijc.25348; Murata-Kamiya N, 2010, CELL HOST MICROBE, V7, P399, DOI 10.1016/j.chom.2010.04.005; Ohnishi N, 2008, P NATL ACAD SCI USA, V105, P1003, DOI 10.1073/pnas.0711183105; Poy MN, 2009, P NATL ACAD SCI USA, V106, P5813, DOI 10.1073/pnas.0810550106; Saadat I, 2007, NATURE, V447, P330, DOI 10.1038/nature05765; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Shmuely H, 2001, AM J GASTROENTEROL, V96, P3406; Tan YJ, 2010, STEM CELLS DEV, V19, P1365, DOI 10.1089/scd.2009.0386; Taube JH, 2010, J BIOL CHEM, V285, P16135, DOI 10.1074/jbc.M109.088096; Tsang YH, 2010, ONCOGENE, V29, P5643, DOI 10.1038/onc.2010.304; Ueno K, 2011, BRIT J CANCER, V104, P308, DOI 10.1038/sj.bjc.6606028; Vatamaniuk MZ, 2006, DIABETES, V55, P2730, DOI 10.2337/db05-0470; Wan HJ, 2005, J BIOL CHEM, V280, P13809, DOI 10.1074/jbc.M414122200; Wong BCY, 2004, JAMA-J AM MED ASSOC, V291, P187, DOI 10.1001/jama.291.2.187; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Yang HB, 2009, AM J GASTROENTEROL, V104, P1642, DOI 10.1038/ajg.2009.172; Ye DZ, 2009, GASTROENTEROLOGY, V137, P2052, DOI 10.1053/j.gastro.2009.08.059; Yeh JM, 2009, INT J CANCER, V124, P157, DOI 10.1002/ijc.23864; Zhu YL, 2005, ONCOGENE, V24, P3886, DOI 10.1038/sj.onc.1208551; Zhu YL, 2005, WORLD J GASTROENTERO, V11, P880, DOI 10.3748/wjg.v11.i6.880	40	49	57	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35147	10.1371/journal.pone.0035147	http://dx.doi.org/10.1371/journal.pone.0035147			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536353	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339200039
J	Furukawa, TA; Horikoshi, M; Kawakami, N; Kadota, M; Sasaki, M; Sekiya, Y; Hosogoshi, H; Kashimura, M; Asano, K; Terashima, H; Iwasa, K; Nagasaku, M; Grothaus, LC				Furukawa, Toshi A.; Horikoshi, Masaru; Kawakami, Norito; Kadota, Masayo; Sasaki, Megumi; Sekiya, Yuki; Hosogoshi, Hiroki; Kashimura, Masami; Asano, Kenichi; Terashima, Hitomi; Iwasa, Kazunori; Nagasaku, Minoru; Grothaus, Louis C.		GENKI Project	Telephone Cognitive-Behavioral Therapy for Subthreshold Depression and Presenteeism in Workplace: A Randomized Controlled Trial	PLOS ONE			English	Article							INTERNATIONAL DIAGNOSTIC INTERVIEW; WORLD-HEALTH-ORGANIZATION; MENTAL-HEALTH; MINOR DEPRESSION; PRIMARY-CARE; PSYCHOLOGICAL DISTRESS; SCREENING SCALES; PSYCHOTHERAPY; MANAGEMENT; PERFORMANCE	Background: Subthreshold depression is highly prevalent in the general population and causes great loss to society especially in the form of reduced productivity while at work (presenteeism). We developed a highly-structured manualized eight-session cognitive-behavioral program with a focus on subthreshold depression in the workplace and to be administered via telephone by trained psychotherapists (tCBT). Methods: We conducted a parallel-group, non-blinded randomized controlled trial of tCBT in addition to the pre-existing Employee Assistance Program (EAP) versus EAP alone among workers with subthreshold depression at a large manufacturing company in Japan. The primary outcomes were depression severity as measured with Beck Depression Inventory-II (BDI-II) and presenteeism as measured with World Health Organization Health and Work Productivity Questionnaire (HPQ). In the course of the trial the follow-up period was shortened in order to increase acceptability of the study. Results: The planned sample size was 108 per arm but the trial was stopped early due to low accrual. Altogether 118 subjects were randomized to tCBT+EAP (n = 58) and to EAP alone (n = 60). The BDI-II scores fell from the mean of 17.3 at baseline to 11.0 in the intervention group and to 15.7 in the control group after 4 months (p<0.001, Effect size = 0.69, 95% CI: 0.32 to 1.05). However, there was no statistically significant decrease in absolute and relative presenteeism (p = 0.44, ES = 0.15, -0.21 to 0.52, and p = 0.50, ES = 0.02, -0.34 to 0.39, respectively). Conclusion: Remote CBT, including tCBT, may provide easy access to quality-assured effective psychotherapy for people in the work force who present with subthreshold depression. Further studies are needed to evaluate the effectiveness of this approach in longer terms. The study was funded by Sekisui Chemicals Co. Ltd.	[Horikoshi, Masaru] Natl Ctr Neurol & Psychiat, Kodaira, Tokyo, Japan; [Furukawa, Toshi A.; Kadota, Masayo] Nagoya City Univ, Grad Sch Med Sci, Dept Psychiat & Cognit Behav Med, Nagoya, Aichi, Japan; [Kawakami, Norito] Univ Tokyo, Dept Mental Hlth, Grad Sch Med, Tokyo, Japan; [Sasaki, Megumi] Naruto Univ Educ, Ctr Educ & Res Sci Prevent Educ, Naruto 772, Japan; [Kashimura, Masami; Terashima, Hitomi] Univ Tsukuba, Grad Sch Comprehens Human Sci, Inst Psychol, Tsukuba, Ibaraki, Japan; [Hosogoshi, Hiroki] Kyoto Bunkyo Univ, Fac Clin Psychol, Kyoto, Japan; [Asano, Kenichi] Tokyo Seitoku Univ, Fac Appl Psychol, Tokyo, Japan; [Iwasa, Kazunori] Shujitsu Univ, Fac Educ, Okayama, Japan; [Nagasaku, Minoru] Surugadai Univ, Fac Psychol, Hanno, Japan; [Grothaus, Louis C.] Grp Hlth, Grp Hlth Res Inst, Seattle, WA USA	National Center for Neurology & Psychiatry - Japan; Nagoya City University; University of Tokyo; Naruto University of Education; University of Tsukuba	Furukawa, TA (corresponding author), Kyoto Univ, Grad Sch Med, Dept Hlth Promot & Human Behav, Kyoto, Japan.	furukawa@kuhp.kyoto-u.ac.jp	Furukawa, Toshi A./B-9259-2011	Furukawa, Toshi A./0000-0003-2159-3776; Niwa, Madoka/0000-0003-4284-3885; Iwasa, Kazunori/0000-0001-8908-5335; Sasaki, Megumi/0000-0003-2396-303X; Kashimura, Masami/0000-0002-5894-6881	Sekisui Chemical Co. Ltd.; Astellas; Dai-Nippon Sumitomo; Eli Lilly; GlaxoSmithKline; Janssen; Kyorin; MSD; Meiji; Mochida; Otsuka; Pfizer; Shionogi; Tanabe-Mitsubishi; Eizai	Sekisui Chemical Co. Ltd.; Astellas(Astellas Pharmaceuticals); Dai-Nippon Sumitomo(Dainippon Sumitomo Pharma Co., Ltd.); Eli Lilly(Eli Lilly); GlaxoSmithKline(GlaxoSmithKline); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Kyorin; MSD; Meiji; Mochida; Otsuka(Otsuka Pharmaceutical); Pfizer(Pfizer); Shionogi; Tanabe-Mitsubishi; Eizai	The study was funded by Sekisui Chemical Co. Ltd.. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; TAF has received honoraria for speaking at CME meetings sponsored by Astellas, Dai-Nippon Sumitomo, Eli Lilly, GlaxoSmithKline, Janssen, Kyorin, MSD, Meiji, Mochida, Otsuka, Pfizer, Shionogi, and Tanabe-Mitsubishi. He is on the advisory board for Sekisui Chemicals and Takeda Science Foundation. He has received royalties from Igaku-Shoin, Seiwa-Shoten, Nihon Bunka Kagaku-sha and American Psychiatric Publishing. MH is on the advisory board for Sekisui Chemicals and the Ministry of Justice. He has received royalties from Shogakukan Shueisha Production, Kangokyokai Shuppan and Kongo Shuppan. NK has received honoraria for speaking at CME meetings sponsored by GlaxoSmithKline, Eizai and Pfizer. He is on the advisory board for Sekisui Chemicals and Junpukai Health Care Center. He has received royalties from Chuo-Hoki-Shuppan, Igaku-Shoin, Kyobun-do, Life Science, Maruzen, Nanko-do, Nanzan-do, and Fujitsu Software Technologies, Ltd.. MK, MS, YS, HH, MK, KA, HT, KI, MN and LCG have received honoraria for their managerial or psychotherapeutic works or for statistical advice for the current study by Sekisui Chemicals. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Andrews G, 2001, AUST NZ J PUBL HEAL, V25, P494, DOI 10.1111/j.1467-842X.2001.tb00310.x; Andrews G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013196; [Anonymous], 2008, SAS 9 2; Barbui C, 2011, BRIT J PSYCHIAT, V198, P11, DOI 10.1192/bjp.bp.109.076448; Beck A.T., 1979, COGNITIVE THERAPY EM; Beck A.T., 1996, PSYCHOL ASSESS, V10, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Bee PE, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-60; Churchill R, 2001, HEALTH TECHNOL ASSES, V5, P1, DOI DOI 10.3310/HTA5350; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cuijpers P, 2007, ACTA PSYCHIAT SCAND, V115, P434, DOI 10.1111/j.1600-0447.2007.00998.x; Cuijpers P, 2007, ACTA PSYCHIAT SCAND, V115, P229, DOI 10.1111/j.1600-0447.2006.00851.x; Cuijpers P, 2004, ACTA PSYCHIAT SCAND, V109, P325, DOI 10.1111/j.1600-0447.2004.00301.x; Cuijpers P, 2010, PSYCHOL MED, V40, P211, DOI 10.1017/S0033291709006114; Driessen E, 2010, J CONSULT CLIN PSYCH, V78, P668, DOI 10.1037/a0020570; Fergusson DM, 2005, ARCH GEN PSYCHIAT, V62, P66, DOI 10.1001/archpsyc.62.1.66; Fournier JC, 2010, JAMA-J AM MED ASSOC, V303, P47, DOI 10.1001/jama.2009.1943; Furukawa TA, 2003, PSYCHOL MED, V33, P357, DOI 10.1017/S0033291702006700; Furukawa TA, 2008, INT J METH PSYCH RES, V17, P152, DOI 10.1002/mpr.257; Haro JM, 2006, INT J METH PSYCH RES, V15, P167, DOI 10.1002/mpr.196; Hiroe T, 2005, PSYCHIAT RES, V135, P229, DOI 10.1016/j.psychres.2004.03.014; Kawakami N, 2005, PSYCHIAT CLIN NEUROS, V59, P441, DOI 10.1111/j.1440-1819.2005.01397.x; Kessler RC, 2003, ARCH GEN PSYCHIAT, V60, P184, DOI 10.1001/archpsyc.60.2.184; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Kessler RC, 2004, J OCCUP ENVIRON MED, V46, pS23, DOI 10.1097/01.jom.0000126683.75201.c5; Kessler RC, 2004, INT J METH PSYCH RES, V13, P93, DOI 10.1002/mpr.168; Kessler RC, 2003, J OCCUP ENVIRON MED, V45, P156, DOI 10.1097/01.jom.0000052967.43131.51; Kessler RC, 1997, J AFFECT DISORDERS, V45, P19, DOI 10.1016/S0165-0327(97)00056-6; Lewinsohn PM, 1984, COPING DEPRESSION CO; Ludman EJ, 2007, J CONSULT CLIN PSYCH, V75, P257, DOI 10.1037/0022-006X.75.2.257; Mohr DC, 2005, ARCH GEN PSYCHIAT, V62, P1007, DOI 10.1001/archpsyc.62.9.1007; Oslin DW, 2003, PSYCHOSOM MED, V65, P931, DOI 10.1097/01.PSY.0000097335.35776.FB; Preisig M, 2001, ACTA PSYCHIAT SCAND, V104, P96, DOI 10.1034/j.1600-0447.2001.00284.x; Rapaport MH, 2002, AM J PSYCHIAT, V159, P637, DOI 10.1176/appi.ajp.159.4.637; Richardson KM, 2008, J OCCUP HEALTH PSYCH, V13, P69, DOI 10.1037/1076-8998.13.1.69; ROBINS LN, 1988, ARCH GEN PSYCHIAT, V45, P1069; Rost K, 2004, MED CARE, V42, P1202, DOI 10.1097/00005650-200412000-00007; Rucci P, 2003, J AFFECT DISORDERS, V76, P171, DOI 10.1016/S0165-0327(02)00087-3; Simon G, 2006, CREATING BALANCE STE; Simon GE, 2004, JAMA-J AM MED ASSOC, V292, P935, DOI 10.1001/jama.292.8.935; SPSS Inc, 2009, SPSS WIND VERS 18 0; van der Klink JJL, 2001, AM J PUBLIC HEALTH, V91, P270, DOI 10.2105/AJPH.91.2.270; Wagner HR, 2000, PSYCHOL MED, V30, P1377, DOI 10.1017/S0033291799002998; Wang PS, 2007, JAMA-J AM MED ASSOC, V298, P1401, DOI 10.1001/jama.298.12.1401; Watanabe N, 2007, ACTA PSYCHIAT SCAND, V116, P84, DOI 10.1111/j.1600-0447.2007.01018.x; WELLS KB, 1989, JAMA-J AM MED ASSOC, V262, P914, DOI 10.1001/jama.262.7.914	46	46	48	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e35330	10.1371/journal.pone.0035330	http://dx.doi.org/10.1371/journal.pone.0035330			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TL	22532849	Green Submitted, Green Published, gold			2022-12-27	WOS:000305336200034
J	Fenning, S; Woolcock, R; Haga, K; Iqbal, J; Fox, KA; Murray, SA; Denvir, MA				Fenning, Stephen; Woolcock, Rebecca; Haga, Kristin; Iqbal, Javaid; Fox, Keith A.; Murray, Scott A.; Denvir, Martin A.			Identifying Acute Coronary Syndrome Patients Approaching End-of-Life	PLOS ONE			English	Article							ADVANCED HEART-FAILURE; CARDIAC TROPONIN-T; GRACE RISK SCORE; PALLIATIVE CARE; GLOBAL REGISTRY; HOSPITAL MORTALITY; COMMUNITY; EVENTS; VALIDATION; STATEMENT	Background: Acute coronary syndrome (ACS) is common in patients approaching the end-of-life (EoL), but these patients rarely receive palliative care. We compared the utility of a palliative care prognostic tool (Gold Standards Framework (GSF)) and the Global Registry of Acute Coronary Events (GRACE) score, to help identify patients approaching EoL. Methods and Findings: 172 unselected consecutive patients with confirmed ACS admitted over an eight-week period were assessed using prognostic tools and followed up for 12 months. GSF criteria identified 40 (23%) patients suitable for EoL care while GRACE identified 32 (19%) patients with >= 10% risk of death within 6 months. Patients meeting GSF criteria were older (p = 0.006), had more comorbidities (1.6 +/- 0.7 vs. 1.2 +/- 0.9, p = 0.007), more frequent hospitalisations before (p = 0.001) and after (0.0001) their index admission, and were more likely to die during follow-up (GSF+ 20% vs GSF-7%, p = 0.03). GRACE score was predictive of 12-month mortality (C-statistic 0.75) and this was improved by the addition of previous hospital admissions and previous history of stroke (C-statistic 0.88). Conclusions: This study has highlighted a potentially large number of ACS patients eligible for EoL care. GSF or GRACE could be used in the hospital setting to help identify these patients. GSF identifies ACS patients with more comorbidity and at increased risk of hospital readmission.	[Fenning, Stephen; Woolcock, Rebecca; Haga, Kristin; Fox, Keith A.; Denvir, Martin A.] Royal Infirm Edinburgh NHS Trust, Edinburgh Heart Ctr, Edinburgh, Midlothian, Scotland; [Iqbal, Javaid] Univ Sheffield, Dept Cardiovasc Sci, Sheffield, S Yorkshire, England; [Murray, Scott A.] Univ Edinburgh, Primary Palliat Care Res Grp, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland	Royal Infirmary of Edinburgh; University of Edinburgh; University of Sheffield; University of Edinburgh	Fenning, S (corresponding author), Royal Infirm Edinburgh NHS Trust, Edinburgh Heart Ctr, Edinburgh, Midlothian, Scotland.	mdenvir@staffmail.ed.ac.uk	Denvir, Martin A/ABA-3141-2021; Fox, keith A A/I-3742-2013	Fox, Keith/0000-0002-0140-2752; Iqbal, Javaid/0000-0002-9729-7503; Fenning, Stephen/0000-0001-9297-7393	National Institute for Health Research [CL-2009-04-001] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Abu-Assi E, 2010, AM HEART J, V160, P826, DOI 10.1016/j.ahj.2010.06.053; Al-Hweish A, 2010, HEMODIAL INT, V14, P308, DOI 10.1111/j.1542-4758.2010.00455.x; Barnett M, 2006, Nurs Stand, V21, P41; Boyd K, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4863; Boyd KJ, 2004, EUR J HEART FAIL, V6, P585, DOI 10.1016/j.ejheart.2003.11.018; Chang VT, 1998, CANCER, V83, P173, DOI 10.1002/(SICI)1097-0142(19980701)83:1<173::AID-CNCR23>3.0.CO;2-T; Ekerstad N, 2011, CIRCULATION, V124, P2397, DOI 10.1161/CIRCULATIONAHA.111.025452; Elbarouni B, 2009, AM HEART J, V158, P392, DOI 10.1016/j.ahj.2009.06.010; England & Wales Department of Health, 2008, END LIF CAR STRAT PR; Goodlin SJ, 2004, J CARD FAIL, V10, P200, DOI 10.1016/j.cardfail.2003.09.006; Gurm HS, 2012, AM J CARDIOL, V109, P19, DOI 10.1016/j.amjcard.2011.07.062; Hanratty B, 2002, BRIT MED J, V325, P581, DOI 10.1136/bmj.325.7364.581; Hauptman PJ, 2005, ARCH INTERN MED, V165, P374, DOI 10.1001/archinte.165.4.374; HEDLEY R, 1986, J FAM PRACTICE, V22, P141; Hogg W, 2009, CAN FAM PHYSICIAN, V55, pE76; Hoiseth AD, 2011, THORAX, V66, P775, DOI 10.1136/thx.2010.153122; Hsieh BPC, 2009, AM HEART J, V158, P673, DOI 10.1016/j.ahj.2009.07.021; Jaarsma T, 2009, EUR J HEART FAIL, V11, P433, DOI 10.1093/eurjhf/hfp041; Moores L, 2010, J THROMB HAEMOST, V8, P517, DOI 10.1111/j.1538-7836.2009.03725.x; Murray SA, 2005, BRIT MED J, V330, P611, DOI 10.1136/bmj.330.7492.611; Murray SA, 2002, BRIT MED J, V325, P929, DOI 10.1136/bmj.325.7370.929; Murray SA, 2005, BMJ-BRIT MED J, V330, P1007, DOI 10.1136/bmj.330.7498.1007; National End of Life Care Programme, 2006, GOLD STAND FRAM PROG; NHS Quality Improvement Scotland, 2010, 18 NHS QUAL IMPR SCO, P31; Pieper KS, 2009, AM HEART J, V157, P1097, DOI 10.1016/j.ahj.2009.04.004; Scottish Intercollegiate Guidelines Network, 2007, AC COR SYNDR NAT CLI; Yusufali A, 2011, ANGIOLOGY, V62, P390, DOI 10.1177/0003319710387921	27	19	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35536	10.1371/journal.pone.0035536	http://dx.doi.org/10.1371/journal.pone.0035536			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22530044	Green Published, Green Accepted, gold			2022-12-27	WOS:000305350600096
J	Hanelt, B; Bolek, MG; Schmidt-Rhaesa, A				Hanelt, Ben; Bolek, Matthew G.; Schmidt-Rhaesa, Andreas			Going Solo: Discovery of the First Parthenogenetic Gordiid (Nematomorpha: Gordiida)	PLOS ONE			English	Article							HAIRWORMS NEMATOMORPHA; EVOLUTION; REDESCRIPTION; BIOLOGY; WORM	Despite the severe fitness costs associated with sexual reproduction, its persistence and pervasiveness among multicellular organisms testifies to its intrinsic, short-term advantages. However, the reproductive assurance hypothesis predicts selection favoring asexual reproduction in sparse populations and when mate finding is difficult. Difficulties in finding mates is especially common in parasites, whose life cycles involve multiple hosts, or being released from the host into the external environment where the parasite can find itself trapped without a sexual partner. To solve this problem and guarantee reproduction, parasites in numerous phyla have evolved reproductive strategies, as predicted by the reproductive assurance hypothesis, such as hermaphroditism or parthenogenesis. However, this type of strategy has not been reported from species in the phylum Nematomorpha, whose populations have often been described as sparse. A new Nematomorpha species, Paragordius obamai n.sp., was discovered from Kenya, Africa, and appears to have solved the problem of being trapped without a mate by eliminating the need for males. Paragordius obamai n.sp. represents the first and only known species within this phylum to reproduce asexually. To determine the mechanism of this mating strategy, we ruled out the involvement of reproduction manipulating endosymbionts by use of next generation sequencing data, thus suggesting that parthenogenesis is determined genetically and may have evolved as a means to assure reproduction. Since this new parthenogenetic species and a closely related gonochoristic North American congener, P. varius, are easy to propagate in the laboratory, these gordiids can be used as model systems to test hypotheses on the genetic advantages and disadvantages of asexual reproduction and the genetic determinants of reproductive strategies in parasites.	[Hanelt, Ben] Univ New Mexico, Dept Biol, Ctr Evolutionary & Theoret Immunol, Albuquerque, NM 87131 USA; [Bolek, Matthew G.] Oklahoma State Univ, Dept Zool, Stillwater, OK 74078 USA; [Schmidt-Rhaesa, Andreas] Univ Hamburg, Bioctr Grindel, Zool Museum & Inst, Hamburg, Germany	University of New Mexico; Oklahoma State University System; Oklahoma State University - Stillwater; University of Hamburg	Hanelt, B (corresponding author), Univ New Mexico, Dept Biol, Ctr Evolutionary & Theoret Immunol, Albuquerque, NM 87131 USA.	bhanelt@unm.edu		Hanelt, Ben/0000-0001-9298-7356	National Science Foundation [DEB-0949951, DEB-0950066]; National Institute of Health [AI044913]; National Institutes of Health from the Institute Development Award Program of the National Center for Research Resources [1P20RR18754]; Direct For Biological Sciences [0949951] Funding Source: National Science Foundation; Division Of Environmental Biology [0950066] Funding Source: National Science Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018754] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044913] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health from the Institute Development Award Program of the National Center for Research Resources; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Science Foundation, DEB-0949951 to MG Bolek and DEB-0950066 to B Hanelt and A Schmidt-Rhaesa, and travel was supported by National Institute of Health grant AI044913 to ES Loker. Support was also provided by the UNM Center for Evolutionary and Theoretical Immunology (CETI) and the University of New Mexico Molecular Biology Facility, supported by National Institutes of Health grant 1P20RR18754 from the Institute Development Award Program of the National Center for Research Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bell G, 1982, MASTERPIECE NATURE E; Biron DG, 2006, INSECT MOL BIOL, V15, P731, DOI 10.1111/j.1365-2583.2006.00671.x; Bolek Matthew G., 2010, Zootaxa, V2631, P36; Cordaux R, 2011, TRENDS GENET, V27, P332, DOI 10.1016/j.tig.2011.05.002; de Villalobos C, 2000, P ACAD NAT SCI PHILA, V150, P135; de Villalobos LC, 2001, CONTRIB ZOOL, V70, P73, DOI 10.1163/18759866-07002002; Dowd SE, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-93; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Duron O, 2007, CURR MICROBIOL, V55, P193, DOI 10.1007/s00284-006-0578-4; FELSENSTEIN J, 1974, GENETICS, V78, P737; Ghosh A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022451; Gontcharova Viktoria, 2010, Open Microbiol J, V4, P47, DOI 10.2174/1874285801004010047; Hanelt B, 2009, PARASITOLOGY, V136, P211, DOI 10.1017/S0031182008005337; Hanelt B, 2005, ADV PARASIT, V59, P243, DOI 10.1016/S0065-308X(05)59004-3; Hanelt B, 2003, INVERTEBR BIOL, V122, P12, DOI 10.1111/j.1744-7410.2003.tb00068.x; Hanelt B, 2004, J NAT HIST, V38, P939, DOI 10.1080/0022293021000058718; Hanelt B, 2002, J PARASITOL, V88, P557, DOI 10.1645/0022-3395(2002)088[0557:MAONCO]2.0.CO;2; Hanelt B, 2001, J PARASITOL, V87, P1049, DOI 10.1645/0022-3395(2001)087[1049:PSASOF]2.0.CO;2; Hudson AJ, 2009, J PARASITOL, V95, P1545, DOI 10.1645/GE-2145.1; Inoue I., 1959, Annotationes Zoologicae Japonenses, V32, P209; JAIN SK, 1976, ANNU REV ECOL SYST, V7, P469, DOI 10.1146/annurev.es.07.110176.002345; Kirjanova E. S., 1959, Zoologicheskii Zhurnal, V38, P509; Koivisto RKK, 2003, BIOL J LINN SOC, V79, P43, DOI 10.1046/j.1095-8312.2003.00185.x; KONDRASHOV AS, 1988, NATURE, V336, P435, DOI 10.1038/336435a0; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Lloyd DG, 1980, DEMOGRAPHY EVOLUTION; Looney C, 2012, J PARASITOL IN PRESS; Maynard Smith J., 1971, GROUP SELECTION, P163; Middelbos IS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009768; Montgomery Jr TH, 1903, ZOOL JB ANAT ONTOG, V18, P387; POULIN R, 1995, J PARASITOL, V81, P121, DOI 10.2307/3284023; PRICE PW, 1977, EVOLUTION, V31, P405, DOI [10.2307/2407761, 10.1111/j.1558-5646.1977.tb01021.x]; Pritchard MH, 1982, COLLECTION PRESERVAT; RAJARAM B, 1975, ACTA HISTOCHEM, V54, P257; Schmidt-Rhaesa A, 2005, ZOOMORPHOLOGY, V124, P33, DOI 10.1007/s00435-005-0109-z; Schmidt-Rhaesa A, 2003, P ACAD NAT SCI PHILA, V153, P77, DOI 10.1635/0097-3157(2003)153[0077:RACONF]2.0.CO;2; Schmidt-Rhaesa A., 1997, SUSSWASSERFAUNA MITT, P1; Schmidt-Rhaesa Andreas, 2008, Verhandlungen des Naturwissenschaftlichen Vereins in Hamburg, P37; Schmidt-Thaesa Andreas, 2010, Zootaxa, V2533, P1; Sciacchitano I., 1964, Annali Mus Stor nat Giacomo Doria, V73, P272; SMITH JM, 1978, EVOLUTION SEX; Suomalainen E, 1987, CYTOLOGY EVOLUTION P; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thomas F, 2002, J EVOLUTION BIOL, V15, P356, DOI 10.1046/j.1420-9101.2002.00410.x; THORNE GERALD, 1940, JOUR WASHINGTON ACAD SCI, V30, P219; von Linstow O, 1906, MITT ZOOL MUS BERLIN, V3, P241	47	22	22	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e34472	10.1371/journal.pone.0034472	http://dx.doi.org/10.1371/journal.pone.0034472			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529916	Green Published, gold			2022-12-27	WOS:000305350600015
J	Haroon, F; Handel, U; Angenstein, F; Goldschmidt, J; Kreutzmann, P; Lison, H; Fischer, KD; Scheich, H; Wetzel, W; Schluter, D; Budinger, E				Haroon, Fahad; Haendel, Ulrike; Angenstein, Frank; Goldschmidt, Juergen; Kreutzmann, Peter; Lison, Holger; Fischer, Klaus-Dieter; Scheich, Henning; Wetzel, Wolfram; Schlueter, Dirk; Budinger, Eike			Toxoplasma gondii Actively Inhibits Neuronal Function in Chronically Infected Mice	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; CRYPTOGENIC EPILEPSY; HOST-CELLS; BEHAVIOR; SEROPOSITIVITY; MODULATION; PERSISTENT; PROTEIN; GRA3	Upon infection with the obligate intracellular parasite Toxoplasma gondii, fast replicating tachyzoites infect a broad spectrum of host cells including neurons. Under the pressure of the immune response, tachyzoites convert into slow-replicating bradyzoites, which persist as cysts in neurons. Currently, it is unclear whether T. gondii alters the functional activity of neurons, which may contribute to altered behaviour of T. gondii-infected mice and men. In the present study we demonstrate that upon oral infection with T. gondii cysts, chronically infected BALB/c mice lost over time their natural fear against cat urine which was paralleled by the persistence of the parasite in brain regions affecting behaviour and odor perception. Detailed immunohistochemistry showed that in infected neurons not only parasitic cysts but also the host cell cytoplasm and some axons stained positive for Toxoplasma antigen suggesting that parasitic proteins might directly interfere with neuronal function. In fact, in vitro live cell calcium (Ca2+) imaging studies revealed that tachyzoites actively manipulated Ca2+ signalling upon glutamate stimulation leading either to hyper- or hypo-responsive neurons. Experiments with the endoplasmatic reticulum Ca2+ uptake inhibitor thapsigargin indicate that tachyzoites deplete Ca2+ stores in the endoplasmatic reticulum. Furthermore in vivo studies revealed that the activity-dependent uptake of the potassium analogue thallium was reduced in cyst harbouring neurons indicating their functional impairment. The percentage of nonfunctional neurons increased over time In conclusion, both bradyzoites and tachyzoites functionally silence infected neurons, which may significantly contribute to the altered behaviour of the host.	[Haroon, Fahad; Haendel, Ulrike; Schlueter, Dirk] Otto Von Guericke Univ, Inst Med Mikrobiol, Magdeburg, Germany; [Angenstein, Frank] Leibniz Inst Neurobiol, Speziallab Nichtinvas Bildgebung, Magdeburg, Germany; [Goldschmidt, Juergen; Lison, Holger; Scheich, Henning; Budinger, Eike] Leibniz Inst Neurobiol, Abt Akust Lernen & Sprache, Magdeburg, Germany; [Kreutzmann, Peter; Fischer, Klaus-Dieter] Otto Von Guericke Univ, Inst Biochem & Zellbiol, Magdeburg, Germany; [Wetzel, Wolfram] Leibniz Inst Neurobiol, Speziallab Verhaltenspharmakol, Magdeburg, Germany	Otto von Guericke University; University of Hamburg; University Medical Center Hamburg-Eppendorf; Leibniz Institut fur Neurobiologie (LIN); Leibniz Institut fur Neurobiologie (LIN); Otto von Guericke University; Leibniz Institut fur Neurobiologie (LIN)	Haroon, F (corresponding author), Otto Von Guericke Univ, Inst Med Mikrobiol, Magdeburg, Germany.	dirk.schlueter@med.ovgu.de		Budinger, Eike/0000-0003-2420-8159	Deutsche Forschungsgemeinschaft [SCHL 392/7-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (grant SCHL 392/7-1, http://www.dfg.de/index.jsp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akyol A, 2007, SEIZURE-EUR J EPILEP, V16, P233, DOI 10.1016/j.seizure.2006.12.008; Badea A, 2007, NEUROIMAGE, V37, P683, DOI 10.1016/j.neuroimage.2007.05.046; Fendt M, 2006, J CHEM ECOL, V32, P2617, DOI 10.1007/s10886-006-9186-9; FERGUSON DJP, 1987, PARASITOL RES, V73, P483, DOI 10.1007/BF00535321; FERGUSON DJP, 1989, PARASITOL RES, V75, P599, DOI 10.1007/BF00930955; Gail M, 2001, MOL GENET GENOMICS, V265, P905, DOI 10.1007/s004380100487; Gieseler A, 2009, BIOCHEM PHARMACOL, V77, P888, DOI 10.1016/j.bcp.2008.11.003; Gilbert LA, 2007, EUKARYOT CELL, V6, P73, DOI 10.1128/EC.00309-06; Goldschmidt J, 2004, NEUROIMAGE, V23, P638, DOI 10.1016/j.neuroimage.2004.05.023; Goldschmidt J, 2010, NEUROIMAGE, V49, P303, DOI 10.1016/j.neuroimage.2009.08.012; Henriquez FL, 2005, PARASITOLOGY, V131, P169, DOI 10.1017/S0031182005007559; Henriquez SA, 2009, NEUROIMMUNOMODULAT, V16, P122, DOI 10.1159/000180267; Hermes G, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-48; Hinze-Selch D, 2010, FOLIA PARASIT, V57, P129, DOI 10.14411/fp.2010.016; Kijlstra A, 2008, INT J PARASITOL, V38, P1359, DOI 10.1016/j.ijpara.2008.06.002; Kim JY, 2008, KOREAN J PARASITOL, V46, P209, DOI 10.3347/kjp.2008.46.4.209; Luder CGK, 2005, CURR TOP MICROBIOL, V289, P219; Palmer BS, 2007, SEIZURE-EUR J EPILEP, V16, P657, DOI 10.1016/j.seizure.2007.05.010; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Prandota J, 2009, INT J NEUROSCI, V119, P2144, DOI 10.3109/00207450903149217; Ravindran S, 2008, TRAFFIC, V9, P647, DOI 10.1111/j.1600-0854.2008.00723.x; Schluter D, 2002, J IMMUNOL, V169, P315, DOI 10.4049/jimmunol.169.1.315; Schwarcz R, 2007, SCHIZOPHRENIA BULL, V33, P652, DOI 10.1093/schbul/sbm030; Stommel EW, 2001, EPILEPSIA, V42, P436, DOI 10.1046/j.1528-1157.2001.25500.x; Vyas A, 2007, NEUROSCIENCE, V148, P342, DOI 10.1016/j.neuroscience.2007.06.021; Vyas A, 2007, P NATL ACAD SCI USA, V104, P6442, DOI 10.1073/pnas.0608310104; Webster JP, 2010, FOLIA PARASIT, V57, P95, DOI 10.14411/fp.2010.012; Xie CS, 2000, FREE RADICAL BIO MED, V28, P665, DOI 10.1016/S0891-5849(99)00268-3; Yolken RH, 2008, MOL PSYCHIATR, V13, P470, DOI 10.1038/mp.2008.5; Zhang YW, 2001, INFECT IMMUN, V69, P501, DOI 10.1128/IAI.69.1.501-507.2001	30	62	69	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35516	10.1371/journal.pone.0035516	http://dx.doi.org/10.1371/journal.pone.0035516			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22530040	gold, Green Published, Green Submitted			2022-12-27	WOS:000305350600093
J	Hospodsky, D; Qian, J; Nazaroff, WW; Yamamoto, N; Bibby, K; Rismani-Yazdi, H; Peccia, J				Hospodsky, Denina; Qian, Jing; Nazaroff, William W.; Yamamoto, Naomichi; Bibby, Kyle; Rismani-Yazdi, Hamid; Peccia, Jordan			Human Occupancy as a Source of Indoor Airborne Bacteria	PLOS ONE			English	Article							RIBOSOMAL-RNA GENE; RESIDENTIAL INDOOR; PARTICULATE MATTER; DIVERSITY; COMMUNITY; EXPOSURE; PARTICLES; TIME; RESUSPENSION; FRAGMENTS	Exposure to specific airborne bacteria indoors is linked to infectious and noninfectious adverse health outcomes. However, the sources and origins of bacteria suspended in indoor air are not well understood. This study presents evidence for elevated concentrations of indoor airborne bacteria due to human occupancy, and investigates the sources of these bacteria. Samples were collected in a university classroom while occupied and when vacant. The total particle mass concentration, bacterial genome concentration, and bacterial phylogenetic populations were characterized in indoor, outdoor, and ventilation duct supply air, as well as in the dust of ventilation system filters and in floor dust. Occupancy increased the total aerosol mass and bacterial genome concentration in indoor air PM10 and PM2.5 size fractions, with an increase of nearly two orders of magnitude in airborne bacterial genome concentration in PM10. On a per mass basis, floor dust was enriched in bacterial genomes compared to airborne particles. Quantitative comparisons between bacterial populations in indoor air and potential sources suggest that resuspended floor dust is an important contributor to bacterial aerosol populations during occupancy. Experiments that controlled for resuspension from the floor implies that direct human shedding may also significantly impact the concentration of indoor airborne particles. The high content of bacteria specific to the skin, nostrils, and hair of humans found in indoor air and in floor dust indicates that floors are an important reservoir of human-associated bacteria, and that the direct particle shedding of desquamated skin cells and their subsequent resuspension strongly influenced the airborne bacteria population structure in this human-occupied environment. Inhalation exposure to microbes shed by other current or previous human occupants may occur in communal indoor environments.	[Hospodsky, Denina; Qian, Jing; Yamamoto, Naomichi; Bibby, Kyle; Rismani-Yazdi, Hamid; Peccia, Jordan] Yale Univ, Dept Chem & Environm Engn, New Haven, CT 06520 USA; [Nazaroff, William W.] Univ Calif Berkeley, Dept Civil & Environm Engn, Berkeley, CA 94720 USA; [Yamamoto, Naomichi] Japan Soc Promot Sci, Chiyoda Ku, Tokyo, Japan	Yale University; University of California System; University of California Berkeley; Japan Society for the Promotion of Science	Hospodsky, D (corresponding author), Yale Univ, Dept Chem & Environm Engn, New Haven, CT 06520 USA.	Jordan.peccia@yale.edu	Nazaroff, William W/C-4106-2008; Yamamoto, Naomichi/D-4099-2014; Nazaroff, William/AAJ-7352-2021; Bibby, Kyle J/C-6189-2018	Nazaroff, William W/0000-0001-5645-3357; Yamamoto, Naomichi/0000-0002-5969-5500; Nazaroff, William/0000-0001-5645-3357; Bibby, Kyle J/0000-0003-3142-6090; Qian, Jing/0000-0002-9666-210X	Alfred P. Sloan Foundation "Microbiology for the Built Environment Program''	Alfred P. Sloan Foundation "Microbiology for the Built Environment Program''	The research was funded by the Alfred P. Sloan Foundation "Microbiology for the Built Environment Program''. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Bibby K, 2010, WATER RES, V44, P4252, DOI 10.1016/j.watres.2010.05.039; Boreson J, 2004, ATMOSPHERIC ENV; Bowers RM, 2011, ISME J, V5, P601, DOI 10.1038/ismej.2010.167; Bowers RM, 2009, APPL ENVIRON MICROB, V75, P5121, DOI 10.1128/AEM.00447-09; Brasche S, 2005, INT J HYG ENVIR HEAL, V208, P247, DOI 10.1016/j.ijheh.2005.03.003; Brodie EL, 2007, P NATL ACAD SCI USA, V104, P299, DOI 10.1073/pnas.0608255104; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cephas KD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023503; Chen Q, 2009, ENVIRON SCI TECHNOL, V43, P4641, DOI 10.1021/es802296j; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Douwes J, 2003, ANN OCCUP HYG, V47, P187, DOI 10.1093/annhyg/meg032; Falkinham JO, 2009, J APPL MICROBIOL, V107, P356, DOI 10.1111/j.1365-2672.2009.04161.x; Ferro AR, 2004, ENVIRON SCI TECHNOL, V38, P1759, DOI 10.1021/es0263893; Fields BS, 2002, CLIN MICROBIOL REV, V15, P506, DOI 10.1128/CMR.15.3.506-526.2002; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; Fox A, 2005, J ENVIRON MONITOR, V7, P450, DOI 10.1039/b418038k; Fox K, 2010, J ENVIRON MONITOR, V12, P917, DOI 10.1039/b925250a; Frank DN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010598; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Ilic B, 2001, J VAC SCI TECHNOL B, V19, P2825, DOI 10.1116/1.1421572; Johnson GR, 2009, J AEROSOL MED PULM D, V22, P229, DOI 10.1089/jamp.2008.0720; Klepeis NE, 2001, J EXPO ANAL ENV EPID, V11, P231, DOI 10.1038/sj.jea.7500165; Koistinen KJ, 2004, SCAND J WORK ENV HEA, V30, P36; Kopperud RJ, 2004, J AIR WASTE MANAGE, V54, P1188, DOI 10.1080/10473289.2004.10470983; Lamoth F, 2010, FEMS MICROBIOL REV, V34, P260, DOI 10.1111/j.1574-6976.2009.00207.x; Lazarev V. N., 2010, Biotekhnologiya, P11; Leaderer BP, 2002, ENVIRON HEALTH PERSP, V110, P419, DOI 10.1289/ehp.02110419; Lee ZMP, 2009, NUCLEIC ACIDS RES, V37, pD489, DOI 10.1093/nar/gkn689; LEYDEN JJ, 1987, J INVEST DERMATOL, V88, pS65, DOI 10.1111/1523-1747.ep12468965; Li Y, 2007, INDOOR AIR, V17, P2, DOI 10.1111/j.1600-0668.2006.00445.x; Lighthart B, 1997, FEMS MICROBIOL ECOL, V23, P263, DOI 10.1016/S0168-6496(97)00036-6; Liu ZZ, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm541; MACKINTOSH CA, 1978, J HYG-CAMBRIDGE, V81, P471, DOI 10.1017/S0022172400025341; Milstone LM, 2004, J DERMATOL SCI, V36, P131, DOI 10.1016/j.jdermsci.2004.05.004; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; Nasidze I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023352; Nasidze I, 2009, GENOME RES, V19, P636, DOI 10.1101/gr.084616.108; National Research Council, 1998, COMM RES PRIOR AIRB; Nicas M, 2005, J OCCUP ENVIRON HYG, V2, P143, DOI 10.1080/15459620590918466; NOBLE WC, 1976, J MED MICROBIOL, V9, P53, DOI 10.1099/00222615-9-1-53; Ozkaynak H, 1996, J EXPO ANAL ENV EPID, V6, P57; Peccia J, 2008, ENVIRON SCI TECHNOL, V42, P4631; Qian J, 2012, INDOOR AIR, V22, P339, DOI 10.1111/j.1600-0668.2012.00769.x; Qian J, 2008, J AIR WASTE MANAGE, V58, P502, DOI 10.3155/1047-3289.58.4.502; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Rintala H, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-56; ROTH RR, 1988, ANNU REV MICROBIOL, V42, P441, DOI 10.1146/annurev.mi.42.100188.002301; Scheff P A, 2000, Appl Occup Environ Hyg, V15, P835; Taubel M, 2009, J ALLERGY CLIN IMMUN, V124, P834, DOI 10.1016/j.jaci.2009.07.045; THATCHER TL, 1995, ATMOS ENVIRON, V29, P1487, DOI 10.1016/1352-2310(95)00016-R; Viau E, 2010, ENVIRON SCI TECHNOL, V44, P3142, DOI 10.1021/es902943w; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Xie XJ, 2009, J R SOC INTERFACE, V6, pS703, DOI 10.1098/rsif.2009.0388.focus; Yang W, 2011, J EXPO SCI ENV EPID, V21, P310, DOI 10.1038/jes.2010.23; Zaura E, 2009, BMC MICROBIOL, V9; Zhang HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006108	59	314	322	10	187	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e34867	10.1371/journal.pone.0034867	http://dx.doi.org/10.1371/journal.pone.0034867			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529946	Green Published, gold			2022-12-27	WOS:000305350600034
J	Middelberg, RPS; Heath, AC; Madden, PAF; Montgomery, GW; Martin, NG; Whitfield, JB				Middelberg, Rita P. S.; Heath, Andrew C.; Madden, Pamela A. F.; Montgomery, Grant W.; Martin, Nicholas G.; Whitfield, John B.			Evidence of Differential Allelic Effects between Adolescents and Adults for Plasma High-Density Lipoprotein	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; LIPID-LEVELS; POPULATION; LOCI; CHILDREN; TWINS; RISK	A recent meta-analysis of genome-wide association (GWA) studies identified 95 loci that influence lipid traits in the adult population and found that collectively these explained about 25-30% of heritability for each trait. Little is known about how these loci affect lipid levels in early life, but there is evidence that genetic effects on HDL- and LDL-cholesterol (HDL-C, LDLC) and triglycerides vary with age. We studied Australian adults (N = 10,151) and adolescents (N = 2,363) who participated in twin and family studies and for whom we have lipid phenotypes and genotype information for 91 of the 95 genetic variants. Heterogeneity tests between effect sizes in adult and adolescent cohorts showed an excess of heterogeneity for HDL-C (p(Het)<0.05 at 5 out of 37 loci), but no more than expected by chance for LDL-C (1 out of 14 loci), or trigycerides (0 out 24). There were 2 (out of 5) with opposite direction of effect in adolescents compared to adults for HDL-C, but none for LDL-C. The biggest difference in effect size was for LDL-C at rs6511720 near LDLR, adolescents (0.021 +/- 0.033 mmol/L) and adults (0.157 +/- 0.023 mmol/L), p(Het) = 0.013; followed by ZNF664 (p(Het) = 0.018) and PABPC4 (p(Het) = 0.034) for HDL-C. Our findings suggest that some of the previously identified variants associate differently with lipid traits in adolescents compared to adults, either because of developmental changes or because of greater interactions with environmental differences in adults.	[Middelberg, Rita P. S.; Montgomery, Grant W.; Martin, Nicholas G.; Whitfield, John B.] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Middelberg, Rita P. S.] Prince Charles Hosp, Dept Med, Brisbane, Qld, Australia; [Heath, Andrew C.; Madden, Pamela A. F.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Heath, Andrew C.; Madden, Pamela A. F.] Midwest Alcoholism Res Ctr, St Louis, MO USA	QIMR Berghofer Medical Research Institute; Prince Charles Hospital; Washington University (WUSTL)	Middelberg, RPS (corresponding author), Queensland Inst Med Res, Brisbane, Qld 4006, Australia.	ritaM@qimr.edu.au	Montgomery, Grant W/B-7148-2008; Martin, Nicholas/R-9235-2019	Montgomery, Grant W/0000-0002-4140-8139; Martin, Nicholas/0000-0003-4069-8020; Whitfield, John/0000-0002-1103-0876	National Health and Medical Research Council [241944, 389875]; NIH [AA07535, AA13320, AA13321, AA14041, AA11998, AA17688, DA012854, DA019951]; Wellcome Trust [WT084766/Z/08/Z]; NHMRC [619667, 611512]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P50AA011998, R01AA014041, R01AA007535, P60AA011998, R01AA013321, R01AA013320, K05AA017688] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R56DA012854, R01DA012854, K08DA019951] Funding Source: NIH RePORTER	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Financial support was provided by the National Health and Medical Research Council (http://www.nhmrc.gov.au)(241944, 389875), NIH (http://www.nih.gov/)(AA07535, AA13320, AA13321, AA14041, AA11998, AA17688, DA012854, DA019951), and Wellcome Trust for funding (WT084766/Z/08/Z). GWM was supported by a NHMRC Fellowship (619667), and RPSM was supported by a NHMRC Training Fellowship (611512). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; Azizi F, 2001, EUR J EPIDEMIOL, V17, P281, DOI 10.1023/A:1017932212350; BERENSON GS, 1981, AM J EPIDEMIOL, V113, P157, DOI 10.1093/oxfordjournals.aje.a113080; CARR AB, 1981, CLIN CHEM, V27, P1469; Heath AC, 2011, BIOL PSYCHIAT, V70, P513, DOI 10.1016/j.biopsych.2011.02.028; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; LEMAY A, 1991, CLIN ENDOCRINOL, V35, P305, DOI 10.1111/j.1365-2265.1991.tb03541.x; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; MARTIN NG, 1985, BEHAV GENET, V15, P93, DOI 10.1007/BF01065891; McGregor B, 1999, GENET EPIDEMIOL, V16, P40, DOI 10.1002/(SICI)1098-2272(1999)16:1<40::AID-GEPI4>3.3.CO;2-T; Medland SE, 2009, AM J HUM GENET, V85, P750, DOI 10.1016/j.ajhg.2009.10.009; Middelberg RP, 2006, TWIN RES HUM GENET, V9, P550, DOI 10.1375/twin.9.4.550; Middelberg RPS, 2007, TWIN RES HUM GENET, V10, P127, DOI 10.1375/twin.10.1.127; Nance W E, 1998, Twin Res, V1, P3, DOI 10.1375/twin.1.1.3; Painter JN, 2011, NAT GENET, V43, P51, DOI 10.1038/ng.731; Smith EN, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001094; Snieder H, 1997, AM J HUM GENET, V60, P638; *STATACORP, 1997, STAT STAT SOFTW REL; Sullivan PF, 2009, MOL PSYCHIATR, V14, P359, DOI 10.1038/mp.2008.125; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Whitfield JB, 1998, ALCOHOL CLIN EXP RES, V22, P1463; WHITFIELD JB, 1983, ATHEROSCLEROSIS, V48, P265, DOI 10.1016/0021-9150(83)90044-8; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Wright M, 2001, Twin Res, V4, P48, DOI 10.1375/1369052012146; Wright MJ, 2004, AUST J PSYCHOL, V56, P65, DOI 10.1080/00049530410001734865; Zhu G, 1999, AM J HUM GENET, V65, P483, DOI 10.1086/302494	28	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35605	10.1371/journal.pone.0035605	http://dx.doi.org/10.1371/journal.pone.0035605			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22530058	Green Published, Green Submitted, gold			2022-12-27	WOS:000305350600104
J	Mima, Y; Fukumoto, S; Koyama, H; Okada, M; Tanaka, S; Shoji, T; Emoto, M; Furuzono, T; Nishizawa, Y; Inaba, M				Mima, Yohei; Fukumoto, Shinya; Koyama, Hidenori; Okada, Masahiro; Tanaka, Shinji; Shoji, Tetsuo; Emoto, Masanori; Furuzono, Tsutomu; Nishizawa, Yoshiki; Inaba, Masaaki			Enhancement of Cell-Based Therapeutic Angiogenesis Using a Novel Type of Injectable Scaffolds of Hydroxyapatite-Polymer Nanocomposite Microspheres	PLOS ONE			English	Article							ASSEMBLING PEPTIDE NANOFIBERS; MARROW MONONUCLEAR-CELLS; MYOCARDIAL-INFARCTION; INTERNAL-FIXATION; PROGENITOR CELLS; TRANSPLANTATION; TISSUE; IMPLANTATION; GROWTH; BIOCOMPATIBILITY	Background: Clinical trials demonstrate the effectiveness of cell-based therapeutic angiogenesis in patients with severe ischemic diseases; however, their success remains limited. Maintaining transplanted cells in place are expected to augment the cell-based therapeutic angiogenesis. We have reported that nano-hydroxyapatite (HAp) coating on medical devices shows marked cell adhesiveness. Using this nanotechnology, HAp-coated poly(L-lactic acid) (PLLA) microspheres, named nano-scaffold (NS), were generated as a non-biological, biodegradable and injectable cell scaffold. We investigate the effectiveness of NS on cell-based therapeutic angiogenesis. Methods and Results: Bone marrow mononuclear cells (BMNC) and NS or control PLLA microspheres (LA) were intramuscularly co-implanted into mice ischemic hindlimbs. When BMNC derived from enhanced green fluorescent protein (EGFP)-transgenic mice were injected into ischemic muscle, the muscle GFP level in NS+BMNC group was approximate fivefold higher than that in BMNC or LA+BMNC groups seven days after operation. Kaplan-Meier analysis demonstrated that NS+BMNC markedly prevented hindlimb necrosis (P < 0.05 vs. BMNC or LA+BMNC). NS+BMNC revealed much higher induction of angiogenesis in ischemic tissues and collateral blood flow confirmed by three-dimensional computed tomography angiography than those of BMNC or LA+BMNC groups. NS-enhanced therapeutic angiogenesis and arteriogenesis showed good correlations with increased intramuscular levels of vascular endothelial growth factor and fibroblast growth factor-2. NS co-implantation also prevented apoptotic cell death of transplanted cells, resulting in prolonged cell retention. Conclusion: A novel and feasible injectable cell scaffold potentiates cell-based therapeutic angiogenesis, which could be extremely useful for the treatment of severe ischemic disorders.	[Mima, Yohei; Fukumoto, Shinya; Koyama, Hidenori; Tanaka, Shinji; Shoji, Tetsuo; Emoto, Masanori; Furuzono, Tsutomu; Nishizawa, Yoshiki; Inaba, Masaaki] Osaka City Univ, Grad Sch Med, Dept Metab Endocrinol & Mol Med, Osaka 558, Japan; [Furuzono, Tsutomu] Kinki Univ, Sch Biol Oriented Sci & Technol, Dept Biomed Engn, Wakayama, Japan	Osaka Metropolitan University; Kindai University (Kinki University)	Mima, Y (corresponding author), Osaka City Univ, Grad Sch Med, Dept Metab Endocrinol & Mol Med, Osaka 558, Japan.	sfukumoto@med.osaka-cu.ac.jp	Koyama, Hidenori/AAU-2346-2020	Koyama, Hidenori/0000-0001-7930-2228; Okada, Masahiro/0000-0001-9441-3284	Ministry of Education, Culture, Sports, Science and Technology, Japan [20592102]; R&D of Nano-devices for Practical Utilization of Nanotechnology of the New Energy and Industrial Technology Development Organization (NEDO), Japan [08007436-0, 10000354-0]; Japan Science and Technology Agency (JST) [AS2314097F]; Grants-in-Aid for Scientific Research [23591329] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); R&D of Nano-devices for Practical Utilization of Nanotechnology of the New Energy and Industrial Technology Development Organization (NEDO), Japan(New Energy and Industrial Technology Development Organization (NEDO)); Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by a Grant-in-Aid for Scientific Research (20592102 to S. F.) from the Ministry of Education, Culture, Sports, Science and Technology, Japan. This study was also supported in part by the R&D of Nano-devices for Practical Utilization of Nanotechnology of the New Energy and Industrial Technology Development Organization (NEDO), Japan (08007436-0 to S. F. and 10000354-0 to T. F.), and Adaptable and Seamless Technology transfer Program through target-driven R&D (A-STEP) by Japan Science and Technology Agency (JST) (AS2314097F to S. F.). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott JD, 2004, CIRCULATION, V110, P3300, DOI 10.1161/01.CIR.0000147780.30124.CF; Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004; Aoki, 1994, MED APPL HYDROXYAPAT; Aranguren XL, 2009, J MOL MED, V87, P3, DOI 10.1007/s00109-008-0394-3; Athanasiou KA, 1996, BIOMATERIALS, V17, P93, DOI 10.1016/0142-9612(96)85754-1; Awad O, 2006, ARTERIOSCL THROM VAS, V26, P758, DOI 10.1161/01.ATV.0000203513.29227.6f; Bostman O, 2000, BIOMATERIALS, V21, P2615, DOI 10.1016/S0142-9612(00)00129-0; Brenner W, 2004, J NUCL MED, V45, P512; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Cheng AS, 2008, SEMIN THORAC CARDIOV, V20, P94, DOI 10.1053/j.semtcvs.2008.04.003; Cho HJ, 2007, J EXP MED, V204, P3257, DOI 10.1084/jem.20070166; Clausen BH, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-46; Couffinhal T, 1998, AM J PATHOL, V152, P1667; Davis ME, 2005, CIRCULATION, V111, P442, DOI 10.1161/01.CIR.0000153847.47301.80; Dubois G, 2008, J BIOMED MATER RES B, V87B, P222, DOI 10.1002/jbm.b.31099; Fujii S, 2009, LANGMUIR, V25, P9759, DOI 10.1021/la901100z; Furuzono T, 2006, ASAIO J, V52, P315, DOI 10.1097/01.mat.0000214860.08820.f9; Furuzono T, 2004, J MATER SCI-MATER M, V15, P19, DOI 10.1023/B:JMSM.0000010093.39298.5a; Furuzono T, 2009, J BIOMED MATER RES B, V89B, P77, DOI 10.1002/jbm.b.31189; Hiasa K, 2004, CIRCULATION, V109, P2454, DOI 10.1161/01.CIR.0000128213.96779.61; Hile DD, 2004, J BIOMED MATER RES B, V71B, P201, DOI 10.1002/jbm.b.30091; Iba O, 2002, CIRCULATION, V106, P2019, DOI 10.1161/01.CIR.0000031332.45480.79; Ignatius AA, 1996, BIOMATERIALS, V17, P831, DOI 10.1016/0142-9612(96)81421-9; Kadono H, 2010, ASAIO J, V56, P61, DOI 10.1097/MAT.0b013e3181c945ae; Kajiguchi M, 2007, CIRC J, V71, P196, DOI 10.1253/circj.71.196; Kamihata H, 2001, CIRCULATION, V104, P1046, DOI 10.1161/hc3501.093817; Kondo K, 2009, ARTERIOSCL THROM VAS, V29, P61, DOI 10.1161/ATVBAHA.108.166496; Korf-Klingebiel M, 2008, EUR HEART J, V29, P2851, DOI 10.1093/eurheartj/ehn456; LEHTO M, 1985, J BONE JOINT SURG BR, V67, P820, DOI 10.1302/0301-620X.67B5.3902851; Malafaya PB, 2007, ADV DRUG DELIVER REV, V59, P207, DOI 10.1016/j.addr.2007.03.012; Matoba S, 2008, AM HEART J, V156, P1010, DOI 10.1016/j.ahj.2008.06.025; Nakagawa M, 2006, J BIOMED MATER RES A, V77A, P112, DOI 10.1002/jbm.a.30521; Narmoneva DA, 2005, BIOMATERIALS, V26, P4837, DOI 10.1016/j.biomaterials.2005.01.005; Okada M, 2007, J NANOPART RES, V9, P807, DOI 10.1007/s11051-006-9126-1; Okada M, 2010, MATER SCI ENG B-ADV, V173, P199, DOI 10.1016/j.mseb.2009.12.009; Phelps EA, 2009, REGEN MED, V4, P65, DOI 10.2217/17460751.4.1.65; Qin S, 2008, CIRC J, V72, P2075, DOI 10.1253/circj.CJ-08-0392; Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039; SCHAKENRAAD JM, 1990, J BIOMED MATER RES, V24, P529, DOI 10.1002/jbm.820240502; Schioppa T, 2003, J EXP MED, V198, P1391, DOI 10.1084/jem.20030267; Shoji T, 2006, DIABETES, V55, P2245, DOI 10.2337/db05-1375; Sieveking DP, 2009, VASC MED, V14, P153, DOI 10.1177/1358863X08098698; Sung HJ, 2004, BIOMATERIALS, V25, P5735, DOI 10.1016/j.biomaterials.2004.01.066; Suuronen EJ, 2006, CIRCULATION, V114, pI138, DOI 10.1161/CIRCULATIONAHA.105.001081; Takahashi M, 2010, CIRC J, V74, P418, DOI 10.1253/circj.CJ-09-1021; Takahashi M, 2006, AM J PHYSIOL-HEART C, V291, pH886, DOI 10.1152/ajpheart.00142.2006; Tang YL, 2009, CIRC RES, V104, P1209, DOI 10.1161/CIRCRESAHA.109.197723; Tateno K, 2006, CIRC RES, V98, P1194, DOI 10.1161/01.RES.0000219901.13974.15; Toma C, 2002, CIRCULATION, V105, P93, DOI 10.1161/hc0102.101442; van Weel V, 2008, ANN VASC SURG, V22, P582, DOI 10.1016/j.avsg.2008.02.017; WILLIAMS DF, 1977, J BIOENG, V1, P231; Wragg A, 2008, J MOL MED, V86, P1221, DOI 10.1007/s00109-008-0390-7; Yanagida H, 2009, J BIOSCI BIOENG, V108, P235, DOI 10.1016/j.jbiosc.2009.04.003; Yau TM, 2005, CIRCULATION, V112, pI123, DOI 10.1161/CIRCULATIONAHA.104.525147; Zhang G, 2008, TISSUE ENG PT A, V14, P1025, DOI 10.1089/ten.tea.2007.0289; Zhuang ZW, 2006, RADIOLOGY, V240, P698, DOI 10.1148/radiol.2403050976	56	52	52	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35199	10.1371/journal.pone.0035199	http://dx.doi.org/10.1371/journal.pone.0035199			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529991	gold, Green Published, Green Submitted			2022-12-27	WOS:000305350600067
J	Bid, HK; Oswald, D; Li, CL; London, CA; Lin, JY; Houghton, PJ				Bid, Hemant K.; Oswald, Duane; Li, Chenglong; London, Cheryl A.; Lin, Jiayuh; Houghton, Peter J.			Anti-Angiogenic Activity of a Small Molecule STAT3 Inhibitor LLL12	PLOS ONE			English	Article							PRECLINICAL TESTING PROGRAM; GROWTH-SUPPRESSIVE ACTIVITY; BREAST-CANCER CELLS; SIGNAL TRANSDUCER; ENDOTHELIAL-CELLS; ACTIVATOR; TRANSCRIPTION-3; OSTEOSARCOMA; EXPRESSION; TUMORS	Background: Recent data indicate the Signal Transducer and Activator of Transcription 3 (STAT3) pathway is required for VEGF production and angiogenesis in various types of cancers. STAT3 inhibitors have been shown to reduce tumor microvessel density in tumors but a direct anti-angiogenic activity has not been described. Methodology/Principal Findings: We investigated the direct action of a small molecule inhibitor of STAT3 (LLL12) in human umbilical cord vascular endothelial cells (HUVECs) in vitro, in a Matrigel model for angiogenesis in vivo, and its antitumor activity in a xenograft model of osteosarcoma. LLL12 (100 nM) significantly inhibited VEGF-stimulated STAT3 phosphorylation in HUVECs, reduced their proliferation/migration and inhibited VEGF-induced tube formation. Morphologic analysis of LLL12 treated HUVECs demonstrated marked changes in actin/tubulin distribution and bundling. In scid mice, LLL12 reduced microvessel invasion into VEGF-infused Matrigel plugs by similar to 90% at a dose of 5 mg/kg daily. Following a period of tumor progression (2 weeks), LLL12 completely suppressed further growth of established OS-1 osteosarcoma xenografts. Pharmacodynamic studies showed robust phosphorylated STAT3 in control tumors, whereas phospho-STAT3 was not detected in LLL12-treated OS-1 tumors. Treated tumors demonstrated decreased proliferation (Ki67 staining), and decreased microvessel density (CD34 staining), but no significant increase in apoptosis (TUNEL staining), relative to controls. Assay of angiogenic factors, using an antibody array, showed VEGF, MMP-9, Angiopoietin1/2, Tissue Factor and FGF-1 expression were dramatically reduced in LLL12-treated tumors compared to control tumors. Conclusions: These findings provide the first evidence that LLL12 effectively inhibits tumor angiogenesis both in vitro and in vivo.	[Bid, Hemant K.; Oswald, Duane; Lin, Jiayuh; Houghton, Peter J.] Nationwide Childrens Hosp, Ctr Childhood Canc, Columbus, OH USA; [Li, Chenglong] Ohio State Univ, Coll Pharm, Columbus, OH 43210 USA; [London, Cheryl A.] Ohio State Univ, Coll Vet Med, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Bid, HK (corresponding author), Nationwide Childrens Hosp, Ctr Childhood Canc, Columbus, OH USA.	Peter.Houghton@nationwidechildrens.org	London, Cheryl/E-6561-2012; Lin, Jiayuh/E-3515-2011; Li, Chenglong/E-7182-2010; Houghton, Peter/E-3265-2011	Li, Chenglong/0000-0003-3174-8719; 	Research Institute at Nationwide Children's Hospital; Ohio State University	Research Institute at Nationwide Children's Hospital(Ohio State University); Ohio State University(Ohio State University)	This work was supported by internal funds (start-up) from The Research Institute at Nationwide Children's Hospital, and a seed grant from Ohio State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018820; Bartoli M, 2003, FASEB J, V17, P1562, DOI 10.1096/fj.02-1084fje; Buettner R, 2002, CLIN CANCER RES, V8, P945; Chen CL, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-111; Chen Z, 2008, MED RES REV, V28, P185, DOI 10.1002/med.20101; Dechow TN, 2004, P NATL ACAD SCI USA, V101, P10602, DOI 10.1073/pnas.0404100101; Fossey SL, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-81; Hedvat M, 2009, CANCER CELL, V16, P487, DOI 10.1016/j.ccr.2009.10.015; Houghton PJ, 2007, PEDIATR BLOOD CANCER, V49, P928, DOI 10.1002/pbc.21078; Lai R, 2006, J PATHOL, V208, P624, DOI 10.1002/path.1941; Li WC, 2006, CLIN CANCER RES, V12, P7140, DOI 10.1158/1078-0432.CCR-06-0484; Lin L, 2010, CANCER RES, V70, P2445, DOI 10.1158/0008-5472.CAN-09-2468; Lin L, 2010, NEOPLASIA, V12, P39, DOI 10.1593/neo.91196; Maris JM, 2008, PEDIATR BLOOD CANCER, V51, P42, DOI 10.1002/pbc.21535; Maris JM, 2008, PEDIATR BLOOD CANCER, V50, P581, DOI 10.1002/pbc.21232; MEYER WH, 1990, CANCER RES, V50, P2781; Neale G, 2008, CLIN CANCER RES, V14, P4572, DOI 10.1158/1078-0432.CCR-07-5090; Niu GL, 2002, ONCOGENE, V21, P2000, DOI 10.1038/sj.onc.1205260; Osugi T, 2002, J BIOL CHEM, V277, P6676, DOI 10.1074/jbc.M108246200; Scehnet JS, 2009, BLOOD, V113, P254, DOI 10.1182/blood-2008-02-140020; Song H, 2005, P NATL ACAD SCI USA, V102, P4700, DOI 10.1073/pnas.0409894102; Teng TS, 2009, J CELL SCI, V122, P4150, DOI 10.1242/jcs.057109; Thaloor D, 1998, CELL GROWTH DIFFER, V9, P305; Verma NK, 2009, J BIOL CHEM, V284, P12349, DOI 10.1074/jbc.M807761200; Wei DY, 2003, ONCOGENE, V22, P319, DOI 10.1038/sj.onc.1206122; Yahata Y, 2003, J BIOL CHEM, V278, P40026, DOI 10.1074/jbc.M301866200	26	39	42	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e35513	10.1371/journal.pone.0035513	http://dx.doi.org/10.1371/journal.pone.0035513			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22530037	Green Submitted, gold, Green Published			2022-12-27	WOS:000305347400056
J	Armenteras, D; Retana, J				Armenteras, Dolors; Retana, Javier			Dynamics, Patterns and Causes of Fires in Northwestern Amazonia	PLOS ONE			English	Article							CLIMATE-CHANGE; INTERANNUAL VARIABILITY; SOUTH-AMERICA; DEFORESTATION; RAINFALL; FOREST; TRENDS; BRAZIL	According to recent studies, two widespread droughts occurred in the Amazon basin, one during 2005 and one during 2010. The drought increased the prevalence of climate-driven fires over most of the basin. Given the importance of human-atmosphere-vegetation interactions in tropical rainforests, these events have generated concerns over the vulnerability of this area to climate change. This paper focuses on one of the wettest areas of the basin, Northwestern Amazonia, where the interactions between the climate and fires are much weaker and where little is known about the anthropogenic drivers of fires. We have assessed the response of fires to climate over a ten-year period, and analysed the socio-economic and demographic determinants of fire occurrence. The patterns of fires and climate and their linkages in Northwestern Amazonia differ from the enhanced fire response to climate variation observed in the rest of Amazonia. The highest number of recorded fires in Northwestern Amazonia occurred in 2004 and 2007, and this did not coincide with the periods of extreme drought experienced in Amazonia in 2005 and 2010. Rather, during those years, Northwestern Amazonia experienced a relatively small numbers of fire hotspots. We have shown that fire occurrence correlated well with deforestation and was determined by anthropogenic drivers, mainly small-scale agriculture, cattle ranching (i.e., pastures) and active agricultural frontiers (including illegal crops). Thus, the particular climatic conditions for air convergence and rainfall created by proximity to the Andes, coupled with the presence of one of the most active colonisation fronts in the region, make this region differently affected by the general drought-induced fire patterns experienced by the rest of the Amazon. Moreover, the results suggest that, even in this wet region, humans are able to modify the frequency of fires and impact these historically well preserved forests.	[Armenteras, Dolors] Univ Nacl Colombia, Fac Sci, Dept Biol, Landscape Ecol & Ecosyst Modelling Lab, Bogota, Colombia; [Retana, Javier] Univ Autonoma Barcelona, CREAF, E-08193 Barcelona, Spain; [Retana, Javier] Univ Autonoma Barcelona, Unitat Ecol, E-08193 Barcelona, Spain	Universidad Nacional de Colombia; Autonomous University of Barcelona; Centro de Investigacion Ecologica y Aplicaciones Forestales (CREAF); University of Barcelona; Autonomous University of Barcelona	Armenteras, D (corresponding author), Univ Nacl Colombia, Fac Sci, Dept Biol, Landscape Ecol & Ecosyst Modelling Lab, Bogota, Colombia.	darmenterasp@unal.edu.co	Armenteras, Dolors/A-4000-2010; Retana, Javier/L-1214-2014	Armenteras, Dolors/0000-0003-0922-7298; Retana, Javier/0000-0002-7505-9467				Alencar AAC, 2004, ECOL APPL, V14, pS139; [Anonymous], 2006, EOS T AM GEOPHYS UNI, DOI DOI 10.1029/2006EO260001; [Anonymous], 1985, NAT CENS POP 1985 19; [Anonymous], 2005, NAT CENS POP 1985 19; [Anonymous], 1993, NAT CENS POP 1985 19; Aragao LEOC, 2008, PHILOS T R SOC B, V363, P1779, DOI 10.1098/rstb.2007.0026; Aragao LEOC, 2007, GEOPHYS RES LETT, V34, DOI [10.1029/2006GL028946., 10.1029/2006GL028946]; Armenteras D, 2006, ECOL INDIC, V6, P353, DOI 10.1016/j.ecolind.2005.03.014; Armenteras-Pascual D, 2011, AGR FOREST METEOROL, V151, P279, DOI 10.1016/j.agrformet.2010.11.002; Asner GP, 2010, NEW PHYTOL, V187, P569, DOI 10.1111/j.1469-8137.2010.03310.x; Bowman DMJS, 2009, SCIENCE, V324, P481, DOI 10.1126/science.1163886; Cochrane MA, 2003, NATURE, V421, P913, DOI 10.1038/nature01437; Davalos LM, 2011, ENVIRON SCI TECHNOL, V45, P1219, DOI 10.1021/es102373d; Etter A, 2005, FOREST ECOL MANAG, V208, P249, DOI 10.1016/j.foreco.2004.12.008; Giglio L, 2003, REMOTE SENS ENVIRON, V87, P273, DOI 10.1016/S0034-4257(03)00184-6; Giles J, 2006, NATURE, V442, P726, DOI 10.1038/442726c; IDEAM IGAC IAvH INVEMAR SINCHI IIAP, 2007, EC CONT COST MAR COL; Instituto de Hidrologia Meteorologia y Estudios Ambientales-IDEAM, 2011, MEM TECN CU IN PRESS; Kummerow C, 1998, J ATMOS OCEAN TECH, V15, P809, DOI 10.1175/1520-0426(1998)015<0809:TTRMMT>2.0.CO;2; Lewis SL, 2011, SCIENCE, V331, P554, DOI 10.1126/science.1200807; Li WH, 2008, PHILOS T R SOC B, V363, P1767, DOI 10.1098/rstb.2007.0022; Malhi Y, 2004, PHILOS T R SOC B, V359, P311, DOI 10.1098/rstb.2003.1433; Malhi Y, 2008, SCIENCE, V319, P169, DOI 10.1126/science.1146961; Malhi Y, 2009, P NATL ACAD SCI USA, V106, P20610, DOI 10.1073/pnas.0804619106; Marengo JA, 2008, PHILOS T R SOC B, V363, P1773, DOI 10.1098/rstb.2007.0015; Marengo JA, 1998, J GEOPHYS RES-ATMOS, V103, P1775, DOI 10.1029/97JD02551; MARENGO JA, 1992, INT J CLIMATOL, V12, P853, DOI 10.1002/joc.3370120808; Metzger JP, 2002, LANDSCAPE ECOL, V17, P419, DOI 10.1023/A:1021250306481; Morton DC, 2008, GLOBAL CHANGE BIOL, V14, P2262, DOI 10.1111/j.1365-2486.2008.01652.x; National Aeronautics and Space Administration, 2009, MONTHL 0 25 0 25 TRM; Poveda G, 2006, PALAEOGEOGR PALAEOCL, V234, P3, DOI 10.1016/j.palaeo.2005.10.031; Ray D, 2005, ECOL APPL, V15, P1664, DOI 10.1890/05-0404; Rodriguez N, 2012, BIOTROPICA, V44, P123, DOI 10.1111/j.1744-7429.2011.00770.x; Rudel TK, 2009, CONSERV BIOL, V23, P1396, DOI 10.1111/j.1523-1739.2009.01332.x; Silvestrini RA, 2011, ECOL APPL, V21, P1573, DOI 10.1890/10-0827.1; United Nations Office on Drugs and Crime, 2010, INT SYST ILL CROPS M; van der Werf GR, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB003122; Villar JCE, 2009, INT J CLIMATOL, V29, P1574, DOI 10.1002/joc.1791; Wassenaar T, 2007, GLOBAL ENVIRON CHANG, V17, P86, DOI 10.1016/j.gloenvcha.2006.03.007	40	21	22	2	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e35288	10.1371/journal.pone.0035288	http://dx.doi.org/10.1371/journal.pone.0035288			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523580	gold, Green Published			2022-12-27	WOS:000305345000052
J	Petrie, JR; Vanhercke, T; Shrestha, P; El Tahchy, A; White, A; Zhou, XR; Liu, Q; Mansour, MP; Nichols, PD; Singh, SP				Petrie, James R.; Vanhercke, Thomas; Shrestha, Pushkar; El Tahchy, Anna; White, Adam; Zhou, Xue-Rong; Liu, Qing; Mansour, Maged P.; Nichols, Peter D.; Singh, Surinder P.			Recruiting a New Substrate for Triacylglycerol Synthesis in Plants: The Monoacylglycerol Acyltransferase Pathway	PLOS ONE			English	Article							LYSOPHOSPHATIDIC ACID-PHOSPHATASE; DIACYLGLYCEROL ACYLTRANSFERASE; FUNCTIONAL-CHARACTERIZATION; ARABIDOPSIS-THALIANA; GENE; IDENTIFICATION; MGAT2; YEAST; SEEDS; BIOSYNTHESIS	Background: Monoacylglycerol acyltransferases (MGATs) are predominantly associated with lipid absorption and resynthesis in the animal intestine where they catalyse the first step in the monoacylglycerol (MAG) pathway by acylating MAG to form diacylglycerol (DAG). Typical plant triacylglycerol (TAG) biosynthesis routes such as the Kennedy pathway do not include an MGAT step. Rather, DAG and TAG are synthesised de novo from glycerol-3-phosphate (G-3-P) by a series of three subsequent acylation reactions although a complex interplay with membrane lipids exists. Methodology/Principal Findings: We demonstrate that heterologous expression of a mouse MGAT acyltransferase in Nicotiana benthamiana significantly increases TAG accumulation in vegetative tissues despite the low levels of endogenous MAG substrate available. In addition, DAG produced by this acyltransferase can serve as a substrate for both native and coexpressed diacylglycerol acyltransferases (DGAT). Finally, we show that the Arabidopsis thaliana GPAT4 acyltransferase can produce MAG in Saccharomyces cerevisiae using oleoyl-CoA as the acyl-donor. Conclusions/Significance: This study demonstrates the concept of a new method of increasing oil content in vegetative tissues by using MAG as a substrate for TAG biosynthesis. Based on in vitro yeast assays and expression results in N. benthamiana, we propose that co-expression of a MAG synthesising enzyme such as A. thaliana GPAT4 and a MGAT or bifunctional M/DGAT can result in DAG and TAG synthesis from G-3-P via a route that is independent and complementary to the endogenous Kennedy pathway and other TAG synthesis routes.	[Petrie, James R.; Shrestha, Pushkar; El Tahchy, Anna; White, Adam; Liu, Qing; Mansour, Maged P.; Nichols, Peter D.; Singh, Surinder P.] CSIRO Food Futures Natl Res Flagship, Canberra, ACT, Australia; [Vanhercke, Thomas; Zhou, Xue-Rong] CSIRO Plant Ind, Canberra, ACT, Australia; [Mansour, Maged P.; Nichols, Peter D.] CSIRO Marine & Atmospher Res, Hobart, Tas, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Petrie, JR (corresponding author), CSIRO Food Futures Natl Res Flagship, Canberra, ACT, Australia.	surinder.singh@csiro.au	Zhou, Xue-Rong/D-4706-2009; singh, surinder/C-9528-2009; El Tahchy, Anna/AAE-8701-2022; Nichols, Peter D/C-5128-2011; Petrie, James R/D-4598-2009; Vanhercke, Thomas/B-6647-2011; tahchy, Anna El/B-6997-2012; Shrestha, Pushkar/A-2728-2010; Liu, Qing/A-1395-2010	Zhou, Xue-Rong/0000-0003-3717-2984; singh, surinder/0000-0003-4488-8147; Petrie, James R/0000-0002-5892-798X; Vanhercke, Thomas/0000-0003-1397-7622; Shrestha, Pushkar/0000-0001-9642-6636; Liu, Qing/0000-0001-6617-6859; Belide, Srinivas/0000-0001-9536-8200; , Maged/0000-0002-4646-8472	CSIRO	CSIRO(Commonwealth Scientific & Industrial Research Organisation (CSIRO))	The authors are all employees of the funder of the study, CSIRO. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Athenstaedt K, 2011, EUR J LIPID SCI TECH, V113, P1188, DOI 10.1002/ejlt.201100051; Bates PD, 2007, J BIOL CHEM, V282, P31206, DOI 10.1074/jbc.M705447200; Bates PD, 2009, PLANT PHYSIOL, V150, P55, DOI 10.1104/pp.109.137737; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bouvier-Nave P, 2000, EUR J BIOCHEM, V267, P85, DOI 10.1046/j.1432-1327.2000.00961.x; Cao JS, 2007, J LIPID RES, V48, P583, DOI 10.1194/jlr.M600331-JLR200; Cao JS, 2003, J BIOL CHEM, V278, P25657, DOI 10.1074/jbc.M302835200; Cao JS, 2003, J BIOL CHEM, V278, P13860, DOI 10.1074/jbc.M300139200; Carrasco S, 2007, TRENDS BIOCHEM SCI, V32, P27, DOI 10.1016/j.tibs.2006.11.004; Chibalin AV, 2008, CELL, V132, P375, DOI 10.1016/j.cell.2007.12.035; Heier C, 2010, BBA-MOL CELL BIOL L, V1801, P1063, DOI 10.1016/j.bbalip.2010.06.001; HIRAYAMA O, 1965, AGR BIOL CHEM TOKYO, V29, P1; Igal RA, 2001, J LIPID RES, V42, P88; James CN, 2010, P NATL ACAD SCI USA, V107, P17833, DOI 10.1073/pnas.0911359107; KENNEDY EP, 1961, FED PROC, V20, P934; LAKSHMINARAYANA G, 1984, J AM OIL CHEM SOC, V61, P1249, DOI 10.1007/BF02636264; Lu CF, 2009, P NATL ACAD SCI USA, V106, P18837, DOI 10.1073/pnas.0908848106; PANEKINA T V, 1978, Chemistry of Natural Compounds (English Translation of Khimiya Prirodnykh Soedinenii), V14, P33, DOI 10.1007/BF00565871; Parthibane V, 2012, J BIOL CHEM, V287, P1946, DOI 10.1074/jbc.M111.309955; PERRY HJ, 1993, PHYTOCHEMISTRY, V33, P329, DOI 10.1016/0031-9422(93)85512-P; Rani SH, 2010, J BIOL CHEM, V285, P38337, DOI 10.1074/jbc.M110.133116; Reddy VS, 2008, J BIOL CHEM, V283, P8846, DOI 10.1074/jbc.M706752200; Reddy VS, 2010, BBA-MOL CELL BIOL L, V1801, P455, DOI 10.1016/j.bbalip.2009.12.005; Sandager L, 2002, J BIOL CHEM, V277, P6478, DOI 10.1074/jbc.M109109200; Stobart K, 1997, PLANTA, V203, P58, DOI 10.1007/s004250050165; Tumaney AW, 2001, J BIOL CHEM, V276, P10847, DOI 10.1074/jbc.M100005200; Vega-Sanchez ME, 2010, CURR OPIN BIOTECH, V21, P218, DOI 10.1016/j.copbio.2010.02.002; Vogel G, 1996, PLANT PHYSIOL, V110, P923, DOI 10.1104/pp.110.3.923; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Weselake RJ, 2009, BIOTECHNOL ADV, V27, P866, DOI 10.1016/j.biotechadv.2009.07.001; Wood CC, 2009, PLANT BIOTECHNOL J, V7, P914, DOI 10.1111/j.1467-7652.2009.00453.x; Yang WL, 2010, P NATL ACAD SCI USA, V107, P12040, DOI 10.1073/pnas.0914149107; Yen CLE, 2003, J BIOL CHEM, V278, P18532, DOI 10.1074/jbc.M301633200; Yen CLE, 2002, P NATL ACAD SCI USA, V99, P8512, DOI 10.1073/pnas.132274899; Zheng ZF, 2001, J BIOL CHEM, V276, P41710, DOI 10.1074/jbc.M104749200; Zhou XR, 2011, J BIOL CHEM, V286, P43644, DOI 10.1074/jbc.M111.266114	36	122	160	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e35214	10.1371/journal.pone.0035214	http://dx.doi.org/10.1371/journal.pone.0035214			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	23145108	Green Published, gold, Green Submitted			2022-12-27	WOS:000305345000048
J	Liao, MZ; Nie, XJ; Pan, RJ; Wang, CX; Ruan, SM; Zhang, CQ; Kang, DM; Fu, JH; Qian, YS; Tao, XR; Zhao, JK				Liao, Meizhen; Nie, Xijuan; Pan, Rongjian; Wang, Chuangxin; Ruan, Shiman; Zhang, Changqing; Kang, Dianming; Fu, Jihua; Qian, Yuesheng; Tao, Xiaorun; Zhao, Jinkou			Consistently Low Prevalence of Syphilis among Female Sex Workers in Jinan, China: Findings from Two Consecutive Respondent Driven Sampling Surveys	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED-DISEASES; HUMAN-IMMUNODEFICIENCY-VIRUS; METHAMPHETAMINE USE; HIV PREVALENCE; RISK; MEN; INFECTION; PROVINCE; TRIAL	Background: Routine surveillance using convenient sampling found low prevalence of HIV and syphilis among female sex workers in China. Two consecutive surveys using respondent driven sampling were conducted in 2008 and 2009 to examine the prevalence of HIV and syphilis among female sex workers in Jinan, China. Methods: A face-to-face interview was conducted to collect demographic, behavioral and service utilization information using a structured questionnaire. Blood samples were drawn for serological tests of HIV-1 antibody and syphilis antibody. Respondent Driven Sampling Analysis Tool was used to generate population level estimates. Results: In 2008 and in 2009, 363 and 432 subjects were recruited and surveyed respectively. Prevalence of syphilis was 2.8% in 2008 and 2.2% in 2009, while no HIV case was found in both years. Results are comparable to those from routine sentinel surveillance system in the city. Only 60.8% subjects in 2008 and 48.3% in 2009 reported a consistent condom use with clients during the past month. Over 50% subjects had not been covered by any HIV-related services in the past year, with only 15.6% subjects in 2008 and 13.1% in 2009 ever tested for HIV. Conclusions: Despite the low prevalence of syphilis and HIV, risk behaviors are common. Targeted interventions to promote the safe sex and utilization of existing intervention services are still needed to keep the epidemic from growing.	[Liao, Meizhen; Kang, Dianming; Fu, Jihua; Qian, Yuesheng; Tao, Xiaorun] Shandong Prov Ctr Dis Control & Prevent, Inst AIDS STD Control & Prevent, Jinan, Shandong Provin, Peoples R China; [Nie, Xijuan; Pan, Rongjian; Wang, Chuangxin] Licheng Dist Ctr Dis Control & Prevent, Inst AIDS STD Control & Prevent, Jinan, Shandong Provin, Peoples R China; [Ruan, Shiman; Zhang, Changqing] Jinan Municipal Ctr Dis Control & Prevent, Inst AIDS STD Control & Prevent, Jinan, Shandong Provin, Peoples R China; [Zhao, Jinkou] Global Fund Fight AIDS TB & Malaria, Monitoring & Evaluat Unit, Geneva, Switzerland		Liao, MZ (corresponding author), Shandong Prov Ctr Dis Control & Prevent, Inst AIDS STD Control & Prevent, Jinan, Shandong Provin, Peoples R China.	jinkou.zhao@theglobalfund.org	Yang, Xiaobo/G-3854-2016; Zhang, Youjie/F-7346-2016	Zhang, Youjie/0000-0002-6035-8536; mo, zengnan/0000-0002-3047-3138; Zhao, Jinkou/0000-0001-9184-3385	China-US cooperation on HIV prevention and care	China-US cooperation on HIV prevention and care	This work was supported by the China-US cooperation on HIV prevention and care. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, 2011 EST HIV AIDS EP; Brown T, 2004, SEX TRANSM INFECT, V80, DOI 10.1136/sti.2004.010165; Chapman J, 2008, SEX HEALTH, V5, P291, DOI 10.1071/SH07057; China CDC, 2011, NAT BEH BIOL SURV RE; China-CDC, 2009, NAT GUID DET HIV AID; Chow EPF, 2011, SEX TRANSM DIS, V38, P845, DOI 10.1097/OLQ.0b013e31821a4f43; Cohen J, 2004, SCIENCE, V304, P1934, DOI 10.1126/science.304.5679.1934; Colfax G, 2006, CLIN INFECT DIS, V42, P1463, DOI 10.1086/503259; Fu JH, 2009, CHIN J PUBLIC HLTH, V25, P1004; Goel S, 2009, STAT MED, V28, P2202, DOI 10.1002/sim.3613; Heimer R, 2005, AIDS BEHAV, V9, P403, DOI 10.1007/s10461-005-9030-1; Johnston LG, 2006, J URBAN HEALTH, V83, pI16, DOI 10.1007/s11524-006-9099-5; Kamb ML, 1998, JAMA-J AM MED ASSOC, V280, P1161, DOI 10.1001/jama.280.13.1161; Kang DM, 2011, AIDS CARE, V23, P26, DOI 10.1080/09540121.2011.560930; Li Y, 2010, JAIDS-J ACQ IMM DEF, V53, pS48, DOI 10.1097/QAI.0b013e3181c7d72f; Liao MZ, 2011, SEX TRANSM DIS, V38, P57, DOI 10.1097/OLQ.0b013e3181ebb475; Liu HJ, 2009, AIDS BEHAV, V13, P652, DOI 10.1007/s10461-008-9475-0; Ma X, 2007, J ACQ IMMUN DEF SYND, V45, P581; Magnani R, 2005, AIDS, V19, pS67, DOI 10.1097/01.aids.0000172879.20628.e1; Pascom AR, 2010, BRAZ J INFECT DIS, V14, P385, DOI 10.1590/S1413-86702010000400014; Potula R, 2008, AM J PATHOL, V172, P1467, DOI 10.2353/ajpath.2008.080130; Rou KM, 2007, AIDS, V21, pS95, DOI 10.1097/01.aids.0000304703.77755.c7; Ruan SM, 2008, AIDS BEHAV, V12, P469, DOI 10.1007/s10461-008-9361-9; Ruan SM, 2009, AIDS BEHAV, V13, P671, DOI 10.1007/s10461-009-9567-5; Scorgie F, 2011, AIDS BEHAV IN PRESS; Shandong Provincial CDC, 2010, COMPR REP HIV AIDS S; Shandong Provincial CDC, 2011, COMPR REP HIV AIDS S; Stormer A, 2006, J URBAN HEALTH, V83, pI73, DOI 10.1007/s11524-006-9105-y; Tabet S, 2002, AIDS, V16, P1271, DOI 10.1097/00002030-200206140-00010; UNODC, 2008, 2008 WORLD DRUG REP; van den Hoek A, 2001, AIDS, V15, P753, DOI 10.1097/00002030-200104130-00011; Wang Lan, 2009, Zhonghua Yu Fang Yi Xue Za Zhi, V43, P1009; Wang Y, 2009, AIDS BEHAV, V13, P866, DOI 10.1007/s10461-008-9446-5; World Health Organization, 2000, 2 GEN SURV HIV NEXT; Wu ZY, 2006, SCIENCE, V312, P1475, DOI 10.1126/science.1120682; Yang HM, 2005, SEX TRANSM DIS, V32, P270, DOI 10.1097/01.olq.0000162360.11910.5a; Yang XS, 2006, AIDS EDUC PREV, V18, P333, DOI 10.1521/aeap.2006.18.4.333	37	30	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e34085	10.1371/journal.pone.0034085	http://dx.doi.org/10.1371/journal.pone.0034085			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UP	22737230	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341000007
J	Liao, M; Huang, XH; Gao, Y; Tan, AH; Lu, Z; Wu, CL; Zhang, YJ; Yang, XB; Zhang, HY; Qin, X; Mo, ZN				Liao, Ming; Huang, Xianghua; Gao, Yong; Tan, Aihua; Lu, Zheng; Wu, Chunlei; Zhang, Youjie; Yang, Xiaobo; Zhang, Haiying; Qin, Xue; Mo, Zengnan			Testosterone Is Associated with Erectile Dysfunction: A Cross-Sectional Study in Chinese Men	PLOS ONE			English	Article							AGE-RELATED DECLINE; SEX-HORMONE LEVELS; AREA MALE HEALTH; RISK-FACTORS; INTERNATIONAL INDEX; ANDROGEN DEFICIENCY; METABOLIC SYNDROME; PHYSICAL-ACTIVITY; PREVALENCE; SYMPTOMS	Background: Testosterone is essential for the regulation of erectile physiology, but the relationship between low testosterone and erectile dysfunction (ED) has not been firmly established. Purpose: To examine the association between serum total, free and bio-available testosterone and ED in a population-based sample. Methods: A consecutive series of 1776 men aged 20-77 participated in the routine physical examination from September 2009 to December 2009 in Guangxi, China. ED was assessed using the five-item International Index of Erectile Function (IIEF-5) questionnaire. Total testosterone (TT), sex hormone binding globulin (SHBG) and other biochemical profiles were measured. Free testosterone (FT) and bio-available testosterone (BT) were calculated based on Vermeulen's formula. Data were collected with regard to smoking, alcoholic drinking, physical activity and metabolic syndrome. Results: The prevalence of ED (IIEF-5<22) was 47.6%. Men with ED were significantly older, and more prone to smoke cigarettes (>= 20 cigarettes/day) or drink alcohol (>= 3 drinks/week), and more likely to have elevated blood pressure (P = 0.036) or hyperglycemia (P < 0.001) compared with those without ED. The significant increase in SHBG with age was parallel to its increase with increasing severity of ED (P < 0.001). The obscure increase in TT across the ED status was detected without significance (P = 0.418), but TT was positively associated with ED after adjustment for age [odds ratio (OR) = 1.02, 95% CI (confidence internal): 1.00-1.04]. FT and BT were inversely associated with ED (OR = 0.14, 95% CI: 0.06-0.33; OR = 0.92 (95% CI: 0.89-0.96, respectively) in the univariate analysis, and this inverse association appeared to be independent of smoking status, alcoholic drinking, physical activity, hyper-triglyceridemia and hyperglycemia. Conclusions: FT and BT are inversely related to worsening ED, whereas the positive association between TT and ED is most likely due to the increase in SHBG.	[Liao, Ming; Gao, Yong; Lu, Zheng; Wu, Chunlei; Zhang, Youjie; Mo, Zengnan] Guangxi Med Univ, Affiliated Hosp 1, Inst Urol & Nephrol, Nanning, Guangxi Zhuang, Peoples R China; [Liao, Ming; Huang, Xianghua; Gao, Yong; Tan, Aihua; Lu, Zheng; Wu, Chunlei; Zhang, Youjie; Yang, Xiaobo; Zhang, Haiying; Qin, Xue; Mo, Zengnan] Guangxi Med Univ, Ctr Genom & Personalized Med, Nanning, Guangxi Zhuang, Peoples R China; [Tan, Aihua] Guangxi Med Univ, Affiliated Hosp 1, Ctr Metab Dis & Diabet, Nanning, Guangxi Zhuang, Peoples R China; [Yang, Xiaobo; Zhang, Haiying] Guangxi Med Univ, Sch Publ Hlth, Dept Occupat Hlth & Environm Hlth, Nanning, Guangxi Zhuang, Peoples R China; [Qin, Xue] Guangxi Med Univ, Affiliated Hosp 1, Dept Clin Lab, Nanning, Guangxi Zhuang, Peoples R China; [Gao, Yong] Fudan Univ, Sch Life Sci, Fudan VARI Ctr Genet Epidemiol, Shanghai 200433, Peoples R China; [Huang, Xianghua] Guigang Peoples Hosp, Dept Urol, Guigang, Guangxi Zhuang, Peoples R China	Guangxi Medical University; Guangxi Medical University; Guangxi Medical University; Guangxi Medical University; Guangxi Medical University; Fudan University	Liao, M (corresponding author), Guangxi Med Univ, Affiliated Hosp 1, Inst Urol & Nephrol, Nanning, Guangxi Zhuang, Peoples R China.	zengnanmo@hotmail.com	Yang, Xiaobo/G-3854-2016; Zhang, Youjie/F-7346-2016	Zhang, Youjie/0000-0002-6035-8536; mo, zengnan/0000-0002-3047-3138; Zhao, Jinkou/0000-0001-9184-3385	National Natural Science Foundation of China [30945204]; Provincial departments of Finance and Education, Guangxi Zhuang Autonomous Region, China [2009GJCJ150]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Provincial departments of Finance and Education, Guangxi Zhuang Autonomous Region, China	The work described in this article is supported by grants from the National Natural Science Foundation of China (Grant No. 30945204) and the Provincial departments of Finance and Education, Guangxi Zhuang Autonomous Region, China (Grant No. 2009GJCJ150). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn HS, 2002, BJU INT, V89, P526, DOI 10.1046/j.1464-410X.2002.02650.x; Grundy Scott M, 2005, Crit Pathw Cardiol, V4, P198; Araujo AB, 2007, J CLIN ENDOCR METAB, V92, P4241, DOI 10.1210/jc.2007-1245; Armagan A, 2006, J ANDROL, V27, P517, DOI 10.2164/jandrol.05157; Bai Q, 2004, ASIAN J ANDROL, V6, P343; Basar MM, 2005, UROLOGY, V66, P597, DOI 10.1016/j.urology.2005.03.060; Bhasin S, 2010, J CLIN ENDOCR METAB, V95, P2536, DOI 10.1210/jc.2009-2354; Christensen BS, 2011, J SEX MED, V8, P1903, DOI 10.1111/j.1743-6109.2011.02291.x; Chughtai B, 2011, CURR OPIN UROL, V21, P514, DOI 10.1097/MOU.0b013e32834b8681; Corona G, 2004, INT J IMPOT RES, V16, P395, DOI 10.1038/sj.ijir.3901225; Corona G, 2009, INT J ANDROL, V32, P720, DOI 10.1111/j.1365-2605.2009.00952.x; Corona G, 2010, J SEX MED, V7, P1362, DOI 10.1111/j.1743-6109.2009.01601.x; Corona G, 2010, J SEX MED, V7, P182, DOI 10.1111/j.1743-6109.2009.01497.x; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; DAMASSA DA, 1977, HORM BEHAV, V8, P275, DOI 10.1016/0018-506X(77)90002-2; FELDMAN HA, 1994, J UROLOGY, V151, P54, DOI 10.1016/S0022-5347(17)34871-1; Fisher AD, 2009, J SEX MED, V6, P866, DOI 10.1111/j.1743-6109.2008.01140.x; Gades NM, 2008, J SEX MED, V5, P2209, DOI 10.1111/j.1743-6109.2008.00924.x; Golden SH, 2009, J CLIN ENDOCR METAB, V94, P1853, DOI 10.1210/jc.2008-2291; Gooren LJG, 1996, BRIT J UROL, V78, P763, DOI 10.1046/j.1464-410X.1996.05918.x; Grover SA, 2006, ARCH INTERN MED, V166, P213, DOI 10.1001/archinte.166.2.213; Hao ZY, 2011, J ANDROL, V32, P496, DOI 10.2164/jandrol.110.012138; Isidori AM, 2005, CLIN ENDOCRINOL, V63, P381, DOI 10.1111/j.1365-2265.2005.02350.x; Kocoglu H, 2011, AGING MALE, V14, P207, DOI 10.3109/13685538.2011.617798; Kupelian V, 2007, EUR UROL, V52, P416, DOI 10.1016/j.eururo.2007.03.015; Kupelian V, 2010, PREV MED, V50, P19, DOI 10.1016/j.ypmed.2009.11.006; Lee ACK, 2010, INT J IMPOT RES, V22, P272, DOI 10.1038/ijir.2010.15; Lee JC, 2011, BJU INT, V107, P956, DOI 10.1111/j.1464-410X.2010.09691.x; Lu Z, 2012, PROSTATE, V72, P193, DOI 10.1002/pros.21421; Ly LP, 2010, CLIN ENDOCRINOL, V73, P382, DOI 10.1111/j.1365-2265.2010.03804.x; Muezzinoglu T, 2007, YONSEI MED J, V48, P1015, DOI 10.3349/ymj.2007.48.6.1015; O'Connor DB, 2011, J CLIN ENDOCR METAB, V96, pE1577, DOI 10.1210/jc.2010-2216; Ohlsson C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002313; Rhoden EL, 2002, INT J IMPOT RES, V14, P167, DOI 10.1038/sj.ijir.3900852; Rhoden EL, 2002, J UROLOGY, V167, P1745, DOI 10.1016/S0022-5347(05)65191-9; Rosen RC, 1999, INT J IMPOT RES, V11, P319, DOI 10.1038/sj.ijir.3900472; Rosner W, 2007, J CLIN ENDOCR METAB, V92, P405, DOI 10.1210/jc.2006-1864; Shiels MS, 2009, CANCER CAUSE CONTROL, V20, P877, DOI 10.1007/s10552-009-9318-y; Tan AH, 2011, METABOLISM, V60, P1186, DOI 10.1016/j.metabol.2011.01.002; Traish AM, 2007, EUR UROL, V52, P54, DOI 10.1016/j.eururo.2007.02.034; Traish AM, 2006, J SEX MED, V3, P382, DOI 10.1111/j.1743-6109.2006.00245.x; Tsujimura A, 2003, J UROLOGY, V170, P2345, DOI 10.1097/01.ju.0000089768.17091.c0; Vermeulen A, 1999, J CLIN ENDOCR METAB, V84, P3666, DOI 10.1210/jc.84.10.3666; VERMEULEN A, 1993, ANN MED, V25, P531; Wu CL, 2011, J ANDROL, V33, P59, DOI 10.2164/jandrol.110.012542; Wu FCW, 2010, NEW ENGL J MED, V363, P123, DOI 10.1056/NEJMoa0911101	46	30	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e39234	10.1371/journal.pone.0039234	http://dx.doi.org/10.1371/journal.pone.0039234			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KY	22737230	Green Published, gold, Green Submitted			2022-12-27	WOS:000305695100028
